entity,author,overall_polarity
 ‚öï Ô∏è Scientists,Hematopoiesis News,Negative
 Phase II study,Hematopoiesis News,Negative
 acalabrutinib,Hematopoiesis News,Negative
 acalabrutinib,Lymphoma Hub,Positive
 acalabrutinib,Helen Oram,Negative
 acalabrutinib,Paperbirds_Hematology,Positive
 acalabrutinib,Cardio-Targets,Positive
 acalabrutinib,Lymphoma Papers,Positive
 acalabrutinib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 acalabrutinib,Medivizor,Positive
 acalabrutinib,OncLive.com,Positive
 acalabrutinib,Toby Eyre,Negative
 acalabrutinib,Benlazar S.M Amin√©,Negative
 acalabrutinib,"Joseph Cioccio, DO",Negative
 acalabrutinib,Trip Database,Negative
 acalabrutinib,NICE,Positive
 acalabrutinib,Colin Cesvette,Positive
 acalabrutinib,European Pharmaceutical Review,Positive
 acalabrutinib,OncLive SOSS,Positive
 acalabrutinib,Economic Times,Positive
 acalabrutinib,Mango News,Positive
 acalabrutinib,Cancer Review,Positive
 acalabrutinib,Cancer Update,Positive
 acalabrutinib,Cancer Research News,Positive
 acalabrutinib,HemOnc Today,Negative
 acalabrutinib,Targeted Oncology,Positive
 acalabrutinib,"Steven Artandi, MD, PhD",Negative
 acalabrutinib,OncologyNurseAdvisor,Negative
 acalabrutinib,Hematology Advisor,Positive
 acalabrutinib,CancerTherapyAdvisor,Positive
 acalabrutinib,MD Anderson Cancer Center,Negative
 acalabrutinib,Vinay Prasad MD MPH,Positive
 acalabrutinib,Apostz,Positive
 acalabrutinib,Medical News Bulletin,Positive
 acalabrutinib,WCM Englander Institute for Precision Medicine,Positive
 acalabrutinib,Andreas Charalambous,Positive
 acalabrutinib,The Cancer Letter,Negative
 acalabrutinib,iflyplaces,Positive
 acalabrutinib,Investor News,Negative
 acalabrutinib,WCM Lymphoma,Positive
 acalabrutinib,Stray,Positive
 acalabrutinib,Matt Willemsen,Positive
 acalabrutinib,Victoria Recche,Positive
 acalabrutinib,delthia ricks üî¨,Positive
 acalabrutinib,Mr Graham,Positive
 acalabrutinib,NatureRevClinOncol,Positive
 acalabrutinib,joewhitworth,Positive
 acalabrutinib,Taylor & Francis Medicine and Health,Positive
 acalabrutinib,Dr. Andy Evens,Negative
 acalabrutinib,Chan Cheah,Positive
 acalabrutinib,PressReleasePoint,Negative
 acalabrutinib,TAP Clinical Trial Network,Negative
 acalabrutinib,Oncology Learning Network,Negative
 acalabrutinib,Renal Cell Carcinoma,Positive
 acalabrutinib,VJHemOnc,Negative
 acalabrutinib,ClinicalOncologyNews,Negative
 acalabrutinib,Lysa Lymphoma,Positive
 acalabrutinib,Tim Fenske,Negative
 acalabrutinib,The Lancet Haematology,Negative
 acalabrutinib,Paul D. Rennert,Positive
 acalabrutinib,COPD News,Negative
 acalabrutinib,"Kelly Norsworthy, MD",Positive
 acalabrutinib,"Amber Koehler, PA-C",Positive
 acalabrutinib,ASH Clinical News,Negative
 acalabrutinib,Sigrid Sk√•nland,Negative
 acalabrutinib,Lung Cancer News,Positive
 acalabrutinib,Chocolatiere Phys,Negative
 acalabrutinib,Vijaya L,Positive
 acalabrutinib,SHM,Positive
 acalabrutinib,ALI ALAHMARI.,Negative
 acalabrutinib,MDEdge,Negative
 acalabrutinib,MDedge Hematology & Oncology,Negative
 acalabrutinib,FlatBio,Negative
 acalabrutinib,"Junaid ""Jay"" Abdulghani, MD PhD",Positive
 acalabrutinib,Cancer News,Positive
 acalabrutinib,Pharm Digest,Negative
 acalabrutinib,The Oncologist,Negative
 acalabrutinib,"Kelley D. Carlstrom, PharmD, BCOP",Positive
 acalabrutinib,OncoPharm,Positive
 acalabrutinib,Lisa Astor,Negative
 acalabrutinib,Verdi Oncology,Positive
 acalabrutinib,LymphomaAction,Negative
 acalabrutinib,"Mazyar Shadman, MD MPH",Negative
 acalabrutinib,Mazen M,Negative
 acalabrutinib,Crwe World,Positive
 acalabrutinib,Latest News from Business Wire,Negative
 acalabrutinib,"chadi nabhan MD, MBA, FACP",Negative
 acalabrutinib,Clarivate Cortellis,Positive
 acalabrutinib,EurekaMag,Negative
 acalabrutinib,Anthony Mato,Positive
 acalabrutinib,Ed,Positive
 acalabrutinib,CCO Oncology,Positive
 acalabrutinib,WCMNYPJCTO,Negative
 acalabrutinib,minoti hiremath,Positive
 acalabrutinib,Mayo Clinic Cancer Center,Negative
 acalabrutinib,Lambda Kappa Sigma,Positive
 acalabrutinib,Financial Buzz,Negative
 acalabrutinib,ANTELLIS,Positive
 acalabrutinib,Business Wire-Health,Negative
 acalabrutinib,BusinessWireProducts,Negative
 acalabrutinib,Business Wire-TS,Negative
 acalabrutinib,BusinessWire-Science,Negative
 acalabrutinib,Stockboard Media Inc,Negative
 acalabrutinib,The Pharmaceutical Marketing Group,Negative
 acalabrutinib,NE Live,Negative
 acalabrutinib,"Matthew Matasar, MD",Positive
 acalabrutinib,Ahmad Halwani,Positive
 acalabrutinib,Josh Kunken,Positive
 acalabrutinib,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 acalabrutinib,Laura Nikolaides,Positive
 acalabrutinib,New Drug Approvals,Negative
 acalabrutinib,Drugs.com,Negative
 acalabrutinib,PharmaStar,Negative
 acalabrutinib,Simon Rule,Positive
 acalabrutinib,Pavan Anne,Positive
 acalabrutinib,"Michael Wang, MD",Negative
 acalabrutinib,Sally Church,Positive
 acalabrutinib,Salutedomani,Negative
 acalabrutinib,Hlthnews,Positive
 acalabrutinib,Farmacia Nenna,Positive
 acalabrutinib,SartoriusRoyston,Positive
 acalabrutinib,Pharmafocus,Positive
 acalabrutinib,Derma News OK,Positive
 acalabrutinib,saluteH24.com,Positive
 acalabrutinib,Antonio Caperna,Positive
 acalabrutinib,Share News,Positive
 acalabrutinib,AstraZenecaUS,Positive
 acalabrutinib,StockNews.com,Positive
 acalabrutinib,Briefing.com,Negative
 acalabrutinib,Sharecast.com,Positive
 acalabrutinib,Danvantri Farma,Positive
 acalabrutinib,Jacob Plieth,Negative
 acalabrutinib,TumorImmunoPapers,Negative
 acalabrutinib,Cure Cancer Now,Negative
 acalabrutinib,ComplexPharm,Positive
 acalabrutinib,"John P. Leonard, MD",Positive
 acalabrutinib,ACAFARMUR,Positive
 acalabrutinib,pharmabr,Negative
 acalabrutinib,Pharma Industry News,Positive
 acalabrutinib,Pharmaceutical Mkt,Positive
 acalabrutinib,Pharmaceutical News,Negative
 acalabrutinib,Drug Delivery News,Positive
 acalabrutinib,Sum,Positive
 acalabrutinib,karin55marin,Negative
 acalabrutinib,Knowsis Healthcare,Positive
 acalabrutinib,Healthcare Industry,Positive
 acalabrutinib,Maxx Mangusta,Positive
 patients,Hematopoiesis News,Negative
 patients,Lymphoma Hub,Positive
 patients,European Pharmaceutical Review,Positive
 patients,Amit Patelüá¨üáß,Positive
 patients,Blood Advances,Positive
 patients,Targeted Oncology,Positive
 patients,OncLive.com,Positive
 patients,Trip Database,Negative
 patients,Pharma News,Positive
 patients,1stOncology,Positive
 patients,Company News HQ,Positive
 patients,Cision News,Positive
 patients,CHItraders,Positive
 patients,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 patients,Gordon Gekko,Negative
 patients,Investor News,Negative
 patients,Breaking News,Negative
 patients,Hottest Stocks Now,Positive
 patients,Lynne Mac Lean,Positive
 patients,Paul Wright,Positive
 patients,Medivizor,Positive
 patients,"Amber Koehler, PA-C",Positive
 patients,„ÅÑ„Å§„ÇÇÊÇ©„Çì„Åß„Çã‰∫∫,Positive
 patients,BiopharmaAsia,Positive
 patients,Carlo Centemeri,Positive
 patients,Miguel Angel Grullon C.,Positive
 patients,WebWire,Negative
 patients,maybeawriter,Positive
 patients,Briefing.com,Positive
 patients,mednetnews,Negative
 patients,Daniel J Drucker,Positive
 patients,PressReleasePoint,Positive
 patients,FirstWord Pharma,Negative
 patients,Al Arabiya English,Positive
 patients,Bloomberg Australia,Positive
 patients,Bloomberg,Positive
 patients,gRttwit,Positive
 patients,Cancer Review,Positive
 patients,Cancer Update,Positive
 patients,Cancer Research News,Positive
 patients,TAP Clinical Trial Network,Positive
 patients,Specialty Pharmacy Continuum,Positive
 patients,"Narinder Grewal, MD",Positive
 patients,Anesthesiology News,Positive
 patients,Dr. Iv√°n R. Gonz√°lez,Positive
 patients,Medicine Matters oncology,Positive
 patients,Hematology Advisor,Positive
 patients,CONQUER the patient voice,Positive
 patients,CURE Magazine,Positive
 patients,InfectiousDiseaseSE,Positive
 patients,ClinicalOncologyNews,Negative
 patients,Pharmacy Practice News,Positive
 patients,Pete Afrasiabi,Positive
 patients,Jill Feldman,Positive
 patients,Om Prakash Sharma,Positive
 patients,ThePrint Science,Negative
 patients,Mohd wamique,Positive
 patients,seshutatikola,Positive
 patients,ThePrintIndia,Negative
 patients,Oncology Nursing News,Positive
 patients,Mark Sparta,Positive
 patients,"Mike Thompson, MD, PhD, FASCO",Positive
 patients,WCM Lymphoma,Positive
 patients,ahealthierphilly,Positive
 patients,hemomeeting,Negative
 patients,HLC,Positive
 patients,Clinical Cancer Research,Positive
 patients,McKesson Corporation,Positive
 patients,Randall Brenneman,Positive
 patients,Stephanie,Positive
 patients,GraniteShares Europe,Negative
 patients,SAFH,Positive
 patients,NASDAQ,Positive
 patients,Matt Willemsen,Positive
 patients,"John Damianos, M.D.",Positive
 patients,Benyam Muluneh,Positive
 patients,13WREX,Positive
 patients,Medicalnewser.com,Negative
 patients,denni üåº #evindekal #stayhome #restaacasa,Positive
 patients,Global Business Alliance,Positive
 patients,Living Safely,Negative
 patients,Journal of Clinical and Cellular Immunology,Positive
 patients,Firstpost,Positive
 patients,Roots Analysis,Negative
 patients,Bargad,Positive
 patients,delthia ricks üî¨,Positive
 patients,Amir Faisal,Positive
 patients,Deccan Herald,Positive
 patients,Roland Baker,Positive
 patients,Dr. Thomas Kloss,Positive
 patients,Josie B.,Positive
 patients,DelveInsight,Positive
 patients,The Cancer Letter,Negative
 patients,Michael Rynne,Positive
 patients,"Dr T. Comeau , MD",Positive
 patients,Patient Power,Positive
 patients,I Am Biotech,Positive
 patients,Blood Journal,Positive
 patients,Ancora.ai Cancer Clinical Trials for All,Positive
 patients,Ned Pagliarulo,Positive
 patients,ExpPharma,Negative
 patients,"Raul Cordoba, MD, PhD",Positive
 patients,Benlazar S.M Amin√©,Positive
 patients,Aloysius Pendergast,Positive
 patients,OncLive SOSS,Positive
 patients,the paper link,Positive
 patients,Oncology Learning Network,Positive
 patients,Lymphoma Papers,Positive
 patients,Cure Cancer Now,Positive
 patients,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 patients,Renal Cell Carcinoma,Positive
 patients,Lia Palomba,Positive
 patients,NatureRevClinOncol,Positive
 patients,re-how.net,Positive
 patients,i3 Health,Positive
 patients,COPD News,Positive
 patients,Plexus Ventures,Positive
 patients,Philly Bio,Positive
 patients,ASH Clinical News,Positive
 patients,Lung Cancer News,Positive
 patients,TGA Australia,Negative
 patients,Chocolatiere Phys,Positive
 patients,CALQUENCE¬Æ (acalabrutinib),Negative
 patients,"Trustwell Law Group, LLP",Positive
 patients,Lisa Astor,Positive
 patients,Phil Talamo,Negative
 patients,Alan Skarbnik,Negative
 patients,LYMPHOMA & MYELOMA CONNECT,Positive
 patients,EurekaMag,Positive
 patients,CLL Society Inc.,Positive
 patients,Mois√©s Uriarte,Positive
 patients,markcl208041,Positive
 patients,Cancer News,Positive
 patients,The PMI (Pharmaceutical Managers' Institute),Positive
 patients,dyke on the loose ‚ò≠,Positive
 patients,Marcelo Bellesso üáßüá∑üë®‚Äçüë©‚Äçüëß‚Äçüëßüî¨üìöüé∏,Positive
 patients,MDedge Hematology & Oncology,Positive
 patients,"Alkis Papachristos, PharmD, PhD",Positive
 patients,Chan Cheah,Positive
 patients,minoti hiremath,Positive
 patients,Medscape Education,Positive
 patients,Mayo Clinic Cancer Center,Positive
 patients,ColumbiaCancer,Positive
 patients,Graham Collins,Negative
 patients,"Les Yonemoto, MD MBA",Positive
 patients,Simon Rule,Positive
 patients,Adam Feuerstein,Positive
 patients,Sue Mockus,Positive
 patients,timelivenews,Positive
 patients,Lymphoma Canada,Positive
 patients,Sheila A. Crowe,Positive
 patients,StockNews.com,Negative
 patients,Odi Bruckman,Positive
 patients,Dr. Andre Goy,Negative
 patients,Dr Musa Fares Alzahrani,Negative
 patients,Mike Ward,Positive
 patients,Marc Gozlan,Positive
 patients,knowmedge,Positive
 patients,Biotech2050,Positive
 patients,CLLSA,Positive
 patients,ECOG-ACRIN Cancer Research Group,Positive
 patients,"Tom Curley, MD",Positive
 patients,APSHO,Positive
 patients,JADPRO,Positive
 patients,Paperbirds_Hematology,Positive
 patients,noel cole,Positive
 patients,Jan Rynne,Positive
 patients,CMRO Journal,Positive
 patients,Dr. Liz Samander,Positive
 patients,SeattleCancerCareAlliance,Negative
 patients,Anthony Mato,Positive
 patients,HemaSphere_EHA,Positive
 patients,"chadi nabhan MD, MBA, FACP",Positive
 patients,donnashort,Positive
 patients,Patient Empowerment Network,Positive
 patients,Shouting at people in my underpants,Negative
 patients,UW Medicine Newsroom,Positive
 patients,CCO Infectious Disease,Positive
 patients,Erick Lansigan,Positive
 patients,HemOnc Today,Positive
 patients,KeiraSmith_i3Health,Positive
 patients,Lisa Palacios,Negative
 patients,Flatiron Health,Positive
 patients,CLL Ireland,Positive
 patients,EmatoInfo,Positive
 patients,Bristol Myers Squibb,Positive
 patients,Adam Kittai,Positive
 patients,CLL Advocates Network,Positive
 patients,InvestorsObserver,Positive
 patients,Research To Practice,Negative
 patients,Oncology CE,Positive
 patients,Sigrid Sk√•nland,Positive
 patients,Leukaemia Care,Positive
 patients,Toby Eyre,Positive
 patients,Vindico Medical Education,Positive
 patients,Barry Shrier,Positive
 patients,VJHemOnc,Positive
 patients,Talha Badar,Positive
 patients,HHF,Negative
 patients,Izaskun Zeberio,Positive
 patients,ImmuneGCPapers,Positive
 patients,Eduardo Flavio Oliveira Ribeiro,Negative
 patients,Mahmoud Aljurf,Positive
 patients,Journal of the @NCCN,Positive
 patients,OncologyNurseAdvisor,Positive
 patients,NIH NHLBI,Positive
 patients,Frontiers Immunology,Negative
 patients,Andrew Schorr,Positive
 patients,Oncology Publishers Feed,Negative
 patients,Biosimilar Today iMagazine,Negative
 patients,HEORO,Positive
 patients,MUVBBvirtual,Negative
 patients,DynaMed¬Æ,Positive
 patients,clonoSEQ,Positive
 patients,ASCO Publications,Negative
 patients,R√©my Dul√©ry,Positive
 patients,pathdoc3,Positive
 patients,RIOH,Positive
 patients,Esther Schorr,Positive
 patients,Karmanos Cancer Institute,Positive
 patients,Raffaella Ravinetto,Positive
 patients,MEI Pharma,Positive
 patients,Say It Forward,Positive
 patients,Joe,Negative
 patients,healthbook,Positive
 patients,Journal of Clinical Pathways,Negative
 patients,Biologics by McKesson,Negative
 patients,@URHemOncFellows,Positive
 patients,SpecialtyPTimes,Negative
 patients,JAMA Oncology,Positive
 patients,Dr. Andy Evens,Negative
 patients,ACS Journal Cancer,Positive
 patients,THE MUSIC üë•,Positive
 patients,"Ian McMillan, CMT",Positive
 patients,MyPathologyReport.ca,Positive
 patients,Dana-Farber,Positive
 patients,Adam Mead,Positive
 patients,M3 India Oncology,Positive
 patients,Jennifer Smith,Positive
 patients,Janssen EMEA,Positive
 patients,"Jill Lykon, PharmD, BCOP",Positive
 patients,IQVIA,Positive
 patients,Lymphoma Research Foundation,Positive
 patients,ASGCT,Positive
 patients,The ASCO Post,Negative
 patients,MDSUK PatientSupport üíô,Positive
 patients,ur-trading,Positive
 patients,PSK2329 - JHC,Positive
 patients,Quant Data,Positive
 patients,Vegastrader66,Positive
 patients,Scientific Data,Positive
 patients,The Tisch Cancer Institute,Positive
 patients,Cord Blood News,Negative
 patients,Paradigm Med Comm,Positive
 patients,RedMedEd,Negative
 patients,Matthew P. Cheng,Positive
 patients,Streetwise Reports,Positive
 patients,Life Sciences Report,Positive
 patients,CellworksLife,Positive
 patients,NCI Media Relations,Positive
 patients,Hematopoiesis,Positive
 patients,Danielle M. Brander,Positive
 patients,Taylor Lab UM,Positive
 patients,Cancer Papers,Positive
 patients,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 patients,JAMA,Negative
 patients,#Memory,Positive
 patients,ÿπŸÑŸä ÿπÿ®ÿØÿßŸÑŸÑŸá ÿßŸÑÿÆŸÑŸäŸÅÿ©,Positive
 patients,"Dr. Paul DeSantis, PharmD",Negative
 patients,Beacon Targeted Therapies,Positive
 patients,knowMRD,Positive
 patients,The Lancet Haematology,Positive
 patients,Natacha Bola√±os,Negative
 patients,NHLBI Bethesda Labs,Positive
 patients,Virtute_USMLE,Positive
 patients,Pearson Lab,Positive
 patients,"Conquer Cancer, the ASCO Foundation",Positive
 patients,AASM SleepTM,Positive
 patients,MDEdge,Positive
 patients,Cancer Support Community,Negative
 patients,Carlo Franzini,Negative
 patients,AbbVie US,Positive
 patients,Stock Sharks,Positive
 patients,"Pharmacyclics, an AbbVie Company",Positive
 patients,Kevin Wolcott,Positive
 patients,Tamar Aprahamian,Positive
 patients,Robert Z. Orlowski,Positive
 patients,Michele Nadeem-Baker,Positive
 patients,MD Anderson Cancer Center,Positive
 patients,MDedge Dermatology,Positive
 patients,Current Oncology,Negative
 patients,Expert Perspectives in Oncology,Positive
 patients,CancerTherapyAdvisor,Positive
 patients,Fredrik √ñhrn,Positive
 patients,Sarah Williams,Positive
 patients,Prof John,Positive
 patients,CIRM,Positive
 patients,PHRI Population Health Research Institute,Positive
 patients,Amy Paturel,Positive
 patients,ALI ALAHMARI.,Positive
 patients,Zack Pemberton-Whiteley,Positive
 patients,Razan Mohty,Positive
 patients,3PSolution,Negative
 patients,CancerEpiPapers,Negative
 patients,Icahn School of Medicine at Mount Sinai,Positive
 patients,SunAWARE,Positive
 patients,Casey Foster,Positive
 patients,Diagnostics News,Positive
 patients,The Patient's Channel,Positive
 patients,CenterForBiosimilars,Positive
 patients,Daniel Auclair,Positive
 patients,"Steven Artandi, MD, PhD",Negative
 patients,"Eduard Alberts, PhD",Positive
 patients,NCI Center for Cancer Research,Positive
 patients,Medscape Oncology,Positive
 patients,Stanford Medicine,Positive
 patients,Theresa (Clementi) Doan,Positive
 patients,Verastem Oncology,Positive
 patients,Katie Kosko,Positive
 patients,BlueBee,Negative
 patients,"Krizs√°n Szilvia, MD",Positive
 patients,David Panian,Positive
 patients,The James,Positive
 patients,Judith Trotman,Positive
 patients,PersonalizeAF,Positive
 patients,Charlotte Martin,Positive
 patients,MedPage Oncology,Negative
 patients,NEJM,Positive
 patients,NMDP/Be The Match Advocacy,Positive
 patients,the limbic,Negative
 patients,EMG GOLD,Positive
 patients,Snowdome Foundation,Positive
 patients,A Nasser Nourallah. MD.FASCO,Positive
 patients,"Maria Roussakis, MLT, MSc",Positive
 patients,iwCLL,Negative
 patients,flypapers,Positive
 patients,XpertDox,Positive
 patients,john randall,Positive
 patients,Dr Tony Truong,Positive
 patients,palliativewise,Positive
 patients,Milo≈° Miljkoviƒá,Positive
 patients,Mayo Clinic,Negative
 patients,Suvir Singh,Positive
 patients,Genentech,Negative
 patients,Cancer Frontline,Positive
 patients,Dr.Alberto Mussetti,Negative
 patients,Fred Hutch,Positive
 patients,OSU Psych Advising,Positive
 patients,BloodCancerCure,Positive
 patients,Andre Williams,Positive
 patients,ACCC,Positive
 patients,The Leukemia & Lymphoma Society,Negative
 patients,pharmaphorum,Negative
 patients,pocroncology,Positive
 patients,Halima,Positive
 patients,AplusA World,Negative
 patients,Lars M√∏rland Knudsen,Positive
 patients,Doctors*Overseas,Negative
 patients,SGHC,Positive
 patients,RTI Health Solutions,Positive
 patients,pseudomonaspapers,Positive
 patients,Rare Disease Report,Positive
 patients,Wilmot Cancer Institute,Positive
 patients,medwireNews,Positive
 patients,Nick,Positive
 patients,Haematology Peter MacCallum CC & Royal Melbourne,Positive
 patients,Joana Koury,Positive
 patients,AbbVie,Positive
 patients,MoJo,Positive
 patients,"W. Keith Hoots, M.D.",Negative
 patients,CLL_Fightersüéó,Positive
 patients,UCL Discovery,Negative
 patients,Hugo Cabrera,Positive
 patients,Guillermo Sanz,Positive
 patients,ASH,Positive
 patients,Solomon Kamal,Positive
 patients,Suzette Serving You!,Positive
 patients,Melanoma MRV,Positive
 patients,Melanoma On My Mind,Positive
 patients,Leukemia & Lymphoma Society Research,Positive
 patients,BioSpace,Positive
 patients,Elsevier Hematology,Positive
 patients,"Jose Sandoval S, MD FACP",Positive
 patients,NK cell Biology,Positive
 patients,NK papers,Positive
 patients,AllMedx Oncology,Positive
 patients,BCNI,Negative
 patients,MAISA,Positive
 patients,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 patients,VuMedi Oncology,Positive
 patients,Arjun D. Law,Positive
 patients,Anna Deveau,Positive
 patients,Dana-Farber News,Positive
 patients,Michael's Pharmacy,Positive
 patients,LymphomaAction,Negative
 patients,Carlos De la Torre,Positive
 patients,Lymphoma Coalition,Negative
 patients,Aitana,Positive
 patients,National Cancer Institute,Positive
 patients,Derriford Hospital,Positive
 patients,University Hospitals Plymouth NHS Trust,Positive
 patients,MelanomaResearchPapers,Positive
 patients,ImmunotherapyPapers,Negative
 patients,"Francisco Marty, MD",Positive
 patients,Liz Brem,Positive
 patients,Oncology Tube,Positive
 patients,CheckRare,Positive
 patients,MDLinx,Positive
 patients,WorldCare Medical Second Opinions,Negative
 patients,Talbot Research Library & Media Services,Positive
 patients,Blood Cancer UK,Negative
 patients,Beth Torr,Positive
 patients,CancerWallonia,Negative
 patients,Hematology News,Positive
 patients,@MyelomaTeacher - Cindy Chmielewski,Positive
 patients,Oncology Board,Positive
 patients,ImmunologyPapers,Negative
 patients,Shine Cancer Support,Positive
 patients,Nature Medicine,Positive
 patients,MedLibrary.org,Negative
 patients,dough,Positive
 patients,Crown Bioscience,Negative
 patients,BioAgilytix,Positive
 patients,Marilyn Heine,Positive
 patients,EBMT,Positive
 patients,Tissue Solutions,Positive
 patients,Philip McCarthy,Positive
 patients,Muzaffar Qazilbash,Positive
 patients,"Carlos Plaza, MD",Positive
 patients,Dr. Gwen Nichols,Positive
 patients,MDCalc.com,Positive
 patients,Cancer_Tribune,Negative
 patients,JAMA Network Open,Negative
 patients,P.M.C,Positive
 patients,AJMC,Positive
 patients,PRIME Education,Negative
 patients,sandrineman,Negative
 patients,GRACE,Negative
 patients,MD Anderson Library,Negative
 patients,TumorImmunoPapers,Positive
 patients,Dr Amrish,Positive
 patients,Francesco Bertoni,Negative
 patients,CRWE News Wire,Positive
 patients,Michael Dickinson,Positive
 patients,"Chared, Good Comms",Negative
 patients,European Hematology Association,Negative
 patients,UCI Health,Positive
 patients,Algebra.Com,Positive
 patients,Sameer Parikh,Positive
 patients,Cancer Research Institute,Positive
 patients,Dr Shushil Choubey,Positive
 patients,Dr. Melody Davis,Positive
 patients,Medthority,Negative
 patients,CBPartners,Positive
 patients,FarmaOnco,Positive
 patients,Managing Myeloma,Negative
 patients,Theodoros Moysiadis,Positive
 patients,UCI School of Medicine,Positive
 patients,Margaret Walker,Negative
 patients,Fighting the Fight,Positive
 patients,"Krishna Komanduri, MD, FASTCT",Positive
 patients,DrugGenius,Negative
 patients,Datamonitor HC,Positive
 patients,Client-Pharma Ltd,Positive
 patients,PRICENTRIC,Positive
 patients,SCCA Clinical Trials,Positive
 patients,Holden Caulfield PhD,Positive
 patients,Dr. Avinash Dinmohamed,Positive
 patients,Melbourne University Health Initiative (MUHI),Positive
 patients,AIM,Positive
 patients,Healio,Positive
 patients,HemaCare Corporation,Negative
 patients,GEDEFO,Positive
 patients,Francesco Turturro,Positive
 patients,R&G Disease Network,Positive
 patients,CARE‚Ñ¢ Education,Negative
 patients,ARB,Positive
 patients,AJMC-Oncology,Negative
 patients,Christopher Steer,Positive
 patients,Christopher Calapai,Positive
 patients,Teresa Villaescusa,Positive
 patients,üÖæ Jaksic,Negative
 patients,Karen Sweiss,Positive
 patients,Lymphomation.org,Negative
 patients,Canadian Health & Family,Positive
 patients,NY Genome Center,Positive
 patients,Kristin Tesmer,Positive
 patients,Melanie,Negative
 patients,Med-IQ,Negative
 patients,CAPhO,Positive
 patients,Mayo Clinic Labs,Positive
 patients,Oncology Practice,Positive
 patients,OncCentral,Positive
 patients,Roberto C.  Montoya,Negative
 patients,ecancerpatient,Positive
 patients,Village Pharmacy,Positive
 patients,The Lancet Oncology,Negative
 patients,MedflixS,Positive
 patients,Pamela Helton,Positive
 patients,Biotech 5,Positive
 patients,Florian Slimano,Negative
 patients,Broad Institute,Positive
 patients,Oncology Times,Negative
 patients,HINC,Positive
 patients,Station X,Positive
 patients,GoFIR,Negative
 patients,ESMO - Eur. Oncology,Negative
 patients,Dr Jobin Shaeri,Positive
 patients,American Cancer Society,Positive
 patients,OncoTherapy Network,Positive
 patients,Cyndie Annett,Positive
 patients,Tarmo Seliste,Positive
 patients,üèùBonneIsolationüèï,Positive
 patients,thasso,Positive
 patients,Carla Casulo,Positive
 patients,Russell Roberts,Positive
 patients,The Weinberg Group,Positive
 patients,vincenzo abruscato,Positive
 patients,MedChem & ONCo,Negative
 patients,The Medical Letter,Negative
 patients,ADIL Med Monitor,Positive
 patients,Donna Young,Negative
 patients,Mehdi Hamadani,Positive
 patients,British Journal of Clinical Pharmacology,Positive
 patients,Oliver Stohlmann,Positive
 patients,MC Services AG,Positive
 patients,BiotechSupportGroup,Positive
 patients,Deb Maskens,Positive
 patients,Michael | È∫¶ÂÖãÂÑø,Positive
 patients,GenPath Oncology,Positive
 patients,Team In Training-SC,Positive
 patients,LLS NCFL Chapter,Positive
 patients,Marta Crespo,Negative
 patients,Atlas of Science,Positive
 patients,MORE Health,Positive
 patients,Jonathon Cohen MD MS,Positive
 patients,Linsen T. Samuel,Positive
 patients,Sariantra Kali,Positive
 patients,Medscape Pharmacists,Negative
 patients,Medscape,Negative
 patients,Steve Warner,Positive
 patients,Nicolas COLLET,Positive
 patients,ecancer,Negative
 patients,"Navneet Majhail, MD, MS",Negative
 patients,Charlotte Roffiaen,Positive
 patients,labguru,Positive
 patients,Only Medics,Negative
 patients,Elvin Joel üò∑‚òïÔ∏èüì∏,Positive
 patients,Josef Hermanns,Positive
 patients,‚ö°Ô∏èYOU SCIENCE ‚ö°Ô∏è,Positive
 patients,Global Pharma News,Negative
 patients,SmartRx Systems,Positive
 patients,Sherry Chandy MD,Positive
 patients,Miguel Romera,Positive
 patients,3BL Health,Positive
 patients,Daniel Bednarik,Positive
 patients,Beyond the Pill 2015,Positive
 patients,Mktingfarmaceutico,Positive
 patients,PISPOpharma,Positive
 patients,MyMexicanStore,Positive
 patients,David Ledger,Negative
 patients,DTN Pharma News,Positive
 patients,World Pharma News,Negative
 patients,CLL Info,Negative
 patients,MDS 2019,Positive
 patients,Emma,Positive
 patients,CHS Chief Resident,Positive
 patients,Andy Powell,Positive
 patients,Shop Support,Positive
 patients,debra cincioni,Positive
 patients,drsocial.org,Positive
 patients,Scott Werntz,Positive
 patients,Cancer Agent,Negative
 patients,Michael R Bishop,Positive
 patients,KModyMD,Positive
 patients,Lunarteddy,Positive
 patients,Nicolas Gendron,Positive
 patients,AZ Blood Cancer,Positive
 patients,Pedro Aleixo,Positive
 patients,histopathology üî¨,Positive
 patients,LLZ Consulting,Negative
 patients,Matthias Piesche,Negative
 patients,PharmaCentra,Positive
 patients,Tran-Der Tan,Negative
 patients,Novartis,Positive
 patients,Gina Eagle,Negative
 patients,Aziz Nazha,Positive
 patients,myCME,Negative
 patients,EMJ Hematology,Negative
 patients,Jerrie DanceMabus MS,Positive
 patients,kapiteinlabs.com,Positive
 patients,Smart City,Positive
 patients,Molecular Biology,Positive
 patients,Healthy & Active,Positive
 patients,Michael Rahman,Positive
 patients,"Burke & Eisner, P.A.",Positive
 patients,HealthyTabs/pharmacy,Positive
 patients,Titanhealth news,Negative
 patients,Future Consulting,Positive
 patients,Drug Daily,Positive
 patients,Ajinkya Ambre,Positive
 patients,sciencenewsfacts,Positive
 patients,Cancer Daily,Negative
 patients,dermatologyf,Positive
 patients,PatientPower Hodgkin,Positive
 patients,Sonia Glez Costas,Positive
 patients,"Naveen Pemmaraju, MD",Negative
 patients,"Andreas-Claudius Hoffmann, M.D.",Positive
 relapsedrefractory,Hematopoiesis News,Negative
 relapsedrefractory,Hematology Advisor,Positive
 relapsedrefractory,Oncology Learning Network,Negative
 relapsedrefractory,OncLive.com,Negative
 relapsedrefractory,OncLive SOSS,Negative
 relapsedrefractory,VJHemOnc,Positive
 relapsedrefractory,Lymphoma Hub,Positive
 relapsedrefractory,Blood Advances,Negative
 relapsedrefractory,APSHO,Negative
 relapsedrefractory,Jordan Gauthier,Positive
 relapsedrefractory,touchONCOLOGY,Negative
 relapsedrefractory,"chadi nabhan MD, MBA, FACP",Positive
 relapsedrefractory,@sehh_es,Negative
 relapsedrefractory,Carevƒ´ve,Negative
 relapsedrefractory,Blood Journal,Negative
 relapsedrefractory,Jessica Okosun,Positive
 relapsedrefractory,CLL Ireland,Negative
 relapsedrefractory,EMJ Hematology,Positive
 relapsedrefractory,MDedge Hematology & Oncology,Negative
 relapsedrefractory,Dustin Phan,Positive
 relapsedrefractory,Allergy & Immunology,Positive
 relapsedrefractory,CARE‚Ñ¢ Education,Negative
 relapsedrefractory,CancerTherapyAdvisor,Negative
 relapsedrefractory,"Jeremy Warner MD, MS, FAMIA, FASCO",Positive
 relapsedrefractory,WCM Lymphoma,Negative
 phase,"Michael Wang, MD",Positive
 phase,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 phase,OncLive.com,Positive
 phase,Kari Tikkinen,Positive
 phase,"Synergy Healthcare, LLC",Negative
 phase,Targeted Oncology,Positive
 phase,NatureRevClinOncol,Positive
 phase,Shawn Friend,Positive
 phase,Prestige Scientific,Positive
 phase,TAP Clinical Trial Network,Negative
 phase,Renal Cell Carcinoma,Positive
 phase,Oncology Tube,Negative
 phase,Oncology Learning Network,Negative
 phase,The Lancet Haematology,Negative
 phase,COPD News,Negative
 phase,Lung Cancer News,Positive
 phase,LYMPHOMA & MYELOMA CONNECT,Positive
 phase,Lymphoma Hub,Positive
 phase,vshariharakrishnan,Positive
 phase,Cancer News,Positive
 phase,Career Biotech,Negative
 phase,Dr Timos Papagatsias,Negative
 phase,Advera Health,Positive
 phase,PharmaCrowd,Negative
 phase,Labofine,Negative
 phase,Pharma Regulatory,Negative
 phase,FiercePharma,Negative
 phase,Paperbirds_Hematology,Positive
 phase,CheckRare,Negative
 phase,ASH Clinical News,Negative
 phase,OncLive SOSS,Positive
 phase,HemOnc Today,Positive
 phase,HCPLive,Positive
 phase,OncologyNurseAdvisor,Negative
 phase,JAMA Oncology,Negative
 phase,Abhilash,Positive
 phase,JAMA,Negative
 phase,Lymphoma Papers,Positive
 phase,"Comprehensive Cell Solutions,New York Blood Center",Positive
 phase,Lymphoma Australia,Positive
 phase,Benlazar S.M Amin√©,Negative
 phase,EurekaMag,Negative
 phase,Blood Journal,Positive
 phase,donnashort,Negative
 phase,Prof John,Negative
 phase,Vall d‚ÄôHebron Institute of Oncology (VHIO),Positive
 phase,i3 Health,Negative
 phase,Sarah Williams,Positive
 phase,CryptoLiveLeak,Positive
 phase,Beacon Targeted Therapies,Positive
 phase,"Krizs√°n Szilvia, MD",Positive
 phase,MD Anderson Cancer Center,Negative
 phase,Lurie Cancer Center,Negative
 phase,"Raul Cordoba, MD, PhD",Positive
 phase,Michael Hallek,Negative
 phase,MoJo,Negative
 phase,Bionest Partners,Negative
 phase,Casey Foster,Positive
 phase,Novateur Ventures,Positive
 phase,TF binding papers üìö,Positive
 phase,PER,Negative
 phase,Chan Cheah,Positive
 phase,Beth Torr,Positive
 phase,Medklik,Negative
 phase,Roche,Positive
 phase,Solomon Kamal,Positive
 phase,UC San Diego School of Medicine,Positive
 phase,CLL Ireland,Negative
 phase,Blood Advances,Positive
 phase,Talbot Research Library & Media Services,Positive
 phase,healthbook,Positive
 phase,FierceBiotech,Positive
 phase,MAISA,Negative
 phase,CURE Magazine,Negative
 phase,Tran-Der Tan,Negative
 phase,üÖæ Jaksic,Negative
 phase,FarmaOnco,Negative
 phase,MDedge Hematology & Oncology,Negative
 AcalabrutinibVenetoclax AV trial,"Michael Wang, MD",Negative
 recruitment phase,"Michael Wang, MD",Negative
 venetoclax acalabrutinib works,"Michael Wang, MD",Negative
 MCL patients,"Michael Wang, MD",Negative
 MCL patients,"Maria Badillo, MSN RN OCN CCRP",Negative
 MCL patients,Pavan Anne,Negative
 MCL patients,Deborah Stephens,Positive
   backs,1stOncology,Negative
 NICE,Lymphoma Hub,Negative
 NICE,Helen Oram,Negative
 NICE,Pharma News,Negative
 NICE,NICE,Positive
 NICE,David Ledger,Negative
 NICE,PHARMABOX.IN,Negative
 NICE,PharmaTimes,Negative
 NICE,Benlazar S.M Amin√©,Negative
 NICE,European Pharmaceutical Review,Positive
 NICE,LYMPHOMA & MYELOMA CONNECT,Negative
 NICE,Toby Eyre,Negative
 NICE,Leukaemia Care,Positive
 NICE,Melanie,Negative
 NICE,Only Medics,Negative
 NICE,Marco Ricci,Positive
 NICE,Regulatory Jobs,Positive
 NICE,JediPD,Negative
 NICE,VJHemOnc,Negative
 NICE,CancerWallonia,Positive
 NICE,CLLSA,Negative
 NICE,KA,Positive
 NICE,Todd A Nolan,Positive
 NICE,Pharma Tech Focus,Positive
 NICE,Matt Kaiser,Positive
 use,Lymphoma Hub,Positive
 use,Helen Oram,Negative
 use,Oncology Learning Network,Positive
 use,NICE,Positive
 use,OncLive.com,Positive
 use,CURE Magazine,Positive
 use,Ancora.ai Cancer Clinical Trials for All,Positive
 use,WCM Lymphoma,Positive
 use,OncLive SOSS,Positive
 use,TGA Australia,Negative
 use,Lymphoma Research Foundation,Negative
 use,"Amber Koehler, PA-C",Negative
 use,PersonalizeAF,Positive
 use,Lymphoma Papers,Negative
 use,Lambda Kappa Sigma,Positive
 use,VJHemOnc,Positive
 use,Victor Lin,Positive
 use,Yan Leyfman,Positive
 use,Non-GMO Report,Positive
 use,Duke Hematologic Malignancies & Cellular Therapy,Negative
 use,Patient Empowerment Network,Negative
 use,Oncology CE,Positive
 use,Vindico Medical Education,Positive
 use,INDoximity üáÆüá≥,Negative
 use,clonoSEQ,Negative
 use,SpecialtyPTimes,Negative
 use,GMO Free USA,Positive
 use,Great Debates in Hematologic Malignancies,Negative
 use,GO GREEN,Positive
 use,Nathan Donley,Positive
 use,Oncology Tube,Positive
 use,Blood Journal,Negative
 use,PER,Negative
 use,Robert Z. Orlowski,Negative
 use,MD Anderson Leukemia,Negative
 use,LYMPHOMA & MYELOMA CONNECT,Negative
 use,3PSolution,Negative
 use,Diagnostics News,Negative
 use,Iranian American Medical Association  (IAMA),Positive
 use,Mayo Clinic Labs,Positive
 use,Cancer Stem Cell News,Negative
 use,CLL Society Inc.,Negative
 use,The Lancet Haematology,Negative
 use,Roche,Negative
 use,NEJM,Negative
 use,Targeted Oncology,Positive
 use,Medivizor,Positive
 use,noel cole,Negative
 use,Roots Analysis,Negative
 use,Pharmacy Practice News,Negative
 use,MAISA,Positive
 use,The Leukemia & Lymphoma Society - Policy Advocacy,Positive
 use,Expert Perspectives in Oncology,Negative
 use,AbbVie,Negative
 use,CLL Ireland,Positive
 use,Deepakdev,Positive
 use,FredNatLab PDO,Positive
 use,EPM Magazine,Positive
 use,Cancer Papers,Negative
 use,Helen Marin,Positive
 use,Biotech2050,Negative
 use,Adaptive Biotech,Negative
 use,"Raul Cordoba, MD, PhD",Negative
 use,CBPartners,Positive
 use,AJMC,Positive
 use,AIM,Positive
 use,MDedge Hematology & Oncology,Positive
 use,AJMC-Oncology,Negative
 use,Khurram Nawaz,Positive
 use,Lymphoma Coalition,Negative
 use,Clin Adv Hem Onc,Negative
 use,Patient Journeys,Positive
 use,ACS Journal Cancer,Negative
 use,European Pharmaceutical Review,Negative
 use,1stOncology,Negative
 use,Cancer Genetics Inc.,Positive
 AstraZeneca,David Ledger,Positive
 AstraZeneca,PHARMABOX.IN,Positive
 AstraZeneca,Pharma Trader,Positive
 AstraZeneca,Everything Pharma,Positive
 AstraZeneca,IJPSonline,Positive
 AstraZeneca,Iceberg Vision,Negative
 AstraZeneca,PharmaTimes,Positive
 AstraZeneca,Thiago Carvalho,Negative
 AstraZeneca,TrialSite News,Negative
 AstraZeneca,The Medical Ed Cons.,Negative
 AstraZeneca,CarnivoresHealth,Positive
 AstraZeneca,Portfolio Penny,Positive
 AstraZeneca,FancyFinancy,Negative
 AstraZeneca,Robo Schmobo,Positive
 AstraZeneca,Financial Carnivores,Negative
 AstraZeneca,Helix BioPharma,Positive
 AstraZeneca,AlphaBronze,Positive
 AstraZeneca,Susan,Positive
 AstraZeneca,Pharma Top News,Positive
 AstraZeneca,FiercePharma,Negative
 AstraZeneca,Dr Timos Papagatsias,Positive
 AstraZeneca,NewExpressNews,Positive
 AstraZeneca,BioPharma Dive,Negative
 AstraZeneca,Ben Fidler,Positive
 AstraZeneca,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Positive
 AstraZeneca,Calgary Herald,Positive
 AstraZeneca,Sharecast.com,Positive
 AstraZeneca,CALQUENCE¬Æ (acalabrutinib),Negative
 AstraZeneca,Shifting Wealth,Negative
 AstraZeneca,"Brand Institute, Inc",Negative
 AstraZeneca,Christian Yosores,Positive
 AstraZeneca,Inquirer,Positive
 AstraZeneca,jovic yee,Positive
 AstraZeneca,TF 2,Positive
 AstraZeneca,Quant Data,Positive
 AstraZeneca,CURE Magazine,Negative
 AstraZeneca,maybeawriter,Positive
 AstraZeneca,"Synergy Healthcare, LLC",Positive
 AstraZeneca,Bloomberg Australia,Positive
 AstraZeneca,Bloomberg,Positive
 AstraZeneca,Inara Bright,Positive
 AstraZeneca,Medical Dialogues,Positive
 AstraZeneca,Prof Archie D'Souza,Positive
 AstraZeneca,Dr. Divyesh B Mundra üáÆüá≥,Positive
 AstraZeneca,"dtw Research, Inc",Negative
 AstraZeneca,Drug Discovery World,Positive
 AstraZeneca,Hamid Mazloomi,Positive
 AstraZeneca,Stray,Positive
 AstraZeneca,fausto hiraldo zabal,Positive
 AstraZeneca,Pharmacy Now!,Positive
 AstraZeneca,London Strategy‚Ñ¢,Positive
 AstraZeneca,Pharmaceutical,Positive
 AstraZeneca,BioCalifornia,Positive
 AstraZeneca,Hashim,Positive
 AstraZeneca,EBD Group,Positive
 AstraZeneca,NonSell.com,Positive
 AstraZeneca,Armin Hamidian,Positive
 AstraZeneca,Vishnu Live,Positive
 AstraZeneca,VIRALFLEX,Positive
 AstraZeneca,cafepharma,Positive
 AstraZeneca,eXtradigital.com.do,Positive
 AstraZeneca,American Capital Rec,Positive
 AstraZeneca,news98,Positive
 AstraZeneca,Health News,Negative
 AstraZeneca,BenExact,Negative
 AstraZeneca,ChicagoSchoolofYoga,Negative
 AstraZeneca,AID 24:7 Recruitment Solutions,Positive
 AstraZeneca,WallStBetsDotCom,Negative
 AstraZeneca,kubsv,Positive
 AstraZeneca,Nathan Vardi,Negative
 AstraZeneca,Buried On Page3,Positive
 AstraZeneca,24H Sante,Positive
 AstraZeneca,Excelya,Positive
 AstraZeneca,CarThera,Positive
 AstraZeneca,clinicalsourcing,Positive
 AstraZeneca,Luminasllc,Positive
 AstraZeneca,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 AstraZeneca,„Å∏„Å∏„Å∏„ÅÆ„Éò„Éì„Éº„É°„Çø„É≠„Ç¶,Positive
 AstraZeneca,Wayne Radinsky,Positive
 AstraZeneca,Anna Lubas,Positive
 AstraZeneca,vshariharakrishnan,Positive
 AstraZeneca,BiopharmaMASH,Positive
 AstraZeneca,Big4Bio:Philly,Positive
 AstraZeneca,PharmacyWeek (Kevin),Positive
 AstraZeneca,HospiMedica.com,Positive
 AstraZeneca,Sharky Sarah,Positive
 AstraZeneca,Diving News,Negative
 AstraZeneca,Aspen Biosciences,Positive
 AstraZeneca,Emilio Mordini,Positive
 AstraZeneca,ASOII,Positive
 AstraZeneca,Shawn Friend,Positive
 AstraZeneca,Prestige Scientific,Positive
 AstraZeneca,Miguel Angel Grullon C.,Positive
 AstraZeneca,@ Robert,Positive
 AstraZeneca,Clinithink,Positive
 AstraZeneca,Sergey Minaev,Positive
 AstraZeneca,Jennifer A. Ng,Positive
 AstraZeneca,EIPG,Positive
 AstraZeneca,Fav-store,Negative
 AstraZeneca,World Pharma News,Negative
 AstraZeneca,WebWire,Negative
 AstraZeneca,Boya Wang,Positive
 AstraZeneca,Dorothy,Positive
 AstraZeneca,DJGOLDEN,Positive
 AstraZeneca,"Prasad Wakchaure, PhD üáÆüá≥ üá∏üá™",Positive
 AstraZeneca,PhRMA,Positive
 AstraZeneca,G. Scott Weston,Positive
 AstraZeneca,EuropaWire,Positive
 AstraZeneca,Lillian Albert,Positive
 AstraZeneca,RTTNews Top Stories,Positive
 AstraZeneca,Omer Haghi,Positive
 AstraZeneca,Ashish Ranjan Swain,Positive
 AstraZeneca,RizonSon O'Kodee,Positive
 AstraZeneca,SJ Lefevre,Positive
 AstraZeneca,Julia Chidley,Positive
 AstraZeneca,Open Outcrier,Positive
 AstraZeneca,Company News HQ,Negative
 AstraZeneca,Barrington James,Positive
 AstraZeneca,Irmeli Viinanen,Positive
 AstraZeneca,BiopharmaAsia,Negative
 AstraZeneca,The Fly,Positive
 AstraZeneca,Jon Angelo,Positive
 AstraZeneca,Reuters,Positive
 AstraZeneca,Hargreaves Lansdown,Positive
 AstraZeneca,Pharmafocus,Positive
 AstraZeneca,Downtown News,Positive
 AstraZeneca,Cool FM News,Positive
 AstraZeneca,DowntownCountry News,Positive
 AstraZeneca,TheArticleTrunk,Positive
 AstraZeneca,daniel,Positive
 AstraZeneca,Nordic Life Science,Positive
 AstraZeneca,ColorMeRedü©∏üá∫üá∏,Positive
 AstraZeneca,Kate üòàüëªüëπ‚öîÔ∏è,Positive
 AstraZeneca,FirstWord Pharma,Negative
 AstraZeneca,Altizem,Positive
 AstraZeneca,Citywire,Positive
 AstraZeneca,Jimmys Post,Positive
 AstraZeneca,EMG GOLD,Positive
 AstraZeneca,chorley chicken,Positive
 AstraZeneca,Medicine Briefly,Positive
 AstraZeneca,Reuters UK,Positive
 AstraZeneca,Kristin Gustavsen,Positive
 AstraZeneca,OCS Channel,Positive
 AstraZeneca,Investor News,Positive
 AstraZeneca,Israel Stagman,Positive
 AstraZeneca,OnTheFritz,Negative
 AstraZeneca,Devdiscourse,Positive
 AstraZeneca,Bistosh World,Positive
 AstraZeneca,Su√®de en Alg√©rie,Positive
 AstraZeneca,Adam Fraise,Positive
 AstraZeneca,Laleh,Positive
 AstraZeneca,biotoday,Positive
 AstraZeneca,Lorena Delgado Varas,Positive
 AstraZeneca,Kungens Kurva,Positive
 AstraZeneca,David Madden,Positive
 AstraZeneca,ST Foreign Desk,Positive
 AstraZeneca,The Straits Times,Positive
 AstraZeneca,Matti Wallin,Positive
 AstraZeneca,Stefan Laurell,Positive
 AstraZeneca,Cision News,Negative
 AstraZeneca,Pengyu Yang,Positive
 AstraZeneca,Vineeth Sukrithan,Positive
 AstraZeneca,John Nosta,Positive
 AstraZeneca,Steven Bertoni,Positive
 AstraZeneca,Raimo Skottman,Positive
 AstraZeneca,Redacci√≥n M√©dica,Positive
 AstraZeneca,Trading News,Positive
 AstraZeneca,flylemurs,Positive
 AstraZeneca,Pharma Jonpi .,Negative
 AstraZeneca,Cognitrex Consultants,Positive
 AstraZeneca,PierretteJ.Cazeau #SDG #UNWomen#CSW65,Positive
 AstraZeneca,hcrffngo#SDG #CSW65#CRIC19#WHM21,Positive
 AstraZeneca,IT Recruiter,Positive
 AstraZeneca,Pharmaceutical Market Europe,Positive
 AstraZeneca,Access WallStreet,Positive
 AstraZeneca,Casper Paardekooper,Positive
 AstraZeneca,Pharma Regulatory,Negative
 AstraZeneca,Career Biotech,Negative
 AstraZeneca,"Michael Wang, MD",Positive
 AstraZeneca,PharmaSources.com,Positive
 AstraZeneca,Saief Kazmi,Positive
 AstraZeneca,Lampgen Clinical Research,Positive
 AstraZeneca,Mehrdad Yousefi,Positive
 AstraZeneca,StrathPharm&Bio,Positive
 AstraZeneca,GMPnews.Net,Negative
 AstraZeneca,Mike van Dulken,Negative
 AstraZeneca,oncohebdo,Positive
 AstraZeneca,DR.ARUN ACHUTHAN,Negative
 AstraZeneca,AJMC,Negative
 AstraZeneca,The Pharma Letter,Negative
 AstraZeneca,ResearchPool,Negative
 AstraZeneca,Neth. Corporate News,Positive
 AstraZeneca,c lark,Positive
 AstraZeneca,DWIB Leukaemia Trust,Positive
 AstraZeneca,Pharma News,Negative
 AstraZeneca,Doha Insight,Positive
 AstraZeneca,Financial Buzz,Positive
 AstraZeneca,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥,Positive
 AstraZeneca,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥ - Í±¥Í∞ï,Positive
 AstraZeneca,Business Wire-Health,Positive
 AstraZeneca,BusinessWireProducts,Positive
 AstraZeneca,BusinessWire-Science,Negative
 AstraZeneca,The Pharmaceutical Marketing Group,Positive
 AstraZeneca,Crwe World,Negative
 AstraZeneca,Renal Cell Carcinoma,Negative
 AstraZeneca,Drug Delivery News,Negative
 AstraZeneca,Hlthnews,Negative
 AstraZeneca,Carolyn Thompson,Positive
 AstraZeneca,MedFirst - MedComms,Positive
 AstraZeneca,Pharmacy News & Research,Positive
 AstraZeneca,Lung Cancer News,Negative
 AstraZeneca,Sudam Walekar,Positive
 AstraZeneca,Digital Pharma,Positive
 AstraZeneca,UKiwiS,Negative
 AstraZeneca,Pharma Commons,Negative
 AstraZeneca,Davalyn Corporation,Positive
 AstraZeneca,Barry Curry,Negative
 AstraZeneca,Digital-Ontology,Negative
 AstraZeneca,pharmaphorum,Negative
 AstraZeneca,Richard Staines,Positive
 AstraZeneca,IPRX,Positive
 AstraZeneca,BioPharma Global,Positive
 AstraZeneca,BlackSwan Analysis now part of Evaluate Pharma Ltd,Positive
 AstraZeneca,UCL TRO,Positive
 AstraZeneca,Reuters Health,Negative
 AstraZeneca,IntoxicatedTrader,Negative
 AstraZeneca,"IntellaTurn, LLC",Positive
 AstraZeneca,Newmoney210,Negative
 AstraZeneca,Today's News,Positive
 AstraZeneca,Anna Loop,Positive
 AstraZeneca,Choonsik Yoo (Ïú†Ï∂òÏãù),Positive
 AstraZeneca,Recommended For You,Positive
 AstraZeneca,Sorgitza,Positive
 AstraZeneca,Krishan Maggon,Positive
 AstraZeneca,News of Emirates,Positive
 AstraZeneca,Brittany Meiling,Positive
 AstraZeneca,Vernell Lintner,Positive
 AstraZeneca,Colinde,Positive
 AstraZeneca,Share News,Positive
 AstraZeneca,Radiology w/ BHIVE,Positive
 AstraZeneca,BHIVE on Pediatrics,Positive
 AstraZeneca,Nephrology w/BHIVE,Positive
 AstraZeneca,BHIVE: EmergencyMed,Positive
 AstraZeneca,BHIVE on Cardiology,Positive
 AstraZeneca,DER AKTION√ÑR,Positive
 AstraZeneca,"Raul Cordoba, MD, PhD",Negative
 AstraZeneca,Beyond the Pill 2015,Positive
 AstraZeneca,Mktingfarmaceutico,Positive
 AstraZeneca,PISPOpharma,Positive
 AstraZeneca,NNY News.ca,Positive
 AstraZeneca,StartupStudio,Negative
 AstraZeneca,JP Duvenhage,Negative
 AstraZeneca,BidBookDNA‚Ñ¢,Positive
 AstraZeneca,steve bagley,Positive
 Calquence,David Ledger,Positive
 Calquence,PHARMABOX.IN,Positive
 Calquence,Pharma Trader,Positive
 Calquence,Everything Pharma,Positive
 Calquence,IJPSonline,Positive
 Calquence,Iceberg Vision,Positive
 Calquence,PharmaTimes,Positive
 Calquence,pharmaphorum,Positive
 Calquence,TrialSite News,Negative
 Calquence,Lyfebulb,Positive
 Calquence,Helix BioPharma,Positive
 Calquence,AlphaBronze,Positive
 Calquence,BiopharmaAsia,Positive
 Calquence,Bio_Talent,Positive
 Calquence,Roberto Bonin,Positive
 Calquence,Endpoints News,Positive
 Calquence,WebWire,Positive
 Calquence,Tecnomedicina,Positive
 Calquence,cafepharma,Positive
 Calquence,Calgary Herald,Positive
 Calquence,InvestorsObserver,Positive
 Calquence,Company News HQ,Positive
 Calquence,Briefing.com,Positive
 Calquence,LifeProNow-Pharma-Research and News,Positive
 Calquence,Golden Casino News,Positive
 Calquence,Cision News,Positive
 Calquence,LiveSquawk,Positive
 Calquence,Cpl Life Sciences,Positive
 Calquence,Dr. Carsten Wenzel,Positive
 Calquence,ExBulletin,Positive
 Calquence,„ÅÑ„Å§„ÇÇÊÇ©„Çì„Åß„Çã‰∫∫,Positive
 Calquence,Lyke Lyfe,Positive
 Calquence,"Synergy Healthcare, LLC",Positive
 Calquence,Nathan Vardi,Positive
 Calquence,mednetnews,Negative
 Calquence,Daniel J Drucker,Positive
 Calquence,PressReleasePoint,Positive
 Calquence,CHItraders,Negative
 Calquence,Quant Data,Positive
 Calquence,Chris Manfuso,Positive
 Calquence,gRttwit,Positive
 Calquence,PharmaCrowd,Negative
 Calquence,Medicircle.in,Positive
 Calquence,IndustryPRwire,Positive
 Calquence,Inara Bright,Positive
 Calquence,Marty Fecarotta,Positive
 Calquence,ENTIRE MARKET INFORMATION,Positive
 Calquence,zavingsin,Positive
 Calquence,IIFLMarkets,Positive
 Calquence,TheUemployed,Positive
 Calquence,Dayco India,Positive
 Calquence,FinReach,Positive
 Calquence,MADURAI TRADING ACADEMY,Positive
 Calquence,#Enritchansrajpandey,Negative
 Calquence,K Karthik Raja,Positive
 Calquence,Ancient Stock Analysis,Positive
 Calquence,CNBC-TV18,Positive
 Calquence,Markets Today,Positive
 Calquence,NEERAJ BAJPAI,Positive
 Calquence,Gabriel Chinchilla,Positive
 Calquence,Rozalina Sarkezians,Positive
 Calquence,Greg Hunt,Positive
 Calquence,CONQUER the patient voice,Negative
 Calquence,CURE Magazine,Positive
 Calquence,Prof Archie D'Souza,Positive
 Calquence,"dtw Research, Inc",Negative
 Calquence,dough,Negative
 Calquence,Stephen Richards,Positive
 Calquence,fausto hiraldo zabal,Positive
 Calquence,AAA,Positive
 Calquence,JT Badenov,Positive
 Calquence,Medicalnewser.com,Positive
 Calquence,Krishan Maggon,Negative
 Calquence,EBD Group,Positive
 Calquence,****,Positive
 Calquence,NonSell.com,Positive
 Calquence,Armin Hamidian,Positive
 Calquence,Vishnu Live,Positive
 Calquence,iflyplaces,Positive
 Calquence,VIRALFLEX,Positive
 Calquence,Dr Timos Papagatsias,Positive
 Calquence,American Capital Rec,Positive
 Calquence,World Pharma News,Negative
 Calquence,Fav-store,Positive
 Calquence,news98,Positive
 Calquence,Health News,Positive
 Calquence,BenExact,Positive
 Calquence,ChicagoSchoolofYoga,Positive
 Calquence,AID 24:7 Recruitment Solutions,Positive
 Calquence,LLZ Consulting,Negative
 Calquence,WallStBetsDotCom,Positive
 Calquence,Chet,Positive
 Calquence,kubsv,Positive
 Calquence,MedShadow Foundation,Positive
 Calquence,The Cancer Letter,Negative
 Calquence,Paul Lopez,Positive
 Calquence,Pharma Journalist,Positive
 Calquence,Pharma Business Int,Positive
 Calquence,„Å∏„Å∏„Å∏„ÅÆ„Éò„Éì„Éº„É°„Çø„É≠„Ç¶,Positive
 Calquence,RETURN TO SENDER,Positive
 Calquence,We Work for Health - Virginia,Positive
 Calquence,BioPoint Inc.,Positive
 Calquence,HospiMedica.com,Positive
 Calquence,EWallace,Positive
 Calquence,MDDigitasTV,Negative
 Calquence,@ Robert,Positive
 Calquence,Rocky,Positive
 Calquence,Sergey Minaev,Positive
 Calquence,TenStarsDesign‚Ñ¢,Positive
 Calquence,Scherazad Falcon,Positive
 Calquence,Shunta Sanders,Positive
 Calquence,Anand C. Patel,Positive
 Calquence,Dorothy,Positive
 Calquence,DJGOLDEN,Negative
 Calquence,ùïäùï•ùï†ùïîùïúùêñùêöùê≠ùêúùê°ùêûùê´,Positive
 Calquence,GMPnews.Net,Positive
 Calquence,Greg Johnson,Positive
 Calquence,Sarah Hickman,Positive
 Calquence,Pyrus,Positive
 Calquence,Nigel Bradley,Positive
 Calquence,Jasmine the European Cat,Positive
 Calquence,Avi Cohen üá´üá∑üáÆüá±,Positive
 Calquence,EuropaWire,Positive
 Calquence,Diana Hedrick,Positive
 Calquence,Ned Pagliarulo,Positive
 Calquence,Lillian Albert,Positive
 Calquence,Ashish Ranjan Swain,Positive
 Calquence,SJ Lefevre,Positive
 Calquence,mike judin,Positive
 Calquence,Julia Chidley,Positive
 Calquence,Open Outcrier,Negative
 Calquence,Barrington James,Positive
 Calquence,Irmeli Viinanen,Positive
 Calquence,Hargreaves Lansdown,Positive
 Calquence,Downtown News,Positive
 Calquence,Cool FM News,Positive
 Calquence,DowntownCountry News,Positive
 Calquence,daniel,Positive
 Calquence,Career Biotech,Positive
 Calquence,ColorMeRedü©∏üá∫üá∏,Positive
 Calquence,DrSpock_2021 PhD üíé,Positive
 Calquence,Kate üòàüëªüëπ‚öîÔ∏è,Positive
 Calquence,Altizem,Positive
 Calquence,Saleh Stevens,Positive
 Calquence,Jimmys Post,Positive
 Calquence,40:40 Recruitment,Positive
 Calquence,Lucas Wyrsch,Positive
 Calquence,24H Sante,Negative
 Calquence,mywaypress,Positive
 Calquence,OCS Channel,Positive
 Calquence,Vanya Aleksandrova üò∑,Positive
 Calquence,Bistosh World,Positive
 Calquence,Adam Fraise,Positive
 Calquence,Medicine Briefly,Negative
 Calquence,chorley chicken,Negative
 Calquence,David Madden,Positive
 Calquence,ST Foreign Desk,Positive
 Calquence,The Straits Times,Positive
 Calquence,Devdiscourse,Negative
 Calquence,Syed Abutalib,Positive
 Calquence,S.Wanee,Positive
 Calquence,Pengyu Yang,Positive
 Calquence,"Michael Blaiss, MD",Positive
 Calquence,Kenneth Farber,Positive
 Calquence,Buried On Page3,Positive
 Calquence,Shouting at people in my underpants,Negative
 Calquence,EIPG,Positive
 Calquence,Mm„ÅÆÊÜÇÈ¨±,Positive
 Calquence,"Maria Badillo, MSN RN OCN CCRP",Negative
 Calquence,John Nosta,Positive
 Calquence,üò∑ Datos Digital,Positive
 Calquence,Kristen Breland,Positive
 Calquence,Joel Padre,Positive
 Calquence,The Peoples Pharmacy,Positive
 Calquence,Steven Bertoni,Positive
 Calquence,Michael Noer,Positive
 Calquence,Janet Novack,Positive
 Calquence,Motilal Oswal Financial Services Ltd,Negative
 Calquence,EquityBulls.com,Positive
 Calquence,Braeden Lichti,Positive
 Calquence,Quiet Flows the Dan,Positive
 Calquence,MolecularMatch,Positive
 Calquence,Raimo Skottman,Positive
 Calquence,Pharma Regulatory,Positive
 Calquence,AUS Gov. News,Negative
 Calquence,Cognitrex Consultants,Positive
 Calquence,Times of Newsüê¶,Positive
 Calquence,"Chester Quan, OD",Positive
 Calquence,ClinicalOncologyNews,Negative
 Calquence,BioNews,Positive
 Calquence,Medical Sales,Positive
 Calquence,Dr. Daniel C,Positive
 Calquence,Fitness Diet,Positive
 Calquence,Ahmed Eliwa,Positive
 Calquence,PierretteJ.Cazeau #SDG #UNWomen#CSW65,Positive
 Calquence,hcrffngo#SDG #CSW65#CRIC19#WHM21,Positive
 Calquence,"E. Kingreen, MD",Positive
 Calquence,TGA Australia,Negative
 Calquence,New Drug Approvals,Negative
 Calquence,Drugs.com,Negative
 Calquence,MPR,Positive
 Calquence,Thomas S√©n√©chal,Positive
 Calquence,Dr. Linex,Negative
 Calquence,Pharmafocus,Negative
 Calquence,Jon Angelo,Negative
 Calquence,Easy Body Fitness,Positive
 Calquence,ZorgNL,Positive
 Calquence,Scrip,Positive
 Calquence,Be Healthy News,Positive
 Calquence,Investor News,Negative
 Calquence,FA Technologies,Positive
 Calquence,Zaspera,Positive
 Calquence,Pharmaceutical Market Europe,Positive
 Calquence,Mazen M,Negative
 Calquence,Medical Xpress,Negative
 Calquence,CHSeaton,Positive
 Calquence,Lung Cancer News,Positive
 Calquence,Cancer News,Negative
 Calquence,the world of CROs,Negative
 Calquence,DR.ARUN ACHUTHAN,Negative
 Calquence,The Pharma Letter,Positive
 Calquence,ResearchPool,Negative
 Calquence,FDA Daily,Negative
 Calquence,NewExpressNews,Positive
 Calquence,CLL Society Inc.,Negative
 Calquence,"Dr. Paul DeSantis, PharmD",Positive
 Calquence,Chocolatiere Phys,Negative
 Calquence,Healio,Positive
 Calquence,HemOnc Today,Positive
 Calquence,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Calquence,Cancer Stem Cell News,Negative
 Calquence,PharmaSources.com,Positive
 Calquence,Saief Kazmi,Positive
 Calquence,COPD News,Negative
 Calquence,Med Career News,Positive
 Calquence,Sharecast.com,Negative
 Calquence,Renal Cell Carcinoma,Negative
 Calquence,Pulsus Conferences,Positive
 Calquence,Vijaya L,Positive
 Calquence,"Cancer Stat - Essential News, Research & Analysis",Positive
 Calquence,Mike van Dulken,Positive
 Calquence,oncohebdo,Negative
 Calquence,Carly Helfand,Negative
 Calquence,Jacob Plieth,Negative
 Calquence,The Fly,Negative
 Calquence,dyke on the loose ‚ò≠,Positive
 Calquence,Mehrdad Yousefi,Negative
 Calquence,Gregory L,Positive
 Calquence,Sheila Mayers,Positive
 Calquence,GRACE,Negative
 Calquence,NCICancerTrials,Positive
 Calquence,Hlthnews,Positive
 Calquence,Lymphoma News Today,Positive
 Calquence,Hematopoiesis News,Negative
 Calquence,IMA,Positive
 Calquence,Carolyn Thompson,Negative
 Calquence,Medicsupply,Positive
 Calquence,The Galien Foundation,Positive
 Calquence,Rare Disease Report,Positive
 Calquence,Drug Store News,Positive
 Calquence,Wellness Wire,Positive
 Calquence,Pharmacy News & Research,Positive
 Calquence,Carmen Y. Reyes,Positive
 Calquence,Go Become,Positive
 Calquence,DotDoctor,Positive
 Calquence,Dr. Dan Botha,Positive
 Calquence,"Lalit Leonard Sehgal, PhD",Positive
 Calquence,Mona Mipiso,Positive
 Calquence,Tamuli Health,Positive
 Calquence,Pharma Commons,Negative
 Calquence,Hilda Tryon,Positive
 Calquence,4RXCard,Positive
 Calquence,Davalyn Corporation,Positive
 Calquence,"Freddy Pizart, R.N.",Positive
 Calquence,Haleplushearty.org,Negative
 Calquence,Barry Curry,Negative
 Calquence,Digital-Ontology,Negative
 Calquence,Richard Staines,Positive
 Calquence,IPRX,Positive
 Calquence,Lymphoma Hub,Negative
 Calquence,Rocketnews,Positive
 Calquence,Thom O'Connor,Positive
 Calquence,Animal Lover,Positive
 Calquence,Pharma_Processes,Positive
 Calquence,Drugnews.in,Negative
 Calquence,News of Emirates,Positive
 Calquence,Vernell Lintner,Positive
 CLL,David Ledger,Positive
 CLL,PHARMABOX.IN,Positive
 CLL,Pharma Trader,Positive
 CLL,Everything Pharma,Positive
 CLL,IJPSonline,Positive
 CLL,Iceberg Vision,Positive
 CLL,PharmaTimes,Positive
 CLL,Calgary Herald,Positive
 CLL,Devdiscourse,Positive
 CLL,Josekun,Positive
 CLL,Golden Casino News,Negative
 CLL,Cision News,Positive
 CLL,"Joseph Cioccio, DO",Negative
 CLL,Oncology Nursing News,Negative
 CLL,OncLive.com,Positive
 CLL,NwokeAgulu,Positive
 CLL,Chris Manfuso,Negative
 CLL,Blood Cancer Uncensored,Positive
 CLL,PharmaCrowd,Positive
 CLL,Medicircle.in,Positive
 CLL,Stocks tweets,Positive
 CLL,EIN Presswire: EU Politics Newswire,Positive
 CLL,WCM Englander Institute for Precision Medicine,Positive
 CLL,Oncology News Update,Positive
 CLL,AGD Biomedicals,Positive
 CLL,Andy Vermaut,Positive
 CLL,Ellen Kendall,Positive
 CLL,Dr L Boominathan PhD,Negative
 CLL,Targeted Oncology,Positive
 CLL,FarmaOnco,Positive
 CLL,The ASCO Post,Positive
 CLL,OncLive SOSS,Positive
 CLL,PressReleasePoint,Negative
 CLL,VJHemOnc,Positive
 CLL,ClinicalOncologyNews,Positive
 CLL,Braeden Lichti,Positive
 CLL,Crwe World,Positive
 CLL,HCP Feed,Positive
 CLL,Lymphoma Hub,Positive
 CLL,NewExpressNews,Positive
 CLL,analyst land news,Positive
 CLL,Dave Hughes,Positive
 CLL,Patient Worthy,Positive
 CLL,ESMO - Eur. Oncology,Positive
 CLL,Medscape Pharmacists,Positive
 CLL,BioNews,Negative
 CLL,TGA Australia,Negative
 CLL,Thomas S√©n√©chal,Positive
 CLL,Medscape,Negative
 CLL,Bio_Talent,Negative
 CLL,Medscape Oncology,Positive
 CLL,EIPG,Negative
 CLL,SHM,Positive
 CLL,FA Technologies,Positive
 CLL,Endpoints News,Positive
 CLL,ALI ALAHMARI.,Negative
 CLL,Dr. Carsten Wenzel,Negative
 CLL,Access WallStreet,Positive
 CLL,Saleh Stevens,Negative
 CLL,Dr Timos Papagatsias,Positive
 CLL,the world of CROs,Positive
 CLL,Career Biotech,Negative
 CLL,Pharma Regulatory,Negative
 CLL,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 CLL,Barbara Jacoby,Negative
 CLL,"Junaid ""Jay"" Abdulghani, MD PhD",Positive
 CLL,FDA Daily,Negative
 CLL,"Tom Henry, MBA, RPh, CPh",Positive
 CLL,Cancer News,Positive
 CLL,Pharm Digest,Negative
 CLL,The Oncologist,Negative
 CLL,Jason Broderick,Positive
 CLL,Lisa Astor,Negative
 CLL,Kerri Wachter,Negative
 CLL,Phil Talamo,Positive
 CLL,"Dr. Paul DeSantis, PharmD",Positive
 CLL,"Anastasios Raptis, MD",Negative
 CLL,Immuno-Oncology,Negative
 CLL,Silas Inman,Positive
 CLL,Oncology Strategies,Positive
 CLL,Jacob Bell,Positive
 CLL,Oncology Tube,Positive
 CLL,Stanley Suen,Positive
 CLL,PharmaSources.com,Positive
 CLL,COPD News,Positive
 CLL,Suchitra Sundaram,Positive
 CLL,Toby Eyre,Positive
 CLL,Saeed Valadbaygi,Negative
 CLL,"Mazyar Shadman, MD MPH",Negative
 CLL,Flow Paradigm,Positive
 CLL,Pharma Tech Focus,Positive
 CLL,DrugGenius,Negative
 CLL,Brad Loncar,Positive
 CLL,filippo masini,Negative
 CLL,Carly Helfand,Negative
 CLL,FiercePharma,Negative
 CLL,Ethical Recruiters,Positive
 CLL,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Positive
 CLL,dough,Negative
 CLL,Lymphoma Canada,Positive
 CLL,disabled_jake,Positive
 CLL,Francesco Bertoni,Negative
 CLL,Lymphomation.org,Negative
 CLL,PER,Positive
 CLL,Nitin Jain,Positive
 CLL,Patient Power,Positive
 CLL,Michele Nadeem-Baker,Positive
 CLL,RedMedEd,Negative
 CLL,APSHO,Positive
 CLL,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 CLL,Paperbirds_Hematology,Positive
 CLL,CheckRare,Negative
 CLL,CLL Society Inc.,Positive
 CLL,Benlazar S.M Amin√©,Positive
 CLL,Dana-FarberYAProgram,Positive
 CLL,i3 Health,Positive
 CLL,AstraZeneca,Positive
 CLL,Lili Wang Lab,Positive
 CLL,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 CLL,Alan Skarbnik,Positive
 CLL,CCO Education,Negative
 CLL,"Chris Cogbill, MD",Positive
 CLL,CLL Ireland,Positive
 CLL,Gail Williams,Positive
 CLL,CLL Advocates Network,Negative
 CLL,Michael O'Dwyer,Positive
 CLL,QUB Blood Cancer Research,Positive
 CLL,clonoSEQ,Negative
 CLL,IMPACT Medicom,Positive
 CLL,CONQUER the patient voice,Positive
 CLL,CancerTherapyAdvisor,Positive
 CLL,Touch-type Read and Spell (TTRS),Positive
 CLL,National Comprehensive Cancer Network (NCCN),Negative
 CLL,chetan padghan,Positive
 CLL,"Andrew Johns, MD",Positive
 CLL,Andrew Schorr,Positive
 CLL,Leukaemia Care,Positive
 CLL,@linfopedia,Positive
 CLL,TrialBulletin,Negative
 CLL,CURE Magazine,Negative
 CLL,Medscape Education,Negative
 CLL,Dr.Virendra Singh,Positive
 CLL,Michael Hallek,Negative
 CLL,Anthony Mato,Positive
 CLL,Adam Kittai,Negative
 CLL,CAR-TCR,Positive
 CLL,Joe Fournet,Positive
 CLL,Coping with Cancer,Negative
 CLL,Brave Is Now¬Æ,Positive
 CLL,CLLSA,Positive
 CLL,Jerry Clay English Hub,Positive
 CLL,HemOnc Today,Negative
 CLL,Elaine Schattner,Positive
 CLL,ESCofNJ,Positive
 CLL,FEDERICO GAITI,Positive
 CLL,Simple Charts,Positive
 CLL,Carolyn Matyjanka,Positive
 CLL,Hospital del Mar_Translational Hematology,Positive
 CLL,BeiGene,Negative
 CLL,LLZ Consulting,Negative
 CLL,Esther Schorr,Positive
 CLL,Anas Nasir,Positive
 CLL,Jenn,Positive
 CLL,Kenneth M. Garofalo,Positive
 CLL,CryptoLiveLeak,Positive
 CLL,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Positive
 CLL,David -mogeladze,Positive
 CLL,Cure Cancer,Positive
 CLL,Expert Perspectives in Oncology,Positive
 CLL,MD Anderson Cancer Center,Negative
 CLL,Fleur Peters,Positive
 CLL,Oncology Learning Network,Positive
 CLL,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Positive
 CLL,AstraZenecaUS,Negative
 CLL,Robert Z. Orlowski,Negative
 CLL,MD Anderson Leukemia,Positive
 CLL,LiveTracker¬Æ,Positive
 CLL,"Pharmacyclics, an AbbVie Company",Positive
 CLL,Club Libertad Limpe√±o,Negative
 CLL,WheelieDealer,Negative
 CLL,CLL Warwick Uni,Negative
 CLL,"Bruce Levine, Ph.D.",Positive
 CLL,Penn Path & Lab Medicine,Positive
 CLL,Pro-CME,Positive
 CLL,Penn IFI,Positive
 CLL,Eduardo Flavio Oliveira Ribeiro,Negative
 CLL,LYMPHOMA & MYELOMA CONNECT,Negative
 CLL,Patient Empowerment Network,Positive
 CLL,"Cowan, Liebowitz",Negative
 CLL,RazzleTazzle,Positive
 CLL,NEJM,Negative
 CLL,Hematolog√≠a Salamanca,Negative
 CLL,Nela Klein-Gonz√°lez,Positive
 CLL,üá≤üáΩ Leonardo Collado-Torres,Positive
 CLL,Saad kenderian,Positive
 CLL,Prof John,Positive
 CLL,CellworksLife,Positive
 CLL,UCI Health,Negative
 CLL,BloodCancerCure,Negative
 CLL,JanssenUS,Positive
 CLL,Shouting at people in my underpants,Negative
 CLL,genuinedrugs123,Positive
 CLL,Manan Ja,Positive
 CLL,keep in luv,Positive
 CLL,Diving News,Negative
 CLL,Petra Kodeda,Positive
 CLL,Kjetil Tasken,Positive
 CLL,Miss Joyce,Positive
 CLL,Milton Aranha,Positive
 CLL,Lampe & Company,Negative
 CLL,Blood Cancer UK Research,Negative
 CLL,HEORO,Negative
 CLL,Biobanking.com,Positive
 CLL,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 CLL,aeses.com,Positive
 CLL,S.K.,Positive
 CLL,Susan Ehret,Positive
 CLL,Leukemia Research Foundation,Negative
 CLL,cafepharma,Negative
 CLL,Green Tea HP,Positive
 CLL,Francesc Bosch,Positive
 CLL,Cancer_Tribune,Positive
 CLL,Cyberknife,Positive
 CLL,"Raul Cordoba, MD, PhD",Positive
 CLL,Neil Sankar,Positive
 CLL,BBC Current Affairs,Positive
 CLL,Hannah Davis,Positive
 CLL,WhatNext.com,Positive
 CLL,Clinical Trials,Positive
 CLL,RIOH,Negative
 CLL,SurvivalGear,Positive
 CLL,Dr Amrish,Positive
 CLL,US Banking News,Positive
 CLL,ASCO,Positive
 CLL,medXclusive Learning,Positive
 CLL,iOncoAnalytics,Positive
 CLL,AU Oncology Reviews,Positive
 CLL,joeyetta is FERGUSON,Positive
 CLL,CARE‚Ñ¢ Education,Negative
 CLL,osakahiro,Positive
 CLL,MarketBeat,Positive
 CLL,NACDA Program on Aging,Positive
 CLL,Lisa Palacios,Negative
 CLL,Cancer And I,Negative
 CLL,EPR Network,Positive
 CLL,ACGS,Positive
 CLL,Broker Ratings,Positive
 CLL,Predictive Analytics,Positive
 CLL,"Neil Sankar M.D.,MPH",Positive
 CLL,Dr. Jos√© A. Queiz√°n,Negative
 CLL,hematologist,Negative
 CLL,Penn Medicine News,Positive
 CLL,ivy science,Positive
 CLL,Hematon,Negative
 CLL,iwCLL,Negative
 CLL,PathGeek,Positive
 CLL,Dr. Melody Davis,Positive
 CLL,Matthews & Associates,Positive
 CLL,Isaura R. Penin,Positive
 CLL,Christopher Steer,Positive
 CLL,Anna Deveau,Negative
 CLL,Liquid Grids,Positive
 CLL,Oxford Nanopore,Positive
 CLL,Lymphoma News Today,Positive
 CLL,Ana Rosa Rubio,Positive
 CLL,"Darcy Burbage, DNP, RN, AOCN",Negative
 CLL,"Meagan Bryan, RN",Negative
 CLL,1stOncology,Negative
 CLL,balaji jegannathan,Positive
 CLL,"Dr T. Comeau , MD",Negative
 CLL,Mike Hennessy,Positive
 CLL,Sanne v‚≠ïn Wüíâssen,Positive
 CLL,Elma Research,Positive
 CLL,David A. Cohen,Negative
 CLL,Canadian Health & Family,Positive
 CLL,MoJo,Negative
 CLL,Maria Goreth,Negative
 CLL,AJMC,Positive
 CLL,GRACE,Negative
 CLL,AJMC-Oncology,Positive
 CLL,Miriam Fallon,Positive
 CLL,Dr. JOSE VELASQUEZ,Positive
 CLL,Current Oncology,Negative
 CLL,Mednet (was: Medidact),Positive
 CLL,Clin Adv Hem Onc,Negative
 CLL,Oncology.TV,Negative
 CLL,jonathan r goodman,Positive
 CLL,Diaceutics PLC,Negative
 CLL,LLSCanada,Negative
 CLL,Rachel Webster,Positive
 CLL,Team Intake.Me,Positive
 CLL,Light The Night NCA,Positive
 CLL,"Anne Villeneuve-Magness, PhD",Positive
 CLL,Business Wire-Health,Negative
 CLL,BusinessWireServices,Negative
 CLL,SeguidorFinanzas,Positive
 CLL,Doctors Lounge,Negative
 CLL,Oncology Consortium,Positive
 CLL,AJHO,Positive
 CLL,Lymphoma Coalition,Positive
 CLL,Birger Armstrong üí¨,Positive
 CLL,Dana-Farber,Negative
 CLL,JediPD,Negative
 CLL,Moreaux J√©r√¥me,Positive
 CLL,Cord Blood News,Negative
 CLL,David Kroll,Positive
 CLL,Ahmad Halwani,Positive
 CLL,The Leukemia & Lymphoma Society,Negative
 CLL,TawasulLinks ÿ™ŸàÿßÿµŸÑ,Negative
 CLL,BioProcessing - Informa Connect,Positive
 CLL,[iito] Life Science,Positive
 CLL,Ferez Nallaseth,Positive
 CLL,CLL Info,Negative
 CLL,Scott Merville,Negative
 CLL,Scott Werntz,Positive
 CLL,GenPath Oncology,Negative
 CLL,Clinical Epidemiology journal,Positive
 CLL,Dove Press Patient,Positive
 CLL,DovePressTherapeutic,Positive
 CLL,Ana Catarina Bento,Positive
 CLL,PANNA SHARMA,Positive
 CLL,Jon Henderson üçªüç∫ üíõüíô,Positive
 CLL,Haider Alleg,Positive
 CLL,Neel Fotedar,Negative
 CLL,Kainjoo,Positive
 CLL,treatmybrand,Positive
 CLL,Dr. Leona Saunders,Positive
 CLL,CLL,Positive
 CLL,Long Stop,Positive
 CLL,Healthy & Active,Positive
 CLL,Michael Rahman,Positive
 CLL,LINE AGENT,Positive
 CLL,Los Lobos,Negative
 England,N Wales Cancer Forum,Positive
 England,Pharma News,Negative
 England,Blood Cancer Uncensored,Negative
 England,CLL Advocates Network,Negative
 England,MedPage Oncology,Negative
 England,pharmaphorum,Negative
 England,Client-Pharma Ltd,Positive
 England,Tommy D,Positive
 England,Mike Ward,Negative
 decisions,N Wales Cancer Forum,Positive
 decisions,JanssenUS,Negative
 decisions,Patient Power,Negative
 decisions,Kim Kirchherr,Negative
 Wales,N Wales Cancer Forum,Positive
 Wales,CLL Ireland,Negative
 Wales,CLL Advocates Network,Negative
 Wales,Client-Pharma Ltd,Positive
 AstraZeneca Calquence acalabrutinib,European Pharmaceutical Review,Negative
 AstraZeneca Calquence acalabrutinib,PHARMABOX.IN,Negative
 AstraZeneca Calquence acalabrutinib,PharmaShots - Incisive news in 3 shots,Positive
 AstraZeneca Calquence acalabrutinib,HealthcarePRwire,Positive
 AstraZeneca Calquence acalabrutinib,Regulatory Jobs,Positive
 AstraZeneca Calquence acalabrutinib,Client-Pharma Ltd,Positive
 AstraZeneca Calquence acalabrutinib,Yemen News,Positive
 AstraZeneca Calquence acalabrutinib,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥,Positive
 AstraZeneca Calquence acalabrutinib,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥ - Í±¥Í∞ï,Positive
 AstraZeneca Calquence acalabrutinib,Financial Buzz,Negative
 AstraZeneca Calquence acalabrutinib,Business Wire-Health,Negative
 AstraZeneca Calquence acalabrutinib,Business Wire-TS,Negative
 AstraZeneca Calquence acalabrutinib,BusinessWireProducts,Negative
 AstraZeneca Calquence acalabrutinib,The Pharmaceutical Marketing Group,Negative
 AstraZeneca Calquence acalabrutinib,Gilles Gallant,Positive
 AstraZeneca Calquence acalabrutinib,Duncan Young,Positive
 chemotherapyfree monotherapy,European Pharmaceutical Review,Negative
 chronic lymphocytic,European Pharmaceutical Review,Negative
 chronic lymphocytic,Cpl Life Sciences,Negative
 chronic lymphocytic,Company News HQ,Negative
 chronic lymphocytic,GraniteShares Europe,Positive
 chronic lymphocytic,ESMO - Eur. Oncology,Negative
 chronic lymphocytic,WCM Lymphoma,Negative
 chronic lymphocytic,Medivizor,Positive
 chronic lymphocytic,i3 Health,Positive
 chronic lymphocytic,pharmaphorum,Negative
 chronic lymphocytic,Healio,Positive
 chronic lymphocytic,HemOnc Today,Positive
 chronic lymphocytic,Lampe & Company,Negative
 chronic lymphocytic,CellworksLife,Negative
 chronic lymphocytic,Patient Power,Negative
 chronic lymphocytic,KeiraSmith_i3Health,Positive
 chronic lymphocytic,CLLSA,Negative
 chronic lymphocytic,Alaric DeArment,Positive
 chronic lymphocytic,JanssenUS,Positive
 chronic lymphocytic,Annette Hay,Positive
 chronic lymphocytic,MEI Pharma,Positive
 chronic lymphocytic,ATOPP Summit,Positive
 chronic lymphocytic,MyPathologyReport.ca,Negative
 chronic lymphocytic,Janssen EMEA,Negative
 chronic lymphocytic,Cord Blood News,Negative
 chronic lymphocytic,NCI Media Relations,Positive
 chronic lymphocytic,Dana-Farber,Positive
 chronic lymphocytic,ASH Clinical News,Positive
 chronic lymphocytic,Lymphoma Papers,Negative
 chronic lymphocytic,Gianluigi Zangari del Balzo,Negative
 chronic lymphocytic,ColumbiaCancer,Positive
 chronic lymphocytic,BlueBee,Positive
 chronic lymphocytic,Professione Oculista,Positive
 chronic lymphocytic,Barry Shrier,Negative
 chronic lymphocytic,noel cole,Negative
 chronic lymphocytic,MedPage Oncology,Positive
 chronic lymphocytic,AASM SleepTM,Positive
 chronic lymphocytic,Stefano Cattaneo DVM,Positive
 chronic lymphocytic,AbbVie,Negative
 chronic lymphocytic,"Pharmacyclics, an AbbVie Company",Positive
 chronic lymphocytic,Blood Journal,Positive
 chronic lymphocytic,MD Anderson Cancer Center,Positive
 chronic lymphocytic,CELLINK,Positive
 chronic lymphocytic,researchjobs.cz,Positive
 chronic lymphocytic,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 chronic lymphocytic,Human Immunology News,Negative
 chronic lymphocytic,OncLive.com,Negative
 chronic lymphocytic,Hematology Advisor,Negative
 chronic lymphocytic,NCI Center for Cancer Research,Positive
 chronic lymphocytic,Targeted Oncology,Positive
 chronic lymphocytic,OKCHEM,Positive
 chronic lymphocytic,Catherine Vel√°zquez,Positive
 chronic lymphocytic,Mary Ruberry,Positive
 chronic lymphocytic,Genentech,Positive
 chronic lymphocytic,Cancer Discovery,Negative
 chronic lymphocytic,Anubhav Srivastava,Positive
 chronic lymphocytic,Broad Institute,Positive
 chronic lymphocytic,Nature Reviews Disease Primers,Positive
 chronic lymphocytic,Leukaemia Cancer,Positive
 chronic lymphocytic,"Scot Ackerman, M.D.",Positive
 chronic lymphocytic,Life Science Jobs,Negative
 chronic lymphocytic,Janssen Global,Negative
 chronic lymphocytic,"W. Keith Hoots, M.D.",Positive
 chronic lymphocytic,ACS Journal Cancer,Positive
 chronic lymphocytic,AJMC,Positive
 chronic lymphocytic,Cancer News,Negative
 chronic lymphocytic,Health Adviser,Positive
 chronic lymphocytic,Dr. Drew Dahlgren,Positive
 chronic lymphocytic,Univ. of Rochester School of Medicine & Dentistry,Positive
 chronic lymphocytic,UR Medicine,Positive
 chronic lymphocytic,SIAM,Positive
 chronic lymphocytic,Hematology Conference,Positive
 chronic lymphocytic,National Cancer Institute,Negative
 chronic lymphocytic,MDLinx,Negative
 chronic lymphocytic,suetodd16,Positive
 chronic lymphocytic,Medklik,Negative
 chronic lymphocytic,Roche,Positive
 chronic lymphocytic,Visitor_Z,Positive
 chronic lymphocytic,ReR üåê,Positive
 chronic lymphocytic,"Bruce Levine, Ph.D.",Positive
 chronic lymphocytic,The Lancet Oncology,Negative
 chronic lymphocytic,H4B Boston,Positive
 chronic lymphocytic,Future Oncology,Positive
 chronic lymphocytic,Reaction Biology,Positive
 chronic lymphocytic,AbbVie Canada,Negative
 chronic lymphocytic,JAMA Network Open,Negative
 chronic lymphocytic,sandrineman,Negative
 chronic lymphocytic,OncologyNurseAdvisor,Positive
 chronic lymphocytic,MD Anderson Library,Negative
 chronic lymphocytic,RTI Health Solutions,Negative
 chronic lymphocytic,Collegium Ramazzini,Positive
 chronic lymphocytic,Science Disseminat..,Positive
 chronic lymphocytic,Cancer Papers,Positive
 chronic lymphocytic,Cancer Research Institute,Positive
 chronic lymphocytic,J Immunol,Negative
 chronic lymphocytic,Dr. Andre Goy,Positive
 chronic lymphocytic,Open Access Gov,Positive
 chronic lymphocytic,Advances in Therapy,Negative
 chronic lymphocytic,"Raul Cordoba, MD, PhD",Positive
 chronic lymphocytic,Atrium Health Navicent,Positive
 chronic lymphocytic,Diseases-Disorders,Positive
 chronic lymphocytic,RewiseMD,Positive
 chronic lymphocytic,JTCancerCenter,Positive
 chronic lymphocytic,Nature Genetics,Positive
 chronic lymphocytic,California Partnership for Access to Treatment,Positive
 chronic lymphocytic,ICGEB Official,Positive
 chronic lymphocytic,Chan Cheah,Negative
 chronic lymphocytic,The James,Negative
 chronic lymphocytic,TweetedScience,Negative
 chronic lymphocytic,Genetic Engineering & Biotechnology News,Negative
 chronic lymphocytic,Oncology Times,Negative
 chronic lymphocytic,Lymphoma Research Foundation,Positive
 chronic lymphocytic,Sumit Middha,Positive
 chronic lymphocytic,Genetics at BMC,Positive
 chronic lymphocytic,Regulatory Jobs,Positive
 chronic lymphocytic,"SLIMS by Genohm, A part of Agilent",Positive
 chronic lymphocytic,Atlantis Healthcare,Positive
 chronic lymphocytic,MedWatch News,Positive
 chronic lymphocytic,Encore BioMed,Positive
 chronic lymphocytic,EMJ Hematology,Negative
 chronic lymphocytic,Station X,Positive
 chronic lymphocytic,Biologics by McKesson,Negative
 chronic lymphocytic,American Cancer Society,Positive
 chronic lymphocytic,Gitte Pedersen,Positive
 chronic lymphocytic,STRT Boston,Positive
 chronic lymphocytic,VJHemOnc,Positive
 chronic lymphocytic,Clin Adv Hem Onc,Negative
 chronic lymphocytic,Michelle Holder,Positive
 chronic lymphocytic,British Journal of Clinical Pharmacology,Positive
 chronic lymphocytic,"BernadetteHromin,MD",Positive
 chronic lymphocytic,LARVOL,Negative
 chronic lymphocytic,NACDA Program on Aging,Negative
 chronic lymphocytic,Indian Med Guru,Positive
 chronic lymphocytic,Future Science OA,Positive
 chronic lymphocytic,Complete True Life,Positive
 chronic lymphocytic,McCann Health Medical Communications,Positive
 chronic lymphocytic,1stOncology,Positive
 chronic lymphocytic,www.releaseinsider.com,Positive
 chronic lymphocytic,Med-IQ,Positive
 chronic lymphocytic,JAAD Journals,Negative
 chronic lymphocytic,doctor chris,Positive
 chronic lymphocytic,Biotech-Spain.com,Positive
 chronic lymphocytic,Oncology Central,Positive
 chronic lymphocytic,Gilead Sciences,Positive
 chronic lymphocytic,HemaCare Corporation,Negative
 chronic lymphocytic,Cancer Treatment Centers of America (CTCA),Positive
 chronic lymphocytic,Dr Jobin Shaeri,Positive
 chronic lymphocytic,AtlanticJOMedicine,Negative
 chronic lymphocytic,Mayo Clinic,Positive
 chronic lymphocytic,JAMA Oncology,Negative
 chronic lymphocytic,Matthias Piesche,Negative
 chronic lymphocytic,myCME,Negative
 chronic lymphocytic,MD Anderson Leukemia,Negative
 chronic lymphocytic,CAPO,Positive
 chronic lymphocytic,Michael Fisch MD MPH,Positive
 chronic lymphocytic,"Johanna Craig, PhD.",Positive
 chronic lymphocytic,antonio ramon mu√±oz,Positive
 chronic lymphocytic,Cleveland Clinic MD,Negative
 Superstar,Graham Collins,Negative
 CLL patients,CLL Ireland,Positive
 CLL patients,Michele Nadeem-Baker,Negative
 CLL patients,David Ledger,Positive
 CLL patients,40:40 Recruitment,Positive
 CLL patients,Pharma Business Int,Negative
 CLL patients,Saleh Stevens,Negative
 CLL patients,Everything Pharma,Positive
 CLL patients,Pharma Trader,Positive
 CLL patients,Barry Curry,Positive
 CLL patients,PharmaTimes,Positive
 CLL patients,Pharma Regulatory,Negative
 CLL patients,CLL Society Inc.,Positive
 CLL patients,Andrew Schorr,Positive
 CLL patients,Paperbirds_Hematology,Positive
 CLL patients,CCO Infectious Disease,Positive
 CLL patients,Patient Power,Positive
 CLL patients,PharmAnt,Positive
 CLL patients,Patient Empowerment Network,Positive
 CLL patients,Ariez BV,Positive
 CLL patients,CLLSA,Positive
 CLL patients,Faheema Hasan,Positive
 CLL patients,Joseph Shatzel,Positive
 CLL patients,VJHemOnc,Negative
 CLL patients,Donna Gairns,Positive
 CLL patients,the limbic,Negative
 CLL patients,ISBT Central Office,Negative
 CLL patients,Toby Eyre,Negative
 CLL patients,Bionest Partners,Negative
 CLL patients,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 CLL patients,Nick,Negative
 CLL patients,Lymphoma Hub,Positive
 CLL patients,Leukemia Research Foundation,Negative
 CLL patients,‚öæÔ∏èüèÄ‚öΩÔ∏èüé∏ü•Åüéßüé´ü§øüèäüèº‚Äç‚ôÇÔ∏èüèù,Positive
 CLL patients,Cancer Medicine,Positive
 CLL patients,Sherie Masse,Positive
 CLL patients,Stephen Brown,Negative
 CLL patients,Shankara Paneesha,Negative
 CLL patients,Blood Buff,Positive
 drug,CLL Ireland,Negative
 drug,ExpPharma,Positive
 drug,CNN Philippines,Positive
 drug,Prof Archie D'Souza,Positive
 drug,ToxiVen,Positive
 drug,13WREX,Positive
 drug,ahealthierphilly,Negative
 drug,PhillyVoice,Positive
 drug,delthia ricks üî¨,Positive
 drug,TAP Clinical Trial Network,Negative
 drug,BioCanRx - Canada's Immunotherapy Network,Positive
 drug,"Prasad Wakchaure, PhD üáÆüá≥ üá∏üá™",Positive
 drug,Downtown News,Positive
 drug,Cool FM News,Positive
 drug,DowntownCountry News,Positive
 drug,Sheikh Anvakh - ÿßŸÑŸÇÿ∑ Ÿäÿ±ŸäÿØ ÿßŸÑÿ∑ÿπÿßŸÖ ŸÖÿ±ÿ© ÿ£ÿÆÿ±Ÿâ,Positive
 drug,Shouting at people in my underpants,Negative
 drug,Vineeth Sukrithan,Positive
 drug,The PMI (Pharmaceutical Managers' Institute),Negative
 drug,Pharmacy News & Research,Positive
 drug,MDedge Hematology & Oncology,Positive
 drug,"Matthew Matasar, MD",Positive
 drug,Mike Ward,Negative
 drug,Pietro Di Ciaccio,Positive
 drug,PharmaFactz,Positive
 drug,Phronetik,Positive
 drug,Ohio State Pharmacy,Positive
 drug,Dr Musa Fares Alzahrani,Negative
 drug,Diagnostics News,Negative
 drug,Roots Analysis,Negative
 drug,Nagy √Åkos,Positive
 drug,The James,Negative
 drug,Local 12/WKRC-TV,Positive
 drug,"Scot Ackerman, M.D.",Positive
 drug,WCM Lymphoma,Negative
 drug,Andrew Schorr,Positive
 drug,pharmaphorum,Negative
 drug,PLN,Positive
 drug,Derek Clarke,Negative
 drug,Marilyn Heine,Positive
 drug,Rockefeller U. Press,Positive
 drug,Plexus Ventures,Negative
 drug,"Raul Cordoba, MD, PhD",Negative
 drug,Dale Godfrey,Positive
 drug,ValueBase,Positive
 drug,MedWatch News,Positive
 drug,MedflixS,Positive
 drug,European Pharmaceutical Review,Negative
 drug,The Weinberg Group,Positive
 drug,AIS Health,Negative
 drug,Tolero Pharma,Positive
 drug,Mohamed Elamin Awad,Positive
 drug,Lymphoma Hub,Negative
 drug,Christopher Steer,Negative
 drug,Nigel Ten Fleming,Positive
 Ibrutinib,CLL Ireland,Positive
 Ibrutinib,TrialSite News,Positive
 Ibrutinib,Silas Inman,Positive
 Ibrutinib,OncLive.com,Positive
 Ibrutinib,Value's Vector,Positive
 Ibrutinib,Devdiscourse,Negative
 Ibrutinib,LiveSquawk,Positive
 Ibrutinib,Andrew Schorr,Negative
 Ibrutinib,Garbi√±e Lizeaga,Positive
 Ibrutinib,ACIR.org,Positive
 Ibrutinib,Chimeric Antigen Receptor T-Cell (CAR-T),Positive
 Ibrutinib,#Memory,Positive
 Ibrutinib,Lymphoma Papers,Positive
 Ibrutinib,TumorImmunoPapers,Positive
 Ibrutinib,OncLive SOSS,Positive
 Ibrutinib,"Michael Wang, MD",Positive
 Ibrutinib,Anirban Maitra,Negative
 Ibrutinib,CCO Oncology,Positive
 Ibrutinib,Immuno-Oncology,Negative
 Ibrutinib,Frank Zambrano,Positive
 Ibrutinib,Jerry Lee,Positive
 Ibrutinib,Lymphomation.org,Positive
 Ibrutinib,PracticeUpdate,Positive
 Ibrutinib,ClinOwl Haematology,Negative
 Ibrutinib,"Tom Henry, MBA, RPh, CPh",Positive
 Ibrutinib,Stock Market Catalyst News üåé,Positive
 Ibrutinib,Biotech & Tech Stock Focus,Negative
 Ibrutinib,Dan Brickner,Positive
 Ibrutinib,STOCKMASTER2000,Positive
 Ibrutinib,"OTC Dynamics, Inc.",Positive
 Ibrutinib,Stock News Bot,Positive
 Ibrutinib,Stock Titan,Positive
 Ibrutinib,Paperbirds_Hematology,Positive
 Ibrutinib,Benlazar S.M Amin√©,Positive
 Ibrutinib,CureHuntr,Positive
 Ibrutinib,TrialBulletin,Positive
 Ibrutinib,Krishan Maggon,Positive
 Ibrutinib,Lisa Palacios,Positive
 Ibrutinib,WCM Lymphoma,Negative
 Ibrutinib,Michael Rynne,Negative
 Ibrutinib,"Mike Thompson, MD, PhD, FASCO",Negative
 Ibrutinib,Journal of the @NCCN,Negative
 Ibrutinib,AJMC,Positive
 Ibrutinib,SAGE Clinical Med,Positive
 Ibrutinib,UofU3i,Positive
 Ibrutinib,NK papers,Negative
 Ibrutinib,Cancer Papers,Positive
 Ibrutinib,Physician's Weekly,Positive
 Ibrutinib,Boya Wang,Positive
 Ibrutinib,MD Anderson Leukemia,Positive
 Ibrutinib,arun achuthan/dr/mr,Positive
 Ibrutinib,"Wafik S. El-Deiry, MD, PhD, FACP",Positive
 Ibrutinib,ImmunotherapyPapers,Negative
 Ibrutinib,Oncology,Positive
 Ibrutinib,"Naveen Pemmaraju, MD",Negative
 Ibrutinib,Pharmacutical Daily,Positive
 Ibrutinib,Crwe World,Negative
 Ibrutinib,Biotech2050,Positive
 Ibrutinib,dough,Negative
 Ibrutinib,Jake,Negative
 Ibrutinib,The Stock Sniper,Positive
 Ibrutinib,TraderZ,Positive
 Ibrutinib,Amp Trades,Negative
 Ibrutinib,ASCO Publications,Negative
 Ibrutinib,Mahmoud Aljurf,Positive
 Ibrutinib,ClinicalTrialsData,Positive
 Ibrutinib,Medivizor,Positive
 Ibrutinib,RIOH,Negative
 Ibrutinib,Chocolatiere Phys,Positive
 Ibrutinib,Oncology Times,Positive
 Ibrutinib,Phronetik,Positive
 Ibrutinib,JAAPA,Positive
 Ibrutinib,Anthony Mato,Positive
 Ibrutinib,E Lambrechts,Positive
 Ibrutinib,James Kerwin,Positive
 Ibrutinib,chonsone,Positive
 Ibrutinib,Francesco Bertoni,Negative
 Ibrutinib,Bone Marrow Transplantation,Positive
 Ibrutinib,"Hawkins Gay, MD, MPH",Positive
 Ibrutinib,Vin√≠cius Molla,Positive
 Ibrutinib,"chadi nabhan MD, MBA, FACP",Positive
 Ibrutinib,Robert Z. Orlowski,Negative
 Ibrutinib,Will,Positive
 Ibrutinib,JAMA Network Open,Positive
 Ibrutinib,"Raul Cordoba, MD, PhD",Positive
 Ibrutinib,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 Ibrutinib,Jenn,Positive
 Ibrutinib,donnashort,Negative
 Ibrutinib,CellworksLife,Positive
 Ibrutinib,Cure Cancer Now,Positive
 Ibrutinib,Hematology Advisor,Negative
 Ibrutinib,"Georgios Pongas, MD",Positive
 Ibrutinib,YGLDMETG,Positive
 Ibrutinib,"Dr T. Comeau , MD",Positive
 Ibrutinib,Oncology Tube,Positive
 Ibrutinib,Izaskun Zeberio,Positive
 Ibrutinib,Juan Marquet,Negative
 Ibrutinib,Claire Harrison,Positive
 Ibrutinib,"Lymphoma, Leukemia & Myeloma Congress",Positive
 Ibrutinib,Great Debates in Hematologic Malignancies,Negative
 Ibrutinib,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 Ibrutinib,Razan Mohty,Positive
 Ibrutinib,Oncology Learning Network,Negative
 Ibrutinib,Kenar Jhaveri,Positive
 Ibrutinib,ALI ALAHMARI.,Positive
 Ibrutinib,Konstantinos Vlachos,Positive
 Ibrutinib,Prof John,Positive
 Ibrutinib,Florent Malard,Negative
 Ibrutinib,"PXN, board-certified prostitute",Positive
 Ibrutinib,Philip McCarthy,Negative
 Ibrutinib,Dr. Jos√© A. Queiz√°n,Negative
 Ibrutinib,Montse Carrere,Positive
 Ibrutinib,Merche Gironella,Positive
 Ibrutinib,Medicine Briefly,Negative
 Ibrutinib,Hematolog√≠a Salamanca,Positive
 Ibrutinib,Adriana Aguilar,Positive
 Ibrutinib,Al-Ola A Abdallah MD,Positive
 Ibrutinib,HemOnc Today,Positive
 Ibrutinib,ASH Clinical News,Negative
 Ibrutinib,Healio,Negative
 Ibrutinib,Cancer Library VCC,Positive
 Ibrutinib,Eduardo Flavio Oliveira Ribeiro,Negative
 Ibrutinib,GEDEFO,Positive
 Ibrutinib,"Bachar Samra, MD",Positive
 Ibrutinib,Semmelweis University CompBio Group,Positive
 Ibrutinib,Targeted Oncology,Positive
 Ibrutinib,The Lancet Haematology,Negative
 Ibrutinib,NEJM,Positive
 Ibrutinib,Roy Tindle,Positive
 Ibrutinib,LIVINGSTRONGTV.COM,Positive
 Ibrutinib,YoBuzz,Negative
 Ibrutinib,BeyondIgY‚Ñ¢,Positive
 Ibrutinib,Cancer News,Positive
 Ibrutinib,Patrick J. Hanley üß¨,Positive
 Ibrutinib,Dr.Alberto Mussetti,Negative
 Ibrutinib,European Hematology Association,Negative
 Ibrutinib,Toby Eyre,Negative
 Ibrutinib,The Oncologist,Positive
 Ibrutinib,CLL Advocates Network,Negative
 Ibrutinib,NCI CTEP Clinical Research,Positive
 Ibrutinib,Taylor Lab UM,Negative
 Ibrutinib,The ASCO Post,Positive
 Ibrutinib,Medscape,Negative
 Ibrutinib,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Positive
 Ibrutinib,Talal Hilal ü©∫,Negative
 Ibrutinib,Miguel Perales M.D.,Positive
 Ibrutinib,"W. Keith Hoots, M.D.",Negative
 Ibrutinib,MedPage Today,Negative
 Ibrutinib,Carlos Chiattone,Positive
 Ibrutinib,Cureus,Negative
 Ibrutinib,World Neonatology Congress,Positive
 Ibrutinib,Dr Anya Hotinski,Positive
 Ibrutinib,NEJM Journal Watch,Positive
 Ibrutinib,OncologyNurseAdvisor,Negative
 Ibrutinib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Ibrutinib,CancerTherapyAdvisor,Positive
 Ibrutinib,"Stephen Cohen, MD",Positive
 Ibrutinib,Aitana,Negative
 Ibrutinib,Elsevier Oncology,Positive
 Ibrutinib,Nick,Positive
 Ibrutinib,CLLSA,Positive
 Ibrutinib,ImmunologyPapers,Negative
 Ibrutinib,Juan Luis Steegmann,Positive
 Ibrutinib,Kuro_Unplugged,Positive
 Ibrutinib,CLL Society Inc.,Positive
 Ibrutinib,Blood Research & Hematologic Diseases,Positive
 Ibrutinib,Anna Deveau,Negative
 Ibrutinib,CIDEGEN,Positive
 Ibrutinib,JAMA Oncology,Negative
 Ibrutinib,Suvir Singh,Positive
 Ibrutinib,COPD News,Negative
 Ibrutinib,Renal Cell Carcinoma,Negative
 Ibrutinib,Chan Cheah,Negative
 Ibrutinib,Lymphoma Canada,Negative
 Ibrutinib,Christopher Steer,Positive
 Ibrutinib,Cancer And I,Negative
 Ibrutinib,Mehmet Tuna,Positive
 Ibrutinib,Shohta Kadomura Hospital Pharmacist,Negative
 Ibrutinib,Immune Regulation News,Negative
 Ibrutinib,Wendy Carvotta,Positive
 Ibrutinib,ivy science,Positive
 Ibrutinib,Penn Medicine News,Positive
 Ibrutinib,Lymphoma Hub,Positive
 Ibrutinib,Fighting the Fight,Positive
 Ibrutinib,Evidera,Positive
 Ibrutinib,Dr. Melody Davis,Positive
 Ibrutinib,SOBRAFO,Positive
 Ibrutinib,Oncology Board,Negative
 Ibrutinib,"Philippe Aftimos, MD",Positive
 Ibrutinib,Joseph Shatzel,Positive
 Ibrutinib,NACDA Program on Aging,Positive
 Ibrutinib,Tracia.my.tupperware.com,Positive
 Ibrutinib,GRACE,Negative
 Ibrutinib,Hematopoiesis News,Negative
 Ibrutinib,CARE‚Ñ¢ Education,Negative
 Ibrutinib,CADTH,Negative
 Ibrutinib,Doctors*Overseas,Negative
 Ibrutinib,knowmedge,Positive
 Ibrutinib,EMJ Hematology,Positive
 Ibrutinib,MD Anderson Library,Negative
 Ibrutinib,AJMC-Oncology,Negative
 Ibrutinib,Mohammad Alhomoud,Positive
 Ibrutinib,Atlantis Healthcare,Positive
 Ibrutinib,Blood Cancer UK,Negative
 Ibrutinib,Clin Adv Hem Onc,Negative
 Ibrutinib,XpertDox,Positive
 Ibrutinib,Tolga Artan,Positive
 Ibrutinib,"Robinson Ortiz, MD",Negative
 Ibrutinib,Patient Power,Negative
 Ibrutinib,JaimePerezdeOteyza,Positive
 Ibrutinib,Connie Batlevi,Positive
 Ibrutinib,VJHemOnc,Negative
 Ibrutinib,rattenniMD,Positive
 Ibrutinib,Kimryn Rathmell,Positive
 Ibrutinib,Roel Verhaak,Positive
 Ibrutinib,Emilio Monte,Positive
 Ibrutinib,John,Negative
 Ibrutinib,Feeds Medicina,Positive
 Ibrutinib,Tim Fenske,Negative
 Ibrutinib,Muzaffar Qazilbash,Positive
 Ibrutinib,Pico üíâüíâ,Positive
 Ibrutinib,ŸÖÿ±ŸÉÿ≤ ÿßŸÑÿ£ÿ®ÿ≠ÿßÿ´,Positive
 Ibrutinib,doctorportal,Negative
 Ibrutinib,Florian Slimano,Negative
 Ibrutinib,"Barbara McGrath, PhD",Positive
 Ibrutinib,"Jeremy Warner MD, MS, FAMIA, FASCO",Positive
 Ibrutinib,Shankara Paneesha,Negative
 Ibrutinib,Rafael Fonseca MD,Positive
 Ibrutinib,MDLinx,Negative
 Ibrutinib,Tom Heston,Negative
 Ibrutinib,MoJo,Negative
 Ibrutinib,Tom,Positive
 Ibrutinib,Michael O'Dwyer,Positive
 Ibrutinib,Richard Schilsky,Positive
 Ibrutinib,FarmaOnco,Negative
 Ibrutinib,Emma Judson,Positive
 Ibrutinib,"Tom Iarocci, MD",Negative
 Ibrutinib,Jesus F Sierra,Positive
 Ibrutinib,Cancer Cell,Negative
 Ibrutinib,"Michael Green, PhD",Negative
 Ibrutinib,Hematology Review,Positive
 Ibrutinib,Science agent,Positive
 Ibrutinib,Pharm Digest,Negative
 Ibrutinib,Bill Rodgers,Negative
 Ibrutinib,Survival Plan Kits,Negative
 Ibrutinib,Olivier Elemento,Negative
 Ibrutinib,michael.naafs,Positive
 Ibrutinib,Douglas Allan,Positive
 Ibrutinib,Blood Buff,Positive
 Ibrutinib,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Ibrutinib,[iito] Life Science,Positive
 Ibrutinib,Sandra Kear,Positive
 Ibrutinib,CHS Chief Resident,Positive
 Ibrutinib,Francesco Turturro,Negative
 Ibrutinib,"Dr Mrinal Ranjan, MD",Positive
 Ibrutinib,EMJ Rheumatology,Positive
 Ibrutinib,Scott Werntz,Negative
 UK Acalabrutinib,CLL Ireland,Negative
 Optimal Management,Mice Ideas,Positive
 HighRisk CLL,Mice Ideas,Positive
 HighRisk CLL,Silas Inman,Negative
 HighRisk CLL,OncLive.com,Negative
 Acalabrutinib March,Mice Ideas,Positive
 pm,Mice Ideas,Positive
 pm,Patient Empowerment Network,Positive
 pm,CLLSA,Positive
 pm,AnCan,Negative
 pm,Lurie Cancer Center,Negative
 pm,Te Atatu Roosters Rugby League,Positive
 pm,STTR Cancer,Positive
 pm,"Bionano Genomics, Inc.",Positive
 pm,ESCofNJ,Negative
 pm,DawnKA,Positive
 pm,Joe,Negative
 pm,Siteman Cancer Center,Positive
 pm,Patient Power,Positive
 pm,UNMC Pathology & Microbiology,Negative
 pm,Robert Z. Orlowski,Negative
 pm,"W. Keith Hoots, M.D.",Positive
 pm,FDA Oncology,Negative
 pm,BCNI,Negative
 pm,CLL Warwick Uni,Negative
 pm,"Pharmacyclics, an AbbVie Company",Positive
 pm,UCI Health,Positive
 pm,Mount Sinai LIVE,Positive
 pm,Michael Towner,Positive
 pm,NWCR - UoL,Positive
 pm,3'z Company YT,Positive
 pm,Francisco,Negative
 pm,Emily Drake üò∑ #AYACSM,Positive
 pm,ASU Art,Positive
 pm,Matthew Kauffman,Positive
 pm,NC Chapter LLS ,Positive
 pmSpeaker,Mice Ideas,Positive
 Dr P G Subramanian Mumbai Speaker    Group Captain Dr Harshit Khurana PuneChair Dr S H,Mice Ideas,Positive
 Advani MumbaiModerator Dr M B Agarwal MumbaiLink,Mice Ideas,Positive
 Acalabrutinib,Farooq A Wandroo,Positive
 Acalabrutinib,Lymphoma Papers,Positive
 Acalabrutinib,mednetnews,Positive
 Acalabrutinib,OncLive.com,Positive
 Acalabrutinib,Silas Inman,Positive
 Acalabrutinib,Paperbirds_Hematology,Positive
 Acalabrutinib,TYR Kinase papers,Negative
 Acalabrutinib,DZBB Super Radyo,Positive
 Acalabrutinib,Benlazar S.M Amin√©,Positive
 Acalabrutinib,Pepvax Inc,Negative
 Acalabrutinib,NwokeAgulu,Negative
 Acalabrutinib,Medivizor,Positive
 Acalabrutinib,PracticeUpdate,Negative
 Acalabrutinib,Prashant Mehta,Positive
 Acalabrutinib,Urology,Positive
 Acalabrutinib,Oncology,Positive
 Acalabrutinib,David Henry,Positive
 Acalabrutinib,Univadis,Positive
 Acalabrutinib,MEDWAVE,Negative
 Acalabrutinib,Thiago Carvalho,Positive
 Acalabrutinib,Medscape Pharmacists,Positive
 Acalabrutinib,EJ,Positive
 Acalabrutinib,Medscape,Positive
 Acalabrutinib,Medscape Oncology,Positive
 Acalabrutinib,INDoximity üáÆüá≥,Positive
 Acalabrutinib,clinicaltherapeutics,Positive
 Acalabrutinib,Oncology Tube,Positive
 Acalabrutinib,filippo masini,Positive
 Acalabrutinib,Targeted Oncology,Positive
 Acalabrutinib,CureHuntr,Positive
 Acalabrutinib,TrialBulletin,Positive
 Acalabrutinib,Stem Cells in the News,Positive
 Acalabrutinib,Stem cell Watch,Positive
 Acalabrutinib,Oncology News Update,Positive
 Acalabrutinib,Mahmoud Aljurf,Positive
 Acalabrutinib,The ASCO Post,Positive
 Acalabrutinib,"Tom Henry, MBA, RPh, CPh",Negative
 Acalabrutinib,Renal & Urology News,Positive
 Acalabrutinib,Amer. Urol. Assn.,Positive
 Acalabrutinib,CancerTherapyAdvisor,Positive
 Acalabrutinib,Trip Database,Negative
 Acalabrutinib,ESMO - Eur. Oncology,Negative
 Acalabrutinib,Pete Afrasiabi,Negative
 Acalabrutinib,Latika,Positive
 Acalabrutinib,SAyub Mazher,Positive
 Acalabrutinib,GK,Positive
 Acalabrutinib,Oncology Board,Negative
 Acalabrutinib,FarmaciaHUAP,Negative
 Acalabrutinib,National Comprehensive Cancer Network (NCCN),Negative
 Acalabrutinib,LymphomaAction,Negative
 Acalabrutinib,CLL Advocates Network,Negative
 Acalabrutinib,Jerry Lee,Positive
 Acalabrutinib,abej,Negative
 Acalabrutinib,MedNet,Positive
 Acalabrutinib,Le√≥n Waxtein  M.,Positive
 Acalabrutinib,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 Acalabrutinib,Ana L√≥pez,Positive
 Acalabrutinib,Karlos (wear a fucking mask),Positive
 Acalabrutinib,Pedro Vall√≠n,Positive
 Acalabrutinib,David Garc√≠a Marco,Positive
 Acalabrutinib,Marc Kaufman MD MS üò∑,Positive
 Acalabrutinib,Benyam Muluneh,Positive
 Acalabrutinib,ASCO Publications,Negative
 Acalabrutinib,Crwe World,Positive
 Acalabrutinib,ahealthierphilly,Negative
 Acalabrutinib,Immuno-Oncology,Positive
 Acalabrutinib,Health Evangelists,Positive
 Acalabrutinib,Daily Coronavirus News üò∑üåçüìà,Positive
 Acalabrutinib,Amir,Positive
 Acalabrutinib,Lou,Positive
 Acalabrutinib,Peter Nash,Positive
 Acalabrutinib,Paul,Positive
 Acalabrutinib,nigelj,Positive
 Acalabrutinib,PhillyVoice,Positive
 Acalabrutinib,Arsalan Ashraf,Positive
 Acalabrutinib,Bob Turner,Positive
 Acalabrutinib,K Pavithran,Positive
 Acalabrutinib,Joseph Aslan,Positive
 Acalabrutinib,Medical Dialogues,Positive
 Acalabrutinib,Manam,Positive
 Acalabrutinib,ClinOwl Oncology,Positive
 Acalabrutinib,ALI ALAHMARI.,Positive
 Acalabrutinib,Lymphoma Hub,Negative
 Acalabrutinib,"Anastasios Raptis, MD",Positive
 Acalabrutinib,Hallwang Clinic,Positive
 Acalabrutinib,Famela and Friends,Positive
 Acalabrutinib,MHC,Positive
 Acalabrutinib,Tom Heston,Negative
 Acalabrutinib,renalRCTs,Positive
 Acalabrutinib,Oncology Nursing News,Negative
 Acalabrutinib,Anthony Mato,Positive
 Acalabrutinib,Krishan Maggon,Positive
 Acalabrutinib,Juan Marquet,Negative
 Acalabrutinib,Young Hematologists,Positive
 Acalabrutinib,Michael Rynne,Negative
 Acalabrutinib,Dalia ElGamal,Positive
 Acalabrutinib,Cure Cancer Now,Positive
 Acalabrutinib,Jason Broderick,Negative
 Acalabrutinib,"Prasad Wakchaure, PhD üáÆüá≥ üá∏üá™",Positive
 Acalabrutinib,Andrew Schorr,Negative
 Acalabrutinib,Garbi√±e Lizeaga,Negative
 Acalabrutinib,JAVIER DE LA SERNA,Positive
 Acalabrutinib,ASH Clinical News,Positive
 Acalabrutinib,Renal Cell Carcinoma,Positive
 Acalabrutinib,Adam Kittai,Negative
 Acalabrutinib,ACIR.org,Positive
 Acalabrutinib,Cancer Discovery,Positive
 Acalabrutinib,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 Acalabrutinib,#Memory,Positive
 Acalabrutinib,TumorImmunoPapers,Negative
 Acalabrutinib,OncLive SOSS,Positive
 Acalabrutinib,Nicolas Zarjevski,Positive
 Acalabrutinib,COPD News,Negative
 Acalabrutinib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Acalabrutinib,HemOnc Today,Positive
 Acalabrutinib,"Mark Geyer, M.D.",Positive
 Acalabrutinib,The Lancet Haematology,Negative
 Acalabrutinib,Alan Skarbnik,Positive
 Acalabrutinib,Lung Cancer News,Positive
 Acalabrutinib,"BioRealty, Inc.",Positive
 Acalabrutinib,"Raul Cordoba, MD, PhD",Negative
 Acalabrutinib,ADIL Med Monitor,Positive
 Acalabrutinib,Dr. Linex,Negative
 Acalabrutinib,"Caner Saygin, MD",Positive
 Acalabrutinib,Phil Talamo,Negative
 Acalabrutinib,"Matthew Davids, MD, MMSc",Positive
 Acalabrutinib,"Michael Wang, MD",Positive
 Acalabrutinib,SpecialtyPTimes,Positive
 Acalabrutinib,Suchitra Sundaram,Positive
 Acalabrutinib,HealthEconBot,Positive
 Acalabrutinib,noel cole,Negative
 Acalabrutinib,Delreo Johnson,Positive
 Acalabrutinib,Which e Cars,Positive
 Acalabrutinib,Andy Vermaut,Positive
 Acalabrutinib,A Nasser Nourallah. MD.FASCO,Positive
 Acalabrutinib,Joe Librescu,Positive
 Acalabrutinib,"Andres Chang, MD, PhD",Positive
 Acalabrutinib,Patient Worthy,Negative
 Acalabrutinib,Chocolatiere Phys,Positive
 Acalabrutinib,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Acalabrutinib,Blood Advances,Negative
 Acalabrutinib,Cancer News,Positive
 Acalabrutinib,ecancer,Negative
 Acalabrutinib,CLL Society Inc.,Positive
 Acalabrutinib,GEDEFO,Negative
 Acalabrutinib,"Maria Badillo, MSN RN OCN CCRP",Negative
 Acalabrutinib,JTCancerCenter,Positive
 Acalabrutinib,Marcelo Bellesso üáßüá∑üë®‚Äçüë©‚Äçüëß‚Äçüëßüî¨üìöüé∏,Positive
 Acalabrutinib,U-M Rogel Cancer Center,Positive
 Acalabrutinib,Toby Eyre,Negative
 Acalabrutinib,Oncology Times,Negative
 Acalabrutinib,Dean Calhoun,Positive
 Acalabrutinib,Êµ∑Â§ñ„Åå„ÇìÂåªÁôÇÊÉÖÂ†±„É™„Éï„Ç°„É¨„É≥„Çπ,Positive
 Acalabrutinib,Philip Bachour,Positive
 Acalabrutinib,"Pharmacy, Medications, & Health Blog",Positive
 Acalabrutinib,Connie Batlevi,Negative
 Acalabrutinib,Francesco Bertoni,Positive
 Acalabrutinib,BioNews,Positive
 Acalabrutinib,Lymphoma News Today,Positive
 Acalabrutinib,Mednet (was: Medidact),Positive
 Acalabrutinib,CLL Ireland,Negative
 Acalabrutinib,Federal Practitioner,Positive
 Acalabrutinib,The Lancet,Positive
 Acalabrutinib,Daniel Ernst,Positive
 Acalabrutinib,Devona Williams,Positive
 Acalabrutinib,MD Anderson Cancer Center,Negative
 Acalabrutinib,CTOAM,Positive
 Acalabrutinib,JM Mart√≠nez Sesmero #StopTheVirus,Positive
 Acalabrutinib,Silver Valley Doctor,Positive
 Acalabrutinib,The Purple Society,Negative
 Acalabrutinib,GoFIR,Negative
 Acalabrutinib,Jenn Joy,Positive
 Acalabrutinib,Mar√≠a Jos√© Calasanz,Positive
 Acalabrutinib,Cancer Library VCC,Positive
 Acalabrutinib,Daryl McGrath,Positive
 Acalabrutinib,ARB,Positive
 Acalabrutinib,"David Dahan, PhD",Positive
 Acalabrutinib,Carla Casulo,Positive
 Acalabrutinib,Dr. Erel Joffe,Positive
 Acalabrutinib,Lampe & Company,Negative
 Acalabrutinib,Ethical Recruiters,Positive
 Acalabrutinib,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Positive
 Acalabrutinib,OncologyNurseAdvisor,Negative
 Acalabrutinib,AJPB_Journal,Positive
 Acalabrutinib,@INSIGHTHealth,Positive
 Acalabrutinib,Bursatil Biotech,Positive
 Acalabrutinib,VHSPL,Positive
 Acalabrutinib,OyeCricket.com,Positive
 Acalabrutinib,"Les Yonemoto, MD MBA",Positive
 Acalabrutinib,jason gill,Positive
 Acalabrutinib,Stephen Clark,Positive
 Acalabrutinib,Alan Teh,Positive
 Acalabrutinib,MyelomaLymphoma,Positive
 Acalabrutinib,Medical HotSpot,Positive
 Acalabrutinib,"Matthew Matasar, MD",Positive
 Acalabrutinib,Lymphoma Canada,Positive
 Acalabrutinib,"Khan, BA",Positive
 Acalabrutinib,Pedro Perdomo M,Positive
 Acalabrutinib,Elizabeth Ramirez,Positive
 Acalabrutinib,American Preclinical,Negative
 Acalabrutinib,Sue Mockus,Positive
 Acalabrutinib,CancerConnect,Negative
 Acalabrutinib,pharmatutor,Positive
 Acalabrutinib,Pharma Business Int,Negative
 Acalabrutinib,Pharmaceutical News,Positive
 Acalabrutinib,SUMIT SHARMA,Negative
 Acalabrutinib,Graham Collins,Negative
 Acalabrutinib,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Acalabrutinib,Sheila A. Crowe,Positive
 Acalabrutinib,Biotechnology,Positive
 Acalabrutinib,Corixis,Positive
 Acalabrutinib,Biotech World,Positive
 Acalabrutinib,Pharmaceutical,Positive
 Acalabrutinib,WheelieDealer,Negative
 Acalabrutinib,Cision News,Negative
 Acalabrutinib,Raquel O√±a Navarrete,Positive
 Acalabrutinib,Stockboard Media Inc,Negative
 Acalabrutinib,"chadi nabhan MD, MBA, FACP",Negative
 Acalabrutinib,Oncologiavet,Negative
 Acalabrutinib,Hematology News,Negative
 Acalabrutinib,Anirban Maitra,Positive
 Acalabrutinib,Maxim,Positive
 Acalabrutinib,Oncology Practice,Positive
 Acalabrutinib,Crown Bioscience,Negative
 Acalabrutinib,Regulatory Jobs,Positive
 Acalabrutinib,Prestige_Pharma,Positive
 Acalabrutinib,Ira Kholmyansky,Positive
 Acalabrutinib,3BL Health,Positive
 Acalabrutinib,Digital-Ontology,Positive
 Acalabrutinib,Global Pharma News,Negative
 Acalabrutinib,Mohammed Saied Faraj,Positive
 Acalabrutinib,SmartRx Systems,Positive
 Acalabrutinib,Beyond the Pill 2015,Positive
 Acalabrutinib,Mktingfarmaceutico,Positive
 Acalabrutinib,PISPOpharma,Positive
 Acalabrutinib,MyMexicanStore,Positive
 Acalabrutinib,World Pharma News,Negative
 Acalabrutinib,David Ledger,Negative
 Acalabrutinib,Gunel Huseynova,Positive
 Acalabrutinib,"Neil Sankar M.D.,MPH",Positive
 Acalabrutinib,SwanBio,Positive
 Acalabrutinib,Sravani Ganji,Positive
 Acalabrutinib,Oncology Report,Positive
 Acalabrutinib,disabled_jake,Positive
 Acalabrutinib,FarmaOnco,Negative
 Acalabrutinib,PER,Negative
 Acalabrutinib,Lucas Pueyo,Positive
 Acalabrutinib,Philip McCarthy,Negative
 Acalabrutinib,Kristen Hallam,Positive
 Acalabrutinib,Dr Musa Fares Alzahrani,Negative
 Acalabrutinib,New Article Bot,Positive
 Acalabrutinib,"Jeremy Warner MD, MS, FAMIA, FASCO",Positive
 Acalabrutinib,tehmina tahir,Positive
 Acalabrutinib,Cancer Cell,Negative
 Acalabrutinib,NEJM,Negative
 forms,Farooq A Wandroo,Positive
 forms,Joe,Positive
 forms,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 forms,LymphomaAction,Negative
 forms,People Who UK,Positive
 CLL NICE,Farooq A Wandroo,Positive
 monotherapy option,Helen Oram,Negative
 adults,Helen Oram,Negative
 adults,Cardio-Targets,Positive
 adults,Lymphoma Papers,Positive
 adults,Paperbirds_Hematology,Positive
 adults,Targeted Oncology,Negative
 adults,"Brand Institute, Inc",Negative
 adults,CNBC-TV18,Negative
 adults,"KOLKATA RAVI SPECIALITIES PHARMA PVT.LTD.,",Positive
 adults,delhi-ravi worldwide medicines,Positive
 adults,OncLive.com,Negative
 adults,ADIL Med Monitor,Positive
 adults,Vijaya L,Positive
 adults,MDEdge,Negative
 adults,MDedge Hematology & Oncology,Positive
 adults,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 adults,FDA Oncology,Negative
 adults,Health Canada and PHAC,Positive
 adults,Trip Database,Negative
 adults,National Cancer Institute,Negative
 adults,ASH Clinical News,Negative
 adults,GRACE,Negative
 adults,NCICancerTrials,Positive
 adults,Lambda Kappa Sigma,Positive
 adults,OncologyNurseAdvisor,Positive
 adults,Carolyn Thompson,Negative
 adults,Hlthnews,Negative
 adults,SchwietermanPharmacy,Positive
 adults,tristatemedicalgroup,Negative
 adults,PRINCE ADEKOYA,Negative
 adults,Kaup Pharmacy,Positive
 adults,Marcrom's Pharmacy,Negative
 adults,Bengal Rx,Positive
 adults,Churchill Pharmacy,Positive
 adults,Phipps Pharmacy,Positive
 adults,Custom Compounding,Positive
 adults,Horseshoe Health & M,Negative
 adults,CDS #10 Pharmacy,Positive
 adults,The Medicine Shoppe,Negative
 adults,Greenwood Drug,Negative
 adults,Medicine Shoppe 1822,Positive
 adults,Medicine To Go,Negative
 adults,Sullivan'sGifts,Positive
 adults,Joseph Pharmacy,Positive
 adults,Greenhill Pharmacy,Positive
 adults,Scott Pharmacy,Positive
 adults,Greenbrier Pharmacy,Positive
 adults,Sam's Health Mart,Positive
 adults,Brehme Drug,Positive
 adults,Food City RX Marion,Negative
 adults,Crown Pharmacy,Positive
 adults,LibertyHillPharmacy,Positive
 adults,Hopkinton Drug,Negative
 adults,Delran Pharmacy,Positive
 adults,Fox Drug of Torrance,Negative
 adults,Hartzells Pharmacy,Positive
 adults,Cascade Custom RX,Positive
 adults,Coastal Pharmacy,Positive
 adults,Valley Pharmacy,Positive
 adults,Rare Disease Report,Positive
 adults,European Pharmaceutical Review,Negative
 adults,Farmacia Nenna,Positive
 adults,Dr. Andre Goy,Negative
 adults,Coping with Cancer,Negative
 adults,CancerCare,Negative
 adults,Salutedomani,Positive
 adults,Antonio Caperna,Positive
 adults,saluteH24.com,Positive
 adults,Derma News OK,Positive
 adults,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 adults,Ancora.ai Cancer Clinical Trials for All,Positive
 adults,David Wang,Positive
 adults,Oncology Nursing News,Negative
 adults,DelveInsight,Positive
 adults,Oncology Learning Network,Negative
 adults,CLL Ireland,Negative
 adults,JanssenUS,Negative
 adults,"Pharmacyclics, an AbbVie Company",Negative
 adults,Leukaemia Cancer,Positive
 adults,HemOnc Today,Positive
 adults,Dr. Melody Davis,Negative
 adults,Michele Nadeem-Baker,Negative
 adults,iwCLL,Positive
 adults,Pharmafocus,Negative
 adults,Adaptive Biotech,Negative
 with‚Ä¢a p ¬† deletion,Helen Oram,Negative
 TP,Helen Oram,Positive
 TP,TeamHaem,Positive
 TP,Paperbirds_Hematology,Positive
 TP,GenQA (Genomics Quality Assessment),Negative
 TP,Michele Nadeem-Baker,Negative
 TP,Juan Marquet,Negative
 TP,"Raul Cordoba, MD, PhD",Negative
 TP,CLL-seq,Negative
 TP,"Caner Saygin, MD",Negative
 TP,microRNApapers,Negative
 TP,Blood Journal,Negative
 mutation or‚Ä¢no p ¬† deletion,Helen Oram,Negative
 mutation,Helen Oram,Negative
 mutation,Gianluigi Zangari del Balzo,Negative
 mutation,CEITEC Connect,Negative
 mutation,Gift from a Child,Positive
 mutation,donnashort,Negative
 mutation,VJHemOnc,Negative
 mutation,CLL Ireland,Negative
 mutation,Living Safely,Negative
 fludarabine,Helen Oram,Negative
 fludarabine,OncLive.com,Negative
 fludarabine,Benlazar S.M Amin√©,Positive
 fludarabine,Garbi√±e Lizeaga,Negative
 fludarabine,Total Well Being,Positive
 fludarabine,The Lancet Haematology,Positive
 fludarabine,Dana-Farber News,Positive
 fludarabine,Anna Deveau,Negative
 fludarabine,Marek Trneny,Positive
 fludarabine,Cancer Papers,Negative
 cyclophosphamide,Helen Oram,Negative
 cyclophosphamide,Benlazar S.M Amin√©,Positive
 cyclophosphamide,Garbi√±e Lizeaga,Negative
 cyclophosphamide,Total Well Being,Positive
 cyclophosphamide,Dana-Farber News,Positive
 cyclophosphamide,Cancer Papers,Negative
 FCR,Helen Oram,Negative
 FCR,Toby Eyre,Positive
 FCR,Benlazar S.M Amin√©,Positive
 FCR,Targeted Oncology,Positive
 FCR,Paperbirds_Hematology,Positive
 FCR,OncLive.com,Positive
 FCR,The Lancet Haematology,Negative
 FCR,"chadi nabhan MD, MBA, FACP",Positive
 FCR,"Raul Cordoba, MD, PhD",Positive
 FCR,Oncology Tube,Negative
 FCR,Lymphoma Papers,Negative
 FCR,Marko Skelin MPharm PhD,Positive
 FCR,"Tom Henry, MBA, RPh, CPh",Negative
 FCR,Medscape Education,Negative
 FCR,Diagnostics News,Negative
 FCR,AplusA World,Positive
 FCR,Glenn Sabin,Positive
 FCR,"Mike Thompson, MD, PhD, FASCO",Negative
 FCR,Jeff Szer,Negative
 FCR,Taylor Lab UM,Negative
 FCR,Teresa Martin,Positive
 FCR,"Amber Koehler, PA-C",Negative
 FCR,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 FCR,Patient Power,Negative
 FCR,palliativewise,Positive
 FCR,"Matt Kalaycio, MD",Positive
 FCR,Journal of Clinical Pathways,Negative
 FCR,CLL Ireland,Positive
 FCR,BloodWork,Positive
 FCR,Marek Trneny,Positive
 FCR,CAPhO,Positive
 FCR,NE Live,Negative
 FCR,"F Haroun, MD",Positive
 FCR,Lymphoma Hub,Negative
 FCR,Francesco Turturro,Negative
 FCR,Jeff Folloder,Positive
 FCR,CancerTherapyAdvisor,Positive
 FCR,ASH,Positive
 FCR,Christopher Steer,Negative
 FCR,Chan Cheah,Negative
 bendamustine,Helen Oram,Negative
 bendamustine,NatureRevClinOncol,Negative
 bendamustine,ASH Clinical News,Negative
 bendamustine,OncLive.com,Negative
 bendamustine,Targeted Oncology,Positive
 bendamustine,Lymphoma Papers,Negative
 bendamustine,Paperbirds_Hematology,Positive
 bendamustine,Benlazar S.M Amin√©,Negative
 bendamustine,FarmaciaHUAP,Negative
 bendamustine,Lung Cancer News,Negative
 bendamustine,Mary Ellen Schneider,Negative
 bendamustine,Medivizor,Positive
 bendamustine,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 bendamustine,Garbi√±e Lizeaga,Negative
 bendamustine,Cancer_Tribune,Negative
 bendamustine,"Dr T. Comeau , MD",Negative
 bendamustine,Toby Eyre,Negative
 bendamustine,donnashort,Negative
 bendamustine,US Oncology Network,Positive
 bendamustine,McKesson Corporation,Negative
 bendamustine,MAISA,Negative
 bendamustine,CancerTherapyAdvisor,Negative
 bendamustine,Lymphoma Hub,Positive
 bendamustine,Cancer Papers,Negative
 bendamustine,"Chaitra Ujjani, MD",Positive
 bendamustine,RIOH,Negative
 bendamustine,JADPRO,Negative
 bendamustine,Chan Cheah,Negative
 rituximab BR,Helen Oram,Negative
 brand,HealthWatch,Positive
 brand,Breaking Data,Negative
 brand,Q,Positive
 brand,LGC Mikromol‚Ñ¢,Positive
 New article Phase,Paperbirds_Hematology,Positive
 study,Paperbirds_Hematology,Positive
 study,dough,Negative
 study,CALQUENCE¬Æ (acalabrutinib),Positive
 study,Inquirer,Positive
 study,jovic yee,Positive
 study,Helen Ong,Positive
 study,InfectiousDiseaseAdv,Positive
 study,"COTA, Inc.",Positive
 study,MD Anderson Cancer Center,Negative
 study,LymphomaAction,Negative
 study,Living Safely,Negative
 study,satokun,Positive
 study,Cheryl Amber Dotson,Positive
 study,MediHelp Solutions,Negative
 study,Firstpost,Positive
 study,Nathan Vardi,Negative
 study,WaYs2rOcK,Positive
 study,Outbreak News,Positive
 study,Antibiotic StewardüÜîü¶†Bassam Ghanem,Positive
 study,Forbes Science,Positive
 study,"Michael Wang, MD",Positive
 study,Dr. Andy Evens,Negative
 study,WWFHTX,Positive
 study,Lymphoma Papers,Positive
 study,Oncology Learning Network,Positive
 study,The Lancet Haematology,Negative
 study,Lymphoma Hub,Negative
 study,"Amber Koehler, PA-C",Negative
 study,OncLive.com,Negative
 study,Targeted Oncology,Positive
 study,Sandy Pond GCP,Positive
 study,Biotech2050,Negative
 study,Satyen Gohil,Positive
 study,Taylor Lab UM,Positive
 study,Human Immunology News,Negative
 study,Dana-FarberYAProgram,Positive
 study,"Bionano Genomics, Inc.",Positive
 study,Billy Bostickson üè¥üëÅ&üëÅ üÜì,Positive
 study,Joe,Negative
 study,Journal of the @NCCN,Positive
 study,OncologyNurseAdvisor,Negative
 study,CLL Society Inc.,Positive
 study,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 study,Wolfgang Huber,Positive
 study,UW-Madison Nutri Sci,Positive
 study,CONQUER the patient voice,Positive
 study,Harsh Shah,Positive
 study,Toby Eyre,Positive
 study,"Luisa Torres, PhD",Positive
 study,ASH Clinical News,Negative
 study,PRAJAK BARDE,Positive
 study,"chadi nabhan MD, MBA, FACP",Positive
 study,@balbensi üá∫üá∏ üáÆüáπ,Positive
 study,Blood Journal,Negative
 study,"Raul Cordoba, MD, PhD",Positive
 study,Benlazar S.M Amin√©,Positive
 study,ColumbiaCancer,Positive
 study,Prof John,Negative
 study,ECOG-ACRIN Cancer Research Group,Negative
 study,BeiGene,Negative
 study,i3 Health,Negative
 study,Sarah Williams,Positive
 study,Covaris,Positive
 study,NEJM,Negative
 study,ASBlearns,Positive
 study,COPD News,Negative
 study,CLL Ireland,Positive
 study,MoJo,Negative
 study,Advera Health,Negative
 study,Miguel Perales M.D.,Negative
 study,Danielle Ternyila,Positive
 study,The James,Positive
 study,UCL Discovery,Negative
 study,Novateur Ventures,Positive
 study,Marilyn Heine,Positive
 study,TF binding papers üìö,Positive
 study,Arts and Sciences,Positive
 study,HemOnc Today,Negative
 study,Norm Stahl,Positive
 study,Univadis UK,Positive
 study,cnag-crg,Negative
 study,Blood Advances,Positive
 study,Talbot Research Library & Media Services,Positive
 study,healthbook,Positive
 study,Renal Cell Carcinoma,Negative
 study,Michele Nadeem-Baker,Negative
 study,MAISA,Negative
 study,Algebra.Com,Positive
 study,Crown Equity CRWE,Positive
 study,Alan Teh,Positive
 study,James Porreca,Positive
 study,Penn Medicine News,Negative
 study,Adaptive Biotech,Negative
 study,Anna Deveau,Negative
 study,Holden Caulfield PhD,Positive
 study,"Krishna Komanduri, MD, FASTCT",Positive
 study,Master Li,Positive
 study,WCMNYPJCTO,Negative
 study,Patient Power,Negative
 study,Francesco Turturro,Negative
 study,Tran-Der Tan,Negative
 study,üÖæ Jaksic,Negative
 study,FarmaOnco,Negative
 study,Lymphoma Canada,Negative
 study,WCM Lymphoma,Positive
 study,Nicolas COLLET,Positive
 study,CancerDotNet,Negative
 PATIENTS,Pharma News,Negative
 PATIENTS,Al,Positive
 PATIENTS,Jeremy,Positive
 PATIENTS,Sharp street trading insights,Positive
 PATIENTS,NewsFreak,Positive
 PATIENTS,Breaking Market News,Positive
 PATIENTS,Redbox Global,Positive
 PATIENTS,First Squawk,Positive
 PATIENTS,Hematology,Positive
 PATIENTS,Pacientes LMC,Positive
 PATIENTS,TrialBulletin,Negative
 PATIENTS,Davalyn Corporation,Negative
 PATIENTS,oncoletter,Negative
 PATIENTS,CFPR,Positive
 PATIENTS,satPRnews,Positive
 PATIENTS,Andrew Young,Positive
 PATIENTS,Medibooks,Positive
 CHRONIC LYMPHOCYTIC LEUKAEMIA CLL,Pharma News,Negative
 UK,CLL Ireland,Positive
 UK,Toby Eyre,Positive
 UK,Michael Rynne,Positive
 UK,Lymphoma News Today,Positive
 UK,BioNews,Negative
 UK,Nick,Negative
 UK,LymphomaAction,Positive
 UK,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Positive
 UK,VJHemOnc,Negative
 UK,CLLSA,Negative
 UK,ASH Clinical News,Negative
 UK,CLL_Fightersüéó,Negative
 UK,"Raul Cordoba, MD, PhD",Positive
 UK,Marco Ricci,Positive
 UK,pharmaphorum,Negative
 UK,ValueBase,Positive
 UK,Melanie,Negative
 UK,Medthority,Negative
 UK,Patient Power,Negative
 UK,Lifelong Learning,Negative
 UK,Pharma Commons,Negative
 UK,Scott Werntz,Negative
 NHS use,pharmaphorum,Negative
 NHS use,Pharmafocus,Positive
 NHS use,CLL Ireland,Negative
 NHS use,Margaret Walker,Negative
 BR,Toby Eyre,Positive
 BR,"Andres Chang, MD, PhD",Positive
 BR,OncLive.com,Negative
 BR,CancerWallonia,Negative
 BR,Crwe World,Negative
 BR,Lymphomation.org,Negative
 BR,Suvir Singh,Positive
 BR,Benlazar S.M Amin√©,Positive
 BR,Oncology Tube,Negative
 BR,"chadi nabhan MD, MBA, FACP",Positive
 BR,Taylor Lab UM,Negative
 BR,"Caner Saygin, MD",Negative
 BR,Dr Henry,Positive
 BR,"Raul Cordoba, MD, PhD",Negative
 BR,Jessica Okosun,Positive
 BR,Lymphoma Hub,Positive
 BR,CAPhO,Negative
 BR,NE Live,Negative
 BR,Medscape Pharmacists,Negative
 BR,Medscape Oncology,Negative
 BR,Medscape,Negative
 pts TP mutdel,Toby Eyre,Negative
 Chair,Toby Eyre,Negative
 Chair,Nick,Negative
 Chair,CLLSA,Negative
 Trustees Marc Auckland,Toby Eyre,Negative
 Sky News,Toby Eyre,Negative
 Great news,Toby Eyre,Positive
 Great news,"Amber Koehler, PA-C",Positive
 Great news,Michael Rynne,Negative
 Great news,"Michael Wang, MD",Negative
 Great news,Deborah Stephens,Positive
 Great news,CLL Ireland,Positive
 Great news,LYMPHOMA & MYELOMA CONNECT,Negative
 Great news,Fiona üêû,Positive
 Great news,Myeloid & Lymphoid disorders in practice,Positive
 Great news,Dr. Gwen Nichols,Positive
 Great news,"Raul Cordoba, MD, PhD",Positive
 Great news,Michele Rhee,Positive
 Great news,"Pharmacyclics, an AbbVie Company",Negative
 Great news,Tolero Pharma,Positive
 Great news,SensisHealth,Positive
 Great news,Stephen Brown,Negative
 Great news,Patient Power,Negative
 Great news,Susan Murphy,Positive
   pts,Toby Eyre,Negative
   pts,Andrew Schorr,Positive
   pts,CAPhO,Negative
 Safety,Lymphoma Papers,Positive
 Safety,OncLive.com,Positive
 Safety,onsVegas,Positive
 Safety,Paperbirds_Hematology,Positive
 Safety,clinicaltherapeutics,Negative
 Safety,U-M Rogel Cancer Center,Positive
 Safety,"Raul Cordoba, MD, PhD",Positive
 Safety,Blood Advances,Negative
 Safety,ClinicalTrialsData,Positive
 Safety,TrialBulletin,Positive
 Safety,Biotech2050,Negative
 Safety,CureHuntr,Positive
 Safety,HEDGE accordinglyüìà,Negative
 Safety,Saeed Valadbaygi,Negative
 Safety,pressdaily,Negative
 Safety,Cureus,Negative
 Safety,1stOncology,Negative
 Safety,RazzleTazzle,Negative
 Safety,NASDAQ,Positive
 Safety,"Dr T. Comeau , MD",Negative
 Safety,Oncology Tube,Positive
 Safety,Garbi√±e Lizeaga,Negative
 Safety,BibliotecaHUVH. ICS,Positive
 Safety,"chadi nabhan MD, MBA, FACP",Negative
 Safety,Tom Silver,Negative
 Safety,Cancer Papers,Negative
 Safety,AJMC,Negative
 Safety,Health Adviser,Positive
 Safety,MDRing,Negative
 Safety,AtlanticJOMedicine,Negative
 Antitumor Activity,Lymphoma Papers,Negative
 Antitumor Activity,Krishan Maggon,Negative
 RelapsedRefractory Bcell Malignancies,Lymphoma Papers,Negative
 Congress,Lymphoma Hub,Positive
 Congress,Verastem Oncology,Negative
 results,Lymphoma Hub,Positive
 results,Al Arabiya English,Positive
 results,CURE Magazine,Positive
 results,hemomeeting,Negative
 results,Drug Discovery World,Positive
 results,Antibiotic StewardüÜîü¶†Bassam Ghanem,Positive
 results,Oncology Learning Network,Positive
 results,Philly Bio,Negative
 results,WCM Lymphoma,Positive
 results,Alberto L√≥pez Garc√≠a,Positive
 results,ESMO - Eur. Oncology,Positive
 results,Vijaya L,Positive
 results,BioPharma Dive,Negative
 results,OncLive SOSS,Positive
 results,Targeted Oncology,Positive
 results,CTOAM,Positive
 results,Business Wire-Health,Positive
 results,NE Live,Negative
 results,CheckRare,Positive
 results,CLLSA,Negative
 results,"Bionano Genomics, Inc.",Positive
 results,KeiraSmith_i3Health,Positive
 results,Eli Lilly and Company,Positive
 results,Bristol Myers Squibb,Positive
 results,VJHemOnc,Positive
 results,Haematologica,Positive
 results,donnashort,Negative
 results,CLL Society Inc.,Negative
 results,Adam Kittai,Negative
 results,Journal of Clinical Pathways,Negative
 results,MedPage Oncology,Negative
 results,Managed Healthcare,Positive
 results,GenQA (Genomics Quality Assessment),Positive
 results,ur-trading,Positive
 results,Vegastrader66,Positive
 results,PSK2329 - JHC,Negative
 results,Quant Data,Negative
 results,Hematology Advisor,Negative
 results,ERN EuroBloodNet,Negative
 results,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 results,Vin√≠cius Molla,Positive
 results,Sigrid Sk√•nland,Positive
 results,The Lancet Haematology,Negative
 results,Genentech,Positive
 results,ESCofNJ,Negative
 results,Guillermo Sanz,Negative
 results,Michael Hallek,Negative
 results,"Eric K. Singhi, MD",Positive
 results,ECOG-ACRIN Cancer Research Group,Negative
 results,i3 Health,Negative
 results,Sarah Williams,Positive
 results,MoJo,Negative
 results,Christian Reinhardt,Positive
 results,Beacon Targeted Therapies,Positive
 results,MD Anderson Cancer Center,Negative
 results,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 results,Sarah Sunshine,Positive
 results,Proactive,Negative
 results,CLL Ireland,Positive
 results,Mary Ellen Schneider,Negative
 results,The James,Positive
 results,Medscape,Negative
 results,Jeff Szer,Negative
 results,Casey Foster,Positive
 results,Rare Disease Report,Negative
 results,CLL_Fightersüéó,Negative
 results,"Amber Koehler, PA-C",Negative
 results,AbbVie,Negative
 results,Arjun D. Law,Positive
 results,Research To Practice,Negative
 results,"chadi nabhan MD, MBA, FACP",Negative
 results,Medklik,Negative
 results,Roche,Negative
 results,Blood Journal,Negative
 results,Anna Deveau,Negative
 results,Patient Power,Negative
 results,MAISA,Negative
 results,BiotechInvest,Positive
 results,Cancer Research Institute,Positive
 results,SeattleCancerCareAlliance,Negative
 results,TG Therapeutics,Positive
 results,AlfonsoValencia,Negative
 results,"Raul Cordoba, MD, PhD",Negative
 results,Pathowitter,Positive
 results,AJMC,Negative
 results,Bursatil Biotech,Positive
 results,Michael | È∫¶ÂÖãÂÑø,Positive
 results,Bill Rodgers,Positive
 results,Survival Plan Kits,Positive
 results,Kathryn Stephens,Positive
 results,Science United,Positive
 results,Jessica McDonald,Positive
 results,Biocom California,Positive
 results,Weill Cornell Medicine Meyer Cancer Center,Negative
 results,KModyMD,Positive
 ZUMA study,Lymphoma Hub,Negative
 RR mantel cell lymphoma,Lymphoma Hub,Negative
 morphology,Lymphoma Hub,Negative
 NewTrip Acalabrutinib Calquence,Trip Database,Positive
 treatment,Trip Database,Negative
 treatment,Lyfebulb,Positive
 treatment,BiopharmaAsia,Positive
 treatment,1stOncology,Positive
 treatment,WebWire,Positive
 treatment,LifeProNow-Pharma-Research and News,Negative
 treatment,Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,Negative
 treatment,Cision News,Positive
 treatment,Company News HQ,Positive
 treatment,LARVOL,Positive
 treatment,Benlazar S.M Amin√©,Positive
 treatment,Samir Sheth ‚òï,Positive
 treatment,gRttwit,Positive
 treatment,Lymphoma Hub,Positive
 treatment,Medicircle.in,Positive
 treatment,HealthcarePRwire,Positive
 treatment,IndustryPRwire,Positive
 treatment,Mehrdad Yousefi,Negative
 treatment,GraniteShares Europe,Positive
 treatment,Golden Casino News,Negative
 treatment,CALQUENCE¬Æ (acalabrutinib),Negative
 treatment,BloombergQuint,Positive
 treatment,PINSIDER NEWS,Positive
 treatment,Aaj Ka Samachar,Positive
 treatment,Greg Hunt,Positive
 treatment,Hematology Advisor,Negative
 treatment,CancerTherapyAdvisor,Positive
 treatment,CONQUER the patient voice,Positive
 treatment,ESMO - Eur. Oncology,Positive
 treatment,Dr.Virendra Singh,Positive
 treatment,CLL Advocates Network,Negative
 treatment,The Cancer Letter,Positive
 treatment,WCM Lymphoma,Positive
 treatment,Bonny Wrightüêù,Positive
 treatment,Taylor & Francis Medicine and Health,Positive
 treatment,Famela and Friends,Positive
 treatment,MedShadow Foundation,Positive
 treatment,AIS Health,Positive
 treatment,Oncology Nursing News,Positive
 treatment,Michael Rynne,Negative
 treatment,Shawn Friend,Positive
 treatment,Prestige Scientific,Positive
 treatment,Miguel Angel Grullon C.,Positive
 treatment,OncLive.com,Positive
 treatment,Ancora.ai Cancer Clinical Trials for All,Positive
 treatment,FirstWord Pharma,Positive
 treatment,TGA Australia,Positive
 treatment,Targeted Oncology,Positive
 treatment,NatureRevClinOncol,Positive
 treatment,Oncology Learning Network,Positive
 treatment,Drug Topics,Positive
 treatment,ADIL Med Monitor,Positive
 treatment,Investor News,Positive
 treatment,CancerCare,Negative
 treatment,AstraZenecaUS,Positive
 treatment,Renal Cell Carcinoma,Negative
 treatment,Paperbirds_Hematology,Positive
 treatment,Lymphoma Papers,Positive
 treatment,COPD News,Positive
 treatment,Medivizor,Positive
 treatment,noel cole,Positive
 treatment,"Aaron Logan, MD, PhD, MPhil ‚Äî DONATE BLOOD!",Positive
 treatment,"Bichoy Gabra, R.Ph., Ph.D.",Positive
 treatment,OncLive SOSS,Positive
 treatment,PersonalizeAF,Positive
 treatment,Lampe & Company,Positive
 treatment,"Pharmacy, Medications, & Health Blog",Positive
 treatment,Mayo Clinic Cancer Center,Positive
 treatment,CTOAM,Positive
 treatment,Frank Zambrano,Positive
 treatment,GRACE,Negative
 treatment,NCICancerTrials,Positive
 treatment,Lambda Kappa Sigma,Positive
 treatment,CRWE News Wire,Positive
 treatment,OncologyNurseAdvisor,Positive
 treatment,Rare Disease Report,Positive
 treatment,"Lalit Leonard Sehgal, PhD",Positive
 treatment,StockNews.com,Positive
 treatment,VJHemOnc,Positive
 treatment,American Preclinical,Negative
 treatment,pharmatutor,Positive
 treatment,CBPartners,Positive
 treatment,Lymphoma Canada,Negative
 treatment,Sheila A. Crowe,Positive
 treatment,Briefing.com,Negative
 treatment,Odi Bruckman,Negative
 treatment,984 pharmacy,Positive
 treatment,GDMEDS,Positive
 treatment,ECOG-ACRIN Cancer Research Group,Negative
 treatment,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 treatment,CLL Society Inc.,Positive
 treatment,PROvendis GmbH,Positive
 treatment,Shouting at people in my underpants,Negative
 treatment,defeatHIV,Positive
 treatment,The Indian Pharma,Positive
 treatment,PharmaFactz,Negative
 treatment,WEGO Health,Positive
 treatment,HARMONY Alliance,Negative
 treatment,CURE Magazine,Positive
 treatment,Journal of the @NCCN,Positive
 treatment,Dana-FarberYAProgram,Positive
 treatment,MDBriefCase,Positive
 treatment,JADPRO,Positive
 treatment,Medscape Education,Negative
 treatment,"Pharmacyclics, an AbbVie Company",Positive
 treatment,Felipe de Galiza,Positive
 treatment,Oncology CE,Positive
 treatment,Sigrid Sk√•nland,Positive
 treatment,European Pharmaceutical Review,Negative
 treatment,Current Oncology,Negative
 treatment,Vindico Medical Education,Positive
 treatment,Maddy from GlobalData Healthcare,Positive
 treatment,Research To Practice,Positive
 treatment,H.C. Wainwright & Co.,Positive
 treatment,BioPharma Global,Positive
 treatment,BondJamesBond,Positive
 treatment,"Mazyar Shadman, MD MPH",Positive
 treatment,NIH NHLBI,Negative
 treatment,ASH Clinical News,Positive
 treatment,Patient Empowerment Network,Positive
 treatment,Patient Power,Positive
 treatment,IMPACT Medicom,Positive
 treatment,filippo masini,Negative
 treatment,XIV Raisa Gorbacheva Memorial Meeting,Positive
 treatment,"University of Maryland, Baltimore",Positive
 treatment,Biologics by McKesson,Negative
 treatment,SpecialtyPTimes,Negative
 treatment,PeerView,Negative
 treatment,CLL Ireland,Positive
 treatment,LLSCanada,Negative
 treatment,Frontiers Oncology,Negative
 treatment,Nick,Negative
 treatment,Leukaemia Care,Positive
 treatment,ecancer,Positive
 treatment,TradeHawk,Positive
 treatment,Hetero Healthcare,Positive
 treatment,China Science,Positive
 treatment,JointHealth,Positive
 treatment,J Cancer Sci Ther,Positive
 treatment,Ariez BV,Positive
 treatment,Cord Blood News,Positive
 treatment,"Brand Institute, Inc",Negative
 treatment,"Andreas-Claudius Hoffmann, M.D.",Positive
 treatment,CellworksLife,Positive
 treatment,Oncology Tube,Positive
 treatment,Gear√≥id √ì Crotaigh #CareCantWait,Negative
 treatment,CLLSA,Positive
 treatment,Clinical Lab Manager,Positive
 treatment,MD Anderson Cancer Center,Positive
 treatment,NHLBI Bethesda Labs,Positive
 treatment,CLL Epigenetics,Negative
 treatment,Francesco Bertoni,Positive
 treatment,Will,Negative
 treatment,Maria Tsagiopoulou,Positive
 treatment,Expert Perspectives in Oncology,Positive
 treatment,Teresa Martin,Positive
 treatment,MedPage Oncology,Negative
 treatment,Zusia:Dr Jackie Volk,Positive
 treatment,Alicia Bell IFBB Pro,Negative
 treatment,Simple Charts,Negative
 treatment,MedLibrary.org,Positive
 treatment,CNSA,Positive
 treatment,Diagnostics News,Negative
 treatment,"Raul Cordoba, MD, PhD",Positive
 treatment,GESDAT GmbH,Positive
 treatment,Verastem Oncology,Negative
 treatment,The Medical Letter,Positive
 treatment,dr upendra sharma,Positive
 treatment,Savepig Invest #GotSilver,Positive
 treatment,NEJM,Negative
 treatment,NEJM Resident 360,Positive
 treatment,Crwe World,Negative
 treatment,i3 Health,Negative
 treatment,emilylevitch_i3Health,Positive
 treatment,ImmunologyPapers,Negative
 treatment,Lisa Astor,Positive
 treatment,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Positive
 treatment,The James,Positive
 treatment,Mazen M,Negative
 treatment,The Galien Foundation,Positive
 treatment,digitalLIFE4CE,Positive
 treatment,ipharmacenter,Positive
 treatment,Medicalnewser.com,Positive
 treatment,Muiro Yatakama,Positive
 treatment,Randy S. Benedict,Positive
 treatment,Joe,Negative
 treatment,Michele Nadeem-Baker,Positive
 treatment,AplusA World,Negative
 treatment,The Leukemia & Lymphoma Society,Negative
 treatment,Lymphoma Research Foundation,Positive
 treatment,Jaime Rosenberg,Positive
 treatment,JCM Compounding Knowledge,Positive
 treatment,Wilmot Cancer Institute,Negative
 treatment,Solomon Kamal,Positive
 treatment,AJMC-Oncology,Positive
 treatment,Medklik,Positive
 treatment,Roche,Positive
 treatment,AJMC,Negative
 treatment,MDedge Hematology & Oncology,Positive
 treatment,Anna Deveau,Positive
 treatment,Univadis,Positive
 treatment,Blood Cancer UK Research,Negative
 treatment,GoFIR,Positive
 treatment,PharmacyChecker,Negative
 treatment,Roots Analysis,Positive
 treatment,VuMedi Oncology,Positive
 treatment,FDA Oncology,Positive
 treatment,NEJM Journal Watch,Negative
 treatment,Ravispecialitiespharma_RSP,Positive
 treatment,Helen Jane Mee,Positive
 treatment,Dr. Drew Dahlgren,Positive
 treatment,Cancer News,Negative
 treatment,Andrew Schorr,Positive
 treatment,Marta Crespo,Positive
 treatment,EurekaMag,Positive
 treatment,Blood-Cancer.com,Positive
 treatment,suetodd16,Positive
 treatment,Jayson Johnson,Positive
 treatment,Catherine Vel√°zquez,Positive
 treatment,Genentech,Negative
 treatment,Crown Bioscience,Negative
 treatment,Shine Cancer Support,Positive
 treatment,HemOnc Today,Positive
 treatment,Marilyn Heine,Positive
 treatment,Biotech2050,Negative
 treatment,AbbVie Canada,Negative
 treatment,Teresa Bau,Positive
 treatment,Cancer Papers,Positive
 treatment,Right Write,Positive
 treatment,Margaret Walker,Negative
 treatment,DentalCinicList,Positive
 treatment,Medical Xpress,Negative
 treatment,Christopher Steer,Positive
 treatment,Massimo Martino,Positive
 treatment,Benito,Positive
 treatment,Dr Shushil Choubey,Positive
 treatment,Cristina Popa,Positive
 treatment,Cancer And I,Negative
 treatment,Cleveland Clinic MD,Positive
 treatment,Talal Hilal ü©∫,Negative
 treatment,CIMSFHUVH,Positive
 treatment,Sunesis Pharma,Positive
 treatment,myallhealthtips,Positive
 treatment,Carmine DeLuca,Negative
 treatment,"Dr T. Comeau , MD",Negative
 treatment,Amin G T Amin,Positive
 treatment,HappiDoc,Positive
 treatment,TalkAboutHealth,Positive
 treatment,Medical Daily,Positive
 treatment,Nature Reviews Disease Primers,Negative
 treatment,Bill Both,Positive
 treatment,JLOCF,Positive
 treatment,CARE‚Ñ¢ Education,Negative
 treatment,AbbVie,Positive
 treatment,The ASCO Post,Negative
 treatment,Zack Pemberton-Whiteley,Negative
 treatment,Medthority,Positive
 treatment,TumorImmunoPapers,Positive
 treatment,RIOH,Negative
 treatment,Katie Gould,Positive
 treatment,miguel oliveira,Positive
 treatment,NNY News.ca,Positive
 treatment,Pure Leverage Rep,Positive
 treatment,karin55marin,Positive
 treatment,Thomas Van Ahn,Positive
 treatment,NYC Social Group,Positive
 treatment,TTC,Positive
 treatment,JP Duvenhage,Negative
 treatment,StartupStudio,Negative
 treatment,URL Shortener,Positive
 treatment,Healthcare Industry,Positive
 treatment,Cedar Consultants,Positive
 treatment,Charlotte Biz Owners,Positive
 treatment,Fredi Skwar,Positive
 treatment,I.Gazette,Positive
 treatment,Hanung Nugroho,Positive
 treatment,mediat XEX business,Positive
 treatment,WorldNews,Positive
 treatment,Michel Francoeur,Positive
 treatment,MAISA,Negative
 treatment,Paul Devereaux,Positive
 treatment,Davalyn Corporation,Positive
 treatment,Mca Represenative,Positive
 treatment,indofx,Positive
 treatment,Today's Deals,Positive
 treatment,OyoBoi,Negative
 treatment,Francesco Turturro,Positive
 treatment,Village Pharmacy,Positive
 treatment,Cesar,Positive
 treatment,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 treatment,MedflixS,Positive
 treatment,carlota bernal,Positive
 treatment,Dr Jobin Shaeri,Positive
 treatment,AML Hub,Positive
 treatment,thasso,Positive
 treatment,MedChem & ONCo,Positive
 treatment,Triona N√≠ Chonghaile,Negative
 treatment,Donna Young,Negative
 treatment,Alexis Rae‚úåÔ∏è,Negative
 treatment,GxPeople,Positive
 treatment,GEDEFO,Positive
 treatment,Michael O'Dwyer,Positive
 treatment,Dana-Farber,Negative
 treatment,"Francisco Marty, MD",Negative
 treatment,Tracking Healthcare,Positive
 treatment,ASH,Negative
 treatment,Team In Training-SC,Positive
 treatment,LLS NCFL Chapter,Positive
 treatment,Elias Mokbel,Positive
 treatment,"chadi nabhan MD, MBA, FACP",Negative
 treatment,Mohamed Elamin Awad,Positive
 treatment,Ralph Casale,Positive
 treatment,ACP Massachusetts,Positive
 treatment,qGenomics,Negative
 treatment,Issels Treatment,Positive
 treatment,Winter Genomics,Positive
 treatment,XploreHealth_en,Positive
 treatment,Biotech-Spain.com,Positive
 treatment,Immunology,Positive
 treatment,Clinical Epidemiology journal,Positive
 treatment,Dove Press Patient,Positive
 treatment,DovePressTherapeutic,Positive
 treatment,drsocial.org,Positive
 treatment,Michael R Bishop,Positive
 treatment,UGCFarmacia Hosp. CG,Positive
 treatment,Pharm Digest,Negative
 treatment,Kevin Nacho,Positive
 treatment,Pharma in Focus,Positive
 treatment,palliativewise,Negative
 treatment,Acupath Laboratories,Positive
 treatment,Steve Carpowich,Positive
 treatment,Gilead Sciences,Negative
 Calquence Commercial,Osgood,Positive
 PRETTY Lady,Osgood,Positive
 Solidarity,Thiago Carvalho,Negative
 cancer drug acalabrutinib,Thiago Carvalho,Negative
 cancer drug acalabrutinib,ITSM - Industrial,Positive
 cancer drug acalabrutinib,PINSIDER NEWS,Positive
 cancer drug acalabrutinib,Guwahati News,Positive
 cancer drug acalabrutinib,"MAJ DR B P SINGH,SG Medallist*(SIACHEN GLACIER*)",Positive
 cancer drug acalabrutinib,JINU JAMES,Positive
 cancer drug acalabrutinib,ET Industry News,Positive
 cancer drug acalabrutinib,ETHealthWorld,Positive
 cancer drug acalabrutinib,Aaj Ka Samachar,Positive
 cancer drug acalabrutinib,Ketan,Positive
 cancer drug acalabrutinib,V.V. Ganesha,Positive
 cancer drug acalabrutinib,ThePrint Science,Negative
 cancer drug acalabrutinib,Himani Chandna,Positive
 cancer drug acalabrutinib,ThePrintIndia,Negative
 cancer drug acalabrutinib,A.n.n.,Positive
 cancer drug acalabrutinib,M√≥nica,Positive
 cancer drug acalabrutinib,ReFigure,Positive
 cancer drug acalabrutinib,LiberalFish,Positive
 cancer drug acalabrutinib,Deccan Herald,Positive
 cancer drug acalabrutinib,LCW,Positive
 ICYMI,Kartos Therapeutics,Positive
 ICYMI,Medscape Education,Positive
 ICYMI,Patient Power,Negative
 ICYMI,OncLive SOSS,Negative
 ICYMI,The Lancet Haematology,Positive
 ICYMI,AA&MDSIF,Positive
 ICYMI,AbbVie,Negative
 ICYMI,HemOnc Today,Positive
 ICYMI,LymphomaAction,Negative
 ICYMI,Bio-Collaboration,Negative
 ICYMI,DrugGenius,Positive
 ICYMI,Moffitt Research,Positive
   TiP poster presentation,Kartos Therapeutics,Positive
 IQVIA RDS Argentina SRL,Apoli Naria,Positive
 Argentina,Apoli Naria,Positive
 amp Prevention BV,Apoli Naria,Positive
 Pharma BV,Apoli Naria,Positive
 AstraZeneca AB Amgen,Apoli Naria,Positive
 role,Cardio-Targets,Positive
 role,Lymphoma Papers,Negative
 role,Paperbirds_Hematology,Positive
 role,Jeff Sharman,Positive
 role,Daniel J Drucker,Positive
 role,OncLive.com,Positive
 role,hemomeeting,Negative
 role,Famela and Friends,Positive
 role,Medscape Pharmacists,Negative
 role,Medscape Oncology,Positive
 role,CLL Ireland,Positive
 role,Mayo Clinic Cancer Center,Negative
 role,OncLive SOSS,Positive
 role,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 role,CLL-seq,Negative
 role,MDBriefCase,Positive
 role,Sussex Haematology,Positive
 role,Lili Wang Lab,Positive
 role,Moffitt Cancer Center,Positive
 role,ESH (Haematology),Negative
 role,Benlazar S.M Amin√©,Positive
 role,ASH Clinical News,Positive
 role,Shankara Paneesha,Negative
 role,NACE,Positive
 role,Jerry Clay English Hub,Positive
 role,Medscape Education,Negative
 role,Didi Jasmin,Positive
 role,Lymphoma Hub,Positive
 role,Oncology Tube,Positive
 role,SpecialtyPTimes,Negative
 role,ACCC,Positive
 role,Patient Power,Negative
 role,VJHemOnc,Positive
 role,Expert Perspectives in Oncology,Positive
 role,Future Science OA,Positive
 role,AJMC,Negative
 role,Hospital Medicine Virtual Journal Club,Positive
 role,Cancer Papers,Positive
 role,Silvana Novelli,Positive
 role,Silvia Foster-Frau,Positive
 role,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 role,AU Oncology Reviews,Negative
 role,"chadi nabhan MD, MBA, FACP",Positive
 role,Dr. Andre Goy,Negative
 role,iwCLL,Negative
 role,Andrew Schorr,Negative
 role,Genetics at BMC,Positive
 role,TumorImmunoPapers,Positive
 role,GRACE,Negative
 role,JADPRO,Negative
 role,Blood Journal,Negative
 role,MD Anderson Leukemia,Negative
 role,WCM Lymphoma,Positive
 role,"Navneet Majhail, MD, MS",Negative
 role,TumImmTxpapers,Negative
 role,Robert Z. Orlowski,Negative
 role,Moreaux J√©r√¥me,Positive
 New article,Paperbirds_Hematology,Positive
 New article,FintechZoom,Positive
 New article,Future Science OA,Positive
 New article,RIOH,Negative
 New article,Lymphoma Hub,Positive
 New article,Martin A. Nowak,Positive
 CD,Jeff Sharman,Positive
 CD,DDNews Online,Negative
 CD,PharmaFactz,Negative
 CD,Paperbirds_Hematology,Positive
 CD,EurekaMag,Negative
 CD,Lymphoma Hub,Negative
 CD,Benlazar S.M Amin√©,Negative
 CD,Lymphoma Papers,Positive
 CD,Cancer Papers,Positive
 CD,Frontiers Oncology,Negative
 CD,Ashley Carter,Positive
 CD,Targeted Oncology,Negative
 CD,Continuous Lifecycle London (online),Negative
 CD,CellworksLife,Positive
 CD,Cure Cancer Now,Positive
 CD,"Raul Cordoba, MD, PhD",Positive
 CD,CIB Margarita Salas (CSIC),Positive
 CD,European Hematology Association,Negative
 CD,Journal of Clinical Investigation,Negative
 CD,OTOdocs,Positive
 CD,JournalAgent,Positive
 CD,McHeyzer-Williams,Negative
 CD,Doctors*Overseas,Positive
 CD,"Lazy Intern Doctor, MD",Positive
 CD,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 CD,TumorImmunoPapers,Negative
 CD,Medibooks,Negative
 CD,Lymphomation.org,Negative
 CD,Neel Fotedar,Positive
 CD,Frontiers Immunology,Negative
 addition,Jeff Sharman,Positive
 addition,OncLive.com,Positive
 addition,MAISA,Negative
 addition,OncologyNurseAdvisor,Negative
 addition,"Amber Koehler, PA-C",Negative
 addition,Targeted Oncology,Negative
 addition,JSF Group,Positive
 addition,MedPage Oncology,Negative
 addition,COPD News,Negative
 addition,PER,Negative
 addition,Toby Eyre,Positive
 addition,CURE Magazine,Negative
 addition,Oncology Nursing News,Negative
 addition,Research UMCG,Positive
 addition,medwireNews,Positive
 addition,Lymphoma Hub,Negative
 addition,Dr Timos Papagatsias,Negative
 addition,"Raul Cordoba, MD, PhD",Negative
 addition,Anna Deveau,Negative
 BTK inhibitors,Jeff Sharman,Positive
 BTK inhibitors,Samir Sheth ‚òï,Positive
 BTK inhibitors,Michele Nadeem-Baker,Negative
 BTK inhibitors,"Narinder Grewal, MD",Positive
 BTK inhibitors,Anesthesiology News,Positive
 BTK inhibitors,OncLive.com,Positive
 BTK inhibitors,CLL Advocates Network,Negative
 BTK inhibitors,The Cancer Letter,Negative
 BTK inhibitors,joewhitworth,Positive
 BTK inhibitors,Patient Power,Negative
 BTK inhibitors,Pengyu Yang,Positive
 BTK inhibitors,Kenneth Farber,Positive
 BTK inhibitors,"John P. Leonard, MD",Positive
 BTK inhibitors,"Howard Green, MD",Positive
 BTK inhibitors,Targeted Oncology,Negative
 BTK inhibitors,OncLive SOSS,Positive
 BTK inhibitors,CCO Oncology,Positive
 BTK inhibitors,Sumanta Pal,Positive
 BTK inhibitors,Anirban Maitra,Negative
 BTK inhibitors,VJHemOnc,Negative
 BTK inhibitors,Medscape Education,Positive
 BTK inhibitors,PeerView,Positive
 BTK inhibitors,Lymphoma Hub,Negative
 BTK inhibitors,COPD News,Negative
 BTK inhibitors,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 BTK inhibitors,Oncology Tube,Negative
 BTK inhibitors,Elaine Schattner,Negative
 BTK inhibitors,JADPRO,Negative
 BTK inhibitors,Taylor Lab UM,Negative
 BTK inhibitors,Donna Gairns,Positive
 BTK inhibitors,"Raul Cordoba, MD, PhD",Positive
 BTK inhibitors,CancerTherapyAdvisor,Negative
 comparaci√≥n con ibrutinib,IM M√©dico,Positive
 LLC,IM M√©dico,Positive
 LLC,contacto sciencelink,Negative
 LLC,Felipe Pe√±a Mu√±oz,Positive
 LLC,1stOncology,Positive
 ELEVATERR trial,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 efficacy,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 efficacy,TF 2,Positive
 efficacy,Targeted Oncology,Positive
 efficacy,BioPoint Inc.,Positive
 efficacy,EuropaWire,Negative
 efficacy,ESMO - Eur. Oncology,Positive
 efficacy,OncLive.com,Positive
 efficacy,Saeed Valadbaygi,Negative
 efficacy,OncLive SOSS,Negative
 efficacy,Clarivate Cortellis,Negative
 efficacy,Hematology Board,Negative
 efficacy,Hematology News,Negative
 efficacy,Oncology Practice,Positive
 efficacy,Marc Gozlan,Positive
 efficacy,Medscape Education,Negative
 efficacy,Benlazar S.M Amin√©,Positive
 efficacy,CURE Magazine,Negative
 efficacy,CancerTherapyAdvisor,Negative
 efficacy,ASH Clinical News,Negative
 efficacy,VJHemOnc,Positive
 efficacy,Hematology Advisor,Negative
 efficacy,Lymphoma Hub,Positive
 efficacy,Blood Journal,Negative
 efficacy,"Raul Cordoba, MD, PhD",Positive
 efficacy,Lymphoma Papers,Negative
 efficacy,CONQUER the patient voice,Negative
 efficacy,"Amber Koehler, PA-C",Negative
 efficacy,Paperbirds_Hematology,Negative
 efficacy,Toby Eyre,Negative
 efficacy,Jennifer Smith,Positive
 efficacy,Research UMCG,Positive
 efficacy,Danielle Ternyila,Positive
 efficacy,UCL Discovery,Negative
 efficacy,CLL Ireland,Positive
 efficacy,Anna Deveau,Negative
 efficacy,OncologyNurseAdvisor,Positive
 efficacy,MDedge Hematology & Oncology,Positive
 efficacy,Cancer Papers,Positive
 efficacy,Biotech2050,Positive
 efficacy,"chadi nabhan MD, MBA, FACP",Positive
 efficacy,Flow Paradigm,Negative
 efficacy,David A. Cohen,Negative
 efficacy,Christopher Steer,Negative
 efficacy,Ralph Casale,Positive
 efficacy,WCM Lymphoma,Negative
 efficacy,Patient Power,Positive
 safety tolerability profile,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 CLL Research Acalabrutinib,"Tom Henry, MBA, RPh, CPh",Negative
 Analysis,"Tom Henry, MBA, RPh, CPh",Negative
 Analysis,Industry News Engine,Positive
 Analysis,NwokeAgulu,Negative
 Analysis,OncLive.com,Negative
 Analysis,Oncology Times,Positive
 Analysis,Frontiers Immunology,Negative
 Analysis,Depp Gaikwad,Negative
 Analysis,Lymphoma Papers,Negative
 Analysis,Cytof Manchester,Positive
 Analysis,Yuval Avnir,Positive
 Analysis,Nita Sonwane,Positive
 Analysis,Toby Eyre,Negative
 Analysis,Science Examiner,Positive
 Analysis,EurekaMag,Negative
 Analysis,Adroit Market Research,Positive
 Analysis,CLL-seq,Negative
 Analysis,Industry Today,Positive
 Analysis,UC San Diego ACTRI,Positive
 Analysis,JAMA Oncology,Negative
 Analysis,Blood Journal,Negative
 Analysis,NPCE,Positive
 Analysis,CancerWallonia,Negative
 Analysis,Newsliner.in,Negative
 Analysis,jonathan r goodman,Positive
 Analysis,Business Wire-Health,Positive
 Analysis,"Pharmacyclics, an AbbVie Company",Negative
 Analysis,El gipi,Positive
 Analysis,Laboratory Robotics,Positive
 Analysis,PersonalizedMedicine,Positive
 Analysis,LabAutomation (LRIG),Positive
 Analysis,Automated Storage,Positive
 Analysis,Joe Whittaker,Positive
 Analysis,Genetics report,Positive
 Analysis,GeneScan,Positive
 Analysis,Phil Ochs Ghost,Positive
 Analysis,Surma Health & Info.,Positive
 Analysis,AllCEUs Counselor Education with Dawn-Elise Snipes,Positive
 Analysis,VoyagerMed,Positive
 Analysis,Medi-Science Daily,Positive
 Analysis,Graham Atherton,Positive
 Analysis,National Aspergillosis Centre,Negative
 Analysis,Scott Werntz,Positive
 Analysis,Invest World News,Negative
 Analysis,Financial Buzz,Negative
 Analysis,Paul Lane,Negative
 Analysis,Penny Stock Irish,Negative
 Analysis,Ez2Trade,Negative
 Analysis,Penny Stocks,Negative
 Analysis,IntoxicatedTrader,Negative
 Analysis,Cancer Daily,Negative
 Cardiovascular,"Tom Henry, MBA, RPh, CPh",Negative
 Events,"Tom Henry, MBA, RPh, CPh",Negative
 Events,Adam Curtis Bot,Positive
 Events,Michele Nadeem-Baker,Negative
 Events,CLL Society Inc.,Negative
 Events,Chocolatiere Phys,Negative
 Events,CLL Ireland,Negative
 Events,Andrew Merron,Positive
 Events,Heather Rivet,Positive
 MCL Survival,mednetnews,Negative
 Reason,mednetnews,Negative
 Reason,AJMC,Negative
 Reason,Deborah Stephens,Positive
 Discontinuation,mednetnews,Negative
 Discontinuation,"Raul Cordoba, MD, PhD",Negative
 Mantle Cell Lymphoma Survival,AJMC,Negative
 Acalabrutinib Discontinuation,AJMC,Negative
 CALQUENCE Beneficial,Patient Worthy,Negative
 CLL Study Shows,Patient Worthy,Negative
      Number,Hemalatha Rangarajan MD,Positive
 Mantle Cell Lymphoma Treatment Market,mednetnews,Negative
 Product Type Acalabrutinib JCAR,mednetnews,Negative
 EndUsersApplication,mednetnews,Negative
 Hospital Clinic Market Share Forecast Data InDepth Analysis,mednetnews,Negative
 review,Bita Fakhri,Positive
 review,Hematopoiesis News,Negative
 review,Sigrid Sk√•nland,Negative
 review,clonoSEQ,Negative
 review,Ikemen Mas Kot,Positive
 review,Thomas Eliot Lew,Positive
 review,"Tom Henry, MBA, RPh, CPh",Negative
 review,Toby Eyre,Negative
 review,Dr Effie Kostareli,Negative
 review,Kermit Murray,Positive
 review,Paperbirds_Hematology,Negative
 review,BioMassSpec,Positive
 review,HofNorthwell Kidney,Positive
 review,European Hematology Association,Negative
 review,"Raul Cordoba, MD, PhD",Negative
 review,"chadi nabhan MD, MBA, FACP",Positive
 review,CLLSA,Negative
 review,Cancer Papers,Negative
 review,ESMO - Eur. Oncology,Negative
 review,Waleed Osman,Positive
 review,Patient Power,Negative
 review,CADTH,Negative
 Acalabrutinib Calquence,NCPE,Positive
 Acalabrutinib Calquence,Pharma News,Negative
 Acalabrutinib Calquence,Clarivate Cortellis,Negative
 Acalabrutinib Calquence,Oncology Tube,Positive
 Acalabrutinib Calquence,The Medical Letter,Negative
 Acalabrutinib Calquence,AdisInsight,Positive
 HTA ID,NCPE,Positive
 National Centre,NCPE,Positive
 Pharmacoeconomics,NCPE,Positive
 News von,JOURNAL ONKOLOGIE,Positive
 √§mie,JOURNAL ONKOLOGIE,Negative
 √§mie,Pilgrim,Positive
 √§mie,Daniela Hennrich,Positive
 √§mie,AbbVie Deutschland,Negative
 √§mie,Roche Deutschland,Negative
 video,Oncology Learning Network,Positive
 video,Leukaemia Care,Positive
 video,ecancer,Negative
 video,Pine Biotech,Positive
 video,VJHemOnc,Positive
 video,Medscape Education,Positive
 video,SpecialtyPTimes,Negative
 video,PeerView,Negative
 video,Cancer Support Community,Positive
 video,undead viking zombie,Positive
 video,Targeted Oncology,Negative
 video,Penn Medicine MD,Positive
 video,iwCLL,Negative
 video,Patient Power,Positive
 video,Andrew Schorr,Negative
 video,Blood Cancer UK,Negative
 video,B,Positive
 video,WCM Lymphoma,Negative
 video,Los Lobos,Negative
 Dr Danilov,Oncology Learning Network,Negative
 Dr Danilov,Targeted Oncology,Positive
 Dr Danilov,CLL Society Inc.,Negative
 Dr Danilov,Verastem Oncology,Negative
 treatment option,Oncology Learning Network,Negative
 treatment option,CALQUENCE¬Æ (acalabrutinib),Negative
 treatment option,Jill Hamer-Wilson üá®üá¶,Positive
 treatment option,Cancer Medicine,Positive
 treatment option,Targeted Oncology,Negative
 treatment option,CLL Ireland,Positive
 treatment option,Verastem Oncology,Negative
 treatment option,Leukaemia Care,Negative
 CLL SLL,Oncology Learning Network,Negative
 CLL SLL,"Chester Quan, OD",Negative
 CLL SLL,Medical Sales,Positive
 CLL SLL,Dr. Daniel C,Positive
 CLL SLL,Ahmed Eliwa,Negative
 CLL SLL,"E. Kingreen, MD",Positive
 CLL SLL,ADIL Med Monitor,Positive
 CLL SLL,Easy Body Fitness,Positive
 CLL SLL,Be Healthy News,Positive
 CLL SLL,Mazen M,Negative
 CLL SLL,Drugs.com,Negative
 CLL SLL,Lymphoma Australia,Positive
 CLL SLL,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 MCLWatch,Oncology Learning Network,Negative
 video interview,Oncology Learning Network,Negative
 video interview,ESH (Haematology),Positive
 video interview,Lymphoma Hub,Positive
 video interview,CryptoLiveLeak,Positive
 video interview,NE Live,Negative
 Dr Graff,Oncology Learning Network,Negative
 evolving treatment landscape,Oncology Learning Network,Negative
 evolving treatment landscape,Targeted Oncology,Positive
 evolving treatment landscape,CO_Oncology,Positive
 evolving treatment landscape,Juan Marquet,Negative
 trial investigators,OncLive.com,Negative
 ibrutinib,OncLive.com,Positive
 ibrutinib,BrainSights iOS App,Negative
 ibrutinib,Corporate News,Negative
 ibrutinib,"OTC Dynamics, Inc.",Negative
 ibrutinib,Latest News from Business Wire,Negative
 ibrutinib,IMPharma News,Positive
 ibrutinib,Crwe World,Positive
 ibrutinib,Stock Titan,Positive
 ibrutinib,Jon,Negative
 ibrutinib,Targeted Oncology,Positive
 ibrutinib,Tim Fenske,Negative
 ibrutinib,OncLive SOSS,Positive
 ibrutinib,"Michael Wang, MD",Negative
 ibrutinib,Anna Deveau,Positive
 ibrutinib,Ed,Positive
 ibrutinib,donnashort,Negative
 ibrutinib,Graham Collins,Positive
 ibrutinib,Medivizor,Positive
 ibrutinib,noel cole,Positive
 ibrutinib,American College of Cardiology,Negative
 ibrutinib,Paperbirds_Hematology,Positive
 ibrutinib,"Dr T. Comeau , MD",Positive
 ibrutinib,Benlazar S.M Amin√©,Positive
 ibrutinib,Paul Wright,Negative
 ibrutinib,Lynne Mac Lean,Negative
 ibrutinib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 ibrutinib,Alicia Bell IFBB Pro,Negative
 ibrutinib,Blood Journal,Positive
 ibrutinib,OncologyNurseAdvisor,Positive
 ibrutinib,Lisa Palacios,Negative
 ibrutinib,Lymphoma Hub,Positive
 ibrutinib,HemOnc Today,Positive
 ibrutinib,MasdelMedio,Negative
 ibrutinib,NwokeAgulu,Positive
 ibrutinib,Adam Kittai,Positive
 ibrutinib,"chadi nabhan MD, MBA, FACP",Positive
 ibrutinib,VJHemOnc,Positive
 ibrutinib,Srujana Joga,Positive
 ibrutinib,OncoKB,Positive
 ibrutinib,CancerTherapyAdvisor,Positive
 ibrutinib,Barry Shrier,Positive
 ibrutinib,Victor Lin,Positive
 ibrutinib,GEDEFO,Positive
 ibrutinib,"Steven Artandi, MD, PhD",Negative
 ibrutinib,NCI CTEP Clinical Research,Negative
 ibrutinib,Company News HQ,Positive
 ibrutinib,BuxMont Forum,Positive
 ibrutinib,Lymphoma Papers,Positive
 ibrutinib,Oncology Learning Network,Positive
 ibrutinib,ClinOwl Haematology,Negative
 ibrutinib,@Clinical Practice,Positive
 ibrutinib,Vall d‚ÄôHebron Institute of Oncology (VHIO),Positive
 ibrutinib,Saeed Valadbaygi,Negative
 ibrutinib,Simple Charts,Negative
 ibrutinib,VPO/PR Newswire,Positive
 ibrutinib,The Lancet Haematology,Positive
 ibrutinib,pressdaily,Negative
 ibrutinib,Robert Z. Orlowski,Negative
 ibrutinib,Cancer Frontline,Positive
 ibrutinib,RIOH,Negative
 ibrutinib,Oncology Tube,Negative
 ibrutinib,ALI ALAHMARI.,Positive
 ibrutinib,CancerEpiPapers,Negative
 ibrutinib,SpecialtyPTimes,Negative
 ibrutinib,CenterForBiosimilars,Positive
 ibrutinib,Cancer Stem Cell News,Negative
 ibrutinib,Ïù¥ÏÉÅÏõê,Positive
 ibrutinib,Renal Cell Carcinoma,Positive
 ibrutinib,Toby Eyre,Positive
 ibrutinib,Marko Skelin MPharm PhD,Positive
 ibrutinib,Hematology Advisor,Negative
 ibrutinib,Dana-Farber News,Positive
 ibrutinib,Cancer Education and Research Institute,Positive
 ibrutinib,Pallawi Torka,Positive
 ibrutinib,Charlotte Martin,Positive
 ibrutinib,NEJM,Negative
 ibrutinib,Jennifer Smith,Positive
 ibrutinib,the limbic,Negative
 ibrutinib,Evaluate Pharma,Positive
 ibrutinib,The James,Positive
 ibrutinib,Milo≈° Miljkoviƒá,Positive
 ibrutinib,Beta-BlockerPapers,Positive
 ibrutinib,Clinical Practice,Positive
 ibrutinib,"Amber Koehler, PA-C",Positive
 ibrutinib,Rare Disease Report,Negative
 ibrutinib,ASH Clinical News,Positive
 ibrutinib,Financial Buzz,Positive
 ibrutinib,HEDGE accordinglyüìà,Positive
 ibrutinib,RazzleTazzle,Positive
 ibrutinib,Marketbit.pro,Negative
 ibrutinib,Jeff Szer,Negative
 ibrutinib,CRE Demographics,Positive
 ibrutinib,Penn Medicine News,Negative
 ibrutinib,Jordan Gauthier,Positive
 ibrutinib,Joana Koury,Positive
 ibrutinib,Cancer News,Positive
 ibrutinib,LymphomaAction,Negative
 ibrutinib,ASH,Positive
 ibrutinib,"Navneet Majhail, MD, MS",Negative
 ibrutinib,AA&MDSIF,Positive
 ibrutinib,Cancer Papers,Positive
 ibrutinib,Blood Advances,Positive
 ibrutinib,"Raul Cordoba, MD, PhD",Positive
 ibrutinib,christopher franskin,Positive
 ibrutinib,Autotestdrivers.com,Positive
 ibrutinib,TalkingScarsMedia.com,Positive
 ibrutinib,ShareHRnews,Positive
 ibrutinib,Biedex Markets,Positive
 ibrutinib,CLL Ireland,Positive
 ibrutinib,OBR,Negative
 ibrutinib,Odi Bruckman,Negative
 ibrutinib,Cancer_Tribune,Negative
 ibrutinib,Christopher Steer,Positive
 ibrutinib,Dr. Luis Villela,Positive
 ibrutinib,Marta Crespo,Negative
 ibrutinib,WCM Lymphoma,Positive
 ibrutinib,FredNatLab PDO,Positive
 ibrutinib,COPD News,Negative
 ibrutinib,Dana-Farber,Negative
 ibrutinib,Patient Power,Negative
 ibrutinib,Talal Hilal ü©∫,Positive
 ibrutinib,Healio,Negative
 ibrutinib,JAAD Journals,Negative
 ibrutinib,Ana Laura Caballero,Positive
 ibrutinib,Tom Silver,Negative
 ibrutinib,IntoxicatedTrader,Positive
 ibrutinib,Financial GamblR,Negative
 ibrutinib,CBPartners,Positive
 ibrutinib,Cell Tribune,Positive
 ibrutinib,Luis H Camacho,Positive
 ibrutinib,EMJ Hematology,Negative
 ibrutinib,ACS Journal Cancer,Negative
 ibrutinib,The Lancet Oncology,Negative
 ibrutinib,UpToDate,Positive
 ibrutinib,EMJ Oncology,Negative
 ibrutinib,NE Live,Negative
 ibrutinib,European Pharmaceutical Review,Positive
 ibrutinib,Lymphoma Coalition,Negative
 ibrutinib,OncoTherapy Network,Positive
 ibrutinib,Lymphoma Research Foundation,Negative
 ibrutinib,Diaceutics PLC,Negative
 ibrutinib,NEWS.GNOM.ES,Negative
 ibrutinib,TradeXchange,Negative
 ibrutinib,DynaMed¬Æ,Positive
 ibrutinib,Süíâmon M‚≠ïÔ∏è‚≠ïÔ∏èijaart,Positive
 ibrutinib,Brad M.D.,Negative
 ibrutinib,Tapan Kadia,Negative
 ibrutinib,MD Anderson Cancer Center,Negative
 ibrutinib,Journal of Comparative Effectiveness Research,Positive
 ibrutinib,Coding Inside,Positive
 ibrutinib,JADPRO,Negative
 ibrutinib,Dr. Melody Davis,Negative
 ibrutinib,Innate Pharma,Positive
 ibrutinib,JanssenUS,Negative
 ibrutinib,EMJ Reviews,Positive
 ibrutinib,Michael R Bishop,Positive
 ibrutinib,Francesco Turturro,Positive
 ibrutinib,truebluetribune,Positive
 ibrutinib,MDLinx,Negative
 Primary Efficacy Endpoint,TrialSite News,Positive
 HeadtoHead Trial,TrialSite News,Negative
 HeadtoHead Trial,1stOncology,Negative
 HeadtoHead Trial,BrainSights iOS App,Negative
 HeadtoHead Trial,Corporate News,Negative
 HeadtoHead Trial,"OTC Dynamics, Inc.",Negative
 HeadtoHead Trial,Latest News from Business Wire,Negative
 HeadtoHead Trial,IMPharma News,Negative
 HeadtoHead Trial,Crwe World,Negative
 HeadtoHead Trial,Stock Titan,Negative
 Chronic Lymphocytic Leukemia,TrialSite News,Positive
 Chronic Lymphocytic Leukemia,Paperbirds_Hematology,Positive
 Chronic Lymphocytic Leukemia,BrainSights iOS App,Negative
 Chronic Lymphocytic Leukemia,Corporate News,Positive
 Chronic Lymphocytic Leukemia,"OTC Dynamics, Inc.",Positive
 Chronic Lymphocytic Leukemia,Latest News from Business Wire,Positive
 Chronic Lymphocytic Leukemia,IMPharma News,Positive
 Chronic Lymphocytic Leukemia,Crwe World,Positive
 Chronic Lymphocytic Leukemia,Stock Titan,Positive
 Chronic Lymphocytic Leukemia,TYR Kinase papers,Positive
 Chronic Lymphocytic Leukemia,Pepvax Inc,Positive
 Chronic Lymphocytic Leukemia,mednetnews,Negative
 Chronic Lymphocytic Leukemia,Prescient Healthcare Group,Positive
 Chronic Lymphocytic Leukemia,Biotech & Tech Stock Focus,Positive
 Chronic Lymphocytic Leukemia,OncLive.com,Positive
 Chronic Lymphocytic Leukemia,INDoximity üáÆüá≥,Positive
 Chronic Lymphocytic Leukemia,clinicaltherapeutics,Negative
 Chronic Lymphocytic Leukemia,Jerry Lee,Positive
 Chronic Lymphocytic Leukemia,Patient Power,Positive
 Chronic Lymphocytic Leukemia,Cure Cancer Now,Positive
 Chronic Lymphocytic Leukemia,The ASCO Post,Positive
 Chronic Lymphocytic Leukemia,BioPharmaDevice,Positive
 Chronic Lymphocytic Leukemia,HealthyCarnivores,Positive
 Chronic Lymphocytic Leukemia,About Medtech,Positive
 Chronic Lymphocytic Leukemia,CarnivoresHealth,Positive
 Chronic Lymphocytic Leukemia,Olderpreneurs,Positive
 Chronic Lymphocytic Leukemia,FRANCIS_ABAT,Positive
 Chronic Lymphocytic Leukemia,Shohta Kadomura Hospital Pharmacist,Negative
 Chronic Lymphocytic Leukemia,CureHuntr,Positive
 Chronic Lymphocytic Leukemia,VCapital,Positive
 Chronic Lymphocytic Leukemia,ContentPro.IO,Positive
 Chronic Lymphocytic Leukemia,Swedish Biotech,Positive
 Chronic Lymphocytic Leukemia,Chelli Miller,Positive
 Chronic Lymphocytic Leukemia,New Drug Approvals,Positive
 Chronic Lymphocytic Leukemia,Drugs.com,Positive
 Chronic Lymphocytic Leukemia,Pharma Regulatory,Negative
 Chronic Lymphocytic Leukemia,cafepharma,Negative
 Chronic Lymphocytic Leukemia,Corixis,Positive
 Chronic Lymphocytic Leukemia,Pharmaceutical,Positive
 Chronic Lymphocytic Leukemia,Biotechnology,Positive
 Chronic Lymphocytic Leukemia,BioCalifornia,Positive
 Chronic Lymphocytic Leukemia,The Oncologist,Positive
 Chronic Lymphocytic Leukemia,CHSeaton,Positive
 Chronic Lymphocytic Leukemia,PharmaShots - Incisive news in 3 shots,Positive
 Chronic Lymphocytic Leukemia,FDA Daily,Positive
 Chronic Lymphocytic Leukemia,Lung Cancer News,Positive
 Chronic Lymphocytic Leukemia,Pharmacutical Daily,Positive
 Chronic Lymphocytic Leukemia,Saeed Valadbaygi,Positive
 Chronic Lymphocytic Leukemia,Renal Cell Carcinoma,Positive
 Chronic Lymphocytic Leukemia,Infectdis,Positive
 Chronic Lymphocytic Leukemia,Marc Gozlan,Positive
 Chronic Lymphocytic Leukemia,Health Advicer (I Follow Back),Positive
 Chronic Lymphocytic Leukemia,Senders,Positive
 Chronic Lymphocytic Leukemia,KristopherMaday PA-C,Positive
 Chronic Lymphocytic Leukemia,Cancer Papers,Positive
 Chronic Lymphocytic Leukemia,Lymphoma Papers,Positive
 Chronic Lymphocytic Leukemia,Kid Facts,Positive
 Chronic Lymphocytic Leukemia,Vincenzo Scipioni,Positive
 Chronic Lymphocytic Leukemia,Kyle J. Norton,Negative
 Chronic Lymphocytic Leukemia,"Tom Henry, MBA, RPh, CPh",Negative
 Chronic Lymphocytic Leukemia,StopEndlessWar,Positive
 Chronic Lymphocytic Leukemia,Xuan Cindy Li,Positive
 Chronic Lymphocytic Leukemia,Benlazar S.M Amin√©,Positive
 Chronic Lymphocytic Leukemia,"Dr T. Comeau , MD",Positive
 Chronic Lymphocytic Leukemia,Disability DATA,Positive
 Chronic Lymphocytic Leukemia,Oligotherapeutics,Positive
 Chronic Lymphocytic Leukemia,StarSeekerDragon,Positive
 Chronic Lymphocytic Leukemia,Walter M Chesnut,Positive
 Chronic Lymphocytic Leukemia,Pine Biotech,Positive
 Chronic Lymphocytic Leukemia,BioSolveIT,Positive
 Chronic Lymphocytic Leukemia,Habib Olapade,Positive
 Chronic Lymphocytic Leukemia,Francis Jenkins RE,Positive
 Chronic Lymphocytic Leukemia,EurekaMag,Positive
 Chronic Lymphocytic Leukemia,Ingentium Melanoma,Positive
 Chronic Lymphocytic Leukemia,CellworksLife,Positive
 Chronic Lymphocytic Leukemia,ClinOwl Haematology,Positive
 Chronic Lymphocytic Leukemia,Oncology Board,Positive
 Chronic Lymphocytic Leukemia,BibliotecaHUVH. ICS,Positive
 Chronic Lymphocytic Leukemia,SeattleCancerCareAlliance,Negative
 Chronic Lymphocytic Leukemia,European Hematology Association,Positive
 Chronic Lymphocytic Leukemia,Oncology,Positive
 Chronic Lymphocytic Leukemia,pathdoc3,Positive
 Chronic Lymphocytic Leukemia,Blood Cancer Discovery,Negative
 Chronic Lymphocytic Leukemia,Current Oncology,Negative
 Chronic Lymphocytic Leukemia,Michie Lab,Negative
 Chronic Lymphocytic Leukemia,American Journal of Forensic Medicine & Pathology,Positive
 Chronic Lymphocytic Leukemia,iwCLL,Positive
 Chronic Lymphocytic Leukemia,Shouting at people in my underpants,Positive
 Chronic Lymphocytic Leukemia,Blood Journal,Negative
 Chronic Lymphocytic Leukemia,Bion at bitpharma.com,Positive
 Chronic Lymphocytic Leukemia,ImmunotherapyPapers,Negative
 Chronic Lymphocytic Leukemia,Tom,Positive
 Chronic Lymphocytic Leukemia,Blood Cancer Uncensored,Negative
 Chronic Lymphocytic Leukemia,Oncology Times,Positive
 Chronic Lymphocytic Leukemia,Cancer Health,Positive
 Chronic Lymphocytic Leukemia,Timesnest,Positive
 Chronic Lymphocytic Leukemia,IUOPA,Positive
 Chronic Lymphocytic Leukemia,Pharma News,Positive
 Chronic Lymphocytic Leukemia,PHARMABOX.IN,Negative
 Chronic Lymphocytic Leukemia,Investor News,Positive
 Chronic Lymphocytic Leukemia,Bio Stocks‚Ñ¢,Positive
 Chronic Lymphocytic Leukemia,PressNewsAgency,Positive
 Chronic Lymphocytic Leukemia,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 Chronic Lymphocytic Leukemia,Towelie,Positive
 Chronic Lymphocytic Leukemia,NwokeAgulu,Negative
 Chronic Lymphocytic Leukemia,Hottest Stocks Now,Positive
 Chronic Lymphocytic Leukemia,Stock Market News,Positive
 Chronic Lymphocytic Leukemia,AlphaBronze,Positive
 Chronic Lymphocytic Leukemia,Tina Witte,Positive
 Chronic Lymphocytic Leukemia,Mazeraski,Positive
 Chronic Lymphocytic Leukemia,Jodie Insights,Positive
 Chronic Lymphocytic Leukemia,Biotech2050,Negative
 Chronic Lymphocytic Leukemia,dough,Positive
 Chronic Lymphocytic Leukemia,Felipe de Galiza,Positive
 Chronic Lymphocytic Leukemia,Frontiers Immunology,Positive
 Chronic Lymphocytic Leukemia,Biblioteca HUCA,Positive
 Chronic Lymphocytic Leukemia,Healthing.ca,Positive
 Chronic Lymphocytic Leukemia,Rajesh Sharma,Negative
 Chronic Lymphocytic Leukemia,CLL Society Inc.,Positive
 Chronic Lymphocytic Leukemia,microRNApapers,Positive
 Chronic Lymphocytic Leukemia,CLL-seq,Positive
 Chronic Lymphocytic Leukemia,Mraz Lab,Positive
 Chronic Lymphocytic Leukemia,ChristosArgyropoulos,Negative
 Chronic Lymphocytic Leukemia,Lili Wang Lab,Negative
 Chronic Lymphocytic Leukemia,Noor Faisal,Positive
 Chronic Lymphocytic Leukemia,Cytof Manchester,Positive
 Chronic Lymphocytic Leukemia,Balkan Medical Journal,Positive
 Chronic Lymphocytic Leukemia,U2 Fans,Positive
 Chronic Lymphocytic Leukemia,Aloysius Pendergast,Positive
 Chronic Lymphocytic Leukemia,Flash Alert,Positive
 Chronic Lymphocytic Leukemia,kokoshungsan.net,Positive
 Chronic Lymphocytic Leukemia,Northumbria University Open Research,Positive
 Chronic Lymphocytic Leukemia,Elaine Schattner,Positive
 Chronic Lymphocytic Leukemia,Oscar Lahoud,Positive
 Chronic Lymphocytic Leukemia,filippo masini,Negative
 Chronic Lymphocytic Leukemia,Irene Mangues,Positive
 Chronic Lymphocytic Leukemia,Richard Rosenquist Brandell,Positive
 Chronic Lymphocytic Leukemia,"David Dahan, PhD",Positive
 Chronic Lymphocytic Leukemia,Mary Rack,Positive
 Chronic Lymphocytic Leukemia,Biosimilar Today iMagazine,Negative
 Chronic Lymphocytic Leukemia,Mayo Clinic Hematology-Oncology Fellowship,Positive
 Chronic Lymphocytic Leukemia,UofU3i,Positive
 Chronic Lymphocytic Leukemia,Lifeboat Foundation,Positive
 Chronic Lymphocytic Leukemia,The Curable Recipes,Positive
 Chronic Lymphocytic Leukemia,OncoKB,Positive
 Chronic Lymphocytic Leukemia,Sumanta Pal,Positive
 Chronic Lymphocytic Leukemia,Oncology CE,Positive
 Chronic Lymphocytic Leukemia,Aspen Biosciences,Positive
 Chronic Lymphocytic Leukemia,Pharm2Market,Positive
 Chronic Lymphocytic Leukemia,Jessi M,Positive
 Chronic Lymphocytic Leukemia,DennisPartners,Negative
 Chronic Lymphocytic Leukemia,Bastion Balance Seoul Korea,Positive
 Chronic Lymphocytic Leukemia,Oncology Tube,Positive
 Chronic Lymphocytic Leukemia,Fish Chromosomes,Positive
 Chronic Lymphocytic Leukemia,George,Negative
 Chronic Lymphocytic Leukemia,Janet,Positive
 Chronic Lymphocytic Leukemia,Ibrahim Muhsen,Positive
 Chronic Lymphocytic Leukemia,Philip McCarthy,Positive
 Chronic Lymphocytic Leukemia,ALI ALAHMARI.,Positive
 Chronic Lymphocytic Leukemia,Vindico Medical Education,Positive
 Chronic Lymphocytic Leukemia,"Amparo Santamaria Ortiz MD, PhD",Positive
 Chronic Lymphocytic Leukemia,Kimberly Curseen,Positive
 Chronic Lymphocytic Leukemia,3@amritsood1,Positive
 Chronic Lymphocytic Leukemia,"University of Maryland, Baltimore",Positive
 Chronic Lymphocytic Leukemia,Boya Wang,Positive
 Chronic Lymphocytic Leukemia,Yiqun Zhang,Positive
 Chronic Lymphocytic Leukemia,clonoSEQ,Positive
 Chronic Lymphocytic Leukemia,Raymond DuBois,Positive
 Chronic Lymphocytic Leukemia,Daniel,Positive
 Chronic Lymphocytic Leukemia,Ariel Herzog,Positive
 Chronic Lymphocytic Leukemia,BW Capital,Positive
 Chronic Lymphocytic Leukemia,„Éù„Ç±Go„Éà„É¨„Éº„Éä„Éº È≠îÁã∏Ôº†30Ê≠≥,Positive
 Chronic Lymphocytic Leukemia,Talha Badar,Positive
 Chronic Lymphocytic Leukemia,Florent Malard,Positive
 Chronic Lymphocytic Leukemia,Say It Forward,Negative
 Chronic Lymphocytic Leukemia,Krishan Maggon,Positive
 Chronic Lymphocytic Leukemia,AGD Biomedicals,Negative
 Chronic Lymphocytic Leukemia,Florian Slimano,Positive
 Chronic Lymphocytic Leukemia,"Andrew Johns, MD",Positive
 Chronic Lymphocytic Leukemia,john morley,Positive
 Chronic Lymphocytic Leukemia,arun achuthan/dr/mr,Positive
 Chronic Lymphocytic Leukemia,FocusGroups.org,Positive
 Chronic Lymphocytic Leukemia,"Wafik S. El-Deiry, MD, PhD, FACP",Positive
 Chronic Lymphocytic Leukemia,Izaskun Zeberio,Negative
 Chronic Lymphocytic Leukemia,Eduardo Flavio Oliveira Ribeiro,Negative
 Chronic Lymphocytic Leukemia,Adrien Contejean,Positive
 Chronic Lymphocytic Leukemia,CancerCoachLive,Positive
 Chronic Lymphocytic Leukemia,NACE,Positive
 Chronic Lymphocytic Leukemia,JCM MDPI,Positive
 Chronic Lymphocytic Leukemia,pomento.in üáÆüá≥,Positive
 Chronic Lymphocytic Leukemia,Bloodbytes,Positive
 Chronic Lymphocytic Leukemia,ClinicalTrialsData,Negative
 Chronic Lymphocytic Leukemia,ASCO Publications,Positive
 Chronic Lymphocytic Leukemia,Alisyn Gayle,Positive
 Chronic Lymphocytic Leukemia,Patient Worthy,Positive
 Chronic Lymphocytic Leukemia,LLSCanada,Positive
 Chronic Lymphocytic Leukemia,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 Chronic Lymphocytic Leukemia,Pathology Alerts (Guidelines & Reviews),Positive
 Chronic Lymphocytic Leukemia,"Viren Kaul, MD",Positive
 Chronic Lymphocytic Leukemia,BioPharma Global,Positive
 Chronic Lymphocytic Leukemia,Oncology Publishers Feed,Negative
 Chronic Lymphocytic Leukemia,Medical Vision,Positive
 Chronic Lymphocytic Leukemia,Adam Mead,Positive
 Chronic Lymphocytic Leukemia,Fabrice Leclerc,Positive
 Chronic Lymphocytic Leukemia,SeqComplete,Positive
 Chronic Lymphocytic Leukemia,Captain Syn,Positive
 Chronic Lymphocytic Leukemia,"Habib M. Razavi, MD, PHD, FRCPC",Positive
 Chronic Lymphocytic Leukemia,Cancer Support Community,Positive
 Chronic Lymphocytic Leukemia,Cureus,Positive
 Chronic Lymphocytic Leukemia,gilbert c faure,Positive
 Chronic Lymphocytic Leukemia,@COVID_Evidence,Negative
 Chronic Lymphocytic Leukemia,Francesco Bertoni,Positive
 Chronic Lymphocytic Leukemia,BSH - Haematology,Positive
 Chronic Lymphocytic Leukemia,MitochondriaNews,Positive
 Chronic Lymphocytic Leukemia,"Matthew Davids, MD, MMSc",Positive
 Chronic Lymphocytic Leukemia,Toby Eyre,Negative
 Chronic Lymphocytic Leukemia,ingentium_COVID,Positive
 Chronic Lymphocytic Leukemia,Exergen,Positive
 Chronic Lymphocytic Leukemia,RD360,Positive
 Chronic Lymphocytic Leukemia,ur-trading,Positive
 Chronic Lymphocytic Leukemia,"Redington, Inc.",Positive
 Chronic Lymphocytic Leukemia,Vegastrader66,Positive
 Chronic Lymphocytic Leukemia,Behavioral Finance,Positive
 Chronic Lymphocytic Leukemia,PSK2329 - JHC,Negative
 Chronic Lymphocytic Leukemia,Quant Data,Negative
 Chronic Lymphocytic Leukemia,Jake,Negative
 Chronic Lymphocytic Leukemia,Day Trading Alerts,Positive
 Chronic Lymphocytic Leukemia,Swing Trading,Positive
 Chronic Lymphocytic Leukemia,Michelle Solly,Positive
 Chronic Lymphocytic Leukemia,Michel Doepke,Positive
 Chronic Lymphocytic Leukemia,Amp Trades,Negative
 Chronic Lymphocytic Leukemia,TradeXchange,Positive
 Chronic Lymphocytic Leukemia,learn coronavirus Life,Positive
 Chronic Lymphocytic Leukemia,NewExpressNews,Negative
 Chronic Lymphocytic Leukemia,BioSpace,Positive
 Chronic Lymphocytic Leukemia,Drugs Caps,Positive
 Chronic Lymphocytic Leukemia,Juan Marquet,Positive
 Chronic Lymphocytic Leukemia,Meli Rockhold,Positive
 Chronic Lymphocytic Leukemia,Victoria Gescheidle,Positive
 Chronic Lymphocytic Leukemia,Anthony Mato,Positive
 Chronic Lymphocytic Leukemia,National Aspergillosis Centre,Positive
 Chronic Lymphocytic Leukemia,Wellcome-home,Positive
 Chronic Lymphocytic Leukemia,Saeid Shamsian MD,Positive
 Chronic Lymphocytic Leukemia,Michelle St John,Positive
 Chronic Lymphocytic Leukemia,Chantel Martiromo,Positive
 Chronic Lymphocytic Leukemia,CONQUER the patient voice,Positive
 Chronic Lymphocytic Leukemia,Europe PMC articles,Positive
 Chronic Lymphocytic Leukemia,Prof Dr Zafer Ko√ßak,Positive
 Chronic Lymphocytic Leukemia,"Brandon Lujan, MD",Positive
 Chronic Lymphocytic Leukemia,Ritesh Patil,Negative
 Chronic Lymphocytic Leukemia,Brave Is Now¬Æ,Positive
 Chronic Lymphocytic Leukemia,Baby MLSüë∂üëº,Positive
 Chronic Lymphocytic Leukemia,Dr Shibley,Positive
 Chronic Lymphocytic Leukemia,Pharma Jonpi .,Positive
 Chronic Lymphocytic Leukemia,Mustafa F,Positive
 Chronic Lymphocytic Leukemia,EIN Presswire: Press Releases,Positive
 Chronic Lymphocytic Leukemia,Health Radio Online,Positive
 Chronic Lymphocytic Leukemia,Virtute_USMLE,Positive
 Chronic Lymphocytic Leukemia,NK cell Biology,Negative
 Chronic Lymphocytic Leukemia,NK papers,Positive
 Chronic Lymphocytic Leukemia,Lovisa Bray,Positive
 Chronic Lymphocytic Leukemia,ArthurPotatoeHammer,Negative
 Chronic Lymphocytic Leukemia,Lifewaysvillage.com/lifestyle,Negative
 Chronic Lymphocytic Leukemia,Patient Empowerment Network,Negative
 Chronic Lymphocytic Leukemia,"Raul Cordoba, MD, PhD",Positive
 Chronic Lymphocytic Leukemia,Brian Uherek,Positive
 Chronic Lymphocytic Leukemia,HemOnc Today,Negative
 Chronic Lymphocytic Leukemia,"Candice B. Limper, M.S.",Positive
 Chronic Lymphocytic Leukemia,Cancer News,Positive
 Chronic Lymphocytic Leukemia,DelveInsight,Positive
 Chronic Lymphocytic Leukemia,ron white,Positive
 Chronic Lymphocytic Leukemia,ClinOwl,Positive
 Chronic Lymphocytic Leukemia,Simple Charts,Positive
 Chronic Lymphocytic Leukemia,Carolyn Matyjanka,Positive
 Chronic Lymphocytic Leukemia,RK,Positive
 Chronic Lymphocytic Leukemia,Nutritional Epigenetic News,Positive
 Chronic Lymphocytic Leukemia,Chocolatiere Phys,Positive
 Chronic Lymphocytic Leukemia,"Hawkins Gay, MD, MPH",Negative
 Chronic Lymphocytic Leukemia,HEDGE accordinglyüìà,Positive
 Chronic Lymphocytic Leukemia,pressdaily,Negative
 Chronic Lymphocytic Leukemia,Will,Negative
 Chronic Lymphocytic Leukemia,JAMA Network Open,Positive
 Chronic Lymphocytic Leukemia,Cannabis Insight,Positive
 Chronic Lymphocytic Leukemia,HubRoot,Positive
 Chronic Lymphocytic Leukemia,CannabisNet,Positive
 Chronic Lymphocytic Leukemia,Monterey Holistic,Positive
 Chronic Lymphocytic Leukemia,GMPnews.Net,Negative
 Chronic Lymphocytic Leukemia,Alicia Bell IFBB Pro,Positive
 Chronic Lymphocytic Leukemia,HSMN,Positive
 Chronic Lymphocytic Leukemia,Crowdfunding Center,Positive
 Chronic Lymphocytic Leukemia,CARTI Arkansas,Positive
 Chronic Lymphocytic Leukemia,Ilan Schwartz MD PhD,Positive
 Chronic Lymphocytic Leukemia,Targeted Oncology,Positive
 Chronic Lymphocytic Leukemia,Prof John,Positive
 Chronic Lymphocytic Leukemia,@balbensi üá∫üá∏ üáÆüáπ,Positive
 Chronic Lymphocytic Leukemia,Michele Nadeem-Baker,Positive
 Chronic Lymphocytic Leukemia,The Lynx Group,Positive
 Chronic Lymphocytic Leukemia,Tim Fenske,Positive
 Chronic Lymphocytic Leukemia,ImmunologyPapers,Positive
 Chronic Lymphocytic Leukemia,Teresa Martin,Positive
 Chronic Lymphocytic Leukemia,"Larry Sanchez Perezmarchand, Ed.S, M.S.",Positive
 Chronic Lymphocytic Leukemia,Frontiers Genetics,Positive
 Chronic Lymphocytic Leukemia,Heather Swift Morrison,Positive
 Chronic Lymphocytic Leukemia,Chan Cheah,Positive
 Chronic Lymphocytic Leukemia,Take The Date,Positive
 Chronic Lymphocytic Leukemia,the paper link,Negative
 Chronic Lymphocytic Leukemia,‚ö°AiMS,Positive
 Chronic Lymphocytic Leukemia,SPI News,Positive
 Chronic Lymphocytic Leukemia,Elena,Positive
 Chronic Lymphocytic Leukemia,SNN Network,Positive
 Chronic Lymphocytic Leukemia,Fiona üêû,Positive
 Chronic Lymphocytic Leukemia,LabMedica.com,Positive
 Chronic Lymphocytic Leukemia,AboutLawsuits.com,Positive
 Chronic Lymphocytic Leukemia,CSC Central Indiana,Positive
 Chronic Lymphocytic Leukemia,AONN+,Positive
 Chronic Lymphocytic Leukemia,CARE‚Ñ¢ Education,Negative
 Chronic Lymphocytic Leukemia,sound57,Positive
 Chronic Lymphocytic Leukemia,Heather Dorosh,Positive
 Chronic Lymphocytic Leukemia,Contemporary Clinic,Positive
 Chronic Lymphocytic Leukemia,2 Minute Medicine¬Æ,Negative
 Chronic Lymphocytic Leukemia,COPD News,Positive
 Chronic Lymphocytic Leukemia,Kerri Wachter,Negative
 Chronic Lymphocytic Leukemia,BioNews,Positive
 Chronic Lymphocytic Leukemia,Atanas G. Atanasov,Positive
 Chronic Lymphocytic Leukemia,Lou DiVito,Positive
 Chronic Lymphocytic Leukemia,Kenar Jhaveri,Positive
 Chronic Lymphocytic Leukemia,Miyorch,Positive
 Chronic Lymphocytic Leukemia,AIRR-seq papers,Positive
 Chronic Lymphocytic Leukemia,SciTech Research,Negative
 Chronic Lymphocytic Leukemia,Researchphilia,Positive
 Chronic Lymphocytic Leukemia,NEJM,Positive
 Chronic Lymphocytic Leukemia,Konstantinos Vlachos,Positive
 Chronic Lymphocytic Leukemia,Dr. Jos√© A. Queiz√°n,Negative
 Chronic Lymphocytic Leukemia,Montse Carrere,Positive
 Chronic Lymphocytic Leukemia,MHC,Positive
 Chronic Lymphocytic Leukemia,JediPD,Positive
 Chronic Lymphocytic Leukemia,Merche Gironella,Positive
 Chronic Lymphocytic Leukemia,Hematolog√≠a Salamanca,Negative
 Chronic Lymphocytic Leukemia,Adriana Aguilar,Positive
 Chronic Lymphocytic Leukemia,Al-Ola A Abdallah MD,Positive
 Chronic Lymphocytic Leukemia,Super Res Microscopy,Positive
 Chronic Lymphocytic Leukemia,DR.ARUN ACHUTHAN,Positive
 Chronic Lymphocytic Leukemia,Maniriho Etienne,Positive
 Chronic Lymphocytic Leukemia,Marcel van den Brink,Positive
 Chronic Lymphocytic Leukemia,"Michael Green, PhD",Positive
 Chronic Lymphocytic Leukemia,Bloodsucking Parasites,Positive
 Chronic Lymphocytic Leukemia,Research Watch,Positive
 Chronic Lymphocytic Leukemia,The Purple Society,Positive
 Chronic Lymphocytic Leukemia,Denise Fetters,Positive
 Chronic Lymphocytic Leukemia,Henning,Positive
 Chronic Lymphocytic Leukemia,CHItraders,Negative
 Chronic Lymphocytic Leukemia,PressReleasePoint,Positive
 Chronic Lymphocytic Leukemia,RazzleTazzle,Positive
 Chronic Lymphocytic Leukemia,Verastem Oncology,Negative
 Chronic Lymphocytic Leukemia,Mazen M,Positive
 Chronic Lymphocytic Leukemia,Dee Jones,Positive
 Chronic Lymphocytic Leukemia,PressRelease.cc,Negative
 Chronic Lymphocytic Leukemia,ABNewswire,Negative
 Chronic Lymphocytic Leukemia,Drugnews.in,Positive
 Chronic Lymphocytic Leukemia,Physician's Weekly,Positive
 Chronic Lymphocytic Leukemia,CME Schedule,Positive
 Chronic Lymphocytic Leukemia,ipharmacenter,Negative
 Chronic Lymphocytic Leukemia,RAVIKANTH S,Positive
 Chronic Lymphocytic Leukemia,CRO Contract Res.,Positive
 Chronic Lymphocytic Leukemia,Value-Based Cancer Care,Negative
 Chronic Lymphocytic Leukemia,Joe Librescu,Positive
 Chronic Lymphocytic Leukemia,Tim Durkan,Positive
 Chronic Lymphocytic Leukemia,Mira Larkin,Negative
 Chronic Lymphocytic Leukemia,maria jose agustin,Positive
 Chronic Lymphocytic Leukemia,SDEF Women's & Pediatrics Dermatology Seminar,Positive
 Chronic Lymphocytic Leukemia,Syed Abutalib,Positive
 Chronic Lymphocytic Leukemia,Frontiers Oncology,Positive
 Chronic Lymphocytic Leukemia,Robert Z. Orlowski,Negative
 Chronic Lymphocytic Leukemia,Caprice Alexander-Perez,Positive
 Chronic Lymphocytic Leukemia,Treatment Scores,Positive
 Chronic Lymphocytic Leukemia,Orbis Biosciences,Positive
 Chronic Lymphocytic Leukemia,Christopher DeBoever,Positive
 Chronic Lymphocytic Leukemia,Zheng Zhao,Positive
 Chronic Lymphocytic Leukemia,Medicalnewser.com,Positive
 Chronic Lymphocytic Leukemia,Junaid Hussain,Positive
 Chronic Lymphocytic Leukemia,Odi Bruckman,Positive
 Chronic Lymphocytic Leukemia,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 Chronic Lymphocytic Leukemia,Doctors*Overseas,Positive
 Chronic Lymphocytic Leukemia,SGHC,Positive
 Chronic Lymphocytic Leukemia,NCI CTEP Clinical Research,Negative
 Chronic Lymphocytic Leukemia,McHeyzer-Williams,Positive
 Chronic Lymphocytic Leukemia,epigenetics_papers,Positive
 Chronic Lymphocytic Leukemia,Kevin Liu,Positive
 Chronic Lymphocytic Leukemia,Molly Earley,Positive
 Chronic Lymphocytic Leukemia,Audrey Earley,Positive
 Chronic Lymphocytic Leukemia,MD.,Positive
 Chronic Lymphocytic Leukemia,L McSherry,Negative
 Chronic Lymphocytic Leukemia,Expert Perspectives in Oncology,Positive
 Chronic Lymphocytic Leukemia,TrialBulletin,Positive
 Chronic Lymphocytic Leukemia,OncLive SOSS,Negative
 Chronic Lymphocytic Leukemia,"Houlston Lab, ICR",Positive
 Chronic Lymphocytic Leukemia,Kursad Turksen,Positive
 Chronic Lymphocytic Leukemia,FDA Oncology,Negative
 Chronic Lymphocytic Leukemia,topbiopapers,Positive
 Chronic Lymphocytic Leukemia,Sue Carlson,Positive
 Chronic Lymphocytic Leukemia,WorldStemCellSummit,Positive
 Chronic Lymphocytic Leukemia,Miss Joyce,Positive
 Chronic Lymphocytic Leukemia,ASCI,Positive
 Chronic Lymphocytic Leukemia,CLL Ireland,Positive
 Chronic Lymphocytic Leukemia,Freelance Writer,Positive
 Chronic Lymphocytic Leukemia,Sharmaine Fuentes,Negative
 Chronic Lymphocytic Leukemia,Kyle Schmanke,Positive
 Chronic Lymphocytic Leukemia,Seattle's Banker,Positive
 Chronic Lymphocytic Leukemia,CRE Demographics,Negative
 Chronic Lymphocytic Leukemia,Today's News,Positive
 Chronic Lymphocytic Leukemia,South Shore Skin CTR,Positive
 Chronic Lymphocytic Leukemia,dorothy cook,Positive
 Chronic Lymphocytic Leukemia,Girl,Positive
 Chronic Lymphocytic Leukemia,ETHealthWorld,Positive
 Chronic Lymphocytic Leukemia,MedGenome,Positive
 Chronic Lymphocytic Leukemia,Eternal¬†Beauty¬†Mobile¬†Esthetics,Positive
 Chronic Lymphocytic Leukemia,Muhammad Usman,Positive
 Chronic Lymphocytic Leukemia,Hotstocks.nyc,Positive
 Chronic Lymphocytic Leukemia,Carlos Chiattone,Positive
 Chronic Lymphocytic Leukemia,Betsy Mullen #SignUp2SaveAJ,Positive
 Chronic Lymphocytic Leukemia,Random PubMed,Positive
 Chronic Lymphocytic Leukemia,Elsevier Oncology,Positive
 Chronic Lymphocytic Leukemia,ANTELLIS,Positive
 Chronic Lymphocytic Leukemia,Internal Medicine: Open Access,Positive
 Chronic Lymphocytic Leukemia,Integra Medical,Positive
 Chronic Lymphocytic Leukemia,TumorImmunoPapers,Positive
 Chronic Lymphocytic Leukemia,Mahmoud Aljurf,Positive
 Chronic Lymphocytic Leukemia,dermatologyf,Positive
 Chronic Lymphocytic Leukemia,AmoebaPapers,Positive
 Chronic Lymphocytic Leukemia,Curatio Technologies,Positive
 Chronic Lymphocytic Leukemia,Dr. Mahesh Jain,Negative
 Chronic Lymphocytic Leukemia,BioCeryx,Positive
 Chronic Lymphocytic Leukemia,Doctr,Positive
 Chronic Lymphocytic Leukemia,Brenda Feldman,Positive
 Chronic Lymphocytic Leukemia,maria cilia matos,Positive
 Chronic Lymphocytic Leukemia,Kathleen Montone,Positive
 Chronic Lymphocytic Leukemia,SexGenomics,Positive
 Chronic Lymphocytic Leukemia,Amie,Positive
 Chronic Lymphocytic Leukemia,Abdullah Al Mosabbir,Positive
 Chronic Lymphocytic Leukemia,Candace Lewis,Positive
 Chronic Lymphocytic Leukemia,KHALID HEMATOLOGIST,Positive
 Chronic Lymphocytic Leukemia,TawasulLinks ÿ™ŸàÿßÿµŸÑ,Positive
 Chronic Lymphocytic Leukemia,"Meagan Bryan, RN",Positive
 Chronic Lymphocytic Leukemia,OncologyNurseAdvisor,Positive
 Chronic Lymphocytic Leukemia,Alec Stone,Positive
 Chronic Lymphocytic Leukemia,Medivizor,Negative
 Chronic Lymphocytic Leukemia,Hematopoiesis News,Positive
 Chronic Lymphocytic Leukemia,Dr. StrangeBot,Positive
 Chronic Lymphocytic Leukemia,Centre for Genomic Regulation (CRG),Negative
 Chronic Lymphocytic Leukemia,flosz,Positive
 Chronic Lymphocytic Leukemia,James Dean,Positive
 Chronic Lymphocytic Leukemia,Dean James,Positive
 Chronic Lymphocytic Leukemia,BIO Deutschland,Positive
 Chronic Lymphocytic Leukemia,Sicilia Informazioni,Positive
 Chronic Lymphocytic Leukemia,BioGer,Positive
 Chronic Lymphocytic Leukemia,DGAP-News-Int,Positive
 Chronic Lymphocytic Leukemia,cls_ksu,Positive
 Chronic Lymphocytic Leukemia,Pharm Processing,Positive
 Chronic Lymphocytic Leukemia,JournalAgent,Positive
 Chronic Lymphocytic Leukemia,Cancer Stem Cell News,Negative
 Chronic Lymphocytic Leukemia,Kikka Kinnunen,Positive
 Chronic Lymphocytic Leukemia,"Stayin' Alive: Body, Mind, Spirit",Positive
 Chronic Lymphocytic Leukemia,CLLSA,Negative
 Chronic Lymphocytic Leukemia,BIOCIENCIA,Positive
 Chronic Lymphocytic Leukemia,Leukemia Research Foundation,Negative
 Chronic Lymphocytic Leukemia,UKiwiS,Negative
 Chronic Lymphocytic Leukemia,NeuroStemCells,Positive
 Chronic Lymphocytic Leukemia,newswise,Positive
 Chronic Lymphocytic Leukemia,S.K.,Positive
 Chronic Lymphocytic Leukemia,Prof. Dr. Omprakash Nautiyal,Positive
 Chronic Lymphocytic Leukemia,Stephen B. Harris,Positive
 Chronic Lymphocytic Leukemia,Patrick Arieno,Positive
 Chronic Lymphocytic Leukemia,Children‚Äôs Oncology Group,Negative
 Chronic Lymphocytic Leukemia,Centro Medico Qx,Positive
 Chronic Lymphocytic Leukemia,AmericanPharmacyNews,Negative
 Chronic Lymphocytic Leukemia,ReachMD,Positive
 Chronic Lymphocytic Leukemia,Dr. Keesha Ewers,Positive
 Chronic Lymphocytic Leukemia,leukemia,Positive
 Chronic Lymphocytic Leukemia,Lymphomation.org,Positive
 Chronic Lymphocytic Leukemia,SpecialtyPTimes,Positive
 Chronic Lymphocytic Leukemia,ùê¶ùêöùê†ùêßùêÆùê¨‚Å∑,Positive
 Chronic Lymphocytic Leukemia,Cell Therapy News,Positive
 Chronic Lymphocytic Leukemia,FarmaOnco,Positive
 Chronic Lymphocytic Leukemia,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Chronic Lymphocytic Leukemia,Health MasterDoctor,Positive
 Chronic Lymphocytic Leukemia,Medindia.net,Positive
 Chronic Lymphocytic Leukemia,mitopapers,Positive
 Chronic Lymphocytic Leukemia,Walaa,Positive
 Chronic Lymphocytic Leukemia,ImmunePCPapers,Positive
 Chronic Lymphocytic Leukemia,BioNJ,Positive
 Chronic Lymphocytic Leukemia,Armani Chiropractic,Positive
 Chronic Lymphocytic Leukemia,CURE Magazine,Positive
 Chronic Lymphocytic Leukemia,"Aaron Gerds MD, MS",Positive
 Chronic Lymphocytic Leukemia,Ryan HamNer,Negative
 Chronic Lymphocytic Leukemia,Rare Diseases,Positive
 Chronic Lymphocytic Leukemia,Sophie #HelpPH,Positive
 Chronic Lymphocytic Leukemia,FNest,Positive
 Chronic Lymphocytic Leukemia,MirandaüíÉüèª,Positive
 Chronic Lymphocytic Leukemia,Billy Goco,Positive
 Chronic Lymphocytic Leukemia,cohesin_papers,Positive
 Chronic Lymphocytic Leukemia,Colorectal Cancer Charity,Positive
 Chronic Lymphocytic Leukemia,Live Well Toronto,Positive
 Chronic Lymphocytic Leukemia,Zeal Access,Positive
 Chronic Lymphocytic Leukemia,Human Immunology News,Negative
 Chronic Lymphocytic Leukemia,CIDEGEN,Positive
 Chronic Lymphocytic Leukemia,Christopher Steer,Positive
 Chronic Lymphocytic Leukemia,PER,Positive
 Chronic Lymphocytic Leukemia,Lymphoma Canada,Positive
 Chronic Lymphocytic Leukemia,GEDEFO,Positive
 Chronic Lymphocytic Leukemia,JAMA Oncology,Positive
 Chronic Lymphocytic Leukemia,üÖæ Jaksic,Positive
 Chronic Lymphocytic Leukemia,BBC Current Affairs,Positive
 Chronic Lymphocytic Leukemia,APSHO,Positive
 Chronic Lymphocytic Leukemia,Marty needs a new handle,Positive
 Chronic Lymphocytic Leukemia,Articlesly,Positive
 Chronic Lymphocytic Leukemia,Lord Chonza | üáøüá≤,Positive
 Chronic Lymphocytic Leukemia,RTCP24 NEWS‚Ñ¢,Positive
 Chronic Lymphocytic Leukemia,Jim Graham,Positive
 Chronic Lymphocytic Leukemia,Mol Oncol Res,Positive
 Chronic Lymphocytic Leukemia,Farid Ahmed PhD,Positive
 Chronic Lymphocytic Leukemia,Md. Badiuzzaman,Positive
 Chronic Lymphocytic Leukemia,OHSU IM Residency,Positive
 Chronic Lymphocytic Leukemia,Yasser Amer,Positive
 Chronic Lymphocytic Leukemia,CancerWallonia,Positive
 Chronic Lymphocytic Leukemia,Kam Laurence,Positive
 Chronic Lymphocytic Leukemia,"Pharmacyclics, an AbbVie Company",Positive
 Chronic Lymphocytic Leukemia,CamTheMan,Positive
 Chronic Lymphocytic Leukemia,Business Wire-Health,Positive
 Chronic Lymphocytic Leukemia,BusinessWireWebcasts,Negative
 Chronic Lymphocytic Leukemia,The Pharmaceutical Marketing Group,Positive
 Chronic Lymphocytic Leukemia,Stockboard Media Inc,Negative
 Chronic Lymphocytic Leukemia,$Stocknewsalerts,Negative
 Chronic Lymphocytic Leukemia,Financial Buzz,Positive
 Chronic Lymphocytic Leukemia,Business Wire-TS,Positive
 Chronic Lymphocytic Leukemia,Penny Stocks News,Positive
 Chronic Lymphocytic Leukemia,Lymphoma News Today,Negative
 Chronic Lymphocytic Leukemia,Medical HotSpot,Positive
 Chronic Lymphocytic Leukemia,Nematode_papers,Positive
 Chronic Lymphocytic Leukemia,ASCO,Negative
 Chronic Lymphocytic Leukemia,Garbi√±e Lizeaga,Positive
 Chronic Lymphocytic Leukemia,Life Extension,Positive
 Chronic Lymphocytic Leukemia,Medical & Surgical Pathology,Positive
 Chronic Lymphocytic Leukemia,medXclusive Learning,Positive
 Chronic Lymphocytic Leukemia,AlejandroL√≥pezCature,Positive
 Chronic Lymphocytic Leukemia,BusinessWireProducts,Positive
 Chronic Lymphocytic Leukemia,Theoreticalthinker,Positive
 Chronic Lymphocytic Leukemia,MAISA,Negative
 Chronic Lymphocytic Leukemia,Ahmad Halwani,Positive
 Chronic Lymphocytic Leukemia,Mohsin Ali,Positive
 Chronic Lymphocytic Leukemia,3PSolution,Positive
 Chronic Lymphocytic Leukemia,susan baker,Positive
 Chronic Lymphocytic Leukemia,N8 CIR,Positive
 Chronic Lymphocytic Leukemia,Immuno-Oncology,Negative
 Chronic Lymphocytic Leukemia,ImmuneGCPapers,Positive
 Chronic Lymphocytic Leukemia,Dow Diagnostics,Positive
 Chronic Lymphocytic Leukemia,Review Your Life,Positive
 Chronic Lymphocytic Leukemia,HoneymoonGondol,Positive
 Chronic Lymphocytic Leukemia,AJKD,Positive
 Chronic Lymphocytic Leukemia,JAMA Internal Medicine,Positive
 Chronic Lymphocytic Leukemia,JAMA,Positive
 Chronic Lymphocytic Leukemia,JAMA Network,Positive
 Chronic Lymphocytic Leukemia,Oncocheck,Positive
 Chronic Lymphocytic Leukemia,Dua Centre,Positive
 Chronic Lymphocytic Leukemia,sandrineman,Negative
 Chronic Lymphocytic Leukemia,CADTH,Positive
 Chronic Lymphocytic Leukemia,Elad Sharon,Positive
 Chronic Lymphocytic Leukemia,Angelica Cortez,Positive
 Chronic Lymphocytic Leukemia,Mike Luise,Positive
 Chronic Lymphocytic Leukemia,Fantastic Baby Items,Positive
 Chronic Lymphocytic Leukemia,CV and Parts. Transmission and Drivetrain,Positive
 Chronic Lymphocytic Leukemia,Asim Shahzad,Positive
 Chronic Lymphocytic Leukemia,summodiscrimine,Positive
 Chronic Lymphocytic Leukemia,"Mike Thompson, MD, PhD, FASCO",Positive
 Chronic Lymphocytic Leukemia,Biologics by McKesson,Positive
 Chronic Lymphocytic Leukemia,SFBC,Positive
 Chronic Lymphocytic Leukemia,Matthews & Associates,Positive
 Chronic Lymphocytic Leukemia,ClinChemINFO,Positive
 Chronic Lymphocytic Leukemia,Teva Pharmaceuticals,Positive
 Chronic Lymphocytic Leukemia,„Éë„É©„Éä„Çà„ÇäÊÑõ„Çí„Åì„ÇÅ„Å¶,Positive
 Chronic Lymphocytic Leukemia,Pro-CME,Positive
 Chronic Lymphocytic Leukemia,Mount Sinai LIVE,Positive
 Chronic Lymphocytic Leukemia,fadra tedesco,Positive
 Chronic Lymphocytic Leukemia,ccdt,Positive
 Chronic Lymphocytic Leukemia,Lymphoma Hub,Positive
 Chronic Lymphocytic Leukemia,Saifur Rahman Ali,Positive
 Chronic Lymphocytic Leukemia,UCI Health,Negative
 Chronic Lymphocytic Leukemia,Survival-Hunters‚Ñ¢ üîµ,Positive
 Chronic Lymphocytic Leukemia,Dr. Melody Davis,Positive
 Chronic Lymphocytic Leukemia,NU Internal Medicine,Positive
 Chronic Lymphocytic Leukemia,Autophagy Papers,Positive
 Chronic Lymphocytic Leukemia,Nicolas Robine,Positive
 Chronic Lymphocytic Leukemia,Cytokine News,Positive
 Chronic Lymphocytic Leukemia,J Clin Pathol Res,Positive
 Chronic Lymphocytic Leukemia,Gate 2 Wordy Freedom,Positive
 Chronic Lymphocytic Leukemia,BizPR,Negative
 Chronic Lymphocytic Leukemia,fatal atraction #312,Positive
 Chronic Lymphocytic Leukemia,Katia Zevelekakis,Positive
 Chronic Lymphocytic Leukemia,Katia Davis,Positive
 Chronic Lymphocytic Leukemia,Malakistan,Positive
 Chronic Lymphocytic Leukemia,pinmania,Positive
 Chronic Lymphocytic Leukemia,OSCO,Positive
 Chronic Lymphocytic Leukemia,OSCO Nurses,Positive
 Chronic Lymphocytic Leukemia,CIUSSS Centre-Ouest-de-l'√éle-de-Montr√©al,Positive
 Chronic Lymphocytic Leukemia,Jasmin Abd-el-Baki,Positive
 Chronic Lymphocytic Leukemia,Oknaija,Positive
 Chronic Lymphocytic Leukemia,Tweet Dealz,Positive
 Chronic Lymphocytic Leukemia,SOBRAFO,Positive
 Chronic Lymphocytic Leukemia,Dean Celia,Positive
 Chronic Lymphocytic Leukemia,MPLN,Negative
 Chronic Lymphocytic Leukemia,CCDT,Positive
 Chronic Lymphocytic Leukemia,CUTIS,Positive
 Chronic Lymphocytic Leukemia,Augustino Chengula,Positive
 Chronic Lymphocytic Leukemia,cyberconic,Positive
 Chronic Lymphocytic Leukemia,GURU,Positive
 Chronic Lymphocytic Leukemia,Glenn Sabin,Positive
 Chronic Lymphocytic Leukemia,Get This Hub,Positive
 Chronic Lymphocytic Leukemia,Janssen Sverige,Positive
 Chronic Lymphocytic Leukemia,P&T,Positive
 Chronic Lymphocytic Leukemia,P&TCommunity,Positive
 Chronic Lymphocytic Leukemia,balaji jegannathan,Positive
 Chronic Lymphocytic Leukemia,Pakalert Press,Positive
 Chronic Lymphocytic Leukemia,MSHO,Positive
 Chronic Lymphocytic Leukemia,Bill Both,Positive
 Chronic Lymphocytic Leukemia,TumImmTxpapers,Positive
 Chronic Lymphocytic Leukemia,EventsInAmerica.com,Positive
 Chronic Lymphocytic Leukemia,GRACE,Negative
 Chronic Lymphocytic Leukemia,Casey Foster,Positive
 Chronic Lymphocytic Leukemia,biotechnologies,Positive
 Chronic Lymphocytic Leukemia,Ayobami Seun,Positive
 Chronic Lymphocytic Leukemia,Nancy Drew,Positive
 Chronic Lymphocytic Leukemia,ÈÉ°Â±±Â•≥Â≠êÂ§ßÂ≠¶Âõ≥Êõ∏È§®,Positive
 Chronic Lymphocytic Leukemia,Dominic Brewington,Positive
 Chronic Lymphocytic Leukemia,Surviving Hub,Positive
 Chronic Lymphocytic Leukemia,Danilo Menezes,Positive
 Chronic Lymphocytic Leukemia,pammyeol,Positive
 Chronic Lymphocytic Leukemia,Just Cancer News,Positive
 Chronic Lymphocytic Leukemia,CompBiolPapers,Positive
 Chronic Lymphocytic Leukemia,1stOncology,Negative
 Chronic Lymphocytic Leukemia,Tripti Sahu,Positive
 Chronic Lymphocytic Leukemia,Gendron Recherche,Positive
 Chronic Lymphocytic Leukemia,Selvyn Kennedy,Positive
 Chronic Lymphocytic Leukemia,Danvantri Farma,Positive
 Chronic Lymphocytic Leukemia,Gilles Gallant,Positive
 Chronic Lymphocytic Leukemia,Shoppingdealer,Positive
 Chronic Lymphocytic Leukemia,A M Billah Sumon,Negative
 Chronic Lymphocytic Leukemia,MsPrissySis,Positive
 Chronic Lymphocytic Leukemia,The Medical Ed Cons.,Positive
 Chronic Lymphocytic Leukemia,Dennis Blomberg,Positive
 Chronic Lymphocytic Leukemia,Papers Wanted,Positive
 Chronic Lymphocytic Leukemia,satPRnews,Negative
 Chronic Lymphocytic Leukemia,(((Rich Stein)))Stay safeüò∑ü¶† & be kind,Positive
 Chronic Lymphocytic Leukemia,Endocrine News,Positive
 Chronic Lymphocytic Leukemia,VPO/PR Newswire,Negative
 Chronic Lymphocytic Leukemia,"Darcy Burbage, DNP, RN, AOCN",Negative
 Chronic Lymphocytic Leukemia,LRA: New articles,Positive
 Chronic Lymphocytic Leukemia,"Lazy Intern Doctor, MD",Negative
 Chronic Lymphocytic Leukemia,Francesco Turturro,Positive
 Chronic Lymphocytic Leukemia,Health&Wealth,Positive
 Chronic Lymphocytic Leukemia,Andrew Merron,Positive
 Chronic Lymphocytic Leukemia,Casilda valles,Positive
 Chronic Lymphocytic Leukemia,cairns haematology a,Positive
 Chronic Lymphocytic Leukemia,AJMC,Positive
 Chronic Lymphocytic Leukemia,Intrinsic Imaging,Positive
 Chronic Lymphocytic Leukemia,Olivier Elemento,Positive
 Chronic Lymphocytic Leukemia,Clin Adv Hem Onc,Positive
 Chronic Lymphocytic Leukemia,Maria Goreth,Positive
 Chronic Lymphocytic Leukemia,Raghuraj Panchabhai,Positive
 Chronic Lymphocytic Leukemia,eCatalysis,Positive
 Chronic Lymphocytic Leukemia,Mayo Clinic Cancer Center,Positive
 Chronic Lymphocytic Leukemia,AURELIAN UDRISTIOIU,Negative
 Chronic Lymphocytic Leukemia,Dr. JOSE VELASQUEZ,Negative
 Chronic Lymphocytic Leukemia,NewYorkHealthWorks,Positive
 Chronic Lymphocytic Leukemia,NGO News,Positive
 Chronic Lymphocytic Leukemia,News World,Positive
 Chronic Lymphocytic Leukemia,Alessandro Mangogna,Positive
 Chronic Lymphocytic Leukemia,Torchlight Med,Positive
 Chronic Lymphocytic Leukemia,Alyssa Howard,Negative
 Chronic Lymphocytic Leukemia,Institut Catal√† d'Oncologia,Positive
 Chronic Lymphocytic Leukemia,AmerAssn Bioanalysts,Positive
 Chronic Lymphocytic Leukemia,Mohammad Alhomoud,Positive
 Chronic Lymphocytic Leukemia,"Terry Cralle, R.N.",Positive
 Chronic Lymphocytic Leukemia,supersurvivalguide,Positive
 Chronic Lymphocytic Leukemia,jonathan r goodman,Positive
 Chronic Lymphocytic Leukemia,Clinical Leader,Positive
 Chronic Lymphocytic Leukemia,Jose F. Ruiz,Positive
 Chronic Lymphocytic Leukemia,INN Life Science,Positive
 Chronic Lymphocytic Leukemia,Krunox,Positive
 Chronic Lymphocytic Leukemia,BioRunUp,Negative
 Chronic Lymphocytic Leukemia,copperpeony,Positive
 Chronic Lymphocytic Leukemia,brett johnson,Positive
 Chronic Lymphocytic Leukemia,Pilade Cortellazzi,Positive
 Chronic Lymphocytic Leukemia,Sajida Tabusam,Positive
 Chronic Lymphocytic Leukemia,Ana Rosa Rubio,Positive
 Chronic Lymphocytic Leukemia,The Medical Letter,Negative
 Chronic Lymphocytic Leukemia,James Porreca,Positive
 Chronic Lymphocytic Leukemia,Diaceutics PLC,Positive
 Chronic Lymphocytic Leukemia,Oncology.TV,Positive
 Chronic Lymphocytic Leukemia,Cancer Daily,Negative
 Chronic Lymphocytic Leukemia,tDot libraryBot,Positive
 Chronic Lymphocytic Leukemia,Prof. N. Campbell,Positive
 Chronic Lymphocytic Leukemia,Roberto C.  Montoya,Positive
 Chronic Lymphocytic Leukemia,World Wellness,Positive
 Chronic Lymphocytic Leukemia,Mary Regan,Positive
 Chronic Lymphocytic Leukemia,National Cancer Institute,Positive
 Chronic Lymphocytic Leukemia,Chiragjani,Positive
 Chronic Lymphocytic Leukemia,American Association of Pharmaceutical Scientists,Positive
 Chronic Lymphocytic Leukemia,Feel on,Negative
 Chronic Lymphocytic Leukemia,Âø´ÈÅ©ÂÆ∂ÈõªLife,Negative
 Chronic Lymphocytic Leukemia,Market Cheetah,Positive
 Chronic Lymphocytic Leukemia,JAMA Dermatology,Positive
 Chronic Lymphocytic Leukemia,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Positive
 Chronic Lymphocytic Leukemia,MDRing,Positive
 Chronic Lymphocytic Leukemia,John James,Positive
 Chronic Lymphocytic Leukemia,Joe Fournet,Negative
 Chronic Lymphocytic Leukemia,GrantDev,Positive
 Chronic Lymphocytic Leukemia,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",Positive
 Chronic Lymphocytic Leukemia,GPSN,Positive
 Chronic Lymphocytic Leukemia,Jane Freeman,Positive
 Chronic Lymphocytic Leukemia,Andie Williams,Positive
 Chronic Lymphocytic Leukemia,Rebecca Hong,Positive
 Chronic Lymphocytic Leukemia,Holly Vanwinkle,Positive
 Chronic Lymphocytic Leukemia,Kerri Logsdon,Positive
 Chronic Lymphocytic Leukemia,Minna Saavedra,Positive
 Chronic Lymphocytic Leukemia,Stanley Weber,Positive
 Chronic Lymphocytic Leukemia,Bhavna Saxena,Positive
 Chronic Lymphocytic Leukemia,ARRS GoldMiner¬Æ,Positive
 Chronic Lymphocytic Leukemia,Paul Kent,Positive
 Chronic Lymphocytic Leukemia,Health-News,Positive
 Chronic Lymphocytic Leukemia,muzaffar,Positive
 Chronic Lymphocytic Leukemia,Medical Reel,Negative
 Chronic Lymphocytic Leukemia,YWNH,Positive
 Chronic Lymphocytic Leukemia,MedicinaMX,Positive
 Chronic Lymphocytic Leukemia,Green Inc USA,Positive
 Chronic Lymphocytic Leukemia,C.A.I. Corporation,Positive
 Chronic Lymphocytic Leukemia,Hilda Tryon,Positive
 Chronic Lymphocytic Leukemia,Health Information,Positive
 Chronic Lymphocytic Leukemia,Little Bugs Store,Positive
 Chronic Lymphocytic Leukemia,Science.gov,Positive
 Chronic Lymphocytic Leukemia,NaturalMedicines,Positive
 Chronic Lymphocytic Leukemia,Hands on Health,Positive
 Chronic Lymphocytic Leukemia,8 Pack Abs,Positive
 Chronic Lymphocytic Leukemia,Eleonor_Morgan,Positive
 Chronic Lymphocytic Leukemia,Welly Wired,Positive
 Chronic Lymphocytic Leukemia,Mahesh Khuman,Positive
 Chronic Lymphocytic Leukemia,Salubrious Diet,Positive
 Chronic Lymphocytic Leukemia,Biblioteca CCBS-UFCG,Negative
 Chronic Lymphocytic Leukemia,Carole S Giampalmi,Positive
 Chronic Lymphocytic Leukemia,WK Anatomy & Health,Positive
 Chronic Lymphocytic Leukemia,Alpha Diagnostic Int,Positive
 Chronic Lymphocytic Leukemia,Focus on Cancer,Positive
 Chronic Lymphocytic Leukemia,Hemomadrid,Positive
 Chronic Lymphocytic Leukemia,FurriesAgainstWords,Positive
 Chronic Lymphocytic Leukemia,JNCI,Positive
 Chronic Lymphocytic Leukemia,nbmtLINK,Positive
 Chronic Lymphocytic Leukemia,Victor Norberto Cerasale Morteo,Positive
 Chronic Lymphocytic Leukemia,Polonius Josifovitz,Positive
 Chronic Lymphocytic Leukemia,tanifel,Positive
 Chronic Lymphocytic Leukemia,tara,Positive
 Chronic Lymphocytic Leukemia,KeleSkellk,Positive
 Chronic Lymphocytic Leukemia,Rhia Steele@ravishingrhia.com,Positive
 Chronic Lymphocytic Leukemia,Marie Ennis-O'Connor,Positive
 Chronic Lymphocytic Leukemia,ŸÉŸàŸÑŸÉÿ¥ÿß || kolkcha,Positive
 Chronic Lymphocytic Leukemia,BernCarte Pharma,Positive
 Chronic Lymphocytic Leukemia,Farmacia Son Espases,Positive
 Chronic Lymphocytic Leukemia,Blausen Medical,Positive
 Chronic Lymphocytic Leukemia,CancerConnect,Positive
 Chronic Lymphocytic Leukemia,dlvr health,Positive
 Chronic Lymphocytic Leukemia,Google  News,Positive
 Chronic Lymphocytic Leukemia,Diplomat,Positive
 Chronic Lymphocytic Leukemia,Pharmaceutical News,Negative
 Chronic Lymphocytic Leukemia,VJHemOnc,Negative
 Chronic Lymphocytic Leukemia,ZoZoTrader,Positive
 Chronic Lymphocytic Leukemia,AL Pharmacy Brd Atty,Positive
 Chronic Lymphocytic Leukemia,Pharmacy Podcast Network,Positive
 Chronic Lymphocytic Leukemia,Rx Generator | Business Strategy,Positive
 Chronic Lymphocytic Leukemia,Health & Lifestyle,Positive
 Chronic Lymphocytic Leukemia,Cancer Blog,Positive
 Chronic Lymphocytic Leukemia,"Hayes, Inc",Positive
 Chronic Lymphocytic Leukemia,MedPipeline,Positive
 Chronic Lymphocytic Leukemia,henrietta,Positive
 Chronic Lymphocytic Leukemia,BusinessWireServices,Negative
 Chronic Lymphocytic Leukemia,Realpharmacyx,Positive
 Chronic Lymphocytic Leukemia,PGM/Trumbull Labs,Positive
 Chronic Lymphocytic Leukemia,RFL of Elkton MD,Positive
 Chronic Lymphocytic Leukemia,Erica,Positive
 Chronic Lymphocytic Leukemia,Gunel Huseynova,Positive
 Chronic Lymphocytic Leukemia,@EPMScientific,Positive
 Chronic Lymphocytic Leukemia,Hlthnews,Positive
 Chronic Lymphocytic Leukemia,Roche,Positive
 Chronic Lymphocytic Leukemia,Medicine Science,Positive
 Chronic Lymphocytic Leukemia,Jess  Ochieng,Positive
 Chronic Lymphocytic Leukemia,Avery92,Positive
 Chronic Lymphocytic Leukemia,CNBC-TV18,Negative
 Chronic Lymphocytic Leukemia,DR. JAWAHAR TICKU,Positive
 Chronic Lymphocytic Leukemia,Cancer Research News,Positive
 Chronic Lymphocytic Leukemia,Clinical Pharmacy,Negative
 Chronic Lymphocytic Leukemia,M Jos√© Mart√≠nez Bautista,Positive
 Chronic Lymphocytic Leukemia,"John C. Wunsch, P.C.",Positive
 Chronic Lymphocytic Leukemia,IntoxicatedTrader,Negative
 Chronic Lymphocytic Leukemia,LIBERTADOR ¬Æ,Positive
 Chronic Lymphocytic Leukemia,frothmouth,Positive
 Chronic Lymphocytic Leukemia,Pharma Digest,Positive
 Chronic Lymphocytic Leukemia,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 Chronic Lymphocytic Leukemia,Jos√© Lu√≠s Marques Br,Positive
 Chronic Lymphocytic Leukemia,PEYRAT Jean-Pierre,Positive
 Chronic Lymphocytic Leukemia,Connie Batlevi,Negative
 Chronic Lymphocytic Leukemia,"Krishna Talluri, MD",Positive
 Chronic Lymphocytic Leukemia,crewmilitary,Positive
 Chronic Lymphocytic Leukemia,PRN Biotech,Negative
 Chronic Lymphocytic Leukemia,NEWS.GNOM.ES,Positive
 Chronic Lymphocytic Leukemia,"Tom Iarocci, MD",Positive
 Chronic Lymphocytic Leukemia,Cyndie Annett,Positive
 Chronic Lymphocytic Leukemia,EIN Presswire: Prostate Cancer Newswire,Positive
 Chronic Lymphocytic Leukemia,EIN Presswire: Lung Cancer Newswire,Positive
 Chronic Lymphocytic Leukemia,EIN Presswire: Education Newswire,Positive
 Chronic Lymphocytic Leukemia,Cision News,Negative
 Chronic Lymphocytic Leukemia,John Mclean,Positive
 Chronic Lymphocytic Leukemia,Emma Gabriela,Positive
 Chronic Lymphocytic Leukemia,journalneurooph,Positive
 Chronic Lymphocytic Leukemia,Lab Tests Online,Positive
 Chronic Lymphocytic Leukemia,Eye Center,Positive
 Chronic Lymphocytic Leukemia,Reddit FoodNerds,Positive
 Chronic Lymphocytic Leukemia,Cancer Journal,Positive
 Chronic Lymphocytic Leukemia,Jean Plante,Negative
 Chronic Lymphocytic Leukemia,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 Chronic Lymphocytic Leukemia,T√ºrkiye Klinikleri,Positive
 Chronic Lymphocytic Leukemia,Medcomic,Positive
 Chronic Lymphocytic Leukemia,Armand!!,Negative
 Chronic Lymphocytic Leukemia,MORE Health,Positive
 Chronic Lymphocytic Leukemia,"Born Integrative Medicine Specialists, PLLC",Positive
 Chronic Lymphocytic Leukemia,Atlas of Science,Positive
 Chronic Lymphocytic Leukemia,Kerri Connell,Positive
 Chronic Lymphocytic Leukemia,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Positive
 Chronic Lymphocytic Leukemia,rattenniMD,Positive
 Chronic Lymphocytic Leukemia,"Sean Young, PhD",Positive
 Chronic Lymphocytic Leukemia,Kimryn Rathmell,Positive
 Chronic Lymphocytic Leukemia,Roel Verhaak,Positive
 Chronic Lymphocytic Leukemia,Paul Wicks,Positive
 Chronic Lymphocytic Leukemia,John,Negative
 Chronic Lymphocytic Leukemia,Feeds Medicina,Positive
 Chronic Lymphocytic Leukemia,Muzaffar Qazilbash,Positive
 Chronic Lymphocytic Leukemia,Pico üíâüíâ,Positive
 Chronic Lymphocytic Leukemia,Sheri Hendricks,Positive
 Chronic Lymphocytic Leukemia,ŸÖÿ±ŸÉÿ≤ ÿßŸÑÿ£ÿ®ÿ≠ÿßÿ´,Positive
 Chronic Lymphocytic Leukemia,Comfycozys for Chemo,Positive
 Chronic Lymphocytic Leukemia,Healthcanal,Positive
 Chronic Lymphocytic Leukemia,JebSource,Positive
 Chronic Lymphocytic Leukemia,Tapan Kadia,Negative
 Chronic Lymphocytic Leukemia,Shankara Paneesha,Negative
 Chronic Lymphocytic Leukemia,Rafael Fonseca MD,Positive
 Chronic Lymphocytic Leukemia,Mike Gauthier,Negative
 Chronic Lymphocytic Leukemia,IScienceWriter,Positive
 Chronic Lymphocytic Leukemia,Sue Pearson,Positive
 Chronic Lymphocytic Leukemia,Christie Library,Positive
 Chronic Lymphocytic Leukemia,Tom Heston,Negative
 Chronic Lymphocytic Leukemia,MoJo,Negative
 Chronic Lymphocytic Leukemia,Precision Medicine,Positive
 Chronic Lymphocytic Leukemia,Tom Carleton,Positive
 Chronic Lymphocytic Leukemia,Bill Rodgers,Negative
 Chronic Lymphocytic Leukemia,Survival Plan Kits,Negative
 Chronic Lymphocytic Leukemia,Michael O'Dwyer,Positive
 Chronic Lymphocytic Leukemia,Richard Schilsky,Positive
 Chronic Lymphocytic Leukemia,Doctors Lounge,Negative
 Chronic Lymphocytic Leukemia,Oxford virtual,Positive
 Chronic Lymphocytic Leukemia,First4Training,Positive
 Chronic Lymphocytic Leukemia,ivy science,Negative
 Chronic Lymphocytic Leukemia,Penn Medicine News,Negative
 Chronic Lymphocytic Leukemia,Hematology Review,Positive
 Chronic Lymphocytic Leukemia,Science agent,Positive
 Chronic Lymphocytic Leukemia,Pharm Digest,Negative
 Chronic Lymphocytic Leukemia,KevinFitts,Negative
 Chronic Lymphocytic Leukemia,Tom Silver,Positive
 Chronic Lymphocytic Leukemia,Cristina Reyes,Positive
 Chronic Lymphocytic Leukemia,Moffitt Research,Positive
 Chronic Lymphocytic Leukemia,Miguel Perales M.D.,Negative
 Chronic Lymphocytic Leukemia,Health|VBProfiles,Positive
 Chronic Lymphocytic Leukemia,dlvr news,Positive
 Chronic Lymphocytic Leukemia,C. Michael Gibson MD,Positive
 Chronic Lymphocytic Leukemia,michael.naafs,Positive
 Chronic Lymphocytic Leukemia,Hospital Medicine Virtual Journal Club,Positive
 Chronic Lymphocytic Leukemia,IMPPC,Positive
 Chronic Lymphocytic Leukemia,Health News Center,Positive
 Chronic Lymphocytic Leukemia,Penn Medicine MD,Positive
 Chronic Lymphocytic Leukemia,Personalized Nutrition Intervention 24/7 On Demand,Positive
 Chronic Lymphocytic Leukemia,Deborah Fitzerman,Positive
 Chronic Lymphocytic Leukemia,Dendritic cells,Positive
 Chronic Lymphocytic Leukemia,Labcold üíô,Positive
 Chronic Lymphocytic Leukemia,Ph√∫c Nguy·ªÖn,Positive
 Chronic Lymphocytic Leukemia,jt120651,Positive
 Chronic Lymphocytic Leukemia,Amy Houston,Positive
 Chronic Lymphocytic Leukemia,Tran-Der Tan,Positive
 Chronic Lymphocytic Leukemia,LightTheNightOntario,Positive
 Chronic Lymphocytic Leukemia,Dr Ortega,Positive
 Chronic Lymphocytic Leukemia,NACDA Program on Aging,Positive
 Chronic Lymphocytic Leukemia,RUBEN DARIO FONSECA,Positive
 Chronic Lymphocytic Leukemia,INQUISITR Sports,Positive
 Chronic Lymphocytic Leukemia,Jon Fisher,Positive
 Chronic Lymphocytic Leukemia,Hemoglobin News,Positive
 Chronic Lymphocytic Leukemia,Screenshots,Positive
 Chronic Lymphocytic Leukemia,Johan Van Weyenbergh,Positive
 Chronic Lymphocytic Leukemia,Cancer & Oncology,Positive
 Chronic Lymphocytic Leukemia,VoyagerMed,Positive
 Chronic Lymphocytic Leukemia,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Chronic Lymphocytic Leukemia,Mayo Clinic,Negative
 Chronic Lymphocytic Leukemia,Service Ebooks,Positive
 Chronic Lymphocytic Leukemia,Aiden Wallace,Positive
 Chronic Lymphocytic Leukemia,Immunology,Positive
 Chronic Lymphocytic Leukemia,Lorna Schamber,Positive
 Chronic Lymphocytic Leukemia,—ï.œâŒ±‚Ñì–∫—î—è,Positive
 Chronic Lymphocytic Leukemia,MS Papers,Positive
 Chronic Lymphocytic Leukemia,Bradford Holland MD FACS,Positive
 Chronic Lymphocytic Leukemia,CLL Info,Positive
 Chronic Lymphocytic Leukemia,Sean Tiernan,Positive
 Chronic Lymphocytic Leukemia,Graham Atherton,Positive
 Chronic Lymphocytic Leukemia,tan jie,Positive
 Chronic Lymphocytic Leukemia,Internet Medical,Positive
 Chronic Lymphocytic Leukemia,CPhI Online,Positive
 Chronic Lymphocytic Leukemia,Brighter Futures Inc,Positive
 Chronic Lymphocytic Leukemia,Scott Werntz,Positive
 Chronic Lymphocytic Leukemia,GMD,Positive
 Chronic Lymphocytic Leukemia,Donny Gilbreath,Negative
 Chronic Lymphocytic Leukemia,Cord Blood News,Negative
 Chronic Lymphocytic Leukemia,MGT Candidates,Positive
 Chronic Lymphocytic Leukemia,SysFlash,Positive
 Chronic Lymphocytic Leukemia,Ken Yaw Agyeman-Badu,Positive
 Chronic Lymphocytic Leukemia,Melissa Loomis,Positive
 Chronic Lymphocytic Leukemia,Stephane Jankowski,Positive
 Chronic Lymphocytic Leukemia,Kawther Salam,Positive
 Chronic Lymphocytic Leukemia,Literature Bot,Negative
 Chronic Lymphocytic Leukemia,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 Chronic Lymphocytic Leukemia,Jonathan Friedberg,Positive
 Chronic Lymphocytic Leukemia,genetic insidER,Positive
 Chronic Lymphocytic Leukemia,Ellen Una,Positive
 Chronic Lymphocytic Leukemia,Cyndi Joycelyn,Positive
 Chronic Lymphocytic Leukemia,jennifermcaiyr1983,Positive
 Chronic Lymphocytic Leukemia,Lelah Lakita,Positive
 Chronic Lymphocytic Leukemia,Early Detection,Positive
 Chronic Lymphocytic Leukemia,Columbia Med School,Positive
 Chronic Lymphocytic Leukemia,Linda Bohannon,Positive
 Chronic Lymphocytic Leukemia,yukiüåæ„äóÔ∏èÔºñ„Åï„ÅÑüéâ‚öî,Positive
 Chronic Lymphocytic Leukemia,Kalyani Bambal,Positive
 Chronic Lymphocytic Leukemia,Pedro Lendinez,Positive
 Chronic Lymphocytic Leukemia,BVirtual Murciasalud,Negative
 Chronic Lymphocytic Leukemia,SPEC,Positive
 Chronic Lymphocytic Leukemia,Dibson Gondim M.D.,Positive
 Chronic Lymphocytic Leukemia,Cary Higgins,Positive
 Chronic Lymphocytic Leukemia,Medscape Education,Negative
 Chronic Lymphocytic Leukemia,Geekgirl,Positive
 Chronic Lymphocytic Leukemia,Best Online  MD,Positive
 Chronic Lymphocytic Leukemia,Shawn Watson,Positive
 Chronic Lymphocytic Leukemia,Team In Training GAT,Positive
 Chronic Lymphocytic Leukemia,„Éê„Ç§„Ç™„Éû„Éº„Ç±„ÉÉ„Éàjp,Positive
 Chronic Lymphocytic Leukemia,Francois Maignen,Positive
 Chronic Lymphocytic Leukemia,Jimmy Herard,Positive
 Chronic Lymphocytic Leukemia,Wiley Genetics,Positive
 Chronic Lymphocytic Leukemia,EMJ Oncology,Negative
 NewTrip Acalabrutinib,Trip Database,Negative
 Japan,Lyfebulb,Positive
 Japan,1stOncology,Positive
 Japan,OncLive.com,Negative
 Japan,WebWire,Negative
 Japan,Calgary Herald,Positive
 Japan,Devdiscourse,Positive
 Japan,Shifting Wealth,Negative
 Japan,LifeProNow-Pharma-Research and News,Negative
 Japan,Josekun,Positive
 Japan,Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,Negative
 Japan,Golden Casino News,Negative
 Japan,Cision News,Positive
 Japan,Company News HQ,Negative
 Japan,MEDWAVE,Negative
 Japan,Patient Daily,Negative
 News Acalabrutinib,Lymphoma Hub,Negative
 News Acalabrutinib,FarmaOnco,Negative
 News Acalabrutinib,The Lancet Oncology,Negative
 un nouveau,NetCancer,Positive
 atteints d‚Äôune √©mie Lympho√Øde Chronique Retrouvez,NetCancer,Positive
 headtohead study,DMGAZ,Positive
   drugs,DMGAZ,Positive
   drugs,LymphomaAction,Negative
   drugs,Abigail Jones,Positive
 Impact,Amit Patelüá¨üáß,Positive
 Impact,NK cell Biology,Positive
 Impact,Paperbirds_Hematology,Positive
 Impact,Dendritic cells,Positive
 Impact,NK papers,Positive
 Impact,Dendritic Cell Papers,Positive
 Impact,#Memory,Positive
 Impact,Psychiatry Intel,Positive
 Impact,"Dr T. Comeau , MD",Negative
 Impact,Oncology,Negative
 Impact,Trip Database,Negative
 Impact,TrialBulletin,Positive
 Impact,Eduardo Flavio Oliveira Ribeiro,Negative
 Impact,ClinOwl Haematology,Positive
 Impact,Miriam L√≥pez P√©rez,Positive
 Impact,Juan Marquet,Negative
 Impact,ALI ALAHMARI.,Negative
 Impact,ClinOwl,Positive
 Impact,JAVIER DE LA SERNA,Positive
 Impact,Benlazar S.M Amin√©,Negative
 Impact,filippo masini,Negative
 Impact,INDoximity üáÆüá≥,Negative
 Impact,James Kerwin,Positive
 Impact,Fish Chromosomes,Positive
 Impact,"Matthew Davids, MD, MMSc",Positive
 Impact,vlDNApapers,Positive
 Impact,CureHuntr,Negative
 Impact,Elsevier Hematology,Positive
 Impact,Shouting at people in my underpants,Negative
 Impact,palliativewise,Negative
 Impact,"Raul Cordoba, MD, PhD",Positive
 Impact,NES Guisot,Positive
 Impact,Patient Power,Negative
 Impact,Oncology Tube,Negative
 Impact,NACDA Program on Aging,Negative
 Impact,AJMC,Negative
 Impact,AJMC-Oncology,Negative
 Impact,OncLive.com,Negative
 Impact,MDLinx,Negative
 therapy,Amit Patelüá¨üáß,Positive
 therapy,McKesson Corporation,Negative
 therapy,ASCO Publications,Positive
 therapy,The James,Negative
 therapy,"Mark Geyer, M.D.",Negative
 therapy,VJHemOnc,Positive
 therapy,Blood Cancer Discovery,Positive
 therapy,Benlazar S.M Amin√©,Positive
 therapy,Eduardo Flavio Oliveira Ribeiro,Negative
 therapy,Journal of the @NCCN,Negative
 therapy,Rajesh Sharma,Negative
 therapy,AstrologyNewsNetwork,Positive
 therapy,The ASCO Post,Negative
 therapy,Onco.com,Positive
 therapy,"Comprehensive Cell Solutions,New York Blood Center",Positive
 therapy,Medical Xpress,Negative
 therapy,Prof John,Negative
 therapy,Patient Power,Positive
 therapy,Deborah Stephens,Positive
 therapy,Michael Hallek,Negative
 therapy,Toby Eyre,Positive
 therapy,AplusA World,Positive
 therapy,CLL Society Inc.,Negative
 therapy,Jennifer Kwan MD PhD,Positive
 therapy,1stOncology,Negative
 therapy,Florent Malard,Negative
 therapy,MDedge Hematology & Oncology,Positive
 therapy,Lymphoma Papers,Negative
 therapy,"Bruce Levine, Ph.D.",Positive
 therapy,Cancer Papers,Positive
 therapy,"chadi nabhan MD, MBA, FACP",Positive
 therapy,palliativewise,Positive
 therapy,Hottest Stocks Now,Negative
 therapy,CLL_Fightersüéó,Negative
 therapy,CLL Ireland,Negative
 therapy,MPMI_UoM,Positive
 therapy,"Raul Cordoba, MD, PhD",Positive
 therapy,Luis H Camacho,Positive
 therapy,CBPartners,Positive
 therapy,RIOH,Negative
 therapy,FirstWord Pharma,Negative
 therapy,synbiopapers,Positive
 therapy,"Pharmacyclics, an AbbVie Company",Negative
 therapy,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Positive
 therapy,CancerTherapyAdvisor,Negative
 therapy,TumorImmunoPapers,Negative
 therapy,Cure Cancer Now,Negative
 therapy,Vincent Rajkumar,Negative
 therapy,Living Safely,Positive
 therapy,MDS 2019,Positive
 therapy,Christopher Steer,Negative
 therapy,Ward Health,Positive
 therapy,Matthias Piesche,Negative
 therapy,MD Anderson Cancer Center,Negative
 therapy,JAMA Oncology,Negative
 therapy,Oncology Times,Negative
 cell,Amit Patelüá¨üáß,Positive
 cell,TessEunkyoung Yoo,Positive
 cell,Toby Eyre,Negative
 cell,Oncology Learning Network,Negative
 cell,RIOH,Negative
 cell,"Raul Cordoba, MD, PhD",Positive
 cell,CancerWallonia,Negative
 cohort,Amit Patelüá¨üáß,Positive
 cohort,Jan Rynne,Positive
 failure,Amit Patelüá¨üáß,Positive
 failure,Clinical Cancer Research,Positive
 failure,George,Negative
 failure,Patient Power,Negative
 failure,Joana Koury,Positive
 failure,Bernie Marini,Positive
 Acalabrutinib monotherapy,Blood Advances,Negative
 Acalabrutinib monotherapy,"Dr T. Comeau , MD",Negative
 Acalabrutinib monotherapy,Blood Journal,Negative
 Acalabrutinib monotherapy,Benlazar S.M Amin√©,Positive
 Acalabrutinib monotherapy,Aloysius Pendergast,Positive
 Acalabrutinib monotherapy,Lymphoma Papers,Positive
 Acalabrutinib monotherapy,Lia Palomba,Positive
 Acalabrutinib monotherapy,EurekaMag,Negative
 Acalabrutinib monotherapy,Lampe & Company,Positive
 Acalabrutinib monotherapy,Toby Eyre,Negative
 Acalabrutinib monotherapy,Mois√©s Uriarte,Positive
 Acalabrutinib monotherapy,markcl208041,Positive
 Acalabrutinib monotherapy,OncLive.com,Negative
 Acalabrutinib monotherapy,The ASCO Post,Negative
 Acalabrutinib monotherapy,CancerTherapyAdvisor,Negative
 Acalabrutinib monotherapy,Francesco Bertoni,Negative
 Acalabrutinib monotherapy,Medscape Education,Negative
 Acalabrutinib monotherapy,Lymphoma Hub,Negative
 Noninferior PFS Atrial Fibrillation,Silas Inman,Negative
 Noninferior PFS,OncLive.com,Negative
 things,AnalySource: Premier Drug Pricing Services,Positive
 things,Patient Power,Positive
 things,CURE Magazine,Negative
 things,Adam Kittai,Negative
 things,Kim Kirchherr,Negative
 things,CLLSA,Negative
 things,The Leukemia & Lymphoma Society,Negative
 things,MDEdge,Negative
 things,Tinu Abayomi-Paul,Negative
 things,Saltanat Shafqat,Positive
 things,Welty,Positive
 things,CARE‚Ñ¢ Education,Negative
 things,Nick,Negative
 things,"Jose Sandoval S, MD FACP",Positive
 things,Giuseppe Cotellessa,Positive
 pharma marketers,AnalySource: Premier Drug Pricing Services,Positive
 Tuesday January,AnalySource: Premier Drug Pricing Services,Positive
 Roundup   MMampM,AnalySource: Premier Drug Pricing Services,Positive
 Medical Marketing,AnalySource: Premier Drug Pricing Services,Positive
 Media,AnalySource: Premier Drug Pricing Services,Positive
 Media,TGA Australia,Negative
 Media,BMTx3,Positive
 CALQUENCE,TrialSite News,Negative
 CALQUENCE,CALQUENCE¬Æ (acalabrutinib),Positive
 CALQUENCE,Ashleigh Walls,Positive
 CALQUENCE,April Golightly,Positive
 CALQUENCE,This Messy Season Family Blog,Positive
 CALQUENCE,Cook Eat Go,Positive
 CALQUENCE,Tamara Bowman,Positive
 CALQUENCE,"OTC Dynamics, Inc.",Negative
 CALQUENCE,Stock Titan,Negative
 CALQUENCE,Investor News,Positive
 CALQUENCE,Keeping Life Sane,Positive
 CALQUENCE,Shifting Wealth,Negative
 CALQUENCE,BrainSights iOS App,Negative
 CALQUENCE,Pharmacutical Daily,Positive
 CALQUENCE,Stock Market News,Negative
 CALQUENCE,Hottest Stocks Now,Negative
 CALQUENCE,IMPharma News,Negative
 CALQUENCE,Crwe World,Positive
 CALQUENCE,Latest News from Business Wire,Positive
 CALQUENCE,"Brand Institute, Inc",Negative
 CALQUENCE,Rebecca Miller,Positive
 CALQUENCE,IceCreamStickyFinger,Positive
 CALQUENCE,Catherine Lewis,Positive
 CALQUENCE,Home Jobs by MOM,Positive
 CALQUENCE,Angie Agerter,Positive
 CALQUENCE,icefairy,Positive
 CALQUENCE,Candy Washington,Positive
 CALQUENCE,Leave The Cannoli,Positive
 CALQUENCE,Mafiusa,Positive
 CALQUENCE,Emily Reviews,Positive
 CALQUENCE,Kelly & Alex,Positive
 CALQUENCE,Cleverly Changing (She/her),Positive
 CALQUENCE,Alexandria,Positive
 CALQUENCE,Stephanie BeautyBrite ‚ìã,Positive
 CALQUENCE,Jennifer Soltys,Positive
 CALQUENCE,Kimberly Kong,Positive
 CALQUENCE,What's up dearie?,Positive
 CALQUENCE,melissa weintraub,Positive
 CALQUENCE,HEATHER | Pink Ninja Blogger,Positive
 CALQUENCE,Garf,Positive
 CALQUENCE,Susie's Reviews,Positive
 CALQUENCE,Anne-Marie @ This Mama Cooks! On a Diet,Positive
 CALQUENCE,MissingLynxx,Positive
 CALQUENCE,Trendy Cyndie Reviewz & Newz,Positive
 CALQUENCE,Tara Pittman,Positive
 CALQUENCE,Mr. Rama Vs. Comics,Positive
 CALQUENCE,"KOLKATA RAVI SPECIALITIES PHARMA PVT.LTD.,",Positive
 CALQUENCE,delhi-ravi worldwide medicines,Positive
 CALQUENCE,dubai GlobalNews,Positive
 CALQUENCE,Health Radio Online,Positive
 CALQUENCE,ÿµÿ≠ÿ™ŸÉ 24,Positive
 CALQUENCE,+Recortes Salvajes,Positive
 CALQUENCE,Oncology Tube,Negative
 CALQUENCE,Philly Bio,Negative
 CALQUENCE,Cancer News,Negative
 CALQUENCE,Trading News,Positive
 CALQUENCE,onsVegas,Positive
 CALQUENCE,CancerCare,Negative
 CALQUENCE,Diagnostics News,Negative
 CALQUENCE,Saeed Valadbaygi,Negative
 CALQUENCE,Zeal Access,Positive
 CALQUENCE,Alicia Bell IFBB Pro,Negative
 CALQUENCE,The Pharmaceutical Marketing Group,Positive
 CALQUENCE,Briefing.com,Positive
 CALQUENCE,Mazen M,Negative
 CALQUENCE,DrugPatentWatch,Positive
 CALQUENCE,Gerry Post,Positive
 CALQUENCE,StockNews.com,Positive
 CALQUENCE,Financial Buzz,Positive
 CALQUENCE,ANTELLIS,Positive
 CALQUENCE,Business Wire-Health,Positive
 CALQUENCE,BusinessWireProducts,Positive
 CALQUENCE,Business Wire-TS,Negative
 CALQUENCE,BusinessWire-Science,Negative
 CALQUENCE,Stockboard Media Inc,Positive
 CALQUENCE,Giuseppe Michieli,Negative
 CALQUENCE,CRWE News Wire,Positive
 CALQUENCE,McKesson Corporation,Negative
 CALQUENCE,Biologics by McKesson,Negative
 CALQUENCE,IntoxicatedTrader,Negative
 CALQUENCE,Newmoney210,Negative
 CALQUENCE,Today's News,Positive
 CALQUENCE,Krishan Maggon,Negative
 headtohead Trial,TrialSite News,Negative
 Outcomes,Toby Eyre,Positive
 Outcomes,Benlazar S.M Amin√©,Negative
 Outcomes,Amer. Urol. Assn.,Positive
 Outcomes,Dr. Andre Goy,Negative
 Outcomes,Lymphoma Papers,Positive
 Outcomes,Chris Frei,Positive
 Outcomes,Paperbirds_Hematology,Negative
 Outcomes,COVID-19 Literature Surveillance Team,Positive
 Outcomes,The ASCO Post,Negative
 Outcomes,Blood Journal,Negative
 Outcomes,Oncology,Positive
 Outcomes,Mahmoud Aljurf,Positive
 Outcomes,National Aspergillosis Centre,Negative
 Outcomes,Donna Gairns,Positive
 Outcomes,Oncology Tube,Positive
 Outcomes,Cancer Health,Positive
 Outcomes,Medivizor,Positive
 Outcomes,noel cole,Negative
 Outcomes,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Outcomes,"chadi nabhan MD, MBA, FACP",Negative
 Outcomes,"Raul Cordoba, MD, PhD",Positive
 Outcomes,ALI ALAHMARI.,Negative
 Outcomes,Lymphoma Canada,Negative
 Outcomes,gilbert c faure,Negative
 Outcomes,Krishan Maggon,Negative
 Outcomes,Tracia.my.tupperware.com,Positive
 Outcomes,CLL Ireland,Negative
 Outcomes,CancerWallonia,Negative
 Outcomes,JAMA Oncology,Positive
 Outcomes,everett jackson,Positive
 Outcomes,Journal of Clinical Pathways,Negative
 Outcomes,ACS Journal Cancer,Negative
 Outcomes,PracticeUpdate,Negative
 Outcomes,Cancer Papers,Negative
 Outcomes,AJMC,Positive
 Outcomes,TumorImmunoPapers,Negative
 Outcomes,"Tom Iarocci, MD",Negative
 Outcomes,Comfycozys for Chemo,Positive
 Outcomes,TumImmTxpapers,Negative
 Outcomes,Muzaffar Qazilbash,Negative
 Outcomes,Francesco Turturro,Positive
 Outcomes,ASCO,Negative
 Outcomes,"Andreas-Claudius Hoffmann, M.D.",Positive
 Outcomes,MediTech Media,Positive
 Outcomes,MDLinx,Negative
 Outcomes,Scott Werntz,Negative
 Outcomes,Just Cancer News,Negative
 Outcomes,ASH,Negative
 Outcomes,Aziz Nazha,Positive
 Outcomes,FarmaOnco,Negative
 Outcomes,Sonia Glez Costas,Positive
 Outcomes,"Naveen Pemmaraju, MD",Negative
 Outcomes,Hematopoiesis News,Negative
 relapsed mantle cell lymphoma patients,Toby Eyre,Negative
 discontinuing,Toby Eyre,Negative
 discontinuing,Benlazar S.M Amin√©,Negative
 European Medicines Agency Review,Paperbirds_Hematology,Negative
 European Medicines Agency Review,TYR Kinase papers,Negative
 Treatment,Paperbirds_Hematology,Positive
 Treatment,TYR Kinase papers,Negative
 Treatment,Quant Data,Positive
 Treatment,Inara Bright,Positive
 Treatment,filippo masini,Negative
 Treatment,OncLive.com,Positive
 Treatment,Oncology Nursing News,Positive
 Treatment,Rafael H Carrasco,Positive
 Treatment,HealthDay News,Positive
 Treatment,Giuseppe LiMandri,Positive
 Treatment,TrialBulletin,Positive
 Treatment,Dalia ElGamal,Positive
 Treatment,Renal Cell Carcinoma,Positive
 Treatment,COPD News,Negative
 Treatment,CureHuntr,Positive
 Treatment,Lung Cancer News,Positive
 Treatment,Shohta Kadomura Hospital Pharmacist,Negative
 Treatment,Targeted Oncology,Positive
 Treatment,HemOnc Today,Negative
 Treatment,CURE Magazine,Negative
 Treatment,BioNews,Negative
 Treatment,CancerConnect,Positive
 Treatment,Saleh Stevens,Negative
 Treatment,Newmoney210,Negative
 Treatment,IntoxicatedTrader,Negative
 Treatment,Medicalnewser.com,Positive
 Treatment,1stOncology,Positive
 Treatment,Dr. Alan Tan,Positive
 Treatment,The ASCO Post,Negative
 Treatment,OBR,Negative
 Treatment,Josh Rehrer,Positive
 Treatment,Financial Buzz,Positive
 Treatment,BusinessWireProducts,Positive
 Treatment,Business Wire-Health,Positive
 Treatment,Stockboard Media Inc,Negative
 Treatment,BusinessWire-Science,Positive
 Treatment,Cancer News,Negative
 Treatment,Drug Delivery News,Negative
 Treatment,Oncology Tube,Positive
 Treatment,KristopherMaday PA-C,Positive
 Treatment,Kyle J. Norton,Positive
 Treatment,myCME,Negative
 Treatment,SeattleCancerCareAlliance,Negative
 Treatment,"Mazyar Shadman, MD MPH",Negative
 Treatment,CAR-TCR,Positive
 Treatment,Alicia Bell IFBB Pro,Positive
 Treatment,hematologist,Negative
 Treatment,Mellalta Meets,Negative
 Treatment,Tina Witte,Positive
 Treatment,Biotech & Tech Stock Focus,Positive
 Treatment,Mazeraski,Negative
 Treatment,IMPharma News,Positive
 Treatment,Jodie Insights,Negative
 Treatment,dough,Positive
 Treatment,Bio Stocks‚Ñ¢,Positive
 Treatment,Stock Titan,Positive
 Treatment,Medscape Education,Positive
 Treatment,EurekaMag,Negative
 Treatment,Patient Empowerment Network,Negative
 Treatment,U2 Fans,Negative
 Treatment,AlphaBronze,Positive
 Treatment,Aloysius Pendergast,Positive
 Treatment,BiopharmIQ by Amp,Positive
 Treatment,Flash Alert,Negative
 Treatment,"David Dahan, PhD",Positive
 Treatment,Benlazar S.M Amin√©,Positive
 Treatment,The Curable Recipes,Positive
 Treatment,MD Anderson Leukemia,Negative
 Treatment,Investor News,Negative
 Treatment,Aspen Biosciences,Positive
 Treatment,Pharm2Market,Positive
 Treatment,Jessi M,Positive
 Treatment,DennisPartners,Positive
 Treatment,Crwe World,Positive
 Treatment,Pharma News,Positive
 Treatment,Bastion Balance Seoul Korea,Positive
 Treatment,George,Negative
 Treatment,Hematology Advisor,Negative
 Treatment,Ibrahim Muhsen,Positive
 Treatment,Lymphomation.org,Positive
 Treatment,touchONCOLOGY,Positive
 Treatment,Yiqun Zhang,Positive
 Treatment,"Mike Thompson, MD, PhD, FASCO",Negative
 Treatment,„Éù„Ç±Go„Éà„É¨„Éº„Éä„Éº È≠îÁã∏Ôº†30Ê≠≥,Positive
 Treatment,Talha Badar,Positive
 Treatment,Young Hematologists,Positive
 Treatment,Miriam L√≥pez P√©rez,Positive
 Treatment,Lymphoma Papers,Positive
 Treatment,Florent Malard,Negative
 Treatment,Florian Slimano,Negative
 Treatment,"Andrew Johns, MD",Positive
 Treatment,john morley,Positive
 Treatment,Izaskun Zeberio,Negative
 Treatment,Eduardo Flavio Oliveira Ribeiro,Negative
 Treatment,Adrien Contejean,Positive
 Treatment,JCM MDPI,Positive
 Treatment,Patient Worthy,Negative
 Treatment,Pharmacutical Daily,Positive
 Treatment,Oncology Publishers Feed,Positive
 Treatment,"OTC Dynamics, Inc.",Negative
 Treatment,ASH Clinical News,Positive
 Treatment,PRpro.be,Positive
 Treatment,Cureus,Negative
 Treatment,Christie Library,Positive
 Treatment,"Redington, Inc.",Positive
 Treatment,Behavioral Finance,Positive
 Treatment,Jake,Negative
 Treatment,Day Trading Alerts,Positive
 Treatment,Swing Trading,Positive
 Treatment,Michelle Solly,Positive
 Treatment,Michel Doepke,Positive
 Treatment,Amp Trades,Negative
 Treatment,TradeXchange,Negative
 Treatment,Leukemia,Negative
 Treatment,NewExpressNews,Negative
 Treatment,PressReleasePoint,Negative
 Treatment,Company News HQ,Negative
 Treatment,BuxMont Forum,Positive
 Treatment,NwokeAgulu,Negative
 Treatment,SpecialtyPTimes,Positive
 Treatment,Odi Bruckman,Positive
 Treatment,CONQUER the patient voice,Positive
 Treatment,Chantel Martiromo,Positive
 Treatment,Wellcome-home,Positive
 Treatment,ALI ALAHMARI.,Positive
 Treatment,E Lambrechts,Negative
 Treatment,"Raul Cordoba, MD, PhD",Positive
 Treatment,National Aspergillosis Centre,Negative
 Treatment,ClinOwl,Positive
 Treatment,Simple Charts,Negative
 Treatment,SciTech Research,Negative
 Treatment,Vegastrader66,Positive
 Treatment,Anthony Mato,Negative
 Treatment,CHItraders,Negative
 Treatment,leo uzych,Negative
 Treatment,Value-Based Cancer Care,Negative
 Treatment,RAVIKANTH S,Positive
 Treatment,Yo-Bio,Positive
 Treatment,TrialSite News,Negative
 Treatment,Heather Swift Morrison,Negative
 Treatment,CLL_Fightersüéó,Negative
 Treatment,Oncology Times,Negative
 Treatment,Christy2x,Positive
 Treatment,gilbert c faure,Negative
 Treatment,FDA Oncology,Negative
 Treatment,Medivizor,Positive
 Treatment,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Treatment,HSMN,Negative
 Treatment,Seattle's Banker,Negative
 Treatment,HEDGE accordinglyüìà,Negative
 Treatment,CRE Demographics,Negative
 Treatment,Today's News,Positive
 Treatment,RazzleTazzle,Positive
 Treatment,CLL Ireland,Positive
 Treatment,CancerWallonia,Positive
 Treatment,HRI Portal,Negative
 Treatment,CLL-seq,Negative
 Treatment,Integra Medical,Positive
 Treatment,"Dr T. Comeau , MD",Positive
 Treatment,Francesco Bertoni,Negative
 Treatment,Hematopoiesis News,Negative
 Treatment,Cancer Stem Cell News,Negative
 Treatment,SNN Network,Negative
 Treatment,BioRunUp,Positive
 Treatment,The Pharmaceutical Marketing Group,Negative
 Treatment,APSHO,Negative
 Treatment,Patient Power,Positive
 Treatment,Stem Cell Tracker,Positive
 Treatment,Lymphoma Coalition,Negative
 Treatment,Oncology Advance,Positive
 Treatment,GEDEFO,Negative
 Treatment,Cancer Papers,Negative
 Treatment,A. Vroom - Ten Wolde,Negative
 Treatment,Janssen Sverige,Positive
 Treatment,Nature Reviews Disease Primers,Negative
 Treatment,biotechnologies,Positive
 Treatment,SPI News,Negative
 Treatment,Oncology Board,Positive
 Treatment,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Treatment,AJMC,Positive
 Treatment,AJMC-Oncology,Positive
 Treatment,Denver Greene,Negative
 Treatment,Clinical Leader,Positive
 Treatment,Alyssa Howard,Negative
 Treatment,INN Life Science,Positive
 Treatment,Danvantri Farma,Negative
 Treatment,Biotech2050,Negative
 Treatment,Krunox,Positive
 Treatment,Timothy Kelly,Positive
 Treatment,EMJ Hematology,Negative
 Treatment,NACDA Program on Aging,Positive
 Treatment,clinicaltherapeutics,Negative
 Treatment,Focus on Cancer,Positive
 Treatment,Cell Therapy News,Negative
 Treatment,Google  News,Positive
 Treatment,Diplomat,Negative
 Treatment,Pharmaceutical News,Negative
 Treatment,ZoZoTrader,Positive
 Treatment,Realpharmacyx,Positive
 Treatment,AJPB_Journal,Negative
 Treatment,Pharmacy Times,Negative
 Treatment,Reddit FoodNerds,Positive
 Treatment,T√ºrkiye Klinikleri,Negative
 Treatment,Cord Blood News,Negative
 Treatment,EMJ Oncology,Negative
 Treatment,"Born Integrative Medicine Specialists, PLLC",Positive
 Treatment,Clinical Pharmacy,Negative
 Treatment,Bill Rodgers,Negative
 Treatment,Survival Plan Kits,Negative
 Treatment,Priti Nagda,Positive
 Treatment,Sandra Kear,Positive
 Treatment,Personalized Nutrition Intervention 24/7 On Demand,Negative
 Treatment,LightTheNightOntario,Positive
 Treatment,LLSCanada,Negative
 Treatment,Scott Werntz,Positive
 Treatment,Pro-CME,Negative
 Treatment,Cure Cancer Now,Negative
 Treatment,Just Cancer News,Positive
 Treatment,NC Chapter LLS ,Positive
 Treatment,bhavna princesss,Positive
 Treatment,"Pharmacyclics, an AbbVie Company",Negative
 Treatment,Francesco Turturro,Negative
 Treatment,Man VS Cancer,Positive
 Adult Patients,Paperbirds_Hematology,Negative
 Adult Patients,TYR Kinase papers,Negative
 Adult Patients,The ASCO Post,Negative
 Adult Patients,onsVegas,Positive
 Adult Patients,Hematopoiesis News,Negative
 Adult Patients,1stOncology,Negative
 Adult Patients,Oncology Times,Negative
 Adult Patients,U2 Fans,Negative
 Adult Patients,AlphaBronze,Positive
 Adult Patients,IMPharma News,Negative
 Adult Patients,Aloysius Pendergast,Positive
 Adult Patients,BiopharmIQ by Amp,Positive
 Adult Patients,Biotech & Tech Stock Focus,Negative
 Adult Patients,dough,Negative
 Adult Patients,Flash Alert,Negative
 Adult Patients,Bio Stocks‚Ñ¢,Negative
 Adult Patients,Stock Titan,Negative
 Adult Patients,Vegastrader66,Positive
 Imbruvica,Bio_Talent,Negative
 Imbruvica,Susan,Positive
 Imbruvica,FiercePharma,Positive
 Imbruvica,Dr Timos Papagatsias,Positive
 Imbruvica,NewExpressNews,Positive
 Imbruvica,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Positive
 Imbruvica,PHARMABOX.IN,Positive
 Imbruvica,David Ledger,Negative
 Imbruvica,****,Negative
 Imbruvica,PharmaTimes,Negative
 Imbruvica,dough,Negative
 Imbruvica,"Maria Badillo, MSN RN OCN CCRP",Negative
 Imbruvica,DR.ARUN ACHUTHAN,Positive
 Imbruvica,cafepharma,Positive
 Imbruvica,Pharma Regulatory,Positive
 Imbruvica,Yanbo Zhang,Positive
 Imbruvica,ZorgNL,Positive
 Imbruvica,Scrip,Positive
 Imbruvica,Bionest Partners,Positive
 Imbruvica,Lung Cancer News,Negative
 Imbruvica,Cancer News,Negative
 Imbruvica,PharmaCrowd,Positive
 Imbruvica,EIPG,Positive
 Imbruvica,analyst land news,Positive
 Imbruvica,Carly Helfand,Positive
 Imbruvica,Worldcatholicnews,Positive
 Imbruvica,Labofine,Positive
 Imbruvica,"Cancer Stat - Essential News, Research & Analysis",Positive
 Imbruvica,vshariharakrishnan,Positive
 Imbruvica,Advera Health,Negative
 Imbruvica,Jacob Plieth,Negative
 Imbruvica,Cormac Sheridan,Positive
 Imbruvica,Patient Power,Negative
 Imbruvica,CURE Magazine,Positive
 Imbruvica,Helix BioPharma,Positive
 Imbruvica,40:40 Recruitment,Positive
 Imbruvica,PharmaShots - Incisive news in 3 shots,Negative
 Imbruvica,Market Intelligence: Healthcare,Positive
 Imbruvica,Alisyn Gayle,Positive
 Imbruvica,"dtw Research, Inc",Negative
 Imbruvica,PER,Negative
 Imbruvica,Daniel Kovach,Positive
 Imbruvica,Cancer Education and Research Institute,Positive
 Imbruvica,Value-Based Cancer Care,Negative
 Imbruvica,"Robinson Ortiz, MD",Positive
 Imbruvica,Andrew Merron,Positive
 Imbruvica,Diving News,Negative
 Imbruvica,Petra Kodeda,Positive
 Imbruvica,Patient Daily,Positive
 Imbruvica,Holden Caulfield PhD,Positive
 Imbruvica,John Pennett,Positive
 Imbruvica,Margaret Walker,Positive
 Imbruvica,FirstWord Pharma,Negative
 Imbruvica,Current Oncology,Negative
 Imbruvica,Paul Devereaux,Positive
 Imbruvica,Pure Leverage Rep,Negative
 Imbruvica,Davalyn Corporation,Positive
 Imbruvica,URL Shortener,Positive
 Imbruvica,Thomas Van Ahn,Negative
 Imbruvica,NYC Social Group,Negative
 Imbruvica,Mca Represenative,Positive
 Imbruvica,Cedar Consultants,Negative
 Imbruvica,indofx,Positive
 Imbruvica,I.Gazette,Negative
 Imbruvica,Today's Deals,Positive
 Imbruvica,OyoBoi,Negative
 Imbruvica,CancerConnect,Negative
 Imbruvica,ValueBase,Positive
 Imbruvica,Focus on Cancer,Negative
 Imbruvica,Only Medics,Negative
 Imbruvica,Regulatory Jobs,Positive
 Imbruvica,MAISA,Negative
 Imbruvica,Biotech 5,Positive
 Imbruvica,GxPeople,Positive
 Imbruvica,Pharmafocus,Negative
 Imbruvica,LARVOL,Negative
 Imbruvica,Sean McGrath,Positive
 Imbruvica,MORE Health,Positive
 Imbruvica,Pharma in Focus,Positive
 Imbruvica,takytavP,Positive
 ha raggiunto,Roberto Bonin,Positive
 ha raggiunto,Tecnomedicina,Positive
 di efficacia nello studio,Roberto Bonin,Positive
 di efficacia nello studio,Tecnomedicina,Positive
 testa contro ibrutinib nella leucemia linfocitica cronica,Roberto Bonin,Positive
 testa contro ibrutinib nella leucemia linfocitica cronica,Tecnomedicina,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç´„É´„Ç±„É≥„Çπ,Taro Shiga,Positive
 Calquence safety win,Susan,Positive
 Calquence safety win,FiercePharma,Negative
 Calquence safety win,Dr Timos Papagatsias,Negative
 Calquence safety win,NewExpressNews,Negative
 Calquence safety win,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 Calquence safety win,PHARMABOX.IN,Negative
 leukemia trial showdown,Susan,Positive
 leukemia trial showdown,FiercePharma,Negative
 leukemia trial showdown,Dr Timos Papagatsias,Negative
 leukemia trial showdown,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 leukemia trial showdown,PHARMABOX.IN,Negative
 RelapsedRefractory CLL,OncLive.com,Positive
 RelapsedRefractory CLL,Stem Cells in the News,Positive
 RelapsedRefractory CLL,Stem cell Watch,Positive
 RelapsedRefractory CLL,The Lynx Group,Positive
 RelapsedRefractory CLL,Immuno-Oncology,Positive
 RelapsedRefractory CLL,Crwe World,Positive
 RelapsedRefractory CLL,CLL Society Inc.,Negative
 RelapsedRefractory CLL,GEDEFO,Negative
 RelapsedRefractory CLL,Paperbirds_Hematology,Negative
 RelapsedRefractory CLL,ASCO,Negative
 RelapsedRefractory CLL,Bio Stocks‚Ñ¢,Negative
 RelapsedRefractory CLL,Targeted Oncology,Negative
 RelapsedRefractory CLL,SurvivalGear,Negative
 RelapsedRefractory CLL,orphanpedia,Positive
 RelapsedRefractory CLL,Dr. Melody Davis,Negative
 RelapsedRefractory CLL,"Wafik S. El-Deiry, MD, PhD, FACP",Negative
 relapsed mantle cell   patients,Benlazar S.M Amin√©,Negative
 American Journal,Benlazar S.M Amin√©,Negative
 American Journal,Anju,Positive
 American Journal,HofNorthwell Kidney,Positive
 American Journal,Giuseppe Ingravallo,Positive
 Hematology,Benlazar S.M Amin√©,Negative
 Hematology,"Yiping Yang, MD, PhD",Positive
 Hematology,"Raul Cordoba, MD, PhD",Positive
 Hematology,Paul Winston MD,Positive
 Hematology,"OTC Dynamics, Inc.",Negative
 Hematology,Mraz Lab,Positive
 Hematology,Toby Eyre,Positive
 Hematology,Current Oncology,Negative
 Hematology,Lymphoma Papers,Negative
 Hematology,Paperbirds_Hematology,Negative
 Hematology,"Eduardo Anguita, MD, PhD",Positive
 Hematology,Richard Rosenquist Brandell,Positive
 Hematology,Juan Marquet,Negative
 Hematology,ALI ALAHMARI.,Negative
 Hematology,Mustafa F,Positive
 Hematology,Ang√©lica Aranda,Positive
 Hematology,gilbert c faure,Negative
 Hematology,Medicom Medical Publishers,Positive
 Hematology,HofNorthwell Kidney,Positive
 Hematology,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Wiley Online Library,Benlazar S.M Amin√©,Positive
 Wiley Online Library,Francesco Bertoni,Negative
 üÜï   Topline results,HemOnc Today,Negative
 CALQUENCE Met Primary Efficacy Endpoint,BrainSights iOS App,Negative
 CALQUENCE Met Primary Efficacy Endpoint,Latest News from Business Wire,Negative
 CALQUENCE Met Primary Efficacy Endpoint,IMPharma News,Negative
 CALQUENCE Met Primary Efficacy Endpoint,Crwe World,Negative
 Neuro Central,BrainSights iOS App,Negative
 BrainSights,BrainSights iOS App,Positive
 iOS,BrainSights iOS App,Positive
 leukemia trial,NewExpressNews,Negative
 showdown,NewExpressNews,Negative
 showdown,pharmaphorum,Negative
 AstraZenecas Calquence,Market Intelligence: Healthcare,Positive
 AstraZenecas Calquence,Gordon Gekko,Positive
 AstraZenecas Calquence,Investor News,Positive
 AstraZenecas Calquence,Stocks tweets,Positive
 AstraZenecas Calquence,Shifting Wealth,Positive
 AstraZenecas Calquence,Pharmafocus,Positive
 AstraZenecas Calquence,Jon Angelo,Positive
 AstraZenecas Calquence,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 AstraZenecas Calquence,FancyFinancy,Negative
 AstraZenecas Calquence,BiotechBioPharma,Positive
 AstraZenecas Calquence,Financial Carnivores,Negative
 AstraZenecas Calquence,Swedish Biotech,Positive
 AstraZenecas Calquence,Vikesh Gudka,Positive
 AstraZenecas Calquence,CarnivoresHealth,Positive
 AstraZenecas Calquence,ECAM Norway,Positive
 AstraZenecas Calquence,Carlo Centemeri,Positive
 AstraZenecas Calquence,Pharmaceutical,Positive
 AstraZenecas Calquence,Miguel Angel Grullon C.,Positive
 AstraZenecas Calquence,BioCalifornia,Negative
 AstraZenecas Calquence,FiercePharma,Positive
 AstraZenecas Calquence,R Mandy Alcuria,Positive
 AstraZenecas Calquence,Continental Clinical,Positive
 AstraZenecas Calquence,Kevin Paul Oge,Positive
 AstraZenecas Calquence,Dr Timos Papagatsias,Positive
 AstraZenecas Calquence,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 AstraZenecas Calquence,FirstWord Pharma,Positive
 AstraZenecas Calquence,Redivex News,Positive
 AstraZenecas Calquence,Giuseppe LiMandri,Negative
 AstraZenecas Calquence,Forbes Tech,Positive
 AstraZenecas Calquence,WallStBetsDotCom,Negative
 AstraZenecas Calquence,BioPharma Dive,Positive
 AstraZenecas Calquence,Yanbo Zhang,Positive
 AstraZenecas Calquence,Bionest Partners,Positive
 AstraZenecas Calquence,BioCentury,Positive
 AstraZenecas Calquence,PharmaCrowd,Negative
 AstraZenecas Calquence,PharmaState,Positive
 AstraZenecas Calquence,EIPG,Positive
 AstraZenecas Calquence,cafepharma,Positive
 AstraZenecas Calquence,analyst land news,Positive
 AstraZenecas Calquence,Breaking News,Positive
 AstraZenecas Calquence,Carly Helfand,Positive
 AstraZenecas Calquence,Pharma Regulatory,Positive
 AstraZenecas Calquence,Labofine,Negative
 AstraZenecas Calquence,Advera Health,Negative
 AstraZenecas Calquence,ASOII,Positive
 AstraZenecas Calquence,Vignesh Sekar,Positive
 AstraZenecas Calquence,UKiwiS,Positive
 AstraZenecas Calquence,Martin JS Dyer,Positive
 AstraZenecas Calquence,M-Solutions,Positive
 AstraZenecas Calquence,Prem Raj Shakya,Positive
 AstraZenecas Calquence,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 AstraZenecas Calquence,Referral Kings,Positive
 AstraZenecas Calquence,ali bajwa,Positive
 AstraZenecas Calquence,Medical Web Times,Negative
 AstraZenecas Calquence,Paul Devereaux,Positive
 AstraZenecas Calquence,Kevin J Donaldson,Positive
 AstraZenecas Calquence,karin55marin,Negative
 AstraZenecas Calquence,Reuters Health,Negative
 AstraZenecas Calquence,the world of CROs,Negative
 AstraZenecas Calquence,Jonathan I Lawrence,Positive
 AstraZenecas Calquence,Healthy And Yeah,Positive
 AstraZenecas Calquence,Ecz.Gizem Usta,Positive
 AstraZenecas Calquence,Xeling,Positive
 AstraZenecas Calquence,Cabbages & King Mag.,Positive
 AstraZenecas Calquence,Tracia.my.tupperware.com,Positive
 AstraZenecas Calquence,Imran Haque,Positive
 AstraZenecas Calquence,Christine,Positive
 AstraZenecas Calquence,Lorna BArnett,Positive
 AstraZenecas Calquence,iQtipsy,Positive
 Johnson amp Johnsons Imbruvica,Market Intelligence: Healthcare,Positive
 progression,Market Intelligence: Healthcare,Positive
 progression,DelveInsight,Positive
 progression,re-how.net,Negative
 progression,LYMPHOMA & MYELOMA CONNECT,Negative
 progression,razo,Positive
 progression,Michael Rynne,Negative
 progression,MitochondriaNews,Positive
 progression,Paperbirds_Hematology,Positive
 progression,palliativewise,Negative
 progression,Blood Journal,Positive
 progression,"Amber Koehler, PA-C",Negative
 progression,CLL Epigenetics,Negative
 progression,Benlazar S.M Amin√©,Negative
 progression,Hematology Advisor,Negative
 progression,MDedge Hematology & Oncology,Negative
 progression,CancerTherapyAdvisor,Negative
 progression,"Raul Cordoba, MD, PhD",Positive
 progression,Mahmoud Aljurf,Negative
 progression,Patient Power,Negative
 progression,"chadi nabhan MD, MBA, FACP",Negative
 progression,Dr. Melody Davis,Negative
 progression,VJHemOnc,Positive
 progression,Oncocheck,Positive
 progression,Life Length,Positive
 type,Market Intelligence: Healthcare,Positive
 type,LymphomaAction,Positive
 type,OncLive.com,Negative
 type,Sarah Jones,Positive
 type,Mayo Clinic Cancer Center,Positive
 type,National Cancer Institute,Negative
 type,CLL Advocates Network,Negative
 type,MyPathologyReport.ca,Negative
 type,CLL Ireland,Negative
 type,Pfizer Inc.,Positive
 type,"Pharmacyclics, an AbbVie Company",Positive
 type,PER,Negative
 type,BeiGene,Positive
 type,ABPI,Positive
 type,JanssenUS,Negative
 type,GMO Free USA,Negative
 type,leukemia,Negative
 type,CLLSA,Positive
 type,Andrew Schorr,Negative
 type,AbbVie,Negative
 type,CLL Info,Negative
 type,Pitch Ticker,Positive
 blood cancer,Market Intelligence: Healthcare,Positive
 blood cancer,CHItraders,Negative
 blood cancer,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 blood cancer,Gordon Gekko,Negative
 blood cancer,Breaking News,Negative
 blood cancer,7NEWS Sydney,Positive
 blood cancer,McKesson Corporation,Negative
 blood cancer,13WREX,Positive
 blood cancer,Rocky,Positive
 blood cancer,ü•ìSara Dankerü•ì,Positive
 blood cancer,Dawn Ain't Playin',Positive
 blood cancer,CLL Society Inc.,Negative
 blood cancer,Ohio Infusion Services,Positive
 blood cancer,Emily Bell,Positive
 blood cancer,CP DA DON,Positive
 blood cancer,BeiGene,Negative
 blood cancer,Andrew Schorr,Negative
 blood cancer,Matthews & Associates,Positive
 blood cancer,Venkatraman Radhakrishnan (Venky),Positive
 blood cancer,helpsy,Positive
 blood cancer,Indian Med Guru,Positive
 latestage study,Market Intelligence: Healthcare,Positive
 AZN JNJ,Market Intelligence: Healthcare,Positive
 AZ,cafepharma,Negative
 AZ,LifeProNow-Pharma-Research and News,Negative
 AZ,Pharmaceutical Market Europe,Positive
 AZ,Chris Manfuso,Negative
 AZ,David Ledger,Positive
 AZ,PHARMABOX.IN,Negative
 AZ,Pharma Trader,Negative
 AZ,Iceberg Vision,Negative
 AZ,Everything Pharma,Negative
 AZ,PharmaCrowd,Negative
 AZ,Zenopa Recruitment,Positive
 AZ,PharmaTimes,Negative
 AZ,DrSpock_2021 PhD üíé,Positive
 AZ,Saleh Stevens,Negative
 AZ,40:40 Recruitment,Positive
 AZ,"eCare Vault, Inc.",Positive
 AZ,Claude Waddington,Positive
 AZ,DR.ARUN ACHUTHAN,Negative
 AZ,Worldcatholicnews,Positive
 AZ,GMPnews.Net,Negative
 AZ,EIPG,Negative
 AZ,Pharma Regulatory,Negative
 AZ,Pharma Business Int,Negative
 AZ,Scrip,Negative
 AZ,****,Negative
 AZ,Pharmamarketeer,Positive
 AZ,Jon Angelo,Negative
 AZ,AstraZenecaUS,Positive
 AZ,OncologyInfo,Positive
 AZ,"John P. Leonard, MD",Positive
 AZN AstraZeneca,Biotech & Tech Stock Focus,Negative
 AZN AstraZeneca,Briefing.com,Positive
 AZN AstraZeneca,ClinicalTrialsData,Negative
 AZN AstraZeneca,NASDAQ,Positive
 AZN AstraZeneca,CHItraders,Negative
 AZN AstraZeneca,Proactive,Negative
 AZN AstraZeneca,Stockboard Media Inc,Positive
 win,Dr Timos Papagatsias,Negative
 win,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 win,IT Recruiter,Positive
 win,pharmaphorum,Negative
 win,Richard Staines,Positive
 win,IPRX,Positive
 win,Sherie Masse,Positive
 Eli Lilly,Dr Timos Papagatsias,Negative
 Eli Lilly,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 heels,Dr Timos Papagatsias,Negative
 heels,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 AZN CALQUENCE,Corporate News,Positive
 AZN CALQUENCE,"OTC Dynamics, Inc.",Positive
 AZN CALQUENCE,Stock Titan,Positive
 AZN CALQUENCE,Neco‚Ñ¢,Positive
 AZN CALQUENCE,Odi Bruckman,Negative
 Met Primary Efficacy Endpoint,Corporate News,Negative
 Met Primary Efficacy Endpoint,"OTC Dynamics, Inc.",Negative
 Met Primary Efficacy Endpoint,Stock Titan,Negative
 AZN,InvestorsObserver,Positive
 AZN,Jan Ehses,Positive
 AZN,Investor News,Negative
 AZN,1stOncology,Positive
 AZN,Helen Ong,Positive
 AZN,MAISA,Positive
 AZN,Briefing.com,Negative
 AZN,CHItraders,Negative
 AZN,Breaking Market News,Negative
 AZN,BioPharma Dive,Negative
 AZN,Ned Pagliarulo,Positive
 AZN,Open Outcrier,Positive
 AZN,Bio Stocks‚Ñ¢,Negative
 AZN,GraniteShares Europe,Negative
 AZN,Jon Gardner,Positive
 AZN,Endpoints News,Negative
 AZN,Francis Alexander,Positive
 AZN,Seeking Alpha,Positive
 AZN,Jacob Plieth,Positive
 AZN,Carly Helfand,Negative
 AZN,ResearchPool,Negative
 AZN,Siti van der Meij,Positive
 AZN,Breaking News,Positive
 AZN,c lark,Positive
 AZN,Bursatil Biotech,Positive
 AZN,FiercePharma,Positive
 AZN,Hottest Stocks Now,Negative
 AZN,John Carroll,Positive
 AZN,Donna Young,Positive
 AZN,CBPartners,Positive
 AZN,StockNews.com,Negative
 AZN,Sarcasm Bot,Positive
 AZN,Cormac Sheridan,Positive
 AZN,Candice Nulsen,Positive
 AZN,Joe Hedden,Negative
 BRIEFAstraZeneca,Devdiscourse,Positive
 BRIEFAstraZeneca,EIN Presswire: EU Politics Newswire,Positive
 BRIEFAstraZeneca,Drug Delivery News,Positive
 BRIEFAstraZeneca,Sum,Positive
 BRIEFAstraZeneca,karin55marin,Negative
 BRIEFAstraZeneca,Knowsis Healthcare,Positive
 BRIEFAstraZeneca,Healthcare Industry,Positive
 AZN AstraZenecas Calquence,CHItraders,Positive
 AZN AstraZenecas Calquence,Biotech & Tech Stock Focus,Negative
 AwesomeCapital AstraZeneca Calquence,****,Positive
 AstraZenecas CALQUENCE,Quant Data,Negative
 Primary Efficacy EndpointRelated Tickers,Quant Data,Negative
 AZN   AstraZenecas Calquence,Breaking News,Positive
 AZNAstraZenecas Calquence,Soumyajyoti Biswas,Positive
 CLL treatmentAZN,Shifting Wealth,Negative
 L CLL noninferior PFS,dough,Negative
 Goldman bel√§sst Astrazeneca auf,FinanzLinksRatings,Positive
 Sell   Ziel,FinanzLinksRatings,Positive
 Pence NEW YORK,FinanzLinksRatings,Positive
 dpaAFX Analyser,FinanzLinksRatings,Positive
 Die,FinanzLinksRatings,Positive
 Die,Gelbe Liste,Negative
 Die,medtoday Germany,Negative
 Die,German Cheer Dad (GCD),Negative
 Die,Roche Deutschland,Negative
 Goldman Sachs hat,FinanzLinksRatings,Positive
 Einstufung f√ºr,FinanzLinksRatings,Positive
 Astrazeneca angesichts positiver,FinanzLinksRatings,Positive
 mit dem Medikament Calquence zur Behandlung,FinanzLinksRatings,Negative
 AKTIENCHECK,FinanzLinksRatings,Negative
 dpaAFX Goldman bel√§sst Astrazeneca auf,FinanzLinksRatings,Positive
 mit dem Medikament Calquence zur,FinanzLinksRatings,Negative
 FINANZTREFF,FinanzLinksRatings,Negative
 BRIEFAstraXeneca,Josekun,Positive
 BRIEFAstraXeneca,Devdiscourse,Negative
 AstraZenecas leukaemia treatment,Josekun,Positive
 AstraZenecas leukaemia treatment,EIN Presswire: Pharmaceutical Newswire,Negative
 approval,Josekun,Positive
 approval,EIN Presswire: Pharmaceutical Newswire,Negative
 approval,Benlazar S.M Amin√©,Negative
 approval,OncLive SOSS,Negative
 approval,Teena Thacker,Positive
 approval,1stOncology,Positive
 approval,Company News HQ,Negative
 approval,DirectorsTalk,Positive
 approval,Francis Alexander,Negative
 approval,Cision News,Negative
 approval,"dtw Research, Inc",Negative
 approval,OncLive.com,Positive
 approval,"Kelly Norsworthy, MD",Positive
 approval,CURE Magazine,Negative
 approval,"Trustwell Law Group, LLP",Positive
 approval,Alan Skarbnik,Negative
 approval,Michael Dickinson,Negative
 approval,OncologyNurseAdvisor,Positive
 approval,Hlthnews,Negative
 approval,NTRC,Positive
 approval,MyOncoPath,Positive
 approval,dario pasqualini,Positive
 approval,Medical Microbiology,Positive
 approval,"Lalit Leonard Sehgal, PhD",Positive
 approval,Sonali Prusty,Positive
 approval,Talbot Research Library & Media Services,Positive
 approval,MG,Positive
 approval,Lymphoma Hub,Positive
 approval,AstraZenecaUS,Negative
 approval,CancerTherapyAdvisor,Negative
 approval,Healio,Negative
 approval,HemOnc Today,Negative
 approval,Jacob Plieth,Negative
 approval,Targeted Oncology,Positive
 approval,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 approval,CLLSA,Negative
 approval,Great Debates in Hematologic Malignancies,Negative
 approval,NCI CTEP Clinical Research,Negative
 approval,GeneOnline,Positive
 approval,ECOG-ACRIN Cancer Research Group,Negative
 approval,AACR Foundation,Negative
 approval,Cord Blood News,Negative
 approval,CLL Society Inc.,Negative
 approval,Bionest Partners,Negative
 approval,MPR,Negative
 approval,Roche,Positive
 approval,AbbVie US,Negative
 approval,AbbVie,Positive
 approval,The PMI (Pharmaceutical Managers' Institute),Negative
 approval,CLL Ireland,Positive
 approval,Verastem Oncology,Negative
 approval,Solomon Kamal,Positive
 approval,"Jose Sandoval S, MD FACP",Positive
 approval,"Neil Sankar M.D.,MPH",Positive
 approval,"Liseth M Parra, PhD",Positive
 approval,National Cancer Institute,Positive
 approval,CheckRare,Positive
 approval,NFCR,Positive
 approval,LLS National Capital,Positive
 approval,Andrew Schorr,Positive
 approval,Blood-Cancer.com,Positive
 approval,MAISA,Negative
 approval,Jackie Julian,Positive
 approval,ESMO - Eur. Oncology,Negative
 approval,Christopher Steer,Negative
 approval,ASH Clinical News,Positive
 approval,Biotech2050,Negative
 approval,Patient Daily,Positive
 approval,CareAcross,Positive
 approval,"Pharmacyclics, an AbbVie Company",Negative
 approval,Lampe & Company,Negative
 approval,GenomeWeb Daily News,Positive
 approval,Tolero Pharma,Positive
 approval,VigiePharma,Positive
 approval,Women's Health News,Positive
 approval,Pharmafocus,Negative
 approval,Genentech,Negative
 approval,Sherie Masse,Positive
 approval,WCM Lymphoma,Negative
 approval,Patient Power,Negative
 approval,VJHemOnc,Negative
 approval,The Pharma Letter,Negative
 approval,Francesco Turturro,Negative
 approval,Pharma Commons,Negative
 approval,Hal Palmer,Positive
 approval,Scott Werntz,Negative
 approval,ABABioBlurb,Positive
 Japan Calquence,Josekun,Positive
 Japan Calquence,EIN Presswire: Pharmaceutical Newswire,Negative
 AZN Calquence,Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,Positive
 AZN Calquence,GraniteShares Europe,Positive
 AZN Calquence,biotechradar.eu,Positive
 AZN Calquence,FrankTheTooth,Positive
 AZN Calquence,Bio Stocks‚Ñ¢,Negative
 AZN Calquence,BioPharmCatalyst,Negative
 Met Primary Endpoint,Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,Negative
 Met Primary Endpoint,LiveSquawk,Positive
 Met Primary Endpoint,Hematopoiesis News,Negative
 Met Primary Endpoint,1stOncology,Negative
 Met Primary Endpoint,Cord Blood News,Negative
 Met Primary Endpoint,Rare Diseases,Negative
 Met Primary Endpoint,‚öõÔ∏èLibertyüåä,Positive
 Met Primary Endpoint,Odi Bruckman,Negative
 Met Primary Endpoint,CPhI Online,Positive
 Met Primary Endpoint,Donna Young,Negative
 IbrutinibMET PRIMARY EFFICACY ENDPOINT,Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,Negative
 HEADTOHEAD TRIAL,Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,Negative
 HEADTOHEAD TRIAL,Mathan,Positive
 IBRUTINIB,Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,Negative
 IBRUTINIB,Mathan,Positive
 IBRUTINIB,Hematology,Positive
 IBRUTINIB,Francesco Bertoni,Negative
 IBRUTINIB,Benlazar S.M Amin√©,Negative
 IBRUTINIB,dough,Negative
 IBRUTINIB,oncoletter,Negative
 IBRUTINIB,American Preclinical,Negative
 IBRUTINIB,satPRnews,Positive
 KEY SECONDARY ENDPOINT,Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,Negative
 ATRIAL FIBRILLATION,Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,Negative
 ATRIAL FIBRILLATION,Benlazar S.M Amin√©,Negative
 LiveSquawk AZN,Value's Vector,Positive
 AstraZeneca Plc,Value's Vector,Positive
 Calquence Met Primary Endpoint,Value's Vector,Positive
 Calquence Met Primary Endpoint,Devdiscourse,Negative
 IbrutinibCalquence Met Primary Efficacy Endpoint,Value's Vector,Positive
 IbrutinibCalquence Met Primary Efficacy Endpoint,LiveSquawk,Positive
 HeadToHead Trial,Value's Vector,Positive
 HeadToHead Trial,LiveSquawk,Positive
 Chronic Lymphocytic Leukaemia,Value's Vector,Positive
 Chronic Lymphocytic Leukaemia,LiveSquawk,Positive
 Chronic Lymphocytic Leukaemia,PHARMABOX.IN,Negative
 Chronic Lymphocytic Leukaemia,PharmaShots - Incisive news in 3 shots,Negative
 Chronic Lymphocytic Leukaemia,NonSell.com,Positive
 Chronic Lymphocytic Leukaemia,WheelieDealer,Negative
 Chronic Lymphocytic Leukaemia,BiopharmaAsia,Negative
 Chronic Lymphocytic Leukaemia,Paperbirds_Hematology,Positive
 Chronic Lymphocytic Leukaemia,Hetero Healthcare,Positive
 Chronic Lymphocytic Leukaemia,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 Chronic Lymphocytic Leukaemia,ABPI,Negative
 Chronic Lymphocytic Leukaemia,ESH (Haematology),Negative
 Chronic Lymphocytic Leukaemia,ID Medical,Positive
 Chronic Lymphocytic Leukaemia,Prof John,Negative
 Chronic Lymphocytic Leukaemia,Rustique Chic,Positive
 Chronic Lymphocytic Leukaemia,genuinedrugs123,Positive
 Chronic Lymphocytic Leukaemia,Manan Ja,Positive
 Chronic Lymphocytic Leukaemia,CLL Ireland,Negative
 Chronic Lymphocytic Leukaemia,Illingworth Research,Positive
 Chronic Lymphocytic Leukaemia,Leukaemia Care,Positive
 Chronic Lymphocytic Leukaemia,Margaret Walker,Positive
 Chronic Lymphocytic Leukaemia,RBCH Research,Positive
 ASTRAZENECA PLC,Mathan,Positive
 IBRUTINIBCALQUENCE MET PRIMARY EFFICACY ENDPOINT,Mathan,Positive
 CHRONIC LYMPHOCYTIC LEUKAEMIA,Mathan,Positive
 AZN   AstraZeneca Plc,LiveSquawk,Positive
 AstraZenecas New CALQUENCE,Health Radio Online,Positive
 ¬Æ Data,Health Radio Online,Positive
 ¬Æ Data,Pharmacutical Daily,Negative
 ¬Æ Data,Crwe World,Negative
 ¬Æ Data,Odi Bruckman,Negative
 ¬Æ Data,Diaceutics PLC,Negative
 Mantle Cell Lymphoma,Health Radio Online,Positive
 Mantle Cell Lymphoma,Quant Data,Negative
 Mantle Cell Lymphoma,NEERAJ BAJPAI,Positive
 Mantle Cell Lymphoma,Lymphoma Papers,Positive
 Mantle Cell Lymphoma,CureHuntr,Negative
 Mantle Cell Lymphoma,OncLive.com,Positive
 Mantle Cell Lymphoma,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 Mantle Cell Lymphoma,FarmaOnco,Negative
 Mantle Cell Lymphoma,Sheila Mayers,Positive
 Mantle Cell Lymphoma,Oncology Times,Negative
 Mantle Cell Lymphoma,The Purple Society,Negative
 Mantle Cell Lymphoma,Jenn Joy,Positive
 Mantle Cell Lymphoma,Cure Cancer Now,Negative
 Mantle Cell Lymphoma,Mar√≠a Jos√© Calasanz,Positive
 Mantle Cell Lymphoma,Daryl McGrath,Positive
 Mantle Cell Lymphoma,Zachary McLellan,Positive
 Mantle Cell Lymphoma,The Hindu Patrika,Positive
 Mantle Cell Lymphoma,Lymphoma News Today,Positive
 Mantle Cell Lymphoma,"Carol Evans, MD",Positive
 Mantle Cell Lymphoma,Cancer Health,Negative
 Mantle Cell Lymphoma,IMA,Positive
 Mantle Cell Lymphoma,CancerConnect,Positive
 Mantle Cell Lymphoma,Hlthnews,Negative
 Mantle Cell Lymphoma,AJPB_Journal,Positive
 Mantle Cell Lymphoma,DOCTOR MENDOZA CANCER NEWS,Positive
 Mantle Cell Lymphoma,"Chester Quan, OD",Negative
 Mantle Cell Lymphoma,OncLive SOSS,Negative
 Mantle Cell Lymphoma,Drugnews.in,Positive
 Mantle Cell Lymphoma,VHSPL,Positive
 Mantle Cell Lymphoma,Medicalnewser.com,Positive
 Mantle Cell Lymphoma,Wellness Wire,Positive
 Mantle Cell Lymphoma,Amer Coll Clin Pharm,Positive
 Mantle Cell Lymphoma,Carmen Y. Reyes,Positive
 Mantle Cell Lymphoma,Go Become,Positive
 Mantle Cell Lymphoma,Ahmed Eliwa,Negative
 Mantle Cell Lymphoma,DotDoctor,Positive
 Mantle Cell Lymphoma,Dr. Dan Botha,Positive
 Mantle Cell Lymphoma,balaji jegannathan,Positive
 Mantle Cell Lymphoma,UKiwiS,Positive
 Mantle Cell Lymphoma,Encore BioMed,Positive
 Mantle Cell Lymphoma,Krishan Maggon,Negative
 Mantle Cell Lymphoma,Tamuli Health,Positive
 Mantle Cell Lymphoma,Ethical Recruiters,Positive
 Mantle Cell Lymphoma,Hilda Tryon,Positive
 Mantle Cell Lymphoma,Lymphomation.org,Negative
 Mantle Cell Lymphoma,4RXCard,Positive
 Mantle Cell Lymphoma,"Freddy Pizart, R.N.",Positive
 Mantle Cell Lymphoma,ehealthandfitness,Positive
 Mantle Cell Lymphoma,GEDEFO,Negative
 Mantle Cell Lymphoma,Bronx Voice,Positive
 Mantle Cell Lymphoma,Rocketnews,Negative
 Mantle Cell Lymphoma,Thom O'Connor,Positive
 Mantle Cell Lymphoma,Newmoney210,Negative
 Mantle Cell Lymphoma,IntoxicatedTrader,Negative
 Mantle Cell Lymphoma,Animal Lover,Positive
 Mantle Cell Lymphoma,Pharma_Processes,Positive
 Mantle Cell Lymphoma,osakahiro,Positive
 Mantle Cell Lymphoma,ACS Research,Positive
 Mantle Cell Lymphoma,New Drug Approvals,Negative
 Mantle Cell Lymphoma,Drugs.com,Positive
 Mantle Cell Lymphoma,Kazeem Olalekan,Positive
 Mantle Cell Lymphoma,Tom,Negative
 Mantle Cell Lymphoma,Immuno-Oncology,Negative
 Mantle Cell Lymphoma,PER,Negative
 Mantle Cell Lymphoma,Mens Sexual Health,Positive
 Mantle Cell Lymphoma,Pharm Digest,Negative
 Mantle Cell Lymphoma,Junaid Hussain,Positive
 Mantle Cell Lymphoma,Silas Inman,Negative
 Mantle Cell Lymphoma,Mike van Dulken,Negative
 Mantle Cell Lymphoma,Dr. Alan Tan,Positive
 Mantle Cell Lymphoma,The ASCO Post,Negative
 Mantle Cell Lymphoma,Patient Worthy,Negative
 Mantle Cell Lymphoma,BioPharma Global,Positive
 Mantle Cell Lymphoma,Pharmacutical Daily,Negative
 Mantle Cell Lymphoma,Oncology Publishers Feed,Negative
 Mantle Cell Lymphoma,ClinicalTrialsData,Negative
 Mantle Cell Lymphoma,Cancer Papers,Negative
 Mantle Cell Lymphoma,Paperbirds_Hematology,Negative
 Mantle Cell Lymphoma,Maniriho Etienne,Positive
 Mantle Cell Lymphoma,JournalAgent,Positive
 Mantle Cell Lymphoma,Women's Publications,Positive
 Mantle Cell Lymphoma,Clin Dermatol Res J,Positive
 Mantle Cell Lymphoma,Clin Image Case Rep,Positive
 Comparing acalabrutinib,Medivizor,Negative
 CADTH,CADTH,Positive
 L trial,Toby Eyre,Negative
 transformationRCHOP,Toby Eyre,Negative
 RCHOPacalabrutinibWe,Toby Eyre,Negative
 quarter,Toby Eyre,Negative
 quarter,"dtw Research, Inc",Negative
 quarter,Hematopoiesis News,Negative
 quarter,Proactive,Negative
 quarter,"chadi nabhan MD, MBA, FACP",Negative
 quarter,CancerTherapyAdvisor,Positive
 way,Toby Eyre,Negative
 way,Surviving Myeloma,Positive
 way,"Maria Badillo, MSN RN OCN CCRP",Negative
 way,Patient Power,Negative
 way,Andrew Schorr,Negative
 way,undead viking zombie,Positive
 way,AbbVie,Positive
 way,Felix Keller,Positive
 way,LyLe Foreningen,Negative
 way,The James,Negative
 way,"Pharmacyclics, an AbbVie Company",Positive
 way,Catherine Vel√°zquez,Positive
 way,Genentech,Negative
 way,"David Steensma, MD",Positive
 way,Jonathan Pearce,Negative
 way,LiveYourLife,Negative
 way,AbbVie US,Negative
 way,John Walker,Positive
 way,Higher Ground at Lake Louise,Negative
 way,AJMC,Negative
 way,Leukaemia Care,Negative
 way,Jah Kuu,Negative
 way,VJHemOnc,Negative
 way,Sarah Sunshine,Positive
 way,"chadi nabhan MD, MBA, FACP",Negative
 way,Anita Shaffer,Positive
 way,Huntsville AL Now,Positive
 Mit Acalabrutinib,Pharmazeutische Zeitung,Positive
 Global Acalabrutinib Market InDepth Analysis Report,Amar Bhandari,Positive
 Acalabrutinib Market Report,Industry News Engine,Positive
 Global Manufacturers,Industry News Engine,Positive
 PFS,Targeted Oncology,Positive
 PFS,Mahmoud Aljurf,Negative
 PFS,NatureRevClinOncol,Positive
 PFS,"Michael Wang, MD",Negative
 PFS,OncLive.com,Positive
 PFS,David Ledger,Positive
 PFS,40:40 Recruitment,Positive
 PFS,"eCare Vault, Inc.",Positive
 PFS,Saleh Stevens,Negative
 PFS,Everything Pharma,Positive
 PFS,Pharma Trader,Positive
 PFS,Barry Curry,Positive
 PFS,CellworksLife,Positive
 PFS,PharmaTimes,Positive
 PFS,HemOnc Today,Positive
 PFS,"Mark Geyer, M.D.",Negative
 PFS,Alberto L√≥pez Garc√≠a,Positive
 PFS,The Lancet Haematology,Negative
 PFS,ASH Clinical News,Negative
 PFS,Pharma Regulatory,Negative
 PFS,EmatoInfo,Positive
 PFS,Immuno-Oncology,Positive
 PFS,Crwe World,Positive
 PFS,Toby Eyre,Positive
 PFS,CLL Society Inc.,Negative
 PFS,Career Biotech,Negative
 PFS,GEDEFO,Negative
 PFS,Oncology Learning Network,Negative
 PFS,Biotech2050,Negative
 PFS,PRAJAK BARDE,Positive
 PFS,"chadi nabhan MD, MBA, FACP",Positive
 PFS,Lymphoma Hub,Positive
 PFS,Michele Nadeem-Baker,Negative
 PFS,Lampe & Company,Negative
 PFS,Dr Timos Papagatsias,Negative
 PFS,Jeff Szer,Negative
 PFS,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 PFS,Miguel Perales M.D.,Positive
 PFS,"Amber Koehler, PA-C",Negative
 PFS,John DeRosier,Positive
 PFS,Chan Cheah,Positive
 PFS,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 PFS,the limbic,Negative
 PFS,CancerTherapyAdvisor,Negative
 PFS,Blood Journal,Negative
 PFS,"Raul Cordoba, MD, PhD",Positive
 PFS,Healio,Positive
 PFS,Odi Bruckman,Negative
 PFS,Christopher Steer,Positive
 PFS,Anna Deveau,Negative
 PFS,CancerWallonia,Negative
 PFS,Oncology Board,Positive
 PFS,MsPrissySis,Positive
 PFS,MedPage Today,Negative
 PFS,Lymphomation.org,Negative
 PFS,Beatriz P√©rez Sanz,Positive
 PFS,Mary Jo Dales,Positive
 PFS,The ASCO Post,Positive
 PFS,T Allen,Positive
 PFS,JUICEPharma,Positive
 PFS,European Pharmaceutical Review,Negative
 PFS,PANNA SHARMA,Positive
 PFS,Paul Lane,Negative
 PFS,Philip Shaheen,Positive
 acalabrutinib arms,Targeted Oncology,Negative
 ELEVATE CLL TN trial,Targeted Oncology,Negative
 control,Targeted Oncology,Negative
 control,Adam Curtis Bot,Positive
 control,Carlos Loinaz,Positive
 control,ClinOwl Haematology,Negative
 control,Paperbirds_Hematology,Negative
 control,Patient Power,Negative
 control,Publish PressRelease,Positive
 Leucemia linfatica cronica acalabrutinib √® approvato,Medicina e Informazione,Positive
 Europa,Medicina e Informazione,Positive
 Europa,Bls-D.Com,Positive
 Europa,Salutedomani,Negative
 Europa,saluteH24.com,Positive
 Europa,Antonio Caperna,Positive
 Europa,Derma News OK,Positive
 Europa,Medinews,Negative
 Europa,Delos Clinical,Positive
 Europa,Victor Norberto Cerasale Morteo,Negative
 Europa,PMFarma,Positive
 Europa,onmedic,Positive
 un beneficio,Medicina e Informazione,Positive
 un beneficio,Ritrattodellasalute,Positive
 termini,Medicina e Informazione,Positive
 termini,EmatoInfo,Positive
 termini,Ritrattodellasalute,Positive
 termini,Medinews,Negative
 di efficacia,Medicina e Informazione,Positive
 di efficacia,Ritrattodellasalute,Positive
 di efficacia,Medinews,Negative
 e tollerabilit√† lungo termine,Medicina e Informazione,Positive
 e tollerabilit√† lungo termine,Ritrattodellasalute,Positive
 nel trattamento,Medicina e Informazione,Positive
 prima linea,Medicina e Informazione,Positive
 quanto nella malattia,Medicina e Informazione,Positive
 o refrattaria,Medicina e Informazione,Positive
   CALQUENCE,CALQUENCE¬Æ (acalabrutinib),Positive
 adult patients,CALQUENCE¬Æ (acalabrutinib),Positive
 adult patients,OncLive.com,Positive
 adult patients,LARVOL,Negative
 adult patients,Lymphoma Hub,Positive
 adult patients,HealthcarePRwire,Positive
 adult patients,Mehrdad Yousefi,Negative
 adult patients,GraniteShares Europe,Positive
 adult patients,CURE Magazine,Negative
 adult patients,Drug Topics,Positive
 adult patients,Investor News,Negative
 adult patients,CancerCare,Negative
 adult patients,Targeted Oncology,Positive
 adult patients,octagonchem,Positive
 adult patients,Lymphoma Research Foundation,Positive
 adult patients,Financial Journal,Positive
 adult patients,Oncology Nursing News,Positive
 adult patients,Zeal Access,Positive
 adult patients,Alicia Bell IFBB Pro,Negative
 adult patients,Hlthnews,Negative
 adult patients,Gilles Gallant,Positive
 adult patients,The Galien Foundation,Positive
 adult patients,OncLive SOSS,Negative
 adult patients,Margaret Walker,Negative
 adult patients,Regulatory Jobs,Positive
 adult patients,David Ledger,Negative
 adult patients,Pharma Commons,Negative
 adult patients,UKiwiS,Positive
 adult patients,Digital-Ontology,Positive
 adult patients,Global Pharma News,Negative
 adult patients,World Pharma News,Negative
 adult patients,Krishan Maggon,Negative
 adult patients,OncologyInfo,Positive
 adult patients,Zahedi Mujawar,Positive
 adult patients,Duncan Young,Positive
 adult patients,StockNews.com,Negative
 adult patients,H.C. Wainwright & Co.,Positive
 adult patients,BondJamesBond,Positive
 adult patients,China Science,Positive
 adult patients,"Brand Institute, Inc",Negative
 adult patients,Roche,Negative
 adult patients,Anna Deveau,Positive
 adult patients,Cancer Stem Cell News,Negative
 adult patients,The Cancer Letter,Negative
 adult patients,The Medical Letter,Negative
 adult patients,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 adult patients,ASH Clinical News,Negative
 adult patients,OKCHEM,Positive
 adult patients,CellworksLife,Negative
 adult patients,i3 Health,Negative
 adult patients,E2DG,Positive
 adult patients,emilylevitch_i3Health,Positive
 adult patients,FDA Oncology,Negative
 adult patients,MAISA,Positive
 adult patients,The Leukemia & Lymphoma Society - Policy Advocacy,Positive
 adult patients,JCM Compounding Knowledge,Positive
 adult patients,Hottest Stocks Now,Negative
 adult patients,Medical Evidence üáÆüáπ,Positive
 adult patients,Professione Farmacia,Positive
 adult patients,Univadis,Positive
 adult patients,dario pasqualini,Positive
 adult patients,Rare Disease Report,Positive
 adult patients,MedChem & ONCo,Negative
 adult patients,PharmacyChecker,Negative
 adult patients,Renovatio Biom√©dica,Positive
 adult patients,Dr.Alberto Mussetti,Negative
 adult patients,Talbot Research Library & Media Services,Positive
 adult patients,Michael Mijares,Positive
 adult patients,ËÖ´Áò§Â≠∏Êñ∞Áü• | Cancer Informer,Positive
 adult patients,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 adult patients,Stefan Busch,Positive
 person,"Joseph Cioccio, DO",Negative
 person,AstraZenecaUS,Negative
 person,Shouting at people in my underpants,Negative
 person,JanssenUS,Negative
 person,Patient Power,Positive
 person,Dr. Drew Dahlgren,Positive
 person,AbbVie US,Negative
 person,Cancer Papers,Negative
 person,Venkatraman Radhakrishnan (Venky),Positive
 person,CLL_Fightersüéó,Positive
 person,Jeff Folloder,Positive
 person,cyberconic,Positive
 person,Michael Towner,Positive
 person,Maria Goreth,Negative
 anemic BM,"Joseph Cioccio, DO",Negative
 Rai III Dx,"Joseph Cioccio, DO",Negative
 BM BxTx,"Joseph Cioccio, DO",Negative
 venetoclaxobinutuzumab,"Joseph Cioccio, DO",Negative
 venetoclaxobinutuzumab,Blood Journal,Negative
 venetoclaxobinutuzumab,Mary Ruberry,Positive
 obinuFCR AIHA DX DAT,"Joseph Cioccio, DO",Negative
 ‚¨Ü Ô∏è t bili,"Joseph Cioccio, DO",Negative
 ‚¨Ü,"Joseph Cioccio, DO",Positive
 ‚¨Ü,Toby Eyre,Negative
 ‚¨Ü,(((Rich Stein)))Stay safeüò∑ü¶† & be kind,Positive
 Ô∏èldh,"Joseph Cioccio, DO",Negative
 Ô∏è reticTx roids,"Joseph Cioccio, DO",Negative
 PRCA ‚¨á Ô∏è retics,"Joseph Cioccio, DO",Negative
 Tx,"Joseph Cioccio, DO",Negative
 Tx,Tontarn Chutima,Positive
 Tx,"chadi nabhan MD, MBA, FACP",Positive
 Tx,The ASCO Post,Negative
 Tx,Jane Cheung,Positive
 Tx,NE Live,Positive
   Rituximab Acalabrutinib,CureHuntr,Negative
 Durvalumab RAD,CureHuntr,Negative
 Durvalumab RAD,TrialBulletin,Negative
 Primary CNS Lymphoma,CureHuntr,Negative
 Rituximab Acalabrutinib,TrialBulletin,Negative
 Primary CNS Lymphoma Status,TrialBulletin,Negative
 Condition Summary Primary Central Nervous System Lymphoma PCNSL,TrialBulletin,Negative
 rationale,OncLive SOSS,Positive
 rationale,Thiago Carvalho,Negative
 rationale,Targeted Oncology,Positive
 rationale,OncLive.com,Positive
 rationale,Medscape Education,Negative
 rationale,MoJo,Negative
 rationale,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 rationale,Andrew Schorr,Negative
 rationale,Lymphoma Hub,Negative
 New Comparing acalabrutinib,Medivizor,Negative
   Product,DRUGDOCS,Positive
 Monograph Prescribing Info Health Technology Assessments,DRUGDOCS,Positive
 Access Drug Documents,DRUGDOCS,Positive
 case,Oncology Nursing News,Positive
 case,Oncology Times,Positive
 case,Targeted Oncology,Positive
 case,Lymphoma Papers,Negative
 case,Paperbirds_Hematology,Positive
 case,SPA,Positive
 case,Michael Hallek,Negative
 case,Lymphoma Hub,Positive
 case,Fernando Mart√≠n Moro,Positive
 case,Adam Mead,Positive
 case,Stefano Cattaneo DVM,Negative
 case,Oncologiavet,Negative
 case,Michele Nadeem-Baker,Negative
 case,Lupus News,Positive
 case,New Scientist Zone,Positive
 case,Bijoy Telivala,Negative
 case,JELEU,Negative
 case,"Amber Koehler, PA-C",Negative
 case,Patient Power,Positive
 case,CURE Magazine,Positive
 case,Dr. Andy Evens,Negative
 case,Generation Medics,Positive
 case,Jordan Gauthier,Positive
 case,Mom No Longer Needs To Resist! WE WON!,Positive
 case,Dermpath-L,Positive
 case,i3 Health,Negative
 case,CLLSA,Negative
 case,Only Medics,Negative
 case,Regulatory Jobs,Positive
 case,Cancer Papers,Negative
 case,Erin Early,Positive
 case,The Other A. Sharpton,Positive
 case,Titanhealth news,Negative
 case,Regulatory Insights,Positive
    Nuove importanti,EmatoInfo,Positive
 combinazione nel,EmatoInfo,Positive
 di risposta,EmatoInfo,Positive
 completa,EmatoInfo,Positive
 e MRD negativit√† Le parole di Francesca Romana Mauro,EmatoInfo,Positive
 Patients,Oncology Nursing News,Positive
 Patients,OncLive.com,Positive
 Patients,Investor News,Positive
 Patients,BrainSights iOS App,Positive
 Patients,SeattleCancerCareAlliance,Negative
 Patients,IMPharma News,Positive
 Patients,Biotech & Tech Stock Focus,Positive
 Patients,Crwe World,Positive
 Patients,Pharmacutical Daily,Positive
 Patients,Devdiscourse,Negative
 Patients,"OTC Dynamics, Inc.",Positive
 Patients,Stock Titan,Positive
 Patients,Wall St. Justin Bieber think.tradeüí≠,Positive
 Patients,Stock Market News,Positive
 Patients,Corporate News,Negative
 Patients,Latest News from Business Wire,Positive
 Patients,PILOTforPULMONARY,Positive
 Patients,Lyke Lyfe,Positive
 Patients,CHItraders,Positive
 Patients,Quant Data,Positive
 Patients,Urology,Negative
 Patients,Oncology,Positive
 Patients,HemOnc Today,Negative
 Patients,Lymphoma Papers,Positive
 Patients,Oncology Board,Positive
 Patients,"Mike Thompson, MD, PhD, FASCO",Positive
 Patients,CLL Advocates Network,Negative
 Patients,Jerry Lee,Positive
 Patients,Julie Lakeview,Positive
 Patients,ZC,Positive
 Patients,Swedish Biotech,Positive
 Patients,Financial Carnivores,Negative
 Patients,Voz Entrerriana,Positive
 Patients,HealthIT and Biotech,Positive
 Patients,Truth Studio,Negative
 Patients,MySmallCap,Positive
 Patients,"eCare Vault, Inc.",Positive
 Patients,Pharmaceutical,Positive
 Patients,BioCalifornia,Negative
 Patients,Armin Hamidian,Negative
 Patients,VIRALFLEX,Positive
 Patients,Dr.Virendra Singh,Positive
 Patients,news98,Positive
 Patients,"Anastasios Raptis, MD",Positive
 Patients,Victor YosefMelt Campos,Positive
 Patients,The ASCO Post,Positive
 Patients,√únal Metin Tokat,Positive
 Patients,Jorie graham,Positive
 Patients,Plexus Ventures,Negative
 Patients,Cure Cancer Now,Positive
 Patients,Foreign Confidential,Positive
 Patients,Irmeli Viinanen,Positive
 Patients,John Nosta,Positive
 Patients,Value-Based Cancer Care,Positive
 Patients,Shohta Kadomura Hospital Pharmacist,Positive
 Patients,Oncology Tube,Positive
 Patients,Cancer News,Positive
 Patients,Trading News,Positive
 Patients,"Raul Cordoba, MD, PhD",Positive
 Patients,CureHuntr,Positive
 Patients,TrialBulletin,Positive
 Patients,The James,Negative
 Patients,Paperbirds_Hematology,Positive
 Patients,PharmaShots - Incisive news in 3 shots,Positive
 Patients,Cancer Trials Support Unit,Positive
 Patients,Mazen M,Positive
 Patients,Targeted Oncology,Positive
 Patients,"Bichoy Gabra, R.Ph., Ph.D.",Positive
 Patients,Renal Cell Carcinoma,Positive
 Patients,U-M Rogel Cancer Center,Positive
 Patients,Lymphomation.org,Positive
 Patients,OncLive SOSS,Negative
 Patients,Saleh Stevens,Negative
 Patients,Medicalnewser.com,Positive
 Patients,OBR,Negative
 Patients,Josh Rehrer,Positive
 Patients,Financial Buzz,Positive
 Patients,BusinessWireProducts,Positive
 Patients,Business Wire-Health,Positive
 Patients,Stockboard Media Inc,Negative
 Patients,BusinessWire-Science,Positive
 Patients,Drug Delivery News,Negative
 Patients,ÕèWilliam Avery Hudson,Positive
 Patients,Patient Empowerment Network,Positive
 Patients,The Oncologist,Negative
 Patients,Michele Nadeem-Baker,Positive
 Patients,CURE Magazine,Positive
 Patients,Giuseppe Michieli,Negative
 Patients,Stock Market Catalyst News üåé,Positive
 Patients,Dan Brickner,Positive
 Patients,STOCKMASTER2000,Positive
 Patients,Stock News Bot,Positive
 Patients,"Dr T. Comeau , MD",Positive
 Patients,ClinOwl Haematology,Positive
 Patients,BibliotecaHUVH. ICS,Positive
 Patients,ClinicalTrialsData,Positive
 Patients,R Marcos-Gragera üéó,Positive
 Patients,INDoximity üáÆüá≥,Negative
 Patients,Alicia Bell IFBB Pro,Positive
 Patients,Oncology Publishers Feed,Negative
 Patients,Patient Power,Positive
 Patients,HAM,Negative
 Patients,Bitchin' Science,Positive
 Patients,Sarang Pokhare,Negative
 Patients,Pharma News,Positive
 Patients,IUOPA,Negative
 Patients,Tom Silver,Positive
 Patients,Lisa Palacios,Positive
 Patients,@globalfirstnews,Positive
 Patients,Benlazar S.M Amin√©,Positive
 Patients,Mellalta Meets,Positive
 Patients,1stOncology,Positive
 Patients,AlphaBronze,Positive
 Patients,Tina Witte,Positive
 Patients,Mazeraski,Positive
 Patients,Jodie Insights,Positive
 Patients,Biotech2050,Positive
 Patients,dough,Positive
 Patients,Bio Stocks‚Ñ¢,Positive
 Patients,Shouting at people in my underpants,Negative
 Patients,PRIME Education,Negative
 Patients,The Political Hedge,Positive
 Patients,mednetnews,Negative
 Patients,ArthurPotatoeHammer,Positive
 Patients,Biblioteca HUCA,Negative
 Patients,"Naveen Pemmaraju, MD",Positive
 Patients,Gail Williams,Positive
 Patients,CLL Ireland,Positive
 Patients,CellworksLife,Positive
 Patients,Jan Rynne,Positive
 Patients,Oscar Lahoud,Positive
 Patients,filippo masini,Negative
 Patients,Irene Mangues,Positive
 Patients,AJMC,Positive
 Patients,Mayo Clinic Hematology-Oncology Fellowship,Positive
 Patients,UofU3i,Positive
 Patients,OncologyNurseAdvisor,Positive
 Patients,Hematology Advisor,Negative
 Patients,CancerEpiPapers,Negative
 Patients,Cytof Manchester,Positive
 Patients,Oncology Times,Positive
 Patients,Joe,Negative
 Patients,Daniel,Positive
 Patients,Basil,Positive
 Patients,Ariel Herzog,Positive
 Patients,BW Capital,Positive
 Patients,NEJM,Positive
 Patients,Patient Worthy,Negative
 Patients,Tom,Positive
 Patients,"Viren Kaul, MD",Positive
 Patients,MyPathologyReport.ca,Negative
 Patients,Wellcome-home,Negative
 Patients,DennisPartners,Negative
 Patients,Fuzzy,Positive
 Patients,@COVID_Evidence,Negative
 Patients,BSH - Haematology,Positive
 Patients,"Matthew Davids, MD, MMSc",Positive
 Patients,Toby Eyre,Negative
 Patients,ingentium_COVID,Positive
 Patients,ASCO Publications,Negative
 Patients,TrialSite News,Positive
 Patients,EurekaMag,Positive
 Patients,"Redington, Inc.",Positive
 Patients,Behavioral Finance,Positive
 Patients,Matt Fanning,Positive
 Patients,Jake,Negative
 Patients,Day Trading Alerts,Positive
 Patients,Swing Trading,Positive
 Patients,Michelle Solly,Positive
 Patients,Michel Doepke,Positive
 Patients,Amp Trades,Negative
 Patients,TradeXchange,Negative
 Patients,learn coronavirus Life,Positive
 Patients,NewExpressNews,Negative
 Patients,Journal of the @NCCN,Negative
 Patients,PressReleasePoint,Positive
 Patients,Company News HQ,Positive
 Patients,BuxMont Forum,Positive
 Patients,NwokeAgulu,Negative
 Patients,Odi Bruckman,Positive
 Patients,Meli Rockhold,Positive
 Patients,Victoria Gescheidle,Positive
 Patients,Anthony Mato,Positive
 Patients,Thomas C. Keefe,Negative
 Patients,CAR-TCR,Positive
 Patients,LLZ Consulting,Positive
 Patients,HSMN,Positive
 Patients,COPD News,Positive
 Patients,HomenusRevelio3,Positive
 Patients,AbbVie US,Positive
 Patients,Hans Scheurer,Positive
 Patients,CLL Society Inc.,Positive
 Patients,SC,Positive
 Patients,Jordan Gauthier,Positive
 Patients,Dr Shibley,Positive
 Patients,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Patients,Lymphoma Australia,Positive
 Patients,Clinical OMICs,Positive
 Patients,Lovisa Bray,Positive
 Patients,"Navneet Majhail, MD, MS",Positive
 Patients,CONQUER the patient voice,Positive
 Patients,The Patient's Channel,Negative
 Patients,Simple Charts,Positive
 Patients,ACS Journal Cancer,Negative
 Patients,"Hawkins Gay, MD, MPH",Negative
 Patients,Mary Caffrey,Positive
 Patients,Saeed Valadbaygi,Negative
 Patients,MasdelMedio,Negative
 Patients,pressdaily,Negative
 Patients,Robert Z. Orlowski,Negative
 Patients,MD Anderson Leukemia,Positive
 Patients,Will,Negative
 Patients,JAMA Network Open,Negative
 Patients,GMPnews.Net,Negative
 Patients,Esther Schorr,Negative
 Patients,James Kerwin,Positive
 Patients,David -mogeladze,Positive
 Patients,CLL_Fightersüéó,Positive
 Patients,National Aspergillosis Centre,Positive
 Patients,YGLDMETG,Positive
 Patients,BenXM,Positive
 Patients,Cancer Medicine,Positive
 Patients,SNN Network,Positive
 Patients,Greenlight Stocks,Positive
 Patients,HCP Feed,Positive
 Patients,‚ö°AiMS,Negative
 Patients,The Lynx Group,Positive
 Patients,RIOH,Negative
 Patients,AONN+,Positive
 Patients,ImmunologyPapers,Negative
 Patients,Prof John,Negative
 Patients,SpecialtyPTimes,Negative
 Patients,ASH Clinical News,Negative
 Patients,AJMC-Oncology,Negative
 Patients,Place Matters,Positive
 Patients,SciTech Research,Positive
 Patients,Trip Database,Negative
 Patients,"Robinson Ortiz, MD",Negative
 Patients,Carevƒ´ve,Negative
 Patients,SPI News,Positive
 Patients,DocWire News,Positive
 Patients,RazzleTazzle,Positive
 Patients,HempNews,Negative
 Patients,Marketbit.pro,Positive
 Patients,Lung Cancer News,Negative
 Patients,Verastem Oncology,Negative
 Patients,Cancer Library VCC,Positive
 Patients,Dr. Jos√© A. Queiz√°n,Negative
 Patients,maria jose agustin,Positive
 Patients,NK papers,Positive
 Patients,Daniel Auclair,Positive
 Patients,Triona N√≠ Chonghaile,Negative
 Patients,Heather Swift Morrison,Negative
 Patients,CancerWallonia,Positive
 Patients,NCI CTEP Clinical Research,Negative
 Patients,US Oncology Network,Negative
 Patients,Glenn Sabin,Positive
 Patients,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 Patients,Seattle's Banker,Positive
 Patients,HEDGE accordinglyüìà,Positive
 Patients,CRE Demographics,Positive
 Patients,ALI ALAHMARI.,Negative
 Patients,Mahmoud Aljurf,Positive
 Patients,Expert Perspectives in Oncology,Negative
 Patients,Hematopoiesis News,Positive
 Patients,Today's News,Positive
 Patients,Chan Cheah,Negative
 Patients,HRI Portal,Negative
 Patients,Internal Medicine: Open Access,Negative
 Patients,Solomon Kamal,Positive
 Patients,Matthew Wakefield,Positive
 Patients,Garbi√±e Lizeaga,Positive
 Patients,AAU,Positive
 Patients,Cancer Papers,Positive
 Patients,TumorImmunoPapers,Positive
 Patients,dermatologyf,Positive
 Patients,melanomacan,Positive
 Patients,Marlowe S Tessmer,Positive
 Patients,ŸÜÿßÿØŸä ÿßŸÑÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿ¨ŸÑÿØŸäÿ©,Positive
 Patients,Sicilia Informazioni,Positive
 Patients,Cancer Stem Cell News,Positive
 Patients,NeuroStemCells,Positive
 Patients,Jim Till,Positive
 Patients,Rare Diseases,Positive
 Patients,Philip McCarthy,Negative
 Patients,leukemia,Negative
 Patients,FarmaOnco,Positive
 Patients,Health MasterDoctor,Positive
 Patients,Medindia.net,Negative
 Patients,CSI Specialty Group,Positive
 Patients,AssistRx,Positive
 Patients,Cyberknife,Positive
 Patients,Dr. Luis Villela,Positive
 Patients,Marta Crespo,Negative
 Patients,epigenetics_papers,Negative
 Patients,cohesin_papers,Positive
 Patients,Colorectal Cancer Charity,Positive
 Patients,Human Immunology News,Negative
 Patients,Lymphoma Canada,Positive
 Patients,E Lambrechts,Negative
 Patients,"Meagan Bryan, RN",Positive
 Patients,Huntsman Cancer Institute,Positive
 Patients,CancerTherapyAdvisor,Negative
 Patients,BioRunUp,Positive
 Patients,The Pharmaceutical Marketing Group,Negative
 Patients,Radiation Research Society,Positive
 Patients,The Purple Society,Positive
 Patients,"Les Yonemoto, MD MBA",Positive
 Patients,Jim Graham,Positive
 Patients,ASH,Negative
 Patients,AIRR-seq papers,Positive
 Patients,Margaret Walker,Negative
 Patients,Mohs College,Positive
 Patients,Christoph Westphal,Positive
 Patients,Immuno-Oncology,Negative
 Patients,Henning,Negative
 Patients,DTR Medical ¬Æ,Positive
 Patients,Asim Shahzad,Positive
 Patients,Lymphoma Coalition,Positive
 Patients,orphanpedia,Positive
 Patients,JAMA Oncology,Positive
 Patients,CBPartners,Positive
 Patients,sandrineman,Negative
 Patients,ccdt,Positive
 Patients,everett jackson,Positive
 Patients,GEDEFO,Positive
 Patients,microRNApapers,Positive
 Patients,Evidera,Positive
 Patients,Journal of Clinical Pathways,Positive
 Patients,CCDT,Positive
 Patients,"Darcy Burbage, DNP, RN, AOCN",Positive
 Patients,MoJo,Positive
 Patients,PracticeUpdate,Positive
 Patients,MD Anderson Library,Positive
 Patients,Nature Reviews Disease Primers,Negative
 Patients,Krishan Maggon,Positive
 Patients,Gendron Recherche,Negative
 Patients,Selvyn Kennedy,Positive
 Patients,Danvantri Farma,Negative
 Patients,Gilles Gallant,Positive
 Patients,Andrew Schorr,Negative
 Patients,PER,Negative
 Patients,EMJ Hematology,Negative
 Patients,Cancers MDPI,Negative
 Patients,Dr. JOSE VELASQUEZ,Positive
 Patients,BluntAdvice,Positive
 Patients,Mohammad Alhomoud,Positive
 Patients,copperpeony,Positive
 Patients,brett johnson,Positive
 Patients,Swine Flu News,Positive
 Patients,Stem Cell News,Positive
 Patients,Invest World News,Negative
 Patients,NACDA Program on Aging,Negative
 Patients,National Cancer Institute,Positive
 Patients,Diaceutics PLC,Positive
 Patients,Grupo PK.gen SEFH,Positive
 Patients,John James,Positive
 Patients,Joe Fournet,Negative
 Patients,Dr. Leona Saunders,Positive
 Patients,militaryeyed,Positive
 Patients,PRN Biotech,Positive
 Patients,IntoxicatedTrader,Positive
 Patients,A. Vroom - Ten Wolde,Negative
 Patients,GPSN,Positive
 Patients,Bhavna Saxena,Positive
 Patients,Paul Kent,Positive
 Patients,Health-News,Positive
 Patients,muzaffar,Positive
 Patients,Medical Reel,Negative
 Patients,YWNH,Positive
 Patients,MedicinaMX,Positive
 Patients,Green Inc USA,Positive
 Patients,C.A.I. Corporation,Positive
 Patients,MHC,Negative
 Patients,Hilda Tryon,Positive
 Patients,Health Information,Positive
 Patients,Little Bugs Store,Positive
 Patients,Science.gov,Positive
 Patients,NaturalMedicines,Positive
 Patients,Hands on Health,Positive
 Patients,8 Pack Abs,Positive
 Patients,Eleonor_Morgan,Positive
 Patients,Welly Wired,Positive
 Patients,Mahesh Khuman,Positive
 Patients,Salubrious Diet,Positive
 Patients,Biblioteca CCBS-UFCG,Negative
 Patients,Margaret_Farrell,Positive
 Patients,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 Patients,vincenzo abruscato,Positive
 Patients,Sean McGrath,Positive
 Patients,AJHO,Positive
 Patients,JNCI,Negative
 Patients,Matthias Piesche,Negative
 Patients,Cord Blood News,Positive
 Patients,Roberto C.  Montoya,Negative
 Patients,henrietta,Positive
 Patients,CMLHope,Positive
 Patients,Eva M Kozlowski|Student Pilot|Oncology Pharmacist,Positive
 Patients,Ashley Phillips,Positive
 Patients,Clinical Pharmacy,Negative
 Patients,Connie Batlevi,Negative
 Patients,"Tom Iarocci, MD",Positive
 Patients,Cyndie Annett,Positive
 Patients,TheraGlobal,Positive
 Patients,EIN Presswire: Prostate Cancer Newswire,Positive
 Patients,EIN Presswire: Lung Cancer Newswire,Positive
 Patients,EIN Presswire: Education Newswire,Positive
 Patients,Cision News,Negative
 Patients,Centro Medico Qx,Negative
 Patients,MD.,Negative
 Patients,John Mclean,Positive
 Patients,newswise,Negative
 Patients,Emma Gabriela,Positive
 Patients,CancerConnect,Negative
 Patients,MORE Health,Positive
 Patients,The Medical Ed Cons.,Negative
 Patients,rattenniMD,Positive
 Patients,leo uzych,Negative
 Patients,"Sean Young, PhD",Positive
 Patients,Kimryn Rathmell,Positive
 Patients,Roel Verhaak,Positive
 Patients,Emilio Monte,Positive
 Patients,John,Negative
 Patients,Francesco Turturro,Positive
 Patients,Feeds Medicina,Positive
 Patients,Tim Fenske,Negative
 Patients,Muzaffar Qazilbash,Positive
 Patients,Pico üíâüíâ,Positive
 Patients,UKNEQASLI,Positive
 Patients,WUN,Positive
 Patients,ŸÖÿ±ŸÉÿ≤ ÿßŸÑÿ£ÿ®ÿ≠ÿßÿ´,Positive
 Patients,Comfycozys for Chemo,Positive
 Patients,JebSource,Positive
 Patients,doctorportal,Negative
 Patients,Florian Slimano,Negative
 Patients,Shankara Paneesha,Negative
 Patients,Rafael Fonseca MD,Positive
 Patients,Christie Library,Positive
 Patients,JADPRO,Negative
 Patients,Tom Heston,Negative
 Patients,Sandra Kear,Positive
 Patients,Empire Genomics LLC,Positive
 Patients,Michael O'Dwyer,Positive
 Patients,Richard Schilsky,Positive
 Patients,Christopher Steer,Negative
 Patients,Drug Discovery & Dev,Positive
 Patients,Jesus F Sierra,Positive
 Patients,"Michael Green, PhD",Negative
 Patients,Hematology Review,Positive
 Patients,Science agent,Positive
 Patients,Pharm Digest,Negative
 Patients,KevinFitts,Negative
 Patients,Olivier Elemento,Negative
 Patients,Miguel Perales M.D.,Negative
 Patients,michael.naafs,Positive
 Patients,Dendritic cells,Positive
 Patients,OncoTherapy Network,Negative
 Patients,Johan Van Weyenbergh,Positive
 Patients,Cancer & Oncology,Positive
 Patients,Moffitt Research,Positive
 Patients,VoyagerMed,Positive
 Patients,National Comprehensive Cancer Network (NCCN),Negative
 Patients,conciergedoc,Positive
 Patients,Immunology,Positive
 Patients,Healthcanal,Negative
 Patients,Graham Atherton,Positive
 Patients,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 Patients,Scott Werntz,Positive
 Patients,Penny Stocks,Positive
 Patients,Penny Stock Irish,Positive
 Patients,Focus on Cancer,Negative
 Patients,TumImmTxpapers,Negative
 Patients,Tran-Der Tan,Negative
 Patients,Hot Trades,Positive
 Patients,Daniel Able,Positive
 Patients,Security Stocks,Positive
 Patients,Ez2Trade,Positive
 Patients,Stock Runners,Positive
 Patients,satPRnews,Negative
 Patients,Dominique,Positive
 Patients,genetic insidER,Positive
 Patients,Michael,Positive
 Patients,Paul Lane,Positive
 Patients,Ellen Una,Positive
 Patients,Cyndi Joycelyn,Positive
 Patients,jennifermcaiyr1983,Positive
 Patients,Lelah Lakita,Positive
 Patients,Cancer Blog,Negative
 Patients,CRO Contract Res.,Negative
 Patients,dlvr news,Negative
 Patients,SPEC,Positive
 Patients,ASCO,Negative
 Patients,"Andreas-Claudius Hoffmann, M.D.",Positive
 Patients,Just Cancer News,Negative
 Patients,"Pharmacyclics, an AbbVie Company",Positive
 Patients,Oncology News Update,Negative
 Results,OncLive.com,Positive
 Results,LymphomaAction,Negative
 Results,Lymphoma Hub,Positive
 Results,CONQUER the patient voice,Positive
 Results,The Lancet Haematology,Negative
 Results,"Raul Cordoba, MD, PhD",Positive
 Results,"Ganjly, Reliable Cannabis News",Positive
 Results,"Naveen Pemmaraju, MD",Negative
 Results,Jeff Neurman,Negative
 Results,OncologyNurseAdvisor,Negative
 Results,@ScottWaudbyHaemResLeics,Positive
 Results,CURE Magazine,Negative
 Results,NCI CTEP Clinical Research,Negative
 Results,Patient Worthy,Positive
 Results,Paperbirds_Hematology,Negative
 Results,Oncology Learning Network,Negative
 Results,Benlazar S.M Amin√©,Negative
 Results,ASH Clinical News,Positive
 Results,LYMPHOMA & MYELOMA CONNECT,Negative
 Results,Stanford Department of Medicine,Positive
 Results,Toby Eyre,Negative
 Results,HemOnc Today,Negative
 Results,AJMC-Oncology,Negative
 Results,MoJo,Negative
 Results,Miguel Perales M.D.,Negative
 Results,Targeted Oncology,Negative
 Results,CLL Warwick Uni,Negative
 Results,CLL Ireland,Negative
 Results,Cell Stem Cell,Positive
 Results,"Salvatore Papa, PhD",Positive
 Results,Roche,Positive
 Results,SeattleCancerCareAlliance,Negative
 Results,Oncology Tube,Negative
 Results,PSBR,Positive
 Results,Lymphoma Coalition,Positive
 Results,Salutedomani,Positive
 Results,fainfo salute,Positive
 Results,Derma News OK,Positive
 Results,saluteH24.com,Positive
 Results,Antonio Caperna,Positive
 Results,BusinessWireProducts,Negative
 Results,dlvr news,Negative
 Results,$Stocknewsalerts,Negative
 Results,Aserrano,Positive
 Results,scottidiego,Positive
 Results,Dr. Melody Davis,Negative
 Results,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 Results,IntoxicatedTrader,Negative
 Results,Financial Buzz,Negative
 Results,wallstreet:online.de,Positive
 Results,Frank,Positive
 Results,Aktienmanufaktur,Negative
 Results,VPO/PR Newswire,Negative
 Results,stocksandmoney.com,Positive
 Results,Medindia.net,Negative
 Results,Health MasterDoctor,Positive
 Results,Gendron Recherche,Negative
 Results,Paul Lane,Negative
 AstraZenecas Phase,pharmanewsintel,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence ¬Æ Ôºâ„ÄÅ„Å§„ÅÆË©¶È®ì„Éá„Éº„Çø„Å´„Çà„Å£„Å¶„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊÇ£ËÄÖ„Åï„Çì„ÅÆÂøÉË°ÄÁÆ°ÂÆâÂÖ®ÊÄß„Éó„É≠ „Äî „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ „Äï,JPubb Êó•Êú¨‰ºÅÊ•≠ „É™„É™„Éº„Çπ ÂåªËñ¨ÂìÅ,Positive
 ¬Æ Ôºâ „ÄÅ „Å§„ÅÆË©¶È®ì„Éá„Éº„Çø„Å´„Çà„Å£„Å¶„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊÇ£ËÄÖ„Åï„Çì„ÅÆÂøÉË°Ä,PR TIMES„Éì„Ç∏„Éç„Çπ,Positive
 ¬Æ Ôºâ „ÄÅ „Å§„ÅÆË©¶È®ì„Éá„Éº„Çø„Å´„Çà„Å£„Å¶„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊÇ£ËÄÖ„Åï„Çì„ÅÆÂøÉË°Ä,PR TIMES„Éã„É•„Éº„Çπ,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceRÔºâ„ÄÅ„Å§„ÅÆË©¶È®ì„Éá„Éº„Çø„Å´„Çà„Å£„Å¶„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊÇ£ËÄÖ„Åï„Çì„ÅÆÂøÉË°ÄÁÆ°ÂÆâÂÖ®ÊÄß„Éó„É≠„Éï„Ç°„Ç§„É´„ÇíË©ï‰æ°,WMR Tokyo - „Çπ„Çø„Éº„Éà„Ç¢„ÉÉ„Éó,Positive
 adult,Ashleigh Walls,Positive
 adult,April Golightly,Positive
 adult,This Messy Season Family Blog,Positive
 adult,Cook Eat Go,Positive
 adult,Tamara Bowman,Positive
 adult,Anne Sweden,Positive
 adult,Keeping Life Sane,Positive
 adult,Rebecca Miller,Positive
 adult,IceCreamStickyFinger,Positive
 adult,Catherine Lewis,Positive
 adult,Angie Agerter,Positive
 adult,icefairy,Positive
 adult,Leave The Cannoli,Positive
 adult,Kelly & Alex,Positive
 adult,Cleverly Changing (She/her),Positive
 adult,Alexandria,Positive
 adult,Stephanie BeautyBrite ‚ìã,Positive
 adult,Jennifer Soltys,Positive
 adult,Kimberly Kong,Positive
 adult,melissa weintraub,Positive
 adult,HEATHER | Pink Ninja Blogger,Positive
 adult,Garf,Positive
 adult,Liz Cleland,Positive
 adult,Susie's Reviews,Positive
 adult,Trendy Cyndie Reviewz & Newz,Positive
 adult,Tara Pittman,Positive
 adult,Pharma Journalist,Positive
 CLL medication,bargainbriana,Positive
 CLL medication,William V. Sweeney,Positive
 CLL medication,Caryn Bailey,Positive
 CLL medication,Kami Allen,Positive
 CLL medication,Coralie Seright (Lovebugs and Postcards),Positive
 CLL medication,Elizabeth hurt,Positive
 CLL medication,Lisa O'Driscoll,Positive
 CLL medication,LaVonne Cladoosby Long,Positive
 CLL medication,Kelly Tomlinson,Positive
 CLL medication,Mommy's Playbook,Positive
 CLL medication,Brittany,Positive
 CLL medication,Carrie,Positive
 CLL medication,Maria,Positive
 CLL medication,Heidi Bee,Positive
 CLL medication,Kathy Hodson,Positive
 CLL medication,Ana,Positive
 CLL medication,Lindsey G.,Positive
 CLL medication,Imperfect Women,Positive
 CLL medication,Lauren Beth,Positive
 CLL medication,Deliciously Savvy,Positive
 CLL medication,ELMENS,Positive
 CLL medication,Jaclyn,Positive
 CLL medication,Stephanie BeautyBrite ‚ìã,Positive
 CLL medication,Vanessa Diaz,Positive
 CLL medication,Colleen Padilla,Positive
 CLL medication,Jenn p,Positive
 CLL medication,Jays SweetNSour Life,Positive
 CLL medication,Mariah Moon,Positive
 CLL medication,Erica Valentin,Positive
 CLL medication,Amy Smith,Positive
 CLL medication,MomGlenz,Positive
 CLL medication,Da Vinci - Also follow @OutdoorsyBW,Positive
 CLL medication,My Life is a Journeyüá®üá¥üò∑,Positive
 CLL medication,Wrapped Up N U,Positive
 CLL medication,pamelamaynard,Positive
 CLL medication,SensiblySara,Positive
 CLL medication,The Frugal Navy Wife,Positive
 CLL medication,Christine | The Growing Creatives,Positive
 CLL medication,The Zamp Camp,Positive
 CLL medication,Lori Felix,Positive
 CLL medication,niecyisms by CLC Studios,Positive
 CLL medication,TheYumYumFoodie,Positive
 CLL medication,Amanda Taylor,Positive
 CLL medication,Shelly Belly,Positive
 CLL medication,Krystal üë©üèª‚Äçüíª,Positive
 CLL medication,Kaila Yu,Positive
 CLL medication,Olivia Douglass,Positive
 CLL medication,Momma Lew - Food and Fun by Reesa Lewandowski,Positive
 AZN LR OP Multiple bestinclass oncology portfolio,dough,Negative
 premium Oncology portfolio,dough,Negative
 multiple potentially bestinclass assets,dough,Negative
 Tagrisso Lynparza Calquence Enhertu,dough,Negative
 Imfinzi,dough,Negative
 Cancer drug,jorge,Positive
 Cancer drug,Radyo Agila DZEC 1062 Khz,Positive
 Cancer drug,Jeff Karp (Pronouns: he/him/his),Positive
 Cancer drug,PhillyVoice,Positive
 Cancer drug,ahealthierphilly,Negative
 COVID treatment,jorge,Positive
 COVID treatment,BioCanRx - Canada's Immunotherapy Network,Positive
 COVID treatment,Sharky Sarah,Positive
 COVID treatment,Diving News,Negative
 √≥n    Los datos,iSanidad,Negative
 de,iSanidad,Positive
 de,Jos√© Viurquis,Positive
 de,Pumpy_Fantasy,Positive
 de,Leonardo Mej√≠a B,Negative
 de,Gimena dos Santos,Positive
 de,SNU P√¥le Emploi FSU Occitanie,Negative
 de,"J. Cornago Navascu√©s, MD",Positive
 de,@AplusA_France,Positive
 de,Lenko Sins,Positive
 de,XNL,Positive
 de,Pocho,Positive
 de,Mascarasraison2.0,Positive
 de,Teresa Bau,Positive
 de,Bella Carstairs,Positive
 ensayos,iSanidad,Negative
 ensayos,Econom√≠a Digital,Positive
 cl√≠nicos refuerzan su perfil de seguridad,iSanidad,Negative
 cardiovascular,iSanidad,Negative
 pacientes con,iSanidad,Positive
 pacientes con,YaEsHora,Positive
 pacientes con,Ese Migue,Positive
 pacientes con,La Disidente,Positive
 linfoc√≠tica cr√≥nica,iSanidad,Positive
 linfoc√≠tica cr√≥nica,Kevin Marcelo,Positive
 linfoc√≠tica cr√≥nica,Francisco Acedo,Positive
 linfoc√≠tica cr√≥nica,IM M√©dico,Positive
 linfoc√≠tica cr√≥nica,Farmacia Cl√≠nico,Positive
   Los datos,iSanidad,Negative
 cl√≠nicos refuerzan su perfil de seguridad cardiovascular,iSanidad,Negative
 cl√≠nicos refuerzan su perfil de seguridad cardiovascular,IM M√©dico,Positive
 Kinumpirma ng Department,Radyo La Verdad 1350,Positive
 Health,Radyo La Verdad 1350,Positive
 Health,Non-GMO Report,Positive
 Health,GMWatch,Positive
 Health,GO GREEN,Positive
 gagamitin sa World Health Organization,Radyo La Verdad 1350,Positive
 solidarity trial,Radyo La Verdad 1350,Positive
 ng therapeutics,Radyo La Verdad 1350,Positive
 o mga gamot,Radyo La Verdad 1350,Positive
 ang Acalabrutinib,Radyo La Verdad 1350,Positive
 Acalabrutinib hindi,Radyo La Verdad 1350,Positive
 Acalabrutinib hindi,UNTV News and Rescue,Positive
 gagamitin sa,Radyo La Verdad 1350,Positive
 gagamitin sa,UNTV News and Rescue,Positive
 decision,Ronald M. Chavin,Positive
 decision,Dr. Andy Evens,Negative
 decision,Silvia Foster-Frau,Positive
 decision,Melanie,Negative
   pasyente nakumpleto,DZBB Super Radyo,Positive
 Acalabrutinibinalis,Radyo Agila DZEC 1062 Khz,Positive
 na sa mga gamot,Radyo Agila DZEC 1062 Khz,Positive
 kasama sa,Radyo Agila DZEC 1062 Khz,Positive
 Nagbigay,CNN Philippines,Positive
 ng recommendation,CNN Philippines,Positive
 ang,CNN Philippines,Positive
 ang,Leiy Bustamante,Negative
 Paggamit ng cancer drug,DZBB Super Radyo,Positive
 bilang bahagi ng solidarity trial sa paghanap ng gamot,DZBB Super Radyo,Positive
 sa COVID hindi,DZBB Super Radyo,Positive
 ng World Health Organization o,DZBB Super Radyo,Positive
 NEW Comparing acalabrutinib,Medivizor,Negative
 Los datos de Calquence de,IM M√©dico,Positive
 pacientes con LLC,IM M√©dico,Positive
 NewTrip p deletion testing,Trip Database,Negative
 access,Trip Database,Negative
 access,TAP Clinical Trial Network,Negative
 access,Dr. Andy Evens,Negative
 access,Michael Rynne,Positive
 access,CLLSA,Positive
 access,Diverse Health Hub,Positive
 access,"Mazyar Shadman, MD MPH",Negative
 access,SpecialtyPTimes,Positive
 access,CLL Ireland,Negative
 access,Nick,Negative
 access,Shine Cancer Support,Positive
 access,WCMNYPJCTO,Negative
 access,Kevin Ellis,Positive
 access,"chadi nabhan MD, MBA, FACP",Negative
 access,Melanie,Negative
 access,"Pharmacyclics, an AbbVie Company",Negative
 demonstrated safety tolerability profile,CALQUENCE¬Æ (acalabrutinib),Negative
 Dr Michael Wang,CALQUENCE¬Æ (acalabrutinib),Negative
    Leucemia linfatica cronica il trattamento con acalabrutinib,EmatoInfo,Positive
 monoterapia si caratterizza,EmatoInfo,Positive
 l‚Äôottimo profilo di safety,EmatoInfo,Positive
 decisivo,EmatoInfo,Positive
 nellambito,EmatoInfo,Positive
 di,EmatoInfo,Positive
 di,Angelo Piemontese,Positive
 di,Medinews,Negative
 di,Il Vittoriale,Positive
 di,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 patologia Lintervista,EmatoInfo,Positive
 Paolo Ghia,EmatoInfo,Positive
 Paolo Ghia,ESH (Haematology),Negative
 Paolo Ghia,ASH Clinical News,Negative
 Paolo Ghia,Lymphoma Hub,Positive
 Paolo Ghia,OncLive.com,Negative
 Paolo Ghia,Michael Hallek,Negative
 Paolo Ghia,Sigrid Sk√•nland,Negative
 Paolo Ghia,Dr Effie Kostareli,Negative
 Paolo Ghia,VJHemOnc,Positive
 ND,Benlazar S.M Amin√©,Negative
 RR MCL,Benlazar S.M Amin√©,Negative
 RR MCL,"Maria Badillo, MSN RN OCN CCRP",Negative
 RR MCL,NE Live,Negative
 RR MCL,"Raul Cordoba, MD, PhD",Negative
 RR MCL,NatureRevClinOncol,Negative
 RR MCL,MyelomaLymphoma,Positive
 RR MCL,Lymphoma Hub,Positive
 AVO Acalabrutinib,Benlazar S.M Amin√©,Negative
 Venettoclax,Benlazar S.M Amin√©,Negative
 RO,Benlazar S.M Amin√©,Negative
 RR,Benlazar S.M Amin√©,Positive
 RR,hemomeeting,Negative
 RR,Toby Eyre,Positive
 RR,"Lalit Leonard Sehgal, PhD",Positive
 RR,Lymphoma Hub,Positive
 RR,JADPRO,Negative
 RR,"Jennifer Crombie, MD",Positive
 RR,Eduardo Flavio Oliveira Ribeiro,Negative
 RR,VJHemOnc,Positive
 RR,"chadi nabhan MD, MBA, FACP",Positive
 RR,Hematologia ICO Hospitalet,Positive
 RR,Adriana Bello,Positive
 RR,Taylor Lab UM,Negative
 RR,MoJo,Negative
 RR,Genentech,Negative
 RR,Oncologie Up-to-date,Positive
 RR,Christopher Steer,Negative
 RR,Odi Bruckman,Negative
 RR,CLL Ireland,Negative
 RR,"Raul Cordoba, MD, PhD",Negative
 RR,CARE‚Ñ¢ Education,Negative
 RR,EMJ Hematology,Negative
 RR,Mike Gauthier,Negative
 RR,Chan Cheah,Positive
 RR,Biotech2050,Negative
 Low Cardiac Risk,Pepvax Inc,Negative
 Low Cardiac Risk,mednetnews,Negative
 Low Cardiac Risk,NwokeAgulu,Negative
 Low Cardiac Risk,OncLive.com,Negative
 Targeted Oncology,Pepvax Inc,Negative
 Targeted Oncology,Stem cell Watch,Positive
 Targeted Oncology,Saeed Valadbaygi,Negative
 Targeted Oncology,Oncology Board,Positive
 NHS England,pharmaphorum,Negative
 NHS England,MDedge Hematology & Oncology,Negative
 Oncology,mednetnews,Negative
 Oncology,Benlazar S.M Amin√©,Negative
 Oncology,Annals of Oncology,Positive
 Oncology,Lymphoma Hub,Negative
 Oncology,Paperbirds_Hematology,Negative
 Oncology,The Pharmaceutical Marketing Group,Negative
 Oncology,Latest News from Business Wire,Negative
 Oncology,Oncology Board,Negative
 Oncology,Isaura R. Penin,Negative
 AstraZenecas Calquence BeiGenes Brukinsa,Bionest Partners,Negative
 heads,Bionest Partners,Negative
 heads,vshariharakrishnan,Positive
 heads,Pharma Top News,Positive
 heads,Biotech & Tech Stock Focus,Negative
 heads,cafepharma,Negative
 heads,analyst land news,Positive
 heads,ExBulletin,Positive
 heads,Dr Timos Papagatsias,Negative
 heads,PharmaCrowd,Negative
 heads,Continental Clinical,Positive
 heads,NewExpressNews,Negative
 heads,PHARMABOX.IN,Negative
 heads,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 AZ Calquence,David Ledger,Positive
 AZ Calquence,PharmaTimes,Positive
 AZ Calquence,Barry Curry,Positive
 AZ Calquence,Everything Pharma,Positive
 AZ Calquence,Pharma Trader,Positive
 AZ Calquence,PharmaCrowd,Negative
 AZ Calquence,Pharma Regulatory,Negative
 Management,Benlazar S.M Amin√©,Positive
 Management,MedscapeLIVE,Positive
 Management,Medscape Education,Positive
 Management,Medscape Oncology,Positive
 Management,Medscape Nurses,Positive
 Management,Current Oncology,Negative
 Management,Paperbirds_Hematology,Negative
 Management,"Mike Thompson, MD, PhD, FASCO",Negative
 Management,Noopur Raje,Positive
 Management,DynaMed¬Æ,Positive
 Management,Lymphoma Papers,Positive
 Management,palliativewise,Negative
 Management,S.E.F.H,Positive
 Management,Anthony Mato,Negative
 Management,Carlos De la Torre,Positive
 Management,Lymphoma Coalition,Negative
 Management,Monterey Holistic,Negative
 Management,MelanomaResearchPapers,Positive
 Management,ImmunotherapyPapers,Negative
 Management,"Raul Cordoba, MD, PhD",Positive
 Management,Cancer Papers,Positive
 Management,Sameer Parikh,Negative
 Management,Irene Mangues,Positive
 Management,Dr. Jos√© A. Queiz√°n,Positive
 Management,Oncology Tube,Negative
 Management,Isaura R. Penin,Positive
 Management,Christopher Steer,Positive
 Management,Ana Rosa Rubio,Positive
 Management,EMJ Hematology,Negative
 Management,Francesco Turturro,Negative
 Management,Javier Martinez Peromingo,Positive
 Management,Cancer Library VCC,Positive
 Management,Med-IQ,Negative
 Management,AJHO,Positive
 Management,CureHuntr,Negative
 Management,National Comprehensive Cancer Network (NCCN),Negative
 Management,Oncology Central,Positive
 Management,Journal of the @NCCN,Negative
 Management,Jonathan Friedberg,Positive
 Management,NC Chapter LLS ,Positive
 Management,MDLinx,Negative
 Waldenstr√∂m Macroglobulinemia,Benlazar S.M Amin√©,Negative
 Waldenstr√∂m Macroglobulinemia,Saeid Shamsian MD,Negative
 Waldenstr√∂m Macroglobulinemia,TrialBulletin,Negative
 Waldenstr√∂m Macroglobulinemia,CureHuntr,Negative
 Zanubrutinib,Benlazar S.M Amin√©,Negative
 Zanubrutinib,SeattleCancerCareAlliance,Negative
 Zanubrutinib,"Michael Wang, MD",Negative
 Zanubrutinib,OncLive.com,Negative
 Zanubrutinib,Judith Trotman,Positive
 Zanubrutinib,VJHemOnc,Negative
 Zanubrutinib,"Mazyar Shadman, MD MPH",Positive
 Zanubrutinib,Oncology,Negative
 Zanubrutinib,MDEdge,Positive
 Zanubrutinib,MDedge Hematology & Oncology,Positive
 Zanubrutinib,Taylor Lab UM,Negative
 Zanubrutinib,Barbara Pro,Positive
 Zanubrutinib,SPI News,Negative
 Zanubrutinib,Crwe World,Positive
 Zanubrutinib,Hematopoiesis News,Negative
 Zanubrutinib,Financial Buzz,Negative
 Zanubrutinib,Bio Stocks‚Ñ¢,Positive
 Zanubrutinib,Odi Bruckman,Positive
 NICE backs,Plexus Ventures,Negative
 NICE backs,MDedge Hematology & Oncology,Negative
 NICE recommendation,Pharmafocus,Negative
 NICE recommendation,Jon Angelo,Negative
 Dr Brown,Targeted Oncology,Negative
 Dr Brown,Lymphoma Canada,Negative
 Dr Brown,donnashort,Negative
 Dr Brown,Expert Perspectives in Oncology,Negative
 Dr Brown,Anna Deveau,Negative
 Dr Brown,VJHemOnc,Negative
 Dr Brown,Dana-Farber,Negative
 implications,Targeted Oncology,Negative
 implications,Benlazar S.M Amin√©,Negative
 implications,"Raul Cordoba, MD, PhD",Negative
 implications,MedPage Oncology,Negative
 implications,GenPath Oncology,Negative
 findings,Targeted Oncology,Positive
 findings,Mr Graham,Positive
 findings,Mrs D'Onofrio,Positive
 findings,joewhitworth,Positive
 findings,ASH Clinical News,Positive
 findings,ecancer,Negative
 findings,OncLive.com,Negative
 findings,MedPage Oncology,Negative
 findings,Lymphoma Hub,Negative
 findings,APSHO,Negative
 findings,Takeda Oncology,Positive
 findings,Hottest Stocks Now,Negative
 findings,Stanford Department of Medicine,Positive
 findings,Sarah Cannon Docs,Positive
 findings,Oncology Learning Network,Negative
 findings,medwireNews,Negative
 findings,Patient Power,Negative
 pooled analysis,Targeted Oncology,Negative
 pooled analysis,WCM Lymphoma,Positive
 pooled analysis,Children‚Äôs Oncology Group,Positive
 Eligible patients,Pharma News,Negative
 Chronic Lymphocytic Leukaemia CLL,Pharma News,Negative
 Chronic Lymphocytic Leukaemia CLL,Sussex Haematology,Positive
 Chronic Lymphocytic Leukaemia CLL,AbbVie New Zealand,Positive
 Calquence data,Pharma News,Negative
 Calquence data,Company News HQ,Negative
 Calquence data,Cision News,Positive
 Calquence data,pharmaphorum,Negative
 trials,Pharma News,Negative
 trials,1stOncology,Positive
 trials,Company News HQ,Negative
 trials,Cision News,Negative
 trials,Kari Tikkinen,Positive
 trials,Ronald M. Chavin,Positive
 trials,GraniteShares Europe,Negative
 trials,"Michael Wang, MD",Negative
 trials,VJHemOnc,Positive
 trials,Anirban Maitra,Negative
 trials,LYMPHOMA & MYELOMA CONNECT,Negative
 trials,donnashort,Negative
 trials,APSHO,Negative
 trials,COPD News,Negative
 trials,Toby Eyre,Positive
 trials,Milo≈° Miljkoviƒá,Positive
 trials,CLL_Fightersüéó,Negative
 trials,ASGCT,Negative
 trials,the limbic,Positive
 trials,CLL Ireland,Negative
 trials,Clinical Trials,Negative
 trials,Zack Pemberton-Whiteley,Positive
 trials,Andrew Schorr,Negative
 trials,AJMC,Negative
 trials,Lymphoma Hub,Negative
 trials,AbbVie,Positive
 trials,Matt Kaiser,Positive
 cardiovascular safety profile,Pharma News,Negative
 cardiovascular safety profile,Company News HQ,Negative
 cardiovascular safety profile,Cision News,Negative
 Clinical Trials,NwokeAgulu,Negative
 Clinical Trials,OncLive.com,Negative
 Clinical Trials,Patient Empowerment Network,Negative
 Clinical Trials,Hottest Stocks Now,Negative
 Clinical Trials,MD Anderson Leukemia,Negative
 Clinical Trials,Michele Nadeem-Baker,Negative
 Clinical Trials,Lymphoma Papers,Negative
 Clinical Trials,Swallow This - The War On Cancer! üò∑,Positive
 Clinical Trials,Mahmoud Aljurf,Negative
 Clinical Trials,Oncology Tube,Negative
 Clinical Trials,Stem Cell Tracker,Positive
 Clinical Trials,Anna Deveau,Negative
 Clinical Trials,The ASCO Post,Negative
 Clinical Trials,Nora Sheffield,Negative
 Prescient coverage,Prescient Healthcare Group,Positive
 Day,Prescient Healthcare Group,Positive
 Day,Deb Amlen,Positive
 Day,CLL Society Inc.,Negative
 Day,ESH (Haematology),Negative
 Day,"Lymphoma, Leukemia & Myeloma Congress",Positive
 Day,VJHemOnc,Negative
 Day,Society of Hematologic Oncology (SOHO),Positive
 Day,BeiGene,Negative
 Day,CLL Ireland,Positive
 Day,Donna Gairns,Positive
 Day,myRockworld,Positive
 Day,Jonathan Pearce,Negative
 Day,Great Debates in Hematologic Malignancies,Negative
 Day,Patient Power,Positive
 Day,Ayesha Hawkins,Positive
 Day,Nick,Negative
 Day,CAPART,Positive
 Day,Lymphoma Hub,Negative
 Day,"Caner Saygin, MD",Negative
 Day,Stephen Brown,Negative
 Day,Zack Pemberton-Whiteley,Negative
 Day,Cindy Beelen,Negative
 Day,deanne gordon,Positive
 Aprobaci√≥n de acalabrutinib contra leucemia linfoc√≠tica cr√≥nica,Smart Clinical Pharmacology,Positive
 Aprobaci√≥n de acalabrutinib contra leucemia linfoc√≠tica cr√≥nica,BIOCIENCIA,Negative
 Aprobaci√≥n de acalabrutinib contra leucemia linfoc√≠tica cr√≥nica,Dr Pablo Marcelo Lombardo,Positive
 AZ ‚Äô Calquence,PHARMABOX.IN,Negative
 AZ ‚Äô Calquence,David Ledger,Positive
 AZ ‚Äô Calquence,40:40 Recruitment,Positive
 AZ ‚Äô Calquence,Saleh Stevens,Negative
 AZ ‚Äô Calquence,Everything Pharma,Negative
 AZ ‚Äô Calquence,Pharma Trader,Negative
 AZ ‚Äô Calquence,Barry Curry,Negative
 AZ ‚Äô Calquence,PharmaTimes,Positive
 AZ ‚Äô Calquence,Bio_Talent,Negative
 AZ ‚Äô Calquence,Haybury,Positive
 AZ ‚Äô Calquence,Digital Pharma,Positive
 AZ ‚Äô Calquence,Pharma Regulatory,Positive
 AZ ‚Äô Calquence,Oncology Forum UK,Positive
 data,1stOncology,Positive
 data,Shifting Wealth,Negative
 data,hemomeeting,Negative
 data,Lymphoma Hub,Positive
 data,DelveInsight,Positive
 data,Targeted Oncology,Positive
 data,Breaking Data,Positive
 data,Alan Skarbnik,Negative
 data,"Dr. Paul DeSantis, PharmD",Negative
 data,pharmaphorum,Negative
 data,OncLive.com,Positive
 data,OncLive SOSS,Negative
 data,WCM Lymphoma,Negative
 data,Briefing.com,Negative
 data,Joe Hedden,Positive
 data,Josie B.,Negative
 data,Victor Lin,Positive
 data,TAP Clinical Trial Network,Negative
 data,Alaric DeArment,Positive
 data,"Mazyar Shadman, MD MPH",Negative
 data,CLL Society Inc.,Positive
 data,HCPLive,Positive
 data,"Pharmacyclics, an AbbVie Company",Positive
 data,Anthony Mato,Negative
 data,"Cindy M. Pabon, MD",Positive
 data,Andrew Schorr,Negative
 data,Blood Journal,Positive
 data,Scientific Data,Positive
 data,Adam Kittai,Negative
 data,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 data,Taylor Lab UM,Negative
 data,Danielle M. Brander,Positive
 data,COPD News,Positive
 data,Oncology Tube,Positive
 data,Anal Bioanal Chem,Positive
 data,For health-promoting environments,Positive
 data,Michael Dickinson,Negative
 data,Trading News,Positive
 data,AbbVie,Negative
 data,Toby Eyre,Positive
 data,Chan Cheah,Negative
 data,"chadi nabhan MD, MBA, FACP",Positive
 data,VJHemOnc,Negative
 data,Michael Hallek,Negative
 data,"Eric D Whitman, MD",Positive
 data,CHItraders,Negative
 data,Markets,Positive
 data,Blood Cancer UK Research,Negative
 data,MDEdge,Negative
 data,Clinical Trials,Negative
 data,JanssenUS,Negative
 data,Adaptive Biotech,Negative
 data,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 data,Danielle Ternyila,Positive
 data,"Caner Saygin, MD",Negative
 data,HARMONY Alliance,Negative
 data,Solomon Kamal,Positive
 data,QuadShot News,Positive
 data,CLL Ireland,Negative
 data,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 data,Jessica Okosun,Positive
 data,Anna Deveau,Negative
 data,iwCLL,Negative
 data,Christopher Steer,Negative
 data,cairns haematology a,Positive
 data,NE Live,Negative
 data,"Raul Cordoba, MD, PhD",Negative
 data,David Kroll,Positive
 data,Gilead Sciences,Positive
 data,Roche,Negative
 data,Pharma Commons,Negative
 data,Hal Palmer,Positive
 data,Scott Werntz,Positive
 data,ABABioBlurb,Positive
 safety profile,1stOncology,Positive
 safety profile,OncLive.com,Positive
 safety profile,Targeted Oncology,Negative
 safety profile,Biotech2050,Negative
 safety profile,Cancer Papers,Negative
 ASH AstraZenecas Calquence BeiGenes Brukinsa,vshariharakrishnan,Positive
 ASH AstraZenecas Calquence BeiGenes Brukinsa,cafepharma,Negative
 ASH AstraZenecas Calquence BeiGenes Brukinsa,analyst land news,Positive
 ASH AstraZenecas Calquence BeiGenes Brukinsa,Dr Timos Papagatsias,Negative
 ASH AstraZenecas Calquence BeiGenes Brukinsa,PharmaCrowd,Negative
 ASH AstraZenecas Calquence BeiGenes Brukinsa,Continental Clinical,Positive
 ASH AstraZenecas Calquence BeiGenes Brukinsa,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 pts,"Joseph Cioccio, DO",Negative
 pts,Dr. Andy Evens,Positive
 pts,Toby Eyre,Positive
 pts,NatureRevClinOncol,Positive
 pts,Lysa Lymphoma,Positive
 pts,"Maria Badillo, MSN RN OCN CCRP",Negative
 pts,EmatoInfo,Positive
 pts,NE Live,Negative
 pts,Dr.Alberto Mussetti,Positive
 pts,VJHemOnc,Positive
 pts,"Mazyar Shadman, MD MPH",Negative
 pts,Benlazar S.M Amin√©,Negative
 pts,clonoSEQ,Negative
 pts,Lymphoma Hub,Positive
 pts,Adam Kittai,Negative
 pts,"Jose Sandoval S, MD FACP",Positive
 pts,Anna Deveau,Positive
 pts,Andrew Schorr,Negative
 pts,"Raul Cordoba, MD, PhD",Positive
 pts,Lisa Palacios,Positive
 pts,MD Anderson Leukemia,Positive
 pts,Christopher Steer,Positive
 pts,"chadi nabhan MD, MBA, FACP",Negative
 pts,OncLive SOSS,Negative
 pts,The Lancet Oncology,Negative
 pts,Chan Cheah,Negative
 pts,JAMA Oncology,Positive
 pts,ASH,Negative
 pts,Adaptive Biotech,Negative
 chemo,"Joseph Cioccio, DO",Negative
 chemo,M,Positive
 chemo,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 chemo,Oncology Tube,Negative
 chemo,Tim Durkan,Positive
 chemo,donnashort,Negative
 chemo,RJW,Negative
 chemo,Hematology News,Negative
 chemo,Jackie Michele,Positive
 chemo,KnotGrumpy,Positive
 chemo,GRACE,Negative
 chemo,Lymphoma Hub,Negative
 chemo,The Rob Branham Foundation,Positive
 chemo,C. Michael Gibson MD,Positive
 chemo,Francesco Turturro,Negative
 AstraZeneca Reports LongTerm Efficacy,PHARMABOX.IN,Negative
 AstraZeneca Reports LongTerm Efficacy,PharmaShots - Incisive news in 3 shots,Negative
 Tolerability,PHARMABOX.IN,Negative
 Tolerability,BrainSights iOS App,Positive
 Tolerability,Crwe World,Positive
 Tolerability,Pharmacutical Daily,Positive
 Tolerability,"OTC Dynamics, Inc.",Positive
 Tolerability,Stock Titan,Positive
 Tolerability,Investor News,Positive
 Tolerability,PharmaShots - Incisive news in 3 shots,Negative
 Tolerability,Wall St. Justin Bieber think.tradeüí≠,Positive
 Tolerability,Stock Market News,Negative
 Tolerability,Corporate News,Negative
 Tolerability,IMPharma News,Negative
 Tolerability,Latest News from Business Wire,Negative
 Tolerability,Quant Data,Negative
 Tolerability,BiopharmaAsia,Negative
 Tolerability,TrialBulletin,Negative
 Tolerability,ClinicalTrialsData,Negative
 Tolerability,NASDAQ,Positive
 Tolerability,Oncology,Negative
 Tolerability,PracticeUpdate,Negative
 Tolerability,CancerWallonia,Negative
 Tolerability,Diaceutics PLC,Negative
 Tolerability,Scott Werntz,Positive
 Tolerability,Michelet St. Preuve,Positive
 Tolerability,IntoxicatedTrader,Negative
 Calquence acalabrutinib,PHARMABOX.IN,Positive
 Calquence acalabrutinib,PharmaShots - Incisive news in 3 shots,Positive
 Calquence acalabrutinib,MAISA,Negative
 Calquence acalabrutinib,Medicalnewser.com,Negative
 Calquence acalabrutinib,CURE Magazine,Positive
 Calquence acalabrutinib,Adi Singh,Positive
 Calquence acalabrutinib,CP Graduate Academy,Positive
 Calquence acalabrutinib,Financial Journal,Positive
 Calquence acalabrutinib,Health Canada and PHAC,Positive
 Calquence acalabrutinib,Saief Kazmi,Positive
 Calquence acalabrutinib,Lampe & Company,Negative
 Calquence acalabrutinib,Neth. Corporate News,Positive
 Calquence acalabrutinib,DWIB Leukaemia Trust,Positive
 Calquence acalabrutinib,Pharma News,Negative
 Calquence acalabrutinib,Financial Buzz,Negative
 Calquence acalabrutinib,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥,Positive
 Calquence acalabrutinib,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥ - Í±¥Í∞ï,Positive
 Calquence acalabrutinib,Business Wire-Health,Negative
 Calquence acalabrutinib,BusinessWireProducts,Negative
 Calquence acalabrutinib,BusinessWire-Science,Negative
 Calquence acalabrutinib,The Pharmaceutical Marketing Group,Negative
 Calquence acalabrutinib,SchwietermanPharmacy,Positive
 Calquence acalabrutinib,tristatemedicalgroup,Negative
 Calquence acalabrutinib,PRINCE ADEKOYA,Negative
 Calquence acalabrutinib,Marcrom's Pharmacy,Negative
 Calquence acalabrutinib,Custom Compounding,Positive
 Calquence acalabrutinib,Horseshoe Health & M,Negative
 Calquence acalabrutinib,The Medicine Shoppe,Negative
 Calquence acalabrutinib,Greenwood Drug,Negative
 Calquence acalabrutinib,Medicine To Go,Negative
 Calquence acalabrutinib,Greenbrier Pharmacy,Positive
 Calquence acalabrutinib,Sam's Health Mart,Positive
 Calquence acalabrutinib,Brehme Drug,Positive
 Calquence acalabrutinib,Food City RX Marion,Negative
 Calquence acalabrutinib,Crown Pharmacy,Positive
 Calquence acalabrutinib,LibertyHillPharmacy,Positive
 Calquence acalabrutinib,Hopkinton Drug,Negative
 Calquence acalabrutinib,Delran Pharmacy,Positive
 Calquence acalabrutinib,Fox Drug of Torrance,Negative
 Calquence acalabrutinib,Cascade Custom RX,Positive
 Calquence acalabrutinib,Coastal Pharmacy,Positive
 Calquence acalabrutinib,Regulatory Jobs,Positive
 Calquence acalabrutinib,Blue Matter,Positive
 Calquence acalabrutinib,TheSocialMedwork,Positive
 Calquence acalabrutinib,Hottest Stocks Now,Negative
 Calquence acalabrutinib,Krishan Maggon,Positive
 Calquence acalabrutinib,CancerCare,Negative
 Calquence acalabrutinib,OncologyInfo,Positive
 Calquence acalabrutinib,Zahedi Mujawar,Positive
 Calquence acalabrutinib,Khurram Nawaz,Positive
 Pll ACELY Study,PHARMABOX.IN,Negative
 Pll ACELY Study,PharmaShots - Incisive news in 3 shots,Negative
 MCL,PHARMABOX.IN,Positive
 MCL,David Ledger,Negative
 MCL,LifeProNow-Pharma-Research and News,Negative
 MCL,Dr. Carsten Wenzel,Negative
 MCL,PharmaTimes,Negative
 MCL,PharmaShots - Incisive news in 3 shots,Negative
 MCL,OncLive.com,Positive
 MCL,Targeted Oncology,Positive
 MCL,Tim Fenske,Negative
 MCL,Cancer Medicine,Positive
 MCL,Alicia Bell IFBB Pro,Negative
 MCL,Oncology Tube,Positive
 MCL,JTCancerCenter,Positive
 MCL,OncLive SOSS,Positive
 MCL,Crwe World,Positive
 MCL,FiercePharma,Negative
 MCL,Immuno-Oncology,Positive
 MCL,ColumbiaCancer,Positive
 MCL,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Positive
 MCL,Heather Swift Morrison,Negative
 MCL,Blue Matter,Positive
 MCL,Laura Nikolaides,Positive
 MCL,T Allen,Positive
 MCL,Lucie Kaisin,Positive
 MCL,"Mike Thompson, MD, PhD, FASCO",Negative
 MCL,Fernando Medina,Positive
 MCL,Lymphoma Canada,Negative
 MCL,"Hunan Huateng Pharmaceutical Co., Ltd",Positive
 MCL,BioCentury,Positive
 MCL,Silas Inman,Negative
 MCL,Pavan Anne,Negative
 MCL,Paperbirds_Hematology,Negative
 MCL,ClinicalTrialsData,Negative
 MCL,Sophie Barille-Nion,Positive
 MCL,Lymphoma Hub,Negative
 MCL,Francesco Turturro,Negative
 UK   CARAMEL pilot trial,Toby Eyre,Negative
 AwesomeCapital ASH AstraZenecas Calquence BeiGenes Brukinsa t,****,Negative
 CALQUENCE Data,Investor News,Negative
 CALQUENCE Data,IMPharma News,Negative
 Trials,Investor News,Negative
 Trials,IMPharma News,Negative
 Trials,Biotech & Tech Stock Focus,Negative
 Trials,"OTC Dynamics, Inc.",Negative
 Trials,Stock Titan,Negative
 Trials,Pulsus Conferences,Positive
 Trials,Vijaya L,Positive
 Trials,CLL_Fightersüéó,Negative
 Trials,Helen Jane Mee,Negative
 Trials,AJMC-Oncology,Negative
 Trials,Lymphomation.org,Negative
 Reinforces Cardiovascular Safety Profile,Investor News,Negative
 Reinforces Cardiovascular Safety Profile,IMPharma News,Negative
 Reinforces Cardiovascular Safety Profile,Biotech & Tech Stock Focus,Negative
 Reinforces Cardiovascular Safety Profile,"OTC Dynamics, Inc.",Negative
 Reinforces Cardiovascular Safety Profile,Stock Titan,Negative
 Chronic Lymphocytic Leukemia AZN,Investor News,Negative
 CORRECTING REPLACING ¬† CALQUENCE,BrainSights iOS App,Negative
 CORRECTING REPLACING ¬† CALQUENCE,Pharmacutical Daily,Negative
 LongTerm Efficacy,BrainSights iOS App,Positive
 LongTerm Efficacy,Pharmacutical Daily,Positive
 LongTerm Efficacy,"OTC Dynamics, Inc.",Positive
 LongTerm Efficacy,Stock Titan,Positive
 LongTerm Efficacy,Investor News,Positive
 LongTerm Efficacy,Stock Market News,Negative
 LongTerm Efficacy,Corporate News,Negative
 LongTerm Efficacy,IMPharma News,Negative
 LongTerm Efficacy,Crwe World,Negative
 LongTerm Efficacy,Latest News from Business Wire,Negative
 Years,BrainSights iOS App,Positive
 Years,Crwe World,Positive
 Years,Pharmacutical Daily,Positive
 Years,"OTC Dynamics, Inc.",Positive
 Years,Stock Titan,Positive
 Years,Investor News,Positive
 Years,Wall St. Justin Bieber think.tradeüí≠,Positive
 Years,Stock Market News,Negative
 Years,Corporate News,Negative
 Years,IMPharma News,Negative
 Years,Latest News from Business Wire,Negative
 Years,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Years,@globalfirstnews,Positive
 Years,Paperbirds_Hematology,Negative
 Years,Brave Is Now¬Æ,Negative
 Years,TrialSite News,Negative
 Years,suetodd16,Positive
 Years,Genentech,Negative
 Years,WhatNext.com,Negative
 Years,Oncology Tube,Negative
 Relapsed Refractory Mantle Cell Lymphoma   Neuro Central,BrainSights iOS App,Positive
 ASH   AstraZenecas Calquence BeiGenes Brukinsa,Pharma Top News,Positive
 longterm efficacy,David Ledger,Negative
 longterm efficacy,LifeProNow-Pharma-Research and News,Negative
 longterm efficacy,Dr. Carsten Wenzel,Negative
 longterm efficacy,CHItraders,Negative
 longterm efficacy,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 longterm efficacy,Gordon Gekko,Negative
 longterm efficacy,Investor News,Negative
 longterm efficacy,Breaking News,Negative
 longterm efficacy,PharmaTimes,Negative
 longterm efficacy,PHARMABOX.IN,Negative
 longterm efficacy,1stOncology,Positive
 longterm efficacy,Company News HQ,Positive
 longterm efficacy,Cision News,Positive
 longterm efficacy,GraniteShares Europe,Negative
 longterm efficacy,Oncology Learning Network,Negative
 longterm efficacy,Blood Journal,Negative
 longterm efficacy,"Pharmacyclics, an AbbVie Company",Negative
 tolerability,David Ledger,Negative
 tolerability,LifeProNow-Pharma-Research and News,Negative
 tolerability,Dr. Carsten Wenzel,Negative
 tolerability,CHItraders,Negative
 tolerability,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 tolerability,Gordon Gekko,Negative
 tolerability,Investor News,Negative
 tolerability,Breaking News,Negative
 tolerability,PharmaTimes,Negative
 tolerability,PHARMABOX.IN,Negative
 tolerability,1stOncology,Positive
 tolerability,Company News HQ,Positive
 tolerability,Cision News,Positive
 tolerability,GraniteShares Europe,Negative
 tolerability,"Dr. Paul DeSantis, PharmD",Negative
 tolerability,Lymphoma Papers,Negative
 tolerability,Toby Eyre,Negative
 tolerability,Oncology Learning Network,Negative
 tolerability,Fox Chase Cancer Center,Positive
 tolerability,Blood Journal,Negative
 tolerability,GEDEFO,Negative
 tolerability,Francesco Turturro,Positive
 tolerability,"Raul Cordoba, MD, PhD",Negative
 tolerability,"Dr T. Comeau , MD",Negative
 tolerability,ARB,Positive
 tolerability,TumorImmunoPapers,Negative
 tolerability,Teresa Villaescusa,Positive
 tolerability,Philip McCarthy,Negative
 tolerability,üÖæ Jaksic,Negative
 tolerability,Karen Sweiss,Negative
 tolerability,Lymphoma Hub,Negative
 Today,SeattleCancerCareAlliance,Negative
 Today,Leukaemia Care,Negative
 Today,HARMONY Alliance,Negative
 Today,Deb Amlen,Positive
 Today,Michael Rynne,Positive
 Today,CLL Advocates Network,Negative
 Today,"Mazyar Shadman, MD MPH",Negative
 Today,"Pharmacyclics, an AbbVie Company",Positive
 Today,Lurie Cancer Center,Negative
 Today,HemaSphere_EHA,Positive
 Today,Patient Power,Negative
 Today,Andrew Schorr,Positive
 Today,GenQA (Genomics Quality Assessment),Negative
 Today,MyPathologyReport.ca,Negative
 Today,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 Today,LyLe Foreningen,Negative
 Today,CLL Ireland,Positive
 Today,CLLSA,Positive
 Today,Philly Sports Guy in SC,Positive
 Today,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 Today,EYFS Resources,Positive
 Today,RIOH,Negative
 Today,Lorna Warwick,Positive
 Today,Shweta Prakash,Positive
 Today,Chris  Douglas,Positive
 Today,OncLive.com,Negative
 Today,CURE Magazine,Positive
 Today,Children‚Äôs Oncology Group,Negative
 Today,LiveYourLife,Negative
 Today,CLL Warwick Uni,Negative
 Today,Janssen Global,Negative
 Today,NWCR - UoL,Positive
 Today,Los Lobos,Negative
 Today,Ana Catarina Bento,Negative
 Poster session,SeattleCancerCareAlliance,Negative
 MD MPH    Phase,SeattleCancerCareAlliance,Negative
 Study,SeattleCancerCareAlliance,Negative
 Study,ClinicalTrialsData,Positive
 Study,TrialBulletin,Positive
 Study,Emilio Mordini,Positive
 Study,Air Medical Today,Positive
 Study,Middle-East & Pakistan Times of News,Positive
 Study,Zenopa Recruitment,Positive
 Study,Journal of Cancer Research and Immuno-Oncology,Positive
 Study,ExBulletin,Positive
 Study,Tom Andrewsüíô,Positive
 Study,"Robert West, PhD",Positive
 Study,Scienzer,Positive
 Study,National Cancer Institute,Negative
 Study,The Purple Society,Negative
 Study,Value-Based Cancer Care,Negative
 Study,Cancer Medicine,Positive
 Study,"Raul Cordoba, MD, PhD",Positive
 Study,Paperbirds_Hematology,Positive
 Study,Alex Keown,Positive
 Study,Renal Cell Carcinoma,Positive
 Study,Lymphomation.org,Positive
 Study,"Mike Thompson, MD, PhD, FASCO",Negative
 Study,Jordan üíä,Positive
 Study,Biotech2050,Positive
 Study,"Michael Wang, MD",Negative
 Study,CellworksLife,Positive
 Study,Adam R. Fox,Positive
 Study,Mayo Clinic Cancer Center,Negative
 Study,Oncology Publishers Feed,Negative
 Study,1stOncology,Positive
 Study,Pharmacutical Daily,Positive
 Study,"OTC Dynamics, Inc.",Negative
 Study,Stock Titan,Negative
 Study,Crwe World,Negative
 Study,dough,Positive
 Study,Jake,Positive
 Study,The Stock Sniper,Positive
 Study,TraderZ,Positive
 Study,Amp Trades,Positive
 Study,TrialSite News,Negative
 Study,"Redington, Inc.",Positive
 Study,Behavioral Finance,Positive
 Study,Quant Data,Negative
 Study,Day Trading Alerts,Positive
 Study,Swing Trading,Positive
 Study,Michelle Solly,Positive
 Study,Michel Doepke,Positive
 Study,Bio Stocks‚Ñ¢,Negative
 Study,TradeXchange,Negative
 Study,Clinical OMICs,Positive
 Study,MAISA,Positive
 Study,Monterey Holistic,Negative
 Study,LYMPHOMA & MYELOMA CONNECT,Negative
 Study,The ASCO Post,Negative
 Study,Contemporary Clinic,Positive
 Study,Icahn School of Medicine at Mount Sinai,Positive
 Study,Gary Annable,Positive
 Study,PressReleasePoint,Negative
 Study,Bioengineer.org,Positive
 Study,info-over-kanker,Positive
 Study,Scott Merville,Positive
 Study,Oncology Strategies,Negative
 Study,Science Codex,Positive
 Study,Muiro Yatakama,Positive
 Study,Science and Technology News,Positive
 Study,Art Fridrich,Positive
 Study,Oncology Tube,Negative
 Study,AJMC,Negative
 Study,SunAWARE,Positive
 Study,Children's Melanoma,Positive
 Study,Tom Silver,Negative
 Study,Targeted Oncology,Negative
 Study,Covington Beasley,Positive
 Study,ABABioBlurb,Positive
 Study,Right Write,Positive
 Study,Medicalnewser.com,Negative
 Study,EMJ Hematology,Negative
 Study,The Medicine Maker,Positive
 Study,Dana-Farber,Negative
 Study,Mark Kirkpatrick,Positive
 Study,Vera Marie Reed,Positive
 Study,üïäüïäüïäüïäüïäüïäüïäüïä,Positive
 Study,Maggie Baker,Positive
 Study,Gwen Eve Lewis,Positive
 Study,Biyoloji,Positive
 Study,Ajinkya Ambre,Positive
 Study,‚ö°Ofra Ziv‚ö°,Positive
 Study,ASH Clinical News,Positive
 Study,Cancer Research Institute,Positive
 Study,Juno Therapeutics,Positive
 Study,CLL Ireland,Negative
 Study,Anna Deveau,Negative
 Study,CancerWallonia,Positive
 Study,Lymphoma News Today,Positive
 Study,Cancer Epi &Genetics,Positive
 Study,Lung Cancer News,Negative
 Study,CU Cancer Center,Positive
 Study,CancerTherapyAdvisor,Positive
 Study,Matthias Piesche,Negative
 Study,TECH JOBS,Positive
 Study,All Jobs,Negative
 Study,James Porreca,Negative
 Study,Market Ready Rx,Positive
 Study,MD Anderson Cancer Center,Negative
 Study,"Bruce Rogers, Ph.D.",Positive
 Study,MDedge Hematology & Oncology,Negative
 Study,BCAwareness,Negative
 Study,CLL Society Inc.,Negative
 Study,WCM Lymphoma,Negative
 Study,VoyagerMed,Positive
 Study,Hematopoiesis News,Negative
 Study,IntoxicatedTrader,Positive
 Study,HHF,Negative
 Study,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 Study,PRN Biotech,Negative
 Study,Scott Werntz,Positive
 Study,Penny Stocks,Negative
 Study,Penny Stock Irish,Negative
 Study,Robert Z. Orlowski,Negative
 Study,JAMA Oncology,Negative
 RelapsedRefractory BCell Malignancies Intolerant,SeattleCancerCareAlliance,Negative
 IbrutinibAcalabrutinib,SeattleCancerCareAlliance,Negative
 AZN CALQUENCE Data,Biotech & Tech Stock Focus,Negative
 AZN CALQUENCE Data,"OTC Dynamics, Inc.",Negative
 AZN CALQUENCE Data,Stock Titan,Negative
 Business Wire,Biotech & Tech Stock Focus,Positive
 Business Wire,Saeed Valadbaygi,Negative
 Business Wire,DWIB Leukaemia Trust,Positive
 Business Wire,Josh Rehrer,Positive
 Business Wire,Bitchin' Science,Negative
 Business Wire,Scott Werntz,Negative
 CORRECTING,Crwe World,Negative
 CORRECTING,Investor News,Negative
 REPLACINGampnbspCALQUENCE Shows LongTerm Efficacy,Crwe World,Negative
 R,Crwe World,Negative
 R,Francesco Bertoni,Negative
 R,Toby Eyre,Positive
 R,Financial Buzz,Positive
 R,Michael Dickinson,Negative
 Relapsed Refractory Mantle Cell,Pharmacutical Daily,Positive
 Lymphoma,Pharmacutical Daily,Positive
 Lymphoma,Cancer Medicine,Positive
 Lymphoma,BioNews,Positive
 Lymphoma,Lymphoma News Today,Positive
 Lymphoma,Medical HotSpot,Positive
 Lymphoma,CLL Society Inc.,Positive
 Lymphoma,BeiGene,Negative
 Lymphoma,mednetnews,Negative
 Lymphoma,Paperbirds_Hematology,Positive
 Lymphoma,Lymphoma Papers,Negative
 Lymphoma,Bloodbytes,Positive
 Lymphoma,CARE‚Ñ¢ Education,Negative
 Lymphoma,Total Health Conferencing,Positive
 Lymphoma,EIN Presswire: Press Releases,Positive
 Lymphoma,Verastem Oncology,Negative
 Lymphoma,CRO Contract Res.,Positive
 Lymphoma,HEDGE accordinglyüìà,Negative
 Lymphoma,RazzleTazzle,Negative
 Lymphoma,Matthews & Associates,Negative
 Lymphoma,The Pharmaceutical Marketing Group,Negative
 Lymphoma,Children‚Äôs Oncology Group,Negative
 Lymphoma,COPD News,Negative
 Lymphoma,Oncology Tube,Positive
 Lymphoma,Oncology,Negative
 Lymphoma,GRACE,Negative
 Lymphoma,Birger Armstrong üí¨,Positive
 Lymphoma,"Raul Cordoba, MD, PhD",Negative
 Lymphoma,Lymphoma Hub,Negative
 Lymphoma,James Porreca,Negative
 Lymphoma,Trip Guidelines,Positive
 analysis,The British Journal of Cardiology,Positive
 analysis,Targeted Oncology,Negative
 analysis,MD Anderson Cancer Center,Negative
 analysis,K Pavithran,Positive
 analysis,Genentech,Positive
 analysis,"chadi nabhan MD, MBA, FACP",Positive
 analysis,ABNewswire,Negative
 analysis,SouthernIndiaReporte,Positive
 analysis,New Jersey Headlines,Positive
 analysis,Joe Hedden,Negative
 Calquence Discontinued Treatment,Devdiscourse,Negative
 Cardiac Adverse Events,Devdiscourse,Negative
 Pooled Analysis,Devdiscourse,Negative
 AZN CORRECTING,"OTC Dynamics, Inc.",Negative
 AZN CORRECTING,Stock Titan,Negative
 REPLACING,"OTC Dynamics, Inc.",Negative
 REPLACING,Stock Titan,Negative
 REPLACING,Investor News,Negative
 Relapsed Refractory Mantle Cell Lymphoma,"OTC Dynamics, Inc.",Positive
 Relapsed Refractory Mantle Cell Lymphoma,Stock Titan,Positive
 Relapsed Refractory Mantle Cell Lymphoma,Wall St. Justin Bieber think.tradeüí≠,Positive
 Relapsed Refractory Mantle Cell Lymphoma,Stock Market News,Negative
 Relapsed Refractory Mantle Cell Lymphoma,Corporate News,Negative
 Relapsed Refractory Mantle Cell Lymphoma,IMPharma News,Negative
 Relapsed Refractory Mantle Cell Lymphoma,Latest News from Business Wire,Negative
 Relapsed Refractory Mantle Cell Lymphoma,Cancer News,Negative
 Relapsed Refractory Mantle Cell Lymphoma,CureHuntr,Negative
 Relapsed Refractory Mantle Cell Lymphoma,Renal Cell Carcinoma,Negative
 Relapsed Refractory Mantle Cell Lymphoma,TrialBulletin,Negative
 Relapsed Refractory Mantle Cell Lymphoma,"Fatih Uckun, M.D.",Positive
 Relapsed Refractory Mantle Cell Lymphoma,Financial Buzz,Negative
 Relapsed Refractory Mantle Cell Lymphoma,Cancer Papers,Negative
 Refractory,Investor News,Negative
 Refractory,The ASCO Post,Negative
 Refractory,Stock Market News,Negative
 Refractory,Latest News from Business Wire,Negative
 Refractory,INDoximity üáÆüá≥,Negative
 Refractory,Paperbirds_Hematology,Positive
 Refractory,Benlazar S.M Amin√©,Negative
 Refractory,CellworksLife,Negative
 Refractory,Monterey Holistic,Negative
 Refractory,BenXM,Positive
 Refractory,EurekaMag,Negative
 Refractory,Kam Laurence,Positive
 Refractory,Lymphomation.org,Positive
 Refractory,satPRnews,Negative
 Refractory,Biotech2050,Negative
 Mantle,Investor News,Negative
 Calquence trials,Shifting Wealth,Negative
 CV safety,Shifting Wealth,Negative
 CLLAZN,Shifting Wealth,Negative
 AZN BGNE ASH AstraZenecas Calquence BeiGenes Brukinsa,Biotech & Tech Stock Focus,Negative
 ACELY Phase II trial results substantiate,BiopharmaAsia,Negative
 efficacy safety profile,BiopharmaAsia,Negative
 VIŒõ,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 WIC“ö∆∏Ô∏éƒê ‚úß,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 FINŒõNCIŒõL REŒõDS,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 blood cancer AZN,Investor News,Negative
 Longterm followup results,Medicircle.in,Positive
 years,1stOncology,Negative
 years,Shifting Wealth,Negative
 years,Company News HQ,Negative
 years,Cision News,Negative
 years,CLL Advocates Network,Negative
 years,Targeted Oncology,Positive
 years,Lymphomation.org,Negative
 years,"Raul Cordoba, MD, PhD",Positive
 years,Living A Busy Life - With Cancer,Positive
 years,CLL Ireland,Positive
 years,Toby Eyre,Negative
 years,Hematology Advisor,Negative
 years,ron white,Positive
 years,Joe Lehr,Positive
 years,WheelieDealer,Negative
 years,ABPI,Negative
 years,AstraZenecaUS,Negative
 years,Prof John,Negative
 years,ALI ALAHMARI.,Positive
 years,Lia Palomba,Positive
 years,Lymphoma Papers,Negative
 years,CancerEpiPapers,Negative
 years,Benlazar S.M Amin√©,Positive
 years,AstraZeneca,Positive
 years,Marko Skelin MPharm PhD,Positive
 years,Florian Slimano,Negative
 years,Susan Oehlers,Positive
 years,Charlotte Martin,Positive
 years,VJHemOnc,Negative
 years,Jeff Sharman,Positive
 years,donnashort,Negative
 years,AplusA World,Negative
 years,"Pharmacyclics, an AbbVie Company",Positive
 years,WCM Lymphoma,Negative
 years,"chadi nabhan MD, MBA, FACP",Positive
 years,CLLSA,Negative
 years,RIOH,Negative
 years,Joana Koury,Positive
 years,CLL Warwick Uni,Negative
 years,Michael's Pharmacy,Positive
 years,Dr. Drew Dahlgren,Positive
 years,Daniel Ernst,Positive
 years,Anna Deveau,Positive
 years,P.M.C,Negative
 years,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 years,Biotech2050,Negative
 years,Andrew Schorr,Negative
 years,Steve Hunsley,Positive
 years,OncLive SOSS,Negative
 years,Decision Resources Group,Negative
 years,Lymphoma Hub,Negative
 years,Mithu Storoni MD PhD,Positive
 years,Roberto C.  Montoya,Negative
 years,lccmassage,Positive
 years,Barts Cancer Institute,Positive
 years,UFCW Canada,Positive
 years,Aspen Biosciences,Positive
 years,Mark Fortner,Positive
 years,Aziz Nazha,Positive
 years,"Naveen Pemmaraju, MD",Negative
 longterm efficacy tolerability,Shifting Wealth,Negative
 RR MCL AZN,Shifting Wealth,Negative
 ‚Äú cytokine storms,Enosi Life Sciences,Positive
 ASH AstraZeneca,ExBulletin,Positive
 ASH AstraZeneca,NewExpressNews,Positive
 ASH AstraZeneca,PHARMABOX.IN,Negative
 ASH AstraZeneca,Lampgen Clinical Research,Positive
 BeiGene,ExBulletin,Positive
 BeiGene,BeiGene,Positive
 BeiGene,Wellcome-home,Negative
 BeiGene,DennisPartners,Negative
 BeiGene,Crwe World,Negative
 Brukinsa,ExBulletin,Positive
 Brukinsa,NewExpressNews,Negative
 Brukinsa,PHARMABOX.IN,Negative
 Brukinsa,BioPharma Dive,Negative
   NEWS ALERT AstraZeneca,Wall St. Justin Bieber think.tradeüí≠,Positive
 Longterm Efficacy,Wall St. Justin Bieber think.tradeüí≠,Positive
 Longterm Efficacy,BiopharmaAsia,Negative
 Presentation,Wall St. Justin Bieber think.tradeüí≠,Positive
 Presentation,ASCO Publications,Negative
 Presentation,Paperbirds_Hematology,Negative
 Presentation,AIRR-seq papers,Negative
 ASH   TimeDate Tthinktrade,Wall St. Justin Bieber think.tradeüí≠,Positive
 Calquence BeiGene,NewExpressNews,Negative
 Calquence BeiGene,PHARMABOX.IN,Negative
 AZN Reveals findings,Hottest Stocks Now,Negative
 midstage trial,Hottest Stocks Now,Negative
 midstage trial,MAISA,Negative
 Relapsed Refractory Mantle Cell Lymphoma AZN,Investor News,Negative
 Refractory Mantle C,Crwe World,Negative
 Refractory Mantle C,Stockboard Media Inc,Negative
 mantle cell,Ingrid Glimelius,Positive
 mantle cell,Cancer Medicine,Positive
 mantle cell,Blood Journal,Negative
 mantle cell,Federal Practitioner,Positive
 mantle cell,The Lancet,Negative
 mantle cell,National Cancer Institute,Negative
 mantle cell,JM Mart√≠nez Sesmero #StopTheVirus,Positive
 mantle cell,OncologyNurseAdvisor,Positive
 mantle cell,Carolyn Thompson,Negative
 mantle cell,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 mantle cell,Regulatory Jobs,Positive
 mantle cell,dario pasqualini,Positive
 mantle cell,Lisa Astor,Negative
 mantle cell,AstraZenecaUS,Negative
 mantle cell,CancerCare,Negative
 mantle cell,Salutedomani,Negative
 mantle cell,Healio,Positive
 mantle cell,HemOnc Today,Positive
 mantle cell,Sue Mockus,Positive
 mantle cell,pharmatutor,Positive
 mantle cell,PharmaSources.com,Positive
 mantle cell,Lymphoma Canada,Negative
 mantle cell,BluePrint Orphan,Positive
 mantle cell,Cision News,Negative
 mantle cell,DDNews Online,Negative
 mantle cell,Lymphoma Hub,Negative
 mantle cell,"Raul Cordoba, MD, PhD",Negative
 trav√©s,BIOCIENCIA,Negative
 acaba,Medscape ES,Positive
 adultos La terapia,Medscape ES,Positive
 ser aplicada por un especialista,Medscape ES,Positive
 f√°rmacos neopl√°sicos,Medscape ES,Positive
 Congratulations,"Brand Institute, Inc",Negative
 Congratulations,RIOH,Negative
 Congratulations,US Oncology Network,Negative
 Congratulations,"Yiping Yang, MD, PhD",Positive
 Congratulations,Cells and Molecules Research at UoB,Positive
 Congratulations,Jackie Fairley,Positive
 Congratulations,BluePrint Orphan,Positive
 Congratulations,Ingo Ringshausen,Positive
 Congratulations,Alfredo Rivas-Delgado,Positive
 Congratulations,Leukaemia Foundation,Negative
 Congratulations,Wilmot Cancer Institute,Negative
 Congratulations,Sigrid Sk√•nland,Negative
 Congratulations,BinderLab,Positive
 Congratulations,Federation University,Positive
 Congratulations,"Cowan, Liebowitz",Negative
 Congratulations,Mraz Lab,Positive
 Congratulations,Clinical Research Forum,Positive
 Congratulations,UW-Madison Nutri Sci,Positive
 Congratulations,Martin JS Dyer,Positive
 Congratulations,Christian Pallasch,Positive
 Congratulations,CeMM,Positive
 Congratulations,@balbensi üá∫üá∏ üáÆüáπ,Positive
 Congratulations,"Sanam Loghavi, MD",Positive
 Congratulations,MD Anderson Leukemia,Negative
 Congratulations,Michael Hallek,Negative
 Congratulations,Carla Casulo,Positive
 Congratulations,Abdel-Wahab Lab,Positive
 Congratulations,Cancer Research Wales,Positive
 Congratulations,Novateur Ventures,Positive
 Congratulations,BSMS,Positive
 Congratulations,Gerry Rodrigues,Positive
 Congratulations,Retrogenix,Positive
 Congratulations,Elies Campo,Positive
 Congratulations,Claranet,Positive
 Congratulations,Regina M Maxwell,Positive
 Congratulations,Blood Cancer UK Research,Negative
 Congratulations,SIU Press,Negative
 Congratulations,Lymphoma Hub,Negative
 Congratulations,Estela de la Torre OLY üá≤üáΩ,Negative
 Congratulations,"Raul Cordoba, MD, PhD",Negative
 Congratulations,Middleton C.C.,Positive
 Congratulations,Jon Henderson üçªüç∫ üíõüíô,Positive
 Congratulations,Barts Cancer Institute,Positive
 Congratulations,InConcertForCancer,Positive
 EMA approval,"Brand Institute, Inc",Positive
 prescription medicine,"Brand Institute, Inc",Negative
 prescription medicine,"KOLKATA RAVI SPECIALITIES PHARMA PVT.LTD.,",Positive
 prescription medicine,delhi-ravi worldwide medicines,Positive
 prescription medicine,Medicine For World,Negative
   Attention   attendees Tune,CALQUENCE¬Æ (acalabrutinib),Negative
 Dec,CALQUENCE¬Æ (acalabrutinib),Negative
 Dec,Medscape Education,Positive
 Dec,PeerView,Negative
 Dec,ESCofNJ,Negative
 Dec,Patient Power,Negative
 Dec,LiveYourLife,Positive
 Dr Paolo Ghia,CALQUENCE¬Æ (acalabrutinib),Negative
 Dr Paolo Ghia,CARE‚Ñ¢ Education,Negative
 Q Acalabrutinib,knowmedge,Positive
 condition,knowmedge,Positive
 condition,bluestatestuff,Positive
 condition,Patient Power,Negative
 condition,Rustique Chic,Positive
 condition,Cleveland Clinic Abu Dhabi,Positive
 condition,Patient Empowerment Network,Negative
 condition,NaturesZestNutrition,Positive
 condition,VJHemOnc,Negative
 DOH,Christian Yosores,Positive
 DOH,Inquirer,Positive
 DOH,jovic yee,Positive
 Acalabrutinib arm,Christian Yosores,Positive
 WHOs Solidarity Trial,Christian Yosores,Positive
 evidence,Christian Yosores,Positive
 evidence,Shouting at people in my underpants,Negative
 evidence,Blood Cancer Uncensored,Negative
 evidence,CLL Society Inc.,Positive
 evidence,Toby Eyre,Negative
 evidence,CLLSA,Negative
 evidence,a follower,Positive
 evidence,OSU Psych Advising,Positive
 evidence,Guillermo Sanz,Negative
 evidence,IDIVAL Direccion,Positive
 evidence,"Andrea Romanos-Nanclares, MS, BS üá™üá∏",Positive
 evidence,"chadi nabhan MD, MBA, FACP",Negative
 evidence,Matthews & Associates,Negative
 evidence,CBPartners,Positive
 evidence,Oncology Tube,Negative
 evidence,"Ola Landgren, M.D.",Positive
 evidence,Dr. Ilin Gilberto de la Torre MD üò∑,Positive
 evidence,NACDA Program on Aging,Negative
 evidence,AtlanticJOMedicine,Negative
 evidence,Dr Gail Miflin,Positive
 evidence,Mehdi Hamadani,Positive
 trial,Christian Yosores,Positive
 trial,Nathan Vardi,Negative
 trial,Targeted Oncology,Positive
 trial,The Cancer Letter,Negative
 trial,Shawn Friend,Positive
 trial,Prestige Scientific,Positive
 trial,EuropaWire,Positive
 trial,John Lauerman,Positive
 trial,OnTheFritz,Positive
 trial,John Wilander,Positive
 trial,"Amber Koehler, PA-C",Negative
 trial,The Lancet Haematology,Positive
 trial,1stOncology,Negative
 trial,"Michael Wang, MD",Positive
 trial,BioSpace,Positive
 trial,pharmaphorum,Negative
 trial,The PMI (Pharmaceutical Managers' Institute),Negative
 trial,EMG GOLD,Positive
 trial,Mehrdad Yousefi,Negative
 trial,"Raul Cordoba, MD, PhD",Positive
 trial,Devona Williams,Positive
 trial,ALI ALAHMARI.,Negative
 trial,Mahmoud Aljurf,Positive
 trial,ARB,Positive
 trial,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 trial,"Mazyar Shadman, MD MPH",Positive
 trial,JAMA Oncology,Negative
 trial,GEDEFO,Negative
 trial,JAMA,Negative
 trial,Oncology Learning Network,Positive
 trial,Paperbirds_Hematology,Negative
 trial,EurekaMag,Negative
 trial,OncLive.com,Negative
 trial,"chadi nabhan MD, MBA, FACP",Negative
 trial,Lung Cancer News,Negative
 trial,Michael Rynne,Positive
 trial,i3 Health,Negative
 trial,Sarah Williams,Positive
 trial,Becky Bishop,Positive
 trial,Michele Nadeem-Baker,Negative
 trial,"Bachar Samra, MD",Positive
 trial,Toby Eyre,Negative
 trial,Lymphoma Papers,Negative
 trial,VJHemOnc,Positive
 trial,COPD News,Negative
 trial,Michael Hallek,Negative
 trial,Plexus Ventures,Negative
 trial,Tom,Negative
 trial,Rare Disease Report,Negative
 trial,Lymphoma Hub,Positive
 trial,Integra Medical,Positive
 trial,The Lancet Oncology,Positive
 trial,HemOnc Today,Positive
 trial,"A. Emre E≈ükazan, MD ü©∏üî¨",Positive
 trial,Andrew Schorr,Negative
 trial,Silvana Novelli,Positive
 trial,healthbook,Positive
 trial,Biotech2050,Negative
 trial,NE Live,Negative
 trial,EMJ Hematology,Negative
 trial,Tanya Wildes MD,Positive
 trial,Senior Care Corner,Negative
 trial,Michael O'Dwyer,Positive
 trial,Marc Gozlan,Positive
 trial,Blood Buff,Positive
 trial,MDedge Hematology & Oncology,Negative
 trial,Elvin Joel üò∑‚òïÔ∏èüì∏,Positive
 trial,‚ö°Ô∏èYOU SCIENCE ‚ö°Ô∏è,Positive
 trial,Sherry Chandy MD,Positive
 trial,Miguel Romera,Positive
 trial,WCM Lymphoma,Negative
 trial,EMJ Reviews,Positive
 trial,Oksana Komarova,Positive
 trial,Scott Werntz,Negative
 acalabrutinib arm,Inquirer,Positive
 acalabrutinib arm,jovic yee,Positive
 WHOled Solidarity Therapeutics Trial,Inquirer,Positive
 WHOled Solidarity Therapeutics Trial,jovic yee,Positive
 anticancer drug,Inquirer,Positive
 anticancer drug,jovic yee,Positive
 anticancer drug,Kit-Kay Mak,Positive
 anticancer drug,delhi-ravi worldwide medicines,Positive
 anticancer drug,"KOLKATA RAVI SPECIALITIES PHARMA PVT.LTD.,",Positive
 deaths,Inquirer,Positive
 deaths,jovic yee,Positive
 deaths,CancerTherapyAdvisor,Negative
 need,Inquirer,Positive
 need,jovic yee,Positive
 need,WISH-TV,Positive
 need,EuropaWire,Negative
 need,TheStreet,Positive
 need,OncLive.com,Positive
 need,Targeted Oncology,Negative
 need,LYMPHOMA & MYELOMA CONNECT,Negative
 need,SunAWARE,Positive
 need,CURE Magazine,Negative
 need,Prof Dr Mustafa Benekli ü©∫,Positive
 need,CLLSA,Negative
 need,CLL Advocates Network,Negative
 need,AEGLE,Negative
 need,VJHemOnc,Positive
 need,AIM,Positive
 need,ACS Journal Cancer,Negative
 need,Chris Thomson,Negative
   ,@COVID_Evidence,Negative
   ,International Conference on Malignant Lymphoma,Negative
   ,Cells MDPI,Positive
   ,Philip Brooks,Positive
   ,Michele Nadeem-Baker,Negative
   ,a follower,Positive
   ,Verastem Oncology,Negative
   ,CLL Ireland,Negative
   ,David A. Cohen,Negative
   ,M.F.A.S,Positive
   ,EMJ Hematology,Positive
   ,Patient Power,Negative
   ,label,Positive
   ,Patient Empowerment Network,Negative
   ,Equality Couple,Negative
   ,EMJ Rheumatology,Negative
 Solidarity Trial,@COVID_Evidence,Negative
 COVID Treatments Condition,@COVID_Evidence,Negative
 Covid Interventions ¬†  Drug ¬† Remdesivir ¬†  Drug ¬† Acalabrutinib ¬†  Drug,@COVID_Evidence,Negative
 Zum,Gelbe Liste,Negative
 Dezember,Gelbe Liste,Negative
 kommt das Arzneimittel,Gelbe Liste,Negative
 Acalabrutinib auf den deutschen,Gelbe Liste,Negative
 Markt Es handelt sich um eine neue Behandlungsoption bei chronisch,Gelbe Liste,Negative
 lymphatischer √§mie CLL,Gelbe Liste,Positive
 story Acalabrutinib,Lynne Mac Lean,Negative
 story Acalabrutinib,Paul Wright,Negative
 earlystage data,TF 2,Positive
 Headline News,Mafiusa,Positive
 Steals amp Deals,Mafiusa,Positive
 ‚òÖ „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÄÅ„ÄåCALAVIË©¶È®ì„ÅØÊÆãÂøµ„Å™ÁµêÊûú„Å´,„ÉÜ„Ç£„Éº„Ç∫,Positive
 ‚úè Contribuez,Haute Autorit√© de sant√©,Positive
 AstraZeneca cancer drug,FancyFinancy,Negative
 AstraZeneca cancer drug,BiotechBioPharma,Positive
 AstraZeneca cancer drug,Financial Carnivores,Negative
 AstraZeneca cancer drug,Swedish Biotech,Positive
 AstraZeneca cancer drug,CarnivoresHealth,Positive
 AstraZeneca cancer drug,Pharma Top News,Positive
 AstraZeneca cancer drug,cafepharma,Negative
 AstraZeneca cancer drug,Ben Fidler,Positive
 AstraZeneca cancer drug,@Easy_Branches #guestpostingservices,Positive
 COVID,FancyFinancy,Negative
 COVID,BiotechBioPharma,Positive
 COVID,Financial Carnivores,Negative
 COVID,Swedish Biotech,Positive
 COVID,BiopharmaAsia,Negative
 COVID,CarnivoresHealth,Positive
 COVID,PILOTforPULMONARY,Positive
 COVID,Pharma Top News,Positive
 COVID,cafepharma,Negative
 COVID,Lyke Lyfe,Positive
 COVID,PHARMABOX.IN,Negative
 COVID,PharmaShots - Incisive news in 3 shots,Positive
 COVID,Medelis: OncologyCRO,Positive
 COVID,"COTA, Inc.",Positive
 COVID,"Mike Thompson, MD, PhD, FASCO",Negative
 COVID,HLC,Positive
 COVID,Apostz,Positive
 COVID,Medical News Bulletin,Positive
 COVID,Andreas Charalambous,Positive
 COVID,Emanuel Vila,Positive
 COVID,Matt Willemsen,Positive
 COVID,Ana L√≥pez,Positive
 COVID,Alejandro (Alex) Barbagelata,Positive
 COVID,Teresa MASIA PERALES,Positive
 COVID,13WREX,Positive
 COVID,Sweta_Entomon üáÆüá≥ #StaySafe #üò∑,Positive
 COVID,Syrian is not white,Positive
 COVID,"Carlos F. Camargo, Ph.D. | DRE #01988431",Positive
 COVID,Josh Marshall,Positive
 COVID,BIOCIENCIA,Negative
 COVID,Para,Positive
 COVID,Andy Vermaut,Positive
 COVID,Daily Coronavirus News üò∑üåçüìà,Positive
 COVID,David Ledger,Positive
 COVID,PharmaTimes,Positive
 COVID,Barry Curry,Negative
 COVID,Everything Pharma,Negative
 COVID,Pharma Trader,Negative
 COVID,PharmaCrowd,Negative
 COVID,Career Biotech,Positive
 COVID,K Pavithran,Positive
 COVID,Joseph Aslan,Positive
 COVID,Victor YosefMelt Campos,Positive
 COVID,clinicalsourcing,Positive
 COVID,√únal Metin Tokat,Positive
 COVID,Pharma Journalist,Positive
 COVID,Anna Lubas,Positive
 COVID,PharmaSources.com,Positive
 COVID,vshariharakrishnan,Positive
 COVID,Jorie graham,Positive
 COVID,HospiMedica.com,Positive
 COVID,Aspen Biosciences,Positive
 COVID,Emilio Mordini,Positive
 COVID,Adi Singh,Positive
 COVID,Miguel Angel Grullon C.,Positive
 COVID,EIPG,Negative
 COVID,LAKSHMIN NANDAGOPAL,Positive
 COVID,GMPnews.Net,Negative
 COVID,Andrew Schorr,Positive
 COVID,G. Scott Weston,Positive
 COVID,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 COVID,Lillian Albert,Positive
 COVID,Jon Angelo,Negative
 COVID,Saleh Stevens,Negative
 COVID,40:40 Recruitment,Positive
 COVID,CLL Society Inc.,Positive
 COVID,Paperbirds_Hematology,Positive
 COVID,Michele Nadeem-Baker,Positive
 COVID,David Henry,Positive
 COVID,MDEdge,Negative
 COVID,MDedge Hematology & Oncology,Negative
 COVID,CCO Infectious Disease,Positive
 COVID,OncLive.com,Negative
 COVID,COVID-19 Literature Surveillance Team,Positive
 COVID,Patient Empowerment Network,Negative
 COVID,Blood Journal,Positive
 COVID,Toby Eyre,Positive
 COVID,Oncology,Negative
 COVID,healthbook,Positive
 COVID,Jeff Neurman,Negative
 COVID,Oncology Publishers Feed,Negative
 COVID,Market Research,Positive
 COVID,"Matthew Davids, MD, MMSc",Positive
 COVID,ingentium_COVID,Positive
 COVID,CLL Advocates Network,Negative
 COVID,"Cowan, Liebowitz",Negative
 COVID,Meli Rockhold,Positive
 COVID,Victoria Gescheidle,Positive
 COVID,CLL Ireland,Negative
 COVID,Michael Hallek,Negative
 COVID,Anthony Mato,Positive
 COVID,CLLSA,Negative
 Phase,FancyFinancy,Negative
 Phase,BiotechBioPharma,Positive
 Phase,Financial Carnivores,Negative
 Phase,Swedish Biotech,Positive
 Phase,Vikesh Gudka,Positive
 Phase,CarnivoresHealth,Positive
 Phase,Pharmaceutical,Positive
 Phase,BioCalifornia,Positive
 Phase,Biotech & Tech Stock Focus,Positive
 Phase,Kevin Paul Oge,Positive
 Phase,CureHuntr,Negative
 Phase,TrialBulletin,Negative
 Phase,Jeff Sharman,Positive
 Phase,Value-Based Cancer Care,Negative
 Phase,Oncology Tube,Positive
 Phase,"Amber Koehler, PA-C",Positive
 Phase,Pharmacutical Daily,Positive
 Phase,Saeed Valadbaygi,Negative
 Phase,Crwe World,Positive
 Phase,Renal Cell Carcinoma,Positive
 Phase,BioNews,Negative
 Phase,"Mike Thompson, MD, PhD, FASCO",Negative
 Phase,OncLive.com,Negative
 Phase,"Raul Cordoba, MD, PhD",Negative
 Phase,Hematology Board,Negative
 Phase,Victor Lin,Positive
 Phase,Paperbirds_Hematology,Positive
 Phase,Stock Market Catalyst News üåé,Positive
 Phase,Dan Brickner,Positive
 Phase,STOCKMASTER2000,Positive
 Phase,"OTC Dynamics, Inc.",Positive
 Phase,Stock News Bot,Positive
 Phase,Stock Titan,Positive
 Phase,Pharma News,Negative
 Phase,IMPharma News,Positive
 Phase,Investor News,Positive
 Phase,Lymphoma Hub,Positive
 Phase,Bio Stocks‚Ñ¢,Positive
 Phase,Lisa Palacios,Negative
 Phase,PressNewsAgency,Positive
 Phase,Corporate News,Negative
 Phase,Latest News from Business Wire,Negative
 Phase,VJHemOnc,Negative
 Phase,1stOncology,Positive
 Phase,AlphaBronze,Positive
 Phase,Mazeraski,Negative
 Phase,Jodie Insights,Negative
 Phase,Biotech2050,Positive
 Phase,Stock Market News,Negative
 Phase,Lymphoma Papers,Positive
 Phase,Benlazar S.M Amin√©,Positive
 Phase,Mellalta Meets,Negative
 Phase,The Political Hedge,Positive
 Phase,mednetnews,Negative
 Phase,ArthurPotatoeHammer,Negative
 Phase,Jordan üíä,Positive
 Phase,INDoximity üáÆüá≥,Negative
 Phase,Philip McCarthy,Negative
 Phase,MD Anderson Leukemia,Negative
 Phase,@ScottWaudbyHaemResLeics,Positive
 Phase,TrialSite News,Positive
 Phase,ClinicalTrialsData,Positive
 Phase,YGLDMETG,Positive
 Phase,LYMPHOMA & MYELOMA CONNECT,Negative
 Phase,Blood Journal,Negative
 Phase,UoW BioMed Research,Positive
 Phase,BeiGene,Negative
 Phase,Cancer Stem Cell News,Negative
 Phase,BioPharm Insight,Positive
 Phase,PressReleasePoint,Negative
 Phase,Verastem Oncology,Negative
 Phase,Clinical Connection,Positive
 Phase,AbbVie,Negative
 Phase,Plexus Ventures,Negative
 Phase,Financial Buzz,Positive
 Phase,Seattle's Banker,Positive
 Phase,Laurent G - Francis,Negative
 Phase,Marketbit.pro,Negative
 Phase,HEDGE accordinglyüìà,Negative
 Phase,CRE Demographics,Positive
 Phase,RazzleTazzle,Positive
 Phase,Integra Medical,Positive
 Phase,gilbert c faure,Negative
 Phase,OBR,Negative
 Phase,AmericanPharmacyNews,Positive
 Phase,JanssenUS,Negative
 Phase,Mike Gauthier,Negative
 Phase,HSMN,Negative
 Phase,BIOCIENCIA,Positive
 Phase,"chadi nabhan MD, MBA, FACP",Negative
 Phase,Tom Silver,Negative
 Phase,christopher franskin,Positive
 Phase,Autotestdrivers.com,Positive
 Phase,TalkingScarsMedia.com,Positive
 Phase,ShareHRnews,Positive
 Phase,VPO/PR Newswire,Negative
 Phase,Biedex Markets,Positive
 Phase,Cancer Medicine,Positive
 Phase,newswise,Negative
 Phase,S.K.,Positive
 Phase,Prof. Dr. Omprakash Nautiyal,Positive
 Phase,Stephen B. Harris,Positive
 Phase,Patrick Arieno,Positive
 Phase,Centro Medico Qx,Negative
 Phase,MD.,Negative
 Phase,SpecialtyPTimes,Negative
 Phase,Rare Disease Report,Positive
 Phase,CancerWallonia,Positive
 Phase,Briefing.com,Negative
 Phase,Lymphoma News Today,Positive
 Phase,nsure io,Positive
 Phase,Business Wire-Health,Negative
 Phase,CLL Ireland,Negative
 Phase,MAISA,Negative
 Phase,BiotechInvest,Positive
 Phase,"F Haroun, MD",Positive
 Phase,‚öæÔ∏èüèÄ‚öΩÔ∏èüé∏ü•Åüéßüé´ü§øüèäüèº‚Äç‚ôÇÔ∏èüèù,Positive
 Phase,NACDA Program on Aging,Negative
 Phase,Krishan Maggon,Negative
 Phase,Dr. Melody Davis,Negative
 Phase,ForexTV,Positive
 Phase,Odi Bruckman,Negative
 Phase,Senior Care Corner,Negative
 Phase,Invest World News,Negative
 Phase,Diaceutics PLC,Negative
 Phase,IntoxicatedTrader,Positive
 Phase,Pam de Butler,Positive
 Phase,BusinessWireProducts,Negative
 Phase,Gilead Sciences,Negative
 Phase,dlvr news,Negative
 Phase,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 Phase,Blood Buff,Positive
 Phase,"Bruce Rogers, Ph.D.",Positive
 Phase,Jason Ford,Positive
 Phase,pharmatutor,Positive
 Phase,Mike McFarlane,Positive
 Phase,Nicolas COLLET,Positive
 Phase,Lymphomation.org,Negative
 Phase,Cord Blood News,Negative
 Phase,Hematopoiesis News,Negative
 Phase,HHF,Negative
 Phase,CancerTherapyAdvisor,Negative
 Phase,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 Phase,Scott Werntz,Positive
 Phase,PRN Biotech,Negative
 Phase,Penny Stocks,Negative
 Phase,Penny Stock Irish,Negative
 Phase,"Pharmacyclics, an AbbVie Company",Negative
 Phase,Cure Cancer Now,Negative
 Phase,Chan Cheah,Negative
 Phase,Just Cancer News,Negative
 Leucemia linfocitica acalabrutinib approvato,Zazoom Social News,Positive
 UE,Zazoom Social News,Positive
 EU,"Amber Koehler, PA-C",Negative
 EU,Ritrattodellasalute,Positive
 EU,1stOncology,Positive
 EU,Chris Manfuso,Negative
 EU,David Ledger,Negative
 EU,Sporoƒçila za javnost O-STA,Positive
 EU,gRttwit,Positive
 EU,BiopharmaAsia,Negative
 EU,PHARMABOX.IN,Negative
 EU,Pharma Trader,Negative
 EU,Iceberg Vision,Negative
 EU,Everything Pharma,Negative
 EU,PharmaCrowd,Negative
 EU,WebWire,Negative
 EU,IndustryPRwire,Positive
 EU,LARVOL,Negative
 EU,Company News HQ,Positive
 EU,Inara Bright,Positive
 EU,WheelieDealer,Negative
 EU,GraniteShares Europe,Positive
 EU,EIN Presswire: EU Politics Newswire,Positive
 EU,Golden Casino News,Negative
 EU,DirectorsTalk,Positive
 EU,Cision News,Negative
 EU,GMPnews.Net,Negative
 EU,EIPG,Negative
 EU,RAC Medical Consulting,Positive
 EU,Pharma Regulatory,Negative
 EU,rapsorg,Positive
 EU,European Pharmaceutical Review,Negative
 EU,40:40 Recruitment,Positive
 EU,BioNews,Negative
 EU,PharmaJobs.co.uk,Positive
 EU,Pf Magazine,Positive
 EU,#WeAreE4H,Positive
 EU,Lucie Ellis,Positive
 EU,Biotechnology News,Positive
 EU,Private Puff,Positive
 EU,MyHealthShare,Positive
 EU,Rachel Webster,Positive
 EU,Encore BioMed,Positive
 EU,NACDA Program on Aging,Negative
 EU,92 News HD Plus,Positive
 EU,Pharma Commons,Negative
 EU,C. Michael Gibson MD,Positive
 EU,Filtered News,Positive
 EU,Loveworld Plus News,Positive
 EU,Asia Pacific News,Positive
 EU,FutureStarr Promotion,Positive
 EU,Troy Gibson,Positive
 EU,filmoreanton,Positive
 EU,flora,Positive
 EU,Newsco Inc.,Positive
 EU,ValdemarVittorio,Positive
 EU,HuseinJonathon,Positive
 EU,JosiahXever,Positive
 EU,JohnyTadio,Positive
 EU,deweycharley6,Positive
 EU,TheodosiaKrispin,Positive
 EU,PepitaGiorgi,Positive
 EU,JyotiKip,Positive
 EU,SmithDurham,Positive
 EU,KassiaTimmie,Positive
 EU,Reuters Health,Positive
 EU,Business of Turkey,Positive
 EU,info,Positive
 EU,Helen Hudson,Positive
 EU,Delivered Faster,Positive
 EU,Donald Middleton,Positive
 EU,Florence Morgan,Positive
 EU,Martin Williams,Positive
 EU,Rosa Almeida,Positive
 EU,John Hurley,Positive
 EU,Dr Alex Concorde,Positive
 EU,Deborah Ford,Positive
 EU,Healthy Feeder,Positive
 EU,Glen Mazzarella,Positive
 EU,Joan Lowery,Positive
 EU,Mca Represenative,Positive
 EU,ntengh.com,Positive
 EU,karin55marin,Negative
 EU,Roche,Negative
 EU,MSHPM,Positive
 EU,Au Lac,Positive
 EU,Medical Web Times,Negative
 EU,Prem Raj Shakya,Negative
 EU,NewsHitterTeam,Positive
 EU,Kevin J Donaldson,Positive
 EU,Paul Devereaux,Positive
 EU,Healthy And Yeah,Positive
 EU,Bulgarian Tweets,Positive
 EU,NJ,Positive
 EU,Event Design Planner,Positive
 EU,Snakebite Publications,Positive
 EU,Vernell Lintner,Positive
 EU,Shawn Franz,Positive
 EU,Andy Elmosta,Positive
 EU,Diana Brown,Positive
 EU,Jonathan I Lawrence,Positive
 EU,IMPACTMeds,Positive
 EU,Xeling,Positive
 EU,Emma Rose,Positive
 EU,Emma Kilkenny,Positive
 EU,Money News,Positive
 EU,Tracia.my.tupperware.com,Positive
 EU,World Medical News,Positive
 EU,Healthiest Mag,Positive
 EU,Check Health News,Positive
 EU,Healthier News,Positive
 EU,A World Lifestyle,Positive
 EU,Be Healthy Be Us,Positive
 EU,Recreate Your Style,Positive
 EU,Newest Lifestyle,Positive
 EU,Very Healthy Mag,Positive
 EU,Your Health Value,Positive
 EU,Value Your Health,Positive
 EU,Know Your Safety,Positive
 EU,H & L Hour,Positive
 EU,Mind & Body Journal,Positive
 EU,Caring Magazines,Positive
 EU,WebMD Health News,Positive
 EU,Check Your Lifestyle,Positive
 EU,Lifestyles Hacks,Positive
 EU,The Healthy Life,Positive
 EU,Your Health Guide,Positive
 EU,Go For Health,Positive
 EU,Great Living News,Positive
 EU,Initiate Wellness,Positive
 EU,Rules Solutions,Positive
 EU,Eleonor_Morgan,Positive
 EU,URL Shortener,Negative
 EU,Stepcho Nigeria,Positive
 EU,Hanung Nugroho,Positive
 EU,Guiding Step USA,Positive
 EU,First4Training,Positive
 EU,Kobys Health Reviews,Positive
 EU,Ahmad Rufai Musa,Positive
 EU,19health,Positive
 EU,ClearCutDeals,Positive
 EU,Arogboritse Ebami,Positive
 EU,ParrisWebDeals,Positive
 EU,Exermiushealth.gener,Positive
 EU,OffTheWallBargains,Positive
 EU,SYDWebDeals,Positive
 EU,AvalonSavings,Positive
 EU,smartwebsale,Positive
 EU,Science Lover,Positive
 EU,DDHWebDeals,Positive
 EU,AlanSuperDeal,Positive
 EU,ABDUUL AIG,Positive
 EU,nowyouprosper,Positive
 EU,CarmellOnClaudine,Positive
 EU,HermansDiscountMall,Positive
 EU,shelbylaneMD,Positive
 EU,ssunflowerjewel,Positive
 EU,AYODEJI OLUWATOSIN,Positive
 EU,NaturalMedicines,Positive
 EU,Healthfunder,Positive
 EU,LOGUNLEKO,Positive
 EU,CryptoRambo,Positive
 EU,Top News,Positive
 EU,shikha,Positive
 EU,OSHO,Positive
 EU,Biotech2050,Negative
 Incorporating acalabrutinib,Lymphoma Papers,Negative
 approvals,OncLive.com,Negative
 CLL treatment paradigm,OncLive.com,Negative
 power,OncLive.com,Negative
 power,WEGO Health,Negative
 power,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 power,Michele Nadeem-Baker,Positive
 power,Haitham Abdelhakim,Positive
 power,CancerTherapyAdvisor,Negative
 power,CLL Warwick Uni,Negative
 combination,OncLive.com,Positive
 combination,TAP Clinical Trial Network,Positive
 combination,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 combination,Saeed Valadbaygi,Negative
 combination,Clarivate Cortellis,Negative
 combination,Cancer News,Positive
 combination,Medivizor,Positive
 combination,noel cole,Negative
 combination,Paul Wright,Negative
 combination,Lynne Mac Lean,Negative
 combination,Targeted Oncology,Positive
 combination,Benlazar S.M Amin√©,Positive
 combination,CURE Magazine,Positive
 combination,European Pharmaceutical Review,Negative
 combination,H.C. Wainwright & Co.,Positive
 combination,BioPharma Global,Positive
 combination,BondJamesBond,Positive
 combination,OncLive SOSS,Negative
 combination,donnashort,Negative
 combination,Barry Shrier,Negative
 combination,Paperbirds_Hematology,Negative
 combination,Lymphoma Hub,Positive
 combination,Great Debates in Hematologic Malignancies,Negative
 combination,PSK2329 - JHC,Negative
 combination,Quant Data,Negative
 combination,Patient Power,Negative
 combination,GeneOnline,Positive
 combination,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 combination,Society for Immunotherapy of Cancer,Negative
 combination,Lymphoma Research Foundation,Positive
 combination,AACR,Positive
 combination,Rare Disease Report,Negative
 combination,FDA Oncology,Negative
 combination,Anna Deveau,Negative
 combination,Oncology Learning Network,Positive
 combination,ClinOwl Haematology,Negative
 combination,Cancer Papers,Positive
 combination,PER,Negative
 combination,CellworksLife,Positive
 combination,Vall d‚ÄôHebron Institute of Oncology (VHIO),Positive
 combination,"chadi nabhan MD, MBA, FACP",Negative
 combination,Toby Eyre,Positive
 combination,The Lancet Haematology,Negative
 combination,Lung Cancer News,Negative
 combination,"Michael Wang, MD",Negative
 combination,VJHemOnc,Positive
 combination,Lymphoma Papers,Negative
 combination,MedLibrary.org,Negative
 combination,CenterForBiosimilars,Positive
 combination,"Steven Artandi, MD, PhD",Negative
 combination,Cancer Stem Cell News,Negative
 combination,i3 Health,Negative
 combination,emilylevitch_i3Health,Positive
 combination,Stanford Medicine,Negative
 combination,ASH Clinical News,Negative
 combination,NCICancerTrials,Positive
 combination,National Cancer Institute,Negative
 combination,Jacinto Convit World Organization,Positive
 combination,Genentech,Positive
 combination,MAISA,Positive
 combination,A Nasser Nourallah. MD.FASCO,Positive
 combination,HemOnc Today,Positive
 combination,Lisa Astor,Negative
 combination,Oncology Nursing News,Negative
 combination,Roots Analysis,Negative
 combination,CLL Society Inc.,Negative
 combination,The Oncologist,Positive
 combination,Pharmacy Practice News,Negative
 combination,AJMC-Oncology,Negative
 combination,The Leukemia & Lymphoma Society - Policy Advocacy,Positive
 combination,Jaime Rosenberg,Positive
 combination,cafepharma,Negative
 combination,pocroncology,Positive
 combination,Andrew Merron,Positive
 combination,"Raul Cordoba, MD, PhD",Positive
 combination,US Oncology Network,Positive
 combination,Biotech2050,Negative
 combination,CLL Ireland,Positive
 combination,Joana Koury,Positive
 combination,CLL_Fightersüéó,Negative
 combination,Solomon Kamal,Positive
 combination,Bionest Partners,Negative
 combination,Blood Advances,Positive
 combination,Talbot Research Library & Media Services,Positive
 combination,medwireNews,Negative
 combination,Charles River Labs,Positive
 combination,Lymphoma Canada,Negative
 combination,Healio,Negative
 combination,CBPartners,Positive
 combination,Novartis,Positive
 combination,NCCP,Positive
 combination,Master Li,Positive
 combination,Khurram Nawaz,Positive
 combination,Pharmafocus,Negative
 combination,Dr. Melody Davis,Negative
 combination,Innate Pharma,Positive
 Pembrolizumab,PracticeUpdate,Negative
 Pembrolizumab,Urology,Positive
 Pembrolizumab,Oncology,Positive
 Pembrolizumab,"Tian Zhang, MD, MHS",Positive
 Pembrolizumab,Amer. Urol. Assn.,Positive
 Pembrolizumab,ClinicalTrialsData,Negative
 Pembrolizumab,Medivizor,Negative
 Pembrolizumab,AU Oncology Reviews,Positive
 Pembrolizumab,NACDA Program on Aging,Negative
 Pembrolizumab,CLL Ireland,Negative
 Pembrolizumab,Blood Journal,Negative
 Pembrolizumab,TrialBulletin,Negative
 Pembrolizumab,TumorImmunoPapers,Negative
 Pembrolizumab,Philip McCarthy,Negative
 Pembrolizumab,Sameer Parikh,Negative
 Pembrolizumab,Muzaffar Qazilbash,Negative
 PlatinumResistant Metastatic   CarcinomaÔ∏è,PracticeUpdate,Negative
 Europ√§ische Kommission hat,Gelbe Liste,Negative
 mit dem,Gelbe Liste,Negative
 Wirkstoff,Gelbe Liste,Negative
 Zulassung f√ºr,Gelbe Liste,Negative
 Zulassung f√ºr,@INSIGHTHealth,Positive
 Behandlung von chronisch,Gelbe Liste,Negative
 Êñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÄßÂëºÂê∏Âô®ÁóáÁä∂„ÇíÊúâ„Åô„ÇãÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÇíÂØæË±°„Å®„Åô„Çã„ÄÅ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence ¬Æ ÔºâCALAVIÁ¨¨‚Ö°Áõ∏Ë©¶È®ì„ÅÆÊúÄ „Äî „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ „Äï,JPubb Êó•Êú¨‰ºÅÊ•≠ „É™„É™„Éº„Çπ ÂåªËñ¨ÂìÅ,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Ê†™Âºè‰ºöÁ§æ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÄßÂëºÂê∏Âô®ÁóáÁä∂„ÇíÊúâ„Åô„ÇãÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÇíÂØæË±°„Å®„Åô„Çã„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâCALAVIÁ¨¨‚Ö°Áõ∏Ë©¶È®ì„ÅÆÊúÄÊñ∞ÊÉÖÂ†±,NEWSRELEA.SE,Positive
   Êñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÄßÂëºÂê∏Âô®ÁóáÁä∂„ÇíÊúâ„Åô„ÇãÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÇíÂØæË±°„Å®„Åô„Çã„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâCALAVIÁ¨¨‚Ö°Áõ∏Ë©¶È®ì„ÅÆÊúÄÊñ∞ÊÉÖÂ†±,„Ç≥„É≠„Éä vs. AI ÊúÄÊñ∞„ÉÜ„ÇØ„Éé„É≠„Ç∏„Éº„ÅßÊÑüÊüìÁóá„Å´Êåë„ÇÄ„ÄêÊõ∏Á±ç„Äë,Positive
 ÂâµËñ¨AI,„Ç≥„É≠„Éä vs. AI ÊúÄÊñ∞„ÉÜ„ÇØ„Éé„É≠„Ç∏„Éº„ÅßÊÑüÊüìÁóá„Å´Êåë„ÇÄ„ÄêÊõ∏Á±ç„Äë,Positive
 Êñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÄßÂëºÂê∏Âô®ÁóáÁä∂„ÇíÊúâ„Åô„ÇãÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÇíÂØæË±°„Å®„Åô„Çã„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâCALAVIÁ¨¨IIÁõ∏Ë©¶È®ì„ÅÆÊúÄÊñ∞ÊÉÖÂ†±,WMR Tokyo - „Çπ„Çø„Éº„Éà„Ç¢„ÉÉ„Éó,Positive
 story Treatment,Colin Cesvette,Positive
 CLLSLL,Colin Cesvette,Positive
 CLLSLL,"dtw Research, Inc",Negative
 CLLSLL,OyeCricket.com,Positive
 CLLSLL,Jon Gardner,Positive
 CLLSLL,The ASCO Post,Negative
 CLLSLL,"Stayin' Alive: Body, Mind, Spirit",Positive
 CLLSLL,FlatBio,Negative
 CLLSLL,Jeff Szer,Negative
 CLLSLL,S O P A,Positive
 CLLSLL,Joe Birkett-Crest,Positive
 CLLSLL,"Matthew Davids, MD, MMSc",Positive
 CLLSLL,Oncology Times,Negative
 CLLSLL,Michele Nadeem-Baker,Negative
 CLLSLL,Lisa Palacios,Negative
 CLLSLL,MyPathologyReport.ca,Negative
 CLLSLL,TrialBulletin,Positive
 CLLSLL,Targeted Oncology,Negative
 CLLSLL,Verastem Oncology,Positive
 CLLSLL,CLL Society Inc.,Negative
 CLLSLL,CLL Ireland,Negative
 CLLSLL,JanssenUS,Negative
 CLLSLL,Lymphoma Canada,Negative
 CLLSLL,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 CLLSLL,"Chris Cogbill, MD",Positive
 CLLSLL,Allison,Positive
 MCL   CALQUENCE,Colin Cesvette,Positive
 recommendation,CADTH,Negative
 recommendation,CLL Society Inc.,Negative
 recommendation,OncLive.com,Negative
 Presentations,Quant Data,Negative
 Presentations,Targeted Oncology,Negative
 Calquence Efficacy,Quant Data,Negative
 Longterm Followup,Quant Data,Negative
 Longterm Followup,GEDEFO,Negative
 Pooled Safety Data,Quant Data,Negative
 Chronic Lymphocytic LeukaemiaRelated Tickers,Quant Data,Negative
 „Ç¢„Çπ„ÉÜ„É©„Çº„Éç„Ç´,„ÅÑ„Å§„ÇÇÊÇ©„Çì„Åß„Çã‰∫∫,Positive
 CALAVI Phase II trials,„ÅÑ„Å§„ÇÇÊÇ©„Çì„Åß„Çã‰∫∫,Positive
 CALAVI Phase II trials,WebWire,Negative
 CALAVI Phase II trials,Briefing.com,Positive
 CALAVI Phase II trials,mednetnews,Negative
 CALAVI Phase II trials,Company News HQ,Negative
 CALAVI Phase II trials,Daniel J Drucker,Positive
 CALAVI Phase II trials,PressReleasePoint,Negative
 CALAVI Phase II trials,Cision News,Negative
 CURE amp AstraZeneca,CURE Magazine,Negative
 CALQUENCE Connections,CURE Magazine,Negative
 November,CURE Magazine,Positive
 November,OncLive.com,Negative
 November,PharmaState,Positive
 November,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 November,Living Safely,Negative
 November,Lymphoma Research Foundation,Negative
 November,"Michael Wang, MD",Negative
 November,CLL Ireland,Negative
 November,AJNR,Positive
 November,Solomon Kamal,Positive
 November,Patient Power,Negative
 November,Lifelong Learning,Positive
 November,Christopher Steer,Negative
 PM,CURE Magazine,Negative
 PM,Nikita Mehra,Positive
 PM,Jesus-Others-Myself,Positive
 PM,Patient Power,Negative
 PM,Paradigm Med Comm,Negative
 PM,Lisa Palacios,Positive
 PM,MD Anderson Leukemia,Positive
 PM,CancerWallonia,Negative
 PM,Penn Medicine MD,Positive
 ET,CURE Magazine,Negative
 ET,Patient Empowerment Network,Negative
 ET,Michele Nadeem-Baker,Negative
 ET,Patient Power,Negative
 ET,OMedLive,Positive
 Mark,OncLive.com,Negative
 Mark,Midmark News,Positive
 Mark,Patient Power,Negative
 Mark,Matthew Kauffman,Negative
 Hospitalized,OncLive.com,Negative
 Related Respiratory Symptoms,OncLive.com,Negative
 BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÇíÈÅ©Âøú„Å´EU„ÅßÊâøË™çÂèñÂæó,Medical Tribune„ÄäÂÖ¨Âºè„Äã,Positive
 CLL Treatment Research Final ASCEND study data Acalabrutinib,Michele Nadeem-Baker,Negative
 standard,Michele Nadeem-Baker,Negative
 standard,WCM Lymphoma,Negative
 standard,OncLive.com,Negative
 standard,ASH Clinical News,Negative
 standard,Biotech2050,Negative
 standard,Targeted Oncology,Negative
 standard,HemOnc Today,Negative
 standard,CURE Magazine,Negative
 standard,Blood Cancer UK Research,Negative
 standard,CLL Ireland,Negative
 standard,"Raul Cordoba, MD, PhD",Negative
 standard,Janice Oliver,Positive
 standard,Genentech,Negative
 standard,VJHemOnc,Negative
 standard,Medscape Pharmacists,Negative
 standard,Medscape Oncology,Negative
 standard,Medscape,Negative
 care,Michele Nadeem-Baker,Negative
 care,Patient Power,Positive
 care,AstraZeneca,Positive
 care,Patient Empowerment Network,Negative
 care,JanssenUS,Negative
 care,OncLive.com,Negative
 care,ASH Clinical News,Negative
 care,AbbVie US,Positive
 care,@URHemOncFellows,Positive
 care,Nick,Negative
 care,Biotech2050,Negative
 care,Duke Hematologic Malignancies & Cellular Therapy,Negative
 care,Targeted Oncology,Negative
 care,MD Anderson Cancer Center,Negative
 care,AJMC,Negative
 care,Michael Hallek,Negative
 care,HemOnc Today,Positive
 care,AbbVie,Positive
 care,Verastem Oncology,Negative
 care,Lymphoma Hub,Negative
 care,donnashort,Negative
 care,COPD News,Negative
 care,MedPage Oncology,Negative
 care,CURE Magazine,Negative
 care,ACCC,Positive
 care,Blood Cancer UK Research,Negative
 care,CLL Ireland,Positive
 care,Dana-Farber News,Positive
 care,"Fumiko Ladd Chino, MD",Positive
 care,CLLSA,Negative
 care,"Raul Cordoba, MD, PhD",Negative
 care,WCM Lymphoma,Negative
 care,PRIME Education,Negative
 care,Carevƒ´ve,Negative
 care,Janice Oliver,Positive
 care,Genentech,Negative
 care,VJHemOnc,Negative
 care,Oncology Tube,Negative
 care,"chadi nabhan MD, MBA, FACP",Negative
 care,Medscape Pharmacists,Negative
 care,Medscape Oncology,Negative
 care,Medscape,Negative
 care,Alicia Maston Coffin,Positive
 rr CLL,Michele Nadeem-Baker,Negative
 rr CLL,Joe Hedden,Negative
 rr CLL,Andy Biotech,Positive
 Calquence   acalabrutinib,CISMeF Quoi de neuf,Positive
 Updated CALAVI Phase II trials Results,BiopharmaAsia,Negative
 symptoms,BiopharmaAsia,Negative
 symptoms,Al Arabiya English,Positive
 symptoms,Jeff Karp (Pronouns: he/him/his),Positive
 symptoms,Dana-FarberYAProgram,Positive
 symptoms,Patient Power,Negative
 symptoms,Janssen EMEA,Negative
 symptoms,Balkan Medical Journal,Negative
 symptoms,MyPathologyReport.ca,Positive
 symptoms,Leukaemia Care,Positive
 symptoms,Virtute_USMLE,Negative
 symptoms,Patient Empowerment Network,Positive
 symptoms,CURE Magazine,Negative
 symptoms,CLLSA,Negative
 symptoms,AstraZeneca,Positive
 symptoms,OurHealth,Positive
 symptoms,"Pharmacyclics, an AbbVie Company",Positive
 symptoms,GenoptixInc,Positive
 symptoms,Andrew Schorr,Positive
 symptoms,US Oncology Network,Positive
 symptoms,McKesson Corporation,Negative
 symptoms,HemOnc Today,Negative
 symptoms,Healio,Negative
 symptoms,Holden Caulfield PhD,Positive
 symptoms,CML AdvocatesNetwork,Negative
 symptoms,CLL Info,Negative
 Oncology News Update Acalabrutinib,Oncology News Australia,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence ¬Æ Ôºâ„ÄÅEU„Å´„Åä„ÅÑ„Å¶ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶ÊâøË™çÂèñÂæó „Äî „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ „Äï,JPubb Êó•Êú¨‰ºÅÊ•≠ „É™„É™„Éº„Çπ ÂåªËñ¨ÂìÅ,Positive
 Âπ¥ÊúàÊó•„Äê„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ÔΩúÊó•„Äë„Äé„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence,a watcher,Positive
 Ôºâ „ÄÅ EU„Å´„Åä„ÅÑ„Å¶ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶ÊâøË™çÂèñÂæó„Äè„ÅåÂÖ¨Èñã„Åï„Çå„Å¶„ÅÑ„Åæ„ÅôËã±Êú¨Á§æÁô∫Ë°®ÊäÑË®≥Êú™Ê≤ªÁôÇ„ÄÅ„Åæ„Åü„ÅØÂÜçÁô∫ÔºèÈõ£Ê≤ªÊÄßÊÇ£ËÄÖ„Åï„Çì„ÅÆ„ÅÑ„Åö„Çå„Å´„Åä„ÅÑ„Å¶„ÇÇÂ§ßÂπÖ„Å™ÁÑ°Â¢óÊÇ™ÁîüÂ≠òÊúüÈñì„ÅÆÂª∂Èï∑„Å®ËâØÂ•Ω„Å™ÂøçÂÆπÊÄß,a watcher,Positive
 BioSpace,Vikesh Gudka,Positive
 BioSpace,Biotech & Tech Stock Focus,Positive
 BioSpace,Kevin Paul Oge,Positive
 BioSpace,Hamid Mazloomi,Positive
 BioSpace,"Nathan Letts, PhD",Positive
 BioSpace,Bitchin' Science,Negative
 BioSpace,Jessi M,Positive
 COVID study,ECAM Norway,Positive
 COVID study,Pharmaceutical Market Europe,Positive
 COVID study,FiercePharma,Negative
 COVID study,R Mandy Alcuria,Positive
 COVID study,Continental Clinical,Positive
 COVID study,Dr Timos Papagatsias,Negative
 COVID study,NewExpressNews,Negative
 COVID study,PHARMABOX.IN,Negative
 COVID study,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 list,ECAM Norway,Positive
 list,Helen Ong,Positive
 list,FiercePharma,Negative
 list,R Mandy Alcuria,Positive
 list,Continental Clinical,Positive
 list,Dr Timos Papagatsias,Negative
 list,NewExpressNews,Negative
 list,PHARMABOX.IN,Negative
 list,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 list,Lymphoma Hub,Positive
 list,Cancer Health,Negative
 list,CLL Society Inc.,Negative
 list,brian brown,Negative
 list,Erika,Positive
 list,Patient Empowerment Network,Negative
 list,Biotech2050,Negative
 NOVITA NEL TRATTAMENTO DELLA LEUCEMIA LINFATICA CRONICA,Carlo Franzini,Negative
 Approvato,Carlo Franzini,Negative
 di   gratuita,Carlo Franzini,Negative
 alle,Carlo Franzini,Negative
 Newsletter Xagena,Carlo Franzini,Negative
 di Medicina,Carlo Franzini,Negative
 Join CURE amp,CURE Magazine,Negative
 PM ET,CURE Magazine,Negative
 PM ET,Clinical Care Solutions,Positive
 PM ET,Research To Practice,Positive
 PM ET,Janssen Global,Negative
 PM ET,Asembia,Positive
 PM ET,Cancer News,Negative
 PM ET,CRO Contract Res.,Negative
 CALQUENCE Connections Dr Jeff Sharman,CURE Magazine,Negative
 Jim,CURE Magazine,Negative
 patient,CURE Magazine,Negative
 patient,TeamHaem,Positive
 patient,Dr Musa Fares Alzahrani,Positive
 patient,Paperbirds_Hematology,Positive
 patient,filippo masini,Negative
 patient,ü¶ìü¶ì H√∂micidal Barcode ü¶ìü¶ì,Positive
 patient,WEGO Health,Negative
 patient,Nicolas Martinez üá®üá¥üá®üá¥,Positive
 patient,Journal of the @NCCN,Positive
 patient,ChristosArgyropoulos,Negative
 patient,CLL Advocates Network,Negative
 patient,Joe,Positive
 patient,Lymphoma Papers,Positive
 patient,Michael Rynne,Negative
 patient,Patient Empowerment Network,Negative
 patient,clonoSEQ,Negative
 patient,"Naveen Pemmaraju, MD",Negative
 patient,Journal of Medical and Surgical Pathology,Positive
 patient,CLL Ireland,Negative
 patient,"Jocelyn Solis-Moreira, MS",Positive
 patient,The Lancet Haematology,Negative
 patient,Shouting at people in my underpants,Negative
 patient,Lymphoma Hub,Negative
 patient,Mazen M,Negative
 patient,Pooja,Positive
 patient,New Scientist Zone,Positive
 patient,Kenny Price,Positive
 patient,Sciinov Insights,Positive
 patient,Patient Power,Positive
 patient,"Vitaly Terushkin, MD, FACMS",Positive
 patient,Targeted Oncology,Positive
 patient,Beta-BlockerPapers,Positive
 patient,Barbaros √áetin,Positive
 patient,CLL_Fightersüéó,Negative
 patient,Joana Koury,Positive
 patient,Andrew Schorr,Negative
 patient,Angela Reeves Tate,Positive
 patient,NK papers,Negative
 patient,Penn Microbiology,Positive
 patient,Candida Papers,Positive
 patient,Blood Journal,Negative
 patient,Pathowitter,Positive
 patient,NPCE,Positive
 patient,Odi Bruckman,Negative
 patient,Cancer Papers,Positive
 patient,JAAD Journals,Negative
 patient,Charlotte Roffiaen,Positive
 patient,EurekaMag,Negative
 patient,Pearls4Peers,Positive
 patient,ImmunePCPapers,Negative
 patient,Med-IQ,Positive
 patient,TumorImmunoPapers,Negative
 patient,CatseqBiotech,Positive
 patient,HCMS,Positive
 patient,AtlanticJOMedicine,Negative
 patient,The James,Negative
 patient,pseudomonaspapers,Negative
 patient,"Andreas-Claudius Hoffmann, M.D.",Positive
 patient,AntibioticResistance,Positive
 patient,Milly Evans,Negative
 patient,dentapress.com,Positive
 CALAVI Phase II Trials Calquence acalabrutinib,PILOTforPULMONARY,Positive
 Mortality,PILOTforPULMONARY,Positive
 Mortality,Oncology,Negative
 Respiratory Failure,PILOTforPULMONARY,Positive
 de la EMA,EL GLOBAL,Positive
 Comisi√≥n Europea ha aprobado tambi√©n este,EL GLOBAL,Positive
 un inhibidor,EL GLOBAL,Positive
 selectivo de la tirosina kinasa de Bruton,EL GLOBAL,Positive
 AstraZeneca press release,Kari Tikkinen,Positive
   research,Kari Tikkinen,Positive
   research,CLL Ireland,Negative
   research,COPD News,Negative
 BioPharma Dive,Pharma Top News,Positive
 BioPharma Dive,Sharky Sarah,Positive
 BioPharma Dive,Diving News,Positive
 Costco,FintechZoom,Positive
 Costco,"Cowan, Liebowitz",Negative
 AstraZenecas AZN Calquence,FintechZoom,Positive
 AstraZenecas AZN Calquence,Takehiko Yoshino,Positive
 AstraZenecas AZN Calquence,Nikita,Positive
 Coronavirus Study,FintechZoom,Positive
 Coronavirus Study,Takehiko Yoshino,Positive
 Coronavirus Study,Nikita,Positive
 Fintech Zoom,FintechZoom,Positive
 solo,Ester Hern√°ndez,Positive
 hay avances,Ester Hern√°ndez,Positive
 con la vacuna de la COVIDAprobado el,Ester Hern√°ndez,Positive
 tratamiento contra,Ester Hern√°ndez,Positive
 la Leucemia linfoc√≠tica cr√≥nica,Ester Hern√°ndez,Positive
   demostr√≥ una,ecancer en espa√±ol,Positive
 frontline treatments,Journal of the @NCCN,Negative
 frontline treatments,Medivizor,Positive
 frontline treatments,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 frontline treatments,COPD News,Negative
 frontline treatments,Taylor Lab UM,Negative
 focus,Journal of the @NCCN,Negative
 focus,CLLSA,Negative
 focus,Patient Power,Negative
 focus,VJHemOnc,Negative
 AstraZenaca,European Pharmaceutical Review,Negative
 proportion,European Pharmaceutical Review,Negative
 hospitalised   patients,European Pharmaceutical Review,Negative
 La UE aprueba Calquence AstraZeneca,Salvador S,Positive
 La UE aprueba Calquence AstraZeneca,Fuerza/Fuerza,Positive
 leucemia linfoc√≠tica cr√≥nica,Salvador S,Positive
 leucemia linfoc√≠tica cr√≥nica,Fuerza/Fuerza,Positive
 leucemia linfoc√≠tica cr√≥nica,Luis Pereira Lopez,Positive
 leucemia linfoc√≠tica cr√≥nica,Renovatio Biom√©dica,Positive
 leucemia linfoc√≠tica cr√≥nica,Acta Sanitaria,Positive
 leucemia linfoc√≠tica cr√≥nica,Pharma Jonpi .,Negative
 leucemia linfoc√≠tica cr√≥nica,LifeStyle Profesional (by El Neuropediatra),Positive
 leucemia linfoc√≠tica cr√≥nica,contacto sciencelink,Negative
 leucemia linfoc√≠tica cr√≥nica,Dicaf,Positive
 leucemia linfoc√≠tica cr√≥nica,@investigando,Positive
 Covid   le Calquence un traitement efficace contre les chocs,Sortiraparis,Positive
 Covid   le Calquence un traitement efficace contre les chocs,Laurent Pradal,Positive
   cancer drug,Pharma Prime Time,Positive
 tcouvuaaHxl,Pharma Prime Time,Positive
 COVID respiratory symptomsAcalabrutinib est√° aprobado para el,Miguel Angel Grullon C.,Positive
 tratamiento de adultos con leucemia linfoc√≠tica cr√≥nica,Miguel Angel Grullon C.,Positive
 adultos con linfoma de c√©lulas del manto,Miguel Angel Grullon C.,Positive
 AstraZenecanƒ±n umut olan,Sosyal Medya,Positive
 AstraZenecanƒ±n umut olan,Siber Gazete,Positive
 sisteminde olu≈üan sorunlarƒ± baskƒ±lamasƒ± ama√ßlanan kan kanseri ilacƒ± Calquencein,Sosyal Medya,Positive
 sisteminde olu≈üan sorunlarƒ± baskƒ±lamasƒ± ama√ßlanan kan kanseri ilacƒ± Calquencein,Siber Gazete,Positive
 La,@investigando,Positive
 La,WGM,Positive
 La,Pedro Perdomo M,Positive
 La,Carlos Llavador,Positive
 del inhibidor BTK acalabrutinib al tratamiento,@investigando,Positive
 en pacientes hospitalizados con s√≠ntomas respiratorios,@investigando,Positive
 de la COVID,@investigando,Positive
 de la COVID,Al√≥ Ciudadano,Positive
 Update,Lyke Lyfe,Positive
 Update,WebWire,Negative
 Update,mednetnews,Negative
 Update,Company News HQ,Negative
 Update,Cision News,Negative
 Update,LYMPHOMA & MYELOMA CONNECT,Positive
 Update,Oncology Times,Negative
 Update,Brave Is Now¬Æ,Negative
 Update,Carmine DeLuca,Negative
 Update,The ASCO Post,Negative
 Update,Teresa Martin,Positive
 Update,Oncology Tube,Positive
 Update,Onica L. Pinz√≥n C. MD,Positive
 Update,UNC Lineberger Cancer Network,Positive
 Update,EurekaMag,Negative
 Update,CLL_Fightersüéó,Negative
 Update,Targeted Oncology,Negative
 Update,Marta Crespo,Positive
 Update,Medivizor,Negative
 Update,Cancer Papers,Negative
 Update,Allied Conferences,Positive
 Update,Hematology Conference,Negative
 Update,Financial Buzz,Negative
 Update,Business Wire-Health,Negative
 Update,The Pharmaceutical Marketing Group,Negative
 Update,Andrew Schorr,Negative
 Update,Edison,Positive
 Update,EdisonHealthcare,Positive
 Update,Lymphoma Coalition,Negative
 Update,GRACE,Negative
 Update,cairns haematology a,Positive
 Update,Patient Power,Negative
 Update,CAPhO,Negative
 Update,WebPathology,Positive
 Update,NC Chapter LLS ,Positive
 CALAVI Phase II Trials,Lyke Lyfe,Positive
 Respiratory Symptoms,Lyke Lyfe,Positive
 Respiratory Symptoms,CHItraders,Negative
 Respiratory Symptoms,Quant Data,Negative
   nieuw goed door EU gekeurd medicijn Calquence Astrazenica voor bloedkankersoorten,Brainstormer üá≥üá±üá≥üá±,Positive
 een trial geweest ook onder ziekenhuis opname,Brainstormer üá≥üá±üá≥üá±,Positive
 European Union,OncLive.com,Negative
 European Union,TRiBECA¬Æ Knowledge,Negative
 European Union,CIMAGO,Positive
 nextgeneration BTK inhibitor acalabrutinib,OncLive.com,Negative
 BTK inhibitor Calquence,Pharmaceutical Market Europe,Positive
 BTK inhibitor Calquence,Miguel Angel Grullon C.,Positive
 BTK inhibitor Calquence,FirstWord Pharma,Negative
 BTK inhibitor Calquence,Investor News,Negative
 AstraZenca,PHARMABOX.IN,Negative
 AstraZenca,PharmaShots - Incisive news in 3 shots,Negative
 AstraZenca,The Daily Protein,Positive
 Primary Endpoint,PHARMABOX.IN,Negative
 Primary Endpoint,PharmaShots - Incisive news in 3 shots,Negative
 Primary Endpoint,CHItraders,Negative
 Primary Endpoint,ArthurPotatoeHammer,Negative
 Primary Endpoint,gilbert c faure,Negative
 Primary Endpoint,San Francisco Biotechnology Network,Positive
 Primary Endpoint,COPD News,Negative
 Primary Endpoint,Mr Bentley Onelly,Positive
 Primary Endpoint,Michelle Solly,Positive
 Primary Endpoint,Crwe World,Negative
 Primary Endpoint,MAISA,Negative
 PII Studies,PHARMABOX.IN,Negative
 PII Studies,PharmaShots - Incisive news in 3 shots,Negative
 todays,Endpoints News,Negative
 todays,CNBC-TV18,Negative
 todays,"Chaitra Ujjani, MD",Positive
 todays,Patient Power,Negative
 todays,Broad Institute,Positive
 todays,German Cheer Dad (GCD),Negative
 todays,Jackie Julian,Positive
 todays,Lab Tests Online,Positive
 todays,Genentech,Negative
 roundup,Endpoints News,Negative
 roundup,CURE Magazine,Positive
 roundup,nanaval,Positive
 Otro anticuerpo,Infectotuits,Positive
 Acalabrutinib –æ–∫–∞–∑–∞–ª—Å—è,ZdravMedInfo,Positive
 Acalabrutinib –æ–∫–∞–∑–∞–ª—Å—è,–ù–æ–≤–æ—Å—Ç–∏ GMP,Positive
 —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–µ–Ω,ZdravMedInfo,Positive
 –≤,ZdravMedInfo,Positive
 –≤,–õ–µ—á–µ–Ω–∏–µ —Ä–∞–∫–∞,Positive
 ƒ∞ngiltereƒ∞sve√ß ortaklƒ±ƒüƒ± olan √ºnl√º,Koronavir√ºs Haber ‚ò£Ô∏è,Positive
 bloodcancer medicine Calquence,maybeawriter,Positive
 bloodcancer medicine Calquence,Bloomberg Australia,Positive
 bloodcancer medicine Calquence,Bloomberg,Positive
 AstraZeneca Calquence,NewExpressNews,Negative
 AstraZeneca Calquence,PHARMABOX.IN,Negative
 AstraZeneca Calquence,Jon Angelo,Negative
 AstraZeneca Calquence,Contentoflifer,Positive
 AstraZeneca Calquence,DirectorsTalk,Positive
 AstraZeneca Calquence,Francis Alexander,Negative
 AstraZeneca Calquence,pharmanewsintel,Positive
 AstraZeneca Calquence,atoxquiteran,Positive
 AstraZeneca Calquence,ClinicalTrialsArena,Positive
 AstraZeneca Calquence,arthur james lobo,Positive
 AstraZeneca Calquence,Pharmaceutical Market Europe,Positive
 AstraZeneca Calquence,****,Negative
 AstraZeneca Calquence,Stanley Suen,Positive
 AstraZeneca Calquence,Client-Pharma Ltd,Positive
 AstraZeneca Calquence,Seeking Alpha,Positive
 AstraZeneca Calquence,the world of CROs,Negative
 AstraZeneca Calquence,Pharma Tech Focus,Positive
 AstraZeneca Calquence,BioSpace,Positive
 AstraZeneca Calquence,Margaret Walker,Negative
 COVID tracker Moderna,"Synergy Healthcare, LLC",Negative
 vaccine review,"Synergy Healthcare, LLC",Negative
 COVID trial,"Synergy Healthcare, LLC",Negative
 COVID trial,fausto hiraldo zabal,Positive
 COVID trial,Earle Burgess,Positive
 COVID trial,MDDigitasTV,Negative
 COVID trial,@ Robert,Positive
 COVID trial,Sergey Minaev,Positive
 COVID trial,Dorothy,Positive
 COVID trial,DJGOLDEN,Negative
 COVID trial,Ashish Ranjan Swain,Positive
 COVID trial,Julia Chidley,Positive
 COVID trial,Open Outcrier,Negative
 COVID trial,Barrington James,Positive
 COVID trial,Hargreaves Lansdown,Positive
 COVID trial,daniel,Positive
 COVID trial,Kate üòàüëªüëπ‚öîÔ∏è,Positive
 COVID trial,Jimmys Post,Positive
 COVID trial,24H Sante,Negative
 COVID trial,OCS Channel,Positive
 COVID trial,Bistosh World,Positive
 COVID trial,Adam Fraise,Positive
 COVID trial,Medicine Briefly,Negative
 COVID trial,chorley chicken,Negative
 COVID trial,David Madden,Positive
 COVID trial,ST Foreign Desk,Positive
 COVID trial,The Straits Times,Positive
 COVID trial,Devdiscourse,Negative
   La UE,Redacci√≥n M√©dica,Positive
 aprueba Calquence,Redacci√≥n M√©dica,Positive
 Kristin Jensen AZN RHHBY NVS SNY REGN,Ben Fidler,Positive
   acalabrutinib,Lu Chen #nobias,Positive
   acalabrutinib,Professione Farmacia,Negative
   acalabrutinib,Medical Evidence üáÆüáπ,Negative
 laterstage Covid patients,Nathan Vardi,Negative
 Disappointing,Nathan Vardi,Negative
 √únl√º,HABER3.com üáπüá∑,Positive
 AstraZenecanƒ±n,HABER3.com üáπüá∑,Positive
 kanseri ilacƒ± Calquenceƒ±n,HABER3.com üáπüá∑,Positive
 AwesomeCapital AstraZenecas Calquence,****,Negative
 midstage COVID,****,Negative
 midstage COVID,Ronald M. Chavin,Positive
 Kanser ilacƒ± Calquenceƒ±n,ABC Gazetesi,Positive
 Yo,Mr. Rama Vs. Comics,Positive
 ads,Mr. Rama Vs. Comics,Positive
 ads,Samir Sheth ‚òï,Positive
 shit,Mr. Rama Vs. Comics,Positive
 failures,Anand C. Patel,Positive
 BTKi,Anand C. Patel,Positive
 BTKi,Benyam Muluneh,Positive
 BTKi,CLL Society Inc.,Negative
 BTKi,Judith Trotman,Positive
 BTKi,"Mazyar Shadman, MD MPH",Negative
 BTKi,Toby Eyre,Positive
 BTKi,Paperbirds_Hematology,Negative
 BTKi,Blood Journal,Negative
 news FPRX,Allison Gatlin,Positive
 –ù–∞–¥–µ–∂–¥–∞ AstraZeneca –Ω–∞ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ø—Ä–æ—Ç–∏–≤–æ—Ä–∞–∫–æ–≤–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞,bioinvest.io,Positive
 Calquence –≤ –ª–µ—á–µ–Ω–∏–∏,bioinvest.io,Positive
 –Ω–µ,bioinvest.io,Positive
 –æ–ø—Ä–∞–≤–¥–∞–ª–∞—Å—å,bioinvest.io,Positive
 –í–æ,bioinvest.io,Positive
 —Ñ–∞–∑–µ,bioinvest.io,Positive
 –∫–ª–∏–Ω –∏—Å–ø—ã—Ç–∞–Ω–∏–π Calquence,bioinvest.io,Positive
 —É–ª—É—á—à–∏–ª –≤—ã–∂–∏–≤–∞–µ–º–æ—Å—Ç—å —Ç—è–∂–µ–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤,bioinvest.io,Positive
 survival rates,Jon Angelo,Negative
 survival rates,Al Arabiya English,Positive
 survival rates,Journal of the @NCCN,Negative
 survival rates,Oncology Learning Network,Negative
 survival rates,MORE Health,Positive
 coronavirus patients,Jon Angelo,Negative
 coronavirus patients,JT Badenov,Positive
 coronavirus patients,24H Sante,Negative
 coronavirus patients,Jennifer A. Ng,Positive
 coronavirus patients,PhRMA,Positive
 coronavirus patients,Omer Haghi,Positive
 coronavirus patients,RizonSon O'Kodee,Positive
 coronavirus patients,Reuters,Negative
 coronavirus patients,TheArticleTrunk,Positive
 coronavirus patients,chorley chicken,Negative
 coronavirus patients,Medicine Briefly,Negative
 coronavirus patients,Reuters UK,Positive
 coronavirus patients,LBC News,Positive
 coronavirus patients,Investor News,Negative
 coronavirus patients,Devdiscourse,Negative
 cancer drug,CDE News,Positive
 cancer drug,Medical Dialogues,Positive
 cancer drug,The Hans India,Positive
 cancer drug,Teena Thacker,Positive
 cancer drug,Economic Times,Positive
 cancer drug,Mango News,Positive
 cancer drug,ahealthierphilly,Positive
 cancer drug,debuglies,Positive
 cancer drug,MedShadow Foundation,Positive
 cancer drug,PharmacyWeek (Kevin),Positive
 cancer drug,JP Duvenhage,Positive
 cancer drug,StartupStudio,Positive
 cancer drug,Davies Wealth Management,Positive
 cancer drug,Michel Francoeur,Positive
 cancer drug,NNY News.ca,Positive
 cancer drug,BidBookDNA‚Ñ¢,Positive
 cancer drug,Michael O'Dwyer,Positive
 cancer drug,GxPeople,Positive
 √≠rus Medicamento,Terra,Positive
 c√¢ncer da AstraZeneca tem resultado,Terra,Positive
 decepcionante,Terra,Positive
 tratamento,Terra,Positive
 da,Terra,Positive
 Pharmaceutical giant AstraZeneca,The Medical Ed Cons.,Negative
 Pharmaceutical giant AstraZeneca,Biggomamma,Positive
 Pharmaceutical giant AstraZeneca,Daily Mail U.K.,Positive
 Pharmaceutical giant AstraZeneca,STRANGER THAN FICTION NEWS,Positive
 Pharmaceutical giant AstraZeneca,odenOracle,Positive
 Pharmaceutical giant AstraZeneca,LBC News,Positive
 Pharmaceutical giant AstraZeneca,John B Tawn,Positive
 blood cancer drug Calquence,The Medical Ed Cons.,Negative
 blood cancer drug Calquence,Global Business Alliance,Positive
 blood cancer drug Calquence,clinicalsourcing,Positive
 blood cancer drug Calquence,Anna Lubas,Positive
 blood cancer drug Calquence,vshariharakrishnan,Positive
 blood cancer drug Calquence,Biggomamma,Positive
 blood cancer drug Calquence,Aspen Biosciences,Positive
 blood cancer drug Calquence,Emilio Mordini,Positive
 blood cancer drug Calquence,EIPG,Negative
 blood cancer drug Calquence,Daily Mail U.K.,Positive
 blood cancer drug Calquence,G. Scott Weston,Positive
 blood cancer drug Calquence,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 blood cancer drug Calquence,Market Intelligence: Healthcare,Positive
 blood cancer drug Calquence,Jon Angelo,Negative
 blood cancer drug Calquence,Pharmafocus,Negative
 blood cancer drug Calquence,STRANGER THAN FICTION NEWS,Positive
 blood cancer drug Calquence,odenOracle,Positive
 blood cancer drug Calquence,John B Tawn,Positive
 coronavirus trials,The Medical Ed Cons.,Negative
 coronavirus trials,Biggomamma,Positive
 coronavirus trials,Daily Mail U.K.,Positive
 coronavirus trials,STRANGER THAN FICTION NEWS,Positive
 coronavirus trials,odenOracle,Positive
 coronavirus trials,John B Tawn,Positive
 AZNAstraZeneca NASDAQAZN,Soumyajyoti Biswas,Positive
 Phase II results,Soumyajyoti Biswas,Positive
 Phase II results,Lymphoma Hub,Positive
 CALAVI trials,Soumyajyoti Biswas,Positive
 BTK inhibitor Calquence acalabrutinib,Soumyajyoti Biswas,Positive
 BTK inhibitor Calquence acalabrutinib,Shawn Friend,Positive
 BTK inhibitor Calquence acalabrutinib,Prestige Scientific,Positive
 SFBN Feed Covid,San Francisco Biotechnology Network,Positive
 AstraZenecas attempt,San Francisco Biotechnology Network,Positive
 Calquence flops,San Francisco Biotechnology Network,Positive
 Calquence flops,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 Calquence flops,Endpoints News,Negative
 BTK   Update,Daniel J Drucker,Positive
 Covid roundup AstraZenecas attempt,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 Covid roundup AstraZenecas attempt,Endpoints News,Negative
 midstage COVID study,CHItraders,Negative
 midstage COVID study,Gordon Gekko,Negative
 midstage COVID study,Breaking News,Negative
   Update,PressReleasePoint,Negative
   Update,Journal of the @NCCN,Negative
   Update,Oncology Times,Positive
   Update,WheelieDealer,Negative
   Update,Patient Power,Negative
   Update,Noticias en tiempo real,Positive
 AstraZenecas   drug,Market Intelligence: Healthcare,Positive
 disappoints,Market Intelligence: Healthcare,Positive
 midstage COVID trials,Market Intelligence: Healthcare,Positive
 Apr√®s Novartis et,Nicolas Viudez,Positive
 son,Nicolas Viudez,Positive
 son,isthisreal,Positive
 son,Alison Evans,Negative
 son,Amy C. Cavers,Negative
 canakinumab,Nicolas Viudez,Positive
 Calavi Phase Ii Trials,CHItraders,Negative
 Calavi Phase Ii Trials,Quant Data,Negative
 Covid,CHItraders,Negative
 Covid,Quant Data,Negative
 Covid,PINSIDER NEWS,Positive
 Covid,Aaj Ka Samachar,Positive
 Covid,El Grillo de Yucat√°n,Positive
 Covid,David Garc√≠a Marco,Positive
 Covid,Forbes Brasil,Positive
 Covid,WEGO Health,Negative
 Covid,Nita Sonwane,Negative
 Primary EndpointRelated Tickers AZN,Quant Data,Negative
 blood cancer treatment Calquence,Al Arabiya English,Positive
 lung failure,Al Arabiya English,Positive
 drugmaker,Al Arabiya English,Positive
 midstage trials,Al Arabiya English,Positive
 El f√°rmaco contra la leucemia calquence desarrollado por,Econom√≠a Digital,Positive
 Astrazeneca,Econom√≠a Digital,Positive
 Astrazeneca,Commercial Awareness,Positive
 Astrazeneca,Pharmacy News & Research,Positive
 ha fracasado,Econom√≠a Digital,Positive
 los,Econom√≠a Digital,Positive
 los,Club Libertad Limpe√±o,Negative
 los,Estelar Gimnasia,Negative
 que estudiaban,Econom√≠a Digital,Positive
 pacientes con coronavirus,Econom√≠a Digital,Positive
 pacientes con coronavirus,TekCrispy,Positive
 pacientes con coronavirus,primo8k,Negative
 pacientes con coronavirus,TendenciasTech,Positive
 CALAVI,Nel Sestayo,Positive
 CALAVI,EuropaWire,Negative
 CALAVI,John Wilander,Positive
 AZN acalabrutinib,M,Positive
 AZN acalabrutinib,Adam Feuerstein,Positive
 Covid trial,M,Positive
   linfatica cronica,Ritrattodellasalute,Positive
   linfatica cronica,Medinews,Negative
   linfatica cronica,PharmaStar,Negative
 approvato,Ritrattodellasalute,Positive
 approvato,Medinews,Negative
 European Commission,LARVOL,Negative
 European Commission,CellworksLife,Negative
 European Commission,OncLive.com,Negative
 European Commission,COPD News,Negative
 European Commission,AbbVie,Positive
 s,LARVOL,Negative
 s,GraniteShares Europe,Negative
 s,Lung Cancer News,Negative
 s,Sonali Prusty,Positive
 s,Pharmaceutical News,Negative
 s,CancerWallonia,Negative
 s,Elsa Willebrand,Positive
 s,JAMA Oncology,Negative
 s,CLL Society Inc.,Negative
 s,Anna Stewart ‚òòÔ∏è‚òòÔ∏è,Positive
 s,Breaking Data,Negative
 s,Daniel Bachurski,Positive
 s,Stanford Department of Medicine,Positive
 s,Roots Analysis,Positive
 s,Hottest Stocks Now,Negative
 s,The James,Negative
 s,GESDAT GmbH,Positive
 s,LymphomaAction,Positive
 s,Patient Power,Positive
 s,Zack Pemberton-Whiteley,Negative
 s,LLS Sacramento,Positive
 s,Glenn Sabin,Positive
 s,Lymphomation.org,Negative
 s,MedWatch News,Positive
 s,Light The Night NCA,Positive
 s,Light The Night,Positive
 s,Sean McGrath,Positive
 s,Steve Warner,Positive
 s,Plexus Ventures,Negative
 s,"Andreas-Claudius Hoffmann, M.D.",Positive
 TUMORI RARI,I Malati Invisibili,Positive
 LEUCEMIA LINFATICA CRONICA,I Malati Invisibili,Positive
 LLC LA COMMISSIONE EUROPEA HA APPROVATO ACALABRUTINIB,I Malati Invisibili,Negative
 LA CE aprob√≥ el inhibidor selectivo BTK acalabrutinib para,@investigando,Positive
 Europe,Benlazar S.M Amin√©,Negative
 Europe,OncLive.com,Negative
 Europe,Lymphoma Hub,Negative
 Europe,Stocks tweets,Positive
 Europe,FirstWord Pharma,Negative
 Europe,Regulatory Jobs,Positive
 Europe,Ira Kholmyansky,Positive
 Europe,3BL Health,Positive
 Europe,Digital-Ontology,Positive
 Europe,Global Pharma News,Negative
 Europe,Mohammed Saied Faraj,Positive
 Europe,SmartRx Systems,Positive
 Europe,Beyond the Pill 2015,Positive
 Europe,Mktingfarmaceutico,Positive
 Europe,PISPOpharma,Positive
 Europe,MyMexicanStore,Positive
 Europe,World Pharma News,Negative
 Europe,David Ledger,Negative
 Europe,DTN Pharma News,Positive
 Europe,Gunel Huseynova,Positive
 Europe,Dr. Melody Davis,Negative
 Europe,1stOncology,Negative
 Europe,Breaking News,Negative
 Europe,Anirban Maitra,Negative
 Europe,Pharmaceutical News,Negative
 Europe,Drug Delivery News,Positive
 Europe,Sum,Positive
 Europe,karin55marin,Negative
 Europe,Knowsis Healthcare,Positive
 Europe,Healthcare Industry,Positive
 Europe,Mellalta Meets,Negative
 Europe,The Political Hedge,Positive
 Europe,mednetnews,Negative
 Europe,ArthurPotatoeHammer,Negative
 Europe,IMPharma News,Negative
 Europe,40:40 Recruitment,Positive
 Europe,COPD News,Negative
 Europe,WheelieDealer,Negative
 Europe,CLL_Fightersüéó,Negative
 Europe,Alaric DeArment,Positive
 Europe,CancerWallonia,Negative
 Europe,"Chared, Good Comms",Negative
 Europe,European Hematology Association,Negative
 Europe,VJHemOnc,Positive
 Europe,ASH Clinical News,Positive
 Europe,Margaret Walker,Negative
 Europe,Marco Ricci,Positive
 Europe,Charlotte Roffiaen,Positive
 tweet,Samir Sheth ‚òï,Positive
 tweet,Danielle M. Brander,Positive
 tweet,BEARDED FRENCH MAN,Positive
 tweet,Michael Hallek,Negative
 tweet,CLL_Fightersüéó,Negative
 tweet,Ancy,Positive
 tweet,Swapnil Devale,Negative
 pharma,Samir Sheth ‚òï,Positive
 event,Samir Sheth ‚òï,Positive
 event,myCME,Negative
 event,Patient Power,Positive
 event,Community Legacy League,Positive
 event,RIOH,Negative
 event,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 event,CLL Society Inc.,Negative
 event,Women's Health News,Positive
 event,CLL Warwick Uni,Negative
 event,VJHemOnc,Negative
 event,CLL Ireland,Negative
 event,Carmine DeLuca,Positive
 event,Andrew Schorr,Positive
 CLL courtesy,Samir Sheth ‚òï,Positive
 calquence acalabrutinib,Samir Sheth ‚òï,Positive
   EU,Plexus Ventures,Negative
 Approves,Plexus Ventures,Negative
 Chronic Lymphocytic,Plexus Ventures,Positive
 Chronic Lymphocytic,Inara Bright,Positive
 Chronic Lymphocytic,NewExpressNews,Negative
 Chronic Lymphocytic,The Pharmaceutical Marketing Group,Negative
 Chronic Lymphocytic,Eastern,Positive
 Chronic Lymphocytic,Giuseppe Michieli,Negative
 Chronic Lymphocytic,Journal of the @NCCN,Negative
 Chronic Lymphocytic,Psychiatry Intel,Positive
 Chronic Lymphocytic,Raymond DuBois,Positive
 Chronic Lymphocytic,CellworksLife,Positive
 Chronic Lymphocytic,ESMO - Eur. Oncology,Negative
 Chronic Lymphocytic,Oncology Times,Positive
 Chronic Lymphocytic,ICGEB Official,Positive
 Chronic Lymphocytic,SAGE Clinical Med,Positive
 Chronic Lymphocytic,AbbVie Canada,Positive
 Chronic Lymphocytic,touchONCOLOGY,Negative
 Chronic Lymphocytic,Pharmacutical Daily,Positive
 Chronic Lymphocytic,Shohta Kadomura Hospital Pharmacist,Negative
 Chronic Lymphocytic,NurseGroups,Positive
 Chronic Lymphocytic,ÏòÅÏßÄ,Positive
 Chronic Lymphocytic,Company News HQ,Negative
 Chronic Lymphocytic,Cancers MDPI,Positive
 Chronic Lymphocytic,Oncology,Positive
 Chronic Lymphocytic,Ritesh Patil,Negative
 Chronic Lymphocytic,PracticeUpdate,Positive
 Chronic Lymphocytic,OncLive.com,Negative
 Chronic Lymphocytic,"Conquer Cancer, the ASCO Foundation",Positive
 Chronic Lymphocytic,Mary Ruberry,Positive
 Chronic Lymphocytic,MD Anderson Leukemia,Negative
 Chronic Lymphocytic,Kyle J. Norton,Negative
 Chronic Lymphocytic,Targeted Oncology,Negative
 Chronic Lymphocytic,BenXM,Positive
 Chronic Lymphocytic,Value-Based Cancer Care,Negative
 Chronic Lymphocytic,JELEU,Negative
 Chronic Lymphocytic,Chronic Disease Coalition,Positive
 Chronic Lymphocytic,leo uzych,Positive
 Chronic Lymphocytic,Cellero,Positive
 Chronic Lymphocytic,Radiology Clinics,Positive
 Chronic Lymphocytic,SciTech Research,Negative
 Chronic Lymphocytic,Cancer Health,Positive
 Chronic Lymphocytic,AplusA World,Negative
 Chronic Lymphocytic,Ron Grunsby,Positive
 Chronic Lymphocytic,HEDGE accordinglyüìà,Positive
 Chronic Lymphocytic,RazzleTazzle,Positive
 Chronic Lymphocytic,Living Safely,Positive
 Chronic Lymphocytic,World Neonatology Congress,Positive
 Chronic Lymphocytic,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Chronic Lymphocytic,realtimes,Positive
 Chronic Lymphocytic,SpecialtyPTimes,Positive
 Chronic Lymphocytic,MedSource,Negative
 Chronic Lymphocytic,MC Services AG,Positive
 Chronic Lymphocytic,Rare Diseases,Negative
 Chronic Lymphocytic,Pf Magazine,Negative
 Chronic Lymphocytic,tradingbrezz,Positive
 Chronic Lymphocytic,Financial Buzz,Negative
 Chronic Lymphocytic,StockGuru,Positive
 Chronic Lymphocytic,SPI News,Negative
 Chronic Lymphocytic,leukemia,Negative
 Chronic Lymphocytic,Medical HotSpot,Positive
 Chronic Lymphocytic,Sumit Middha,Positive
 Chronic Lymphocytic,CCS,Positive
 Chronic Lymphocytic,Jack Shields,Positive
 Chronic Lymphocytic,ShieldsRx,Positive
 Chronic Lymphocytic,dorothy cook,Negative
 Chronic Lymphocytic,iOncoAnalytics,Positive
 Chronic Lymphocytic,MAISA,Negative
 Chronic Lymphocytic,Cancer Papers,Positive
 Chronic Lymphocytic,News Medical,Positive
 Chronic Lymphocytic,ARC Journals,Positive
 Chronic Lymphocytic,"Raul Cordoba, MD, PhD",Positive
 Chronic Lymphocytic,Hematopoiesis News,Positive
 Chronic Lymphocytic,Connexion Healthcare,Positive
 Chronic Lymphocytic,Matthews & Associates,Positive
 Chronic Lymphocytic,CancerCare,Negative
 Chronic Lymphocytic,EMJ Oncology,Negative
 Chronic Lymphocytic,Fanny Paris,Positive
 Chronic Lymphocytic,Medicine Matters oncology,Positive
 Chronic Lymphocytic,NACDA Program on Aging,Positive
 Chronic Lymphocytic,MD Anderson Library,Positive
 Chronic Lymphocytic,Christopher Steer,Negative
 Chronic Lymphocytic,CADTH,Negative
 Chronic Lymphocytic,EBioMedicine ‚Äì Published by The Lancet,Positive
 Chronic Lymphocytic,Margaret Walker,Negative
 Chronic Lymphocytic,Educancer,Positive
 Chronic Lymphocytic,1stOncology,Positive
 Chronic Lymphocytic,Denver Greene,Negative
 Chronic Lymphocytic,Advances in Therapy,Positive
 Chronic Lymphocytic,Alyssa Howard,Negative
 Chronic Lymphocytic,Timothy Kelly,Positive
 Chronic Lymphocytic,Torrance Memorial,Positive
 Chronic Lymphocytic,Nicole Brudos Ferrara,Positive
 Chronic Lymphocytic,Cancer Genetics Inc.,Positive
 Chronic Lymphocytic,John Stock Pro,Positive
 Chronic Lymphocytic,Immune Regulation News,Negative
 Chronic Lymphocytic,Virtute_USMLE,Positive
 Chronic Lymphocytic,Grupo PK.gen SEFH,Positive
 Chronic Lymphocytic,militaryeyed,Positive
 Chronic Lymphocytic,vincenzo abruscato,Positive
 Chronic Lymphocytic,Cell Therapy News,Negative
 Chronic Lymphocytic,Matthias Piesche,Negative
 Chronic Lymphocytic,Cord Blood News,Positive
 Chronic Lymphocytic,Oncology Now,Negative
 Chronic Lymphocytic,GW BMES,Positive
 Chronic Lymphocytic,Wellmighty,Positive
 Chronic Lymphocytic,AJPB_Journal,Negative
 Chronic Lymphocytic,Pharmacy Times,Negative
 Chronic Lymphocytic,IntoxicatedTrader,Negative
 Chronic Lymphocytic,TheraGlobal,Positive
 Chronic Lymphocytic,UroToday.com,Positive
 Chronic Lymphocytic,Michael Baker,Positive
 Chronic Lymphocytic,Atlas of Science,Positive
 Chronic Lymphocytic,Moffitt Research,Positive
 Chronic Lymphocytic,"dtw Research, Inc",Negative
 Chronic Lymphocytic,Oncology Rounds,Positive
 Chronic Lymphocytic,DailyRounds | Marrow,Positive
 Chronic Lymphocytic,Baby MLSüë∂üëº,Positive
 Chronic Lymphocytic,Krishan Maggon,Negative
 Chronic Lymphocytic,Biotech2050,Negative
 Chronic Lymphocytic,Oncolytics Biotech,Positive
 Chronic Lymphocytic,Trip Guidelines,Positive
 Chronic Lymphocytic,Light The Night SD,Negative
 Chronic Lymphocytic,Paul Lane,Positive
 Chronic Lymphocytic,CancerDartmouth,Positive
 Chronic Lymphocytic,ASCO,Negative
 Chronic Lymphocytic,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Chronic Lymphocytic,MediTech Media,Positive
 Chronic Lymphocytic,J Mol Diagnostics,Positive
 Chronic Lymphocytic,myCME,Negative
 Chronic Lymphocytic,ProPath,Positive
 Chronic Lymphocytic,CancerTherapyAdvisor,Negative
 Chronic Lymphocytic,Curatio Technologies,Negative
 Chronic Lymphocytic,Dr. Mahesh Jain,Positive
 Leucemia linfatica cronica Acalabrutinib ottiene l‚Äôapprovazione,Bls-D.Com,Positive
 El medicamento acalabrutinib,Jos√© Viurquis,Positive
 pacientes,Jos√© Viurquis,Positive
 pacientes,SalvadorSchwartzmann,Positive
 pacientes,contacto sciencelink,Negative
 situaci√≥n grave de COVID Publicado,Jos√© Viurquis,Positive
 la secci√≥n,Jos√© Viurquis,Positive
 Venetoclax,Blood Cancer Uncensored,Negative
 Venetoclax,Lung Cancer News,Positive
 Venetoclax,Cancer News,Positive
 Venetoclax,Judith Trotman,Positive
 Venetoclax,ClinicalTrialsData,Negative
 Venetoclax,"Dr T. Comeau , MD",Positive
 Venetoclax,MDBriefCase,Positive
 Venetoclax,Lisa Palacios,Positive
 Venetoclax,Tom Silver,Negative
 Venetoclax,@globalfirstnews,Positive
 Venetoclax,HemOnc Today,Negative
 Venetoclax,CureHuntr,Positive
 Venetoclax,TrialBulletin,Positive
 Venetoclax,Eduardo Flavio Oliveira Ribeiro,Positive
 Venetoclax,Hematology Advisor,Negative
 Venetoclax,ClinOwl Haematology,Negative
 Venetoclax,Miriam L√≥pez P√©rez,Positive
 Venetoclax,Juan Marquet,Positive
 Venetoclax,ALI ALAHMARI.,Positive
 Venetoclax,ClinOwl,Positive
 Venetoclax,JAVIER DE LA SERNA,Positive
 Venetoclax,filippo masini,Negative
 Venetoclax,CellworksLife,Positive
 Venetoclax,Paperbirds_Hematology,Positive
 Venetoclax,INDoximity üáÆüá≥,Positive
 Venetoclax,Oncology,Negative
 Venetoclax,Cytof Manchester,Positive
 Venetoclax,The ASCO Post,Positive
 Venetoclax,"Andrew Johns, MD",Positive
 Venetoclax,Philip McCarthy,Positive
 Venetoclax,Benlazar S.M Amin√©,Positive
 Venetoclax,MD Anderson Leukemia,Positive
 Venetoclax,Lymphoma Papers,Positive
 Venetoclax,"Naveen Pemmaraju, MD",Positive
 Venetoclax,CLL Advocates Network,Negative
 Venetoclax,CLL Ireland,Positive
 Venetoclax,"chadi nabhan MD, MBA, FACP",Positive
 Venetoclax,Blood Journal,Positive
 Venetoclax,Medivizor,Positive
 Venetoclax,CLL Society Inc.,Positive
 Venetoclax,noel cole,Negative
 Venetoclax,Anthony Mato,Negative
 Venetoclax,Oncology Times,Negative
 Venetoclax,Michelle Solly,Positive
 Venetoclax,James Kerwin,Positive
 Venetoclax,APSHO,Negative
 Venetoclax,Dana-Farber News,Positive
 Venetoclax,Cancer Frontline,Positive
 Venetoclax,Robert Z. Orlowski,Negative
 Venetoclax,"Mike Thompson, MD, PhD, FASCO",Positive
 Venetoclax,"khmerxbxboi ""Sot Ali"" (STOCKBUM-God) üá∫üá∏ üá∞üá≠",Positive
 Venetoclax,Dr. Jos√© A. Queiz√°n,Positive
 Venetoclax,"Sagar Patel, MD",Positive
 Venetoclax,"Raul Cordoba, MD, PhD",Positive
 Venetoclax,"Georgios Pongas, MD",Positive
 Venetoclax,The Oncologist,Negative
 Venetoclax,Mahmoud Aljurf,Positive
 Venetoclax,Izaskun Zeberio,Negative
 Venetoclax,Claire Harrison,Positive
 Venetoclax,Prof John,Negative
 Venetoclax,Diagnostics News,Negative
 Venetoclax,MEDWAVE,Negative
 Venetoclax,Oncology Learning Network,Negative
 Venetoclax,Cancer Library VCC,Positive
 Venetoclax,GEDEFO,Positive
 Venetoclax,"Bachar Samra, MD",Positive
 Venetoclax,Lymphoma Hub,Positive
 Venetoclax,Scott Merville,Negative
 Venetoclax,The Purple Society,Positive
 Venetoclax,Targeted Oncology,Positive
 Venetoclax,DocWire News,Positive
 Venetoclax,Taylor Lab UM,Positive
 Venetoclax,NEJM Resident 360,Positive
 Venetoclax,NEJM,Positive
 Venetoclax,Hematolog√≠a Salamanca,Negative
 Venetoclax,Mazen M,Negative
 Venetoclax,Triona N√≠ Chonghaile,Positive
 Venetoclax,Margaret Walker,Positive
 Venetoclax,NCI CTEP Clinical Research,Positive
 Venetoclax,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 Venetoclax,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Venetoclax,Blood Cancer UK Research,Negative
 Venetoclax,gilbert c faure,Negative
 Venetoclax,TawasulLinks ÿ™ŸàÿßÿµŸÑ,Negative
 Venetoclax,EurekaMag,Positive
 Venetoclax,AONN+,Negative
 Venetoclax,NFCR,Positive
 Venetoclax,MedSource,Positive
 Venetoclax,Cure Cancer Now,Positive
 Venetoclax,Alec Stone,Positive
 Venetoclax,AU Oncology Reviews,Negative
 Venetoclax,Mike Gauthier,Negative
 Venetoclax,HSMN,Negative
 Venetoclax,Seattle's Banker,Negative
 Venetoclax,RazzleTazzle,Negative
 Venetoclax,Lymphomation.org,Positive
 Venetoclax,"Meagan Bryan, RN",Positive
 Venetoclax,OncologyNurseAdvisor,Positive
 Venetoclax,FarmaOnco,Positive
 Venetoclax,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Venetoclax,Cancer Papers,Positive
 Venetoclax,Daniel Ernst,Positive
 Venetoclax,tradingbrezz,Positive
 Venetoclax,BioNJ,Positive
 Venetoclax,Financial Buzz,Positive
 Venetoclax,SNN Network,Negative
 Venetoclax,StockGuru,Positive
 Venetoclax,SPI News,Negative
 Venetoclax,Muzaffar Qazilbash,Positive
 Venetoclax,"Carlos Plaza, MD",Positive
 Venetoclax,LabRoots,Positive
 Venetoclax,A. Vroom - Ten Wolde,Negative
 Venetoclax,"Marc Succi, MD",Positive
 Venetoclax,Prithi Inamdar,Positive
 Venetoclax,adel aljatham,Positive
 Venetoclax,Rishi Dhawan MD. DM,Positive
 Venetoclax,RAUL FERRANDO,Positive
 Venetoclax,"Wafik S. El-Deiry, MD, PhD, FACP",Positive
 Venetoclax,NE Live,Negative
 Venetoclax,Isaura R. Penin,Negative
 Venetoclax,Marcelo Dom√≠nguez,Positive
 Venetoclax,Junaid Hussain,Positive
 Venetoclax,Dr. Andres G Palomo,Positive
 Venetoclax,Lymphoma Canada,Positive
 Venetoclax,SurvivalGear,Negative
 Venetoclax,palliativewise,Negative
 Venetoclax,sandrineman,Positive
 Venetoclax,MD Anderson Library,Negative
 Venetoclax,TumorImmunoPapers,Positive
 Venetoclax,Chan Cheah,Negative
 Venetoclax,Christopher Steer,Positive
 Venetoclax,CancerTherapyAdvisor,Positive
 Venetoclax,Neil Sankar,Positive
 Venetoclax,"Neil Sankar M.D.,MPH",Positive
 Venetoclax,CLLSA,Negative
 Venetoclax,Medical HotSpot,Positive
 Venetoclax,Massimo Martino,Positive
 Venetoclax,osakahiro,Positive
 Venetoclax,NACDA Program on Aging,Positive
 Venetoclax,DTR Medical ¬Æ,Positive
 Venetoclax,Garbi√±e Lizeaga,Negative
 Venetoclax,Jerry Lee,Negative
 Venetoclax,Mehmet Tuna,Positive
 Venetoclax,HematoMontpellier,Positive
 Venetoclax,NPCE,Positive
 Venetoclax,Monash University School of Clinical Sciences,Positive
 Venetoclax,Andrew Schorr,Negative
 Venetoclax,Amanda Jayne Griffin,Positive
 Venetoclax,Rare Disease Report,Positive
 Venetoclax,Dr. Melody Davis,Positive
 Venetoclax,Dana-Farber,Negative
 Venetoclax,Krishan Maggon,Negative
 Venetoclax,copperpeony,Positive
 Venetoclax,Mary Regan,Positive
 Venetoclax,European Pharmaceutical Review,Negative
 Venetoclax,Barbara Jacoby,Positive
 Venetoclax,Carole S Giampalmi,Positive
 Venetoclax,Dr. JOSE VELASQUEZ,Positive
 Venetoclax,LR Perrett,Positive
 Venetoclax,Hemomadrid,Negative
 Venetoclax,JNCI,Negative
 Venetoclax,nbmtLINK,Positive
 Venetoclax,HINC,Positive
 Venetoclax,OncLive.com,Negative
 Venetoclax,OncoTherapy Network,Positive
 Venetoclax,Oncology Nursing News,Negative
 Venetoclax,Carla Casulo,Positive
 Venetoclax,Mayur Kherdikar,Positive
 Venetoclax,Elaine Schattner,Negative
 Venetoclax,Tom,Positive
 Venetoclax,doctorportal,Positive
 Venetoclax,Jean Plante,Negative
 Venetoclax,Saudi Leukemia Net,Negative
 Venetoclax,Sonia Glez Costas,Positive
 Venetoclax,Jos√© Clemente D√≠az M,Negative
 Venetoclax,Ferg,Positive
 Venetoclax,Bitlattice Woman,Positive
 Venetoclax,Atlantic Research Group,Positive
 Venetoclax,EUFUCKBACK2,Positive
 Venetoclax,Francesco Turturro,Negative
 Venetoclax,"Jason Westin, MD FACP",Positive
 Venetoclax,Anthony Howards,Positive
 Venetoclax,Dr Darren Saunders,Positive
 Venetoclax,La chuleta del FIR,Negative
 Venetoclax,Armand!!,Negative
 Venetoclax,Shankara Paneesha,Positive
 Venetoclax,Cord Blood News,Positive
 Venetoclax,Tolero Pharma,Positive
 Venetoclax,PAULO VEGA,Positive
 Venetoclax,BioSpace,Positive
 Venetoclax,Medical News Today,Positive
 Venetoclax,Alejandro Hernandez,Positive
 Venetoclax,Salutedomani,Positive
 Venetoclax,ukhealthhub,Positive
 Venetoclax,MG Retail Consulting,Positive
 Venetoclax,4Locum,Positive
 Venetoclax,Ahmed Dahduli,Positive
 Venetoclax,Impactiviti,Positive
 Venetoclax,fainfo salute,Positive
 Venetoclax,Derma News OK,Positive
 Venetoclax,saluteH24.com,Positive
 Venetoclax,Antonio Caperna,Positive
 Venetoclax,Tapan Kadia,Negative
 Venetoclax,Tim Fenske,Negative
 Venetoclax,"Jeremy Warner MD, MS, FAMIA, FASCO",Positive
 Venetoclax,Kwai Chi,Positive
 Venetoclax,Meso Cancer Circle,Positive
 Venetoclax,BlackSwan Analysis now part of Evaluate Pharma Ltd,Positive
 Venetoclax,rattenniMD,Negative
 Venetoclax,Indi Gene,Positive
 Venetoclax,Alicia Kim,Positive
 Venetoclax,Feeds4U,Positive
 Venetoclax,Biotech 5,Positive
 Venetoclax,Dr Timos Papagatsias,Negative
 Venetoclax,Rajat Agarwal,Positive
 Venetoclax,Tabish Waseem,Positive
 Venetoclax,Heyner Pacheco,Positive
 Venetoclax,Rob BM,Positive
 Venetoclax,Lorrie Gibson,Positive
 Venetoclax,Kerri Harris,Positive
 Venetoclax,mandy best,Positive
 Venetoclax,Diann Dyer,Positive
 Venetoclax,Luz Frazier,Positive
 Venetoclax,Cecilia Cline,Positive
 Venetoclax,Justin Vonnegut,Positive
 Venetoclax,IT News For You,Positive
 Venetoclax,Dr. Craig Brown,Positive
 Venetoclax,Web.,Positive
 Venetoclax,Danvantri Farma,Negative
 Venetoclax,Health News Update,Positive
 Venetoclax,Mark Higbee üá∫üá∏,Positive
 Venetoclax,Business Webhosting,Positive
 Venetoclax,Cancer Review,Positive
 Venetoclax,Cancer Update,Positive
 Venetoclax,Reseller Hosting,Positive
 Venetoclax,Mehul (Mike) Patel,Positive
 Venetoclax,Fahad Anwar Khan,Positive
 Venetoclax,üçÜ üçÜ üçÜ,Positive
 Venetoclax,OyoBoi,Positive
 Venetoclax,Glyn Lewis,Positive
 Venetoclax,Facebook Fan Pages,Positive
 Venetoclax,Abdull Kajo,Positive
 Venetoclax,Jim Selemon,Positive
 Venetoclax,Vigan Tech,Positive
 Venetoclax,Sachin,Positive
 Venetoclax,Shem,Positive
 Venetoclax,Mike L.,Positive
 Venetoclax,Publishing@SFU,Positive
 Venetoclax,FIXMYPC,Positive
 Venetoclax,Jean,Positive
 Venetoclax,Patriotic Geek,Positive
 Venetoclax,James Avril,Positive
 Venetoclax,AdvancingRetail,Positive
 Venetoclax,Tracia.my.tupperware.com,Positive
 Venetoclax,VPS Hosting,Positive
 Venetoclax,Talented Tech PRO,Positive
 Venetoclax,Stephanie Longpre,Positive
 Venetoclax,Tech News Round,Positive
 Venetoclax,Eddie,Positive
 Venetoclax,Cloud Hosting,Positive
 Venetoclax,Lucas Wyrsch,Positive
 Venetoclax,newsaiya,Positive
 Venetoclax,Uzzi Ohana,Positive
 Venetoclax,ricardo,Positive
 Venetoclax,Nilesh Kumar,Positive
 Venetoclax,Joelle Hertogue,Positive
 Venetoclax,11 Health,Positive
 Venetoclax,Dr. Paul Zemella,Positive
 Venetoclax,MEDICAL HEADHUNTERS,Positive
 Venetoclax,Shyam Alaparthy,Positive
 Venetoclax,nicole edouard,Positive
 Venetoclax,‚Ñôùïíùïîùï†ùïäùïöùï•ùïñ,Positive
 Venetoclax,abdul abdi,Positive
 Venetoclax,Aakash Vidhyarthi,Positive
 Venetoclax,Joshua Seth Liew,Positive
 Venetoclax,Simeon Ayanlade,Positive
 Venetoclax,Gary,Positive
 Venetoclax,GUANXI SPAIN,Positive
 Venetoclax,Deepak Taneja,Positive
 Venetoclax,Jefferson Faudan,Positive
 Venetoclax,Marcos Gallo,Positive
 Venetoclax,Ragam Info News,Positive
 Venetoclax,Health News,Negative
 Venetoclax,üá¶üá∫ techvedi‚Ñ¢ üá∫üá∏,Positive
 Venetoclax,Steven,Positive
 Venetoclax,Club Signage,Positive
 Venetoclax,Shakshi Shah,Positive
 Venetoclax,Regina Phalange,Positive
 Venetoclax,Neo,Positive
 Venetoclax,Oddgeir Lium,Positive
 Venetoclax,Aris,Positive
 Venetoclax,Ricardo F.,Positive
 Venetoclax,Muhammad Fahmi,Positive
 Venetoclax,UBI MEDIA 2.0,Positive
 Venetoclax,Anthony Roux,Positive
 Venetoclax,Ja More,Positive
 Venetoclax,business,Positive
 Venetoclax,Smart Investor,Positive
 Venetoclax,ICT Africa,Positive
 Venetoclax,Jason Hartsoe,Positive
 Venetoclax,wordperson,Positive
 Venetoclax,Business Unwrapped,Positive
 Venetoclax,Jigs Heather,Positive
 Venetoclax,WRAPmail ($WRAP),Positive
 Venetoclax,Billy Russel,Positive
 Venetoclax,Martin Roselle,Positive
 Venetoclax,Anthony Fraser Teale,Positive
 Venetoclax,Sarjana Galau,Positive
 Venetoclax,Apple Fanboy,Positive
 Venetoclax,UberCTO,Positive
 Venetoclax,Dr. Samuel N. Dodobi MD,Positive
 Venetoclax,ritu malik,Positive
 Venetoclax,Jessica,Positive
 Venetoclax,CHINTAN RAJGURU,Positive
 Venetoclax,Bilaal,Positive
 Venetoclax,LatestNews Nigeria,Positive
 Venetoclax,Ale Guzman,Positive
 Venetoclax,World Info,Positive
 Venetoclax,Nestor Ni√±o Maestre,Positive
 Venetoclax,BoundlessTalentsLLC,Positive
 Venetoclax,Encik Parody,Positive
 Venetoclax,Eugen Platon,Positive
 Venetoclax,Carole Sanek,Positive
 Venetoclax,hubinbiz,Positive
 Venetoclax,Imad Bousaid,Positive
 Venetoclax,MR EN üá≥üá¶,Positive
 Venetoclax,Arsoft,Positive
 Venetoclax,‚ôõFabby‚ôõ#TEAMMZBNIKKI,Positive
 Venetoclax,DeeKosh noticeMe Pls,Positive
 Venetoclax,Q Malik Fulton,Positive
 Venetoclax,Akolade Daniels,Positive
 Venetoclax,Repeat Repeat,Positive
 Venetoclax,Tom Heston,Negative
 Venetoclax,Â∞èÊöÆ„ÅÆ„Ç´„Ç∫„ÇÑ„Çì,Positive
 Venetoclax,Oncology Rounds,Positive
 Venetoclax,DailyRounds | Marrow,Positive
 Venetoclax,Hojoon Choi,Positive
 Venetoclax,Pharm Digest,Negative
 Venetoclax,KevinFitts,Negative
 Venetoclax,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 Venetoclax,Gioacchino Catania,Positive
 Venetoclax,The Medical Ed Cons.,Negative
 Venetoclax,Miguel Perales M.D.,Negative
 Venetoclax,IntoxicatedTrader,Positive
 Venetoclax,wallstreet:online.de,Positive
 Venetoclax,Frank,Positive
 Venetoclax,Roche,Negative
 Venetoclax,Aktienmanufaktur,Negative
 Venetoclax,VPO/PR Newswire,Negative
 Venetoclax,stocksandmoney.com,Positive
 Venetoclax,Hematopoiesis News,Negative
 Venetoclax,HHF,Negative
 Venetoclax,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 Venetoclax,Michael Pietrack,Positive
 Venetoclax,CPhI Online,Positive
 Venetoclax,Scott Werntz,Positive
 Venetoclax,PRN Biotech,Negative
 Venetoclax,Penny Stocks,Negative
 Venetoclax,Penny Stock Irish,Negative
 Venetoclax,BioRunUp,Negative
 Venetoclax,Pharmacy Times,Negative
 Venetoclax,JediPD,Negative
 Venetoclax,Pedro Lendinez,Positive
 obinutuzumab,Blood Cancer Uncensored,Negative
 obinutuzumab,Medscape Pharmacists,Negative
 obinutuzumab,"Freddy Pizart, R.N.",Positive
 obinutuzumab,Medscape,Negative
 obinutuzumab,Medscape Oncology,Negative
 obinutuzumab,eDNA,Positive
 obinutuzumab,"Steven Artandi, MD, PhD",Negative
 obinutuzumab,FarmaciaHUAP,Negative
 obinutuzumab,Lymphoma Hub,Positive
 obinutuzumab,Hallwang Clinic,Positive
 obinutuzumab,"Michael Wang, MD",Negative
 obinutuzumab,MHC,Negative
 obinutuzumab,Tom Heston,Negative
 obinutuzumab,renalRCTs,Positive
 obinutuzumab,ClinOwl,Positive
 obinutuzumab,Krishan Maggon,Negative
 obinutuzumab,Juan Marquet,Negative
 obinutuzumab,Young Hematologists,Positive
 obinutuzumab,OncLive.com,Positive
 obinutuzumab,ASH Clinical News,Positive
 obinutuzumab,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 obinutuzumab,Hematology Advisor,Negative
 obinutuzumab,NatureRevClinOncol,Negative
 obinutuzumab,Philly Bio,Positive
 obinutuzumab,Targeted Oncology,Positive
 obinutuzumab,"Amber Koehler, PA-C",Positive
 obinutuzumab,Dr. Luis Villela,Positive
 obinutuzumab,"Mark Geyer, M.D.",Positive
 obinutuzumab,LYMPHOMA & MYELOMA CONNECT,Positive
 obinutuzumab,Vijaya L,Positive
 obinutuzumab,Clarivate Cortellis,Negative
 obinutuzumab,Medivizor,Positive
 obinutuzumab,Lymphoma Papers,Negative
 obinutuzumab,Paperbirds_Hematology,Negative
 obinutuzumab,Benlazar S.M Amin√©,Negative
 obinutuzumab,Barry Shrier,Negative
 obinutuzumab,VJHemOnc,Negative
 obinutuzumab,Anna Deveau,Negative
 obinutuzumab,Cancer Stem Cell News,Negative
 obinutuzumab,NCICancerTrials,Positive
 obinutuzumab,Jacinto Convit World Organization,Positive
 obinutuzumab,NEJM,Negative
 obinutuzumab,NEJM Resident 360,Positive
 obinutuzumab,Oncology Nursing News,Negative
 obinutuzumab,Jaime Rosenberg,Positive
 obinutuzumab,Rare Disease Report,Negative
 obinutuzumab,"Dr T. Comeau , MD",Negative
 obinutuzumab,DDNews Online,Positive
 obinutuzumab,Garbi√±e Lizeaga,Negative
 obinutuzumab,The Lancet Oncology,Positive
 obinutuzumab,BibliotecaHUVH. ICS,Positive
 obinutuzumab,Cancer_Tribune,Negative
 obinutuzumab,US Oncology Network,Negative
 obinutuzumab,Advances in Therapy,Negative
 obinutuzumab,Cancer Papers,Negative
 obinutuzumab,KA,Negative
 NICE acalabrutinib,Blood Cancer Uncensored,Negative
 end,Blood Cancer Uncensored,Negative
 end,Meedo,Positive
 end,Bargad,Positive
 end,Kaj Jakobsson,Positive
 end,Dr. Ankur Parikh,Positive
 end,"Andrew Johns, MD",Positive
 end,OncLive.com,Negative
 end,medwireNews,Negative
 end,ID Medical,Positive
 end,i3 Health,Negative
 end,Susan Oehlers,Positive
 end,@linfopedia,Positive
 end,Anna Deveau,Negative
 end,John Riches,Positive
 end,CLLSA,Negative
 end,Hematopoiesis,Positive
 end,Heyside FC,Positive
 FCR chemotherapy,Blood Cancer Uncensored,Negative
 Leucemia linfatica cronica approvata,Repubblica Salute,Positive
 libera dalla Commissione europea,Repubblica Salute,Positive
 acalabrutinib un farmaco,Repubblica Salute,Positive
 di nuova,Repubblica Salute,Positive
 il,Repubblica Salute,Positive
 il,EmatoInfo,Positive
 trattamento,Repubblica Salute,Positive
 dans,Theriaque_officiel,Positive
 dans,J√©r√©mie Zerbit,Positive
 la leuc√©mie lympho√Øde chronique tcoRhdGyiKwRQ,Theriaque_officiel,Positive
 Terapia leucemia linfatica cronica acalabrutinib approvato,Salutedomani,Negative
 Terapia leucemia linfatica cronica acalabrutinib approvato,saluteH24.com,Positive
 Terapia leucemia linfatica cronica acalabrutinib approvato,Antonio Caperna,Positive
 Terapia leucemia linfatica cronica acalabrutinib approvato,Derma News OK,Positive
 significativo,Medinews,Negative
 e tollerabilit√† lungo termine nel trattamento,Medinews,Negative
 generation BTKi acalabrutinib,Lymphoma Hub,Negative
 CLL Acalabrutinib,Lymphoma Hub,Negative
 CLL Acalabrutinib,Marcio,Positive
 EU Approval,PHARMABOX.IN,Negative
 EU Approval,PharmaShots - Incisive news in 3 shots,Negative
 EU Approval,BiopharmaAsia,Negative
 EU Approval,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 whopping   L month,Prashant Mehta,Positive
 PAP SupportWith,Prashant Mehta,Positive
 Ibrutinib generic,Prashant Mehta,Positive
 Learnings,Himani Chandna,Positive
 European Union EU,HealthcarePRwire,Positive
 EU approval,Briefing.com,Negative
 EU approval,40:40 Recruitment,Positive
 EU approval,PRICENTRIC,Positive
 AstraZenecas Calquence OKd,Stocks tweets,Positive
 AstraZenecas BTK inhibitor Calquence,FirstWord Pharma,Positive
 AstraZenecas BTK inhibitor Calquence,Jon Angelo,Negative
 AstraZenecas BTK inhibitor Calquence,Pharmafocus,Negative
 CLL   AZN,FirstWord Pharma,Negative
 CLL   AZN,Bionest Partners,Negative
 AstraZeneca EU Approves Calquence,NonSell.com,Positive
 Market News Source Nasdaq News,NonSell.com,Positive
 Eu,Quant Data,Negative
 Chronic Lymphocytic LeukaemiaRelated Tickers AZN,Quant Data,Negative
 AstraZenecas,Mehrdad Yousefi,Negative
 drug Calquence,Mehrdad Yousefi,Negative
 drug Calquence,john markarian,Positive
 drug Calquence,The Jerusalem Post,Positive
 drug Calquence,I Am Biotech,Positive
 drug Calquence,Pharmafocus,Negative
 European Union approval,Mehrdad Yousefi,Negative
   Calquence,WheelieDealer,Positive
   Calquence,PressReleasePoint,Positive
   Calquence,Career Biotech,Negative
   Calquence,Fitness Diet,Positive
 PlatinumResistant Metastatic Urothelial Cancer,Urology,Negative
 PlatinumResistant Metastatic Urothelial Cancer,Oncology,Negative
 PlatinumResistant Metastatic Urothelial Carcinoma,Oncology,Negative
 PlatinumResistant Metastatic Urothelial Carcinoma,Urology,Negative
 chronic lymphocytic   research,WCM Englander Institute for Precision Medicine,Positive
 Safety Study Supports Acalabrutinib,WCM Englander Institute for Precision Medicine,Positive
 Combination,WCM Englander Institute for Precision Medicine,Positive
 Combination,Garbi√±e Lizeaga,Negative
 Combination,ACIR.org,Positive
 Combination,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 Combination,#Memory,Positive
 Combination,Lymphoma Papers,Positive
 Combination,TumorImmunoPapers,Negative
 Combination,OncLive.com,Positive
 Combination,CureHuntr,Positive
 Combination,TrialBulletin,Positive
 Combination,Oncology Times,Negative
 Combination,1stOncology,Positive
 Combination,Lisa Palacios,Positive
 Combination,Tina Witte,Positive
 Combination,Biotech & Tech Stock Focus,Positive
 Combination,Mazeraski,Negative
 Combination,IMPharma News,Positive
 Combination,Jodie Insights,Negative
 Combination,dough,Positive
 Combination,Bio Stocks‚Ñ¢,Positive
 Combination,Stock Titan,Positive
 Combination,Jordan üíä,Positive
 Combination,U2 Fans,Negative
 Combination,AlphaBronze,Positive
 Combination,Aloysius Pendergast,Positive
 Combination,BiopharmIQ by Amp,Positive
 Combination,Crwe World,Positive
 Combination,Flash Alert,Positive
 Combination,Plexus Ventures,Negative
 Combination,The ASCO Post,Negative
 Combination,Jerry Lee,Negative
 Combination,@ScottWaudbyHaemResLeics,Positive
 Combination,ClinicalTrialsData,Positive
 Combination,RD360,Positive
 Combination,Alicia Bell IFBB Pro,Positive
 Combination,"Redington, Inc.",Positive
 Combination,Behavioral Finance,Positive
 Combination,Matt Fanning,Positive
 Combination,Quant Data,Positive
 Combination,Jake,Negative
 Combination,Day Trading Alerts,Positive
 Combination,Swing Trading,Positive
 Combination,Michelle Solly,Positive
 Combination,Michel Doepke,Positive
 Combination,Amp Trades,Negative
 Combination,TradeXchange,Negative
 Combination,CellworksLife,Negative
 Combination,Cure Cancer Now,Positive
 Combination,Martin JS Dyer,Positive
 Combination,Biotech2050,Positive
 Combination,HSMN,Positive
 Combination,Lung Cancer News,Negative
 Combination,Mahmoud Aljurf,Negative
 Combination,YGLDMETG,Positive
 Combination,"Dr T. Comeau , MD",Negative
 Combination,Benlazar S.M Amin√©,Negative
 Combination,SpecialtyPTimes,Negative
 Combination,SPI News,Positive
 Combination,Oncology Tube,Negative
 Combination,PressReleasePoint,Negative
 Combination,Pharmacutical Daily,Negative
 Combination,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Combination,NASDAQ,Positive
 Combination,CancerWallonia,Negative
 Combination,ASGCT,Negative
 Combination,Financial Buzz,Positive
 Combination,MoJo,Negative
 Combination,ALI ALAHMARI.,Negative
 Combination,Seattle's Banker,Positive
 Combination,Marketbit.pro,Positive
 Combination,HEDGE accordinglyüìà,Negative
 Combination,CRE Demographics,Negative
 Combination,RazzleTazzle,Positive
 Combination,HemOnc Today,Negative
 Combination,Hotstocks.nyc,Positive
 Combination,HRI Portal,Negative
 Combination,gilbert c faure,Negative
 Combination,Rob Wilson,Positive
 Combination,AmericanPharmacyNews,Negative
 Combination,aeses.com,Positive
 Combination,Mike Gauthier,Negative
 Combination,FDA Daily,Negative
 Combination,MD Anderson Leukemia,Negative
 Combination,OncLive SOSS,Negative
 Combination,Lymphoma Hub,Negative
 Combination,"Raul Cordoba, MD, PhD",Negative
 Combination,Shohta Kadomura Hospital Pharmacist,Negative
 Combination,Journal of Clinical Pathways,Negative
 Combination,Dr. Melody Davis,Negative
 Combination,ForexTV,Positive
 Combination,Denver Greene,Negative
 Combination,üí• OTC ARMY üí•,Positive
 Combination,Alyssa Howard,Negative
 Combination,biotechnologies,Negative
 Combination,Odi Bruckman,Negative
 Combination,A. Vroom - Ten Wolde,Negative
 Combination,Cancer Papers,Negative
 Combination,üê∏ gab.ai/wu üê∏,Positive
 Combination,IntoxicatedTrader,Negative
 Combination,Patient Power,Negative
 Combination,MDedge Hematology & Oncology,Negative
 Combination,VoyagerMed,Positive
 Combination,Sean Tiernan,Positive
 Combination,Michael,Positive
 Combination,PANNA SHARMA,Positive
 Combination,Aktienmanufaktur,Negative
 Combination,Scott Werntz,Positive
 Combination,Financescom-stocks,Positive
 Combination,Francesco Turturro,Negative
 Member Richard Furman MD,WCM Englander Institute for Precision Medicine,Positive
 Mantle Cell Lymphoma MCL,CALQUENCE¬Æ (acalabrutinib),Positive
 Mantle Cell Lymphoma MCL,PharmaShots - Incisive news in 3 shots,Negative
 Mantle Cell Lymphoma MCL,Jordan üíä,Positive
 Mantle Cell Lymphoma MCL,Kevin Wolcott,Positive
 SakigakeDesignated HAE Med Berotralstat AZ,MEDWAVE,Positive
 Acalabrutinib Clear PAFSC Review OrphanPacific,MEDWAVE,Negative
 REMoDLA CI,Kate Cwynarski,Positive
 Andy Daviestrial design,Kate Cwynarski,Positive
 HDMTX prophylaxis,Kate Cwynarski,Positive
 RCHOP Acalabrutinib,Kate Cwynarski,Positive
 nextgen BTK inhibitor,David Henry,Positive
 prolonged progressionfree survival,David Henry,Positive
 prolonged progressionfree survival,OncLive.com,Negative
 Dr Richard Furman,WCM Lymphoma,Positive
 Dr Richard Furman,Weill Cornell Medicine,Positive
 Dr Richard Furman,Carmine DeLuca,Negative
 Dr Richard Furman,Oncology Tube,Negative
 Dr Richard Furman,Patient Power,Positive
 Dr Richard Furman,Andrew Schorr,Negative
 Brutons tyrosine kinase BTK inhibitors,WCM Lymphoma,Negative
 ibrutinib acalabrutinib,WCM Lymphoma,Negative
 ibrutinib acalabrutinib,OncLive SOSS,Negative
 ibrutinib acalabrutinib,HemOnc Today,Negative
 ibrutinib acalabrutinib,"Michael Wang, MD",Negative
 zanubrutinib,WCM Lymphoma,Negative
 zanubrutinib,OncLive.com,Positive
 zanubrutinib,Sujeet Kumar,Positive
 zanubrutinib,Tim Fenske,Negative
 zanubrutinib,OncoPharm,Positive
 zanubrutinib,Cancer Medicine,Positive
 zanubrutinib,Medivizor,Positive
 zanubrutinib,Barry Shrier,Negative
 zanubrutinib,Lymphoma Papers,Positive
 zanubrutinib,Paperbirds_Hematology,Positive
 zanubrutinib,ASH Clinical News,Negative
 zanubrutinib,Benlazar S.M Amin√©,Positive
 zanubrutinib,Targeted Oncology,Negative
 zanubrutinib,ImmunologyPapers,Negative
 zanubrutinib,NK papers,Negative
 zanubrutinib,Francesco Bertoni,Negative
 zanubrutinib,Daniel Auclair,Positive
 people,WCM Lymphoma,Positive
 people,Leukaemia Foundation,Positive
 people,LymphomaAction,Positive
 people,Sarcasm Bot,Positive
 people,CLLSA,Positive
 people,Dawn Ain't Playin',Positive
 people,Blood Cancer UK,Negative
 people,NCI Cancer Stats,Negative
 people,CLL Ireland,Positive
 people,Anthony Mato,Negative
 people,JanssenUS,Positive
 people,Janssen EMEA,Positive
 people,European Pharmaceutical Review,Negative
 people,Heartland Cancer Foundation,Positive
 people,CLL Society Inc.,Negative
 people,Patient Power,Positive
 people,MyPathologyReport.ca,Negative
 people,Patient Empowerment Network,Negative
 people,CLEVER Network,Positive
 people,CLL Advocates Network,Negative
 people,Gear√≥id √ì Crotaigh #CareCantWait,Negative
 people,"Pharmacyclics, an AbbVie Company",Positive
 people,AbbVie US,Positive
 people,AA&MDSIF,Positive
 people,Cancer Support Community,Negative
 people,ID Medical,Positive
 people,AstraZeneca,Positive
 people,"Steven Artandi, MD, PhD",Negative
 people,Place Matters,Positive
 people,Sigrid Sk√•nland,Negative
 people,Charlotte Martin,Positive
 people,Janssen Global,Positive
 people,Genentech,Negative
 people,Brian Barrett,Negative
 people,The Galien Foundation,Positive
 people,Andrew Schorr,Negative
 people,CURE Magazine,Negative
 people,Helen Jane Mee,Positive
 people,"Eric D Whitman, MD",Positive
 people,Myeloid & Lymphoid disorders in practice,Positive
 people,Medklik,Positive
 people,Roche,Positive
 people,PRICENTRIC,Positive
 people,Blood Cancer UK Research,Negative
 people,LiveYourLife,Positive
 people,ReR üåê,Positive
 people,Scripps Research,Positive
 people,WCMNYPJCTO,Positive
 people,Cancer Policy Institute,Positive
 people,CLL Warwick Uni,Negative
 people,Te Ha,Negative
 people,Rhia Steele@ravishingrhia.com,Positive
 people,CMLHope,Negative
 people,Paula Pyzia,Negative
 people,Matthew Kauffman,Negative
 people,Sandy D.,Negative
 people,Kimberley Thomas,Negative
 people,Grayson (he),Positive
 people,International Pain Foundation¬Æ,Negative
 people,Cassi Schmigotzki,Negative
 people,Debbie Woodbury,Negative
 people,Chronic Sex,Positive
 people,SeparatriX,Positive
 people,Pamela Helton,Positive
 people,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 people,CureClick,Positive
 people,WEGO Health,Negative
 people,Lampe & Company,Negative
 people,Rajkumar Gupta Basics of DRA,Positive
 people,HYVE,Positive
 people,AbbVie Canada,Negative
 people,Idea Couture,Positive
 people,1stOncology,Negative
 people,Vegan NoGluten Sara,Positive
 people,Melanie Johnson,Positive
 people,Carole Johnson,Positive
 people,CLL Info,Negative
 people,Linda Bohannon,Positive
 Science Global trial,„Å®„Çä„Åï„Çì@obsoleted,Positive
 drugs pivots,„Å®„Çä„Åï„Çì@obsoleted,Positive
 ACCEPT,Lymphoma Papers,Negative
 ACCEPT,ÕèWilliam Avery Hudson,Negative
 vincristine,Lymphoma Papers,Negative
 prednisolone RCHOP,Lymphoma Papers,Negative
 Diffuse Large Bcell Lymphoma DLBCL study protocol,Lymphoma Papers,Negative
 Phase IbII openlabel,Lymphoma Papers,Negative
 ICMR,ThePrint Science,Positive
 ICMR,Shekhar Gupta,Positive
 ICMR,ThePrintIndia,Positive
 ICMR,PINSIDER NEWS,Positive
 ICMR,Guwahati News,Positive
 ICMR,Mango News,Positive
 ICMR,"MAJ DR B P SINGH,SG Medallist*(SIACHEN GLACIER*)",Positive
 ICMR,JINU JAMES,Positive
 ICMR,ET Industry News,Positive
 ICMR,Aaj Ka Samachar,Positive
 ICMR,Ketan,Positive
 ICMR,V.V. Ganesha,Positive
 Interferon,ThePrint Science,Negative
 Interferon,Shekhar Gupta,Positive
 Interferon,ThePrintIndia,Negative
 Interferon,Í™ÄÍ™ñùïõ·≠ôÍ™ñ,Positive
 cancer drug Acalabrutinib,ThePrint Science,Negative
 cancer drug Acalabrutinib,Shekhar Gupta,Positive
 cancer drug Acalabrutinib,ThePrintIndia,Negative
 cancer drug Acalabrutinib,Medical Dialogues,Positive
 Solidarity trial,ThePrintIndia,Negative
 reportstcoNgrQkEfrH,ThePrintIndia,Negative
 Acalabrutinib allein oder,univadis,Positive
 Kombination,univadis,Positive
 Kombination,APOTHEKE ADHOC,Positive
 mit Obinutuzumab zeigt,univadis,Positive
 monoterapia o,Univadis,Positive
 combinazione con obinutuzumab ottiene una sopravvivenza libera da progressione progressionfree survival,Univadis,Positive
 PFS e una sopravvivenza complessiva,Univadis,Positive
 World Health Organization eyes cancer drug,Medelis: OncologyCRO,Positive
 World Health Organization eyes cancer drug,ABS-CBN News,Positive
 World Health Organization eyes cancer drug,ABS-CBN News Channel,Positive
 Inclusion,Medical Dialogues,Positive
 PAFSC Review,MEDWAVE,Negative
 Oct,MEDWAVE,Negative
 Oct,TAP Clinical Trial Network,Negative
 Oct,"Courtney R., B.S., B.A.",Negative
 Oct,Patient Empowerment Network,Negative
 Oct,ESCofNJ,Positive
 Oct,Brian Barrett,Positive
 Oct,BCNI,Negative
 Oct,Leukemia Irst-Irccs della Romagna,Positive
 anticancer drug acalabrutinib,SunStar Cebu,Positive
 anticancer drug acalabrutinib,Sun Star Pampanga,Positive
 MT,"Mike Thompson, MD, PhD, FASCO",Negative
 MT,MedChemExpress,Negative
 MT,Matthias Piesche,Positive
 MT,JAMA,Negative
 MT,CAPO,Positive
 MT,Michael Fisch MD MPH,Positive
 MT,Marco,Positive
 Oct     amp   partner,"Mike Thompson, MD, PhD, FASCO",Negative
 n acalabrutinib,COVID-19 and Cancer Consortium (CCC19) Registry,Positive
 AstraZeneca Pharma India,ENTIRE MARKET INFORMATION,Positive
 AstraZeneca Pharma India,zavingsin,Positive
 AstraZeneca Pharma India,IIFLMarkets,Negative
 AstraZeneca Pharma India,TheUemployed,Positive
 AstraZeneca Pharma India,Dayco India,Positive
 AstraZeneca Pharma India,The Hans India,Positive
 AstraZeneca Pharma India,CNBC-TV18,Negative
 AstraZeneca Pharma India,Medical Dialogues,Positive
 India,ENTIRE MARKET INFORMATION,Positive
 India,ExpPharma,Negative
 India,zavingsin,Positive
 India,IIFLMarkets,Negative
 India,TheUemployed,Positive
 India,FinReach,Positive
 India,MADURAI TRADING ACADEMY,Positive
 India,#Enritchansrajpandey,Positive
 India,K Karthik Raja,Positive
 India,Ancient Stock Analysis,Positive
 India,CNBC-TV18,Positive
 India,Markets Today,Positive
 India,NEERAJ BAJPAI,Positive
 India,Economic Times,Positive
 India,Om Prakash Sharma,Positive
 India,ThePrint Science,Negative
 India,Mohd wamique,Positive
 India,Himani Chandna,Positive
 India,seshutatikola,Positive
 India,ThePrintIndia,Negative
 India,Motilal Oswal Financial Services Ltd,Negative
 India,Lymphoma Papers,Negative
 India,Bloodbytes,Positive
 India,Paperbirds_Hematology,Positive
 India,ASCO Publications,Negative
 India,Clarivate Cortellis,Negative
 BTK inhibitor,Thiago Carvalho,Negative
 BTK inhibitor,A.n.n.,Positive
 BTK inhibitor,Andreas Charalambous,Positive
 BTK inhibitor,"John Damianos, M.D.",Positive
 BTK inhibitor,M√≥nica,Positive
 BTK inhibitor,Bonny Wrightüêù,Positive
 BTK inhibitor,LiberalFish,Positive
 BTK inhibitor,Health Evangelists,Negative
 BTK inhibitor,K Pavithran,Positive
 BTK inhibitor,LCW,Positive
 BTK inhibitor,Targeted Oncology,Negative
 BTK inhibitor,Oncology Nursing News,Negative
 BTK inhibitor,OncLive.com,Positive
 BTK inhibitor,Andrew Schorr,Negative
 BTK inhibitor,Ned Pagliarulo,Positive
 BTK inhibitor,Jacob Plieth,Negative
 BTK inhibitor,Oncologiavet,Negative
 BTK inhibitor,MDedge Hematology & Oncology,Negative
 BTK inhibitor,Victor Lin,Positive
 BTK inhibitor,Oncology Learning Network,Negative
 BTK inhibitor,Lymphoma Papers,Negative
 BTK inhibitor,Paperbirds_Hematology,Negative
 BTK inhibitor,Michael Dickinson,Negative
 BTK inhibitor,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 BTK inhibitor,CellworksLife,Negative
 BTK inhibitor,Novartis,Positive
 BTK inhibitor,Francesco Turturro,Positive
 mantle cell lymphoma,Thiago Carvalho,Negative
 mantle cell lymphoma,CNBC-TV18,Negative
 mantle cell lymphoma,Targeted Oncology,Positive
 mantle cell lymphoma,Lung Cancer News,Negative
 mantle cell lymphoma,Chocolatiere Phys,Negative
 mantle cell lymphoma,Jonathan Friedberg,Positive
 mantle cell lymphoma,Cancer News,Negative
 mantle cell lymphoma,Lymphoma Papers,Negative
 mantle cell lymphoma,EurekaMag,Negative
 mantle cell lymphoma,OncLive SOSS,Negative
 mantle cell lymphoma,minoti hiremath,Positive
 mantle cell lymphoma,FabriceAndre,Positive
 mantle cell lymphoma,GRACE,Negative
 mantle cell lymphoma,NCICancerTrials,Positive
 mantle cell lymphoma,Lambda Kappa Sigma,Positive
 mantle cell lymphoma,Hlthnews,Negative
 mantle cell lymphoma,SchwietermanPharmacy,Positive
 mantle cell lymphoma,tristatemedicalgroup,Negative
 mantle cell lymphoma,PRINCE ADEKOYA,Negative
 mantle cell lymphoma,Marcrom's Pharmacy,Negative
 mantle cell lymphoma,Custom Compounding,Positive
 mantle cell lymphoma,Horseshoe Health & M,Negative
 mantle cell lymphoma,The Medicine Shoppe,Negative
 mantle cell lymphoma,Greenwood Drug,Negative
 mantle cell lymphoma,Medicine To Go,Negative
 mantle cell lymphoma,Greenbrier Pharmacy,Positive
 mantle cell lymphoma,Sam's Health Mart,Positive
 mantle cell lymphoma,Brehme Drug,Positive
 mantle cell lymphoma,Food City RX Marion,Negative
 mantle cell lymphoma,Crown Pharmacy,Positive
 mantle cell lymphoma,LibertyHillPharmacy,Positive
 mantle cell lymphoma,Hopkinton Drug,Negative
 mantle cell lymphoma,Delran Pharmacy,Positive
 mantle cell lymphoma,Fox Drug of Torrance,Negative
 mantle cell lymphoma,Cascade Custom RX,Positive
 mantle cell lymphoma,Coastal Pharmacy,Positive
 mantle cell lymphoma,RxSpark,Positive
 mantle cell lymphoma,Rare Disease Report,Positive
 mantle cell lymphoma,UKiwiS,Negative
 mantle cell lymphoma,Drug Store News,Positive
 mantle cell lymphoma,Margaret Walker,Negative
 mantle cell lymphoma,Farmacia Nenna,Positive
 mantle cell lymphoma,Medical Microbiology,Positive
 mantle cell lymphoma,Sonali Prusty,Positive
 mantle cell lymphoma,Talbot Research Library & Media Services,Positive
 mantle cell lymphoma,pharmabr,Positive
 mantle cell lymphoma,Coping with Cancer,Negative
 mantle cell lymphoma,"Caner Saygin, MD",Negative
 mantle cell lymphoma,MPR,Negative
 mantle cell lymphoma,CancerTherapyAdvisor,Negative
 mantle cell lymphoma,ICI Research,Positive
 mantle cell lymphoma,Antonio Caperna,Positive
 mantle cell lymphoma,Salutedomani,Negative
 mantle cell lymphoma,saluteH24.com,Positive
 mantle cell lymphoma,Derma News OK,Positive
 mantle cell lymphoma,FirstWord Pharma,Positive
 mantle cell lymphoma,Ned Pagliarulo,Positive
 mantle cell lymphoma,StockNews.com,Negative
 mantle cell lymphoma,Pharma_Processes,Positive
 mantle cell lymphoma,Danvantri Farma,Negative
 mantle cell lymphoma,Pharmaceutical News,Positive
 mantle cell lymphoma,Brad Loncar,Positive
 mantle cell lymphoma,Ryan HamNer,Positive
 mantle cell lymphoma,CLL Society Inc.,Negative
 mantle cell lymphoma,c lark,Positive
 mantle cell lymphoma,B. West #sand,Positive
 mantle cell lymphoma,Siti van der Meij,Negative
 mantle cell lymphoma,Breaking News,Negative
 mantle cell lymphoma,Andrew Merron,Positive
 mantle cell lymphoma,Odi Bruckman,Negative
 mantle cell lymphoma,OncLive.com,Negative
 mantle cell lymphoma,"Chris Cogbill, MD",Positive
 mantle cell lymphoma,China Science,Positive
 mantle cell lymphoma,Biotech2050,Negative
 mantle cell lymphoma,LifeCare Medicines,Positive
 Oct   stock trades,zavingsin,Positive
 Oct   stock trades,TheUemployed,Positive
 Health experts,CNN Philippines,Positive
 cancer patients,CNN Philippines,Positive
 cancer patients,7NEWS Sydney,Positive
 cancer patients,Walter M Chesnut,Positive
 cancer patients,CLL Society Inc.,Positive
 cancer patients,WEGO Health,Negative
 cancer patients,Michele Nadeem-Baker,Negative
 cancer patients,Paperbirds_Hematology,Negative
 cancer patients,Patient Empowerment Network,Negative
 cancer patients,Patient Power,Negative
 cancer patients,Shouting at people in my underpants,Negative
 cancer patients,Bon in NC,Positive
 cancer patients,CLL Ireland,Negative
 cancer patients,Cancer And I,Negative
 cancer patients,VJHemOnc,Negative
 Health undersecretary Maria Rosario Vergeire,Doktor Net PH,Positive
 IndiaNews,Dayco India,Positive
 brand Calquence,Medical Dialogues,Positive
 brand Calquence,The Hans India,Positive
 HERO MOTO,Vikas kumar sharma,Positive
 ‡§®‡•á ‡§®‡§à Pleasure,Vikas kumar sharma,Positive
 ‡§ï‡•Ä,Vikas kumar sharma,Positive
 ‡§π‡•à,Vikas kumar sharma,Positive
 ‡§ï‡•Ä‡§Æ‡§§,Vikas kumar sharma,Positive
 ‡§∞‡•Å‡§™‡§è ‡§∏‡•á ‡§∂‡•Å‡§∞‡•Ç,Vikas kumar sharma,Positive
 ‡§π‡•à‡•§ASTRAZENECA,Vikas kumar sharma,Positive
 ‡§Ö‡§ï‡•ç‡§ü‡•Ç‡§¨‡§∞ ‡§ï‡•ã ‡§¶‡•á‡§∂ ‡§Æ‡•á‡§Ç Mantle Cell Lymphoma,Vikas kumar sharma,Positive
 ‡§¶‡§µ‡§æ Calquence,Vikas kumar sharma,Positive
 ‡§ï‡§∞‡•á‡§ó‡•Ä‡•§PERSISTENT SYSTEMS ‡§™‡§∞,Vikas kumar sharma,Positive
 ‡§´‡•ã‡§ï‡§∏ ‡§Ö‡§Æ‡•á‡§∞‡§ø‡§ï‡•Ä,Vikas kumar sharma,Positive
 ‡§ï‡§Ç‡§™‡§®‡•Ä,Vikas kumar sharma,Positive
 ‡§ï‡•ã,Vikas kumar sharma,Positive
 ‡§ï‡•ã,myupchar,Positive
 ‡§≤‡§æ‡§ñ,Vikas kumar sharma,Positive
 ‡§°‡•â‡§≤‡§∞,Vikas kumar sharma,Positive
 ‡§Æ‡•á‡§Ç,Vikas kumar sharma,Positive
 ‡§ñ‡§∞‡•Ä‡§¶‡•á‡§ó‡•Ä,Vikas kumar sharma,Positive
 AstraZeneca Pharma,FinReach,Positive
 AstraZeneca Pharma,Markets Today,Positive
 AstraZeneca Pharma,BloombergQuint,Positive
 AstraZeneca Pharma,IIFLMarkets,Negative
 October,FinReach,Positive
 October,MADURAI TRADING ACADEMY,Positive
 October,#Enritchansrajpandey,Negative
 October,K Karthik Raja,Positive
 October,The Hans India,Positive
 October,Markets Today,Positive
 October,NEERAJ BAJPAI,Positive
 October,CNBC-TV18,Negative
 October,"Courtney R., B.S., B.A.",Negative
 October,Flash Alert,Negative
 October,Toby Eyre,Negative
 October,CLL Society Inc.,Negative
 October,ESCofNJ,Negative
 October,Iowa Cancer Consortium,Positive
 October,CLLSA,Negative
 October,Kanga Exchange,Positive
 October,Patient Empowerment Network,Negative
 October,Patient Power,Negative
 October,Dr Jobin Shaeri,Positive
 October,Targeted Oncology,Negative
 October,Lifelong Learning,Positive
   Pharma   Company,MADURAI TRADING ACADEMY,Positive
 Good Morning,#Enritchansrajpandey,Negative
 ‚òÄ Ô∏è Exclusive Morning Market News amp,#Enritchansrajpandey,Negative
 Update ‚òÄ,#Enritchansrajpandey,Negative
 Pharma,#Enritchansrajpandey,Negative
 Pharma,Business Wire-Health,Negative
 Pharma,Ghazi Tadmouri,Positive
 Pharma,Medicine For World,Negative
 Pharma,Anna Deveau,Negative
 Company,#Enritchansrajpandey,Negative
 Company,AIM Alerts!,Positive
 Company,Cancer News,Negative
 Company,CLL Ireland,Negative
 Company,MDedge Hematology & Oncology,Negative
 Company,tennessee companies,Positive
 import market permission,#Enritchansrajpandey,Negative
 import market permission,IIFLMarkets,Negative
 Drugs Controller General,#Enritchansrajpandey,Negative
 March,#Enritchansrajpandey,Negative
 March,CLL Society Inc.,Positive
 March,JADPRO,Negative
 March,Patient Empowerment Network,Negative
 March,CLLSA,Negative
 March,APSHO,Negative
 March,Phoebe Needles,Negative
 March,JCM MDPI,Positive
 March,MerMer Goodburn üåàüá™üá∫ü©∏,Positive
 March,ESH (Haematology),Negative
 March,Flash Alert,Negative
 March,RAUL FERRANDO,Positive
 March,Helen Jane Mee,Negative
 March,Patient Power,Positive
 March,CryptoLiveLeak,Negative
 March,LymphomaAction,Positive
 March,Heather DelaCruz,Negative
 March,Cathy Wu,Positive
 March,CLL,Negative
 AstraZeneca Pharma   Company,K Karthik Raja,Positive
 AstraZeneca ¬† Pharma ¬† Drug firm AstraZeneca Pharma India,Markets Today,Negative
 todays trade,Ancient Stock Analysis,Positive
 Persistent,Ancient Stock Analysis,Positive
 Persistent,CNBC-TV18,Negative
 USbased CAPIOT Software,Ancient Stock Analysis,Positive
 USbased CAPIOT Software,CNBC-TV18,Negative
 m amp AstraZeneca,Ancient Stock Analysis,Positive
 m amp AstraZeneca,CNBC-TV18,Negative
 lymphoma treatment,Ancient Stock Analysis,Positive
 lymphoma treatment,CNBC-TV18,Negative
 October KPMG,Markets Today,Negative
 auditor,Markets Today,Negative
 effect,Markets Today,Negative
 effect,Cancer News,Negative
 effect,OncLive.com,Positive
 effect,Medivizor,Positive
 effect,CLLSA,Negative
 effect,CLL Society Inc.,Negative
 effect,Paperbirds_Hematology,Negative
 effect,Sarah Cannon Docs,Positive
 effect,Verastem Oncology,Positive
 effect,Patient Power,Negative
 effect,"Raul Cordoba, MD, PhD",Positive
 effect,MDLinx,Negative
 UPL material arm,Markets Today,Negative
 Mauritius   UPL Corporation,Markets Today,Negative
 combo,Medscape Pharmacists,Negative
 combo,"Freddy Pizart, R.N.",Positive
 combo,Medscape,Negative
 combo,Medscape Oncology,Negative
 combo,OncLive.com,Negative
 combo,CADTH,Negative
 combo,1stOncology,Positive
 combo,Plexus Ventures,Positive
 combo,"Steven Artandi, MD, PhD",Negative
 combo,Roy Tindle,Positive
 combo,LIVINGSTRONGTV.COM,Positive
 combo,YoBuzz,Negative
 combo,BeyondIgY‚Ñ¢,Positive
 combo,MDedge Hematology & Oncology,Negative
 combo,John Pennett,Positive
 combo,MedWatch News,Positive
 combo,Mike Ward,Negative
 combo,Biotech2050,Negative
 ASTRAZENECAAstraZeneca Pharma India,NEERAJ BAJPAI,Positive
 Alert Calquence Medicine,NEERAJ BAJPAI,Positive
 Adults,NEERAJ BAJPAI,Positive
 Adults,BioNews,Negative
 Adults,New Drug Approvals,Positive
 Adults,Drugs.com,Positive
 Adults,CHSeaton,Positive
 Adults,FDA Daily,Negative
 Adults,NewExpressNews,Negative
 Adults,Cancer Health,Negative
 Adults,Hlthnews,Negative
 Adults,Amer Coll Clin Pharm,Positive
 Adults,Newmoney210,Negative
 Adults,Medicalnewser.com,Negative
 Adults,IntoxicatedTrader,Negative
 Adults,Mike van Dulken,Negative
 Adults,Quant Data,Negative
 Adults,ClinicalTrialsData,Negative
 Adults,TrialBulletin,Negative
 Adults,CureHuntr,Negative
 Adults,Amanda Haddock üß¨,Negative
 Acalabrutinib   milligram capsules,BloombergQuint,Positive
 types,BloombergQuint,Positive
 types,Meagan Phelan,Positive
 types,The James,Negative
 types,Sarah Jones,Positive
 types,Leukemia,Positive
 types,UTSW Simmons Comprehensive Cancer Center,Positive
 types,Laboratory Career,Negative
 types,Leukemia I'm Fine,Negative
 types,Matthews & Associates,Positive
 types,Adam Marshall Dobrin üîØ‚òÄ‚ÅÇ @suzq@rettiwtkcuf.social,Positive
 types,SkillAcquire,Positive
 types,Genevieve Gutierrez,Positive
 types,The Scientist,Positive
 types,"‚ÄúNicky""",Positive
 types,Patient Power,Positive
 types,Helen Jane Mee,Negative
 types,AnamjemWAK,Positive
 types,Lampe & Company,Negative
 types,CLL Ireland,Negative
 types,Patient Empowerment Network,Negative
 types,Healthguru,Positive
 types,Targeted Oncology,Negative
 types,@EbruTVKenya,Positive
 types,International Pain Foundation¬Æ,Negative
 types,Allison,Positive
 blood cancers,BloombergQuint,Positive
 blood cancers,ahealthierphilly,Negative
 blood cancers,M√≥nica,Positive
 blood cancers,PhillyVoice,Positive
 blood cancers,LiberalFish,Positive
 blood cancers,Health Evangelists,Negative
 blood cancers,LCW,Positive
 blood cancers,Downtown News,Positive
 blood cancers,Cool FM News,Positive
 blood cancers,DowntownCountry News,Positive
 blood cancers,SeattleCancerCareAlliance,Negative
 blood cancers,AbbVie US,Positive
 blood cancers,Esther Schorr,Positive
 blood cancers,Oncology Nursing News,Negative
 blood cancers,CLLSA,Negative
 blood cancers,Cancer And I,Negative
 blood cancers,CLL Ireland,Negative
 blood cancers,Lymphoma Hub,Negative
 blood cancers,JanssenUS,Negative
 ASTRAZENECA PHARMA CO,Redbox India,Positive
 LAUNCH CALQUENCE,Redbox India,Positive
 INDIA,Redbox India,Positive
 OCT    CALQUENCE,Redbox India,Positive
 TREAT ADULTS,Redbox India,Positive
 MANTLE CELL LYMPHOMA,Redbox India,Positive
 MANTLE CELL LYMPHOMA,Mike van Dulken,Negative
 ASTRAZEN   Launch,BSE Corporate News,Positive
 Acalabrutinib Mg Capsules Calquence,BSE Corporate News,Positive
    ‡§°‡•ç‡§∞‡§ó,myupchar,Positive
 ‡§è‡§ï‡§≤‡§æ‡§¨‡•ç‡§∞‡•Å‡§ü‡§ø‡§®‡§ø‡§¨,myupchar,Positive
 ‡§ï‡•á,myupchar,Positive
 ‡§Æ‡§∞‡•Ä‡§ú‡•ã‡§Ç ‡§™‡§∞,myupchar,Positive
 ‡§Ü‡§ú‡§Æ‡§æ‡§®‡§æ,myupchar,Positive
 ‡§ö‡§æ‡§π‡§§‡§æ ‡§π‡•à,myupchar,Positive
 ‡§∏‡§∞‡§ï‡§æ‡§∞ ‡§ï‡•á,myupchar,Positive
 ‡§™‡•à‡§®‡§≤ ‡§ï‡•á ‡§∏‡§æ‡§Æ‡§®‡•á ‡§™‡•ç‡§∞‡§∏‡•ç‡§§‡§æ‡§µ,myupchar,Positive
 ETIndustryNews ICMR,ITSM - Industrial,Positive
 experts panel,ITSM - Industrial,Positive
 experts panel,PINSIDER NEWS,Positive
 experts panel,Guwahati News,Positive
 experts panel,"MAJ DR B P SINGH,SG Medallist*(SIACHEN GLACIER*)",Positive
 experts panel,JINU JAMES,Positive
 experts panel,ET Industry News,Positive
 experts panel,ETHealthWorld,Positive
 experts panel,Aaj Ka Samachar,Positive
 experts panel,Ketan,Positive
 testing,ITSM - Industrial,Positive
 testing,PINSIDER NEWS,Positive
 testing,Guwahati News,Positive
 testing,Economic Times,Positive
 testing,Mango News,Positive
 testing,"MAJ DR B P SINGH,SG Medallist*(SIACHEN GLACIER*)",Positive
 testing,JINU JAMES,Positive
 testing,ET Industry News,Positive
 testing,ETHealthWorld,Positive
 testing,Aaj Ka Samachar,Positive
 testing,Ketan,Positive
 testing,The Business Network,Positive
 testing,AAA,Positive
 testing,Jared O‚Äô üáÆüáπ,Positive
 testing,BCABA Network,Positive
 testing,Patient Power,Positive
 testing,Patient Empowerment Network,Negative
 testing,CLL Society Inc.,Negative
 testing,Continuous Lifecycle London (online),Negative
 testing,Robert Z. Orlowski,Negative
 Covid treatment,ITSM - Industrial,Positive
 Covid treatment,Guwahati News,Positive
 Covid treatment,"MAJ DR B P SINGH,SG Medallist*(SIACHEN GLACIER*)",Positive
 Covid treatment,JINU JAMES,Positive
 Covid treatment,ET Industry News,Positive
 Covid treatment,ETHealthWorld,Positive
 Covid treatment,Ketan,Positive
 ‚Å¶‚Å©,Teena Thacker,Positive
 ‚Å¶‚Å©,Prof David Sebag üíô,Positive
 ‚Å¶‚Å©,"Kelly Norsworthy, MD",Positive
 ‚Å¶‚Å©,Anthony Mato,Positive
 ‚Å¶‚Å©,Michele Nadeem-Baker,Positive
 ‚Å¶‚Å©,donnashort,Positive
 ‚Å¶‚Å©,"Raul Cordoba, MD, PhD",Positive
 ‚Å¶‚Å©,Michael Hallek,Negative
 ‚Å¶‚Å©,Talha Badar,Positive
 ‚Å¶‚Å©,"Carrie Thompson, MD",Positive
 ‚Å¶‚Å©,SNU P√¥le Emploi FSU Occitanie,Positive
 ‚Å¶‚Å©,Christian Reinhardt,Positive
 ‚Å¶‚Å©,Mark Winfrey,Positive
 ‚Å¶‚Å©,Prof John,Positive
 ‚Å¶‚Å©,Hematolog√≠a Salamanca,Positive
 ‚Å¶‚Å©,"Tom Henry, MBA, RPh, CPh",Negative
 ‚Å¶‚Å©,Jonathan Pearce,Negative
 ‚Å¶‚Å©,Jeremy Scott,Positive
 ‚Å¶‚Å©,"Naveen Pemmaraju, MD",Negative
 govt,Teena Thacker,Positive
 govt,Mango News,Positive
 panel,Teena Thacker,Positive
 panel,Economic Times,Positive
 panel,Mango News,Positive
 panel,Patient Power,Positive
 panel,Lisa Palacios,Negative
 panel,Breaking Data,Negative
 panel,SpecialtyPTimes,Positive
 panel,Robert Z. Orlowski,Negative
 panel,MD Anderson Leukemia,Positive
 panel,Esther Schorr,Negative
 panel,Patient Empowerment Network,Positive
 panel,Lymphoma Hub,Negative
 panel,Penn Medicine MD,Positive
 panel,Expert Perspectives in Oncology,Positive
 panel,Andrew Schorr,Negative
 panel,WCM Lymphoma,Negative
 experts,Teena Thacker,Positive
 experts,Economic Times,Positive
 experts,Mango News,Positive
 experts,Patient Power,Positive
 experts,donnashort,Positive
 experts,MOASC,Positive
 experts,RedMedEd,Positive
 experts,Oncology CE,Positive
 experts,Vindico Medical Education,Positive
 experts,Lisa Palacios,Negative
 experts,PeerView,Positive
 experts,Andrew Schorr,Positive
 experts,VJHemOnc,Positive
 experts,National Comprehensive Cancer Network (NCCN),Negative
 experts,Leukaemia Care,Negative
 experts,CLL Ireland,Negative
 experts,Nick,Negative
 experts,Targeted Oncology,Negative
 experts,Toby Eyre,Negative
 experts,STTR Cancer,Positive
 experts,CURE Magazine,Negative
 experts,Robert Z. Orlowski,Negative
 experts,MD Anderson Leukemia,Positive
 experts,CLLSA,Negative
 experts,Patient Empowerment Network,Positive
 experts,SpecialtyPTimes,Negative
 experts,CancerCare,Negative
 experts,Oncology Learning Network,Negative
 experts,Expert Perspectives in Oncology,Positive
 experts,Helen Jane Mee,Negative
 experts,SES,Positive
 experts,Lab Tests Online,Positive
 experts,Mallory Ahern,Negative
 experts,Managing Myeloma,Negative
 experts,Jeff Folloder,Positive
 experts,iwCLL,Negative
 BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅØÊó•Êú¨‰∫∫„ÅÆÂÜçÁô∫„ÉªÈõ£Ê≤ªÊÄßCLLSLL„ÄÅMCL„Åß„ÇÇÂøçÂÆπÊÄß„Åå„ÅÇ„ÇäÊúâÂäπÊÄßÁ§∫„Åô„ÄêÊó•Êú¨Ë°ÄÊ∂≤Â≠¶‰ºö,Êó•Áµå„É°„Éá„Ç£„Ç´„É´,Positive
 BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅØÊó•Êú¨‰∫∫„ÅÆÂÜçÁô∫„ÉªÈõ£Ê≤ªÊÄßCLLSLL„ÄÅMCL„Åß„ÇÇÂøçÂÆπÊÄß„Åå„ÅÇ„ÇäÊúâÂäπÊÄßÁ§∫„Åô„ÄêÊó•Êú¨Ë°ÄÊ∂≤Â≠¶‰ºö,ÂåªÂ≠¶Â≠¶‰ºö„Éã„É•„Éº„Çπ,Positive
 BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅØÊó•Êú¨‰∫∫„ÅÆÂÜçÁô∫„ÉªÈõ£Ê≤ªÊÄßCLLSLL„ÄÅMCL„Åß„ÇÇÂøçÂÆπÊÄß„Åå„ÅÇ„ÇäÊúâÂäπÊÄßÁ§∫„Åô„ÄêÊó•Êú¨Ë°ÄÊ∂≤Â≠¶‰ºö,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 health research bodyIndian Council,Economic Times,Positive
 Medical Research,Economic Times,Positive
 Medical Research,Lymphoma Hub,Negative
 Medical Research,MedPage Oncology,Negative
 government,Economic Times,Positive
 BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅØÊó•Êú¨‰∫∫„ÅÆÂÜçÁô∫„ÉªÈõ£Ê≤ªÊÄßCLLSLL„ÄÅMCL„Åß„ÇÇÂøçÂÆπÊÄß„Åå„ÅÇ„ÇäÊúâÂäπÊÄßÁ§∫„Åô„ÄêÊó•Êú¨Ë°ÄÊ∂≤Â≠¶‰ºö„ÄëÔºö„Åå„Çì„Éä„ÉìÊó•Êú¨„Åß„ÇÇÊó©„ÅèÊâøË™ç„Åï„Çå„Çã„Åì„Å®„ÇíÈ°ò„Å£„Å¶„ÅÑ„Åæ„Åô,„Åå„Çì„Éä„ÉìÈÄö‰ø°,Positive
 drugs,Mango News,Positive
 drugs,CONQUER the patient voice,Negative
 drugs,"COTA, Inc.",Positive
 drugs,Stray,Positive
 drugs,Around The Globe News,Positive
 drugs,Manam,Positive
 drugs,MyelomaDad,Positive
 drugs,Natacha Bola√±os,Negative
 drugs,Encore BioMed,Positive
 drugs,Biotech Pipeline Tracker,Positive
 drugs,PER,Negative
 drugs,Dana-Farber News,Positive
 drugs,LiveTracker¬Æ,Positive
 drugs,"Steven Artandi, MD, PhD",Negative
 drugs,Stanford Medicine,Negative
 drugs,Joe,Negative
 drugs,SIBBM,Positive
 drugs,Lymphomation.org,Negative
 drugs,Cellero,Positive
 drugs,LymphomaAction,Negative
 drugs,Catalyst Trading,Positive
 drugs,Targeted Oncology,Negative
 drugs,Anna Deveau,Negative
 drugs,Ravispecialitiespharma_RSP,Negative
 drugs,CLL Ireland,Negative
 drugs,AJMC,Negative
 drugs,Cancer And I,Negative
 drugs,Patient Power,Negative
 drugs,VJHemOnc,Negative
 drugs,Oncology Tube,Negative
 drugs,Piotr Stƒôpniak,Positive
 drugs,CancerTherapyAdvisor,Negative
 drugs,Jonathon Cohen MD MS,Positive
 drugs,Christopher Steer,Negative
 drugs,Matthias Piesche,Negative
 App,"MAJ DR B P SINGH,SG Medallist*(SIACHEN GLACIER*)",Positive
 App,$Stocknewsalerts,Negative
 Medscape Acalabrutinib,"Freddy Pizart, R.N.",Positive
 govt panel approval,V.V. Ganesha,Positive
 govt panel approval,ThePrint Science,Negative
 govt panel approval,Himani Chandna,Positive
 govt panel approval,ThePrintIndia,Negative
 BREAKING   ICMR,Himani Chandna,Positive
 Naj√≠t √∫ƒçinnou l√©ƒçbu medikamenty pro onemocnƒõn√≠,www.zdravezpravy.cz,Positive
 covid pomohou,www.zdravezpravy.cz,Positive
 Medscape HematologyOncology Headlinesgtgt Acalabrutinib Bests Frontline CLL Therapies,AGD Biomedicals,Negative
   CLL sequencing ‚ö†,eDNA,Positive
 Ô∏èPhase III RCTs st line,eDNA,Positive
 RESONATE,eDNA,Positive
 RESONATE,Lymphoma Hub,Positive
 RESONATE,ALI ALAHMARI.,Positive
 RESONATE,Lymphoma Papers,Negative
 RESONATE,CancerEpiPapers,Negative
 RESONATE,Benlazar S.M Amin√©,Negative
 RESONATE,NYCDoc29,Negative
 RESONATE,ASH Clinical News,Negative
 RESONATE,AJMC-Oncology,Positive
 RESONATE,EMJ Hematology,Positive
 RESONATE,Connie Batlevi,Negative
 RESONATE,Journal of Comparative Effectiveness Research,Positive
 RESONATE,Blood Buff,Positive
 RESONATE,Scott Werntz,Negative
 RESONATE,EMJ Rheumatology,Positive
 RESONATE,EMJ Oncology,Negative
 amp E OS benefit,eDNA,Positive
 ü§® ELEVATETN,eDNA,Positive
 üßê Acalabrutinib,eDNA,Positive
 ‚ÜîÔ∏è,eDNA,Positive
 ‚¨á Ô∏è,eDNA,Positive
 rashVenetoclax consolidation,eDNA,Positive
 UMRD BCL   BTK CD,eDNA,Positive
 AZN Phase,ClinicalTrialsData,Positive
 Acalabrutinib Study,ClinicalTrialsData,Negative
 Relative Bioavailability Proton Pump Inhibitor PPI Rabeprazole Effect Food Effect,ClinicalTrialsData,Negative
 Relative Bioavailability Proton Pump Inhibitor PPI Rabeprazole Effect Food Effect,TrialBulletin,Negative
 Relative Bioavailability Proton Pump Inhibitor PPI Rabeprazole Effect Food Effect,CureHuntr,Negative
 Particle Size Effect,ClinicalTrialsData,Negative
 Particle Size Effect,TrialBulletin,Negative
 Particle Size Effect,CureHuntr,Negative
 New Acalabrutinib Tablet,ClinicalTrialsData,Negative
 New Acalabrutinib Tablet,TrialBulletin,Negative
 New Acalabrutinib Tablet,CureHuntr,Negative
 Healthy Subjects,ClinicalTrialsData,Negative
 Healthy Subjects,CureHuntr,Negative
 NCT Estimated Primary Completion Date,ClinicalTrialsData,Positive
 Êó•Áµå„É°„Éá„Ç£„Ç´„É´,Êó•Áµå„É°„Éá„Ç£„Ç´„É´,Positive
 „ÅÇ„ÅπÊ≠ØÁßëÂåªÁôÇ„Éã„É•„Éº„ÇπÔΩêÔΩâÔΩÉÔΩãUP ‚òÖ,abe dental,Negative
 ‚òÖ Á¶èÂ≤°Â∏ÇÊù±Âå∫„ÉªÊ≠ØÂë®ÁóÖ„Éª„Ç§„É≥„Éó„É©„É≥„Éà„Éª„ÅÇ„ÅπÊ≠ØÁßë„ÇØ„É™„Éã„ÉÉ„ÇØ,abe dental,Positive
 El Instituto Nacional del C√°ncer analiz√≥ que,Taan Pacheco,Positive
 con acalabrutinib,Taan Pacheco,Positive
 puede ser efectivo,Taan Pacheco,Positive
 combatir el COVID,Taan Pacheco,Positive
 Informaci√≥n,Taan Pacheco,Positive
   amp   partner,HemOnc Today,Negative
 Trial,Cancer Review,Positive
 Trial,Cancer Update,Positive
 Trial,Cancer Research News,Positive
 Trial,CureHuntr,Negative
 Trial,TrialBulletin,Negative
 Trial,Cancer News,Negative
 Trial,Lymphoma News Today,Negative
 Trial,Pharmaceuticals repo,Positive
 Trial,Pharmacutical Daily,Negative
 Trial,Biotech & Tech Stock Focus,Negative
 Trial,"OTC Dynamics, Inc.",Negative
 Trial,PressNewsAgency,Positive
 Trial,Corporate News,Negative
 Trial,Crwe World,Positive
 Trial,Bio Stocks‚Ñ¢,Positive
 Trial,Latest News from Business Wire,Negative
 Trial,Stock Titan,Negative
 Trial,Joe Fournet,Negative
 Trial,OncLive.com,Negative
 Trial,Lymphoma Hub,Negative
 Trial,Oncology Tube,Positive
 Trial,COPD News,Negative
 Trial,Benlazar S.M Amin√©,Negative
 Trial,SpecialtyPTimes,Negative
 Trial,BIOCIENCIA,Negative
 Trial,Hematopoiesis News,Negative
 Trial,AmericanPharmacyNews,Negative
 Trial,1stOncology,Negative
 Trial,‚öõÔ∏èLibertyüåä,Positive
 Trial,MoJo,Negative
 Trial,OBR,Negative
 Trial,Odi Bruckman,Negative
 Trial,The James,Negative
 Trial,CLL Ireland,Negative
 Trial,MAISA,Negative
 Trial,Holden Caulfield PhD,Positive
 Trial,Patient Worthy,Negative
 Trial,CMLHope,Positive
 Trial,CancerWallonia,Negative
 Trial,Scott Werntz,Negative
 blood cancer COVID,Cancer Review,Positive
 blood cancer COVID,Cancer Update,Positive
 blood cancer COVID,Cancer Research News,Positive
 Healio,Cancer Review,Positive
 Healio,Cancer Update,Positive
 CALQUENCE Drug Profile,DrugPatentWatch,Positive
 Comparative Efficacy,INDoximity üáÆüá≥,Negative
 Comparative Efficacy,clinicaltherapeutics,Negative
 Frontline Treatment,INDoximity üáÆüá≥,Negative
 Frontline Treatment,clinicaltherapeutics,Negative
 Frontline Treatment,Paperbirds_Hematology,Negative
 Frontline Treatment,ALI ALAHMARI.,Negative
 Frontline Treatment,Prof John,Negative
 Frontline Treatment,SOBRAFO,Positive
 Frontline Treatment,NACDA Program on Aging,Negative
 Frontline Treatment,PER,Negative
 Frontline Treatment,CURE Magazine,Negative
 Systematic Review,INDoximity üáÆüá≥,Negative
 Systematic Review,clinicaltherapeutics,Negative
 Systematic Review,Paperbirds_Hematology,Positive
 Systematic Review,Lymphoma Papers,Negative
 Systematic Review,"Raul Cordoba, MD, PhD",Negative
 Network Metaanalysis,INDoximity üáÆüá≥,Negative
 Network Metaanalysis,clinicaltherapeutics,Negative
 Network Metaanalysis,Paperbirds_Hematology,Negative
 acalabrutinib drug,Vasanthi Ilangovan,Positive
 BTK Briton Tyrosine Kinase protein,Vasanthi Ilangovan,Positive
 cytokines,Vasanthi Ilangovan,Positive
 cytokines,Hospital del Mar_Translational Hematology,Positive
 oxygenation,Vasanthi Ilangovan,Positive
 oxygenation,Amir Faisal,Positive
 Hydroxychloroquine Remdesivir Calquence Jakafi Olumiant Kineret Ilaris MavrilimumabWhy,Sid Murlidhar,Positive
 l,Medivizor,Negative
 l,SNU P√¥le Emploi FSU Occitanie,Negative
 Phase III ASCEND Randomized Trial,Oncology Tube,Negative
 Paolo Ghia MD PhD,Oncology Tube,Negative
 Paolo Ghia MD PhD,OncLive.com,Negative
 Paolo Ghia MD PhD,PER,Negative
 Video,Oncology Tube,Negative
 Video,VJHemOnc,Negative
 Video,LYMPHOMA & MYELOMA CONNECT,Negative
 Video,Cholmangou,Positive
 Video,Annie Urag,Positive
 Video,The Organic Institute CLG,Positive
 Video,Stanley E Cook,Positive
 Video,Harold Kinyanjui,Positive
 Video,Cornelius,Positive
 Video,CryptoLiveLeak,Negative
 Video,CLL Ireland,Negative
 Video,AIM,Positive
 Video,NACDA Program on Aging,Negative
 Q AstraZeneca,"dtw Research, Inc",Negative
 campaignÔ∏è,"dtw Research, Inc",Negative
 September,Cancer Discovery,Negative
 September,Lymphoma Australia,Positive
 September,Greg Hunt,Positive
 September,BioAscend,Positive
 September,Oncology State Societies at ACCC,Negative
 September,TAP Clinical Trial Network,Negative
 September,Medscape Education,Negative
 September,üíô Katharine Parker üò∑#WearAMasküò∑,Positive
 September,RIOH,Negative
 September,PeerView,Negative
 September,Lea,Positive
 September,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 September,CLL Advocates Network,Negative
 September,GatewayC,Positive
 September,OGT,Negative
 September,ecancer,Negative
 September,AACR Foundation,Negative
 September,Kerry,Negative
 September,‚ú®üåû Mask Up and over your damn nose please! üåû‚ú®,Positive
 September,iwCLL,Negative
 September,CURE Magazine,Negative
 September,Univadis,Positive
 September,Sean C. Breathnach,Positive
 September,Patient Empowerment Network,Negative
 September,MerMer Goodburn üåàüá™üá∫ü©∏,Positive
 September,Bag It - Cancer Support,Positive
 September,LiveYourLife,Negative
 September,CLLSA,Positive
 September,LymphomaAction,Positive
 September,Matthews & Associates,Negative
 September,JanssenUS,Negative
 AwarenessMonth ICYMI Acalabrutinib,Cancer Discovery,Negative
 treatmentna√Øve,Cancer Discovery,Positive
 treatmentna√Øve,Cancer Medicine,Positive
 treatmentna√Øve,Oncology Learning Network,Positive
 treatmentna√Øve,NatureRevClinOncol,Negative
 treatmentna√Øve,OncLive.com,Negative
 treatmentna√Øve,Benlazar S.M Amin√©,Negative
 pembrolizumabacalabrutinib,"Tian Zhang, MD, MHS",Positive
 progressionfree survival benefit,OncLive SOSS,Negative
 hypothesis,Occupandi Temporis,Positive
 hypothesis,"chadi nabhan MD, MBA, FACP",Negative
 hypothesis,Illumina Live Events,Positive
 ASCEND Phase III Randomized Trial,Oncology Tube,Negative
 ASCEND Phase III Randomized Trial,filippo masini,Positive
 ASCEND Phase III Randomized Trial,INDoximity üáÆüá≥,Negative
 ASCEND Phase III Randomized Trial,ClinOwl Oncology,Positive
 ASCEND Phase III Randomized Trial,Benlazar S.M Amin√©,Negative
 ASCEND Phase III Randomized Trial,ALI ALAHMARI.,Negative
 amp,TAP Clinical Trial Network,Negative
 amp,CCO_Hepatitis,Positive
 amp,FlatBio,Positive
 amp,Cancer Medicine,Positive
 amp,NYCDoc29,Negative
 amp,Carlo Franzini,Negative
 amp,MyelomaLymphoma,Positive
 amp,Oncology Tube,Positive
 amp,VJHemOnc,Positive
 amp,CLLSA,Positive
 amp,Patient Power,Positive
 amp,J. De Munter,Positive
 amp,American College of Cardiology,Negative
 amp,Breaking Data,Negative
 amp,Kimmo Porkka,Positive
 amp,CLL Society Inc.,Negative
 amp,CCO Infectious Disease,Positive
 amp,APWA,Positive
 amp,"chadi nabhan MD, MBA, FACP",Positive
 amp,OncLive.com,Negative
 amp,AbbVie Canada,Positive
 amp,DDNews Online,Positive
 amp,HemaSphere_EHA,Positive
 amp,Kirstie Page,Positive
 amp,Joe,Positive
 amp,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 amp,AIM Alerts!,Negative
 amp,Avneeti,Positive
 amp,Dr. Andy Evens,Negative
 amp,RU Cancer Patient Education,Positive
 amp,"Raul Cordoba, MD, PhD",Positive
 amp,PeerView,Negative
 amp,Toby Eyre,Negative
 amp,CLL_Fightersüéó,Positive
 amp,Michele Nadeem-Baker,Positive
 amp,Gianluigi Zangari del Balzo,Positive
 amp,Ciara üò∑ masking for a friend,Positive
 amp,Prof John,Positive
 amp,TrialSite News,Positive
 amp,John,Negative
 amp,SeattleCancerCareAlliance,Negative
 amp,Lymphoma Hub,Positive
 amp,Lymphoma Australia,Positive
 amp,Duke Hematologic Malignancies & Cellular Therapy,Negative
 amp,Ohio State Pharmacy,Positive
 amp,Medscape Education,Negative
 amp,Weill Cornell Medicine,Positive
 amp,The Lancet Oncology,Negative
 amp,Guillermo Sanz,Positive
 amp,LymphomaAction,Positive
 amp,GatewayC,Positive
 amp,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 amp,The Lancet Haematology,Positive
 amp,CLL Ireland,Positive
 amp,Broad Institute,Positive
 amp,Matthews & Associates,Negative
 amp,Cellero,Positive
 amp,Esther Schorr,Negative
 amp,Cancer Cell,Positive
 amp,medwireNews,Negative
 amp,Tom,Negative
 amp,Fred Hutch,Positive
 amp,Helen Jane Mee,Positive
 amp,Nick,Positive
 amp,Parc Cient√≠fic de Barcelona,Positive
 amp,cnag-crg,Negative
 amp,Patient Empowerment Network,Negative
 amp,Andrew Schorr,Positive
 amp,Jon,Negative
 amp,CLL Advocates Network,Positive
 amp,The Patient's Channel,Negative
 amp,Biotech2050,Positive
 amp,LiveYourLife,Negative
 amp,Association for Molecular Pathology,Negative
 amp,Archive: Nita Lowey,Positive
 amp,ASCO,Negative
 amp,Carrie Stricker,Positive
 amp,NeoGenomics,Positive
 amp,BrandUK,Positive
 amp,Misha Sakharoff,Positive
 amp,J Immunol,Negative
 amp,Lab Tests Online,Positive
 amp,gn√∫bila France,Positive
 amp,David MANSET,Positive
 amp,ASH,Positive
 amp,ESMO - Eur. Oncology,Negative
 amp,Atrium Health Navicent,Positive
 amp,MD Anderson Leukemia,Negative
 amp,Scientia,Positive
 amp,Brad Tompkins,Positive
 amp,CARE‚Ñ¢ Education,Positive
 amp,joel mathews,Positive
 amp,Genentech,Negative
 amp,Steve McCabe,Positive
 amp,JAMA Oncology,Negative
 amp,RCCG | TOD Youths,Positive
 amp,EIN Presswire: Pharmaceutical Newswire,Negative
 amp,HMRN UK,Positive
 amp,Lymphoma Canada,Negative
 amp,Anand Rotte,Positive
 amp,Connie Erpelding,Positive
 amp,Hematopoiesis News,Negative
 amp,Dr.Gretchen Morrison,Positive
 amp,Esther Wroughton,Positive
 amp,Adaptive Biotech,Negative
 amp,Christopher Steer,Negative
 amp,Lymphomation.org,Negative
 amp,Lymphoma News Today,Positive
 amp,Matthias Piesche,Negative
 amp,Mehdi Hamadani,Positive
 amp,Paul Brennan (He/His),Positive
 amp,Brownskin_cee,Positive
 amp,1stOncology,Negative
 amp,Robert Z. Orlowski,Negative
 Phase III Clinical TrialBased Early Economic Evaluation,filippo masini,Negative
 Phase III Clinical TrialBased Early Economic Evaluation,Benlazar S.M Amin√©,Negative
 Relapsed Chronic Lymphocytic Leukaemia,filippo masini,Negative
 Relapsed Chronic Lymphocytic Leukaemia,Benlazar S.M Amin√©,Negative
 Relapsed Chronic Lymphocytic Leukaemia,HealthEconBot,Positive
 Relapsed Chronic Lymphocytic Leukaemia,Paperbirds_Hematology,Negative
 Therapeutic Potential,filippo masini,Negative
 Therapeutic Potential,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Short Review,filippo masini,Negative
 Michael Wang MD,Oncology Tube,Negative
 Michael Wang MD,Cancer Medicine,Positive
 STELLAR UPDATECongratulations,TAP Clinical Trial Network,Negative
 WATCH Jennifer Woyach MD,OncLive.com,Negative
 mantle cell lymphoma MCL,"KOLKATA RAVI SPECIALITIES PHARMA PVT.LTD.,",Positive
 mantle cell lymphoma MCL,delhi-ravi worldwide medicines,Positive
 mantle cell lymphoma MCL,Trip Database,Positive
 mantle cell lymphoma MCL,Health Canada and PHAC,Positive
 mantle cell lymphoma MCL,The Galien Foundation,Positive
 mantle cell lymphoma MCL,"Hatem Murad, MD,FAAN.     ÿ≠ÿßÿ™ŸÖ ŸÖÿ±ÿßÿØ",Positive
 superiority,Targeted Oncology,Negative
 superiority,NYCDoc29,Negative
 superiority,the world of CROs,Negative
 superiority,Pharma Tech Focus,Positive
 superiority,Michael Hallek,Negative
 superiority,MoJo,Negative
 superiority,Turmeric,Negative
 terms,Targeted Oncology,Negative
 terms,Proactive,Negative
 terms,CLLSA,Negative
 terms,Toby Eyre,Negative
 terms,Michael's Pharmacy,Positive
 terms,Margaret Walker,Negative
 terms,Publish PressRelease,Positive
 terms,"Raul Cordoba, MD, PhD",Positive
 extended progressionfree survival,Targeted Oncology,Negative
   LCCC,CureHuntr,Negative
 RelapsedRefractory Primary,CureHuntr,Negative
 RelapsedRefractory Primary,TrialBulletin,Negative
 Secondary CNS,CureHuntr,Negative
 Secondary CNS,TrialBulletin,Negative
 Lymphomas,CureHuntr,Negative
 Lymphomas,Oncology Tube,Negative
 Lymphomas,Internal Medicine: Open Access,Positive
 LCCC,TrialBulletin,Negative
 Lymphomas Status,TrialBulletin,Negative
 Condition Summary Lymphoma,TrialBulletin,Negative
 WATCH Paolo Ghia MD PhD,OncLive.com,Negative
 Superior PFS,Stem Cells in the News,Positive
 Superior PFS,Stem cell Watch,Positive
 Superior PFS,MoJo,Negative
 StandardfCare,Stem Cells in the News,Positive
 StandardfCare,Stem cell Watch,Positive
 Sustained Superiority,Stem Cells in the News,Positive
 Sustained Superiority,OncLive.com,Negative
 StandardofCare,Stem Cells in the News,Positive
 StandardofCare,OncLive.com,Negative
 Regimens,Stem Cells in the News,Positive
 Regimens,OncLive.com,Negative
 Regimens,COPD News,Negative
 Regimens,CURE Magazine,Positive
 Relapsed,Stem Cells in the News,Positive
 Relapsed,CureHuntr,Negative
 Relapsed,TrialBulletin,Negative
 Relapsed,The ASCO Post,Positive
 Relapsed,Crwe World,Positive
 Relapsed,Yemen News,Positive
 Relapsed,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥,Positive
 Relapsed,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥ - Í±¥Í∞ï,Positive
 Relapsed,EIN Presswire: Pharmaceutical Newswire,Negative
 Relapsed,BusinessWireProducts,Positive
 Relapsed,Stockboard Media Inc,Negative
 Relapsed,INDoximity üáÆüá≥,Negative
 Relapsed,"Andrew Johns, MD",Positive
 Relapsed,Philip McCarthy,Negative
 Relapsed,Benlazar S.M Amin√©,Negative
 Relapsed,CellworksLife,Negative
 Relapsed,Bloodsucking Parasites,Positive
 Relapsed,Elsevier Oncology,Negative
 Relapsed,Financial Buzz,Positive
 Relapsed,"Raul Cordoba, MD, PhD",Negative
 Relapsed,Lymphomation.org,Positive
 Relapsed,Dominique,Positive
 Relapsed,Dr. Leona Saunders,Positive
 Relapsed,IntoxicatedTrader,Negative
 Relapsed,satPRnews,Negative
 Dr Woyach,Oncology News Update,Negative
 Dr Woyach,Targeted Oncology,Positive
 Dr Woyach,"Amber Koehler, PA-C",Negative
 Dr Woyach,"Mark Geyer, M.D.",Negative
 Dr Woyach,Chan Cheah,Negative
 Dr Woyach,Carmine DeLuca,Negative
 Role,Oncology News Update,Negative
 Role,Delreo Johnson,Positive
 Role,Which e Cars,Positive
 Role,Andy Vermaut,Positive
 Role,OncLive.com,Positive
 Role,Paperbirds_Hematology,Positive
 Role,CAR-TCR,Positive
 Role,Tom,Negative
 Role,Lymphoma Papers,Negative
 Role,Medscape Education,Positive
 Role,EurekaMag,Positive
 Role,Toby Eyre,Negative
 Role,CLL-seq,Positive
 Role,Enfermeria y Seguridad del Paciente,Positive
 Role,MD Anderson Leukemia,Negative
 Role,Renal Cell Carcinoma,Negative
 Role,RAVIKANTH S,Negative
 Role,Oncology Tube,Positive
 Role,Junaid Hussain,Positive
 Role,Internal Medicine: Open Access,Negative
 Role,Cancer Papers,Positive
 Role,microRNApapers,Positive
 Role,CLL Ireland,Negative
 Role,JournalAgent,Positive
 Role,leukemia,Positive
 Role,Garbi√±e Lizeaga,Negative
 Role,GEDEFO,Positive
 Role,APSHO,Negative
 Role,Benito,Positive
 Role,sandrineman,Negative
 Role,Oncology Times,Negative
 Role,"Raul Cordoba, MD, PhD",Negative
 Role,Helen Ong,Positive
 Role,AURELIAN UDRISTIOIU,Negative
 Role,BioinfoPapers,Positive
 Role,TumorImmunoPapers,Positive
 Role,Lymphoma Coalition,Negative
 Role,NACDA Program on Aging,Positive
 Role,Pharm Digest,Negative
 Role,CancerWallonia,Positive
 Role,Frontiers Immunology,Negative
 Role,Biblioteca CCBS-UFCG,Positive
 Role,News Reactions,Positive
 Role,Breaking News,Negative
 Role,Media Tower,Positive
 Role,News Stories,Positive
 Role,Scott Werntz,Negative
 SOHO,Gabriel Chinchilla,Positive
 SOHO,Paperbirds_Hematology,Positive
 Information,Gabriel Chinchilla,Positive
 Information,CONQUER the patient voice,Negative
 Information,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 Information,Robin Hood,Positive
 Information,Oncology Tube,Negative
 CONGRESS,Lymphoma Hub,Positive
 Bortezomib,Lymphoma Hub,Negative
 carfilzomib,Lymphoma Hub,Negative
 NEWS,HemOnc Today,Positive
 NEWS,Lymphoma Hub,Negative
 debate,Seema Ali Bhat,Positive
 debate,Targeted Oncology,Negative
 debate,Lymphoma Hub,Negative
 debate,Jeff Sharman,Positive
 debate,ASH Clinical News,Negative
 CLL answer,Seema Ali Bhat,Positive
 ASCEND trial,Lymphoma Hub,Negative
 ASCEND trial,VJHemOnc,Negative
 P Ghia     Acalabrutinib,Lymphoma Hub,Negative
    Trials,Ronald M. Chavin,Positive
 China,Ronald M. Chavin,Positive
 China,dough,Negative
 China,Pablo AQ,Positive
 China,Bitchin' Science,Positive
 China,Stock Market News,Negative
 China,Pharmacutical Daily,Negative
 China,Sarang Pokhare,Negative
 China,IMPharma News,Negative
 China,Latest News from Business Wire,Negative
 China,Crwe World,Positive
 China,China Science,Positive
 China,Wellcome-home,Negative
 China,DennisPartners,Negative
 China,Quant Data,Negative
 China,Stock Titan,Negative
 China,Odi Bruckman,Positive
 China,"Amber Koehler, PA-C",Negative
 China,PharmaShots - Incisive news in 3 shots,Negative
 China,Bio Stocks‚Ñ¢,Negative
 IL blocker tocilizumab trials,Ronald M. Chavin,Positive
 Italy,Ronald M. Chavin,Positive
 IL blocker anakinra,Ronald M. Chavin,Positive
 Mantle cell lymphoma,Dr. Luis Villela,Positive
 Mantle cell lymphoma,donnashort,Positive
 Mantle cell lymphoma,Haleplushearty.org,Positive
 M,Dr. Luis Villela,Positive
 M,Jeff Cranmer,Positive
 M,Kompetenznetz Maligne Lymphome e.V.,Negative
 M,Clean Food,Positive
 M,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 M,UM Human Resources,Positive
 M,NEJM CPC,Positive
 M,El Rey de la Bodegaüá™üá®,Positive
 M,Biotech2050,Positive
 M,Oxford virtual,Positive
 M,Labiotech.eu,Positive
 M,Scott Werntz,Negative
 yo,Dr. Luis Villela,Positive
 yo,Aurora Cancer Care,Positive
 yo,"Mike Thompson, MD, PhD, FASCO",Positive
 mediastinum xcm amp abdomen,Dr. Luis Villela,Positive
 RCHOPRDHAP PETCT,Dr. Luis Villela,Positive
 SCI member Steve Coutre,"Steven Artandi, MD, PhD",Positive
 colleagues,"Steven Artandi, MD, PhD",Positive
 colleagues,"Maria Badillo, MSN RN OCN CCRP",Negative
 colleagues,The Lancet Haematology,Negative
 colleagues,UoB Cardiovascular,Positive
 colleagues,CRUK Birmingham Centre,Positive
 colleagues,MOASC,Positive
 colleagues,"Chaitra Ujjani, MD",Positive
 colleagues,"chadi nabhan MD, MBA, FACP",Positive
 colleagues,Michael Hallek,Positive
 colleagues,Lymphoma Hub,Negative
 colleagues,JExpMed,Negative
 colleagues,Anthony Mato,Negative
 colleagues,"Krizs√°n Szilvia, MD",Positive
 colleagues,MedPage Oncology,Positive
 colleagues,Didi Jasmin,Positive
 colleagues,ClinicalBid,Positive
 colleagues,Dene Peters,Positive
 colleagues,Paul Br√∂ckelmann,Positive
 colleagues,Taylor Lab UM,Negative
 colleagues,Research To Practice,Negative
 colleagues,Dr. Andre Goy,Negative
 colleagues,Michael Moles,Positive
 colleagues,Patient Power,Negative
 colleagues,ASCO,Negative
 progressionfree survival,"Steven Artandi, MD, PhD",Negative
 progressionfree survival,Dr. Andy Evens,Negative
 progressionfree survival,Hallwang Clinic,Positive
 progressionfree survival,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 progressionfree survival,re-how.net,Negative
 progressionfree survival,Chocolatiere Phys,Negative
 progressionfree survival,ecancer,Negative
 progressionfree survival,CURE Magazine,Positive
 progressionfree survival,i3 Health,Negative
 progressionfree survival,HemOnc Today,Negative
 progressionfree survival,KeiraSmith_i3Health,Positive
 progressionfree survival,HCPLive,Positive
 progressionfree survival,Fish Chromosomes,Positive
 progressionfree survival,Targeted Oncology,Positive
 progressionfree survival,OncLive.com,Negative
 progressionfree survival,CellworksLife,Negative
 progressionfree survival,InfocusRx Today,Positive
 progressionfree survival,Cancer Papers,Negative
 progressionfree survival,Lymphoma Papers,Negative
 progressionfree survival,"Pharmacyclics, an AbbVie Company",Negative
 progressionfree survival,2 Minute Medicine¬Æ,Positive
 progressionfree survival,"Marc Succi, MD",Positive
 progressionfree survival,CLL Ireland,Negative
 progressionfree survival,"Raul Cordoba, MD, PhD",Negative
 progressionfree survival,Francesco Bertoni,Negative
 progressionfree survival,ASH Clinical News,Negative
 progressionfree survival,ASH,Negative
 progressionfree survival,CancerTherapyAdvisor,Negative
 Phase III Randomized Trial,Mahmoud Aljurf,Negative
 Phase III Randomized Trial,Francesco Bertoni,Negative
 Idelalisib,Mahmoud Aljurf,Negative
 Idelalisib,The ASCO Post,Positive
 Idelalisib,filippo masini,Positive
 Idelalisib,Trip Database,Positive
 Idelalisib,abej,Negative
 Idelalisib,INDoximity üáÆüá≥,Negative
 Idelalisib,ClinOwl Oncology,Positive
 Idelalisib,Benlazar S.M Amin√©,Positive
 Idelalisib,ALI ALAHMARI.,Positive
 Idelalisib,Oncology,Positive
 Idelalisib,Oncology Publishers Feed,Negative
 Idelalisib,Paperbirds_Hematology,Negative
 Idelalisib,Jerry Lee,Negative
 Idelalisib,@ScottWaudbyHaemResLeics,Positive
 Idelalisib,CellworksLife,Negative
 Idelalisib,Cure Cancer Now,Positive
 Idelalisib,Martin JS Dyer,Positive
 Idelalisib,Lymphoma Papers,Negative
 Idelalisib,ClinOwl,Positive
 Idelalisib,James Kerwin,Positive
 Idelalisib,ClinicalTrialsData,Negative
 Idelalisib,Elsevier Oncology,Negative
 Idelalisib,Dr. Jos√© A. Queiz√°n,Negative
 Idelalisib,maria jose agustin,Positive
 Idelalisib,Blood Advances,Negative
 Idelalisib,ImmunotherapyPapers,Negative
 Idelalisib,FDA Oncology,Negative
 Idelalisib,Cancer Papers,Positive
 Idelalisib,Robert Z. Orlowski,Negative
 Idelalisib,Lymphoma Hub,Positive
 Idelalisib,HemOnc Today,Positive
 Idelalisib,Healio,Negative
 Idelalisib,Immuno-Oncology,Negative
 Idelalisib,"Darcy Burbage, DNP, RN, AOCN",Negative
 Idelalisib,CARE‚Ñ¢ Education,Negative
 Idelalisib,"Raul Cordoba, MD, PhD",Positive
 Idelalisib,NACDA Program on Aging,Positive
 Idelalisib,FarmaOnco,Negative
 Idelalisib,Gendron Recherche,Negative
 Idelalisib,Cancer Daily,Negative
 Idelalisib,OncLive.com,Negative
 Idelalisib,Dr. JOSE VELASQUEZ,Positive
 Idelalisib,Christopher Steer,Negative
 Idelalisib,TumorImmunoPapers,Negative
 Idelalisib,CancerTherapyAdvisor,Negative
 Idelalisib,Stem Cell News,Negative
 Idelalisib,Targeted Oncology,Negative
 Idelalisib,Cancer Cell,Negative
 Idelalisib,PracticeUpdate,Negative
 Idelalisib,Tran-Der Tan,Negative
 Idelalisib,Lymphomation.org,Negative
 Idelalisib,VoyagerMed,Positive
 Idelalisib,CureHuntr,Negative
 Idelalisib,CHS Chief Resident,Positive
 Idelalisib,Dr Zia ur Rehman,Positive
 Idelalisib,Doctors*Overseas,Negative
 Idelalisib,"Junaid Ansari, MD",Positive
 Rituximab,Mahmoud Aljurf,Positive
 Rituximab,The ASCO Post,Positive
 Rituximab,filippo masini,Positive
 Rituximab,Trip Database,Positive
 Rituximab,abej,Positive
 Rituximab,INDoximity üáÆüá≥,Positive
 Rituximab,ClinOwl Oncology,Positive
 Rituximab,Benlazar S.M Amin√©,Positive
 Rituximab,ALI ALAHMARI.,Positive
 Rituximab,Renal Cell Carcinoma,Negative
 Rituximab,CureHuntr,Positive
 Rituximab,TrialBulletin,Positive
 Rituximab,U-M Rogel Cancer Center,Positive
 Rituximab,PharmaFactz,Negative
 Rituximab,"Dr T. Comeau , MD",Positive
 Rituximab,MDBriefCase,Positive
 Rituximab,Alicia Bell IFBB Pro,Positive
 Rituximab,Paperbirds_Hematology,Positive
 Rituximab,@globalfirstnews,Positive
 Rituximab,Eduardo Flavio Oliveira Ribeiro,Negative
 Rituximab,Aloysius Pendergast,Positive
 Rituximab,ClinOwl Haematology,Negative
 Rituximab,Miriam L√≥pez P√©rez,Positive
 Rituximab,Juan Marquet,Negative
 Rituximab,ClinOwl,Positive
 Rituximab,JAVIER DE LA SERNA,Positive
 Rituximab,CellworksLife,Negative
 Rituximab,SAGE Clinical Med,Positive
 Rituximab,PharmaShots - Incisive news in 3 shots,Negative
 Rituximab,Alisyn Gayle,Positive
 Rituximab,Frontiers Oncology,Negative
 Rituximab,FarmaciaHUAP,Negative
 Rituximab,Oncology Times,Positive
 Rituximab,NewExpressNews,Negative
 Rituximab,Cord Blood News,Negative
 Rituximab,PressReleasePoint,Negative
 Rituximab,Company News HQ,Negative
 Rituximab,SeqComplete,Negative
 Rituximab,BuxMont Forum,Positive
 Rituximab,NwokeAgulu,Negative
 Rituximab,Jesus F Sierra,Positive
 Rituximab,Simple Charts,Negative
 Rituximab,"Raul Cordoba, MD, PhD",Positive
 Rituximab,James Kerwin,Positive
 Rituximab,HSMN,Positive
 Rituximab,Bio Stocks‚Ñ¢,Negative
 Rituximab,Lung Cancer News,Negative
 Rituximab,ClinicalTrialsData,Negative
 Rituximab,Cureus,Negative
 Rituximab,Lymphoma Papers,Positive
 Rituximab,2 Minute Medicine¬Æ,Negative
 Rituximab,Oncology,Positive
 Rituximab,Kenar Jhaveri,Positive
 Rituximab,NEJM,Positive
 Rituximab,Konstantinos Vlachos,Positive
 Rituximab,Prof John,Negative
 Rituximab,Florent Malard,Negative
 Rituximab,"Wafik S. El-Deiry, MD, PhD, FACP",Positive
 Rituximab,Philip McCarthy,Negative
 Rituximab,Dr. Jos√© A. Queiz√°n,Positive
 Rituximab,Montse Carrere,Positive
 Rituximab,Merche Gironella,Positive
 Rituximab,Medicine Briefly,Negative
 Rituximab,Hematolog√≠a Salamanca,Negative
 Rituximab,Adriana Aguilar,Positive
 Rituximab,Al-Ola A Abdallah MD,Positive
 Rituximab,COPD News,Negative
 Rituximab,Bloodsucking Parasites,Positive
 Rituximab,Medivizor,Positive
 Rituximab,Medscape Education,Negative
 Rituximab,NASDAQ,Positive
 Rituximab,maria jose agustin,Positive
 Rituximab,"Michael Cautillo, J.D.",Positive
 Rituximab,Oncology Tube,Negative
 Rituximab,Medscape,Negative
 Rituximab,HEDGE accordinglyüìà,Positive
 Rituximab,RazzleTazzle,Positive
 Rituximab,Marketbit.pro,Positive
 Rituximab,MoJo,Positive
 Rituximab,Seattle's Banker,Positive
 Rituximab,CRE Demographics,Positive
 Rituximab,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Rituximab,CLL Ireland,Negative
 Rituximab,Crwe World,Negative
 Rituximab,Today's News,Positive
 Rituximab,HRI Portal,Negative
 Rituximab,gilbert c faure,Negative
 Rituximab,Rob Wilson,Positive
 Rituximab,EurekaMag,Negative
 Rituximab,AmericanPharmacyNews,Negative
 Rituximab,aeses.com,Positive
 Rituximab,Targeted Oncology,Negative
 Rituximab,Mike Gauthier,Negative
 Rituximab,Sicilia Informazioni,Positive
 Rituximab,Financial Buzz,Positive
 Rituximab,FDA Daily,Negative
 Rituximab,Cancer Papers,Positive
 Rituximab,A. Vroom - Ten Wolde,Negative
 Rituximab,‰πÖ‰ΩèËã±‰∫åÔºà„Åè„Åô„Åø„Åà„ÅÑ„ÅòÔºâ,Positive
 Rituximab,adel aljatham,Positive
 Rituximab,Rishi Dhawan MD. DM,Positive
 Rituximab,RAUL FERRANDO,Positive
 Rituximab,NE Live,Negative
 Rituximab,Isaura R. Penin,Negative
 Rituximab,Marcelo Dom√≠nguez,Positive
 Rituximab,Junaid Hussain,Positive
 Rituximab,Dr. Andres G Palomo,Positive
 Rituximab,"Mike Thompson, MD, PhD, FASCO",Negative
 Rituximab,GEDEFO,Positive
 Rituximab,"Salvatore Papa, PhD",Positive
 Rituximab,Robert Z. Orlowski,Negative
 Rituximab,Muzaffar Qazilbash,Negative
 Rituximab,Garbi√±e Lizeaga,Negative
 Rituximab,SurvivalGear,Negative
 Rituximab,Benito,Positive
 Rituximab,sandrineman,Negative
 Rituximab,MD Anderson Leukemia,Negative
 Rituximab,Lisa Palacios,Negative
 Rituximab,osakahiro,Positive
 Rituximab,NACDA Program on Aging,Positive
 Rituximab,Lymphoma Canada,Negative
 Rituximab,Shohta Kadomura Hospital Pharmacist,Negative
 Rituximab,üê∏ gab.ai/wu üê∏,Positive
 Rituximab,CancerTherapyAdvisor,Negative
 Rituximab,BusinessWireProducts,Negative
 Rituximab,dlvr news,Negative
 Rituximab,$Stocknewsalerts,Negative
 Rituximab,Chan Cheah,Negative
 Rituximab,Dr Ortega,Negative
 Rituximab,pharmatutor,Positive
 Rituximab,PracticeUpdate,Negative
 Rituximab,Tran-Der Tan,Negative
 Rituximab,Lymphomation.org,Negative
 Rituximab,Dr Zia ur Rehman,Positive
 Rituximab,ASH,Positive
 Rituximab,Doctors*Overseas,Negative
 Rituximab,"Junaid Ansari, MD",Positive
 Rituximab,Cancer News,Negative
 Bendamustine,Mahmoud Aljurf,Negative
 Bendamustine,The ASCO Post,Negative
 Bendamustine,filippo masini,Positive
 Bendamustine,Trip Database,Negative
 Bendamustine,abej,Negative
 Bendamustine,INDoximity üáÆüá≥,Negative
 Bendamustine,Francesco Bertoni,Negative
 Bendamustine,ClinOwl Oncology,Positive
 Bendamustine,Benlazar S.M Amin√©,Positive
 Bendamustine,ALI ALAHMARI.,Negative
 Bendamustine,U-M Rogel Cancer Center,Positive
 Bendamustine,Lymphomation.org,Negative
 Bendamustine,"Dr T. Comeau , MD",Positive
 Bendamustine,Oncology,Positive
 Bendamustine,Medivizor,Positive
 Bendamustine,ClinOwl Haematology,Negative
 Bendamustine,Lung Cancer News,Negative
 Bendamustine,@balbensi üá∫üá∏ üáÆüáπ,Positive
 Bendamustine,Toby Eyre,Negative
 Bendamustine,MoJo,Negative
 Bendamustine,"Raul Cordoba, MD, PhD",Positive
 Bendamustine,Izaskun Zeberio,Negative
 Bendamustine,Lymphoma Canada,Negative
 Bendamustine,ÕèWilliam Avery Hudson,Negative
 Bendamustine,CLL Ireland,Negative
 Bendamustine,CancerTherapyAdvisor,Negative
 Bendamustine,PracticeUpdate,Negative
 Bendamustine,BusinessWireProducts,Negative
 Bendamustine,dlvr news,Negative
 Bendamustine,$Stocknewsalerts,Negative
 Bendamustine,Dr Ortega,Negative
 Bendamustine,pharmatutor,Positive
 Bendamustine,aeses.com,Negative
 Bendamustine,Cancer Papers,Negative
 Relapsed Refractory CLL Acalabrutinib,Mahmoud Aljurf,Negative
 IR BR amp,Mahmoud Aljurf,Negative
 New   Acalabrutinib   Obinutuzumab,MD Anderson Leukemia,Negative
 TX,MD Anderson Leukemia,Negative
 PI Jan Burger MD PhD     NCT,MD Anderson Leukemia,Negative
 ProgressionFree Survival,The ASCO Post,Negative
 ProgressionFree Survival,Pharmacutical Daily,Negative
 ProgressionFree Survival,Saeed Valadbaygi,Positive
 ProgressionFree Survival,Crwe World,Positive
 ProgressionFree Survival,Renal Cell Carcinoma,Negative
 ProgressionFree Survival,Patient Power,Negative
 ProgressionFree Survival,LLZ Consulting,Negative
 ProgressionFree Survival,1stOncology,Negative
 ProgressionFree Survival,Stock Market News,Negative
 ProgressionFree Survival,Simple Charts,Negative
 ProgressionFree Survival,MasdelMedio,Negative
 ProgressionFree Survival,pressdaily,Negative
 ProgressionFree Survival,Pharma News,Positive
 ProgressionFree Survival,SpecialtyPTimes,Positive
 ProgressionFree Survival,HEDGE accordinglyüìà,Negative
 ProgressionFree Survival,RazzleTazzle,Negative
 ProgressionFree Survival,CRE Demographics,Negative
 ProgressionFree Survival,"Darcy Burbage, DNP, RN, AOCN",Negative
 ProgressionFree Survival,Oncology,Negative
 ProgressionFree Survival,aeses.com,Negative
 ProgressionFree Survival,Michael,Positive
 ProgressionFree Survival,Aktienmanufaktur,Negative
 ProgressionFree Survival,Scott Werntz,Negative
 ProgressionFree Survival,Financescom-stocks,Positive
 Relapsed Refractory CLL,The ASCO Post,Negative
 Relapsed Refractory CLL,abej,Negative
 Relapsed Refractory CLL,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 Relapsed Refractory CLL,Dr Timos Papagatsias,Negative
 Relapsed Refractory CLL,OncoTherapy Network,Negative
 Drs Seema Bhat amp Jennifer Woyach Final ASCEND Results Confirm Acalabrutinib,The ASCO Post,Negative
 Standard,The ASCO Post,Negative
 Standard,Oncology Times,Negative
 Standard,Patient Power,Negative
 Standard,Oncology Tube,Positive
 Relapsed CLL,The ASCO Post,Negative
 Relapsed CLL,CancerTherapyAdvisor,Positive
 Relapsed CLL,Doctors Lounge,Positive
 Relapsed CLL,Oncology,Negative
 Relapsed CLL,Dr. JOSE VELASQUEZ,Negative
   Australians,7NEWS Sydney,Positive
 Federal Health Minister,Lymphoma Australia,Positive
 Keytruda,Lymphoma Australia,Positive
 Keytruda,Clarivate Cortellis,Negative
 PBS,Lymphoma Australia,Positive
 PBS,Greg Hunt,Positive
 relapsedrefractory PMBCL amp Calquence Acalabrutinib,Lymphoma Australia,Positive
 CLL amp SLL Great news,Lymphoma Australia,Positive
 lymphoma patients,Lymphoma Australia,Positive
 lymphoma patients,Michael Rynne,Negative
 World Lymphoma Awareness month,Rozalina Sarkezians,Positive
 Acalabrutinib PBS,haemdoc,Positive
 PY Inhibitors,haemdoc,Positive
 Cancer drugs,Specialty Pharmacy Continuum,Positive
 Cancer drugs,InfectiousDiseaseSE,Positive
 Cancer drugs,Pharmacy Practice News,Positive
 SecondGeneration BTKi,"Tom Henry, MBA, RPh, CPh",Negative
 Brilliant news,Leukaemia Foundation,Negative
 Brilliant news,Deirdre O'Connor,Positive
 DanaFarber LeedsHospitals,"Narinder Grewal, MD",Positive
 time,Greg Hunt,Positive
 time,re-how.net,Negative
 time,Pharma News,Negative
 time,Briefing.com,Positive
 time,1stOncology,Positive
 time,Qollor,Positive
 time,Cision News,Positive
 time,PressReleasePoint,Negative
 time,iwCLL,Positive
 time,Mass Eye and Ear,Positive
 time,Patient Power,Positive
 time,ASH Clinical News,Positive
 time,Michael Rynne,Negative
 time,Patient Empowerment Network,Positive
 time,Jeff Neurman,Negative
 time,Te Atatu Roosters Rugby League,Negative
 time,MyPathologyReport.ca,Positive
 time,"Andreas-Claudius Hoffmann, M.D.",Positive
 time,"Amber Koehler, PA-C",Negative
 time,Clinical Lab Manager,Positive
 time,Medivizor,Negative
 time,Barry Shrier,Negative
 time,noel cole,Negative
 time,Memorial Sloan Kettering Cancer Center,Negative
 time,Paperbirds_Hematology,Negative
 time,Benlazar S.M Amin√©,Negative
 time,LymphomaAction,Negative
 time,Gear√≥id √ì Crotaigh #CareCantWait,Negative
 time,Joe,Negative
 time,Toby Eyre,Positive
 time,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 time,Janssen EMEA,Negative
 time,CURE Magazine,Negative
 time,Brotman Baty,Positive
 time,ISBT Central Office,Positive
 time,Tom,Negative
 time,AbbVie Canada,Negative
 time,MDedge Hematology & Oncology,Negative
 time,CLL Ireland,Negative
 time,CLL_Fightersüéó,Negative
 time,LiveYourLife,Positive
 time,CLL Advocates Network,Negative
 time,Leukaemia Care,Negative
 time,CLL Warwick Uni,Negative
 time,Sherry ‚öæÔ∏è BaseballBabe üíúSkol Lady üíõ RTB,Positive
 time,Dr. Melody Davis,Negative
 time,Holden Caulfield PhD,Positive
 time,Lab Tests Online,Positive
 time,Helen Jane Mee,Negative
 time,VJHemOnc,Negative
 time,Oncology Tube,Negative
 time,Oncology Nursing News,Negative
 time,Joey Snella,Positive
 time,CancerTherapyAdvisor,Negative
 time,Blood Journal,Negative
 time,Erika,Positive
 time,"Navneet Majhail, MD, MS",Negative
 time,"Mario Cerdan, MD",Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,filippo masini,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Trip Database,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,INDoximity üáÆüá≥,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,ClinOwl Oncology,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,ALI ALAHMARI.,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Mazen M,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,Latest News from Business Wire,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,Corporate News,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,"OTC Dynamics, Inc.",Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,The ASCO Post,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Paperbirds_Hematology,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,ClinicalTrialsData,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,E Lambrechts,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,EurekaMag,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,"Naveen Pemmaraju, MD",Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,A. Vroom - Ten Wolde,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Tom,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,‰πÖ‰ΩèËã±‰∫åÔºà„Åè„Åô„Åø„Åà„ÅÑ„ÅòÔºâ,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,adel aljatham,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Rishi Dhawan MD. DM,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,NEJM,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,AGD Biomedicals,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,"Wafik S. El-Deiry, MD, PhD, FACP",Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,Isaura R. Penin,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,Marcelo Dom√≠nguez,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Junaid Hussain,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Internet Medical,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Dr. Andres G Palomo,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,"Mike Thompson, MD, PhD, FASCO",Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,MHC,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,GEDEFO,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,"Dr T. Comeau , MD",Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,"Salvatore Papa, PhD",Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,"Raul Cordoba, MD, PhD",Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Robert Z. Orlowski,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,Muzaffar Qazilbash,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,Christoph Westphal,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,üá∫üá∏jonnyüá∫üá∏,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,MantasTrades,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Mark,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,ANTELLIS,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,N A S A,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Business Wire-Health,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,Business Wire-TS,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,BusinessWireWebcasts,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,BusinessWireProducts,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,üò∑ Caleph B. Wilson,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,The Pharmaceutical Marketing Group,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,BusinessWire-Science,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,"Darcy Burbage, DNP, RN, AOCN",Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,TrialBulletin,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,CureHuntr,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,T√ºrkiye Klinikleri,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,TumorImmunoPapers,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia,fainfo salute,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia,Scott Werntz,Negative
   phase,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
   phase,Rare Disease Report,Negative
 ACECL trial,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 ACECL trial,Lymphoma Hub,Negative
 ACECL trial,EuropaWire,Negative
 pembrolizumab,Dr. Iv√°n R. Gonz√°lez,Positive
 pembrolizumab,Medicine Matters oncology,Positive
 pembrolizumab,OncologyNurseAdvisor,Negative
 pembrolizumab,Renal & Urology News,Positive
 pembrolizumab,CancerTherapyAdvisor,Negative
 pembrolizumab,the paper link,Positive
 pembrolizumab,Clarivate Cortellis,Negative
 pembrolizumab,ECOG-ACRIN Cancer Research Group,Negative
 pembrolizumab,Targeted Oncology,Negative
 pembrolizumab,OncLive.com,Negative
 pembrolizumab,Lymphoma Hub,Negative
 FDA approval,ACS Journal Cancer,Negative
 FDA approval,Oncology Learning Network,Negative
 FDA approval,Becca Peterson,Positive
 FDA approval,Pharmaceutical Market Europe,Positive
 FDA approval,Pharma Regulatory,Negative
 FDA approval,OncLive.com,Negative
 FDA approval,The Galien Foundation,Positive
 FDA approval,medwireNews,Negative
 FDA approval,Evaluate Pharma,Positive
 FDA approval,OyeCricket.com,Positive
 FDA approval,ipharmacenter,Negative
 FDA approval,VHSPL,Positive
 FDA approval,Targeted Oncology,Positive
 FDA approval,CLL Advocates Network,Negative
 FDA approval,Bionest Partners,Negative
 FDA approval,Koch Institute at MIT,Positive
 FDA approval,Medklik,Negative
 FDA approval,Roche,Negative
 FDA approval,"Robinson Ortiz, MD",Negative
 FDA approval,Michele Nadeem-Baker,Negative
 FDA approval,Biologics by McKesson,Negative
 FDA approval,Jad Adaimi,Positive
 FDA approval,WCM Lymphoma,Negative
 BTK inhibitor acalabrutinib,ACS Journal Cancer,Negative
 BTK inhibitor acalabrutinib,"COTA, Inc.",Positive
 BTK inhibitor acalabrutinib,OncLive.com,Negative
 BTK inhibitor acalabrutinib,Oncology Nursing News,Negative
 BTK inhibitor acalabrutinib,Medscape Pharmacists,Negative
 BTK inhibitor acalabrutinib,Medscape,Negative
 BTK inhibitor acalabrutinib,NatureRevClinOncol,Negative
 BTK inhibitor acalabrutinib,Targeted Oncology,Negative
 BTK inhibitor acalabrutinib,PharmaSources.com,Positive
 BTK inhibitor acalabrutinib,FirstWord Pharma,Negative
 BTK inhibitor acalabrutinib,Marc Gozlan,Positive
 News Adding acalabrutinib,Medicine Matters oncology,Positive
 et al,Medicine Matters oncology,Positive
 et al,Chan Cheah,Negative
 et al,LYMPHOMA & MYELOMA CONNECT,Positive
 et al,"Mike Thompson, MD, PhD, FASCO",Positive
 et al,Josie B.,Negative
 et al,Alexander Luchinin,Positive
 et al,MUVBBvirtual,Negative
 et al,"Navneet Majhail, MD, MS",Positive
 et al,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 et al,Researchphilia,Positive
 et al,ASCO Publications,Negative
 et al,Toby Eyre,Positive
 et al,CLL Ireland,Negative
 et al,VJHemOnc,Negative
 et al,Dr. Jos√© A. Queiz√°n,Negative
 et al,"Jason Westin, MD FACP",Positive
   REtreatment,CureHuntr,Negative
 VEnetoclax,CureHuntr,Negative
 VEnetoclax,TrialBulletin,Negative
 Venetoclax Limited Duration REVEAL,CureHuntr,Negative
 REtreatment,TrialBulletin,Negative
 Venetoclax Limited Duration REVEAL Status,TrialBulletin,Negative
 Condition Summary CLLSLL,TrialBulletin,Negative
 Suivi,Fondation ARC,Positive
 outcomes,Renal & Urology News,Positive
 outcomes,CancerTherapyAdvisor,Positive
 outcomes,"Guru Sonpavde, MD",Positive
 outcomes,OncLive.com,Negative
 outcomes,"Freddy Pizart, R.N.",Positive
 outcomes,Medscape Pharmacists,Negative
 outcomes,"John Damianos, M.D.",Positive
 outcomes,Medscape,Negative
 outcomes,ClinicalTrialsArena,Positive
 outcomes,arthur james lobo,Positive
 outcomes,Targeted Oncology,Negative
 outcomes,U-M Rogel Cancer Center,Negative
 outcomes,ECOG-ACRIN Cancer Research Group,Negative
 outcomes,Paperbirds_Hematology,Negative
 outcomes,Adam Kittai,Negative
 outcomes,HARMONY Alliance,Positive
 outcomes,Michael Rynne,Negative
 outcomes,healthbook,Positive
 outcomes,Toby Eyre,Positive
 outcomes,Oncology Learning Network,Positive
 outcomes,Blood Journal,Positive
 outcomes,Current Oncology,Negative
 outcomes,Lymphoma Papers,Negative
 outcomes,Medivizor,Positive
 outcomes,Judith Trotman,Positive
 outcomes,HemOnc Today,Negative
 outcomes,Hematology Advisor,Negative
 outcomes,"Raul Cordoba, MD, PhD",Positive
 outcomes,Marilyn Heine,Positive
 outcomes,"chadi nabhan MD, MBA, FACP",Negative
 outcomes,CLL Ireland,Negative
 outcomes,AJMC,Positive
 outcomes,Cancer Papers,Negative
 outcomes,Lymphoma Hub,Positive
 outcomes,"Rob Dean, MD",Positive
 outcomes,VJHemOnc,Positive
 outcomes,"Pharmacyclics, an AbbVie Company",Negative
 outcomes,Pamela Helton,Positive
 outcomes,Journal of Clinical Pathways,Negative
 outcomes,"YAZ, MD",Positive
 outcomes,Med-IQ,Positive
 Nurseled approaches,Hematology Advisor,Negative
 Nurseled approaches,CancerTherapyAdvisor,Negative
 patient adherence,Hematology Advisor,Negative
 patient adherence,CancerTherapyAdvisor,Negative
 patient adherence,SpecialtyPTimes,Negative
 Clinical Journal,Hematology Advisor,Negative
 Clinical Journal,Andrew Schorr,Negative
 Nursing,Hematology Advisor,Negative
 treatment adherence,Hematology Advisor,Negative
 AEs,Hematology Advisor,Negative
 AEs,Toby Eyre,Positive
 AEs,"Maria Badillo, MSN RN OCN CCRP",Negative
 AEs,RedMedEd,Positive
 AEs,"chadi nabhan MD, MBA, FACP",Negative
 introduction,CONQUER the patient voice,Negative
 introduction,OncLive.com,Positive
 introduction,Targeted Oncology,Negative
 introduction,Big4Bio:Philly,Positive
 introduction,ASH Clinical News,Negative
 introduction,3PSolution,Negative
 introduction,VJHemOnc,Negative
 introduction,CLL Ireland,Negative
 introduction,AJMC,Negative
 introduction,People Who UK,Positive
 Bcell antigen receptor pathway,CONQUER the patient voice,Negative
 firstline treatment,CONQUER the patient voice,Negative
 firstline treatment,MDedge Hematology & Oncology,Positive
 firstline treatment,JanssenUS,Negative
 firstline treatment,Journal of Clinical Pathways,Negative
 firstline treatment,Oncology Learning Network,Negative
 firstline treatment,Sigrid Sk√•nland,Negative
 firstline treatment,VJHemOnc,Positive
 firstline treatment,Bibliosaude,Positive
 firstline treatment,The Lancet Haematology,Positive
 firstline treatment,NEJM,Negative
 firstline treatment,Research UMCG,Positive
 firstline treatment,Joule Inc.,Positive
 firstline treatment,Lampe & Company,Negative
 firstline treatment,pocroncology,Positive
 firstline treatment,Targeted Oncology,Negative
 firstline treatment,Patient Power,Positive
 firstline treatment,Current Oncology,Positive
 firstline treatment,1stOncology,Negative
 firstline treatment,Lymphoma Papers,Negative
 firstline treatment,CLL Ireland,Negative
 firstline treatment,Advances in Therapy,Negative
 firstline treatment,ComplexPharm,Positive
 firstline treatment,manda materne,Positive
 firstline treatment,PharmaLeaders,Negative
 firstline treatment,Lymphoma Hub,Positive
 firstline treatment,gilbert c faure,Negative
 firstline treatment,Pharmaceutical Mkt,Positive
 firstline treatment,CPhI Online,Positive
 firstline treatment,Pharmafocus,Negative
 firstline treatment,Headcount,Positive
 firstline treatment,LARVOL,Negative
 firstline treatment,Beyond the Pill 2015,Positive
 firstline treatment,pharmabr,Negative
 firstline treatment,PISPOpharma,Positive
 firstline treatment,Fleming. Pharma,Positive
 firstline treatment,Pharma Industry News,Positive
 firstline treatment,Danvantri Farma,Negative
 firstline treatment,MAISA,Negative
 firstline treatment,Briefing.com,Negative
 firstline treatment,Blood Buff,Positive
 longterm responses,CONQUER the patient voice,Negative
 Relapsed mUC,Amer. Urol. Assn.,Positive
   Patienten mit platinrefrakt√§rem metastasiertem Urothelkarzinom,univadis,Positive
 randomisiert Pembrolizumab mit oder ohne Acalabrutinib zugeteilt,univadis,Positive
 WATCH,OncLive.com,Positive
 WATCH,Oncology Times,Negative
 Ian Flinn MD,OncLive.com,Negative
 Tycel Jovelle Phillips MD,OncLive.com,Negative
 Bijal Shah MD,OncLive.com,Negative
 Javier Munoz MD FACP,OncLive.com,Negative
 RR mantle cell lymphoma,OncLive.com,Negative
 RR mantle cell lymphoma,VJHemOnc,Negative
 RR mantle cell lymphoma,"Michael Wang, MD",Negative
 Estudio,TekCrispy,Positive
 FDA puede,TekCrispy,Positive
 FDA puede,primo8k,Negative
 FDA puede,TendenciasTech,Positive
 la tormenta de citoquinas,TekCrispy,Positive
 la tormenta de citoquinas,primo8k,Positive
 la tormenta de citoquinas,TendenciasTech,Positive
 NewTrip ASCEND Phase III Randomized Trial,Trip Database,Negative
 Followup data,CURE Magazine,Positive
 Followup data,"Pharmacyclics, an AbbVie Company",Negative
 Hay   ensayos,Alejandro de Bary,Positive
 cl√≠nicos,Alejandro de Bary,Positive
 cl√≠nicos,Rock&Pop 94.1,Positive
 cl√≠nicos,Radio Chaparrastique 106.1 FM,Positive
 cl√≠nicos,Noticias 4Visi√≥n,Positive
 Per√∫ relacionados al CovidLos tratamientos,Alejandro de Bary,Positive
 IvermectinaMavrilimumabRuxolitinibAcalabrutinibHidroxicloroquinaTocilzumabSolidaridad OMS    f√°rmacosResultados,Alejandro de Bary,Positive
 unos meses,Alejandro de Bary,Positive
 Game,PharmacyPhunQuiz,Positive
 article,"Maria Badillo, MSN RN OCN CCRP",Negative
 article,SeattleCancerCareAlliance,Negative
 article,Balkan Medical Journal,Negative
 article,Patient Power,Positive
 article,Journal of Clinical Pathways,Negative
 article,Thomas Lofaro,Positive
 article,Welty,Positive
 article,MDEdge,Negative
 article,MDedge Dermatology,Positive
 article,Kim Kirchherr,Negative
 article,RIOH,Negative
 article,"Michael Wang, MD",Negative
 article,Benlazar S.M Amin√©,Negative
 article,JELEU,Negative
 article,Flash Alert,Positive
 article,Jeff Sharman,Positive
 article,"Amber Koehler, PA-C",Negative
 article,Lars M√∏rland Knudsen,Positive
 article,Expert Perspectives in Oncology,Positive
 article,European Association for Haematopathology,Negative
 article,Targeted Oncology,Negative
 article,Andrew Schorr,Negative
 article,Leukaemia Care,Negative
 article,"Anna Bartus, MD",Positive
 article,ACGS,Positive
 article,Blood Journal,Negative
 article,Why Am I Still Sick?,Positive
 article,Funkabillybongo,Positive
 standardofcare,CURE Magazine,Negative
 ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄß ÁôΩË°ÄÁóÖ „Å´ÂØæ„Åó„Å¶,„Ç™„É≥„Ç≥„É≠,Positive
 Acalabrutinib BTK inhibitors,"Guru Sonpavde, MD",Positive
 MDSCs   pembro,"Guru Sonpavde, MD",Positive
 pembro,"Guru Sonpavde, MD",Positive
   Phase,Nash Peters,Positive
   Phase,abej,Negative
   Phase,HealthEconBot,Positive
   Phase,1stOncology,Positive
   Phase,Milo≈° Miljkoviƒá,Positive
   Phase,"Raul Cordoba, MD, PhD",Negative
   Phase,TrialSite News,Negative
   Phase,PressReleasePoint,Negative
   Phase,Cell Stem Cell,Positive
 editorial,Ali Khaki,Positive
 editorial,LYMPHOMA & MYELOMA CONNECT,Negative
 European Medicines Agency,LymphomaAction,Positive
 European Medicines Agency,OncLive.com,Negative
 European Medicines Agency,Targeted Oncology,Negative
 European Medicines Agency,Financial Buzz,Negative
 European Medicines Agency,MedFirst - MedComms,Positive
 Acalabrutinib   une v√©ritable avanc√©e,H√©matologie,Positive
 New   Phase II Study,MD Anderson Leukemia,Negative
 Acalabrutinib ACA,MD Anderson Leukemia,Negative
 Venetoclax VEN,MD Anderson Leukemia,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá‰æã„ÅÆÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÅÆÂ§ßÂ§öÊï∞„Å´„Åä„ÅÑ„Å¶ÊúâÊúõ„Å™Ëá®Â∫äÂäπÊûú„ÇíÁ§∫„Åô   „Åã„Çâ,„ÉÄ„Éì„Éáüß¨Aqours„Éâ„Éº„É†„ÉÑ„Ç¢„ÉºÊàêÂäüÁ•àÈ°òüê≥,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶„ÄÅÊ¨ßÂ∑ûÂåªËñ¨ÂìÅË©ï‰æ°ÂßîÂì°‰ºö„Çà„ÇäÊâøË™çÂãßÂëä„ÇíÂèñÂæó „Äî,JPubb Êó•Êú¨‰ºÅÊ•≠ „É™„É™„Éº„Çπ ÂåªËñ¨ÂìÅ,Positive
 Myriad trials,ClinicalOncologyNews,Negative
 blood cancer agents,ClinicalOncologyNews,Negative
 cytokine storm,ClinicalOncologyNews,Negative
 cytokine storm,Arsalan Ashraf,Positive
 cytokine storm,Miguel Angel Grullon C.,Positive
 cytokine storm,OncLive.com,Negative
 cytokine storm,FirstWord Pharma,Negative
 cytokine storm,Pengyu Yang,Positive
 cytokine storm,Kenneth Farber,Positive
 cytokine storm,Shouting at people in my underpants,Negative
 cytokine storm,Steven Bertoni,Positive
 Researchers,"COTA, Inc.",Positive
 Researchers,A.n.n.,Positive
 Researchers,M√≥nica,Positive
 Researchers,Cancer Research Institute,Positive
 Researchers,LiberalFish,Positive
 Researchers,Non-GMO Report,Positive
 Researchers,Gary Skinner,Positive
 Researchers,Hematology Advisor,Positive
 Researchers,Medical Xpress,Positive
 Researchers,GMO Free USA,Negative
 Researchers,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Researchers,Nathan Donley,Positive
 Researchers,NCI Media Relations,Positive
 Researchers,NHLBI Bethesda Labs,Negative
 Researchers,Science Translational Medicine,Positive
 Researchers,CURE Magazine,Negative
 Researchers,i3 Health,Negative
 Researchers,Chocolatiere Phys,Negative
 Researchers,Children's Melanoma,Positive
 Researchers,SunAWARE,Positive
 Researchers,Casey Foster,Positive
 Researchers,Belong.Life,Positive
 Researchers,KeiraSmith_i3Health,Positive
 Researchers,"Brian Lawenda, MD",Positive
 Researchers,Broad Institute,Positive
 Researchers,Wellzio,Positive
 Researchers,Mayo Clinic,Positive
 Researchers,Visitor_Z,Positive
 Researchers,84$$ ¬Æ,Positive
 Researchers,Marta Crespo,Negative
 Researchers,Biotech-Spain.com,Positive
 Researchers,Wilmot Cancer Institute,Negative
 Researchers,NIH NHLBI,Positive
 Researchers,OncologyNurseAdvisor,Positive
 Researchers,NIH Clinical Center,Positive
 Researchers,MDLinx,Negative
 Researchers,CLL Ireland,Positive
 Researchers,KualiResearch,Positive
 Researchers,MapTheGap,Positive
 Researchers,Specialist Global,Positive
 Researchers,The Medlink Team,Positive
 Researchers,"NCGS, Inc.",Positive
 Researchers,Medicalnewser.com,Negative
 Researchers,healthnews,Positive
 Researchers,DaiyPost,Positive
 Researchers,cnag-crg,Negative
 Researchers,ReR üåê,Positive
 Researchers,Tissue Solutions,Positive
 Researchers,Dahir Galabgure,Positive
 Researchers,EMJ Hematology,Negative
 Researchers,AJMC,Negative
 Researchers,Biyoloji,Positive
 Researchers,Adetola A. Kehinde (IGBOMINA),Positive
 Researchers,Victor Okwudiri,Positive
 Researchers,Remy Barrios Smith,Positive
 Researchers,Lymphoma Canada,Negative
 Researchers,Junaid Mirza,Positive
 Researchers,Robert Caro,Positive
 Researchers,Nicholas JVPR,Positive
 Researchers,Cesar Perez,Positive
 Researchers,JV Public Relations NY,Positive
 Researchers,TheBioConnection,Positive
 Researchers,Algebra.Com,Positive
 Researchers,Masonic Cancer Alliance,Positive
 Researchers,HemaCare Corporation,Positive
 Researchers,Anna Deveau,Negative
 Researchers,Bentham Science,Positive
 Researchers,Cassi Schmigotzki,Positive
 Researchers,Biotechnology News,Negative
 Researchers,Only Medics,Positive
 Researchers,Cpl Life Sciences,Negative
 Researchers,labguru,Positive
 Researchers,Josef Hermanns,Positive
 Researchers,Global Pharma News,Negative
 Researchers,SmartRx Systems,Positive
 Researchers,3BL Health,Positive
 Researchers,Daniel Bednarik,Positive
 Researchers,Beyond the Pill 2015,Positive
 Researchers,Mktingfarmaceutico,Positive
 Researchers,PISPOpharma,Positive
 Researchers,MyMexicanStore,Positive
 Researchers,David Ledger,Negative
 Researchers,World Pharma News,Negative
 Researchers,Station X,Positive
 Researchers,Mayo Clinic Cancer Center,Negative
 Researchers,‡¶ì‡¶∞‡ßá ‡¶ó‡ßç‡¶∞‡¶π‡¶¨‡¶æ‡¶∏‡ßÄ ‡¶ñ‡ßã‡¶≤ ‡¶ó‡¶æ‡¶Å*üòí ‡¶ñ‡ßã‡¶≤!!!,Positive
 Researchers,Josh Goldstein,Positive
 Researchers,myCME,Negative
 inhibitors,"COTA, Inc.",Positive
 inhibitors,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 inhibitors,"Raul Cordoba, MD, PhD",Positive
 inhibitors,VJHemOnc,Negative
 inhibitors,Paperbirds_Hematology,Negative
 inhibitors,CrozrX,Positive
 inhibitors,Oncology Tube,Negative
 inhibitors,Patient Power,Positive
 inhibitors,Blood Advances,Positive
 inhibitors,Klaus Okkenhaug,Positive
 inhibitors,"Dr T. Comeau , MD",Negative
 inhibitors,AlfonsoValencia,Negative
 inhibitors,Blood Journal,Negative
 blood,"COTA, Inc.",Positive
 blood,Function_1st,Positive
 blood,Health Evangelists,Negative
 blood,Firstpost,Positive
 blood,Mayo Clinic Cancer Center,Positive
 blood,Joe,Negative
 blood,DDNews Online,Negative
 blood,UI Holden Comprehensive Cancer Center,Positive
 blood,OncLive SOSS,Negative
 blood,OncLive.com,Negative
 blood,MyPathologyReport.ca,Positive
 blood,Hematopoiesis,Positive
 blood,Paperbirds_Hematology,Negative
 blood,Pfizer Inc.,Positive
 blood,Medivizor,Negative
 blood,Chocolatiere Phys,Negative
 blood,Paul Wright,Negative
 blood,Lynne Mac Lean,Negative
 blood,ACS Journal Cancer,Negative
 blood,GMO Free USA,Negative
 blood,"Pharmacyclics, an AbbVie Company",Positive
 blood,Bay Biosciences LLC,Positive
 blood,Daniel Roberts,Positive
 blood,Bruce Samuelson,Negative
 blood,Lampe & Company,Negative
 blood,Margaret Walker,Negative
 blood,Andrew Schorr,Negative
 blood,World Wellness,Positive
 blood,Cancer Papers,Negative
 blood,Roche,Positive
 benefit,"COTA, Inc.",Positive
 benefit,OncLive.com,Negative
 benefit,"Amber Koehler, PA-C",Negative
 benefit,HemOnc Today,Negative
 benefit,Nitin Jain,Negative
 benefit,VJHemOnc,Negative
 benefit,Toby Eyre,Positive
 benefit,Guillermo Sanz,Negative
 benefit,Patient Power,Negative
 benefit,Suvir Singh,Positive
 benefit,CLLSA,Negative
 benefit,Janice Oliver,Positive
 benefit,Genentech,Negative
 benefit,Dr. Andre Goy,Negative
 benefit,Cancer Cell,Negative
 benefit,Matthias Piesche,Negative
   Acalabrutinib,Pete Afrasiabi,Negative
   Acalabrutinib,Jon,Negative
   Acalabrutinib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
   Acalabrutinib,CureHuntr,Positive
   Acalabrutinib,PersonalizeAF,Positive
   Acalabrutinib,AACR Foundation,Negative
   Acalabrutinib,OBR,Negative
   Acalabrutinib,ÕèWilliam Avery Hudson,Negative
 percent improvement,Pete Afrasiabi,Positive
 oxygen,Pete Afrasiabi,Positive
 ventilators,Pete Afrasiabi,Positive
 EMA,ESMO - Eur. Oncology,Positive
 EMA,–§–∞—Ä–º–ê–∫—Ç–∞,Positive
 EMA,VJHemOnc,Negative
 EMA,Medklik,Negative
 EMA,Roche,Negative
 EMA,"Raul Cordoba, MD, PhD",Negative
 EMA,European Pharmaceutical Review,Negative
 Marketing Authorisation,ESMO - Eur. Oncology,Negative
 Bruton,ESMO - Eur. Oncology,Negative
 Bruton,"Mike Thompson, MD, PhD, FASCO",Negative
 Bruton,teens get cancer too,Positive
 Bruton,Stephanie,Positive
 Bruton,SAFH,Positive
 Bruton,denni üåº #evindekal #stayhome #restaacasa,Negative
 Bruton,Roland Baker,Positive
 Bruton,"Michael Wang, MD",Positive
 Bruton,SpecialtyPTimes,Negative
 Bruton,PER,Negative
 Bruton,Targeted Oncology,Negative
 Bruton,MDedge Hematology & Oncology,Negative
 Bruton,JanssenUS,Negative
 Bruton,CIMSFHUVH,Positive
 Bruton,Clin Adv Hem Onc,Negative
 Acalabrutinib zur Zulassung,√Ñrzte Zeitung,Positive
 wesentlicher Treiber der chronisch,√Ñrzte Zeitung,Positive
 lymphatischen Leuk√§mie,√Ñrzte Zeitung,Positive
 der BZellRezeptorSignalweg,√Ñrzte Zeitung,Positive
 dem,√Ñrzte Zeitung,Positive
 dem,MEDtalks CH,Positive
 BrutonTyrosinkinase BTK eine zentrale Position einnimmt Acalabrutinib hemmt,√Ñrzte Zeitung,Positive
 BTK,√Ñrzte Zeitung,Positive
 BTK,CLL Advocates Network,Negative
 BTK,Waggoner Lab,Positive
 BTK,Bobby Landmanü¶é,Positive
 BTK,NTRC,Positive
 BTK,Brad Loncar,Positive
 BTK,Anthony Mato,Negative
 BTK,Joe,Negative
 BTK,OncoKB,Positive
 BTK,OncLive.com,Negative
 BTK,"Raul Cordoba, MD, PhD",Positive
 BTK,RNAi papers,Positive
 BTK,VJHemOnc,Negative
 Medscape HematologyOncology Headlinesgtgt Green Light,AGD Biomedicals,Positive
 Avapritinib,AGD Biomedicals,Positive
 Avapritinib,Andy Vermaut,Positive
 GIST Acalabrutinib,AGD Biomedicals,Positive
 GIST Acalabrutinib,Andy Vermaut,Positive
    AstraZenecas acalabrutinib,Ronald M. Chavin,Positive
 JanssenPharmacyclics ibrutinib,Ronald M. Chavin,Positive
 cancer drugs,Ronald M. Chavin,Positive
 cancer drugs,BioPharma Dive,Negative
 cancer drugs,BioPortfolio - Eli Lilly - news and research,Positive
 News CHMP,Lymphoma Hub,Negative
 CHMP,BiopharmaAsia,Negative
 CHMP,Company News HQ,Negative
 CHMP,Cision News,Negative
 CHMP,ASH Clinical News,Positive
 CHMP,"Raul Cordoba, MD, PhD",Negative
 CHMP,AbbVie,Negative
 CHMP,MDedge Hematology & Oncology,Negative
 CHMP,Lymphoma Hub,Negative
 Effects,TrialBulletin,Negative
 Effects,CureHuntr,Negative
 Effects,Lung Cancer News,Negative
 Effects,Paperbirds_Hematology,Negative
 Effects,Benlazar S.M Amin√©,Negative
 Effects,Research Watch,Positive
 Effects,Dr.Alberto Mussetti,Negative
 Effects,CLL Ireland,Negative
 Effects,DrugGenius,Negative
 Effects,microRNApapers,Negative
 Effects,Cancer Papers,Negative
 Protonpump Inhibitor,TrialBulletin,Negative
 Protonpump Inhibitor,CureHuntr,Negative
 Acalabrutinib Capsule,TrialBulletin,Negative
 Acalabrutinib Capsule,CureHuntr,Negative
 COCACOLA,TrialBulletin,Negative
 COCACOLA,CureHuntr,Negative
 Healthy Participants,TrialBulletin,Negative
 Healthy Participants,CureHuntr,Negative
 Status Recruiting Condition Summary Infectious Disease,TrialBulletin,Negative
   Study,CureHuntr,Positive
   Study,MoJo,Negative
   Study,PressReleasePoint,Negative
   Study,Oncology Tube,Negative
   kann sich Hoffnung auf,APOTHEKE ADHOC,Positive
 Zulassung von zwei Krebsmedikamenten,APOTHEKE ADHOC,Positive
 der Europ√§ischen Union,APOTHEKE ADHOC,Positive
 Die Europ√§ische   habe,APOTHEKE ADHOC,Positive
 Zulassung von    sowie von    empfohlen,APOTHEKE ADHOC,Positive
 Status Recruiting Condition,TrialBulletin,Negative
 „ÅÇ„ÅπÊ≠ØÁßëÂåªÁôÇ„Éã„É•„Éº„ÇπÔΩêÔΩâÔΩÉÔΩãUP ‚òÖ BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅåCLL„ÇíÂØæË±°„Å´Ê¨ßÂ∑û„ÅßÊâøË™çÊé®Ëñ¶,abe dental,Negative
 acalabrutinib„ÅÆÊâøË™çÊé®Ëñ¶„ÅØ„ÄÅÊú™Ê≤ªÁôÇ„ÅÆCLLÊÇ£ËÄÖ„ÇíÂØæË±°„Å´ÂÆüÊñΩ„Åï„Çå„Åü„Éï„Çß„Éº„Ç∫Ë©¶È®ì„Åß„ÅÇ„ÇãELEVATE TNË©¶È®ì„Å®ÂÜçÁô∫„ÉªÈõ£Ê≤ªÊÄßCLLÊÇ£ËÄÖ„ÇíÂØæË±°„Å´ÂÆüÊñΩ„Åï„Çå„Åü ¬† „É™„É≥„ÇØ,Tweets,Positive
 EMA Green Light,Andy Vermaut,Positive
 „Äê ÂåªÂ∏´ „Äë BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅåCLL„ÇíÂØæË±°„Å´Ê¨ßÂ∑û„ÅßÊâøË™çÊé®Ëñ¶ „Åæ„ÅüASCENDË©¶È®ì„Å´„Åä„ÅÑ„Å¶„ÄÅÂÜçÁô∫„ÄÅÈõ£Ê≤ªÊÄß„ÅÆCLL„Å´ÂØæ„Åó„Å¶acalabrutinib„ÅÆÂçòÂâ§Êäï‰∏é„Åå„ÄÅÂåªÂ∏´ÈÅ∏ÊäûÊ≤ªÁôÇÔºà„É™„ÉÑ„Ç≠„Ç∑„Éû„ÉñÔºãidelalisib„Åæ„Åü„ÅØ„É™„ÉÑ„Ç≠„Ç∑„Éû„ÉñÔºã,ÂåªÁôÇ„Éã„É•„Éº„ÇπÈÄüÂ†±,Negative
 CHMP recommendations,Jon Angelo,Negative
 CHMP recommendations,Pharmafocus,Negative
 AstraZeneca Imfinzi,Jon Angelo,Negative
 AstraZeneca Imfinzi,Pharmafocus,Negative
 firstline lung cancer Calquence,Jon Angelo,Negative
 firstline lung cancer Calquence,Pharmafocus,Negative
 marketing authorisation,GraniteShares Europe,Negative
 marketing authorisation,The PMI (Pharmaceutical Managers' Institute),Negative
 marketing authorisation,ESMO - Eur. Oncology,Negative
 EU     AZN,Francis Alexander,Negative
 AZN   AstraZeneca PLC Calquence,Daniel Macdonald,Positive
 MALATTIE RARE,I Malati Invisibili,Positive
 LEUCEMIA LINFOCITICA CRONICA PARERE,I Malati Invisibili,Negative
 POSITIVO DEL CHMP,I Malati Invisibili,Negative
 DELL‚ÄôEMA,I Malati Invisibili,Negative
     autorizza tre nuovi studi,Emergency Live,Positive
 su,Emergency Live,Positive
 su,Pedro Lendinez,Positive
 su,Susana Garc√≠a,Positive
 su,Luis Pereira Lopez,Positive
 su,@sehh_es,Negative
 su,IM M√©dico,Positive
 su,PharmaStar,Negative
 Œ≤a,Emergency Live,Positive
 e la molecola tcoEkwnGaokP,Emergency Live,Positive
 viability,MD Anderson Cancer Center,Negative
 viability,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Positive
 relapsed mantle cell lymphoma,MD Anderson Cancer Center,Negative
 NEOPLASIE DELLE,I Malati Invisibili,Negative
 CELLULE B,I Malati Invisibili,Negative
 PROFILO,I Malati Invisibili,Negative
 DI SICUREZZA FAVOREVOLE,I Malati Invisibili,Negative
 L‚ÄôINIBITORE,I Malati Invisibili,Negative
 DI BTK DI NUOVA GENERAZIONE ACALABRUTINIB,I Malati Invisibili,Positive
 differences,WCM Lymphoma,Positive
 differences,OncLive SOSS,Negative
 differences,Medscape Education,Positive
 differences,MD Anderson Leukemia,Negative
 differences,CLL Ireland,Negative
 differences,JADPRO,Negative
 BTK inhibitors ibrutinib st generation acalabrutinib amp zanubrutinib nd generation,WCM Lymphoma,Negative
 w,WCM Lymphoma,Positive
 w,NYCDoc29,Negative
 w,VJHemOnc,Positive
 w,American College of Cardiology,Positive
 w,Medivizor,Negative
 w,VJRegenMed,Positive
 w,Dr. Andy Evens,Negative
 w,VJ Oncology,Positive
 w,PHRI Population Health Research Institute,Positive
 w,SiriusXM FC 157 ‚öΩÔ∏èüìª,Negative
 w,Research Results in Pharmacology,Positive
 w,Robert Z. Orlowski,Negative
 w,MD Anderson Leukemia,Positive
 w,"Pamela Schlembach,MD",Positive
 w,84$$ ¬Æ,Positive
 w,Lymphoma Research Foundation,Negative
 w,"chadi nabhan MD, MBA, FACP",Positive
 w,Cancer Policy Institute,Positive
 w,Andrew Schorr,Positive
 w,Patient Power,Positive
 w,Lisa Palacios,Positive
 w,Association for Molecular Pathology,Negative
 w,ASCO,Negative
 w,MD Anderson Cancer Center,Positive
 w,Lab Tests Online,Positive
 w,Immune Regulation News,Negative
 w,Wendy Carvotta,Positive
 w,"Matt Kalaycio, MD",Negative
 w,NY Genome Center,Negative
 w,Med-IQ,Negative
 w,JAMA Oncology,Positive
 w,Hematopoiesis News,Negative
 w,"Mike Thompson, MD, PhD, FASCO",Negative
 w,Patient Empowerment Network,Negative
 w,"Sean Young, PhD",Positive
 w,Sarah Cannon Docs,Positive
 lymphoma drug acalabrutinib,Emilio Mordini,Positive
 lymphoma drug acalabrutinib,Air Medical Today,Positive
 lymphoma drug acalabrutinib,Middle-East & Pakistan Times of News,Positive
 drug acalabrutinib,Karrie Esther Moen,Positive
 drug acalabrutinib,ColumbiaCancer,Positive
 Rapid improvement,Jill Feldman,Positive
 symptoms amp oxygenation,Jill Feldman,Positive
 label use,SAyub Mazher,Positive
 Louis Staudt   support,Liz Highleyman,Positive
 idea,Liz Highleyman,Positive
 idea,AbbVie Canada,Negative
 Louis Staudt   Acalabrutinib Calquence,Liz Highleyman,Positive
 inflammation amp,Liz Highleyman,Positive
 Research,A.n.n.,Positive
 Research,HLC,Positive
 Research,Paperbirds_Hematology,Negative
 Research,"Matthew Davids, MD, MMSc",Positive
 Research,Journal of the @NCCN,Negative
 Research,Molecular Oncology,Positive
 Research,Dana-Farber News,Positive
 Research,MedPage Oncology,Negative
 Research,Clinical Trials Congress 2019,Positive
 Research,CLL Ireland,Positive
 Research,Ken Research,Negative
 Research,Viracta Therapeutics,Positive
 Research,ACS Journal Cancer,Negative
 Research,CamTheMan,Positive
 Research,CLL_Fightersüéó,Negative
 Research,Financial Buzz,Negative
 Research,Business Wire-Health,Positive
 Research,Oncology Tube,Negative
 Research,MDedge Hematology & Oncology,Negative
 Research,Feel on,Positive
 Research,Âø´ÈÅ©ÂÆ∂ÈõªLife,Positive
 Research,Market Cheetah,Positive
 Research,"Pharmacyclics, an AbbVie Company",Negative
 Research,Patient Power,Negative
 Research,Fierce Life Sciences Events,Positive
 Research,Trader Dave,Positive
 Research,EIN Presswire: Glaxo Newswire,Positive
 Research,Scott Werntz,Positive
 Research,LLSCanada,Positive
 offlabel use,A.n.n.,Positive
 offlabel use,M√≥nica,Positive
 offlabel use,LiberalFish,Positive
 offlabel use,LCW,Positive
 offlabel use,Juan C Ivancevich MD,Positive
 Louis Staudt,Liz Highleyman,Positive
 ÿ≥ÿ™ÿ±ÿßÿ≤ŸäŸÜŸäŸÉÿß ÿ™ÿ∑ÿ±ÿ≠ ÿπŸÇÿßÿ±,dubai GlobalNews,Positive
 Acalabrutinib Managing Adverse Events,Lymphoma Papers,Negative
 Adherence,Lymphoma Papers,Positive
 Adherence,Paperbirds_Hematology,Negative
 Adherence,Fight Cancer Team,Positive
 Adherence,CLL Society Inc.,Negative
 Adherence,@immunoonco_Meed,Positive
 Adherence,Invest World News,Negative
 Adherence,Paul Lane,Negative
 EHA Virtual Congress,Health Radio Online,Positive
 ¬Æ Trial Results,Health Radio Online,Positive
 Chronic Lymphocytic LeukemiaRead,Health Radio Online,Positive
 Chronic Lymphocytic LeukemiaRead,Integra Ventures,Positive
 Chronic Lymphocytic LeukemiaRead,Allied Conferences,Positive
 Chronic Lymphocytic LeukemiaRead,Hematology Conference,Negative
 Tirosina quinasa de Bruton BTK,Pacientesconidp,Positive
 Final ASCEND Data Confirm Safety Efficacy,OncLive.com,Negative
 RR CLL,OncLive.com,Negative
 RR CLL,abej,Negative
 RR CLL,NatureRevClinOncol,Positive
 RR CLL,Saeed Valadbaygi,Negative
 RR CLL,Lymphoma Hub,Positive
 RR CLL,"Andres Chang, MD, PhD",Positive
 RR CLL,Alexander Luchinin,Positive
 RR CLL,"Mark Geyer, M.D.",Negative
 RR CLL,Krish Patel,Positive
 RR CLL,Toby Eyre,Negative
 RR CLL,Odi Bruckman,Negative
 RR CLL,ËÖ´Áò§Â≠∏Êñ∞Áü• | Cancer Informer,Positive
 RR CLL,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 RR CLL,AU Oncology Reviews,Negative
 RR CLL,Dr. JOSE VELASQUEZ,Negative
 RR CLL,CancerTherapyAdvisor,Negative
 Hematologylife ‚Äç ‚öï Ô∏è√±oldebuenosaires,Adry Pm,Positive
 ‡§™‡§∞ ‡§ï‡•à‡§Ç‡§∏‡§∞,ThePrintHindi,Positive
 ‡§ï‡•Ä ‡§¶‡§µ‡§æ,ThePrintHindi,Positive
 ‡§è‡§ï‡•ç‡§≤‡§æ‡§¨‡•ç‡§∞‡•Å‡§ü‡§ø‡§®‡§ø‡§¨ ‡§ï‡•á,ThePrintHindi,Positive
 ‡§≤‡§ø‡§è ‡§≠‡§æ‡§∞‡§§ ‡§Æ‡•á‡§Ç,ThePrintHindi,Positive
 ‡§ï‡•Ä ‡§ú‡§ó‡§π,ThePrintHindi,Positive
 ‡§Æ‡§∞‡•Ä‡§ú,ThePrintHindi,Positive
 ‡§π‡§ø‡§Æ‡§æ‡§®‡•Ä ‡§ö‡§æ‡§Ç‡§¶‡§®‡§æ,ThePrintHindi,Positive
 decreased inflammation,OncLive.com,Negative
 decreased inflammation,Oncology Nursing News,Negative
 price,Ronald M. Chavin,Positive
 price,Patient Power,Negative
 price,CLL Ireland,Negative
 price,Guillermo Sanz,Negative
 month,Ronald M. Chavin,Positive
 month,Oncology CE,Positive
 month,Vindico Medical Education,Positive
 month,Cancer clinical trials,Positive
 month,Carmine DeLuca,Negative
 month,ASH Clinical News,Negative
 month,ecancer,Negative
 month,Iranian American Medical Association  (IAMA),Positive
 month,Mayo Clinic Labs,Positive
 month,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 month,Teresa Bau,Positive
 month,Patient Power,Negative
 month,CLLSA,Negative
 month,Nature Reviews Disease Primers,Negative
 month,UCI Health,Negative
 month,Bill Both,Positive
 month,Alexis Rae‚úåÔ∏è,Negative
 slowness,Ronald M. Chavin,Positive
 ŸÅŸä,ÿßŸÑŸÄŸÄÿ≥ŸÄŸäŸÄŸÄŸÄÿ≥ŸÄŸÄŸÄŸâ ÿ≠ÿ®ŸäŸÄŸÄŸÄŸÄŸÄŸÄŸÄŸÄŸÄŸÄŸÄŸÄÿ® ÿßŸÑŸÖŸÑÿßŸäŸäŸÜ,Positive
 group,WhiteCoats,Positive
 group,Dr Alan G Ramsay,Positive
 group,Lili Wang Lab,Positive
 group,Anthony Mato,Positive
 group,Patient Power,Negative
 group,CeMM,Positive
 group,@balbensi üá∫üá∏ üáÆüáπ,Positive
 group,"Naveen Pemmaraju, MD",Negative
 group,IDIVAL,Positive
 group,Patient Empowerment Network,Positive
 group,Targeted Oncology,Negative
 group,CIB Margarita Salas (CSIC),Positive
 group,Dr. Andy Evens,Negative
 group,CLL Ireland,Negative
 group,Verastem Oncology,Negative
 group,IQPC,Positive
 group,Cold Chain Global Forum,Positive
 group,labguru,Positive
 group,Josef Hermanns,Positive
 group,Global Pharma News,Negative
 group,SmartRx Systems,Positive
 group,3BL Health,Positive
 group,Daniel Bednarik,Positive
 group,Beyond the Pill 2015,Positive
 group,Mktingfarmaceutico,Positive
 group,PISPOpharma,Positive
 group,MyMexicanStore,Positive
 group,David Ledger,Negative
 group,DTN Pharma News,Positive
 group,World Pharma News,Negative
 researchers,WhiteCoats,Positive
 researchers,Deccan Herald,Positive
 researchers,Hematopoiesis News,Positive
 researchers,Cell Therapy News,Negative
 researchers,KrisA,Positive
 researchers,"COTA, Inc.",Positive
 researchers,"Harold L. Paz, MD",Positive
 researchers,Avneeti,Positive
 researchers,Clinical Lab Manager,Positive
 researchers,PER,Negative
 researchers,Ohio State Pharmacy,Positive
 researchers,"Pharmacyclics, an AbbVie Company",Negative
 researchers,DDNews Online,Negative
 researchers,The James,Positive
 researchers,Mats Ohlin,Positive
 researchers,Patient Power,Negative
 researchers,Beth Torr,Positive
 researchers,OHSU IM Residency,Positive
 researchers,Rockefeller U. Press,Positive
 researchers,Dr. Melody Davis,Negative
 researchers,CIMAGO,Positive
 researchers,Jonathon Cohen MD MS,Positive
 Calquence con k de queso dijo mi,·ó∞OO·ëé.,Positive
 ASTRAZENECA LYMPHOMA DRUG ACALABRUTINIB,Stocktrend,Positive
 ASTRAZENECA LYMPHOMA DRUG ACALABRUTINIB,Jeremy,Positive
 ASTRAZENECA LYMPHOMA DRUG ACALABRUTINIB,Breaking Market News,Negative
 ASTRAZENECA LYMPHOMA DRUG ACALABRUTINIB,First Squawk,Positive
 POTENTIAL THERAPY,Stocktrend,Positive
 POTENTIAL THERAPY,joe ele,Positive
 POTENTIAL THERAPY,Jeremy,Positive
 POTENTIAL THERAPY,Breaking Market News,Negative
 POTENTIAL THERAPY,First Squawk,Positive
 SEVERE COVID,Stocktrend,Positive
 SEVERE COVID,joe ele,Positive
 SEVERE COVID,Jeremy,Positive
 SEVERE COVID,Breaking Market News,Negative
 SEVERE COVID,First Squawk,Positive
 azn,Stocktrend,Positive
 scam mrna,Stocktrend,Positive
 AZNPLC ASTRAZENECA LYMPHOMA DRUG ACALABRUTINIB,joe ele,Positive
 Early Data Suggest Acalabrutinib,OncLive.com,Negative
 Benefit Patients,OncLive.com,Negative
 New study,Mark Sparta,Positive
 New study,Meghan Mott,Positive
 New study,Journal of the @NCCN,Negative
 New study,Patient Journal,Positive
 New study,Brotman Baty,Positive
 New study,Washington Research Foundation & WRF Capital,Positive
 New study,Prof John,Negative
 New study,AJMC,Negative
 New study,MD Anderson Cancer Center,Negative
 New study,FredNatLab PDO,Positive
 New study,CLL Ireland,Negative
 New study,RTI Health Solutions,Negative
 New study,Dr. Andre Goy,Negative
 New study,BSH - Haematology,Positive
 New study,"Naveen Pemmaraju, MD",Negative
 lymphoma drug,Mark Sparta,Positive
 Lymphoma drug acalabrutinib,Raman Pathak (Quant Trader),Positive
 Lymphoma drug acalabrutinib,Medical Dialogues,Positive
 bestinclass growth,dough,Negative
 E sales CAGR,dough,Positive
 CLL Enhertu,dough,Negative
 postKadcyla breast cancer,dough,Negative
 ongoing,dough,Negative
 endE Farxiga heart failure,dough,Negative
 New paper,Vinay Prasad MD MPH,Positive
 New paper,CRUK Birmingham Centre,Positive
 New paper,Sussex Haematology,Positive
 New paper,Fleur Peters,Positive
 New paper,Michael Hallek,Negative
 New paper,"Amber Koehler, PA-C",Negative
 New paper,reactome,Positive
 New paper,IHEC_Epigenomes,Positive
 New paper,Penn Microbiology,Positive
 New paper,JAKSTAT-Target,Positive
 New paper,RIOH,Negative
 New paper,qGenomics,Negative
 Sunny Kim   Heme Onc Fellow,Vinay Prasad MD MPH,Positive
 Cancer journal,Vinay Prasad MD MPH,Positive
    Announces CALAVI Trial,"Mike Thompson, MD, PhD, FASCO",Negative
 Examine Acalabrutinib,"Mike Thompson, MD, PhD, FASCO",Negative
 Examine Acalabrutinib,Victor YosefMelt Campos,Positive
 Examine Acalabrutinib,√únal Metin Tokat,Positive
 Examine Acalabrutinib,Jorie graham,Positive
 April,"Mike Thompson, MD, PhD, FASCO",Negative
 April,ESH (Haematology),Negative
 April,SeattleCancerCareAlliance,Negative
 April,CLL Society Inc.,Positive
 April,Kompetenznetz Maligne Lymphome e.V.,Negative
 April,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 April,Society for Immunotherapy of Cancer,Negative
 April,Lymphoma Research Foundation,Negative
 April,CLLSA,Negative
 April,IPSCIO,Positive
 April,RoyaltySource¬Æ,Positive
 April,ValueDiscovery,Positive
 April,Phoebe Needles,Negative
 April,WCM Lymphoma,Negative
 April,"Amber Koehler, PA-C",Negative
 April,CLL Warwick Uni,Negative
 April,LiveYourLife,Negative
 April,Village Pharmacy,Positive
 April,Blood Journal,Negative
 April,IDIBAPS,Positive
 April,Lifelong Learning,Negative
 Matthew Fowler,"Mike Thompson, MD, PhD, FASCO",Negative
 Press Release,"Mike Thompson, MD, PhD, FASCO",Negative
 Press Release,Flash Alert,Negative
 LEUCEMIA LINFATICA CRONICA RICADUTAREFRATTARIA ACALABRUTINIB,I Malati Invisibili,Negative
 CONFERMA LA SUA,I Malati Invisibili,Negative
 ALTA EFFICIENZA,I Malati Invisibili,Negative
 LUNGO TERMINE,I Malati Invisibili,Negative
 Cancer Research,Javed Khan,Positive
 Cancer Research,RutgersCancerInstNJ,Negative
 Time,Javed Khan,Positive
 Time,Oncology Tube,Positive
 Time,Cancer News,Negative
 Time,Trading News,Positive
 Time,Latest News from Business Wire,Positive
 Time,Investor News,Negative
 Time,Mazen M,Negative
 Time,Crwe World,Negative
 Time,STATinMED Research,Positive
 Time,Michele Nadeem-Baker,Negative
 Time,Michael Hallek,Negative
 Time,Lymphoma Papers,Negative
 Time,Paperbirds_Hematology,Negative
 Time,Anthony Mato,Negative
 Time,Jeff Neurman,Negative
 Time,"Raul Cordoba, MD, PhD",Negative
 Time,Emily Smith,Positive
 Time,Fabrice Leclerc,Negative
 Time,Frontiers Oncology,Negative
 Time,Andrew Schorr,Negative
 Time,Toby Eyre,Negative
 Time,Gavin Conboy,Positive
 Time,Sumit Middha,Positive
 Time,Roche,Negative
 Time,Matthew Kauffman,Negative
 John C Byrd MD,The ASCO Post,Negative
 John C Byrd MD,OncLive.com,Negative
 John C Byrd MD,PER,Negative
 CLLSLL Acalabrutinib,The ASCO Post,Negative
 TreatmentNaive Patients,The ASCO Post,Negative
 TreatmentNaive Patients,Lymphoma Papers,Negative
 TreatmentNaive Patients,Paperbirds_Hematology,Negative
 TreatmentNaive Patients,PressReleasePoint,Negative
 TreatmentNaive Patients,Zheng Zhao,Positive
 TreatmentNaive Patients,Financescom-stocks,Positive
 work,Ellen Kendall,Positive
 work,Anthony Mato,Negative
 work,Nicolas Martinez üá®üá¥üá®üá¥,Positive
 work,Orchard Primary Academy Nursery,Negative
 work,Andrew Lipsky,Positive
 work,CLL Epigenetics,Positive
 work,CLL Society Inc.,Negative
 work,Katrina Sondermann,Positive
 work,Britta Velten,Positive
 work,Toby Eyre,Negative
 work,BioTechniques,Positive
 work,Bryjalab,Positive
 work,Marcius Lab,Positive
 work,FEDERICO GAITI,Positive
 work,Dana-Farber News,Positive
 work,Christian Reinhardt,Positive
 work,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 work,Anthony Norris,Positive
 work,Dr Effie Kostareli,Negative
 work,Abdel-Wahab Lab,Positive
 work,Michelle Collett,Positive
 work,Dr. Rajan Chaudhari,Positive
 work,CURE Magazine,Negative
 work,AbbVie,Positive
 work,Hoofcare+Lameness,Positive
 work,RIOH,Negative
 work,Wag-O-Shag Lodge #280,Positive
 work,Patient Power,Negative
 work,CLL Warwick Uni,Negative
 work,Regina M Maxwell,Positive
 work,Oncology Tube,Positive
 work,VJHemOnc,Positive
 work,Matthew Will,Positive
 work,Zack Pemberton-Whiteley,Negative
 work,"chadi nabhan MD, MBA, FACP",Negative
 work,Andrew Schorr,Negative
 work,Marta Crespo,Negative
 work,"Francisco Marty, MD",Negative
 acalabrutinib Lucky,Ellen Kendall,Positive
 chlorambucil,FarmaciaHUAP,Positive
 chlorambucil,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 chlorambucil,MHC,Negative
 chlorambucil,Tom Heston,Negative
 chlorambucil,renalRCTs,Positive
 chlorambucil,ClinOwl,Positive
 chlorambucil,"Raul Cordoba, MD, PhD",Negative
 chlorambucil,Krishan Maggon,Negative
 chlorambucil,Juan Marquet,Negative
 chlorambucil,Young Hematologists,Positive
 chlorambucil,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 chlorambucil,Philly Bio,Negative
 chlorambucil,VJHemOnc,Negative
 chlorambucil,OncologyNurseAdvisor,Negative
 chlorambucil,Medivizor,Positive
 chlorambucil,Targeted Oncology,Positive
 chlorambucil,OncLive.com,Negative
 chlorambucil,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 chlorambucil,MedLibrary.org,Negative
 chlorambucil,Oncology Nursing News,Negative
 chlorambucil,Research UMCG,Positive
 chlorambucil,medwireNews,Negative
 chlorambucil,"Mike Thompson, MD, PhD, FASCO",Negative
 chlorambucil,DDNews Online,Negative
 chlorambucil,Dr Anya Hotinski,Positive
 chlorambucil,Patient Daily,Negative
 chlorambucil,Hypoxia Adaptation,Positive
 chlorambucil,Christopher Steer,Negative
 chlorambucil,GEDEFO,Negative
 chlorambucil,DynaMed¬Æ,Positive
 chlorambucil,Süíâmon M‚≠ïÔ∏è‚≠ïÔ∏èijaart,Positive
 chlorambucil,Brad M.D.,Negative
 chlorambucil,PharmaFactz,Negative
 chlorambucil,Society of Junior Doctors,Positive
 chlorambucil,The Lancet,Positive
   Prof Paolo Ghia,ecancer,Negative
 safety,WCM Lymphoma,Negative
 safety,VJHemOnc,Positive
 safety,WCM Englander Institute for Precision Medicine,Positive
 safety,BioPoint Inc.,Positive
 safety,EuropaWire,Negative
 safety,Renal Cell Carcinoma,Positive
 safety,OncLive.com,Negative
 safety,Marc Gozlan,Positive
 safety,Targeted Oncology,Negative
 safety,Lymphoma Papers,Positive
 safety,APWA,Positive
 safety,Hematology Advisor,Negative
 safety,Lymphoma Hub,Positive
 safety,CONQUER the patient voice,Negative
 safety,Paperbirds_Hematology,Negative
 safety,"Raul Cordoba, MD, PhD",Positive
 safety,Danielle Ternyila,Positive
 safety,UCL Discovery,Negative
 safety,Blood Journal,Negative
 safety,Biotech2050,Negative
 safety,Cancer Papers,Positive
 safety,Benito,Positive
 safety,Contracting Business,Positive
 safety,CIMSFHUVH,Positive
 safety,CLL Ireland,Positive
 safety,FarmaOnco,Negative
 safety,NCCP,Positive
 safety,Patient Power,Positive
 acalabrutinib monotherapy,WCM Lymphoma,Negative
 acalabrutinib monotherapy,Lymphoma Hub,Positive
 acalabrutinib monotherapy,Weill Cornell Medicine,Positive
 acalabrutinib monotherapy,Cancer Medicine,Positive
 acalabrutinib monotherapy,Dr. Andy Evens,Negative
 acalabrutinib monotherapy,Targeted Oncology,Negative
 acalabrutinib monotherapy,The Lancet Haematology,Negative
 acalabrutinib monotherapy,OncLive.com,Positive
 FDA,Jon,Negative
 FDA,MolecularMatch,Positive
 FDA,OncLive.com,Positive
 FDA,Jon Gardner,Positive
 FDA,Drug Topics,Positive
 FDA,ClinicalOncologyNews,Negative
 FDA,BioNews,Positive
 FDA,PierretteJ.Cazeau #SDG #UNWomen#CSW65,Positive
 FDA,hcrffngo#SDG #CSW65#CRIC19#WHM21,Positive
 FDA,New Drug Approvals,Negative
 FDA,Drugs.com,Negative
 FDA,Jon Angelo,Positive
 FDA,Investor News,Positive
 FDA,Vijaya L,Positive
 FDA,CancerCare,Positive
 FDA,CHSeaton,Positive
 FDA,MDEdge,Negative
 FDA,MDedge Hematology & Oncology,Positive
 FDA,Targeted Oncology,Positive
 FDA,FlatBio,Negative
 FDA,NatureRevClinOncol,Positive
 FDA,PharmaShots - Incisive news in 3 shots,Positive
 FDA,Krishan Maggon,Positive
 FDA,Deborah Stephens,Positive
 FDA,FDA Daily,Positive
 FDA,NewExpressNews,Negative
 FDA,octagonchem,Positive
 FDA,CLL Society Inc.,Negative
 FDA,Lymphoma Research Foundation,Negative
 FDA,Financial Journal,Positive
 FDA,Phil Talamo,Positive
 FDA,The Medical Letter,Positive
 FDA,Oncology Nursing News,Positive
 FDA,"Matthew Davids, MD, MMSc",Positive
 FDA,"Naveen Pemmaraju, MD",Negative
 FDA,Chocolatiere Phys,Negative
 FDA,Jacob Bell,Positive
 FDA,EMG GOLD,Positive
 FDA,ZdravMedInfo,Positive
 FDA,COPD News,Negative
 FDA,AstraZenecaUS,Positive
 FDA,–ù–æ–≤–æ—Å—Ç–∏ GMP,Positive
 FDA,WheelieDealer,Negative
 FDA,OncLive SOSS,Negative
 FDA,"Michael Wang, MD",Negative
 FDA,Strand Urgent Care,Positive
 FDA,National Cancer Institute,Negative
 FDA,Lambda Kappa Sigma,Positive
 FDA,AACR Foundation,Negative
 FDA,Hlthnews,Positive
 FDA,Vignesh Sekar,Positive
 FDA,OncologyNurseAdvisor,Positive
 FDA,Cancer Health,Negative
 FDA,Dean Celia,Positive
 FDA,CancerConnect,Negative
 FDA,Gilles Gallant,Positive
 FDA,RxSpark,Positive
 FDA,Rare Disease Report,Negative
 FDA,UKiwiS,Positive
 FDA,Margaret Walker,Negative
 FDA,Farmacia Nenna,Positive
 FDA,David Ledger,Positive
 FDA,Digital Pharma,Positive
 FDA,Pharma Commons,Positive
 FDA,"Lalit Leonard Sehgal, PhD",Positive
 FDA,Sonali Prusty,Positive
 FDA,Digital-Ontology,Positive
 FDA,Global Pharma News,Positive
 FDA,World Pharma News,Positive
 FDA,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 FDA,Laura Nikolaides,Positive
 FDA,Davalyn Corporation,Positive
 FDA,Barry Curry,Negative
 FDA,Everything Pharma,Negative
 FDA,PharmaTimes,Negative
 FDA,Pharma Trader,Negative
 FDA,Lymphoma Hub,Positive
 FDA,M-Solutions,Positive
 FDA,Philip McCarthy,Positive
 FDA,Coping with Cancer,Positive
 FDA,Simon Rule,Positive
 FDA,OncologyInfo,Positive
 FDA,Prem Raj Shakya,Positive
 FDA,Referral Kings,Positive
 FDA,Zahedi Mujawar,Positive
 FDA,Duncan Young,Positive
 FDA,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Positive
 FDA,ali bajwa,Positive
 FDA,Medical Web Times,Positive
 FDA,Paul Devereaux,Positive
 FDA,karin55marin,Negative
 FDA,News of Emirates,Positive
 FDA,Antonio Caperna,Positive
 FDA,Salutedomani,Negative
 FDA,saluteH24.com,Positive
 FDA,Derma News OK,Positive
 FDA,Reuters Health,Negative
 FDA,Vernell Lintner,Positive
 FDA,the world of CROs,Positive
 FDA,Jonathan I Lawrence,Positive
 FDA,Healthy And Yeah,Positive
 FDA,Ecz.Gizem Usta,Positive
 FDA,Xeling,Positive
 FDA,Cabbages & King Mag.,Positive
 FDA,Tracia.my.tupperware.com,Positive
 FDA,Imran Haque,Positive
 FDA,Christine,Positive
 FDA,Lorna BArnett,Positive
 FDA,iQtipsy,Positive
 FDA,Mike van Dulken,Positive
 FDA,Ned Pagliarulo,Positive
 FDA,Adam Feuerstein,Positive
 FDA,American Preclinical,Positive
 FDA,Lymphoma News Today,Positive
 FDA,"chadi nabhan MD, MBA, FACP",Negative
 FDA,Saleh Stevens,Negative
 FDA,Lymphoma Canada,Positive
 FDA,SStevens,Positive
 FDA,Newmoney210,Negative
 FDA,IntoxicatedTrader,Positive
 FDA,Medicalnewser.com,Positive
 FDA,Anna Deveau,Negative
 FDA,1stOncology,Positive
 FDA,Pharma_Processes,Positive
 FDA,Danvantri Farma,Positive
 FDA,Pharmaceutical News,Positive
 FDA,PharmaLeaders,Positive
 FDA,pharmabr,Positive
 FDA,European Pharmaceutical Review,Positive
 FDA,MedicalResearch News,Positive
 FDA,Gary Skinner,Positive
 FDA,FirstWord Pharma,Negative
 FDA,Sharecast.com,Negative
 FDA,Cision News,Positive
 FDA,Graham Collins,Negative
 FDA,Sheila A. Crowe,Positive
 FDA,OBR,Positive
 FDA,Josh Rehrer,Positive
 FDA,Financial Buzz,Positive
 FDA,BusinessWireProducts,Positive
 FDA,Business Wire-Health,Positive
 FDA,Stockboard Media Inc,Negative
 FDA,BusinessWire-Science,Positive
 FDA,Cancer News,Negative
 FDA,Drug Delivery News,Negative
 FDA,StockNews.com,Negative
 FDA,Briefing.com,Negative
 FDA,CURE Magazine,Negative
 FDA,Mazeraski,Negative
 FDA,U2 Fans,Negative
 FDA,AlphaBronze,Positive
 FDA,IMPharma News,Positive
 FDA,Aloysius Pendergast,Positive
 FDA,Biotech & Tech Stock Focus,Negative
 FDA,Crwe World,Positive
 FDA,BondJamesBond,Positive
 FDA,dough,Negative
 FDA,Flash Alert,Positive
 FDA,Bio Stocks‚Ñ¢,Negative
 FDA,Stock Titan,Negative
 FDA,Patient Power,Negative
 FDA,FSTP,Positive
 FDA,Aspen Biosciences,Positive
 FDA,Pharm2Market,Positive
 FDA,Jessi M,Positive
 FDA,DennisPartners,Negative
 FDA,Pharma News,Positive
 FDA,Bastion Balance Seoul Korea,Positive
 FDA,VJHemOnc,Positive
 FDA,ALI ALAHMARI.,Negative
 FDA,Great Debates in Hematologic Malignancies,Negative
 FDA,Jean Zhao,Positive
 FDA,Cord Blood News,Positive
 FDA,StemExpress,Positive
 FDA,BioSpace,Positive
 FDA,Headwaters Communications,Positive
 FDA,BioCalifornia,Negative
 FDA,The Oncologist,Negative
 FDA,Dr. Saadvik Raghuram y,Positive
 FDA,Javid Moslehi,Positive
 FDA,Guillaume P. Andrieu,Positive
 FDA,Kevin Wolcott,Positive
 FDA,Kerri Wachter,Positive
 FDA,Michele Nadeem-Baker,Positive
 FDA,"Comprehensive Cell Solutions,New York Blood Center",Positive
 FDA,Beacon Targeted Therapies,Positive
 FDA,Patient Worthy,Positive
 FDA,Prime Care Health Solutions,Positive
 FDA,Rajesh Vagh,Positive
 FDA,Michelle Petersen,Positive
 FDA,Claire Telford ‚òòÔ∏è,Positive
 FDA,matiere*,Positive
 FDA,"Liseth M Parra, PhD",Positive
 FDA,carlota bernal,Positive
 FDA,Renovatio Biom√©dica,Positive
 FDA,Cayte Truza,Positive
 FDA,LLZ Consulting,Negative
 FDA,Kaushik A.Sejpal,Positive
 FDA,Pharma Regulatory,Positive
 FDA,SpecialtyPTimes,Negative
 FDA,HSMN,Positive
 FDA,"Trustwell Law Group, LLP",Positive
 FDA,ADIL Med Monitor,Positive
 FDA,The Cancer Letter,Negative
 FDA,vshariharakrishnan,Positive
 FDA,Mazen M,Negative
 FDA,YoBuzz,Negative
 FDA,Medical Xpress,Negative
 FDA,E2DG,Positive
 FDA,PharmacyChecker,Positive
 FDA,Genentech,Positive
 FDA,Roche,Positive
 FDA,emilylevitch_i3Health,Positive
 FDA,Snowdome Foundation,Positive
 FDA,PressReleasePoint,Negative
 FDA,"Krishna Talluri, MD",Positive
 FDA,AA&MDSIF,Positive
 FDA,ipharmacenter,Positive
 FDA,TEAM Pharmacy Consulting,Positive
 FDA,The Pharmaceutical Marketing Group,Positive
 FDA,Latest News from Business Wire,Negative
 FDA,Coast To Coast Cures,Positive
 FDA,Cellero,Positive
 FDA,cafepharma,Positive
 FDA,JCM Compounding Knowledge,Positive
 FDA,"Robinson Ortiz, MD",Positive
 FDA,Odi Bruckman,Positive
 FDA,Hotstocks.nyc,Positive
 FDA,Marketbit.pro,Negative
 FDA,AllMedx Oncology,Positive
 FDA,GoFIR,Positive
 FDA,CellworksLife,Negative
 FDA,INDLUB (UK) LTD,Positive
 FDA,Michael Mijares,Positive
 FDA,PharmacyTimesCE,Positive
 FDA,VuMedi Oncology,Positive
 FDA,FDA Oncology,Positive
 FDA,Catalyst Trading,Positive
 FDA,LLS National Capital,Positive
 FDA,Andrew Schorr,Negative
 FDA,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 FDA,Pharmacy Practice News,Negative
 FDA,Blood-Cancer.com,Positive
 FDA,PLN,Positive
 FDA,S.K.,Positive
 FDA,Medklik,Negative
 FDA,Susan Ehret,Positive
 FDA,PRICENTRIC,Positive
 FDA,CLL Ireland,Positive
 FDA,PharmAnt,Positive
 FDA,HemOnc Today,Negative
 FDA,Hematopoiesis News,Positive
 FDA,Cancer Stem Cell News,Positive
 FDA,Clarivate Cortellis,Negative
 FDA,SNN Network,Negative
 FDA,BioRunUp,Negative
 FDA,Beverley Newbury,Positive
 FDA,CancerTherapyAdvisor,Positive
 FDA,Lymphoma Coalition,Negative
 FDA,Frank Sotzik,Positive
 FDA,Usman Razzaq,Positive
 FDA,InstitutoRoche,Positive
 FDA,Fredi Skwar,Positive
 FDA,DDNews Online,Negative
 FDA,ComplexPharm,Positive
 FDA,GPSN,Positive
 FDA,FirstCare Wellness,Positive
 FDA,IHS4U,Positive
 FDA,Jose Carlos,Positive
 FDA,Sean McGrath,Positive
 FDA,OACS IRELAND,Positive
 FDA,Kim Bertrand,Positive
 FDA,Focus on Cancer,Negative
 FDA,Next Generation,Positive
 FDA,Denver Greene,Negative
 FDA,Station X,Positive
 FDA,Heather Swift Morrison,Negative
 FDA,MediTech Media,Positive
 FDA,TRACServices,Positive
 FDA,Farmacia Son Espases,Positive
 FDA,Dana-Farber,Negative
 FDA,Manuel Manrique,Positive
 FDA,CareAcross,Negative
 FDA,Dale's Pharmacy,Positive
 FDA,Central Drug,Positive
 FDA,Benzer Pharmacy,Positive
 FDA,ESMO - Eur. Oncology,Negative
 FDA,Woman,Positive
 FDA,Patient Daily,Positive
 FDA,Amanda,Positive
 FDA,Dr Jobin Shaeri,Positive
 FDA,Carlos Alvarez,Positive
 FDA,"Pragnesh Panchamvedi, RAC, ERT",Positive
 FDA,American Health Crew,Positive
 FDA,Prof Katrina Bramstedt üá¶üá∫ üáÆüáπ,Positive
 FDA,BIOCIENCIA,Negative
 FDA,Jos√© Ant. Marcos,Positive
 FDA,"Francisco Marty, MD",Negative
 FDA,American Cancer Society,Positive
 FDA,John Gerecitano,Positive
 FDA,lucasvm1980g,Positive
 FDA,Dale Taylor,Positive
 FDA,Richard Rovin,Positive
 FDA,BlackSwan Analysis now part of Evaluate Pharma Ltd,Positive
 FDA,Cancer Agent,Positive
 FDA,Tarmo Seliste,Positive
 FDA,Paul Kent,Positive
 FDA,1Mcancerprayers,Positive
 FDA,Robert Demichelis II,Positive
 FDA,‚óà Cory B. Phillips ‚óà,Positive
 FDA,CCNZ,Positive
 FDA,Health News Wire,Positive
 FDA,India Oncology 2.0,Positive
 FDA,My Health Now! „ÉÑ,Positive
 FDA,STRT Boston,Positive
 FDA,HealthyTabs/pharmacy,Positive
 FDA,GxP Lang. Services,Positive
 FDA,AllTheBestNews,Positive
 FDA,DSNPharmacistJournal,Positive
 FDA,Biotech 5,Positive
 FDA,pharmatutor,Positive
 FDA,Today Topics,Positive
 FDA,"Barbara Ebel, MD",Positive
 FDA,VigiePharma,Positive
 FDA,Women's Health News,Positive
 FDA,Pharmafocus,Positive
 FDA,Muzaffar Qazilbash,Negative
 FDA,Anthony M Crasto DR.,Positive
 FDA,LucidQuest,Negative
 FDA,Dr Timos Papagatsias,Negative
 FDA,Sharon Roberts,Positive
 FDA,"David Woessner, PhD",Positive
 FDA,Diaceutics PLC,Positive
 FDA,LuisC Fern√°ndezLis√≥n,Positive
 FDA,MedicijnBalans,Positive
 FDA,Ethan Goddard-Borger,Positive
 FDA,Joanna Tierno,Positive
 FDA,AIS Health,Negative
 FDA,U.S. FDA,Positive
 FDA,Anand Rotte,Positive
 FDA,MrTopStep,Positive
 FDA,AJPB_Journal,Negative
 FDA,Being Doctor,Positive
 FDA,FDA Drug Information,Positive
 FDA,vincenzo abruscato,Positive
 FDA,Dr. Melody Davis,Negative
 FDA,Marty Murphy,Positive
 FDA,Elite Exec Search,Positive
 FDA,Rajiv P Shrestha,Positive
 FDA,Blai Coll,Positive
 FDA,Oncology CRO,Positive
 FDA,Dustin Phan,Positive
 FDA,"Raul Cordoba, MD, PhD",Negative
 FDA,Teri Huenink,Positive
 FDA,Drug developmen,Positive
 FDA,"Tom Iarocci, MD",Negative
 FDA,GeneRef,Positive
 FDA,Amy Johnson,Positive
 FDA,TradeOnTheWire,Positive
 FDA,FoodSafety News,Positive
 FDA,Sword Achiever,Positive
 FDA,BMI Calculator USA,Positive
 FDA,RQS Consultants,Positive
 FDA,FDA/GMP Compliance,Positive
 FDA,Science.gov,Positive
 FDA,Elaine Schattner,Negative
 FDA,GovCare,Positive
 FDA,News Shooting Self D,Positive
 FDA,Diner Foodie,Positive
 FDA,Cynthia Roxbury,Positive
 FDA,Media Affairs,Positive
 FDA,WCM Lymphoma,Negative
 FDA,Rare Diseases,Positive
 FDA,manda materne,Positive
 FDA,OncoTherapy Network,Negative
 FDA,GxPeople,Positive
 FDA,Orbis Biosciences,Negative
 FDA,gilbert c faure,Negative
 FDA,CPhI Online,Positive
 FDA,Vicente Torres,Positive
 FDA,Headcount,Positive
 FDA,LARVOL,Negative
 FDA,JaimePerezdeOteyza,Positive
 FDA,Beyond the Pill 2015,Positive
 FDA,PISPOpharma,Positive
 FDA,Fleming. Pharma,Positive
 FDA,Brum-Jobs,Positive
 FDA,JediPD,Positive
 FDA,NEWS.GNOM.ES,Negative
 FDA,Michael O'Dwyer,Positive
 FDA,TradeXchange,Negative
 FDA,üê∏ gab.ai/wu üê∏,Positive
 FDA,HHF,Negative
 FDA,MedWatcher,Positive
 FDA,A. Vroom - Ten Wolde,Positive
 FDA,aeses.com,Negative
 FDA,NYCDoc29,Negative
 FDA,drsocial.org,Positive
 FDA,Steve Nolito,Positive
 FDA,Biotech Stock,Positive
 FDA,Abahoo,Positive
 FDA,United States News,Positive
 FDA,EZ HomeCare,Positive
 FDA,NaturalMedicines,Positive
 FDA,Silver Valley Doctor,Positive
 FDA,US Health News,Positive
 FDA,Gary Ross,Positive
 FDA,CGB3 Beck,Positive
 FDA,takytavP,Positive
 FDA,Sarah DiGiulio,Positive
 Occupy BTK,Benlazar S.M Amin√©,Negative
 Occupy BTK,Blood Journal,Negative
 key,Benlazar S.M Amin√©,Negative
 key,Blood Journal,Negative
 key,Paperbirds_Hematology,Negative
 key,B. Smirnov,Positive
 key,Lymphoma Hub,Positive
 STELLAR UPDATERecruitment,TAP Clinical Trial Network,Negative
 investigation,TAP Clinical Trial Network,Negative
 investigation,OncLive.com,Negative
 investigation,OncLive SOSS,Positive
 investigation,CLL Ireland,Negative
 investigation,Targeted Oncology,Negative
 CHOPR,TAP Clinical Trial Network,Positive
 CHOPR,Cancer News,Positive
    CALQUENCE,CALQUENCE¬Æ (acalabrutinib),Negative
 Obinutuzumab,The ASCO Post,Positive
 Obinutuzumab,"Anastasios Raptis, MD",Positive
 Obinutuzumab,JAVIER DE LA SERNA,Positive
 Obinutuzumab,Paperbirds_Hematology,Negative
 Obinutuzumab,OncLive.com,Negative
 Obinutuzumab,Jeff Sharman,Positive
 Obinutuzumab,Aloysius Pendergast,Positive
 Obinutuzumab,The Lancet Haematology,Positive
 Obinutuzumab,"Raul Cordoba, MD, PhD",Positive
 Obinutuzumab,Cancer News,Positive
 Obinutuzumab,CureHuntr,Positive
 Obinutuzumab,TrialBulletin,Positive
 Obinutuzumab,Oncology,Positive
 Obinutuzumab,Biotech2050,Positive
 Obinutuzumab,ClinicalTrialsData,Negative
 Obinutuzumab,PSK2329 - JHC,Negative
 Obinutuzumab,Quant Data,Positive
 Obinutuzumab,Alicia Bell IFBB Pro,Positive
 Obinutuzumab,Matt Fanning,Positive
 Obinutuzumab,Crwe World,Negative
 Obinutuzumab,Lung Cancer News,Positive
 Obinutuzumab,MD Anderson Leukemia,Positive
 Obinutuzumab,Monterey Holistic,Negative
 Obinutuzumab,Benlazar S.M Amin√©,Negative
 Obinutuzumab,ALI ALAHMARI.,Negative
 Obinutuzumab,Prof John,Negative
 Obinutuzumab,Garbi√±e Lizeaga,Negative
 Obinutuzumab,Total Well Being,Positive
 Obinutuzumab,PressReleasePoint,Negative
 Obinutuzumab,Oncology Times,Negative
 Obinutuzumab,Medicalnewser.com,Negative
 Obinutuzumab,FDA Daily,Negative
 Obinutuzumab,HSMN,Negative
 Obinutuzumab,Odi Bruckman,Negative
 Obinutuzumab,NCI CTEP Clinical Research,Positive
 Obinutuzumab,HEDGE accordinglyüìà,Negative
 Obinutuzumab,RazzleTazzle,Positive
 Obinutuzumab,CRE Demographics,Negative
 Obinutuzumab,Robert Z. Orlowski,Negative
 Obinutuzumab,Hotstocks.nyc,Positive
 Obinutuzumab,Targeted Oncology,Negative
 Obinutuzumab,Seattle's Banker,Positive
 Obinutuzumab,Sicilia Informazioni,Positive
 Obinutuzumab,NK cell Biology,Negative
 Obinutuzumab,NK papers,Negative
 Obinutuzumab,CancerTherapyAdvisor,Negative
 Obinutuzumab,Cancer Papers,Positive
 Obinutuzumab,CLL Ireland,Negative
 Obinutuzumab,NACDA Program on Aging,Negative
 Obinutuzumab,Master Li,Positive
 Obinutuzumab,Clinical Pharmacy,Negative
 Obinutuzumab,Clinical Epidemiology journal,Positive
 Obinutuzumab,Dove Press Patient,Positive
 Obinutuzumab,DovePressTherapeutic,Positive
 Obinutuzumab,KA,Negative
 Obinutuzumab,Chan Cheah,Negative
 Obinutuzumab,Biblioteca CHT,Positive
 ChlorambucilObinutuzumab,The ASCO Post,Negative
 ChlorambucilObinutuzumab,"Anastasios Raptis, MD",Positive
 PULSE,ÂåªÁôÇ„Éã„É•„Éº„ÇπÈÄüÂ†±,Negative
 ‰∏ñÁïå„ÅÆÊúÄÂÖàÁ´ØÂåªÁôÇ„Éã„É•„Éº„Çπ,ÂåªÁôÇ„Éã„É•„Éº„ÇπÈÄüÂ†±,Negative
 New Drug,AustralianPrescriber,Positive
 New Drug,GPSN,Positive
 New Drug,WUN,Positive
 New Drug,Drug Discovery & Dev,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÊ≤ªÁôÇËñ¨Calquence„ÅÆË©¶È®ìÁµêÊûú„ÇíÁô∫Ë°®,MedTech! PULSE,Positive
 ASCO Final Results,National Comprehensive Cancer Network (NCCN),Negative
 ASCEND Trial,National Comprehensive Cancer Network (NCCN),Negative
 Resistant CLLLearn,National Comprehensive Cancer Network (NCCN),Negative
 JNCCN,National Comprehensive Cancer Network (NCCN),Positive
 JNCCN,"Jocelyn Solis-Moreira, MS",Positive
 BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÄÅCLL„Å§„ÅÆË©¶È®ì„ÅßÊúâÁî®ÊÄßÔºè„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´,„Ç±„Ç¢„Éç„ÉÉ„Éà„ÄäÂÖ¨Âºè„Äã,Positive
 days,ahealthierphilly,Positive
 days,Emanuel Vila,Positive
 days,Matt Willemsen,Positive
 days,Amir Faisal,Positive
 days,Pavan Anne,Negative
 days,ChristosArgyropoulos,Positive
 days,MD Anderson Cancer Center,Negative
 days,Bio-Rad EMEA,Negative
 days,Alba Maiques-Diaz,Positive
 days,Sigrid Sk√•nland,Negative
 days,LymphomaAction,Negative
 days,LyLe Foreningen,Negative
 days,Continuous Lifecycle London (online),Positive
 days,Andrew Schorr,Negative
 days,Amanda Kruse RD,Positive
 days,ASCO,Negative
 days,"Raul Cordoba, MD, PhD",Negative
 days,iwCLL,Negative
 Acalabrutinib de   muestra eficacia,Redacci√≥n M√©dica,Positive
 linfoc√≠tica Los resultados,Redacci√≥n M√©dica,Positive
 presentaron durante el Congreso Anual de la,Redacci√≥n M√©dica,Positive
 Asociaci√≥n Europea de √≠a ‚û°,Redacci√≥n M√©dica,Positive
 Ô∏è,Redacci√≥n M√©dica,Positive
 Ô∏è,Helen Ong,Positive
 Ô∏è,Lymphoma Hub,Negative
 Ô∏è,Club Libertad Limpe√±o,Positive
 Ô∏è,Chad Slagter,Negative
 Ô∏è,VJHemOnc,Negative
 Ô∏è,tradingbrezz,Positive
 Ô∏è,(((Rich Stein)))Stay safeüò∑ü¶† & be kind,Positive
 Ô∏è,JT O'Sullivan,Positive
 New Acalabrutinib,Medivizor,Negative
 Dra Adriana Scheliga,hemomeeting,Positive
 Acalabrutinib de AstraZeneca muestra eficacia,Ciencia,Positive
 Acalabrutinib de AstraZeneca muestra eficacia,Lab Tests Online ES,Positive
 leucemia linfoc√≠tica,Ciencia,Positive
 leucemia linfoc√≠tica,Lab Tests Online ES,Positive
 Blood samples,Dr.Virendra Singh,Positive
 COVID pts,Dr.Virendra Singh,Positive
 levels,Dr.Virendra Singh,Positive
 levels,Firstpost,Positive
 levels,NatureRevClinOncol,Negative
 levels,Kate Freeman,Positive
 levels,Patient Power,Negative
 levels,Chris Thomson,Negative
 interleukin,Dr.Virendra Singh,Positive
 interleukin,lucy gorelli,Positive
 hyper,Dr.Virendra Singh,Positive
 acalabrutinib Counts,Dr.Virendra Singh,Positive
 lymphocytes,Dr.Virendra Singh,Positive
 lymphocytes,ü¶ìü¶ì H√∂micidal Barcode ü¶ìü¶ì,Negative
 lymphocytes,EurekaMag,Positive
 lymphocytes,Alyssa Howard,Negative
 lymphocytes,CML AdvocatesNetwork,Negative
 lymphocytes,Denver Greene,Negative
 lymphocytes,AbbVie,Negative
 lymphocytes,Brecka,Positive
 lymphocytes,KristopherMaday PA-C,Negative
 lymphocytes,CLL Info,Negative
 Loxo,"Michael Wang, MD",Negative
 Loxo,Alaric DeArment,Positive
   boosts,Lu Chen #nobias,Positive
 SARSCoV replication,Lu Chen #nobias,Positive
 NEW Acalabrutinib,Medivizor,Negative
    ACECL trial,EmatoInfo,Positive
 Dr Alan Skarbnik,hemomeeting,Negative
 Dr Alan Skarbnik,JTCancerCenter,Positive
 ASCEND,hemomeeting,Negative
 ASCEND,Toby Eyre,Negative
 ASCEND,OncLive.com,Negative
 ASCEND,Suchitra Sundaram,Positive
 ASCEND,EmatoInfo,Positive
 Acalabrutinib aumenta,Kevin Marcelo,Positive
 supervivencia libre de progresi√≥n,Kevin Marcelo,Positive
 o leucemia,Kevin Marcelo,Positive
 refractaria,Kevin Marcelo,Positive
 refractaria,contacto sciencelink,Negative
 ecancer,Kevin Marcelo,Positive
 Bcl inhibitor APG vs RR CLLSLL,DDNews Online,Negative
 collab,DDNews Online,Negative
 collab,Dr. Andy Evens,Negative
 collab,"chadi nabhan MD, MBA, FACP",Negative
 monotherapy,DDNews Online,Negative
 monotherapy,VJHemOnc,Negative
 monotherapy,WCM Englander Institute for Precision Medicine,Positive
 monotherapy,TAP Clinical Trial Network,Negative
 monotherapy,WCM Lymphoma,Negative
 monotherapy,Chan Cheah,Negative
 monotherapy,PANNA SHARMA,Positive
 monotherapy,medwireNews,Negative
 monotherapy,OncLive.com,Negative
 monotherapy,Hematology Board,Negative
 monotherapy,Hematology News,Negative
 monotherapy,Oncology Practice,Positive
 monotherapy,Journal of the @NCCN,Negative
 monotherapy,Toby Eyre,Negative
 monotherapy,Oncology Learning Network,Negative
 monotherapy,MDedge Hematology & Oncology,Negative
 monotherapy,Lymphoma Hub,Positive
 monotherapy,Francesco Turturro,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Ê†™Âºè‰ºöÁ§æ„ÄÅ„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÊÇ£ËÄÖ„Åï„Çì„Å´ÂØæ„Åô„ÇãÈï∑ÊúüÊúâÂäπÊÄß„Å®ÂøçÂÆπÊÄß„Çí„Å§„ÅÆËá®Â∫äË©¶È®ì„ÅßÁ§∫„Åô,NEWSRELEA.SE,Positive
 Ascentage Acerta,OyeCricket.com,Positive
 APG CALQUENCE combo,OyeCricket.com,Positive
 rr,OyeCricket.com,Positive
 rr,Benyam Muluneh,Positive
 rr,DrugGenius,Negative
 rr,Brad Loncar,Positive
 rr,"Caner Saygin, MD",Negative
 rr,Medscape Education,Negative
 rr,SY Investing,Positive
 rr,Cellero,Positive
 rr,OncologyNurseAdvisor,Negative
 rr,Anna Deveau,Negative
 rr,VJHemOnc,Negative
 rr,MDedge Hematology & Oncology,Negative
 rr,CBPartners,Positive
 rr,1stOncology,Negative
 El acalabrutinib,Revista Caretas,Positive
 El acalabrutinib,Doctiplus,Positive
 el,Revista Caretas,Positive
 el,Fran!,Negative
 el,Alison Evans,Negative
 el,Dweasley ü¶Ä (Œ® 7 ) 13 üé∏,Positive
 el,Farmacia Cl√≠nico,Positive
 el,Telemundo Deportes,Positive
 el,qGenomics,Negative
 contra,Revista Caretas,Positive
 relapsedrefractory disease,OncLive.com,Negative
 relapsedrefractory disease,CURE Magazine,Negative
 PHASE,FarmaciaHUAP,Negative
 PHASE,Prof John,Negative
 PHASE,Mohammed Saied Faraj,Positive
 PHASE,Ahmed Dahduli,Positive
 PHASE,Andrew Young,Positive
 TRIAL,FarmaciaHUAP,Negative
 TRIAL,Prof John,Negative
 ACALABRUTINIB PLUS,FarmaciaHUAP,Negative
 Dr Dr Thomas WitzigEHA Library Jun,FarmaciaHUAP,Negative
 Dr John Byrd,CLL Advocates Network,Negative
 Dr John Byrd,The James,Positive
 Dr John Byrd,The Ohio State University College of Medicine,Positive
 Dr John Byrd,ACS Journal Cancer,Negative
 Dr John Byrd,Ohio State,Positive
 Dr John Byrd,Targeted Oncology,Negative
 Naive CLL Comparisons,CLL Advocates Network,Negative
 maybe effects,CLL Advocates Network,Negative
 options,CLL Advocates Network,Positive
 options,Michael Rynne,Negative
 options,NCICCR_VaccineBranch,Positive
 options,Targeted Oncology,Positive
 options,Dana-Farber,Negative
 options,"David Kahn, MD",Positive
 options,Kim Kirchherr,Negative
 options,"Amber Koehler, PA-C",Negative
 options,Andrew Schorr,Positive
 options,Patient Power,Positive
 options,Beth Faiman PhD,Positive
 options,Amin G T Amin,Positive
 options,International Pain Foundation¬Æ,Positive
 options,susanna sargsyan,Negative
 options,Sharon Ann,Positive
 options,aWildAndFlakyGuy ‚ôøÔ∏è,Positive
 options,Jennifer Bergman,Positive
 options,circa1835,Positive
 options,Sandy D.,Positive
 options,Te Ha,Positive
 options,tangerine McDaniel,Positive
 options,Jennifer Huber,Positive
 options,Cassi Schmigotzki,Positive
 options,Shelley Webb,Negative
 options,Rhia Steele@ravishingrhia.com,Positive
 options,James C Whitfield,Positive
 options,Milton Donald,Positive
 options,WEGO Health,Positive
 options,Canadian Health & Family,Positive
 options,Lynn Nowik,Positive
 options,Ibrhm,Positive
 options,Susan Rahn,Positive
 options,"Holly Bertone, CNHP, PMP",Positive
 options,Elizabeth Evans,Positive
 options,Senior Care Corner,Positive
 options,Debbie Woodbury,Positive
 options,AJMC-Oncology,Negative
 options,Grayson (he),Positive
 options,SeparatriX,Positive
 options,Kimberley Thomas,Positive
 options,mjohemme,Positive
 options,Colleen Busch,Positive
 options,Lymphoma Hub,Negative
 options,Nora Sheffield,Positive
 options,DOMINIC GONZALES,Positive
 options,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 options,Anita Shaffer,Positive
 patientsless,CLL Advocates Network,Negative
 hypertension,CLL Advocates Network,Negative
 Live QampAPaolo Ghia,Lymphoma Hub,Negative
 Reapertura de centros comerciales,Revista Caretas,Positive
 impulsar econom√≠a,Revista Caretas,Positive
 La   advierte de un,Revista Caretas,Positive
 acalabrutinib„ÄÅÊñ∞Âûã„Ç≥„É≠„ÉäÈáçÁóá‰æã„ÅÆ„Çµ„Ç§„Éà„Ç´„Ç§„É≥„Çπ„Éà„Éº„É†ÊîπÂñÑÔºè„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ CarenetÂåªÁôÇ„Éã„É•„Éº„Çπ,‰πÖ‰øù„ÄÄ‰∏ÄÂ§´,Positive
 Gli update,EmatoInfo,Positive
 un‚Äôinteressante opzione terapeutica,EmatoInfo,Positive
 anche prima linea,EmatoInfo,Positive
 La parole di Alessandra Tedeschi,EmatoInfo,Positive
 Effectivement ce ne sont pas les,Marseille Immunopole,Positive
 pr√©liminaires de   mais ceux dun essai,Marseille Immunopole,Positive
 de   linhibiteur de BTK   chez les patients,Marseille Immunopole,Positive
 dune,Marseille Immunopole,Positive
 John Byrd,Lymphoma Hub,Negative
 John Byrd,Anthony Mato,Negative
 John Byrd,Cancer Discovery,Negative
 John Byrd,The James,Negative
 John Byrd,Erick Lansigan,Positive
 treatmentna√Øve   patients,Lymphoma Hub,Negative
   La cloroquina,Revista Caretas,Negative
 la azitromicina,Revista Caretas,Negative
 el ritonavir,Revista Caretas,Negative
 ivermectina son usados para tratar casos,Revista Caretas,Negative
 de   estos,Revista Caretas,Negative
 los √∫ltimos,Revista Caretas,Negative
 los √∫ltimos,Radio La Red 102.1FM,Negative
 Favorable LongTerm Efficacy,OncLive.com,Negative
 Ôºª„Éñ„É≠„Ç∞ÔºΩ„Åè„Åô„Çä„ÅÆÊúâÂÆ≥‰∫ãË±°„Å®Ëñ¨Ââ§Áñ´Â≠¶COVID„Å´Èñ¢„Åô„ÇãËñ¨Ââ§„ÅÆÂÆâÂÖ®ÊÄßÊÉÖÂ†±„ÇíË™ø„Åπ„Å¶„Åø„Åæ„Åó„Åü„ÄÇÊúâÂÆ≥‰∫ãË±°DBÔºàÔºâ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàAcalabrutinibÔºâ„ÄÅÂõΩÂÜÖÊú™ÊâøË™ç„ÄÅÊµ∑Â§ñË≤©Â£≤ÂêçÔºöCalquenceÔºà„Ç´„É´„ÇØ„Ç®„É≥„Çπ Ôºâ,CzeekV,Positive
   organization,HLC,Positive
 √ìN El acalabrutinib,Revista Caretas,Negative
 ‚Äì Medical News,Apostz,Positive
 tcoFkHUEWwkch,Medical News Bulletin,Positive
 Acalabrutinib pharmacodynamics,Clinical Cancer Research,Positive
 link,WCM Englander Institute for Precision Medicine,Positive
 link,VJHemOnc,Negative
 link,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 link,HemOnc_ACCP,Positive
 link,AplusA World,Negative
 link,Natacha Bola√±os,Negative
 link,Anthony Mato,Negative
 link,CLL Society Inc.,Positive
 link,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 link,Higher Ground at Lake Louise,Positive
 link,CLLSA,Negative
 link,Archive: Nita Lowey,Positive
 link,CLL_Fightersüéó,Negative
 link,"Raul Cordoba, MD, PhD",Negative
 link,Rhia Steele@ravishingrhia.com,Negative
 link,Cassi Schmigotzki,Negative
 link,Te Ha,Negative
 link,Milton Donald,Negative
 link,Nora Sheffield,Negative
 link,Kimberley Thomas,Negative
 link,International Pain Foundation¬Æ,Negative
 link,mjohemme,Negative
 link,Colleen Busch,Positive
 link,DOMINIC GONZALES,Positive
 link,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 link,circa1835,Negative
 link,Oncology.TV,Negative
 link,Annie Appleseed,Positive
 link,Barts Cancer Institute,Positive
 Member Richard R Furman MD,WCM Englander Institute for Precision Medicine,Positive
 improvement,pharmanewsintel,Positive
 improvement,McKesson Corporation,Negative
 improvement,@mariuskarma,Positive
 improvement,Forbes Tech,Positive
 improvement,Michael Hallek,Negative
 improvement,"Raul Cordoba, MD, PhD",Positive
 improvement,Cancer Papers,Negative
 improvement,Lymphoma Papers,Negative
 improvement,Casey Foster,Positive
 Los m√©dicos han publicado sus conclusiones,Saber Vivir,Positive
 revista Science Immunology Consideran que,Saber Vivir,Positive
 la clave est√°,Saber Vivir,Positive
 prote√≠na BTK y que este,Saber Vivir,Positive
 f√°rmaco,Saber Vivir,Positive
 Demiurge AIbased    outcome predictions,DemiurgeTech,Positive
 Da Paolo Ghia un,EmatoInfo,Positive
 finale dello studio ASCEND presentato ad,EmatoInfo,Positive
 con ulteriori evidenze,EmatoInfo,Positive
 acalabrutinib nella leucemia linfatica cronica,EmatoInfo,Positive
 CARETAS El,Revista Caretas,Negative
 reactivaci√≥n,Revista Caretas,Negative
 los comercios,Revista Caretas,Negative
 La OIT advierte de un dr√°stico,Revista Caretas,Negative
 medication,WISH-TV,Positive
 medication,Kaup Pharmacy,Positive
 medication,Bengal Rx,Positive
 medication,Churchill Pharmacy,Positive
 medication,Phipps Pharmacy,Positive
 medication,CDS #10 Pharmacy,Positive
 medication,Medicine Shoppe 1822,Positive
 medication,Sullivan'sGifts,Positive
 medication,Joseph Pharmacy,Positive
 medication,Greenhill Pharmacy,Positive
 medication,Scott Pharmacy,Positive
 medication,Hartzells Pharmacy,Positive
 medication,Valley Pharmacy,Positive
 medication,PharmacyPhunQuiz,Positive
 medication,Tweemol,Positive
 medication,David Wang,Positive
 medication,Ravispecialitiespharma_RSP,Negative
 medication,AtoZ Drugs Bangladesh.,Positive
 cancer,WISH-TV,Positive
 cancer,Ned Pagliarulo,Positive
 cancer,CLL Society Inc.,Positive
 cancer,Anirban Maitra,Negative
 cancer,GRACE,Negative
 cancer,NCICancerTrials,Positive
 cancer,Sarah Jones,Positive
 cancer,Mayo Clinic Cancer Center,Positive
 cancer,Patient Power,Positive
 cancer,National Cancer Institute,Negative
 cancer,CLL Ireland,Positive
 cancer,JanssenUS,Negative
 cancer,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 cancer,Jeff Neurman,Positive
 cancer,UI Holden Comprehensive Cancer Center,Positive
 cancer,The Lancet Oncology,Positive
 cancer,MyPathologyReport.ca,Negative
 cancer,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 cancer,Cancer Support Community,Negative
 cancer,Matthews & Associates,Positive
 cancer,Memorial Sloan Kettering Cancer Center,Negative
 cancer,Tamar Aprahamian,Positive
 cancer,ABPI,Negative
 cancer,Esther Schorr,Negative
 cancer,Adam Marshall Dobrin üîØ‚òÄ‚ÅÇ @suzq@rettiwtkcuf.social,Positive
 cancer,Jemrath Bikombo,Positive
 cancer,Genevieve Gutierrez,Positive
 cancer,GMO Free USA,Negative
 cancer,Ravispecialitiespharma_RSP,Negative
 cancer,Place Matters,Positive
 cancer,"‚ÄúNicky""",Positive
 cancer,Andrew Schorr,Positive
 cancer,OSU Psych Advising,Positive
 cancer,@MyelomaTeacher - Cindy Chmielewski,Negative
 cancer,UKNEQASLI,Positive
 cancer,AnamjemWAK,Positive
 cancer,ron white,Positive
 cancer,CancerDotNet,Negative
 cancer,Green Tea HP,Positive
 cancer,CLLSA,Negative
 cancer,"chadi nabhan MD, MBA, FACP",Negative
 cancer,Beverley Newbury,Positive
 cancer,LymphomaAction,Positive
 cancer,AbbVie,Positive
 cancer,World Wellness,Positive
 cancer,Idea Couture,Positive
 cancer,CLL Info,Negative
 cancer,MDLinx,Negative
 inflammation,WISH-TV,Positive
 inflammation,The PMI (Pharmaceutical Managers' Institute),Negative
 inflammation,SitaravammaputrSamba,Positive
 inflammation,RVGSM,Positive
 inflammation,Firstpost,Positive
 inflammation,WallStBetsDotCom,Negative
 Dr,CCO_Hepatitis,Positive
 Dr,"Maria Badillo, MSN RN OCN CCRP",Positive
 Dr,Patient Empowerment Network,Negative
 Dr,clonoSEQ,Negative
 Dr,Patient Power,Positive
 Dr,SeattleCancerCareAlliance,Positive
 Dr,MD Anderson Leukemia,Positive
 Dr,LymphomaAction,Negative
 Dr,Andrew Schorr,Positive
 Dr,CLL_Fightersüéó,Negative
 Dr,The Leukemia & Lymphoma Society,Negative
 Dr,Razan Mohty,Positive
 Dr,CLL Ireland,Negative
 expert,CCO_Hepatitis,Positive
 expert,Targeted Oncology,Positive
 expert,Patient Empowerment Network,Positive
 expert,CLL Advocates Network,Negative
 expert,CLL Society Inc.,Positive
 expert,MD Anderson Leukemia,Negative
 expert,CURE Magazine,Negative
 expert,Patient Power,Positive
 expert,CLL Ireland,Negative
 expert,Christy2x,Positive
 expert,Expert Perspectives in Oncology,Negative
 expert,Andrew Schorr,Positive
 expert,LymphomaAction,Negative
 expert,Biotech Research & Innovation Centre (BRIC),Positive
 expert,HemOnc Today,Positive
 expert,Healio,Negative
 expert,"Raul Cordoba, MD, PhD",Negative
 expert,The James,Negative
 expert,OncCentral,Positive
 expert,Weill Cornell Medicine Meyer Cancer Center,Negative
 COVID patients,McKesson Corporation,Negative
 COVID patients,MARIA da GLORIA,Positive
 COVID patients,PhillyVoice,Positive
 COVID patients,SitaravammaputrSamba,Positive
 COVID patients,MediHelp Solutions,Positive
 COVID patients,ahealthierphilly,Negative
 COVID patients,satokun,Positive
 COVID patients,RVGSM,Positive
 COVID patients,Cheryl Amber Dotson,Positive
 COVID patients,Nnankya,Positive
 COVID patients,Health Evangelists,Negative
 COVID patients,WaYs2rOcK,Positive
 COVID patients,Outbreak News,Positive
 COVID patients,BiopharmaMASH,Positive
 COVID patients,Ancora.ai Cancer Clinical Trials for All,Positive
 COVID patients,Nathan Vardi,Negative
 Oncology Research physicians,McKesson Corporation,Negative
 expertise,McKesson Corporation,Negative
 expertise,BSI UK,Positive
 fight,McKesson Corporation,Negative
 fight,Fortis Healthcare,Positive
 fight,ABPI,Negative
 fight,Jo-El Sidbury,Positive
 fight,UKNEQASLI,Positive
 fight,FriendsShow,Positive
 fight,Midmark News,Positive
 fight,Open Access Gov,Positive
 pandemic,McKesson Corporation,Negative
 pandemic,ILLINOIS Social Work,Negative
     trial,EmatoInfo,Positive
     trial,Michael Hallek,Negative
 New Phase II data,Pharma News,Positive
 New Phase II data,1stOncology,Negative
 New Phase II data,Investor News,Negative
 New Phase II data,Pharmacutical Daily,Negative
 New Phase II data,Crwe World,Negative
 New Phase II data,Latest News from Business Wire,Negative
 regimen,Pharma News,Positive
 regimen,1stOncology,Negative
 regimen,Investor News,Negative
 regimen,Pharmacutical Daily,Negative
 regimen,Crwe World,Negative
 regimen,Latest News from Business Wire,Negative
 regimen,HemOnc Today,Positive
 regimen,OncLive.com,Negative
 regimen,Saeed Valadbaygi,Negative
 regimen,Targeted Oncology,Positive
 regimen,Solomon Kamal,Positive
 regimen,AJMC,Negative
 Truxima,Pharma News,Positive
 Truxima,Investor News,Negative
 Truxima,Pharmacutical Daily,Negative
 Truxima,Crwe World,Negative
 Truxima,BW_France,Positive
 Truxima,Business Wire-German,Positive
 Truxima,Latest News from Business Wire,Negative
 Truxima,Trip Database,Negative
 Truxima,Alaric DeArment,Positive
 Pharmacodynamic Analysis,Jerry Lee,Negative
 Pharmacodynamic Analysis,Cure Cancer Now,Negative
 BTK Inhibition,Jerry Lee,Negative
 BTK Inhibition,Cure Cancer Now,Negative
 BTK Inhibition,OncLive.com,Positive
 BTK Inhibition,COPD News,Negative
 Randomized Trial,abej,Negative
 Randomized Trial,MD Anderson Leukemia,Negative
 Randomized Trial,Lisa Palacios,Negative
 Randomized Trial,"Raul Cordoba, MD, PhD",Negative
 Investigator,abej,Negative
 Investigator,Dr Timos Papagatsias,Negative
 Investigator,The ASCO Post,Negative
 Choice,abej,Negative
 Choice,Dr Timos Papagatsias,Negative
 Choice,The ASCO Post,Negative
 Choice,SAGE Clinical Med,Positive
 Choice,Paperbirds_Hematology,Negative
 RCT,abej,Negative
 RCT,Lymphomation.org,Negative
 RCT,Brad M.D.,Negative
 RCT,Chan Cheah,Negative
 RCT,Society of Junior Doctors,Negative
 RCT,The Lancet,Negative
 M√©dicos del hospital Walter Reed,Saber Vivir,Positive
 Maryland Estados Unidos han descubierto que el medicamento,Saber Vivir,Positive
 metaphorically treatment,The Cancer Letter,Negative
 tocilizumab,The Cancer Letter,Negative
 anakinra,The Cancer Letter,Negative
 limbs,The Cancer Letter,Negative
 tree,The Cancer Letter,Positive
 trunk,The Cancer Letter,Negative
 Dexamethasone,iflyplaces,Positive
 IdelalisibRituximab,The ASCO Post,Negative
 IdelalisibRituximab,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 BendamustineRituximab,The ASCO Post,Positive
 BendamustineRituximab,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 BendamustineRituximab,OncLive.com,Positive
 BendamustineRituximab,Lymphoma Papers,Negative
 BendamustineRituximab,Dr Ortega,Negative
 BendamustineRituximab,pharmatutor,Positive
 BendamustineRituximab,aeses.com,Negative
 Relapsed Refractory CLL ASCEND Trial,The ASCO Post,Negative
 zonder obinutuzumab,MedNet,Negative
 chloorambucil,MedNet,Negative
 obinutuzmab als,MedNet,Negative
 Jefferies analysts,TRiBECA¬Æ Knowledge,Positive
 companies,TRiBECA¬Æ Knowledge,Negative
 companies,dan.schell@lifescienceleader.com,Positive
 companies,Lymphoma Coalition,Negative
 companies,Jonathan Pearce,Negative
 companies,Jon,Positive
 companies,InConcertForCancer,Positive
 companies,Genentech,Negative
 coronavirus,TRiBECA¬Æ Knowledge,Negative
 coronavirus,Rocky,Positive
 coronavirus,Patient Power,Negative
 Calquence acalabrutinib oncology trials,Drug Discovery World,Positive
 lack,Emanuel Vila,Positive
 lack,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 lack,Guillermo Sanz,Negative
 lack,CLL Warwick Uni,Negative
 lack,"chadi nabhan MD, MBA, FACP",Negative
 WM patients,Emanuel Vila,Positive
 fulldose ibrutinibibrutinib,Emanuel Vila,Positive
 mgd,Emanuel Vila,Positive
 mgd,Tapan Kadia,Negative
 Early Data Potential Benefit,Le√≥n Waxtein  M.,Positive
 Early Data Potential Benefit,Marc Kaufman MD MS üò∑,Positive
 Severe COVID,Le√≥n Waxtein  M.,Positive
 Severe COVID,HealthDay News,Positive
 Severe COVID,Marc Kaufman MD MS üò∑,Positive
 Severe COVID,Paperbirds_Hematology,Negative
 Severe COVIDJune,Rafael H Carrasco,Positive
 Physicians Briefing,Rafael H Carrasco,Positive
 Medscape Acalabrutinib Calquence AstraZeneca,Beyond Conventional Cancer Therapies,Positive
 Bruton tyrosine kinase BTK inhibitor,Beyond Conventional Cancer Therapies,Positive
 La compa√±√≠a que administra acalabrutinib iniciar√°,Rock&Pop 94.1,Positive
 biosimilar      RA,1stOncology,Negative
 Nuovi,Roberto Bonin,Positive
 Nuovi,Tecnomedicina,Positive
 Nuovi,BusinessWire-Italian,Positive
 II indicano che un regime combinato,Roberto Bonin,Positive
 II indicano che un regime combinato,Tecnomedicina,Positive
 di Truxima,Roberto Bonin,Positive
 di Truxima,Tecnomedicina,Positive
 AstraZenecas Blood Cancer Drug Calquence,Julie Lakeview,Positive
 AstraZenecas Blood Cancer Drug Calquence,ZC,Positive
 AstraZenecas Blood Cancer Drug Calquence,Swedish Biotech,Positive
 AstraZenecas Blood Cancer Drug Calquence,Financial Carnivores,Negative
 AstraZenecas Blood Cancer Drug Calquence,HealthIT and Biotech,Positive
 AstraZenecas Blood Cancer Drug Calquence,Truth Studio,Negative
 AstraZenecas Blood Cancer Drug Calquence,MySmallCap,Positive
 Benefit SeverelyIll,Julie Lakeview,Positive
 Benefit SeverelyIll,ZC,Positive
 Benefit SeverelyIll,Swedish Biotech,Positive
 Benefit SeverelyIll,Financial Carnivores,Negative
 Benefit SeverelyIll,Hamid Mazloomi,Positive
 Benefit SeverelyIll,HealthIT and Biotech,Positive
 Benefit SeverelyIll,Truth Studio,Negative
 Benefit SeverelyIll,MySmallCap,Positive
 Benefit SeverelyIll,Epidemiology Publishers Feed,Positive
 Benefit SeverelyIll,Pharmaceutical,Positive
 Benefit SeverelyIll,BioCalifornia,Negative
 ¬Æ lenalidomide,Investor News,Negative
 acalabrutinib„ÄÅÊñ∞Âûã„Ç≥„É≠„ÉäÈáçÁóá‰æã„ÅÆ„Çµ„Ç§„Éà„Ç´„Ç§„É≥„Çπ„Éà„Éº„É†ÊîπÂñÑÔºè„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´,„Ç±„Ç¢„Éç„ÉÉ„Éà„ÄäÂÖ¨Âºè„Äã,Positive
 acalabrutinib„ÄÅÊñ∞Âûã„Ç≥„É≠„ÉäÈáçÁóá‰æã„ÅÆ„Çµ„Ç§„Éà„Ç´„Ç§„É≥„Çπ„Éà„Éº„É†ÊîπÂñÑÔºè„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´,ÂåªÁôÇ„Éã„É•„Éº„ÇπÈÄüÂ†±,Negative
 biosimilar rituximab,Crwe World,Negative
 biosimilar rituximab,Business Wire Dutch,Positive
 biosimilar rituximab,Lymphoma Papers,Negative
 acalabrutinib RA,Crwe World,Negative
 „Éó„É¨„Çπ„É™„É™„Éº„ÇπÂÖ¨ÈñãÊó•„ÄÅÂπ¥,„Åø„Å§„ÅÜ„Çç„Åì,Positive
 Êúà,„Åø„Å§„ÅÜ„Çç„Åì,Positive
 Êó•„Äå„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá‰æã„ÅÆÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÅÆÂ§ßÂ§öÊï∞„Å´„Åä„ÅÑ„Å¶ÊúâÊúõ„Å™Ëá®Â∫äÂäπÊûú„ÇíÁ§∫„Åô,„Åø„Å§„ÅÜ„Çç„Åì,Positive
 „Äç,„Åø„Å§„ÅÜ„Çç„Åì,Positive
 „Äç,„ÄéÂåªÁßëÁÇπÊï∞Ë°®„ÅÆËß£Èáà„ÄèÁ∑®ÈõÜÈÉ®„ÄÄ(Ê†™)Á§æ‰ºö‰øùÈô∫Á†îÁ©∂ÊâÄ,Positive
 De nouvelles,BW_France,Positive
 donn√©es de Phase II,BW_France,Positive
 indiquent quun traitement combinant,BW_France,Positive
 ¬Æ rituximab biosimilaire l√©nalidomide,BW_France,Positive
 et acalabrutinib RA,BW_France,Positive
 √™tre efficace,BW_France,Positive
 et,BW_France,Positive
 et,Silvers Antonio,Positive
 et,MUVBBvirtual,Negative
 et,Pallawi Torka,Positive
 et,SNU P√¥le Emploi FSU Occitanie,Negative
 et,Ahlem Bousserwel,Positive
 tol√©r√© par,BW_France,Positive
 les patients,BW_France,Positive
 les patients,Pierre B√©zier,Positive
 les patients,H24 News Canada FR,Positive
 les patients,Le Journal de Montr√©al,Positive
 dun,BW_France,Positive
 lymphome √† cellules B agressif,BW_France,Positive
 Nieuwe,Business Wire Dutch,Positive
 aan,Business Wire Dutch,Positive
 dat regime van Truxima,Business Wire Dutch,Positive
 acalabrutinib RA wellicht goed wordt verdragen en effectief,Business Wire Dutch,Positive
 Neue PhaseIIDaten deuten auf gute,Business Wire-German,Positive
 Vertr√§glichkeit und,Business Wire-German,Positive
 RituximabBiosimilar Lenalidomid und Acalabrutinib RA bei rezidiviertenrefrakt√§ren,Business Wire-German,Positive
 aggressiven BZellLymphomen,Business Wire-German,Positive
 indican que el r√©gimen,BusinessWire-Spanish,Positive
 de Truxima,BusinessWire-Spanish,Positive
 el linfoma de c√©lulas B agresivo recidivanterefractario,BusinessWire-Spanish,Positive
 II indicano che un regime combinato di Truxima,BusinessWire-Italian,Positive
 rituximab biosimilare lenalidomide e acalabrutinib RA pu√≤,BusinessWire-Italian,Positive
 ben tollerato ed efficace nella terapia del,BusinessWire-Italian,Positive
 cellule B aggressivo refrattariorecidivato,BusinessWire-Italian,Positive
 La ‚Äú tormenta de citoquinas,Antonio Guerrero,Positive
 de la COVID podr√≠a ser calmada,Antonio Guerrero,Positive
 con Acalabrutinib seg√∫n publicaci√≥n,Antonio Guerrero,Positive
 Ë™åÂπ¥ÊúàÊó•Âè∑„Å´„ÇÇÂêåÊôÇÊé≤Ëºâ„Åï„Çå„Åü „ÄÇ ÁèæÂú®„ÄÅ„Ç¶„Ç§„É´„ÇπË™òÁô∫ÊÄß„ÅÆÈÅéÂâ∞ÂÖçÁñ´ÂèçÂøúÔºàÈ´ò„Çµ„Ç§„Éà„Ç´„Ç§„É≥Ë°ÄÁóá,ÂåªÁôÇ„Éã„É•„Éº„ÇπÈÄüÂ†±,Negative
 Kanser ilacƒ± Acalabrutinib,Haberdar,Positive
 Kanser ilacƒ± Acalabrutinib,BirG√ºn Gazetesi,Positive
 Covid vakalarƒ±nda,Haberdar,Positive
 Covid vakalarƒ±nda,BirG√ºn Gazetesi,Positive
 U,Hikmet Ge√ßkil üêû,Positive
 U,Targeted Oncology,Negative
 U,Biotech2050,Positive
 U,TG Therapeutics,Positive
 U,Toby Eyre,Negative
 U,UM Human Resources,Positive
 U,UW_BMS,Positive
 Majority Acalabrutinib,Hikmet Ge√ßkil üêû,Positive
 trouble,Randall Brenneman,Positive
 house,Randall Brenneman,Positive
 house,Michael Rynne,Negative
 house,CLL Ireland,Negative
 house,Razan Mohty,Positive
 house,EYELATeachingSchool,Positive
 house,"chadi nabhan MD, MBA, FACP",Negative
 house,Mallory Ahern,Negative
 house,The Hope of the Hillside,Positive
 fire,Randall Brenneman,Positive
 lungs,Randall Brenneman,Positive
 Dr Staudt,Randall Brenneman,Positive
 drug acalabrutinibcan,Randall Brenneman,Positive
 Buena noticia para pacientes de coronavirus,Apunte Digital,Positive
 prueban con √©xito f√°rmaco Acalabrutinib,Apunte Digital,Positive
 LEUCEMIA LINFATICA CRONICA DIMOSTRATA,Medicina e Informazione,Positive
 L‚ÄôEFFICACIA E LA TOLLERABILIT√Ä,Medicina e Informazione,Positive
 LUNGO TERMINE DI ACALABRUTINIBI,Medicina e Informazione,Positive
 presentati al,Medicina e Informazione,Positive
 ¬∞ Congresso EHA European Hematology Association,Medicina e Informazione,Positive
 Leucemia linfatica cronica dimostrata affidabilit√† e,Angelo Piemontese,Positive
 tollerabilit√†,Angelo Piemontese,Positive
 JCO ASCEND Phase III Randomized Trial,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 BTK PIK SYK BCL ÈòªÂÆ≥Ëñ¨‰ΩøÁî®Ê≠¥„ÅØÈô§Â§ñ„Åï„Çå„Å¶„ÅÑ„ÇãÁÇπ„Å´Ê≥®ÊÑè,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 cause,Stephen Richards,Positive
 cause,"Jose Sandoval S, MD FACP",Positive
 cause,Heather Dorosh,Positive
 cause,CancerTherapyAdvisor,Negative
 COVID outbreak,Stephen Richards,Positive
 Celebrating Inclusion,Stephen Richards,Positive
 Diversity,Stephen Richards,Positive
 Diversity,Taylor Lab UM,Negative
 Diversity,Michele Nadeem-Baker,Negative
 LGBTQA Pride Month,Stephen Richards,Positive
 Coronavirus,Policenama,Positive
 Coronavirus,"Ruth Ann Crystal, MD",Positive
 Coronavirus,Muzaffar Qazilbash,Negative
 Coronavirus,Diario HOY,Positive
 Coronavirus,Stray,Positive
 Coronavirus,S√©bastien BERNIOTüá´üá∑ ‚≠êÔ∏è‚≠êÔ∏è#Jemeferaivacciner,Positive
 Coronavirus,Laurent Pradal,Positive
 Coronavirus,Patient Power,Negative
 Coronavirus,Brave Is Now,Positive
 Coronavirus,The Thinker,Positive
 Coronavirus,jneed,Positive
 ‡§¨‡•ç‡§≤‡§°,Policenama,Positive
 ‚Äô ‡§π‡•á ‚Äô ‡§î‡§∑‡§ß ‡§ï‡§∞‡•Ç,Policenama,Positive
 ‡§ï‡•ã‡§∞‡•ã‡§®‡§æ,Policenama,Positive
 ‡§ú‡§æ‡§£‡•Ç‡§® ‡§ò‡•ç‡§Ø‡§æ,Policenama,Positive
 ‡§π‡•á,Policenama,Positive
 Lancet Acalabrutinib w,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 wo obinutuzumab,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 Blood Cancer Drug Calquence,Hamid Mazloomi,Positive
 Blood Cancer Drug Calquence,Epidemiology Publishers Feed,Positive
 Blood Cancer Drug Calquence,Pharmaceutical,Positive
 Blood Cancer Drug Calquence,BioCalifornia,Negative
 Han dicho Acalabrutinib,Karan,Positive
 LaSexta Noche,Karan,Positive
 L   phase II trialnm median fup dc,Toby Eyre,Negative
 date,Toby Eyre,Positive
 date,Sigrid Sk√•nland,Negative
 date,JanssenUS,Positive
 date,"Pharmacyclics, an AbbVie Company",Positive
 date,OMedLive,Positive
 date,Lymphoma Australia,Positive
 date,Biotech2050,Negative
 date,Lymphoma Hub,Negative
 date,DawnKA,Positive
 date,Michael Hallek,Negative
 date,Paradigm Med Comm,Negative
 date,John Riches,Positive
 date,Joana Koury,Positive
 date,VJHemOnc,Negative
 date,"chadi nabhan MD, MBA, FACP",Negative
 date,Mahmoud Turki,Positive
 SPM   infection,Toby Eyre,Negative
 PDTox,Toby Eyre,Negative
 G HTN,Toby Eyre,Negative
 ‚Äò Cytokine Storm,"Ruth Ann Crystal, MD",Positive
 ‚Äò Cytokine Storm,Muzaffar Qazilbash,Negative
 Drugs,"Ruth Ann Crystal, MD",Positive
 Drugs,Muzaffar Qazilbash,Negative
 Drugs,Giuseppe Michieli,Positive
 Drugs,Nature Reviews Disease Primers,Negative
 Drugs,"Darcy Burbage, DNP, RN, AOCN",Negative
 EE UU dieron con un f√°rmaco capaz de vencer las formas m√°s,Cambio16,Positive
 de la,Cambio16,Positive
 de la,PedagoCLL,Positive
 El hallazgo,Cambio16,Positive
 se produjo gracias al descubrimiento de la prote√≠na que podr√≠a ser,Cambio16,Positive
 la,Cambio16,Positive
 la,Latina.pe,Positive
 la,Radio Mambi 710 üéô,Positive
 la,Loreto Noticias,Positive
 la,JDiegoTR,Positive
 la,EmatoInfo,Positive
 la,NCI en espa√±ol,Positive
 la,oncohebdo,Positive
 la,SNU P√¥le Emploi FSU Occitanie,Positive
 la,PedagoCLL,Positive
 la,@fechacochaco,Positive
 la,Ahlem Bousserwel,Positive
 la,Uni San Raffaele,Positive
 la,HematologiaValdecilla,Positive
 la,AEAL,Positive
 la,John Drago,Positive
 la,Sadoudounn,Positive
 la,I News Boutique,Positive
 la,juanchi,Positive
 la,Deux Fans,Positive
 la,‚àû,Positive
 enfermedad la prote√≠na BTK,Cambio16,Positive
 Proponen al f√°rmaco acalabrutinib para frenar,Cuaderno de Ciencia,Positive
 G un,Benlazar S.M Amin√©,Negative
 Estados Unidos dio con un f√°rmaco que vence las formas m√°s,Cambio16,Negative
    cancer drug,I Am Biotech,Positive
 ‚Äú improvement,I Am Biotech,Positive
 Acalabrutinib como medicamento para tratar,4ID SCIENCE,Positive
 Acalabrutinib como medicamento para tratar,ACFC,Positive
 Parece que ya,Yerson Gutierrez Ch.,Positive
 Parece que ya,MEMEO,Positive
 Leucemia terapia con Acalabrutinib efficace e tollerata,lpd,Positive
 ü¶†    √°rmaco,Diario HOY,Positive
 Probaron un f√°rmaco,Diario HOY,Positive
 weekend,MPR,Negative
 weekend,Krystal,Positive
 weekend,Concessionary L.L,Negative
 weekend,Patient Power,Negative
 weekend,Kaitlyn Boulbol,Positive
 STELLAR UPDATE,TAP Clinical Trial Network,Negative
 Patient recruitment,TAP Clinical Trial Network,Negative
 Cohort,TAP Clinical Trial Network,Negative
 Cohort,Lisa Palacios,Positive
 Cohort,Joe,Positive
 STELLAR,TAP Clinical Trial Network,Positive
 TC Bec,TAP Clinical Trial Network,Positive
 Thanks,TAP Clinical Trial Network,Positive
 Thanks,StrathPharm&Bio,Positive
 Thanks,Chase_Rhi,Positive
 Thanks,Andrew Schorr,Positive
 Thanks,Annette Hay,Positive
 Thanks,Satyen Gohil,Positive
 Thanks,Nick,Positive
 Thanks,Toby Eyre,Positive
 Thanks,"Harold L. Paz, MD",Positive
 Thanks,Danielle M. Brander,Positive
 Thanks,"Pharmacyclics, an AbbVie Company",Positive
 Thanks,Michie Lab,Negative
 Thanks,The Ohio State University College of Medicine,Positive
 Thanks,LymphomaAction,Positive
 Thanks,Rutgers Biomedical and Health Sciences,Positive
 Thanks,Kim Kirchherr,Negative
 Thanks,Sigrid Sk√•nland,Positive
 Thanks,Verastem Oncology,Negative
 Thanks,Michael Hallek,Negative
 Thanks,Mukesh P Yadav,Positive
 Thanks,Wilmot Cancer Institute,Negative
 Thanks,CLL_Fightersüéó,Positive
 Thanks,VJHemOnc,Negative
 Thanks,Geoffrey Berguet,Positive
 Thanks,CLL Ireland,Negative
 Thanks,CLLSA,Negative
 Thanks,LiveYourLife,Negative
 Thanks,Zack Pemberton-Whiteley,Negative
 Thanks,CognitionStudio,Positive
 Thanks,ACGS,Positive
 Thanks,Lymphoma Hub,Negative
 Thanks,Patient Power,Positive
 Thanks,Coach J Keller Crush,Positive
 Thanks,AbbVie,Positive
 Thanks,Dr. Andre Goy,Negative
 Thanks,Anthony Mato,Positive
 Thanks,BaronVonFunkenstein,Positive
 Thanks,Pearl Ortiz,Positive
 Thanks,Equality Couple,Positive
 Thanks,Sue Zurface,Positive
 Research Nurses Sian,TAP Clinical Trial Network,Negative
 Jess PI Dr Fox,TAP Clinical Trial Network,Negative
 rest,TAP Clinical Trial Network,Positive
 rest,flylemurs,Positive
 rest,Graham Collins,Negative
 rest,iwCLL,Negative
 rest,Patient Power,Negative
 rest,Shadley vanSchalkwyk,Positive
 research team,TAP Clinical Trial Network,Negative
 ‚Äò cytokine storm,Stray,Positive
 it‚Äúthe cancer drug Calquence,Stray,Positive
 cytokine supply,Stray,Positive
 source,Stray,Positive
 Encontraron f√°rmaco que vence las formas m√°s,Al√≥ Ciudadano,Positive
 Encontraron f√°rmaco que vence las formas m√°s,Enrique L√≥pez üò∑üí®‚¨ÖÔ∏è‚û°Ô∏èüìàC02 #COVIDseRESPIRA Covid0,Positive
 AZN AstraZeneca Calquence,NASDAQ,Positive
 AZN AstraZeneca Calquence,Briefing.com,Negative
 longterm efficacy amp tolerability,NASDAQ,Positive
 Leucemia linfatica cronica dimostrata,Cerca Soluzioni Cruciverba,Positive
 l‚Äôefficacia,Cerca Soluzioni Cruciverba,Positive
 e,Cerca Soluzioni Cruciverba,Positive
 e,Il Vittoriale,Positive
 e,ŸÖÿ±ÿØ ŸÖÿ¨ÿßÿ≤Ÿä,Positive
 lungo termine di Acalabrutinib,Cerca Soluzioni Cruciverba,Positive
 BTK Inhibitor Acalabrutinib,Matt Willemsen,Positive
 BTK Inhibitor Acalabrutinib,Teresa MASIA PERALES,Positive
 BTK Inhibitor Acalabrutinib,Sweta_Entomon üáÆüá≥ #StaySafe #üò∑,Positive
 BTK Inhibitor Acalabrutinib,Syrian is not white,Positive
 BTK Inhibitor Acalabrutinib,"Carlos F. Camargo, Ph.D. | DRE #01988431",Positive
 BTK Inhibitor Acalabrutinib,Josh Marshall,Positive
 BTK Inhibitor Acalabrutinib,BIOCIENCIA,Negative
 BTK Inhibitor Acalabrutinib,Para,Positive
 BTK Inhibitor Acalabrutinib,Andy Vermaut,Positive
 BTK Inhibitor Acalabrutinib,Lymphoma Papers,Negative
 Early Promise,Matt Willemsen,Positive
 Early Promise,Alejandro (Alex) Barbagelata,Positive
 Early Promise,Teresa MASIA PERALES,Positive
 Early Promise,Sweta_Entomon üáÆüá≥ #StaySafe #üò∑,Positive
 Early Promise,Syrian is not white,Positive
 Early Promise,"Carlos F. Camargo, Ph.D. | DRE #01988431",Positive
 Early Promise,Josh Marshall,Positive
 Early Promise,BIOCIENCIA,Negative
 Early Promise,Para,Positive
 Early Promise,Andy Vermaut,Positive
 Early Promise,Olivier Elemento,Negative
 Early Promise,Paul Lopez,Positive
 Early Promise,RETURN TO SENDER,Positive
 Early Promise,EWallace,Positive
 Early Promise,TenStarsDesign‚Ñ¢,Positive
 Early Promise,Scherazad Falcon,Positive
 Early Promise,Shunta Sanders,Positive
 Early Promise,Anand C. Patel,Positive
 Early Promise,ùïäùï•ùï†ùïîùïúùêñùêöùê≠ùêúùê°ùêûùê´,Positive
 Early Promise,Greg Johnson,Positive
 Early Promise,Sarah Hickman,Positive
 Early Promise,Pyrus,Positive
 Early Promise,Nigel Bradley,Positive
 Early Promise,Jasmine the European Cat,Positive
 Early Promise,Avi Cohen üá´üá∑üáÆüá±,Positive
 Early Promise,Diana Hedrick,Positive
 Early Promise,SJ Lefevre,Positive
 Early Promise,mike judin,Positive
 Early Promise,Foreign Confidential,Positive
 Early Promise,Irmeli Viinanen,Positive
 Early Promise,Lucas Wyrsch,Positive
 Early Promise,mywaypress,Positive
 Early Promise,Syed Abutalib,Positive
 Early Promise,S.Wanee,Positive
 Early Promise,Pengyu Yang,Positive
 Early Promise,"Michael Blaiss, MD",Positive
 Early Promise,Kenneth Farber,Positive
 Early Promise,cafepharma,Negative
 Early Promise,Buried On Page3,Positive
 Early Promise,Chris Manfuso,Negative
 Early Promise,Shouting at people in my underpants,Negative
 Early Promise,EIPG,Negative
 Early Promise,Mm„ÅÆÊÜÇÈ¨±,Positive
 Early Promise,****,Negative
 Early Promise,John Nosta,Positive
 Early Promise,üò∑ Datos Digital,Positive
 Early Promise,Kristen Breland,Positive
 Early Promise,Joel Padre,Positive
 Early Promise,The Peoples Pharmacy,Positive
 Early Promise,Steven Bertoni,Positive
 Early Promise,Dr Timos Papagatsias,Negative
 Early Promise,Michael Noer,Positive
 Early Promise,Janet Novack,Positive
 Early Promise,Health News,Negative
 Early Promise,ChicagoSchoolofYoga,Negative
 Early Promise,BenExact,Negative
 Early Promise,OncLive.com,Positive
 Early Promise,COPD News,Negative
 Un estudio con   pacientes,Sociedad Qu√≠mica de Panam√°,Positive
 con COVID que requirieron hospitalizaci√≥n,Sociedad Qu√≠mica de Panam√°,Positive
 por bajos niveles,Sociedad Qu√≠mica de Panam√°,Positive
 de ox√≠geno y un,Sociedad Qu√≠mica de Panam√°,Positive
 cuadro de inflamaci√≥n demostr√≥ que,Sociedad Qu√≠mica de Panam√°,Positive
 el medicamento Acalabrutinib,Sociedad Qu√≠mica de Panam√°,Positive
 es,Sociedad Qu√≠mica de Panam√°,Positive
 es,Noticias √ânfasis,Positive
 ben√©fico sobre,Sociedad Qu√≠mica de Panam√°,Positive
 administra,Sociedad Qu√≠mica de Panam√°,Positive
 al inicio,Sociedad Qu√≠mica de Panam√°,Positive
 de la tormenta de citoquinas,Sociedad Qu√≠mica de Panam√°,Positive
 Resultat fr√•n tv√• nya studier pekar p√• att,Life Science Sweden,Positive
 √§r mycket god,Life Science Sweden,Positive
 med Calquence,Life Science Sweden,Positive
 patienter med kronisk lymfatisk leukemi,Life Science Sweden,Positive
 Nello studio ACECL acalabrutinib dimostra un tasso di,Medinews,Negative
 globale del,Medinews,Negative
 e un profilo,Medinews,Negative
 di sicurezza prolungato nel trattamento,Medinews,Negative
 con,Medinews,Negative
 con,Hematolog√≠a Salamanca,Negative
 linfatica cronica,Medinews,Negative
 non pretrattati,Medinews,Negative
 Acalabrutinib √®,Ritrattodellasalute,Positive
 e tollerato,Ritrattodellasalute,Positive
 lungo termine nel,Ritrattodellasalute,Positive
 linfatica cronica LLC la forma pi√π comune di leucemia dell‚ÄôadultotcoWqOkdRl,Ritrattodellasalute,Positive
 Tras los √©xitos,Luis M Ruiz,Positive
 nuestras,Luis M Ruiz,Positive
 y dem√°s vedettesllega,Luis M Ruiz,Positive
 muestras pantallas,Luis M Ruiz,Positive
 Medscape BTK inhibitor acalabrutinib,"Freddy Pizart, R.N.",Positive
 de la COVID Podr√≠a ser,Cambio16,Negative
 el virus,Cambio16,Negative
 la prote√≠na BTK El descubrimiento da esperanza,Cambio16,Negative
 en la consecuci√≥n de un,Cambio16,Negative
 Doctors,Daniel Lopez,Positive
 Doctors,himanshu singh,Positive
 Doctors,Linda Dudek üçë‚úçüèº,Positive
 Doctors,AaMaldives,Positive
 Doctors,Saud Nasser Aldosery,Positive
 Doctors,Convenience Store News.,Positive
 Doctors,Barbara Lazarus,Positive
 Doctors,Duarte ‚≠ï,Positive
 Doctors,JT Badenov,Positive
 Doctors,GeekinfoNow,Positive
 Doctors,Chris Smith,Positive
 Doctors,News_Actualizadas,Positive
 Doctors,BGR.com,Positive
 Doctors,Noah Swint,Positive
 Doctors,CLL Society Inc.,Negative
 Doctors,Patient Power,Negative
 Doctors,Leukemia I'm Fine,Negative
 Doctors,CLL Ireland,Negative
 Doctors,CLL_Fightersüéó,Negative
 Doctors,CURE Magazine,Negative
 Doctors,Scripps Research,Positive
 Doctors,Lymphoma News Today,Positive
 Doctors,BioNews,Negative
 drugs amp devices,Function_1st,Positive
 Una esperanza para,Aldo Sol√≠s üí¢,Positive
 Una esperanza para,Radio Mambi 710 üéô,Positive
 Una esperanza para,Patricio S√°nchez üêç,Positive
 los pacientes de coronavirus,Aldo Sol√≠s üí¢,Positive
 los pacientes de coronavirus,Radio Mambi 710 üéô,Positive
 los pacientes de coronavirus,Patricio S√°nchez üêç,Positive
 estado cr√≠tico probaron con √©xito el Acalabrutinib un f√°rmaco,Aldo Sol√≠s üí¢,Positive
 ya,Aldo Sol√≠s üí¢,Positive
 ya,Dr. Iv√°n R. Gonz√°lez,Positive
 ya,Vaibhav kumar gupta,Positive
    Investigadores observaron que el uso del medicamento,Radio Chaparrastique 106.1 FM,Positive
    Investigadores observaron que el uso del medicamento,Noticias 4Visi√≥n,Positive
 un f√°rmaco,Radio Chaparrastique 106.1 FM,Positive
 un f√°rmaco,Noticias 4Visi√≥n,Positive
 el tratamiento de varios,Radio Chaparrastique 106.1 FM,Positive
 el tratamiento de varios,√ìscar Peraza,Positive
 el tratamiento de varios,OPR,Positive
 el tratamiento de varios,ITR Noticias - Oficial,Positive
 el tratamiento de varios,Noticias 4Visi√≥n,Positive
 tipos de c√°ncer de sangre proporcion√≥ beneficios,Radio Chaparrastique 106.1 FM,Positive
 tipos de c√°ncer de sangre proporcion√≥ beneficios,√ìscar Peraza,Positive
 tipos de c√°ncer de sangre proporcion√≥ beneficios,OPR,Positive
 tipos de c√°ncer de sangre proporcion√≥ beneficios,ITR Noticias - Oficial,Positive
 tipos de c√°ncer de sangre proporcion√≥ beneficios,Noticias 4Visi√≥n,Positive
 los pacientes cr√≠ticos por,Radio Chaparrastique 106.1 FM,Positive
 los pacientes cr√≠ticos por,√ìscar Peraza,Positive
 los pacientes cr√≠ticos por,OPR,Positive
 los pacientes cr√≠ticos por,ITR Noticias - Oficial,Positive
 los pacientes cr√≠ticos por,Noticias 4Visi√≥n,Positive
 El acalabrutinib inhibidor de la tirosina,Carlos Arturo √Ålvarez Moreno,Positive
 quinasa de Bruton BTK podria ser √∫til,Carlos Arturo √Ålvarez Moreno,Positive
 en el tratamiento,Carlos Arturo √Ålvarez Moreno,Positive
 de casos severos,Carlos Arturo √Ålvarez Moreno,Positive
 de    publica estudio de mejor√≠a con su,Carlos Arturo √Ålvarez Moreno,Positive
 Ahora toca,Carlos Arturo √Ålvarez Moreno,Positive
 hacer un,Carlos Arturo √Ålvarez Moreno,Positive
 clinico,Carlos Arturo √Ålvarez Moreno,Positive
 Leyendo sobre la inflamacion,Felix A.,Positive
 provocada por el,Felix A.,Positive
 estudios con pacientes de paises,Felix A.,Positive
 mas afectados,Felix A.,Positive
 y,Felix A.,Positive
 y,Manuel Muro,Positive
 y,Gorka Orive,Positive
 y,Toby Eyre,Positive
 y,"Raul Cordoba, MD, PhD",Negative
 y,Felipe Pe√±a Mu√±oz,Positive
 y,Just Jen,Positive
 y,Prometheus‚Äô Trainee,Positive
 y,Dario Antilen,Positive
 y,Club Libertad Limpe√±o,Negative
 y,Radio La Red 102.1FM,Positive
 y,WWE Noticias FM,Negative
 y,Hematolog√≠a SantPau,Positive
 y,TVBUS Noticias de Oaxaca,Positive
 y,Giannina,Positive
 y,Beatriz Albella Rdgz,Positive
 y,Estela de la Torre OLY üá≤üáΩ,Negative
 y,Bella Carstairs,Negative
 y,A.G.,Positive
 y,Centro Luso Larense,Negative
 aparece,Felix A.,Positive
 Panam√°,Felix A.,Positive
 la prote√≠na BTK llamado acalabrutinib,Felix A.,Positive
 Y aqu√≠,Felix A.,Positive
 x q,Felix A.,Positive
 la OMS,Felix A.,Positive
 ha aprobado tal cosasusalaaabaaoo,Felix A.,Positive
 Exciting news,Mercy Durango,Positive
 Exciting news,WCM Lymphoma,Negative
 Exciting news,Leukemia Research Foundation,Negative
 Exciting news,iwCLL,Negative
 Exciting news,Alliance for Cancer Gene Therapy,Positive
 acalabrutinib un f√°rmaco de AstraZeneca que trata,Barricada Azul,Positive
 y ahora el acalabrutinib aparecen,Daniel Murriel,Positive
   El Acalabrutinib fue,Latina.pe,Positive
 casos de Covid y logr√≥ combatir con √©xito,Latina.pe,Positive
 estados avanzados,Latina.pe,Positive
 estados avanzados,Radio Mambi 710 üéô,Positive
 estados avanzados,Loreto Noticias,Positive
 Evan Kirstel,Vasyl Pawlowsky,Positive
 Twitter,Vasyl Pawlowsky,Positive
 Twitter,Chloe Mac,Positive
 Twitter,Anthony Mato,Negative
 Twitter,Dr Timos Papagatsias,Positive
 Twitter,Haitham Abdelhakim,Positive
 Twitter,Sharmaine Fuentes,Positive
 Twitter,Crashilda Corvis,Positive
 Prueban con √©xito el Acalabrutinib para pacientes con coronavirus,Apunte Digital,Negative
 estado grave,Apunte Digital,Negative
 prueban con √©xito un f√°rmaco Acalabrutinib,Apunte Digital,Negative
 SI SE SALVA ALGUNA VIDA,LEON ***,Negative
 BIENVENIDA SEA,LEON ***,Negative
 NEWS AUN,LEON ***,Negative
 SIGO,LEON ***,Negative
 CIENTIFICA MEDICA,LEON ***,Negative
 MONEY,LEON ***,Negative
 GOOD NEWS,LEON ***,Positive
 GOOD NEWS,Lymphoma News Today,Negative
 ACALABRUTINIB ESTE,LEON ***,Negative
 Y SEA OTRO FAKE PARA AMASAR MONEY,LEON ***,Negative
 case study,"John Damianos, M.D.",Positive
 case study,"Jocelyn Solis-Moreira, MS",Positive
 case study,MedPage Oncology,Negative
 case study,Michigan Pathology,Positive
 case study,Andy Higgs,Positive
   ACALABRUTINIB,LEON ***,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá„ÇíÂØæË±°„Å®„Åó„ÅüCALAVIË©¶È®ì„ÇíÈñãÂßã,Stray,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá„ÇíÂØæË±°„Å®„Åó„ÅüCALAVIË©¶È®ì„ÇíÈñãÂßã,„Éö„É≥„ÇÆ„É≥„Çø„Ç§„É†„Ç∫,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá„ÇíÂØæË±°„Å®„Åó„ÅüCALAVIË©¶È®ì„ÇíÈñãÂßã,PR TIMES„Éì„Ç∏„Éç„Çπ,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá„ÇíÂØæË±°„Å®„Åó„ÅüCALAVIË©¶È®ì„ÇíÈñãÂßã,PR TIMES„Éã„É•„Éº„Çπ,Positive
 M√©dicos,Cambio16,Negative
 Estados Unidos dieron con un f√°rmaco capaz de combatir y vencer las formas m√°s,Cambio16,Negative
 de la   COVID,Cambio16,Negative
 prueban con √©xito un f√°rmaco ya existente El Acalabrutinib,Apunte Digital,Negative
 El estudio,P√°gina Central Jujuy,Positive
 desarrollado para probar si el bloqueo,P√°gina Central Jujuy,Positive
 de la prote√≠na,P√°gina Central Jujuy,Positive
 BTK con Acalabrutinib,P√°gina Central Jujuy,Positive
   un medicamento que se usa,A construir 1pa√≠s!,Positive
 medicamento,El Grillo de Yucat√°n,Positive
 medicamento,Oncopharma,Positive
 medicamento,El Farmac√©utico Independiente,Negative
 que ‚Äú salvar√≠a,El Grillo de Yucat√°n,Positive
 Resultados inesperados,Benjam√≠n N√∫√±ez Vega,Positive
 el producto,Benjam√≠n N√∫√±ez Vega,Positive
 bienvenido,Benjam√≠n N√∫√±ez Vega,Positive
 especialmente dise√±ado para bloquear,Benjam√≠n N√∫√±ez Vega,Positive
 la BTK y aprobado para el tratamiento de algunos c√°nceres,Benjam√≠n N√∫√±ez Vega,Positive
 Cytokine storm BTK Inhibitor Acalabrutinib,Alejandro (Alex) Barbagelata,Positive
 Acalabrutinib f√°rmaco para,Manuel Muro,Negative
 la BTK Tirosina kinasa de Bruton,Manuel Muro,Negative
 Covid con buenos resultados,Manuel Muro,Negative
 de ellos,Manuel Muro,Negative
 estado cr√≠tico probaron con √©xito un f√°rmaco,Radio Mambi 710 üéô,Positive
 ya existenteEl,Radio Mambi 710 üéô,Positive
 uso del Acalabrutinib usado contra el c√°ncer logr√≥ combatir con √©xito,Radio Mambi 710 üéô,Positive
    Investigadores observaron que el uso del medicamento ‚Äú Acalabrutinib ‚Äù un f√°rmaco,√ìscar Peraza,Positive
    Investigadores observaron que el uso del medicamento ‚Äú Acalabrutinib ‚Äù un f√°rmaco,OPR,Positive
    Investigadores observaron que el uso del medicamento ‚Äú Acalabrutinib ‚Äù un f√°rmaco,ITR Noticias - Oficial,Positive
 El uso del Acalabrutinib,Loreto Noticias,Positive
 usado contra el c√°ncer logr√≥ combatir con √©xito,Loreto Noticias,Positive
 El remedio,Loreto Noticias,Positive
 estado cr√≠tico probaron con √©xito un f√°rmaco ya existente,Patricio S√°nchez üêç,Positive
 F√°rmaco Acalabrutinib,pawel,Positive
 Hola,M√≥et,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàÔºâ„ÄÅÊñ∞Âûã „É™„É≥„ÇØ,Tweets,Positive
 „Ç∞Ôºö„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ „ÅäÁü•„Çâ„Åõ,Tweets,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Ê†™Âºè‰ºöÁ§æ„ÄÅ„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá‰æã„ÅÆÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÅÆÂ§ßÂ§öÊï∞„Å´„Åä„ÅÑ„Å¶ÊúâÊúõ„Å™Ëá®Â∫äÂäπÊûú„ÇíÁ§∫„Åô,NEWSRELEA.SE,Positive
 El f√°rmaco acalabrutinib un inhibidor que controla,Jos√© Manuel Bautista,Positive
 Cancer drug acalabrutinib,MARIA da GLORIA,Positive
 potential,MARIA da GLORIA,Positive
 potential,"Michael Wang, MD",Negative
 potential,medwireNews,Negative
 potential,Briefing.com,Negative
 potential,StockNews.com,Negative
 potential,CRWE News Wire,Positive
 potential,OncLive SOSS,Negative
 potential,JediPD,Negative
 potential,Paperbirds_Hematology,Negative
 potential,OncLive.com,Negative
 potential,Sussex Haematology,Positive
 potential,Lymphoma Hub,Negative
 potential,MedChemExpress,Positive
 potential,Patient Power,Negative
 potential,Dana-Farber,Negative
 potential,Michael Rynne,Negative
 potential,CLL Society Inc.,Negative
 potential,VJHemOnc,Positive
 potential,Charlotte Martin,Positive
 potential,Diagnostics News,Negative
 potential,CURE Magazine,Negative
 potential,US Oncology Network,Negative
 potential,CLL Ireland,Positive
 potential,Hugo Cabrera,Positive
 potential,Targeted Oncology,Negative
 potential,Beth Torr,Positive
 potential,Grant Beasley,Positive
 potential,CLL_Fightersüéó,Negative
 potential,AEGLE,Negative
 potential,Winship Cancer Institute of Emory University,Negative
 un f√°rmaco anticanceroso,+Recortes Salvajes,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ „ÅÆ „Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„Çπ,natsume | ‰πæÁô¨ | „Éò„É´„Çπ„Ç±„Ç¢,Positive
 ÊÑüÊüìÁóá‰æã„ÅÆÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÅÆÂ§ßÂ§öÊï∞„Å´„Åä„ÅÑ„Å¶ÊúâÊúõ„Å™Ëá®Â∫äÂäπÊûú„ÇíÁ§∫„Åô „ÄÇ ÔºÉÂÖçÁñ´ „ÄÄ ÔºÉCOVID,natsume | ‰πæÁô¨ | „Éò„É´„Çπ„Ç±„Ç¢,Positive
 de la enzima,Gorka Orive,Positive
 en,Gorka Orive,Positive
 en,Raquel O√±a Navarrete,Negative
 en,Visitador a M√©dicos,Positive
 en,onmedic,Positive
 en,ùïµùñäùñâùñé ùïΩùñäùñïùñöùñáùñëùñéùñàùñÜùñìùñî üî¥üü°üü£,Positive
 en,Jolanda,Positive
 en,Club Deportivo Moto Kart Jovita,Negative
 en,Club Libertad Limpe√±o,Negative
 en,XNL,Positive
 en,Cultura Lucha Libre,Positive
 en,Monte S,Positive
 en,John Drago,Positive
 mejora su capacidad de oxigenaci√≥n,Gorka Orive,Positive
 „Äê ÊÑüÊüìÁóá,ÂåªÁôÇ„Éã„É•„Éº„ÇπÈÄüÂ†±,Positive
 Estudios,CEPROFAR - Centro de Profesionales Farmac√©uticos,Positive
 de   contra,CEPROFAR - Centro de Profesionales Farmac√©uticos,Positive
 nota de   para,CEPROFAR - Centro de Profesionales Farmac√©uticos,Positive
 Clar√≠n,CEPROFAR - Centro de Profesionales Farmac√©uticos,Positive
 con la opini√≥n,CEPROFAR - Centro de Profesionales Farmac√©uticos,Positive
 Credit,Convenience Store News.,Positive
 ‚Å¶,AAA,Positive
 ‚Å¶,"Naveen Pemmaraju, MD",Negative
 ‚Å¶,Elena,Positive
 ‚Å¶,Prof John,Positive
 Coca Cola,JT Badenov,Positive
 Coca Cola,Vineeth Sukrithan,Positive
 parody article,Sharon K. Gilbert,Positive
 HonestDoctors,Sharon K. Gilbert,Positive
 mind,Benyam Muluneh,Positive
 mind,Shouting at people in my underpants,Negative
 mind,OncLive.com,Negative
 mind,OncLive SOSS,Negative
 mind,Jeff Neurman,Negative
 mind,LymphomaAction,Negative
 mind,CBPartners,Positive
 mind,Patient Power,Positive
 Dr Nicole Lamanna,OncLive.com,Negative
 Dr Nicole Lamanna,Patient Power,Positive
 Dr Nicole Lamanna,Andrew Schorr,Positive
 Dr Nicole Lamanna,Lymphoma Hub,Negative
 Dr Jan Burger,OncLive.com,Negative
 Dr Jan Burger,Expert Perspectives in Oncology,Positive
 Dr Jan Burger,iwCLL,Negative
 Dr Jan Burger,MD Anderson Cancer Center,Negative
 Dr Javier PinillaIbarz,OncLive.com,Negative
 Dr Javier PinillaIbarz,Patient Empowerment Network,Negative
 Dr Javier PinillaIbarz,Moffitt Research,Positive
 ASCEND acalabrutinib trial,OncLive.com,Negative
 investigators,ASCO Publications,Negative
 investigators,Rutgers Biomedical and Health Sciences,Positive
 investigators,Targeted Oncology,Negative
 POSSIBLE TREATMENT Calquence,13WREX,Positive
 promise,13WREX,Positive
 promise,The PMI (Pharmaceutical Managers' Institute),Negative
 promise,David Ledger,Negative
 promise,PharmaTimes,Negative
 promise,"eCare Vault, Inc.",Positive
 promise,Barry Curry,Negative
 promise,Jon Angelo,Negative
 promise,Everything Pharma,Negative
 promise,Pharma Trader,Negative
 promise,Pharmafocus,Negative
 promise,PharmaCrowd,Negative
 promise,Career Biotech,Negative
 promise,Patricia Kime,Positive
 promise,Oncology Tube,Positive
 promise,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 promise,Maddy from GlobalData Healthcare,Positive
 promise,John,Negative
 promise,Prof John,Negative
 promise,i3 Health,Negative
 promise,Richard Lobb,Positive
 promise,emilylevitch_i3Health,Positive
 promise,Plexus Ventures,Negative
 promise,Liz Highleyman,Positive
 promise,WCM Lymphoma,Negative
 promise,Nick,Negative
 promise,EPM Magazine,Positive
 promise,MD Anderson Cancer Center,Negative
 promise,HemOnc Today,Positive
 promise,VJHemOnc,Negative
 promise,medwireNews,Negative
 promise,Healio,Negative
 promise,EMJ Hematology,Positive
 promise,Genetic Engineering & Biotechnology News,Negative
 promise,Allergy & Immunology,Positive
 promise,Francesco Turturro,Negative
 promise,APhA DrugInfoLine,Positive
 promise,Ferg,Positive
 promise,Patient Power,Negative
 promise,MDedge Hematology & Oncology,Negative
 promise,Andy Powell,Positive
 promise,Shop Support,Positive
 promise,debra cincioni,Positive
 promise,Scott Werntz,Negative
 promise,Cancer Agent,Negative
 research,13WREX,Positive
 research,DMD (ASPET),Positive
 research,Nicolas Martinez üá®üá¥üá®üá¥,Positive
 research,"Pharmacyclics, an AbbVie Company",Positive
 research,Patient Empowerment Network,Positive
 research,Annette Hay,Positive
 research,MedPage Oncology,Negative
 research,City of Hope | Orange County,Positive
 research,Sigrid Sk√•nland,Positive
 research,Federation University,Positive
 research,CLL Ireland,Positive
 research,CLL Society Inc.,Negative
 research,Clinical Lab Products Magazine,Positive
 research,Ginny McLean,Positive
 research,Anthony Mato,Negative
 research,"David Bartlett, PhD",Negative
 research,AbbVie,Negative
 research,RTI Health Solutions,Positive
 research,Toby Eyre,Negative
 research,Verastem Oncology,Negative
 research,AstraZenecaUS,Negative
 research,Patient Power,Positive
 research,CLL Advocates Network,Negative
 research,LymphomaAction,Negative
 research,Madison Taylor,Positive
 research,Harvard Medical School,Positive
 research,global hematology,Positive
 research,Covaris,Positive
 research,Renal Cell Carcinoma,Negative
 research,The James,Positive
 research,"Amber Koehler, PA-C",Negative
 research,VJHemOnc,Positive
 research,Andre Williams,Positive
 research,JanssenUS,Positive
 research,MDEdge,Negative
 research,MDedge Hematology & Oncology,Negative
 research,Penn Medicine MD,Positive
 research,Dana-Farber News,Positive
 research,OncLive SOSS,Negative
 research,Peter Mac Cancer Centre,Positive
 research,Andrew Schorr,Positive
 research,suetodd16,Positive
 research,Genentech,Negative
 research,Hematopoiesis News,Negative
 research,CLL_Fightersüéó,Negative
 research,SeattleCancerCareAlliance,Negative
 research,AEGLE,Negative
 research,EBioMedicine ‚Äì Published by The Lancet,Positive
 research,"chadi nabhan MD, MBA, FACP",Negative
 research,Te Ha,Negative
 research,Katie Gould,Positive
 research,Rhia Steele@ravishingrhia.com,Positive
 research,Paula Pyzia,Negative
 research,Lymphoma Hub,Negative
 research,Sandy D.,Negative
 research,WEGO Health,Positive
 research,Kimberley Thomas,Negative
 research,Grayson (he),Positive
 research,International Pain Foundation¬Æ,Negative
 research,Cassi Schmigotzki,Negative
 research,Debbie Woodbury,Negative
 research,Chronic Sex,Positive
 research,SeparatriX,Positive
 research,Pamela Helton,Positive
 research,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 research,CureClick,Positive
 research,Susan Rahn,Positive
 research,Dana-Farber,Negative
 research,Michael | È∫¶ÂÖãÂÑø,Positive
 research,Speaking of Research,Positive
 research,Michele Nadeem-Baker,Negative
 El f√°rmaco acalabrutinib aprobado por,univadis_es,Positive
 para,univadis_es,Positive
 tipos de c√°ncer de linfocitos B mejor√≥ los niveles de oxigenaci√≥n,univadis_es,Positive
 disminuy√≥ los marcadores,univadis_es,Positive
 de inflamaci√≥n,univadis_es,Positive
 Se,Diario de Chiapas,Positive
 Calquence aprobado para tratar el linfoma y que pertenece,Diario de Chiapas,Positive
 una,Diario de Chiapas,Positive
 conocida como inhibidores de BTK,Diario de Chiapas,Positive
 Comenta,Diario de Chiapas,Positive
 y RT,Diario de Chiapas,Positive
    Bruton tyrosine kinase,Erwin Loh,Positive
 LongTerm Tolerability,Crwe World,Negative
 LongTerm Tolerability,OncLive.com,Negative
 LongTerm Tolerability,Immuno-Oncology,Negative
 BCell Malignancies,Crwe World,Negative
 BCell Malignancies,OncLive.com,Negative
 BCell Malignancies,Immuno-Oncology,Negative
 BCell Malignancies,Lymphoma Papers,Negative
 BCell Malignancies,Paperbirds_Hematology,Positive
 BCell Malignancies,Targeted Oncology,Negative
 BCell Malignancies,Lymphomation.org,Negative
 trav√©s de,BIOCIENCIA,Negative
 trav√©s de,R Marcos-Gragera üéó,Positive
 Research Finds Cancer Drug,Colorado Headlines,Positive
 Longterm data,Oncology Nursing News,Negative
 Longterm data,OncLive.com,Negative
 Longterm data,Journal of the @NCCN,Negative
 acalabrutinib Calquence,Oncology Nursing News,Positive
 acalabrutinib Calquence,SY Investing,Positive
 acalabrutinib Calquence,Saeed Valadbaygi,Negative
 acalabrutinib Calquence,"Mike Thompson, MD, PhD, FASCO",Negative
 Rapid improvements,Vanessa K Abrahamson,Positive
 Promising Clinical Improvement,"eCare Vault, Inc.",Positive
 Majority,"eCare Vault, Inc.",Positive
 MedNews,"eCare Vault, Inc.",Positive
 MedNews,Zaspera,Positive
 MedNews,Rondaxe Pharma,Positive
 L‚Äôacalabrutinib serait b√©n√©fique pour,Pierre B√©zier,Positive
 L‚Äôacalabrutinib serait b√©n√©fique pour,H24 News Canada FR,Positive
 L‚Äôacalabrutinib serait b√©n√©fique pour,Le Journal de Montr√©al,Positive
 gravement atteintsUn m√©dicament contre le cancer pour aider des malades de la COVID,Pierre B√©zier,Positive
 JDQ,Pierre B√©zier,Positive
 Promise,Pharmacy Now!,Positive
 Promise,Giuseppe LiMandri,Negative
 Promise,OncLive.com,Positive
 Promise,disabled_jake,Positive
 Promise,Francesco Bertoni,Negative
 Promise,Silas Inman,Negative
 Promise,FarmaOnco,Negative
 Promise,PER,Negative
 Promise,Oncology News Update,Negative
 Promise,CellworksLife,Negative
 Promise,CLL Society Inc.,Negative
 Promise,Anthony Mato,Negative
 Promise,Cancer Health,Positive
 Promise,CLL Ireland,Negative
 Promise,Miguel Perales M.D.,Negative
 Promise,Brian Uherek,Negative
 Promise,Armani Chiropractic,Positive
 Promise,CURE Magazine,Negative
 Promise,"Aaron Gerds MD, MS",Positive
 Promise,Ryan HamNer,Negative
 Promise,HRA,Positive
 Promise,The ASCO Post,Negative
 Promise,Patient Power,Negative
 Promise,Drugs.com,Negative
 Hospitalized COVID Patients,Pharmacy Now!,Positive
 Hospitalized COVID Patients,PharmaShots - Incisive news in 3 shots,Negative
 Hospitalized COVID Patients,ChicagoSchoolofYoga,Negative
 Hospitalized COVID Patients,AID 24:7 Recruitment Solutions,Positive
 Hospitalized COVID Patients,kubsv,Positive
 Hospitalized COVID Patients,Nathan Vardi,Negative
   AstraZenecas,The PMI (Pharmaceutical Managers' Institute),Negative
 COVID Improved markers,The PMI (Pharmaceutical Managers' Institute),Negative
 Bruton tyrosine kinase BTK protein,Health Evangelists,Negative
 JCO„ÄëÂÜçÁô∫Èõ£Ê≤ªÊÄßÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„Å´ÂØæ„Åô„Çãacalabrutinib„ÅÆÁ¨¨‚Ö¢Áõ∏Ë©¶È®ìÁµêÊûú,È£ØÂ°öÁóÖÈô¢ Ë°ÄÊ∂≤ÂÜÖÁßë,Positive
   Improvement,Daily Coronavirus News üò∑üåçüìà,Positive
 Administration,Daily Coronavirus News üò∑üåçüìà,Positive
 Administration,Lisa Scott,Positive
 Social Reach Low,Daily Coronavirus News üò∑üåçüìà,Positive
 search,Around The Globe News,Positive
 search,CancerTherapyAdvisor,Negative
 search,Thomas Leavitt,Positive
 search,MDedge Hematology & Oncology,Negative
   doctors,Around The Globe News,Positive
   doctors,CLL_Fightersüéó,Negative
   doctors,Patient Power,Negative
 Le rem√®de Scrabble du,Phil from Montreal,Positive
 jour   AcalabrutinibElle d√©sactive,Phil from Montreal,Positive
 AstraZenecas cancer drug Acalabrutinib,SitaravammaputrSamba,Positive
 AstraZenecas cancer drug Acalabrutinib,MediHelp Solutions,Negative
 AstraZenecas cancer drug Acalabrutinib,RVGSM,Positive
 breathing difficulties,SitaravammaputrSamba,Positive
 breathing difficulties,RVGSM,Positive
 breathing difficulties,Journal of Clinical and Cellular Immunology,Negative
 Acalabrutinib targets,Waggoner Lab,Positive
 macrophages,Waggoner Lab,Positive
 macrophages,ALI ALAHMARI.,Negative
 macrophages,"Raul Cordoba, MD, PhD",Positive
 macrophages,Total Well Being,Positive
 macrophages,VJHemOnc,Positive
 gravement atteints,H24 News Canada FR,Positive
 gravement atteints,Le Journal de Montr√©al,Positive
 Favipiravir Acalabrutinib la gente que busca,Martin Capote,Positive
 para el,Martin Capote,Positive
 covid,Martin Capote,Positive
 Las Ketchup,Martin Capote,Positive
 El acalabrutinib muestra una,victor torres,Positive
 un peque√±o grupo de pacientes,victor torres,Positive
 con COVID grave estudioSeg√∫n los hallazgos del estudio publicados,victor torres,Positive
 Science Immunology Referencia,victor torres,Positive
 Science Immunology,victor torres,Positive
 Science Immunology,KFL üïäÔ∏èü§çüïäÔ∏è,Positive
 Science Immunology,WallStBetsDotCom,Negative
 value,Bonny Wrightüêù,Positive
 value,Kate Cwynarski,Positive
 value,Toby Eyre,Negative
 value,Taylor Lab UM,Negative
 value,VJHemOnc,Positive
 value,Jeff Sharman,Positive
 value,AEGLE,Negative
 value,NYCDoc29,Negative
 value,Publish PressRelease,Positive
 value,OncLive.com,Negative
 value,Anthony Howards,Positive
 value,Dr Darren Saunders,Positive
 value,GenPath Oncology,Negative
 COVID patients Acalabrutinib   Wikipedia,Bonny Wrightüêù,Positive
 Un,SalvadorSchwartzmann,Positive
 contra el c√°ncer podr√≠a ser,SalvadorSchwartzmann,Positive
 √∫til,SalvadorSchwartzmann,Positive
 casos severos de coronavirus El acalabrutinib,SalvadorSchwartzmann,Positive
 probado con buenos resultados,SalvadorSchwartzmann,Positive
 que faltan,SalvadorSchwartzmann,Positive
 estudios m√°s completos y que,SalvadorSchwartzmann,Positive
 muy caro,SalvadorSchwartzmann,Positive
 report,Sandeep Saluja,Positive
 report,"One Health, India",Positive
 report,CEITEC Connect,Negative
 report,CARE‚Ñ¢ Education,Positive
 report,MedPage Today,Negative
 report,Wiley Oncology & Hematology,Positive
 report,medwireNews,Negative
 report,Gill Budgell,Positive
 report,COPD News,Negative
 report,ASBMB,Positive
 report,AliKat üíô,Positive
 report,CLL Ireland,Negative
 report,CLLSA,Positive
 report,Molecular & Cellular Proteomics,Positive
 report,Michele Nadeem-Baker,Negative
 report,Salvatore Klein,Positive
 report,Anna Deveau,Negative
 report,"Raul Cordoba, MD, PhD",Negative
 report,Canadian Hematology,Positive
 report,Wise Guy Reports,Positive
 report,Dr Lesly Huxley,Positive
 AstraZeneca Reports Results,Medicalnewser.com,Negative
 AstraZeneca Reports Results,PharmaShots - Incisive news in 3 shots,Positive
 CALAVI Study,Medicalnewser.com,Negative
 CALAVI Study,PharmaShots - Incisive news in 3 shots,Negative
 Hospitalized COVID,Medicalnewser.com,Negative
 Patients ShotsThe CALAVI program,Medicalnewser.com,Negative
 BSC,Medicalnewser.com,Positive
 BSC,EuropaWire,Negative
 monothx,Medicalnewser.com,Negative
 Covid results,Zenopa Recruitment,Positive
 offlabel,denni üåº #evindekal #stayhome #restaacasa,Negative
   Investigaciones,Noticias √ânfasis,Positive
 sugieren que el,Noticias √ânfasis,Positive
 tratamiento,Noticias √ânfasis,Positive
 con   puede ser efectivo porque su objetivo del BTK,Noticias √ânfasis,Positive
 hiperactivo,Noticias √ânfasis,Positive
 las c√©lulas inmunes,Noticias √ânfasis,Positive
 conoce m√°s,Noticias √ânfasis,Positive
 AZN —Å–µ–≥–æ–¥–Ω—è,–°–µ—Ä–∂ü§¶–°–∞–º—Å–æ–Ω–æ–≤,Positive
 Con acalabrutinib rapido miglioramento dei,PharmaStar,Negative
 sintomi,PharmaStar,Negative
 Studio su Science Immunology,PharmaStar,Negative
 laterstage,Global Business Alliance,Positive
 Public Health   storm,Living Safely,Negative
 Improvement,"Synergy Healthcare, LLC",Negative
 Improvement,EBD Group,Positive
 Improvement,NonSell.com,Positive
 Improvement,Armin Hamidian,Positive
 Improvement,Vishnu Live,Positive
 Improvement,VIRALFLEX,Positive
 Improvement,cafepharma,Negative
 Improvement,Dr Timos Papagatsias,Negative
 Improvement,American Capital Rec,Positive
 Improvement,news98,Positive
 Improvement,Health News,Negative
 Improvement,BenExact,Negative
 Improvement,ChicagoSchoolofYoga,Negative
 Improvement,AID 24:7 Recruitment Solutions,Positive
 Improvement,kubsv,Positive
 Improvement,Nathan Vardi,Negative
 Improvement,TrialBulletin,Negative
 Small Group,"Synergy Healthcare, LLC",Negative
 Small Group,EBD Group,Positive
 Small Group,NonSell.com,Positive
 Small Group,Armin Hamidian,Positive
 Small Group,Vishnu Live,Positive
 Small Group,VIRALFLEX,Positive
 Small Group,cafepharma,Negative
 Small Group,Dr Timos Papagatsias,Negative
 Small Group,American Capital Rec,Positive
 Small Group,news98,Positive
 Small Group,Health News,Negative
 Small Group,BenExact,Negative
 Small Group,ChicagoSchoolofYoga,Negative
 Small Group,AID 24:7 Recruitment Solutions,Positive
 Small Group,kubsv,Positive
 Small Group,Nathan Vardi,Negative
 Hospitalized Covid Patients,"Synergy Healthcare, LLC",Negative
 Hospitalized Covid Patients,EBD Group,Positive
 Hospitalized Covid Patients,NonSell.com,Positive
 Hospitalized Covid Patients,Armin Hamidian,Negative
 Hospitalized Covid Patients,Vishnu Live,Positive
 Hospitalized Covid Patients,cafepharma,Negative
 Hospitalized Covid Patients,Dr Timos Papagatsias,Negative
 Hospitalized Covid Patients,American Capital Rec,Positive
 Hospitalized Covid Patients,Health News,Negative
 Hospitalized Covid Patients,BenExact,Negative
 MEDIA,NCI Media Relations,Positive
 MEDIA,CIHR,Positive
 cancer drug Calquence acalabrutinib,Meghan Mott,Positive
 Cytokine storm Acalabrutinib,satokun,Positive
 Cytokine storm Acalabrutinib,Cheryl Amber Dotson,Positive
 Cytokine storm Acalabrutinib,MediHelp Solutions,Negative
 Cytokine storm Acalabrutinib,WaYs2rOcK,Positive
 Cytokine storm Acalabrutinib,Outbreak News,Positive
 CORONAVIRUS ASTRA PHARM DRUG POTENTIAL,john markarian,Positive
 Outbreak News,Cheryl Amber Dotson,Positive
 AwesomeCapital AstraZeneca,****,Positive
 drug Acalabrutinib,Journal of Clinical and Cellular Immunology,Negative
 recovery,Jon Angelo,Negative
 recovery,Pharmafocus,Negative
 recovery,"Navneet Majhail, MD, MS",Negative
 interleukin IL,Firstpost,Positive
 bodies,Firstpost,Positive
 Complex Event Analysis,SiteFocus,Positive
 ForbesTech AstraZenecas Calquence,@mariuskarma,Positive
   approved anticancer drug,Roots Analysis,Negative
 inflammatory responses,Roots Analysis,Negative
 details,Roots Analysis,Negative
 details,Patient Power,Negative
 details,GenQA (Genomics Quality Assessment),Positive
 details,Arush Emmanuel Michael,Positive
 details,HemOnc_ACCP,Positive
 details,LymphomaAction,Negative
 details,CLL Society Inc.,Negative
 details,Kanga Exchange,Positive
 details,leukemia,Negative
 details,Andrew Schorr,Negative
 Der BrutonKinase BTKInhibitor Acalabrutinib der,KFL üïäÔ∏èü§çüïäÔ∏è,Positive
 zur Behandlung bestimmter Lymphome entwickelt wurde hat,KFL üïäÔ∏èü§çüïäÔ∏è,Positive
 zur Behandlung bestimmter Lymphome entwickelt wurde hat,Deutsches √Ñrzteblatt,Positive
 einer offenen Studie,KFL üïäÔ∏èü§çüïäÔ∏è,Positive
 einer offenen Studie,Deutsches √Ñrzteblatt,Positive
 den Zytokinsturm bei Patienten abgeschw√§cht,KFL üïäÔ∏èü§çüïäÔ∏è,Positive
 COVID erkrankt waren,KFL üïäÔ∏èü§çüïäÔ∏è,Positive
 BTKInhibitor zeigt klinische Wirkung bei COVID,Deutsches √Ñrzteblatt,Positive
 Bethesda,Deutsches √Ñrzteblatt,Positive
 ‚Äì Der BrutonKinase BTKInhibitor Acalabrutinib der,Deutsches √Ñrzteblatt,Positive
   AZ ‚Äô Calquence,Career Biotech,Negative
 n „Ç≥„É≠„ÉäÊ≤ªÁôÇËñ¨,Wind Rose,Positive
 Covid patients,ClinicalTrialsArena,Positive
 Covid patients,arthur james lobo,Positive
 Covid patients,Downtown News,Positive
 Covid patients,Cool FM News,Positive
 Covid patients,DowntownCountry News,Positive
 Covid patients,ColorMeRedü©∏üá∫üá∏,Positive
 ‡§Æ‡§π‡§§‡•ç‡§§‡•ç‡§µ‡§æ‡§ö‡§Ç,sakalmedia,Positive
 ‡§∏‡§Ç‡§∂‡•ã‡§ß‡§®,sakalmedia,Positive
 ‡§π‡•á ‡§î‡§∑‡§ß ‡§ï‡§∞‡•Ç,sakalmedia,Positive
 ‡§ï‡•ã‡§∞‡•ã‡§®‡§æ ‡§∞‡•Å‡§ó‡•ç‡§£‡§æ‡§Ç‡§®‡§æ ‡§¨‡§∞‡§Ç,sakalmedia,Positive
 CLLÊ≤ªÁôÇËñ¨„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Åå„ÇìÊ≤ªÁôÇËñ¨„ÄÅÊñ∞Âûã„Ç≥„É≠„ÉäÊ≤ªÁôÇ„ÅßÊúâÊúõ„Å™ÂàùÊúüÁµêÊûú,Stray,Positive
 Trials Arena,arthur james lobo,Positive
 El estudio aplic√≥ el medicamento contra el c√°ncer,El Diario NTR Guadalajara,Positive
 „Åù„Åì„ÇíÊäë„Åà„Çå„Å∞„Åü„Å†„ÅÆ„Ç´„Çº,silexÁü•„ÅÆÊñáÁåÆ„Çµ„Éº„Éì„Çπ,Positive
 ÈÅéÂâ∞ÂÖçÁñ´ÂèçÂøú„ÅÆÈçµ„ÇíÊè°„Çã „Éû„ÇØ„É≠„Éï„Ç°„Éº„Ç∏,silexÁü•„ÅÆÊñáÁåÆ„Çµ„Éº„Éì„Çπ,Positive
 „Åå„ÄÅ‰∫∫„ÅÆÈáçÁóáÊÇ£ËÄÖ„ÅÆ„Äå„Åª„Å®„Çì„Å©ÂÖ®Âì°„ÅßÊó•„ÅßÂäπ„ÅÑ„Åü„ÄÅCRP„ÇÇIl,silexÁü•„ÅÆÊñáÁåÆ„Çµ„Éº„Éì„Çπ,Positive
 „ÇÇÊøÄÊ∏õ„Åó„Åü„ÄÅÂçäÊï∞ÊäúÁÆ°„Äç„Å®Â†±Âëä„ÄÇ‰ªäÂ∫¶„ÅØ„Åª„Çì„Å®„ÅÜ„ÅÆ„Äå„Ç≤„Éº„É†„ÉÅ„Çß„É≥„Ç∏„É£„Éº„ÄçÔºüÔºüÔºöNCI,silexÁü•„ÅÆÊñáÁåÆ„Çµ„Éº„Éì„Çπ,Positive
 News Medical Approved drug,NanoTrac Technologies,Positive
   AZN Data,SY Investing,Positive
 BTK inhibitor usage,SY Investing,Positive
 protein Bruton tyrosine kinase BTK,Health Evangelists,Negative
 protein Bruton tyrosine kinase BTK,Deccan Herald,Positive
 tcoIfpNRSZLu,Health Evangelists,Negative
 inside color,Nathan Vardi,Negative
 UK hospitals,#DestroyTheAadhaar    TwiLightOFTheGODS,Positive
 UK hospitals,Manam,Positive
 UK hospitals,Antibiotic StewardüÜîü¶†Bassam Ghanem,Positive
 Cytokine Storm Acalabrutinib,ExBulletin,Positive
 COVID Patients,ExBulletin,Positive
 COVID Patients,Tom Andrewsüíô,Positive
 COVID Patients,Olivier Elemento,Negative
 COVID Patients,Paul Lopez,Positive
 COVID Patients,RETURN TO SENDER,Positive
 COVID Patients,EWallace,Positive
 COVID Patients,TenStarsDesign‚Ñ¢,Positive
 COVID Patients,Scherazad Falcon,Positive
 COVID Patients,Shunta Sanders,Positive
 COVID Patients,Anand C. Patel,Positive
 COVID Patients,ùïäùï•ùï†ùïîùïúùêñùêöùê≠ùêúùê°ùêûùê´,Positive
 COVID Patients,Greg Johnson,Positive
 COVID Patients,Sarah Hickman,Positive
 COVID Patients,Pyrus,Positive
 COVID Patients,Nigel Bradley,Positive
 COVID Patients,Jasmine the European Cat,Positive
 COVID Patients,Avi Cohen üá´üá∑üáÆüá±,Positive
 COVID Patients,Diana Hedrick,Positive
 COVID Patients,SJ Lefevre,Positive
 COVID Patients,mike judin,Positive
 COVID Patients,Lucas Wyrsch,Positive
 COVID Patients,mywaypress,Positive
 COVID Patients,Syed Abutalib,Positive
 COVID Patients,S.Wanee,Positive
 COVID Patients,Pengyu Yang,Positive
 COVID Patients,"Michael Blaiss, MD",Positive
 COVID Patients,Kenneth Farber,Positive
 COVID Patients,cafepharma,Negative
 COVID Patients,Buried On Page3,Positive
 COVID Patients,Chris Manfuso,Negative
 COVID Patients,Shouting at people in my underpants,Negative
 COVID Patients,EIPG,Negative
 COVID Patients,Mm„ÅÆÊÜÇÈ¨±,Positive
 COVID Patients,üò∑ Datos Digital,Positive
 COVID Patients,Kristen Breland,Positive
 COVID Patients,Joel Padre,Positive
 COVID Patients,The Peoples Pharmacy,Positive
 COVID Patients,Steven Bertoni,Positive
 COVID Patients,Dr Timos Papagatsias,Negative
 COVID Patients,Michael Noer,Positive
 COVID Patients,Janet Novack,Positive
 COVID Patients,Health News,Negative
 COVID Patients,ChicagoSchoolofYoga,Negative
 COVID Patients,BenExact,Negative
 Acalabrutinib zdravilo,Roman Jerala,Positive
 ki se uporablja,Roman Jerala,Positive
 za zdravljenje,Roman Jerala,Positive
 Bceliƒçnih limfomov je pokazalo dobre rezultate pri zdravljenju pacientov z resnim,Roman Jerala,Positive
 Zdravilo inibira,Roman Jerala,Positive
 Coronavirus Impact Economy Market News Source Forbes,NonSell.com,Positive
 Abordar la inflamaci√≥n excesiva con un inhibidor de la tirosina,Salud juntos,Positive
 ser una estrategia terap√©utica eficaz,Salud juntos,Positive
 Blood cancer drug Calquence,The Daily Protein,Positive
 Este medicamento puede calmar,primo8k,Negative
 pacientes con coronavirus Estudio revela que el medicamento acalabrutinib aprobado por,primo8k,Negative
 Probioticbased Chemotherapy PCT,Dr L Boominathan PhD,Negative
 cancer stem cells,Dr L Boominathan PhD,Positive
 immuneinhibitory receptors,Dr L Boominathan PhD,Positive
 Hospitalized Covid,Armin Hamidian,Negative
 Hospitalized Covid,VIRALFLEX,Positive
 Hospitalized Covid,news98,Positive
 Acalabrutinib Bruton Tyrosine Kinase BTK Inhibitor,Tom Andrewsüíô,Positive
 Severe Respiratory Distress,Tom Andrewsüíô,Positive
 Interesting study,Dr. Dave On Call,Positive
 Interesting study,Victor Lin,Positive
 Interesting study,CLL Ireland,Negative
 Science Immunology Acalabrutinib,Dr. Dave On Call,Positive
 ‚≠ê Ô∏èNEW drug,"Ruth Ann Crystal, MD",Positive
 APTO,Bargad,Positive
 APTO,Persimmon Tree Investments,Positive
 APTO,Jonathan Faison,Positive
 APTO,Grant Beasley,Positive
 APTO,Joe,Positive
 acalabrutinib treatment,Bargad,Positive
 acalabrutinib treatment,OncLive.com,Negative
 acalabrutinib treatment,BluePrint Orphan,Positive
 Cacncermedicinen Acalabrutinib ser v√§ldigt lovande,jorgenponder ‚Äî om coronavirusepidemin,Positive
 ut,jorgenponder ‚Äî om coronavirusepidemin,Positive
 Liten studie ingen kontrollgrupp men bra resultat amp en st√∂rre studie ska nu g√∂ras Acalabrutinib modulerar immunf√∂rsvaret,jorgenponder ‚Äî om coronavirusepidemin,Positive
 Acalabrutinib FDA Approved Drug,Benlazar S.M Amin√©,Negative
 Cytokine Storm,Benlazar S.M Amin√©,Negative
 Natl Cancer Institute,delthia ricks üî¨,Positive
 CoronavirusHace,mercado digital 24,Positive
 hora,mercado digital 24,Positive
 Reuters Foto de archivo del logo,mercado digital 24,Positive
 de AstraZeneca,mercado digital 24,Positive
 Bolsa de Nueva York,mercado digital 24,Positive
 Por Ludwig Burger FR√ÅNCFORT,mercado digital 24,Positive
 jun Reuters,mercado digital 24,Positive
 El medicamento contra el c√°ncer Calquence de AstraZeneca LON,mercado digital 24,Positive
 Calquence medicamento contra el c√°ncer de AstraZeneca,C√≥digo Libre,Positive
 trial design,Antibiotic StewardüÜîü¶†Bassam Ghanem,Positive
 ¬† CALAVI acalabrutinib,Antibiotic StewardüÜîü¶†Bassam Ghanem,Positive
 El medicamento contra el c√°ncer leucemia Calquence de la empresa farmac√©utica,eXtradigital.com.do,Positive
 spectaculaires sur des patients,Jean-Pierre Lavergne,Positive
 Study Finds Single Agent Acalabrutinib Superior,Oncology Times,Negative
 Relapsed Chronic Lymphocytic,Oncology Times,Negative
 Relapsed Chronic Lymphocytic,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 Relapsed Chronic Lymphocytic,Lampe & Company,Negative
 Relapsed Chronic Lymphocytic,1stOncology,Positive
 Relapsed Chronic Lymphocytic,Oncology Rounds,Positive
 Relapsed Chronic Lymphocytic,DailyRounds | Marrow,Positive
 AstraZeneca cancer drug Calquence,Funops.com,Positive
  ,Prof John,Negative
  ,EuropaWire,Negative
  ,The EY Tagteam,Positive
  ,Just Jen,Positive
  ,"Cancer Stat - Essential News, Research & Analysis",Positive
  ,VJHemOnc,Negative
  ,Leukaemia Care,Negative
  ,"Erin Hickey, PharmD, BCOP",Positive
  ,JanssenUS,Positive
  ,Janssen Global,Negative
  ,Winifred Council,Positive
  ,medwireNews,Negative
  ,cnag-crg,Positive
  ,Michael Hallek,Negative
  ,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
  ,Michele Nadeem-Baker,Negative
  ,Genentech,Negative
  ,WheelieDealer,Negative
  ,Finsbury Park & Stroud Green Neighbourhood Forum,Positive
  ,UK Health Radio‚Ñ¢,Positive
  ,Chan Cheah,Negative
  ,Visitor_Z,Positive
  ,NYCDoc29,Negative
  ,Patient Power,Positive
  ,Andrew Schorr,Positive
  ,"Raul Cordoba, MD, PhD",Negative
  ,Dua Centre,Positive
  ,"Pharmacyclics, an AbbVie Company",Negative
  ,John Harrington,Positive
  ,Francesco Turturro,Negative
  ,Dweasley ü¶Ä (Œ® 7 ) 13 üé∏,Positive
  ,Dennis Blomberg,Positive
  ,Lymphoma Hub,Negative
  ,FirstWord Pharma,Negative
  ,Sonja,Positive
  ,MDUNGE,Positive
  ,Lisa Marie,Positive
  ,EMJ Hematology,Negative
  ,VigiePharma,Positive
  ,APSHO,Positive
  ,SpringerMedizin.de,Positive
  ,Middleton C.C.,Positive
  ,Los Lobos,Negative
  ,Patient Empowerment Network,Positive
 Pathological Monocyte   Macrophage Activation,Prof John,Negative
 amp Dampen,Prof John,Negative
 SARSCov Infection,Prof John,Negative
 ‚Å©,Prof John,Positive
 target BTK,Mr Graham,Positive
 Hope,Jill Hamer-Wilson üá®üá¶,Positive
 Hope,Ellen Schafer,Positive
 Hope,Oncology Publishers Feed,Negative
 Hope,Michele Nadeem-Baker,Negative
 Hope,"Navneet Majhail, MD, MS",Positive
 Hope,Esther Schorr,Negative
 Hope,CLL Society Inc.,Negative
 Hope,MPMI_UoM,Positive
 Hope,Melanie,Negative
 Hope,Dixy_Dalton,Positive
 Hope,Muzaffar Qazilbash,Negative
 Hope,Francesco Turturro,Negative
 Hope,Jerry Lee,Negative
 Hope,ASCO,Negative
 Hope,PER,Negative
 Hope,Scott Werntz,Negative
 Hope,FarmaOnco,Negative
 AstraZeneca blood cancer drug,Medicalnewser.com,Negative
 AstraZeneca blood cancer drug,Cancer News,Negative
 signs,Medicalnewser.com,Negative
 signs,WallStBetsDotCom,Negative
 signs,HeartcoR Solutions,Positive
 signs,Paperbirds_Hematology,Negative
 signs,Toby Eyre,Negative
 signs,GenoptixInc,Positive
 signs,Andrew Schorr,Negative
 COVID patients Health News ET HealthWorld REUTERSStefan,Medicalnewser.com,Negative
 WermuthFile,Medicalnewser.com,Negative
 PhotoBy Ludwig,Medicalnewser.com,Negative
 AstraZeneca‚Äòs cancer drug Calquence,Medicalnewser.com,Negative
 √≠a   Estudio revela que el medicamento acalabrutinib aprobado por,TendenciasTech,Positive
   day treatment course acalabrutinib,Amir Faisal,Positive
 majority,Amir Faisal,Positive
 majority,Blood Advances,Negative
 majority,the limbic,Negative
 majority,Targeted Oncology,Negative
 majority,Green Tea HP,Positive
 majority,"Chared, Good Comms",Negative
 majority,European Hematology Association,Negative
 majority,Guillermo Sanz,Negative
 AstraZeneca blood cancer drug Calquence,Business Journal,Positive
   AstraZenecas blood cancer drug Calquence,Business Today,Positive
 COVID   Acalabrutinib efficace,Medimagazine,Positive
 il trattamento,Medimagazine,Positive
 di gravi,Medimagazine,Positive
 respiratorie,Medimagazine,Positive
 BTK inhibitor drug acalabrutinib,Dr.Virendra Singh,Positive
 BTK inhibitor drug acalabrutinib,CBPartners,Positive
 mg,Dr.Virendra Singh,Positive
 mg,Joe,Positive
 mg,Derek Clarke,Negative
 blood cawas,Dr.Virendra Singh,Positive
    Acalabrutinib Dosis,Dr. MAURICIO BERNAL.,Positive
 mg por,Dr. MAURICIO BERNAL.,Positive
 Calquence medicamento contra el c√°ncer,YaEsHora,Positive
 Calquence medicamento contra el c√°ncer,Ese Migue,Positive
 Calquence medicamento contra el c√°ncer,La Disidente,Positive
 El medicamento contra el c√°ncer,The Mexico Post,Positive
 indicios,The Mexico Post,Positive
 los pacientes hospitalizados con,The Mexico Post,Positive
 superar lo,The Mexico Post,Positive
 superar lo,ContraR√©plica,Positive
 peor de la enfermeda,The Mexico Post,Positive
 gtgtgt,Dr Timos Papagatsias,Positive
 inhibitor,Tariq Janjua MD,Positive
 inhibitor,EuropaWire,Negative
 inhibitor,Joe,Negative
 inhibitor,VJHemOnc,Negative
 inhibitor,Matthias Piesche,Negative
 improved outcome,Tariq Janjua MD,Positive
 La pruebas de la farmac√©utica brit√°nica tienen el respaldo de Institutos Nacionales de Salud de Estados Unidos,Proceso,Positive
 Cytokine storm,K Pavithran,Positive
 Cytokine storm,OncLive.com,Negative
 CoV Researchers,LCW,Positive
 Acalabrutinib kan vara v√§rd att l√§gga p√• minnet,Kenneth Bodin,Positive
 Nu n√§r det blir,Kenneth Bodin,Positive
 att den kritiska sjukdomen √§r kardiovaskul√§r s√• kommer flera nya approacher,Kenneth Bodin,Positive
 l√§kemedel Bra,Kenneth Bodin,Positive
 El medicamento contra el √°ncer Calquence de ¬†¬† mostr√≥,ContraR√©plica,Positive
 indicios de que puede,ContraR√©plica,Positive
 ayudar,ContraR√©plica,Positive
 pacientes hospitalizados con,ContraR√©plica,Positive
 peor de la,ContraR√©plica,Positive
 enfermedad,ContraR√©plica,Positive
 ÿ≠ÿµŸÑ ÿßŸÜŸáÿßÿ±ÿØŸá ÿ™ÿ∑Ÿàÿ± ŸÖŸáŸÖ,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 ÿπŸÑÿßÿ¨ ÿßŸÑŸÉŸàÿ±ŸàŸÜÿß,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 ÿßÿØŸàŸäŸá,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 ŸÅŸä ÿßŸÑÿπÿßŸÑŸÖ ÿ®Ÿäÿ™ŸÖ ÿ™ÿ¨ÿ±ÿ®ÿ™ŸáŸÖ,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 ÿ®ÿ¥ŸÉŸÑ ÿØŸÇŸäŸÇ,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 ÿ¨ÿØÿß ŸÖŸÜŸáŸÖ,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 ŸàŸÜÿ™ÿßŸäÿ¨Ÿá ÿ®ÿ™ÿ∏Ÿáÿ± ÿ®ÿπÿØ,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 ŸäŸàŸÖÿßŸÜŸáÿßÿ±ÿØŸá,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 Selective Bruton tyrosine kinase,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 ŸàŸÉÿßŸÜÿ™ ŸÖÿ®ÿ¥ÿ±Ÿá,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 ÿ¨ÿØÿß ÿ±ÿ®ŸÜÿß ŸäŸÉÿ±ŸÖ,ÿ£ÿ≠ŸÖÿØÿµÿßŸÑÿ≠Ahmd Saleh,Positive
 InternacionalEl medicamento contra el c√°ncer,Radio Tepeaca,Positive
 Calquence de AstraZeneca,Radio Tepeaca,Positive
   El medicamento contra el c√°ncer Calquence de AstraZeneca,EDN TV HN,Positive
 Science Immunology „Å´ Êñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„Çπ ÊÑüÊüìÁóá„ÅÆÊñ∞„Åó„ÅÑÊ≤ªÁôÇËñ¨ÂÄôË£ú„ÅÆË´ñÊñá„ÅåÊé≤Ëºâ„Åï„Çå„Åæ„Åó„Åü„ÄÇBruton tyrosine kinase BTK „ÄÅ „Åì„Çå„ÅØ„Çø„É≥„Éë„ÇØË≥™„É™„É≥ÈÖ∏ÂåñÈÖµÁ¥†„Åß„Åù„ÅÆÊ¥ªÊÄßÈòªÂÆ≥Ââ§„Åå,Á†îÁ©∂ËÄÖ(ÂåªÂçö) ÂíåÁî∞Âø†Â£´,Positive
 Acalabrutinib scheint bei schweren,Dr. Thomas Kloss,Positive
 Covid Erkrankungen hilfreichInhibition,Dr. Thomas Kloss,Positive
    drugs,Ronald M. Chavin,Positive
 mab,Ronald M. Chavin,Positive
 nib,Ronald M. Chavin,Positive
 IL,lucy gorelli,Positive
 IL,Paperbirds_Hematology,Negative
 IL,Lymphoma Papers,Negative
 IL,NIH Clinical Center,Negative
 IL,J Immunol,Positive
 IL,Prof John,Negative
 IL,R Orentas,Positive
 IL,Cancer Papers,Negative
 IL,Francesco Turturro,Negative
 IL,Blood Journal,Positive
 IL,"Raul Cordoba, MD, PhD",Negative
 IL,@sehh_es,Negative
 IL,ASH,Negative
 IL,Lymphoma Hub,Positive
 AZN news Calquence,GraniteShares Europe,Negative
 Astra Zeneca,Dagens industri,Positive
 Astra Zeneca,Lymphoma Canada,Negative
 Astra Zeneca,CheckRare,Negative
 Astra Zeneca,CLL Ireland,Negative
 Astra Zeneca,Health and Fitness Loveaffair,Positive
 lovande kliniska,Dagens industri,Positive
 f√∂r flertalet,Dagens industri,Positive
 de   covidpatienter som,Dagens industri,Positive
 med blodcancerl√§kemedlet Calquence,Dagens industri,Positive
 Astra Zenecas kliniska,Omni Ekonomi,Positive
 med l√§kemedlet Calquence hos,Omni Ekonomi,Positive
   Calquence acalabrutinib,üß¨ Adam Grant,Positive
   Calquence acalabrutinib,epocrates,Positive
 BTK inhibitor deoxygenation,üß¨ Adam Grant,Positive
 blood cancer drug,Josie B.,Negative
 blood cancer drug,CarThera,Positive
 blood cancer drug,Forbes Science,Positive
 blood cancer drug,Bruce Berger,Positive
 blood cancer drug,Radiology w/ BHIVE,Positive
 blood cancer drug,BHIVE on Pediatrics,Positive
 blood cancer drug,Nephrology w/BHIVE,Positive
 blood cancer drug,BHIVE: EmergencyMed,Positive
 blood cancer drug,BHIVE on Cardiology,Positive
 hospitalized COVID patients,WallStBetsDotCom,Negative
 AZN Results,WallStBetsDotCom,Negative
 markers,WallStBetsDotCom,Negative
 markers,ASH Clinical News,Positive
 markers,CLL_Fightersüéó,Negative
 markers,AJMC,Negative
 Acalabrutinib FDAapproved,Meagan Phelan,Positive
 B cell cancers,Meagan Phelan,Positive
 B cell cancers,Market Intelligence: Healthcare,Positive
 oxygenation levels,Meagan Phelan,Positive
 Blood cancer drug,Patricia Kime,Positive
 AstraZeneca anuncia que Calquence un medicamento para tratar el c√°ncer muestra,Gualestrit,Positive
 de ayudar,Gualestrit,Positive
 pacientes de   hospitalizados,Gualestrit,Positive
 ASTRAZENECAS CANCER DRUG CALQUENCE SHOWS INITIAL SIGNS,Al,Positive
 ASTRAZENECAS CANCER DRUG CALQUENCE SHOWS INITIAL SIGNS,Breaking Market News,Negative
 HELPING,Al,Positive
 HELPING,Sharp street trading insights,Positive
 HELPING,Breaking Market News,Negative
 HOSPITALISED COVID,Al,Positive
 HOSPITALISED COVID,Sharp street trading insights,Positive
 HOSPITALISED COVID,Breaking Market News,Negative
 AZNL,Paul Marc,Positive
 cancer drug Calquence,Paul Marc,Positive
 cancer drug Calquence,24H Sante,Negative
 cancer drug Calquence,BiopharmaMASH,Positive
 cancer drug Calquence,Jennifer A. Ng,Positive
 cancer drug Calquence,PhRMA,Positive
 cancer drug Calquence,Omer Haghi,Positive
 cancer drug Calquence,RizonSon O'Kodee,Positive
 cancer drug Calquence,Reuters,Negative
 cancer drug Calquence,TheArticleTrunk,Positive
 cancer drug Calquence,CHItraders,Negative
 cancer drug Calquence,chorley chicken,Negative
 cancer drug Calquence,Medicine Briefly,Negative
 cancer drug Calquence,Reuters UK,Positive
 cancer drug Calquence,LBC News,Positive
 cancer drug Calquence,Investor News,Negative
 cancer drug Calquence,Devdiscourse,Negative
 cancer drug Calquence,pharmaphorum,Negative
 ASTRAZENECAS CANCER DRUG CALQUENCE,Jeremy,Positive
 ASTRAZENECAS CANCER DRUG CALQUENCE,Sharp street trading insights,Positive
 ASTRAZENECAS CANCER DRUG CALQUENCE,Breaking Market News,Negative
 ASTRAZENECAS CANCER DRUG CALQUENCE,Redbox Global,Positive
 ASTRAZENECAS CANCER DRUG CALQUENCE,First Squawk,Positive
 INITIAL SIGNS,Jeremy,Positive
 INITIAL SIGNS,Sharp street trading insights,Positive
 INITIAL SIGNS,NewsFreak,Positive
 INITIAL SIGNS,Breaking Market News,Negative
 INITIAL SIGNS,Redbox Global,Positive
 INITIAL SIGNS,First Squawk,Positive
 HELPING HOSPITALISED COVID,Jeremy,Positive
 HELPING HOSPITALISED COVID,NewsFreak,Positive
 HELPING HOSPITALISED COVID,Breaking Market News,Negative
 HELPING HOSPITALISED COVID,Redbox Global,Positive
 HELPING HOSPITALISED COVID,First Squawk,Positive
 RTRS,Jeremy,Positive
 RTRS,NewsFreak,Positive
 RTRS,Breaking Market News,Negative
 RTRS,Redbox Global,Positive
 RTRS,First Squawk,Positive
 RTRS,LiveSquawk,Positive
 COVID patients Reuters,WallStBetsDotCom,Negative
 AZN ¬†  Related Items,WallStBetsDotCom,Negative
 RTRSPUMP,Sharp street trading insights,Positive
 SPY,Sharp street trading insights,Positive
 QQQ,Sharp street trading insights,Positive
   ASTRAZENECAS CANCER DRUG CALQUENCE,NewsFreak,Positive
 AstraZenecas Cancer Drug Calquence,LiveSquawk,Positive
 Initial Signs,LiveSquawk,Positive
 Hospitalised COVID Patients,LiveSquawk,Positive
 Friday Lymphoma Lunch,Chan Cheah,Negative
 management,Chan Cheah,Negative
 management,Oncology Learning Network,Negative
 management,Paperbirds_Hematology,Positive
 management,Aptitude Health,Positive
 management,Benlazar S.M Amin√©,Positive
 management,Anthony Mato,Negative
 management,Patient Empowerment Network,Negative
 management,OncLive.com,Negative
 management,VJHemOnc,Positive
 management,Rajesh Sharma,Positive
 management,Lymphoma Papers,Negative
 management,Raffaella Ravinetto,Positive
 management,SeqComplete,Negative
 management,CLL Ireland,Negative
 management,Lymphoma Hub,Positive
 management,RedMedEd,Positive
 management,The Tisch Cancer Institute,Positive
 management,Medscape Education,Negative
 management,Expert Perspectives in Oncology,Negative
 management,iwCLL,Negative
 management,Razan Mohty,Positive
 management,Medivizor,Positive
 management,Muge Cevik,Positive
 management,dough,Negative
 management,Christopher Steer,Negative
 management,Andrew Schorr,Negative
 management,Imedex,Positive
 management,Waleed Osman,Positive
 management,Cancer Papers,Negative
 management,NACDA Program on Aging,Negative
 management,Francesco Turturro,Negative
 transformation,Chan Cheah,Negative
 transformation,Paperbirds_Hematology,Negative
 transformation,Toby Eyre,Negative
 transformation,VJHemOnc,Positive
 transformation,MoJo,Negative
 transformation,CLL Ireland,Negative
 transformation,Oncology Times,Negative
 Visita El Post,Doctiplus,Positive
 En Facebook,Doctiplus,Positive
 de c√©lulas del,Doctiplus,Positive
 de c√©lulas del,NCI en espa√±ol,Positive
 de c√©lulas del,APRHIFAC,Positive
 manto,Doctiplus,Positive
 manto,Anvisa,Negative
 MCL un c√°ncer de crecimiento r√°pido que empieza,Doctiplus,Positive
 las c√©lulas del sistema inmune que,Doctiplus,Positive
 ya ha sido tratado con al menos otro medicamento de quimioterapia,Doctiplus,Positive
 El aca,Doctiplus,Positive
 Data,NatureRevClinOncol,Negative
 Data,LYMPHOMA & MYELOMA CONNECT,Negative
 Data,OncLive.com,Positive
 Data,OncLive SOSS,Negative
 Data,JTCancerCenter,Positive
 Data,MDedge Hematology & Oncology,Negative
 Data,"chadi nabhan MD, MBA, FACP",Positive
 Data,MedscapeLIVE,Positive
 Data,Medscape Oncology,Positive
 Data,Medscape Education,Positive
 Data,Medscape Nurses,Negative
 Data,Anthony Mato,Negative
 Data,HemOnc Today,Positive
 Data,CellworksLife,Negative
 Data,Michael Hallek,Negative
 Data,1stOncology,Positive
 Data,BioPharma Dive,Negative
 Data,"Raul Cordoba, MD, PhD",Negative
 Data,JAMA Oncology,Negative
 Data,CLL Ireland,Positive
 Data,Odi Bruckman,Negative
 Data,Financial GamblR,Negative
 Data,NeuroBrain,Positive
 Data,CBPartners,Positive
 Data,Oncology Tube,Positive
 Data,BioSpace,Positive
 Data,militaryape,Positive
 Data,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 Data,MilitaryLoop,Positive
 Data,PRNhealth,Positive
 Data,PRN Biotech,Negative
 Data,Melanie Johnson,Positive
 Data,myCME,Negative
 Data,Scott Werntz,Negative
 III ASCEND trial,NatureRevClinOncol,Negative
 idelalisib,NatureRevClinOncol,Negative
 idelalisib,ASH Clinical News,Positive
 idelalisib,Lymphoma Hub,Positive
 idelalisib,Lymphoma Papers,Negative
 idelalisib,James Kerwin,Positive
 idelalisib,ClinOwl Haematology,Negative
 idelalisib,Paperbirds_Hematology,Negative
 idelalisib,Oncology Learning Network,Negative
 idelalisib,VJHemOnc,Negative
 idelalisib,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 idelalisib,"Steven Artandi, MD, PhD",Negative
 idelalisib,Medivizor,Positive
 idelalisib,Lurie Cancer Center,Negative
 idelalisib,Christopher Steer,Negative
 idelalisib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 idelalisib,ASH,Negative
 idelalisib,"Raul Cordoba, MD, PhD",Negative
 idelalisib,NCCP,Positive
 idelalisib,Oncology Tube,Positive
 idelalisib,MD Anderson Leukemia,Negative
 idelalisib,WCM Lymphoma,Negative
 idelalisib,Patient Journeys,Positive
 idelalisib,CancerTherapyAdvisor,Positive
 idelalisib,Tran-Der Tan,Negative
 idelalisib,üÖæ Jaksic,Negative
 idelalisib,FarmaOnco,Negative
 idelalisib,OncLive.com,Negative
 idelalisib,European Pharmaceutical Review,Negative
 idelalisib,Philip Shaheen,Positive
 idelalisib,MDLinx,Negative
 rituximab,NatureRevClinOncol,Positive
 rituximab,Breaking Data,Negative
 rituximab,ASH Clinical News,Positive
 rituximab,OncLive.com,Positive
 rituximab,JADPRO,Negative
 rituximab,Lymphoma Hub,Positive
 rituximab,Hematology Advisor,Negative
 rituximab,OncLive SOSS,Negative
 rituximab,donnashort,Negative
 rituximab,Lymphoma Papers,Positive
 rituximab,Physician's Weekly,Positive
 rituximab,Paperbirds_Hematology,Positive
 rituximab,Great Debates in Hematologic Malignancies,Positive
 rituximab,"Steven Artandi, MD, PhD",Positive
 rituximab,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 rituximab,NCI CTEP Clinical Research,Negative
 rituximab,Jean Zhao,Positive
 rituximab,Targeted Oncology,Positive
 rituximab,GeneOnline,Positive
 rituximab,StemExpress,Positive
 rituximab,Leukemia Research Foundation,Negative
 rituximab,The Oncologist,Positive
 rituximab,Dr. Saadvik Raghuram y,Positive
 rituximab,Society for Immunotherapy of Cancer,Negative
 rituximab,Lymphoma Research Foundation,Negative
 rituximab,Philip McCarthy,Negative
 rituximab,Kevin Wolcott,Positive
 rituximab,Rare Disease Report,Negative
 rituximab,FDA Oncology,Negative
 rituximab,Kerri Wachter,Negative
 rituximab,Vall d‚ÄôHebron Institute of Oncology (VHIO),Positive
 rituximab,The Lancet Haematology,Negative
 rituximab,Medivizor,Positive
 rituximab,Lung Cancer News,Negative
 rituximab,"Lymphoma, Leukemia & Myeloma Congress",Positive
 rituximab,Chocolatiere Phys,Negative
 rituximab,SpecialtyPTimes,Negative
 rituximab,CenterForBiosimilars,Positive
 rituximab,Gear√≥id √ì Crotaigh #CareCantWait,Negative
 rituximab,"PXN, board-certified prostitute",Positive
 rituximab,Marko Skelin MPharm PhD,Positive
 rituximab,Toby Eyre,Positive
 rituximab,AJMC,Negative
 rituximab,HemOnc Today,Positive
 rituximab,Benlazar S.M Amin√©,Negative
 rituximab,Oncology Times,Negative
 rituximab,"Raul Cordoba, MD, PhD",Positive
 rituximab,Dana-Farber News,Positive
 rituximab,"chadi nabhan MD, MBA, FACP",Positive
 rituximab,Lurie Cancer Center,Negative
 rituximab,CellworksLife,Positive
 rituximab,Research UMCG,Positive
 rituximab,Blood Journal,Positive
 rituximab,Mary Ellen Schneider,Positive
 rituximab,Dr Timos Papagatsias,Negative
 rituximab,Jeff Szer,Negative
 rituximab,Miguel Perales M.D.,Positive
 rituximab,Prof Dr Mustafa Benekli ü©∫,Positive
 rituximab,Anna Deveau,Positive
 rituximab,Solomon Kamal,Positive
 rituximab,MAISA,Negative
 rituximab,CancerTherapyAdvisor,Positive
 rituximab,Garbi√±e Lizeaga,Negative
 rituximab,AU Oncology Reviews,Negative
 rituximab,Cancer_Tribune,Negative
 rituximab,Blood Advances,Positive
 rituximab,"Dr T. Comeau , MD",Negative
 rituximab,2 Minute Medicine¬Æ,Positive
 rituximab,"Marc Succi, MD",Positive
 rituximab,Prithi Inamdar,Positive
 rituximab,Izaskun Zeberio,Negative
 rituximab,CLL Ireland,Positive
 rituximab,Oncology Tube,Negative
 rituximab,Robert Z. Orlowski,Negative
 rituximab,Lymphoma Coalition,Positive
 rituximab,EMJ Hematology,Positive
 rituximab,The Lancet Oncology,Negative
 rituximab,Margaret Walker,Negative
 rituximab,Oncology Board,Positive
 rituximab,Healio,Positive
 rituximab,Allergy & Immunology,Positive
 rituximab,Roberto C.  Montoya,Negative
 rituximab,Mary Jo Dales,Positive
 rituximab,Tran-Der Tan,Negative
 rituximab,üÖæ Jaksic,Negative
 rituximab,FarmaOnco,Negative
 rituximab,Medscape Pharmacists,Negative
 rituximab,Medscape Oncology,Negative
 rituximab,Medscape,Negative
 rituximab,Biothera Pharma,Positive
 rituximab,drryna,Positive
 grant,joewhitworth,Positive
 grant,Mazen M,Negative
 grant,RIOH,Negative
 Acerta Pharma maker,joewhitworth,Positive
 RR Chronic Lymphocytic,Francesco Bertoni,Negative
 secondgeneration,DelveInsight,Positive
 secondgeneration,Patient Power,Negative
 sarscov treatment trial,Manam,Positive
 Nebulised Heparin,Manam,Positive
 Bemcentinib,Manam,Positive
 MEDI,Manam,Positive
 Zilucoplan,Manam,Positive
 FDAapproved treatments,G.ms.P,Positive
 co Remdesivir Hydroxychloroquinchloroquine AzithromycinConvalescent plasmaActemratocilizumabCalquence acalabrutinibXeljanz tofacitinibJakafi ruxolitinibOlumiant,G.ms.P,Positive
 presents,Weill Cornell Medicine,Positive
 presents,"Mark Geyer, M.D.",Negative
 presents,VJHemOnc,Negative
 presents,iwCLL,Negative
 ‚Äú Safety,Weill Cornell Medicine,Positive
 Poster Safety,Cancer Medicine,Positive
 Poster Acalabrutinib,Cancer Medicine,Positive
 CLL Mature,Cancer Medicine,Positive
 PhII study,Cancer Medicine,Positive
 CLL UpdateIbrutinib,Mariam Alasfour,Positive
 CONGRESS     ASCEND trial,Lymphoma Hub,Negative
 Relapsed Refractory Chronic Lymphocytic,Benlazar S.M Amin√©,Negative
 Relapsed Refractory Chronic Lymphocytic,Joe von Wallerstein,Positive
 novel,Toby Eyre,Negative
 novel,Deborah Stephens,Positive
 novel,ClinicalBiochemistry,Positive
 Acalabrutinib Post Blood,TrialBulletin,Negative
 Acalabrutinib Post Blood,CureHuntr,Negative
 Marrow Transplantation,TrialBulletin,Negative
 Marrow Transplantation,CureHuntr,Negative
 Marrow Transplantation,Xavier Tello,Positive
 Marrow Transplantation,COPD News,Negative
 Marrow Transplantation,ALI ALAHMARI.,Negative
 Marrow Transplantation,"Raul Cordoba, MD, PhD",Negative
 Subjects,TrialBulletin,Positive
 Subjects,CureHuntr,Positive
 Subjects,"Mike Thompson, MD, PhD, FASCO",Negative
 Subjects,E Lambrechts,Negative
 Subjects,ClinicalTrialsData,Positive
 Subjects,MD Anderson Leukemia,Negative
 Subjects,NASDAQ,Positive
 Subjects,Cancer News,Positive
 Subjects,Lung Cancer News,Negative
 Subjects,Lymphomation.org,Negative
 Subjects,Biotech2050,Negative
 Mantle Cell Lymphoma Status,TrialBulletin,Negative
 Condition Summary Mantle Cell Lymphoma,TrialBulletin,Positive
   Treatment,CureHuntr,Negative
   Treatment,Medscape Education,Negative
 Bruce,Leukaemia Foundation,Negative
 Expert Review,"Michael Wang, MD",Negative
 Expert Review,Saifur Rahman Ali,Positive
 Clinical Pharmacology,"Michael Wang, MD",Negative
 Dr Jurczak,"Michael Wang, MD",Negative
 authors,"Michael Wang, MD",Negative
 authors,European Hematology Association,Negative
 authors,Toby Eyre,Negative
 authors,"chadi nabhan MD, MBA, FACP",Negative
 authors,Prof John,Negative
 authors,Blood Cancer UK Research,Negative
 novel BTK inhibitor acalabrutinib,"Michael Wang, MD",Negative
 novel BTK inhibitor acalabrutinib,OncLive.com,Negative
 novel BTK inhibitor acalabrutinib,Oncologiavet,Negative
 le Calquence un traitement efficace contre les chocs,S√©bastien BERNIOTüá´üá∑ ‚≠êÔ∏è‚≠êÔ∏è#Jemeferaivacciner,Positive
 le Calquence un traitement efficace contre les chocs,Laurent Pradal,Positive
 ELEVATE TN interim analysis,Lymphoma Hub,Negative
    Acalabrutinib Study,@COVID_Evidence,Positive
 indepth evaluation,Taylor & Francis Medicine and Health,Positive
 indepth evaluation,Renal Cell Carcinoma,Negative
 indepth evaluation,Paperbirds_Hematology,Negative
 indepth evaluation,Lymphoma Papers,Negative
 mantlecell lymphoma,Taylor & Francis Medicine and Health,Positive
 mantlecell lymphoma,Renal Cell Carcinoma,Negative
 mantlecell lymphoma,Paperbirds_Hematology,Negative
 mantlecell lymphoma,Lymphoma Papers,Negative
 Interview de Marisol,Industrie Pharma Magazine,Positive
 Rx,Dr. Andy Evens,Negative
 Rx,Toby Eyre,Positive
 Rx,BloodWork,Positive
 Rx,Patient Power,Positive
 Rx,"Navneet Majhail, MD, MS",Negative
 obinutuzuman,Dr. Andy Evens,Negative
   acalabrutinib trial,Lu Chen #nobias,Positive
 Ce soir,Sylvie Latieule.,Positive
 Ce soir,ùìÅùí∂ùìä,Positive
 Marisol Urbieta directrice m√©dicale,Sylvie Latieule.,Positive
 Oncologie France,Sylvie Latieule.,Positive
 Baml AZN Oncology feedback PO,dough,Negative
 United KingdomTagrisso adjuvant DFS,dough,Negative
 CLLÊ¨°Ê≤ªÁôÇ„ÄÅacalabrutinib„ÅÆÁ¨¨IIIÁõ∏Ë©¶È®ìÊàêÁ∏æÔºèLancet,„Ç±„Ç¢„Éç„ÉÉ„Éà„ÄäÂÖ¨Âºè„Äã,Positive
 importance,Targeted Oncology,Positive
 importance,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 importance,"Mazyar Shadman, MD MPH",Negative
 importance,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 importance,OncLive.com,Positive
 importance,OncLive SOSS,Negative
 importance,Patient Empowerment Network,Negative
 importance,VJHemOnc,Positive
 importance,Fish Chromosomes,Positive
 importance,SpecialtyPTimes,Negative
 importance,Michele Nadeem-Baker,Negative
 importance,AstraZenecaUS,Negative
 importance,Patient Power,Negative
 importance,WCM Lymphoma,Positive
 importance,Lymphoma Hub,Positive
 importance,CLL Ireland,Positive
 importance,Mayo Clinic Labs,Positive
 importance,CLL Society Inc.,Negative
 importance,Oncology Learning Network,Negative
 importance,OSU Psych Advising,Positive
 importance,Lymphoma Papers,Negative
 importance,The Leukemia & Lymphoma Society,Negative
 importance,"Amber Koehler, PA-C",Negative
 importance,Expert Perspectives in Oncology,Negative
 importance,CLL_Fightersüéó,Negative
 importance,MoJo,Positive
 importance,Health Adviser,Positive
 importance,Andrew Schorr,Negative
 importance,CLLSA,Negative
 importance,ecancer,Negative
 importance,"chadi nabhan MD, MBA, FACP",Negative
 importance,HemePathDude,Positive
 importance,Lymphomation.org,Negative
 importance,AJMC,Negative
 importance,AbbVie,Negative
 importance,Bursatil Biotech,Positive
 importance,BMC,Positive
 treatment outcomes,Targeted Oncology,Negative
 treatment outcomes,i3 Health,Negative
 realworld patients,Targeted Oncology,Negative
 realworld patients,"Raul Cordoba, MD, PhD",Negative
 Dr Leslie,Targeted Oncology,Negative
 ¬° Novedad‚ÄòGlosario,Fernando A. Navarro,Positive
 de covid ‚Äô ü¶†,Fernando A. Navarro,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´,Ë£ΩËñ¨„Åï„Çì: Ë£ΩËñ¨‰ºÅÊ•≠Á†îÁ©∂ÂÆ∂√óÂâØÂèéÂÖ•Ê∫êÊé¢„Åó‰∏≠,Positive
 m„Äç„Ç§„Éü„Éï„Ç£„É≥„Ç∏ m „É™„É†„Éë„Éº„Ç∂ mCalquence mÔºàÔºâ„Äç„Åì„Çå„Å´„Ç®„É≥„Éè„Éº„ÉÑ„Åå„Éó„É©„Çπ„Åï„Çå„Çã,Ë£ΩËñ¨„Åï„Çì: Ë£ΩËñ¨‰ºÅÊ•≠Á†îÁ©∂ÂÆ∂√óÂâØÂèéÂÖ•Ê∫êÊé¢„Åó‰∏≠,Positive
 Highlights,Medscape Education,Positive
 Highlights,Paperbirds_Hematology,Positive
 Highlights,MedMedia,Positive
 Highlights,Current Oncology,Negative
 Highlights,filippo masini,Negative
 Highlights,Cancer Papers,Positive
 Highlights,Diagnostics News,Negative
 Highlights,Amanda Marie,Positive
 Highlights,Patient Power,Negative
 Highlights,Lymphoma Hub,Positive
 Highlights,CARE‚Ñ¢ Education,Negative
 Highlights,VJHemOnc,Negative
 Highlights,Patient Empowerment Network,Negative
 Use,Medscape Education,Positive
 Use,Famela and Friends,Positive
 Use,CureHuntr,Positive
 Use,TrialBulletin,Positive
 Use,EurekaMag,Negative
 Use,minoti hiremath,Positive
 Use,Paperbirds_Hematology,Positive
 Use,Oncology Tube,Positive
 Use,OncLive.com,Negative
 Use,"Raul Cordoba, MD, PhD",Negative
 Use,CLL Ireland,Negative
 Use,Cancer Papers,Negative
 Use,Financial Buzz,Negative
 Use,MedFirst - MedComms,Positive
 Use,Christopher Steer,Negative
 Use,Scott Werntz,Positive
 Use,Value Trader,Positive
 BTK Inhibitors,Medscape Education,Positive
 BTK Inhibitors,Oncology Tube,Positive
 BTK Inhibitors,CCO Education,Negative
 BTK Inhibitors,BSH - Haematology,Positive
 BTK Inhibitors,Toby Eyre,Negative
 BTK Inhibitors,Benlazar S.M Amin√©,Positive
 BTK Inhibitors,OncLive.com,Positive
 BTK Inhibitors,Elie Mouhayar,Positive
 BTK Inhibitors,Christopher Steer,Negative
 BTK Inhibitors,Dr. JOSE VELASQUEZ,Negative
 Skills Challenge,Medscape Education,Positive
 Clinical Pearls Ibrutinib,Medscape Education,Negative
 Acalabrutinib DrugDrug Interactions,Medscape Education,Negative
 Acalabrutinib Dosing,Medscape Education,Negative
 kudos,Dr. Andy Evens,Negative
 CD antibody,Dr. Andy Evens,Negative
 CD antibody,EurekaMag,Negative
 CD antibody,CLL Ireland,Negative
 HR,Dr. Andy Evens,Negative
 HR,Alexander Luchinin,Positive
 HR,Toby Eyre,Positive
 HR,"Raul Cordoba, MD, PhD",Negative
 acalabrutinibobinutuzumab,Dr. Andy Evens,Negative
 CI,Dr. Andy Evens,Negative
 CI,"Raul Cordoba, MD, PhD",Positive
 CI,OncLive.com,Negative
 einer,univadis,Positive
 Vergleichsstudie verl√§ngerte der BrutonKinaseInhibitor Acalabrutinib,univadis,Positive
 das progressionsfreie √úberleben von erstmals,univadis,Positive
 Patienten mit chronisch,univadis,Positive
 lymphatischer Leuk√§mie CLL erheblich,univadis,Positive
 Nach,univadis,Positive
 Jahren betrug der Anteil,univadis,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá„ÇíÂØæË±°„Å®„Åó„ÅüCALAVIË©¶È®ì„ÇíÈñãÂßãÔºöÊôÇ‰∫ã„Éâ„ÉÉ„Éà„Ç≥„É†,„Éü„Ç™„Éè„É≥,Positive
 COVID treatment medications,Phil üò∑ Kinzler,Positive
 planets,Phil üò∑ Kinzler,Positive
 Guardians,Phil üò∑ Kinzler,Positive
 Galaxy‚ÄùRemdesivirFavipiravirTocilizumabBaricitinibAcalabrutinib,Phil üò∑ Kinzler,Positive
 Acalabrutinib CALQUENCE,GNHIndiapharma,Positive
 Baml AZN LN AstraZeneca Q,dough,Negative
 EPS,dough,Negative
 beat Guide,dough,Negative
 Buy   BUY,dough,Negative
 United KingdomBuy,dough,Negative
 class growth,dough,Positive
 launches,dough,Negative
 cons Calquence L Enhertu Roxa china,dough,Negative
 Farxiga HF,dough,Negative
 Calquence Study,Buried On Page3,Positive
 Calquence Study,ASOII,Positive
 Coronavirus Treatment,Buried On Page3,Positive
 Coronavirus Treatment,ASOII,Positive
   con o sin,Cl√≠nica Hallwang,Positive
 mejor√≥,Cl√≠nica Hallwang,Positive
 Êó•Êú¨„ÅßË©±È°å„ÅÆÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÂØæÂøú‰ª£ÊõøËñ¨„ÅÆË©±È°å„ÅØ„É¨„É†„Éá„Ç∑„Éì„É´„Å®„Ç¢„Éì„Ç¨„É≥„Å∞„Å£„Åã„Åó„Å†„Åë„Å©„ÄÅÊµ∑Â§ñ„Åß„ÅØCalquenceÔºà„Ç´„É´„ÇØ„Ç®„É≥„ÇπÔºâ„ÅåË©±È°å„ÅÆ„Éà„ÉÉ„Éó„ÄÇ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´,Á¨πÂ±±ÁôªÁîü,Positive
 „ÅÆËñ¨„ÅÆ„Çà„ÅÜ„Åß„ÄÅÊó•Êú¨„Åã„Çâ„ÇÇÂÄã‰∫∫Ëº∏ÂÖ•‰ª£Ë°å„Åß„ÄÅÊâã„Å´ÂÖ•„Çå„ÇãÈÅì„ÅØ„ÅÇ„Çã„ÄÇ„Åß„ÇÇ‰æ°Ê†º„ÅÆÈ´ò„ÅÑ„ÅÆ„Å´„Å≥„Å£„Åè„Çä„ÄÇ„Åì„Çå,Á¨πÂ±±ÁôªÁîü,Positive
 burton kinase inhibitor,Famela and Friends,Positive
 burton kinase,Famela and Friends,Positive
 b cell develoment,Famela and Friends,Positive
 mainstream pub,Chris Yeh,Positive
 Politico,Chris Yeh,Positive
 AstraZeneca Announces CALAVI Trial,Victor YosefMelt Campos,Positive
 AstraZeneca Announces CALAVI Trial,√únal Metin Tokat,Positive
 AstraZeneca Announces CALAVI Trial,Jorie graham,Positive
 impact,24H Sante,Negative
 impact,I Am Biotech,Positive
 impact,Jennifer A. Ng,Positive
 impact,PhRMA,Positive
 impact,Omer Haghi,Positive
 impact,RizonSon O'Kodee,Positive
 impact,ExpPharma,Negative
 impact,Reuters,Negative
 impact,TheArticleTrunk,Positive
 impact,CHItraders,Negative
 impact,chorley chicken,Negative
 impact,Medicine Briefly,Negative
 impact,Reuters UK,Positive
 impact,LBC News,Positive
 impact,Investor News,Negative
 impact,Devdiscourse,Negative
 impact,OncLive.com,Positive
 impact,Medivizor,Positive
 impact,WEGO Health,Negative
 impact,ClinOwl Haematology,Negative
 impact,Toby Eyre,Negative
 impact,Paperbirds_Hematology,Positive
 impact,CLLSA,Negative
 impact,VJHemOnc,Positive
 impact,CLL Society Inc.,Negative
 impact,THE MUSIC üë•,Positive
 impact,COPD News,Positive
 impact,ASH Clinical News,Negative
 impact,James Kerwin,Positive
 impact,Kim Kirchherr,Negative
 impact,Christian Reinhardt,Positive
 impact,Benlazar S.M Amin√©,Negative
 impact,i3 Health,Negative
 impact,Sarah Williams,Positive
 impact,Lymphoma Hub,Positive
 impact,Patient Power,Negative
 impact,"chadi nabhan MD, MBA, FACP",Positive
 impact,"Raul Cordoba, MD, PhD",Positive
 impact,AEGLE,Negative
 impact,RIOH,Negative
 impact,PeerView,Negative
 impact,DirectorsTalk,Positive
 impact,Issels Treatment,Positive
 impact,Cancer Support Community,Negative
 impact,Janssen EMEA,Negative
 God,24H Sante,Negative
 God,Matthew Will,Positive
 God,RCCG | TOD Youths,Positive
 ELEVATETN Acalabrutinib,The ASCO Post,Negative
 James,The James,Positive
 James,StrathPharm&Bio,Positive
 James,Local 12/WKRC-TV,Positive
 James,Heather Kidder,Negative
 quality,The James,Positive
 quality,palliativewise,Positive
 quality,McKesson Corporation,Negative
 quality,US Oncology Network,Negative
 quality,VJHemOnc,Negative
 quality,AACR Foundation,Negative
 quality,OncologyNurseAdvisor,Positive
 life,The James,Positive
 life,Patient Power,Positive
 life,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 life,AbbVie UK,Positive
 life,Patient Empowerment Network,Negative
 life,Living A Busy Life - With Cancer,Positive
 life,"Raul Cordoba, MD, PhD",Positive
 life,Jerry Clay English Hub,Positive
 life,CP DA DON,Positive
 life,Mindy Hermann,Positive
 life,OurHealth,Positive
 life,Jeff Neurman,Negative
 life,CLL Society Inc.,Negative
 life,Jimmy Side Eye,Positive
 life,LymphomaAction,Negative
 life,Vinci-Biochem Srl,Positive
 life,Northwest Radiology,Positive
 life,AbbVie US,Negative
 life,AbbVie,Negative
 life,US Oncology Network,Positive
 life,palliativewise,Positive
 life,McKesson Corporation,Negative
 life,Cancer Papers,Negative
 life,VJHemOnc,Negative
 life,CLL Ireland,Negative
 life,AACR Foundation,Negative
 life,NewYork-Presbyterian,Positive
 life,OncologyNurseAdvisor,Positive
 life,MD Anderson Cancer Center,Negative
 life,Melanie,Negative
 life,Michael O'Dwyer,Positive
 life,Gilead Sciences,Negative
 life,Vegan NoGluten Sara,Positive
 life,Lymphoma Coalition,Negative
 life,Christopher Steer,Negative
 life,CANDI Xtra,Positive
 life,Teresa Aguiar,Positive
   patients,The James,Positive
   patients,Shouting at people in my underpants,Negative
   patients,Graham Collins,Negative
   patients,"Chaitra Ujjani, MD",Positive
   patients,CLL Ireland,Positive
   patients,Andrew Schorr,Positive
   patients,Michael Rynne,Positive
   patients,CLL Society Inc.,Negative
   patients,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Positive
   patients,Michele Nadeem-Baker,Positive
   patients,Oncology Tube,Negative
   patients,Weill Cornell Leukemia,Positive
   patients,Chan Cheah,Negative
   patients,Patient Power,Positive
   patients,Dr Timos Papagatsias,Negative
   patients,Medscape Oncology,Negative
   patients,Patient Empowerment Network,Negative
   patients,MDedge Hematology & Oncology,Negative
   patients,the limbic,Negative
   patients,CLL_Fightersüéó,Negative
   patients,VJHemOnc,Negative
   patients,Leukaemia Care,Negative
   patients,Fred Hutch,Positive
   patients,Margaret Walker,Negative
   patients,JanssenUS,Negative
   patients,Blood Journal,Negative
   patients,Francesco Turturro,Negative
   patients,"Pharmacyclics, an AbbVie Company",Negative
   patients,Anthony Mato,Negative
   patients,Jeff Folloder,Positive
   patients,Lymphoma Canada,Negative
 effects,The James,Positive
 effects,Walter M Chesnut,Positive
 effects,Cancer Support Community,Positive
 effects,Barry Shrier,Negative
 effects,Medivizor,Positive
 effects,Patient Empowerment Network,Negative
 effects,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 effects,SIBBM,Positive
 effects,Patient Power,Positive
 effects,ecancer,Negative
 effects,eSahai,Positive
 effects,Cancer_Tribune,Negative
 effects,Cancer News,Positive
 effects,Andrew Schorr,Negative
 effects,Holden Caulfield PhD,Positive
 effects,MD Anderson Cancer Center,Positive
 effects,Oncology Tube,Negative
 effects,JADPRO,Negative
 effects,VJHemOnc,Negative
 effects,Cancer Support Community Pasadena,Positive
 effects,Canadian Hematology,Positive
 effects,Rotten Dead Pool,Positive
 study acalabrutinib,"Michael Wang, MD",Negative
 NIH,CarThera,Positive
 NIH,clinicalsourcing,Positive
 NIH,Anna Lubas,Positive
 NIH,vshariharakrishnan,Positive
 NIH,Aspen Biosciences,Positive
 NIH,Emilio Mordini,Positive
 NIH,EIPG,Negative
 NIH,G. Scott Weston,Positive
 NIH,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 NIH,GMO Free USA,Negative
 NIH,Nathan Donley,Positive
 NIH,CLL Society Inc.,Negative
    „ÇÇ,Shohta Kadomura Hospital Pharmacist,Negative
 Ôºü,Shohta Kadomura Hospital Pharmacist,Negative
 „Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ „ÄÄ Êñ∞Âûã„Ç≥„É≠„Éä„ÇíÂØæË±°„Å®„Åó„ÅüÊ≤ªÈ®ìÈñãÂßã,Shohta Kadomura Hospital Pharmacist,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ ÂåªËñ¨ÈÄö‰ø°Á§æ,Shohta Kadomura Hospital Pharmacist,Negative
 Ôºà „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá„ÇíÂØæË±°„Å®„Åó„ÅüCALAVIË©¶È®ì„ÇíÈñãÂßãpdf Ôºâ,Êµ¶Â±±Êòé‰øä,Positive
 PR TIMES,„Éö„É≥„ÇÆ„É≥„Çø„Ç§„É†„Ç∫,Positive
 effort,MedShadow Foundation,Positive
 COVID scientists,MedShadow Foundation,Positive
 theory,MedShadow Foundation,Positive
 possibility,MedShadow Foundation,Positive
 possibility,OncLive.com,Negative
 possibility,CLL Society Inc.,Negative
 possibility,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Datapoint,AIS Health,Positive
   updates,The Cancer Letter,Negative
   updates,VJHemOnc,Positive
   updates,Patient Power,Negative
 Collins,Zach Brennan,Positive
   Nurse Times,Nurse Times,Positive
 Nurse Times Coronavirus,Nurse Times,Positive
 allo studio farmaco,Nurse Times,Positive
 trattare,Nurse Times,Positive
 di citochine associata,Nurse Times,Positive
 all‚Äôinfezione,Nurse Times,Positive
 Si tratta di acalabrutinib inibitore della ¬† tirosina chinasi di Bruton Lo,Nurse Times,Positive
 Informazione Sanit√†,Nurse Times,Positive
 serio ed affidabile,Nurse Times,Positive
 PNN,L Michael Posey,Positive
 Apr    Lancet Acalabrutinib,L Michael Posey,Positive
 Selektif Bruton,deniztural,Positive
 tyrosine kinase,deniztural,Positive
 tyrosine kinase,MDedge Hematology & Oncology,Negative
 sitokin fƒ±rtƒ±nasƒ±nda etkinliƒüini ara≈ütƒ±racak,deniztural,Positive
 AstraZeneca Calquence BTK inhibitor,Olivier Elemento,Negative
 EXCLUSIVE AstraZeneca,Paul Lopez,Positive
 EXCLUSIVE AstraZeneca,RETURN TO SENDER,Positive
 EXCLUSIVE AstraZeneca,EWallace,Positive
 EXCLUSIVE AstraZeneca,TenStarsDesign‚Ñ¢,Positive
 EXCLUSIVE AstraZeneca,Scherazad Falcon,Positive
 EXCLUSIVE AstraZeneca,Shunta Sanders,Positive
 EXCLUSIVE AstraZeneca,Anand C. Patel,Positive
 EXCLUSIVE AstraZeneca,ùïäùï•ùï†ùïîùïúùêñùêöùê≠ùêúùê°ùêûùê´,Positive
 EXCLUSIVE AstraZeneca,Greg Johnson,Positive
 EXCLUSIVE AstraZeneca,Sarah Hickman,Positive
 EXCLUSIVE AstraZeneca,Pyrus,Positive
 EXCLUSIVE AstraZeneca,Nigel Bradley,Positive
 EXCLUSIVE AstraZeneca,Jasmine the European Cat,Positive
 EXCLUSIVE AstraZeneca,Avi Cohen üá´üá∑üáÆüá±,Positive
 EXCLUSIVE AstraZeneca,Diana Hedrick,Positive
 EXCLUSIVE AstraZeneca,mike judin,Positive
 EXCLUSIVE AstraZeneca,Lucas Wyrsch,Positive
 EXCLUSIVE AstraZeneca,mywaypress,Positive
 EXCLUSIVE AstraZeneca,Syed Abutalib,Positive
 EXCLUSIVE AstraZeneca,S.Wanee,Positive
 EXCLUSIVE AstraZeneca,"Michael Blaiss, MD",Positive
 EXCLUSIVE AstraZeneca,cafepharma,Negative
 EXCLUSIVE AstraZeneca,Buried On Page3,Positive
 EXCLUSIVE AstraZeneca,Chris Manfuso,Negative
 EXCLUSIVE AstraZeneca,Shouting at people in my underpants,Negative
 EXCLUSIVE AstraZeneca,üò∑ Datos Digital,Positive
 EXCLUSIVE AstraZeneca,Kristen Breland,Positive
 EXCLUSIVE AstraZeneca,Joel Padre,Positive
 EXCLUSIVE AstraZeneca,The Peoples Pharmacy,Positive
 EXCLUSIVE AstraZeneca,Dr Timos Papagatsias,Negative
 EXCLUSIVE AstraZeneca,Michael Noer,Positive
 EXCLUSIVE AstraZeneca,Janet Novack,Positive
 EXCLUSIVE AstraZeneca,Health News,Negative
 EXCLUSIVE AstraZeneca,ChicagoSchoolofYoga,Negative
 EXCLUSIVE AstraZeneca,BenExact,Negative
 „Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàAcalabrutinibÔºâÔºöBTKÈòªÂÆ≥Ëñ¨„ÅßÈùû„Éõ„Ç∏„Ç≠„É≥„É™„É≥„ÉëËÖ´„ÅÆÊ≤ªÁôÇËñ¨ÔºéBTKÈòªÂÆ≥Ëñ¨„Ç§„Éñ„É´„ÉÅ„Éã„Éñ„Çà„Çä„ÇÇÔºåÈ´ò„ÅÑÈÅ∏ÊäûÊÄß„Å®BTKÈòªÂÆ≥ÊÄß„ÇíÊåÅ„Å§,RahumJ,Positive
 Articles Acalabrutinib,ClinOwl,Positive
 Longterm followup data,OncLive.com,Negative
 Longterm followup data,JanssenUS,Negative
 III ACECL study,OncLive.com,Negative
 COVIDÂÖ•Èô¢ÊÇ£ËÄÖ„ÇíÂØæË±°„Å®„Åó„ÅüAcalabrutinib„ÅÆÊúâÂäπÊÄß„Å®ÂÆâÂÖ®ÊÄß„ÅÆÁ¨¨Áõ∏ÁÑ°‰ΩúÁÇ∫ÂåñÊØîËºÉË©¶È®ìÂêç„Ç™„Éº„Éó„É≥„É©„Éô„É´Ë©¶È®ìÈñãÂßã‰∫àÂÆöÊó• Âπ¥ÊúàÊó•„Éà„ÉÉ„Éó„É©„Ç§„É≥ÔºöÂπ¥ÊúàÊó•AstraZenecaAcerta Pharma BV,REAL TONARINO AGETIN‡∏î‡πá‡πá‡πá‡πá‡πá‡πá‡πá‡πá‡πá,Positive
 TAP STELLAR,TAP Clinical Trial Network,Negative
 phase II randomised study,TAP Clinical Trial Network,Negative
 obinutuzmab,"Raul Cordoba, MD, PhD",Negative
 Acalabrutinib BTK inhibitor,Nathan Twala,Positive
 III study,OncLive.com,Negative
 III study,Medklik,Positive
 III study,Roche,Positive
 III study,"chadi nabhan MD, MBA, FACP",Negative
 singleagent acalabrutinib,OncLive.com,Negative
 treatment initiation,OncLive.com,Negative
 relapsedrefractory chronic lymphocytic,OncLive.com,Negative
 relapsedrefractory chronic lymphocytic,ASH Clinical News,Positive
 relapsedrefractory chronic lymphocytic,Biotech2050,Negative
 relapsedrefractory chronic lymphocytic,i3 Health,Negative
 relapsedrefractory chronic lymphocytic,Sarah Williams,Positive
 relapsedrefractory chronic lymphocytic,Rare Disease Report,Positive
 relapsedrefractory chronic lymphocytic,OncologyNurseAdvisor,Negative
 relapsedrefractory chronic lymphocytic,The Lancet Oncology,Negative
 Cancer Network,√únal Metin Tokat,Positive
 Cancer Network,Lymphoma Canada,Positive
 Cancer Network,Swallow This - The War On Cancer! üò∑,Positive
 Cancer Network,SurvivalGear,Positive
 Cancer Network,SOBRAFO,Positive
 Cancer Network,TheraGlobal,Positive
 AstraZeneca Initiates CALAVI Clinical Trial,Pharma Journalist,Positive
 Overheden kunnen,ùïäùï•ùï†ùïîùïúùêñùêöùê≠ùêúùê°ùêûùê´,Positive
 clinic,Pharma Business Int,Negative
 clinic,Nick,Negative
 clinic,"chadi nabhan MD, MBA, FACP",Negative
 „Äê Êñ∞ÁùÄË®ò‰∫ã„ÄëAZÈñãÁô∫„ÅÆBKTÈòªÂÆ≥Ëñ¨acalabrutinib„ÄÅCOVIDÈáçÁóáÊÇ£ËÄÖ„ÇíÂØæË±°„Å´„É©„É≥„ÉÄ„É†ÂåñÊØîËºÉË©¶È®ì„ÇíÈñãÂßã,Oncology_Tribune,Positive
 Clinical Trial,„Å∏„Å∏„Å∏„ÅÆ„Éò„Éì„Éº„É°„Çø„É≠„Ç¶,Positive
 Clinical Trial,Financial Buzz,Negative
 Clinical Trial,Odi Bruckman,Negative
 Clinical Trial,Michele Nadeem-Baker,Negative
 Clinical Trial,Biotech2050,Negative
 COVID Treatment,„Å∏„Å∏„Å∏„ÅÆ„Éò„Éì„Éº„É°„Çø„É≠„Ç¶,Positive
 Comment Acalabrutinib,ClinOwl,Positive
 ELEVATETN,Chan Cheah,Negative
 ELEVATETN,Adam Kittai,Negative
 ELEVATETN,"Amber Koehler, PA-C",Negative
 ELEVATETN,OncLive.com,Negative
 ELEVATETN,Suchitra Sundaram,Positive
 PFS benefit,Chan Cheah,Negative
 Acalabrutinib LongTerm Benefit,Immuno-Oncology,Negative
 Acalabrutinib LongTerm Benefit,Crwe World,Negative
 Acalabrutinib LongTerm Benefit,ImmunotherapyPapers,Negative
 Acalabrutinib LongTerm Benefit,OncLive.com,Negative
 Acalabrutinib LongTerm Benefit,Jason Broderick,Negative
 CLL Captured,Immuno-Oncology,Negative
 CLL Captured,Crwe World,Negative
 CLL Captured,ImmunotherapyPapers,Negative
 CLL Captured,OncLive.com,Negative
 CLL Captured,Jason Broderick,Negative
 Published Data,Immuno-Oncology,Negative
 Published Data,Crwe World,Negative
 Published Data,ImmunotherapyPapers,Negative
 Published Data,OncLive.com,Negative
 Published Data,Jason Broderick,Negative
 study results,Jeff Sharman,Positive
 fda approval,Jeff Sharman,Positive
 CALAVI trial,BioPoint Inc.,Positive
 CALAVI trial,OncLive.com,Negative
 play,Jonathan Faison,Positive
 play,Lifelong Learning,Negative
 New trial lead,BioCanRx - Canada's Immunotherapy Network,Positive
 randomized P study,Earle Burgess,Positive
 acalabrutinib BTK inhibitor,Earle Burgess,Positive
 Medicamento Calquence da AstraZeneca,Maria Rejane Rocha,Positive
 Ireland,Michael Rynne,Positive
 Ireland,CLL Ireland,Positive
 Ireland,Gear√≥id √ì Crotaigh #CareCantWait,Positive
 AstraZeneca Initiates Calquence Clinical Trial,PharmaSources.com,Positive
 Blood cancer drugs,Surviving Myeloma,Positive
 New post,BiopharmaMASH,Positive
 New post,Amanda Marie,Positive
 New post,Augustino Chengula,Negative
 New post,CARE‚Ñ¢ Education,Negative
 New post,Âø´ÈÅ©ÂÆ∂ÈõªLife,Negative
 New post,Rx Times¬Æ,Positive
 New post,adan martinez,Positive
    BTK inhibitor,Dragana Obradovic,Positive
 CLL specialists,Medscape Oncology,Negative
 CLL specialists,Patient Power,Negative
 Acalabrutinib COVID Trial,SaraSmallMD,Positive
     Acalabrutinib,COVID19 Clinical Trials & Research: Covidmune.com,Positive
     Acalabrutinib,Nicolas Zarjevski,Positive
   drug,COVID19 Clinical Trials & Research: Covidmune.com,Positive
   drug,Shouting at people in my underpants,Negative
   drug,Clinical Lab Manager,Positive
   drug,The James,Negative
   drug,CLL Ireland,Negative
   drug,British Journal of Clinical Pharmacology,Positive
 Burtons,COVID19 Clinical Trials & Research: Covidmune.com,Positive
 kinaseI wonder,COVID19 Clinical Trials & Research: Covidmune.com,Positive
 applications,Big4Bio:Philly,Positive
 Btk inhibitor Calquence,Big4Bio:Philly,Positive
 COVIDAstraZeneca,PharmacyWeek (Kevin),Positive
 Cancer medicine,McGill Oncology,Positive
 COVID AstraZeneca Plc,McGill Oncology,Positive
    Medicamento Calquence da AstraZeneca,Forbes Brasil,Positive
 obt√©m resultados promissores contra,Forbes Brasil,Positive
 Global Clinical Trial,HospiMedica.com,Positive
 Global Clinical Trial,Value Trader,Positive
 Global Clinical Trial,Scott Werntz,Negative
 InfectionAstraZeneca Cambridgeshire,HospiMedica.com,Positive
 „Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÅÆÊúÄÊñ∞ÊÉÖÂ†±„Äë„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÅØÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„Çπ,Dr.tomohiro,Positive
 „Åï„Çì„Åã„Çâ,Dr.tomohiro,Positive
 leukemia drug,Sharky Sarah,Positive
 leukemia drug,Diving News,Negative
 leukemia drug,STRT Boston,Positive
 leukemia drug,Lymphoma Hub,Negative
 TODAY Experts,Patient Power,Negative
 discuss,Patient Power,Positive
 Ibrutinib Acalabrutinib impact,Patient Power,Negative
 TODAYs,Patient Power,Negative
 webinar,Patient Power,Negative
 webinar,CLLSA,Positive
 webinar,J. De Munter,Negative
 webinar,CLL Ireland,Positive
 webinar,OGT,Negative
 webinar,Rajesh Sharma,Negative
 webinar,Fluxion Biosciences,Positive
 webinar,Duke Hematologic Malignancies & Cellular Therapy,Negative
 webinar,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 webinar,BioAscend,Positive
 webinar,Leukaemia Care,Positive
 webinar,CURE Magazine,Positive
 webinar,ERN EuroBloodNet,Negative
 webinar,STTR Cancer,Positive
 webinar,Dana-Farber,Negative
 webinar,Carevƒ´ve,Positive
 webinar,Light The Night NCA,Positive
 questions,Patient Power,Positive
 questions,Targeted Oncology,Positive
 questions,MJ Platform,Positive
 questions,donnashort,Positive
 questions,Michele Nadeem-Baker,Negative
 questions,BioAscend,Positive
 questions,CLL Society Inc.,Positive
 questions,Karmanos Cancer Institute,Positive
 questions,Andrew Schorr,Positive
 questions,Leukaemia Care,Negative
 questions,VJHemOnc,Negative
 questions,CLL Advocates Network,Negative
 questions,CLL Ireland,Negative
 questions,"chadi nabhan MD, MBA, FACP",Negative
 questions,Danielle Ternyila,Positive
 questions,Patient Empowerment Network,Positive
 questions,PeerView,Positive
 questions,Managing Myeloma,Positive
 questions,MediCom Oncology,Positive
 questions,ivy science,Negative
 questions,AZ Blood Cancer,Positive
 questions,thesecondopinion,Positive
   initiates,CDE News,Positive
 evidencia cient√≠fica s√≥lida que respalda el papel de la v√≠a BTK,Miguel Angel Grullon C.,Positive
 en la producci√≥n de citocinas inflamatorias,Miguel Angel Grullon C.,Positive
 Acalabrutinib   Trial,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 ŒöŒøœÅŒøŒΩŒøœäœåœÇ ŒïŒªœÄŒπŒ¥ŒøœÜœåœÅŒ±,Nikolaos M. Mastrogiorgis,Positive
 ŒöŒøœÅŒøŒΩŒøœäœåœÇ ŒïŒªœÄŒπŒ¥ŒøœÜœåœÅŒ±,capital.gr,Positive
 ŒöŒøœÅŒøŒΩŒøœäœåœÇ ŒïŒªœÄŒπŒ¥ŒøœÜœåœÅŒ±,DIOGENIS CHARALAMPIDIS,Positive
 Test Impact,Plexus Ventures,Negative
 Test Impact,Boya Wang,Positive
 Test Impact,"Prasad Wakchaure, PhD üáÆüá≥ üá∏üá™",Positive
 Test Impact,Israel Stagman,Positive
 Drug,Plexus Ventures,Negative
 Drug,CancerWallonia,Negative
 Drug,The San Bruno Beacon,Positive
 Drug,SanFranciscoTickets,Positive
 Drug,Clinical Trials,Negative
 Drug,Ayesha Trites,Positive
 Drug,Yuriko Dille,Positive
 Drug,Healthy Liver,Positive
 Drug,Calynn Burell,Positive
 Drug,Cheap-Mall,Positive
 Drug,Hiboo - Michele,Positive
 Drug,Michael Zons,Positive
 Drug,Danny Zacfie,Positive
 Drug,Betty Dorsey,Positive
 Drug,Jamiu Abdulhafeez,Positive
 Drug,kilokeal,Positive
 Drug,Prince,Positive
 Drug,Science Updates,Positive
 Drug,TrialSite News,Positive
 Drug,DAMSonians,Positive
 Drug,CLL Ireland,Negative
 Drug,Margaret Walker,Negative
 Drug,MDedge Hematology & Oncology,Positive
 Drug,Andy Powell,Positive
 Drug,Shop Support,Positive
 Drug,Scott Werntz,Negative
 Drug,Cancer Agent,Negative
      AstraZeneca,MDDigitasTV,Negative
 COVIDÊÇ£ËÄÖ„Å∏„ÅÆAstraZeneca„ÅÆBTKÈòªÂÆ≥Ââ§Calquence„ÅÆÂ§ßË¶èÊ®°Ë©¶È®ì„ÅåÂßã„Åæ„Çã,BB9XYDB@Â§öÊßòÊÄß„Å´ÂØå„ÇÄÈáéÁêÉ„ÇíÊúõ„ÇÄËÄÖ,Positive
 Insights PharmaÂà•„ÅÆ„Ç¢„Éó„É≠„Éº„ÉÅ„Åã„Çâ„ÅÆÊó¢Â≠òËñ¨Ê≤ªÈ®ìÈñãÂßã,BB9XYDB@Â§öÊßòÊÄß„Å´ÂØå„ÇÄÈáéÁêÉ„ÇíÊúõ„ÇÄËÄÖ,Positive
 plans,Clinithink,Positive
 plans,CP Graduate Academy,Positive
 plans,Patient Power,Negative
 plans,cafepharma,Negative
 Coronavirus AstraZeneca,The Business Network,Positive
 Coronavirus AstraZeneca,Jared O‚Äô üáÆüáπ,Positive
 Coronavirus AstraZeneca,BCABA Network,Positive
 Blood Cancer Drug Shows Promise,Rocky,Positive
 Coronavirus drug,Rocky,Positive
 ForbesResearchers,Rocky,Positive
 National Cancer Institute,Rocky,Positive
 National Cancer Institute,Montse Carrere,Positive
 Blodkreftlegemidlet Calquence,HealthTalk,Positive
 p√•,HealthTalk,Positive
 p√•,LyLe Foreningen,Positive
 p√•,Lars M√∏rland Knudsen,Positive
 p√•,√Öbo Akademi University,Positive
 Cytokinstorm   handlar det om v√§der,Ulla Nyman,Positive
 Nej det √§r den √∂verreaktion fr√•n immunf√∂rsvaret,Ulla Nyman,Positive
 som vissa Covidpatienter,Ulla Nyman,Positive
 ut f√∂r och som ger,Ulla Nyman,Positive
 lungskador,Ulla Nyman,Positive
 Nu testar,Ulla Nyman,Positive
 ett,Ulla Nyman,Positive
 Hopefully lead,martijn antonisse,Positive
 relieve,martijn antonisse,Positive
    battle,martijn antonisse,Positive
 ‚Å¶Encouraging news,AAA,Positive
 ‚Å© ‚Äú Coronavirus AstraZeneca,AAA,Positive
 Ëã±„Ç¢„Çπ„Éà„É©„ÄÅÊäó„Åå„ÇìÂâ§„Åå„Ç≥„É≠„Éä„Å´„Çà„ÇãÈÅéÂâ∞„Å™ÂÖçÁñ´ÂèçÂøúÊäë„Åà„ÇãÂäπÊûúÊ§úË®º„Å∏„Éñ„É´„Éà„É≥Âûã„ÉÅ„É≠„Ç∑„É≥„Ç≠„Éä„Éº„ÇºÔºàÔº¢Ôº¥Ôº´ÔºâÈòªÂÆ≥Ââ§„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàÂïÜÂìÅÂêç„ÄåCalquence„ÄçÔºâ„ÅØÊñ∞Âûã„Ç≥„É≠„Éä„ÅßÁîü„Åò„ÇãÁÇéÁóá„ÇíÊäë„ÅàÂëºÂê∏Âõ∞Èõ£„ÅÆÁ®ãÂ∫¶„ÇíÁ∑©Âíå„Åô„ÇãÂèØËÉΩÊÄß„Åå„ÅÇ„Çã„ÄÇÔº¢Ôº¥Ôº´„ÅØÁÇéÁóá„Å´„Åã„Åã„Çè„Çã„Çø„É≥„Éë„ÇØË≥™,Stray,Positive
 Article,Jennifer A. Ng,Positive
 Article,LyLe Foreningen,Negative
 Article,Taylor Lab UM,Negative
 Article,MedPage Today,Negative
 Article,Lymphoma Hub,Positive
 Article,Gina Eagle,Negative
 AMP,Jennifer A. Ng,Positive
 AMP,Vanya Aleksandrova üò∑,Positive
 AMP,Adam Fraise,Positive
 AMP,Association for Molecular Pathology,Negative
 Reuters,Jennifer A. Ng,Positive
 Reuters,Hargreaves Lansdown,Positive
 Reuters,daniel,Positive
 Reuters,Israel Stagman,Positive
 Reuters,Vanya Aleksandrova üò∑,Positive
 Reuters,Kiran Bhole,Positive
 Reuters,lalit pachpande,Positive
 Reuters,Fredi Skwar,Positive
 Reuters,Bryan Zwan,Positive
 Reuters,HHF,Negative
 AstraZeneca anunciou o in√≠cio,Onconews,Positive
 efic√°cia,Onconews,Positive
 tto da hipercitocinemia,Onconews,Positive
 O medicamento,Onconews,Positive
 Calquence un medicamento contra la leucemia podr√≠a ser,httpp://,Positive
 Calquence un medicamento contra la leucemia podr√≠a ser,El Cierre Digital,Positive
   hope,Kim Kovarik,Positive
 Tuesday,MAISA,Negative
 Tuesday,Rare Disease Report,Negative
 Tuesday,CLL Society Inc.,Negative
 Tuesday,Iowa Cancer Consortium,Positive
 Tuesday,Tom,Negative
 Tuesday,Vivian Cain,Positive
 Tuesday,BioAscend,Positive
 Tuesday,CLL Ireland,Negative
 Tuesday,Higher Ground at Lake Louise,Negative
 Tuesday,Lifelong Learning,Negative
 Cancer Drug Calquence,Boya Wang,Positive
 Cancer Drug Calquence,"Prasad Wakchaure, PhD üáÆüá≥ üá∏üá™",Positive
 Cancer Drug Calquence,RTTNews Top Stories,Positive
 Cancer Drug Calquence,Israel Stagman,Positive
 Coronavirus Patients,Boya Wang,Positive
 Coronavirus Patients,"Prasad Wakchaure, PhD üáÆüá≥ üá∏üá™",Positive
 Coronavirus Patients,Israel Stagman,Positive
 PharmaScrip   AstraZeneca,ZorgNL,Positive
 Calquence Trial,ZorgNL,Positive
 Calquence Trial,Scrip,Negative
 Calquence Trial,OBR,Negative
 AstraZeneca testet,coronavirus.host24.space,Positive
 Wirkung des Krebsmedikaments Calquence auf,coronavirus.host24.space,Positive
 Twittersmash,coronavirus.host24.space,Positive
 Trial Launching,OncLive.com,Negative
 Trial Launching,Jason Broderick,Negative
 immunosuppressant,"Prasad Wakchaure, PhD üáÆüá≥ üá∏üá™",Positive
 AstraZeneca Launches Drug    trial,Giuseppe LiMandri,Negative
 AstraZeneca Initiates Clinical Trial,GMPnews.Net,Negative
 complications,Andrew Schorr,Negative
 complications,Dr. Nancy PerlmanüÜòÔ∏è,Positive
 complications,Patricia S Limbacher,Positive
 complications,Mayo Clinic Cancer Center,Positive
 complications,Razan Mohty,Positive
 complications,Amie,Positive
 complications,Seattle DJC,Positive
 complications,ACE,Positive
 complications,contractmag,Positive
 complications,VJHemOnc,Positive
 COVID Taskforce,Scrip,Negative
 ÿ≥Ÿäÿ™ŸÖ ÿßÿÆÿ™ÿ®ÿßÿ± ÿØŸàÿßÿ° Calquence ÿπŸÑŸâ ŸÖÿ±ÿ∂Ÿâ ŸÉŸàŸÅŸäÿØ,sputnik_ar,Positive
 ŸÅŸä ÿßŸÑŸÖÿ≥ÿ™ÿ¥ŸÅŸäÿßÿ™,sputnik_ar,Positive
 ÿå ÿ®ŸÖÿß,sputnik_ar,Positive
 ŸÅŸä ÿ∞ŸÑŸÉ ÿßŸÑÿ®ÿπÿ∂,sputnik_ar,Positive
 ŸÖŸÖŸÜ Ÿäÿ™ŸÑŸÇŸàŸÜ ÿßŸÑÿØÿπŸÖ ŸÅŸä Ÿàÿ≠ÿØÿßÿ™ ÿßŸÑÿπŸÜÿßŸäÿ© ÿßŸÑŸÖÿ±ŸÉÿ≤ÿ©ÿ≥ÿ®Ÿàÿ™ŸÜŸäŸÉ,sputnik_ar,Positive
 perspective,Pyrus,Positive
 perspective,NE Live,Negative
 perspective,Patient Empowerment Network,Negative
 perspective,WCM Lymphoma,Negative
 perspective,AbbVie,Negative
 perspective,HemOnc Today,Positive
 perspective,Healio,Negative
 perspective,MDedge Hematology & Oncology,Negative
 perspective,Stephen Brown,Negative
 Astra Zenecas l√§kemedel,The Dude,Positive
 Astra Zenecas l√§kemedel,Roslund,Positive
 mot blodcancer,The Dude,Positive
 p√• allvarligt virussjuka,The Dude,Positive
 cancer treatment,Ancora.ai Cancer Clinical Trials for All,Positive
 cancer treatment,STTR Cancer,Positive
 cancer treatment,Esther Schorr,Negative
 blood   drug Calquence,Ancora.ai Cancer Clinical Trials for All,Positive
   AZN AstraZeneca,SY Investing,Positive
   plans,Market Intelligence: Healthcare,Positive
 goal,EuropaWire,Negative
 goal,CLLSA,Negative
 goal,donnashort,Negative
 goal,Equality Couple,Negative
 goal,Prairie Lakes Church,Negative
 goal,Oncology Now,Negative
 mortality,EuropaWire,Negative
 mortality,MUVBBvirtual,Negative
 mortality,Brave Is Now¬Æ,Negative
 mortality,Anthony Mato,Negative
 COVID AstraZeneca,EuropaWire,Negative
 ÿßÿ≥ÿ™ÿ±ÿßÿ≤ŸÜŸäŸÉÿß,Agha,Positive
 ÿπŸÑŸä ÿßŸÑÿÆÿ∑,Agha,Positive
 ÿå ÿßŸÜÿß ÿ®ÿ¥ŸàŸÅŸáÿß ÿ¥ÿ±ŸÉÿ© ÿπŸÖŸÑÿßŸÇŸá,Agha,Positive
 ŸàŸÅÿ±ŸäŸÇŸáÿß ÿßŸÑÿ®ÿ≠ÿ´Ÿä,Agha,Positive
 ÿßŸÇŸàŸä,Agha,Positive
 Test,RTTNews Top Stories,Positive
 Test,CLL Society Inc.,Negative
 Blood,RTTNews Top Stories,Positive
 Blood,CRUK Birmingham Centre,Positive
 Blood,Chris Pepper,Positive
 Blood,Blood Journal,Negative
 Blood,Cancer Papers,Negative
 Blood,Lymphoma Papers,Negative
 Blood,"Raul Cordoba, MD, PhD",Negative
 Blood,Lymphoma Hub,Negative
 Blood,"Naveen Pemmaraju, MD",Negative
 Covid Patients,RTTNews Top Stories,Positive
   AstraZeneca,PressReleasePoint,Negative
   AstraZeneca,Nathan Vardi,Negative
   AstraZeneca,OBR,Negative
   AstraZeneca,Cancer News,Negative
   AstraZeneca,John Carroll,Positive
   AstraZeneca,Pharmaceutical News,Negative
 Astra Zenica≈°vedskobritanska,Budimirka Vuletic,Positive
 New News EXCLUSIVE,SJ Lefevre,Positive
 NCI,Juan C Ivancevich MD,Positive
 administration,Juan C Ivancevich MD,Positive
 administration,VJHemOnc,Negative
 administration,Lymphoma Hub,Negative
 CE ELABOREAZA PLAN DE RELANSARE,zarnescu  valentin,Positive
 EC DE   MLDEUROACALABRUTINIBVANDUT DE ASTRAZENECA SUB NUMELE DE CALQUENCEA ARATAT,zarnescu  valentin,Positive
 SEMNE POZITIVE LA O SERIE DE SUBIECTI,zarnescu  valentin,Positive
 CU COVID DIN,zarnescu  valentin,Positive
 MEDICAMENT E FOLOSIT,zarnescu  valentin,Positive
 SCHEMA DE TRATAMENT VS,zarnescu  valentin,Positive
 LEUCEMIEFRANTADRDIDIER,zarnescu  valentin,Positive
 DUR,zarnescu  valentin,Positive
 AZN inicia el,Investors Squad,Positive
 cl√≠nico CALAVI con Calquence contra,Investors Squad,Positive
 cancer drug fight,John Lauerman,Positive
 Covid AstraZeneca,John Lauerman,Positive
 lymphoma treatment Calquence,John Lauerman,Positive
 Astrazeneca soars,Julianna Tatelbaum,Positive
 Pharmaceutical giant,New Model Adviser,Positive
 start,New Model Adviser,Positive
 start,Leukaemia Care,Positive
 start,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Positive
 start,CLL Ireland,Negative
 start,CLLSA,Positive
 start,CLL Warwick Uni,Negative
 start,Sanne v‚≠ïn Wüíâssen,Positive
 start,Zack Pemberton-Whiteley,Negative
 start,GodisGreat,Positive
 Shares,Wealth Manager,Positive
 pharma giant AstraZeneca surge,Wealth Manager,Positive
 CV,Downtown News,Positive
 CV,Cool FM News,Positive
 CV,DowntownCountry News,Positive
 CV,DrSpock_2021 PhD üíé,Positive
 thought,Downtown News,Positive
 thought,Cool FM News,Positive
 thought,DowntownCountry News,Positive
 thought,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 thought,Maureen,Positive
 thought,cnaamani,Positive
 harm,Downtown News,Positive
 harm,Cool FM News,Positive
 harm,DowntownCountry News,Positive
 harm,Patient Power,Negative
 AZNs,TheStreet,Positive
 AZNs,Jacob Bell,Positive
 AZNs,BioPharma Dive,Negative
 leukemia treatment Calquence,TheStreet,Positive
 coronavirus symptoms,TheStreet,Positive
 respirators,TheStreet,Positive
 company,TheStreet,Positive
 company,PeterDFokes,Positive
 company,ur-trading,Positive
 company,PSK2329 - JHC,Positive
 company,Quant Data,Positive
 company,Vegastrader66,Positive
 company,OGT,Negative
 company,Big4Bio:SFBay,Positive
 company,dough,Negative
 company,DirectorsTalk,Positive
 AstraZeneca shares,Working Capital Consulting,Positive
 pharmaceuticals giant,Working Capital Consulting,Positive
 Calquence drug,Working Capital Consulting,Positive
   AZ,Career Biotech,Negative
 moves,The PMI (Pharmaceutical Managers' Institute),Negative
 infection,FirstWord Pharma,Negative
 infection,ChristosArgyropoulos,Negative
 infection,VJHemOnc,Negative
 infection,Journal of the @NCCN,Negative
 infection,CLL Advocates Network,Negative
 infection,Medivizor,Positive
 infection,The Lancet Haematology,Negative
 infection,noel cole,Negative
 infection,CLLSA,Negative
 infection,"Raul Cordoba, MD, PhD",Negative
 infection,Dr. Melody Davis,Negative
 infection,Janssen Nederland,Positive
 Astrazeneca startar klinisk,Maths Nilsson,Positive
 substans,Maths Nilsson,Positive
 som verkar kunna lugna den inflammatoriska reaktionen,Maths Nilsson,Positive
 som skapar stora problem,Maths Nilsson,Positive
 Update Shares,Citywire,Positive
 UPDATE,TheArticleTrunk,Negative
 UPDATE,Investor News,Negative
 UPDATE,LymphomaAction,Negative
 VigorBot,Medicine Briefly,Negative
 FAR DANGEROUS amp EXPENSIVE,Sheikh Anvakh - ÿßŸÑŸÇÿ∑ Ÿäÿ±ŸäÿØ ÿßŸÑÿ∑ÿπÿßŸÖ ŸÖÿ±ÿ© ÿ£ÿÆÿ±Ÿâ,Positive
   AZN,Aakash Jagadeesh B,Positive
   AZN,Pharmaceutical News,Positive
 behandla,Roslund,Positive
 covid Det skriver Forbes,Roslund,Positive
 AZN GSK,Investor News,Negative
 NYT,Israel Stagman,Positive
 NYT,Laila Kj√¶rb√¶k,Positive
 BRIEFAstraZeneca Initiates Trial,Vanya Aleksandrova üò∑,Positive
 COVID   Article,Vanya Aleksandrova üò∑,Positive
 enrollment,OnTheFritz,Negative
 enrollment,"Mazyar Shadman, MD MPH",Negative
 enrollment,WCMNYPJCTO,Negative
 enrollment,Crown Equity CRWE,Positive
 UK Astra Zeneca,Aldo Sterone,Positive
 de tester un m√©dicament pour,Aldo Sterone,Positive
 leuc√©mie sur des malades,Aldo Sterone,Positive
 de Covid Il,Aldo Sterone,Positive
 Euros,Aldo Sterone,Positive
 boite,Aldo Sterone,Positive
 de   comprim√©s,Aldo Sterone,Positive
 ÔΩ¥Ôæà,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 COVIDÔΩ¥ÔΩµÔΩºÔæîÔΩ§ÔæòÔΩ§ÔæéAstraZenecaÔΩ§ÔæéBTKÔæÅÔæãÔΩ≥ÔΩ≤ÔΩ∫ÔæûCalquenceÔΩ§ÔæéÔæÇÈÇ®ÔΩ¨ÔæåÔæèÔΩªÔΩ≥ÔΩ§ÔΩ¨ÔΩªÔæèÔΩ§ÔæûÔΩ§,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 MEDICIN Astra Zeneca inleder tester,Samtiden,Positive
 l√§kemedlet Calquence mot,Samtiden,Positive
 l√§kemedlet Calquence mot,G√∂teborgs-Posten,Positive
 Light,Kaj Jakobsson,Positive
 Light,Oncology Tube,Negative
 Light,Lymphoma Coalition,Negative
    tunnelAstraZeneca,Kaj Jakobsson,Positive
 Astra Zeneca inleder tester,G√∂teborgs-Posten,Positive
 AstraZeneca rozpoczyna testy leku,Pani Blondynka,Positive
 Bra nyheter fr√•n,Jonas Medin,Positive
 Astra,Jonas Medin,Positive
 antiinflammatory benefit,Pengyu Yang,Positive
 hours,PeterDFokes,Positive
 hours,ILLINOIS Social Work,Negative
 hours,CLL Ireland,Negative
 hours,"Pat Euglow, Legacy Newbie",Negative
 COVIDEXCLUSIVE AstraZeneca,Kenneth Farber,Positive
 Amazing discovery Acalabrutinib amp Ibrutinib,Shouting at people in my underpants,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆÁôΩË°ÄÁóÖÊ≤ªÁôÇËñ¨„ÅåÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„Çπ„Å´ÂäπÊûú„Åå„ÅÇ„Çä„Åù„ÅÜ„ÄÇÊñ∞„Åü„Å™„Éâ„É©„ÉÉ„Ç∞„É™„Éù„Ç∏„Ç∑„Éß„Éã„É≥„Ç∞„ÅÆÂØæË±°„Å´,Mm„ÅÆÊÜÇÈ¨±,Positive
 „ÄÇ AstraZeneca,Mm„ÅÆÊÜÇÈ¨±,Positive
 doctors,Vineeth Sukrithan,Positive
 doctors,Patient Power,Positive
 doctors,Journal of the @NCCN,Negative
 doctors,CLL Ireland,Positive
 doctors,Jeff Neurman,Negative
 doctors,Team In Training,Positive
 doctors,The James,Positive
 doctors,Dr. Drew Dahlgren,Positive
 doctors,VJHemOnc,Positive
 tube,Vineeth Sukrithan,Positive
 solution,Vineeth Sukrithan,Positive
 CocaCola,Vineeth Sukrithan,Positive
 acidity,Vineeth Sukrithan,Positive
 powderAcalabrutinib,Vineeth Sukrithan,Positive
 rescue,Vineeth Sukrithan,Positive
 team,"Maria Badillo, MSN RN OCN CCRP",Negative
 team,Journal of Leukocyte Biology,Positive
 team,VJHemOnc,Negative
 team,TAP Clinical Trial Network,Negative
 team,Adam Kittai,Negative
 team,Martin JS Dyer,Positive
 team,Donna Gairns,Positive
 team,medwireNews,Negative
 team,SeattleCancerCareAlliance,Negative
 team,"chadi nabhan MD, MBA, FACP",Negative
 team,MD Anderson Cancer Center,Negative
 team,CLL Ireland,Positive
 team,MGH Cancer Center,Negative
 team,Mats Ohlin,Positive
 team,Lucy Mills,Positive
 team,AVMA (American Veterinary Medical Association),Positive
 team,Rockefeller U. Press,Positive
 team,Patient Power,Negative
 team,Anthony Mato,Negative
 team,"John P. Leonard, MD",Positive
 team,POG Research,Positive
 team,TH96 Charity Run,Positive
 team,Werneth Cricket,Positive
 CO,****,Negative
 COVIDHmmm,"John P. Leonard, MD",Positive
 Forbes,The Peoples Pharmacy,Positive
 shelter,Steven Bertoni,Positive
 „Ç§„ÇÆ„É™„Çπ„ÅÆ„ÄÅÊé®„Åó„ÅØCalquence„Åã„Å™ Ôºü,dotsÔºøkate,Positive
   drug giant,Global Capital Asset Management,Positive
 Kinase Inhibitors   Suffix tinibImatinib   CML,PharmaFactz,Negative
 ALLErlotinib,PharmaFactz,Positive
 colleague,Antoine Gara,Positive
 colleague,"Michael Wang, MD",Positive
 colleague,ron white,Positive
 colleague,Patient Power,Negative
 AZN forecast,dough,Negative
 growth,dough,Negative
 growth,Lung Cancer News,Negative
 growth,SkillAcquire,Positive
 growth,Medical Xpress,Negative
 growth,Washington Research Foundation & WRF Capital,Positive
 growth,CLL Ireland,Negative
 growth,Cesar,Positive
 patient trial,Nathan Vardi,Negative
 treatment landscape,OncLive.com,Positive
 treatment landscape,CURE Magazine,Positive
 treatment landscape,CLL Advocates Network,Negative
 treatment landscape,Ron Grunsby,Positive
 treatment landscape,OncLive SOSS,Negative
 treatment landscape,Felix Keller,Positive
 treatment landscape,Targeted Oncology,Negative
 treatment landscape,The James,Negative
 treatment landscape,OncCentral,Positive
 treatment landscape,Brandcast Health,Positive
 treatment landscape,VJHemOnc,Negative
 treatment landscape,Aziz Nazha,Positive
    monotherapy,"Raul Cordoba, MD, PhD",Negative
 Antitumor Potency,Garbi√±e Lizeaga,Negative
 Antitumor Potency,ACIR.org,Positive
 Antitumor Potency,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 Antitumor Potency,#Memory,Positive
 Antitumor Potency,Lymphoma Papers,Negative
 Antitumor Potency,TumorImmunoPapers,Negative
 AntiCD Chimeric Antigen Receptor TCell Therapy Lisocabtagene Maraleucel,Garbi√±e Lizeaga,Negative
 AntiCD Chimeric Antigen Receptor TCell Therapy Lisocabtagene Maraleucel,ACIR.org,Positive
 AntiCD Chimeric Antigen Receptor TCell Therapy Lisocabtagene Maraleucel,#Memory,Positive
 AntiCD Chimeric Antigen Receptor TCell Therapy Lisocabtagene Maraleucel,Lymphoma Papers,Negative
 AntiCD Chimeric Antigen Receptor TCell Therapy Lisocabtagene Maraleucel,TumorImmunoPapers,Negative
 venetoclax,OncLive.com,Positive
 venetoclax,OncLive SOSS,Positive
 venetoclax,"Mark Geyer, M.D.",Negative
 venetoclax,Lung Cancer News,Negative
 venetoclax,"Michael Wang, MD",Negative
 venetoclax,CheckRare,Negative
 venetoclax,Paperbirds_Hematology,Positive
 venetoclax,Targeted Oncology,Positive
 venetoclax,Blood Journal,Positive
 venetoclax,JADPRO,Negative
 venetoclax,OncologyNurseAdvisor,Negative
 venetoclax,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 venetoclax,Pietro Di Ciaccio,Positive
 venetoclax,Medivizor,Positive
 venetoclax,European Pharmaceutical Review,Positive
 venetoclax,LYMPHOMA & MYELOMA CONNECT,Negative
 venetoclax,Lymphoma Hub,Positive
 venetoclax,Lymphoma Papers,Positive
 venetoclax,Michael O'Dwyer,Positive
 venetoclax,Blood Advances,Negative
 venetoclax,ASCO Publications,Negative
 venetoclax,Journal of Clinical Pathways,Negative
 venetoclax,VJHemOnc,Positive
 venetoclax,ASH Clinical News,Positive
 venetoclax,Taylor Lab UM,Negative
 venetoclax,Biotech2050,Positive
 venetoclax,Patient Power,Negative
 venetoclax,COPD News,Positive
 venetoclax,Oncology Learning Network,Positive
 venetoclax,Barry Shrier,Negative
 venetoclax,"Amber Koehler, PA-C",Positive
 venetoclax,Faheema Hasan,Positive
 venetoclax,Toby Eyre,Positive
 venetoclax,Stock Sharks,Positive
 venetoclax,Hottest Stocks Now,Negative
 venetoclax,Simple Charts,Negative
 venetoclax,VPO/PR Newswire,Positive
 venetoclax,"chadi nabhan MD, MBA, FACP",Positive
 venetoclax,pressdaily,Negative
 venetoclax,"Mazyar Shadman, MD MPH",Negative
 venetoclax,Benlazar S.M Amin√©,Positive
 venetoclax,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Positive
 venetoclax,HemOnc Today,Negative
 venetoclax,Healio,Negative
 venetoclax,"Dr T. Comeau , MD",Negative
 venetoclax,Izaskun Zeberio,Positive
 venetoclax,"Raul Cordoba, MD, PhD",Negative
 venetoclax,NCICancerTrials,Positive
 venetoclax,Hematology Advisor,Negative
 venetoclax,ADIL Med Monitor,Positive
 venetoclax,Charlotte Martin,Positive
 venetoclax,Oncology Nursing News,Negative
 venetoclax,NEJM,Negative
 venetoclax,Roy Tindle,Positive
 venetoclax,LIVINGSTRONGTV.COM,Positive
 venetoclax,YoBuzz,Positive
 venetoclax,BeyondIgY‚Ñ¢,Positive
 venetoclax,MedPipeline,Negative
 venetoclax,CellworksLife,Positive
 venetoclax,vshariharakrishnan,Positive
 venetoclax,Mazen M,Negative
 venetoclax,emilylevitch_i3Health,Positive
 venetoclax,Snowdome Foundation,Positive
 venetoclax,A Nasser Nourallah. MD.FASCO,Positive
 venetoclax,Lisa Astor,Negative
 venetoclax,Eduardo Flavio Oliveira Ribeiro,Negative
 venetoclax,Florent Malard,Negative
 venetoclax,Milo≈° Miljkoviƒá,Positive
 venetoclax,Dr Timos Papagatsias,Negative
 venetoclax,Medscape Oncology,Negative
 venetoclax,WCM Lymphoma,Positive
 venetoclax,DDNews Online,Negative
 venetoclax,Blood Cancer UK Research,Negative
 venetoclax,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 venetoclax,S.K.,Positive
 venetoclax,Susan Ehret,Positive
 venetoclax,Elaine Schattner,Negative
 venetoclax,Rare Disease Report,Positive
 venetoclax,CLL Ireland,Positive
 venetoclax,"Liseth M Parra, PhD",Positive
 venetoclax,Kerri Wachter,Negative
 venetoclax,christopher franskin,Positive
 venetoclax,Financial Buzz,Negative
 venetoclax,Autotestdrivers.com,Positive
 venetoclax,TalkingScarsMedia.com,Positive
 venetoclax,Crwe World,Negative
 venetoclax,ShareHRnews,Positive
 venetoclax,CRE Demographics,Negative
 venetoclax,RazzleTazzle,Negative
 venetoclax,Biedex Markets,Positive
 venetoclax,Cancer_Tribune,Negative
 venetoclax,Nick,Negative
 venetoclax,ACRF,Positive
 venetoclax,Leukaemia Care,Negative
 venetoclax,Haybury,Positive
 venetoclax,AU Oncology Reviews,Positive
 venetoclax,CADTH,Positive
 venetoclax,Cancer Papers,Negative
 venetoclax,Ana Rosa Rubio,Positive
 venetoclax,The James,Negative
 venetoclax,"Chaitra Ujjani, MD",Positive
 venetoclax,Katie Gould,Positive
 venetoclax,ASH,Negative
 venetoclax,Lymphoma Canada,Negative
 venetoclax,CancerTherapyAdvisor,Negative
 venetoclax,Dr Jobin Shaeri,Positive
 venetoclax,American Cancer Society,Positive
 venetoclax,Gitte Pedersen,Positive
 venetoclax,"David Woessner, PhD",Positive
 venetoclax,New Drug Approvals,Negative
 venetoclax,Drugs.com,Negative
 venetoclax,Donna Young,Negative
 venetoclax,Michael | È∫¶ÂÖãÂÑø,Positive
 venetoclax,Senology,Positive
 venetoclax,Stan Whittaker,Positive
 venetoclax,Chan Cheah,Negative
 venetoclax,CP Graduate Academy,Positive
 venetoclax,Scott Werntz,Negative
 Second generation BTK inhibitors,ALI ALAHMARI.,Negative
 anti‚Äêfungal response,ALI ALAHMARI.,Negative
 neutrophils,ALI ALAHMARI.,Negative
 CLL patients acalabrutinib,ALI ALAHMARI.,Negative
 Benjamin L Lampson MD PhD,OncLive.com,Negative
 Acalabrutinib Triplet Impresses,Crwe World,Negative
 Acalabrutinib Triplet Impresses,OncLive.com,Negative
 Frontline CLL Advances,Crwe World,Negative
 Frontline CLL Advances,OncLive.com,Negative
 III Study,Crwe World,Negative
 III Study,OncLive.com,Negative
 III Study,"Dr T. Comeau , MD",Negative
 III Study,Eduardo Flavio Oliveira Ribeiro,Negative
 III Study,ClinOwl Haematology,Negative
 III Study,Miriam L√≥pez P√©rez,Positive
 III Study,Juan Marquet,Negative
 III Study,ALI ALAHMARI.,Negative
 III Study,ClinOwl,Positive
 III Study,JAVIER DE LA SERNA,Positive
 III Study,Benlazar S.M Amin√©,Negative
 III Study,filippo masini,Negative
 III Study,Paperbirds_Hematology,Negative
 III Study,INDoximity üáÆüá≥,Negative
 III Study,Progetto Odin,Positive
 Dr Sharman,Targeted Oncology,Positive
 Dr Sharman,CLL Society Inc.,Negative
 Dr Sharman,Patient Power,Negative
   Lori Leslie MD,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 John Theurer Cancer Center,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 realworld data,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 realworld data,iwCLL,Negative
 realworld data,AJMC,Negative
 realworld data,"chadi nabhan MD, MBA, FACP",Negative
 ‚úÖ Tyrosine Kinase Inhibitors,PharmaFactz,Negative
 Prefix inibImatinib,PharmaFactz,Negative
 CML,PharmaFactz,Negative
 CML,BloodCancerCure,Negative
 CML,leukemia,Negative
 CML,CancerSystemsBiology,Positive
 Overall Dr Sharman,Targeted Oncology,Negative
 utilization,OncLive SOSS,Negative
 ¬ø,#SiguemeYTeSigoDeVuelta,Positive
 ¬ø,datahack,Positive
 o,#SiguemeYTeSigoDeVuelta,Positive
 o,Mauricio Ambriz,Positive
 o,Professione Farmacia,Negative
 o,Medical Evidence üáÆüáπ,Negative
 o,News Farma,Positive
 o,Medivizor,Negative
 enfermedades,#SiguemeYTeSigoDeVuelta,Positive
 se prescribe el Acalabrutinib,#SiguemeYTeSigoDeVuelta,Positive
 frontline patients,Toby Eyre,Negative
   era,Toby Eyre,Negative
   era,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
   era,Sumit Middha,Positive
 VIDEO Acalabrutinib venetoclax,VJHemOnc,Negative
 phase II trial,NatureRevClinOncol,Positive
 phase II trial,Toby Eyre,Negative
 phase II trial,Lymphoma Hub,Negative
 phase II trial,WCM Lymphoma,Negative
 phase II trial,Patient Power,Negative
 phase II trial,CLL Ireland,Negative
 phase II trial,Targeted Oncology,Negative
 phase II trial,Clarivate Cortellis,Negative
 ORR,NatureRevClinOncol,Positive
 ORR,Toby Eyre,Negative
 ORR,Lysa Lymphoma,Positive
 ORR,OncLive.com,Positive
 ORR,Graham Collins,Positive
 ORR,Carla Casulo,Positive
 ORR,T Allen,Positive
 ORR,"Raul Cordoba, MD, PhD",Positive
 ORR,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Positive
 ORR,Targeted Oncology,Negative
 ORR,Joe Hedden,Negative
 ORR,Crwe World,Negative
 ORR,Pharma News,Negative
 ORR,Chan Cheah,Negative
 ORR,Anna Deveau,Negative
 ORR,Juno Therapeutics,Positive
 ORR,Sandra Kear,Positive
 Acalabrutinib Monotherapy,Value-Based Cancer Care,Negative
 Acalabrutinib Monotherapy,The Lynx Group,Positive
 Acalabrutinib Monotherapy,Saeed Valadbaygi,Negative
 Acalabrutinib Monotherapy,Oncology Tube,Positive
 Acalabrutinib Monotherapy,OncLive.com,Positive
 RelapsedRefractory CLL Month,Value-Based Cancer Care,Negative
 FollowUp,Value-Based Cancer Care,Negative
 FollowUp,Saeed Valadbaygi,Negative
 FollowUp,OncLive.com,Negative
 FollowUp,Mahmoud Aljurf,Negative
 FollowUp,CancerWallonia,Negative
 New IWMF Acalabrutinib,IWMF,Positive
 Updated Rituximab Fact Sheets,IWMF,Positive
 TreatmentNaive RelapsedRefractory Chronic Lymphocytic Leukemia,JAVIER DE LA SERNA,Positive
 TreatmentNaive RelapsedRefractory Chronic Lymphocytic Leukemia,Paperbirds_Hematology,Negative
 TreatmentNaive RelapsedRefractory Chronic Lymphocytic Leukemia,Garbi√±e Lizeaga,Negative
 student Krista Isaac,Anthony Mato,Negative
 ELEVATE TN Study,Oncology Tube,Negative
 Washington,Oncology Tube,Negative
 Washington,"David Bartlett, PhD",Negative
 Obinutuzumab Superior,The ASCO Post,Negative
 Chlorambucil,The ASCO Post,Positive
 Chlorambucil,Jeff Sharman,Positive
 Chlorambucil,Aloysius Pendergast,Positive
 Chlorambucil,TrialBulletin,Positive
 Chlorambucil,CureHuntr,Positive
 Chlorambucil,Biotech2050,Positive
 Chlorambucil,Doctors*Overseas,Negative
 Chlorambucil,Oncology,Negative
 Chlorambucil,Seattle's Banker,Positive
 Chlorambucil,Sicilia Informazioni,Positive
 Chlorambucil,RazzleTazzle,Negative
 Chlorambucil,Cancer Papers,Negative
 Chlorambucil,Hottest Stocks Now,Negative
 Chlorambucil,Christopher Steer,Positive
 Chlorambucil,Invest World News,Negative
 Chlorambucil,Mohammed Saied Faraj,Positive
 FrontLine Treatment,The ASCO Post,Positive
 March issue Acalabrutinib,Cancer Discovery,Negative
 receipt,Motilal Oswal Financial Services Ltd,Positive
 launch,Motilal Oswal Financial Services Ltd,Negative
 launch,OGT,Negative
 launch,MedGenome,Positive
 launch,CLL Ireland,Negative
 launch,CLLSA,Positive
 launch,BizDirect,Positive
 Acalabrutinib mg,Motilal Oswal Financial Services Ltd,Negative
 DCGI nod,Medical Dialogues,Positive
 CalquenceAcalabrutinib mg capsules pharmaindia controllergeneralofindia capsules leukaemia,Medical Dialogues,Positive
 Trend,the paper link,Positive
 et al J,the paper link,Positive
 Bruton tyrosine kinase inhibitor acalabrutinib,the paper link,Positive
 DCGI,IIFLMarkets,Negative
 DCGI,EquityBulls.com,Positive
 Trend new,the paper link,Negative
 AstraZeneca Pharma India Ltd,Dr Timos Papagatsias,Negative
 AstraZeneca Pharma India Ltd,EquityBulls.com,Positive
 permission,Dr Timos Papagatsias,Negative
 permission,EquityBulls.com,Positive
 DCGI   Equity Bulls,Dr Timos Papagatsias,Negative
 Hi dr,Dr. Luis Villela,Positive
 TAG   AusPAR Acalabrutinib,AUS Gov. News,Positive
 SLL,TGA Australia,Negative
 SLL,PressReleasePoint,Negative
 SLL,Daniel Garcia Estrada (Retire),Positive
 SLL,Medscape Pharmacists,Negative
 SLL,Times of Newsüê¶,Positive
 SLL,ClinicalOncologyNews,Negative
 SLL,Medscape,Negative
 SLL,CellworksLife,Negative
 SLL,Medscape Oncology,Negative
 SLL,Fav-store,Negative
 SLL,FA Technologies,Positive
 SLL,Medical Xpress,Negative
 SLL,ALI ALAHMARI.,Negative
 SLL,"Junaid ""Jay"" Abdulghani, MD PhD",Positive
 SLL,FDA Daily,Negative
 SLL,HCP Feed,Negative
 SLL,Pharm Digest,Negative
 SLL,The Oncologist,Negative
 SLL,Lisa Astor,Negative
 SLL,Phil Talamo,Negative
 SLL,Jacob Bell,Positive
 SLL,Lymfklierkanker VV vzw,Positive
 SLL,LYMPHOMA & MYELOMA CONNECT,Negative
 SLL,TrialBulletin,Negative
 SLL,Paperbirds_Hematology,Negative
 SLL,Lymphoma Hub,Negative
 SLL,Oncology Learning Network,Positive
 SLL,Michele Nadeem-Baker,Negative
 SLL,CLL_Fightersüéó,Negative
 SLL,Blood Journal,Negative
 SLL,Odi Bruckman,Negative
 SLL,Dr. Andy Evens,Negative
 SLL,MDedge Hematology & Oncology,Positive
 SLL,Lampe & Company,Negative
 SLL,"Neil Sankar M.D.,MPH",Positive
 SLL,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Positive
 SLL,ËÖ´Áò§Â≠∏Êñ∞Áü• | Cancer Informer,Positive
 SLL,Targeted Oncology,Negative
 SLL,S.K.,Positive
 SLL,Susan Ehret,Positive
 SLL,Elaine Schattner,Negative
 SLL,CLL Ireland,Negative
 SLL,"A. Emre E≈ükazan, MD ü©∏üî¨",Positive
 SLL,Leukemia Research Foundation,Negative
 SLL,Diaceutics PLC,Negative
 SLL,The ASCO Post,Negative
 SLL,Lymphomation.org,Negative
 SLL,"Nadia Naumova, MD",Positive
 WATCH Dr Awan,OncLive.com,Negative
 Utilizing Acalabrutinib,OncLive.com,Negative
 Dr Ryan,Targeted Oncology,Positive
 physicians,Targeted Oncology,Positive
 physicians,"Pharmacyclics, an AbbVie Company",Positive
 physicians,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 physicians,Oncology Tube,Negative
 physicians,Dr. Melody Davis,Negative
 physicians,Brotman Baty,Positive
 physicians,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 physicians,"Rustin M. Moore, DVM, PhD",Positive
 physicians,"John P. Leonard, MD",Positive
 realworld,Targeted Oncology,Positive
 realworld,VJHemOnc,Negative
 setting,Targeted Oncology,Positive
 setting,Paperbirds_Hematology,Negative
 Acalabrutinib Shows Promise,RD360,Positive
 Acalabrutinib Shows Promise,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Positive
 Acalabrutinib Shows Promise,Targeted Oncology,Negative
 Acalabrutinib Shows Promise,Lymphoma Canada,Negative
 RelapsedRefractory Mantle Cell Lymphoma,RD360,Positive
 RelapsedRefractory Mantle Cell Lymphoma,Lymphoma Papers,Negative
 RelapsedRefractory Mantle Cell Lymphoma,Paperbirds_Hematology,Negative
 RelapsedRefractory Mantle Cell Lymphoma,clinicaltherapeutics,Negative
 RelapsedRefractory Mantle Cell Lymphoma,U-M Rogel Cancer Center,Negative
 RelapsedRefractory Mantle Cell Lymphoma,Bitchin' Science,Positive
 RelapsedRefractory Mantle Cell Lymphoma,Stock Market News,Negative
 RelapsedRefractory Mantle Cell Lymphoma,Sarang Pokhare,Negative
 RelapsedRefractory Mantle Cell Lymphoma,IMPharma News,Negative
 RelapsedRefractory Mantle Cell Lymphoma,Latest News from Business Wire,Negative
 RelapsedRefractory Mantle Cell Lymphoma,Wellcome-home,Negative
 RelapsedRefractory Mantle Cell Lymphoma,DennisPartners,Negative
 RelapsedRefractory Mantle Cell Lymphoma,Stock Titan,Negative
   Project Orbis FDA,PressReleasePoint,Negative
 Trial Coordinator Bec,TAP Clinical Trial Network,Negative
 site,TAP Clinical Trial Network,Negative
 site,Graham Collins,Negative
 site,VJHemOnc,Negative
 site,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 SIV,TAP Clinical Trial Network,Negative
 II randomised study,TAP Clinical Trial Network,Negative
 New   article,Journal for ImmunoTherapy of Cancer,Positive
 New   article,ASCO Publications,Negative
 New   article,ACS Journal Cancer,Negative
 cell lymphoma,TGA Australia,Negative
 amp   colleagues,Anirban Maitra,Negative
 randomized trial,Anirban Maitra,Negative
 randomized trial,"David Steensma, MD",Positive
 BTK inhibitor Acalabrutinib v combo,Anirban Maitra,Negative
 Pembro,Anirban Maitra,Negative
 Pembro,Paulo G Bergerot,Positive
 number,OncLive.com,Negative
 number,DRG Epidemiology,Negative
 number,Breaking Data,Negative
 number,Hematology Advisor,Positive
 number,Lymphoma Hub,Negative
 number,HARMONY Alliance,Negative
 number,"Mazyar Shadman, MD MPH",Negative
 number,Tania Jayesuria,Positive
 number,Biotech2050,Negative
 number,Wilmot Cancer Institute,Negative
 number,NaturesZestNutrition,Positive
 number,CancerEpiPapers,Negative
 number,Andrew Schorr,Negative
 number,Amin G T Amin,Positive
 number,Paul Brennan (He/His),Positive
 number,Pharma Models,Positive
 number,Lymphomation.org,Negative
 Jennifer Woyach MD,OncLive.com,Positive
 Jennifer Woyach MD,OncLive SOSS,Positive
 Jennifer Woyach MD,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Jennifer Woyach MD,COPD News,Negative
 Jennifer Woyach MD,Cancer News,Negative
 Jennifer Woyach MD,CLL Ireland,Negative
 advances,OncLive.com,Negative
 advances,"Michael Wang, MD",Negative
 advances,RedMedEd,Positive
 advances,OncLive SOSS,Negative
 advances,Patient Empowerment Network,Negative
 advances,"Pharmacyclics, an AbbVie Company",Negative
 advances,Nick,Negative
 advances,Marilyn Heine,Positive
 advances,Andrew Schorr,Negative
 advances,VJHemOnc,Negative
 advances,Lymphoma Hub,Negative
 frontline,OncLive.com,Negative
 frontline,Phillip Scheinberg,Positive
 frontline,"Amber Koehler, PA-C",Negative
 frontline,"chadi nabhan MD, MBA, FACP",Positive
 frontline,Adriana Bello,Positive
 frontline,"Eric K. Singhi, MD",Positive
 frontline,Toby Eyre,Negative
 frontline,Lymphoma Hub,Negative
 frontline,CLL Society Inc.,Positive
 frontline,ASH Clinical News,Negative
 frontline,Patient Power,Negative
 frontline,Abdel-Wahab Lab,Positive
 frontline,Targeted Oncology,Negative
 frontline,VJHemOnc,Positive
 frontline,MDedge Hematology & Oncology,Negative
 frontline,"Caner Saygin, MD",Positive
 frontline,Carmine DeLuca,Negative
 frontline,FarmaOnco,Negative
 frontline,Francesco Turturro,Negative
 frontline,"Raul Cordoba, MD, PhD",Negative
 frontline,TumorImmunoPapers,Negative
 frontline,Chan Cheah,Negative
 strategies,OncLive.com,Negative
 strategies,MD Anderson Cancer Center,Negative
 strategies,ESH (Haematology),Negative
 strategies,Prof John,Negative
 strategies,Patient Power,Negative
 strategies,CLL Society Inc.,Negative
 strategies,Expert Perspectives in Oncology,Negative
 strategies,ASH,Negative
 strategies,Francesco Turturro,Negative
 space,OncLive.com,Negative
 space,BioAscend,Positive
 space,Kenneth M. Garofalo,Positive
 space,Targeted Oncology,Negative
 space,Wolverhampton LTT,Positive
 Todays,Scitrus,Positive
 Todays,i3 Health,Negative
 Todays,HARMONY Alliance,Negative
 Todays,finnCap,Positive
 Todays,CLLSA,Negative
 Todays,GodisGreat,Positive
 Todays,Los Lobos,Positive
 Jeff Sharman MD,Oncology Learning Network,Negative
 Jeff Sharman MD,Oncology Tube,Negative
 Jeff Sharman MD,i3 Health,Positive
 Jeff Sharman MD,Journal of Clinical Pathways,Negative
 ELEVATE TN trial,Oncology Learning Network,Negative
 ELEVATE TN trial,LYMPHOMA & MYELOMA CONNECT,Negative
 ELEVATE TN trial,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Listen,Oncology Learning Network,Positive
 Listen,SiriusXM FC 157 ‚öΩÔ∏èüìª,Negative
 RealWorld Analysis Explores Current Role,"Raul Cordoba, MD, PhD",Negative
 Mantle cell,"Raul Cordoba, MD, PhD",Negative
 Mantle cell,Medicine For World,Negative
 interview,Targeted Oncology,Positive
 interview,i3 Health,Negative
 interview,Sarah Williams,Positive
 interview,medwireNews,Negative
 interview,CURE Magazine,Positive
 interview,Lymphoma Hub,Positive
 interview,Taylor Lab UM,Negative
 interview,VJHemOnc,Positive
 interview,Andrew Schorr,Positive
 interview,CELLINK,Positive
 interview,emilylevitch_i3Health,Positive
 interview,MDEdge,Negative
 interview,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 interview,Cancer News,Negative
 interview,MD Anderson Cancer Center,Negative
 interview,Krista Rossi,Positive
 interview,CLL_Fightersüéó,Negative
 interview,HARMONY Alliance,Negative
 interview,CLL Ireland,Positive
 interview,Higher Ground at Lake Louise,Negative
 interview,NE Live,Positive
 interview,Clin Adv Hem Onc,Negative
 interview,Senior Care Corner,Positive
 CLL acalabrutinib,Targeted Oncology,Negative
 acalabrutinib patients,Targeted Oncology,Negative
   „ÇÇÂâ§„ÅÆÊôÇ‰ª£„Åå,Shohta Kadomura Hospital Pharmacist,Negative
 Therapy,Shohta Kadomura Hospital Pharmacist,Negative
 Therapy,Paperbirds_Hematology,Positive
 Therapy,Seema Ali Bhat,Positive
 Therapy,AJMC,Negative
 Therapy,Mayo Clinic Cancer Center,Negative
 Therapy,gilbert c faure,Negative
 Therapy,Francesco Bertoni,Negative
 Therapy,Juan Marquet,Negative
 Therapy,Robert Z. Orlowski,Negative
 Therapy,MD Anderson Leukemia,Negative
 Therapy,CAR-TCR,Positive
 Therapy,Ritesh Patil,Negative
 Therapy,RK,Positive
 Therapy,Benlazar S.M Amin√©,Negative
 Therapy,"Raul Cordoba, MD, PhD",Positive
 Therapy,CellworksLife,Negative
 Therapy,CancerWallonia,Negative
 Therapy,Medscape Education,Negative
 Therapy,dorothy cook,Negative
 Therapy,CLL Ireland,Negative
 Therapy,Journal of Preventive Medicine,Positive
 Therapy,Katia Davis,Negative
 Therapy,Katia Zevelekakis,Negative
 Therapy,Malakistan,Positive
 Therapy,pinmania,Positive
 Therapy,Medicine Matters oncology,Positive
 Therapy,Ayobami Seun,Positive
 Therapy,Danilo Menezes,Positive
 Therapy,CML AdvocatesNetwork,Negative
 Therapy,News World,Positive
 Therapy,Michele Nadeem-Baker,Negative
 Therapy,Health News Center,Positive
 Therapy,jt120651,Positive
 Therapy,SysFlash,Positive
 TreatmentNa√Øve Chronic Lymphocytic Leukemia,Shohta Kadomura Hospital Pharmacist,Negative
 TreatmentNa√Øve Chronic Lymphocytic Leukemia,"Raul Cordoba, MD, PhD",Negative
 Acalabrutinib Monotherapy Active,Saeid Shamsian MD,Negative
 Oncology Learning Network,Saeid Shamsian MD,Positive
 Inhibidores de BTK BTK,JDiegoTR,Positive
 tirosina quinasa de Bruton Desempe√±a un papel central,JDiegoTR,Positive
 maduraci√≥n,JDiegoTR,Positive
 de las c√©lulas B Ejemplos acalabrutinib Calquence Indicaci√≥n,JDiegoTR,Positive
 Efectos secundarios,JDiegoTR,Positive
 trombocitopenia,JDiegoTR,Positive
 leucopenia,JDiegoTR,Positive
 anemia,JDiegoTR,Positive
 anemia,Patient Power,Positive
 fatiga,JDiegoTR,Positive
 Dolor de cabeza,JDiegoTR,Positive
 √∂mmacroglobulinemia,Benlazar S.M Amin√©,Positive
 Waldenstr√∂m macroglobulinemia,Lymphoma Papers,Negative
 Waldenstr√∂m macroglobulinemia,Lia Palomba,Positive
 Waldenstr√∂m macroglobulinemia,Lysa Lymphoma,Positive
 Waldenstr√∂m macroglobulinemia,OncLive.com,Negative
 singlearm multicentre phase,Lymphoma Papers,Negative
 singlearm multicentre phase,Lia Palomba,Positive
 Pharmacodynamic analysis,Cure Cancer Now,Negative
 BTK inhibition,Cure Cancer Now,Negative
 BTK inhibition,Toby Eyre,Negative
 BTK inhibition,Expert Perspectives in Oncology,Negative
 BTK inhibition,Broad Institute,Positive
   triplet regimen,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 acalabrutinib venetoclax,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 acalabrutinib venetoclax,ASH Clinical News,Negative
 acalabrutinib venetoclax,OncLive.com,Negative
 acalabrutinib venetoclax,Targeted Oncology,Negative
 acalabrutinib venetoclax,"Amber Koehler, PA-C",Negative
 acalabrutinib venetoclax,Lymphoma Hub,Negative
 frontline therapy,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 frontline therapy,OncLive.com,Positive
 frontline therapy,Benlazar S.M Amin√©,Negative
 frontline therapy,Oncology Nursing News,Negative
 frontline therapy,Lymphoma Papers,Negative
 frontline therapy,Paperbirds_Hematology,Negative
 frontline therapy,Robert Z. Orlowski,Negative
 frontline therapy,Bioengineer.org,Positive
 frontline therapy,info-over-kanker,Positive
 frontline therapy,Roy Tindle,Positive
 frontline therapy,Mazen M,Negative
 frontline therapy,Muiro Yatakama,Positive
 frontline therapy,LIVINGSTRONGTV.COM,Positive
 frontline therapy,Science Codex,Negative
 frontline therapy,Science and Technology News,Positive
 frontline therapy,YoBuzz,Negative
 frontline therapy,Art Fridrich,Positive
 frontline therapy,BeyondIgY‚Ñ¢,Positive
 frontline therapy,"Amber Koehler, PA-C",Positive
 frontline therapy,Targeted Oncology,Negative
 frontline therapy,Lymphoma Hub,Negative
 frontline therapy,CancerTherapyAdvisor,Negative
 frontline therapy,ACS Journal Cancer,Negative
 frontline therapy,"Naveen Pemmaraju, MD",Negative
 WATCH Dr Davids,OncLive.com,Positive
 Exciting Data,OncLive.com,Negative
   yo Pt,Juan Lopez-Mattei,Positive
 htn paroxysmal AF SAVR gt,Juan Lopez-Mattei,Positive
 AntiCD CAR Tcell Therapy,Renal Cell Carcinoma,Negative
 Bcell Lymphoma,Renal Cell Carcinoma,Negative
 III trial,Renal Cell Carcinoma,Negative
 III trial,ASH Clinical News,Negative
 III trial,Lymphoma Hub,Positive
 III trial,Targeted Oncology,Negative
 axicabtagene ciloleucel,Renal Cell Carcinoma,Negative
 Bcell lymphoma Acalabrutinib,Renal Cell Carcinoma,Negative
 VIDEO Resistance,VJHemOnc,Negative
 BTK mutations w Jennifer Woyach,VJHemOnc,Negative
 VIDEO ELEVATETN approval,VJHemOnc,Negative
 adult CLL w,VJHemOnc,Negative
 BTK inhibitors novel combinations,OncLive.com,Negative
 treatmentnaive,Hematology Advisor,Negative
 discusses,ClinicalOncologyNews,Negative
 discusses,OncLive SOSS,Positive
 discusses,Patient Empowerment Network,Negative
 discusses,VJHemOnc,Positive
 discusses,Journal of the @NCCN,Negative
 discusses,CLL Ireland,Negative
 discusses,Sarah Williams,Positive
 discusses,Ravi A Madan M.D.,Positive
 discusses,Patient Power,Positive
 discusses,David A. Cohen,Negative
 discusses,OncLive.com,Negative
 ELEVATE TN results,ClinicalOncologyNews,Negative
 benefits,ClinicalOncologyNews,Negative
 benefits,Winship Cancer Institute of Emory University,Negative
 benefits,Georgetown Lombardi,Positive
 benefits,1stOncology,Negative
 benefits,Rare Disease Report,Negative
 benefits,VJHemOnc,Negative
 benefits,Med-IQ,Negative
 benefits,AJMC,Negative
 benefits,Spud Lovr,Positive
 benefits,ASCO,Negative
 CLL Exciting times,Adam Kittai,Negative
 Timelimited frontline therapy,ASH Clinical News,Negative
 rates,ASH Clinical News,Negative
 rates,Matthew P. Cheng,Positive
 update,LymphomaAction,Negative
 update,Future Oncology,Positive
 update,Paperbirds_Hematology,Positive
 update,EurekaMag,Negative
 update,CheckRare,Negative
 update,Patient Power,Positive
 update,The Lancet Haematology,Negative
 update,Lymphoma Hub,Negative
 update,Michael Rynne,Negative
 update,"Jose Sandoval S, MD FACP",Positive
 update,sganguly,Positive
 update,AplusA World,Negative
 update,Anna Deveau,Negative
 update,CLLSA,Negative
 update,dough,Negative
 update,El tal Toni üéó#JoActuo #LlibertatPresosPolitics,Positive
 update,CancerCare,Negative
 update,Andrew Schorr,Negative
 update,Lymphomation.org,Negative
 update,Moffitt Research,Positive
 months,LymphomaAction,Positive
 months,NatureRevClinOncol,Negative
 months,Philly Bio,Negative
 months,Journal of Leukocyte Biology,Positive
 months,"Mazyar Shadman, MD MPH",Negative
 months,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 months,The Lancet Haematology,Negative
 months,Lymphoma Hub,Positive
 months,Hematologia ICO Hospitalet,Positive
 months,Dr Tony Truong,Positive
 months,Toby Eyre,Negative
 months,"Raul Cordoba, MD, PhD",Negative
 months,Pamela Combs,Positive
 months,CLLSA,Negative
 months,Dr. Melody Davis,Negative
 months,Scot Walker,Positive
 months,Pippa Jones,Positive
 months,MedChem & ONCo,Negative
 months,I Am Biotech,Positive
 months,ASH Clinical News,Negative
 trial acalabrutinib,"Early Phase Clinical Trials Unit, Oxford",Positive
 RCHOP,"Early Phase Clinical Trials Unit, Oxford",Positive
 RCHOP,Renal Cell Carcinoma,Positive
 RCHOP,ÕèWilliam Avery Hudson,Negative
 RCHOP,Oncology Tube,Negative
 RCHOP,VJHemOnc,Negative
 L DLBCL PhIII,"Early Phase Clinical Trials Unit, Oxford",Positive
 Tussle,"Early Phase Clinical Trials Unit, Oxford",Positive
 Southampton amp Oxford,"Early Phase Clinical Trials Unit, Oxford",Positive
 RealWorld Study Defines Acalabrutinib Users,AONN+,Negative
 FDA nod,Braeden Lichti,Positive
 FDA nod,David Ledger,Negative
 FDA nod,Bio_Talent,Negative
 FDA nod,Dr. Carsten Wenzel,Negative
 FDA nod,PharmaTimes,Negative
 FDA nod,Saleh Stevens,Negative
 FDA nod,Claude Waddington,Positive
 FDA nod,DR.ARUN ACHUTHAN,Negative
 FDA nod,Pharma Regulatory,Negative
 FDA nod,MedFirst - MedComms,Positive
 FDA nod,Pharmacy News & Research,Positive
 FDA nod,Lung Cancer News,Negative
 PhramaTimes,Braeden Lichti,Positive
 Responses,The Lynx Group,Positive
 Responses,"Mike Thompson, MD, PhD, FASCO",Negative
 Responses,The ASCO Post,Negative
 Responses,Cancer clinical trials,Positive
 Responses,OncLive.com,Negative
 Responses,Lymphoma Canada,Negative
 Responses,Francesco Turturro,Negative
 Phase III ELEVATE TN Trial,Oncology Tube,Negative
 III ELEVATE TN trial,Oncology Tube,Negative
 III ELEVATE TN trial,Benlazar S.M Amin√©,Negative
 American Society,Leukaemia Care,Negative
 American Society,EuropaWire,Negative
 American Society,Shouting at people in my underpants,Negative
 American Society,"Raul Cordoba, MD, PhD",Positive
 American Society,Pharma News,Negative
 American Society,IMPharma News,Negative
 American Society,"OTC Dynamics, Inc.",Negative
 American Society,Stock Titan,Negative
 American Society,Current Oncology,Negative
 American Society,Lymphoma Papers,Negative
 American Society,Paperbirds_Hematology,Negative
 American Society,gilbert c faure,Negative
 American Society,Yasin Murat Yiƒüit,Positive
 American Society,Patient Power,Negative
 American Society,Leukemia Research Foundation,Negative
 Hematology ASH,Leukaemia Care,Negative
 Hematology ASH,Diagnostics News,Negative
 Evaluating acalabrutinib,Medivizor,Negative
 New Evaluating acalabrutinib,Medivizor,Negative
 Lancet Haematology,Lia Palomba,Positive
 Lancet Haematology,Biotech & Tech Stock Focus,Negative
 Lancet Haematology,Dan Brickner,Positive
 Lancet Haematology,Stock News Bot,Positive
 Lancet Haematology,Stock Titan,Negative
 Disease Progression,Oncology Tube,Negative
 Disease Progression,Cancer News,Negative
 Disease Progression,Trading News,Positive
 Disease Progression,Latest News from Business Wire,Positive
 Disease Progression,Investor News,Negative
 Disease Progression,Mazen M,Negative
 Disease Progression,Crwe World,Positive
 Disease Progression,Paperbirds_Hematology,Positive
 Disease Progression,DR.ARUN ACHUTHAN,Negative
 Disease Progression,Medicare Consumer,Positive
 Disease Progression,Health|VBProfiles,Positive
 Disease Progression,Business Wire-Health,Negative
 Disease Progression,Business Wire-TS,Negative
 Disease Progression,BusinessWireConsumer,Positive
 Disease Progression,The Pharmaceutical Marketing Group,Negative
 Disease Progression,Lisa Palacios,Negative
 Disease Progression,MD Anderson Leukemia,Negative
 Disease Progression,Carolyn Thompson,Negative
 Disease Progression,1stOncology,Negative
 Death,Oncology Tube,Negative
 Death,Cancer News,Negative
 Death,Trading News,Positive
 Death,Latest News from Business Wire,Negative
 Death,Investor News,Negative
 Death,R Marcos-Gragera üéó,Positive
 Death,PressReleasePoint,Negative
 Death,1stOncology,Negative
 Death,The Pharmaceutical Marketing Group,Positive
 Death,Financial Buzz,Negative
 Death,T Allen,Positive
 Death,Crwe World,Negative
 Death,Armando Guglielmetti,Negative
 Death,Health|VBProfiles,Positive
 Death,Business Wire-Health,Negative
 Death,Business Wire-TS,Negative
 Death,BusinessWireConsumer,Positive
 Death,Invest World News,Negative
 fuck outta,Quiet Flows the Dan,Positive
 Journal,ACIR.org,Positive
 Journal,"Dr T. Comeau , MD",Positive
 Journal,Miriam L√≥pez P√©rez,Positive
 Journal,Benlazar S.M Amin√©,Positive
 Journal,F. Hernandez Mohedo,Positive
 Journal,"Hayder Saeed, MD",Positive
 Journal,Enfermeria y Seguridad del Paciente,Positive
 Journal,CLL Ireland,Negative
 immunotherapy,ACIR.org,Positive
 immunotherapy,Paperbirds_Hematology,Negative
 immunotherapy,iMM,Positive
 immunotherapy,TumorImmunoPapers,Negative
 immunotherapy,TumImmTxpapers,Positive
 immunotherapy,Cure Cancer Now,Negative
 immunotherapy,Francesco Turturro,Negative
 digest,ACIR.org,Positive
 gt,ACIR.org,Positive
 gt,Doctors*Overseas,Negative
 gt,Virtute_USMLE,Negative
 macroglobulinemia de Waldenstr√∂m monoterapia con ACALABRUTINIB,Mauricio Ambriz,Positive
 activa con un,Mauricio Ambriz,Positive
 perfil de seguridad manejable en pacientes,Mauricio Ambriz,Positive
 refractariaLancet,Mauricio Ambriz,Positive
 Haematol,Mauricio Ambriz,Positive
 DOI,Mauricio Ambriz,Positive
 DOI,Benlazar S.M Amin√©,Negative
 IbII study,NatureRevClinOncol,Negative
 CLL ORRs,NatureRevClinOncol,Negative
 CRs,NatureRevClinOncol,Negative
 RR disease,NatureRevClinOncol,Negative
 RR disease,"Andrew Johns, MD",Positive
 grade toxicities,NatureRevClinOncol,Negative
 L,Toby Eyre,Positive
 L,Theriaque_officiel,Positive
 L,oncohebdo,Negative
 L,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 L,Lymphoma Hub,Negative
 L,Francesco Turturro,Negative
 UK CLL Forum Paper,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 monthAcalabrutinib,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 thoughts,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Positive
 thoughts,Journal of Blood Disorder and Treatment,Positive
 thoughts,"Pharmacyclics, an AbbVie Company",Positive
 thoughts,Sunitha Daniel,Positive
 thoughts,Toby Eyre,Negative
 thoughts,CLL Ireland,Negative
 thoughts,Patient Power,Negative
 thoughts,PeerView,Negative
 thoughts,Sigrid Sk√•nland,Negative
 thoughts,Expert Perspectives in Oncology,Positive
 thoughts,FriendsShow,Positive
 thoughts,WCM Lymphoma,Negative
 thoughts,ASCO,Negative
 thoughts,Andrew Schorr,Negative
 thoughts,Stephen Brown,Negative
 thoughts,Adaptive Biotech,Negative
 forum,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Positive
 st study,Lysa Lymphoma,Positive
 st study,Adam Kittai,Negative
 treatment na√Øve,Lysa Lymphoma,Positive
 treatment na√Øve,Benlazar S.M Amin√©,Negative
 RR patients,Lysa Lymphoma,Positive
 toxicities,Targeted Oncology,Negative
 toxicities,Duke Hematologic Malignancies & Cellular Therapy,Negative
 toxicities,SpecialtyPTimes,Negative
 toxicities,"chadi nabhan MD, MBA, FACP",Positive
 toxicities,"Raul Cordoba, MD, PhD",Positive
 toxicities,VJHemOnc,Negative
 nd gen Btk inhibitors acalabrutinib,Sujeet Kumar,Positive
 resultsof,Brian Mattys,Positive
 III ELEVATE TN studyof acalabrutinib,Brian Mattys,Positive
 update analysis,NatureRevClinOncol,Negative
 median DoR,NatureRevClinOncol,Negative
 Une perc√©e contre le type de leuc√©mie le,journal le soir,Positive
 r√©pandu,journal le soir,Positive
 AstraZeneca Canada,journal le soir,Positive
 AstraZeneca Canada,PharmaShots - Incisive news in 3 shots,Negative
 que √©,journal le soir,Positive
 Canada,journal le soir,Positive
 Canada,Medscape Pharmacists,Negative
 Canada,Medscape,Negative
 Canada,Medscape Oncology,Negative
 Canada,"Michael Wang, MD",Negative
 Canada,Breaking News,Negative
 Canada,Paperbirds_Hematology,Negative
 Canada,Current Oncology,Positive
 Canada,The PMI (Pharmaceutical Managers' Institute),Negative
 Canada,DennisPartners,Negative
 Canada,@MyelomaTeacher - Cindy Chmielewski,Negative
 Canada,Bill Both,Positive
 Canada,Ahmed Dahduli,Positive
 Canada,AbbVie Canada,Negative
 Canada,Patient Power,Negative
 Clinic Acalabrutinib,The ASCO Post,Negative
 Small Lymphocytic Lymphoma,The ASCO Post,Positive
 Small Lymphocytic Lymphoma,Shohta Kadomura Hospital Pharmacist,Negative
 Small Lymphocytic Lymphoma,Lung Cancer News,Positive
 Small Lymphocytic Lymphoma,Cancer News,Positive
 Small Lymphocytic Lymphoma,CureHuntr,Negative
 Small Lymphocytic Lymphoma,Bitchin' Science,Positive
 Small Lymphocytic Lymphoma,Stock Market News,Negative
 Small Lymphocytic Lymphoma,Pharmacutical Daily,Positive
 Small Lymphocytic Lymphoma,Sarang Pokhare,Negative
 Small Lymphocytic Lymphoma,IMPharma News,Positive
 Small Lymphocytic Lymphoma,Latest News from Business Wire,Positive
 Small Lymphocytic Lymphoma,Pharma News,Negative
 Small Lymphocytic Lymphoma,Investor News,Negative
 Small Lymphocytic Lymphoma,"OTC Dynamics, Inc.",Positive
 Small Lymphocytic Lymphoma,Bio Stocks‚Ñ¢,Positive
 Small Lymphocytic Lymphoma,Stock Titan,Positive
 Small Lymphocytic Lymphoma,Biotech & Tech Stock Focus,Negative
 Small Lymphocytic Lymphoma,PressNewsAgency,Positive
 Small Lymphocytic Lymphoma,Corporate News,Negative
 Small Lymphocytic Lymphoma,OncoKB,Positive
 Small Lymphocytic Lymphoma,Paperbirds_Hematology,Negative
 Small Lymphocytic Lymphoma,Wellcome-home,Negative
 Small Lymphocytic Lymphoma,DennisPartners,Negative
 Small Lymphocytic Lymphoma,Quant Data,Negative
 Small Lymphocytic Lymphoma,Odi Bruckman,Positive
 Small Lymphocytic Lymphoma,ClinicalTrialsData,Negative
 Small Lymphocytic Lymphoma,NASDAQ,Positive
 Small Lymphocytic Lymphoma,Pharm Processing,Positive
 Small Lymphocytic Lymphoma,UKiwiS,Negative
 Small Lymphocytic Lymphoma,üá∫üá∏jonnyüá∫üá∏,Positive
 Small Lymphocytic Lymphoma,MantasTrades,Positive
 Small Lymphocytic Lymphoma,Mark,Positive
 Small Lymphocytic Lymphoma,N A S A,Positive
 Small Lymphocytic Lymphoma,Business Wire-TS,Positive
 Small Lymphocytic Lymphoma,BusinessWireWebcasts,Positive
 Small Lymphocytic Lymphoma,BusinessWireProducts,Negative
 Small Lymphocytic Lymphoma,üò∑ Caleph B. Wilson,Positive
 Small Lymphocytic Lymphoma,The Pharmaceutical Marketing Group,Positive
 Small Lymphocytic Lymphoma,BusinessWire-Science,Negative
 Small Lymphocytic Lymphoma,CamTheMan,Positive
 Small Lymphocytic Lymphoma,Business Wire-Health,Negative
 Small Lymphocytic Lymphoma,CRO Contract Res.,Negative
 Small Lymphocytic Lymphoma,Oncology,Negative
 Small Lymphocytic Lymphoma,Cancer Papers,Negative
 Preclinical studies,NatureRevClinOncol,Negative
 antiCD CAR T cell function,NatureRevClinOncol,Negative
 Bruton tyrosine kinase inhibitors,NatureRevClinOncol,Negative
 Bruton tyrosine kinase inhibitors,Lymphoma Papers,Positive
 Bruton tyrosine kinase inhibitors,ACS Journal Cancer,Negative
 memorylike type   Thelper cell phenotype,NatureRevClinOncol,Negative
 AntiCD   T Chimeric Antigen Receptor TCell Therapy Lisocabtagene Maraleucel,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 Leucemia linfatica cronica maggiore efficacia di Calquence,Carlo Franzini,Negative
 monoterapia,Carlo Franzini,Negative
 treatmentna√Øve patients,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 treatmentna√Øve patients,OncLive.com,Negative
 treatmentna√Øve patients,Rare Disease Report,Negative
 treatmentna√Øve patients,Med-Chemist- Researcher & Academician by Choiceü§î,Positive
 treatmentna√Øve patients,Carrot Recruitment,Positive
 treatmentna√Øve patients,Diaceutics PLC,Negative
 treatmentna√Øve patients,Oncology by News-Medical,Positive
 treatmentna√Øve patients,Scott Werntz,Negative
 treatmentna√Øve patients,Cancer News by News-Medical,Positive
 treatmentna√Øve patients,AFOLABI LUKMAN,Positive
 treatmentna√Øve patients,World Medical News,Positive
 treatmentna√Øve patients,VoyagerMed,Positive
 CELLAE,Prof John,Negative
 Importance,Prof John,Negative
 Importance,OncLive.com,Negative
 Importance,Crwe World,Negative
 Importance,Lauren Evoy Davis,Positive
 Importance,CLL-seq,Negative
 Importance,Oncology Tube,Positive
 Importance,EurekaMag,Negative
 Importance,Dr kamala maddali DVM PhD,Positive
 Importance,Cancer Papers,Negative
 Importance,microRNApapers,Negative
 Importance,CLL Ireland,Positive
 Importance,"chadi nabhan MD, MBA, FACP",Positive
 Importance,"Raul Cordoba, MD, PhD",Negative
 Frontline,OncLive.com,Positive
 Frontline,CellworksLife,Negative
 Frontline,Benlazar S.M Amin√©,Negative
 Frontline,MD Anderson Leukemia,Negative
 Frontline,"chadi nabhan MD, MBA, FACP",Negative
 Frontline,CancerWallonia,Positive
 Frontline,Margaret Walker,Negative
 Frontline,Sandra Kear,Positive
 Highly Active,OncLive.com,Positive
 Highly Active,Silas Inman,Negative
   Dr Mato,OncLive SOSS,Negative
 formation,Becca Peterson,Positive
   Institute,Becca Peterson,Positive
 ImmunoOncology,Becca Peterson,Positive
 collaboration,Becca Peterson,Positive
 collaboration,"Mazyar Shadman, MD MPH",Negative
 collaboration,CLL Advocates Network,Negative
 collaboration,CancerCoachLive,Positive
 collaboration,GenQA (Genomics Quality Assessment),Negative
 collaboration,Dr. Andy Evens,Negative
 collaboration,Centre for Genomic Regulation (CRG),Negative
 collaboration,Broad Institute,Positive
 collaboration,Toby Eyre,Negative
 collaboration,Abdel-Wahab Lab,Positive
 collaboration,Michael Rynne,Negative
 collaboration,Ron Grunsby,Positive
 collaboration,"chadi nabhan MD, MBA, FACP",Positive
 collaboration,CLLSA,Negative
 collaboration,Bio-Collaboration,Positive
 collaboration,DrugGenius,Positive
 collaboration,CRO Contract Res.,Negative
 collaboration,Cancer News,Negative
 collaboration,antonio ramon mu√±oz,Positive
 researchers donors,Becca Peterson,Positive
 leaders,Becca Peterson,Positive
 leaders,"Fumiko Ladd Chino, MD",Positive
 leaders,Connie Erpelding,Positive
 infrastructure,Becca Peterson,Positive
 discoveries,Becca Peterson,Positive
 Acalabrutinib Benefit,OncLive.com,Positive
 LongTerm FollowUp,OncLive.com,Positive
 LongTerm FollowUp,Oncology Tube,Negative
 Sharman,OncLive.com,Positive
 Sharman,Crwe World,Negative
 Sharman,HCP Feed,Negative
 Frontline Acalabrutinib Activity,OncLive.com,Positive
 Frontline Acalabrutinib Activity,Crwe World,Negative
 Frontline Acalabrutinib Activity,HCP Feed,Negative
 KASIM   ARALIK,Prof. Dr. H. ƒ∞smail Sarƒ±,Positive
 FDA ONAYLARI,Prof. Dr. H. ƒ∞smail Sarƒ±,Positive
 WATCH Dr Lampson,OncLive.com,Negative
 Efficacy,OncLive.com,Positive
 Efficacy,"Raul Cordoba, MD, PhD",Positive
 Efficacy,Lymphoma Papers,Positive
 Efficacy,Paperbirds_Hematology,Positive
 Efficacy,clinicaltherapeutics,Negative
 Efficacy,"chadi nabhan MD, MBA, FACP",Negative
 Efficacy,U-M Rogel Cancer Center,Positive
 Efficacy,OncLive SOSS,Negative
 Efficacy,Jerry Lee,Negative
 Efficacy,Michele Nadeem-Baker,Negative
 Efficacy,Benlazar S.M Amin√©,Positive
 Efficacy,ClinicalTrialsData,Positive
 Efficacy,Thomas Roy Webb,Positive
 Efficacy,MD Anderson Leukemia,Negative
 Efficacy,Biotech2050,Negative
 Efficacy,TrialBulletin,Positive
 Efficacy,Monterey Holistic,Negative
 Efficacy,Cureus,Negative
 Efficacy,Blood Journal,Negative
 Efficacy,"Dr T. Comeau , MD",Positive
 Efficacy,CureHuntr,Positive
 Efficacy,Izaskun Zeberio,Positive
 Efficacy,Hematology Advisor,Negative
 Efficacy,Eduardo Flavio Oliveira Ribeiro,Negative
 Efficacy,Florent Malard,Negative
 Efficacy,Toby Eyre,Positive
 Efficacy,Garbi√±e Lizeaga,Negative
 Efficacy,Tom Silver,Negative
 Efficacy,MLM Medical Labs,Positive
 Efficacy,CLL Ireland,Positive
 Efficacy,FarmaOnco,Negative
 Efficacy,NCCP,Positive
 Efficacy,Health Adviser,Positive
 Efficacy,AJMC,Negative
 Efficacy,Advances in Therapy,Positive
 Efficacy,Hematopoiesis News,Negative
 Efficacy,Matthias Piesche,Positive
 Efficacy,Sandra Kear,Positive
 Efficacy,Scott Werntz,Positive
 Efficacy,Helen Ong,Positive
 Efficacy,"Pharmacyclics, an AbbVie Company",Positive
 Efficacy,Diaceutics PLC,Positive
 Efficacy,Michelet St. Preuve,Positive
 Efficacy,IntoxicatedTrader,Positive
 Efficacy,Warren Research,Positive
 Efficacy,"Tom Iarocci, MD",Negative
 Efficacy,Dr. Leona Saunders,Positive
 Acalabrutinib Venetoclax,OncLive.com,Negative
 Acalabrutinib Venetoclax,"Raul Cordoba, MD, PhD",Negative
 Singleagent acalabrutinib,Oncology Learning Network,Negative
 Singleagent acalabrutinib,CancerTherapyAdvisor,Negative
 OLN,Oncology Learning Network,Negative
   phase II RR   median,Toby Eyre,Negative
 linesAF,Toby Eyre,Negative
 development,"Michael Wang, MD",Negative
 development,Patient Power,Negative
 development,Lymphoma Papers,Negative
 development,Cancer Papers,Negative
 development,Medscape Education,Negative
 development,NYCDoc29,Negative
 development,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 development,Kadir C Akdemir,Positive
 development,CLL Ireland,Positive
 development,Lymphoma Hub,Negative
 development,ASH,Negative
 science,"Matthew Rehrl, MD MS üñã",Positive
 science,ANTARES,Positive
 science,Kim Kirchherr,Negative
 science,Some Blonde Scientist - Dr Georgia Atkin-Smith,Positive
 science,Tom Cloyd,Positive
 science,Sigrid Sk√•nland,Negative
 science,Nick Wong,Positive
 science,Canadian Health & Family,Positive
 science,Vegan NoGluten Sara,Positive
 scientists,"Matthew Rehrl, MD MS üñã",Positive
 scientists,ü•ìSara Dankerü•ì,Positive
 scientists,Hematopoiesis News,Negative
 scientists,Immune Regulation News,Negative
 scientists,Human Immunology News,Positive
 scientists,Broad Institute,Positive
 scientists,Parc Cient√≠fic de Barcelona,Negative
 scientists,Lymphoma Hub,Negative
 Orelabrutinib,Tim Fenske,Negative
 Orelabrutinib,Bitchin' Science,Positive
 Orelabrutinib,Stock Market News,Negative
 Orelabrutinib,Pharmacutical Daily,Negative
 Orelabrutinib,Sarang Pokhare,Negative
 Orelabrutinib,IMPharma News,Negative
 Orelabrutinib,Latest News from Business Wire,Negative
 Orelabrutinib,Crwe World,Negative
 ASH,"Michael Wang, MD",Positive
 ASH,Phil Talamo,Negative
 ASH,Alan Skarbnik,Positive
 ASH,Saeed Valadbaygi,Negative
 ASH,PressReleasePoint,Negative
 ASH,Crwe World,Negative
 ASH,Oncology,Positive
 ASH,Biotech & Tech Stock Focus,Negative
 ASH,Michele Nadeem-Baker,Negative
 ASH,Nick,Negative
 ASH,Esther Schorr,Positive
 ASH,Patient Power,Negative
 ASH,CLL Society Inc.,Positive
 ASH,VJHemOnc,Positive
 ASH,Research To Practice,Negative
 ASH,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 ASH,Shouting at people in my underpants,Negative
 ASH,Cancer News,Positive
 ASH,Lymphoma Hub,Negative
 ASH,The Patient's Channel,Positive
 ASH,BioPharma Dive,Negative
 ASH,Zack Pemberton-Whiteley,Negative
 ASH,Lorna Warwick,Positive
 ASH,Anna Deveau,Negative
 ASH,Oncology Tube,Positive
 ASH,Lung Cancer News,Negative
 ASH,BusinessWireWebcasts,Negative
 ASH,The Pharmaceutical Marketing Group,Negative
 ASH,Business Wire-TS,Negative
 ASH,Oncology Board,Negative
 ASH,Sanne v‚≠ïn Wüíâssen,Positive
 ASH,cairns haematology a,Positive
 ASH,Andrew Schorr,Negative
 ASH,rattenniMD,Negative
 NEW research,The Lancet Haematology,Positive
 Roger Owen,The Lancet Haematology,Negative
 singleagent therapy,The Lancet Haematology,Negative
 Phase III ELEVATE TN,Lymphoma Hub,Negative
 summary,Lymphoma Hub,Positive
 summary,Sigrid Sk√•nland,Negative
 summary,Levine Cancer Institute,Positive
 summary,CLL Ireland,Negative
 summary,CLLSA,Positive
   meeting,Lymphoma Hub,Negative
   meeting,BioAscend,Positive
   meeting,Dr. Cary Presant,Positive
   meeting,VJHemOnc,Negative
   meeting,ESH (Haematology),Positive
   meeting,Michael Hallek,Negative
   meeting,CLLSA,Positive
   meeting,"chadi nabhan MD, MBA, FACP",Negative
   meeting,Patient Power,Negative
 obinutuzumab   chlorambucil,Lymphoma Hub,Negative
 obinutuzumab   chlorambucil,ASH Clinical News,Negative
   √∂m,Nicolas Zarjevski,Positive
 monoth√©rapie,Nicolas Zarjevski,Positive
 AstraZeneca Co Ltd,re-how.net,Negative
 death,re-how.net,Negative
 death,Pharma News,Negative
 death,Philly Bio,Negative
 death,Briefing.com,Negative
 death,Pharma Regulatory,Negative
 death,1stOncology,Negative
 death,Cision News,Negative
 death,LYMPHOMA & MYELOMA CONNECT,Negative
 death,OncLive.com,Negative
 death,Michael Rynne,Negative
 death,ASH Clinical News,Negative
 death,Targeted Oncology,Positive
 death,Oncology Nursing News,Negative
 death,ron white,Positive
 death,VJHemOnc,Negative
 death,Dr. Melody Davis,Negative
 death,Andrew Schorr,Negative
 death,Francesco Turturro,Negative
 James N Gerson MD,OncLive SOSS,Negative
 rr MCL,OncLive SOSS,Negative
 rr MCL,Ahmad Halwani,Positive
 rr MCL,CBPartners,Positive
 III ELEVATETN trial,Targeted Oncology,Negative
 prima linea da,Professione Farmacia,Negative
 prima linea da,Medical Evidence üáÆüáπ,Negative
 combinazione,Professione Farmacia,Negative
 combinazione,Medical Evidence üáÆüáπ,Negative
 allontana la progressione,Professione Farmacia,Negative
 allontana la progressione,Medical Evidence üáÆüáπ,Negative
 Chronic Lymphocytic Leukemia CLL,CALQUENCE¬Æ (acalabrutinib),Negative
 Chronic Lymphocytic Leukemia CLL,knowmedge,Positive
 Chronic Lymphocytic Leukemia CLL,Wellcome-home,Negative
 Chronic Lymphocytic Leukemia CLL,CLL-seq,Positive
 Chronic Lymphocytic Leukemia CLL,CureHuntr,Positive
 Chronic Lymphocytic Leukemia CLL,"Mazyar Shadman, MD MPH",Positive
 Chronic Lymphocytic Leukemia CLL,Aurora Cancer Care,Positive
 Chronic Lymphocytic Leukemia CLL,Alicia Bell IFBB Pro,Positive
 Chronic Lymphocytic Leukemia CLL,"Bionano Genomics, Inc.",Positive
 Chronic Lymphocytic Leukemia CLL,ChampionsOncology,Positive
 Chronic Lymphocytic Leukemia CLL,IMPharma News,Positive
 Chronic Lymphocytic Leukemia CLL,Investor Press Releases,Positive
 Chronic Lymphocytic Leukemia CLL,MasdelMedio,Positive
 Chronic Lymphocytic Leukemia CLL,Stock Market News,Negative
 Chronic Lymphocytic Leukemia CLL,"OTC Dynamics, Inc.",Negative
 Chronic Lymphocytic Leukemia CLL,Flash Alert,Negative
 Chronic Lymphocytic Leukemia CLL,HempNews,Negative
 Chronic Lymphocytic Leukemia CLL,Stock Titan,Positive
 Chronic Lymphocytic Leukemia CLL,Jordan üíä,Positive
 Chronic Lymphocytic Leukemia CLL,javiboix,Negative
 Chronic Lymphocytic Leukemia CLL,Ohio Infusion Services,Positive
 Chronic Lymphocytic Leukemia CLL,ClinicalTrialsData,Positive
 Chronic Lymphocytic Leukemia CLL,Laboratory Career,Negative
 Chronic Lymphocytic Leukemia CLL,Tom,Negative
 Chronic Lymphocytic Leukemia CLL,MoonAngelWings....NO DM,Positive
 Chronic Lymphocytic Leukemia CLL,Cancer Support Community,Positive
 Chronic Lymphocytic Leukemia CLL,CompBiolPapers,Negative
 Chronic Lymphocytic Leukemia CLL,Frontiers in Cell and Developmental Biology,Positive
 Chronic Lymphocytic Leukemia CLL,Yuval Avnir,Positive
 Chronic Lymphocytic Leukemia CLL,Joe Fournet,Negative
 Chronic Lymphocytic Leukemia CLL,PressReleasePoint,Negative
 Chronic Lymphocytic Leukemia CLL,BuxMont Forum,Positive
 Chronic Lymphocytic Leukemia CLL,NwokeAgulu,Negative
 Chronic Lymphocytic Leukemia CLL,SC,Positive
 Chronic Lymphocytic Leukemia CLL,SNN,Positive
 Chronic Lymphocytic Leukemia CLL,Oncology Tube,Negative
 Chronic Lymphocytic Leukemia CLL,Biotech2050,Negative
 Chronic Lymphocytic Leukemia CLL,Myrtle Newsam,Positive
 Chronic Lymphocytic Leukemia CLL,Lifewaysvillage.com/lifestyle,Positive
 Chronic Lymphocytic Leukemia CLL,CLL Society Inc.,Positive
 Chronic Lymphocytic Leukemia CLL,Kevin Wolcott,Positive
 Chronic Lymphocytic Leukemia CLL,Saeed Valadbaygi,Negative
 Chronic Lymphocytic Leukemia CLL,VPO/PR Newswire,Negative
 Chronic Lymphocytic Leukemia CLL,pressdaily,Negative
 Chronic Lymphocytic Leukemia CLL,Centre for Genomic Regulation (CRG),Negative
 Chronic Lymphocytic Leukemia CLL,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia CLL,Lymphomation.org,Negative
 Chronic Lymphocytic Leukemia CLL,"Mike Thompson, MD, PhD, FASCO",Positive
 Chronic Lymphocytic Leukemia CLL,Value-Based Cancer Care,Positive
 Chronic Lymphocytic Leukemia CLL,TrialBulletin,Positive
 Chronic Lymphocytic Leukemia CLL,"Robinson Ortiz, MD",Positive
 Chronic Lymphocytic Leukemia CLL,NEJM,Negative
 Chronic Lymphocytic Leukemia CLL,Leukemia Research Foundation,Negative
 Chronic Lymphocytic Leukemia CLL,Andrew Taylor,Positive
 Chronic Lymphocytic Leukemia CLL,Financial Buzz,Negative
 Chronic Lymphocytic Leukemia CLL,Crwe World,Negative
 Chronic Lymphocytic Leukemia CLL,HEDGE accordinglyüìà,Negative
 Chronic Lymphocytic Leukemia CLL,RazzleTazzle,Positive
 Chronic Lymphocytic Leukemia CLL,"Naveen Pemmaraju, MD",Negative
 Chronic Lymphocytic Leukemia CLL,"Pharmacyclics, an AbbVie Company",Positive
 Chronic Lymphocytic Leukemia CLL,HARMONY Alliance,Negative
 Chronic Lymphocytic Leukemia CLL,Med Perfectionalis,Positive
 Chronic Lymphocytic Leukemia CLL,Matthews & Associates,Positive
 Chronic Lymphocytic Leukemia CLL,NFCR,Positive
 Chronic Lymphocytic Leukemia CLL,The Pharmaceutical Marketing Group,Negative
 Chronic Lymphocytic Leukemia CLL,Tom Silver,Negative
 Chronic Lymphocytic Leukemia CLL,ImmunologyPapers,Positive
 Chronic Lymphocytic Leukemia CLL,Cancer Papers,Positive
 Chronic Lymphocytic Leukemia CLL,CSI Specialty Group,Positive
 Chronic Lymphocytic Leukemia CLL,Sicilia Informazioni,Positive
 Chronic Lymphocytic Leukemia CLL,ALL UNIVERSITY NEWS,Positive
 Chronic Lymphocytic Leukemia CLL,Business Wire-Health,Positive
 Chronic Lymphocytic Leukemia CLL,ALI ALAHMARI.,Negative
 Chronic Lymphocytic Leukemia CLL,CellworksLife,Positive
 Chronic Lymphocytic Leukemia CLL,Lymphoma Research Foundation,Negative
 Chronic Lymphocytic Leukemia CLL,Augustino Chengula,Negative
 Chronic Lymphocytic Leukemia CLL,Markets & Reports,Negative
 Chronic Lymphocytic Leukemia CLL,CancerPOP,Positive
 Chronic Lymphocytic Leukemia CLL,Lillian Boone,Positive
 Chronic Lymphocytic Leukemia CLL,AURELIAN UDRISTIOIU,Negative
 Chronic Lymphocytic Leukemia CLL,Julio Rodrigo Ortiz,Positive
 Chronic Lymphocytic Leukemia CLL,Haematologica,Positive
 Chronic Lymphocytic Leukemia CLL,Financial GamblR,Negative
 Chronic Lymphocytic Leukemia CLL,BizPR,Negative
 Chronic Lymphocytic Leukemia CLL,Rene Discarte,Positive
 Chronic Lymphocytic Leukemia CLL,DrugGenius,Positive
 Chronic Lymphocytic Leukemia CLL,ConferenceSeries,Positive
 Chronic Lymphocytic Leukemia CLL,Sultan Ibrahim Aljarba,Positive
 Chronic Lymphocytic Leukemia CLL,"Dr T. Comeau , MD",Negative
 Chronic Lymphocytic Leukemia CLL,Krishan Maggon,Positive
 Chronic Lymphocytic Leukemia CLL,Judith Jones,Positive
 Chronic Lymphocytic Leukemia CLL,SPI News,Positive
 Chronic Lymphocytic Leukemia CLL,Javier Martinez Peromingo,Positive
 Chronic Lymphocytic Leukemia CLL,Isaura R. Penin,Negative
 Chronic Lymphocytic Leukemia CLL,OncologyEducation,Negative
 Chronic Lymphocytic Leukemia CLL,Dana-Farber,Negative
 Chronic Lymphocytic Leukemia CLL,Prachi,Positive
 Chronic Lymphocytic Leukemia CLL,CORE Diagnostics,Positive
 Chronic Lymphocytic Leukemia CLL,"Raul Cordoba, MD, PhD",Negative
 Chronic Lymphocytic Leukemia CLL,Info Batam,Negative
 Chronic Lymphocytic Leukemia CLL,BATAM Kepri,Negative
 Chronic Lymphocytic Leukemia CLL,Noticias en tiempo real,Positive
 Chronic Lymphocytic Leukemia CLL,Brecka,Positive
 Chronic Lymphocytic Leukemia CLL,–Æ–ª–∏—è –ï—Ñ–∏–º–æ–≤–∞,Positive
 Chronic Lymphocytic Leukemia CLL,CAPhO,Negative
 Chronic Lymphocytic Leukemia CLL,Elite Exec Search,Positive
 Chronic Lymphocytic Leukemia CLL,Paula Pyzia,Negative
 Chronic Lymphocytic Leukemia CLL,Team Intake.Me,Negative
 Chronic Lymphocytic Leukemia CLL,TumorImmunoPapers,Negative
 Chronic Lymphocytic Leukemia CLL,AIRR-seq papers,Negative
 Chronic Lymphocytic Leukemia CLL,Toju Micheal Ogbe,Positive
 Chronic Lymphocytic Leukemia CLL,NACDA Program on Aging,Negative
 Chronic Lymphocytic Leukemia CLL,UFCW Canada,Positive
 Chronic Lymphocytic Leukemia CLL,Philip Payne,Positive
 Chronic Lymphocytic Leukemia CLL,Klaus Okkenhaug,Positive
 Chronic Lymphocytic Leukemia CLL,Drugs.com,Negative
 Chronic Lymphocytic Leukemia CLL,NCI Cancer Stats,Positive
 Chronic Lymphocytic Leukemia CLL,CLL Info,Negative
 Chronic Lymphocytic Leukemia CLL,Scott Werntz,Positive
 Chronic Lymphocytic Leukemia CLL,EIN Presswire: Glaxo Newswire,Positive
 Chronic Lymphocytic Leukemia CLL,John Pennett,Positive
 Chronic Lymphocytic Leukemia CLL,Francesco Turturro,Negative
 Chronic Lymphocytic Leukemia CLL,Marn√© Prinsloo,Positive
 Chronic Lymphocytic Leukemia CLL,Rachel Smith,Positive
 Chronic Lymphocytic Leukemia CLL,Stocks News&Markets,Positive
 Chronic Lymphocytic Leukemia CLL,Fundamentaltechs,Positive
 Chronic Lymphocytic Leukemia CLL,Symposier,Positive
 Chronic Lymphocytic Leukemia CLL,Symposier Allergy,Positive
 Chronic Lymphocytic Leukemia CLL,Symposier MedStudent,Positive
 Chronic Lymphocytic Leukemia CLL,Symposier Radiology,Positive
 Chronic Lymphocytic Leukemia CLL,Symposier Oncology,Positive
 Chronic Lymphocytic Leukemia CLL,Symposier Pharmaco,Positive
 Chronic Lymphocytic Leukemia CLL,Sympo PathoBiology,Positive
 Chronic Lymphocytic Leukemia CLL,Symposier Hematology,Positive
 Chronic Lymphocytic Leukemia CLL,Sy Internal Medicine,Positive
 Chronic Lymphocytic Leukemia CLL,Symposier Family,Positive
 Chronic Lymphocytic Leukemia CLL,Hematopoiesis News,Negative
 Chronic Lymphocytic Leukemia CLL,Oncology News Update,Negative
   linfatica cronica acalabrutinib migliora significativamente il tempo,Medinews,Positive
 da progressione,Medinews,Negative
 Jeff P Sharman MD,The ASCO Post,Negative
 Jeff P Sharman MD,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 CLL Trial Results,The ASCO Post,Negative
 CLL Trial Results,OncLive.com,Negative
 Acalabrutinib Obinutuzumab,The ASCO Post,Negative
 Leucemia linfatica cronica acalabrutinib migliora significativamente il tempo,Salutedomani,Negative
 Leucemia linfatica cronica acalabrutinib migliora significativamente il tempo,saluteH24.com,Positive
 Leucemia linfatica cronica acalabrutinib migliora significativamente il tempo,Antonio Caperna,Positive
 Leucemia linfatica cronica acalabrutinib migliora significativamente il tempo,Derma News OK,Positive
 Leucemia linfatica cronica acalabrutinib migliora significativamente il tempo,Zazoom Social News,Positive
 Leucemia linfatica cronica acalabrutinib migliora significativamente il tempo,Roberto Bonin,Positive
 Leucemia linfatica cronica acalabrutinib migliora significativamente il tempo,Tecnomedicina,Positive
 ALLONTANA LA PROGRESSIONE,I Malati Invisibili,Negative
 SIA DA SOLO CHE,I Malati Invisibili,Negative
 COMBINAZIONE,I Malati Invisibili,Negative
 Zanubrutinib ASH data,Paul D. Rennert,Positive
 headhead trial tho,Paul D. Rennert,Positive
 discontinuations,Paul D. Rennert,Positive
 discontinuations,Targeted Oncology,Negative
 discontinuations,Biotech2050,Negative
 acalabrutinib CalquenceNuevas,Daniel Garcia Estrada (Retire),Positive
 aprobadas para adultos con leucemia linfoc√≠tica cr√≥nica,Daniel Garcia Estrada (Retire),Positive
 CLL o,Daniel Garcia Estrada (Retire),Positive
 ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÔºàCLLÔºâÔºèÂ∞è„É™„É≥„ÉëÁêÉÊÄß„É™„É≥„ÉëËÖ´ÔºàSLLÔºâÊàê‰∫∫ÊÇ£ËÄÖ„ÅÆÊ≤ªÁôÇ„ÅÆ„Åü„ÇÅ„Å´CALQUENCE„ÇíÊâøË™ç Êèê‰æõÂÖÉ,MEDWAVE,Negative
 PRODUCT APPROVALS Drug,MEDWAVE,Negative
 Chronic Graft,COPD News,Negative
 Host Disease,COPD News,Negative
 Host Disease,Paperbirds_Hematology,Negative
 II trial studies,COPD News,Negative
 Leucemia linfatica cronica,Salutedomani,Negative
 migliora significativamente,Salutedomani,Negative
 ‚Ä¶   salutedomani podcast,Salutedomani,Negative
 ASH AstraZenecas Calquence posts skyhigh,Labofine,Negative
 ASH AstraZenecas Calquence posts skyhigh,PharmaCrowd,Negative
 ASH AstraZenecas Calquence posts skyhigh,EIPG,Negative
 ASH AstraZenecas Calquence posts skyhigh,Continental Clinical,Positive
 ASH AstraZenecas Calquence posts skyhigh,Dr Timos Papagatsias,Negative
 ASH AstraZenecas Calquence posts skyhigh,analyst land news,Positive
 survival numbers,Labofine,Negative
 survival numbers,Lampgen Clinical Research,Positive
 survival numbers,lukabiotech,Positive
 survival numbers,PharmaCrowd,Negative
 survival numbers,EIPG,Negative
 survival numbers,Continental Clinical,Positive
 survival numbers,Dr Timos Papagatsias,Negative
 survival numbers,NewExpressNews,Negative
 survival numbers,analyst land news,Positive
 AbbVies Imbruvica,Labofine,Negative
 AbbVies Imbruvica,BioPharma Dive,Negative
 AbbVies Imbruvica,EIPG,Negative
 AbbVies Imbruvica,cafepharma,Positive
 AbbVies Imbruvica,FiercePharma,Negative
 AbbVies Imbruvica,Dr Timos Papagatsias,Negative
 AbbVies Imbruvica,Pharma Regulatory,Negative
 AbbVies Imbruvica,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 AbbVies Imbruvica,Gordon Gekko,Negative
 AbbVies Imbruvica,Investor News,Negative
 AbbVies Imbruvica,Breaking News,Negative
 AZs rising Calquence,Labofine,Negative
 AZs rising Calquence,EIPG,Negative
 AZs rising Calquence,cafepharma,Negative
 AZs rising Calquence,FiercePharma,Negative
 AZs rising Calquence,Dr Timos Papagatsias,Negative
 AZs rising Calquence,Pharma Regulatory,Negative
 da progressione o mo,saluteH24.com,Positive
 da progressione o mo,Salutedomani,Negative
 da progressione o mo,Antonio Caperna,Positive
 da progressione o mo,Derma News OK,Positive
 da progressione o morte,Zazoom Social News,Positive
 AstraZenecas Calquence Wins FDA Approval,BioPharmaDevice,Positive
 AstraZenecas Calquence Wins FDA Approval,HealthyCarnivores,Positive
 AstraZenecas Calquence Wins FDA Approval,About Medtech,Positive
 AstraZenecas Calquence Wins FDA Approval,CarnivoresHealth,Positive
 AstraZenecas Calquence Wins FDA Approval,Olderpreneurs,Positive
 AstraZenecas Calquence Wins FDA Approval,FRANCIS_ABAT,Positive
 AstraZenecas Calquence Wins FDA Approval,VCapital,Positive
 AstraZenecas Calquence Wins FDA Approval,ContentPro.IO,Positive
 AstraZenecas Calquence Wins FDA Approval,Swedish Biotech,Positive
 AstraZenecas Calquence Wins FDA Approval,Chelli Miller,Positive
 AstraZenecas Calquence Wins FDA Approval,Pharma Regulatory,Negative
 AstraZenecas Calquence Wins FDA Approval,cafepharma,Negative
 AstraZenecas Calquence Wins FDA Approval,Corixis,Positive
 AstraZenecas Calquence Wins FDA Approval,Pharmaceutical,Positive
 AstraZenecas Calquence Wins FDA Approval,Biotechnology,Positive
 AstraZenecas Calquence Wins FDA Approval,BioCalifornia,Negative
 AstraZenecas Calquence Wins FDA Approval,The Oncologist,Negative
 triplet regimen,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 triplet regimen,Targeted Oncology,Positive
 triplet regimen,OncLive.com,Positive
 Calquence acalabrutinib mejora la supervivencia libre de progresi√≥n,Luis Pereira Lopez,Positive
 Calquence acalabrutinib mejora la supervivencia libre de progresi√≥n,Renovatio Biom√©dica,Positive
   prueba que Calquence,Acobur,Positive
 vida de pacientes con leucemia,Acobur,Positive
 FirstLine CLL,Pharma Regulatory,Negative
 FirstLine CLL,ZorgNL,Positive
 FirstLine CLL,Scrip,Negative
 pacientes con   linfoc√≠tica cr√≥nica seg√∫n los resultados completos del,IM M√©dico,Positive
 Mercks,BioPharma Dive,Negative
 ArQule,BioPharma Dive,Negative
 ArQule,BioPortfolio - Eli Lilly - news and research,Positive
 competition,BioPharma Dive,Negative
 competition,BioPortfolio - Eli Lilly - news and research,Positive
 competition,Deepakdev,Positive
 competition,VietNamstockeXchange,Positive
 competition,VJHemOnc,Negative
 class,BioPharma Dive,Negative
 class,BioPortfolio - Eli Lilly - news and research,Positive
 class,Patient Empowerment Network,Negative
 class,Lymphomation.org,Negative
 class,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 class,Anna Deveau,Positive
 class,Patient Power,Positive
 AbbVie,BioPharma Dive,Negative
 AbbVie,BioPortfolio - Eli Lilly - news and research,Positive
 AbbVie,pharmaphorum,Negative
 AbbVie,Worldcatholicnews,Positive
 AbbVie,Advera Health,Positive
 AbbVie,buzz lightyear,Positive
 AbbVie,Carly Helfand,Negative
 AbbVie,Martin JS Dyer,Positive
 AbbVie,IMPharma News,Negative
 AbbVie,Bionest Partners,Positive
 AbbVie,PHARMABOX.IN,Negative
 AbbVie,PharmaShots - Incisive news in 3 shots,Positive
 AbbVie,Quant Data,Positive
 AbbVie,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 AbbVie,MasdelMedio,Negative
 AbbVie,Stock Market News,Negative
 AbbVie,Company News HQ,Positive
 AbbVie,Crwe World,Positive
 AbbVie,HempNews,Positive
 AbbVie,Investor News,Negative
 AbbVie,FancyFinancy,Negative
 AbbVie,Financial Carnivores,Negative
 AbbVie,Robo Schmobo,Positive
 AbbVie,BioPharmaDevice,Positive
 AbbVie,Laura Smalley,Positive
 AbbVie,Alicia Bell IFBB Pro,Negative
 AbbVie,Matt Fanning,Positive
 AbbVie,Thomas C. Keefe,Positive
 AbbVie,LLZ Consulting,Positive
 AbbVie,Oncology Tube,Positive
 AbbVie,HSMN,Positive
 AbbVie,Pharma News,Positive
 AbbVie,Oncology Board,Negative
 AbbVie,Market Cheetah,Positive
 AbbVie,Simple Charts,Negative
 AbbVie,flylemurs,Positive
 AbbVie,420 Ag,Positive
 AbbVie,Sigrid Sk√•nland,Negative
 AbbVie,MEDWAVE,Negative
 AbbVie,RazzleTazzle,Positive
 AbbVie,Drug Store News,Positive
 AbbVie,MedPipeline,Negative
 AbbVie,FDA Daily,Positive
 AbbVie,ipharmacenter,Negative
 AbbVie,PSK2329 - JHC,Negative
 AbbVie,Total Pharma News,Positive
 AbbVie,CLL Society Inc.,Negative
 AbbVie,Michael Oholendt,Positive
 AbbVie,Flash Alert,Negative
 AbbVie,ChemDiv,Positive
 AbbVie,HEDGE accordinglyüìà,Positive
 AbbVie,Financial Buzz,Positive
 AbbVie,Seattle's Banker,Positive
 AbbVie,CRE Demographics,Positive
 AbbVie,Connie Hampton,Positive
 AbbVie,BioCalifornia,Negative
 AbbVie,Today's News,Positive
 AbbVie,HRI Portal,Negative
 AbbVie,PRICENTRIC,Positive
 AbbVie,gilbert c faure,Negative
 AbbVie,Rob Wilson,Positive
 AbbVie,AmericanPharmacyNews,Positive
 AbbVie,aeses.com,Negative
 AbbVie,Mike Gauthier,Positive
 AbbVie,cafepharma,Positive
 AbbVie,UKiwiS,Negative
 AbbVie,Pf Magazine,Negative
 AbbVie,Parallel Learning,Positive
 AbbVie,CancerEpiPapers,Negative
 AbbVie,RTCP24 NEWS‚Ñ¢,Positive
 AbbVie,Endpoints News,Negative
 AbbVie,Kara Jill Stancell,Negative
 AbbVie,orphanpedia,Positive
 AbbVie,1stOncology,Negative
 AbbVie,Patient Daily,Negative
 AbbVie,AbbVie Schweiz,Positive
 AbbVie,Margaret Walker,Negative
 AbbVie,Biotech World,Positive
 AbbVie,Regulatory Jobs,Positive
 AbbVie,Cpl Life Sciences,Positive
 AbbVie,Marco Ricci,Positive
 AbbVie,Diaceutics PLC,Negative
 AbbVie,EMJ Hematology,Negative
 AbbVie,IntoxicatedTrader,Positive
 AbbVie,NACDA Program on Aging,Negative
 AbbVie,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",Positive
 AbbVie,Hematopoiesis News,Negative
 AbbVie,George Papadopoulos,Positive
 AbbVie,Lymphoma Hub,Positive
 AbbVie,Gunel Huseynova,Positive
 AbbVie,Krishan Maggon,Negative
 AbbVie,Medelis: OncologyCRO,Positive
 AbbVie,PRN Biotech,Positive
 AbbVie,vincenzo abruscato,Positive
 AbbVie,Pharmafocus,Negative
 AbbVie,Salutedomani,Positive
 AbbVie,fainfo salute,Positive
 AbbVie,Derma News OK,Positive
 AbbVie,saluteH24.com,Positive
 AbbVie,Antonio Caperna,Positive
 AbbVie,Dr. Melody Davis,Negative
 AbbVie,Health News view,Positive
 AbbVie,Bill Rodgers,Negative
 AbbVie,Survival Plan Kits,Negative
 AbbVie,militaryape,Positive
 AbbVie,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Positive
 AbbVie,Medicine World,Positive
 AbbVie,Medicine Plaza,Positive
 AbbVie,Dora Wurth,Positive
 AbbVie,MilitaryLoop,Positive
 AbbVie,Aktienmanufaktur,Positive
 AbbVie,PRNhealth,Positive
 AbbVie,wallstreet:online.de,Positive
 AbbVie,Frank,Positive
 AbbVie,VPO/PR Newswire,Negative
 AbbVie,stocksandmoney.com,Positive
 AbbVie,Cord Blood News,Negative
 AbbVie,NYCDoc29,Negative
 AbbVie,visiongain Pharma,Positive
 JampJs Imbruvica,BioPharma Dive,Negative
 JampJs Imbruvica,buzz lightyear,Positive
 JampJs Imbruvica,Carly Helfand,Negative
 JampJs Imbruvica,Martin JS Dyer,Positive
 que Calquence,Redacci√≥n M√©dica,Positive
 vida de pacientes con,Redacci√≥n M√©dica,Positive
 Presentaci√≥n de   sobre datos de Calquence,Acta Sanitaria,Negative
 Leukemia rivals,BioPortfolio - Eli Lilly - news and research,Positive
 Merck Lilly,BioPortfolio - Eli Lilly - news and research,Positive
 JampampJamps Imbruvica,BioPortfolio - Eli Lilly - news and research,Positive
 AstraZenecaamps Calquence,BioPortfolio - Eli Lilly - news and research,Positive
 disease progression,Pharma News,Negative
 disease progression,Philly Bio,Negative
 disease progression,Briefing.com,Positive
 disease progression,Career Biotech,Negative
 disease progression,Pharma Regulatory,Negative
 disease progression,1stOncology,Positive
 disease progression,Cision News,Positive
 disease progression,OncLive.com,Negative
 disease progression,Mike van Dulken,Negative
 disease progression,Francis Alexander,Negative
 disease progression,PressReleasePoint,Negative
 disease progression,The PMI (Pharmaceutical Managers' Institute),Negative
 disease progression,Blood Cancer Discovery,Positive
 disease progression,Blood Journal,Negative
 disease progression,COPD News,Negative
 disease progression,Cancer Papers,Positive
 disease progression,ASH Clinical News,Negative
 disease progression,CURE Magazine,Negative
 disease progression,H4B Boston,Positive
 disease progression,CLL-seq,Negative
 disease progression,Teresa Martin,Positive
 disease progression,"Raul Cordoba, MD, PhD",Negative
 disease progression,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 disease progression,Prof John,Negative
 disease progression,myCME,Negative
 Calquence acalabrutinib de   prolonga significativamente el tiempo que los   con,Francisco Acedo,Positive
 tratada previamente,Francisco Acedo,Positive
 s   boosts,Plexus Ventures,Negative
 inhibiteur de la kinase fait,Theriaque_officiel,Positive
 preuves,Theriaque_officiel,Positive
 Acalabrutinib un,Carlo Franzini,Negative
 della tirosinkinasi,Carlo Franzini,Negative
 di Bruton,Carlo Franzini,Negative
 ha ottenuto la designazione,Carlo Franzini,Negative
 di terapia fortemente innovativa nel linfoma mantellare,Carlo Franzini,Negative
 Month,Saeed Valadbaygi,Negative
 Month,SUMIT SHARMA,Negative
 Month,UCI Health,Positive
 Month,CLLSA,Negative
 Month,Bag It - Cancer Support,Positive
 Month,Oncology Tube,Negative
 Month,Matthew Kauffman,Negative
 Month,Ro Lewis,Positive
 Jeff Sharman,medwireNews,Negative
 Jeff Sharman,Sigrid Sk√•nland,Negative
 Jeff Sharman,The Lancet Haematology,Negative
 Jeff Sharman,Dr Timos Papagatsias,Negative
 Oncology Network,medwireNews,Negative
 Oncology Network,Anna Deveau,Negative
 Dr Furman,Targeted Oncology,Negative
 Dr Furman,Patient Power,Negative
 Dr Furman,CLL Society Inc.,Positive
 Dr Furman,Susan H Yarbrough,Positive
 Dr Furman,WCM Lymphoma,Negative
 Dr Furman,Lymphoma Research Foundation,Negative
 Dr Furman,Senior Care Corner,Positive
 Dr Furman,WCMNYPJCTO,Negative
 month followup data,Targeted Oncology,Negative
 Toxicities,Dr. Andre Goy,Negative
 Toxicities,"Raul Cordoba, MD, PhD",Positive
 Toxicities,Anna Deveau,Negative
 AcalabrutinibTreated Patients,Dr. Andre Goy,Negative
 Chronic Lymphocytic Leukemia Retrospective Analysis,Dr. Andre Goy,Negative
 Phase III ELEVATE TN trial,Philly Bio,Negative
 AstraZeneca trial,Pharmafocus,Positive
 AstraZeneca trial,Jon Angelo,Negative
 II study,OncLive.com,Negative
 II study,Targeted Oncology,Negative
 II study,Lymphoma Hub,Negative
 II study,Paperbirds_Hematology,Negative
 II study,Lymphoma Papers,Negative
 II study,Michael Hallek,Negative
 AVO,OncLive.com,Negative
 AVO,"chadi nabhan MD, MBA, FACP",Negative
 survival,Pharma Business Int,Negative
 survival,flylemurs,Positive
 survival,i3 Health,Negative
 survival,Paperbirds_Hematology,Positive
 survival,Rockefeller U. Press,Positive
 survival,JExpMed,Negative
 survival,Lymphoma Papers,Positive
 survival,Hematology Advisor,Negative
 survival,RTI Health Solutions,Negative
 survival,CLLSA,Negative
 survival,Icahn School of Medicine at Mount Sinai,Positive
 survival,AJMC,Negative
 survival,"Raul Cordoba, MD, PhD",Negative
 survival,Benlazar S.M Amin√©,Negative
 survival,ASH Clinical News,Positive
 survival,Medivizor,Positive
 survival,Greiner Bio-One IT,Positive
 survival,CDD press,Negative
 survival,Nature Reviews Disease Primers,Negative
 survival,CancerTherapyAdvisor,Negative
 survival,MDCalc.com,Positive
 survival,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 survival,ClinChemINFO,Positive
 survival,DrugGenius,Negative
 survival,TumorImmunoPapers,Negative
 survival,Hypoxia Adaptation,Positive
 survival,Cancer Papers,Negative
 survival,IamMitochondria,Positive
 survival,HMRN UK,Positive
 survival,GEDEFO,Negative
 survival,Douglas Allan,Positive
 survival,Med-Chemist- Researcher & Academician by Choiceü§î,Positive
 survival,ecancerpatient,Positive
 survival,Carrot Recruitment,Positive
 survival,Diaceutics PLC,Negative
 survival,Oncology by News-Medical,Positive
 survival,Scott Werntz,Positive
 survival,Cancer News by News-Medical,Positive
 survival,AFOLABI LUKMAN,Positive
 survival,World Medical News,Positive
 survival,VoyagerMed,Positive
 AstraZeneca data,Pharma Business Int,Negative
 AstraZenecas Calquence posts skyhigh,lukabiotech,Positive
 Calquence tripartite review,Jon Gardner,Positive
 Project Orbis,Jon Gardner,Positive
 Project Orbis,Tom Henry,Positive
 Project Orbis,Phil Talamo,Negative
 Project Orbis,David Firn,Positive
 Dr Nicholas Richardson,"Kelly Norsworthy, MD",Positive
 MD,US Oncology Network,Negative
 MD,OncLive.com,Negative
 MD,Targeted Oncology,Negative
 MD,MedPage Oncology,Negative
 MD,Alliance for Clinical Trials in Oncology,Positive
 MD,Columbia Med School,Positive
 ASH AZ,DR.ARUN ACHUTHAN,Positive
 ASH AZ,cafepharma,Negative
 PIII ELEVATE TN Study,PharmaShots - Incisive news in 3 shots,Negative
 HemsOncs,Breaking Data,Negative
 insights,Breaking Data,Negative
 insights,Expert Perspectives in Oncology,Positive
 insights,NewYork-Presbyterian,Positive
 insights,AbbVie Australia,Positive
 insights,LymphomaAction,Negative
 insights,Wilmot Cancer Institute,Negative
 insights,CCO Oncology,Positive
 insights,NY Genome Center,Negative
 insights,PRIME Education,Negative
 insights,CLLSA,Negative
 insights,CARE‚Ñ¢ Education,Positive
 acalabrutinib acalabrutinib,Breaking Data,Negative
 venetoclax   obinutuzumab ibrutinib,Breaking Data,Negative
 venetoclax zanubrutinib ibrutinib,Breaking Data,Negative
 Learn,Breaking Data,Negative
 Learn,Cancer Trials Support Unit,Positive
 Learn,Hugo Barona,Positive
 Learn,The James,Negative
 Breaking Data,Breaking Data,Negative
 CLL Rapid Impact Report,Breaking Data,Negative
 Acalabrutinib Regimens,CellworksLife,Negative
 TreatmentNa√Øve Patients,CellworksLife,Negative
 TreatmentNa√Øve Patients,Alicia Bell IFBB Pro,Negative
 TreatmentNa√Øve Patients,Medicalnewser.com,Negative
 TreatmentNa√Øve Patients,FDA Daily,Negative
 TreatmentNa√Øve Patients,HSMN,Negative
 TreatmentNa√Øve Patients,HEDGE accordinglyüìà,Negative
 TreatmentNa√Øve Patients,RazzleTazzle,Negative
 TreatmentNa√Øve Patients,Odi Bruckman,Negative
 TreatmentNa√Øve Patients,Tom Silver,Negative
 TreatmentNa√Øve Patients,Paul Lane,Negative
 TreatmentNa√Øve Patients,Scott Werntz,Negative
 leukaemia drug Calquence,Jon Angelo,Negative
 leukaemia drug Calquence,Pharmafocus,Negative
 time patients,Career Biotech,Negative
 time patients,Pharma Regulatory,Negative
 time patients,oncoletter,Negative
 previously untreated   AZN,1stOncology,Negative
 ELEVATETN„Åä„Çà„Å≥ASCENDË©¶È®ì„ÅÆË§áÊï∞„ÅÆË©¶È®ì„Å´„Åä„ÅÑ„Å¶„ÄÅ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÅØËâØÂ•Ω „É™„É≥„ÇØ,Tweets,Positive
 „Ç∞ÔºöË©¶È®ì,Tweets,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Ê†™Âºè‰ºöÁ§æ„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâÁ±≥ÂõΩ„Å´„Åä„ÅÑ„Å¶ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÔºàCLLÔºâÊàê‰∫∫ÊÇ£ËÄÖ„Åï„Çì„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶ÊâøË™çÂèñÂæó,‰∏≠‰∫ï‰∫ÆÂ§™ÈÉé,Positive
 Calquence Acalarutinib adalah obat baru untuk kanker leukemia yaitu Mantle Cell Lymphoma,Majalah Farmasetika,Positive
 MCL dan Chronic Lymphocytic Leukimia CLL,Majalah Farmasetika,Positive
 Pada   Food Drug Administration,Majalah Farmasetika,Positive
 Government FDA telah menyetujui Calquence,Majalah Farmasetika,Positive
 Calquence Acalarutinib adalah obat baru untuk kanker leukemia yaitu Mantle Cell Lymphoma MCL dan Chronic Lymphocytic Leukimia CLL   Pada   Food Drug Administration Government,Info Farmasi Terkini,Positive
 Êñ∞ÁùÄË®ò‰∫ã„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâÁ±≥ÂõΩ„Å´„Åä„ÅÑ„Å¶ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÔºàCLLÔºâÊàê‰∫∫ÊÇ£ËÄÖ,Ëñ¨Ââ§Â∏´„Ç¶„Ç©„ÉÉ„ÉÅ„ÄÄÁõ∏‰∫í„Éï„Ç©„É≠„Éº,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâÁ±≥ÂõΩ„Å´„Åä„ÅÑ„Å¶ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÔºàCLLÔºâÊàê‰∫∫ÊÇ£ËÄÖ„Åï„Çì„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó,PR TIMES„Éì„Ç∏„Éç„Çπ,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâÁ±≥ÂõΩ„Å´„Åä„ÅÑ„Å¶ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÔºàCLLÔºâÊàê‰∫∫ÊÇ£ËÄÖ„Åï„Çì„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó,PR TIMES„Éã„É•„Éº„Çπ,Positive
 longterm followup study,WCM Lymphoma,Negative
 RR   patients,WCM Lymphoma,Negative
 RR   patients,VJHemOnc,Negative
 RR   patients,"chadi nabhan MD, MBA, FACP",Negative
 RR   patients,Lymphoma Hub,Negative
 RR   patients,"Raul Cordoba, MD, PhD",Negative
 RR   patients,Marta Crespo,Negative
 w acalabrutinib,WCM Lymphoma,Negative
 Excellent summary,"Amber Koehler, PA-C",Negative
 Excellent summary,Kate Cwynarski,Positive
 Excellent summary,CLL Society Inc.,Negative
   experience,"Amber Koehler, PA-C",Positive
   experience,Tinu Abayomi-Paul,Negative
   experience,Patient Power,Negative
 Jennifer Woyach,Lymphoma Hub,Positive
 Jennifer Woyach,Research To Practice,Negative
 Jennifer Woyach,Taylor Lab UM,Negative
 Jennifer Woyach,Sigrid Sk√•nland,Negative
 Jennifer Woyach,The James,Negative
 Jennifer Woyach,VJHemOnc,Positive
 discusses mechanisms,Lymphoma Hub,Negative
 resistance,Lymphoma Hub,Negative
 resistance,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 resistance,ClinOwl Haematology,Negative
 resistance,the paper link,Negative
 resistance,TYR Kinase papers,Negative
 resistance,Lymphoma Papers,Negative
 resistance,Paperbirds_Hematology,Positive
 resistance,minnlab_litbot,Positive
 resistance,donnashort,Negative
 resistance,"chadi nabhan MD, MBA, FACP",Negative
 resistance,ac,Positive
 resistance,Blood Advances,Negative
 resistance,Aloysius Pendergast,Positive
 resistance,"Raul Cordoba, MD, PhD",Positive
 resistance,AbbVie US,Positive
 resistance,Benlazar S.M Amin√©,Positive
 resistance,Fleur Peters,Positive
 resistance,Toby Eyre,Negative
 resistance,Zusia:Dr Jackie Volk,Positive
 resistance,VJHemOnc,Positive
 resistance,Prof John,Negative
 resistance,Michael Hallek,Negative
 resistance,Medscape Education,Negative
 resistance,Triona N√≠ Chonghaile,Negative
 resistance,Cancer Discovery,Negative
 resistance,CLL Society Inc.,Negative
 resistance,CLL Ireland,Positive
 resistance,Living Safely,Negative
 resistance,Taylor Lab UM,Negative
 resistance,SIAM,Positive
 resistance,Santiago Carmona üß¨ üñ•Ô∏è üë®üèæ‚Äçüî¨,Positive
 resistance,Hyun Goo Woo,Positive
 resistance,Penn Path & Lab Medicine,Positive
 resistance,SiCORE in Immunoregulation,Positive
 resistance,CRISP_SCIENCE,Positive
 resistance,ImmunotherapyPapers,Negative
 resistance,TumImmTxpapers,Negative
 resistance,Krishan Maggon,Negative
 resistance,"Bruce Levine, Ph.D.",Positive
 resistance,Continuum AEP,Positive
 resistance,All Ways Well,Positive
 resistance,NY Genome Center,Negative
 resistance,MDedge Hematology & Oncology,Negative
 resistance,ARUP Laboratories,Positive
 resistance,TumorImmunoPapers,Negative
 resistance,Oncology Tube,Negative
 resistance,Blood Journal,Negative
 resistance,Broad Institute,Positive
 resistance,Targeted Oncology,Negative
 resistance,Vincent Rajkumar,Negative
 resistance,Cancer Papers,Negative
 resistance,CHS Chief Resident,Positive
 resistance,Francesco Turturro,Negative
 resistance,ImmunologyPapers,Negative
 characteristics,"Mark Geyer, M.D.",Negative
 characteristics,Medscape Education,Negative
 characteristics,Patient Power,Positive
 BTK C mutations,Chan Cheah,Negative
 acalabrutinib resistant CLL,Chan Cheah,Negative
 Acalabrutinib Treatment Superior,Jeff Sharman,Positive
 Acalabrutinib Treatment Superior,Aloysius Pendergast,Positive
 TreatmentNa√Øve CLL,Jeff Sharman,Positive
 TreatmentNa√Øve CLL,Aloysius Pendergast,Positive
 TreatmentNa√Øve CLL,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 TreatmentNa√Øve CLL,CancerTherapyAdvisor,Negative
 triplet,OncLive.com,Negative
 triplet,Targeted Oncology,Negative
 ASH   Acalabrutinib con o sin obinutuzumab mejora,contacto sciencelink,Negative
 la SLP,contacto sciencelink,Positive
 ScienceLink,contacto sciencelink,Positive
 cycle,Targeted Oncology,Negative
 cycle,Dr. Luis Villela,Positive
 cycle,Joe,Negative
 cycle,Toby Eyre,Negative
 cycle,adam,Positive
 cycle,AbbVie,Negative
 cycle,Patient Power,Negative
 improved progressionfree survival,ASH Clinical News,Negative
 improved progressionfree survival,1stOncology,Negative
 improved progressionfree survival,Cision News,Negative
 treatmentna√Øve chronic lymphocytic,ASH Clinical News,Negative
 disease progression death,FirstWord Pharma,Positive
 Frontline CLL,Silas Inman,Negative
 Frontline CLL,OncLive.com,Negative
 Frontline CLL,Immuno-Oncology,Negative
 Frontline CLL,Crwe World,Negative
 Frontline CLL,CLL Ireland,Negative
   Approves Acalabrutinib,The ASCO Post,Negative
   Approves Acalabrutinib,CellworksLife,Negative
 Frontline acalabrutinib regimen,Oncology Board,Negative
 acalabrutinib data,Phil Talamo,Negative
 acalabrutinib data,Judith Trotman,Positive
 acalabrutinib data,"Caner Saygin, MD",Negative
 acalabrutinib data,MG,Positive
 RICE,CureHuntr,Negative
 RICE,TrialBulletin,Negative
 Refractory Lymphoma,CureHuntr,Negative
 Refractory Lymphoma,TrialBulletin,Negative
 Status,TrialBulletin,Positive
 Status,MDedge Hematology & Oncology,Negative
 Large B Cell Lymphoma Chronic Lymphocytic Leukemia,TrialBulletin,Negative
 Clinical News,Aloysius Pendergast,Positive
 Clinical News,Michele Nadeem-Baker,Negative
 Clinical News,Guillermo Sanz,Negative
 Clinical News,"Raul Cordoba, MD, PhD",Negative
 footsteps,Dave Hughes,Positive
 novel agents,Dave Hughes,Positive
 novel agents,"Michael Wang, MD",Negative
 novel agents,Medivizor,Positive
 novel agents,RedMedEd,Positive
 novel agents,Paperbirds_Hematology,Negative
 novel agents,CLL Advocates Network,Negative
 novel agents,INDoximity üáÆüá≥,Negative
 novel agents,Alan Skarbnik,Negative
 novel agents,ASH Clinical News,Positive
 novel agents,APSHO,Negative
 novel agents,Taylor Lab UM,Negative
 novel agents,CURE Magazine,Negative
 novel agents,CLL Society Inc.,Negative
 novel agents,Patient Power,Negative
 novel agents,Expert Perspectives in Oncology,Positive
 novel agents,"Jill Kleczko, MPA, CCRP",Positive
 novel agents,"Raul Cordoba, MD, PhD",Positive
 novel agents,CLL Ireland,Negative
 novel agents,Anna Deveau,Negative
 novel agents,"Caner Saygin, MD",Negative
 novel agents,WCM Lymphoma,Negative
 novel agents,"chadi nabhan MD, MBA, FACP",Negative
 novel agents,MD Anderson Leukemia,Negative
 novel agents,VJHemOnc,Positive
 novel agents,Waleed Osman,Positive
 novel agents,Targeted Oncology,Negative
 Dr Lampson,Targeted Oncology,Negative
 Dr Lampson,"chadi nabhan MD, MBA, FACP",Negative
 lead author,Targeted Oncology,Negative
 frontline AVO triplet,Targeted Oncology,Negative
 Location coverage,ASH Clinical News,Negative
 highlights,ASH Clinical News,Negative
 highlights,OncLive.com,Negative
 highlights,Toby Eyre,Negative
 highlights,Sigrid Sk√•nland,Negative
 highlights,LYMPHOMA & MYELOMA CONNECT,Positive
 highlights,Patient Power,Negative
 highlights,rfcb,Positive
 highlights,Lymphoma Hub,Positive
 highlights,VJHemOnc,Positive
 highlights,Team Intake.Me,Negative
 highlights,WCM Lymphoma,Negative
 highlights,James Ball,Positive
 day,ASH Clinical News,Negative
 day,"Mazyar Shadman, MD MPH",Negative
 day,Lymphoma Hub,Positive
 day,CHELSEA DAKAR SUPPORTERS CLUB,Positive
 day,AbbVie Canada,Positive
 day,GenQA (Genomics Quality Assessment),Negative
 day,Stephen Brown,Positive
 day,Raj Chakraborty,Positive
 day,Anthony Mato,Negative
 day,medwireNews,Negative
 day,CLL Advocates Network,Negative
 day,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 day,Sigrid Sk√•nland,Negative
 day,CryptoLiveLeak,Negative
 day,√ìrla Stewart üíô,Positive
 day,CLL Ireland,Negative
 day,CLL Warwick Uni,Positive
 day,RIOH,Negative
 day,Shweta Prakash,Positive
 day,Gina Angel,Positive
 day,OncLive.com,Negative
 day,CURE Magazine,Positive
 day,Beth Torr,Positive
 day,VJHemOnc,Negative
 day,Amanda Marie,Positive
 day,Stock Bot,Positive
 day,PER,Negative
 day,EYFSMagic,Positive
 day,Patient Power,Negative
 day,CLLSA,Negative
 day,BloodWork,Positive
 day,CADTH,Negative
 day,Katie Gould,Positive
 day,C_R_Williamson,Positive
 day,Rob P,Positive
 day,Kiheikat,Positive
 day,TESL Canada,Positive
 day,ASH,Negative
 look,ASH Clinical News,Positive
 look,VJHemOnc,Negative
 look,Research To Practice,Negative
 look,healthbook,Positive
 look,Lymphoma Hub,Positive
 look,CLLSA,Positive
 look,MedPage Oncology,Negative
 look,AplusA World,Negative
 look,RTI Health Solutions,Positive
 look,Targeted Oncology,Negative
 look,Jon,Negative
 look,Juan Carlos Garc√©s,Positive
 look,Future Oncology,Negative
 look,Leukaemia Care,Positive
 look,Patient Power,Negative
 look,Prairie Lakes Church,Positive
 News,HemOnc Today,Positive
 News,Lymphoma Hub,Negative
 News,Delreo Johnson,Positive
 News,Leukemia Research Foundation,Positive
 News,medwireNews,Negative
 News,Hlthnews,Negative
 News,American Cancer Society,Positive
 News,HSMN,Positive
 News,Anthony Mato,Negative
 News,TRADY77,Positive
 News,Liz Highleyman,Positive
 News,AbbVie,Negative
 News,CryptoLiveLeak,Positive
 News,The Lancet Oncology,Negative
 News,CLL Ireland,Positive
 News,Michele Nadeem-Baker,Negative
 News,Novartis,Positive
 News,Women's Health News,Positive
 News,Scott Merville,Negative
 News,Patient Power,Positive
 News,Biotech-Spain.com,Positive
 News,Brand Communications,Positive
 Frontline acalabrutinib,HemOnc Today,Negative
 Huge Calquence booth,Brian Skorney,Positive
 Mechanism,Ayushi Chauhan,Positive
 Mechanism,ImmunologyPapers,Negative
 Mechanism,Frontiers Oncology,Negative
 Mechanism,J Immunol,Negative
 Mechanism,MoJo,Negative
 Mechanism,Oncology Board,Negative
 Mechanism,Oncology Tube,Negative
 headache,Ayushi Chauhan,Positive
 headache,donnashort,Negative
 clinic experience,Ayushi Chauhan,Positive
 Dr Bruce Cheson,Ayushi Chauhan,Positive
 Dr Bruce Cheson,Biotech2050,Negative
 thing,Ayushi Chauhan,Positive
 thing,CLL Society Inc.,Negative
 thing,VJHemOnc,Negative
 thing,Teresa Martin,Positive
 coffee,Ayushi Chauhan,Positive
 coffee,Genentech,Negative
 Headache,Toby Eyre,Negative
 Headache,Medscape Education,Negative
 Q,Watzan,Positive
 Q,Brad Loncar,Positive
 Q,M,Positive
 Q,Lab Test,Positive
 Q,Patient Worthy,Negative
 Q,hematologist,Negative
 Q,iwCLL,Positive
 Q,Patient Power,Negative
 Q,Mayo Clinic,Positive
    FYI,"Dr. Paul DeSantis, PharmD",Negative
 patients dc Ibrutinib,"Dr. Paul DeSantis, PharmD",Negative
 tox,"Dr. Paul DeSantis, PharmD",Negative
 tox,Toby Eyre,Negative
 Calquence combination,flylemurs,Positive
 leukemia patients,flylemurs,Positive
 leukemia patients,Patient Daily,Negative
 leukemia patients,ReaderUSA,Positive
 leukemia patients,JUICEPharma,Positive
 story,flylemurs,Positive
 story,Giuseppe Michieli,Positive
 story,Jacob Plieth,Negative
 story,Patient Empowerment Network,Negative
 story,Paul Wright,Positive
 story,Lynne Mac Lean,Positive
 story,"Chaitra Ujjani, MD",Positive
 story,Just Jen,Positive
 story,MEI Pharma,Positive
 story,Cancer Support Community,Negative
 story,Cancer Papers,Negative
 story,Paperbirds_Hematology,Negative
 story,UVA Science Pubs,Positive
 story,Christopher DeBoever,Positive
 story,CLL Society Inc.,Negative
 story,Oak Tree Primary School,Positive
 story,CLL Ireland,Positive
 story,Penn IFI,Positive
 story,Immune Regulation News,Negative
 story,CLLSA,Positive
 story,Andrew Schorr,Positive
 story,Leukaemia Care,Negative
 story,Digital Health Space,Positive
 story,Targeted Oncology,Negative
 story,Patient Power,Positive
 story,CLL Warwick Uni,Negative
 story,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 story,Dr. Andy Evens,Negative
 story,Rachel Tompa,Positive
 story,marina,Positive
 story,foreignmoney.com,Positive
 story,thesecondopinion,Positive
 wacala x month,"Amber Koehler, PA-C",Negative
 risk,"Amber Koehler, PA-C",Positive
 risk,LYMPHOMA & MYELOMA CONNECT,Negative
 risk,OncLive.com,Negative
 risk,FirstWord Pharma,Negative
 risk,Ed,Positive
 risk,"Tom Curley, MD",Positive
 risk,CLL Society Inc.,Negative
 risk,Michele Nadeem-Baker,Negative
 risk,Jan Rynne,Positive
 risk,VJHemOnc,Positive
 risk,DRG Epidemiology,Negative
 risk,GMO Free USA,Positive
 risk,Non-GMO Report,Positive
 risk,Lymphoma Papers,Positive
 risk,MD Anderson Cancer Center,Negative
 risk,OncLive SOSS,Negative
 risk,Toby Eyre,Positive
 risk,Paperbirds_Hematology,Positive
 risk,GO GREEN,Positive
 risk,Extinction Crisis,Positive
 risk,Nathan Donley,Positive
 risk,Javid Moslehi,Positive
 risk,CLL Advocates Network,Negative
 risk,Medivizor,Positive
 risk,noel cole,Negative
 risk,Taylor Lab UM,Negative
 risk,Leukemia I'm Fine,Negative
 risk,Chocolatiere Phys,Negative
 risk,Lynne Mac Lean,Negative
 risk,ASH Clinical News,Negative
 risk,Targeted Oncology,Positive
 risk,Oncology Nursing News,Negative
 risk,MDedge Hematology & Oncology,Negative
 risk,Graviola Finland,Positive
 risk,Jennifer Kwan MD PhD,Positive
 risk,CLL Ireland,Positive
 risk,Mahmoud Aljurf,Negative
 risk,ASH,Negative
 risk,Peter G,Positive
 risk,Blood Journal,Negative
 risk,"Raul Cordoba, MD, PhD",Negative
 risk,Oscar Lahoud,Positive
 risk,Cancer_Tribune,Negative
 risk,@immunoonco_Meed,Positive
 risk,Claire Vajdic,Positive
 risk,Philip McCarthy,Negative
 risk,MoJo,Negative
 risk,CLL_Fightersüéó,Negative
 risk,Lymphoma Hub,Negative
 risk,EMJ Hematology,Negative
 risk,Süíâmon M‚≠ïÔ∏è‚≠ïÔ∏èijaart,Positive
 risk,"Pharmacyclics, an AbbVie Company",Negative
 risk,MDLinx,Negative
 risk,Dr Steve,Positive
 risk,TumorImmunoPapers,Negative
 risk,Libro Azul,Positive
 risk,"Naveen Pemmaraju, MD",Negative
 infusion rxn,"Amber Koehler, PA-C",Negative
 obin,"Amber Koehler, PA-C",Negative
 Ven,"Amber Koehler, PA-C",Negative
 C,"Amber Koehler, PA-C",Negative
 C,ivy science,Negative
 C,Financial Buzz,Negative
 C,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 TLS,"Amber Koehler, PA-C",Negative
 TLS,Faheema Hasan,Positive
 TLS,Toby Eyre,Negative
 TLS,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 TLS,"chadi nabhan MD, MBA, FACP",Negative
 TLS,Tapan Kadia,Negative
 CLL Interesting outcome,Dr. Luis Villela,Positive
 BM MRD Neg,Dr. Luis Villela,Positive
 Benjamin Lampson,Lymphoma Hub,Negative
 II data,Lymphoma Hub,Negative
 II data,Chan Cheah,Negative
 II data,Toby Eyre,Negative
 frontline CLL therapy,Lymphoma Hub,Negative
 rampup AVO w duration,"Mark Geyer, M.D.",Negative
 MRD,"Mark Geyer, M.D.",Negative
 MRD,CLL Society Inc.,Negative
 MRD,VJHemOnc,Positive
 MRD,Nitin Jain,Negative
 MRD,Krish Patel,Positive
 MRD,clonoSEQ,Positive
 MRD,NeoGenomics,Positive
 MRD,MD Anderson Leukemia,Negative
 MRD,OncLive SOSS,Negative
 MRD,OncLive.com,Negative
 MRD,Rajesh Sharma,Negative
 MRD,Lymphoma Research Foundation,Negative
 MRD,Michele Nadeem-Baker,Negative
 MRD,Anthony Mato,Negative
 MRD,PRAJAK BARDE,Positive
 MRD,"chadi nabhan MD, MBA, FACP",Positive
 MRD,Medscape Education,Negative
 MRD,Oncology Tube,Negative
 MRD,Medivizor,Positive
 MRD,Lymphoma Hub,Positive
 MRD,AbbVie,Positive
 MRD,Anna Deveau,Negative
 MRD,CLL Ireland,Negative
 MRD,PharmaStar,Negative
 MRD,"Raul Cordoba, MD, PhD",Negative
 MRD,Pathowitter,Positive
 MRD,Beatriz P√©rez Sanz,Positive
 MRD,Roche,Negative
 Conclusions,Sigrid Sk√•nland,Negative
 Conclusions,"Caner Saygin, MD",Positive
 Conclusions,"chadi nabhan MD, MBA, FACP",Positive
 Conclusions,"Amber Koehler, PA-C",Negative
 Conclusions,Lymphoma Hub,Negative
 ELEVATE TN study,Sigrid Sk√•nland,Negative
 ELEVATE TN study,LYMPHOMA & MYELOMA CONNECT,Negative
 ELEVATE TN Phase,Cancer Medicine,Positive
 ELEVATE TN Phase,"Raul Cordoba, MD, PhD",Negative
 ELEVATE TN Phase,Paperbirds_Hematology,Negative
 Acalabrutinib Combo wObinutuzumab,Cancer Medicine,Positive
 Vs OChlorambucil,Cancer Medicine,Positive
 TreatmentNaive CLL Session,Cancer Medicine,Positive
 Sat Dec   Hall D Level,Cancer Medicine,Positive
 Orange Co Conv Ctr,Cancer Medicine,Positive
 curves,"Amber Koehler, PA-C",Negative
 curves,donnashort,Negative
 improved PFS,"Amber Koehler, PA-C",Negative
 improved PFS,The Lancet Haematology,Negative
 improved PFS,"Raul Cordoba, MD, PhD",Negative
 improved PFS,Lymphoma Hub,Negative
 improved PFS,NE Live,Negative
 improved PFS,Michael Goodman,Negative
 CR,"Amber Koehler, PA-C",Negative
 CR,MyelomaLymphoma,Positive
 CR,Benlazar S.M Amin√©,Negative
 CR,"chadi nabhan MD, MBA, FACP",Negative
 CR,"Dr. Paul DeSantis, PharmD",Negative
 CR,Anna Deveau,Positive
 CR,Adaptive Biotech,Positive
 ELEVATE,Alberto L√≥pez Garc√≠a,Positive
 ELEVATE,"chadi nabhan MD, MBA, FACP",Negative
 m,Alberto L√≥pez Garc√≠a,Positive
 m,Toby Eyre,Positive
 m,Vaibhav kumar gupta,Positive
 m,Christopher Steer,Negative
 ELEVATE study,Marcio,Positive
 ELEVATE study,Miguel Canales,Positive
 ELEVATE study,"chadi nabhan MD, MBA, FACP",Negative
 VS   Chlorambucil,Marcio,Positive
 CLL morning session,The Lancet Haematology,Negative
 ELEVATE TN phase,The Lancet Haematology,Negative
 Chrorambucil trial,The Lancet Haematology,Negative
 PFS comparison,The Lancet Haematology,Negative
 combination tx,The Lancet Haematology,Negative
 GAcala,Miguel Canales,Positive
 GChl,Miguel Canales,Positive
 GChl,Alan Skarbnik,Negative
 abstract,Alan Skarbnik,Negative
 abstract,TAP Clinical Trial Network,Negative
 abstract,Sigrid Sk√•nland,Negative
 abstract,NNECOS,Positive
 abstract,"Raul Cordoba, MD, PhD",Negative
 TN CLL,Alan Skarbnik,Negative
 Acalabrutinib   Obinutuzumab,Alan Skarbnik,Negative
 acala monotherapy,Alan Skarbnik,Negative
 OFS benefit,Alan Skarbnik,Negative
 IGHV mutated patients,Alan Skarbnik,Negative
 IGHV mutated patients,Jeff Szer,Negative
 IbrutinibIntolerant Mantle Cell Lymphoma,CureHuntr,Negative
 IbrutinibIntolerant Mantle Cell Lymphoma,Lung Cancer News,Negative
 IbrutinibIntolerant Mantle Cell Lymphoma Status,TrialBulletin,Negative
 ibrutinib Acalabrutinib,Lung Cancer News,Negative
 Accelerated approval,Health Canada and PHAC,Positive
 L‚Äôhomologation,Sant√© Canada et l‚ÄôASPC,Positive
 acc√©l√©r√©e de Calquence qui,Sant√© Canada et l‚ÄôASPC,Positive
 AZN BGNE,NYCDoc29,Negative
 headtohead trial,OncLive SOSS,Negative
 headtohead trial,"Michael Wang, MD",Negative
 deletion p,OncLive SOSS,Negative
 q,OncLive SOSS,Negative
 q,Paperbirds_Hematology,Negative
 q,ClinChemINFO,Positive
 tcoqIGyVoZbT,OncLive SOSS,Negative
 IYCMI CALQUENCE,Patient Worthy,Negative
 FDA Approval,Patient Worthy,Negative
 FDA Approval,Shohta Kadomura Hospital Pharmacist,Negative
 FDA Approval,The Purple Society,Negative
 FDA Approval,Professione Farmacia,Negative
 FDA Approval,Pharmacy Edge,Positive
 FDA Approval,Pharmacy Times,Negative
 FDA Approval,PSK2329 - JHC,Negative
 FDA Approval,carlota bernal,Positive
 FDA Approval,Hematopoiesis News,Negative
 FDA Approval,kyookine,Positive
 Benefit Adults,Patient Worthy,Negative
 Dr Mato,OncLive SOSS,Negative
 Dr Mato,CLL Society Inc.,Negative
 Dr Mato,Patient Empowerment Network,Negative
 Dr Mato,Targeted Oncology,Negative
 Dr Mato,Expert Perspectives in Oncology,Negative
 Dr Mato,Lymphoma Hub,Negative
 Dr Mato,6HN Oncology Nurses,Negative
 Jeezus,BiotechObserver,Positive
 Food Drug Administration,CURE Magazine,Positive
 Food Drug Administration,Regulatory Jobs,Positive
 Food Drug Administration,GRACE,Negative
 Food Drug Administration,Mellalta Meets,Negative
 Food Drug Administration,Tina Witte,Positive
 Food Drug Administration,Biotech & Tech Stock Focus,Negative
 Food Drug Administration,IMPharma News,Negative
 Food Drug Administration,Jodie Insights,Negative
 Food Drug Administration,dough,Negative
 Food Drug Administration,Stock Titan,Negative
 Food Drug Administration,Society for Immunotherapy of Cancer,Negative
 Food Drug Administration,National Cancer Institute,Positive
 Food Drug Administration,Drug Store News,Positive
 Food Drug Administration,LLS WA/AK Chapter,Positive
 Food Drug Administration,"LLS, Georgia Chapter",Positive
 Food Drug Administration,ArkansasLLS,Positive
 Food Drug Administration,pocroncology,Positive
 Food Drug Administration,MAISA,Negative
 Food Drug Administration,Joyjeet Paul,Positive
 acalabrutinib Calquence AstraZeneca,Drug Topics,Positive
   presenta datos de Calquence,Acobur,Positive
   presentar√° los datos del ensayo Fase III ELEVATETN de Calquence acalabrutinib,IM M√©dico,Positive
 primera l√≠nea,IM M√©dico,Positive
 como otros avances,IM M√©dico,Positive
 Preliminary Safety,"Raul Cordoba, MD, PhD",Negative
 Phase   Study,"Raul Cordoba, MD, PhD",Negative
 Phase   Study,Tom Silver,Negative
 Obinutuzumab O,"Raul Cordoba, MD, PhD",Negative
 Obinutuzumab O,Paperbirds_Hematology,Negative
 Vs O Plus Chlorambucil Clb,"Raul Cordoba, MD, PhD",Negative
 Vs O Plus Chlorambucil Clb,Paperbirds_Hematology,Negative
 TreatmentNaive Chronic Lymphocytic Leukemia CLL,"Raul Cordoba, MD, PhD",Negative
 TreatmentNaive Chronic Lymphocytic Leukemia CLL,Paperbirds_Hematology,Negative
 diciembre los primeros datos de Calquence,Pharma Jonpi .,Negative
     presenta datos de Calquence,Redacci√≥n M√©dica,Positive
 √©utica AstraZeneca presenta datos de Calquence,Redacci√≥n M√©dica,Positive
 V√≠a   AstraZeneca presenta nuevos datos de Calquence,LifeStyle Profesional (by El Neuropediatra),Positive
 Nuevos datos,Acta Sanitaria,Negative
 de   sobre Calquence,Acta Sanitaria,Negative
 FDA Approves Acalabrutinib,ESMO - Eur. Oncology,Negative
 FDA Approves Acalabrutinib,"Stayin' Alive: Body, Mind, Spirit",Positive
 FDA Approves Acalabrutinib,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 FDA Approves Acalabrutinib,Barbara Jacoby,Negative
 FDA Approves Acalabrutinib,FDA Daily,Negative
 FDA Approves Acalabrutinib,HCP Feed,Positive
 FDA Approves Acalabrutinib,"Tom Henry, MBA, RPh, CPh",Negative
 FDA Approves Acalabrutinib,Jeff Szer,Negative
 FDA Approves Acalabrutinib,SpecialtyPTimes,Negative
 FDA Approves Acalabrutinib,Jason Broderick,Negative
 FDA Approves Acalabrutinib,S O P A,Positive
 FDA Approves Acalabrutinib,Kerri Wachter,Negative
 FDA Approves Acalabrutinib,Immuno-Oncology,Positive
 FDA Approves Acalabrutinib,Silas Inman,Positive
 FDA Approves Acalabrutinib,Oncology Strategies,Negative
 FDA Approves Acalabrutinib,OncLive SOSS,Negative
 FDA Approves Acalabrutinib,UKiwiS,Positive
 FDA Approves Acalabrutinib,Ethical Recruiters,Positive
 FDA Approves Acalabrutinib,PER,Negative
 SLL Evidence,ESMO - Eur. Oncology,Positive
 ELEVATETN ASCEND studies,ESMO - Eur. Oncology,Positive
   approved acalabrutinib,Lymphoma Hub,Negative
   approved acalabrutinib,Lymphoma Research Foundation,Negative
 CognitrexCancerDigest FDA,Cognitrex Consultants,Positive
 lymp,Cognitrex Consultants,Positive
 Weekly Drug News,Drugs.com,Negative
 FDA drug approval news,Drugs.com,Negative
 Oxbryta,Drugs.com,Negative
 Title Calquence,Catherine Cohen,Positive
 CLL SLLCategory Health NewsCreated,Catherine Cohen,Positive
 AMLast Editorial Review,Catherine Cohen,Positive
 Australia,Medscape Pharmacists,Negative
 Australia,Medscape,Negative
 Australia,Medscape Oncology,Negative
 Australia,BioCentury,Positive
 Australia,CLL Ireland,Positive
 Australia,CLL Society Inc.,Negative
 Australia,Christopher Steer,Negative
 Australia,ecancer,Negative
 Treat CLL,Times of Newsüê¶,Positive
 Treat CLL,Fav-store,Negative
 CLLSLL„ÅåÊù•Âπ¥„ÅÇ„Åü„Çä„Åã„ÇâÊÖå„Åü„Å†„Åó„Åè„Å™„Çä„Åù„ÅÜ„Å™‰∫àÊÑü„Åô„Åß„Å´ven„ÇÇÁô∫Â£≤„Åï„Çå„Åæ„Åó„Åü„Åå,Shohta Kadomura Hospital Pharmacist,Negative
   FDA Approves Acalabrutinib,ESMO - Eur. Oncology,Negative
 Treatment Option,BioNews,Negative
 Chronic Lymphocytic Leukemia Status,TrialBulletin,Positive
 Condition Summary Chronic Lymphocytic Leukemia Binet Staging System,TrialBulletin,Negative
   cronica Fda approva acalabrutinib,Medical Evidence üáÆüáπ,Negative
   cronica Fda approva acalabrutinib,Professione Farmacia,Negative
 treatments,Medivizor,Negative
 treatments,Chocolatiere Phys,Negative
 treatments,Wilmot Cancer Institute,Positive
 treatments,Patient Power,Positive
 treatments,CLL Ireland,Positive
 treatments,Jan Rynne,Positive
 treatments,BioPharma Global,Positive
 treatments,Michael Rynne,Positive
 treatments,ColumbiaCancer,Positive
 treatments,"Shonali Midha, M.D.",Positive
 treatments,Patient Empowerment Network,Negative
 treatments,Targeted Oncology,Negative
 treatments,Charlotte Martin,Positive
 treatments,NMDP/Be The Match Advocacy,Positive
 treatments,WCMNYPJCTO,Negative
 treatments,Abigail Jones,Positive
 treatments,AliKat üíô,Positive
 treatments,ASH,Negative
 treatments,NIHR Research,Positive
 treatments,VJHemOnc,Negative
 treatments,Only Medics,Negative
 treatments,Seema Vaidyanathan,Positive
 treatments,OncologyEducation,Negative
 treatments,FirstWord Pharma,Negative
 treatments,Lymphoma Hub,Negative
 treatments,jonathan r goodman,Positive
 treatments,Biocom California,Positive
 treatments,Mayo Clinic,Positive
 treatments,Matthias Piesche,Negative
 Leucemia linfatica cronica Fda approva acalabrutinib,informatori.it,Positive
 Calquence ÿßŸÑŸÖÿπÿ™ŸÖÿØÿ©,Arab Medical Pro,Positive
 Calquence ÿßŸÑŸÖÿπÿ™ŸÖÿØÿ©,ArabMedical.Pro,Positive
 CLL ÿå SLL,Arab Medical Pro,Positive
 CLL ÿå SLL,ArabMedical.Pro,Positive
 CLL SLL Title Calquence,Fitness Diet,Positive
 Treat CLL SLL Category Health News,Fitness Diet,Positive
 chronic lymphoma,PierretteJ.Cazeau #SDG #UNWomen#CSW65,Positive
 chronic lymphoma,hcrffngo#SDG #CSW65#CRIC19#WHM21,Positive
 chronic lymphoma,Jon Angelo,Negative
 chronic lymphoma,Pharmaceutical Market Europe,Positive
 chronic lymphoma,Pharma Regulatory,Negative
 Pharmafile,PierretteJ.Cazeau #SDG #UNWomen#CSW65,Positive
 Pharmafile,hcrffngo#SDG #CSW65#CRIC19#WHM21,Positive
 treat,Medivizor,Negative
 treat,CLL Ireland,Negative
 treat,CLL Society Inc.,Negative
 treat,PLN,Positive
 TGA approval,TGA Australia,Negative
 TGA approval,AUS Gov. News,Negative
 TGA approval,Pharma in Focus,Positive
 SLL cancersThe TGA,TGA Australia,Negative
 People,WCM Lymphoma,Negative
 People,Renal Cell Carcinoma,Positive
 People,Michele Nadeem-Baker,Negative
 People,Patient Power,Negative
 People,CLLSA,Positive
 People,Pharmacutical Daily,Positive
 People,Corporate News,Negative
 People,Parent Security,Positive
 People,Gregory D. Evans,Positive
 People,Crwe World,Positive
 People,"OTC Dynamics, Inc.",Negative
 People,Stock Market News,Negative
 People,Biotech & Tech Stock Focus,Negative
 People,Latest News from Business Wire,Negative
 People,MoonAngelWings....NO DM,Positive
 People,MyPathologyReport.ca,Negative
 People,TrialBulletin,Negative
 People,The Thinker,Positive
 People,CLL Ireland,Positive
 People,AbbVie US,Positive
 People,AbbVie,Positive
 People,The Pharmaceutical Marketing Group,Positive
 People,FDA Daily,Positive
 People,Armando Guglielmetti,Positive
 People,Sharon Johnson,Positive
 People,PressReleasePoint,Positive
 People,1stOncology,Positive
 People,Financial Buzz,Positive
 People,T Allen,Positive
 People,Gerry Ward,Positive
 People,Peter Schellinck,Positive
 People,Univ. of Rochester School of Medicine & Dentistry,Positive
 People,UR Medicine,Positive
 People,Hematopoiesis News,Negative
 People,Medicalnewser.com,Negative
 People,Connie Hampton,Positive
 People,Rare Diseases,Negative
 People,Pharma Commons,Negative
 People,DennisPartners,Negative
 People,ANTELLIS,Positive
 People,Anand Rotte,Positive
 People,Cancer Health,Negative
 People,Dr. Leona Saunders,Positive
 People,Vitamin D Council,Positive
 People,GPSN,Positive
 People,Jean-Michel TERME,Positive
 People,Mike Gauthier,Negative
 People,Health|VBProfiles,Positive
 People,Aktienmanufaktur,Negative
 People,BusinessWireProducts,Negative
 People,dlvr news,Negative
 People,Business Wire-Health,Negative
 People,Business Wire-TS,Negative
 People,dlvr health,Negative
 People,Matthew Kauffman,Negative
 Trial results,MPR,Negative
 Trial results,Plexus Ventures,Negative
 Trial results,VJHemOnc,Negative
 AstraZeneca scores,Thomas S√©n√©chal,Positive
 AstraZeneca scores,EIPG,Negative
 AstraZeneca scores,Endpoints News,Positive
 AstraZeneca scores,Dr Timos Papagatsias,Negative
 AstraZeneca scores,the world of CROs,Negative
 BTK race,Thomas S√©n√©chal,Positive
 BTK race,EIPG,Negative
 BTK race,Endpoints News,Positive
 BTK race,Dr Timos Papagatsias,Negative
 BTK race,the world of CROs,Negative
 Effects Interactions amp,Dr. Linex,Positive
 chronic,Pharmafocus,Negative
 chronic,New OhioLINK ETDs,Positive
 chronic,Lung Cancer News,Negative
 chronic,Avicenna J of Med,Positive
 chronic,Biotech2050,Negative
 CLL Claim,Pharma Regulatory,Negative
 CLL Claim,ZorgNL,Positive
 CLL Claim,Scrip,Negative
 Keeping Track,Derrick,Positive
 Approvals,Derrick,Positive
 Novel Drugs Givlaari,Derrick,Positive
 Project Orbis Collaboration Calquence,Derrick,Positive
 Humira Biosimilar,Derrick,Positive
 WATCH Dr Mato,OncLive.com,Negative
 label expansion,Investor News,Negative
 label expansion,BioCentury,Positive
 RHHBY AZN BIIB GILD,Investor News,Negative
 TAG   Acalabrutinib,AUS Gov. News,Negative
 CLL SLL cancers,AUS Gov. News,Negative
 Medivizor,Chocolatiere Phys,Negative
 p,Medivizor,Negative
 p,ResearchPool,Positive
 p,Psychiatry Intel,Positive
 p,WheelieDealer,Negative
 p,Henning,Negative
 p,Dr. Andy Evens,Negative
 p,MDedge Hematology & Oncology,Negative
 p,Daniel Ernst,Positive
 p,Anna Deveau,Negative
 p,EurekaMag,Negative
 p,TumorImmunoPapers,Negative
 p,BianFahrezy.,Positive
 p,Lymphoma Hub,Negative
 p,"Jeremy Warner MD, MS, FAMIA, FASCO",Positive
 p,Paul Kettle,Positive
 p,Salutedomani,Negative
 p,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 p,Frank,Positive
 p,Free Cello Tuner,Negative
 p,Ian Morgan-Smith,Positive
 ÿ™ÿßÿ¶€åÿØ ÿØÿßÿ±Ÿà€å Calquence,Phana,Positive
 ÿØÿ±ŸÖÿßŸÜ CLL Ÿà,Phana,Positive
 SLLÿØÿßÿ±Ÿà€å Calquence acalabrutinib ÿ¥ÿ±⁄©ÿ™ ÿßÿ≥ÿ™ÿ±ÿßÿ≤ŸÜ⁄©ÿß,Phana,Positive
 Project Orbis initiative,OncLive.com,Negative
 phase III randomized trials,OncLive.com,Negative
 Drs John Byrd,"Yiping Yang, MD, PhD",Positive
 Jen Woyach,"Yiping Yang, MD, PhD",Positive
 FDAapproval,"Yiping Yang, MD, PhD",Positive
 Fridays company news roundup,BioCentury,Positive
 Project,BioCentury,Positive
 Project,PharmaShots - Incisive news in 3 shots,Negative
 Project,TrialBulletin,Negative
 FDA Canada,BioCentury,Positive
 news,BioCentury,Positive
 news,ATOPP Summit,Positive
 news,Jacob Plieth,Negative
 news,[iito] Life Science,Positive
 news,European Pharmaceutical Review,Negative
 news,CLL Society Inc.,Negative
 news,(bio)technerd,Positive
 news,Brian Kenney,Positive
 news,CLL Ireland,Negative
 news,Michele Nadeem-Baker,Positive
 news,Andrew Schorr,Positive
 news,Patient Power,Positive
 news,Dr Timos Papagatsias,Positive
 news,MedPage Today,Negative
 news,Wilmot Cancer Institute,Negative
 news,Hoofcare+Lameness,Positive
 news,VJHemOnc,Positive
 news,Cancer_Tribune,Negative
 news,Patient Empowerment Network,Negative
 news,the cummunist,Positive
 news,brandingscience,Positive
 news,JUICEPharma,Positive
 ViiV Neon Horizon SK Bio,BioCentury,Positive
 WuXi Vaccines,BioCentury,Positive
 AZN NTGN,BioCentury,Positive
 Treat CLL SLL,Zaspera,Positive
 Êñ∞ÁùÄË®ò‰∫ãFDA Approves Acalabrutinib,Ëñ¨Ââ§Â∏´„Ç¶„Ç©„ÉÉ„ÉÅ„ÄÄÁõ∏‰∫í„Éï„Ç©„É≠„Éº,Negative
 CLL Indication,Ëñ¨Ââ§Â∏´„Ç¶„Ç©„ÉÉ„ÉÅ„ÄÄÁõ∏‰∫í„Éï„Ç©„É≠„Éº,Negative
 acalabrutinib Efficacy,onsVegas,Positive
 BTKinhibitor,onsVegas,Positive
 Previously Treated Mantle Cell LymphomaLOCATIONFlemingsDATEDec    PM PMRSVPJason,onsVegas,Positive
 McDonald   jasonmcdonaldcom,onsVegas,Positive
 resources,CALQUENCE¬Æ (acalabrutinib),Negative
 resources,Tinu Abayomi-Paul,Positive
 resources,Guillermo Sanz,Negative
 resources,Patient Power,Negative
 resources,Janette Speyer - Digital Marketing Strategy,Positive
 resources,Amy Vernon üíôüá∫üá∏üè≥Ô∏è‚Äçüåàüíô,Positive
 resources,TheraGlobal,Positive
 resources,Lymphoma Research Foundation,Negative
 ¬Æ acalabrutinib capsules,CancerCare,Negative
 Project Orbis FDA,ALI ALAHMARI.,Negative
 Project Orbis FDA,"Junaid ""Jay"" Abdulghani, MD PhD",Positive
 Project Orbis FDA,Cancer News,Negative
 Project Orbis FDA,Pharm Digest,Negative
 Project Orbis FDA,The Oncologist,Negative
 Acalabrutinib FDA,Bernie Marini,Positive
 FDA Nod,Access WallStreet,Positive
 FDA Nod,Yost Pharmacy Inc,Positive
 FDA Nod,Digital Pharmacist,Positive
 Calquence Line Extension,Access WallStreet,Positive
 option,"Trustwell Law Group, LLP",Positive
 option,OncLive SOSS,Negative
 option,üá≤üáΩ Leonardo Collado-Torres,Positive
 option,Lynn Nowik,Positive
 option,International Pain Foundation¬Æ,Positive
 option,Te Ha,Negative
 option,circa1835,Positive
 option,"Holly Bertone, CNHP, PMP",Positive
 option,Debbie Woodbury,Negative
 option,Rhia Steele@ravishingrhia.com,Negative
 option,WEGO Health,Positive
 option,Grayson (he),Positive
 option,SeparatriX,Positive
 option,Senior Care Corner,Positive
 option,Kimberley Thomas,Negative
 option,Nora Sheffield,Positive
 option,Cassi Schmigotzki,Positive
 option,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 intolerance,"Trustwell Law Group, LLP",Positive
 intolerance,VJHemOnc,Positive
 intolerance,RedMedEd,Positive
 intolerance,Benlazar S.M Amin√©,Positive
 intolerance,Targeted Oncology,Negative
 Food Drug Administration FDA,Client-Pharma Ltd,Positive
 Food Drug Administration FDA,Lymphoma Research Foundation,Positive
 Food Drug Administration FDA,Lymphoma Hub,Negative
 Food Drug Administration FDA,Kaup Pharmacy,Positive
 Food Drug Administration FDA,Bengal Rx,Positive
 Food Drug Administration FDA,Churchill Pharmacy,Positive
 Food Drug Administration FDA,Phipps Pharmacy,Positive
 Food Drug Administration FDA,CDS #10 Pharmacy,Positive
 Food Drug Administration FDA,Medicine Shoppe 1822,Positive
 Food Drug Administration FDA,Sullivan'sGifts,Positive
 Food Drug Administration FDA,Joseph Pharmacy,Positive
 Food Drug Administration FDA,Greenhill Pharmacy,Positive
 Food Drug Administration FDA,Scott Pharmacy,Positive
 Food Drug Administration FDA,Hartzells Pharmacy,Positive
 Food Drug Administration FDA,Valley Pharmacy,Positive
 Food Drug Administration FDA,CheckRare,Positive
 Food Drug Administration FDA,NFCR,Positive
 Food Drug Administration FDA,ANYKINDAPILLS,Positive
 AstraZenecas Calquence garners FDA approval,Tina Witte,Positive
 AstraZenecas Calquence garners FDA approval,FirstWord Pharma,Positive
 Amazing   grand rounds,Pallawi Torka,Positive
   approval,pharmaphorum,Negative
   approval,OncLive SOSS,Negative
   approval,CLL Ireland,Negative
   approval,CellworksLife,Negative
   approval,Sarah Williams,Positive
   approval,Roots Analysis,Negative
 s Calquence,pharmaphorum,Negative
 s Calquence,Evaluate Pharma,Positive
 JampJ,pharmaphorum,Negative
 JampJ,BioPharma Dive,Negative
 Phase III data,Casper Paardekooper,Positive
 Phase III data,Briefing.com,Negative
 Phase III data,Roche,Negative
 Phase III data,Tracking Healthcare,Positive
 Phase III data,Novartis,Positive
   FDA nod,Career Biotech,Negative
 Pharma Industry News,PharmaState,Positive
 Roche,PharmaState,Positive
 Roche,Roche,Positive
 Roche,PharmaShots - Incisive news in 3 shots,Negative
 Roche,oncohebdo,Positive
 Roche,Connie Hampton,Positive
 Roche,BioSpace,Positive
 Roche,Medklik,Positive
 Roche,BioCalifornia,Negative
 Roche,PRICENTRIC,Positive
 Roche,Bionest Partners,Positive
 Roche,Advera Health,Negative
 Roche,cafepharma,Negative
 Roche,Kara Jill Stancell,Positive
 Roche,Endpoints News,Negative
 Roche,Loveworld Plus News,Positive
 Roche,ntengh.com,Positive
 Roche,Vernell Lintner,Positive
 Roche,"Pragnesh Panchamvedi, RAC, ERT",Negative
 Roche,BioWorld,Positive
 Roche,the world of CROs,Negative
 Roche,Jon Angelo,Negative
 Roche,Krishan Maggon,Negative
 Roche,Pharma Tech Focus,Positive
 Atezolizumab,PharmaState,Positive
 India Laurus Labs Vidakhapatnam units,PharmaState,Positive
 USFDA inspection,PharmaState,Positive
 USFDA,PharmaState,Positive
 CLL approval,dough,Negative
 AZN   ASTRAZENECA Calquence,ResearchPool,Negative
 record time,ResearchPool,Positive
 CLL   BUY,ResearchPool,Negative
 NEUTRAL,ResearchPool,Positive
 ASTRAZENECA,ResearchPool,Negative
 BUY,ResearchPool,Negative
 CLL Calquence,ResearchPool,Negative
 Approval,PharmaShots - Incisive news in 3 shots,Positive
 Approval,Lymphoma News Today,Positive
 Approval,BioNews,Negative
 Approval,Bitchin' Science,Positive
 Approval,Stock Market News,Negative
 Approval,Pharmacutical Daily,Negative
 Approval,Sarang Pokhare,Positive
 Approval,IMPharma News,Negative
 Approval,Latest News from Business Wire,Negative
 Approval,Crwe World,Positive
 Approval,Wellcome-home,Negative
 Approval,DennisPartners,Positive
 Approval,Stock Titan,Negative
 Approval,Odi Bruckman,Negative
 Approval,1stOncology,Negative
 Approval,HSMN,Negative
 Approval,Pharmacy Times,Negative
 Approval,Yo-Bio,Positive
 Approval,HRI Portal,Positive
 Approval,RazzleTazzle,Negative
 Approval,PressReleasePoint,Negative
 Approval,TawasulLinks ÿ™ŸàÿßÿµŸÑ,Negative
 Approval,MedSource,Negative
 Approval,Cure Cancer Now,Negative
 Approval,Alec Stone,Positive
 Approval,The Purple Society,Negative
 Approval,Anand Rotte,Positive
 Approval,Oncology Nursing News,Negative
 Approval,"chadi nabhan MD, MBA, FACP",Negative
 Approval,"Think, Stop The Silenceüè≥‚Äçüåà",Positive
 Approval,Steve Nolito,Positive
 Approval,Biotech Stock,Positive
 Approval,Abahoo,Positive
 Approval,Healthy Society,Positive
 Approval,United States News,Positive
 Approval,EZ HomeCare,Positive
 Approval,NaturalMedicines,Positive
 Approval,Silver Valley Doctor,Positive
 Approval,US Health News,Positive
 Approval,Gary Ross,Positive
   FDA,Career Biotech,Negative
   FDA,Kevin J Donaldson,Positive
   FDA,Pharmaceutical News,Negative
   FDA,MedicalResearch News,Positive
   FDA,PressReleasePoint,Negative
   FDA,FederalGov News,Positive
   FDA,Rajkumar Gupta Basics of DRA,Positive
   FDA,"Hayes, Inc",Positive
   FDA,CMLHope,Negative
   FDA,Oncology Nursing News,Negative
   FDA,OncNursingNews Editor,Positive
   FDA,Genentech,Negative
 „Äê Êñ∞ÁùÄË®ò‰∫ã„ÄëCLLSLL„Å´ÂØæ„Åô„Çãacalabrutinib„ÇíÁ±≥„ÉªFDA„ÅåËøÖÈÄüÊâøË™ç„ÄêFDA,Oncology_Tribune,Positive
 FDA Approves AZNs Calquence GLYCs,Saeed Valadbaygi,Negative
 ENLV Withdraws,Saeed Valadbaygi,Negative
 Offering,Saeed Valadbaygi,Negative
 Nasdaq,Saeed Valadbaygi,Negative
 FDA Approves AZNs Calquence GLYCs Data,RTTNews Top Stories,Positive
 FDA Approves AZNs Calquence GLYCs Data,Bitcoin Headline News,Positive
 ENLV Withdraws Offering,RTTNews Top Stories,Positive
 FDA TGA,Snowdome Foundation,Positive
 Leukemia,NewExpressNews,Negative
 Leukemia,The Pharmaceutical Marketing Group,Negative
 Leukemia,Xuan Cindy Li,Positive
 Leukemia,Psychiatry Intel,Positive
 Leukemia,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 Leukemia,Pharmacutical Daily,Positive
 Leukemia,Parent Security,Positive
 Leukemia,Gregory D. Evans,Positive
 Leukemia,kokoshungsan.net,Positive
 Leukemia,UI Holden Comprehensive Cancer Center,Positive
 Leukemia,Elmer Puddpucker,Positive
 Leukemia,pomento.in üáÆüá≥,Positive
 Leukemia,Paperbirds_Hematology,Negative
 Leukemia,ANTARES,Positive
 Leukemia,Ritesh Patil,Positive
 Leukemia,Adam Marshall Dobrin üîØ‚òÄ‚ÅÇ @suzq@rettiwtkcuf.social,Positive
 Leukemia,SkillAcquire,Positive
 Leukemia,Jemrath Bikombo,Positive
 Leukemia,BenXM,Positive
 Leukemia,Genevieve Gutierrez,Positive
 Leukemia,David Henry,Positive
 Leukemia,"‚ÄúNicky""",Positive
 Leukemia,SciTech Research,Negative
 Leukemia,Debbie La Torre üìä,Positive
 Leukemia,Northwest Medical,Positive
 Leukemia,Cancer Research Wales,Positive
 Leukemia,The Oncologist,Positive
 Leukemia,Alvin,Positive
 Leukemia,Jeff Karp (Pronouns: he/him/his),Positive
 Leukemia,HEDGE accordinglyüìà,Positive
 Leukemia,RazzleTazzle,Positive
 Leukemia,realtimes,Positive
 Leukemia,StockGuru,Positive
 Leukemia,Medical HotSpot,Positive
 Leukemia,Articlesly,Negative
 Leukemia,dorothy cook,Negative
 Leukemia,MAISA,Negative
 Leukemia,NACDA Program on Aging,Negative
 Leukemia,fatal atraction #312,Positive
 Leukemia,Cancer Papers,Negative
 Leukemia,TumorImmunoPapers,Negative
 Leukemia,ImmunologyPapers,Negative
 Leukemia,CLL-seq,Negative
 Leukemia,TumImmTxpapers,Negative
 Leukemia,Timothy Kelly,Positive
 Leukemia,JAAD Journals,Negative
 Leukemia,Jane Freeman,Positive
 Leukemia,Andie Williams,Positive
 Leukemia,Rebecca Hong,Positive
 Leukemia,Holly Vanwinkle,Positive
 Leukemia,Kerri Logsdon,Positive
 Leukemia,Minna Saavedra,Positive
 Leukemia,Stanley Weber,Positive
 Leukemia,Polonius Josifovitz,Positive
 Leukemia,tanifel,Positive
 Leukemia,tara,Positive
 Leukemia,KeleSkellk,Positive
 Leukemia,Focus on Cancer,Negative
 Leukemia,Tolga Artan,Positive
 Leukemia,TheraGlobal,Positive
 Leukemia,Lymphoma News Today,Negative
 Leukemia,Dr. Melody Davis,Negative
 Leukemia,Susan Murphy,Positive
 Leukemia,Hematopoiesis News,Negative
 Leukemia,Indian Med Guru,Positive
 Leukemia,Tom Carleton,Positive
 Leukemia,"Emilio Madrigal, DO",Positive
 Leukemia,Dana-Farber,Negative
 Leukemia,Children's Wish,Positive
 Regulatory News,Living Safely,Positive
 Food amp Drug Administration   approvals,Living Safely,Negative
 Thursday,Living Safely,Negative
 Thursday,CLL Ireland,Negative
 Thursday,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Thursday,CLL Warwick Uni,Negative
 Thursday,Einstein Montefiore Medicine,Positive
 NDA,Living Safely,Positive
 NDA,Pharmacy News & Research,Positive
 NDA,EuropaWire,Negative
 NDA,OncLive.com,Negative
 NDA,AstraZenecaUS,Negative
 NDA,StockNews.com,Negative
 NDA,Briefing.com,Negative
 NDA,Bill F.,Positive
 NDA,Bio Stocks‚Ñ¢,Negative
 NDA,Odi Bruckman,Negative
 NDA,Clarivate Cortellis,Negative
 NDA,European Pharmaceutical Review,Negative
 ANDA,Living Safely,Negative
 Biotech,BioPharmCatalyst,Positive
 GLYC data delay,BioPharmCatalyst,Negative
 AZN Calquence FDA ApprovalIntraday offerings,BioPharmCatalyst,Negative
 ONTX,BioPharmCatalyst,Negative
 BPTH ENLV,BioPharmCatalyst,Negative
 BIIB ENTA ENTX IMRN IOVA SNY TNXP XERS,BioPharmCatalyst,Negative
 Australia Canada Approve New Drug,ÿßÿ≠ŸÖÿØ,Positive
 Blood Cancers,ÿßÿ≠ŸÖÿØ,Positive
 Blood Cancers,Renal Cell Carcinoma,Negative
 Blood Cancers,Drug Delivery News,Negative
 Blood Cancers,Cancer News,Negative
 Blood Cancers,Michele Nadeem-Baker,Negative
 Blood Cancers,AnCan,Positive
 Blood Cancers,Oncology Nursing News,Negative
 Blood Cancers,Judith Jones,Positive
 Blood Cancers,–Æ–ª–∏—è –ï—Ñ–∏–º–æ–≤–∞,Positive
 Blood Cancers,Lymphoma Coalition,Negative
 AstraZenecas Calquence acalabrutinib,octagonchem,Positive
 AstraZenecas Calquence acalabrutinib,RANJAN BUDA.,Positive
 AstraZenecas Calquence acalabrutinib,Pharmaceuticals repo,Positive
 AstraZenecas Calquence acalabrutinib,Renal Cell Carcinoma,Negative
 AstraZenecas Calquence acalabrutinib,Drug Delivery News,Negative
 AstraZenecas Calquence acalabrutinib,Lung Cancer News,Negative
 AstraZenecas Calquence acalabrutinib,Hlthnews,Negative
 AstraZenecas Calquence acalabrutinib,David Ledger,Negative
 AstraZenecas Calquence acalabrutinib,Pharma Commons,Negative
 AstraZenecas Calquence acalabrutinib,UKiwiS,Positive
 AstraZenecas Calquence acalabrutinib,Digital-Ontology,Positive
 AstraZenecas Calquence acalabrutinib,Global Pharma News,Negative
 AstraZenecas Calquence acalabrutinib,World Pharma News,Negative
 SLL Oncology Newsburst,Cancer News,Negative
 acalabrutinib CALQUENCE AstraZeneca,Lymphoma Research Foundation,Negative
 acalabrutinib CALQUENCE AstraZeneca,FDA Oncology,Negative
 CLL IndicationMore,SpecialtyPTimes,Negative
 FDA aprueba acalabrutinib,contacto sciencelink,Negative
 el tratamiento de la LLC,contacto sciencelink,Negative
 Nov    FDA,FDA Oncology,Negative
 AwesomeCapital FDA OKs,****,Negative
 lymphocytic le,****,Negative
 ELEVATETN ASCEND trials comparing ¬† Calquence,Tontarn Chutima,Positive
 indication,"Kelley D. Carlstrom, PharmD, BCOP",Positive
 indication,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 indication,Society for Immunotherapy of Cancer,Negative
 indication,Lymphoma Research Foundation,Negative
 indication,FDA Oncology,Negative
 indication,"chadi nabhan MD, MBA, FACP",Negative
 indication,Anna Deveau,Negative
 FDA OKs AstraZenecas Calquence,Investor News,Negative
 AZN   FDA OKs,Breaking News,Negative
 FYI,OncoPharm,Positive
 Pod,OncoPharm,Positive
 BREAKING,Phil Talamo,Negative
 BREAKING,Oncology Nursing News,Positive
 BREAKING,OncLive.com,Negative
 BREAKING,Targeted Oncology,Positive
 BREAKING,Khurram Nawaz,Positive
 BREAKING,CURE Magazine,Positive
 BREAKING,AbbVie,Negative
 nd generation BTK inhibitor,Phil Talamo,Negative
 nd agent,Phil Talamo,Negative
 Approves Acalabrutinib,Phil Talamo,Negative
 Approves Acalabrutinib,OncLive.com,Negative
 Excellent news,Joe Birkett-Crest,Positive
 Excellent news,CLL Society Inc.,Positive
 Excellent news,Toby Eyre,Negative
 ibrutinib FDA Approves Acalabrutinib,Joe Birkett-Crest,Positive
 tool,"Anastasios Raptis, MD",Negative
 tool,Carla Casulo,Positive
 CLLFDA Approves Acalabrutinib,"Anastasios Raptis, MD",Negative
 CLL Happy,Alan Skarbnik,Negative
 proud ro,Alan Skarbnik,Negative
 frontline Phase III trial,Alan Skarbnik,Negative
 Project Orbis success AZNs Calquence,Jacob Bell,Positive
 Early Obinutuzumab,Lung Cancer News,Negative
 High Risk Recurrent,Lung Cancer News,Negative
 ASH newsletter,LYMPHOMA & MYELOMA CONNECT,Negative
 tcoirGwYHzf,LYMPHOMA & MYELOMA CONNECT,Negative
 Pascal Soriot,Nathalia Le Hen,Positive
 La Chine,Nathalia Le Hen,Positive
 est,Nathalia Le Hen,Positive
 est,Charente-Maritime,Positive
 AstraZeneca aussi,Nathalia Le Hen,Positive
 globe acalabrutinib,"Michael Wang, MD",Negative
 BeiGene FDA cancer drug nod,Cancer News,Negative
 breakthrough,Cancer News,Negative
 breakthrough,KCL Alumni,Positive
 breakthrough,Ginny McLean,Positive
 breakthrough,Coventry University Cricket Club üèè,Positive
 breakthrough,Cancer And I,Positive
 breakthrough,Ali Urman,Positive
 lymphoma,BioPharma Dive,Negative
 lymphoma,Carly Helfand,Negative
 lymphoma,Dr Timos Papagatsias,Negative
 lymphoma,David Durand,Positive
 lymphoma,Anirban Maitra,Negative
 lymphoma,Lymphomation.org,Negative
 lymphoma,Patient Empowerment Network,Negative
 lymphoma,Oncology Learning Network,Negative
 lymphoma,Lymphoma Hub,Negative
 lymphoma,Michael Rynne,Negative
 lymphoma,Helen Jane Mee,Negative
 lymphoma,Amy C. Cavers,Positive
 lymphoma,Charlotte Roffiaen,Positive
 experience,Toby Eyre,Negative
 experience,Jordan Gauthier,Positive
 experience,Lymphoma Hub,Negative
 experience,WCM Lymphoma,Negative
 experience,BSI UK,Positive
 experience,CLL Ireland,Positive
 experience,"Raul Cordoba, MD, PhD",Positive
 experience,JanssenUS,Negative
 experience,CLL Advocates Network,Negative
 experience,VJHemOnc,Negative
 experience,Toula Castillo,Positive
 experience,a follower,Positive
 experience,Patient Power,Positive
 experience,CLLSA,Negative
 experience,AbbVie Canada,Negative
 experience,Andrew Schorr,Positive
 experience,Blood Cancer UK,Negative
 experience,Swedish,Positive
 experience,Chris Thomson,Negative
 trialsn,Toby Eyre,Negative
 L   RR RR prior BTKiPrior intol,Toby Eyre,Negative
 ibr,Toby Eyre,Negative
 ibr,Financial Buzz,Negative
 Indirect Comparisons,Lymphoma Papers,Negative
 Indirect Comparisons,clinicaltherapeutics,Negative
 Indirect Comparisons,"Raul Cordoba, MD, PhD",Negative
 Targeted Therapies,Lymphoma Papers,Positive
 Targeted Therapies,Paperbirds_Hematology,Positive
 Targeted Therapies,clinicaltherapeutics,Negative
 Targeted Therapies,EurekaMag,Positive
 Targeted Therapies,MD Anderson Leukemia,Negative
 Targeted Therapies,Juan Marquet,Negative
 Targeted Therapies,Casey Foster,Positive
 Targeted Therapies,Patient Worthy,Negative
 Targeted Therapies,Cancer Papers,Negative
 Targeted Therapies,microRNApapers,Negative
 Targeted Therapies,Cancer Health,Negative
 Targeted Therapies,The ASCO Post,Negative
 Targeted Therapies,TumorImmunoPapers,Negative
 Targeted Therapies,JNCI,Negative
 Targeted Therapies,Personalized Nutrition Intervention 24/7 On Demand,Negative
 Matchingadjusted Indirect Comparisons,Paperbirds_Hematology,Negative
 Selectivity,Toby Eyre,Negative
 BTK occupancy,Toby Eyre,Negative
   conference,"Maria Badillo, MSN RN OCN CCRP",Negative
   conference,Duke Hematologic Malignancies & Cellular Therapy,Negative
   conference,CLLSA,Positive
   conference,Leukaemia Care,Negative
   conference,LiveYourLife,Negative
   conference,Helen Jane Mee,Positive
   conference,Helen Marin,Positive
   conference,LymphomaAction,Positive
   conference,PeerView,Negative
 poster,"Maria Badillo, MSN RN OCN CCRP",Positive
 poster,U-M Rogel Cancer Center,Negative
 poster,Judith Trotman,Positive
 poster,LyLe Foreningen,Negative
 poster,Calyx,Positive
 poster,Lili Wang Lab,Negative
 poster,Adam Kittai,Negative
 poster,SIU Press,Negative
 poster,OGT,Negative
 poster,Michael Dickinson,Negative
 poster,Michael Hallek,Negative
 poster,Sigrid Sk√•nland,Negative
 poster,"David Bartlett, PhD",Positive
 poster,Optum,Positive
 poster,MGH Cancer Center,Positive
 poster,"chadi nabhan MD, MBA, FACP",Positive
 poster,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 poster,Stony Brook Pathology,Positive
 poster,Lymphoma Hub,Positive
 poster,JTCancerCenter,Positive
 Adverse Events,"Maria Badillo, MSN RN OCN CCRP",Negative
 Adverse Events,Paperbirds_Hematology,Negative
 Adverse Events,The Lynx Group,Positive
 Adverse Events,Value-Based Cancer Care,Positive
 Adverse Events,Patient Worthy,Negative
 Adverse Events,AONN+,Negative
 Adverse Events,MedPipeline,Negative
 Pts,"Maria Badillo, MSN RN OCN CCRP",Negative
 Pts,Chan Cheah,Negative
 Pts,Robert Z. Orlowski,Negative
 Pts,MD Anderson Leukemia,Negative
 Pts,Andrew Schorr,Negative
 Pts,Shohta Kadomura Hospital Pharmacist,Negative
 Pts,"Naveen Pemmaraju, MD",Negative
 Pts,Tapan Kadia,Negative
 Pts,MediTech Media,Positive
 AcalabrutinibClinical Experience,"Maria Badillo, MSN RN OCN CCRP",Negative
 MDACC,"Maria Badillo, MSN RN OCN CCRP",Negative
   trial,"Maria Badillo, MSN RN OCN CCRP",Negative
   trial,NYCDoc29,Negative
   trial,"chadi nabhan MD, MBA, FACP",Positive
   trial,1stOncology,Negative
   trial,MedPage Oncology,Negative
   trial,Dr Timos Papagatsias,Negative
   trial,OncologyGo,Positive
   trial,healthbook,Positive
   trial,The ASCO Post,Negative
 „Äê Êñ∞ÁùÄË®ò‰∫ã„ÄëÊ¨°‰∏ñ‰ª£BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅÆÁ¨¨‚Ö¢Áõ∏ELEVATETN„ÅÆÊúÄÂàù„ÅÆ„Éá„Éº„Çø„ÇíASH „ÅßÁô∫Ë°®,Oncology_Tribune,Positive
 Mantle Cell Lymphoma Design Development,Paperbirds_Hematology,Negative
 Place,Paperbirds_Hematology,Negative
 Place,"Cowan, Liebowitz",Negative
   data,1stOncology,Negative
   data,VJHemOnc,Negative
   data,"chadi nabhan MD, MBA, FACP",Negative
   data,Michael Dickinson,Positive
 Phase III,1stOncology,Negative
 Phase III,"Raul Cordoba, MD, PhD",Negative
 Phase III,Business Wire-Health,Negative
 Phase III,Scott Werntz,Negative
 Phase III,Financial Buzz,Negative
 Phase III,Paul Lane,Negative
 Phase III,Penny Stock Irish,Negative
 Phase III,Ez2Trade,Negative
 Phase III,Penny Stocks,Negative
 Phase III,IntoxicatedTrader,Negative
 Phase III,Cancer Daily,Negative
 Phase III,"Pharmacyclics, an AbbVie Company",Negative
 III FrontLine,Pharmacutical Daily,Negative
 III FrontLine,Saeed Valadbaygi,Negative
 III FrontLine,Renal Cell Carcinoma,Negative
 ASH   Annual ¬† Meeting,Pharmacutical Daily,Negative
 Annual Meeting,Saeed Valadbaygi,Negative
 Annual Meeting,Trading News,Positive
 Annual Meeting,Lymphoma Hub,Negative
 III FrontLine Chronic Lymphocytic Leukemia,Crwe World,Negative
 CALQUENCE√Ç Data,Renal Cell Carcinoma,Negative
 ASH   Annual Meeting Robust,Renal Cell Carcinoma,Negative
 earlystage,Renal Cell Carcinoma,Negative
 earlystage,"Mike Thompson, MD, PhD, FASCO",Negative
 earlystage,Targeted Oncology,Negative
 earlystage,Cancer Papers,Negative
 earlystage,CLL-seq,Negative
 earlystage,lncRNApapers,Positive
 earlystage,AtlanticJOMedicine,Negative
 pipeline advancements,Renal Cell Carcinoma,Negative
 presentations,Renal Cell Carcinoma,Negative
 presentations,LaVoieHealthScience,Positive
 presentations,VJHemOnc,Negative
 presentations,Michael Hallek,Negative
 presentations,Dana-Farber,Negative
 ASH   abstracts,CLL Society Inc.,Negative
 ASH abstracts,Alan Skarbnik,Negative
 improved progressionfree,Cision News,Negative
 WATCH Dr Wang,OncLive.com,Negative
 Addition,OncLive.com,Negative
 Addition,VJHemOnc,Negative
 Addition,ASCO Publications,Negative
 Addition,Lovisa Bray,Positive
 Addition,Benlazar S.M Amin√©,Negative
 Addition,CancerWallonia,Negative
 Addition,Dr. Andre Goy,Negative
 Addition,MDedge Hematology & Oncology,Negative
 Addition,Healio,Negative
 Addition,HemOnc Today,Positive
 Addition,Lymphoma Hub,Negative
 Addition,Biotech2050,Negative
 pipeline newsflowfocus,dough,Negative
 newsflow,dough,Negative
 Calquence L CLL data ASH,dough,Negative
 Nov Roxadustat anaemia PIII CV data,dough,Negative
 ‚Å¶‚Å© ‚Å¶‚Å©,"Ajay Nooka, MD, MPH",Positive
 ‚Å¶‚Å© ‚Å¶‚Å©,Prof John,Negative
 ‚Å¶‚Å© ‚Å¶‚Å©,donnashort,Positive
 ‚Å¶‚Å© ‚Å¶‚Å©,"chadi nabhan MD, MBA, FACP",Negative
 ‚Å¶‚Å© ‚Å¶‚Å©,Vincent Rajkumar,Negative
 ‚Å© Jonathon Cohen,"Ajay Nooka, MD, MPH",Positive
 obinutizumab   acalabrutinib,"Ajay Nooka, MD, MPH",Positive
 state,"Ajay Nooka, MD, MPH",Positive
 state,MJ Platform,Positive
 state,Catherine Gegaris,Positive
 state,Toby Eyre,Negative
 science summit,"Ajay Nooka, MD, MPH",Positive
 Health Canada,Health Canada and PHAC,Positive
 Health Canada,Zeal Access,Positive
 Health Canada,Alicia Bell IFBB Pro,Negative
 Health Canada,OncLive.com,Negative
 Health Canada,JointHealth,Positive
 Health Canada,AbbVie Canada,Negative
 Health Canada,HRI Portal,Positive
 Health Canada,Ro Patel,Positive
 Health Canada,RazzleTazzle,Negative
 Health Canada,Paul Devereaux,Positive
 Health Canada,Pure Leverage Rep,Negative
 Health Canada,Davalyn Corporation,Positive
 Health Canada,URL Shortener,Positive
 Health Canada,Thomas Van Ahn,Negative
 Health Canada,NYC Social Group,Negative
 Health Canada,Mca Represenative,Positive
 Health Canada,Cedar Consultants,Negative
 Health Canada,indofx,Positive
 Health Canada,I.Gazette,Negative
 Health Canada,Today's Deals,Positive
 Health Canada,OyoBoi,Negative
 Sant√© Canada,Sant√© Canada et l‚ÄôASPC,Positive
 homologu√© Calquence acalabrutinib pour,Sant√© Canada et l‚ÄôASPC,Positive
 atteints,Sant√© Canada et l‚ÄôASPC,Positive
 atteints,Club Trecento Sant√©,Positive
 de lymphome,Sant√© Canada et l‚ÄôASPC,Positive
 √† cellules,Sant√© Canada et l‚ÄôASPC,Positive
 √† cellules,oncohebdo,Positive
 du manteau LCM ayant essay√©,Sant√© Canada et l‚ÄôASPC,Positive
 moins un traitement,Sant√© Canada et l‚ÄôASPC,Positive
   callprediction Calquence,"Dr. Paul DeSantis, PharmD",Negative
 arrival,"Dr. Paul DeSantis, PharmD",Negative
 L CLL,"Dr. Paul DeSantis, PharmD",Negative
 approval max,"Dr. Paul DeSantis, PharmD",Negative
 market share,"Dr. Paul DeSantis, PharmD",Negative
 lt Imbruvica data,"Dr. Paul DeSantis, PharmD",Negative
 L risk statussubtypes,"Dr. Paul DeSantis, PharmD",Negative
 HOPE,"Dr. Paul DeSantis, PharmD",Negative
 HOPE,Stephen Brown,Negative
 NCCN language,"Dr. Paul DeSantis, PharmD",Negative
 Dr Siddiqi,Targeted Oncology,Negative
 Dr Siddiqi,Lymphoma Australia,Positive
 Dr Siddiqi,Razan Mohty,Positive
 B cell lymphoma,"Michael Wang, MD",Positive
 B cell lymphoma,Renal Cell Carcinoma,Negative
 Julie Durocher,"Michael Wang, MD",Negative
 Grand Round,"Michael Wang, MD",Negative
 lymphoma therapy,"Michael Wang, MD",Negative
 McGill University Acalabrutinib,"Michael Wang, MD",Negative
 faculties,"Michael Wang, MD",Negative
 invitation,"Michael Wang, MD",Negative
 Paul Vardanis,"Michael Wang, MD",Negative
   study,Jonathan Friedberg,Positive
   study,EmatoInfo,Positive
   study,Vall d‚ÄôHebron Institute of Oncology (VHIO),Positive
   study,VJHemOnc,Negative
   study,MedPage Oncology,Negative
   study,Anna Deveau,Negative
   study,i3 Health,Negative
   study,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
   study,medwireNews,Negative
   study,WCMNYPJCTO,Negative
 press Fiveyear outcomes,Jonathan Friedberg,Positive
 S study,Jonathan Friedberg,Positive
 RhyperCVAD vs Rbendamustine,Jonathan Friedberg,Positive
 pre ASCT,Jonathan Friedberg,Positive
 SVB Leerinks Porges,Ned Pagliarulo,Positive
 acalabrutinib breakthrough designation,OncLive.com,Negative
 August,OncLive.com,Negative
 August,SUMIT SHARMA,Negative
 August,Psychedelic Jukebox,Positive
 August,CLLSA,Positive
 August,Daniel,Positive
 August,Anthony Mato,Negative
 August,AstrologyNewsNetwork,Positive
 August,Phoebe Needles,Negative
 August,CLL Warwick Uni,Negative
 August,Alan Skarbnik,Negative
 August,James Porreca,Negative
 August,Matthew Kauffman,Negative
 Acalabrutinib Shows Benefit,OncLive.com,Negative
 Acalabrutinib Shows Benefit,Crwe World,Negative
 Acalabrutinib Shows Benefit,ImmunotherapyPapers,Negative
 Acalabrutinib Shows Benefit,Immuno-Oncology,Negative
 IbrutinibTreated RelapsedRefractory CLL,OncLive.com,Negative
 IbrutinibTreated RelapsedRefractory CLL,Crwe World,Negative
 IbrutinibTreated RelapsedRefractory CLL,ImmunotherapyPapers,Negative
 IbrutinibTreated RelapsedRefractory CLL,Immuno-Oncology,Negative
 Toxicity Profiles,OncLive.com,Negative
 Toxicity Profiles,OncLive SOSS,Negative
 Ibrutinib Acalabrutinib,OncLive.com,Negative
   Durable response,"Raul Cordoba, MD, PhD",Negative
 singleagent,"Raul Cordoba, MD, PhD",Positive
 singleagent,Francesco Turturro,Negative
 toxicity profiles,Cancer Medicine,Positive
 BTK inhibitors ibrutinib acalabrutinib,Cancer Medicine,Positive
 Health Canada Approval,PharmaShots - Incisive news in 3 shots,Negative
 Health Canada Approval,Alicia Bell IFBB Pro,Negative
 Health Canada Approval,Matt Fanning,Positive
 Health Canada Approval,Crwe World,Negative
 Health Canada Approval,Quant Data,Negative
 ¬Æ acalabrutinib,Zeal Access,Positive
 ¬Æ acalabrutinib,Alicia Bell IFBB Pro,Negative
 ¬Æ acalabrutinib,The Pharmaceutical Marketing Group,Positive
 ¬Æ acalabrutinib,Crwe World,Negative
 ¬Æ acalabrutinib,Latest News from Business Wire,Negative
 ¬Æ acalabrutinib,Neco‚Ñ¢,Positive
 ¬Æ acalabrutinib,Stockboard Media Inc,Negative
 ¬Æ acalabrutinib,Odi Bruckman,Negative
 ¬Æ acalabrutinib,McKesson Corporation,Negative
 ¬Æ acalabrutinib,"Lalit Leonard Sehgal, PhD",Positive
 ¬Æ acalabrutinib,Business Wire-Health,Negative
 ¬Æ acalabrutinib,Biologics by McKesson,Negative
 ¬Æ acalabrutinib,Lymphoma Hub,Negative
 ¬Æ acalabrutinib,IntoxicatedTrader,Positive
 ¬Æ acalabrutinib,Newmoney210,Positive
 ¬Æ acalabrutinib,UKiwiS,Negative
 ¬Æ acalabrutinib,Today's News,Positive
 previouslytreated mantle cell lymphoma,Zeal Access,Positive
 previouslytreated mantle cell lymphoma,Alicia Bell IFBB Pro,Negative
 previouslytreated mantle cell lymphoma,Hlthnews,Negative
 previouslytreated mantle cell lymphoma,David Ledger,Negative
 previouslytreated mantle cell lymphoma,Pharma Commons,Negative
 previouslytreated mantle cell lymphoma,Biologics by McKesson,Negative
 previouslytreated mantle cell lymphoma,Digital-Ontology,Negative
 previouslytreated mantle cell lymphoma,OncologyInfo,Positive
 AZN   AstraZenecas Calquence OKd,Breaking News,Negative
 WATCH Dr Eradat,OncLive.com,Negative
 Dr Eradat,OncLive SOSS,Negative
 Comparison,Lung Cancer News,Negative
 Comparison,Jerry Lee,Negative
 Comparison,"Raul Cordoba, MD, PhD",Positive
 Comparison,TumorImmunoPapers,Negative
 Comparison,Cure Cancer Now,Negative
 Comparison,Paperbirds_Hematology,Positive
 Comparison,Eduardo Flavio Oliveira Ribeiro,Negative
 Comparison,Lymphoma Papers,Positive
 Comparison,Bloodbytes,Positive
 Comparison,Anthony Mato,Negative
 Comparison,JAAD Journals,Negative
 Comparison,Cancer Papers,Negative
 Comparison,Mazen M,Negative
 Comparison,COPD News,Negative
 Comparison,dermatologyf,Positive
 Comparison,Lymphoma Hub,Negative
 Comparison,ISEV-JEV,Positive
 Cytarabine BendamustineHighDose CytarabineAcalabrutinib BendamustineRituximab,Cancer Trials Support Unit,Positive
 login,Cancer Trials Support Unit,Positive
 login,ecancer,Negative
 Tyrosine Kinase BTK,"Michael Wang, MD",Positive
 opinion,"Michael Wang, MD",Negative
 opinion,Oncology Tube,Negative
 opinion,Patient Power,Negative
 opinion,ùêíùê°ùê®ùê®ùê≠ùêûùê´,Positive
 Wang Rule et alLong term resultsACELY fup m RR    CR,Toby Eyre,Negative
 PETmDOR mmPFS,Toby Eyre,Negative
 Acalabrutinib macht Ibrutinib,Medical Tribune,Positive
 der Therapie der CLL Konkurrenz,Medical Tribune,Positive
 Phase   ASCEND study results,Sharon Worcester,Positive
 coverage,Lymphoma Hub,Positive
 coverage,VJHemOnc,Negative
 coverage,LymphomaAction,Negative
 La FDA otorga la designaci√≥n de terapia innovadora de acalabrutinib para,Rafael Ortiz Gimenez,Positive
 Lenalidomide,Renal Cell Carcinoma,Negative
 Lenalidomide,CureHuntr,Negative
 Lenalidomide,TrialBulletin,Negative
 Lenalidomide,ClinOwl Haematology,Negative
 Lenalidomide,Jerry Lee,Negative
 Lenalidomide,CellworksLife,Negative
 Lenalidomide,Cure Cancer Now,Positive
 Lenalidomide,ClinicalTrialsData,Negative
 Lenalidomide,AIRR-seq papers,Positive
 Lenalidomide,Medivizor,Negative
 Lenalidomide,Philip McCarthy,Negative
 Lenalidomide,Frontiers Immunology,Negative
 Lenalidomide,CLL Society Inc.,Positive
 Lenalidomide,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 Lenalidomide,TumorImmunoPapers,Negative
 Lenalidomide,NK papers,Negative
 RelapsedRefractory Bcell NonHodgkin Lymphoma NCCN guidelines,Renal Cell Carcinoma,Negative
 Dr Siddiqi acalabrutinib,Targeted Oncology,Negative
 RelapsedRefractory Bcell NonHodgkin Lymphoma,CureHuntr,Negative
 RelapsedRefractory Bcell NonHodgkin Lymphoma Status Recruiting Condition Summary Nonhodgkin LymphomaB Cell,TrialBulletin,Negative
 ÿßŸÑŸÄ FDA ÿ™ŸÖŸÜÿ≠ ÿµŸÅÿ© ÿßŸÑÿßÿÆÿ™ÿ±ÿßŸÇ ŸÑÿØŸàÿßÿ°,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Breakthrough Therapy Designation,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Breakthrough Therapy Designation,Bio_Talent,Negative
 Breakthrough Therapy Designation,Cancer Stem Cell News,Negative
 Breakthrough Therapy Designation,Haybury,Positive
 Breakthrough Therapy Designation,Saief Kazmi,Positive
 Breakthrough Therapy Designation,PharmaTimes,Negative
 Breakthrough Therapy Designation,The Pharmaceutical Marketing Group,Negative
 Breakthrough Therapy Designation,Digital Pharma,Positive
 Breakthrough Therapy Designation,Client-Pharma Ltd,Positive
 Breakthrough Therapy Designation,David Ledger,Negative
 Breakthrough Therapy Designation,Med Career News,Positive
 Breakthrough Therapy Designation,biotechradar.eu,Positive
 Breakthrough Therapy Designation,Pharma Regulatory,Negative
 Breakthrough Therapy Designation,Crwe World,Negative
 Breakthrough Therapy Designation,Latest News from Business Wire,Negative
 Breakthrough Therapy Designation,Renal Cell Carcinoma,Negative
 Breakthrough Therapy Designation,FrankTheTooth,Positive
 Breakthrough Therapy Designation,Bio Stocks‚Ñ¢,Negative
 Breakthrough Therapy Designation,PharmaShots - Incisive news in 3 shots,Negative
 Breakthrough Therapy Designation,PressReleasePoint,Negative
 Breakthrough Therapy Designation,Francis Alexander,Negative
 Breakthrough Therapy Designation,Cision News,Positive
 Breakthrough Therapy Designation,"Mike Thompson, MD, PhD, FASCO",Negative
 Breakthrough Therapy Designation,American Preclinical,Negative
 Breakthrough Therapy Designation,Sue Mockus,Positive
 Breakthrough Therapy Designation,CancerConnect,Negative
 Breakthrough Therapy Designation,Saleh Stevens,Negative
 Breakthrough Therapy Designation,Lymphoma Canada,Negative
 Breakthrough Therapy Designation,Sheila A. Crowe,Positive
 Breakthrough Therapy Designation,AstraZenecaUS,Negative
 Breakthrough Therapy Designation,Briefing.com,Negative
 Breakthrough Therapy Designation,Roche,Negative
 Breakthrough Therapy Designation,Cord Blood News,Positive
 Breakthrough Therapy Designation,üê∏ gab.ai/wu üê∏,Positive
 Breakthrough Therapy Designation,Hematopoiesis News,Negative
 Breakthrough Therapy Designation,Tracking Healthcare,Positive
 Breakthrough Therapy Designation,CancerTherapyAdvisor,Negative
 Breakthrough Therapy Designation,Financial Buzz,Negative
 Breakthrough Therapy Designation,IntoxicatedTrader,Positive
 Breakthrough Therapy Designation,Scott Werntz,Negative
 Breakthrough Therapy Designation,Ann F Cheung,Positive
 Breakthrough Therapy Designation,LLZ Consulting,Negative
 Breakthrough Therapy Designation,WCM Lymphoma,Negative
 Breakthrough Therapy Designation,Dominique,Positive
 Breakthrough Therapy Designation,Dr. Leona Saunders,Positive
 Breakthrough Therapy Designation,satPRnews,Negative
 JP AZN CEO,dough,Negative
 Takeaways,dough,Negative
 Bullish,dough,Negative
 CONGRESS     Followup data,Lymphoma Hub,Negative
 Baml AZN pick,dough,Negative
 sales CAGR,dough,Negative
 Pipeline catalysts,dough,Negative
 Emerging treatments,RedMedEd,Negative
 WM,RedMedEd,Negative
 WM,MDedge Hematology & Oncology,Negative
 WM,Connie Batlevi,Negative
 zanubrutinib acalabrutinib venetoclax,RedMedEd,Negative
 ofatumumab,RedMedEd,Negative
 ofatumumab,"Dr T. Comeau , MD",Negative
 ofatumumab,Benlazar S.M Amin√©,Negative
 ofatumumab,STCK.PRO,Positive
 ofatumumab,Medivizor,Positive
 ofatumumab,GEDEFO,Negative
 ofatumumab,ClinOwl Haematology,Negative
 ofatumumab,Lymphoma Papers,Positive
 ofatumumab,Toby Eyre,Negative
 ofatumumab,Paperbirds_Hematology,Negative
 ofatumumab,EurekaMag,Negative
 ofatumumab,Hematology Advisor,Negative
 ofatumumab,Blood Advances,Negative
 ofatumumab,"Raul Cordoba, MD, PhD",Negative
 ofatumumab,Blood Journal,Negative
 ofatumumab,Targeted Oncology,Positive
 ofatumumab,ASH,Negative
 ofatumumab,Lymphoma Hub,Positive
 ofatumumab,CLL Ireland,Positive
 ofatumumab,FarmaOnco,Negative
 ofatumumab,NCCP,Positive
 ofatumumab,ASH Clinical News,Negative
 ofatumumab,Christopher Steer,Negative
 ofatumumab,Bursatil Biotech,Positive
 ofatumumab,MedSource,Negative
 ofatumumab,Lymphoma Research Foundation,Negative
 ofatumumab,Matthias Piesche,Negative
 ofatumumab,OncLive.com,Negative
 ofatumumab,Sarah DiGiulio,Positive
 ofatumumab,Francesco Turturro,Positive
 ofatumumab,AtlanticJOMedicine,Negative
 ofatumumab,Erika Hunt,Positive
 ofatumumab,Scott Werntz,Negative
 ofatumumab,Society of Junior Doctors,Negative
 ofatumumab,Chan Cheah,Negative
 ofatumumab,The Lancet,Negative
 Breakthrough Therapy Designation BTD,Verdi Oncology,Positive
 Breakthrough Therapy Designation BTD,Lymphoma Hub,Negative
 Breakthrough Therapy Designation BTD,AstraZenecaUS,Negative
 clearance,Living Safely,Negative
 clearance,Scripps Research,Positive
 API,Living Safely,Negative
 NoDeal,Living Safely,Negative
 Adult Subjects,TrialBulletin,Negative
 Adult Subjects,CureHuntr,Negative
 MHRA Cleared API,GMPnews.Net,Negative
 Export,GMPnews.Net,Negative
 NoDeal Brexit,GMPnews.Net,Negative
 NoDeal Brexit,EIPG,Negative
 NoDeal Brexit,RAC Medical Consulting,Positive
 NoDeal Brexit,Pharma Regulatory,Negative
 NoDeal Brexit,rapsorg,Positive
 EU Regulatory Roundup AstraZeneca,EIPG,Negative
 EU Regulatory Roundup AstraZeneca,RAC Medical Consulting,Positive
 EU Regulatory Roundup AstraZeneca,Pharma Regulatory,Negative
 EU Regulatory Roundup AstraZeneca,rapsorg,Positive
 Clearance,EIPG,Negative
 Clearance,RAC Medical Consulting,Positive
 Clearance,Pharma Regulatory,Negative
 Clearance,rapsorg,Positive
 Export Calquence API,EIPG,Negative
 Export Calquence API,RAC Medical Consulting,Positive
 Export Calquence API,Pharma Regulatory,Negative
 Export Calquence API,rapsorg,Positive
 RAPS,EIPG,Negative
 Focus,rapsorg,Positive
 Focus,Christopher Steer,Negative
 Focus,"Dr T. Comeau , MD",Negative
 Focus,Anna Deveau,Negative
 Focus,TawasulLinks ÿ™ŸàÿßÿµŸÑ,Negative
 Kerry Rogers MD,The ASCO Post,Positive
 Kerry Rogers MD,OncLive.com,Negative
 Kerry Rogers MD,Oncology_Tribune,Positive
 Chronic Lymphocytic Leukemia Acalabrutinib,The ASCO Post,Positive
 TreatmentNaive,The ASCO Post,Positive
 TreatmentNaive,U-M Rogel Cancer Center,Negative
 TreatmentNaive,"Andrew Johns, MD",Positive
 TreatmentNaive,CancerWallonia,Negative
 TreatmentNaive,Cord Blood News,Negative
 Refractory Disease,The ASCO Post,Positive
   grants breakthrough designation,Lampe & Company,Negative
   grants breakthrough designation,Matthias Piesche,Negative
 tcoBgylAcuFNA,Lampe & Company,Negative
 ÈòøÊñØÂà©Â∫∑ÔºàAstraZenecaÔºâËøëÊó•ÂÆ£Â∏ÉÔºåÁæéÂõΩÈ£üÂìÅÂíåËçØÁâ©ÁÆ°ÁêÜÂ±ÄÔºàFDAÔºâÂ∑≤Êéà‰∫àÈù∂ÂêëÊäóÁôåËçØCalquenceÔºàacalabrutinibÔºâÁ™ÅÁ†¥ÊÄßËçØÁâ©ËµÑÊ†ºÔºàBTDÔºâÔºå‰Ωú‰∏∫‰∏ÄÁßçÂçïËçØÁñóÊ≥ïÊ≤ªÁñóÊÖ¢ÊÄßÊ∑ãÂ∑¥ÁªÜËÉûÁôΩË°ÄÁóÖÔºàCLLÔºâÊàê‰∫∫ÊÇ£ËÄÖ„ÄÇCLLÊòØÊàê‰∫∫ÊúÄÂ∏∏ËßÅÁöÑÁôΩË°ÄÁóÖÁ±ªÂûã‰πã‰∏Ä,ÂéöÊú¥ÊñπËàü,Positive
 Acalabrutinib Trial,Oncology Tube,Positive
 Acalabrutinib Key Clinical Data,Oncology Tube,Positive
   Grants Breakthrough Therapy Designation,SpecialtyPTimes,Positive
 AstraZenecas juggernaut PARP player Lynparza,Thomas S√©n√©chal,Positive
 AstraZenecas juggernaut PARP player Lynparza,Miles Collier,Positive
 AstraZenecas juggernaut PARP player Lynparza,Dr Timos Papagatsias,Negative
 AstraZenecas juggernaut PARP player Lynparza,Endpoints News,Negative
 FDAs Breakthrough Status,Stanley Suen,Positive
 AZN priority medicines,dough,Negative
 forwardmedicines,dough,Negative
 oncology,dough,Negative
 oncology,pharmaphorum,Negative
 oncology,Richard Staines,Positive
 oncology,IPRX,Positive
 oncology,Paradigm Med Comm,Positive
 oncology,SeqComplete,Negative
 oncology,WCM Lymphoma,Negative
 TagrissoCalquence Lynparza Imfinzi,dough,Negative
 designation,OncLive.com,Negative
 designation,BluePrint Orphan,Positive
 designation,ipharmacenter,Positive
 designation,The James,Negative
 designation,1stOncology,Negative
 III ELEVATETN ASCEND studies,OncLive.com,Negative
 Calquence Earns Breakthrough Therapy Designation,Digital Pharma,Positive
 Calquence Earns Breakthrough Therapy Designation,BioCalifornia,Negative
 BrutonTKI,Shohta Kadomura Hospital Pharmacist,Negative
 ‰∫åÁï™ÊâãÊù•„Åæ„Åó„Åü„Å≠„ÄÇ‰∏ñ‰ª£„ÇÇ„ÅÇ„Å£„Å¶„Åã„ÄÅ„Å©„ÅÜ„Åó„Å¶„ÇÇ„ÄÅ„Åì„ÅÆËñ¨Ââ§Âêç„ÇíË¶ã„Çã„Å®„ÄÅ„Å®„Çì„Å≠„Çã„Åö„ÅåCM„Åó„Å¶„Åü„ÉØ„Ç§„É≥„ÅÆ„ÄÅ„ÄåËµ§„É¨„Çº„É´„Éñ„ÄÅÁôΩ„É¨„Çº„É´„Éñ,Shohta Kadomura Hospital Pharmacist,Negative
 monotherapy treatment,Lymphoma Hub,Negative
 breakthrough therapy status,PharmaSources.com,Positive
 breakthrough therapy status,Saief Kazmi,Positive
 breakthrough therapy designation,EMG GOLD,Positive
 breakthrough therapy designation,Targeted Oncology,Negative
 breakthrough therapy designation,OncLive.com,Negative
 breakthrough therapy designation,COPD News,Negative
 breakthrough therapy designation,Mehrdad Yousefi,Negative
 breakthrough therapy designation,timelivenews,Positive
 breakthrough therapy designation,Share News,Positive
 breakthrough therapy designation,CancerTherapyAdvisor,Negative
 breakthrough therapy designation,Sharecast.com,Negative
 breakthrough therapy designation,Cision News,Negative
 breakthrough therapy designation,Oncology Board,Negative
 breakthrough therapy designation,European Pharmaceutical Review,Negative
 breakthrough therapy designation,Roche,Negative
 Astrazenecas leukaemia treatment Calquence,EMG GOLD,Positive
 CLLThe FDA,Saief Kazmi,Positive
   Designation,1stOncology,Negative
   Designation,Plexus Ventures,Negative
 Breakthrough designation,Pharma Business Int,Negative
 Breakthrough designation,European Pharmaceutical Review,Negative
 Breakthrough designation,JediPD,Negative
 juggernaut PARP player Lynparza,John Carroll,Positive
 juggernaut PARP player Lynparza,Lampgen Clinical Research,Positive
 AstraZenecas juggernaut,Endpoints News,Negative
 player,Endpoints News,Negative
 –ø—Ä–µ–ø–∞—Ä–∞—Ç—É Calquence,ZdravMedInfo,Positive
 –ø—Ä–µ–ø–∞—Ä–∞—Ç—É Calquence,–ù–æ–≤–æ—Å—Ç–∏ GMP,Positive
 FDA Grants Acalabrutinib Breakthrough Designation,COPD News,Negative
 FDA Grants Acalabrutinib Breakthrough Designation,OncLive.com,Negative
 FDA Grants Acalabrutinib Breakthrough Designation,Jason Broderick,Negative
 FDA Grants Acalabrutinib Breakthrough Designation,Crwe World,Positive
 FDA Grants Acalabrutinib Breakthrough Designation,Silas Inman,Negative
 press,Suchitra Sundaram,Positive
 press,Esther Schorr,Negative
 press,Hartford Hospital Pathology,Positive
 press,Anthony Mato,Negative
 breakthrough designation,Suchitra Sundaram,Positive
 breakthrough designation,Graham Collins,Negative
 ‚Äò Breakthrough ‚Äô status,The Pharma Letter,Negative
 III Successes,BioCalifornia,Negative
   grants breakthrough therapy designation,HemOnc Today,Positive
   grants breakthrough therapy designation,Healio,Negative
 CALQUENCE√Ç acalabrutinib,Renal Cell Carcinoma,Positive
 CALQUENCE√Ç acalabrutinib,Drug Delivery News,Positive
 CALQUENCE√Ç acalabrutinib,Cancer News,Negative
 CALQUENCE√Ç acalabrutinib,Pharmacy News & Research,Positive
 Chronic Lymphocytic Leukemia Designation,Renal Cell Carcinoma,Negative
 AZN oncology,John Carroll,Positive
 PhIIIsAstraZenecas juggernaut PARP player Lynparza,John Carroll,Positive
 calquence,Mehrdad Yousefi,Negative
 progress,Sharecast.com,Negative
 progress,OncLive.com,Negative
 progress,HemaSphere_EHA,Positive
 progress,Haematologica,Positive
 progress,Memorial Sloan Kettering Cancer Center,Negative
 progress,MedPage Oncology,Negative
 progress,CLL Society Inc.,Positive
 progress,Taylor Lab UM,Negative
 progress,Patient Power,Negative
 progress,VJHemOnc,Negative
 progress,CryptoLiveLeak,Negative
 progress,Theodoros Moysiadis,Positive
 Lynparza,Sharecast.com,Negative
 Calquence Breakthrough Therapy Designation,WheelieDealer,Negative
 Lymphocytic Leukaemia,WheelieDealer,Negative
 Breakthrough Ther,****,Negative
 AstraZeneca plc Calquence,Francis Alexander,Negative
 WATCH Dr Sharman,OncLive.com,Negative
 Potential Future,OncLive.com,Negative
 Acalabrutinib Therapy Infection Rate amp Headaches,Oncology Tube,Positive
 Baml AZN,dough,Positive
 PO,dough,Negative
 ve roxa news,dough,Negative
 VIDEO Impact,VJHemOnc,Negative
 w Barbara Eichhorst,VJHemOnc,Positive
 Sameem Abedin MD,OncLive SOSS,Negative
 aspects,OncLive SOSS,Negative
 Dr Kipps,"Michael Wang, MD",Negative
 Dr Kipps,CLL Society Inc.,Negative
 Dr Kipps,Andrew Schorr,Positive
 Dr Kipps,Patient Power,Positive
 reports,"Michael Wang, MD",Negative
 reports,Jordan Gauthier,Positive
 reports,WFMZ-TV 69News,Positive
 Dr Abedin,OncLive SOSS,Negative
 Differences,OncLive SOSS,Negative
 Differences,CellworksLife,Negative
 Differences,Frontiers Immunology,Negative
 Differences,TumorImmunoPapers,Negative
 Differences,"chadi nabhan MD, MBA, FACP",Negative
 Differences,JADPRO,Negative
 UsesThis medication,Ravispecialitiespharma_RSP,Negative
 BJH Single,Francesco Bertoni,Negative
 ampRaised sales guide,dough,Negative
 Tam et alZanubrutinib,Toby Eyre,Negative
 Ô∏è BTK occupancy,Toby Eyre,Negative
 bd dosingn,Toby Eyre,Negative
 dose findingCLL cohort subcut,Toby Eyre,Negative
 G,Toby Eyre,Positive
 pt,Toby Eyre,Positive
 pt,Bijoy Telivala,Positive
 pt,"Mazyar Shadman, MD MPH",Negative
 pt,(((Rich Stein)))Stay safeüò∑ü¶† & be kind,Positive
 pt,Patient Empowerment Network,Negative
 toxORR,Toby Eyre,Negative
 TN PD,Toby Eyre,Negative
 ptshort fupDoes,Toby Eyre,Negative
 matter,Toby Eyre,Negative
   Le zanubrutinib inhibiteur de Bruton TK ach√®ve sa phase,J√©r√©mie Zerbit,Positive
 la leuc√©mie lympho√Øde chronique,J√©r√©mie Zerbit,Positive
 SpringerLink,Benlazar S.M Amin√©,Positive
 EHA congress,David Henry,Positive
 Dr Karmali,Targeted Oncology,Negative
 Dr Karmali,donnashort,Negative
 developments,LymphomaAction,Negative
 developments,Kernteam Economie,Positive
 developments,Toby Eyre,Negative
 developments,Patient Power,Negative
 developments,Helen Jane Mee,Negative
 developments,OncLive.com,Negative
 developments,VJHemOnc,Positive
 relapsed   refractory,LymphomaAction,Negative
 MDSCs,OncLive.com,Negative
 BTK inhibitors ibrutinib,OncLive.com,Negative
 III Clinical TrialBased Early Economic Evaluation,HealthEconBot,Positive
 WATCH Dr Woyach,OncLive.com,Positive
 Year,OncLive.com,Negative
 Year,HemOnc Today,Negative
 Year,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Year,Oncology Tube,Negative
 Year,Focus on Cancer,Negative
 Year,Lymphoma Hub,Negative
 Year,CAPO,Positive
 Year,Michael Fisch MD MPH,Positive
 Year,Michael A. Cantrell,Positive
 Year,"Merry-Jennifer Markham, MD, FACP, FASCO",Positive
 Year,Gilead Sciences,Negative
 AcalabrutinibObinutuzumab Combo,OncLive.com,Negative
 AcalabrutinibObinutuzumab Combo,CellworksLife,Negative
 AcalabrutinibObinutuzumab Combo,Immuno-Oncology,Negative
 AcalabrutinibObinutuzumab Combo,Crwe World,Negative
 DAEPOCHR,Renal Cell Carcinoma,Positive
 Calquence Acalabrutinib AstraZenecaAcerta Global Drug Overview,SPI News,Negative
 Outlook,SPI News,Negative
 Outlook,CRO Contract Res.,Positive
 Outlook,Renal Cell Carcinoma,Positive
 Outlook,Colorectal Cancer Charity,Positive
 Outlook,Radiation Research Society,Positive
 Outlook,The Purple Society,Negative
 Outlook,Jim Graham,Positive
 Outlook,TumorImmunoPapers,Negative
 Outlook,JNCI,Negative
 Calquence acalabrutinib AstraZenecaAcerta Overview,Renal Cell Carcinoma,Negative
 Product profile,Renal Cell Carcinoma,Negative
 Report,Renal Cell Carcinoma,Positive
 Report,CRO Contract Res.,Positive
 Report,Danish hussain,Positive
 Report,Research News24 üíé,Positive
 Report,JCM MDPI,Positive
 Report,COPD News,Positive
 Report,Tech News by Qiosk,Negative
 Report,Cancer News,Negative
 WIREampThe ampCalquenceamp report,Renal Cell Carcinoma,Negative
 Calquence acalabrutinib AstraZenecaAcerta Overview Product profile Report,Latest News from Business Wire,Negative
 Acalabrutinib nel,Carlo Franzini,Negative
 cellule,Carlo Franzini,Negative
 del mantello recidivato o refrattario studio ACELY,Carlo Franzini,Negative
 BTK inhibitor trials,Anirban Maitra,Negative
 failedA,Anirban Maitra,Negative
 GemAbraxane,Anirban Maitra,Negative
 IbrutinibB,Anirban Maitra,Negative
 DurvalumabC Acalabrutinib,Anirban Maitra,Negative
 KeytrudaI,Anirban Maitra,Negative
 ecancerÔºöË°ÄÊ∂≤ÔºöEHA,Clinical Newswire,Positive
 Acalabrutinib„ÅØÂÜçÁô∫ÊÄß„Åæ„Åü„ÅØÈõ£Ê≤ªÊÄß„ÅÆÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„Å´„Åä„ÅÑ„Å¶Ëëó„Åó„ÅÑÊúâÁõäÊÄß„ÇíÁ§∫„Åô,Clinical Newswire,Positive
 El,iSanidad,Positive
 El,LoZ PirataZ,Positive
 ASCEND compar√≥ acalabrutinib con rituximab,iSanidad,Positive
 combinaci√≥n con idelalisib o bendamustina,iSanidad,Positive
 AstraZeneca anuncia los resultados detallados del an√°lisis intermedio,iSanidad,Negative
 Astrazeneca anuncia resultados positivos de acalabrutinib para,iSanidad,Positive
 la leucemia linfoc√≠tica cr√≥nica recurrente,iSanidad,Negative
 Leucemia Linfatica Cronica acalabrutinib prolunga significativamente,Medicina e Informazione,Positive
 il tempo di vita senza progressione,Medicina e Informazione,Positive
 il tempo di vita senza progressione,Cerca Soluzioni Cruciverba,Positive
 il tempo di vita senza progressione,Zazoom Social News,Positive
 longterm acalabrutinibobinutuzumab trial,OncLive.com,Negative
 CLL Shows Good Tolerability,Delreo Johnson,Positive
 CLL Shows Good Tolerability,Andy Vermaut,Positive
 Good Tolerability AMSTERDAM,Which e Cars,Positive
 Helen,StrathPharm&Bio,Positive
 SIPBS,StrathPharm&Bio,Positive
   AstraZeneca aumenta,Acobur,Positive
 la supervivencia de pacientes con leucemia,Acobur,Positive
 Calquence AstraZeneca,Pharma Jonpi .,Negative
 o refractaria,Pharma Jonpi .,Negative
 VIDEO Acalabrutinibobinutuzumab,VJHemOnc,Negative
 year followup,VJHemOnc,Negative
 year followup,Lymphoma Papers,Negative
 year followup,Lymphoma Hub,Positive
 year followup,Blood Journal,Negative
 year followup,CLL Ireland,Negative
 year followup,"Raul Cordoba, MD, PhD",Negative
 year followup,MDedge Hematology & Oncology,Positive
 year followup,Francesco Turturro,Positive
 Kerry Rogers,VJHemOnc,Negative
 Kerry Rogers,Lymphoma Hub,Negative
 Kerry Rogers,OncLive.com,Negative
 Kerry Rogers,Targeted Oncology,Negative
 AstraZeneca Calquence CLL Data,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 AstraZeneca Calquence CLL Data,Investing.com Stocks,Positive
 Prof Paolo Ghia,ecancer,Negative
 Prof Paolo Ghia,Donna Gairns,Positive
 Prof Paolo Ghia,LyLe Foreningen,Negative
 Prof Paolo Ghia,CLL Advocates Network,Negative
    meeting,ecancer,Negative
    meeting,Michael Hallek,Negative
    meeting,"chadi nabhan MD, MBA, FACP",Negative
    meeting,Jeff Folloder,Positive
    meeting,VJHemOnc,Negative
 ASCEND studyWatch,ecancer,Negative
 JNJ Biotech Analysis Central AstraZeneca Calquence,Terry Chrisomalis,Positive
 CLL Data,Terry Chrisomalis,Positive
 CLL Data,Seeking Alpha,Positive
 Woyach Highlights LongTerm AcalabrutinibObinutuzumab Data,OncLive.com,Negative
 Woyach Highlights LongTerm AcalabrutinibObinutuzumab Data,Crwe World,Negative
 obinutuzumab Gazyva,Saeed Valadbaygi,Negative
 obinutuzumab Gazyva,National Cancer Institute,Negative
 obinutuzumab Gazyva,Oncology Nursing News,Negative
 obinutuzumab Gazyva,The Leukemia & Lymphoma Society - Policy Advocacy,Positive
 obinutuzumab Gazyva,pocroncology,Positive
 obinutuzumab Gazyva,CLL Ireland,Negative
 bo,Saeed Valadbaygi,Negative
 presentation,Joe Birkett-Crest,Positive
 presentation,"Maria Badillo, MSN RN OCN CCRP",Negative
 presentation,Anthony Mato,Negative
 presentation,Lisa Palacios,Negative
 presentation,CLL Advocates Network,Negative
 presentation,Mraz Lab,Positive
 presentation,Lymphoma Australia,Positive
 presentation,Toby Eyre,Negative
 presentation,MSKHemOncTrials,Positive
 presentation,Targeted Oncology,Negative
 presentation,ESH (Haematology),Negative
 presentation,VJHemOnc,Negative
 presentation,"W. Keith Hoots, M.D.",Positive
 presentation,The James,Negative
 presentation,Jeff Szer,Negative
 presentation,Ordre Pharmaciens LB,Positive
 presentation,Ravi Goyal,Positive
 presentation,"Pharmacyclics, an AbbVie Company",Negative
 presentation,Carevƒ´ve,Negative
 presentation,Penn Medicine News,Negative
 presentation,Lymphoma Hub,Positive
 presentation,David Basanta Gutierrez,Positive
 presentation,Biotech2050,Negative
 presentation,ASH,Negative
 Êú¨Êó•„ÅÆÁúãË≠∑„ÉªÂåªÁôÇ„Éã„É•„Éº„Çπ„Åß„Åô„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ Calquence„ÄÅÂÜçÁô∫Âèà„ÅØÈõ£Ê≤ªÊÄßÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÊÇ£ËÄÖ„Åï„Çì„ÅÆÁÑ°Â¢óÊÇ™ÁîüÂ≠òÊúüÈñì„ÇíÊúâÊÑè„Å´Âª∂Èï∑,„Äå„Éä„Éº„ÇπÂ∞ÇÁßë„Äç„Å§„Å∂„ÇÑ„ÅçÈöä,Positive
 VIDEO AstraZeneca executive,HemOnc Today,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Ê†™Âºè‰ºöÁ§æ„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ Calquence „ÄÅ ÂÜçÁô∫Âèà„ÅØÈõ£Ê≤ªÊÄßÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÊÇ£ËÄÖ„Åï„Çì„ÅÆÁÑ°Â¢óÊÇ™ÁîüÂ≠òÊúüÈñì„ÇíÊúâÊÑè„Å´Âª∂Èï∑,‰∏≠‰∫ï‰∫ÆÂ§™ÈÉé,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ Calquence,PR TIMES„Éì„Ç∏„Éç„Çπ,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ Calquence,PR TIMES„Éã„É•„Éº„Çπ,Positive
 AstraZeneca acarabultinib Calquence,re-how.net,Negative
 Opiniondecision,Pharma Regulatory,Negative
 success,"Michael Wang, MD",Negative
 success,DrugGenius,Negative
 success,Brad Loncar,Positive
 success,Carly Helfand,Negative
 success,Dr Timos Papagatsias,Negative
 success,FiercePharma,Negative
 success,CLL Society Inc.,Negative
 success,Biologics by McKesson,Negative
 success,SpecialtyPTimes,Negative
 success,Teresa Martin,Positive
 success,VJHemOnc,Negative
 success,Crown Bioscience,Negative
 success,AliKat üíô,Positive
 success,Dr. William J. Smith,Positive
 success,MD Anderson Cancer Center,Positive
 success,Charger Baseball,Positive
 success,Lymphoma Hub,Negative
 success,Bryan Zwan,Positive
 success,HHF,Negative
 success,Visiongain,Positive
 Mantle Cell Lymphoma Program,"Michael Wang, MD",Negative
 Excellence,"Michael Wang, MD",Negative
 MD Anderson,"Michael Wang, MD",Negative
 MD Anderson,Michele Nadeem-Baker,Negative
 MD Anderson,Lisa Palacios,Negative
 MD Anderson,Andrew Schorr,Negative
 MD Anderson,VJHemOnc,Negative
 MD Anderson,Scott Merville,Negative
 kind,"Michael Wang, MD",Negative
 kind,undead viking zombie,Positive
 kind,Kim Kirchherr,Negative
 world,"Michael Wang, MD",Negative
 world,CLL Society Inc.,Positive
 world,KrisA,Positive
 world,RIOH,Negative
 world,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 world,Matthews & Associates,Positive
 world,An Deveaux,Positive
 world,Total Health Conferencing,Positive
 world,Zack Pemberton-Whiteley,Negative
 world,donnashort,Negative
 world,Chan Cheah,Negative
 world,EMJ Hematology,Positive
 world,Lymphoma Hub,Negative
 world,Maureen,Positive
 world,Patient Power,Negative
 world,EMJ Rheumatology,Negative
 Viable Option,A Nasser Nourallah. MD.FASCO,Positive
 Viable Option,OncLive.com,Negative
 IbrutinibIntolerant RelapsedRefractory CLLAcalabrutinib,A Nasser Nourallah. MD.FASCO,Positive
 NEI,I Malati Invisibili,Positive
 O REFRATTARI ACALABRUTINIB,I Malati Invisibili,Negative
 MIGLIORA IL TEMPO,I Malati Invisibili,Negative
 DA PROGRESSIONEtcoDkQZGriga,I Malati Invisibili,Negative
 IbrutinibIntolerant RelapsedRefractory CLL,OncLive.com,Negative
 LEUCEMIA LINFATICA CRONICA ACALABRUTINIB,Salutedomani,Negative
 LEUCEMIA LINFATICA CRONICA ACALABRUTINIB,Antonio Caperna,Positive
 LEUCEMIA LINFATICA CRONICA ACALABRUTINIB,saluteH24.com,Positive
 LEUCEMIA LINFATICA CRONICA ACALABRUTINIB,Derma News OK,Positive
 LEUCEMIA LINFATICA CRONICA ACALABRUTINIB,I Malati Invisibili,Negative
 Risque de fibrillation atriale,cardio-online,Positive
 Risque de fibrillation atriale,Virginie Bagouet,Positive
 les anticanc√©reux acalabrutinib ibrutinib,cardio-online,Positive
 et sonid√©gib,cardio-online,Positive
 EHA insights gtgtgt,Dr Timos Papagatsias,Positive
 ASCO Post,Dr Timos Papagatsias,Negative
 ASCO Post,Aloysius Pendergast,Positive
 ASCO Post,"Andrew Johns, MD",Positive
 ASCO Post,Joe Librescu,Positive
 ASCO Post,CancerWallonia,Negative
 ASCO Post,Krishan Maggon,Negative
 ASCO Post,Lymphomation.org,Positive
 Twitter ASCEND Trial Compares Acalabrutinib,Dr Timos Papagatsias,Negative
 da progressione dei pazienti,Roberto Bonin,Positive
 da progressione dei pazienti,Tecnomedicina,Positive
 o refrattari,Roberto Bonin,Positive
 o refrattari,Tecnomedicina,Positive
 ASCEND Trial Compares Acalabrutinib,The ASCO Post,Negative
 Unimportante nuova arma terapeutica,Ritrattodellasalute,Positive
 VIDEO     intolerant   patients,VJHemOnc,Negative
 Leucemia linfatica cronica acalabrutinib migliora,PharmaStar,Negative
 Leucemia linfatica cronica acalabrutinib migliora,Cerca Soluzioni Cruciverba,Positive
 Leucemia linfatica cronica acalabrutinib migliora,Zazoom Social News,Positive
 il tempo,PharmaStar,Negative
 CLL Question,"Mazyar Shadman, MD MPH",Negative
 P Ghia,Lymphoma Hub,Negative
 III ASCEND study,Lymphoma Hub,Negative
 Ghia et al ASCEND,Toby Eyre,Negative
 idelaR BR BTKi superior PFS,Toby Eyre,Negative
 relapse,Toby Eyre,Negative
 relapse,AACR Foundation,Positive
 relapse,Michele Nadeem-Baker,Negative
 relapse,Targeted Oncology,Negative
 relapse,VJHemOnc,Negative
 relapse,"Raul Cordoba, MD, PhD",Positive
 idelaR,Toby Eyre,Negative
 Dr Vose,OncLive.com,Negative
 AcalabrutinibPembrolizumab Combo,OncLive.com,Negative
 DLBCL,OncLive.com,Negative
 DLBCL,AplusA World,Negative
 DLBCL,Lymphoma Hub,Negative
 BTKIs,Natacha Bola√±os,Negative
 Brown Highlights,OncLive.com,Negative
 Future,OncLive.com,Negative
 Future,Oncology Tube,Positive
 Future,Rajesh Sharma,Negative
 Future,Paperbirds_Hematology,Negative
 Future,CancerWallonia,Negative
 Future,donnashort,Negative
 Future,MoJo,Negative
 Future,Carevƒ´ve,Positive
 Future,Journal of Clinical Pathways,Negative
 Future,EMJ Oncology,Positive
 Future,AJMC,Negative
 Future,EMJ Reviews,Positive
 Future,David MANSET,Positive
 CLL Treatment,OncLive.com,Negative
 CLL Treatment,Patient Worthy,Negative
 CLL Treatment,AJMC,Positive
 Press release,Jeff Sharman,Positive
 New Post Seven Acerta Collaborate,Lymphoma News Today,Negative
 Triple Combo Therapy,Lymphoma News Today,Negative
 DLBCL Patients,Lymphoma News Today,Negative
 sights,Bionest Partners,Negative
 sights,cafepharma,Positive
 sights,EIPG,Negative
 sights,Dr Timos Papagatsias,Negative
 sights,FiercePharma,Negative
 sights,Labofine,Negative
 sights,Pharma Regulatory,Negative
 sights,"Pat Euglow, Legacy Newbie",Negative
 Compelling Calquence CLL data,The Pharma Letter,Negative
 basis,The Pharma Letter,Negative
 basis,Toby Eyre,Negative
 basis,Patient Power,Negative
 basis,Anna Deveau,Negative
 basis,ImmunologyPapers,Negative
 submissions,The Pharma Letter,Negative
 Acalabrutinib verbetert PFS,Mednet (was: Medidact),Positive
 RRCLL,Mednet (was: Medidact),Positive
 SingleAgent Acalabrutinib,Immuno-Oncology,Negative
 SingleAgent Acalabrutinib,OncLive.com,Positive
 SingleAgent Acalabrutinib,Crwe World,Negative
 Potential PracticeChanging Data,Immuno-Oncology,Negative
 Potential PracticeChanging Data,OncLive.com,Negative
 Potential PracticeChanging Data,Crwe World,Negative
 Acalabrutinib incrementa,contacto sciencelink,Negative
 AstraZeneca PLC LONAZN drug,YouHalal.com,Positive
   AZ Calquence,OBR,Negative
 PFS Benefit,OBR,Negative
 CLL Patients,OBR,Negative
 CLL Patients,Lauren Evoy Davis,Positive
 CLL Patients,Paperbirds_Hematology,Positive
 CLL Patients,Michele Nadeem-Baker,Negative
 CLL Patients,Brave Is Now¬Æ,Negative
 CLL Patients,Brave Is Now,Positive
 CLL Patients,Patient Worthy,Negative
 CLL Patients,Oncology Tube,Negative
 CLL Patients,CellworksLife,Negative
 CLL Patients,Marketbit.pro,Negative
 CLL Patients,Swallow This - The War On Cancer! üò∑,Positive
 CLL Patients,Oncology Times,Negative
 CLL Patients,1stOncology,Negative
 CLL Patients,Carolyn Thompson,Negative
 CLL Patients,NACDA Program on Aging,Negative
 CLL Patients,Swine Flu News,Positive
 CLL Patients,COPD News,Negative
 CLL Patients,CancerTherapyAdvisor,Positive
 PIII ASCEND Study,PharmaShots - Incisive news in 3 shots,Positive
 AbbVieJohnson amp Johnson,"Cancer Stat - Essential News, Research & Analysis",Positive
 Detailed Data,GMPnews.Net,Negative
 Calquence Phase III Clinical Trials,GMPnews.Net,Negative
 trattamento della,EmatoInfo,Positive
 allo studio,EmatoInfo,Positive
 dimostra,EmatoInfo,Positive
 efficacia e sicurezza,EmatoInfo,Positive
 trattamenti,EmatoInfo,Positive
 Ne abbiamo parlato con Paolo Ghia,EmatoInfo,Positive
 encouraging effects,Proactive,Negative
 leukaemia treatment Calquence,Proactive,Negative
 acalabrutinib„ÅØÂÜçÁô∫„ÄÅÈõ£Ê≤ªÊÄßCLL„ÅÆÂ¢óÊÇ™„ÄÅÊ≠ª‰∫°„É™„Çπ„ÇØ„ÇíÊó¢Â≠òÊ≤ªÁôÇ„Çà„ÇäÔºÖ‰ΩéÊ∏õ   Êó•Áµå„É°„Éá„Ç£„Ç´„É´,Êó•Áµå„É°„Éá„Ç£„Ç´„É´,Positive
 patients month survival,Mike van Dulken,Negative
 Babcock,Mehrdad Yousefi,Negative
 takeover approach,Mehrdad Yousefi,Negative
 Serco AstraZeneca,Mehrdad Yousefi,Negative
 AstraZeneca PLC Calquence,Francis Alexander,Negative
 time patient,Francis Alexander,Negative
 time patient,Cision News,Negative
 Investing,FinInsyn,Positive
 Astra Zeneca f√•r positiva resultat fr√•n leukemistudie med Calquence,FinInsyn,Negative
 Astra Zeneca f√•r positiva resultat fr√•n leukemistudie med Calquence,Investing.com Sverige üá∏üá™,Positive
 acalabrutinib„ÅØÂÜçÁô∫„ÄÅÈõ£Ê≤ªÊÄßCLL„ÅÆÂ¢óÊÇ™„ÄÅÊ≠ª‰∫°„É™„Çπ„ÇØ„ÇíÊó¢Â≠òÊ≤ªÁôÇ„Çà„ÇäÔºÖ‰ΩéÊ∏õ Ôºà Êó•ÁµåBP Ôºâ,ÁßëÂ≠¶„Éã„É•„Éº„Çπ,Positive
 acalabrutinib„ÅØÂÜçÁô∫„ÄÅÈõ£Ê≤ªÊÄßCLL„ÅÆÂ¢óÊÇ™„ÄÅÊ≠ª‰∫°„É™„Çπ„ÇØ„ÇíÊó¢Â≠òÊ≤ªÁôÇ„Çà„ÇäÔºÖ‰ΩéÊ∏õ,ÂåªÂ≠¶Â≠¶‰ºö„Éã„É•„Éº„Çπ,Positive
 Safe Significantly,OncLive.com,Negative
 offtarget activity,Joe Librescu,Positive
 offtarget activity,Federal Practitioner,Positive
 target safety,Joe Librescu,Positive
 ibrutinib arql,Joe Librescu,Positive
 Universit√† VitaSalute San Raffaele,Lymphoma Hub,Negative
    ASCEND,NYCDoc29,Negative
 IdR,"Andres Chang, MD, PhD",Positive
 AwesomeCapital AstraZeneca CALQUENCE Prolonged Leukemia Survival,****,Negative
 K Maddocks,Lymphoma Hub,Negative
 III study results,Lymphoma Hub,Negative
 acalabrutinib   pembrolizumab,Lymphoma Hub,Negative
 RR DLBCL,Lymphoma Hub,Negative
 RR DLBCL,Toby Eyre,Negative
 MCL research efforts,OncLive.com,Negative
 chemotherapyfree induction therapy,OncLive.com,Negative
 Meets,TrialSite News,Negative
 Interim,TrialSite News,Negative
 Site News,TrialSite News,Positive
 calendars,AstraZenecaUS,Negative
 calendars,RWJBarnabas,Positive
 calendars,MDEdge,Negative
 calendars,MDedge Hematology & Oncology,Negative
 PM CEST,AstraZenecaUS,Negative
 PM CEST,Gilead Sciences,Negative
 Ich habe,oncoletter,Positive
 Paolo Ghia Acalabrutinib,oncoletter,Negative
 Acalabrutinib nuova,EmatoInfo,Positive
 terapeutica,EmatoInfo,Positive
 Ghia P   study,EmatoInfo,Positive
 previously treated   LB,EmatoInfo,Positive
 Blood Spotlight Acalabrutinib,Blood Journal,Negative
 AstraZeneca Co Ltd AstraZeneca,re-how.net,Negative
 acarabultinib Calquence,re-how.net,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Ê†™Âºè‰ºöÁ§æ„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence Ôºâ ÂâçÊ≤ªÁôÇÊ≠¥„ÅÆ„Å™„ÅÑÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÇíÂØæË±°„Å®„Åó„Åü,‰∏≠‰∫ï‰∫ÆÂ§™ÈÉé,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence,PR TIMES„Éì„Ç∏„Éç„Çπ,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence,PR TIMES„Éã„É•„Éº„Çπ,Positive
 Ôºâ ÂâçÊ≤ªÁôÇÊ≠¥„ÅÆ„Å™„ÅÑÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÇíÂØæË±°„Å®„Åó„Åü,PR TIMES„Éì„Ç∏„Éç„Çπ,Positive
 Ôºâ ÂâçÊ≤ªÁôÇÊ≠¥„ÅÆ„Å™„ÅÑÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÇíÂØæË±°„Å®„Åó„Åü,PR TIMES„Éã„É•„Éº„Çπ,Positive
    au,Luu-Ly Do-Quang,Positive
 congr√®s    de fibrillation atriale,Luu-Ly Do-Quang,Positive
 les anticanc√©reux acalabrutinib ibrutinib et sonid√©gib,Luu-Ly Do-Quang,Positive
 les anticanc√©reux acalabrutinib ibrutinib et sonid√©gib,Virginie Bagouet,Positive
   congr√®s,Virginie Bagouet,Positive
 ICYMI AstraZenecas Calquence,Carly Helfand,Negative
 Imbruvicas turf,Carly Helfand,Negative
 Imbruvicas turf,Advera Health,Negative
 Imbruvicas turf,Bionest Partners,Negative
 Imbruvicas turf,FPCsWorld,Positive
 Imbruvicas turf,FiercePharma,Negative
 L√©tude de phase,oncohebdo,Positive
 ELEVATETN atteint lobjectif principal,oncohebdo,Negative
 de survie sans progression,oncohebdo,Negative
 √©mie,oncohebdo,Negative
 √©mie,@AplusA_France,Positive
 AstraZenecaÁ§æ„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÂØæË±°„ÅÆBTKÈòªÂÆ≥Ââ§Calquence„ÅÆÁ¨¨Áõ∏Ë©¶È®ì„Åß‰∏ªË¶ÅË©ï‰æ°È†ÖÁõÆÈÅîÊàê,ÂâçÁî∞ÈùôÂêæÔΩúÊµ∑Â§ñÊÉÖÂ†±Ê¥ªÁî®„Ç≥„É≥„Çµ„É´„Çø„É≥„Éà„ÄÄInsights4 PharmaÁ∑®ÈõÜÈï∑,Negative
 AstraZeneca suma otro √©xito,Cluster Salud - AE,Positive
 ensayo cl√≠nico de Calquence,Cluster Salud - AE,Positive
 Combination therapy,Flow Paradigm,Positive
 Combination therapy,Targeted Oncology,Negative
 Combination therapy,Hematology Advisor,Negative
 Combination therapy,AJMC,Negative
 Combination therapy,"Kerry J. Laing, PhD üë©üèª‚Äçüî¨ üè¥Û†ÅßÛ†Å¢Û†Å≥Û†Å£Û†Å¥Û†Åø üá∫üá∏",Positive
 Phase   trial acalabrutinib,Vijaya L,Positive
    Calquence,Cpl Life Sciences,Negative
 endpoints,Cpl Life Sciences,Negative
 endpoints,David Ledger,Negative
 endpoints,PharmaTimes,Positive
 endpoints,Oncology Forum UK,Positive
 endpoints,Pharma Regulatory,Positive
 endpoints,Everything Pharma,Negative
 endpoints,Pharma Trader,Negative
 endpoints,PharmaCrowd,Negative
 endpoints,Barry Curry,Negative
 latestage,Cpl Life Sciences,Negative
 latestage leukemia trial,David Ledger,Negative
 latestage leukemia trial,PharmaTimes,Negative
 latestage leukemia trial,Oncology Forum UK,Positive
 latestage leukemia trial,Pharma Regulatory,Negative
   Calquence Phase III ELEVATETN trial,PressReleasePoint,Negative
 Endpoint,ASOII,Positive
 Endpoint,Scrip,Negative
 nd CLL Study,ASOII,Positive
 LEUCEMIA LINFATICA CRONICA LLC,I Malati Invisibili,Negative
 FASE   ACALABRUTINIB CENTRA,I Malati Invisibili,Negative
 Calquence trial,DR.ARUN ACHUTHAN,Negative
 Calquence trial,EIPG,Negative
 Calquence trial,cafepharma,Negative
 Calquence trial,Pharmafocus,Positive
 Calquence trial,Pharmamarketeer,Positive
 Calquence trial,Jon Angelo,Negative
    hits endpoints,Plexus Ventures,Negative
 latestage   trial,Plexus Ventures,Negative
 goals,The Pharma Letter,Negative
 goals,Haybury,Positive
 goals,German Cheer Dad (GCD),Negative
 goals,CLL Ireland,Negative
 goals,VJHemOnc,Negative
 goals,iwCLL,Negative
 Leucemia linfatica cronica acalabrutinib centra,PharmaStar,Positive
 point,PharmaStar,Positive
 point,Gear√≥id √ì Crotaigh #CareCantWait,Negative
 point,Atrium Health Navicent,Positive
 point,Bruce Samuelson,Negative
 point,Patient Power,Negative
 point,CLLSA,Negative
 Calquence ammunition,Endpoints News,Positive
 Calquence ammunition,EIPG,Negative
 Calquence ammunition,Dr Timos Papagatsias,Negative
 Calquence ammunition,DennisPartners,Negative
 Calquence ammunition,Amber Tong,Positive
 Leucemia linfoc√≠tica cr√≥nica Acalabrutinib,contacto sciencelink,Negative
 Investigators,BioSpace,Positive
 Investigators,Hematology Advisor,Negative
 Investigators,OncLive.com,Negative
 Investigators,MDedge Hematology & Oncology,Negative
 Investigators,Scott Werntz,Negative
 mark,BioSpace,Positive
 mark,"Cowan, Liebowitz",Negative
 CLL Phase III Study,Scrip,Negative
 strength,Pharmafocus,Positive
 strength,Jon Angelo,Negative
 strength,Taylor Lab UM,Negative
 strength,Melissa Palomo Ramon,Positive
 strength,Proactive,Negative
 strength,FriendsShow,Positive
   Ends,Alex Keown,Positive
 Endpoints,Alex Keown,Positive
 Endpoints,BioCalifornia,Negative
 CLL Study,BioCalifornia,Negative
 CLL Study,Lymphoma News Today,Negative
 CLL Study,CancerTherapyAdvisor,Negative
 CLL Study,Scott Werntz,Negative
 PIII ELEVATETN Trial,PharmaShots - Incisive news in 3 shots,Negative
 III,1stOncology,Negative
 III,Lymphoma Hub,Negative
 III,CancerWallonia,Positive
 Trial Met Primary Endpoint,1stOncology,Negative
 Interim Analysis,1stOncology,Negative
 Interim Analysis,BiopharmaAsia,Negative
 PreviouslyUntreated,1stOncology,Negative
 premarket,Investor News,Negative
 premarket,Breaking News,Negative
 AZN RHHBY,Breaking News,Negative
 Astra Zeneca n√•dde prim√§rm√•l,FinInsyn,Negative
 Astra Zeneca n√•dde prim√§rm√•l,Investing.com Sverige üá∏üá™,Positive
 chemoobi,M,Positive
 L CLL Data,M,Positive
 EHA Ibrutinib P,M,Positive
 Acalabrutinib centra,PharmaStar,Negative
 pont,PharmaStar,Negative
 AstraZeneca Calquence Phase III ELEVATETN trial,Mike van Dulken,Negative
 AstraZeneca Calquence Phase III ELEVATETN trial,Francis Alexander,Negative
 AZNUK Calquence Phase III ELEVATETN trial,TradeTheNews.com,Positive
 Calquence Phase III ELEVATETN trial,Cision News,Positive
 Acalabrutinib Combo Induces High Responses,OncLive.com,Negative
 Chronic Lymphocytic Leukem,Oncology_Tribune,Positive
 „Ç≠„É£„É≥„Éö„Éº„É≥,Oncology_Tribune,Positive
 Treatment combination,Clarivate Cortellis,Negative
      Tues,"Mike Thompson, MD, PhD, FASCO",Positive
 E    Chairs Bartlett,"Mike Thompson, MD, PhD, FASCO",Positive
 amp Davids     rr CLL acalabrutinib amp obinutuzumab   Woyach,"Mike Thompson, MD, PhD, FASCO",Negative
 fib,"Mike Thompson, MD, PhD, FASCO",Negative
 amp Davids,"Mike Thompson, MD, PhD, FASCO",Positive
 Woyach,"Mike Thompson, MD, PhD, FASCO",Positive
 Woyach,Aurora Cancer Care,Positive
 Woyach,Taylor Lab UM,Negative
   Woyach,"Aaron Logan, MD, PhD, MPhil ‚Äî DONATE BLOOD!",Positive
 yr followup,"Aaron Logan, MD, PhD, MPhil ‚Äî DONATE BLOOD!",Positive
 AcalabrutinibObinutuzumab,"Aaron Logan, MD, PhD, MPhil ‚Äî DONATE BLOOD!",Positive
 st line n,"Aaron Logan, MD, PhD, MPhil ‚Äî DONATE BLOOD!",Positive
 salvage,"Aaron Logan, MD, PhD, MPhil ‚Äî DONATE BLOOD!",Positive
 Acerta AstraZeneca Evaluating Acalabrutinib,TrialSite News,Negative
 IbrutinibIntolerant RR Chronic Lymphocytic,TrialSite News,Negative
 VIDEO Longterm followup,VJHemOnc,Negative
 New patent,BioCalifornia,Positive
 New patent,DrugPatentWatch,Positive
 New patent,Mazen M,Negative
 New patent,Pharmacy News & Research,Positive
 Astrazeneca drug CALQUENCE,BioCalifornia,Positive
 Astrazeneca drug CALQUENCE,Mazen M,Negative
 Astrazeneca drug,DrugPatentWatch,Positive
 Influence,CureHuntr,Negative
 Influence,TrialBulletin,Negative
 Influence,Paperbirds_Hematology,Negative
 Influence,CLL Society Inc.,Negative
 Influence,AJMC,Negative
 Severe Hepatic Impairment,CureHuntr,Negative
 Severe Hepatic Impairment,TrialBulletin,Negative
 Pharmacokinetics,CureHuntr,Negative
 Pharmacokinetics,TrialBulletin,Positive
 Pharmacokinetics,ClinicalTrialsData,Negative
 Pharmacokinetics,Lymphoma Papers,Negative
 Pharmacokinetics,Lymphomation.org,Negative
 Pharmacokinetics,Cancer Papers,Negative
 Metabolite,CureHuntr,Negative
 Metabolite Status Completed Condition Summary Hepatic Impairment Hepatic Insufficiency Healthy Subjects,TrialBulletin,Negative
 STELLAR trial,Europe PMC articles,Positive
 STELLAR trial,Cancer News,Negative
 STELLAR trial,Toby Eyre,Positive
 TN RR     TN,Toby Eyre,Negative
 RR pts,Toby Eyre,Negative
 RR pts,Tapan Kadia,Negative
 Common G,Toby Eyre,Negative
 LongTerm Outcome,Oncology Tube,Positive
 ÂÜçÁô∫Èõ£Ê≤ªÊÄßÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÔºàCLLÔºâÊÇ£ËÄÖ„Å´ÂØæ„Åô„ÇãBTKÈòªÂÆ≥Ëñ¨„Åß„ÅÇ„ÇãacalabrutinibÂçòÂâ§ÁôÇÊ≥ï„ÅÆÊúâÂäπÊÄß„ÄÅÂÆâÂÖ®ÊÄß„ÇíÊØîËºÉÊ§úË®º„Åó„ÅüÁ¨¨Áõ∏„ÅÆASCENDË©¶È®ì„ÅÆÁÑ°Â¢óÊÇ™ÁîüÂ≠òÊúüÈñìÔºàPFSÔºâ„ÅÆÁµêÊûú„ÅåÂÖ¨Ë°®„Åï„Çå„Åæ„Åó„Åü„ÄÇÁÑ°Â¢óÊÇ™ÁîüÂ≠òÊúüÈñì„ÅØacalabrutinibÁæ§„ÅßÊúâÊÑè„Å´ÂÑ™„Çå„Çã„Åì„Å®„ÅåË®ºÊòé„Åï„Çå„Åæ„Åó„Åü,„Ç™„É≥„Ç≥„É≠,Positive
 ASCO data,Advera Health,Negative
 ASCO data,EIPG,Negative
 ASCO data,Total Pharma News,Negative
 ASCO data,PharmaCrowd,Negative
 ASCO data,FiercePharma,Negative
 ASCO data,Carly Helfand,Negative
 ASCO data,Dr Timos Papagatsias,Negative
 ASCO data,Pharma Regulatory,Negative
 ASCO data,Labofine,Negative
 Calquence rival Imbruvica,Advera Health,Negative
 Calquence rival Imbruvica,EIPG,Negative
 Calquence rival Imbruvica,Total Pharma News,Negative
 Calquence rival Imbruvica,PharmaCrowd,Negative
 Calquence rival Imbruvica,FiercePharma,Negative
 Calquence rival Imbruvica,Dr Timos Papagatsias,Negative
 Calquence rival Imbruvica,Pharma Regulatory,Negative
 Calquence rival Imbruvica,Labofine,Negative
 analyst,Advera Health,Negative
 FiercePharma,Advera Health,Positive
 „Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÄÅÂÜçÁô∫„Åæ„Åü„ÅØÈõ£Ê≤ªÊÄßCLLÂØæË±°„ÅÆPË©¶È®ì„Åß‰∏ªË¶ÅË©ï‰æ°È†ÖÁõÆÈÅîÊàêÔºçËã±AZ,QLifeProÂåªÁôÇÊÉÖÂ†±,Positive
 „Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÄÅÂÜçÁô∫„Åæ„Åü„ÅØÈõ£Ê≤ªÊÄßCLLÂØæË±°„ÅÆPË©¶È®ì„Åß‰∏ªË¶ÅË©ï‰æ°È†ÖÁõÆÈÅîÊàêÔºçËã±AZ,„Ç¢„Ç§„Ç¢„Éº„É´„Ç®„ÉÉ„ÇØ„Çπ„Éª„É°„Éá„Ç£„Ç∑„É≥„ÄêÂÖ¨Âºè„Äë,Positive
 QLifePro,QLifeProÂåªÁôÇÊÉÖÂ†±,Positive
 QLifePro ÂåªÁôÇ„Éã„É•„Éº„Çπ,„Ç¢„Ç§„Ç¢„Éº„É´„Ç®„ÉÉ„ÇØ„Çπ„Éª„É°„Éá„Ç£„Ç∑„É≥„ÄêÂÖ¨Âºè„Äë,Positive
 QLifePro ÂåªÁôÇ„Éã„É•„Éº„Çπ,QLifeProÂåªÁôÇÊÉÖÂ†±,Positive
 CLL analyst,EIPG,Negative
 CLL analyst,Total Pharma News,Negative
 CLL analyst,PharmaCrowd,Negative
 CLL analyst,FiercePharma,Negative
 CLL analyst,Carly Helfand,Negative
 CLL analyst,Dr Timos Papagatsias,Negative
 CLL analyst,Pharma Regulatory,Negative
 CLL analyst,Labofine,Negative
 AwesomeCapital ASCO data,****,Negative
 Calquence rival Imbruvic,****,Negative
 Current Issue,Infectdis,Positive
 Current Issue,CO_Oncology,Positive
 Cryptococcal Infection,Infectdis,Positive
 Patient Receiving Acalabrutinib,Infectdis,Positive
 center,AJMC,Negative
 center,Anthony Mato,Negative
 center,"Pharmacyclics, an AbbVie Company",Negative
 AstraZenecas Calquence preps,vshariharakrishnan,Positive
 AstraZenecas Calquence preps,Bionest Partners,Negative
 AstraZenecas Calquence preps,Dr Timos Papagatsias,Negative
 AstraZenecas Calquence preps,Advera Health,Negative
 AstraZenecas Calquence preps,PharmaCrowd,Negative
 AstraZenecas Calquence preps,Labofine,Negative
 AstraZenecas Calquence preps,Pharma Regulatory,Negative
 AstraZenecas Calquence preps,FiercePharma,Negative
 AZ„ÅÆ„Ç™„É≥„Ç≥„É≠„Ç∏„Éº„ÅØ„ÇÑ„Å£„Å±„ÇäÂáÑ„ÅÑ„Å™ÔΩû„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÂÜçÁô∫Âèà„ÅØÈõ£Ê≤ªÊÄßÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÇíÂØæË±°„Å®„Åó„ÅüÁ¨¨‚Ö¢Áõ∏ASCENDË©¶È®ì„ÅÆ ‰∏≠ÈñìËß£Êûê„Å´„Åä„ÅÑ„Å¶‰∏ªË¶ÅË©ï‰æ°È†ÖÁõÆ„ÇíÈÅîÊàê„Åó„ÄÅË©¶È®ì„ÇíÊó©     „Åã„Çâ,„ÇÜ„Å£„Å¶„ÅÉ„ÉºMR,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Ê†™Âºè‰ºöÁ§æ„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÂÜçÁô∫Âèà„ÅØÈõ£Ê≤ªÊÄßÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÇíÂØæË±°„Å®„Åó„ÅüÁ¨¨IIIÁõ∏ASCENDË©¶È®ì„ÅÆ,‰∏≠‰∫ï‰∫ÆÂ§™ÈÉé,Positive
 Acala dose reductions,Toby Eyre,Negative
 ibrutinib intolerant pts,Toby Eyre,Negative
 Pleased,Toby Eyre,Negative
     monotherapy,"Raul Cordoba, MD, PhD",Negative
 Treating,Cancer News,Positive
 Treating,CureHuntr,Positive
 Treating,TrialBulletin,Negative
 Treating,OncLive.com,Negative
 Treating,Cancers MDPI,Negative
 Treating,Oncology Tube,Negative
 venetoclax acalabrutinib work,Cancer News,Negative
 B√©nefices,oncohebdo,Negative
 survie sans,oncohebdo,Negative
 de l Calquence,oncohebdo,Negative
 Acalabrutinib study,Bernie Marini,Positive
 Ô∏è PFS,Bernie Marini,Positive
 comparator,Bernie Marini,Positive
 Calquence Phase III ASCEND trial,Taylor Lab UM,Negative
 Calquence Phase III ASCEND trial,Cision News,Negative
 Dr Brian Koffman comments,CLL Society Inc.,Positive
 Findings,Targeted Oncology,Positive
 Findings,MD Anderson Cancer Center,Negative
 Findings,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Findings,Yale Cancer Center,Positive
 Competition,CLL Society Inc.,Negative
 Competition,Higher Ground at Lake Louise,Negative
 race,CLL Society Inc.,Negative
 race,"chadi nabhan MD, MBA, FACP",Positive
 thanks,Chocolatiere Phys,Positive
 thanks,Dana-Farber,Negative
 thanks,Fernando LE√ìN SOL√çS,Positive
 thanks,Ysgolllanbedr,Positive
 thanks,Abdel-Wahab Lab,Positive
 thanks,Jonathan Pearce,Negative
 thanks,CLLSA,Negative
 thanks,EMJ Hematology,Negative
 thanks,PRIME Education,Negative
 thanks,Ethical Strategies,Positive
 thanks,"Raul Cordoba, MD, PhD",Negative
 F,DDNews Online,Positive
 F,Total Pharma News,Positive
 F,Business Wire-Health,Negative
 cells,DDNews Online,Negative
 cells,Punjikasthala,Positive
 cells,Anna Kabanova,Positive
 cells,Victor Lin,Positive
 cells,MyPathologyReport.ca,Negative
 cells,Blood Advances,Negative
 cells,Cancer clinical trials,Positive
 cells,Leukemia I'm Fine,Negative
 cells,Blood Journal,Positive
 cells,Daniel Auclair,Positive
 cells,"Krizs√°n Szilvia, MD",Positive
 cells,KHALID HEMATOLOGIST,Positive
 cells,Toby Eyre,Negative
 cells,Atrium Health Navicent,Positive
 cells,Lars M√∏rland Knudsen,Positive
 cells,Dermpath-L,Positive
 cells,CLL Ireland,Positive
 cells,Cancer Education and Research Institute,Positive
 cells,Guillermo Sanz,Negative
 cells,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Positive
 cells,Internist to be,Positive
 cells,MDLinx,Negative
 cells,"Raul Cordoba, MD, PhD",Negative
 cells,CLL_Fightersüéó,Negative
 cells,iwCLL,Positive
 cells,Publish PressRelease,Positive
 cells,AJMC-Oncology,Negative
 cells,Press Releases,Positive
 cells,satPRnews,Negative
 cells,Oncology Tube,Negative
 cells,VJHemOnc,Positive
 cells,RIOH,Negative
 cells,Prof John,Positive
 cells,Genentech,Negative
 cells,Lymphoma Hub,Negative
 cells,Steve Warner,Positive
 cells,Francesco Turturro,Negative
 cells,GenPath Oncology,Negative
 cells,Marta Crespo,Negative
 Weekly news roundup AZ Imbruvica Rival,pharmavoice,Positive
 Positive Trial Results Patents,pharmavoice,Positive
 Scrutiny FDA OKs,pharmavoice,Positive
 Rare Disease Drug,pharmavoice,Positive
 leukaemiaRead,ecancer,Positive
 AZ ‚Äô Calquence ¬† trial,PharmaTimes,Negative
 AZ ‚Äô Calquence ¬† trial,Everything Pharma,Negative
 AZ ‚Äô Calquence ¬† trial,Pharma Trader,Negative
 AZ ‚Äô Calquence ¬† trial,PharmaCrowd,Negative
 AZ ‚Äô Calquence ¬† trial,Pharma Regulatory,Negative
 AZ ‚Äô Calquence ¬† trial,Barry Curry,Negative
 consequence,Decipher Analytics,Positive
 frontline role,OncLive.com,Negative
 CLL paradigm,OncLive.com,Negative
 patients venetoclax duvelisib,OncLive.com,Negative
 Phase    win,Bionest Partners,Negative
 Calquence challenge,Bionest Partners,Negative
 Phase   success,Pharmafocus,Positive
 Phase   success,Pharmamarketeer,Positive
 Phase   success,Jon Angelo,Negative
 Calquence Phase III trial,The Pharma Letter,Negative
   AstraZeneca blood cancer drug Calquence,Career Biotech,Negative
 III Ascend trial,Career Biotech,Negative
 RR Chronic Lymphocytic Leukaemia,PharmaShots - Incisive news in 3 shots,Negative
 Êó¢Ê≤ªÁôÇCLL„Å´BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅÆÂçòÂâ§Êäï‰∏é„ÅåÂåªÂ∏´ÈÅ∏ÊäûÊ≤ªÁôÇ„Çà„Çä„ÇÇÊúâÊÑè„Å´PFS„ÇíÂª∂Èï∑   Êó•Áµå„É°„Éá„Ç£„Ç´„É´,Êó•Áµå„É°„Éá„Ç£„Ç´„É´,Positive
 Calquence help,BioPharma Dive,Negative
 AZNs majority stake,BioPharma Dive,Negative
 Acerta,BioPharma Dive,Negative
 Acerta,Business Wire-Health,Negative
 Acerta,ÊòüÁ©∫,Positive
 Acerta,"John P. Leonard, MD",Positive
 Acerta,Beyond the Pill 2015,Positive
 Acerta,Mktingfarmaceutico,Positive
 Acerta,PISPOpharma,Positive
 Acerta,David Ledger,Negative
 Acerta,JP Duvenhage,Positive
 Acerta,StartupStudio,Positive
 Acerta,Davies Wealth Management,Positive
 Acerta,Michel Francoeur,Positive
 Acerta,NNY News.ca,Positive
 Acerta,BidBookDNA‚Ñ¢,Positive
 Acerta,Joe Hedden,Negative
 ABBVs Imbruvica,BioPharma Dive,Negative
 study goal,Cancer News,Negative
 Exciting day,Stephanie Malveira,Positive
 AstraZeneca Announce Calquence Phase,BiopharmaAsia,Negative
 III ASCEND Trial Met Primary Endpoint,BiopharmaAsia,Negative
 Relapsed Refractory Chronic Lymphocytic Leukaemia,BiopharmaAsia,Negative
 Relapsed Refractory Chronic Lymphocytic Leukaemia,Oncology,Negative
 Calquence monotherapy,CURE Magazine,Negative
 CLL win,Pharma Regulatory,Negative
 CLL win,BioWorld,Positive
 Leucemia linfoc√≠tica cr√≥nica refractaria Estudio fase III ASCEND evaluando acalabrutinib alcanza objetivo primario,contacto sciencelink,Negative
 an√°lisis interino y cerrara anticipadamente,contacto sciencelink,Negative
   Phase III ASCEND trial,1stOncology,Negative
 Êñ∞ÁùÄË®ò‰∫ãÊó¢Ê≤ªÁôÇCLL„Å´BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅÆÂçòÂâ§Êäï‰∏é„ÅåÂåªÂ∏´ÈÅ∏ÊäûÊ≤ªÁôÇ„Çà„Çä„ÇÇÊúâÊÑè„Å´PFS„ÇíÂª∂Èï∑,Ëñ¨Ââ§Â∏´„Ç¶„Ç©„ÉÉ„ÉÅ„ÄÄÁõ∏‰∫í„Éï„Ç©„É≠„Éº,Positive
 ‚ñ∂ UBS bel√§sst Astrazeneca auf,FinanzLinksRatings,Negative
 Pence Z√úRICH,FinanzLinksRatings,Negative
 Analyser,FinanzLinksRatings,Negative
 Die Schweizer Gro√übank UBS hat,FinanzLinksRatings,Negative
 Astrazeneca nach,FinanzLinksRatings,Negative
 neuen Daten einer,FinanzLinksRatings,Negative
 Leuk√§mieStudie,FinanzLinksRatings,Negative
 Calquence auf Sell mit einem Kursziel von,FinanzLinksRatings,Negative
 ONVISTA DPA,FinanzLinksRatings,Negative
 AZN GILD,Breaking News,Negative
 RHHBY   AstraZenecas Calquence,Breaking News,Negative
 latestage leukemia study,Breaking News,Negative
 Einstufung f√ºr Astrazeneca nach,FinanzLinksRatings,Positive
   stops,pharmaphorum,Negative
   stops,üá®üá¶‚ÄùMagic‚Äù Max Pincombeüá®üá¶,Positive
 Phase III trial,pharmaphorum,Negative
 Phase III trial,dough,Negative
 Phase III trial,Lymphoma Hub,Negative
 Phase III trial,VJHemOnc,Negative
 Phase III trial,1stOncology,Negative
 Phase III trial,Dr. Melody Davis,Negative
 Phase III trial,Innate Pharma,Positive
   Calquence Phase III ASCEND trial,PressReleasePoint,Negative
 AstraZenecas Calquence phase,EMG GOLD,Positive
 Êó¢Ê≤ªÁôÇCLL„Å´BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅÆÂçòÂâ§Êäï‰∏é„ÅåÂåªÂ∏´ÈÅ∏ÊäûÊ≤ªÁôÇ„Çà„Çä„ÇÇÊúâÊÑè„Å´PFS„ÇíÂª∂Èï∑ Ôºà Êó•ÁµåBP Ôºâ,ÁßëÂ≠¶„Éã„É•„Éº„Çπ,Positive
 AstraZeneca Calquence Phase III ASCEND trial,Mike van Dulken,Negative
    Company,"Robert Barron, MCSI",Positive
 AstraZeneca Plc Calquence Phase III ASCEND trial,Francis Alexander,Negative
 RT Astra Calquence P monotherapy,DrugGenius,Negative
 Astra Calquence P monotherapy,Brad Loncar,Positive
 Calquence PhIII ASCEND trial,Cision News,Negative
 NSFW Radio,Arthur Barbato,Positive
 Da F,Arthur Barbato,Positive
 ‚óá,Arthur Barbato,Positive
 ck,Arthur Barbato,Positive
 Playin Wit,Arthur Barbato,Positive
   Mafia,Arthur Barbato,Positive
 plethora,OncLive SOSS,Negative
 frontline trials,OncLive SOSS,Negative
 Danielle Brander MD,OncLive SOSS,Negative
 Danielle Brander MD,Duke Hematologic Malignancies & Cellular Therapy,Positive
 comparing ibrutinib,OncLive SOSS,Negative
 Chinese Adult Subjects,CureHuntr,Negative
 Chinese Adult Subjects,Renal Cell Carcinoma,Negative
 Chinese Adult Subjects,TrialBulletin,Negative
 Bcell Malignancies,CureHuntr,Negative
 Bcell Malignancies,Renal Cell Carcinoma,Negative
 openlabel twopart study,Renal Cell Carcinoma,Negative
 safety tolerability pharmacokinetics,Renal Cell Carcinoma,Negative
 clinical,Renal Cell Carcinoma,Negative
 Bcell Malignancies Status,TrialBulletin,Negative
 Condition Summary Phase,TrialBulletin,Negative
 Acalabrutinib Therapy Infection Rate amp Headache,Oncology Tube,Negative
 Bijal Shah MD    Center,"Bichoy Gabra, R.Ph., Ph.D.",Negative
   Inhibitors     ‚Äã Response Assessment,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 tcoKjRNpllqVj,"Bichoy Gabra, R.Ph., Ph.D.",Positive
 Bijal Shah MD HematologistOncologist,"Bichoy Gabra, R.Ph., Ph.D.",Positive
    Center,"Bichoy Gabra, R.Ph., Ph.D.",Positive
   Inhibitors,"Bichoy Gabra, R.Ph., Ph.D.",Positive
 Mantle Cell Lymphoma Treatment,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 Mantle Cell Lymphoma Treatment,CURE Magazine,Negative
 Response Assessment,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 Summary,"Maria Badillo, MSN RN OCN CCRP",Negative
 Summary,Benlazar S.M Amin√©,Negative
 Summary,Mehdi Hamadani,Positive
 Summary,Dr. Andre Goy,Negative
 Summary,Dr. 'CLL' Khan,Positive
 Summary,doctorportal,Negative
 Oncology Nursing Society Congress   conference,"Maria Badillo, MSN RN OCN CCRP",Negative
 Dr Matthew Davids,OncLive SOSS,Negative
 Dr Matthew Davids,CURE Magazine,Negative
 Dr Matthew Davids,"Mazyar Shadman, MD MPH",Negative
 Dr Matthew Davids,WorldCare Medical Second Opinions,Negative
 Dr Matthew Davids,Lymphoma Hub,Negative
 frontline treatment,OncLive SOSS,Positive
 frontline treatment,OncLive.com,Positive
 frontline treatment,Lymphoma Papers,Negative
 frontline treatment,Lymphoma Hub,Positive
 frontline treatment,Targeted Oncology,Positive
 frontline treatment,WhatNext.com,Negative
 frontline treatment,Matt Feyen,Positive
 frontline treatment,"Mike Thompson, MD, PhD, FASCO",Negative
 frontline treatment,Blood Journal,Negative
 frontline treatment,Dr. Jos√© A. Queiz√°n,Negative
 frontline treatment,"Dr T. Comeau , MD",Negative
 frontline treatment,Prof John,Negative
 frontline treatment,Hematology Advisor,Negative
 frontline treatment,"Naveen Pemmaraju, MD",Negative
 frontline treatment,Snowdome Foundation,Positive
 frontline treatment,A Nasser Nourallah. MD.FASCO,Positive
 frontline treatment,CURE Magazine,Negative
 frontline treatment,Oncology Nursing News,Negative
 frontline treatment,CLL Ireland,Negative
 frontline treatment,AJMC-Oncology,Positive
 frontline treatment,VJHemOnc,Negative
 frontline treatment,Cancer Papers,Negative
 frontline treatment,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 frontline treatment,Clin Adv Hem Onc,Negative
 frontline treatment,HemOnc Today,Negative
 frontline treatment,"Robinson Ortiz, MD",Negative
 frontline treatment,Biblioteca CHT,Positive
 ONS Congress,"Maria Badillo, MSN RN OCN CCRP",Negative
 Oncology Nursing Society Congress,"Maria Badillo, MSN RN OCN CCRP",Negative
 Anaheim,"Maria Badillo, MSN RN OCN CCRP",Negative
 CHOPR Therapy,Cancer News,Negative
 Newly Diagnosed Richters Syndrome,Cancer News,Negative
 PHOENIX trial RCHOPibrutinib,Toby Eyre,Negative
 L DLBCL,Toby Eyre,Negative
 Overall EFS,Toby Eyre,Negative
 diff,Toby Eyre,Positive
 arms Convincing EFS advantage,Toby Eyre,Negative
 Whitewash Radio TiltAWhirl,Arthur Barbato,Positive
 ty,Arthur Barbato,Positive
 vagina,Arthur Barbato,Positive
 Novit√†,Carlo Franzini,Positive
 Xagena,Carlo Franzini,Positive
 amp Database,Carlo Franzini,Negative
 Ematologia amp,Carlo Franzini,Negative
 OncoEmatologia,Carlo Franzini,Positive
 Phase III trials,Targeted Oncology,Negative
 highrisk patients,Targeted Oncology,Negative
 highrisk patients,Expert Perspectives in Oncology,Positive
 activity,Targeted Oncology,Negative
 activity,OncLive.com,Negative
 activity,Francesco Bertoni,Negative
 activity,Lampe & Company,Negative
 activity,Gerry Post,Positive
 activity,Oncologiavet,Negative
 activity,Cancer Cell,Negative
 activity,RedMedEd,Positive
 activity,Kirstie Page,Positive
 activity,Joe,Negative
 activity,NACE,Positive
 activity,Paperbirds_Hematology,Positive
 activity,Michael Dickinson,Negative
 activity,"Raul Cordoba, MD, PhD",Negative
 activity,HemOnc Today,Negative
 activity,MDedge Hematology & Oncology,Positive
 activity,EdisonHealthcare,Positive
 activity,Deborah Stephens,Positive
 activity,CancerTherapyAdvisor,Negative
 activity,Steve Warner,Positive
 activity,AtlanticJOMedicine,Negative
 activity,Mehdi Hamadani,Positive
 activity,Chan Cheah,Negative
 activity,OncoTherapy Network,Negative
 Venetoclax Treatment,Cancer News,Negative
 Newly Diagnosed Patients,Cancer News,Negative
 Newly Diagnosed Patients,Lung Cancer News,Negative
 Newly Diagnosed Patients,Christopher Steer,Negative
 High Risk,Cancer News,Negative
 Infection,Cancer News,Negative
 Infection,ImmunologyPapers,Negative
 Infection,Cancer Papers,Negative
 Early Treatment,Cancer News,Negative
 Early Treatment,Lung Cancer News,Negative
 Early Treatment,yeast_papers,Positive
 Xagena Acalabrutinib,Carlo Franzini,Positive
 Aggiornamenti,Carlo Franzini,Negative
 interest,Lymphomation.org,Positive
 interest,Frontiers Immunology,Negative
 interest,CLL Ireland,Positive
 interest,Michael Rynne,Positive
 interest,Lymphoma Hub,Negative
 interest,CRUK Cambridge Centre: Haematological Malignancies,Positive
 interest,"chadi nabhan MD, MBA, FACP",Negative
 interest,James Porreca,Negative
 Dr Goy,JTCancerCenter,Positive
 Dr Goy,OncLive.com,Negative
 Promising,JTCancerCenter,Positive
 Promising,OncLive.com,Negative
 Promising,Patient Worthy,Negative
 Promising,Biotech2050,Negative
 Promising,IntoxicatedTrader,Negative
 Promising,Science United,Positive
 Dr Byrd,CLL Society Inc.,Positive
 Dr Byrd,"Caner Saygin, MD",Negative
 Dr Byrd,OncLive.com,Negative
 Dr Byrd,Targeted Oncology,Negative
 mantle cell lymphoma space,CURE Magazine,Negative
 Dr Wang,OncLive.com,Positive
 Dr Wang,Targeted Oncology,Negative
 Dr Wang,Ahmad Halwani,Positive
 Updated Data,OncLive.com,Negative
 Updated Data,Oncology Times,Negative
 Updated Data,Pharma News,Negative
 Updated Data,IMPharma News,Negative
 Updated Data,Investor News,Negative
 Updated Data,"OTC Dynamics, Inc.",Negative
 Updated Data,Stock Titan,Negative
 P study,Paulo G Bergerot,Positive
 acalabrutinib w PBMCs profiling ‚û° Ô∏ècomb,Paulo G Bergerot,Positive
 PDL monocytes amp CD T cells,Paulo G Bergerot,Positive
 activ periph Tregs,Paulo G Bergerot,Positive
 CRPR pts,Paulo G Bergerot,Positive
 marginalization,Paulo G Bergerot,Positive
 Tregs,Paulo G Bergerot,Positive
 Tregs,Blood Advances,Negative
 frontline phase,"Michael Wang, MD",Negative
 ECHO trials,"Michael Wang, MD",Negative
 SYMPATICO,"Michael Wang, MD",Negative
 Kite Zuma,"Michael Wang, MD",Negative
 JunoCelgene Car T trial,"Michael Wang, MD",Negative
 Shine study,"Michael Wang, MD",Negative
 w John Byrd,VJHemOnc,Negative
 Podoll et al,DMD (ASPET),Positive
 Bioavailability Metabolism,DMD (ASPET),Positive
 Excretion,DMD (ASPET),Positive
 Excretion,MetaBot,Positive
 Excretion,BioMassSpec,Positive
 CAcalabrutinib,DMD (ASPET),Positive
    novel,Journal of Blood Disorder and Treatment,Positive
 Share,Journal of Blood Disorder and Treatment,Positive
 knowldege,Journal of Blood Disorder and Treatment,Positive
 topic,Journal of Blood Disorder and Treatment,Positive
 topic,Lymphoma Hub,Negative
 topic,RDA Europe,Positive
 topic,global hematology,Positive
 topic,Leukemia Research Foundation,Negative
 topic,Expert Perspectives in Oncology,Positive
 Novel agents,RedMedEd,Negative
 Novel agents,CURE Magazine,Positive
 Novel agents,VJHemOnc,Negative
 Novel agents,"Dr T. Comeau , MD",Negative
 B cell lymphomas,RedMedEd,Negative
 agents,RedMedEd,Negative
 agents,WCM Lymphoma,Negative
 agents,VJHemOnc,Negative
 agents,Targeted Oncology,Negative
 agents,Concessionary L.L,Negative
 Astrazeneca drug CALQUENCE Annual Drug Patent Expirations,Pharmacy News & Research,Positive
 CALQUENCE Calquence,Pharmacy News & Research,Positive
 Anvisa aprovou,Oncologia Brasil,Positive
 registro de Calquence,Oncologia Brasil,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´Ê≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDA Ôºâ,Ëñ¨Ââ§Â∏´„Ç¶„Ç©„ÉÉ„ÉÅ„ÄÄÁõ∏‰∫í„Éï„Ç©„É≠„Éº,Negative
 Longterm followup findings,OncLive.com,Negative
 BTK inhibitors acalabrutinib,OncLive.com,Negative
 Tycel Phillips,U-M Rogel Cancer Center,Positive
 TV,U-M Rogel Cancer Center,Negative
 TV,Mayo Clinic Cancer Center,Negative
 TV,NewsLeeds,Positive
 TV,CLL Ireland,Negative
 TV,Andrew Schorr,Negative
 Dr Patel,OncLive.com,Negative
 Durable Response,OncLive.com,Negative
 Durable Response,Marlowe S Tessmer,Negative
 Durable Response,Lymphoma Canada,Negative
 Durable Response,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Lead Researcher,OncLive.com,Negative
 Lead Researcher,CancerWallonia,Negative
 Lead Researcher,Crwe World,Negative
 Response Rates,filippo masini,Negative
 Response Rates,Swallow This - The War On Cancer! üò∑,Positive
 Response Rates,Clinical OMICs,Positive
 Response Rates,Crown Bioscience,Negative
 Lead Researcher Highlights Latest    Data,CancerWallonia,Negative
 Dr Tycel Phillips,U-M Rogel Cancer Center,Negative
 NonHodgkin lymphoma,U-M Rogel Cancer Center,Negative
 Dr Phillips,OncLive.com,Negative
 Dr Phillips,Targeted Oncology,Negative
 Responses PFS,OncLive.com,Negative
 OS,OncLive.com,Negative
 OS,Oncology Learning Network,Negative
 OS,"Marc Braunstein, MD, PhD, FACP",Positive
 OS,"Raul Cordoba, MD, PhD",Positive
 OS,CellworksLife,Negative
 OS,Michael Hallek,Negative
 OS,"Amber Koehler, PA-C",Negative
 OS,SNU P√¥le Emploi FSU Occitanie,Negative
 OS,Targeted Oncology,Negative
 OS,Lymphoma Hub,Positive
 OS,Anna Deveau,Negative
 OS,The ASCO Post,Positive
 OS,T Allen,Positive
 OS,Christopher Steer,Negative
 OS,JUICEPharma,Positive
 longterm followup confirming efficacy,OncLive.com,Negative
 Lead Researcher Highlights Latest Acalabrutinib MCL Data,Immuno-Oncology,Negative
 Lead Researcher Highlights Latest Acalabrutinib MCL Data,Crwe World,Negative
 Watch Robert Dean MD,OncLive SOSS,Negative
 New Post Calquence,Lymphoma News Today,Positive
 Durable Responses,Lymphoma News Today,Positive
 Durable Responses,BioNews,Positive
 Durable Responses,info@medicalresearch.com,Positive
 Durable Responses,1stOncology,Negative
 Durable Responses,Dominique,Positive
 Novel BTK inhibitor acalabrutinib,Oncology Tube,Positive
   Novel agents,OncLive.com,Negative
   Novel agents,NYCDoc29,Negative
 ibrutinib venetoclax idelalisib,OncLive.com,Negative
 Neil E Kay MD,OncLive.com,Negative
 Neil E Kay MD,Oncology Tube,Negative
 Neil E Kay MD,COPD News,Negative
 Neil E Kay MD,PER,Negative
   Dr Goy,OncLive.com,Negative
 hope,Targeted Oncology,Negative
 hope,LLSCanada,Negative
 hope,Andrew Schorr,Negative
 hope,JanssenUS,Negative
 hope,CLL Advocates Network,Negative
 hope,Place Matters,Positive
 hope,Lymphoma Hub,Negative
 hope,Michele Nadeem-Baker,Positive
 hope,CLL Ireland,Positive
 hope,Canadian Health & Family,Positive
 hope,Ohio State,Positive
 hope,MedflixS,Positive
 hope,Patient Power,Positive
 Aprovado novo,Anvisa,Positive
 tipo agressivo de linfoma,Anvisa,Positive
 O produto √© o Calquence,Anvisa,Negative
 adultos que j√° tenham,Anvisa,Negative
 adultos que j√° tenham,Revista Medicina S/A,Positive
 tratamento pr√©vio de linfoma de c√©lulas,Anvisa,Negative
 LCMConfira mais,Anvisa,Negative
 informa√ß√µes,Anvisa,Negative
 portal da Anvisa,Anvisa,Negative
 Efficacia di Acalabrutinib un,Carlo Franzini,Negative
 BTK nel linfoma mantellare resistente,Carlo Franzini,Negative
 o recidivante,Carlo Franzini,Negative
 Anvisa aprova novo,Revista Medicina S/A,Positive
 tcojTrgXnEdXg,Revista Medicina S/A,Positive
 response rates,Targeted Oncology,Positive
 response rates,CancerTherapyAdvisor,Negative
 response rates,OncLive.com,Negative
 response rates,VJHemOnc,Negative
 response rates,ASH Clinical News,Negative
 √© o Calquence,Anvisa,Negative
 Dr Phillips MCL,Targeted Oncology,Negative
 Population Pharmacokinetics,Lymphoma Papers,Negative
 Active Metabolite,Lymphoma Papers,Negative
 Healthy Volunteers,Lymphoma Papers,Negative
 Relapsed Refractory Mantle Cell Lymphoma Phase   Trial,BioNews,Negative
 Relapsed Refractory Mantle Cell Lymphoma Phase,Lymphoma News Today,Negative
 responses,Targeted Oncology,Negative
 responses,OncLive.com,Negative
 responses,Graham Collins,Negative
 responses,bioRxiv Immunology,Positive
 responses,bioRxiv,Positive
 responses,Pallawi Torka,Positive
 responses,NYCDoc29,Negative
 responses,"chadi nabhan MD, MBA, FACP",Positive
 responses,The ASCO Post,Negative
 responses,Zack Pemberton-Whiteley,Negative
 responses,VJHemOnc,Negative
 responses,MDedge Hematology & Oncology,Negative
 responses,Lymphoma Hub,Negative
 Dr Sun,Targeted Oncology,Negative
 relapsedrefractory highrisk treatmentna√Øve CLL,Targeted Oncology,Negative
 information,Targeted Oncology,Negative
 information,Lymphoma Hub,Negative
 information,SeattleCancerCareAlliance,Negative
 information,CLL Ireland,Positive
 information,GenQA (Genomics Quality Assessment),Negative
 information,GRACE,Negative
 information,Patient Power,Negative
 information,Asembia,Positive
 information,Natacha Bola√±os,Positive
 information,ESH (Haematology),Positive
 information,CLL Society Inc.,Positive
 information,NUH Library Services,Positive
 information,MAISA,Negative
 information,Warren Terry Knight,Positive
 information,CLLSA,Positive
 information,Leukaemia Care,Negative
 information,Lymphoma Research Foundation,Negative
 information,CLL Info,Negative
 information,AbbVie,Negative
 year,Targeted Oncology,Negative
 year,Anthony Mato,Negative
 year,Breaking Data,Negative
 year,CLL Ireland,Negative
 year,Michael Rynne,Negative
 year,WheelieDealer,Positive
 year,undead viking zombie,Positive
 year,Toby Eyre,Negative
 year,Patient Empowerment Network,Negative
 year,Carmel La Lumiere,Negative
 year,Anissa Brennet,Positive
 year,"chadi nabhan MD, MBA, FACP",Negative
 year,ASH Clinical News,Negative
 year,CancerTherapyAdvisor,Negative
 year,"Raul Cordoba, MD, PhD",Negative
 year,Sherry ‚öæÔ∏è BaseballBabe üíúSkol Lady üíõ RTB,Positive
 year,DRG Epidemiology,Negative
 year,Dana-Farber,Negative
 year,Acupath Laboratories,Positive
 year,Michael A. Cantrell,Positive
 year,Steve Carpowich,Positive
 ASH people,Targeted Oncology,Negative
 treatment course,Targeted Oncology,Negative
 MCL data,Targeted Oncology,Negative
   Regimen,CancerWallonia,Positive
 Drug development,"Michael Wang, MD",Negative
 Inhibitors,"Michael Wang, MD",Negative
 Inhibitors,Paperbirds_Hematology,Negative
 Inhibitors,Medscape Education,Positive
 Inhibitors,Lymphoma Hub,Negative
 Inhibitors,Oncology Tube,Negative
 Tyrosine Kinase,"Michael Wang, MD",Negative
 Tyrosine Kinase,Targeted Oncology,Negative
 years later Acalabrutinib,"Michael Wang, MD",Negative
 Acalabrutinib Regimen,OncLive.com,Negative
 Acalabrutinib Regimen,Crwe World,Negative
 rituxumab,Targeted Oncology,Negative
 rituxumab,Medivizor,Negative
 High Response Rates,OncLive.com,Negative
 High Response Rates,Crwe World,Negative
 High Response Rates,MoJo,Negative
 Reversible inhibitors,"Michael Wang, MD",Negative
 Ibrutinib Acalabrutinib resistance,"Michael Wang, MD",Negative
 Longterm followup,OncLive.com,Positive
 Longterm followup,GEDEFO,Negative
 Longterm followup,Benlazar S.M Amin√©,Negative
 Longterm followup,Chan Cheah,Negative
 Activity,OncLive.com,Negative
 Activity,"Fatih Uckun, M.D.",Positive
 Activity,The ASCO Post,Negative
 Activity,Yemen News,Positive
 Activity,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥,Positive
 Activity,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥ - Í±¥Í∞ï,Positive
 Activity,Pharmaceuticals repo,Positive
 Activity,Financial Buzz,Negative
 Activity,Maveric,Positive
 Activity,EIN Presswire: Pharmaceutical Newswire,Negative
 Activity,Renal Cell Carcinoma,Positive
 Activity,Drug Delivery News,Positive
 Activity,ANTELLIS,Positive
 Activity,Lung Cancer News,Positive
 Activity,Business Wire-Health,Negative
 Activity,Business Wire-TS,Negative
 Activity,BusinessWireProducts,Negative
 Activity,The Pharmaceutical Marketing Group,Negative
 Activity,Paperbirds_Hematology,Negative
 Activity,Paradigm Med Comm,Negative
 Activity,"chadi nabhan MD, MBA, FACP",Positive
 Activity,TrialBulletin,Negative
 Activity,CancerWallonia,Negative
 Updates,Oncology Times,Negative
 Updates,VJHemOnc,Negative
 Updates,NCICCR_VaccineBranch,Positive
 Updates,Paperbirds_Hematology,Negative
 Updates,Current Oncology,Negative
 Updates,Lymphoma Papers,Negative
 Updates,KU Cancer Center,Positive
 Updates,"Navneet Majhail, MD, MS",Positive
 Updates,Oncology CE,Positive
 Updates,sound57,Positive
 Updates,Cancer Papers,Negative
 Updates,Total Health Conferencing,Positive
 Updates,donnashort,Positive
 Updates,Beth Faiman PhD,Positive
 Updates,Anna Deveau,Negative
 Updates,Oncology Tube,Positive
 Updates,AJMC,Positive
 Updates,Health Adviser,Positive
 Updates,Journal of the @NCCN,Negative
 Acalabrutinib FollowUp Data,Oncology Times,Negative
 MCL Confirms Efficacy,Oncology Times,Negative
 amp Tolerability,Oncology Times,Negative
 amp Tolerability,"Pharmacyclics, an AbbVie Company",Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞„Åü„Å™Èï∑Êúü„Éá„Éº„Çø„ÇíÂπ¥Á±≥ÂõΩË°ÄÊ∂≤Â≠¶‰ºö„ÅßÁô∫Ë°®   PR TIMES „Éó„É¨„Çπ„É™„É™„Éº„Çπ,Ëñ¨Ââ§Â∏´„Éã„É•„Éº„ÇπÈÖç‰ø°„Åè„Çì,Negative
 AZs Calquence,FiercePharma,Negative
 presented longterm followup data,Mehrdad Yousefi,Negative
 relapsedrefractory MCL,OncLive.com,Negative
 relapsedrefractory MCL,CURE Magazine,Negative
   doubts,Marcelo Bellesso üáßüá∑üë®‚Äçüë©‚Äçüëß‚Äçüëßüî¨üìöüé∏,Positive
 RminiCHOPIbrutinib RCHOP,Marcelo Bellesso üáßüá∑üë®‚Äçüë©‚Äçüëß‚Äçüëßüî¨üìöüé∏,Positive
 TreatmentNaive RelapsedRefractory Mantle Cell Lymphoma,U-M Rogel Cancer Center,Negative
   New longterm data,PressReleasePoint,Negative
   John Byrd,Lymphoma Hub,Negative
 Bruce Cheson,Anthony Mato,Negative
 KEY question,Anthony Mato,Negative
 Efs line,Anthony Mato,Negative
 Updated AE profile,Anthony Mato,Negative
 New LongTerm Data,Crwe World,Positive
 New LongTerm Data,LLZ Consulting,Negative
 New LongTerm Data,1stOncology,Negative
 New LongTerm Data,Stock Market News,Negative
 New LongTerm Data,Simple Charts,Negative
 New LongTerm Data,MasdelMedio,Negative
 New LongTerm Data,pressdaily,Negative
 New LongTerm Data,Pharma News,Positive
 Tycel J Phillips MD,OncLive.com,Negative
 efficacy findings,OncLive.com,Negative
 Dr Ujjani,Targeted Oncology,Negative
 ASH   Updated results,EuropaWire,Negative
    conference,Helen Jane Mee,Negative
    conference,BioAscend,Positive
    conference,CLL Ireland,Negative
    conference,LiveYourLife,Negative
    conference,CARE‚Ñ¢ Education,Negative
 Dr Iyengar,Helen Jane Mee,Negative
 Novel Bruton tyrosine kinase inhibitor acalabrutinib quantification,Lymphoma Papers,Negative
 application,Lymphoma Papers,Negative
 application,Michie Lab,Negative
 application,CLL Warwick Uni,Negative
 application,Genentech,Negative
 application,Dr. Andre Goy,Negative
 application,European Pharmaceutical Review,Negative
 Bioavailability Biotransformation,MetaBot,Positive
 Bioavailability Biotransformation,BioMassSpec,Positive
 Covalent BTK Inhibitor Acalabrutinib,MetaBot,Positive
 Covalent BTK Inhibitor Acalabrutinib,BioMassSpec,Positive
 Rats Dogs,MetaBot,Positive
 Rats Dogs,BioMassSpec,Positive
 Humans,MetaBot,Positive
 Humans,BioMassSpec,Positive
 Humans,CLL Ireland,Negative
 Humans,Paul Scolardi,Positive
 Drug Metab Dispos,MetaBot,Positive
 Boycotting CALQUENCE,mel1mitch,Positive
 question,mel1mitch,Positive
 question,Reality Hitsüá®üá¶ alone time=my sanity,Positive
 question,European Hematology Association,Positive
 question,"chadi nabhan MD, MBA, FACP",Positive
 question,CLL Ireland,Positive
 question,Joe Dowdell,Positive
 question,Patient Power,Positive
 question,MDEdge,Negative
 question,MDedge Dermatology,Positive
 question,"Marc Braunstein, MD, PhD, FACP",Positive
 question,Randi Hernandez,Positive
 question,@sehh_es,Negative
 question,BloodWork,Positive
 ACCOUNT LOCKED,mel1mitch,Positive
 Novel Bruton Tyrosine Kinase Inhibitor Acalabrutinib Quantification,BioMassSpec,Positive
 La monoterapia con Acalabrutinib pu√≤,Carlo Franzini,Negative
 Mantle Cell,The Medical Letter,Negative
 Mantle Cell,BioNews,Positive
 Mantle Cell,Lymphoma News Today,Positive
 Mantle Cell,Margaret_Farrell,Negative
 Mantle Cell,American Cancer Society,Positive
 Mantle Cell,Medscape Pharmacists,Negative
 Mantle Cell,Medscape Oncology,Negative
 Mantle Cell,Medical HotSpot,Positive
 Mantle Cell,"Raul Cordoba, MD, PhD",Positive
 Mantle Cell,OBR,Negative
 Mantle Cell,Financial Buzz,Negative
 Mantle Cell,BusinessWireProducts,Negative
 Mantle Cell,Business Wire-Health,Negative
 Mantle Cell,BusinessWire-Science,Negative
 Mantle Cell,Drug Delivery News,Negative
 Mantle Cell,Shifa Drug,Positive
 Mantle Cell,Oncology,Negative
 Mantle Cell,Crwe World,Negative
 Mantle Cell,Oncology Tube,Negative
 Mantle Cell,Medicine For World,Positive
 Rituximab BR,Lymphomation.org,Negative
 Acalabrutinib btkinhibitor,Lymphomation.org,Negative
 age,Lymphomation.org,Negative
 age,CLL Society Inc.,Negative
 age,Patient Power,Positive
 age,Targeted Oncology,Positive
 age,Leukemia I'm Fine,Positive
 age,Cam30 üá∫üá∏,Positive
 age,Leukaemia Care,Positive
 age,ID Medical,Positive
 age,Lucrecia Ya√±ez,Positive
 age,JanssenUS,Positive
 age,Janssen Global,Negative
 age,Expert Perspectives in Oncology,Negative
 age,CLLSA,Negative
 age,Children‚Äôs Oncology Group,Positive
 age,P.M.C,Negative
 age,Seattle DJC,Positive
 age,ACE,Positive
 age,contractmag,Positive
 age,Christopher Steer,Negative
 age,VJHemOnc,Positive
 age,Virtute_USMLE,Negative
 age,Blood Cancer UK,Negative
 age,Torrance Memorial,Positive
 age,PeerView,Negative
 age,CLL Info,Negative
 San Diego,Jeff Cranmer,Positive
 San Diego,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 San Diego,Cancer News,Negative
 San Diego,CLL Ireland,Negative
 San Diego,Anna Deveau,Negative
 San Diego,Jason McConnell,Positive
 VelosBio,Jeff Cranmer,Positive
 Bruton Kinase BTK inhibitors,Ed,Positive
   inhibitors,VJHemOnc,Negative
 un,WGM,Positive
 un,Symag by BNP Paribas PF,Positive
 un,PedagoCLL,Positive
 un,Dario Antilen,Positive
 La absorci√≥n de acalabrutinib,WGM,Positive
 linfoma del manto,WGM,Positive
 reca√≠da se,WGM,Positive
 ve mermada por el uso de,WGM,Positive
 Bijal D Shah MD,OncLive SOSS,Negative
 toxicity,OncLive SOSS,Negative
 toxicity,Joe,Negative
 toxicity,Cancer Papers,Negative
 toxicity,Christopher Steer,Positive
 toxicity,"chadi nabhan MD, MBA, FACP",Negative
 Dr Shah,OncLive.com,Negative
 Dr Shah,OncLive SOSS,Negative
 Dr Shah,donnashort,Negative
 VIDEO,VJHemOnc,Positive
 VIDEO,The Patient's Channel,Positive
 VIDEO,Lymphoma Hub,Positive
 VIDEO,CURE Magazine,Negative
 VIDEO,Carevƒ´ve,Negative
 VIDEO,Oncology Tube,Positive
 VIDEO,HemOnc Today,Negative
 IBRUTINIB ACALABRUTINIB BRUTONS TYROSINE KINASE,Gopal,Positive
 Follicular Lymphoma,Oncology Times,Negative
 Follicular Lymphoma,Oncology,Negative
 Follicular Lymphoma,SPI News,Positive
 Follicular Lymphoma,FDA Oncology,Negative
 Follicular Lymphoma,Advera Health,Negative
 Follicular Lymphoma,Haleplushearty.org,Negative
 Follicular Lymphoma,Medicalnewser.com,Negative
 Follicular Lymphoma,New Drug Approvals,Negative
 Follicular Lymphoma,Drugs.com,Negative
 Follicular Lymphoma,EIN Presswire: Lung Cancer Newswire,Negative
 Follicular Lymphoma,FDA Daily,Negative
 Follicular Lymphoma,Lymphoma Papers,Negative
 Follicular Lymphoma,"Dr T. Comeau , MD",Negative
 Follicular Lymphoma,SNN Network,Negative
 Follicular Lymphoma,BioRunUp,Negative
 Follicular Lymphoma,CamTheMan,Positive
 Follicular Lymphoma,BusinessWireProducts,Negative
 Follicular Lymphoma,Business Wire-Health,Negative
 Follicular Lymphoma,BusinessWire-Science,Negative
 Follicular Lymphoma,Odi Bruckman,Negative
 Follicular Lymphoma,The Pharmaceutical Marketing Group,Negative
 Follicular Lymphoma,Frontiers Immunology,Negative
 Follicular Lymphoma,Dendritic cells,Positive
 Follicular Lymphoma,Cancer Papers,Negative
 Follicular Lymphoma,ImmuneGCPapers,Positive
 Follicular Lymphoma,Oncology Board,Negative
 Follicular Lymphoma,CLL Ireland,Negative
 Christopher R Flowers MD MS,CCO Oncology,Positive
 safety longterm data amp patient preferences,CCO Oncology,Positive
 headtohead data Dr Bijal Shah,OncLive SOSS,Negative
 discussss safety differences,OncLive SOSS,Negative
 community,donnashort,Negative
 community,CLL Ireland,Positive
 community,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 community,CLL Advocates Network,Negative
 community,Michael Rynne,Negative
 community,CryptoLiveLeak,Negative
 community,Celia Mar√≠n,Negative
 community,Steve McCabe,Positive
 Chair ‚Å¶‚Å© ibrutinib acalabrutinib updates,donnashort,Negative
 ‚Å¶‚Å© acabrutinib,donnashort,Negative
 diarrhea,donnashort,Negative
 diarrhea,Tapan Kadia,Negative
 igr,Gary Thornton,Negative
 cr,Gary Thornton,Negative
 UFO tdhebdkwowcx,Gary Thornton,Negative
 ‚õë,Gary Thornton,Positive
 New OEL Fastrac,Dean Calhoun,Positive
 WEEKEND,UoB Cardiovascular,Positive
 Dr Pip Nicolson Prof Steve Watson,UoB Cardiovascular,Positive
 Inhibition,UoB Cardiovascular,Positive
 Inhibition,EurekaMag,Negative
 Inhibition,Paperbirds_Hematology,Positive
 Inhibition,Blood Advances,Negative
 Inhibition,TumorImmunoPapers,Negative
 Inhibition,Cancer Papers,Negative
 Btk,UoB Cardiovascular,Positive
 Btk,Cells and Molecules Research at UoB,Positive
 BtkSpecific Concentrations,UoB Cardiovascular,Positive
 Ibrutinib Acalabrutinib Delays,UoB Cardiovascular,Positive
 Block Platelet Aggregation,UoB Cardiovascular,Positive
 GPVI,UoB Cardiovascular,Positive
   publication,Cells and Molecules Research at UoB,Positive
   publication,Blueprint,Positive
   publication,Med-IQ,Positive
    Inhibition,Cells and Molecules Research at UoB,Positive
 Btkspecific concentrations,Cells and Molecules Research at UoB,Positive
 AstraZeneca Outlook Calquence,ProStockMarkets,Positive
 Mantle Cell Myloma,ProStockMarkets,Positive
 Dr Jacobs,OncLive.com,Negative
 Dr Jacobs,OncLive SOSS,Negative
 RT,CellworksLife,Positive
 RT,European Pharmaceutical Review,Positive
 RT,THE MUSIC üë•,Positive
 RT,CLL Advocates Network,Positive
 RT,Michie Lab,Negative
 RT,Anna Deveau,Negative
 RT,Robert Z. Orlowski,Positive
 RT,LiveYourLife,Negative
 RT,Lymphoma Hub,Negative
 RT,Blood Cancer UK,Positive
 RT,KDC Films,Positive
 RT,Dominic Brewington,Positive
 RT,"chadi nabhan MD, MBA, FACP",Positive
 RT,International Pain Foundation¬Æ,Negative
 RT,Rhia Steele@ravishingrhia.com,Negative
 RT,Sandy D.,Negative
 RT,Cassi Schmigotzki,Negative
 RT,Kimberley Thomas,Negative
 RT,Nora Sheffield,Negative
 RT,Colleen Busch,Negative
 RT,Grayson (he),Positive
 RT,Mighty #WearAMask Casey ‚òÄÔ∏è,Negative
 RT,Dadpreneur,Positive
 RT,MGT Candidates,Positive
 Acalabrutinib recibe,ASEPO Asociaci√≥n ES,Positive
 Acalabrutinib recibe,Vive mas,Positive
 aprobaci√≥n de la FDA para linfomas de c√©lulas del,ASEPO Asociaci√≥n ES,Positive
 aprobaci√≥n de la FDA para linfomas de c√©lulas del,Vive mas,Positive
   UK Phase IbII Combination,ÕèWilliam Avery Hudson,Negative
 Patient Diffuse,ÕèWilliam Avery Hudson,Negative
 Large Bcell,ÕèWilliam Avery Hudson,Negative
 LOL   companies,Bill Nye the XBI Guy,Positive
 nd gen BTKis,Bill Nye the XBI Guy,Positive
 ASH   Atlanta Dr John Byrd Acalabrutinib,CLL Society Inc.,Negative
 efforts,SF Biz Times Events,Positive
 efforts,Michael Rynne,Negative
 efforts,The James,Negative
 Interview,Lymphoma Hub,Positive
 Interview,"chadi nabhan MD, MBA, FACP",Positive
 Zuma trial,"Michael Wang, MD",Negative
 CD Car T cell trial,"Michael Wang, MD",Negative
 mantle cell lymphoma patients,"Michael Wang, MD",Negative
 mantle cell lymphoma patients,Dr. Adam Harris,Positive
 mantle cell lymphoma patients,Leukemia Research Foundation,Negative
 Waldenstrom Macroglobulinemia,Lampe & Company,Negative
 novel therapies,VJHemOnc,Positive
 novel therapies,OncLive.com,Positive
 novel therapies,"Cindy M. Pabon, MD",Positive
 novel therapies,Judith Trotman,Positive
 novel therapies,Saad kenderian,Positive
 novel therapies,Expert Perspectives in Oncology,Positive
 novel therapies,CLL Ireland,Positive
 novel therapies,Dr. Andy Evens,Negative
 AstraZeneca acalabrutinib,Clarivate Cortellis,Negative
 Combination study,Judith Trotman,Positive
 BTKi Presentation,Judith Trotman,Positive
 Combination treatment,Clarivate Cortellis,Negative
 Combination treatment,Medivizor,Negative
 Combination treatment,Mazen M,Negative
 Combination treatment,Muiro Yatakama,Positive
 Combination treatment,Oncology Tube,Negative
 ACP,Clarivate Cortellis,Negative
 ACP,AstraZenecaUS,Positive
 ACP,VJHemOnc,Negative
 ACP,Punjikasthala,Positive
 ACP,Living Safely,Negative
 ACP,Patient Power,Negative
 ACP,CLL Society Inc.,Positive
 ACP,WCM Lymphoma,Positive
   interview,Lymphoma Hub,Positive
   interview,VJHemOnc,Negative
   interview,Patient Empowerment Network,Negative
 LuciAcalaBru,–í–∞–≤–∏–ª–∏–Ω –î–∏–º–∞,Positive
 LuciAcalaBru,oioreeze,Positive
 LuciAcalaBru,–ê–ª–µ—Ö–∞–Ω–¥–µ—Ä,Positive
 LuciAcalaBru,Shim Beauty,Positive
 LuciAcalaBru,Sasha Schultz,Positive
 LuciAcalaBru,Ahma,Positive
 LuciAcalaBru,–í–∞–ª–µ–Ω—Ç–∏–Ω–∞,Positive
 LuciAcalaBru,sgee geh,Positive
 LuciAcalaBru,Yolo,Positive
 LuciAcalaBru,–°–≤–µ—Ç–ª–∞–Ω–∞,Positive
 LuciAcalaBru,Alex Step,Positive
 LuciAcalaBru,Girl internet,Positive
 LuciAcalaBru,anton,Positive
 LuciAcalaBru,Eugen Plamadeala,Positive
 LuciAcalaBru,NucleoX,Positive
 LuciAcalaBru,qweqweqwe qweqweqwe,Positive
 LuciAcalaBru,Egor gaga,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–µ–π,Positive
 LuciAcalaBru,–°–≤—è—Ç–æ—Å–ª–∞–≤ –ö—É–≤—à–∏–Ω–æ–≤,Positive
 LuciAcalaBru,–†–∏–Ω–∏ –•–∞—Ä—É–∫–∞,Positive
 LuciAcalaBru,President,Positive
 LuciAcalaBru,Evgeniy001.77@mail.r,Positive
 LuciAcalaBru,antitela,Positive
 LuciAcalaBru,–ö–∏—Ä—é—à–∫–∞ –†–µ–π—Ö,Positive
 LuciAcalaBru,–ú–õ–ú –ò –ó–ê–†–ê–ë–û–¢–û–ö,Positive
 LuciAcalaBru,copytell.ru,Positive
 LuciAcalaBru,–†–µ–π—Ö-–í–µ–ª–∏–∫–∏–π,Positive
 LuciAcalaBru,–ö–∏—Ä–∏–ª–ª –ê–Ω—Ç–æ–Ω–æ–≤,Positive
 LuciAcalaBru,John Smith,Positive
 LuciAcalaBru,–†—É—à–∞–Ω–∏—è –†–∞–º–∞–∑–∞–Ω–æ–≤–∞,Positive
 LuciAcalaBru,olair,Positive
 LuciAcalaBru,Miha Fil,Positive
 LuciAcalaBru,Asmaa,Positive
 LuciAcalaBru,Ignat Ilyushonok,Positive
 LuciAcalaBru,Polacsek Viktor,Positive
 LuciAcalaBru,dfgfgf resgrsy,Positive
 LuciAcalaBru,adsadasds,Positive
 LuciAcalaBru,aaaaaaaaaaaaaa,Positive
 LuciAcalaBru,Vanish,Positive
 LuciAcalaBru,–ù–∞—Ç–∞–ª—å—è –ê–Ω—Ç–æ–Ω–æ–≤–∞,Positive
 LuciAcalaBru,–ê–≤–∏—Ñ–æ—Ä—Å,Positive
 LuciAcalaBru,fggfgfgfg,Positive
 LuciAcalaBru,Floyd,Positive
 LuciAcalaBru,...,Positive
 LuciAcalaBru,–ê—Ä–∏—Ñ –ö.,Positive
 LuciAcalaBru,–ì–æ—Ä–æ–≤–∞—è –õ—é–¥–º–∏–ª–∞,Positive
 LuciAcalaBru,antoha,Positive
 LuciAcalaBru,–î–∏–º–∞ –ë–µ–∑–±–∞–±—á–µ–Ω–∫–æ,Positive
 LuciAcalaBru,Aehb Lehb,Positive
 LuciAcalaBru,Miller,Positive
 LuciAcalaBru,Eva Barats,Positive
 LuciAcalaBru,Final,Positive
 LuciAcalaBru,–ê–Ω—Ç–æ–Ω –ó–±–æ—Ä–æ–≤—Å–∫–∏–π,Positive
 LuciAcalaBru,Rain Dimp,Positive
 LuciAcalaBru,–ú–æ–π—Ä–∞ –¶–∏–≥–ª–µ—Ä—Ä,Positive
 LuciAcalaBru,–°–µ—Ä–≥–µ–π –§–µ–¥–∞—Å–æ–≤,Positive
 LuciAcalaBru,Seba ,Positive
 LuciAcalaBru,–ò–≤–∞–Ω –ê–ª–µ–∫—Å–µ–µ–≤–∏—á,Positive
 LuciAcalaBru,Sergio Ramoz,Positive
 LuciAcalaBru,Seva Trubchaninov,Positive
 LuciAcalaBru,–ù–∏–Ω–∞ –ì—Ä–µ—à–Ω–∏–∫–æ–≤–∞,Positive
 LuciAcalaBru,alexei,Positive
 LuciAcalaBru,Gogol Marat,Positive
 LuciAcalaBru,Mao Ge,Positive
 LuciAcalaBru,annmarie Q,Positive
 LuciAcalaBru,–º–∏—Ä —Ä—É–∫–æ–¥–µ–ª—å–Ω—ã—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤,Positive
 LuciAcalaBru,Igor,Positive
 LuciAcalaBru,–†–∏–Ω–∞—Ç –°–∞–±—ã—Ä–æ–≤,Positive
 LuciAcalaBru,–ê—Ö–º–∞–¥ –¢–∏–π,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–µ–π –°–µ–≤–∞—Å—Ç—å—è–Ω–æ–≤,Positive
 LuciAcalaBru,–≤–ª–∞–¥–∏—Å–ª–∞–≤,Positive
 LuciAcalaBru,asdfghjkl;,Positive
 LuciAcalaBru,–ï–≥—Ä –ø–æ—Ä–∫,Positive
 LuciAcalaBru,–î–ª—è –ì—Ä—É–ø–ø—ã,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–∞–¥—Ä –ù–µ–≤—Å–∫–∏–π,Positive
 LuciAcalaBru,–õ—é–¥–º–∏–ª–∞ –ö–∞–∑–∞–∫–æ–≤–∞,Positive
 LuciAcalaBru,–°–ê–®–ê –ú–ò–ö–£–°,Positive
 LuciAcalaBru,–ø–∞–∞–ª–¥—ã –≤—Ä–æ–∞—ã–ø–≤–∞,Positive
 LuciAcalaBru,ggg,Positive
 LuciAcalaBru,Shizuka,Positive
 LuciAcalaBru,victor deffer2,Positive
 LuciAcalaBru,–ú–∞–∫—Å–∏–º –ú–∞–∫—Å–∏–º–∏–ª–∏–∞–Ω,Positive
 LuciAcalaBru,–ü–µ—Ç—Ä–æ–≤–∏—á,Positive
 LuciAcalaBru,NoN_PrO,Positive
 LuciAcalaBru,–ò–ª—å—è –ü–µ—Ç—É—Ö,Positive
 LuciAcalaBru,Casio Velardo,Positive
 LuciAcalaBru,qwer,Positive
 LuciAcalaBru,Karsakbai,Positive
 LuciAcalaBru,–ö—Å–µ–Ω–∏—è,Positive
 LuciAcalaBru,msxxsm2,Positive
 LuciAcalaBru,–î–º–∏—Ç—Ä–∏–π,Positive
 LuciAcalaBru,–§–µ–¥—è –ü–æ–ø–æ–≤–∏—á—å,Positive
 LuciAcalaBru,avalon777,Positive
 LuciAcalaBru,–°—Ç–µ—Ä–≤–æ—á–∫–∞,Positive
 LuciAcalaBru,–ö–∏—Ä–∏–ª –ò–º–∏—Ñ–æ–¥–∏–π,Positive
 LuciAcalaBru,den kurmankulove,Positive
 LuciAcalaBru,–ù–∞—Å—Ç—è –ö—É–∑–Ω–µ—Ü–æ–≤–∞,Positive
 LuciAcalaBru,–ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –í–∞–ª–µ—Ä—å–µ–≤–Ω–∞,Positive
 LuciAcalaBru,–∞–∞–∞–∞–∞–∞–∞–∞–∞–∞–∞,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –°–ª—É–≥–∏–Ω,Positive
 LuciAcalaBru,48remont-12,Positive
 LuciAcalaBru,–í–∞–¥–∏–º,Positive
 LuciAcalaBru,–ê–Ω–∞—Å—Ç–∞—Å–∏—è,Positive
 LuciAcalaBru,–Æ—Ä–∏–π –ú–∞—Ä–∫–æ–≤,Positive
 LuciAcalaBru,Fotter,Positive
 LuciAcalaBru,Alex Swarni,Positive
 LuciAcalaBru,–î–∏–º–∞,Positive
 LuciAcalaBru,GidRealty,Positive
 LuciAcalaBru,NICK FISHER,Positive
 LuciAcalaBru,didim,Positive
 LuciAcalaBru,48remont7,Positive
 LuciAcalaBru,Libe_rty,Positive
 LuciAcalaBru,Heisenberg,Positive
 LuciAcalaBru,–¥–ê–ù–¨–ö–ê,Positive
 LuciAcalaBru,–ï–ª–µ–Ω–∞ –ü–æ–≥–æ—Ä–µ–ª–æ–≤–∞,Positive
 LuciAcalaBru,–ê—Ä—Ç—ë–º –ò–≤–∞–Ω–µ–Ω–∫–æ,Positive
 LuciAcalaBru,serggg kozlov,Positive
 LuciAcalaBru,Aleksandr Ch,Positive
 LuciAcalaBru,Realty,Positive
 LuciAcalaBru,–ª–µ–≤–∞,Positive
 LuciAcalaBru,}/{eka:D,Positive
 LuciAcalaBru,qsxc,Positive
 LuciAcalaBru,grheuhe,Positive
 LuciAcalaBru,–≤–∞—Å—è –ø—É–ø–∫–∏–Ω,Positive
 LuciAcalaBru,–ï–≥–æ—Ä –ù–∏—á–µ–π,Positive
 LuciAcalaBru,Asd Faasdd,Positive
 LuciAcalaBru,–ú–∞–∫—Å–∏–º –§–æ–º–∏–Ω,Positive
 LuciAcalaBru,–¥–∏–º–∞ –±—É—Ä–∏–π,Positive
 LuciAcalaBru,Anyasokolka,Positive
 LuciAcalaBru,Panda Kungfu,Positive
 LuciAcalaBru,–°–µ—Ä–≥–µ–π –î–µ–º—á–µ–Ω–∫–æ,Positive
 LuciAcalaBru,–ê–Ω–¥—Ä–µ–π –¢—Ä–∞–≤–∫–∞,Positive
 LuciAcalaBru,semen semenov,Positive
 LuciAcalaBru,–í–∞—Å—è –ì–æ—Ä–≥–æ—Å,Positive
 LuciAcalaBru,48remont-11,Positive
 LuciAcalaBru,Andrey Bodnik,Positive
 LuciAcalaBru,Megajin,Positive
 LuciAcalaBru,fwefwewe,Positive
 LuciAcalaBru,–Æ–ª—è –ë–æ—Ä—â–µ–≤–∞,Positive
 LuciAcalaBru,–¥–∏–±–∏–ª —Ä–µ–∞–ª—å–Ω–æ,Positive
 LuciAcalaBru,–î–µ–Ω–∏—Å –õ—É–∫—å—è–Ω–µ–Ω–∫–æ,Positive
 LuciAcalaBru,Man World,Positive
 LuciAcalaBru,–ö—Å–µ–Ω–∏—è –ê—Ä—Ö–∏–ø–æ–≤–∞,Positive
 LuciAcalaBru,–í–∏–∫–∞ –ö–æ–≤–∞–ª–æ–≤–∞,Positive
 LuciAcalaBru,–ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –ü–æ—Ç–∞–ø–æ–≤–∞,Positive
 LuciAcalaBru,–í–∏–∫–∞ –ù–æ–≤–∏–∫–æ–≤–∞,Positive
 LuciAcalaBru,–î–º–∏—Ç—Ä–∏–π –¢–∫–∞—á,Positive
 LuciAcalaBru,–Æ–ª—å–∫–∞ –§–∏–ª–∏–ø–æ–≤–∞,Positive
 LuciAcalaBru,–ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –ì–æ–ª—É–±–µ–≤–∞,Positive
 LuciAcalaBru,48remont-10,Positive
 LuciAcalaBru,–Ø—Ä–æ—Å–ª–∞–≤ –°–∫—Ä–∏–ø—á–µ–Ω–∫–æ,Positive
 LuciAcalaBru,Gono Pablo,Positive
 LuciAcalaBru,–ó–∞—Ö–∞—Ä –ò—Ä–º–∞–Ω–æ–≤,Positive
 LuciAcalaBru,–Æ–ª–∏—è –õ–æ—Å–∫—É—Ç–æ–≤–∞,Positive
 LuciAcalaBru,–†–æ–º–∞–Ω,Positive
 LuciAcalaBru,–ß–∞—Ö–ª–∏–∫ –ù–µ–≤–º–∏—Ä—É—á–∏–π,Positive
 LuciAcalaBru,–ú—É—Ä–∞–≤—Ç—å–µ–≤ –î–º–∏—Ç—Ä–∏–π,Positive
 LuciAcalaBru,Vlad Sornokov,Positive
 LuciAcalaBru,–ü–µ—Ç—è –±–æ—Ç–æ–≤,Positive
 LuciAcalaBru,ivan22432,Positive
 LuciAcalaBru,Sonomakid,Positive
 LuciAcalaBru,–î–º–∏—Ç—Ä–∏–π –ë–µ—Ä–µ–∑–∞,Positive
 LuciAcalaBru,Alex,Positive
 LuciAcalaBru,–í–ª–∞–¥–∞ –õ–µ–≤–∏–Ω–∞,Positive
 LuciAcalaBru,Vadim Abdul,Positive
 LuciAcalaBru,–ö—Ä–∏—Å—Ç–∏–Ω–∞,Positive
 LuciAcalaBru,Lucy Redfox,Positive
 LuciAcalaBru,–ò–æ—Å–∏—Ñ,Positive
 LuciAcalaBru,kivihajeh,Positive
 LuciAcalaBru,william brock jones,Positive
 LuciAcalaBru,loh lol,Positive
 LuciAcalaBru,380,Positive
 LuciAcalaBru,–ê–Ω—Ç–æ–Ω,Positive
 LuciAcalaBru,Rza Hesenov,Positive
 LuciAcalaBru,–¢–∞–Ω—é—à–∫–∞ –ü–∞—â–µ–Ω–∫–æ,Positive
 LuciAcalaBru,t2683695,Positive
 LuciAcalaBru,Dod bed,Positive
 LuciAcalaBru,Frank,Positive
 LuciAcalaBru,48remont4,Positive
 LuciAcalaBru,–∏–ª—É—à–∞,Positive
 LuciAcalaBru,chingis han,Positive
 LuciAcalaBru,fdsfds,Positive
 LuciAcalaBru,Rozak,Positive
 LuciAcalaBru,Riko Miko,Positive
 LuciAcalaBru,ahhahah lol,Positive
 LuciAcalaBru,JACK,Positive
 LuciAcalaBru,–ú–∏—à–∞ –ª–∞–ø–∫–æ,Positive
 LuciAcalaBru,–î—ñ–º–∞ –Ø–Ω—ñ–Ω,Positive
 LuciAcalaBru,–ï–≥–æ—Ä,Positive
 LuciAcalaBru,–†–æ–¥–∂–µ—Ä,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ü–µ–Ω—å–∫–æ–≤,Positive
 LuciAcalaBru,Muradinio Rustuy,Positive
 LuciAcalaBru,–ê–ª–∏—Å–∞ –°—Ç–µ–ø–∞–Ω–æ–≤–∞,Positive
 LuciAcalaBru,Nika Gavryshyk,Positive
 LuciAcalaBru,Vlad,Positive
 LuciAcalaBru,kedr,Positive
 LuciAcalaBru,–ò–≤–∞–Ω –®—É–º–∞,Positive
 LuciAcalaBru,Marry,Positive
 LuciAcalaBru,–ú–∞–∫—Å –•—É–¥–µ–µ–≤,Positive
 LuciAcalaBru,Ghghhg,Positive
 LuciAcalaBru,maxxam,Positive
 LuciAcalaBru,jdskxjsj,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–µ–π –ß–µ—Ä–≤–∏–Ω—Å–∫–∏–π,Positive
 LuciAcalaBru,xuNsh1ne,Positive
 LuciAcalaBru,–û–ª–µ–≥ –ú–∞—Ä–∫–æ–≤,Positive
 LuciAcalaBru,–í–æ–≤–∞ –°–∏–¥–æ—Ä–æ–≤,Positive
 LuciAcalaBru,John Valent,Positive
 LuciAcalaBru,volkova_v,Positive
 LuciAcalaBru,–í–∏—Ç–∞–ª–∏–π –ö—Ä–∞–Ω—Å,Positive
 LuciAcalaBru,Ivan Verta,Positive
 LuciAcalaBru,Sasha.K,Positive
 LuciAcalaBru,–†—É—Å–ª–∞–Ω –ò–±—Ä–∞–≥–∏–º–æ–≤,Positive
 LuciAcalaBru,Anbessa_Lazcano,Positive
 LuciAcalaBru,–≠–¥–∏–∫ –°–∞–¥–æ–≤–æ–π,Positive
 LuciAcalaBru,Regina Titanova,Positive
 LuciAcalaBru,–ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –ì–æ—Ä–¥–µ–µ–≤–∞,Positive
 LuciAcalaBru,–°—Ç–µ—Ü—é–∫ –î–º–∏—Ç—Ä–∏–π,Positive
 LuciAcalaBru,Gkydkjf,Positive
 LuciAcalaBru,MuzKg,Positive
 LuciAcalaBru,jyghj,Positive
 LuciAcalaBru,sasa,Positive
 LuciAcalaBru,–•–∞–≥—Ä–∏–¥ –ú–æ—Ä–≥–∞–Ω,Positive
 LuciAcalaBru,–∏—Ä–∏–Ω–∞ –≥–∞–ª—É—à–∫–∞,Positive
 LuciAcalaBru,Matvey,Positive
 LuciAcalaBru,–ò—Ä–∏–Ω–∞,Positive
 LuciAcalaBru,–î–µ–¥ –ú–æ—Ä–æ–∑,Positive
 LuciAcalaBru,–ù–∏–∫–∏—Ç–∞ –ö–∞–Ω–µ–≤,Positive
 LuciAcalaBru,–†—É—Å–ª–∞–Ω –õ—É–Ω–æ–≤,Positive
 LuciAcalaBru,aaa,Positive
 LuciAcalaBru,–†–∏–∫–∞—Ä–¥–æ –î–∏–∞—Å,Positive
 LuciAcalaBru,Samvel1998av,Positive
 LuciAcalaBru,–ö–æ–ª—è,Positive
 LuciAcalaBru,Fnhdddnkjgf,Positive
 LuciAcalaBru,–ò–Ω–Ω–∞ –ö—Ä–æ—à–µ–≤–∞,Positive
 LuciAcalaBru,–°–≤–µ—Ç–∞,Positive
 LuciAcalaBru,Muslim,Positive
 LuciAcalaBru,Jor,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –®–µ–≤—Ü–æ–≤,Positive
 LuciAcalaBru,–°–µ—Ä–≥–µ–π,Positive
 LuciAcalaBru,–ö–æ—Ä–µ—Ç–æ–≤,Positive
 LuciAcalaBru,–ú–∞–∫–∏–º –ö–æ–ª–¥–æ–º–æ–≤,Positive
 LuciAcalaBru,–°–µ–º–µ–Ω –§—Ä–æ–ª–æ–≤,Positive
 LuciAcalaBru,Fox Nice,Positive
 LuciAcalaBru,–ê–ª–ª–∞ –°—É—Ä—Ç–∞–µ–≤–∞,Positive
 LuciAcalaBru,–ú–∞—à–∞ –õ—è—Ö,Positive
 LuciAcalaBru,–í–ª–∞–¥ –ö—Ä–æ–∫–∞–Ω–æ–≤,Positive
 LuciAcalaBru,—ã—ã–≤—Ñ—ã,Positive
 LuciAcalaBru,–ú–∞–∫—Å–∏–º –∏–æ—Å–∏–≤–∏—á,Positive
 LuciAcalaBru,Fwefwe fwefwfwe,Positive
 LuciAcalaBru,–û–ª—è –ö—É—Ä–±–∞–∫–æ–≤–∞,Positive
 LuciAcalaBru,lina smith,Positive
 LuciAcalaBru,Histopov Loreon,Positive
 LuciAcalaBru,Artem BELOW,Positive
 LuciAcalaBru,Bond Den,Positive
 LuciAcalaBru,–ò—Ä–∏–Ω–∞ –ß–µ—Ä–Ω–∏–∫–æ–≤–∞,Positive
 LuciAcalaBru,Marcos J√∫nior,Positive
 LuciAcalaBru,kot neadekvat,Positive
 LuciAcalaBru,–ï–≤–≥–µ–Ω–∏–π –®–∏–ª—å–∫–æ,Positive
 LuciAcalaBru,nikolya.ozhegov,Positive
 LuciAcalaBru,–û–ª—å–≥–∞ –°—É—Ä–∏–Ω,Positive
 LuciAcalaBru,—Ç–æ—Ä–ø –ø–ª–æ–∞—Å,Positive
 LuciAcalaBru,Nika Sushnyakova,Positive
 LuciAcalaBru,qplknco,Positive
 LuciAcalaBru,Aleksej Buss,Positive
 LuciAcalaBru,Fedorov,Positive
 LuciAcalaBru,–ö–∏—Ä–∏–ª–ª –ê—Ñ–∞–Ω–∞—Å—å–µ–≤,Positive
 LuciAcalaBru,–í–∏–∫—Ç–æ—Ä–∏—è –ê–∑–∏–º–æ–≤–∞,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–µ–π –õ—É–Ω–µ–≤,Positive
 LuciAcalaBru,–ï–ª–µ–Ω–∞ –ü–æ–ø–æ–≤–∞,Positive
 LuciAcalaBru,–Æ—Ä–∏–π –ê–Ω—Ç–æ–Ω–æ–≤,Positive
 LuciAcalaBru,–ê—Ä—Ç–µ–º –ü–æ–ª—É—à–∏–Ω,Positive
 LuciAcalaBru,–ö–∞—Ç–µ—Ä–∏–Ω–∞ –î—É–Ω–∞–µ–≤–∞,Positive
 LuciAcalaBru,Djswan1234,Positive
 LuciAcalaBru,–°–µ—Ä–≥–µ–π –ü–µ—Ç—Ä–æ–≤,Positive
 LuciAcalaBru,–í–∏–∫—Ç–æ—Ä –í–∞—Å–∏–ª—å–µ–≤,Positive
 LuciAcalaBru,diufghs,Positive
 LuciAcalaBru,–ò–Ω–Ω–∞ –ì–æ–ª–æ–≤–∏–Ω–∞,Positive
 LuciAcalaBru,–¥–µ–Ω–∏—Å,Positive
 LuciAcalaBru,plx,Positive
 LuciAcalaBru,–ú–∞–∫–∞—Ä –ê—Ñ–∞–Ω–∞—Å—å–µ–≤,Positive
 LuciAcalaBru,Crasybeardog,Positive
 LuciAcalaBru,Veronika Blum,Positive
 LuciAcalaBru,–ú–∏—à–∞ –°–∞–ª—å–Ω–∏–∫–æ–≤–≤,Positive
 LuciAcalaBru,Nonna Chizhova,Positive
 LuciAcalaBru,–ö—Ä–∏—Å—Ç–∏–Ω–∞ –í–æ–ª—å—Ñ–æ–≤—Å–∫–∞—è,Positive
 LuciAcalaBru,–ù–∏–∫–∏—Ç–∞ –ö—É—Ä–∫–∏–Ω,Positive
 LuciAcalaBru,–û–ª—å–≥–∞ –°–ø–∏—Ä–∏–¥–æ–Ω–æ–≤–∞,Positive
 LuciAcalaBru,Normalniypots55x55,Positive
 LuciAcalaBru,kek kekov,Positive
 LuciAcalaBru,InstaPromoVideo,Positive
 LuciAcalaBru,BoiK,Positive
 LuciAcalaBru,–ò–≤–∞–Ω–æ–≤ –°–µ—Ä–≥–µ–π –ü–µ—Ç—Ä–æ–≤–∏—á,Positive
 LuciAcalaBru,Denchik,Positive
 LuciAcalaBru,Yarema Dyackiv,Positive
 LuciAcalaBru,miausy,Positive
 LuciAcalaBru,Kevlar_11,Positive
 LuciAcalaBru,–ê—Ä—Ç—ë–º –ö–æ—Å—Ç—é—á–µ–Ω–∫–æ,Positive
 LuciAcalaBru,–ü–µ—Ç—Ä –°–µ–º–µ–Ω–æ–≤,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ë–µ—Ä–≥,Positive
 LuciAcalaBru,–°–≤–µ—Ç–ª–∞–Ω–∞ –ü–ª–µ—á–∏—Å—Ç—ã—Ü–∞,Positive
 LuciAcalaBru,Maks Panch,Positive
 LuciAcalaBru,–ö–∞–º–∏–ª–∞ –ê–Ω—Ç–æ–Ω–æ–≤–∞,Positive
 LuciAcalaBru,Hacker,Positive
 LuciAcalaBru,–ê–ª–∏—Å–∞ –õ–µ–æ–Ω–æ–≤–∞,Positive
 LuciAcalaBru,–°–µ—Ä–≥–µ–π –ò–≤–∞–Ω–æ–≤,Positive
 LuciAcalaBru,–ù–∞–¥—ñ—è –í–æ–ª–æ–¥–∏–º–∏—Ä—ñ–≤–Ω–∞,Positive
 LuciAcalaBru,–ù–∏–∫–æ–ª–∞–π,Positive
 LuciAcalaBru,–ò–ª—å—è –ö–∞–ª–∞—à–Ω–∏–∫–æ–≤,Positive
 LuciAcalaBru,Valentin Grevtcov,Positive
 LuciAcalaBru,–°–µ—Ä—ë–≥–∞ –®–∞—Ç–∞–ª–æ–≤,Positive
 LuciAcalaBru,–¥–º–∏—Ç—Ä–∏–π —É–∞—É—ã–∞,Positive
 LuciAcalaBru,fghjk,Positive
 LuciAcalaBru,mediavlogster,Positive
 LuciAcalaBru,Stark,Positive
 LuciAcalaBru,–ê—Ä—Ç—ë–º –†–µ–∑–Ω–∏–∫–æ–≤,Positive
 LuciAcalaBru,arkadi naftaliev,Positive
 LuciAcalaBru,üçæ,Positive
 LuciAcalaBru,–ê–Ω—é—Ç–∞ –¢–∞—Ä–∞—Å–æ–≤–∞,Positive
 LuciAcalaBru,–ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –ù–µ—Å–≤–µ—Ç–∞–µ–≤–∞,Positive
 LuciAcalaBru,–Ω–∏–∫–æ–ª–æ—Å –∫–µ–π–¥–∂,Positive
 LuciAcalaBru,Lovee,Positive
 LuciAcalaBru,Vlad Maliovanyi,Positive
 LuciAcalaBru,–ê–Ω–Ω–∞ –ü–µ—Ç—Ä–æ–≤–∞,Positive
 LuciAcalaBru,abdul,Positive
 LuciAcalaBru,–ò–≤–∞–Ω –†–æ–º–∞–Ω–æ–≤,Positive
 LuciAcalaBru,Roby wilams,Positive
 LuciAcalaBru,„Äå Knyazev XII„ÄçüçÅ,Positive
 LuciAcalaBru,Xoma feb,Positive
 LuciAcalaBru,Team FOETBT,Positive
 LuciAcalaBru,olwfkw fowmkfowmfw,Positive
 LuciAcalaBru,Zakhar Phylyppo,Positive
 LuciAcalaBru,Sobaka Kysaka,Positive
 LuciAcalaBru,–ù–∏–∫–∏—Ç–∞ Prohorow,Positive
 LuciAcalaBru,elena.vlogster,Positive
 LuciAcalaBru,–ê–ª–µ–Ω–∞ –ò–≤–∞–Ω–æ–≤–∞,Positive
 LuciAcalaBru,–°–∞—à–∞ –ú–∞—Ä–∏–Ω–∏—á,Positive
 LuciAcalaBru,Johnny Dillinger,Positive
 LuciAcalaBru,regeter,Positive
 LuciAcalaBru,–§–µ–¥—è –ì–∞–ª–∞–∫—Ç–∏–æ–Ω–æ–≤,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–µ–π –°–∞–π–≥—É–ª–æ–≤,Positive
 LuciAcalaBru,–í–∞–¥–∏–º–æ–≤–Ω–∞ –î–∞—Ä–∏—è,Positive
 LuciAcalaBru,ANTON,Positive
 LuciAcalaBru,–ê–Ω–∞—Å—Ç–∞—Å–∏—è –≥—Ä—É–¥–∏–Ω–∏–Ω–∞,Positive
 LuciAcalaBru,–ñ–µ–Ω–µ—á–∫–∞ –ö—É—Å–∞–∫–∏–Ω–∞,Positive
 LuciAcalaBru,horror_history,Positive
 LuciAcalaBru,b.l.o.o.d.y.k.n.ig.h.t6.6.6.6.66@gmail.com,Positive
 LuciAcalaBru,Denix,Positive
 LuciAcalaBru,–î–º–∏—Ç—Ä–∏–π –õ–µ–Ω—Ü,Positive
 LuciAcalaBru,–î–∞—à–∞ –ß–∏–∂–æ–≤–∞,Positive
 LuciAcalaBru,–Ø—Ä–æ—Å–ª–∞–≤ –ß–∏—Ä–∫–æ–≤,Positive
 LuciAcalaBru,Yernar Asirov,Positive
 LuciAcalaBru,–°–æ–Ω—è –û—Ä–ª–æ–≤–∞,Positive
 LuciAcalaBru,–û–∫—Å–∞–Ω–∞ –°–ø–∏—Ä–∏–Ω–∞,Positive
 LuciAcalaBru,*–¶–∏—Ç–∞—Ç—ã*,Positive
 LuciAcalaBru,–î–º–∏—Ç—Ä–∏–π –°—Ç–µ–Ω–Ω–∏–∫–æ–≤ ,Positive
 LuciAcalaBru,bot 1728,Positive
 LuciAcalaBru,Echo of Mars,Positive
 LuciAcalaBru,prvlogster,Positive
 LuciAcalaBru,marinavlogster,Positive
 LuciAcalaBru,Black Kingutu,Positive
 LuciAcalaBru,herhejhed,Positive
 LuciAcalaBru,Vladislav Vargasov,Positive
 LuciAcalaBru,–í—Å–µ—Ç–ª–∞–Ω–∞ –ï–ª–∏—Å–µ–µ–≤–∞,Positive
 LuciAcalaBru,–ï–≥–æ—Ä –î—É—Ö–æ–≤–Ω—ã–π,Positive
 LuciAcalaBru,gekpaker,Positive
 LuciAcalaBru,balƒ±kesir byn,Positive
 LuciAcalaBru,–î–∞–Ω–∏–∏–ª –î–µ–º–∏–¥–æ–≤,Positive
 LuciAcalaBru,–ï–≤–≥–µ–Ω–∏–π,Positive
 LuciAcalaBru,gwgrgrwgwrg,Positive
 LuciAcalaBru,–ê–Ω—Ç–æ–Ω –î—è—á–µ–Ω–∫–æ,Positive
 LuciAcalaBru,–°–∞–≤–µ–ª–∏–π –ì—Ä–∞–¥–∫–æ–≤,Positive
 LuciAcalaBru,ArlNakru,Positive
 LuciAcalaBru,Antony Terras,Positive
 LuciAcalaBru,Andrey Kur'yanov,Positive
 LuciAcalaBru,ozoz ozoz,Positive
 LuciAcalaBru,–ê–Ω–¥—Ä–µ–π –ú–∞—Ä—Ç—ã–Ω–µ–Ω–∫–æ,Positive
 LuciAcalaBru,ASUNWQ,Positive
 LuciAcalaBru,Volka,Positive
 LuciAcalaBru,–ò–≤–∞–Ω –ö–æ–∑–ª–æ–≤,Positive
 LuciAcalaBru,–ú—É–ª—å—Ç–∏–∫–∏ –¥–ª—è –º–∞–ª–µ–Ω—å–∫–∏—Ö - –î–µ—Ç—Å–∫–∏–π –∫–∞–Ω–∞–ª –ú–§–û‚Ñ¢,Positive
 LuciAcalaBru,lialia,Positive
 LuciAcalaBru,–ö–∏—Ä–∏–ª–ª –®–ø—Ä–æ—Ç–æ–≤,Positive
 LuciAcalaBru,–ù–∏–∫–æ–ª–∞–π –ì–µ—Ä–æ–º,Positive
 LuciAcalaBru,–í–æ–ª–æ–¥—è,Positive
 LuciAcalaBru,asfdf,Positive
 LuciAcalaBru,–ö–∏—Ä–∏–ª–ª –£–∫–æ–ª–æ–≤,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ò–≤–∞–Ω–æ–≤,Positive
 LuciAcalaBru,sdawdwad,Positive
 LuciAcalaBru,berma012,Positive
 LuciAcalaBru,karimessa_k,Positive
 LuciAcalaBru,–°–æ–ª–¥–∞—Ç–µ–Ω–∫–æ–≤–∞ —Ç–∞—Ç—å—è–Ω–∞,Positive
 LuciAcalaBru,Andrey Mays,Positive
 LuciAcalaBru,jgfg bgvg,Positive
 LuciAcalaBru,–í–∞—Å—è,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–µ–π –¢—Ä–æ—Ñ–∏–º–æ–≤,Positive
 LuciAcalaBru,kirillantonov,Positive
 LuciAcalaBru,Imperator Casino,Positive
 LuciAcalaBru,Vasyl,Positive
 LuciAcalaBru,–ê–Ω–¥—Ä–µ–π –í–∞—Ä—Ö–∏–Ω—è–Ω,Positive
 LuciAcalaBru,–¢–∞—Ç—å—è–Ω–∞ –¢—É—á–∫–æ–≤–∞,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å –¢–∏—Ö–∏–π,Positive
 LuciAcalaBru,–ö—Ä–∞–≤—Ü–æ–≤–∞,Positive
 LuciAcalaBru,Alena Starkova,Positive
 LuciAcalaBru,–í–∞—Å—è –ü—É–ø–∫–∏–Ω,Positive
 LuciAcalaBru,–ú–∞–∫—Å–∏–º –ú–µ–¥–≤–µ–¥–µ–≤,Positive
 LuciAcalaBru,Evkak,Positive
 LuciAcalaBru,Ivan A,Positive
 LuciAcalaBru,–ú–∞–∫—Å–∏–º –ö–∞—Ä–ª—ã–∫–æ–≤,Positive
 LuciAcalaBru,–†–∞–¥–º–∏—Ä,Positive
 LuciAcalaBru,–Æ–ª—è –ü–∏–ª–∏–ø–µ–Ω–∫–æ,Positive
 LuciAcalaBru,hjhjhjj,Positive
 LuciAcalaBru,carpooling,Positive
 LuciAcalaBru,–ò–≥–æ—Ä—å –ú–æ—Å–∫–≤–∏–Ω,Positive
 LuciAcalaBru,theonlyone,Positive
 LuciAcalaBru,–í–ª–∞–¥ –ü–µ—Ç—Ä–æ–≤,Positive
 LuciAcalaBru,Nkita Berkut,Positive
 LuciAcalaBru,Djon EBLO,Positive
 LuciAcalaBru,–ö–∏—Ä–∏–ª–ª –ò–≤–∞–Ω–æ–≤,Positive
 LuciAcalaBru,–ù–∞—Ç–∞—à–∞ –ü–æ–ø–æ–≤–∞,Positive
 LuciAcalaBru,—Ç—É—Ä–∏–∫ –∞–∑–∏–∑–æ–≤,Positive
 LuciAcalaBru,vfrcbv,Positive
 LuciAcalaBru,Jesionekk,Positive
 LuciAcalaBru,–ú–∏—Å—Ç–µ—Ä –ó—É–±–æ—á–∏—Å—Ç–∫–∞,Positive
 LuciAcalaBru,–¢–∏–º—É—Ä,Positive
 LuciAcalaBru,Caballeros de lujo,Positive
 LuciAcalaBru,–ü–∞—à–æ–∫,Positive
 LuciAcalaBru,–ù–∞—Ç–∞–ª–∏—è –ö–∏–º,Positive
 LuciAcalaBru,–õ—é–¥–≤–∏–≥ –ê—Ä–∏—Å—Ç–∞—Ä—Ö–æ–≤–∏—á,Positive
 LuciAcalaBru,–°–∞–≤–µ–ª–∏–π,Positive
 LuciAcalaBru,Ô∏è,Positive
 LuciAcalaBru,–°–ª–∞–≤–∞ –ö–∏—Ä–∏–ª–æ–≤,Positive
 LuciAcalaBru,–ê–Ω–¥—Ä–µ–π –ö—É—á–µ—Ä,Positive
 LuciAcalaBru,–í–∏—Ç–∞–ª–∏–∫ –°—Ç–µ–ø–∞–Ω–æ–≤,Positive
 LuciAcalaBru,Madad Fada,Positive
 LuciAcalaBru,–î–∂—ç–∫–∏ –ß–∞–Ω,Positive
 LuciAcalaBru,Sonya Kotova,Positive
 LuciAcalaBru,–æ–ª–µ–≥ —Å—Ç–µ–ø–∞–Ω–æ–≤,Positive
 LuciAcalaBru,–ò–≤–∞–Ω–Ω–∞ –õ–∞–≤—Ä–µ–Ω—Ç–µ–≤–∞,Positive
 LuciAcalaBru,–ù–∏–∫–∏—Ç–∞ –ù–∏–∫–∏—Ç–∏–Ω,Positive
 LuciAcalaBru,AndreySmoke,Positive
 LuciAcalaBru,–°–µ—Ä–≥–µ–π –í–æ—Ä–æ–Ω,Positive
 LuciAcalaBru,–û–ª–µ–≥,Positive
 LuciAcalaBru,Serhii Ryzhenko,Positive
 LuciAcalaBru,–∞–ª–µ–∫—Å—É–π –∏–≤–∞–Ω–æ–≤,Positive
 LuciAcalaBru,sf srfsr,Positive
 LuciAcalaBru,hjnvb bgngh,Positive
 LuciAcalaBru,Catherine Lain,Positive
 LuciAcalaBru,–ê–Ω–¥—Ä–µ–π –ì–∞—Ä–∫–∏–Ω,Positive
 LuciAcalaBru,Olenka,Positive
 LuciAcalaBru,aman zhaman,Positive
 LuciAcalaBru,Nikole Aniston,Positive
 LuciAcalaBru,–ö—Å—é—à–∞ –ê–ª–µ—â–µ–Ω–∫–æ,Positive
 LuciAcalaBru,–ê–Ω–¥—Ä–µ–π –≥–æ–ª—É–±–∫–æ–≤,Positive
 LuciAcalaBru,Egor Pluse,Positive
 LuciAcalaBru,–õ–∞–¥–∞ –ú–∞—Ä—Ç–æ–≤–∞,Positive
 LuciAcalaBru,–ù–∏–Ω–∞ –ü–µ—Ç—Ä–µ–Ω–∫–æ–≤–∞,Positive
 LuciAcalaBru,Sobat_rere,Positive
 LuciAcalaBru,Julia Shocinx,Positive
 LuciAcalaBru,–ª–µ–Ω–∞ –±–ª–∏–Ω–æ–≤–∞,Positive
 LuciAcalaBru,–ù–∏–∫–∏—Ç–∞ –ö–∞–ª–∞—á–µ–≤,Positive
 LuciAcalaBru,–¥–∏–º–∞,Positive
 LuciAcalaBru,–û–ª—å–≥–∞ –ê–±—Ä–∞–º–æ–≤—Å–∫–∞—è,Positive
 LuciAcalaBru,–≠–¥,Positive
 LuciAcalaBru,–°–∏–Ω–æ–ø—Å–∫–∞—è –í–∞—Ä–≤–∞—Ä–∞,Positive
 LuciAcalaBru,–°–≤–µ—Ç–ª–∞–Ω–∞ –î–º–∏—Ç—Ä–∏–µ–≤–∞,Positive
 LuciAcalaBru,–°–µ—Ä–≥–µ–π –ö—É–∑–Ω–µ—Ü–æ–≤,Positive
 LuciAcalaBru,Magnify,Positive
 LuciAcalaBru,Madin Hadif,Positive
 LuciAcalaBru,shine lylz,Positive
 LuciAcalaBru,Sasha Motychko,Positive
 LuciAcalaBru,The Godfather Quotes,Positive
 LuciAcalaBru,–ì–∞–ª–∏–Ω–∞ –°–∞–≤—á—É–∫,Positive
 LuciAcalaBru,–ï–ª–µ–Ω–∞ –û–±—Ä–∞–º–æ–≤–∞,Positive
 LuciAcalaBru,–ò—É–∞–Ω –ì—Ä–æ–∑–Ω—ã–π,Positive
 LuciAcalaBru,Fylhtq,Positive
 LuciAcalaBru,–†–µ–Ω–∞—Ç –ê—Ö–º–µ—Ç–∑—è–Ω–æ–≤,Positive
 LuciAcalaBru,–ö–æ–ª—è –ú–æ—Ä–æ–∑,Positive
 LuciAcalaBru,–ö–æ–ª—è –ë–æ–±–∏–∫,Positive
 LuciAcalaBru,solomin,Positive
 LuciAcalaBru,Aton Anikovich,Positive
 LuciAcalaBru,–ê–Ω–¥—Ä–µ–π –Ø–æ–º@–Ω–¢–∏–∫,Positive
 LuciAcalaBru,J.Kndel,Positive
 LuciAcalaBru,Happy Unicornü¶Ñ,Positive
 LuciAcalaBru,‚àÜ,Positive
 LuciAcalaBru,123ewq21,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ê–Ω—É—Ñ—Ä–∏–µ–≤-–°–∞–ª—ã–≥–∞,Positive
 LuciAcalaBru,OLGA,Positive
 LuciAcalaBru,neon_clovds,Positive
 LuciAcalaBru,–î–∞–Ω–∏–ª–∞ –ë—É—Ä–º–∏—Å—Ç—Ä–æ–≤,Positive
 LuciAcalaBru,oleg,Positive
 LuciAcalaBru,–ê–Ω–¥—Ä–µ–π –ö—É–∑–Ω–µ—Ü–æ–≤,Positive
 LuciAcalaBru,Nik Romashkinn,Positive
 LuciAcalaBru,Electronika-Rostov,Positive
 LuciAcalaBru,afaf,Positive
 LuciAcalaBru,–û–Ω–∏—â—É–∫ –†—É—Å–ª–∞–Ω,Positive
 LuciAcalaBru,–º–∏—Ä–æ–Ω,Positive
 LuciAcalaBru,Enedin,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–µ–π –°—Ç–∞—Ä–∫–æ–≤,Positive
 LuciAcalaBru,–ê—Ä—Ç–µ–º –ö–æ–Ω–æ–Ω–æ–≤,Positive
 LuciAcalaBru,–í–∞–ª–µ—Ä–∏—è –ö—É–¥—Ä—è–≤—Ü–µ–≤–∞,Positive
 LuciAcalaBru,Ilona Vojnich,Positive
 LuciAcalaBru,–ê–Ω–¥—Ä–µ–π –ó–∞–¥–æ—Ä–æ–∂–Ω—ã–π,Positive
 LuciAcalaBru,Trema Erema,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ì—É—Å–∞—Ä—É–∫,Positive
 LuciAcalaBru,Alice Cooper,Positive
 LuciAcalaBru,dfgthfhjjgyjyg,Positive
 LuciAcalaBru,–ê–ª–µ–∫—Å,Positive
 LuciAcalaBru,MankinMikhail,Positive
 LuciAcalaBru,gjdscghktsngyuc,Positive
 LuciAcalaBru,AnnaGrigorenko,Positive
 LuciAcalaBru,Capt Nikolskiy,Positive
 LuciAcalaBru,–û–õ–¨–ì–ê  –°–ê–õ–¢–ê–ù–û–í–ê,Positive
 terapia de Macroglobulinemia Waldenstr√∂m Fase II,Philip Bachour,Positive
 Bruton tirosino kinase resposta duradoura Novas,Philip Bachour,Positive
 ‚Ñ¢,NTRC,Positive
 ICs,NTRC,Positive
 anticancer drugs,NTRC,Positive
 cell lines,NTRC,Positive
 NTRC,NTRC,Positive
 compound database,NTRC,Positive
 Acalabrutinib blinatumomab,Cancer DDIs,Positive
 ABBV   Inc,ResearchPool,Negative
 Calquence Set,ResearchPool,Negative
 bn Drug Calquence,ResearchPool,Negative
 Dr Peter Martin,WCM Lymphoma,Negative
 promising response rates,WCM Lymphoma,Negative
 promising response rates,Francesco Bertoni,Negative
 follicular,WCM Lymphoma,Negative
 generic,"Pharmacy, Medications, & Health Blog",Positive
 medicine,"Pharmacy, Medications, & Health Blog",Positive
 medicine,Patient Power,Negative
 medicine,Ravispecialitiespharma_RSP,Negative
 medicine,Esther Schorr,Negative
 medicine,Vincent Rajkumar,Negative
 medicine,Rajkumar Gupta Basics of DRA,Positive
 medicine,Roche,Positive
 medicine,VJHemOnc,Negative
 Waldenstrom macroglobulinemia,CancerTherapyAdvisor,Negative
 Waldenstrom macroglobulinemia,VJHemOnc,Negative
 host site,WCMNYPJCTO,Negative
 WAY,Charles Weiler,Positive
 ADand,Charles Weiler,Negative
 Abstract Acalabrutinib,"Alkis Papachristos, PharmD, PhD",Positive
 Waldenstr√∂m macroglobulinemia WM Dr ROwen,"Alkis Papachristos, PharmD, PhD",Positive
 wa Mantle Cell Lymphoma patient,"John P. Leonard, MD",Positive
   Abst   Acalabrutinib,"Jason Westin, MD FACP",Positive
 Proton,"Raul Cordoba, MD, PhD",Negative
 exclusion criteria,"Raul Cordoba, MD, PhD",Negative
 waldenstrom macroglobulinemia ü§î,"Raul Cordoba, MD, PhD",Negative
      Oral Abstracts Hematologic Malignancies Lymphoma,Dr. Hedrick,Positive
 CLLAbstract Acalabrutinib,Dr. Hedrick,Positive
 Waldenstroms Macroglobulinemia,Dr. Hedrick,Positive
 New treatment option,Medivizor,Negative
 New treatment option,AstraZenecaUS,Negative
 New treatment option,Neil Sankar,Positive
 Tagrisso,Gregory L,Negative
 TWTR,Gregory L,Positive
 Dyer et al,Chan Cheah,Negative
 relapsedrefractory DLBCL,Chan Cheah,Negative
 lot,Gregory L,Negative
 lot,Lymphoma Hub,Negative
 lot,CLLSA,Positive
 lot,Dr. Andy Evens,Negative
 lot,Andrew Schorr,Positive
 lot,Patient Power,Negative
 lot,"Jose Sandoval S, MD FACP",Positive
 lot,Chan Cheah,Negative
 lot,Higher Ground at Lake Louise,Negative
 Pharmacy Forum,Oncology Times,Positive
 FL,Francesco Bertoni,Negative
 FL,Neil Sankar,Positive
 FL,MDedge Hematology & Oncology,Negative
 FL,HGSMVM‚ù§Ô∏è,Positive
 FL,Lymphomation.org,Negative
 ASCO,Francesco Bertoni,Negative
 ASCO,Paperbirds_Hematology,Positive
 ASCO,Current Oncology,Negative
 ASCO,filippo masini,Negative
 ASCO,CLL Society Inc.,Positive
 ASCO,CARE‚Ñ¢ Education,Negative
 ASCO,PressReleasePoint,Negative
 ASCO,Pharmacutical Daily,Negative
 ASCO,Flash Alert,Negative
 ASCO,RazzleTazzle,Negative
 ASCO,Amy C. Cavers,Negative
 ASCO,Oncology Times,Negative
 ASCO,dough,Negative
 ASCO,cafepharma,Negative
 ASCO,VuMedi Oncology,Positive
 ASCO,Ana Laura Caballero,Positive
 ASCO,IntoxicatedTrader,Negative
 ASCO,Financial Buzz,Positive
 ASCO,Financial GamblR,Positive
 ASCO,NeuroBrain,Positive
 ASCO,VPO/PR Newswire,Negative
 ASCO,TG Therapeutics,Positive
 ASCO,ivy science,Negative
 ASCO,Roberto C.  Montoya,Negative
 ASCO,Diaceutics PLC,Negative
 ASCO,Oncology Tube,Positive
 ASCO,Dr. Jos√© A. Queiz√°n,Negative
 al,Graham Collins,Positive
 al,Toby Eyre,Negative
 al,Club Deportivo Moto Kart Jovita,Negative
 al,"Mike Thompson, MD, PhD, FASCO",Negative
 al,"chadi nabhan MD, MBA, FACP",Negative
 rel   ref DLBCL,Graham Collins,Negative
 CR   response,Graham Collins,Negative
 GCB,Graham Collins,Negative
 ABC,Graham Collins,Negative
 gt   months,Graham Collins,Negative
 Ryan W Jacobs MD,OncLive SOSS,Positive
 Acalabrutinib ACP,Krishan Maggon,Negative
 Acalabrutinib ACP,"Mike Thompson, MD, PhD, FASCO",Negative
 Acalabrutinib ACP,Anthony M Crasto DR.,Positive
 Acalabrutinib ACP,Lymphomation.org,Positive
 Acalabrutinib ACP,Amir Ahmed Toor,Positive
 Acalabrutinib ACP,Tom,Positive
 Acalabrutinib ACP,MedChemExpress,Negative
 Acalabrutinib ACP,Jos√© Clemente D√≠az M,Positive
 Acalabrutinib ACP,Jean Plante,Negative
 Acalabrutinib ACP,Tim Fenske,Negative
 Acalabrutinib ACP,Armand!!,Negative
 Acalabrutinib ACP,Shankara Paneesha,Negative
 Acalabrutinib ACP,MedChem & ONCo,Negative
 Acalabrutinib ACP,Dicaf,Positive
 Acalabrutinib ACP,A. Vroom - Ten Wolde,Negative
 Acalabrutinib ACP,ALLEN KUO,Positive
 Acalabrutinib ACP,Lindsey Summers üò∑‚úäüèº,Positive
 Acalabrutinib ACP,Joaquin KM,Positive
 Acalabrutinib ACP,Rafael Fonseca MD,Positive
 Acalabrutinib ACP,FarmaOnco,Negative
 Acalabrutinib ACP,Tom Heston,Negative
 Acalabrutinib ACP,Leslie Andritsos,Positive
 Acalabrutinib ACP,Pharmicals,Positive
 Acalabrutinib ACP,NEJM,Negative
 Acalabrutinib ACP,Richard Schilsky,Positive
 Acalabrutinib ACP,üÖæ Jaksic,Negative
 Acalabrutinib ACP,Pharm Digest,Negative
 Acalabrutinib ACP,Muzaffar Qazilbash,Negative
 Acalabrutinib ACP,The Medical Ed Cons.,Negative
 Acalabrutinib ACP,Nitin Jain,Negative
 Acalabrutinib ACP,Johnson & Johnson,Positive
 Acalabrutinib ACP,DrugGenius,Negative
 Acalabrutinib ACP,Business Wire-Health,Negative
 Acalabrutinib ACP,Purvis Lee Everette,Positive
 Relapsed Chronic Lymphocytic Leukemia,Krishan Maggon,Negative
 Relapsed Chronic Lymphocytic Leukemia,"Mike Thompson, MD, PhD, FASCO",Negative
 Relapsed Chronic Lymphocytic Leukemia,Amir Ahmed Toor,Positive
 Relapsed Chronic Lymphocytic Leukemia,Lymphomation.org,Negative
 Relapsed Chronic Lymphocytic Leukemia,Tom,Positive
 Relapsed Chronic Lymphocytic Leukemia,Tran-Der Tan,Negative
 Relapsed Chronic Lymphocytic Leukemia,NEJM,Positive
 Relapsed Chronic Lymphocytic Leukemia,Jos√© Clemente D√≠az M,Positive
 Relapsed Chronic Lymphocytic Leukemia,Jean Plante,Positive
 Relapsed Chronic Lymphocytic Leukemia,Francesco Turturro,Positive
 Relapsed Chronic Lymphocytic Leukemia,Tim Fenske,Positive
 Relapsed Chronic Lymphocytic Leukemia,La chuleta del FIR,Positive
 Relapsed Chronic Lymphocytic Leukemia,Armand!!,Positive
 Relapsed Chronic Lymphocytic Leukemia,Shankara Paneesha,Positive
 Relapsed Chronic Lymphocytic Leukemia,MedChem & ONCo,Negative
 Relapsed Chronic Lymphocytic Leukemia,A. Vroom - Ten Wolde,Negative
 Relapsed Chronic Lymphocytic Leukemia,frothmouth,Positive
 Relapsed Chronic Lymphocytic Leukemia,ALLEN KUO,Positive
 Relapsed Chronic Lymphocytic Leukemia,Joaquin KM,Positive
 Relapsed Chronic Lymphocytic Leukemia,Rafael Fonseca MD,Positive
 Relapsed Chronic Lymphocytic Leukemia,FarmaOnco,Positive
 Relapsed Chronic Lymphocytic Leukemia,Tom Heston,Positive
 Relapsed Chronic Lymphocytic Leukemia,Leslie Andritsos,Positive
 Relapsed Chronic Lymphocytic Leukemia,Richard Schilsky,Positive
 Relapsed Chronic Lymphocytic Leukemia,üÖæ Jaksic,Negative
 Relapsed Chronic Lymphocytic Leukemia,Pharm Digest,Positive
 Relapsed Chronic Lymphocytic Leukemia,Muzaffar Qazilbash,Positive
 Relapsed Chronic Lymphocytic Leukemia,The Medical Ed Cons.,Positive
 Relapsed Chronic Lymphocytic Leukemia,Purvis Lee Everette,Positive
 Relapsed Chronic Lymphocytic Leukemia,Trip Database,Negative
 Relapsed Chronic Lymphocytic Leukemia,The ASCO Post,Negative
 Relapsed Chronic Lymphocytic Leukemia,Aloysius Pendergast,Positive
 Relapsed Chronic Lymphocytic Leukemia,Albeena Nisar,Positive
 Relapsed Chronic Lymphocytic Leukemia,filippo masini,Negative
 Relapsed Chronic Lymphocytic Leukemia,DrSac,Positive
 Relapsed Chronic Lymphocytic Leukemia,INDoximity üáÆüá≥,Negative
 Relapsed Chronic Lymphocytic Leukemia,F. Hernandez Mohedo,Positive
 Relapsed Chronic Lymphocytic Leukemia,"Hayder Saeed, MD",Positive
 Relapsed Chronic Lymphocytic Leukemia,Brave Is Now¬Æ,Negative
 Relapsed Chronic Lymphocytic Leukemia,James Kerwin,Positive
 Relapsed Chronic Lymphocytic Leukemia,ClinicalTrialsData,Negative
 Relapsed Chronic Lymphocytic Leukemia,NASDAQ,Positive
 Relapsed Chronic Lymphocytic Leukemia,Cancer Library VCC,Positive
 Relapsed Chronic Lymphocytic Leukemia,Dr. Jos√© A. Queiz√°n,Negative
 Relapsed Chronic Lymphocytic Leukemia,maria jose agustin,Positive
 Relapsed Chronic Lymphocytic Leukemia,AmericanPharmacyNews,Negative
 Relapsed Chronic Lymphocytic Leukemia,Swapnil Devale,Negative
 Relapsed Chronic Lymphocytic Leukemia,Oncology Tube,Negative
 Relapsed Chronic Lymphocytic Leukemia,AJHO,Positive
 Relapsed Chronic Lymphocytic Leukemia,Saudi Leukemia Net,Negative
 Relapsed Chronic Lymphocytic Leukemia,Sonia Glez Costas,Positive
 Relapsed Chronic Lymphocytic Leukemia,Bitlattice Woman,Positive
 Relapsed Chronic Lymphocytic Leukemia,EUFUCKBACK2,Positive
 Relapsed Chronic Lymphocytic Leukemia,Ronny Allan üíô,Positive
 Relapsed Chronic Lymphocytic Leukemia,"Jason Westin, MD FACP",Positive
 Relapsed Chronic Lymphocytic Leukemia,Tapan Kadia,Negative
 Relapsed Chronic Lymphocytic Leukemia,"chadi nabhan MD, MBA, FACP",Negative
 Relapsed Chronic Lymphocytic Leukemia,rattenniMD,Negative
 Relapsed Chronic Lymphocytic Leukemia,$Stocknewsalerts,Negative
 Relapsed Chronic Lymphocytic Leukemia,Aserrano,Positive
 Relapsed Chronic Lymphocytic Leukemia,scottidiego,Positive
 Relapsed Chronic Lymphocytic Leukemia,Â∞èÊöÆ„ÅÆ„Ç´„Ç∫„ÇÑ„Çì,Positive
 Relapsed Chronic Lymphocytic Leukemia,Hojoon Choi,Positive
 Relapsed Chronic Lymphocytic Leukemia,KevinFitts,Negative
 Relapsed Chronic Lymphocytic Leukemia,Gioacchino Catania,Positive
 Relapsed Chronic Lymphocytic Leukemia,Miguel Perales M.D.,Negative
 Relapsed Chronic Lymphocytic Leukemia,Dr Zia ur Rehman,Positive
 Relapsed Chronic Lymphocytic Leukemia,Rare Disease Report,Positive
 Relapsed Chronic Lymphocytic Leukemia,Doctors*Overseas,Negative
 Relapsed Chronic Lymphocytic Leukemia,"Junaid Ansari, MD",Positive
 NEJM,Krishan Maggon,Positive
 NEJM,"Amparo Santamaria Ortiz MD, PhD",Positive
 NEJM,Kenar Jhaveri,Positive
 NEJM,Adriana Aguilar,Positive
 NEJM,Hematolog√≠a Salamanca,Negative
 Participants,Cancer News,Negative
 Participants,CureHuntr,Positive
 Participants,TrialBulletin,Positive
 Participants,Karmanos Cancer Institute,Positive
 Participants,Monterey Holistic,Negative
 Participants,Patient Power,Negative
 Participants,Oncology Tube,Negative
 Participants,VoyagerMed,Positive
 EarlyStage Chronic Lymphocytic Leukemia,Cancer News,Negative
 EarlyStage Chronic Lymphocytic Leukemia,CureHuntr,Negative
 EarlyStage Chronic Lymphocytic Leukemia,TrialBulletin,Negative
 EarlyStage Chronic Lymphocytic Leukemia,BibliotecaHUVH. ICS,Positive
 EarlyStage Chronic Lymphocytic Leukemia,Lymphoma Papers,Negative
 EarlyStage Chronic Lymphocytic Leukemia,Paperbirds_Hematology,Negative
 EarlyStage Chronic Lymphocytic Leukemia,Chocolatiere Phys,Negative
 EarlyStage Chronic Lymphocytic Leukemia,CLL Society Inc.,Negative
 EarlyStage Chronic Lymphocytic Leukemia,JAMA Internal Medicine,Positive
 EarlyStage Chronic Lymphocytic Leukemia,JAMA Network,Negative
 EarlyStage Chronic Lymphocytic Leukemia,Cancer Papers,Negative
 phase II trials studies,Cancer News,Negative
 obinutuzumab works,Cancer News,Negative
 treating,Cancer News,Negative
 Small Lymphocytic Lymphoma Status,TrialBulletin,Negative
 Condition Summary CCND Negative Chronic Lymphocytic Leukemia Small Lymphocyt,TrialBulletin,Negative
 Goy Shares Insights,Targeted Oncology,Negative
 Ibrutinib Data,Targeted Oncology,Negative
 MCL Thanks,Targeted Oncology,Negative
 Acalabrutinib treatment,The ASCO Post,Negative
 Acalabrutinib treatment,JTCancerCenter,Positive
 Acalabrutinib treatment,NatureRevClinOncol,Negative
 New Post Phase   ACCEPT Trial Explores Adding,Lymphoma News Today,Negative
 Standard DLBCL Treatment,Lymphoma News Today,Negative
 Interesting LOXO,Bobby Landmanü¶é,Positive
 LOXO,Bobby Landmanü¶é,Positive
 LOXO,ASH Clinical News,Positive
 LOXO,Benlazar S.M Amin√©,Negative
 LOXO,Victor Lin,Positive
 LOXO,Oncology Times,Negative
 LOXO,Pharma News,Negative
 LOXO,IMPharma News,Negative
 LOXO,Investor News,Negative
 LOXO,Biotech & Tech Stock Focus,Negative
 LOXO,"OTC Dynamics, Inc.",Negative
 LOXO,Bio Stocks‚Ñ¢,Negative
 LOXO,Stock Titan,Negative
 LOXO,"Amber Koehler, PA-C",Negative
 Dr Barrientos,OncLive.com,Positive
 Dr Barrientos,Targeted Oncology,Positive
 Dr Barrientos,VJHemOnc,Positive
 Discusses Acalabrutinib,OncLive.com,Positive
 gerecidiveerd,Mednet (was: Medidact),Positive
 refractair mantelcellymfoom,Mednet (was: Medidact),Positive
 Acalabrutinib Market Launch Insights,Sylvia Joyner,Positive
 Dose escalation study,Medscape Education,Negative
 Goy Lends,CancerWallonia,Negative
 Andre Goy MD,OncLive.com,Negative
 excitement,OncLive.com,Negative
 excitement,CLLSA,Negative
 excitement,OncLive SOSS,Negative
 Goy Lends Insight,Immuno-Oncology,Negative
 Goy Lends Insight,OncLive.com,Negative
 Acalabrutinib Launch Insight   Report,Drug Delivery News,Negative
 Prices,Drug Delivery News,Positive
 Prices,CRO Contract Res.,Positive
 Prices,Renal Cell Carcinoma,Positive
 Prices,COPD News,Positive
 Prices,Tech News by Qiosk,Positive
 Prices,Cancer News,Positive
 Prices,Bio-Collaboration,Positive
 Prices,DrugGenius,Positive
 Prices,Johnson & Johnson,Positive
 Prices,SPI News,Positive
 USD,Drug Delivery News,Positive
 USD,MAISA,Negative
 USD,COPD News,Positive
 USD,DrugGenius,Positive
 USD,CRO Contract Res.,Positive
 USD,Renal Cell Carcinoma,Positive
 USD,Unidrugscom,Positive
 USD,Tech News by Qiosk,Positive
 USD,Cancer News,Positive
 USD,Johnson & Johnson,Positive
 USD,Bio-Collaboration,Positive
 USD,SPI News,Positive
 DelveInsights Acalabrutinib Launch Insight   report,Drug Delivery News,Negative
 Dr Logan,OncLive.com,Negative
 Dr Neil Kay,CLL Ireland,Negative
 Dr Neil Kay,Mayo Clinic Cancer Center,Negative
 Dr Neil Kay,CLL Society Inc.,Negative
 Dr Neil Kay,Patient Power,Negative
 Kay,CLL Ireland,Negative
 Kay,Melissa Nickolson,Positive
 ma,Medivizor,Negative
 Dr Kay,OncLive.com,Negative
 Dr Kay,"Amber Koehler, PA-C",Negative
 Dr Kay,Targeted Oncology,Positive
 Dr Kay,"chadi nabhan MD, MBA, FACP",Negative
 Dr Kay,Mayo Clinic Labs,Positive
 Dr Kay,Nicole Brudos Ferrara,Positive
 Dr Kay,MD Anderson Leukemia,Negative
 Acalabrutinib Therapy,FarmaOnco,Negative
 ASH   Atlanta Dr Richard Furman,CLL Society Inc.,Negative
 „Äê Êú¨Êó•„ÅÆÂåªÁôÇÊúÄÂâçÁ∑ö„Éã„É•„Éº„Çπ,„Éâ„ÇØ„Çø„Éº„Ç∫„Ç≤„Éº„Éà,Positive
 New New treatment option,Medivizor,Negative
 Acalabrutinib‰ΩµÁî®„ÅØÊú™Ê≤ªÁôÇÔºèÂÜçÁô∫ÁôΩË°ÄÁóÖ„Å´ÂÆâÂÖ®„Åã„Å§ÊúâÂäπ,Êµ∑Â§ñ„Åå„ÇìÂåªÁôÇÊÉÖÂ†±„É™„Éï„Ç°„É¨„É≥„Çπ,Positive
 Jerry,Cancer Medicine,Positive
 Acalabrutinib BTK inh,FabriceAndre,Positive
 Brian T Hill MD PhD,OncLive.com,Negative
 insight,OncLive.com,Positive
 insight,Lymphoma Hub,Positive
 insight,Michele Nadeem-Baker,Negative
 insight,Zack Pemberton-Whiteley,Negative
 insight,LymphomaAction,Positive
 insight,SpecialtyPTimes,Negative
 insight,AJMC,Negative
 insight,Targeted Oncology,Negative
 insight,Patient Power,Positive
 insight,Trader Dave,Positive
 insight,JExpMed,Negative
 insight,LLSCanada,Positive
 Efficacy amp Safety,"Mike Thompson, MD, PhD, FASCO",Negative
 w RelapsedRefractory CLL amp Intolerant,"Mike Thompson, MD, PhD, FASCO",Negative
 Ibrutinib Therapy,"Mike Thompson, MD, PhD, FASCO",Negative
 Ibrutinib Therapy,The Oncologist,Negative
 Ibrutinib Therapy,Mayo Clinic Hematology-Oncology Fellowship,Positive
 Ibrutinib Therapy,CancerEpiPapers,Negative
 Ibrutinib Therapy,Adam R. Fox,Positive
 Ibrutinib Therapy,Oncology Publishers Feed,Negative
 Ibrutinib Therapy,National Aspergillosis Centre,Negative
 Ibrutinib Therapy,Lymphoma Papers,Negative
 Ibrutinib Therapy,AmoebaPapers,Positive
 Ibrutinib Therapy,MsPrissySis,Positive
 Ibrutinib Therapy,Christopher Steer,Negative
 Ibrutinib Therapy,EP Lab Digest,Positive
 n Est,"Mike Thompson, MD, PhD, FASCO",Negative
 completion,"Mike Thompson, MD, PhD, FASCO",Negative
 completion,CLLSA,Negative
 completion,nic...                                         ...,Positive
 Discuss Acalabrutinib,OncLive.com,Negative
 Byrd,"Mike Thompson, MD, PhD, FASCO",Negative
 Byrd,OncLive.com,Positive
 Byrd,disabled_jake,Positive
 Byrd,Francesco Bertoni,Negative
 Byrd,Silas Inman,Negative
 Byrd,FarmaOnco,Negative
 Byrd,PER,Negative
 Byrd,Oncology News Update,Negative
 ACELY study,The Lancet,Negative
 ACELY study,Zachary McLellan,Positive
 ACELY,Lymphoma Hub,Positive
 ACELY,Nicolas Zarjevski,Positive
 RR MCL patients,Lymphoma Hub,Positive
 Latest   study reports,Dr. Adam Harris,Positive
 Bruton tyrosine kinase inhibitor,Dr. Adam Harris,Positive
 Bruton tyrosine kinase inhibitor,Benlazar S.M Amin√©,Negative
 Bruton tyrosine kinase inhibitor,NCI Media Relations,Positive
 efectivo,Daniel Ernst,Positive
 Resultados de fase   sin rama control poco,Daniel Ernst,Positive
 Plaquetas mejor que Ibrutinib al parecer,Daniel Ernst,Positive
 Mantle Cell Lymphoma Patients Benefit,Leukemia Research Foundation,Negative
 Mantle Cell Lymphoma Patients Benefit,Lymphoma News Today,Positive
 Mantle Cell Lymphoma Patients Benefit,BioNews,Negative
 Calquence AstraZeneca Reports,Leukemia Research Foundation,Negative
 Calquence AstraZeneca Reports,Lymphoma News Today,Positive
 Calquence AstraZeneca Reports,BioNews,Negative
 Acalabrutinib recibe aprobaci√≥n de la FDA para linfomas de c√©lulas del manto,ASEPO Asociaci√≥n ES,Positive
 Trends,Kernteam Economie,Positive
 Trends,Top 10,Negative
 biotech page,Kernteam Economie,Positive
 Life Sciences Industry Oss,Kernteam Economie,Positive
 –ê–∫–∞–ª–∞–±—Ä—É—Ç–∏–Ω–∏–±,Anthony M Crasto DR.,Positive
 ÈòøÂèØÊõøÂ∞º,Anthony M Crasto DR.,Positive
 gtgt,Lymphoma News Today,Positive
 gtgt,VJHemOnc,Negative
 AstraZeneca Reports,Pharmacy News & Research,Positive
 AstraZeneca Reports,Women's Health News,Positive
 Cancer Drug Sales,Pharmacy News & Research,Positive
 Cancer Drug Sales,Women's Health News,Positive
 NewsAstraZeneca,Pharmacy News & Research,Positive
 NewsAstraZeneca,Women's Health News,Positive
 product sales,Pharmacy News & Research,Positive
 product sales,Women's Health News,Positive
 product sales,Cancer News,Negative
   AstraZeneca Reports,Cancer News,Negative
 Cost,Alexis Rodr√≠guez,Positive
 Cost,Cancer Papers,Negative
 Cost,FarmaOnco,Negative
 Cost,Lymphoma Coalition,Negative
 Cost,Oncology Tube,Negative
 Cost,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Cost,Francesco Turturro,Negative
 Cost,EMJ Oncology,Positive
 UPDATED AstraZeneca,Julie Lakeview,Positive
 UPDATED AstraZeneca,Jane Swift,Positive
 UPDATED AstraZeneca,About Medtech,Positive
 UPDATED AstraZeneca,Olderpreneurs,Positive
 UPDATED AstraZeneca,Truth Studio,Positive
 UPDATED AstraZeneca,FancyFinancy,Positive
 UPDATED AstraZeneca,Financial Carnivores,Positive
 UPDATED AstraZeneca,ZC,Positive
 UPDATED AstraZeneca,MySmallCap,Positive
 UPDATED AstraZeneca,Piggy Bank People,Positive
 UPDATED AstraZeneca,Zack Capp,Positive
 UPDATED AstraZeneca,Portfolio Penny,Positive
 UPDATED AstraZeneca,Grant Beasley,Positive
 UPDATED AstraZeneca,Uri Baruch,Positive
 UPDATED AstraZeneca,Endpoints News,Positive
 UPDATED AstraZeneca,David Coleman,Positive
 UPDATED AstraZeneca,John Carroll,Positive
 New Post,Lymphoma News Today,Negative
 Targeting B cell receptor,Anirban Maitra,Negative
   article,Anirban Maitra,Negative
   article,Andrew Schorr,Negative
   article,ScienceSource Images,Positive
 New Molecularly Targeted Therapeutic,AACR Foundation,Negative
 NonHodgkin Lymphoma,AACR Foundation,Negative
 NonHodgkin Lymphoma,ClinicalTrialsData,Negative
 NonHodgkin Lymphoma,Lymphoma Papers,Negative
 NonHodgkin Lymphoma,Oncology Tube,Negative
 NonHodgkin Lymphoma,"Raul Cordoba, MD, PhD",Negative
 NonHodgkin Lymphoma,Lymphomation.org,Negative
 NonHodgkin Lymphoma,Clinical Pharmacy,Negative
 NonHodgkin Lymphoma,Scott Werntz,Positive
 NonHodgkin Lymphoma,Shawn Watson,Positive
 NonHodgkin Lymphoma,COPD News,Negative
 w mantle cell lymphoma,Trip Database,Negative
 ibrutinib Dr Owen OConnor,ColumbiaCancer,Positive
 FDA Grants Accelerated Approval,Sheila Mayers,Positive
 FDA Grants Accelerated Approval,Lymphoma News Today,Positive
 FDA Grants Accelerated Approval,VHSPL,Positive
 FDA Grants Accelerated Approval,BioNews,Negative
 FDA Grants Accelerated Approval,Krishan Maggon,Negative
 FDA Grants Accelerated Approval,Medical HotSpot,Positive
 drug acalabrutinib Calquence,National Cancer Institute,Negative
 accelerated approval,ASH Clinical News,Negative
 accelerated approval,GRACE,Negative
 accelerated approval,NCICancerTrials,Positive
 accelerated approval,NatureRevClinOncol,Negative
 accelerated approval,OncLive SOSS,Negative
 accelerated approval,OncLive.com,Negative
 accelerated approval,Dr. Andre Goy,Negative
 accelerated approval,Stephen Clark,Positive
 accelerated approval,"Caner Saygin, MD",Negative
 accelerated approval,MPR,Negative
 accelerated approval,HemOnc Today,Positive
 accelerated approval,GoFIR,Negative
 accelerated approval,PharmacyChecker,Negative
 accelerated approval,FDA Oncology,Negative
 accelerated approval,"Pragnesh Panchamvedi, RAC, ERT",Negative
 accelerated approval,Lymphoma Hub,Negative
 accelerated approval,the world of CROs,Negative
 accelerated approval,Jon Angelo,Negative
 kinase inhibitor acalabrutinib,ASH Clinical News,Negative
 El   de octubre,NCI en espa√±ol,Positive
 aprob√≥ acalabrutinib para el tratamiento de adultos con,NCI en espa√±ol,Positive
 Aprenda m√°s,NCI en espa√±ol,Positive
 sobre la,NCI en espa√±ol,Positive
 Accelerated Approval,"dtw Research, Inc",Negative
 Accelerated Approval,Targeted Oncology,Negative
 Accelerated Approval,Thom O'Connor,Positive
 Accelerated Approval,Animal Lover,Positive
 Accelerated Approval,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 Accelerated Approval,Mike van Dulken,Negative
 Accelerated Approval,George Papadopoulos,Positive
 Aliqopa,"dtw Research, Inc",Negative
 Launch,"dtw Research, Inc",Negative
 Launch,CryptoLiveLeak,Negative
 Unbranded Campaign,"dtw Research, Inc",Negative
 Calquence Featured,"dtw Research, Inc",Negative
 Q   Lymphoma SnapShot,"dtw Research, Inc",Negative
 Acalabrutinib amp,Frank Zambrano,Positive
 cure,Frank Zambrano,Positive
 cure,ESH (Haematology),Negative
 cure,Benlazar S.M Amin√©,Negative
 cure,CLL Ireland,Positive
 cure,Blood Journal,Negative
 cure,"Raul Cordoba, MD, PhD",Negative
 cure,CLLSA,Negative
 cure,Thomas Leavitt,Positive
 cure,Joshashland,Positive
 cure,Medical Independent,Positive
 cure,iwCLL,Negative
 Dr OConnor,OncLive.com,Negative
 impair aggregation response,Graham Collins,Negative
 highrisk CLL,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 highrisk CLL,Anna Deveau,Negative
 highrisk CLL,CancerTherapyAdvisor,Negative
 LINFOMA CELLULE MANTELLARI,I Malati Invisibili,Negative
 AcertaAZs Acalabrutinib,PANNA SHARMA,Positive
 HGH response rates,PANNA SHARMA,Positive
 Dr Zelenetz,OncLive.com,Negative
 Dr Zelenetz,OncLive SOSS,Negative
 Dr Zelenetz,Patient Power,Positive
 Potential,OncLive.com,Negative
 Potential,OncLive SOSS,Negative
 Potential,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Positive
 Potential,TumImmTxpapers,Negative
 BGB,OncLive.com,Negative
 BGB,OncLive SOSS,Negative
 BGB,CureHuntr,Negative
 BGB,Lymphoma Hub,Negative
 Dr Brown Discusses Acalabrutinib,OncLive.com,Negative
 Dr Brown Discusses Acalabrutinib,Jason Broderick,Negative
 relapsed refractory Mantle Cell   trial,Lampe & Company,Negative
 MCL phase II,Graham Collins,Negative
 FDA update,Oncology Times,Negative
 Expert,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 Expert,OncLive.com,Negative
 Expert,Crwe World,Negative
 Expert,HAM,Negative
 Expert,Patient Power,Positive
 Expert,Andrew Schorr,Negative
 Expert,Patient Empowerment Network,Positive
 Expert,SpecialtyPTimes,Negative
 Expert,CancerWallonia,Negative
 Expert,CLL_Fightersüéó,Positive
 Expert,McMaster Textbook of Internal Medicine,Positive
 Expert,Targeted Oncology,Negative
 Expert,HemOnc Today,Positive
 Expert,Healio,Negative
 Expert,Lisa Palacios,Negative
 Expert,MD Anderson Leukemia,Negative
 Expert,Oncology Tube,Negative
 Expert,CLL Ireland,Negative
 Expert,Helen Ong,Positive
 Expert,Lymphoma Coalition,Negative
 Acalabrutinib Approval,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 Acalabrutinib Approval,OncLive.com,Negative
 Acalabrutinib Approval,Crwe World,Negative
 Steps,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 Steps,OncLive.com,Negative
 Steps,CLL Ireland,Negative
 Ag,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 delay,Sandy Pond GCP,Positive
 delay,CLLSA,Negative
 delay,John Harrington,Positive
 protocol amendment,Sandy Pond GCP,Positive
 IRB,Sandy Pond GCP,Positive
 sponsor,Sandy Pond GCP,Positive
 ASH   Acalabrutinib,"Fatih Uckun, M.D.",Positive
 Oral Abstract   Read coverage,Lymphoma Hub,Negative
 Chemofree therapy,OncLive.com,Negative
 chemotherapy,OncLive.com,Negative
 chemotherapy,Fleur Peters,Positive
 chemotherapy,Paperbirds_Hematology,Negative
 chemotherapy,medwireNews,Negative
 chemotherapy,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 chemotherapy,"Steven Artandi, MD, PhD",Negative
 chemotherapy,Cancer Health,Negative
 chemotherapy,Michael Hallek,Negative
 chemotherapy,pharmaphorum,Negative
 chemotherapy,The Olde Hippie,Positive
 chemotherapy,"Dr T. Comeau , MD",Negative
 chemotherapy,Garbi√±e Lizeaga,Negative
 chemotherapy,OncologyNurseAdvisor,Positive
 chemotherapy,Hospital Medicine Virtual Journal Club,Positive
 chemotherapy,BibliotecaHUVH. ICS,Positive
 chemotherapy,Dr. Keesha Ewers,Positive
 chemotherapy,CLL Ireland,Positive
 chemotherapy,Cancer Papers,Positive
 chemotherapy,The Medicine Maker,Positive
 chemotherapy,contclin,Positive
 chemotherapy,Science Codex,Negative
 chemotherapy,Mark Kirkpatrick,Positive
 chemotherapy,Vera Marie Reed,Positive
 chemotherapy,üïäüïäüïäüïäüïäüïäüïäüïä,Positive
 chemotherapy,Maggie Baker,Positive
 chemotherapy,Gwen Eve Lewis,Positive
 chemotherapy,PressReleasePoint,Negative
 chemotherapy,Biyoloji,Positive
 chemotherapy,Ajinkya Ambre,Positive
 chemotherapy,‚ö°Ofra Ziv‚ö°,Positive
 chemotherapy,Cancer And I,Negative
 chemotherapy,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 chemotherapy,Nature Reviews Disease Primers,Negative
 chemotherapy,KnotGrumpy,Positive
 chemotherapy,VJHemOnc,Negative
 chemotherapy,Lymphoma Hub,Negative
 chemotherapy,We Work for Health - Pennsylvania,Positive
 chemotherapy,drryna,Positive
 Refractory Mantle Cell Lymphoma,The ASCO Post,Negative
 Refractory Mantle Cell Lymphoma,Crwe World,Negative
 Secondgeneration BTK inhibitor acalabrutinib Calquence AstraZeneca,Encore BioMed,Positive
 kinase inhibitor,Lambda Kappa Sigma,Positive
 Chronic Lymphocytic Leukaemia Trials,RANJAN BUDA.,Positive
 Chronic Lymphocytic Leukaemia Trials,c lark,Positive
 Chronic Lymphocytic Leukaemia Trials,Open Outcrier,Negative
 Chronic Lymphocytic Leukaemia Trials,DWIB Leukaemia Trust,Positive
 Chronic Lymphocytic Leukaemia Trials,Financial Buzz,Negative
 Chronic Lymphocytic Leukaemia Trials,EIN Presswire: Pharmaceutical Newswire,Negative
 Chronic Lymphocytic Leukaemia Trials,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥,Positive
 Chronic Lymphocytic Leukaemia Trials,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥ - Í±¥Í∞ï,Positive
 Chronic Lymphocytic Leukaemia Trials,Business Wire-Health,Negative
 Chronic Lymphocytic Leukaemia Trials,BusinessWireProducts,Negative
 Chronic Lymphocytic Leukaemia Trials,BusinessWire-Science,Negative
 Chronic Lymphocytic Leukaemia Trials,The Pharmaceutical Marketing Group,Negative
 „Äê Bioimpact News,Ê†™Âºè‰ºöÁ§æ„Éê„Ç§„Ç™„Ç§„É≥„Éë„ÇØ„Éà,Positive
 Êñ∞BTKÈòªÂÆ≥Ââ§Acalabrutinib„ÅåÂÜçÁô∫Ê≤ªÁôÇÊäµÊäóÊÄß„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´„ÅÆÂâ≤„Å´Â•èÂäü,Ê†™Âºè‰ºöÁ§æ„Éê„Ç§„Ç™„Ç§„É≥„Éë„ÇØ„Éà,Positive
 Lancet ArticleAcalabrutinib,Mahmoud Aljurf,Negative
 Acalabrutinib Activity,OncLive.com,Negative
 Downstream approach,AdisInsight,Positive
 ability,AdisInsight,Positive
 ability,OncLive.com,Negative
 ability,AbbVie,Positive
 ability,"chadi nabhan MD, MBA, FACP",Negative
 tumoursurvival,AdisInsight,Positive
 pat,AdisInsight,Positive
 le lymphome du manteau,Nicolas Zarjevski,Positive
 rechute ou,Nicolas Zarjevski,Positive
 essai de phase,Nicolas Zarjevski,Positive
 multicentrique,Nicolas Zarjevski,Positive
 CR rate,OncLive.com,Negative
 CR rate,Christopher Steer,Negative
 AstraZenecas acalabrutinib,Siti van der Meij,Positive
 AstraZenecas acalabrutinib,Breaking News,Positive
 AstraZenecas acalabrutinib,Ryan HamNer,Positive
 AstraZenecas acalabrutinib,CLL Society Inc.,Negative
 AstraZenecas acalabrutinib,B. West #sand,Positive
 AstraZenecas acalabrutinib,Brum-Jobs,Positive
 treatment effect,Siti van der Meij,Negative
 treatment effect,Breaking News,Negative
 treatment effect,CEITEC Connect,Negative
 CLL studies,Siti van der Meij,Negative
 CLL studies,Breaking News,Negative
 Refractory Mantle Cell Lymphoma Trial,Yemen News,Positive
 Refractory Mantle Cell Lymphoma Trial,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥,Positive
 Refractory Mantle Cell Lymphoma Trial,Îâ¥Ïä§ÏôÄÏù¥Ïñ¥ - Í±¥Í∞ï,Positive
 Refractory Mantle Cell Lymphoma Trial,BusinessWireProducts,Positive
 Chronic,Neth. Corporate News,Positive
 Chronic,Pharma News,Negative
 Chronic,Crwe World,Positive
 Chronic,J Mol Diagnostics,Positive
 Chronic,Leukemia,Negative
 Chronic,TrialSite News,Positive
 Chronic,OBR,Negative
 Chronic,Hikmat Daghestani,Positive
 Chronic,AbbVie Canada,Negative
 Chronic,Biotech2050,Negative
 Chronic,Celixir,Positive
 Chronic,Penn Medicine News,Negative
 Chronic,New OhioLINK ETDs,Positive
 Chronic,World Wellness,Positive
 Chronic,Financial Buzz,Negative
 Chronic,Plexus Ventures,Negative
 Chronic,IntoxicatedTrader,Negative
 Chronic,CMLHope,Negative
 Chronic,ProPath,Positive
 Chronic,Cancer Papers,Negative
 Chronic,Financescom-stocks,Positive
 AZN Reports Phase III data,StockNews.com,Negative
 AZN Reports data,StockNews.com,Negative
 AstraZenecas Calquence visar potential,Investing.com Sverige üá∏üá™,Positive
 Calquence ¬† acalabrutinib Demonstrates Activity,Doha Insight,Positive
 Relapsed Refractory Mantle Cell Lymphoma Trial,Doha Insight,Positive
 Relapsed Refractory Mantle Cell Lymphoma Trial,Maveric,Positive
 Relapsed Refractory Mantle Cell Lymphoma Trial,Renal Cell Carcinoma,Positive
 Relapsed Refractory Mantle Cell Lymphoma Trial,Drug Delivery News,Positive
 Relapsed Refractory Mantle Cell Lymphoma Trial,ANTELLIS,Positive
 Relapsed Refractory Mantle Cell Lymphoma Trial,Lung Cancer News,Positive
 Relapsed Refractory Mantle Cell Lymphoma Trial,Business Wire-TS,Negative
 Relapsed Refractory Mantle Cell Lymphoma Trial,Cancer News,Positive
 Relapsed Refractory Mantle Cell Lymphoma Trial,The Pharmaceutical Marketing Group,Positive
 Chronic Lymphocytic Leukemia Trials,Financial Buzz,Negative
 Chronic Lymphocytic Leukemia Trials,ANTELLIS,Positive
 Chronic Lymphocytic Leukemia Trials,Crwe World,Negative
 Chronic Lymphocytic Leukemia Trials,BusinessWireProducts,Negative
 Chronic Lymphocytic Leukemia Trials,Business Wire-TS,Negative
 Chronic Lymphocytic Leukemia Trials,BusinessWire-Science,Negative
 Chronic Lymphocytic Leukemia Trials,Stockboard Media Inc,Negative
 Chronic Lymphocytic Leukemia Trials,The Pharmaceutical Marketing Group,Negative
 AstraZeneca amprsquos Calquence acalabrutinib,EIN Presswire: Pharmaceutical Newswire,Positive
 Chronic Lymphocytic Leukemia Trials WILMINGTON DelBUSINESS WIREAstraZeneca,Business Wire-Health,Negative
 Acerta Pharma,Business Wire-Health,Positive
 Acerta Pharma,AstraZenecaUS,Negative
 Acerta Pharma,Sarcasm Bot,Positive
 Acerta Pharma,steve bagley,Positive
 hematology research development center,Business Wire-Health,Positive
 excellence,Business Wire-Health,Positive
 excellence,Alicia Maston Coffin,Positive
 CAMBRIDGE EnglandBUSINESS WIREAstraZeneca,Business Wire-Health,Negative
 haematology research development centre,Business Wire-Health,Positive
 BusinessWire,The Pharmaceutical Marketing Group,Positive
 Acalabrutinibobinotuzumab,Dr. Erel Joffe,Positive
 stLampRR CLL    CR,Dr. Erel Joffe,Positive
 PR,Dr. Erel Joffe,Positive
 PR,Benlazar S.M Amin√©,Negative
 PR,Daniel,Positive
 PR,"Raul Cordoba, MD, PhD",Negative
 ibrutinibR,Dr. Erel Joffe,Positive
 yPFS,Dr. Erel Joffe,Positive
 IR,Dr. Erel Joffe,Positive
 IR,Toby Eyre,Negative
 IR,"Caner Saygin, MD",Negative
 Watch Dr Neil Berinstein,NE Live,Negative
 ph   ACELY study,NE Live,Negative
 ab,NE Live,Negative
 ab,AbbVie Deutschland,Negative
 Acalabrutinib Yields,Swallow This - The War On Cancer! üò∑,Positive
 RelapsedRefractory Mantle Cell Lymphoma   Cancer Therapy Advisor,Swallow This - The War On Cancer! üò∑,Positive
 Relapsed Refractory Mantle Cell Lymphoma T,Financial Buzz,Negative
 ¬Æ acalabrutinib Demonstrates Activity,Financial Buzz,Negative
 ¬Æ acalabrutinib Demonstrates Activity,Crwe World,Negative
 ¬Æ acalabrutinib Demonstrates Activity,Business Wire-Health,Negative
 ¬Æ acalabrutinib Demonstrates Activity,BusinessWireProducts,Negative
 ¬Æ acalabrutinib Demonstrates Activity,The Pharmaceutical Marketing Group,Negative
 AZN    AstraZeneca Announces CALQUENCE,Maveric,Positive
 phase II ACELY trial,Clarivate Cortellis,Negative
 RR MCL ORR,Clarivate Cortellis,Negative
 Drugs amp,Giuseppe Michieli,Negative
 Pharma Cos News AstraZeneca,Giuseppe Michieli,Negative
 acalabrutinib dem,Giuseppe Michieli,Negative
 Refractory Mantle,EIN Presswire: Pharmaceutical Newswire,Negative
 AstraZenecas CALQUENCE√Ç acalabrutinib,Renal Cell Carcinoma,Negative
 AstraZenecas CALQUENCE√Ç acalabrutinib,Drug Delivery News,Negative
 AstraZenecas CALQUENCE√Ç acalabrutinib,Lung Cancer News,Negative
 AZN Reveals,CRWE News Wire,Positive
 Demonstrates Activity,Neco‚Ñ¢,Positive
 Demonstrates Activity,Stockboard Media Inc,Negative
 Demonstrates Activity,Odi Bruckman,Negative
 RR Mantle Cell Lymphoma Trial,Neco‚Ñ¢,Positive
 RR Mantle Cell Lymphoma Trial,Odi Bruckman,Negative
   AstraZeneca Calquence acalabrutinib,ANTELLIS,Positive
   Acalabrutinib data,Zachary McLellan,Positive
   news,Lung Cancer News,Positive
   news,COPD News,Positive
   news,Diagnostics News,Negative
   news,VJHemOnc,Negative
   news,CLL Society Inc.,Negative
   news,Danielle Ternyila,Positive
   news,Targeted Oncology,Negative
   news,Michele Nadeem-Baker,Positive
   news,Patient Power,Positive
   news,Swine Flu News,Positive
 Tri,Crwe World,Negative
 Relapsed Refractory Mantle Cell Lymphoma Trial WILMINGTON DelBUSINESS WIREAstraZeneca,Business Wire-Health,Negative
 Relapsed Refractory Mantle Cell Lymphoma Trial CAMBRIDGE,Business Wire-Health,Negative
 EnglandBUSINESS WIREAstraZeneca Acerta Pharma,Business Wire-Health,Negative
   AstraZenecas Calquence acalabrutinib Demonstrates Activity,Cancer News,Negative
   AstraZenecas CALQUENCE√Ç acalabrutinib Demonstrates Activity,Cancer News,Negative
 Michael Wang,Marek Trneny,Positive
 relapsed MCL,"David Dahan, PhD",Positive
   investors,"Matthew Matasar, MD",Positive
 acalabrutinib talk,"Matthew Matasar, MD",Positive
 session,"Matthew Matasar, MD",Positive
 session,VJHemOnc,Positive
 session,ESH (Haematology),Negative
 session,Taylor Lab UM,Negative
 session,Orchard Primary Academy Nursery,Negative
 session,Katrina Sondermann,Positive
 session,Dr. Antonia V.,Positive
 session,Toby Eyre,Negative
 session,Christian Reinhardt,Positive
 session,The Lancet Haematology,Negative
 session,School of Cancer & Pharmaceutical Sciences,Positive
 session,LyLe Foreningen,Negative
 session,Beth Torr,Positive
 session,LymphomaAction,Negative
 session,AssistRx,Positive
 session,Marta Crespo,Negative
 session,Lymphoma Hub,Negative
 session,CML AdvocatesNetwork,Positive
 session,Patient Empowerment Network,Negative
 session,Patient Power,Negative
 Rude,"Matthew Matasar, MD",Positive
 MCL ORR,Graham Collins,Negative
 CRR,Graham Collins,Negative
 Lugano,Graham Collins,Negative
 Lugano,Kompetenznetz Maligne Lymphome e.V.,Negative
 Cheson,Graham Collins,Negative
 relapsed    study Dr Wang,Carla Casulo,Positive
 amp CR,Carla Casulo,Positive
 RR MCL   CR   PR,Dr. Erel Joffe,Positive
 MCL ACELY Good BTK,"Matthew Matasar, MD",Positive
 ITK inh,"Matthew Matasar, MD",Positive
 N,"Matthew Matasar, MD",Positive
 N,Cancer Journal,Positive
 N,DR NAVIN CH. JOSHI,Positive
 Acalabrutinib Obat Baru Untuk Terapi Lymphoma Sel Mantel,Majalah Farmasetika,Positive
 Paper Efficacy,"Raul Cordoba, MD, PhD",Negative
 Monotherapy,"Raul Cordoba, MD, PhD",Negative
 Monotherapy,Chan Cheah,Negative
 Monotherapy,1stOncology,Negative
 Monotherapy,Dr. Mahesh Jain,Negative
 Monotherapy,Curatio Technologies,Negative
 RelapsedRefractory Mantle Cell,"Raul Cordoba, MD, PhD",Negative
 RelapsedRefractory Mantle Cell,Pharmacutical Daily,Negative
 ACELY Study,"Raul Cordoba, MD, PhD",Negative
 Commitment,Renal Cell Carcinoma,Negative
 Commitment,Drug Delivery News,Negative
 Commitment,Cancer News,Negative
   American Society,Renal Cell Carcinoma,Negative
   American Society,Drug Delivery News,Negative
   American Society,Cancer News,Negative
   American Society,Paperbirds_Hematology,Positive
   American Society,Patient Power,Negative
   American Society,Anna Deveau,Negative
 Hematology Annual Meeting,Renal Cell Carcinoma,Negative
 Hematology Annual Meeting,Drug Delivery News,Negative
 Hematology Annual Meeting,Pharma News,Negative
 Hematology Annual Meeting,IMPharma News,Negative
 Hematology Annual Meeting,Stock Titan,Negative
 data presentation,Renal Cell Carcinoma,Negative
 data presentation,Drug Delivery News,Negative
 Hematology Annual Meeting data presentation,Cancer News,Negative
 Hale Plus Hearty Calquence,Haleplushearty.org,Negative
 Meet Peninsula company,San Francisco Business Times,Positive
 Meet Peninsula company,SFBTRileyMcD,Positive
 Meet Peninsula company,Riley Guti√©rrez McDermid,Positive
 st   drug win,San Francisco Business Times,Positive
 st   drug win,SFBTRileyMcD,Positive
 st   drug win,Riley Guti√©rrez McDermid,Positive
 Ê∑ãÂ∑¥Áò§Êñ∞ËçØÂä†ÈÄüËé∑ÊâπÔºåÁºìËß£ÁéáÔºÖ‰ª•‰∏äÊó•ÂâçÔºåÁæéÂõΩFDAÂÆ£Â∏ÉÂä†ÈÄüÊâπÂáÜÈòøÊñØÂà©Â∫∑ÔºàAstraZenecaÔºâÁöÑCalquenceÔºàacalabrutinibÔºâÔºåÁî®‰∫éÊ≤ªÁñóÁΩπÊÇ£Â•óÁªÜËÉûÊ∑ãÂ∑¥Áò§Ôºàmantle,ÂÅ•Â∫∑Êê¨ËøêÂ∑•,Positive
 cell lymphomaÔºâ‰∏îÊõæÊé•ÂèóËøáËá≥Â∞ë,ÂÅ•Â∫∑Êê¨ËøêÂ∑•,Positive
 FDA Approves Acalabrutinib Calquence,The Hindu Patrika,Positive
 FDA Approves Acalabrutinib Calquence,DOCTOR MENDOZA CANCER NEWS,Positive
 FDA Approves Acalabrutinib Calquence,balaji jegannathan,Positive
 FDA Approves Acalabrutinib Calquence,Encore BioMed,Positive
 FDA Approves Acalabrutinib Calquence,ehealthandfitness,Positive
 FDA Approves Acalabrutinib Calquence,GEDEFO,Negative
 FDA Approves Acalabrutinib Calquence,Bronx Voice,Positive
 FDA Approves Acalabrutinib Calquence,osakahiro,Positive
 FDA Approves Acalabrutinib Calquence,UKiwiS,Negative
 FDA Approves Acalabrutinib Calquence,Tom,Negative
 FDA Approves Acalabrutinib Calquence,Mens Sexual Health,Positive
 FDA Approves Acalabrutinib Calquence,Pharm Digest,Negative
 FDA Approves Acalabrutinib Calquence,Junaid Hussain,Positive
 Lymphoma RX,Newhard Pharmacy,Positive
 Acalabrutinib MCL Approval,"Mike Thompson, MD, PhD, FASCO",Negative
 Acalabrutinib MCL Approval,Phil Talamo,Negative
 Acalabrutinib MCL Approval,OncLive.com,Negative
 Acalabrutinib MCL Approval,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 Sequencing Questions,"Mike Thompson, MD, PhD, FASCO",Negative
 Sequencing Questions,Phil Talamo,Negative
 Sequencing Questions,OncLive.com,Negative
 Sequencing Questions,SeqComplete,Positive
 Sequencing Questions,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 Angelica Welch,"Mike Thompson, MD, PhD, FASCO",Negative
 Dr O‚ÄôConnor,Biotech2050,Negative
 guy,Biotech2050,Negative
 guy,Dana,Positive
 guy,ùì¢ùì∂ùì™ùìµùìµ1ùìµùì≠ùîÇ No FBR Lists Please,Positive
 guy,ü•ÄLŒ±œÖ…æŒπ D MŒπ Ö Ö“Ω…æ‚öò,Positive
 armamentarium,OncLive.com,Positive
 armamentarium,Targeted Oncology,Negative
 armamentarium,Lymphoma Hub,Negative
    presents,Chan Cheah,Negative
 rr mantle cell lymphoma,Chan Cheah,Negative
 median,Chan Cheah,Negative
 Delaney Clause,Past Daily,Positive
     Acalabrutinib MCL Approval,SeqComplete,Positive
 Wang et,Graham Collins,Negative
 al   acalabrutinib mono,Graham Collins,Negative
 mo PFS,Graham Collins,Negative
 RR mantle cell,Graham Collins,Negative
 Major improvement,Graham Collins,Negative
 JR Brown,Dr.Alberto Mussetti,Negative
 Acalabrutinib efficace nel linfoma mantellare resistente o recidivante,Giuseppe Giannini,Positive
 FDA Approves,Hematopoiesis News,Negative
 FDA Approves,New Drug Approvals,Positive
 FDA Approves,Drugs.com,Positive
 FDA Approves,"Raul Cordoba, MD, PhD",Negative
 FDA Approves,vincenzo abruscato,Positive
 FDA Approves,Plexus Ventures,Positive
 FDA Approves,Christopher Steer,Positive
 FDA Approves,Dr. Sujie Tang,Positive
 FDA Approves,1stOncology,Negative
 PreviouslyTreated Mantle Cell,Hematopoiesis News,Negative
 PreviouslyTreated Mantle Cell,Oncology Times,Negative
 FDA Approves BTK Inhibitor Calquence,"Carol Evans, MD",Positive
 FDA Approves BTK Inhibitor Calquence,UKiwiS,Negative
 FDA Approves New Treatment,Cancer Health,Positive
 BMO AZN Calquence Acalabrutinib,dough,Negative
 MCL Label,dough,Negative
 Linfoma de C√©lulas,Medicsupply,Positive
 Manto,Medicsupply,Positive
 CBC Test,Dean Celia,Positive
 Office,Dean Celia,Positive
 Use Calquence,Dean Celia,Positive
 Mantle Cell Lymphoma GCSF,Dean Celia,Positive
 Priming,Dean Celia,Positive
 amp ¬†¬† ClinicalEdg,Dean Celia,Positive
 „Äê „Éã„É•„Éº„Çπ,„Éü„ÇØ„ÇπÁ∑®ÈõÜÈÉ®,Positive
 MCLÊ≤ªÁôÇËñ¨„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÇíÊâøË™ç Á±≥È£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅØÊúàÊó•„ÄÅËã±„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Á§æ„ÅÆ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´ÔºàMCLÔºâÊ≤ªÁôÇËñ¨Calquence„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÇíÊâøË™ç„Åó„Åü„ÄÇÈÅ©ÂøúÁóá„ÅØ„ÄÅÊàê‰∫∫„Å´„Åä„Åë„ÇãÂ∞ë„Å™„Åè„Å®„ÇÇ„Å§‰ª•‰∏ä„ÅÆÂèóÁôÇÊ≠¥„ÅÆ„ÅÇ„Çã,„Éü„ÇØ„ÇπÁ∑®ÈõÜÈÉ®,Positive
 Á±≥FDA „ÄÄ MCLÊ≤ªÁôÇËñ¨„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÇíÊâøË™ç Á±≥È£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅØÊúàÊó•„ÄÅËã±„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Á§æ„ÅÆ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´ÔºàMCLÔºâÊ≤ªÁôÇËñ¨Calquence„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÇíÊâøË™ç„Åó„Åü„ÄÇÈÅ©ÂøúÁóá„ÅØ„ÄÅÊàê‰∫∫„Å´„Åä„Åë„ÇãÂ∞ë„Å™„Åè„Å®„ÇÇ„Å§,MEDWAVE,Negative
 Calquence Treatment,CancerConnect,Negative
 Linfoma Mantellare Acalabrutinib,Salutedomani,Positive
 Linfoma Mantellare Acalabrutinib,Derma News OK,Positive
 Linfoma Mantellare Acalabrutinib,Antonio Caperna,Positive
 Linfoma Mantellare Acalabrutinib,saluteH24.com,Positive
 di AstraZeneca approvato,Salutedomani,Negative
 dall‚ÄôFDA,Salutedomani,Negative
   approves,Pharma Journalist,Positive
   approves,Journal of the @NCCN,Negative
   approves,Lymphoma Research Foundation,Positive
   approves,"Bichoy Gabra, R.Ph., Ph.D.",Negative
   approves,CancerWallonia,Negative
 FDA grants,Hlthnews,Negative
 FDA grants,dario pasqualini,Positive
 FDA grants,Medical Microbiology,Positive
 FDA grants,Talbot Research Library & Media Services,Positive
 FDA grants,timelivenews,Positive
 FDA grants,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 FDA grants,Share News,Positive
 FDA grants,Richard Staines,Positive
 FDA grants,Marco Ricci,Positive
 FDA grants,pharmaphorum,Negative
 FDA grants,IPRX,Positive
 FDA grants,Ida Sooks ‚úàÔ∏è,Positive
 FDA grants,Sharecast.com,Negative
 FDA grants,Oncology Board,Negative
 FDA grants,European Pharmaceutical Review,Negative
 FDA grants,Roche,Negative
 mantle cell lymphoma ecancer,Hlthnews,Negative
 FDA Approves Calquence acalabrutinib,Hlthnews,Negative
 FDA Approves Calquence acalabrutinib,Newmoney210,Negative
 FDA Approves Calquence acalabrutinib,Medicalnewser.com,Negative
 FDA Approves Calquence acalabrutinib,IntoxicatedTrader,Negative
 RxWiki,SchwietermanPharmacy,Positive
 RxWiki,tristatemedicalgroup,Negative
 RxWiki,PRINCE ADEKOYA,Negative
 RxWiki,Marcrom's Pharmacy,Negative
 RxWiki,Custom Compounding,Positive
 RxWiki,Horseshoe Health & M,Negative
 RxWiki,The Medicine Shoppe,Negative
 RxWiki,Greenwood Drug,Negative
 RxWiki,Medicine To Go,Negative
 RxWiki,Greenbrier Pharmacy,Positive
 RxWiki,Sam's Health Mart,Positive
 RxWiki,Brehme Drug,Positive
 RxWiki,Food City RX Marion,Negative
 RxWiki,Crown Pharmacy,Positive
 RxWiki,LibertyHillPharmacy,Positive
 RxWiki,Hopkinton Drug,Negative
 RxWiki,Delran Pharmacy,Positive
 RxWiki,Fox Drug of Torrance,Negative
 RxWiki,Cascade Custom RX,Positive
 RxWiki,Coastal Pharmacy,Positive
 New Lymphoma Rx,Kaup Pharmacy,Positive
 New Lymphoma Rx,Bengal Rx,Positive
 New Lymphoma Rx,Churchill Pharmacy,Positive
 New Lymphoma Rx,Phipps Pharmacy,Positive
 New Lymphoma Rx,CDS #10 Pharmacy,Positive
 New Lymphoma Rx,Medicine Shoppe 1822,Positive
 New Lymphoma Rx,Sullivan'sGifts,Positive
 New Lymphoma Rx,Joseph Pharmacy,Positive
 New Lymphoma Rx,Greenhill Pharmacy,Positive
 New Lymphoma Rx,Scott Pharmacy,Positive
 New Lymphoma Rx,Hartzells Pharmacy,Positive
 New Lymphoma Rx,Valley Pharmacy,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCALQUENCEÔºâ„ÄÅÊó¢Ê≤ªÁôÇ„ÅÆ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´ÔºàMCLÔºâÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„Çà„ÇäÊâøË™ç„ÇíÂèñÂæó,e„Éã„É•„Éº„Çπ - „Éï„É™„Éº„É©„Ç§„Çø„Éº/„Éñ„É≠„Ç¨„Éº„ÅÆ„Åü„ÇÅ„ÅÆË®ò‰∫ã„Éç„ÇøÔºàeÈÄö‰ø°Á§æÔºâ,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCALQUENCEÔºâ„ÄÅÊó¢Ê≤ªÁôÇ„ÅÆ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´ÔºàMCLÔºâÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„Çà„ÇäÊâøË™ç„ÇíÂèñÂæó,Ëñ¨Ââ§Â∏´„Éã„É•„Éº„ÇπÈÖç‰ø°„Åè„Çì,Negative
     Nieuws uit PW FDA geeft,Northeast Apotheek,Positive
 aan acalabrutinib,Northeast Apotheek,Positive
 aan acalabrutinib,Northeast Personeel,Positive
 aan acalabrutinib,PW,Positive
 PW,Northeast Personeel,Positive
 previouslytreated mantle cell lymphoma amp,McKesson Corporation,Negative
 Biologics,McKesson Corporation,Negative
 Biologics,Pharmacy News & Research,Positive
 Biologics,CRO Contract Res.,Negative
 Biologics,Drug Delivery News,Negative
 Biologics,Renal Cell Carcinoma,Negative
 Biologics,Business Wire-Health,Negative
 Biologics,Biologics by McKesson,Positive
 Biologics,re-how.net,Negative
 FDA geeft,PW,Positive
 „Éó„É¨„Çπ„É™„É™„Éº„Çπ„Éª„Çø„Ç§„Éà„É´„É™„Çπ„Éà,MEDWAVE,Negative
 „Äê „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„Äë„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñCALQUENCE„ÄÅÊó¢Ê≤ªÁôÇ„ÅÆ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´MCLÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄFDA„Çà„ÇäÊâøË™ç„ÇíÂèñÂæó,MEDWAVE,Negative
   Grants Accelerated Approval,AJPB_Journal,Positive
 ‚óÜ Ê•≠Áïå„Éã„É•„Éº„Çπ,„ÄêËñ¨Ââ§Â∏´Âêë„Åë„ÄëÂêÑÁ®Æ„ÅäÂΩπÁ´ã„Å°ÊÉÖÂ†±,Positive
 ‚óÜ „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCALQUENCEÔºâ„ÄÅÊó¢Ê≤ªÁôÇ„ÅÆ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´ÔºàMCLÔºâÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶    Ëñ¨Ââ§Â∏´,„ÄêËñ¨Ââ§Â∏´Âêë„Åë„ÄëÂêÑÁ®Æ„ÅäÂΩπÁ´ã„Å°ÊÉÖÂ†±,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCALQUENCEÔºâ„ÄÅÊó¢Ê≤ªÁôÇ„ÅÆ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´ÔºàMCLÔºâÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶,„É¢„Éã„Çø„Éº„Çµ„É≥„Éó„É´Ë©¶„ÅóÈöä,Positive
 PR TIMES „Éó„É¨„Çπ„É™„É™„Éº„Çπ,Ëñ¨Ââ§Â∏´„Éã„É•„Éº„ÇπÈÖç‰ø°„Åè„Çì,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCALQUENCEÔºâ„ÄÅÊó¢Ê≤ªÁôÇ„ÅÆ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´ÔºàMCLÔºâÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩÈ£üÂìÅÂåªËñ¨,PR TIMES„Éì„Ç∏„Éç„Çπ,Positive
 Congrats,The Galien Foundation,Positive
 Congrats,Julie Papanek Grant,Positive
 Congrats,Josie B.,Negative
 Congrats,Anthony Mato,Negative
 Congrats,Helix BioPharma,Positive
 Congrats,"Brand Institute, Inc",Negative
 Congrats,Duke Hematologic Malignancies & Cellular Therapy,Negative
 Congrats,Michael Hallek,Negative
 Congrats,Dr. Jean Fan,Positive
 Congrats,UMN DOM Research,Positive
 Congrats,CLL_Fightersüéó,Negative
 Congrats,Exec Director VCCC,Positive
 Congrats,james smith,Positive
 Congrats,"Raul Cordoba, MD, PhD",Negative
 Congrats,BluePrint Orphan,Positive
 Congrats,QxMD | Decision Support & Quality Improvement,Positive
 Congrats,Connie Erpelding,Positive
 Congrats,Tapan Kadia,Negative
 Congrats,Matthew Kauffman,Negative
 Congrats,This Girl Can,Positive
 Congrats,Anita Shaffer,Positive
 ndgen BTK inhibitor,NatureRevClinOncol,Negative
    approval,"Mike Thompson, MD, PhD, FASCO",Negative
 gt L mantle cell lymphoma,"Mike Thompson, MD, PhD, FASCO",Negative
 approvalsWatch News Acalabrutinib,medwireNews,Negative
 Pharma news,Evaluate Pharma,Positive
 Nov     comment,Evaluate Pharma,Positive
 ÿßŸÑÿ∫ÿ∞ÿßÿ° Ÿà ÿßŸÑÿØŸàÿßÿ° ÿßŸÑÿπÿßŸÑŸÖŸäÿ© ÿ™ŸàÿßŸÅŸÇ ÿπŸÑŸâ ÿØŸàÿßÿ° acalabrutinibŸÑÿπŸÑÿßÿ¨ ÿ£ÿ≠ÿØ ÿ£ŸÜŸàÿßÿπ ÿ≥ÿ±ÿ∑ÿßŸÜÿßÿ™ ÿßŸÑÿØŸÖ ÿßŸÑŸÜÿßÿØÿ±ÿ© mantle cell lymphoma,ÿØ. ŸäŸàÿ≥ŸÅ ÿ¥ŸÖÿ≥ ÿßŸÑÿØŸäŸÜ,Positive
   Congratulations,NTRC,Positive
   Congratulations,cnag-crg,Negative
 Organon Kinase Immunology Team members,NTRC,Positive
 alcalabrutinib Gene expression analysis,NTRC,Positive
 selectivity,NTRC,Positive
 FDA otorg√≥ la,APRHIFAC,Positive
 acelerada de acalabrutinib Calquence para linfoma de c√©lulas del manto,APRHIFAC,Positive
 Behandlung von Mantelzellenlymphomen bei Erwachsenen,@INSIGHTHealth,Positive
 ÂÜçÁô∫Èõ£Ê≤ªÊÄß„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´„ÅÆÊñ∞Ëñ¨„Åß„ÅÇ„Çã„Éñ„É´„Éà„É≥„ÉÅ„É≠„Ç∑„É≥„Ç≠„Éä„Éº„ÇºBTK,„É¢„Éã„Çø„Éº„Çµ„É≥„Éó„É´Ë©¶„ÅóÈöä,Positive
 „Åå„ÇìÊÉÖÂ†±„Çµ„Ç§„Éà„Äå„Ç™„É≥„Ç≥„É≠,Ëñ¨Ââ§Â∏´„Éã„É•„Éº„ÇπÈÖç‰ø°„Åè„Çì,Negative
 st√§mmer AstraZeneca vill,Investing.com Sverige üá∏üá™,Positive
 f√∂r Calquence,Investing.com Sverige üá∏üá™,Positive
 Acalabrutinib Receives‚ÄòBreakthrough Therapy Designation‚Äôin Mantle Cell Lymphoma,Medindia.net,Negative
 FDA otorg√≥ la aprobaci√≥n acelerada de acalabrutinib Calquencepara,APRHIFAC,Positive
 expectations,OncLive SOSS,Negative
 expectations,Proactive,Positive
 expectations,John,Negative
 expectations,Andrew Merron,Positive
 expectations,Andrew Scott,Positive
 expectations,WheelieDealer,Negative
 expectations,VJHemOnc,Negative
 PDUFA,OncLive SOSS,Negative
 PDUFA,John Carroll,Positive
 Calquence –∫–æ–º–ø–∞–Ω–∏–∏ AstraZeneca –ï—â–µ,M2-Interior.ru,Positive
 –Ω–∞,M2-Interior.ru,Positive
 Ibruvica,Bursatil Biotech,Positive
 JNJ,Bursatil Biotech,Positive
 JNJ,Beacon Targeted Therapies,Positive
 JNJ,CureHuntr,Negative
 JNJ,TrialBulletin,Negative
 JNJ,1stOncology,Positive
 JNJ,Mary Caffrey,Positive
 JNJ,Bionest Partners,Negative
 JNJ,E Lambrechts,Negative
 JNJ,David Durand,Positive
   Research Pharmacodynamics,Cytokine News,Positive
 AstraZeneca Calquence secures FDA approval,PharmaLeaders,Positive
 AstraZeneca Calquence secures FDA approval,pharmabr,Negative
 mantle cell ¬† lymphoma,PharmaLeaders,Positive
 AstraZenecas   siphon share,Advera Health,Negative
 JampJs,Advera Health,Negative
 AstraZenecas drug Calquence,RxSpark,Positive
 Acalabrutinib Receives¬ëBreakthrough Therapy,Drugnews.in,Negative
 source esmo,VHSPL,Positive
 Pharmacodynamics,Cancer Papers,Negative
 Acalabrutinib ReceivesBreakthrough Therapy Designationin Mantle Cell Lymphoma,Gendron Recherche,Negative
 Acalabrutinib ReceivesBreakthrough Therapy Designationin Mantle Cell Lymphoma,Selvyn Kennedy,Positive
 ABBV sues,Odi Bruckman,Negative
 patent royalties,Odi Bruckman,Negative
 CIENCIASMEDICASNEWS Calquence,Victor Norberto Cerasale Morteo,Negative
 Mantle Cell Lymphoma Medli,Victor Norberto Cerasale Morteo,Negative
 Acalabrutinib Gains FDA Approval,Heather Swift Morrison,Negative
 Acalabrutinib Gains FDA Approval,Lucie Kaisin,Positive
 Calquence   Drug Store News,MedFirst - MedComms,Positive
 FDA Aprova Acalabrutinib para Linfoma Folicular,Fernando Medina,Positive
 AZN Approval,David Durand,Positive
 mantle zone lymphoma drug Acalabrutinib,David Durand,Positive
 Mantle h√ºcreli lenfoma,Galeri Haber,Positive
 i√ßin acalabrutinib FDA onayƒ± aldƒ±,Galeri Haber,Positive
 Read s article FDA,MyOncoPath,Positive
 acalabrutinib   mantle cell,MyOncoPath,Positive
 David SalazarThe mantle cell lymphoma treatment,Pharmacy News & Research,Positive
 David SalazarThe mantle cell lymphoma treatment,Lung Cancer News,Negative
         ƒülƒ±khaber,"Mustafa √ñzdoƒüan, MD",Positive
 FDA Approves CALQUENCE Acalabrutinib,Amer Coll Clin Pharm,Positive
 acalabrutinib Calquencenew treatment,Farmacia Nenna,Positive
 acalabrutinib Calquencenew treatment,Antonio Caperna,Positive
 acalabrutinib Calquencenew treatment,Salutedomani,Negative
 acalabrutinib Calquencenew treatment,saluteH24.com,Positive
 acalabrutinib Calquencenew treatment,Derma News OK,Positive
 Diplomat,1stOncology,Negative
 Diplomat,Financial Buzz,Positive
 Diplomat,Diplomat,Positive
 Diplomat,Cell Therapy News,Negative
 Diplomat,Google  News,Positive
 Diplomat,ZoZoTrader,Positive
 Diplomat,COPD News,Negative
 Dispense,1stOncology,Negative
 Dispense,Cell Therapy News,Negative
 Dispense,Financial Buzz,Negative
 Dispense,Google  News,Positive
 Dispense,Diplomat,Negative
 Dispense,Pharmaceutical News,Negative
 Dispense,ZoZoTrader,Positive
 PreviouslyTreated   DPLO,1stOncology,Negative
 Cancer Calquence acalabrutinibFDA,Treatment Scores,Positive
 FDA Approves AZ,1stOncology,Negative
 PreviouslyTreated,1stOncology,Negative
 USAs FDA medger p√•skyndat godk√§nnande f√∂r cancerl√§kemedlet acalabrutinib,Lars √ñhrstr√∂m,Positive
 La FDA,Cristina Kroll,Positive
 La FDA,PharmaBiz,Positive
 un nuevo oncol√≥gico de AstraZeneca,Cristina Kroll,Positive
 un nuevo oncol√≥gico de AstraZeneca,PharmaBiz,Positive
 √≥n   √≥gico,Cristina Kroll,Positive
 √≥n   √≥gico,PharmaBiz,Positive
 tcoPqIppOVx,PharmaBiz,Positive
 Calquence –∫–æ–º–ø–∞–Ω–∏–∏,–†–∞–∑–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω—ã–π —Å–∞–π—Ç UWDESHKI,Positive
 Calquence gegen MCLAstraZeneca bekommt,APOTHEKE ADHOC,Positive
 Zulassung f√ºr Calquence,APOTHEKE ADHOC,Positive
 Avella,Sudam Walekar,Positive
 Avella,IntoxicatedTrader,Negative
 Avella,Newmoney210,Negative
 CALQUENCE acalabrutinib,Sudam Walekar,Positive
 CALQUENCE acalabrutinib,StockNews.com,Negative
 wwwbiospectrumasiacom,Sudam Walekar,Positive
   nets ultrafast approval,Riya Verma,Positive
 Imbruvica rival CalquencetcoMXQxkJkVfy,Riya Verma,Positive
 Mantle Cell Lymphoma Title Calquence,Fitness Diet,Positive
 Mantle Cell Lymphoma Category,Fitness Diet,Positive
 Potential Lymphoma Blockbuster Calquence,Pharma_Processes,Positive
 Potential Lymphoma Blockbuster Calquence,SDBN,Positive
 Potential Lymphoma Blockbuster Calquence,Pharma Commons,Negative
 Potential Lymphoma Blockbuster Calquence,LucidQuest,Positive
 Potential Lymphoma Blockbuster Calquence,Dr Timos Papagatsias,Positive
 Potential Lymphoma Blockbuster Calquence,Biotech World,Positive
 Potential Lymphoma Blockbuster Calquence,BioCalifornia,Negative
 Dispense CALQUENCE,Financial Buzz,Negative
 Dispense CALQUENCE,Diplomat,Negative
 PreviouslyTreated Mantle Cell Lymphoma,Financial Buzz,Negative
 PreviouslyTreated Mantle Cell Lymphoma,Josh Kunken,Positive
 PreviouslyTreated Mantle Cell Lymphoma,Diplomat,Negative
 PreviouslyTreated Mantle Cell Lymphoma,Pharmacy News & Research,Positive
 PreviouslyTreated Mantle Cell Lymphoma,Lung Cancer News,Negative
 PreviouslyTreated Mantle Cell Lymphoma,CRO Contract Res.,Negative
 PreviouslyTreated Mantle Cell Lymphoma,Drug Delivery News,Negative
 PreviouslyTreated Mantle Cell Lymphoma,Renal Cell Carcinoma,Negative
 PreviouslyTreated Mantle Cell Lymphoma,Cancer News,Negative
 PreviouslyTreated Mantle Cell Lymphoma,The Pharmaceutical Marketing Group,Negative
 PreviouslyTreated Mantle Cell Lymphoma,Business Wire-Health,Negative
 DPLO Diplomat Pharmacy,Briefing.com,Negative
 Êñ∞ÁùÄË®ò‰∫ãFDA Approves BTK Inhibitor Calquence,Ëñ¨Ââ§Â∏´„Ç¶„Ç©„ÉÉ„ÉÅ„ÄÄÁõ∏‰∫í„Éï„Ç©„É≠„Éº,Negative
 Mantle Cel,Ëñ¨Ââ§Â∏´„Ç¶„Ç©„ÉÉ„ÉÅ„ÄÄÁõ∏‰∫í„Éï„Ç©„É≠„Éº,Negative
 Order,Pharmacy News & Research,Positive
 Order,CRO Contract Res.,Negative
 Order,Drug Delivery News,Negative
 Order,Renal Cell Carcinoma,Negative
 Order,Cancer News,Negative
 Order,The Pharmaceutical Marketing Group,Negative
 Order,Business Wire-Health,Negative
 SDBN Feed AstraZeneca,SDBN,Positive
 SDBN,SDBN,Positive
   news CALQUENCE√Ç acalabrutinib,Lung Cancer News,Negative
 Acalabrutinib approval,MD Anderson Cancer Center,Negative
 Peninsula company,Vicki Thompson,Positive
 Peninsula company,John Stedman,Positive
 Peninsula company,Julian Chen,Positive
 Peninsula company,Kim Gerhardt,Positive
 Peninsula company,Robert Robledo,Positive
 Peninsula company,Kursad Turksen,Positive
 Peninsula company,San Francisco agent,Positive
 Peninsula company,Ron Leuty,Positive
 Peninsula company,Biotech Day,Positive
 Peninsula company,Miles Frenzetta,Positive
 Peninsula company,Nevo Financial,Positive
   CALQUENCE√Ç acalabrutinib,CRO Contract Res.,Negative
   CALQUENCE√Ç acalabrutinib,Cancer News,Negative
 Biologics Inc,The Pharmaceutical Marketing Group,Negative
 Biologics Inc,Cord Blood News,Negative
 Biologics Inc,dlvr health,Negative
 Biologics Inc,Business Wire-Health,Negative
 AstraZenecas mantle cell lymphoma drug Calquence,buzz lightyear,Positive
 Mantle Cell LymphomaSource HealthDayRelated MedlinePlus Pages Lymphoma,Mona Mipiso,Positive
 Calquence approval,BioWorld,Positive
 st cancer drug win,Julian Chen,Positive
 st cancer drug win,Kim Gerhardt,Positive
 st cancer drug win,San Francisco agent,Positive
 st cancer drug win,Miles Frenzetta,Positive
 st cancer drug win,Nevo Financial,Positive
 tx,Dr. Andre Goy,Positive
 tx,Duke Hematologic Malignancies & Cellular Therapy,Negative
 tx,"Andrew Johns, MD",Positive
 tx,"Amber Koehler, PA-C",Negative
 tx,MDCalc.com,Positive
 tx,CAPhO,Positive
 w mantle cell,Dr. Andre Goy,Negative
 mantle cell lymphoma treatment,OyeCricket.com,Positive
 secondline treatment,Laura Nikolaides,Positive
 secondline treatment,Targeted Oncology,Positive
 secondline treatment,Paperbirds_Hematology,Negative
 Votre Argent,Titrespresse.com,Positive
 AmericanCancer News USFDA Approves Calquence,Margaret_Farrell,Negative
 Hot news FDA,TheSocialMedwork,Positive
 acc approval,TheSocialMedwork,Positive
 Approves Calquence,American Cancer Society,Positive
 TGTX Excellent,Don van Vliet,Positive
 pik delta inhibitor safety data,Don van Vliet,Positive
 w acalabrutinib label,Don van Vliet,Positive
 MCL AZN,MG,Positive
 FDA Approves Acalabrutinib btk inhibitor,Lymphomation.org,Negative
 BTK inhibitor amp Potential Lymphoma Blockbuster Calquence,"Nathan Letts, PhD",Positive
 FDA„ÅåÊàê‰∫∫„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´„Å´acalabrutinib„ÇíÊâøË™ç,Êµ∑Â§ñ„Åå„ÇìÂåªÁôÇÊÉÖÂ†±„É™„Éï„Ç°„É¨„É≥„Çπ,Positive
 hematology teams,AstraZenecaUS,Negative
 AZNs Calquence,BioWorld,Positive
 hematology market,BioWorld,Positive
 Imbruvica footsteps,BioWorld,Positive
 B payout,BioWorld,Positive
 Acerta shareholders,BioWorld,Positive
 lymphoma nod,BioPharma Global,Positive
 lymphoma nod,Carolyn Thompson,Negative
 Imbruvica rival Calquence,BioPharma Global,Positive
 Imbruvica rival Calquence,Carolyn Thompson,Negative
 LINFOMA MANTELLARE,I Malati Invisibili,Positive
 APPROVAZIONE FDA ACCELERATA,I Malati Invisibili,Negative
 ACALABRUTINIB,I Malati Invisibili,Positive
 Medscape,ehealthandfitness,Positive
 Medscape,Mens Sexual Health,Positive
 Good news,Sharecast.com,Negative
 Good news,CLLSA,Positive
 Good news,CLL Advocates Network,Negative
 Good news,Ancora.ai Cancer Clinical Trials for All,Positive
 Good news,Patient Empowerment Network,Negative
 Good news,@linfopedia,Positive
 Good news,Ian Hazzard,Positive
 Good news,MoJo,Negative
 Good news,Medscape Pharmacists,Negative
 Good news,Medscape Nurses,Negative
 Good news,CLL_Fightersüéó,Positive
 Good news,LymphomaAction,Negative
 Good news,Lee King,Positive
 Good news,Lymphoma Hub,Positive
 Good news,Oliver Stohlmann,Positive
     Calquence,News Assistant,Positive
 nd line mantle cell lymphoma,Stephen Clark,Positive
 Good CR rate,Pallawi Torka,Positive
 tgtx nd BTK Acalabrutinib approval,T Allen,Positive
 FDA approval alert Acalabrutinib,Medscape Pharmacists,Negative
 FDA approval alert Acalabrutinib,Medscape Oncology,Negative
 TUESDAY,Rocketnews,Negative
 HealthDay News,Rocketnews,Negative
 Regulatory News   drug approvalschanges,Living Safely,Negative
 Tuesday October,Living Safely,Negative
 Calquence Prexxartan Zegerid,Living Safely,Negative
 velcade,MyelomaLymphoma,Positive
 Revlimid   Ibrutinib,MyelomaLymphoma,Positive
 randomized comparison,MyelomaLymphoma,Positive
 Acal RR,MyelomaLymphoma,Positive
 approvalSTML dataMYL,BioPharmCatalyst,Negative
 claims,BioPharmCatalyst,Negative
 ACOR CPRX,BioPharmCatalyst,Negative
 MRNS,BioPharmCatalyst,Negative
 Approved Acalabrutinib Calquence,Lisa Astor,Negative
 FDA OKs,Hottest Stocks Now,Positive
 Early Approval,"IntellaTurn, LLC",Positive
 Blood Cancer Drug,"IntellaTurn, LLC",Positive
 FDA APPROVES ASTRAZENECAS CALQUENCE,UKiwiS,Negative
 FDA APPROVES ASTRAZENECAS CALQUENCE,IntoxicatedTrader,Negative
 FDA APPROVES ASTRAZENECAS CALQUENCE,Newmoney210,Negative
 ADULT PATIENTS,UKiwiS,Negative
 ADULT PATIENTS,IntoxicatedTrader,Negative
 ADULT PATIENTS,Newmoney210,Negative
 AstraZeneca plc FDA,UKiwiS,Negative
     Avella,Today's News,Positive
 FDA Approves Calquence Acalabrutinib,ACS Research,Positive
 patients w mantle cell lymphoma,Lymphoma Research Foundation,Negative
 Reuters AstraZeneca,Eugenio,Positive
 Reuters AstraZeneca,Fazeen (DEAN)üéà,Positive
 Reuters AstraZeneca,Ron Bourne,Positive
 Reuters AstraZeneca,JusticeOutcry,Positive
 Reuters AstraZeneca,Martha Leah Nangalama,Positive
 Reuters AstraZeneca,Himanish Prabhakar¬Æ,Positive
 bleeding event rate,Don van Vliet,Positive
 acalabrutinb Calquence,Don van Vliet,Positive
 PREVIOUSLY,IntoxicatedTrader,Negative
 PREVIOUSLY,Newmoney210,Negative
 PREVIOUSLY,Health|VBProfiles,Positive
 PREVIOUSLY,BusinessWireProducts,Negative
 PREVIOUSLY,Business Wire-Health,Negative
 PREVIOUSLY,wallstreet:online.de,Positive
 PREVIOUSLY,dlvr news,Negative
 REUTERS AstraZeneca,The Briefing Room,Positive
 RT Reuters AstraZeneca,Tony De Vos,Positive
    FDA,Anna Deveau,Negative
    FDA,PharmaSources.com,Positive
    FDA,FDA News & Info,Positive
   Approved,Drugs.com,Negative
   Approved,1stOncology,Negative
 Linfoma mantellare approvazione Fda accelerata,PharmaStar,Negative
 FDA Approves Calquence,UKiwiS,Negative
 previouslytreated m,Krishan Maggon,Negative
   FDA Approves Acalabrutinib Calquence,Kazeem Olalekan,Positive
   grants,CancerTherapyAdvisor,Negative
   grants,Healio,Positive
   grants,HemOnc Today,Positive
   grants,CBPartners,Positive
   grants,MDedge Hematology & Oncology,Negative
   grants,DDNews Online,Negative
   grants,Bionest Partners,Negative
   grants,R&G Disease Network,Positive
   grants,Lampe & Company,Negative
   grants,CancerWallonia,Negative
   grants,Donna Young,Negative
 MCL   options,Simon Rule,Positive
 post,PER,Negative
 post,VJHemOnc,Negative
 post,CLL Ireland,Negative
 post,NYCDoc29,Negative
 post,Brian Abbott,Positive
 post,Cancer And I,Negative
 post,Alexander M. J.,Positive
 post,"Naveen Pemmaraju, MD",Negative
 Aggressive Mantle cell lymphoma,Neil Sankar,Positive
 Second BTK inhibitor,Pavan Anne,Negative
 Food amp Drug Administration,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Interactive Investor,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Black Swan Intelligen,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 deadline,Carly Helfand,Negative
 deadline,International Conference on Malignant Lymphoma,Negative
 FDA OKs AstraZenecas acalabrutinib,Milton Financial Market Research Institute,Positive
 FDA OKs AstraZenecas acalabrutinib,Davalyn Corporation,Negative
 FDA OKs AstraZenecas acalabrutinib,Siti van der Meij,Negative
 FDA OKs AstraZenecas acalabrutinib,Breaking News,Negative
 mantle cell lymphoma shares,Milton Financial Market Research Institute,Positive
 mantle cell lymphoma shares,Davalyn Corporation,Negative
 mantle cell lymphoma shares,Siti van der Meij,Negative
 mantle cell lymphoma shares,Breaking News,Negative
 previouslytreated MCL,Zahedi Mujawar,Positive
 previouslytreated MCL,OncLive.com,Negative
   FDA approves s Calquence,Ida Sooks ‚úàÔ∏è,Positive
 Autorisation,oncohebdo,Negative
 proc√©dure,oncohebdo,Negative
 par,oncohebdo,Negative
 par,Biotech2050,Negative
 de l dans,oncohebdo,Negative
 le,oncohebdo,Positive
 le,Jesus F Sierra,Positive
 du manteau,oncohebdo,Positive
 FDA godk√§nner AstraZenecas Calquence acalabrutinib f√∂r,Cision News,Negative
 BREAKING NEWS,AJPB_Journal,Negative
 BREAKING NEWS,The Leukemia & Lymphoma Society,Positive
 BREAKING NEWS,LLS WA/AK Chapter,Positive
 BREAKING NEWS,"LLS, Georgia Chapter",Positive
 BREAKING NEWS,LLS Greater L.A.,Positive
 BREAKING NEWS,Coast To Coast Cures,Positive
 BREAKING NEWS,The Leukemia & Lymphoma Society - Policy Advocacy,Positive
 BREAKING NEWS,"Pharmacyclics, an AbbVie Company",Negative
 BREAKING NEWS,VuMedi Oncology,Positive
 Grants Accelerated Approval,AJPB_Journal,Negative
 AZN BTK inhibitor acalabrutinib,ICI Research,Positive
 FYI Spreading,Sarah Parks,Positive
 health news,Sarah Parks,Positive
 grants acc approval,Khurram Nawaz,Positive
 BREAKING Calquence,CURE Magazine,Negative
 AstraZeneca Pharmaceuticals New Treatment,Mike van Dulken,Negative
 AZN Calquence acalabrutinib,Ned Pagliarulo,Positive
 BTK inhibitor space,Jacob Plieth,Negative
 chart,Jacob Plieth,Negative
 August Acalabrutinib,Jacob Plieth,Negative
 approval AZN,Jacob Plieth,Negative
 CALQUENCE label,Brian Skorney,Positive
   PR,Donna Young,Negative
 AZN FDA,StockNews.com,Negative
 AZN FDA,Option Runners,Positive
 AZN FDA,Odi Bruckman,Negative
   approval details,Donna Young,Negative
 AstraZenecas mantle cell lymphoma treatment Calquence,Option Runners,Positive
 mantle cell lymphoma Brand Calquence Recall,Adam Feuerstein,Positive
 Imbruvica killer,Adam Feuerstein,Positive
 ‰ºÅÊ•≠ÔºöÊäóÁôåÂâ§„Éª„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàacalabrutinibÔºâÔºö„Ç¢„Çµ„Éº„Çø„Éª„Éï„Ç°„Éº„ÉûÁ§æÔºàAcerta PharmaÔºâÔºàÁ±≥ÂõΩ Ôºâ Research„ÄçË´ñÊñá„ÅÆ„Éá„Éº„ÇøÊîπ„Åñ„Çì„ÇíË™ç„ÇÅ„Åü,ÁôΩÊ•Ω„É≠„ÉÉ„ÇØ„Éì„É´,Positive
 AstraZeneca Retracts Preclinical Paper,Lymphoma Canada,Negative
 AstraZeneca Retracts Preclinical Paper,"Khan, BA",Positive
 AstraZeneca Retracts Preclinical Paper,Pedro Perdomo M,Positive
 AstraZeneca Retracts Preclinical Paper,Elizabeth Ramirez,Positive
 AstraZeneca Retracts Preclinical Paper,Dr Amy mitchell,Positive
 Acalabrutinib BTKi,"Mike Thompson, MD, PhD, FASCO",Negative
 PriorityReview,Encore BioMed,Positive
 acalabrutinibMCL,Encore BioMed,Positive
 alectibibNSCLC,Encore BioMed,Positive
 ATOAPL,Encore BioMed,Positive
 bosutinibCML,Encore BioMed,Positive
 brentuximabCTCL,Encore BioMed,Positive
 VIDEO Sideeffects,VJHemOnc,Negative
 Peter Hillmen,VJHemOnc,Positive
 Falsified Data,"Khan, BA",Positive
 Falsified Data,Elizabeth Ramirez,Positive
 Astra Zeneca retracts Acalabrutinib,"Neil Sankar M.D.,MPH",Positive
 Astra Zeneca retracts,"Neil Sankar M.D.,MPH",Positive
 ‚Äú √©tica ‚Äù de la industria,Pedro Perdomo M,Positive
 Admits Falsified Data,Pedro Perdomo M,Positive
 Stunning AstraZeneca,Robert Z. Orlowski,Negative
 Acalabrutinibsome,Dr Amy mitchell,Positive
 ÈòøÊñØÂà©Â∫∑Ë°®Á§∫ÔºåÁî±‰∫éÈóÆÈ¢òÊï∞ÊçÆÊâÄÊ∂âÂèäÁöÑËØïÈ™åÊòØÊù•Ëá™Êï∞ÂçÅ‰∏™ËØïÈ™å‰∏≠ÁöÑ‰∏Ä‰∏™Ôºå‰∏îÂèëÁîüÂú®ÂÖ•ËÇ°‰πãÂâçÔºåÂõ†Ê≠§ÂÖ¨Âè∏ÈùûÂ∏∏Ëø´ÂàáÊÉ≥Ë¶ÅÊêûÊ∏ÖÊ•öÊ≠§Ê¨°‰∫ã‰ª∂ÊòØÂê¶‰ºöÊçüÂÆ≥AcalabrutinibÁöÑÊúâÊïàÊÄßÊï∞ÊçÆ„ÄÇÂÖ¨Âè∏ËøòÁâπÂà´Âº∫Ë∞ÉÔºåÊ≠§Ê¨°Â≠§Á´ã‰∫ã‰ª∂‰∏ç‰ºöÂØπÂú®‰ªª‰Ωï‰∫∫‰Ωì‰∏¥Â∫äËØïÈ™å‰∏≠ÁöÑÊï∞ÊçÆÂÆåÊï¥ÊÄßÈÄ†ÊàêÂΩ±ÂìçÔºå‰πü‰∏ç‰ºöÂØπÊÇ£ËÄÖÂÅ•Â∫∑Â∏¶Êù•È£éÈô©,ÊòüÁ©∫,Positive
 ÊçÆÂà∂ËçØË°å‰∏ö‰∏ì‰∏öÂ™í‰ΩìPharmafileÊä•ÈÅìÔºåÈòøÊñØÂà©Â∫∑ÂèëÁé∞ÔºåÂÖ∂ÊéßËÇ°ÂÖ¨Âè∏Acerta,ÊòüÁ©∫,Positive
 Cancer drug Acalabrutinib study data,Ash Paul,Positive
 Acalabrutinib Breakthrough Designation,OncLive.com,Negative
 FDA Revis√£o da,Fernando Medina,Positive
 de Acalabrutinib,Fernando Medina,Positive
 FDA News,SUMIT SHARMA,Negative
 ONCOLOGY Acalabrutinib,SUMIT SHARMA,Negative
 Priority Review,SUMIT SHARMA,Positive
 Priority Review,EuropaWire,Negative
 Priority Review,Pharma Business Int,Negative
 Priority Review,Targeted Oncology,Negative
 Priority Review,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 Priority Review,BioCentury,Positive
 Priority Review,StockNews.com,Negative
 Priority Review,Briefing.com,Negative
 Priority Review,WheelieDealer,Negative
 Priority Review,cafepharma,Positive
 Priority Review,OBR,Negative
 Priority Review,HSMN,Negative
 Priority Review,Odi Bruckman,Negative
 Priority Review,Crwe World,Negative
 Priority Review,Financial Buzz,Negative
 Priority Review,Hotstocks.nyc,Positive
 Priority Review,Marketbit.pro,Negative
 Priority Review,Joey Sales,Positive
 Priority Review,CLL Society Inc.,Negative
 Priority Review,DDNews Online,Negative
 Priority Review,MedWatch News,Positive
 Priority Review,"Joseph Gulfo, MD",Positive
 Priority Review,European Pharmaceutical Review,Negative
 Priority Review,Michele Nadeem-Baker,Negative
 Priority Review,Matthias Piesche,Negative
 Priority Review,A. Vroom - Ten Wolde,Negative
 MCL CPX,SUMIT SHARMA,Negative
   IO comboNMRK AntiPD   AZN BTKi acalabrutinib combo,Andy Biotech,Positive
 New Combo Treatment,Lymphoma News Today,Positive
 New Combo Treatment,BioNews,Negative
 DLBCL RChop,Lymphoma News Today,Positive
 DLBCL RChop,BioNews,Negative
 Oxford,Graham Collins,Positive
 Oxford,CLL Ireland,Negative
 Oxford,LymphomaAction,Positive
 Oxford,MD Anderson Leukemia,Negative
 ACCEPT trial,Graham Collins,Negative
 RCHOPacalabrutinibtcoMCkbKNJEe,Graham Collins,Negative
 AstraZeneca NDA,Lymphoma News Today,Positive
 AstraZeneca NDA,BioNews,Negative
 Salute Domani,Salutedomani,Negative
 Linfoma mantellare FDA Breakthrough Therapy Designation e Priority Review,Salutedomani,Negative
 Linfoma mantellare FDA Breakthrough Therapy Designation e Priority Review,Farmacia Nenna,Positive
 Linfoma mantellare FDA Breakthrough Therapy Designation e Priority Review,Derma News OK,Positive
 Linfoma mantellare FDA Breakthrough Therapy Designation e Priority Review,saluteH24.com,Positive
 Linfoma mantellare FDA Breakthrough Therapy Designation e Priority Review,Antonio Caperna,Positive
 AstraZenecas Acalabrutinib,Pf Magazine,Positive
 AstraZenecas Acalabrutinib,Parallel Learning,Positive
 AstraZenecas Acalabrutinib,Pharma_Processes,Positive
 AstraZenecas Acalabrutinib,Danvantri Farma,Negative
 AstraZenecas Acalabrutinib,pharmabr,Negative
 FDA Breakthrough Therapy Designation,Pf Magazine,Positive
 FDA Breakthrough Therapy Designation,Parallel Learning,Positive
 FDA Breakthrough Therapy Designation,AstraZenecaUS,Negative
 FDA Breakthrough Therapy Designation,WheelieDealer,Negative
 FDA Breakthrough Therapy Designation,Andy Biotech,Positive
 Lymphoma Treatment Acalabrutinib,"chadi nabhan MD, MBA, FACP",Negative
 Breakthrough Therapy Status,"chadi nabhan MD, MBA, FACP",Negative
 FDA Grants Breakthrough Therapy Designation,Lymphoma News Today,Positive
 FDA Grants Breakthrough Therapy Designation,BioNews,Negative
 Breakthrough Therapy Designation status,Hlthnews,Negative
 Breakthrough Therapy Designation status,European Pharmaceutical Review,Negative
 Breakthrough Therapy Designation status,Danvantri Farma,Negative
 FDA considera acalabrutinib uma terap√™utica inovadora,News Farma,Positive
 Linfoma mantellare,Giuseppe Spinnato,Positive
 Linfoma mantellare,JobInPharma,Positive
 Linfoma mantellare,Salutedomani,Negative
 Usa acalabrutinib ottiene,Giuseppe Spinnato,Positive
 Usa acalabrutinib ottiene,JobInPharma,Positive
 la breakthrough therapy designation,Giuseppe Spinnato,Positive
 la breakthrough therapy designation,JobInPharma,Positive
 Potential Mantle Cell Lymphoma Therapy Acalabrutinib Wins FDA Priority Review Status,Lymphoma Canada,Negative
 FDA Accepts Regulatory Submission,Hlthnews,Negative
 FDA Accepts Regulatory Submission,Newmoney210,Negative
 FDA Accepts Regulatory Submission,IntoxicatedTrader,Negative
 FDA Accepts Regulatory Submission,Medicalnewser.com,Negative
 FDA Accepts Regulatory Submission,Drugnews.in,Negative
 Acalabrutinib Grants Priority Review,Hlthnews,Negative
 Acalabrutinib Grants Priority Review,Newmoney210,Negative
 Acalabrutinib Grants Priority Review,IntoxicatedTrader,Negative
 Acalabrutinib Grants Priority Review,Medicalnewser.com,Negative
 Acalabrutinib Grants Priority Review,Drugnews.in,Negative
 Treat Mantle,BioNews,Negative
 Treat Mantle,Lymphoma News Today,Negative
 Clinical Trials Acalabrutinib,Saleh Stevens,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,Lymphoma Canada,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,Newmoney210,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,IntoxicatedTrader,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,Medicalnewser.com,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,Targeted Oncology,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,Josh Rehrer,Positive
 Acalabrutinib Granted Breakthrough Therapy Designation,Financial Buzz,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,BusinessWireProducts,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,Business Wire-Health,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,BusinessWire-Science,Negative
 Acalabrutinib Granted Breakthrough Therapy Designation,Drug Delivery News,Negative
    Acalabrutinib Granted Breakthrough Therapy Designation,SStevens,Positive
    Acalabrutinib Granted Breakthrough Therapy Designation,Cancer News,Negative
 Treatmen,SStevens,Positive
 Treatmen,Stock Advisor,Positive
   Awards,CancerWallonia,Negative
   Grants    Designation,CancerWallonia,Negative
 acalabrutinib Breakthrough Therapy Designation,Anna Deveau,Negative
 relapsedrefractory Mantle Cell Lymphoma,Anna Deveau,Negative
 secondgeneration BTK inhibitors,OncLive SOSS,Negative
 Designation,pharmatutor,Positive
 Designation,1stOncology,Negative
 vistusertib,Graham Collins,Negative
 acalabrutinib BTKi trial ACELY,Graham Collins,Negative
 ‚óÜ „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö,„ÄêËñ¨Ââ§Â∏´Âêë„Åë„ÄëÂêÑÁ®Æ„ÅäÂΩπÁ´ã„Å°ÊÉÖÂ†±,Negative
 Ëñ¨Ââ§Â∏´,„ÄêËñ¨Ââ§Â∏´Âêë„Åë„ÄëÂêÑÁ®Æ„ÅäÂΩπÁ´ã„Å°ÊÉÖÂ†±,Negative
   grants acalabrutinib,Lymphoma Hub,Negative
 NDA Priority Review,Lymphoma Hub,Negative
 Regulatory Submission,1stOncology,Negative
 Grants,1stOncology,Negative
   Granted,1stOncology,Negative
 priority review,OncLive.com,Positive
 priority review,Pharma_Processes,Positive
 priority review,Danvantri Farma,Negative
 priority review,Pharmaceutical News,Negative
 priority review,PharmaSources.com,Positive
 priority review,PharmaLeaders,Negative
 priority review,pharmabr,Negative
 priority review,Healio,Negative
 priority review,HemOnc Today,Positive
 priority review,FirstWord Pharma,Negative
 priority review,Targeted Oncology,Positive
 priority review,"Robinson Ortiz, MD",Negative
 priority review,Rare Disease Report,Negative
 priority review,MDedge Hematology & Oncology,Positive
 priority review,Donna Young,Negative
 priority review,Genentech,Negative
 Priority review,Regulatory Jobs,Positive
 Priority review,SartoriusRoyston,Positive
 Priority review,David Ledger,Negative
 Priority review,Pharma Commons,Negative
 Priority review,Crwe World,Negative
 Priority review,BioInnoPlayground,Positive
 Priority review,Davalyn Corporation,Negative
 Priority review,Everything Pharma,Negative
 Priority review,PharmaTimes,Negative
 Priority review,Barry Curry,Negative
 Priority review,Pharma Trader,Negative
 Priority review,Digital-Ontology,Negative
 Priority review,Danvantri Farma,Negative
 Priority review,Sarah DiGiulio,Positive
 breakthrough status,Regulatory Jobs,Positive
 breakthrough status,SartoriusRoyston,Positive
 breakthrough status,David Ledger,Negative
 breakthrough status,Bruce Berger,Positive
 breakthrough status,"Edwin van Bloois, PhD",Positive
 breakthrough status,Pharma Commons,Negative
 breakthrough status,Crwe World,Negative
 breakthrough status,Pharmaceutical News,Negative
 breakthrough status,Radiology w/ BHIVE,Positive
 breakthrough status,BHIVE on Pediatrics,Positive
 breakthrough status,Nephrology w/BHIVE,Positive
 breakthrough status,BHIVE: EmergencyMed,Positive
 breakthrough status,BioInnoPlayground,Positive
 breakthrough status,Davalyn Corporation,Negative
 breakthrough status,Everything Pharma,Negative
 breakthrough status,PharmaTimes,Negative
 breakthrough status,Barry Curry,Negative
 breakthrough status,Pharma Trader,Negative
 breakthrough status,Digital-Ontology,Negative
 breakthrough status,Danvantri Farma,Negative
 breakthrough status,BHIVE on Cardiology,Positive
 breakthrough status,visiongain Pharma,Positive
 AZ ‚Äô acalabrutinib,Regulatory Jobs,Positive
 AZ ‚Äô acalabrutinib,David Ledger,Negative
 AZ ‚Äô acalabrutinib,"Edwin van Bloois, PhD",Positive
 AZ ‚Äô acalabrutinib,Pharma Commons,Negative
 AZ ‚Äô acalabrutinib,Crwe World,Negative
 AZ ‚Äô acalabrutinib,BioInnoPlayground,Positive
 AZ ‚Äô acalabrutinib,Davalyn Corporation,Negative
 AZ ‚Äô acalabrutinib,Everything Pharma,Negative
 AZ ‚Äô acalabrutinib,PharmaTimes,Negative
 AZ ‚Äô acalabrutinib,Barry Curry,Negative
 AZ ‚Äô acalabrutinib,Pharma Trader,Negative
 AZ ‚Äô acalabrutinib,Digital-Ontology,Negative
 AZ ‚Äô acalabrutinib,Danvantri Farma,Negative
 „Äê „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„Äë„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´Ê≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„Çà„ÇäÁîªÊúüÁöÑÊ≤ªÁôÇËñ¨„Å´ÊåáÂÆö „Äê „Ç∏„Éß„É≥„ÇΩ„É≥„Éª„Ç®„É≥„Éâ„Éª„Ç∏„Éß„É≥,MEDWAVE,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö,„É¢„Éã„Çø„Éº„Çµ„É≥„Éó„É´Ë©¶„ÅóÈöä,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö,prnotamenoid,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö,„ÅÇ„Çã‰∫∫„ÅÆÂëü„Åç,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö,Ëñ¨Ââ§Â∏´„Éã„É•„Éº„ÇπÈÖç‰ø°„Åè„Çì,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö,PR TIMES„Éã„É•„Éº„Çπ,Positive
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö,PR TIMES„Éì„Ç∏„Éç„Çπ,Positive
 Êñ∞ÁùÄË®ò‰∫ã„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´Ê≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDA Ôºâ,Ëñ¨Ââ§Â∏´„Ç¶„Ç©„ÉÉ„ÉÅ„ÄÄÁõ∏‰∫í„Éï„Ç©„É≠„Éº,Negative
 ÊÑüÊüìÁóá,ÂåªÁôÇ„Éã„É•„Éº„ÇπÈÄüÂ†±,Negative
 „Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´Ê≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„Çà„ÇäÁîªÊúüÁöÑÊ≤ªÁôÇËñ¨„Å´ÊåáÂÆö   PR TIMES „Éó„É¨„Çπ„É™„É™„Éº„Çπ,Ëñ¨Ââ§Â∏´„Éã„É•„Éº„ÇπÈÖç‰ø°„Åè„Çì,Negative
 acalabrutinib breakthrough status,Dr. Andre Goy,Negative
 hematology,AstraZenecaUS,Negative
 hematology,COPD News,Negative
 FDA Awards Acalabrutinib Priority Review,Crwe World,Negative
 FDA Awards Acalabrutinib Priority Review,"Hunan Huateng Pharmaceutical Co., Ltd",Positive
 FDA Awards Acalabrutinib Priority Review,Immuno-Oncology,Negative
 FDA Awards Acalabrutinib Priority Review,OncLive.com,Negative
 FDA Awards Acalabrutinib Priority Review,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
   grants acalabrutinib Breakthrough Therapy Designation,Lymphoma Hub,Negative
 AstraZeneca Acalabrutinib,PharmaLeaders,Negative
 AstraZenecas good news,Pharmafocus,Positive
 FDA Priority Review,Pharmafocus,Positive
 FDA Priority Review,AstraZenecaUS,Negative
 FDA Priority Review,JediPD,Negative
 mantle cel,timelivenews,Positive
 Êù•Ëá™,"Hunan Huateng Pharmaceutical Co., Ltd",Positive
   mantellare dall,Francesca Bariggi,Positive
 PhIII breakdown AstraZeneca,Endpoints News,Positive
 PhIII breakdown AstraZeneca,Sean McGrath,Positive
 PhIII breakdown AstraZeneca,cafepharma,Negative
 PhIII breakdown AstraZeneca,the world of CROs,Negative
 PhIII breakdown AstraZeneca,John Carroll,Positive
 FDA decision,Endpoints News,Negative
 FDA decision,Sean McGrath,Positive
 FDA decision,cafepharma,Negative
 FDA decision,the world of CROs,Negative
 FDA decision,John Carroll,Positive
       review,"Edwin van Bloois, PhD",Positive
 AZs acalabrutinib,BioCentury,Positive
 AZs acalabrutinib,ScienceSeeker Feed,Positive
 AZs acalabrutinib,Danvantri Farma,Negative
 AZs acalabrutinib,Pharmaceutical News,Negative
 Linfoma mantellare   Breakthrough Therapy Designation e Priority ‚Ä¶   salutedomani podcast,Salutedomani,Negative
 Linfoma mantellare dallFda doppio,PharmaStar,Negative
 program,AstraZenecaUS,Negative
 program,CancerCoachLive,Positive
 program,Phoebe Needles,Negative
 program,Medscape Education,Negative
 program,"chadi nabhan MD, MBA, FACP",Negative
 program,VJHemOnc,Positive
 DALL‚ÄôFDA DOPPIO RICONOSCIMENTO,I Malati Invisibili,Negative
 Breakthrough Therapy Designation e Priority Review,Salutedomani,Negative
 FDA acceptance,AstraZenecaUS,Negative
 acalabrutinib Priority Review status,AstraZenecaUS,Negative
   Acalabrutinib Granted Breakthrough Therapy Designation,MedicalResearch News,Positive
   Acalabrutinib Granted Breakthrough Therapy Designation,Pharmaceutical News,Negative
 Treatmen Read Blog,MedicalResearch News,Positive
 Treatmen Read Blog,Pharmaceutical News,Negative
 WX,MedicalResearch News,Positive
 WX,Pharmaceutical News,Negative
   Priority review,Pharmaceutical News,Negative
 AZ acalabrutinib,Pharmaceutical News,Negative
 AstraZeneca revue prioritaire pour acalabrutinib,Buy Cryptocurrency,Positive
 AstraZeneca revue prioritaire pour acalabrutinib,Investing.com France üá´üá∑,Positive
 InvestingFrance,Buy Cryptocurrency,Positive
 AstraZeneca FDA Accepts Acalabrutinib Filing amp Grants Priority Review   UK news,[iito] Life Science,Positive
 FDA Breakthrough Designation,AstraZenecaUS,Negative
 FDA Breakthrough Designation,Pharmacy Podcast Network,Positive
 FDA Breakthrough Designation,Pharmacy Times,Negative
 Clock,Pharmaceutical Market Europe,Positive
 Clock,Gemma Jones,Positive
 Clock,ScienceSeeker Feed,Positive
 Clock,Danvantri Farma,Negative
 FDA review,Pharmaceutical Market Europe,Positive
 FDA review,Gemma Jones,Positive
 FDA review,ScienceSeeker Feed,Positive
 FDA review,Danvantri Farma,Negative
 s acalabrutinib,Pharmaceutical Market Europe,Positive
 s acalabrutinib,Gemma Jones,Positive
   decision,Endpoints News,Negative
 PharmaTimes,BioInnoPlayground,Positive
 PharmaTimes,Margaret Walker,Positive
 FDA beviljar Astra Zenecas acalabrutinib prioriterad,Investing.com Sverige üá∏üá™,Positive
   AZ acalabrutinib submission,Pharmaceutical News,Negative
 Mantle Cell Lymphoma FDA Grants Breakthrough Therapy Designation,Krishan Maggon,Negative
 Mantle Cell Lymphoma FDA Grants Breakthrough Therapy Designation,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 AZN Acalabrutinib FDA,WheelieDealer,Negative
 Submission,WheelieDealer,Negative
 Submission,HSMN,Negative
 drip drip,WheelieDealer,Negative
 Pipeline RNSs,WheelieDealer,Negative
 BTK announcement,Jacob Plieth,Negative
 Acerta owners,Jacob Plieth,Negative
 bn,Jacob Plieth,Negative
 AstraZeneca priority review,Sharecast.com,Negative
 FDA Grants Acalabrutinib Breakthrough Therapy Designation,Dr. Alan Tan,Positive
   PLC   AZ acalabrutinib submission,Pharmaceutical News,Negative
 AZN PDUFA,Brad Loncar,Positive
 AZ acalabrutinib submission,Cision News,Negative
 con linfoma Grants Acalabrutinib Breakthrough Therapy Designation,Dr. Luis Villela,Positive
 Breakthrough Therapy,Ryan HamNer,Positive
 Breakthrough Therapy,CLL Society Inc.,Negative
 Breakthrough Therapy,c lark,Positive
 Breakthrough Therapy,B. West #sand,Positive
 Breakthrough Therapy,Siti van der Meij,Negative
 Breakthrough Therapy,Breaking News,Negative
 Breakthrough Therapy,Scott Werntz,Negative
 AZN MCL,CLL Society Inc.,Negative
   Grants Acalabrutinib Breakthrough Therapy Designation,The ASCO Post,Negative
 MYSTIC disappointment,Pavan Anne,Negative
 breakthrough designations,Pavan Anne,Negative
 durvalumab,Pavan Anne,Negative
 lung,Pavan Anne,Negative
 AZNAstraZenecas acalabrutinib,c lark,Positive
 Mantle cell lymphoma FDA grants,CancerTherapyAdvisor,Negative
 Cancer Therapy Advisor,BlackSwan Analysis now part of Evaluate Pharma Ltd,Positive
 Cancer Therapy Advisor,Oncology Publishers Feed,Negative
 Cancer Therapy Advisor,Anthony Mato,Negative
 Cancer Therapy Advisor,CAR-TCR,Positive
 Cancer Therapy Advisor,Lymphoma Canada,Positive
 Cancer Therapy Advisor,Predictive Analytics,Positive
 Cancer Therapy Advisor,Dr. Melody Davis,Negative
 Cancer Therapy Advisor,HHF,Positive
 Cancer Therapy Advisor,Christopher Steer,Negative
 Cancer Therapy Advisor,Stem cell Watch,Positive
 Bl,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 mantle cell lymp,Sheila A. Crowe,Positive
   PLC Release Acalabrutinib Granted Breakthrough Therapy Designation,Pharmaceutical News,Negative
 Acalabrutinib Breakthrough therapy,"Hatem Murad, MD,FAAN.     ÿ≠ÿßÿ™ŸÖ ŸÖÿ±ÿßÿØ",Positive
 breakthrough therapy designation status,Ida Sooks ‚úàÔ∏è,Positive
 AstraZeneca AZN,BluePrint Orphan,Positive
 FDA grants acalabrutinib BTD,Andrew Merron,Positive
 Exciting times,Andrew Merron,Positive
 Exciting times,Xenia Schmidt,Positive
 market,Andrew Merron,Positive
 market,Nita Sonwane,Negative
 forecasts,Andrew Merron,Positive
 Pharma Giant AstraZeneca PLC Scores,Biotechnology,Positive
 Pharma Giant AstraZeneca PLC Scores,Corixis,Positive
 Pharma Giant AstraZeneca PLC Scores,Biotech World,Positive
 Pharma Giant AstraZeneca PLC Scores,Pharmaceutical,Positive
 Breakthrough,Biotechnology,Positive
 Breakthrough,Corixis,Positive
 Breakthrough,Biotech World,Positive
 Breakthrough,Pharmaceutical,Positive
 Breakthrough,Kerry David,Positive
 Granted Breakthrough Therapy Designation,OBR,Negative
 Granted Breakthrough Therapy Designation,Stockboard Media Inc,Negative
 AZN Acalabrutinib,Stockboard Media Inc,Negative
 AZN Acalabrutinib,JQ,Positive
 LOXO amp REDX,Jacob Plieth,Negative
 reversibility,Jacob Plieth,Negative
   d√©signation de traitement novateur,oncohebdo,Negative
 le traitement,oncohebdo,Negative
 du,oncohebdo,Negative
 du,C√©gep de L√©vis,Positive
 du,Carmel La Lumiere,Positive
 AZN Granted Breakthrough Therapy Designation,StockNews.com,Negative
 mant,StockNews.com,Negative
 Astra Zenecas acalabrutinib har erh√•llit genombrottsstatus hos FDA,Investing.com Sverige üá∏üá™,Positive
 Acalabrutinib breakthrough designation,Odi Bruckman,Negative
 N√§chster FDABreakthroughTherapyStatus f√ºr,DER AKTION√ÑR,Positive
   PLC,Pharmaceutical News,Negative
 BTD,Pharmaceutical News,Negative
 AstraZenecas ACALABRUTINIB,Mike van Dulken,Negative
 BREAKTHROUGH THERAPY DESIGNATION,Mike van Dulken,Negative
 TREATMENT,Mike van Dulken,Negative
 TREATMENT,Francesco Bertoni,Negative
 TREATMENT,Benlazar S.M Amin√©,Negative
 TREATMENT,Paperbirds_Hematology,Negative
 TREATMENT,touchONCOLOGY,Negative
 TREATMENT,Davalyn Corporation,Negative
 TREATMENT,Medibooks,Negative
 Ensayo cl√≠nico para pacientes,MD Anderson Madrid,Positive
 con Leucemia Linfocitica Cronica refractaria M√°s,MD Anderson Madrid,Positive
 AZN Acalabrutinib BTK submission,M,Positive
 H,M,Positive
 H,Accern,Positive
 H,Andy Biotech,Positive
 H,Sukaina Virji,Positive
 H,NHLBI Bethesda Labs,Positive
 H,Biotech2050,Negative
 H,Jean-Michel TERME,Negative
 Q Bydureon,M,Positive
 efficacy endpt manufacturing issues,M,Positive
 B drug ZS,M,Positive
 Director Marketing Acalabrutinib Team Jobs,Marketing Jobs,Negative
 Gaithersburg MD,Marketing Jobs,Negative
 Selective Bruton Tyrosine Kinase Inhibitor,Jerry Lee,Negative
 Chronic Lymphocytic L,Jerry Lee,Negative
 Vistusertib,ÕèWilliam Avery Hudson,Negative
 RelapsedRefractory,ÕèWilliam Avery Hudson,Positive
 RelapsedRefractory,Lymphomation.org,Negative
 RelapsedRefractory,ClinicalTrialsData,Negative
 RelapsedRefractory,OncLive.com,Negative
 RelapsedRefractory,1stOncology,Positive
 RelapsedRefractory,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 RelapsedRefractory,Targeted Oncology,Negative
 RelapsedRefractory,CIDEGEN,Positive
 RelapsedRefractory,Mahmoud Aljurf,Negative
 RelapsedRefractory,"Raul Cordoba, MD, PhD",Negative
 RelapsedRefractory,CLL Ireland,Positive
 RelapsedRefractory,Medscape Education,Negative
 RelapsedRefractory,Oncology Tube,Negative
 RelapsedRefractory,Christopher Steer,Positive
 RelapsedRefractory,Sandra Kear,Positive
 RelapsedRefractory,Francesco Turturro,Negative
 Japanese Adult Patients,Renal Cell Carcinoma,Negative
 Advanced Bcell Malignancies,Renal Cell Carcinoma,Negative
 AstraZeneca Pharmaceuticals LP Global Brand Manager Acala,JOBS EmploymentBoard,Positive
 leucemia linf√°tica cr√≥nica B,Raquel O√±a Navarrete,Negative
 leucemia linf√°tica cr√≥nica,Raquel O√±a Navarrete,Negative
 reca√≠da,Raquel O√±a Navarrete,Negative
 Bruton Tyrosine Kinase BTK Inhibitor Acalabrutinib,Jerry Lee,Negative
 Potent OnTarget Effects,Jerry Lee,Negative
 Andrew Zelenetz MD PhD,OncLive SOSS,Negative
 acalabrutinib BGB,OncLive SOSS,Negative
 AstraZeneca Pharmaceuticals LP Global Medical Aff,JOBS EmploymentBoard,Positive
 VIDEO   Richters transformation,VJHemOnc,Negative
 P Hillmen,VJHemOnc,Negative
 P Hillmen,Dr.Alberto Mussetti,Negative
 Acalabrutinib ONO,Oncology Tube,Positive
 novel BTK inhibitors,Oncology Tube,Positive
 nd BTKi,JQ,Positive
 ph headtohead trial,JQ,Positive
 Ibrutinib BGNE BGB,JQ,Positive
 WM st,JQ,Positive
 Common SideEffects,Oncology Tube,Negative
 VIDEO P Hillmen,VJHemOnc,Negative
 Richters transformation amp,VJHemOnc,Negative
 VIDEO J Woyach,VJHemOnc,Negative
 VIDEO Peter Hillmen,VJHemOnc,Positive
 IbrutinibIntolerant CLLSLL,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Positive
 IbrutinibIntolerant CLLSLL,Targeted Oncology,Negative
 IbrutinibIntolerant CLLSLL,Lymphoma Canada,Negative
 IbrutinibIntolerant CLLSLL,Kathleen Finlayüéó,Positive
 IbrutinibIntolerant CLLSLL,OncLive.com,Negative
 IbrutinibIntolerant CLLSLL,HRA,Positive
 Richter Transformation,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Positive
 Richter Transformation,Targeted Oncology,Negative
 Richter Transformation,Silas Inman,Negative
 Richter Transformation,OncLive.com,Negative
 Richter Transformation,EurekaMag,Negative
 Richter Transformation,Chocolatiere Phys,Negative
 Richter Transformation,CLL Ireland,Negative
 Richter Transformation,Christopher Steer,Negative
 Richters transformation,VJHemOnc,Negative
 Richters transformation,Toby Eyre,Negative
 Richters transformation,Paperbirds_Hematology,Positive
 Richters transformation,Benlazar S.M Amin√©,Positive
 Richters transformation,CLL Advocates Network,Negative
 tcoAcVstcPN,Targeted Oncology,Negative
 New data,BioCentury,Positive
 New data,SpecialtyPTimes,Negative
 New data,Targeted Oncology,Negative
 New data,donnashort,Negative
 New data,Lymphoma Hub,Negative
 New data,Roche,Positive
 New data,"Pharmacyclics, an AbbVie Company",Negative
 Btk inhibitors Imbruvica acalabrutinib,BioCentury,Positive
   PLC Release,Pharmaceutical News,Positive
 Acalabrutinib Safe Effective,Kathleen Finlayüéó,Positive
 Acalabrutinib Safe Effective,OncLive.com,Negative
 RT Acalabrutinib Safe Effective,HRA,Positive
   ibrutinib,"Oscar Segurado, MD PhD",Positive
   ibrutinib,‚öõÔ∏èLibertyüåä,Positive
   ibrutinib,Lymphoma Hub,Negative
 T cell ITK pathway,"Oscar Segurado, MD PhD",Positive
 AZN   plc,ResearchPool,Negative
 AZN Early Data Demonstrate Clinical Activity,Stockboard Media Inc,Negative
 DifficulttoTreat Chronic Lymphocytic,Stockboard Media Inc,Negative
 Dr Awan acalabrutinib,Jacob Plieth,Negative
 Imbruvicaintolerant,Jacob Plieth,Negative
 ph,Jacob Plieth,Negative
 ph,NE Live,Negative
 AE profile,Anthony Mato,Negative
   Words,"Matthew Matasar, MD",Positive
 skepticism Grade   fungal infection,"Matthew Matasar, MD",Positive
 patents,OncLive.com,Negative
 Richter transformation,OncLive.com,Negative
 Richter transformation,Blood Journal,Positive
 Richter transformation,"Hayder Saeed, MD",Positive
 Richter transformation,Srujana Joga,Positive
 Richter transformation,Fernando Mart√≠n Moro,Positive
 Richter transformation,Lymphoma Papers,Positive
 Richter transformation,Izaskun Zeberio,Negative
 Richter transformation,"Jose Sandoval S, MD FACP",Positive
 Richter transformation,NEJM Resident 360,Positive
 Richter transformation,CLL Ireland,Positive
 Richter transformation,@immunoonco_Meed,Positive
 Richter transformation,Immuno-Oncology,Negative
 Richter transformation,Blood Advances,Positive
 Richter transformation,Dr George Paterakis,Positive
 Acalabrutinib Monotherapy Effective,Silas Inman,Negative
 Acalabrutinib Monotherapy Effective,OncLive.com,Negative
   Dr Hillman acalabrutinib bid,"Matthew Matasar, MD",Positive
 Richter ORR,"Matthew Matasar, MD",Positive
 Median DOR,"Matthew Matasar, MD",Positive
 Brutons,Cure Cancer Now,Negative
 Brutons,Lymphoma Papers,Positive
 Brutons,TYR Kinase papers,Negative
 Brutons,Paperbirds_Hematology,Negative
 Brutons,Benito,Positive
 Brutons,CLL Ireland,Negative
 Brutons,Cancer Papers,Negative
 Brutons,Oncology Tube,Positive
 Brutons,VJHemOnc,Negative
 kinase BTK inhibitor acalabrutinib,Cure Cancer Now,Negative
 Overview,Oncology Tube,Positive
 Overview,Patient Empowerment Network,Positive
 Overview,CLL-seq,Positive
 Overview,CLL Ireland,Positive
 Overview,Zack Pemberton-Whiteley,Negative
 Overview,VJHemOnc,Positive
 Upcoming Trials,Oncology Tube,Negative
 ÂïÜÈ°òÂïÜÊ®ôCALQUENCE Âá∫È°ò‰∫∫„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ „Ç¢„ÇØ„ÉÅ„Éú„É©„Ç∞ Âá∫È°òÊó•Âπ¥ÊúàÊó•,ÂïÜÊ®ôÈÄüÂ†±bot,Positive
 Acalabrutinib filing,Accern,Positive
 durva,Accern,Positive
 durva,Andy Biotech,Positive
 HNSCC early filing plan,Accern,Positive
 HNSCC early filing plan,Andy Biotech,Positive
 Durvatrem,Accern,Positive
 AZN Q setbacks Acalabrutinib filing,Andy Biotech,Positive
 Durvatreme HNSCC,Andy Biotech,Positive
 ABBV BTK,M,Positive
 breathing room,M,Positive
 AZN Latters BTK acalabrutinib filing guidance,M,Positive
 P H,M,Positive
 VIDEO Andrew Davies,VJHemOnc,Negative
 talks,VJHemOnc,Positive
 talks,Ghazi Tadmouri,Positive
 talks,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 talks,CLL Ireland,Positive
 talks,Paula Cramer,Positive
 talks,Helen Jane Mee,Negative
 talks,Michigan Pathology,Positive
 talks,Patient Power,Positive
 talks,ecancer,Positive
 talks,Targeted Oncology,Negative
 b,"chadi nabhan MD, MBA, FACP",Positive
 b,Bionest Partners,Negative
   NextGen BTKiBGNE Bgb Acalabrutinib,Andy Biotech,Positive
 story acalabrutinib,rob halkes,Positive
 vijf jaar van startup naar miljardenbedrijf,Hans Tenk,Positive
 VIDEO Davies,VJHemOnc,Positive
 dogs,Oncologiavet,Positive
 Bcell lymphoma,Oncologiavet,Negative
 Bcell lymphoma,Maria Leticia Solari,Positive
 Bcell lymphoma,Benlazar S.M Amin√©,Negative
 Checkpoint Inhibitor,Oncology Tube,Negative
 Acalabrutinib   ONO BTK inhibitors,Oncology Tube,Negative
 foco,"Raul Cordoba, MD, PhD",Negative
 oncolog√≠a con lanzamiento de   nuevos f√°rmacos hasta,"Raul Cordoba, MD, PhD",Negative
 Para hematolog√≠a,"Raul Cordoba, MD, PhD",Negative
 Preclinical evaluation,Oncologiavet,Negative
 Preclinical evaluation,Paperbirds_Hematology,Negative
 canine models,Oncologiavet,Negative
 Bcell nonHodgkin lymphoma,Oncologiavet,Negative
 Hematology Overview,Hematology Board,Negative
 PROMETTENTE NEI,I Malati Invisibili,Negative
 PAZIENTI NA√èVE,I Malati Invisibili,Negative
 Hematology News Acalabrutinib,Hematology Board,Negative
 future,Anirban Maitra,Negative
 future,Paperbirds_Hematology,Negative
 future,CURE Magazine,Negative
 future,Patient Power,Positive
 future,Leukaemia Care,Negative
 future,OncLive SOSS,Negative
 future,ASH Clinical News,Negative
 future,iwCLL,Positive
 future,Northstream Global Partners,Positive
 future,CLL Ireland,Negative
 future,Wilmot Cancer Institute,Negative
 future,Targeted Oncology,Negative
 future,AbbVie,Negative
 future,MoJo,Negative
 future,VJHemOnc,Positive
 future,WCM Lymphoma,Negative
 future,Dr Shushil Choubey,Positive
 future,AJMC,Negative
 future,doctor chris,Positive
 future,ecancer,Negative
 future,David Costello,Positive
 future,Marta Crespo,Negative
 Durva,Anirban Maitra,Negative
 AZN asset,Anirban Maitra,Negative
   posible opci√≥n,Gaceta M√©dica,Positive
 primera l√≠nea para tratar,Gaceta M√©dica,Positive
 AstraZeneca Acerta Pharmas Acalabrutinib,dave chapman,Positive
 AstraZeneca Acerta Pharmas Acalabrutinib,Tony Baller,Positive
 Orphan Drug Status,dave chapman,Positive
 Orphan Drug Status,Pharmaceutical News,Negative
 Orphan Drug Status,Tony Baller,Positive
 EMA   Bidness Etc,dave chapman,Positive
 EMA   Bidness Etc,Tony Baller,Positive
 EMA committee,ComplexPharm,Positive
 EMA committee,Hlthnews,Negative
 EMA committee,Danvantri Farma,Negative
 EMA committee,pharmabr,Negative
 orphan drug status,ComplexPharm,Positive
 orphan drug status,Hlthnews,Negative
 orphan drug status,Danvantri Farma,Negative
 orphan drug status,pharmabr,Negative
 orphan drug status,Pharma Industry News,Positive
 orphan drug status,Anirban Maitra,Negative
 indications,ComplexPharm,Positive
 indications,Crown Bioscience,Negative
 indications,Regulatory Jobs,Positive
 indications,Ira Kholmyansky,Positive
 indications,European Pharmaceutical Review,Negative
 indications,ACAFARMUR,Positive
 indications,Hlthnews,Negative
 indications,3BL Health,Positive
 indications,Digital-Ontology,Positive
 indications,Global Pharma News,Negative
 indications,Mohammed Saied Faraj,Positive
 indications,SmartRx Systems,Positive
 indications,Beyond the Pill 2015,Positive
 indications,Mktingfarmaceutico,Positive
 indications,PISPOpharma,Positive
 indications,MyMexicanStore,Positive
 indications,World Pharma News,Negative
 indications,David Ledger,Negative
 indications,DTN Pharma News,Positive
 indications,Danvantri Farma,Positive
 indications,pharmabr,Negative
 indications,Pharma Industry News,Positive
 indications,Gunel Huseynova,Positive
 indications,Dr. Melody Davis,Negative
 indications,Breaking News,Negative
 indications,Pharmaceutical Mkt,Positive
 indications,PharmaFactz,Negative
 indications,MDLinx,Negative
 indications,Expert Perspectives in Oncology,Negative
 indications,Patient Power,Negative
 indications,LiveTracker¬Æ,Positive
 indications,ASH Clinical News,Negative
 indications,WCM Lymphoma,Negative
 TGTX,T Allen,Positive
 TGTX,Biotech2050,Positive
 TGTX,CURE Magazine,Negative
 TGTX,Tom Silver,Positive
 TGTX,InvestorsObserver,Positive
 TGTX,MAISA,Positive
 TGTX,H.C. Wainwright & Co.,Positive
 TGTX,BondJamesBond,Positive
 TGTX,1stOncology,Positive
 TGTX,Scott Spencer,Positive
 TGTX,Hottest Stocks Now,Negative
 TGTX,dough,Negative
 TGTX,Crown Equity CRWE,Positive
 TGTX,Anna Deveau,Positive
 TGTX,TG Therapeutics,Positive
 TGTX,"Dr. Paul DeSantis, PharmD",Negative
 TGTX,BluePrint Orphan,Positive
 Acalabrutinib Challenges Ibrutinib,OncLive.com,Negative
 Acalabrutinib Challenges Ibrutinib,GEDEFO,Negative
 Acalabrutinib Challenges Ibrutinib,CLL Society Inc.,Negative
 Acalabrutinib Challenges Ibrutinib,Dr. Melody Davis,Negative
 Acalabrutinib Challenges Ibrutinib,Oncology Consortium,Negative
 Acalabrutinib Challenges Ibrutinib,NACDA Program on Aging,Negative
 Acalabrutinib Challenges Ibrutinib,Jason Broderick,Negative
 Acalabrutinib Challenges Ibrutinib,PER,Negative
 Acalabrutinib Challenges Ibrutinib,Oncology News Update,Negative
 HighRisk CLL Trial,OncLive.com,Negative
 HighRisk CLL Trial,GEDEFO,Negative
 HighRisk CLL Trial,CLL Society Inc.,Negative
 HighRisk CLL Trial,Dr. Melody Davis,Negative
 HighRisk CLL Trial,CMLHope,Positive
 HighRisk CLL Trial,Oncology Consortium,Negative
 HighRisk CLL Trial,NACDA Program on Aging,Negative
 HighRisk CLL Trial,Jason Broderick,Negative
 HighRisk CLL Trial,PER,Negative
 HighRisk CLL Trial,Oncology News Update,Negative
 B,"John P. Leonard, MD",Positive
 B,Priti Arora,Positive
 B,Lymphoma Papers,Negative
 B,Biotech2050,Positive
 B,Paperbirds_Hematology,Negative
 B,Cancers MDPI,Negative
 B,BMC,Positive
 B,SexGenomics,Negative
 B,CDDF,Negative
 B,OTOdocs,Negative
 B,Cancer Papers,Positive
 B,Advera Health,Negative
 B,Malaria Papers,Positive
 B,EurekaMag,Negative
 B,Marta Crespo,Negative
 B,CureHuntr,Negative
 B,satPRnews,Negative
 B,CancerWallonia,Negative
 B,TumorImmunoPapers,Negative
 B,Oncologiavet,Negative
 B,tan jie,Positive
 Oncology Links Acalabrutinib Challenges Ibrutinib,Oncology Links,Negative
 HighRisk CLL Trial Patients,Oncology Links,Negative
   Acalabrutinib Challenges Ibrutinib,CMLHope,Positive
 ‚Äú simi,CMLHope,Positive
    drug,CancerWallonia,Negative
 Director Marketing,Marketing Jobs,Negative
 Acalabrutinib Team Jobs,Marketing Jobs,Negative
 Testing,Lymphomation.org,Positive
 Testing,Fish Chromosomes,Positive
 Testing,CLL-seq,Negative
 Testing,Benlazar S.M Amin√©,Negative
 Testing,Lymphoma Papers,Negative
 Testing,ImmunotherapyPapers,Negative
 Testing,Crwe World,Negative
 Testing,Oncology Tube,Negative
 Testing,Andrew Schorr,Negative
 ACP Acalabrutinib,Lymphomation.org,Negative
 Intolerant,Lymphomation.org,Negative
   Director Marketing Acalabrutinib Team Gaithersburg MD,Gaithersburg Jobs,Positive
 Director,Gaithersburg Jobs,Positive
 Director,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 Director,Expert Perspectives in Oncology,Positive
 Director,WheelieDealer,Negative
 Director,CLLUWISTA,Positive
 Clinical Trial Acalabrutinib,ÕèWilliam Avery Hudson,Negative
 La EMA recomienda acalabrutinib como medicamento hu√©rfano,univadis_es,Positive
 La EMA recomienda acalabrutinib como medicamento hu√©rfano,El Farmac√©utico Independiente,Negative
 en tres,univadis_es,Positive
 en tres,ACAFARMUR,Positive
 en tres,El Farmac√©utico Independiente,Negative
 en tres,Clash of Clans,Positive
 tipos de tumores,univadis_es,Positive
 tipos de tumores,ACAFARMUR,Positive
 tipos de tumores,El Farmac√©utico Independiente,Negative
 tipos de tumores,MedicinaTV,Positive
 tipos de tumores,‚ñ∫Noticias de Salud,Positive
 tipos de tumores,Inter SEO Labs,Positive
 La UE,EL GLOBAL,Positive
 La UE,Oncopharma,Positive
 La UE,El Farmac√©utico Independiente,Negative
 medicamento hu√©rfano,EL GLOBAL,Positive
   para tres tipos de √°ncer,EL GLOBAL,Positive
     ACP,Francesco Turturro,Positive
 acalabrutinib para tres,Oncopharma,Positive
 acalabrutinib para tres,El Farmac√©utico Independiente,Negative
 La EMA recomienda Acalabrutinib,Pedro Lendinez,Positive
 La EMA recomienda Acalabrutinib,Susana Garc√≠a,Positive
 La EMA recomienda Acalabrutinib,Luis Pereira Lopez,Positive
 La EMA recomienda Acalabrutinib,IM M√©dico,Positive
 como medicamento hu√©rfano,Pedro Lendinez,Positive
 como medicamento hu√©rfano,Susana Garc√≠a,Positive
 como medicamento hu√©rfano,Luis Pereira Lopez,Positive
 como medicamento hu√©rfano,@sehh_es,Negative
 como medicamento hu√©rfano,IM M√©dico,Positive
 tipos de c√°ncer,Pedro Lendinez,Positive
 tipos de c√°ncer,Delos Clinical,Positive
 tipos de c√°ncer,Visitador a M√©dicos,Positive
 tipos de c√°ncer,El Farmac√©utico Independiente,Positive
 tipos de c√°ncer,Susana Garc√≠a,Positive
 tipos de c√°ncer,Luis Pereira Lopez,Positive
 tipos de c√°ncer,PMFarma,Positive
 tipos de c√°ncer,onmedic,Positive
 tipos de c√°ncer,@sehh_es,Negative
 Acalabrutinib de AstraZeneca recomendado,Visitador a M√©dicos,Positive
 Acalabrutinib de AstraZeneca recomendado,Acta Sanitaria,Negative
 Europa como medicamento hu√©rfano Lee m√°s,Visitador a M√©dicos,Positive
 Acalabrutinib medicamento,Delos Clinical,Positive
 Acalabrutinib medicamento,Visitador a M√©dicos,Positive
 Acalabrutinib medicamento,PMFarma,Positive
 Acalabrutinib medicamento,onmedic,Positive
 Europa Lee m√°s,Visitador a M√©dicos,Positive
 Acalabrutinib de   recomendado,@sehh_es,Negative
 Acalabrutinib de   recomendado,Fundaci√≥n IDIS,Positive
 Europa como medicamento hu√©rfano,@sehh_es,Negative
 Europa como medicamento hu√©rfano,Fundaci√≥n IDIS,Positive
 Europa como medicamento hu√©rfano,Acta Sanitaria,Negative
 v√≠a,@sehh_es,Negative
 v√≠a,Fundaci√≥n IDIS,Positive
 v√≠a,Guillermo Sanz,Negative
 v√≠a,HematologiaValdecilla,Positive
 v√≠a,"Raul Cordoba, MD, PhD",Positive
 v√≠a,Dr. JOSE VELASQUEZ,Positive
 herenciageneticayenfermedad Acalabrutinib recomendado,Victor Norberto Cerasale Morteo,Negative
 para su desig,Victor Norberto Cerasale Morteo,Negative
 EMA recomend√≥ acalabrutinib como medicamento hu√©rfano,ACAFARMUR,Positive
 La EMA recomend√≥ acalabrutinib como medicamento hu√©rfano,El Farmac√©utico Independiente,Negative
 tres,El Farmac√©utico Independiente,Positive
 tres,MedicinaTV,Positive
 tres,Ascol,Positive
 tres,‚ñ∫Noticias de Salud,Positive
 tres,Qu√© se cuece,Positive
 tres,Inter SEO Labs,Positive
 ‚òÖ,‚ñ∫Noticias de C√°ncer,Positive
 Mirada,‚ñ∫Noticias de C√°ncer,Positive
 La   recomienda como medicamento hu√©rfano,EL GLOBAL,Positive
   para tres tumores,EL GLOBAL,Positive
 La EMA recomienda acalabrutinib,MedicinaTV,Positive
 La EMA recomienda acalabrutinib,El Farmac√©utico Independiente,Negative
 La EMA recomienda acalabrutinib,Ascol,Positive
 La EMA recomienda acalabrutinib,Clash of Clans,Positive
 La EMA recomienda acalabrutinib,‚ñ∫Noticias de C√°ncer,Negative
 La EMA recomienda acalabrutinib,Qu√© se cuece,Positive
 La EMA recomienda acalabrutinib,Inter SEO Labs,Positive
 La EMA recomienda acalabrutinib,ùïµùñäùñâùñé ùïΩùñäùñïùñöùñáùñëùñéùñàùñÜùñìùñî üî¥üü°üü£,Positive
 AstraZeneca como medicamento hu√©rfano,MedicinaTV,Positive
 AstraZeneca como medicamento hu√©rfano,El Farmac√©utico Independiente,Negative
 AstraZeneca como medicamento hu√©rfano,Ascol,Positive
 AstraZeneca como medicamento hu√©rfano,Clash of Clans,Positive
 AstraZeneca como medicamento hu√©rfano,‚ñ∫Noticias de C√°ncer,Negative
 AstraZeneca como medicamento hu√©rfano,Qu√© se cuece,Positive
 AstraZeneca como medicamento hu√©rfano,Inter SEO Labs,Positive
 AstraZeneca como medicamento hu√©rfano,ùïµùñäùñâùñé ùïΩùñäùñïùñöùñáùñëùñéùñàùñÜùñìùñî üî¥üü°üü£,Positive
 herenciageneticayenfermedad La EMA recomienda Acalabrutinib,Victor Norberto Cerasale Morteo,Negative
 su designaci√≥,Victor Norberto Cerasale Morteo,Negative
 orphan drug designation,Crown Bioscience,Negative
 orphan drug designation,Regulatory Jobs,Positive
 orphan drug designation,Ira Kholmyansky,Positive
 orphan drug designation,3BL Health,Positive
 orphan drug designation,Digital-Ontology,Positive
 orphan drug designation,Global Pharma News,Negative
 orphan drug designation,Mohammed Saied Faraj,Positive
 orphan drug designation,SmartRx Systems,Positive
 orphan drug designation,Beyond the Pill 2015,Positive
 orphan drug designation,Mktingfarmaceutico,Positive
 orphan drug designation,PISPOpharma,Positive
 orphan drug designation,MyMexicanStore,Positive
 orphan drug designation,World Pharma News,Negative
 orphan drug designation,David Ledger,Negative
 orphan drug designation,DTN Pharma News,Positive
 orphan drug designation,Gunel Huseynova,Positive
 orphan drug designation,Sravani Ganji,Positive
 orphan drug designation,Pharmaceutical News,Positive
 orphan drug designation,Drug Delivery News,Positive
 orphan drug designation,Sum,Positive
 orphan drug designation,karin55marin,Positive
 orphan drug designation,Knowsis Healthcare,Positive
 orphan drug designation,Healthcare Industry,Positive
 orphan drug designation,Dustin Phan,Positive
 orphan drug designation,VJHemOnc,Negative
 orphan drug designation,MAISA,Negative
 orphan drug designation,NYC Social Group,Negative
 orphan drug designation,Cedar Consultants,Negative
 La EMA recomienda acalabrutinib para,@sehh_es,Negative
 La EMA recomienda como medicamento,COF Pontevedra,Positive
 acalabrutinib para tres tumores,COF Pontevedra,Positive
 tipos de tumores raros,Ascol,Positive
 tipos de,IM M√©dico,Positive
   News,Clash of Clans,Positive
   News,The Purple Society,Negative
   News,Patient Power,Positive
   News,GSK GlaxoSmithKline,Positive
   News,Stem Cell News,Negative
 ‚òÖ La EMA recomienda acalabrutinib AstraZeneca como medicamento,‚ñ∫Noticias de Salud,Positive
 ‚Üí ‚òÖ,‚ñ∫Noticias de C√°ncer,Negative
 tipos de tumores raros v√≠a,Qu√© se cuece,Positive
 tumores,ùïµùñäùñâùñé ùïΩùñäùñïùñöùñáùñëùñéùñàùñÜùñìùñî üî¥üü°üü£,Positive
 raros   v√≠a,ùïµùñäùñâùñé ùïΩùñäùñïùñöùñáùñëùñéùñàùñÜùñìùñî üî¥üü°üü£,Positive
 EU orphan drug designation,Brum-Jobs,Positive
 ESPERTI,I Malati Invisibili,Negative
 EMA RACCOMANDANO LA DESIGNAZIONE,I Malati Invisibili,Negative
 DI FARMACO,I Malati Invisibili,Negative
 ORFANO,I Malati Invisibili,Negative
 EU orphan status,Paul Lane,Negative
 EU orphan status,Mr. Brian Uberig,Negative
 EU orphan status,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 EU orphan status,Archana,Positive
 EU orphan status,IBTimes üáÆüá≥,Positive
 EU orphan status,MedSource,Negative
 EU orphan status,David Ledger,Negative
 EU orphan status,Danvantri Farma,Negative
 EU orphan status,Dr. Carsten Wenzel,Negative
 EU orphan status,Beyond the Pill 2015,Positive
 EU orphan status,Mktingfarmaceutico,Positive
 EU orphan status,patientincluded,Positive
 EU orphan status,MedicalFactsEU,Positive
 EU orphan status,Everything Pharma,Negative
 EU orphan status,Pronounce Media Medical & Pharmacutical News.,Positive
 EU orphan status,Digital-Ontology,Negative
 EU orphan status,PharmaTimes,Negative
 EU orphan status,Pharma Trader,Negative
 Orphan drug designation,European Pharmaceutical Review,Negative
 Orphan drug designation,ACAFARMUR,Positive
 Orphan drug designation,SwanBio,Positive
 Orphan drug designation,Danvantri Farma,Negative
 Orphan drug designation,Pharmaceutical Mkt,Positive
 PRT,European Pharmaceutical Review,Positive
 Ya,Mari√°ngel Gil,Positive
 Ya,Florencia,Positive
 Acertas,Novateur Ventures,Positive
 Acertas,Pharmaceutical News,Positive
 EU   status,Novateur Ventures,Positive
    AZN,Pharmaceutical News,Positive
 Acerta Pharmas Acalabrutinib,Pharmaceutical News,Negative
 DTN Pharma News Acalabrutinib,DTN Pharma News,Positive
 European Medicines Ag,pharmabr,Negative
 Pharma News EMA committee,Pharma Industry News,Positive
 Acerta cancer drug acalabrutinib,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Acerta cancer drug acalabrutinib,Archana,Positive
 Acerta cancer drug acalabrutinib,IBTimes üáÆüá≥,Positive
 International Business Times India Edition,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 vi,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 AstraZeneca Acerta Pharmas acalabrutinib,Dr. Melody Davis,Negative
 AstraZeneca Acerta Pharmas acalabrutinib,Breaking News,Negative
 Orphan Drug,Dr. Melody Davis,Negative
 Orphan Drug,Breaking News,Negative
 Orphan Drug,Lymphoma News Today,Positive
 Orpan drug recommendations,"Neil Sankar M.D.,MPH",Positive
 Haem malignancy indications,"Neil Sankar M.D.,MPH",Positive
 haem malignancies,SwanBio,Positive
 OrphanDrug Designation,1stOncology,Negative
   Indications,1stOncology,Negative
 –ü—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç acalabrutinib –ø–æ–ª—É—á–∏–ª,–§–∞—Ä–º–ê–∫—Ç–∞,Positive
 Acalabrutinib CLL SCL MCL,JediPD,Negative
 Billion year,JediPD,Negative
 earningsEyes,JediPD,Negative
 horizon,JediPD,Negative
 horizon,Christy2x,Positive
 horizon,Targeted Oncology,Positive
 Acerta Acalabrutinib ACP,Anirban Maitra,Negative
 Indications,Pharmaceutical News,Positive
 Indications,[iito] Life Science,Positive
 Indications,PharmaFactz,Positive
    AZN PLC,Pharmaceutical News,Negative
 BRIEF   AZN,Pharmaceutical News,Negative
 Europe Acalabrutinib recommend,Drug Delivery News,Negative
 ACALABRUTINIB ORPHAN DRUG DESIGNATION RECOMMENDED,Cision News,Negative
 ORPHAN DRUG DESIGNATION,CMLHope,Negative
 EUROPE,CMLHope,Negative
 INDICATIONS,CMLHope,Negative
 CMLHope ACALABRUTINIB ORPHAN DRUG DESIGNATION RECOMMENDED,CMLHope,Negative
 Chronic Lymphocytic Leukemia Leuk,CMLHope,Negative
   ACALABRUTINIB ORPHAN DRUG DESIGNATION RECOMMENDED Market News alert AstraZeneca PLC,FTSE100 RNS,Positive
 Acalabrutinib recomm,Sum,Positive
 Acalabrutinib recomm,Healthcare Industry,Positive
   COMP,Elsa Willebrand,Positive
 orphan designations,Elsa Willebrand,Positive
 Read,Pharmaceutical News,Negative
 Read,Targeted Oncology,Negative
 Read,Lymphoma Hub,Negative
 Read,Patient Power,Negative
 EU Orphan Designation,[iito] Life Science,Positive
 News NASDAQ OMX GlobeNewswire ACALABRUTINIB ORPHAN DRUG DESIGNATION,iHangout,Positive
 AstraZeneca    ACALABRUTINIB,Vox Markets Podcast,Positive
 NEJM Acalabrutinib ACP,Tran-Der Tan,Negative
 NEJM Acalabrutinib ACP,La chuleta del FIR,Negative
 New Leukemia drug,ColumbiaCancer,Positive
 „Éñ„É´„Éà„É≥Âûã„ÉÅ„É≠„Ç∑„É≥„Ç≠„Éä„Éº„ÇºÈòªÂÆ≥Ââ§acalabrutinib„ÅØÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÊ≤ªÁôÇ„Å´„Åä„ÅÑ„Å¶ÂÆâÂÖ®„Åã„Å§ÊúâÂäπ,Êµ∑Â§ñ„Åå„ÇìÂåªÁôÇÊÉÖÂ†±„É™„Éï„Ç°„É¨„É≥„Çπ,Positive
 „Åå„Çì,Êµ∑Â§ñ„Åå„ÇìÂåªÁôÇÊÉÖÂ†±„É™„Éï„Ç°„É¨„É≥„Çπ,Positive
 Original Article Acalabrutinib ACP,NEJM,Negative
 Et tu,Richard Lehman,Positive
 Bruton   New metoo Bruton kinase inhibitor acalabrutinib,Richard Lehman,Positive
 reviews,Richard Lehman,Positive
 reviews,Genentech,Negative
 reviews,AtlanticJOMedicine,Negative
 reviews,Cecilia,Positive
 reviews,ASH,Negative
 class drug,Shankara Paneesha,Negative
 PubMed,MedChem & ONCo,Negative
 PubMed,Biblioteca HUCA,Positive
 PubMed,Fabrice Leclerc,Positive
 PubMed,SeqComplete,Negative
 PubMed,CancerWallonia,Positive
 PubMed,Michelle Holder,Positive
 PubMed,Tim Fenske,Negative
 PubMed,Bloodsucking Parasites,Positive
 PubMed,Integra Medical,Positive
 PubMed,MoJo,Positive
 PubMed,"Naveen Pemmaraju, MD",Negative
 PubMed,yukiüåæ„äóÔ∏èÔºñ„Åï„ÅÑüéâ‚öî,Positive
 NCBI,MedChem & ONCo,Negative
 NCBI,CancerWallonia,Positive
 NCBI,Michelle Holder,Positive
 NCBI,Tim Fenske,Negative
 NCBI,Benlazar S.M Amin√©,Negative
 NCBI,Fabrice Leclerc,Negative
 NCBI,Integra Medical,Positive
 NCBI,MoJo,Positive
 NCBI,Bitlattice Woman,Positive
 NCBI,yukiüåæ„äóÔ∏èÔºñ„Åï„ÅÑüéâ‚öî,Positive
 LEUKEMIA CLLAcalabrutinib,MedChem & ONCo,Negative
 Selective BTK InhibitorVenetoclax BCL protein inhibitor,MedChem & ONCo,Negative
 Strong Responses,MedChem & ONCo,Negative
 Dr Jacqueline Barrientos,VJHemOnc,Negative
 Dr Jacqueline Barrientos,"Raul Cordoba, MD, PhD",Negative
 Selective BTK inhibitor acalabrutinib,Dr. Andre Goy,Negative
 safety amp efficacy profiles,Dr. Andre Goy,Negative
 Acaba de ser,"Raul Cordoba, MD, PhD",Negative
 Espa√±a,"Raul Cordoba, MD, PhD",Negative
 ya tenemos,"Raul Cordoba, MD, PhD",Negative
 puertas otro,"Raul Cordoba, MD, PhD",Negative
 generaci√≥n,"Raul Cordoba, MD, PhD",Negative
 John Byrd MD,OncLive.com,Negative
 John Byrd MD,Cancer Papers,Negative
 John Byrd MD,OMedLive,Positive
 John Byrd MD,ASH,Negative
 alacabrutinib,OncLive.com,Negative
 PAL query Find studies,Lymphomation.org,Negative
 btk pathway,Lymphomation.org,Negative
   Venetoclax Acalabrutinib Active,Oncology,Negative
   Venetoclax Acalabrutinib Active,PracticeUpdate,Negative
 Acalabrutinib ACP Shows Efficacy Safety,Toni,Positive
 Acalabrutinib ACP Shows Efficacy Safety,OncoTherapy Network,Negative
 Acalabrutinib ACP Shows Efficacy Safety,Lauren Evoy Davis,Positive
 Adult CLL,Toni,Positive
 Adult CLL,OncoTherapy Network,Negative
 Adult CLL,Lauren Evoy Davis,Positive
 Adult CLL,COPD News,Negative
 Adult CLL,Stem Cell News,Negative
 ‚Äú Acalabrutinib ACP,frothmouth,Positive
 ‚Äî NEJM,frothmouth,Positive
 WM„ÅÆÊÜÇÈ¨±„ÄÇËã±ÂõΩAstaraZenecaÁ§æ„ÅåÂÑÑ„Éâ„É´„ÅßËò≠Á±≥Acerta PharmaÁ§æ„ÇíË≤∑Âèé„ÄÅP „Å´ÂÖ•„Å£„Å¶„ÅÑ„ÇãBTKÈòªÂÆ≥Ââ§ÔºàÔº¢Á¥∞ËÉûÁôΩË°ÄÁóÖÊ≤ªÁôÇËñ¨ Ôºâ acalabrutinib „ÅÆÊ®©Âà©Á¢∫‰øù„ÄÇÊúüÂæÖ„ÅÆ„Éñ„É≠„ÉÉ„ÇØ„Éê„Çπ„Çø„Éº„Å†„Åå„ÄÅÂáÑ„ÅÑÈáëÈ°ç„Åß„ÅÇ„Çã,Mm„ÅÆÊÜÇÈ¨±,Positive
 tcoLhPGiizDd,Punjikasthala,Positive
 Acerta Pharma Phase III BTK inhibitor acalabrutinib,Krishan Maggon,Negative
 AstraZeneca comprar√° fatia majorit√°ria,Negociando Agora Web,Positive
 AstraZeneca comprar√° fatia majorit√°ria,Weverton Souza,Positive
 AstraZeneca comprar√° fatia majorit√°ria,EXAME Neg√≥cios,Positive
 bi Transa√ß√£o visa o medicamento acalabrutinib cont,Negociando Agora Web,Positive
 bi Transa√ß√£o visa o medicamento acalabrutinib cont,Weverton Souza,Positive
 bi Transa√ß√£o visa o medicamento acalabrutinib cont,EXAME Neg√≥cios,Positive
 UPDATE AstraZeneca,JP Duvenhage,Positive
 UPDATE AstraZeneca,StartupStudio,Positive
 UPDATE AstraZeneca,Davies Wealth Management,Positive
 UPDATE AstraZeneca,Michel Francoeur,Positive
 UPDATE AstraZeneca,NNY News.ca,Positive
 UPDATE AstraZeneca,BidBookDNA‚Ñ¢,Positive
 Believes,JP Duvenhage,Negative
 Believes,StartupStudio,Negative
 Believes,Davies Wealth Management,Positive
 Believes,Michel Francoeur,Positive
 r,JP Duvenhage,Negative
 r,StartupStudio,Negative
 r,Davies Wealth Management,Positive
 r,Michel Francoeur,Positive
 Imbruvia challenger acalabrutinibs development plan,Sukaina Virji,Positive
 acalabrutinib sales,NNY News.ca,Positive
 acalabrutinib sales,StartupStudio,Negative
 acalabrutinib sales,JP Duvenhage,Negative
 acalabrutinib sales,BidBookDNA‚Ñ¢,Positive
 incantation,Kristen Hallam,Positive
 Harry Potter,Kristen Hallam,Positive
 Harry Potter,Potter Papers,Positive
 ‚É£ Acalabrutinib,Dr Musa Fares Alzahrani,Negative
 rights,Ghazi Tadmouri,Positive
 promising blood,Ghazi Tadmouri,Positive
 compound acalabrutinib,Ghazi Tadmouri,Positive
 acquisition talks,steve bagley,Positive
 blood cancer compound acalabrutinib,steve bagley,Positive
   news Acalabrutinib ACP Shows Efficacy Safety,COPD News,Negative
   News Acalabrutinib ACP Shows Efficacy Safety,Stem Cell News,Negative
 Research News,Living Safely,Positive
 Research News,Patient Power,Negative
 relapsed Chronic,Living Safely,Negative
 Acerta Pharma Btk inhibitor acalabrutinib ACP,Cormac Sheridan,Positive
 Dutch,Mike Ward,Negative
 Dutch,The Patient's Channel,Negative
 target,Mike Ward,Negative
 target,Marcel van den Brink,Positive
 target,Henning,Negative
 target,Paperbirds_Hematology,Negative
 target,Biotech2050,Negative
 target,Christopher Steer,Negative
 Acalabrutinib   ORR,liz,Positive
 RR CLL Ibrutinib,liz,Positive
 Amy Johnson,Targeted Oncology,Negative
 bn acquisition,Joe Hedden,Negative
 nd genImbruvica competitor acalabrutinib,Joe Hedden,Negative
 Acerta Pharma Announces Study,Lindsey Summers üò∑‚úäüèº,Positive
 Acerta Pharma Announces Study,Pharmicals,Positive
 Acerta Pharma Announces Study,Cancer Blog,Negative
 Acerta Pharma Announces Study,Business Wire-Health,Negative
 New England Journal,Lindsey Summers üò∑‚úäüèº,Positive
 New England Journal,Pharmicals,Positive
 New England Journal,Cancer Blog,Negative
 New England Journal,Johnson & Johnson,Positive
 New England Journal,DrugGenius,Negative
 New England Journal,Business Wire-Health,Negative
 New England Journal,AGD Biomedicals,Positive
 New England Journal,AstrologyNewsNetwork,Positive
 New England Journal,1stOncology,Negative
 New England Journal,PressReleasePoint,Negative
 New England Journal,Pharmacutical Daily,Negative
 New England Journal,Flash Alert,Negative
 New England Journal,CLL Ireland,Negative
 Medicine,Lindsey Summers üò∑‚úäüèº,Positive
 Medicine,Pharmicals,Positive
 Medicine,Cancer Blog,Negative
 Medicine,Johnson & Johnson,Positive
 Medicine,DrugGenius,Negative
 Medicine,Business Wire-Health,Negative
 Medicine,AstrologyNewsNetwork,Positive
 Medicine,Oncology Tube,Positive
 Medicine,Michele Nadeem-Baker,Negative
 Medicine,PressReleasePoint,Negative
 Medicine,Pharmacutical Daily,Negative
 Medicine,Flash Alert,Negative
 Medicine,Expert Perspectives in Oncology,Positive
 Medicine,Hoofcare+Lameness,Positive
 Medicine,Ardalan Ahmad,Negative
 Medicine,CLL Ireland,Positive
 Medicine,AURELIAN UDRISTIOIU,Negative
 Medicine,NU Internal Medicine,Positive
 ndgen,MDedge Hematology & Oncology,Negative
 PubMed   NCBI,CancerWallonia,Positive
 PubMed   NCBI,CLL Ireland,Negative
 PubMed   NCBI,Fabrice Leclerc,Negative
   New BTK Inhibitor Active,Demetrios Perdikis,Positive
 RelapsedRefractory CLL CMECE MedPage Today,Demetrios Perdikis,Positive
 Acalabrutinib le,Demetrios Perdikis,Positive
 secondgeneration BTK inhibitor acalabrutinib,OncLive.com,Negative
 III CLL study,OncLive.com,Negative
 III CLL study,Targeted Oncology,Negative
 ASH Venetoclax Acalabrutinib Active,Doctors Lounge,Positive
 studies,Doctors Lounge,Negative
 studies,Sigrid Sk√•nland,Negative
 studies,"chadi nabhan MD, MBA, FACP",Negative
 studies,Matthews & Associates,Positive
 studies,Memorial Sloan Kettering Cancer Center,Negative
 studies,CLL Society Inc.,Positive
 studies,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 studies,SunAWARE,Positive
 studies,Aziz Khan,Positive
 studies,Medscape Education,Negative
 studies,Toby Eyre,Negative
 studies,WCM Lymphoma,Negative
 studies,OncologyNurseAdvisor,Negative
 studies,VJHemOnc,Negative
 Presented,NEJM,Positive
 relapsed CLL,tehmina tahir,Positive
 relapsed CLL,LymphomaAction,Negative
 relapsed CLL,Lymphoma Hub,Negative
 relapsed CLL,Pamela Helton,Positive
 relapsed CLL,CureClick,Positive
 Uncontrolled phase,Cancer Cell,Negative
 Acalabrutinib ACP S,Cancer Blog,Negative
 News Acerta Pharma Announces Study,Johnson & Johnson,Positive
 News Acerta Pharma Announces Study,DrugGenius,Negative
 Prognostic Significance,Paperbirds_Hematology,Negative
 Prognostic Significance,Benlazar S.M Amin√©,Negative
 Prognostic Significance,Tom,Negative
 Prognostic Significance,touchONCOLOGY,Negative
 Prognostic Significance,Oncology,Negative
 delq,Paperbirds_Hematology,Negative
 Jacqueline Claudia Barrientos MD MS,OncLive SOSS,Positive
 Jacqueline Claudia Barrientos MD MS,OncLive.com,Negative
     dates,MedscapeLIVE,Positive
 Advances,MedscapeLIVE,Positive
 Advances,Medscape Oncology,Positive
 Advances,Medscape Education,Positive
 Advances,Shouting at people in my underpants,Negative
 Advances,Medscape Nurses,Positive
 Advances,VJHemOnc,Negative
 Advances,MD Anderson Cancer Center,Negative
 Advances,OncLive.com,Negative
 Advances,Biren Sahoo,Positive
 Advances,Mary Ruberry,Positive
 Advances,Nutritional Epigenetic News,Positive
 Advances,MD Anderson Leukemia,Negative
 Advances,Oncology Tube,Positive
 Advances,Guillermo Sanz,Negative
 Advances,ImmunotherapyPapers,Negative
 Advances,CancerWallonia,Negative
 Advances,Carevƒ´ve,Negative
 Advances,microRNApapers,Negative
 Advances,"Raul Cordoba, MD, PhD",Negative
 Advances,"Dr T. Comeau , MD",Negative
 Advances,Cancer Papers,Negative
 Advances,Janssen Sverige,Positive
 Advances,Judith Jones,Positive
 Advances,JLOCF,Positive
 Advances,Debbie Woodbury,Negative
 Advances,Rhia Steele@ravishingrhia.com,Negative
 Advances,WEGO Health,Negative
 Advances,‚ô•Melissa‚ô•,Positive
 Advances,Ebookspk,Positive
 Advances,Sandy D.,Negative
 Advances,Paula Pyzia,Negative
 Advances,Senior Care Corner,Negative
 Advances,International Pain Foundation¬Æ,Negative
 Advances,Colleen Busch,Negative
 Advances,Katie,Positive
 Advances,–Æ–ª–∏—è –ï—Ñ–∏–º–æ–≤–∞,Positive
 Advances,CancerConnect,Negative
 Advances,Patient Power,Positive
 Advances,Lymphoma Coalition,Negative
 Life,MedscapeLIVE,Positive
 Life,Patient Power,Positive
 Life,Medscape Oncology,Positive
 Life,Medscape Education,Positive
 Life,Medscape Nurses,Negative
 Life,Living A Busy Life - With Cancer,Positive
 Life,Biosimilar Today iMagazine,Negative
 Life,Kimberly Curseen,Positive
 Life,Paperbirds_Hematology,Negative
 Life,CureHuntr,Negative
 Life,TrialBulletin,Negative
 Life,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 Life,Lisa Palacios,Negative
 Life,MD Anderson Leukemia,Negative
 Life,Dr Amrish,Positive
 Life,CLL Ireland,Negative
 Life,"Pharmacyclics, an AbbVie Company",Negative
 Life,JanssenUS,Negative
 Life,Matthew Kauffman,Negative
 Life,Francesco Turturro,Negative
 Register,MedscapeLIVE,Positive
 Register,BioAscend,Positive
 Register,Medscape Education,Negative
 Register,"Cowan, Liebowitz",Negative
 Register,Karmanos Cancer Institute,Negative
 Register,Patient Power,Positive
 Register,STTR Cancer,Positive
 Register,CLL Society Inc.,Negative
 Register,Patient Empowerment Network,Negative
 Register,OHC,Negative
 Register,Carevƒ´ve,Positive
 Register,WCM Lymphoma,Negative
 Monoclonal Bcell Lymphocytosis,Paperbirds_Hematology,Negative
 Prednisolone Therapy,Paperbirds_Hematology,Negative
 Dermatomyositis,Paperbirds_Hematology,Negative
     projects,QUB Blood Cancer Research,Positive
 answers,Patient Power,Positive
 answers,European Hematology Association,Negative
 answers,Oncology Tube,Negative
 answers,VJHemOnc,Negative
 treatment paradigm,Oncology Nursing News,Negative
 treatment paradigm,OncLive.com,Positive
 treatment paradigm,Rajesh Sharma,Negative
 treatment paradigm,Targeted Oncology,Negative
 treatment paradigm,CARE‚Ñ¢ Education,Negative
 Ublituximab,PracticeUpdate,Positive
 Ublituximab,Stock Market Catalyst News üåé,Positive
 Ublituximab,Biotech & Tech Stock Focus,Positive
 Ublituximab,Dan Brickner,Positive
 Ublituximab,STOCKMASTER2000,Positive
 Ublituximab,"OTC Dynamics, Inc.",Negative
 Ublituximab,Stock News Bot,Positive
 Ublituximab,Crwe World,Positive
 Ublituximab,Stock Titan,Positive
 Ublituximab,Mellalta Meets,Negative
 Ublituximab,Tina Witte,Positive
 Ublituximab,Mazeraski,Negative
 Ublituximab,IMPharma News,Positive
 Ublituximab,Jodie Insights,Negative
 Ublituximab,dough,Positive
 Ublituximab,Bio Stocks‚Ñ¢,Positive
 Ublituximab,U2 Fans,Negative
 Ublituximab,H.C. Wainwright & Co.,Positive
 Ublituximab,AlphaBronze,Positive
 Ublituximab,Aloysius Pendergast,Positive
 Ublituximab,Quant Data,Positive
 Ublituximab,Flash Alert,Negative
 Ublituximab,ASCO Publications,Negative
 Ublituximab,RD360,Positive
 Ublituximab,ClinicalTrialsData,Positive
 Ublituximab,Biotech2050,Negative
 Ublituximab,Blood Journal,Negative
 Ublituximab,YGLDMETG,Positive
 Ublituximab,Krishan Maggon,Negative
 Ublituximab,Tim Fenske,Negative
 Ublituximab,Lymphoma Papers,Negative
 Ublituximab,CureHuntr,Negative
 Ublituximab,TrialBulletin,Positive
 Ublituximab,Fernando Medina,Positive
 Ublituximab,Mehmet Tuna,Positive
 Ublituximab,Lymphoma Hub,Negative
 Ublituximab,Oncology,Negative
 Ublituximab,HRA,Positive
 Final,International Conference on Malignant Lymphoma,Negative
 abstracts,International Conference on Malignant Lymphoma,Positive
 abstracts,iwCLL,Negative
 abstracts,Lymphoma Hub,Positive
 abstracts,Breaking Data,Negative
 abstracts,Oncology Times,Negative
 abstracts,"Amber Koehler, PA-C",Negative
 abstracts,RIOH,Negative
   Submissions,International Conference on Malignant Lymphoma,Negative
 CET Submit,International Conference on Malignant Lymphoma,Negative
   TY,Michele Nadeem-Baker,Positive
 vaccine,Michele Nadeem-Baker,Negative
 vaccine,"Chaitra Ujjani, MD",Positive
 weeks,Michele Nadeem-Baker,Negative
 weeks,Broad Institute,Positive
 weeks,VJHemOnc,Negative
 weeks,Andrew Schorr,Negative
 weeks,Nic üíô,Positive
 weeks,Joe,Negative
 weeks,CURE Magazine,Negative
 weeks,Lymphoma Hub,Negative
 weeks,Verastem Oncology,Negative
 weeks,Helen Jane Mee,Negative
 weeks,Heather DelaCruz,Positive
 weeks,Los Lobos,Positive
 weeks,OncLive.com,Negative
 weeks,Patient Power,Negative
 weeks,Christopher Steer,Negative
 weeks,Thommed Snooze üò¥,Positive
 Numbers,Nicolas Martinez üá®üá¥üá®üá¥,Positive
 Numbers,Scott Werntz,Negative
 Phase III RCT results,Nicolas Martinez üá®üá¥üá®üá¥,Positive
 CD markers,knowmedge,Positive
 Rectal cancer,"Documents Delivered, LLC",Positive
 shares treatment considerations,OncLive SOSS,Positive
 ublituximab,Targeted Oncology,Positive
 ublituximab,Biotech2050,Positive
 ublituximab,CURE Magazine,Negative
 ublituximab,KeiraSmith_i3Health,Positive
 ublituximab,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 ublituximab,BioPharma Global,Positive
 ublituximab,BondJamesBond,Positive
 ublituximab,CLL Society Inc.,Negative
 ublituximab,OncLive.com,Positive
 ublituximab,Dr. Andre Goy,Negative
 ublituximab,John Pennett,Positive
 ublituximab,Healio,Negative
 ublituximab,HemOnc Today,Negative
   COVID CDC,CLL Society Inc.,Negative
 CDC,CLL Society Inc.,Negative
 Interim Recommendations,CLL Society Inc.,Negative
   Town Hall address,Patient Power,Negative
 AdvocateExperts,Patient Power,Negative
 patient guests,Patient Power,Negative
 care partners,Patient Power,Positive
 care partners,Esther Schorr,Negative
 care partners,Theresa (Clementi) Doan,Positive
 care partners,Andrew Schorr,Negative
 stay,Patient Power,Negative
 stay,VJHemOnc,Negative
 Shuo Ma MD PhD amp Jennifer Boyer MSN APRN NPC,Lurie Cancer Center,Negative
 Deborah Stephens,Lurie Cancer Center,Negative
 Treatment Landscape,Patient Power,Negative
 Treatment Landscape,Brave Is Now¬Æ,Negative
 Treatment Landscape,Weill Cornell Medicine Meyer Cancer Center,Negative
 Facebook,Patient Power,Negative
 Facebook,Aaron C.,Positive
 Facebook,Michele Nadeem-Baker,Negative
 Facebook,Brian Barrett,Negative
 Facebook,Matthew Kauffman,Negative
 Prediction,Lymphoma Hub,Negative
 Prediction,"Dr T. Comeau , MD",Negative
 Prediction,INDoximity üáÆüá≥,Negative
 Prediction,Oscar Lahoud,Positive
 Prediction,ClinOwl Haematology,Negative
 Prediction,filippo masini,Negative
 Prediction,Irene Mangues,Positive
 Prediction,Benlazar S.M Amin√©,Negative
 Prediction,ACS Journal Cancer,Negative
 Prediction,"Raul Cordoba, MD, PhD",Negative
 ibrutinib efficacy,Lymphoma Hub,Negative
 Live Town Hall,Patient Power,Negative
 Current CLL Treatment Landscape,Patient Power,Negative
 CareWere,Patient Power,Negative
 intros,Patient Power,Negative
 stages,Patient Power,Negative
 stages,Cagatay M. CULCUOGLU,Positive
 stages,"Massive Bio, Inc.",Positive
 amp questions,Patient Power,Negative
 doctor,Patient Power,Positive
 doctor,Kirk Kirlin,Positive
 doctor,CLL Advocates Network,Negative
 doctor,CURE Magazine,Negative
 doctor,AbbVie US,Negative
 doctor,Andrew Schorr,Positive
 doctor,Warren Terry Knight,Positive
 doctor,my sharona,Positive
 doctor,Cancer And I,Negative
 doctor,Esther Schorr,Negative
 doctor,Sarah Sunshine,Positive
 Tune,Patient Power,Positive
 Tune,WCM Lymphoma,Negative
 Tune,CLLUWISTA,Positive
 live,Patient Power,Positive
 live,ESH (Haematology),Negative
 Facebook page,Patient Power,Negative
 Facebook page,Jhawn Paul,Positive
 Facebook page,CLL Warwick Uni,Negative
 TODAY,Patient Power,Positive
 TODAY,Medscape Education,Negative
 TODAY,Michele Nadeem-Baker,Positive
 TODAY,VJHemOnc,Negative
 TODAY,Research To Practice,Positive
 TODAY,LLSCanada,Negative
 TODAY,MD Anderson Leukemia,Negative
 TODAY,Prof John,Negative
 TODAY,Bio-Rad EMEA,Negative
 TODAY,BioAscend,Positive
 Activation,Eastern,Positive
 Activation,ClinOwl Haematology,Negative
 Activation,TYR Kinase papers,Negative
 Activation,AIRR-seq papers,Positive
 Activation,ASH,Negative
 Activation,CellworksLife,Negative
 Activation,Blood Journal,Negative
 Activation,Philip McCarthy,Negative
 Activation,Cancer Papers,Negative
 Activation,Mehdi Hamadani,Positive
 Resistance,Eastern,Positive
 Resistance,Paperbirds_Hematology,Positive
 Resistance,Robert Z. Orlowski,Negative
 Resistance,MD Anderson Leukemia,Negative
 Resistance,"chadi nabhan MD, MBA, FACP",Negative
 Resistance,Cancer Immunology Research,Negative
 Resistance,UNMC Pathology & Microbiology,Positive
 Resistance,McHeyzer-Williams,Positive
 Resistance,Taylor Lab UM,Negative
 Resistance,TumorImmunoPapers,Negative
 Resistance,CancerWallonia,Negative
 Resistance,WorldStemCellSummit,Positive
 Resistance,Oncology Board,Negative
 Resistance,"Raul Cordoba, MD, PhD",Negative
 Resistance,"Philippe Aftimos, MD",Positive
 Resistance,Christopher Steer,Negative
 Resistance,GEDEFO,Negative
 Resistance,Oncology Tube,Negative
 Resistance,Targeted Oncology,Negative
 JAKSrcSTATMcl,Eastern,Positive
 Pathway,Eastern,Positive
 Pathway,Oncology Tube,Negative
 umbralisib,Biotech2050,Negative
 umbralisib,CURE Magazine,Negative
 umbralisib,TG Therapeutics,Positive
 umbralisib,Anthony Mato,Negative
 umbralisib,BioPharma Global,Positive
 umbralisib,Targeted Oncology,Positive
 umbralisib,BondJamesBond,Positive
 umbralisib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 umbralisib,OncLive.com,Negative
 umbralisib,Blood Journal,Negative
 umbralisib,Chan Cheah,Negative
 umbralisib,Medivizor,Positive
 umbralisib,COPD News,Negative
 umbralisib,"chadi nabhan MD, MBA, FACP",Negative
 umbralisib,The Lancet Oncology,Negative
 chemoimmunotherapy,Biotech2050,Negative
 chemoimmunotherapy,Lymphoma Papers,Positive
 chemoimmunotherapy,Cancer Papers,Negative
 chemoimmunotherapy,UVA Science Pubs,Positive
 chemoimmunotherapy,Paperbirds_Hematology,Positive
 chemoimmunotherapy,VJHemOnc,Positive
 chemoimmunotherapy,OncLive SOSS,Negative
 chemoimmunotherapy,ASH Clinical News,Positive
 chemoimmunotherapy,Physician's Weekly,Positive
 chemoimmunotherapy,Targeted Oncology,Negative
 chemoimmunotherapy,Barry Shrier,Negative
 chemoimmunotherapy,noel cole,Negative
 chemoimmunotherapy,HemOnc Today,Positive
 chemoimmunotherapy,Benlazar S.M Amin√©,Negative
 chemoimmunotherapy,Vin√≠cius Molla,Positive
 chemoimmunotherapy,Robert Z. Orlowski,Negative
 chemoimmunotherapy,MD Anderson Cancer Center,Negative
 chemoimmunotherapy,Raj Chakraborty,Positive
 chemoimmunotherapy,"chadi nabhan MD, MBA, FACP",Negative
 chemoimmunotherapy,Medivizor,Positive
 chemoimmunotherapy,Chocolatiere Phys,Negative
 chemoimmunotherapy,Winship Cancer Institute of Emory University,Negative
 chemoimmunotherapy,"PXN, board-certified prostitute",Positive
 chemoimmunotherapy,Toby Eyre,Negative
 chemoimmunotherapy,Expert Perspectives in Oncology,Negative
 chemoimmunotherapy,Abdel-Wahab Lab,Positive
 chemoimmunotherapy,ecancer,Negative
 chemoimmunotherapy,Blood Cancer UK,Negative
 chemoimmunotherapy,palliativewise,Negative
 chemoimmunotherapy,"Raul Cordoba, MD, PhD",Negative
 chemoimmunotherapy,Francesco Bertoni,Negative
 chemoimmunotherapy,Dr. Andre Goy,Negative
 chemoimmunotherapy,Nature Reviews Disease Primers,Negative
 chemoimmunotherapy,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 chemoimmunotherapy,Lymphoma Hub,Negative
 chemoimmunotherapy,Nicolas Gendron,Positive
 chemoimmunotherapy,Muzaffar Qazilbash,Negative
 chemoimmunotherapy,Francesco Turturro,Negative
 chemoimmunotherapy,GEDEFO,Negative
 disease state,Biotech2050,Negative
 disease state,Dr Becs,Positive
 Eternal,Garret Majorüß∏,Positive
 timelimited treatment strategies,OncLive.com,Negative
 jab,Tony Rothwell,Positive
 jab,CLLSA,Negative
 test,Tony Rothwell,Positive
 test,DDNews Online,Negative
 test,MyPathologyReport.ca,Positive
 test,RedMedEd,Negative
 test,Michele Nadeem-Baker,Negative
 test,JADPRO,Negative
 test,Blood Journal,Negative
 Monday,Tony Rothwell,Positive
 Monday,"Mazyar Shadman, MD MPH",Negative
 Monday,Verastem Oncology,Negative
 Monday,CURE Magazine,Negative
 Monday,MC Services AG,Positive
 Monday,Lifelong Learning,Negative
 antibodies,Tony Rothwell,Positive
 antibodies,NaturesZestNutrition,Positive
 antibodies,Patient Power,Negative
 antibodies,ACS Journal Cancer,Negative
 antibodies,Scott Werntz,Negative
 Tcell dysfunction,ClinOwl Haematology,Negative
 Tcell dysfunction,Fleur Peters,Positive
 Tcell dysfunction,Lymphoma Papers,Negative
 Tcell dysfunction,Oncology Tube,Negative
 Tcell dysfunction,VJHemOnc,Negative
 chronic lymphoc,Medivizor,Positive
 discusses updates,OncLive SOSS,Negative
 March rd,International Conference on Malignant Lymphoma,Negative
 CETDont,International Conference on Malignant Lymphoma,Negative
 opportunity,International Conference on Malignant Lymphoma,Negative
 opportunity,Jordan Gauthier,Positive
 opportunity,ESH (Haematology),Positive
 opportunity,Karmanos Cancer Institute,Positive
 opportunity,Dr Effie Kostareli,Negative
 opportunity,CURE Magazine,Negative
 opportunity,Leukaemia Care,Negative
 opportunity,Adam Kittai,Negative
 opportunity,Michie Lab,Negative
 opportunity,CLL Ireland,Negative
 opportunity,"Raul Cordoba, MD, PhD",Negative
 opportunity,LymphomaAction,Negative
 opportunity,Michael Rynne,Negative
 opportunity,Bioevents - Sharing Biomed Knowledge,Positive
 opportunity,MAISA,Negative
 opportunity,Patient Empowerment Network,Negative
 opportunity,Marta Crespo,Negative
 opportunity,Anthony Mato,Negative
 opportunity,Helen Jane Mee,Negative
 opportunity,BaronVonFunkenstein,Positive
   blood cancer community,Jan Rynne,Positive
 Telemedicine Challenges,Patient Empowerment Network,Positive
 Opportunities,Patient Empowerment Network,Positive
 Opportunities,Paperbirds_Hematology,Negative
 Opportunities,CRO Contract Res.,Negative
 Disease Flare,The Oncologist,Negative
 Disease Flare,Mayo Clinic Hematology-Oncology Fellowship,Positive
 Disease Flare,AJMC,Negative
 Disease Flare,CancerEpiPapers,Negative
 Temporary Interruption,The Oncologist,Negative
 Temporary Interruption,Mayo Clinic Hematology-Oncology Fellowship,Positive
 Temporary Interruption,CancerEpiPapers,Negative
 doctors office,Tyler Steele,Positive
 ad,Tyler Steele,Positive
 info,CLLSA,Positive
 info,Karmanos Cancer Institute,Negative
 info,Patient Power,Positive
 info,AnCan,Negative
 info,Kim Kirchherr,Negative
 info,Helen Jane Mee,Positive
 info,Leukaemia Care,Negative
 info,Andrew Schorr,Negative
 info,Charlotte Roffiaen,Positive
 info,Margaret Walker,Positive
 info,AML Hub,Positive
 info,Anthony Howards,Positive
 info,Dr Darren Saunders,Positive
 info,WCM Lymphoma,Negative
 info,Medthority,Negative
 info,Chris Thomson,Negative
 info,CLL,Negative
 spread amp impact,CLLSA,Positive
 series,CLLSA,Positive
 series,CLL Warwick Uni,Negative
 series,Novateur Ventures,Positive
 series,Christopher Steer,Negative
 series,AtlanticJOMedicine,Negative
 series,Cecilia,Positive
 series,ASH,Negative
 series,People Who UK,Positive
 surveys,CLLSA,Positive
 Ibrunat mg s Capsules,984 pharmacy,Positive
 Ibrunat mg s Capsules,GDMEDS,Positive
 DNA,ü•ìSara Dankerü•ì,Positive
 DNA,SGHC,Positive
 DNA,Elaine Schattner,Negative
 DNA,StudentLoansNetwork.com,Positive
 DNA,Nadia Rice,Positive
 DNA,Rachel Roberts,Positive
 DNA,Elena Jones,Positive
 DNA,Vegan NoGluten Sara,Positive
 DNA,Melanie Johnson,Positive
 DNA,Carole Johnson,Positive
 DNA,Stephanie Ford,Positive
 changes,ü•ìSara Dankerü•ì,Positive
 changes,Sunny Sovereign,Positive
 changes,CLL Ireland,Negative
 changes,CLL Epigenetics,Positive
 changes,Mayo Clinic Cancer Center,Negative
 changes,Prof John,Negative
 changes,J Immunol,Negative
 changes,PharmacyTimesCE,Positive
 changes,"chadi nabhan MD, MBA, FACP",Negative
 changes,HappiDoc,Positive
 changes,Decision Resources Group,Negative
 changes,Oncology Tube,Negative
 changes,VJHemOnc,Negative
 mRNA inactivate tumorsuppressing proteins,ü•ìSara Dankerü•ì,Positive
 cancer growth,ü•ìSara Dankerü•ì,Positive
 Intensity,Lymphoma Papers,Negative
 Intensity,Paperbirds_Hematology,Negative
 antigen expression,Lymphoma Papers,Negative
 antigen expression,Paperbirds_Hematology,Negative
 Picture SymptomsTreatment,Health Advicer (I Follow Back),Positive
 New mRNA Cancer Drivers,Senders,Positive
 New mRNA Cancer Drivers,Vincenzo Scipioni,Positive
 New mRNA Cancer Drivers,Muhammad Usman,Positive
 New mRNA Cancer Drivers,LabMedica.com,Positive
 New mRNA Cancer Drivers,BioCeryx,Positive
 GenomeWeb,Senders,Positive
    Study Tracks COVID Vaccine Response,Michele Nadeem-Baker,Negative
 R Gregory Bociek MD,OncLive SOSS,Positive
 R Gregory Bociek MD,OncLive.com,Positive
 vivo ex vivo,Paperbirds_Hematology,Negative
 AstraZeneca leukaemia treatment,Pharmafocus,Positive
 üß¨ Trisomy   tri,Hematopoiesis News,Negative
 JoinShare,Patient Empowerment Network,Positive
 Active Role,Patient Empowerment Network,Negative
 CLL Treatment Decisions Webinar,Patient Empowerment Network,Negative
 PT,Patient Empowerment Network,Negative
 PT,Patient Power,Positive
 PT,Club Libertad Limpe√±o,Positive
 PT,US Banking News,Positive
 PT,MarketBeat,Positive
 Treatments,David Henry,Positive
 Treatments,The ASCO Post,Negative
 Treatments,AJMC,Positive
 Treatments,Dana-Farber,Negative
 Treatments,Elsevier Pharma,Positive
 innate immunity,ClinOwl Haematology,Negative
 innate immunity,Paperbirds_Hematology,Negative
 innate immunity,Mehdi Hamadani,Positive
 family backtoback kinase inhibitors,Paperbirds_Hematology,Negative
 allogeneic stem cell transplant,OncLive SOSS,Negative
 allogeneic stem cell transplant,OncLive.com,Negative
 allogeneic stem cell transplant,Medivizor,Negative
 allogeneic stem cell transplant,Lymphoma Papers,Negative
 allogeneic stem cell transplant,Chocolatiere Phys,Negative
 allogeneic stem cell transplant,CLL Ireland,Negative
 allogeneic stem cell transplant,Oliver Bogler,Positive
 Saturdays hour town hall,Andrew Schorr,Negative
 Drs Shuo Ma,Andrew Schorr,Negative
 Debbie Stephens,Andrew Schorr,Negative
 opportunities,BioAscend,Positive
 opportunities,Patient Empowerment Network,Negative
 opportunities,"Amber Koehler, PA-C",Negative
 DEADLINE,ESH (Haematology),Negative
 Apply,ESH (Haematology),Negative
 rd ESH JOHN GOLDMAN INTERNATIONAL RESEARCH,ESH (Haematology),Negative
 research project,ESH (Haematology),Negative
 research project,HARMONY Alliance,Positive
 biomarkers,ESH (Haematology),Negative
 biomarkers,Blood Journal,Negative
 biomarkers,"Raul Cordoba, MD, PhD",Negative
 longterm remission,ESH (Haematology),Negative
 Selfperceived,Paperbirds_Hematology,Negative
 Human,Paperbirds_Hematology,Negative
   EHA,European Hematology Association,Negative
 Unplugged,European Hematology Association,Negative
 Antonio Jos√© CabreraSerrano,Lymphoma Hub,Negative
 validation,Lymphoma Hub,Negative
 genomewide association study,Lymphoma Hub,Negative
 genomewide association study,James Kerwin,Positive
 genomewide association study,robo_gwas,Positive
 variants,Lymphoma Hub,Negative
 Evaluating zanubrutinib,Medivizor,Negative
 ch,Medivizor,Negative
 ch,Crwe World,Negative
 Cancer,Michele Nadeem-Baker,Positive
 Cancer,Paperbirds_Hematology,Positive
 Cancer,CancerCareMBFdn,Positive
 Cancer,Fortis Healthcare,Positive
 Cancer,Norton Healthcare,Positive
 Cancer,Patient Power,Negative
 Cancer,Maria Marta P.M.üçÄ,Positive
 Cancer,emily nunn,Positive
 Cancer,AI News Feed,Positive
 Cancer,dr upendra sharma,Positive
 Cancer,Patient Worthy,Negative
 Cancer,CSC Central Indiana,Negative
 Cancer,Angela Reeves Tate,Positive
 Cancer,Nature Reviews Disease Primers,Negative
 Cancer,Mike Luise,Positive
 Cancer,Cancer News,Positive
 Cancer,Lung Cancer News,Negative
 Cancer,CureHuntr,Negative
 Cancer,TrialBulletin,Negative
 Cancer,A M Billah Sumon,Positive
 Cancer,AbbVie Canada,Negative
 Cancer,Oncology Now,Negative
 Cancer,Lymphoma News Today,Positive
 Cancer,Sean McGrath,Positive
 neoantigen vaccines,Satyen Gohil,Positive
 ideas,Briar Hill Primary School,Positive
 ideas,Ashbridge Nursery at Maxy Farm,Positive
 ideas,Didi Jasmin,Positive
 ideas,iwCLL,Positive
 ideas,Idea Couture,Positive
 Anthony Mato MD,CheckRare,Positive
 Anthony Mato MD,Teresa Martin,Positive
 Memorial Sloan Kettering Cancer Center,CheckRare,Positive
 Memorial Sloan Kettering Cancer Center,Expert Perspectives in Oncology,Negative
 Memorial Sloan Kettering Cancer Center,Anthony Mato,Negative
 overview,CheckRare,Positive
 overview,Breaking Data,Negative
 overview,AplusA World,Positive
 overview,Lymphoma Hub,Negative
 overview,SpecialtyPTimes,Negative
 overview,Wiley Oncology & Hematology,Positive
 overview,CLL Ireland,Positive
 overview,Cancer Support Ohio,Positive
 overview,"Caner Saygin, MD",Negative
 overview,VJHemOnc,Positive
 overview,Patient Power,Negative
 Noxxon,MASSI,Positive
   marrow,Sarah Jones,Positive
 challenge,Lizbeth A. Leon,Positive
 challenge,Patient Power,Positive
 challenge,Izaskun Zeberio,Negative
 challenge,Adam Mead,Positive
 challenge,CLL Ireland,Positive
 challenge,Paperbirds_Hematology,Negative
 challenge,Higher Ground at Lake Louise,Negative
 challenge,OncLive.com,Negative
 Tissue Counterpart,Paperbirds_Hematology,Negative
 Monoclonal BCell Lymphocytosis,Paperbirds_Hematology,Positive
 Monoclonal BCell Lymphocytosis,"Raul Cordoba, MD, PhD",Negative
 Clonal evolution,ClinOwl Haematology,Negative
 Clonal evolution,Lymphoma Papers,Negative
 Clonal evolution,CLL Ireland,Negative
 Clonal evolution,Blood Advances,Positive
 Clonal evolution,Luis H Camacho,Positive
 Clonal evolution,"Raul Cordoba, MD, PhD",Positive
 Clonal evolution,Francesco Turturro,Negative
 Clonal evolution,"Dr. Paul DeSantis, PharmD",Negative
 Clonal evolution,Olivier Elemento,Negative
 Clonal evolution,NY Genome Center,Negative
 Clonal evolution,Broad Institute,Positive
 Chromosome banding analysis,ClinOwl Haematology,Negative
 Chromosome banding analysis,BibliotecaHUVH. ICS,Positive
 Higherorder connections,Blood Journal,Negative
 stereotyped subsets implications,Blood Journal,Negative
   MKSAP Pearl Intravenous immunoglobulin G replacement therapy,"Tom Curley, MD",Positive
 infections,"Tom Curley, MD",Positive
 infections,Paperbirds_Hematology,Negative
 infections,"Raul Cordoba, MD, PhD",Positive
 infections,Benlazar S.M Amin√©,Negative
 infections,Lymphoma Papers,Negative
 infections,Expert Perspectives in Oncology,Negative
 infections,Lymphoma Hub,Negative
 infections,Talal Hilal ü©∫,Negative
 infections,CLL Ireland,Negative
 infections,Nature Reviews Disease Primers,Negative
 infections,VJHemOnc,Positive
 infections,Oncology Tube,Negative
 infections,Carl Jackson,Positive
 review paper,Fleur Peters,Positive
 review paper,Talal Hilal ü©∫,Negative
 Novel Agent,Patient Power,Negative
 multikinase inhibitor TG,CellworksLife,Negative
 multikinase inhibitor TG,Cancer Papers,Negative
 multikinase inhibitor TG,Paperbirds_Hematology,Negative
 apoptosis blocks Bcell receptor,CellworksLife,Negative
 apoptosis blocks Bcell receptor,Cancer Papers,Negative
 apoptosis blocks Bcell receptor,Paperbirds_Hematology,Negative
 MidAtlantic Region,Duke Hematologic Malignancies & Cellular Therapy,Negative
   expert,Duke Hematologic Malignancies & Cellular Therapy,Negative
   expert,Patient Power,Positive
   expert,CLL Advocates Network,Negative
   expert,Patient Empowerment Network,Positive
   expert,CLL Ireland,Positive
   expert,Targeted Oncology,Negative
   expert,Andrew Schorr,Positive
   expert,HemOnc Today,Positive
   expert,Healio,Positive
   expert,Debbie Woodbury,Negative
   expert,Rhia Steele@ravishingrhia.com,Negative
   expert,WEGO Health,Negative
   expert,‚ô•Melissa‚ô•,Positive
   expert,Sandy D.,Negative
   expert,Paula Pyzia,Negative
   expert,Senior Care Corner,Negative
   expert,International Pain Foundation¬Æ,Negative
   expert,Colleen Busch,Negative
   expert,Katie,Positive
 Tanja Stankovics lab,CRUK Birmingham Centre,Positive
 mRNA shots,Sunny Sovereign,Positive
 Othman AlSawaf MD,Targeted Oncology,Negative
 Othman AlSawaf MD,CheckRare,Positive
 Othman AlSawaf MD,Oncology Learning Network,Negative
 Pirtobrutinib LOXO,Taylor Lab UM,Negative
 RR     lymphomas,Taylor Lab UM,Negative
 sustained efficacy,OncLive.com,Negative
 deskwalls,ü•∞,Positive
 ReedampHarbor,ü•∞,Positive
 sequence therapies,Medscape Education,Negative
 Conjugate Pneumococcal Vaccine,The ASCO Post,Negative
 Response,"Mazyar Shadman, MD MPH",Negative
 Response,Artocarpus,Positive
 Response,Garbi√±e Lizeaga,Negative
 Response,Jerry Lee,Negative
 Response,Katrina Sondermann,Positive
 Response,Cure Cancer Now,Negative
 Response,Cancer Papers,Negative
 Response,Verastem Oncology,Negative
 Response,Robert Z. Orlowski,Negative
 Response,MD Anderson Leukemia,Negative
 Response,Elsevier Oncology,Positive
 Response,H4B Boston,Positive
 Response,Wei Du,Positive
 Response,CancerWallonia,Positive
 Response,Krishan Maggon,Negative
 Response,The ASCO Post,Positive
 Response,JAMA Oncology,Positive
 Response,CLL Ireland,Negative
 Response,JAMA Internal Medicine,Positive
 Response,JAMA,Negative
 Response,AJMC-Oncology,Negative
 heme cancers,"Mazyar Shadman, MD MPH",Negative
 Diagnosis,Wellcome-home,Negative
 Diagnosis,hematologist,Negative
 Diagnosis,Benlazar S.M Amin√©,Negative
 Diagnosis,EurekaMag,Negative
 Diagnosis,ImmunotherapyPapers,Negative
 Diagnosis,Crwe World,Negative
 Diagnosis,gilbert c faure,Negative
 Diagnosis,CLL-seq,Negative
 Diagnosis,Lymphoma Papers,Negative
 Diagnosis,CIHR,Positive
 Diagnosis,VJHemOnc,Negative
 Diagnosis,iwCLL,Negative
 Diagnosis,Cancer Papers,Negative
 Diagnosis,TumorImmunoPapers,Negative
 Diagnosis,Francois Maignen,Positive
 Diagnosis,JAMA,Negative
 Staging,Wellcome-home,Negative
 Staging,Leukemia,Negative
 Staging,CLLSA,Negative
 Healthline,Wellcome-home,Negative
 chineselgz,Wellcome-home,Negative
 Bispecific SingleDomain Antibody,Cancer Papers,Negative
 Bispecific SingleDomain Antibody,Jerry Lee,Negative
 Bispecific SingleDomain Antibody,Cure Cancer Now,Positive
 Bispecific SingleDomain Antibody,CellworksLife,Negative
 CDd,Cancer Papers,Positive
 CDd,Jerry Lee,Negative
 CDd,Cure Cancer Now,Positive
 CDd,CellworksLife,Negative
 CDd,Augusto Cezar Schmidt,Positive
 CDd,"Raul Cordoba, MD, PhD",Negative
 CDd,Jon Humphries,Positive
 evaluation,Paperbirds_Hematology,Positive
 evaluation,Lymphoma Papers,Negative
 evaluation,cnaamani,Positive
 QampA,Patient Power,Negative
 QampA,Verastem Oncology,Negative
 QampA,Targeted Oncology,Negative
 QampA,CancerCare,Negative
 WorldRenowned Experts,Patient Power,Negative
 Vit D insufficiency amp prognosis,"Mike Thompson, MD, PhD, FASCO",Negative
 Hun Ju Lee MD,OncLive.com,Negative
 Content validity,Health Services Research at BMC,Positive
 Content validity,JPatientRepOutcomes,Positive
 Bruton Tyrosine Kinase Inhibitors,Paperbirds_Hematology,Negative
 Truth,Michele Nadeem-Baker,Positive
 Truth,Nicolas Martinez üá®üá¥üá®üá¥,Positive
 Truth,Patient Empowerment Network,Positive
 Truth,TheDayThatChangedMyL,Positive
 Truth,SOLUTIONS Cancer,Positive
 MAPK pathway,ClinOwl Haematology,Negative
 MAPK pathway,the paper link,Negative
 MAPK pathway,TYR Kinase papers,Negative
 PIK inhibitors,ClinOwl Haematology,Negative
 PIK inhibitors,the paper link,Negative
 PIK inhibitors,TYR Kinase papers,Negative
 PIK inhibitors,Duke Hematologic Malignancies & Cellular Therapy,Negative
 PIK inhibitors,Paperbirds_Hematology,Negative
 PIK inhibitors,Lymphoma Papers,Negative
 CMECE curriculum,RedMedEd,Negative
 MCL pt care,RedMedEd,Negative
 amp Dr Steven Coutre MD,Patient Power,Negative
 cover topics,Patient Power,Negative
 response,ASH Clinical News,Negative
 response,TYR Kinase papers,Negative
 response,Paperbirds_Hematology,Positive
 response,minnlab_litbot,Positive
 response,Lymphoma Research Foundation,Negative
 response,TAP Clinical Trial Network,Negative
 response,JAMA Oncology,Positive
 response,JAMA,Negative
 response,Adam Kittai,Negative
 response,VJHemOnc,Negative
 response,Expert Perspectives in Oncology,Negative
 response,Sarah Cannon Docs,Positive
 response,Andre Williams,Positive
 response,"Raul Cordoba, MD, PhD",Positive
 response,Blood Journal,Negative
 response,Santiago Carmona üß¨ üñ•Ô∏è üë®üèæ‚Äçüî¨,Positive
 response,CLL Ireland,Negative
 response,Hyun Goo Woo,Positive
 response,Nature Medicine,Positive
 response,Penn Path & Lab Medicine,Positive
 response,SiCORE in Immunoregulation,Positive
 response,CRISP_SCIENCE,Positive
 response,ImmunotherapyPapers,Negative
 response,TumImmTxpapers,Negative
 response,MDedge Hematology & Oncology,Positive
 response,Krishan Maggon,Negative
 response,"Bruce Levine, Ph.D.",Positive
 response,Continuum AEP,Positive
 response,All Ways Well,Positive
 response,Targeted Oncology,Negative
 response,Nick,Negative
 response,"chadi nabhan MD, MBA, FACP",Negative
 response,Healio,Negative
 response,HemOnc Today,Negative
 response,AJMC,Negative
 response,AJMC-Oncology,Positive
 efficacy rates,ASH Clinical News,Negative
 y COVID,Felipe Pe√±a Mu√±oz,Positive
 implicaci√≥n del sistema inmune,Felipe Pe√±a Mu√±oz,Positive
 Yeahhhhh gebeld,Jolanda,Positive
 door het,Jolanda,Positive
 ik,Jolanda,Positive
 krijg de vaccinatie,Jolanda,Positive
 wordt onderzocht,Jolanda,Positive
 na,Jolanda,Positive
 aanmaken Zooooo,Jolanda,Positive
 blij,Jolanda,Positive
 namelijk geen fijne combi,Jolanda,Positive
 New article Ibrutinib,Paperbirds_Hematology,Positive
 New article Ibrutinib,JTH,Positive
 Utility,Lymphoma Papers,Positive
 Utility,TYR Kinase papers,Negative
 Utility,Paperbirds_Hematology,Negative
 Utility,OncLive.com,Negative
 Utility,COPD News,Negative
 Utility,john randall,Positive
 hotspot mutation,Paperbirds_Hematology,Negative
 transcription factor,Paperbirds_Hematology,Negative
 IKZF,Paperbirds_Hematology,Negative
 IKZF,Immune Regulation News,Negative
 B cell neoplasia,Paperbirds_Hematology,Negative
 phase b study,OncLive.com,Negative
 phase b study,Targeted Oncology,Negative
 phase b study,Benlazar S.M Amin√©,Negative
 phase b study,"Naveen Pemmaraju, MD",Negative
 phase b study,Francesco Turturro,Negative
 phase b study,Bud Capital,Positive
 VAY,OncLive.com,Negative
 Prayer Warriors,Christian Healthcare Ministries,Positive
 ‚ù§,Christian Healthcare Ministries,Positive
 ‚ù§,Dario Antilen,Positive
 ‚ù§,Chloe Atkinson,Positive
 ‚ù§,Brownskin_cee,Positive
 ‚ù§,Ana Catarina Bento,Negative
 Zanubrutinib BGB,Paperbirds_Hematology,Negative
 Zanubrutinib BGB,Mahmoud Aljurf,Negative
 Zanubrutinib BGB,Lymphoma Papers,Negative
 Zanubrutinib BGB,Blood Advances,Negative
 Zanubrutinib BGB,Benlazar S.M Amin√©,Negative
 Zanubrutinib BGB,CureHuntr,Positive
 Zanubrutinib BGB,TrialBulletin,Positive
 Zanubrutinib BGB,Lymphomation.org,Negative
 surface,PharmaFactz,Negative
 surface,Blood Journal,Negative
 surface,OTOdocs,Negative
 surface,Cancer Papers,Negative
 B cellsRituximab,PharmaFactz,Negative
 Murali,the paper link,Negative
 Brown JR Blood Activation,the paper link,Negative
 Dr Jennifer Brown,Hematopoiesis News,Negative
 Dr Jennifer Brown,"Sanam Loghavi, MD",Negative
 Dr Jennifer Brown,"Bachar Samra, MD",Positive
 Dr Jennifer Brown,Expert Perspectives in Oncology,Positive
 Dr Jennifer Brown,Patient Power,Positive
 Dr Jennifer Brown,Patient Empowerment Network,Negative
 Dr Jennifer Brown,Andrew Schorr,Positive
 Dr Jennifer Brown,CLL Ireland,Negative
 Dr Jennifer Brown,Katie Gould,Positive
 Dr Jennifer Brown,"Sean Young, PhD",Positive
 Dr Jennifer Brown,Cancer Treatment Centers of America (CTCA),Positive
 MAPKERK activation,Hematopoiesis News,Negative
 William Wierda MD PhD,CheckRare,Positive
 William Wierda MD PhD,Lisa Palacios,Positive
 William Wierda MD PhD,MD Anderson Leukemia,Positive
 William Wierda MD PhD,Cancer Medicine,Positive
 William Wierda MD PhD,Caprice Alexander-Perez,Positive
 William Wierda MD PhD,OncLive SOSS,Negative
 William Wierda MD PhD,OncLive.com,Negative
 MD Anderson Cancer Center,CheckRare,Positive
 MD Anderson Cancer Center,BioAscend,Positive
 MD Anderson Cancer Center,Human Immunology News,Negative
 MD Anderson Cancer Center,Patient Power,Negative
 MD Anderson Cancer Center,Oncology Times,Negative
 MD Anderson Cancer Center,Expert Perspectives in Oncology,Negative
 CAPTIVATE trial,CheckRare,Positive
 CAPTIVATE trial,Targeted Oncology,Negative
 CAPTIVATE trial,"chadi nabhan MD, MBA, FACP",Positive
 CAPTIVATE trial,OncLive SOSS,Negative
 Alexander Egle,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 FOXO,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 CLL proliferation cell cycle arresnt,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 apoptosis,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 apoptosis,Lymphoma Papers,Positive
 apoptosis,Wnt publications,Negative
 apoptosis,CLL-seq,Negative
 apoptosis,Dip√≤sit Digital UB,Positive
 apoptosis,Cancer Papers,Positive
 apoptosis,CLL Society Inc.,Negative
 apoptosis,Lymphoma Hub,Negative
 apoptosis,Fanni Gergely,Positive
 UK CLL forum,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 UK CLL forum,Donna Gairns,Positive
 UK CLL forum,LyLe Foreningen,Negative
 help,AbbVie UK,Positive
 help,Ashbridge Nursery at Maxy Farm,Positive
 help,Lorna Warwick,Positive
 help,CLL Ireland,Negative
 help,Glen Janred,Positive
 help,Midmark News,Positive
 help,CLLSA,Negative
 help,Lazarex Cancer Fdn,Positive
 help,Equality Couple,Negative
 CLL Download,AbbVie UK,Positive
 Centret f√∂r livsl√•ngt l√§rande ser,Bildningsalliansen,Positive
 ett √∂kande intresse f√∂r samarbete,Bildningsalliansen,Positive
 Managing   Patients,APSHO,Positive
 BTK Inhibitor Treatment Considerations,APSHO,Positive
 th,APSHO,Positive
 th,PeerView,Negative
 th,Te Atatu Roosters Rugby League,Negative
 th,Pharmacutical Daily,Negative
 th,SNN Network,Negative
 th,‚ö°AiMS,Negative
 th,Cancer News,Negative
 th,Michael Hallek,Negative
 th,CLL Ireland,Negative
 th,Higher Ground at Lake Louise,Positive
 th,Caldicott Computing,Positive
 th,LiveYourLife,Negative
 th,CLL Society Inc.,Negative
 th,School of Oncology,Positive
 th,Theodoros Moysiadis,Positive
 th,NY Blood Center,Positive
 APs role,APSHO,Positive
 APs role,JADPRO,Negative
 Imatinib,PharmaFactz,Positive
 Imatinib,Turmeric,Negative
 Featured Click,APWA,Positive
 Illegal Dumping Fund,APWA,Positive
 TOMORROW Advances,Medscape Education,Negative
 LIVE dates,Medscape Education,Positive
 Dr Catherine Wu,Immune Regulation News,Negative
 driving role,Immune Regulation News,Negative
 NEW Researchers,Patient Power,Negative
 Pirtobrutinib,Taylor Lab UM,Negative
 Pirtobrutinib,R√©my Dul√©ry,Positive
 Splash,Taylor Lab UM,Negative
 New CLL Drug,Taylor Lab UM,Negative
 Registration,CLLSA,Negative
 Registration,Patient Empowerment Network,Negative
 Registration,BioAscend,Positive
 Registration,ERN EuroBloodNet,Negative
 Registration,Sigrid Sk√•nland,Negative
 Registration,Patient Power,Positive
 Registration,Sarah Cannon Docs,Positive
 Registration,Heather DelaCruz,Negative
 Registration,Team Intake.Me,Positive
 March pm GMT Prof Hillmen,CLLSA,Negative
 FLAIR trial,CLLSA,Negative
 launching,CLLSA,Negative
   malignancies,Sarah Jones,Positive
   malignancies,Leukemia,Negative
 cancers,Sarah Jones,Positive
 cancers,Yan Leyfman,Positive
 cancers,Leukemia,Negative
 cancers,Taylor Lab UM,Negative
 cancers,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 cancers,Scripps Research,Positive
 cancers,Michael Rynne,Positive
 cancers,Patient Power,Positive
 cancers,Andrew Schorr,Negative
 cancers,Cellero,Positive
 cancers,Dr. Drew Dahlgren,Positive
 cancers,suetodd16,Positive
 cancers,Genentech,Positive
 cancers,Matthews & Associates,Negative
    marrow,Sarah Jones,Positive
    marrow,Leukemia,Negative
 nodes,Sarah Jones,Positive
 classification,Sarah Jones,Positive
 classification,Leukemia,Negative
 classification,Sanne v‚≠ïn Wüíâssen,Positive
 leukemia,Sarah Jones,Positive
 leukemia,razo,Positive
 leukemia,Ilera tv,Positive
 leukemia,MD Anderson Cancer Center,Positive
 leukemia,Leukemia I'm Fine,Negative
 leukemia,Patient Empowerment Network,Negative
 leukemia,Matthews & Associates,Negative
 leukemia,SkillAcquire,Positive
 leukemia,Cancer Health,Negative
 leukemia,BloodCancerCure,Negative
 leukemia,Graviola Finland,Positive
 leukemia,FriendsShow,Positive
 leukemia,LiveTracker¬Æ,Positive
 leukemia,Betty C. Jung,Positive
 leukemia,Dr. Drew Dahlgren,Positive
 leukemia,Essay Yard,Positive
 leukemia,Canada National NW,Positive
 leukemia,Ryan Maloney,Positive
 leukemia,HuffPost Canada,Positive
 leukemia,CBC News Alerts,Positive
 leukemia,CIRM,Positive
 leukemia,Amy C. Cavers,Positive
 leukemia,Georges Azzi,Positive
 leukemia,B. Smirnov,Positive
 leukemia,Rachel House,Positive
 leukemia,VJHemOnc,Negative
 leukemia,CancerTherapyAdvisor,Negative
 leukemia,helpsy,Positive
 leukemia,Stephen Brown,Negative
 leukemia,CancerSystemsBiology,Positive
 Ib,Paperbirds_Hematology,Negative
 Ib,Crwe World,Negative
 Ib,ivy science,Negative
 New article Development,Paperbirds_Hematology,Positive
 Characterization,Paperbirds_Hematology,Negative
 Characterization,5hmCpapers,Positive
 Characterization,Calibr8 Your Life,Positive
 Characterization,Cancer Papers,Negative
 Venetoclax Nanocrystals,Paperbirds_Hematology,Negative
 Oral Bioavailability Enhancement,Paperbirds_Hematology,Negative
 paper,Centre for Thrombosis and Haemostasis Research OUS,Positive
 paper,"chadi nabhan MD, MBA, FACP",Positive
 paper,bespinet_HMar,Positive
 paper,Chris Pepper,Positive
 paper,Francesc Bosch,Positive
 paper,Elsevier Biotech,Negative
 paper,Dr. Rajeev K. Singla,Positive
 paper,Satyen Gohil,Positive
 paper,Albert„ÉªEin„ÉªShredder„ÄÄPh.D,Positive
 paper,Christian Pallasch,Positive
 paper,Paula R√≠o,Positive
 paper,LYMPHOMA & MYELOMA CONNECT,Negative
 paper,JSF Group,Positive
 paper,RIOH,Negative
 paper,Michael Hallek,Negative
 paper,Steve Williamson,Positive
 paper,Talal Hilal ü©∫,Negative
 paper,Claire Vajdic,Positive
 paper,NY Genome Center,Negative
 paper,Andr√© Rendeiro,Positive
 paper,Gina Eagle,Positive
 Xueyan Cui,Centre for Thrombosis and Haemostasis Research OUS,Positive
 TFPI,Centre for Thrombosis and Haemostasis Research OUS,Positive
   Populations,"When reason fails, what then.",Positive
 laboratory testing,Paperbirds_Hematology,Negative
 LEF protein expression,Paperbirds_Hematology,Negative
 diagnosis,Paperbirds_Hematology,Negative
 diagnosis,Living A Busy Life - With Cancer,Positive
 diagnosis,MEI Pharma,Positive
 diagnosis,Mayo Clinic Cancer Center,Negative
 diagnosis,Tai ü¶åüêØ,Positive
 diagnosis,RIOH,Negative
 diagnosis,CLLSA,Positive
 diagnosis,Medivizor,Positive
 diagnosis,"Raul Cordoba, MD, PhD",Positive
 diagnosis,Benlazar S.M Amin√©,Negative
 diagnosis,Lymphoma Papers,Negative
 diagnosis,Brotman Baty,Positive
 diagnosis,PharmacyTimesCE,Positive
 diagnosis,CLL Ireland,Positive
 diagnosis,The Leukemia & Lymphoma Society,Negative
 diagnosis,"Amber Koehler, PA-C",Negative
 diagnosis,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 diagnosis,COPD News,Negative
 diagnosis,LymphomaAction,Negative
 diagnosis,OncLive.com,Negative
 diagnosis,Cancer News,Negative
 diagnosis,Marilyn Heine,Positive
 diagnosis,LiveYourLife,Negative
 diagnosis,UAMS Cancer,Positive
 diagnosis,N8 CIR,Positive
 diagnosis,Cristina Popa,Positive
 diagnosis,Janssen Canada,Positive
 diagnosis,Zack Pemberton-Whiteley,Negative
 diagnosis,Blood Journal,Negative
 diagnosis,Theresa Harrington,Positive
 diagnosis,Francesco Turturro,Negative
 diagnosis,Stephen Brown,Negative
 diagnosis,ecancer,Negative
 diagnosis,Gilead Sciences,Negative
 diagnosis,Christopher Steer,Negative
 diagnosis,BioVox,Positive
 diagnosis,NK papers,Negative
 differential diagnosis,Paperbirds_Hematology,Negative
 differential diagnosis,Weird Diseases,Positive
 Bruton tyrosine kinase,Paperbirds_Hematology,Negative
 noncovalent inhibitors,Paperbirds_Hematology,Negative
 B cell malignancies,Paperbirds_Hematology,Negative
 B cell malignancies,"Raul Cordoba, MD, PhD",Negative
 Webinar,Lymfklierkanker VV vzw,Positive
 Webinar,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 Webinar,CURE Magazine,Negative
 Webinar,HemOnc_ACCP,Positive
 Webinar,"Raul Cordoba, MD, PhD",Negative
 Webinar,CLLSA,Negative
 Webinar,Taylor Lab UM,Negative
 Webinar,Carrie Stricker,Positive
 Webinar,Med-IQ,Negative
 zeldzame nonhodgkinlymfomen,Lymfklierkanker VV vzw,Positive
 Question stem,EM Board bombs,Positive
 CART,"Mazyar Shadman, MD MPH",Negative
 CART,Ten nis,Positive
 CART,CLL Ireland,Positive
 CART,Shouting at people in my underpants,Negative
 CART,Penn Medicine MD,Positive
 CART,Aaron Charles,Negative
 era,"Mazyar Shadman, MD MPH",Negative
 era,Anna Deveau,Negative
 era,Shankara Paneesha,Negative
 era,VJHemOnc,Positive
 era,Blood Journal,Negative
 era,"Raul Cordoba, MD, PhD",Positive
 era,Health Content Collective (HCC),Positive
 era,Guillermo Ruiz-Arg√ºelles,Positive
 era,CONQUER the patient voice,Negative
 era,Michael Hallek,Negative
 era,Expert Perspectives in Oncology,Negative
 era,ASH,Negative
 era,Talal Hilal ü©∫,Negative
 era,CLL Ireland,Negative
 era,"Rob Dean, MD",Positive
 era,Oncology Tube,Negative
 Treatment Algorithm,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 Dr Carlo Moreno,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 CLL Comparison,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 GREEN trial,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Superporous PolyHydroxyethyl MethacrylateBased Scaffolds,Paperbirds_Hematology,Negative
 D,Paperbirds_Hematology,Negative
 Vitro,Paperbirds_Hematology,Positive
 Vitro,Lymphoma Papers,Negative
 Vitro,NK cell Biology,Negative
 Vitro,NK papers,Negative
 NonCoding RNAs,Paperbirds_Hematology,Negative
 Dark Matter,Paperbirds_Hematology,Negative
 CLL Universe,Paperbirds_Hematology,Negative
 Monica D Mead MD,OncLive.com,Negative
 utility,OncLive.com,Negative
 utility,OncLive SOSS,Positive
 utility,"Daniela Hermelin, MD",Positive
 utility,Lymphoma Papers,Negative
 utility,CancerTherapyAdvisor,Negative
 utility,The Pathologist,Positive
 Ibrutinib   Venetoclax,Benlazar S.M Amin√©,Negative
 Ibrutinib   Venetoclax,"Raul Cordoba, MD, PhD",Negative
 Rationale,Benlazar S.M Amin√©,Negative
 Rationale,OncLive.com,Negative
 Rationale,Cancer Papers,Negative
 Combo,Benlazar S.M Amin√©,Negative
 Combo,Quant Data,Negative
 Combo,CancerWallonia,Positive
 Combo,MDedge Hematology & Oncology,Positive
 Combo,Odi Bruckman,Positive
 Combo,CLL Ireland,Negative
 Combo,Paul Lane,Negative
 Combo,Biotech2050,Positive
 line   therapy,Benlazar S.M Amin√©,Negative
   line trials,Benlazar S.M Amin√©,Negative
   therapy evolution,Benlazar S.M Amin√©,Negative
 Research paper STAT,Oncotarget,Positive
 expression,Oncotarget,Positive
 expression,Paperbirds_Hematology,Negative
 expression,CLLSA,Negative
 expression,EurekaMag,Positive
 expression,OTOdocs,Negative
 expression,Cancer Papers,Positive
 expression,NK cell Biology,Negative
 expression,NK papers,Negative
 expression,"Raul Cordoba, MD, PhD",Negative
 expression,Lymphoma Hub,Negative
 expression,epigenetics_papers,Negative
 expression,TumorImmunoPapers,Negative
 expression,Blood Journal,Negative
 GLI,Oncotarget,Positive
   prof,J. De Munter,Negative
 Daan Dierickx,J. De Munter,Negative
 zeer,J. De Munter,Negative
 amp Wildgroei,J. De Munter,Negative
 speciale   voor,J. De Munter,Positive
 amp Wildgroei organiseren,J. De Munter,Negative
 een,J. De Munter,Negative
 singletube multiplex method,Lymphoma Papers,Positive
 mutations,Lymphoma Papers,Positive
 mutations,Toby Eyre,Negative
 mutations,Hematology Advisor,Negative
 mutations,CLL-seq,Positive
 mutations,Florian Slimano,Negative
 mutations,Patient Power,Positive
 mutations,Molecular Oncology,Positive
 mutations,CLL_Fightersüéó,Negative
 mutations,iwCLL,Negative
 mutations,Blood Journal,Negative
 mutations,Francesco Turturro,Negative
 mutations,Ang√©lica Figueroa Conde-Valv√≠s,Positive
 mutations,Mar√≠a Jos√© Calasanz,Positive
 mutations,Roberto C.  Montoya,Negative
 mutations,WCM Lymphoma,Negative
 cysteine,Lymphoma Papers,Positive
 Bruton Tyrosine Kinase BTK gene,Lymphoma Papers,Positive
 nuestra   Raquel que cumple   a√±os con nosotrosPor muchos,Clinica Lacasa Litner,Negative
 a√±os m√°s,Clinica Lacasa Litner,Negative
 el equipo,Clinica Lacasa Litner,Positive
 üß° üß° üß°,Clinica Lacasa Litner,Positive
   Natural Prevention,Kyle J. Norton,Positive
   Natural Prevention,The Curable Recipes,Negative
   Natural Prevention,Chantel Martiromo,Positive
 Memorial Sloan Kettering,Taylor Lab UM,Positive
 Memorial Sloan Kettering,VJHemOnc,Negative
 TG,CURE Magazine,Negative
 TG,MAISA,Negative
 TG,‚öæÔ∏èüèÄ‚öΩÔ∏èüé∏ü•Åüéßüé´ü§øüèäüèº‚Äç‚ôÇÔ∏èüèù,Positive
 TG,Odi Bruckman,Positive
 TG,Dr. Melody Davis,Negative
 TG,Financial Buzz,Positive
 TG,ForexTV,Positive
 TG,Orbis Biosciences,Negative
 TG,Denver Greene,Negative
 TG,üí• OTC ARMY üí•,Positive
 TG,Alyssa Howard,Negative
 TG,biotechnologies,Negative
 TG,SPI News,Negative
 TG,Bio Stocks‚Ñ¢,Negative
 TG,John Stock Pro,Positive
 TG,satPRnews,Negative
 TG,StockGuru,Negative
   Registration,International Conference on Malignant Lymphoma,Negative
   Registration,Business News,Positive
 reopenedRegistration,International Conference on Malignant Lymphoma,Negative
 New Research Paper,Sussex Cancer Fund,Positive
 SCF Equipment Dr Andrea Pepper,Sussex Cancer Fund,Positive
 previously treatmentresistant,Josie B.,Negative
 clients,Josie B.,Negative
 Loxo team,Josie B.,Negative
 Telemedicine,Patient Empowerment Network,Positive
 Telemedicine,Diverse Health Hub,Positive
 LongTerm Survivorship Tool,Patient Empowerment Network,Positive
 Reaserch Advance,EurekaMag,Negative
 Inhibitor,EurekaMag,Negative
 Inhibitor,Cancer Papers,Negative
 BCell Receptor Pathway,EurekaMag,Negative
 Chronic Lymphocytic Leukemia Review,EurekaMag,Negative
 Chronic Lymphocytic Leukemia Review,"Dr T. Comeau , MD",Negative
 Digital Advocacy,Patient Empowerment Network,Negative
 Health Equity,Patient Empowerment Network,Negative
 Universit√§t,CheckRare,Positive
 zu K√∂ln,CheckRare,Positive
 followup data,CheckRare,Negative
 followup data,MD Anderson Cancer Center,Negative
 followup data,flylemurs,Positive
 CLL trial,CheckRare,Negative
 CLL trial,OncLive.com,Negative
 CLL trial,Lymphoma Hub,Negative
 CLL trial,Oncology Tube,Positive
 CLL trial,"Eric K. Singhi, MD",Positive
 CLL trial,"Raul Cordoba, MD, PhD",Negative
 CLL trial,Michael Hallek,Negative
 CLL trial,Haybury,Positive
 CLL trial,VJHemOnc,Negative
 bone marrow,Mayo Clinic Cancer Center,Positive
 bone marrow,Leukemia,Negative
 bone marrow,National Cancer Institute,Negative
 bone marrow,Ohio Infusion Services,Positive
 bone marrow,OncLive SOSS,Negative
 bone marrow,OncLive.com,Negative
 bone marrow,BeiGene,Negative
 bone marrow,ABPI,Negative
 bone marrow,Adam Marshall Dobrin üîØ‚òÄ‚ÅÇ @suzq@rettiwtkcuf.social,Positive
 bone marrow,Genevieve Gutierrez,Positive
 bone marrow,"‚ÄúNicky""",Positive
 bone marrow,Jhawn Paul,Positive
 bone marrow,Cleveland Clinic Abu Dhabi,Positive
 bone marrow,AnamjemWAK,Positive
 bone marrow,"Sofia Garces, MD",Positive
 bone marrow,Essay Yard,Positive
 bone marrow,Teva Pharmaceuticals,Positive
 bone marrow,AbbVie,Positive
 bone marrow,HemaCare Corporation,Negative
 bone marrow,Roche,Positive
 CLL Research Ublituximab,"Tom Henry, MBA, RPh, CPh",Negative
 Tissue factor pathway inhibitor,Wnt publications,Negative
 CXCR expression,Wnt publications,Negative
 Therapeutic targeting,Paperbirds_Hematology,Negative
 mitochondrial onecarbon pathway,Paperbirds_Hematology,Negative
 pitfalls,Paperbirds_Hematology,Negative
 e la Fondazione hanno sottoscritto una,Il Vittoriale,Positive
 il progetto,Il Vittoriale,Positive
 Residenza,Il Vittoriale,Positive
 un soggiorno mensile presso,Il Vittoriale,Positive
 tre traduttori,Il Vittoriale,Positive
 madre Info,Il Vittoriale,Positive
 Friday views Chronic Lymphocytic Leukemia,Dr.,Positive
   Scientists,Dawn Ain't Playin',Positive
   Scientists,Immunology of Infectious Disease News,Positive
 substantial,Dawn Ain't Playin',Positive
 encouraging data,Pietro Di Ciaccio,Positive
 Ground breaking data,"Chaitra Ujjani, MD",Positive
 loxo,"Chaitra Ujjani, MD",Positive
     pts,"Chaitra Ujjani, MD",Positive
     pts,Robert Z. Orlowski,Negative
     pts,Dr. Elizabeth Shpall,Positive
 New article Validation,Paperbirds_Hematology,Positive
 B cell malignancy,Victor Lin,Positive
 B cell malignancy,Nature Reviews Disease Primers,Negative
 novel combination,OncLive.com,Negative
 gamechanging data,OncLive.com,Negative
 Mississippi,MJ Platform,Positive
 Initiative,MJ Platform,Positive
 medicaluse,MJ Platform,Positive
 LRF,Lymphoma Research Foundation,Positive
 LRF,gilbert c faure,Negative
 Christopher Flowers MD MS,Lymphoma Research Foundation,Negative
 Join Lurie Cancer Center oncologist Dr Shuo Ma,Lurie Cancer Center,Negative
 nurse practitioner Jennifer Boyer,Lurie Cancer Center,Positive
 HIF alpha antibody,StressMarq,Positive
 Blood eosinophil count,Journal of the @NCCN,Negative
 prognosis,Journal of the @NCCN,Negative
 prognosis,Targeted Oncology,Positive
 prognosis,EurekaMag,Negative
 prognosis,microRNApapers,Negative
 prognosis,Pastel BioScience,Positive
 prognosis,Michael Hallek,Negative
 prognosis,CLL Ireland,Negative
 prognosis,UChicagoCancerCenter,Positive
 prognosis,JAMA Oncology,Negative
   Testing,CLL Society Inc.,Negative
   webinar,JADPRO,Negative
   webinar,Patient Empowerment Network,Negative
   webinar,Leukaemia Care,Negative
   webinar,PRIME Education,Negative
   webinar,Managing Myeloma,Positive
   webinar,MediCom Oncology,Negative
 BTK Inhibitor therapy,JADPRO,Negative
   role,JADPRO,Negative
   role,MoJo,Negative
   role,Lymph_m_ni_c,Positive
   role,Francesco Turturro,Positive
 unmet needs,National Alliance for Caregiving,Positive
 unmet needs,VJHemOnc,Negative
 consolidation,Lymphoma Papers,Positive
 consolidation,Cancer Papers,Negative
 consolidation,UVA Science Pubs,Positive
 consolidation,Paperbirds_Hematology,Negative
 ianalumab,OncLive.com,Negative
 ianalumab,Targeted Oncology,Negative
 Pour le maintien d‚Äôune Agence,SNU P√¥le Emploi FSU Occitanie,Negative
 centre,SNU P√¥le Emploi FSU Occitanie,Negative
 centre,CancerCareMBFdn,Positive
 ville de   Gr√®ve ce,SNU P√¥le Emploi FSU Occitanie,Negative
 √† l‚Äôappel,SNU P√¥le Emploi FSU Occitanie,Negative
 Reminder upcoming   week RSVP,Phoebe Needles,Negative
 Friday March,Phoebe Needles,Negative
 word,UCSF Cancer Center,Positive
 word,"Cowan, Liebowitz",Negative
 word,Lorna Warwick,Positive
 word,Michele Nadeem-Baker,Negative
 word,LymphomaAction,Negative
 word,Helen Jane Mee,Negative
 word,Patient Power,Negative
 favorite,Mikhaila Rice,Positive
 favorite,Deanna Rogers,Positive
 Pharmacy Grand Rounds presentations,Mikhaila Rice,Positive
 March   issue,HemaSphere_EHA,Positive
   patient Sandy Peterson,Patient Empowerment Network,Negative
 CLL Treatment Decisions,Patient Empowerment Network,Negative
 New   Cancer Drivers,StopEndlessWar,Positive
 sister,CLLSA,Negative
 sister,Ellen Schafer,Positive
 sister,karla,Positive
 sister,Michele Nadeem-Baker,Negative
 sister,Mona Simpson,Positive
 sister,Triche,Positive
 sister,susan baker,Positive
 Mikhaila Rice PharmD,Mayo Clinic Pharmacy Residency Programs,Positive
 BCPS,Mayo Clinic Pharmacy Residency Programs,Positive
 CaLLing,Mayo Clinic Pharmacy Residency Programs,Positive
 Targeted Therapies Advancements,Mayo Clinic Pharmacy Residency Programs,Positive
 Chronic Lymphocytic LeukemiaPharmacology CE,Mayo Clinic Pharmacy Residency Programs,Positive
 pharmacists physicians physician assistants,Mayo Clinic Pharmacy Residency Programs,Positive
 nurse practitionerstcoyhRP,Mayo Clinic Pharmacy Residency Programs,Positive
 Illustration,somersault1824,Positive
 Âπ¥ÊúàÈÄ±ÁõÆÁ±≥ÂõΩÊ†™„Çπ„Çø„Éº„ÉÜ„Ç£„É≥„Ç∞„É°„É≥„Éê„Éº,Ê†™ÈÅìüìà„Åü„Åè„ÅøÈüø,Positive
 ‚Äª„Çµ„Éñ„É°„É≥„Éê„Éº,Ê†™ÈÅìüìà„Åü„Åè„ÅøÈüø,Positive
 oncologist Dr Shuo Ma,Lurie Cancer Center,Negative
 Sat March,Lurie Cancer Center,Negative
 Preexisting,Paperbirds_Hematology,Negative
 treatmentemergent autoimmune cytopenias,Paperbirds_Hematology,Negative
 targeted drugs,Paperbirds_Hematology,Negative
 targeted drugs,Cancer Papers,Negative
 New article Association,Paperbirds_Hematology,Positive
 Chilblains CaseControl Study,Paperbirds_Hematology,Negative
 Higher Physical Fitness Regulates,medRxiv,Positive
 Vitro Tumor Cell Growth,medRxiv,Positive
 Older Adults,medRxiv,Positive
 Older Adults,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Treatment Naive Chronic Lymphocytic Leukemia CLL,medRxiv,Positive
   patient panel,Leukaemia Care,Negative
 patient informationInput,Leukaemia Care,Negative
 New article Impact,Paperbirds_Hematology,Positive
 age treatment institution,Paperbirds_Hematology,Negative
 chroni,Medivizor,Negative
 Siglec,Marcel van den Brink,Positive
 Siglec,Henning,Negative
 Siglec,Paperbirds_Hematology,Negative
 Alpha,Paperbirds_Hematology,Negative
 Macroglobulin,Paperbirds_Hematology,Negative
 IgGAggregation,Paperbirds_Hematology,Negative
 Chronic Activation,Paperbirds_Hematology,Negative
 Complement System,Paperbirds_Hematology,Negative
 Assessing Patients Knowledge,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Validation,Paperbirds_Hematology,Negative
 ERIC CLL Knowledge Questionnaire,Paperbirds_Hematology,Negative
 Greece,Paperbirds_Hematology,Negative
 Greece,Fredrik √ñhrn,Positive
 practicechanging abstracts,Lymphoma Hub,Positive
 steering committee,Lymphoma Hub,Negative
 steering committee,CLL Advocates Network,Negative
 ‚û° Ô∏è,Lymphoma Hub,Positive
 ‚û° Ô∏è,Medscape Nurses,Positive
 kr√≥nikus lymphoid leukaemia mai kezel√©s√©nek interdiszciplin√°ris,Paperbirds_Hematology,Negative
 k√©rd√©sei,Paperbirds_Hematology,Negative
 MURANO trial,VJHemOnc,Negative
 MURANO trial,CURE Magazine,Negative
 MURANO trial,AbbVie,Negative
 MURANO trial,"Raul Cordoba, MD, PhD",Negative
 MURANO trial,Targeted Oncology,Negative
 MURANO trial,Lymphoma Hub,Negative
 MURANO trial,Jeff Szer,Positive
 MURANO trial,touchONCOLOGY,Negative
 MURANO trial,"chadi nabhan MD, MBA, FACP",Negative
 RR   SLL,VJHemOnc,Negative
 RR   SLL,Benlazar S.M Amin√©,Negative
 Richter,VJHemOnc,Negative
 Richter,CLL Society Inc.,Negative
 Richter,Anas Nasir,Positive
 Richter,Oncology,Negative
 Richter,Just Cancer News,Negative
 Syndrome,VJHemOnc,Negative
 longterm ibrutinib treatment,NK cell Biology,Positive
 longterm ibrutinib treatment,Paperbirds_Hematology,Negative
 longterm ibrutinib treatment,Dendritic cells,Positive
 longterm ibrutinib treatment,NK papers,Negative
 longterm ibrutinib treatment,Dendritic Cell Papers,Positive
 longterm ibrutinib treatment,#Memory,Positive
 longterm ibrutinib treatment,Psychiatry Intel,Positive
 Damian Kovalovsky,Cell Therapy News,Negative
 Siglec antigen,Cell Therapy News,Negative
 Pourquoi les,Silvers Antonio,Positive
 relations de nos jours,Silvers Antonio,Positive
 ne,Silvers Antonio,Positive
 longtemps,Silvers Antonio,Positive
 NEW Comparing ibrutinib,Medivizor,Negative
 ZAP,ClinOwl,Positive
 ZAP,ClinOwl Haematology,Negative
 ZAP,EurekaMag,Negative
 ZAP,J Immunol,Negative
 ZAP,Cancer Papers,Negative
 ZAP,IJAR,Positive
 ZAP,ProPath,Positive
 ZAP,Patient Power,Negative
 gene expression,ClinOwl,Positive
 gene expression,ClinOwl Haematology,Negative
 gene expression,Paperbirds_Hematology,Negative
 gene expression,Hospital del Mar_Translational Hematology,Positive
 gene expression,epigenetics_papers,Negative
 gene expression,5hmCpapers,Positive
 gene expression,Calibr8 Your Life,Positive
 protein synthesis,ClinOwl,Positive
 protein synthesis,ClinOwl Haematology,Negative
 Syed Ali Abutalib MD,The ASCO Post,Negative
 Jennifer R Brown MD PhD,The ASCO Post,Negative
 Jennifer R Brown MD PhD,Expert Perspectives in Oncology,Positive
 Novel Approaches,The ASCO Post,Negative
 generation,Anthony Mato,Negative
 generation,Thomas Eliot Lew,Positive
 generation,Xenia Schmidt,Positive
 generation,VJHemOnc,Negative
 therapies,Anthony Mato,Negative
 therapies,VJHemOnc,Positive
 therapies,MEI Pharma,Positive
 therapies,CLL Society Inc.,Negative
 therapies,CLL Advocates Network,Negative
 therapies,Talal Hilal ü©∫,Negative
 therapies,Razan Mohty,Positive
 therapies,"chadi nabhan MD, MBA, FACP",Negative
 therapies,Torchlight Med,Positive
 therapies,AJMC-Oncology,Negative
 therapies,Fred Hutch,Negative
 therapies,Med-IQ,Positive
 therapies,Christopher Steer,Negative
 therapies,ASH,Negative
 therapies,JExpMed,Negative
 New molecules,Anthony Mato,Negative
 winter hematology conference Great crossfire section,Anthony Mato,Negative
 Drs Goy Brown ChananKhan,Anthony Mato,Negative
 Cortes,Anthony Mato,Negative
 Norway,Sigrid Sk√•nland,Positive
 IowaMayo Clinic,Mayo Clinic Cancer Center,Positive
 J‚Äôaime le temps,Silvers Antonio,Positive
 Panel,donnashort,Positive
 Panel,Centre for Genomic Regulation (CRG),Negative
 audience,donnashort,Negative
 audience,CLL Ireland,Negative
 audience,"chadi nabhan MD, MBA, FACP",Negative
 audience,Penn Medicine MD,Positive
 ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å©,donnashort,Negative
 Jaarlijks krijgen    mensen,Lymfklierkanker VV vzw,Positive
 de diagnose van,Lymfklierkanker VV vzw,Positive
 Nav zeldzame ziektendag wil Evy haar,Lymfklierkanker VV vzw,Positive
 een hart onder,Lymfklierkanker VV vzw,Positive
 de riem steken,Lymfklierkanker VV vzw,Positive
 chronische lymfatische leukemie CLL,Lymfklierkanker VV vzw,Positive
 Quant,Silvers Antonio,Positive
 pense n√©gativement,Silvers Antonio,Positive
 trouve des probl√®mes partout,Silvers Antonio,Positive
 le matin,Silvers Antonio,Positive
 le soir sain,Silvers Antonio,Positive
 et sauf,Silvers Antonio,Positive
 est une gr√¢ce que Dieux t‚Äôaccorde alors,Silvers Antonio,Positive
 dit lui merci,Silvers Antonio,Positive
 drague,Silvers Antonio,Positive
 TP alterations,Paperbirds_Hematology,Negative
 TP alterations,CLL-seq,Negative
 fixedduration,Blood Journal,Negative
 fixedduration,American Pharma Outsourcing,Positive
 fixedduration,Paperbirds_Hematology,Negative
 day history,American College of Cardiology,Negative
 melena chest discomfort amp lightheadedness,American College of Cardiology,Negative
 Multiple,American College of Cardiology,Negative
 novel targets,Yan Leyfman,Positive
 ATTN,iwCLL,Negative
 abstracts Meeting registration,iwCLL,Negative
 Frontiers,Markus P. Vallaster,Positive
 Frontiers,Benlazar S.M Amin√©,Negative
 Phosphoinositide Kinase,Markus P. Vallaster,Positive
 Phosphoinositide Kinase,Paperbirds_Hematology,Negative
 Tumor Microenvironment,Markus P. Vallaster,Positive
 Tumor Microenvironment,Paperbirds_Hematology,Positive
 Tumor Microenvironment,Frontiers Immunology,Negative
 Tumor Microenvironment,Lymphoma Papers,Negative
 Tumor Microenvironment,Cytof Manchester,Positive
 Tumor Microenvironment,AIRR-seq papers,Positive
 Tumor Microenvironment,Philip McCarthy,Negative
 Tumor Microenvironment,"Raul Cordoba, MD, PhD",Negative
 Tumor Microenvironment,Olivier Elemento,Negative
 Tumor Microenvironment,Hematopoiesis News,Negative
 CLL Ireland,CLL Ireland,Negative
 Immune,Giuseppe Michieli,Negative
 Challenges,Giuseppe Michieli,Negative
 Challenges,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Positive
 Challenges,AJMC-Oncology,Negative
 Challenges,EPR Network,Positive
 Challenges,VJHemOnc,Negative
 Challenges,Oncology Tube,Negative
 Challenges,EKLLRF,Positive
 Challenges,UC San Diego CME,Positive
 Challenges,NACDA Program on Aging,Negative
 Challenges,Sandra Kear,Positive
 Pandemic Acta Haematol,Giuseppe Michieli,Negative
 USANYNew York Advanced Practice Provider Nurse Practitioner,"Our Ability, Inc.",Positive
 Physician Assistant,"Our Ability, Inc.",Positive
 Chronic Lymphocytic LeukemiaCLLClinical Research,"Our Ability, Inc.",Positive
 Coevolution,Xuan Cindy Li,Positive
 Coevolution,TumorImmunoPapers,Negative
 Coevolution,CLL-seq,Negative
 Coevolution,TumImmTxpapers,Negative
 Host Immune Cells,Xuan Cindy Li,Positive
 Host Immune Cells,TumorImmunoPapers,Negative
 Host Immune Cells,ImmunologyPapers,Negative
 Host Immune Cells,CLL-seq,Negative
 Host Immune Cells,TumImmTxpapers,Negative
 transplant outcomes,Journal of the @NCCN,Negative
 Australasia,Journal of the @NCCN,Negative
   Case,Journal of the @NCCN,Negative
 acceleratedphase,Journal of the @NCCN,Negative
 relapsing,Journal of the @NCCN,Negative
 relapsing,PeerView,Negative
 transplantation,Journal of the @NCCN,Negative
 transplantation,Medivizor,Positive
 transplantation,Chocolatiere Phys,Negative
 transplantation,Paul Wright,Negative
 transplantation,Lynne Mac Lean,Negative
 transplantation,COPD News,Negative
 transplantation,CancerTherapyAdvisor,Negative
 transplantation,VJHemOnc,Negative
 transplantation,WCM Lymphoma,Negative
 hematology clinic,American College of Cardiology,Negative
 spots,Patient Power,Negative
 spots,Dr. Andy Evens,Negative
 spots,Continuous Lifecycle London (online),Negative
 TONIGHTS Chronic Lymphocytic Leukemia,Patient Power,Negative
 Day   Starts,Great Debates in Hematologic Malignancies,Negative
 Anthony Mato MD MSCE,Targeted Oncology,Negative
 Anthony Mato MD MSCE,OMedLive,Positive
 Anthony Mato MD MSCE,Expert Perspectives in Oncology,Positive
 Richters,Paperbirds_Hematology,Negative
 Richters,CLL Ireland,Negative
 Richters,VJHemOnc,Negative
 Hsp inhibitor SNX,Paperbirds_Hematology,Negative
 p EST Advances,Medscape Education,Negative
 TGTXTG Therapeutics,Biotech Pipeline Tracker,Positive
 pipeline,Biotech Pipeline Tracker,Positive
 pipeline,Verastem Oncology,Negative
 pipeline,Biotech2050,Negative
 pipeline,A. Vroom - Ten Wolde,Negative
 poem,Shouting at people in my underpants,Negative
 poem,Patient Empowerment Network,Negative
 Publication Population,ICR - IUCT Oncopole,Positive
 modelling,ICR - IUCT Oncopole,Positive
 modelling,Psychiatry Intel,Positive
 lymphocyte dynamics,ICR - IUCT Oncopole,Positive
 lymphocyte dynamics,Psychiatry Intel,Positive
 Dr Rossana Maffei,Human Immunology News,Negative
 IRF levels,Human Immunology News,Negative
 IRF,TYR Kinase papers,Negative
 IRF,labi lab innsbruck,Positive
 BCR activation,TYR Kinase papers,Negative
 BCR activation,Paperbirds_Hematology,Negative
 BCR activation,VJHemOnc,Negative
 New article Outcomes,Paperbirds_Hematology,Positive
 Epigenetic Trajectories,Benlazar S.M Amin√©,Negative
 PremalignanttoMalignant Transition,Benlazar S.M Amin√©,Negative
 PremalignanttoMalignant Transition,Blood Cancer Discovery,Negative
 Blood Cancer Discovery,Benlazar S.M Amin√©,Negative
 tcovMlUxlOfl,Benlazar S.M Amin√©,Negative
 Rural Settings,myCME,Positive
   Patient Final,myCME,Negative
 Strategies,myCME,Negative
 Strategies,EurekaMag,Negative
 Strategies,purushottam,Positive
 Strategies,Enfermeria y Seguridad del Paciente,Positive
 Strategies,Patient Power,Negative
 Strategies,Info Batam,Negative
 Strategies,BATAM Kepri,Negative
 Strategies,Hemomadrid,Negative
 Strategies,Avery92,Positive
 Strategies,DR. JAWAHAR TICKU,Positive
 barriers,myCME,Negative
 care treatment adherence,myCME,Negative
 CMS measures,myCME,Negative
   twitter,Reality Hitsüá®üá¶ alone time=my sanity,Positive
 Emergence,filippo masini,Negative
 Emergence,Lymphoma Papers,Negative
 Emergence,Biotech2050,Negative
 overt myeloma,filippo masini,Negative
 overt myeloma,Lymphoma Papers,Negative
   SARSCoV antibodies,Michele Nadeem-Baker,Negative
 Smudge Cells,ASCP,Positive
 Chronic Lymphocytic Leukemia Pathophysiology Laboratory Considerations,ASCP,Positive
 Clinical Significance,ASCP,Positive
 IL levels,Paperbirds_Hematology,Negative
 New article IRF,Paperbirds_Hematology,Negative
 CLL   Derivates,PROvendis GmbH,Negative
 paraNOASA,PROvendis GmbH,Positive
 revised   priority list,ùôÖùô§ùôùùô£ ùôíùôñùô°ùô°,Positive
 everybody,Jan Rynne,Positive
 everybody,Zack Pemberton-Whiteley,Negative
   community,Jan Rynne,Positive
   community,WEGO Health,Negative
   community,CLL Ireland,Positive
   community,Michael Rynne,Positive
   community,Lymphoma Hub,Negative
   community,CLL Advocates Network,Positive
   community,Patient Power,Negative
 patient community,Jan Rynne,Positive
 patient community,Michele Rhee,Positive
 sense,Jan Rynne,Positive
 sense,Jeff Neurman,Negative
 sense,CLL Society Inc.,Negative
 sense,Talal Hilal ü©∫,Negative
 vaccination,Jan Rynne,Positive
 Mazyar Shadman MD shares treatment considerations,OncLive SOSS,Negative
 SCI member Steven Coutre,"Steven Artandi, MD, PhD",Positive
 Immunoglobulin gene analysis,CLL-seq,Positive
 Immunoglobulin gene analysis,CompBiolPapers,Negative
 Immunoglobulin gene analysis,Richard Rosenquist Brandell,Positive
 Evaluation,CLL-seq,Positive
 Evaluation,EurekaMag,Negative
 Evaluation,"Dr T. Comeau , MD",Negative
 Evaluation,Eduardo Flavio Oliveira Ribeiro,Negative
 Evaluation,ClinOwl Haematology,Negative
 Evaluation,Miriam L√≥pez P√©rez,Positive
 Evaluation,Juan Marquet,Negative
 Evaluation,ALI ALAHMARI.,Negative
 Evaluation,ClinOwl,Positive
 Evaluation,JAVIER DE LA SERNA,Positive
 Evaluation,Benlazar S.M Amin√©,Negative
 Evaluation,filippo masini,Negative
 Evaluation,Paperbirds_Hematology,Positive
 Evaluation,INDoximity üáÆüá≥,Negative
 Evaluation,CompBiolPapers,Negative
 Evaluation,Lymphoma Papers,Positive
 Evaluation,TrialBulletin,Negative
 Evaluation,Rare Diseases,Negative
 Evaluation,microRNApapers,Negative
 Evaluation,Cancer Papers,Positive
 Evaluation,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 Evaluation,Ashley Carter,Positive
 Somatic Hypermutation Status,CLL-seq,Positive
 Somatic Hypermutation Status,CompBiolPapers,Negative
 Somatic Hypermutation Status,Frontiers in Cell and Developmental Biology,Positive
 Somatic Hypermutation Status,Yuval Avnir,Positive
 Era,CLL-seq,Positive
 Era,EurekaMag,Negative
 Era,Fabrice Leclerc,Negative
 Era,SeqComplete,Negative
 Era,CompBiolPapers,Negative
 Era,Frontiers in Cell and Developmental Biology,Positive
 Era,Yuval Avnir,Positive
 Era,Paperbirds_Hematology,Positive
 Era,Lymphoma Papers,Negative
 Era,Juan Marquet,Negative
 Era,National Aspergillosis Centre,Negative
 Era,ALI ALAHMARI.,Negative
 Era,Dow Diagnostics,Positive
 Era,Anthony Mato,Negative
 Era,JAMA Oncology,Positive
 Era,JAMA Network,Negative
 Era,MSHO,Positive
 Era,Christopher Steer,Negative
 Era,The Medical Ed Cons.,Negative
 Era,Cancer Papers,Negative
 Era,VJHemOnc,Negative
 Era,MD Anderson Leukemia,Positive
 Generation Sequencing,CLL-seq,Positive
 Generation Sequencing,Paperbirds_Hematology,Negative
 Generation Sequencing,CompBiolPapers,Negative
 Generation Sequencing,TrialBulletin,Negative
 Generation Sequencing,Scott Werntz,Negative
 Comparative analysis,CLL-seq,Positive
 Comparative analysis,ClinOwl Haematology,Negative
 Comparative analysis,CompBiolPapers,Negative
 Comparative analysis,Benlazar S.M Amin√©,Negative
 targeted nextgeneration sequencing panels,CLL-seq,Positive
 targeted nextgeneration sequencing panels,ClinOwl Haematology,Negative
 targeted nextgeneration sequencing panels,CompBiolPapers,Negative
 detection,CLL-seq,Positive
 detection,CEITEC Connect,Negative
 detection,Targeted Oncology,Negative
 detection,ClinOwl Haematology,Negative
 detection,CompBiolPapers,Negative
 detection,Paperbirds_Hematology,Negative
 detection,Michele Nadeem-Baker,Negative
 detection,ecancer,Negative
 gene mutations,CLL-seq,Positive
 gene mutations,Benlazar S.M Amin√©,Negative
 gene mutations,Fish Chromosomes,Positive
 gene mutations,ClinOwl Haematology,Negative
 gene mutations,CompBiolPapers,Negative
 gene mutations,"Raul Cordoba, MD, PhD",Negative
 Minimal Residual Disease,Paperbirds_Hematology,Positive
 Minimal Residual Disease,TrialBulletin,Negative
 Minimal Residual Disease,CLL-seq,Negative
 Minimal Residual Disease,Invivoscribe,Positive
 Minimal Residual Disease,Oncology Tube,Negative
 Minimal Residual Disease,Lymphoma Papers,Negative
 Minimal Residual Disease,"Raul Cordoba, MD, PhD",Negative
 Minimal Residual Disease,Rare Diseases,Negative
 Minimal Residual Disease,ALI ALAHMARI.,Negative
 Minimal Residual Disease,Dow Diagnostics,Positive
 Minimal Residual Disease,Anthony Mato,Negative
 Minimal Residual Disease,JAMA Oncology,Positive
 Minimal Residual Disease,JAMA Network,Negative
 Minimal Residual Disease,PracticeUpdate,Negative
 Minimal Residual Disease,Oncology,Positive
 Minimal Residual Disease,FarmaOnco,Negative
 Minimal Residual Disease,CureHuntr,Negative
 Minimal Residual Disease,OncLive.com,Negative
 Minimal Residual Disease,Oncolytics Biotech,Positive
 Chronic Lymphocytic Leukemia Highlights,Paperbirds_Hematology,Positive
 Scleral Nodule,Paperbirds_Hematology,Positive
 Scleral Nodule,Ophthopedia,Positive
 chance Register,APWA,Positive
 PFAS,APWA,Positive
 waterwhat,APWA,Positive
 ESH JOHN,ESH (Haematology),Negative
 GOLDMAN INTERNATIONAL RESEARCH AWARD,ESH (Haematology),Negative
 TGTX TG Therapeutics Announces Publication,Stock Market Catalyst News üåé,Positive
 TGTX TG Therapeutics Announces Publication,Biotech & Tech Stock Focus,Positive
 TGTX TG Therapeutics Announces Publication,STOCKMASTER2000,Positive
 TGTX TG Therapeutics Announces Publication,"OTC Dynamics, Inc.",Positive
 TGTX TG Therapeutics Announces Publication,Stock News Bot,Positive
 TGTX TG Therapeutics Announces Publication,Stock Titan,Positive
 Final Results,Stock Market Catalyst News üåé,Positive
 Final Results,Biotech & Tech Stock Focus,Negative
 Final Results,Dan Brickner,Positive
 Final Results,STOCKMASTER2000,Positive
 Final Results,"OTC Dynamics, Inc.",Negative
 Final Results,Stock News Bot,Positive
 Final Results,Crwe World,Negative
 Final Results,Stock Titan,Negative
 Final Results,James Kerwin,Positive
 Final Results,Dr. Jos√© A. Queiz√°n,Negative
 Final Results,maria jose agustin,Positive
 Final Results,Isabella Pierre,Positive
 GENUINE Trial,Stock Market Catalyst News üåé,Positive
 GENUINE Trial,Biotech & Tech Stock Focus,Negative
 GENUINE Trial,Dan Brickner,Positive
 GENUINE Trial,STOCKMASTER2000,Positive
 GENUINE Trial,"OTC Dynamics, Inc.",Negative
 GENUINE Trial,Stock News Bot,Positive
 GENUINE Trial,Crwe World,Negative
 GENUINE Trial,Stock Titan,Negative
 GENUINE Trial,‚öæÔ∏èüèÄ‚öΩÔ∏èüé∏ü•Åüéßüé´ü§øüèäüèº‚Äç‚ôÇÔ∏èüèù,Positive
 RelapsedRefractory HighRisk Chronic Lymphocytic Leukemia,Stock Market Catalyst News üåé,Positive
 RelapsedRefractory HighRisk Chronic Lymphocytic Leukemia,Biotech & Tech Stock Focus,Negative
 RelapsedRefractory HighRisk Chronic Lymphocytic Leukemia,Dan Brickner,Positive
 RelapsedRefractory HighRisk Chronic Lymphocytic Leukemia,STOCKMASTER2000,Positive
 RelapsedRefractory HighRisk Chronic Lymphocytic Leukemia,"OTC Dynamics, Inc.",Negative
 RelapsedRefractory HighRisk Chronic Lymphocytic Leukemia,Stock News Bot,Positive
 RelapsedRefractory HighRisk Chronic Lymphocytic Leukemia,Stock Titan,Negative
 RelapsedRefractory HighRisk Chronic Lymphocytic Leukemia,Scott Werntz,Negative
 Lancet,Stock Market Catalyst News üåé,Positive
 Lancet,Biotech2050,Negative
 Lancet,"Raul Cordoba, MD, PhD",Negative
 TG Therapeutics Announces Publication,Dan Brickner,Positive
 TG Therapeutics Announces Publication,Crwe World,Positive
 TG Therapeutics Announces Publication,AlphaBronze,Positive
 TG Therapeutics Announces Publication,Pharmacutical Daily,Negative
 TG Therapeutics Announces Publication,IMPharma News,Negative
 TG Therapeutics Announces Publication,Biotech2050,Negative
 TG Therapeutics Announces Publication,Stock Market News,Negative
 TG Therapeutics Announces Publication,Investor News,Negative
 TG Therapeutics Inc TGTX,Dan Brickner,Positive
 Hoy,Alberto L√≥pez Garc√≠a,Positive
 Hoy,Hematolog√≠a Salamanca,Negative
 Hoy,The Pepex Family,Negative
 Hoy,Indy Wrestling Chile,Positive
 las,Alberto L√≥pez Garc√≠a,Positive
 las,Dario Antilen,Positive
 las,Indy Wrestling Chile,Negative
 las,Orozcoüå™,Positive
 las,CLL Esto es Lucha!,Positive
 se,Alberto L√≥pez Garc√≠a,Positive
 se,Dario Antilen,Positive
 las nuevas,Alberto L√≥pez Garc√≠a,Positive
 para el diagn√≥stico,Alberto L√≥pez Garc√≠a,Positive
 Paolo Ghia Lydia Scarf√≥ Barbara Eichhorst Moritz F√ºrstenau,Alberto L√≥pez Garc√≠a,Positive
 Dr William Wierda,MD Anderson Cancer Center,Negative
 Dr William Wierda,Patient Power,Positive
 Dr William Wierda,MD Anderson Leukemia,Negative
 Dr William Wierda,Patient Empowerment Network,Negative
 Dr William Wierda,Cancer Medicine,Positive
 Dr William Wierda,VJHemOnc,Negative
 Dr William Wierda,OncLive.com,Negative
 Dr William Wierda,Robert Z. Orlowski,Negative
 Dr William Wierda,PER,Negative
 OHC cancer expert Dr James Essell,OHC,Negative
 healthcare professionals,OHC,Negative
 healthcare professionals,Patient Power,Negative
 healthcare professionals,AEGLE,Negative
 amp survivors,OHC,Negative
 Surviving amp Thriving wBlood Cancer,OHC,Negative
 Zoom Dr Essell,OHC,Negative
 Kings researchers,KCL Alumni,Positive
 fields,Lymphoma Hub,Negative
 Click,Lymphoma Hub,Negative
 Click,CLL Society Inc.,Negative
 LIVE date,Medscape Education,Negative
 „Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ,„Åå„Çì„Éó„É©„Çπ,Positive
 FINAL   charge,Jack Lydon,Positive
   MD,OncLive.com,Negative
 CAR Tcell therapy,OncLive.com,Positive
 CAR Tcell therapy,OncLive SOSS,Positive
 CAR Tcell therapy,Targeted Oncology,Negative
 CAR Tcell therapy,UTSW Simmons Comprehensive Cancer Center,Positive
 CAR Tcell therapy,Patient Power,Negative
 CAR Tcell therapy,Benlazar S.M Amin√©,Positive
 CAR Tcell therapy,Lymphoma Hub,Negative
 CAR Tcell therapy,Society for Immunotherapy of Cancer,Positive
 CAR Tcell therapy,Krishan Maggon,Negative
 CAR Tcell therapy,ImmunotherapyPapers,Positive
 CAR Tcell therapy,VJHemOnc,Negative
 CAR Tcell therapy,CellworksLife,Negative
 CAR Tcell therapy,info-over-kanker,Positive
 CAR Tcell therapy,CLL Ireland,Negative
 CAR Tcell therapy,HemOnc Today,Positive
 CAR Tcell therapy,Mr. Brian Uberig,Positive
 CAR Tcell therapy,Marco,Positive
 CAR Tcell therapy,Hal Palmer,Positive
 CAR Tcell therapy,Alliance for Cancer Gene Therapy,Positive
 CAR Tcell therapy,Cpl Life Sciences,Negative
 CAR Tcell therapy,MDedge Hematology & Oncology,Negative
 Identification,Cancer epigenetics papers üìö,Positive
 Identification,Pine Biotech,Positive
 Identification,Fragments,Positive
 Identification,CLL-seq,Negative
 Identification,Paperbirds_Hematology,Negative
 Identification,CellworksLife,Negative
 Identification,AIRR-seq papers,Positive
 Identification,Cancer Papers,Negative
 Identification,CancerEpiPapers,Negative
 Identification,CIB Margarita Salas (CSIC),Positive
 Identification,Leukemia & Lymphoma Society Research,Positive
 Identification,Henning,Negative
 Identification,SEAP-IAP,Positive
 Identification,CCS,Positive
 Identification,Biocomputing,Positive
 Identification,Margaret Walker,Negative
 Identification,Marcy Stiebs,Positive
 Identification,Medical Daily,Positive
 er art√≠culo del nuevo m√≥dulo deü©∏,Alberto L√≥pez Garc√≠a,Positive
 Relapsed Chronic Lymphocytic Leukemia Market Research Report,SouthernIndiaReporte,Positive
 Relapsed Chronic Lymphocytic Leukemia Market Research Report,Shillong Herald,Positive
 Relapsed Chronic Lymphocytic Leukemia Market Research Report,Sikkim Journal,Positive
 Relapsed Chronic Lymphocytic Leukemia Market Research Report,Chhattisgarh Journal,Positive
 Relapsed Chronic Lymphocytic Leukemia Market Research Report,PressRelease.cc,Negative
 Relapsed Chronic Lymphocytic Leukemia Market Research Report,ABNewswire,Negative
 man,JAMA Oncology,Negative
 man,Melissa Palomo Ramon,Positive
 man,Carefree Blues Pod,Positive
 man,James Nova,Positive
 man,Andrew Schorr,Negative
 man,Welty,Positive
 man,Matt Boulton,Positive
 man,Tia Stavely,Positive
 man,Keri Carpenter,Positive
 Upregulation,tampapers,Positive
 Upregulation,Immuno-Oncology,Negative
 Upregulation,Henning,Negative
 Upregulation,Cancer Papers,Positive
 AXL,tampapers,Positive
 Œ≤catenin,tampapers,Positive
 contribution,Paperbirds_Hematology,Negative
 Preneoplastic Alterations,Paperbirds_Hematology,Negative
 Define CLL DNA Methylome,Paperbirds_Hematology,Negative
 Persist,Paperbirds_Hematology,Negative
 HAPPENING,WCM Lymphoma,Positive
   Heme Malignancies Virtual Meeting,WCM Lymphoma,Negative
 Dr John Allan,WCM Lymphoma,Positive
 Dr John Allan,NewYork-Presbyterian,Positive
 William G Wierda MD PhD,Targeted Oncology,Negative
 William G Wierda MD PhD,Journal of the @NCCN,Negative
 challenges,Targeted Oncology,Positive
 challenges,"Chaitra Ujjani, MD",Positive
 challenges,Patient Empowerment Network,Negative
 challenges,Lymphoma Hub,Negative
 challenges,Hematology Advisor,Negative
 challenges,NantHealth,Positive
 challenges,OGT,Negative
 challenges,OncLive.com,Negative
 challenges,LyLe Foreningen,Positive
 challenges,Expert Perspectives in Oncology,Negative
 challenges,Razan Mohty,Positive
 challenges,The James,Positive
 challenges,LymphomaAction,Positive
 challenges,AbbVie,Negative
 challenges,VJHemOnc,Positive
 challenges,Antonio V. Borderia,Positive
 challenges,Zack Pemberton-Whiteley,Negative
 challenges,Med-IQ,Negative
 Mr David Ozor,Samuel Olaiya Afolaranmi,Positive
 Chronic Lymphocytic Leukemia Blood Cancer amp,Samuel Olaiya Afolaranmi,Positive
 Million Naira,Samuel Olaiya Afolaranmi,Positive
 Great Debates,Joseph Mikhael,Positive
 amp Updates,Joseph Mikhael,Positive
 Hematologic Malignancies,Joseph Mikhael,Positive
 Hematologic Malignancies,Paperbirds_Hematology,Positive
 Hematologic Malignancies,OncLive SOSS,Negative
 Hematologic Malignancies,Targeted Oncology,Negative
 Hematologic Malignancies,Lymphoma Papers,Negative
 Hematologic Malignancies,Oncology CE,Positive
 Hematologic Malignancies,Siteman Cancer Center,Positive
 Hematologic Malignancies,Verastem Oncology,Negative
 Hematologic Malignancies,Cancer Papers,Negative
 Hematologic Malignancies,Expert Perspectives in Oncology,Negative
 Hematologic Malignancies,Children‚Äôs Oncology Group,Negative
 Hematologic Malignancies,PER,Negative
 Hematologic Malignancies,Lymphoma Canada,Negative
 Hematologic Malignancies,Anna Deveau,Negative
 NEW ARTICLE,CMRO Journal,Positive
 Realworld healthcare resource utilization,CMRO Journal,Positive
 Realworld healthcare resource utilization,Lymphoma Papers,Negative
 costs,CMRO Journal,Positive
 costs,Lymphoma Papers,Positive
 costs,Barry Shrier,Negative
 costs,Medivizor,Negative
 costs,noel cole,Negative
 costs,Georges Azzi,Positive
 costs,MDedge Hematology & Oncology,Negative
   MD MMSc,OncLive.com,Positive
 year analysis,OncLive.com,Negative
 year analysis,David Henry,Positive
 MURANO study,OncLive.com,Negative
 MURANO study,HemOnc Today,Negative
 MURANO study,VJHemOnc,Negative
 MURANO study,Jessica Okosun,Positive
 Combinig Venetoclax,Benlazar S.M Amin√©,Negative
 TOMORROW,WCM Lymphoma,Negative
 TOMORROW,Managing Myeloma,Negative
 TOMORROW,MediCom Oncology,Negative
 TOMORROW,Patient Power,Negative
 SCCA,SeattleCancerCareAlliance,Positive
 Dr Mazyar Shadman,SeattleCancerCareAlliance,Negative
 Dr Mazyar Shadman,CURE Magazine,Negative
 treatment considerations,SeattleCancerCareAlliance,Negative
   program,Phoebe Needles,Positive
   program,"Raul Cordoba, MD, PhD",Negative
   program,ERN EuroBloodNet,Negative
   program,Andrew Schorr,Negative
   program,Memorial Sloan Kettering Cancer Center,Negative
   program,VJHemOnc,Negative
    Market Global Forecast,Ryan Smith,Positive
 Market,Ryan Smith,Positive
 Market,A. Vroom - Ten Wolde,Negative
 Market,Info Batam,Negative
 Market,Batam Port,Positive
 Market,BATAM Kepri,Negative
 Market,Alessio Rombolotti,Positive
 Outcome,"Dr T. Comeau , MD",Positive
 Outcome,INDoximity üáÆüá≥,Positive
 Outcome,filippo masini,Positive
 Outcome,Oscar Lahoud,Positive
 Outcome,"Mazyar Shadman, MD MPH",Negative
 Outcome,ClinOwl Haematology,Negative
 Outcome,Irene Mangues,Positive
 Outcome,Benlazar S.M Amin√©,Negative
 Outcome,Internal Medicine: Open Access,Negative
 Outcome,"Raul Cordoba, MD, PhD",Positive
 Outcome,Mahmoud Aljurf,Negative
 Outcome,palliativewise,Negative
 Outcome,The ASCO Post,Negative
 Outcome,Johan Van Weyenbergh,Negative
 Ibrutinib Development,"Dr T. Comeau , MD",Negative
 Ibrutinib Development,INDoximity üáÆüá≥,Negative
 Ibrutinib Development,Oscar Lahoud,Positive
 Ibrutinib Development,ClinOwl Haematology,Negative
 Ibrutinib Development,filippo masini,Negative
 Ibrutinib Development,Irene Mangues,Positive
 Ibrutinib Development,Benlazar S.M Amin√©,Negative
 Validation,"Dr T. Comeau , MD",Negative
 Validation,INDoximity üáÆüá≥,Negative
 Validation,Oscar Lahoud,Positive
 Validation,ClinOwl Haematology,Negative
 Validation,filippo masini,Negative
 Validation,Irene Mangues,Positive
 Validation,Benlazar S.M Amin√©,Negative
 Validation,Lymphoma Papers,Negative
 Validation,Paperbirds_Hematology,Negative
 FourFactor Prognostic Model   Journal,"Dr T. Comeau , MD",Negative
 FourFactor Prognostic Model   Journal,Oscar Lahoud,Positive
 FourFactor Prognostic Model   Journal,Benlazar S.M Amin√©,Negative
 Clinical Oncology,"Dr T. Comeau , MD",Positive
 Clinical Oncology,Oscar Lahoud,Positive
 Clinical Oncology,Benlazar S.M Amin√©,Positive
 Clinical Oncology,Miriam L√≥pez P√©rez,Positive
 Clinical Oncology,Oncology State Societies at ACCC,Positive
 Clinical Oncology,F. Hernandez Mohedo,Positive
 Clinical Oncology,"Hayder Saeed, MD",Positive
 Clinical Oncology,GEDEFO,Negative
 Clinical Oncology,Mahmoud Aljurf,Negative
 Clinical Oncology,Bernie Marini,Positive
 Clinical Oncology,"Philippe Aftimos, MD",Positive
 FourFactor Score,"Dr T. Comeau , MD",Negative
 FourFactor Score,INDoximity üáÆüá≥,Negative
 FourFactor Score,filippo masini,Negative
 Ibrutinib Treatment,"Dr T. Comeau , MD",Negative
 Ibrutinib Treatment,INDoximity üáÆüá≥,Negative
 Ibrutinib Treatment,The ASCO Post,Negative
 Ibrutinib Treatment,filippo masini,Negative
 Ibrutinib Treatment,Clinical Cancer Research,Positive
 Ibrutinib Treatment,Jerry Lee,Negative
 Ibrutinib Treatment,Cure Cancer Now,Positive
 Ibrutinib Treatment,Lymphoma Papers,Positive
 Ibrutinib Treatment,TrialBulletin,Negative
 Chronic Lymphocytic Leukemia Prognostic Model,"Dr T. Comeau , MD",Negative
 Chronic Lymphocytic Leukemia Prognostic Model,INDoximity üáÆüá≥,Negative
 Chronic Lymphocytic Leukemia Prognostic Model,filippo masini,Negative
 Risk Group Definition,"Dr T. Comeau , MD",Negative
 Risk Group Definition,INDoximity üáÆüá≥,Negative
 Risk Group Definition,filippo masini,Negative
 Mapping comorbidity,Kuro_Unplugged,Positive
   Venetoclax Rituximab,CureHuntr,Negative
 TN Patients,CureHuntr,Negative
 TN Patients,TrialBulletin,Negative
 CLL Undetectable Minimal Residual Disease uMRD,CureHuntr,Negative
 CLL Undetectable Minimal Residual Disease uMRD,TrialBulletin,Negative
 Treatmentna√Øve Patients,CureHuntr,Negative
 Treatmentna√Øve Patients,TrialBulletin,Negative
 Treatmentna√Øve Patients,Orbis Biosciences,Negative
 Venetoclax Rituximab,TrialBulletin,Negative
 Chronic Lymphocytic Leukemia CLL Status,TrialBulletin,Positive
 Condition Summary Chronic Lymphocytic Leukemia CL,TrialBulletin,Negative
 Ophthopedia Update Chronic Lymphocytic Leukemia,Ophthopedia,Positive
 voice,Seema Ali Bhat,Positive
 voice,CLL Advocates Network,Negative
 voice,Michael Rynne,Negative
 voice,CLL Ireland,Negative
 voice,Julia's class,Positive
 Coronavirus Vaccines,Michele Nadeem-Baker,Negative
 Stephan Stilgenbauer MD,OncLive.com,Negative
 Stephan Stilgenbauer MD,ASH Clinical News,Negative
 Stephan Stilgenbauer MD,Oncology Tube,Negative
 MD Phd,OncLive.com,Negative
 Jennifer Brown MD PhD,OncLive.com,Negative
 Frontline Treatment Options,OncLive.com,Negative
 Frontline Treatment Options,"Dr T. Comeau , MD",Negative
 Surveys,Patient Power,Negative
 Mein Mann,Pilgrim,Positive
 zur,Pilgrim,Positive
 zur,AbbVie Deutschland,Negative
 zur,Deutsches √Ñrzteblatt,Positive
 geh√∂rend aufgrund von,Pilgrim,Positive
 wartet noch,Pilgrim,Positive
 mir zusammen ich Asthmatikerin u seine,Pilgrim,Positive
 Ehefrau auf,Pilgrim,Positive
 Impfung Er kann nicht mal,Pilgrim,Positive
 machen,Pilgrim,Positive
 CART cell generation,Benlazar S.M Amin√©,Negative
 presence,Benlazar S.M Amin√©,Negative
 presence,David Henry,Positive
 presence,ASGCT,Negative
 presence,Oncocheck,Positive
 presence,Anna Deveau,Negative
 presence,Cancer Papers,Negative
 ibrutinib results,Benlazar S.M Amin√©,Negative
 Imbruvicas Cardiotoxicity Claims,Tom Lamb,Positive
 Recent Chronic Lymphocytic Leukemia Study,Tom Lamb,Positive
 CLL experts,Patient Power,Positive
 CLL experts,CLL Ireland,Negative
 CLL experts,CLL Society Inc.,Negative
 CLL experts,Patient Empowerment Network,Negative
 NCCN,CURE Magazine,Negative
 NCCN,Abdullah Al Mosabbir,Positive
 NCCN,"Raul Cordoba, MD, PhD",Negative
 NCCN,TheraGlobal,Positive
 NCCN,Lymphoma News Today,Negative
 recommendations,CURE Magazine,Negative
 recommendations,Biologics by McKesson,Negative
 recommendations,SpecialtyPTimes,Negative
 recommendations,Dog Cancer Help,Negative
 recommendations,"Raul Cordoba, MD, PhD",Negative
 recommendations,Cancer Papers,Negative
 recommendations,Jordan Gauthier,Positive
 recommendations,Biocom California,Positive
 Good news chemo drug,Bobby Martin,Positive
 Opening,Kimmo Porkka,Positive
 Opening,Toby Eyre,Negative
 Opening,Josh Towsley,Positive
 Opening,Dr. Melody Davis,Negative
 Opening,Innate Pharma,Positive
 CET,Kimmo Porkka,Positive
 CET,European Hematology Association,Negative
 CET,ESH (Haematology),Negative
 prof J Gribben president   Registration,Kimmo Porkka,Positive
 Pill,Disability DATA,Positive
 Chemotherapy,Disability DATA,Positive
 Chemotherapy,The ASCO Post,Negative
 Chemotherapy,Paperbirds_Hematology,Negative
 Chemotherapy,AbbVie,Negative
 Chemotherapy,RAVIKANTH S,Negative
 Chemotherapy,Oncology Tube,Negative
 Chemotherapy,Heather Swift Morrison,Negative
 Chemotherapy,Jack Shields,Positive
 Chemotherapy,ShieldsRx,Positive
 Chemotherapy,newswise,Negative
 Chemotherapy,MD.,Negative
 Chemotherapy,Centro Medico Qx,Negative
 Chemotherapy,SOBRAFO,Positive
 Chemotherapy,NACDA Program on Aging,Negative
 Chemotherapy,VJHemOnc,Negative
 Chemotherapy,Targeted Oncology,Negative
 Chemotherapy,Sariantra Kali,Positive
 Chemotherapy,Afshine Emrani  MD FACC,Positive
 Chemotherapy,Equality Couple,Negative
 SIRPŒ±,Artocarpus,Positive
 Therapeutic Antibodies,Artocarpus,Positive
 Nurse,Artocarpus,Positive
 Nurse,CLL Ireland,Negative
 Cells,Artocarpus,Positive
 Cells,Psychiatry Intel,Positive
 Cells,Paperbirds_Hematology,Negative
 Cells,ImmunologyPapers,Negative
 Cells,Salt,Positive
 Cells,ACS Journal Cancer,Negative
 Cells,Cancer Papers,Negative
 Cells,Hematopoiesis News,Positive
 Cells,Journal of Clinical Pathways,Negative
 Cells,Oncology Tube,Negative
 Cells,HRA,Positive
 Cells,Baby MLSüë∂üëº,Positive
 Chronic Lymphocytic Leukemia Patients,Artocarpus,Positive
 Chronic Lymphocytic Leukemia Patients,Paperbirds_Hematology,Positive
 Chronic Lymphocytic Leukemia Patients,Pharma News,Negative
 Chronic Lymphocytic Leukemia Patients,Pharmacutical Daily,Negative
 Chronic Lymphocytic Leukemia Patients,Umair Subhani,Positive
 Chronic Lymphocytic Leukemia Patients,Biotech & Tech Stock Focus,Negative
 Chronic Lymphocytic Leukemia Patients,STCK.PRO,Positive
 Chronic Lymphocytic Leukemia Patients,Genmab,Positive
 Chronic Lymphocytic Leukemia Patients,IMPharma News,Negative
 Chronic Lymphocytic Leukemia Patients,"OTC Dynamics, Inc.",Negative
 Chronic Lymphocytic Leukemia Patients,biotechradar.eu,Positive
 Chronic Lymphocytic Leukemia Patients,Brave Is Now¬Æ,Negative
 Chronic Lymphocytic Leukemia Patients,Virtute_USMLE,Negative
 Chronic Lymphocytic Leukemia Patients,ArthurPotatoeHammer,Negative
 Chronic Lymphocytic Leukemia Patients,gilbert c faure,Positive
 Chronic Lymphocytic Leukemia Patients,MAISA,Negative
 Chronic Lymphocytic Leukemia Patients,San Francisco Biotechnology Network,Positive
 Chronic Lymphocytic Leukemia Patients,Mr Bentley Onelly,Positive
 Chronic Lymphocytic Leukemia Patients,HODOR,Positive
 Chronic Lymphocytic Leukemia Patients,quantumup,Positive
 Chronic Lymphocytic Leukemia Patients,CellworksLife,Positive
 Chronic Lymphocytic Leukemia Patients,Semmelweis University CompBio Group,Positive
 Chronic Lymphocytic Leukemia Patients,Jerry Lee,Negative
 Chronic Lymphocytic Leukemia Patients,Cure Cancer Now,Negative
 Chronic Lymphocytic Leukemia Patients,COPD News,Negative
 Chronic Lymphocytic Leukemia Patients,Cord Blood News,Negative
 Chronic Lymphocytic Leukemia Patients,Hematopoiesis,Positive
 Chronic Lymphocytic Leukemia Patients,lncRNApapers,Positive
 Chronic Lymphocytic Leukemia Patients,Oncology Tube,Positive
 Chronic Lymphocytic Leukemia Patients,Lymphoma News Today,Positive
 Chronic Lymphocytic Leukemia Patients,BioNews,Negative
 Chronic Lymphocytic Leukemia Patients,Wendy Carvotta,Positive
 Chronic Lymphocytic Leukemia Patients,Oncology,Negative
 Chronic Lymphocytic Leukemia Patients,Fighting the Fight,Positive
 Chronic Lymphocytic Leukemia Patients,Disease Alerts,Positive
 Chronic Lymphocytic Leukemia Patients,First4Training,Positive
 Chronic Lymphocytic Leukemia Patients,Penn Medicine News,Negative
 Chronic Lymphocytic Leukemia Patients,Scott Werntz,Negative
 Chronic Lymphocytic Leukemia Patients,JournalAgent,Positive
 TLR expression,Oligotherapeutics,Positive
 TLR expression,NatureRevClinOncol,Negative
 TLR expression,Michie Lab,Negative
 Save   dates,Medscape Nurses,Positive
 programs,Medscape Nurses,Negative
 programs,ESCofNJ,Negative
 programs,FierceBiotech,Positive
 vet,StarSeekerDragon,Positive
 Envy,StarSeekerDragon,Positive
 Assessment,Benlazar S.M Amin√©,Negative
 Assessment,Shelley Henry,Positive
 Assessment,TCRT Cancer Journal,Positive
 Spike Protein,Walter M Chesnut,Positive
 SARSCoV,Walter M Chesnut,Positive
 Endoplasmic Reticulum,Walter M Chesnut,Positive
 stress,Walter M Chesnut,Positive
 stress,Dana-FarberYAProgram,Positive
 stress,Patient Power,Negative
 stress,OSU Psych Advising,Positive
 stress,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 stress,Arts and Sciences,Positive
 stress,AJMC,Negative
 stress,Ohio State News,Positive
 stress,Cancer Papers,Negative
 TRF,Walter M Chesnut,Positive
 Shelterin Complex,Walter M Chesnut,Positive
 TELOMERE,Walter M Chesnut,Positive
 TELOMERE FUSION,Walter M Chesnut,Positive
 Simay Dolaner,Pine Biotech,Positive
 Research Project,Pine Biotech,Positive
 lncRNAs,Pine Biotech,Positive
 Therapeutic Targets,Pine Biotech,Positive
 Therapeutic Targets,ICGEB Official,Positive
 Therapeutic Targets,Paperbirds_Hematology,Negative
 CAR T,CLL Ireland,Negative
 CAR T,Michael Rynne,Negative
 CAR T,Memorial Sloan Kettering Cancer Center,Negative
 CAR T,Penn Medicine News,Negative
 CAR T,Juno Therapeutics,Positive
 February,MOASC,Positive
 February,CLL Society Inc.,Positive
 February,CLL Ireland,Negative
 February,OncLive.com,Negative
 February,AEGLE,Negative
 February,Continuous Lifecycle London (online),Negative
 February,Team In Training GAT,Positive
 network,MOASC,Positive
 network,Paperbirds_Hematology,Negative
 network,Patient Empowerment Network,Negative
 network,CLL Advocates Network,Negative
 CLLers,Michele Nadeem-Baker,Negative
 Expert Live QampA,Michele Nadeem-Baker,Negative
 CLL Specialists,Michele Nadeem-Baker,Negative
 Genomic Instability,Journal of the @NCCN,Negative
 Genomic Instability,Paperbirds_Hematology,Negative
 Clonal Evolution,Journal of the @NCCN,Negative
 Clonal Evolution,Paperbirds_Hematology,Negative
 Clonal Evolution,Oncology Tube,Negative
 Clinical Relevance,Journal of the @NCCN,Negative
 Clinical Relevance,Benlazar S.M Amin√©,Negative
 Clinical Relevance,Lymphoma Papers,Negative
 Clinical Relevance,Calyx,Positive
 Clinical Relevance,Random PubMed,Positive
 Clinical Relevance,microRNApapers,Negative
 master thesis,Anna Kabanova,Positive
 lab,Anna Kabanova,Positive
 lab,Lili Wang Lab,Negative
 lab,Laboratory Career,Negative
 lab,@balbensi üá∫üá∏ üáÆüáπ,Positive
 lab,Michie Lab,Negative
 lab,Daniel Bachurski,Positive
 lab,Patient Power,Negative
 lab,Sigrid Sk√•nland,Negative
 gene editing,Anna Kabanova,Positive
 Warmest congratulations,Anna Kabanova,Positive
 lives,AbbVie UK,Positive
 lives,"Pharmacyclics, an AbbVie Company",Positive
 lives,CEITEC Connect,Negative
 lives,RIOH,Negative
 lives,CLL Ireland,Negative
 lives,The James,Positive
 lives,CLL Society Inc.,Negative
 lives,Russell Roberts,Positive
 change,AbbVie UK,Positive
 change,VJHemOnc,Negative
 change,CLLSA,Negative
 change,CLL Ireland,Negative
 change,ESMO - Eur. Oncology,Negative
 change,Chris Thomson,Negative
 direction,AbbVie UK,Positive
 direction,Proactive,Negative
 Cerebral Invasive Aspergillosis,TYR Kinase papers,Negative
 Case,TYR Kinase papers,Negative
 Case,EurekaMag,Negative
 Case,Targeted Oncology,Negative
 Case,Paperbirds_Hematology,Positive
 Case,Lymphoma Papers,Negative
 Case,Cureus,Positive
 Case,Oncology Times,Negative
 Case,AJNR,Positive
 Case,Integra Medical,Positive
 Case,donnashort,Negative
 Case,Reddit FoodNerds,Positive
 Case,"Born Integrative Medicine Specialists, PLLC",Positive
 Case,Krishan Maggon,Negative
 Bruton Tyrosine Kinase Inhibitor,TYR Kinase papers,Negative
 Bruton Tyrosine Kinase Inhibitor,HEDGE accordinglyüìà,Negative
 Bruton Tyrosine Kinase Inhibitor,RazzleTazzle,Negative
 lymph nodes,Leukemia,Negative
 lymph nodes,Victor Lin,Positive
 lymph nodes,MyPathologyReport.ca,Negative
 articles,Nitin Jain,Negative
 articles,Lymphoma Hub,Negative
 articles,The Lancet Oncology,Negative
 articles,BMC,Positive
 articles,ARRS GoldMiner¬Æ,Negative
 Tests,Patient Empowerment Network,Positive
   professionals,HARMONY Alliance,Negative
   professionals,Medthority,Negative
   professionals,Patient Power,Positive
 partners,HARMONY Alliance,Negative
 partners,Helix BioPharma,Positive
 partners,AA&MDSIF,Positive
 partners,Geoffrey Berguet,Positive
 partners,FredNatLab PDO,Positive
 partners,Gilead Sciences,Negative
 partners,Matthias Piesche,Negative
 NEW Evaluating zanubrutinib,Medivizor,Negative
 c,Medivizor,Negative
 c,60s Folks,Positive
 c,"chadi nabhan MD, MBA, FACP",Negative
 Good Afternoon,Brown Emmanuel,Positive
 friend,Brown Emmanuel,Positive
 friend,CLL Ireland,Positive
 friend,Michael Rynne,Negative
 friend,Mark Noblet,Positive
 friend,Kathleen Ebert,Positive
 friend,"Stefano Luminari, MD",Positive
 friend,Patient Power,Positive
 friend,Andrew Schorr,Positive
 friend,ùê¶ùêöùê†ùêßùêÆùê¨‚Å∑,Positive
 friend,Triche,Positive
 friend,Peter James Cowan,Positive
 friend,Mila Araujo,Positive
 WhatsApp,Brown Emmanuel,Positive
 WhatsApp,Shifa Drug,Positive
 WhatsApp,World Cancer medicine,Positive
 conversation,Brown Emmanuel,Positive
 conversation,Anthony Mato,Negative
 conversation,SpecialtyPTimes,Negative
 conversation,ASH Clinical News,Negative
 conversation,@MyelomaTeacher - Cindy Chmielewski,Negative
 scoring system,VJHemOnc,Negative
 evolution,VJHemOnc,Positive
 evolution,AbbVie US,Positive
 evolution,Patient Power,Negative
 evolution,ESH (Haematology),Negative
 evolution,CLL Ireland,Positive
 evolution,Aziz Khan,Positive
 evolution,Angus Macaulay,Positive
 evolution,AJMC,Negative
 evolution,Crown Bioscience,Negative
 evolution,Carmine DeLuca,Negative
 evolution,iwCLL,Negative
 evolution,"Raul Cordoba, MD, PhD",Negative
 evolution,Senior Care Corner,Negative
 syndrome,VJHemOnc,Negative
 syndrome,NEJM Resident 360,Positive
 Andrea Visentin,VJHemOnc,Negative
 Winter Hematology Update,Anthony Mato,Negative
 men,BeiGene,Negative
 men,"Pharmacyclics, an AbbVie Company",Negative
 men,JanssenUS,Positive
 men,Janssen Global,Negative
 Immunotherapy,Clinical Cancer Research,Positive
 Immunotherapy,Patient Power,Negative
 Immunotherapy,NIH Clinical Center,Negative
 Immunotherapy,Paperbirds_Hematology,Positive
 Immunotherapy,Krishan Maggon,Positive
 Immunotherapy,Lymphoma Papers,Negative
 Immunotherapy,CARE‚Ñ¢ Education,Negative
 Immunotherapy,gilbert c faure,Negative
 Immunotherapy,Benlazar S.M Amin√©,Negative
 Immunotherapy,Bill Both,Positive
 Immunotherapy,Pepvax Inc,Negative
 Immunotherapy,Diagnostics News,Negative
 Immunotherapy,Just Cancer News,Negative
 Immunotherapy,Jerry Lee,Negative
 Immunotherapy,Francesco Turturro,Negative
 Immunotherapy,MoJo,Negative
 BcR stereotypy,Clinical Cancer Research,Positive
 Lymphocyte doubling time,Nagy √Åkos,Positive
 ùó¶ùóßùóîùó•ùóßùóúùó°ùóö ùó¶ùó¢ùó¢ùó° Join Dr,Clinical Care Solutions,Positive
 Design,BioSolveIT,Positive
 Design,CellworksLife,Negative
 Design,OncLive.com,Negative
 BCL Inhibitors,BioSolveIT,Positive
 BCL Inhibitors,OncLive.com,Negative
 Shiyu Wang,BioSolveIT,Positive
   project,BioSolveIT,Positive
   project,Sigrid Sk√•nland,Positive
   project,Pallawi Torka,Positive
   project,CIMAGO,Positive
   project,"chadi nabhan MD, MBA, FACP",Negative
   project,cnaamani,Positive
 week,BioSolveIT,Positive
 week,Living A Busy Life - With Cancer,Positive
 week,VJHemOnc,Negative
 week,PeerView,Negative
 week,"Cowan, Liebowitz",Negative
 week,CLL Ireland,Negative
 week,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 week,Broad Institute,Positive
 week,Danielle Ternyila,Positive
 week,CLL Warwick Uni,Negative
 week,WhatNext.com,Negative
 week,MarieSk≈ÇodowskaCurie,Positive
 week,LiveYourLife,Negative
 week,Patient Power,Negative
 week,Community Legacy League,Negative
 week,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
 week,Lifelong Learning,Negative
 week,Tishylishy,Positive
 week,Prairie Lakes Church,Negative
 week,Jeff Honeysett,Positive
 Florida CLL‚Äôers,Michele Nadeem-Baker,Negative
 Past,Habib Olapade,Positive
 Post ‚öì,Habib Olapade,Positive
 Tomorrow,CLL Society Inc.,Negative
 Tomorrow,Patient Power,Positive
 Tomorrow,CLLSA,Negative
 Tomorrow,Pippa Jones,Positive
 Tomorrow,AbbVie Canada,Negative
 Lymphoma Research Foundation,CLL Society Inc.,Positive
 Lymphoma Research Foundation,CRO Contract Res.,Negative
 webinar Update,CLL Society Inc.,Positive
 Oral Therapies,CLL Society Inc.,Positive
 Oral Therapies,Medscape Education,Negative
 pm ET,CLL Society Inc.,Positive
 pm ET,Patient Power,Negative
 pm ET,Patient Empowerment Network,Negative
 pm ET,CURE Magazine,Negative
 pm ET,Mary Ellen Schneider,Negative
 pm ET,"Pharmacyclics, an AbbVie Company",Negative
 pm ET,Mayo Clinic Med Ed,Positive
 pm ET,Michele Nadeem-Baker,Negative
 Dr Jonathon Cohen,CLL Society Inc.,Positive
 Emory University    Helpline,CLL Society Inc.,Positive
 Things,Francis Jenkins RE,Positive
 Things,"Larry Sanchez Perezmarchand, Ed.S, M.S.",Positive
 Things,Heather Swift Morrison,Negative
 Things,Chronic Disease Coalition,Positive
 Things,Anna Kabanova,Positive
 Things,"Tom Henry, MBA, RPh, CPh",Negative
 Things,John Riches,Positive
 Common Blood Cancer,Francis Jenkins RE,Positive
 Healthy,Francis Jenkins RE,Positive
 Advanced Practice Perspectives,Paperbirds_Hematology,Negative
 Preventing,Paperbirds_Hematology,Negative
 Preventing,CLL Ireland,Negative
 Managing Tumor Lysis Syndrome,Paperbirds_Hematology,Negative
 Neutropenia,Paperbirds_Hematology,Negative
 Clinical Outcomes,Paperbirds_Hematology,Negative
 Clinical Outcomes,Jordan Gauthier,Positive
 Clinical Outcomes,"Raul Cordoba, MD, PhD",Negative
 RealWorld Patients,Paperbirds_Hematology,Negative
 RealWorld Patients,Oncology Times,Positive
 Concomitant Extensive Chronic Graft,Paperbirds_Hematology,Negative
 Allogeneic Haematopoietic Stem Cell Transplantation,Paperbirds_Hematology,Negative
 Michael Bishop,Lymphoma Hub,Negative
 Michael Bishop,VJHemOnc,Negative
 TRANSCEND CLL   trial,Lymphoma Hub,Negative
 RR CLLSLL,Lymphoma Hub,Negative
 RR CLLSLL,CancerTherapyAdvisor,Negative
 Video   shares findings,ASH Clinical News,Negative
   coverage,VJHemOnc,Positive
   coverage,Patient Power,Positive
   coverage,Lymphoma Hub,Negative
   coverage,Dr Timos Papagatsias,Negative
   coverage,MedPage Today,Negative
 Active Akt,Blood Journal,Negative
 triggers,Blood Journal,Negative
 triggers,TU M√ºnchen,Positive
 triggers,Paperbirds_Hematology,Negative
 overactivation,Blood Journal,Negative
 overactivation,Paperbirds_Hematology,Negative
 Notch,Blood Journal,Negative
 Notch,Paperbirds_Hematology,Positive
 Current   Treatment Approaches,Patient Empowerment Network,Negative
   excellence program,alberto santos,Positive
 cases,Journal of the @NCCN,Negative
 cases,CLLSA,Negative
 cases,Human Immunology News,Negative
 cases,Fleur Peters,Positive
 cases,K Pavithran,Positive
 cases,Clean Cape Fear,Positive
 cases,Expert Perspectives in Oncology,Negative
 cases,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 cases,Targeted Oncology,Positive
 cases,Matthews & Associates,Positive
 Deals,DaysInnBryanCS,Positive
 advantage,DaysInnBryanCS,Positive
 advantage,Bionest Partners,Negative
 advantage,CLL Society Inc.,Negative
 programme,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 programme,LymphomaAction,Negative
 UK CLL Forum,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 UK CLL Forum,Oxford Centre for Haematology,Positive
 UK CLL Forum,Nick,Negative
 UK CLL Forum,Blood Cancer UK Research,Negative
 UK CLL Forum,Helen Jane Mee,Negative
 UK CLL Forum,Michael Moles,Positive
 Prof Gunnar Larfors Sweden,European Hematology Association,Negative
 Access,European Hematology Association,Negative
 Access,Breaking Data,Negative
 Access,Lymphoma Papers,Negative
 Access,Bloodbytes,Positive
 Access,Paperbirds_Hematology,Negative
 Access,Brave Is Now¬Æ,Negative
 Access,EIN Presswire: Press Releases,Positive
 Access,CARE‚Ñ¢ Education,Negative
 Access,CLLSA,Positive
 Access,Dendritic cells,Positive
 Access,TumorImmunoPapers,Negative
 acute   leukemia acute myeloid leukemia,Leukemia,Negative
 CD Expression,EurekaMag,Positive
 CD Expression,Maniriho Etienne,Positive
 CD Expression,JournalAgent,Positive
 CD Expression,Cancer Papers,Positive
 CD Expression,Oncology,Negative
 CD Expression,TumorImmunoPapers,Negative
 Differentiating Markers,EurekaMag,Negative
 Mature BCell Neoplasms,EurekaMag,Negative
 MicroRNAs Tiny Regulators,Hematopoiesis,Positive
 MicroRNAs Tiny Regulators,CLL-seq,Negative
 Gene Expression,Hematopoiesis,Positive
 Gene Expression,CLL-seq,Negative
 Gene Expression,gilbert c faure,Negative
 Pivotal Roles,Hematopoiesis,Positive
 Pivotal Roles,CLL-seq,Negative
 Author Correction Determinants,minnlab_litbot,Positive
 Author Correction Determinants,Paperbirds_Hematology,Negative
 CD chimeric antigen receptor CAR T cell therapy,minnlab_litbot,Positive
 CD chimeric antigen receptor CAR T cell therapy,Paperbirds_Hematology,Negative
 CD chimeric antigen receptor CAR T cell therapy,Santiago Carmona üß¨ üñ•Ô∏è üë®üèæ‚Äçüî¨,Positive
 CD chimeric antigen receptor CAR T cell therapy,Hyun Goo Woo,Positive
 CD chimeric antigen receptor CAR T cell therapy,Penn Path & Lab Medicine,Positive
 CD chimeric antigen receptor CAR T cell therapy,SiCORE in Immunoregulation,Positive
 CD chimeric antigen receptor CAR T cell therapy,CRISP_SCIENCE,Positive
 CD chimeric antigen receptor CAR T cell therapy,ImmunotherapyPapers,Negative
 CD chimeric antigen receptor CAR T cell therapy,TumImmTxpapers,Negative
 CD chimeric antigen receptor CAR T cell therapy,Krishan Maggon,Negative
 CD chimeric antigen receptor CAR T cell therapy,Continuum AEP,Positive
 CD chimeric antigen receptor CAR T cell therapy,All Ways Well,Positive
 Oncologists,Dr. Liz Samander,Positive
 Oncologists,CLL Society Inc.,Negative
 Oncologists,OncLive.com,Negative
 Oncologists,Targeted Oncology,Negative
 Dr Brian Koffman,CLL Society Inc.,Positive
 Dr Brian Koffman,CLL Ireland,Negative
 Dr Brian Koffman,Patient Empowerment Network,Negative
 Dr Brian Koffman,CLL Advocates Network,Negative
 Dr Brian Koffman,AbbVie,Negative
 Dr Brian Koffman,Patient Power,Positive
 CNN,CLL Society Inc.,Negative
 Covid vaccines,CLL Society Inc.,Negative
 Cure Panel,FindACurePanel,Positive
 Current Treatment,"Dr T. Comeau , MD",Negative
 RefractoryRelapsed Chronic Lymphocytic Leukemia Focus,"Dr T. Comeau , MD",Negative
 Novel Drugs,"Dr T. Comeau , MD",Negative
 Novel Drugs,Lymphoma Papers,Negative
 Novel Drugs,Bloodbytes,Positive
 Novel Drugs,Paperbirds_Hematology,Negative
 Novel Drugs,Oncology Tube,Negative
 FullText,"Dr T. Comeau , MD",Negative
 Acta Haematologica,"Dr T. Comeau , MD",Negative
 Karger Publishers,"Dr T. Comeau , MD",Negative
 Karger Publishers,Benlazar S.M Amin√©,Negative
 Robert Figlin MD,"Mazyar Shadman, MD MPH",Negative
 Mazyar Shadman MD MPH,"Mazyar Shadman, MD MPH",Negative
 Mazyar Shadman MD MPH,OncLive.com,Negative
 Mazyar Shadman MD MPH,Cellero,Positive
 Population,Psychiatry Intel,Positive
 Population,Philip McCarthy,Negative
 Population,Mahmoud Aljurf,Negative
 Population,FarmaOnco,Negative
 Population,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Population,Cancer Papers,Negative
 Population,UroToday.com,Positive
 country,"Chaitra Ujjani, MD",Positive
 country,CLL Advocates Network,Negative
 country,"Mazyar Shadman, MD MPH",Negative
 country,ACCC,Positive
 country,Patient Empowerment Network,Negative
 country,Isabella Elmi,Positive
   vaccine,"Chaitra Ujjani, MD",Positive
   vaccine,Patient Power,Positive
   vaccine,CLLSA,Negative
   SCCA,SeattleCancerCareAlliance,Negative
 vaccinations,SeattleCancerCareAlliance,Negative
 Development,Ish,Positive
 Development,Oxford Centre for Haematology,Positive
 Development,James Kerwin,Positive
 Development,"Habib M. Razavi, MD, PHD, FRCPC",Positive
 Development,CLL-seq,Negative
 Development,Paperbirds_Hematology,Negative
 Development,Medscape Education,Negative
 Development,DukePathDept,Positive
 Development,TCRT Cancer Journal,Positive
 Development,Patient Power,Negative
 Development,Cancer Papers,Positive
 Development,Jon Henderson üçªüç∫ üíõüíô,Positive
 cellline model,Ish,Positive
 cellline model,Paperbirds_Hematology,Negative
 cellline model,James Kerwin,Positive
 prosurvival effect,Ish,Positive
 prosurvival effect,Paperbirds_Hematology,Negative
 prosurvival effect,James Kerwin,Positive
 nurselike cells,Ish,Positive
 nurselike cells,Paperbirds_Hematology,Negative
 nurselike cells,James Kerwin,Positive
 nurselike cells,TumorImmunoPapers,Negative
 nurselike cells,Cancer Papers,Negative
 nurselike cells,ImmunologyPapers,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market Growth Demand Applications Market Research Report,Industry Today,Positive
 NFAT,Psychiatry Intel,Positive
 STUB Facilitates Malignant Cell Survival,Psychiatry Intel,Positive
 p MAPK Activation,Psychiatry Intel,Positive
 AQP,Psychiatry Intel,Positive
 Tara Graff,OncLive.com,Negative
 Telemedicine Impact TimeLimited Therapy,Patient Empowerment Network,Positive
   curriculum,RedMedEd,Positive
 mom,designated dilf fucker,Positive
 mom,Ellen Schafer,Positive
 mom,Kerry,Negative
 mom,Ali Ansari,Positive
 mom,Ashley Caneup,Positive
 mom,Amanda Marie,Positive
 mom,Debbie La Torre üìä,Positive
 mom,Angela Smith,Positive
 mom,Alexis Rae‚úåÔ∏è,Positive
 mom,Jackie Michele,Positive
 mom,N'Dygo Jonez,Positive
 mom,Allison Petersen,Positive
 mom,The Hope of the Hillside,Positive
 mom,Erika,Positive
 mom,Sarah Cannon Docs,Positive
 Ofatumumab Arzerra KesimptaOfatumumab,PharmaFactz,Negative
 Op Ô∏è,Lymfklierkanker VV vzw,Positive
 journeyPatient Leaders,WEGO Health,Negative
 Jeff,WEGO Health,Positive
 Jeff,Patient Power,Negative
 brother,Anna Stewart ‚òòÔ∏è‚òòÔ∏è,Positive
 brother,Ellen Schafer,Positive
 brother,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
 brother,Paul Mitchell,Positive
 Treat,CLL Society Inc.,Negative
 Vi k√¶mper,LyLe Foreningen,Negative
 √¶ft,LyLe Foreningen,Positive
 og,LyLe Foreningen,Positive
 og,Lars M√∏rland Knudsen,Positive
 en   fri,LyLe Foreningen,Negative
 din egen,LyLe Foreningen,Negative
   Today ASH,CLL Society Inc.,Positive
 James Gerson MD,OncLive SOSS,Positive
 James Gerson MD,OncLive.com,Negative
 HARMONY,HARMONY Alliance,Positive
 HARMONY,European Hematology Association,Negative
 HARMONY,Nick,Negative
   organizations,HARMONY Alliance,Negative
   Delphi Survey,CLL Advocates Network,Negative
 Unusual Case,Paperbirds_Hematology,Negative
 Prolymphocytic Leukemia Transformation,Paperbirds_Hematology,Negative
 Patient,Paperbirds_Hematology,Positive
 Patient,Prof John,Negative
 Patient,Balkan Medical Journal,Positive
 Patient,INDoximity üáÆüá≥,Negative
 Patient,Cancer Papers,Positive
 Patient,Adam Mead,Positive
 Patient,EurekaMag,Positive
 Patient,Crwe World,Positive
 Patient,Prof Dr Zafer Ko√ßak,Positive
 Patient,Brave Is Now¬Æ,Negative
 Patient,Lymphoma Papers,Positive
 Patient,Ilan Schwartz MD PhD,Positive
 Patient,SNN Network,Negative
 Patient,Greenlight Stocks,Positive
 Patient,HCP Feed,Negative
 Patient,Latest News from Business Wire,Negative
 Patient,‚ö°AiMS,Negative
 Patient,Mazen M,Negative
 Patient,JanssenUS,Positive
 Patient,Cureus,Positive
 Patient,JCM MDPI,Positive
 Patient,Mycobacterium Papers,Positive
 Patient,AmoebaPapers,Positive
 Patient,Hematology & Thromboembolic Diseases,Positive
 Patient,leukemia,Negative
 Patient,Nematode_papers,Positive
 Patient,Fred Hutch,Negative
 Patient,Pro-CME,Negative
 blood cancer patients,Michael Rynne,Positive
 blood cancer patients,AstraZeneca,Positive
 blood cancer patients,Shouting at people in my underpants,Negative
 blood cancer patients,Blood Cancer Uncensored,Negative
 blood cancer patients,CLL Society Inc.,Negative
 blood cancer patients,CLL Advocates Network,Negative
 families,Michael Rynne,Positive
 families,Esther Schorr,Positive
 families,Patient Empowerment Network,Negative
 families,Danielle M. Brander,Positive
 families,CLLSA,Negative
 families,Eyemagistus ‚úçüèº,Positive
 families,RIOH,Negative
 families,Disraelly Guti√©rrez,Positive
 families,David T.,Positive
 families,Kathrinabentley(KB),Positive
 families,Nick,Positive
 families,Blood Journal,Positive
 Bcell Receptor Stereotypy,Ingentium Melanoma,Positive
 Bcell Receptor Stereotypy,Jerry Lee,Negative
 Bcell Receptor Stereotypy,CellworksLife,Negative
 Bcell Receptor Stereotypy,Cure Cancer Now,Negative
 Design Tailored Immunotherapy,Ingentium Melanoma,Positive
 Design Tailored Immunotherapy,Jerry Lee,Negative
 Design Tailored Immunotherapy,Cure Cancer Now,Negative
 ideation,"Amber Koehler, PA-C",Negative
 Kudos,"Amber Koehler, PA-C",Negative
 Kudos,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 Kudos,Michele Nadeem-Baker,Negative
 Kudos,RutgersCancerInstNJ,Negative
 Kudos,Daniel Bachurski,Positive
 Kudos,"Raul Cordoba, MD, PhD",Negative
      Ph RCT   Ibrutinib   Obinutuzumab   Venetoclax,Aurora Cancer Care,Positive
      Ph RCT   Ibrutinib   Obinutuzumab   Venetoclax,"Mike Thompson, MD, PhD, FASCO",Negative
 Untreated Older Patients,Aurora Cancer Care,Positive
 Untreated Older Patients,"Mike Thompson, MD, PhD, FASCO",Positive
 Untreated Older Patients,Oncology,Negative
 Untreated Older Patients,PracticeUpdate,Negative
 Untreated Older Patients,Tran-Der Tan,Negative
 PI,Aurora Cancer Care,Positive
 PI,"Mike Thompson, MD, PhD, FASCO",Negative
 PI,MD Anderson Leukemia,Positive
 practice aids,PeerView,Negative
 download,PeerView,Negative
 EOMES,Lymphoma Papers,Negative
 Pathological RANK,Ariakas Enoreth,Positive
 Pathological RANK,JExpMed,Negative
 Pathological RANK,Paperbirds_Hematology,Negative
 Pathological RANK,Lymphoma Papers,Negative
 B cells,Ariakas Enoreth,Positive
 B cells,JExpMed,Negative
 B cells,Paperbirds_Hematology,Negative
 B cells,Lymphoma Papers,Negative
 B cells,"Pharmacyclics, an AbbVie Company",Negative
 B cells,Lymphoma Hub,Negative
 B cells,Cesar,Positive
 B cells,ImmunologyPapers,Negative
 autoimmunity,Ariakas Enoreth,Positive
 autoimmunity,Paperbirds_Hematology,Negative
 autoimmunity,Lymphoma Papers,Negative
 PDQ Cancer Information Summaries,Paperbirds_Hematology,Positive
 Natural History,ClinOwl Haematology,Negative
 Natural History,Paperbirds_Hematology,Negative
 Natural History,Blood Journal,Negative
 Monoclonal Bcell Lymphocytosis MBL,ClinOwl Haematology,Negative
 Monoclonal Bcell Lymphocytosis MBL,Paperbirds_Hematology,Negative
 Monoclonal Bcell Lymphocytosis MBL,Blood Journal,Negative
 Relatives,ClinOwl Haematology,Negative
 Relatives,Paperbirds_Hematology,Negative
 Relatives,Blood Journal,Negative
 Chronic Lymphocytic Leukemia CLL Families,ClinOwl Haematology,Negative
 Chronic Lymphocytic Leukemia CLL Families,Paperbirds_Hematology,Negative
 Bcell Acute Lymphoblastic Leukemia,ClinOwl Haematology,Negative
 Bcell Acute Lymphoblastic Leukemia,BibliotecaHUVH. ICS,Positive
 th February,CLL Advocates Network,Negative
 BTKigtgtgtBendamustine,Benlazar S.M Amin√©,Negative
 Remote Tools,Patient Empowerment Network,Negative
 stories,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Positive
 stories,Satyen Gohil,Positive
 stories,CLL Ireland,Negative
 stories,NET The Ferns Primary Academy,Positive
 stories,Jerry Clay English Hub,Positive
 stories,HemOnc Today,Negative
 stories,Oak Tree Primary School,Positive
 stories,Patient Power,Negative
 stories,Lifelong Learning,Negative
 actions props,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 creativity,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 links,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 links,Offsite Airport Park,Positive
 links,Cleveland Clinic MD,Negative
 CACHE EYE unit,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Positive
 EYP unit,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Positive
 DanaFarber Cancer Institute,CURE Magazine,Negative
 DanaFarber Cancer Institute,Michele Nadeem-Baker,Negative
 DanaFarber Cancer Institute,Oncology Tube,Negative
 DanaFarber Cancer Institute,Expert Perspectives in Oncology,Negative
 DanaFarber Cancer Institute,Betsy Mullen #SignUp2SaveAJ,Positive
 CAR TCell therapy,CURE Magazine,Negative
 CAR TCell therapy,Patient Power,Negative
 CAR TCell therapy,Merge Communications,Positive
 Tv√¶rsproglighed,Laila Kj√¶rb√¶k,Positive
 treatment Office,NHLBI Bethesda Labs,Negative
 Patient Recruitment,NHLBI Bethesda Labs,Positive
 Pathological   protein,TU M√ºnchen,Positive
 Noncatalytic Brutons tyrosine kinase,Paperbirds_Hematology,Positive
 PLCŒ≥ variants,Paperbirds_Hematology,Positive
 ibrutinib resistance,Paperbirds_Hematology,Positive
 ibrutinib resistance,Benlazar S.M Amin√©,Negative
 ibrutinib resistance,Anna Deveau,Negative
 ibrutinib resistance,WCM Lymphoma,Negative
 ibrutinib resistance,Francesco Turturro,Positive
 ibrutinib resistance,"Dr. Paul DeSantis, PharmD",Negative
 ibrutinib resistance,OncLive.com,Negative
 ibrutinib resistance,Cancer Papers,Positive
 ibrutinib resistance,Lymphoma Hub,Negative
 ibrutinib resistance,Olivier Elemento,Negative
 ibrutinib resistance,TumorImmunoPapers,Negative
 Evidence Supports BTK Inhibition,Oncology Board,Negative
 Targeted Oncology Evidence Supports BTK Inhibition,Oncology Board,Negative
 Human AntiCD Chimeric Antigen Receptor T Cells,TrialBulletin,Negative
 Relapsed Refractory Lymphoid Malignancies Status,TrialBulletin,Negative
 Condition Summary Non Hodgkin Lymphoma Acute Lymphoblastic Leukemia Chronic Lymphocytic Leukemia,TrialBulletin,Negative
 Dr John Pagel,Patient Empowerment Network,Positive
 Dr John Pagel,Oncology Tube,Negative
 Dr John Pagel,ACCC,Positive
 Dr John Pagel,CLL Society Inc.,Negative
 Dr John Pagel,"Binay Shah, MD, MHA",Positive
 Dr John Pagel,VJHemOnc,Negative
 Dr John Pagel,Patient Power,Negative
 Tips,Patient Empowerment Network,Negative
 Tips,Patient Power,Negative
 Tips,CLL Ireland,Negative
 Tips,APSHO,Negative
   Telemedicine Visit,Patient Empowerment Network,Negative
 CBC,Patient Power,Negative
 ConcernA   expert,Patient Power,Negative
 aim,AstraZeneca,Positive
 aim,CLLSA,Negative
 aim,BCNI,Negative
 millions,AstraZeneca,Positive
 millions,Pumpy_Fantasy,Positive
 millions,GO GREEN,Positive
 Lenalidomide     Text complet,BibliotecaHUVH. ICS,Positive
   Richters syndrome,Ahmad Alharthi,Positive
 sur Castrum,Pumpy_Fantasy,Positive
 qui monte,Pumpy_Fantasy,Positive
 mon score de monture,Pumpy_Fantasy,Positive
   oui je vient de massoir,Pumpy_Fantasy,Positive
 une mascotte ultra moche,Pumpy_Fantasy,Positive
 Goldilocks,Orchard Primary Academy Nursery,Negative
 home learning challenge,Orchard Primary Academy Nursery,Negative
 cancer Dr Barrientos,Kristine Olson,Positive
 Comparing ibrutinib,Medivizor,Negative
 Comparing ibrutinib,"chadi nabhan MD, MBA, FACP",Negative
   MD PhD,OncLive.com,Negative
 Genomewide association study,eQTLpapers,Positive
 Genomewide association study,robo_gwas,Positive
 risk loci,eQTLpapers,Positive
 risk loci,robo_gwas,Positive
 Diary,Jane Fleming,Positive
 Detour,Jane Fleming,Positive
 Stern,Jane Fleming,Positive
 memoir,Jane Fleming,Positive
 couples,Patient Power,Positive
 SCCA CLL expert,SeattleCancerCareAlliance,Negative
 Current Perspectives,SeattleCancerCareAlliance,Negative
 Current Perspectives,"Mazyar Shadman, MD MPH",Negative
 Current Perspectives,gilbert c faure,Negative
 Current Perspectives,Francesco Bertoni,Negative
 Current Perspectives,Juan Marquet,Negative
 Current Perspectives,Paperbirds_Hematology,Negative
   Based L Therapy Sustains Efficacy Safety,"Raul Cordoba, MD, PhD",Negative
 TP Chronic Lymphocytic Leukemia,"Raul Cordoba, MD, PhD",Negative
 PODCASTÔ∏è Developments,VJHemOnc,Negative
 generations,Nicolas Martinez üá®üá¥üá®üá¥,Positive
 Fastest nonneurosurg journal,Kevin Paul Ferraris,Positive
 Diagnostic Value,Paperbirds_Hematology,Negative
 Plasma miR,Paperbirds_Hematology,Negative
 Targeting,Paperbirds_Hematology,Negative
 Targeting,mitopapers,Positive
 Targeting,"Raul Cordoba, MD, PhD",Negative
 Targeting,Lymphoma Hub,Negative
 Targeting,Hematopoiesis News,Negative
 Targeting,doctorportal,Negative
 APRIL Oncogene,Paperbirds_Hematology,Negative
 Bcell Chronic Lymphocytic Leukemia,Paperbirds_Hematology,Negative
 Bcell Chronic Lymphocytic Leukemia,Cancer Papers,Negative
 Bcell Chronic Lymphocytic Leukemia,Krishan Maggon,Negative
 Bcell Chronic Lymphocytic Leukemia,TumorImmunoPapers,Negative
 Bcell Chronic Lymphocytic Leukemia,Francesco Turturro,Negative
 Musashi,Paperbirds_Hematology,Negative
 Entospletinib,Paperbirds_Hematology,Negative
 Entospletinib,Jerry Lee,Negative
 Entospletinib,@ScottWaudbyHaemResLeics,Positive
 Entospletinib,CellworksLife,Negative
 Entospletinib,Cure Cancer Now,Positive
 Entospletinib,Martin JS Dyer,Positive
 Benefits,VJHemOnc,Negative
 Benefits,Oncology Tube,Negative
 Benefits,1stOncology,Negative
 Benefits,Patient Power,Negative
 Ian Flinn,VJHemOnc,Positive
 dasatinib,HemaSphere_EHA,Positive
 Feb,European Hematology Association,Negative
 Feb,Michele Nadeem-Baker,Negative
 Feb,Dr. Andy Evens,Negative
 Feb,LiveYourLife,Negative
 Feb,Andrew Schorr,Positive
 Feb,Lisa Palacios,Negative
 Feb,MD Anderson Leukemia,Negative
 Feb,CLL,Negative
 Prof Eichhorst amp Prof Ghia,European Hematology Association,Negative
 discussion,European Hematology Association,Negative
 discussion,Nitin Jain,Negative
 discussion,WCM Lymphoma,Negative
 discussion,Alan Skarbnik,Negative
 discussion,Targeted Oncology,Negative
 discussion,JADPRO,Negative
 discussion,Patient Power,Negative
 discussion,SpecialtyPTimes,Negative
 discussion,NHLBI Bethesda Labs,Negative
 discussion,Anthony Mato,Negative
 discussion,Toby Eyre,Negative
 discussion,"chadi nabhan MD, MBA, FACP",Negative
 discussion,CLL Ireland,Negative
 discussion,Association for Molecular Pathology,Positive
 discussion,ASCO,Positive
 discussion,VJHemOnc,Negative
 discussion,Cancer Medicine,Positive
 discussion,Barts Cancer Institute,Positive
 discussion,Jason Broderick,Negative
 EHA Endorsement,European Hematology Association,Negative
 ESMO Clinical Practice Guidelines,European Hematology Association,Negative
 Diagnosis Treatment amp Followup,European Hematology Association,Negative
 Serum Monoclonal Component,Oncology,Negative
 comparison,Biotech Jim,Positive
 comparison,Biotech2050,Positive
 comparison,Christopher Steer,Negative
 comparison,"Andreas-Claudius Hoffmann, M.D.",Positive
 IDPH,Biotech Jim,Positive
 analyses,Breaking Data,Negative
 analyses,JanssenUS,Negative
 analyses,Targeted Oncology,Negative
 analyses,NE Live,Negative
 Hear,BioAscend,Positive
 Hear,PRIME Education,Negative
 Hear,Andrew Schorr,Negative
 Hear,Patient Power,Positive
 Hear,CLLSA,Negative
   takeaways,BioAscend,Positive
 answer,BioAscend,Positive
 answer,CLL Ireland,Negative
 answer,Andrew Schorr,Negative
 answer,Janssen Nederland,Positive
 answer,Journal of Clinical Pathways,Negative
 allogeneic stem cell transplant ou,Medivizor,Negative
 GOAL,Michele Nadeem-Baker,Negative
 GOAL,AhramOnlineSports,Positive
 corners,Michele Nadeem-Baker,Negative
 Safety data,Michele Nadeem-Baker,Negative
 New article Regulation,Paperbirds_Hematology,Positive
 BclXL,Paperbirds_Hematology,Negative
 noncanonical NFŒ∫B,Paperbirds_Hematology,Negative
 context,Paperbirds_Hematology,Positive
 fingers,Orchard Primary Academy Nursery,Negative
 nursery,Orchard Primary Academy Nursery,Positive
 pattern cards,Orchard Primary Academy Nursery,Negative
 lisocabtagene maraleucel,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 lisocabtagene maraleucel,Targeted Oncology,Negative
 yearold woman,O'Neal Comprehensive Cancer Center at UAB,Positive
 yearold woman,Targeted Oncology,Positive
 yearold woman,NEJM,Negative
 yearold woman,Generation Medics,Positive
 yearold woman,JAMA,Negative
 doctor Dr Randall Davis,O'Neal Comprehensive Cancer Center at UAB,Positive
 ü•∞ ü•≥ ü•≥,Ana Bacelar,Positive
 RR Bcell malignanciesDOR,"chadi nabhan MD, MBA, FACP",Negative
 highrisk disease features,Patient Power,Negative
 discussions,Toby Eyre,Negative
 discussions,Didi Jasmin,Positive
 discussions,CLLSA,Negative
 discussions,VJHemOnc,Negative
 ASH   Lots,Toby Eyre,Negative
 topics,RedMedEd,Positive
 topics,Leukemia Research Foundation,Negative
 topics,HARMONY Alliance,Negative
 topics,CARE‚Ñ¢ Education,Negative
 topics,LymphomaAction,Negative
 topics,Oncology Learning Network,Negative
 topics,VJHemOnc,Negative
 prognosis frontline chemoimmunotherapy,RedMedEd,Positive
 Attn YA Chronic Lymphocytic Leukemia Survivors,Dana-FarberYAProgram,Positive
 CLL Coach,Dana-FarberYAProgram,Positive
 app,Dana-FarberYAProgram,Positive
 app,QxMD | Decision Support & Quality Improvement,Positive
 gain,Dana-FarberYAProgram,Positive
 gain,Bionest Partners,Negative
 gain,Helix BioPharma,Positive
 skills,Dana-FarberYAProgram,Positive
 skills,BSI Philippines,Positive
 skills,RedMedEd,Negative
 skills,Kim Kirchherr,Negative
 skills,ASBlearns,Positive
 matthewleblancedu,Dana-FarberYAProgram,Positive
 RHHBF Phase,ClinicalTrialsData,Negative
 Zanubrutinib Obinutuzumab,ClinicalTrialsData,Negative
 Chronic Lymphocytic Leukemia CLL Small Lymphocytic Leukemia SLL,ClinicalTrialsData,Negative
 New Comparing ibrutinib,Medivizor,Negative
 Wnt,Paperbirds_Hematology,Negative
 Wnt,Prof John,Negative
 Wnt,Cancer Papers,Negative
 MSC Communication,Paperbirds_Hematology,Negative
 New article Effects,Paperbirds_Hematology,Positive
 Freedom,Hematology Cancer Consortium,Positive
 mindStrength,Hematology Cancer Consortium,Positive
 words Zeal,Hematology Cancer Consortium,Positive
 hearts,Hematology Cancer Consortium,Positive
 hearts,CLL Ireland,Negative
 Lets,Hematology Cancer Consortium,Positive
 Lets,Michele Nadeem-Baker,Negative
 Lets,Janina Nett,Positive
 Lets,CLL Society Inc.,Negative
 Lets,Zack Pemberton-Whiteley,Negative
 Lets,Alison Evans,Negative
 Lets,Talal Hilal ü©∫,Negative
 Lets,Celia Mar√≠n,Negative
 Lets,ASH,Negative
 Lets,Patient Power,Negative
 Lets,Ian Morgan-Smith,Positive
 nation,Hematology Cancer Consortium,Positive
   pt pcomplex,"Mazyar Shadman, MD MPH",Negative
 yrs,"Mazyar Shadman, MD MPH",Negative
 yrs,Berto üá®üá¶,Positive
 yrs,Toby Eyre,Positive
 yrs,"Pharmacyclics, an AbbVie Company",Negative
 yrs,Andrew Schorr,Negative
 yrs,iwCLL,Positive
 yrs,Anthony Howards,Positive
 yrs,Dr Darren Saunders,Positive
 NMA allo Pre allo sp,"Mazyar Shadman, MD MPH",Negative
 lines,"Mazyar Shadman, MD MPH",Negative
 lines,Joe,Negative
 lines,ASCO Publications,Negative
 lines,AplusA World,Positive
 lines,Rachel Webster,Positive
 CIT,"Mazyar Shadman, MD MPH",Negative
 CIT,Benlazar S.M Amin√©,Negative
 CIT,MD Anderson Leukemia,Negative
 CIT,Medscape Education,Negative
 CIT,"chadi nabhan MD, MBA, FACP",Negative
 Efficacy Data,Lisa Palacios,Negative
 Efficacy Data,Paul Lane,Negative
 Heavily Pretreated SLL,Lisa Palacios,Negative
 Potential Benefit,Lisa Palacios,Negative
 Lisocel Combination,Lisa Palacios,Negative
 Ibrutinib   Willliam Wierda MD PhD,Lisa Palacios,Negative
 ÂÜçÁô∫„ÉªÈõ£Ê≤ªÊÄß„ÅÆCLL„ÇíÂØæË±°„Å´ÈÅ∏ÊäûÁöÑ„Éñ„É´„Éà„É≥Âûã„ÉÅ„É≠„Ç∑„É≥„Ç≠„Éä„Éº„ÇºÈòªÂÆ≥Ëñ¨„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÅåÊâøË™çÔºö„Åå„Çì„Éä„ÉìÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„Å´Êñ∞Ëñ¨„ÅåÊâøË™ç„Åï„Çå„Åæ„Åó„Åü,„Åå„Çì„Éä„ÉìÈÄö‰ø°,Positive
   estimated cases,Zusia:Dr Jackie Volk,Positive
 üßê,pathdoc3,Positive
 CalcitriolVitamin D Receptor System,pathdoc3,Positive
 CalcitriolVitamin D Receptor System,Paperbirds_Hematology,Negative
 Pathways,pathdoc3,Positive
 Pathways,Jerry Lee,Negative
 Pathways,Cure Cancer Now,Positive
 Pathways,Paperbirds_Hematology,Negative
 Pathways,Richard Rosenquist Brandell,Positive
 Pathways,APSHO,Negative
 Chronic Lymphocytic Leukemia Prognostic Factors,ASCO Publications,Negative
 Chronic Lymphocytic Leukemia Prognostic Factors,Paperbirds_Hematology,Negative
 ResourceLimited Center,ASCO Publications,Negative
 ResourceLimited Center,Paperbirds_Hematology,Negative
 New article Expression profiles,Paperbirds_Hematology,Negative
 HMGB,Paperbirds_Hematology,Negative
 chance,myCME,Negative
 chance,Oncology CE,Positive
 chance,Vindico Medical Education,Positive
 chance,"chadi nabhan MD, MBA, FACP",Negative
 chance,Continuous Lifecycle London (online),Negative
 chance,CDDF,Positive
 chance,Patient Power,Positive
 chance,OncLive.com,Negative
 chance,Targeted Oncology,Negative
 chance,AEGLE,Negative
 chance,Elizabeth Castillo,Positive
 chance,OMedLive,Positive
 chance,Helen Jane Mee,Negative
 chance,Cancer Papers,Negative
 chance,Higher Ground at Lake Louise,Negative
 chance,Light The Night SD,Negative
 Earn,myCME,Negative
 Earn,Medscape Education,Negative
 Earn,APSHO,Negative
 Earn,PeerView,Negative
 patie,Medivizor,Negative
 humor,Coping with Cancer,Negative
 humor,Jeff Neurman,Positive
 laughter,Coping with Cancer,Negative
 laughter,Melanie,Negative
 Treatment strategies,donnashort,Positive
 Treatment strategies,"Maria Roussakis, MLT, MSc",Positive
 pdeletion,donnashort,Positive
 pdeletion,MedChem & ONCo,Negative
 FISH p,donnashort,Positive
 IGHV mutation,donnashort,Positive
 IGHV mutation,CancerTherapyAdvisor,Positive
 novel targeted biologics,RedMedEd,Negative
 casebased   activity,RedMedEd,Positive
 selectionduration,RedMedEd,Negative
 treatment management,RedMedEd,Negative
 treatmentrelated toxicities,RedMedEd,Negative
 treatmentrelated toxicities,Hematology News,Negative
 treatmentrelated toxicities,MDEdge,Negative
 disease outcomes,RedMedEd,Negative
 Year DFS Rates,Lisa Palacios,Negative
 Placebo,Lisa Palacios,Negative
 IbrutinibVenetoclax,Lisa Palacios,Negative
 IbrutinibVenetoclax,OncLive.com,Negative
   issues,"Amber Koehler, PA-C",Negative
   issues,Targeted Oncology,Negative
 stories links,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 CACHE EYE units,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Positive
 BTEC CPLD unit,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Positive
 Supporting Emergent Literacy,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Positive
 place,CLLSA,Positive
 place,Orchard Primary Academy Nursery,Negative
 place,Joana Koury,Positive
 place,SiriusXM FC 157 ‚öΩÔ∏èüìª,Negative
 place,Toby Eyre,Negative
 place,Lymphoma Hub,Positive
 place,CLL Ireland,Positive
 place,Olivier Lafleur,Positive
 place,Marek Trneny,Positive
 place,LymphomaAction,Negative
 place,Patient Power,Negative
 place,Andrew Schorr,Negative
 place,LiveYourLife,Positive
 place,Helen Jane Mee,Negative
 place,BloodWork,Positive
 place,H.A.dilshan kaushaly,Positive
 place,OncoTherapy Network,Negative
 place,Sid,Positive
 January,CLLSA,Negative
 January,ACE,Positive
 January,contractmag,Positive
 January,iwCLL,Positive
 January,Hematology Board,Positive
 January,James Porreca,Negative
 January,Lifelong Learning,Positive
   thanks,Jordan Gauthier,Positive
 Dr Guillaume Cartron,Jordan Gauthier,Positive
 CD CAR T cells,Jordan Gauthier,Positive
 CD CAR T cells,Lymphoma Hub,Negative
 CD CAR T cells,Eslam Katab,Positive
 CD CAR T cells,AJMC,Negative
 Relapsed Chronic Lymphocytic Leukemia Year Results,"Dr T. Comeau , MD",Negative
 Relapsed Chronic Lymphocytic Leukemia Year Results,Eduardo Flavio Oliveira Ribeiro,Negative
 Relapsed Chronic Lymphocytic Leukemia Year Results,ClinOwl Haematology,Negative
 Relapsed Chronic Lymphocytic Leukemia Year Results,Miriam L√≥pez P√©rez,Positive
 Relapsed Chronic Lymphocytic Leukemia Year Results,Juan Marquet,Negative
 Relapsed Chronic Lymphocytic Leukemia Year Results,ALI ALAHMARI.,Negative
 Relapsed Chronic Lymphocytic Leukemia Year Results,ClinOwl,Positive
 Relapsed Chronic Lymphocytic Leukemia Year Results,JAVIER DE LA SERNA,Positive
 Relapsed Chronic Lymphocytic Leukemia Year Results,Benlazar S.M Amin√©,Negative
 Relapsed Chronic Lymphocytic Leukemia Year Results,filippo masini,Negative
 Relapsed Chronic Lymphocytic Leukemia Year Results,Paperbirds_Hematology,Negative
 Relapsed Chronic Lymphocytic Leukemia Year Results,INDoximity üáÆüá≥,Negative
 Genomic Complexity,"Dr T. Comeau , MD",Negative
 Genomic Complexity,Eduardo Flavio Oliveira Ribeiro,Negative
 Genomic Complexity,ClinOwl Haematology,Negative
 Genomic Complexity,Miriam L√≥pez P√©rez,Positive
 Genomic Complexity,Juan Marquet,Negative
 Genomic Complexity,ALI ALAHMARI.,Negative
 Genomic Complexity,ClinOwl,Positive
 Genomic Complexity,JAVIER DE LA SERNA,Positive
 Genomic Complexity,Benlazar S.M Amin√©,Negative
 Genomic Complexity,filippo masini,Negative
 Genomic Complexity,Paperbirds_Hematology,Negative
 Genomic Complexity,INDoximity üáÆüá≥,Negative
 Gene Mutations,"Dr T. Comeau , MD",Negative
 Gene Mutations,Eduardo Flavio Oliveira Ribeiro,Negative
 Gene Mutations,ClinOwl Haematology,Negative
 Gene Mutations,Miriam L√≥pez P√©rez,Positive
 Gene Mutations,Juan Marquet,Negative
 Gene Mutations,ALI ALAHMARI.,Negative
 Gene Mutations,ClinOwl,Positive
 Gene Mutations,JAVIER DE LA SERNA,Positive
 Gene Mutations,Benlazar S.M Amin√©,Negative
 Gene Mutations,filippo masini,Negative
 Gene Mutations,Paperbirds_Hematology,Negative
 Gene Mutations,INDoximity üáÆüá≥,Negative
 MURANO Phase,"Dr T. Comeau , MD",Negative
 MURANO Phase,Eduardo Flavio Oliveira Ribeiro,Negative
 MURANO Phase,ClinOwl Haematology,Negative
 MURANO Phase,Miriam L√≥pez P√©rez,Positive
 MURANO Phase,Juan Marquet,Negative
 MURANO Phase,ALI ALAHMARI.,Negative
 MURANO Phase,ClinOwl,Positive
 MURANO Phase,JAVIER DE LA SERNA,Positive
 MURANO Phase,Benlazar S.M Amin√©,Negative
 MURANO Phase,filippo masini,Negative
 MURANO Phase,Paperbirds_Hematology,Negative
 MURANO Phase,INDoximity üáÆüá≥,Negative
 MURANO Phase,CancerEpiPapers,Negative
 MURANO Phase,Progetto Odin,Positive
 √©,HAM,Negative
 √©,Patient Power,Negative
 de la √©mie,HAM,Negative
 Une √©tude,HAM,Negative
 compl√®te explore l√©norme,HAM,Negative
 Jumbo News,HAM,Negative
   epidemiology,DRG Epidemiology,Positive
 Hematologic experts,donnashort,Negative
 ‚Å¶‚Å© answer community questions,donnashort,Negative
 chair ‚Å¶‚Å© ‚Å¶‚Å©,donnashort,Negative
 Drs Verstovsek,donnashort,Negative
 Neelapu,donnashort,Negative
 Mechanisms,donnashort,Negative
 Mechanisms,Paperbirds_Hematology,Positive
 Mechanisms,Benlazar S.M Amin√©,Positive
 Mechanisms,Katrina Sondermann,Positive
 Mechanisms,UNMC Pathology & Microbiology,Positive
 Mechanisms,CancerPOP,Positive
 Mechanisms,VJHemOnc,Negative
 Mechanisms,Vincent Rajkumar,Negative
 cart therapy,donnashort,Negative
 maintenance,donnashort,Negative
 maintenance,Toby Eyre,Negative
 maintenance,CancerTherapyAdvisor,Negative
 maintenance,MDedge Hematology & Oncology,Positive
 maintenance,epigenetics_papers,Negative
 maintenance,Just Cancer News,Negative
 ‚Å¶‚Å© ‚Å¶,donnashort,Negative
 installment,Research To Practice,Negative
 installment,CURE Magazine,Negative
 installment,Patient Empowerment Network,Negative
 Review,Research To Practice,Negative
 Review,Medscape Education,Negative
 Review,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 Review,Cancer Papers,Positive
 Review,Paperbirds_Hematology,Positive
 Review,Lymphoma Papers,Positive
 Review,Dr. Andy Evens,Negative
 Review,LYMPHOMA & MYELOMA CONNECT,Negative
 Review,Ilan Schwartz MD PhD,Positive
 Review,Contemporary Clinic,Positive
 Review,Chan Cheah,Negative
 Review,MEDWAVE,Negative
 Review,JCM MDPI,Positive
 Review,Mycobacterium Papers,Positive
 Review,CryptoLiveLeak,Negative
 Review,CancerWallonia,Positive
 Review,International Cancer Imaging Society,Positive
 Review,Med-IQ,Negative
 Review,Business Wire-Health,Negative
 Review,Tina J Hieken MD,Positive
 Review,Patient Power,Negative
 Review,CHS Chief Resident,Positive
 Review,Lymphoma Coalition,Negative
 Dr Love,Research To Practice,Negative
 Dr Love,Nitin Jain,Negative
 COVID infection,Fred Spencer,Positive
 immunodeficient patient,Fred Spencer,Positive
 convalescent plasma,Fred Spencer,Positive
 design,OncLive.com,Negative
 design,OncLive SOSS,Negative
 design,"chadi nabhan MD, MBA, FACP",Negative
 design,Lymphomation.org,Negative
 UNITY trials,OncLive.com,Negative
 Respiratory Complications,Paperbirds_Hematology,Negative
 SARSCoV Clinical Experience,Paperbirds_Hematology,Negative
 Pivotal Role,Paperbirds_Hematology,Negative
 Viruses,Paperbirds_Hematology,Negative
 Pathogeny,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Monoclonal Type,Paperbirds_Hematology,Negative
 IgG K Cryoglobulinemia,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Diagnosis,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Diagnosis,KristopherMaday PA-C,Negative
 Chronic Lymphocytic Leukemia Diagnosis,L McSherry,Negative
 Chronic Lymphocytic Leukemia Diagnosis,AboutLawsuits.com,Positive
 Course,Paperbirds_Hematology,Negative
 Course,Clinical Oncology,Positive
 Course,"Cowan, Liebowitz",Negative
 Course,Cureus,Negative
 Human Metapneumovirus Infection,Paperbirds_Hematology,Negative
 Key Immune Signaling Pathways,Paperbirds_Hematology,Negative
 Solid Cancers,Paperbirds_Hematology,Negative
 T Cell Dysfunction,Paperbirds_Hematology,Negative
 Similarities,Paperbirds_Hematology,Negative
 Distinctions,Paperbirds_Hematology,Negative
 Proud,Dr Alan G Ramsay,Positive
 Proud,Holger Heyn,Positive
 Proud,WK Anatomy & Health,Positive
 Nick,Dr Alan G Ramsay,Positive
 Nick,The Patient's Channel,Negative
 Nick,Blood Cancer UK,Negative
 publication,Dr Alan G Ramsay,Positive
 publication,InvestorsObserver,Positive
 publication,Deborah Stephens,Positive
 publication,Maria Tsagiopoulou,Positive
 publication,Dr. Melody Davis,Negative
 publication,Michael Hallek,Negative
 publication,Leukemia & Lymphoma Society Research,Positive
 publication,CIB Margarita Salas (CSIC),Positive
 assays,Dr Alan G Ramsay,Positive
 action,Dr Alan G Ramsay,Positive
 action,TAP Clinical Trial Network,Negative
 action,Oncology CE,Positive
 action,Vindico Medical Education,Positive
 action,WheelieDealer,Negative
 action,Nick,Negative
 action,Michele Nadeem-Baker,Negative
 action,VJHemOnc,Negative
 action,Winship Cancer Institute of Emory University,Negative
 action,Michelle,Positive
 action,OncLive.com,Negative
 Preneoplastic alterations,Blood Cancer Discovery,Positive
 DNA methylome,Blood Cancer Discovery,Positive
 Commentary Epigenetic Trajectories,Blood Cancer Discovery,Negative
 telemedicine Dr John Pagel,Patient Empowerment Network,Negative
 providers,Patient Empowerment Network,Negative
 visits,Patient Empowerment Network,Negative
 visits,Andrew Schorr,Negative
 Tcell activity,Blood Journal,Negative
 New article Comparison,Paperbirds_Hematology,Positive
 Transplant,Paperbirds_Hematology,Negative
 Transplant,Medivizor,Negative
 Transplant,Oncology.TV,Negative
 Transplant,OncLive.com,Negative
 Transplant,Janette Fuller,Positive
 Transplant,MD Anderson Leukemia,Negative
 Transplant,CancerTherapyAdvisor,Negative
 Nontransplant HighRisk Chronic Lymphocytic Leukemia Patients,Paperbirds_Hematology,Negative
 Novel Targeted Therapy Era,Paperbirds_Hematology,Negative
 Die Chronisch Lymphatische √§mie ist,EuropeanHospital_D,Negative
 h√§ufigste Leuk√§mieerkrankung bei Erwachsenen,EuropeanHospital_D,Negative
 zwar meist langsam verl√§uft,EuropeanHospital_D,Negative
 jedoch bisher nicht heilbar,EuropeanHospital_D,Negative
 neuen Impfstoff gegen,EuropeanHospital_D,Negative
 Chemotherapy drug,The Indian Pharma,Negative
 Younger Patients CAR TCell Therapy,CAR-TCR,Positive
 Smallmolecule agents,APSHO,Negative
   treatment landscape,PeerView,Negative
 expert panel,PeerView,Negative
 expert panel,Karmanos Cancer Institute,Negative
 expert panel,CancerCoachLive,Positive
 expert panel,CLL Society Inc.,Positive
 expert panel,Expert Perspectives in Oncology,Positive
 expert panel,Patient Power,Negative
 expert panel,Lymphoma Coalition,Negative
 hematologists,PeerView,Negative
 hematologists,Sigrid Sk√•nland,Negative
 hematologists,Jane Cheung,Negative
 oncologists,PeerView,Negative
 oncologists,AbbVie,Negative
 oncologists,Michael Hallek,Negative
 oncologists,OncLive.com,Negative
 oncologists,Lymphoma Hub,Negative
 oncologists,Targeted Oncology,Negative
 patient perspective,PeerView,Negative
 patient perspective,Leukaemia Care,Negative
 patient perspective,Patient Empowerment Network,Negative
 novel therapeutics,PeerView,Negative
 novel therapeutics,PRIME Education,Negative
 treatment options,PeerView,Negative
 treatment options,UW Medicine Newsroom,Positive
 treatment options,Julie McCrossin AM,Positive
 treatment options,CLL Society Inc.,Negative
 treatment options,Cagatay M. CULCUOGLU,Positive
 treatment options,"Massive Bio, Inc.",Positive
 treatment options,Patient Power,Positive
 treatment options,LymphomaAction,Negative
 treatment options,VJHemOnc,Positive
 treatment options,Oncology Nursing News,Negative
 treatment options,David Panian,Positive
 treatment options,Targeted Oncology,Positive
 treatment options,CLL Advocates Network,Negative
 treatment options,Teresa Martin,Positive
 treatment options,Patient Empowerment Network,Negative
 treatment options,Northwest Radiology,Positive
 treatment options,CLL Ireland,Negative
 treatment options,Winship Cancer Institute of Emory University,Positive
   video,PeerView,Negative
   video,Oncology CE,Positive
   video,Nick,Negative
   video,WCM Lymphoma,Negative
   video,Fred Hutch,Negative
   video,Patient Power,Negative
   video,Los Lobos,Negative
   video,Weill Cornell Medicine Meyer Cancer Center,Negative
 BPK Symbasis Sign MOU,Patient Worthy,Negative
 Terms,Patient Empowerment Network,Negative
 Thousands,Breaking Data,Negative
 Thousands,Leukaemia Cancer,Positive
 Thousands,Andrew Schorr,Negative
 insights impressions amp changes,Breaking Data,Negative
 behaviors,Breaking Data,Negative
 Recurrent XPO mutations alter pathogenesis,CellworksLife,Negative
 Recurrent XPO mutations alter pathogenesis,Cancer epigenetics papers üìö,Positive
 BGNE Phase,ClinicalTrialsData,Negative
 Superb program,Kimmo Porkka,Positive
 virtual,Kimmo Porkka,Positive
 La migration,Symag by BNP Paribas PF,Positive
 de   chez,Symag by BNP Paribas PF,Positive
 tr√®s,Symag by BNP Paribas PF,Positive
 avance,Symag by BNP Paribas PF,Positive
 hospital,CLL Society Inc.,Positive
 hospital,Balkan Medical Journal,Negative
 hospital,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 hospital,adam,Positive
 COVID symptoms,CLL Society Inc.,Positive
 Comorbidities,R Marcos-Gragera üéó,Positive
 Comorbidities,Philip McCarthy,Negative
 Comorbidities,"Raul Cordoba, MD, PhD",Positive
 Comorbidities,Christopher Steer,Negative
 Comorbidities,HemOnc Today,Negative
 Comorbidities,Seattle's Banker,Positive
 Comorbidities,Sicilia Informazioni,Positive
 Comorbidities,RazzleTazzle,Negative
 Comorbidities,OHSU IM Residency,Positive
 Diagnosis Survival,R Marcos-Gragera üéó,Positive
 Cause,R Marcos-Gragera üéó,Positive
 Chronic Lymphocytic Leukemia PopulationBased Study,R Marcos-Gragera üéó,Positive
 Chronic Lymphocytic Leukemia PopulationBased Study,Tom,Negative
 afternoon,Dr Vicky Forster,Positive
 afternoon,Nic Hall,Positive
 afternoon,CLL Ireland,Negative
 afternoon,CLL Warwick Uni,Negative
 Quickie,PharmacyPhunQuiz,Positive
 Tremfya guselkumab,PharmacyPhunQuiz,Positive
 Thoughts,Seema Ali Bhat,Positive
 Thoughts,Peter James Cowan,Positive
 Thoughts,"chadi nabhan MD, MBA, FACP",Negative
 referrals,Seema Ali Bhat,Positive
 twos,Seema Ali Bhat,Positive
 world ü§î ü§î,Seema Ali Bhat,Positive
 Treatment considerations,OncLive.com,Negative
 BHdomaintargeting peptide,Paperbirds_Hematology,Negative
 Bcl,Paperbirds_Hematology,Negative
 BaxBakindependent cell death,Paperbirds_Hematology,Negative
 Bcell cancers,Paperbirds_Hematology,Negative
 Bcell cancers,ASH19 VIP,Positive
 Bcell cancers,Edison,Positive
 Bcell cancers,EdisonHealthcare,Positive
 mitochondrial Cadependent mPTP opening,Paperbirds_Hematology,Negative
 Radon,Paperbirds_Hematology,Negative
 cancer mortality,Paperbirds_Hematology,Negative
 Multi Cytogenetic Changes,Paperbirds_Hematology,Negative
 CoExisting MDS,Paperbirds_Hematology,Negative
 CLL Progresses,Paperbirds_Hematology,Negative
 Enhanced Expression,Paperbirds_Hematology,Negative
 miRb,Paperbirds_Hematology,Negative
 miRb,microRNApapers,Negative
 B Cells,Paperbirds_Hematology,Negative
 AntiTumor Cytotoxic T Cell Response,Paperbirds_Hematology,Negative
 FourFactor Prognostic Model,INDoximity üáÆüá≥,Negative
 FourFactor Prognostic Model,ClinOwl Haematology,Negative
 FourFactor Prognostic Model,filippo masini,Negative
 FourFactor Prognostic Model,Irene Mangues,Positive
 Practical Advice,Patient Empowerment Network,Negative
   Diagnosis,Patient Empowerment Network,Negative
   Diagnosis,Patient Power,Negative
 NEW,Genomics Education,Positive
 NEW,Medivizor,Positive
 NEW,DAVA Oncology,Negative
 blog,Genomics Education,Positive
 blog,Living A Busy Life - With Cancer,Positive
 blog,Jeff Neurman,Negative
 blog,NCICancerTrials,Positive
 blog,Toula Castillo,Positive
 blog,LymphomaAction,Negative
 blog,BloodCancerCure,Positive
 blog,Blood Cancer UK Research,Negative
 blog,Cancer And I,Negative
 blog,doctor chris,Positive
 GEP fellow Niamh Appleby,Genomics Education,Positive
 CDloss,Lymphoma Hub,Negative
 Wisconsin,Lymphoma Hub,Negative
 LV,Lymphoma Hub,Negative
    nnnnntknnnnsla,Asdrubal P√©rez,Positive
 g,Asdrubal P√©rez,Positive
 n N,Asdrubal P√©rez,Positive
 nnnnpH,Asdrubal P√©rez,Positive
 √±,Asdrubal P√©rez,Positive
 g Nn√±,Asdrubal P√©rez,Positive
 lasnVB nnn,Asdrubal P√©rez,Positive
 N√±nn nnl koko,Asdrubal P√©rez,Positive
 unn,Asdrubal P√©rez,Positive
 n Nn nnnnmm√±nnnmnnjnnn,Asdrubal P√©rez,Positive
 Nn,Asdrubal P√©rez,Positive
 nnn nn nntnnn,Asdrubal P√©rez,Positive
 ni jtnn,Asdrubal P√©rez,Positive
 tcolvRBQoSZNg,LYMPHOMA & MYELOMA CONNECT,Negative
 Vaccinations,Benlazar S.M Amin√©,Negative
 gtgtgt Effect,Benlazar S.M Amin√©,Negative
 Hematology Nov,Shouting at people in my underpants,Negative
 PEITC,jorge  gonzalez,Negative
 Natural Molecule,jorge  gonzalez,Negative
 Drug Resistant Chronic Lymphocytic,jorge  gonzalez,Negative
 Chronic Myeloid Leukemia,jorge  gonzalez,Negative
 Chronic Myeloid Leukemia,Paperbirds_Hematology,Negative
 CellsDr Steve Martin,jorge  gonzalez,Negative
 Í∞úÏõî ÎßàÎã§,TessEunkyoung Yoo,Positive
 Ïò¨,TessEunkyoung Yoo,Positive
 Ï±ÑÌòà,TessEunkyoung Yoo,Positive
 Î≥ëÏõê   Ï±ÑÌòàÏ†ïÍ∏∞Í≤ÄÏßÑ,TessEunkyoung Yoo,Positive
 ÎåÄÍµ¨ÌååÌã∞ÎßàÎ≥ëÏõê,TessEunkyoung Yoo,Positive
 Haematology experts Dr James D‚ÄôRozario,MDBriefCase,Positive
 Professor John Seymour,MDBriefCase,Positive
 landscape,Patient Power,Positive
 landscape,Lymphoma Papers,Negative
 landscape,Paperbirds_Hematology,Negative
 landscape,"Amber Koehler, PA-C",Negative
 landscape,MoJo,Negative
 landscape,Targeted Oncology,Negative
 landscape,Blood Cancer UK Research,Negative
 landscape,MDedge Hematology & Oncology,Negative
 landscape,VJHemOnc,Negative
 landscape,Christopher Steer,Negative
 Emerging   Treatments,Patient Empowerment Network,Negative
 Care,Patient Empowerment Network,Negative
 Care,MD Anderson Leukemia,Negative
 Care,"Matthew Davids, MD, MMSc",Positive
 Care,Paperbirds_Hematology,Negative
 Care,The ASCO Post,Negative
 Care,CancerWallonia,Positive
 Care,EurekaMag,Negative
 Care,Christopher Steer,Negative
 Care,Health|VBProfiles,Positive
 Care,Business Wire-Health,Negative
 Care,Business Wire-TS,Negative
 Care,BusinessWireConsumer,Positive
 Care,The Pharmaceutical Marketing Group,Negative
 Care,Patient Power,Negative
 Care,Oncology Tube,Positive
 Care,CLL Ireland,Negative
 Care,Margaret Walker,Negative
 News Health Canada,Lymphoma Hub,Negative
 ibrutinib   rituximab,Lymphoma Hub,Negative
 Members ‚Äô Library Highlight Reading Construction Plans,APWA,Positive
 Tailored,CellworksLife,Negative
 mechanism,TAP Clinical Trial Network,Negative
 mechanism,Lymphoma Hub,Negative
 mechanism,NK cell Biology,Negative
 mechanism,NK papers,Negative
 mechanism,Paperbirds_Hematology,Negative
 mechanism,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 mechanism,Triona N√≠ Chonghaile,Negative
 mechanism,ABG_INTL,Positive
 mechanism,Randi Hernandez,Positive
 mechanism,VJHemOnc,Negative
 mechanism,Winship Cancer Institute of Emory University,Negative
 Bcell receptor pathway inhibition,TAP Clinical Trial Network,Negative
 manuscript,TAP Clinical Trial Network,Negative
 manuscript,JSF Group,Positive
 manuscript,European Hematology Association,Negative
 stated outcomes,TAP Clinical Trial Network,Negative
 IcICLLe extension,TAP Clinical Trial Network,Negative
 longerterm,TAP Clinical Trial Network,Negative
 preparation,TAP Clinical Trial Network,Negative
 preparation,Biotech2050,Negative
 gemcitabine resistance,Paperbirds_Hematology,Negative
 Cholangiocarcinoma cells,Paperbirds_Hematology,Negative
 EMT,Paperbirds_Hematology,Negative
 properties,Paperbirds_Hematology,Negative
 miRpBCLL,Paperbirds_Hematology,Negative
 Oral Targeted Therapy,Paperbirds_Hematology,Negative
 Oral Targeted Therapy,Current Oncology,Negative
 Economic Burden,Paperbirds_Hematology,Negative
 Economic Burden,Current Oncology,Negative
 Economic Burden,MSHO,Positive
 Economic Burden,Christopher Steer,Negative
 Economic Burden,The Medical Ed Cons.,Negative
 Economic Burden,(((Rich Stein)))Stay safeüò∑ü¶† & be kind,Positive
 Economic Burden,Cancer Papers,Negative
 Lesen Sie,JOURNAL ONKOLOGIE,Negative
 Lesen Sie,DeutschesGesundheitsPortal,Positive
 jetzt den vollst√§ndigen Beitrag unter,JOURNAL ONKOLOGIE,Negative
 Chronic Lymphocytic Leukemia Increases Peripheral Blood Hematopoietic Stem Cells,Rafael Ruiloba,Positive
 Dr Brander,Targeted Oncology,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,razo,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,Hematology,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,chetan padghan,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,Pacientes LMC,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,Paperbirds_Hematology,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA,Ezzy,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,touchONCOLOGY,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA,Benlazar S.M Amin√©,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA,Ravi Goyal,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,NK papers,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA,Cancer Papers,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,Malaria Papers,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,Cure Cancer Now,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,Medibooks,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,IJAR,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,Pauly@spz_trader,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA,Just Cancer News,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA,Scott Werntz,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA,JediPD,Positive
   Clinical Trials,Patient Empowerment Network,Negative
 Health Canada Approves IMBRUVICA,Alicia Bell IFBB Pro,Negative
 Health Canada Approves IMBRUVICA,Diaceutics PLC,Negative
 Health Canada Approves IMBRUVICA,NACDA Program on Aging,Negative
 postASH   Sessions,VJHemOnc,Negative
 John Gribben Alessandra Tedeschi,VJHemOnc,Negative
   diagnosis,AstraZenecaUS,Negative
   diagnosis,Heartland Cancer Foundation,Positive
   diagnosis,Patient Power,Positive
   diagnosis,AbbVie US,Positive
   diagnosis,AbbVie,Negative
   diagnosis,CLLSA,Negative
   diagnosis,The Leukemia & Lymphoma Society,Negative
   diagnosis,Janssen EMEA,Negative
   diagnosis,Amin G T Amin,Positive
   diagnosis,Lymphoma Canada,Negative
   Chronic Lymphocytic Leukemia,hematologist,Negative
   Chronic Lymphocytic Leukemia,"Pharmacyclics, an AbbVie Company",Negative
   Chronic Lymphocytic Leukemia,Mol Oncol Res,Positive
   Chronic Lymphocytic Leukemia,@ReportsandMarkets,Positive
   Chronic Lymphocytic Leukemia,CRO Contract Res.,Negative
   Chronic Lymphocytic Leukemia,David McLean,Positive
   Chronic Lymphocytic Leukemia,SeguidorFinanzas,Positive
   Chronic Lymphocytic Leukemia,INFO Kebutuhan Darah dari Blood4LifeID,Negative
   Chronic Lymphocytic Leukemia,Service Ebooks,Positive
   Chronic Lymphocytic Leukemia,Donny Gilbreath,Negative
 Stages Symptoms Risk Factors,hematologist,Negative
 period,Patient Power,Negative
 period,Andrew Schorr,Negative
 CST details,Lisa Palacios,Negative
 Concomittant occurence,Lymphoma Papers,Negative
 welldifferentiated thyroid carcinoma metastasis,Lymphoma Papers,Negative
   Impact,Current Oncology,Negative
   Impact,"Raul Cordoba, MD, PhD",Negative
 Jean Lachaine,Current Oncology,Negative
 Catherine Beauchemin,Current Oncology,Negative
 et al Ô∏è,Current Oncology,Negative
 ELEVATETN trial,OncLive SOSS,Negative
 ELEVATETN trial,OncLive.com,Negative
 treatmentna√Øve CLL,OncLive SOSS,Negative
 Cancer experts,UW Medicine Newsroom,Positive
 sustainability,Targeted Oncology,Negative
 sustainability,ALLAB@ PSU,Positive
 frontline ibrutinibbased therapy,Targeted Oncology,Negative
 Paolo Ghia MD Phd   Jennifer Brown MD PhD,OncLive.com,Negative
 treatmentcConsiderations,OncLive.com,Negative
 Newly Diagnosed CLL,OncLive.com,Negative
 Treatment Approach,Patient Empowerment Network,Negative
 th issue,Sigrid Sk√•nland,Negative
 th issue,ISOPP,Positive
 Blood Advances,Sigrid Sk√•nland,Negative
 Risk,Oncology Publishers Feed,Negative
 Risk,Gail Williams,Positive
 Risk,Brave Is Now,Positive
 Risk,Brave Is Now¬Æ,Negative
 Risk,AI News Feed,Positive
 Risk,Oncology,Negative
 Risk,Medical Xpress,Negative
 Risk,National Aspergillosis Centre,Negative
 Risk,Hematology Advisor,Negative
 Risk,CURE Magazine,Negative
 Risk,Francesco Bertoni,Negative
 Risk,Public Health,Positive
 Risk,PressReleasePoint,Negative
 Risk,1stOncology,Negative
 Risk,The Pharmaceutical Marketing Group,Positive
 Risk,Financial Buzz,Negative
 Risk,T Allen,Positive
 Risk,Crwe World,Positive
 Risk,Armando Guglielmetti,Negative
 Risk,Targeted Oncology,Negative
 Risk,CLL Ireland,Negative
 Risk,Health|VBProfiles,Positive
 Risk,Business Wire-Health,Negative
 Risk,Business Wire-TS,Negative
 Risk,BusinessWireConsumer,Positive
 Risk,Int J Dermatology,Positive
 Risk,Cancer Papers,Negative
 Risk,LRA: New articles,Positive
 Risk,Christopher Steer,Negative
 Risk,EP Lab Digest,Positive
 Risk,CancerTherapyAdvisor,Negative
 Risk,Dr. Mahesh Jain,Negative
 Risk,Curatio Technologies,Negative
 Risk,Gitte Pedersen,Negative
 Risk,Invest World News,Negative
 Risk,DatZoom PR,Positive
 Risk,satPRnews,Negative
 Risk,Ez2Trade,Positive
 Risk,Hot Trades,Positive
 Risk,Penny Stocks,Negative
 Risk,Daniel Able,Positive
 Risk,PRN Biotech,Negative
 Risk,Security Stocks,Positive
 Risk,Stock Runners,Positive
 Risk,Penny Stock Irish,Negative
 Risk,CancerWallonia,Negative
 CLL Indolent NHL,Oncology Publishers Feed,Negative
 AnticoagulationAntiplatelet Therapy,Oncology Publishers Feed,Negative
 Dr Jennifer Woyach,Patient Empowerment Network,Negative
 Dr Jennifer Woyach,The James,Positive
 Dr Jennifer Woyach,Clinical Research Forum,Positive
 Dr Jennifer Woyach,VJHemOnc,Negative
 Dr Jennifer Woyach,The ASCO Post,Positive
 Dr Jennifer Woyach,Matthias Piesche,Negative
   MKSAP Pearl Immune thrombocytopenic purpura,"Tom Curley, MD",Positive
 ‚úÖ Endorsement,HemaSphere_EHA,Positive
 ESMO    Practical,HemaSphere_EHA,Positive
 Dr Blanca Espinet,"Bionano Genomics, Inc.",Positive
 Dr Anna Puiggros,"Bionano Genomics, Inc.",Positive
 Barcelona Spain,"Bionano Genomics, Inc.",Positive
 noncomplex,"Bionano Genomics, Inc.",Positive
 Bu,Fevzi Altunta≈ü,Positive
 konu≈üacaƒüƒ±z ƒ∞lgi,Fevzi Altunta≈ü,Positive
 duyan ve vakti olanlarƒ± bekleriz,Fevzi Altunta≈ü,Positive
 Join    Emil J Freireich Hematology Grand Rounds,Lisa Palacios,Negative
 Join    Emil J Freireich Hematology Grand Rounds,MD Anderson Leukemia,Negative
 ‚Äú   Update,Lisa Palacios,Negative
 Eyes,Paperbirds_Hematology,Negative
   researchers,Technology Networks,Positive
   researchers,Extinction Crisis,Positive
   researchers,BlueBee,Negative
   researchers,Stanford Department of Medicine,Positive
   researchers,NIH NHLBI,Negative
 Dr Nguyen,Daniel Bachurski,Positive
 VEGF,jorge  gonzalez,Positive
 growth factor,jorge  gonzalez,Positive
 cancer cells,jorge  gonzalez,Negative
 cancer cells,MyPathologyReport.ca,Positive
 cancer cells,Ravispecialitiespharma_RSP,Negative
 cancer cells,NCI Center for Cancer Research,Positive
 cancer cells,Quint Fit,Positive
   activity,Oncology CE,Positive
   activity,Vindico Medical Education,Positive
   activity,RedMedEd,Positive
   activity,Francesco Turturro,Positive
 field,Oncology CE,Positive
 field,Vindico Medical Education,Positive
 field,HARMONY Alliance,Negative
 field,Harry Fuentes MD MSc,Positive
 field,LyLe Foreningen,Negative
 field,OncLive.com,Negative
 field,Amy Ramos,Negative
 field,Targeted Oncology,Negative
 field,OncLive SOSS,Negative
 field,Bernard A Fox,Positive
 field,VJHemOnc,Negative
 field,"Raul Cordoba, MD, PhD",Negative
 field,Patient Power,Negative
 John M Burke MD amp Manuel Santiago MD gtgt,Oncology CE,Positive
 John M Burke MD amp Manuel Santiago MD gtgt,Vindico Medical Education,Positive
 Super day,Orchard Primary Academy Nursery,Negative
 Jan Burger MD PhD,Lisa Palacios,Positive
 Jan Burger MD PhD,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Jan Burger MD PhD,MD Anderson Leukemia,Negative
 Jan Burger MD PhD,Expert Perspectives in Oncology,Negative
 FirstLine Ibrutinib Effective,Lisa Palacios,Negative
 SLL Irrespective,Lisa Palacios,Negative
 Cytogenetic Mutational Risk Features,Lisa Palacios,Negative
 CAP,TrialBulletin,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Status,TrialBulletin,Positive
 Condition Summary Lymphocytic Leukemia Chronic SLL,TrialBulletin,Negative
   CAP,CureHuntr,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,CureHuntr,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,Bitchin' Science,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,Stock Market News,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Pharmacutical Daily,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Sarang Pokhare,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,IMPharma News,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Latest News from Business Wire,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,OncLive.com,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Pharma News,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,MigraineClinicalTrialTracker,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,Wellcome-home,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,DennisPartners,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Quant Data,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Stock Titan,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Lymphoma Papers,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,James Kerwin,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,ScienceSeeker Feed,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,Simple Charts,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Benlazar S.M Amin√©,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,"Georgios Pongas, MD",Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,Mahmoud Aljurf,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,"Dr T. Comeau , MD",Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Izaskun Zeberio,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Juan Marquet,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Claire Harrison,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,Cancer Papers,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,ALI ALAHMARI.,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,Eduardo Flavio Oliveira Ribeiro,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,GEDEFO,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,"Bachar Samra, MD",Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,Lymphomation.org,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Tom,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,World Neonatology Congress,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Seattle's Banker,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Marketbit.pro,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,HEDGE accordinglyüìà,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,CRE Demographics,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,RazzleTazzle,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Hematopoiesis News,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,TrialBulletin,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Bio Stocks‚Ñ¢,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Chan Cheah,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Matthew Wakefield,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,Garbi√±e Lizeaga,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Jerry Lee,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Marlowe S Tessmer,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Cure Cancer Now,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,"Meagan Bryan, RN",Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,OncologyNurseAdvisor,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,The ASCO Post,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Financial GamblR,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,NeuroBrain,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,PER,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Medscape Education,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,PRN Biotech,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Scott Werntz,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia,Penny Stocks,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,Penny Stock Irish,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia,BioRunUp,Negative
 NewTrip Venetoclax,Trip Database,Negative
 yr Results amp Evaluation,Trip Database,Negative
 Genomic Complexity amp Gene Mutations,Trip Database,Negative
 MURANO Phase III Study,Trip Database,Negative
 MURANO Phase III Study,"Raul Cordoba, MD, PhD",Negative
 w Lydia Scarf√≤,VJHemOnc,Positive
 Cancer Stat Facts sheet,NCI Cancer Stats,Negative
 Tanya Siddiqi MD,OncLive SOSS,Positive
 Tanya Siddiqi MD,OncLive.com,Negative
 Tanya Siddiqi MD,City of Hope | Orange County,Positive
 Tanya Siddiqi MD,City of Hope,Positive
 rituximabarrx,Lymphoma Hub,Negative
 rituximabarrx,Oncology Nursing News,Negative
 rituximab biosimilar,Lymphoma Hub,Negative
 rituximab biosimilar,Oncology Learning Network,Negative
 nonHodgkin lymphoma,Lymphoma Hub,Negative
 nonHodgkin lymphoma,Paperbirds_Hematology,Negative
 nonHodgkin lymphoma,Market Intelligence: Healthcare,Positive
 nonHodgkin lymphoma,"Trustwell Law Group, LLP",Positive
 nonHodgkin lymphoma,Matthews & Associates,Negative
 nonHodgkin lymphoma,Ravispecialitiespharma_RSP,Positive
 nonHodgkin lymphoma,Clarivate Cortellis,Negative
 nonHodgkin lymphoma,TumImmTxpapers,Negative
 Live Attenuated Varicella Vaccination,Paperbirds_Hematology,Negative
 Live Attenuated Zoster Vaccination,Paperbirds_Hematology,Negative
 Hairy cell leukemia coexistent,Blood Journal,Negative
 CLL Advocates Network COVID statement,CLL Advocates Network,Negative
    Tr√®s engag√©,Jean-Philippe Calmus üá´üá∑üá±üá∫,Positive
 GC   Follicular colonization,ImmuneGCPapers,Positive
 Colorado   patients,Patient Power,Negative
 Follicular colonization,Lymphoma Papers,Negative
 Control,Paperbirds_Hematology,Negative
 Control,Patient Empowerment Network,Negative
 Control,"Raul Cordoba, MD, PhD",Negative
 Control,TumorImmunoPapers,Negative
 Control,gilbert c faure,Negative
 Choroidal,Paperbirds_Hematology,Negative
 IGHV testing reference centers,Paperbirds_Hematology,Negative
 Spain,Paperbirds_Hematology,Negative
 Spain,Patient Power,Negative
 Red initiative,Paperbirds_Hematology,Negative
   team,Sussex Haematology,Positive
   team,VJHemOnc,Negative
   team,Lymphoma Hub,Positive
   team,Michael Hallek,Negative
   team,LiveYourLife,Negative
   team,Helen Jane Mee,Negative
   team,CLL Warwick Uni,Negative
   team,LymphomaAction,Negative
   team,CLL Ireland,Negative
   team,Oksana Komarova,Positive
 TLR,Sussex Haematology,Positive
 TLR,Prof John,Negative
 TLR,Anna Deveau,Negative
 TLR,Lymphomation.org,Negative
 piece,Ingo Ringshausen,Positive
 piece,Alaric DeArment,Positive
 piece,MDSUK PatientSupport üíô,Positive
 piece,Taylor Lab UM,Negative
 TLR puzzle,Ingo Ringshausen,Positive
 team effort,Chris Pepper,Positive
 Infiltration,American Journal of Forensic Medicine & Pathology,Positive
 Infiltration,Paperbirds_Hematology,Negative
   American Journal,American Journal of Forensic Medicine & Pathology,Positive
 Forensic Medicine,American Journal of Forensic Medicine & Pathology,Positive
 Pathology,American Journal of Forensic Medicine & Pathology,Positive
 Pathology,Fact a Minute,Positive
 registration,iwCLL,Positive
 registration,GenQA (Genomics Quality Assessment),Negative
 registration,CDDF,Positive
 registration,Carevƒ´ve,Negative
 OPEN,iwCLL,Negative
   International Workshop,iwCLL,Negative
   International Workshop,VJHemOnc,Negative
 Head,iwCLL,Negative
 Head,"Pharmacyclics, an AbbVie Company",Positive
 Head,Paperbirds_Hematology,Negative
 Head,Lymphoma Hub,Negative
 Medicare beneficiary,PAN Foundation,Negative
 George,PAN Foundation,Positive
 George,The Patient's Channel,Negative
 Prognostic Indices,ChampionsOncology,Positive
   Patients Access,Patient Empowerment Network,Negative
 ICYMI Experts,Patient Power,Negative
 Advice,Patient Power,Positive
 Concurrent BK polyomavirus adenovirus,Paperbirds_Hematology,Negative
 cytomegalovirus infections,Paperbirds_Hematology,Negative
 vaccines,CLL Ireland,Negative
 vaccines,Shouting at people in my underpants,Negative
 vaccines,Blood Cancer Uncensored,Negative
 vaccines,Patient Power,Negative
 vaccines,Oncology Tube,Negative
 TP network,Francesc Bosch,Positive
 Annals,Francesc Bosch,Positive
 Annals,Annals of Oncology,Positive
 Annals,Isaura R. Penin,Negative
 Hematology Thanks,Francesc Bosch,Positive
 Checkpoint Blockade,Melanoma MRV,Positive
 Checkpoint Blockade,Ingentium Melanoma,Positive
 Melanoma Patients,Melanoma MRV,Positive
 Melanoma Patients,Ingentium Melanoma,Positive
 Underlying Chronic Lymphocytic Leukemia,Melanoma MRV,Positive
 Underlying Chronic Lymphocytic Leukemia,Ingentium Melanoma,Positive
 Downloaded,Elsevier Biotech,Negative
 Downloaded,Dr. Rajeev K. Singla,Positive
 carotenoidenriched extract,Elsevier Biotech,Positive
 carotenoidenriched extract,Iv√°n Dario Cruz P,Positive
 carotenoidenriched extract,Dr. Rajeev K. Singla,Positive
 carotenoidenriched extract,Nattha Saravutanukul,Positive
 carotenoidenriched extract,Nature's Medicines,Positive
 carotenoidenriched extract,Newyork Fitness,Positive
 carotenoidenriched extract,Science Updates,Positive
 carotenoidenriched extract,Science Lover,Positive
 carotenoidenriched extract,Online Pharmacy,Positive
 carotenoidenriched extract,Nature Watcher,Positive
 carotenoidenriched extract,Fabrice Leclerc,Negative
 carotenoidenriched extract,International Natural Product Sciences Taskforce,Positive
 carotenoidenriched extract,Atanas G. Atanasov,Positive
 pumpkin delays cell proliferation,Elsevier Biotech,Positive
 pumpkin delays cell proliferation,Iv√°n Dario Cruz P,Positive
 pumpkin delays cell proliferation,Dr. Rajeev K. Singla,Positive
 pumpkin delays cell proliferation,Nattha Saravutanukul,Positive
 pumpkin delays cell proliferation,Nature's Medicines,Positive
 pumpkin delays cell proliferation,Science Updates,Positive
 pumpkin delays cell proliferation,Science Lover,Positive
 pumpkin delays cell proliferation,Online Pharmacy,Positive
 pumpkin delays cell proliferation,Nature Watcher,Positive
 pumpkin delays cell proliferation,Australian Adventure,Positive
 pumpkin delays cell proliferation,Fabrice Leclerc,Negative
 pumpkin delays cell proliferation,International Natural Product Sciences Taskforce,Positive
 pumpkin delays cell proliferation,Atanas G. Atanasov,Positive
   Recommends,AJMC,Negative
 FirstLine SecondLine Therapy,AJMC,Negative
 Print Preneoplastic alterations,Blood Cancer Discovery,Negative
 CLL expert,Patient Empowerment Network,Negative
 CLL expert,Patient Power,Positive
 viewpoint,Patient Empowerment Network,Negative
 longterm survivorship care,Patient Empowerment Network,Negative
 Winship hematologist Jonathon Cohen,Winship Cancer Institute of Emory University,Negative
 MD MS,Winship Cancer Institute of Emory University,Negative
 MD MS,PRC Clinical,Positive
 WATCH Kerry Rogers MD,OncLive.com,Negative
 watch,Patient Power,Positive
 watch,Chris  Douglas,Positive
 watch,CLLSA,Negative
 watch,LymphomaAction,Negative
 watch,OncLive.com,Negative
 watch,Prairie Lakes Church,Negative
 waitPatient advocate Jay Blatt,Patient Power,Negative
 Visit,BioAscend,Positive
 Visit,Patient Empowerment Network,Negative
 WATCH Othman AlSawaf MD,OncLive.com,Negative
 Germany,OncLive.com,Negative
 Germany,Ruth Gemmell,Negative
 Germany,Proactive,Negative
 steps,OncLive.com,Negative
 steps,Patient Empowerment Network,Negative
 steps,COPD News,Negative
 steps,VJHemOnc,Negative
 steps,TalkAboutHealth,Positive
 Families,Blood Journal,Negative
 Families,Patient Power,Negative
 Families,RIOH,Negative
 Families,Mayo Clinic Med Ed,Positive
 Svar fra,LyLe Foreningen,Negative
 p√• mange sp√∏rgsm√•l,LyLe Foreningen,Negative
 mod     hvordan,LyLe Foreningen,Negative
 og hvorn√•r kontakt egen l√¶ge,LyLe Foreningen,Negative
 √¶ft √¶mi,LyLe Foreningen,Positive
 Leukemia Microenviroment,Paperbirds_Hematology,Negative
 regulation,Paperbirds_Hematology,Positive
 regulation,"Raul Cordoba, MD, PhD",Negative
 regulation,microRNApapers,Positive
 regulation,BioinfoPapers,Positive
 regulation,SexGenomics,Negative
 Lisocel,VJHemOnc,Negative
   Market Size,MarketStudyReport,Positive
 CLL Society,Shouting at people in my underpants,Negative
 CLL Society,CLL Ireland,Negative
 CLL Society,CLL Society Inc.,Positive
 CLL Society,Michael Rynne,Negative
 CLL Society,"Tom Henry, MBA, RPh, CPh",Negative
 Official Statement,Shouting at people in my underpants,Negative
 SARSCoV Vaccine,Shouting at people in my underpants,Negative
 Global Chronic Lymphocytic Leukemia Treatment Market Production Capacity Revenue Price Gross Margin Analysis,Depp Gaikwad,Negative
 Forecast,Depp Gaikwad,Positive
 Forecast,Stock Market News,Negative
 Forecast,Rohit K,Positive
 Forecast,Global News Report,Positive
 Forecast,Kiran Bhole,Positive
 Forecast,lalit pachpande,Positive
 Forecast,PressRelease.cc,Positive
 Forecast,ABNewswire,Negative
 Forecast,Research News24 üíé,Positive
 Forecast,EIN Presswire: Press Releases,Negative
 Forecast,Industry Today,Positive
 Forecast,Tech Journal Hub,Positive
 Forecast,1MarketResearch.com,Positive
 Forecast,Gosretort777666,Positive
 Forecast,jayant khairkar,Positive
 Forecast,Denver Greene,Negative
 Forecast,Publish PressRelease,Positive
 Forecast,Top 10,Negative
 Forecast,Info Batam,Positive
 Forecast,BATAM Kepri,Negative
 IQWiG,idw Nachrichten,Positive
 bei nicht vorbehandelter,idw Nachrichten,Positive
 bei nicht vorbehandelter,IQWiG,Positive
 Hinweis auf,idw Nachrichten,Positive
 Hinweis auf,IQWiG,Positive
 Zusatznutzen f√ºr,idw Nachrichten,Positive
 Zusatznutzen f√ºr,IQWiG,Positive
 Patienten mit gutem Allgemeinzustand,idw Nachrichten,Positive
 Patienten mit gutem Allgemeinzustand,IQWiG,Positive
 Kombination verl√§ngert das Gesamt√ºberleben F√ºr andere Patientengruppen liegen keine,idw Nachrichten,Positive
 Kombination verl√§ngert das Gesamt√ºberleben F√ºr andere Patientengruppen liegen keine,IQWiG,Positive
 vor,idw Nachrichten,Positive
 vor,IQWiG,Positive
 Telemedicine Activate,Patient Empowerment Network,Negative
 Novant Health Cancer Institute,OncLive.com,Negative
 Leukemic Extracellular Vesicles,Bion at bitpharma.com,Positive
 Leukemic Extracellular Vesicles,ImmunotherapyPapers,Negative
 Leukemic Extracellular Vesicles,Cancer Papers,Negative
 Leukemic Extracellular Vesicles,Paperbirds_Hematology,Negative
 Chimeric Antigen Receptor T Cell Dysfunction,Bion at bitpharma.com,Positive
 Chimeric Antigen Receptor T Cell Dysfunction,ImmunotherapyPapers,Negative
 Chimeric Antigen Receptor T Cell Dysfunction,Cancer Papers,Negative
 Chimeric Antigen Receptor T Cell Dysfunction,Paperbirds_Hematology,Negative
 wrench,David Henry,Positive
 wrench,MDEdge,Negative
 wrench,MDedge Hematology & Oncology,Negative
 Startling Case Study,Shouting at people in my underpants,Negative
 Asymptomatic COVID Carrier,Shouting at people in my underpants,Negative
 FFDG,Tom,Negative
 FFDG,Lymphoma Papers,Negative
 Detecting Richter Transformation,Tom,Negative
 Detecting Richter Transformation,Lymphoma Papers,Negative
 Predicting,Tom,Negative
 Predicting,Lymphoma Papers,Negative
 Predicting,Andre Williams,Positive
 Overall Survival,Tom,Negative
 Overall Survival,Lymphoma Papers,Negative
 Overall Survival,Dr Henry,Positive
 Overall Survival,Invest World News,Negative
 Overall Survival,Mohammed Saied Faraj,Positive
 PFE     PF PsoriasisPhase    Phase   data,Aleksandar Starcevic,Positive
 identification,Cancer Papers,Negative
 identification,Paperbirds_Hematology,Positive
 identification,EurekaMag,Negative
 Paul M Barr MD,OncLive.com,Positive
 Paul M Barr MD,Oncology Tube,Negative
 Large Granular Lymphocytic Leukemia LGLTweetorial,Aaron Goodman - ‚ÄúPapa Heme‚Äù,Positive
 flavors,Aaron Goodman - ‚ÄúPapa Heme‚Äù,Positive
 Rare Case Presentation,Clinical Oncology,Positive
 Lymphocytic,Clinical Oncology,Negative
 Lymphocytic,Sumit Middha,Positive
 Lymphocytic,Medscape Education,Negative
 Lymphocytic,Cord Blood News,Negative
 Lymphocytic,Rare Diseases,Negative
 Chronic Myeloid,Clinical Oncology,Negative
 LeukemiaBy Patkar Salil Panchal Harsha Asha Anand Patel Apurva,Clinical Oncology,Negative
 Parikh SoniaRead,Clinical Oncology,Negative
 text article,Clinical Oncology,Negative
 Chronic Lymphocytic Leukemia Clinical Relevance,Paperbirds_Hematology,Negative
 Microenvironment Remodeling,Paperbirds_Hematology,Negative
 Subsequent Clinical Implications,Paperbirds_Hematology,Negative
 New article case,Paperbirds_Hematology,Positive
 Coverage,Benlazar S.M Amin√©,Negative
 Coverage,The Oncologist,Positive
 Coverage,Lymphoma Hub,Negative
 nd ASH Annual Meeting,Benlazar S.M Amin√©,Negative
 nd ASH Annual Meeting,MEDtalks CH,Positive
 nd ASH Annual Meeting,Biotech & Tech Stock Focus,Negative
 nd ASH Annual Meeting,Corporate News,Negative
 nd ASH Annual Meeting,Latest News from Business Wire,Negative
 nd ASH Annual Meeting,Stock Titan,Negative
 nd ASH Annual Meeting,CCO Education,Negative
 amp ExpositionFocus,Benlazar S.M Amin√©,Negative
 Closer Look,Oncology Times,Positive
 Adolescents,Oncology Times,Positive
 Young Adults,Oncology Times,Positive
 Experts,Patient Power,Positive
 Experts,ESH (Haematology),Negative
 Experts,Michele Nadeem-Baker,Positive
 Experts,Targeted Oncology,Positive
 Experts,OncLive.com,Positive
 Experts,CLL Ireland,Negative
 Experts,PeerView,Negative
 Experts,Silas Inman,Negative
 Molecular Remission,NK papers,Negative
 LowDose Immunotherapy,NK papers,Negative
 Minimal Toxicities,NK papers,Negative
 John N Allan MD,OncLive.com,Negative
 John N Allan MD,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 biosimilar Riabni,OncologyNurseAdvisor,Negative
 NonHodgkin Lymphoma Chronic Lymphocytic Leukemia Granulomatosis,OncologyNurseAdvisor,Negative
 Polyangiitis,OncologyNurseAdvisor,Negative
 Microscopic Polyangiitis,OncologyNurseAdvisor,Negative
 Subset,Patient Empowerment Network,Negative
 Subset,Talha Badar,Positive
 Subset,Patient Power,Negative
 Choices,HAM,Negative
 Aberrations,HAM,Negative
 Active STAT,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Clinical Trial,Paperbirds_Hematology,Negative
 STAT Inhibitor Pyrimethamine,Paperbirds_Hematology,Negative
 Pharmacodynamic Analyses,Paperbirds_Hematology,Negative
 New article Relationship,Paperbirds_Hematology,Positive
 CDxCD DART molecule treatment,Benlazar S.M Amin√©,Positive
 CDxCD DART molecule treatment,Journal for ImmunoTherapy of Cancer,Negative
 CDxCD DART molecule treatment,Lymphoma Papers,Negative
 CDxCD DART molecule treatment,Paperbirds_Hematology,Negative
 Feasibility,Benlazar S.M Amin√©,Positive
 Feasibility,Blood Journal,Negative
 Feasibility,Cancer Papers,Negative
 Feasibility,Krishan Maggon,Negative
 Feasibility,TumorImmunoPapers,Negative
 CDtargeted CAR T cells,Benlazar S.M Amin√©,Positive
 CDtargeted CAR T cells,Blood Journal,Negative
 CDtargeted CAR T cells,Adam Kittai,Negative
   Œ¥ inhibitor,Cancer Immunology Research,Positive
 treatment promotes,Cancer Immunology Research,Positive
 ASCO Annual Meeting Highlights,Paperbirds_Hematology,Negative
 Advanced Practitioner Hematologic Malignancies,Paperbirds_Hematology,Negative
 EFFECTS,Paperbirds_Hematology,Negative
 IONIZING RADIATION,Paperbirds_Hematology,Negative
 LEVEL,Paperbirds_Hematology,Negative
 CHROMOSOME INSTABILITY,Paperbirds_Hematology,Negative
 HUMAN SOMATIC CELLS,Paperbirds_Hematology,Negative
 DEVELOPMENT,Paperbirds_Hematology,Negative
 TUMORINDUCED BYSTANDER,Paperbirds_Hematology,Negative
 New article C glomerulopathy,Paperbirds_Hematology,Negative
 Gene Expression Profiling,TumImmTxpapers,Negative
 Gene Expression Profiling,Paperbirds_Hematology,Negative
 Sensitivity,TumImmTxpapers,Negative
 Sensitivity,Paperbirds_Hematology,Negative
 Sensitivity,Invitro Diagnostics News & Research,Positive
 Chronic Lymphocytic Leukemia Cells,TumImmTxpapers,Negative
 Chronic Lymphocytic Leukemia Cells,Paperbirds_Hematology,Positive
 Chronic Lymphocytic Leukemia Cells,CLL-seq,Negative
 Chronic Lymphocytic Leukemia Cells,Wnt publications,Positive
 Chronic Lymphocytic Leukemia Cells,Grant Beasley,Positive
 Chronic Lymphocytic Leukemia Cells,Joe,Negative
 Chronic Lymphocytic Leukemia Cells,Prof John,Negative
 Chronic Lymphocytic Leukemia Cells,Lovisa Bray,Positive
 Chronic Lymphocytic Leukemia Cells,SignPath Pharma,Positive
 Chronic Lymphocytic Leukemia Cells,Invitro Diagnostics News & Research,Positive
 Chronic Lymphocytic Leukemia Cells,Wei Du,Positive
 Chronic Lymphocytic Leukemia Cells,ImmunologyPapers,Negative
 Chronic Lymphocytic Leukemia Cells,Cancer Papers,Negative
 Chronic Lymphocytic Leukemia Cells,Libro Azul,Positive
 Chronic Lymphocytic Leukemia Cells,epigenetics_papers,Negative
 Chronic Lymphocytic Leukemia Cells,JournalAgent,Positive
 Dasatinib,TumImmTxpapers,Negative
 Dasatinib,Paperbirds_Hematology,Negative
 guest,CryptoLiveLeak,Negative
 guest,Patient Power,Negative
   ShowWell,CryptoLiveLeak,Negative
 Companies Drugs,Journal of Phlebology and Lymphology VOL 13 ISS 2,Positive
 Companies Drugs,SouthernIndiaReporte,Positive
 Companies Drugs,shimla-online,Positive
 Companies Drugs,Shillong Herald,Positive
 Companies Drugs,New Jersey Headlines,Positive
 Companies Drugs,Chhattisgarh Journal,Positive
 Companies Drugs,ABNewswire,Negative
 Competitive Analysis,Journal of Phlebology and Lymphology VOL 13 ISS 2,Positive
 Competitive Analysis,SouthernIndiaReporte,Positive
 Competitive Analysis,shimla-online,Positive
 Competitive Analysis,Shillong Herald,Positive
 Competitive Analysis,New Jersey Headlines,Positive
 Competitive Analysis,Chhattisgarh Journal,Positive
 Competitive Analysis,ABNewswire,Negative
 DelveInsight,Journal of Phlebology and Lymphology VOL 13 ISS 2,Positive
 DelveInsight,SouthernIndiaReporte,Positive
 DelveInsight,shimla-online,Positive
 DelveInsight,Shillong Herald,Positive
 DelveInsight,New Jersey Headlines,Positive
 DelveInsight,Chhattisgarh Journal,Positive
 DelveInsight,ABNewswire,Negative
 Presents,IMPharma News,Negative
 Presents,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 Presents,MasdelMedio,Negative
 Presents,Company News HQ,Negative
 Presents,Crwe World,Negative
 Presents,HempNews,Negative
 Presents,Investor News,Negative
 Extended FollowUp Data,IMPharma News,Negative
 Extended FollowUp Data,1stOncology,Negative
 Extended FollowUp Data,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 Extended FollowUp Data,MasdelMedio,Negative
 Extended FollowUp Data,Towelie,Positive
 Extended FollowUp Data,Company News HQ,Negative
 Extended FollowUp Data,Crwe World,Negative
 Extended FollowUp Data,HempNews,Negative
 Extended FollowUp Data,Investor News,Negative
 Fixed Duration Treatment VENCLEXTA,IMPharma News,Negative
 Fixed Duration Treatment VENCLEXTA,Investor Press Releases,Positive
 Fixed Duration Treatment VENCLEXTA,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 Fixed Duration Treatment VENCLEXTA,MasdelMedio,Negative
 Fixed Duration Treatment VENCLEXTA,Stock Market News,Negative
 Fixed Duration Treatment VENCLEXTA,Company News HQ,Negative
 Fixed Duration Treatment VENCLEXTA,Crwe World,Negative
 Fixed Duration Treatment VENCLEXTA,"OTC Dynamics, Inc.",Negative
 Fixed Duration Treatment VENCLEXTA,Flash Alert,Negative
 Fixed Duration Treatment VENCLEXTA,HempNews,Negative
 Fixed Duration Treatment VENCLEXTA,Investor News,Negative
 Fixed Duration Treatment VENCLEXTA,Stock Titan,Negative
 VENCLYXTO,IMPharma News,Positive
 VENCLYXTO,Investor Press Releases,Positive
 VENCLYXTO,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 VENCLYXTO,MasdelMedio,Positive
 VENCLYXTO,NwokeAgulu,Negative
 VENCLYXTO,Stock Market News,Negative
 VENCLYXTO,Company News HQ,Positive
 VENCLYXTO,Crwe World,Positive
 VENCLYXTO,"OTC Dynamics, Inc.",Negative
 VENCLYXTO,Flash Alert,Negative
 VENCLYXTO,HempNews,Negative
 VENCLYXTO,Investor News,Negative
 VENCLYXTO,Stock Titan,Positive
 VENCLYXTO,Thomas C. Keefe,Negative
 VENCLYXTO,LLZ Consulting,Negative
 VENCLYXTO,Oncology Tube,Negative
 VENCLYXTO,Pharma News,Negative
 VENCLYXTO,Odi Bruckman,Negative
 VENCLYXTO,Saeed Valadbaygi,Negative
 VENCLYXTO,Simple Charts,Negative
 VENCLYXTO,VPO/PR Newswire,Negative
 VENCLYXTO,pressdaily,Negative
 VENCLYXTO,Financial Buzz,Negative
 VENCLYXTO,Seattle's Banker,Positive
 VENCLYXTO,Marketbit.pro,Negative
 VENCLYXTO,CRE Demographics,Positive
 VENCLYXTO,RazzleTazzle,Positive
 VENCLYXTO,Laurent G - Francis,Negative
 VENCLYXTO,Today's News,Positive
 VENCLYXTO,1stOncology,Negative
 ¬Æ venetoclax,IMPharma News,Negative
 ¬Æ venetoclax,Investor Press Releases,Positive
 ¬Æ venetoclax,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 ¬Æ venetoclax,MasdelMedio,Negative
 ¬Æ venetoclax,Stock Market News,Negative
 ¬Æ venetoclax,Company News HQ,Negative
 ¬Æ venetoclax,Crwe World,Positive
 ¬Æ venetoclax,"OTC Dynamics, Inc.",Negative
 ¬Æ venetoclax,Flash Alert,Negative
 ¬Æ venetoclax,HempNews,Positive
 ¬Æ venetoclax,Stock Titan,Negative
 ¬Æ venetoclax,Saeed Valadbaygi,Negative
 ¬Æ venetoclax,Thanasis Chalikias,Positive
 ¬Æ venetoclax,RazzleTazzle,Positive
 ¬Æ venetoclax,FDA Daily,Negative
 ¬Æ venetoclax,Financial Buzz,Negative
 ¬Æ venetoclax,Seattle's Banker,Positive
 ¬Æ venetoclax,Marketbit.pro,Negative
 ¬Æ venetoclax,HEDGE accordinglyüìà,Positive
 ¬Æ venetoclax,CRE Demographics,Positive
 ¬Æ venetoclax,Today's News,Positive
 ¬Æ venetoclax,Lymphoma Hub,Negative
 Business WireInnoCare,Sarang Pokhare,Negative
 RelapsedRefractory Chronic Lymphocytic,Crwe World,Negative
 RelapsedRefractory Chronic Lymphocytic,LLZ Consulting,Negative
 RelapsedRefractory Chronic Lymphocytic,Cancer Library VCC,Positive
 RelapsedRefractory Chronic Lymphocytic,sandrineman,Negative
 RelapsedRefractory Chronic Lymphocytic,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Positive
 RelapsedRefractory Chronic Lymphocytic,Dr. Melody Davis,Negative
 RelapsedRefractory Chronic Lymphocytic,IntoxicatedTrader,Positive
 RelapsedRefractory Chronic Lymphocytic,Hematopoiesis News,Negative
 Duration VenetoclaxObinutuzumab Therapy Effective MRD Eradication,Oncology Times,Negative
 FixedDuration IbrutinibVenetoclax,Oncology,Positive
 Promising FirstLine Option,Oncology,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Oncology,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Cancer Trials Support Unit,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Anju,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,ClinicalTrialsData,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,SPI News,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Oncology Times,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,CRE Demographics,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Verastem Oncology,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Latest News from Business Wire,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Advera Health,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Medicalnewser.com,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,New Drug Approvals,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Drugs.com,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,EIN Presswire: Lung Cancer Newswire,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,FDA Daily,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Cancer Papers,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Lymphoma Papers,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,NeuroStemCells,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Oncology Board,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,$Stocknewsalerts,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,SNN Network,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,BioRunUp,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,CamTheMan,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,BusinessWireProducts,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Business Wire-Health,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,BusinessWire-Science,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,The Pharmaceutical Marketing Group,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Marlowe S Tessmer,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,MDRing,Negative
 New FollowUp Data Highlights Venetoclax Treatment,Oncology Times,Positive
 Chronic Lymphocytic Leukemia B cell,iScience journal,Positive
 Derived TNFŒ±,iScience journal,Positive
 Impairs Bone Marrow Myelopoiesis,iScience journal,Positive
 amp Young Adults,Oncology Times,Negative
 huCARTIL,TrialBulletin,Negative
 NHLCLL Patients Status,TrialBulletin,Negative
 Condition Summary Chronic Lymphocytic Leukemia Nonhodgkin Lymphoma,TrialBulletin,Negative
 FDA Approves Riabni rituximabarrx,Dr. Mihir,Positive
 Amgen Riabni rituximabarrx,Dr. Mihir,Positive
 ASH   FixedDuration IbrutinibVenetoclax,Oncology,Negative
 FirstLine Option,Oncology,Negative
 ASH   combination therapies,VJHemOnc,Negative
 w John Allan,VJHemOnc,Negative
 FixedDuration ImbruvicaVenclexta Combo Benefits People,Hematology,Positive
 FixedDuration ImbruvicaVenclexta Combo Benefits People,Cancer Health,Negative
 Chronic Lymphocytic tcouTYjogpLa,Hematology,Positive
 yearold patient,Targeted Oncology,Positive
 yearold patient,Anna Ercilla,Positive
 yearold patient,Ty Fraser,Positive
 yearold patient,BourgeoisBohemianüîØ,Positive
 yearold patient,IFLScience,Positive
 Year Analysis,OncLive.com,Negative
 MURANO Study,OncLive.com,Negative
 Evidence,Victor Lin,Positive
 Evidence,CAR-TCR,Positive
 Evidence,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Evidence,Jordan Gauthier,Positive
 Evidence,Anthony Mato,Negative
 Evidence,Monterey Holistic,Negative
 Evidence,Matthews & Associates,Negative
 Evidence,"Raul Cordoba, MD, PhD",Negative
 Evidence,HealthyBuilds West Palm,Positive
 Evidence,IDA Construction,Positive
 Evidence,Sanders Inc.,Positive
 Evidence,"Stephanie Zimmerman, MSN",Positive
 Evidence,Paul Scolardi,Positive
 BRUIN Clinical Trial,Oncology Times,Negative
 BRUIN Clinical Trial,Pharma News,Negative
 BRUIN Clinical Trial,IMPharma News,Negative
 BRUIN Clinical Trial,Investor News,Negative
 BRUIN Clinical Trial,"OTC Dynamics, Inc.",Negative
 BRUIN Clinical Trial,Bio Stocks‚Ñ¢,Negative
 BRUIN Clinical Trial,Stock Titan,Negative
 Changes,Blood Journal,Negative
 Changes,Michele Nadeem-Baker,Negative
 Changes,CLL Advocates Network,Negative
 Changes,CLL Ireland,Positive
 Changes,Oncology Tube,Negative
 Changes,MDRing,Negative
 Changes,Cary Higgins,Positive
 Bcl members,Blood Journal,Negative
 Bcl members,"Raul Cordoba, MD, PhD",Negative
 LowDose,Cells MDPI,Positive
 Minimal,Cells MDPI,Positive
 Poor   IGHV,Cells MDPI,Positive
   Drug Trial news,Michele Nadeem-Baker,Negative
 Dr Anthony Mato LOXO,Michele Nadeem-Baker,Negative
 seasons greetings,Michael Hallek,Negative
 friends,Michael Hallek,Positive
 friends,CLLSA,Negative
 friends,CLL Ireland,Positive
 friends,Michael Rynne,Positive
 friends,Patient Power,Positive
 friends,Esther Schorr,Positive
 friends,CLL Society Inc.,Negative
 friends,Eduardo Flavio Oliveira Ribeiro,Negative
 friends,Fabrice Leclerc,Negative
 friends,Michele Nadeem-Baker,Negative
 friends,Derriford Hospital,Negative
 friends,University Hospitals Plymouth NHS Trust,Negative
 friends,Nick,Negative
 friends,LymphomaAction,Negative
 friends,Marek Trneny,Positive
 friends,Lymphoma SA,Positive
 friends,Lymphoma Research Foundation,Negative
 friends,Zack Pemberton-Whiteley,Negative
 friends,CaturLifeLive,Positive
 Restriction requirements,CLL Ireland,Negative
 England Scotland,CLL Ireland,Negative
 ASHASTCT,CLL Society Inc.,Negative
 Vaccines,CLL Society Inc.,Negative
 Questions      ASHs FAQs,CLL Society Inc.,Negative
 CLL Dr Wiestner,CLL Society Inc.,Negative
 Nextgeneration,OncLive.com,Negative
 Bruton Tyrosine Kinase inhibitors,OncLive.com,Negative
 chimeric antigen receptor Tcell therapy,OncLive.com,Negative
 chimeric antigen receptor Tcell therapy,@Clinical Practice,Positive
 chimeric antigen receptor Tcell therapy,Clinical Practice,Positive
 chimeric antigen receptor Tcell therapy,Targeted Oncology,Negative
 dad,crafti,Positive
 dad,Blood Cancer UK,Negative
 dad,The Leukemia & Lymphoma Society,Negative
 dad,Heather Dorosh,Positive
 dad,Anastasia Turchetta,Positive
 dad,Tim James,Positive
 dad,James Nova,Positive
 dad,Marty needs a new handle,Positive
 dad,hematologist,Negative
 dad,Keri Carpenter,Positive
 dad,üáß‚Äãüá¥üá¨‚Äãüá©üá¶üá≥ÀÅ(‚¶ø·¥•‚¶ø)ÀÄ,Positive
 Umbralisibublituximab,i3 Health,Negative
   strength,Michele Nadeem-Baker,Negative
 CLL dedifferentiation,Blood Advances,Negative
 Alemtuzumab,Tweemol,Positive
 Alemtuzumab,COPD News,Negative
 Alemtuzumab,Benlazar S.M Amin√©,Negative
 Alemtuzumab,PharmaFactz,Negative
 Alemtuzumab,Mohamed Elamin Awad,Positive
 Coronary Arteries,Paperbirds_Hematology,Positive
 Coronary Arteries,Lymphoma Papers,Negative
 Incidental Autopsy Finding,Paperbirds_Hematology,Negative
 Novel CDROR Assay,Paperbirds_Hematology,Negative
 interface,CCO Infectious Disease,Positive
 amp „Éº pandemic,CCO Infectious Disease,Positive
 expert answers,CCO Infectious Disease,Positive
 FAQs,CCO Infectious Disease,Positive
 FAQs,CLL Advocates Network,Negative
 COVID outcomes,CCO Infectious Disease,Positive
 CLL treatments,CCO Infectious Disease,Positive
 CLL treatments,Esther Schorr,Negative
 CLL treatments,Healthguru,Positive
 CLL treatments,ecancer,Negative
 pandemic BTK amp PIK inhibition,CCO Infectious Disease,Positive
 Mmmmm,Shouting at people in my underpants,Negative
   highlight video,JADPRO,Negative
 Sara Tinsley PhD APRN AOCN,JADPRO,Positive
 Sara Tinsley PhD APRN AOCN,APSHO,Negative
 Moffitt Cancer Center,JADPRO,Negative
 Moffitt Cancer Center,Targeted Oncology,Negative
 MURANO study findings,JADPRO,Negative
 Monday blues,i3 Health,Negative
 motivation,i3 Health,Negative
 words,AbbVie UK,Positive
 words,Robert Z. Orlowski,Negative
 words,Katrina Sondermann,Positive
 words,Broad Institute,Positive
 words,Malachy Chidera,Positive
 words,CLL Warwick Uni,Negative
 wisdom,AbbVie UK,Positive
 wisdom,Connie Erpelding,Positive
 Norah,AbbVie UK,Positive
 CLL Stories,AbbVie UK,Positive
 Ab,Paperbirds_Hematology,Negative
 Spillover Compensation,Paperbirds_Hematology,Negative
 CyTOF Data,Paperbirds_Hematology,Negative
 Untreated Patients,Oncology,Negative
 Untreated Patients,IMPharma News,Negative
 Untreated Patients,1stOncology,Negative
 Untreated Patients,MasdelMedio,Negative
 Untreated Patients,NwokeAgulu,Negative
 Untreated Patients,Stock Titan,Negative
 Untreated Patients,The ASCO Post,Negative
 C category,Andrew Schorr,Negative
 vaccine distribution,Andrew Schorr,Negative
 duvelisib,Benlazar S.M Amin√©,Negative
 duvelisib,OncLive SOSS,Positive
 duvelisib,Anna Deveau,Negative
 duvelisib,Targeted Oncology,Positive
 duvelisib,Medivizor,Negative
 duvelisib,Marek Trneny,Positive
 duvelisib,MAISA,Negative
 duvelisib,New Drug Approvals,Negative
 duvelisib,Drugs.com,Negative
 duvelisib,VuMedi Oncology,Positive
 duvelisib,Verastem Oncology,Negative
 duvelisib,Don Seiffert,Positive
 FCR DFCR,Benlazar S.M Amin√©,Negative
 National Institutes,Non-GMO Report,Positive
 National Institutes,GO GREEN,Positive
 frontline targeted therapies,OncLive SOSS,Positive
 frontline targeted therapies,OncLive.com,Negative
 faces,CLL Ireland,Negative
 faces,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 world experts,CLL Ireland,Positive
 Hermed   specifikt nyhedsbrev,LyLe Foreningen,Negative
 hvor,LyLe Foreningen,Negative
 LYLE udtaler sig,LyLe Foreningen,Negative
 udgivet,LyLe Foreningen,Negative
 rescue dog,AbbVie UK,Positive
 CLL w Kerry Rogers,VJHemOnc,Negative
 Systems biology drug screening,Lymphoma Papers,Negative
 Systems biology drug screening,Oncology & Machine Learning,Positive
 statins,Lymphoma Papers,Negative
 statins,Oncology & Machine Learning,Positive
 enhancers,Lymphoma Papers,Negative
 enhancers,Oncology & Machine Learning,Positive
 Erlene Seymour MD,OncLive SOSS,Positive
 Erlene Seymour MD,OncLive.com,Negative
    reviewREGISTER,VJHemOnc,Negative
 premature,Toby Eyre,Negative
 dc,Toby Eyre,Negative
 VRlty ‚¨á Ô∏è PFS,Toby Eyre,Negative
 prem,Toby Eyre,Negative
 reason,Toby Eyre,Negative
 reason,MyPathologyReport.ca,Negative
 reason,NCI Media Relations,Positive
 reason,Biotech2050,Positive
 reason,CLL Ireland,Negative
 reason,ACS Journal Cancer,Negative
 reason,Sam,Positive
 AEInterrupt,Toby Eyre,Negative
 AE,Toby Eyre,Negative
 PFSOSTox mxcontinued Rx,Toby Eyre,Negative
 VenR PFS outcome,Toby Eyre,Negative
 Speakers,Nikita Mehra,Positive
 Speakers,Society of Hematologic Oncology (SOHO),Positive
 Speakers,Gill Budgell,Positive
 Speakers,Carmine DeLuca,Negative
 MD Anderson TX PGIMER Chandigarh,Nikita Mehra,Positive
 AIIMS New DelhiThe Zoom link,Nikita Mehra,Positive
 Slides,Nitin Jain,Negative
 Slides,"chadi nabhan MD, MBA, FACP",Negative
 updates,Nitin Jain,Positive
 updates,"Jennifer Crombie, MD",Positive
 updates,OncLive.com,Negative
 updates,Current Oncology,Negative
 updates,VJHemOnc,Positive
 updates,filippo masini,Negative
 updates,CLL Ireland,Negative
 updates,The Tisch Cancer Institute,Positive
 updates,Duke Hematologic Malignancies & Cellular Therapy,Negative
 updates,ATOPP Summit,Positive
 updates,Michael Rynne,Negative
 updates,Dana-Farber,Negative
 updates,Toby Eyre,Negative
 updates,Oncology State Societies at ACCC,Negative
 updates,Patient Power,Positive
 updates,Leukaemia Care,Negative
 updates,Targeted Oncology,Negative
 updates,Anthony Mato,Negative
 updates,iwCLL,Negative
 updates,Canadian Hematology,Positive
 updates,The James,Negative
 updates,CARE‚Ñ¢ Education,Negative
 updates,ASH,Negative
 updates,The Levy Library at Icahn School of Medicine,Positive
 updates,Michele Nadeem-Baker,Negative
 TP polymorphisms,Paperbirds_Hematology,Negative
 chemotherapyfree treatments,Medivizor,Positive
 chemotherapyfree treatments,HHF,Negative
 treatment na√Øve chronic,Medivizor,Negative
 IMBRUVICA,IMPharma News,Positive
 IMBRUVICA,Company News HQ,Positive
 IMBRUVICA,Investor Press Releases,Positive
 IMBRUVICA,NwokeAgulu,Positive
 IMBRUVICA,mednetnews,Positive
 IMBRUVICA,Stock Market News,Positive
 IMBRUVICA,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Positive
 IMBRUVICA,MasdelMedio,Positive
 IMBRUVICA,HEDGE accordinglyüìà,Positive
 IMBRUVICA,Saeed Valadbaygi,Positive
 IMBRUVICA,Crwe World,Positive
 IMBRUVICA,Simple Charts,Negative
 IMBRUVICA,VPO/PR Newswire,Positive
 IMBRUVICA,pressdaily,Positive
 IMBRUVICA,Alicia Bell IFBB Pro,Negative
 IMBRUVICA,Bio Stocks‚Ñ¢,Positive
 IMBRUVICA,RazzleTazzle,Positive
 IMBRUVICA,ChemDiv,Positive
 IMBRUVICA,PRICENTRIC,Positive
 IMBRUVICA,Financial Buzz,Positive
 IMBRUVICA,CRE Demographics,Positive
 IMBRUVICA,OBR,Negative
 IMBRUVICA,Odi Bruckman,Positive
 IMBRUVICA,Hotstocks.nyc,Positive
 IMBRUVICA,Marketbit.pro,Negative
 IMBRUVICA,Pf Magazine,Negative
 IMBRUVICA,TalkingScarsMedia.com,Positive
 IMBRUVICA,Autotestdrivers.com,Positive
 IMBRUVICA,MineListings.com,Positive
 IMBRUVICA,IntoxicatedTrader,Positive
 IMBRUVICA,ShareHRnews,Positive
 IMBRUVICA,iTruck NEWS,Positive
 IMBRUVICA,Mr Slot,Positive
 IMBRUVICA,Seattle's Banker,Negative
 IMBRUVICA,Newmoney210,Negative
 IMBRUVICA,Hottest Stocks Now,Negative
 IMBRUVICA,Anna Deveau,Negative
 IMBRUVICA,Ana Laura Caballero,Positive
 IMBRUVICA,Dr. Melody Davis,Negative
 IMBRUVICA,NeuroBrain,Positive
 IMBRUVICA,TEKGROUP Healthcare News,Positive
 IMBRUVICA,satPRnews,Positive
 IMBRUVICA,EMJ Hematology,Negative
 IMBRUVICA,ComplexPharm,Positive
 IMBRUVICA,Pharmaceutical News,Negative
 IMBRUVICA,NACDA Program on Aging,Negative
 IMBRUVICA,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",Positive
 IMBRUVICA,"Pharmacyclics, an AbbVie Company",Negative
 IMBRUVICA,MedFirst - MedComms,Positive
 IMBRUVICA,PharmaLeaders,Negative
 IMBRUVICA,gilbert c faure,Negative
 IMBRUVICA,Pharmaceutical Mkt,Positive
 IMBRUVICA,American Preclinical,Negative
 IMBRUVICA,Headcount,Positive
 IMBRUVICA,eyeonfda,Positive
 IMBRUVICA,Beyond the Pill 2015,Positive
 IMBRUVICA,pharmabr,Negative
 IMBRUVICA,PISPOpharma,Positive
 IMBRUVICA,Fleming. Pharma,Positive
 IMBRUVICA,Pharma Industry News,Positive
 IMBRUVICA,Danvantri Farma,Negative
 IMBRUVICA,Diaceutics PLC,Positive
 IMBRUVICA,MAISA,Negative
 IMBRUVICA,Briefing.com,Negative
 IMBRUVICA,NEWS.GNOM.ES,Negative
 IMBRUVICA,Cord Blood News,Negative
 IMBRUVICA,aeses.com,Negative
 IMBRUVICA,DatZoom PR,Positive
 IMBRUVICA,JanssenUS,Negative
 IMBRUVICA,PRN Biotech,Negative
 IMBRUVICA,Penny Stock Irish,Negative
 IMBRUVICA,Ez2Trade,Negative
 IMBRUVICA,Penny Stocks,Negative
 IMBRUVICA,SPEC,Positive
 IMBRUVICA,truebluetribune,Positive
 IMBRUVICA,Michelet St. Preuve,Positive
 IMBRUVICA,Scott Werntz,Positive
 IMBRUVICA,"Tom Iarocci, MD",Negative
 IMBRUVICA,Dr. Leona Saunders,Positive
 VENCLEXTA,IMPharma News,Negative
 VENCLEXTA,MasdelMedio,Positive
 VENCLEXTA,NwokeAgulu,Negative
 VENCLEXTA,Stock Titan,Negative
 VENCLEXTA,PSK2329 - JHC,Negative
 VENCLEXTA,Quant Data,Positive
 VENCLEXTA,Alicia Bell IFBB Pro,Positive
 VENCLEXTA,Matt Fanning,Positive
 VENCLEXTA,Crwe World,Positive
 VENCLEXTA,SC,Positive
 VENCLEXTA,LLZ Consulting,Negative
 VENCLEXTA,Saeed Valadbaygi,Positive
 VENCLEXTA,Stock Market News,Negative
 VENCLEXTA,Simple Charts,Positive
 VENCLEXTA,pressdaily,Positive
 VENCLEXTA,Pharma News,Positive
 VENCLEXTA,Company News HQ,Negative
 VENCLEXTA,VPO/PR Newswire,Positive
 VENCLEXTA,Thanasis Chalikias,Positive
 VENCLEXTA,RazzleTazzle,Positive
 VENCLEXTA,FDA Daily,Positive
 VENCLEXTA,HempNews,Negative
 VENCLEXTA,Financial Buzz,Positive
 VENCLEXTA,Seattle's Banker,Negative
 VENCLEXTA,Laurent G - Francis,Negative
 VENCLEXTA,Marketbit.pro,Negative
 VENCLEXTA,CRE Demographics,Positive
 VENCLEXTA,HRI Portal,Negative
 VENCLEXTA,Ro Patel,Positive
 VENCLEXTA,Rob Wilson,Positive
 VENCLEXTA,AmericanPharmacyNews,Negative
 VENCLEXTA,aeses.com,Negative
 VENCLEXTA,christopher franskin,Positive
 VENCLEXTA,Autotestdrivers.com,Positive
 VENCLEXTA,TalkingScarsMedia.com,Positive
 VENCLEXTA,ShareHRnews,Positive
 VENCLEXTA,Biedex Markets,Positive
 VENCLEXTA,Odi Bruckman,Negative
 VENCLEXTA,Pharmaceutical News,Negative
 VENCLEXTA,ZoZoTrader,Positive
 VENCLEXTA,vincenzo abruscato,Positive
 venetoclax Combination,IMPharma News,Negative
 venetoclax Combination,MasdelMedio,Negative
 venetoclax Combination,NwokeAgulu,Negative
 venetoclax Combination,Stock Titan,Negative
 High Rates,IMPharma News,Negative
 High Rates,1stOncology,Negative
 High Rates,MasdelMedio,Negative
 High Rates,NwokeAgulu,Negative
 High Rates,Stock Titan,Negative
 High Rates,OncLive.com,Negative
 High Rates,CellworksLife,Negative
 High Rates,Saeed Valadbaygi,Negative
 High Rates,SpecialtyPTimes,Negative
 DiseaseFree Survival Year PostTreatment,IMPharma News,Negative
 DiseaseFree Survival Year PostTreatment,1stOncology,Negative
 DiseaseFree Survival Year PostTreatment,MasdelMedio,Negative
 DiseaseFree Survival Year PostTreatment,NwokeAgulu,Negative
 DiseaseFree Survival Year PostTreatment,Stock Titan,Negative
 Tumor lysis syndrome,Nabil Omar,Positive
 Tumor lysis syndrome,Abdulqadir Nashwan,Positive
 Tumor lysis syndrome,Hematology Advisor,Negative
 Tumor lysis syndrome,VJHemOnc,Negative
   Impact TimeLimited Therapy,Patient Empowerment Network,Negative
 biosimilar,Targeted Oncology,Negative
 biosimilar,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 biosimilar,Oncology Nursing News,Negative
 biosimilar,"Brand Institute, Inc",Negative
 biosimilar,The Cancer Letter,Negative
 biosimilar,Lymphoma Research Foundation,Negative
 biosimilar,Horizon Oncology,Positive
 biosimilar,Oncology Times,Negative
 biosimilar,Yo-Bio,Positive
 biosimilar,The PMI (Pharmaceutical Managers' Institute),Negative
 biosimilar,DennisPartners,Negative
 biosimilar,Bionest Partners,Negative
    CLL Doc,Michele Nadeem-Baker,Negative
 assortment,WCM Lymphoma,Negative
 NEW   survivor,Patient Power,Negative
 advice,Patient Power,Positive
 advice,Patient Empowerment Network,Negative
 advice,CLL Advocates Network,Negative
 advice,Gear√≥id √ì Crotaigh #CareCantWait,Negative
 advice,CLL Ireland,Negative
 advice,Healthguru,Positive
 advice,AbbVie,Negative
 advice,Leukaemia Care,Negative
 advice,VJHemOnc,Negative
 advice,ColumbiaCancer,Positive
 rituximabarrx Riabni,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Case Report Chronic Lymphocytic Leukemia,CLL-seq,Negative
 Rare Translocation tqq,CLL-seq,Negative
 Rare Translocation tqq,Paperbirds_Hematology,Negative
 IGHBCL Rearrangements Report,CLL-seq,Negative
 IGHBCL Rearrangements Report,Paperbirds_Hematology,Negative
 Mabtas RA mg Injection,MCare Exports,Positive
 New article Case Report,Paperbirds_Hematology,Negative
 New article Monitoring,Paperbirds_Hematology,Negative
 Complement System Status,Paperbirds_Hematology,Negative
 BCL,Paperbirds_Hematology,Positive
 BCL,"Chaitra Ujjani, MD",Positive
 BCL,VJHemOnc,Negative
 BCL,MD Anderson Leukemia,Negative
 BCL,OncLive.com,Negative
 BCL,Kevin Wolcott,Positive
 BCL,Lymphoma Papers,Negative
 BCL,Dene Peters,Positive
 BCL,Suvir Singh,Positive
 BCL,Medscape Oncology,Negative
 BCL,LabRoots,Positive
 BCL,"Mike Thompson, MD, PhD, FASCO",Negative
 BCL,"Dr T. Comeau , MD",Negative
 BCL,Lymphoma Hub,Negative
 BCL,Cancer Papers,Negative
 BCL,Clin Adv Hem Onc,Negative
 BCL,Oncology Tube,Negative
 BCL,AU Oncology Reviews,Negative
 BCL,@sehh_es,Positive
 BCL,ASH,Positive
 BCL,BioWorld,Positive
 BCL,Krishan Maggon,Negative
 BCL,Medelis: OncologyCRO,Positive
 BCL,IntoxicatedTrader,Negative
 BCL,Tom,Positive
 BCL,doctorportal,Positive
 BCL,Jean Plante,Negative
 BCL,Saudi Leukemia Net,Negative
 BCL,Sonia Glez Costas,Positive
 BCL,Jos√© Clemente D√≠az M,Negative
 BCL,Bitlattice Woman,Positive
 BCL,EUFUCKBACK2,Positive
 BCL,"Jason Westin, MD FACP",Positive
 BCL,La chuleta del FIR,Negative
 BCL,Armand!!,Negative
 BCL,Christopher Steer,Negative
 BCL,Shankara Paneesha,Positive
 BCL,NEJM,Positive
 BCL,Tapan Kadia,Negative
 BCL,Tim Fenske,Negative
 BCL,Senology,Positive
 BCL,rattenniMD,Negative
 BCL,Tom Heston,Negative
 BCL,Stan Whittaker,Positive
 BCL,Â∞èÊöÆ„ÅÆ„Ç´„Ç∫„ÇÑ„Çì,Positive
 BCL,FarmaOnco,Negative
 BCL,Hojoon Choi,Positive
 BCL,Pharm Digest,Negative
 BCL,KevinFitts,Negative
 BCL,Gioacchino Catania,Positive
 BCL,The Medical Ed Cons.,Negative
 BCL,Miguel Perales M.D.,Negative
 BCL,Muzaffar Qazilbash,Negative
 association,Paperbirds_Hematology,Positive
 association,THE NORTHCAP UNIV,Positive
 association,IDIVAL Direccion,Positive
 association,"Andrea Romanos-Nanclares, MS, BS üá™üá∏",Positive
 association,ImmunologyPapers,Negative
 association,Cancer Papers,Negative
 association,JAAD Journals,Positive
 association,Prof John,Negative
 association,JNCI,Negative
 association,Int J Dermatology,Negative
 outcome,Paperbirds_Hematology,Negative
 outcome,palliativewise,Positive
 outcome,ACS Journal Cancer,Positive
 outcome,CLLSA,Negative
 outcome,Benlazar S.M Amin√©,Negative
 outcome,"Raul Cordoba, MD, PhD",Positive
 outcome,Mahmoud Aljurf,Negative
 outcome,CLL_Fightersüéó,Negative
 outcome,VJHemOnc,Negative
 outcome,Elsevier Hematology,Positive
 outcome,NK cell Biology,Negative
 outcome,NK papers,Negative
 outcome,BVirtual Murciasalud,Negative
 outcome,MarlaJan- Luck Fupus,Positive
 outcome,ImmunologyPapers,Negative
 outcome,TumorImmunoPapers,Negative
 Rituxan biosimilar Riabni,CURE Magazine,Negative
 Chronic Lymphocytic Leukemia Biological,Benlazar S.M Amin√©,Negative
 Chronic Lymphocytic Leukemia Biological,Lymphoma Papers,Negative
 tcoPOanLRWT,Benlazar S.M Amin√©,Negative
   Changes,"Raul Cordoba, MD, PhD",Negative
 Hey guys,Kathleen Casey,Positive
 Hey guys,karla,Positive
 WATCH   experts Dr Stacey Gray,Patient Power,Negative
   Phase II   study update,Journal of the @NCCN,Negative
 NEW   Research,Oncology Times,Negative
 ‚Äú Soccer ball ‚Äù chromatin,"David B. Wilson, MD",Positive
 PEN Chronic Lymphocytic Leukemia,Patient Empowerment Network,Negative
 Network Manager Volleen White,Patient Empowerment Network,Negative
 CLL patient,Patient Empowerment Network,Positive
 CLL patient,Andrew Schorr,Positive
 CLL patient,CLL Society Inc.,Negative
 CLL patient,Patient Power,Negative
 CLL patient,Toula Castillo,Positive
 CLL patient,Medical Web Times,Negative
 CLL patient,VJHemOnc,Negative
 Fiveyear followup data,CURE Magazine,Negative
 Venclexta,CURE Magazine,Positive
 Venclexta,Helix BioPharma,Positive
 Venclexta,Patient Power,Negative
 Venclexta,PER,Negative
 Venclexta,Cancer Health,Negative
 Venclexta,"Robinson Ortiz, MD",Positive
 Venclexta,PressReleasePoint,Positive
 Venclexta,Pharmacutical Daily,Positive
 Venclexta,Crwe World,Positive
 Venclexta,Flash Alert,Positive
 Venclexta,The Cancer Letter,Negative
 Venclexta,Bionest Partners,Positive
 Venclexta,ipharmacenter,Negative
 Venclexta,The Pharmaceutical Marketing Group,Positive
 Venclexta,oncohebdo,Positive
 Venclexta,FDA Daily,Positive
 Venclexta,Armando Guglielmetti,Positive
 Venclexta,Sharon Johnson,Positive
 Venclexta,The Galien Foundation,Positive
 Venclexta,AA&MDSIF,Positive
 Venclexta,CLL Society Inc.,Negative
 Venclexta,cafepharma,Negative
 Venclexta,Latest News from Business Wire,Negative
 Venclexta,Advera Health,Positive
 Venclexta,Financial Buzz,Positive
 Venclexta,T Allen,Positive
 Venclexta,MAISA,Negative
 Venclexta,Andrew Schorr,Positive
 Venclexta,Hematopoiesis News,Positive
 Venclexta,Blood-Cancer.com,Positive
 Venclexta,Medicalnewser.com,Negative
 Venclexta,Connie Hampton,Positive
 Venclexta,Rare Diseases,Negative
 Venclexta,Lymphoma Hub,Negative
 Venclexta,Pharma Commons,Negative
 Venclexta,DennisPartners,Negative
 Venclexta,ANTELLIS,Positive
 Venclexta,Anand Rotte,Positive
 Venclexta,RTCP24 NEWS‚Ñ¢,Positive
 Venclexta,Health|VBProfiles,Positive
 Venclexta,Business Wire-Health,Negative
 Venclexta,Business Wire-TS,Negative
 Venclexta,BusinessWireConsumer,Positive
 Venclexta,Dr. Leona Saunders,Positive
 Venclexta,Village Pharmacy,Positive
 Venclexta,Focus on Cancer,Positive
 Venclexta,Station X,Positive
 Venclexta,Lampe & Company,Negative
 Venclexta,Cord Blood News,Negative
 Venclexta,CancerConnect,Negative
 Venclexta,NACDA Program on Aging,Negative
 Venclexta,Lymphoma News Today,Negative
 Venclexta,"Pragnesh Panchamvedi, RAC, ERT",Negative
 Venclexta,Biologics by McKesson,Negative
 Venclexta,Cyndie Annett,Positive
 Venclexta,Pharmafocus,Negative
 Venclexta,the world of CROs,Negative
 Venclexta,Jon Angelo,Negative
 Venclexta,Russell Roberts,Positive
 Venclexta,Doctors Lounge,Negative
 Rituxan,CURE Magazine,Negative
 Rituxan,Cancer Health,Negative
 Rituxan,Bionest Partners,Negative
 Rituxan,MEDWAVE,Negative
 Rituxan,Hematopoiesis News,Negative
 Rituxan,Medicalnewser.com,Negative
 Rituxan,Connie Hampton,Positive
 Rituxan,FDA Daily,Positive
 Rituxan,Rare Diseases,Negative
 Rituxan,Lymphoma Hub,Negative
 Rituxan,PressReleasePoint,Negative
 Rituxan,The Pharmaceutical Marketing Group,Positive
 Rituxan,Financial Buzz,Negative
 Rituxan,Pharma Commons,Negative
 Rituxan,DennisPartners,Negative
 Rituxan,ANTELLIS,Positive
 Rituxan,Armando Guglielmetti,Negative
 Rituxan,Anand Rotte,Positive
 Rituxan,Andrew Schorr,Negative
 Rituxan,MAISA,Positive
 Rituxan,"Neil Sankar M.D.,MPH",Positive
 Rituxan,Health|VBProfiles,Positive
 Rituxan,Business Wire-Health,Negative
 Rituxan,Business Wire-TS,Negative
 Rituxan,BusinessWireConsumer,Positive
 Rituxan,Crwe World,Negative
 Rituxan,Dr. Leona Saunders,Positive
 Rituxan,Odi Bruckman,Negative
 Rituxan,CancerConnect,Negative
 ONEHOUR REMINDER,ACCC,Positive
 guests,ACCC,Positive
 VACCINE,CLL Ireland,Negative
 umbralisibublituximab,i3 Health,Negative
 S,Cancer Trials Support Unit,Positive
 S,Clarivate Cortellis,Negative
 S,Gilles Gallant,Positive
 S,Cure Cancer Now,Negative
 EVOLVE CLLSLL,Cancer Trials Support Unit,Positive
 Study Testing,Cancer Trials Support Unit,Positive
 Newly Diagnosed Asymptomatic HighRisk Patients,Cancer Trials Support Unit,Positive
 CTSU members ‚Äô website,Cancer Trials Support Unit,Positive
 Downregulation,NK papers,Negative
 Downregulation,ClinChemINFO,Positive
 Lymphoid enhancerbinding factor,NK papers,Negative
 LEF expression,NK papers,Negative
 immunohistochemistry flow cytometry,NK papers,Negative
 chronic Lymphocytic Leukemia,NK papers,Negative
 chronic Lymphocytic Leukemia,Master Li,Positive
 chronic Lymphocytic Leukemia,Living Safely,Negative
 chronic lymphocyt,Medivizor,Positive
 Allison Winter MD,OncLive SOSS,Negative
 Allison Winter MD,OncLive.com,Negative
 Novel Insights,Oncology Tube,Negative
 Randomized Phase,Oncology Tube,Negative
 Randomized Phase,"Raul Cordoba, MD, PhD",Negative
 CLL Trial John Pagel MD          Link,Oncology Tube,Negative
 Patients Access,Patient Empowerment Network,Negative
 TGR,CURE Magazine,Negative
 TGR,ClinicalTrialsData,Positive
 TGR,Biotech2050,Positive
 TGR,"Raul Cordoba, MD, PhD",Negative
 TGR,VJHemOnc,Positive
 TGR,Orbis Biosciences,Negative
 TGR,Lymphomation.org,Negative
 TGR,Denver Greene,Positive
 TGR,Financial Buzz,Positive
 TGR,Dustin Phan,Positive
 TGR,Alyssa Howard,Positive
 TGR,biotechnologies,Positive
 TGR,Odi Bruckman,Positive
 TGR,SPI News,Negative
 TGR,Bio Stocks‚Ñ¢,Positive
 TGR,Clinical Leader,Positive
 TGR,INN Life Science,Positive
 TGR,MAISA,Negative
 TGR,Danvantri Farma,Negative
 TGR,Stock Advisor,Positive
 TGR,karin55marin,Negative
 TGR,NYC Social Group,Negative
 TGR,Cedar Consultants,Negative
 TGR,Krunox,Positive
 TGR,BioRunUp,Negative
 TGR,Timothy Kelly,Positive
 TGR,John Stock Pro,Positive
 TGR,satPRnews,Negative
 TGR,StockGuru,Negative
 encouraging rate,CURE Magazine,Negative
 New article Response assessment,Paperbirds_Hematology,Negative
 New Skin Manifestation,Paperbirds_Hematology,Negative
 Site,Paperbirds_Hematology,Negative
 Previously Healed Dermatosis Case,Paperbirds_Hematology,Negative
 Wolfs Isotopic Response,Paperbirds_Hematology,Negative
 ASH Highlights,MEDtalks CH,Positive
 December,MEDtalks CH,Positive
 December,Flash Alert,Positive
 December,Anna Deveau,Positive
 December,CLL Ireland,Negative
 December,Cancer News,Negative
 December,CRO Contract Res.,Negative
 December,MediCom Oncology,Negative
 December,Managing Myeloma,Negative
 December,Bill Rodgers,Negative
 December,Survival Plan Kits,Negative
 Handy   vaccine QampA,CLLSA,Negative
 der,MedMedia,Positive
 der,Krebsgesellschaft,Positive
 der,AbbVie Schweiz,Positive
 der,Pharma Fakten,Positive
 der,Deutsches √Ñrzteblatt,Positive
 Chronic Lymphocytic Leukemia Treatment Market,Depp Gaikwad,Positive
 Chronic Lymphocytic Leukemia Treatment Market,Science Examiner,Positive
 Chronic Lymphocytic Leukemia Treatment Market,Kiran Bhole,Positive
 Chronic Lymphocytic Leukemia Treatment Market,Sheetal,Positive
 Chronic Lymphocytic Leukemia Treatment Market,PressRelease.cc,Negative
 Outstanding Growth,Depp Gaikwad,Positive
 Ublituximab Doublet Bests Chemoimmunotherapy,Oncology Board,Negative
 Targeted Oncology Ublituximab Doublet Bests Chemoimmunotherapy,Oncology Board,Negative
 YouTube,Kenneth M. Garofalo,Positive
 Nitin Jain MD,Lisa Palacios,Negative
 Nitin Jain MD,MD Anderson Leukemia,Positive
 Nitin Jain MD,Oncology Learning Network,Positive
 LisoCel,Lisa Palacios,Negative
 LisoCel,OncLive.com,Negative
 RR SLL,Lisa Palacios,Negative
 therapies impact patient care ¬† Dr Jennifer Woyach,Patient Empowerment Network,Negative
 CLL Clinical Trials,Patient Empowerment Network,Negative
 CLL Clinical Trials,TrialSite News,Negative
 New    tools,HeartcoR Solutions,Positive
 Current CLL Treatment Approaches,Patient Empowerment Network,Negative
 Join Lymphoma Canada,Survivor Network CA,Positive
 Dec   PMPM,Hematology Cancer Consortium,Positive
 Imbruvica treatment,CURE Magazine,Negative
 Chronic Lymphocytic Leukemia Market New Business Experts Ideas,Stem Cells in the News,Positive
 Ono pharmaceuticals,Stem Cells in the News,Positive
 Congratulations Dr Yvonne Gomez,PSJA Jefferson TSTEM,Positive
 Latest Research,Patient Power,Negative
 Latest Research,Danish hussain,Positive
 Combination Therapy,Patient Power,Negative
 Combination Therapy,Saeed Valadbaygi,Negative
 Combination Therapy,PharmaShots - Incisive news in 3 shots,Negative
 Combination Therapy,Oncology Tube,Negative
 Combination Therapy,Scott Merville,Negative
 Combination Therapy,The Purple Society,Negative
 Combination Therapy,Professione Farmacia,Negative
 Combination Therapy,Pharmacy Edge,Positive
 Combination Therapy,Pharmacy Times,Positive
 Combination Therapy,Oncology Times,Positive
 Combination Therapy,Financial Buzz,Negative
 immunotherapies,Patient Power,Negative
 atnm,Bubbafox,Positive
   s,Wilmot Cancer Institute,Positive
   s,American Pharma Outsourcing,Positive
   s,RTI Health Solutions,Negative
   s,Patient Power,Negative
 Dr Paul Barr,Wilmot Cancer Institute,Negative
 Dr Paul Barr,Michael Rynne,Negative
 Dr Paul Barr,CLL Ireland,Negative
 Dr Paul Barr,Andrew Schorr,Positive
 Dr Paul Barr,CLL Society Inc.,Negative
 Novel Agents,Timesnest,Positive
 Novel Agents,The Oncologist,Negative
 Novel Agents,Oncology Board,Negative
 Novel Agents,HAM,Negative
 Novel Agents,CancerWallonia,Positive
 Novel Agents,Medscape Education,Negative
 Novel Agents,ALI ALAHMARI.,Negative
 Novel Agents,Dow Diagnostics,Positive
 Novel Agents,Anthony Mato,Negative
 Novel Agents,JAMA Oncology,Positive
 Novel Agents,JAMA Network,Negative
 Novel Agents,Oncology Tube,Negative
 Novel Agents,AJMC,Negative
 Novel Agents,Lymphoma Coalition,Negative
 Download Kindle Medifocus Guidebook,Emily Grahamb,Positive
 Chronic Lymphocytic Leukemia gt,Emily Grahamb,Positive
 purplish skin nodules,Paperbirds_Hematology,Negative
 Firstline treatments,Psychiatry Intel,Positive
 Longitudinal CITESeq profiling,Transcriptomes,Positive
 Longitudinal CITESeq profiling,Paperbirds_Hematology,Negative
   years,OncologyNurseAdvisor,Negative
   years,Lymphoma Hub,Negative
   years,MD Anderson Cancer Center,Negative
   years,"chadi nabhan MD, MBA, FACP",Negative
   years,"Pharmacyclics, an AbbVie Company",Negative
   years,CLL Ireland,Positive
   years,California Partnership for Access to Treatment,Positive
   years,fiona olivier,Positive
   years,EMJ Hematology,Negative
   years,Francesco Turturro,Negative
 treatment response,OncologyNurseAdvisor,Negative
 treatment response,Journal of the @NCCN,Negative
 treatment response,Cancer Papers,Negative
 treatment response,VJHemOnc,Negative
 fixedtreatment duration,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 CLL analysis,OGT,Negative
 burden,OGT,Negative
 Oral Adherence,TrialBulletin,Negative
 Hematological Oncology Agents,TrialBulletin,Negative
 Comorbid Therapy Adherence Status,TrialBulletin,Negative
 Condition Summary Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Multiple Myeloma Multiple Chronic Conditions,TrialBulletin,Negative
 COVERAGE,Patient Power,Negative
 pair,SpecialtyPTimes,Negative
 pair,Vicente Torres,Positive
 treatmentfree remission,Lisa Palacios,Negative
 treatmentfree remission,HemOnc Today,Negative
 population‚Äêbased study,Biosimilar Today iMagazine,Positive
 Chronic Myeloid LeukemiaVisit,Clinical Oncology,Negative
 BNTX Phase,ClinicalTrialsData,Negative
 Pilot Study,ClinicalTrialsData,Negative
 Pilot Study,MD Anderson Leukemia,Negative
 Pilot Study,Lisa Palacios,Negative
 Personalized Neoantigen Cancer Vaccine,ClinicalTrialsData,Negative
 Personalized Neoantigen Cancer Vaccine,Anna Deveau,Negative
 LowDose Cyclophosphamide,ClinicalTrialsData,Negative
 Treatment Naive Asymptomatic Patients,ClinicalTrialsData,Negative
   Society ASH Day,CLL Society Inc.,Negative
 CDCAR T Cells,CLL Society Inc.,Negative
 Ascentage Pharma Announces Updates,Crwe World,Negative
 Ascentage Pharma Announces Updates,Pharma News,Negative
 Clinical Development,Crwe World,Negative
 Clinical Development,Pharma News,Negative
 APG,Crwe World,Negative
 APG,Pharma News,Negative
 APG,Targeted Oncology,Negative
 APG,TrialBulletin,Negative
 Drs John M Burke,Oncology CE,Positive
 Drs John M Burke,Vindico Medical Education,Positive
 amp Manuel Santiago,Oncology CE,Positive
 amp Manuel Santiago,Vindico Medical Education,Positive
 factors,Patient Empowerment Network,Positive
 factors,OncLive.com,Negative
 factors,OncLive SOSS,Negative
 factors,Patient Power,Positive
 factors,Zusia:Dr Jackie Volk,Positive
 factors,STTR Cancer,Positive
 factors,"chadi nabhan MD, MBA, FACP",Negative
 factors,Toby Eyre,Negative
 factors,Andrew Schorr,Positive
 factors,CLL Ireland,Negative
 factors,VJHemOnc,Negative
 factors,"Raul Cordoba, MD, PhD",Negative
   treatment decision,Patient Empowerment Network,Negative
 CLL Expert Answers Questions,Patient Power,Negative
 Vaccine amp,Patient Power,Negative
 Latest Cancer,Patient Power,Negative
 NewsDr Philip Thompson,Patient Power,Negative
 Dr Fauci,Patient Power,Negative
 immunocompromised patients,Patient Power,Negative
 Inh BTK LOXO,@investigando,Positive
 y linfoma linfoc√≠tico,@investigando,Positive
 podcastOur,CLL Ireland,Negative
 shares,CLL Ireland,Negative
 shares,Patient Empowerment Network,Negative
 shares,Patient Power,Positive
 shares,Jen Horonjeff üò∑ #askpatients,Positive
 difficulties,CLL Ireland,Positive
 Jacqueline Barrientos Feinstein Institutes,Lymphoma Hub,Negative
 combos gain,American Pharma Outsourcing,Positive
 steam,American Pharma Outsourcing,Positive
 steam,Bionest Partners,Negative
 steam,Helix BioPharma,Positive
 Chronic Lymphocytic   CLL,"Massive Bio, Inc.",Positive
 Chronic Lymphocytic   CLL,Cancer Library VCC,Positive
 Chronic Lymphocytic   CLL,CancerDartmouth,Negative
 Parexel Informatics,Calyx,Positive
 Residual Persistent,Calyx,Positive
 HEUTE,Kompetenznetz Maligne Lymphome e.V.,Positive
 KMLVideoberichte vom,Kompetenznetz Maligne Lymphome e.V.,Negative
 H√§matologen von,Kompetenznetz Maligne Lymphome e.V.,Negative
 √§tsmedizin,Kompetenznetz Maligne Lymphome e.V.,Negative
 √∂ttingen,Kompetenznetz Maligne Lymphome e.V.,Negative
    ICYMI,Medscape Education,Negative
 slides,Medscape Education,Negative
 slides,CLL Ireland,Negative
 slides,"Amber Koehler, PA-C",Negative
 slides,Biotech2050,Negative
 slides,Amy C. Cavers,Negative
 slides,i3 Health,Negative
 slides,"chadi nabhan MD, MBA, FACP",Negative
 slides,Oncology Tube,Negative
 panelists,Medscape Education,Negative
 panelists,Expert Perspectives in Oncology,Negative
 Der letzte,medtoday Germany,Negative
 startet ab,medtoday Germany,Negative
 Uhr mit den,medtoday Germany,Negative
 Tracks,medtoday Germany,Negative
 mit,medtoday Germany,Positive
 mit,Kompetenznetz Maligne Lymphome e.V.,Negative
 mit,APOTHEKE ADHOC,Positive
 Schwerpunkt,medtoday Germany,Positive
 sowie,medtoday Germany,Negative
 Studien zusammengefasst von unseren,medtoday Germany,Negative
 TopExperten Machen Sie,medtoday Germany,Negative
 gleich mit auf,medtoday Germany,Negative
 J Clin Med Driver Mutations,IUOPA,Negative
 Single Copy Number Abnormalities,IUOPA,Negative
 Binet Stage,IUOPA,Negative
 Binet Stage,Biblioteca HUCA,Negative
 Binet Stage,Scott Werntz,Negative
 Aggressive Progression,IUOPA,Negative
 Aggressive Progression,Biblioteca HUCA,Negative
 dr Wierdas presentation,LYMPHOMA & MYELOMA CONNECT,Negative
 TRANSCEND CLL,LYMPHOMA & MYELOMA CONNECT,Negative
 TRANSCEND CLL,Lymphoma Hub,Positive
 TRANSCEND CLL,Targeted Oncology,Positive
 TRANSCEND CLL,Beacon Targeted Therapies,Positive
 TRANSCEND CLL,Razan Mohty,Positive
 Science Thankyou,KrisA,Positive
 amp HCW,KrisA,Positive
 resulting drug venetoclax,KrisA,Positive
 gamechanger,KrisA,Positive
 gamechanger,The James,Negative
 Roches fixedduration,Bionest Partners,Negative
 Roches fixedduration,Helix BioPharma,Positive
 Venclexta combos,Bionest Partners,Negative
 Venclexta combos,Helix BioPharma,Positive
 Constantine Tam MD MBBS FRACP FRCPA,"Pharmacyclics, an AbbVie Company",Positive
 advancements,"Pharmacyclics, an AbbVie Company",Positive
 advancements,CLL Ireland,Negative
 advancements,"Mazyar Shadman, MD MPH",Negative
 advancements,Targeted Oncology,Negative
 advancements,Verastem Oncology,Negative
 Clinical Science,"Pharmacyclics, an AbbVie Company",Positive
 Danelle James MD MAS,"Pharmacyclics, an AbbVie Company",Positive
 avenues,"Pharmacyclics, an AbbVie Company",Positive
 patients caregivers,"Pharmacyclics, an AbbVie Company",Positive
 patients caregivers,ReaderUSA,Positive
 Technical Advance,Journal of Leukocyte Biology,Positive
 Heitmann Muller,Journal of Leukocyte Biology,Positive
 novel flow,Journal of Leukocyte Biology,Positive
 cytometry‚Äêbased assay,Journal of Leukocyte Biology,Positive
 government facilities leaders,APWA,Positive
 building,APWA,Positive
 Subcutaneous Masses,EurekaMag,Negative
 Subcutaneous Masses,Lymphoma Papers,Negative
 Unusual Manifestation,EurekaMag,Negative
 Unusual Manifestation,Lymphoma Papers,Negative
 Unusual Manifestation,Paperbirds_Hematology,Positive
 Unusual Manifestation,Cancer Papers,Negative
 Relapse,EurekaMag,Negative
 Relapse,Lymphoma Papers,Negative
 Relapse,Paperbirds_Hematology,Positive
 Relapse,Journal of Clinical Pathways,Negative
 Relapse,Oncology Tube,Negative
 Relapse,Patient Power,Negative
 Relapse,Tran-Der Tan,Negative
 Atypical Chronic Lymphocytic Leukemia,EurekaMag,Negative
 Atypical Chronic Lymphocytic Leukemia,Lymphoma Papers,Negative
 Atypical Chronic Lymphocytic Leukemia,Paperbirds_Hematology,Negative
 Prolymphocytoid Transformation,EurekaMag,Negative
 Prolymphocytoid Transformation,Lymphoma Papers,Negative
 Prolymphocytoid Transformation,Paperbirds_Hematology,Negative
 Complex Karyotype,EurekaMag,Negative
 Complex Karyotype,Lymphoma Papers,Negative
 Complex Karyotype,Paperbirds_Hematology,Negative
 Complex Karyotype,Brave Is Now¬Æ,Negative
 Complex Karyotype,Jenn,Positive
 Diagnostic Dilemma,EurekaMag,Negative
 Diagnostic Dilemma,Lymphoma Papers,Negative
 Diagnostic Dilemma,Paperbirds_Hematology,Negative
 Treatm,EurekaMag,Negative
 Treatm,Krishan Maggon,Negative
 Symptoms,Patient Power,Negative
 Symptoms,Shouting at people in my underpants,Negative
 Symptoms,Patient Empowerment Network,Positive
 Symptoms,Freelance Writer,Positive
 Symptoms,Mike Luise,Positive
 Symptoms,A M Billah Sumon,Positive
 Symptoms,Zack Pemberton-Whiteley,Negative
 Symptoms,Prachi,Positive
 Symptoms,CORE Diagnostics,Positive
 Monitor SymptomsPatient,Patient Power,Negative
 Jay Blatt,Patient Power,Negative
 needs,Michael Rynne,Negative
 needs,ILLINOIS Social Work,Negative
 needs,CLLSA,Negative
 familiesPatients,Michael Rynne,Negative
 DiseaseFree Survival Data,Company News HQ,Negative
 DiseaseFree Survival Data,Investor Press Releases,Positive
 DiseaseFree Survival Data,MasdelMedio,Negative
 DiseaseFree Survival Data,IMPharma News,Negative
 DiseaseFree Survival Data,mednetnews,Negative
 DiseaseFree Survival Data,Stock Market News,Negative
 DiseaseFree Survival Data,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 DiseaseFree Survival Data,NwokeAgulu,Negative
 CAPTIVATE Study Demonstrate Benefit,Company News HQ,Negative
 CAPTIVATE Study Demonstrate Benefit,Investor Press Releases,Positive
 CAPTIVATE Study Demonstrate Benefit,MasdelMedio,Negative
 CAPTIVATE Study Demonstrate Benefit,IMPharma News,Negative
 CAPTIVATE Study Demonstrate Benefit,mednetnews,Negative
 CAPTIVATE Study Demonstrate Benefit,Stock Market News,Negative
 CAPTIVATE Study Demonstrate Benefit,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 CAPTIVATE Study Demonstrate Benefit,NwokeAgulu,Negative
 longterm outcomes,WCM Lymphoma,Negative
 longterm outcomes,Blood Journal,Negative
 longterm outcomes,"Raul Cordoba, MD, PhD",Negative
 longterm outcomes,Francesco Turturro,Negative
 spot,Nicolas Martinez üá®üá¥üá®üá¥,Positive
 spot,The Leukemia & Lymphoma Society,Negative
 spot,PeerView,Negative
 spot,Light The Night SD,Negative
 alSEERMedicare,Dr. Shakira J Grant MBBS,Positive
 OAs,Dr. Shakira J Grant MBBS,Positive
   TGTX umbralisib,Biotech2050,Positive
 ublituximab U,Biotech2050,Negative
   TGTX UMBRALISIB,Biotech2050,Negative
 UBLITUXIMAB,Biotech2050,Negative
 UVEN,Biotech2050,Negative
 Loxo Oncology,Pharma News,Negative
 Loxo Oncology,IMPharma News,Negative
 Loxo Oncology,Investor News,Negative
 Loxo Oncology,Eli Lilly and Company,Positive
 Lilly Announces,Pharma News,Negative
 Lilly Announces,IMPharma News,Negative
 Lilly Announces,Investor News,Negative
 Lilly Announces,"OTC Dynamics, Inc.",Negative
 Lilly Announces,Stock Titan,Negative
 IgG testing rates,Flatiron Health,Positive
 Scotland,CLL Ireland,Positive
 Scotland,Eduardo Flavio Oliveira Ribeiro,Negative
 Scotland,Patient Worthy,Negative
 trial data,Kate Cwynarski,Positive
 trial data,VJHemOnc,Negative
 reminder,Kate Cwynarski,Positive
 reminder,CLLSA,Positive
 reminder,Brave Is Now¬Æ,Negative
 reminder,Biotech2050,Negative
 reminder,ESCofNJ,Negative
 reminder,"Pharmacyclics, an AbbVie Company",Negative
 reminder,CLL Ireland,Positive
 OK N,Prof John,Negative
 PERSON,Prof John,Negative
 Convalescent PlasmaMediated Resolution,Prof John,Negative
 LESSONS LEARNT,Prof John,Negative
 Carla,Blood Cancer UK,Negative
 NHL   Lymphocytic   CLL,Select Justice,Positive
 Scottish Medicines Consortium SMC,CLLSA,Negative
 Reports Results,PHARMABOX.IN,Negative
 Reports Results,PharmaShots - Incisive news in 3 shots,Negative
 Imbruvica ibrutinib,PHARMABOX.IN,Positive
 Imbruvica ibrutinib,PharmaShots - Incisive news in 3 shots,Positive
 Imbruvica ibrutinib,Headwaters Communications,Positive
 Imbruvica ibrutinib,MAISA,Negative
 Imbruvica ibrutinib,cafepharma,Negative
 Imbruvica ibrutinib,Medthority,Negative
 Imbruvica ibrutinib,CPhI Online,Positive
 PIII Studies,PHARMABOX.IN,Negative
 PIII Studies,PharmaShots - Incisive news in 3 shots,Negative
 L Treatment,PHARMABOX.IN,Positive
 L Treatment,PharmaShots - Incisive news in 3 shots,Positive
 Chronic Lymphocytic Leukemia Treatment Market Ready,Depp Gaikwad,Negative
 Record Breaking Growth,Depp Gaikwad,Negative
 SDGR,Canadian Stocks Market üá®üá¶,Positive
 Umbralisib Ublituximab,Tom Silver,Negative
 Umbralisib Ublituximab,Biotech2050,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia CLL,Tom Silver,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia CLL,ClinicalTrialsData,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia CLL,dough,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia CLL,Scott Werntz,Negative
 BTK inhibitor LOXO,Alaric DeArment,Positive
 LLY,Alaric DeArment,Positive
 Mobi Free Medifocus Guidebook,Penny Hayners,Positive
 Chronic Lymphocytic Leukemia gtgt,Penny Hayners,Positive
   TG Therapeutics Inc,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 umbralisib TGR,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 umbralisib TGR,dough,Negative
 New Data Demonstrate LongTerm Benefit,Company News HQ,Negative
 New Data Demonstrate LongTerm Benefit,NwokeAgulu,Negative
 New Data Demonstrate LongTerm Benefit,mednetnews,Negative
 New Data Demonstrate LongTerm Benefit,Stock Market News,Negative
 New Data Demonstrate LongTerm Benefit,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 New Data Demonstrate LongTerm Benefit,IMPharma News,Negative
 ¬Æ ibrutinib,Company News HQ,Negative
 ¬Æ ibrutinib,NwokeAgulu,Negative
 ¬Æ ibrutinib,mednetnews,Negative
 ¬Æ ibrutinib,Stock Market News,Negative
 ¬Æ ibrutinib,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 ¬Æ ibrutinib,IMPharma News,Negative
 ¬Æ ibrutinib,Alicia Bell IFBB Pro,Negative
 ¬Æ ibrutinib,ChemDiv,Positive
 ¬Æ ibrutinib,PRICENTRIC,Positive
 ¬Æ ibrutinib,HEDGE accordinglyüìà,Negative
 ¬Æ ibrutinib,RazzleTazzle,Negative
 ¬Æ ibrutinib,Marketbit.pro,Negative
 ¬Æ ibrutinib,Diaceutics PLC,Negative
 ¬Æ ibrutinib,CLL Society Inc.,Negative
 ¬Æ ibrutinib,NACDA Program on Aging,Negative
 ¬Æ ibrutinib,Dr. Leona Saunders,Positive
 ¬Æ ibrutinib,Financial Buzz,Positive
 ¬Æ ibrutinib,militaryeyed,Positive
 ¬Æ ibrutinib,PRN Biotech,Positive
 ¬Æ ibrutinib,Luke üî¥‚ö´Ô∏è #MTW,Positive
 ¬Æ ibrutinib,IntoxicatedTrader,Positive
 ¬Æ ibrutinib,MedFirst - MedComms,Positive
 ¬Æ ibrutinib,"John C. Wunsch, P.C.",Negative
 ¬Æ ibrutinib,frothmouth,Positive
 ¬Æ ibrutinib,Jos√© Lu√≠s Marques Br,Positive
 ¬Æ ibrutinib,Giuseppe Michieli,Negative
 ¬Æ ibrutinib,JanssenUS,Negative
 ¬Æ ibrutinib,"Krishna Talluri, MD",Positive
 ¬Æ ibrutinib,crewmilitary,Positive
 ¬Æ ibrutinib,NEWS.GNOM.ES,Negative
 FirstLine Treatment,Company News HQ,Negative
 FirstLine Treatment,NwokeAgulu,Negative
 FirstLine Treatment,mednetnews,Negative
 FirstLine Treatment,Stock Market News,Negative
 FirstLine Treatment,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 FirstLine Treatment,IMPharma News,Negative
 FirstLine Treatment,"Naveen Pemmaraju, MD",Positive
 FirstLine Treatment,MD Anderson Leukemia,Positive
 FirstLine Treatment,Oncology Times,Negative
 FirstLine Treatment,HEDGE accordinglyüìà,Negative
 FirstLine Treatment,Saeed Valadbaygi,Negative
 FirstLine Treatment,pressdaily,Negative
 FirstLine Treatment,Paperbirds_Hematology,Positive
 FirstLine Treatment,Lymphoma Papers,Negative
 FirstLine Treatment,Michele Nadeem-Baker,Negative
 FirstLine Treatment,SpecialtyPTimes,Positive
 FirstLine Treatment,Benlazar S.M Amin√©,Negative
 FirstLine Treatment,"Raul Cordoba, MD, PhD",Negative
 FirstLine Treatment,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 FirstLine Treatment,NEJM,Negative
 FirstLine Treatment,CancerWallonia,Negative
 FirstLine Treatment,Hematolog√≠a Salamanca,Negative
 FirstLine Treatment,1stOncology,Positive
 FirstLine Treatment,Lisa Palacios,Negative
 FirstLine Treatment,Oncology Tube,Positive
 FirstLine Treatment,Diaceutics PLC,Negative
 FirstLine Treatment,Hematopoiesis News,Negative
 FirstLine Treatment,Dr. Leona Saunders,Positive
 FirstLine Treatment,Financial Buzz,Negative
 FirstLine Treatment,militaryeyed,Positive
 FirstLine Treatment,PRN Biotech,Negative
 FirstLine Treatment,IntoxicatedTrader,Negative
 FirstLine Treatment,Oncology Now,Negative
 FirstLine Treatment,LIBERTADOR ¬Æ,Positive
 FirstLine Treatment,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 FirstLine Treatment,Medicine Science,Negative
 FirstLine Treatment,Drug Discovery & Dev,Positive
 FirstLine Treatment,MedPipeline,Negative
 FirstLine Treatment,Plexus Ventures,Negative
 FirstLine Treatment,Hlthnews,Negative
 FirstLine Treatment,New Drug Approvals,Negative
 FirstLine Treatment,Drugs.com,Negative
 FirstLine Treatment,PEYRAT Jean-Pierre,Positive
 FirstLine Treatment,Symposier,Positive
 FirstLine Treatment,Symposier Allergy,Positive
 FirstLine Treatment,Symposier MedStudent,Positive
 FirstLine Treatment,Symposier Radiology,Positive
 FirstLine Treatment,Symposier Oncology,Positive
 FirstLine Treatment,Symposier Pharmaco,Positive
 FirstLine Treatment,Sympo PathoBiology,Positive
 FirstLine Treatment,Symposier Hematology,Positive
 FirstLine Treatment,Sy Internal Medicine,Positive
 FirstLine Treatment,Symposier Family,Positive
 HighRisk Chronic,Company News HQ,Negative
 HighRisk Chronic,Biotech2050,Negative
 CLL project,Lymphoma Hub,Negative
 year data,HemOnc Today,Negative
 year data,VJHemOnc,Negative
 venetoclaxrituximab,HemOnc Today,Negative
 Venetoclax Rituximab Sustains Survival Benefit,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Ame LLY,Investor News,Negative
   News Patients,CURE Magazine,Negative
 pm Bo,Lili Wang Lab,Negative
 Ibrutinib oncedaily Bruton kinase inhibitor,MDedge Hematology & Oncology,Negative
 targeted therapy,MDedge Hematology & Oncology,Negative
 targeted therapy,LYMPHOMA & MYELOMA CONNECT,Negative
 targeted therapy,Lymphoma Hub,Negative
 targeted therapy,VJHemOnc,Positive
 targeted therapy,Targeted Oncology,Negative
 targeted therapy,"chadi nabhan MD, MBA, FACP",Negative
 targeted therapy,Hematology Advisor,Negative
 targeted therapy,Cancer Papers,Negative
 targeted therapy,Lymphoma Papers,Negative
 targeted therapy,"Raul Cordoba, MD, PhD",Positive
 targeted therapy,International Cancer Imaging Society,Positive
 targeted therapy,Talal Hilal ü©∫,Negative
 DV,"Jennifer Crombie, MD",Positive
 Key   Treatment DecisionMaking Factors,Patient Empowerment Network,Positive
 UNITY CLL,VJHemOnc,Negative
 ‚Äç ‚öï Ô∏è,VJHemOnc,Negative
 Great   Flex research,Paul Winston MD,Positive
 Hodgkin Variant,Paul Winston MD,Positive
 Chronic Lymphocytic Leukemia CLLSmall Lymphocytic Lymphoma SLL Patients,Paul Winston MD,Positive
 British Columbia BC Canada American Society,Paul Winston MD,Positive
 patientstcoCJfiVUIU,HCPLive,Positive
 pts Intolerant,"Mazyar Shadman, MD MPH",Negative
 BTKis,"Mazyar Shadman, MD MPH",Negative
 BTKis,Thomas Eliot Lew,Positive
 CLL   NEWS,Michele Nadeem-Baker,Negative
    Stefano Molica,EmatoInfo,Positive
 yrs update,EmatoInfo,Positive
 finiteduration treatment,EmatoInfo,Positive
 client,LaVoieHealthScience,Positive
 client,RNpedia,Positive
 Dr Gribben,LaVoieHealthScience,Positive
 Dr Gribben,Carmine DeLuca,Negative
 Dr Zinzani,LaVoieHealthScience,Positive
 informCLL registry,Lymphoma Hub,Negative
   presentation,Taylor Lab UM,Negative
   presentation,Journal of Clinical Pathways,Negative
   presentation,Lymphoma Hub,Negative
   presentation,NY Genome Center,Negative
 Tanya Siddiqi,Lymphoma Hub,Positive
 Tanya Siddiqi,VJHemOnc,Positive
 mos followup,Lymphoma Hub,Negative
 lisocel monotherapy,Lymphoma Hub,Negative
 CRCRi Responses,Lymphoma Hub,Negative
 DOR,Lymphoma Hub,Negative
 LLY Lilly Announces Updated Phase,Biotech & Tech Stock Focus,Negative
 CLL amp,Biotech & Tech Stock Focus,Negative
 CLL amp,Patient Power,Negative
 CLL amp,CLL Ireland,Negative
 SLL Data,Biotech & Tech Stock Focus,Negative
 Ohad,Lymphoma Hub,Negative
 Benjamini,Lymphoma Hub,Negative
 Benjamini,"Mazyar Shadman, MD MPH",Negative
 lisocel,Lymphoma Hub,Negative
 lisocel,Beacon Targeted Therapies,Positive
 HR CLL patients,Lymphoma Hub,Negative
 todayDr Gribben,TG Therapeutics,Positive
 Ph UNITYCLL data,TG Therapeutics,Positive
 TN,TG Therapeutics,Positive
 TN,Toby Eyre,Negative
 TN,Krish Patel,Positive
 TN,CLL Ireland,Negative
 TN,NE Live,Negative
 amp RR   Zinzani,TG Therapeutics,Positive
 UNITYNHL Ph data,TG Therapeutics,Positive
 RR TGTX Press Release,TG Therapeutics,Positive
 UblituximabUmbralisibRRL,Toby Eyre,Negative
 vs OChl RCTnlt,Toby Eyre,Negative
 m PFS diffmPFS m L,Toby Eyre,Negative
 U m,Toby Eyre,Negative
 RRU,Toby Eyre,Negative
   G diarrhoeaInteresting butBTKi,Toby Eyre,Negative
 VENO,Toby Eyre,Negative
 Wierda MD PhD,Lisa Palacios,Negative
 Transcend    Phase,Lisa Palacios,Negative
 Lisocabtagene Maraleucel lisocel,Lisa Palacios,Positive
 RelapsedRefractory RR Chronic Lymphocytic Small Lymphocytic Lymphoma CLLSLL,Lisa Palacios,Negative
 LLY Loxo Oncology,"OTC Dynamics, Inc.",Negative
 LLY Loxo Oncology,Stock Titan,Negative
 Lilly,Eli Lilly and Company,Positive
 Phase   BRUIN study,Eli Lilly and Company,Positive
 BRUIN study,Lymphoma Hub,Negative
 withBTKi LOXO,Lymphoma Hub,Negative
 CLLSLL ORR,Lymphoma Hub,Negative
 RR   ptsphase,Toby Eyre,Negative
 IIInoncovalent reversible BTKi,Toby Eyre,Negative
 LOXO LLY Announces Updated Data,Bio Stocks‚Ñ¢,Negative
 Jennifer Crombie MD,Dana-Farber News,Positive
 Ella Thompson,Michael Dickinson,Negative
   Presenting,Bristol Myers Squibb,Positive
 Venetoclax   obinutuzumab,LymphomaAction,Negative
 NHS,LymphomaAction,Negative
 NHS,CLLSA,Negative
 NHS,Patient Worthy,Negative
 Transcend,Lisa Palacios,Negative
 RelapsedRefractory RR Chronic Lymphocytic Small Lymphocytic,Lisa Palacios,Negative
 Satellitensymposium mit,medtoday Germany,Negative
 Uhr gibt,medtoday Germany,Negative
 hier eine Expertendiskussion,medtoday Germany,Negative
 √ºber Auf,medtoday Germany,Negative
 Chronic Lymphocytic Leukemia Market,Industry Today,Positive
 Chronic Lymphocytic Leukemia Market,Pharma News,Positive
 Chronic Lymphocytic Leukemia Market,Wellcome-home,Positive
 Chronic Lymphocytic Leukemia Market,Daniel Kovach,Positive
 Chronic Lymphocytic Leukemia Market,STCK.PRO,Positive
 Chronic Lymphocytic Leukemia Market,The Chief Observer,Positive
 Chronic Lymphocytic Leukemia Market,Total Pharma News,Negative
 Chronic Lymphocytic Leukemia Market,Soft Solutions,Positive
 Chronic Lymphocytic Leukemia Market,Alyssa Howard,Negative
 Chronic Lymphocytic Leukemia Market,Denver Greene,Negative
 Chronic Lymphocytic Leukemia Market,Top 10,Positive
 Chronic Lymphocytic Leukemia Market,AttyCreditRepair,Positive
 Chronic Lymphocytic Leukemia Market,LeadValets Lead Generation Agency,Positive
 Chronic Lymphocytic Leukemia Market,iPlethora,Positive
 Chronic Lymphocytic Leukemia Market,REI Lending,Positive
 Chronic Lymphocytic Leukemia Market,New Jersey Headlines,Positive
 Chronic Lymphocytic Leukemia Market,Shillong Herald,Positive
 Chronic Lymphocytic Leukemia Market,ABNewswire,Positive
 Chronic Lymphocytic Leukemia Market,ohanna johnson,Positive
 Global Analysis amp Forecast,Industry Today,Positive
 Market Research Report,Industry Today,Positive
 Market Research Report,MRR,Positive
 AbbVies VenclextaVenclyxto combination bebeficial,CHItraders,Negative
 AbbVies VenclextaVenclyxto combination bebeficial,Investor News,Negative
 AbbVies VenclextaVenclyxto combination bebeficial,DesignYourInvestments üì°,Positive
 AbbVies VenclextaVenclyxto combination bebeficial,Gordon Gekko,Negative
 AbbVies VenclextaVenclyxto combination bebeficial,Breaking News,Negative
 Ô∏é AbbVies VenclextaVenclyxto combination bebeficial,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 ABBV RHHBY,Breaking News,Negative
 ABBV RHHBY,Kara Jill Stancell,Negative
 Tracks f√ºr,medtoday Germany,Negative
 heute von,medtoday Germany,Negative
 Daten zu,medtoday Germany,Negative
 und,medtoday Germany,Positive
 und,idw Nachrichten,Positive
 und,EuropeanHospital_D,Negative
 und,Roche Deutschland,Negative
 Machen Sie,medtoday Germany,Negative
 mit auf,medtoday Germany,Negative
 Jan,CLL Ireland,Positive
 Jan,Michael Rynne,Negative
 Jan,VJHemOnc,Negative
 Jan,Ciara üò∑ masking for a friend,Positive
 Jan,ESCofNJ,Negative
 Jan,Wnt publications,Negative
 Jan,Seattle DJC,Positive
 Jan,CARE‚Ñ¢ Education,Negative
 treatment benefit,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,Positive
 treatment benefit,Gordon Gekko,Negative
 treatment benefit,Investor News,Negative
 treatment benefit,Breaking News,Negative
 ABBV,Breaking News,Negative
 ABBV,1stOncology,Positive
 ABBV,Anna Deveau,Negative
 ABBV,Bio Stocks‚Ñ¢,Positive
 ABBV,Odi Bruckman,Positive
 ABBV,Hottest Stocks Now,Positive
 ABBV,Plexus Ventures,Negative
 ABBV,CHItraders,Negative
 ABBV,Andrew Dunn,Positive
 ABBV,Algoslinger,Positive
 ABBV,Flash Alert,Negative
 ABBV,Biotech2050,Positive
 ABBV,MAISA,Positive
 ABBV,Marketbit.pro,Negative
 ABBV,Open Outcrier,Negative
 ABBV,BernCarte Pharma,Positive
 ABBV,RA Komins,Positive
 ABBV,Dustin Phan,Positive
 ABBV,Frank Tarazi,Positive
 ABBV,Bud Capital,Positive
 Chronic Lymphocytic Leukemia Survival,Êùë‰∫ï Ë™†Âè∏,Positive
 Chronic Lymphocytic Leukemia Survival,EurekaMag,Negative
 Chronic Lymphocytic Leukemia Survival,Paperbirds_Hematology,Negative
 MD Magazine,Êùë‰∫ï Ë™†Âè∏,Positive
 Roche Reports LongTerm Benefits,PHARMABOX.IN,Negative
 Roche Reports LongTerm Benefits,PharmaShots - Incisive news in 3 shots,Negative
 VenclextaVenclyxto Based Combination,PHARMABOX.IN,Negative
 VenclextaVenclyxto Based Combination,PharmaShots - Incisive news in 3 shots,Negative
 RR Chronic Lymphocytic Leukemia,PHARMABOX.IN,Negative
 RR Chronic Lymphocytic Leukemia,PharmaShots - Incisive news in 3 shots,Negative
 RR Chronic Lymphocytic Leukemia,Odi Bruckman,Positive
   Presents,1stOncology,Negative
   Presents,Medscape Education,Negative
 Fixed Duration Treatment,1stOncology,Positive
 Fixed Duration Treatment,Michael Oholendt,Positive
 Fixed Duration Treatment,Algoslinger,Positive
 Fixed Duration Treatment,RazzleTazzle,Positive
 Fixed Duration Treatment,Pharma News,Negative
 Fixed Duration Treatment,Flash Alert,Negative
 Fixed Duration Treatment,Bio Stocks‚Ñ¢,Negative
 Fixed Duration Treatment,Crwe World,Negative
 Fixed Duration Treatment,Marketbit.pro,Negative
 Fixed Duration Treatment,aeses.com,Negative
 Fixed Duration Treatment,FDA Daily,Negative
 EP receptor agonist L,Lymphoma Papers,Negative
 cytotoxic activities,Lymphoma Papers,Negative
 ibrutinib idelalisib,Lymphoma Papers,Negative
 ibrutinib idelalisib,AU Oncology Reviews,Negative
 ibrutinib idelalisib,Ana Rosa Rubio,Positive
 Clonal dynamics,Lymphoma Papers,Negative
 Clonal dynamics,Cancer Papers,Negative
 Clonal dynamics,EurekaMag,Positive
 Clonal dynamics,Cancer epigenetics papers üìö,Positive
 Clonal dynamics,Single Cell papers,Positive
 Clonal dynamics,mgl,Positive
 Clonal dynamics,Sigrid Sk√•nland,Negative
 Clonal dynamics,"Dr T. Comeau , MD",Negative
 Clonal dynamics,Kadir C Akdemir,Positive
 Survival Benefit,@globalfirstnews,Positive
 OncLive December,@globalfirstnews,Positive
 Janssen Reports LongTerm Benefits,PHARMABOX.IN,Negative
 Janssen Reports LongTerm Benefits,PharmaShots - Incisive news in 3 shots,Negative
 HighRisk Chronic Lymphocytic Leukemia,PHARMABOX.IN,Negative
 HighRisk Chronic Lymphocytic Leukemia,PharmaShots - Incisive news in 3 shots,Negative
 HighRisk Chronic Lymphocytic Leukemia,NwokeAgulu,Negative
 HighRisk Chronic Lymphocytic Leukemia,mednetnews,Negative
 HighRisk Chronic Lymphocytic Leukemia,Stock Market News,Negative
 HighRisk Chronic Lymphocytic Leukemia,IMPharma News,Negative
 HighRisk Chronic Lymphocytic Leukemia,Lung Cancer News,Negative
 HighRisk Chronic Lymphocytic Leukemia,GEDEFO,Negative
 HighRisk Chronic Lymphocytic Leukemia,Hematopoiesis News,Negative
 HighRisk Chronic Lymphocytic Leukemia,The ASCO Post,Negative
 Relapsed gtLower,Suvir Singh,Positive
   TGTX,Biotech2050,Negative
 Questions,Robert Albero Gallego,Positive
 Questions,Haematologica,Positive
 Questions,Shouting at people in my underpants,Negative
 Questions,Michael Hallek,Negative
 Questions,ASH Clinical News,Negative
 Questions,Robert Z. Orlowski,Negative
 Questions,MD Anderson Leukemia,Negative
 Questions,Matthias Piesche,Negative
 APTO History,Joe,Negative
   session,"Mazyar Shadman, MD MPH",Negative
   session,"chadi nabhan MD, MBA, FACP",Negative
   session,Charlotte Martin,Positive
 PST Exciting session,"Mazyar Shadman, MD MPH",Negative
 LOXO U CART √ó,"Mazyar Shadman, MD MPH",Negative
 RWE Drs    Gribben,"Mazyar Shadman, MD MPH",Negative
 Siddiqi,"Mazyar Shadman, MD MPH",Negative
   Society ASH,CLL Society Inc.,Positive
 Update Dr Anthony Fauci,CLL Society Inc.,Negative
 immunity,CLL Society Inc.,Negative
 immunity,Patient Power,Negative
 Dr Koffman,CLL Society Inc.,Positive
 Dr Koffman,Oncology State Societies at ACCC,Negative
 Dr Koffman,CML AdvocatesNetwork,Negative
 CAPTIVATE CLARITY MURANO,CLL Society Inc.,Negative
 ABBV AbbVie,Investor Press Releases,Positive
 ABBV AbbVie,Biotech & Tech Stock Focus,Negative
 ABBV AbbVie,"OTC Dynamics, Inc.",Positive
 ABBV AbbVie,Stock Titan,Negative
 ABBV AbbVie,CHItraders,Negative
 ABBV AbbVie,Marketbit.pro,Positive
 ABBV AbbVie,Briefing.com,Positive
 ABBV AbbVie,Suchit Gupta,Positive
 Presents Extended FollowUp Data,Investor Press Releases,Positive
 Presents Extended FollowUp Data,"OTC Dynamics, Inc.",Negative
 Presents Extended FollowUp Data,Flash Alert,Negative
 Presents Extended FollowUp Data,Stock Titan,Negative
 BeiGene Announces Data,Pharmacutical Daily,Negative
 BeiGene Announces Data,Crwe World,Negative
 BeiGene Announces Data,Latest News from Business Wire,Negative
 BRUKINSA,Pharmacutical Daily,Negative
 BRUKINSA,Biotech & Tech Stock Focus,Negative
 BRUKINSA,"OTC Dynamics, Inc.",Negative
 BRUKINSA,PressNewsAgency,Positive
 BRUKINSA,Corporate News,Negative
 BRUKINSA,Crwe World,Negative
 BRUKINSA,Bio Stocks‚Ñ¢,Negative
 BRUKINSA,Latest News from Business Wire,Negative
 BRUKINSA,Stock Titan,Negative
 BRUKINSA,Quant Data,Negative
 ¬Æ Zanubrutinib,Pharmacutical Daily,Negative
 ¬Æ Zanubrutinib,Biotech & Tech Stock Focus,Negative
 ¬Æ Zanubrutinib,"OTC Dynamics, Inc.",Negative
 ¬Æ Zanubrutinib,PressNewsAgency,Positive
 ¬Æ Zanubrutinib,Corporate News,Negative
 ¬Æ Zanubrutinib,Crwe World,Negative
 ¬Æ Zanubrutinib,Latest News from Business Wire,Negative
 ¬Æ Zanubrutinib,Stock Titan,Negative
 Phase   Trial,Pharmacutical Daily,Negative
 Phase   Trial,Biotech & Tech Stock Focus,Negative
 Phase   Trial,"OTC Dynamics, Inc.",Negative
 Phase   Trial,PressNewsAgency,Positive
 Phase   Trial,Corporate News,Negative
 Phase   Trial,Crwe World,Negative
 Phase   Trial,Bio Stocks‚Ñ¢,Negative
 Phase   Trial,Latest News from Business Wire,Negative
 Phase   Trial,Stock Titan,Negative
 Phase   Trial,B3C newswire,Positive
 Marginal Zone Lymphoma,Pharmacutical Daily,Negative
 Marginal Zone Lymphoma,Biotech & Tech Stock Focus,Negative
 Marginal Zone Lymphoma,"OTC Dynamics, Inc.",Negative
 Marginal Zone Lymphoma,PressNewsAgency,Positive
 Marginal Zone Lymphoma,Corporate News,Negative
 Marginal Zone Lymphoma,Crwe World,Negative
 Marginal Zone Lymphoma,Bio Stocks‚Ñ¢,Negative
 Marginal Zone Lymphoma,Latest News from Business Wire,Negative
 Marginal Zone Lymphoma,Stock Titan,Negative
 Marginal Zone Lymphoma,Biotech2050,Negative
 nd ASH Annual ¬† Meeting,Pharmacutical Daily,Negative
 nd ASH Annual ¬† Meeting,PressNewsAgency,Positive
 BGNE BeiGene Announces Data,Biotech & Tech Stock Focus,Negative
 BGNE BeiGene Announces Data,"OTC Dynamics, Inc.",Negative
 BGNE BeiGene Announces Data,Corporate News,Negative
 BGNE BeiGene Announces Data,Stock Titan,Negative
 Longterm integrated analysis,JanssenUS,Negative
 phase   studies,JanssenUS,Negative
 highrisk chronic lymphocytic,JanssenUS,Negative
 highrisk chronic lymphocytic,ecancer,Negative
 highrisk chronic lymphocytic,SeraCare,Positive
 highrisk chronic lymphocytic,HemOnc Today,Negative
 highrisk chronic lymphocytic,Nature Medicine,Positive
 highrisk chronic lymphocytic,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 HighRisk Chronic Lymphocytic,ÿßŸÑŸÜÿßÿ¥ÿ± publisher,Negative
 Kind reminder,Lili Wang Lab,Negative
 poster presentation,Lili Wang Lab,Positive
 poster presentation,"Bionano Genomics, Inc.",Positive
 METTL,Lili Wang Lab,Positive
 nd ASH Annual M,"OTC Dynamics, Inc.",Negative
 Cmut,Jessica Okosun,Positive
 BTKi resis,Jessica Okosun,Positive
 Intellasia East Asia News ‚Äì BeiGene Announces Data,PressNewsAgency,Positive
 BGNE Announces Data,Bio Stocks‚Ñ¢,Negative
   Kerry Rogers,VJHemOnc,Negative
   Kerry Rogers,Lymphoma Hub,Negative
 Phase Ib trial,VJHemOnc,Negative
 Senior Medical Director Jim Dean MD PhD,"Pharmacyclics, an AbbVie Company",Positive
 ASH AbbVie,Helix BioPharma,Positive
 CLL AbbVie,Helix BioPharma,Positive
 tandem,Helix BioPharma,Positive
 talk,Anthony Mato,Negative
 talk,VJHemOnc,Negative
 talk,OncLive SOSS,Negative
 talk,Lymphoma Hub,Positive
 talk,Duke Hematologic Malignancies & Cellular Therapy,Negative
 talk,CLL Ireland,Negative
 talk,Patient Power,Positive
 talk,CARE‚Ñ¢ Education,Negative
 talk,Zack Pemberton-Whiteley,Positive
 talk,brandingscience,Positive
 talk,David Costello,Positive
 poster session,Lili Wang Lab,Negative
 mA,Lili Wang Lab,Negative
   „Éº,Seema Ali Bhat,Positive
 Excellent work,Toby Eyre,Negative
 Excellent work,"chadi nabhan MD, MBA, FACP",Negative
 othersI promise,Toby Eyre,Negative
   Worldwide Examination,"Raul Cordoba, MD, PhD",Negative
 „Éº Contribution,"Raul Cordoba, MD, PhD",Negative
   HamWasserman lecture,"Raul Cordoba, MD, PhD",Negative
 Dr Andrew Roberts,"Raul Cordoba, MD, PhD",Negative
 Dr Andrew Roberts,"Mazyar Shadman, MD MPH",Negative
 Therapeutic Develepment,"Raul Cordoba, MD, PhD",Negative
 Current Uses,"Raul Cordoba, MD, PhD",Negative
 BCL Inhibition,"Raul Cordoba, MD, PhD",Negative
 BCL Inhibition,Prof John,Negative
 knowledge,"Raul Cordoba, MD, PhD",Positive
 knowledge,AplusA World,Negative
 knowledge,Lymphoma Hub,Positive
 knowledge,Kim Kirchherr,Negative
 knowledge,Oncology State Societies at ACCC,Negative
 knowledge,"Pharmacyclics, an AbbVie Company",Negative
 knowledge,MedPage Today,Positive
 knowledge,MedPage Oncology,Negative
 knowledge,Medthority,Positive
 knowledge,Marta Crespo,Negative
 New Evaluating zanubrutinib,Medivizor,Negative
 ABBV Abbvie Presents,Towelie,Positive
 Fixed Duration Treatment VenclextaVenclyxto,Towelie,Positive
 Dec   Reuters,Towelie,Positive
 Abbvie Inc,Towelie,Positive
 ‚Ä¢,Towelie,Positive
 ‚Ä¢,CEC Oncology,Positive
 ABBVIE PRESENTS EXTENDED FOLLOWUP DATA,Towelie,Positive
 line,Pietro Di Ciaccio,Positive
 line,Benlazar S.M Amin√©,Negative
 line,Michael Rynne,Positive
 line,LYMPHOMA & MYELOMA CONNECT,Negative
 line,donnashort,Positive
 line,LLSCanada,Negative
 line,Proactive,Negative
 line,Lymphoma Hub,Positive
 line,Biotech2050,Positive
 line,MoJo,Negative
 line,JanssenUS,Positive
 line,Guillermo Sanz,Negative
 line,"Raul Cordoba, MD, PhD",Positive
 line,WheelieDealer,Positive
 line,NYCDoc29,Negative
 line,Christopher Steer,Negative
 line,CAPhO,Negative
 line,NE Live,Negative
 line,"Pharmacyclics, an AbbVie Company",Negative
 line,Genentech,Negative
 line,Martin Luke,Negative
 Australia options,Pietro Di Ciaccio,Positive
 FixedDuration Measurable Residual Disease,Oncology,Negative
 Guided Approach,Oncology,Negative
 CAPTIVATE data,Nitin Jain,Negative
 CAPTIVATE data,Michael Dickinson,Negative
 ITT marrow MRD neg,Nitin Jain,Negative
 PB,Nitin Jain,Negative
 Longer followup,Nitin Jain,Negative
 MRD randomization,Nitin Jain,Negative
 yr,Nitin Jain,Negative
 yr,"Raul Cordoba, MD, PhD",Negative
 yr,Andrew Schorr,Negative
 yr,Patient Empowerment Network,Negative
 MRD neg,Nitin Jain,Negative
 continued VenIbr,Nitin Jain,Negative
 Ibr monotherapy,Nitin Jain,Negative
 Ibr monotherapy,"Dr. Paul DeSantis, PharmD",Negative
 Excellent presentation,"Chaitra Ujjani, MD",Positive
 Excellent presentation,"chadi nabhan MD, MBA, FACP",Negative
 Excellent presentation,Michael Hallek,Negative
 Kirsten Fischer,Lymphoma Hub,Negative
 Kirsten Fischer,Christian Reinhardt,Positive
 Kirsten Fischer,Michael Hallek,Negative
 Nicole Lamanna,Lymphoma Hub,Positive
 Nicole Lamanna,Patient Empowerment Network,Positive
 Today year DFS data,LYMPHOMA & MYELOMA CONNECT,Negative
 st line ibrutinib,LYMPHOMA & MYELOMA CONNECT,Negative
 combinations,LYMPHOMA & MYELOMA CONNECT,Negative
 combinations,"chadi nabhan MD, MBA, FACP",Negative
 combinations,Anna Deveau,Negative
 combinations,VJHemOnc,Positive
 combinations,OncLive SOSS,Negative
 efficacy data,Toby Eyre,Negative
 efficacy data,Verastem Oncology,Negative
 efficacy data,VJHemOnc,Negative
 threeinone tablet,Toby Eyre,Negative
 Genentech Announces New Data,Pharmacutical Daily,Negative
 Genentech Announces New Data,Crwe World,Negative
 Genentech Announces New Data,Stock Market News,Negative
 Genentech Announces New Data,Latest News from Business Wire,Negative
 LongTerm Benefit,Pharmacutical Daily,Negative
 LongTerm Benefit,Corporate News,Negative
 LongTerm Benefit,Parent Security,Positive
 LongTerm Benefit,Gregory D. Evans,Positive
 LongTerm Benefit,Crwe World,Negative
 LongTerm Benefit,"OTC Dynamics, Inc.",Negative
 LongTerm Benefit,Stock Market News,Negative
 LongTerm Benefit,Biotech & Tech Stock Focus,Negative
 LongTerm Benefit,Latest News from Business Wire,Negative
 VenclextaBased Combination,Pharmacutical Daily,Negative
 VenclextaBased Combination,Corporate News,Negative
 VenclextaBased Combination,Parent Security,Positive
 VenclextaBased Combination,Gregory D. Evans,Positive
 VenclextaBased Combination,Crwe World,Negative
 VenclextaBased Combination,"OTC Dynamics, Inc.",Negative
 VenclextaBased Combination,Stock Market News,Negative
 VenclextaBased Combination,Biotech & Tech Stock Focus,Negative
 VenclextaBased Combination,Latest News from Business Wire,Negative
 Right   Treatment,Patient Power,Negative
 NeedsDr Nicole Lamanna MD Hematologist,Patient Power,Negative
 BCLi,Benlazar S.M Amin√©,Negative
 del p TP mut,Benlazar S.M Amin√©,Positive
 BTKi resistance,Benlazar S.M Amin√©,Negative
 BCRi,Benlazar S.M Amin√©,Negative
 BCRi,Toby Eyre,Positive
 BCRi,"Raul Cordoba, MD, PhD",Positive
 BCRi,"Dr T. Comeau , MD",Negative
 care treatment,WCM Lymphoma,Negative
 CAPTIVATEMRDdriven RCTy DFS,Toby Eyre,Negative
 uMRD cohort,Toby Eyre,Negative
 Ibr,Toby Eyre,Negative
 Ibr,Lymphoma Hub,Negative
 observation post m,Toby Eyre,Negative
 IBRgt cycles,Toby Eyre,Negative
 IVuMRD PB   BM,Toby Eyre,Negative
 uMRD cohortNo diff,Toby Eyre,Negative
 DFS IBR,Toby Eyre,Negative
 Targeted trt,Benlazar S.M Amin√©,Negative
 anti CD Mabs,Benlazar S.M Amin√©,Negative
 fun way,"Chaitra Ujjani, MD",Positive
 line chemo,Benlazar S.M Amin√©,Negative
 Jacob D Soumerai,Lymphoma Research Foundation,Negative
   yr fu CLL,Krish Patel,Positive
 Dr AlSawaf yr,Krish Patel,Positive
 PFS   vs   chlorobi,Krish Patel,Positive
 yrs Time,Krish Patel,Positive
 therapy freedom,Krish Patel,Positive
 ChlorObi,Krish Patel,Positive
 OS diff,Krish Patel,Positive
 RO Genentech Announces,Corporate News,Negative
 New Data,Corporate News,Negative
 New Data,Parent Security,Positive
 New Data,Gregory D. Evans,Positive
 New Data,"OTC Dynamics, Inc.",Negative
 New Data,Biotech & Tech Stock Focus,Negative
 New Data,Pharmacutical Daily,Positive
 New Data,Stock Market News,Negative
 New Data,Latest News from Business Wire,Negative
 New Data,Laurent G - Francis,Negative
 New Data,Marketbit.pro,Negative
 New Data,Ana Laura Caballero,Positive
 New Data,IntoxicatedTrader,Negative
 New Data,Financial Buzz,Negative
 New Data,Financial GamblR,Negative
 New Data,Dana-Farber,Positive
 Algorithm treatment,Benlazar S.M Amin√©,Positive
 line VenetoclaxObinutuzumab progression,Benlazar S.M Amin√©,Negative
 BTKi progression,Benlazar S.M Amin√©,Negative
 ABBV Presents,Stock Market News,Negative
 FollowUp Data,Stock Market News,Negative
 FollowUp Data,Biotech2050,Negative
   yr Murano fu,Krish Patel,Positive
 mths,Krish Patel,Positive
 PFS OS update,Nitin Jain,Negative
 Dr AlSawaf    Congratulations,Nitin Jain,Negative
 MURANO fu,"Mazyar Shadman, MD MPH",Negative
 MRD reappearance,"Mazyar Shadman, MD MPH",Negative
 Factors,Benlazar S.M Amin√©,Negative
 Factors,Leukemia,Negative
 Factors,Targeted Oncology,Negative
 Factors,Patient Power,Positive
 Factors,AJMC,Negative
 map,Benlazar S.M Amin√©,Negative
 Changing Landscape,Benlazar S.M Amin√©,Negative
 Chronic L,Company News HQ,Negative
 Chronic L,Mohammed Saied Faraj,Positive
 ABBV Reveals New Findings,Hottest Stocks Now,Negative
 VENCLEXTAVENCLYXTO,Hottest Stocks Now,Negative
 DTRM,"chadi nabhan MD, MBA, FACP",Negative
    Genentech Announces,Parent Security,Positive
    Genentech Announces,Gregory D. Evans,Positive
 Relaps,Crwe World,Negative
 RHHBY Genentech Announces,"OTC Dynamics, Inc.",Negative
 RHHBY Genentech Announces,Biotech & Tech Stock Focus,Negative
 IbrutinibVen,Eduardo Flavio Oliveira Ribeiro,Negative
 st line Captivate,Eduardo Flavio Oliveira Ribeiro,Negative
 TAP Clarity,Eduardo Flavio Oliveira Ribeiro,Negative
 fiveyear update,"chadi nabhan MD, MBA, FACP",Negative
 Issued Press Release,Flash Alert,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia   Business Wire,Biotech & Tech Stock Focus,Negative
 CLARITY trial,"chadi nabhan MD, MBA, FACP",Positive
 CLARITY trial,LYMPHOMA & MYELOMA CONNECT,Negative
 CLARITY trial,Becky Bishop,Positive
 CLARITY trial,CLLSA,Positive
 CLARITY trial,Gina Eagle,Negative
 CLARITY trial,VJHemOnc,Negative
 confirmation,"chadi nabhan MD, MBA, FACP",Negative
 confirmation,Michael Hallek,Negative
 confirmation,Toby Eyre,Negative
 confirmation,"Eric D Whitman, MD",Positive
 confirmation,Biotech2050,Negative
 treatment discontinuation,"chadi nabhan MD, MBA, FACP",Positive
 aid,"chadi nabhan MD, MBA, FACP",Negative
   trial schedule,"chadi nabhan MD, MBA, FACP",Negative
 Excellent data amp presentation,"chadi nabhan MD, MBA, FACP",Negative
   Researchers,"Pharmacyclics, an AbbVie Company",Negative
   Researchers,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 MRDnegative,"chadi nabhan MD, MBA, FACP",Negative
 MRDnegative,Toby Eyre,Negative
 CAPTIVATE,"chadi nabhan MD, MBA, FACP",Positive
 CAPTIVATE,Miguel Canales,Positive
 ü©∏ Fraser,Alexander Luchinin,Positive
 HELIOS,Alexander Luchinin,Positive
 HELIOS,AJMC-Oncology,Negative
 HELIOS,NE Live,Negative
 Ibrutinib   RB,Alexander Luchinin,Positive
 Delp Patients,Alexander Luchinin,Positive
 PFS IBR,Alexander Luchinin,Positive
 mo BR,Alexander Luchinin,Positive
 IBR,Alexander Luchinin,Positive
 IBR,Toby Eyre,Positive
 OS benefit HR,Alexander Luchinin,Positive
 ABBV IMBRUVICA,Stock Titan,Negative
 ABBV IMBRUVICA,Marketbit.pro,Negative
 ABBV IMBRUVICA,Odi Bruckman,Positive
 schedule      Nescaf√© readyWonder,"chadi nabhan MD, MBA, FACP",Negative
 breakfast,"chadi nabhan MD, MBA, FACP",Negative
 breakfast,CEC Oncology,Positive
 breakfast,Michael Rynne,Negative
 Education Session,Duke Hematologic Malignancies & Cellular Therapy,Negative
 identification amp mgmt,Duke Hematologic Malignancies & Cellular Therapy,Negative
 Today pm PT,Duke Hematologic Malignancies & Cellular Therapy,Negative
 Daddy,Adam Kittai,Negative
 T T,Adam Kittai,Negative
 karyotypic complexity,Adam Kittai,Negative
 Club Success Mantra,THE NORTHCAP UNIV,Positive
 Student Activities,THE NORTHCAP UNIV,Positive
 Leadership subcommittee SAL,THE NORTHCAP UNIV,Positive
 Center,THE NORTHCAP UNIV,Positive
 Center,ESCofNJ,Positive
 Center,The Oncologist,Positive
 Center,Patient Worthy,Negative
 Center,nwfdailynews,Positive
 Center,janine‚Äôs reputationüè≥Ô∏è‚Äçüåà,Positive
 Center,jessetink,Positive
 Center,Light The Night SD,Negative
 Language Learning,THE NORTHCAP UNIV,Positive
 CLL   session,"Chaitra Ujjani, MD",Positive
   Approaches,"Raul Cordoba, MD, PhD",Negative
 chemotherapyfree frontline,"Raul Cordoba, MD, PhD",Negative
   TGTX TG Therapeutics Initiates Rolling Submission,Mellalta Meets,Negative
   TGTX TG Therapeutics Initiates Rolling Submission,Jodie Insights,Negative
 Biologics License Application,Mellalta Meets,Negative
 Biologics License Application,Tina Witte,Positive
 Biologics License Application,Biotech & Tech Stock Focus,Negative
 Biologics License Application,Mazeraski,Negative
 Biologics License Application,IMPharma News,Negative
 Biologics License Application,Jodie Insights,Negative
 Biologics License Application,dough,Negative
 Biologics License Application,Stock Titan,Negative
 Chronic Lymphocytic Leukemia gtgtRFP,Mellalta Meets,Negative
 Excellent session,Raj Gauba,Positive
 Excellent session,Michie Lab,Negative
 Excellent session,CML AdvocatesNetwork,Negative
 CLLSusan M O‚ÄôBrienJohn PagelIan Flinn,Raj Gauba,Positive
 Meet Doris,"Pharmacyclics, an AbbVie Company",Negative
 patient advocate,"Pharmacyclics, an AbbVie Company",Negative
 patient advocate,Lorna Warwick,Positive
 patient advocate,Patient Power,Negative
 Sat Symposia,Lymphoma Hub,Negative
 MRD status,Lymphoma Hub,Negative
 MRD status,CLL Society Inc.,Positive
 MRD status,"chadi nabhan MD, MBA, FACP",Negative
 MRD status,Genentech,Negative
 Surgical Pathology,Anju,Positive
 Surgical Pathology,Giuseppe Ingravallo,Positive
 past   years,CLL Advocates Network,Negative
 past   years,Frontiers Immunology,Negative
 past   years,CARTI Arkansas,Positive
 COVID era,sganguly,Positive
   Attendees Subscribe,Lisa Palacios,Negative
    Insights Newsletter,Lisa Palacios,Negative
 frontline options,Alan Skarbnik,Negative
 frontline options,Targeted Oncology,Negative
 process,OncLive.com,Negative
 process,Carlos Loinaz,Positive
 process,SpecialtyPTimes,Negative
 process,suetodd16,Positive
 process,Genentech,Negative
 process,Patient Power,Positive
 RelapsedRefractory Small Lymphocytic Lymphoma,MigraineClinicalTrialTracker,Positive
 Dr Weirda,"Hayder Saeed, MD",Positive
 timelimited therapy,Patient Empowerment Network,Negative
 timelimited therapy,Lymphoma Hub,Negative
 Flashback,Danielle M. Brander,Positive
 Flashback,"Cowan, Liebowitz",Negative
 Twitterversary,Danielle M. Brander,Positive
 accumulation,AbbVie US,Positive
 BCL protein,AbbVie US,Positive
 BCL protein,AIS Health,Negative
 cancer cell survival,AbbVie US,Positive
 Frontline therapy,"Cindy M. Pabon, MD",Positive
 decade,"Cindy M. Pabon, MD",Positive
 decade,Targeted Oncology,Negative
 decade,Leukaemia Care,Positive
 decade,Marilyn Heine,Positive
 symposia,Erick Lansigan,Positive
 symposia,"chadi nabhan MD, MBA, FACP",Negative
   web broadcast,PeerView,Positive
 polling,PeerView,Positive
 credit,PeerView,Positive
 credit,Medscape Education,Negative
 Dr PinillaIbarz,Moffitt Cancer Center,Positive
 Dr PinillaIbarz,VJHemOnc,Negative
 panel discussion,Moffitt Cancer Center,Positive
 panel discussion,WCM Lymphoma,Negative
 PIK inhibitors treatment,Moffitt Cancer Center,Positive
 Dr John Gribben,CLL Society Inc.,Negative
 Dr John Gribben,PeerView,Negative
    Peerivew,CLL Society Inc.,Positive
 preASH   event,CLL Society Inc.,Positive
 cancer vaccine,Paperbirds_Hematology,Negative
 weapons,Paperbirds_Hematology,Negative
 lifetime,Janssen EMEA,Positive
 confusion,CLLSA,Negative
 confusion,Charlotte Roffiaen,Positive
 announcement,CLLSA,Negative
 announcement,ArthurPotatoeHammer,Negative
 announcement,AbbVie,Negative
 Survival,"chadi nabhan MD, MBA, FACP",Negative
 Survival,Paperbirds_Hematology,Positive
 Survival,"Raul Cordoba, MD, PhD",Negative
 Survival,Drugs Caps,Negative
 Survival,"Pacylex Pharmaceuticals, Inc.",Positive
 Survival,Christopher Walker,Positive
 Survival,Olderpreneurs,Positive
 Survival,Benlazar S.M Amin√©,Negative
 Survival,PracticeUpdate,Negative
 Survival,MUA,Positive
 Survival,Robo Schmobo,Positive
 Survival,Oncology,Positive
 Survival,Portfolio Penny,Positive
 Survival,Financial Carnivores,Negative
 Survival,CarnivoresHealth,Positive
 Survival,FA Technologies,Positive
 Survival,Mazen M,Negative
 Survival,COPD News,Negative
 Survival,2 Minute Medicine¬Æ,Negative
 Survival,Oncology Times,Negative
 Survival,Financial Buzz,Positive
 Survival,HEDGE accordinglyüìà,Negative
 Survival,RazzleTazzle,Negative
 Survival,Crwe World,Negative
 Survival,Marketbit.pro,Negative
 Survival,Dr Jayaprakash Madhavavan,Positive
 Survival,World Neonatology Congress,Negative
 Survival,Children‚Äôs Oncology Group,Positive
 Survival,SurvivalGear,Negative
 Survival,Lymphoma Canada,Negative
 Survival,CLL Society Inc.,Negative
 Survival,Predictive Analytics,Positive
 Survival,Journal of Clinical Pathways,Negative
 Survival,Invest World News,Negative
 Survival,TerkkoLib,Positive
 Survival,Sheri Hendricks,Positive
 Survival,CURE Magazine,Negative
 Survival,Bill Rodgers,Positive
 Survival,Survival Plan Kits,Positive
 Survival,Dr. Melody Davis,Negative
 Survival,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 Survival,IntoxicatedTrader,Negative
 Survival,DrugGenius,Negative
 Survival,Johan Van Weyenbergh,Negative
 gender,"chadi nabhan MD, MBA, FACP",Negative
 gender,palliativewise,Negative
 UK CLL pilot,Nick,Negative
 Dr  ,Nick,Negative
 Genomics England   Genomes Project,Nick,Negative
 patients genomes,Nick,Negative
 WGS,Nick,Negative
 SIL,Stephanie ü¶Äüç∞,Positive
 Delineation,JAAD Journals,Negative
 PST,Lisa Palacios,Negative
 PST,PeerView,Negative
 PST,Paradigm Med Comm,Negative
 New Era,Lisa Palacios,Negative
 New Era,PeerView,Negative
 New Era,ManagedCareMag,Positive
 New Era,P&T,Positive
 Management Precision Medicine,Lisa Palacios,Negative
 Management Precision Medicine,PeerView,Negative
 Patient Perspectives,Lisa Palacios,Negative
 Patient Perspectives,PeerView,Negative
 TreatmentNa√Øve,Lisa Palacios,Negative
 TreatmentNa√Øve,PeerView,Negative
 TreatmentNa√Øve,INDoximity üáÆüá≥,Negative
 TreatmentNa√Øve,Philip McCarthy,Negative
 TreatmentNa√Øve,Benlazar S.M Amin√©,Negative
 TreatmentNa√Øve,CellworksLife,Negative
 TreatmentNa√Øve,Paperbirds_Hematology,Negative
 TreatmentNa√Øve,Pacientes LMC,Positive
 TreatmentNa√Øve,El tal Toni üéó#JoActuo #LlibertatPresosPolitics,Positive
 TreatmentNa√Øve,CIDEGEN,Positive
 TreatmentNa√Øve,Mahmoud Aljurf,Negative
 TreatmentNa√Øve,sandrineman,Negative
 TreatmentNa√Øve,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Positive
 TreatmentNa√Øve,"Raul Cordoba, MD, PhD",Negative
 Relapsed Disease,Lisa Palacios,Negative
 Relapsed Disease,PeerView,Negative
 Philip Thompson MB MS,Lisa Palacios,Positive
 Philip Thompson MB MS,MD Anderson Leukemia,Negative
 Philip Thompson MB MS,PeerView,Positive
    PST,Lisa Palacios,Negative
 TG Therapeutics Inc,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 TG Therapeutics Inc,dough,Positive
 TG Therapeutics Inc,ur-trading,Positive
 Dr Danielle Brander,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 Dr Danielle Brander,Patient Empowerment Network,Positive
 Dr Danielle Brander,The Leukemia & Lymphoma Society,Negative
 future   expert,Anthony Mato,Negative
 Twitter community,Anthony Mato,Negative
 leukemia cells,Ilera tv,Positive
 Tomorrow Dec Dr John Gribben,CLL Society Inc.,Negative
   Announces Publication,1stOncology,Positive
 Immune Response Dysfunction,ImmunologyPapers,Negative
 Molecular Mechanisms,ImmunologyPapers,Negative
 Microenvironmental,ImmunologyPapers,Negative
 PST   Mapping,PeerView,Negative
 Join s expert tumor board,PeerView,Positive
 telemedicine,Patient Empowerment Network,Positive
 telemedicine,Diverse Health Hub,Positive
 Phase   data,InvestorsObserver,Positive
 Data Evaluating Umbralisib,AlphaBronze,Positive
 Data Evaluating Umbralisib,Biotech & Tech Stock Focus,Negative
 Data Evaluating Umbralisib,Pharmacutical Daily,Negative
 Data Evaluating Umbralisib,Mazeraski,Negative
 Data Evaluating Umbralisib,Jodie Insights,Negative
 Data Evaluating Umbralisib,"OTC Dynamics, Inc.",Negative
 Data Evaluating Umbralisib,IMPharma News,Negative
 Data Evaluating Umbralisib,Biotech2050,Negative
 Data Evaluating Umbralisib,Stock Market News,Negative
 Data Evaluating Umbralisib,Crwe World,Negative
 Data Evaluating Umbralisib,Investor News,Negative
 Data Evaluating Umbralisib,Stock Titan,Negative
 M people,AstraZenecaUS,Negative
 Umbralisib,Paperbirds_Hematology,Negative
 Umbralisib,Tina Witte,Positive
 Umbralisib,Biotech & Tech Stock Focus,Positive
 Umbralisib,Mazeraski,Negative
 Umbralisib,IMPharma News,Positive
 Umbralisib,Jodie Insights,Negative
 Umbralisib,dough,Positive
 Umbralisib,Bio Stocks‚Ñ¢,Positive
 Umbralisib,Stock Titan,Positive
 Umbralisib,Biotech2050,Negative
 Umbralisib,U2 Fans,Negative
 Umbralisib,AlphaBronze,Positive
 Umbralisib,Aloysius Pendergast,Positive
 Umbralisib,Quant Data,Positive
 Umbralisib,Flash Alert,Negative
 Umbralisib,Journal of the @NCCN,Negative
 Umbralisib,RD360,Positive
 Umbralisib,"Redington, Inc.",Positive
 Umbralisib,Behavioral Finance,Positive
 Umbralisib,Jake,Negative
 Umbralisib,Day Trading Alerts,Positive
 Umbralisib,Swing Trading,Positive
 Umbralisib,Michelle Solly,Positive
 Umbralisib,Michel Doepke,Positive
 Umbralisib,Amp Trades,Negative
 Umbralisib,TradeXchange,Negative
 Umbralisib,Targeted Oncology,Negative
 Umbralisib,Krishan Maggon,Negative
 Umbralisib,Tim Fenske,Negative
 Umbralisib,Lymphoma Papers,Negative
 Umbralisib,CureHuntr,Negative
 Umbralisib,TrialBulletin,Positive
 Umbralisib,"chadi nabhan MD, MBA, FACP",Negative
 Umbralisib,"Raul Cordoba, MD, PhD",Negative
 TG Therapeutics Initiates Rolling Submission,Tina Witte,Positive
 TG Therapeutics Initiates Rolling Submission,IMPharma News,Negative
 Announces Publication,Mazeraski,Negative
   TGTX TG Therapeutics Announces Publication,Jodie Insights,Negative
 Chronic Lymphocytic Leu,Crwe World,Positive
 Watch,AbbVie US,Negative
 Watch,Living A Busy Life - With Cancer,Positive
 Watch,Patient Power,Positive
 Watch,Michele Nadeem-Baker,Negative
 Watch,Andrew Schorr,Negative
 Watch,Leukaemia Care,Positive
 Watch,CLL Ireland,Positive
 Watch,Oncology Tube,Negative
   DEZ,Kompetenznetz Maligne Lymphome e.V.,Negative
 Uhr LIVEDiskussion der KMLVideoberichte   jetzt anmelden f√ºr,Kompetenznetz Maligne Lymphome e.V.,Negative
 News vom,Kompetenznetz Maligne Lymphome e.V.,Negative
 mit den Themen,Kompetenznetz Maligne Lymphome e.V.,Negative
 von   Infos,Kompetenznetz Maligne Lymphome e.V.,Negative
 amp Anmeldung,Kompetenznetz Maligne Lymphome e.V.,Negative
   rule changes,CLLSA,Negative
 Comprehensiveinformation,CLLSA,Negative
 website,CLLSA,Positive
 website,Shifa Drug,Positive
 website,CryptoLiveLeak,Positive
 website,LymphomaAction,Negative
 website,VJHemOnc,Negative
 website,Leukaemia Care,Positive
 website,Patient Power,Negative
 website,Lifelong Learning,Negative
 website,CLL,Negative
 Inherited,CLL Society Inc.,Negative
 inherited defect,CLL Society Inc.,Negative
 Newest data Clinical trial,Anthony Mato,Negative
 NEW Long term outcomes,Medivizor,Negative
 amp    BTKi PIKŒ¥i intol,Toby Eyre,Negative
 TP dx Reasons,Toby Eyre,Negative
 caregivers,Patient Empowerment Network,Negative
 caregivers,Karmanos Cancer Institute,Positive
 caregivers,Patient Power,Positive
 caregivers,"Amber Koehler, PA-C",Positive
 caregivers,CLL Society Inc.,Negative
 caregivers,UCI Health,Positive
 caregivers,Healthguru,Positive
 caregivers,Andrew Schorr,Negative
 caregivers,ReaderUSA,Positive
 telemedicine visits,Patient Empowerment Network,Negative
 Join Drs Flinn O‚ÄôBrien,CCO Education,Negative
 Dec   PM PT,CCO Education,Negative
 Medical Need,CCO Education,Negative
 Outcomes Friday Satellite Symposium,CCO Education,Negative
 Exposition,CCO Education,Negative
 Exposition,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Curing,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 CLL MRD immunotherapy,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 HSCT Webinar,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 TGTX TG Therapeutics Initiates Rolling Submission,Biotech & Tech Stock Focus,Negative
 TGTX TG Therapeutics Initiates Rolling Submission,dough,Negative
 TGTX TG Therapeutics Initiates Rolling Submission,Stock Titan,Negative
 TGTX Initiates Rolling Submission,Mazeraski,Negative
 TGTX Initiates Rolling Submission,Bio Stocks‚Ñ¢,Negative
 range,BSI UK,Positive
 BLA,Bio Stocks‚Ñ¢,Negative
 Chronic Lymphocytic LeukemiaCompletion,Bio Stocks‚Ñ¢,Negative
 ObinutuzumabRelated Adverse Events,Paperbirds_Hematology,Negative
 MetaAnalysis,Paperbirds_Hematology,Negative
 VIDEO Updates,VJHemOnc,Positive
 Early Intervention,Jerry Lee,Negative
 Early Intervention,CellworksLife,Negative
 Early Intervention,Cure Cancer Now,Negative
 Early Intervention,CONQUER the patient voice,Negative
 Highrisk Chronic Lymphocytic Leukemia,Jerry Lee,Negative
 Highrisk Chronic Lymphocytic Leukemia,CellworksLife,Negative
 Highrisk Chronic Lymphocytic Leukemia,Cure Cancer Now,Negative
 Covid Vaccines,Shouting at people in my underpants,Negative
 Brian Koffman,Shouting at people in my underpants,Negative
 Brian Koffman,CLL Society Inc.,Negative
 Brian Koffman,Toula Castillo,Positive
 Brian Koffman,AbbVie,Negative
 seven presentations,BeiGene,Negative
 Nicole Lamanna MD,OncLive.com,Positive
 Nicole Lamanna MD,CCO Education,Positive
 Nicole Lamanna MD,MedPage Oncology,Negative
 Nicole Lamanna MD,Clin Adv Hem Onc,Negative
 Nicole Lamanna MD,ColumbiaDoctors,Positive
 University,OncLive.com,Negative
 University,Lymphoma Hub,Negative
 University,Jennifer Smith,Positive
 University,Total Health Conferencing,Positive
 University,"Brian Lawenda, MD",Positive
 University,Michael Hallek,Negative
 University,Anthony J. Rivera,Positive
 University,MD Anderson Leukemia,Negative
 University,SIAM,Positive
 University,CLL Warwick Uni,Negative
 University,VJHemOnc,Negative
 University,Marn√© Prinsloo,Positive
 Herbst Irving Comprehensive Cancer Center,OncLive.com,Negative
 Singleagent zanubrutinib,Lymphoma Hub,Negative
 highrisk treatmentna√Øve patients,Lymphoma Hub,Negative
 New OnDemand Activity,PRIME Education,Negative
 Shared DecisionMaking,PRIME Education,Negative
 CLL Solutions,PRIME Education,Negative
 Providers,PRIME Education,Negative
 Comutations,"chadi nabhan MD, MBA, FACP",Negative
 yo M w,Felipe de Galiza,Positive
 VenetoclaxR,Felipe de Galiza,Positive
 communityTop    experts,CLL Ireland,Negative
 changing landscape,CLL Ireland,Negative
 changing landscape,Nick,Negative
 changing landscape,Biotech2050,Negative
 multicenter GIBB study,Lymphoma Papers,Negative
 multicenter GIBB study,Paperbirds_Hematology,Negative
 multicenter GIBB study,Benlazar S.M Amin√©,Negative
 Risk factors,Medscape Oncology,Negative
 Risk factors,Anthony Mato,Negative
 Risk factors,EBMT,Positive
 Risk factors,AU GP Research Review,Positive
 keratinocyte,Medscape Oncology,Negative
 AustraliaDrug combination approval,CLL Advocates Network,Negative
 Deborah Sims,CLL Advocates Network,Negative
 Deborah Sims,CLL Ireland,Positive
 patient shares,CLL Advocates Network,Negative
 diagnosedWhile,Patient Power,Negative
 Dr Davids,Targeted Oncology,Positive
 Dr Davids,donnashort,Positive
 Dr Davids,CLL Ireland,Negative
 Dr Davids,NE Live,Negative
 VIDEO CARTBE ARI,VJRegenMed,Positive
 CD malignancies,VJRegenMed,Positive
 F√ºr den   werden,medtoday Germany,Negative
 Schwabing den Track der,medtoday Germany,Negative
 vertreten,medtoday Germany,Negative
 Daten des   pr√§sentieren,medtoday Germany,Negative
 Serine,Paperbirds_Hematology,Negative
 individuals,HARMONY Alliance,Positive
 individuals,"Raul Cordoba, MD, PhD",Negative
 individuals,UCI Health,Negative
 individuals,@MyelomaTeacher - Cindy Chmielewski,Positive
 individuals,Women's Health News,Positive
 individuals,Andrew Schorr,Negative
 individuals,WCM Lymphoma,Negative
 individuals,MDLinx,Negative
    John Allan MD,OncLive.com,Negative
 John M Burke MD Rocky Mountain Cancer Centers,OncLive.com,Negative
 Disease,"chadi nabhan MD, MBA, FACP",Negative
 Disease,CLL_Fightersüéó,Positive
 Disease,CLL Ireland,Positive
 Disease,MoJo,Negative
 Disease,"Raul Cordoba, MD, PhD",Negative
 allogeneic stem cell transplant outcomes,Medivizor,Negative
 Partner,Patient Empowerment Network,Positive
 Partner,"OTC Dynamics, Inc.",Negative
 Partner,Mr Bentley Onelly,Positive
 Partner,Michelle Solly,Positive
   Care,Patient Empowerment Network,Positive
 complexities,PeerView,Positive
 complexities,Kim Kirchherr,Negative
 complexities,Patient Power,Negative
 therapeutics,PeerView,Positive
 w John Gribben,VJHemOnc,Positive
 w John Gribben,Brandcast Health,Positive
 lacrimal gland,"Chris Cogbill, MD",Positive
 upper,"Chris Cogbill, MD",Positive
 kinase selectivity,OncLive SOSS,Positive
 New Research Method,Frontiers Immunology,Negative
 Mass Cytometry Application,Frontiers Immunology,Negative
 Mass Cytometry Application,Lymphoma Papers,Negative
 Mass Cytometry Application,Cytof Manchester,Positive
 tumor microenvironment,Frontiers Immunology,Negative
 tumor microenvironment,Cancer Cell,Negative
 TME,Frontiers Immunology,Negative
 Chronic Lymphocytic Leukemia Treatment Market Size Industry Analysis,Swapna Supekar,Positive
 Key Findings Share,Swapna Supekar,Positive
 Emerging Technologies Revenue,Swapna Supekar,Positive
 Key ¬† Findings,Swapna Supekar,Positive
 recognition,CLLSA,Negative
 recognition,Jeff Neurman,Negative
 recognition,ESCofNJ,Negative
 recognition,Exec Director VCCC,Positive
 stress amp anxiety,CLLSA,Negative
 funds,CLLSA,Negative
 funds,Novateur Ventures,Positive
 Global Chronic Lymphocytic Leukemia Treatment Market,Depp Gaikwad,Negative
 Global Chronic Lymphocytic Leukemia Treatment Market,Report consultant,Positive
 Immense Growth,Depp Gaikwad,Negative
 game,Research To Practice,Negative
 game,Amy Ramos,Negative
 game,Ashton Cricket Club,Positive
 game,Esther Schorr,Positive
 game,STRT Boston,Positive
 game,Nick Barker,Positive
 game,Chris Murray,Positive
 frontline therapies,Research To Practice,Negative
 frontline therapies,RTI Health Solutions,Positive
 frontline therapies,Targeted Oncology,Negative
 CLL discussion,Michael Rynne,Negative
 dataThis treatment,Michael Rynne,Negative
 IbrutinibDr Brian Koffman,CLL Ireland,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market,Dr Timos Papagatsias,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market,akonter,Positive
 Chronic Lymphocytic Leukemia Therapeutics Market,Pitch Ticker,Positive
 Near Future,Dr Timos Papagatsias,Negative
 Near Future,Priti Sharma,Positive
 Cheshire Media,Dr Timos Papagatsias,Negative
   thoughts,Seema Ali Bhat,Positive
   S FL,NoShtickJewishChick,Positive
 lots,NoShtickJewishChick,Positive
 lots,Patient Power,Negative
 lots,üá≤üáΩ Leonardo Collado-Torres,Positive
 lots,CARE‚Ñ¢ Education,Negative
 lots,"Amber Koehler, PA-C",Negative
 lots,Jeff Folloder,Positive
 minds,NoShtickJewishChick,Positive
 Macrophage Polarization,Psychiatry Intel,Positive
 Chronic Lymphocytic Leukemia NurseLike Cells,Psychiatry Intel,Positive
 Caretakers,Psychiatry Intel,Positive
 Caretakers,Biomedicines,Positive
 Leukemic,Psychiatry Intel,Positive
 Fouryear FU,"chadi nabhan MD, MBA, FACP",Negative
 limitations,"chadi nabhan MD, MBA, FACP",Negative
 limitations,Dr. Andre Goy,Negative
   Ascentage,Mellalta Meets,Negative
 Pharma Announces Patient,Mellalta Meets,Negative
 IbII Study,Mellalta Meets,Negative
 IbII Study,The Political Hedge,Positive
 IbII Study,mednetnews,Negative
 IbII Study,ArthurPotatoeHammer,Negative
 IbII Study,IMPharma News,Negative
 Bcl inhibitor APG,Mellalta Meets,Negative
 Bcl inhibitor APG,The Political Hedge,Positive
 Bcl inhibitor APG,mednetnews,Negative
 Bcl inhibitor APG,ArthurPotatoeHammer,Negative
 Bcl inhibitor APG,IMPharma News,Negative
 Bcl inhibitor APG,FSTP,Positive
 Ascentage Pharma Announces Patient,The Political Hedge,Positive
 Ascentage Pharma Announces Patient,mednetnews,Negative
 Ascentage Pharma Announces Patient,IMPharma News,Negative
 RelapsedRefractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,The Political Hedge,Positive
 RelapsedRefractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,ArthurPotatoeHammer,Negative
 RelapsedRefractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,IMPharma News,Negative
 RelapsedRefractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Alexander M. J.,Positive
 RelapsedRefractory Chronic Lymphocytic LeukemiaSmall Lymphocytic,mednetnews,Negative
   Pharma Announces Patient,ArthurPotatoeHammer,Negative
 SUZHOU Ch,ArthurPotatoeHammer,Negative
 advent,Targeted Oncology,Negative
 outlook,Targeted Oncology,Negative
 outlook,caitxluhn562155,Positive
 Fannie Mae Freddie Mac conforming loan limits,South Shore REALTORS,Positive
 release,South Shore REALTORS,Positive
   map,South Shore REALTORS,Positive
 CLL treatment,Patient Power,Positive
 CLL treatment,Patient Empowerment Network,Negative
 CLL treatment,Michele Nadeem-Baker,Negative
 CLL treatment,Gear√≥id √ì Crotaigh #CareCantWait,Negative
 CLL treatment,The Leukemia & Lymphoma Society,Negative
 CLL treatment,Paresh Sewpaul,Positive
 Dr Paolo Caimi,Patient Power,Negative
 amp Dr Brian Hill,Patient Power,Negative
 Join Drs Gribben Jacobs Tedeschi,PeerView,Positive
 Thompson,PeerView,Positive
 Thompson,Andrew Schorr,Negative
 Reminder,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 Reminder,Oncology CE,Positive
 tomorrow,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 tomorrow,Leukaemia Care,Negative
 tomorrow,ESCofNJ,Negative
 tomorrow,annemarie,Positive
 tomorrow,Patient Power,Negative
 tomorrow,Jonathan Pearce,Negative
 tomorrow,Patient Empowerment Network,Negative
 official,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 lymphopenia,Journal of the @NCCN,Negative
 Prognostic Role,Paperbirds_Hematology,Negative
 LymphocyteMonocyte Ratio,Paperbirds_Hematology,Negative
 Dr Seymour,Targeted Oncology,Negative
 frontline treatment options,Targeted Oncology,Negative
 frontline treatment options,UCI School of Medicine,Positive
   Polarization,Biomedicines,Positive
 Chronic   NurseLike Cells,Biomedicines,Positive
 Leukemic Cells,Biomedicines,Positive
 Leukemic Cells,"Candice B. Limper, M.S.",Positive
 Leukemic Cells,Pharma Jonpi .,Negative
 Global Chronic Lymphocytic Leukemia Treatment Market Research Report,Depp Gaikwad,Negative
 Lymphoid aggregates,Sanjeev Sethi,Positive
 biopsy,Sanjeev Sethi,Positive
 Happy Week,UC Davis CLL,Positive
 globe,VJHemOnc,Negative
 globe,CLL Advocates Network,Positive
 globe,Nick,Negative
 globe,CLL Ireland,Negative
 w Robin Fo√†,VJHemOnc,Negative
   pandemic,OncLive.com,Negative
   pandemic,Patient Power,Negative
   pandemic,STTR Cancer,Positive
   pandemic,Gear√≥id √ì Crotaigh #CareCantWait,Negative
    role,Dr. Mihnea-Alexandru GƒÉman,Positive
 Pigmentary traits sun exposure,Lymphoma Papers,Negative
 Driver Mutations,Biblioteca HUCA,Negative
 Driver Mutations,Jerry Lee,Negative
 Driver Mutations,Cure Cancer Now,Positive
 Driver Mutations,Paperbirds_Hematology,Negative
 Driver Mutations,Richard Rosenquist Brandell,Positive
 Single Copy,Biblioteca HUCA,Negative
 Number Abnormalities,Biblioteca HUCA,Negative
 text,Biblioteca HUCA,Positive
 text,Michele Nadeem-Baker,Negative
 Chronic Lymphocytic Leukemia CLL Focus,"Naveen Pemmaraju, MD",Negative
 ‚Å¶‚Å© amp,"Naveen Pemmaraju, MD",Positive
 New treatment,CLL Ireland,Negative
 New treatment,LyLe Foreningen,Negative
 New treatment,Newhard Pharmacy,Positive
 New treatment,Michael A. Cantrell,Positive
 CLL treatment resistance,VJHemOnc,Negative
 Dimitar Efremov,VJHemOnc,Negative
 CD antibodies,Paperbirds_Hematology,Negative
 CD antibodies,Antibody Resource,Positive
 Bcell receptor,Paperbirds_Hematology,Negative
 Bcell receptor,NEJM Resident 360,Positive
 Bcell receptor,Expert Perspectives in Oncology,Negative
 Bcell receptor,"Raul Cordoba, MD, PhD",Negative
 Bcell receptor,Cancer Papers,Positive
 Bcell receptor,Francesco Turturro,Negative
 Bcell receptor,Blood Journal,Negative
 Bcell receptor,VJHemOnc,Negative
 Bcell receptor,LRA: New articles,Positive
 Bcell receptor,TumorImmunoPapers,Positive
 Bcell receptor,ImmunologyPapers,Positive
 Bcell receptor,NK papers,Negative
 signalling,Paperbirds_Hematology,Negative
 step,Paperbirds_Hematology,Negative
 step,CLL Society Inc.,Negative
 step,Jo-El Sidbury,Positive
 step,WCM Lymphoma,Negative
 step,Kris Griffin,Positive
 step,Connie Erpelding,Positive
 IGLVR,#Memory,Positive
 Paper,Talha Badar,Positive
 Paper,BeiGene,Negative
 Paper,Sigrid Sk√•nland,Negative
 yr Analysis,Talha Badar,Positive
 Murano Study,Talha Badar,Positive
 Murano Study,Ang√©lica Aranda,Positive
 Murano Study,Benlazar S.M Amin√©,Negative
 Murano Study,"Raul Cordoba, MD, PhD",Negative
 Enduring Undetectable Minimal Residual Disease uMRD,Talha Badar,Positive
 VIDEO RESONATE,VJHemOnc,Negative
 w Jan Burger,VJHemOnc,Negative
 Phase II trial,Journal of the @NCCN,Negative
 shortcourse,Journal of the @NCCN,Negative
 Friday December,PeerView,Negative
 TIMgalectin,Henning,Negative
 Augmented Human Intelligence,Paperbirds_Hematology,Negative
 Automated Diagnosis,Paperbirds_Hematology,Negative
 Flow Cytometry,Paperbirds_Hematology,Positive
 Flow Cytometry,"Raul Cordoba, MD, PhD",Negative
 William Wierda MD,Lisa Palacios,Negative
   Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,Kristen Fernandes,Positive
 Doctor,Lymphoma Research Foundation,Negative
 Doctor,Patient Empowerment Network,Positive
 Doctor,VJHemOnc,Negative
 Doctor,Patient Power,Positive
 Doctor,Weill Cornell Medicine Meyer Cancer Center,Negative
 Doctor,WCM Lymphoma,Negative
 program Dr Raghuveer Ranganathan,Lymphoma Research Foundation,Negative
 patients questions,Lymphoma Research Foundation,Negative
 effectiveness,Lymphoma Research Foundation,Negative
 effectiveness,Journal of the @NCCN,Negative
 effectiveness,Paperbirds_Hematology,Negative
 effectiveness,Medivizor,Positive
 effectiveness,ColumbiaCancer,Positive
 effectiveness,Renal Cell Carcinoma,Negative
 CART cell therapy,Lymphoma Research Foundation,Negative
 CART cell therapy,AcademicTransfer,Positive
 CART cell therapy,Michele Nadeem-Baker,Negative
 CART cell therapy,VJHemOnc,Negative
 CART cell therapy,"Thilo J Zander, MD",Positive
 CART cell therapy,ImmunologyPapers,Negative
 CART cell therapy,Andrew Schorr,Negative
 CART cell therapy,CURE Magazine,Positive
 CART cell therapy,Hugo Cabrera,Positive
 Dr Ranganathan,Lymphoma Research Foundation,Negative
 Threeyear followup,CancerTherapyAdvisor,Negative
 treatment choices,Andrew Schorr,Negative
 cost,Patient Empowerment Network,Negative
 cost,CURE Magazine,Negative
 cost,CLL Society Inc.,Positive
 cost,Patient Power,Positive
 cost,Disraelly Guti√©rrez,Positive
 cost,"chadi nabhan MD, MBA, FACP",Positive
 cost,Aitana,Negative
 cost,Talal Hilal ü©∫,Negative
 cost,VJHemOnc,Positive
 CLL care,Patient Empowerment Network,Negative
 CLL care,Patient Power,Negative
   Bill Wierda,Michael Hallek,Negative
 ESH EConference,ESH (Haematology),Positive
 SESSION VIII Clonal heterogeneity clonal evolution amp mechanisms,ESH (Haematology),Negative
 drug resistance Chairs Davide Rossi John Seymour,ESH (Haematology),Negative
 Dr Hoffman,Targeted Oncology,Positive
    Medscape LIVE town hall,Medscape Education,Negative
 Physicians,Medscape Education,Negative
 Dr Moles,Michie Lab,Negative
   Meet,ESH (Haematology),Negative
   Meet,JanssenUS,Negative
 Expert SessionsSeats,ESH (Haematology),Negative
 ‚û°,ESH (Haematology),Positive
 Chronic Lymphocytic Leukemia New Treatments Achieve Deeper Remissions,The ASCO Post,Negative
 WGS analysisUK CHOPOfat,Toby Eyre,Negative
 RS,Toby Eyre,Negative
 RS,Benlazar S.M Amin√©,Negative
 poorrisk,Toby Eyre,Negative
 drivers amp genes,Toby Eyre,Negative
 DNA damage response pathwayMAPK pathway,Toby Eyre,Negative
 work oxford team,Toby Eyre,Negative
 Jenny K,Toby Eyre,Negative
 Mithralog EC Induces Chronic Lymphocytic Leukemia Cell Death,Biblioteca HUCA,Positive
 Mithralog EC Induces Chronic Lymphocytic Leukemia Cell Death,Prof John,Negative
 Mithralog EC Induces Chronic Lymphocytic Leukemia Cell Death,Transcriptomes,Positive
 Mithralog EC Induces Chronic Lymphocytic Leukemia Cell Death,NK papers,Negative
 Mithralog EC Induces Chronic Lymphocytic Leukemia Cell Death,Paperbirds_Hematology,Negative
 Tonic BCell Receptor,Biblioteca HUCA,Positive
 Tonic BCell Receptor,Prof John,Negative
 Tonic BCell Receptor,NK papers,Negative
 Tonic BCell Receptor,Paperbirds_Hematology,Negative
 risk stratification,OncLive SOSS,Negative
 risk stratification,MediCom Oncology,Positive
 risk stratification,Managing Myeloma,Positive
 SESSION VII Efficacy,ESH (Haematology),Negative
 safetyChairs,ESH (Haematology),Negative
 Barbara,ESH (Haematology),Negative
 Eichhorst Cologne Javid Moslehi Nashville,ESH (Haematology),Negative
 SESSION VI,ESH (Haematology),Negative
 cost effects,Patient Power,Negative
 November newsletter,CLLSA,Negative
 flu jabs details,CLLSA,Negative
 webinar news,CLLSA,Negative
 treatments tips,CLLSA,Negative
   CLL Management,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 ‚è∞,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 KSA time,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 GMTü©∫ Health care professionals,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
   Arnon Kater,Michael Hallek,Negative
   ‚Å¶‚Å©,Michael Hallek,Negative
 SESSION V,ESH (Haematology),Negative
 Venetoclax Review,Paperbirds_Hematology,Negative
 Venetoclax Review,Lymphoma Papers,Negative
 Venetoclax Review,COPD News,Negative
 Venetoclax Review,Benlazar S.M Amin√©,Negative
 Venetoclax Review,Cancer Papers,Negative
 Venetoclaxbased,Paperbirds_Hematology,Negative
 Venetoclaxbased,Eduardo Flavio Oliveira Ribeiro,Negative
 Bruton Tyrosine Kinase,Paperbirds_Hematology,Negative
 Upfront Treatment,Paperbirds_Hematology,Negative
 Upfront Treatment,OncLive.com,Positive
 Method,Lymphoma Papers,Negative
 hour,CCO Education,Negative
 hour,Pallawi Torka,Positive
 hour,Futureproof,Positive
 hour,John Harrington,Positive
 hour,"Pat Euglow, Legacy Newbie",Negative
 hour,Tolero Pharma,Positive
 hour,Schlesinger Group UK,Positive
 hour,Keri Carpenter,Positive
 hour,Teresa Aguiar,Positive
 Ian W Flinn MD,CCO Education,Negative
 pm CTpm ET,CCO Education,Negative
 B Cell Malignancies,Paperbirds_Hematology,Positive
 Heterogeneity,Paperbirds_Hematology,Negative
 TP Mutations,Paperbirds_Hematology,Negative
 P Protein Residual Function,Paperbirds_Hematology,Negative
 Relationship,Paperbirds_Hematology,Negative
 Relationship,OTOdocs,Negative
 Relationship,Cancer Papers,Positive
 Relationship,Francesco Bertoni,Negative
 Relationship,everett jackson,Positive
 Relationship,"Raul Cordoba, MD, PhD",Negative
 Relationship,Patient Power,Negative
 Leukocyte Telomere Length,Paperbirds_Hematology,Negative
 Cancer RiskMortality,Paperbirds_Hematology,Negative
 UK Biobank,Paperbirds_Hematology,Negative
 TCGA,Paperbirds_Hematology,Negative
 Datasets,Paperbirds_Hematology,Negative
 Genetic Risk Score,Paperbirds_Hematology,Negative
 Mendelian Randomization,Paperbirds_Hematology,Negative
 Approaches,Paperbirds_Hematology,Negative
 Approaches,CancerWallonia,Negative
 Approaches,Targeted Oncology,Negative
 Approaches,Patient Power,Negative
 Rush   PGY Resident,Rush Pharmacy,Positive
 Dr David Spaner,Shouting at people in my underpants,Negative
 CLL Diagnosis,Shouting at people in my underpants,Negative
 Managing,Shouting at people in my underpants,Negative
 BIOLOGY,ESH (Haematology),Negative
 MENTORED POSTER WALKLeaders Alexey Danilov,ESH (Haematology),Negative
 Lindsey Roeker,Michael Hallek,Negative
 New York,Michael Hallek,Negative
 New York,EIN Presswire: Press Releases,Negative
 New York,Randall Weis,Positive
 New York,Verastem Oncology,Negative
 New York,Oncology Tube,Negative
 New York,VJHemOnc,Negative
 sequencing,Michael Hallek,Negative
 sequencing,PeerView,Negative
 sequencing,Toby Eyre,Negative
 sequencing,Juan Marquet,Negative
 sequencing,CLL-seq,Negative
 sequencing,Memorial Sloan Kettering Cancer Center,Negative
 sequencing,VJHemOnc,Negative
 therapies BTKi,Michael Hallek,Negative
 SESSION,ESH (Haematology),Negative
 Temporal Trends,Gail Williams,Positive
 Bacterial Infections,Gail Williams,Positive
   presentations,VJHemOnc,Negative
 ondemand Sessions,VJHemOnc,Negative
 indepth discussion,VJHemOnc,Negative
 genesis,VJHemOnc,Negative
 CLL frontline treatment,VJHemOnc,Negative
 immunocompromised cancer patients,Billy Bostickson üè¥üëÅ&üëÅ üÜì,Positive
 archives,Paperbirds_Hematology,Negative
 Mitigate Financial Toxicity,Diverse Health Hub,Positive
 CLL Patients Dr John Pagel,Diverse Health Hub,Positive
 CD CD,Michael Bayerl MD,Positive
 choices,Patient Power,Negative
 choices,VJHemOnc,Negative
 SESSION III,ESH (Haematology),Negative
 RELEASED ‚Äú ERes Salud,"Raul Cordoba, MD, PhD",Negative
 Efremov amp team,ICGEB Official,Positive
 CLINICAL,ESH (Haematology),Negative
 CLINICAL,Medibooks,Negative
 MENTORED POSTER WALKLeaders,ESH (Haematology),Negative
 Matthew Davids amp Alessandra TedeschiAgenda,ESH (Haematology),Negative
 Samples,GenQA (Genomics Quality Assessment),Positive
   Chronic Lymphocytic Leukaemia CLL EQAs,GenQA (Genomics Quality Assessment),Positive
 TP analysis,GenQA (Genomics Quality Assessment),Negative
 IGHV analysis,GenQA (Genomics Quality Assessment),Negative
 Login,GenQA (Genomics Quality Assessment),Negative
 GenQA,GenQA (Genomics Quality Assessment),Positive
 CET SESSION II,ESH (Haematology),Negative
 BCR activation amp,ESH (Haematology),Negative
 CLL Chairs Paolo Ghia Kostas StamatopoulosAccess,ESH (Haematology),Negative
 Welcome   SESSION,ESH (Haematology),Negative
 Nov pm,CLLSA,Negative
 problems,CLLSA,Negative
 problems,CLL Ireland,Negative
 problems,VJHemOnc,Negative
 problems,AEGLE,Negative
 England Venetoclax   obinutuzumab combo,Ancora.ai Cancer Clinical Trials for All,Positive
 chairpersons,ESH (Haematology),Positive
 J Brown P Ghia,ESH (Haematology),Negative
 generation BTK inhibitors,Anthony Mato,Negative
 st Translational Research Conference Chronic Lymphocytic Leukemia,Anthony Mato,Negative
 ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å©,Anthony Mato,Negative
 ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å©,Prof John,Negative
 ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å©,Gorka Coloma,Positive
 ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å©,donnashort,Negative
 LIVE town hall,Medscape Education,Negative
 LIVE town hall,Patient Power,Negative
 Grande Juan,Gimena dos Santos,Positive
 Buen,Gimena dos Santos,Positive
 D√≠a   Juan Francisco Idiarte,Gimena dos Santos,Positive
 un caf√© con Federico Paz,Gimena dos Santos,Positive
 LIVE,ESH (Haematology),Negative
 ‚Üí   Translational Research EConference,ESH (Haematology),Negative
 J Brown P Ghia M HallekInformation,ESH (Haematology),Negative
 Leukaemia Care,Leukaemia Care,Positive
 family members,Leukaemia Care,Positive
 family members,Patient Power,Negative
 family members,Andrew Schorr,Negative
 restrictions,Leukaemia Care,Positive
 restrictions,Michael Rynne,Negative
 restrictions,CLL Ireland,Negative
 restrictions,pharmaphorum,Negative
 restrictions,LymphomaAction,Negative
 New Long term outcomes,Medivizor,Negative
 chro,Medivizor,Negative
 Dr Pleyer,Targeted Oncology,Negative
 Ennio,Kirk Kirlin,Positive
 T education,Diverse Health Hub,Positive
 telemedicine tools,Diverse Health Hub,Positive
 phases,Patient Empowerment Network,Negative
 phases,Patient Power,Negative
 followup,Targeted Oncology,Negative
 followup,Annals of Oncology,Positive
 followup,Prof John,Negative
 followup,Lymphoma Papers,Negative
 followup,CancerEpiPapers,Negative
 followup,WCM Lymphoma,Negative
 followup,Lung EOPH_papers,Positive
 followup,Cancer Papers,Negative
   NEWS,Lymphoma Hub,Positive
 grants,Lymphoma Hub,Negative
 grants,AA&MDSIF,Positive
 yetTake,ESH (Haematology),Negative
 Enhanced IL secretion,Paperbirds_Hematology,Negative
 pShcdeficient CLL cells,Paperbirds_Hematology,Negative
 chemokine landscape,Paperbirds_Hematology,Negative
 aegis,Rajesh Sharma,Negative
 aegis,Manav Rachna,Positive
 Mumbai Hematology GroupDetails,Rajesh Sharma,Negative
 belowTopic   Shifting treatment paradigm,Rajesh Sharma,Negative
 Chr,Rajesh Sharma,Negative
 Manitoba Primary Care Providers,CancerCare Manitoba,Positive
 HOUR,OncLive.com,Negative
 LeukemiaLymphoma IPC,OncLive.com,Negative
 pm ET Register,OncLive.com,Negative
 CME web broadcast,PeerView,Negative
   ASH Annual Meeting,PeerView,Negative
   ASH Annual Meeting,OncLive.com,Negative
   ASH Annual Meeting,The Oncologist,Positive
 treatment approach,Patient Empowerment Network,Negative
 treatment approach,Health Content Collective (HCC),Positive
 Recordatorio Algoritmo de Tratamiento,Hematolog√≠a Salamanca,Negative
 ra,Hematolog√≠a Salamanca,Negative
 ra,Club Libertad Limpe√±o,Negative
 l√≠nea para,Hematolog√≠a Salamanca,Negative
 Leucemia Linf√°tica Cr√≥nica,Hematolog√≠a Salamanca,Negative
 Recordar el algoritmo de tratamiento,Hematolog√≠a Salamanca,Negative
 Hoy con,Hematolog√≠a Salamanca,Negative
 El Dr Marco Gonz√°lez,Hematolog√≠a Salamanca,Negative
 Jefe de Servicio,Hematolog√≠a Salamanca,Negative
 presenta,Hematolog√≠a Salamanca,Negative
 presenta,The Pepex Family,Positive
 presenta,Thu Pepex,Positive
 presenta,Indy Wrestling Chile,Positive
 presenta,Don Pepex,Positive
 Gu√≠as LLC de,Hematolog√≠a Salamanca,Negative
 Nitib Capsule,MCare Exports,Positive
 Alexey V Danilov MD PhD,OncLive.com,Negative
 Alexey V Danilov MD PhD,Casey Foster,Positive
 BCL inhibitors,OncLive.com,Negative
 BCL inhibitors,"chadi nabhan MD, MBA, FACP",Negative
 paradigm shift,OncLive.com,Negative
 mornings work,Ashbridge Nursery at Maxy Farm,Positive
 boys,Ashbridge Nursery at Maxy Farm,Positive
 boys,Marc Pavan,Positive
 boys,Selma Errol Hassan,Positive
 disagreements,Ashbridge Nursery at Maxy Farm,Positive
 UKs,CLL Society Inc.,Negative
 UKs,LiveYourLife,Negative
 UKs,VJHemOnc,Negative
 father,Matt Phillippi,Positive
 father,AstraZeneca Canada,Positive
 father,Leukaemia Care,Positive
 father,Esther Schorr,Negative
 father,F.M.A.Book Reviews,Positive
 father,Team In Training,Positive
 father,Paresh Sewpaul,Positive
 father,"Voula Saridakis, Ph.D.",Positive
 right,Matt Phillippi,Positive
 chemotherapyfree combination,Lymphoma Hub,Negative
 chemotherapyfree combination,Targeted Oncology,Negative
 chemotherapyfree combination,CLL Ireland,Negative
 venetoclax   obinutuzumab,Lymphoma Hub,Negative
 miR Modulates CD,microRNApapers,Negative
 miR Modulates CD,CLL-seq,Negative
 TRAF,microRNApapers,Negative
 TRAF,CLL-seq,Negative
 TRAF,Mraz Lab,Positive
 Axis,microRNApapers,Negative
 Axis,CLL-seq,Negative
 Axis,Mraz Lab,Positive
 BCR inhibitors,microRNApapers,Negative
 BCR inhibitors,CLL-seq,Negative
 BCR inhibitors,Mraz Lab,Positive
 BCR inhibitors,Michele Nadeem-Baker,Negative
 BCR inhibitors,@sehh_es,Negative
 BCR inhibitors,VJHemOnc,Negative
 Translational Research EConference,ESH (Haematology),Negative
 MEET,ESH (Haematology),Negative
 EXPERT SESSIONSDo,ESH (Haematology),Negative
 APTO CC,Joe,Negative
 mein,Joe,Negative
 UR LATEST,Mraz Lab,Positive
 Blood miR Modulates CD,Mraz Lab,Positive
 Blood   American Society,Mraz Lab,Positive
 Blood   American Society,Toby Eyre,Positive
 Blood   American Society,"Eduardo Anguita, MD, PhD",Positive
 Blood   American Society,Richard Rosenquist Brandell,Positive
 Blood   American Society,Juan Marquet,Negative
 Blood   American Society,ALI ALAHMARI.,Negative
 Blood   American Society,Mustafa F,Positive
 Blood   American Society,Ang√©lica Aranda,Positive
 Blood   American Society,gilbert c faure,Negative
 mean survival time,Paperbirds_Hematology,Negative
 LLY APTO LOXOLilly Announces Details,Helen Ong,Positive
 LOXO Presentations,Helen Ong,Positive
   ‚ñ™,Helen Ong,Positive
 Cold flu season,Mass Eye and Ear,Positive
 Cold flu season,Andrew Schorr,Negative
 increased risk,Mass Eye and Ear,Positive
 increased risk,Hematology Advisor,Negative
 increased risk,CLLSA,Negative
 increased risk,"Eric D Whitman, MD",Positive
 increased risk,Graviola Finland,Positive
 increased risk,Nature Reviews Disease Primers,Negative
 increased risk,Lymphoma Hub,Negative
 increased risk,summodiscrimine,Negative
 increased risk,Robert Z. Orlowski,Negative
 sinus infections,Mass Eye and Ear,Positive
 APTO nodal reductionCLL,Joe,Negative
 IbrutinibInduced Cardiac Tamponade,Paperbirds_Hematology,Negative
 Genetic,Paperbirds_Hematology,Negative
 NonGenetic Mechanisms,Paperbirds_Hematology,Negative
 BCR,Paperbirds_Hematology,Negative
 BCR,Europe PMC articles,Positive
 BCR,"Raul Cordoba, MD, PhD",Positive
 BCR,Journal of Leukocyte Biology,Positive
 BCR,Prof John,Positive
 BCR,Cancer Papers,Negative
 BCR,Blood Advances,Positive
 BCR,Medscape Education,Negative
 BCR,Klaus Okkenhaug,Positive
 BCR,"Dr T. Comeau , MD",Negative
 BCR,Lymphoma Hub,Positive
 BCR,Anna Deveau,Negative
 BCR,Oncology Tube,Negative
 BCR,Blood Journal,Positive
 BCR,ICSCCB Pune,Positive
 BCR,WCM Lymphoma,Negative
 times,Michele Nadeem-Baker,Negative
 times,Diverse Health Hub,Positive
 times,Univ. of Rochester School of Medicine & Dentistry,Positive
 times,UR Medicine,Positive
 times,"Chared, Good Comms",Negative
 times,European Hematology Association,Negative
 times,Guillermo Sanz,Negative
 Great News,CLL Advocates Network,Negative
 chemotherapyfree fixedduration treatment option,CLL Advocates Network,Negative
 Nice,CLL Ireland,Negative
 Nice,Christy2x,Positive
 New   trial,E Lambrechts,Negative
 amp   Safety,E Lambrechts,Negative
 Efficacy Study,E Lambrechts,Negative
 Epcoritamab,E Lambrechts,Negative
 RelapsedRefractory Chronic Lymphocytic GMAB,E Lambrechts,Negative
 tcoeuEddqp,E Lambrechts,Negative
 Kirkland nursing home,ChristosArgyropoulos,Negative
 SARSCOV virus,ChristosArgyropoulos,Negative
 MHG,Rajesh Sharma,Negative
 couple,Patient Power,Negative
 couple,Bio-Rad EMEA,Negative
 founders,Patient Power,Negative
 COVID health crisis telemedicine,Diverse Health Hub,Positive
 ‚Äù Link,Living A Busy Life - With Cancer,Positive
 Bio,Living A Busy Life - With Cancer,Positive
 Zur Anmeldung,MedMedia,Positive
 Chronischen,MedMedia,Positive
 Lymphatischen,MedMedia,Positive
 fundamentale,MedMedia,Positive
 Webinar CLL alles,MedMedia,Positive
 schon wieder,MedMedia,Positive
 Sponsored Join DIAs,DIA,Positive
 Robin Weinick SVP,DIA,Positive
    ENIGMA,Prof John,Negative
 CD FUNCTION,Prof John,Negative
    CD,Prof John,Negative
 gatekeeper,Prof John,Negative
 resting stage,Prof John,Negative
 human B cells,Prof John,Negative
 Comparing chemotherapyfree treatments,Medivizor,Negative
 VIDEO Treatment,VJHemOnc,Negative
 mutated unmutated   w Freda Stevenson,VJHemOnc,Negative
 IBIO,Persephone,Positive
 implementation,ALLAB@ PSU,Positive
 teaching methodology,ALLAB@ PSU,Positive
 efficiency,ALLAB@ PSU,Positive
 practicum students,ALLAB@ PSU,Positive
 community partners,ALLAB@ PSU,Positive
 community partners,ILLINOIS Social Work,Negative
 Attiah Hossameldin,ALLAB@ PSU,Positive
 Zoom Room,ALLAB@ PSU,Positive
 Chronic Lymphocytic Leukemiavisit,Arush Emmanuel Michael,Positive
 New Comparing frontline treatments,Medivizor,Negative
 GAIACLL trial,VJHemOnc,Negative
 MMIT Reality Check,MMIT Network,Positive
 Chronic Lymphocytic Leukemia Nov,MMIT Network,Positive
 ÿ≥ÿ§ÿßŸÑÿßŸÑÿßÿ≥ÿ®Ÿàÿπ ŸÖÿ±Ÿäÿ∂ŸÉ ÿßŸÑÿ∞Ÿä Ÿäÿ®ŸÑÿ∫,ÿßŸÑÿ™ÿ´ŸÇŸäŸÅ ÿßŸÑÿ∑ÿ®Ÿäüåü,Positive
 ÿßŸÑÿπŸÖÿ±,ÿßŸÑÿ™ÿ´ŸÇŸäŸÅ ÿßŸÑÿ∑ÿ®Ÿäüåü,Positive
 Ÿäÿ£ÿ™Ÿä,ÿßŸÑÿ™ÿ´ŸÇŸäŸÅ ÿßŸÑÿ∑ÿ®Ÿäüåü,Positive
 ŸÑÿ•ÿ¨ÿ±ÿßÿ° ÿßŸÑŸÅÿ≠Ÿàÿµÿßÿ™ ÿßŸÑÿ±Ÿàÿ™ŸäŸÜŸäÿ© ŸàŸäÿÆÿ®ÿ±ŸÉ ÿ£ŸÜŸá ŸäÿπÿßŸÜŸä,ÿßŸÑÿ™ÿ´ŸÇŸäŸÅ ÿßŸÑÿ∑ÿ®Ÿäüåü,Positive
 ŸÖÿ§ÿÆÿ±ÿß ŸàÿÆÿ≥ÿßÿ±ÿ©,ÿßŸÑÿ™ÿ´ŸÇŸäŸÅ ÿßŸÑÿ∑ÿ®Ÿäüåü,Positive
 ŸÅŸä ÿßŸÑŸàÿ≤ŸÜ ÿå ÿπÿØÿß ÿ∞ŸÑŸÉ ŸÑÿßŸäÿ¥ÿ™ŸÉŸä,ÿßŸÑÿ™ÿ´ŸÇŸäŸÅ ÿßŸÑÿ∑ÿ®Ÿäüåü,Positive
 ŸàÿßŸÑÿ™ÿ≠ÿßŸÑŸäŸÑ ŸÖÿ±ŸÅŸÇÿ©ü©∏ ‚ö™ Ô∏èÿßŸÑÿ™ÿ¥ÿÆŸäÿµ,ÿßŸÑÿ™ÿ´ŸÇŸäŸÅ ÿßŸÑÿ∑ÿ®Ÿäüåü,Positive
 ÿü,ÿßŸÑÿ™ÿ´ŸÇŸäŸÅ ÿßŸÑÿ∑ÿ®Ÿäüåü,Positive
 ÿü,ÿ±ÿ∂ŸàŸâ üê¨,Positive
 AAML BCML CChronic Lymphocytic Leukemia CLL,ÿßŸÑÿ™ÿ´ŸÇŸäŸÅ ÿßŸÑÿ∑ÿ®Ÿäüåü,Positive
 Giacopelli Brian Global DNA methylation analysis,New OhioLINK ETDs,Positive
 New article Pathogenesis,Paperbirds_Hematology,Negative
 EFFECT,Paperbirds_Hematology,Negative
 Œ±LIPOIC,Paperbirds_Hematology,Negative
 ACID,Paperbirds_Hematology,Negative
 late relapse,Benlazar S.M Amin√©,Negative
 Nathan Tirey,Heartland Cancer Foundation,Positive
 European Society,LymphomaAction,Negative
 Medical Oncology,LymphomaAction,Negative
 Medical Oncology,Cancer Treatment Centers of America (CTCA),Positive
   Pharmacokinetics,CureHuntr,Negative
 generating sequencing,CLL Advocates Network,Negative
 Chronic Lymphocytic Leukemia Status Recruiting Condition Summary Chronic Lymphocytic Leukemia,TrialBulletin,Positive
 Christmas PyjamasBy,Face To Face Market,Positive
 Threedrug combo,HemOnc Today,Negative
 ONCT ASH Paper Cirmtuzumab,Jordan üíä,Positive
 AntiROR Antibody,Jordan üíä,Positive
 Ibrutinib Clinical Activity,Jordan üíä,Positive
 Bo Zhang,Lili Wang Lab,Negative
 visiting scholar,Lili Wang Lab,Negative
 Yiming Wu,Lili Wang Lab,Negative
 postdoc,Lili Wang Lab,Negative
 Integrative Transcriptome Quantitative Proteome Analyses,Lili Wang Lab,Negative
 Identify,Lili Wang Lab,Negative
 Identify,Patient Power,Negative
 Identify,GMD,Positive
 Key Regulator,Lili Wang Lab,Negative
 Aberrant RNA Processing,Lili Wang Lab,Negative
 et almedian,Toby Eyre,Negative
 ymedian,Toby Eyre,Negative
 Epidemiological data,Zusia:Dr Jackie Volk,Positive
 Venetoclax UVen,Biotech2050,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia CLLTGTX,Biotech2050,Negative
 OChl,Biotech2050,Negative
 Treatment Na√Øve amp RelapsedRefractory RR Chronic Lymphocytic Leukemia CLL Results,Biotech2050,Negative
 classic   patients,Joe,Negative
 ontarget lymphocytosis,Joe,Negative
 initiation,Joe,Negative
 initiation,BeiGene,Negative
 initiation,"chadi nabhan MD, MBA, FACP",Negative
 initiation,epigenetics_papers,Negative
 initiation,Just Cancer News,Negative
 CG therapy,Joe,Negative
 inhibition,Joe,Negative
 inhibition,Victor Lin,Positive
 inhibition,"Bruce Levine, Ph.D.",Positive
 inhibition,VJHemOnc,Negative
 phosphoBTK,Joe,Negative
 ELISA,Joe,Negative
 plasma inhibitor activity,Joe,Negative
 PIA,Joe,Negative
 reporter cells,Joe,Negative
 Active AKT,Paperbirds_Hematology,Negative
 Bcell malignancies,Paperbirds_Hematology,Negative
 Bcell malignancies,Streetwise Reports,Positive
 Bcell malignancies,Life Sciences Report,Positive
 Bcell malignancies,Prof John,Positive
 Bcell malignancies,Donna Gairns,Positive
 Bcell malignancies,PharmacyTimesCE,Positive
 Bcell malignancies,Blood Journal,Negative
 Secondary ITP,Paperbirds_Hematology,Negative
 Secondary ITP,bluestatestuff,Positive
 VIDEO Relapse,VJHemOnc,Negative
 stem cell transplant differences,VJHemOnc,Negative
 Worldwide Chronic Lymphocytic Leukemia Treatment Market Witness Remarkable Growth,Depp Gaikwad,Negative
 Ibrutinib Resistance,EurekaMag,Negative
 Ibrutinib Resistance,Paperbirds_Hematology,Negative
 Ibrutinib Resistance,Cancer News,Negative
 Ibrutinib Resistance,ASCO Publications,Negative
 Ibrutinib Resistance,Ahmed Gunied,Positive
 Ibrutinib Resistance,CLL Ireland,Negative
 Ibrutinib Resistance,FarmaOnco,Negative
 Ibrutinib Resistance,Dr. Melody Davis,Negative
 Ibrutinib Resistance,Lymphoma Canada,Negative
 FFDGPET,Benlazar S.M Amin√©,Positive
 FFDGPET,Paperbirds_Hematology,Positive
 Bcell receptor inhibitor,Benlazar S.M Amin√©,Positive
 Haematologica,Benlazar S.M Amin√©,Negative
 STRESS RELIEF,AnCan,Negative
 Blood   Video Chat Virtual Meeting,AnCan,Negative
 UblituximabUmbralisib Combo,Patient Worthy,Negative
 CLL Receives Fast Track Designation,Patient Worthy,Negative
 followers,Joe Dowdell,Positive
 followers,üë£Helen's Journeyüë£ (Blogger‚ôî & Poetüìù),Positive
 followers,LiveYourLife,Negative
 Proliferative Signals,Lymphoma Papers,Negative
 Proliferative Signals,Elaine Schattner,Negative
 Curso Chronic Lymphocytic Leukemia,Omniprex,Positive
 tweets,RedMedEd,Negative
     expert Dr Richard Furman,WCM Lymphoma,Negative
 patients ‚Äô risk,WCM Lymphoma,Negative
 Firstinclass biologic drugs,Maddy from GlobalData Healthcare,Positive
 laryngeal cancer,Maddy from GlobalData Healthcare,Positive
 B Cell Receptor Stereotypy,Noor Faisal,Positive
 B Cell Receptor Stereotypy,CellworksLife,Negative
 B Cell Receptor Stereotypy,Cure Cancer Now,Negative
 Tailored Immunotherapy,Noor Faisal,Positive
 Tailored Immunotherapy,Cure Cancer Now,Negative
 Resistance Mechanisms,EurekaMag,Negative
 Resistance Mechanisms,Lymphoma Papers,Negative
 Targeted Agents,EurekaMag,Negative
 Targeted Agents,Katrina Sondermann,Positive
 Targeted Agents,Lymphoma Papers,Negative
 Costeffectiveness,EurekaMag,Negative
 Costeffectiveness,Blood Journal,Positive
 Costeffectiveness,Talha Badar,Positive
 Costeffectiveness,Izaskun Zeberio,Negative
 Costeffectiveness,Paperbirds_Hematology,Positive
 Costeffectiveness,Benlazar S.M Amin√©,Negative
 Costeffectiveness,Eduardo Flavio Oliveira Ribeiro,Negative
 Costeffectiveness,ASH,Negative
 Costeffectiveness,GEDEFO,Negative
 Costeffectiveness,"Navneet Majhail, MD, MS",Negative
 Costeffectiveness,"Dr T. Comeau , MD",Negative
 Costeffectiveness,AA&MDSIF,Positive
 Costeffectiveness,Cancer Papers,Positive
 Costeffectiveness,Blood Advances,Negative
 Costeffectiveness,Elsevier Pharma,Positive
 New Targeted Agents,EurekaMag,Negative
 New Targeted Agents,Paperbirds_Hematology,Negative
 Targeted Oncology Case Based Peer Perspectives event,Targeted Oncology,Negative
 year results,Lymphoma Hub,Negative
 III MURANO study,Lymphoma Hub,Negative
 Arnon Kater,Lymphoma Hub,Positive
 Arnon Kater,VJHemOnc,Positive
 Arnon Kater,Michael Hallek,Negative
 Arnon Kater,The Patient's Channel,Negative
 today,Jeff Neurman,Negative
 today,CLL Advocates Network,Negative
 today,Wendy Dance,Positive
 today,Ian Hazzard,Positive
 today,Marcia Villalba ü¶Ñ,Positive
 today,CLL Warwick Uni,Negative
 today,Expert Perspectives in Oncology,Negative
 today,CryptoLiveLeak,Negative
 today,Dana-Farber,Negative
 today,iwCLL,Negative
 today,JTCancerCenter,Positive
 today,"chadi nabhan MD, MBA, FACP",Negative
 today,Lymphoma Hub,Negative
 today,MaryTiffany,Positive
 ‚Äú holiday,Jeff Neurman,Negative
 EDT,APSHO,Negative
 encore presentation,APSHO,Negative
 subset,Patient Empowerment Network,Negative
 subset,AJMC,Positive
 subset,Cancer Papers,Negative
 Farrukh Awan MD,UTSW Simmons Comprehensive Cancer Center,Positive
 Scale Bail,RedMedEd,Negative
 Fail,RedMedEd,Negative
 BCell Lymphoma Edition,RedMedEd,Negative
 online,RedMedEd,Negative
 online,Patient Power,Negative
 patient care,RedMedEd,Negative
 Ross Salvaris,Future Oncology,Positive
 corner,BioPharm Insight,Positive
 FATE,BioPharm Insight,Positive
 Diagnostic,Paperbirds_Hematology,Negative
 Diagnostic,Women's Publications,Negative
 Diagnostic,Clin Dermatol Res J,Positive
 Diagnostic,Clin Image Case Rep,Negative
 Extracellular Vesicles,Paperbirds_Hematology,Negative
 Extracellular Vesicles,CLL-seq,Negative
 New article COVID,Paperbirds_Hematology,Positive
 Ascorbic acid vitamin C,Paperbirds_Hematology,Negative
 New article GeneReviews,Paperbirds_Hematology,Negative
 Targeted Oncology Case,Targeted Oncology,Negative
 Based Peer Perspectives event Dr Brander,Targeted Oncology,Negative
 Join Drs Gribben Jacbos Tedeschi,PeerView,Negative
 allogeneic stem cell transplant outcomes f,Medivizor,Negative
 LLC evoluci√≥n,Ana Bacelar,Positive
 New Comparing chemotherapyfree treatments,Medivizor,Negative
 Vitamin Cinduced cytotoxicity,Walaa,Positive
 Bruton TyrosineKinase inhibitors,Eduardo Flavio Oliveira Ribeiro,Negative
 Ibrutinib treatment,Lymphoma Papers,Negative
 Ibrutinib treatment,Journal of Clinical Investigation,Negative
 Ibrutinib treatment,Cancer Papers,Negative
 Dual PDLAG,Cytof Manchester,Positive
 checkpoint blockade,Cytof Manchester,Positive
 checkpoint blockade,bioRxiv Immunology,Positive
 checkpoint blockade,bioRxiv,Positive
 limits,Cytof Manchester,Positive
 tumor development,Cytof Manchester,Positive
 murine model,Cytof Manchester,Positive
 murine model,ASH,Negative
 murine model,"Raul Cordoba, MD, PhD",Negative
 murine model,Blood Journal,Negative
 murine model,Broad Institute,Positive
 Frontiers   Method,Cytof Manchester,Positive
 Immunology,Cytof Manchester,Positive
 Immunology,D4 demon,Positive
 Immunology,Dr Alex Concorde,Negative
 RANKL,JExpMed,Negative
 damage,Concrete Logistics,Positive
 damage,John,Negative
   changes,Public Cord Blood Bank Crete,Positive
   changes,CLL Epigenetics,Negative
   changes,Brotman Baty,Positive
 patients ‚Äô lives,Public Cord Blood Bank Crete,Positive
 d√©but dor   La suite,CHELSEA DAKAR SUPPORTERS CLUB,Positive
   bimonthly newsletter,Lymphoma Hub,Negative
 inbox,Lymphoma Hub,Negative
 October edition ‚û° Ô∏è,Lymphoma Hub,Negative
 Meaningful Long Noncoding RNA,Paperbirds_Hematology,Negative
 Oncogenesis,Paperbirds_Hematology,Negative
 Innovation,TBRC,Positive
 Innovation,MD Anderson Leukemia,Negative
 Innovation,CARE‚Ñ¢ Education,Negative
 Innovation,The James,Positive
 Innovation,Cancer News,Negative
 Innovation,CryptoLiveLeak,Positive
 Innovation,TumorImmunoPapers,Negative
 Innovation,"Raul Cordoba, MD, PhD",Negative
 Innovation,MD Anderson Cancer Center,Negative
 partnerships,TBRC,Positive
    market,TBRC,Positive
    market,Jimi Richards,Positive
 ARQL,Joe,Negative
 ARQL,BiopharmIQ by Amp,Positive
 ARQL,Kevin Wolcott,Positive
 ARQL,BioPharm Insight,Positive
 th cohort mg,Joe,Negative
 st PR,Joe,Negative
 wks,Joe,Negative
 drugAPTO,Joe,Negative
 Soo Jin Seung,CAPT-ACTP,Positive
 Finding,Patient Empowerment Network,Negative
 Finding,Patient Power,Negative
 Finding,Oncology Tube,Negative
 Best Option,Patient Empowerment Network,Positive
 firstline,Blood Journal,Negative
 firstline,Talha Badar,Positive
 firstline,Izaskun Zeberio,Negative
 firstline,Benlazar S.M Amin√©,Negative
 firstline,Eduardo Flavio Oliveira Ribeiro,Negative
 firstline,Sarah Williams,Positive
 firstline,Miguel Canales,Positive
 firstline,MDedge Hematology & Oncology,Negative
 firstline,Bionest Partners,Negative
 firstline,Dr. Luis Villela,Positive
 firstline,Paul Lane,Negative
 thirdline ibrutinib,Blood Journal,Negative
 thirdline ibrutinib,Talha Badar,Positive
 thirdline ibrutinib,Izaskun Zeberio,Negative
 thirdline ibrutinib,Benlazar S.M Amin√©,Negative
 thirdline ibrutinib,Eduardo Flavio Oliveira Ribeiro,Negative
 ‚Äú Meet Professor ‚Äù webinar,Research To Practice,Negative
 Developing collaboration,CML AdvocatesNetwork,Negative
 patient groups,CML AdvocatesNetwork,Negative
 patient groups,CLL Advocates Network,Positive
 patient groups,Zack Pemberton-Whiteley,Negative
 family,Michael Rynne,Negative
 family,Patient Empowerment Network,Negative
 family,Susan Oehlers,Positive
 family,Patient Power,Negative
 family,K.,Positive
 family,Derriford Hospital,Negative
 family,University Hospitals Plymouth NHS Trust,Negative
 family,Melanie,Negative
 monthMy father,"Courtney R., B.S., B.A.",Negative
 health issues,"Courtney R., B.S., B.A.",Negative
 exposure,"Courtney R., B.S., B.A.",Negative
 exposure,Lymphoma Papers,Negative
 exposure,Matthews & Associates,Negative
 exposure,"Raul Cordoba, MD, PhD",Negative
 exposure,summodiscrimine,Negative
 service,"Courtney R., B.S., B.A.",Positive
 service,Adam Kittai,Negative
 Essential Genetic Tests,Patient Empowerment Network,Negative
 lets,LYMPHOMA & MYELOMA CONNECT,Negative
 Dr Alexey Danilov,LYMPHOMA & MYELOMA CONNECT,Negative
 youVisit,LYMPHOMA & MYELOMA CONNECT,Negative
 TG Therapeutics,Ozmosi,Positive
 TG Therapeutics,BioPharma Global,Positive
 TG Therapeutics,BioTuesdays,Positive
 TG Therapeutics,Day Trading Alerts,Positive
 TG Therapeutics,Swing Trading,Positive
 TG Therapeutics,‚öæÔ∏èüèÄ‚öΩÔ∏èüé∏ü•Åüéßüé´ü§øüèäüèº‚Äç‚ôÇÔ∏èüèù,Positive
 TG Therapeutics,bored2tears,Positive
 TG Therapeutics,Endpoints News,Positive
 FDA Fast Track designation,Ozmosi,Positive
 CLL Chronic Lymphocytic Leukemia,Ozmosi,Positive
 CLL Chronic Lymphocytic Leukemia,Julie McCrossin AM,Positive
 CLL Chronic Lymphocytic Leukemia,GRACE,Negative
 CLL Chronic Lymphocytic Leukemia,Shouting at people in my underpants,Negative
 CLL Chronic Lymphocytic Leukemia,Laboratory Career,Negative
 CLL Chronic Lymphocytic Leukemia,Oncology Tube,Positive
 CLL Chronic Lymphocytic Leukemia,Odessa Ramos,Positive
 CLL Chronic Lymphocytic Leukemia,JediPD,Negative
 yearold man,Balkan Medical Journal,Negative
 yearold man,AuntMinnie.com,Positive
 yearold man,Targeted Oncology,Positive
 yearold man,ACR Radiology,Positive
 yearold man,Mastopedia,Positive
 fatigue,Balkan Medical Journal,Negative
 fatigue,Patient Journal,Positive
 fatigue,Michael Rynne,Negative
 fatigue,LymphomaAction,Negative
 dyspnea,Balkan Medical Journal,Negative
 ‚Äù,Balkan Medical Journal,Negative
 Gastrointestinal Involvement,Balkan Medical Journal,Positive
 Gastrointestinal Involvement,Prof Dr Zafer Ko√ßak,Positive
 Wnta,Cancer Papers,Positive
 Wnta,Wnt publications,Positive
 Wnta,Blood Journal,Negative
 Wnta,Scott Werntz,Negative
 proliferation,Cancer Papers,Negative
 proliferation,Paperbirds_Hematology,Negative
 proliferation,Prof John,Negative
 proliferation,Wnt publications,Negative
 proliferation,CLL-seq,Negative
 proliferation,Marta Crespo,Negative
 VIDEO Retrospective analysis,VJHemOnc,Negative
 Lydia Scarfo,VJHemOnc,Negative
 TG Therapeutics Announces Fast Track Designation,U2 Fans,Negative
 TG Therapeutics Announces Fast Track Designation,AlphaBronze,Positive
 TG Therapeutics Announces Fast Track Designation,IMPharma News,Negative
 TG Therapeutics Announces Fast Track Designation,Aloysius Pendergast,Positive
 TG Therapeutics Announces Fast Track Designation,Crwe World,Negative
 TG Therapeutics Announces Fast Track Designation,Flash Alert,Negative
 ibrutinib induced atrial fib,"Jose Sandoval S, MD FACP",Positive
 arrhythmias Inhibition,"Jose Sandoval S, MD FACP",Positive
 CSK,"Jose Sandoval S, MD FACP",Positive
 offtarget effect,"Jose Sandoval S, MD FACP",Positive
 Editor ‚Å¶‚Å© questions,donnashort,Negative
 Helping patients,donnashort,Negative
 year survival,donnashort,Negative
 Dr Bryan,donnashort,Negative
 mechanisms,Oncology CE,Positive
 mechanisms,Vindico Medical Education,Positive
 mechanisms,Expert Perspectives in Oncology,Negative
 mechanisms,Michael Hallek,Negative
 mechanisms,Walaa,Positive
 mechanisms,CLL Ireland,Negative
 mechanisms,Medscape Oncology,Negative
 mechanisms,suetodd16,Positive
 mechanisms,Genentech,Negative
 mechanisms,VJHemOnc,Negative
 mechanisms,Lymphoma Hub,Positive
 mechanisms,Illumina Live Events,Positive
 mechanisms,NY Genome Center,Negative
 mechanisms,OncLive.com,Negative
 mechanisms,CHS Chief Resident,Positive
 mechanisms,Francesco Turturro,Negative
 contexts,Oncology CE,Positive
 contexts,Vindico Medical Education,Positive
 JCWO,Jacinto Convit World Organization,Positive
 BCL inhibitor,Lymphoma Papers,Negative
 BCL inhibitor,Paperbirds_Hematology,Negative
 BCL inhibitor,Stock Sharks,Positive
 BCL inhibitor,Diagnostics News,Negative
 BCL inhibitor,the limbic,Negative
 BCL inhibitor,VJHemOnc,Negative
 Virtueel symposium Lymmcare,Yvonne van Batenburg,Positive
 ITP,bluestatestuff,Positive
 asViral infections,bluestatestuff,Positive
 C EpsteinBarr,bluestatestuff,Positive
 Matthew S Davids MD MMSc director,Dana-Farber,Negative
 Chimeric Antigen Receptor T Cells,EurekaMag,Negative
 Chimeric Antigen Receptor T Cells,Lymphoma Papers,Negative
 Chimeric Antigen Receptor T Cells,European Hematology Association,Negative
 Flu Shot,Lauren Evoy Davis,Positive
 med lab scientist,Berto üá®üá¶,Positive
 squaric,JSF Group,Positive
 anilines,JSF Group,Positive
 anti activity,JSF Group,Positive
 products,JSF Group,Positive
 products,Victor Lin,Positive
 debates,Didi Jasmin,Positive
 debates,Anthony Mato,Negative
 debates,MD Anderson Leukemia,Negative
 Inflection Biosciences,Inflection Biosciences Ltd.,Positive
 Publication,Inflection Biosciences Ltd.,Positive
 GC   CXCL plasma levels,ImmuneGCPapers,Positive
 biomarker,ImmuneGCPapers,Positive
 disease activity,ImmuneGCPapers,Positive
 leadership footsteps,Mindy Hermann,Positive
 vice chair,Mindy Hermann,Positive
 chronic cancer,Jan Rynne,Positive
 chronic cancer,LymphomaAction,Negative
 delaycancellation,Jan Rynne,Positive
 Drak,Health & Life Sci Research at Teesside University,Positive
 treatment na√Øve c,Medivizor,Negative
 Fast Track Designation,H.C. Wainwright & Co.,Positive
 Fast Track Designation,BioPharma Global,Positive
 Fast Track Designation,TG Therapeutics,Positive
 Fast Track Designation,BondJamesBond,Positive
 Umbralisib U,H.C. Wainwright & Co.,Positive
 Prof John Seymour amp Prof Andrew Roberts,Leukaemia Foundation,Negative
 GGAL,oxfe,Positive
 ü™Å sigue,oxfe,Positive
 mostrar debilidad,oxfe,Positive
 APTO CG,Joe,Positive
 New Class,Joe,Negative
 DrugsOnly Agent,Joe,Negative
 andFLT,Joe,Negative
 IBL,Michael O'Dwyer,Positive
 IBL,Blood Advances,Negative
 Sandra Kurtin PhD ANPC AOCN,JADPRO,Negative
 education sessions,JADPRO,Negative
 REGISTRATION,ESH (Haematology),Negative
 OPEN Translational Research EConference,ESH (Haematology),Negative
 ‚Üí Register   November     Jennifer Brown Paolo Ghia Michael HallekVisit,ESH (Haematology),Negative
 EConference platform,ESH (Haematology),Negative
 Chronic Lymphocytic Leukemia TGTX,AlphaBronze,Positive
   mgthis medicine,Shifa Drug,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Waldenstrom Macroglobulinemia Marginal Zone Lymphoma,Shifa Drug,Positive
 WeChat amp,Shifa Drug,Positive
 singlecell detection,Paperbirds_Hematology,Negative
 multiplex CRISPRedited gene modifications,Paperbirds_Hematology,Negative
 DAP KinaseRelated ApoptosisInducing Protein Kinase,Paperbirds_Hematology,Negative
 DAP KinaseRelated ApoptosisInducing Protein Kinase,Northumbria University Open Research,Positive
 DRAK,Paperbirds_Hematology,Negative
 DRAK,Northumbria University Open Research,Positive
 Key Regulator Molecular Marker,Paperbirds_Hematology,Negative
 Key Regulator Molecular Marker,Northumbria University Open Research,Positive
   Dr John Pagels ASH,CLL Society Inc.,Negative
 Dr Sameer Parikh Monoclonal Bcell lymphocytosis MBL,CLL Society Inc.,Negative
 population,CLL Society Inc.,Negative
 population,CLL Ireland,Negative
   ùó•ùó≤ùó∫ùó∂ùóªùó±ùó≤ùóø   ùóØùó≤ùó¥ùó∂ùóªùòÄ,Bioevents - Sharing Biomed Knowledge,Negative
 ùó∂ùóª,Bioevents - Sharing Biomed Knowledge,Negative
 ùóµùóºùòÇùóøùòÄView program,Bioevents - Sharing Biomed Knowledge,Negative
 CDC Birx Slammed FDA,sandi - wear a mask to save someone - anyone,Positive
 Power Heartland COVID Crush,sandi - wear a mask to save someone - anyone,Positive
 MedPage,sandi - wear a mask to save someone - anyone,Positive
   Grants UblituximabUmbralisib Combo Fast Track Status,Raymond DuBois,Positive
 Fast Track designation,Targeted Oncology,Negative
 Dr Susan O‚ÄôBrien,Patient Empowerment Network,Positive
 Dr Susan O‚ÄôBrien,Tapan Kadia,Negative
 Dr Susan O‚ÄôBrien,Expert Perspectives in Oncology,Negative
 TGTX   TG Therapeutics Announces Fast Track Designation,BiopharmIQ by Amp,Positive
 Chronic Lymphocytic LeukemiaSee,BiopharmIQ by Amp,Positive
 TGTX AmpCard,BiopharmIQ by Amp,Positive
 Epigenomewide analysis,CellworksLife,Negative
 FirstLine Chronic Lymphocytic Leukemia,EurekaMag,Negative
 FirstLine Chronic Lymphocytic Leukemia,Enfermeria y Seguridad del Paciente,Positive
 FirstLine Chronic Lymphocytic Leukemia,Paperbirds_Hematology,Negative
 Chemoimmunotherapy,EurekaMag,Negative
 Chemoimmunotherapy,ASH Clinical News,Negative
 Chemoimmunotherapy,Benlazar S.M Amin√©,Positive
 Chemoimmunotherapy,Lymphoma Papers,Positive
 Chemoimmunotherapy,Paperbirds_Hematology,Positive
 Chemoimmunotherapy,Enfermeria y Seguridad del Paciente,Positive
 Chemoimmunotherapy,the paper link,Negative
 Chemoimmunotherapy,2 Minute Medicine¬Æ,Negative
 Chemoimmunotherapy,COPD News,Negative
 Chemoimmunotherapy,Anthony Mato,Negative
 Chemoimmunotherapy,SpecialtyPTimes,Positive
 Chemoimmunotherapy,Oncology,Negative
 Chemoimmunotherapy,"Dr T. Comeau , MD",Negative
 Chemoimmunotherapy,Kenar Jhaveri,Positive
 Chemoimmunotherapy,Researchphilia,Positive
 Chemoimmunotherapy,NEJM,Negative
 Chemoimmunotherapy,Konstantinos Vlachos,Positive
 Chemoimmunotherapy,Prof John,Negative
 Chemoimmunotherapy,Florent Malard,Negative
 Chemoimmunotherapy,"Wafik S. El-Deiry, MD, PhD, FACP",Negative
 Chemoimmunotherapy,Philip McCarthy,Negative
 Chemoimmunotherapy,Dr. Jos√© A. Queiz√°n,Negative
 Chemoimmunotherapy,Montse Carrere,Positive
 Chemoimmunotherapy,MHC,Negative
 Chemoimmunotherapy,JediPD,Negative
 Chemoimmunotherapy,Merche Gironella,Positive
 Chemoimmunotherapy,Medicine Briefly,Negative
 Chemoimmunotherapy,"Raul Cordoba, MD, PhD",Positive
 Chemoimmunotherapy,Hematolog√≠a Salamanca,Negative
 Chemoimmunotherapy,ALI ALAHMARI.,Negative
 Chemoimmunotherapy,Adriana Aguilar,Positive
 Chemoimmunotherapy,Al-Ola A Abdallah MD,Positive
 Chemoimmunotherapy,Expert Perspectives in Oncology,Positive
 Chemoimmunotherapy,Syed Abutalib,Positive
 Chemoimmunotherapy,ecancer,Negative
 Chemoimmunotherapy,Cancer Papers,Positive
 Chemoimmunotherapy,Lymphoma Coalition,Negative
 Chemoimmunotherapy,Clin Adv Hem Onc,Negative
 Chemoimmunotherapy,Lymphoma Hub,Negative
 Chemoimmunotherapy,The ASCO Post,Positive
 Chemoimmunotherapy,Dr. Melody Davis,Negative
 Chemoimmunotherapy,MD Anderson Leukemia,Positive
 heterogeneity,QUB Blood Cancer Research,Positive
 heterogeneity,Claire Eyers,Positive
 heterogeneity,iwCLL,Negative
 treatment na√Øve ch,Medivizor,Negative
 TGTX TG Therapeutics Announces Fast Track Designation,Biotech & Tech Stock Focus,Negative
 TGTX TG Therapeutics Announces Fast Track Designation,dough,Negative
 TGTX TG Therapeutics Announces Fast Track Designation,Stock Titan,Negative
   mutation,Journal of the @NCCN,Negative
 TG Therapeutics Reports FDA Fast Track Designation,Quant Data,Negative
 Artikel,LyLe Foreningen,Negative
 hvordan,LyLe Foreningen,Negative
 √¶matologisk,LyLe Foreningen,Positive
 klarer sig,LyLe Foreningen,Negative
 Umbralisib fo,Crwe World,Negative
 TGTX   Announces Fast Track Designation,Bio Stocks‚Ñ¢,Negative
 Catherine Holliday Chief,Julie McCrossin AM,Positive
 Exec,Julie McCrossin AM,Positive
 Geneva,Julie McCrossin AM,Positive
 PEEK Study,Julie McCrossin AM,Positive
 Patient Advocate Neil Mathews,Julie McCrossin AM,Positive
 UKAust patients,Julie McCrossin AM,Positive
 amp family,Julie McCrossin AM,Positive
 amp family,Esther Schorr,Negative
 Thanks Prof Peter Hillman,Julie McCrossin AM,Positive
 Sharon Winton CEO,Julie McCrossin AM,Positive
 improvements,Julie McCrossin AM,Positive
 MC webinar,Julie McCrossin AM,Positive
            √¶ft,LyLe Foreningen,Negative
 Treatment Breakthroughs,kokoshungsan.net,Positive
 Treatment Breakthroughs,pomento.in üáÆüá≥,Positive
 Treatment Breakthroughs,Ritesh Patil,Negative
 Treatment Breakthroughs,Articlesly,Negative
 Treatment Breakthroughs,Jane Freeman,Positive
 Treatment Breakthroughs,Andie Williams,Positive
 Treatment Breakthroughs,Rebecca Hong,Positive
 Treatment Breakthroughs,Holly Vanwinkle,Positive
 Treatment Breakthroughs,Kerri Logsdon,Positive
 Treatment Breakthroughs,Minna Saavedra,Positive
 Treatment Breakthroughs,Stanley Weber,Positive
 Treatment Breakthroughs,Polonius Josifovitz,Positive
 Treatment Breakthroughs,tanifel,Positive
 Treatment Breakthroughs,tara,Positive
 Treatment Breakthroughs,KeleSkellk,Positive
   Q,hematologist,Positive
 frontline delp,"Mazyar Shadman, MD MPH",Negative
 Mask,Show Me Nourish,Positive
 allogeneic stem cell transpla,Medivizor,Negative
 Mind Blog,"Cowan, Liebowitz",Positive
 brand names,David Wang,Positive
 New Article AlertChronic Lymphocytic Leukemia,Journal of American Society of Cytopathology,Positive
 Second Primary NonLymphoid Malignanc,Journal of American Society of Cytopathology,Positive
 Shuo Ma MD PhD,OncLive SOSS,Negative
   ùóóùóîùó¨ùó¶ ùó®ùó°ùóßùóúùóü,Bioevents - Sharing Biomed Knowledge,Negative
 Fluorescence,Paperbirds_Hematology,Negative
 Fluorescence,SexGenomics,Negative
 Fluorescence,Cancer Papers,Negative
 Situ Hybridization,Paperbirds_Hematology,Positive
 Situ Hybridization,SexGenomics,Negative
 Molecular Cytogenetic Abnormalities,Paperbirds_Hematology,Negative
 Enterobius vermicularis Infection,Paperbirds_Hematology,Negative
 Lung Associated,Paperbirds_Hematology,Negative
 AntiApoptotic Role,Paperbirds_Hematology,Negative
 EBVLMP,Paperbirds_Hematology,Negative
 Lymphoma Cells,Paperbirds_Hematology,Negative
 Fixedduration venetoclax,OncologyNurseAdvisor,Negative
 Fixedduration venetoclax,Hematology Advisor,Negative
 VenR,OncologyNurseAdvisor,Negative
 VenR,Benlazar S.M Amin√©,Negative
 progressionfree survival PFS,OncologyNurseAdvisor,Negative
 progressionfree survival PFS,"Lymphoma, Leukemia & Myeloma Congress",Positive
 progressionfree survival PFS,Great Debates in Hematologic Malignancies,Negative
 NEW Comparing chemotherapyfree treatments,Medivizor,Negative
 novel biomarkers,VJHemOnc,Negative
 classification system,VJHemOnc,Negative
 CLL w Andreas Agathangelidis,VJHemOnc,Negative
 Impact   Patients,Patient Empowerment Network,Negative
 diagnosis treatment,Annals of Oncology,Positive
 diagnosis treatment,Andrew Schorr,Negative
 diagnosis treatment,Lymphoma Coalition,Negative
 p√• fredag kun,LyLe Foreningen,Negative
   snakker,LyLe Foreningen,Negative
 og √•r√∏rende,LyLe Foreningen,Negative
 √¶r med til,LyLe Foreningen,Negative
 bestemme LyLes fremtid,LyLe Foreningen,Negative
 Matthew S Davids MD MMSc,Journal of the @NCCN,Negative
 Matthew S Davids MD MMSc,Targeted Oncology,Negative
 Matthew S Davids MD MMSc,CLL Ireland,Negative
 Targeted Oncology Novel Agents,Oncology Board,Negative
   ‰æùÈ≤ÅÊõøÂ∞º Ê∑ãÂ∑¥Áôå,World Cancer medicine,Positive
 ·ªánhb·∫°chc·∫ßum√£nt√≠nh,World Cancer medicine,Positive
 –õ—É—á—à–∏–π –ø—Ä–æ–¥—É–∫—Ç –¥–ª—è –±–æ—Ä—å–±—ã,World Cancer medicine,Positive
 —Å      –õ–µ–π–∫–µ–º–∏—è Ÿäÿ≥ÿ™ÿÆÿØŸÖ Ÿáÿ∞ÿß ÿßŸÑÿØŸàÿßÿ° ŸÑÿÆŸÑÿßŸäÿß ÿπÿ®ÿßÿ°ÿ© ÿ≥ÿ±ÿ∑ÿßŸÜ ÿßŸÑÿ∫ÿØÿØ ÿßŸÑŸÑŸäŸÖŸÅÿßŸàŸäÿ© ÿ≥ÿ±ÿ∑ÿßŸÜ,World Cancer medicine,Positive
 VIDEO CLL cell treatment resistance,VJHemOnc,Negative
 microenvironmental interactions,VJHemOnc,Negative
 microenvironmental interactions,ClinOwl Haematology,Negative
 microenvironmental interactions,Life Science Jobs,Positive
 Pulmonary arterial hypertension,J Cardio Medicine,Positive
 Pulmonary arterial hypertension,PHpapers,Positive
 Anticancer,Journal of Cancer Research and Immuno-Oncology,Positive
 B cell cancer therapy,Journal of Cancer Research and Immuno-Oncology,Positive
 CLL cell proliferation,VJHemOnc,Negative
 Targeted Therapy,EurekaMag,Negative
 Targeted Therapy,CLL-seq,Negative
 Targeted Therapy,Paperbirds_Hematology,Negative
 Targeted Therapy,Journal of Clinical Pathways,Negative
 Targeted Therapy,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 Targeted Therapy,Matthias Piesche,Positive
 Targeted Therapy,The ASCO Post,Positive
 Targeted Therapy,Patient Power,Negative
 Targeted Therapy,FarmaOnco,Negative
 Targeted Therapy,Michael Baker,Positive
 Targeted Therapy,NACDA Program on Aging,Negative
 Targeted Therapy,Tom,Negative
 Targeted Therapy,TumorImmunoPapers,Positive
 Targeted Therapy,Cancer Papers,Negative
 Targeted Therapy,Armand!!,Negative
 Targeted Therapy,Edurne Gamarra,Positive
 Shuo Ma MD,Lurie Cancer Center,Positive
 Developing Novel Agents,Lurie Cancer Center,Negative
 BTK Inhibitor,Lurie Cancer Center,Negative
 Seema Bhat MD,OncLive SOSS,Positive
 timelimited combination,OncLive SOSS,Negative
 fourfactor prediction model,NIH NHLBI,Negative
 Scientists,Cytiva,Positive
 Scientists,10x Genomics,Positive
 Scientists,"Scot Ackerman, M.D.",Positive
 Scientists,Jonathan Kimmelman,Positive
 Scientists,CLL Ireland,Positive
 Scientists,ASBMB,Positive
 Scientists,Molecular & Cellular Proteomics,Positive
 Scientists,The Health Elixir,Positive
 Scientists,Harrison and Star,Positive
 compounds,Cytiva,Positive
 pathway,Cytiva,Positive
 pathway,VJHemOnc,Negative
 pathway,Cancer Papers,Positive
 pathway,Wnt publications,Negative
 pathway,TECH JOBS,Positive
 pathway,All Jobs,Positive
 Zanubrutinib monotherapy,Benlazar S.M Amin√©,Negative
 p deletion,Benlazar S.M Amin√©,Negative
 p deletion,Felix Keller,Positive
 p deletion,Joana Koury,Positive
 p deletion,Targeted Oncology,Negative
 p deletion,dario pasqualini,Positive
 p deletion,S.K.,Positive
 p deletion,Susan Ehret,Positive
 p deletion,CLL Ireland,Positive
 p deletion,Lymphoma Hub,Positive
 p deletion,"Liseth M Parra, PhD",Positive
 p deletion,Kerri Wachter,Negative
 p deletion,DAMSonians,Positive
 p deletion,HemOnc Today,Positive
 p deletion,CAPhO,Negative
 p deletion,Francesco Turturro,Negative
 p deletion,CancerTherapyAdvisor,Negative
 p deletion,Melanie,Negative
 p deletion,Gitte Pedersen,Positive
 p deletion,Patient Power,Negative
 p deletion,The Medical Letter,Negative
 p deletion,Emma,Positive
 p deletion,Donna Young,Negative
 p deletion,1stOncology,Negative
 p deletion,LLZ Consulting,Negative
 past,VJHemOnc,Negative
 past,iwCLL,Positive
 past,"Pharmacyclics, an AbbVie Company",Negative
 past,Teresa Martin,Positive
 present,VJHemOnc,Negative
 present,PER,Negative
 immunoglobulin genes,VJHemOnc,Negative
 RealWorld Evidence,EurekaMag,Negative
 RealWorld Evidence,Juan Marquet,Negative
 Webinar   Treatment,Patient Empowerment Network,Negative
 Tues,Patient Empowerment Network,Negative
 PT   pm ET Register,Patient Empowerment Network,Negative
 Predictive Model,The ASCO Post,Negative
 Virtual Light,Jesus-Others-Myself,Positive
 Night,Jesus-Others-Myself,Positive
   yr SURVIVOR,Jesus-Others-Myself,Positive
 Chronic Lymphocytic Leukemia CLL‚ÄúI,Jesus-Others-Myself,Positive
 Cancer‚ÄùMike Giannamore,Jesus-Others-Myself,Positive
 Night Walk Fund,Jesus-Others-Myself,Positive
 Page,Jesus-Others-Myself,Positive
 Copyright Developments,"Cowan, Liebowitz",Positive
 Denial,"Cowan, Liebowitz",Negative
 Certiorari Leaves,"Cowan, Liebowitz",Negative
 Ninth Circuit,"Cowan, Liebowitz",Negative
 En Banc Decision Finding,"Cowan, Liebowitz",Negative
 Infringement,"Cowan, Liebowitz",Negative
 Stairway,"Cowan, Liebowitz",Negative
 Heaven,"Cowan, Liebowitz",Negative
 tcoTtyOpOcE,"Cowan, Liebowitz",Negative
 th Annual National Patient Conference,AbbVie Canada,Negative
 evolving treatment paradigm,WCM Lymphoma,Negative
 evolving treatment paradigm,OncLive.com,Negative
 evolving treatment paradigm,Renal Cell Carcinoma,Negative
 evolving treatment paradigm,SpecialtyPTimes,Negative
 combination therapies,WCM Lymphoma,Negative
 combination therapies,OncLive SOSS,Negative
 combination therapies,CLL Society Inc.,Positive
 combination therapies,VJHemOnc,Positive
 combination therapies,Ralph Casale,Positive
 Peer Exchange,WCM Lymphoma,Positive
 Webinar zur,Kompetenznetz Maligne Lymphome e.V.,Negative
 des CIO K√∂ln Referentin,Kompetenznetz Maligne Lymphome e.V.,Negative
 Prof Dr,Kompetenznetz Maligne Lymphome e.V.,Negative
 Barbara Eichhorst,Kompetenznetz Maligne Lymphome e.V.,Negative
 Barbara Eichhorst,VJHemOnc,Positive
 Barbara Eichhorst,Lymphoma Hub,Negative
 Ober√§rztin der Klinik,Kompetenznetz Maligne Lymphome e.V.,Negative
 VIDEO Networking science,VJHemOnc,Negative
 politics,VJHemOnc,Negative
 w Ulrich J√§ger,VJHemOnc,Negative
 Shifting Paradigm,EurekaMag,Negative
 Monitor,clonoSEQ,Negative
 Alankus Ruland   amp colleagues,Rockefeller U. Press,Positive
 Beg√ºm Alankus J√ºrgen Ruland,JExpMed,Negative
 Healthcare resource utilization,Lymphoma Papers,Negative
 firstline ibrutinib,Lymphoma Papers,Negative
 firstline ibrutinib,MD Anderson Cancer Center,Negative
 chemoimmunotherapy treatment,Lymphoma Papers,Negative
 Medicare beneficiaries,Lymphoma Papers,Negative
 Medicare beneficiaries,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Medicare beneficiaries,JAMA Oncology,Negative
 Rare case,Journal of the @NCCN,Negative
 Rare case,Lymphoma Papers,Negative
 Mutational Landscape,Paperbirds_Hematology,Negative
 Mutational Landscape,CLL-seq,Negative
 Bystander Cells DrugPromoted Blood Cancer,Paperbirds_Hematology,Negative
 HighPrevalence Preneoplasias,Paperbirds_Hematology,Negative
 BRAF Inhibitors,Paperbirds_Hematology,Negative
 Mighty,javiboix,Negative
 origins,VJHemOnc,Negative
 Treatment Health Care Resource Utilization,STATinMED Research,Positive
 Treatment Health Care Resource Utilization,Lymphoma Papers,Negative
 Treatment Health Care Resource Utilization,Paperbirds_Hematology,Negative
 Costs,STATinMED Research,Positive
 Costs,Paperbirds_Hematology,Positive
 Costs,Advances in Therapy,Negative
 Costs,Lymphoma Papers,Negative
 Costs,Anthony Mato,Negative
 Costs,CLL Society Inc.,Negative
 Ibrutinib Use,STATinMED Research,Positive
 Ibrutinib Use,Ana Rosa Rubio,Positive
 Ibrutinib Use,Christopher Steer,Negative
 Ibrutinib Use,JAMA Network,Negative
 Ibrutinib Use,JAMA Dermatology,Positive
 Ibrutinib Use,M Jos√© Mart√≠nez Bautista,Positive
 Ibrutinib Use,CancerTherapyAdvisor,Negative
 Veterans,STATinMED Research,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma RealWorld Retrospective Analysis,STATinMED Research,Positive
 Dr Sandoval Sus,Targeted Oncology,Negative
 guidelinerecommended treatment options,Targeted Oncology,Negative
 Join Jacob D Soumerai MD,CCO Education,Negative
 Stephan Stilgenbauer,ASH Clinical News,Negative
 Stephan Stilgenbauer,VJHemOnc,Positive
 Stephan Stilgenbauer,Michael Hallek,Positive
 Susan O‚ÄôBrien,ASH Clinical News,Negative
 Susan O‚ÄôBrien,Sigrid Sk√•nland,Negative
 Susan O‚ÄôBrien,Francesc Bosch,Positive
 Susan O‚ÄôBrien,VJHemOnc,Negative
 Dr Khan,Targeted Oncology,Negative
 bone marrow biopsy,Targeted Oncology,Negative
 JoinShare CLL Treatment,Patient Empowerment Network,Negative
 SCIENTIFIC RATIONALE,Hematology,Positive
 LOWER DOSE,Hematology,Positive
 slowgrowing type,Ohio Infusion Services,Positive
 tissues,Ohio Infusion Services,Positive
 tissues,Adam Marshall Dobrin üîØ‚òÄ‚ÅÇ @suzq@rettiwtkcuf.social,Positive
 tissues,Genevieve Gutierrez,Positive
 tissues,"‚ÄúNicky""",Positive
 tissues,AnamjemWAK,Positive
 SOHO State,Lymphoma Papers,Negative
 Art Updates,Lymphoma Papers,Negative
 Questions Clonal Evolution,Lymphoma Papers,Negative
 New article Case,Paperbirds_Hematology,Negative
 COVIDInduced Lymphocytosis,Paperbirds_Hematology,Negative
 TreatmentNaive CLL,Paperbirds_Hematology,Negative
 Richter transformation w Barbara Eichhorst,VJHemOnc,Negative
 Tiara,Siegenthaler_Lab,Positive
 PhD,Siegenthaler_Lab,Negative
 PhD,Bryjalab,Positive
 PhD,Michael Moles,Positive
 triggersuspicion,Srujana Joga,Positive
 Susan M OBrien MD,Srujana Joga,Positive
 Susan M OBrien MD,OncLive.com,Negative
 disease management w Robin Fo√†,VJHemOnc,Negative
 Awesome paper,Eduardo Flavio Oliveira Ribeiro,Negative
 Increase,Benlazar S.M Amin√©,Negative
 Increase,Odessa Ramos,Positive
 IgA,Benlazar S.M Amin√©,Negative
 IgA,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 ibrutinib therapy,Benlazar S.M Amin√©,Positive
 ibrutinib therapy,Paperbirds_Hematology,Negative
 ibrutinib therapy,"Raul Cordoba, MD, PhD",Negative
 ibrutinib therapy,Lymphoma Papers,Negative
 ibrutinib therapy,ALI ALAHMARI.,Negative
 ibrutinib therapy,WCMNYPJCTO,Negative
 ibrutinib therapy,Renal Cell Carcinoma,Negative
 ibrutinib therapy,"chadi nabhan MD, MBA, FACP",Negative
 ibrutinib therapy,CancerTherapyAdvisor,Negative
 infection rate,Benlazar S.M Amin√©,Negative
 history,AuntMinnie.com,Positive
 history,Mayo Clinic Pathology,Positive
 history,NEJM,Negative
 history,CLL Ireland,Negative
 history,Leukaemia Care,Negative
 history,Virtute_USMLE,Negative
 physician,INDoximity üáÆüá≥,Negative
 physician,Katrina Sondermann,Positive
 physician,Medscape Oncology,Positive
 physician,Toula Castillo,Positive
 „Åì„ÅÆÁµêÊûú„ÅØ„Åô„Åî„ÅÑ,yokoyamaisao2018,Positive
 John Allan MD,OncLive.com,Positive
 John M Burke MD,OncLive.com,Negative
 John M Burke MD,Oncology CE,Positive
 John M Burke MD,Vindico Medical Education,Positive
 New Research Genetic Loss,Frontiers Immunology,Negative
 LCK Kinase,Frontiers Immunology,Negative
 LCK Kinase,Paperbirds_Hematology,Negative
 Acceleration,Frontiers Immunology,Negative
 Acceleration,Paperbirds_Hematology,Negative
 CT scans,Patient Power,Negative
 CT scans,OncLive.com,Negative
 CT scans,WCM Lymphoma,Negative
 tests,Patient Power,Positive
 tests,RYŒõNN LYNN WŒûLLŒûR üî•,Positive
 tests,CLLSA,Negative
 tests,Charlotte Roffiaen,Positive
 tests,CML AdvocatesNetwork,Negative
 generation sequencing,Patient Power,Negative
 FISH,Patient Power,Positive
 FISH,NeoGenomics,Positive
 FISH,GenPath Oncology,Positive
 trigger,Patient Power,Negative
 treatment CLL expert Dr Richard Furman,Patient Power,Negative
 ‚§µÔ∏è,Patient Power,Negative
 upcoming   webinar CLL Treatment,Patient Empowerment Network,Negative
 rs polymorphism,Paperbirds_Hematology,Negative
 PRX gene,Paperbirds_Hematology,Negative
 interferon,Paperbirds_Hematology,Negative
 T cells,Paperbirds_Hematology,Negative
 T cells,AcademicTransfer,Positive
 T cells,Lymphoma Papers,Negative
 T cells,Prof John,Negative
 T cells,3PSolution,Negative
 T cells,The Scientist,Positive
 T cells,Nature Medicine,Positive
 T cells,CLL-seq,Negative
 T cells,Klaus Okkenhaug,Positive
 T cells,TumorImmunoPapers,Positive
 T cells,iMM,Positive
 T cells,Francesco Turturro,Negative
 avadomide sensitizes CLL,Paperbirds_Hematology,Negative
 ‚Äç,VJHemOnc,Positive
 ‚Äç,Proyecto Lucha Libre,Positive
 ‚Äç,Bruce Samuelson,Positive
 ‚Äç,œÄ,Positive
 ‚Äç,Jah Kuu,Negative
   Bestimmte Risikofaktoren,AbbVie Deutschland,Negative
 Lebenserwartung von Menschen mit chronischer lymphatischer √§mie,AbbVie Deutschland,Negative
 ICP,TrialBulletin,Negative
 Suggested focus,Zusia:Dr Jackie Volk,Positive
   Society Q    Tribune,CLL Society Inc.,Negative
 Dear Abby,CLL Society Inc.,Negative
 Lab Scientist,CLL Society Inc.,Negative
 Pharmacist,CLL Society Inc.,Negative
 Hospice doctor,CLL Society Inc.,Negative
 NYC,WCM Lymphoma,Positive
 NYC,CLL Society Inc.,Negative
 NYC,Andrew Schorr,Negative
 NYC,Anthony Mato,Negative
 NYC,@MyelomaTeacher - Cindy Chmielewski,Negative
 NYC,6HN Oncology Nurses,Negative
 Improved Patient Classification,Richard Rosenquist Brandell,Positive
 CMM,Richard Rosenquist Brandell,Positive
           wwwatozdrugscom,AtoZ Drugs Bangladesh.,Positive
 Pete,JanssenUS,Negative
   diagnosis Pete,JanssenUS,Negative
 ibrutinib plus fludarabine cyclophosphamide,OncLive SOSS,Negative
 survey,Michael Rynne,Negative
 survey,CLLSA,Negative
 survey,Natacha Bola√±os,Positive
 survey,GenQA (Genomics Quality Assessment),Negative
 survey,Research To Practice,Negative
 survey,"chadi nabhan MD, MBA, FACP",Negative
 survey,Zack Pemberton-Whiteley,Positive
 survey,Patient Power,Negative
 Update Year MURANO study,CLL Advocates Network,Negative
 New Chronic Lymphocytic Leukemia CLL Toolkit,PRIME Education,Negative
 Power,PRIME Education,Negative
 Power,Michele Nadeem-Baker,Positive
 Power,World Neonatology Congress,Negative
 Power,Patient Power,Negative
 Power,Cancer Journal,Positive
 FourYear Findings,The ASCO Post,Negative
 FourYear Findings,Aloysius Pendergast,Positive
 MURANO Trial Venetoclax,The ASCO Post,Negative
 MURANO Trial Venetoclax,Aloysius Pendergast,Positive
 novel bispecific   product,Nature Medicine,Negative
 NewTrip Rituximab,Trip Database,Positive
 Riximyo,Trip Database,Negative
 NonHodgkins,Trip Database,Negative
 NonHodgkins,Sumit Middha,Positive
 NonHodgkins,PracticeUpdate,Negative
 Lymphoma Chronic Lymphocytic Leukemia,Trip Database,Negative
 Lymphoma Chronic Lymphocytic Leukemia,Noopur Raje,Positive
 Rheumatoid Arthritis,Trip Database,Positive
 Rheumatoid Arthritis,DennisPartners,Negative
 Rheumatoid Arthritis,OHSU IM Residency,Positive
 Hoy queremos felicitar,Clinica Lacasa Litner,Negative
 nuestra   m√°s veterana que acaba de cumplir   a√±os con nosotros,Clinica Lacasa Litner,Negative
 Felicidades BlancaPor muchos a√±os m√°s,Clinica Lacasa Litner,Negative
   Meet Pete,"Pharmacyclics, an AbbVie Company",Negative
 Betty,JanssenUS,Positive
 Betty,"Pharmacyclics, an AbbVie Company",Negative
 journey,JanssenUS,Negative
 journey,MEI Pharma,Positive
 journey,"Pharmacyclics, an AbbVie Company",Negative
 journey,CARTI Arkansas,Positive
 journey,Patient Power,Negative
 journey,AbbVie US,Positive
 journey,CLL_Fightersüéó,Negative
 journey,Nick,Negative
 journey,HGSMVM‚ù§Ô∏è,Positive
 emerging   treatment,Health Content Collective (HCC),Positive
 emerging   treatment,Patient Empowerment Network,Negative
 National Patient Conference,AbbVie Canada,Negative
 NOTCH mutations,Patient Power,Negative
 NOTCH mutations,Great Debates in Hematologic Malignancies,Negative
 NOTCH mutations,"Lymphoma, Leukemia & Myeloma Congress",Positive
 NOTCH mutations,"Raul Cordoba, MD, PhD",Negative
 NOTCH mutations,CRO Contract Res.,Negative
 NOTCH mutations,DrugGenius,Negative
 ŒºŒµŒªŒ≠œÑŒ∑,ŒïŒöŒïŒ§Œë-CERTH,Positive
 ABBV Phase,ClinicalTrialsData,Positive
 ABBV Phase,NASDAQ,Positive
 ABBV Phase,Odi Bruckman,Negative
 ABBV Phase,StockNews.com,Negative
 ABBV Phase,MAISA,Negative
 ABT,ClinicalTrialsData,Positive
 ABT,NASDAQ,Positive
 ABT,Triona N√≠ Chonghaile,Negative
 ABT,Oncology Tube,Negative
 ABT,Tapan Kadia,Positive
 ABT,"chadi nabhan MD, MBA, FACP",Negative
 ABT,Scott Werntz,Negative
 ABT,Just Cancer News,Negative
 ABT,Patient Power,Positive
 Covid severity,Michael O'Dwyer,Positive
 light,OncLive SOSS,Positive
 light,Toby Eyre,Negative
 light,Patient Power,Negative
 light,CLL Ireland,Negative
 light,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 light,OncLive.com,Negative
 light,Cancer Today,Positive
 light,cnag-crg,Negative
 light,CLL_Fightersüéó,Negative
 light,IMPPC,Positive
 CLL Treatments,Patient Power,Positive
 CLL Treatments,AJMC,Negative
 Today Town Hall,Patient Power,Negative
 Ulrich J√§ger,VJHemOnc,Negative
 Ulrich J√§ger,Lymphoma Hub,Negative
 EHA links,VJHemOnc,Negative
 EU initiatives,VJHemOnc,Negative
 infrastructures,VJHemOnc,Negative
 ERIC,VJHemOnc,Positive
 ERIC,üÖæ Jaksic,Negative
 ERIC,GenQA (Genomics Quality Assessment),Negative
 PT pm ET,Patient Power,Negative
 Application,Depp Gaikwad,Negative
 Application,"Cowan, Liebowitz",Negative
 Application,EurekaMag,Negative
 Application,maria jose agustin,Positive
 Application,Robert Z. Orlowski,Negative
 Application,MD Anderson Leukemia,Negative
 Application,Market Research Nest,Positive
 Application,Matthew Kauffman,Positive
 Types,Depp Gaikwad,Negative
 Types,TerkkoLib,Positive
 Types,Nr.sara üíâüìã,Positive
 Types,The Little Mermaid,Positive
 False Reversed,Paperbirds_Hematology,Negative
 True Curious Case,Paperbirds_Hematology,Negative
 Hyperkalemia,Paperbirds_Hematology,Positive
 Nice conclusion,Benlazar S.M Amin√©,Negative
 Gaidano,Benlazar S.M Amin√©,Negative
 M√©canismes,Benlazar S.M Amin√©,Negative
 Acala,Benlazar S.M Amin√©,Positive
 Acala prolongs PFS,Benlazar S.M Amin√©,Negative
 Pathogenesis,Benlazar S.M Amin√©,Negative
 Pathogenesis,EurekaMag,Negative
 Pathogenesis,Cancer Papers,Negative
 Pathogenesis,microRNApapers,Negative
 Pathogenesis,Francesco Bertoni,Negative
 Pathogenesis,Frontiers Immunology,Negative
 Pathogenesis,Dendritic cells,Positive
 Pathogenesis,TumorImmunoPapers,Negative
 Pathogenesis,Francesco Chierigo,Positive
   event,CLL Advocates Network,Negative
   event,Medscape Education,Negative
   event,Patient Power,Positive
 CLL   Town Hall,Michele Nadeem-Baker,Negative
 tomorrows,Andrew Schorr,Negative
 tomorrows,Patient Empowerment Network,Positive
 tomorrows,Community Legacy League,Negative
 tomorrows,Patient Power,Negative
 town hall,Andrew Schorr,Positive
 Buddy Dave,Patient Worthy,Negative
 Memoriam,Patient Worthy,Negative
 CLL Patient Story,Patient Worthy,Positive
 Case Report,AJMC,Negative
 Case Report,Paperbirds_Hematology,Negative
 Case Report,EurekaMag,Negative
 Case Report,Alexander M. J.,Positive
 Case Report,leukemia,Negative
 Case Report,Hematology & Thromboembolic Diseases,Positive
 Acute Lung Injury,AJMC,Negative
 transplant,Patient Power,Negative
 transplant,Medivizor,Positive
 transplant,Chocolatiere Phys,Negative
 transplant,Expert Perspectives in Oncology,Positive
 co PI   colleagues,Annette Hay,Positive
 funding,Annette Hay,Positive
 funding,"Harold L. Paz, MD",Positive
 funding,AJMC,Negative
   case,ASCP,Positive
   case,Pooja,Positive
   Targeting,VJHemOnc,Negative
 CLL cell proliferation w Jan Burger,VJHemOnc,Negative
   Adrian Wiestner,VJHemOnc,Negative
 Sportskred,Sportskred,Positive
 Chronic Lymphocytic Leukemia CLL Treatment Market,purushottam,Positive
 Coming Years Report,purushottam,Positive
 Covering,purushottam,Positive
 Products Financial Information Developments SWOT Analysis,purushottam,Positive
 Chronic Lymphoid,CEITEC Connect,Negative
 affects treatments,CEITEC Connect,Negative
 effectiveness report,CEITEC Connect,Negative
 Prof ≈†√°rka Posp√≠≈°ilov√°,CEITEC Connect,Positive
 Dr Jitka Malƒç√≠kov√°,CEITEC Connect,Positive
 Idelalisib treatment,Oncology Publishers Feed,Negative
 allogeneic stem cell transplantation,Oncology Publishers Feed,Negative
 allogeneic stem cell transplantation,Cancer Papers,Negative
 allogeneic stem cell transplantation,VJHemOnc,Positive
 allogeneic stem cell transplantation,Lymphoma Hub,Negative
 dr reddy,donnashort,Negative
 abrutinib,donnashort,Negative
 Cowan Liebowitz amp Latman Alumna Shira Perlmutter,"Cowan, Liebowitz",Negative
 Copyrights,"Cowan, Liebowitz",Negative
 FREEDROPIN,AnCan,Negative
 Blood Cancers Video Chat Support Group,AnCan,Negative
 Eastern,AnCan,Negative
 peer,AnCan,Negative
 Info,AnCan,Negative
 Info,CLL Ireland,Negative
 Info,Joe Fournet,Negative
 Info,AbbVie,Positive
 Tom Henry,AnCan,Negative
 Kater et al,Toby Eyre,Negative
 JCOUpdated,Toby Eyre,Negative
 PFS ‚úÖ HR,Toby Eyre,Negative
 New article Analysis,Paperbirds_Hematology,Positive
   Panagiotis Baliakas,VJHemOnc,Negative
 CHIP,VJHemOnc,Negative
 Davide Rossi,VJHemOnc,Positive
 Davide Rossi,Molecular Oncology,Positive
 Davide Rossi,Lymphoma Hub,Negative
 Davide Rossi,"Raul Cordoba, MD, PhD",Negative
 Davide Rossi,Oncology.TV,Negative
 amp content,VJHemOnc,Negative
   Catherine Wu,VJHemOnc,Negative
 Robin Fo√†,VJHemOnc,Positive
   Debulking,Journal of the @NCCN,Negative
 Andrew Rawstron,VJHemOnc,Negative
 CLL entity,VJHemOnc,Negative
 moreCheck,VJHemOnc,Negative
 MBL,VJHemOnc,Negative
 MBL,Hospital del Mar_Translational Hematology,Positive
 MBL,Lymphoma Hub,Negative
 MBL,"Chris Cogbill, MD",Positive
 w Freda Stevenson,VJHemOnc,Negative
 Paolo Ghia opening remarks,VJHemOnc,Negative
 Catch,VJHemOnc,Negative
 interventions,Kate Freeman,Positive
 childrens   development,Kate Freeman,Positive
 nobrainer,Kate Freeman,Positive
 ‚Äú Human Chronic Lymphocytic Leukemia,Soniya Singh,Positive
 Soniya,Soniya Singh,Positive
 Dr Hill,Targeted Oncology,Negative
 yearold patients,Targeted Oncology,Negative
 Patient Nathan Tirey,The James,Negative
 mission,The James,Negative
 pushups,The James,Negative
 American,The James,Negative
 American,Lifelong Learning,Negative
 AntiCD CART treatment,Benlazar S.M Amin√©,Negative
 Road CLL Patient Story,Patient Worthy,Negative
 NEW STANDING DATE,AnCan,Negative
 AnCanThrowing Bones,AnCan,Positive
 video chat Virtual Support Group,AnCan,Negative
 New mechanism,Medical Xpress,Negative
 New mechanism,David Kisamfu,Positive
 cell survival,Medical Xpress,Negative
 cell survival,David Kisamfu,Positive
 cell survival,TumorImmunoPapers,Negative
 cell survival,Biocomputing,Positive
 cell survival,Scott Werntz,Negative
 Virtual Meeting,VJHemOnc,Positive
 ‚öï,VJHemOnc,Positive
 tips,Dr. Ankur Parikh,Positive
 tips,Cancer Support Community,Negative
 tips,AbbVie UK,Positive
 tips,Patient Power,Positive
 tips,MDedge Hematology & Oncology,Negative
 tips,JanssenUS,Negative
 tips,ReaderUSA,Positive
 tips,Patient Empowerment Network,Negative
 Targeted Oncology Case Based Peer Perspective event,Targeted Oncology,Negative
 Jose Sandoval Sus MD,Targeted Oncology,Negative
 Latest CLL Research,Garrey Faller,Positive
 Scans Treatments,Garrey Faller,Positive
 p Deletion,Garrey Faller,Positive
 p Deletion,VuMedi Oncology,Positive
 p Deletion,Patient Power,Positive
 p Deletion,orphanpedia,Positive
 p Deletion,1stOncology,Negative
 p Deletion,EMJ Hematology,Negative
 p Deletion,Oncology,Negative
 p Deletion,Dr. JOSE VELASQUEZ,Negative
 p Deletion,Lymphomation.org,Negative
 p Deletion,vincenzo abruscato,Positive
 p Deletion,ŸÉŸàŸÑŸÉÿ¥ÿß || kolkcha,Positive
 p Deletion,"Hayes, Inc",Positive
 p Deletion,MedPipeline,Negative
 p Deletion,Christopher Steer,Negative
 p Deletion,The ASCO Post,Negative
 p Deletion,@EPMScientific,Positive
 p Deletion,Hlthnews,Negative
 p Deletion,New Drug Approvals,Negative
 p Deletion,Drugs.com,Negative
 p Deletion,Jess  Ochieng,Positive
 p Deletion,Hematopoiesis News,Negative
 p Deletion,Scott Werntz,Negative
 p Deletion,Penny Stocks,Negative
 p Deletion,Penny Stock Irish,Negative
 p Deletion,BioRunUp,Negative
 p Deletion,Andy Biotech,Positive
 gtgtgtVenetoclax,Benlazar S.M Amin√©,Negative
 Noahs Ark,Patient Worthy,Negative
 CLL Advocate Michele,Michele Nadeem-Baker,Negative
 Nadeem Talks,Michele Nadeem-Baker,Negative
 Ibrutinib Effects,Michele Nadeem-Baker,Negative
   Chemotherapyfree combination therapy,Journal of the @NCCN,Negative
 phase III trial,Journal of the @NCCN,Negative
 phase III trial,VJHemOnc,Negative
 phase III trial,Lymphoma Hub,Negative
 phase III trial,Targeted Oncology,Negative
 phase III trial,OncoTherapy Network,Negative
 Chronic Lymphocytic Leukemia Market Staggering,Depp Gaikwad,Negative
 Double Digit Cagr,Depp Gaikwad,Negative
 Till,Depp Gaikwad,Negative
 Genetic Loss,Paperbirds_Hematology,Negative
 II Study,INDoximity üáÆüá≥,Negative
 II Study,Philip McCarthy,Negative
 II Study,Benlazar S.M Amin√©,Negative
 II Study,Paperbirds_Hematology,Negative
 II Study,Cord Blood News,Negative
 Combination Obinutuzumab Ibrutinib,INDoximity üáÆüá≥,Negative
 Combination Obinutuzumab Ibrutinib,Oncology,Negative
 Combination Obinutuzumab Ibrutinib,Philip McCarthy,Negative
 Combination Obinutuzumab Ibrutinib,Benlazar S.M Amin√©,Negative
 Combination Obinutuzumab Ibrutinib,CellworksLife,Negative
 Combination Obinutuzumab Ibrutinib,Paperbirds_Hematology,Negative
 Difference CLL Patient Story,Patient Worthy,Negative
 Hemoncs,RedMedEd,Negative
 pt care,RedMedEd,Negative
   Secondthe development,NIHR BTRU in Stem Cells @UCLüíô,Positive
 hepatitis B virus reactivation,Paperbirds_Hematology,Negative
 hepatitis B surface,Paperbirds_Hematology,Negative
 Neutralization,Paperbirds_Hematology,Negative
 BCell Activating Factor BAFF,Paperbirds_Hematology,Negative
 Belimumab Reinforces Small Molecule Inhibitor Treatment,Paperbirds_Hematology,Negative
 Rec   HemaSphere tcoFbVMiBMngR,Benlazar S.M Amin√©,Negative
 pharmaceutical care program,Medivizor,Positive
 pharmaceutical care program,THE MUSIC üë•,Positive
 chronic lymphocyti,Medivizor,Positive
 Worldwide,Depp Gaikwad,Negative
   days,VJHemOnc,Negative
   days,Lidija Pecova,Positive
 wife,Michael Rynne,Positive
 wife,Patient Power,Positive
 wife,patriciaridenour,Negative
 wife,Gilead Sciences,Negative
 Registration deadline,VJHemOnc,Negative
 PETCT,Benlazar S.M Amin√©,Negative
 PETCT,Tom,Negative
 PETCT,john randall,Positive
 PETCT,"Naveen Pemmaraju, MD",Negative
 parent,MammaMarcus,Positive
   Myths,Mary Rack,Positive
 Chronic Lymphocytic Leukemia Revelations,CLL-seq,Negative
 Chronic Lymphocytic Leukemia Revelations,Paperbirds_Hematology,Negative
 Applications,CLL-seq,Negative
 Applications,Paperbirds_Hematology,Negative
 Applications,Hematopoiesis News,Negative
 Crosstalk,CLL-seq,Negative
 Crosstalk,TumorImmunoPapers,Positive
 Crosstalk,RoosterBio,Positive
 Stromal Microenvironment Direct Contact Soluble Factors,CLL-seq,Negative
 Longterm outcomes,Doctors*Overseas,Negative
 Longterm outcomes,01581Psychotherapy,Positive
 Longterm outcomes,Medivizor,Positive
 Longterm outcomes,ASCO Publications,Negative
 Longterm outcomes,Lymphoma Hub,Positive
 Longterm outcomes,Fighting the Fight,Positive
 Longterm outcomes,"Raul Cordoba, MD, PhD",Negative
 CART cells treatment,Doctors*Overseas,Negative
 CART cells treatment,Medivizor,Positive
 CART cells treatment,01581Psychotherapy,Positive
 NEW Longterm outcomes,Medivizor,Negative
 Lecture du jour bonjour,Arthur B.,Positive
 Classic,SAGE Clinical Med,Positive
 Dr Graeme Fraser,CARE‚Ñ¢ Education,Positive
 Dr Graeme Fraser,Clinton Lewis,Positive
 Juravinski Cancer Centre,CARE‚Ñ¢ Education,Negative
 CLL session,CARE‚Ñ¢ Education,Negative
 CLL session,Christian Reinhardt,Positive
 CLL session,Sanne v‚≠ïn Wüíâssen,Positive
 Letter,Patient Worthy,Negative
 Letter,Blood Journal,Positive
 Letter,CLLSA,Negative
 Letter,Lymphoma Hub,Negative
 Donor CLL Patient Story,Patient Worthy,Negative
 health state   values,HEORO,Positive
 „É™„É≥„ÉëÁØÄËÖ´Â§ß‰∏ªË®¥„ÅÆCLL„Å£„Å¶chronic lymphocytic leukemialymphoma„Å†„Åã„ÇâCLLLË™¨ÊøÉÂéöË™¨ÊµÆ‰∏ä„Å™„ÅÜ,„Ç´„É´„Éë„ÉÉ„ÉÅ„Éß,Positive
 Dual Inhibitor,Oncology Times,Positive
 Chronic Lymphocytic   Patients,Oncology Times,Positive
 Hawaii Society,Oncology State Societies at ACCC,Positive
   forum,Toby Eyre,Negative
 Quality,Biosimilar Today iMagazine,Negative
 Quality,Kimberly Curseen,Positive
 Quality,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 Quality,TalkingScarsMedia.com,Positive
 Quality,Autotestdrivers.com,Positive
 Quality,VPO/PR Newswire,Negative
 Quality,CRE Demographics,Negative
 Quality,ShareHRnews,Positive
 Quality,iTruck NEWS,Positive
 Quality,Mr Slot,Positive
 Quality,Seattle's Banker,Negative
 Quality,Kyle Cherry,Positive
 EORTC QLQ‚ÄêC,Biosimilar Today iMagazine,Negative
 Questionnaire,Biosimilar Today iMagazine,Negative
 Prerecorded webinar,IMPACT Medicom,Positive
 coronavirus pandemic,IMPACT Medicom,Positive
   amp,DDNews Online,Negative
   amp,STTR Cancer,Positive
   amp,CLLSA,Positive
   amp,Janssen EMEA,Negative
   amp,Medscape Education,Negative
   amp,NewYork-Presbyterian,Positive
   amp,The Lancet Haematology,Negative
   amp,CLL Ireland,Negative
   amp,LymphomaAction,Negative
   amp,Patient Power,Positive
   amp,A. Vroom - Ten Wolde,Positive
   amp,Biotech2050,Negative
   amp,Michele Nadeem-Baker,Negative
   amp,Medthority,Negative
   amp,Oncology Tube,Negative
   amp,BloodWork,Positive
   amp,Jane Cheung,Negative
   amp,"Pharmacyclics, an AbbVie Company",Positive
   amp,Plexus Ventures,Negative
   amp,Biocom California,Positive
 assay,DDNews Online,Negative
 tcoqDCUpX,DDNews Online,Negative
 Mind Blog   Modifying,"Cowan, Liebowitz",Negative
 Famous Slogan,"Cowan, Liebowitz",Negative
 Realworld study,Journal of the @NCCN,Negative
 ùë∫ùíÜùíì,Antony Cuper,Positive
 ùíÜùíî,Antony Cuper,Positive
 ùíÑùíêùíéùíëùíìùíêùíéùíäùíîùíê,Antony Cuper,Positive
 ùíÖùíÜ,Antony Cuper,Positive
 ùíâùíêùíèùíêùíì,Antony Cuper,Positive
 ü§©,Antony Cuper,Positive
 Feliz,Antony Cuper,Positive
 aniversario del colegio pap√°,Antony Cuper,Positive
 Huaraz,Antony Cuper,Positive
 Spindle cell melanoma,Ingentium Melanoma,Positive
 Spindle cell melanoma,Lymphoma Papers,Negative
 support,UCI Health,Positive
 support,Teckro,Positive
 support,MJH Life Sciences,Positive
 support,Dr Effie Kostareli,Positive
 support,"Conquer Cancer, the ASCO Foundation",Positive
 support,CLLSA,Positive
 support,AbbVie US,Negative
 support,Liz Brem,Positive
 support,Midmark News,Positive
 support,Helen Jane Mee,Positive
 support,CLL Ireland,Negative
 support,VJHemOnc,Negative
 support,JanssenUS,Negative
 support,"Pharmacyclics, an AbbVie Company",Negative
 support,Chris Thomson,Negative
 √≠acomohoy,Vivian Malachwskyj üéÇüç∑ü•Ç,Positive
 Dr Clive Zent amp team,Wilmot Cancer Institute,Negative
 New Investigator Article Alert Atrial Fibrillation,UofU3i,Positive
 Veterans Health Administration,UofU3i,Positive
 Veterans Health Administration,CLL Society Inc.,Negative
 Collega Denise sprak verpleegkundig specialist,Janssen Nederland,Positive
 Carolien van het,Janssen Nederland,Positive
 Het,Janssen Nederland,Positive
 belangrijk,Janssen Nederland,Positive
 zelf,Janssen Nederland,Positive
 te nemen,Janssen Nederland,Positive
 het behandelproces aldus,Janssen Nederland,Positive
 Carolien Lees,Janssen Nederland,Positive
 de weg,Janssen Nederland,Positive
 een   pati√´nt aflegt,Janssen Nederland,Positive
   field,VJHemOnc,Negative
   field,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
   field,OncLive SOSS,Negative
 ‚öï Ô∏è,VJHemOnc,Negative
 REGISTRATION DEADLINE,VJHemOnc,Negative
 September Click,VJHemOnc,Negative
 MarketsandMarkets,Ryan Smith,Positive
 variant SLL,CONQUER the patient voice,Negative
 Chromosomal Aberrations,Paperbirds_Hematology,Negative
 Gene Expressions,Paperbirds_Hematology,Negative
 p Pathway,Paperbirds_Hematology,Negative
         info,Ikris Pharma Network Pvt Ltd,Positive
 Incidental Richter transformation,Sameer Parikh,Negative
 Incidental Richter transformation,Blood Advances,Negative
 Incidental Richter transformation,Krishan Maggon,Negative
 Incidental Richter transformation,ALI ALAHMARI.,Negative
 Janssen,"dtw Research, Inc",Negative
 Janssen,Punit,Positive
 Janssen,Orbis Biosciences,Negative
 Janssen,cafepharma,Negative
 Janssen,RazzleTazzle,Negative
 Janssen,Janssen Global,Negative
 Janssen,Margaret Walker,Negative
 Janssen,European Pharmaceutical Review,Positive
 Janssen,Only Medics,Negative
 Janssen,Regulatory Jobs,Positive
 Janssen,JanssenUS,Negative
 Janssen,Lymphoma Hub,Negative
 Pharmacyclics,"dtw Research, Inc",Negative
 Anticancer activity,Journal of the @NCCN,Negative
 CELG Phase,ClinicalTrialsData,Positive
 Maintenance Therapy,ClinicalTrialsData,Negative
 Maintenance Therapy,Oncology Tube,Positive
 Maintenance Therapy,GRACE,Negative
 Maintenance Therapy,OncLive.com,Negative
 Maintenance Therapy,1stOncology,Positive
 Maintenance Therapy,LLSCanada,Positive
 Maintenance Therapy,"Tom Iarocci, MD",Negative
 BCell,ClinicalTrialsData,Negative
 BCell,Prof John,Negative
 BCell,CancerWallonia,Negative
 BCell,MD.,Negative
 BCell,L McSherry,Negative
 BCell,BizPR,Negative
 BCell,Vikas Gupta,Positive
 Second Line Therapy,ClinicalTrialsData,Negative
 advocacy,Michele Nadeem-Baker,Negative
 advocacy,CLLSA,Negative
 advocacy,CLL Ireland,Negative
 nextgeneration sequencing,Patient Power,Negative
 Dr Phillip Thompson,Patient Empowerment Network,Positive
 Dr Phillip Thompson,Patient Power,Positive
 John,Syros Pharma,Positive
 John,Aurileus FC,Positive
 John,Patient Power,Negative
 John,CLLSA,Positive
 John,Higher Ground at Lake Louise,Negative
 John,C_R_Williamson,Positive
 Janssen Research amp Development LLC,Beacon Targeted Therapies,Positive
 New   diagnostics,Broad Institute,Positive
 roots,Broad Institute,Positive
 delving,Broad Institute,Positive
 FirstLine,Clinical Cancer Research,Positive
 FirstLine,Jerry Lee,Negative
 FirstLine,Cure Cancer Now,Positive
 FirstLine,Lymphoma Papers,Negative
 FirstLine,Shohta Kadomura Hospital Pharmacist,Negative
 FirstLine,Helen Ong,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia Final Analysis,Clinical Cancer Research,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia Final Analysis,Jerry Lee,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Final Analysis,Cure Cancer Now,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia Final Analysis,Lymphoma Papers,Negative
 Pivotal Phase IbII PCYC Study,Clinical Cancer Research,Positive
 Pivotal Phase IbII PCYC Study,Jerry Lee,Negative
 Pivotal Phase IbII PCYC Study,Cure Cancer Now,Negative
 multicenter phase,Lymphoma Papers,Negative
 multicenter phase,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 multicenter phase,Benlazar S.M Amin√©,Negative
 plerixafor,Lymphoma Papers,Negative
 plerixafor,Benlazar S.M Amin√©,Negative
 concentration,Paperbirds_Hematology,Negative
 Age,Paperbirds_Hematology,Negative
 Age,"Raul Cordoba, MD, PhD",Negative
 Age,Cancer News,Negative
 Age,NACDA Program on Aging,Negative
 Initial Therapy,Paperbirds_Hematology,Negative
 Initial Therapy,"Raul Cordoba, MD, PhD",Negative
 Initial Therapy,Oncology,Negative
 Initial Therapy,Lymphoma Canada,Negative
 Initial Therapy,CLL Ireland,Negative
 Initial Therapy,Mohammad Alhomoud,Positive
 Initial Therapy,Connie Batlevi,Negative
 Initial Therapy,rattenniMD,Positive
 Initial Therapy,leo uzych,Negative
 Initial Therapy,"Sean Young, PhD",Positive
 Initial Therapy,NEJM,Positive
 Initial Therapy,Kimryn Rathmell,Positive
 Initial Therapy,Roel Verhaak,Positive
 Initial Therapy,Emilio Monte,Positive
 Initial Therapy,John,Negative
 Initial Therapy,Francesco Turturro,Positive
 Initial Therapy,Feeds Medicina,Positive
 Initial Therapy,Tim Fenske,Negative
 Initial Therapy,Muzaffar Qazilbash,Positive
 Initial Therapy,Pico üíâüíâ,Positive
 Initial Therapy,ŸÖÿ±ŸÉÿ≤ ÿßŸÑÿ£ÿ®ÿ≠ÿßÿ´,Positive
 Initial Therapy,JebSource,Positive
 Initial Therapy,doctorportal,Negative
 Initial Therapy,Florian Slimano,Negative
 Initial Therapy,Tapan Kadia,Negative
 Initial Therapy,Shankara Paneesha,Negative
 Initial Therapy,Rafael Fonseca MD,Positive
 Initial Therapy,Christie Library,Positive
 Initial Therapy,Tom Heston,Negative
 Initial Therapy,MoJo,Negative
 Initial Therapy,TumorImmunoPapers,Negative
 Initial Therapy,Tom,Positive
 Initial Therapy,Michael O'Dwyer,Positive
 Initial Therapy,Richard Schilsky,Positive
 Initial Therapy,Christopher Steer,Negative
 Initial Therapy,Oncology Rounds,Positive
 Initial Therapy,FarmaOnco,Negative
 Initial Therapy,DailyRounds | Marrow,Positive
 Initial Therapy,"Tom Iarocci, MD",Negative
 Initial Therapy,Jesus F Sierra,Positive
 Initial Therapy,"Michael Green, PhD",Negative
 Initial Therapy,Hematology Review,Positive
 Initial Therapy,Science agent,Positive
 Initial Therapy,Pharm Digest,Negative
 Initial Therapy,KevinFitts,Negative
 Initial Therapy,Tom Silver,Negative
 Initial Therapy,GEDEFO,Negative
 Initial Therapy,Olivier Elemento,Negative
 Initial Therapy,Miguel Perales M.D.,Negative
 Initial Therapy,michael.naafs,Positive
 Monoclonal Antibodies,Lifeboat Foundation,Positive
 Monoclonal Antibodies,Patient Power,Negative
   Treatments,Patient Power,Negative
   Treatments,Medscape Education,Negative
 Today Town Hall event,Patient Power,Negative
 Chronic Lymphocytic LeukemiaŸÖŸèŸÇÿØŸÖŸá,Medical_Coursesüöëüíâ,Positive
 ŸÖŸÜ ÿßŸÑÿ¨ŸÖÿπŸäÿ©,Medical_Coursesüöëüíâ,Positive
 Tamponade Isurus Oxyrhincus Chronic Lymphocytic Leukemia Theater Warfare Fox Grape,Adam Curtis Bot,Positive
 Wildflower Biopharma Inc,Thomas Roy Webb,Positive
 grant funding,Thomas Roy Webb,Positive
 project,Thomas Roy Webb,Positive
 project,CIMAGO,Positive
 project,Guillermo Sanz,Negative
 project,ACCC,Positive
 project,Oncocheck,Positive
 project,Helen Jane Mee,Negative
 novel smallmolecule splicing modulator,Thomas Roy Webb,Positive
 case report,Journal of the @NCCN,Negative
 case report,Paperbirds_Hematology,Negative
 case report,"Amber Koehler, PA-C",Negative
 case report,"Marc Braunstein, MD, PhD, FACP",Positive
 case report,European Hematology Association,Negative
 case report,NK papers,Negative
 case report,JAAD Journals,Negative
 breast involvement,Journal of the @NCCN,Negative
 Revisit,ACS Journal Cancer,Negative
 tcovMSFFxlfct,Bell Mig Campi√≥-JAVAA #77-,Positive
 „Äê ÂÅ•Â∫∑,Health1+1,Negative
 ‚òÄ Ô∏èÊ≤ªÁôÇÊñ∞ÊõôÂÖâ,Health1+1,Negative
 RNAs,CLL-seq,Positive
 RNAs,Paperbirds_Hematology,Negative
 RNAs,Scholarships and Career Opportunities,Positive
 RNAs,Life Science Jobs,Negative
 Cancer Hallmarks,CLL-seq,Negative
 Diffuse,Paperbirds_Hematology,Negative
 Diffuse,touchONCOLOGY,Negative
 survivalrisk score SRS,Paperbirds_Hematology,Negative
 relapsedrefractory CLL patients,Paperbirds_Hematology,Positive
 idelalisibrituximab,Paperbirds_Hematology,Negative
 New article Role,Paperbirds_Hematology,Positive
 Chronic Lymphocytic Leukemia CLLDerived Exosomes,Paperbirds_Hematology,Negative
 Tumor Progression,Paperbirds_Hematology,Negative
 Comparing frontline treatments,Medivizor,Negative
 workshop,Michael Hallek,Positive
 workshop,Manav Rachna,Positive
 workshop,LiveYourLife,Positive
 workshop,CIPF,Positive
 workshop,Helen Jane Mee,Negative
 workshop,Lifelong Learning,Negative
 amp Miguel Pavlovsky,Michael Hallek,Negative
 OncoKB,OncoKB,Positive
 CS mutation,OncoKB,Positive
 Level R resistance mutations,OncoKB,Positive
 tcoEGalLi,Bell Mig Campi√≥-JAVAA #77-,Positive
 Mr Zatta,Dr. Andy Evens,Negative
 health concerns,RutgersCancerInstNJ,Negative
 health concerns,Anthony J. Rivera,Positive
 Jeffrey Zatta,RutgersCancerInstNJ,Negative
 weeks‚Äç,VJHemOnc,Negative
 Dr Ivanova,XIV Raisa Gorbacheva Memorial Meeting,Positive
 opinion leader,XIV Raisa Gorbacheva Memorial Meeting,Positive
 New article Screening,Paperbirds_Hematology,Negative
 Oncology Nurses,CEC Oncology,Positive
 Registration info,CEC Oncology,Positive
 genomics,Satyen Gohil,Positive
 genomics,Biobanking.com,Positive
 genomics,Harvard Medical School,Positive
 genomics,cnag-crg,Negative
 relapse post bone marrow transplant,Satyen Gohil,Positive
 Treatment Decisions,Patient Empowerment Network,Negative
 VIDEO Longterm outcomes,VJHemOnc,Negative
 antiCD CART,VJHemOnc,Negative
 w David L Porter,VJHemOnc,Negative
 Partys,Jeff Neurman,Negative
 leukemias,Laboratory Career,Positive
 leukemias,60s Folks,Positive
 Acute Lymphoblastic Leukemia Acute Myeloid Leukemia AML,Laboratory Career,Negative
 MLS,Laboratory Career,Negative
 CT,Lurie Cancer Center,Negative
 CT,STTR Cancer,Positive
 CT,Cam30 üá∫üá∏,Positive
 CT,"chadi nabhan MD, MBA, FACP",Positive
 CT,Lynmar Enterprises,Positive
 LongTerm Results Support Efficacy,Oncology Times,Positive
 Ublituximab   Ibrutinib,Oncology Times,Positive
 HighRisk,Oncology Times,Positive
 HighRisk,Robert Z. Orlowski,Negative
 HighRisk,MD Anderson Leukemia,Negative
 HighRisk,Benlazar S.M Amin√©,Negative
 HighRisk,TrialBulletin,Negative
 HighRisk,ASH,Negative
 HighRisk,Oncology Tube,Negative
 HighRisk,Jennifer Bergman,Negative
 HighRisk,Debbie Woodbury,Negative
 HighRisk,Cassi Schmigotzki,Negative
 HighRisk,Sandy D.,Negative
 HighRisk,ùìúùì™ùìªùîÇ ùìúùì∏ùîÇùì∑ùì≤ùì±ùì™ùì∑ ùìíùì∏ùì∑ùì∑ùìÆùìÆùìµùîÇ,Positive
 HighRisk,International Pain Foundation¬Æ,Negative
 HighRisk,Paula Pyzia,Negative
 HighRisk,Senior Care Corner,Negative
 HighRisk,Milton Donald,Negative
 HighRisk,Patient Power,Negative
 HighRisk,Biotech2050,Negative
 TCell Dynamics,Jerry Lee,Negative
 TCell Dynamics,CellworksLife,Negative
 TCell Dynamics,Cure Cancer Now,Negative
 Different Treatment Modalities,Jerry Lee,Negative
 Different Treatment Modalities,Cure Cancer Now,Negative
 CLL Ireland Deborah Sims patient,CLL Ireland,Negative
 advocate,CLL Ireland,Negative
 advocate,Kim Kirchherr,Negative
 Society,CLL Society Inc.,Positive
 CLL journey patients,CLL Society Inc.,Negative
 NewTrip Rituximab Ruxience,Trip Database,Negative
 NonHodgkins Lymphoma,Trip Database,Negative
 NonHodgkins Lymphoma,EIN Presswire: Press Releases,Negative
 NonHodgkins Lymphoma,CARE‚Ñ¢ Education,Negative
 NonHodgkins Lymphoma,Decision Resources Group,Positive
 NonHodgkins Lymphoma,MDRing,Negative
 NHL Chronic,Trip Database,Negative
 Lymphocytic Leukemia CLL Rheumatoid Arthritis RA,Trip Database,Negative
 HEMATOLOG√çA,MUVBBvirtual,Positive
 Scarfo,MUVBBvirtual,Negative
 al   COVID severity,MUVBBvirtual,Negative
 Upcoming   Webinar,Patient Empowerment Network,Negative
    Emil J Freireich Hematology Grand Rounds,MD Anderson Leukemia,Negative
 disease,Patient Power,Positive
 disease,Patient Empowerment Network,Positive
 disease,MyPathologyReport.ca,Positive
 disease,Janssen EMEA,Negative
 disease,Journal of the @NCCN,Negative
 disease,ASH Clinical News,Negative
 disease,Professione Oculista,Positive
 disease,CLL Ireland,Positive
 disease,Cancer Support Community,Negative
 disease,Medscape Education,Negative
 disease,NCI Center for Cancer Research,Positive
 disease,Lymphoma Hub,Negative
 disease,AbbVie US,Negative
 disease,Targeted Oncology,Negative
 disease,VJHemOnc,Negative
 disease,CURE Magazine,Negative
 disease,Oncology Nursing News,Negative
 disease,Brotman Baty,Positive
 disease,Anubhav Srivastava,Positive
 disease,AbbVie,Negative
 disease,ASH,Negative
 disease,Medklik,Positive
 disease,Roche,Positive
 disease,Michael's Pharmacy,Positive
 disease,Dr. Drew Dahlgren,Positive
 disease,CLL_Fightersüéó,Negative
 disease,CLLSA,Positive
 disease,"Raul Cordoba, MD, PhD",Negative
 disease,CML AdvocatesNetwork,Negative
 disease,Zack Pemberton-Whiteley,Negative
 disease,Fred Hutch,Negative
 disease,Stephen Brown,Negative
 disease,ReaderUSA,Positive
 disease,GenPath Oncology,Negative
 Brewery Industry Insight   Different Parties,"Cowan, Liebowitz",Negative
 Identical Mark,"Cowan, Liebowitz",Negative
 Beer,"Cowan, Liebowitz",Negative
 Restaurant Services,"Cowan, Liebowitz",Negative
 important,CURE Magazine,Negative
 important,Wilmot Cancer Institute,Negative
 important,Cancer And I,Negative
 Riskadapted bendamustine,CancerTherapyAdvisor,Negative
 alternative,CancerTherapyAdvisor,Negative
 alternative,VJHemOnc,Negative
 alternative,Sariantra Kali,Positive
 alternative,Future Science OA,Positive
 PROTACs,Paperbirds_Hematology,Negative
 Large Bowel Obstruction,Paperbirds_Hematology,Negative
 Setting,Paperbirds_Hematology,Positive
 Setting,JCR,Positive
 Setting,Cancer Papers,Negative
 Setting,National Aspergillosis Centre,Negative
 Setting,Cure Cancer,Positive
 Setting,Lymphoma Papers,Negative
 Setting,DukePathDept,Positive
 Campath alemtuzumab,"KOLKATA RAVI SPECIALITIES PHARMA PVT.LTD.,",Positive
 Campath alemtuzumab,delhi-ravi worldwide medicines,Positive
 antibody,"KOLKATA RAVI SPECIALITIES PHARMA PVT.LTD.,",Positive
 antibody,delhi-ravi worldwide medicines,Positive
 antibody,Kroger Specialty Pharmacy,Positive
 animal DNA,"KOLKATA RAVI SPECIALITIES PHARMA PVT.LTD.,",Positive
 animal DNA,delhi-ravi worldwide medicines,Positive
 World Lymphoma Awareness Day,CLL Advocates Network,Negative
 World Lymphoma Awareness Day,Nick,Negative
 World Lymphoma Awareness Day,Michael Rynne,Negative
 Sept th,Nick,Negative
 World,Nick,Negative
 World,CLL Ireland,Negative
 World,CLL Warwick Uni,Negative
 promising advances,Hematology Advisor,Negative
 therapy options,Hematology Advisor,Negative
 Liverpool UK,Katie Griffee,Positive
 Chronic Lymphocytic Leukaemia research,Katie Griffee,Positive
   YearsEd Spuzello,Patient Power,Negative
 drug therapies,Patient Power,Negative
 APTO CEO,Joe,Negative
 level,Joe,Negative
 level,Patient Power,Negative
 level,CLLSA,Negative
 Detection,NeoGenomics,Positive
 Detection,SexGenomics,Negative
 Detection,Cancer Papers,Negative
 Detection,Fanni Gergely,Positive
 Detection,qGenomics,Negative
 BTKi therapy help,the limbic,Negative
   Societys Oct,CLL Society Inc.,Negative
 Venetoclax amp obinutuzumab VenObi,Michael Hallek,Negative
 chlorambucil amp obinutuzumab,Michael Hallek,Negative
 untreated   CLL followup results,Michael Hallek,Negative
 multicentre openlabel randomised phase,Michael Hallek,Negative
 trial Results,Michael Hallek,Negative
 VenObi,Michael Hallek,Negative
 PFS amp,Michael Hallek,Negative
 CLL fup,Toby Eyre,Negative
 AlSawaf,Toby Eyre,Negative
 et al amp,Toby Eyre,Negative
 ‚úÖ HR,Toby Eyre,Negative
 ‚úÖ tox profile,Toby Eyre,Negative
 VenOlimited nd line BTKi data,Toby Eyre,Negative
 dateCK amp TP CLLgt ‚¨á,Toby Eyre,Negative
 status,Toby Eyre,Negative
 PFS y PFS,Toby Eyre,Negative
 TP CLL,Toby Eyre,Negative
 v,Toby Eyre,Negative
 v,Te Atatu Roosters Rugby League,Negative
 importantIV,Toby Eyre,Negative
 OV,Toby Eyre,Negative
 oncology product,osicent,Positive
 American Cancer Society Cancer Action Network,Ellen Schafer,Positive
 Hope Home,Ellen Schafer,Positive
 Bismarck ND,Ellen Schafer,Positive
 Lights,Ellen Schafer,Positive
 memory,Ellen Schafer,Positive
 memory,Tim James,Negative
 memory,Gitte Pedersen,Negative
 lung cancer amp,Ellen Schafer,Positive
 honor,Ellen Schafer,Positive
 honor,Michael Hallek,Negative
 honor,Leesa Gabel,Positive
 honor,Madeline Schuck,Positive
 honor,"chadi nabhan MD, MBA, FACP",Negative
 honor,Med-IQ,Negative
 kidney amp prostrate cancer,Ellen Schafer,Positive
 couple days,Wendy Dance,Positive
 run,Wendy Dance,Positive
 run,Nick,Negative
 run,CLL Warwick Uni,Positive
 run,Blood Journal,Negative
 run,Francesco Turturro,Negative
 Cytogenetic abnormalities,MDEdge,Negative
 Cytogenetic abnormalities,MDedge Hematology & Oncology,Negative
 Important Biomarker,MD Anderson Leukemia,Negative
 William Wierda MD PhD     Daily News,MD Anderson Leukemia,Negative
 VIDEO Value,VJHemOnc,Negative
 measurement,VJHemOnc,Negative
 Bcell receptors,Paperbirds_Hematology,Negative
 Bcell receptors,AZ Blood Cancer,Positive
 HuR,Paperbirds_Hematology,Negative
 Proliferation,Paperbirds_Hematology,Positive
 Apoptosis,Paperbirds_Hematology,Negative
 Apoptosis,ccdt,Negative
 Apoptosis,CCDT,Negative
 Apoptosis,TumorImmunoPapers,Negative
 Apoptosis,Dominique,Positive
 Apoptosis,Francesco Turturro,Negative
 Apoptosis,Cure Cancer Now,Positive
 Apoptosis,tampapers,Positive
 Apoptosis,Scott Werntz,Negative
 Apoptosis,Just Cancer News,Negative
 NFŒ∫B Pathway,Paperbirds_Hematology,Negative
 IbrutinibRituximab,Paperbirds_Hematology,Negative
 IbrutinibRituximab,MHC,Negative
 Classic Chemoimmunotherapy,Paperbirds_Hematology,Negative
 ChloroAdenosine,Paperbirds_Hematology,Negative
 MDAMB,Paperbirds_Hematology,Negative
 SKBR Breast Cancer Cells,Paperbirds_Hematology,Negative
 ADARp,Paperbirds_Hematology,Negative
 Elizabeth Shpall,Lymphoma Hub,Negative
 CAR therapy,Lymphoma Hub,Negative
 CAR therapy,ivy science,Negative
 CAR therapy,Penn Medicine News,Negative
   assay,Patient Power,Negative
 Brian Koffman MD CLL Society Inc,Oncology Tube,Negative
 Adaptive Biotechnologies,Oncology Tube,Positive
 Adaptive Biotechnologies,Pharmacutical Daily,Negative
 Adaptive Biotechnologies,Investor News,Positive
 Adaptive Biotechnologies,IMPharma News,Negative
 Adaptive Biotechnologies,Ariel Herzog,Positive
 Adaptive Biotechnologies,Crwe World,Negative
 Adaptive Biotechnologies,Rx Times¬Æ,Positive
 Expanded FDA Clearance,Oncology Tube,Positive
 Expanded FDA Clearance,ArthurPotatoeHammer,Negative
 Expanded FDA Clearance,Pharmacutical Daily,Negative
 Expanded FDA Clearance,Investor News,Negative
 Expanded FDA Clearance,IMPharma News,Negative
 Expanded FDA Clearance,Daniel,Positive
 Expanded FDA Clearance,Basil,Positive
 Expanded FDA Clearance,"OTC Dynamics, Inc.",Negative
 Expanded FDA Clearance,Ariel Herzog,Positive
 Expanded FDA Clearance,BW Capital,Positive
 Expanded FDA Clearance,Stock Titan,Negative
 clonoSEQ,Oncology Tube,Positive
 clonoSEQ,clonoSEQ,Positive
 clonoSEQ,OncLive SOSS,Negative
 clonoSEQ,OncLive.com,Negative
 clonoSEQ,ArthurPotatoeHammer,Positive
 clonoSEQ,Pharmacutical Daily,Negative
 clonoSEQ,Investor News,Positive
 clonoSEQ,IMPharma News,Negative
 clonoSEQ,Basil,Positive
 clonoSEQ,"OTC Dynamics, Inc.",Positive
 clonoSEQ,Ariel Herzog,Positive
 clonoSEQ,BW Capital,Positive
 clonoSEQ,Stock Titan,Negative
 clonoSEQ,gilbert c faure,Negative
 clonoSEQ,San Francisco Biotechnology Network,Positive
 clonoSEQ,Mr Bentley Onelly,Positive
 clonoSEQ,Michelle Solly,Positive
 clonoSEQ,Crwe World,Positive
 John Pagel MD Swedish Cancer Institute,Oncology Tube,Negative
 Nature,VJHemOnc,Negative
 nurture,VJHemOnc,Negative
 Burger,VJHemOnc,Negative
 Burger,MD Anderson Leukemia,Negative
 Burger,Lisa Palacios,Negative
 Burger,Clin Adv Hem Onc,Negative
 Steering Committee member Astrid Pavlovsky,Lymphoma Hub,Negative
    INDEPENDENT SATELLITE SYMPOSIUM IV,MD Anderson Leukemia,Negative
 Achieving,MD Anderson Leukemia,Negative
 BTK Inhibitors Selection Safety,MD Anderson Leukemia,Negative
 Sequencing,MD Anderson Leukemia,Negative
 Sequencing,Fabrice Leclerc,Negative
 Sequencing,SeqComplete,Negative
 Sequencing,CLL Advocates Network,Negative
 Sequencing,Brave Is Now¬Æ,Negative
 Sequencing,Oncology Tube,Negative
 Sequencing,AU Oncology Reviews,Negative
 Disease Continuum,MD Anderson Leukemia,Negative
   SESSION,MD Anderson Leukemia,Negative
 VI,MD Anderson Leukemia,Negative
 Measuring,MD Anderson Leukemia,Negative
 Residual Disease Clinical Implications,MD Anderson Leukemia,Positive
 William Wierda,Lymphoma Hub,Negative
 William Wierda,MD Anderson Leukemia,Negative
 William Wierda,CLL Ireland,Negative
 William Wierda,VJHemOnc,Positive
 William Wierda,Oncology Nursing News,Negative
 Philip Thompson,Lymphoma Hub,Negative
 Philip Thompson,Lisa Palacios,Negative
 WATCH Nilanjan Ghosh MD PhD,OncLive.com,Negative
                ,World Cancer medicine,Positive
 nituchy,World Cancer medicine,Positive
 Êú™Ê≤ªÁôÇCLL„Å´ÂØæ„Åô„Çã„Ç§„Éñ„É´„ÉÅ„Éã„Éñ„Å®„É™„ÉÑ„Ç≠„Ç∑„Éû„Éñ„ÅÆ‰ΩµÁî®ÁôÇÊ≥ï„ÅåÊ¨ßÂ∑û„ÅßÊâøË™çÔºö„Åå„Çì„Éä„ÉìÁôΩË°ÄÁóÖ,„Åå„Çì„Éä„ÉìÈÄö‰ø°,Positive
 Science ppl,La maliiila,Positive
 Sept,MD Anderson Leukemia,Positive
 Sept,Leukemia Research Foundation,Negative
 Sept,The Lancet Oncology,Negative
 Sept,Society of Hematologic Oncology (SOHO),Positive
 Sept,iwCLL,Negative
 Sept,Patient Empowerment Network,Negative
 Sept,Patient Power,Negative
 Sept,LiveYourLife,Negative
 Sept,Andrew Schorr,Negative
 Prognostic Predictive Molecular Biomarkers,J Mol Diagnostics,Positive
 Prognostic Predictive Molecular Biomarkers,Pathology Alerts (Guidelines & Reviews),Positive
 Prognostic Predictive Molecular Biomarkers,Paperbirds_Hematology,Negative
 required hospitalization amp,DynaMed¬Æ,Positive
 study amp,DynaMed¬Æ,Positive
 PM CST   Session VI,MD Anderson Leukemia,Negative
 Multiple Myeloma,Oncology CE,Positive
 Multiple Myeloma,Vindico Medical Education,Positive
 Multiple Myeloma,Eyemagistus ‚úçüèº,Positive
 Multiple Myeloma,Disraelly Guti√©rrez,Positive
 Multiple Myeloma,David T.,Positive
 Multiple Myeloma,Harry Moritz,Positive
 Multiple Myeloma,Noopur Raje,Positive
 Multiple Myeloma,missmaybell,Positive
 Multiple Myeloma,Cancer Papers,Positive
 Multiple Myeloma,Patient Worthy,Negative
 Multiple Myeloma,flosz,Positive
 Multiple Myeloma,Janssen Sverige,Positive
 Multiple Myeloma,MinuteCE,Positive
 Multiple Myeloma,Oncology Tube,Positive
 Community,Oncology CE,Positive
 Community,Vindico Medical Education,Positive
 Community,Patient Power,Negative
 Improving Outcomes,Oncology CE,Positive
 Improving Outcomes,Vindico Medical Education,Positive
 Latest Clinical Advances,Oncology CE,Positive
 Latest Clinical Advances,Vindico Medical Education,Positive
 John M Burke MD amp Manuel Santiago MD,Oncology CE,Positive
 John M Burke MD amp Manuel Santiago MD,Vindico Medical Education,Positive
 credits,Oncology CE,Positive
 credits,Vindico Medical Education,Positive
 credits,Medscape Education,Negative
 Happy September,wAIHA Warriors,Positive
 CLL Trial Followup Venetoclax,The ASCO Post,Negative
 ‚òÄ,Health1+1,Positive
 Ô∏èËÄÅ‰∫∫Á™ÅÁÑ∂È´îÈáç‰∏ãÈôçÔºåË¶∫ÂæóÁñ≤Á¥ØÔºåÂà∞Â∫ïÊòØËÄÅÂåñÈÇÑÊòØÂæó‰∫ÜÁôΩË°ÄÁóÖ ü§î,Health1+1,Negative
 Ô∏èÊòéÊòéÂæó‰∫ÜË°ÄÁôåÔºåÈÜ´ÁîüÁÇ∫‰ªÄÈ∫ºË™™„ÄåËßÄÂØüÂ∞±Â•Ω „Äç Ôºü ü§î,Health1+1,Negative
 Katrine Melvold,Sigrid Sk√•nland,Negative
 Janssens,Dr.  Amit Dang,Positive
 Janssens,The PMI (Pharmaceutical Managers' Institute),Negative
 European Commissions approval,Dr.  Amit Dang,Positive
 marketing authorization,Dr.  Amit Dang,Positive
 Clinical Oncology Annual Meeting,Paperbirds_Hematology,Positive
 Clinical Oncology Annual Meeting,Stock Titan,Negative
 Clinical Oncology Annual Meeting,dough,Negative
 Clinical Oncology Annual Meeting,Jake,Negative
 Clinical Oncology Annual Meeting,The Stock Sniper,Positive
 Clinical Oncology Annual Meeting,Amp Trades,Negative
 Clinical Oncology Annual Meeting,Anna Deveau,Negative
 LymphomaAwarenessDay,Teckro,Positive
 Dr Susan OBrien,Teckro,Positive
 Dr Susan OBrien,MJH Life Sciences,Positive
 Dr Susan OBrien,Patient Empowerment Network,Negative
 Dr Susan OBrien,Verastem Oncology,Negative
 Dr Susan OBrien,CLL Ireland,Negative
 Dr Susan OBrien,Patient Power,Negative
 Dr Susan OBrien,MD Anderson Leukemia,Negative
 behalf,Teckro,Positive
 behalf,MJH Life Sciences,Positive
 behalf,CLLSA,Negative
 behalf,LYMPHOMA & MYELOMA CONNECT,Negative
 behalf,PROvendis GmbH,Negative
 behalf,CURE Magazine,Negative
 behalf,CLL Ireland,Positive
 behalf,CLL,Negative
 ONLINE,International Journal of Cancer,Positive
 ONLINE,Paradigm Med Comm,Negative
 earlystage chronic lymphocytic,ASH Clinical News,Positive
 Free   Video Chat Peer Support,AnCan,Negative
 pm EDT,AnCan,Negative
 Allogeneic stem cell transplantation,Deborah Stephens,Positive
 Allogeneic stem cell transplantation,British Society of Blood & Marrow Transplantation,Positive
 Allogeneic stem cell transplantation,F. Hernandez Mohedo,Positive
 Allogeneic stem cell transplantation,Blood Advances,Negative
 Allogeneic stem cell transplantation,Saudi Leukemia Net,Negative
 Allogeneic stem cell transplantation,Marcel van den Brink,Positive
 Allogeneic stem cell transplantation,Cancer Papers,Negative
 Allogeneic stem cell transplantation,ALI ALAHMARI.,Negative
 video series,MJH Life Sciences,Positive
 video series,Oncology Learning Network,Negative
 Litigation Law Alert,"Cowan, Liebowitz",Positive
 Tiffany,"Cowan, Liebowitz",Negative
 million Summary Judgement,"Cowan, Liebowitz",Negative
 Trademark Infringement,"Cowan, Liebowitz",Negative
 Appeal,"Cowan, Liebowitz",Negative
 Chronic Lymphocytic Leukemia amp Small Lymphocytic Lymphoma,Leukemia Research Foundation,Negative
 Chronic Lymphocytic Leukemia amp Small Lymphocytic Lymphoma,UKiwiS,Negative
 Dr Parameswaran Venugopal,Leukemia Research Foundation,Negative
   New Emerging Treatments,Leukemia Research Foundation,Negative
 Blood Cancers Virtual Series Register,Leukemia Research Foundation,Negative
   MTP Session XIX,MD Anderson Leukemia,Positive
 Park,MD Anderson Leukemia,Negative
   Announces,Plexus Ventures,Negative
   Announces,1stOncology,Positive
   Announces,TrialSite News,Negative
 Decision,Plexus Ventures,Negative
 Decision,1stOncology,Negative
 Expanded Use,Plexus Ventures,Negative
 Expanded Use,1stOncology,Positive
 Previously Untreated Patients,Plexus Ventures,Negative
 Previously Untreated Patients,PharmaShots - Incisive news in 3 shots,Negative
 Previously Untreated Patients,1stOncology,Positive
 Previously Untreated Patients,Cancer Papers,Negative
 Previously Untreated Patients,Turmeric,Negative
 Previously Untreated Patients,Saeed Valadbaygi,Negative
 Previously Untreated Patients,Simple Charts,Negative
 Previously Untreated Patients,VPO/PR Newswire,Negative
 Previously Untreated Patients,pressdaily,Negative
 Previously Untreated Patients,Benlazar S.M Amin√©,Negative
 Previously Untreated Patients,HSMN,Negative
 Previously Untreated Patients,PRICENTRIC,Positive
 Previously Untreated Patients,HEDGE accordinglyüìà,Positive
 Previously Untreated Patients,RazzleTazzle,Negative
 STELLAR UPDATEHaving,TAP Clinical Trial Network,Negative
 nd,TAP Clinical Trial Network,Negative
 nd,CLLSA,Negative
 nd,Daniel F. Baranowski,Positive
 nd,Paula Cramer,Positive
 nd,Joe,Negative
 nd,UCI Health,Negative
 PI Dr Ben Kennedy,TAP Clinical Trial Network,Negative
   MTP Session IX,MD Anderson Leukemia,Positive
 Moreno   Thompson   Jain,MD Anderson Leukemia,Negative
 Join webinar,MD Anderson Leukemia,Negative
   month,VJHemOnc,Negative
 Glucocorticoid,Paperbirds_Hematology,Negative
 diabetes,Paperbirds_Hematology,Negative
 lymphoid malignancy survivors,Paperbirds_Hematology,Negative
 Atrial fibrillation,Medivizor,Positive
 Atrial fibrillation,"Jill Lykon, PharmD, BCOP",Positive
 Atrial fibrillation,Lymphoma Papers,Negative
 Atrial fibrillation,"chadi nabhan MD, MBA, FACP",Negative
 Atrial fibrillation,"Raul Cordoba, MD, PhD",Positive
   Good outcomes,Seema Ali Bhat,Positive
 NonHodgkin Lymphoma NHL,CureHuntr,Negative
 NonHodgkin Lymphoma NHL,TrialBulletin,Negative
 NonHodgkin Lymphoma NHL,Virtute_USMLE,Negative
 Ascentage Pharma,FSTP,Positive
 orphan drug Designation,FSTP,Positive
 Alessandra Ferrajoli MD,MD Anderson Leukemia,Positive
 Alessandra Ferrajoli MD,Robert Z. Orlowski,Negative
 Alessandra Ferrajoli MD,OncLive SOSS,Negative
 Managing BTK Inhibitor Toxicities,MD Anderson Leukemia,Negative
 CST,MD Anderson Leukemia,Positive
 presents BTK,MD Anderson Leukemia,Positive
 Sept     CST,MD Anderson Leukemia,Negative
 Philip Thompson MB BS,MD Anderson Leukemia,Positive
 Philip Thompson MB BS,Robert Z. Orlowski,Negative
 scope,40:40 Recruitment,Positive
   Grants Orphan Drug Designation,Raymond DuBois,Positive
 Novel   inhibitor,Raymond DuBois,Positive
 Orphan Drug designation,Targeted Oncology,Negative
 Priti Patel,AstraZenecaUS,Negative
 Heroes,AstraZenecaUS,Negative
 EC,PharmaShots - Incisive news in 3 shots,Positive
 EC,MDedge Hematology & Oncology,Negative
 EC,PT. BI Group Mining,Positive
 EC,European Pharmaceutical Review,Positive
 Marketing Authorization,PharmaShots - Incisive news in 3 shots,Negative
 Chronic Lymphocytic Lymphoma,Patient Empowerment Network,Negative
 Condition Summary Lymphoma NonHodgkin Leukemia Lymphocytic Chronic BCell,TrialBulletin,Negative
 Brutons Tyrosine Kinase BTK,Pharmacology Research & Perspectives,Positive
 treatment na√Øve patients,The PMI (Pharmaceutical Managers' Institute),Negative
 chronic   leukaemia,The PMI (Pharmaceutical Managers' Institute),Negative
 tcojwiZOnyWkf,The PMI (Pharmaceutical Managers' Institute),Negative
 Arzerra,"KOLKATA RAVI SPECIALITIES PHARMA PVT.LTD.,",Positive
 Arzerra,delhi-ravi worldwide medicines,Positive
 Arzerra,CURE Magazine,Positive
 Arzerra,Bio Stocks‚Ñ¢,Negative
 Arzerra,R&G Disease Network,Positive
 Arzerra,A. Vroom - Ten Wolde,Negative
 Arzerra,Bursatil Biotech,Positive
 Arzerra,miguel oliveira,Positive
 Arzerra,NNY News.ca,Positive
 Arzerra,Pure Leverage Rep,Negative
 Arzerra,karin55marin,Negative
 Arzerra,Thomas Van Ahn,Negative
 Arzerra,NYC Social Group,Negative
 Arzerra,TTC,Positive
 Arzerra,JP Duvenhage,Negative
 Arzerra,StartupStudio,Negative
 Arzerra,URL Shortener,Negative
 Arzerra,Healthcare Industry,Positive
 Arzerra,Cedar Consultants,Negative
 Arzerra,Charlotte Biz Owners,Positive
 Arzerra,Fredi Skwar,Positive
 Arzerra,I.Gazette,Negative
 Arzerra,Hanung Nugroho,Positive
 Arzerra,mediat XEX business,Positive
 Arzerra,WorldNews,Positive
 Arzerra,Michel Francoeur,Positive
 Arzerra,CancerCare,Negative
 Arzerra,HemOnc Today,Positive
 Arzerra,Sarah DiGiulio,Positive
 Arzerra,SPRTG,Positive
 Arzerra,Biocom California,Positive
 Arzerra,Pharma Commons,Negative
 Arzerra,Hal Palmer,Positive
 Arzerra,European Pharmaceutical Review,Negative
 Arzerra,Scott Werntz,Negative
 Arzerra,ABABioBlurb,Positive
 Arzerra,PharmaCentra,Positive
 Arzerra,Matthias Piesche,Negative
 Arzerra,Todd A Nolan,Positive
 brandname prescription drug,"KOLKATA RAVI SPECIALITIES PHARMA PVT.LTD.,",Positive
 brandname prescription drug,delhi-ravi worldwide medicines,Positive
 Evolution,Lymphoma Papers,Negative
 Evolution,Paperbirds_Hematology,Negative
 Evolution,"Raul Cordoba, MD, PhD",Negative
 Evolution,Francesco Bertoni,Negative
 Evolution,VJHemOnc,Negative
 Evolution,CML AdvocatesNetwork,Negative
 Evolution,Oncology Board,Negative
 Evolution,Oncology Tube,Negative
 Evolution,Patient Power,Negative
 Evolution,Vincent Rajkumar,Positive
 Evolution,TumorImmunoPapers,Negative
 perspectives,Haematologica,Positive
 perspectives,OncLive.com,Negative
 clinics,Haematologica,Positive
 Ascentage Pharmas Bcl Inhibitor APG Granted Orphan Drug Designation,Investor News,Negative
 Ascentage Pharmas Bcl Inhibitor APG Granted Orphan Drug Designation,Aspen Biosciences,Positive
 Ascentage Pharmas Bcl Inhibitor APG Granted Orphan Drug Designation,Pharm2Market,Positive
 Ascentage Pharmas Bcl Inhibitor APG Granted Orphan Drug Designation,Jessi M,Positive
 Ascentage Pharmas Bcl Inhibitor APG Granted Orphan Drug Designation,DennisPartners,Negative
 Ascentage Pharmas Bcl Inhibitor APG Granted Orphan Drug Designation,Crwe World,Negative
 Ascentage Pharmas Bcl Inhibitor APG Granted Orphan Drug Designation,Pharma News,Positive
 Ascentage Pharmas Bcl Inhibitor APG Granted Orphan Drug Designation,Bastion Balance Seoul Korea,Positive
 Ascentage Pharmas Bcl Inhibitor APG Granted Orphan Drug Designation,IMPharma News,Negative
 EC approval,ExpPharma,Negative
 EC approval,Khurram Nawaz,Positive
 Blood Cancer Patients,Michele Nadeem-Baker,Negative
 ear,Michele Nadeem-Baker,Negative
 Answers,Michele Nadeem-Baker,Negative
 Answers,Patient Power,Negative
 Answers,Dog Cancer Help,Positive
 Answers,jneed,Positive
 CLL MM,clonoSEQ,Positive
 BALL,clonoSEQ,Positive
 BALL,CancerTherapyAdvisor,Negative
 Meet Michele Kenny amp Richard,AnCan,Negative
 Virtual Support Group Sep     pm,AnCan,Negative
 MabThera,Market Intelligence: Healthcare,Positive
 MabThera,oncohebdo,Positive
 MabThera,PharmaJobs.co.uk,Positive
 MabThera,Pf Magazine,Positive
 MabThera,#WeAreE4H,Positive
 MabThera,PRICENTRIC,Positive
 MabThera,PT. BI Group Mining,Positive
 MabThera,European Pharmaceutical Review,Positive
 firstline combination therapy,Market Intelligence: Healthcare,Positive
 treatment patients,Cellfood SA,Positive
 Cutaneous manifestations,Cancer Papers,Negative
 Bcell,Cancer Papers,Negative
 Bcell,Krishan Maggon,Negative
 Bcell,Syed Abutalib,Positive
 Bcell,Europe PMC articles,Positive
 Bcell,Blood Journal,Positive
 Bcell,researchjobs.cz,Positive
 Bcell,Vinci-Biochem Srl,Positive
 Bcell,Wei Du,Positive
 Bcell,LymphomaLeukemia,Positive
 Bcell,NPCE,Positive
 Bcell,Journal of Clinical and Cellular Immunology,Negative
 Bcell,MD Anderson Cancer Center,Negative
 Bcell,VJHemOnc,Negative
 Bcell,Biotech2050,Negative
 Realworld outcomes,Medivizor,Negative
 faculty,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 faculty,OHSU IM Residency,Positive
 Alloa,Shankara Paneesha,Negative
 novel drugs,Shankara Paneesha,Negative
 novel drugs,VJHemOnc,Positive
 novel drugs,"Raul Cordoba, MD, PhD",Negative
 novel drugs,Oncology Tube,Positive
 Dr Paul Hampel,"Sid Yadav MD, FACP",Positive
 GREEN study,VJHemOnc,Negative
 w V√©ronique Leblond,VJHemOnc,Negative
 Algoritmo de tratamiento,Leonardo Mej√≠a B,Positive
 o refractario,Leonardo Mej√≠a B,Negative
 Combination obinutuzumab ibrutinib,ASCO Publications,Negative
 LongTerm Outcomes,Albeena Nisar,Positive
 LongTerm Outcomes,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 LongTerm Outcomes,filippo masini,Negative
 LongTerm Outcomes,INDoximity üáÆüá≥,Negative
 LongTerm Outcomes,F. Hernandez Mohedo,Positive
 LongTerm Outcomes,"Hayder Saeed, MD",Positive
 LongTerm Outcomes,"Bruce Levine, Ph.D.",Positive
 LongTerm Outcomes,"Meagan Bryan, RN",Negative
 LongTerm Outcomes,OncologyNurseAdvisor,Negative
 Randomized Dose Optimization Study,Albeena Nisar,Positive
 Randomized Dose Optimization Study,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 Randomized Dose Optimization Study,filippo masini,Negative
 Randomized Dose Optimization Study,INDoximity üáÆüá≥,Negative
 Randomized Dose Optimization Study,F. Hernandez Mohedo,Positive
 Randomized Dose Optimization Study,"Hayder Saeed, MD",Positive
 Randomized Dose Optimization Study,"Bruce Levine, Ph.D.",Positive
 Chimeric Antigen Receptor Modified T Cells,Albeena Nisar,Positive
 Chimeric Antigen Receptor Modified T Cells,filippo masini,Negative
 Chimeric Antigen Receptor Modified T Cells,INDoximity üáÆüá≥,Negative
 Chimeric Antigen Receptor Modified T Cells,F. Hernandez Mohedo,Positive
 Chimeric Antigen Receptor Modified T Cells,"Hayder Saeed, MD",Positive
 Chimeric Antigen Receptor Modified T Cells,"Bruce Levine, Ph.D.",Positive
 Indicaciones de,Leonardo Mej√≠a B,Negative
   Mantle Cell LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaWaldenstrom MacroglobulinemiaMarginal Zone Lymphoma,Shifa Drug,Positive
 Contact,Shifa Drug,Positive
 ordersWeChat amp,Shifa Drug,Positive
 alloSCT post novel agents,Toby Eyre,Negative
      √¶mi,LyLe Foreningen,Negative
 Chronic Lymphocytic Leukemia Oncologist,CancerEpiPapers,Negative
 Ô∏èBoth watchandwait,R√©my Dul√©ry,Positive
 Faculty,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 ThirdYear Oncology Fellow,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 upcoming   session,"Binaytara Foundation - Advocate, Educate, Innovate",Positive
 Dr Hampel,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
   symposium,Medscape Education,Positive
   symposium,Carevƒ´ve,Negative
   symposium,Mallory Ahern,Positive
   symposium,PeerView,Positive
   symposium,Carmine DeLuca,Negative
 Discover,Medscape Education,Negative
 Discover,VJHemOnc,Negative
 Discover,Janssen EMEA,Negative
 awareness,CLL Advocates Network,Positive
 awareness,HemaSphere_EHA,Positive
 awareness,CLEVER Network,Positive
 awareness,Michael Rynne,Negative
 awareness,CLL Ireland,Negative
 awareness,CLLSA,Positive
 awareness,Blood Cancer UK,Positive
 awareness,yosra salah,Positive
 T Chimeric Antigen Receptor Modified T Cells,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
    lymphoma,BeiGene,Negative
 CLL AML,Esther Schorr,Positive
 MPNs,Esther Schorr,Positive
   Publishes Analysis,1stOncology,Negative
 Years Patients,1stOncology,Negative
 herd immunity,Patient Power,Negative
 Dr Anthony Mato,Patient Power,Negative
 Dr Anthony Mato,PRIME Education,Negative
 Dr Anthony Mato,MDedge Hematology & Oncology,Positive
 Dr Anthony Mato,Expert Perspectives in Oncology,Positive
 Dr Anthony Mato,Patient Empowerment Network,Negative
 Dr Anthony Mato,Targeted Oncology,Negative
 Blood Cancer awareness month,üíô Katharine Parker üò∑#WearAMasküò∑,Positive
 Ben je opmerkelijk vaak verkouden vaak moe heb je opgezette lymfeklieren Ga,Jolanda,Positive
 naar,Jolanda,Positive
 je,Jolanda,Positive
 je,JU,Positive
 laat je controleren,Jolanda,Positive
 leukemie,Jolanda,Positive
 education,HemaSphere_EHA,Positive
 education,LYMPHOMA & MYELOMA CONNECT,Negative
 education,Patient Power,Positive
 education,Atlantis Healthcare,Positive
 Chronic Lymphocytic Leukemia Treatment Market   Size Share Leading Growth Drivers Emerging Audience Segments Industry,Swapna Supekar,Positive
 concise editorial,"chadi nabhan MD, MBA, FACP",Negative
 evolving   treatment paradigm,VJHemOnc,Negative
 Carsten Niemann,VJHemOnc,Negative
 Carsten Niemann,Antonio V. Borderia,Positive
 World Leukaemia Day,Michael Rynne,Negative
 Sims,Michael Rynne,Negative
 Steven Treon MD PhD,Journal of the @NCCN,Negative
 Mattsson M,MUVBBvirtual,Negative
   Outcomes,"Raul Cordoba, MD, PhD",Negative
   Outcomes,CAPhO,Negative
 Emili Montserrat,Toby Eyre,Negative
 Emili Montserrat,VJHemOnc,Positive
 editorial commentary,Toby Eyre,Negative
    series,Toby Eyre,Negative
   Phillip Thompson MD,MD Anderson Leukemia,Negative
   patient,CLL Ireland,Positive
   patient,Patient Power,Positive
   patient,Jan Rynne,Positive
   patient,CLL Advocates Network,Positive
   patient,Hematologia ICO Hospitalet,Positive
   patient,The Patient's Channel,Negative
   patient,"Francisco Marty, MD",Negative
   patient,Andrew Schorr,Positive
   patient,EMJ Hematology,Negative
   patient,Life Extension,Negative
   patient,Medical Xpress,Negative
   patient,VJHemOnc,Negative
   patient,Blood Cancer UK,Positive
   patient,Chris Hillis,Positive
   patient,Patient Empowerment Network,Negative
   patient,AZ Blood Cancer,Positive
 ‚Äú differential methylation,Environmental Epigenetics,Positive
 retrotransposons,Environmental Epigenetics,Positive
 flexibility,BSI UK,Positive
 feel,BSI UK,Positive
 P√• tide det nationale,LyLe Foreningen,Negative
 med,LyLe Foreningen,Negative
 √¶ldnesygdomme som,LyLe Foreningen,Negative
 ex,LyLe Foreningen,Negative
 og √¶ft √¶ft     √¶ftdagen,LyLe Foreningen,Negative
 Concordance,Lymphoma Papers,Negative
 Optic neuropathy,Medical Dialogues,Positive
 sign,Medical Dialogues,Positive
 sign,Talal Hilal ü©∫,Negative
 sign,Anna Deveau,Negative
 sign,Andrew Schorr,Positive
 Case report,Journal of the @NCCN,Negative
 Acquisition,Cytof Manchester,Positive
 Acquisition,Paperbirds_Hematology,Negative
 Acquisition,Daniel Auclair,Positive
 Acquisition,"Raul Cordoba, MD, PhD",Negative
 Acquisition,Mahmoud Aljurf,Negative
 Recurrent GlyVal Mutation,Cytof Manchester,Positive
 Recurrent GlyVal Mutation,Daniel Auclair,Positive
 Recurrent GlyVal Mutation,"Raul Cordoba, MD, PhD",Negative
 Recurrent GlyVal Mutation,Triona N√≠ Chonghaile,Negative
 Recurrent GlyVal Mutation,"Mike Thompson, MD, PhD, FASCO",Negative
 Recurrent GlyVal Mutation,Mahmoud Aljurf,Negative
 BCL Confers Resistance,Cytof Manchester,Positive
 BCL Confers Resistance,Daniel Auclair,Positive
 BCL Confers Resistance,"Raul Cordoba, MD, PhD",Negative
 BCL Confers Resistance,Triona N√≠ Chonghaile,Negative
 BCL Confers Resistance,"Mike Thompson, MD, PhD, FASCO",Negative
 BCL Confers Resistance,Mahmoud Aljurf,Negative
 Progressive Chronic Lymphocytic Leukemia,Cytof Manchester,Positive
 Progressive Chronic Lymphocytic Leukemia,"Raul Cordoba, MD, PhD",Negative
 Progressive Chronic Lymphocytic Leukemia,Triona N√≠ Chonghaile,Negative
 Progressive Chronic Lymphocytic Leukemia,Mahmoud Aljurf,Negative
 Gobsmacked,Michele Nadeem-Baker,Negative
 ¬Æ Assay,Oncology Tube,Positive
 ¬Æ Assay,ArthurPotatoeHammer,Positive
 ¬Æ Assay,Pharmacutical Daily,Negative
 ¬Æ Assay,Investor News,Negative
 ¬Æ Assay,IMPharma News,Negative
 ¬Æ Assay,Basil,Positive
 ¬Æ Assay,"OTC Dynamics, Inc.",Positive
 ¬Æ Assay,Ariel Herzog,Positive
 ¬Æ Assay,BW Capital,Positive
 ¬Æ Assay,Stock Titan,Negative
 ¬Æ Assay,gilbert c faure,Negative
 ¬Æ Assay,San Francisco Biotechnology Network,Positive
 ¬Æ Assay,Mr Bentley Onelly,Positive
 ¬Æ Assay,Michelle Solly,Positive
 ¬Æ Assay,Crwe World,Negative
 Assess Minimal Residual Disease MRD,Oncology Tube,Positive
 Assess Minimal Residual Disease MRD,ArthurPotatoeHammer,Negative
 Assess Minimal Residual Disease MRD,Pharmacutical Daily,Negative
 Assess Minimal Residual Disease MRD,IMPharma News,Negative
 Assess Minimal Residual Disease MRD,Basil,Positive
 Assess Minimal Residual Disease MRD,"OTC Dynamics, Inc.",Negative
 Assess Minimal Residual Disease MRD,Ariel Herzog,Positive
 Assess Minimal Residual Disease MRD,BW Capital,Positive
 Assess Minimal Residual Disease MRD,Stock Titan,Negative
 ClonoS,Oncology Tube,Negative
 Common Questions,Oncology Tube,Negative
 John Pagel MD S,Oncology Tube,Negative
 Assess MRD,Oncology Tube,Positive
 FDA clearance,Oncology Tube,Negative
 Brian K,Oncology Tube,Negative
 Debate,Journal of the @NCCN,Negative
 Debate,The ASCO Post,Negative
 Debate,CONQUER the patient voice,Negative
 Debate,CLL Ireland,Negative
 Debate,CLLSA,Positive
 Debate,MD Anderson Leukemia,Positive
 John Burke MD,OncLive.com,Negative
 Rocky Mountain Cancer Centers,OncLive.com,Negative
 Dr Barr,Targeted Oncology,Negative
 Dr Barr,Patient Power,Negative
 Dr Barr,Biotech2050,Negative
 microRNAap,Paperbirds_Hematology,Negative
 extracellular vesicles,Paperbirds_Hematology,Negative
 extracellular vesicles,"Bruce Levine, Ph.D.",Positive
 Kappa,Paperbirds_Hematology,Negative
 Lambda Immunohistochemistry,Paperbirds_Hematology,Negative
 Atypical Cutaneous Lymphoid,Paperbirds_Hematology,Negative
 th anniversary issue,The Lancet Oncology,Negative
 papers,The Lancet Oncology,Positive
 papers,Continuous Lifecycle London (online),Negative
 ‚Äú Vitamin D levels,pathdoc3,Positive
 chronic lymphocytic l,Medivizor,Negative
 chronic lymphocytic l,THE MUSIC üë•,Positive
 chronic lymphocytic l,Michelet St. Preuve,Positive
 New threedrug combination therapy,Patient Power,Negative
 half,Patient Power,Negative
 half,Psychedelic Jukebox,Positive
 half,Paperbirds_Hematology,Negative
 half,CLLSA,Negative
 half,Amy C. Cavers,Negative
 oncology patient access program,CURE Magazine,Negative
 Patient Access Novartis Oncology,CURE Magazine,Negative
 Blood Cancer Awareness Month,RIOH,Negative
 Blood Cancer Awareness Month,MerMer Goodburn üåàüá™üá∫ü©∏,Positive
 Blood Cancer Awareness Month,Nick,Negative
 Blood Cancer Awareness Month,CLLSA,Negative
 teams,RIOH,Negative
 teams,The James,Positive
 teams,Dr. Melody Davis,Negative
 teams,Jacko,Positive
 clinicians scientists,RIOH,Negative
 epidemiologists,RIOH,Negative
 Food Industry,"Cowan, Liebowitz",Negative
 Insight,"Cowan, Liebowitz",Negative
 Insight,Mar√≠a Jos√© Calasanz,Positive
 Insight,Atanas G. Atanasov,Positive
 Insight,Daniel Castellano,Positive
 Insight,Behav Ecol Papers,Positive
 Insight,"Ricardo Lebr√≥n, Ph.D.",Positive
 Insight,EPR Network,Positive
 Insight,CLL Ireland,Negative
 Insight,AJMC,Positive
 Overcoming Trademark Genericism,"Cowan, Liebowitz",Negative
 D‚ÄôIngenuity,"Cowan, Liebowitz",Negative
 Le Creativity,"Cowan, Liebowitz",Negative
 starter fokus √¶ft,LyLe Foreningen,Negative
   Societys ASCO,CLL Society Inc.,Negative
 Conference Coverage End,CLL Society Inc.,Negative
 suspense,CLL Society Inc.,Negative
 Dr Koffmans,CLL Society Inc.,Negative
 Pick,CLL Society Inc.,Negative
 CLL   Trial,CLL Society Inc.,Negative
 fixedduration venetoclaxobinutuzumab,CLL Society Inc.,Negative
   Societys BIG Global Virtual Educational Forum,CLL Society Inc.,Negative
    Olivier Tournilhac,Lymphoma Hub,Negative
 fall,Lymphoma Hub,Negative
 alloHCT,Lymphoma Hub,Negative
 alloHCT,"Raul Cordoba, MD, PhD",Negative
 alloHCT,CancerTherapyAdvisor,Negative
 alloHCT,Miguel Perales M.D.,Negative
 EBMT database,Lymphoma Hub,Negative
 decrease,Lymphoma Hub,Negative
 decrease,Cell Reports,Positive
 availability,Lymphoma Hub,Negative
 availability,Bio Stocks‚Ñ¢,Negative
 availability,Medivizor,Positive
 availability,noel cole,Negative
 availability,ASH Clinical News,Negative
 availability,CLL Ireland,Negative
 availability,Kathryn Evans Nu√±ez,Positive
 Best Treatment,Fish Chromosomes,Positive
 Best Treatment,CLL-seq,Negative
 Best Treatment,Benlazar S.M Amin√©,Negative
 Best Treatment,Lymphoma Papers,Negative
 Best Treatment,Clinical Trials,Positive
 Tsunami,Fish Chromosomes,Positive
 Tsunami,CLL-seq,Negative
 Tsunami,Benlazar S.M Amin√©,Negative
 Tsunami,Lymphoma Papers,Negative
 Tsunami,Oncology Tube,Negative
 New Treatment Options,Fish Chromosomes,Positive
 New Treatment Options,CLL-seq,Negative
 New Treatment Options,Benlazar S.M Amin√©,Negative
 New Treatment Options,Lymphoma Papers,Negative
 New Treatment Options,PER,Negative
 emergence,VJHemOnc,Negative
 emergence,COPD News,Negative
 emergence,Weill Cornell Medicine,Positive
 nextgeneration techniques,VJHemOnc,Negative
 w Richard Rosenquist,VJHemOnc,Negative
 Combination therapies,MD Anderson Cancer Center,Negative
   Society   Patient Survey,CLL Society Inc.,Negative
 CAR T cells,CancerTherapyAdvisor,Negative
 CAR T cells,Frontiers Oncology,Negative
 CAR T cells,Lymphoma Hub,Negative
 CAR T cells,Anna Deveau,Positive
 CAR T cells,Human Immunology News,Negative
 CAR T cells,"Bruce Levine, Ph.D.",Positive
 pregnancy,Patient Power,Negative
 Chronic Lymphocytic Leukemia Complete Remission,George,Negative
 EGCG,George,Negative
 Green Tea,George,Positive
 Green Tea,Anthony Mato,Negative
 Green Tea,Monterey Holistic,Negative
 ExtractA Case,George,Negative
 Complete Durable Molecular Remission,George,Negative
 Complete Durable Molecular Remission,Integra Medical,Positive
 Complete Durable Molecular Remission,Reddit FoodNerds,Positive
 Complete Durable Molecular Remission,"Born Integrative Medicine Specialists, PLLC",Positive
 Complete Durable Molecular Remission,Krishan Maggon,Negative
 Complete Durable Molecular Remission,Cureus,Positive
 Epigallocatechingallate,George,Negative
 Epigallocatechingallate,Integra Medical,Positive
 Extract,George,Negative
 Extract,Integra Medical,Positive
   Longitudinal health‚Äêrelated quality,"Raul Cordoba, MD, PhD",Negative
 first‚Äêline,"Raul Cordoba, MD, PhD",Negative
 best   treatments,Patient Power,Negative
 patient questions,Patient Power,Negative
 patient questions,Andrew Schorr,Negative
 Fantastic talk,Dr. Andy Evens,Negative
 Fantastic talk,Dr Effie Kostareli,Negative
 Phase b study,Lymphoma Papers,Negative
 Phase b study,Blood Journal,Positive
 Phase b study,Mary Ruberry,Positive
 Phase b study,"Raul Cordoba, MD, PhD",Negative
 Phase b study,"Mike Thompson, MD, PhD, FASCO",Negative
 Phase b study,"Dr T. Comeau , MD",Negative
 Phase b study,GEDEFO,Negative
 Phase b study,Jordan Gauthier,Positive
 Phase b study,Philip McCarthy,Negative
 Phase b study,ŸÖÿ±ŸÉÿ≤ ÿßŸÑÿ£ÿ®ÿ≠ÿßÿ´,Positive
 Phase b study,AA&MDSIF,Positive
 Reduced Frequency Dosing,Paperbirds_Hematology,Negative
 Complete Partial Remission Pilot Study,Paperbirds_Hematology,Negative
 antibody response,Paperbirds_Hematology,Negative
 Chidamide,Paperbirds_Hematology,Negative
 histone deacetylase inhibitor,Paperbirds_Hematology,Negative
 autophagy,Paperbirds_Hematology,Negative
 autophagy,EurekaMag,Negative
 autophagy,Lymphoma Papers,Negative
 autophagy,Cancer Papers,Negative
 autophagy,Autophagy Papers,Positive
 Dr Portell,Targeted Oncology,Negative
 Certain inherited genes,MD Anderson Cancer Center,Negative
 blood diseases,MD Anderson Cancer Center,Negative
 Scotts battle,Janet,Positive
 Whewsigh,Gamer Kitteh,Positive
 reliefThis,Gamer Kitteh,Positive
 chance amp,Gamer Kitteh,Positive
 Dr Courtney D DiNardo,Esther Schorr,Negative
 reality,Esther Schorr,Negative
 reality,Leukaemia Care,Negative
 International Ultman Chicago Lymphoma Symposium ‚Å¶‚Å©,"Krishna Komanduri, MD, FASTCT",Positive
 Hereditary   Founder,MD Anderson Leukemia,Negative
 amp Courtney DiNardo MD,MD Anderson Leukemia,Negative
 Hereditary Hematologic Malignancy Clinic Leader,MD Anderson Leukemia,Negative
 Verb vocab,Kirstie Page,Positive
 children,Kirstie Page,Positive
 children,Miss Nolan,Positive
 children,LymphomaAction,Negative
 children,Orchard Primary Academy Nursery,Negative
 children,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 children,MedPage Oncology,Negative
 children,Graviola Finland,Positive
 children,CLL Warwick Uni,Negative
 children,Children‚Äôs Oncology Group,Positive
 children,Rachel House,Positive
 children,Patient Power,Negative
 sentences,Kirstie Page,Positive
 amp tell stories,Kirstie Page,Positive
 Verbs,Kirstie Page,Positive
 tip amp splash,Kirstie Page,Positive
 water area,Kirstie Page,Positive
 stick tear,Kirstie Page,Positive
   WCRFAICR cancer prevention guidelines,Fight Cancer Team,Positive
   WCRFAICR cancer prevention guidelines,Paperbirds_Hematology,Negative
   WCRFAICR cancer prevention guidelines,Lymphoma Papers,Negative
 antiCDb,Paperbirds_Hematology,Negative
 enhanced Fc function,Paperbirds_Hematology,Negative
 B plasma cell malignancies,Paperbirds_Hematology,Negative
 angioedema,Paperbirds_Hematology,Negative
 husbands,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 husbands,CauseISaidSo ü•ÉüíÑü¶áüåπüë†üè≥Ô∏è‚Äçüåà,Positive
 mask,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 mask,CLL Advocates Network,Negative
 Tumor Lysis Syndrome,EurekaMag,Negative
 Tumor Lysis Syndrome,Lymphoma Papers,Negative
 Tumor Lysis Syndrome,GEDEFO,Negative
 Tumor Lysis Syndrome,Garbi√±e Lizeaga,Negative
 Chronic Lymphocytic Leukemia Rare Case Report,EurekaMag,Negative
 Nephrology,EurekaMag,Negative
 Nephrology,HofNorthwell Kidney,Positive
 pm PST pm EST,Patient Power,Negative
 ‚Äú Phase,"Michael Wang, MD",Negative
   experts,AbbVie US,Positive
   experts,Patient Empowerment Network,Negative
   experts,VJHemOnc,Negative
   experts,CLL Ireland,Negative
   experts,Patient Power,Positive
 Stay,CLL Society Inc.,Negative
 home Limit contact,CLL Society Inc.,Negative
 Obinutuzumab Ibrutinib,The ASCO Post,Negative
 Obinutuzumab Ibrutinib,"Andrew Johns, MD",Positive
 VIDEO EHA,VJHemOnc,Negative
 Highlights w Paolo Ghia,VJHemOnc,Negative
    Session,Society of Hematologic Oncology (SOHO),Positive
 Session Chairs Jennifer Brown amp Florence Cymbalista,Society of Hematologic Oncology (SOHO),Positive
 Exciting data,"Andrew Johns, MD",Positive
 Dr Rogers ‚Äô team,"Andrew Johns, MD",Positive
 MRDnegative pts,"Andrew Johns, MD",Positive
 mos,"Andrew Johns, MD",Positive
 mos,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 txnaive,"Andrew Johns, MD",Positive
 Refractory CLL,"Andrew Johns, MD",Positive
 Refractory CLL,Dr. JOSE VELASQUEZ,Negative
 Refractory CLL,Oncology,Negative
 Refractory CLL,PracticeUpdate,Negative
 Dr Wei Wang,Human Immunology News,Negative
 LP mutation,Human Immunology News,Negative
 MYD gene,Human Immunology News,Negative
 Reviews BTK Inhibitors,MD Anderson Leukemia,Negative
 CDT,PeerView,Negative
 Bona Fide Intent,"Cowan, Liebowitz",Negative
 Commerce,"Cowan, Liebowitz",Negative
 CLL Market Report FTSE,Proactive,Negative
 investors,Proactive,Negative
 TOMORROW Join Erlene Seymour MD,Karmanos Cancer Institute,Negative
 Chronic Lymphocytic Leukemia webinar,Karmanos Cancer Institute,Positive
 live Register,Karmanos Cancer Institute,Negative
 „Äê „Éã„É•„Éº„Çπ„Äë„Ç´„É´„ÇØ„Ç®„É≥„Çπ„Åå„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶„ÄÅÊ¨ßÂ∑ûÂåªËñ¨ÂìÅÂ∫Å„ÅÆÂåªËñ¨ÂìÅË©ï‰æ°ÂßîÂì°‰ºö„ÅåÊâøË™çÂãßÂëäÊâøË™çÂãßÂëä„ÅÆÂü∫„Å®„Å™„Å£„ÅüËá®Â∫äË©¶È®ì„ÅÆ„Å§„ÄåELEVATE TNË©¶È®ì„Äç„ÅÆÁµêÊûú„ÄÅ„Ç´„É´„ÇØ„Ç®„É≥„ÇπÔºã„Ç¨„Ç∂„Ç§„Éê„ÅÆ‰ΩµÁî®ÁôÇÊ≥ï„ÄÅÁóÖÂã¢ÈÄ≤Ë°å„Åæ„Åü„ÅØÊ≠ª‰∫°„É™„Çπ„ÇØ„ÇíÔºÖ‰Ωé‰∏ã „Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ,„Åå„Çì„Éó„É©„Çπ,Negative
 Allo transplant,Alan Skarbnik,Negative
   Allogeneic,"Raul Cordoba, MD, PhD",Negative
 cell transplantation,"Raul Cordoba, MD, PhD",Negative
 cell transplantation,Lymphoma Hub,Negative
 Advantage,Patient Empowerment Network,Negative
 Progress,Andrew Schorr,Negative
 Progress,john davis,Positive
 Progress,Medical Tribune,Positive
 Progress,CLL Society Inc.,Negative
 Progress,"Jose Sandoval S, MD FACP",Positive
 Progress,FarmaOnco,Negative
 Progress,NACDA Program on Aging,Negative
 Progress,Tom,Negative
 Progress,TumorImmunoPapers,Negative
 Progress,Cancer Papers,Negative
 Progress,Armand!!,Negative
 Progress,Francesco Turturro,Negative
   Society Registration,CLL Society Inc.,Negative
 Dr Neil Love,Research To Practice,Negative
 Lisa,BinderLab,Positive
 Lisa,Leukaemia Care,Positive
 Lisa,CLL Advocates Network,Negative
 Multidisciplinary diagnostics,EurekaMag,Negative
 PD inhibition,Current Oncology,Negative
 Raman,Lymphoma Papers,Negative
 fingerprint characteristics,Lymphoma Papers,Negative
 SLAMF receptors,NK cell Biology,Negative
 SLAMF receptors,NK papers,Negative
 B cell receptor,NK cell Biology,Negative
 B cell receptor,NK papers,Negative
 B cell receptor,Nature Reviews Disease Primers,Positive
 B cell receptor,Christopher Steer,Negative
 longerterm followup data,Targeted Oncology,Negative
 Reminder age,Lymphomation.org,Negative
 study participants,Lymphomation.org,Negative
 lymphoma    Idelalisib,Lymphomation.org,Negative
 Relapsed Follicular Lymphoma,Lymphomation.org,Negative
 Relapsed Follicular Lymphoma,ALI ALAHMARI.,Negative
 Relapsed Follicular Lymphoma,Lymphoma Papers,Negative
 Relapsed Follicular Lymphoma,ClinOwl,Positive
 Chronic Lymphocytic LeukemiaA Comparison,Lymphomation.org,Negative
 Treatment Outcomes,Lymphomation.org,Negative
 Treatment Outcomes,"Raul Cordoba, MD, PhD",Positive
 Treatment Outcomes,Lymphoma Papers,Negative
 Treatment Outcomes,EurekaMag,Negative
 Treatment Outcomes,TalkingScarsMedia.com,Positive
 Treatment Outcomes,Autotestdrivers.com,Positive
 Treatment Outcomes,MineListings.com,Positive
 Treatment Outcomes,VPO/PR Newswire,Negative
 Treatment Outcomes,CRE Demographics,Negative
 Treatment Outcomes,ShareHRnews,Positive
 Treatment Outcomes,iTruck NEWS,Positive
 Treatment Outcomes,Mr Slot,Positive
 Treatment Outcomes,Seattle's Banker,Negative
 Treatment Outcomes,RazzleTazzle,Negative
 Treatment Outcomes,Odi Bruckman,Negative
 Treatment Outcomes,Crwe World,Negative
 Treatment Outcomes,Financial Buzz,Negative
 Clinical Trial Participants,Lymphomation.org,Negative
 Clinical Trial Participants,"Raul Cordoba, MD, PhD",Positive
 Clinical Trial Participants,Lymphoma Papers,Negative
 Medicare Beneficiaries,Lymphomation.org,Negative
 Medicare Beneficiaries,"Raul Cordoba, MD, PhD",Positive
 Medicare Beneficiaries,Lymphoma Papers,Negative
 Tcellbased immunotherapy,Paperbirds_Hematology,Negative
 VIDEO Frontline,VJHemOnc,Negative
 EHA,VJHemOnc,Negative
 EHA,healthbook,Positive
 EHA,CARE‚Ñ¢ Education,Negative
 EHA,Amy C. Cavers,Positive
 EHA,SPI News,Negative
 EHA,James Dean,Positive
 EHA,Dean James,Positive
 EHA,BioGer,Positive
 EHA,orphanpedia,Positive
 EHA,Oncology Tube,Positive
 w Peter Hillmen,VJHemOnc,Negative
   Announces Plan,1stOncology,Negative
 Transition,1stOncology,Negative
   Access Program,1stOncology,Negative
 GMAB,1stOncology,Negative
   Faculty Spotlight,"Binaytara Foundation - Advocate, Educate, Innovate",Positive
 Chairman,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 Chairman,Didi Jasmin,Positive
 Precision Oncology Alliance,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 Medical Oncologist,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 Discussion topics,CURE Magazine,Positive
 panel faculty,CURE Magazine,Positive
 CURE,CURE Magazine,Positive
 CURE,OncLive.com,Negative
 ILI,Paperbirds_Hematology,Negative
 Metabolic Immune Checkpoint,Paperbirds_Hematology,Negative
 AHR,Paperbirds_Hematology,Negative
 Promotes Tumor Progression,Paperbirds_Hematology,Negative
 Transition Arzerra,Pharma News,Negative
 Transition Arzerra,Pharmacutical Daily,Negative
 Transition Arzerra,Umair Subhani,Positive
 Transition Arzerra,Biotech & Tech Stock Focus,Negative
 Transition Arzerra,STCK.PRO,Positive
 Transition Arzerra,Genmab,Positive
 Transition Arzerra,IMPharma News,Negative
 Transition Arzerra,"OTC Dynamics, Inc.",Negative
 Transition Arzerra,Crwe World,Negative
 Transition Arzerra,biotechradar.eu,Positive
 ¬Æ ofatumumab,Pharma News,Negative
 ¬Æ ofatumumab,Pharmacutical Daily,Negative
 ¬Æ ofatumumab,Umair Subhani,Positive
 ¬Æ ofatumumab,Biotech & Tech Stock Focus,Negative
 ¬Æ ofatumumab,Genmab,Positive
 ¬Æ ofatumumab,IMPharma News,Negative
 ¬Æ ofatumumab,"OTC Dynamics, Inc.",Negative
 ¬Æ ofatumumab,Crwe World,Negative
 ¬Æ ofatumumab,biotechradar.eu,Positive
 Oncology Access Program,Pharma News,Negative
 Oncology Access Program,Pharmacutical Daily,Negative
 Oncology Access Program,Umair Subhani,Positive
 Oncology Access Program,Biotech & Tech Stock Focus,Negative
 Oncology Access Program,STCK.PRO,Positive
 Oncology Access Program,Genmab,Positive
 Oncology Access Program,IMPharma News,Negative
 Oncology Access Program,"OTC Dynamics, Inc.",Negative
 Oncology Access Program,Crwe World,Negative
 Oncology Access Program,biotechradar.eu,Positive
   Die Deutsche Gesellschaft f√ºr,AbbVie Deutschland,Negative
 und Medizinische,AbbVie Deutschland,Negative
 eV,AbbVie Deutschland,Negative
 empfiehlt,AbbVie Deutschland,Negative
 ihrer,AbbVie Deutschland,Negative
 Leitlinie zur,AbbVie Deutschland,Negative
 Untersuchungen auf bestimmte Risikofaktoren,AbbVie Deutschland,Negative
 Einleitung einer Therapie Mehr,AbbVie Deutschland,Negative
 MRD Assay,ALI ALAHMARI.,Negative
 ¬†,Pharmacutical Daily,Negative
 CLL overview role,Lymphoma Australia,Positive
 NEWS Genmab Announces Plan,Umair Subhani,Negative
 GMAB NVS Genmab,Biotech & Tech Stock Focus,Negative
 Announces Plan,Biotech & Tech Stock Focus,Negative
 GMAB NEW ARTICLE,STCK.PRO,Positive
 Genmab Announces Plan,STCK.PRO,Positive
 GMAB Genmab Announces Plan,"OTC Dynamics, Inc.",Negative
 Genmab GMAB Announces Plan,biotechradar.eu,Positive
 GMAB Novartis,Bio Stocks‚Ñ¢,Negative
 oncology access program,Bio Stocks‚Ñ¢,Negative
 PR Genmab Announces Plan,Umair Subhani,Negative
 Worth,Dark Horse Duo Plan,Positive
 fro UT,Dark Horse Duo Plan,Positive
 Chronic Lymphocytic LeukemiaNot,Dark Horse Duo Plan,Positive
 ones energy amp general,Dark Horse Duo Plan,Positive
 healthIf,Dark Horse Duo Plan,Positive
 Local Connotations,"Cowan, Liebowitz",Negative
 Proposed TrademarkIn,"Cowan, Liebowitz",Negative
 trademark,"Cowan, Liebowitz",Positive
 st September pm,CLLSA,Negative
 Chronic Lymphocytic Leukemia BALL,clonoSEQ,Negative
 Multiple Myeloma   clonoSEQ,clonoSEQ,Negative
 FRIDAY,Research To Practice,Negative
 profiles,Lymphoma Research Foundation,Negative
 profiles,Scientific Data,Positive
 profiles,Xuan Shirley Li,Positive
   Career Development Award CDA,Lymphoma Research Foundation,Negative
 Postdoctoral Fellowship Grantees,Lymphoma Research Foundation,Negative
 pursuit,Lymphoma Research Foundation,Negative
 Dr Coutre,Targeted Oncology,Negative
 Dr Coutre,AJMC,Positive
 Phase II Study,Cancer Papers,Negative
 Phase II Study,Turmeric,Negative
 Phase II Study,MD Anderson Leukemia,Negative
 Phase II Study,Lisa Palacios,Negative
 ShortCourse Fludarabine,Cancer Papers,Negative
 Conceptual Model,Paperbirds_Hematology,Negative
 Better,Paperbirds_Hematology,Negative
 Patient Experience,Paperbirds_Hematology,Negative
 haben Bezeichnungen wie,AbbVie Deutschland,Negative
 p und TP mit der chronischen lymphatischen √§mie,AbbVie Deutschland,Negative
 kurz,AbbVie Deutschland,Negative
 zu,AbbVie Deutschland,Negative
 zu,Kompetenznetz Maligne Lymphome e.V.,Negative
 tun Dieser Artikel,AbbVie Deutschland,Negative
 Resident   ltmeta propertytwitterimage content gt ltmeta propertyogimage content gt,"Amparo Santamaria Ortiz MD, PhD",Positive
 LLNI,Dr Effie Kostareli,Negative
 VIDEO Significance,VJHemOnc,Negative
 ERIC study,VJHemOnc,Negative
 ERIC study,Lymphoma Hub,Negative
 p mutants,VJHemOnc,Negative
 w Kostas Stamatopoulos,VJHemOnc,Positive
 w Kostas Stamatopoulos,eos,Positive
 William G Wierda MD,PeerView,Negative
 William G Wierda MD,CLL Ireland,Negative
 sequencing BTK inhibitors,PeerView,Negative
 severity,Targeted Oncology,Negative
 severity,NCI Center for Cancer Research,Positive
 increases,Targeted Oncology,Negative
 Background Leukemia,Emily Bell,Positive
 chronic Acute Leukemia,Emily Bell,Positive
 literatureinformed   opinion,Raffaella Ravinetto,Positive
 Fatigue,Toby Eyre,Negative
 Fatigue,Andrew Schorr,Negative
 Fatigue,CLL Ireland,Negative
 Fatigue,Oncology Tube,Negative
 DYK,Patient Empowerment Network,Negative
 WEBINAR,Patient Empowerment Network,Negative
 CLL Webinar,Patient Empowerment Network,Negative
 Advancements,MEI Pharma,Positive
 Advancements,1stOncology,Negative
 Advancements,SNN Network,Negative
 Advancements,ANTELLIS,Positive
 Advancements,The Pharmaceutical Marketing Group,Negative
 Advancements,Cancer News,Negative
 treatment decisions,MEI Pharma,Positive
 treatment decisions,VJHemOnc,Negative
 treatment decisions,Targeted Oncology,Negative
 treatment decisions,Patient Power,Positive
 treatment decisions,Janssen Global,Negative
 treatment decisions,CAPhO,Negative
   impact   patients,Patient Empowerment Network,Negative
 view,Patient Empowerment Network,Negative
 view,Leukemia,Negative
 view,Toby Eyre,Negative
 view,Dr Amrish,Positive
 High CXCR,Paperbirds_Hematology,Negative
 Leukemic Cells Distinguishes,Paperbirds_Hematology,Negative
 IgHV mut,Paperbirds_Hematology,Negative
 IgHV unmut,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Evidence,Paperbirds_Hematology,Negative
 CDhigh,Paperbirds_Hematology,Negative
 CDlow Clones,Paperbirds_Hematology,Negative
 wholegenome sequencing,Paperbirds_Hematology,Negative
 Leukemia research,Fluxion Biosciences,Positive
 Brighton amp Sussex Medical School,Fluxion Biosciences,Positive
 BioFlux   system,Fluxion Biosciences,Positive
 cell interactions,Fluxion Biosciences,Positive
    cell therapy,Amit Patelüá¨üáß,Positive
 pluripotent stem cells,Amit Patelüá¨üáß,Positive
 Dr Peter Anglin,CARE‚Ñ¢ Education,Negative
 Southlake Regional Health Centre,CARE‚Ñ¢ Education,Negative
 JT,Aurileus FC,Positive
 JT,Carefree Blues Pod,Positive
 JT,.,Positive
 JT,Tommy D,Positive
 JT,Kyle Cherry,Positive
 JT,Sully,Positive
 JT,NoonesChampion,Negative
 JT,James Ball,Positive
 JT,Sid,Positive
 JT,Mike C.,Positive
 JT,Kevin Adatsi üëÅ,Positive
 JT,Spence,Positive
 PL,Aurileus FC,Positive
 Join Erlene Seymour MD,Karmanos Cancer Institute,Negative
 CLL information,Karmanos Cancer Institute,Negative
 Sanofi,40:40 Recruitment,Positive
 Principia Biopharma,40:40 Recruitment,Positive
 Das Vorliegen,AbbVie Deutschland,Negative
 Nichtvorhandensein von,AbbVie Deutschland,Negative
 genetischen,AbbVie Deutschland,Negative
 Merkmalen bei einer,AbbVie Deutschland,Negative
 beeinflusst nicht nur das Tempo,AbbVie Deutschland,Negative
 dem der,AbbVie Deutschland,Negative
 fortschreitet,AbbVie Deutschland,Negative
   Society,CLL Society Inc.,Positive
 Number Blocs stick puppets,Lea,Positive
 approach,Touch-type Read and Spell (TTRS),Positive
 approach,Mayo Clinic Cancer Center,Negative
 approach,"Mazyar Shadman, MD MPH",Negative
 approach,RIOH,Negative
 approach,Expert Perspectives in Oncology,Negative
 approach,Health Adviser,Positive
 approach,MoJo,Negative
 approach,Lymphoma Hub,Negative
 child,Touch-type Read and Spell (TTRS),Positive
 child,CLL,Negative
 Merkel cell carcinoma,EurekaMag,Negative
 pasamos al,Emaa,Positive
 etiology,MedStudent,Positive
 Line,Paperbirds_Hematology,Negative
 Line,Oncology Tube,Negative
 Beneficial Harmful Effects,Paperbirds_Hematology,Negative
 Reactive Oxygen Species,Paperbirds_Hematology,Negative
 Reactive Oxygen Species,TumorImmunoPapers,Negative
 Miniaturized Drug Sensitivity Resistance Test,Paperbirds_Hematology,Negative
 PatientDerived Cells,Paperbirds_Hematology,Negative
 DropletMicroarray,Paperbirds_Hematology,Negative
 Study Explores Causes,AJMC,Negative
 MCL Taking,AJMC,Negative
 tools,Cochrane UK,Positive
 tools,The Cochrane Library,Positive
 tools,Patient Power,Positive
 tools,Patient Empowerment Network,Negative
 PAID   phone interview,Say It Forward,Negative
 Chronic Lyphocytic Leukemia,Say It Forward,Negative
 Different Treatment Modalities tcoapltVbL,CellworksLife,Negative
 Grandma Fantastic,‚ìÇÔ∏é‚ìá‚ìà ‚íº‚í∫‚í∫üë©üèª‚Äçüè´,Positive
 EYFS team,‚ìÇÔ∏é‚ìá‚ìà ‚íº‚í∫‚í∫üë©üèª‚Äçüè´,Positive
 Recent Advances,touchONCOLOGY,Positive
 ÿ≥ÿ±ÿ∑ÿßŸÜ ÿßŸÑÿØŸÖ ÿßŸÑŸÑŸäŸÖŸÅÿßŸàŸä,ÿ¥ÿ®ŸÉÿ© ŸÅŸáÿ±ÿ≥,Positive
 FLT inhibitor,Joe,Negative
 CG IND,Joe,Negative
 AML,Joe,Negative
 disease amp,Joe,Negative
 Treatment Naive,Adam Kittai,Negative
 symposium,Adam Kittai,Negative
 symposium,Oncology State Societies at ACCC,Negative
 symposium,Gilead Sciences,Negative
 symposium,"Raul Cordoba, MD, PhD",Negative
 symposium,Christopher Steer,Negative
 Societys,CLL Society Inc.,Negative
 Treat Survey,CLL Society Inc.,Positive
 triplet combination,Targeted Oncology,Positive
 triplet combination,Lymphoma Hub,Negative
 APTO CG Phase,Joe,Negative
 Clinical Development Plan,Joe,Negative
 Lymphoid    Myeloid   Malignancies,Joe,Negative
 CLARITY UPDATE,TAP Clinical Trial Network,Negative
 Genabschnitt der bei der,AbbVie Deutschland,Negative
 mutiert sein kann Patienten mit unmutiertem IGHVStatus haben,AbbVie Deutschland,Negative
    Lymphoid Malignancies Session,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 Dr William Bensinger,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 Dr Venugopal,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 talented   amp,Satyen Gohil,Positive
 conference highlights,Oncology Times,Negative
 forefront,City of Hope | Orange County,Positive
 Pharmacy experts,"University of Maryland, Baltimore",Positive
 considerations,"University of Maryland, Baltimore",Positive
 considerations,The ASCO Post,Negative
 considerations,RGA,Positive
 TP Alterations,Boya Wang,Positive
 TP Alterations,Krishan Maggon,Negative
 TP Alterations,AGD Biomedicals,Negative
 TP Alterations,arun achuthan/dr/mr,Positive
 TP Alterations,Paperbirds_Hematology,Negative
 TP Alterations,"Wafik S. El-Deiry, MD, PhD, FACP",Negative
 patient education,SpecialtyPTimes,Negative
 VIDEO TRANSCENDCLL,VJHemOnc,Negative
 maraleucel,VJHemOnc,Negative
 w Tanya Siddiqi,VJHemOnc,Negative
 GEORGE THOROGOODIn effort,Elmer Puddpucker,Positive
 difference,Elmer Puddpucker,Positive
 difference,CrozrX,Positive
 difference,WCM Lymphoma,Negative
 difference,"Raul Cordoba, MD, PhD",Positive
 difference,NewYorkHealthWorks,Positive
 difference,Patient Power,Positive
 difference,Targeted Oncology,Negative
 difference,AZ Blood Cancer,Positive
 Delaware rocker,Elmer Puddpucker,Positive
 dollar,Elmer Puddpucker,Positive
 ticket,Elmer Puddpucker,Positive
 Badder,Elmer Puddpucker,Positive
 Lymphoma Society,Elmer Puddpucker,Positive
 Lymphoma Society,fatal atraction #312,Positive
 Lymphoma Society,Tom Carleton,Positive
 Lymphoma Society,Children's Wish,Positive
 CanadaI,Elmer Puddpucker,Positive
 CLL       Chronic Lymphocytic Leukemia,Elmer Puddpucker,Positive
 Dr Jonathon B Cohen,Targeted Oncology,Negative
 year woman,Targeted Oncology,Negative
 kinds,Patient Power,Negative
 kinds,Leukemia I'm Fine,Negative
 careers,Patient Power,Negative
 cofounder,Patient Power,Negative
 ICICLLE UPDATEWe,TAP Clinical Trial Network,Negative
 longterm,TAP Clinical Trial Network,Negative
 longterm,Prof John,Negative
 longterm,AbbVie,Negative
   Society Dr Nitin Jain,CLL Society Inc.,Positive
 MRD testing MRD,CLL Society Inc.,Positive
 lymphatischen √§mie,AbbVie Deutschland,Negative
 Lebenserwartung von Patienten Mehr,AbbVie Deutschland,Negative
 CII Seeking Ban,npnews24,Positive
 CII Seeking Ban,Pune Samachar,Positive
 Chinese Technology Huawei,npnews24,Positive
 Chinese Technology Huawei,Pune Samachar,Positive
 ZTE,npnews24,Positive
 ZTE,Pune Samachar,Positive
 G Network,npnews24,Positive
 G Network,Pune Samachar,Positive
   Faculty SpotlightDr Arvind Chaudhry,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 Summit Cancer Centers,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 boardcertified Medical Oncologist,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 term,Kroger Specialty Pharmacy,Positive
 term,Miss Nolan,Positive
 term,Patient Empowerment Network,Negative
   conditions,Kroger Specialty Pharmacy,Positive
 Immunoglobulin G lgG,Kroger Specialty Pharmacy,Positive
 Primary Immune Deficiency Disease,Kroger Specialty Pharmacy,Positive
 Chronic BCell Lymphocytic leukemia,Kroger Specialty Pharmacy,Positive
 Kroger Specialty Pharmacy,Kroger Specialty Pharmacy,Positive
 Brutons tyrosine kinase inhibitor,Paperbirds_Hematology,Negative
 Brutons tyrosine kinase inhibitor,Vall d‚ÄôHebron Institute of Oncology (VHIO),Positive
 Brutons tyrosine kinase inhibitor,Cancer Papers,Negative
     Cello Health PLC Scheme,AIM Alerts!,Negative
 Arrangement,AIM Alerts!,Negative
 featured faculty,"Binaytara Foundation - Advocate, Educate, Innovate",Negative
 Kennys,AnCan,Negative
 rock face,AnCan,Negative
 brain fog,Tony Rothwell,Positive
 Rang doctor,Tony Rothwell,Positive
   Society Adaptive Biotechnologies,CLL Society Inc.,Negative
 RT MassiveBio Leuekemia patients,Cagatay M. CULCUOGLU,Positive
 subtypes,Cagatay M. CULCUOGLU,Positive
 subtypes,"Massive Bio, Inc.",Positive
 subtypes,Matthews & Associates,Negative
 subtypes,Helen Jane Mee,Negative
 subtypes,Andrew Schorr,Negative
 Leuekemia patients,"Massive Bio, Inc.",Positive
     Cello Health PLC Relevant Securities,AIM Alerts!,Negative
 Issue,AIM Alerts!,Negative
 Issue,Oncology Tube,Negative
 ¬Æ assay,OncLive SOSS,Negative
 ¬Æ assay,OncLive.com,Negative
 Zanubrutinib treatment,Medivizor,Positive
     Cello Health PLC Exercise,AIM Alerts!,Negative
 Options,AIM Alerts!,Negative
 Options,CLL Ireland,Negative
 Options,Clinical Trials,Positive
 Options,AJMC,Negative
 Therapeutic Option,Paperbirds_Hematology,Negative
 Advanced Melanoma,Paperbirds_Hematology,Negative
 Health State Utility Values,Paperbirds_Hematology,Negative
 Hematologic Malignancies Catalog,Paperbirds_Hematology,Negative
 Utilities,Paperbirds_Hematology,Negative
 Brian Coffman MDCM FCFP DABFM MS Ed,OncLive.com,Negative
   clearing,OncLive.com,Negative
 clonoSEQ assay,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 DoseEscalation,TrialBulletin,Negative
 DoseEscalation,MD Anderson Leukemia,Negative
 DoseExpansion Study,TrialBulletin,Negative
 ZXA,TrialBulletin,Negative
 RelapsedResistant Refractory Advanced Hematologic Malignancies Status,TrialBulletin,Negative
 Condition Summary Nonhodgkin Lymphoma Chronic Lymphocytic Leukemia Small Lymphocytic,TrialBulletin,Negative
 COVID Severity,Oncology,Negative
 SPA,SPA,Positive
 kit,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 kit,PeerView,Negative
 tshirt,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 Lee,clonoSEQ,Negative
 Chronic Lymphocytic Leukemia CLL Jul    Burger,"Mike Thompson, MD, PhD, FASCO",Negative
     Cello Health PLC Court Sanction,AIM Alerts!,Negative
 Scheme,AIM Alerts!,Negative
     Cello Health PLC Additional Block Listing,AIM Alerts!,Negative
 Ordinary Shares,AIM Alerts!,Negative
   Biotechnologies,ArthurPotatoeHammer,Positive
 Chronic Lymphocytic LeukemiaA Media Snippet,ArthurPotatoeHammer,Negative
 imag,ArthurPotatoeHammer,Negative
 trabajar,Jose Chinchilla üê≠,Positive
 mi marca,Jose Chinchilla üê≠,Positive
   Assay,Raymond DuBois,Positive
   Clears MRD Assay,OncLive.com,Negative
 Practice,National Comprehensive Cancer Network (NCCN),Negative
 Practice,Living Safely,Positive
 Practice,"chadi nabhan MD, MBA, FACP",Negative
 Practice,sganguly,Positive
 feedback,National Comprehensive Cancer Network (NCCN),Negative
 peers,National Comprehensive Cancer Network (NCCN),Negative
 peers,CLLSA,Negative
 peers,Patient Power,Negative
 Stochastic Buy Signal,SwingTradeBot UK,Negative
 MRD testing,clonoSEQ,Negative
 MRD testing,Adaptive Biotech,Negative
 Join,Patient Power,Negative
 Join,International Pain Foundation¬Æ,Positive
 Join,susanna sargsyan,Negative
 Join,Sharon Ann,Positive
 Join,aWildAndFlakyGuy ‚ôøÔ∏è,Positive
 Join,Jennifer Bergman,Positive
 Join,circa1835,Negative
 Join,Te Ha,Positive
 Join,tangerine McDaniel,Positive
 Join,Jennifer Huber,Negative
 Join,Cassi Schmigotzki,Positive
 Join,James C Whitfield,Positive
 Join,Sandy D.,Negative
 Join,Milton Donald,Negative
 Join,Susan Rahn,Positive
 Join,Rhia Steele@ravishingrhia.com,Negative
 Join,Senior Care Corner,Positive
 Join,Debbie Woodbury,Negative
 VIDEO Examples,VJHemOnc,Negative
 biology,VJHemOnc,Negative
 biology,Oncology Tube,Negative
 biology,@sehh_es,Negative
 biology,Christopher Steer,Negative
 biology,"Navneet Majhail, MD, MS",Negative
   tcomFrsxwu,"Mazyar Shadman, MD MPH",Negative
 Volunteer Network Manager,Patient Empowerment Network,Negative
 passionate volunteer   network manager,Patient Empowerment Network,Negative
 Assess Minimal Residual Disease,Investor News,Negative
 Assess Minimal Residual Disease,Daniel,Positive
 Chronic Lymphocytic Leukemia ADPT,Investor News,Positive
 ADPTAdaptive Biotechnologies,Daniel,Positive
 ClonoSEQ Assay,Daniel,Positive
 ADPT Adaptive Biotechnologies,Basil,Positive
 ADPT Adaptive Biotechnologies,"OTC Dynamics, Inc.",Positive
 ADPT Adaptive Biotechnologies,BW Capital,Positive
 ADPT Adaptive Biotechnologies,Stock Titan,Negative
 Chronic Lymphocytic LeukemiaHuge news,Basil,Positive
 Psychological Distress,Paperbirds_Hematology,Negative
 Outpatients,Paperbirds_Hematology,Negative
 COVID Pandemic,Paperbirds_Hematology,Negative
 COVID Pandemic,CURE Magazine,Negative
 COVID Pandemic,learn coronavirus Life,Positive
 era novel therapies,Talha Badar,Positive
 era novel therapies,Expert Perspectives in Oncology,Negative
 Jan Burger,Talha Badar,Positive
 Jan Burger,VJHemOnc,Negative
 Recommendations,Benlazar S.M Amin√©,Positive
 Recommendations,"Raul Cordoba, MD, PhD",Negative
   Pandemic,Benlazar S.M Amin√©,Negative
   Bullish List,SwingTradeBot UK,Positive
 Profile,Young Hematologists,Positive
 Singerkeyboardist George Duke Frank Zappa collaborator,Psychedelic Jukebox,Positive
 ClarkeDuke Project,Psychedelic Jukebox,Positive
 George Duke,All Jazz Radio,Positive
 George Duke,Uncle Duke,Positive
 George Duke,The Hot Mammas,Positive
 IMO APTO,Joe,Negative
 star,Joe,Negative
 star,Cherry Garden School üçí,Positive
 Kinase inhibitors,NEJM Resident 360,Positive
 BCL Bcell lymphoma,NEJM Resident 360,Positive
 antagonist venetoclax,NEJM Resident 360,Positive
 cc,Joe,Negative
 cc,CLL_Fightersüéó,Positive
 cc,Stacey Tinianov,Positive
 yesterday CEO,Joe,Negative
 rd,Joe,Negative
 rd,LymphomaAction,Positive
 rd,brian brown,Positive
 Male breast involvement,Lymphoma Papers,Negative
 Meld,LyLe Foreningen,Positive
   Sessions,VJHemOnc,Negative
 John Gribben Susan OBrien,VJHemOnc,Negative
 amp Barbara EichhorstNow,VJHemOnc,Negative
 Got,Shouting at people in my underpants,Negative
 health forum,Shouting at people in my underpants,Negative
 Ibrutinibmediated macrophage inhibition,Hematology Advisor,Negative
 Chronic Lymphocytic Leukemia    article,Miriam L√≥pez P√©rez,Positive
 Review Article Chronic Lymphocytic Leukemia,NEJM,Negative
   Norah Grant,CLLSA,Negative
 Radio,CLLSA,Negative
 Programme,CLLSA,Negative
 Saturday,CLLSA,Negative
 Saturday,CLL Ireland,Positive
 Saturday,CLL Warwick Uni,Negative
 Saturday,Tim James,Negative
 Saturday,Andrew Schorr,Positive
 Saturday,Patient Power,Negative
 pausing,CLLSA,Negative
   measures,CLLSA,Negative
 Chronic Lymphocytic Leukemia Evidence Expectations,Lymphoma Papers,Negative
 Future Prospects,Lymphoma Papers,Negative
 Expanded Clinical Phenotype Oncological Associations,Paperbirds_Hematology,Negative
 Immunopathologic Insights,Paperbirds_Hematology,Negative
 Paraneoplastic Kelchlike Protein Encephalitis,Paperbirds_Hematology,Negative
   SessionsDont fret,VJHemOnc,Negative
 tcoUVDVEqt,CLL Advocates Network,Negative
 New Zanubrutinib treatment,Medivizor,Negative
 Case study,Journal of the @NCCN,Negative
 humoral immunity therapy,Journal of the @NCCN,Negative
 Bruce G Raphael MD,OncLive SOSS,Positive
 Bruce G Raphael MD,OncLive.com,Negative
 Primer d√≠a,Gimena dos Santos,Positive
 el Institut Pasteur,Gimena dos Santos,Positive
 PAID   phone interview opportunity,Say It Forward,Negative
 Link   email melikanixoncom,Say It Forward,Negative
 best   therapy,Patient Empowerment Network,Negative
 HDAC,bioRxiv,Positive
 HDAC,Cancer epigenetics papers üìö,Positive
 HDAC,Blood Advances,Negative
 HDAC,SeqComplete,Negative
 chromatin landscape,bioRxiv,Positive
 ESTJoin Matthew Davids MD MMSc,OMedLive,Positive
   hours,VJHemOnc,Negative
   hours,Helen Jane Mee,Negative
   hours,Erin Elizabeth,Positive
 webinarDont,VJHemOnc,Negative
     Cello Health PLC Results,AIM Alerts!,Negative
 Court Meeting,AIM Alerts!,Negative
 General Meeting,AIM Alerts!,Negative
 NEW Comparing frontline treatments,Medivizor,Negative
 VIDEO Challenges,VJHemOnc,Negative
 w Florence Cymbalista,VJHemOnc,Negative
 COVID severity,Brave Is Now¬Æ,Negative
 COVID severity,Anthony Mato,Negative
 Goodbye Boston,Satyen Gohil,Positive
 RNA editing,Happy Scientist,Positive
 epitranscriptome diversity,Happy Scientist,Positive
 nonCLL Clonal BCell Lymphocytosis,Paperbirds_Hematology,Negative
   Sessions webinar,VJHemOnc,Negative
 ASCO amp,VJHemOnc,Negative
 beginsDont,VJHemOnc,Negative
 Medicine Search Results,AGD Biomedicals,Positive
 HematologyOncologygtgt,AGD Biomedicals,Positive
 Healthcare professionals,The James,Negative
 Healthcare professionals,Medthority,Negative
 treatment innovation,The James,Negative
   COVID,CLL Society Inc.,Negative
 Picks,CLL Society Inc.,Positive
 longterm followup,CLL Society Inc.,Negative
 longterm followup,Targeted Oncology,Negative
 longterm followup,COPD News,Negative
 antiCD CAR Tcell therapy,CLL Society Inc.,Negative
 antiCD CAR Tcell therapy,Maria Leticia Solari,Positive
 antiCD CAR Tcell therapy,Benlazar S.M Amin√©,Negative
 ppt,chetan padghan,Positive
 ppt,chonsone,Positive
 Halftime,Te Atatu Roosters Rugby League,Negative
   lead,Te Atatu Roosters Rugby League,Negative
 Glenora Rugby League Football Club,Te Atatu Roosters Rugby League,Negative
 EST,Te Atatu Roosters Rugby League,Negative
 EST,CancerCoachLive,Positive
 EST,Patient Power,Negative
 EST,DawnKA,Positive
 THREAD,Shouting at people in my underpants,Negative
 LIVE Webinar,Patient Empowerment Network,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market Analysis amp Technological Innovation,FancyFinancy,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market Analysis amp Technological Innovation,Financial Carnivores,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market Analysis amp Technological Innovation,Robo Schmobo,Positive
 Chronic Lymphocytic Leukemia Therapeutics Market Analysis amp Technological Innovation,BioPharmaDevice,Positive
 Leading Key Players,FancyFinancy,Negative
 Leading Key Players,Financial Carnivores,Negative
 Leading Key Players,Robo Schmobo,Positive
 Leading Key Players,BioPharmaDevice,Positive
 HoffmannLa Roche Ltd,FancyFinancy,Negative
 HoffmannLa Roche Ltd,Financial Carnivores,Negative
 HoffmannLa Roche Ltd,Robo Schmobo,Positive
 HoffmannLa Roche Ltd,BioPharmaDevice,Positive
 HoffmannLa Roche Ltd,ChaitanyaG,Positive
 Inc,FancyFinancy,Negative
 Inc,Financial Carnivores,Negative
 Inc,Robo Schmobo,Positive
 Inc,BioPharmaDevice,Positive
 Teva Pharmaceutical Industries Ltd Johnson amp Johnson Services ‚Äì Medic Report,FancyFinancy,Negative
 Teva Pharmaceutical Industries Ltd Johnson amp Johnson Services ‚Äì Medic Report,Financial Carnivores,Negative
 Teva Pharmaceutical Industries Ltd Johnson amp Johnson Services ‚Äì Medic Report,Robo Schmobo,Positive
 Teva Pharmaceutical Industries Ltd Johnson amp Johnson Services ‚Äì Medic Report,BioPharmaDevice,Positive
 Clinical Pearls amp Morning Reports Chronic Lymphocytic Leukemia,NEJM Resident 360,Positive
 ‰ªäÈÄ±„ÅÆ„É¨„Éì„É•„Éº„ÅØÊãÖÂΩìÈ†òÂüü„Å†„Åã„ÇâË™≠„Åæ„Å™„ÅÑ„Å®„ÄÇÊó•Êú¨„ÅØPIKi„ÅØ„ÅÑ„Å§‰Ωø„Åà„Çã„Çà„ÅÜ„Å´„Å™„Çã„Çì„Åß„Åó„Çá„ÅÜÔºü ü§î Treatment,Shohta Kadomura Hospital Pharmacist,Negative
 Excellent review,"Andrew Johns, MD",Positive
 Excellent review,Klaus Okkenhaug,Positive
 Excellent review,Sabela Bobillo,Positive
 Dr Burger,"Andrew Johns, MD",Positive
 Dr Burger,Michele Nadeem-Baker,Negative
 Dr Burger,Expert Perspectives in Oncology,Negative
 Dr Burger,MD Anderson Leukemia,Negative
 Dr Burger,Patient Power,Negative
 Hammer Candlestick,SwingTradeBot UK,Positive
 risk factors,CancerTherapyAdvisor,Negative
 risk factors,ColumbiaCancer,Positive
 risk factors,Collegium Ramazzini,Negative
 relevance,VJHemOnc,Negative
 relevance,Expert Perspectives in Oncology,Negative
 relevance,"Raul Cordoba, MD, PhD",Positive
     Cello Health PLC Holdings,AIM Alerts!,Positive
 Therapy efficacy,Clinical Cancer Research,Positive
 Online Focus Group,FocusGroups.org,Positive
 BDNF,Lymphoma Papers,Negative
 nurselike cell secretome,Lymphoma Papers,Negative
 nurselike cell secretome,Paperbirds_Hematology,Negative
 Vitamin D levels,Lymphoma Papers,Negative
 New article BDNF,Paperbirds_Hematology,Negative
 v glenorabears,Te Atatu Roosters Rugby League,Negative
 home ground,Te Atatu Roosters Rugby League,Negative
 Harold Moody Park,Te Atatu Roosters Rugby League,Negative
 duration,Izaskun Zeberio,Negative
 duration,CURE Magazine,Negative
 duration,CLL Society Inc.,Positive
 duration,"chadi nabhan MD, MBA, FACP",Negative
 drug exposure,Izaskun Zeberio,Negative
 Review article,ATOPP Summit,Positive
 Review article,BloodWork,Positive
 Todays   webinar,CURE Magazine,Positive
 NEW Atrial fibrillation,Medivizor,Negative
 CohortExpansion Study,MD Anderson Leukemia,Negative
 VLS,MD Anderson Leukemia,Negative
 VLS,TrialBulletin,Negative
 Hematological Malignancies,MD Anderson Leukemia,Negative
 Hematological Malignancies,Paperbirds_Hematology,Positive
 Hematological Malignancies,Total Health Conferencing,Positive
 PI Philip Thompson,MD Anderson Leukemia,Negative
 VSTM,Daniel,Positive
 VSTM,SNN Network,Positive
 VSTM,PPNUMBA1,Positive
 VSTM,Anna Deveau,Positive
 VSTM,$Stocknewsalerts,Positive
 VSTM,Kara Jill Stancell,Negative
 VSTM,BioRunUp,Negative
 VSTM,CamTheMan,Positive
 VSTM,Odi Bruckman,Positive
 VSTM,MantasTrades,Positive
 VSTM,Mark,Positive
 VSTM,Kam Laurence,Positive
 VSTM,CRWE News Wire,Positive
 VSTM,Stockboard Media Inc,Negative
 VSTM,Penny Stocks News,Positive
 VSTM,Scot Walker,Positive
 VSTM,BiotechInvest,Positive
 VSTM,George,Negative
 VSTM,Ace Analyst,Positive
 IbrutinibResistant Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLLEstimated Study,Daniel,Positive
 Start Date,Daniel,Positive
 Clinical Oncology Annual Meeting Commentary,Paperbirds_Hematology,Negative
 recording,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 CLL Management Webinar,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Positive
 YouTube channel,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 YouTube channel,CLL,Negative
   Sessions expert discussions,VJHemOnc,Negative
 CLL updates,VJHemOnc,Negative
 CLL updates,BioAscend,Positive
 Room,"Mike Thompson, MD, PhD, FASCO",Negative
 Room,"chadi nabhan MD, MBA, FACP",Negative
 Improvement Immunization,"Mike Thompson, MD, PhD, FASCO",Negative
 Pts w Monoclonal BCell Lymphocytosis,"Mike Thompson, MD, PhD, FASCO",Positive
 CLL Jul,"Mike Thompson, MD, PhD, FASCO",Negative
 Whitaker,"Mike Thompson, MD, PhD, FASCO",Negative
 UK CLL treatment algorithm,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 Dr Peter Hillmen,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 Dr Peter Hillmen,Andrew Schorr,Negative
 Dr Peter Hillmen,Patient Power,Negative
 Milestones,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 CLL Management,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 CLL Management,Lymphoma Coalition,Negative
 Dr Hillmen,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Positive
 Dr Hillmen,Dr.Alberto Mussetti,Negative
 Dr Hillmen,Andrew Schorr,Negative
 truth,Andrew Schorr,Negative
 truth,Patient Empowerment Network,Positive
 upcoming   Webinar,Patient Empowerment Network,Negative
 Aug,CancerCoachLive,Positive
 Aug,Connie Erpelding,Positive
 BTK inhibitor treatment,CancerCoachLive,Positive
 Certification Mark Protectability,"Cowan, Liebowitz",Negative
 Intussuception,EurekaMag,Negative
 complication,EurekaMag,Negative
 complication,Anas Nasir,Positive
 complication,"chadi nabhan MD, MBA, FACP",Negative
     Cello Health PLC Notification,AIM Alerts!,Negative
 Major Holdings,AIM Alerts!,Negative
 July,CURE Magazine,Negative
 July,RutgersCancerInstNJ,Positive
 July,RU Cancer Patient Education,Positive
 July,Targeted Oncology,Negative
 July,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 July,LymphomaAction,Positive
 July,Sophie Baczynski,Positive
 July,CLL Warwick Uni,Positive
 July,LiveYourLife,Negative
 July,Shouting at people in my underpants,Negative
 July,"Mike Thompson, MD, PhD, FASCO",Negative
 July,Patient Empowerment Network,Negative
 leukemia lymphoma experts,CURE Magazine,Negative
 StabilityIndicating Analytical Method,Paperbirds_Hematology,Negative
 Determination,Paperbirds_Hematology,Negative
 Monoclonal gammopathy,Paperbirds_Hematology,Negative
 serum,Paperbirds_Hematology,Negative
 immunoglobulin levels,Paperbirds_Hematology,Negative
 Enhancement,Paperbirds_Hematology,Negative
 Lignin Extraction,Paperbirds_Hematology,Negative
 Poplar,Paperbirds_Hematology,Negative
 Deep Eutectic Solvent,Paperbirds_Hematology,Negative
 Low Halogen Content,Paperbirds_Hematology,Negative
 VIDEO Prevalence,VJHemOnc,Negative
 BTK PLCŒ≥ mutations,VJHemOnc,Negative
 w Paolo Ghia,VJHemOnc,Positive
 Clinical Updates,NACE,Positive
 yearold ma,Targeted Oncology,Negative
 DNA methylation profiles,DNA-binding drugsüìö,Positive
 DNA methylation profiles,Vinci-Biochem Srl,Positive
 partner,Laura Smalley,Positive
 partner,Sciinov Insights,Positive
 partner,Paul DuBois,Positive
 partner,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 partner,Team Intake.Me,Negative
 Genentech allege,Laura Smalley,Positive
 Dr Reddys,Laura Smalley,Positive
   Advances,JCM MDPI,Positive
   Advances,ecancer,Negative
 manuscripts,JCM MDPI,Positive
 „Äê „Éã„É•„Éº„Çπ„ÄëÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„Å´ÂØæ„Åó„ÄÅ„Ç´„É´„ÇØ„Ç®„É≥„Çπ„ÇíË©ï‰æ°„Åó„Åü„Å§„ÅÆËá®Â∫äË©¶È®ì„Åß„ÄÅÈï∑ÊúüÊúâÂäπÊÄß„Å®ÂøçÂÆπÊÄß„ÇíÁ¢∫Ë™çACECLË©¶È®ì„ÅÆÂÖ®Â•èÂäπÁéáÔºÖ„ÄÅASCENDË©¶È®ì„Åß„ÅØÁóÖÂã¢ÈÄ≤Ë°å„ÅÆ„Å™„ÅÑÁîüÂ≠òÁéá„ÅåÔºÖ,„Åå„Çì„Éó„É©„Çπ,Negative
 John Gribben MD DSc,OncLive.com,Negative
 minute,Medscape Education,Positive
 minute,"chadi nabhan MD, MBA, FACP",Negative
 nominations,Michele Nadeem-Baker,Negative
 Patient Influencer,Michele Nadeem-Baker,Negative
 Reporting work,Michele Nadeem-Baker,Negative
 VIDEO CLL trial,VJHemOnc,Negative
 Othman AlSawaf,VJHemOnc,Negative
 Othman AlSawaf,Lymphoma Hub,Positive
 capacity,Victor Lin,Positive
 yield,Victor Lin,Positive
 function,Victor Lin,Positive
 function,Paperbirds_Hematology,Negative
 function,"Robert West, PhD",Positive
 function,CLLSA,Negative
 function,Journal of Clinical Investigation,Positive
 function,CLL Ireland,Negative
 function,Prof John,Negative
 function,MD Anderson Library,Negative
 function,TumorImmunoPapers,Negative
 function,Blood Journal,Negative
 Tcell differentiation,Victor Lin,Positive
 enrichment,Victor Lin,Positive
 lessdifferentiated T cells,Victor Lin,Positive
 CART cell expansion,Victor Lin,Positive
   Receives,1stOncology,Positive
   Receives,CancerWallonia,Negative
 Positive Opinion,1stOncology,Negative
 Positive Opinion,Financial Buzz,Negative
 Positive Opinion,MedFirst - MedComms,Positive
 Oats,Te Atatu Roosters Rugby League,Negative
 Tat,Te Atatu Roosters Rugby League,Negative
     otahuhuleopards,Te Atatu Roosters Rugby League,Negative
 veisarikid,Te Atatu Roosters Rugby League,Positive
 Jack Colvin Park,Te Atatu Roosters Rugby League,Negative
 Educated Patient,CURE Magazine,Negative
 ¬Æ Webinar,CURE Magazine,Negative
 HighThroughput Analysis,"Mike Thompson, MD, PhD, FASCO",Negative
 T Cell Receptor Gene Repertoire,"Mike Thompson, MD, PhD, FASCO",Negative
 LowCount Monoclonal B Cell Lymphocytosis MBL Reveals Distinct Profile,"Mike Thompson, MD, PhD, FASCO",Negative
 Chronic Lymphocytic Leukemia CLL Jan,"Mike Thompson, MD, PhD, FASCO",Negative
 Agathangelidis,"Mike Thompson, MD, PhD, FASCO",Negative
 Monoclonal Bcell lymphocytosis MBL,"Mike Thompson, MD, PhD, FASCO",Negative
 EMA CHMP,Punit,Positive
 EMA CHMP,"Pharmacyclics, an AbbVie Company",Negative
 improved   chimeric antigen receptor T cell production,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 New article MetaAnalysis,Paperbirds_Hematology,Negative
 Significant Sex Differences,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Progression,Paperbirds_Hematology,Negative
 E¬µTCL Transgenic Mouse Model,Paperbirds_Hematology,Negative
 Ill,ŸÜÿ∏Ÿäÿ±Ÿá,Positive
 Ill,Brad Hoylman,Positive
 Ill,"Pat Euglow, Legacy Newbie",Positive
 Ill,Sam Cameron,Positive
 Waipareira Sponsored     otahuhuleopards,Te Atatu Roosters Rugby League,Negative
 Jack Colvin,Te Atatu Roosters Rugby League,Negative
 lesson,Danielle M. Brander,Positive
 Bendamustine ofatumumab,Medivizor,Negative
 New Research,Frontiers Endocrinology,Positive
 Cannabis Industry Insight,"Cowan, Liebowitz",Negative
 Trademark Registrations,"Cowan, Liebowitz",Negative
 Foods,"Cowan, Liebowitz",Negative
 Dietary Supplements,"Cowan, Liebowitz",Negative
 HempDerived CBD,"Cowan, Liebowitz",Negative
 grade   transaminase elevation,Anthony Mato,Negative
 threedrug treatment,CURE Magazine,Negative
 competitors,Community Legacy League,Negative
 United States,Lymphoma Papers,Negative
 United States,Bloodbytes,Positive
 United States,Paperbirds_Hematology,Negative
 United States,Mahmoud Aljurf,Negative
 United States,"Raul Cordoba, MD, PhD",Negative
 United States,Michele Nadeem-Baker,Negative
 United States,MSHO,Positive
 learning,BSI Philippines,Positive
 learning,Patient Power,Negative
 learning,APSHO,Negative
 BSIs Connected Learning,BSI Philippines,Positive
 Dr Dressler,Dog Cancer Help,Positive
 form,Dog Cancer Help,Positive
 form,Dr. Drew Dahlgren,Positive
 form,Essay Yard,Positive
 episode,Dog Cancer Help,Positive
 episode,Blood Journal,Negative
 episode,CLL Society Inc.,Negative
 episode,CURE Magazine,Negative
 Listen amp subscribe,Dog Cancer Help,Positive
 July    KSA   GMT,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 VIDEO BTK PLCG mutations,VJHemOnc,Negative
 ¬ø Est√°,BSI M√©xico,Positive
 un curso de capacitaci√≥n,BSI M√©xico,Positive
 ISO Conozca,BSI M√©xico,Positive
 Brian,AstraZeneca Canada,Positive
 Brian,AACR Foundation,Positive
 Anticancer screening,Saarumsciences,Positive
 Anticancer screening,Sapien Biosciences Pvt Ltd,Positive
 LIVE webinar,Lymphoma Australia,Positive
   weekend v otahuhuleopards,Te Atatu Roosters Rugby League,Negative
   game,Te Atatu Roosters Rugby League,Positive
   game,FlappyCrypto,Positive
   game,Sully,Positive
   game,Chris Williams,Positive
 Waipareira Sponsored,Te Atatu Roosters Rugby League,Negative
 ways,Te Atatu Roosters Rugby League,Negative
 ways,CURE Magazine,Positive
 ways,CONQUER the patient voice,Negative
 ways,Patient Power,Positive
 ways,CLLSA,Negative
 ways,Dana-Farber News,Positive
 ways,"Pharmacyclics, an AbbVie Company",Negative
 MRD importance,Michele Nadeem-Baker,Negative
 IbrutinibUblituximab Combo,Patient Worthy,Negative
 Better Outcomes,Patient Worthy,Negative
     MILLENNIUM PARTNERS LP Form    Cello Health plc,AIM Alerts!,Positive
     Cello Health PLC Block,AIM Alerts!,Positive
 Listing Update,AIM Alerts!,Negative
 Total Voting Rights,AIM Alerts!,Negative
 New article Antimicrobial use,Paperbirds_Hematology,Negative
 History,Paperbirds_Hematology,Negative
 History,Cureus,Negative
 Antimicrobial use,CancerEpiPapers,Negative
 TGTX Phase,ClinicalTrialsData,Positive
 fixedduration regimen,OncLive.com,Negative
 Pt,"Mazyar Shadman, MD MPH",Negative
 Pt,Adam Kittai,Negative
 Case Report TreatmentEmergent Tumor Lysis Syndrome,ASCO Publications,Negative
 PIKInhibition,ASCO Publications,Negative
 CAR TCell Therapy,ASCO Publications,Negative
 CAR TCell Therapy,Lymphoma Papers,Negative
 CAR TCell Therapy,Muzaffar Qazilbash,Negative
 CAR TCell Therapy,Paperbirds_Hematology,Positive
 CAR TCell Therapy,Oncology Times,Negative
 CAR TCell Therapy,WorldStemCellSummit,Positive
 CAR TCell Therapy,Krishan Maggon,Negative
 CAR TCell Therapy,The ASCO Post,Positive
 CAR TCell Therapy,CLL Ireland,Negative
 CAR TCell Therapy,Patient Power,Negative
 CAR TCell Therapy,Oncology Tube,Positive
 Q   AbbVie,"dtw Research, Inc",Negative
 Genentech,"dtw Research, Inc",Negative
 Genentech,"OTC Dynamics, Inc.",Negative
 Genentech,Mr Bentley Onelly,Positive
 Genentech,Michelle Solly,Positive
 Genentech,Mateen Dalal,Positive
 Genentech,San Francisco Biotechnology Network Jobs,Positive
 Genentech,CHItraders,Negative
 Genentech,Pharmacy Practice News,Negative
 Genentech,CancerEpiPapers,Negative
 Genentech,Lee King,Positive
 Genentech,GPSN,Positive
 Genentech,Anand Rotte,Positive
 Genentech,vincenzo abruscato,Positive
 Genentech,Tracking Healthcare,Positive
 Genentech,Cpl Life Sciences,Negative
 Genentech,ANYKINDAPILLS,Positive
 market leaders,"dtw Research, Inc",Negative
 Glenn Sabin,Radical Remission,Positive
 Glenn Sabin,Shouting at people in my underpants,Negative
   survivor,Radical Remission,Positive
   survivor,MD Anderson Cancer Center,Positive
 Chronic Myelogenous Leukemia,re-how.net,Negative
 Chronic Lymphocytic Leukemia Acute,re-how.net,Negative
 Acute Myeloid Leukemia,re-how.net,Negative
 Drug Class Small Molecule,re-how.net,Negative
 Region,re-how.net,Negative
 Fore,re-how.net,Negative
 Cody Steeves PharmD BCOP,Biologics by McKesson,Negative
 community physicians,Biologics by McKesson,Negative
 community physicians,SpecialtyPTimes,Negative
 YearOld Man,Journal of Phlebology and Lymphology VOL 13 ISS 2,Positive
 Relpased Chronic Lymphocytic Leukemia,Journal of Phlebology and Lymphology VOL 13 ISS 2,Positive
 ¬Æ ÿßŸÑŸàŸäÿ®ŸäŸÜÿßÿ± ŸäŸàŸÖ ÿßŸÑÿ£ÿ±ÿ®ÿπÿßÿ°,khaleel Saeed,Positive
 ŸäŸàŸÑŸäŸà ÿßŸÑÿ≥ÿßÿπÿ©,khaleel Saeed,Positive
 ÿ®ÿßŸÑÿ™ŸàŸÇŸäÿ™ ÿßŸÑÿ¥ÿ±ŸÇŸä ÿßŸÑŸàŸÑŸäÿßÿ™ ÿßŸÑŸÖÿ™ÿ≠ÿØÿ© ÿßŸÑÿßŸÖÿ±ŸäŸÉŸäÿ© ÿ≥ÿ¨ŸÑ ÿßŸÑŸäŸàŸÖ,khaleel Saeed,Positive
 New Atrial fibrillation,Medivizor,Negative
 Dr Nancy Torres,@URHemOncFellows,Positive
 Sharon,@URHemOncFellows,Positive
 Sharon,LymphomaAction,Positive
 Dr Clive Zent,@URHemOncFellows,Positive
 Dr Clive Zent,Wilmot Cancer Institute,Positive
 Dr Clive Zent,Oncology Times,Negative
 Dr Clive Zent,Jonathan Friedberg,Positive
 outpatient clinic,@URHemOncFellows,Positive
 Initial Findings Promise,Oncology Times,Negative
 Triplet Therapy,Oncology Times,Negative
 New article Delineation,Paperbirds_Hematology,Negative
 Aging,Paperbirds_Hematology,Negative
 TherapyRelated Hypogammaglobulinemia,Paperbirds_Hematology,Negative
 Pneumonia,Paperbirds_Hematology,Negative
 Chaotic COVID Pandemic,Paperbirds_Hematology,Negative
 campaign,CLLSA,Positive
 research lab,Avneeti,Positive
 pathogenesis,Albert„ÉªEin„ÉªShredder„ÄÄPh.D,Positive
 pathogenesis,Lymphoma Papers,Negative
 pathogenesis,Blood Journal,Positive
 BCell nonHodgkin Lymphoma,Lymphoma Papers,Negative
 BCell nonHodgkin Lymphoma,Muzaffar Qazilbash,Negative
 Chronic Lymphocytic Leukemia Clinical Trials,Lymphoma Papers,Negative
 Chronic Lymphocytic Leukemia Clinical Trials,Muzaffar Qazilbash,Negative
 Chronic Lymphocytic Leukemia Clinical Trials,Oncology Times,Negative
 RealWorld Experiences,Lymphoma Papers,Negative
 RealWorld Experiences,Muzaffar Qazilbash,Negative
 RealWorld Experiences,Frontiers Oncology,Negative
 Howick score,Te Atatu Roosters Rugby League,Negative
 metre,Te Atatu Roosters Rugby League,Negative
 Paparoa Park,Te Atatu Roosters Rugby League,Negative
 Home,Te Atatu Roosters Rugby League,Negative
 Home,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 Home,Carevƒ´ve,Negative
 Home,CromptonCricketClub,Positive
 Howick Hornets,Te Atatu Roosters Rugby League,Negative
 heme lecture,Fact a Minute,Positive
 Section SMUDGE CELLS,Fact a Minute,Positive
 BASKET CELLSChronic Lymphocytic,Fact a Minute,Positive
 Girl,Tinu Abayomi-Paul,Negative
 Expert pharmacists,SpecialtyPTimes,Negative
 Trademark Law Alert,"Cowan, Liebowitz",Positive
 LADY Case,"Cowan, Liebowitz",Negative
 Interesting Issues,"Cowan, Liebowitz",Negative
 Successful Outcomes,Paperbirds_Hematology,Negative
 VIDEO Patients,VJHemOnc,Negative
 VIDEO Patients,Oncology Nursing News,Negative
 Interleukin suppression,bioRxiv Immunology,Positive
 Interleukin suppression,bioRxiv,Positive
 Tcell,bioRxiv Immunology,Positive
 Tcell,bioRxiv,Positive
 Tcell,filippo masini,Negative
 Tcell,Susan Murphy,Positive
 Tcell,CancerTherapyAdvisor,Negative
 Tcell,Cancer & Oncology,Positive
 Tcell,Goda Choi,Positive
 FDA Grants Orphan Drug Designation,Patient Worthy,Negative
 Oncternal Therapeutics,Patient Worthy,Negative
 Oncternal Therapeutics,BioPharma Global,Positive
     Cello Health PLC Form    Cello Health plc,AIM Alerts!,Positive
 ‚ÄºÔ∏è‚ÄºÔ∏è,deFacto Research,Positive
   Jacob Soumerai MD,MedPage Oncology,Negative
 Pseudohypoxemia,Paperbirds_Hematology,Negative
 AMG,Jerry Lee,Negative
 AMG,Cure Cancer Now,Positive
 Mcl Antagonist,Jerry Lee,Negative
 Mcl Antagonist,Cure Cancer Now,Negative
 Preclinical Efficacy,Jerry Lee,Negative
 Preclinical Efficacy,Cure Cancer Now,Negative
 cousin,Snaggle Tooth,Positive
 cousin,Lunny1607,Positive
 Katelyn Brown,Snaggle Tooth,Positive
 oncology appointment,CauseISaidSo ü•ÉüíÑü¶áüåπüë†üè≥Ô∏è‚Äçüåà,Positive
 Waipareira,Te Atatu Roosters Rugby League,Positive
 administration sequence,Journal of the @NCCN,Negative
 Brian Koffmans,CLL Society Inc.,Positive
 Residents,Patient Power,Negative
 South,Patient Power,Negative
 South,Helen Jane Mee,Negative
   Dinner,Patient Power,Positive
 Docs series,Patient Power,Positive
   conversation,Patient Power,Positive
 patients docs,Patient Power,Positive
 Number,CLL Society Inc.,Positive
 Number,Jerry Lee,Negative
 Number,Cure Cancer Now,Positive
 Number,Paperbirds_Hematology,Negative
 Number,Richard Rosenquist Brandell,Positive
 PFS ORR,CLL Society Inc.,Negative
 PFS ORR,Biotech2050,Negative
 MRD negativity,CLL Society Inc.,Negative
 MRD negativity,Biotech2050,Negative
 MRD negativity,ClinicalBid,Positive
 MRD negativity,Charlotte Martin,Positive
 MRD negativity,Expert Perspectives in Oncology,Negative
 MRD negativity,Medscape Education,Negative
 MRD negativity,AbbVie,Negative
 MRD negativity,"chadi nabhan MD, MBA, FACP",Negative
 MRD negativity,"Raul Cordoba, MD, PhD",Negative
 MRD negativity,CLL Ireland,Negative
 MRD negativity,HemOnc Today,Negative
     Cello Health PLC Update,AIM Alerts!,Negative
 Susan OBrien University,Lymphoma Hub,Negative
 California Irvine,Lymphoma Hub,Negative
 California Irvine,SIAM,Positive
   ‰∏≠ÁõÆÈªí„É™„É•„Éº„Ç∏„Éº„Ç∫ Ë±™ËèØ„É°„É≥„Éê„Éº ‰ªäÂ∏ÇÈöÜ‰∫å,ryuji..c.mama,Positive
 Èñì„Å´Âêà„Å£„Åü‚ÄºÔ∏èÊ•Ω„Åó„Åø„É°„É≥„Éá„Ç£„Éº„ÅÆ„ÄåÂ••„ÅïÔΩû„Çì„Äç„Å´ ÁàÜÊ≠ª„Åô„Çã„É°„É≥„Éê„ÉºÔºàÁ¨ë Ôºâ,ryuji..c.mama,Positive
 New research FrontLine Therapy,Frontiers Oncology,Negative
 Elderly Chronic Lymphocytic Leukemia Patients Bendamustine,Frontiers Oncology,Negative
 Chlorambucil Plus Rituximab RealLife Retrospective Multicenter Study,Frontiers Oncology,Negative
 Lazio Region Previous studies,Frontiers Oncology,Negative
 Supreme Court,"Cowan, Liebowitz",Positive
 Community Oncology program,Dr. Andy Evens,Negative
 Today Residents,Patient Power,Negative
 Central,Patient Power,Negative
 Central,Anton Anderson,Positive
 Central,Jack Payette,Positive
 girls,Reed Rowell,Positive
 girls,Matt Trinite,Positive
 rise,Reed Rowell,Positive
 rise,Pharma Models,Positive
 panel discussions,PeerView,Negative
 panel discussions,HARMONY Alliance,Negative
 therapy selection safety,PeerView,Negative
 treatment continuum,PeerView,Negative
 Invitation,LyLe Foreningen,Negative
 med meget,LyLe Foreningen,Negative
 shift,CLL Society Inc.,Negative
 shift,Targeted Oncology,Negative
 shift,JanssenUS,Negative
 case series,Adrian Warnock,Positive
 case series,Helen Parry üíô,Positive
     BARCLAYS PLC,AIM Alerts!,Negative
 Form    CELLO HEALTH PLC,AIM Alerts!,Negative
     Cello Health PLC Publication,AIM Alerts!,Negative
 Scheme Document,AIM Alerts!,Negative
 CARNK,Andrew Schorr,Negative
 CARNK,HemOnc Today,Negative
 Official result,Te Atatu Roosters Rugby League,Negative
   v richmondrovers,Te Atatu Roosters Rugby League,Positive
 Saturdays   game,Te Atatu Roosters Rugby League,Negative
 Richmond Bulldogs Grey Lynn Park,Te Atatu Roosters Rugby League,Positive
 Platelet Function,Oncology,Negative
 longterm followup results,Targeted Oncology,Positive
 Plesiomonas shigelloides,"Naveen Pemmaraju, MD",Negative
 ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å©,"Naveen Pemmaraju, MD",Negative
 antiCD CARNK cells,JAMA Oncology,Negative
 antiCD CARNK cells,JAMA,Negative
 cord blood,JAMA Oncology,Negative
 cord blood,JAMA,Negative
 cord blood,"Comprehensive Cell Solutions,New York Blood Center",Positive
 Rapid Emergence,Cancer Papers,Negative
 JAK Inhibitor Therapy,Cancer Papers,Negative
 JAK Inhibitor Therapy,Adam Mead,Positive
 Myelofibrosis,Cancer Papers,Negative
 Myelofibrosis,Lymphoma Papers,Negative
 Stability Degradation Pathways,Paperbirds_Hematology,Negative
 Stress Conditions,Paperbirds_Hematology,Negative
 Food Drug Administration approvals,Lymphoma Papers,Negative
 richmondrovers,Te Atatu Roosters Rugby League,Positive
 westernleader,Te Atatu Roosters Rugby League,Negative
 events,Dr. Andy Evens,Negative
 events,CLL Society Inc.,Negative
 events,The James,Negative
 events,LymphomaAction,Negative
 events,Patient Power,Negative
 amp families,Dr. Andy Evens,Negative
 amp families,JanssenUS,Negative
 community oncologists,Dr. Andy Evens,Negative
 community oncologists,Targeted Oncology,Positive
 Dinner,Dr. Andy Evens,Negative
 EHA SWG Day,VJHemOnc,Negative
 sessions,VJHemOnc,Negative
 sessions,Hugo Barona,Positive
 sessions,LyLe Foreningen,Negative
 sessions,CARE‚Ñ¢ Education,Negative
 sessions,Dana-Farber,Negative
 sessions,Dana-Farber News,Positive
 sessions,Lymphoma Hub,Negative
 sessions,@sehh_es,Negative
 sessions,Carmine DeLuca,Negative
 New commentary,ACS Journal Cancer,Negative
 FDA approvals,ACS Journal Cancer,Negative
 medivizor,THE MUSIC üë•,Positive
 Hell,Te Atatu Roosters Rugby League,Negative
 havoc,Te Atatu Roosters Rugby League,Negative
 havoc,AbbVie,Negative
 CancerNetwork ¬Æ Tumor Board Series,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
   month checkup,David Garrison,Positive
 CLL Campus,üÖæ Jaksic,Negative
 Frontline Chemoimmunotherapy,Tom,Negative
 IVIG infusion day,Andrew Schorr,Negative
     Sand Grove Capital Management Form    Cello Health Plc,AIM Alerts!,Positive
 immunoglobulin generearrangements,Francesco Maura,Positive
 Tammi,LLSCanada,Positive
 Unique   Effects,1stOncology,Negative
   whet,Te Atatu Roosters Rugby League,Negative
 appetite,Te Atatu Roosters Rugby League,Negative
 Tonights   pilot,Community Legacy League,Negative
   players,Community Legacy League,Negative
 tonights,Community Legacy League,Negative
 MTG   event,Community Legacy League,Negative
 rounds,Community Legacy League,Negative
 rounds,Gary H,Positive
 rounds,Weill Cornell Medicine,Positive
 swiss,Community Legacy League,Negative
 phase b trial,Targeted Oncology,Negative
 ‚Äú Chronic Lymphocytic,RutgersCancerInstNJ,Negative
 Docs,RutgersCancerInstNJ,Positive
 Docs,RU Cancer Patient Education,Positive
 Docs,RedMedEd,Negative
 Docs,CLL_Fightersüéó,Negative
 Docs,EKLLRF,Positive
 Drs Andrew Evens Roger Strair Rajat Bannerji Kathy Toomey Seth Cohen amp Robert Grossman,RutgersCancerInstNJ,Negative
 cell function,DDNews Online,Negative
 ex vivo amp,DDNews Online,Negative
 mouse,DDNews Online,Negative
 Œµ mitigates   impairment,DDNews Online,Negative
 Œ¥ inhibition,DDNews Online,Negative
 Œ¥ inhibition,"SLIMS by Genohm, A part of Agilent",Positive
 patients ‚Äô ages,Journal of Medical and Surgical Pathology,Positive
 males,Journal of Medical and Surgical Pathology,Positive
 males,Leukemia I'm Fine,Negative
 nurse,·¥Ä·¥Ä Ä·¥è…¥·¥ä ú…™ ü ü ü§¨,Positive
 nurse,"Kantor & Kantor, LLP",Positive
 ‚¨á Ô∏è Research Opportunity ‚¨á Ô∏èRegister,deFacto Research,Positive
 TGTX TG Therapeutics Engages,"Ian McMillan, CMT",Positive
 medicines,"Ian McMillan, CMT",Positive
 medicines,Genentech,Positive
 medicines,Patient Power,Negative
 medicines,Andrew Schorr,Negative
 COVID Trademark Alert   Protection,"Cowan, Liebowitz",Negative
 Counterfeit Face MasksYou,"Cowan, Liebowitz",Negative
 excluded attributes,Paperbirds_Hematology,Negative
 choice,Paperbirds_Hematology,Negative
 choice,ABPI,Negative
 tumor lysis syndrome,OncLive SOSS,Negative
 tumor lysis syndrome,Lymphoma Papers,Negative
 tumor lysis syndrome,Chan Cheah,Negative
 tumor lysis syndrome,VJHemOnc,Negative
 Chronic Lymphocytic Leukemia RealWorld Data,ASCO Publications,Negative
 Chronic Lymphocytic Leukemia RealWorld Data,Paperbirds_Hematology,Negative
 ‚Äú CLL Chronic Lymphocytic    Dinner,RU Cancer Patient Education,Positive
 w Drs Andrew Evens Roger Strair Rajat Bannerji Kathleen,RU Cancer Patient Education,Positive
 Toomey Seth Cohen amp Robert Grossman Register,RU Cancer Patient Education,Positive
 Barriers,Leukemia,Negative
 Barriers,SpecialtyPTimes,Positive
 ReducedIntensity   Stem Cell Transplant,Leukemia,Negative
 Chronic   Leukemia,Leukemia,Negative
 Chronic   Leukemia,Living Safely,Negative
 Chronic   Leukemia,A M Billah Sumon,Negative
 Pathophysiology,EurekaMag,Negative
 Pathophysiology,Transcriptomes,Positive
 Pathophysiology,Paperbirds_Hematology,Negative
 Pathophysiology,Frontiers Immunology,Negative
 July Register,CLLSA,Negative
 coordinatororguk,CLLSA,Negative
 Long NonCoding,Paperbirds_Hematology,Negative
 pathways,Paperbirds_Hematology,Negative
 pathways,Hematology Advisor,Negative
 pathways,ImmunoSCOPE,Positive
 pathways,Wnt publications,Negative
 pathways,Cancer Papers,Negative
 pathways,ImmunologyPapers,Negative
 Leukemia progression,Paperbirds_Hematology,Negative
 Mum,Claire üåàüíú,Positive
 Mum,Pippa Jones,Positive
 Bcell receptor antagonists,VJHemOnc,Negative
 novel approaches,OncLive SOSS,Positive
 cell proliferation,Newyork Fitness,Positive
 T cell dynamics,CLL-seq,Negative
 T cell dynamics,Lymphoma Papers,Negative
 T cell dynamics,Cure Cancer Now,Negative
 Leukostasis,Paperbirds_Hematology,Negative
 TreatmentEmergent Tumor Lysis Syndrome,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 TreatmentEmergent Tumor Lysis Syndrome,Paperbirds_Hematology,Negative
 PIKŒ¥Œ≥ Inhibition,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 PIKŒ¥Œ≥ Inhibition,Paperbirds_Hematology,Negative
 TCell Therapy,Chimeric Antigen Receptor T-Cell (CAR-T),Negative
 TCell Therapy,CancerWallonia,Negative
 generation technology,Jacinto Convit World Organization,Positive
 CancerNetwork,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Tumor Board Series,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Chronic Lymphoblastic Leukemia,Patient Power,Negative
 New Jersey   Community,Patient Power,Negative
 Docs talks,Patient Power,Negative
 neighbors,Patient Power,Negative
 gift card,Patient Power,Negative
 household,Patient Power,Negative
 Register CLL webinar,BioAscend,Positive
 New article Response,Paperbirds_Hematology,Positive
     Cello Health PLC Replacement   Form,AIM Alerts!,Negative
 OPD   Cello Health plc,AIM Alerts!,Negative
 Michael Choi MD,OncLive SOSS,Positive
 Michael Choi MD,OncLive.com,Negative
 emerging treatments,OncLive SOSS,Negative
 emerging treatments,The ASCO Post,Negative
 WEGO Health Awards BEST,Michele Nadeem-Baker,Negative
 SECRET amp ROOKIE,Michele Nadeem-Baker,Negative
 YEAR,Michele Nadeem-Baker,Negative
 Awards,Michele Nadeem-Baker,Negative
 WEGO Health,Michele Nadeem-Baker,Negative
 print ITGA gene methylation status,Future Science OA,Positive
 Paraneoplastic Pemphigus,Paperbirds_Hematology,Negative
 Indication,Paperbirds_Hematology,Negative
 Indication,Pharmacy Podcast Network,Positive
 Rurality Race,Paperbirds_Hematology,Negative
 Ethnicity,Paperbirds_Hematology,Negative
 NonHodgkin Lymphoma Incidence,Paperbirds_Hematology,Negative
 New article Correction,Paperbirds_Hematology,Positive
     Cello Health PLC Form,AIM Alerts!,Negative
 Competitive Landscape,Stock Market News,Negative
 Competitive Landscape,Nita Sonwane,Negative
 Competitive Landscape,satPRnews,Negative
   Patients,"Raul Cordoba, MD, PhD",Negative
   Patients,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
   Patients,Michele Nadeem-Baker,Positive
   Patients,Autism Gazette,Positive
   Patients,BVirtual Murciasalud,Positive
   Patients,Patient Power,Negative
   Patients,GenPath Oncology,Negative
   Patients,Patient Empowerment Network,Positive
 IGHVunmutated,"Raul Cordoba, MD, PhD",Negative
 delq trisomy   ATM NOTCH SFB,"Raul Cordoba, MD, PhD",Negative
 BIRC mutations,"Raul Cordoba, MD, PhD",Negative
 üÜï,HemOnc Today,Negative
 Expansion Breakout,SwingTradeBot UK,Negative
 MACD Bullish Signal Line Cross,SwingTradeBot UK,Negative
 CLL Chronic Lymphocytic,RutgersCancerInstNJ,Negative
 w Drs Andrew Evens Roger Strair,RutgersCancerInstNJ,Negative
 Rajat Bannerji Kathy Toomey Seth Cohen amp Robert GrossmanRegister,RutgersCancerInstNJ,Negative
 Genetics,Blood Journal,Negative
 Genetics,Paperbirds_Hematology,Negative
 Genetics,MD Anderson Leukemia,Negative
 targeted   therapy,Blood Journal,Negative
 targeted   therapy,Deborah Stephens,Positive
 CLL Cello Healths takeover,Proactive,Negative
 health care marketing sector,Proactive,Negative
 Liberum,Proactive,Negative
 New research CAR TCell Therapy,Frontiers Oncology,Negative
 BCell nonHodgkin Lymphoma Chronic Lymphocytic Leukemia Clinical Trials,Frontiers Oncology,Negative
 Chimeric antigen,Frontiers Oncology,Negative
 CLL Market Report,Proactive,Negative
 gold,Proactive,Negative
 fit patients,Paperbirds_Hematology,Negative
 fit patients,"Raul Cordoba, MD, PhD",Negative
 venetoclaxbased combinations,Paperbirds_Hematology,Negative
 venetoclax activity,Paperbirds_Hematology,Negative
 issue,Sigrid Sk√•nland,Negative
 issue,Adam Mead,Positive
 issue,ACS Journal Cancer,Negative
 issue,"Jose Sandoval S, MD FACP",Positive
 issue,"chadi nabhan MD, MBA, FACP",Negative
 issue,VJHemOnc,Positive
 issue,Chris Thomson,Negative
 CLL Cello Health,Proactive,Positive
 CLL Cello Health,Ruth Gemmell,Positive
 CLL Cello Health,Jon Bircher,Positive
 acquisition,Proactive,Negative
 acquisition,Market Intelligence: Healthcare,Positive
 Dr Marice Alcantara,Federation University,Positive
 PhD thesis,Federation University,Positive
   agreed bid,Rhomboid1,Positive
 premium,Rhomboid1,Positive
 Investegate Arsenal Capital Mgmt Announcements,Rhomboid1,Positive
 Arsenal Capital Mgmt RECOMMENDED CASH OFFER,Rhomboid1,Positive
 Pathologic Findings,"Viren Kaul, MD",Positive
 Pathologic Findings,Lymphoma Papers,Negative
 Bronchopulmonary Leukemic,"Viren Kaul, MD",Positive
 Bronchopulmonary Leukemic,Lymphoma Papers,Negative
 cirmtuzumab,Targeted Oncology,Negative
 cirmtuzumab,CURE Magazine,Negative
 Orphan status,DDNews Online,Negative
 ROR,DDNews Online,Negative
 ROR,Paperbirds_Hematology,Negative
 ROR,Prof John,Positive
 ROR,Wnt publications,Positive
 ROR,Blood Journal,Negative
 ROR,Cancer Stem Cell News,Negative
 ROR,Hematopoiesis News,Positive
 ROR,Cancer Papers,Negative
 ROR,CLL Ireland,Negative
 ROR,ImmunologyPapers,Negative
 ROR,iwCLL,Negative
 ROR,VJHemOnc,Negative
 ROR,Marco,Positive
 tconnJAGotd,DDNews Online,Negative
 David Lauterstein CEO,"Cowan, Liebowitz",Negative
 longtime client,"Cowan, Liebowitz",Negative
 Nasty Pig Inc,"Cowan, Liebowitz",Negative
 Orphan Drug Designations,BioPharma Global,Positive
 Cirmtuzumab,BioPharma Global,Positive
 Cirmtuzumab,TradeHawk,Positive
 Cirmtuzumab,Lymphoma Hub,Negative
 Cirmtuzumab,Bradley J. Fikes ü¶î,Positive
 Cirmtuzumab,DrugGenius,Negative
 Cirmtuzumab,TumorImmunoPapers,Negative
 Higher Incidence,Adam R. Fox,Positive
 Higher Incidence,Mayo Clinic Cancer Center,Negative
 Higher Incidence,Oncology Publishers Feed,Negative
 Atrial Fibrillation,Adam R. Fox,Positive
 Atrial Fibrillation,Oncology Publishers Feed,Negative
    CME activities,RedMedEd,Negative
 VIDEO Sequence,VJHemOnc,Negative
 Oncternal Therapeutics Announces Orphan Drug Designations,Pharmacutical Daily,Negative
 Oncternal Therapeutics Announces Orphan Drug Designations,Oncology Publishers Feed,Negative
 Oncternal Therapeutics Announces Orphan Drug Designations,"OTC Dynamics, Inc.",Negative
 Oncternal Therapeutics Announces Orphan Drug Designations,Crwe World,Negative
 Cirmtuzumab ROR Antibody,Pharmacutical Daily,Negative
 Cirmtuzumab ROR Antibody,Oncology Publishers Feed,Negative
 Cirmtuzumab ROR Antibody,"OTC Dynamics, Inc.",Negative
 Cirmtuzumab ROR Antibody,Crwe World,Negative
 ONCT,"OTC Dynamics, Inc.",Negative
 ONCT,Flash Alert,Negative
 Chronic Lymphocytic Leukemia Treatment Market   Analysis,Swapna Supekar,Positive
 Global Industry Revenue Share Size Status Growth Rate Services,Swapna Supekar,Positive
 Solutions Forecast,Swapna Supekar,Positive
   entre,Dr. Iv√°n R. Gonz√°lez,Positive
 con LeucemiaLinfoc√≠ticaCr√≥nica tratados con,Dr. Iv√°n R. Gonz√°lez,Positive
 base,Dr. Iv√°n R. Gonz√°lez,Positive
 ¬°,Dr. Iv√°n R. Gonz√°lez,Positive
 ¬°,datahack,Positive
 ¬°,Club Libertad Limpe√±o,Positive
 ¬°,Edeb√© Chile,Positive
 ¬°,Estela de la Torre OLY üá≤üáΩ,Negative
 group PhD candidate,Fleur Peters,Positive
 Anne Martens,Fleur Peters,Positive
 CDxCD,Fleur Peters,Positive
 todays talks,Nick,Negative
   Tablets,MedsDots,Positive
   patients immune system,CLL Ireland,Negative
 area,CLL Ireland,Negative
 area,Helen Jane Mee,Negative
 area,Rhia Steele@ravishingrhia.com,Negative
 area,Cassi Schmigotzki,Negative
 area,Te Ha,Negative
 area,WEGO Health,Negative
 area,Milton Donald,Negative
 area,Kimberley Thomas,Negative
 area,International Pain Foundation¬Æ,Negative
 area,mjohemme,Positive
 area,Colleen Busch,Positive
 area,DOMINIC GONZALES,Positive
 area,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 area,circa1835,Negative
 area,Paul Brennan (He/His),Positive
 Pevonedistat,CLL Ireland,Negative
 Pevonedistat,CLL Society Inc.,Negative
 amGet,Leukaemia Care,Negative
 CLL Society ASH,CLL Society Inc.,Negative
 amp Dr Alexey Danilov,CLL Society Inc.,Negative
 New Clinical Trial,Michele Nadeem-Baker,Negative
 New Clinical Trial,OncoTherapy Network,Negative
 amp NonHodgkin Lymphoma patients,Michele Nadeem-Baker,Negative
 Clinical Trial Corner June,Michele Nadeem-Baker,Negative
 Coronavirus Risks,MoonAngelWings....NO DM,Positive
 CAPTIVATE MRD,MDedge Hematology & Oncology,Negative
 CAPTIVATE MRD,MDEdge,Negative
 Chronic Lymphocytic Leukemia experts,CURE Magazine,Negative
 partnership,CURE Magazine,Negative
 partnership,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 partnership,CLL Society Inc.,Negative
 partnership,Jeffrey Miller,Positive
 TimeLimited,Paperbirds_Hematology,Negative
 Triplet Therapy Induces,Paperbirds_Hematology,Negative
 Rapid Undetectable MRD Responses,Paperbirds_Hematology,Negative
 husband,Olivia Bercow,Positive
 husband,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 husband,Patient Power,Negative
 husband,Kerry,Positive
 husband,Hyde Park Blast,Positive
 husband,patriciaridenour,Positive
 husband,Gina Angel,Positive
 husband,Sarah Cannon Docs,Positive
 firefighter,Olivia Bercow,Positive
 paramedic,Olivia Bercow,Positive
 relapsedrefractory CLL,Targeted Oncology,Positive
 relapsedrefractory CLL,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 relapsedrefractory CLL,Datamonitor HC,Positive
 venetoclax interruptions,Targeted Oncology,Negative
 Chronic Lymphocytic Leukemia Clinical Applications Drug Resistance,Paperbirds_Hematology,Negative
 Prospects,Paperbirds_Hematology,Negative
 Chronic   Leukemia Current Status,Leukemia,Negative
   VENICEI,Journal of the @NCCN,Negative
 Flow cytometry,MyPathologyReport.ca,Negative
 immunohistochemistry,MyPathologyReport.ca,Negative
 tumour,MyPathologyReport.ca,Negative
 diseases,MyPathologyReport.ca,Negative
 diseases,Alaric DeArment,Positive
 microscope,MyPathologyReport.ca,Negative
 microscope,Margaret Walker,Negative
 autoantibodies,MyPathologyReport.ca,Negative
 organs,MyPathologyReport.ca,Negative
 organs,Atrium Health Navicent,Positive
   Genetics,"Raul Cordoba, MD, PhD",Negative
   Genetics,Michele Nadeem-Baker,Negative
 targeted ¬† therapy,"Raul Cordoba, MD, PhD",Negative
 Expert Dr Steven Coutre,Patient Empowerment Network,Negative
   options,Patient Empowerment Network,Negative
 Fast Quiz RelapsedRefractory Chronic Lymphocytic Leukemia CLL,ÿØ. ÿπÿ®ÿØÿßŸÑŸÑŸá ÿ®ŸÜ ÿπŸÑŸä ÿßŸÑÿ≥ÿ±ÿ≠ÿßŸÜŸä Dr AL Serhani,Positive
 Quiz Chronic Lymphocytic Leukemia CLL Treatment,ÿØ. ÿπÿ®ÿØÿßŸÑŸÑŸá ÿ®ŸÜ ÿπŸÑŸä ÿßŸÑÿ≥ÿ±ÿ≠ÿßŸÜŸä Dr AL Serhani,Positive
 Selecting,"Cowan, Liebowitz",Negative
 Trademarks,"Cowan, Liebowitz",Negative
 Trademarks,Business News,Positive
 BMY,Biotech2050,Negative
   Connections Dinner,@MyelomaTeacher - Cindy Chmielewski,Negative
 Docs   Central NJ,@MyelomaTeacher - Cindy Chmielewski,Negative
 Current Issue Systemic LargeVessel Vasculitis,JCR,Positive
 Retroperitoneal Fibrosis,JCR,Positive
 Retroperitoneal Fibrosis,Paperbirds_Hematology,Negative
 TCell,JCR,Positive
 TCell,Paperbirds_Hematology,Negative
 TCell,AIRR-seq papers,Negative
 TCell,CLL-seq,Negative
 Chronic Lymphocytic Leukemia Case Report,JCR,Positive
 Chronic Lymphocytic Leukemia Case Report,ClinPulmonaryMed,Positive
 Chronic Lymphocytic Leukemia Case Report,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Case Report,BJSTR Journal-Claudia Henson,Positive
 Chronic Lymphocytic Leukemia Case Report,Lymphoma Papers,Positive
 fading star,Paperbirds_Hematology,Negative
 Longterm effects,Medivizor,Positive
 BTK inhibitor therapy,Blood Journal,Negative
 BTK inhibitor therapy,Medscape Education,Negative
 InPerson Treatment,Brave Is Now¬Æ,Negative
 gift,CONQUER the patient voice,Negative
 gift,Deborah Reynolds,Positive
 parainfluenza coinfection,Paperbirds_Hematology,Negative
 Nuclear NOTCH,Paperbirds_Hematology,Negative
 Gliotoxin Recovers,Paperbirds_Hematology,Negative
 TumorSuppressor NOTCH Activity,Paperbirds_Hematology,Negative
 ePROBased Palliative Care Intervention,Paperbirds_Hematology,Negative
 Cancer Patients,Paperbirds_Hematology,Negative
 Participatory Design Approach,Paperbirds_Hematology,Negative
 Prevalence,Annals of Laboratory Medicine,Positive
 Prevalence,Paperbirds_Hematology,Positive
 Prevalence,Benlazar S.M Amin√©,Negative
 Prevalence,Florian Slimano,Negative
 Prevalence,Europe PMC articles,Positive
 Prevalence,India Oncology 2.0,Positive
 Prevalence,JournalAgent,Positive
 Characteristics,Annals of Laboratory Medicine,Positive
 Characteristics,Paperbirds_Hematology,Negative
 Characteristics,Oncology Tube,Positive
 Characteristics,Alyssa Howard,Negative
 Characteristics,Denver Greene,Negative
 BTKBCL order,Toby Eyre,Negative
 tyrosine kinase inhibitor monotherapy,SpecialtyPTimes,Negative
 unmet need,Rajesh Sharma,Negative
 unmet need,Blood Cancer UK Research,Negative
 unmet need,Oncology Tube,Negative
 unmet need,Blood Journal,Negative
 Covid era,Rajesh Sharma,Negative
 triumph,Rajesh Sharma,Negative
 Research Report,Priti Sharma,Positive
 Research Report,Journal of Clinical Pathways,Negative
 Research Report,Scott Werntz,Negative
     Therapeutics Market Tremendous Growth,Priti Sharma,Positive
 SNSS,MAISA,Negative
 SNSS,Hottest Stocks Now,Negative
 SNSS,Anna Deveau,Negative
 SNSS,Grant Beasley,Positive
 SNSS,Edison,Positive
 SNSS,EdisonHealthcare,Positive
 SNSS,Odi Bruckman,Negative
 trading,MAISA,Negative
 trading,Proactive,Negative
 trading,John,Negative
 noncovalent BTK inhibitor vecabrutinib,MAISA,Negative
 CLL   Pathogenesis,Medical Vision,Positive
 Clinical Presentation,Medical Vision,Positive
 Clinical Presentation,Doctors*Overseas,Negative
 Clinical Presentation,Manual Of Medicine,Positive
 Clinic Ibrutinib,The ASCO Post,Negative
 ŸÜŸÉŸÖŸÑ ÿ´ÿ±ŸäÿØ ÿßŸÑŸÑŸàŸÉŸäŸÖŸäÿß ÿ™ŸÉŸÑŸÖŸÜÿß ÿπŸÜ ÿßŸÑacute ÿßŸÑÿ¢ŸÜ,MLT|ÿ¨ŸèŸàÿ±Ÿä ÿßŸÑÿ≠ÿ±ÿ®Ÿäüî¨üß™,Positive
 Chronic Lymphocytic Leukemia Market Size Overview,Nita Sonwane,Negative
 Industry Trends Share Growth Factor,Nita Sonwane,Negative
 ONCT Oncternal Therapeutics,TradeHawk,Positive
 FDA Orphan Drug Designation,TradeHawk,Positive
 Restaurant Industry Insight,"Cowan, Liebowitz",Negative
 Descriptive Restaurant,"Cowan, Liebowitz",Negative
 Matt,MerMer Goodburn üåàüá™üá∫ü©∏,Positive
 Royal Marsden,MerMer Goodburn üåàüá™üá∫ü©∏,Positive
 Royal Marsden,Nick,Negative
 Wednesday,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 Wednesday,Robert Z. Orlowski,Positive
 Wednesday,Cancer Support Ohio,Positive
 Wednesday,Leukemia Research Foundation,Negative
 Hemasphere Nikos Sousos,Adam Mead,Positive
 MF,Adam Mead,Positive
 MF,MDEdge,Negative
 MF,MDedge Dermatology,Positive
 LPD Rapid Emergence,Adam Mead,Positive
 Myelofibrosis HemaSphere,Adam Mead,Positive
 Biomimetic nanoparticle,Paperbirds_Hematology,Negative
 obatoclax mesylate,Paperbirds_Hematology,Negative
 nonsmallcell lung cancer NSCLC,Paperbirds_Hematology,Negative
 suppressing Bcl,Paperbirds_Hematology,Negative
   story,Fabrice Leclerc,Positive
   story,CLLSA,Negative
   story,Patient Power,Positive
   story,Patient Empowerment Network,Negative
   story,Sarah Cannon Docs,Positive
 Immunoglobulin Gene Analysis,Fabrice Leclerc,Negative
 Immunoglobulin Gene Analysis,FAES,Positive
 Generation,Fabrice Leclerc,Negative
 Generation,SeqComplete,Negative
 Generation,Frontiers in Cell and Developmental Biology,Positive
 Generation,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
     Immunoglobulin Gene Analysis,SeqComplete,Negative
 Novel insights,Dr Effie Kostareli,Negative
 Novel insights,Dr. Birep Ayg√ºn,Positive
 Novel insights,Lymphoma Hub,Negative
 CLL heterogeneity,Dr Effie Kostareli,Negative
 rheumatoid arthritis RA,M3 India Oncology,Positive
 Mom,Captain Syn,Positive
 Mom,üåπMarie Wikleüíô‚òïÔ∏è,Positive
 Mom,Randal Harrison,Positive
 scenario,@linfopedia,Positive
 Summarize,@linfopedia,Positive
 love,The EY Tagteam,Positive
 love,Mira Larkin,Negative
 love,AliKat üíô,Positive
 love,MD Anderson Cancer Center,Negative
 Literacy,The EY Tagteam,Positive
 props,The EY Tagteam,Positive
 props,Selma Errol Hassan,Positive
 Hairy McClary,The EY Tagteam,Positive
      slides,SeqComplete,Negative
 Building blocks,SeqComplete,Negative
 Building blocks,CLL Ireland,Negative
 treatmentsSequencing therapiesTools,SeqComplete,Negative
 treatmentsSequencing therapiesTools,CLL Ireland,Negative
 generation diagnostics,SeqComplete,Negative
 generation diagnostics,CLL Ireland,Negative
 adaptation,Lymphoma Hub,Negative
 highrisk,Lymphoma Hub,Positive
 highrisk,Paperbirds_Hematology,Negative
 highrisk,VJHemOnc,Positive
 highrisk,Benlazar S.M Amin√©,Negative
 highrisk,Oncology Learning Network,Negative
 highrisk,RNA-Seq Blog,Positive
 highrisk,Patient Power,Negative
 highrisk,"Raul Cordoba, MD, PhD",Negative
 highrisk,MDedge Hematology & Oncology,Negative
 highrisk,Juno Therapeutics,Positive
 highrisk,ASH,Positive
 highrisk,Healio,Negative
 highrisk,HemOnc Today,Positive
 highrisk,Fabio Gratton,Positive
 highrisk,Dr. Avinash Dinmohamed,Positive
 highrisk,Rhia Steele@ravishingrhia.com,Negative
 highrisk,Debbie Woodbury,Negative
 highrisk,WEGO Health,Positive
 highrisk,Sandy D.,Negative
 highrisk,CureClick,Positive
 highrisk,Senior Care Corner,Negative
 highrisk,Cassi Schmigotzki,Negative
 highrisk,Colleen Busch,Negative
 highrisk,International Pain Foundation¬Æ,Negative
 highrisk,APhA DrugInfoLine,Positive
 highrisk,Susan Rahn,Positive
 highrisk,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 highrisk,Steve Warner,Positive
 highrisk,Miguel Perales M.D.,Negative
 highrisk,Biotech2050,Negative
 highrisk,WCM Lymphoma,Negative
 Live QampA,Lymphoma Hub,Positive
 Fabienne,Lymphoma Hub,Negative
 MeierAbt,Lymphoma Hub,Negative
 AnneSophie Michallet,Lymphoma Hub,Negative
 ICLL,Lymphoma Hub,Negative
 FILO study,Lymphoma Hub,Negative
   interview w Carsten Niemann,VJHemOnc,Negative
 fixedduration venobinutuzumab,Lymphoma Hub,Negative
 uMRD,Lymphoma Hub,Negative
 therapy cessation,Lymphoma Hub,Negative
   Targeted therapy,VJHemOnc,Negative
 QampA session,VJHemOnc,Negative
 View,VJHemOnc,Negative
 View,Rohit K,Positive
 View,Verastem Oncology,Negative
 EHA content gtgt,VJHemOnc,Negative
 RR   Arnon Kater,VJHemOnc,Negative
 pathology,Michael Rynne,Negative
 pathology,EurekaMag,Negative
 pathology,Pastel BioScience,Positive
 Dept,Michael Rynne,Negative
 Dept,Michael Hallek,Positive
 Dept,Mats Ohlin,Positive
 Generation Sequencing machine,Michael Rynne,Negative
 cancersWell,Michael Rynne,Negative
 Live QampA   Carsten Niemann,Lymphoma Hub,Negative
 Bruton tyrosine kinase inhibitor BTKi,ASH Clinical News,Negative
 generation treatments,CLL Ireland,Negative
 Gianluca Gaidano,Lymphoma Hub,Negative
 Gianluca Gaidano,Jennifer Smith,Positive
 Eastern Piedmont,Lymphoma Hub,Negative
 Eastern Piedmont,VJHemOnc,Negative
 discussed tools,Lymphoma Hub,Negative
 todayCombination treatments,CLL Advocates Network,Negative
 ObinutuzumabIbrutinib,CLL Advocates Network,Negative
 VenetoclaxImpressive uMRD,CLL Advocates Network,Negative
 New article News,Paperbirds_Hematology,Negative
 LCFACSeq,Paperbirds_Hematology,Negative
 method,Paperbirds_Hematology,Negative
 BTK PLCG mutations,VJHemOnc,Negative
 BTK PLCG mutations,Benlazar S.M Amin√©,Negative
 BTK PLCG mutations,"Raul Cordoba, MD, PhD",Negative
 research View,HARMONY Alliance,Negative
 projects,HARMONY Alliance,Negative
 projects,ILLINOIS Social Work,Negative
 projects,Mahmoud Turki,Negative
 projects,"chadi nabhan MD, MBA, FACP",Negative
 projects,VJHemOnc,Negative
 projects,CLL,Negative
 greats,Michael Rynne,Negative
 Chronic   Leukemia Advantages,Leukemia,Negative
 Monoclones,Leukemia,Negative
 Team Bad Blood,Nancy Zurawski,Positive
 Thursday night,Nancy Zurawski,Positive
 Carol Moreno,Lymphoma Hub,Negative
 Carol Moreno,Dr Effie Kostareli,Negative
 Stuart Blakemore,Lymphoma Hub,Negative
 Stuart Blakemore,Christian Pallasch,Positive
 activation,Lymphoma Hub,Negative
 activation,Madison Taylor,Positive
 AKT causes transformation,Lymphoma Hub,Negative
   Proud,Petr Taus,Positive
 highschool student,Petr Taus,Positive
 Jakub Henzl,Petr Taus,Positive
 Composite Lymphoma,"Habib M. Razavi, MD, PHD, FRCPC",Positive
 Cody Steeves,Biologics by McKesson,Negative
 PharmD BCOP,Biologics by McKesson,Negative
 video panel discussion,Biologics by McKesson,Negative
 CLL Care,Brave Is Now¬Æ,Negative
 Junyan Lu,Lymphoma Hub,Negative
 multiomics integration data,Lymphoma Hub,Negative
 CLL Limited Evidence,Oncology Publishers Feed,Negative
 Good Outcomes,Oncology Publishers Feed,Negative
 Chronic Lymphocytic Leukemia CLL   Pathogenesis,Doctors*Overseas,Negative
 Chronic Lymphocytic Leukemia CLL   Pathogenesis,Manual Of Medicine,Positive
 BTKi therapy,"Raul Cordoba, MD, PhD",Negative
   BTK inhibitor therapy,"Raul Cordoba, MD, PhD",Positive
   Seema Bhat MD,MedPage Oncology,Negative
 hematologist,MedPage Oncology,Negative
 hematologist,Dallas W. Thompson,Positive
   studies,MedPage Oncology,Negative
 Stochastic Sell Signal,SwingTradeBot UK,Positive
 Otto D Trautz,VTDigger,Positive
 Vermonts,VTDigger,Positive
   treatment,Nick,Negative
   treatment,Michele Nadeem-Baker,Negative
   treatment,MAISA,Negative
   treatment,Andrew Schorr,Positive
   treatment,"Jose Sandoval S, MD FACP",Positive
   treatment,Patient Power,Negative
   treatment,CLL Ireland,Negative
   treatment,Regulatory Jobs,Positive
 Dr David Allsup,Nick,Negative
 CLL CNS Helen Knight,Nick,Negative
 Lydia Scarf√≤,Lymphoma Hub,Negative
 Lydia Scarf√≤,Uni San Raffaele,Positive
 BTK amp PLCG mutations,Lymphoma Hub,Negative
 realworld evidence,Lymphoma Hub,Negative
 anorexiaRespiratoryChestBronchiaLung Cancer,Maria Marta P.M.üçÄ,Positive
 carcinoma Constriction Pain,Maria Marta P.M.üçÄ,Positive
 left agg,Maria Marta P.M.üçÄ,Positive
 coughBlood,Maria Marta P.M.üçÄ,Positive
 CD MFI,Benlazar S.M Amin√©,Negative
 CAPTIVATE study,Lymphoma Hub,Negative
 CAPTIVATE study,Patient Power,Negative
 CAPTIVATE study,knowMRD,Positive
 CAPTIVATE study,Sigrid Sk√•nland,Negative
 ibrutinib venetoclax combination,Lymphoma Hub,Negative
 CONGRESSCLLGIVE trial,Lymphoma Hub,Negative
 Henriette Huber,Lymphoma Hub,Negative
 obinutuzumabibrutinibvenetoclax therapy,Lymphoma Hub,Negative
 Today Register,CLL Society Inc.,Negative
 Community Meeting,CLL Society Inc.,Negative
 Managing ReEntry,CLL Society Inc.,Negative
 June,CLL Society Inc.,Positive
 June,PeerView,Negative
 June,Flash Alert,Negative
 June,Patient Power,Negative
 June,OncLive.com,Negative
 June,Catalyst Trading,Positive
 June,Targeted Oncology,Negative
 June,Medscape Education,Negative
 June,UC San Diego ACTRI,Positive
 June,AACR,Positive
 June,School of Oncology,Positive
 June,Lymphoma Hub,Negative
 Dr Kimberly Hanson,CLL Society Inc.,Positive
 Dr Susan Leclair,CLL Society Inc.,Positive
 Dr Susan Leclair,Patient Power,Positive
 Dr Susan Leclair,Andrew Schorr,Negative
 shielding,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 New Therapeutic Advances,Leukemia,Negative
 Community Meeting Managing ReEntry,CLL Society Inc.,Negative
 Excessive,Paperbirds_Hematology,Negative
 Œºcalpain,Paperbirds_Hematology,Negative
 glucoselipid metabolism,Paperbirds_Hematology,Negative
 Selinexor,Paperbirds_Hematology,Negative
 Selinexor,ClinicalTrialsData,Negative
 Selinexor,ASH Clinical News,Negative
 Selinexor,Lymphomation.org,Negative
 Cryptococcal meningitis,Paperbirds_Hematology,Negative
 literature review,Paperbirds_Hematology,Negative
 literature review,AJCP,Positive
 Phase Ib Study,Jerry Lee,Negative
 Phase Ib Study,Cure Cancer Now,Negative
 Tirabrutinib,Jerry Lee,Negative
 Tirabrutinib,@ScottWaudbyHaemResLeics,Positive
 Tirabrutinib,CellworksLife,Negative
 Tirabrutinib,Cure Cancer Now,Positive
 Tirabrutinib,Martin JS Dyer,Positive
 Tirabrutinib,ClinicalTrialsData,Negative
 Hetero Healthcare Launches Anti Cancer Drug,Hetero Healthcare,Positive
    Congress Coverage Focus,"Raul Cordoba, MD, PhD",Negative
 F Morschhauser,"Raul Cordoba, MD, PhD",Negative
 T Witzig,"Raul Cordoba, MD, PhD",Negative
 ‚Äú Update,"Raul Cordoba, MD, PhD",Negative
 Tcell lymphomas,"Raul Cordoba, MD, PhD",Negative
 Andrew Ip MD,MJH Life Sciences,Positive
 Susan M O‚ÄôBrien MD,MJH Life Sciences,Positive
 Susan M O‚ÄôBrien MD,ASH Clinical News,Negative
 Susan M O‚ÄôBrien MD,Clin Adv Hem Onc,Negative
     web rebroadcast,PeerView,Positive
 Preliminary Efficacy Study,TrialBulletin,Negative
 Preliminary Efficacy Study,CureHuntr,Negative
 CC,TrialBulletin,Negative
 CC,CureHuntr,Negative
 CC,ClinicalTrialsData,Negative
 CC,"chadi nabhan MD, MBA, FACP",Positive
 Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Status,TrialBulletin,Negative
 Condition Summary Lymphoma NonHodgkin,TrialBulletin,Negative
   Safety,CureHuntr,Positive
 Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,CureHuntr,Negative
 Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,SNN Network,Negative
 Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Greenlight Stocks,Positive
 Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,HCP Feed,Negative
 Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Latest News from Business Wire,Negative
 Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,‚ö°AiMS,Negative
 CLL EQAs,GenQA (Genomics Quality Assessment),Negative
 IGHV,GenQA (Genomics Quality Assessment),Negative
 IGHV,donnashort,Negative
 IGHV,MedGenome,Positive
 Chronic Lymphocytic Leukemia Therapeutics Market Research Report,Market Research,Positive
 Global Forecast,Market Research,Positive
 Cumulative Impact,Market Research,Positive
 GlobeNewswire,Market Research,Positive
 Ib Study,@ScottWaudbyHaemResLeics,Positive
 Chronic Lymphocytic Leukemia Treatment Market Growth,Swapna Supekar,Positive
 Novel BCL mutations,Blood Journal,Negative
 Steve,Cancer Support Community,Negative
 Lynn,Cancer Support Community,Positive
 Chronic Lymphocytic Leukemia patient,Cancer Support Community,Negative
 Knowledge,Cancer Support Community,Negative
 Knowledge,WEGO Health,Negative
 variety,Cancer Support Community,Negative
 variety,Teresa Martin,Positive
 variety,Mike Dicks,Positive
 variety,Oncology Learning Network,Negative
 variety,Mayo Clinic Cancer Center,Negative
 variety,‡¶ì‡¶∞‡ßá ‡¶ó‡ßç‡¶∞‡¶π‡¶¨‡¶æ‡¶∏‡ßÄ ‡¶ñ‡ßã‡¶≤ ‡¶ó‡¶æ‡¶Å*üòí ‡¶ñ‡ßã‡¶≤!!!,Positive
 CLL survivors Steve,Cancer Support Community,Negative
 Flag Day Greetings,"Cowan, Liebowitz",Negative
 Zelenetz,Toby Eyre,Negative
 Zelenetz,VJHemOnc,Negative
 al    tripletm ZanuO,Toby Eyre,Negative
 ‚¨á,Toby Eyre,Negative
 Ô∏èTLS,Toby Eyre,Negative
 web rebroadcast,PeerView,Negative
 PM EDT,PeerView,Negative
 PM EDT,BioAscend,Positive
 CEST,PeerView,Negative
 QUANTITATIVE CROSSSECTIONAL STUDY,Pacientes LMC,Positive
 BEHALF,Pacientes LMC,Positive
 AIL ASSOCIAZIONE ITALIANA CONTRO LE LEUCEMIELINFOMI E MIELOMI,Pacientes LMC,Positive
 Marsden,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 RealWorld Treatment Patterns Adverse Events Resource Use,Paperbirds_Hematology,Negative
 Commercially Insured Younger Patients,Paperbirds_Hematology,Negative
 USA Retrospective Cohort Study,Paperbirds_Hematology,Negative
 ibrutinib venetoclax,OncLive.com,Negative
   pandemic Recommendations,Jennifer Smith,Positive
 Eastern Piedmont Novara,Jennifer Smith,Positive
 Review Finds Questions,The Tisch Cancer Institute,Positive
 Ibrutinib Dose Modification,The Tisch Cancer Institute,Positive
 Dr Janice Gabrilove,The Tisch Cancer Institute,Positive
 author,The Tisch Cancer Institute,Positive
 author,Dr. Ronald Hoffman,Positive
 CLARITY trial update,CLL Ireland,Negative
 Rawstron et alMRD data,Toby Eyre,Negative
 UK   CLARITY trial,Toby Eyre,Negative
 amp   combination,Toby Eyre,Negative
 Hear Lydia Scarfo,VJHemOnc,Negative
 relationship,VJHemOnc,Negative
 relationship,Paperbirds_Hematology,Negative
 relationship,Dr. Birep Ayg√ºn,Positive
 relationship,AbbVie US,Negative
 relationship,cnag-crg,Negative
 relationship,CLL-seq,Negative
 relationship,MD Anderson Library,Negative
 relationship,Cancer Papers,Negative
 relationship,Patient Power,Negative
 Scarfo et,Toby Eyre,Negative
 amp PLCG,Toby Eyre,Negative
 mut,Toby Eyre,Positive
 mut,Daniel Ernst,Positive
 relapsing post,Toby Eyre,Negative
 interruptionsERIC,Toby Eyre,Negative
 Michallet et alResponse,Toby Eyre,Negative
 BM MRD velt,Toby Eyre,Negative
 m post,Toby Eyre,Negative
 MRDve ibrutinib mono,Toby Eyre,Negative
 modified prelysis sample preparation technique,Lymphoma Papers,Negative
 Incidence,Lymphoma Papers,Positive
 Incidence,60s Folks,Positive
 Incidence,"Raul Cordoba, MD, PhD",Positive
 Incidence,Christopher Steer,Negative
 Incidence,DRG Epidemiology,Negative
 Incidence,EurekaMag,Negative
 Incidence,UroToday.com,Positive
 characterization,Lymphoma Papers,Negative
 Uhr LIVEStream der KMLVideoberichte auf,Kompetenznetz Maligne Lymphome e.V.,Negative
 Aktuelle News vom,Kompetenznetz Maligne Lymphome e.V.,Negative
 mit LIVEDiskussion,Kompetenznetz Maligne Lymphome e.V.,Positive
 zu        aus dem,Kompetenznetz Maligne Lymphome e.V.,Positive
 K√∂lner Studio,Kompetenznetz Maligne Lymphome e.V.,Positive
 Weitere Infos,Kompetenznetz Maligne Lymphome e.V.,Negative
 Anmeldung,Kompetenznetz Maligne Lymphome e.V.,Negative
 Global Oncology Trial Management,Michele Nadeem-Baker,Negative
 T√§n√§√§n debytoi my√∂s chicagolacrosseleague,Suomi Lacrosse,Positive
 ü•ç,Suomi Lacrosse,Positive
 Prognosis Factors,EurekaMag,Negative
 Encouraging data,Thomas Eliot Lew,Positive
 improved tolerability,Thomas Eliot Lew,Positive
 Richter syndrome,K Pavithran,Positive
 Richter syndrome,Stefano Cattaneo DVM,Negative
 Richter syndrome,ASH,Negative
 Richter syndrome,Blood Journal,Positive
 Richter syndrome,Philip McCarthy,Negative
 Richter syndrome,Cancer Papers,Positive
 Richter syndrome,TumorImmunoPapers,Negative
 Richter syndrome,Lymphoma Papers,Negative
 Richter syndrome,filippo masini,Positive
 Richter syndrome,VJHemOnc,Negative
 Richter syndrome,CLL Ireland,Negative
 Spanish Chronic Lymphocytic Leukemia Study Group,K Pavithran,Positive
 Dr Lee,Targeted Oncology,Negative
   opening ceremony,CLL Advocates Network,Negative
 EHA President Prof Gribben,CLL Advocates Network,Negative
 GOOD BOY,George,Negative
 sentence,George,Negative
 orthodox   medicin,George,Negative
 YTD CASH,Tong,Negative
 Prof Arnon Kater,LYMPHOMA & MYELOMA CONNECT,Negative
 Heute Abend,medtoday Germany,Negative
 Ihnen vor,medtoday Germany,Negative
 Beginn des,medtoday Germany,Negative
 vorstellen ist,medtoday Germany,Negative
 Schwabing Sein Thema,medtoday Germany,Negative
 Jetzt noch schnell regsitrieren,medtoday Germany,Negative
 Sonali Sharma,Mraz Lab,Positive
 EHA congress MIR INFLUENCES CD,Mraz Lab,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA CLL,Mraz Lab,Positive
 SLL patient,Joe,Negative
 dose,Joe,Negative
 dose,RIOH,Positive
 dose,Marek Trneny,Positive
 dose,"Raul Cordoba, MD, PhD",Negative
 Novel t Translocation,Paperbirds_Hematology,Negative
 IGL Gene Deletion,Paperbirds_Hematology,Negative
 CLL Patient Transforming,Paperbirds_Hematology,Negative
 BPLL,Paperbirds_Hematology,Negative
 Gain,Paperbirds_Hematology,Negative
 Gain,CancerWallonia,Negative
 European Hematology Association EHAEHAVirtual Advances,PRpro.be,Positive
 High Risk Chronic Lymphocytic Leukemia,PRpro.be,Positive
 High Risk Chronic Lymphocytic Leukemia,yeast_papers,Positive
 Chronic Lymphocytic Leukemia New Horizons,HemOnc_ACCP,Positive
 BTK InhibitorsTune,HemOnc_ACCP,Positive
   Datos,Prometheus‚Äô Trainee,Positive
 de una leucemia linf√°tica cr√≥nica,Prometheus‚Äô Trainee,Positive
 M√°s frecuente,Prometheus‚Äô Trainee,Positive
 el anciano de las leucemiasManchas de GumprechtLa mayor√≠a,Prometheus‚Äô Trainee,Positive
 inmunofenotipo,Prometheus‚Äô Trainee,Positive
 BExpresan marcadores,Prometheus‚Äô Trainee,Positive
 de c√©lulas T CD y ZAPCuando expresan CD,Prometheus‚Äô Trainee,Positive
 y ZAP hay mal pron√≥stico,Prometheus‚Äô Trainee,Positive
 MACD Bullish Centerline Cross,SwingTradeBot UK,Positive
   Novel BCL mutations,"Raul Cordoba, MD, PhD",Negative
 Matthias B√∂ttcher Mougiakakoss lab tumor microenvironment confers,Alessandro Donada,Positive
 ARDS,ClinPulmonaryMed,Positive
 Presenting Complication,ClinPulmonaryMed,Positive
 Hyperviscosity Syndrome,ClinPulmonaryMed,Positive
 New article CostEffectiveness,Paperbirds_Hematology,Negative
 FirstLine Ibrutinib,Paperbirds_Hematology,Negative
 FirstLine Ibrutinib,Christopher Steer,Negative
 FirstLine Ibrutinib,Mohammed Saied Faraj,Positive
 ThirdLine,Paperbirds_Hematology,Negative
 Lipid Nanoparticles Primary CLL Cell Transfection,Paperbirds_Hematology,Negative
 Present,Deborah Reynolds,Positive
   group,Adam Kittai,Positive
   group,MD Anderson Leukemia,Negative
   group,Florian Slimano,Negative
 appropriateness,Targeted Oncology,Negative
   Clinical Research Achievement Award,Clinical Research Forum,Positive
 apto,BiopharmIQ by Amp,Positive
 apto,Anna Deveau,Negative
 KLL √áALI≈ûMASI,Prof. Dr. H. ƒ∞smail Sarƒ±,Positive
 REJƒ∞Mƒ∞Nƒ∞N UZUN D√ñNEM SONU√áLARI DA OLUMLU,Prof. Dr. H. ƒ∞smail Sarƒ±,Positive
 √∂semi,Prof. Dr. H. ƒ∞smail Sarƒ±,Positive
 Mind Blog   Cause Marketing Legal issues,"Cowan, Liebowitz",Negative
 Partnering,"Cowan, Liebowitz",Negative
 NonProfits,"Cowan, Liebowitz",Negative
 Paraneoplastic Pemphigus Indication,Cureus,Negative
 Available Treatment,The Indian Pharma,Negative
 NEW Zanubrutinib treatment,Medivizor,Negative
 New article Reconstitution,Paperbirds_Hematology,Negative
 humoral immunity,Paperbirds_Hematology,Negative
 humoral immunity,"Navneet Majhail, MD, MS",Negative
 humoral immunity,Francesco Turturro,Negative
 Small Lymphocytic Lymphoma Mimicking Primary Cutaneous Marginal Zone Lymphoma,Paperbirds_Hematology,Negative
 Colonization,Paperbirds_Hematology,Negative
 Germinal Center Follicles,Paperbirds_Hematology,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA CLLIt,Pearl David,Positive
 carotenoidenriched   extract,Australian Adventure,Positive
 market access,China Science,Positive
 selfdeveloped cancer drug Brukinsa zanubrutinib,China Science,Positive
 Oxford Gene Technology,Clinical Lab Products Magazine,Positive
 SureSeq CLL   CNV panel,Clinical Lab Products Magazine,Positive
 nextgeneration,Clinical Lab Products Magazine,Positive
 CD CART therapy,Flow Paradigm,Negative
 Veteran ¬†  Minutes,Dr. Nancy PerlmanüÜòÔ∏è,Positive
 correspondent Ed Bradley,Dr. Nancy PerlmanüÜòÔ∏è,Positive
 Mount Sinai Hospital,Dr. Nancy PerlmanüÜòÔ∏è,Positive
 Mount Sinai Hospital,Patricia S Limbacher,Positive
 Mount Sinai Hospital,Oncology Tube,Negative
 Manhattan,Dr. Nancy PerlmanüÜòÔ∏è,Positive
 Manhattan,Patricia S Limbacher,Positive
    list story,Fabrice Leclerc,Negative
 Batman Ears,WheelieDealer,Negative
 Etiopathogenesis,EurekaMag,Negative
 Etiopathogenesis,Paperbirds_Hematology,Negative
 Ken Hill,FirstHealth,Positive
 Pinehurst,FirstHealth,Positive
 year survivor,FirstHealth,Positive
 year survivor,Bailey O'Brien,Positive
 modifications,Paperbirds_Hematology,Negative
 Ed Bradley,Patricia S Limbacher,Positive
 Overall study,Targeted Oncology,Negative
 Emotionallymentallyjust brokenGot,RYŒõNN LYNN WŒûLLŒûR üî•,Positive
 phone,RYŒõNN LYNN WŒûLLŒûR üî•,Positive
 phone,LymphomaAction,Negative
 phone,H,Positive
 phone,Chelsea‚ú®,Positive
 MomAfter,RYŒõNN LYNN WŒûLLŒûR üî•,Positive
 Exposure,TrialBulletin,Negative
 Exposure,Brave Is Now,Positive
 Exposure,EIN Presswire: Press Releases,Positive
 Exposure,Top Class Actions,Positive
 Popular   Research,Oncology Times,Negative
 earlyphase trial,CURE Magazine,Negative
 Lyn kinase,Bryjalab,Positive
 chemotaxis,Bryjalab,Positive
 chemotaxis,Scott Werntz,Negative
 migration,Bryjalab,Positive
 migration,Wnt publications,Positive
 migration,ImmunologyPapers,Negative
 migration,iwCLL,Negative
 migration,Marta Crespo,Negative
   Juni,Kompetenznetz Maligne Lymphome e.V.,Negative
 Uhr LIVEStream der KMLVideoberichte Aktuelle News vom,Kompetenznetz Maligne Lymphome e.V.,Negative
 Dr Tait Shanafelt,Katrina Sondermann,Positive
 Dr Tait Shanafelt,eCatalysis,Positive
 Dr Tait Shanafelt,Mayo Clinic Cancer Center,Negative
 guest lecture,Katrina Sondermann,Positive
 burnout amp,Katrina Sondermann,Positive
 MIND,Katrina Sondermann,Positive
 BLOWN,Katrina Sondermann,Positive
 FDA Update Ibrutinib,Oncology Times,Negative
 survivor Mike Boston,Patient Power,Negative
 chance meeting,Patient Power,Negative
 chance meeting,Andrew Schorr,Negative
 Patient Power founder,Patient Power,Negative
 Today Join,Patient Power,Negative
 Today Join,Asembia,Positive
 expert doctors,Patient Power,Negative
 pros,Patient Power,Negative
 cons,Patient Power,Negative
 BRUKINSATM Zanubrutinib,Wellcome-home,Negative
 Stockhouse,Wellcome-home,Negative
   Access,AplusA World,Negative
 evolving market,AplusA World,Negative
 BRUKINSA ‚Ñ¢ Zanubrutinib,DennisPartners,Negative
 BRUKINSA ‚Ñ¢ Zanubrutinib,Crwe World,Negative
 BRUKINSA ‚Ñ¢ Zanubrutinib,Stock Titan,Negative
 BRUKINSA ‚Ñ¢ Zanubrutinib,Trading News,Positive
 RESONATE phase,GEDEFO,Negative
 CLL highlights,Blood Cancer Uncensored,Negative
 New Longterm effects,Medivizor,Negative
 RelapsedRefractory Chronic,Crwe World,Negative
 RelapsedRefractory Chronic,OBR,Negative
 BeiGene Announces Approval,Quant Data,Negative
 RelapsedRefractory Mantle Cell LymphomaamRelated Tickers BGNE,Quant Data,Negative
 BGNE BeiGene,Stock Titan,Negative
 Autoimmune Hemolytic Anemia,Paperbirds_Hematology,Positive
 Autoimmune Hemolytic Anemia,Alexander M. J.,Positive
 machine learning,Paperbirds_Hematology,Negative
 Constantine Tam,VJHemOnc,Positive
 Constantine Tam,Lymphoma Hub,Negative
 Constantine Tam,The Lancet Haematology,Negative
 webcast,LLSCanada,Negative
 webcast,Carevƒ´ve,Negative
 Advent,Paperbirds_Hematology,Negative
 Lymphoproliferative Neoplasms,Paperbirds_Hematology,Negative
 Clinical Practice,Paperbirds_Hematology,Negative
 Radar,Leukemia,Negative
   discusses,OncLive SOSS,Negative
   discusses,MD Anderson Cancer Center,Positive
 IQVIA experts,IQVIA,Positive
 mind researchers,GMO Free USA,Negative
 „Ç¢„É°„Éñ„É≠„ÇíÊõ¥Êñ∞„Åó„Åæ„Åó„Åü „ÄÇ „Äé ‚óÜ CLLÊÇ£ËÄÖ‰ºö‰∏ªÂÇ¨„Çª„Éü„Éä„Éº ‚óÜ „Äè,„Ç∑„Ç∑„Ç£Ôº†ÁôΩË°ÄÁóÖÔºàCMLÔºâ,Positive
 ÁôΩË°ÄÁóÖ,„Ç∑„Ç∑„Ç£Ôº†ÁôΩË°ÄÁóÖÔºàCMLÔºâ,Positive
   Announces Final Results,1stOncology,Negative
 Previously Treated HighRisk,1stOncology,Negative
 Lyn,LiteratureFeed,Positive
 Lyn,AtlanticJOMedicine,Negative
 motility,LiteratureFeed,Positive
 CLL cells,LiteratureFeed,Positive
 CLL cells,iReceptor Plus,Positive
 CLL cells,Blood Advances,Negative
 CLL cells,CLLSA,Negative
 CLL cells,Brotman Baty,Positive
 CLL cells,Nitin Jain,Negative
 CLL cells,Prof John,Negative
 CLL cells,RNA-Seq Blog,Positive
 phosphorylation,LiteratureFeed,Positive
   Zanubrutinib obinutuzumab,Taylor Lab UM,Negative
 antiCD mab   BTKi story twists,Toby Eyre,Negative
 ROR Hun Ju Lee,Lymphoma Hub,Negative
 Long intergenic noncoding RNAp,CLL-seq,Negative
 CONGRESS     MURANO phase,Lymphoma Hub,Negative
 GENUINE,Lymphoma Hub,Positive
 CLL updateCAR T cell therapy,Mariam Alasfour,Positive
 MURANO,Managed Healthcare,Positive
 MURANO,oncohebdo,Negative
 Hey   colleagues,"Amber Koehler, PA-C",Negative
 JAKSTAT Pathway,EurekaMag,Negative
 JAKSTAT Pathway,Paperbirds_Hematology,Negative
 CLL Cell Death,EurekaMag,Negative
 CLL Cell Death,Paperbirds_Hematology,Negative
 Protective Bone Marrow Microenvironment,EurekaMag,Negative
 Protective Bone Marrow Microenvironment,Paperbirds_Hematology,Negative
 blood malignancies,Fuzzy,Positive
 blood malignancies,HomenusRevelio3,Positive
 blood malignancies,Hans Scheurer,Positive
 patient readiness,Patient Power,Negative
 CAR Tcell therapy Watch,Patient Power,Negative
   followup,Maria Leticia Solari,Positive
 TG Therapeutics Announces Final Results,Pharmacutical Daily,Positive
 TG Therapeutics Announces Final Results,Crwe World,Negative
 TG Therapeutics Announces Final Results,Biotech2050,Negative
 TG Therapeutics Announces Final Results,TraderZ,Positive
 GENUINE Phase,Pharmacutical Daily,Positive
 GENUINE Phase,"OTC Dynamics, Inc.",Negative
 GENUINE Phase,Stock Titan,Negative
 GENUINE Phase,Crwe World,Negative
 GENUINE Phase,Biotech2050,Negative
 GENUINE Phase,dough,Negative
 GENUINE Phase,Jake,Negative
 GENUINE Phase,The Stock Sniper,Positive
 GENUINE Phase,TraderZ,Positive
 GENUINE Phase,Amp Trades,Negative
 Evaluating Ublituximab,Pharmacutical Daily,Positive
 Evaluating Ublituximab,"OTC Dynamics, Inc.",Negative
 Evaluating Ublituximab,Stock Titan,Negative
 Evaluating Ublituximab,Crwe World,Negative
 Evaluating Ublituximab,Biotech2050,Negative
 Evaluating Ublituximab,dough,Negative
 Evaluating Ublituximab,Jake,Negative
 Evaluating Ublituximab,The Stock Sniper,Positive
 Evaluating Ublituximab,TraderZ,Positive
 Evaluating Ublituximab,Amp Trades,Negative
 Previously Treated HighRisk Chronic Lymphocytic Leukemia,Pharmacutical Daily,Positive
 Previously Treated HighRisk Chronic Lymphocytic Leukemia,Stock Titan,Negative
 Previously Treated HighRisk Chronic Lymphocytic Leukemia,Biotech2050,Negative
 Previously Treated HighRisk Chronic Lymphocytic Leukemia,dough,Negative
 Previously Treated HighRisk Chronic Lymphocytic Leukemia,Jake,Negative
 Previously Treated HighRisk Chronic Lymphocytic Leukemia,The Stock Sniper,Positive
 Previously Treated HighRisk Chronic Lymphocytic Leukemia,TraderZ,Positive
 Previously Treated HighRisk Chronic Lymphocytic Leukemia,Amp Trades,Negative
 th American Society,Pharmacutical Daily,Positive
 th American Society,Stock Titan,Negative
 th American Society,Biotech2050,Negative
 th American Society,dough,Negative
 th American Society,Jake,Negative
 th American Society,The Stock Sniper,Positive
 th American Society,TraderZ,Positive
 th American Society,Amp Trades,Negative
 Clinical Oncology Annual ¬† Meeting,Pharmacutical Daily,Positive
 TGTX TG Therapeutics Announces Final Results,"OTC Dynamics, Inc.",Negative
 TGTX TG Therapeutics Announces Final Results,Stock Titan,Negative
 TGTX TG Therapeutics Announces Final Results,dough,Negative
 TGTX TG Therapeutics Announces Final Results,Jake,Negative
 TGTX TG Therapeutics Announces Final Results,The Stock Sniper,Positive
 TGTX TG Therapeutics Announces Final Results,Amp Trades,Negative
 Previo,Crwe World,Negative
 Clinical Oncology Annual,Biotech2050,Negative
 Panelists,OncLive.com,Negative
 Clinical Oncology Educational Book,gilbert c faure,Negative
   Free Light Chain Ratios,Leukemia,Negative
 Progression,Leukemia,Positive
 Progression,vlDNApapers,Positive
 Progression,Paperbirds_Hematology,Negative
 Progression,gilbert c faure,Negative
 Progression,Onko Community,Negative
 Progression,Financial Buzz,Negative
 Progression,Pepvax Inc,Negative
 Progression,"Raul Cordoba, MD, PhD",Positive
 Progression,Crwe World,Negative
 Progression,Mahmoud Aljurf,Negative
 Progression,VJHemOnc,Negative
 Progression,Oncology Tube,Negative
 Progression,Olivier Elemento,Negative
 Progression,Invest World News,Negative
 Progression,DatZoom PR,Positive
 Progression,satPRnews,Negative
 Progression,Ez2Trade,Positive
 Progression,Hot Trades,Positive
 Progression,Penny Stocks,Negative
 Progression,Daniel Able,Positive
 Progression,PRN Biotech,Negative
 Progression,Security Stocks,Positive
 Progression,Stock Runners,Positive
 Progression,Penny Stock Irish,Negative
    Observatory,@COVID_Evidence,Negative
 Lymphocytic Lymphoma,@COVID_Evidence,Negative
 Lymphocytic Lymphoma,ingentium_COVID,Positive
 Waldenstrom Disease,@COVID_Evidence,Negative
 Waldenstrom Disease,ingentium_COVID,Positive
 COVID Condition,@COVID_Evidence,Negative
 Chronic Lymphocytic Leukemia Lymphocytic Lymphoma,@COVID_Evidence,Negative
 STATInduced Wnta,Wnt publications,Negative
 STATInduced Wnta,Prof John,Negative
 Survival Advantage Related Articles STATInduced Wnta,Wnt publications,Negative
 Survival Advantage J Immunol     Authors Rozovski,Wnt publications,Negative
 Clinical Value,Paperbirds_Hematology,Negative
 NOTCH Mutations Detection,Paperbirds_Hematology,Negative
 NonAspergillus,Paperbirds_Hematology,Negative
 ü©∏,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 Wer sind,Krebsgesellschaft,Positive
 Unerm√ºdlichen,Krebsgesellschaft,Positive
 Ma√üst√§be setzen,Krebsgesellschaft,Positive
 Vor,Krebsgesellschaft,Positive
 Jahren,Krebsgesellschaft,Positive
 Jahren,Pharma Fakten,Positive
 Deutschen Krebspreis f√ºr,Krebsgesellschaft,Positive
 Forschung Zum,Krebsgesellschaft,Positive
 VIDEO Horizon scan,VJHemOnc,Negative
 T w Constantine Tam,VJHemOnc,Negative
 Meeting Library,Benlazar S.M Amin√©,Negative
 Meeting Library,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 ibrutinib Imbruvica Pharmacyclics,Great Debates in Hematologic Malignancies,Negative
 Met goede,‚Ñã‚ÑØùìÅ‚ÑØ‚ÑØùìÉ ùíÆùìâùìäùíæùíªùìèùí∂ùìÉùíπ,Positive
 terug uit t ziekenhuis gekomen,‚Ñã‚ÑØùìÅ‚ÑØ‚ÑØùìÉ ùíÆùìâùìäùíæùíªùìèùí∂ùìÉùíπ,Positive
   booklet,AbbVie UK,Positive
 wd,fendy wahab,Positive
 Imatinib Gleevec,PharmaFactz,Negative
 island,CLL Ireland,Positive
 discontinuation reason,Toby Eyre,Negative
 Infectious Complications,Paperbirds_Hematology,Negative
 Infectious Complications,Medscape Education,Negative
 Infectious Complications,National Aspergillosis Centre,Negative
 Tyrosine Kinase Inhibitors,Paperbirds_Hematology,Negative
 BOVen regimen,Anthony Mato,Negative
 Drs Brown,Targeted Oncology,Negative
 Skarbnik,Targeted Oncology,Negative
 Pancreatic Involvement,EurekaMag,Negative
 Pancreatic Involvement,Paperbirds_Hematology,Negative
 Remdesivir,Michele Nadeem-Baker,Negative
 cureall,Michele Nadeem-Baker,Negative
 experts Checkout data,Michele Nadeem-Baker,Negative
 NIAID Trial,Michele Nadeem-Baker,Negative
 BJH Article Protective Role,BSH - Haematology,Positive
 COVID‚Äê,BSH - Haematology,Positive
 COVID‚Äê,Toby Eyre,Negative
   Mitochondrial GenomeDerived circRNA,MitochondriaNews,Positive
 Functions,MitochondriaNews,Positive
 Functions,CLL-seq,Negative
 Oncogene,MitochondriaNews,Positive
 Oncogene,CLL-seq,Negative
 Targeting CD,Blood Advances,Negative
 Targeting CD,Clinical Cancer Research,Positive
 CD Tcell responses,Blood Advances,Negative
 Mitochondrial GenomeDerived circRNA,CLL-seq,Negative
 New Longterm outcomes,Medivizor,Negative
 chromosomal aberrations,Fish Chromosomes,Positive
 Sytuacja chorych,medicalpress.pl,Positive
 rzadkie w czasie,medicalpress.pl,Positive
 pandemii,medicalpress.pl,Positive
 tcoCStGwgmy,medicalpress.pl,Positive
 print,Taylor Lab UM,Negative
 print,Abdel-Wahab Lab,Positive
 print,"chadi nabhan MD, MBA, FACP",Positive
 air,"Matthew Davids, MD, MMSc",Positive
   hour,"Matthew Davids, MD, MMSc",Positive
 Understanding,"Matthew Davids, MD, MMSc",Positive
 Understanding,Patient Power,Negative
 Understanding,"Houlston Lab, ICR",Positive
 Understanding,Heather Swift Morrison,Negative
 Understanding,OncLive.com,Negative
   Lunch,Hugo Barona,Positive
     activities,RedMedEd,Negative
   updatey,Toby Eyre,Negative
 risk grps,Toby Eyre,Negative
 mutated IGHV pts HR PB uMRD,Toby Eyre,Negative
 m post venG MRD,Toby Eyre,Negative
 EOT,Toby Eyre,Negative
 PFS Interesting SPM,Toby Eyre,Negative
 ven,Toby Eyre,Negative
 chl,Toby Eyre,Negative
 sort,Toby Eyre,Negative
 conclusion,Toby Eyre,Negative
 Protective Role,Benlazar S.M Amin√©,Negative
 Pseudohyperkalemia,Paperbirds_Hematology,Negative
 Pseudohyperkalemia,INDoximity üáÆüá≥,Negative
 MGRS,Paperbirds_Hematology,Negative
     Cello Health PLC Result,AIM Alerts!,Negative
 AGM,AIM Alerts!,Positive
 Cello,Calisto Portfolio,Positive
 Cello,Investor's Champion,Positive
 Cello,Share Prophets,Positive
 Cello Signal,WheelieDealer,Positive
 Virus impact,WheelieDealer,Negative
 Small Division,WheelieDealer,Negative
 Decent business,WheelieDealer,Negative
 Cash,WheelieDealer,Negative
 Cash,tradingbrezz,Positive
 Cello Health,Share Prophets,Positive
 Cello Health,John Harrington,Positive
 Cello Health,John,Negative
 Cello Health,Ruth Gemmell,Negative
 Cello Health,Andrew Scott,Positive
 Cello Health,Proactive,Negative
 Cello Health,James Flavin,Positive
     Cello Health PLC AGM Statement,AIM Alerts!,Negative
 Observatory,ingentium_COVID,Positive
 New Research Evaluation,Frontiers in Cell and Developmental Biology,Positive
 Sequencing Somatic hypermutation SHM status,Frontiers in Cell and Developmental Biology,Positive
 Frontiers   Evaluation,Yuval Avnir,Positive
 Generation Sequencing   Cell,Yuval Avnir,Positive
 Developmental Biology,Yuval Avnir,Positive
 Latest   study,Royal Society Publishing,Positive
 unrespons,Medivizor,Negative
 MACD Bearish Centerline Cross,SwingTradeBot UK,Negative
 EQA Summary Report,GenQA (Genomics Quality Assessment),Negative
 Individual Laboratory Report ILR,GenQA (Genomics Quality Assessment),Positive
 EQAs Chronic Lymphocytic Leukaemia CLL IGHV mutation,GenQA (Genomics Quality Assessment),Negative
 ISPOR   REALWORLD,Anthony Mato,Negative
 HEALTHCARE RESOURCE UTILIZATION,Anthony Mato,Negative
 TOTAL COST,Anthony Mato,Negative
 CARE,Anthony Mato,Negative
 CARE,CARE‚Ñ¢ Education,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING FIRSTLINE,Anthony Mato,Negative
 IBRUTINIB VS CHEMOIMMUNOTHERAPY,Anthony Mato,Negative
 Chronic Lymphocytic Leukemia    expert Dr Ian Flinn,Patient Power,Negative
 ACP bekijkt vergoeding medicijn,Nationale Zorggids,Positive
 Nationale Zorggids,Nationale Zorggids,Positive
 householdsfamily,Jan Rynne,Positive
 timelimited therapies,OncLive SOSS,Negative
 expert interview,touchONCOLOGY,Negative
 expert interview,Patient Power,Negative
 Dr Ian W Flinn,touchONCOLOGY,Negative
 Safe,ASCO Publications,Negative
 Safe,"Raul Cordoba, MD, PhD",Negative
 Chronic Lymphocytic Leukemia    expert,Patient Power,Negative
 pesticide dicamba,GMO Free USA,Negative
 pesticide dicamba,GO GREEN,Positive
 pesticide dicamba,Extinction Crisis,Positive
 Study findings,Oncology Learning Network,Negative
 Study findings,NMDP/Be The Match Advocacy,Positive
 antiCD CAR Tcell infusion,Oncology Learning Network,Negative
 salvage therapy,Mahmoud Aljurf,Negative
 salvage therapy,"Raul Cordoba, MD, PhD",Negative
 salvage therapy,Bone Marrow Transplantation,Positive
 salvage therapy,CellworksLife,Negative
 salvage therapy,Lymphoma Papers,Negative
 salvage therapy,Paperbirds_Hematology,Negative
 salvage therapy,Garbi√±e Lizeaga,Negative
 salvage therapy,Benlazar S.M Amin√©,Negative
 salvage therapy,Medivizor,Positive
 salvage therapy,Targeted Oncology,Negative
 salvage therapy,Marta Crespo,Negative
 allogeneic HCT,Mahmoud Aljurf,Negative
 allogeneic HCT,"Raul Cordoba, MD, PhD",Positive
 allogeneic HCT,Bone Marrow Transplantation,Positive
 allogeneic HCT,CellworksLife,Negative
 allogeneic HCT,Lymphoma Papers,Negative
 allogeneic HCT,Paperbirds_Hematology,Negative
 allogeneic HCT,Garbi√±e Lizeaga,Negative
 allogeneic HCT,Benlazar S.M Amin√©,Negative
 allogeneic HCT,Blood Journal,Negative
 allogeneic HCT,Francesco Turturro,Positive
 New article Survey,Paperbirds_Hematology,Negative
 definition,CLLSA,Negative
 Links,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Positive
 Links,Top Class Actions,Positive
 Emergent Literacy child,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 books,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 books,"Eric K. Singhi, MD",Positive
 books,Amy C. Cavers,Positive
 books,Kimberly Bender,Positive
 amp Manuel Santiago MD,Oncology CE,Positive
 amp Manuel Santiago MD,Vindico Medical Education,Positive
 guidance,Oncology CE,Positive
 guidance,Vindico Medical Education,Positive
 guidance,Michael Rynne,Negative
 guidance,Pharmafocus,Positive
 guidance,VJHemOnc,Negative
 Dr Bourne,Arkana Laboratories,Positive
 Intent,"Cowan, Liebowitz",Negative
 NEW Ibrutinib,Medivizor,Negative
 drug synergies,Britta Velten,Positive
 SAMHD,Paperbirds_Hematology,Negative
 Forodesine,Paperbirds_Hematology,Negative
 Cytotoxicity,Paperbirds_Hematology,Negative
 dGTP,Paperbirds_Hematology,Negative
 Association,EurekaMag,Negative
 Association,Toby Eyre,Negative
 Association,Elena,Positive
 Association,Total Well Being,Positive
 Association,"Raul Cordoba, MD, PhD",Positive
 Association,CLL Warwick Uni,Negative
 Association,CureHuntr,Negative
 Association,TrialBulletin,Negative
 Association,ImmunologyPapers,Negative
 Association,Internal Medicine: Open Access,Positive
 Association,Mahmoud Aljurf,Negative
 Association,ASH,Negative
 Association,Peter G,Positive
 Association,Blood Journal,Negative
 Association,Graham Collins,Negative
 Association,@immunoonco_Meed,Positive
 Association,Philip McCarthy,Negative
 Association,Human Immunology News,Negative
 Association,Cancer Papers,Positive
 Association,Fanny Paris,Positive
 Association,Christopher Steer,Negative
 Association,‚óà Cory B. Phillips ‚óà,Negative
 Association,Tom,Negative
 GRP HIFŒ±,EurekaMag,Negative
 GRP HIFŒ±,Paperbirds_Hematology,Negative
 BAG Expression,EurekaMag,Negative
 BAG Expression,Paperbirds_Hematology,Negative
 Severity,EurekaMag,Negative
 Severity,Paperbirds_Hematology,Negative
   TGTX Final results,SY Investing,Positive
 GENIUNE Phase,SY Investing,Positive
 ublituximab   ibrutinib,SY Investing,Positive
 IB n ORR,SY Investing,Positive
 CRCRi,SY Investing,Positive
 MRDneg   vs   Results support maintenance therapy,SY Investing,Positive
 UTXAbstract,SY Investing,Positive
 Effect,Biotech2050,Negative
 Effect,Oncology Tube,Positive
 Effect,Marta Gunjaca,Positive
 Effect,Verastem Oncology,Negative
 Effect,Lymphoma Hub,Negative
 Effect,Francesco Turturro,Negative
 New Treatments,Exergen,Positive
 New Treatments,Lifewaysvillage.com/lifestyle,Negative
 New Treatments,EurekaMag,Negative
 New Treatments,JAMA Oncology,Positive
 New Treatments,JAMA Internal Medicine,Positive
 New Treatments,JAMA,Negative
 New Treatments,Chiragjani,Positive
 FDA Approves Imbruvica,Cancer Health,Negative
 FDA Approves Imbruvica,Shohta Kadomura Hospital Pharmacist,Negative
 FDA Approves Imbruvica,Medicalnewser.com,Negative
 FDA Approves Imbruvica,FDA Daily,Negative
 FDA Approves Imbruvica,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 FDA Approves Imbruvica,Medicine Science,Negative
 FDA Approves Imbruvica,Drug Discovery & Dev,Positive
 FDA Approves Imbruvica,MedPipeline,Negative
 FDA Approves Imbruvica,Hlthnews,Negative
 FDA Approves Imbruvica,New Drug Approvals,Negative
 FDA Approves Imbruvica,Drugs.com,Negative
 GRACE Blood Cancer Video Library Dr Joshua Brody,GRACE,Negative
 Multiple BCL mutations,"Mike Thompson, MD, PhD, FASCO",Negative
 Multiple BCL mutations,"Eduardo Anguita, MD, PhD",Positive
 Multiple BCL mutations,Eduardo Flavio Oliveira Ribeiro,Negative
 Multiple BCL mutations,Prof John,Negative
 Multiple BCL mutations,Hematologia ICO Hospitalet,Positive
 Multiple BCL mutations,Michie Lab,Negative
 RealWorld   Patterns Adverse Events Resource Use,Advances in Therapy,Negative
 Commercially Insured Younger,Advances in Therapy,Negative
   Retrospective Cohort Study,Advances in Therapy,Negative
 tomorrows webinar,ERN EuroBloodNet,Negative
 tomorrows webinar,Andrew Schorr,Negative
 Sampling,Paperbirds_Hematology,Negative
 Prognosis Assessment,BibliotecaHUVH. ICS,Positive
 Prognosis Assessment,Lymphoma Papers,Negative
 Prognosis Assessment,Paperbirds_Hematology,Negative
 Biosimilar Rituximab Riximyo,JointHealth,Positive
     patient care knowledge,RedMedEd,Negative
 Deborah G Kirkland RN BSN MPH CNBN,MDMercy Media,Positive
 Book Title,"Cowan, Liebowitz",Negative
 panic mode,Christy2x,Positive
 PubMed   Mutations,Biblioteca HUCA,Negative
 RASBRAFMAPKERK pathway,Biblioteca HUCA,Negative
 RASBRAFMAPKERK pathway,IUOPA,Negative
 RASBRAFMAPKERK pathway,elizabeth,Positive
 NutriSci Assistant Professor Jing Fan,UW-Madison Nutri Sci,Positive
 UW award,UW-Madison Nutri Sci,Positive
 Metabolic profiling,UW-Madison Nutri Sci,Positive
 Blood Commentary CART,Blood Journal,Negative
 ÿ£ÿØÿßÿ© ÿ¨ÿØŸäÿØ ÿ™ÿ≥ÿßÿπÿØ ÿπŸÑŸâ ÿ™ÿ≠ÿØŸäÿØ,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 VIDEO    disease discontinuation,VJHemOnc,Negative
 wBarbara Eichhorst,VJHemOnc,Negative
   talk,Patient Power,Negative
   talk,Tom,Negative
   talk,6HN Oncology Nurses,Negative
   talk,"chadi nabhan MD, MBA, FACP",Negative
 Treatment Challenge,Lymphoma Papers,Negative
 Treatment Challenge,Paperbirds_Hematology,Negative
 New article Subcutaneous Masses,Paperbirds_Hematology,Negative
 RNA Editing Alters,CLL-seq,Negative
 RNA Editing Alters,Paperbirds_Hematology,Negative
 Function,CLL-seq,Negative
 Function,Paperbirds_Hematology,Negative
 Function,VJHemOnc,Negative
 Utilizing RealWorld Evidence RWE,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Challenges,Paperbirds_Hematology,Negative
 IGHV Mutation Analysis,Paperbirds_Hematology,Negative
 timelimited triplet,Biotech2050,Negative
 umbralisib ublituximab,Biotech2050,Negative
 umbralisib ublituximab,OncLive.com,Negative
 umbralisib ublituximab,"Amber Koehler, PA-C",Negative
 umbralisib ublituximab,Lymphoma Hub,Negative
 Dr Laura Michaelis,The ASCO Post,Negative
 Chronic Lymphocytic Leukemia Treatment PDQ,Interesting Weird Facts,Positive
 Chronic Lymphocytic Leukemia Treatment PDQ,Chocolatiere Phys,Negative
 Chronic Lymphocytic Leukemia Treatment PDQ,Montse Carrere,Positive
 Professional Version,Interesting Weird Facts,Negative
 Professional Version,Montse Carrere,Positive
 National Cancer Institute NCI,Interesting Weird Facts,Negative
 Pensando,datahack,Positive
 lo dudes m√°s p√°sate por nuestra,datahack,Positive
 y descubre todos nuestros,datahack,Positive
 y √°sterdigitales,datahack,Positive
 con los que podr√°s,datahack,Positive
 y convertirte,datahack,Positive
 un   de √©xito,datahack,Positive
 √≥nOnline,datahack,Positive
 UNITYCLL trial,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Challenge,Journal of Clinical Pathways,Negative
 Challenge,Nic üíô,Positive
 Challenge,Oncology Tube,Negative
 Developing,Journal of Clinical Pathways,Negative
 Developing,CRO Contract Res.,Negative
 Rapidly Evolving Clinical Space,Journal of Clinical Pathways,Negative
 Case StudyAuthors,Journal of Clinical Pathways,Negative
   UpdatePandemic Edition,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 Dr Ian Flinn,CURE Magazine,Negative
 Dr Ian Flinn,Sarah Cannon Docs,Positive
 Dr Ian Flinn,CLL Ireland,Negative
 Demonstrates,TrialSite News,Negative
 Demonstrates,Michael Hallek,Negative
 Battle,EurekaMag,Negative
 Battle,Lymphoma Papers,Negative
 Battle,NK papers,Negative
 Impulsa tu carrera con nuestro,datahack,Positive
 en la soluci√≥n m√°s eficiente,datahack,Positive
 memoria,datahack,Positive
 lo,datahack,Positive
 Comenzamos,datahack,Positive
 M√°s,datahack,Positive
 CELG Phase Phase,ClinicalTrialsData,Negative
 Openlabel Dose Finding Study,ClinicalTrialsData,Negative
 doublet,OncLive.com,Negative
 Proceeding,Leukemia,Negative
 Intensity   Stem Cell Transplant,Leukemia,Negative
   Thursday Webinar,ERN EuroBloodNet,Negative
 Venetoclax BTK Inhibitor Sequencing Question,Toby Eyre,Negative
 Venetoclax BTK Inhibitor Sequencing Question,Paperbirds_Hematology,Negative
 line therapy,Faheema Hasan,Positive
 line therapy,"chadi nabhan MD, MBA, FACP",Negative
   Feasibility,"Raul Cordoba, MD, PhD",Negative
 CDtargeted,"Raul Cordoba, MD, PhD",Negative
     approved ibrutinib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 ThreeGene Expression Signature,EurekaMag,Negative
 ThreeGene Expression Signature,Paperbirds_Hematology,Negative
 Cluster,EurekaMag,Negative
 Cluster,Paperbirds_Hematology,Negative
 Short Survival,EurekaMag,Negative
 Short Survival,Paperbirds_Hematology,Negative
 CLL experts patients,Patient Power,Negative
 Firstline therapy,Fish Chromosomes,Positive
 nd webinar,Leukaemia Care,Negative
 Thks,MDSUK PatientSupport üíô,Positive
 isolation issues,MDSUK PatientSupport üíô,Positive
 treatmentThe lack,MDSUK PatientSupport üíô,Positive
 ‚ôÇ,CLL_Fightersüéó,Negative
 ‚ôÇ,Jah Kuu,Negative
 ‚ôÄ,CLL_Fightersüéó,Negative
 Trump,GO GREEN,Positive
 Trump,Artislove,Positive
 Trump,Peacock,Positive
 Dicamba   Researchers,GO GREEN,Positive
 LIVE CE,Asembia,Positive
 Progressionfree Survival,RD360,Positive
 amp   webinar,Leukaemia Care,Negative
 UNITYCLL Phase   study,ur-trading,Positive
 UNITYCLL Phase   study,Vegastrader66,Positive
 UNITYCLL Phase   study,PSK2329 - JHC,Negative
 UNITYCLL Phase   study,Quant Data,Negative
 Efficient,Paperbirds_Hematology,Negative
 targeted degradation,Paperbirds_Hematology,Negative
 Covid infection,Krishan Maggon,Negative
 Covid infection,Shankara Paneesha,Negative
 Covid infection,Syed Abutalib,Positive
 therapynaive patients,Krishan Maggon,Negative
 therapynaive patients,Shankara Paneesha,Negative
 therapynaive patients,Syed Abutalib,Positive
 Market cap x peak,Biotech2050,Negative
 revenue potential,Biotech2050,Negative
 Chronic Lymphocytic Leukemia CLL treatment brand,CLEVER Network,Positive
   touts topline Ph   data,DDNews Online,Negative
 year followup results,National Comprehensive Cancer Network (NCCN),Negative
 FirstLine Ibrutinib treatment,National Comprehensive Cancer Network (NCCN),Negative
 Cationic Amino Acid TransporterMediated Arginine Uptake,EurekaMag,Negative
 Cationic Amino Acid TransporterMediated Arginine Uptake,Transporters and Solute carriers,Positive
 Chronic Lymphocytic Leukemia Cell Proliferation,EurekaMag,Negative
 Chronic Lymphocytic Leukemia Cell Proliferation,Transporters and Solute carriers,Positive
 Viability,EurekaMag,Negative
 Viability,Transporters and Solute carriers,Positive
 AbbVie shares,PSK2329 - JHC,Negative
 AbbVie shares,Quant Data,Negative
 Health Canada approval,PSK2329 - JHC,Negative
 Health Canada approval,Quant Data,Negative
 Experts Dr Kerry Rogers,Patient Power,Negative
 fact,Patient Power,Negative
 fact,CrozrX,Positive
 fact,Patient Empowerment Network,Negative
 fact,Melanie,Negative
 fiction,Patient Power,Negative
 fiction,Patient Empowerment Network,Negative
 fiction,Lifelong Learning,Negative
 TG Therapeutics Announces Positive Topline Results,"Redington, Inc.",Positive
 UNITYCLL Phase,"Redington, Inc.",Positive
 UNITYCLL Phase,Behavioral Finance,Positive
 UNITYCLL Phase,Quant Data,Negative
 UNITYCLL Phase,Jake,Negative
 UNITYCLL Phase,Day Trading Alerts,Positive
 UNITYCLL Phase,Swing Trading,Positive
 UNITYCLL Phase,dough,Negative
 UNITYCLL Phase,Michelle Solly,Positive
 UNITYCLL Phase,Michel Doepke,Positive
 UNITYCLL Phase,Bio Stocks‚Ñ¢,Negative
 UNITYCLL Phase,Amp Trades,Negative
 UNITYCLL Phase,TradeXchange,Negative
 Ublituximab U,"Redington, Inc.",Positive
 Ublituximab U,Behavioral Finance,Positive
 Ublituximab U,Jake,Negative
 Ublituximab U,Day Trading Alerts,Positive
 Ublituximab U,Swing Trading,Positive
 Ublituximab U,dough,Negative
 Ublituximab U,Michelle Solly,Positive
 Ublituximab U,Michel Doepke,Positive
 Ublituximab U,Bio Stocks‚Ñ¢,Negative
 Ublituximab U,Amp Trades,Negative
 Ublituximab U,TradeXchange,Negative
 Pascal Lefevre lab    DAPK,Molecular Oncology,Positive
 mRNA processing,Molecular Oncology,Positive
 Medifocus Guidebook,ÏòÅÏßÄ,Positive
 Medifocus Guidebook,Shop Like a Freak,Positive
 Medifocus Guidebook,tDot libraryBot,Positive
 Medifocus Guidebook,Deborah Fitzerman,Positive
 PDF ePub Mobi TXT fb Kindle DjVu AudioBook mp maRead,ÏòÅÏßÄ,Positive
 Download,ÏòÅÏßÄ,Positive
 Download,Download Ebooks,Positive
 TGTX   PM TG,SY Investing,Positive
    Key Opinion Leader,Biotech2050,Negative
 TG Therapeutics shares,Vegastrader66,Positive
 TG Therapeutics shares,PSK2329 - JHC,Negative
 TG Therapeutics shares,Quant Data,Negative
 tgtxTG Therapeutics Announces Positive Topline Results,Behavioral Finance,Positive
 decades,J Cancer Sci Ther,Positive
 TGTX    PM Positive Ph UNITY results,Scott Spencer,Positive
 Amazing news,Drive for Show,Positive
 Amazing news,Woman in Science,Positive
 TG Therapeutics Announces Topline Results,Quant Data,Negative
 TGTX TG Therapeutics Announces Positive Topline Results,Jake,Negative
 TGTX TG Therapeutics Announces Positive Topline Results,dough,Negative
 TGTX TG Therapeutics Announces Positive Topline Results,Michelle Solly,Positive
 TGTX TG Therapeutics Announces Positive Topline Results,Amp Trades,Negative
 TGTX TG Therapeutics Announces Positive Topline Results,TradeXchange,Negative
 TGTX Announces Positive Topline Results,Michel Doepke,Positive
 TGTX Announces Positive Topline Results,Bio Stocks‚Ñ¢,Negative
     Cello Health PLC Issue,AIM Alerts!,Negative
 Equity,AIM Alerts!,Negative
 Brand,Ferran Fece de la Cruz,Positive
 Hand,Cancer Papers,Negative
 Hand,Paperbirds_Hematology,Negative
 DNA methylation,Biotexcel,Positive
 DNA methylation,Cancer Papers,Negative
 DNA methylation,DNAMethylationPapers,Positive
 DNA methylation,Paperbirds_Hematology,Negative
 DNA methylation,Lymphoma Papers,Negative
 DNA methylation,VJHemOnc,Negative
 DNA methylation,CellworksLife,Negative
 DNA methylation,Qatar Research,Positive
 DNA methylation,microRNApapers,Negative
 antiCD CAR Tcells,ASCO Publications,Negative
 antiCD CAR Tcells,VJHemOnc,Negative
 Godspeed     delta gamma inhibitor,CrozrX,Positive
 battle,CrozrX,Positive
 battle,Anastasia Turchetta,Positive
 battle,Miss Joyce,Positive
 battle,Miriam Fallon,Positive
 battle,The James,Negative
 battle,Team Buckeye,Positive
 Graves disease update,Thyroid4patients,Positive
 Paul,Mark Noblet,Positive
 Paul,Leukaemia Care,Positive
 III CLL trial,OncLive SOSS,Negative
 III CLL trial,OncLive.com,Negative
 fixedduration treatment,OncLive SOSS,Negative
 Clinical Pearls Adherence,Medscape Education,Negative
 Nurses Role,Medscape Education,Negative
 Clinical Pearls Myalgia,Medscape Education,Negative
 Clinical Pearls,Medscape Education,Positive
 Headaches,Medscape Education,Negative
 Clinical Pearls Fatigue,Medscape Education,Negative
 Clinical Pearls Hypertension,Medscape Education,Negative
 Clinical Pearls Atrial Fibrillation,Medscape Education,Negative
 Clinical Pearls BleedingBruising,Medscape Education,Negative
 Clinical Pearls Fungal Infections,Medscape Education,Negative
 Cytopenias,Medscape Education,Negative
 Hematologic Events,Medscape Education,Negative
 Gastrointestinal Events,Medscape Education,Negative
 Skills Challenge Clinical Pearls BTK Inhibitors,Medscape Education,Negative
 Preferred Regimens,Medscape Education,Negative
 ibrutinibrituximab combo,CellworksLife,Negative
 Ya queda menos para comenzar de nuevo Estamos,Centro Las Lomas,Positive
 trabajando para asegurar,Centro Las Lomas,Positive
 Centro Las Lomas,Centro Las Lomas,Positive
 Outpts,Toby Eyre,Negative
 Dicamba use,Paperbirds_Hematology,Negative
 cancer incidence,Paperbirds_Hematology,Negative
 Leukemia Regulation,Leukemia,Negative
 Shooting,SwingTradeBot UK,Negative
 Star Candlestick,SwingTradeBot UK,Negative
 Copyright Protection,"Cowan, Liebowitz",Negative
 Works,"Cowan, Liebowitz",Negative
 Legislators,"Cowan, Liebowitz",Negative
 Judges,"Cowan, Liebowitz",Negative
 Official Duties,"Cowan, Liebowitz",Negative
 B cell tumors,Anna Kabanova,Positive
 Coronavirus Turmoil,Pharma News,Negative
 Toll,Pharma News,Negative
 Nearterm Growth,Pharma News,Negative
 BCell Receptor,Leukemia,Negative
 BCell Receptor,Wei Du,Positive
 BCell Receptor,Clin Adv Hem Onc,Negative
 Signaling,Leukemia,Negative
 Signaling,NK papers,Negative
 differential responses,Scientific Data,Positive
 differential responses,"chadi nabhan MD, MBA, FACP",Negative
 resource,Scientific Data,Positive
 resource,Patient Empowerment Network,Negative
 resource,i3 Health,Negative
 relationships,Scientific Data,Positive
 relationships,Patient Empowerment Network,Negative
   Turmeric,The Curable Recipes,Negative
 Natural Prevention,The Curable Recipes,Negative
 Natural Prevention,Kyle J. Norton,Negative
 E lead,NCI CTEP Clinical Research,Negative
 Infections,EurekaMag,Negative
 Infections,CancerTherapyAdvisor,Negative
 Infections,"Raul Cordoba, MD, PhD",Negative
 Infections,CLL Ireland,Positive
 Intracellular Signaling Machinery,Paperbirds_Hematology,Negative
 Hematological Disorders,Paperbirds_Hematology,Negative
 New tool,Ariez BV,Positive
 BJH,Ariez BV,Positive
 BJH,Dustin Phan,Positive
   Abstract,Biotech2050,Negative
   Abstract,Prof John,Negative
 FDA Approves Imbruvica ibrutinib,NewExpressNews,Negative
 Stem cell factor,ClinOwl Haematology,Negative
 New CLL Therapies,Teresa Martin,Positive
 Improved Patient Outcomes,Teresa Martin,Positive
 CLL Diagnosis Watch,Teresa Martin,Positive
 KMLExperten,Kompetenznetz Maligne Lymphome e.V.,Negative
 vom,Kompetenznetz Maligne Lymphome e.V.,Negative
 √ºber       Cells auf,Kompetenznetz Maligne Lymphome e.V.,Negative
 CLLLymphoma,"Dr. Paul DeSantis, PharmD",Negative
 treatment regimen,Targeted Oncology,Negative
 treatment regimen,Patient Empowerment Network,Negative
 nearly month,MD Anderson Cancer Center,Negative
   ICU,MD Anderson Cancer Center,Negative
 ventilator,MD Anderson Cancer Center,Negative
 patient Mary Hernandez,MD Anderson Cancer Center,Negative
   CD,E Lambrechts,Negative
 CD antibody variants,E Lambrechts,Negative
 headline,Taylor Lab UM,Negative
 paragraph,Taylor Lab UM,Negative
 Katy Rezvani MD PhD,Oncology Learning Network,Negative
 ibrutinib Imbruvica,Patient Power,Negative
 ibrutinib Imbruvica,Oncology Nursing News,Negative
 ibrutinib Imbruvica,National Cancer Institute,Negative
 ibrutinib Imbruvica,The Leukemia & Lymphoma Society - Policy Advocacy,Positive
 ibrutinib Imbruvica,pocroncology,Positive
 ibrutinib Imbruvica,Targeted Oncology,Negative
 Drs Joshua Brody Richard Bakst,The Tisch Cancer Institute,Positive
 Amir Steinberg MD,The Tisch Cancer Institute,Positive
 CLL   Society,CLL Society Inc.,Negative
 Specific Features,Cancer Papers,Negative
 Specific Features,Hematopoiesis,Positive
 Interactions,Cancer Papers,Negative
 Interactions,Hematopoiesis,Positive
 Interactions,Paperbirds_Hematology,Negative
 Interactions,Matthias Piesche,Negative
 Interactions,palliativewise,Negative
 E trial,OncLive.com,Negative
 E trial,The Lancet Haematology,Negative
 E trial,medwireNews,Negative
    HUGE TY,Michele Nadeem-Baker,Negative
 patient leaders,Michele Nadeem-Baker,Negative
 communities,Michele Nadeem-Baker,Negative
 Grateful,Michele Nadeem-Baker,Negative
 Grateful,"Amber Koehler, PA-C",Negative
 Gratitude Babble breakout group,Michele Nadeem-Baker,Negative
 NEW Longterm effects,Medivizor,Negative
 HealtheDinner,Michele Nadeem-Baker,Negative
 Lymphoid Neoplasia,Paperbirds_Hematology,Negative
 Retrospective Analysis,Paperbirds_Hematology,Negative
 Warthin Tumor Single Institution Experience,Paperbirds_Hematology,Negative
 Gatekeeper,Paperbirds_Hematology,Negative
 BTK inhibitor Imbruvica ibrutinib,GeneOnline,Positive
 Cell Death DifferentiationNFŒ∫BpNRF survival,gerry melino,Positive
 TG BTKInhibitor   trial,Biotech2050,Negative
 positiveTGTX,Biotech2050,Negative
 incidence characteristics,Oncology Learning Network,Negative
 Richter transformationVisit,Oncology Learning Network,Negative
 drug potency signature,MitochondriaNews,Positive
 drug potency signature,Paperbirds_Hematology,Negative
   approved ibrutinib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
   Annual Meeting,Lymphoma Hub,Positive
   Annual Meeting,VJHemOnc,Negative
   week,Lymphoma Hub,Negative
   week,JTCancerCenter,Positive
 LIVEWebinar,Kompetenznetz Maligne Lymphome e.V.,Negative
 Uhr,Kompetenznetz Maligne Lymphome e.V.,Negative
 Uhr,AbbVie Deutschland,Negative
 Empfehlungen f√ºr,Kompetenznetz Maligne Lymphome e.V.,Negative
 √Ñrzte und Interessierte,Kompetenznetz Maligne Lymphome e.V.,Negative
 ua,Kompetenznetz Maligne Lymphome e.V.,Negative
 ua,idw Nachrichten,Positive
 Dreyling P Borchmann Engert,Kompetenznetz Maligne Lymphome e.V.,Negative
 Zell,Kompetenznetz Maligne Lymphome e.V.,Negative
 Humoral Immune Responses,Paperbirds_Hematology,Negative
 B Cell Tolerance,Paperbirds_Hematology,Negative
 IgM Fc Receptor FcŒºR,Paperbirds_Hematology,Negative
 expanded indication,OncLive.com,Negative
 daysDetermine optimal therapytreatment,Paradigm Med Comm,Negative
 JampJ AbbVies Imbruvica,Bionest Partners,Negative
 JampJ AbbVies Imbruvica,Regulatory Insights,Positive
 lead,Bionest Partners,Negative
 lead,Market Intelligence: Healthcare,Positive
 lead,Andrew Schorr,Negative
 lead,CLL_Fightersüéó,Negative
 lead,Lymphoma Hub,Negative
 Chaitra Ujjani MD,Oncology Tube,Negative
 CAPTIVATE Study,Oncology Tube,Negative
 CAPTIVATE Study,Brave Is Now¬Æ,Negative
 CAPTIVATE Study,Paperbirds_Hematology,Negative
   FDA Approves IMBRUVICA ibrutinib,PressReleasePoint,Positive
 patients FDA,Leukemia Research Foundation,Negative
 PShc,Cancers MDPI,Negative
 Laura Patrussi,Cancers MDPI,Negative
 letters,CLLSA,Negative
 ibrutinibrituximab combination patients,Big4Bio:Philly,Positive
   FDA Approves Ibrutinib,SeqComplete,Negative
 HCPLive,SeqComplete,Negative
 Encouraging report,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 safety efficacy,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 safety efficacy,CLL Ireland,Negative
 LiveWebinar   Aktuelle Therapiekonzepte bei Lymphomen        Zell,idw Nachrichten,Positive
 Hinweisen mit,idw Nachrichten,Positive
 lymphoid malignancies,Paperbirds_Hematology,Negative
 lymphoid malignancies,Sarah ü¶Ñüëëüñ§üíé,Positive
 lymphoid malignancies,ESH (Haematology),Negative
 lymphoid malignancies,"Raul Cordoba, MD, PhD",Negative
 novel   coronavirus CoVid,Paperbirds_Hematology,Negative
 nearly   weeks,Michael Rynne,Negative
 VIDEO   outcomes,VJHemOnc,Negative
 CD T,VJHemOnc,Negative
 Delaware County Daily Times,NwokeAgulu,Negative
 ibrutinib IMBRUVICA Pharmacyclics LLC,Society for Immunotherapy of Cancer,Negative
 ibrutinib IMBRUVICA Pharmacyclics LLC,Lymphoma Research Foundation,Negative
 ibrutinib IMBRUVICA Pharmacyclics LLC,FDA Oncology,Negative
 FDA UPDATE,Lymphoma Research Foundation,Positive
 frontline CLL,Javid Moslehi,Positive
 frontline CLL,HemOnc Today,Negative
 frontline CLL,Connie Batlevi,Negative
 mention,Javid Moslehi,Positive
 mention,Toby Eyre,Positive
 ECOG E,Sarah Williams,Positive
 Tait Shanafelt,Sarah Williams,Positive
 Tait Shanafelt,Stanford Department of Medicine,Positive
 Tait Shanafelt,VJHemOnc,Negative
 rituximab Rituxan,Oncology Nursing News,Negative
 molecularly targeted therapeutic,AACR,Positive
 immunotherapeutic,AACR,Positive
 Today FDA,FDA Oncology,Positive
 Today FDA,Media Affairs,Positive
 CLRB Douglas,Cellectar Biosciences,Positive
 Chronic Lymphocytic Leukemia Survivor,Cellectar Biosciences,Positive
 Chronic Lymphocytic Leukemia Survivor,Tinu Abayomi-Paul,Negative
 amp LLS Volunteer,Cellectar Biosciences,Positive
 Chronic Lymphocytic Leukemia MRD Updates,Oncology Tube,Negative
 live   webinar,BD Biosciences,Positive
 live   webinar,Patient Empowerment Network,Negative
 solutions,BD Biosciences,Positive
 Immunophenotypic Characteristics,Paperbirds_Hematology,Negative
 Functional Differences,Paperbirds_Hematology,Negative
 EBV,Paperbirds_Hematology,Negative
 CMVSpecific CD T cells,Paperbirds_Hematology,Negative
 Demonstrate Heterogeneity,Paperbirds_Hematology,Negative
 T cell Dysfunction,Paperbirds_Hematology,Negative
 neck,Paperbirds_Hematology,Negative
 neutrophil,Paperbirds_Hematology,Negative
 Œ≥Œ¥ T cell functions,Paperbirds_Hematology,Negative
 specialists,CLLSA,Negative
 specialists,DanielNewmaŒ∑,Positive
 specialists,LyLe Foreningen,Negative
 specialists,Esther Schorr,Negative
 specialists,Medthority,Positive
 specialists,Andrew Schorr,Negative
 specialists,Lymphomation.org,Negative
 CLL amp SLL,CLLSA,Negative
 masks,CLL Advocates Network,Negative
     Cello Health PLC Annual Report,AIM Alerts!,Negative
 Notice,AIM Alerts!,Negative
 Notice,Ro Patel,Positive
 Dr Rod Humerickhouse AbbVie,CheckRare,Negative
 NVS Phase,ClinicalTrialsData,Positive
 OfatumumabMethylprednisolone,ClinicalTrialsData,Positive
 OfatumumabLenalidomide,ClinicalTrialsData,Positive
 RelapsedRefractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,ClinicalTrialsData,Positive
 Warm Autoimmune Hemolytic Anemia Clinical Profile,Paperbirds_Hematology,Negative
 Herpes Simplex Necrotic Lymphadenitis Masquerading,Lymphoma Papers,Negative
 Richters Transformation,Lymphoma Papers,Positive
 Richters Transformation,Paperbirds_Hematology,Positive
 Richters Transformation,Andrew Schorr,Negative
 Richters Transformation,Oncology Tube,Positive
 Richters Transformation,TumImmTxpapers,Negative
 Richters Transformation,Muzaffar Qazilbash,Negative
 Richters Transformation,Francesco Turturro,Positive
 Richters Transformation,MediTech Media,Positive
 Richters Transformation,Scott Werntz,Negative
 New Ibrutinib,Medivizor,Negative
 novel flow cytometrybased assay,TumorImmunoPapers,Negative
 novel flow cytometrybased assay,Paperbirds_Hematology,Negative
 Small Molecule Inhibitors,SpecialtyPTimes,Negative
 Chronic Lymphocytic LeukemiaMore,SpecialtyPTimes,Positive
 Herpes Simplex Necrotic Lymphadenitis,Paperbirds_Hematology,Negative
 AA adenosine receptor counteracts immunosuppression,Paperbirds_Hematology,Negative
 vivo,Paperbirds_Hematology,Negative
 vivo,Wei Du,Positive
 mouse model,Paperbirds_Hematology,Negative
 SOON,Paradigm Med Comm,Negative
 Ô∏èDetermine optimal therapytreatment,Paradigm Med Comm,Positive
 Probioticbased chemotherapy,Dr L Boominathan PhD,Positive
 Probioticbased ChemoAntibody Therapy PCAT,Dr L Boominathan PhD,Negative
 roles,WEGO Health,Negative
 amp rules,WEGO Health,Negative
 innovation,WEGO Health,Negative
 innovation,AstraZenecaUS,Negative
 innovation,Chris Thomson,Negative
 leading Covid fighting drug contenders,WEGO Health,Negative
 CEO,WEGO Health,Negative
 CEO,Lorna Warwick,Positive
 CEO,Kanga Exchange,Positive
 CEO,CryptoLiveLeak,Positive
 cytokine,WEGO Health,Negative
 master regulator,WEGO Health,Negative
 Postdoctoral fellow,AcademicTransfer,Positive
 ERC Consolidator project,AcademicTransfer,Positive
 CDK,Paperbirds_Hematology,Positive
 voruciclib,Paperbirds_Hematology,Positive
 cell death,Paperbirds_Hematology,Positive
 cell death,Catherine Vel√°zquez,Positive
 cell death,Genentech,Positive
 cell death,suetodd16,Positive
 cell death,Lymphoma Hub,Negative
 cell death,TumorImmunoPapers,Negative
 cell death,Cure Cancer Now,Negative
 BSI,BSI UK,Positive
 Connected Leaning,BSI UK,Positive
     Cello Health PLC Total Voting Rights,AIM Alerts!,Positive
 reassurance,CLL Ireland,Negative
 carers,Michael Rynne,Positive
 carers,Lymphoma Australia,Positive
 carers,CLL Ireland,Negative
     patient webinar,STTR Cancer,Positive
 Tuesday April st,STTR Cancer,Positive
 Pfizer,"Brand Institute, Inc",Negative
 Pfizer,40:40 Recruitment,Positive
 Pfizer,Horizon Oncology,Positive
 Pfizer,Cellero,Positive
 RUXIENCE,"Brand Institute, Inc",Negative
 RUXIENCE,Cord Blood News,Negative
 Novel Targeted Therapies,Paperbirds_Hematology,Positive
 Novel Targeted Therapies,Lymphoma Papers,Positive
 Elderly Patients,Paperbirds_Hematology,Negative
 Elderly Patients,Lymphoma Papers,Negative
 Elderly Patients,RAVIKANTH S,Negative
 Elderly Patients,"Raul Cordoba, MD, PhD",Negative
 Elderly Patients,CLL Ireland,Negative
 Elderly Patients,balaji jegannathan,Positive
 Elderly Patients,Christopher Steer,Negative
 Elderly Patients,Lymphoma Canada,Negative
 WEBINAR Epigenetic Tools,Epigenetics Podcast,Positive
 Blood Cancer Research,Epigenetics Podcast,Positive
 ¬Æ ‚Äì Patient Version,Interesting Weird Facts,Negative
 tcokHYsXV,Seema Ali Bhat,Positive
 nonCOVID paperAwesome work,Matthew P. Cheng,Positive
 Christine Ryan,Matthew P. Cheng,Positive
 Quantification,ImmunologyPapers,Negative
 New article Utilization,Paperbirds_Hematology,Negative
 Eightyear followup,Targeted Oncology,Negative
 IbII PCYC trial,Targeted Oncology,Negative
 Noncorona academics,Ind J Med Ped Oncology,Positive
 ASH   Dr Mato,Brave Is Now¬Æ,Negative
 Chronic Lymphocytic Leukemia CLL therapies,Brave Is Now¬Æ,Negative
 Venetoclax   CLL Society,Brave Is Now¬Æ,Negative
 CLL questions,CLL Society Inc.,Negative
 PT    PM MT   PM CT   PM ET Register,CLL Society Inc.,Negative
 BALL survival risk score,Benlazar S.M Amin√©,Negative
 reallife relapsedrefractory,Benlazar S.M Amin√©,Negative
 Profiling Bioinformatics Analyses Reveal Chronic Lymphocytic Leukemia Cells,Transcriptomes,Positive
 Profiling Bioinformatics Analyses Reveal Chronic Lymphocytic Leukemia Cells,CLL-seq,Negative
 Uniqu,Transcriptomes,Positive
 NEW Bendamustine,Medivizor,Negative
 GroupEx Dividend Date,Ex Dividend Date,Positive
 Payment Date,Ex Dividend Date,Positive
 Claim,"Cowan, Liebowitz",Negative
 Abandonment,"Cowan, Liebowitz",Negative
 NeverUsed Registered Mark,"Cowan, Liebowitz",Negative
 Unique Circular RNA Expression Pattern,CLL-seq,Negative
 Unique Circular RNA Expression Pattern,Paperbirds_Hematology,Negative
 Profiling,Paperbirds_Hematology,Negative
 Bioinformatics,Paperbirds_Hematology,Negative
 Analyses,Paperbirds_Hematology,Negative
 Reveal Chronic Lymphocytic Leukemia Cells,Paperbirds_Hematology,Negative
 IbrutinibAssociated Cardiac Tamponade,Paperbirds_Hematology,Negative
 Concurrent Antiplatelet Therapy,Paperbirds_Hematology,Negative
 Longer COVID Incubation Period,Dr.Virendra Singh,Positive
   pts med list,"Mazyar Shadman, MD MPH",Negative
 Tumor,"Andreas-Claudius Hoffmann, M.D.",Positive
 Tumor,Frontiers Oncology,Negative
 International Prognostic Score,"Eduardo Anguita, MD, PhD",Positive
 International Prognostic Score,ClinOwl Haematology,Negative
 International Prognostic Score,Richard Rosenquist Brandell,Positive
 International Prognostic Score,Paperbirds_Hematology,Negative
 International Prognostic Score,Juan Marquet,Negative
 International Prognostic Score,ALI ALAHMARI.,Negative
 Asymptomatic Earlystage Chronic Lymphocytic Leukemia,"Eduardo Anguita, MD, PhD",Positive
 Asymptomatic Earlystage Chronic Lymphocytic Leukemia,ClinOwl Haematology,Negative
 Asymptomatic Earlystage Chronic Lymphocytic Leukemia,Richard Rosenquist Brandell,Positive
 Asymptomatic Earlystage Chronic Lymphocytic Leukemia,Paperbirds_Hematology,Negative
 Asymptomatic Earlystage Chronic Lymphocytic Leukemia,Juan Marquet,Negative
 Asymptomatic Earlystage Chronic Lymphocytic Leukemia,ALI ALAHMARI.,Negative
 home,Pallawi Torka,Positive
 home,BSI America,Positive
 home,BKingTX,Positive
 preclin models Clin trial,Pallawi Torka,Positive
 Pfizer Inc,Cord Blood News,Negative
 nonHodgkin,Cord Blood News,Negative
 nonHodgkin,CIRM,Positive
 nonHodgkin,Gil Morgan,Positive
 nonHodgkin,European Association for Haematopathology,Positive
 nonHodgkin,histopathology üî¨,Positive
 nonHodgkin,Lymphoma Papers,Negative
 nonHodgkin,Matthews & Associates,Negative
 nonHodgkin,Dana-Farber,Negative
 nonHodgkin,VJHemOnc,Negative
 nonHodgkin,ASH Clinical News,Negative
 nonHodgkin,Lymphoma Hub,Negative
    Learning,Francis Chartier,Positive
 Key Statistics,Drugs Caps,Negative
 Chronic Lymphocytic Leukemia SLL,Drugs Caps,Negative
 Chronic Lymphocytic Leukemia SLL,Medicalnewser.com,Negative
 Chronic Lymphocytic Leukemia SLL,Drugnews.in,Negative
 FDA Approves Venetoclax,Drugs Caps,Negative
 FDA Approves Venetoclax,Drugnews.in,Positive
 FDA Approves Venetoclax,Physician's Weekly,Positive
 FDA Approves Venetoclax,CME Schedule,Positive
 FDA Approves Venetoclax,Rondaxe Pharma,Positive
 FDA Approves Venetoclax,UKiwiS,Negative
 FDA Approves Venetoclax,Roberto C.  Montoya,Negative
 Dr Michael Choi,Patient Power,Negative
 Dr Jeff Sharman,Patient Power,Positive
 Dr Jeff Sharman,CLL Ireland,Positive
 Dr Jeff Sharman,Andrew Schorr,Negative
 Dr Jeff Sharman,Jennifer Bergman,Negative
 Dr Jeff Sharman,Debbie Woodbury,Positive
 Dr Jeff Sharman,Rhia Steele@ravishingrhia.com,Negative
 Dr Jeff Sharman,Cassi Schmigotzki,Negative
 Dr Jeff Sharman,‚ô•Melissa‚ô•,Positive
 Dr Jeff Sharman,Sandy D.,Positive
 Dr Jeff Sharman,Paula Pyzia,Positive
 Dr Jeff Sharman,ùìúùì™ùìªùîÇ ùìúùì∏ùîÇùì∑ùì≤ùì±ùì™ùì∑ ùìíùì∏ùì∑ùì∑ùìÆùìÆùìµùîÇ,Positive
 Dr Jeff Sharman,International Pain Foundation¬Æ,Positive
 Dr Jeff Sharman,Senior Care Corner,Positive
 Dr Jeff Sharman,Colleen Busch,Negative
 Dr Jeff Sharman,Katie,Positive
 Dr Jeff Sharman,Milton Donald,Negative
 New Coronavirus,Patient Power,Negative
 MPN CLL,Patient Power,Negative
 webinars,Patient Power,Negative
 facts,Patient Power,Negative
 facts,Patient Empowerment Network,Negative
 facts,Michael Hallek,Negative
 facts,OncologyNurseAdvisor,Positive
 myths,Patient Power,Negative
 Mon,Patient Power,Negative
 Updated Perspective,Lymphoma Papers,Negative
 Updated Perspective,Paperbirds_Hematology,Negative
 Current Prognostic Predictive Biomarkers,Lymphoma Papers,Negative
 Current Prognostic Predictive Biomarkers,Paperbirds_Hematology,Negative
 Context,Lymphoma Papers,Negative
 Context,Paperbirds_Hematology,Negative
 Context,Prof John,Negative
 Context,CLL Ireland,Negative
 Novel Targeted Therapy,Lymphoma Papers,Negative
 Novel Targeted Therapy,Paperbirds_Hematology,Negative
 Selective B Cell Autophagy,Paperbirds_Hematology,Negative
 Prooxidant Adaptor,Paperbirds_Hematology,Negative
    promotes disease progression,"Raul Cordoba, MD, PhD",Negative
 Observational Trial,TrialBulletin,Negative
 RealWorld Treatment Utilization,TrialBulletin,Negative
 Effectiveness,TrialBulletin,Negative
 Effectiveness,CureHuntr,Negative
 Effectiveness,Medivizor,Negative
 PIKinhibitors,TrialBulletin,Negative
 FL Status,TrialBulletin,Negative
 Condition Summary Lymphoma Small Lymphocytic Lymphoma Lymphoma NonHodgkin Chronic Lymphocytic Leukemia Fo,TrialBulletin,Negative
 Bruton tyrosine kinase BTK inhibitors,CURE Magazine,Negative
 Hvis du har brug,LyLe Foreningen,Negative
 snak s√• kontakt,LyLe Foreningen,Negative
 el Tlf,LyLe Foreningen,Negative
 √•alenemedblodkr√¶ft,LyLe Foreningen,Negative
 Vi,LyLe Foreningen,Positive
 ogs√•,LyLe Foreningen,Negative
   Trial,CrozrX,Positive
   Trial,UpToDate,Positive
 RealWorld,CrozrX,Positive
 RealWorld,Cure Cancer,Positive
 REAL,CrozrX,Positive
 care Expert Nicole Lamanna   member,ColumbiaCancer,Positive
 oncologist,ColumbiaCancer,Positive
 oncologist,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 oncologist,Pamela Combs,Positive
 oncologist,Randal Harrison,Positive
 treatment changes,ColumbiaCancer,Positive
   Proteins,Cancers MDPI,Negative
 BCell NonHodgkin,Cancers MDPI,Negative
 Magdalena Klanova,Cancers MDPI,Negative
 Pavel Klener,Cancers MDPI,Negative
 Connect CLL Registry,Paperbirds_Hematology,Negative
 International   Score,"Andreas-Claudius Hoffmann, M.D.",Positive
 Asymptomatic Earlystage Chronic Lymphocytic,"Andreas-Claudius Hoffmann, M.D.",Positive
 Chronic Lymphocytic Leukemia Changes,WhatNext.com,Negative
 Chronic Lymphocytic Leukemia Version,CLL Advocates Network,Negative
 Chronic Lymphocytic Leukemia Version,BluntAdvice,Positive
 recruit,Toby Eyre,Negative
 BTKi trial,Toby Eyre,Negative
 Dr Wei Ding,Mayo Clinic Cancer Center,Negative
 practice,Mayo Clinic Cancer Center,Negative
 practice,Becky Bishop,Positive
 practice,"Caner Saygin, MD",Positive
 practice,"chadi nabhan MD, MBA, FACP",Negative
 practice,Jeff Sharman,Positive
 practice,Barton Clough Primary School,Positive
 practice,donnashort,Negative
 practice,Amy Ramos,Negative
 longer   incubation period,CancerTherapyAdvisor,Negative
   Medicare beneficiaries,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
   questions,Patient Power,Negative
   questions,Lymphoma Hub,Negative
   Community Learning Lab,ILLINOIS Social Work,Positive
   minutes,Leukaemia Care,Negative
   minutes,MDedge Hematology & Oncology,Negative
   minutes,Patient Power,Negative
   minutes,CLLSA,Positive
 NCI researchers,NIH Clinical Center,Negative
 ARTICLE,VJHemOnc,Negative
 ARTICLE,Shouting at people in my underpants,Negative
 RelapsedRefractory TGTX U,Biotech2050,Negative
 Leukemic Arthritis,Cancer Papers,Negative
 Gout,Cancer Papers,Negative
 Septic Arthritis,Cancer Papers,Negative
 dividend commitment,Investor's Champion,Positive
 commitment,Investor's Champion,Positive
 commitment,Verastem Oncology,Positive
 NEW VIRTUAL SUPPORT GROUP,AnCan,Negative
 BLOOD CANCERS,AnCan,Negative
 April     pm EDT   Free Dropin,AnCan,Negative
 click link,AnCan,Negative
 CLL Cello Health PLC,Ruth Gemmell,Negative
 CLL Cello Health PLC,Proactive,Negative
 Patent amp Trademark Law Alert,"Cowan, Liebowitz",Negative
 CARES Act,"Cowan, Liebowitz",Negative
 Patent Trademark Office,"Cowan, Liebowitz",Negative
 Filing,"Cowan, Liebowitz",Negative
 Fee Deadlines,"Cowan, Liebowitz",Negative
 Applicants,"Cowan, Liebowitz",Negative
 VIDEO   Cello Health PLC,Andrew Scott,Positive
 Ascentage Pharma Announces Approval,Crwe World,Negative
 Phase IbII Clinical Study,Crwe World,Negative
 Phase IbII Clinical Study,Odi Bruckman,Negative
 Bcl Inhibitor APG,Crwe World,Negative
 Bcl Inhibitor APG,Odi Bruckman,Negative
   Pharma Announces,Odi Bruckman,Negative
 Differential diagnosis,Lymphoma Papers,Negative
 Differential diagnosis,medicalzone,Positive
 Journals Case study,The Lancet Haematology,Negative
 Mark S Lesney,The Lancet Haematology,Negative
     Cello Health PLC COVID Update,AIM Alerts!,Negative
 chronic lymphocy,Medivizor,Negative
 Honored,Michele Nadeem-Baker,Negative
 Prof Fegan,CLLSA,Negative
 Prof Fegan,Nick,Negative
 Prof Fegan,LyLe Foreningen,Negative
   epidemiology report,DRG Epidemiology,Positive
 PODCAST CART,VJHemOnc,Negative
   spaceListen,VJHemOnc,Negative
 New Bendamustine,Medivizor,Negative
 Fate Therapeutics Shares,Streetwise Reports,Positive
 Fate Therapeutics Shares,Life Sciences Report,Positive
 Person,Streetwise Reports,Positive
 Person,Life Sciences Report,Positive
 AntiCancer Therapy   company,Streetwise Reports,Positive
 AntiCancer Therapy   company,Life Sciences Report,Positive
 firstinhuman trial,Streetwise Reports,Positive
 firstinhuman trial,Life Sciences Report,Positive
 firstinhuman trial,Clinical Connection,Positive
 FT,Streetwise Reports,Positive
 FT,Life Sciences Report,Positive
 Venetoclax Discontinuation,Oncology,Negative
 Clinical FlowCytometric Testing,Lymphoma Papers,Positive
 salvage treatment,Medivizor,Positive
 salvage treatment,Chocolatiere Phys,Negative
 salvage treatment,Garbi√±e Lizeaga,Negative
 salvage treatment,"Dr T. Comeau , MD",Negative
 salvage treatment,Toby Eyre,Negative
 remission,Targeted Oncology,Negative
 remission,ron white,Positive
 remission,HemOnc Today,Negative
 remission,Healio,Negative
 remission,Cancer Health,Negative
 remission,Life Extension,Negative
 remission,Sid Shah,Positive
 remission,Medical Web Times,Negative
 remission,Medical Xpress,Negative
 remission,Cancer Papers,Negative
 remission,Fred Hutch,Negative
 rituximab biosimilar Ruxience,CellworksLife,Negative
 rituximab biosimilar Ruxience,Horizon Oncology,Positive
 leading   specialists,Shouting at people in my underpants,Negative
 BLOOD CANCER folks,AnCan,Negative
 Astrid Pavlovsky,Lymphoma Hub,Negative
 CD CAR NK cell therapy,Cancer clinical trials,Positive
 infusion,Cancer clinical trials,Positive
 infusion,Arjun D. Law,Positive
 persistence,Cancer clinical trials,Positive
 year postinfusion,Cancer clinical trials,Positive
 April newsletter,CLLSA,Negative
 Coronavirus CLL,Patient Power,Negative
 Dr Lamanna,Patient Power,Positive
 Dr Lamanna,Targeted Oncology,Negative
 Dr Lamanna,6HN Oncology Nurses,Positive
 Dr Lamanna,ColumbiaCancer,Positive
 PSTNOON,Patient Power,Negative
 FATE    ah patient,Palmer,Positive
 MabThera biosimilar,40:40 Recruitment,Positive
 Hairy Cell Leukemia,Paperbirds_Hematology,Negative
 Hairy Cell Leukemia,Matthews & Associates,Positive
 Hairy Cell Leukemia,Alessandro Mangogna,Positive
 Hairy Cell Leukemia,Alyssa Howard,Negative
 Ground Water Contamination,Paperbirds_Hematology,Negative
 Industrial Solvents,Paperbirds_Hematology,Negative
 fiveyear followup,Paperbirds_Hematology,Negative
 input,CLL Ireland,Negative
 input,Michael Hallek,Negative
 input,CADTH,Positive
   Market,Nita Sonwane,Positive
   Market,Adroit Market Research,Positive
 Disruptions,Nita Sonwane,Negative
 Divergent Richters Transformation,Lymphoma Papers,Negative
 Overexpression,EurekaMag,Negative
 Overexpression,Lung Cancer News,Negative
 Overexpression,Sophie Barille-Nion,Positive
 Overexpression,Henning,Negative
 Overexpression,Cancer Papers,Negative
 FATE   ah patient,Palmer,Positive
   Prognostic model,"Raul Cordoba, MD, PhD",Negative
 PLEASANT news,Joshua Brody MD,Positive
 interruptions,NCI Media Relations,Positive
 shorterning,NCI Media Relations,Positive
 Drs Mazyar Shadman John Byrd Michael Hallek Jennifer Brown Peter Hillmen Anthony Mato,Michael Hallek,Negative
 anxiety,Carlos Loinaz,Positive
 anxiety,Patient Power,Negative
 Relax,Carlos Loinaz,Positive
 frontline treatment considerations,OncLive SOSS,Negative
 New FAQ,"Amber Koehler, PA-C",Negative
 COVID pandemics impact,CURE Magazine,Negative
 cancer community,CURE Magazine,Negative
 firstline therapy,Dana-Farber,Negative
 firstline therapy,Lymphoma Hub,Negative
 firstline therapy,Guillermo Sanz,Negative
 firstline therapy,ASH,Negative
 firstline therapy,GEDEFO,Negative
 firstline therapy,"Navneet Majhail, MD, MS",Negative
 firstline therapy,"Dr T. Comeau , MD",Negative
 firstline therapy,AA&MDSIF,Positive
 firstline therapy,Cancer Papers,Negative
 firstline therapy,Blood Advances,Negative
 firstline therapy,Marta Crespo,Negative
 firstline therapy,Patient Daily,Negative
 Selected   Abstracts,The ASCO Post,Negative
 Newly Diagnosed Disease,The ASCO Post,Negative
 New Combining obinutuzumab,Medivizor,Negative
 Performance,Krishan Maggon,Negative
 Performance,Paperbirds_Hematology,Negative
 Performance,Journal for ImmunoTherapy of Cancer,Negative
 Performance,Oncology Tube,Negative
 antiCD chimeric antigen receptor T cells,Krishan Maggon,Negative
 antiCD chimeric antigen receptor T cells,Paperbirds_Hematology,Negative
 antiCD chimeric antigen receptor T cells,Journal for ImmunoTherapy of Cancer,Negative
 prayer,secamimom,Positive
 OS benefit,Toby Eyre,Negative
 OS benefit,VJHemOnc,Negative
 five‚Äêyear follow‚Äêup,Toby Eyre,Negative
 Acute Pancreatitis,Cancer Papers,Negative
 Acute Pancreatitis,Paperbirds_Hematology,Negative
 Complications,Cancer Papers,Negative
 Complications,Paperbirds_Hematology,Negative
 Complications,Brave Is Now¬Æ,Negative
 Influenza,Cancer Papers,Negative
 Influenza,Paperbirds_Hematology,Negative
 Chase,Veterinary Cancer Group,Positive
 Birthday,Veterinary Cancer Group,Positive
 Birthday,Krystal,Positive
 couple week,Sarah ü¶Ñüëëüñ§üíé,Positive
 Chronic Lymphocytic Leukemia cancer,Sarah ü¶Ñüëëüñ§üíé,Positive
 Chronic Lymphocytic Leukemia cancer,Jhawn Paul,Positive
 bloodbone marrow,Sarah ü¶Ñüëëüñ§üíé,Positive
 production,Sarah ü¶Ñüëëüñ§üíé,Positive
 production,AbbVie,Negative
 hemonc pharm residents,Benyam Muluneh,Positive
 Investigation,Hematopoiesis,Positive
 Investigation,Paperbirds_Hematology,Positive
 Investigation,Oncology Times,Negative
 Investigation,Medit,Positive
 Investigation,microRNApapers,Negative
 Investigation,Cancer Papers,Negative
 miR level,Hematopoiesis,Positive
 miR level,Paperbirds_Hematology,Negative
 Dr Rod Humerickhouse,CheckRare,Positive
 AbbVie Pharmaceuticals,CheckRare,Positive
 Facets,Paperbirds_Hematology,Negative
 TumorMicroenvironment Cell Interactions,Paperbirds_Hematology,Negative
 rent,Brad Hoylman,Positive
 Landlord,Brad Hoylman,Positive
   Firstline treatment,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 BIG THANKS,Prof John,Negative
 Online April,Prof John,Negative
   Society expert panel,CLL Society Inc.,Negative
 Round Answers,CLL Society Inc.,Negative
 Virtual Community Meeting,CLL Society Inc.,Negative
 PT   pm MT pm CT pm ET Register,CLL Society Inc.,Negative
 Clinical Picture,The Lancet Haematology,Negative
 Fulllength transcript characterization,nanopore_papers,Positive
 Fulllength transcript characterization,DTHSTR,Positive
 Fulllength transcript characterization,Yungang Xu (Âæê‰∫ëÂàö),Positive
 Fulllength transcript characterization,Gianluigi Zangari del Balzo,Negative
 Fulllength transcript characterization,Happy Scientist,Positive
 Fulllength transcript characterization,Hard Lock,Positive
 Fulllength transcript characterization,A Naqvi,Positive
 Fulllength transcript characterization,Eduardo Eyras,Positive
 Fulllength transcript characterization,bxv_genomics,Positive
 Fulllength transcript characterization,bioRxiv Genomics,Positive
 Fulllength transcript characterization,bioRxiv,Positive
 SFB mutation,nanopore_papers,Positive
 SFB mutation,Europe PMC articles,Positive
 SFB mutation,Yungang Xu (Âæê‰∫ëÂàö),Positive
 SFB mutation,Happy Scientist,Positive
 SFB mutation,Hard Lock,Positive
 SFB mutation,Leukemia & Lymphoma Society Research,Positive
 SFB mutation,A Naqvi,Positive
 SFB mutation,Eduardo Eyras,Positive
 SFB mutation,SeqComplete,Negative
 SFB mutation,bxv_genomics,Positive
 SFB mutation,bioRxiv Genomics,Positive
 SFB mutation,bioRxiv,Positive
 SFB mutation,Cancer Papers,Negative
 Invasive Aspergillosis,National Aspergillosis Centre,Positive
     Cello Health PLC Grant,AIM Alerts!,Negative
 rumor,Taylor Lab UM,Negative
 HSE,Michael Rynne,Negative
 media briefing,Michael Rynne,Negative
 RTE News NowMain topic,Michael Rynne,Negative
 Waves,"dtw Research, Inc",Negative
 Nanopore Sequencing,Biotech Feed,Positive
 Nanopore Sequencing,Cancer News,Negative
 Study FullLength Transcripts Splicing IsoformsChronic Lymphocytic Leukemia CLL,Biotech Feed,Positive
 Molecular Epidemiology,Paperbirds_Hematology,Negative
 EpsteinBarr virus EBV,Paperbirds_Hematology,Negative
 Pivotal Phase b PCYC Study,Lymphoma Papers,Negative
 Pivotal Phase b PCYC Study,Cure Cancer Now,Negative
   Society COVID Virtual Community Meeting,CLL Society Inc.,Negative
 II,CLL Society Inc.,Negative
 II,CancerWallonia,Positive
 Anthony Mato Dr Danielle Brander Dr John Pagel Lab Scientist Dr Susan Leclair,CLL Society Inc.,Negative
 Pharmacist Thomas Henry drug supply,CLL Society Inc.,Negative
 Richters syndrome localization,Lymphoma Papers,Negative
 liver,Lymphoma Papers,Negative
 liver,Doctors*Overseas,Negative
 liver,Virtute_USMLE,Negative
 thyroid,Lymphoma Papers,Negative
 CDd expression,Paperbirds_Hematology,Negative
 CDd expression,NeoGenomics,Positive
 money,Marisa - Allton Reptiles & More,Positive
 money,BSI America,Negative
 money,Claire Eyers,Positive
 money,Spud Lovr,Positive
 money,Melanie,Negative
 John Chemo Medication Click,Marisa - Allton Reptiles & More,Positive
 Bcell receptor inhibitors,ASH Clinical News,Negative
 Bcell receptor inhibitors,Paperbirds_Hematology,Negative
 Bcell receptor inhibitors,TumorImmunoPapers,Positive
 Bcell receptor inhibitors,Francesco Turturro,Negative
        information,PatientView,Positive
 idelalisib differs,ASH Clinical News,Negative
 amp chronic lymphocytic,ASH Clinical News,Negative
   specialists,CLLSA,Negative
   specialists,Hematology Board,Negative
   specialists,Dana-Farber,Negative
 Globe,Wellcome-home,Positive
 CLLAN   COVID statement,CLL Advocates Network,Negative
 progressing,Stefano Cattaneo DVM,Negative
 progressing,MoJo,Negative
 Open Access,UCL Discovery,Negative
 Open Access,JAMA Network Open,Positive
 Fulllength,Europe PMC articles,Positive
   Jennifer Woyach MD,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 American Cancer Society,Beloved Foundation,Positive
   people,Beloved Foundation,Positive
   people,AbbVie US,Positive
   people,Andrew Schorr,Positive
   people,Matthews & Associates,Negative
 chromosome,ANTARES,Positive
 chromosome,BVirtual Murciasalud,Negative
 Philadelphia,ANTARES,Positive
 Philadelphia,Total Health Conferencing,Positive
 NHL,Adam Kittai,Negative
 NHL,Lymphoma Hub,Negative
 NHL,ASH Clinical News,Negative
 NHL,ESMO - Eur. Oncology,Negative
 fellow wonderworkers,Derren Brown,Positive
 Human medicines,Agenparl,Positive
 Human medicines,Pharma Regulatory,Positive
 Human medicines,Renal Cell Carcinoma,Positive
 Constantine S Tam MBBS MD,ASH Clinical News,Negative
 delp,ASH Clinical News,Negative
 delp,Benlazar S.M Amin√©,Positive
 delp,CARE‚Ñ¢ Education,Negative
 young pt,"Amber Koehler, PA-C",Negative
 NEW Combining obinutuzumab,Medivizor,Negative
 blood doctors,CLL Ireland,Negative
   Wtf,Winn Schott,Positive
 participationEach question,Danielle M. Brander,Positive
 empower innovate,Danielle M. Brander,Positive
 Study FullLength Transcripts,Cancer News,Negative
 Splicing Isoforms,Cancer News,Negative
 Combining obinutuzumab,Medivizor,Negative
 Constantine S Tam MD MBBS,OncLive.com,Negative
      ¬Æ,CancerWallonia,Negative
 Version,CancerWallonia,Negative
 Version,Chocolatiere Phys,Negative
 Version,Serv. Farmacia CHUAC,Positive
 Version,CLL Ireland,Negative
 Version,Michele Nadeem-Baker,Negative
   dad,Nikki Greenwood,Positive
   Society Virtual Community Meeting Q,CLL Society Inc.,Negative
 format,CLL Society Inc.,Negative
 format,BSI America,Negative
 Drs Anthony Mato,CLL Society Inc.,Negative
 Danielle Brander Dr Susan Leclair,CLL Society Inc.,Negative
 Pharmacist Tom Henry,CLL Society Inc.,Negative
 Global Chronic Lymphocytic Leukemia Therapeutics Market,Investor News,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market,ABNewswire,Negative
 Global Chronic Lymphocytic Leukemia Therapeutics Market,Market Research Nest,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market,DrugGenius,Negative
 Global Chronic Lymphocytic Leukemia Therapeutics Market,9Dimen Group,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market,june Garcia,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market,Tuesday Rosales,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market,World Tech News,Negative
 Global Chronic Lymphocytic Leukemia Therapeutics Market,Vegas Blog App,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market,EIN Presswire: Pfizer Newswire,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market,Lisa Scott,Negative
 Global Chronic Lymphocytic Leukemia Therapeutics Market,Sandler Research,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market,Scott Werntz,Negative
 Premium Insight Competitive News Feed Analysis Company,Investor News,Positive
 Usability Profiles Market Sizing,Investor News,Positive
 Forecasts,Investor News,Positive
 Forecasts,Kiran Bhole,Positive
 Forecasts,EPR Network,Positive
 Forecasts,Market Research,Positive
 Forecasts,Mark Research new,Positive
 Forecasts,satPRnews,Negative
 Forecasts,BizPR,Negative
 Forecasts,BizDirect,Positive
 Forecasts,Financial Buzz,Negative
 Forecasts,Scott Werntz,Negative
 Chronic Lymphocytic Leukemia Market Size,Shillong Herald,Positive
 Chronic Lymphocytic Leukemia Market Size,SouthernIndiaReporte,Positive
 Chronic Lymphocytic Leukemia Market Size,shimla-online,Positive
 Chronic Lymphocytic Leukemia Market Size,Sikkim Journal,Positive
 Chronic Lymphocytic Leukemia Market Size,ABNewswire,Negative
 Chronic Lymphocytic Leukemia Market Size,RSSFeedsCloud,Positive
 Chronic Lymphocytic Leukemia Market Size,PressRelease.cc,Negative
 Chronic Lymphocytic Leukemia Market Size,Scott Werntz,Negative
 Epidemiology,Shillong Herald,Positive
 Epidemiology,SouthernIndiaReporte,Positive
 Epidemiology,shimla-online,Positive
 Epidemiology,Sikkim Journal,Positive
 Epidemiology,ABNewswire,Negative
 Epidemiology,RSSFeedsCloud,Positive
 Epidemiology,PressRelease.cc,Negative
 Epidemiology,National Aspergillosis Centre,Negative
 Epidemiology,"Raul Cordoba, MD, PhD",Negative
 Market Forecast,Shillong Herald,Positive
 Market Forecast,SouthernIndiaReporte,Positive
 Market Forecast,shimla-online,Positive
 Market Forecast,Sikkim Journal,Positive
 Market Forecast,ABNewswire,Negative
 Market Forecast,RSSFeedsCloud,Positive
 Market Forecast,PressRelease.cc,Negative
 Market Forecast,COPD News,Positive
 Market Forecast,DrugGenius,Negative
 Market Forecast,Epidemiology Live 2020,Positive
 Market Forecast,RazzleTazzle,Negative
 fear,Michael Rynne,Negative
 Times journalist Sean O,Michael Rynne,Negative
 Neill,Michael Rynne,Negative
 leukemia cases,Leukemia I'm Fine,Negative
 CLL Town Hall,Patient Power,Positive
 Immunomodulatory effects,Lymphoma Papers,Negative
 pevonedistat,Lymphoma Papers,Negative
 NEDDactivating enzyme inhibitor,Lymphoma Papers,Negative
 Registrations,CLLSA,Negative
 Registrations,Andrew Schorr,Negative
 Registrations,Margaret Walker,Positive
 Sean ONeill,CLL Advocates Network,Negative
 Times UK,CLL Advocates Network,Negative
 BTK Inhibitors Transform Treatment,COPD News,Negative
 CLL MCL,COPD News,Negative
 Waldenstrom Macroglobulinemia Constantine S Tam MD MBBS,COPD News,Negative
 Support     physicians,NIH Clinical Center,Negative
 occurrence,Medivizor,Positive
 European Commission Approval,Thomas C. Keefe,Negative
 European Commission Approval,LLZ Consulting,Negative
 European Commission Approval,Oncology Tube,Negative
 European Commission Approval,Company News HQ,Negative
 European Commission Approval,HSMN,Positive
 European Commission Approval,Pharma News,Negative
 European Commission Approval,Crwe World,Positive
 European Commission Approval,1stOncology,Negative
 European Commission Approval,Seattle's Banker,Negative
 European Commission Approval,Laurent G - Francis,Negative
 European Commission Approval,HEDGE accordinglyüìà,Negative
 European Commission Approval,CRE Demographics,Negative
 European Commission Approval,Today's News,Positive
 European Commission Approval,RazzleTazzle,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia,Thomas C. Keefe,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia,Oncology Tube,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia,HSMN,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia,Pharma News,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia,Odi Bruckman,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia,Bio Stocks‚Ñ¢,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia,RazzleTazzle,Negative
 News Center,Thomas C. Keefe,Negative
 News Center,LLZ Consulting,Positive
 News Center,Michael Oholendt,Positive
 Bay Area Rep Mark DeSaulnier,San Francisco Chronicle,Positive
 Brad S Kahl MD,OncLive.com,Negative
 walk,√òistein Jansen,Positive
 walk,Heather Dorosh,Positive
 walk,Kerry,Negative
 walk,Patrick,Positive
 park,√òistein Jansen,Positive
 Chronic Lymphocytic Leukemia Market Review Epidemiology,COPD News,Negative
 Chronic Lymphocytic Leukemia Market Review Epidemiology,DrugGenius,Negative
 View Insight Prices,COPD News,Negative
 View Insight Prices,DrugGenius,Negative
 FirstView Market Insight,COPD News,Negative
 FirstView Market Insight,DrugGenius,Negative
 Chronic Lymphocytic Leukemia Market Review,COPD News,Negative
 Chronic Lymphocytic Leukemia Market Review,DrugGenius,Negative
   crisis,CLL Ireland,Negative
 Replays,Andrew Schorr,Negative
 CLL Patient Carol Butler,Patient Power,Negative
 care partner,Patient Power,Positive
 care partner,Patient Empowerment Network,Positive
 FBW,Paperbirds_Hematology,Negative
 rituximab resistance,Paperbirds_Hematology,Negative
 Expert Assessment,OncLive.com,Negative
 Expert Assessment,COPD News,Negative
 Latest Advice,The Thinker,Positive
 Blood Cancer,The Thinker,Positive
 Blood Cancer,Paperbirds_Hematology,Negative
 March supplement issue,ASH Clinical News,Negative
 Coronavirus Risk,Patient Power,Negative
 Blood Test,Patient Power,Negative
 ICYMI Eviti CMO Dr Flood,NantHealth,Negative
 evolving   space,NantHealth,Positive
 published piece,NantHealth,Positive
 CAR NK cell therapy,Lymphoma Hub,Negative
 CARNK cells,Lymphoma Hub,Negative
 goaround,Adam Kittai,Negative
 celloforigin,Paperbirds_Hematology,Negative
 iSFBi mutation,DTHSTR,Positive
 NEAT Long Isoform,CLL-seq,Negative
 NEAT Long Isoform,Paperbirds_Hematology,Negative
 Cytogenetic Groups,CLL-seq,Negative
 Cytogenetic Groups,Paperbirds_Hematology,Negative
 Clinical Outcome,CLL-seq,Negative
 Clinical Outcome,Paperbirds_Hematology,Negative
 Clinical Outcome,VJHemOnc,Negative
 Clinical Outcome,Scott Werntz,Negative
 dose modification,Paperbirds_Hematology,Negative
 Cytotoxic Effects,Paperbirds_Hematology,Negative
 Mangifera Indica L,Paperbirds_Hematology,Negative
 Juglans RegiaAqueous Extract,Paperbirds_Hematology,Negative
 Human Chronic Lymphocytic Leukemia,Paperbirds_Hematology,Negative
 Human Chronic Lymphocytic Leukemia,Cancer Papers,Negative
 conduction block,Mazen M,Negative
 conduction block,Paperbirds_Hematology,Negative
 pan‚Äêneurofascin antibodies,Mazen M,Negative
 SFB,Christopher DeBoever,Positive
 SFB,Nicolas Robine,Positive
 Hemorrhagic Brain Masses,EurekaMag,Negative
 Hemorrhagic Brain Masses,Paperbirds_Hematology,Negative
 Sepsis,EurekaMag,Negative
 Sepsis,Paperbirds_Hematology,Negative
 Sepsis,pseudomonaspapers,Negative
 expert broadcasts,Andrew Schorr,Negative
 Thurs    PT PM ET,Patient Power,Negative
 Eviti CMO Dr Flood,NantHealth,Negative
 PT PM ET,Patient Power,Negative
 downregulation,Gianluigi Zangari del Balzo,Negative
 retained üß¨,Gianluigi Zangari del Balzo,Negative
 ‚ôæ,Gianluigi Zangari del Balzo,Negative
 CLL Cello Health gains momentum,Ruth Gemmell,Negative
 fullyear profits,Ruth Gemmell,Negative
 revenues,Ruth Gemmell,Negative
 Alliance,OncLive.com,Negative
 Alliance,"Mike Thompson, MD, PhD, FASCO",Negative
 Alliance,Alliance for Clinical Trials in Oncology,Positive
     Cello Health PLC,AIM Alerts!,Positive
 Preliminary Results,AIM Alerts!,Negative
 Preliminary Results,Cancer Papers,Negative
 Acute leukemia,Leukemia I'm Fine,Negative
 RT PhysRelations RT,Robert Z. Orlowski,Positive
 wwierda,Robert Z. Orlowski,Positive
 MDAndersonNews,Robert Z. Orlowski,Positive
 OncLive,Robert Z. Orlowski,Positive
 CLL Lori Leslie MD Medical Oncologist Regional Cancer Care Associates,Oncology Tube,Negative
 Trademark,"Cowan, Liebowitz",Negative
 Goat,"Cowan, Liebowitz",Negative
 Attend,Patient Power,Negative
 Attend,Lisa Palacios,Negative
 Attend,MD Anderson Leukemia,Negative
 Additional Bcell malignancies,Cancer Papers,Negative
 Additional Bcell malignancies,Lymphoma Papers,Negative
 New article Expression,Paperbirds_Hematology,Positive
 HLADR molecules,Paperbirds_Hematology,Negative
 monocytes,Paperbirds_Hematology,Negative
 Intracellular Mycobacterium Tuberculosis Growth,Paperbirds_Hematology,Negative
 Inducing Macrophage Autophagy,Paperbirds_Hematology,Negative
 Frontline VenObin CLL,"Bachar Samra, MD",Positive
 Investigators Pursue LessToxic Treatment,COPD News,Negative
 Investigators Pursue LessToxic Treatment,OncLive.com,Negative
 Frontline CLL Investigators,COPD News,Negative
 VIDEO ARQ,VJHemOnc,Negative
   activity experts,Oncology CE,Positive
   activity experts,Vindico Medical Education,Positive
 field address,Oncology CE,Positive
 field address,Vindico Medical Education,Positive
 Venclyxto,40:40 Recruitment,Positive
 Venclyxto,Anna Deveau,Negative
 Venclyxto,oncohebdo,Positive
 Venclyxto,PharmaJobs.co.uk,Positive
 Venclyxto,Pf Magazine,Positive
 Venclyxto,#WeAreE4H,Positive
 Venclyxto,Solomon Kamal,Positive
 Venclyxto,PRICENTRIC,Positive
 Venclyxto,Lymphoma Hub,Negative
 Venclyxto,Kristin Tesmer,Positive
 Coronavirus Update,Patient Power,Negative
 Andrew Schorr,Patient Power,Negative
 Andrew Schorr,Oncology Tube,Negative
 answer patients ‚Äô CLL questions,Patient Power,Negative
 Prognostic Markers,Lymphoma Papers,Negative
 Prognostic Markers,T√ºrkiye Klinikleri,Negative
 pals,Ciara üò∑ masking for a friend,Positive
 Drs Susan OBrien,The ASCO Post,Negative
 amp Stephan Stilgenbauer,The ASCO Post,Negative
 EarlyStage Treatment Options,The ASCO Post,Negative
 Current Role,The ASCO Post,Negative
 III Alliance,OncLive SOSS,Negative
 Precision Medicine Management,Lymphoma Papers,Negative
 Precision Medicine Management,Cancers MDPI,Negative
 regimens,OncLive.com,Negative
 regimens,Targeted Oncology,Negative
 concerns,CLLSA,Positive
 concerns,CLL Ireland,Negative
 concerns,CLL Warwick Uni,Negative
 UKCLL Forum,CLLSA,Negative
 amp advice,CLLSA,Negative
 New occurrence,Medivizor,Negative
 MRK Phase Phase,ClinicalTrialsData,Negative
 Preliminary Efficacy,ClinicalTrialsData,Negative
 Chronic Lymphocytic Leukemia Impacts Disease Outcome,Jerry Lee,Negative
 Chronic Lymphocytic Leukemia Impacts Disease Outcome,Cure Cancer Now,Positive
 Chronic Lymphocytic Leukemia Impacts Disease Outcome,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Impacts Disease Outcome,Richard Rosenquist Brandell,Positive
 Worldwide Opportunities Market Share Key Players,Nita Sonwane,Negative
 Early Look,CAR-TCR,Positive
 PreviouslyUntreated Chronic Lymphocytic,LLZ Consulting,Negative
 Lymphoplasmacytic Lymphoma,Paperbirds_Hematology,Negative
 Trisomy,Paperbirds_Hematology,Negative
 Lymphoid Population Deletion q,Paperbirds_Hematology,Negative
 Unstimulated Cell Culture,Paperbirds_Hematology,Negative
 novel combinations,OncLive.com,Negative
 novel combinations,COPD News,Negative
 novel combinations,Targeted Oncology,Positive
 Personalized CLL Care,jneed,Positive
 Patient Power,jneed,Positive
 Patient Power,Brave Is Now¬Æ,Negative
 Patient Power,Patient Power,Positive
 Patient Power,Michele Nadeem-Baker,Negative
 Patient Power,Teresa Bau,Positive
 Patient Power,Andrew Schorr,Negative
 fixeddose combination,OncLive.com,Negative
 fixeddose combination,COPD News,Negative
 New UK CLL Forum   guidance,CLL Advocates Network,Negative
 UK CLL experts,Michael Rynne,Negative
 consultant,Gear√≥id √ì Crotaigh #CareCantWait,Negative
 consultant,CLLSA,Negative
 consultant,Tha Dze,Positive
 New treatment combination,Roche,Negative
 Frontline Therapy,OncLive.com,Negative
 Frontline Therapy,COPD News,Negative
 Frontline Therapy,Paperbirds_Hematology,Negative
 Frontline Therapy,Robert Z. Orlowski,Negative
 Frontline Therapy,MD Anderson Leukemia,Negative
 Frontline Therapy,SciTech Research,Negative
 CostSavings Considerations,OncLive.com,Negative
 CostSavings Considerations,COPD News,Negative
 New UK CLL forum guidance,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 CLL Matthew S Davids MD MMSc,COPD News,Negative
 Frontline VenetoclaxObinutuzumab,COPD News,Negative
 Frontline VenetoclaxObinutuzumab,OncLive.com,Negative
 Medical Independent Sales Representatives,HSMN,Positive
 Medical Distributors,HSMN,Positive
 VENCLYXTOR Combination Regimen,HSMN,Negative
 Dual Regimen,PharmaShots - Incisive news in 3 shots,Negative
 European Commission EC,Anna Deveau,Negative
 European Commission EC,Solomon Kamal,Positive
 ABBV Receives European Commission Approval,Odi Bruckman,Negative
 ¬Æ Combination Regimen,Odi Bruckman,Negative
 EC Approval,Bio Stocks‚Ñ¢,Negative
 EC Approval,EMJ Hematology,Negative
 VENCLYXTO Combination Regimen,Bio Stocks‚Ñ¢,Negative
 PreviouslyUntreat,Crwe World,Negative
 Synchronous Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Paperbirds_Hematology,Negative
 Metastatic Squamous Cell Carcinoma,Paperbirds_Hematology,Negative
 Cervix,Paperbirds_Hematology,Negative
 Cervix,Lymphoma Papers,Negative
 Acute Myocardial Infarction,Paperbirds_Hematology,Negative
 Acute Myocardial Infarction,Lymphoma Papers,Negative
 Cdc,Paperbirds_Hematology,Negative
 Fmc Negativity,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Poor Prognostic,Paperbirds_Hematology,Negative
 Tracing CLLbiased,Paperbirds_Hematology,Negative
 immunoglobulin gene rearrangements,Paperbirds_Hematology,Negative
 Synchronous Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Metastatic Squamous Cell Carcinoma,Lymphoma Papers,Negative
 Mode,palliativewise,Negative
 Mode,Hematology Advisor,Negative
 Mode,"Raul Cordoba, MD, PhD",Positive
 Mode,Mahmoud Aljurf,Positive
 line treatment,palliativewise,Negative
 line treatment,"David Kahn, MD",Positive
 line treatment,Gear√≥id √ì Crotaigh #CareCantWait,Negative
 line treatment,"Raul Cordoba, MD, PhD",Positive
 line treatment,Mahmoud Aljurf,Negative
 line treatment,Zack Pemberton-Whiteley,Negative
 line treatment,Biotech 5,Positive
 Leukemias Chronic Lymphocytic Leukemia,VoiceAmericaHealthW,Positive
 Frontline Treatments,COPD News,Negative
 associate professor,COPD News,Negative
 CancerNetwork√Çabout,COPD News,Negative
   UK forum,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 notice,UK Chronic Lymphocytic Leukaemia (CLL) Forum,Negative
 Chronic Lymphocytic Leukemiaby Riccardo Moia Andrea Patriarca,Cancers MDPI,Negative
 lab measured oxygen consumption,RIOH,Negative
 treated   cells,RIOH,Negative
 mitochondria,RIOH,Negative
 TP SFB,Great Debates in Hematologic Malignancies,Negative
 TP SFB,"Lymphoma, Leukemia & Myeloma Congress",Positive
 El   ha contribuido al estudio,cnag-crg,Negative
 entre otras cosas mediante,cnag-crg,Negative
 secuenciaci√≥n,cnag-crg,Negative
 de tumores primarios de leucemia linf√°tica cr√≥nica,cnag-crg,Negative
 Chronic Lymphocytic   Staging,CONQUER the patient voice,Negative
 Triggers,CONQUER the patient voice,Negative
 Triggers,Cancer News,Negative
 ibrutinib checkpoint blockade,ClinOwl Haematology,Negative
 ibrutinib checkpoint blockade,Paperbirds_Hematology,Negative
 CD Tcell function,ClinOwl Haematology,Negative
 CD Tcell function,Paperbirds_Hematology,Negative
 CD Tcell function,Prof John,Negative
 buparlisib,Paperbirds_Hematology,Negative
 buparlisib,Lymphoma Papers,Negative
 IND,Lymphoma Papers,Negative
 Alexey Danilov,Martin JS Dyer,Positive
 Alexey Danilov,LYMPHOMA & MYELOMA CONNECT,Negative
 Good jobPhase b Study,Martin JS Dyer,Positive
   dancing fairy,GPII Eco,Positive
 RealWorld Frontline Treatment,Oncology,Negative
 Phase b Study,Cure Cancer Now,Negative
 Phase b Study,ClinicalTrialsData,Negative
 Phase b Study,NASDAQ,Positive
 Phase b Study,CLL Society Inc.,Negative
 Phase b Study,Financial Buzz,Negative
 Phase b Study,IntoxicatedTrader,Negative
 Phase b Study,PRN Biotech,Negative
 Phase b Study,Penny Stocks,Negative
 Phase b Study,Hot Trades,Positive
 Phase b Study,Daniel Able,Positive
 Phase b Study,Security Stocks,Positive
 Phase b Study,Ez2Trade,Positive
 Phase b Study,Penny Stock Irish,Negative
 Phase b Study,Stock Runners,Positive
 Phase b Study,satPRnews,Negative
 Cellfree IgGaggregates,COPD News,Negative
 plasma,COPD News,Negative
 Composite Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Cancer Papers,Negative
 Composite Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Paperbirds_Hematology,Negative
 Small Cell Variant Real Diagnostic Challenge Case Presentation,Cancer Papers,Negative
 Literature,Cancer Papers,Negative
 Literature,Paperbirds_Hematology,Negative
 Literature,Ilan Schwartz MD PhD,Positive
 Literature,Chan Cheah,Negative
 Literature,Lymphoma Papers,Negative
 Literature,Frontiers Oncology,Negative
 Cognitive function,#Memory,Positive
 patterns,Paperbirds_Hematology,Negative
 patterns,Hematopoiesis News,Negative
 patterns,Muiro Yatakama,Positive
 patterns,Washington Research Foundation & WRF Capital,Positive
 patterns,Dana-Farber News,Positive
 Small Cell,Paperbirds_Hematology,Negative
 Variant Real Diagnostic Challenge Case Presentation,Paperbirds_Hematology,Negative
 NEW Venetoclax,Medivizor,Negative
 Chronic Lymphocytic Leukemia gtuL,Official Kaplan Edupac Indonesia (HQ),Positive
 Chronic Lymphocytic Leukemia gtuL,Kaplan Medical,Positive
 JOIN,FLASCO,Positive
 JOIN,VIB,Positive
 INFORMATIVE NEW PROGRAM,FLASCO,Positive
 VIDEO Ibrutinib,VJHemOnc,Negative
 venetoclax upfront,VJHemOnc,Negative
 fractions,Blood Advances,Negative
 BCL inhibition,Prof John,Negative
 BCL inhibition,Blood Journal,Negative
 BCL inhibition,Paperbirds_Hematology,Negative
 BCL inhibition,Ayushi Chauhan,Positive
 CLL    Important New   Study,Prof John,Negative
 issues,CLL Ireland,Negative
 issues,CLL Advocates Network,Negative
 issues,CLLSA,Negative
 issues,Robin-RedBirdy,Positive
 issues,ESMO - Eur. Oncology,Negative
 Treatment Challenges,OncLive.com,Negative
   Majors Dodgers,Amy Ramos,Negative
 Claremont American Little League,Amy Ramos,Positive
 JOHN TERRY,BEARDED FRENCH MAN,Positive
 Krazyhorse,undead viking zombie,Positive
 Farmhouse,undead viking zombie,Positive
 especially   community,CLL Ireland,Negative
 Leading Cancer Research agency,CLL Ireland,Negative
 Wanna,sadaf fazeli,Positive
 Wanna,Toula Castillo,Positive
 cells ‚Äô morphology,sadaf fazeli,Positive
 interaction mechanism,Paperbirds_Hematology,Negative
 fludarabine human serum albumin,Paperbirds_Hematology,Negative
 Curcumin,Paperbirds_Hematology,Negative
 Curcumin,Turmeric,Positive
 Curcumin,CLL_Fightersüéó,Negative
 Curcumin,Cancer Papers,Negative
 New article Chromosomal,Paperbirds_Hematology,Negative
 PFFund,Tong,Positive
 YTD,Tong,Negative
 PFShare,Tong,Negative
 YTD CASH Sold Reduce,Tong,Negative
 Add,Tong,Negative
 Blood Multiple BCL mutations,Blood Journal,Negative
 GlyVal,Blood Journal,Negative
 GlyVal,"Raul Cordoba, MD, PhD",Positive
 Mitochondrial Apoptosis,Paperbirds_Hematology,Negative
 Treatment Resistance,Paperbirds_Hematology,Negative
 Treatment Resistance,Patient Power,Negative
 Explores interventions,Blood Journal,Negative
 sepsis,Blood Journal,Negative
 NETs,Blood Journal,Negative
 novel strategy,Blood Journal,Negative
 antigens,Blood Journal,Negative
 antigens,Lymphoma Hub,Negative
 travel partner,"Carrie Thompson, MD",Positive
 Saudi Arabia,"Carrie Thompson, MD",Positive
 Hematology Congress,"Carrie Thompson, MD",Positive
   Treatment Paradigm,OncLive.com,Negative
 Novel Combo Regimens,OncLive.com,Negative
   Multiple   mutations,"Raul Cordoba, MD, PhD",Positive
 CLL Treatment Paradigm,COPD News,Negative
 CLL Treatment Paradigm,MedShr,Positive
 Novel Combo Regimens Bruce G Raphael MD,COPD News,Negative
 Reception,NET The Ferns Primary Academy,Positive
 Reception,Oak Tree Primary School,Positive
 Reception,Richard Drewyor,Positive
 Reception,ASU Art,Positive
 Stories,NET The Ferns Primary Academy,Negative
 Stories,NEJM Journal Watch,Negative
 forest,NET The Ferns Primary Academy,Negative
 forest,Woodvale Primary Academy,Positive
 Join Drs Adrian Wiestner,NHLBI Bethesda Labs,Negative
 Chris Pleyer,NHLBI Bethesda Labs,Negative
 un Antiheroe un gusano por donde quiera que se le mire,Dario Antilen,Positive
 panneurofascin antibodies,Paperbirds_Hematology,Negative
 hematooncology market,AplusA World,Negative
 CLL Blood Test Result Anxiety,Brave Is Now¬Æ,Negative
 BioTechniques ‚Äô Editor,BioTechniques,Positive
 Chief,BioTechniques,Positive
 Chief,JTCancerCenter,Positive
 Karla Plevova,BioTechniques,Positive
 Karla Plevova,Biobanking.com,Positive
 Ron J Keller author,SIU Press,Negative
 Lincoln,SIU Press,Positive
 Illinois Legislature,SIU Press,Negative
 Concise Lincoln Library series,SIU Press,Negative
 SIU Press,SIU Press,Negative
 book,SIU Press,Positive
 book,Bishopton Primary School,Positive
 book,CLLSA,Positive
 book,Anna Deveau,Negative
 book,CLL_Fightersüéó,Negative
 book,Helen Jane Mee,Negative
 Texas,Oncology Learning Network,Negative
 Texas,EIN Presswire: Press Releases,Negative
 Texas,Art Fridrich,Positive
 Texas,Anthony J. Rivera,Positive
 Texas,Scott Werntz,Negative
 relapsedrefractory chronic lymphocytic   Listen,Oncology Learning Network,Negative
 TOMORROW March,Patient Power,Negative
 CLL Expert   minute,Patient Power,Negative
 QampA program Register,Patient Power,Negative
 ŸÖÿ≥ÿßÿ° ÿßŸÑÿÆŸäÿ± Ÿäÿß ÿ£ÿµÿØŸÇÿßÿ°,M y W a y I C U & E R,Positive
 nearly   million Americans,AstraZenecaUS,Negative
 loved,AstraZenecaUS,Negative
 loved,Patient Power,Negative
 loved,Esther Schorr,Negative
 illness,AstraZenecaUS,Negative
 illness,Andrew Schorr,Negative
 Mary,AstraZenecaUS,Negative
 support system,AstraZenecaUS,Negative
 Differential Expression Profile,CLL-seq,Negative
 miRb miRa,CLL-seq,Negative
 miR,CLL-seq,Negative
 miR,EurekaMag,Negative
 miR,Cancer Papers,Negative
 miR,microRNApapers,Negative
 miR,Lymphomation.org,Negative
 miR,ClinChemINFO,Positive
 Breast Cancer Patients,CLL-seq,Negative
 PhD student Rebecka Svanberg,Sigrid Sk√•nland,Negative
 Carsten Niemann group,Sigrid Sk√•nland,Negative
 Copenhagen,Sigrid Sk√•nland,Negative
 Copenhagen,Jonathan Pearce,Negative
 IL impact,NK papers,Negative
 IL impact,NK cell Biology,Negative
 NK cells activity Implication,NK papers,Negative
 NK cells activity Implication,NK cell Biology,Negative
 Contributes,Europe PMC articles,Positive
 Autophagy Regulation,Europe PMC articles,Positive
 Fri,Duke Hematologic Malignancies & Cellular Therapy,Negative
 Nashville TN,Patient Power,Positive
 Attend inperson,Patient Power,Positive
 Karinas birthday,Runway to Hope,Positive
 Karina,Runway to Hope,Positive
 comedy amp fashion amp,Runway to Hope,Positive
 model,Runway to Hope,Positive
 model,Hematology Advisor,Negative
 model,R Orentas,Positive
 model,"Raul Cordoba, MD, PhD",Negative
 model,POG Research,Positive
 ASH   Page   Update,Oncology Tube,Positive
 New Chronic Lymphocytic Leukemia Drugs ASH   Page   Update,Oncology Tube,Positive
 New Chronic Lymphocytic Leukemia Drugs,Oncology Tube,Positive
 New Chronic Lymphocytic Leukemia Drugs,GRACE,Negative
 ride,undead viking zombie,Positive
 Ace Cafe Iconic location,undead viking zombie,Positive
 Brighton,undead viking zombie,Positive
 potent   degrader,MedChemExpress,Negative
 technology,MedChemExpress,Negative
 technology,Wolverhampton LTT,Positive
 technology,Lymphoma Hub,Negative
 technology,Chris Thomson,Negative
 DC,MedChemExpress,Negative
 DC,"David Bartlett, PhD",Negative
 nM MT,MedChemExpress,Negative
 Fc ReceptorLike,Paperbirds_Hematology,Negative
 FCRL Discloses Progenitor B Cell Heterogeneity,Paperbirds_Hematology,Negative
 Independent Pathways,Paperbirds_Hematology,Negative
 Natural Antibody Selection,Paperbirds_Hematology,Negative
 melanoma,Paperbirds_Hematology,Negative
 melanoma,Children's Melanoma,Positive
 melanoma,SunAWARE,Positive
 melanoma,"Mike Thompson, MD, PhD, FASCO",Negative
 melanoma,palliativewise,Negative
 melanoma,CLL Ireland,Negative
 melanoma,Carlos De la Torre,Positive
 melanoma,Lymphoma Coalition,Negative
 melanoma,MelanomaResearchPapers,Positive
 melanoma,ImmunotherapyPapers,Negative
 melanoma,Gitte Pedersen,Negative
 realworld treatment patterns,Paperbirds_Hematology,Negative
 Michael,CLL Ireland,Positive
 Michael,Leukaemia Care,Negative
 Michael,LymphomaAction,Negative
 Michael,"Krishna Komanduri, MD, FASTCT",Positive
 tireless advocate,CLL Ireland,Negative
 tireless advocate,CLL Advocates Network,Negative
 amp advocates,CLL Ireland,Negative
 gene panels,Hematology Advisor,Negative
 Peripheral Blood,CLL Society Inc.,Negative
 Peripheral Blood,Anthony Mato,Negative
 Peripheral Blood,Scott Werntz,Negative
 Tribulations Clinical Trial Perspective,Joe Fournet,Negative
 Chronic Lymphocytic Leukemia Patient,Joe Fournet,Negative
 Chronic Lymphocytic Leukemia Patient,EurekaMag,Negative
 Chronic Lymphocytic Leukemia Patient,SeqComplete,Negative
 New Venetoclax,Medivizor,Negative
   Market      Fortune Business Insights,Nita Sonwane,Negative
 Market Size Growth Supply Chain Analysis,Nita Sonwane,Negative
 Recent Technological Developments,Nita Sonwane,Negative
 Novel Mutation Hotspots,Bibliosaude,Positive
 Novel Mutation Hotspots,CLL-seq,Negative
 Regulatory Regions,Bibliosaude,Positive
 Regulatory Regions,CLL-seq,Negative
 Chronic Lymphocytic Leukemia Genome,Bibliosaude,Positive
 Chronic Lymphocytic Leukemia Genome,CLL-seq,Negative
 ASH   Page   Maintenance Therapy,Oncology Tube,Positive
 Chronic Lymphocytic Leukemia ASH,Oncology Tube,Negative
 Page   Maintenance Therapy,Oncology Tube,Negative
 Indian,undead viking zombie,Positive
 nostalgia inspires,undead viking zombie,Positive
 DOCK protein,Paperbirds_Hematology,Negative
 exon isoforms,Paperbirds_Hematology,Negative
 DOCK,Paperbirds_Hematology,Negative
 DOCK,Blood Journal,Negative
 DOCK,Prof John,Negative
 DOCK,Cancer Papers,Negative
 Gareth Auckland,CLLSA,Negative
 Opening day,Amy Ramos,Negative
   patient education event,"Mazyar Shadman, MD MPH",Negative
   patient education event,Dr. Andy Evens,Negative
    diagnosis prognosis,"Jose Sandoval S, MD FACP",Positive
 Tx options,"Jose Sandoval S, MD FACP",Positive
 K,Shark Lexy,Positive
 K,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Positive
 K,Kimberly Bender,Positive
 K,Bill Both,Positive
 K,Jim Fowler,Positive
 stomach flu,Shark Lexy,Positive
 CD CAR Tcells,Oncology Learning Network,Negative
 venetoclax discontinuation,VJHemOnc,Negative
 ‚ö°,Lymphoma Hub,Negative
 compilation,Lymphoma Hub,Negative
 expert interviews,Lymphoma Hub,Negative
 RT EuropeanCancer RT ERNEuroBloodNet,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 February Newsletter,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Lymphoma Coalition Global Patient Survey,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Lymphoma Coalition Global Patient Survey,ERN EuroBloodNet,Positive
 Global Chronic Lymphocytic Leukemia Market Growth Trends,Stock Market News,Negative
   February Newsletter,ERN EuroBloodNet,Negative
 Frontline treatment,ClinOwl Haematology,Negative
 Frontline treatment,Cancer Papers,Positive
 obinutuzumab¬±chlorambucil,ClinOwl Haematology,Negative
 obinutuzumab¬±chlorambucil,Cancer Papers,Negative
   weeks,Michael Rynne,Negative
   weeks,LymphomaAction,Negative
   weeks,CLL Ireland,Negative
   weeks,Patient Power,Negative
 school cameras,NET The Ferns Primary Academy,Negative
 March   program,Phoebe Needles,Negative
 Voices,Phoebe Needles,Negative
 Faith,Phoebe Needles,Negative
 SHOUTOUT,Michele Nadeem-Baker,Negative
 SEX,Michele Nadeem-Baker,Negative
 CANCER,Michele Nadeem-Baker,Negative
 Authors,touchONCOLOGY,Negative
 Authors,Journal of Clinical Pathways,Negative
 Ian W Flinn Oncology amp Hematology Review,touchONCOLOGY,Negative
 freetoaccess article,touchONCOLOGY,Negative
 NonCoding,CLL-seq,Negative
 NonCoding,Paperbirds_Hematology,Negative
 Immunotherapy Approaches,CLL-seq,Negative
 Immunotherapy Approaches,Paperbirds_Hematology,Negative
 Immunotherapy Approaches,NACDA Program on Aging,Negative
 Bone Marrow Stromal Cells,Paperbirds_Hematology,Negative
 Key Hallmarks,Paperbirds_Hematology,Negative
 ISHBT ERIC tweets,Gaurav Prakash M.D.,Positive
 CLL workshop,Gaurav Prakash M.D.,Positive
 Chandigarh,Gaurav Prakash M.D.,Positive
 VigiBase,Insights @ VUMC,Positive
 BTK BCL inhibitors,OncLive.com,Negative
 New Milestones,OncLive.com,Negative
 CLL TreatmentInfection Model,Journal of Clinical Pathways,Negative
 Resilience,Brave Is Now¬Æ,Negative
 Relapse   Patient Power,Brave Is Now¬Æ,Negative
 CLL patient advocate Jay Blatt,Patient Power,Negative
 health,Patient Power,Positive
 health,MD Anderson Cancer Center,Negative
 health,CP DA DON,Positive
 health,WheelieDealer,Negative
 health,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 health,Helen Jane Mee,Positive
 health,Contracting Business,Positive
 health,Andrew Schorr,Negative
 ENCLEXTA,Alicia Bell IFBB Pro,Negative
 British Columbia,Alicia Bell IFBB Pro,Negative
 Rituximab Treatment,SC,Positive
 st Translational Research Conference,ESH (Haematology),Negative
 Chairs J Brown P Ghia M HallekDO,ESH (Haematology),Negative
 MISS,ESH (Haematology),Negative
 MISS,Med-IQ,Negative
 OPPORTUNITY ‚û° REGISTER,ESH (Haematology),Negative
   information,ESH (Haematology),Negative
 box,undead viking zombie,Positive
 box,Juan Luis Steegmann,Positive
 Unilateral Blurred Vision,"Brandon Lujan, MD",Positive
 Sole Presenting Symptom,"Brandon Lujan, MD",Positive
 Bruce Raphael MD,OncLive SOSS,Negative
   tonight,OncLive SOSS,Negative
   tonight,"Pat Euglow, Legacy Newbie",Negative
 podcast,Oncology Learning Network,Positive
 podcast,Glenn Sabin,Positive
 Diop,"Krizs√°n Szilvia, MD",Positive
 BIRC,"Krizs√°n Szilvia, MD",Positive
 BIRC,OGT,Negative
 BIRC,Toby Eyre,Negative
 New Combination Therapies,SpecialtyPTimes,Negative
 New Combination Therapies,Wellcome-home,Negative
 Chronic Lymphocytic Leukemia NonHodgkin Lymphoma,Oncology Tube,Positive
 HL patients,Oncology Tube,Positive
 Pharmacy Times,Wellcome-home,Negative
 Pharmacy Times,Brenda Feldman,Positive
 Pharmacy Times,Rare Diseases,Negative
 PH Balance,Ritesh Patil,Negative
 PH Balance,RK,Positive
 PH Balance,dorothy cook,Positive
 PH Balance,Jeff T Bowles,Positive
 PH Balance,Articlesly,Negative
 PH Balance,Review Your Life,Positive
 PH Balance,Survival-Hunters‚Ñ¢ üîµ,Positive
 PH Balance,Katia Zevelekakis,Positive
 PH Balance,Katia Davis,Positive
 PH Balance,Malakistan,Positive
 PH Balance,pinmania,Positive
 PH Balance,Oknaija,Positive
 PH Balance,Augustino Chengula,Positive
 PH Balance,cyberconic,Positive
 PH Balance,Pakalert Press,Positive
 PH Balance,Ayobami Seun,Positive
 PH Balance,Dominic Brewington,Positive
 PH Balance,Surviving Hub,Positive
 PH Balance,Danilo Menezes,Positive
 PH Balance,Maria Goreth,Positive
 PH Balance,News World,Positive
 PH Balance,supersurvivalguide,Positive
 PH Balance,Health News Center,Positive
 PH Balance,jt120651,Positive
 PH Balance,SysFlash,Positive
 theactivity,jorge  gonzalez,Negative
 order,jorge  gonzalez,Negative
 order,Beth Torr,Positive
 order,DAVA Oncology,Negative
 spread,jorge  gonzalez,Negative
 spread,California Partnership for Access to Treatment,Positive
 cancersVEGF,jorge  gonzalez,Negative
 Lipid Bicelle,Paperbirds_Hematology,Negative
 Chemical LiftOff Lithography,Paperbirds_Hematology,Negative
 EBMT,Paperbirds_Hematology,Negative
 EBMT,"Raul Cordoba, MD, PhD",Negative
 Handbook Hematopoietic Stem Cell Transplantation,Paperbirds_Hematology,Negative
 Cellular Therapies,Paperbirds_Hematology,Negative
 Cellular Therapies,MD Anderson Leukemia,Negative
 Hungry Caterpillar‚ÄôThis morning,Miss Nolan,Positive
   caterpillars,Miss Nolan,Positive
 play dough,Miss Nolan,Positive
 DISCO Application,TrialBulletin,Negative
 Financial Outcomes,TrialBulletin,Negative
 Hematologic Cancer Status,TrialBulletin,Negative
 Condition Summary Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia BCRABL Positive Plasma Cell Myeloma,TrialBulletin,Negative
 STAT,Archives of Medical Science (AMS),Positive
 STAT,Paperbirds_Hematology,Negative
 STAT,ImmunologyPapers,Negative
 STAT,Acetylome,Positive
 STAT,R Orentas,Positive
 STAT,Frontiers Immunology,Negative
 STAT,UVA Science Pubs,Positive
 STAT,Sigtrans,Positive
 STAT,Tracia.my.tupperware.com,Positive
 STAT,Cancer Papers,Negative
 STAT,Oncology Times,Negative
 STAT,Atlas of Science,Positive
 Achievement,"chadi nabhan MD, MBA, FACP",Negative
 BCL Inhibitor,Paperbirds_Hematology,Negative
 BCL Inhibitor,"khmerxbxboi ""Sot Ali"" (STOCKBUM-God) üá∫üá∏ üá∞üá≠",Positive
 BCL Inhibitor,Oncology Tube,Negative
 BCL Inhibitor,Hematopoiesis News,Negative
 BCL Inhibitor,Financial Buzz,Positive
 BCL Inhibitor,PRN Biotech,Negative
 Chemotherapeutic Agents,Paperbirds_Hematology,Negative
 WildType ABCGOverexpressionMediated MDR Cancer Cells,Paperbirds_Hematology,Negative
 CLL Trial Outcomes Lori Leslie MD HematologistOncologist Lymphoma Department John Theurer Cancer Center Hackensack Meridian Health shares details,Oncology Tube,Positive
 Miami Leukemia Symposium,Taylor Lab UM,Negative
 Sex,Michele Nadeem-Baker,Negative
 CLL Data Trial,Oncology Tube,Positive
 Chronic Lymphocytic Leukemia Paul M Barr MD Associate Professor,Oncology Tube,Negative
 Wilmot Cancer Institute,Oncology Tube,Positive
 Wilmot Cancer Institute,Casey Foster,Positive
 Chronic Lymphocytic Leukemia Risks,Brave Is Now¬Æ,Negative
 New article Generation,Paperbirds_Hematology,Negative
 Antibody,Paperbirds_Hematology,Negative
 Antibody,"Raul Cordoba, MD, PhD",Negative
 Antibody,New OhioLINK ETDs,Positive
 Antibody,MDedge Hematology & Oncology,Positive
 Canine CD,Paperbirds_Hematology,Negative
 Diagnostic Future Therapeutic Purposes,Paperbirds_Hematology,Negative
 Treatment Tips,MDedge Hematology & Oncology,Negative
 Treatment Tips,MDEdge,Negative
 course,MDedge Hematology & Oncology,Negative
 course,MDEdge,Negative
 course,Patient Power,Positive
 course,Brotman Baty,Positive
 course,CLL Ireland,Negative
 course,Jon,Negative
 course,CLL Warwick Uni,Negative
 course,Patient Empowerment Network,Negative
 course,Lifelong Learning,Positive
 effect profile,MDedge Hematology & Oncology,Negative
 effect profile,MDEdge,Negative
 pouring rain,undead viking zombie,Positive
 east wittering,undead viking zombie,Positive
 suppressor cells,Lymphoma Papers,Negative
 suppressor cells,Cancer Papers,Negative
 suppressor cells,Paperbirds_Hematology,Negative
 suppressor cells,Renal Cell Carcinoma,Negative
   Hemato Oncology Key Points,AplusA World,Positive
 fastmoving market,AplusA World,Positive
 Foto cortes√≠a de troublephotos,Lenko Sins,Positive
 Important Role,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukaemia Biology,Paperbirds_Hematology,Negative
 ceremony,Jeffrey Miller,Positive
 ceremony,Joey Snella,Positive
 Clinical Trial Combination Therapies,Brave Is Now¬Æ,Negative
 Background,Wellcome-home,Negative
 Background,BJD,Positive
 derth,Adam Kittai,Negative
 Previously Treated HighRisk Chronic Lymphocytic Leukemia CLL,ClinicalTrialsData,Positive
 MEMBER,Prof John,Negative
 targeted novel therapies,Benlazar S.M Amin√©,Negative
 SMUDGE CELLS,Baby MLSüë∂üëº,Positive
 WBCs Smudge cells,Baby MLSüë∂üëº,Positive
 frei f√ºr,Christoph Habel,Positive
 Potential Milestone,Michele Nadeem-Baker,Negative
 IND application,Michele Nadeem-Baker,Negative
 IND application,Beacon Targeted Therapies,Positive
 IND application,Future Med Chem Jnl,Positive
 Safer CAR,Michele Nadeem-Baker,Negative
 NK cells,Michele Nadeem-Baker,Negative
 NK cells,Dr Tony Truong,Positive
 NK cells,NK cell Biology,Negative
 NK cells,NK papers,Negative
 NK cells,TumorImmunoPapers,Negative
 colon,Blood Journal,Negative
 ABNORMAL LYMPHOID CELLSPeripheral blood smear,ÿπŸÑŸä ÿπÿ®ÿØÿßŸÑŸÑŸá ÿßŸÑÿÆŸÑŸäŸÅÿ©,Positive
 Man w Chronic Lymphocytic Leukemia,Shouting at people in my underpants,Negative
 Patients CD CAR NKcell therapy,Patient Empowerment Network,Negative
 response rate,Patient Empowerment Network,Negative
 response rate,Fred Hutch,Negative
 CLL CNV analysis,OGT,Negative
 NGS panel,OGT,Positive
 NGS panel,CAP TODAY MAGAZINE,Positive
 capability,OGT,Negative
 SureSeq ‚Ñ¢ CLL   CNV panel,OGT,Negative
 CNVs,OGT,Negative
 CLL samples,OGT,Negative
 Latest   collaboration RR   ptsOutcomes,Toby Eyre,Negative
 Systemic LargeVessel Vasculitis,Paperbirds_Hematology,Negative
 Long Term Followup Data,Paperbirds_Hematology,Negative
 HealthRelated Quality,Paperbirds_Hematology,Negative
 Fit Patients,Paperbirds_Hematology,Negative
 Fit Patients,Christopher Steer,Negative
 Fit Patients,Dr. Melody Davis,Negative
 BR CLL Trial,Paperbirds_Hematology,Negative
 GCLLSG,Paperbirds_Hematology,Negative
 GCLLSG,"Eric K. Singhi, MD",Positive
 GCLLSG,VJHemOnc,Positive
 UT MD Anderson Cancer Center,"Comprehensive Cell Solutions,New York Blood Center",Positive
 frontline relapsedrefractory settings,OncLive.com,Negative
 Tweeps,Jordan Gauthier,Positive
 poster todayPoster,Jordan Gauthier,Positive
 Relapsed Refractory Disease,Jordan Gauthier,Positive
 CDSpecific   therapy,Jordan Gauthier,Positive
 Fantastic   Tweetorial,"Daniela Hermelin, MD",Positive
 albumin smears,"Daniela Hermelin, MD",Positive
 Andrew,Patient Power,Positive
 Esther Schorr,Patient Power,Positive
 trip,Patient Power,Negative
 trip,Melin Gruffydd,Negative
 Vietnam,Patient Power,Negative
 Implementation,Anal Bioanal Chem,Positive
 classification strategy,Anal Bioanal Chem,Positive
   Jennifer Specht,Lymphoma Hub,Negative
 ROR targeted CAR Tcell therapy,Lymphoma Hub,Negative
 cancer treatment information,Paperbirds_Hematology,Negative
 Medicare hospital discharge data,Paperbirds_Hematology,Negative
 women,Paperbirds_Hematology,Negative
 women,"Pharmacyclics, an AbbVie Company",Negative
 women,JanssenUS,Negative
 Los Angeles County casecontrol study,Paperbirds_Hematology,Negative
 Kite Pharma,"Comprehensive Cell Solutions,New York Blood Center",Positive
 Therapy KTEX,"Comprehensive Cell Solutions,New York Blood Center",Positive
 Priority Review designation,"Comprehensive Cell Solutions,New York Blood Center",Positive
 student,Bryjalab,Positive
 M√≠≈°a,Bryjalab,Positive
 ≈Ωiva,Bryjalab,Positive
 potentially practicechanging BTK inhibitor combinations,OncLive.com,Negative
 Expert Highlights Evolution,OncLive.com,Negative
 Finite treatment duration,AbbVie US,Positive
 Candidates,Brave Is Now¬Æ,Negative
 Allogeneic Hematopoietic Cell Transplant,Brave Is Now¬Æ,Negative
 LifeChanging CLL Diagnosis Finding Balance,Brave Is Now¬Æ,Negative
 Chronic Cancer,Brave Is Now¬Æ,Negative
 Ofatumumab Prolong Survival,Brave Is Now¬Æ,Negative
 Survival Trends,Brave Is Now¬Æ,Negative
 Netherlands,Brave Is Now¬Æ,Negative
 Netherlands,Hematology Advisor,Negative
 Machine Learning Identifies Newly Diagnosed CLL Patients,Brave Is Now¬Æ,Negative
 Machine Learning Identifies Newly Diagnosed CLL Patients,AI News Feed,Positive
 Certain Outcomes,Brave Is Now¬Æ,Negative
 Certain Outcomes,AI News Feed,Positive
 Venetoclax Obinutuzumab Benefit CLL Patients,Brave Is Now¬Æ,Negative
 Venetoclax Obinutuzumab Benefit CLL Patients,Jenn,Positive
 Â§ßÊûó„Äå„Å∏„Éº„ÄÅBÁ¥∞ËÉû„Åå‰ΩïÊïÖ„ÅÑ„Çã„ÅÆ„ÅãÊ∞ó„Å´„Å™„Çã„Å™„ÅÅ,Êé®„ÅóÁ¥∞ËÉû„ÅåÂ∞ä„ÅÑ,Positive
 Decreased Survival,Dr Shibley,Positive
 Malignant Melanoma,Dr Shibley,Positive
 Merkel Cell Carcinoma,Dr Shibley,Positive
 Merkel Cell Carcinoma,Paperbirds_Hematology,Negative
 SEER PopulationBased Study,Dr Shibley,Positive
 Immunoregulatory Effects,Pharma Jonpi .,Negative
 Lurbinectedin,Pharma Jonpi .,Negative
 BTK inhib¬≠itors,Targeted Oncology,Negative
 Delayed Treatment,Lung Cancer News,Negative
 Experimental CAR NKCell Therapy,Patient Worthy,Negative
 NonHodgkin Lymphona,Patient Worthy,Negative
 Controle,Jolanda,Positive
 het,Jolanda,Positive
 het,Jacquelien (wat een toestand moidje),Negative
 Annu Rev Pathol Genomic,IUOPA,Negative
 Epigenomic Alterations,IUOPA,Negative
 Differential Diagnosis,EurekaMag,Negative
 Differential Diagnosis,Maniriho Etienne,Positive
 Differential Diagnosis,JournalAgent,Positive
 Noon,Prof John,Negative
 Noon,MD Anderson Leukemia,Negative
 Noon,Lisa Palacios,Negative
 PT    GMT,Prof John,Negative
 guys,undead viking zombie,Positive
 guys,Harry Fuentes MD MSc,Positive
 guys,CLL_Fightersüéó,Negative
 TimeLimited Treatments,OncLive.com,Negative
 Interleukin,Paperbirds_Hematology,Negative
 Interleukin,Biocomputing,Positive
 Interleukin,Just Science News,Positive
 Interleukin,Krishan Maggon,Negative
 Interleukin,New OhioLINK ETDs,Positive
 kinase,Paperbirds_Hematology,Negative
 tolllike receptor,Paperbirds_Hematology,Negative
 onchip fluorescence imaging,Paperbirds_Hematology,Negative
 Redhill Local Councillors,Wellcome-home,Positive
 Good News,Wellcome-home,Negative
 Cardiac Myxoma,Lymphoma Papers,Negative
 Cardiac Myxoma,Paperbirds_Hematology,Negative
 Cerebral Metastases,Lymphoma Papers,Negative
 Cerebral Metastases,Paperbirds_Hematology,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Case Report,Lymphoma Papers,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Case Report,Paperbirds_Hematology,Negative
 Allogeneic Haploidentical Blood,Xavier Tello,Positive
 Allogeneic Haploidentical Blood,COPD News,Negative
 Allogeneic Haploidentical Blood,ALI ALAHMARI.,Negative
 PostTransplantation Cyclophosphamide,Xavier Tello,Positive
 Chronic Lymphocytic LeukemiaMi amigo el Dr Javier Bola√±os,Xavier Tello,Positive
 hemat√≥logo mexicano,Xavier Tello,Positive
 de   es,Xavier Tello,Positive
 coautor,Xavier Tello,Positive
 depth,Adam Kittai,Negative
 depth,VJHemOnc,Negative
 w PFS,Adam Kittai,Negative
 Un reciente estudio sobre pacientes,TenS Holanda,Positive
 con leucemia linfoc√≠tica cr√≥nica üß¨,TenS Holanda,Positive
 Pa√≠ses Bajos,TenS Holanda,Positive
 ha confirmado que,TenS Holanda,Positive
 personas con esta,TenS Holanda,Positive
 enfermedad se,TenS Holanda,Positive
 ha visto,TenS Holanda,Positive
   cool analysis,"Dr. Paul DeSantis, PharmD",Negative
 Bone Marrow samples,"Dr. Paul DeSantis, PharmD",Negative
 PRspoiler alert PRs,"Dr. Paul DeSantis, PharmD",Negative
   landscape,Toby Eyre,Negative
   landscape,VJHemOnc,Negative
 Lenalidomide dexamethasone,Toby Eyre,Negative
 alemtuzumab,Toby Eyre,Negative
 alemtuzumab,CancerTherapyAdvisor,Negative
 alemtuzumab,TumorImmunoPapers,Positive
 alemtuzumab,NK papers,Negative
 alemtuzumab,Biothera Pharma,Positive
 Expression,Mustafa F,Positive
 Expression,Research Watch,Positive
 Expression,Wnt publications,Negative
 Expression,Autophagy Papers,Positive
 Expression,TumorImmunoPapers,Positive
 Expression,ImmunologyPapers,Positive
 Expression,Biocomputing,Positive
 Expression,SexGenomics,Positive
 Expression,Just Science News,Positive
 Expression,Krishan Maggon,Negative
 Expression,Scott Werntz,Negative
 Expression,Moreaux J√©r√¥me,Positive
 TigitCDCD ReceptorsLigand System,Mustafa F,Positive
 CARNK Cell Therapy,OncLive.com,Negative
 CARNK Cell Therapy,Robert Z. Orlowski,Negative
 CARNK Cell Therapy,MD Anderson Leukemia,Negative
 Dr Brian Hill Dr Matthew Davids,Patient Power,Negative
 nearly,John,Negative
 Spreadex account,John,Negative
 Calibr,Beacon Targeted Therapies,Positive
 CLBR   SWI,Beacon Targeted Therapies,Positive
 position,John,Positive
 position,MB Top Employers,Positive
 Paula Soler,Marcius Lab,Positive
 languages,ERN EuroBloodNet,Negative
 patients associations,ERN EuroBloodNet,Negative
 advocates,ERN EuroBloodNet,Negative
 advocates,Patient Power,Negative
 advocates,CLL Advocates Network,Negative
 advocates,CURE Magazine,Negative
 advocates,Nick,Negative
 advocates,Zack Pemberton-Whiteley,Positive
 Bien que,@AplusA_France,Positive
 les efforts,@AplusA_France,Positive
 Apprenezen,@AplusA_France,Positive
 dans notre article,@AplusA_France,Positive
 Dr Rachel Thilssen,Mohamed I. Saad,Positive
 tumour heterogeneity,Mohamed I. Saad,Positive
 Dr Charles Berry,MD Anderson Cancer Center,Positive
 Way,"Gretchen A. McNally PhD, ANP-BC, AOCNP",Positive
 Way,Funky Sunshine,Positive
 Way,Glen de Vries,Positive
 Way,Giacomo Mancini,Positive
 Dr Woyach Dr Rogers,"Gretchen A. McNally PhD, ANP-BC, AOCNP",Positive
 Dr Bhatt,"Gretchen A. McNally PhD, ANP-BC, AOCNP",Positive
 demo,FlappyCrypto,Positive
 demo,AEGLE,Negative
 Google Play,FlappyCrypto,Positive
 app stores,FlappyCrypto,Positive
 beach,undead viking zombie,Positive
 immunogenicity,Paperbirds_Hematology,Negative
 relation,Paperbirds_Hematology,Negative
 relation,Benlazar S.M Amin√©,Negative
 relation,Lymphoma Hub,Negative
 TESTLEUKEMIA DIAGNOSTIC PANEL,Dr Lalpath Lab Crossings Republik,Positive
 Address Shop,Dr Lalpath Lab Crossings Republik,Positive
 FF Paramount Spectrum Market Crossings Republik Ghaziabad,Dr Lalpath Lab Crossings Republik,Positive
 Drs Woyach Rogers,Adam Kittai,Negative
 Bhat,Adam Kittai,Negative
 unt,Medivizor,Negative
 Produces,TrialSite News,Negative
 Patient carer survey,CLL Ireland,Negative
 James Dean MD Sr Medical Director,CheckRare,Negative
 Pharmacyclics Inc,CheckRare,Negative
 Pharmacyclics Inc,Scott Werntz,Negative
 Changing lives,CrozrX,Positive
 Chronic Lymphoid   patients,CEITEC Connect,Negative
   leading CLL experts,Michele Nadeem-Baker,Negative
 Research amp Updates,Michele Nadeem-Baker,Negative
 Offer,Michele Nadeem-Baker,Negative
 untr,Medivizor,Negative
 licence,LymphomaAction,Negative
 Bcell lymphomas,LymphomaAction,Negative
 Bcell lymphomas,European Association for Haematopathology,Positive
 Bcell lymphomas,histopathology üî¨,Positive
 Bcell lymphomas,Lymphoma Papers,Negative
 amp adults,LymphomaAction,Negative
 Genetic Molecular Basis,Paperbirds_Hematology,Negative
 Canine Models,Paperbirds_Hematology,Negative
 Human Leukemia,Paperbirds_Hematology,Negative
 Canadianled research team,Gift from a Child,Positive
 discovery,Gift from a Child,Positive
 discovery,Michie Lab,Negative
 discovery,Sigrid Sk√•nland,Negative
 discovery,JanssenUS,Negative
 discovery,Ardalan Ahmad,Negative
 discovery,VJHemOnc,Negative
 Integrative analysis,Blood Journal,Negative
 Integrative analysis,Prof John,Negative
 ICYMI Addition,"Amber Koehler, PA-C",Negative
    months ago yesterday TGTX Announces Completion,Biotech2050,Negative
 Target Enrollment,Biotech2050,Negative
 Target Enrollment,MAISA,Negative
 Target Enrollment,"Bruce Rogers, Ph.D.",Positive
 Target Enrollment,Jason Ford,Positive
 Target Enrollment,Mike McFarlane,Positive
 Target Enrollment,Matt Miller,Positive
 UNITYCLL Phase   Trial U,Biotech2050,Negative
 Gavyza   Chlorambucil,Biotech2050,Negative
 RR   months,Biotech2050,Negative
 tumour lysis syndrome,The Lancet Haematology,Negative
 Ongoing Alliance Trial,OncLive.com,Negative
   PT,Club Deportivo Moto Kart Jovita,Positive
 GOOOOOOOOOOOOOOLAle Caligaris anota el segundo para el,Club Deportivo Moto Kart Jovita,Negative
 GOOOOOOOOOOOOOOLJoni Casalis,Club Deportivo Moto Kart Jovita,Negative
 ventaja,Club Deportivo Moto Kart Jovita,Negative
 Prognostic Testing,Lymphoma Papers,Negative
 Prognostic Testing,Paperbirds_Hematology,Negative
 Treatment Patterns,Lymphoma Papers,Negative
 Treatment Patterns,Paperbirds_Hematology,Negative
 Treatment Patterns,"Raul Cordoba, MD, PhD",Negative
 informCLL Registry,Lymphoma Papers,Negative
 informCLL Registry,Paperbirds_Hematology,Negative
 Lew et al,Toby Eyre,Negative
 MRD analysis,Toby Eyre,Negative
 Cumplimos el primer objetivo tenemos,Fran!,Negative
 Urdinarrain,Fran!,Positive
 Urdinarrain,Lucas ‚ôö,Positive
 Neil Kay,Rafael Fonseca MD,Positive
 Mayo Clinic,Rafael Fonseca MD,Positive
 Mayo Clinic,Lifewaysvillage.com/lifestyle,Positive
 Mayo Clinic,Andrew Taylor,Positive
 Mayo Clinic,APSHO,Negative
 Mayo Clinic,Rowing HQ,Positive
 Mayo Clinic,Sameer Parikh,Negative
 Rochester,Rafael Fonseca MD,Positive
 Early Findings Promise,Renal Cell Carcinoma,Negative
 CAR NKCell Therapy,Renal Cell Carcinoma,Negative
 Leukemia Lymphoma Patients,Renal Cell Carcinoma,Negative
 Uitstekende,Yvonne van Batenburg,Positive
 bijeenkomst,Yvonne van Batenburg,Positive
 door,Yvonne van Batenburg,Positive
 door,CLLSA,Negative
 samenwerking,Yvonne van Batenburg,Positive
 humorvolle tips voor,Yvonne van Batenburg,Positive
 de pati√´nt door,Yvonne van Batenburg,Positive
 Bart van Echteld,Yvonne van Batenburg,Positive
 moderates,ColumbiaCancer,Positive
 peer exchange discussion,ColumbiaCancer,Positive
 polyneuropathy,Paperbirds_Hematology,Negative
   Lymphoma Coalition Global Patient Survey,Natacha Bola√±os,Negative
 ChemotherapyFree Treatment,Patient Worthy,Negative
 PTCE,PharmacyTimesCE,Positive
 Live Symposia,PharmacyTimesCE,Positive
 HOPAs,PharmacyTimesCE,Positive
 Survival trends,Hematology Advisor,Negative
 Drs Matthew Davids,CARE‚Ñ¢ Education,Negative
 Graeme Fraser,CARE‚Ñ¢ Education,Negative
   Lymphoma Coalition   Global Patient Survey,Lorna Warwick,Positive
 Lymphomas amp CLL,Lorna Warwick,Positive
 ACCC,Adam Kittai,Negative
 ACCC,ACCC,Positive
 QI program,Adam Kittai,Negative
 Prognostic Value,Paperbirds_Hematology,Positive
 Prognostic Value,Benlazar S.M Amin√©,Negative
 MiR,Paperbirds_Hematology,Negative
 MiR,microRNApapers,Negative
 MiR,Cancer Papers,Negative
     Exciting results,Prof John,Negative
 antiCD chimeric antigen receptors,Prof John,Negative
 elements,CLL Epigenetics,Negative
 ACCC Quality Improvement Workshops Address,CLL Society Inc.,Negative
 Need,CLL Society Inc.,Negative
 Need,"Raul Cordoba, MD, PhD",Positive
 Need,Oncology Board,Negative
 Need,Oncology Tube,Negative
 Need,WEGO Health,Negative
 Need,Senior Care Corner,Negative
 Improved Chronic Lymphocytic Leukemia Care,CLL Society Inc.,Negative
 CD CARNK cells,Raj Chakraborty,Positive
 ‚û° Ô∏è ùê®ùêÆùê≠,Raj Chakraborty,Positive
 ùê®ùêü,Raj Chakraborty,Positive
 ùêÇùê®ùê¶ùê©ùê•ùêûùê≠ùêû ùêëùêûùê¨ùê©ùê®ùêßùê¨ùêû,Raj Chakraborty,Positive
 ùêçùê® ùêÜùêØùêáùêÉùêçùê® ùêÇùêëùêíùêçùê® ùêçùêûùêÆùê´ùê®ùê≠ùê®ùê±,Raj Chakraborty,Positive
 Machine learning,CancerTherapyAdvisor,Negative
 charge,John,Negative
 charge,CEC Oncology,Positive
 MMPs,Flow Paradigm,Negative
 CLL migration,Flow Paradigm,Negative
 disease process,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 increase,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 increase,"Pamela Schlembach,MD",Negative
 increase,Dr. Melody Davis,Negative
 miR levels,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
   debate,Malgorzata Osmola,Positive
   debate,CLLSA,Positive
 Venetoclax discontinuation,Benlazar S.M Amin√©,Negative
 hsa‚ÄêmiR‚Äê‚Äêp ‚Äêa‚Äêp ‚Äê‚Äêp ‚Äê‚Äêp,Biblioteca EASP,Positive
 ‚Äê‚Äêp,Biblioteca EASP,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Version,Paperbirds_Hematology,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Version,Talbot Research Library & Media Services,Positive
 NCCN Clinical Practice Guidelines,Paperbirds_Hematology,Negative
 Veneto,Benlazar S.M Amin√©,Negative
 HME,Benlazar S.M Amin√©,Negative
 HME debates,Benlazar S.M Amin√©,Negative
 Acess Intelligence,Proactive,Negative
 Pulsar deal,Proactive,Negative
     Cello Health PLC Settlement,AIM Alerts!,Negative
 Access Intelligence,AIM Alerts!,Negative
 concentrations,For health-promoting environments,Positive
 toxins,For health-promoting environments,Positive
 News Study,HemOnc Today,Negative
 expanding role,Paperbirds_Hematology,Negative
 expanding role,VJHemOnc,Negative
 expanding role,"Chaitra Ujjani, MD",Positive
 Trametinib,Paperbirds_Hematology,Negative
 Dabrafenib,Paperbirds_Hematology,Negative
 grandson,Beebe Healthcare,Positive
 James Beebe,Beebe Healthcare,Positive
 Ralph Williams,Beebe Healthcare,Positive
 family legacy,Beebe Healthcare,Positive
 ‚Å¶‚Å© speaking tonight ‚Å¶‚Å© event,Anthony Mato,Negative
 Topic,Anthony Mato,Negative
 Venetoclax treatment strategies,Anthony Mato,Negative
 superb day,John,Negative
 transcriptomebased treatment monitoring technique,BlueBee,Negative
 firstin human phase b doseescalation study,Beacon Targeted Therapies,Positive
 JBH,Beacon Targeted Therapies,Positive
 explosion,OncLive.com,Negative
 explosion,EMJ Hematology,Positive
 explosion,EMJ Rheumatology,Positive
 Cancer Clinical Trials,Michele Nadeem-Baker,Negative
 Roundup Options Legal Center,EIN Presswire: Press Releases,Negative
 Alabama,EIN Presswire: Press Releases,Negative
 Users,EIN Presswire: Press Releases,Negative
 Users,Kenneth M. Garofalo,Positive
 Users,CryptoLiveLeak,Negative
 Roundup Diagnosed,EIN Presswire: Press Releases,Negative
 Attorneys,EIN Presswire: Press Releases,Positive
 Steinberg Law Group,EIN Presswire: Press Releases,Positive
 Glyphosate,Matthews & Associates,Positive
 includingNonHodgkin,Matthews & Associates,Negative
 LymphomaLarge Diffuse BcellFollicullar LymphomaCutaneous TCellAnapalastic TcellChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma,Matthews & Associates,Negative
 Hundreds,Matthews & Associates,Positive
 Roundup,Matthews & Associates,Positive
 Roundup,Eyemagistus ‚úçüèº,Positive
 de fact standard,AJMC,Negative
 reception children,Bishopton Primary School,Positive
 emperor penguins,Bishopton Primary School,Positive
 glioblastoma brain cancer husband,Kerry,Negative
 Super reading stay,Orchard Primary Academy Nursery,Negative
 Blossom class,Orchard Primary Academy Nursery,Positive
 Breakthroughs,Local 12/WKRC-TV,Positive
 world cancer day,CLL Ireland,Negative
 CLL Support,CLLSA,Negative
 education support,CLLSA,Negative
 February               Cancer,K√∂nigin Connie Zuckerberg von der Schweiz *QUEENIE,Positive
 Novel Agents Approaches,OncLive.com,Negative
 Paradigm,OncLive.com,Positive
 drug development arm,Scripps Research,Positive
 Scripps Research,Scripps Research,Positive
 patient trials,Scripps Research,Positive
 Colds Flu VirusesWash,Michele Nadeem-Baker,Negative
 hands,Michele Nadeem-Baker,Negative
 hands,donnashort,Negative
 hands,Sanne v‚≠ïn Wüíâssen,Positive
 Ô∏è levels,Lymphoma Hub,Negative
 SingleCell Analysis,Clinical OMICs,Positive
 value analysis,"Jeremy Lorber, M.D.",Positive
 venobinutuzmab v ibrutinib Ibrutinib,"Jeremy Lorber, M.D.",Positive
 survival data,"Jeremy Lorber, M.D.",Positive
   Das,AbbVie Deutschland,Negative
 Teil der Erbinformation den nur M√§nner haben Von einer,AbbVie Deutschland,Negative
 chronischen lymphatischen,AbbVie Deutschland,Positive
 chronischen lymphatischen,Deutsches √Ñrzteblatt,Positive
 chronischen lymphatischen,Krebsgesellschaft,Positive
   reduction,OncLive.com,Negative
 patient population,OncLive.com,Negative
 patient population,ipharmacenter,Negative
 trade,AtoZ Drugs Bangladesh.,Positive
 CLL IPI,Deepesh Lad,Positive
 CLL IPI,"Mike Thompson, MD, PhD, FASCO",Negative
 Premedication,Medivizor,Negative
 methylprednisolone,Medivizor,Positive
 methylprednisolone,Lymphoma Hub,Negative
 CLL diagnosis,Patient Power,Negative
 Free FixedDuration Treatment,1stOncology,Negative
 Previous Treatment ABBV,1stOncology,Negative
 PIKAKT pathway,Pastel BioScience,Positive
 PIKAKT pathway,Richard Rosenquist Brandell,Positive
 druggable target,Pastel BioScience,Positive
 druggable target,ASH,Negative
 druggable target,"Raul Cordoba, MD, PhD",Negative
 druggable target,Blood Journal,Negative
 Risk stratification,Faheema Hasan,Positive
 Committee,OncLive.com,Negative
 Committee,Targeted Oncology,Negative
 Medicinal Products,OncLive.com,Negative
 Medicinal Products,Targeted Oncology,Negative
 Human Use,OncLive.com,Negative
 Human Use,Targeted Oncology,Negative
 Kollegerna,Majlen Saarinen,Positive
 har producerat denna inspirerande film fr√•n,Majlen Saarinen,Positive
 √•boakademi √§rande,Majlen Saarinen,Positive
 EU Panel,OncLive.com,Negative
 Lectures,Saudi Blood (SSBD) ÿ£ŸÖÿ±ÿßÿ∂ ÿßŸÑÿØŸÖ,Negative
 Brazil,Phillip Scheinberg,Positive
 Brazil,LiveTracker¬Æ,Positive
 section chief,Adam Kittai,Negative
 Grand Rounds Resistance,Adam Kittai,Negative
 Irritative Lower Urinary Tract Symptoms,JELEU,Positive
 Nonvisible Hematuria,JELEU,Positive
 manifestation,Professione Oculista,Positive
 leader primers,Paperbirds_Hematology,Negative
 Chromatin mapping,Paperbirds_Hematology,Negative
 Chromatin mapping,Arash Davari Serej,Positive
 Chromatin mapping,Fabrice Leclerc,Negative
 Chromatin mapping,Mickp,Positive
 Chromatin mapping,bioRxiv,Positive
   Nicht alle,AbbVie Deutschland,Negative
 Leuk√§mien,AbbVie Deutschland,Negative
 aggressiv voran,AbbVie Deutschland,Negative
 Patienten,AbbVie Deutschland,Negative
 Patienten,Pharma Fakten,Positive
 werden nie oder,AbbVie Deutschland,Negative
 Japan Snodgrass Bequest panel,Michie Lab,Negative
 NFŒ∫BpNRF survival,Lymphoma Papers,Negative
 Chronic Lymphocytic Leukemia CLL Changes,Matt Feyen,Positive
 IJMS,Krishan Maggon,Positive
 IJMS,gilbert c faure,Negative
 Engaging Cytotoxic T,Krishan Maggon,Positive
 Engaging Cytotoxic T,Paperbirds_Hematology,Negative
 Engaging Cytotoxic T,gilbert c faure,Negative
 NK Cells,Krishan Maggon,Positive
 NK Cells,Lymphoma Papers,Negative
 NK Cells,Paperbirds_Hematology,Negative
 NK Cells,gilbert c faure,Negative
 NK Cells,Benlazar S.M Amin√©,Negative
 NK Cells,NK papers,Negative
 NK Cells,COPD News,Negative
 NK Cells,Anna Deveau,Negative
 cancer diagnosis,Patient Power,Negative
 cancer diagnosis,CLL Society Inc.,Negative
 cancer diagnosis,Nick,Negative
 st Translational Research Conference Chronic Lymphocytic,ESH (Haematology),Negative
 LeukaemiaDON‚ÄôT,ESH (Haematology),Negative
 FORGET,ESH (Haematology),Negative
 J Brown P Ghia M Hallek   Paris France ‚û°,ESH (Haematology),Negative
 Final ChanceGroundbreaking Updates,OncLive.com,Negative
 Visual Dermatology Regression,Paperbirds_Hematology,Negative
 Atypical Cutaneous Infiltration,Paperbirds_Hematology,Negative
 physicians choice,Paperbirds_Hematology,Negative
 Modified CLL International Prognostic Index CLLLIPI,Paperbirds_Hematology,Negative
 NEW viewpoint,The Lancet Haematology,Negative
 Tumour lysis syndrome,The Lancet Haematology,Negative
 New Premedication,Medivizor,Negative
 Studie   verbesserte,Onko Community,Negative
 developed therapy,The James,Negative
 treatment health care resource utilization,Medivizor,Positive
 treatment health care resource utilization,Barry Shrier,Negative
 treatment health care resource utilization,noel cole,Negative
 Sad news,CLL Advocates Network,Negative
 Sad news,Michael Rynne,Negative
 passing,CLL Advocates Network,Positive
 passing,Kyle Cherry,Positive
 Elena Georgieva,CLL Advocates Network,Negative
 Bulgarian Lymphoma Association Elena,CLL Advocates Network,Negative
   Symptoms,Patient Empowerment Network,Negative
 Lilly Presents Interim Clinical Data,Oncology Tube,Negative
 LOXO Dose Escalation Trial,Oncology Tube,Negative
 BCell Leukemias,Oncology Tube,Negative
 American Society Hematology Annual Meeting Responses,Oncology Tube,Negative
 dose levels,Oncology Tube,Negative
 dose levels,Kevin Wolcott,Positive
 dose levels,Joe,Negative
 Feb st,Sigrid Sk√•nland,Negative
 Singlecell sequencing,Medical Xpress,Negative
 Singlecell sequencing,Arash Davari Serej,Positive
 visitor,Orchard Primary Academy Nursery,Negative
 Sitges,Lymphoma Hub,Negative
 nd European,Lymphoma Hub,Negative
   amp Lymphoma patients,CLL Ireland,Negative
 NEJM Venetoclax,Jesus F Sierra,Positive
 Relapsed Refractory Chronic Lymphocytic LeukemiaInteresante estudio,Jesus F Sierra,Positive
 Un par de limitaciones,Jesus F Sierra,Positive
 de aplicabilidad,Jesus F Sierra,Positive
 veo C√≥mo,Jesus F Sierra,Positive
 son bienvenidas las opiniones,Jesus F Sierra,Positive
 ‚Äç ‚ôÇ Ô∏è,Fran!,Negative
 Al dolor,Fran!,Negative
 de seguir vivoQue,Fran!,Negative
 lo bueno que tiene el dolorY tambi√©n al placer de ganar y perderCuando,Fran!,Negative
 todo parece jodido,Fran!,Negative
 cuando hay que poner,Fran!,Negative
 Older Patients,"Raul Cordoba, MD, PhD",Positive
 Older Patients,APSHO,Negative
 Older Patients,GrupoCronosSEFH,Positive
 Older Patients,Benlazar S.M Amin√©,Negative
 Older Patients,Michele Nadeem-Baker,Negative
 Older Patients,Value-Based Cancer Care,Negative
 Older Patients,Targeted Oncology,Negative
 Older Patients,maria jose agustin,Positive
 Older Patients,NCI CTEP Clinical Research,Negative
 Older Patients,Clinical Trials,Positive
 Older Patients,Chirurgia Senologica,Positive
 Older Patients,The ASCO Post,Positive
 Older Patients,Oncology Times,Negative
 Older Patients,Cancer News,Negative
 Older Patients,Mahmoud Aljurf,Negative
 Older Patients,Journal of Clinical Pathways,Negative
 Older Patients,Oncology Tube,Negative
 Older Patients,AJMC-Oncology,Negative
 Older Patients,AJMC,Negative
 Older Patients,Lymphomation.org,Negative
 Older Patients,MDRing,Negative
 Older Patients,Christopher Steer,Negative
 Older Patients,Mohammed Saied Faraj,Positive
 Older Patients,OncLive.com,Negative
 Older Patients,Journal of the @NCCN,Negative
 Heres,Andrew Schorr,Positive
 Heres,ABPI,Negative
 Heres,Cancer Health,Negative
 Heres,Biotexcel,Positive
 Heres,RTI Health Solutions,Positive
 Heres,The James,Negative
 Heres,Warren Terry Knight,Positive
 Heres,Hematology News,Negative
 Heres,CLLSA,Negative
 Heres,CLL_Fightersüéó,Negative
 Heres,Lymphoma Hub,Positive
 Heres,"Susannah Koontz, PharmD, BCOP üò∑",Positive
 Heres,Lifelong Learning,Negative
 Heres,Steve Wartenberg,Positive
 Heres,SGLifeSciences,Positive
 Dr Alessandra Ferrajoli,Andrew Schorr,Negative
 Dr Alessandra Ferrajoli,Patient Power,Negative
 upcoming Center,Phoebe Needles,Negative
 Lifelong Learning program,Phoebe Needles,Negative
 professor,Phoebe Needles,Negative
 Dr Delia Heck,Phoebe Needles,Negative
 therapy Office,NHLBI Bethesda Labs,Positive
 cos,Medivizor,Negative
 Cytotoxic T,Lymphoma Papers,Negative
 Cytotoxic T,Benlazar S.M Amin√©,Negative
   bears,Orchard Primary Academy Nursery,Negative
 Entrenando,Lenko Sins,Positive
 poder mas,Lenko Sins,Positive
 patient response amp prognosis,CLL Epigenetics,Negative
 Chronic Lymphocytic Leukemia Treatment,Virtute_USMLE,Negative
 Chronic Lymphocytic Leukemia Treatment,ManagedCareMag,Positive
 Chronic Lymphocytic Leukemia Treatment,P&T,Positive
 Chronic Lymphocytic Leukemia Treatment,EIN Presswire: Press Releases,Negative
 Chronic Lymphocytic Leukemia Treatment,Cure Cancer,Positive
 Chronic Lymphocytic Leukemia Treatment,Industry Today,Positive
 Chronic Lymphocytic Leukemia Treatment,Garbi√±e Lizeaga,Negative
 Chronic Lymphocytic Leukemia Treatment,GEDEFO,Negative
 Chronic Lymphocytic Leukemia Treatment,Robert Caro,Positive
 Chronic Lymphocytic Leukemia Treatment,Nicholas JVPR,Positive
 Chronic Lymphocytic Leukemia Treatment,Cesar Perez,Positive
 Chronic Lymphocytic Leukemia Treatment,JV Public Relations NY,Positive
 Chronic Lymphocytic Leukemia Treatment,TheBioConnection,Positive
 Chronic Lymphocytic Leukemia Treatment,Sumit Wadhwa,Positive
 Chronic Lymphocytic Leukemia Treatment,Benito,Positive
 Chronic Lymphocytic Leukemia Treatment,sandrineman,Negative
 Chronic Lymphocytic Leukemia Treatment,Hottest Stocks Now,Negative
 Chronic Lymphocytic Leukemia Treatment,Pharmaceutical News,Negative
 Chronic Lymphocytic Leukemia Treatment,Diaceutics PLC,Negative
 Chronic Lymphocytic Leukemia Treatment,Kosius,Positive
 Chronic Lymphocytic Leukemia Treatment,Pharmacy Podcast Network,Positive
 Chronic Lymphocytic Leukemia Treatment,Rx Generator | Business Strategy,Positive
 marrow,Virtute_USMLE,Negative
 marrow,EMJ Hematology,Negative
 marrow,"chadi nabhan MD, MBA, FACP",Negative
 Chronic Lymphocytic Leukemia   Infiltration,Virtute_USMLE,Negative
 parts,Virtute_USMLE,Negative
 age gt,Virtute_USMLE,Negative
 Expert Outlines Key Steps,Patient Empowerment Network,Negative
 New Comparing time,Medivizor,Negative
 DuoBodyCDxCD,Prof John,Negative
 potent Tcellkilling,Prof John,Negative
 Natural Killer Cell Hyporesponsiveness,Lymphoma Papers,Negative
 Natural Killer Cell Hyporesponsiveness,NK cell Biology,Negative
 Natural Killer Cell Hyporesponsiveness,NK papers,Negative
 Adequate Activating Signaling,Lymphoma Papers,Negative
 Adequate Activating,NK cell Biology,Negative
 Adequate Activating,NK papers,Negative
 Exciting New Updates,OncLive.com,Positive
 patient interviews,CLL Ireland,Negative
 Prof John Gribben,CLL Ireland,Positive
 Prof John Gribben,VJHemOnc,Negative
 Prof John Gribben,EMJ Hematology,Negative
   Survival,"Raul Cordoba, MD, PhD",Negative
 Hofland T Endstra S Gomes,NK papers,Negative
 CKP de Boer R de Weerdt,NK papers,Negative
 V Riedl JA Heukers R,NK papers,Negative
 MJ Eldering E Levin,NK papers,Negative
 Therapeutic Efficacy,Paperbirds_Hematology,Negative
 Therapeutic Efficacy,"Raul Cordoba, MD, PhD",Negative
 Nyctanthes,Paperbirds_Hematology,Negative
 Flowers,Paperbirds_Hematology,Negative
 Inhibit Proliferation,Paperbirds_Hematology,Negative
 Acute,Paperbirds_Hematology,Negative
 Acute,Run Direct Magazine,Positive
 Chronic Primary Human Leukemia Cells,Paperbirds_Hematology,Negative
 Adipocyte Differentiation,Paperbirds_Hematology,Negative
 Silico Analysis,Paperbirds_Hematology,Negative
 participation,"Raul Cordoba, MD, PhD",Negative
 participation,Lymphoma SA,Positive
    event,"Raul Cordoba, MD, PhD",Negative
    event,Andrew Schorr,Negative
    event,Patient Power,Negative
 WATCH Dr Fakhri,OncLive.com,Negative
 PIK Inhibitors,OncLive.com,Negative
 PIK Inhibitors,Kanakidis,Positive
 PIK Inhibitors,Anna Deveau,Negative
 Treatment Advances,Patient Empowerment Network,Negative
 Treatment Advances,AJPB_Journal,Negative
 FINDINGS,Paperbirds_Hematology,Negative
 FINDINGS,Prof John,Negative
 Enucleation Specimens,Paperbirds_Hematology,Negative
 Risks,Paperbirds_Hematology,Negative
 Risks,"Pamela Schlembach,MD",Negative
 Imputation,Paperbirds_Hematology,Negative
 Gene Expression Data,Paperbirds_Hematology,Negative
 Significance,Paperbirds_Hematology,Negative
 Significance,EurekaMag,Negative
 Significance,Patient Power,Negative
 Significance,Oncology Tube,Negative
 Inferring Biological Pathways,Paperbirds_Hematology,Negative
 Acquired qMLL rearrangement,Paperbirds_Hematology,Negative
 Cell     Treatment Market,Rohit K,Positive
 Trends Analysis Statistics,Rohit K,Positive
 Causes,Patient Empowerment Network,Negative
 Causes,Mike Luise,Positive
 Causes,A M Billah Sumon,Positive
 Long Term Results,Shouting at people in my underpants,Negative
   paradigm,OncLive.com,Negative
 combination strategies,OncLive.com,Negative
 Duvelisib,Paperbirds_Hematology,Negative
 Duvelisib,Dana-Farber News,Positive
 Duvelisib,"chadi nabhan MD, MBA, FACP",Negative
 Duvelisib,CellworksLife,Negative
 Duvelisib,"Robinson Ortiz, MD",Negative
 Duvelisib,Targeted Oncology,Negative
 Duvelisib,Medicalnewser.com,Negative
 Duvelisib,Hematopoiesis News,Negative
 Duvelisib,Cancer Stem Cell News,Negative
 Duvelisib,SNN Network,Negative
 Duvelisib,BioRunUp,Negative
 Duvelisib,Davalyn Corporation,Negative
 Duvelisib,BusinessWireProducts,Negative
 Duvelisib,Financial Buzz,Negative
 Duvelisib,Business Wire-Health,Negative
 Duvelisib,BusinessWire-Science,Negative
 Duvelisib,Odi Bruckman,Negative
 Duvelisib,The Pharmaceutical Marketing Group,Negative
 Duvelisib,HemOnc Today,Positive
 Duvelisib,Healio,Negative
 Duvelisib,ComplexPharm,Positive
 Duvelisib,pharmabr,Negative
 Duvelisib,Danvantri Farma,Negative
 Duvelisib,Scott Werntz,Negative
 Duvelisib,Financescom-stocks,Positive
 Ofatumumab,Paperbirds_Hematology,Negative
 Ofatumumab,Hematology Advisor,Negative
 Ofatumumab,chonsone,Positive
 Ofatumumab,ClinicalTrialsData,Negative
 Ofatumumab,Medscape Education,Negative
 Ofatumumab,"Naveen Pemmaraju, MD",Negative
 Ofatumumab,Hematopoiesis News,Negative
 Ofatumumab,Targeted Oncology,Negative
 Ofatumumab,Cancer Papers,Positive
 Ofatumumab,Dr Liz Hoffman,Positive
 Ofatumumab,Hypoxia Adaptation,Positive
 Ofatumumab,HemOnc Today,Negative
 Ofatumumab,Lampe & Company,Negative
 Ofatumumab,OncoTherapy Network,Negative
 Ofatumumab,Europe PMC articles,Positive
 Ofatumumab,Krishan Maggon,Negative
 Ofatumumab,OncLive.com,Negative
 Ofatumumab,NACDA Program on Aging,Positive
 Ofatumumab,Oncology Nursing News,Negative
 Ofatumumab,ASH,Negative
 Ofatumumab,Oncology,Negative
 Ofatumumab,PracticeUpdate,Negative
 Ofatumumab,TumImmTxpapers,Negative
 Ofatumumab,aeses.com,Negative
 Ofatumumab,PANNA SHARMA,Positive
 Ofatumumab,Aktienmanufaktur,Negative
 Ofatumumab,Scott Werntz,Negative
 Ofatumumab,Financescom-stocks,Positive
 Ofatumumab,Kevin Nacho,Positive
 DUO Crossover Extension Study,Paperbirds_Hematology,Negative
 Rice Bran Arabinoxylan,Lovisa Bray,Positive
 Rice Bran Arabinoxylan,Turmeric,Negative
 Curcumin Therapy,Lovisa Bray,Positive
 Benefit,Lovisa Bray,Positive
 EarlyStage BCell Lymphoid Malignancies Monoclonal Gammopathy,Lovisa Bray,Positive
 Undetermined Significance Smoldering Multiple Myeloma,Lovisa Bray,Positive
 Stage,Lovisa Bray,Positive
 Stage,Sue Carlson,Positive
 Stage,WorldStemCellSummit,Positive
 Stage,CLL Ireland,Negative
 Stage,Patient Power,Negative
   Bearish List,SwingTradeBot UK,Negative
 Everyday,ü§∑‚Äç‚ôÄÔ∏èSarah ~D,Positive
 school day,ü§∑‚Äç‚ôÄÔ∏èSarah ~D,Positive
 meditation,Patient Power,Negative
 mindfulness,Patient Power,Negative
 likeminded individuals,Patient Power,Negative
 ELEVATETN Trial,OncLive.com,Negative
 Interim Review,AIM Alerts!,Negative
   ID,Pearson Lab,Positive
 study comparing outcomes,Oncology Learning Network,Negative
 Erweiterung f√ºr,APOTHEKE ADHOC,Positive
 Anwendung f√ºr,APOTHEKE ADHOC,Positive
 durch,APOTHEKE ADHOC,Positive
 Beh√∂rden,APOTHEKE ADHOC,Positive
 Bita Fakhri MD,OncLive.com,Negative
 consideration,CLL Epigenetics,Negative
 consideration,Oncology Tube,Negative
 hmc,CLL Epigenetics,Negative
 CLL Kanduri group,CLL Epigenetics,Negative
 nod,Plexus Ventures,Positive
 SLL patients,CLL Advocates Network,Negative
 Rapid Pace,OncLive.com,Negative
 Chronic lymphocytic   CLL,"Pharmacyclics, an AbbVie Company",Positive
 Chronic lymphocytic   CLL,JanssenUS,Positive
 Chronic lymphocytic   CLL,AstraZenecaUS,Negative
 slowgrowing blood cancer,"Pharmacyclics, an AbbVie Company",Positive
 Super story maps,Orchard Primary Academy Nursery,Negative
 group time,Orchard Primary Academy Nursery,Negative
 Dr Adam Olszewski,AJMC-Oncology,Negative
 FirstLine Therapy,AJMC-Oncology,Negative
 FirstLine Therapy,Clinical Trials,Negative
 FirstLine Therapy,Hematopoiesis News,Negative
 FirstLine Therapy,AmericanPharmacyNews,Negative
 FirstLine Therapy,1stOncology,Negative
 FirstLine Therapy,Cord Blood News,Negative
 FirstLine Therapy,Rare Diseases,Negative
 FirstLine Therapy,‚öõÔ∏èLibertyüåä,Positive
 FirstLine Therapy,MoJo,Negative
 FirstLine Therapy,OBR,Negative
 FirstLine Therapy,Crwe World,Negative
 FirstLine Therapy,Odi Bruckman,Negative
 FirstLine Therapy,Financial Buzz,Positive
 FirstLine Therapy,Pharmaceutical News,Negative
 FirstLine Therapy,COPD News,Negative
 FirstLine Therapy,Google  News,Positive
 FirstLine Therapy,IntoxicatedTrader,Negative
 FirstLine Therapy,Diplomat,Negative
 Rendeiro,CeMM,Positive
 Christoph Bock,CeMM,Positive
 CeMM,CeMM,Positive
 GlyVal emerge,Prof John,Negative
 Prof John Seymour,Lymphoma Australia,Positive
 Prof John Seymour,Medscape Education,Negative
 Prof John Seymour,Peter Mac Cancer Centre,Positive
 Prof John Seymour,ecancer,Negative
 Royal Melbourne Hospital,Lymphoma Australia,Positive
 medications,PER,Negative
 medications,Crain's New York,Positive
 medications,ICES,Positive
 medications,OncLive.com,Negative
   Progression,Taylor Lab UM,Negative
   Progression,Michele Nadeem-Baker,Negative
 Persistence,Taylor Lab UM,Negative
 Persistence,Michele Nadeem-Baker,Negative
 Persistence,"Raul Cordoba, MD, PhD",Negative
 Link,Taylor Lab UM,Negative
 Link,Michele Nadeem-Baker,Negative
 Link,Cureus,Negative
 Link,Leukemia & Lymphoma Society Research,Positive
 Link,CLL_Fightersüéó,Negative
 Link,CLL Ireland,Negative
 Link,Jasmin Abd-el-Baki,Positive
 Subclone,Taylor Lab UM,Negative
 Subclone,Michele Nadeem-Baker,Negative
 Newest Treatments,OncLive.com,Negative
   DERMATOSIS,Michelle Holder,Positive
 HANDS,Michelle Holder,Positive
 HANDS,Paperbirds_Hematology,Negative
 CHRONIC LYMPHOCYTIC,Michelle Holder,Positive
 CHRONIC LYMPHOCYTIC,researchjobs.cz,Negative
 Immunohistochemical Expression,Paperbirds_Hematology,Negative
 Lymphoid Enhancer Binding Factor,Paperbirds_Hematology,Negative
 CDPositive Marginal Zone Lymphoplasmacytic,Paperbirds_Hematology,Negative
 Follicular Lymphomas,Paperbirds_Hematology,Negative
 VIDEO Tirabrutinib,VJHemOnc,Negative
 entospletinib,VJHemOnc,Negative
 entospletinib,"Amber Koehler, PA-C",Negative
 entospletinib,CancerTherapyAdvisor,Negative
 RR   w Barbara Eichhorst,VJHemOnc,Negative
 Unusual Presentation,Lymphoma Papers,Negative
 Unusual Presentation,Paperbirds_Hematology,Negative
 Liver,Lymphoma Papers,Negative
 Liver,Paperbirds_Hematology,Negative
 Liver,Cancer Papers,Negative
 Lung,Lymphoma Papers,Negative
 Lung,Paperbirds_Hematology,Negative
 FLabeled FluoroDeoxyglucose Positron Emission,Lymphoma Papers,Negative
 FLabeled FluoroDeoxyglucose Positron Emission,Paperbirds_Hematology,Negative
 TomographyComputed Tomography,Lymphoma Papers,Negative
 TomographyComputed Tomography,Paperbirds_Hematology,Negative
 OGT,CAP TODAY MAGAZINE,Positive
 OGT,OGT,Positive
 GlyVal Multiple BCL mutations,Toby Eyre,Negative
 Medical Care,Irene‚Ñ¢ ìÖì,Positive
 Medical Care,TSmrecansky,Positive
 CLL expert Dr Justin Taylor,Patient Power,Negative
 cathelicidin hCAPLL,Paperbirds_Hematology,Negative
   Genentech Partner,ArthurPotatoeHammer,Negative
 Measure Minimal Residual Disease,ArthurPotatoeHammer,Negative
 Measure Minimal Residual Disease,gilbert c faure,Negative
 Measure Minimal Residual Disease,San Francisco Biotechnology Network,Positive
 Measure Minimal Residual Disease,"OTC Dynamics, Inc.",Negative
 Measure Minimal Residual Disease,COPD News,Negative
 Measure Minimal Residual Disease,Mr Bentley Onelly,Positive
 Measure Minimal Residual Disease,Michelle Solly,Positive
 Measure Minimal Residual Disease,Crwe World,Negative
 Phase III Study,ArthurPotatoeHammer,Negative
 Phase III Study,gilbert c faure,Negative
 Phase III Study,San Francisco Biotechnology Network,Positive
 Phase III Study,COPD News,Negative
 Phase III Study,Mr Bentley Onelly,Positive
 Phase III Study,Michelle Solly,Positive
 Phase III Study,Oncology Tube,Negative
 clinic staff,MD Anderson Cancer Center,Negative
 YTD ATH,Tong,Negative
 daysPFShare,Tong,Negative
 YTD ATH   daysThe,Tong,Negative
 PF ATH,Tong,Negative
   facts,Michele Nadeem-Baker,Negative
 bit misleading amp,Michele Nadeem-Baker,Negative
   cases,Zusia:Dr Jackie Volk,Positive
 CART Therapy,CAR-TCR,Positive
 CART Therapy,Journal of Clinical Pathways,Negative
 Value,CAR-TCR,Positive
 Value,CryptoLiveLeak,Positive
 Value,AJMC,Positive
 Value,OncLive.com,Negative
 Value,NACDA Program on Aging,Negative
 Value,CLL Society Inc.,Negative
 Considerations,CAR-TCR,Positive
 Considerations,Cancer Papers,Negative
 Considerations,AJMC,Negative
 Considerations,Janina Reed,Positive
 Considerations,CancerWallonia,Negative
    scientists,The Royal Vox Post,Positive
 Minimal Residual Disease Assessment,Paperbirds_Hematology,Negative
 Minimal Residual Disease Assessment,"Raul Cordoba, MD, PhD",Negative
 CLL Ready,Paperbirds_Hematology,Negative
 Clinical Routine,Paperbirds_Hematology,Negative
    steht f√ºr einen Genabschnitt der bei,AbbVie Deutschland,Negative
 mutiert sein kann Der IGHVStatus,AbbVie Deutschland,Negative
 Status haben,AbbVie Deutschland,Negative
 m Vergleich,AbbVie Deutschland,Negative
 Prognose Noch,AbbVie Deutschland,Negative
    ‚Å¶‚Å©,Prof John,Negative
 l Nice work,Prof John,Negative
 BEATING,Prof John,Negative
 BETA BATTERS B CELLS,Prof John,Negative
 Stromal protein kinase,Prof John,Negative
 CŒ≤ inhibition,Prof John,Negative
 chemosensitivity,Prof John,Negative
 amp overcomes drug resistance,Prof John,Negative
 Cool study,Prof John,Negative
 Sequencing test,LabPulse,Positive
   Diagnostics NextGeneration Sequencing,Michele Nadeem-Baker,Negative
 ÈòªÂÆ≥Ëñ¨,„Åå„Çì„Éó„É©„Çπ,Negative
 Hypertension,Anthony Mato,Positive
 Hypertension,"Hawkins Gay, MD, MPH",Negative
 Hypertension,Will,Negative
 Hypertension,JAMA Network Open,Negative
 Hypertension,Jenn,Positive
 Kettering Cancer Center,Anthony Mato,Negative
 CLL expert Dr Jennifer Woyach,Patient Power,Negative
 CLL remission duration trial data,Patient Power,Negative
   T therapy,"Comprehensive Cell Solutions,New York Blood Center",Positive
 chemotherapyStudies,"Comprehensive Cell Solutions,New York Blood Center",Positive
 TGTX      prevalence,Biotech2050,Negative
 NEW VIDEO,Lymphoma Research Foundation,Negative
 NEW VIDEO,VJHemOnc,Negative
 Lindsey Roeker MD,Lymphoma Research Foundation,Negative
 todays Feast,Hybridan,Positive
 New trial,E Lambrechts,Positive
 New trial,CLL Ireland,Negative
 GMAB JNJ tconQjjbHiK,E Lambrechts,Negative
 New article Guidance document validation,Paperbirds_Hematology,Negative
 HLA class,Paperbirds_Hematology,Negative
 Lymphoma Coalition   Global Patient Survey,LymphomaAction,Negative
 line cash position,John,Negative
 divi increase,John,Negative
 finals,John,Negative
 division,John,Negative
 division,Oracle Seer #OracleSeer,Positive
 Brexit,John,Negative
 CLL Signal,John Harrington,Positive
 business,John Harrington,Positive
 business,T‚Ç¨¬£JA¬•,Positive
     Cello Health PLC PreClose Trading Statement,AIM Alerts!,Negative
 Michele NadeemBaker,Patient Power,Negative
 Michele NadeemBaker,Michele Nadeem-Baker,Negative
 Michele NadeemBaker,Dr Timos Papagatsias,Negative
 Michele NadeemBaker,Oncology Tube,Negative
 CLL patient advocate perspective,Patient Power,Negative
 Hematology ASH Annual Meeting,Patient Power,Negative
 Adaptive Genentech Partner,gilbert c faure,Negative
 Adaptive Genentech Partner,COPD News,Negative
 Adaptive Genentech Partner,Crwe World,Negative
 RNASeq profiling,Paperbirds_Hematology,Negative
 deregulated miRs,Paperbirds_Hematology,Negative
 Mcl antagonist,Cure Cancer Now,Negative
     Lymphoma Coalition Global Patient Survey,"Raul Cordoba, MD, PhD",Positive
 amp caregivers,"Raul Cordoba, MD, PhD",Positive
 amp caregivers,Michele Nadeem-Baker,Negative
 Warthin tumor,Lisa Rooper,Positive
 lymphocytes Involvement,Lisa Rooper,Positive
 SureSeq CLL   CNV Panel,OGT,Negative
 Multiple B cell malignancies,Lymphoma Papers,Negative
 BCell Lymphoma BCL,Paperbirds_Hematology,Negative
 hallmarks,Paperbirds_Hematology,Negative
 cancer implications,Paperbirds_Hematology,Negative
   assay indications,AJMC-Oncology,Negative
 ADPT Adaptive Genentech Partner,MAISA,Negative
 Clonoseq Assay,MAISA,Negative
   Genetic Testing,Patient Empowerment Network,Negative
   Genetic Testing,Michele Nadeem-Baker,Negative
 SFBN Feed Adaptive,San Francisco Biotechnology Network,Positive
 Genentech Partner,San Francisco Biotechnology Network,Positive
 SEATTLE Jan,San Francisco Biotechnology Network,Positive
 ADPT Adaptive,"OTC Dynamics, Inc.",Negative
 ADPT Adaptive,Mr Bentley Onelly,Positive
 ADPT Adaptive,Michelle Solly,Positive
 Primary,"OTC Dynamics, Inc.",Negative
 clonoSEQ√Ç,COPD News,Negative
 Assay,COPD News,Negative
 Chronic Lymphocytic Leukemia Patients SEATTLE Jan,COPD News,Negative
 GLOBE,COPD News,Negative
 NEWSWIRE,COPD News,Negative
 Adaptive Biotechnologies Corporation,COPD News,Negative
 Chronic Lymphocytic Leukemia PatientsMulti year partnership,Michelle Solly,Positive
 Expanded Medicare Coverage,ArthurPotatoeHammer,Negative
 Expanded Medicare Coverage,Investor News,Negative
 Expanded Medicare Coverage,Crwe World,Negative
 Expanded Medicare Coverage,"OTC Dynamics, Inc.",Negative
 Monitoring MRD,ArthurPotatoeHammer,Negative
 Monitoring MRD,Investor News,Negative
 Monitoring MRD,Crwe World,Negative
 Monitoring MRD,"OTC Dynamics, Inc.",Negative
 Dr Tanya Siddiqi,Lymphoma Australia,Positive
 Dr Tanya Siddiqi,Lymphoma Hub,Negative
 Dr Tanya Siddiqi,CLL Society Inc.,Negative
 USA,Lymphoma Australia,Positive
 USA,CBPartners,Positive
 CLL patient amp patient advocate,Lymphoma Australia,Positive
 ASH meeting,Lymphoma Australia,Positive
   cents,ùó°ùó∂ùóµùóÆùóø ùóóùó≤ùòÄùóÆùó∂ ùó†ùóóü©∏,Positive
 WATCH Dr Kahl,OncLive.com,Negative
 Frontline BTK Inhibitor Selection,OncLive.com,Negative
 Appreciation luncheon,Nitin Jain,Negative
 Examination,Fish Chromosomes,Positive
 Examination,Benlazar S.M Amin√©,Negative
 retrotransposon subfamily DNA methylation,Paperbirds_Hematology,Negative
 CLARITY Study,James Kerwin,Positive
 CLARITY Study,"Georgios Pongas, MD",Positive
 CLARITY Study,Mahmoud Aljurf,Negative
 CLARITY Study,Juan Marquet,Negative
 CLARITY Study,ALI ALAHMARI.,Positive
 CLARITY Study,Cancer Library VCC,Positive
 CLARITY Study,Eduardo Flavio Oliveira Ribeiro,Negative
 CLARITY Study,GEDEFO,Negative
 CLARITY Study,"Bachar Samra, MD",Positive
 Mutations,Taylor Lab UM,Negative
 Mutations,MDedge Hematology & Oncology,Negative
 Mutations,elizabeth,Positive
 Mutations,CLL Ireland,Negative
 Mutations,Journal of Clinical Pathways,Negative
 Mutations,DrugGenius,Negative
 Mutations,"Raul Cordoba, MD, PhD",Positive
 Mutations,Blood Journal,Negative
 Mutations,Gabor Harsanyi,Positive
 Mutations,European Pharmaceutical Review,Negative
 Mutations,ihealthkonnect,Positive
 Mutations,Complete True Life,Positive
 Mutations,McCann Health Medical Communications,Positive
 Mutations,Health and Beauty Website Directory,Positive
 Mutations,Oxford virtual,Positive
 Mutations,Bryn Williams,Positive
 Mutations,Henrique Castro,Positive
 Mutations,Biodips,Positive
 Mutations,Cancer Agent,Negative
 Mutations,Mohd Sarfaraz Nawaz,Positive
 Mutations,Just Medical News,Positive
 Mutations,Glove Up Training,Positive
 Mutations,Medical Reel,Negative
 Mutations,Rajat Agarwal,Positive
 Mutations,Tom,Negative
 Mutations,üòä Bill Ballentine,Positive
 Mutations,Healthy & Active,Positive
 Mutations,Michael Rahman,Positive
 Mutations,Tracia.my.tupperware.com,Positive
 Mutations,Healthy Feeder,Positive
 Mutations,Michael White ‚òòÔ∏èüá¨üáßüáÆüá™,Positive
 Mutations,TDKmarketing,Positive
 Mutations,Praise Club,Positive
 Mutations,OccuWorld üè¥,Positive
 Mutations,Snakebite Publications,Positive
 Mutations,newsaiya,Positive
 Mutations,Voltron the Cat,Positive
 Mutations,wendy goulsbra,Positive
 Mutations,Wittich Science,Positive
 Mutations,Tiffany Jones,Positive
 Mutations,Larry K Chapman,Positive
 Mutations,R.M.C. Inc,Positive
 Mutations,www.releaseinsider.com,Positive
 Mutations,geofry dryer,Positive
 Mutations,Psy_sa,Positive
 Mutations,Jan van de Kamp,Positive
 Mutations,Jennifer,Positive
 Mutations,Flck,Positive
 Mutations,Your Health in Hand,Positive
 Mutations,Strategic North,Positive
 Mutations,Science Enabled,Positive
 Mutations,Cheap-Mall,Positive
 Mutations,Hiboo - Michele,Positive
 Mutations,Michael Zons,Positive
 Mutations,Danny Zacfie,Positive
 Mutations,Betty Dorsey,Positive
 Mutations,Jamiu Abdulhafeez,Positive
 Mutations,kilokeal,Positive
 Mutations,Prince,Positive
 Mutations,"Science Feeds, (msk)",Positive
 Mutations,James Greid,Positive
 Mutations,Keywebco,Positive
 Mutations,Ducit,Positive
 Mutations,Surma Health & Info.,Positive
 Mutations,Sehatrus,Positive
 Mutations,medical_tweets,Positive
 Mutations,Clinical Trials,Negative
 Mutations,Science Updates,Positive
 Mutations,bob lee,Positive
 Mutations,Ayesha Trites,Positive
 Mutations,Calynn Burell,Positive
 Mutations,By C.Marie,Positive
 Mutations,Science News,Positive
 Mutations,Yuriko Dille,Positive
 Mutations,Dining Enthusiasts,Positive
 Mutations,Healthy Liver,Positive
 Mutations,BMETWiki,Positive
 Mutations,Health-News,Positive
 Mutations,Catina Outen,Positive
 Mutations,Sophia,Positive
 Mutations,BMI Calculator Oz,Positive
 Mutations,Dr. Zead T,Positive
 Mutations,newswise,Negative
 Mutations,Centro Medico Qx,Negative
 Mutations,MD.,Negative
 Mutations,Cristina Reyes,Positive
 Mutations,ASH,Negative
 Mutations,AtlanticJOMedicine,Negative
 Mutations,Francesco Turturro,Negative
 UsnRNA,Taylor Lab UM,Negative
 Review   Snapshot,Taylor Lab UM,Negative
 New Ofatumumab maintenance,Medivizor,Negative
 III ALPINE trial,OncLive.com,Negative
 BTK inhibitor ibrutinib,OncLive.com,Negative
 BTK inhibitor ibrutinib,Targeted Oncology,Negative
 BTK inhibitor ibrutinib,AtlanticJOMedicine,Negative
 Hypercalcemia,Lymphoma Papers,Positive
 Small Lymphocytic LymphomaChronic Lymphocytic Leukemia,Lymphoma Papers,Negative
 Optimal Treatment,OncLive.com,Negative
 Optimal Treatment,CLL Ireland,Negative
 NOTCH mut response,Toby Eyre,Negative
 antiCD,Toby Eyre,Positive
 antiCD,"chadi nabhan MD, MBA, FACP",Negative
 antiCD,"Raul Cordoba, MD, PhD",Negative
 antiCD,A. Vroom - Ten Wolde,Negative
 antiCD,Chan Cheah,Negative
 COMPLEMENT trial Mech,Toby Eyre,Negative
 immunochemotherapy,Toby Eyre,Negative
 basisWill hold,Toby Eyre,Negative
 Novel,Toby Eyre,Negative
 Novel,CancerWallonia,Positive
 tcoPCxkWuoh,Toby Eyre,Negative
 PF,John,Positive
 New holdings,John,Negative
 disappointing,John,Negative
 fashion,John,Negative
 Analysts,MedTech Dive,Positive
 Analysts,US Banking News,Negative
 Cowen,MedTech Dive,Positive
 earlierthanexpected decision,MedTech Dive,Positive
 Adaptive,MedTech Dive,Positive
   increase,MedTech Dive,Positive
 clonoSEQ sales,MedTech Dive,Positive
 Relapsed Follicular,"Raul Cordoba, MD, PhD",Positive
 JAMA Oncology,"Raul Cordoba, MD, PhD",Negative
 JAMA Oncology,Lymphomation.org,Negative
 Sandra E Kurtin PhD ANPC AOCN,JADPRO,Negative
 CAGR,Jimi Richards,Positive
 CAGR,Adroit Market Research,Positive
 CAGR,PressRelease.cc,Negative
 CAGR,BizPR,Positive
 CAGR,Shrikant Mandlik,Positive
 CAGR,satPRnews,Negative
 CAGR,AttyCreditRepair,Positive
 CAGR,LeadValets Lead Generation Agency,Positive
 CAGR,iPlethora,Positive
 CAGR,REI Lending,Positive
 CAGR,New Jersey Headlines,Positive
 CAGR,Shillong Herald,Positive
 CAGR,ABNewswire,Positive
 CAGR,CMLHope,Negative
 CAGR,Radiant Insights,Positive
 CAGR,RiyaSen,Positive
 CAGR,ohanna johnson,Positive
 CAGR,Stock_Tracker,Positive
 CAGR,Roche,Negative
 CAGR,Johnson & Johnson,Positive
 CAGR,Financial Buzz,Negative
 CAGR,EIN Presswire: Pharmaceutical Newswire,Negative
 CAGR,Business Wire-Health,Negative
 Dr Tam,Targeted Oncology,Negative
 Dr Tam,Lymphoma Hub,Negative
 Dr Tam,MD Anderson Leukemia,Negative
 Dr Tam,Patient Power,Negative
 tactics,Medscape Education,Negative
 AlexeyDanilov,Michele Nadeem-Baker,Negative
 Attention Mining,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 HL,John,Negative
 Zanubrutinib Faces,OncLive.com,Negative
 Woyach Highlights Progress,OncLive.com,Negative
 Breakout,John,Negative
 Chron,Crwe World,Positive
 Chron,Aktienmanufaktur,Negative
 Phase   Randomized Study,Biotech2050,Negative
 New article Sortilin,Paperbirds_Hematology,Negative
 Novel Diagnostic Therapeutic Biomarker,Paperbirds_Hematology,Negative
 Cup,SwingTradeBot UK,Positive
 Handle,SwingTradeBot UK,Positive
 Marinederived Trabectedin Targets Leukemic Cells,Shouting at people in my underpants,Negative
 Restores Immune Cell Function,Shouting at people in my underpants,Negative
 Restores Immune Cell Function,"Candice B. Limper, M.S.",Positive
 Restores Immune Cell Function,Pharma Jonpi .,Negative
 Models,Shouting at people in my underpants,Negative
 Models,"Candice B. Limper, M.S.",Positive
 Models,Pharma Jonpi .,Negative
 Models,Rare Diseases,Negative
 Ian W Flinn,HemOnc Today,Negative
   Articles,HemOnc Today,Negative
 IGHV mutation status,GenQA (Genomics Quality Assessment),Negative
 st January,GenQA (Genomics Quality Assessment),Negative
 st January,Lifelong Learning,Negative
 Chronic Myeloid Leukemia Case Report,Paperbirds_Hematology,Negative
 Ryan Jacobs MD,MedPage Oncology,Negative
 Javier PinillaIbarz MD PhD,MedPage Oncology,Negative
 ABSTRACT,ESH (Haematology),Positive
 DAYS LEFT st Translational Research Conference,ESH (Haematology),Negative
 Paris,ESH (Haematology),Negative
 Paris,Prof John,Negative
 J Brown P Ghia M Hallek,ESH (Haematology),Negative
 Amy Pierre ANPBC,JADPRO,Negative
 currently enrolling phase III trial,JADPRO,Negative
 mess Blossom class,Orchard Primary Academy Nursery,Negative
 clues,Orchard Primary Academy Nursery,Negative
 clues,Virtute_USMLE,Negative
 CLL Research,"Navneet Majhail, MD, MS",Positive
 Strati et alPost hoc analysis,Toby Eyre,Negative
 IbrR,Toby Eyre,Negative
 Ibr RCTCR,Toby Eyre,Negative
 PFSNo predictors,Toby Eyre,Negative
 Trabectedin,"Candice B. Limper, M.S.",Positive
 Trabectedin,CancerTherapyAdvisor,Negative
 Trabectedin,Prof John,Negative
 Trabectedin,CLL-seq,Negative
 Trabectedin,Pharma Jonpi .,Negative
 CLL panel,Patient Power,Negative
   post,Dr. Andy Evens,Negative
 Happy,Dr. Andy Evens,Negative
 International Advisory Board,"Raul Cordoba, MD, PhD",Negative
 causes,Patient Empowerment Network,Positive
 expert Dr Kerry Rogers,Patient Empowerment Network,Positive
 ASH Annual Meeting,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 ASH Annual Meeting,sound57,Positive
 Complete Remission,Paperbirds_Hematology,Negative
 Ibrutinib Clinical Significance,Paperbirds_Hematology,Negative
 Predictive Factors,Paperbirds_Hematology,Negative
 Predictive Factors,Robert Z. Orlowski,Positive
 Predictive Factors,MD Anderson Leukemia,Positive
 YONDELIS,Pharma Jonpi .,Negative
 LEUCEMIA,Pharma Jonpi .,Negative
 Trabectedin Targets,Pharma Jonpi .,Negative
   news CART therapy shows,Liz Highleyman,Positive
 Alliance Trial,Cancer News,Negative
 Alliance Trial,APSHO,Negative
 Ohio State University Comprehensive Cancer Center expert,Cancer News,Negative
 Frontline IbrutinibVenetoclax Combo,OncLive.com,Negative
 IbrutinibRituximab Combo Retains PFS Advantage,OncLive.com,Positive
 Novel Triplet,OncLive.com,Positive
 Pretreated,OncLive.com,Positive
 Happy New Year,CryptoLiveLeak,Negative
 ILDriven B Cell Chronic Lymphocytic Leukemia Cycling Roles,ImmunologyPapers,Negative
 AKT,ImmunologyPapers,Negative
 AKT,Lymphoma Papers,Negative
 Modulating Cyclin D,ImmunologyPapers,Negative
 DNA Damage Response Proteins,ImmunologyPapers,Negative
 NY Lymphoma Rounds,Anthony Mato,Negative
   counting,ron white,Positive
 CLL experts Dr Michael Keating,Patient Power,Negative
 CLL Global Research Foundation,Patient Power,Negative
 prevalence,Biosimilar Today iMagazine,Negative
 prevalence,Paperbirds_Hematology,Negative
 prevalence,Medthority,Negative
   BTK Inhibitors,OncLive.com,Negative
 Power Targeted Therapies,CONQUER the patient voice,Negative
 Extend Survival,CONQUER the patient voice,Negative
 LyLe √∏nsker alle rigtig Godt Nyt√•r,LyLe Foreningen,Negative
 det bedste,LyLe Foreningen,Negative
 fremtiden Vi,LyLe Foreningen,Negative
 er p√•,LyLe Foreningen,Negative
 og Vi,LyLe Foreningen,Negative
 er den √¶r,LyLe Foreningen,Negative
 som f√∏lger alle med √¶ft √¶mi,LyLe Foreningen,Negative
 CNS aspergillosis,Pooja,Positive
 CNS aspergillosis,New Scientist Zone,Positive
 CNS aspergillosis,Paperbirds_Hematology,Negative
 Dr Anthony F Daniyan,"Conquer Cancer, the ASCO Foundation",Positive
 Young Investigator Award,"Conquer Cancer, the ASCO Foundation",Positive
 Young Investigator Award,Oncology Times,Negative
   Dr Brander,OncLive.com,Negative
 Scholarships,ESH (Haematology),Negative
 Susan OBrien,Lymphoma Hub,Negative
 Susan OBrien,VJHemOnc,Negative
 III multicenter ELEVATE TN study,Lymphoma Hub,Negative
 boost,Taylor Lab UM,Negative
 New Year,Taylor Lab UM,Negative
 breakthroughs,Taylor Lab UM,Negative
 breakthroughs,ABPI,Negative
 breakthroughs,OncLive SOSS,Negative
 breakthroughs,NewYorkHealthWorks,Positive
 Proteomics,EurekaMag,Negative
 Proteomics,Pastel BioScience,Positive
 Proteomics,mitopapers,Positive
 Proteomics,Cancer Papers,Negative
 Emergent Literacy,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Positive
   √§mie,Onko Community,Positive
 Baseline Total Metabolic Tumor VolumeMeasured,Benlazar S.M Amin√©,Negative
 FDG PET,Benlazar S.M Amin√©,Negative
 FDG PET,Paperbirds_Hematology,Negative
 Richter Syndrome,Benlazar S.M Amin√©,Negative
 Richter Syndrome,Paperbirds_Hematology,Negative
 Richter Syndrome,Anas Nasir,Positive
 WATCH Dr Seymour,OncLive.com,Negative
 Year Update,OncLive.com,Negative
 MURANO Trial,OncLive.com,Negative
 MURANO Trial,Oncology Tube,Negative
 MURANO Trial,Financial Buzz,Negative
 MURANO Trial,Seattle's Banker,Negative
 MURANO Trial,Laurent G - Francis,Negative
 MURANO Trial,Marketbit.pro,Negative
 MURANO Trial,HEDGE accordinglyüìà,Negative
 MURANO Trial,Crwe World,Negative
 MURANO Trial,CRE Demographics,Negative
 MURANO Trial,RazzleTazzle,Negative
    Natural Prevention,The Curable Recipes,Negative
 Ô∏è Watch Astrid Pavlovsky,Lymphoma Hub,Negative
 WATCH Dr Tam,OncLive.com,Negative
 CAPTIVATE Trial,OncLive.com,Negative
 CAPTIVATE Trial,Michele Nadeem-Baker,Negative
 VIDEO Promising treatments,The Patient's Channel,Positive
 message,The Patient's Channel,Positive
 message,Targeted Oncology,Positive
 message,CLL Ireland,Negative
 message,Anna Deveau,Negative
 w Geroge,The Patient's Channel,Negative
 Dietary Inflammatory Index,Paperbirds_Hematology,Negative
 MCC Spain Study,Paperbirds_Hematology,Negative
   platform,AASM SleepTM,Positive
   platform,CryptoLiveLeak,Negative
 care management,AASM SleepTM,Positive
 BCL family proteins,Taylor & Francis Medicine and Health,Positive
 TRANSCEND CLL   phase III study,Lymphoma Hub,Negative
 CAR Tcell therapy lisocabtagene,Lymphoma Hub,Negative
 Baseline Total Metabolic Tumor Volume,Paperbirds_Hematology,Negative
 WATCH Risk Assessment,OncLive.com,Negative
 health care team,CancerDotNet,Positive
 CLL amp Blood Tests,Patient Power,Negative
 Dr Farrukh Awan,Patient Power,Negative
 recommended tests,Patient Power,Negative
 Transcriptomicsbased validation,SeqComplete,Negative
 Transcriptomicsbased validation,EurekaMag,Negative
 relatedness,SeqComplete,Negative
 relatedness,EurekaMag,Negative
 Leading Players,Report consultant,Positive
   News BCell Chronic Lymphocytic Leukemia Treatment Market,Global News Report,Positive
 Ground,Global News Report,Positive
 Ground,CLL_Fightersüéó,Negative
 Players,Global News Report,Positive
 KOLs,Biotech2050,Positive
 faith,Patient Power,Negative
 faith,Andrew Schorr,Negative
 curveball,Patient Power,Negative
 Randomized Phase III RESONATE PCYC Trial,chonsone,Positive
 „Äê „Éã„É•„Éº„Çπ„ÄëBTKÈòªÂÆ≥Ëñ¨„Ç´„É´„ÇØ„Ç®„É≥„Çπ„Åå„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„Åæ„Åü„ÅØÂ∞è„É™„É≥„ÉëÁêÉÊÄß„É™„É≥„ÉëËÖ´„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩ„ÅßÊâøË™çELEVATETNË©¶È®ì„Åß„ÅØ„ÄÅ„Ç´„É´„ÇØ„Ç®„É≥„Çπ‰ΩµÁî®ÁôÇÊ≥ï„ÅØ„ÄÅÁóÖÂã¢ÈÄ≤Ë°å„Åæ„Åü„ÅØÊ≠ª‰∫°„É™„Çπ„ÇØ„ÅåÔºÖÊ∏õÂ∞ë„Åó„ÄÅ„Ç´„É´„ÇØ„Ç®„É≥„ÇπÂçòÂâ§ÁôÇÊ≥ï„Åß„ÇÇÔºÖÊ∏õÂ∞ë„Åó„Åæ„Åó„Åü „Ç´„É´„ÇØ„Ç®„É≥„Çπ,„Åå„Çì„Éó„É©„Çπ,Negative
 Fungal Infections,National Aspergillosis Centre,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market Analysis,Crwe World,Negative
 Recent Market Developments,Crwe World,Negative
 Industry Forecast,Crwe World,Negative
 CLL patient Dave Kasanicky,Patient Power,Negative
 caregiver,Patient Power,Negative
 caregiver,HGSMVM‚ù§Ô∏è,Positive
 caregiver,MD Anderson Cancer Center,Negative
 Lynnda,Patient Power,Negative
 Happy Holidays,ESCofNJ,Negative
 faculty staff,ESCofNJ,Negative
 students,ESCofNJ,Positive
 students,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 students,CLL Warwick Uni,Positive
 students,Chris Thomson,Negative
 ESCNJ,ESCofNJ,Negative
 facilities,ESCofNJ,Negative
 Winter Recess,ESCofNJ,Negative
 classes,ESCofNJ,Negative
 classes,CLL Warwick Uni,Negative
 Thursday Jan,ESCofNJ,Negative
 Hidden Forces podcast,CLL Society Inc.,Negative
 Demetri KofinasPlease retweet,CLL Society Inc.,Negative
 Cost Effectiveness,OncLive.com,Negative
 TimeLimited Therapy,OncLive.com,Negative
 TimeLimited Therapy,CancerWallonia,Positive
 VenetoclaxObinutuzumab,OncLive.com,Negative
   inhibitor,Dave Hughes,Positive
   inhibitor,VJHemOnc,Negative
 New article Angioedema,Paperbirds_Hematology,Negative
 van Oers,Toby Eyre,Negative
 et al Blood Cancer Journalfinal analysis,Toby Eyre,Negative
   management,Toby Eyre,Negative
   management,wandering md,Positive
   response rate,MDEdge,Positive
   response rate,MDedge Hematology & Oncology,Positive
   response rate,OncLive.com,Negative
 CLL immunology review,Elaine Schattner,Negative
 Tlymphocytes Rx resistance,Elaine Schattner,Negative
 Effective Immunotherapy,Elaine Schattner,Negative
 Effective Immunotherapy,Paperbirds_Hematology,Negative
 BET inhibitor GS,Paperbirds_Hematology,Negative
 eEFA,Paperbirds_Hematology,Negative
 aptamersiRNA,Paperbirds_Hematology,Negative
 T Cells,Paperbirds_Hematology,Negative
 T Cells,"Raul Cordoba, MD, PhD",Negative
 T Cells,Francesco Turturro,Negative
 CLL„ÄÅ„ÄÅ„ÄÅ„Ç§„Éñ„É´„ÉÅ„Éã„ÉñÈï∑ÊúüÈñì‰ΩøÁî®„Åó„Å¶„ÅÑ„ÅÑ„ÇÇ„ÅÆ„Åã„ÄÇÊ≠¢„ÇÅ„Çå„Å∞ÁôΩË°ÄÁêÉ‰∏äÊòáÈñìÈÅï„ÅÑ„Å™„ÅÑ„Åó„ÄÅ„ÄÅ„ÄÅ„Ç∏„É¨„É≥„ÉûÔºÉ„Ç§„Éñ„É´„ÉÅ„Éã„Éñ   ÔºÉÂâØ‰ΩúÁî®,ÊòüÂ±ë„Éã„É£„Éº,Positive
 Relapsed Follicular Lymphomaand,Benlazar S.M Amin√©,Negative
 holiday fun,ESCofNJ,Negative
 photos,ESCofNJ,Negative
 photos,Chelsea‚ú®,Positive
 photos,VJHemOnc,Negative
 NuView Academy,ESCofNJ,Negative
 TRANSCEND    study,Benlazar S.M Amin√©,Negative
 Por Siempre tu alegr√≠a,Dario Antilen,Positive
 m√≠a tambi√©n,Dario Antilen,Positive
 ah√≠,Dario Antilen,Positive
 Ô∏è ü§° Vivan,Dario Antilen,Positive
 Monsanto Roundup cancer lawsuits,Matthews & Associates,Positive
 Epigenomics,Mary Ruberry,Positive
 Epigenomics,Nutritional Epigenetic News,Positive
 Epigenomics,Muin J. Khoury,Positive
 cancerNonHodgkin,Matthews & Associates,Positive
 LymphomaLarge Diffuse BcellFollicullar LymphomaCutaneous TCellAnapalastic TcellChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell LymphomaPrimary Central Nervous System CNS Lymphoma,Matthews & Associates,Negative
 Efficacy results,EurekaMag,Negative
 Efficacy results,Lymphoma Papers,Negative
 Efficacy results,"Raul Cordoba, MD, PhD",Negative
 firstline idelalisib,EurekaMag,Negative
 firstline idelalisib,Lymphoma Papers,Negative
 firstline idelalisib,"Raul Cordoba, MD, PhD",Negative
   Scholar Award,FEDERICO GAITI,Positive
   Scholar Award,"David Bartlett, PhD",Negative
 lineage transformation,FEDERICO GAITI,Positive
 Chart,WheelieDealer,Negative
 Triangle,WheelieDealer,Negative
 Breakout Level,WheelieDealer,Negative
 Forward pe,WheelieDealer,Negative
 ish,WheelieDealer,Negative
 Divvy,WheelieDealer,Negative
   accessibility,Xuan Shirley Li,Positive
 use case,Xuan Shirley Li,Positive
 foothold,OncLive.com,Negative
 Rigtig Gl√¶delig Jul,LyLe Foreningen,Negative
 og Lykkebringende Godt Nyt√•r F√∏lg,LyLe Foreningen,Negative
 og vi,LyLe Foreningen,Negative
 FirstInHuman Phase,Paperbirds_Hematology,Negative
 APPLY scholarships,ESH (Haematology),Negative
 registration fee,ESH (Haematology),Negative
 st Translational Research Conference Chronic Lymphocytic LeukaemiaMarch    ‚û°,ESH (Haematology),Negative
 exercise training,"David Bartlett, PhD",Negative
 Chronic Lymphocytic Leukemia watchful,Cancer Support Community,Negative
 waiting,Cancer Support Community,Negative
 waiting,Andrew Schorr,Negative
 conformational dynamics,Paperbirds_Hematology,Negative
 TyrCys mutation,Paperbirds_Hematology,Negative
 protection,Paperbirds_Hematology,Negative
 telomeres,Paperbirds_Hematology,Negative
 gene,Paperbirds_Hematology,Negative
 Tenalisib RP,TrialBulletin,Negative
 Tenalisib RP,CureHuntr,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia CLL Status Recruiting Condition Summary Leukemia Lymphocytic Chronic BCell,TrialBulletin,Negative
 CLL Anthony R Mato MD MSCE,COPD News,Negative
 video discussions,Andrew Schorr,Negative
 great,Andrew Schorr,Negative
 lot coming,Andrew Schorr,Negative
 location,Esther Schorr,Negative
 location,iwCLL,Negative
 woman,CURE Magazine,Negative
 woman,Amy C. Cavers,Negative
 woman,Matthews & Associates,Negative
   Efficacy,CureHuntr,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia CLL,CureHuntr,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia CLL,Saeed Valadbaygi,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia CLL,Stock Market News,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia CLL,MasdelMedio,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia CLL,pressdaily,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia CLL,Pharma News,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia CLL,Rare Disease Report,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia CLL,Dr. Melody Davis,Negative
 agreement,Simple Charts,Negative
 agreement,Crwe World,Negative
 panCanadian Pharmaceutical Alliance,Simple Charts,Negative
 panCanadian Pharmaceutical Alliance,Crwe World,Negative
 Combination VENCLEXTA,Simple Charts,Negative
 Dr Kanti Rai,The Tisch Cancer Institute,Positive
 Dr Kanti Rai,"Tian Zhang, MD, MHS",Positive
 Dr Kanti Rai,"Neil Sankar M.D.,MPH",Positive
 Dr Kanti Rai,Vincent Rajkumar,Negative
 Dr Kanti Rai,JanssenUS,Negative
 Dr Kanti Rai,NU Internal Medicine,Positive
 Dr Kanti Rai,Patient Power,Negative
   Stories,Oncology,Negative
 Treatment Discontinuation,Oncology,Negative
 Dr Isabel Cunningham,Oncology,Positive
 Cytogenetic landscape,Biosimilar Today iMagazine,Negative
 Quedate con quien te mire como,Dario Antilen,Positive
 Tony Pogo,Dario Antilen,Positive
 Optimized Xenograft Protocol,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Results,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Results,papersformax,Positive
 Chronic Lymphocytic Leukemia Results,Jerry Lee,Negative
 Chronic Lymphocytic Leukemia Results,Cancer Papers,Negative
 High Engraftment Efficiency,Paperbirds_Hematology,Negative
 CLL Subgroups,Paperbirds_Hematology,Negative
 MedlinePlus,Carolyn Matyjanka,Positive
 career,MD Anderson Cancer Center,Negative
 career,COPD News,Negative
 career,VJHemOnc,Positive
 astronauts,MD Anderson Cancer Center,Negative
 Diagnosisamp Treatment,Lifewaysvillage.com/lifestyle,Negative
 Diagnosisamp Treatment,Med Perfectionalis,Negative
 CLL expert Dr William Wierda,Patient Power,Negative
 Orlando,Patient Power,Negative
 Orlando,idw Nachrichten,Positive
 Orlando,CLL Society Inc.,Negative
 Orlando,Lymphoma Hub,Negative
 Orlando,Lymphoma Coalition,Negative
 treatment effect management testing,Patient Power,Negative
 Travelling extras,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 snapshots,ESCofNJ,Positive
 Lifelong Learnings,ESCofNJ,Negative
 retweet,eos,Positive
 retweet,Nick,Negative
 retweet,Equality Couple,Negative
 CERTHellas RT VJHemOnc VIDEO BCR receptor sterotypes,eos,Positive
 CERTHellas,eos,Positive
 VJHemOnc,eos,Positive
 VJHemOnc,Dr Timos Papagatsias,Negative
 VJHemOnc,VJHemOnc,Negative
 Y que van hacer enanos cuando regrese,Lenko Sins,Positive
 Snyder,„Éá„É¨„Çπ„ÉÜÊîªÁï•ÈÄüÂ†±Ôº†ÁÆ°ÁêÜ‰∫∫,Positive
 Web site,„Éá„É¨„Çπ„ÉÜÊîªÁï•ÈÄüÂ†±Ôº†ÁÆ°ÁêÜ‰∫∫,Positive
 Informative review,"Shonali Midha, M.D.",Positive
 Jonathan Ferland,C√©gep de L√©vis,Positive
 √©t√© nomm√© entra√Æneurchef de l√©quipe de hockey,C√©gep de L√©vis,Positive
 masculin D des Faucons,C√©gep de L√©vis,Positive
 du C√©gep de L√©visLauzon,C√©gep de L√©vis,Positive
 WATCH Dr Danilov,OncLive.com,Negative
 Rituximab Biosimilars,OncLive.com,Negative
    Dream team,Michele Nadeem-Baker,Negative
 Press,"Mazyar Shadman, MD MPH",Negative
 venetoclax Video,JADPRO,Negative
 Genetic Polymorphisms,Paperbirds_Hematology,Negative
 Bcell CLLlymphoma,Paperbirds_Hematology,Negative
 Confer Susceptibility,Paperbirds_Hematology,Negative
 Antituberculous Therapy Associated Drug Induced Liver Injury,Paperbirds_Hematology,Negative
 Venetoclax chemotherapyfree combination regimen,Carlo Franzini,Negative
 Leukemia amp Lymphoma,Taylor & Francis Medicine and Health,Positive
 Rituximab Biosimilar,OncLive.com,Negative
 Rituximab Biosimilar,MD Anderson Leukemia,Negative
 CD BCell NonHodgkin,OncLive.com,Negative
 WATCH Dr Smith,OncLive.com,Negative
 Fixed Duration Trial,OncLive.com,Negative
   Refractory Chronic Lymphocytic Leukemia CLL Clinical Trials Guide Companies Drugs Phases,CRO Contract Res.,Positive
 Current Status,CRO Contract Res.,Positive
 Current Status,Renal Cell Carcinoma,Positive
 New Evaluating blood,Medivizor,Negative
 Recomendamos el material,Revista El Repollero,Positive
 de   con Kari Vega   una,Revista El Repollero,Positive
 basquet y f√∫tbol campeona con,Revista El Repollero,Positive
 ‚ö° Ô∏è ‚Äú   Elderly onset,#MondayNightIBD,Positive
 malignancy,#MondayNightIBD,Positive
 malignancy,Nature Reviews Disease Primers,Negative
 malignancy,BloodWork,Positive
 New article Overexpression,Paperbirds_Hematology,Negative
 Targeted Combos Deal,Cancer Health,Negative
 Double Blow,Cancer Health,Negative
 Concursa,Giannina,Positive
 mis,Giannina,Positive
 sociales,Giannina,Positive
 o   y estar√°s participando por una de dos entradas individuales para el √∫ltimo e del √±o,Giannina,Positive
   B,Renal Cell Carcinoma,Positive
 Cell Chronic,Renal Cell Carcinoma,Positive
 Lymphocytic Leukemia,Renal Cell Carcinoma,Positive
 Lymphocytic Leukemia,Todd C Bertsch,Positive
 Lymphocytic Leukemia,Trip Database,Negative
 Lymphocytic Leukemia,Augustino Chengula,Positive
 Lymphocytic Leukemia,Matthews & Associates,Positive
 Lymphocytic Leukemia,Dr. Sujie Tang,Positive
 Lymphocytic Leukemia,Children's Wish,Positive
 Clinical Trials Guide Companies,Renal Cell Carcinoma,Positive
 Drugs Phases,Renal Cell Carcinoma,Positive
 FourYear Analysis,Ang√©lica Aranda,Positive
 Sustained Benefit,Ang√©lica Aranda,Positive
 Sustained Benefit,Benlazar S.M Amin√©,Negative
 TimeLimited VenetoclaxRituximab VenR,Ang√©lica Aranda,Positive
 TimeLimited VenetoclaxRituximab VenR,Benlazar S.M Amin√©,Negative
 RelapsedRefractory RR Chronic Lymphocytic Leukemia CLL,Ang√©lica Aranda,Positive
 RelapsedRefractory RR Chronic Lymphocytic Leukemia CLL,Jeff Szer,Positive
 access issue,"Mazyar Shadman, MD MPH",Negative
 countries,"Mazyar Shadman, MD MPH",Negative
 countries,CLL Advocates Network,Positive
 countries,CryptoLiveLeak,Negative
 countries,Judith Trotman,Positive
 countries,CML AdvocatesNetwork,Negative
 countries,Dustin Phan,Positive
 rick simpson oil,CP DA DON,Positive
 Alexey,Jessica Okosun,Positive
 Realworld data research,RTI Health Solutions,Negative
 bone,ACS Journal Cancer,Negative
 bone,Atrium Health Navicent,Positive
 bone,Hematopoiesis,Positive
 marrow cancer,ACS Journal Cancer,Negative
 study findings,APSHO,Negative
 Karyotypes,Grup de Recerca Translacional Hematologia_GRETNHE,Positive
 MBL Trisomy,Grup de Recerca Translacional Hematologia_GRETNHE,Positive
 VIDEO Fiveyear,VJHemOnc,Negative
 UK   Forum,VJHemOnc,Negative
 UK   Forum,Michael Moles,Positive
 ibrutinib data,VJHemOnc,Negative
 impact treatment,Patient Empowerment Network,Negative
 Dr Kerry Rogers,Patient Empowerment Network,Positive
 Dr Kerry Rogers,The James,Positive
 Dr Kerry Rogers,Andrew Schorr,Negative
 Dr Kerry Rogers,Patient Power,Positive
 Dr Kerry Rogers,CLL Ireland,Negative
 Twodrug combination,Cancer News,Negative
 Twodrug combination,Richard Lobb,Positive
   member Sandra E Kurtin PhD ANPC AOCN,APSHO,Negative
 James Kay,HemOnc Today,Negative
 complaint Otis Chapman,GMO Free USA,Negative
 Dr Pipa√≥n,Paula R√≠o,Positive
 FANCA expression,Paula R√≠o,Positive
 J Bcell,Stefano Cattaneo DVM,Negative
 opportunity SUBMIT,ESH (Haematology),Negative
 Translational Research Conference,ESH (Haematology),Negative
 Chronic Lymphocytic Leukaemia March,ESH (Haematology),Negative
 J Brown P Ghia M HallekSubmit,ESH (Haematology),Negative
 hashtags,Yasin Murat Yiƒüit,Positive
 Hematology Orlando  ,Yasin Murat Yiƒüit,Positive
 users,Yasin Murat Yiƒüit,Positive
 users,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 Centre,Manav Rachna,Positive
 Centre,Dr Anya Hotinski,Positive
 Lifelong Learning,Manav Rachna,Positive
 Lifelong Learning,ESCofNJ,Positive
 Lifelong Learning,nwfdailynews,Positive
 Lifelong Learning,Lifelong Learning,Negative
 working professionals,Manav Rachna,Positive
 Las   se consagran campeonas tambi√©n del,Revista El Repollero,Positive
 Clausura,Revista El Repollero,Positive
 En La Huerta festejaron un nuevo t√≠tulo donde lo ganaron de punta,Revista El Repollero,Positive
 punta,Revista El Repollero,Positive
 ¬° Felicitaciones chicas,Revista El Repollero,Positive
 Epigenetics,Nutritional Epigenetic News,Positive
 Epigenetics,Lymphoma Hub,Negative
 Congratulation Con,Donna Gairns,Positive
   cities,ToppsMuchoBB,Positive
   RT,ToppsMuchoBB,Positive
 Departure dates,ToppsMuchoBB,Positive
 Airports,ToppsMuchoBB,Positive
 Connections,ToppsMuchoBB,Positive
 Great Deal,ToppsMuchoBB,Positive
 VIDEO CAPTIVATE ibrutinibvenetoclax,VJHemOnc,Negative
 CLL symptoms,Patient Empowerment Network,Negative
 Novel Comorbidity Score,Chocolatiere Phys,Negative
 Oncology Times,Chocolatiere Phys,Positive
 Oncology Times,Benlazar S.M Amin√©,Negative
 Dr Pamela Crilley Chair,Cancer Treatment Centers of America (CTCA),Positive
 CTCA Department,Cancer Treatment Centers of America (CTCA),Positive
 Jeff Folloder,Patient Power,Positive
 CLL expert Dr Edward Faber,Patient Power,Negative
 treatment strategies,Patient Power,Positive
 treatment strategies,Invivoscribe,Positive
 treatment strategies,VJHemOnc,Negative
 treatment strategies,Clinical Trials,Negative
 risks,Patient Power,Positive
 risks,Talal Hilal ü©∫,Positive
 risks,"chadi nabhan MD, MBA, FACP",Negative
 risks,MD Anderson Leukemia,Negative
 risks,VJHemOnc,Negative
 risks,AJMC,Negative
 risks,Janssen Nederland,Positive
 Intersyndical National des Organisations Syndicales,SNU P√¥le Emploi FSU Occitanie,Negative
 l√¢che RIEN,SNU P√¥le Emploi FSU Occitanie,Negative
 O√π sont,SNU P√¥le Emploi FSU Occitanie,Negative
 Avec,SNU P√¥le Emploi FSU Occitanie,Negative
 Firstline treatment,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 arm C,OncLive.com,Negative
 arm C,Chan Cheah,Negative
 SEQUOIA,OncLive.com,Negative
 TP Gene Promoter Methylation,vlDNApapers,Positive
 TP Gene Promoter Methylation,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia Pathogenesis,vlDNApapers,Positive
 Chronic Lymphocytic Leukemia Pathogenesis,Paperbirds_Hematology,Negative
 rd January,CLLSA,Negative
   er meget omtalt,LyLe Foreningen,Negative
 risk factor,"Hawkins Gay, MD, MPH",Negative
 Vitamin D,Turmeric,Negative
 New article Inhibition,Paperbirds_Hematology,Negative
   PbNNV,Savepig Invest #GotSilver,Positive
 Novel Targeted Alpha Therapy,Savepig Invest #GotSilver,Positive
 loss,Zusia:Dr Jackie Volk,Positive
 loss,Journal of Leukocyte Biology,Positive
 tumor suppressor gene,Zusia:Dr Jackie Volk,Positive
 ‚ôÇ Ô∏èlevels,Lymphoma Hub,Negative
   influencer,Lymphoma Hub,Negative
 üßê Hypertension,Nicolas Gendron,Positive
 Vor wenigen Minuten endete,idw Nachrichten,Positive
 Erstmals berichtet,idw Nachrichten,Positive
 das,idw Nachrichten,Positive
 das,DocCheck,Positive
 der Reihe LymphomKompetenz KOMPAKT,idw Nachrichten,Positive
 mit kurzen Videoberichten von diesem Kongress      Gru√üwort,idw Nachrichten,Positive
 close,Dana-Farber News,Positive
 close,AbbVie,Negative
 Amy Pierre,APSHO,Negative
 Ibrutinib Obinutuzumab,APSHO,Negative
 Marie Benz MD FAAD MURANO Study Confirms Sustained Benefit,ScienceSeeker Feed,Positive
 TimeLimited VenetoclaxRituximab,ScienceSeeker Feed,Positive
 Gonzalo Blanco,Hospital del Mar_Translational Hematology,Positive
 Poster,Hospital del Mar_Translational Hematology,Positive
 Poster,Verastem Oncology,Negative
 Poster,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 Poster,"chadi nabhan MD, MBA, FACP",Negative
 Poster,"Pharmacyclics, an AbbVie Company",Negative
 Robust Pace,Pharma News,Negative
 cycles,OncLive.com,Negative
 cycles,Patient Power,Negative
 cycles,CLLSA,Negative
 cycles,Anna Deveau,Negative
 Cytokine Analyses,gilbert c faure,Negative
 Markers,gilbert c faure,Negative
 Markers,Paperbirds_Hematology,Negative
 CLLlike Monoclonal BCell Lymphocytosis,gilbert c faure,Negative
 S√Ö god,LyLe Foreningen,Negative
 kommer sj√¶ldent,LyLe Foreningen,Negative
 √¶mi,LyLe Foreningen,Positive
 Merck,Market Intelligence: Healthcare,Positive
 precision medicine pipeline,Market Intelligence: Healthcare,Positive
 B ArQule deal,Market Intelligence: Healthcare,Positive
 Merck access,Market Intelligence: Healthcare,Positive
 ArQules,Market Intelligence: Healthcare,Positive
 pipeline product ARQ,Market Intelligence: Healthcare,Positive
 CDdirected   therapy lisocel,OncLive.com,Negative
 Hall B Level,"Bionano Genomics, Inc.",Positive
 Blanca Espinet,"Bionano Genomics, Inc.",Positive
 Blanca Espinet,VJHemOnc,Negative
 banding analysis,"Bionano Genomics, Inc.",Positive
 microarrays,"Bionano Genomics, Inc.",Positive
 Bionano   data,"Bionano Genomics, Inc.",Positive
 Chronic Lymphocytic Leukemia CLL patients,"Bionano Genomics, Inc.",Positive
 Chronic Lymphocytic Leukemia CLL patients,Patient Empowerment Network,Negative
 Chronic Lymphocytic Leukemia CLL patients,Children's Melanoma,Positive
 Chronic Lymphocytic Leukemia CLL patients,SunAWARE,Positive
 BTK inhibitor zanubrutinib,OncLive.com,Negative
 Aurora Research Institute,Aurora Health Care,Positive
 Tcell function,Takeda Oncology,Positive
 Tcell function,CLL Ireland,Negative
 Tcell function,VJHemOnc,Negative
   syndrome,Michael Dickinson,Negative
 Clare Gould,Michael Dickinson,Negative
 Piers Blombery,Michael Dickinson,Negative
 Wilson Grant,Michael Dickinson,Negative
   attendees,"Bionano Genomics, Inc.",Positive
   attendees,AstraZenecaUS,Negative
 CLL Prognosis,Mustafa F,Positive
 Treatment Options,Mustafa F,Positive
 Treatment Options,Leukemia Research Foundation,Negative
 Treatment Options,OncLive.com,Negative
 Treatment Options,Patient Power,Negative
 Treatment Options,Oncology Tube,Negative
 Treatment Options,AJMC-Oncology,Negative
 Treatment Options,AJMC,Positive
 Treatment Options,TawasulLinks ÿ™ŸàÿßÿµŸÑ,Negative
 MRKs acquisition,BiopharmIQ by Amp,Positive
 RelapsedRefractory CLLSLL,OncLive.com,Negative
   MSK,Memorial Sloan Kettering Cancer Center,Negative
 stem,Memorial Sloan Kettering Cancer Center,Negative
 stem,ISTH President,Positive
 cell transplants,Memorial Sloan Kettering Cancer Center,Negative
 blood clots,Memorial Sloan Kettering Cancer Center,Negative
 CDK inhibitor,Stock Sharks,Positive
 CDK inhibitor,OncoTherapy Network,Negative
 SEQUOIA trial,Targeted Oncology,Negative
 tyrosine kinase inhibitor,Targeted Oncology,Negative
 tyrosine kinase inhibitor,NEJM Journal Watch,Negative
 tyrosine kinase inhibitor,HemOnc Today,Positive
 tyrosine kinase inhibitor,Blood Journal,Negative
 tyrosine kinase inhibitor,Healio,Negative
 Overall Survival Benefits,LLZ Consulting,Negative
 Overall Survival Benefits,1stOncology,Negative
 Overall Survival Benefits,Saeed Valadbaygi,Negative
 Overall Survival Benefits,Crwe World,Negative
 Overall Survival Benefits,Stock Market News,Negative
 Overall Survival Benefits,Simple Charts,Negative
 Overall Survival Benefits,MasdelMedio,Negative
 Overall Survival Benefits,pressdaily,Negative
 Overall Survival Benefits,Pharma News,Positive
 VENCLYXTO ¬Æ venetoclax Combination,LLZ Consulting,Negative
 VENCLYXTO ¬Æ venetoclax Combination,Saeed Valadbaygi,Negative
 VENCLYXTO ¬Æ venetoclax Combination,Stock Market News,Negative
 VENCLYXTO ¬Æ venetoclax Combination,Simple Charts,Negative
 VENCLYXTO ¬Æ venetoclax Combination,MasdelMedio,Negative
 VENCLYXTO ¬Æ venetoclax Combination,pressdaily,Negative
 VENCLYXTO ¬Æ venetoclax Combination,Pharma News,Positive
 REGRESSION ANALYSIS,Prof John,Negative
 Fantastic work,Prof John,Negative
 Fantastic work,Dr Effie Kostareli,Negative
 Fantastic work,CLL Ireland,Negative
 amp Co,Prof John,Negative
 Demonstration,"Bruce Levine, Ph.D.",Positive
 CAR   function,"Bruce Levine, Ph.D.",Positive
 MURANO update,VJHemOnc,Negative
 timelimited VenR amp biomarkers,VJHemOnc,Negative
 w Arnon Kater,VJHemOnc,Positive
 Jessica,LYMPHOMA & MYELOMA CONNECT,Negative
 James Kaye,RTI Health Solutions,Negative
 amp Johnsons,Daniel Kovach,Positive
 Sales Beat Roches,Daniel Kovach,Positive
 Combination Therapy Data,HEDGE accordinglyüìà,Negative
 Combination Therapy Data,pressdaily,Negative
 Studies,HEDGE accordinglyüìà,Negative
 Studies,Saeed Valadbaygi,Negative
 Studies,pressdaily,Negative
 Studies,Michele Nadeem-Baker,Negative
 Studies,Matthews & Associates,Positive
 Studies,Jordan Gauthier,Positive
 Studies,NACDA Program on Aging,Negative
 Studies,Financial Buzz,Negative
 Studies,Lymphomation.org,Negative
 Studies,CareAcross,Negative
 Studies,Huntsville AL Now,Positive
 LongTerm Integrated Analysis,HEDGE accordinglyüìà,Negative
 LongTerm Integrated Analysis,Saeed Valadbaygi,Negative
 LongTerm Integrated Analysis,pressdaily,Negative
 ASH   Efficacy,HEDGE accordinglyüìà,Negative
 ASH   Efficacy,Saeed Valadbaygi,Negative
 ASH   Efficacy,pressdaily,Negative
 JNJ RHHBY NEW ARTICLE,STCK.PRO,Positive
 Johnson amp Johnson,STCK.PRO,Positive
 Imbruvica Sales Beat Roche,STCK.PRO,Positive
 Frontline IbrutinibVenetoclax,CellworksLife,Negative
    subset,Lymphoma Hub,Negative
 Sequioa trial,Lymphoma Hub,Negative
 clinicians,ASH Clinical News,Negative
 clinicians,Sigrid Sk√•nland,Negative
 clinicians,NCI Center for Cancer Research,Positive
 clinicians,CLL Ireland,Negative
 clinicians,Nick,Negative
 clinicians,VJHemOnc,Negative
 associated outcomes,ASH Clinical News,Negative
 monotherapies,Dana-Farber News,Positive
 DanaFarbers Jennifer Crombie MD,Dana-Farber News,Positive
 improved therapy,Dana-Farber News,Positive
 dog,Stefano Cattaneo DVM,Positive
 dog,Michelle Collett,Positive
 nursery rhyme area,Orchard Primary Academy Nursery,Negative
 Inhibitor Exhibits Broad Signaling Inhibition,Grant Beasley,Positive
 Inhibitor Exhibits Broad Signaling Inhibition,Joe,Negative
 Yue Lynn Wang,medwireNews,Negative
 AbbVies,Saeed Valadbaygi,Negative
 AbbVies,EMG GOLD,Positive
 AbbVies,1stOncology,Negative
 AbbVies,Krishan Maggon,Negative
   Announces Oral Presentation,1stOncology,Negative
 Triple Combination Phase III Data,1stOncology,Negative
 patients w Danielle Brander,VJHemOnc,Negative
 abstract   Innovative Telemedicine Platform,CLL Society Inc.,Negative
 Expert Access,CLL Society Inc.,Positive
 Dinner meeting,Sigrid Sk√•nland,Negative
 highlight,Michael Hallek,Negative
 ASH meetings,Michael Hallek,Negative
 friends Discovery,Michael Hallek,Negative
 Trials findings,Hottest Stocks Now,Negative
 Lots,medwireNews,Negative
 Lots,"Amber Koehler, PA-C",Negative
 Lots,CLL Ireland,Negative
 Lots,RIOH,Negative
 Lots,Andrew Schorr,Negative
 Lots,DEYTS,Positive
 Lots,Oxford Media Factory,Positive
 Lots,David Costello,Positive
 Seth Karol,medwireNews,Negative
    VS ‚è± Ô∏è,Club Libertad Limpe√±o,Positive
 FINAAAL,Club Libertad Limpe√±o,Negative
 ‚ö™ ‚ö´,Club Libertad Limpe√±o,Positive
 Kitchen Tip,Eann Olsson,Positive
 NonStick pans,Eann Olsson,Positive
 ST,Club Libertad Limpe√±o,Positive
 Liza Larrea por Karina Vega,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è   ST,Club Libertad Limpe√±o,Positive
 GOOOOOOOOL ‚öΩ,Club Libertad Limpe√±o,Negative
 Stephanie Lacoste,Club Libertad Limpe√±o,Negative
 Stephanie Lacoste,Radio La Red 102.1FM,Negative
 ORRResponses,Kevin Wolcott,Positive
 BTK Resistance BTK Intolerance,Kevin Wolcott,Positive
 Threequarters,Mary Caffrey,Positive
 IbrutinibVenetoclax Combo,Mary Caffrey,Positive
 therapy post venetoclax discontinuation,Pallawi Torka,Positive
    VS ‚è± Ô∏è Inici√≥ el ST,Club Libertad Limpe√±o,Negative
 Griselda Garay por Yanina L√≥pez,Club Libertad Limpe√±o,Negative
 action Lovely presentation,Kate Whitaker,Positive
 BeiGene Announces Clinical Data,Diagnostics News,Negative
 BeiGene Announces Clinical Data,Trading News,Positive
 BRUKINSA Zanubrutinib,Diagnostics News,Negative
 st American Society,Diagnostics News,Negative
 st American Society,Trading News,Positive
   presenting data,"Amber Koehler, PA-C",Positive
 noncovalent BTK inhibitor,"Amber Koehler, PA-C",Negative
    VS ‚è± Ô∏è Entretiempo    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Backtoback Zanubrutinib presentation,Taylor Lab UM,Negative
 Compelling   data,Michael Dickinson,Negative
 Prof Tam,Michael Dickinson,Negative
 frontline p del    ORR,Taylor Lab UM,Negative
 Grade,Taylor Lab UM,Negative
 Nairelis Gutierrez por Laurie Cristaldo,Club Libertad Limpe√±o,Negative
 Session,Taylor Lab UM,Negative
 Session,Patient Power,Negative
 Session,ConferenceSeries,Positive
 CART cells,Taylor Lab UM,Negative
 CART cells,CancerTherapyAdvisor,Negative
 CART cells,Medivizor,Positive
 CART cells,Devan Moodley,Positive
 CART cells,Gaurab Chakrabarti,Positive
    VS ‚è± Ô∏è Arranc√≥ el partido,Club Libertad Limpe√±o,Negative
 Benjamin Lampson MD PhD,Dana-Farber News,Positive
 Fixedduration treatment,Targeted Oncology,Negative
 patients ‚â§ years,OncLive.com,Negative
 New LongTerm,Saeed Valadbaygi,Negative
 PRNewswire,Saeed Valadbaygi,Positive
 PRNewswire,RazzleTazzle,Positive
 firstline combination,OncLive.com,Negative
 earlystage study,Hottest Stocks Now,Positive
 triplecombo ublituximab,Hottest Stocks Now,Negative
 CLL Expert Edward Faber,Patient Power,Negative
   Wow Standing room,Katrina Sondermann,Positive
 amp Resistance,Katrina Sondermann,Positive
 Eloquent review,"Shonali Midha, M.D.",Positive
 comparison ofprogression,"Shonali Midha, M.D.",Positive
   Distinct growth,Fernando Mart√≠n Moro,Positive
 Stats,VJHemOnc,Negative
     Dr Woyach,Lucrecia Ya√±ez,Positive
 Stop,BeiGene,Negative
 Hall D,BeiGene,Negative
 Catherine J Wu,Sigrid Sk√•nland,Negative
 Catherine J Wu,Vall d'Hebron Institut de Recerca,Positive
 Dr Wu,"Amber Koehler, PA-C",Negative
 poster hall,Milo≈° Miljkoviƒá,Positive
 Umbralisibublituximabvenetoclax,Sigrid Sk√•nland,Negative
 Paul M Barr,Sigrid Sk√•nland,Negative
 BTK refractory,"Amber Koehler, PA-C",Negative
 DNA damage response,Tamar Aprahamian,Positive
 DNA damage response,Lymphoma Papers,Negative
 relapsedrefractory Bcell nonHodgkin,Tamar Aprahamian,Positive
 relapsedrefractory Bcell nonHodgkin,Blood Journal,Negative
 Ibrutinibvenetoclax,Sigrid Sk√•nland,Negative
 Nitin Jain,Sigrid Sk√•nland,Negative
 Nitin Jain,Lymphoma Hub,Negative
 Nitin Jain,VJHemOnc,Negative
 Nitin Jain,"Mike Thompson, MD, PhD, FASCO",Negative
 Dr Rai,Eduardo Flavio Oliveira Ribeiro,Negative
 Dr Rai,Targeted Oncology,Negative
 Dr Rai,"chadi nabhan MD, MBA, FACP",Positive
 Dr Rai,HappiDoc,Positive
 Dr Rai,Vincent Rajkumar,Positive
 Alexa,Eduardo Flavio Oliveira Ribeiro,Negative
 RHHBY New Data,"OTC Dynamics, Inc.",Negative
 table,"Amber Koehler, PA-C",Negative
 New   Demonstrate,Saeed Valadbaygi,Negative
 RHHBY,Flash Alert,Positive
 RHHBY,PharmaShots - Incisive news in 3 shots,Negative
 RHHBY,Biotech2050,Positive
 New Data Demonstrate,Flash Alert,Negative
 fouryear analysis,Genentech,Negative
 fixedduration chemofree treatment combination,Genentech,Negative
 Combination  ,Saeed Valadbaygi,Negative
 Disease Clearance,Saeed Valadbaygi,Negative
 Disease Clearance,Simple Charts,Negative
 Disease Clearance,VPO/PR Newswire,Negative
 Disease Clearance,pressdaily,Negative
 venetoclax Combination Data High Rates,Company News HQ,Negative
 venetoclax Combination Data High Rates,Crwe World,Negative
 Disease Cl,Company News HQ,Negative
    population,Lymphoma Hub,Negative
   ChemotherapyFree Treatment Combo,SpecialtyPTimes,Negative
 MRD Negativity,SpecialtyPTimes,Negative
 wwierda discusses,Robert Z. Orlowski,Negative
 New analysis,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 treatment patternsoutcomes,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 beneficiaries,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 Relation,PRAJAK BARDE,Positive
 Relation,"chadi nabhan MD, MBA, FACP",Negative
 RT PhysRelations RT ksondermann,Robert Z. Orlowski,Negative
 ‚Äú study,Robert Z. Orlowski,Negative
 ‚Äú study,Katrina Sondermann,Positive
 Dr Jain,Robert Z. Orlowski,Negative
 Dr Jain,Katrina Sondermann,Positive
 Dr Jain,Targeted Oncology,Negative
 Dr Jain,Patient Power,Positive
 upcoming reports,Michele Nadeem-Baker,Negative
 pm EST,Michele Nadeem-Baker,Negative
 midstage study,Hottest Stocks Now,Negative
 possibilities,AbbVie,Negative
   postdoc fellow Dr Deyi Zhang,NIH NHLBI,Negative
 slide sum,Joe,Negative
 APTO Key findings,Joe,Negative
 CG,Joe,Positive
 CG,Cancer Stem Cell News,Negative
   question,Pallawi Torka,Positive
   question,Patient Empowerment Network,Negative
   question,Patient Power,Negative
   question,EYFSMagic,Positive
 Disease Cleara,Crwe World,Negative
 Combination Data High Rates,Simple Charts,Negative
 Combination Data High Rates,VPO/PR Newswire,Negative
 Combination Data High Rates,pressdaily,Negative
    line MRD,Jiajia Liu,Positive
 Kirsten Fisher,The Lancet Haematology,Negative
 frailolder,The Lancet Haematology,Negative
 w frontline fixedduration venetoclaxobinutuzumab,The Lancet Haematology,Negative
 Dr Fischer,"chadi nabhan MD, MBA, FACP",Positive
 future   trials,"chadi nabhan MD, MBA, FACP",Negative
 TP disruption,Toby Eyre,Negative
    MRD news,Michele Nadeem-Baker,Negative
 Ibrutinib   Venetoclax combo,Michele Nadeem-Baker,Negative
 combination BTK,Ayushi Chauhan,Positive
 ibrutinibvenetoclax,Sigrid Sk√•nland,Negative
 ibrutinibvenetoclax,"Michael Wang, MD",Negative
 Constantine S Tam,Sigrid Sk√•nland,Negative
 CAPTIVATE Trial summary,Michele Nadeem-Baker,Negative
 CAPTIVATEMRD,"Amber Koehler, PA-C",Negative
 frontline IV study pts,"Amber Koehler, PA-C",Negative
 Toxicity profile,Toby Eyre,Negative
 Dr Tam colleagues conclusions,"chadi nabhan MD, MBA, FACP",Negative
 CAPTIVATEMRD cohort study,"chadi nabhan MD, MBA, FACP",Negative
 MRD negativity rate,"chadi nabhan MD, MBA, FACP",Negative
 Con Tam,Michael Dickinson,Negative
 Con Tam,Christopher Steer,Positive
 TLS risk,Michael Dickinson,Negative
 TLS risk,Toby Eyre,Negative
 Assessing MRD,"chadi nabhan MD, MBA, FACP",Negative
 Tait Shanafel,The Lancet Haematology,Negative
 morning,"Pharmacyclics, an AbbVie Company",Negative
 morning,"Nadia Naumova, MD",Positive
 morning,CLLUWISTA,Positive
 CLL Oral Presentation Session,"Pharmacyclics, an AbbVie Company",Negative
 landmark Phase   E study,"Pharmacyclics, an AbbVie Company",Negative
 news release,"Pharmacyclics, an AbbVie Company",Negative
 ECOG,Miguel Canales,Positive
 Ibrutinib benefit,Miguel Canales,Positive
 Dr Shanafelt,"chadi nabhan MD, MBA, FACP",Positive
 Dr Shanafelt,ECOG-ACRIN Cancer Research Group,Negative
 coauthors,"chadi nabhan MD, MBA, FACP",Negative
 trail,Carmine DeLuca,Negative
 IR arm,"chadi nabhan MD, MBA, FACP",Negative
 TP mutation,"chadi nabhan MD, MBA, FACP",Negative
 TP mutation,Benlazar S.M Amin√©,Positive
 AVO regimen,Miguel Canales,Positive
 AVO regimen,"chadi nabhan MD, MBA, FACP",Negative
 Dr lampson,"chadi nabhan MD, MBA, FACP",Negative
 Study schema,"chadi nabhan MD, MBA, FACP",Negative
 treatment decision,"chadi nabhan MD, MBA, FACP",Negative
 AVO combination,"chadi nabhan MD, MBA, FACP",Negative
 initiated trial,"chadi nabhan MD, MBA, FACP",Negative
 NovelNovel combinations,Michael Dickinson,Negative
 elevate tn results,Carmine DeLuca,Negative
 Significant HR,Toby Eyre,Negative
 Oacala,Toby Eyre,Negative
 acala,Toby Eyre,Negative
 time benefit,Toby Eyre,Negative
 antiCD mab,Toby Eyre,Negative
 Independent review committee assessment,"chadi nabhan MD, MBA, FACP",Negative
 Study design,"chadi nabhan MD, MBA, FACP",Negative
 ELEVATE trial,"chadi nabhan MD, MBA, FACP",Negative
 room,"chadi nabhan MD, MBA, FACP",Negative
 room,"Tian Zhang, MD, MHS",Positive
 room,Michael Hallek,Negative
 room,Gary Nolan,Positive
 room,"Amber Koehler, PA-C",Negative
 room,CLL Ireland,Negative
 room,Andrew Schorr,Positive
 room,Zack Pemberton-Whiteley,Negative
 morning session,"chadi nabhan MD, MBA, FACP",Negative
 morning session,Lucy Mills,Positive
 morning session,Patient Power,Negative
 RT PhysRelations RT CancerFrontline ‚Äú Venetoclax,Robert Z. Orlowski,Negative
   likelihood,Robert Z. Orlowski,Negative
   likelihood,Cancer Frontline,Positive
 Treatment algorithm,Benlazar S.M Amin√©,Positive
 RelapsedRefractory CLLw,Medscape Education,Negative
 Pivotal FirstLine Studies,Medscape Education,Negative
 Novel Agentsw Prof Philip Thompson,Medscape Education,Negative
 Approved amp,Medscape Education,Negative
 CLL Approved amp,Medscape Education,Negative
 CLL Targeted Therapy,Medscape Education,Negative
 Partialw Prof Danielle Brander,Medscape Education,Negative
 CLL SHOUTOUT,Michele Nadeem-Baker,Negative
 treatment sequence,Oscar Lahoud,Positive
   guideline,ASH19 VIP,Positive
 btk inhibitors,ASH19 VIP,Positive
 btk inhibitors,Carmine DeLuca,Negative
 Richard Furman MD,PeerView,Negative
 Ultimate   Fighter,CLL_Fightersüéó,Positive
 MRD assessment,VJHemOnc,Negative
 Dr William Wierda wwierda,Robert Z. Orlowski,Negative
 LeukemiaMDA        Venetoclax,Robert Z. Orlowski,Negative
 High Rate,Robert Z. Orlowski,Negative
 High Rate,MD Anderson Leukemia,Negative
 Undetectable Minimal Residual Disease RTS,Robert Z. Orlowski,Negative
 Undetectable Minimal Residual Disease RTS,MD Anderson Leukemia,Negative
 Combined Ibrutinib,Robert Z. Orlowski,Negative
 Combined Ibrutinib,MD Anderson Leukemia,Positive
 Combined Ibrutinib,Paperbirds_Hematology,Negative
 Combined Ibrutinib,ALI ALAHMARI.,Negative
 RelapsedRefractory RR Chronic Lymphocytic,Robert Z. Orlowski,Negative
 NitinJainMD,Robert Z. Orlowski,Positive
 NitinJainMD,Dr Timos Papagatsias,Negative
 Enhancing Model Interpretability,Paperbirds_Hematology,Negative
 Accuracy,Paperbirds_Hematology,Negative
 Disease Progression Prediction,Paperbirds_Hematology,Negative
 PhenotypeBased Patient Similarity Learning,Paperbirds_Hematology,Negative
        Venetoclax,MD Anderson Leukemia,Negative
     ,MD Anderson Leukemia,Negative
     ,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Positive
 Ibrutinib Fludarabine Cyclophosphamide,MD Anderson Leukemia,Positive
 Ibrutinib Fludarabine Cyclophosphamide,Robert Z. Orlowski,Negative
 Ibrutinib Fludarabine Cyclophosphamide,Lisa Palacios,Negative
 IGHVMutated CLL,MD Anderson Leukemia,Negative
 DelpMutated TP,MD Anderson Leukemia,Negative
 CLL physician,CLL Society Inc.,Positive
 Allergy,Will,Negative
 Allergy,Anthony Mato,Negative
 Clinical Immunology,Will,Negative
 Clinical Immunology,Anthony Mato,Negative
 JAMA Network Open,Will,Negative
 JAMA Network Open,Anthony Mato,Negative
 JAMA Network,Will,Negative
 JAMA Network,Anthony Mato,Negative
 KDMN KD,Will,Negative
 cGVHD,Will,Negative
    VS ‚è± Ô∏è Final    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è   ST     GOOOOOOOOL   Liza Larrea ‚öΩ ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 ST     ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Liza Larrea por Karina Vega ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 National Comprehensive Cancer Network Volume   Issue,Enfermeria y Seguridad del Paciente,Positive
 GOOOOL,Club Libertad Limpe√±o,Negative
 Liz Pe√±a ‚öΩ ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Carrasquel,Club Libertad Limpe√±o,Negative
 ‚öΩ,Club Libertad Limpe√±o,Positive
    VS ‚è± Ô∏è Empez√≥ el segundo tiempo,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è Final del primer tiempo,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è Inicia el partido,Club Libertad Limpe√±o,Negative
 w Danielle Brander,VJHemOnc,Positive
 Excited,Felix Keller,Positive
 New article Addition,Paperbirds_Hematology,Negative
 Dr O‚ÄôBrien,Liz Brem,Positive
 Dr O‚ÄôBrien,CLL Ireland,Negative
 Longterm safety,Medivizor,Positive
 Longterm safety,"Raul Cordoba, MD, PhD",Negative
 New Longterm safety,Medivizor,Negative
 Excellent overview,Suchitra Sundaram,Positive
 Excellent overview,Teresa Martin,Positive
 Excellent overview,"Raul Cordoba, MD, PhD",Negative
 Mitochondria,RIOH,Negative
 powerhouse,RIOH,Negative
 Discover Verastem Oncology,Verastem Oncology,Positive
 discusses signs,Patient Empowerment Network,Negative
 overtime analysis,Maria Tsagiopoulou,Positive
   profiles,Maria Tsagiopoulou,Positive
 VIDEO Innovations,VJHemOnc,Negative
 CYCC,"khmerxbxboi ""Sot Ali"" (STOCKBUM-God) üá∫üá∏ üá∞üá≠",Positive
 CYCC,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 CYCC,Joe Librescu,Positive
 Title Phase,"khmerxbxboi ""Sot Ali"" (STOCKBUM-God) üá∫üá∏ üá∞üá≠",Positive
 CDK Inhibitor CYC,"khmerxbxboi ""Sot Ali"" (STOCKBUM-God) üá∫üá∏ üá∞üá≠",Positive
 Dr William G WierdaSession,"khmerxbxboi ""Sot Ali"" (STOCKBUM-God) üá∫üá∏ üá∞üá≠",Positive
 CLL T,"khmerxbxboi ""Sot Ali"" (STOCKBUM-God) üá∫üá∏ üá∞üá≠",Positive
 Silent Killer Treatable,Cannabis Insight,Positive
 Silent Killer Treatable,HubRoot,Positive
 Silent Killer Treatable,CannabisNet,Positive
 Cannabis,Cannabis Insight,Positive
 Cannabis,HubRoot,Positive
 Guest commentary,CLL Society Inc.,Negative
   Chronic Lymphocytic Leukemia CLL Clinical Trials Guide Companies Drugs Phases,CRO Contract Res.,Positive
 CLL Trial FixedDuration ChemotherapyFree Regimen,Pacientes LMC,Positive
 CLL Trial FixedDuration ChemotherapyFree Regimen,El tal Toni üéó#JoActuo #LlibertatPresosPolitics,Positive
 Frail Patients,Pacientes LMC,Positive
 Frail Patients,El tal Toni üéó#JoActuo #LlibertatPresosPolitics,Positive
 Florida woman,"Pharmacyclics, an AbbVie Company",Negative
 Florida woman,JanssenUS,Negative
 slowgrowing,JanssenUS,Negative
 slowgrowing,"Pharmacyclics, an AbbVie Company",Negative
 slowgrowing,Janssen EMEA,Negative
 Inside,Blood Journal,Positive
 Blood Commentary,Blood Journal,Positive
 product,AstraZenecaUS,Negative
 Sponsored,MDedge Hematology & Oncology,Negative
 David,LymphomaAction,Negative
 RIP Clive James,LymphomaAction,Negative
 virus,An Deveaux,Positive
 white matter,An Deveaux,Positive
 Anna DeVeaux MSc,An Deveaux,Positive
 chronic l,Medivizor,Negative
 FCRL,Toby Eyre,Negative
 FCRL,Journal of Clinical and Cellular Immunology,Negative
 Superior Clinical Outcome,"Raul Cordoba, MD, PhD",Negative
 Superior Clinical Outcome,Paperbirds_Hematology,Negative
 Superior Clinical Outcome,Benlazar S.M Amin√©,Negative
 Younger Patients,"Raul Cordoba, MD, PhD",Negative
 Younger Patients,Paperbirds_Hematology,Negative
 Younger Patients,Benlazar S.M Amin√©,Negative
 Younger Patients,Dr. JOSE VELASQUEZ,Positive
 Younger Patients,Christopher Steer,Negative
 Chronic Lymphocytic Leukemia CLL Extended Followup,"Raul Cordoba, MD, PhD",Negative
 Chronic Lymphocytic Leukemia CLL Extended Followup,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia CLL Extended Followup,Benlazar S.M Amin√©,Negative
 E Trial,"Raul Cordoba, MD, PhD",Negative
 E Trial,Paperbirds_Hematology,Negative
 E Trial,Benlazar S.M Amin√©,Negative
 Giving,CLL Society Inc.,Negative
 Giving,Higher Ground at Lake Louise,Negative
 Ibrutinib monotherapy,MDEdge,Positive
 Ibrutinib monotherapy,MDedge Hematology & Oncology,Positive
 Ibrutinib monotherapy,CancerTherapyAdvisor,Negative
 attention,Targeted Oncology,Negative
 attention,Jennifer,Positive
 attention,Winship Cancer Institute of Emory University,Negative
 GOOOOOOOOL,Club Libertad Limpe√±o,Negative
 Neily Carrasquel por,Club Libertad Limpe√±o,Negative
 Damia Cortaza,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è   ST      √Ångeles Portillo por Karina Vega,Club Libertad Limpe√±o,Negative
 Fabiola Sandoval ‚öΩ ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Nairelis Guti√©rrez por Laurie Cristaldo,Club Libertad Limpe√±o,Negative
 Karina Vega ‚öΩ ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è Arranc√≥ el segundo tiempo,Club Libertad Limpe√±o,Negative
 Stephanie Lacoste ‚öΩ ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è INICI√ì EL PARTIDO,Club Libertad Limpe√±o,Negative
 fun time,Daniel F. Baranowski,Positive
 Neutron Radiation Therapy,Paperbirds_Hematology,Negative
 Immune Response,Paperbirds_Hematology,Negative
 VIDEO BCR receptor sterotypes,VJHemOnc,Negative
 International Workshop,Patient Power,Negative
 International Workshop,Esther Schorr,Negative
 International Workshop,Medivizor,Positive
 International Workshop,Oncology Tube,Positive
 International Workshop,Connexion Healthcare,Positive
 International Workshop,EventsInAmerica.com,Positive
 International Workshop,Papers Wanted,Positive
 International Workshop,satPRnews,Negative
 International Workshop,VPO/PR Newswire,Negative
 International Workshop,VJHemOnc,Positive
 International Workshop,"Raul Cordoba, MD, PhD",Negative
 International Workshop,Hematopoiesis News,Negative
 New Exchange,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 ListingThe    CLL,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 LOXO trial,MSKHemOncTrials,Positive
 Risk stratifications,Mansour,Positive
 CLL Chronic Lymphocytic Leukemia Market Size,420 Ag,Positive
 Key Players,420 Ag,Positive
 Key Players,Tech Journal Hub,Positive
 F HoffmanLa Roche,420 Ag,Positive
 F HoffmanLa Roche,Total Pharma News,Negative
 Teva Pharmaceuticals Gilead Sciences Johnson amp,420 Ag,Positive
 Johnson,420 Ag,Positive
 Keine M√∂glichkeit zum,Kompetenznetz Maligne Lymphome e.V.,Negative
 zu reisen KMLExperten informieren,Kompetenznetz Maligne Lymphome e.V.,Negative
 K√ºrze,Kompetenznetz Maligne Lymphome e.V.,Negative
 √ºber,Kompetenznetz Maligne Lymphome e.V.,Negative
 relevante News,Kompetenznetz Maligne Lymphome e.V.,Negative
 zu Lymphomen,Kompetenznetz Maligne Lymphome e.V.,Negative
 Irene Lopez,Centre for Genomic Regulation (CRG),Negative
 PhD project,Centre for Genomic Regulation (CRG),Negative
 PH,Centre for Genomic Regulation (CRG),Negative
 PH,Biotech2050,Negative
 Bone,Paperbirds_Hematology,Negative
 Family Vibes,Zenshi,Positive
 Rootstock amp Vine,Zenshi,Positive
   Review,Medscape Education,Positive
   Treatment New Options,RIOH,Negative
 HopeIn,RIOH,Negative
 Dr Banerji,RIOH,Negative
 CLL management testing treatment decisions,RIOH,Negative
 Review Article Treatmentnaive   lessons,Blood Journal,Negative
 Clive James,Michael Rynne,Negative
 Clive James,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 Clive James,CLL Ireland,Negative
 Approves New Treatment,Patient Worthy,Negative
 International Program,Patient Worthy,Negative
 haematologist appointment,Ian Hazzard,Positive
 lymphocytes count,Ian Hazzard,Positive
 droppedBad news,Ian Hazzard,Positive
 appointment,Ian Hazzard,Positive
 appointment,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 Todos,Dario Antilen,Positive
 pero,Dario Antilen,Positive
 la puedo sacar de la mente,Dario Antilen,Positive
 Y JUSTICIA,Dario Antilen,Positive
 Final    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
    VS,Club Libertad Limpe√±o,Negative
 Segundo tiempo,Club Libertad Limpe√±o,Negative
 marcha,Club Libertad Limpe√±o,Positive
 Entretiempo,Club Libertad Limpe√±o,Negative
 Karina Vega x Griselda Garay y,Club Libertad Limpe√±o,Negative
 Ang√©lica V√°zquez,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è EMPIEZA EL PARTIDO,Club Libertad Limpe√±o,Negative
 cancer diagnosis Husband wife team,Esther Schorr,Negative
 Jay,Esther Schorr,Negative
 Maureen Connolly,Esther Schorr,Negative
 Maureen Connolly,Patient Power,Negative
 Ruth Schorr,Esther Schorr,Negative
 experiences,Esther Schorr,Negative
 experiences,LymphomaAction,Negative
 experiences,CLL Warwick Uni,Positive
 experiences,@MyelomaTeacher - Cindy Chmielewski,Negative
 experiences,Cancer Policy Institute,Positive
 experiences,PRIME Education,Negative
 experiences,Blood Cancer UK,Positive
 friends ‚Äô reactions,Esther Schorr,Negative
 Bendamustine Treatment,Monterey Holistic,Negative
 Evolving Strategies,Paperbirds_Hematology,Negative
 Phosphatidylinositol,Paperbirds_Hematology,Negative
 Kinase Œ¥ Inhibitors Present,Paperbirds_Hematology,Negative
 conference,Janina Nett,Positive
 conference,Michael Hallek,Positive
 conference,Patient Power,Negative
 conference,Fleur Peters,Positive
 conference,Michael Rynne,Positive
 conference,Helen Jane Mee,Positive
 conference,LiveYourLife,Negative
 conference,CLLSA,Negative
 conference,Michele Nadeem-Baker,Negative
 conference,LymphomaAction,Positive
 conference,Zack Pemberton-Whiteley,Negative
 misteries,Janina Nett,Positive
 PhD nightmare,Janina Nett,Positive
 twist,ESCofNJ,Negative
 twist,Nick,Negative
   Truxima,epocrates,Negative
 relapsed CDpositive BCell nonHodgkin lymphoma,epocrates,Negative
 CDpositive BCell nonHodgkin lymphoma,epocrates,Positive
 UMBRAGE,Prof John,Negative
 GOOD Thing,Prof John,Negative
 Ublituximab amp umbralisib,Prof John,Negative
 relapsedrefractory Bcell nonHodgkin lymphoma amp CLL   Nice work,Prof John,Negative
 gene signature,The Lancet Haematology,Negative
 Dr Jennifer Crombie,Dana-Farber,Negative
 Chronic Lymphocytic Leukemia Epidemiology Forecast,Renal Cell Carcinoma,Negative
 Chronic Lymphocytic Leukemia Epidemiology Forecast,COPD News,Negative
 USD   Chronic Lymphocytic Leukemia Epidemiology Forecast,Renal Cell Carcinoma,Negative
 USD   Chronic Lymphocytic Leukemia Epidemiology Forecast,COPD News,Negative
   Leverages,TrialSite News,Negative
 amp Fast Track,TrialSite News,Negative
 Jamie,closed,Positive
 Jamie,CLL Warwick Uni,Negative
 Artificial Neural Network,EurekaMag,Negative
 Rapid uMRD Responses,Benlazar S.M Amin√©,Negative
 Lisocabtagene Maraleucel,Benlazar S.M Amin√©,Negative
 FINAAAAAAAAAAAAL,Club Libertad Limpe√±o,Negative
 GOOOOOOL,Club Libertad Limpe√±o,Negative
    VS ‚è±,Club Libertad Limpe√±o,Negative
 Ô∏è   ST      Claudia Romero por Griselda Garay,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è   ST      Yanina L√≥pez por Karina Vega,Club Libertad Limpe√±o,Negative
 Joana Galeano,Club Libertad Limpe√±o,Negative
 Joana Galeano,Radio La Red 102.1FM,Negative
 Karina Vega ‚öΩ,Club Libertad Limpe√±o,Negative
 Inici√≥ el partido,Club Libertad Limpe√±o,Negative
   treatments,CLL Ireland,Positive
   treatments,Patient Power,Positive
 difficulty,CLL Ireland,Negative
 difficulty,"chadi nabhan MD, MBA, FACP",Negative
 New article Adherence,Paperbirds_Hematology,Negative
 Sao Paolo,"Stefano Luminari, MD",Positive
   Chemotherapy Foundation Symposium Dr Richard Furman,Weill Cornell Medicine,Positive
 VIDEO Biosimilars,VJ Oncology,Positive
 pharmacy practice,VJ Oncology,Positive
 trastuzumab rituximab,VJ Oncology,Positive
 CLL patient Jay Connolly,Patient Power,Negative
 feelings,Patient Power,Negative
 feelings,BCNI,Negative
 feelings,ByQueendomCome,Positive
 blood tests,Patient Power,Negative
 blood tests,Damian Bullimore,Positive
 blood tests,Pamela Combs,Positive
 Spanish Club,Fernando LE√ìN SOL√çS,Positive
 numbers,Deborah Stephens,Positive
 numbers,Dr Becs,Positive
 Second Action,Oncology Times,Negative
 International Collaboration Approves New Treatment Option,Oncology Times,Negative
 Fatal Legionella,Paperbirds_Hematology,Negative
 serogroup,Paperbirds_Hematology,Negative
 FDA Approved New Treatment Option,GMPnews.Net,Negative
 example,Anas Nasir,Positive
 example,"Vitaly Terushkin, MD, FACMS",Positive
 example,Beth Torr,Positive
 example,Illumina Live Events,Positive
 example,Lymphoma Hub,Positive
 example,Dr. Thomas Wilckens,Positive
 Transformation,Anas Nasir,Positive
 Transformation,Blood Journal,Negative
 Transformation,NPCE,Positive
 Transformation,Oncology,Negative
 Transformation,"Andreas-Claudius Hoffmann, M.D.",Positive
 Transformation,Lymphoma Hub,Negative
 Terrific news,Michele Nadeem-Baker,Negative
 EYE unit,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 parentscarers,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Dr Justin Taylor amp Dr Susan Leclair,Patient Power,Negative
 Today New,Kyle J. Norton,Negative
 BPTH BioPath Holdings Announces Clearance,HODOR,Positive
 BPTH BioPath Holdings Announces Clearance,quantumup,Positive
 Investigational New Drug Application,HODOR,Positive
 Investigational New Drug Application,quantumup,Positive
 BPPhase   Clinical Trial,HODOR,Positive
 BPPhase   Clinical Trial,quantumup,Positive
 Ability,HODOR,Positive
 Ability,quantumup,Positive
 BP,HODOR,Positive
 BP,quantumup,Positive
 Targeting Bcl Protein,HODOR,Positive
 Targeting Bcl Protein,quantumup,Positive
 RefractoryRelapsed Lymphoma,HODOR,Positive
 RefractoryRelapsed Lymphoma,quantumup,Positive
 Systematic Synthetic Phonics links,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 impacts,ImmunologyPapers,Negative
 impacts,NK papers,Negative
 impacts,Lymphoma Papers,Negative
 impacts,Francesco Bertoni,Negative
 impacts,Daniel Auclair,Positive
 Yanina L√≥pez,Club Libertad Limpe√±o,Negative
 Yanina L√≥pez,Radio La Red 102.1FM,Negative
 Karina Vega,Club Libertad Limpe√±o,Positive
 Griselda L√≥pez,Club Libertad Limpe√±o,Negative
 Ya se juega el segundo tiempo,Club Libertad Limpe√±o,Negative
 Partido,Club Libertad Limpe√±o,Positive
 play trays,Tishylishy,Positive
 STUDY managing weight,Wilmot Cancer Institute,Negative
 brake,labi lab innsbruck,Positive
 brake,Francesco Turturro,Negative
 Halfway¬°A mitad de camino     Texas OncologyPlano Presby,Francis Camacho,Positive
 Rose,SwingTradeBot UK,Negative
 Upper Bollinger Band,SwingTradeBot UK,Negative
 Esse ano tem denovoMeu respeito ao Rap de Blumenau,Charles R. Uller,Positive
 Molica,LYMPHOMA & MYELOMA CONNECT,Negative
 Molica,Francesco Bertoni,Negative
 Molica,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 Intraepidermal Nerve Fiber Density,Paperbirds_Hematology,Negative
 Postmortem Skin,Paperbirds_Hematology,Negative
 Novel Approach,Paperbirds_Hematology,Negative
 Metabolic Profiles,Paperbirds_Hematology,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA CLL YEARS,Francesco Bertoni,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA CLL YEARS,Benlazar S.M Amin√©,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA CLL YEARS,Paperbirds_Hematology,Negative
 Hematological Oncology,Francesco Bertoni,Negative
 Attention,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 Attention,CryptoLiveLeak,Positive
 CLL    tokens,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 Antitumour Activity,Cancer Papers,Negative
 Glycodendrimer Nanoparticles,Cancer Papers,Negative
 Subcutaneous MEC Xenograft Model,Cancer Papers,Negative
 Light Chain IgLV,papersformax,Positive
 Light Chain IgLV,Jerry Lee,Negative
 New Poor Prognostic Subgroup,papersformax,Positive
 New Poor Prognostic Subgroup,Jerry Lee,Negative
 Multicenter Study,papersformax,Positive
 Multicenter Study,Jerry Lee,Negative
 allo SCT,Joana Koury,Positive
 Nursery,St. Bernadette's,Positive
 Nursery,Oak Tree Primary School,Positive
 Nursery,Mrs Prince,Positive
 Nursery,EYFSMagic,Positive
 role play,St. Bernadette's,Positive
 weeks story,St. Bernadette's,Positive
 lectures,Sigrid Sk√•nland,Negative
 lectures,Michael Hallek,Negative
 patient stratification,Sigrid Sk√•nland,Negative
 patient stratification,VJHemOnc,Negative
 Hematology meeting,Sigrid Sk√•nland,Negative
 JanssenCilag,Sigrid Sk√•nland,Negative
 Alexion,Sigrid Sk√•nland,Negative
   year olds,Nic Hall,Positive
 patience,Nic Hall,Positive
 Humpties,Nic Hall,Positive
   Research Conference,ESH (Haematology),Negative
 Susan O‚ÄôBrien MD,Expert Perspectives in Oncology,Positive
 Susan O‚ÄôBrien MD,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Susan O‚ÄôBrien MD,Oncology Tube,Negative
 atrisk patients,Expert Perspectives in Oncology,Negative
 Randomized Phase III Study,James Kerwin,Positive
 Randomized Phase III Study,Trip Database,Negative
 Randomized Phase III Study,Dr. Jos√© A. Queiz√°n,Negative
 Randomized Phase III Study,maria jose agustin,Positive
 Randomized Phase III Study,MoJo,Positive
 Randomized Phase III Study,Rafael Fonseca MD,Positive
 Randomized Phase III Study,Dr Timos Papagatsias,Negative
 Randomized Phase III Study,"Naveen Pemmaraju, MD",Negative
 Randomized Phase III Study,ALI ALAHMARI.,Negative
 Randomized Phase III Study,CLL,Negative
 OpenLabel Idelalisib,James Kerwin,Positive
 OpenLabel Idelalisib,Trip Database,Negative
 OpenLabel Idelalisib,Elsevier Oncology,Negative
 OpenLabel Idelalisib,Cancer Library VCC,Positive
 OpenLabel Idelalisib,Dr. Jos√© A. Queiz√°n,Negative
 OpenLabel Idelalisib,maria jose agustin,Positive
 Ibtihel Rayen Waaaaw malla google pixel,Mahmoud Turki,Negative
 mayetkassrouch jemla,Mahmoud Turki,Negative
 ¬° FINAAAAAL,Club Libertad Limpe√±o,Negative
    VS   ST,Club Libertad Limpe√±o,Negative
 Yanina L√≥pez por Liz Pe√±a,Club Libertad Limpe√±o,Negative
 GOOOOOOL de Karina Vega ‚öΩ,Club Libertad Limpe√±o,Negative
 YA SE,Club Libertad Limpe√±o,Negative
 JUEGA,Club Libertad Limpe√±o,Negative
 Dr Concannon,Helen Greally,Positive
 Cancrr Care West,Helen Greally,Positive
 New article IBRUTINIB,Paperbirds_Hematology,Negative
 lifetime achievement award,"Tian Zhang, MD, MHS",Positive
 lifetime achievement award,Bernard A Fox,Positive
 PostTransplant Cyclophosphamide,COPD News,Negative
 PostTransplant Cyclophosphamide,ALI ALAHMARI.,Negative
 Chronic Lymphocytic Leukemia Allogeneic blood,COPD News,Negative
 Dr Louise Concannon,CLL Ireland,Negative
 attendees,CLL Ireland,Negative
 attendees,CryptoLiveLeak,Negative
 attendees,CLLSA,Negative
 attendees,"chadi nabhan MD, MBA, FACP",Negative
 stresses,CLL Ireland,Negative
 stresses,Leukaemia Care,Positive
 Descriptive analysis,Current Oncology,Negative
 Descriptive analysis,Lymphoma Papers,Negative
 dosing,Current Oncology,Negative
 dosing,Lymphoma Papers,Negative
 Dr Amjat Hayat,CLL Ireland,Negative
 Galway University Hospital,CLL Ireland,Negative
 Inici√≥ el segundo tiempo,Club Libertad Limpe√±o,Negative
 ¬° PARTIDO,Club Libertad Limpe√±o,Negative
 rummage sale,ESCofNJ,Negative
 school,ESCofNJ,Negative
 greenhouse Way,ESCofNJ,Negative
 Blood Spotlight Venetoclax,Blood Journal,Negative
 truly possibilities,Dropworks,Positive
 Destabilization,Paperbirds_Hematology,Negative
 Th CD T cells,Paperbirds_Hematology,Negative
 Ibrutinib Ibr Plus Venetoclax Ven,Paperbirds_Hematology,Negative
 Chronic Lymphocytic Leukemia CLLSmall Lymphocytic Lymphoma SLL Results,Paperbirds_Hematology,Negative
 MRD Cohort,Paperbirds_Hematology,Negative
 NewTrip Venclexta,Trip Database,Negative
 ibrutinib venetoclaxobinutuzumab,Raj Chakraborty,Positive
     amp,Prof John,Negative
     amp,Andrew Schorr,Negative
 Molecular modelling,Paperbirds_Hematology,Negative
 epitopes,Paperbirds_Hematology,Negative
 neoplastic B lymphocytes,Paperbirds_Hematology,Negative
 ELABELA,Paperbirds_Hematology,Negative
 novel target,Paperbirds_Hematology,Negative
 novel target,Prof John,Negative
 novel target,Blood Journal,Negative
 openNordic Educational Meeting,Sigrid Sk√•nland,Negative
 April Speakers,Sigrid Sk√•nland,Negative
 includeBarbara EichhorstCarol MorenoAdrian WiestnerNicholas ChiorazziMaryam Sarraf Yazdy,Sigrid Sk√•nland,Negative
 Chronic Lymphocytic Leukemia Treatment Market   Global Growth Insights Trends Size Share,Kiran Bhole,Positive
 k grant,Rutgers Biomedical and Health Sciences,Positive
 research models,Rutgers Biomedical and Health Sciences,Positive
   Advertising Platform,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 Ad placement,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 CLL Check,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 power Prepare,WEGO Health,Negative
   wallet,Kenneth M. Garofalo,Positive
   native,Kenneth M. Garofalo,Positive
   Step Guide,CryptoLiveLeak,Negative
 ERC,CryptoLiveLeak,Negative
   Start,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 todayCheck,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 Step,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 Step,Leukaemia Care,Positive
 Step Guide,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 Ad Space,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 Ad Space,CryptoLiveLeak,Negative
 Bendamustine Monotherapy,Lymphoma Papers,Negative
 Chronic Lymphocytic Leukemia Polish Lymphoma Research Group RealLife Analysis,Lymphoma Papers,Negative
 Chris Stevick,Ground War,Positive
 Dr Hossein,RutgersCancerInstNJ,Negative
 Khiabanian,RutgersCancerInstNJ,Negative
 K Translational Award,RutgersCancerInstNJ,Negative
 relapsed delq,Expert Perspectives in Oncology,Negative
 Janssen Announces Health Canada Approval,Alicia Bell IFBB Pro,Negative
 Besoin d‚Äôun rappel de connaissance sur le march√© de l√©matologie,@AplusA_France,Positive
 T√©l√©chargez notre eBook,@AplusA_France,Positive
 chair Dr Shammo,donnashort,Negative
 Blood tests,Michele Nadeem-Baker,Negative
 alphabet soup,Michele Nadeem-Baker,Negative
 bill,Toby Eyre,Negative
 et alIntrathecal,Toby Eyre,Negative
 Frequency,Benlazar S.M Amin√©,Negative
 Frequency,"Raul Cordoba, MD, PhD",Positive
 Frequency,Immuno-Oncology,Negative
 Frequency,Cancer Papers,Negative
 Frequency,Bioline International,Positive
 tRNA fragment signature,GenomeWeb Daily Scan,Positive
 IgM antibody,James Kerwin,Positive
 IgM antibody,robo_gwas,Positive
 phosphorylcholine shared genetics phenotypic relationship,James Kerwin,Positive
 Subcellular Fractionation,Cancer Papers,Negative
 Primary Chronic Lymphocytic Leukemia Cells,Cancer Papers,Negative
 Primary Chronic Lymphocytic Leukemia Cells,Ìè¨Ïä§ÌÖç Î∞ïÌÉúÏ§ÄÌïôÏà†Ï†ïÎ≥¥Í¥Ä,Positive
 Primary Chronic Lymphocytic Leukemia Cells,epigenetics_papers,Negative
 Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System,Paperbirds_Hematology,Negative
 REAL TONIC,Prof John,Negative
 New Options,Michele Nadeem-Baker,Negative
 Rutgers researcher,Mazen M,Negative
 advice enroll,CLL Society Inc.,Negative
 Supplemental New Drug Application,SpecialtyPTimes,Negative
 Supplemental New Drug Application,HSMN,Negative
 Supplemental New Drug Application,Marketbit.pro,Negative
 Supplemental New Drug Application,Cord Blood News,Negative
 Supplemental New Drug Application,European Pharmaceutical Review,Negative
 Supplemental New Drug Application,PRN Biotech,Negative
 Supplemental New Drug Application,IntoxicatedTrader,Negative
 Ibrutinib Rituximab Combo,SpecialtyPTimes,Negative
 Dual BTK,EVA,Positive
 MDM inhibition effects,EVA,Positive
 novel therapy,Expert Perspectives in Oncology,Positive
 novel therapy,Verastem Oncology,Negative
 FLT driver kinase,Joe,Negative
 AMLPrecision,Joe,Negative
 safety targets,Joe,Negative
 amp pathways,Joe,Negative
 living drugs,Paperbirds_Hematology,Negative
 checkpoint inhibitors,Paperbirds_Hematology,Negative
 checkpoint inhibitors,Andrew Schorr,Negative
 precision medicine,Paperbirds_Hematology,Negative
 precision medicine,Sigrid Sk√•nland,Negative
 precision medicine,Kjetil Tasken,Positive
 Paper Combined Ibrutinib,Benlazar S.M Amin√©,Negative
 Chronic Lymphocytic Leukemia CLL tcovOIYJqJH,Benlazar S.M Amin√©,Negative
 Paper Final Results,Benlazar S.M Amin√©,Negative
 Multicenter OpenLabel Phase II GIBB Study,Benlazar S.M Amin√©,Negative
 ObinutuzumabBendamustine,Benlazar S.M Amin√©,Negative
 tcoCsExrtise,Benlazar S.M Amin√©,Negative
 Paper FourYear Analysis,Benlazar S.M Amin√©,Negative
 RelapsedRefractory RR,Benlazar S.M Amin√©,Negative
 Paper Rapid Dose Escalation,Benlazar S.M Amin√©,Negative
 BCell Receptor Inhibitor Therapy,Benlazar S.M Amin√©,Negative
 tcopmPHEYGfe,Benlazar S.M Amin√©,Negative
 Paper Ibrutinib,Benlazar S.M Amin√©,Negative
 tcokOJJCdfBr,Benlazar S.M Amin√©,Negative
 UK   nontrial dataAll st,Toby Eyre,Negative
 NMedian y   blastoid,Toby Eyre,Negative
 Ki‚â•,Toby Eyre,Negative
 SCT L,Toby Eyre,Negative
 mPFS L mORR,Toby Eyre,Negative
 CRu,Toby Eyre,Negative
 mPFS m,Toby Eyre,Negative
 POD Lgt ‚¨á,Toby Eyre,Negative
 Ô∏èPFS,Toby Eyre,Negative
 discont,Toby Eyre,Negative
 toxv diff,Toby Eyre,Negative
 Greatwk Dr McCulloch,Toby Eyre,Negative
 Empieza,Club Libertad Limpe√±o,Negative
 Empieza,Carlos Llavador,Negative
 el ST,Club Libertad Limpe√±o,Negative
 CLL events,Michael Rynne,Negative
 ¬° FINAL DEL PRIMER TIEMPO,Club Libertad Limpe√±o,Negative
 Paola Genes Griselda Garay Damia Cortaza,Club Libertad Limpe√±o,Negative
 Fabiola Sandoval Karina Vega x y,Club Libertad Limpe√±o,Negative
 Liz Pe√±a,Club Libertad Limpe√±o,Negative
 information amp support,CLL Ireland,Positive
 Galway,CLL Ireland,Negative
 Galway,Michael O'Dwyer,Positive
 PETComputed,EurekaMag,Negative
 PETComputed,Chocolatiere Phys,Negative
 Tomography,EurekaMag,Negative
 Tomography,Chocolatiere Phys,Negative
 Ibrutinib fludarabine,Medivizor,Negative
 Roeker et allargest series alloSCT post novel agents,Toby Eyre,Negative
 rd talk,Takeya Kasukawa,Positive
 Ridout,Liz Tseng,Positive
 KR,Genome Biology,Positive
 R√©sultats √©lections,SNU P√¥le Emploi FSU Occitanie,Negative
 er   avec,SNU P√¥le Emploi FSU Occitanie,Negative
 √®me,SNU P√¥le Emploi FSU Occitanie,Positive
 Prof Con Tam,Chan Cheah,Negative
 SEQUOIA study,Chan Cheah,Negative
 Congratulations Dr,"Sanam Loghavi, MD",Negative
    expert,"Sanam Loghavi, MD",Negative
 PathWays Case Study yearold male,Mayo Clinic Pathology,Positive
   supplemental New Drug Application,"Pharmacyclics, an AbbVie Company",Negative
 Pr√≥ximo partido para enfrentarlo juntas,Club Libertad Limpe√±o,Negative
 Vamos    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
   Janssen,Janssen Global,Negative
 Biosimilar,CancerTherapyAdvisor,Negative
 HSMN Janssen Announces,HSMN,Negative
 IMBRUVICAR ibrutinib,HSMN,Positive
 IMBRUVICAR ibrutinib,$Stocknewsalerts,Positive
 ABBV Submits,Bio Stocks‚Ñ¢,Negative
 sNDA,Bio Stocks‚Ñ¢,Negative
 sNDA,cafepharma,Positive
 sNDA,MDedge Hematology & Oncology,Negative
 sNDA,"Pharmacyclics, an AbbVie Company",Negative
 sNDA,JanssenUS,Negative
 de Weerdt,Paperbirds_Hematology,Negative
 Hofland T Lameris R et al Improving CLL VŒ≥VŒ¥Tcell fitness,Paperbirds_Hematology,Negative
 NonHodgkin,Trip Database,Negative
 NonHodgkin,EIN Presswire: Press Releases,Positive
 NonHodgkin,Matthews & Associates,Positive
 NonHodgkin,American Association of Pharmaceutical Scientists,Positive
 NonHodgkin,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Lymphoma amp Chronic Lymphocytic Leukemia,Trip Database,Negative
 Lymphoma amp Chronic Lymphocytic Leukemia,Siteman Cancer Center,Positive
 Details,Trip Database,Negative
 Details,leukemia,Negative
 Details,James Porreca,Positive
 Details,JADPRO,Negative
 BTKI,"chadi nabhan MD, MBA, FACP",Negative
 New Ibrutinib fludarabine,Medivizor,Negative
 Countdown,CLL Advocates Network,Negative
 Dr Brian Koffman cofounder,Patient Empowerment Network,Positive
 New article Improvement,Paperbirds_Hematology,Negative
 autoimmune cytopenia,Paperbirds_Hematology,Negative
 Copanlisib,Lung Cancer News,Negative
 Copanlisib,Lymphoma Hub,Negative
 copanlisib work,Lung Cancer News,Negative
 SingleCell RNA,David -mogeladze,Positive
 Sequencing Characterizes TCell Impairment,David -mogeladze,Positive
 CART Cells,David -mogeladze,Positive
 Singlecell RNA sequencing characterizes Tcell impairment,CancerTherapyAdvisor,Negative
 MedTweetorial    Type,MedTweetorials,Positive
 Met,Mark (Jahdoh),Positive
 Met,Andrew Schorr,Negative
 Diet,Michele Nadeem-Baker,Negative
 Diet,Shouting at people in my underpants,Negative
 Diet,Oncology Tube,Negative
 Cancer Treatment Response,Michele Nadeem-Baker,Negative
 New   combination treatment findings,Michele Nadeem-Baker,Negative
 Featured experts Jennifer R Brown MD,Expert Perspectives in Oncology,Positive
 FASCO Susan O‚ÄôBrien MD,Expert Perspectives in Oncology,Negative
 Venetoclax Effective,Cure Cancer,Positive
 Venetoclax Effective,Lymphoma Canada,Negative
 Venetoclax Effective,"Meagan Bryan, RN",Negative
 rap,Rap Name Bot,Positive
 Acalabrutnib,AV Mena-Duran MD üë®‚Äç‚öïÔ∏èüá™üá∏üåà üïØÔ∏è,Positive
 Court,"Kantor & Kantor, LLP",Positive
 Principal Life Insurance Company,"Kantor & Kantor, LLP",Positive
 longterm disability benefits,"Kantor & Kantor, LLP",Positive
 amp reduced tumor burden,Joe,Negative
 BTKi activity post,Toby Eyre,Negative
 abstractCG,Joe,Negative
 FirstinClass,Joe,Negative
 PanFLTPanBTK,Joe,Negative
 Correct Answer,FAIIDAY,Positive
 Prof Sebastian Kobold    reviews RR,Bernard A Fox,Positive
 amp mech,Bernard A Fox,Positive
 integration,Bernard A Fox,Positive
 integration,√Öbo Akademi University,Positive
 CAR T cell,Bernard A Fox,Positive
 ATM,Prof John,Negative
 ATM activity,Prof John,Negative
 Eddie Robinson Assistant Fire Chief,Northside Hospital,Positive
 Cherokee County,Northside Hospital,Positive
 Tonic BCe,Transcriptomes,Positive
 IVIG,Michele Nadeem-Baker,Negative
 IVIG,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 IVIG,Andrew Schorr,Negative
 IVIG,"Navneet Majhail, MD, MS",Negative
 New campaign,Crowdfunding Center,Positive
 fathers,Crowdfunding Center,Positive
 Second Primary Malignancy,Oncology,Negative
 Survivors,Oncology,Negative
   prescription,Michele Nadeem-Baker,Negative
 FLU,Michele Nadeem-Baker,Negative
 research Dr Danielle Brander,Patient Empowerment Network,Negative
 Bologna,Amy C. Cavers,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,ClinicalTrialsData,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,Surgical Pathology,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,ChemDiv,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,PRICENTRIC,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,HEDGE accordinglyüìà,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,RazzleTazzle,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,Medical & Surgical Pathology,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,histopathology üî¨,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,Sameer Parikh,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,Dendritic cells,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,ImmunotherapyPapers,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL,Verastem Oncology,Negative
    RIP,Cam30 üá∫üá∏,Positive
 Jill Clayburgh actress,Cam30 üá∫üá∏,Positive
 Scissors,Cam30 üá∫üá∏,Positive
 education support amp advocacy,CLLSA,Negative
   day,CLLSA,Negative
 Henlius,PharmaShots - Incisive news in 3 shots,Negative
 Ascentage,PharmaShots - Incisive news in 3 shots,Negative
 LorenzoHerrero S SordoBahamonde C Bretones G Payer √ÅR Gonz√°lezRodr√≠guez AP Gonz√°lezGarc√≠a E P√©rezEscuredo J Villa√Ålvarez,NK papers,Negative
 venetoclax therapy,Paperbirds_Hematology,Negative
 venetoclax therapy,MD Anderson Cancer Center,Negative
 Cytochrome P,Paperbirds_Hematology,Negative
 Oxidizing Bilirubin,Paperbirds_Hematology,Negative
 Physiological Conditions,Paperbirds_Hematology,Negative
 Survival improvement,Lymphoma Papers,Negative
 gentleman,"Krishna Komanduri, MD, FASTCT",Positive
 scholar,"Krishna Komanduri, MD, FASTCT",Positive
 New   Ibrutinib fludarabine cyclophosphamide,Medivizor,Negative
 Dr Cohen,donnashort,Negative
 chair,donnashort,Positive
 ELEVATE update Benefit,donnashort,Negative
 photographer,Stephen Brown,Negative
 photographer,The Bodykit Channel,Positive
 nuggets,Stephen Brown,Negative
 Orlando FL,Medscape Education,Negative
 chronic lymphocytic   w Prof Danielle Brander,Medscape Education,Negative
 amp experts,Medscape Education,Negative
 amp experts,PeerView,Positive
 CLL Open House,ESCofNJ,Negative
 Frontline Ibrutinib,Lymphoma Papers,Negative
 Frontline Ibrutinib,Paperbirds_Hematology,Negative
 CLL Diagnosis   advocate,Patient Empowerment Network,Negative
 discontinuation,Deborah Stephens,Positive
 discontinuation,ACS Journal Cancer,Positive
 discontinuation,Marek Trneny,Positive
 selection,Deborah Stephens,Positive
 nd postgraduate,Michael Hallek,Positive
 John Seymour,Michael Hallek,Negative
 John Seymour,Richard Rosenquist Brandell,Positive
 John Seymour,Toby Eyre,Negative
 John Seymour,Christian Reinhardt,Positive
 John Seymour,VJHemOnc,Positive
 John Seymour,Jeff Szer,Positive
 John Seymour,CLL Ireland,Negative
 John Seymour,The ASCO Post,Negative
 Angela Brooks,Nicolas Robine,Positive
 Ibrutinib fludarabine cyclophosphamide,Medivizor,Negative
   community Fatigue,CLL Ireland,Negative
 CLL Therapies,COPD News,Negative
 Bedside,COPD News,Negative
 Community Michael J Keating MBBS,COPD News,Negative
 means,COPD News,Negative
 means,Vijaya L,Positive
 FINAL,Club Libertad Limpe√±o,Negative
 Gol      Ang√©lica V√°zquez,Club Libertad Limpe√±o,Negative
 Angeles Portillo,Club Libertad Limpe√±o,Negative
 Paola Genes,Club Libertad Limpe√±o,Positive
 ¬° Gol,Club Libertad Limpe√±o,Negative
 Neily Carrasquel,Club Libertad Limpe√±o,Negative
 Gol      Yanina L√≥pez,Club Libertad Limpe√±o,Negative
 Final de la primera etapa,Club Libertad Limpe√±o,Negative
 Fabiola Sandoval,Club Libertad Limpe√±o,Positive
 Liza Larrea,Club Libertad Limpe√±o,Positive
 trial CART,Michael Rynne,Negative
 consultant numbers,Michael Rynne,Negative
 Hazel Thomas,CARTI Arkansas,Positive
 food,Kim Kirchherr,Positive
 food,"Raul Cordoba, MD, PhD",Negative
 food,cnaamani,Positive
 food,MDLinx,Negative
 absorption,Kim Kirchherr,Negative
 nutrients,Kim Kirchherr,Positive
 nutrition science Wayne Campbell,Kim Kirchherr,Negative
 rt,Kim Kirchherr,Negative
 rt,UBI MEDIA 2.0,Positive
 Nutrition Pairing Foods,Kim Kirchherr,Negative
 EBVmiRBHRF Targets p Gene Potential Role,Paperbirds_Hematology,Negative
 EpsteinBarr Virus,Paperbirds_Hematology,Negative
 EpsteinBarr Virus,Scott Merville,Negative
 Associated Chronic Lymphocytic Leukemia,Paperbirds_Hematology,Negative
 Invasive Genitourinary,Ilan Schwartz MD PhD,Positive
 Venetoclax Case Report,Ilan Schwartz MD PhD,Positive
   Mark,Michelle St John,Positive
 survivors,Medical Xpress,Negative
 survivors,Janssen EMEA,Negative
 survivors,Gitte Pedersen,Negative
 survivors,AZ Blood Cancer,Positive
   taber,LyLe Foreningen,Negative
 g√∏re,LyLe Foreningen,Negative
 forskel Vores,LyLe Foreningen,Negative
 s√∏rge,LyLe Foreningen,Negative
 patienterne f√•r bedste,LyLe Foreningen,Negative
 Vi ser,LyLe Foreningen,Negative
 stem cells,SkillAcquire,Positive
 stem cells,Pub Snips üî¨,Positive
 degrees,SkillAcquire,Positive
 Chronic Leukemia,SkillAcquire,Positive
 Chronic Leukemia,CancerTherapyAdvisor,Positive
 Chronic Leukemia,Clinical Pharmacy,Positive
 Chronic Leukemia,HHF,Negative
 Chronic Leukemia,LightTheNightOntario,Positive
 Chronic Leukemia,LLSCanada,Negative
 Chronic Leukemia,Scott Werntz,Negative
 spirit,MD Anderson Leukemia,Negative
     team,MD Anderson Leukemia,Negative
     team,Exec Director VCCC,Positive
 Hauntings,ESCofNJ,Negative
 patient empowerment,Fredrik √ñhrn,Positive
 Daniel Addison MD,Sarah Williams,Positive
 Comparing   regimens,VJHemOnc,Negative
 w John Seymour,VJHemOnc,Negative
 Ibrutinib discontinuation,Lymphoma Papers,Positive
 Ibrutinib discontinuation,CLL Ireland,Negative
 Ahir,Hematologia - Hospital Universitari Vall d'Hebron,Positive
 November issue,The Lancet Oncology,Negative
 November issue,Targeted Oncology,Negative
 droplet digital PCR webinar series,Bio-Rad EMEA,Negative
 BTK PLCG resistance mutations,Bio-Rad EMEA,Positive
 BTK PLCG resistance mutations,DrugGenius,Negative
   Ibrutinib,"Raul Cordoba, MD, PhD",Positive
   Ibrutinib,2 Minute Medicine¬Æ,Negative
   Ibrutinib,Medical Tribune,Positive
   Ibrutinib,EBMT,Positive
   Ibrutinib,CureHuntr,Positive
   Ibrutinib,ClinChemINFO,Positive
   Ibrutinib,Stem Cell News,Negative
   Ibrutinib,KevinFitts,Negative
   Ibrutinib,Medscape Pharmacists,Negative
   Ibrutinib,Medscape Oncology,Negative
   Ibrutinib,Medscape,Negative
 fun,Jeff Neurman,Negative
 fun,Higher Ground at Lake Louise,Negative
 fun,German Cheer Dad (GCD),Negative
 Charmin            tshine,Jeff Neurman,Negative
 Expert Dr Farrukh Awan,Esther Schorr,Negative
 CLL expert Dr Nicole Lamanna,Patient Power,Negative
 Edinburgh,Patient Power,Negative
 Edinburgh,LymphomaAction,Positive
 Edinburgh,Medical Expressions,Positive
 Edinburgh,CLL Advocates Network,Negative
 Edinburgh,Lymphoma Australia,Positive
 Edinburgh,Michael Hallek,Positive
 Edinburgh,Michie Lab,Positive
 Edinburgh,CLL Ireland,Negative
 Edinburgh,LyLe Foreningen,Negative
 Edinburgh,Michael Rynne,Negative
 treatment research developments,Patient Power,Negative
    reports,RIOH,Negative
 CLARITY study,"Michael Wang, MD",Negative
 Practical Dosing Considerations,The Oncologist,Negative
 PCBs,Lymphoma Papers,Negative
 CLL expert Dr Philip Thompson,Patient Power,Negative
   greenhouse gas inventory,Kim Kirchherr,Negative
 slide,Kim Kirchherr,Negative
 slide,Michael Rynne,Negative
 slide,Biotech2050,Negative
 nutrition education conversations,Kim Kirchherr,Negative
 standards,Kim Kirchherr,Positive
 standards,COPD News,Negative
 identity nutrition profile,Kim Kirchherr,Negative
 shoppers,Kim Kirchherr,Negative
 labels,Kim Kirchherr,Positive
 meat products,Kim Kirchherr,Negative
 packages,Kim Kirchherr,Negative
 Implications,Kim Kirchherr,Negative
 Implications,leukemia,Positive
 Implications,Mol Oncol Res,Positive
 Implications,"Raul Cordoba, MD, PhD",Negative
 identity,Kim Kirchherr,Negative
 shopping proteins,Kim Kirchherr,Negative
 nutrition professionals,Kim Kirchherr,Negative
 Novedades LLC,Miguel Canales,Positive
 Tratamiento L   Dra Baltasar,Miguel Canales,Positive
 protein choices,Kim Kirchherr,Negative
 Protein power,Kim Kirchherr,Negative
 diversity,Kim Kirchherr,Negative
 protein options,Kim Kirchherr,Negative
 seats,Kim Kirchherr,Negative
 Fireworks,"Nadia Naumova, MD",Positive
 CLARITY,Lymphoma Hub,Negative
 CLARITY,VJHemOnc,Negative
 CLARITY,CLL Ireland,Negative
 J Brown P Ghia amp M Hallek,ESH (Haematology),Negative
 leadingedge ESH Translational Research Conference,ESH (Haematology),Negative
 registration ‚û° Register,ESH (Haematology),Negative
 der CLL selber,SpringerMedizin.de,Positive
 der Therapie Eine,SpringerMedizin.de,Positive
   rule,Kim Kirchherr,Negative
 reported   Peter Hillmen MD PhD,MedPage Oncology,Negative
 Leeds Institute,MedPage Oncology,Negative
 St Jamess,MedPage Oncology,Negative
 Booth,Kim Kirchherr,Negative
 Booth,Invivoscribe,Negative
 Booth,Verastem Oncology,Negative
 Booth,Oxford Nanopore,Positive
 expo hall,Kim Kirchherr,Negative
 Resources,Kim Kirchherr,Negative
 consumerspeople,Kim Kirchherr,Negative
 label reboot session,Kim Kirchherr,Negative
 Michael Hallek,Didi Jasmin,Positive
 Michael Hallek,Christian Reinhardt,Positive
 Michael Hallek,Dr Timos Papagatsias,Negative
 Michael Hallek,CLL Ireland,Negative
 Michael Hallek,BloodWork,Positive
 Michael Hallek,VJHemOnc,Positive
 Michael Hallek,Lymphoma Hub,Negative
 Michael Hallek,Dr. Thomas Wilckens,Positive
 ESH Scientific Committee sharing thoughts,Didi Jasmin,Positive
 microenvironment,Didi Jasmin,Positive
 microenvironment,CELLINK,Positive
 microenvironment,Lymphoma Hub,Positive
 microenvironment,VJHemOnc,Negative
 microenvironment,Hematopoiesis,Positive
 malignancies,Didi Jasmin,Positive
 malignancies,The Lancet Oncology,Negative
 Breast Cancer Awareness Month,ESCofNJ,Negative
 staff,ESCofNJ,Negative
 staff,Dr. Andre Goy,Negative
 staff,Chris Thomson,Positive
 John Terrys Best Chelsea Moments,The Lion's Shed üè¥Û†ÅßÛ†Å¢Û†Å•Û†ÅÆÛ†ÅßÛ†Åø,Negative
 Anniversary,The Lion's Shed üè¥Û†ÅßÛ†Å¢Û†Å•Û†ÅÆÛ†ÅßÛ†Åø,Negative
 Blues Debut,The Lion's Shed üè¥Û†ÅßÛ†Å¢Û†Å•Û†ÅÆÛ†ÅßÛ†Åø,Negative
 FASCO   Susan O‚ÄôBrien MD,Expert Perspectives in Oncology,Negative
 consolidationmaintenance therapy,Expert Perspectives in Oncology,Negative
 Jeff Neurman,Coping with Cancer,Negative
 PIM kinase inhibitor AZD,EurekaMag,Negative
 protein translation,EurekaMag,Negative
   Paid Opportunity,Barbara Jacoby,Negative
 Chronic Lymphocytic Leukemia CLL Patients,Barbara Jacoby,Negative
 Chronic Lymphocytic Leukemia CLL Patients,Hematopoiesis News,Negative
 Chronic Lymphocytic Leukemia CLL Patients,‚öõÔ∏èLibertyüåä,Positive
 Chronic Lymphocytic Leukemia CLL Patients,Odi Bruckman,Negative
 Chronic Lymphocytic Leukemia CLL Patients,TalkingScarsMedia.com,Positive
 Chronic Lymphocytic Leukemia CLL Patients,Autotestdrivers.com,Positive
 Chronic Lymphocytic Leukemia CLL Patients,VPO/PR Newswire,Negative
 Chronic Lymphocytic Leukemia CLL Patients,CRE Demographics,Negative
 Chronic Lymphocytic Leukemia CLL Patients,ShareHRnews,Positive
 Chronic Lymphocytic Leukemia CLL Patients,Mr Slot,Positive
 Chronic Lymphocytic Leukemia CLL Patients,Seattle's Banker,Negative
 frame,Kim Kirchherr,Negative
 CRISPR,Kim Kirchherr,Negative
 Self care,Kim Kirchherr,Negative
   calendar,Kim Kirchherr,Negative
 mentor,Kim Kirchherr,Negative
 Authenticity,Kim Kirchherr,Negative
 values,Kim Kirchherr,Negative
 values,GenPath Oncology,Negative
 Willkommen,ICS Think Safe Think ICS,Positive
 Willkommen,AbbVie Schweiz,Positive
 m Team,ICS Think Safe Think ICS,Positive
 Cloud Security Engineer,ICS Think Safe Think ICS,Positive
 mwxIndustrial Engineering,ICS Think Safe Think ICS,Positive
 calories,Kim Kirchherr,Negative
 farmers,Kim Kirchherr,Negative
 farmers,Matthews & Associates,Positive
 moderator,Kim Kirchherr,Negative
 Wellness Sustainability Food Agriculture,Kim Kirchherr,Negative
 Dietitians,Kim Kirchherr,Negative
 food supply chain,Kim Kirchherr,Negative
 food nutrition convos,Kim Kirchherr,Negative
 farm,Kim Kirchherr,Negative
 farm,Robert Z. Orlowski,Negative
 shout outs,Kim Kirchherr,Negative
 dietitians,Kim Kirchherr,Negative
 ag,Kim Kirchherr,Negative
 shout,Kim Kirchherr,Negative
 shout,Higher Ground at Lake Louise,Negative
 committee,Kim Kirchherr,Negative
    NEW WAY,Prof John,Negative
 Gute Besserung K√∂bi Kuhn,Felix Keller,Positive
 Bei,Felix Keller,Positive
 BCR Inhibitors,National Aspergillosis Centre,Negative
 Retrospective Single Institution Experience,National Aspergillosis Centre,Negative
 Day   Multiple Myeloma CLL Mantle Cell,@linfopedia,Positive
 Fortaleza,@linfopedia,Positive
 oncologist appt,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 VIDEO Immunoglobulin receptor,VJHemOnc,Negative
 CLL w Stefano Casola,VJHemOnc,Negative
 target therapies,Joana Koury,Positive
 target therapies,"Raul Cordoba, MD, PhD",Negative
 Paradigm Shift,Mahmoud Aljurf,Negative
 Paradigm Shift,"Dr T. Comeau , MD",Negative
 Paradigm Shift,Kerri Wachter,Negative
 Paradigm Shift,Benlazar S.M Amin√©,Negative
 Chronic Lymphocytic Leukemia Ibrutinib,Mahmoud Aljurf,Negative
 LongTerm,Benlazar S.M Amin√©,Negative
 LongTerm,OBR,Negative
 LongTerm,Financial Buzz,Negative
 LongTerm,NeuroBrain,Positive
 LongTerm,Cancer News,Negative
   Final LongTerm Results,1stOncology,Negative
 GENUINE Study,1stOncology,Positive
 GENUINE Study,YGLDMETG,Positive
 GENUINE Study,Crwe World,Negative
 GENUINE Study,Krishan Maggon,Negative
 GENUINE Study,Dr. Melody Davis,Negative
 GENUINE Study,Financial Buzz,Negative
 GENUINE Study,ForexTV,Positive
 GENUINE Study,Odi Bruckman,Negative
 Improved ProgressionFree Survival,1stOncology,Negative
 HighRisk RR,1stOncology,Negative
 Monotherapy TGTX,1stOncology,Negative
   registry,LYMPHOMA & MYELOMA CONNECT,Negative
 Independent Review Committee,OncLive.com,Negative
   B Cell Persistent Lymphocytic,Unidrugscom,Positive
   B Cell Widespread Lymphocytic,Unidrugscom,Positive
   B Cell Vitality Lymphocytic Le,Unidrugscom,Positive
 CLL Treatment Moves,Renal Cell Carcinoma,Negative
 Combo Approaches,Renal Cell Carcinoma,Negative
 CAR TCell Therapy William G Wierda MD PhD,Renal Cell Carcinoma,Negative
 VIDEO Minorclone mutations,VJHemOnc,Negative
 ECR    grant winner Maria Tsagiopoulou,RDA Europe,Positive
 PhD studies,RDA Europe,Positive
 PhD studies,Michie Lab,Negative
 HighRisk RelapsedRefractory Chronic Lymphocytic Leukemia,YGLDMETG,Positive
 TG Therapeutics Announces Final LongTerm Results,Crwe World,Negative
 Co,Crwe World,Negative
 JoVEÎèôÏòÅÏÉÅSubcellular Fractionation,Ìè¨Ïä§ÌÖç Î∞ïÌÉúÏ§ÄÌïôÏà†Ï†ïÎ≥¥Í¥Ä,Positive
 Monitor NuclearCytoplasmic Protein,Ìè¨Ïä§ÌÖç Î∞ïÌÉúÏ§ÄÌïôÏà†Ï†ïÎ≥¥Í¥Ä,Positive
 Ïã§Ìóò   ÎÖºÎ¨∏,Ìè¨Ïä§ÌÖç Î∞ïÌÉúÏ§ÄÌïôÏà†Ï†ïÎ≥¥Í¥Ä,Positive
 CD peptide,Blood Advances,Negative
 eliminates,Blood Advances,Negative
   Cells,Prof John,Negative
 Constitutive STAT,Prof John,Negative
 Survival Advantage,Prof John,Negative
 NEWS Verastem Oncology,Verastem Oncology,Negative
 posters,Verastem Oncology,Negative
 posters,Investor News,Negative
 posters,Kjetil Tasken,Positive
 OffseasonWir stellen,ùêÇùê®ùêöùêúùê° ùêÄùê•ùêûùê± üèàüí™üí•,Positive
 erste Question,ùêÇùê®ùêöùêúùê° ùêÄùê•ùêûùê± üèàüí™üí•,Positive
 Week,ùêÇùê®ùêöùêúùê° ùêÄùê•ùêûùê± üèàüí™üí•,Positive
 Week,Cancer Today,Negative
 Week,AJNR,Positive
 Week,WhatNext.com,Negative
 Week,Patient Empowerment Network,Negative
 Week,ASH,Positive
 freuen uns auf eure,ùêÇùê®ùêöùêúùê° ùêÄùê•ùêûùê± üèàüí™üí•,Positive
 Nursery children,Orchard Primary Academy Nursery,Negative
 inside,Orchard Primary Academy Nursery,Negative
 pumpkin,Orchard Primary Academy Nursery,Negative
 IGHVmutated CLL w Nitin Jain,VJHemOnc,Negative
   Clinical trial,Lymphoma Hub,Negative
 ORR   median OS   months,Lymphoma Hub,Negative
 Cancer Chronic Lymphocytic Leukemia presentation,Gilda's Club QC,Positive
 Read Martha Garcia,Gilda's Club QC,Positive
 Dispatch   Rock Island Argus article,Gilda's Club QC,Positive
 scoop,Gilda's Club QC,Positive
 DLL,Oncogene Journal,Positive
 PostAppeals EQA Summary Report,GenQA (Genomics Quality Assessment),Negative
   Acquired Array EQA,GenQA (Genomics Quality Assessment),Negative
 available   login,GenQA (Genomics Quality Assessment),Negative
 EXCELLENT NEWS,Prof John,Negative
 Longterm efficacy amp safety,Prof John,Negative
 firstline ibrutinib treatment,Prof John,Negative
 RESONATE study,Prof John,Negative
 RESONATE study,Oncology Learning Network,Positive
 RESONATE study,Expert Perspectives in Oncology,Positive
 RESONATE study,JanssenUS,Negative
 Dr Wierda,Targeted Oncology,Positive
 Dr Wierda,"Fumiko Ladd Chino, MD",Positive
 Dr Wierda,CLL Ireland,Negative
 Dr Wierda,Patient Power,Positive
 Dr Wierda,MD Anderson Leukemia,Negative
 Significant Weight Gain,Benlazar S.M Amin√©,Negative
 Potentially Deleterious Consequence,Benlazar S.M Amin√©,Negative
 Joana Galeano por Liz Pe√±a,Club Libertad Limpe√±o,Negative
 Yanina Lopez por Liz Pe√±a,Club Libertad Limpe√±o,Negative
 Fiorella Mart√≠nez por Laurie Cristaldo,Club Libertad Limpe√±o,Negative
 Ô∏è GOOOOOOOOL,Club Libertad Limpe√±o,Negative
 GRISELDA GARAY ‚öΩ,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è GOOOOOOOOL,Club Libertad Limpe√±o,Negative
 LIZ PE√ëA ‚öΩ ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 CLARITY Study   Journal,"Dr T. Comeau , MD",Negative
 CLARITY Study   Journal,Izaskun Zeberio,Negative
 CLARITY Study   Journal,Claire Harrison,Positive
 CLARITY Study   Journal,GEDEFO,Negative
 Minnesota,EIN Presswire: Press Releases,Negative
 Loss,Lymphoma Papers,Negative
 Loss,CLL-seq,Negative
 Loss,TumorImmunoPapers,Negative
 NFAT expression results,Lymphoma Papers,Negative
 NFAT expression results,CLL-seq,Negative
 acceleration,Lymphoma Papers,Negative
 acceleration,CLL-seq,Negative
 Information Support Team,LymphomaAction,Negative
   CLL Horizons conference,LymphomaAction,Positive
 Dr David Maloney,Lymphoma Hub,Negative
 Dr David Maloney,Fred Hutch,Negative
 Dr David Maloney,Patient Power,Negative
 November   program,Phoebe Needles,Negative
 Thinking Habits,Phoebe Needles,Negative
 Dr Andrea Miller,Phoebe Needles,Negative
 CART cell,CIRM,Positive
 afternoon replay,Patient Power,Negative
 ‚Äù Town Meeting viewers,Patient Power,Negative
 Modified Immune Cells CDCD CART Cells,BenXM,Positive
 Modified Immune Cells CDCD CART Cells,Renal Cell Carcinoma,Negative
 BCell Lymphoma,BenXM,Positive
 Lymphoma B,Eyemagistus ‚úçüèº,Positive
 Lymphoma B,Disraelly Guti√©rrez,Positive
 T Cell Chronic Lymphocytic Leukemia Mantle Cell Hairy Cell,Eyemagistus ‚úçüèº,Positive
 T Cell Chronic Lymphocytic Leukemia Mantle Cell Hairy Cell,Harry Moritz,Positive
 T Cell Chronic Lymphocytic Leukemia Mantle Cell Hairy Cell,missmaybell,Positive
 Roundup Weed Killer Victims,Eyemagistus ‚úçüèº,Positive
 Roundup Weed Killer Victims,Disraelly Guti√©rrez,Positive
 Roundup Weed Killer Victims,David T.,Positive
 compensation,Eyemagistus ‚úçüèº,Positive
 compensation,zenwomyn,Positive
 compensation,Disraelly Guti√©rrez,Positive
 compensation,David T.,Positive
 FDA Panel,Michele Nadeem-Baker,Negative
 Cefiderocol,Michele Nadeem-Baker,Negative
 Urinary Tract Infections,Michele Nadeem-Baker,Negative
 ¬° Termina el partido,Radio La Red 102.1FM,Negative
 el Atahualpa,Radio La Red 102.1FM,Positive
 Ô∏è ‚öΩ,Radio La Red 102.1FM,Positive
 Ô∏è Natalia Pe√±a,Radio La Red 102.1FM,Positive
 Ô∏è Griselda Pe√±a,Radio La Red 102.1FM,Negative
 ¬° Finaaaaal,Club Libertad Limpe√±o,Negative
     Neily Carrasquel,Radio La Red 102.1FM,Negative
    Se adicionan,Radio La Red 102.1FM,Negative
 minutos √ëA√ëvsCLL,Radio La Red 102.1FM,Negative
 Claudia Romero,Radio La Red 102.1FM,Negative
 Claudia Romero,Club Libertad Limpe√±o,Negative
 Natalia Pe√±a,Radio La Red 102.1FM,Negative
 Tifanny Villamar,Radio La Red 102.1FM,Negative
 Kerlly Corozo √ëA√ë,Radio La Red 102.1FM,Negative
    VS √ëA√ëAS ‚è±,Club Libertad Limpe√±o,Negative
 Ô∏è   ST,Club Libertad Limpe√±o,Positive
    √ëA√ë,Radio La Red 102.1FM,Positive
 de contragolpear con una jugadora menos,Radio La Red 102.1FM,Negative
 juega,Radio La Red 102.1FM,Negative
 se muestra,Radio La Red 102.1FM,Negative
 el campo,Radio La Red 102.1FM,Negative
    ¬° GOOOL de   Griselda L√≥pez,Radio La Red 102.1FM,Negative
 cruzado abajo para marcar,Radio La Red 102.1FM,Negative
    VS √ëA√ëAS ‚è± Ô∏è GOOOOOOOOL,Club Libertad Limpe√±o,Negative
 Ô∏è EMPIEZA EL TIEMPO,Club Libertad Limpe√±o,Negative
 ¬° Termina el primer tiempo,Radio La Red 102.1FM,Negative
    ¬° GOOOL,Radio La Red 102.1FM,Positive
 de   Natalia Pe√±a,Radio La Red 102.1FM,Negative
 LIZ PE√ëA ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 de   Natalia Pe√±a hizo una,Radio La Red 102.1FM,Negative
 con Galeano y defini√≥ por un costado de C√≥rdoba para marcar,Radio La Red 102.1FM,Negative
 Se salv√≥,Radio La Red 102.1FM,Negative
 Zambrano que trat√≥ de definir por arriba de Bailey,Radio La Red 102.1FM,Negative
 la arquera paraguaya estuvo atenta para evitar el,Radio La Red 102.1FM,Negative
 ecuatoriano√ëA√ëvsCLL,Radio La Red 102.1FM,Negative
 √ëA√ë,Radio La Red 102.1FM,Negative
 defiende tan,Radio La Red 102.1FM,Negative
 cerca de su arco,Radio La Red 102.1FM,Negative
 le ha costado llegar al √°rea rival,Radio La Red 102.1FM,Negative
 minutos√ëA√ëvsCLL,Radio La Red 102.1FM,Negative
    VS √ëA√ëAS ‚è± Ô∏è,Club Libertad Limpe√±o,Negative
    √ëA√ë se muestra impreciso,Radio La Red 102.1FM,Negative
 mantiene mucho tiempo,Radio La Red 102.1FM,Negative
 la pelota,Radio La Red 102.1FM,Negative
 su poder,Radio La Red 102.1FM,Negative
 impone condiciones pero,Radio La Red 102.1FM,Negative
 ha faltado definir√ëA√ëvsCLL,Radio La Red 102.1FM,Negative
 Se acerc√≥,Radio La Red 102.1FM,Negative
 un centro,Radio La Red 102.1FM,Negative
 la pein√≥ y la arquera,Radio La Red 102.1FM,Negative
 C√≥rdoba se,Radio La Red 102.1FM,Negative
    VS √ëA√ëAS ‚è± Ô∏è EMPIEZA EL PARTIDO,Club Libertad Limpe√±o,Negative
 Open House,ESCofNJ,Negative
 Friday,ESCofNJ,Negative
 Friday,CLLSA,Negative
 Friday,Vicente Torres,Positive
 Friday,Tammie Workman,Positive
 Kathy Woods,ESCofNJ,Negative
 kwoodsus,ESCofNJ,Negative
 Cardiology Regional Grand Rounds,PHRI Population Health Research Institute,Positive
 Opinion,Oncology Tube,Negative
 Opinion,CancerWallonia,Negative
 st Line CLL Paul M Barr MD Associate Professor,Oncology Tube,Negative
 Plasma BCell Maturation Antigen Levels,Targeted Oncology,Negative
 Plasma BCell Maturation Antigen Levels,Prof John,Negative
 Plasma BCell Maturation Antigen Levels,Benlazar S.M Amin√©,Negative
 Disease Activity,Targeted Oncology,Negative
 Disease Activity,Prof John,Negative
 Disease Activity,Benlazar S.M Amin√©,Negative
 Joanne Lee,Madison Taylor,Positive
 Mayo CLL group,"Amber Koehler, PA-C",Negative
 Testing Modified Immune Cells CDCD CART Cells,Lymphomation.org,Negative
 Recurrent Refractory BCell Lymphoma,Lymphomation.org,Negative
 Recurrent Refractory BCell Lymphoma,Renal Cell Carcinoma,Negative
 OpenSpeak,CLL Society Inc.,Positive
 Ibrutinib   venetoclax,Hematologia ICO Hospitalet,Positive
 Ibrutinib   venetoclax,Medscape,Negative
 follow,Hematologia ICO Hospitalet,Positive
 follow,Charlotte Martin,Positive
 Great Leukemia seminar,Taylor Lab UM,Negative
    estimates,"Pharmacyclics, an AbbVie Company",Negative
 Emerging Combinations Shift Treatment Paradigm,Cancer Medicine,Positive
 tcojXgQqGy,Cancer Medicine,Positive
 ChemoFree Combination Therapies,Value-Based Cancer Care,Negative
 ChemoFree Combination Therapies,AONN+,Negative
 ChemoFree Combination Therapies,CONQUER the patient voice,Negative
 HemOnc Times CAR TCell Therapy,Oncology Times,Negative
 Reminder gt research opportunity,LymphomaAction,Negative
 focus group,LymphomaAction,Negative
 Manchester,LymphomaAction,Negative
 London,LymphomaAction,Negative
 London,Anissa Brennet,Positive
 London,Nick,Negative
 London,"Raul Cordoba, MD, PhD",Negative
 London,Helen Jane Mee,Negative
 London,Stefano Arganese,Positive
 ¬£ incentive,LymphomaAction,Negative
 Atypical   Presentation,JELEU,Negative
 Chronic Lymphocytic Leukemia Therapy,National Aspergillosis Centre,Negative
 Chronic Lymphocytic Leukemia Therapy,Cancer Papers,Negative
 Chronic Lymphocytic Leukemia Therapy,FarmaOnco,Negative
 Chronic Lymphocytic Leukemia Therapy,SCIENCEDOMAIN Int.,Positive
 √Ä quand,PedagoCLL,Positive
 le r√©seau coll√©gial   ¬´ ce partenariat rendra accessibles,PedagoCLL,Positive
 plateformes novatrices,PedagoCLL,Positive
 permettront de partager les ressources des biblioth√®ques universitaires cr√©ant,PedagoCLL,Positive
 ¬´ ce sont toujours les √©tudiants,PedagoCLL,Positive
 classe,PedagoCLL,Positive
 en t√©l√©enseignement,PedagoCLL,Positive
 Gildas Club Quad Cities,Iowa Cancer Consortium,Positive
 Nassif Community Cancer Center,Iowa Cancer Consortium,Positive
 Chronic Lymphocytic Leukemia Workshop,Iowa Cancer Consortium,Positive
 Stateoftheart,Benlazar S.M Amin√©,Negative
 Stateoftheart,Krishan Maggon,Negative
 Stateoftheart,ImmunotherapyPapers,Negative
 Evolving,MD Anderson Leukemia,Negative
 Evolving,Cancer News,Negative
 Treatment Paradigm,MD Anderson Leukemia,Negative
 Obinutuzumab   Chlorambucil,ClinicalTrialsData,Negative
 Untreated Previously Treated Chronic Lymphocytic Leukemia,ClinicalTrialsData,Negative
 chemo infusion,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 cycle amp blood counts,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 Novel Targeted Agents,EurekaMag,Negative
 Novel Targeted Agents,GEDEFO,Negative
 Novel Targeted Agents,Garbi√±e Lizeaga,Negative
 Novel Targeted Agents,A. Vroom - Ten Wolde,Negative
 RelapseRefractory Chronic Lymphocytic Leukemia Systematic Review,EurekaMag,Negative
 Network MetaAnalysis,EurekaMag,Negative
    VS ‚è± Ô∏è Final del partido,Club Libertad Limpe√±o,Negative
    VS   Liza Larrea por Karina Vega,Club Libertad Limpe√±o,Negative
    VS   Nairelis Guti√©rrez por Carmen Ben√≠tez,Club Libertad Limpe√±o,Negative
    VS   Liz Pe√±a por Yanina L√≥pez,Club Libertad Limpe√±o,Negative
    VS ‚è± Ô∏è FINAL DEL PRIMER TIEMPO,Club Libertad Limpe√±o,Negative
 Ô∏è   Gol de Am√©rica,Club Libertad Limpe√±o,Negative
    Annual Meeting Daniel Persky MD,UA Cancer Center,Positive
 Kirsty Sadler,Leukaemia Care,Positive
 Nice   study,Prof John,Negative
 Transcriptional Modulation,Prof John,Negative
 Transcriptional Modulation,@balbensi üá∫üá∏ üáÆüáπ,Positive
 Synergizes,Prof John,Negative
 ‚Ç¨ M,CIMAGO,Positive
 INTERREGPOCTEP program,CIMAGO,Positive
 prevention,CIMAGO,Positive
 prevention,Expert Perspectives in Oncology,Negative
 prevention,"Raul Cordoba, MD, PhD",Negative
 ÿ≠ÿ™Ÿâ ŸàÿßŸÜÿß ŸÖÿ≠ŸàŸÑ ŸáŸäÿ≥ÿ™Ÿà ÿ®ÿßŸÇŸä ÿßÿ±ÿ¨ÿπ,Raed Al-shehri üß¨üéì,Positive
 ŸÅŸä ÿßŸÑŸáŸäŸÖÿßÿ™ŸàŸÑÿ¨Ÿä,Raed Al-shehri üß¨üéì,Positive
 Ÿàÿ¥ŸàŸÅŸàÿß,Raed Al-shehri üß¨üéì,Positive
 ÿ≠ÿµŸÑÿ™ ŸÖÿ±Ÿäÿ∂ ÿπŸÖÿ±Ÿá ÿ™ÿ¨ÿßŸàÿ≤ ÿßŸÑŸÄ,Raed Al-shehri üß¨üéì,Positive
 ÿ™ŸÖ,Raed Al-shehri üß¨üéì,Positive
 paradigm,Guillermo Sanz,Negative
 paradigm,MoJo,Negative
 ü§î ü§î,Guillermo Sanz,Negative
 Saar Gill Tanya Siddiqi,VJHemOnc,Negative
 roundtable,VJHemOnc,Negative
 Berlin Stuart Blakemore,Christian Pallasch,Positive
 CLL treatment goals,Patient Power,Negative
 Expert Dr Jeffrey Menashe,Patient Power,Negative
 CLL therapy,Patient Power,Negative
 CLL therapy,VJHemOnc,Negative
 conversations,Patient Power,Negative
 conversations,VJHemOnc,Negative
 healthcare team,Patient Power,Negative
 Hoy   Las Gumarelas debutan ante las colombianas del,Revista El Repollero,Positive
 Am√©rica de Cali por,Revista El Repollero,Positive
 Libradores Femenina,Revista El Repollero,Positive
 preceptorshipwith,Benlazar S.M Amin√©,Negative
 Pr CLeblond Paris,Benlazar S.M Amin√©,Negative
 Clinical Oncology Congratulations P Hillman S Fox amp TAP network,Claire Harrison,Positive
 moment,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Mrs HTG,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 lessons,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 finger spelling links,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 readiness,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 itRFGlyCCC,MDS and You - MDS og Dig,Positive
 glyphosate,nanaval,Positive
 nonhodgkins lymphomab,nanaval,Positive
 Stem cell transplantation,Zusia:Dr Jackie Volk,Positive
   Nebula Library Update study,Nebula Genomics,Positive
 Nature Communications,Nebula Genomics,Positive
 TG Therapeutics Announces Data Presentations,U2 Fans,Positive
 TG Therapeutics Announces Data Presentations,Crwe World,Negative
 TG Therapeutics Announces Data Presentations,GNWLive,Positive
 TG Therapeutics Announces Data Presentations,SPI News,Negative
 XVIII International Workshop,U2 Fans,Positive
 XVIII International Workshop,1stOncology,Negative
 XVIII International Workshop,Crwe World,Negative
 XVIII International Workshop,‚ö°AiMS,Negative
 XVIII International Workshop,GNWLive,Positive
 XVIII International Workshop,SPI News,Negative
 XVIII International Workshop,iwCLL,Negative
 Douglas Daily,U2 Fans,Negative
 Access articles,ACS Journal Cancer,Negative
 Nov   issue,ACS Journal Cancer,Negative
 Soooo,Fleur Peters,Positive
 Transcript,Biblioteca HUCA,Negative
 Transcript,IUOPA,Negative
 Transcript,CLLSA,Negative
 Lenalidomide Restore NK Cell Function,Biblioteca HUCA,Negative
 Lenalidomide Restore NK Cell Function,IUOPA,Negative
 Lenalidomide Restore NK Cell Function,Cancer Papers,Negative
 Lenalidomide Restore NK Cell Function,NK papers,Negative
 Fulll text,Biblioteca HUCA,Negative
 Houston,Invivoscribe,Negative
 Houston,Andrew Schorr,Negative
 Houston,Patient Power,Negative
 Houston,Jeff Folloder,Positive
 Come visit booth,Invivoscribe,Negative
   solutions,Invivoscribe,Positive
 B Tcell malignancies,Invivoscribe,Positive
     k,Vaibhav kumar gupta,Positive
 kr   hu,Vaibhav kumar gupta,Positive
 wale,Vaibhav kumar gupta,Positive
 k,Vaibhav kumar gupta,Positive
 Pr kr,Vaibhav kumar gupta,Positive
 h   mujhe,Vaibhav kumar gupta,Positive
 h,Vaibhav kumar gupta,Positive
 k   v itta,Vaibhav kumar gupta,Positive
 nhi h agr mn kre,Vaibhav kumar gupta,Positive
 CANCELLED   Tonights,RIOH,Negative
 wedknown,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Walthamstow,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 non hematologists,Dr Musa Fares Alzahrani,Negative
 Risk Factors,National Aspergillosis Centre,Negative
 Invasive Fungal Infections,National Aspergillosis Centre,Negative
 Padua University,National Aspergillosis Centre,Negative
 ¬†  combinations,literaturereviewcentre,Positive
 Rituximab VS Ibrutinib,literaturereviewcentre,Positive
 Love,Amy Paturel,Positive
 Love,Sigrid Sk√•nland,Negative
 Love,Rachel Haywood,Positive
 Love,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 cancer advances,Amy Paturel,Positive
 Marina Mostafizar,@balbensi üá∫üá∏ üáÆüáπ,Positive
 coauthor,@balbensi üá∫üá∏ üáÆüáπ,Positive
 Idelalisib Synergizes,@balbensi üá∫üá∏ üáÆüáπ,Positive
 journal,@balbensi üá∫üá∏ üáÆüáπ,Positive
 journal,"chadi nabhan MD, MBA, FACP",Negative
 journal,Lymphoma Hub,Negative
 CHC WEST,CARE‚Ñ¢ Education,Negative
 agenda,CARE‚Ñ¢ Education,Negative
 Check,CARE‚Ñ¢ Education,Negative
 Check,Team Intake.Me,Negative
 Check,Canadian Hematology,Positive
 Multiple MyelomaPlasma Cell Dyscrasias Chronic Lymphocytic Leukemia Acute Leukemia amp CarT Updates Integration,CARE‚Ñ¢ Education,Negative
 Biosimilar Benign Hematology Use,CARE‚Ñ¢ Education,Negative
 AutoTransplant,CARE‚Ñ¢ Education,Negative
 GSK Phase   Phase II Eltrombopag,ClinicalTrialsData,Negative
 Son enseignement accompagne certains,PedagoCLL,Positive
 bien apr√®s la fin de leur parcours,PedagoCLL,Positive
 souvent ce,PedagoCLL,Positive
 qui marquent,PedagoCLL,Positive
 Il,PedagoCLL,Positive
 Il,EmatoInfo,Positive
 Il,C√©gep de L√©vis,Positive
 s‚Äôagit davantage d‚Äôune phrase,PedagoCLL,Positive
 moment de confiance de valeurs ou d‚Äôune vision ou d‚Äôune passion,PedagoCLL,Positive
 Bad news guys,TSmrecansky,Positive
 Fridays   lecture,Weill Cornell Medicine Pathology,Positive
 Paolo Ghia MD PhD Deputy Chair,Weill Cornell Medicine Pathology,Positive
 Experimental Oncology Universit√† VitaSalute San Raffaele,Weill Cornell Medicine Pathology,Positive
 ‚Äú Antigens,Weill Cornell Medicine Pathology,Positive
 APTO st   patient,Joe,Negative
 cycleThis   patient,Joe,Negative
 Verastem,Sciinov Insights,Positive
 Verastem,Clarivate Cortellis,Negative
 Yakult Honsha,Sciinov Insights,Positive
 Bld Cancer Alert NonHodgkins Lymphoma B,zenwomyn,Positive
 T Cell Chronic Lymphocytic Leukemia Mantle Cell Hairy Cell Multiple Myeloma,zenwomyn,Positive
 Roundup Weed Killer Victims amp families,zenwomyn,Positive
 cost obligation,zenwomyn,Positive
 Verastem Oncology Announces Dosing,SNN Network,Negative
 Verastem Oncology Announces Dosing,HCP Feed,Negative
 Verastem Oncology Announces Dosing,Latest News from Business Wire,Negative
 Yakult Honsha Co Ltd,SNN Network,Negative
 Yakult Honsha Co Ltd,Greenlight Stocks,Positive
 Yakult Honsha Co Ltd,HCP Feed,Negative
 Yakult Honsha Co Ltd,Latest News from Business Wire,Negative
 Yakult Honsha Co Ltd,‚ö°AiMS,Negative
 Japanese Bridging Study,SNN Network,Negative
 Japanese Bridging Study,Greenlight Stocks,Positive
 Japanese Bridging Study,HCP Feed,Negative
 Japanese Bridging Study,Latest News from Business Wire,Negative
 COPIKTRA,SNN Network,Negative
 COPIKTRA,Greenlight Stocks,Positive
 COPIKTRA,HCP Feed,Negative
 COPIKTRA,Latest News from Business Wire,Positive
 COPIKTRA,The Pharmaceutical Marketing Group,Negative
 video interview Prof Andreas,ESH (Haematology),Negative
 signalling pathways,ESH (Haematology),Negative
 Mc inhibitors,ESH (Haematology),Negative
 CLICK,ESH (Haematology),Negative
   Oncology Announces Dosing,Greenlight Stocks,Positive
 Dr Barbara Eichhorst,ESH (Haematology),Negative
 Dr Barbara Eichhorst,EMJ Hematology,Negative
 genomics novel agents,ESH (Haematology),Negative
 Dr Manali Kamdar,Total Health Conferencing,Positive
 Colorado,Total Health Conferencing,Positive
 VSTMVerastem Oncology Announces Dosing,‚ö°AiMS,Negative
 Hassan Almuhanna,Michie Lab,Negative
 beginning,Michie Lab,Negative
 beginning,Patient Power,Negative
 beginning,Nick,Negative
 beginning,Andrew Schorr,Negative
 beginning,Aaron Charles,Negative
 RelapsedRefractory Follicular Lymphoma,Kanakidis,Positive
 Chronic Lymphocytic Leukemia Effects,Kanakidis,Positive
 Relapsed Refractory Bcell NonHodgkin Lymphoma,Krishan Maggon,Negative
 Relapsed Refractory Bcell NonHodgkin Lymphoma,Tim Fenske,Negative
 Relapsed Refractory Bcell NonHodgkin Lymphoma,Lymphoma Papers,Negative
 Blood Journal,Krishan Maggon,Negative
 Blood Journal,"Raul Cordoba, MD, PhD",Positive
 Blood Journal,üÖæ Jaksic,Negative
 Blood Journal,CLL,Negative
 Chronic lymphocytic,Nature Reviews Disease Primers,Positive
 Chronic lymphocytic,Zusia:Dr Jackie Volk,Positive
 Chronic lymphocytic,Cancer Africa,Positive
 Chronic lymphocytic,Cell Reports,Positive
 Chronic lymphocytic,ESMO - Eur. Oncology,Negative
 illustrated PrimeView,Nature Reviews Disease Primers,Positive
 contributes,"Raul Cordoba, MD, PhD",Negative
 PIKpŒ¥,"Raul Cordoba, MD, PhD",Negative
 PIKpŒ¥,Total Well Being,Positive
 antibody responses,"Raul Cordoba, MD, PhD",Negative
 antibody responses,Total Well Being,Positive
 antibody responses,Human Immunology News,Negative
 Language,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Language,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 communication,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 communication,VJHemOnc,Negative
 deaf school staff member,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 FAQ,Michael Hallek,Negative
 Fortunate Turn,Michele Nadeem-Baker,Negative
 Fortunate Turn,CLL Society Inc.,Negative
 Fortunate Turn,Chocolatiere Phys,Negative
 High Incidence,The Lynx Group,Positive
 High Incidence,Value-Based Cancer Care,Positive
 High Incidence,AONN+,Negative
 Significant Economic Burden,The Lynx Group,Positive
 Significant Economic Burden,Value-Based Cancer Care,Positive
 Significant Economic Burden,AONN+,Negative
 Dr Norma Jean Murphy,CLL Ireland,Negative
 Dr Amjad Hayat,CLL Ireland,Negative
 places,CLL Ireland,Positive
 places,LiveYourLife,Negative
 fortbildningsdag uppbyggd kring programmet,Vasa √∂vningsskola,Positive
 ‚Äù Efter nio,Vasa √∂vningsskola,Positive
 med M√•rten och,Vasa √∂vningsskola,Positive
 Sonja,Vasa √∂vningsskola,Positive
 Excellent rw,Toby Eyre,Negative
 Rx options,Toby Eyre,Negative
 othersAs novel agents,Toby Eyre,Negative
 Neue Studie,DeutschesGesundheitsPortal,Positive
 √§mie Chronisch lymphatische Leuk√§mie   Strategien,DeutschesGesundheitsPortal,Positive
 kompletten Forschungsergebnisse,DeutschesGesundheitsPortal,Positive
 VIDEO Relevance,VJHemOnc,Negative
 KRAS NRAS,Europe PMC articles,Positive
 BRAF mutations,Europe PMC articles,Positive
 BRAF mutations,"Amber Koehler, PA-C",Negative
 Pr Paolo Ghia,ESH (Haematology),Negative
 Drs Syed,The ASCO Post,Negative
 Ali Abutalib,The ASCO Post,Negative
 Sonali M Smith,The ASCO Post,Negative
 biosimilar CLL drugs,Patient Power,Negative
 Estoril Barbara Eichhorst,Michael Hallek,Negative
 Valerie,The Leukemia & Lymphoma Society,Negative
 video interview Dr Dan Landau,ESH (Haematology),Negative
 negativity,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 negativity,VJHemOnc,Negative
 UsesIBRUTINIB,Ravispecialitiespharma_RSP,Negative
 incancer cells,Ravispecialitiespharma_RSP,Negative
 Molecular Interactions,ImmunologyPapers,Negative
 Innate,ImmunologyPapers,Negative
 Innate,Clarivate Cortellis,Negative
 Adaptive Immune Cells,ImmunologyPapers,Negative
 Therapeutic Implications,ImmunologyPapers,Negative
 Hien Nguyen,Christian Reinhardt,Positive
 ‚Å¶lab,Christian Reinhardt,Positive
 mission goals,Patient Empowerment Network,Negative
 reviews programs,Patient Empowerment Network,Negative
 services,Patient Empowerment Network,Negative
 services,CLL,Negative
 Oct   webinar,Patient Empowerment Network,Negative
 Dr ¬† Kerry Rogers,Patient Empowerment Network,Negative
 New research opportunitygt,LymphomaAction,Negative
 alerts,DawnKA,Positive
 ‚è∞ Save,DawnKA,Positive
 unit,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Professional Practice Portfolio,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 st year postchemo,Jeff Neurman,Negative
 ‚Äì,Jeff Neurman,Negative
 Forum,VJHemOnc,Negative
 Forum,LyLe Foreningen,Negative
 w Toby Eyre MD,VJHemOnc,Negative
 Christina Fisher,Patient Power,Negative
 Christina Fisher,Patient Empowerment Network,Negative
 DanaFarbers,Dana-Farber,Negative
 DanaFarbers,Dana-Farber News,Positive
 Cirmtuzumab blocks,Blood Journal,Negative
 stimulation,Blood Journal,Negative
 NFŒ∫B,Blood Journal,Negative
 autocrine STAT activation,Blood Journal,Negative
   things,Medscape Oncology,Positive
     Cello Health PLC Disposal,AIM Alerts!,Negative
 CLL Patient Advocate Shares Tips,Michele Nadeem-Baker,Negative
 Nuevamente,Fran!,Negative
 Entre R√≠os,Fran!,Negative
 expert perspective,WCM Lymphoma,Negative
 expert perspective,Patient Power,Negative
 Precise Outlook,Science Examiner,Positive
 ‚Äì Altor BioScience Amgen Aptevo Therapeutics,Science Examiner,Positive
   goals,SiriusXM FC 157 ‚öΩÔ∏èüìª,Negative
   goals,iwCLL,Negative
 ‚òé,SiriusXM FC 157 ‚öΩÔ∏èüìª,Positive
 ATM pathway,VJHemOnc,Negative
 w Tatjana Stankovic MD PhD,VJHemOnc,Negative
 Alice Sperling care partner,Patient Power,Negative
 Broads   Program Genetic Perturbation Platform Proteomics Platform Metabolism Program,Broad Institute,Positive
 College Station,Easterwood Airport,Positive
 travel shots,Easterwood Airport,Positive
 Leukemia Research    Jain,ClinicalBid,Positive
 improved survival,ClinicalBid,Positive
 improved survival,ASH Clinical News,Negative
 letter word,Simone Laurey,Positive
 C Cult,Simone Laurey,Positive
 Lymphoma   Lymphoma Research Foundation,DawnKA,Positive
 ABCs,Michele Nadeem-Baker,Positive
 ABCs,RIOH,Negative
 Michele NadeemBaker CLL Patient Advocate,Michele Nadeem-Baker,Negative
 pleasure,Sigrid Sk√•nland,Negative
 pleasure,Kristi Rosa,Positive
 pleasure,Corporaci√≥n Lady Lee,Positive
 pleasure,Glenn Sabin,Positive
 Kreftforeningens,Sigrid Sk√•nland,Negative
 yesterday Evening symposium,Sigrid Sk√•nland,Negative
   ChemoSparing Tx Doubles Response,Michele Nadeem-Baker,Negative
 Fit CLL,Michele Nadeem-Baker,Negative
   Edinburgh,Michael Hallek,Positive
 meeting,Michael Hallek,Negative
 meeting,3PSolution,Negative
 meeting,VJHemOnc,Negative
 meeting,Rishikumar Vundi,Positive
 meeting,Patient Power,Negative
 meeting,LymphomaAction,Negative
 meeting,CLL Ireland,Negative
 meeting,The James,Negative
 meeting,Anissa Brennet,Positive
 meeting,Natacha Bola√±os,Negative
 meeting,Francesco Bertoni,Negative
 meeting,LymphomaLeukemia,Positive
 meeting,Lymphoma Hub,Negative
 meeting,CML AdvocatesNetwork,Negative
 meeting,"chadi nabhan MD, MBA, FACP",Negative
 Dan Landau,Michael Hallek,Negative
 Dan Landau,Tal Nawy,Positive
 Dan Landau,Lymphoma Hub,Negative
 Dan Landau,Tawny Cuykendall,Positive
 w Christoph Plass PhD,VJHemOnc,Negative
 Amy Pierre MSN ANPBC,APSHO,Negative
 Nancy M Nix PharmD BCPS BCOP,APSHO,Negative
   perspective,APSHO,Negative
   perspective,Andrew Schorr,Negative
 smoldering,APSHO,Negative
 Buparlisib,ClinicalTrialsData,Negative
 Incidence rates,ID Medical,Positive
 Incidence rates,CLL Ireland,Negative
 Incidence rates,CLL Society Inc.,Positive
 Incidence rates,Erin Early,Positive
 Incidence rates,Titanhealth news,Negative
 Incidence rates,Future Oncology,Positive
 Incidence rates,Future Science OA,Positive
 Cello Health PLC,Broker Ratings,Negative
 Potential Upside,Broker Ratings,Positive
 Liberum Capital,Broker Ratings,Negative
 Thompson et,Toby Eyre,Negative
 alUndetectableMRD,Toby Eyre,Negative
 NGS,Toby Eyre,Negative
 NGS,"Raul Cordoba, MD, PhD",Negative
 NGS,Invivoscribe,Negative
 sensitivity,Toby Eyre,Negative
 sensitivity,Lymphoma Papers,Negative
 Trooper Daniel Jenkins Mike,David Blackwelder,Positive
 Chronic Lymphocytic Leukemia CCL,David Blackwelder,Positive
 Manta Cell Lymphoma MCL,David Blackwelder,Positive
 VIDEO Entospletinib,VJHemOnc,Negative
 RR CLL w Adam Kittai MD,VJHemOnc,Negative
 Vers,PedagoCLL,Positive
 identit√© positive√† l√®re du num√©rique,PedagoCLL,Positive
 Pour le deuxi√®me cycle du,PedagoCLL,Positive
 l‚Äô√©cart de r√©ussite,PedagoCLL,Positive
 √† l‚Äôavantage des filles,PedagoCLL,Positive
 oscille entre un,PedagoCLL,Positive
 et cinq,PedagoCLL,Positive
 de pourcentage,PedagoCLL,Positive
 Au,PedagoCLL,Positive
 Qu√©bec ¬† ¬† points de pourcentage,PedagoCLL,Positive
 Torneo clausura,Club Libertad Limpe√±o,Positive
 ta,Club Libertad Limpe√±o,Positive
 Fecha VS,Club Libertad Limpe√±o,Positive
 Los goles,Club Libertad Limpe√±o,Negative
 ta Fecha,Club Libertad Limpe√±o,Negative
 ENTRE TIEMPO,Club Libertad Limpe√±o,Negative
 Karina Vega     ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 CD expression,Lymphoma Papers,Positive
 CD expression,Benlazar S.M Amin√©,Negative
 CD expression,EurekaMag,Positive
 CD expression,Elsevier Hematology,Positive
 CD expression,NK cell Biology,Positive
 CD expression,NK papers,Positive
 CD expression,AJMC,Negative
 CD expression,AJMC-Oncology,Negative
 modified Matutes,Lymphoma Papers,Negative
 modified Matutes,Benlazar S.M Amin√©,Negative
 VIDEO Realworld evidence,VJHemOnc,Negative
 idelalisib wToby Eyre MD,VJHemOnc,Negative
 Dr Justin Taylor,Patient Power,Negative
 Dr Justin Taylor,Patient Empowerment Network,Negative
 blood work,Patient Power,Negative
   Edinburgh Valentin Goede,Michael Hallek,Negative
   min ‚åõ,Medscape Education,Negative
 Dr Marcos Gonz√°lez Jefe,Hematolog√≠a Salamanca,Negative
 del Servicio   cierra,Hematolog√≠a Salamanca,Negative
 cell chronic lymphatic leukemia,Tanya Fischer,Positive
 Final analysis,ALI ALAHMARI.,Positive
 Final analysis,Lymphoma Papers,Negative
 Final analysis,CancerEpiPapers,Negative
 Final analysis,Benlazar S.M Amin√©,Negative
 follow‚Äêup,ALI ALAHMARI.,Positive
 follow‚Äêup,Benlazar S.M Amin√©,Negative
 New Research New Recurrent Structural Aberrations,Frontiers Genetics,Positive
 Genome,Frontiers Genetics,Positive
   Information Night,RIOH,Negative
 Oct Talks,RIOH,Negative
 CLL Ibrutinib,RIOH,Negative
 CLL Ibrutinib,Oncology Tube,Negative
 CLL Ibrutinib,ASH,Positive
   Awareness Month,Oncology Times,Negative
   Awareness Month,CLLSA,Negative
 promising CAR TCell Therapy,Oncology Times,Negative
 gtgtgtThe utility,Benlazar S.M Amin√©,Negative
 expert advice,Patient Empowerment Network,Positive
                      information visit,MDDigitasTV,Negative
 Chronic Lymphocytic Leukemia New Goal,CLL-seq,Negative
 Dr Paoli Ghia ERIC research initiative,Guillermo Sanz,Negative
      et al phase,Chan Cheah,Negative
 Ib study,Chan Cheah,Negative
 U ublituximab,Chan Cheah,Negative
 PIKdelta,Chan Cheah,Negative
 CKE inhibitor,Chan Cheah,Negative
 RR Bcell lymphoma,Chan Cheah,Negative
 Francesca Vittoria Sbrana PhD,CELLINK,Positive
 San Raffaele Scientific Institute,CELLINK,Positive
 D systems,CELLINK,Positive
 D systems,VJHemOnc,Negative
 Dr Sbrana,CELLINK,Positive
 collaborator,CELLINK,Positive
   Healthcare team,Patient Empowerment Network,Negative
 Voice,Patient Empowerment Network,Positive
 ProActive CLL Patient Toolkit,Patient Empowerment Network,Negative
   microenvironment,VJHemOnc,Negative
 Vittoria Sbrana PhD,VJHemOnc,Negative
   oncology team,Medical Expressions,Positive
 Plant BlLl yn sgwrsio yn Ffrangeg,Melin Gruffydd,Positive
 Dr LesleyAnn Surton ERIC research initiative,Guillermo Sanz,Negative
   Edinburgh Dr Shenmiao Yang Peking,Michael Hallek,Negative
 Munir et al AJHFinal,Toby Eyre,Negative
 y RESONATEPFS,Toby Eyre,Negative
 ofatumumabOS,Toby Eyre,Negative
 crossoverPFS ‚úÖ,Toby Eyre,Negative
 VIDEO Regulating HS,VJHemOnc,Negative
 wCristina Scielzo PhD,VJHemOnc,Negative
 perseverance,Lia Palomba,Positive
 PIKdelta inhibitor umbralisib,Targeted Oncology,Negative
 CART therapy,Oncology Tube,Negative
 CART therapy,CLL Society Inc.,Positive
 CART therapy,CubaHeal,Positive
 CART therapy,Flow Paradigm,Negative
 replacement,Oncology Tube,Negative
 replacement,VJHemOnc,Negative
 SEA SQUIRT,Prof John,Negative
 strategy,Prof John,Negative
 strategy,CLL-seq,Negative
 strategy,KU Cancer Center,Positive
 immunomodulation,Prof John,Negative
 immunomodulation,CLL-seq,Negative
 immunomodulation,"Raul Cordoba, MD, PhD",Positive
 immunomodulation,Blood Advances,Positive
 immunomodulation,Klaus Okkenhaug,Positive
 immunomodulation,"Dr T. Comeau , MD",Negative
 Minimal Residual Disease Negativity,Oncology Tube,Positive
 Minimal Residual Disease Negativity,"John P. Leonard, MD",Positive
 leader,CLL Society Inc.,Negative
 leader,OncLive.com,Negative
 leader,Cancer News,Negative
 leader,AlfonsoValencia,Negative
 CLL Society support groups,CLL Society Inc.,Negative
 CURE magazine,CLL Society Inc.,Negative
 Personalized Management,Oncology Tube,Positive
 Patient Characteristics,Oncology Tube,Negative
 Cytogenetics,Oncology Tube,Negative
 Cytogenetics,JAMA,Negative
 Novel revelations,Oncology Tube,Negative
 venetoclaxibrutinib,Oncology Tube,Negative
 studied population,Serge_Single-Cell MultiOmics BDB,Positive
 Exposureresponse analysis,Lymphoma Papers,Negative
 Dr Montillo Prof Stamatopoulos,3PSolution,Negative
 receptor,3PSolution,Negative
 management tool,donnashort,Negative
 Dr Frey,donnashort,Negative
 Chair Dr Stadtmauer,donnashort,Negative
 Newbie Dr Gerson,donnashort,Negative
 Dr Stadtmauer,donnashort,Negative
 cover,SeattleCancerCareAlliance,Negative
 s Frontline publication,SeattleCancerCareAlliance,Negative
 fellow Dr Nikhil Kamat,SeattleCancerCareAlliance,Negative
   Rounds meeting,SeattleCancerCareAlliance,Negative
 Missed    Head,VJHemOnc,Negative
 Nuovo,Take The Date,Positive
 Times,Take The Date,Positive
 Times,Oncology Times,Negative
 Times,Medscape Education,Positive
 Times,Michele Nadeem-Baker,Negative
 Times,3PSolution,Positive
 AChangin,Take The Date,Positive
 Mitochondrial Reprogramming,Prof John,Negative
 Underlies Resistance,Prof John,Negative
 Lymphoid Malignancies,Prof John,Negative
 Lymphoid Malignancies,"Raul Cordoba, MD, PhD",Negative
 energy metabolism amp,Prof John,Negative
   Announces Data Presentations,1stOncology,Negative
 microRNAs,CLL-seq,Negative
 microRNAs,EurekaMag,Negative
 microRNAs,Cancer Papers,Negative
 microRNAs,microRNApapers,Positive
 microRNAs,BioinfoPapers,Positive
 Untreated Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Lymphoma Papers,Negative
 Shanafelt,the paper link,Negative
 Shanafelt,Researchphilia,Positive
 Shanafelt,"Mike Thompson, MD, PhD, FASCO",Negative
 TD,the paper link,Negative
 TD,Researchphilia,Positive
 et al N Engl J Med IbrutinibRituximab,the paper link,Negative
     post amp,CLLSA,Negative
 patient advocates,CLL Advocates Network,Positive
 patient advocates,Lymphoma Australia,Positive
 patient advocates,Michael Rynne,Negative
            testing,MDDigitasTV,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Venetoclax Venclyxto Venclexta,COPD News,Negative
 Atypical Urology PresentationRead,JELEU,Negative
 Ce e volet,PedagoCLL,Positive
 Chronic Lymphocytic Leukemia Personalized Approach,GrupoCronosSEFH,Positive
 Chronic Lymphocytic Leukemia Personalized Approach,Targeted Oncology,Negative
 Hartmut D√∂hner,Michael Hallek,Negative
   adults,JanssenUS,Negative
   adults,"Pharmacyclics, an AbbVie Company",Negative
 onequarter,AstraZenecaUS,Negative
 NEW updates,Joe,Negative
 APTOs Sep presentation,Joe,Negative
 Oppenheimer,Joe,Negative
 ETst,Joe,Negative
 CG patient,Joe,Negative
 SAEWhat,Joe,Negative
 rd month,Joe,Negative
 Chronic Lymphocytic Leukemia iw,Crwe World,Negative
 TGTXTG Therapeutics Announces Data Presentations,‚ö°AiMS,Negative
 Cellular therapy session,Toby Eyre,Negative
 Noteworthy,Toby Eyre,Negative
 alloSCT,Toby Eyre,Negative
 alloSCT,Anna Deveau,Negative
 alloSCT,Lymphoma Hub,Negative
 alloSCT,Chan Cheah,Negative
 alloSCT post,Toby Eyre,Negative
 series data,Toby Eyre,Negative
 Danielle Brander,Toby Eyre,Negative
 Danielle Brander,VJHemOnc,Negative
 Danielle Brander,Anthony Mato,Negative
 Danielle Brander,Lymphoma Hub,Negative
 intolerant   patients,Toby Eyre,Negative
 Katy Rezvani,Toby Eyre,Negative
 John Byrd Richters transformation,Toby Eyre,Negative
    UKCLLForum Edinburgh,Nick,Negative
 Advocates,Nick,Negative
 Advocates,Michele Nadeem-Baker,Negative
 Advocates,Zack Pemberton-Whiteley,Negative
 UKCLLForum Edinburgh,Nick,Positive
 Matt Davids,Toby Eyre,Negative
 months fixed duration therapy,Toby Eyre,Negative
 MRS status,Toby Eyre,Negative
 time point,Toby Eyre,Negative
   B Cell Power Lymphocytic Leukem,Unidrugscom,Positive
 VPA Research Prices,Renal Cell Carcinoma,Negative
 VPA Research Prices,CRO Contract Res.,Positive
 Lymphoma Nurse Manager Donna Gairns,Lymphoma Australia,Positive
 LYA,Lymphoma Australia,Positive
 CLL Horizons,Lymphoma Australia,Positive
 CLL Horizons,Zack Pemberton-Whiteley,Negative
 iwCLL conferences,Lymphoma Australia,Positive
 sailing schooner,Andrew Schorr,Negative
 Maine coast,Andrew Schorr,Negative
 passengers,Andrew Schorr,Negative
 Weed Killer,Elena,Positive
 SurvivorNet,Elena,Positive
 DUDE WTF,Elena,Positive
 MONSANTO,Elena,Positive
 Prof Susan,Lymphoma Hub,Negative
 OBrien,Lymphoma Hub,Negative
 OBrien,"Naveen Pemmaraju, MD",Negative
 Mary Ann Anderson,Michael Hallek,Negative
 Melbourne group,Michael Hallek,Negative
 Complex mechanisms,Michael Hallek,Negative
 Investtrade Genmab shares,Motivate Minds üá¨üáß,Positive
 Genmab,Motivate Minds üá¨üáß,Positive
 Genmab,MedSource,Negative
 Genmab,The Pharma Letter,Negative
 Lively debate,VJHemOnc,Negative
 assessment,VJHemOnc,Negative
 assessment,NovelHealthStrategie,Positive
 assessment,"Raul Cordoba, MD, PhD",Positive
 E,Toby Eyre,Positive
 E,City of Hope,Positive
 E,"Mike Thompson, MD, PhD, FASCO",Negative
 E,ECOG-ACRIN Cancer Research Group,Negative
 Petra Langerbeins,Paula Cramer,Positive
 Petra Langerbeins,Lymphoma Hub,Negative
 Petra Langerbeins,VJHemOnc,Negative
 st presenting improvement,Paula Cramer,Positive
 EFS,Paula Cramer,Positive
 Binet pts,Paula Cramer,Positive
   CLL trial,Paula Cramer,Positive
 breakfast symposium,Donna Gairns,Positive
 NextGeneration,Medscape Education,Positive
 NextGeneration,PER,Negative
 NextGeneration,Francesco Turturro,Negative
 Malignancies Data Updates,Medscape Education,Positive
 Case Challenge Paradigm Shift,Medscape Education,Positive
 Secondary Malignanciesw Prof Barbara Eichhorst,Medscape Education,Negative
 Fixed Duration,Medscape Education,Negative
 Fixed Duration,Mahmoud Aljurf,Positive
 Fixed Duration,Philip McCarthy,Negative
 Fixed Duration,CancerEpiPapers,Negative
 Fixed Duration,Progetto Odin,Positive
 Fixed Duration,Bernie Marini,Positive
 Continuous Treatmentw,Medscape Education,Negative
 Prof Barbara Eichhorst,Medscape Education,Negative
 Case Challenge,Medscape Education,Negative
 Tailored Treatment Approachw Prof Jacqueline Barrientos,Medscape Education,Negative
 Brander et,Toby Eyre,Negative
 alCLLIPI,Toby Eyre,Negative
   Edinburgh Martina Seiffert,Michael Hallek,Negative
 Heidelberg,Michael Hallek,Negative
 Adam Linley,VJHemOnc,Negative
 signalomics,VJHemOnc,Negative
 antigen engagement,VJHemOnc,Negative
 VSTM Verastem,Investor News,Negative
 UK   forum   data,Toby Eyre,Negative
 Excellent talk,Fleur Peters,Positive
 Excellent talk,Jeremy Scott,Positive
 Excellent talk,healthbook,Positive
 dr MartinSubero,Fleur Peters,Positive
 Inaki MartinSubero,Dr Effie Kostareli,Negative
 CLL knowledge,Alba Maiques-Diaz,Positive
   cofellows,Harry Fuentes MD MSc,Positive
 fellow,Harry Fuentes MD MSc,Positive
 Future leaders,Harry Fuentes MD MSc,Positive
 Limerick,annemarie,Positive
 cancer conference,annemarie,Positive
 BTEC CPLD units,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 speech,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Verastem Oncology Announces COPIKTRA,Pharmacutical Daily,Negative
 Verastem Oncology Announces COPIKTRA,SNN Network,Negative
 Verastem Oncology Announces COPIKTRA,Crwe World,Negative
 Verastem Oncology Announces COPIKTRA,Cancer News,Negative
 ‚Ñ¢ Duvelisib Presentations,Pharmacutical Daily,Negative
 ‚Ñ¢ Duvelisib Presentations,SNN Network,Negative
 ‚Ñ¢ Duvelisib Presentations,Crwe World,Negative
 Annual International Workshop,Pharmacutical Daily,Negative
 Annual International Workshop,SNN Network,Negative
 Annual International Workshop,‚ö°AiMS,Negative
 Annual International Workshop,Cancer News,Negative
 Verastem Oncology Pronounces COPIKTRA,Unidrugscom,Positive
 ‚Ñ¢ Duvelisib Displays,Unidrugscom,Positive
 th Annual International Workshop,Crwe World,Negative
 Conference Coverage,MDedge Hematology & Oncology,Negative
 VSTMVerastem Oncology Announces,‚ö°AiMS,Negative
 Duvelisib Presentations,‚ö°AiMS,Negative
 Duvelisib Presentations,Cancer News,Negative
 Chronic Lymphocytic Leukemia Verastem Inc NasdaqVSTM Verastem Oncology,Cancer News,Negative
   Minutes journalist Ed Bradley,Cancer Today,Positive
 CLL Navigator,Patient Empowerment Network,Negative
   Expert,Patient Empowerment Network,Negative
   Expert,CancerWallonia,Negative
 UKCLL forum,Michie Lab,Negative
 Dr KharfanDabaja,"Ricardo Parrondo, MD",Positive
 Professor Paolo Ghia   shares news,CLL Ireland,Negative
 Prof Chris Fegan,CLL Advocates Network,Negative
 Prof Chris Fegan,CLL Ireland,Negative
 Prof Chris Fegan,Zack Pemberton-Whiteley,Positive
 Prof Chris Fegan,VJHemOnc,Negative
 og science day,LyLe Foreningen,Negative
 Prof,CLL Ireland,Negative
 Prof,Ardalan Ahmad,Positive
 Prof,djp,Positive
 Associate Professor,CLL Ireland,Negative
 Associate Professor,Expert Perspectives in Oncology,Negative
 Haematology University,CLL Ireland,Negative
 TX options,CLL Ireland,Negative
 Dr Anna Schuh,LyLe Foreningen,Negative
 flue vaccine,LyLe Foreningen,Negative
 pneumnokok vaccine,LyLe Foreningen,Negative
 intrinsic,Benlazar S.M Amin√©,Negative
 Edinburgh Patient organisations,Zack Pemberton-Whiteley,Negative
 sun,Michie Lab,Negative
 sun,Michael Rynne,Negative
 sun,Jimmy,Positive
 sun,CromptonCricketClub,Positive
 Jennifer Wilson,CLL Ireland,Negative
 Information Specialists,CLL Ireland,Negative
 amp obstacles,CLL Ireland,Negative
 Dr Kostas Stamatopoulos,CLL Ireland,Negative
 Dr Kostas Stamatopoulos,Zack Pemberton-Whiteley,Positive
 exiting day,LyLe Foreningen,Negative
 Roundup Options Help Center,EIN Presswire: Press Releases,Positive
 Illinois,EIN Presswire: Press Releases,Negative
   patient advocates,"Amber Koehler, PA-C",Negative
 ya soon Edinburgh,"Amber Koehler, PA-C",Negative
 Higher Melanoma RiskMelanoma,LabMedica.com,Positive
 Renforcer,PedagoCLL,Positive
   treatment path Dr Danielle Brander,Patient Empowerment Network,Negative
 Precision Investigational New Drug application,"Trustwell Law Group, LLP",Positive
 PBCARA,"Trustwell Law Group, LLP",Positive
 PBCARA,TrialBulletin,Negative
 SSL,"Trustwell Law Group, LLP",Positive
 Backyard Roundup,PAN UK,Positive
 Backyard Roundup,Justice Pesticides,Positive
 Backyard Roundup,GMO Free USA,Negative
 Backyard Roundup,AboutLawsuits.com,Positive
 Led,PAN UK,Positive
 Led,Justice Pesticides,Positive
 Led,GMO Free USA,Negative
 Led,AboutLawsuits.com,Positive
 Brian koffman,LyLe Foreningen,Negative
   community meeting,CLL Ireland,Negative
 Belle initiative merci,PedagoCLL,Positive
 Adaptation de jeux d‚Äôapprentissages immersifs,PedagoCLL,Positive
 des enfants atteints,PedagoCLL,Positive
 du TDC,PedagoCLL,Positive
 info amp support team,LymphomaAction,Negative
 Patienten unter BTKInhibitor,Medical Tribune,Positive
 ohne,Medical Tribune,Positive
 ICYMI Ibrutinib,Oncology Learning Network,Negative
 ICYMI Ibrutinib,HemOnc Today,Positive
 CLL Paul Barr MD shares year followup data,Oncology Learning Network,Negative
 Secondary Cancer Risk,Cancer News,Negative
 Chronic Lymphocytic Leukemia Lawsuit,GMO Free USA,Negative
 Chronic Lymphocytic Leukemia Lawsuit,kd live,Positive
 Chronic Lymphocytic Leukemia Lawsuit,L McSherry,Negative
 Chronic Lymphocytic Leukemia Lawsuit,AboutLawsuits.com,Positive
 bone marrowThe complaint,GMO Free USA,Negative
   Roundup lawsuits,GMO Free USA,Negative
 Monsanto,GMO Free USA,Negative
 Monsanto,üò∑Cyndy AntiracistüóΩSafety-Pin,Positive
 Monsanto,Matthews & Associates,Negative
 mortality benefit,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 SCIG,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 year duration,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 Verastem Oncology offsite,Amy C. Cavers,Negative
 EngagementInnovationField Medical Team,Amy C. Cavers,Negative
 Blood Cancer Awareness Month Thx MSL Nurse Educator amp Customer Engagement team,Amy C. Cavers,Negative
 Observational Study,TrialBulletin,Negative
 CLLSLL Treatment,TrialBulletin,Negative
 Routine Clinical Practice Status Recruiting Condition Summary Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma,TrialBulletin,Negative
 campus,Tapan Kadia,Negative
 campus,CLL Warwick Uni,Negative
 campus,Lifelong Learning,Positive
 Hematology Grand Rounds,Tapan Kadia,Negative
 Chronic Lymphocytic Leukemia CLL blood,Fernando Mart√≠n Moro,Positive
 designed RCT,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 skirt,Eduardo Flavio Oliveira Ribeiro,Negative
    interview Cello Health,Andrew Scott,Positive
 CLL interview Cello Health,Proactive,Negative
   Headlines,WheelieDealer,Negative
 Health bit,WheelieDealer,Positive
     Cello Health PLC Interim Results,AIM Alerts!,Negative
 worlds,Michael Rynne,Negative
 CLL doctors,Michael Rynne,Negative
 city,Michael Rynne,Negative
 city,Sigrid Sk√•nland,Negative
 city,Matthew Will,Positive
 CLL Advocates Network Horizons conference,CLL Advocates Network,Negative
 NICE     STUDY,Prof John,Negative
 POLISH LABS,Prof John,Negative
 ‚Å©Programmed cell death   expression EpsteinBarr virus infection,Prof John,Negative
 images,PedagoCLL,Positive
 Bcell Internal Controls,Invivoscribe,Positive
 LymphoTrack,Invivoscribe,Positive
 Bcell Low Positive Control,Invivoscribe,Positive
 Tracking,Invivoscribe,Positive
 Tracking,Mark,Positive
 Lawsuit Claims,AboutLawsuits.com,Positive
 Carol Moreno MD,Oncology Tube,Negative
 Examining,Oncology Tube,Negative
 este,"J. Cornago Navascu√©s, MD",Positive
 el   imparte,"J. Cornago Navascu√©s, MD",Positive
 una charla sobre el mecanismo de acci√≥n,"J. Cornago Navascu√©s, MD",Positive
 y los resultados,"J. Cornago Navascu√©s, MD",Positive
 de eficacia,"J. Cornago Navascu√©s, MD",Positive
 pacientes con    Gracias,"J. Cornago Navascu√©s, MD",Positive
   Research Phase,Society for Immunotherapy of Cancer,Positive
 L‚Äô√©ducation ouverte n‚Äôest pas un ph√©nom√®ne nouveau Cependant les sciences,PedagoCLL,Positive
 et citoyennes leurs infrastructures,PedagoCLL,Positive
 leurs pratiques,PedagoCLL,Positive
 Hier gibts,MEDtalks CH,Positive
 das Neueste,MEDtalks CH,Positive
 zur Behandlung von,MEDtalks CH,Positive
 ARZERRA Novartis Pharmaceuticals Corporation Chronic Lymphocytic Leukemia,MedLibrary.org,Negative
 CLL ARZERRA ofatumumab,MedLibrary.org,Negative
 La CAC,@fechacochaco,Positive
 Convenci√≥n Anual de la Asociaci√≥n Latinoamericana de Exportadores de Servicios,@fechacochaco,Positive
 ALES,@fechacochaco,Positive
 Per√∫Segu√≠ leyendo,@fechacochaco,Positive
 county,Clean Cape Fear,Positive
 MN,Clean Cape Fear,Positive
 MN,GetFaPrPhysJobs,Positive
 Det er nu,LyLe Foreningen,Negative
 Drs Stephen M Ansell Jennifer R Brown amp Nitin Jain,Oncology CE,Positive
   lab tests,Patient Empowerment Network,Positive
   path,iwCLL,Positive
     Henriette Huber,Michael Hallek,Negative
 Simone Edenhofer,Michael Hallek,Negative
    venetoclax combination,Michael Hallek,Negative
 Dissection,Benlazar S.M Amin√©,Negative
 JAK,Benlazar S.M Amin√©,Negative
 Functionality,Benlazar S.M Amin√©,Negative
 Healthy Malignant Lymphocytes,Benlazar S.M Amin√©,Negative
 Paul Barr MD shares year followup data,Oncology Learning Network,Negative
 Experts address,Patient Power,Negative
 subtype,Michael Rynne,Negative
 reduction,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 reduction,NaturesZestNutrition,Positive
 reduction,"Pharmacyclics, an AbbVie Company",Negative
 reduction,TumorImmunoPapers,Negative
 infectionSometimes,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 Igs,"Jason K Lee, MD, FRCPC, FAAAAI, FACAAI",Negative
 VIDEO MRD assessment,VJHemOnc,Negative
 SAT   Session XIII,Robert Z. Orlowski,Positive
 SAT   Session XIII,MD Anderson Leukemia,Positive
 SOC,Robert Z. Orlowski,Negative
 SOC,MD Anderson Leukemia,Negative
 CancerMedMDA PhysRelations,Robert Z. Orlowski,Positive
 Case Presentation,Robert Z. Orlowski,Negative
 Case Presentation,MD Anderson Leukemia,Negative
 SAT   Session XIV Questions,Robert Z. Orlowski,Negative
 SAT   Session XIV Questions,MD Anderson Leukemia,Negative
 William Wierda MD PhD wwierda,Robert Z. Orlowski,Negative
 Wow Language communication excellence,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
    progress,Adriana Bello,Positive
     summary,Adriana Bello,Positive
 Andrea Lenartova,Sigrid Sk√•nland,Positive
 Ennio doctor,Kirk Kirlin,Negative
 Plasma Cell Dyscrasias NonHodgkins Lymphoma,CARE‚Ñ¢ Education,Negative
 Hodgkins Lymphoma,CARE‚Ñ¢ Education,Negative
 Myeloid Disease,CARE‚Ñ¢ Education,Negative
 Thrombosis,CARE‚Ñ¢ Education,Negative
 Benign Diseases,CARE‚Ñ¢ Education,Negative
 RR   Dr Tanya Siddiqui,Adriana Bello,Positive
    pipeline therapy,Adriana Bello,Positive
 art,"Bachar Samra, MD",Positive
   Frontline treatment,"Bachar Samra, MD",Positive
 Dr Jennifer R Brown,Lymphoma Hub,Negative
   Dr Jennifer Brown concise therapy overview,Adriana Bello,Positive
     Comb Ibrutinib,Adriana Bello,Positive
 MoAb obinutuzumab frontline RR,Adriana Bello,Positive
     Bavaria Lukas Frenzel,Michael Hallek,Negative
 NonHodgkins Lymphoma Chronic Lymphocytic Leukemia,Trip Database,Negative
 NonHodgkins Lymphoma Chronic Lymphocytic Leukemia,Vegastrader66,Positive
 NonHodgkins Lymphoma Chronic Lymphocytic Leukemia,Yo-Bio,Positive
 NonHodgkins Lymphoma Chronic Lymphocytic Leukemia,DennisPartners,Negative
 acronyms,CLLSA,Negative
 glossary,CLLSA,Negative
 Manuel Fuentes,Purcell Lab,Positive
 Lymphoma symptoms,Shouting at people in my underpants,Negative
 fever   drenching night sweats,Shouting at people in my underpants,Negative
 weight loss,Shouting at people in my underpants,Negative
 weight loss,Targeted Oncology,Negative
 Richard R Furman,Oncology Tube,Negative
 RR High Risk,Oncology Tube,Positive
 Weill Cornell Medicine,Oncology Tube,Positive
 Weill Cornell Medicine,CLL Society Inc.,Negative
 Rod Humerickhouse,Oncology Tube,Positive
 Prof Corradini,3PSolution,Negative
 Custom CLL Panel,OGT,Negative
 genes,OGT,Negative
 genes,News Life Sciences,Positive
 genes,LiteratureFeed,Positive
 genes,BioNetPapers,Positive
 genes,BioGPS,Positive
 genes,Biocomputing,Positive
 genes,Qatar Research,Positive
 genes,microRNApapers,Negative
 genes,epigenetics_papers,Negative
 genes,Peng,Positive
 SFB ATM NOTCH TP,OGT,Negative
 gene list,OGT,Negative
 exon coverage examples,OGT,Negative
 VIDEO Update,VJHemOnc,Negative
 CARNK cell therapy work,VJHemOnc,Negative
 w Prof William Wierda,VJHemOnc,Negative
 CD Chimeric Antigen Receptor T Cells,ImmunologyPapers,Negative
 Chronic Lymphocytic Leukemia Display,ImmunologyPapers,Negative
 Elevated IFNŒ≥ Production Profile,ImmunologyPapers,Negative
    microenvironmental interactions,researchjobs.cz,Negative
 conferences,CLLSA,Negative
 conferences,Mahmoud Turki,Negative
 UK amp,CLLSA,Negative
 members,CLLSA,Positive
 members,Natacha Bola√±os,Negative
 members,Andrew Schorr,Positive
 members,CLL Ireland,Negative
 members,CLL_Fightersüéó,Negative
 members,Charlotte Roffiaen,Positive
 members,VJHemOnc,Negative
 members,Patient Power,Negative
 Y ahora que,Lenko Sins,Positive
 Cyclophosphamide,Cureus,Negative
 Cyclophosphamide,Lampe & Company,Negative
 Resistant Acquired Hemophilia,Cureus,Negative
 Mazziotta et al,Cureus,Negative
 dosage,Targeted Oncology,Negative
 Dynamics,"Robert West, PhD",Positive
 Dynamics,"Raul Cordoba, MD, PhD",Negative
 Dynamics,TumorImmunoPapers,Negative
 architecture,"Robert West, PhD",Positive
 Medimix,LiveTracker¬Æ,Positive
 August RWD,LiveTracker¬Æ,Positive
 LiveTracker CLL Ex,LiveTracker¬Æ,Positive
 st Line treatment RWE,LiveTracker¬Æ,Positive
 HCPS EU,LiveTracker¬Æ,Positive
 Sept April,LiveTracker¬Æ,Positive
 RWD,LiveTracker¬Æ,Positive
 oncologyhematology,LiveTracker¬Æ,Positive
 FISH tests,CLLSA,Negative
 chromosomal abnormalities,CLLSA,Negative
 threequarters,CLLSA,Negative
 abnormalities,CLLSA,Negative
 abnormalities,BVirtual Murciasalud,Negative
 abnormalities,GenPath Oncology,Negative
 molecules,CLLSA,Negative
 increased   cell growth,CLLSA,Negative
 chemokines,ImmunologyPapers,Negative
 chemokines,ACS Journal Cancer,Negative
 chemokines,Cancer Papers,Negative
 cancer stress,ImmunologyPapers,Negative
 cancer stress,ACS Journal Cancer,Negative
 cancer stress,Cancer Papers,Negative
 Oslo University Hospital,Sigrid Sk√•nland,Negative
 Lymphoma Hub,Lymphoma Hub,Positive
 Lymphoma Hub,Dr Timos Papagatsias,Negative
    CLL,AttentionMining‚Ñ¢ (CLL - CryptoLiveLeak Token),Negative
 Ÿà ÿ™ÿ≠ŸàŸÑŸÜÿß,ŸäŸèŸÄŸàŸÜŸèŸÄÿ≥Ÿè ÿßÿ®ŸíŸÄŸÜŸè ŸÖŸéŸÑŸíŸÄŸÄŸÄŸÄ⁄ØÿßŸí,Positive
 ÿ•ŸÑŸâ,ŸäŸèŸÄŸàŸÜŸèŸÄÿ≥Ÿè ÿßÿ®ŸíŸÄŸÜŸè ŸÖŸéŸÑŸíŸÄŸÄŸÄŸÄ⁄ØÿßŸí,Positive
 Ÿäÿß ÿ±ÿ® ÿ™ÿßÿÆÿ∞,ŸäŸèŸÄŸàŸÜŸèŸÄÿ≥Ÿè ÿßÿ®ŸíŸÄŸÜŸè ŸÖŸéŸÑŸíŸÄŸÄŸÄŸÄ⁄ØÿßŸí,Positive
 ÿµÿ≠ÿ™Ÿä,ŸäŸèŸÄŸàŸÜŸèŸÄÿ≥Ÿè ÿßÿ®ŸíŸÄŸÜŸè ŸÖŸéŸÑŸíŸÄŸÄŸÄŸÄ⁄ØÿßŸí,Positive
 Ÿà,ŸäŸèŸÄŸàŸÜŸèŸÄÿ≥Ÿè ÿßÿ®ŸíŸÄŸÜŸè ŸÖŸéŸÑŸíŸÄŸÄŸÄŸÄ⁄ØÿßŸí,Positive
 ÿ™ÿπÿ∑Ÿä ÿßŸÖŸä,ŸäŸèŸÄŸàŸÜŸèŸÄÿ≥Ÿè ÿßÿ®ŸíŸÄŸÜŸè ŸÖŸéŸÑŸíŸÄŸÄŸÄŸÄ⁄ØÿßŸí,Positive
 ŸÜŸàÿ± ÿπŸäŸàŸÜŸä,ŸäŸèŸÄŸàŸÜŸèŸÄÿ≥Ÿè ÿßÿ®ŸíŸÄŸÜŸè ŸÖŸéŸÑŸíŸÄŸÄŸÄŸÄ⁄ØÿßŸí,Positive
   Chronic lymphocytic   CLL,"Pharmacyclics, an AbbVie Company",Negative
   Chronic lymphocytic   CLL,Rachel House,Positive
 Dr Richard R Furman,Oncology Tube,Negative
 Compounds,Birmingham Health Partners üíô,Positive
 SCI member Robert Negrin,"Steven Artandi, MD, PhD",Negative
 Drug Duo,Jennifer Morgan,Positive
 Drug Duo,Healthy Life Pro,Positive
 Drug Duo,onlydiscounted,Positive
 Drug Duo,Brian Uherek,Negative
 Drug Duo,Armani Chiropractic,Positive
 Drug Duo,CURE Magazine,Negative
 Drug Duo,"Aaron Gerds MD, MS",Positive
 Drug Duo,Ryan HamNer,Negative
 Weapon,Jennifer Morgan,Positive
 Weapon,Healthy Life Pro,Positive
 Weapon,onlydiscounted,Positive
 Frontrunner,Michele Nadeem-Baker,Negative
 controversies,Michele Nadeem-Baker,Negative
 knack,Michele Nadeem-Baker,Negative
 Leslie MD,Oncology Tube,Positive
 Trial Outcomes    Hackensack University Medical Center,Oncology Tube,Negative
 JTCC,Oncology Tube,Negative
 MSSO physicianscientist fellow,Daniel Bachurski,Positive
   positions,Life Science Jobs,Positive
 bcell,Life Science Jobs,Positive
 bcell,WCMNYPJCTO,Negative
 B‚Äê cell proliferation,Journal of Leukocyte Biology,Positive
 penny,üò∑Cyndy AntiracistüóΩSafety-Pin,Positive
 Expressed barcodes,Luciano Martelotto üõ†üß¨üíªüá∫üá∏,Positive
 Expressed barcodes,LiteratureFeed,Positive
 Expressed barcodes,Literature Bot,Negative
 Expressed barcodes,Single Cell papers,Positive
 Expressed barcodes,bioRxiv,Positive
   Plus   Superior,YH,Positive
 Certain Patients,YH,Positive
 Oncology Newswatch,YH,Positive
 lymphocytic,"Pharmacyclics, an AbbVie Company",Negative
 lymphocytic,Sumit Middha,Positive
 amp survival,Medicine (PG resident),Positive
 amp survival,Lymphoma Hub,Negative
 barcodes,Kate Vilas,Positive
 relaxation,Tom,Negative
 respect,CNSA,Positive
 ta Fecha VS,Club Libertad Limpe√±o,Positive
 ¬° FINAAAAAAAAALLLLLL,Club Libertad Limpe√±o,Negative
 Fecha,Club Libertad Limpe√±o,Positive
 ‚è±,Club Libertad Limpe√±o,Positive
 GOOOOOOL ‚öΩ,Club Libertad Limpe√±o,Negative
 Autogol,Club Libertad Limpe√±o,Negative
 ta Fecha VS      Claudia Romero por Fabiola Sandoval,Club Libertad Limpe√±o,Negative
 Carmen Ben√≠tez ‚öΩ,Club Libertad Limpe√±o,Negative
 Final de la primera,Club Libertad Limpe√±o,Negative
 etapa ‚öΩ,Club Libertad Limpe√±o,Negative
 ¬° GOOOOL,Club Libertad Limpe√±o,Negative
 HMS professor,Harvard Medical School,Positive
 physician Catherine Wu,Harvard Medical School,Positive
 VIDEO Incorporating checkpointinhibitors,VJHemOnc,Negative
 secondline   therapy w Alison Moskowitz MD,VJHemOnc,Negative
 Relevant Biomarkers,Benlazar S.M Amin√©,Negative
 Hematological   Oncology Times,Benlazar S.M Amin√©,Negative
 Interesting concept,"chadi nabhan MD, MBA, FACP",Negative
 Interesting concept,"Tom Henry, MBA, RPh, CPh",Negative
 amp prolong survival,CLLSA,Negative
 Future Directions Studies,Medscape Education,Negative
 Future Directions,Medscape Education,Positive
 Future Directions,CCO Oncology,Positive
 Future Directions,Oncology.TV,Negative
 Future Directions,Edurne Gamarra,Positive
 Future Directions,TumorImmunoPapers,Negative
 Kinase Inhibitor Typesw Prof Farrukh Awan,Medscape Education,Negative
 firstgeneration BTK inhibitors nextgeneration agents,Medscape Education,Negative
 amp combination therapies,Medscape Education,Negative
 outcomesw Prof Farrukh Awan,Medscape Education,Negative
 patientrelated characteristics,Medscape Education,Negative
 CLL treatment landscape,Medscape Education,Negative
 improved outcomes,Medscape Education,Negative
 improved outcomes,medwireNews,Negative
 yearold Friesian,"Reda Mohamed Guessoum, DVM",Positive
 yearold Friesian,AVMA Journals,Positive
 month history,"Reda Mohamed Guessoum, DVM",Positive
 month history,AVMA Journals,Positive
 Mount Sinai Hospital Icahn School,Oncology Tube,Negative
 Mount Sinai,Oncology Tube,Positive
 Free FullText,gilbert c faure,Negative
 Leader Legend,Aurileus FC,Positive
 Dublin,Michael Rynne,Negative
 Dublin,CLL Ireland,Negative
 Combination Trial,Lymphoma Papers,Negative
 Duvelisib IPI,Lymphoma Papers,Negative
 ACCC Educational Opportunities,Oncology Tube,Negative
 Disease States,Oncology Tube,Negative
 Lymphoma NHL Chronic Lymphocytic Leukemia CLLSmall Lymphocytic Lymphoma Anaplastic LargeCell Lymphoma Angioimmunoblastic Lymphoma Blastic NKCell Lymphoma,Matthews & Associates,Negative
 New lab,Anna Kabanova,Positive
   Week,SpecialtyPTimes,Negative
 Review Pinterest Tackles AntiVaccine Movement,SpecialtyPTimes,Negative
 Higher Melanoma Risk,SpecialtyPTimes,Negative
 September   Week,Contemporary Clinic,Positive
 Higher Risk,Contemporary Clinic,Positive
 Higher Risk,Journal of Clinical Pathways,Negative
 Higher Risk,Dr. Melody Davis,Negative
 Higher Risk,Christopher Steer,Negative
 Higher Risk,NACDA Program on Aging,Negative
 Melanoma Study Links Tramadol,Contemporary Clinic,Positive
 Melanoma,Dr. Melody Davis,Negative
 Melanoma,South Shore Skin CTR,Positive
 Melanoma,Eternal¬†Beauty¬†Mobile¬†Esthetics,Positive
 Melanoma,All WNY News,Positive
 Melanoma,Rare Diseases,Negative
 Melanoma,CLL Society Inc.,Negative
 Melanoma,Jenkers News (ENG),Positive
 Melanoma,DC_Lifestyle,Positive
 Melanoma,Mein Doppelg√§nger ‡≤†_‡≤∞,Positive
 Melanoma,Allison,Positive
 Melanoma,dermatologyf,Positive
 CLL Creates,Dr. Melody Davis,Negative
 Closer Monitoring,Dr. Melody Davis,Negative
 Closer Monitoring,SpecialtyPTimes,Negative
   person cohort,Dr. Melody Davis,Negative
 declaration,Dr. Melody Davis,Negative
 rate,Dr. Melody Davis,Negative
    ,cnag-crg,Positive
    ,Centre for Genomic Regulation (CRG),Positive
    ,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Positive
 EUfunded   Synergy project BCLLatlas,cnag-crg,Positive
 EUfunded   Synergy project BCLLatlas,Centre for Genomic Regulation (CRG),Positive
 olaptesed pegol,Medivizor,Positive
 Leukemias,60s Folks,Positive
 Leukemias,Lymphoma News Today,Negative
 Cancers,60s Folks,Positive
 Cancers,Catherine Vel√°zquez,Positive
 Cancers,Genentech,Negative
 Cancers,EchoPMG,Positive
 Cancers,Lisa Palacios,Negative
 Cancers,MD Anderson Leukemia,Negative
 Cancers,Dr. Melody Davis,Negative
 Cancers,UroToday.com,Positive
 Cancers,Christopher Steer,Negative
 Cancers,NACDA Program on Aging,Negative
 Baby,60s Folks,Positive
 Baby,Sonja,Positive
 Cancer Therapy Advisor Researchers,60s Folks,Positive
 Interestingly incidence,60s Folks,Positive
 ¬° GOOL,Club Libertad Limpe√±o,Negative
 Nairelis Guti√©rrez por,Club Libertad Limpe√±o,Negative
 Laurie Cristaldo,Club Libertad Limpe√±o,Negative
 Fecha VS   ‚è±,Club Libertad Limpe√±o,Negative
 tiempo,Club Libertad Limpe√±o,Negative
 tiempo,LMC AELEMIC Espa√±a,Positive
 Final del,Club Libertad Limpe√±o,Negative
 Griselda Garay,Club Libertad Limpe√±o,Negative
 ta fecha,Club Libertad Limpe√±o,Negative
 VS,Club Libertad Limpe√±o,Positive
 Equipo confirmado ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Es,Club Libertad Limpe√±o,Negative
 hoy,Club Libertad Limpe√±o,Negative
 hoy,Malchofa,Positive
 Sat Sept th CLL patients,Andrew Schorr,Negative
 supercharged town hall meeting,Andrew Schorr,Negative
   increased risk,Children's Melanoma,Positive
   increased risk,SunAWARE,Positive
 causation,SunAWARE,Positive
 Oncology researchers,AbbVie,Negative
 California,EIN Presswire: Press Releases,Negative
 California,CLL Ireland,Negative
 pladser tilbage,LyLe Foreningen,Negative
 VisualAbstract IbrutinibRituximab,COPD News,Negative
   location,CLLSA,Negative
 extent,CLLSA,Negative
 ËØ≠Ë®ÄÂÖÉËÆ§Áü•ÔºöÊñáÂ≠óÊòØË°®ËææÊÑèÊÄùÁöÑÁ¨¶Âè∑Á≥ªÁªüÔºå‰∏çÂêåÁöÑËØ≠Ë®ÄÁî®‰∏çÂêåÁöÑÁ¨¶Âè∑Êù•Ë°®Ëææ„ÄÇÊàë‰ª¨ÁöÑÂèåËØ≠Âπ≥Ë°åËØæÁ®ã‰ªéÂ∞èÂ∞±ÂüπÂÖªÂ≠©Â≠ê‰ª¨ÂØπËØ≠Ë®ÄÁöÑÊÑüÁü•„ÄÇÂõõÂ≤ÅÁè≠ÁöÑ Zhu Malu VillafaneËÄÅÂ∏àÁî®Èô∂ÂúüÊù•ËÆ©Â≠©Â≠ê‰ª¨ÊääÊñáÂ≠óÁî®Èô∂ÂúüÂÅöÂá∫Êù• „ÄÇ        language,Lilian Wong,Positive
 RIC,Benlazar S.M Amin√©,Negative
 alkylating chemotherapy,Benlazar S.M Amin√©,Negative
 survival outcomes,Benlazar S.M Amin√©,Negative
 survival outcomes,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 RR High Risk CLL Personalized Management,Oncology Tube,Negative
 CLL   Years,Tina Price-Johnson üíô,Positive
 Counting,Tina Price-Johnson üíô,Positive
 ProActive   Patient Toolkit Video advice,Patient Empowerment Network,Negative
 planners,Patient Empowerment Network,Negative
 JCO Editorial,Kerri Wachter,Negative
 OSUs Dr Jennifer Woyach,Kerri Wachter,Negative
 Combination Targeted Therapy,Kerri Wachter,Negative
 Paul MBarr MD,Oncology Tube,Negative
     experience,Tina Price-Johnson üíô,Positive
 AWAY,Medscape Education,Negative
 Creates,SpecialtyPTimes,Negative
 Fathers,Oncology Tube,Negative
 Fathers,CLL Ireland,Negative
 chemo treatment,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 Verastem Oncology,Verastem Oncology,Positive
 Verastem Oncology,MAISA,Negative
 Verastem Oncology,Koch Institute at MIT,Positive
 poster presentations,Verastem Oncology,Negative
 Leukemia Awareness Month Learn,AACR Foundation,Negative
 LymphomaLarge Diffuse BcellFollicullar LymphomaCutaneous TCellAnapalastic TcellChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell LymphomaPrimary Central Nervous System Lymphoma,Matthews & Associates,Negative
 MATURE APPROACH,Prof John,Negative
   GOES,Prof John,Negative
 FLOW ‚Å¶‚Å©,Prof John,Negative
 Chronic Lymphocytic Leukemia Incidence Nested CaseControl Study,Jerry Lee,Negative
 Manitoba Canada,Jerry Lee,Negative
 Manitoba Canada,CLL Society Inc.,Negative
 Blood cancer,Michael Rynne,Negative
 Somatic   mutations,CancerWallonia,Negative
 ring sideroblasts,CancerWallonia,Negative
 HematologicRelated MalignancyInduced Eosinophilic Dermatosis,Cancer Papers,Negative
 Dr Bond,Targeted Oncology,Positive
 RECENT ADVANCES,touchONCOLOGY,Negative
 LARGE BCELL LYMPHOMA,touchONCOLOGY,Negative
 FOLLICULAR LYMPHOMA Authors Ian W Flinn Oncology amp Hematology Review,touchONCOLOGY,Negative
 Awareness Month,CLL Ireland,Negative
 ribbon,Kerry,Negative
   consultant,CLLSA,Negative
 ra Fecha VS,Club Libertad Limpe√±o,Positive
 Final ‚öΩ,Club Libertad Limpe√±o,Negative
 San Lorenzo,Club Libertad Limpe√±o,Negative
 vitro assay,Benlazar S.M Amin√©,Negative
 biomarker discovery,Benlazar S.M Amin√©,Negative
 prediction,Benlazar S.M Amin√©,Negative
 prediction,Sigrid Sk√•nland,Negative
 ibrutinib plus venetoclax treatment,Benlazar S.M Amin√©,Negative
 Ang√©lica V√°zquez por Stephenie Lacoste,Club Libertad Limpe√±o,Negative
 ra Fecha VS ‚è± Ô∏è,Club Libertad Limpe√±o,Positive
 ¬° Goool,Club Libertad Limpe√±o,Negative
 Goool,Club Libertad Limpe√±o,Negative
 Claudia Romero por Griselda L√≥pez,Club Libertad Limpe√±o,Negative
 Karina Vega ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 EN MARCHA ‚öΩ,Club Libertad Limpe√±o,Negative
 VIDEO   treatment,VJHemOnc,Positive
 Treatment Healthcare Resource Utilization,Anthony Mato,Negative
 FrontLine Ibrutinib,Anthony Mato,Negative
 ScienceDirect New paper,Anthony Mato,Negative
 st Line,Oncology Tube,Negative
 Loving todays,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 nature,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 curiosity table,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Poundland,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Baby Shower section,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 preview,Sigrid Sk√•nland,Negative
 preview,Great Debates in Hematologic Malignancies,Negative
 upcoming paper,Sigrid Sk√•nland,Negative
        Containers,iContactLanka,Positive
 Solutions,iContactLanka,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA PRECISION MEDICINE,Genomic Medicine UK,Positive
 CLINIC,Genomic Medicine UK,Positive
 Ph RCT,"Mike Thompson, MD, PhD, FASCO",Positive
 Ibrutinib   Obinutuzumab   Venetoclax,"Mike Thompson, MD, PhD, FASCO",Negative
 Chicago IL,Medscape Education,Negative
 Explore,Medscape Education,Negative
 Explore,CFOLD,Positive
 Explore,Lifelong Learning,Negative
 New   Research Phase,Society for Immunotherapy of Cancer,Negative
 BCR autophagy regulation,Benlazar S.M Amin√©,Negative
 VIDEO Brian Koffman,VJHemOnc,Negative
 personal,VJHemOnc,Negative
 personal,UNC Hussman School of Journalism and Media,Positive
 professional,VJHemOnc,Negative
 nurses,Oncology Nursing News,Negative
 nurses,LymphomaAction,Negative
 September issue,The Lancet Haematology,Negative
 September issue,ASH Clinical News,Negative
 September issue,The Lancet Oncology,Negative
 research articles,The Lancet Haematology,Negative
 Chlorambucil rituximab,01581Psychotherapy,Positive
 Chlorambucil rituximab,Medivizor,Negative
 Chlorambucil rituximab,noel cole,Negative
 GREEN light,Prof John,Negative
 New   Medicom Conference Report,Medicom Medical Publishers,Positive
   Conference Portal,Medicom Medical Publishers,Positive
 BCell Chronic Lymphocytic Leukemia Pipeline Review H,Unidrugscom,Positive
 Global Markets Direct Prices,Unidrugscom,Positive
   Obinutuzumab,Benlazar S.M Amin√©,Negative
 Immunoglobulin levels,Medivizor,Negative
 ‚Äú Association,Alyssa Clay-Gilmour,Positive
 New Combining ibrutinib,Medivizor,Negative
 page,CLL Society Inc.,Negative
 page,Patient Power,Negative
 UsesDaunosin mg tablets,Ravispecialitiespharma_RSP,Negative
 daunomycin,Ravispecialitiespharma_RSP,Negative
 chemotherapy medication,Ravispecialitiespharma_RSP,Negative
 LongTerm Studies,Lymphoma Papers,Negative
 Delq Chronic Lymphocytic Leukemia,Lymphoma Papers,Negative
 VIDEO Venetoclax,VJHemOnc,Negative
 description,Chan Cheah,Negative
 description,"Raul Cordoba, MD, PhD",Negative
 description,Nursing Homeworks,Positive
 description,Renal Cell Carcinoma,Negative
 PTCL,Chan Cheah,Negative
 Case Series,Chan Cheah,Negative
 VIDEO ALPINE,VJHemOnc,Negative
 w Constantine Tam,VJHemOnc,Negative
 Hypothesis generating post hoc analysis,Toby Eyre,Negative
 „Äê Á¨¨‰∫åÈÉ®‰ºöÔºöÊúüÂæÖ„ÅÆÂäπËÉΩËøΩÂä†„ÄëË£ΩÂìÅÔºãË£ΩÂìÅÔºàÂπ¥ÊúàÊó• Ôºâ,„ÄéÂåªÁßëÁÇπÊï∞Ë°®„ÅÆËß£Èáà„ÄèÁ∑®ÈõÜÈÉ®„ÄÄ(Ê†™)Á§æ‰ºö‰øùÈô∫Á†îÁ©∂ÊâÄ,Positive
 „Åï„Çì„Åã„Çâ„ÄåÔºÉ„Éô„Éç„ÇØ„É¨„ÇØ„Çπ„ÇøÈå†Ôºà‰∏ÄËà¨ÂêçÔºö„Éô„Éç„Éà„ÇØ„É©„ÇØ„Çπ Ôºâ Ôºö „Äå ÂÜçÁô∫Âèà„ÅØÈõ£Ê≤ªÊÄß„ÅÆ,„ÄéÂåªÁßëÁÇπÊï∞Ë°®„ÅÆËß£Èáà„ÄèÁ∑®ÈõÜÈÉ®„ÄÄ(Ê†™)Á§æ‰ºö‰øùÈô∫Á†îÁ©∂ÊâÄ,Positive
 WATCH Mazyar Shadman MD MPH,OncLive.com,Negative
 venetoclax Venclexta,OncLive.com,Negative
 venetoclax Venclexta,National Cancer Institute,Positive
 venetoclax Venclexta,Oncology Nursing News,Negative
 venetoclax Venclexta,Solomon Kamal,Positive
 venetoclax Venclexta,CLL Ireland,Negative
 Liver Dysfunction,CLL Society Inc.,Negative
 Liver Dysfunction,Sameer Parikh,Negative
 Liver Dysfunction,Cancer Papers,Negative
 Liver Dysfunction,Cancers MDPI,Negative
 Chronic Lymphocytic Leukemia New Findings,CLL Society Inc.,Negative
 √Ångeles Portillo por Liza Larrea,Club Libertad Limpe√±o,Negative
 da Fecha VS ‚è±,Club Libertad Limpe√±o,Positive
 GOOL,Club Libertad Limpe√±o,Negative
 Liz Pe√±a ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Claudia Romero por Damia Cortaza,Club Libertad Limpe√±o,Negative
 da Fecha VS,Club Libertad Limpe√±o,Negative
 ‚è± Ô∏è,Club Libertad Limpe√±o,Positive
 PT GOOL,Club Libertad Limpe√±o,Negative
 da Fecha VS ‚è± Ô∏è PT GOOL,Club Libertad Limpe√±o,Negative
 Fabiola Sandoval    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Doblete de Liza Larrea,Club Libertad Limpe√±o,Negative
 Ang√©lica,Club Libertad Limpe√±o,Negative
 V√°zquez,Club Libertad Limpe√±o,Negative
 Hot Topic ‚Äù Dr Curt Hanson,Iranian American Medical Association  (IAMA),Positive
 Hot Topic ‚Äù Dr Curt Hanson,Mayo Clinic Labs,Positive
 VIDEO message,The Patient's Channel,Positive
 French,The Patient's Channel,Positive
 French,Novateur Ventures,Positive
 French,Anna Deveau,Negative
 Florence Cymbalista,The Patient's Channel,Positive
 Florence Cymbalista,VJHemOnc,Positive
 Florence Cymbalista,Anna Deveau,Negative
 year oldfemale,Mayo Clinic Pathology,Positive
 Intense Uptake,Lovisa Bray,Positive
 Intense Uptake,SignPath Pharma,Positive
 Liposomal Curcumin,Lovisa Bray,Positive
 Liposomal Curcumin,SignPath Pharma,Positive
 Multiple Myeloma Cell Lines Comparison,Lovisa Bray,Positive
 Multiple Myeloma Cell Lines Comparison,SignPath Pharma,Positive
 Normal Lymphocytes Red Blood Cells,Lovisa Bray,Positive
 Normal Lymphocytes Red Blood Cells,SignPath Pharma,Positive
 Highgrade BCell lymphoma,Lymphoma Papers,Negative
 MYC BCL rearrangements,Lymphoma Papers,Negative
 w Dr Barbara Eichhorst,VJHemOnc,Negative
 allcancer incidence,CLL Society Inc.,Negative
 contrast,CLL Society Inc.,Negative
 incidence,CLL Society Inc.,Negative
 incidence,Jennifer Smith,Positive
 incidence,Plant Based Health Professionals UK,Positive
 incidence,LiveTracker¬Æ,Positive
 incidence,VJHemOnc,Negative
 CARE ‚Ñ¢ Perspectives report,CARE‚Ñ¢ Education,Negative
 key news,CARE‚Ñ¢ Education,Negative
 Plasma Cell Dyscrasias PCDs Chronic Lymphocytic Leukemia CLL NonHodgkin Lymphomas NHL,CARE‚Ñ¢ Education,Negative
 Combination Treatment,Patient Worthy,Negative
 Combination Treatment,MAISA,Negative
   Review Stateoftheart,Society for Immunotherapy of Cancer,Negative
 Drug Regimen,SpecialtyPTimes,Negative
 year anniversary,Philly Sports Guy in SC,Positive
   impacts,"Raul Cordoba, MD, PhD",Negative
   impacts,Benlazar S.M Amin√©,Negative
 Peripheral TCell Lymphoma,Lymphoma Papers,Negative
 guideline,Bibliosaude,Positive
 guideline,Joule Inc.,Positive
 guideline,Current Oncology,Negative
 guideline,Lymphoma Papers,Negative
 Sept th webinar Fact Fiction   Treatment Effects,Patient Empowerment Network,Negative
 comorbidity,EurekaMag,Negative
 comorbidity,palliativewise,Negative
 finnCap,Broker Ratings,Positive
 finnCap,finnCap,Positive
 CLL Komplette Remission,Onko Community,Negative
 mit Kombination Ibrutinib und Venetoclax,Onko Community,Negative
 miRa,microRNApapers,Positive
 miRa,EurekaMag,Negative
 miRa,Cancer Papers,Negative
 miRa,ClinChemINFO,Positive
 indicators,microRNApapers,Negative
 treatmentfree survival,microRNApapers,Negative
 treatmentfree survival,CLL Ireland,Negative
 treatmentfree survival,CancerTherapyAdvisor,Negative
 Improved survival outcomes,Hematology Advisor,Negative
 BCELL,Roland Wolff,Positive
 BCELL,researchjobs.cz,Negative
 INCORPORATION,Roland Wolff,Positive
 EMITTERS,Roland Wolff,Positive
 LITERATURERoland Wolff et al,Roland Wolff,Positive
 Global BCell Chronic Lymphocytic Leukemia Treatment Market Analysis Size Share Outlook Study,HAM,Negative
 sub,global hematology,Positive
 tracks,global hematology,Positive
 fixedduration venetoclax,Oncology Tube,Positive
 fixedduration venetoclax,Marta Gunjaca,Positive
 compound,Belong.Life,Positive
 compound,i3 Health,Negative
 compound,KeiraSmith_i3Health,Positive
 compound,"Brian Lawenda, MD",Positive
 compound,The Royal Vox Post,Positive
 compound,Laura Cipullo RD CDE CEDRD RYT,Positive
 chronic leukaemias,AstraZeneca,Positive
 Chronic   cells,AstraZeneca,Positive
 UsesConimab mg,Ravispecialitiespharma_RSP,Negative
 UsesConimab ml,Ravispecialitiespharma_RSP,Negative
 NonHodgkins Lymphoma B,David T.,Positive
 T Cell Chronic Lymphocytic Leukemia Mantle Cell,David T.,Positive
 Hairy Cell,David T.,Positive
 cost obligation review,David T.,Positive
 minutes,David T.,Positive
 minutes,donnashort,Negative
 minutes,MDedge Hematology & Oncology,Negative
 expert faculty Dr Matthew Davids,PRIME Education,Negative
 management considerations,PRIME Education,Negative
 patient cases,PRIME Education,Negative
 patient cases,Medscape Education,Negative
 patient cases,Targeted Oncology,Negative
 Frontline therapies,Benlazar S.M Amin√©,Negative
 IGFR,ASH,Negative
 IGFR,Blood Journal,Negative
 IGFR,Richard Rosenquist Brandell,Positive
 PIKŒ¥ inhibitor resistance,ASH,Negative
 PIKŒ¥ inhibitor resistance,"Raul Cordoba, MD, PhD",Positive
 PIKŒ¥ inhibitor resistance,Blood Journal,Negative
 ra Fecha VS ‚è± Ô∏è ¬° Doblete de Liza Larrea,Club Libertad Limpe√±o,Negative
 y   del segundo tiempo,Club Libertad Limpe√±o,Negative
 √Ångeles,Club Libertad Limpe√±o,Negative
 Portillo por Liz Pe√±a,Club Libertad Limpe√±o,Negative
 Natalia Barros por Ang√©lica V√°zquez,Club Libertad Limpe√±o,Negative
 Liza Larrea por Fabiola Sandoval,Club Libertad Limpe√±o,Negative
 ¬° GOOOL,Club Libertad Limpe√±o,Negative
 ‚è± Ô∏è   ST   Fabiola Sandoval     ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 GOOOL,Club Libertad Limpe√±o,Negative
 FINAL DE LA PRIMERA ETAPA,Club Libertad Limpe√±o,Negative
 Liz Pe√±a     ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 ¬° Equipo confirmado,Club Libertad Limpe√±o,Negative
 Natasha Mart√≠nez Carmen Ben√≠tez,Club Libertad Limpe√±o,Negative
 Paola Genes Stephenie Lacoste Joana Galeano Griselda Garay y,Club Libertad Limpe√±o,Negative
 Fabiola Sandoval Karina Vega y Liz Pe√±a,Club Libertad Limpe√±o,Negative
 ËÄÅ‰∫∫ÂÆ∂‰ΩìÈáç‰∏ãÈôç„ÄÅÂèçË¶ÜÂèëÁÉßÊÅêÊÖ¢ÊÄßÊ∑ãÂ∑¥ÊÄßÁôΩË°ÄÁóÖ,Â§©ËùéÂ∫ßÁöÑÂπ≥Â§¥Âì•,Positive
 Lymphocytic LeukemiaÔºåÁÆÄÁß∞CLLÔºâÔºåÂ•ΩÂèë‰∫éÂÖ≠„ÄÅ‰∏ÉÂçÅÂ≤ÅÈì∂ÂèëÊóèÔºå‰∏îÂõΩÂÜÖÁóÖ‰æãÈÄêÂπ¥‰∏äÂçá„ÄÅÊúâÂπ¥ËΩªÂåñË∂ãÂäø„ÄÇ‰∏çËøá‰∏çÂ∞ëËÄÅ‰∫∫ÂÆ∂Âá∫Áé∞‰∏çÊòéÂéüÂõ†ÁöÑ‰ΩìÈáç‰∏ãÈôç„ÄÅÂèçË¶ÜÂèëÁÉß„ÄÅÂ§úÈó¥ÁõóÊ±óÁ≠âÁóáÁä∂Êó∂ÔºåÂ∏∏Ë¢´ËÆ§‰∏∫ÊòØË°∞ËÄÅÁóáÁä∂ËÄåËΩªËßÜËØäÊñ≠ „ÄÅ,Â§©ËùéÂ∫ßÁöÑÂπ≥Â§¥Âì•,Positive
   Prognostic Score,"Raul Cordoba, MD, PhD",Negative
 Cytogenetic Risk Classification,"Raul Cordoba, MD, PhD",Negative
 Cytogenetic Risk Classification,Benlazar S.M Amin√©,Positive
 Cytogenetic Risk Classification,Jerry Lee,Negative
 Cytogenetic Risk Classification,Cure Cancer Now,Positive
 Cytogenetic Risk Classification,Chocolatiere Phys,Negative
 Cytogenetic Risk Classification,CellworksLife,Negative
 Chronic Lymphocytic Leukemia   Patients,"Raul Cordoba, MD, PhD",Negative
 Report Disease status comorbidity index lymphocyte count,"Raul Cordoba, MD, PhD",Negative
 Complex karyotype,Benlazar S.M Amin√©,Negative
 predictor,Benlazar S.M Amin√©,Negative
 predictor,CancerTherapyAdvisor,Negative
 predictor,Cancer Papers,Negative
 Prognostic Score,Benlazar S.M Amin√©,Positive
 Prognostic Score,Jerry Lee,Negative
 Prognostic Score,Cure Cancer Now,Positive
 Prognostic Score,Chocolatiere Phys,Negative
 Prognostic Score,CellworksLife,Negative
 Chronic Lymphocytic Leukemia Patients Center,Benlazar S.M Amin√©,Positive
 Chronic Lymphocytic Leukemia Patients Center,Jerry Lee,Negative
 Chronic Lymphocytic Leukemia Patients Center,Cure Cancer Now,Positive
 Chronic Lymphocytic Leukemia Patients Center,Chocolatiere Phys,Negative
 International Blood,Benlazar S.M Amin√©,Positive
 International Blood,Jerry Lee,Negative
 International Blood,Cure Cancer Now,Positive
 International Blood,Chocolatiere Phys,Negative
 Marrow Transplant Research Report,Benlazar S.M Amin√©,Positive
 Marrow Transplant Research Report,Jerry Lee,Negative
 Marrow Transplant Research Report,Cure Cancer Now,Positive
 Cancer Alert NonHodgkins Lymphoma B,Harry Moritz,Positive
 Roundup Weed KillerRoundup,Harry Moritz,Positive
 Agent OrangeWe,Harry Moritz,Positive
 d   sep,LyLe Foreningen,Negative
 handler,LyLe Foreningen,Negative
 om,LyLe Foreningen,Negative
 √¶ft √¶ft √¶mi,LyLe Foreningen,Positive
 WEB SPOTLIGHT,Paradigm Med Comm,Negative
 activityClick,Paradigm Med Comm,Positive
 Mutated ATM,OncologyNurseAdvisor,Positive
 Imbruvica Use,BioNews,Negative
 Combo Treatments,BioNews,Negative
 Waldenstr√∂m,BioNews,Negative
 rituximab improved survival,"Steven Artandi, MD, PhD",Negative
 Todays   Episode,Ryan Kia,Positive
 Cello Healths acquisition,Ryan Kia,Positive
 ISS,Ryan Kia,Positive
 ISS,AIM Alerts!,Negative
 CRAC   Cool review,Prof John,Negative
 channels,Prof John,Negative
 Aug   Tecentriq,MEDWAVE,Negative
 Breast Cancer,MEDWAVE,Negative
 nd Biosimilars,MEDWAVE,Negative
 Agenda AbbVie,MEDWAVE,Negative
 Innovative Science Solutions,WheelieDealer,Negative
 Consultancy,WheelieDealer,Negative
 Legal Regulatory work,WheelieDealer,Negative
 Healthcare,WheelieDealer,Negative
 Healthcare,AIM Alerts!,Negative
 Healthcare,David MANSET,Positive
 Quantium Cast Episode,Ryan Kia,Positive
 Quantium Cast Episode,Quantium Research,Positive
 posted Cello Health,Share Prophets,Negative
     Cello Health PLC Acquisition,AIM Alerts!,Negative
 reallife,Benlazar S.M Amin√©,Negative
 reallife,"Raul Cordoba, MD, PhD",Negative
   Recommendations,"Raul Cordoba, MD, PhD",Negative
   Prevalence,"Raul Cordoba, MD, PhD",Negative
 Petra Langerbeins MD,ASH Clinical News,Negative
 Scotland New treatment option,BCAwareness,Negative
 New Immunoglobulin levels,Medivizor,Negative
 Tedeschi et al   Cross trial comparison,Toby Eyre,Negative
 ObinChloramb,Toby Eyre,Negative
 pooled studies,Toby Eyre,Negative
 L   RCT,Toby Eyre,Negative
 OChlWell,Toby Eyre,Negative
 cohortsPFS HR,Toby Eyre,Negative
 Study researchers,OncologyNurseAdvisor,Negative
 European C omission,Cancer Stem Cell News,Negative
 ROOFTOPS,Prof John,Negative
 Repress Autocrine STATActivation,Prof John,Negative
 Scheffold et al,Thiago Carvalho,Negative
 insulinlike growth factor,Thiago Carvalho,Negative
 receptor IGFR,Thiago Carvalho,Negative
 resistance mechanism,Thiago Carvalho,Negative
 Constitutive Activation,Atanas G. Atanasov,Positive
 Constitutive Activation,Super Res Microscopy,Positive
 Constitutive Activation,DR.ARUN ACHUTHAN,Negative
 Constitutive Activation,Marcel van den Brink,Positive
 Constitutive Activation,"Michael Green, PhD",Negative
 B Cell Receptor,Atanas G. Atanasov,Positive
 B Cell Receptor,Super Res Microscopy,Positive
 B Cell Receptor,DR.ARUN ACHUTHAN,Negative
 B Cell Receptor,Marcel van den Brink,Positive
 B Cell Receptor,"Michael Green, PhD",Negative
 Underlies Dysfunctional Signaling,Atanas G. Atanasov,Positive
 Underlies Dysfunctional Signaling,Super Res Microscopy,Positive
 Underlies Dysfunctional Signaling,DR.ARUN ACHUTHAN,Negative
 Underlies Dysfunctional Signaling,Marcel van den Brink,Positive
 Underlies Dysfunctional Signaling,"Michael Green, PhD",Negative
 Acceptance,TrialSite News,Negative
 Acceptance,Odi Bruckman,Negative
 New Comparing outcomes,Medivizor,Negative
 Willima Wierda,Dene Peters,Positive
   discuss,Dene Peters,Positive
 Roger,VCU Massey,Positive
 Anne Boev√©,VCU Massey,Positive
 Combination IbrutinibVenetoclax,ASCO,Negative
 Overall Survival Rates,ASCO,Negative
 CART therapy article,CLL Society Inc.,Negative
 comment,Oncology,Negative
 Á©∫„ÅçÂÆ∂ÂØæÁ≠ñÁ†îÁ©∂„ÉÅ„Éº„É†ÂéöÁîü„Åô„Åø„Åã√ó‰ºäÂã¢„ÇÑ„Åæ„Å†„Åæ„Å°„Å•„Åè„Çä„Çº„Éü„ÄÇÁ©∫„ÅçÂÆ∂ÂïèÈ°å„Å´„Å§„ÅÑ„Å¶„ÄÅÂ≠¶Áîü„ÅåËá™Ê≤ª‰ºö„ÉÅ„Éº„É†„Å´ÊÑèË¶ã„ÇíËÅû„ÅÑ„Å¶„ÇÇ„Çâ„ÅÜÂ†¥„ÇíË®≠„Åë„Åü„ÄÇÁúüÂâ£„Å´ÊÑèË¶ã‰∫§Êèõ„Çí„Åó„Å¶È†Ç„ÅÑ„ÅüÂéöÁîü„Åô„Åø„Åã„Å´„ÅØ„ÄÅÊú¨ÂΩì„Å´ÊÑüË¨ù„Åß„Åô„ÄÇ‰∏âÈáçÁúå ‰ºäÂã¢Â∏Ç,Takahiro Chishima,Positive
 Á©∫„ÅçÂÆ∂ÂØæÁ≠ñÁ†îÁ©∂„ÉÅ„Éº„É†ÂéöÁîü„Åô„Åø„Åã√ó‰ºäÂã¢„ÇÑ„Åæ„Å†„Åæ„Å°„Å•„Åè„Çä„Çº„Éü„ÄÇÁ©∫„ÅçÂÆ∂ÂïèÈ°å„Å´„Å§„ÅÑ„Å¶„ÄÅÂ≠¶Áîü„ÅåËá™Ê≤ª‰ºö„ÉÅ„Éº„É†„Å´ÊÑèË¶ã„ÇíËÅû„ÅÑ„Å¶„ÇÇ„Çâ„ÅÜÂ†¥„ÇíË®≠„Åë„Åü„ÄÇÁúüÂâ£„Å´ÊÑèË¶ã‰∫§Êèõ„Çí„Åó„Å¶È†Ç„ÅÑ„ÅüÂéöÁîü„Åô„Åø„Åã„Å´„ÅØ„ÄÅÊú¨ÂΩì„Å´ÊÑüË¨ù„Åß„Åô„ÄÇ‰∏âÈáçÁúå ‰ºäÂã¢Â∏Ç,„ÇÑ„Åæ„Å†„Åø„Çâ„ÅÑLab,Positive
 ‰ºäÂã¢ Á©∫„ÅçÂÆ∂,Takahiro Chishima,Positive
 ‰ºäÂã¢„ÇÑ„Åæ„Å†Â§ßÂ≠¶ „ÇÑ„Åæ„Å†„Åø„Çâ„ÅÑlab ÁöáÂ≠∏È§®Â§ßÂ≠¶,Takahiro Chishima,Positive
 Á©∫„ÅçÂÆ∂ ÂéöÁîü„Åô„Åø„Åã ‰ºäÂã¢„ÇÑ„Åæ„Å†Â§ßÂ≠¶ „ÇÑ„Åæ„Å†„Åø„Çâ„ÅÑlab ÁöáÂ≠∏È§®Â§ßÂ≠¶,„ÇÑ„Åæ„Å†„Åø„Çâ„ÅÑLab,Positive
 oncology appt,Jeff Neurman,Negative
 messing,Jeff Neurman,Negative
 Covaris Mseries Focusedultrasonicator,Covaris,Positive
 Insomnia,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
   Chemoimmunotherapy,"Raul Cordoba, MD, PhD",Negative
 Chronic Lymphocy,Benlazar S.M Amin√©,Negative
 Chronic Lymphocy,"Bruce Levine, Ph.D.",Positive
 HemaSphere,Benlazar S.M Amin√©,Negative
 HemaSphere,"Raul Cordoba, MD, PhD",Negative
 Chronic Lymphocytic Leukemia Incidence Nested Case,CLL Society Inc.,Negative
 Control Study,CLL Society Inc.,Negative
 UsesChloramax mg,Ravispecialitiespharma_RSP,Negative
 UsesChloramax Tablet,Ravispecialitiespharma_RSP,Negative
 bit,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 bit,Lifelong Learning,Negative
 insomnia,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 Second Cancers,Lou DiVito,Positive
 Key Insights,Oncology Tube,Positive
 Key Insights,gilbert c faure,Negative
 Lymphoma amp Myeloma,Oncology Tube,Positive
 Lymphoma amp Myeloma,gilbert c faure,Negative
 Jacque barrientos,Kenar Jhaveri,Positive
 Expert Access Program,CLL Society Inc.,Negative
 Susahnya,roseXxxx,Positive
 Pada umur mama disahkan menhidapi,roseXxxx,Positive
 Chronic Lymphocytic Leukemia CLLSemoga,roseXxxx,Positive
 Allah,roseXxxx,Positive
 urusan kami sekeluarga,roseXxxx,Positive
 Drug combo,HealthEconFrontier,Positive
 Drug combo,Hematopoiesis News,Negative
 Drug combo,Sam David Management | Black World Studios,Positive
 Drug combo,tom hathaway,Positive
 Drug combo,For Laboratories,Positive
 Drug combo,Clare Jones,Positive
 Drug combo,Muiro Yatakama,Positive
 Drug combo,Gl√≥ria Maria Soares,Positive
 Drug combo,Baronian Consulting,Positive
 Drug combo,Healthcare-Globalüò∑,Positive
 Drug combo,Medit,Positive
 Drug combo,Tim Pugh,Positive
 Drug combo,Cancer Research News,Positive
 Drug combo,Science Codex,Negative
 Drug combo,FA Technologies,Positive
 Drug combo,Mazen M,Negative
 Drug combo,YoBuzz,Negative
 Drug combo,Ken Gusler,Positive
 Drug combo,LIVINGSTRONGTV.COM,Positive
 Drug combo,Brian Kenney,Positive
 Drug combo,Medical Xpress,Negative
 HOULSTON,Prof John,Negative
 congrats,Prof John,Negative
 Tanja Jo amp Eva,Prof John,Negative
 TAK,MedChemExpress,Positive
 New   Review Stateoftheart,Society for Immunotherapy of Cancer,Negative
 Blood Commentary Resolving PIKŒ¥ inhibitor resistance,Blood Journal,Negative
 HLAB Positivity,CLL Society Inc.,Negative
 CLL SLL Outcomes,CLL Society Inc.,Negative
    Dr Angela Howes VP Head,pharmavoice,Positive
 Leukemia Development Janssen RampD,pharmavoice,Positive
 MOMENT,Lymphoma Hub,Positive
 Ô∏è‚Äúst Lymphoma Hub Satellite Symposium,Lymphoma Hub,Negative
 Comparing outcomes,Medivizor,Negative
 areas,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 areas,The Oncologist,Positive
 environment,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 CLL FCR,Oncology Tube,Negative
 Better Jennifer Brown MD,Oncology Tube,Negative
 Harvard Medical School,Oncology Tube,Negative
 HLAB positivity,CancerTherapyAdvisor,Negative
 CLL SLL outcomes,CancerTherapyAdvisor,Negative
 Ôº¥Ôº°Ôº£Ôº¥Ôº©Ôº£Ôº°Ôº¨ „ÄÄ Ôº£Ôº®Ôº≤ÔºØÔºÆÔº©Ôº£,Ôº¥ÔΩÅÔΩÉÔΩîÔΩâÔΩÉÔΩÅÔΩåÔº•ÔΩñÔΩÖÔΩíÔΩôÔº∑ÔΩèÔΩíÔΩÑ,Positive
 Ôº¨ÔºπÔº≠Ôº∞Ôº®ÔºØÔº£ÔºπÔº¥Ôº©Ôº£ „ÄÄ Ôº¨Ôº•ÔºµÔº´Ôº•Ôº≠Ôº©Ôº°,Ôº¥ÔΩÅÔΩÉÔΩîÔΩâÔΩÉÔΩÅÔΩåÔº•ÔΩñÔΩÖÔΩíÔΩôÔº∑ÔΩèÔΩíÔΩÑ,Positive
   plant,i3 Health,Negative
   plant,KeiraSmith_i3Health,Positive
 fellowship,"Eric K. Singhi, MD",Positive
 ‚úÖ Exciting practice,"Eric K. Singhi, MD",Positive
 Figure,"Eric K. Singhi, MD",Positive
 Th Immunity,AIRR-seq papers,Positive
 Th Immunity,Philip McCarthy,Negative
 Clinical Response,AIRR-seq papers,Positive
 Clinical Response,Philip McCarthy,Negative
 Drug Combo Heralds Major Shift,SciTech Research,Negative
 APTO st CG patient,Joe,Negative
 Watch Joshua Brody MD,Oncology Tube,Negative
 Icahn School,Oncology Tube,Negative
 stress signals,NCI Center for Cancer Research,Positive
 Tait Shanafelt SCI member Steven Coutre,"Steven Artandi, MD, PhD",Negative
 Growth Factors Details Trend Analysis Size Share Challenges Competitors Overview,Kiran Bhole,Positive
 Growth Factors Details Trend Analysis Size Share Challenges Competitors Overview,lalit pachpande,Positive
   Chronic Lymphocytic Leukemia Treatment Market,lalit pachpande,Positive
   Chronic Lymphocytic Leukemia Treatment Market,Career Biotech,Negative
 ‚Äú Chronic Lymphocytic Leukemia Tr,lalit pachpande,Positive
 rituximab treatment,Ïù¥ÏÉÅÏõê,Positive
 rituximab treatment,Medivizor,Positive
 Professors,Noopur Raje,Positive
 CME,Noopur Raje,Positive
 CME,MayoProceedings,Positive
 ABIM,Noopur Raje,Positive
 MOCAccredited Audio,Noopur Raje,Positive
 Video Programs,Noopur Raje,Positive
   IbrutinibRituximab,Researchphilia,Positive
 N Engl J,Researchphilia,Positive
 GrammyAward,The Hot Mammas,Positive
 musician,The Hot Mammas,Positive
 Original Article Ibrutinib,NEJM,Positive
   expert webinar,Patient Empowerment Network,Negative
 guests Dr Susan LeClair,Patient Empowerment Network,Negative
 Weymann,ASCO Publications,Negative
 supervised learning algorithm,ASCO Publications,Negative
 bestperforming proxy,ASCO Publications,Negative
 COMPOUND,Prof John,Negative
 Bruce D Cheson MD FACP,Expert Perspectives in Oncology,Negative
 FASCO,Expert Perspectives in Oncology,Negative
 myRockworld,myRockworld,Positive
 QUESTION,Prof John,Negative
 Answer,Prof John,Negative
 Answer,KnotGrumpy,Positive
 ÂæûËä±Â£áÈÄ≤ÂÖ•ÈÜ´Â£áÔºüË∑ØÈÇäÈáéËä±„ÄåÂ∞èÁôΩËèä„ÄçÂèØÊèêÂèñÊäóÁôåÂåñÂêàÁâ©,TechNews ÁßëÊäÄÊñ∞Â†±,Positive
 sports analytics,Christian Capitini,Positive
 patient outcomes,Christian Capitini,Positive
 patient outcomes,Lymphoma Hub,Negative
 patient outcomes,iwCLL,Negative
 Diop et alNoncanonical NFkB pathway,Toby Eyre,Negative
 mut aw resistance,Toby Eyre,Negative
 fludarabinemPFS,Toby Eyre,Negative
 TP mut,Toby Eyre,Negative
 pt seriesadj,Toby Eyre,Negative
 UVA BIRC mut,Toby Eyre,Negative
 MVA IGHV TP mut del p,Toby Eyre,Negative
 includedHigh risk biomarker,Toby Eyre,Negative
 FCR resistance,Toby Eyre,Negative
       testing,MDDigitasTV,Negative
 drug duo,Stanford Medicine,Negative
 chronic   diseasefree,Stanford Medicine,Negative
          goog,Siegfried Treitner,Positive
 Patient advocate,Patient Power,Negative
 CLL survivor Michele NadeemBaker,Patient Power,Negative
 Prognostic Predictive Effect,Lymphoma Papers,Negative
 IGHV Mutational Status,Lymphoma Papers,Negative
 Load,Lymphoma Papers,Negative
 Chronic Lymphocytic Leukemia Focus,Lymphoma Papers,Negative
 BR Treatments,Lymphoma Papers,Negative
 Professor Patrick Thorntons,Michael Rynne,Negative
 ‚Äì Chemoimmunotherapy,Florian Slimano,Negative
 Cancer News Patients,Cancer Today,Negative
 Birmingham,"Brian Lawenda, MD",Positive
 Birmingham,Carevƒ´ve,Negative
 feverfew flowers,"Brian Lawenda, MD",Positive
 ERK,Renal Cell Carcinoma,Negative
 ERK,TrialBulletin,Negative
 Ibrutinib Resistant Bcell Malignancies,Renal Cell Carcinoma,Negative
 study drug LY,Renal Cell Carcinoma,Negative
 PLAYER PROFILEName,Newbury Blues,Positive
 Josh WinfieldAge Position,Newbury Blues,Positive
 RowPlayer Sponsor Studio Nickname WinnersJob Landscaper,Newbury Blues,Positive
 ‚Äç ‚ôÇ Ô∏èPrevious Clubs   Caps Representative Hons,Newbury Blues,Positive
 Ibrutinib Resistant Bcell Malignancies Status,TrialBulletin,Negative
 Condition Summary Chronic Lymphocytic Leukemia Waldenstrom Macroglobulinemia Mantle Cell Lymphoma Marginal Zone Lymphoma,TrialBulletin,Negative
 Distinctive IGHV gene usage,Benlazar S.M Amin√©,Negative
 stereotyped receptors,Benlazar S.M Amin√©,Negative
 homing,Benlazar S.M Amin√©,Negative
 CLL cellsRadiation therapy,Benlazar S.M Amin√©,Negative
 News Zanubrutinib,The Lancet Oncology,Negative
   CLL Kombination ohne Zytostatikum verbessert,"E. Kingreen, MD",Positive
 CLL Kombination ohne Zytostatikum,Deutsches √Ñrzteblatt,Positive
 verbessert Therapieergebnisse,Deutsches √Ñrzteblatt,Positive
 Palo Alto,Deutsches √Ñrzteblatt,Positive
 Eine Kombination,Deutsches √Ñrzteblatt,Positive
    researchers,The Royal Vox Post,Positive
 anticancer properties,The Royal Vox Post,Positive
 Drug Combo,ManagedCareMag,Positive
 Drug Combo,P&T,Positive
 Toxicity,Toby Eyre,Negative
 Toxicity,TrialSite News,Negative
 ALLIANCE trial BR,Toby Eyre,Negative
 ITRM,Toby Eyre,Negative
 ALLIANCE trialAtrial fibrillation,Toby Eyre,Negative
 ALLIANCE trial,Toby Eyre,Negative
 Practice changing results,Marko Skelin MPharm PhD,Positive
 PFS   Plt OS   Plt,Marko Skelin MPharm PhD,Positive
 paatients,Marko Skelin MPharm PhD,Positive
 frontline setting,Marko Skelin MPharm PhD,Positive
 et alLower,Toby Eyre,Negative
 PFS   OS advantage,Toby Eyre,Negative
 favour,Toby Eyre,Negative
 IR MRD,Toby Eyre,Negative
 L lty TP,Toby Eyre,Negative
 OS advUnmut,Toby Eyre,Negative
 Mut,Toby Eyre,Negative
 p nsG,Toby Eyre,Negative
 tox similarTime,Toby Eyre,Negative
 Unmut,Toby Eyre,Negative
 CLLE Immunochemo,Toby Eyre,Negative
 Mut CLL,Toby Eyre,Negative
   Logistical Process,SpecialtyPTimes,Negative
 Oral Oncolytics,SpecialtyPTimes,Negative
   trial E,ECOG-ACRIN Cancer Research Group,Negative
 Rituxan rituximab,The Cancer Letter,Negative
 Rituxan rituximab,MEDWAVE,Negative
 nonHodgkins   chronic lymphocytic   granulomatosis,The Cancer Letter,Negative
 polyangiitis,The Cancer Letter,Negative
 polyangiitis,Oncology Learning Network,Negative
 polyangiitis,Gil Morgan,Positive
 Game changer,Rodney DeKoter,Positive
 Sept Edinburg Scotland Press registration,iwCLL,Positive
 lesions,BJD,Positive
 trunkextremities,BJD,Positive
 Biopsy perivascular eosinophil‚Äêrich,BJD,Positive
 UsesCampath Injection,Ravispecialitiespharma_RSP,Negative
 Chronic Lymphocytic Leukemia VigorBot,Medicine Briefly,Negative
 Combo treatment,Afshine Emrani MD FACC,Positive
 Phase   data E,"Pharmacyclics, an AbbVie Company",Negative
 RCTs,"chadi nabhan MD, MBA, FACP",Negative
 Synchronous Diagnosis,BJSTR Journal-Claudia Henson,Positive
 Primary Myelofibrosis,BJSTR Journal-Claudia Henson,Positive
 Literature Review,BJSTR Journal-Claudia Henson,Positive
 Literature Review,Lymphoma Papers,Negative
 Rodrigue Mintsa Nguema,BJSTR Journal-Claudia Henson,Positive
 Biomedicalopenaccessjournals,BJSTR Journal-Claudia Henson,Positive
 Mohs surgery,"Vitaly Terushkin, MD, FACMS",Positive
 Encouraging phase,"Amber Koehler, PA-C",Negative
 C      Weill Cornell Medicine,Oncology Tube,Negative
    ANSWER Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL           site,Nicholas Koontz,Positive
 Alliance investigator Jennifer Woyach MD,Alliance for Clinical Trials in Oncology,Negative
 immunotherapy trial,Alliance for Clinical Trials in Oncology,Positive
 NICE WORK,Prof John,Negative
 openings,cnag-crg,Positive
 PhD students,cnag-crg,Positive
 amp T,VJHemOnc,Negative
 intricacies,VJHemOnc,Negative
 approved drugs,Cancer Health,Negative
 Ask Expert,Patient Empowerment Network,Negative
 firsttime treatment,Medivizor,Positive
 van Bruggen JAC,the paper link,Negative
 Federal Register notification,Marty Chilberg,Positive
 Story,Oncology Times,Negative
 Story,Selma Errol Hassan,Positive
 Story,Patient Power,Negative
 Story,Erick Lansigan,Positive
 Superres,Cell Reports,Positive
 patientspecific BCR,Cell Reports,Positive
    town meeting,Theresa (Clementi) Doan,Positive
 Cincinnati,Patient Power,Negative
 webinarEnjoy,CLL Society Inc.,Negative
 ICYMI FDA,Oncology Learning Network,Negative
 CDpositive Bcell nonhodgkin lymphoma,Oncology Learning Network,Negative
 granulomatosis,Oncology Learning Network,Negative
 New Combination treatment,Medivizor,Negative
 Outcomes      John Theurer Cancer Center,Oncology Tube,Negative
 Hackensack University Medical Center Hackensack University Medical Center,Oncology Tube,Negative
 Dr Jacqueline C Barrientos,Oncology Tube,Negative
 Sequencing Monotherapy,Oncology Tube,Negative
 August issue,The Lancet Haematology,Negative
 amp rituximab,The Lancet Haematology,Positive
 Global BCell Chronic Lymphocytic Leukemia Treatment Market,HAM,Positive
 Global BCell Chronic Lymphocytic Leukemia Treatment Market,Tech Journal Hub,Positive
 AB Science SA Amgen Inc Celgene Corporation Dynavax Technologies Corporation Eisai,HAM,Positive
 y‚Äôa,JU,Positive
 biosimilar Ruxience,Cancer Stem Cell News,Negative
 John Kuruvilla MD,Oncology Tube,Negative
 Russia,Verastem Oncology,Negative
 CIS Turkey,Verastem Oncology,Negative
 Middle East,Verastem Oncology,Negative
 Africa,Verastem Oncology,Negative
 Joshua Brody MD,Oncology Tube,Negative
 Neuer therapeutischer Ansatz f√ºr,Universit√§t Ulm,Positive
 Chronisch Lymphatische Leuk√§mie CLL,Universit√§t Ulm,Positive
 Forschende wollen Krebszellen,Universit√§t Ulm,Positive
 zellul√§re Unterst√ºtzung,Universit√§t Ulm,Positive
 entziehen   stgAbb,Universit√§t Ulm,Positive
 PD Dr Mertens,Universit√§t Ulm,Positive
 Ziegler,Super Res Microscopy,Positive
 CGK Kim,Super Res Microscopy,Positive
 J Piersanti K OylerYaniv Argyropoulos KV van den Brink MRM Palomba ML AltanBonnet N AltanBonnet G,Super Res Microscopy,Positive
 Ruxience,MDedge Hematology & Oncology,Negative
 Ruxience,Gil Morgan,Positive
 Ruxience,The Medical Letter,Negative
 Ruxience,Cellero,Positive
 Pentostatin Cyclophosphamide,COPD News,Negative
 Pentostatin Cyclophosphamide,Benlazar S.M Amin√©,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia Phase,COPD News,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia Phase,Benlazar S.M Amin√©,Negative
 ECOGAcrin Cancer Research Group E Patients,COPD News,Negative
 cousins,Funky Sunshine,Positive
 New   paper,RIOH,Negative
 New   paper,"chadi nabhan MD, MBA, FACP",Negative
 Patterns,Oncology Times,Positive
 Patterns,Chocolatiere Phys,Negative
 Patterns,Michele Nadeem-Baker,Negative
 Patterns,Bioengineer.org,Positive
 Patterns,CancerWallonia,Negative
 Patterns,Suresh Surenthiran,Positive
 Patterns,Sam David Management | Black World Studios,Positive
 Patterns,DTHSTR,Positive
 Patterns,Royal Free Library,Positive
 Patterns,Ruggero Respigo,Positive
 Patterns,YoBuzz,Negative
 Patterns,healthmedicinet,Positive
 Patterns,Crwe World,Negative
 Patterns,Art Fridrich,Positive
 Patterns,john randall,Positive
 Patterns,BeyondIgY‚Ñ¢,Positive
 Patterns,Jan van de Kamp,Positive
 Patterns,medical_tweets,Positive
 Patterns,bob lee,Positive
 Patterns,Your Health in Hand,Positive
 Patterns,Ace Pain Management & Rehabilitation center.,Positive
 Patterns,Somsirsa Chatterjee,Positive
 Patterns,Muiro Yatakama,Positive
 Patterns,EzBrz,Positive
 Patterns,Mignon Dunbar,Positive
 Patterns,Andy Vermaut,Positive
 Patterns,Larry K Chapman,Positive
 Patterns,Md Abul Khair,Positive
 Patterns,Zyite.news,Positive
 Patterns,Medical Xpress,Negative
 Patterns,Science and Technology News,Positive
 Patterns,"Raul Cordoba, MD, PhD",Negative
 Chronic Lymphocytic Leukemia Growth,Oncology Times,Positive
 Chronic Lymphocytic Leukemia Growth,Chocolatiere Phys,Negative
 SCORING SYSTEM,Benlazar S.M Amin√©,Negative
 RISK,Benlazar S.M Amin√©,Negative
 Visentin     Hematological Oncology,Benlazar S.M Amin√©,Negative
 Peter Hillmen MBChB PhD,i3 Health,Negative
 Peter Hillmen MBChB PhD,Sarah Williams,Positive
 CLL Vibrant sector,Ruth Gemmell,Negative
 CLL Vibrant sector,Proactive,Negative
 tailwind,Ruth Gemmell,Negative
 tailwind,Andrew Scott,Positive
 tailwind,Proactive,Negative
 CEO Scott,Ruth Gemmell,Negative
 CEO Scott,Andrew Scott,Positive
 CEO Scott,Proactive,Negative
   Alert,Oncology Times,Negative
 Hodgkins,Oncology Times,Negative
 VIDEO   Vibrant sector,Andrew Scott,Positive
 Chronic Lymphocytic Leukemia Therapeutics Market Identifies,EPR Network,Positive
 Key Drivers,EPR Network,Positive
 Growth,EPR Network,Positive
 Growth,Denise Fetters,Positive
 Growth,SciTech Research,Negative
 Growth,EMRIndustry,Positive
 Growth,CMLHope,Negative
 Key Industry Players,EPR Network,Positive
   Approves Pfizers Rituximab,Gil Morgan,Positive
 treatment üß¨ üß™,Gil Morgan,Positive
   levels,MoJo,Negative
 exciting   news,Michele Nadeem-Baker,Negative
 RT PhysRelations Study,Robert Z. Orlowski,Negative
 ibrutinib venetoclax combo,Robert Z. Orlowski,Negative
 ibrutinib venetoclax combo,Art Fridrich,Positive
 ECOGAcrin Cancer Research Group,Benlazar S.M Amin√©,Negative
 E   Abstract   Acta Haematologica,Benlazar S.M Amin√©,Negative
 nd biosimilar,The Medical Letter,Negative
 USlicensed Rituxan,The Medical Letter,Negative
 CDpositive Bcell nonHodgkin lymphoma,The Medical Letter,Negative
        testing,MDDigitasTV,Positive
        testing,Jose Arley,Positive
 information visit,MDDigitasTV,Positive
 information visit,Jose Arley,Positive
 StateoftheArt CLL Care,OHC,Positive
 Sat,OHC,Negative
 Sat,Leukemia Research Foundation,Negative
 Sat,Cork ARC Cancer Support House,Positive
 Sat,CLL Ireland,Negative
 Sat,Helen Jane Mee,Negative
 Sat,Carrie Stricker,Positive
 Sat,Carevƒ´ve,Negative
 Sat,Lifelong Learning,Negative
 Great Wolf Lodge,OHC,Negative
 Great,OHC,Negative
 Great,Vincent Rajkumar,Negative
 Wolf Dr Mason,OHC,Negative
 OHC cancer experts,OHC,Negative
     rituximab,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 CDpositive BCell,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 BREAKING FDA,Cellero,Positive
 Non Hodgkin,Cellero,Positive
 Rituxan biosimilar,Katie Kosko,Positive
 Pfizer Announces FDA,Vegastrader66,Positive
 Ruxience RituximabPvvr,Vegastrader66,Positive
 Granulomatosis,Vegastrader66,Positive
 Polyangiiti,Vegastrader66,Positive
 Microscopic Polyangiitis PFE,Vegastrader66,Positive
 immunodeficiency,Expert Perspectives in Oncology,Negative
 CLARITY Ibrutinib,The ASCO Post,Negative
 Appropriate Dose,TrialBulletin,Negative
 Optimize Safety,TrialBulletin,Negative
 Evaluate Clinical Activity,TrialBulletin,Negative
 RelapsedRefractory rr NonHodgkin Lymphoma NHL,TrialBulletin,Negative
   IgA levels,"Raul Cordoba, MD, PhD",Negative
 Global Industry Analysis,Career Biotech,Negative
 IgA levels,Benlazar S.M Amin√©,Negative
 IgA levels,Lymphoma Papers,Negative
 Global Industry Analysis amp Regional Outlook,Sheetal,Positive
 Ô∏è LOCATION LOCATION,Prof John,Negative
 V NICE REVIEW,Prof John,Negative
 Susan Pierce,Prof John,Negative
 amp Colleagues,Prof John,Negative
 Excellent resource,CLL Society Inc.,Negative
 Drs Mohamed KharfanDabaja Mayo Clinic Javier Pinilla Moffitt Cancer Center,"Edgardo S. Santos, M.D., FACP",Positive
 Sajil Kumar Mayo Clinic,"Edgardo S. Santos, M.D., FACP",Positive
 CART cell therapy line therapy,"Edgardo S. Santos, M.D., FACP",Positive
 Pneumatic TubeInduced Reverse Pseudohyperkalemia,EurekaMag,Negative
 Jeg lever med det,LyLe Foreningen,Negative
 President Duterte,PLM CMSC,Positive
 th State,PLM CMSC,Positive
 Nation Address,PLM CMSC,Positive
 Chronic Lymphocytic LeukemiaNew treatments,Place Matters,Positive
 Oncology Newswatch Ibrutinib,Oncology Learning Network,Negative
 Teachers,Anthony Norris,Positive
 Chronic Lymphocytic Leukemia Symptoms Causes,Anthony Mato,Negative
 News ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å©,Anthony Mato,Negative
 Licensee,"Cowan, Liebowitz",Negative
 Licensor,"Cowan, Liebowitz",Negative
 IP Rights   tcoLoVSvBH,"Cowan, Liebowitz",Negative
 shots,üá®üá¶‚ÄùMagic‚Äù Max Pincombeüá®üá¶,Positive
 sv,üá®üá¶‚ÄùMagic‚Äù Max Pincombeüá®üá¶,Positive
 pressure,üá®üá¶‚ÄùMagic‚Äù Max Pincombeüá®üá¶,Positive
 pressure,Amy C. Cavers,Negative
 Cambridge Tower,KU Cancer Center,Positive
 Preclinical Research,Renal Cell Carcinoma,Negative
 ITK Inhibition,Renal Cell Carcinoma,Negative
 Monocytic MDSCs,Renal Cell Carcinoma,Negative
 Tenemos m√°s conexi√≥n de la que creemos o coincidencias que acercan,Jany,Positive
 VIDEO CART data,VJHemOnc,Negative
 ASH   w David Maloney,VJHemOnc,Negative
 Aptose Biosciences Inc,Cancer Stem Cell News,Negative
 panFLTpanBT,Cancer Stem Cell News,Negative
 Study Reports Ibrutinib,SciTech Research,Negative
 Venetoclax Combo Effective,SciTech Research,Negative
 Select Chronic Lymphocytic Leukemia,SciTech Research,Positive
 Joanna M Rhodes,Radiology Clinics,Positive
   pendant,JU,Positive
    UK Stock Market News,Jon,Positive
 Jul    stocks,Jon,Negative
 CLL Cello Health trumpets,Ruth Gemmell,Negative
 CLL Cello Health trumpets,Proactive,Negative
 union,VJHemOnc,Negative
 CARTers,VJHemOnc,Negative
 w David Maloney,VJHemOnc,Negative
 Untold Story,"Bruce Levine, Ph.D.",Positive
 Untold Story,Penn Path & Lab Medicine,Positive
 Untold Story,Penn IFI,Positive
 Untold Story,Oncology Strategies,Negative
 Untold Story,CLL Society Inc.,Negative
 Untold Story,Nela Klein-Gonz√°lez,Positive
 Longest Persisting CAR T Cells,"Bruce Levine, Ph.D.",Positive
 Silence,Jeff Neurman,Negative
 Longest Persisting CART Cells,Penn Path & Lab Medicine,Positive
 Longest Persisting CART Cells,Penn IFI,Positive
 Longest Persisting CART Cells,Oncology Strategies,Negative
 Longest Persisting CART Cells,CLL Society Inc.,Negative
 Longest Persisting CART Cells,Nela Klein-Gonz√°lez,Positive
 j‚Äôai pas toujours bien r√©agis,JU,Positive
 mes,JU,Positive
 mais,JU,Positive
 ChemoMy variety,Mike Dicks,Positive
 New research,BlueBee,Negative
 New research,NEJM,Negative
 New research,Beth Torr,Positive
 New research,VJHemOnc,Negative
 New research,The Lancet,Negative
 varying rates,BlueBee,Negative
 disease growth,BlueBee,Negative
 wings,Prof John,Negative
   Doses,1stOncology,Negative
   Patient,1stOncology,Negative
   Patient,Patient Power,Positive
 Doses Cohort,1stOncology,Negative
 APS,1stOncology,Negative
 Davao rd Stop,IG: AlvinFernandez08,Positive
 Visayas,IG: AlvinFernandez08,Positive
 Mindanao Real Estate Market Research,IG: AlvinFernandez08,Positive
 MEDICINE CHRONIC LYMPHOCYTIC LEUKEMIA,Ezzy,Negative
 langfristig,Pharma Fakten,Positive
 Hemmer besser als,Pharma Fakten,Positive
 Chemotherapie nach,Pharma Fakten,Positive
 Jahren waren,Pharma Fakten,Positive
 noch,Pharma Fakten,Positive
 Leben ChemotherapieGruppe,Pharma Fakten,Positive
 Gefunden auf,Pharma Fakten,Positive
 humansAPTO,Joe,Negative
 st   patients,Joe,Negative
   days cycle,Joe,Negative
 treatment amp,Joe,Negative
 treatment amp,USC Leonard Davis School of Gerontology,Positive
 mgm doseCG,Joe,Negative
 st   patient,Joe,Negative
 activityMore info,Joe,Negative
 Q earnings,Joe,Negative
 APTO st,Joe,Negative
 CG trial,Joe,Negative
 Hoy cumple a√±os una persona,Clinica Lacasa Litner,Negative
 Measurement,CLL-seq,Positive
 Measurement,microRNApapers,Negative
 miRNAs,CLL-seq,Positive
 miRNAs,microRNApapers,Negative
 Chronic Lymphocytic Leukemia Patient Samples,CLL-seq,Positive
 Chronic Lymphocytic Leukemia Patient Samples,microRNApapers,Negative
 Quantitative Reverse Transcription PCR,CLL-seq,Positive
 Quantitative Reverse Transcription PCR,microRNApapers,Negative
 VIDEO Longerterm followup,VJHemOnc,Negative
 CART trials,VJHemOnc,Negative
 David Maloney,VJHemOnc,Negative
 Dose reductions,Benlazar S.M Amin√©,Negative
 Dose reductions,"Raul Cordoba, MD, PhD",Negative
 Dose reductions,Lymphoma Papers,Negative
   course,LymphomaAction,Negative
 Dr George,LymphomaAction,Negative
 Dr George,CLL Ireland,Negative
 amp Dr Rifca LeDieu,LymphomaAction,Negative
   Course,LymphomaAction,Negative
 seminars,LymphomaAction,Negative
 seminars,DCG Seminar Series,Positive
 amp case,LymphomaAction,Negative
 diagnostics PET,LymphomaAction,Negative
 JCO,Becky Bishop,Positive
   grant application,Becky Bishop,Positive
 Lianne Palmer   specialist nurse,LymphomaAction,Negative
 comorbidities,LymphomaAction,Negative
 comorbidities,Guillermo Sanz,Negative
 comorbidities,CLL Ireland,Negative
 comorbidities,Blood Journal,Negative
 comorbidities,"Raul Cordoba, MD, PhD",Negative
 comorbidities,Andrew Zimolzak,Positive
 real‚Äëlife   cohort,Florian Slimano,Negative
 ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å© cochair ‚Å¶‚Å©,donnashort,Negative
 Dr Jabbour,donnashort,Negative
 VIDEO Firstline therapies,VJHemOnc,Negative
 alCLARITY,Toby Eyre,Negative
 New   opens,Michele Nadeem-Baker,Negative
 New Venetoclax   obinutuzumab combination treatment,Medivizor,Negative
 NewTrip Final Results,Trip Database,Negative
 Rituximab w,Trip Database,Negative
 w Relapsed Chronic Lymphocytic Leukemia,Trip Database,Negative
 Blood Commentary Quest,Blood Journal,Negative
   manufacturing facility,Rishikumar Vundi,Positive
   rating,Rishikumar Vundi,Positive
 Indian Green Building Council,Rishikumar Vundi,Positive
 energy environment standards,Rishikumar Vundi,Positive
 Cortactin expression,European Association for Haematopathology,Negative
 Cortactin expression,histopathology üî¨,Positive
 Cortactin expression,Lymphoma Papers,Negative
 Quest,"Raul Cordoba, MD, PhD",Negative
 Quinquenel et alNontrial cohort,Toby Eyre,Negative
 PDNGS,Toby Eyre,Negative
 Ibrutinib Venetoclax Status,TrialBulletin,Negative
 Condition Summary Chronic Lymphocytic Leukemia,TrialBulletin,Positive
 Condition Summary CLL,TrialBulletin,Negative
 EUfunded   Synergy project BCLL,cnag-crg,Negative
 Governor Science üß™ ‚†Ä ‚†Ä,The Governor EVOO,Positive
 √à,EmatoInfo,Positive
 la   n di Ematoinfo Focus sulla esima,EmatoInfo,Positive
 Durante la esima International Conference,EmatoInfo,Positive
 Malignant   sono,EmatoInfo,Positive
 groups,Sigrid Sk√•nland,Negative
 groups,Helen Jane Mee,Negative
 glucocorticoid receptor,Mahmoud Aljurf,Negative
 Venclexta Venetoclax AbbVieRoche Drug Report,MedFirst - MedComms,Positive
 Venclexta Venetoclax AbbVieRoche Drug Report,SPI News,Negative
 Sales,MedFirst - MedComms,Positive
 Sales,SPI News,Positive
 Chronic Lymphocytic Leukemia Multiple Myeloma Acute Myeloid Leukemia,MedFirst - MedComms,Positive
 Chronic Lymphocytic Leukemia Multiple Myeloma Acute Myeloid Leukemia,SPI News,Negative
 Country    GlobeNewswire,MedFirst - MedComms,Positive
 longterm ibrutinib therapy,CancerTherapyAdvisor,Negative
 CLL BTK mutations,CancerTherapyAdvisor,Negative
 Zanubrutinib BeiGene Global Drug Report,SPI News,Negative
 Country,SPI News,Positive
 Navigating Treatment Algorithms,CellworksLife,Negative
 Navigating Treatment Algorithms,COPD News,Negative
 KPTI Phase,ClinicalTrialsData,Negative
 GILD Phase   Safety,ClinicalTrialsData,Negative
 Dr Francesc Bosch,Sabela Bobillo,Positive
 Dr Francesc Bosch,Marta Crespo,Negative
 CLL Rafic Farah MD,COPD News,Negative
 indepth look,COPD News,Negative
 HIFŒ±,"Krizs√°n Szilvia, MD",Positive
 HIFŒ±,Blood Journal,Negative
 HIFŒ±,Cure Cancer Now,Negative
 HIFŒ±,Hypoxia Adaptation,Positive
 HIFŒ±,Cancer Papers,Negative
 disrupted patients,"Krizs√°n Szilvia, MD",Positive
 promising   target,"Krizs√°n Szilvia, MD",Positive
 CLL Cello Health launches,Ruth Gemmell,Negative
 CLL Cello Health launches,Proactive,Negative
 Leukaemia,Gillian Slater,Positive
 Leukaemia,Zack Pemberton-Whiteley,Negative
 Leukaemia,McHeyzer-Williams,Positive
 blood disorders,Gillian Slater,Positive
 Chronic Lymphocytic Leukemia Treatment Market Size Analysis Share Growth Trends Regional Overview Segmentations,PressRelease.cc,Negative
 Josh Brody MD,Oncology Tube,Negative
 New PIKDelta Inhibitor      Icahn School,Oncology Tube,Negative
   ways,MD Anderson Cancer Center,Positive
   ways,CLL Ireland,Negative
   ways,Jeff Folloder,Positive
 Moon Shots Program,MD Anderson Cancer Center,Negative
 wealth,Oncology State Societies at ACCC,Negative
 wealth,Concessionary L.L,Negative
 wealth,The Pharma Letter,Negative
 Kansas Society,Oncology State Societies at ACCC,Positive
 hedgehog,ASH,Negative
 hedgehog,CellworksLife,Negative
 hedgehog,Blood Journal,Negative
 associates,ASH,Negative
 associates,CellworksLife,Negative
 associates,Blood Journal,Negative
 associates,Prof John,Negative
 VIDEO   resistance,VJHemOnc,Negative
 Broadway,Matt Trinite,Positive
 Marrow Transplan,Chocolatiere Phys,Negative
 Dynamic Risk Profiling,"Raul Cordoba, MD, PhD",Negative
 Serial Tumor Biomarkers,"Raul Cordoba, MD, PhD",Negative
 Personalized Outcome Prediction,"Raul Cordoba, MD, PhD",Negative
 Girls,Matt Trinite,Positive
 Saanich,Brad Robinson,Positive
 VIDEO Timelimited therapy,VJHemOnc,Negative
 summer,Sigrid Sk√•nland,Negative
 summer,John Riches,Positive
 summer,Nick Barker,Positive
 Adrian Wiestner,Sigrid Sk√•nland,Negative
 Adrian Wiestner,VJHemOnc,Negative
 Adrian Wiestner,@sehh_es,Negative
 Venetoclax   obinutuzumab combination treatment,Medivizor,Negative
 Subcutaneous Rituximab,EurekaMag,Negative
 Subcutaneous Rituximab,Lymphoma Papers,Negative
 Subcutaneous Rituximab,Dr. JOSE VELASQUEZ,Negative
 Follicular Lymphoma Chronic Lymphocytic Leukemia,EurekaMag,Negative
 Follicular Lymphoma Chronic Lymphocytic Leukemia,Lymphoma Papers,Negative
 Allogeneic transplantation,Suvir Singh,Positive
 Allogeneic transplantation,Jordan Gauthier,Positive
 Lab meeting,Michael Hallek,Negative
 Internal Medicine,Michael Hallek,Positive
 Maximilian Koch,Michael Hallek,Negative
 New research Inactivation,Frontiers Oncology,Negative
 Prostaglandin E,Frontiers Oncology,Negative
 principios de la d√©cada,AMIIF M√©xico,Positive
 los primeros,AMIIF M√©xico,Positive
 de   fueron aprobados,AMIIF M√©xico,Positive
 combinaci√≥n con quimioterapia para el,AMIIF M√©xico,Positive
 tratamiento de la,AMIIF M√©xico,Positive
 Linfoc√≠tica Cr√≥nica,AMIIF M√©xico,Positive
 C√≥mo ha evolucionado el,AMIIF M√©xico,Positive
 tratamiento de la   linfoc√≠tica cr√≥nica,AMIIF M√©xico,Positive
 D√©cadas de investigaci√≥n han,AMIIF M√©xico,Positive
 los cient√≠ficos,AMIIF M√©xico,Positive
 y m√©dicos una mejor comprensi√≥n de la,AMIIF M√©xico,Positive
 y nuevas alternativas terap√©uticas Nos lo muestra,AMIIF M√©xico,Positive
 independence,Jeff Neurman,Negative
 Independence Day,Jeff Neurman,Negative
 Die Chronische Lymphatische √§mie,Pharma Fakten,Positive
 ist,Pharma Fakten,Positive
 unseren,Pharma Fakten,Positive
 Breitengraden,Pharma Fakten,Positive
 h√§ufigsten vorkommende,Pharma Fakten,Positive
 den vergangenen,Pharma Fakten,Positive
 Phase B study,"chadi nabhan MD, MBA, FACP",Negative
 obintuzumab,"chadi nabhan MD, MBA, FACP",Negative
 DUO trial,Sarah Cannon Docs,Positive
 DUO trial,Targeted Oncology,Negative
 DUO trial,Lymphoma Hub,Negative
 dose modifications,Sarah Cannon Docs,Positive
 dose modifications,Verastem Oncology,Positive
 tcooQPAWUKh,Sarah Cannon Docs,Positive
 Blood Commentary onetwo punch,Blood Journal,Negative
 VO KOs,Blood Journal,Negative
 VIDEO Durable responses,VJHemOnc,Negative
 CD CART,VJHemOnc,Negative
 CD CART,"Comprehensive Cell Solutions,New York Blood Center",Positive
 Alexandre Hirayama,VJHemOnc,Negative
 FANC,Prof John,Negative
 Chronic Lymphocytic Leukemia Treatment Market Size,Market Research Nest,Positive
 Global Industry Report,Market Research Nest,Positive
 Clinical Molecular Evidence,Bloodsucking Parasites,Positive
 Atovaquone,Bloodsucking Parasites,Positive
 Atovaquone,HealthyBuilds West Palm,Positive
 Atovaquone,IDA Construction,Positive
 Atovaquone,Sanders Inc.,Positive
 Azithromycin Resistance,Bloodsucking Parasites,Positive
 Azithromycin Resistance,HealthyBuilds West Palm,Positive
 Azithromycin Resistance,IDA Construction,Positive
 Azithromycin Resistance,Sanders Inc.,Positive
 microti Infection,Bloodsucking Parasites,Positive
   risk score,"Krizs√°n Szilvia, MD",Positive
 ‡§Ö‡§¨,dr upendra sharma,Positive
 ‡§á‡§Æ‡•ç‡§Ø‡•Ç‡§®‡•ã‡§•‡•á‡§∞‡•á‡§™‡•Ä ‡§∏‡•á ‡§¶‡•á‡§Ç ‡§ï‡•à‡§Ç‡§∏‡§∞ ‡§ï‡•ã,dr upendra sharma,Positive
 ‡§Æ‡§æ‡§§,dr upendra sharma,Positive
 New CME,Pro-CME,Positive
 Expert Insights,Pro-CME,Negative
 Therapeutic Approaches,Pro-CME,Negative
   Flashback,Levine Cancer Institute,Positive
 VIDEO   trial,VJHemOnc,Negative
 ICML,VJHemOnc,Negative
 ICML,Lymphoma Hub,Positive
 Kuwait Cancer Control Center,VJHemOnc,Negative
 statistics,CryptoLiveLeak,Negative
 Visits,CryptoLiveLeak,Negative
 Registered Users,CryptoLiveLeak,Negative
 Posts,CryptoLiveLeak,Negative
 Comments,CryptoLiveLeak,Negative
 Comments,Cancer Papers,Negative
 Forums,CryptoLiveLeak,Negative
 CLL Points,CryptoLiveLeak,Positive
 Exchanges,CryptoLiveLeak,Negative
 CLL Tokens,CryptoLiveLeak,Negative
 Buddy,Ysgolllanbedr,Positive
 foundation phase,Ysgolllanbedr,Positive
 Fellow Welcoming,Duke Hematologic Malignancies & Cellular Therapy,Negative
 Leukemia cells,JanssenUS,Negative
 Pretreatment factors,HemOnc Today,Negative
 variables influence venetoclax efficacy,HemOnc Today,Negative
 leukaemia fatigue,Mike & Scrabble,Positive
 oncologue,Tha Dze,Positive
 Graduation month,CLL Warwick Uni,Negative
 LPL gene expression,EurekaMag,Negative
 Antileukemic Activity,Jerry Lee,Negative
 Antileukemic Activity,CellworksLife,Negative
 Antileukemic Activity,Cure Cancer Now,Negative
   plus fludarabine cyclophosphamide,"Raul Cordoba, MD, PhD",Negative
 time‚Äêto‚Äêfirst treatment,"Raul Cordoba, MD, PhD",Negative
 P¬∑unmutated IGHV Plt¬∑delq,Toby Eyre,Negative
 Plt,Toby Eyre,Negative
 TTFT MVAmut,Toby Eyre,Negative
 ATM Plt¬∑ampunmut IGHV Plt,Toby Eyre,Negative
 Forscher des   haben herausgefunden dass f√ºr,EuropeanHospital_D,Positive
 Entstehung,EuropeanHospital_D,Positive
 Entstehung,Cancer Core Europe,Positive
 Entstehung,DKFZ,Positive
 einer h√§ufigen Form von,EuropeanHospital_D,Positive
 einer h√§ufigen Form von,Cancer Core Europe,Positive
 einer h√§ufigen Form von,DKFZ,Positive
 neben,EuropeanHospital_D,Negative
 Mutationen,EuropeanHospital_D,Negative
 ASH   Pagel,Oncology Tube,Negative
 ASH   Pagel,GRACE,Positive
   VIDEO,Lymphoma Hub,Positive
 Need Phase   trial,"Tom Henry, MBA, RPh, CPh",Negative
 RR   analysis,VJHemOnc,Negative
 Watch Cathy Skinner,Patient Power,Negative
 stretch routine,Patient Power,Negative
 Speech,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Language DifficultiesDiscover,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Expansion Breakdown,SwingTradeBot UK,Negative
 JMIR,"Raul Cordoba, MD, PhD",Negative
 Mobile,"Raul Cordoba, MD, PhD",Negative
 Increasing Treatment,"Raul Cordoba, MD, PhD",Negative
 P√©rezJover   Journal,"Raul Cordoba, MD, PhD",Negative
 Medical Internet Research,"Raul Cordoba, MD, PhD",Negative
 Michael Reff,SpecialtyPTimes,Negative
 Kirollos Hanna,SpecialtyPTimes,Negative
 Ligandactivated Estrogen Receptors,Research Watch,Positive
 Gazyva Reduces Disease Progression,"Robinson Ortiz, MD",Negative
   CHOUX,Prof John,Negative
 FILO study ‚Å¶‚Å©,Prof John,Negative
 EZH,Blood Advances,Negative
 EZH,Richard Rosenquist Brandell,Positive
 exerts,Blood Advances,Negative
 Speed Predict Outcomes,Michele Nadeem-Baker,Negative
 Immunological changes,ImmunologyPapers,Negative
 Immunological changes,@immunoonco_Meed,Positive
 kinase inhibitor therapy,ImmunologyPapers,Negative
 kinase inhibitor therapy,@immunoonco_Meed,Positive
 July issue,The Lancet Haematology,Negative
 BittersweetLittle League,Susan Oehlers,Positive
 Sean,Susan Oehlers,Positive
 Ô∏è ‚öæ Ô∏è      Santa Fe,Susan Oehlers,Positive
 reatment,Alicia Bell IFBB Pro,Negative
 Chronic Lymphocytic Leukemia Patterns,Patient Worthy,Negative
 Treatment Costs,Patient Worthy,Negative
 Treatment Costs,Patient Power,Negative
 naiveCLL Rxnaive cw UK phase II trial,Toby Eyre,Negative
 N LDH TP WT ‚¨Ü,Toby Eyre,Negative
 overall,Toby Eyre,Negative
 Ô∏èOnDemand,Paradigm Med Comm,Negative
 Webinar Series,Paradigm Med Comm,Negative
 VIDEO CLL   monotherapy,VJHemOnc,Negative
 investigator Dr Jennifer Woyach,Alliance for Clinical Trials in Oncology,Negative
 immunotherapy trial Alliance,Alliance for Clinical Trials in Oncology,Negative
 CancerCare,RIOH,Negative
 CancerCare,Bag It - Cancer Support,Positive
 seniors,RIOH,Negative
 Positive Recommendation,Crwe World,Negative
 Positive Recommendation,RazzleTazzle,Negative
   Satellite Symposium,Lymphoma Hub,Negative
 upcoming trial,Michael Rynne,Negative
 non chemoProf Thornton,Michael Rynne,Negative
 arms,Michael Rynne,Negative
 cancer researchers,David Panian,Positive
 Prof Patrick Thornton,CLL Ireland,Positive
 understanding,"Pharmacyclics, an AbbVie Company",Negative
 understanding,Cancer Core Europe,Positive
 understanding,KAW,Positive
 understanding,Leukaemia Care,Positive
 understanding,Lymphoma Hub,Negative
 understanding,VJHemOnc,Positive
 understanding,Jane Cheung,Negative
 understanding,ASH,Negative
 management experts,SpecialtyPTimes,Negative
 management organizations,SpecialtyPTimes,Negative
 CLL Society Alert,Verastem Oncology,Negative
 blog post,Verastem Oncology,Negative
 blog post,Cancer And I,Negative
   approved venetoclax,Jacinto Convit World Organization,Positive
 significance,Targeted Oncology,Positive
 significance,Expert Perspectives in Oncology,Negative
 significance,Andrew Schorr,Negative
 CAR Tcell therapy lisocabtagene maraleucel,Targeted Oncology,Negative
 KMLVideoberichte,Kompetenznetz Maligne Lymphome e.V.,Negative
 von der ICML,Kompetenznetz Maligne Lymphome e.V.,Negative
 von der ICML,idw Nachrichten,Positive
 sind nun,Kompetenznetz Maligne Lymphome e.V.,Negative
 f√ºnf Videoberichte,Kompetenznetz Maligne Lymphome e.V.,Negative
 zu den Themen,Kompetenznetz Maligne Lymphome e.V.,Negative
 von der,Kompetenznetz Maligne Lymphome e.V.,Negative
 Alle Videos,Kompetenznetz Maligne Lymphome e.V.,Negative
 und Informationen unter,Kompetenznetz Maligne Lymphome e.V.,Negative
 Das Kompetenznetz Maligne Lymphome,idw Nachrichten,Positive
 berichtet mit,idw Nachrichten,Positive
 f√ºnf Videoberichten zu den Themen,idw Nachrichten,Positive
 Alle Videos und informationen unter,idw Nachrichten,Positive
   PRICKLY,Prof John,Negative
 ü¶î,Prof John,Negative
 New   study,Prof John,Negative
 New   study,Ohio State News,Positive
 MEIP Reveals findings,Hottest Stocks Now,Negative
 investigational,Hottest Stocks Now,Negative
 Blood Cancer Alert NonHodgkins Lymphoma B,missmaybell,Positive
     token,CryptoLiveLeak,Negative
 Ohio State doctors,The James,Negative
 terminal,The James,Negative
 Infection control,Benlazar S.M Amin√©,Negative
 Blood Commentary Hedgehog activation,Blood Journal,Negative
 Technology Supported Patient,Carevƒ´ve,Negative
 Outcome Assessment,Carevƒ´ve,Negative
 Clinic,Carevƒ´ve,Negative
 Clinic,GEDEFO,Negative
 Clinic,The ASCO Post,Negative
 Chronic Lymphocytic Leukemia   Poster presentation,Carevƒ´ve,Negative
 June   Session,Carevƒ´ve,Negative
 Digital Health,Carevƒ´ve,Negative
 success story,OurHealth,Positive
 success story,European Hematology Association,Negative
 OurHealth physician Dr Eric Wallisa,OurHealth,Positive
 Statin use,"Cancer Epidemiology, Biomarkers & Prevention",Positive
          BIG DEBATE,@linfopedia,Positive
 lowpotency lipophilic statins fluvastatin,Gary Annable,Positive
 lovastatin,Gary Annable,Positive
    Condoluci,Michael Hallek,Negative
      promising,MoJo,Negative
 headline news,√ìrla Stewart üíô,Positive
 Delgado J EBMT,Jordan Gauthier,Positive
 CIBMTR recommendations,Jordan Gauthier,Positive
 separation,Jeff Neurman,Negative
 Venclexta Venetoclax,Lampe & Company,Negative
 CKT abnormalities,Michael Hallek,Negative
 therapy Need,Michael Hallek,Negative
 KOL endorsement,Biotech2050,Negative
 DirectorPDMR Shareholding,AIM Alerts!,Positive
 BeiGene Announces Phase b Clinical Results,SPI News,Negative
 GAZYVA,SPI News,Negative
 GAZYVA,AmericanPharmacyNews,Negative
 GAZYVA,‚öõÔ∏èLibertyüåä,Positive
 GAZYVA,Pf Magazine,Negative
 GAZYVA,OBR,Negative
 GAZYVA,Crwe World,Negative
 GAZYVA,Odi Bruckman,Negative
 ¬Æ Obinutuzumab,SPI News,Negative
 ¬Æ Obinutuzumab,OSCO Nurses,Negative
 ¬Æ Obinutuzumab,OSCO,Negative
 th International Conference,SPI News,Negative
 Malignant L,SPI News,Negative
 Pretreatment growth patterns,CancerTherapyAdvisor,Negative
 earlystage CLL,CancerTherapyAdvisor,Negative
 disease course,CancerTherapyAdvisor,Negative
 Chronic Lymphocytic Leukemia Methods,OEAPS EU & International Scientific Association,Positive
 Chronic Lymphocytic Leukemia Methods,Jeans and Other Men‚Äôs Clothing,Positive
 Chronic Lymphocytic Leukemia Methods,CRISP_SCIENCE,Positive
 Protocols Methods,OEAPS EU & International Scientific Association,Positive
 Molecular Biology st ed   Edition,OEAPS EU & International Scientific Association,Positive
 eBook,OEAPS EU & International Scientific Association,Positive
 Definition,"Raul Cordoba, MD, PhD",Negative
 KI intolerance,"Raul Cordoba, MD, PhD",Negative
 PiKi,Toby Eyre,Negative
 relapsed   IMHO,Toby Eyre,Negative
 frontline treatment wonder,Michele Nadeem-Baker,Negative
 practicechanging CLL trial,Christian Reinhardt,Positive
 BeiGene Presents Pivotal Phase,Crwe World,Negative
 Clinical Results,Crwe World,Negative
 RelapsedRefractory Chronic Lymph,Crwe World,Negative
 chemofree,VJHemOnc,Negative
 Das,Kompetenznetz Maligne Lymphome e.V.,Negative
 Das,Roche Deutschland,Negative
 und berichtet,Kompetenznetz Maligne Lymphome e.V.,Negative
 ab Samstag,Kompetenznetz Maligne Lymphome e.V.,Negative
 f√ºnf Videobeitr√§gen √ºber neue Ergebnisse zur,Kompetenznetz Maligne Lymphome e.V.,Negative
 zum,Kompetenznetz Maligne Lymphome e.V.,Negative
 Dept Dissection,Semmelweis University CompBio Group,Positive
 Subclonal Evolution,Semmelweis University CompBio Group,Positive
 Temporal Mutation Profiling,Semmelweis University CompBio Group,Positive
 MYC,Richard Rosenquist Brandell,Positive
 Dr Richard R Furman MD,Oncology Tube,Negative
 Great   interview,Stephanie Hill,Positive
 SC member,Stephanie Hill,Positive
 Siempre,Jany,Positive
 Siempre,juanchi,Negative
 un gusto escuchar,Jany,Positive
 voz,Jany,Positive
 Jos Melenhorsts Research,Penn IFI,Positive
 line MCL,Toby Eyre,Negative
      S O‚ÄôBrien,"Raul Cordoba, MD, PhD",Negative
 placebo,"Raul Cordoba, MD, PhD",Negative
 placebo,Toby Eyre,Negative
 placebo,Dr Timos Papagatsias,Negative
 placebo,Michael Hallek,Negative
 placebo,International Pain Foundation¬Æ,Positive
 placebo,susanna sargsyan,Negative
 placebo,Sharon Ann,Positive
 placebo,aWildAndFlakyGuy ‚ôøÔ∏è,Positive
 placebo,Jennifer Bergman,Positive
 placebo,circa1835,Positive
 placebo,Sandy D.,Positive
 placebo,Te Ha,Positive
 placebo,tangerine McDaniel,Positive
 placebo,Jennifer Huber,Positive
 placebo,Cassi Schmigotzki,Positive
 placebo,Shelley Webb,Positive
 placebo,Rhia Steele@ravishingrhia.com,Positive
 placebo,James C Whitfield,Positive
 placebo,Milton Donald,Negative
 placebo,WEGO Health,Positive
 placebo,Amanda Haddock üß¨,Negative
 placebo,Ibrhm,Positive
 placebo,Susan Rahn,Positive
 placebo,Elizabeth Evans,Positive
 placebo,Senior Care Corner,Positive
 placebo,Debbie Woodbury,Negative
 placebo,Kimberley Thomas,Negative
 placebo,John Hoben,Positive
 placebo,Nora Sheffield,Negative
 placebo,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 placebo,Colleen Busch,Negative
 placebo,Grayson (he),Positive
 CLL Improved EFS,Toby Eyre,Negative
 Science,Sigrid Sk√•nland,Negative
 Science,Marilyn Heine,Positive
 Science,Shouting at people in my underpants,Negative
 Science,Bon in NC,Positive
 Dr Carl June,"Thilo J Zander, MD",Positive
 Bayesian Population Model,Lymphoma Papers,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Results,Lymphoma Papers,Negative
 Phase III MURANO Study,Lymphoma Papers,Negative
 CART Cell Therapy,"Mark Geyer, M.D.",Negative
 CART Cell Therapy,Sue Carlson,Positive
 CART Cell Therapy,WorldStemCellSummit,Positive
 CART Cell Therapy,CLL Ireland,Negative
 Chronic    Marginal zone lymphoma Mfg,Medicine For World,Negative
 Ltd,Medicine For World,Negative
 Bangladeshcontactnet,Medicine For World,Negative
 alpha therapy,Savepig Invest #GotSilver,Positive
 PbNNV,Savepig Invest #GotSilver,Positive
 ‚Äú magic,Judith Trotman,Positive
 wards,Judith Trotman,Positive
 Vit D insuff amp prognosis,"Mike Thompson, MD, PhD, FASCO",Positive
 Blood Flashback,"Mike Thompson, MD, PhD, FASCO",Negative
 Blood Flashback,Blood Journal,Negative
 venetoclax Veneclexta,Cancer Education and Research Institute,Positive
 Futureproof Extra Podcast CART,Futureproof,Positive
 Treatment Approaches,OncLive.com,Negative
 Treatment Approaches,Crwe World,Negative
 SE,Amanda Marie,Positive
 SE,suetodd16,Positive
 SE,Genentech,Negative
   Dr Jennifer,TrialSite News,Negative
 NationallyRecognized,TrialSite News,Negative
 JuLƒÅ Creole Cuisine,Big G Artists Agency,Positive
 helpChronic Lymphocytic Leukemia,Big G Artists Agency,Positive
 Cancer Treatment,Big G Artists Agency,Positive
 Peter JaretChemotherapy radiation,Big G Artists Agency,Positive
 cancer treatments,Big G Artists Agency,Positive
 cancer treatments,Patient Power,Negative
 body,Big G Artists Agency,Positive
 body,Patient Power,Negative
 body,RJW,Positive
 body,John Walker,Positive
 body,Publish PressRelease,Positive
 body,Press Releases,Positive
 body,satPRnews,Negative
 Coutre,Toby Eyre,Negative
 safety ax RR    Diarrheoa fatigue infection bleeding neutropenia,Toby Eyre,Negative
 Chronic Lymphocytic Leukemia Updates,ImmunotherapyPapers,Negative
 Chronic Lymphocytic Leukemia Updates,Crwe World,Negative
 Presse Detail Die,Kompetenznetz Maligne Lymphome e.V.,Negative
 Videoberichte vom,Kompetenznetz Maligne Lymphome e.V.,Negative
 Dr Jennifer Brown Dr Bruce D Cheson,Expert Perspectives in Oncology,Negative
 Prof Dr Michael Hallek,AbbVie Deutschland,Negative
 wurde der Jos√© Carreras Award f√ºr seine,AbbVie Deutschland,Negative
 beeindruckende Arbeit,AbbVie Deutschland,Negative
 VIDEO Venetoclaxobinutuzumab combination,HemOnc Today,Negative
 ARQ,BioPharm Insight,Positive
 Protoporphyrin IX,CDD press,Positive
 Senior Marketing Manager E,San Francisco Biotechnology Network Jobs,Positive
 VENCLEXTA Chronic Lymphocytic Leukemia CLL,San Francisco Biotechnology Network Jobs,Positive
 South San Francisco Experience,San Francisco Biotechnology Network Jobs,Positive
     Phase III study,MoJo,Negative
 CLL Interesting results,MoJo,Negative
 BCell Chronic Lymphocytic Leukemia,Markets & Reports,Positive
 BCell Chronic Lymphocytic Leukemia,ABNewswire,Negative
 BCell Chronic Lymphocytic Leukemia,SouthernIndiaReporte,Positive
 BCell Chronic Lymphocytic Leukemia,New Jersey Headlines,Positive
 BCell Chronic Lymphocytic Leukemia,Business Wire-Health,Positive
 BCell Chronic Lymphocytic Leukemia,Financial Buzz,Negative
 BCell Chronic Lymphocytic Leukemia,The Pharmaceutical Marketing Group,Negative
 BCell Chronic Lymphocytic Leukemia,Seattle's Banker,Negative
 BCell Chronic Lymphocytic Leukemia,iTruck NEWS,Positive
 BCell Chronic Lymphocytic Leukemia,Sylvia Joyner,Positive
 BCell Chronic Lymphocytic Leukemia,DrugGenius,Negative
 BCell Chronic Lymphocytic Leukemia,BizPR,Negative
 BCell Chronic Lymphocytic Leukemia,SPI News,Positive
 BCell Chronic Lymphocytic Leukemia,Âø´ÈÅ©ÂÆ∂ÈõªLife,Negative
 BCell Chronic Lymphocytic Leukemia,Danvantri Farma,Negative
 BCell Chronic Lymphocytic Leukemia,Feel on,Negative
 BCell Chronic Lymphocytic Leukemia,„Åä„ÅÑ„Åó„ÅÑÁæéÈ£üÁîüÊ¥ª,Positive
 BCell Chronic Lymphocytic Leukemia,BusinessWireServices,Negative
 BCell Chronic Lymphocytic Leukemia,BusinessWire-Science,Negative
 BCell Chronic Lymphocytic Leukemia,TumorImmunoPapers,Negative
 BCell Chronic Lymphocytic Leukemia,Oncology,Negative
 BCell Chronic Lymphocytic Leukemia,nsure io,Positive
 BCell Chronic Lymphocytic Leukemia,Scott Werntz,Positive
 Pipeline Review H,Markets & Reports,Positive
 Pipeline Review H,The Pharmaceutical Marketing Group,Negative
 Pipeline Review H,Financial GamblR,Negative
 Pipeline Review H,DrugGenius,Positive
 Pipeline Review H,BizPR,Negative
 Pipeline Review H,SPI News,Positive
 Pipeline Review H,Top 10,Negative
 Pipeline Review H,BluntAdvice,Positive
 Pipeline Review H,Financial Buzz,Negative
 Pipeline Review H,Business Wire-Health,Positive
 Pipeline Review H,Swapnil Devale,Negative
 Pipeline Review H,Âø´ÈÅ©ÂÆ∂ÈõªLife,Negative
 Pipeline Review H,Acute Market Reports,Positive
 Pipeline Review H,BizDirect,Positive
 Pipeline Review H,Jean-Michel TERME,Negative
 Pipeline Review H,Scott Werntz,Positive
 Pipeline Review H,EIN Presswire: Glaxo Newswire,Positive
 Pipeline Review H,Pitch Ticker,Positive
 trial results,Targeted Oncology,Negative
 trial results,Rare Disease Report,Positive
 lung cancer,F.M.A.Book Reviews,Positive
   Changing Face,Medscape Education,Positive
 CLL Venetoclax   Obinutuzumab,Medscape Education,Negative
 Untreated CLL,Medscape Education,Negative
 Untreated CLL,Dr. JOSE VELASQUEZ,Positive
 Untreated CLL,"John C. Wunsch, P.C.",Negative
 Untreated CLL,CancerTherapyAdvisor,Negative
 w Prof Stephan Stilgenbauer,Medscape Education,Negative
 RESONATE Ibrutinib,Medscape Education,Negative
 RESONATE Ibrutinib,C. Michael Gibson MD,Positive
 ALLIANCE,Medscape Education,Negative
 ALLIANCE,VJHemOnc,Negative
 Population   Response Rates,Medscape Education,Negative
 w Dr,Medscape Education,Negative
 w Dr,Patient Empowerment Network,Negative
 w Dr,Patient Power,Positive
 E Ibrutinib,Medscape Education,Negative
 Study Design,Medscape Education,Negative
 Perfekt presentation,Paula Cramer,Positive
 Immunosuppressive Treg cells,ImmunologyPapers,Positive
 phenotype,ImmunologyPapers,Positive
 effectorT cells,ImmunologyPapers,Positive
 home message,Targeted Oncology,Negative
 home message,Dr Effie Kostareli,Negative
 III MURANO trial,Targeted Oncology,Negative
 III MURANO trial,Lymphoma Hub,Negative
 III MURANO trial,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Las,Revista El Repollero,Positive
 lo largo del desarrollo del torneo hoy lo coronaron,Revista El Repollero,Positive
 Tuyucua Felicitaciones,Revista El Repollero,Positive
 las chicas de Limpe√±o por este logro que sea el primero de muchos,Revista El Repollero,Positive
 FINAL   vuelta,Club Libertad Limpe√±o,Negative
 EQUIPO CONFIRMADO,Club Libertad Limpe√±o,Negative
 Alicia Bobadilla Carmen Ben√≠tez Laurie Cristaldo Paola Genes Stephenie Lacoste Joana Galeano Griselda Garay Damia Cortaza Fabiola Sandoval Karina Vega Liz Pe√±a    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
    Second cancer incidence,"Raul Cordoba, MD, PhD",Negative
    Infections,"Raul Cordoba, MD, PhD",Negative
 relapsed   Abbvie,Toby Eyre,Negative
    Efficacy,"Raul Cordoba, MD, PhD",Negative
 RVenetoclax,"Raul Cordoba, MD, PhD",Negative
 mDOR m m,"Raul Cordoba, MD, PhD",Negative
 New Directions,Immuno-Oncology,Negative
 New Directions,Crwe World,Negative
 Chronic Lymphocytic Leukemia Care Review,Immuno-Oncology,Negative
 Chronic Lymphocytic Leukemia Care Review,Crwe World,Negative
   di rilievo,EmatoInfo,Positive
 chi si occupa,EmatoInfo,Positive
 commento,EmatoInfo,Positive
 di Francesca Mauro,EmatoInfo,Positive
 Miguel Quijada√Ålamo,Dr Effie Kostareli,Negative
 Saskia Rudat,Dr Effie Kostareli,Negative
 POT,Dr Effie Kostareli,Negative
 POT,Blood Journal,Negative
 lengthening,Targeted Oncology,Negative
 progressionfree survival time,Targeted Oncology,Negative
 Topps Cactus League Legends,Chad Slagter,Negative
 Insert,Chad Slagter,Negative
 ‚öæ,Chad Slagter,Positive
 ‚öæ,JT O'Sullivan,Positive
    Clinical Trial,Michele Nadeem-Baker,Negative
 Interesting analysis,Marek Trneny,Positive
 patient¬¥s immunocompetence,Marek Trneny,Positive
 Enjoyed,"chadi nabhan MD, MBA, FACP",Negative
 Amsterdam,AbbVie,Negative
 Amsterdam,Michael Rynne,Negative
 Ibrutinib activity,"chadi nabhan MD, MBA, FACP",Negative
 FIRE,"chadi nabhan MD, MBA, FACP",Negative
   Longterm safety,PersonalizeAF,Positive
 singleagent ibrutinib,PersonalizeAF,Positive
 singleagent ibrutinib,Lymphoma Hub,Negative
   ARQ,NYCDoc29,Negative
 shortage,NYCDoc29,Negative
 CMLologist,Juan Luis Steegmann,Positive
 education session,Michael Rynne,Negative
 speakers,Michael Rynne,Negative
 speakers,Helen Jane Mee,Negative
 speakers,LymphomaAction,Negative
 R Houlston LA Sutton Kater,Michael Rynne,Negative
 T Robak,Michael Rynne,Negative
   callwrite EPAsenatorsReps,Catherine Gegaris,Positive
 CAR Tcell therapy LisoCel,Targeted Oncology,Negative
 Northwell Health,Oncology Tube,Negative
 Investigators Perspective,Immuno-Oncology,Negative
 Investigators Perspective,Crwe World,Negative
 Chronic Lymphocytic Leukemia Research,Immuno-Oncology,Negative
 Chronic Lymphocytic Leukemia Research,Crwe World,Negative
 Chronic Lymphocytic Leukemia Research,NY Blood Center,Positive
 Shifting Therapeutic Spectrum,Crwe World,Negative
 Success,DocWire News,Positive
 Success,Butler Scientifics,Positive
 Obinutuzumab Use,DocWire News,Positive
 BSI Connected Learning Live CLL,BSI America,Negative
 youngerfit patients,The Lancet Haematology,Negative
 w chronic lymphocytic,The Lancet Haematology,Negative
 multicentre phase,The Lancet Haematology,Negative
 multicentre phase,Biotech2050,Negative
   exhaustion,MoJo,Negative
 Noch,Peter Spork,Positive
 neues,Peter Spork,Positive
     Maloney,MoJo,Negative
    Maloney,Pallawi Torka,Positive
 alDoNOT,Pallawi Torka,Positive
 pts undergoing CAR T cell therapy,Pallawi Torka,Positive
 CRS,Pallawi Torka,Positive
    GIMEMA LLC,"Raul Cordoba, MD, PhD",Negative
 unfit   patients,"Raul Cordoba, MD, PhD",Negative
 New Study Identifies Patterns,Denise Fetters,Positive
 New Study Identifies Patterns,SciTech Research,Negative
 Science amp Technology Research News,Denise Fetters,Positive
 Prof Hallek,The Lancet Haematology,Negative
 Prof Hallek,CLL Ireland,Negative
 Prof Hallek,iwCLL,Negative
 Prof Hallek,VJHemOnc,Negative
 Penultimate presentation,Charlotte Martin,Positive
 ibrutinib patients,Charlotte Martin,Positive
 dose respond,Charlotte Martin,Positive
 Alessandra Tedeschi ASST,Lymphoma Hub,Negative
 Grande Ospedale Metropolitano Niguarda,Lymphoma Hub,Negative
 T cell bispecific antibody combination immunotherapy,Lectures London,Positive
 poster PF,Sigrid Sk√•nland,Negative
 Drug sensitivity screens,Sigrid Sk√•nland,Negative
 Fischer Introduction,EmatoInfo,Positive
 Irelands,CLL Ireland,Negative
 subgroup,Diagnostics News,Negative
 subgroup,elizabeth,Positive
 subgroup,Aitana,Negative
 delpTP CLL,Dr Effie Kostareli,Negative
 VIDEO   Interested,Lymphoma Hub,Negative
 Wojciech Jurczak,Lymphoma Hub,Negative
 expert opinion,Lymphoma Hub,Negative
 medio paso de la consagraci√≥n tremendo triunfo de las gumarelas de Limpe√±o,Revista El Repollero,Positive
   Announces Patient,1stOncology,Negative
 Investigational Agent,1stOncology,Negative
    updates,VJHemOnc,Negative
    updates,"Amber Koehler, PA-C",Negative
    updates,Patient Power,Negative
 Correction,Lymphoma Papers,Negative
 Secondary Bcell lymphoma,Lymphoma Papers,Negative
 EpsteinBarr virus,Lymphoma Papers,Negative
 EpsteinBarr virus,Christopher Calapai,Positive
 T,Janssen EMEA,Negative
 T,MedPage Today,Positive
 T,MedPage Oncology,Negative
 T,Michele Nadeem-Baker,Negative
 T,CancerWallonia,Positive
 T,"Ola Landgren, M.D.",Positive
 T,Oksana Komarova,Positive
 sufferer,Scott Wessels,Positive
   Tolero Pharmaceuticals Announces Patient,PressReleasePoint,Negative
 Investigational Agent TP,PressReleasePoint,Negative
 Members,CLL Advocates Network,Negative
 Members,Heather DelaCruz,Negative
 Final ida VS ‚è± Ô∏è    ST,Club Libertad Limpe√±o,Negative
 GOOOOOOOOOOOOOLLLLL,Club Libertad Limpe√±o,Negative
 Liza Larrea marca el segundo,Club Libertad Limpe√±o,Negative
 Final ida VS ‚è±,Club Libertad Limpe√±o,Negative
 Ô∏è    ST,Club Libertad Limpe√±o,Negative
 Final ida VS ‚è± Ô∏è,Club Libertad Limpe√±o,Negative
 GOOOOOL ‚öΩ,Club Libertad Limpe√±o,Negative
 trial treatment,Beacon Targeted Therapies,Positive
 trial treatment,Illingworth Research,Positive
 NEW data,Verastem Oncology,Positive
 Dr Paul M Barr,LYMPHOMA & MYELOMA CONNECT,Negative
    DAY AWAY,Medscape Education,Negative
   Treatment NEWS CART Cell Therapy LisoCel Deemed Safe,Michele Nadeem-Baker,Negative
 Active,Michele Nadeem-Baker,Negative
 Active,CancerWallonia,Negative
 set,HARMONY Alliance,Negative
 Research Projects,HARMONY Alliance,Negative
 USESCONIMAB MG INJECTION,Ravispecialitiespharma_RSP,Negative
 Verastem team,Verastem Oncology,Negative
 Amsterdam Stop,Verastem Oncology,Negative
 Excellent article,CLL Society Inc.,Positive
 CAR Tcell therapy lisocel,Targeted Oncology,Negative
 Realworld treatment patterns,CancerTherapyAdvisor,Negative
 health care costs,CancerTherapyAdvisor,Negative
 Rod Humerickhouse MD,Oncology Tube,Positive
 VIDEO DUO trial duvelisib,VJHemOnc,Negative
 Tenessee Oncology Nashville,VJHemOnc,Negative
 ZUMA trial KTEX,VJHemOnc,Negative
 Tennessee Oncology,VJHemOnc,Negative
 Nashville,VJHemOnc,Negative
 Multidisciplinary project,CLL Society Inc.,Negative
 physicians patients,CLL Society Inc.,Negative
   Folks,Michele Nadeem-Baker,Negative
 symptoms effects,Patient Empowerment Network,Positive
 Galectin,Henning,Positive
 Galectin,Immuno-Oncology,Negative
 Galectin,Cancer Papers,Negative
 Deletion Short Report,Henning,Negative
 USESMercaptopurine MP,Ravispecialitiespharma_RSP,Negative
 cancer autoimmune diseases,Ravispecialitiespharma_RSP,Negative
 Semifinal   Vuelta VS ‚è± Ô∏è,Club Libertad Limpe√±o,Positive
 Semifinal   Vuelta,Club Libertad Limpe√±o,Negative
 Semifinal   vuelta,Club Libertad Limpe√±o,Negative
 Chronic Lymphocytic Leukemia Ibrutinib Mechanism,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 Acton Mechanism,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 Action,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 Emergent Literacy Links,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 EYE units,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 replay,Patient Power,Positive
 replay,Andrew Schorr,Negative
 replay,Michelle,Positive
 Fischer,Michael Hallek,Negative
 et al    Jun,Michael Hallek,Negative
 Floyd Hasenr√ºck,Michael Hallek,Negative
 Friday lab meeting,Michael Hallek,Negative
 tcomSxczpWUdH,MedPage Today,Negative
 Gazyva,CURE Magazine,Positive
 Gazyva,PressReleasePoint,Positive
 Gazyva,Pharmacutical Daily,Positive
 Gazyva,Crwe World,Positive
 Gazyva,Flash Alert,Positive
 Gazyva,George J Huba PhD,Positive
 Gazyva,Advera Health,Positive
 Gazyva,Maya's Dolly,Positive
 Gazyva,The Pharmaceutical Marketing Group,Positive
 Gazyva,oncohebdo,Negative
 Gazyva,Shahid Raz,Positive
 Gazyva,Angela Keen,Positive
 Gazyva,FaceMyDoc,Positive
 Gazyva,the world of CROs,Negative
 Gazyva,Sai Legal Services,Positive
 Gazyva,CNA,Positive
 Gazyva,TheArticleTrunk,Negative
 Gazyva,chorley chicken,Negative
 Gazyva,Latest Commentary - #LatestComments,Positive
 Gazyva,FirstPressNG,Positive
 Gazyva,Ibex News 24,Positive
 Gazyva,E-Radio.US,Positive
 Gazyva,Ray Noble (The Thin End Show),Positive
 Gazyva,FDA Daily,Negative
 Gazyva,Armando Guglielmetti,Positive
 Gazyva,Sharon Johnson,Positive
 Gazyva,Cancer Health,Negative
 Gazyva,AA&MDSIF,Positive
 Gazyva,Latest News from Business Wire,Negative
 Gazyva,Shohta Kadomura Hospital Pharmacist,Negative
 Gazyva,Pharmacy Practice News,Negative
 Gazyva,Andrew Merron,Positive
 Gazyva,Bionest Partners,Negative
 Gazyva,Financial Buzz,Negative
 Gazyva,T Allen,Positive
 Gazyva,"Robinson Ortiz, MD",Negative
 Gazyva,BioSpace,Positive
 Gazyva,OSCO Nurses,Negative
 Gazyva,OSCO,Negative
 proceedings,CLL Ireland,Negative
   combination,NEJM,Negative
   combination,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
   combination,CLL Ireland,Negative
 BCL inhibitor venetoclax,NEJM,Negative
 BCL inhibitor venetoclax,ASH Clinical News,Positive
 BCL inhibitor venetoclax,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 BCL inhibitor venetoclax,Oncology Board,Negative
 BCL inhibitor venetoclax,Blood Journal,Negative
 BCL inhibitor venetoclax,VJHemOnc,Negative
   expert Dr David Maloney,Patient Power,Negative
   talks,Patient Power,Negative
   talks,ACRF,Positive
 Kac,Acetylome,Positive
 DNA bindin,Acetylome,Positive
 STATKAT pOncotarget,Acetylome,Positive
 Dr Burke,Targeted Oncology,Negative
 Mayo Clinic Labs Curtis Hanson MD,Mayo Clinic Labs,Positive
 CAP TODAY,Mayo Clinic Labs,Positive
 neben DNAMutationen,EuropeanHospital_D,Negative
 neben DNAMutationen,Cancer Core Europe,Positive
 neben DNAMutationen,DKFZ,Positive
 auch,EuropeanHospital_D,Negative
 auch,Cancer Core Europe,Positive
 auch,DKFZ,Positive
 fehlerhafte,EuropeanHospital_D,Negative
 fehlerhafte,Cancer Core Europe,Positive
 fehlerhafte,DKFZ,Positive
 Signale verantwortlich sind,EuropeanHospital_D,Negative
 Signale verantwortlich sind,DKFZ,Positive
 cancer Cancer,Jeff Neurman,Negative
 Hobby,Jeff Neurman,Negative
 th birthday,"Cowan, Liebowitz",Positive
 th birthday,Tim James,Negative
 Copyright Guru,"Cowan, Liebowitz",Negative
 Counsel Richard Dannay,"Cowan, Liebowitz",Negative
 celebrations,"David Steensma, MD",Positive
 Heme malignancies faculty promotion,"David Steensma, MD",Positive
 Professor,"David Steensma, MD",Positive
 Professor,Lymphoma Hub,Negative
 Professor,UNMC Pathology & Microbiology,Positive
 Professor,Expert Perspectives in Oncology,Negative
 expert Jennifer Brown,"David Steensma, MD",Positive
 K√∂lner,Kielia88,Positive
 stellt wegweisende Ergebnisse zur √§mieBehandlung vor,Kielia88,Positive
 tcoBexqtLk,Kielia88,Positive
 Global Chronic Lymphocytic Leukemia Clinical Trial Pipeline Highlights   Market Report,Pharmacutical Daily,Negative
 Reports Recommendation,CHItraders,Negative
 PanCanadian Oncology Drug Review Expert Review Committee,CHItraders,Negative
 Combo VENCLEXTA,CHItraders,Negative
 Rituxuimab,CHItraders,Negative
 story sage advice,CLL Ireland,Negative
 VIDEO MRD decision,VJHemOnc,Negative
 Dr Rokeer,Anthony Mato,Negative
 retweetExpert Access,CLL Society Inc.,Negative
 Semifinal   Ida   VS ‚è± Ô∏è,Club Libertad Limpe√±o,Negative
 Semifinal   Ida   VS ‚è±,Club Libertad Limpe√±o,Negative
 Semifinal   Ida   VS,Club Libertad Limpe√±o,Negative
 ¬° INICI√ì EL ST,Club Libertad Limpe√±o,Negative
 DEL PT,Club Libertad Limpe√±o,Negative
 Liz Pe√±a    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Semifinal   Ida   VS ‚è± Ô∏è PT,Club Libertad Limpe√±o,Negative
 ibrutinib dose interruptions,Blood Journal,Negative
 reductions,Blood Journal,Negative
 reductions,"Raul Cordoba, MD, PhD",Negative
 Semifinal   Ida VS ‚öΩ EQUIPO CONFIRMADO,Club Libertad Limpe√±o,Negative
 ASCO   Chicago Lymphoma Hub Coverage‚ÄùWeve,Lymphoma Hub,Negative
 convenience Click,Lymphoma Hub,Negative
 slides expert interviews,Lymphoma Hub,Negative
 interactions,Lymphoma Hub,Negative
 interactions,VJHemOnc,Negative
 combination therapy,MedPage Oncology,Negative
 combination therapy,Lampe & Company,Negative
 combination therapy,DDNews Online,Negative
 combination therapy,Lymphoma Hub,Negative
 R√©sultats de l√©tude,oncohebdo,Negative
 Lion,Abdel-Wahab Lab,Positive
 Lion,Nikhil Wagle,Positive
   Spanish Guidelines,MoJo,Negative
 Pivotal Phase III   Results,1stOncology,Negative
 Medicine RO,1stOncology,Negative
 Induction,Lymphoma Papers,Negative
 Induction,Dr. JOSE VELASQUEZ,Negative
 Induction,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 MCL inhibitors,Lymphoma Papers,Negative
 Roche Reports Results,PharmaShots - Incisive news in 3 shots,Negative
 VenclextaVenclyxto venetoclax,PharmaShots - Incisive news in 3 shots,Negative
 PIII CLL Study,PharmaShots - Incisive news in 3 shots,Negative
   Pivotal Phase III CLL Results,PressReleasePoint,Negative
 Tables,"Jose Sandoval S, MD FACP",Positive
 Tables,Patient Power,Negative
 Congratulations Dr Pinilla Ibarz,"Jose Sandoval S, MD FACP",Positive
   abstract,Emily Smith,Positive
 Congratulation,Paul Br√∂ckelmann,Positive
 veteran oncologist,"Neil Sankar M.D.,MPH",Positive
 pioneer,"Neil Sankar M.D.,MPH",Positive
 Rai Staging,"Neil Sankar M.D.,MPH",Positive
 Chronic Lymphocytic Leukemias,"Neil Sankar M.D.,MPH",Positive
 Ven Obi,Michael Hallek,Negative
 CLL Coexisting Conditions ‚Å¶‚Å©,"Raul Cordoba, MD, PhD",Negative
 haematologists version,Toby Eyre,Negative
 Messi,Toby Eyre,Negative
 Ronaldo debate,Toby Eyre,Negative
 growth pattern,Brotman Baty,Positive
 Novel Treatment Options,Oncology Tube,Negative
 Novel Treatment Options,Targeted Oncology,Negative
 Cognitive Function,Oncology Times,Negative
 Risk score,Chocolatiere Phys,Negative
 Risk score,HemOnc Today,Negative
    combo,MoJo,Negative
 Presents Data,RazzleTazzle,Negative
 Presents Data,Crwe World,Negative
 Presents Data,Marketbit.pro,Negative
 Venetoclax ChemotherapyFree Combination Regimen,RazzleTazzle,Negative
 Venetoclax ChemotherapyFree Combination Regimen,Crwe World,Negative
 Venetoclax ChemotherapyFree Combination Regimen,HempNews,Negative
 Venetoclax ChemotherapyFree Combination Regimen,Marketbit.pro,Negative
 Pivotal Phase III CLL Results,Pharmacutical Daily,Negative
 Pivotal Phase III CLL Results,Crwe World,Negative
 Pivotal Phase III CLL Results,Flash Alert,Negative
   Davies,The Lancet Haematology,Negative
 Previously Untreated Ch,Crwe World,Negative
 CELG BMY,Biotech2050,Negative
 Abbvie,CHItraders,Negative
 Abbvie,oncohebdo,Positive
 Abbvie,Orbis Biosciences,Negative
 Abbvie,Ward Health,Positive
 Venetoclax ChemotherapyFree combination regimen,CHItraders,Negative
 RHHBY Press Release,Flash Alert,Positive
 Nancy Bartlett MD,Siteman Cancer Center,Positive
 Siteman,Siteman Cancer Center,Positive
 Room E,Siteman Cancer Center,Positive
 Abstract,Siteman Cancer Center,Positive
 Abstract,City of Hope,Positive
 Abstract,Biotech2050,Negative
 Abstract,"Pharmacyclics, an AbbVie Company",Negative
 Jacqueline Claudia Barrientos,Lymphoma Hub,Negative
 mornings lymphoma session,Lymphoma Hub,Negative
 duration frontline chemoimmunotherapy,Lymphoma Hub,Negative
 Anxiety anger fatigue depression,CLL Society Inc.,Negative
 emotionssymptoms,CLL Society Inc.,Negative
 Help,CLL Society Inc.,Negative
 Help,Idea Couture,Positive
 City,City of Hope,Positive
 City,CLL Society Inc.,Negative
 Hopes,City of Hope,Positive
 Frontline CLL Treatment,Duke Hematologic Malignancies & Cellular Therapy,Negative
 ¬Æ ‚ñº   LongTerm Data,1stOncology,Negative
 Pivotal Phase   Studies,1stOncology,Negative
 Pivotal Phase   Studies,RazzleTazzle,Negative
 Demonstrate Sustained Efficacy,1stOncology,Negative
 STIM,Jackson ImmunoResearch,Positive
 STIM,TRP Channel Bot,Positive
 plasma membrane,Jackson ImmunoResearch,Positive
 plasma membrane,Society for Immunotherapy of Cancer,Positive
 plasma membrane,TRP Channel Bot,Positive
 David Bond et al report,Jennifer Smith,Positive
 Paul Barr et al report,Jennifer Smith,Positive
 relref,Jennifer Smith,Positive
 HR breast cancer,"Bachar Samra, MD",Positive
 CLL Ibrutinib IMBRUVICA,info@medicalresearch.com,Positive
 High Risk Patients,info@medicalresearch.com,Positive
 Jim Harlan,Patient Power,Negative
 ACCC Educational Opportunities Addressing Disease States,Oncology Tube,Negative
 CLL amp Myeloma,Oncology Tube,Negative
 CLL data,JanssenUS,Positive
 Phase   RESONATE study,JanssenUS,Negative
   highlights research,NewYork-Presbyterian,Positive
 Dr Daniel Helbig,NewYork-Presbyterian,Positive
 ibrutinib LongTerm Data,RazzleTazzle,Negative
 EHA Demonstrate Sustained Efficacy,RazzleTazzle,Negative
 Waittheres,School of Cancer & Pharmaceutical Sciences,Positive
 sixyear followup data,"Pharmacyclics, an AbbVie Company",Negative
 CT Scans,Chocolatiere Phys,Negative
 CT Scans,CLL Society Inc.,Positive
 CT Scans,JAMA Internal Medicine,Positive
 CT Scans,JAMA Network,Negative
 CT Scans,OncLive.com,Negative
 CT Scans,NACDA Program on Aging,Negative
 New Standard,Value-Based Cancer Care,Negative
 New Standard,Lymphomation.org,Negative
 relapsedrefractory CLLSLL,Verastem Oncology,Negative
 paso firme,Revista El Repollero,Positive
 Limpe√±o sigue comandando,Revista El Repollero,Positive
 el f√∫tbol femenino,Revista El Repollero,Positive
 VS ‚è±,Club Libertad Limpe√±o,Positive
 Liza Larrea     ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Karina Vega    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Positive
 Fabiola Sandoval     ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 En,Club Libertad Limpe√±o,Negative
 En,akemi enriquez,Positive
 En,Scott Werntz,Negative
 marcha ‚è± Ô∏è,Club Libertad Limpe√±o,Negative
 Hepatitis Pancreatitis,Mazen M,Negative
 Rash,Mazen M,Negative
 survivor,Mark DeSaulnier,Positive
 survivor,AJMC,Negative
 survivor,Paul Mitchell,Positive
   Die Kombination aus Ibrutinib und Venetoclax beseitigt,MEDtalks CH,Positive
 Krebszellen,MEDtalks CH,Positive
 connections,Amy C. Cavers,Negative
 connections,AbbVie US,Negative
 Cancer Institute,ACCC,Positive
 Advisory Committee member,ACCC,Positive
 Multidisciplinary Chronic Lymphocytic Leukemia Care project,ACCC,Positive
 upcoming   Information Day,CLL Ireland,Negative
   genes,"Pharmacyclics, an AbbVie Company",Positive
 theme,JanssenUS,Positive
 theme,Lorna Warwick,Positive
 Patient Learning,JanssenUS,Positive
 ibrutininb,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Treatment patterns,RTI Health Solutions,Negative
 Tubular Injury case series,HofNorthwell Kidney,Positive
 literature,HofNorthwell Kidney,Positive
 collaborators,HofNorthwell Kidney,Positive
 Study Reports Ibrutinib Venetoclax Combo Effective,SciTech Research,Negative
 FrontLine Therapy,SciTech Research,Negative
 FrontLine Therapy,Oncology Tube,Negative
 Expert panelists,SpecialtyPTimes,Negative
 Wu labs,Satyen Gohil,Positive
 phase II study,MD Anderson Cancer Center,Negative
 phase II study,Targeted Oncology,Negative
 phase II study,Lymphoma Coalition,Negative
 efficacy results,MD Anderson Cancer Center,Negative
 Growth dynamics,Amit Sud,Positive
 ÂêåÂÆö„Åï„Çå„ÅüÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÂ¢óÊÆñ„Éë„Çø„Éº„É≥,Êè°„Å£„Åü„Åæ„ÅæÈáëË≤®ÈáëÂú∞ÈáëË≤∑Âèñ„ÇäÊâÄ,Positive
 Broad Institute,Broad Institute,Positive
 report patterns,Broad Institute,Positive
 MorganeIm,Charles Herbaux,Positive
 dose interruptions,"Raul Cordoba, MD, PhD",Negative
 mentorship,"Amber Koehler, PA-C",Negative
 PA,"Amber Koehler, PA-C",Negative
   Patterns,PressReleasePoint,Negative
 frontlinetherapy,Scott Merville,Negative
 frontlinetherapy,Oncology Strategies,Negative
 Covaris,Covaris,Positive
 amp Focusedultrasonicator technologies,Covaris,Positive
 chromatin,Covaris,Positive
 research teams,Michael Hallek,Negative
      promising combination,MoJo,Negative
 Publicado hoy,Hematolog√≠a Salamanca,Negative
 town meeting,Theresa (Clementi) Doan,Positive
 town meeting,Michele Nadeem-Baker,Negative
 town meeting,Patient Power,Positive
 Liliane Paquette,Clean Food,Positive
 damages,Clean Food,Positive
 Twodrug frontline combination,MedPage Oncology,Negative
 Venetoclaxibrutinib combination,HemOnc Today,Negative
 Fecha    VS,Club Libertad Limpe√±o,Positive
 √±o ‚è± Ô∏è   ST,Club Libertad Limpe√±o,Negative
 √±o ‚è±,Club Libertad Limpe√±o,Positive
 Laurie Cristaldo    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Carmen Ben√≠tez,Club Libertad Limpe√±o,Negative
 Angeles Portillo     ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 ‚è± Ô∏è FINAL DEL,Club Libertad Limpe√±o,Negative
 inicial Alicia Bobadilla,Club Libertad Limpe√±o,Negative
 Laurie Cristaldo Carmen Ben√≠tez Damia Cortaza,Club Libertad Limpe√±o,Negative
 Joana Galeano Fabiola Sandoval Griselda,Club Libertad Limpe√±o,Negative
 Garay Liz Pe√±a Ang√©lica,Club Libertad Limpe√±o,Negative
 V√°zquez Paola Genes Karina Vega ‚öΩ,Club Libertad Limpe√±o,Negative
 ‚ö´ ‚ö™,Club Libertad Limpe√±o,Positive
 DanaFarber study,Dana-Farber News,Positive
 RT DKFZ Epigenetische Signale,Cancer Core Europe,Positive
 f√∂rdern Entstehung von,Cancer Core Europe,Positive
 DKFZWissenschaftler haben herausgefunden dass f√ºr,Cancer Core Europe,Positive
 DKFZWissenschaftler haben herausgefunden dass f√ºr,DKFZ,Positive
 Signale verantwortl,Cancer Core Europe,Positive
 Epigenetische Signale,DKFZ,Positive
 Leukemia Therapeutics Market,Danish hussain,Positive
 ClbG,Toby Eyre,Negative
 Mayo,Toby Eyre,Negative
 AF,Toby Eyre,Negative
 AF,Lymphoma Hub,Negative
    pt,Toby Eyre,Negative
 New HTN,Toby Eyre,Negative
 prior HTN,Toby Eyre,Negative
 antiHTN rx,Toby Eyre,Negative
 Lenritux displaying activity,Toby Eyre,Negative
 BCRiBCLi exposure,Toby Eyre,Negative
 lecture,Sigrid Sk√•nland,Negative
 lecture,Vincent Rajkumar,Negative
 mothers diagnoses,ùî∏ùïüùïòùïñùïùùïöùï†ùïü‚úØ,Positive
 Heute ist,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 Heute ist,AbbVie Deutschland,Negative
 F√ºr viele PatientInnen hei√üt,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 nach der,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 Diagnose CLL erst einmal,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 abwarten amp beobachten Erfahren Sie,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 OnlineKurs,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 wie,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 Sie,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 mit der Belastung umgehen und selbst aktiv,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 k√∂nnen,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 Dr Brian Koffman interviews Dr William Wierda,CLL Society Inc.,Negative
 dearest friend,@linfopedia,Positive
 Memorial Day,Real Heroes Wear A Mask,Positive
 fwd pe,WheelieDealer,Negative
 ¬£ m Cash,WheelieDealer,Negative
 breakout,WheelieDealer,Negative
 breakout,Free Cello Tuner,Negative
 breakout,Ian Morgan-Smith,Positive
 chart Investors Chronicle,WheelieDealer,Negative
 groups paper,"Sanam Loghavi, MD",Negative
   implications,"Sanam Loghavi, MD",Negative
 VS ‚è± Ô∏è,Club Libertad Limpe√±o,Negative
 Bel√©n Ben√≠tez,Club Libertad Limpe√±o,Negative
 DEL PRIMER TIEMPO,Club Libertad Limpe√±o,Negative
 New Rituximab,Medivizor,Negative
 partido,Club Libertad Limpe√±o,Negative
 inicial ‚öΩ,Club Libertad Limpe√±o,Negative
 Alicia Bobadilla Laurie Cristaldo Carmen Ben√≠tez Damia Cortaza,Club Libertad Limpe√±o,Negative
 V√°zquez Paola Genes Karina Vega   ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Post Options,CancerWallonia,Negative
 Big news,CLL Society Inc.,Negative
 Big news,Toby Eyre,Negative
 Big news,"Jeremy Warner MD, MS, FAMIA, FASCO",Positive
 voor de waardevolle bijdrage,Hematon,Negative
 Gisteren,Michiel Hageman,Positive
 op de    een,Michiel Hageman,Positive
 Immune Mediated Thrombocytopenia,Alexander M. J.,Positive
 Phase III RESONATETM Study,Alexander M. J.,Positive
 Ibrutinib Vs Ofatumumab,Alexander M. J.,Positive
 Dr John C Byrd,Oncology Tube,Negative
 Dr John C Byrd,Targeted Oncology,Negative
 Computer,EurekaMag,Negative
 Drug Designing,EurekaMag,Negative
 Global Trends Market Size Share Status SWOT Analysis,PressRelease.cc,Negative
 Global Trends Market Size Share Status SWOT Analysis,ABNewswire,Negative
 Global Trends Market Size Share Status SWOT Analysis,EIN Presswire: Press Releases,Negative
 Rare Case,Cancer Papers,Negative
 Rare Case,NeuroStemCells,Positive
 Rare Case,Frontiers Neurology,Positive
 Central Nervous System Involvement,Cancer Papers,Negative
 Tcell lymphoma,Milo≈° Miljkoviƒá,Positive
 ATLL,Milo≈° Miljkoviƒá,Positive
 Tcell malignancies,Milo≈° Miljkoviƒá,Positive
 Tired Checkout,Michele Nadeem-Baker,Negative
 Type   Immunoglobulin M Cryoglobulinemic Vasculitis,Cureus,Negative
 Hepatitis C Virus,Cureus,Negative
 Naveen,Cureus,Negative
 Raj,Cureus,Negative
   Dr Richard Furman,WCM Lymphoma,Negative
 Cancer patients,Esther Schorr,Negative
 pCPA,Crwe World,Negative
 Info event,Kathrinabentley(KB),Positive
 education amp support,Kathrinabentley(KB),Positive
 amp carers,Kathrinabentley(KB),Positive
 amp carers,CLL Ireland,Negative
 flares,the limbic,Negative
 UPENN monitors patients,"Comprehensive Cell Solutions,New York Blood Center",Positive
 Fiorela Mart√≠nez,Club Libertad Limpe√±o,Negative
 Ô∏è FINAL DEL,Club Libertad Limpe√±o,Negative
 Bobadilla Laurie Cristaldo Carmen Ben√≠tez Damia Cortaza,Club Libertad Limpe√±o,Negative
 ChemotherapyFree Combination Regimen,MedPipeline,Negative
 ChemotherapyFree Combination Regimen,FDA Daily,Positive
 ChemotherapyFree Combination Regimen,Thanasis Chalikias,Positive
 ChemotherapyFree Combination Regimen,RazzleTazzle,Negative
 ChemotherapyFree Combination Regimen,Crwe World,Negative
 ChemotherapyFree Combination Regimen,HempNews,Negative
 ChemotherapyFree Combination Regimen,PSK2329 - JHC,Negative
 Joel Schmidt Bill Borchard Mary Kevlin,"Cowan, Liebowitz",Negative
 Bob English,"Cowan, Liebowitz",Negative
 Intercambio de datos y conceptos,ACINDES Internacional,Positive
 CLL Nueva,ACINDES Internacional,Positive
 el VHIO con el Dr Bosch Gran grupo,ACINDES Internacional,Positive
 y excelente nivel,ACINDES Internacional,Positive
 features,Mary Ruberry,Positive
 transcription factor networks,Mary Ruberry,Positive
 Improved Interpretability,Lymphoma Papers,Negative
 Machine Learning Model,Lymphoma Papers,Negative
 Predicting Time,Lymphoma Papers,Negative
 Pharmacologic inhibition,Lymphoma Papers,Negative
 ER stress,Lymphoma Papers,Negative
 Deepdives,Fred Hutch,Negative
 CAR Tcells patients,Fred Hutch,Negative
   se convirtieron,WWE Noticias FM,Negative
 los Campeones,WWE Noticias FM,Negative
 Equipo de,WWE Noticias FM,Negative
 √≥n,WWE Noticias FM,Positive
 √≥n,The Pepex Family,Positive
 √≥n,Thu Pepex,Positive
 √≥n,Indy Wrestling Chile,Negative
 Center Director,MD Anderson Leukemia,Negative
 VenetoclaxObinutuzumab combo,Lampe & Company,Negative
 frontline Chronic Lymphocytic,Lampe & Company,Negative
 tcohbGWQmtzV,Lampe & Company,Negative
 genome sequencing,Dimitris Vavoulis,Positive
 genome sequencing,Beth Torr,Positive
 genome sequencing,The North West Genomic Laboratory Hub,Positive
 genome sequencing,Genomics England,Positive
 genome sequencing,LiteratureFeed,Positive
 genome sequencing,CLL-seq,Positive
 RNA expression profiling,Dimitris Vavoulis,Positive
   Agenda,iwCLL,Negative
 Dose Modification,Verastem Oncology,Negative
 Relapsed Refractory SLL,Verastem Oncology,Negative
 DUO Study,Verastem Oncology,Negative
 DUO Study,SNN Network,Negative
 DUO Study,Cancer News,Negative
 DUO Study,Lung Cancer News,Negative
 DUO Study,Crwe World,Negative
 DUO Study,Business Wire-Health,Negative
 DUO Study,BusinessWireWebcasts,Negative
 DUO Study,The Pharmaceutical Marketing Group,Negative
 DUO Study,Stockboard Media Inc,Negative
 DUO Study,Odi Bruckman,Negative
 DUO Study,CRO Contract Res.,Negative
 DUO Study,$Stocknewsalerts,Negative
 DUO Study,Financial Buzz,Negative
 DUO Study,Business Wire-TS,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA CLL PATIENT SAMPLES,DEEPAK B. Thimiri Govinda Raj,Positive
 IDENTIFIES DRUG CANDIDATES,DEEPAK B. Thimiri Govinda Raj,Positive
 PRECISION CANCER THERAPY,DEEPAK B. Thimiri Govinda Raj,Positive
 CLL Society email alerts,CLL Society Inc.,Negative
 cortactin,Wnt publications,Negative
 st,Toby Eyre,Negative
 st,Lifelong Learning,Negative
 Venetoclax   Obinutuzumab,CLL Society Inc.,Negative
 Venclexta venetoclax,FDA Daily,Negative
 Venclexta venetoclax,PharmaShots - Incisive news in 3 shots,Negative
 Venclexta venetoclax,Biologics by McKesson,Negative
 Venclexta venetoclax,Dr Jobin Shaeri,Positive
 Venclexta venetoclax,Jad Adaimi,Positive
 Venclexta venetoclax,CancerCare,Negative
 Venclexta venetoclax,The Medical Letter,Negative
 vector integration site observations,Randi Hernandez,Positive
 CART cell potency,Randi Hernandez,Positive
 BREAKING   News FDA,Michele Nadeem-Baker,Negative
 Untreated Chronic Lymphocytic,Professione Farmacia,Negative
 Untreated Chronic Lymphocytic,Oncology,Negative
   Approves,CancerWallonia,Positive
   Approves,1stOncology,Negative
   Approves,Oncology Now,Positive
 VS ‚è± Ô∏è   ST,Club Libertad Limpe√±o,Positive
 Stephenie Lacoste,Club Libertad Limpe√±o,Negative
 Griselda L√≥pez    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 ¬° ST,Club Libertad Limpe√±o,Negative
 minute review,"Amber Koehler, PA-C",Negative
 ¬° Partido,Club Libertad Limpe√±o,Negative
 el nido,Club Libertad Limpe√±o,Negative
   town meeting,Patient Power,Positive
   town meeting,Andrew Schorr,Negative
 ‚û° Ô∏è Alicia Bobadilla,Club Libertad Limpe√±o,Negative
 Paola Genes Carmen Ben√≠tez Stephenie Lacoste Ang√©lica V√°zquez,Club Libertad Limpe√±o,Negative
 Joana Galeano Griselda,Club Libertad Limpe√±o,Negative
 L√≥pez Damia Cortaza Fabiola Sandoval Karina Vega y Liz Pe√±a,Club Libertad Limpe√±o,Negative
 Crowdsourced Stock Ratings,@MissKonfidentielle üîÜ Val√©rie Desforges,Positive
 Crowdsourced Stock Ratings,Ashish Bedekar,Positive
 Crowdsourced Stock Ratings,üí• Paleo by Leo üí• International Food Blogger,Positive
 nurse Jeanne Schaffer,Patient Power,Negative
 busts,Patient Power,Negative
 myths Tune,Patient Power,Negative
 guest expert opinion Dr Maloney,Patient Power,Negative
 live   town meeting,Patient Power,Negative
 Portland,Patient Power,Negative
 Portland,CLL Society Inc.,Negative
 Portland,Seattle DJC,Positive
 Portland,Andrew Schorr,Negative
 Informative work,Taylor Lab UM,Negative
 ‚Å© Prognostic risk score,Taylor Lab UM,Negative
 New CME Event,CME Schedule,Positive
 Venetoclas indication,Drug Topics,Positive
 Chronic Small Lymphocytic Leukemia,Rondaxe Pharma,Positive
 Chronic Small Lymphocytic Leukemia,Drugnews.in,Negative
 Novel Combination,COPD News,Negative
 CLL Danielle M Brander MD,COPD News,Negative
 Abbvie Roche,Bionest Partners,Negative
 CLL nod,Bionest Partners,Negative
 VenclextaGazyva,Bionest Partners,Negative
 venetoclax AbbVie Inc,E2DG,Positive
 Genentech Inc,E2DG,Positive
 Genentech Inc,FDA Oncology,Negative
 VenclextaGazyva regimen,PharmacyChecker,Negative
    snag,Plexus Ventures,Negative
   nod,Plexus Ventures,Negative
 Small Lymphocytic Lymphoma Analysis,Lymphoma Papers,Negative
 Cohorts,Lymphoma Papers,Negative
 Unfortunately Skin Cancer,CLL Ireland,Negative
 Congratulations Pavlina Janovska,Bryjalab,Positive
 rector¬¥s award,Bryjalab,Positive
 Roche FDA,George J Huba PhD,Positive
 Roche FDA,Advera Health,Negative
 Roche FDA,Physician's Weekly,Positive
 Roche FDA,Maya's Dolly,Positive
 Roche FDA,The Pharmaceutical Marketing Group,Negative
 Roche FDA,Shahid Raz,Positive
 Roche FDA,Angela Keen,Positive
 Roche FDA,FaceMyDoc,Positive
 Roche FDA,the world of CROs,Negative
 Roche FDA,Sai Legal Services,Positive
 Roche FDA,CNA,Positive
 Roche FDA,TheArticleTrunk,Negative
 Roche FDA,chorley chicken,Negative
 Roche FDA,Latest Commentary - #LatestComments,Positive
 Roche FDA,FirstPressNG,Positive
 Roche FDA,Ibex News 24,Positive
 Roche FDA,E-Radio.US,Positive
 Roche FDA,Ray Noble (The Thin End Show),Positive
 drug combo Venclexta,George J Huba PhD,Positive
 drug combo Venclexta,Advera Health,Negative
 drug combo Venclexta,Maya's Dolly,Positive
 drug combo Venclexta,The Pharmaceutical Marketing Group,Negative
 drug combo Venclexta,Shahid Raz,Positive
 drug combo Venclexta,Angela Keen,Positive
 drug combo Venclexta,FaceMyDoc,Positive
 drug combo Venclexta,the world of CROs,Negative
 drug combo Venclexta,Sai Legal Services,Positive
 drug combo Venclexta,CNA,Positive
 drug combo Venclexta,TheArticleTrunk,Negative
 drug combo Venclexta,chorley chicken,Negative
 drug combo Venclexta,Latest Commentary - #LatestComments,Positive
 drug combo Venclexta,FirstPressNG,Positive
 drug combo Venclexta,Ibex News 24,Positive
 drug combo Venclexta,E-Radio.US,Positive
 drug combo Venclexta,Ray Noble (The Thin End Show),Positive
      combination,Roots Analysis,Negative
 s drug,Roots Analysis,Negative
 chemotherapyfree treatment,ipharmacenter,Negative
 chemotherapyfree treatment,cafepharma,Negative
 chemotherapyfree treatment,Rare Disease Report,Negative
 lineThe application,ipharmacenter,Negative
 Oncology Priority Review ProgramThis,ipharmacenter,Negative
 Venclexta amp Gazyva combination,Big4Bio:SFBay,Positive
 FDA Approves Combo Therapy,SpecialtyPTimes,Negative
 Untreated Chronic Lymphocytic LeukemiaMore,SpecialtyPTimes,Negative
   approved venetoclax venclexta,CancerCare,Negative
 adult individuals,CancerCare,Negative
 drug combo,Physician's Weekly,Positive
 chemofree frontline treatment,Lymphoma Research Foundation,Negative
 Gazyva Venclexta combo,ABABioBlurb,Positive
 Genentech Announces FDA Approval,The Pharmaceutical Marketing Group,Positive
 Genentech Announces FDA Approval,Pharmacutical Daily,Positive
 Genentech Announces FDA Approval,FDA Daily,Positive
 Genentech Announces FDA Approval,Crwe World,Negative
 Genentech Announces FDA Approval,Sharon Johnson,Positive
 Genentech Announces FDA Approval,Hematopoiesis News,Negative
 Genentech Announces FDA Approval,Medicalnewser.com,Negative
 Genentech Announces FDA Approval,Connie Hampton,Positive
 Genentech Announces FDA Approval,Financial Buzz,Negative
 Genentech Announces FDA Approval,Pharma Commons,Negative
 Genentech Announces FDA Approval,DennisPartners,Negative
 Autorisation par,oncohebdo,Negative
 la FDA,oncohebdo,Negative
 ¬Æ Roche,oncohebdo,Positive
 L de la √©mie,oncohebdo,Negative
 lympho√Øde chroniquepetit,oncohebdo,Negative
 lymphocytaire,oncohebdo,Negative
 AbbVie Announces FDA Approval,Thanasis Chalikias,Positive
 AbbVie Announces FDA Approval,RazzleTazzle,Negative
 AbbVie Announces FDA Approval,FDA Daily,Negative
 AbbVie Announces FDA Approval,Crwe World,Negative
 AbbVie Announces FDA Approval,HempNews,Negative
 AbbVie Announces FDA Approval,PRICENTRIC,Positive
 L CLL Elderlyunfit PFS Overlay,Reg Myers,Positive
 CLL v,Reg Myers,Positive
 La   approuve,Club Trecento Sant√©,Positive
 le   venetoclax,Club Trecento Sant√©,Positive
 en L,Club Trecento Sant√©,Positive
 traiter les patients,Club Trecento Sant√©,Positive
 ce traitement qualifi√© de perc√©e th√©rapeutique√©,Club Trecento Sant√©,Positive
 Roches treatment,EMG GOLD,Positive
 Venclexta   Gazyva,EMG GOLD,Positive
 Gazyva obinutuzumab Receive FDA,PharmaShots - Incisive news in 3 shots,Negative
 CDspecific chimeric antigen,ImmunologyPapers,Negative
 VenetoclaxObinutuzumab Combo,"Krizs√°n Szilvia, MD",Positive
 Frontline     haszn√°lat√°val,"Krizs√°n Szilvia, MD",Positive
 Prof Andrew Roberts,the limbic,Negative
 Prof Andrew Roberts,Peter Mac Cancer Centre,Positive
 combination use,Snowdome Foundation,Positive
 combination use,CURE Magazine,Negative
 news FDA,"Amber Koehler, PA-C",Positive
 surprise,calliecoombs,Positive
 surprise,Toby Eyre,Negative
 delight,calliecoombs,Positive
 ABBV FDA,MAISA,Positive
 ABBV FDA,George,Negative
 Venclexta drug candidate,MAISA,Negative
 venetoclax VENCLEXTA AbbVie Inc,FDA Oncology,Negative
 News FDA Approves VenetoclaxObinutuzumab Combo,A Nasser Nourallah. MD.FASCO,Positive
 Frontline CLLThe FDA,A Nasser Nourallah. MD.FASCO,Positive
 Jacqueline Barrientos MD,Oncology Tube,Negative
 authorship,Leukemia & Lymphoma Society Research,Positive
 Hongcang Gu,Leukemia & Lymphoma Society Research,Positive
 BREAKING Combination venetoclax,Targeted Oncology,Negative
   Approves Combo Therapy,SpecialtyPTimes,Negative
 ABBV Press Release,Flash Alert,Negative
 Roche Genentech Announces FDA Approval,Armando Guglielmetti,Positive
   combination therapy,AbbVie,Negative
 RealTime Oncology Review RTOR pilot program,AbbVie,Negative
 Venclexta   Gazyva combo,Andrew Dunn,Positive
 firstline CLLSLL treatment,Andrew Dunn,Positive
 realtime oncology review pilot program,Andrew Dunn,Positive
 roughly   months,Andrew Dunn,Positive
 medicine combo,Genentech,Positive
 medicine combo,suetodd16,Positive
 medicine combo,Jayson Johnson,Positive
 medicine combo,Catherine Vel√°zquez,Positive
 medicine combo,Janice Oliver,Positive
 chemotherapyfree treatment option,Genentech,Negative
 Ov VENCLEXTA,PSK2329 - JHC,Negative
 Ibrutinib therapy,Blood Journal,Negative
 Ibrutinib therapy,AA&MDSIF,Positive
 Ibrutinib therapy,GEDEFO,Negative
 Ibrutinib therapy,Cure Cancer Now,Negative
 AID enzyme,Blood Journal,Negative
 AID enzyme,AA&MDSIF,Positive
 AID enzyme,GEDEFO,Negative
 AID enzyme,"Raul Cordoba, MD, PhD",Negative
 Training,BSI America,Negative
 Live Online Format,BSI America,Negative
 Hello London,Marcia Villalba ü¶Ñ,Positive
 Kabouter Funds,WheelieDealer,Negative
 Leukemia Cancer Survivor Mug,Simply,Positive
   Research STIM,Society for Immunotherapy of Cancer,Positive
 Packed house,RIOH,Negative
 Packed house,Matthew Will,Positive
 Packed house,AZ Blood Cancer,Positive
 antiCD antibody,Clinical Connection,Positive
 BI,Clinical Connection,Positive
 BI,Lymphomation.org,Negative
 BI,VoyagerMed,Positive
 BI,CureHuntr,Negative
 u,Karim Bhaloo,Positive
 u,Andrew Schorr,Negative
 u,"chadi nabhan MD, MBA, FACP",Negative
 u,FlytoFindACure,Positive
 u,C_R_Williamson,Positive
 u,Azmat Kamal,Positive
 u,Susan Rahn,Positive
 u,Patient Power,Negative
 u,I ü§ç‚ù§Ô∏è 32 & 26!!,Positive
 illUMINTATE Trial,Oncology Tube,Negative
 Older CLL Patients,Oncology Tube,Negative
 cancer Big Words,Jeff Neurman,Negative
 Cytogenetic complexity,Juan Marquet,Negative
 Cytogenetic complexity,Philip McCarthy,Positive
 Cytogenetic complexity,Blood Journal,Negative
 Cytogenetic complexity,"Dr T. Comeau , MD",Negative
 Cytogenetic complexity,Garbi√±e Lizeaga,Positive
 Cytogenetic complexity,Izaskun Zeberio,Negative
 Cytogenetic complexity,Lymphoma Papers,Negative
   complexity,"Raul Cordoba, MD, PhD",Positive
   complexity,Jitakshi,Positive
 Kari Vega,Club Libertad Limpe√±o,Negative
 y Ang√©lica,Club Libertad Limpe√±o,Negative
 ¬° Fin del primer tiempo,Club Libertad Limpe√±o,Negative
 Kari Vega    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Alicia Bobadilla Laurie Cristaldo Carmen Ben√≠tez Stephenie Lacoste,Club Libertad Limpe√±o,Negative
 Anglica V√°zquez Bel√©n Ben√≠tez Griselda L√≥pez Claudia Romero Liza Larrea M√≥nica Vega Natalia Barros,Club Libertad Limpe√±o,Negative
 license agreement amendment,IPSCIO,Positive
 license agreement amendment,RoyaltySource¬Æ,Positive
 license agreement amendment,ValueDiscovery,Positive
 royalty,IPSCIO,Positive
 royalty,RoyaltySource¬Æ,Positive
 royalty,ValueDiscovery,Positive
 sales,IPSCIO,Positive
 sales,RoyaltySource¬Æ,Positive
 sales,ValueDiscovery,Positive
 Clinical,TrialSite News,Negative
 Clinical,Oncology Board,Positive
 Positive,TrialSite News,Negative
 lenalidomide bendamustine,Lymphoma Papers,Negative
 Blood Jouornal,AA&MDSIF,Positive
 Blood Commentary Ibrutinib,Blood Journal,Negative
 home run,Blood Journal,Negative
 Patient Advocate,Michele Nadeem-Baker,Negative
 CRISPRHis model,üá≤üáΩ Leonardo Collado-Torres,Positive
 ATACseq,üá≤üáΩ Leonardo Collado-Torres,Positive
 machine,üá≤üáΩ Leonardo Collado-Torres,Positive
 Trends Size Share Price Growth Drivers Business Opportunities Adroit Market Research,Adroit Market Research,Positive
 Immunomodulatory Drugs,RAVIKANTH S,Negative
 Active Immunotherapy,RAVIKANTH S,Negative
 exposure w Talha Munir,VJHemOnc,Negative
 ibrutinib venetoclax works,Cancer News,Negative
      therapy,"Raul Cordoba, MD, PhD",Negative
     home run,"Raul Cordoba, MD, PhD",Negative
 GSK Phase,ClinicalTrialsData,Negative
 AlemtuzumabOfatumumab,ClinicalTrialsData,Negative
 Clinical Laboratory Prognostic Indicators,RAVIKANTH S,Negative
 Chronic Lymphocytic Leukemiafrom,Dr. Chad DeMott,Positive
 Chronic Lymphocytic Leukemia Treatment Industry Research Report,Ricerca Alfa,Positive
 Key Market Insights,Ricerca Alfa,Positive
 CD B,Nature Reviews Disease Primers,Negative
 Estimate Primary Completion Date,ClinicalTrialsData,Negative
 Estimate Primary Completion Date,NASDAQ,Positive
 RNAbased Markers,RAVIKANTH S,Negative
 Prognostic Factors,RAVIKANTH S,Negative
 Prognostic Factors,The ASCO Post,Negative
 Prognostic Factors,CLL Ireland,Negative
 Prognostic Factors,Cancer_Tribune,Negative
 Prognostic Factors,Mahmoud Aljurf,Negative
 Prognostic Factors,SexGenomics,Negative
 Prognostic Factors,OncLive.com,Negative
 Prognostic Factors,Cancer Papers,Negative
   doors,Continuous Lifecycle London (online),Positive
 Tuesdayjoin,Continuous Lifecycle London (online),Negative
   advanced   workshops,Continuous Lifecycle London (online),Negative
 fecha,Club Libertad Limpe√±o,Positive
 PT ‚öΩ,Club Libertad Limpe√±o,Negative
 Liz Pe√±a ¬†   ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 VS ‚è± Ô∏è T ¬†¬†¬†   ‚öΩ,Club Libertad Limpe√±o,Negative
 Diana Salinas Laurie Cristaldo Paola Genes Stephenie Lacoste,Club Libertad Limpe√±o,Negative
 Anglica V√°zquez Damia Cortaza Joana Galeano,Club Libertad Limpe√±o,Negative
 Liza Larrea Liz Pe√±a,Club Libertad Limpe√±o,Negative
 y Natalia Barros    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Driven B Cell Chronic Lymphocytic Leukemia Cycling,J Immunol,Negative
 gene expression lead,J Immunol,Negative
 noon,Sidney Kimmel Cancer Center ‚Äì Jefferson Health,Positive
 Dr Nadia Khan,Sidney Kimmel Cancer Center ‚Äì Jefferson Health,Positive
 Elena Gitelson Memorial Lectureship,Sidney Kimmel Cancer Center ‚Äì Jefferson Health,Positive
 novel chronic lymphocytic   therapies,Sidney Kimmel Cancer Center ‚Äì Jefferson Health,Positive
 hits study goal,Mohamad Mohty,Positive
 Amazing HemOnc Grand Rounds,Taylor Lab UM,Negative
 evidencebased approach,Taylor Lab UM,Negative
 VIDEO Lessons,VJHemOnc,Negative
   CLARITY study,VJHemOnc,Negative
 Peptide Vaccination,TrialBulletin,Negative
 IO,TrialBulletin,Positive
 IO,CureHuntr,Positive
   Peptide Vaccination,CureHuntr,Negative
 fatherinlaw,Jo-El Sidbury,Positive
 hell,Jo-El Sidbury,Positive
 Wake Baptist,Jo-El Sidbury,Positive
    Great,Michele Nadeem-Baker,Negative
 Drug Sensitivity Screening,Sigrid Sk√•nland,Negative
 th   congress,Sigrid Sk√•nland,Negative
 Amsterdam June,Sigrid Sk√•nland,Negative
   National   Patient amp Carer Information Day,CLL Ireland,Negative
 Dublins Spencer Hotel IFSC,CLL Ireland,Negative
 treated   patients,AplusA World,Positive
 treated   patients,VJHemOnc,Negative
 BCRIs,AplusA World,Positive
 prenant,@AplusA_France,Positive
 compte,@AplusA_France,Positive
 trait√©s sont trait√©s par,@AplusA_France,Positive
 BCRi et,@AplusA_France,Positive
 FCR En,@AplusA_France,Negative
 savoir plus sur cette maladie,@AplusA_France,Negative
 Live Activity,PharmacyTimesCE,Positive
 guidelines,PharmacyTimesCE,Positive
 guidelines,Medivizor,Positive
 guidelines,Marilyn Heine,Positive
 guidelines,iwCLL,Negative
 guidelines,myCME,Negative
 crummy straw man control arm,"David Steensma, MD",Positive
 CLL verstehen ü§î Da chronische lymphatische,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 Leuk√§mie CLL,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 zu den Lymphomen,selpers - Online-Plattform f√ºr chronisch Kranke,Positive
 BCell Chronic Lymphocytic Leukemia Treatment Adoption,EPR Network,Positive
 drug therapy,EPR Network,Positive
 Global Chronic Lymphocytic Leukemia Market,Total Pharma News,Negative
 Global Chronic Lymphocytic Leukemia Market,BizPR,Positive
 Global Chronic Lymphocytic Leukemia Market,Publish PressRelease,Positive
 Global Chronic Lymphocytic Leukemia Market,Soft Solutions,Positive
 Global Chronic Lymphocytic Leukemia Market,Seductionpros,Positive
 Global Chronic Lymphocytic Leukemia Market,COPD News,Negative
 Global Chronic Lymphocytic Leukemia Market,EIN Presswire: Merck Newswire,Positive
 Global Chronic Lymphocytic Leukemia Market,DrugGenius,Negative
 Global Chronic Lymphocytic Leukemia Market,Business Wire-Health,Negative
 Global Chronic Lymphocytic Leukemia Market,dlvr news,Negative
 HoffmanLa Roche,Total Pharma News,Positive
 Gilead Sciences,Total Pharma News,Negative
 rappel de connaissance,@AplusA_France,Negative
 √©matologie,@AplusA_France,Negative
 LongTerm Followup Addition,The ASCO Post,Negative
   therapy,CLL_Fightersüéó,Negative
   therapy,MDedge Hematology & Oncology,Negative
   therapy,Margaret Walker,Negative
   therapy,Oncology Tube,Negative
   therapy,Oncology Practice,Positive
   therapy,Hematology News,Negative
 RobertsSeymour et al,Chan Cheah,Negative
 Akershus University Hospital,Sigrid Sk√•nland,Negative
 chimeric antigen receptor therapy,"Dr T. Comeau , MD",Negative
    feliz   d√≠a del trabajador,juan moises arana,Positive
    Update,Patient Power,Negative
 Stanford Universitys,Patient Power,Negative
 Dr Neel Gupta,Patient Power,Negative
 Drugs amp Treatment regimes options,CLL_Fightersüéó,Negative
 fighters,CLL_Fightersüéó,Positive
 Research Grants Investment Supports Young Investigators,CRO Contract Res.,Negative
 Patient Therapies,CRO Contract Res.,Negative
 CuresNEW YORK PRWEB,CRO Contract Res.,Negative
 Clinical Grand Rounds,UNMC Pathology & Microbiology,Negative
 PIK Inhibitors Efficacy Toxicity,UNMC Pathology & Microbiology,Positive
 Dr Jennifer Brown Dir Center,UNMC Pathology & Microbiology,Positive
 Chronic Lymphocytic Leukemia Institute Physician,UNMC Pathology & Microbiology,Positive
 ESH,UNMC Pathology & Microbiology,Negative
 Miyita,Lunny1607,Positive
 √ÖAS f√∂klarar,Majlen Saarinen,Positive
 id√©n med √•ngtl√§rande Det,Majlen Saarinen,Positive
 jag f√∂r √∂ppnauniversitetet,Majlen Saarinen,Positive
 √•boakademi,Majlen Saarinen,Positive
 Magpies,Ashbridge Nursery at Maxy Farm,Positive
 library,Ashbridge Nursery at Maxy Farm,Positive
   POSITIONS MICROENVIRONMENTAL INTERACTIONS,researchjobs.cz,Negative
 NONCODING RNAs,researchjobs.cz,Negative
 million Peripheral Blood Mononuclear Cells PBMC samples,Bay Biosciences LLC,Positive
 Witness Heightened Growth,PressRelease.cc,Negative
 MRFR,PressRelease.cc,Negative
 Geoff Grubbs,Georgetown Lombardi,Positive
 selling orphan drugworldwide,Evaluate Pharma,Positive
 Alison Duffy PharmD BCOP,SpecialtyPTimes,Positive
 birdsong,Woodvale Primary Academy,Positive
 todaythe children,Woodvale Primary Academy,Positive
   VS ‚è± Ô∏è,Club Libertad Limpe√±o,Positive
   VS,Club Libertad Limpe√±o,Negative
   VS,AGRESSOR,Positive
 Inici√≥ el primer,Club Libertad Limpe√±o,Negative
 tiempoALICIA BOBADILLA STEPHENIE LACOSTE BEL√âN BEN√çTEZ DAMIA CORTAZA JOHANA,Club Libertad Limpe√±o,Negative
 GALEANO FABIOLA SANDOVAL LIZA LARREA GRISELDA L√ìPEZ ANG√âLICA V√ÅZQUEZ PAOLA GENES KARINA VEGA,Club Libertad Limpe√±o,Negative
 ‚ö´,Club Libertad Limpe√±o,Negative
 Reversal,Lymphoma Papers,Negative
 acquired von Willebrand syndrome,Lymphoma Papers,Negative
 Survival Outcomes,Lymphoma Papers,Negative
 Chronic Lymphocytic Leukemia Systematic Review,Lymphoma Papers,Negative
 Chronic Lymphocytic Leukemia Systematic Review,HealthEconBot,Positive
 Metaanalysis,Lymphoma Papers,Negative
 Metaanalysis,Lymphoma Hub,Positive
 Metaanalysis,Yale School of Public Health,Positive
 Metaanalysis,Krishan Maggon,Negative
 Metaanalysis,gilbert c faure,Negative
 Metaanalysis,GWAS_lit,Positive
 Systematic rwMetaanalysis bendamustine,Toby Eyre,Negative
 OS HR    CI,Toby Eyre,Negative
 comparatorlower risk,Toby Eyre,Negative
 caveats,Toby Eyre,Negative
 incl comparatorsdx subtypes,Toby Eyre,Negative
 Hodgkin lymphoma transformation,CRO Contract Res.,Negative
 Hodgkin lymphoma transformation,Lymphoma Papers,Negative
    Rituximab,Elsevier Oncology,Negative
 heart,"Amber Koehler, PA-C",Negative
 heart,K.,Positive
 heart,Elaine Schattner,Negative
   education seminar,"Amber Koehler, PA-C",Negative
 Minneapolis,"Amber Koehler, PA-C",Positive
 Minneapolis,Saad kenderian,Positive
   Minneapolis Symposium,Saad kenderian,Positive
 CLL motivating talk,Saad kenderian,Positive
   patient symposium,Saad kenderian,Positive
 Diagnosis   Treatment,Saad kenderian,Positive
     ¬†       ¬†          tcoYYncZlylcF,SouseTetemüá≠üáπ,Positive
 Dr Catriona Jamieson,Andrew Schorr,Negative
 North west cancer,Dr.Faten Yasin,Positive
   Clinical Grand Rounds,UNMC Pathology & Microbiology,Negative
 pm ESH,UNMC Pathology & Microbiology,Negative
 ‚Äú ‚Äù days,Michele Nadeem-Baker,Negative
 inspiration Note,Michele Nadeem-Baker,Negative
 Universe,Michele Nadeem-Baker,Negative
 tqqCCNDIGH translocation,Lymphoma Papers,Negative
 JCO Final Results Rituximab,Cancer Library VCC,Positive
      Efficacy,"Raul Cordoba, MD, PhD",Negative
 P Patients,Oncology Tube,Negative
 Bulk TP disruption NOTCH mutations,Toby Eyre,Negative
 BCRi refractoriness,Toby Eyre,Negative
 influence DOR,Toby Eyre,Negative
 Treatment options,Oncology Tube,Positive
 Treatment options,Michele Nadeem-Baker,Negative
 Treatment options,Cancer Frontline,Positive
 Treatment options,Journal of Clinical Pathways,Negative
 Treatment options,Atrium Health Navicent,Positive
 Field,Oncology Tube,Negative
 Field,CancerWallonia,Negative
 Field,COPD News,Negative
 Christian Poulsen,LyLe Foreningen,Negative
 Lymphoma Hub Satellite Symposium,Lymphoma Hub,Negative
 ICML Lymphoid malignancies,Lymphoma Hub,Negative
 Dr Tamar Tadmor,Jonathan Pearce,Negative
 Haifa Israel,Jonathan Pearce,Negative
 advances treatment options,Jonathan Pearce,Negative
    National Meeting,"David Bartlett, PhD",Negative
 Exciting conference,LyLe Foreningen,Negative
 colabpration,LyLe Foreningen,Negative
 listening,LyLe Foreningen,Negative
 Tamar Tadmor,LyLe Foreningen,Negative
 P√• vej,LyLe Foreningen,Negative
 fokusdag m,LyLe Foreningen,Negative
 Aspin Ridge Tenderloin Cipolinni Onions,Brian Barrett,Negative
 Bone Marrow Crumb Horseradish Gel,Brian Barrett,Negative
 Victoria por,Revista El Repollero,Positive
 de Limpe√±o ante,Revista El Repollero,Positive
 Tanto,Revista El Repollero,Positive
 por Liza Larrea,Revista El Repollero,Positive
   VS ‚è±,Club Libertad Limpe√±o,Negative
 Cambio Liz Pe√±a,Club Libertad Limpe√±o,Negative
 Ô∏è √Ångeles,Club Libertad Limpe√±o,Negative
 Portillo   ‚ö´ ‚ö™,Club Libertad Limpe√±o,Negative
 Cambio Kari Vega,Club Libertad Limpe√±o,Negative
 Ô∏è Paola Genes    ‚ö´ ‚ö™,Club Libertad Limpe√±o,Negative
 Frankly Speaking Chronic Lymphocytic,Northwest Medical,Positive
 Alicia Bobadilla Ang√©lica V√°zquez Laurie Cristaldo Stephenie Lacoste Carmen Ben√≠tez Damia Cortaza Joana Galeano Fabiola Sandoval,Club Libertad Limpe√±o,Negative
 Griselda L√≥pez Natalia Pe√±a Karina Vega ‚ö´ ‚ö™,Club Libertad Limpe√±o,Negative
   patient seminar,"Amber Koehler, PA-C",Negative
 conjunction,"Amber Koehler, PA-C",Negative
 bisulfite,DDNews Online,Negative
 Presque   des patients,@AplusA_France,Negative
 trait√©s,@AplusA_France,Negative
 le sont,@AplusA_France,Negative
 BCRIs et,@AplusA_France,Negative
 de   re√ßoivent FCR T√©l√©chargez notre,@AplusA_France,Negative
 savoir,@AplusA_France,Negative
 sur,@AplusA_France,Negative
 Hugh Growth,The Chief Observer,Positive
 Good Revenue Status,The Chief Observer,Positive
 frequency,"chadi nabhan MD, MBA, FACP",Positive
 frequency,Pathology Tweets,Positive
 frequency,AZ Blood Cancer,Positive
 Exciting work,Ankur Singh,Positive
 colleague Dan Landau,Ankur Singh,Positive
 MI MOMENTO,Lenko Sins,Positive
 Key Clinical Trials,SpecialtyPTimes,Negative
 Alessandro Pastore,Abdel-Wahab Lab,Positive
    Fixed Duration,"Raul Cordoba, MD, PhD",Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia   Eradicates,"Raul Cordoba, MD, PhD",Negative
 Prolongs Survival PostTreatment FollowUp,"Raul Cordoba, MD, PhD",Negative
 Prolongs Survival PostTreatment FollowUp,Mahmoud Aljurf,Positive
 Prolongs Survival PostTreatment FollowUp,Philip McCarthy,Negative
 Prolongs Survival PostTreatment FollowUp,CancerEpiPapers,Negative
 Prolongs Survival PostTreatment FollowUp,Progetto Odin,Positive
 Prolongs Survival PostTreatment FollowUp,Bernie Marini,Positive
 New   Research STIM,Society for Immunotherapy of Cancer,Negative
 RBC transfusions,ISBT Central Office,Negative
 Hemoglobin transfusion trigger,ISBT Central Office,Negative
 RBC transfusion,ISBT Central Office,Negative
 VIDEO Limitations,VJHemOnc,Negative
 New Combination Therapy,Bill F.,Positive
 New Combination Therapy,Patient Worthy,Negative
 New Combination Therapy,Imedex,Positive
 Leukemia Patients,Bill F.,Positive
 POSTASH CLL PATIENT,CLL Society Inc.,Negative
 CAREGIVER,CLL Society Inc.,Negative
 EDUCATIONAL FORUM,CLL Society Inc.,Negative
 Leucemia Linfoc√≠tica Cr√≥nica,Gorka Coloma,Positive
 Jacqueline C Barrientos MD MS,Oncology Learning Network,Negative
   Sharing,Michele Nadeem-Baker,Negative
 GPS GutsPurposeStrategy,Michele Nadeem-Baker,Negative
 du        Lien,TRADY77,Positive
 Sept Edinburg,iwCLL,Negative
 Scotland   Press registration,iwCLL,Negative
       Epidemiology Analysis Therapy Development Growth Demand,Research News24 üíé,Positive
 New Technology,Research News24 üíé,Positive
 New Technology,Pramod,Positive
 Key Player,Research News24 üíé,Positive
 Key Player,Pramod,Positive
 Download Sample Copy,Research News24 üíé,Positive
 HOY,The Pepex Family,Positive
 HOY,Thu Pepex,Positive
 HOY,Indy Wrestling Chile,Positive
 HOY,Don Pepex,Positive
 HOY,BLADE ZETA,Positive
 Duelo suspendido entre Limpe√±o y Cerro por el f√∫tbol femenino,Revista El Repollero,Positive
 esperar,Revista El Repollero,Positive
 la reprogramaci√≥n,Revista El Repollero,Positive
 IDELA,CellworksLife,Negative
 Gnocchi,Mira Larkin,Positive
 Kitty,Mira Larkin,Negative
      ,VJHemOnc,Negative
      ,CryptoLiveLeak,Negative
      ,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
 discussed data,Targeted Oncology,Negative
 Signup amp,Michele Nadeem-Baker,Negative
 Managing Effects,Michele Nadeem-Baker,Negative
 ‚Å¶‚Å¶‚Å© Cancer Center,Michele Nadeem-Baker,Negative
 Uyyy,Golden‚ú®,Positive
 Tausch,Toby Eyre,Negative
 et al independent demonstration,Toby Eyre,Negative
 BCL mutation GV,Toby Eyre,Negative
 ice,Brian Barrett,Negative
 ice,Mayo Clinic Cancer Center,Negative
 ice,Mayo Clinic,Negative
 afternoons entertainment,Jon Juane,Positive
   catering boxes,Jon Juane,Positive
 TLS risk assessment,Toby Eyre,Negative
 Onze nieuwste,PATIENT+,Positive
 Teva Pharmaceuticals Gilead Sciences Johnson Johnson,Total Pharma News,Negative
 Market Trends,Total Pharma News,Negative
 Seats,Leukemia Research Foundation,Negative
 Dr Anil Awesti Senior Teaching Fellow,CLL Warwick Uni,Negative
 Tutor,CLL Warwick Uni,Negative
 Jim Judges Senior Academic Technologist,CLL Warwick Uni,Negative
 examples,CLL Warwick Uni,Negative
 outreach activities,CLL Warwick Uni,Negative
 IdelaOfatumumab,Toby Eyre,Negative
 L    discontinuations,Toby Eyre,Negative
 Glad,Jeff Sharman,Positive
 Glad,Ian Morgan-Smith,Positive
 tcokPxLLGtb,Jeff Sharman,Positive
 Final IdelaR,Toby Eyre,Negative
 Rplacebo,Toby Eyre,Negative
 RR CLL LT PFS,Toby Eyre,Negative
 retainedOS benefit,Toby Eyre,Negative
 Fiorella Mart√≠nez,Club Libertad Limpe√±o,Negative
 Griselda Garay y Karina Vega    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Liz Pe√±a Griselda Garay y Karina Vega    ‚ö™ ‚ö´,Club Libertad Limpe√±o,Negative
 Karina Vega y,Club Libertad Limpe√±o,Negative
   VS   CONFIRMADO,Club Libertad Limpe√±o,Negative
 Diana Salinas Carmen Ben√≠tez Ang√©lica V√°zquez,Club Libertad Limpe√±o,Negative
 Stephanie Lacoste Fiorela,Club Libertad Limpe√±o,Negative
 Mart√≠nez Damia Cortaza,Club Libertad Limpe√±o,Negative
 Fabiola Sandoval Griselda L√≥pez Liz Pe√±a Karina Vega,Club Libertad Limpe√±o,Negative
 genials,Gech,Positive
   amb tots,Gech,Positive
 Castors,Gech,Positive
 w Loretta Nastoupil,VJHemOnc,Negative
 video amp,CLLSA,Negative
 Richter syndrome epidemiology,Lymphoma Papers,Negative
 Skola,Utbildning och IT p√• Kimito√∂n,Positive
 Lisa HenleyDurcan,Leukaemia Care,Positive
 Cells Cycle,Prof John,Negative
 Cyclin D,Prof John,Negative
 PIK amp STAT,Prof John,Negative
 CpG,Prof John,Negative
 CLL expert Dr Richard Furman,Patient Power,Positive
 Ibrutinib Therapy Releases Leukemic Surface IgM,gilbert c faure,Negative
 Ibrutinib Therapy Releases Leukemic Surface IgM,Jerry Lee,Negative
 Ibrutinib Therapy Releases Leukemic Surface IgM,CellworksLife,Negative
 Ibrutinib Therapy Releases Leukemic Surface IgM,Cure Cancer Now,Negative
 Antigen Drive,gilbert c faure,Negative
 Antigen Drive,Jerry Lee,Negative
 Antigen Drive,CellworksLife,Negative
 Antigen Drive,Cure Cancer Now,Negative
 Global Chronic Lymphocytic Leukemia Market Outlook,Total Pharma News,Negative
 Teva Pharmaceuticals,Total Pharma News,Negative
 Chronic Lymphoid Leukemia,CEITEC Connect,Negative
 Chronic Lymphoid Leukemia,MDRing,Negative
 Chronic Lymphoid Leukemia,Janssen EMEA,Positive
 App Shopper Chronic Lymphocytic Leukemia Medical,gilbert c faure,Negative
 VIDEO   Care,VJHemOnc,Negative
 doctors w Ben Kennedy,VJHemOnc,Negative
 Hammer,Jhawn Paul,Positive
 Hammer,Jah Kuu,Negative
 Amy Promise,Jhawn Paul,Positive
 donations,Jhawn Paul,Positive
 donations,Midmark News,Positive
 alleged healthcare costs,Jhawn Paul,Positive
 Ultmann Chicago Lymphoma Symposium,Amy C. Cavers,Negative
 reduced ibrutinib doses,Medivizor,Positive
 reduced ibrutinib doses,noel cole,Negative
 Dr   Dr Choi,Patient Power,Negative
 Dr Menashe answers,Patient Power,Negative
 TEVA Canada,Yo-Bio,Positive
 TRUXIMA,Yo-Bio,Positive
 TRUXIMA,DennisPartners,Negative
 Rheumatoid,Yo-Bio,Positive
 Novel CHK inhibitor MU,Lymphoma Papers,Negative
    night sweats sinus infections,Patient Power,Negative
 SafetyPK,TrialBulletin,Negative
 PD,TrialBulletin,Negative
 PD,satPRnews,Negative
 Hematologic Malignancies Status,TrialBulletin,Negative
 Condition Summary Chronic Lymphocytic Leukemia Non Hodgkin Lymphoma,TrialBulletin,Negative
 Talk,Michele Nadeem-Baker,Negative
   participants,Promise Study,Positive
 Chair Dr Richardson,donnashort,Negative
 breve muito,Conex√£o Lado Leste,Positive
 Rap,Conex√£o Lado Leste,Positive
 nois,Conex√£o Lado Leste,Positive
 themes,iwCLL,Positive
 discusses ibrutinib,Oncology Learning Network,Negative
 CLL Cello Health Plc,Ruth Gemmell,Negative
 CLL Cello Health Plc,Proactive,Positive
 Elevator Pitch,Ruth Gemmell,Negative
 Elevator Pitch,Proactive,Positive
   Canada,The PMI (Pharmaceutical Managers' Institute),Negative
 Teva Canada,DennisPartners,Negative
 RITUXAN,DennisPartners,Negative
   VS   ‚è± Ô∏è FINAL DEL PARTIDO,Club Libertad Limpe√±o,Negative
   VS   ‚è±,Club Libertad Limpe√±o,Positive
 Pe√±a Sale Karina Vega    ‚ö´,Club Libertad Limpe√±o,Negative
 Karina Vega    ‚ö´ ‚ö™,Club Libertad Limpe√±o,Negative
 Ingresa Fabiola Sandoval Sale Liza Larrea    ‚ö´ ‚ö™,Club Libertad Limpe√±o,Negative
 segundo tiempo,Club Libertad Limpe√±o,Negative
   VS   ‚è± Ô∏è,Club Libertad Limpe√±o,Positive
 B cell disease,MoJo,Negative
    Capital Markets Event,Oilman Jim,Positive
     Cello Health PLC Capital Markets Event,AIM Alerts!,Negative
 upcoming CLL Society Sponsored Support Group Meetings,CLL Society Inc.,Negative
 Snow,Mayo Clinic Cancer Center,Negative
 Snow,Mayo Clinic,Negative
 cars,Mayo Clinic Cancer Center,Negative
 cars,Mayo Clinic,Negative
 road,Mayo Clinic Cancer Center,Negative
 road,Mayo Clinic,Negative
 road,Oncology Board,Negative
 road,Oncology Tube,Negative
 road,VJHemOnc,Negative
 destination,Mayo Clinic Cancer Center,Negative
 destination,Mayo Clinic,Negative
 New Research Article,Clinical Cancer Research,Positive
 Episode,"chadi nabhan MD, MBA, FACP",Negative
   podcast series,"chadi nabhan MD, MBA, FACP",Negative
 VIDEO Enhancer landscape,VJHemOnc,Negative
 length,Michael Hallek,Negative
   cooperation partners,Michael Hallek,Negative
 Billy Michael Chelliah Jebaraj,Michael Hallek,Negative
 Ulm Germany,Michael Hallek,Negative
 Bear Dr Jan Berger,Michele Nadeem-Baker,Negative
 CABEZAZO,Club Libertad Limpe√±o,Negative
 Y GOOL,Club Libertad Limpe√±o,Negative
 Laurie Cristaldo    ‚ö´ ‚ö™,Club Libertad Limpe√±o,Negative
   VS   ‚è± Ô∏è ARRANC√ì EL SEGUNDO TIEMPO,Club Libertad Limpe√±o,Negative
   VS   ‚è± Ô∏è FINAL DEL PRIMER TIEMPO,Club Libertad Limpe√±o,Negative
 Equipo confirmado,Club Libertad Limpe√±o,Negative
 Diana Salinas Laurie Cristaldo Stephanie Lacoste Carmen Ben√≠tez Paola Genes Damia Cortaza,Club Libertad Limpe√±o,Negative
 Joana Galeano Griselda L√≥pez Claudia Romero Liza Larrea M√≥nica Vega,Club Libertad Limpe√±o,Negative
 Early Studies,Joe Librescu,Positive
 Early Studies,The ASCO Post,Negative
 Ibrutinib Plus,Joe Librescu,Positive
 Ibrutinib Plus,The ASCO Post,Negative
 CAR TCell Combination,Joe Librescu,Positive
 CAR TCell Combination,The ASCO Post,Negative
 support amp information,LymphomaAction,Negative
 TherapyRelated MDS,Lymphoma Papers,Negative
 De Novo MDS SingleInstitution Experience,Lymphoma Papers,Negative
 Lymphoma Coalition Europe,LymphomaAction,Negative
 Lymphoma Coalition Europe,Jonathan Pearce,Negative
 LCE     Community Advisory Board CAB,LymphomaAction,Negative
 Bear Hunt,Oak Tree Primary School,Positive
 Mrs Seddon,Oak Tree Primary School,Positive
 NonChemotherapy Combination Regimen,PressReleasePoint,Negative
 NonChemotherapy Combination Regimen,Medicalnewser.com,Negative
 NonChemotherapy Combination Regimen,FDA Daily,Negative
 NonChemotherapy Combination Regimen,HSMN,Negative
 NonChemotherapy Combination Regimen,HEDGE accordinglyüìà,Negative
 NonChemotherapy Combination Regimen,RazzleTazzle,Negative
 Targeted Treatment,Cancer Health,Negative
 Targeted Treatment,"Raul Cordoba, MD, PhD",Negative
 chemotherapyfree regimen,Cancer Health,Negative
   Best Pharmaceutical Product,The Galien Foundation,Positive
 winners,The Galien Foundation,Positive
 Smudge CellSmudge cells,KHALID HEMATOLOGIST,Positive
 remnants,KHALID HEMATOLOGIST,Positive
 remnants,Internist to be,Positive
 preprint,Andr√© Rendeiro,Positive
 Chronic Lymphocytic Leukemia CLL f,MD Anderson Leukemia,Negative
 Executive Medical Director,MD Anderson Leukemia,Negative
 Section Chief William G Wierda MD PhD tcooaYXpcSxC,MD Anderson Leukemia,Negative
 BCell Chronic     Pipeline Review H,ResearchByMarkets,Positive
 Frontline Combinations,Tom,Negative
 New Agents,Tom,Negative
 New Agents,Oncology Tube,Negative
 New Agents,LRA: New articles,Positive
 New Agents,NCCP,Positive
 New Agents,TumorImmunoPapers,Positive
 New Agents,GrantDev,Positive
 New Agents,FarmaOnco,Negative
 New Agents,The ASCO Post,Positive
 Evolve Chronic Lymphocytic Leukemia Landscape,Tom,Negative
 Dustin,Hyde Park Blast,Positive
 Dustin,Higher Ground at Lake Louise,Negative
 Blast,Hyde Park Blast,Positive
   Genentech Submits Supplemental New Drug Application,PressReleasePoint,Negative
 upcoming CLL SocietyNIH Patient,CLL Society Inc.,Negative
 Caregiver Educational Forum,CLL Society Inc.,Negative
 therapy Watch,Patient Power,Negative
 Meget vigtigt m√∏de,LyLe Foreningen,Negative
 NOTCH SFB MDM,flypapers,Positive
 MYD mutations,flypapers,Positive
 MYD mutations,Tracia.my.tupperware.com,Positive
 LCE LymphomaCLL Community Advisory Board meetings,Lymphoma Coalition,Negative
 expert group,Lymphoma Coalition,Negative
 expert group,Jonathan Pearce,Negative
 Community Advisory Board meeting,Jonathan Pearce,Negative
 Brussels,Jonathan Pearce,Positive
 Dr Esteban,Aaron Llanso,Positive
 Dr Koichi Takahashi,Aaron Llanso,Positive
 Review Series Dissecting,Blood Journal,Negative
 Javier PinillaIbarz,Patient Power,Negative
 Javier PinillaIbarz,VJHemOnc,Negative
 Ben Kennedy,Helen Parry üíô,Positive
 BCell Chronic Lymphocytic Leukemia Treatment Market,HAM,Negative
     Q edition,CLL Society Inc.,Negative
 CLL Society Tribune,CLL Society Inc.,Positive
 Town Meeting,Ron Grunsby,Positive
 Town Meeting,Patient Power,Negative
 Town Meeting,Debbie Woodbury,Positive
 mustread   paper,Patrick R. Benusiglio,Positive
 √±o,Revista El Repollero,Positive
 arranc√≥ de la mejor manera el torneo,Revista El Repollero,Positive
 f√∫tbol femenino,Revista El Repollero,Positive
 super√≥ por,Revista El Repollero,Positive
 Guaran√≠,Revista El Repollero,Positive
 su andar,Revista El Repollero,Positive
 Living,VJHemOnc,Negative
 survey amp,VJHemOnc,Negative
 route,Jonathan Pearce,Negative
 LCEs,Jonathan Pearce,Negative
 Read Carls story,LymphomaAction,Negative
 counselor,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
 Brutons Tyrosine Kinase,CancerWallonia,Negative
 New Open Access Feasibility,Research UMCG,Positive
 CLL immunotherapy,XpertDox,Positive
 Ahn et al evidence,Toby Eyre,Negative
 ibrutinib monotherapy dose reduction,Toby Eyre,Negative
 risk adapted treatment approach,Toby Eyre,Negative
 MRD depth,Toby Eyre,Negative
 FCRgtRmaint,Toby Eyre,Negative
 tumor staging systems,JAAD Journals,Negative
 Florida Blood Cancer Conference,"Jose Sandoval S, MD FACP",Positive
   morning,Mike E „Éû„Ç§„Ç±„É´üò∑üè≥Ô∏è‚Äçüåà #HR1 #ForThePeople,Positive
   morning,Natalie McGreevy,Positive
 Venetoclax Studies,Oncology Tube,Negative
   SWEET,Prof John,Negative
 Baseline PETCT SUV,"Jose Sandoval S, MD FACP",Positive
 BCR inhibitors Tissue,"Jose Sandoval S, MD FACP",Positive
 Trisomy   assessment,Flinders Uni Library,Positive
 WEEK,WheelieDealer,Negative
 Sells,WheelieDealer,Negative
 Fund,WheelieDealer,Negative
 Tip,WheelieDealer,Negative
 Newton Real Return Unit Trust,WheelieDealer,Negative
 DYOR,WheelieDealer,Negative
 Venetoclax amp Carfilzomib Dose Escalation Study,Oncology Tube,Negative
 PRICKLY,Prof John,Negative
 Tom Kipps amp colleagues,Prof John,Negative
 Hedgehog,Prof John,Negative
 CLL Society Patient,CLL Society Inc.,Negative
 Caregiver Forum,CLL Society Inc.,Negative
 Bethesda Details,CLL Society Inc.,Negative
   Expert Opinion,Lymphoma Hub,Negative
 Text World Theory,Jeremy Scott,Positive
 New Cancer Regiments,Oncology Tube,Negative
 Open Access UCL Research   Protoporphyrin IX,UCL Discovery,Positive
 CLL finnCap,Proactive,Negative
 p price target,Proactive,Negative
 Cello Health shares,Proactive,Negative
 wake,Proactive,Negative
 Duarte,CLL Society Inc.,Negative
 training,BSI America,Positive
 comfort,BSI America,Negative
 office,BSI America,Negative
 office,Jean-Marc JOACHIM,Positive
 office,Lidija Pecova,Positive
 office,Kiheikat,Positive
 office,Jimmy,Positive
 travel time,BSI America,Negative
 BSIs Connected Learning Live courses,BSI America,Positive
 TRANSCEND CLL study,VJHemOnc,Negative
 ltlt,VJHemOnc,Negative
 Crucial Role,Talbot Research Library & Media Services,Positive
 corporate   today,finnCap,Positive
 amp register,finnCap,Positive
 Chronic Lymphocytic Leukemia CLL Therapeutics Market Size Share Segment Analysis Growth Drivers,Research News24 üíé,Positive
 Venetoclax EU Venclyxto Venclexta,digitalLIFE4CE,Positive
 IGH translocations,Biosimilar Today iMagazine,Positive
 IGH translocations,Mayo Clinic Labs,Positive
 IGH translocations,ALI ALAHMARI.,Negative
 chronic lymphocytic   Clinicopathologic features,Biosimilar Today iMagazine,Positive
 tcobwUktWmGH,CLL Society Inc.,Negative
 Alliance researcher Jennifer Woyach,Alliance for Clinical Trials in Oncology,Positive
 shelf,Dr Tony Truong,Positive
 Dr Rezvani,Dr Tony Truong,Positive
 Dr Rezvani,Targeted Oncology,Negative
 CLL CR,MoJo,Negative
 CRi,MoJo,Negative
 untreated patientsRate,MoJo,Negative
 Insights Chronic Lymphocytic Small Lymphocytic,Serv. Farmacia CHUAC,Positive
     study,VJHemOnc,Negative
     study,NCI CTEP Clinical Research,Negative
 expansion infusion,Razan Mohty,Positive
 cintur√≥n especial,Mascarasraison2.0,Positive
 mu√±equerasEn charol rojo,Mascarasraison2.0,Positive
 medida pararaizorespartanowrestler,Mascarasraison2.0,Positive
 compares patient,Lymphomation.org,Negative
 lymsm,Lymphomation.org,Negative
   Watch Christian Gisselbrechts,Lymphoma Hub,Negative
 bone marrow function,Wellzio,Positive
 bone marrow function,Mayo Clinic,Negative
 Truly wonder drug,Hans Duvefelt,Positive
 Genomic Profiling,OncLive.com,Negative
 New Advances,Leukemia Research Foundation,Negative
 Therapies,Leukemia Research Foundation,Negative
 Therapies,VJHemOnc,Negative
 Therapies,CLL Ireland,Negative
 Therapies,Journal of Clinical Pathways,Negative
 Dr Paraneswaran Venugopal,Leukemia Research Foundation,Negative
 Blood Cancer Patients Conference Register,Leukemia Research Foundation,Negative
 commentary,CLL Society Inc.,Negative
 commentary,Expert Perspectives in Oncology,Positive
   issue,CLL Society Inc.,Negative
 Los,SEBASTIAN UGARTE,Positive
 bloodstream,"Raul Cordoba, MD, PhD",Negative
 bloodstream,Atrium Health Navicent,Positive
 L   TP disruptedRR    TP,Toby Eyre,Negative
 VIDEO Key,VJHemOnc,Negative
 ppl,Andrew Schorr,Positive
 ppl,Torrance Memorial,Positive
 RGL ≈†√°rka Posp√≠≈°ilov√°,CEITEC,Positive
   IMI HARMONY,CEITEC,Positive
 Czech CLL Study Group,CEITEC,Positive
 CLL experts Dr Susan O‚ÄôBrien,Patient Power,Negative
 Dr Javier Pinilla,Patient Power,Negative
 share,Patient Power,Negative
 share,APSHO,Negative
 International Chronic Lymphocytic Leukemia Treatment Market,Kiran Bhole,Positive
 Estimation,Kiran Bhole,Positive
 Brain invasion,Lymphoma Papers,Negative
 Catalan students,ASBlearns,Positive
 Catalan,ASBlearns,Positive
 Foundation,Lymphoma Research Foundation,Negative
 Ian W Flinn MD PhD,CURE Magazine,Negative
 Ian W Flinn MD PhD,Targeted Oncology,Negative
 Copiktra,CURE Magazine,Negative
 Copiktra,AllMedx Oncology,Positive
 Copiktra,Lampe & Company,Negative
 Copiktra,Patient Worthy,Negative
 Copiktra,MPR,Negative
 DATES,CLL Advocates Network,Negative
 st SEPTEMBER,CLL Advocates Network,Negative
 ENDINBURGH SCOTLAND,CLL Advocates Network,Negative
 INTERNATIONAL CONFERERENCE,CLL Advocates Network,Negative
 Read amp register,finnCap,Positive
   results,WheelieDealer,Positive
   results,CLL Ireland,Negative
   results,VJHemOnc,Negative
   results,CluePoints,Positive
 CLL Cello,Proactive,Negative
 Mar    stocks,Jon,Negative
 Ongoing Trials,Oncology Tube,Negative
 yearold AfricanAmerican female,MedPage Oncology,Negative
 fatigue easy bruising,MedPage Oncology,Negative
 fever,MedPage Oncology,Negative
 tcobjuzvkS,MedPage Oncology,Negative
 March bulletin,CLLSA,Negative
 CLLSA member,CLLSA,Negative
 amp Dr Neil Kay KRAS NRAS,"Amber Koehler, PA-C",Negative
 Novel CDtargeted TriKE,Blood Advances,Negative
 NK cell function,Blood Advances,Negative
 press release,CLL Society Inc.,Negative
 press release,Flash Alert,Positive
 press release,"Pharmacyclics, an AbbVie Company",Negative
 Chronic Lymphocytic Leukemia CLL Patient Treatment Options,CureHuntr,Negative
 Chronic Lymphocytic Leukemia CLL Patient Treatment Options,TrialBulletin,Negative
 enrollement,Milo≈° Miljkoviƒá,Positive
 Effectiveness Status Recruiting Condition Summary Chronic Lymphocytic Leukemia,TrialBulletin,Negative
 Frankfurt,Lymphoma Hub,Negative
 Duvelisib New Treatment,Oncology Tube,Negative
 Relapse Refractory CLL,Oncology Tube,Negative
 Blood Commentary Intricacies,Blood Journal,Negative
 Drs Luedke,DukePathDept,Positive
 Wang,DukePathDept,Positive
 Distinct Pathways,DukePathDept,Positive
 Plasmablastic Lymphoma,DukePathDept,Positive
 Chronic Lymphocytic Leukemia Poster   Tuesday pm Exhibition Hall,DukePathDept,Positive
 pains,Patient Power,Negative
 cramps,Patient Power,Negative
 Current Issue PD Expression,Surgical Pathology,Positive
 CART cell revolution,VJHemOnc,Negative
    presenta,The Pepex Family,Negative
    presenta,Indy Wrestling Chile,Negative
    presenta,Thu Pepex,Negative
 Inicio De Temporada,The Pepex Family,Negative
 Blood Work Hairy cell   coexistent,Blood Journal,Negative
    survivor,Anna Deveau,Negative
 Yesterday,Carlos Chiattone,Positive
 Interesting slide,dough,Negative
 Interesting slide,Patrick J. Hanley üß¨,Positive
 height,Patient Power,Negative
 career Tune,Patient Power,Negative
     wc,Jon,Negative
 MarRNS,Jon,Negative
 universe,Jon,Positive
 weekM,Jon,Negative
 Mar      Mar            Mar    Mar,Jon,Negative
 MarNone,Jon,Negative
 Precedence,CancerWallonia,Negative
 Precedence,CRO Contract Res.,Negative
 Whistler,Anthony Mato,Negative
 NEW LEUKEMIA TREATMENT SHOWS PROMISE,D'Amore Injury Law,Positive
 Brief report,Journal of Leukocyte Biology,Positive
 transcription factors,Journal of Leukocyte Biology,Positive
 Venetoclax obinutuzumab regimen,Chocolatiere Phys,Negative
 RNA Sequencing,Leucine Rich Bio,Positive
 RNA Sequencing,Kumar Sankaran,Positive
 RNA Sequencing,Inamul Hasan.Madar,Positive
 Dysregulated Expression,NK papers,Negative
 Dysregulated Expression,COPD News,Negative
 Tim NKp Receptors,NK papers,Negative
 Tim NKp Receptors,COPD News,Negative
 Hadadi L Hafezi M Amirzargar AA Sharifian RA Abediankenari S AsgarianOmran H,NK papers,Negative
 expression pattern,COPD News,Negative
 NKp,COPD News,Negative
 T cell immunoglobulin,COPD News,Negative
 Tim,COPD News,Negative
 candidates,COPD News,Negative
 candidates,"Navneet Majhail, MD, MS",Negative
 New,Medivizor,Negative
 New,WCMNYPJCTO,Negative
 New,WCM Lymphoma,Negative
 New,Top Class Actions,Positive
 New,Oncology Times,Negative
 New,VPO/PR Newswire,Negative
 New,MDedge Hematology & Oncology,Negative
 New,Te Ha,Negative
 New,Jennifer Huber,Negative
 New,MD Anderson Leukemia,Negative
 New,Rhia Steele@ravishingrhia.com,Positive
 New,Paula Pyzia,Negative
 New,Sandy D.,Negative
 New,Kimberley Thomas,Negative
 New,Grayson (he),Positive
 New,International Pain Foundation¬Æ,Negative
 New,Cassi Schmigotzki,Negative
 New,Debbie Woodbury,Negative
 New,Chronic Sex,Positive
 New,SeparatriX,Positive
 New,Pamela Helton,Positive
 New,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 New,CureClick,Positive
 New,CancerWallonia,Negative
 New,WEGO Health,Negative
 New,Patient Power,Negative
 Maball,Hetero Healthcare,Positive
 New Outcomes,Medivizor,Negative
 Dr Kamala Maddali,CLL Society Inc.,Negative
 good,Amy C. Cavers,Negative
 VenclextaGazyva combination,Oncology Board,Negative
   frontline Tune,Patient Power,Negative
 experts Dr Nicole Lamanna,Patient Power,Positive
 retreatment,Patient Power,Positive
 mutations influence treatment,Patient Power,Negative
 Ibrutinib Imbruvica,CellworksLife,Negative
 Ibrutinib Imbruvica,Dr Timos Papagatsias,Negative
 Ibrutinib Imbruvica,info@medicalresearch.com,Positive
 Ibrutinib Imbruvica,CLL Ireland,Positive
 Ibrutinib Imbruvica,Pharma Express,Positive
 Edinburgh Scotland Press registration,iwCLL,Negative
   GlyVal mutation,Suvir Singh,Positive
 Dr Anil Awesti,CLL Warwick Uni,Negative
   identifies,RNA-Seq Blog,Positive
   identifies,MDedge Hematology & Oncology,Negative
 Progressive,Daniel Auclair,Positive
 privilege,Nick,Positive
 Guidelines,Medivizor,Negative
 Guidelines,CLL-seq,Negative
 Guidelines,@immunoonco_Meed,Positive
 Guidelines,"Raul Cordoba, MD, PhD",Negative
 Guidelines,Chan Cheah,Negative
 Guidelines,Izaskun Zeberio,Negative
 Guidelines,Dr. Jos√© A. Queiz√°n,Negative
 Guidelines,Jos√© Ant. Marcos,Positive
 Guidelines,Garbi√±e Lizeaga,Negative
 CLLSA members,CLLSA,Positive
 CLLSA support group,CLLSA,Negative
 Cancer Discovery,"Raul Cordoba, MD, PhD",Negative
 Cancer Discovery,Triona N√≠ Chonghaile,Negative
 March issue Acquisition,Cancer Discovery,Negative
 M Seiffert,R Orentas,Positive
 T cell exhaustion,R Orentas,Positive
 improves outcome,R Orentas,Positive
 supports,R Orentas,Positive
 AP pathway findings,R Orentas,Positive
 Gene expression patterns,SeraCare,Positive
 Gene expression patterns,HemOnc Today,Negative
   friend,Andrew Schorr,Positive
 midweek,CLL Warwick Uni,Negative
 tix,Continuous Lifecycle London (online),Negative
 offer,Continuous Lifecycle London (online),Negative
 BCL mutation,Triona N√≠ Chonghaile,Negative
 CLL patients Acquisition,Triona N√≠ Chonghaile,Negative
 Cochair,Sylvester Comprehensive Cancer Center,Positive
 Dr Joseph Rosenblatt,Sylvester Comprehensive Cancer Center,Positive
 Consensus,donnashort,Negative
 cochair Dr Rosenblatt,donnashort,Negative
 Grand Rounds,Paradigm Med Comm,Negative
 Grand Rounds,Abdullah Al Mosabbir,Positive
 Grand Rounds,David A. Cohen,Positive
 March      PM,Paradigm Med Comm,Negative
 PM ESTRegister,Paradigm Med Comm,Negative
 anna,Anna shaikh,Positive
 head mind thereforce,Anna shaikh,Positive
 Chris Fegan,Toby Eyre,Negative
 Chris Fegan,VJHemOnc,Negative
 Chris Pepper,Toby Eyre,Negative
 Das   hat,Krebsgesellschaft,Positive
 neue   Chronische lymphatische √§mie herausgegeben,Krebsgesellschaft,Positive
 Sie basiert auf der entsprechenden,Krebsgesellschaft,Positive
 √§rztlichen SLeitlinie,Krebsgesellschaft,Positive
 erschienen ist und ist allgemeinverst√§ndlich formuliert,Krebsgesellschaft,Positive
 Chronic Lymphocytic Leukemia Opportunity Analysis Experiments Evolution Fermentation Research,EPR Network,Positive
 CELG Celgene,dough,Negative
 NCT,dough,Negative
 JCAR,dough,Negative
 JCAR,VJHemOnc,Negative
 JCAR,Fred Hutch,Negative
 JCAR,Lymphoma Hub,Negative
 JCAR,Bursatil Biotech,Positive
 subjects,dough,Negative
 Small Lymphocytic Lymphoma SLL,dough,Negative
 Pi Kinase Inhibitors Autoimmune Toxicity,Oncology Tube,Negative
 New Effectiveness,Medivizor,Negative
 Blood Commentary Targeting CD,Blood Journal,Negative
 backseat,Blood Journal,Negative
 backseat,CellworksLife,Negative
 backseat,MoJo,Negative
 backseat,"Raul Cordoba, MD, PhD",Negative
   patient advocate Lee Swanson interviews Dr Adrian Wiestner,Patient Empowerment Network,Positive
 Genentech Submits Supplemental New Drug Application,AA&MDSIF,Positive
 Genentech Submits Supplemental New Drug Application,The Pharmaceutical Marketing Group,Negative
 Genentech Submits Supplemental New Drug Application,Crwe World,Negative
 Genentech Submits Supplemental New Drug Application,Latest News from Business Wire,Negative
 Pi Kinase Inhibitors Idelalisib Duvelisib,Oncology Tube,Negative
 amp Copanlisib,Oncology Tube,Negative
 Plenary Paper Randomized trial,Blood Journal,Negative
 Timelimited treatment,CURE Magazine,Negative
 Excellent story,CLL Society Inc.,Negative
 Happy Monday,CLL Warwick Uni,Negative
 Statut de perc√©e,oncohebdo,Negative
 ¬Æ Abbvie,oncohebdo,Negative
 Gazyvaro,oncohebdo,Negative
 Gazyvaro,Scott Werntz,Negative
 Gazyvaro,Pharma Tech Focus,Positive
 ¬Æ Gazyva,oncohebdo,Negative
 L de,oncohebdo,Negative
 Multiple Milestones,1stOncology,Negative
 Multiple Milestones,Michael Oholendt,Positive
 Multiple Milestones,Algoslinger,Positive
 Multiple Milestones,RazzleTazzle,Negative
 Multiple Milestones,Pharma News,Negative
 Multiple Milestones,Flash Alert,Negative
 Multiple Milestones,Crwe World,Negative
 Multiple Milestones,Marketbit.pro,Negative
 PreviouslyUntreated   Patients,1stOncology,Negative
   Univ Medical,TrialSite News,Negative
 longterm considerations,HealthCentral,Positive
 fertility preservation,HealthCentral,Positive
 survivorship care plan,HealthCentral,Positive
 hundreds,CLL Ireland,Negative
 Shorter Treatment,CLL Society Inc.,Negative
 Older Adult Focus,Cancer Papers,Negative
 Acute Myeloid Leukemia Chronic Lymphocytic Leukemia,Cancer Papers,Negative
 Jacqueline Barrientos,PRC Clinical,Positive
 Jacqueline Barrientos,The Patient's Channel,Negative
 Jacqueline Barrientos,VJHemOnc,Negative
   Approval,CancerWallonia,Negative
   Approval,Matthias Piesche,Negative
   translocations,Biosimilar Today iMagazine,Negative
 Minor Role,CancerWallonia,Negative
 student ambassador,CLL Warwick Uni,Positive
 Emma,CLL Warwick Uni,Negative
 Persistent janus,Lymphoma Papers,Negative
 Leptomeningeal Carcinomatosis,Lymphoma Papers,Negative
 team members,CLLSA,Negative
 PsychoOncology Service,CLLSA,Negative
 IBR mono,Toby Eyre,Negative
 VEN Data,Toby Eyre,Negative
 Anti,MoJo,Negative
 Video Tutorial,CryptoLiveLeak,Negative
 CryptoLiveleak Token CLL,CryptoLiveLeak,Negative
 tutorial video,Kenneth M. Garofalo,Positive
 ICYMI application,Genentech,Negative
   medicines,Genentech,Positive
 approval consideration,Genentech,Negative
 BPTH,MAISA,Negative
 drug BP,MAISA,Negative
 Plain Language   training,Literacy Works,Positive
 Email,Literacy Works,Positive
 trainingorg,Literacy Works,Positive
 Phase   CLL Venetoclax Study,Michael Oholendt,Positive
 Phase   CLL Venetoclax Study,Algoslinger,Positive
 Phase   CLL Venetoclax Study,RazzleTazzle,Negative
 Phase   CLL Venetoclax Study,Pharma News,Negative
 Phase   CLL Venetoclax Study,Flash Alert,Negative
 Phase   CLL Venetoclax Study,Bio Stocks‚Ñ¢,Negative
 Phase   CLL Venetoclax Study,Crwe World,Negative
 Phase   CLL Venetoclax Study,Marketbit.pro,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia Patients,Michael Oholendt,Positive
 PreviouslyUntreated Chronic Lymphocytic Leukemia Patients,Algoslinger,Positive
 PreviouslyUntreated Chronic Lymphocytic Leukemia Patients,Pharma News,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia Patients,Flash Alert,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia Patients,Bio Stocks‚Ñ¢,Negative
 PreviouslyUntreated Chronic Lymphocytic Leukemia Patients,Marketbit.pro,Negative
   patient Tune,Patient Power,Negative
 expert Dr Javier PinillaIbarz,Patient Power,Negative
 Patients Treatment Response,EIN Presswire: Breast Cancer Newswire,Positive
 Chronic Lymphocytic Leukemia Cut,EIN Presswire: Breast Cancer Newswire,Positive
 Daygt,EIN Presswire: Breast Cancer Newswire,Positive
 Gazyva Combo,cafepharma,Negative
 Chronic Lymphocytic Leukemia Genentech,cafepharma,Negative
 member,cafepharma,Negative
 Spotlight GlyVal BCL mutation,Cancer Discovery,Negative
 Shanmugapriya Thangavadivel,Cancer Discovery,Negative
 ABBV Announces Multiple Milestones,Bio Stocks‚Ñ¢,Negative
 PreviouslyUn,Crwe World,Negative
 Previously Untreated Chroni,Crwe World,Negative
 FDA initiatives,Genentech,Negative
 March    Genentech Submits Supplemental New Drug Application,Flash Alert,Negative
 Sequential Multiple Assignment Randomized Trial SMART Design,maria jose agustin,Positive
 Abnormalities,SIBBM,Positive
 chemokine receptor recycling,SIBBM,Positive
 pShc deficiency,SIBBM,Positive
 EŒºTCL mouse model,SIBBM,Positive
 family amp friends,CLL Ireland,Negative
 family amp friends,Patient Power,Negative
 Family,Michele Nadeem-Baker,Negative
 Family,Nick,Negative
 today food,Steve Williamson,Positive
 Ibrutinib Bests Chemo Drug Combo,Shouting at people in my underpants,Negative
 Older CLL Patients Chronic Lymphocytic Leukemia,Shouting at people in my underpants,Negative
 Prime Education,CLL Society Inc.,Negative
 Leukemia amp Lymphoma Society LLS,CLL Society Inc.,Negative
 New interview,CLL Society Inc.,Negative
 Cathy Wu,DMM Journal,Positive
 growth patterns,DMM Journal,Positive
 subclones,DMM Journal,Positive
 vivo consequences,DMM Journal,Positive
 Dr Philip Thompson,Patient Power,Positive
 Dr Philip Thompson,MD Anderson Cancer Center,Negative
 differs,Patient Power,Negative
 differs,Cellero,Positive
 Elevated IgM,Europe PMC articles,Positive
 Elevated IgM,Vincent Rajkumar,Negative
 Combining,Medivizor,Negative
   Discusses,TrialSite News,Negative
   Discusses,CancerWallonia,Positive
 Therapy Changes,Oncology Tube,Negative
 P Deletion,Oncology Tube,Negative
 Pi Kinase Inhibitors,Oncology Tube,Negative
 Pipeline,Oncology Tube,Negative
 Pipeline,CancerWallonia,Negative
 CLL amp WM,Oncology Tube,Negative
 Infiltrates,SDEF Women's & Pediatrics Dermatology Seminar,Positive
 Excision,SDEF Women's & Pediatrics Dermatology Seminar,Positive
 Nonmelanoma Skin Cancer,SDEF Women's & Pediatrics Dermatology Seminar,Positive
 Treatment Prediction,Fabrice Leclerc,Positive
 Treatment Prediction,Frontiers Oncology,Negative
 New Transcriptional Patterns,Fabrice Leclerc,Negative
 RNAseq Time,Fabrice Leclerc,Negative
 New Tra,Fabrice Leclerc,Negative
 Phase   DUO ‚Ñ¢ data,Verastem Oncology,Negative
 Chronic Lymphocytic Leukemia CLL Therapeutics Market Share Growth Statistics,Research News24 üíé,Positive
 Application Production Revenue,Research News24 üíé,Positive
 Demand Forecast,Research News24 üíé,Positive
 Upfront Management amp Immunotherapy,Oncology Tube,Negative
 touching video,CLL Society Inc.,Negative
 Changing Paradigm,Oncology Tube,Negative
 CLL Society Educational Forums,CLL Society Inc.,Negative
   BAT Basic Attention Token,CryptoLiveLeak,Negative
 Token Holder Addresses,CryptoLiveLeak,Negative
 cheers,CLL Society Inc.,Negative
 CAR Tcell therapy research,Patient Power,Negative
 Por fin una media de   sub,Nestoret,Positive
 Lymphoma Chronic Lymphocytic Leukemia CLL Small Lymphocytic Lymphoma,Matthews & Associates,Negative
 couple Tune,Patient Power,Negative
 lymphocyt,Medivizor,Negative
    Users,CryptoLiveLeak,Negative
 Tokens,CryptoLiveLeak,Negative
 Utility Cycle,CryptoLiveLeak,Negative
   TokenAd payments,CryptoLiveLeak,Negative
 Cork event,CLL Ireland,Negative
   Approves Ibrutinib Combo Regimen,SpecialtyPTimes,Positive
 NCCN Updates Clinical Practice Guideline,CLL Society Inc.,Negative
 Expert panel,donnashort,Negative
 Expert panel,OncLive.com,Negative
 cochair,donnashort,Negative
 cochair,Winship Cancer Institute of Emory University,Negative
 ‚Å¶‚Å©   ‚Å¶‚Å© ‚Å¶‚Å©,donnashort,Negative
 Cork,CLL Ireland,Positive
 Cork,Cork ARC Cancer Support House,Positive
   Short Report p deletion,Society for Immunotherapy of Cancer,Positive
 rituximab elimination,Society for Immunotherapy of Cancer,Positive
 Symposium,Michael Hallek,Negative
 Symposium,Medscape Education,Negative
 Symposium,AbbVie Schweiz,Positive
 Symposium,National Comprehensive Cancer Network (NCCN),Negative
 Michael Kneba,Michael Hallek,Negative
 Kiel,Michael Hallek,Negative
 care professionals,WCM Lymphoma,Negative
 Research Seminar Series   Allergic,RIOH,Negative
 Cancer Repurposing AntiHistamines,RIOH,Negative
 Dr Spencer Gibson,RIOH,Positive
 PhD Section Head Cell Biology,RIOH,Negative
 AH Greenberg Lecture Theatre,RIOH,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL,Latest News from Business Wire,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL,Tech News by Qiosk,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL,Feel on,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL,Âø´ÈÅ©ÂÆ∂ÈõªLife,Positive
 Relapsed Chronic Lymphocytic Leukemia CLL,nsure io,Positive
 Relapsed Chronic Lymphocytic Leukemia CLL,„Åä„ÅÑ„Åó„ÅÑÁæéÈ£üÁîüÊ¥ª,Positive
 Relapsed Chronic Lymphocytic Leukemia CLL,BusinessWireServices,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL,Business Wire-Health,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL,The Pharmaceutical Marketing Group,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL,BusinessWireProducts,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL,dlvr news,Negative
 Pipeline Insight,Latest News from Business Wire,Negative
 Derni√®re,Gestion agricole,Positive
 du e tour pour,Gestion agricole,Positive
 Gestion Agricole,Gestion agricole,Positive
 tattend,Gestion agricole,Positive
   Patient event,Cork ARC Cancer Support House,Positive
 welcome registration,Cork ARC Cancer Support House,Positive
 March pm,Cork ARC Cancer Support House,Positive
 March pm,CLL Ireland,Negative
 Deadline,Life Science Jobs,Negative
 tcouWefxzs,Life Science Jobs,Negative
 Anterior chamber fibrinoid syndrome,Beta-BlockerPapers,Positive
 cataract extraction,Beta-BlockerPapers,Positive
 Registered UsersCome Attention CLL Token,CryptoLiveLeak,Negative
   disease,JanssenUS,Negative
   CLL PATIENTS,Michele Nadeem-Baker,Negative
 cancer team,CLL Society Inc.,Negative
 room collaboration,MedPage Oncology,Negative
 Rare Disease RT,CLL Ireland,Negative
 decisionmakers,CLL Ireland,Negative
 Chronic Lymphocytic Leukemia CLL Market,PressRelease.cc,Positive
 Chronic Lymphocytic Leukemia CLL Market,Diet Recipes & News,Positive
 Chronic Lymphocytic Leukemia CLL Market,Business Wire-Health,Negative
 New Guidelines,Medivizor,Negative
 FDA Approval Ibrutinib,Oncology Times,Negative
 Por,Minerva Vila,Positive
 Por,Maria Angulo,Positive
 una ayuda para,Minerva Vila,Positive
 el hijo del querido amigo,Minerva Vila,Positive
 New test,Medicalnewser.com,Negative
 New test,Muiro Yatakama,Positive
 New test,Randy S. Benedict,Positive
 New test,BioVox,Positive
 ‚Äò game changer,Medicalnewser.com,Negative
 ‚Äò game changer,Muiro Yatakama,Positive
 ‚Äò game changer,Randy S. Benedict,Positive
 Roll,Oncology Tube,Negative
 treatment Tune,Patient Power,Negative
 Cancer Research Wales,Cancer Research Wales,Positive
 PhD work,Cancer Research Wales,Positive
 CaRLoS L√≥PeZ oTiNs scandal,Alfredo Ballesteros Ainsa,Positive
 SCieNTiFiC career Campos,Alfredo Ballesteros Ainsa,Positive
 CLo,Alfredo Ballesteros Ainsa,Positive
 DNA damage,CLL-seq,Negative
 DNA damage,Lymphoma Papers,Negative
 alterations,CLL-seq,Negative
 alterations,Fabrice Leclerc,Negative
 alterations,CompBiolPapers,Negative
 und ChlorambucilKombinationen,Medical Tribune,Positive
 Invited,Syed Abutalib,Positive
 Reviews Free AccessAdvances,Syed Abutalib,Positive
 Drug‚ÄêBased Therapies,Syed Abutalib,Positive
 Future ProspectsJennifer L Crombie Jennifer R BrownFirst,Syed Abutalib,Positive
 Published,Syed Abutalib,Positive
   penetrates,"Raul Cordoba, MD, PhD",Negative
 Ride Sharing Uber,Michele Nadeem-Baker,Negative
 Lyft,Michele Nadeem-Baker,Negative
 CLL Society Sponsored Support Group Meetings,CLL Society Inc.,Negative
 Reception superstars,Lucy Middleton,Positive
 CMECNE EXPIRING SOON Genomics,Oncology Times,Negative
 MedEd,Oncology Times,Negative
 MBCART rr,TrialBulletin,Negative
 CD Bcell Malignancies BCM Status Recruiting Condition Summary Acute Lymphoblastic Leukemia Recurrent Bcell Lymphoma Recurrent Bcell Lymphoma Refractory Chronic Lymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia R,TrialBulletin,Negative
 APTO Aptose Biosciences Submits IND Application,Joe,Negative
 CGCG noncovalent,Joe,Negative
 exciting   data,Xenia Schmidt,Positive
 Energy metabolism,Transcriptomes,Positive
   Plus   TCell Therapy Boosts Response,CancerWallonia,Negative
 Novel   Regimens,CancerWallonia,Negative
 Promising Efficacy,CancerWallonia,Negative
    shares,Michele Nadeem-Baker,Negative
   doc,Michele Nadeem-Baker,Negative
 insightsHow,Michele Nadeem-Baker,Negative
 Excellent interview,CLL Society Inc.,Negative
 Nicole Lamanna MD Columbia,CLL Society Inc.,Negative
 postASH CLL Society Educational Forum,CLL Society Inc.,Negative
 Swedish Medical Center,CLL Society Inc.,Negative
 Seattle Register,CLL Society Inc.,Negative
 Joint PainSome CLL treatments,CLL Ireland,Negative
 toll,CLL Ireland,Positive
 toll,Patient Power,Negative
 patient joints,CLL Ireland,Positive
 patient joints,Patient Power,Negative
 aches,CLL Ireland,Positive
 aches,Patient Power,Negative
 Alemtuzumab CampathH,Nouf Al Marshdi,Positive
 humanized antiCD panlymphocytic,Nouf Al Marshdi,Positive
   mutations,Deyan Yosifov,Positive
   mutations,VJHemOnc,Negative
   mutations,"SLIMS by Genohm, A part of Agilent",Positive
   mutations,MedSource,Negative
   mutations,Medical Xpress,Negative
 binding,Deyan Yosifov,Positive
 NOTCH accumulation target gene activation,Deyan Yosifov,Positive
 CryptoLiveLeak,CryptoLiveLeak,Negative
 Followers,CryptoLiveLeak,Negative
 TwitterEveryone,CryptoLiveLeak,Negative
 CLL Society Patient PlaybookSmart patients,CLL Society Inc.,Negative
 CART Cell therapy,Andrew Schorr,Negative
 RR   Complete MRD responses,Dr.Alberto Mussetti,Negative
 Dr Jordan Gauthier,Fred Hutch,Positive
 solids tumors,Andrew Schorr,Negative
 Dr Phil Thompson,Andrew Schorr,Positive
 CLL specialist,Andrew Schorr,Negative
 honour,CLL Ireland,Negative
 honour,VJHemOnc,Negative
 Professor John Seymour Associate Director,CLL Ireland,Negative
 Clinical Research,CLL Ireland,Negative
 Australias,CLL Ireland,Negative
 amp researchers,CLL Ireland,Negative
   Masterclass,LymphomaAction,Negative
 Jul Book,LymphomaAction,Negative
 placed todaygt,LymphomaAction,Negative
 Final CAI     TFC,BR‚öΩÔ∏èCK,Positive
 Promising Efficacy Suman Kambhampati MD,COPD News,Negative
 CLL Recent advances,Cellero,Positive
 targeted   therapies,Cellero,Positive
 targeted   therapies,Patient Power,Negative
 PIK,Cellero,Positive
 PIK,"Michael Green, PhD",Negative
 PIK,CLL_Fightersüéó,Negative
 PIK,Immune Regulation News,Negative
 PIK,Cancer Papers,Negative
 PIK,TumorImmunoPapers,Negative
 PIK,Europe PMC articles,Positive
 PIK,Klaus Okkenhaug,Positive
 PIK,epigenetics_papers,Negative
 PIK,Just Cancer News,Negative
 tyrosine kinase inhibitors,Cellero,Positive
 tyrosine kinase inhibitors,Benito,Positive
 tyrosine kinase inhibitors,CIMSFHUVH,Positive
 tyrosine kinase inhibitors,Cancer Papers,Negative
 tyrosine kinase inhibitors,Clin Adv Hem Onc,Negative
 CLL Managing amp treating,Cellero,Positive
 Listen amp,Cellero,Positive
 Dr Philip Thomson,Cellero,Positive
 amp benefits,Cellero,Positive
 amp benefits,Patient Power,Negative
 early Tx,Cellero,Positive
 VIDEO resistance,VJHemOnc,Negative
 Barbara Andersen ASC Distinguished Professor,OSU Psych Advising,Positive
 research study,OSU Psych Advising,Positive
 research study,Heather Swift Morrison,Negative
 Excellent video,CLL Society Inc.,Negative
   Download chapters,Oncology Times,Positive
 NonHodgkin Lymphomas,Oncology Times,Positive
 NonHodgkin Lymphomas,Sharmaine Fuentes,Negative
 NonHodgkin Lymphomas,Kyle Schmanke,Positive
 Resource Center,Oncology Times,Positive
 Chronic Lymphocytic Leukemia Therapeutics Market Epidemiology Analysis Therapy Development Growth Demand,Pramod,Positive
 novel contributor,CIB Margarita Salas (CSIC),Positive
 Dr Angeles GarciaPardo,CIB Margarita Salas (CSIC),Positive
 CIB,CIB Margarita Salas (CSIC),Positive
 Fingers,Damian Bullimore,Positive
 Heilungschancen,Daniela Hennrich,Positive
 bei,Daniela Hennrich,Positive
 haben sich dank neuer,Daniela Hennrich,Positive
 Behandlungsm√∂glichkeiten,Daniela Hennrich,Positive
 Neue Forschungserfolge,pressetext.com,Positive
 Chronischer Lymphatischer Leuk√§mie,pressetext.com,Positive
 Neue,pressetext.com,Positive
 VIDEO   Tcells,VJHemOnc,Negative
 CLL Society Expert Access ‚Ñ¢ Program,CLL Society Inc.,Negative
 Peter Hillman,CLL Society Inc.,Negative
 Doubt,CLL Warwick Uni,Negative
 CLL bei,Onko Community,Negative
 √Ñlteren,Onko Community,Negative
 Patienten mit Ibrutinib nach,Onko Community,Negative
 Suman Kambhampati MD,CLL Society Inc.,Negative
 Juan Sebastian,Minerva Vila,Positive
 MRD w John Seymour,VJHemOnc,Negative
 resource page resource library,CLL Society Inc.,Negative
 amp CLARITY w Peter Hillmen,VJHemOnc,Negative
 CLL Society Patient PlaybookIf,CLL Society Inc.,Negative
 CLL Society comments,CLL Society Inc.,Negative
 evolving science,CLL Society Inc.,Negative
 CMS,CLL Society Inc.,Negative
 CART therapy Progress,CLL Society Inc.,Negative
   Combo,CancerWallonia,Positive
 Lower dose,"Thilo J Zander, MD",Positive
   shares news,Michele Nadeem-Baker,Negative
 New Transcriptional Patterns Adri√°n Mosquera Orgueira Beatriz Antelo,Frontiers Oncology,Negative
 Natalia Alonso Vence √Ångeles,Frontiers Oncology,Negative
 Benda√±a L√≥pez Jos√© √Ångel D√≠az Arias,Frontiers Oncology,Negative
 Nicol√°s D√≠az Varela Marta Sonia,Frontiers Oncology,Negative
 Genomics,Oncology Times,Positive
 Genomics,Genomics new,Positive
 Genomics,Genomics Plaza,Positive
 Genomics,Genomics watch,Positive
 Genomics,NursingCenter,Positive
 Chronic Lymphocytic Leukemia Current Research,Oncology Times,Negative
 Chronic Lymphocytic Leukemia Current Research,Genomics new,Positive
 Chronic Lymphocytic Leukemia Current Research,Genomics Plaza,Positive
 Chronic Lymphocytic Leukemia Current Research,Genomics watch,Positive
 amp Future Implications,Oncology Times,Negative
 amp Future Implications,Genomics new,Positive
 amp Future Implications,Genomics Plaza,Positive
 amp Future Implications,Genomics watch,Positive
 shirt amp,Michelle Toman,Positive
 immunosenescence,ABG_INTL,Positive
   Psoas Abscess,JCM MDPI,Positive
 Mycobacterium avium,JCM MDPI,Positive
 Mycobacterium avium,Lymphoma Papers,Negative
 Mycobacterium avium,Mycobacterium Papers,Positive
 ÊÄ•ÊÄßÈ™®È´ÑÊÄßÁôΩË°ÄÁóÖ,‰ºäÂã¢È∫ªÁî∑,Positive
 myelogenousmyeloid leukemia,‰ºäÂã¢È∫ªÁî∑,Positive
 AMLÊÖ¢ÊÄßÈ™®È´ÑÊÄßÁôΩË°ÄÁóÖ,‰ºäÂã¢È∫ªÁî∑,Positive
 RT PhysRelations RT CAMDAnderson William Wierda MD PhD,Robert Z. Orlowski,Negative
 Latest Advsnces,Robert Z. Orlowski,Negative
 Latest Advsnces,Caprice Alexander-Perez,Positive
 PhysRelations,Robert Z. Orlowski,Positive
 RT PhysRelations Dr William Wierda,Robert Z. Orlowski,Negative
 RT PhysRelations,Robert Z. Orlowski,Negative
 VIDEO CART,VJHemOnc,Negative
   demonstrating patients,Michele Nadeem-Baker,Negative
 HUGE NEWS TV Ada,Michele Nadeem-Baker,Negative
 Drug price transparency,Michele Nadeem-Baker,Negative
 CLL   Whitaker,"Mike Thompson, MD, PhD, FASCO",Positive
 Typical Treatment,Treatment Scores,Positive
 Typical Treatment,Yasser Amer,Positive
 partner colleges,CLL Warwick Uni,Negative
 Technology,CLL Warwick Uni,Negative
 Learning Conference,CLL Warwick Uni,Negative
 Biology,"Raul Cordoba, MD, PhD",Negative
   Success Story,"Raul Cordoba, MD, PhD",Negative
 break,European Hematology Association,Negative
 break,Genentech,Negative
 break,lex,Positive
 Retrospective results,CellworksLife,Negative
 romance,CLL Warwick Uni,Negative
 Central Nervous System Lymphoma,Lymphoma Papers,Negative
 ibrutinib obinutuzumab combination,Medivizor,Negative
 Update zu Chronisch lymphatischer Leuk√§mie CLL vom amerikanischen,Leuk√§miehilfe Rhein Main e.V.,Positive
 H√§matologen Kongress,Leuk√§miehilfe Rhein Main e.V.,Positive
 VideoInterviews mit,Leuk√§miehilfe Rhein Main e.V.,Positive
 Prof Dr Georg Hess Uniklinik Mainz,Leuk√§miehilfe Rhein Main e.V.,Positive
 und Prof Dr,Leuk√§miehilfe Rhein Main e.V.,Positive
 Stephan Stilgenbauer Uniklinik,Leuk√§miehilfe Rhein Main e.V.,Positive
 Ulm   tcodznrnqT,Leuk√§miehilfe Rhein Main e.V.,Positive
 esto,Sim√≥n Veliz,Positive
 CIENCIASMEDICASNEWS Chronic Lymphocytic Leukemia Treatment PDQ ¬Æ ‚ÄîHeal,Victor Norberto Cerasale Morteo,Positive
 MISE √Ä JOUR TEMP√äTELe C√©gep,C√©gep de L√©vis,Positive
 est ferm√©,C√©gep de L√©vis,Positive
 la journ√©e,C√©gep de L√©vis,Positive
 et la soir√©e,C√©gep de L√©vis,Positive
 Toutes les activit√©s sont,C√©gep de L√©vis,Positive
 Akademiforums tema ikv√§ll √§r    viktigt tema med representanter fr√•n,Elisabet Backlund-k,Positive
 HOS Folkh√§lsan UBS polisen l√§rare professorer,Elisabet Backlund-k,Positive
 och elevrepresentanter,Elisabet Backlund-k,Positive
   √§r      Viktigt √§mne sowieso,Bj√∂rn Nyberg,Positive
    et al,Nature Protocols,Negative
 protocol,Nature Protocols,Negative
 AssaY,Nature Protocols,Negative
 RNA,Nature Protocols,Positive
 RNA,Elaine Schattner,Negative
 protein,Nature Protocols,Negative
 protein,California Partnership for Access to Treatment,Positive
 protein,Genetics at BMC,Positive
 protein,MedflixS,Positive
 protein,Linsen T. Samuel,Positive
 DadHes,adam,Positive
 blood transfusions,adam,Positive
 ASH Annual Meeting amp Exposition,Targeted Oncology,Negative
 IndiaRead,BloodCancerCure,Positive
 Le C√©gep,C√©gep de L√©vis,Positive
 est ferm√© Consultez le site,C√©gep de L√©vis,Positive
 Internet,C√©gep de L√©vis,Positive
 Internet,Oncology Tube,Negative
 Internet,Donny Gilbreath,Positive
 √† partir de h pour les activit√©s,C√©gep de L√©vis,Positive
 Bonne,C√©gep de L√©vis,Positive
 EMF Paper,Graviola Finland,Positive
 Hardell Group,Graviola Finland,Positive
 power lines,Graviola Finland,Positive
 th European LeukemiaNet Symposium,HARMONY Alliance,Negative
 Mannheim,HARMONY Alliance,Negative
 Hola gente Disculpen por molestar pero si pueden ayudar o difundirlo ayudar√≠an mucho,Ori üíï ‚ü≠‚ü¨‚Å∑,Positive
 Ay√∫denos,Maria Angulo,Positive
 drug resistance,Walaa,Positive
   practice,"Amber Koehler, PA-C",Negative
 VIDEO Current hurdles,VJHemOnc,Negative
 w Lindsey Roeker,VJHemOnc,Negative
 Obinutuzumab GAZYVA,ChemDiv,Positive
 Obinutuzumab GAZYVA,PRICENTRIC,Positive
 Obinutuzumab GAZYVA,HEDGE accordinglyüìà,Negative
 Obinutuzumab GAZYVA,RazzleTazzle,Negative
 Obinutuzumab GAZYVA,Marketbit.pro,Negative
 ChemotherapyFree AntiCD Combination Regimen,ChemDiv,Positive
 ChemotherapyFree AntiCD Combination Regimen,HEDGE accordinglyüìà,Negative
 ChemotherapyFree AntiCD Combination Regimen,RazzleTazzle,Negative
 Psoas Abscess,Lymphoma Papers,Negative
 Psoas Abscess,Mycobacterium Papers,Positive
 Chronic Lymphocytic LeukemiaÔºçCase Report,Lymphoma Papers,Negative
 Chronic Lymphocytic LeukemiaÔºçCase Report,Mycobacterium Papers,Positive
   Con Todo el Pawaaaa,AGRESSOR,Positive
 VIDEO   combinations,VJHemOnc,Negative
 Venetoclaxrituximab combination,Medivizor,Negative
 Venetoclaxrituximab combination,HemOnc Today,Negative
 John Terry,The Lion's Shed üè¥Û†ÅßÛ†Å¢Û†Å•Û†ÅÆÛ†ÅßÛ†Åø,Positive
 John Terry,Dan Collins,Positive
 John Terry,Chelsea‚ú®,Positive
 John Terry,Chelsea Rooter,Positive
 John Terry,MOHAMED SHOUKRY,Positive
 John Terry,Nikki Davidson,Positive
 John Terry,Matt Boulton,Positive
 John Terry,Corlett,Positive
 LSelectin Expression,Henning,Negative
 LSelectin Expression,Cancer Papers,Negative
 Phosphatase Activity,Henning,Negative
 Phosphatase Activity,Cancer Papers,Negative
 scene,"Amber Koehler, PA-C",Negative
 support education group,UCI Health,Negative
 MSKs,Memorial Sloan Kettering Cancer Center,Negative
 CLL patient advocate Lee Swanson interviews Dr Anthony Mato,Patient Empowerment Network,Negative
 Bcell chronic lymphocytic   CLL,leukemia,Negative
 nonchemothetapy combo,CLL Ireland,Negative
 Happy Friday,CLL Warwick Uni,Negative
 Omics profiling,Anubhav Srivastava,Positive
 fat uptake,Anubhav Srivastava,Positive
 Lauren Thurgood,Anubhav Srivastava,Positive
 investigates,Anubhav Srivastava,Positive
 nutrient uptake,Anubhav Srivastava,Positive
 beaut,Michelle Collett,Positive
 Award,Andre Williams,Positive
 VIDEO   updates,VJHemOnc,Negative
 choicew,VJHemOnc,Negative
 John Gribben,VJHemOnc,Positive
 John Gribben,The Patient's Channel,Positive
 John Gribben,Lymphoma Hub,Positive
 John Gribben,Clin Adv Hem Onc,Negative
 Dr Moreno,Danielle Ternyila,Positive
 combination ibrutinib,Danielle Ternyila,Positive
     Cello Health PLC Notice,AIM Alerts!,Negative
 Year Results,AIM Alerts!,Negative
 MD Andersons Paolo Strati MD,Oncology Times,Negative
 Amber,CLL_Fightersüéó,Negative
    guidelines,CLL_Fightersüéó,Negative
    guidelines,CLLSA,Positive
   cell,Prof John,Negative
   cell,Francesco Turturro,Negative
 time ‚Å¶‚Å©,Prof John,Negative
 SummaryTwo naturallyoccurring compoundscurcumin,Jen Tiernay,Positive
 New Combination Treatment Gains Approval,Patient Worthy,Negative
 ImbruvicaGazyva,Lampe & Company,Negative
 ImbruvicaGazyva,cafepharma,Negative
 Chronic Lymphocytic   Small Lymphocytic   CLLSLL,Lampe & Company,Negative
 Phase   DoseEscalation,TrialBulletin,Negative
 CohortExpansion,TrialBulletin,Negative
 Cell Lymphoma,TrialBulletin,Negative
 remission treatment Watch patient advocate Carol Preston,Patient Power,Negative
 Significant Highlights,Nick,Negative
 morning sessions,Nick,Negative
 Anniversary Lecture,CIC bioGUNE,Positive
 Dr El√≠as Campo,CIC bioGUNE,Positive
 trends,AplusA World,Negative
 trends,RTI Health Solutions,Positive
 trends,Anna Deveau,Negative
 NCCN Guidelines Insights Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Version,Irene Mangues,Positive
 NCCN Guidelines Insights Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Version,Lymphoma Papers,Negative
 Treatment„Ç§„É†„Éñ„É´„Éì„Ç´,Shohta Kadomura Hospital Pharmacist,Negative
 Blood Commentary Highs,Blood Journal,Negative
 lows,Blood Journal,Negative
 lows,"Raul Cordoba, MD, PhD",Negative
 patient engagement opportunities,@MyelomaTeacher - Cindy Chmielewski,Negative
   patient advocate Lee Swanson interviews Dr Kerry Rogers,Patient Empowerment Network,Negative
 Ohio State University Medical Center,Patient Empowerment Network,Negative
 AI   artificiell,Utbildning och IT p√• Kimito√∂n,Positive
 med Teemu Roos Stort seminarium f√∂r ledare inom finlandssvensk,Utbildning och IT p√• Kimito√∂n,Positive
 Hanasaari Cultural Centre,Utbildning och IT p√• Kimito√∂n,Positive
 long noncoding RNAs,CLL-seq,Negative
 Suppression,Lymphoma Papers,Negative
 minichromosome maintenance,Lymphoma Papers,Negative
 hey guys,guillotineka,Positive
 dogs cancer bills,guillotineka,Positive
 Combinations,Medivizor,Negative
 Combinations,Targeted Oncology,Negative
 Combinations,CLL Ireland,Positive
 benzene exposure,M A L A N G üî•‚ô†Ô∏è,Positive
 labeling,Pharmacy Practice News,Negative
 Janssens Imbruvica,Pharmacy Practice News,Negative
 Janssens Imbruvica,Cancer Matters,Positive
 FDA Approves Ibrutinib   Obinutuzumab,Orbis Biosciences,Negative
 st Nonchemotherapy Combination Regimen,Orbis Biosciences,Negative
 Abstracts,BioAscend,Positive
 Abstracts,satPRnews,Negative
 Abstracts,VPO/PR Newswire,Negative
 Closing Date,BioAscend,Positive
 UK NEQAS LI,UKNEQASLI,Positive
 BCell Chronic Lymphocytic Leukemia Treatment Revenue,Rohit Kadu,Positive
 Market Share,Rohit Kadu,Positive
 Manufacturer,Rohit Kadu,Positive
 II Classy,Prof John,Negative
 MHC class II,Prof John,Negative
 selfrenewal,Prof John,Negative
 differentiation,Prof John,Negative
 Chemotherapyfree triplet combination,Biotech2050,Negative
 Bcell nonHodgkin,Biotech2050,Negative
 Avui,Heribert Play√†-Albinyana,Positive
 un dia molt,Heribert Play√†-Albinyana,Positive
 Melbourne AUS,Andrew Schorr,Negative
 dexamethasone,Medivizor,Negative
 dexamethasone,UCL Discovery,Negative
 dexamethasone,TF binding papers üìö,Positive
 Educational Case Chronic Lymphocytic Leukemia,gilbert c faure,Negative
 Educational Case Chronic Lymphocytic Leukemia,Krishan Maggon,Negative
 Educational Case Chronic Lymphocytic Leukemia,Cristyan Quintero,Positive
 Murine Model,Christopher DeBoever,Positive
 B CellRestricted Expression,Christopher DeBoever,Positive
 Sfb Mutation,Christopher DeBoever,Positive
 Atm Deletion,Christopher DeBoever,Positive
 amp   Tune,Medscape Education,Negative
 amp   Tune,Patient Power,Negative
 Headlines,Broad Institute,Positive
 Trip Blwyddyn,Melin Gruffydd,Negative
 VenetoclaxRituximab,Mahmoud Aljurf,Positive
 VenetoclaxRituximab,Philip McCarthy,Negative
 VenetoclaxRituximab,CancerEpiPapers,Positive
 VenetoclaxRituximab,Progetto Odin,Positive
 VenetoclaxRituximab,Bernie Marini,Positive
 VenetoclaxRituximab,"Naveen Pemmaraju, MD",Negative
 VenetoclaxRituximab,Tom,Negative
 VenetoclaxRituximab,Internet Medical,Positive
 VenetoclaxRituximab,MHC,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease,Mahmoud Aljurf,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease,Philip McCarthy,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease,CancerEpiPapers,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease,Progetto Odin,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease,Bernie Marini,Positive
 MURANO Phase III Study Journal,Mahmoud Aljurf,Positive
 MURANO Phase III Study Journal,Philip McCarthy,Negative
 MURANO Phase III Study Journal,Bernie Marini,Positive
 Dr Marc Hoffmann,sganguly,Positive
 pearls,sganguly,Positive
 Cancer News Chronic Lymphocytic Leukemia,Malachy Chidera,Positive
 Responders Report,Malachy Chidera,Positive
 Head Neck Cancers,Malachy Chidera,Positive
 Robert Preidt,Malachy Chidera,Positive
 Buckeyes,The James,Negative
 world Heres,The James,Negative
   CLL Patients,Michele Nadeem-Baker,Negative
 Upcoming Teleconference   Update,Ron Grunsby,Positive
 Community Story,Blood-Cancer.com,Positive
 marrow amp,Atrium Health Navicent,Positive
 blood leukemia cells,Atrium Health Navicent,Positive
 meetings,ACCC,Positive
 meetings,Jeff Sharman,Positive
 meetings,CLLSA,Positive
 meetings,TESL Canada,Positive
 expert guidance,ACCC,Positive
 Dr Nasta,Penn Medicine MD,Positive
 Novel Bcl mutation,CLL Ireland,Negative
 progressive   patientsThe study,CLL Ireland,Negative
   prolongs,InfocusRx Today,Positive
   chat,MDedge Hematology & Oncology,Positive
 live twitter chat,Rebecca Williams,Positive
 Dr Andrew Brunner,The Oncologist,Positive
 Massachusetts General Hospital,The Oncologist,Positive
 takeaways,The Oncologist,Positive
 Current   Catherine Wu,Leukemia & Lymphoma Society Research,Positive
 Lili Wang,Leukemia & Lymphoma Society Research,Positive
 ATM deletion,Leukemia & Lymphoma Society Research,Positive
   mouse model,Leukemia & Lymphoma Society Research,Positive
 Current,Leukemia & Lymphoma Society Research,Positive
 Highs,"Raul Cordoba, MD, PhD",Negative
 Evolving Treatment,Oncology Times,Negative
 novel translation inhibitors,Dr. Rajan Chaudhari,Positive
 prosurvival proteins,Dr. Rajan Chaudhari,Positive
 Immunol,IUOPA,Negative
 IgLike,IUOPA,Negative
 IgLike,Cancer Papers,Negative
 IgLike,NK papers,Negative
 ILT Blockade,IUOPA,Negative
 Genes,Nature Reviews Disease Primers,Positive
 Genes,McHeyzer-Williams,Positive
 Ohio State,Local 12/WKRC-TV,Positive
 Ohio State,OncoTherapy Network,Negative
 prescription,Medicine For World,Negative
 Chronic Lymphocytic   treatment Mfg,Medicine For World,Negative
 Emails,Medicine For World,Positive
 Nurserys   book,Oak Tree Primary School,Positive
 upcoming ERIC Consortium Conference,Michele Nadeem-Baker,Negative
 CLL patients caregivers family,Michele Nadeem-Baker,Negative
   shares,Michele Nadeem-Baker,Positive
 chemotherapyfree antiCD combination regimen,LLS Greater L.A.,Positive
 chemotherapyfree antiCD combination regimen,ArkansasLLS,Positive
 chemotherapyfree antiCD combination regimen,Coast To Coast Cures,Positive
 chemotherapyfree antiCD combination regimen,The Leukemia & Lymphoma Society,Negative
 chemotherapyfree antiCD combination regimen,"Pharmacyclics, an AbbVie Company",Negative
 Online Exclusive,Oncology Times,Negative
 HemOnc,Oncology Times,Negative
 HemOnc,Dr Timos Papagatsias,Negative
 FDA Approves IbrutinibObinutuzumab,Zheng Zhao,Positive
 HUGEBREAKING NEWS,ArkansasLLS,Positive
 expert Dr Philip Thompson,Patient Power,Negative
 time symptoms,Patient Power,Negative
 initiating therapy,Patient Power,Negative
 initiating therapy,OncLive.com,Negative
 Anna Schuh,Blood Cancer UK Research,Negative
 Anna Schuh,OCTO Oxford,Positive
 Anna Schuh,VJHemOnc,Positive
 Anna Schuh,Manoj Raghavan,Positive
 hospitals,Blood Cancer UK Research,Negative
 amp ritux,Blood Cancer UK Research,Negative
 untreated   Lots,Blood Cancer UK Research,Negative
 marrow transplant help,BloodCancerCure,Negative
 Venetoclax Mantle Cell Lymphoma,Junaid Hussain,Positive
 BIRC Expression,CellworksLife,Negative
 CLL Progression Defines Treatment Sensitivity,CellworksLife,Negative
 Enhanced NFŒ∫B Nuclear Translocation,CellworksLife,Negative
 drug combination,KU Cancer Center,Positive
 drug combination,VJHemOnc,Negative
 detail,CLL Advocates Network,Negative
 detail,Targeted Oncology,Negative
 tcojglnspvwmZ,CLL Advocates Network,Negative
 obinutuzumab   Gazyva,MAISA,Negative
 New   Short Report p deletion,Society for Immunotherapy of Cancer,Negative
 Johnson amp,Bionest Partners,Negative
 Johnson amp,Advera Health,Negative
 Johnson AbbVie,Bionest Partners,Negative
 Johnson AbbVie,Advera Health,Negative
 Imbruvicas   lead,Bionest Partners,Negative
 Imbruvicas   lead,Advera Health,Negative
   chronic lymphocytic   CLL,Janssen Global,Negative
   treatment questions,MDedge Hematology & Oncology,Negative
 Dr Brian Hill,MDedge Hematology & Oncology,Positive
    Program Director,The Leukemia & Lymphoma Society,Negative
   team Tune,The Leukemia & Lymphoma Society,Negative
 FDA Approves NonChemo Combination Therapy,Alvin,Positive
 FDA Approves NonChemo Combination Therapy,Jeff Karp (Pronouns: he/him/his),Positive
 Form,Alvin,Positive
 Form,Jeff Karp (Pronouns: he/him/his),Positive
 Form,Caldicott Computing,Positive
 Form,Dana-Farber,Negative
 ACTION,Prof John,Negative
 Optimal Proliferation Ex Vivo sIgM   CD,Prof John,Negative
 Similar Path,CLL Ireland,Negative
 experts Dr Byrd,CLL Ireland,Negative
 beste KrebsKombinationstherapie finden Wissenschaftler,|transkript,Positive
 Wiener   haben eine Methode entwickelt,|transkript,Positive
 Kombinationstherapie bei Chronisch Lymphatischer Leuk√§mie,|transkript,Positive
 findet,|transkript,Positive
 Nonchemotherapy combination,MPR,Negative
 CLL Fatigue nausea constipation,RJW,Negative
 war,RJW,Negative
 war,CLL_Fightersüéó,Negative
   Dr Imran Khan,JanssenUS,Negative
 onesizefitsall approach,JanssenUS,Negative
 ibrutinib IMBRUVICA,Lymphoma Research Foundation,Negative
 ibrutinib IMBRUVICA,MedChem & ONCo,Negative
 obinutuzumab GAZYVA,Lymphoma Research Foundation,Negative
 Imbruvica cancer medication,MAISA,Negative
 ¬Æ AbbVie,The Leukemia & Lymphoma Society - Policy Advocacy,Positive
 ¬Æ AbbVie,oncohebdo,Negative
 nonchemotherapy combination regimen,Jaime Rosenberg,Positive
 patientsRead,Jaime Rosenberg,Positive
 ibrutinibs efficacy,Jaime Rosenberg,Positive
 Greenlight,cafepharma,Negative
 th Time Imbruvica,cafepharma,Negative
 Roches Gazyva,cafepharma,Negative
 Une dipl√¥m√©e,C√©gep de L√©vis,Positive
 du   gagne le concours,C√©gep de L√©vis,Positive
 nonchemo,Plexus Ventures,Negative
 ¬Æ   ChemotherapyFree AntiCD Combination Regimen,PRICENTRIC,Positive
     College Station TX,AboveTustin ADSB bot,Positive
 breakthrough year,Janssen Global,Negative
 breakthrough year,"Pharmacyclics, an AbbVie Company",Positive
 AbbVies Imbruvica ibrutinib,JCM Compounding Knowledge,Positive
 IDELALISIB IDEALLY,Prof John,Negative
 BLOCK,Prof John,Negative
 FUNCTION,Prof John,Negative
 frontline tx,"Amber Koehler, PA-C",Negative
 BREAKING Combination ibrutinib,Targeted Oncology,Negative
 combination regimen,JanssenUS,Negative
 treatmentna√Øve chronic lymphocytic   CLL,JanssenUS,Negative
 Medical Distributors FDA,HSMN,Negative
 Chile Lucha Libre,Claudio L√©rtora,Positive
 Santiago Chile,Claudio L√©rtora,Positive
 st line CLL,Andrew Merron,Positive
 chemofree regimen,Andrew Merron,Positive
 st line,Andrew Merron,Positive
 st line,CLL Ireland,Negative
   market,Andrew Merron,Positive
 Announces FDA Approval,HEDGE accordinglyüìà,Negative
 Announces FDA Approval,RazzleTazzle,Positive
 Announces FDA Approval,Rob Wilson,Positive
 Announces FDA Approval,AmericanPharmacyNews,Negative
 Announces FDA Approval,aeses.com,Negative
 Announces FDA Approval,Financial Buzz,Negative
 Announces FDA Approval,FDA Daily,Negative
 Previously,HEDGE accordinglyüìà,Negative
 Previously,RazzleTazzle,Negative
 ibrutinib Plus Obinutuzumab,HEDGE accordinglyüìà,Negative
 ibrutinib Plus Obinutuzumab,RazzleTazzle,Negative
 MURANO phase,Lymphoma Hub,Negative
 III trial Venetoclax,Lymphoma Hub,Negative
 HORSHAM Pa Jan,RazzleTazzle,Negative
 st NonChemo Combo Regimen,Odi Bruckman,Negative
 activity levels,CLLSA,Negative
 Join team,CLLSA,Negative
 Asics,CLLSA,Negative
 k run,CLLSA,Negative
 st July,CLLSA,Negative
 Later Line,CellworksLife,Negative
 Later Line,CancerWallonia,Negative
 ambiente veraniego,Proyecto Lucha Libre,Positive
 de SummerFest,Proyecto Lucha Libre,Positive
 Ô∏è‚Äç,Proyecto Lucha Libre,Positive
 ‚ôÇ Ô∏è ü§º,Proyecto Lucha Libre,Positive
 Centro,Proyecto Lucha Libre,Positive
 Centro,Allan Alves de Jesus,Positive
 IbrutinibOpdivo Combination,CLL Ireland,Negative
 TransformationThe proportion,CLL Ireland,Negative
 New Evaluating ibrutinib obinutuzumab combination,Medivizor,Negative
 VIDEO Ibrutinibrituximab,Mazen M,Negative
   effective,Jennifer Kwan MD PhD,Positive
 Ibrutinib Superior,SpecialtyPTimes,Positive
 Older   Patients,SpecialtyPTimes,Positive
      options,AplusA World,Negative
 upcoming Tweet Chat,Mary Ellen Schneider,Negative
 Alliance North American Intergroup Study comparing ibrutinib,Mary Ellen Schneider,Negative
 Valeria Spina,Molecular Oncology,Positive
 influence,Molecular Oncology,Positive
 influence,Expert Perspectives in Oncology,Negative
 influence,Cancer Papers,Negative
 influence,VJHemOnc,Negative
 PODCAST,CURE Magazine,Negative
 PODCAST,VJHemOnc,Negative
 PODCAST,MD Anderson Cancer Center,Negative
 CURE Talks Cancer,CURE Magazine,Negative
 F√©licitations,C√©gep de L√©vis,Positive
 √† AnneSophie Paquet dipl√¥m√©e,C√©gep de L√©vis,Positive
 remport√©,C√©gep de L√©vis,Positive
 Catherine la e √©dition du Concours,C√©gep de L√©vis,Positive
 agricole,C√©gep de L√©vis,Positive
 De Marr,Graham Collins,Negative
 Dr Helen Marr,Graham Collins,Negative
 Woyach et al BR,Graham Collins,Negative
 improved   immunotherapy response,CLL_Fightersüéó,Negative
 muciniphila,CLL_Fightersüéó,Negative
 adjunct,CLL_Fightersüéó,Negative
 targeted   treatments,CLL_Fightersüéó,Negative
 targeted   treatments,SIAM,Positive
 landmark study,Client-Pharma Ltd,Positive
 landmark study,Loyola Medicine,Positive
 landmark study,Concilium Search,Positive
 landmark study,Michael O'Dwyer,Positive
 NOTCH variants,Pathology Tweets,Positive
 unresp,Medivizor,Negative
 twitter chat,MDEdge,Negative
 twitter chat,MDedge Hematology & Oncology,Negative
 twitter chat,Mary Ellen Schneider,Negative
 synergies,Lars M√∏rland Knudsen,Positive
 synergies,Bionest Partners,Negative
 AXLinhibition,Lars M√∏rland Knudsen,Positive
 Preclinical,Lars M√∏rland Knudsen,Positive
 La journ√©e de lintelligence artificielle se termine,Olivier Lafleur,Positive
 une discussion sur les aspects,Olivier Lafleur,Positive
 et linguistiques de lIA Belle,Olivier Lafleur,Positive
 un beau tour dhorizon,Olivier Lafleur,Positive
 sur lIA et,Olivier Lafleur,Positive
 CLL Rewards,CryptoLiveLeak,Negative
 Kanga Exchange Trading CompetitionThank,CryptoLiveLeak,Negative
 MDedge Hematology amp Oncology,MDedge Hematology & Oncology,Negative
 ofatumomab,ASH Clinical News,Negative
 sur lintelligence artificielle organis√©e par le C√©gep de L√©visLauzon et le CRVI,Olivier Lafleur,Positive
 expert Dr Susan Leclair,Patient Power,Negative
 purpose,Patient Power,Negative
 purpose,CLL Ireland,Negative
 purpose,Renal Cell Carcinoma,Negative
 watchandwait strategy,Patient Power,Negative
 Nursery playground,Leigh Primary School,Positive
 lots changes,Leigh Primary School,Positive
 unre,Medivizor,Negative
   Resistance,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 non‚Äêcoding mutations,Wiley Oncology & Hematology,Positive
 tumorlysis syndrome,"chadi nabhan MD, MBA, FACP",Negative
 amp management,"chadi nabhan MD, MBA, FACP",Negative
 Le   est fier de faire d√©sormais partie de la grande,C√©gep de L√©vis,Positive
 famille de l,C√©gep de L√©vis,Positive
 s‚Äôagit d‚Äôune,C√©gep de L√©vis,Positive
 Suivez ce lien,C√©gep de L√©vis,Positive
 les d√©tails,C√©gep de L√©vis,Positive
 FAT,Prof John,Negative
 Chronic Lymphocytic Leukemia CLL Therapeutics Market,Research News24 üíé,Positive
 Future Impact,Research News24 üíé,Positive
 Propellants,Research News24 üíé,Positive
 CLL Review safety amp efficacy data,Medscape Education,Negative
 w Jennifer Woyach MD,Medscape Education,Negative
 Start Activity,Medscape Education,Negative
 antiCD antibodies,Michael Hallek,Negative
 antiCD antibodies,"Raul Cordoba, MD, PhD",Positive
 NICE approval,Margaret Walker,Negative
 Postdoc Position Microenvironmental interactions,Scholarships and Career Opportunities,Positive
 Veronika Bachanova et al,UMN DOM Research,Positive
 article Donor killercell immunoglobulinlike receptor,UMN DOM Research,Positive
 KIR genotype,UMN DOM Research,Positive
 KIR genotype,NK papers,Negative
 graftversusleukemia responses,UMN DOM Research,Positive
 graftversusleukemia responses,NK papers,Negative
    Cello Health Plc,Andrew Scott,Positive
   Tolllike receptor responses,IGpath,Positive
   importance,IGpath,Positive
 B cell receptor isotypes,IGpath,Positive
 stereotypes,IGpath,Positive
 Osso Bucco,Brian Barrett,Positive
 Lago Restaurant Great job,Brian Barrett,Positive
 Custom Ad Space,CryptoLiveLeak,Negative
 User,CryptoLiveLeak,Negative
 premium placement,CryptoLiveLeak,Negative
 test ad space,CryptoLiveLeak,Negative
 VIDEO Trials,Oncology Board,Negative
 nutshell,Nature Reviews Disease Primers,Negative
 PrimeView,Nature Reviews Disease Primers,Positive
 Systemic Therapy,Anthony Mato,Negative
 Jan Rynne,CLL Ireland,Negative
 apoyo,Abelardo B√°rez,Positive
 lo que tweeteaba ayer el grupo alem√°n tambi√©n lo tiene claro,Abelardo B√°rez,Positive
 Dr William G Wierda,Oncology Times,Negative
 Loyola   Scott Smith MD PhD,Loyola Medicine,Positive
   addition,CryptoLiveLeak,Negative
   addition,Anna Deveau,Negative
 therapy decisions,CLL Ireland,Positive
 involvement,CLL Ireland,Negative
 involvement,CIMAGO,Positive
 involvement,"chadi nabhan MD, MBA, FACP",Positive
 Clinical Pathways,CLL Ireland,Negative
 Clinical Pathways,Casey Foster,Positive
 monthSex differences,BMC,Positive
 Sexrelated DNA methylation differences,BMC,Positive
 Sexrelated DNA methylation differences,SexGenomics,Negative
 Dual inhibition,Lymphoma Papers,Negative
 Dual inhibition,Lymphoma Hub,Negative
 MEK,Lymphoma Papers,Negative
 binimetinib,Lymphoma Papers,Negative
 Todays research,finnCap,Positive
 research portal,finnCap,Positive
 Signal,WheelieDealer,Positive
 Berlin Office,WheelieDealer,Negative
 Net Cash Great business,WheelieDealer,Negative
 pivot,WheelieDealer,Negative
 ABBV CYCC CYC,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 addon,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 eyes,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 eyes,Leukaemia Care,Negative
 eyes,Wag-O-Shag Lodge #280,Positive
 eyes,CLL Ireland,Negative
 investors twist,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 CYC,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Positive
 PRV,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 de wetenschap   Doelgerichte therapie voor,MedZine,Positive
 effectiever,MedZine,Positive
 gebruikLees het artikel,MedZine,Positive
 de MedZine app,MedZine,Positive
 track,Proactive,Negative
 pharma consultancy,Proactive,Negative
 shakles,Talal Hilal ü©∫,Negative
 Targeted therapies,MedPage Today,Negative
 Targeted therapies,Cleveland Clinic MD,Positive
 Targeted therapies,Dana-Farber,Positive
 Targeted therapies,VJHemOnc,Negative
 Targeted therapies,ACP Massachusetts,Positive
 Targeted therapies,"Navneet Majhail, MD, MS",Negative
 Younger Chronic Lymphocytic,Oncology Times,Negative
 VIDEO Factors,VJHemOnc,Negative
 treatment decisionmaking,VJHemOnc,Negative
 w   founder,VJHemOnc,Negative
 takehome points,MDedge Hematology & Oncology,Negative
 Patient Power community member,Patient Power,Positive
 approaches,Patient Power,Negative
 couple years,Patient Power,Negative
 Infectious Diseases,Infectious Diseases & Primary Healthcare,Positive
 amp Primary Healthcare UpdatesOncologists,Infectious Diseases & Primary Healthcare,Positive
 Ibrutinib amp Options,CLL Ireland,Negative
 Onkologie   Nov Epub   Oct Lyme disease,Barbaros √áetin,Positive
 tcolNCObdhG,BloodCancerCure,Negative
 New Treatment Combinations,Patient Worthy,Negative
 chr,Medivizor,Negative
 Sex differences,SGHC,Positive
 methylation,SGHC,Positive
 BTK   phase,"Amber Koehler, PA-C",Negative
 explores efficacy,"Amber Koehler, PA-C",Negative
 FCR trial,ASH Clinical News,Negative
 ‚Äú paradigm shift,ASH Clinical News,Negative
 New Copay Assistance Program,Cancer News,Negative
 Individuals,Cancer News,Negative
 Assistance Fund,Cancer News,Positive
 relapsed nonHodgkin,"Raul Cordoba, MD, PhD",Negative
 VIDEO Telomere length,VJHemOnc,Negative
 Cure,Bill Both,Positive
 Cure,Leukemia Research Foundation,Negative
 Cure,CLLSA,Negative
 Cure,collaborer en europe,Positive
 Cure,Janette Fuller,Positive
 Cancer   immunotherapy drug,Bill Both,Positive
 word cure,CURE Magazine,Negative
 word cure,Oncology Tube,Negative
 EBMT Study,Mahmoud Aljurf,Negative
 varying risk,CellworksLife,Negative
 VIDEO Monoallelic TPmutated   patients,VJHemOnc,Negative
 Loyola Medicine oncologist,Concilium Search,Positive
 doselimited regimens,CLL Ireland,Negative
 doselimited regimens,Targeted Oncology,Negative
 Entospletinib monotherapy,COPD News,Negative
 drug ibrutinib,Quint Fit,Positive
 Crossover,CancerWallonia,Negative
 Crossover,CellworksLife,Negative
 Feasible,CancerWallonia,Negative
 CLL Status,TrialBulletin,Negative
 Landmark study,BioNews Central,Positive
 New Venetoclaxrituximab combination,Medivizor,Negative
 chronic lymphocytic    Clinicopathologic features,Mayo Clinic Labs,Positive
 Perspective Combinations,Blood Journal,Negative
 sequences,Blood Journal,Negative
 Newly Activated    Trial,NCI CTEP Clinical Research,Negative
   length,CLL_Fightersüéó,Negative
   length,Oncocheck,Positive
   length,Life Length,Positive
 FCR chemoimmunotherapy,CLL_Fightersüéó,Negative
 FCR chemoimmunotherapy,VJHemOnc,Negative
 FCR chemoimmunotherapy,Jesus F Sierra,Positive
 research collaboration,CLL_Fightersüéó,Negative
     Treatment,CLL_Fightersüéó,Negative
 Professor Dr Jennifer Woyach,Ohio State Careers,Positive
 Prof Anna Schuh,CLL Ireland,Negative
   specialist,Patient Empowerment Network,Negative
   specialist,Patient Power,Positive
 Dr Richard Furman Director,Patient Empowerment Network,Negative
 CLL Research Center,Patient Empowerment Network,Negative
 Ask,Patient Empowerment Network,Positive
 Dr Gauthier,Targeted Oncology,Negative
 Men,Biology of Sex Differences,Positive
 Lancet Haematology Jan    AML,Cellero,Positive
 therapy phase    trial,Cellero,Positive
 antiPD,Cellero,Positive
 Telomere length,Teresa Martin,Positive
 FCR treatment,Teresa Martin,Positive
 FCR treatment,GEDEFO,Negative
 Practical Implications,Casey Foster,Positive
 Rise,Casey Foster,Positive
 Chronic Lymphocytic Leukemia QampA,Casey Foster,Positive
 Transcript   ILT Blockade,Cancer Papers,Negative
 Transcript   ILT Blockade,NK papers,Negative
 Villa√Ålvarez M SordoBahamonde C LorenzoHerrero S GonzalezRodriguez AP Payer AR GonzalezGarcia E Villa√Ålvarez MC L√≥pezSoto,NK papers,Negative
 w Christopher Fegan,VJHemOnc,Negative
 CDtargeting CAR T cells,Targeted Oncology,Negative
 Commencez lann√©e du bon,C√©gep de L√©vis,Positive
 Leukemia news,Mindy Waizer,Positive
 Springer nature,Mukesh P Yadav,Positive
 Duvelisib monotherapy,OncLive.com,Negative
 NEW TRIAL,Alliance for Clinical Trials in Oncology,Negative
 IGHVmutated,VJHemOnc,Positive
 Dr Rogers,Targeted Oncology,Negative
 II findings,Targeted Oncology,Negative
 II findings,COPD News,Negative
 ALLIANCE amp iLLUMINATE w Barbara Eichhorst,VJHemOnc,Negative
 Catch Optum,Optum,Positive
 Activated    Trial,NCI CTEP Clinical Research,Negative
 Congratulations Sara,Santhilal Subhash,Positive
 amp team,Santhilal Subhash,Positive
 amp team,"Francisco Marty, MD",Negative
 art review,Toby Eyre,Negative
 Richters syndrome,Toby Eyre,Negative
 Drug resistance,The James,Negative
 Happy Sunday,Carmel La Lumiere,Negative
 y ‚Äô,Carmel La Lumiere,Negative
 VIDEO Hot topic Geriatric Assessment,VJHemOnc,Negative
 Hematology GAH scale,VJHemOnc,Negative
 CLL   OncLive FirstLine Therapy,Clinical Trials,Negative
 CLL ¬†¬† OncLive Panelists,Clinical Trials,Negative
 shared risks,Daniel Auclair,Positive
 denial,Christy2x,Positive
 mountain,Christy2x,Positive
 Nicer,Christy2x,Positive
 FixedDuration   Triplet Active,CancerWallonia,Negative
 Baliakas et al Fantastic unpicking,Toby Eyre,Negative
 Miss,OncLive SOSS,Negative
 Miss,Michele Nadeem-Baker,Negative
 director,Andrew Schorr,Negative
 director,Patient Power,Negative
 director,ACRF,Positive
 director,ùìõùìÆùì™ùì±ü¶ã,Positive
 director,Dana-Farber,Negative
 New Yorks,Andrew Schorr,Negative
 New Yorks,Patient Power,Negative
 New Zealanders,AbbVie New Zealand,Positive
 Parametric Modeling,Shouting at people in my underpants,Negative
 ChemotherapyFree Regimens,Shouting at people in my underpants,Negative
 West Nile Encephalitis,EurekaMag,Negative
 Unusual Infection,EurekaMag,Negative
 Retrospective cohort study,RTI Health Solutions,Positive
 JCI,"Michael Green, PhD",Negative
 pŒ¥ inactivation,"Michael Green, PhD",Negative
 pŒ¥ inactivation,CLL_Fightersüéó,Negative
 pŒ¥ inactivation,ASCI,Positive
 Kater,Toby Eyre,Negative
 Kater,VJHemOnc,Negative
 paradigms RChlLen,Toby Eyre,Negative
 fit st line pts gd ORRPFS,Toby Eyre,Negative
 G tox,Toby Eyre,Negative
 Free Workshop,FAES,Positive
 Chronic Lymphocytic Leukemia CLL    ERIC International Meeting,FAES,Positive
   Clinical Center,FAES,Positive
 Bethesda MD Register,FAES,Positive
 specialist,Andrew Schorr,Negative
 specialist,Patient Power,Negative
 specialist,CLL_Fightersüéó,Negative
 State,Andrew Schorr,Negative
 State,Patient Power,Negative
 State,MD Anderson Leukemia,Negative
 State,microRNApapers,Negative
 State,PER,Negative
 nonchemo approaches,Andrew Schorr,Negative
 nonchemo approaches,Patient Power,Negative
 Chronic Lymphocytic Leukemia AMLALL,Great Debates in Hematologic Malignancies,Negative
 Phase II findings,OncLive.com,Negative
 CLL program,Patient Power,Negative
 Velocity Vlog,gilbert c faure,Negative
 Criteria,Expert Perspectives in Oncology,Negative
 Criteria,Amin G T Amin,Positive
 initiating treatment,Expert Perspectives in Oncology,Negative
 triage,Expert Perspectives in Oncology,Negative
 Protocols,Jeans and Other Men‚Äôs Clothing,Positive
 FixedDuration Venetoclax Triplet Active,COPD News,Negative
 Chronic Lymphocytic Leukemia    Analysis,McHeyzer-Williams,Positive
 VIDEO ECOGE,VJHemOnc,Negative
 w TaitShanafelt,VJHemOnc,Negative
 Donor,NK papers,Negative
 Donor,everett jackson,Positive
 Donor,Janette Fuller,Negative
 immunoglobulinlike receptor,NK papers,Negative
 SafeCancerTx,Sharmaine Fuentes,Positive
 ‚Äú Genomics,Sharmaine Fuentes,Negative
 ‚Äú Genomics,Kyle Schmanke,Positive
 Chronic Lymphocytic LeukemiaCurrent Research amp Future Implications,Sharmaine Fuentes,Negative
 Chronic Lymphocytic LeukemiaCurrent Research amp Future Implications,Kyle Schmanke,Positive
 Chronic Lymphocytic Leukemia Current Research amp Future Implications,Oncology Times,Positive
 Chronic Lymphocytic Leukemia Current Research amp Future Implications,NursingCenter,Positive
 survivor outlook,MD Anderson Cancer Center,Positive
    Response,McHeyzer-Williams,Positive
 CD targeted CAR,McHeyzer-Williams,Positive
 Transcriptional Profiles,McHeyzer-Williams,Positive
 Joseph Melenhorst,McHeyzer-Williams,Positive
 illnesses,Show Me the Data,Positive
 illnesses,Crain's New York,Positive
 Agent Orange Blue water Navy veterans,Show Me the Data,Positive
 WATCH Dr Paolo Strati,Oncology Times,Negative
 Young Investigator Awardee,Oncology Times,Negative
 Illness Perceptions,COPD News,Negative
 Chronic Lymphocytic Leukemia Testing Leventhals Selfregulatory Model Leventhals Selfregulatory Model,COPD News,Negative
 health threat eg symptom severity,COPD News,Negative
 Ac√° les dejamos la da parte,Canuto & Cornamenta üê∂ü¶å,Positive
 unboxing de kit de Harry Potter de        en Buenos Aires Argentina,Canuto & Cornamenta üê∂ü¶å,Positive
 New   video,Patient Power,Negative
 expert panelists,Expert Perspectives in Oncology,Negative
 patient age,Expert Perspectives in Oncology,Negative
 fitness,Expert Perspectives in Oncology,Positive
 fitness,Soha,Positive
 treatment selection,Expert Perspectives in Oncology,Negative
 Cancer Network Brad S Kahl MD,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Cancer Network Brad S Kahl MD,Cancer News,Negative
 CLL research,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 CLL research,Cancer News,Negative
 CLL research,"Holly Bertone, CNHP, PMP",Positive
 CLL research,Paula Pyzia,Negative
 CLL research,Rhia Steele@ravishingrhia.com,Positive
 CLL research,ecancer,Negative
 Targeted treatments,RTI Health Solutions,Negative
   community member,Patient Power,Negative
 Integration,shira lev,Positive
 Integration,Dr Richard Palmquist,Positive
 Integration,GEDEFO,Negative
 Timing,"Raul Cordoba, MD, PhD",Negative
 Timing,Lymphoma Hub,Negative
 Obinutuzumab pretreatment,"Raul Cordoba, MD, PhD",Negative
 tumor lysis risk,"Raul Cordoba, MD, PhD",Negative
 tumor lysis risk,Blood Advances,Negative
 genetics,Patient Power,Negative
 genetics,VJHemOnc,Negative
 Pubmed Chromatin Immunoprecipitation Assay,epigenetics_papers,Negative
 Novel NFAT Target Genes,epigenetics_papers,Negative
 Dr Jennifer R Browns commentary,Expert Perspectives in Oncology,Negative
 bleeding risk,Expert Perspectives in Oncology,Negative
 Merry Christmas,Brian Barrett,Positive
 Jennifer Brown MD PhD Jan Burger MD PhD,Expert Perspectives in Oncology,Negative
 MSCE,Expert Perspectives in Oncology,Negative
 interaction,Expert Perspectives in Oncology,Negative
 interaction,AtlanticJOMedicine,Negative
 interaction,Cure Cancer Now,Negative
 interaction,Hypoxia Adaptation,Positive
 interaction,Cancer Papers,Negative
 novel CLL agents,Expert Perspectives in Oncology,Negative
   Regimens,Chirurgia Senologica,Positive
 Untreated,Chirurgia Senologica,Positive
 Untreated,TrialSite News,Negative
 Untreated,leo uzych,Negative
 Untreated,MD Anderson Leukemia,Negative
 Untreated,Sandra Kear,Positive
 ü§î,Bruce Samuelson,Negative
 ü§î,Generation Medics,Positive
 ü§î,Jah Kuu,Negative
 Yayyyyyy ü§¶,Bruce Samuelson,Negative
 Ô∏è ü§¶,Bruce Samuelson,Positive
 pathology report,Bruce Samuelson,Negative
 abscess,Bruce Samuelson,Negative
 Proteomics profiling,Pastel BioScience,Positive
 induction,Pastel BioScience,Positive
 induction,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 induction,EurekaMag,Negative
 induction,CancerTherapyAdvisor,Negative
 caveolin,Pastel BioScience,Positive
 New Lenalidomide,Medivizor,Negative
 chemotherapyfree option,CLL Ireland,Negative
 vers sa fin,Carmel La Lumiere,Negative
 La plupart,Carmel La Lumiere,Negative
 ou gar√ßons voulons,Carmel La Lumiere,Negative
 des habits,Carmel La Lumiere,Negative
 Clinical Oncology Vol,Philip McCarthy,Negative
 Clinical Oncology Vol,Taylor Lab UM,Negative
 Clinical Oncology Vol,Syed Abutalib,Positive
 Clinical Oncology Vol,Mahmoud Aljurf,Negative
 Clinical Oncology Vol,Dr. Melody Davis,Negative
 Clinical Oncology Vol,Lymphoma Canada,Negative
   Associated Atrial Fibrillation,"Raul Cordoba, MD, PhD",Negative
 JACC Clinical Electrophysiology,"Raul Cordoba, MD, PhD",Negative
 GraftVersusHost Disease,Kevin Liu,Positive
 Higher Rates,Kevin Liu,Positive
 Skin Cancer,Kevin Liu,Positive
 Allogeneic Hematopoietic Stem Cell Transplantation,Kevin Liu,Positive
 Pubmed,epigenetics_papers,Positive
 Pubmed,Ribosome Papers,Positive
 Pubmed,yeast_papers,Positive
    Discoveries,Michele Nadeem-Baker,Negative
   Souhaite un,ÿßŸÑŸÖÿØÿ±ÿ® ÿßŸÑÿØŸàŸÑŸä ŸÖÿµÿ∑ŸÅŸâ,Positive
 unr,Medivizor,Negative
 Longterm realworld results,ALI ALAHMARI.,Negative
 Kaposi,SAGE Health & Nursing,Positive
 Kaposi,SAGE Clinical Med,Positive
 sarcoma,SAGE Health & Nursing,Positive
 sarcoma,SAGE Clinical Med,Positive
   Daily Wraps,Patient Power,Negative
 Dr   Lamanna amp,Patient Power,Negative
 pt advocate Lee Swanson,Patient Power,Negative
 Signification,lymphaticpapers,Positive
 protein p isoforms,lymphaticpapers,Positive
 BCL mutation confers resistance,CLL Ireland,Negative
 BCL mutation confers resistance,HemOnc Today,Negative
 amp evidence,CLL Ireland,Negative
      Lymphocytic Leukemia Market Industry Analysis Trend,EMRIndustry,Positive
 Discoveries,Shouting at people in my underpants,Negative
 Discoveries,Cancer News,Negative
 improved understanding,Shouting at people in my underpants,Negative
 holiday season,Michael Hallek,Negative
 HamWasserman lecture award,Michael Hallek,Negative
 Bethesda Handbook,Oncology Times,Positive
 Bethesda Handbook,Sharmaine Fuentes,Negative
 Bethesda Handbook,Kyle Schmanke,Positive
 Clinical Hematology,Oncology Times,Positive
 Clinical Hematology,Sharmaine Fuentes,Negative
 Clinical Hematology,Kyle Schmanke,Positive
 Clinical Hematology,Archi Miedes,Positive
 Research News Scientists,Living Safely,Negative
 VenR amp impact,VJHemOnc,Negative
 ICYMI Acquisition,Cancer Discovery,Negative
 b study,Biotech2050,Negative
   amp    microenvironmental interactions,researchjobs.cz,Negative
 PIK pŒ¥ inactivation,"Raul Cordoba, MD, PhD",Negative
 PIK pŒ¥ inactivation,Journal of Clinical Investigation,Negative
   updates ibrutinibobinutuzumab,VJHemOnc,Negative
 Enhancer architecture,Broad Institute,Positive
 IGVH,Michael Hallek,Negative
 IGVH,"Caner Saygin, MD",Negative
 Jennifer Woyachs,Michael Hallek,Negative
 L treatment BR,Michael Hallek,Negative
 Jennifer,Michael Hallek,Negative
 Jennifer,"Firas El Chaer, MD",Positive
 Jennifer,Andrew Schorr,Negative
 Lymphomatoid papulosis,Lymphoma Papers,Negative
 results ibrutinib,CLL Ireland,Negative
 III Study J Clin Oncol,CancerEpiPapers,Negative
 bloodstream infections,pseudomonaspapers,Negative
 LateBreaking Abstracts,"Aaron Gerds MD, MS",Positive
 unrespon,Medivizor,Negative
 Natalie Grover MD,UNC Lineberger Cancer Network,Positive
 CAR T Therapy,UNC Lineberger Cancer Network,Positive
 Bad news,Medscape Nurses,Negative
 Medscapes,Medscape Nurses,Negative
 Clinical Trend,Medscape Nurses,Negative
 Social Security Disability,Molly Earley,Positive
 Social Security Disability,Audrey Earley,Positive
     Cello Health PLC Block Listing Update,AIM Alerts!,Negative
 year followup data,Targeted Oncology,Negative
 year followup data,"Pharmacyclics, an AbbVie Company",Positive
 year followup data,Health Adviser,Positive
 Chronic Lymphocytic Leukemia Journal,Taylor Lab UM,Negative
 Chronic Lymphocytic Leukemia Journal,Syed Abutalib,Positive
 Chronic Lymphocytic Leukemia Journal,Oncology Board,Positive
 Chronic Lymphocytic Leukemia Journal,Dr. Melody Davis,Negative
 Chronic Lymphocytic Leukemia Journal,"Dr T. Comeau , MD",Negative
 Chronic Lymphocytic Leukemia Journal,Lymphoma Canada,Negative
 Chronic Lymphocytic Leukemia Journal,"Philippe Aftimos, MD",Positive
 Watch amp wait,Esther Schorr,Negative
 Deciphering,ASCO Publications,Negative
 Deciphering,CLL Ireland,Negative
 Deciphering,FarmaOnco,Negative
 Deciphering,Dr. Melody Davis,Negative
 Deciphering,Lymphoma Canada,Negative
 Ibrutinib outperforms chemoimmunotherapy,JULIO CESAR ROBLES,Positive
 Ibrutinib outperforms chemoimmunotherapy,Pavol,Positive
 Ibrutinib outperforms chemoimmunotherapy,Peshie Rubin,Positive
 Ibrutinib outperforms chemoimmunotherapy,Medicalnewser.com,Negative
 Ibrutinib outperforms chemoimmunotherapy,Cancer Research News,Positive
 Ibrutinib outperforms chemoimmunotherapy,DannyShooküé¨Video,Positive
 frontline IbrutinibObinutuzumab combo,Lampe & Company,Negative
 highrisk Chronic Lymphocytic,Lampe & Company,Negative
 ChemoFree Tx,"Aaron Gerds MD, MS",Positive
 Younger CLL Patients,"Aaron Gerds MD, MS",Positive
 infection pathogenesis,"Raul Cordoba, MD, PhD",Negative
 infection pathogenesis,Cancer Papers,Negative
   lat temu,Jacek Kalinowski,Positive
 przewlek≈Ça,Jacek Kalinowski,Positive
 chemoimmunotherapy treatments,CURE Magazine,Positive
 growing Come,CryptoLiveLeak,Negative
 content,CryptoLiveLeak,Negative
 content,Patient Power,Negative
 CLL tokens,CryptoLiveLeak,Negative
 Attention Mining    CLL,CryptoLiveLeak,Negative
 Wierda et al BJ Haem VEN,Toby Eyre,Negative
 Highlevel expression,filippo masini,Negative
 chemokines CCL,filippo masini,Negative
 CCL,filippo masini,Negative
 Dysregulation,filippo masini,Negative
 Dysregulation,"Krishna Komanduri, MD, FASTCT",Positive
 Frizzled,filippo masini,Negative
 Roundup Lawsuit,MD.,Negative
 Roundup Lawsuit,L McSherry,Positive
 Roundup Lawsuit,AboutLawsuits.com,Positive
 Glyphosate Exposure,MD.,Negative
 Glyphosate Exposure,L McSherry,Negative
   weighs,MD Anderson Cancer Center,Negative
   case studies,MD Anderson Cancer Center,Negative
   case studies,VJHemOnc,Negative
 Burger et al IbrutinibRitux,Toby Eyre,Negative
 ibrutinib monotherapy,Toby Eyre,Negative
 translation,Toby Eyre,Negative
 translation,Blood Journal,Positive
 translation,Francesco Turturro,Negative
   Testing patterns,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Prof Kater,CLL Ireland,Negative
 targeting,CLL Ireland,Negative
 CLL therapeutics,Cellero,Positive
 Jennifer R Brown MD PhD comments,Expert Perspectives in Oncology,Negative
 Testing Treatment Patterns,COPD News,Negative
 CLL Testing patterns,COPD News,Negative
 DUO trial duvelisib,Blood Journal,Negative
 refractory,Blood Journal,Negative
 refractory,HemOnc Today,Negative
 refractory,Blood Advances,Positive
 refractory,Talbot Research Library & Media Services,Positive
 refractory,VJHemOnc,Negative
 refractory,AJMC-Oncology,Negative
 refractory,Zack Pemberton-Whiteley,Negative
 refractory,Michelle Holder,Positive
   Carol Preston,Patient Power,Negative
 specialist perspective,Patient Power,Negative
 Dr Blombery,Targeted Oncology,Negative
 research group,Targeted Oncology,Negative
 TP aberrations,Lucas Cantadori,Positive
 TP aberrations,Mahmoud Aljurf,Positive
   Provide Evidence,1stOncology,Negative
 Groups,1stOncology,Negative
 Groups,CancerWallonia,Negative
 CLL JNJ,1stOncology,Negative
 SeptemberStress,gk68,Positive
 Serologic Response,TrialBulletin,Negative
 New Recombinant Adjuvanted Herpes Zoster Vaccine,TrialBulletin,Negative
 New Recombinant Adjuvanted Herpes Zoster Vaccine,CureHuntr,Negative
 FirstLine BTK Inhibitors Status,TrialBulletin,Negative
 Condition Summary Chronic Lymp,TrialBulletin,Negative
 ASH Insights gtgtgt,Dr Timos Papagatsias,Positive
 Federal Practitioner,Dr Timos Papagatsias,Negative
 Twitter Older   patients,Dr Timos Papagatsias,Negative
   Serologic Response,CureHuntr,Negative
 FirstLine BTK Inhibitors,CureHuntr,Negative
 Decembers Feature article,Cancer Cell,Negative
 Ott Brown Bradner,Cancer Cell,Negative
 enhancer architecture,Cancer Cell,Negative
 Brad Kahl MD,OncLive SOSS,Positive
 highlights combinations,OncLive SOSS,Negative
 eye,OncLive SOSS,Negative
 eye,Neil Bonnar,Positive
 Twitter Patienten mit chronischer,Dr Timos Papagatsias,Negative
 lymphatischer,Dr Timos Papagatsias,Negative
 Leuk√§mie,Dr Timos Papagatsias,Negative
 Leuk√§mie,AbbVie Deutschland,Positive
 Leuk√§mie,Deutsches √Ñrzteblatt,Positive
 Patienten mit chronischer lymphatischer Leuk√§mie,SpringerMedizin.de,Positive
 article panelists,Expert Perspectives in Oncology,Positive
 Interpreting Chronic Lymphocytic Leukemia Prognostic Markers,Expert Perspectives in Oncology,Positive
 Novel Treatment Era,Expert Perspectives in Oncology,Positive
 Singleagent ibrutinib,OncLive.com,Negative
 Singleagent ibrutinib,maria jose agustin,Positive
 Singleagent ibrutinib,"Dr T. Comeau , MD",Negative
 Singleagent ibrutinib,Muzaffar Qazilbash,Negative
 Singleagent ibrutinib,Bertrand Delsuc,Positive
 Singleagent ibrutinib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
   patient populations,1stOncology,Negative
 Lisocabtagene maraleucel,OncLive.com,Negative
 Pharmacyclics ‚Äô miracle cure cancer drug,Shouting at people in my underpants,Negative
 biotech company,Shouting at people in my underpants,Negative
 Twitter Nicole Lamana,Dr Timos Papagatsias,Negative
 Nicole Lamana,Jeff Sharman,Positive
 CLL con,ùïÆùñçùñÜùñóùñíùñäùñâùñÜùñóùñêü¶Çüåíüåïüåò,Positive
 VIDEO   discoveries,VJHemOnc,Negative
 Richard Rosenquist,VJHemOnc,Negative
 Dr Kahl,OncLive SOSS,Negative
 Dr Kahl,OncLive.com,Negative
 Dr Kahl,Carmine DeLuca,Negative
 Promising Research,OncLive SOSS,Negative
 Promising Research,OncLive.com,Negative
 Large pooled analysis,Toby Eyre,Negative
    VSTMAEs,Anna Deveau,Negative
 VIDEO update,VJHemOnc,Positive
 ERIC initiatives,VJHemOnc,Negative
 sp,Dr. Andy Evens,Negative
 sp,"Francisco Marty, MD",Negative
 trend,Dr. Andy Evens,Negative
 PFS curves,Dr. Andy Evens,Negative
 fairy close Wonder,Dr. Andy Evens,Negative
 disease factors,Dr. Andy Evens,Negative
 mutated IGHV,Dr. Andy Evens,Negative
 mutated IGHV,Beth Torr,Positive
 home points,Ahmad Halwani,Positive
 home points,Dr. Jos√© A. Queiz√°n,Negative
 Initiating Novel Agents,Expert Perspectives in Oncology,Positive
 Frontline Setting,Expert Perspectives in Oncology,Positive
 Frontline Setting,Targeted Oncology,Negative
 MedPage Today,Dr Timos Papagatsias,Negative
 wrap Check,MedPage Today,Negative
 Recent Clinical Trials Highlight Potential,Patient Worthy,Negative
 Twitter   confers resistance,Dr Timos Papagatsias,Negative
 VIDEO   treatment duration,VJHemOnc,Negative
   confers resistance,MDedge Hematology & Oncology,Negative
 News Chronic lymphocytic   PFS,medwireNews,Negative
 magnitude,Cancer Papers,Negative
 magnitude,Lymphoma Papers,Negative
 ASH successes,cafepharma,Negative
 ASH successes,Diving News,Negative
 ASH successes,Petra Kodeda,Positive
 Robert Z Orlowski,Dr Timos Papagatsias,Negative
 Robert Z Orlowski,Imedex,Positive
 Twitter RT PhysRelations RT,Dr Timos Papagatsias,Negative
 PatientPower video,Dr Timos Papagatsias,Negative
 PatientPower video,Robert Z. Orlowski,Negative
 PhysRe,Dr Timos Papagatsias,Negative
    video,MD Anderson Leukemia,Negative
    video,CLLSA,Negative
 Early DoseEscalation Data,Patient Worthy,Negative
 Potential Treatment,Patient Worthy,Negative
 ‚Å¶‚Å© practicechanging abstracts,"Raul Cordoba, MD, PhD",Negative
 Medscape Oncology,Dr Timos Papagatsias,Negative
 acquired resistance,Dr Timos Papagatsias,Negative
 acquired resistance,Medscape Oncology,Negative
 acquired resistance,Francesco Turturro,Positive
 GlyV,Dr Timos Papagatsias,Negative
   year,Chris  Douglas,Positive
   year,Free Cello Tuner,Negative
   year,Ian Morgan-Smith,Positive
 cancerversary,Chris  Douglas,Positive
 GlyVal mutation,Medscape Oncology,Negative
    VIDEO,Lymphoma Hub,Positive
 SingleAgent Venetoclax,MD Anderson Leukemia,Negative
 VIDEO Opinion,VJHemOnc,Negative
 Drs Porter,Penn Medicine MD,Positive
 Gill,Penn Medicine MD,Positive
 Gill,Adaptive Biotech,Negative
 thought leaders,CLL_Fightersüéó,Negative
 Unusual Relapse,EurekaMag,Negative
 Remission,EurekaMag,Negative
 Remission,Chocolatiere Phys,Negative
 Remission,Stem Cell Tracker,Positive
 Remission,CLL Ireland,Negative
 Remission,Liana Gardner,Positive
 Remission,Peak Medical Editing,Positive
 LeukemiaMDA,Robert Z. Orlowski,Positive
 groundbreaking therapy,The James,Negative
 BTC Trading Pairs,CryptoLiveLeak,Negative
 Kanga Exchange,CryptoLiveLeak,Negative
 CLLBTC,CryptoLiveLeak,Negative
 btc,CryptoLiveLeak,Negative
 ChemoFree Treatment Best Option,Glenn Sabin,Positive
   Suggests,Glenn Sabin,Positive
 Rod Humerickhouse MD PhD,Rare Disease Report,Positive
 Rod Humerickhouse MD PhD,Krista Rossi,Positive
 venetoclaxrituximab therapy,Rare Disease Report,Positive
   shifting landscape,Rare Disease Report,Negative
   READ,Rare Disease Report,Negative
 Johnson amp Johnson AbbVies Imbruvica,Bionest Partners,Negative
   spotlight,Bionest Partners,Negative
   spotlight,Advera Health,Negative
 study wins,Bionest Partners,Negative
 Imbruvica frontline,Bionest Partners,Negative
 w Jacqueline Barrientos,The Patient's Channel,Negative
 w Jacqueline Barrientos,VJHemOnc,Negative
 Venetoclax monotherapy,Targeted Oncology,Negative
 LBA,"Mike Thompson, MD, PhD, FASCO",Negative
 Ibrutinibrituximab,"Mike Thompson, MD, PhD, FASCO",Negative
 Untreated Younger Patients,"Mike Thompson, MD, PhD, FASCO",Negative
 Untreated Younger Patients,MoJo,Positive
 Untreated Younger Patients,Rafael Fonseca MD,Positive
 Untreated Younger Patients,üÖæ Jaksic,Negative
 Untreated Younger Patients,Dr.Alberto Mussetti,Negative
 Untreated Younger Patients,"Naveen Pemmaraju, MD",Negative
 Untreated Younger Patients,ALI ALAHMARI.,Negative
 Untreated Younger Patients,CLL,Negative
 Tue,"Mike Thompson, MD, PhD, FASCO",Negative
 ÿßŸÑÿØŸàÿßÿ°Ÿè ÿßŸÑÿ£ŸÉÿ´ÿ± ŸÅÿπÿßŸÑŸäÿ©Ÿã,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 ŸÑÿßÿ®Ÿäÿ∂ÿßÿ∂Ÿê ÿßŸÑÿØŸÖ ÿßŸÑŸÑŸÖŸÅÿßŸàŸä ÿßŸÑŸÖÿ≤ŸÖŸÜ,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 CLL ÿ≠ÿ≥ÿ® ÿ¢ÿÆÿ± ÿØÿ±ÿßÿ≥ÿ©New Study,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Reception class,angela tambourini,Positive
 ‚Äò enterprise ‚Äô designs,angela tambourini,Positive
 Twitter   shares,Dr Timos Papagatsias,Negative
   Dream Team üß¨,CLL_Fightersüéó,Negative
 ü•º,CLL_Fightersüéó,Negative
   jest,Puls Medycyny,Positive
 jednym z najczƒôstszych rodzaj√≥w bia≈Çaczki,Puls Medycyny,Positive
 Wiƒôkszo≈õƒá chorych,Puls Medycyny,Positive
 w starszym wieku,Puls Medycyny,Positive
 Ultimate   fighter,CLL_Fightersüéó,Negative
 VIDEO Considerations,VJHemOnc,Negative
 Combination Regimen,Financial Buzz,Negative
 Combination Regimen,RazzleTazzle,Negative
 Combination Regimen,Crwe World,Negative
 Combination Regimen,Marketbit.pro,Negative
 Chemoimmunotherapy FCR F,Financial Buzz,Negative
 Beats Standard Chemoimmunotherapy,"Raul Cordoba, MD, PhD",Negative
 ASH Johnson amp Johnson AbbVies Imbruvica,Advera Health,Negative
 Trending terms,"Symplur, a part of Real Chemistry",Positive
 Addon drugs,MedPage Today,Negative
 efficacy tolerability,MedPage Today,Negative
 CAR Tcell therapies,MedPage Today,Negative
 Shannon Maude MD PhD,MedPage Today,Negative
 Instagram,Dr Timos Papagatsias,Negative
 wrap,Dr Timos Papagatsias,Negative
 wrap,Patient Power,Negative
 wrap,CLL Ireland,Negative
 Superieure overleving,Oncologie Up-to-date,Positive
 bij,Oncologie Up-to-date,Positive
 Sidste ny viden fra,LyLe Foreningen,Negative
 √•cll √¶r,LyLe Foreningen,Negative
 √∏lgningsprogram,LyLe Foreningen,Negative
 scene prep,Amy C. Cavers,Negative
 Rai stage,Generation Medics,Positive
 Rai stage,JAMA,Negative
 RPS mutations,Blood Journal,Negative
   LateBreaker,"Pharmacyclics, an AbbVie Company",Negative
 Terrific   LBA presentation,"David Steensma, MD",Positive
 Longitudinal,ACS Journal Cancer,Negative
 multigene,ACS Journal Cancer,Negative
 Goodbye,Krish Patel,Positive
 Mass General Cancer Center,MGH Cancer Center,Positive
 Dr Jacob Soumerai,MGH Cancer Center,Positive
 risk model,MGH Cancer Center,Negative
 Altered patterns,Blood Journal,Negative
 Altered patterns,Ribosome Papers,Positive
   site,CryptoLiveLeak,Negative
 New Phase,HEDGE accordinglyüìà,Negative
 Study Findings IMBRUVICA√Ç,HEDGE accordinglyüìà,Negative
 Fludarabine Cyclophosphamide,HEDGE accordinglyüìà,Negative
 Rituximab FCR,HEDGE accordinglyüìà,Negative
 Aged,HEDGE accordinglyüìà,Negative
 Younger,HEDGE accordinglyüìà,Negative
 Younger,OncLive.com,Negative
 Chemoimmunotherapy FCR Fludarabine Cyclophosphamide,RazzleTazzle,Negative
 Chemoimmunotherapy FCR Fludarabine Cyclophosphamide,Marketbit.pro,Negative
 Younger Chronic Lymphocytic Leukemia CLL Patients,RazzleTazzle,Negative
     Acquisition,"Naveen Pemmaraju, MD",Negative
 abstract Acquisition,Cancer Discovery,Negative
 Compassionate care,The James,Negative
 Hero,The James,Negative
 Hero,—ï.œâŒ±‚Ñì–∫—î—è,Positive
 Congrats Dr Byrd Details,The James,Negative
   Piers Blombery,Taylor Lab UM,Negative
 BCL GlyVal mutations,Taylor Lab UM,Negative
 LATEBREAKER,"Pharmacyclics, an AbbVie Company",Negative
 Chemoimmunotherapy FCR,Crwe World,Negative
 Younger Chronic Lymphocytic Leukemia,Marketbit.pro,Negative
 Dr Shanafelt phase,Dr Victor Noriega,Positive
 III IbrutinibRitux,Dr Victor Noriega,Positive
 RFC,Dr Victor Noriega,Positive
 RFC,Florian Slimano,Negative
 RFC,"chadi nabhan MD, MBA, FACP",Negative
 youngsr patients,Dr Victor Noriega,Positive
 Late Breaking Abstracts,Jeff Szer,Negative
 ECOGintergroup study,Jeff Szer,Negative
 CLL Significantly,Jeff Szer,Negative
 ¬Æ   Data   CLL,1stOncology,Negative
 Seven Years,1stOncology,Negative
 Seven Years,Financial Buzz,Negative
 Seven Years,Crwe World,Negative
 Seven Years,HEDGE accordinglyüìà,Negative
 Seven Years,RazzleTazzle,Negative
 Progressionfree Survival PFS,1stOncology,Negative
 Progressionfree Survival PFS,HEDGE accordinglyüìà,Negative
 Progressionfree Survival PFS,RazzleTazzle,Negative
 Percent,1stOncology,Negative
 Percent,HEDGE accordinglyüìà,Negative
 Percent,RazzleTazzle,Negative
 Percent,Health|VBProfiles,Positive
 Percent,Business Wire-Health,Negative
 Percent,Business Wire-TS,Negative
 Percent,BusinessWireConsumer,Positive
 Percent,The Pharmaceutical Marketing Group,Negative
 Longest Followup,1stOncology,Negative
 Longest Followup,HEDGE accordinglyüìà,Negative
 Longest Followup,RazzleTazzle,Negative
 Date,1stOncology,Negative
 Date,HEDGE accordinglyüìà,Negative
 Date,RazzleTazzle,Negative
 Date,The Leukemia & Lymphoma Society,Negative
 Date,Patient Power,Negative
   Tait Shanafelt,Taylor Lab UM,Negative
 E results,Taylor Lab UM,Negative
 CART Cell Therapy Combination,Miguel Perales M.D.,Negative
 RelapsedRefractory Leukemia,Miguel Perales M.D.,Negative
 chemofree combination,"Pharmacyclics, an AbbVie Company",Negative
   aberrations,CLL_Fightersüéó,Negative
   aberrations,Oncology Practice,Positive
   aberrations,Hematology News,Negative
 Dave Maloney,Tom,Negative
 FHCRCLisoCel Highly Active,Tom,Negative
 LisoCel Highly Active,World Neonatology Congress,Negative
 ILdependent   Jagged expressionprocessing,Greiner Bio-One IT,Positive
 ILdependent   Jagged expressionprocessing,CDD press,Negative
 UK experts,Nick,Negative
 ibrutinib Phase,Financial Buzz,Negative
 ibrutinib Phase,IntoxicatedTrader,Negative
 Combination Data,Financial Buzz,Negative
 Obinutuzumab Finds Significant Improvement,Financial Buzz,Negative
 Researcher scientist Doctor,sganguly,Positive
 Daily Wrap,Patient Power,Negative
 costcomparisons,"chadi nabhan MD, MBA, FACP",Negative
 Ibrutinib CIT,"chadi nabhan MD, MBA, FACP",Negative
 claims data,"chadi nabhan MD, MBA, FACP",Negative
 eveningInterestingly patients,"chadi nabhan MD, MBA, FACP",Negative
   press,"Amber Koehler, PA-C",Negative
 treatment algorithm,"Amber Koehler, PA-C",Negative
 treatment algorithm,CLL_Fightersüéó,Negative
 IMBRUVICA ¬Æ Data,TrialSite News,Negative
 ILLUMINATE,MoJo,Negative
 longterm followup data,Targeted Oncology,Positive
 longterm followup data,"Pharmacyclics, an AbbVie Company",Negative
 longterm followup data,JanssenUS,Negative
 remissions,Targeted Oncology,Negative
 remissions,AbbVie,Negative
 remissions,"Raul Cordoba, MD, PhD",Negative
 remissions,Cpl Life Sciences,Negative
 remissions,MDedge Hematology & Oncology,Negative
 remissions,Oksana Komarova,Positive
 remissions,Aspen Biosciences,Positive
 remissions,Mark Fortner,Positive
 remissions,Devan Moodley,Positive
 success rates,ASGCT,Negative
 percent,ASGCT,Negative
 percent,Healthy & Active,Positive
 percent,Michael Rahman,Positive
   Interview,Dana-Farber News,Positive
 CART therapy Celgene,BioPharma Dive,Negative
 deal,BioPharma Dive,Negative
 Juno,BioPharma Dive,Negative
 path,BioPharma Dive,Negative
 Expert SpotlightJennifer R Brown MD PhD,Expert Perspectives in Oncology,Negative
 CLL Center,Expert Perspectives in Oncology,Negative
 CLL Center,Verastem Oncology,Negative
 Division,Expert Perspectives in Oncology,Negative
 Harvard Medical SchoolView articles,Expert Perspectives in Oncology,Negative
 rapidly evolving treatment model,JanssenUS,Positive
 Imran Khan MD PhD,JanssenUS,Positive
   Medical Affairs team,JanssenUS,Positive
 IMBRUVICA√Ç,HEDGE accordinglyüìà,Positive
 Significant Improvement,HEDGE accordinglyüìà,Negative
 Significant Improvement,RazzleTazzle,Negative
 Significant Improvement,CRE Demographics,Negative
 Chlorambucil Plus Obinutuzumab,HEDGE accordinglyüìà,Negative
 Chlorambucil Plus Obinutuzumab,RazzleTazzle,Negative
 Chlorambucil Plus Obinutuzumab,CRE Demographics,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic,HEDGE accordinglyüìà,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic,RazzleTazzle,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic,The Pharmaceutical Marketing Group,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic,Lymphoma Coalition,Negative
   Inhye Ahn,Lymphoma Hub,Negative
 Kater et al MRD,Krish Patel,Positive
   discussion,Christopher Steer,Negative
   discussion,VJHemOnc,Negative
   discussion,Roswell Park,Positive
 Paula Cramer,Lymphoma Hub,Negative
 Paula Cramer,ecancer,Negative
 prof Seymour,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 al MURANO,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 Rogers,Krish Patel,Positive
 et al Triplet Obin Ibrutinib Ven x cycles,Krish Patel,Positive
 trainees,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 Thomas Lew,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 department,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 department,CLL Warwick Uni,Negative
 department,ACRF,Positive
 Ouderen,Oncologie Up-to-date,Positive
 profiteren van,Oncologie Up-to-date,Positive
 de frontlijn,Oncologie Up-to-date,Positive
 Massive thanks,VJHemOnc,Negative
   update,ALI ALAHMARI.,Negative
   update,helpsy,Positive
   Daily Wrap Ups TONIGHT,Patient Power,Negative
   Carol Moreno,Lymphoma Hub,Negative
 Older,Talal Hilal ü©∫,Negative
 Older,leo uzych,Negative
 Older,The ASCO Post,Negative
 R Younger pts IGVH,Talal Hilal ü©∫,Negative
 treatment algorithms,John Riches,Positive
   education book,John Riches,Positive
 chemotherapyfree treatment combination,Genentech,Negative
 ground,Kjetil Tasken,Positive
 Cancer Drug Sensitivity Screening,Kjetil Tasken,Positive
   poster,"chadi nabhan MD, MBA, FACP",Negative
   poster,FDA Oncology,Negative
   poster,Lymphoma Hub,Negative
   poster,Winship Cancer Institute of Emory University,Negative
   poster,Biothera Pharma,Positive
 HRU,"chadi nabhan MD, MBA, FACP",Negative
 Dr Adrian Weistner,Patient Power,Negative
 Adaptation,MoJo,Negative
 nights,CURE Magazine,Negative
 CART immunotherapy,Liz Highleyman,Positive
 adult CLL,Liz Highleyman,Positive
 IbrutinibR,"chadi nabhan MD, MBA, FACP",Negative
 mutated IgHV CIT Question,"chadi nabhan MD, MBA, FACP",Negative
 set duration,"chadi nabhan MD, MBA, FACP",Negative
 treatmentfree remissions,Rare Disease Report,Negative
 TGTX T Announces Oral Presentation,Biotech2050,Negative
 Triple Combination,Biotech2050,Negative
 RelapsedRefractory   Richter Transformation,Biotech2050,Negative
 tcoMNcickVy,Biotech2050,Negative
 trial ibrutinib,Casey Foster,Positive
 Novel Regimen,World Neonatology Congress,Negative
 HighRisk   Patients,World Neonatology Congress,Negative
 TransplantationOur Link,World Neonatology Congress,Negative
 Att skilja vetenskap fr√•n trams,Utbildning och IT p√• Kimito√∂n,Positive
 med Emma Frans,Utbildning och IT p√• Kimito√∂n,Positive
 Solo Sokos Hotel Torni Tampere,Utbildning och IT p√• Kimito√∂n,Positive
 Siglec Identified,World Neonatology Congress,Negative
 Drug Target,World Neonatology Congress,Negative
 Chronic    Link,World Neonatology Congress,Negative
 Enhancer Architecture,"Houlston Lab, ICR",Positive
 Enhancer Architecture,"Michael Green, PhD",Negative
 Enhancer Architecture,Kursad Turksen,Positive
 Enhancer Architecture,Pengyu Yang,Positive
 Enhancer Architecture,topbiopapers,Negative
 Essential Core Regulatory Circuitry,"Houlston Lab, ICR",Positive
 Essential Core Regulatory Circuitry,"Michael Green, PhD",Negative
 Essential Core Regulatory Circuitry,Kursad Turksen,Positive
 Essential Core Regulatory Circuitry,Pengyu Yang,Positive
 Essential Core Regulatory Circuitry,topbiopapers,Negative
   Presents New Data,1stOncology,Negative
 Phase    Trial,1stOncology,Negative
 ASH CART,cafepharma,Negative
      TGTX Investor,Biotech2050,Negative
 amp Analyst,Biotech2050,Negative
 √Örets,Linda Mannila,Positive
 Mycket sorl,Linda Mannila,Positive
 Suivi m√©dian de   ans,oncohebdo,Negative
 l√©tude phase,oncohebdo,Negative
 ¬Æ AbbVieRoche associ√©,oncohebdo,Negative
 R√©sultats de suivi jusqu√†   ans,oncohebdo,Negative
 fitting tribute,CLL Ireland,Negative
   Load,MoJo,Negative
   Outperforms Chemoimmunotherapy,MoJo,Negative
 ASH Clinical News,MoJo,Negative
 ibrutinib Data,Financial Buzz,Positive
 ibrutinib Data,Crwe World,Negative
 ibrutinib Data,RazzleTazzle,Negative
 ibrutinib Data,IntoxicatedTrader,Positive
 ibrutinib Data,"Tom Iarocci, MD",Negative
 ibrutinib Data,Dr. Leona Saunders,Positive
 ibrutinib Data,Diaceutics PLC,Negative
 ibrutinib Data,Scott Werntz,Negative
 Progressionfree Su,Financial Buzz,Negative
 Presents New Data,Financial Buzz,Negative
 Presents New Data,Seattle's Banker,Negative
 Presents New Data,HEDGE accordinglyüìà,Negative
 Presents New Data,Crwe World,Negative
 Presents New Data,CRE Demographics,Negative
 Presents New Data,RazzleTazzle,Negative
 Presents New Data,Open Outcrier,Negative
   Chair,Lymphoma Hub,Negative
   Updates,VJHemOnc,Negative
   Updates,CancerWallonia,Negative
   Updates,Patient Power,Negative
 response amp decrease,VJHemOnc,Negative
 w Jordan,VJHemOnc,Negative
 Earlystage Study Evaluating Vecabrutinib,Hottest Stocks Now,Negative
 Congratulations Jennifer Woyach,Kevin Kuo,Positive
 Untreated Older Pts,MoJo,Negative
 Plenary,"Caner Saygin, MD",Negative
 contributions,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 contributions,ASH,Negative
 contributions,Jonathan Friedberg,Positive
 Prof Seymour,Haematology Peter MacCallum CC & Royal Melbourne,Negative
 Roberts MRD negativity,Haematology Peter MacCallum CC & Royal Melbourne,Negative
   Jennifer Woyach,Lymphoma Hub,Negative
 presents results,Lymphoma Hub,Negative
 Alliance North American Intergroup study,Lymphoma Hub,Negative
 Woyach et alPh RCT Alliance ABR,"Firas El Chaer, MD",Positive
 BR Ibrutinib,"Firas El Chaer, MD",Positive
   Jennifer,Taylor Lab UM,Negative
 Alliance trial results,Taylor Lab UM,Negative
 Ibrutinib   Rituximab,Taylor Lab UM,Negative
 frontline use,Taylor Lab UM,Negative
 frontline use,Paul Lane,Negative
 frontline use,Lymphoma Hub,Negative
 Signs,"Pharmacyclics, an AbbVie Company",Positive
 Signs,Freelance Writer,Positive
 Signs,Greencrest Pharmacy,Positive
 Energiehuishouding Tcellen belangrijk voor succes,Oncologie Up-to-date,Positive
 Tceltherapie,Oncologie Up-to-date,Positive
 van Bruggen,Oncologie Up-to-date,Positive
 nu,Oncologie Up-to-date,Positive
 nu,MEDtalks,Positive
 substitute,Joana Koury,Positive
 previously untreated   age,Joana Koury,Positive
 David Lesoway Senior Director Marketing,"Pharmacyclics, an AbbVie Company",Negative
 IGHV mutation testing,Janssen Global,Negative
    Regimens,leo uzych,Negative
   Update New Frontline Standard,Oncology Times,Negative
 w Stephan Stilgenbauer,VJHemOnc,Negative
 Progressionfree Surviv,Crwe World,Negative
   chronic lymphocytic,JanssenUS,Positive
   chronic lymphocytic,Janssen Global,Negative
   chronic lymphocytic,suetodd16,Positive
   chronic lymphocytic,Catherine Vel√°zquez,Positive
   chronic lymphocytic,Genentech,Negative
   chronic lymphocytic,Adaptive Biotech,Negative
 Steering Committee member,Lymphoma Hub,Negative
 outcome predictors,Lymphoma Hub,Negative
 MZL,Lymphoma Hub,Negative
 Paolo Strati MD   Combination,Robert Z. Orlowski,Positive
 Paolo Strati MD   Combination,MD Anderson Leukemia,Negative
 Lenalidomide amp Rituximab,Robert Z. Orlowski,Positive
 Lenalidomide amp Rituximab,MD Anderson Leukemia,Positive
 Pts w TreatmentNa√ØVe,Robert Z. Orlowski,Positive
 Pts w TreatmentNa√ØVe,MD Anderson Leukemia,Positive
 Treatment Results,Robert Z. Orlowski,Positive
 Treatment Results,MD Anderson Leukemia,Positive
 Concurrent treatment,Fred Hutch,Negative
 ibrutinib amp CD   therapy,Fred Hutch,Negative
 ¬Æ ibrutinib Data,HEDGE accordinglyüìà,Negative
   Tanya Siddiqi,Lymphoma Hub,Negative
 III TRANSCEND,Lymphoma Hub,Negative
 Jordan Gauthier,Lymphoma Hub,Negative
 leukapheresis,Lymphoma Hub,Negative
 CDspecific   therapy,HemOnc Today,Negative
   Saar Gill,Lymphoma Hub,Negative
 Prospective Clinical Trial,ALI ALAHMARI.,Negative
 AntiCD CAR T Cells,ALI ALAHMARI.,Negative
 High Response Rate,ALI ALAHMARI.,Negative
 High Response Rate,Lymphomation.org,Negative
 High Response Rate,genetic insidER,Positive
 High Response Rate,Krishan Maggon,Negative
 High Response Rate,Paul Lane,Negative
 High Response Rate,Ellen Una,Positive
 High Response Rate,Cyndi Joycelyn,Positive
 High Response Rate,jennifermcaiyr1983,Positive
 High Response Rate,Lelah Lakita,Positive
 High Response Rate,Cancer Blog,Negative
 High Response Rate,CRO Contract Res.,Negative
 High Response Rate,BusinessWireProducts,Negative
 High Response Rate,Scott Werntz,Negative
 High Response Rate,dlvr news,Negative
 Anthony Mato,Lymphoma Hub,Negative
 Anthony Mato,VJHemOnc,Negative
 relapsedrefractory     patients,Lymphoma Hub,Negative
   Paolo Strati MD   Combination,MD Anderson Leukemia,Negative
 Oral Pres,Robert Z. Orlowski,Positive
 Phase II Trial,Robert Z. Orlowski,Negative
 Phase II Trial,MD Anderson Leukemia,Negative
   Paolo Strati,Lymphoma Hub,Negative
 lenalidomide,Lymphoma Hub,Negative
 lenalidomide,UCL Discovery,Negative
 lenalidomide,TF binding papers üìö,Positive
 lenalidomide,Blood Advances,Positive
 lenalidomide,TumorImmunoPapers,Positive
 lenalidomide,NK papers,Negative
 lenalidomide,"Dr T. Comeau , MD",Negative
 lenalidomide,Lymphoma Coalition,Negative
 LBA   Acquisition,"Mike Thompson, MD, PhD, FASCO",Negative
 Progressive Chronic Lymphocytic Leukemia CLL,"Mike Thompson, MD, PhD, FASCO",Negative
 Blombery,"Mike Thompson, MD, PhD, FASCO",Negative
    Oral Pres,MD Anderson Leukemia,Positive
    Oral Pres,Lisa Palacios,Positive
 Response   MarriottMarina Pacific BR,Robert Z. Orlowski,Negative
 Response    Pacific BR,MD Anderson Leukemia,Negative
   moments,MoJo,Negative
 ‚ö° Ô∏è ‚Äú update,Anna Deveau,Positive
 Drs,Dana-Farber,Negative
 Drs,Dana-Farber News,Positive
 Drs,Research To Practice,Negative
 Daniel DeAngelo,Dana-Farber,Negative
 Daniel DeAngelo,Dana-Farber News,Positive
 Jennifer Brown,Dana-Farber,Negative
 Jennifer Brown,Dana-Farber News,Positive
 Jennifer Brown,VJHemOnc,Positive
 Scott Armstrong,Dana-Farber,Negative
 booth,Dana-Farber,Negative
 booth,Verastem Oncology,Negative
 booth,Lidija Pecova,Positive
 booth,AbbVie,Positive
 schedule,Dana-Farber,Negative
 schedule,Dana-Farber News,Positive
 DanaFarber experts,Dana-Farber,Negative
 Twitter CLL Overall Treatment Savings,Dr Timos Papagatsias,Negative
 Higher Prescription Costs,Dr Timos Papagatsias,Negative
 Higher Prescription Costs,info@medicalresearch.com,Positive
 CLL Overall Treatment Savings,info@medicalresearch.com,Positive
 nd day,VJHemOnc,Negative
 nd day,"Chared, Good Comms",Negative
 nd day,European Hematology Association,Negative
 nd day,HARMONY Alliance,Negative
 Ami Solutions News,Laurent G - Francis,Positive
 Treatment decisions,MoJo,Negative
   Clonality,MoJo,Negative
 „Éô„É≥„ÉÄ„Åã„Çâ„Ç§„Éñ„É´„ÉÅ„Éã„Éñ„Åù„ÅÆÊ¨°„ÅØ„Éô„Éç„Éà„ÇØ„É©„ÉÉ„ÇØ„Çπ,Ë°ÄÊ∂≤ÂÜÖÁßëÂåª„ÄÄ‰∏≠Êùë„ÄÄÂπ∏Âó£,Positive
 F Haroun MD,Dr Timos Papagatsias,Negative
   Jae Park,Lymphoma Hub,Negative
   Jae Park,@sehh_es,Negative
   Jae Park,"Raul Cordoba, MD, PhD",Negative
 presents data,Lymphoma Hub,Negative
 checkpoint inhibition,Jordan Gauthier,Positive
 antiCLL T cell,Jordan Gauthier,Positive
 exhaustion,Jordan Gauthier,Positive
 Dr Maria Joao Baptista,"W. Keith Hoots, M.D.",Negative
 clonality,"W. Keith Hoots, M.D.",Negative
 TCR repertoire,"W. Keith Hoots, M.D.",Negative
 San Diego Ballroom,"W. Keith Hoots, M.D.",Negative
 media,The James,Negative
 breakthrough   treatment research,The James,Negative
 VENCLEXTA√Ç,HEDGE accordinglyüìà,Negative
 VENCLYXTO√Ç,HEDGE accordinglyüìà,Positive
   Nitin Jain,Lymphoma Hub,Negative
 Ritux,Crwe World,Negative
 em,"Amber Koehler, PA-C",Negative
 em,Robat Taylor Khalifa,Positive
 ASH excitement,"Amber Koehler, PA-C",Negative
 Minne‚Äùsnow‚Äùta,"Amber Koehler, PA-C",Negative
   John Seymour,Lymphoma Hub,Negative
 feasibility,Lymphoma Hub,Negative
 timelimited venetoclaxrituximab combination therapy,Lymphoma Hub,Negative
 ABBV presents,Odi Bruckman,Negative
 timelimited VenetoclaxRituximab VenR Combination Therapy,Jeff Szer,Negative
   Peter Hillmen,Lymphoma Hub,Negative
   Andy Rawstron,Lymphoma Hub,Negative
 Inconvenient truths,CLL_Fightersüéó,Negative
    HamWasserman lecture,MoJo,Negative
 Summary slide,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Michael Hallek speaker,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 HamWasserman lecture,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 HamWasserman lecture,Alan Skarbnik,Negative
 Creation,Florent Malard,Negative
     HamWasserman Lecture,"Mike Thompson, MD, PhD, FASCO",Positive
 Architecture,"Mike Thompson, MD, PhD, FASCO",Positive
 Translational Research,"Mike Thompson, MD, PhD, FASCO",Positive
 Gesamtkunstwerk,"Mike Thompson, MD, PhD, FASCO",Negative
 Ven amp ibrutinib,"Mike Thompson, MD, PhD, FASCO",Negative
 Dr Hallek,Alan Skarbnik,Negative
 masterclass,Alan Skarbnik,Negative
 lymphocytosis,"Mike Thompson, MD, PhD, FASCO",Negative
 lymphocytosis,NEJM CPC,Positive
 lymphocytosis,"Raul Cordoba, MD, PhD",Negative
 lymphocytosis,Christopher Steer,Negative
 marker,"Mike Thompson, MD, PhD, FASCO",Negative
 marker,VJHemOnc,Negative
 HamWasserman Lecture,Razan Mohty,Positive
 Dr Micheal Hallek,Razan Mohty,Positive
 Join Dr Michael Hallek,"W. Keith Hoots, M.D.",Negative
 Hall AB,"W. Keith Hoots, M.D.",Negative
 Expert series features,Patient Empowerment Network,Negative
 favourite,Zack Pemberton-Whiteley,Negative
 exhibition hall,Zack Pemberton-Whiteley,Negative
 company pipelines,Zack Pemberton-Whiteley,Negative
     treatment,NYCDoc29,Positive
 flowchart,NYCDoc29,Negative
     treatment Mayo Approach,NYCDoc29,Negative
 morning meetings,Zack Pemberton-Whiteley,Negative
     Presentation,NYCDoc29,Negative
 Diagnostics,NYCDoc29,Negative
     prevalence,NYCDoc29,Negative
   State,NYCDoc29,Negative
 Art,NYCDoc29,Negative
 Art,microRNApapers,Negative
 Art,PER,Negative
 Qs,NYCDoc29,Negative
 Qs,Patient Power,Negative
 Qs,Andrew Schorr,Negative
 Qs,Columbia Med School,Positive
   novel combinations,NYCDoc29,Negative
 bullet,NYCDoc29,Negative
   CARs,NYCDoc29,Negative
 BMT,NYCDoc29,Negative
   Nuts n Bolts,NYCDoc29,Negative
   ibrutinib mutations,NYCDoc29,Negative
 Dr Jen Brown Director,Verastem Oncology,Negative
 Phase   DUO study,Verastem Oncology,Negative
 exploratory analysis,Verastem Oncology,Negative
 Chronic Lymphocytic Leukemia CLL Therapy,MoJo,Negative
 Automated,Richard Rosenquist Brandell,Positive
 clustering,Richard Rosenquist Brandell,Positive
 D immunoglobulin protein structures,Richard Rosenquist Brandell,Positive
   stage,The James,Negative
 Sunday,The James,Negative
 Sunday,CLL Warwick Uni,Negative
 Sunday,Amy C. Cavers,Negative
 Sunday,LymphomaAction,Negative
 Sunday,CLLSA,Positive
 Sunday,CAPhO,Negative
 shell,The James,Negative
 Plenary Scientific Session,The James,Negative
 Clin Trials,FDA Oncology,Negative
 Real World Treatment Duration amp Survival,FDA Oncology,Negative
 hyperprogressionflare,Jordan Gauthier,Positive
 Murine data,Jordan Gauthier,Positive
 Tcell responses,Jordan Gauthier,Positive
 Dysfunctional AntigenSpecific T Cell Responses,Jordan Gauthier,Positive
 Experimental CLL,Jordan Gauthier,Positive
 Model,Jordan Gauthier,Positive
 Model,Lymphoma Hub,Negative
 Autologous T CellBased Therapies,Jordan Gauthier,Positive
 Chronic Lymphocytic Leukemia Cancer Cell,Pengyu Yang,Positive
    P Oral,MD Anderson Leukemia,Positive
 Pts w TreatmentNa√Øve HighRisk     Pacific BR,MD Anderson Leukemia,Negative
 P Oral,Robert Z. Orlowski,Negative
 Firstline Treatment,Robert Z. Orlowski,Negative
 Firstline Treatment,MD Anderson Leukemia,Negative
 Firstline Treatment,CureHuntr,Negative
 Firstline Treatment,TrialBulletin,Negative
 Firstline Treatment,Diaceutics PLC,Positive
 Firstline Treatment,1stOncology,Positive
 Firstline Treatment,CLL Society Inc.,Negative
 Firstline Treatment,$Stocknewsalerts,Positive
 Firstline Treatment,NACDA Program on Aging,Negative
 Firstline Treatment,"John C. Wunsch, P.C.",Negative
 Firstline Treatment,Orbis Biosciences,Negative
 Firstline Treatment,frothmouth,Positive
 Firstline Treatment,Rare Diseases,Negative
 Firstline Treatment,Jos√© Lu√≠s Marques Br,Positive
 Firstline Treatment,COPD News,Negative
 Firstline Treatment,"Krishna Talluri, MD",Positive
 Firstline Treatment,crewmilitary,Positive
 Firstline Treatment,IntoxicatedTrader,Positive
 Firstline Treatment,PRN Biotech,Negative
 Firstline Treatment,Financial Buzz,Negative
 Firstline Treatment,NEWS.GNOM.ES,Positive
 Firstline Treatment,TradeXchange,Negative
 w Mutated,Robert Z. Orlowski,Negative
 w Mutated,MD Anderson Leukemia,Negative
 IGHV amp,Robert Z. Orlowski,Negative
 IGHV amp,MD Anderson Leukemia,Negative
 TP Aberrations,Robert Z. Orlowski,Negative
 TP Aberrations,MD Anderson Leukemia,Negative
 TP Aberrations,CancerTherapyAdvisor,Negative
 TP Aberrations,Scott Werntz,Negative
 MarriottMarina Pacific BR,Robert Z. Orlowski,Negative
 Pacific BR,MD Anderson Leukemia,Negative
 Resistant Chronic Lymphocytic Leukemia,The ASCO Post,Negative
 Treatment Armamentarium,The ASCO Post,Negative
   segment,Patient Power,Negative
 TreatmentNa√Øve HighRisk Chronic Lymphocytic Leukemia CLL,ALI ALAHMARI.,Negative
 TreatmentNa√Øve HighRisk Chronic Lymphocytic Leukemia CLL,"Naveen Pemmaraju, MD",Negative
 Post d,Jeff Sharman,Positive
 Patient Advocacy Director Zack,Leukaemia Care,Negative
 San DiegoFollow,Leukaemia Care,Negative
 Change,MoJo,Negative
 Change,Austin Publishing,Positive
 Change,VJHemOnc,Negative
 Based Therapy,MoJo,Negative
 Vs FCR Chemoimmunotherapy,MoJo,Negative
 CLL Trial,MoJo,Negative
 CLL Trial,üÖæ Jaksic,Negative
 ECOGACRIN Cancer Research Group E,MoJo,Positive
 ECOGACRIN Cancer Research Group E,Dr.Alberto Mussetti,Negative
 Human IL rhIL,Cancer News,Negative
 Human IL rhIL,TrialBulletin,Negative
 Relapsed Refractory Chronic Lymphocyte Leukemia Status,TrialBulletin,Negative
 Condition Summary Leukemia Lymphocytic Chronic BCell,TrialBulletin,Positive
 patients ‚Äò Dream Team,CLL_Fightersüéó,Negative
 todays Facebook Live,Andrew Schorr,Negative
    Dr Richard Furman,Oncology Learning Network,Negative
 case amp answer,AJNR,Positive
 yearoldman,AJNR,Positive
 Join LLS,LLS National Capital,Positive
 Expert SpotlightJan Burger MD PhD,Expert Perspectives in Oncology,Negative
 Houston USA View articles,Expert Perspectives in Oncology,Negative
 Web Check,Dr Timos Papagatsias,Negative
 images videos,Dr Timos Papagatsias,Negative
 Refractory Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H   Report,CRO Contract Res.,Negative
 Refractory Chronic Lymphocytic Leukemia,CRO Contract Res.,Negative
 Refractory Chronic Lymphocytic Leukemia,Paul Scolardi,Positive
 Global Clinical Trials,CRO Contract Res.,Negative
   approved Celltrion,Alaric DeArment,Positive
 TEVAs,Alaric DeArment,Positive
 lowgrade,Alaric DeArment,Positive
 ref product Rituxans indications,Alaric DeArment,Positive
 Truximas label,Alaric DeArment,Positive
 Patient Perspective,Nick,Negative
 Patient Perspective,Oncology Tube,Negative
 Deb Sims   patient,Nick,Negative
 mother,Nick,Negative
 mother,Born to die for Freedom,Positive
 mother,H_Ram,Positive
 VŒ≥VŒ¥Tcell fitness,Blood Journal,Negative
 snss,Anna Deveau,Negative
 Event,Anna Deveau,Positive
 Slide Webcast,Anna Deveau,Negative
 Deborah Sims   patient passionate advocate,CLL Ireland,Negative
 Calm,Amy C. Cavers,Negative
 storm,Amy C. Cavers,Negative
 storm,brian brown,Negative
 ASHbiggest blood cancer conf,Amy C. Cavers,Negative
 year stwork mtgs,Amy C. Cavers,Negative
 Del Mar Breatheget,Amy C. Cavers,Negative
 run BLESSED,Amy C. Cavers,Negative
 PIK pŒ¥ Inactivation Antagonizes Chronic Lymphocytic Leukemia amp,Immune Regulation News,Negative
 T Cell Immune Suppression,Immune Regulation News,Positive
 Expert SpotlightAnthony R Mato MD MSCE,Expert Perspectives in Oncology,Negative
 Associate Member,Expert Perspectives in Oncology,Negative
 Chronic Lymphocytic Leukemia CLL ProgramView articles,Expert Perspectives in Oncology,Negative
 tcoygyenc,Sue Carlson,Positive
 vets,Hoofcare+Lameness,Positive
 vets,Continuous Lifecycle London (online),Negative
 Walter Styer,Penn IFI,Positive
 CAR T Cell therapy patient,Penn IFI,Positive
 David Porter,Penn IFI,Positive
 myeloma,Andrew Schorr,Negative
 National Institute,ASH Clinical News,Negative
 Health Care Excellence,ASH Clinical News,Negative
 Open Access UCL Research LenD,UCL Discovery,Negative
 Blwyddyn,Melin Gruffydd,Positive
 yn mwynhau dysgu,Melin Gruffydd,Negative
 addurniadau,Melin Gruffydd,Negative
 Nadolig Fictorianaidd yn,Melin Gruffydd,Negative
 y Pwll Mawr,Melin Gruffydd,Negative
 I√±aki Mart√≠nSubero,VJHemOnc,Negative
 Dr John Byrd Chris Dwyer amp Lisa Minkove RIP,CLL Ireland,Negative
 novel Bcell receptor BCR kinase inhibitor,CLL_Fightersüéó,Negative
 phosphoinositide kinase PIKŒ¥Œ≥,CLL_Fightersüéó,Negative
 New twitter,Champions Laser League,Positive
 Willamette Valley   Institute,CLL_Fightersüéó,Negative
 Research Center,CLL_Fightersüéó,Negative
 Research Center,Patient Empowerment Network,Negative
 een zelfs   tegelijk echt,Bla Fino,Positive
 Expert ‚Äù session,Patient Empowerment Network,Positive
 Expert ‚Äù session,Patient Power,Negative
 specialist Dr Jeff Sharman,Patient Empowerment Network,Negative
 Willamette Valley Cancer Institute,Patient Empowerment Network,Negative
 VIDEO Watch Kanti Rai,VJHemOnc,Negative
 perch,WheelieDealer,Negative
 Fwd pe,WheelieDealer,Negative
 divvy,WheelieDealer,Negative
 meI,Miss Joyce,Positive
 itI,Miss Joyce,Positive
   sessions,Lorna Warwick,Positive
 pilot study,MDS 2019,Positive
 pilot study,"Raul Cordoba, MD, PhD",Negative
 pilot study,Shankara Paneesha,Negative
 pilot study,Blood Journal,Negative
 pilot study,CLL Ireland,Negative
 pilot study,Nimish shah,Positive
 pilot study,Garbi√±e Lizeaga,Negative
   aprendan enanos,Lenko Sins,Positive
 miRa expression,ASH,Negative
 miRa expression,Blood Journal,Negative
 New New treatment recommendations,Medivizor,Negative
 leukaemia patients,PharmaJobs.co.uk,Positive
 leukaemia patients,Pf Magazine,Positive
 leukaemia patients,#WeAreE4H,Positive
 Robin Fo√† MD,CLL Ireland,Negative
 Sapienza University,CLL Ireland,Negative
 Rome Rome Italy,CLL Ireland,Negative
 ibrutinib binds,Thiago Carvalho,Negative
 ITK,Thiago Carvalho,Negative
 Œ≥Œ¥ T cells,Thiago Carvalho,Negative
 Œ≥Œ¥ T cells,"Raul Cordoba, MD, PhD",Negative
 LLC series,EDN.com,Positive
 Inactivation Antagonizes Chronic Lymphocytic Leukemia amp,Immune Regulation News,Negative
 free   webcast,Bag It - Cancer Support,Positive
 CoveredOverview,Bag It - Cancer Support,Positive
 Chronic Lymphocytic Leukemia CLLKey Questions,Bag It - Cancer Support,Positive
 Targeted Therapy Combo Works,Cancer Health,Positive
 countdown,Dr Timos Papagatsias,Negative
 countdown,Lymphoma Hub,Negative
 hematologistoncologist,CLL Ireland,Negative
 chimeric antigen receptor T cell therapy,CLL Ireland,Negative
 VIDEO Novel   combinations,VJHemOnc,Negative
 Eva Kimby,VJHemOnc,Negative
 Rainham London,Helen Jane Mee,Negative
 venue,Helen Jane Mee,Negative
 New Combinations,Medivizor,Negative
 Ibrutinib PCIBased Therapy Vs Standard Fludarabine Cyclophosphamide,Rafael Fonseca MD,Positive
 Ibrutinib PCIBased Therapy Vs Standard Fludarabine Cyclophosphamide,üÖæ Jaksic,Negative
 Ibrutinib PCIBased Therapy Vs Standard Fludarabine Cyclophosphamide,"Naveen Pemmaraju, MD",Negative
 Ibrutinib PCIBased Therapy Vs Standard Fludarabine Cyclophosphamide,ALI ALAHMARI.,Negative
 Ibrutinib PCIBased Therapy Vs Standard Fludarabine Cyclophosphamide,CLL,Negative
 Rituximab FCR Chemoimmunotherapy,Rafael Fonseca MD,Positive
 Rituximab FCR Chemoimmunotherapy,üÖæ Jaksic,Negative
 Rituximab FCR Chemoimmunotherapy,"Naveen Pemmaraju, MD",Negative
 Rituximab FCR Chemoimmunotherapy,ALI ALAHMARI.,Negative
 Rituximab FCR Chemoimmunotherapy,CLL,Negative
 Chronic Lymphocytic Leukemia CLL   LBA Tue,Rafael Fonseca MD,Positive
 ÿ£ÿ∂ŸÅÿ™ ŸÅŸäÿØŸäŸà ÿ•ŸÑŸâ ŸÇÿßÿ¶ŸÖÿ©,Reem üå∏,Positive
 ÿπŸÑŸâ   Chronic Lymphocytic Leukemia CLL,Reem üå∏,Positive
 T cell therapy,CLL Ireland,Negative
 T cell therapy,Andrew Schorr,Negative
 T cell therapy,Michele Nadeem-Baker,Negative
 Framtidsdalen forts√§tter,Utbildning och IT p√• Kimito√∂n,Positive
 Nu,Utbildning och IT p√• Kimito√∂n,Positive
 Joki,Utbildning och IT p√• Kimito√∂n,Positive
 Joki Turku,Utbildning och IT p√• Kimito√∂n,Positive
 VIDEO perspective,VJHemOnc,Negative
 New booklet,CLL Ireland,Negative
 ‚Äì cell fitness,Jitakshi,Positive
 Decorated,Patient Worthy,Negative
 Admiral,Patient Worthy,Negative
 President Trump Spat,Patient Worthy,Negative
 Rare Form,Patient Worthy,Negative
 ü¶É Happy Thanksgiving,CryptoLiveLeak,Negative
 ü¶É,CryptoLiveLeak,Negative
 Human Pathology Cortactin expression,European Association for Haematopathology,Negative
 Framtidsdalen Unga,Utbildning och IT p√• Kimito√∂n,Positive
 delaktighet,Utbildning och IT p√• Kimito√∂n,Positive
 och v√§lf√§rd med Georg Henrik Wrede,Utbildning och IT p√• Kimito√∂n,Positive
 Biocity,Utbildning och IT p√• Kimito√∂n,Positive
 Turku,Utbildning och IT p√• Kimito√∂n,Positive
 leukemiaWallenberg Clinical Scholar Richard Rosenquist Brandell,Cancer Core Europe,Positive
 leukemiaWallenberg Clinical Scholar Richard Rosenquist Brandell,KAW,Positive
 VIDEO Immune exhaustion,VJHemOnc,Negative
 wAdrian Wiestner,VJHemOnc,Negative
 CLL Patient Caf√© Tools,Ron Grunsby,Positive
 MidLife,Ron Grunsby,Positive
 UK NICE,Guillermo Sanz,Negative
 O Jaksic,Dr Timos Papagatsias,Negative
 Ibrutinib PCIBased Therapy Vs Standard Fludarabine Cyclophos,Dr Timos Papagatsias,Negative
 VIDEO Cellextrinsic,VJHemOnc,Negative
    Randomized Phase III Study,üÖæ Jaksic,Negative
 ECOGACRIN Group E,üÖæ Jaksic,Negative
 following topic   Immune Dysfunction Infection Risk,Expert Perspectives in Oncology,Negative
 Ibrutinib PCIBased Therapy Vs FCR,Dr.Alberto Mussetti,Negative
 Chronic Lymphocytic Leukemia CLL Trial,Dr.Alberto Mussetti,Negative
 Chronic Lymphocytic Leukemia CLL Trial,ALI ALAHMARI.,Negative
 Chronic Lymphocytic Leukemia CLL Trial,CLL,Negative
 Chronic Lymphocytic Leukemia CLL Trial,MoJo,Negative
 Ibrutinib   antiCD,Abdel-Wahab Lab,Positive
 lt yo,Abdel-Wahab Lab,Positive
     patients ibrutinib,Lucrecia Ya√±ez,Positive
 PFS amp OS,"chadi nabhan MD, MBA, FACP",Negative
 nonpdeleted lt,"chadi nabhan MD, MBA, FACP",Negative
 Looking,"chadi nabhan MD, MBA, FACP",Negative
 IMO cc,"chadi nabhan MD, MBA, FACP",Negative
 Managing Bleeding Risk,Expert Perspectives in Oncology,Negative
 Milton Aranha,Dr Timos Papagatsias,Negative
 Twitter Pratice change,Dr Timos Papagatsias,Negative
 st line MM,Dr Timos Papagatsias,Negative
 st line MM,Milton Aranha,Positive
 Pratice change,Milton Aranha,Positive
 ASH presentation,Jeff Sharman,Positive
 CLL study,Jeff Sharman,Positive
 ASCI member John C Byrd,ASCI,Positive
 TPIK,ASCI,Positive
 ECOGACRIN,ALI ALAHMARI.,Negative
 cancer stories,TheDayThatChangedMyL,Negative
 cancer stories,SOLUTIONS Cancer,Positive
 ECOGACRIN Cancer Research,CLL,Negative
 Ibrutinib PCIBased Therapy Vs FCR Chemoimmunotherapy,MoJo,Negative
 ECOG trial,"Amber Koehler, PA-C",Negative
 Late Breaking Abstract Session,Guillermo Sanz,Negative
 yr ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å© ‚Å¶‚Å©,Guillermo Sanz,Negative
 ‚Å¶‚Å¶‚Å©,Guillermo Sanz,Positive
 STUDENTS amp STAFF local Forum,Finsbury Park & Stroud Green Neighbourhood Forum,Positive
 views,Finsbury Park & Stroud Green Neighbourhood Forum,Positive
 policy,Finsbury Park & Stroud Green Neighbourhood Forum,Positive
   resistance,Anna Deveau,Negative
 tcofYMmVqrf,Anna Deveau,Negative
     combination,Anna Deveau,Negative
 „Éô„Éç„Éà„ÇØ„É©„ÇØ„Çπ‰ΩµÁî®ÁôÇÊ≥ï„ÄÅCLLÂØæË±°„ÅÆPË©¶È®ì„ÅßÁÑ°Â¢óÊÇ™ÁîüÂ≠òÊúüÈñì„ÇíÈÅîÊàêÔºçÁ±≥„Ç¢„ÉÉ„É¥„Ç£,QLifeProÂåªÁôÇÊÉÖÂ†±,Positive
 Nursery Rhyme number,Rabbits Class,Positive
 BeiGene Initiates Global HeadtoHead Phase III Clinical Trial,Hematopoiesis News,Negative
 Small Lymphocytic,Hematopoiesis News,Negative
 Small Lymphocytic,Lampe & Company,Negative
 Small Lymphocytic,Financial Buzz,Negative
 Small Lymphocytic,Medicine Matters oncology,Positive
 Small Lymphocytic,1stOncology,Negative
 Small Lymphocytic,Oncology,Negative
 McRaven,Artislove,Positive
 McRaven,Peacock,Positive
 McRaven,Anthony J. Rivera,Positive
 McRaven,Gavlarüíô,Positive
 McRaven,EricaGrieder,Positive
 hero,Artislove,Positive
 hero,Verastem Oncology,Negative
 upcoming   program,Phoebe Needles,Negative
 B Sharps,Phoebe Needles,Negative
 holiday cheer,Phoebe Needles,Negative
 party,Peacock,Positive
 party,Selma Errol Hassan,Positive
 rule,Peacock,Positive
 law,Peacock,Positive
 law,Nadya khan Gabol (NG),Positive
 military,Peacock,Positive
 Communication,TrialBulletin,Negative
 Illness   Pilot Study Status Recruiting Condition Summary Malignant Neoplasm Leukemia Lymphocytic Chronic BCell Lung Disease Chronic Congestive Heart Failure Liver Failures Chronic Renal Insuf,TrialBulletin,Negative
 VIDEO   mechanisms,VJHemOnc,Negative
 currently ibrutinib,Anna Deveau,Negative
 MRDibrutinib venetocalx Allo,Anna Deveau,Negative
 tcolAZIjWG,Anna Deveau,Negative
 Retired Adm William H McRaven,William Meyer,Positive
 Pr√≥ximas,Lenko Sins,Positive
 de su,Lenko Sins,Positive
 y pr√≥ximo retador n√∫mero,Lenko Sins,Positive
 Geroge,The Patient's Channel,Negative
 handful,LiveYourLife,Negative
 Marc Auckland,CLLSA,Negative
 Marc,CLLSA,Negative
 Marc,Leukaemia Care,Negative
 Marc,CancerWallonia,Positive
 Charity membership committee,CLLSA,Negative
 conferences CLLSA literature,CLLSA,Negative
 CLL Champions amp,CLLSA,Negative
 strategy amp governance team,CLLSA,Negative
 Frank Mercer,CLLSA,Negative
 Chronic Lymphocytic Leukemia Market CLL Insights Epidemiology,Epidemiology Live 2020,Positive
 Rupert Beazley,CLLSA,Negative
 amp Nephrotic Syndrome,CLLSA,Negative
 Rupert,CLLSA,Negative
 John Moore,CLLSA,Negative
 CLLSAs,CLLSA,Negative
 amp governance work,CLLSA,Negative
 David Innes,CLLSA,Negative
 posts,CLLSA,Negative
 posts,CryptoLiveLeak,Negative
   support,CLLSA,Negative
 VIDEO   therapy,VJHemOnc,Negative
 chancellor,Anthony J. Rivera,Positive
 uncle,EM-LEH,Positive
 uncle,üë£Helen's Journeyüë£ (Blogger‚ôî & Poetüìù),Positive
   Expert session,Patient Power,Negative
 pattern,Gavlarüíô,Positive
 VIDEO   cell dynamics,VJHemOnc,Negative
 Nicholas Chiorazzi,VJHemOnc,Negative
   Treatment Advances,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 VIDEO ERIC,VJHemOnc,Negative
 Happy Thanksgiving,Leiy Bustamante,Negative
 Happy Thanksgiving,Higher Ground at Lake Louise,Negative
 ü§ó,Leiy Bustamante,Negative
 Palms Country Club,Leiy Bustamante,Positive
 Ikaw talaga,Leiy Bustamante,Negative
 saakin,Leiy Bustamante,Negative
 Salamat po ng marame,Leiy Bustamante,Negative
 Dr OBrien,Targeted Oncology,Negative
 Dr OBrien,UCI School of Medicine,Positive
 Dr OBrien,MD Anderson Leukemia,Negative
 Dr OBrien,Jeff Folloder,Positive
 CURE Media Group,SPI News,Negative
 Host Annual Gala Honoring Chronic Lymphocytic Leukemia Heroes,SPI News,Negative
   Media Group,MJH Life Sciences,Positive
 Host,MJH Life Sciences,Positive
 VIDEO Regulation,VJHemOnc,Negative
 puppets,Mrs Prince,Positive
 SENP exerts,Lymphoma Papers,Negative
 anti‚Äëtumor effect,Lymphoma Papers,Negative
 Current Emerging Treatment Options,CLL Ireland,Negative
 tcoxdfpNeh,CLL Ireland,Negative
 VIDEO Current ERIC research,VJHemOnc,Negative
    field,VJHemOnc,Negative
 Marwan Ghosn,Ordre Pharmaciens LB,Positive
 Chronic Lymphocytic Leukemiashifting treatment paradigm,Ordre Pharmaciens LB,Positive
 CEO amp Founder Dr Ayg√ºn Sahin,Cancer Education and Research Institute,Positive
   Chapter,Cancer Education and Research Institute,Positive
 National Chronic Lymphoblastic,Cancer Education and Research Institute,Positive
 Support Group,Cancer Education and Research Institute,Positive
 CART research expert,Cancer Education and Research Institute,Positive
 ICYMI WATCH Dr Paolo Strati,Oncology Times,Negative
 recipient,Oncology Times,Negative
 Dr John Hayslip,AbbVie,Negative
 fellow physicians,AbbVie,Negative
   algorithm,CLL_Fightersüéó,Negative
 VIDEO DUO,VJHemOnc,Negative
 twitter handle,"chadi nabhan MD, MBA, FACP",Negative
 VIDEO   markers,VJHemOnc,Negative
 extension,ipharmacenter,Negative
 extension,CLL,Negative
 patientsMore,ipharmacenter,Negative
 industry,ipharmacenter,Negative
 New Treatment,Medivizor,Negative
 New Treatment,Pharmacy Podcast Network,Positive
 New Treatment,Rx Generator | Business Strategy,Positive
 Fludarabine,Invitro Diagnostics News & Research,Positive
 Fludarabine,Cancer Papers,Negative
 Fludarabine,Lampe & Company,Negative
 Fludarabine,PharmaFactz,Negative
 Fludarabine,ACS Journal Cancer,Negative
 Promotion,Invitro Diagnostics News & Research,Positive
 evenings,CLL Ireland,Negative
 VIDEO European Research Initiative,VJHemOnc,Negative
 VIDEO European Research Initiative,Oncology Tube,Negative
 ERIC International Meetings,VJHemOnc,Negative
 Kostas Stamatopoulos,VJHemOnc,Positive
 Kostas Stamatopoulos,Csaba B√∂d√∂r,Positive
   Therapeutics Market Segmentation,ChaitanyaG,Positive
 TIME TRENDS,Ravi Goyal,Positive
 FRONTLINE SYSTEMIC,Ravi Goyal,Positive
 THERAPY,Ravi Goyal,Positive
 UNITED STATES,Ravi Goyal,Positive
 VIDEO Treatmentchanging advancements,VJHemOnc,Negative
 BTK BCL CD amp,VJHemOnc,Negative
 Kanti Rai,VJHemOnc,Positive
 Kanti Rai,"chadi nabhan MD, MBA, FACP",Negative
 Terry,Glen Janred,Positive
 Terry,andy,Positive
 Terry,Kendall Pino,Positive
 Dr Jennifer Woyachs strategy,ASH,Negative
 Evolving Paradigms,Targeted Oncology,Negative
 MIA,AbbVie,Negative
 Current Treatment Landscape,The ASCO Post,Negative
 Web benefit,Dr Timos Papagatsias,Negative
 Ritux Trial,Dr Timos Papagatsias,Negative
 Ritux Trial,Toby Eyre,Negative
 p del pts,Dr Timos Papagatsias,Negative
 p del pts,Toby Eyre,Negative
 nonp del subgroup,Dr Timos Papagatsias,Negative
 nonp del subgroup,Toby Eyre,Negative
 MUT IGVH,Dr Timos Papagatsias,Negative
 subgrps,Dr Timos Papagatsias,Negative
 PDPDL expression,Journal of Clinical Investigation,Negative
 Discover   commitment,Verastem Oncology,Negative
 research Drop,Verastem Oncology,Negative
 Arnon P Kater,touchONCOLOGY,Negative
     Cello Health PLC Directorate Change,AIM Alerts!,Negative
 chemokine receptor,Vinci-Biochem Srl,Positive
 elixir,Vinci-Biochem Srl,Positive
 presenta Segunda Semifinal,The Pepex Family,Negative
 presenta Segunda Semifinal,Thu Pepex,Negative
 √±orLuchaLibre,The Pepex Family,Negative
 √±orLuchaLibre,Thu Pepex,Negative
 ‚Äú Download chapters,Sharmaine Fuentes,Negative
 ‚Äú Download chapters,Kyle Schmanke,Positive
 VIDEO Cellintrinsic,VJHemOnc,Negative
    Croatian Lacrosse League finals,Emina (Science Pit),Positive
 Zagreb Patriots,Emina (Science Pit),Positive
 season congratulations,Emina (Science Pit),Positive
 Download chapters,Oncology Times,Negative
 capital,LiveYourLife,Negative
 Nov,LiveYourLife,Negative
 Nov,Patient Power,Negative
 Nov,UCI Health,Positive
 Nov,CLL Ireland,Negative
 Nov,Helen Jane Mee,Positive
 Nov,Prof John,Positive
 Living   creates,CLL_Fightersüéó,Negative
 Chronic    Acute Myeloid Leukemia,leukemia,Negative
   Patients Cases,leukemia,Negative
 Concomitant Presence,leukemia,Negative
 Concomitant Presence,ImmunePCPapers,Negative
 Different Malignant   ClonesAuthors,leukemia,Negative
 Mehmet Yilmaz,leukemia,Negative
     patients,CLL Ireland,Negative
     patients,VJHemOnc,Negative
 speed,CLL Ireland,Negative
 chemo experience,Tinu Abayomi-Paul,Positive
 chemo experience,Janette Speyer - Digital Marketing Strategy,Positive
 chemo experience,Amy Vernon üíôüá∫üá∏üè≥Ô∏è‚Äçüåàüíô,Positive
 f,MD Anderson Leukemia,Negative
 Physician,MD Anderson Leukemia,Negative
 Louise O Driscoll Senior Clinical Psychologist,CLL Ireland,Negative
 Elias Campo,VJHemOnc,Negative
 BGNE,JamesTLeePhD,Positive
 BGNE,Odi Bruckman,Positive
 launch delay,JamesTLeePhD,Positive
 competitor,JamesTLeePhD,Positive
 queued HH trial,JamesTLeePhD,Positive
 VIDEO Thoughts,VJHemOnc,Negative
 Daniel Catovsky,VJHemOnc,Negative
 CLLIPI,Lymphoma Papers,Negative
 CLLIPI,MDCalc.com,Positive
 CLLIPI,VJHemOnc,Negative
 CLLIPI,Oncology Tube,Negative
 CLLIPI,"Raul Cordoba, MD, PhD",Negative
 CLLIPI,CancerTherapyAdvisor,Negative
 CLLIPI,ASH Clinical News,Negative
 CLLIPI,Lymphoma Hub,Negative
 DCAREA RESIDENTS,Cancer Support Community,Negative
 support group,Cancer Support Community,Negative
 support group,JTCancerCenter,Positive
 Survival times,Targeted Oncology,Negative
 √Ä surveiller ce soir,C√©gep de L√©vis,Positive
 struggle,Tinu Abayomi-Paul,Negative
 Dr Dina ElSharkawi,Nick,Negative
 Joe Park,Guillermo Sanz,Negative
 CARTs,Guillermo Sanz,Negative
 Intl Symposiumin,Guillermo Sanz,Negative
 NOTCH,VJHemOnc,Negative
 NOTCH,Blood Cancer UK Research,Negative
 NOTCH,Frontiers Oncology,Negative
 NOTCH,Lymphoma Hub,Negative
 NOTCH,DrugGenius,Negative
 Silvia Deaglio,VJHemOnc,Positive
 overloaded train,Nick,Negative
 support information,Nick,Negative
 Les syndicats,SNU P√¥le Emploi FSU Occitanie,Negative
 de    invitent les salari√©s cette apr√®smidi,SNU P√¥le Emploi FSU Occitanie,Negative
 de h √† h,SNU P√¥le Emploi FSU Occitanie,Negative
 St C√©saire,SNU P√¥le Emploi FSU Occitanie,Negative
 San Vicens,SNU P√¥le Emploi FSU Occitanie,Negative
 √† des r√©unions d‚Äôinformation,SNU P√¥le Emploi FSU Occitanie,Negative
 vue de la gr√®ve,SNU P√¥le Emploi FSU Occitanie,Negative
   Evaluation,CureHuntr,Negative
 Daratumumab,CureHuntr,Negative
 Daratumumab,TrialBulletin,Positive
 Daratumumab,Cancer News,Positive
 p Dysfunction,CureHuntr,Negative
 p Dysfunction Status,TrialBulletin,Negative
 Condition Summary Relapsed Refractory Chronic Lymphocytic Leu,TrialBulletin,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Status Recruiting Condition Summary Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma,TrialBulletin,Negative
 glyphosateRoundup,Matthews & Associates,Negative
 Lymphoma Chronic Lymphocytic Leukemia CLLSmall Lymphocytic Lymphoma Anaplastic LargeCell Lymphoma,Matthews & Associates,Negative
 Angioimmunoblastic   Lymphoma,Matthews & Associates,Negative
 Blastic NKCell Lymphoma Burkitt,Matthews & Associates,Negative
 ERIC International Meeting,VJHemOnc,Negative
 BeiGene Initiates Global HeadtoHead Phase,Financial Buzz,Negative
 RelapsedRefractor,Financial Buzz,Negative
 BGNE Initiates Phase,Bio Stocks‚Ñ¢,Negative
 Global HeadtoHead Phase,Odi Bruckman,Negative
 VIDEO Bispecific   response,VJHemOnc,Negative
 Melanoma surveillance,Suzette Serving You!,Positive
 Melanoma surveillance,Melanoma MRV,Positive
 Melanoma surveillance,Melanoma On My Mind,Positive
     health amp wellbeing workshop,Helen Jane Mee,Negative
 Twitter VIDEO,Dr Timos Papagatsias,Negative
 LIH PhD candidate Marina Wierz,LIH_Luxembourg,Positive
 promising research work,LIH_Luxembourg,Positive
 characterisation,LIH_Luxembourg,Positive
 tumour microenvironment,LIH_Luxembourg,Positive
 tumour microenvironment,Lymphoma Hub,Negative
 tumour microenvironment,Cancer Papers,Negative
 surveillance,HemOnc Today,Negative
 surveillance,Robert Z. Orlowski,Negative
 surveillance,"Raul Cordoba, MD, PhD",Negative
   Longterm data,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 III HELIOS trial,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Dr Catherine Wus lab,Leukemia & Lymphoma Society Research,Positive
 TCR variable chain plasmid library,Leukemia & Lymphoma Society Research,Positive
 tumor neoantigens,Leukemia & Lymphoma Society Research,Positive
 System,Leukemia & Lymphoma Society Research,Positive
 candidate epitopes,Leukemia & Lymphoma Society Research,Positive
 VIDEO antibody combinations,VJHemOnc,Negative
 Mitochondrial apoptosis,SzaboLab,Positive
 Alkoxy phenylpropanone,SzaboLab,Positive
 derivatives,SzaboLab,Positive
 VIDEO   interactions,VJHemOnc,Negative
 Roche et AbbVie,oncohebdo,Negative
 annonce lautorisation europ√©enne de lassociation,oncohebdo,Negative
 ¬Æ AbbVieRoche et,oncohebdo,Negative
 technologies,PROvendis GmbH,Negative
 Derivates,PROvendis GmbH,Positive
 Rachet Cancer Questions,Tinu Abayomi-Paul,Positive
 Ella lo,Arturo Victoriano,Positive
 ha hecho,Arturo Victoriano,Positive
 todo mucho antes que,Arturo Victoriano,Positive
 ‚Äú lo varone‚Äù‚Äîgt,Arturo Victoriano,Positive
 VIDEO Preleukemic state,VJHemOnc,Negative
    Combined Ibrutinib,"Naveen Pemmaraju, MD",Negative
 Dr Nitin Jain ‚Å¶‚Å©,"Naveen Pemmaraju, MD",Negative
 amp Dr Bill Wierda,"Naveen Pemmaraju, MD",Negative
 VentoclaxRituximab,Silvana Novelli,Positive
   treatment algorithm,CLL_Fightersüéó,Negative
 Flair trial,CLL_Fightersüéó,Negative
 Flair trial,Helen Jane Mee,Negative
 amp Unity Exploring role,CLL_Fightersüéó,Negative
 amp Unity Exploring role,Helen Jane Mee,Negative
 Green light,Plexus Ventures,Negative
 AbbVieRoche regimen,Bionest Partners,Negative
 AbbVieRoche regimen,Advera Health,Negative
 marks,Bionest Partners,Negative
 marks,Advera Health,Negative
 marks,cafepharma,Negative
 portfolios,Bionest Partners,Negative
 pharma companies,Bionest Partners,Negative
   Plus   Improves,CancerWallonia,Negative
 FirstLine CLL Treatment,Connie Hampton,Positive
 decade testing,AJMC-Oncology,Negative
 decade testing,AJMC,Negative
 Genetics webinar Watch,Patient Power,Negative
   discussions,CDDF,Positive
   NOVEMBER,CDDF,Positive
 CLL Sector,Deepakdev,Positive
 AbbVieRoche Upbeat,Deepakdev,Positive
 FirstLine Venetoclax ComboPositive topline data,Deepakdev,Positive
 AbbVieGenentechs venetoclax combination,Deepakdev,Positive
 UK CLARITY Trial,Toby Eyre,Negative
 VENIBR,Toby Eyre,Negative
 MRDnegativity,Toby Eyre,Negative
 MRDnegativity,"Raul Cordoba, MD, PhD",Negative
 Breaking News EU,CLL Ireland,Negative
 Plenary PFS advantage,Toby Eyre,Negative
 BR st line,Toby Eyre,Negative
 gty median,Toby Eyre,Negative
 MUT,Toby Eyre,Negative
 Subanalysis,Toby Eyre,Negative
 Phase III study,Medklik,Negative
 Phase III study,Roche,Negative
 Phase III study,TumorImmunoPapers,Positive
 Phase III study,NK papers,Negative
 Phase III study,Dr. Andre Goy,Negative
 Phase III study,Oncology Now,Negative
 combination treatment,Medklik,Negative
 combination treatment,Roche,Negative
 combination treatment,Medivizor,Negative
 Chronic Lymphocytic Leukemia Combination Therapy,Oncology Tube,Positive
 Fair Number,Oncology Tube,Positive
 Hematologic amp NonHematologic Adverse Effects,Oncology Tube,Positive
 ICYMI   monotherapy,HemOnc Today,Negative
 III Data,PressReleasePoint,Negative
 III Data,Armando Guglielmetti,Negative
 Disease Worsening,PressReleasePoint,Negative
 Disease Worsening,1stOncology,Negative
 Disease Worsening,The Pharmaceutical Marketing Group,Negative
 Disease Worsening,Financial Buzz,Negative
 Disease Worsening,T Allen,Positive
 Disease Worsening,Crwe World,Negative
 Disease Worsening,Armando Guglielmetti,Negative
 Kahl Highlights Frontline Considerations,CancerWallonia,Positive
 Obinutuzumabvenetoclax combination,John DeRosier,Positive
    TRIL,Anna Deveau,Negative
 Real‚Äêworld testing treatment patterns,ACS Journal Cancer,Positive
 SEER patterns,ACS Journal Cancer,Positive
 care analysis,ACS Journal Cancer,Positive
   Today Combo Therapy,SpecialtyPTimes,Negative
 Delays Disease Progression,SpecialtyPTimes,Negative
 Ph,DDNews Online,Negative
 Ph,Genentech,Negative
 Phase III Data,1stOncology,Negative
 Phase III Data,The Pharmaceutical Marketing Group,Positive
 Phase III Data,Financial Buzz,Negative
 Phase III Data,Crwe World,Negative
 Phase III Data,Dr. Leona Saunders,Positive
 Push,BioCalifornia,Negative
 Push,Lymphoma Hub,Negative
 Firstline CLL Treatment,BioCalifornia,Negative
 Rm,"Mike Thompson, MD, PhD, FASCO",Positive
 Improvement Immuniz,"Mike Thompson, MD, PhD, FASCO",Positive
 HSMN AbbVie,HSMN,Positive
 VENCLYXTOR venetoclax,HSMN,Negative
   Gazyva Combo,CLL Ireland,Negative
 SLL Granted FDA Priority Review,CLL Ireland,Negative
 tcoHTVcgIyA,CLL Ireland,Negative
 Accumulation,Lymphoma Papers,Negative
 alteration,Lymphoma Papers,Negative
 P,Financial Buzz,Positive
 P,Patient Power,Negative
 P,Michael Goodman,Negative
 tgtxPhase III Data,T Allen,Positive
   Invectys,Novateur Ventures,Positive
 lead candidate,Novateur Ventures,Positive
 DNA   vaccine,Novateur Ventures,Positive
 INVAC,Novateur Ventures,Positive
 Previ,Crwe World,Negative
 Roche Genentech Phase,Armando Guglielmetti,Negative
   Phase III study,Genentech,Negative
 CD T lymphocytes,Elsevier Hematology,Positive
 CD T lymphocytes,NK cell Biology,Negative
 CD T lymphocytes,NK papers,Negative
 q deletion,Elsevier Hematology,Positive
 q deletion,NK cell Biology,Negative
 q deletion,NK papers,Negative
 q deletion,CLL Ireland,Negative
 Sab√≠as que,Hematolog√≠a SantPau,Positive
 significa,Hematolog√≠a SantPau,Positive
 Iniciativa Europea,Hematolog√≠a SantPau,Positive
 la Investigaci√≥n,Hematolog√≠a SantPau,Positive
 Ent√©rate de sus,Hematolog√≠a SantPau,Positive
 patient Mark amp    Nelia,Patient Power,Negative
 REGISTRATION OPEN,CDDF,Negative
 visit,Sherry Zimmermann,Positive
 visit,"Pharmacyclics, an AbbVie Company",Negative
 visit,Taylor Wolf,Positive
 Moffitt,Sherry Zimmermann,Positive
 motherinlaw,Melissa Nickolson,Positive
 Comparing duvelisib,Medivizor,Negative
 giant,Vincent Rajkumar,Negative
   l√®ve,Gilles Petitot,Positive
 baggage,"Jose Sandoval S, MD FACP",Positive
 importantly,"Jose Sandoval S, MD FACP",Positive
 Malek S,CRISP_SCIENCE,Positive
 Molecular Biology,CRISP_SCIENCE,Positive
 Oct Gene Disruption,CRISP_SCIENCE,Positive
 Cas Technology Hu,CRISP_SCIENCE,Positive
 N Malek SN,CRISP_SCIENCE,Positive
 Gene Dropout Screens Wu K Malek SN,CRISP_SCIENCE,Positive
 ltThis,South Shore Skin CTR,Positive
 ‚Ä¶ Lymphoma,Tinu Abayomi-Paul,Negative
 Nutritional Therapy,dorothy cook,Negative
 Nutritional Therapy,Jeff T Bowles,Positive
 Nutritional Therapy,Articlesly,Negative
 Nutritional Therapy,Survival-Hunters‚Ñ¢ üîµ,Positive
 Nutritional Therapy,Katia Zevelekakis,Negative
 Nutritional Therapy,Katia Davis,Negative
 Nutritional Therapy,Oknaija,Positive
 Nutritional Therapy,Augustino Chengula,Positive
 Nutritional Therapy,cyberconic,Positive
 Nutritional Therapy,Pakalert Press,Positive
 Nutritional Therapy,Surviving Hub,Positive
 Nutritional Therapy,Maria Goreth,Positive
 Nutritional Therapy,supersurvivalguide,Positive
 Story Diagnosis,dorothy cook,Positive
   Blanca Espinet,VJHemOnc,Negative
 Alessandra,VJHemOnc,Negative
 Tedeschi,VJHemOnc,Negative
   founder,VJHemOnc,Negative
 mutation tests,Wilmot Cancer Institute,Negative
   Paradigm,CancerWallonia,Positive
 Venetoclax Venclexta,Random PubMed,Positive
 Venetoclax Venclexta,The Medical Letter,Negative
 Venetoclax Venclexta,National Cancer Institute,Positive
 Venetoclax Venclexta,Christopher Steer,Negative
 Venetoclax Venclexta,thasso,Positive
 Barcelona,84$$ ¬Æ,Positive
 Barcelona,Marta Crespo,Positive
 Barcelona,Biotech-Spain.com,Positive
 Isabel Barbosa,Natacha Bola√±os,Positive
 Associacao Portuguesa de Leucemias e Linfomas APLL,Natacha Bola√±os,Negative
 Lisbon,Natacha Bola√±os,Negative
 NICE issues,Pharmafocus,Positive
 NICE issues,European Pharmaceutical Review,Negative
 Abbvies Venclyxto,Pharmafocus,Positive
   test results,Patient Power,Negative
 President Paola Ghia,VJHemOnc,Negative
   International Meeting,VJHemOnc,Negative
 chat,VJHemOnc,Negative
 chat,CryptoLiveLeak,Negative
 chat,Emily Drake üò∑ #AYACSM,Positive
 initiatives,VJHemOnc,Negative
 ETHealthworld   MedGenome,Girl,Positive
 ETHealthworld   MedGenome,ETHealthWorld,Positive
 Genetic Test,Girl,Positive
 Genetic Test,ETHealthWorld,Positive
 Genetic Test,Integra Ventures,Positive
 Genetic Test,MedGenome,Positive
 Genetic Test,CLL Ireland,Negative
 interviewees,VJHemOnc,Negative
 Robin Foa   Nicholas Chiorazzi,VJHemOnc,Negative
 amp Inaki MartinSubero,VJHemOnc,Negative
 MedGenome,Integra Ventures,Positive
 MedGenome,CLL Ireland,Negative
 News MedGenome,MedGenome,Positive
 tcolibTmonMUE,MedGenome,Positive
 Ibrutinib Retention,TrialBulletin,Negative
 Ibrutinib Retention,CureHuntr,Negative
 Chronic Lymphocytic Leukemia Participants,TrialBulletin,Negative
 Chronic Lymphocytic Leukemia Participants,CureHuntr,Negative
 Real World Setting Status,TrialBulletin,Negative
 Hardcover,Jeans and Other Men‚Äôs Clothing,Negative
 Book Free Shipping,Jeans and Other Men‚Äôs Clothing,Negative
 CLL Paradigm,COPD News,Negative
 Novel Agents Brian T Hill MD PhD,COPD News,Negative
   Dose,"Raul Cordoba, MD, PhD",Negative
 Haematologica Mutations,IUOPA,Negative
 Novel regimen,CancerTherapyAdvisor,Negative
 highrisk CLL patients,CancerTherapyAdvisor,Negative
 ERIC conference,"Richard Kiss MD, PhD",Positive
 Barcelona lots,"Richard Kiss MD, PhD",Positive
 CELG   data,Biotech2050,Negative
 ASH‚àí Ph III data,Biotech2050,Negative
 luspatercept MEDALIST BELIEVE XLRN‚àí Data,Biotech2050,Negative
 CAR T Lisocel JCAR,Biotech2050,Negative
 bb,Biotech2050,Negative
 JCARH,Biotech2050,Negative
 RRMM,Biotech2050,Negative
 scenes,VJHemOnc,Negative
 scenes,CryptoLiveLeak,Negative
    gt   AML amp,CDDF,Negative
 epigenomics,cnag-crg,Negative
 Investigadors del,Centre for Genomic Regulation (CRG),Negative
   grant,cnag-crg,Negative
 BeiGene Announces Acceptance,Crwe World,Negative
 New Drug Application,Crwe World,Negative
 New Drug Application,1stOncology,Negative
 TopLine Pivotal Data,Crwe World,Negative
 TopLine Pivotal Data,Bio Stocks‚Ñ¢,Negative
 TopLine Pivotal Data,Odi Bruckman,Negative
 Pati,Crwe World,Negative
 BGNE Announces Acceptance,Bio Stocks‚Ñ¢,Negative
   HighThroughput Sequencing,AIRR-seq papers,Negative
 Receptor Beta Chain Gene Repertoire,AIRR-seq papers,Negative
 Receptor Beta Chain Gene Repertoire,CLL-seq,Negative
 HighThroughput Sequencing,CLL-seq,Negative
 Ô∏è Researchers,Biocat,Positive
    Synergy grant,Biocat,Positive
 Peter Mac,Peter Mac Cancer Centre,Positive
   Victoria Prize,Peter Mac Cancer Centre,Positive
 Life Sciences,Peter Mac Cancer Centre,Positive
 platform,Creative-Biolabs,Positive
 platform,Nature Partner Jnls,Positive
 platform,"Marie-Elizabeth A. Barabas, PhD",Positive
 platform,Mats Ohlin,Positive
 platform,"chadi nabhan MD, MBA, FACP",Negative
 phenotypic discovery,Creative-Biolabs,Positive
 phenotypic discovery,Nature Partner Jnls,Positive
 phenotypic discovery,"Marie-Elizabeth A. Barabas, PhD",Positive
 dim CD,Dr. Andy Evens,Negative
 Dates,Canadian Lacrosse League,Positive
 locations,Canadian Lacrosse League,Positive
 locations,LiveYourLife,Negative
   Canada Regional Combines,Canadian Lacrosse League,Positive
   World Junior,Canadian Lacrosse League,Positive
 Championship,Canadian Lacrosse League,Positive
 vasculitis,Nephrology India,Positive
 vasculitis,Cancer Papers,Negative
    team,Parc Cient√≠fic de Barcelona,Negative
    team,LiveYourLife,Negative
 √±akiMartinSubero,Parc Cient√≠fic de Barcelona,Negative
   Synergy Grant,Parc Cient√≠fic de Barcelona,Negative
 ERC MEETS,Holger Heyn,Positive
 Combination Trials Signal,CLL Ireland,Negative
 Combination Trials Signal,CancerWallonia,Negative
 Wave,CLL Ireland,Negative
 Wave,CancerWallonia,Negative
 YESSSSS,Centre for Genomic Regulation (CRG),Negative
    grant,Centre for Genomic Regulation (CRG),Negative
 ‚úå Ô∏èThe   project,Centre for Genomic Regulation (CRG),Negative
 ongoing   CLL,Kanga Exchange,Positive
 ‚û°   competition,Kanga Exchange,Positive
 chance‚Äº,Kanga Exchange,Positive
 prayers,FriendsShow,Positive
 POWER,AnamjemWAK,Positive
 WORLD CHAMP ROMAN REIGNWE,AnamjemWAK,Positive
 GOD HOLY BOOKS RECURE,AnamjemWAK,Positive
 AMENLeukemia,AnamjemWAK,Positive
 CLL Therapy,CCO Oncology,Positive
 Connie Robinson,Mayo Clinic Cancer Center,Negative
 slowgrowing form,Mayo Clinic Cancer Center,Negative
 Mayo Clinics Arizona campus,Mayo Clinic Cancer Center,Negative
 passion,Mayo Clinic Cancer Center,Negative
 hiking,Mayo Clinic Cancer Center,Negative
 Giv,LyLe Foreningen,Negative
 gavn,LyLe Foreningen,Negative
 og til gavn,LyLe Foreningen,Negative
 og deres,LyLe Foreningen,Negative
   √¶mi og        √¶ft,LyLe Foreningen,Negative
 Realworld testing treatment patterns,Cancer Papers,Negative
 BCell Chronic Lymphocytic Leukemia Pipeline Review H   Report,COPD News,Positive
 BCell Chronic Lymphocytic Leukemia Pipeline Review H   Report,Drug Delivery News,Negative
 USD   BCell,COPD News,Negative
 Chronic Lymphocytic Leukemia Pipeline Review H SummaryGlobal Markets,COPD News,Negative
 Ô∏è‚É£ days,VJHemOnc,Negative
 programmes,CDDF,Negative
 booth hall,CDDF,Negative
        hematology,SeqComplete,Negative
 fellow Dr Andrew Lipsky,SeqComplete,Negative
 fellow Dr Andrew Lipsky,WCM Lymphoma,Negative
 Emerging therapies,CLL_Fightersüéó,Negative
   Congress,"Jill Kleczko, MPA, CCRP",Positive
 PCYC,"Jill Kleczko, MPA, CCRP",Positive
    session chair Dr Richard Furman,WCM Lymphoma,Negative
 frontier,WCM Lymphoma,Negative
 Dr Andrew Lipsky,"Jorge Monge, MD",Positive
    hematology,WCM Lymphoma,Negative
 Lenalidomide induces immunity,H4B Boston,Positive
 Dr Flinn,Verastem Oncology,Negative
 Dr Flinn,VJHemOnc,Negative
 MRD positivity,"chadi nabhan MD, MBA, FACP",Negative
 New Comparing duvelisib,Medivizor,Negative
   founding Eagle Pharmaceuticals,Crain's New York,Positive
   approved duvelisib,ASH Clinical News,Negative
   approved duvelisib,Univadis,Positive
 Promising data,CCO Oncology,Positive
 nextgeneration PIK inhibitors,CCO Oncology,Positive
 VIDEO Medication,VJHemOnc,Negative
 Chronic Lymphocytic LeukemiaTo,CLL Ireland,Negative
 enable prediction,CLL Ireland,Negative
 J Gribben EHA Presidentelect,European Hematology Association,Negative
 La FDA va examiner,oncohebdo,Negative
 revue prioritaire,oncohebdo,Negative
 demande dautorisation de l Imbruvica,oncohebdo,Negative
 L de traitement de la √©mie,oncohebdo,Negative
 √†,oncohebdo,Negative
 l Gazyva,oncohebdo,Negative
 FDA Priority review,Targeted Oncology,Negative
 ImbruvicaGazyva combination,HemOnc Today,Negative
 CLL SLL AbbVie Inc NYSEABBV,cafepharma,Negative
 combination therapy ibrutinibobinutuzumab,Rare Disease Report,Negative
   AbbVie,OBR,Positive
   AbbVie,Kara Jill Stancell,Negative
   AbbVie,NGO News,Positive
 Announces Supplemental New Drug Application,HSMN,Negative
 Obinutuzumab GAZYVAR,HSMN,Negative
 Combination GAZYVA,Odi Bruckman,Negative
 ¬Æ ibrutin,Crwe World,Negative
 AbbVie Announces Supplemental New Drug Application,Hotstocks.nyc,Positive
 New   Genetic Test,MedGenome,Positive
 Chronic Lymphocytic Leukemia MedGenome India,MedGenome,Positive
 premier genomics,MedGenome,Positive
 research diagnostics company,MedGenome,Positive
 gene mutation testing,MedGenome,Positive
   Love Tanner,Sue Ettinger DVM,Positive
 groundbreaking discoveries,Elies Campo,Positive
 Ibrutinib leadin,TrialBulletin,Negative
 RR CLL Status,TrialBulletin,Negative
 Condition Summary RelapsedRefractory Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia Leukemia,TrialBulletin,Negative
 Ja trafi≈Çem lepiej,Jacek Kalinowski,Positive
 Na loterii bia≈Çaczek,Jacek Kalinowski,Positive
 CLL reference epigenome project,BioCores,Positive
 Pilot Study Supports Lower Dose,Carlos Chiattone,Positive
 Pilot Study Supports Lower Dose,World Neonatology Congress,Negative
 New Chlorambucil rituximab,Medivizor,Negative
   cells,"Raul Cordoba, MD, PhD",Positive
   cells,Beth Torr,Positive
   cells,iwCLL,Negative
   cells,Genentech,Positive
   cells,Morgan Dulfer,Positive
   cells,Hosmedge. com,Positive
   cells,Michael A. Cantrell,Positive
 ver,Hematolog√≠a SantPau,Positive
 ver,Nebel,Positive
 podemos,Hematolog√≠a SantPau,Positive
 BM Hematopoietic Dysfunction,Hematopoiesis News,Negative
 Untreated   Patients,Hematopoiesis News,Negative
 Phase III DUO Trial Duvelisib,Hematopoiesis News,Negative
 Relapsed amp Refractory SLL,Hematopoiesis News,Negative
 CLL Token Airdrop,CryptoLiveLeak,Negative
 Trading Competition,CryptoLiveLeak,Negative
 Guest,UK Health Radio‚Ñ¢,Positive
 Guest,Patient Power,Negative
 Porkfest,Brian Barrett,Positive
 Xun Wu,RIOH,Negative
 Manitoba   research cluster retreat,RIOH,Negative
 HemOnc Times,Oncology Times,Negative
 halfyear profits,Proactive,Positive
 venetoclax work,Cancer News,Negative
 National Comprehensive Cancer Network,Verastem Oncology,Negative
 National Comprehensive Cancer Network,The Pharmaceutical Marketing Group,Negative
 National Comprehensive Cancer Network,Latest News from Business Wire,Negative
 Clinical Practice Guidelines,Verastem Oncology,Negative
 Clinical Practice Guidelines,The Pharmaceutical Marketing Group,Negative
 Clinical Practice Guidelines,Latest News from Business Wire,Negative
 Distinct Activities,Monterey Holistic,Positive
 Distinct Activities,Hypoxia Adaptation,Positive
 FDA reviewers,Bionest Partners,Negative
 Celltrions Rituxan biosimilar,Bionest Partners,Negative
 panel vote,Bionest Partners,Negative
 Celltrion,Bionest Partners,Negative
 Splicing,JCI insight,Positive
 Splicing,Lymphoma Papers,Negative
 Team SuperMarrow,Betsy Mullen #SignUp2SaveAJ,Positive
 Bringing,Betsy Mullen #SignUp2SaveAJ,Positive
 Awareness,Betsy Mullen #SignUp2SaveAJ,Positive
 Saving,Betsy Mullen #SignUp2SaveAJ,Positive
 Boston MA,Betsy Mullen #SignUp2SaveAJ,Positive
   bests,MDedge Hematology & Oncology,Negative
 Rare Instance,Cureus,Negative
 Simultaneous Infection,Cureus,Negative
 Disseminated Nocardia,Cureus,Negative
 Pulmonary Aspergillus,Cureus,Negative
 Patient Receiving Treatment,Cureus,Negative
 Dotson et al,Cureus,Negative
 Community oncologists,Andrew Schorr,Negative
 community oncologist,Andrew Schorr,Negative
 Adds Verastem Oncology,The Pharmaceutical Marketing Group,Negative
 Adds Verastem Oncology,Latest News from Business Wire,Negative
 ‚Ñ¢ duvelisib Capsules,The Pharmaceutical Marketing Group,Negative
 ‚Ñ¢ duvelisib Capsules,Latest News from Business Wire,Negative
 Stem cell,Zusia:Dr Jackie Volk,Positive
 student Emma Kennedy,BSMS,Positive
 Chronic Lymphocytic Leukemia Moon Shot,MD Anderson Cancer Center,Negative
     author,Robin Daly,Positive
 n,Robin Daly,Positive
 Chronic Lymphocytic Leukemia Free Download,Ashika Khanam Asha,Positive
 Chronic Lymphocytic Leukemia Free Download,Md. Nurul Amin,Positive
 Chronic Lymphocytic Leukemia Free Download,Our Savar,Positive
 Refractory Chronic Lymphocytic,Lampe & Company,Negative
 Official   CLL,CryptoLiveLeak,Negative
 platelettolymphocyte ratio,Future Science OA,Positive
 skin,Patient Power,Negative
 skin,CLL_Fightersüéó,Negative
 sinuses,Patient Power,Negative
 amp Dr Alessandra Ferrajoli,Patient Power,Negative
 support event,BCNI,Positive
 Mullingar Park Hotel,BCNI,Negative
 retirement,The Lion's Shed üè¥Û†ÅßÛ†Å¢Û†Å•Û†ÅÆÛ†ÅßÛ†Åø,Negative
 Aston Villa links,The Lion's Shed üè¥Û†ÅßÛ†Å¢Û†Å•Û†ÅÆÛ†ÅßÛ†Åø,Negative
 Molecular Prognostic Markers,Random PubMed,Positive
 Molecular Prognostic Markers,microRNApapers,Negative
 Lenalidomide consolidation therapy,Medivizor,Negative
 Dad,Krystal,Positive
 Dad,Rachel Haywood,Positive
 Dad,adam,Positive
 Dad,Madeline Schuck,Positive
 Dad,(((Wendi))),Positive
 Dad,Pippa Jones,Positive
 Dad,—ï.œâŒ±‚Ñì–∫—î—è,Positive
 Slawek Zawdzki,Kanga Exchange,Positive
 COO,Kanga Exchange,Positive
 Lukas Minkiewicz,Kanga Exchange,Positive
 Tokenfest conference,Kanga Exchange,Positive
 Boston,Kanga Exchange,Positive
 Boston,Amy C. Cavers,Negative
 RR chronic lymphocytic,Marek Trneny,Positive
 Beausejour MP Dominic LeBlanc,Brad Perry,Positive
 Beausejour MP Dominic LeBlanc,97.3 The Wave News,Positive
 Beausejour MP Dominic LeBlanc,CHSJ News,Positive
   Landscape,CancerWallonia,Negative
 Nobel Prize winner Dr Jim Allison,CLL Ireland,Negative
 Realworld treatment,"Raul Cordoba, MD, PhD",Negative
 Nonredundant role Control,Human Immunology News,Negative
 Chronic Lymphocytic Leukemia Development,Human Immunology News,Negative
 ClonallyExpanded CD TCells,Human Immunology News,Negative
 Functional Exhaustion,Human Immunology News,Negative
 Secondary Lymphoid Tissues,Human Immunology News,Negative
 Venetoclx VenclextaAbbVie Genentech,Lambda Kappa Sigma,Positive
 VIDEO   yields,VJHemOnc,Negative
 Glenn,Shouting at people in my underpants,Negative
 Glenn,Life Extension,Positive
 New Cancer Drug,Patient Worthy,Negative
 New Cancer Drug,LabRoots,Positive
 ‚Ñ¢ duvelisib,Patient Worthy,Negative
 PreCongress Conference program,@sehh_es,Negative
 UTR region,CLL-seq,Negative
 NOTCH gene,CLL-seq,Negative
 Algorithm,MDedge Hematology & Oncology,Negative
 RealWorld Treatment,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Novel Agents Era,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Chronic Lymphocytic Leukemia CD CD tumor cells,"Brandon Zelman, DO",Positive
 B cell,"Brandon Zelman, DO",Positive
 ‚§¥Ô∏è Stress,CLL_Fightersüéó,Negative
 cochair ‚Å¶‚Å© ‚Å¶‚Å¶‚Å© history,donnashort,Negative
 Dr Jakub Svoboda,Total Health Conferencing,Positive
 Meeting,Total Health Conferencing,Positive
 Meeting,CARE‚Ñ¢ Education,Negative
 Meeting,Oncology Tube,Negative
 Meeting,Matthew Kauffman,Negative
 Poor Prognosis,Marilyn Heine,Positive
 Poor Prognosis,Hematopoiesis,Positive
 Network Important,Marilyn Heine,Positive
 moderatetosevere stress,Marilyn Heine,Positive
 andor   symptoms,Marilyn Heine,Positive
   monotherapy,HemOnc Today,Negative
   monotherapy,CARE‚Ñ¢ Education,Negative
   fellow,Stony Brook Pathology,Positive
   fellow,MarieSk≈ÇodowskaCurie,Positive
 lymphnode mimimicro data,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 CLL ABBV,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 CAR,VJHemOnc,Negative
 CAR,LymphomaAction,Negative
 Useful work,Chan Cheah,Negative
 et al Comprehensive Safety Analysis,Chan Cheah,Negative
 Dr Michael Keating,Patient Power,Positive
 Dr Michael Keating,Andrew Schorr,Negative
 Dr Michael Keating,CLL Ireland,Negative
 Dr Michael Keating,CLL_Fightersüéó,Negative
 Dr Michael Keating,Robert Z. Orlowski,Negative
 Kidney,HofNorthwell Kidney,Positive
 NEW study,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 CONQUER,Heather Swift Morrison,Negative
 patient voice,Heather Swift Morrison,Negative
 Magazine,Heather Swift Morrison,Negative
 Silent Disease,Heather Swift Morrison,Negative
 Tag godt,LyLe Foreningen,Negative
 LyLe,LyLe Foreningen,Negative
 Nyt som kan,LyLe Foreningen,Negative
   gerne,LyLe Foreningen,Negative
 du vil,LyLe Foreningen,Negative
 kun,LyLe Foreningen,Negative
 Paul Keane,CLL Ireland,Negative
 Turmeric,Anthony Mato,Negative
 Turmeric,Monterey Holistic,Negative
 ScienceDirect,Anthony Mato,Negative
 GC   Identification,ImmuneGCPapers,Positive
 Token Talks      Introduction,CryptoLiveLeak,Negative
 Online Social Blog Platform,CryptoLiveLeak,Negative
 amp depth understanding,Concessionary L.L,Negative
 Dr Ibarz,Targeted Oncology,Negative
 New Lenalidomide consolidation therapy,Medivizor,Negative
 Clinical Nurse Specialist,The Patient's Channel,Negative
 Clinical Nurse Specialist,Beth Torr,Positive
 Nick York,The Patient's Channel,Negative
 Nick York,Zack Pemberton-Whiteley,Positive
 Knackered CD,Prof John,Negative
 Nu √∂ppnas,√Öbo Akademi University,Positive
 att bli ambassad√∂r f√∂r Sk√§rg√•rdshavets biosf√§romr√•de Lokala akt√∂rer ska kunna dra nytta,√Öbo Akademi University,Positive
 att k√§nna biosf√§romr√•det b√§ttre,√Öbo Akademi University,Positive
 √§rg√•rd,√Öbo Akademi University,Positive
     Cello Health PLC Appointment,AIM Alerts!,Negative
 Executive Director,AIM Alerts!,Negative
 Dr Reddy,Drug Store News,Positive
 imatinib mesylate,Drug Store News,Positive
 INFI,MAISA,Negative
 INFI,BioPharm Insight,Positive
 INFI,Don Seiffert,Positive
   million payment,MAISA,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market   Size Share Outlook Opportunity Analysis,Coherent M I,Positive
   floor,Randall Weis,Positive
 Lavender House,Randall Weis,Positive
 customer,Randall Weis,Positive
 CURE Media Group Announces Chuck Pagano,Women's Health News,Positive
 CURE Media Group Announces Chuck Pagano,SPI News,Negative
 Guest Speaker,Women's Health News,Positive
 Guest Speaker,SPI News,Negative
   Chronic Lymphocytic Leukemia Heroes Awards Ceremony,Women's Health News,Positive
   Chronic Lymphocytic Leukemia Heroes Awards Ceremony,SPI News,Negative
    therapies,Patient Power,Negative
 Dr   Michael Keating,Patient Power,Negative
 contacts,Helen Jane Mee,Negative
 Chelsea,The Lion's Shed üè¥Û†ÅßÛ†Å¢Û†Å•Û†ÅÆÛ†ÅßÛ†Åø,Positive
 Husk vi taler,LyLe Foreningen,Negative
 og har fokus,LyLe Foreningen,Negative
 selvom,LyLe Foreningen,Negative
 F√∏lg,LyLe Foreningen,Negative
 og FB vi har mange aktivteter,LyLe Foreningen,Negative
 Happy SundayAs,Toretha Wright,Positive
 cancer survivor,Toretha Wright,Positive
 Changing Treatment Landscape,CancerWallonia,Positive
 Changing Treatment Landscape,CURE Magazine,Positive
 Standards,CancerWallonia,Positive
 PIKCA mutations,Xuan Shirley Li,Positive
 PIKCD PIKCG,Xuan Shirley Li,Positive
 Succes Temadag,LyLe Foreningen,Negative
 Distinguished University Professor Barbara Andersen,Arts and Sciences,Positive
 Day   update,Stephen Brown,Negative
 Prof Katyoun Rezvani,Blood Cancer UK Research,Negative
 Prof Hillmen,Blood Cancer UK Research,Negative
 Prof Hillmen,CLL Ireland,Positive
 Prof Hillmen,David Cairns,Positive
 Prof Hillmen,VJHemOnc,Negative
 Prof Pete Hillmen,Blood Cancer UK Research,Negative
 Prof Pete Hillmen,Nick,Negative
 Prof Pete Hillmen,Beth Torr,Positive
 Le code des collectivit√©s,Ahlem Bousserwel,Positive
 locales,Ahlem Bousserwel,Positive
 √† travers,Ahlem Bousserwel,Positive
 Des √©changes fructueux,Ahlem Bousserwel,Positive
 Ricters,Nick,Negative
 Professor Francesc Bosch,Blood Cancer UK Research,Positive
 Richters pts,Blood Cancer UK Research,Negative
 TP mutations,Blood Cancer UK Research,Negative
 TP mutations,Cancer Papers,Negative
 TP mutations,"Raul Cordoba, MD, PhD",Negative
 TP mutations,ion papers,Positive
 TP mutations,Lymphoma Hub,Negative
 CDKNAB Myc,Blood Cancer UK Research,Negative
 Prof Francesc Bosch,Blood Cancer UK Research,Negative
 Prof Fox,Blood Cancer UK Research,Negative
 New UK data,Blood Cancer UK Research,Negative
 Prof Chris Fox,Blood Cancer UK Research,Negative
 Donna Munro,Nick,Negative
 pants,Dr Anya Hotinski,Positive
   T,Vijaya L,Positive
   T,CancerWallonia,Negative
 CAR NK cells,Targeted Oncology,Negative
 CAR NK cells,Anna Deveau,Negative
 CPD Credits,Medscape Education,Negative
 Free Activities Handouts,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Information Sheets,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 childrens play,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
      patient,The Patient's Channel,Negative
      patient,Sid Shah,Positive
 video diary ER,The Patient's Channel,Negative
 Harley Hudson,The Patient's Channel,Negative
 rr   lymphoma,GoFIR,Negative
 rr   lymphoma,FDA Oncology,Negative
 todays media digest,HRI Portal,Positive
 Chronic   Lymphocytic Leukemia,HRI Portal,Negative
 New   story,Patient Power,Positive
 Mark Silverstein,Patient Power,Negative
 Mark Silverstein,Andrew Schorr,Negative
   patient amp advocate,Patient Power,Negative
 Chronic Lymphocytic Leukemia Krohem,CLL-seq,Negative
 BCll,CLL-seq,Negative
 Blood Altered patterns,IUOPA,Negative
 Prof Robin Foa,Saudi Leukemia Net,Positive
 Saturdays   town meeting,Patient Power,Positive
 Atlanta,Patient Power,Negative
 Atlanta,Cancer News,Negative
 Atlanta,CRO Contract Res.,Negative
   Leukemia,Michele Nadeem-Baker,Negative
   Leukemia,AbbVie,Negative
   Leukemia,CMLHope,Negative
 duvelisib COPIKTRA Verastem Inc,MedChem & ONCo,Negative
 duvelisib COPIKTRA Verastem Inc,Renovatio Biom√©dica,Positive
 duvelisib COPIKTRA Verastem Inc,Dr.Alberto Mussetti,Negative
 duvelisib COPIKTRA Verastem Inc,Michael Mijares,Positive
 duvelisib COPIKTRA Verastem Inc,Stefan Busch,Positive
 duvelisib COPIKTRA Verastem Inc,Anna Deveau,Negative
 KI faculty members,Koch Institute at MIT,Positive
 Piyush Gupta Eric Lander,Koch Institute at MIT,Positive
 Robert Weinberg,Koch Institute at MIT,Positive
 ET   pmPT,Patient Empowerment Network,Negative
 cllinfo,Patient Empowerment Network,Negative
 SLAMF,Lymphoma Papers,Negative
 TOMORROWs,Patient Power,Negative
 Live    Session,Patient Power,Negative
 SYNT   Phase IbIIa study,Anna Deveau,Negative
 Compliance,Ro Patel,Positive
 duvelisib Copiktra,CellworksLife,Negative
 ICYMI Comorbidities,HemOnc Today,Negative
 Verastem Oncologys Copiktra,PharmacyChecker,Negative
 CryptoLiveLeak Affiliate Program Open,CryptoLiveLeak,Negative
 chronic lympytic,Haleplushearty.org,Negative
 Copiktrap,Haleplushearty.org,Positive
 FDA Approves Copiktra duvelisib Capsules,Advera Health,Negative
 FDA Approves Copiktra duvelisib Capsules,Medicalnewser.com,Negative
 FDA Approves Copiktra duvelisib Capsules,EIN Presswire: Lung Cancer Newswire,Negative
 FDA Approves Copiktra duvelisib Capsules,FDA Daily,Negative
 PIK inhibitor Duvelisb,"Neil Sankar M.D.,MPH",Positive
 FL CLL,"Neil Sankar M.D.,MPH",Positive
 duvelisib COPIKTRA,Lymphoma Research Foundation,Negative
 MiRa,Philip McCarthy,Negative
 MiRa,Cancer Papers,Positive
 MiRa,TumorImmunoPapers,Negative
 MiRa,microRNApapers,Negative
 MiRaexpression,Philip McCarthy,Negative
 host,Patient Empowerment Network,Negative
 host,Kapamilya Defenders,Positive
 host,ABS-CBN Entertainment,Positive
 host,Patient Power,Negative
 host,Andrew Schorr,Negative
 Carol Preston,Patient Empowerment Network,Negative
 Carol Preston,Patient Power,Positive
 TG stock sinks,cafepharma,Negative
 setback,cafepharma,Negative
 blood cancer trial TG Therapeutics,cafepharma,Negative
 accelerated FDA approval,cafepharma,Negative
 ublituximabumbralisib combination,cafepharma,Negative
 chronic Lymphocytic Leukemia Lymphocytic Lymphoma,Haleplushearty.org,Negative
 Verastem Inc VSTM,"Liseth M Parra, PhD",Positive
 ¬£ m mkt cap,James Flavin,Positive
 inflection point,James Flavin,Positive
 ndline,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 Duvelisib FDA,ËÖ´Áò§Â≠∏Êñ∞Áü• | Cancer Informer,Positive
 Duvelisib FDA,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 VIDEO CAR Tcells,VJHemOnc,Negative
 News FDA,"Robinson Ortiz, MD",Negative
 APPROVED Duvelisib,Lisa Astor,Negative
 Linfocitos B,Manuel Muro,Negative
 de Leucemia Linfoide Cr√≥nica CLL Imagen de microscopia,Manuel Muro,Negative
 electr√≥nica de barrido coloreada,Manuel Muro,Negative
 audience members,Andrew Schorr,Negative
 Drs Lamanna amp Ferrajoli,Andrew Schorr,Negative
 personalized care,Andrew Schorr,Negative
 Stress,MDedge Hematology & Oncology,Negative
 Stress,CLL Ireland,Positive
 disease markers,MDedge Hematology & Oncology,Negative
 Refractory Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,Ken Research,Positive
 Refractory Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,Markets & Reports,Negative
 Ken,Ken Research,Negative
 Ken Research,Ken Research,Positive
 GPs,Zack Pemberton-Whiteley,Negative
 GPs,Nick,Negative
     Cello Health PLC Transfer,AIM Alerts!,Negative
 FTSE classification,AIM Alerts!,Negative
   moves,CLLSA,Negative
 mi Instagram,Giannina,Positive
 MiRa expression,Cancer Papers,Negative
 MiRa expression,TumorImmunoPapers,Negative
 Backs,CancerWallonia,Negative
 International CLL meeting,Marta Crespo,Negative
 DCLLSG,Marta Crespo,Negative
 relapsedrefractory patients,CLL Ireland,Negative
 zoo,Gina Angel,Positive
 HigherDose Immunoglobulin Replacement Therapy,World Neonatology Congress,Negative
 Bispecific Antibody,World Neonatology Congress,Negative
 NK allo,Anna Deveau,Negative
   town mtg,Patient Power,Positive
 ABBV Receives,Bio Stocks‚Ñ¢,Negative
   combinations,Anna Deveau,Positive
 MHallek,Anna Deveau,Negative
 Laboratory findings,GateToMedicine PG,Positive
 frontiers,Ville N. Pimenoff,Positive
 El√≠as Campo,Oncobell Symposium,Negative
 CARs,Butler Scientifics,Positive
 CARs,"Navneet Majhail, MD, MS",Negative
 Tokenfest Interview Video,CryptoLiveLeak,Negative
    LEAF,BOSS Bodyworks,Positive
 chemoimmunothera,Medivizor,Negative
 Transplant status,CancerTherapyAdvisor,Negative
 CART therapy outcomes,CancerTherapyAdvisor,Negative
 Pathogen‚Äêspecific B‚Äêcell receptors,Wiley Oncology & Hematology,Positive
 Pathogen‚Äêspecific B‚Äêcell receptors,Krishan Maggon,Negative
 Pathogen‚Äêspecific B‚Äêcell receptors,Science Disseminat..,Positive
   Remission Maintenance Treatment Options,Elsevier Oncology,Positive
 Sep    stocks,Jon,Negative
 Morning,Jon,Negative
 Morning,City Living London,Positive
 RNS,Jon,Negative
 volunteers,NIH NHLBI,Positive
 volunteers,NIH Clinical Center,Positive
 volunteers,Higher Ground at Lake Louise,Negative
 volunteers,Leukaemia Care,Negative
 volunteers,Nora Sheffield,Negative
 volunteers,WCMNYPJCTO,Positive
 PostDocResearch Associate,UM Human Resources,Positive
 Manitoba Chronic Lymphocytic Leukemia research team,UM Human Resources,Positive
 line choice pharmacotherapeutics,Cancer Papers,Negative
 line choice pharmacotherapeutics,COPD News,Negative
 Sept     pm Register,Patient Power,Negative
 Manitoba,MB Top Employers,Positive
 Hing Zachary,New OhioLINK ETDs,Positive
 Nuclear Export,New OhioLINK ETDs,Positive
 Chronic Lymphocytic   cell,New OhioLINK ETDs,Positive
   Pharmacy Times,ANTELLIS,Positive
 Continuing Education,ANTELLIS,Positive
 Continuing Education,Rare Diseases,Negative
 Live Broadcast,ANTELLIS,Positive
 Live Broadcast,Brenda Feldman,Positive
 Dr Jennifer Brown Dr Jan Burger,CLL Ireland,Negative
 amp Dr Anthony Mato,CLL Ireland,Negative
 Prognostic Nomogram,Internal Medicine: Open Access,Negative
 Survival Index,Internal Medicine: Open Access,Negative
 Prognosis,Internal Medicine: Open Access,Negative
 Prognosis,Targeted Oncology,Negative
 Prognosis,Prof John,Negative
 Prognosis,CLL Ireland,Negative
 Prognosis,Medicine Matters oncology,Positive
 Prognosis,ACS Journal Cancer,Negative
 Prognosis,RUBEN DARIO FONSECA,Positive
 Prognosis,JAMA Oncology,Negative
 Prognosis,Lymphomation.org,Negative
 Prognosis,Cancer Papers,Positive
 Prognosis,Kalyani Bambal,Positive
 Prognosis,JAMA,Negative
 Single Center Experience,Internal Medicine: Open Access,Negative
 Toronto Canada,Andrew Schorr,Negative
 Immunoglobulin replacement therapy,Cancer Papers,Negative
 MT PHASE II TRIAL,TrialBulletin,Negative
 MGTA,TrialBulletin,Negative
 HIGHRISK MALIGNANCY,TrialBulletin,Negative
 Condition Summary Acute Myeloid Leukemia Acute Lymphocytic Leukemia BiphenotypicUndifferentiated Leukemia Chronic Myelogenous Leukemia,TrialBulletin,Negative
   update tgtx,Anna Deveau,Negative
 mo,Arjun D. Law,Positive
 mo,Anna Deveau,Negative
 mo,NEJM CPC,Positive
 mo,"Raul Cordoba, MD, PhD",Negative
 Sept issue,The Lancet Oncology,Negative
   series,Research To Practice,Negative
 Pan Pacific Lymphoma Conference   experts,Research To Practice,Negative
 Thomas Kipps amp Prof John Gribben,Research To Practice,Negative
 Saturdays   town mtg,Patient Power,Negative
 Usual Suspects,Prof John,Negative
 Usual Suspects,MD Anderson Leukemia,Negative
 Comprehensive Safety Analysis,Matthew Wakefield,Positive
 Comprehensive Safety Analysis,Garbi√±e Lizeaga,Negative
 Comprehensive Safety Analysis,Jerry Lee,Negative
 Comprehensive Safety Analysis,Marlowe S Tessmer,Negative
 Comprehensive Safety Analysis,Cure Cancer Now,Negative
 Venetoclax Monotherapy,Matthew Wakefield,Positive
 Venetoclax Monotherapy,Garbi√±e Lizeaga,Negative
 Venetoclax Monotherapy,Jerry Lee,Negative
 Venetoclax Monotherapy,Marlowe S Tessmer,Negative
 Venetoclax Monotherapy,Cure Cancer Now,Negative
 WES,Anna Deveau,Negative
 WES,Blood Journal,Negative
 RT MedlyPharmacy Medical News,Chirag Kulkarni,Positive
 Medical News,Medly Pharmacy,Positive
 Medical News,Free Medical Consultation,Positive
 Medical News,ViziMedical,Positive
 Medical News,Brandy News,Positive
 Medical News,Mazen M,Negative
 Medical News,medical_tweets,Positive
 Medical News,Nursing-Resource.com,Positive
 Medical News,A2Z Awareness,Positive
 Medical News,Scott Filler,Positive
 Medical News,#Endsars protest,Positive
 Medical News,Triple E Medical Solutions LLC,Positive
    R√©sistance,Anna Deveau,Negative
   measure,VJHemOnc,Negative
 w Anna Schuh,VJHemOnc,Negative
 leukaemia,CLL Ireland,Positive
 leukaemia,LymphomaAction,Negative
 leukaemia,Charlotte Roffiaen,Positive
    discussion,VJHemOnc,Negative
 ‚ú® Listen,VJHemOnc,Negative
 ‚ú®,VJHemOnc,Negative
 Dr Florence Cymbalista,"Jose Sandoval S, MD FACP",Positive
 unsolved questions,"Jose Sandoval S, MD FACP",Positive
 Debate CIT,Robert Z. Orlowski,Negative
 Debate CIT,MD Anderson Leukemia,Negative
 LeukemiaMDA NitinJainMD,Robert Z. Orlowski,Negative
 NY Fire Chief Files New Lawsuit,InciNotes,Positive
 Sept Related IllnessesUtica Fire Chief Russell Brooks,InciNotes,Positive
 Anna Schuh MD,MD Anderson Leukemia,Negative
 Genomic Landscape,MD Anderson Leukemia,Negative
 Florencia Cymbalista MD PhDof H√¥pital Avicenne,MD Anderson Leukemia,Negative
 Art Update,MD Anderson Leukemia,Positive
 Art Update,Lisa Palacios,Negative
 Michael amp Jan,CLL Ireland,Negative
 CMWP,Jordan Gauthier,Positive
 USESVortuxi   mg Injection,Ravispecialitiespharma_RSP,Negative
 Saturday Session IX,Robert Z. Orlowski,Positive
 DEBATE CIT,Robert Z. Orlowski,Negative
 DEBATE CIT,MD Anderson Leukemia,Negative
 Case Study Case,Robert Z. Orlowski,Negative
 CK,Robert Z. Orlowski,Negative
 CK,Cancer Papers,Negative
 DELpTP Mutation,Robert Z. Orlowski,Negative
    Saturday Session IX,MD Anderson Leukemia,Positive
 Dr Phillip Thompsonof,MD Anderson Leukemia,Negative
 New modules,HEORO,Positive
   C,HEORO,Positive
 s disease,HEORO,Positive
 QLQHL,HEORO,Negative
 EORTC NHLHG EORTC NHLLG,HEORO,Negative
 EORTC,HEORO,Negative
 Kaposis sarcoma,Cancer Papers,Negative
   IgG help,Patient Power,Negative
 sickness,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 Token Fest Day,CryptoLiveLeak,Negative
 diet impact   progression,Patient Power,Negative
   Folloder,Andrew Schorr,Negative
   CAR NK,Anna Deveau,Negative
 Cheers,CryptoLiveLeak,Negative
 Cheers,Overland Park Now,Negative
    person,CLLSA,Negative
 amp help,CLLSA,Negative
 Zach,CryptoLiveLeak,Negative
 Global Conference,CryptoLiveLeak,Negative
 expo,CryptoLiveLeak,Negative
 CLL Chief Compliance Officer Pat Conlin,CryptoLiveLeak,Negative
 Robert Pike,CryptoLiveLeak,Negative
 asset backed security,CryptoLiveLeak,Negative
 Joshua Suh Director,CryptoLiveLeak,Negative
 Operations,CryptoLiveLeak,Negative
 Crowd Create,CryptoLiveLeak,Negative
 crypto marketing,CryptoLiveLeak,Negative
 Noncovalent inhibition,Blood Journal,Negative
 CS Bruton tyrosine kinase,Blood Journal,Negative
 GDC,Blood Journal,Negative
 Venetoclax FDA label,ËÖ´Áò§Â≠∏Êñ∞Áü• | Cancer Informer,Positive
 Venetoclax FDA label,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 Minimal Residual Disease negativity data,ËÖ´Áò§Â≠∏Êñ∞Áü• | Cancer Informer,Positive
 Minimal Residual Disease negativity data,mediPr | ÈÜ´Â≠∏‰ΩúÂÆ∂È¶ôÊ∏Ø,Negative
 tcoGXhRfdIP,ËÖ´Áò§Â≠∏Êñ∞Áü• | Cancer Informer,Positive
 LIVE minute,Patient Empowerment Network,Negative
 LIVE minute,Patient Power,Negative
 PM PT,Patient Empowerment Network,Negative
 PM PT,Patient Power,Negative
    een,Willy van der Most,Positive
 drie enthousiaste,Willy van der Most,Positive
 kundige spreeksters,Willy van der Most,Positive
 MTP VII   Session f Dr Katy Rezvani,Robert Z. Orlowski,Negative
 MTP VII   Session f Dr Katy Rezvani,MD Anderson Leukemia,Negative
 CLL   CancerMedMDA PhysRelations,Robert Z. Orlowski,Negative
 Cornelis Lely Lezing,Joost van de Beek,Positive
 Zuiderzeewet,Joost van de Beek,Positive
 MTP VII   Session f wwierda,Robert Z. Orlowski,Negative
 CART     CancerMedMDA PhysRelations,Robert Z. Orlowski,Negative
    Wednesday,MD Anderson Leukemia,Positive
 MTP VII   Session f,MD Anderson Leukemia,Negative
 label,MAISA,Negative
 label,"Pharmacyclics, an AbbVie Company",Negative
 Venclexta labeling,MPR,Negative
 New Comparing chemoimmunotherapy,Medivizor,Negative
 treatment strategy,Patient Power,Negative
 DNA vaccines,Patient Power,Negative
 Chronic Lymphocytic LeukemiaNew evidence,LabMedica.com,Positive
 USESMabtas N,Ravispecialitiespharma_RSP,Negative
 mg Injection,Ravispecialitiespharma_RSP,Negative
 Cancer Biology,Dr Anya Hotinski,Positive
 Awesome view,Dr Anya Hotinski,Positive
 TLR Expression,Cancer Papers,Negative
 TLR Expression,TumorImmunoPapers,Negative
 Leukemic B Cells,Cancer Papers,Negative
 Leukemic B Cells,TumorImmunoPapers,Negative
 Javier PinillaIbarz MD PhD comments,Health Adviser,Positive
 patientreported outcomes,Health Adviser,Positive
 RESONATE trial,Health Adviser,Positive
 RESONATE trial,VJHemOnc,Positive
 RESONATE trial,AJMC-Oncology,Negative
 RESONATE trial,AJMC,Negative
 RESONATE trial,CURE Magazine,Negative
 RESONATE trial,Targeted Oncology,Negative
 RESONATE trial,NE Live,Negative
 RESONATE trial,ecancer,Negative
   life expectancy survival rates,touchONCOLOGY,Negative
 Professor Freda Stevenson,Allison Stratford,Positive
 UK recipient,Allison Stratford,Positive
 TRADE CELLO GROUP,Market Trading Tips,Positive
 PLC Long   Stop,Market Trading Tips,Positive
 Target,Market Trading Tips,Positive
 RiskReward,Market Trading Tips,Positive
 Quebec,Anna Deveau,Negative
   Hero,OncLive.com,Positive
   Hero,CURE Magazine,Negative
 VI LEVER MED DET,LyLe Foreningen,Negative
 Dr Alison Michie,LymphomaAction,Negative
 Dr Alison Michie,POG Research,Positive
 Novel RNA Cancer Drivers,Cancer Health,Negative
   Fulllength transcript characterization,SeqComplete,Negative
 Les,L‚ÄôAnglicane,Positive
 de l ‚Äô du   sont venus minutieusement dessiner,L‚ÄôAnglicane,Positive
 √âducation √©vis,L‚ÄôAnglicane,Positive
 LAnglicane,L‚ÄôAnglicane,Positive
 new accredited   module,healthbook,Positive
 CME credits,healthbook,Positive
   healthbook,healthbook,Positive
 Chronic Lymphocytic Leukemia CLL Register,Northwest Radiology,Positive
 photo,Jeff Lafferty,Positive
 photo,CLL Society Inc.,Negative
 RealWorld Outcomes,Mahmoud Aljurf,Negative
 Management Strategies,Mahmoud Aljurf,Negative
 Management Strategies,"Raul Cordoba, MD, PhD",Negative
 VenetoclaxTreated Chronic Lymphocytic Leukemia Patients,Mahmoud Aljurf,Negative
 New mRNA,EMJ Hematology,Negative
 Drivers,EMJ Hematology,Negative
 Drivers,"Raul Cordoba, MD, PhD",Negative
 CostEffective,World Neonatology Congress,Negative
 ICER Standards,World Neonatology Congress,Negative
 Chronic Lymphocytic LeukemiaOur Web,World Neonatology Congress,Negative
 Watch Susan M OBrien MD,CCO Oncology,Positive
 expense,Patient Power,Negative
 research misconduct,ASH Clinical News,Negative
 blood IgG,ImmunologyPapers,Negative
 tumor necrosis factoralpha,ImmunologyPapers,Negative
 st site,Chan Cheah,Negative
 Ibrutinib Common,Swallow This - The War On Cancer! üò∑,Positive
 bispecific antibody,CancerTherapyAdvisor,Negative
 bispecific antibody,Lymphomation.org,Negative
 Immunotechnology,Mats Ohlin,Positive
 BioInvent Int AB,Mats Ohlin,Positive
 Progressionfree survival rates,"Raul Cordoba, MD, PhD",Positive
 age lt years,"Raul Cordoba, MD, PhD",Negative
 ‚â• years,"Raul Cordoba, MD, PhD",Positive
 Highrisk chronic lymphocytic,ASH,Negative
 pathway inhibitors,ASH,Negative
 pathway inhibitors,"Raul Cordoba, MD, PhD",Negative
 New Combination Treatment,Patient Worthy,Negative
      update,Anna Deveau,Negative
 Prof Lars Bullinger   University Berlin,HARMONY Alliance,Negative
 sets studies pilot projects,HARMONY Alliance,Negative
 Acute Myeloid Leukemia AML,HARMONY Alliance,Negative
 Dear HaematologistsPlease,Judith Trotman,Positive
 VIDEO Carsten Niemann,VJHemOnc,Positive
 Chose Life,MDS and You - MDS og Dig,Positive
 Days,MDS and You - MDS og Dig,Positive
 improved OS rates,VJHemOnc,Negative
 KICKS,Nick,Negative
 CART amp immunotherapy session,Nick,Negative
 Prof Tal Minor,Nick,Negative
 Leeds UK,Nick,Negative
 attack,Nick,Negative
 activation cell membrane hypersialylation,TumorImmunoPapers,Negative
 age month progressionfree survival lt years,"Raul Cordoba, MD, PhD",Negative
 HOUSE,Nick,Negative
   kicks,Nick,Negative
 haematologists   sharing support,Nick,Negative
 Sustained Efficacy,Mahmoud Aljurf,Negative
 Detailed Clinical,Mahmoud Aljurf,Negative
 FirstLine Ibrutinib Treatment,Mahmoud Aljurf,Negative
 Tumor Staging Systems,Mazen M,Negative
 Tumor Staging Systems,COPD News,Negative
 Tumor Staging Systems,dermatologyf,Positive
 Cutaneous Squamous Cell Carcinoma,Mazen M,Negative
 Cutaneous Squamous Cell Carcinoma,COPD News,Negative
 Cutaneous Squamous Cell Carcinoma,dermatologyf,Positive
 Global Market Key Players,Industry Today,Positive
 SC AbbVie,Industry Today,Positive
 ACEA,Industry Today,Positive
 ADC Therapeutics,Industry Today,Positive
 Aeglea BioTherapeutics,Industry Today,Positive
 Ways,CLL Ireland,Negative
 Announces New Undetectable Minimal Residual Disease Data,gilbert c faure,Negative
 Announces New Undetectable Minimal Residual Disease Data,AmericanPharmacyNews,Negative
 Announces New Undetectable Minimal Residual Disease Data,Mike Gauthier,Negative
 Announces New Undetectable Minimal Residual Disease Data,HSMN,Negative
 Announces New Undetectable Minimal Residual Disease Data,Financial Buzz,Negative
 Announces New Undetectable Minimal Residual Disease Data,Seattle's Banker,Negative
 Announces New Undetectable Minimal Residual Disease Data,RazzleTazzle,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia MURANO Trial,gilbert c faure,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia MURANO Trial,Mike Gauthier,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia MURANO Trial,HSMN,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia MURANO Trial,Seattle's Banker,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia MURANO Trial,RazzleTazzle,Negative
 rd Europe,gilbert c faure,Negative
 Prague,CLL Ireland,Negative
   Horizons   Conference,CLL Ireland,Negative
   Horizons   Conference,Margaret Walker,Negative
   ambassador,CLL Warwick Uni,Negative
 blogger Emma,CLL Warwick Uni,Negative
   Degree Pathway,CLL Warwick Uni,Negative
 CLL ARC education session,Dr Anya Hotinski,Positive
 Relapsed Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,Markets & Reports,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,COPD News,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,SPI News,Negative
 Summer ‚òÄ Ô∏è,CLL Warwick Uni,Negative
 Guts Diarrhea,Cancer Papers,Negative
 Guts Diarrhea,Lymphoma Papers,Negative
 Colonic Involvement,Cancer Papers,Negative
 Colonic Involvement,Lymphoma Papers,Negative
 VIDEO Novel,VJHemOnc,Negative
 Dr Voshtina et al Trying,"Francisco Marty, MD",Negative
 Et,Gestion agricole,Positive
 un d√©part vers,Gestion agricole,Positive
 Expochamps,Gestion agricole,Positive
 de gestion,Gestion agricole,Positive
 Amebic Encephalitis,AmoebaPapers,Positive
 Warwick Campus,CLL Warwick Uni,Negative
 activities,CLL Warwick Uni,Negative
 activities,APSHO,Negative
 glyphosate causes,Matthews & Associates,Negative
 altered gene expression,Curatio Technologies,Negative
 New    Drivers,TrialSite News,Negative
    workshop,LiveYourLife,Negative
 Obinutuzumab treatment,Medivizor,Negative
 Twist Scientists,Elaine Schattner,Negative
 Cancer Drivers,Elaine Schattner,Negative
 Inactivating,McHeyzer-Williams,Positive
 Widespread Intronic PolyAdenylation,McHeyzer-Williams,Positive
 Cancer PathoGenesis,McHeyzer-Williams,Positive
 Christine Mayr,McHeyzer-Williams,Positive
 Prof Peter Hillmen,CLL Ireland,Negative
 Prof Peter Hillmen,CLLSA,Negative
 Prof Peter Hillmen,EMJ Hematology,Positive
 Prof Peter Hillmen,VJHemOnc,Positive
 tip,CLL Warwick Uni,Negative
 Albumin   Fibrinogen ratio,World Neonatology Congress,Negative
 specialist Dr Kerry Rogers,Andrew Schorr,Negative
 friend partner spouse,CLL Ireland,Negative
 family member,CLL Ireland,Negative
 family member,Dixy_Dalton,Positive
 CELG,dough,Negative
 VIDEO Christopher Fox,VJHemOnc,Negative
 Absolutely Links,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 Emergent Literacy CLL,Early Years at LSC (#FE #VocEd #EYFS) üôã‚Äç‚ôÄÔ∏è,Negative
 PatientCentered Approach,Doctr,Positive
 VIDEO   dysfunction,VJHemOnc,Negative
 Sumamos una victoria m√°s que nos permite seguir so√±ando con el t√≠tuloVamos chicas ‚ö™ ‚ö´,Meli Parada,Positive
 Overview Cost Structure Analysis Growth Opportunities,Tech Journal Hub,Positive
 FLAIR Trial,CLLSA,Negative
 account,CryptoLiveLeak,Negative
 cryptocurrency,CryptoLiveLeak,Negative
 videos,CryptoLiveLeak,Negative
 videos,VJHemOnc,Negative
 videos,Patient Power,Negative
 posting content,CryptoLiveLeak,Negative
 Pericardial Involvement,Lymphoma Papers,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Rare Case,Lymphoma Papers,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Rare Case,Zedu #wearamask üò∑,Positive
 Constrictive Pericarditis,Lymphoma Papers,Negative
 Constrictive Pericarditis,Zedu #wearamask üò∑,Positive
 New Obinutuzumab treatment,Medivizor,Negative
   PODCAST,VJHemOnc,Negative
 fieldCheck,VJHemOnc,Negative
 expert speakers,VJHemOnc,Negative
 gen antiCD drugs,Wilmot Cancer Institute,Negative
 scales,Lymphoma Papers,Negative
 Composite Small Lymphocytic LymphomaChronic Lymphocytic Leukemia,Lymphoma Papers,Negative
 Clinicopathological Study,Lymphoma Papers,Negative
 Cases,Lymphoma Papers,Negative
 Cases,SexGenomics,Negative
 Cases,UKNEQASLI,Positive
 New   Study,Prof John,Negative
 LeukemiaThere,Monitor Healthcare Ltd (MHL),Positive
 BCell Chronic Lymphocytic Leukemia Market Pipeline Therapeutics,Tech Journal Hub,Positive
 Drug Description,Tech Journal Hub,Positive
 Target Finding,Tech Journal Hub,Positive
 Relapsed Chronic Lymphocytic Leukemia CLL Pipeline Insight   Report,Financial Buzz,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL Pipeline Insight   Report,COPD News,Negative
 pharmacy,Andrew Schorr,Negative
 ‚Ñ¢ Presents,Rare Diseases,Negative
 CheckOrphan,Rare Diseases,Positive
 treatment endpoint,VJHemOnc,Negative
 Chronic Lymphocytic Leukemia CLL Pipeline Insight,ANTELLIS,Positive
 min,Anna Deveau,Negative
 min,Cultura Lucha Libre,Positive
 min,CLLSA,Positive
 min,Lymphoma Canada,Negative
 fieldListen,VJHemOnc,Negative
 Dr John Fox,AJMC,Positive
 Dr John Fox,AJMC-Oncology,Negative
 coverage determinations,AJMC,Negative
 milestone,Oncology Times,Negative
 AUDIO OMF   Sandi Schussel,WEEI,Positive
 Tcell lymphoma Lynn,WEEI,Positive
 Dr Matthew Davids Associate Director Center,WEEI,Positive
 Chronic Lymphocytic Leukemia Physician DanaFarber,WEEI,Positive
 Sat Sept,Patient Power,Negative
 patient advocate Wesley Bishop,Patient Power,Negative
 CDinduced migration,AA&MDSIF,Positive
 CDinduced migration,ASH,Negative
 CDinduced migration,Blood Advances,Negative
 Tickets,Helen Jane Mee,Negative
 Glasgow   conference,Helen Jane Mee,Negative
 ibrutinib treatments,AJMC,Negative
 ibrutinib treatments,Targeted Oncology,Negative
 treatment pathways,AJMC,Negative
 coverage decisions,AJMC,Negative
 Awesome views,Blake Fisher,Positive
 Texas AampM,Blake Fisher,Positive
 departure,Blake Fisher,Positive
 Big Suprise,Smitt Wesson,Positive
 Fans,Smitt Wesson,Positive
 Fans,Los Lobos,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market Opportunity Analysis,The Pharmaceutical Marketing Group,Negative
 NFŒ∫B cell,Cancer Papers,Negative
 NFŒ∫B cell,Wnt publications,Negative
 Albumintofibrinogen ratio,CancerTherapyAdvisor,Negative
 National Health Service,pharmaphorum,Negative
 press campaign,pharmaphorum,Negative
 CASEPericardial Involvement,Zedu #wearamask üò∑,Positive
 Nearly   percent,Michael's Pharmacy,Positive
 chemofree drug cocktails,Michael's Pharmacy,Positive
 Chronic Lymphocytic Leukemia CLLCLL,Virtute_USMLE,Negative
 TRI,CellworksLife,Negative
 Remission maintenance treatment options,Cancer Papers,Negative
 Melanoma Dangerous Skin Cancer,Drugnews.in,Negative
 Melanoma Dangerous Skin Cancer,realtimes,Positive
 proliferation centers PCs,CLL Ireland,Negative
 bone marrow BM,CLL Ireland,Negative
   Tips,Michele Nadeem-Baker,Negative
 Doc,Michele Nadeem-Baker,Negative
 Doc,MDedge Hematology & Oncology,Negative
 Proliferation Centers,Kathleen Montone,Positive
 Bone Marrow,Kathleen Montone,Positive
 Younger Age,Kathleen Montone,Positive
 Initial Presentation Complex Karyotype,Kathleen Montone,Positive
 TP Disruption,Kathleen Montone,Positive
   SAS team,CLL Warwick Uni,Negative
 Leamington,CLL Warwick Uni,Negative
 Copper Zinc,Shelley Henry,Positive
 bendamustineibrutinib,Cancer_Tribune,Negative
 tcoawHPKhoSL,Cancer_Tribune,Negative
 FirstLine Approach,Oncology Times,Positive
 New Therapeutic Strategies,Oncology Times,Negative
 Quoi de mieux pour,C√©gep de L√©vis,Positive
 amorcer,C√©gep de L√©vis,Positive
 Gene Abnormalities,SexGenomics,Negative
 Half Year Results,AIM Alerts!,Negative
 fairness,EricaGrieder,Positive
 absolutely evidence,EricaGrieder,Positive
 Coventry City Centre Library,CLL Warwick Uni,Negative
 ampm,CLL Warwick Uni,Positive
 Realworld,MDedge Hematology & Oncology,Negative
    Leukemia Life Expectancy amp Survival Rates,NurseGroups,Positive
 Tower,Gerry Rodrigues,Positive
 Stan Kurtz,Gerry Rodrigues,Positive
 Rogers et al phase b study,Chan Cheah,Negative
   study patients,University of Rochester,Positive
     Cello Health PLC Board Changes,AIM Alerts!,Negative
 New Patient Cafe,Patient Power,Negative
     life expectancy survival rates,CancerWallonia,Negative
 Chronic Lymphocytic Leukemia Curable,"Dr T. Comeau , MD",Negative
 professionals,Helen Jane Mee,Negative
 professionals,CLLSA,Negative
 professionals,Patient Power,Negative
 Thanks Dr Mato,Targeted Oncology,Negative
 UK   treatment trials,Nick,Negative
 Lack,"Navneet Majhail, MD, MS",Negative
 Lack,Internal Medicine: Open Access,Positive
 Lack,Cancer Papers,Negative
 depth slide,Healthguru,Positive
 Entwickeln Patienten mit chronischer,SpringerMedizin.de,Positive
 lymphatischer √§mie neurologische Symptome muss,SpringerMedizin.de,Positive
 Befall gedacht,SpringerMedizin.de,Positive
 und zwar unabh√§ngig von Krankheitsstadium,SpringerMedizin.de,Positive
 und aktivit√§t,SpringerMedizin.de,Positive
 Survival rates,Dr. Drew Dahlgren,Positive
 Survival rates,caitxluhn562155,Positive
 New Social Media Platform,CryptoLiveLeak,Negative
 ‚Äî CheckOrphan,Rare Diseases,Negative
 Group,MDedge Hematology & Oncology,Positive
 Group,Healthcanal,Negative
 concept,Medscape Education,Negative
 concept,Christopher Steer,Negative
 Chronic Lymphocytic Leukemia CLL Market Insights Epidemiology,RazzleTazzle,Negative
 GILD Gilead,dough,Negative
 Design MinION testing,The Nanopore Site,Positive
 Design MinION testing,CompBiolPapers,Negative
   targeted gene sequencing panel,The Nanopore Site,Positive
 FGG,Bikudo,Positive
 Male connector EGG,Bikudo,Positive
 CLL Receptacle Audio Video Connector,Bikudo,Positive
 Wesley Bishop,Andrew Schorr,Negative
 dentist,Andrew Schorr,Negative
 East Texas,Andrew Schorr,Negative
 worry,Andrew Schorr,Negative
 roller coaster,AbbVie US,Negative
 resource center,Oncology Times,Positive
 chapters,Oncology Times,Positive
 Videos,CLLSA,Positive
   members meeting,CLLSA,Negative
 viewing pleasure,CLLSA,Negative
 nomination deadline,OncLive.com,Negative
 Team,MDedge Hematology & Oncology,Positive
 Team,Kelsey Stanczyk,Positive
 Team,Matthew Kauffman,Positive
 ObinutuzumabChlorambucil,CLL Ireland,Negative
 KTEC,TrialBulletin,Negative
 KTEC,CureHuntr,Negative
 Condition Summary RelapsedRefractory Chronic Lymphocytic Leukemia,TrialBulletin,Negative
 shock,AbbVie US,Negative
 VIDEO Arnon Kater,VJHemOnc,Positive
 stranger,MD Anderson Cancer Center,Positive
 Sandra,MD Anderson Cancer Center,Positive
 Dominik Wodarz,SIAM,Positive
 models,SIAM,Positive
 models,Carevƒ´ve,Negative
 models,TCS ATX,Positive
 models,Ruth Glendinning,Positive
 models,DEAD RECKONING,Positive
 models,Dr. Steven Eisenberg,Positive
 models,Cancer Agent,Negative
 models,Science agent,Positive
 models,Diabetes Greg,Positive
 models,Titanhealth news,Positive
 models,Medical Xpress,Negative
 models,Larry K Chapman,Positive
 models,Future Consulting,Positive
 models,sciencenewsfacts,Positive
 models,Ajinkya Ambre,Positive
 doi jhumpath CLL,"Sofia Garces, MD",Positive
 proliferation centers,"Sofia Garces, MD",Positive
 Lebensqualit√§t und freude von Menschen mit,AbbVie Deutschland,Negative
 verbessern Auch,AbbVie Deutschland,Negative
 wir,AbbVie Deutschland,Negative
 wollen,AbbVie Deutschland,Negative
 unterst√ºtzen mit,AbbVie Deutschland,Negative
 und umfangreichen Informationen zB,AbbVie Deutschland,Negative
 nanopore targeted gene sequencing panel,CompBiolPapers,Negative
 Parttime student Ray,CLL Warwick Uni,Negative
 Nuneaton Library,CLL Warwick Uni,Positive
 Mother,Amie,Positive
 Mother,Damian Bullimore,Positive
 Kanti R Rai MD,OncLive.com,Negative
 Lyme Disease ConnectionLyme disease,Angela Reeves Tate,Positive
 III CLL study treatment,Targeted Oncology,Negative
 shingles vaccine,Andrew Schorr,Negative
 CDCD bispecific antibody,Tran-Der Tan,Negative
 CDCD bispecific antibody,Dr Alexandros Kanellopoulos,Positive
 CDCD bispecific antibody,Blood Journal,Negative
 CDCD bispecific antibody,Lymphoma Papers,Negative
 CDCD bispecific antibody,Philip McCarthy,Negative
 effectiveimmunotherapy,Tran-Der Tan,Negative
 spectrum,Patient Power,Negative
 shifting treatment paradigm,Targeted Oncology,Negative
 Add‚Äôl Indication,MEDWAVE,Negative
 Chronic Lymphocytic Leukemia Chugai PharmaceuticalZenyaku Kogyo,MEDWAVE,Negative
 CLL Collerina Cobalt maiden ‚Äò HPA ‚Äô process,Proactive Australia,Positive
 Rai,Cancer News,Negative
 Leukemia Kanti R Rai MD,Cancer News,Negative
 Preclinical data,CLL Ireland,Negative
 Preclinical data,EPM Magazine,Positive
 Novel CDCD bispecific antibody,CLL Ireland,Negative
 exhausted T cells,CLL Ireland,Negative
   AntiCD Monoclonal Antibody RITUXAN    Application,PressReleasePoint,Negative
 Additional Indication,PressReleasePoint,Negative
 Additional Indication,1stOncology,Negative
 Additional Indication,Rare Diseases,Negative
 CDPositive Chronic Lymphocytic Leukemia,PressReleasePoint,Negative
 New Transplant,Medivizor,Negative
 cochair Grace Cherry,donnashort,Negative
 faculty Barbara Rogers,donnashort,Negative
 Laura Zitella,donnashort,Negative
 CAR T Cell Therapy Market,ABNewswire,Negative
 Targeted Antigen,ABNewswire,Negative
 Application Leukemia Chronic Lymphocytic Leukemia NonHodgkin,ABNewswire,Negative
 Lymphoma Multiple Myeloma Acute Myeloid Leukemia Hepatocellular Carcinoma,ABNewswire,Negative
 ibrutinib era,Blood Journal,Negative
 Snapshot Chronic Lymphocytic,Hematology Conference,Negative
 Parttime History student Emma,CLL Warwick Uni,Negative
 Leamington Library,CLL Warwick Uni,Positive
 TV Patrol anchor,Kapamilya Defenders,Positive
 TV Patrol anchor,ABS-CBN Entertainment,Positive
 Bantay Bata,Kapamilya Defenders,Positive
 Bantay Bata,ABS-CBN Entertainment,Positive
 stage,Kapamilya Defenders,Positive
 stage,ABS-CBN Entertainment,Positive
 stage,ABNewswire,Negative
 stage,SouthernIndiaReporte,Positive
 stage,New Jersey Headlines,Positive
 stage,"chadi nabhan MD, MBA, FACP",Negative
 stage,AstraZenecaUS,Negative
 stage,MD Anderson Cancer Center,Negative
 stage,Nora Sheffield,Negative
 stage,Jen Ticehurst,Positive
 stage,Los Lobos,Negative
 Latest Developments,Abdullah Al Mosabbir,Positive
 Community Series John C Byrd MD,Abdullah Al Mosabbir,Positive
 Ohio State University Comprehensive    ppt download,Abdullah Al Mosabbir,Positive
 ÊúàÊó•„ÄúÊúàÊó•„ÅÆÊúüÈñì„ÄÅÂ≠¶ÁîüÈ£üÊóÖ,ÁöáÂ≠∏È§®Â§ßÂ≠¶„Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„ÉàÂà©Áî®‰øÉÈÄ≤PJ,Positive
 „Çí„Å§„Åë„Å¶„ÄÅ‰∏âÈáçÁúå„ÅÆÂÜôÁúüÔºàÈ¢®ÊôØ„ÇÑÈ£ü„ÅπÁâ©Ôºâ„Çí„ÄÅInstagram„ÇÑTwitter„Å´ÊäïÁ®ø„Åó„Å¶„ÅÑ„Åü„Å†„Åè„Å®„ÄÅÊäΩÈÅ∏„ÅßË±™ËèØË≥ûÂìÅ„ÅåÂΩì„Åü„Çä„Åæ„ÅôÔºÅÂèÇÂä†„Åó„Å¶„Åè„Å†„Åï„ÅÑ„Å≠ ÔºÅ ÔºÅ,ÁöáÂ≠∏È§®Â§ßÂ≠¶„Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„ÉàÂà©Áî®‰øÉÈÄ≤PJ,Positive
 ÁöáÂ≠∏È§®Â§ßÂ≠¶ „Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„ÉàÂà©Áî®‰øÉÈÄ≤pj „Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„Éà,ÁöáÂ≠∏È§®Â§ßÂ≠¶„Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„ÉàÂà©Áî®‰øÉÈÄ≤PJ,Positive
 ups amp downs,AbbVie US,Negative
 NEW Chemoimmunotherapy,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
   Patient Michele,Patient Power,Negative
   tips,Patient Power,Negative
 dr appts,Patient Power,Negative
 Current perspectives,Hospital Medicine Virtual Journal Club,Positive
 Smudge cells,"Mario L. Marques-Piubelli, MD",Positive
 Smudge cells,Internist to be,Positive
 Smudge cells,GateToMedicine PG,Positive
 Smudge cells,Meddworld Viva,Positive
 Smudge cells,Dua and Azkar,Positive
 Smudge cells,JAMA,Negative
 Gumprecht shadows,"Mario L. Marques-Piubelli, MD",Positive
 rollercoaster,AbbVie US,Negative
 rollercoaster,AbbVie,Negative
 emotions,AbbVie US,Negative
 emotions,AbbVie,Negative
 Benzene,Matthews & Associates,Positive
 NonHodgkins Lymphoma NHLAcute Myeloid Leukemia AMLAcute Lymphocytic Leukemia ALLChronic Lymphocytic Leukemia CLLMultiple MyelomaAplastic Anemia,Matthews & Associates,Negative
 Safety Analysis,Lymphoma Papers,Negative
 Safety Analysis,Oncology Tube,Negative
 Haematologica Adherence,IUOPA,Negative
 Western Prudent,IUOPA,Negative
 Western Prudent,@immunoonco_Meed,Positive
 Increased   exposure,"Raul Cordoba, MD, PhD",Negative
   journey,AbbVie,Negative
   journey,VJHemOnc,Negative
   journey,Liana Gardner,Positive
   journey,Jeff Folloder,Positive
 ups,AbbVie,Negative
 ups,Jonderic,Positive
 downs,AbbVie,Negative
 family relationships,AbbVie US,Negative
 Everyones,Patient Power,Negative
 drs,Patient Power,Negative
 treatment plans,Patient Power,Negative
 objectives,Patient Power,Negative
 Experts Drs Keating,Patient Power,Negative
 Lamanna,Patient Power,Negative
 Lamanna,Andrew Schorr,Negative
 Lamanna,MD Anderson Leukemia,Negative
   conferences,Helen Jane Mee,Negative
 ÿπŸÜÿØŸä ÿ≠ÿßŸÑÿ© ÿ¨ÿßŸäÿ©,ÿπÿ≤Ÿäÿ≤ ŸÉŸÜÿßÿ±Ÿäÿß..,Positive
 Mosaic Chromosomal Alterations,Biobanking.com,Positive
 New Approaches,Biobanking.com,Positive
 New Approaches,Lymphoma Coalition,Negative
 OncoLink,Candace Lewis,Positive
 recipe,VJHemOnc,Negative
 Expert Reviews Current State,CancerWallonia,Negative
 Expert Reviews Current State,COPD News,Negative
 Chronic Lymphocytic Leukemia Paperback,Shop Like a Freak,Positive
 Import,Shop Like a Freak,Positive
 Day Demurrage,Concessionary L.L,Negative
 Dr Keating amp Dr Ferrajoli,Andrew Schorr,Negative
 amp Dr Lamanna,Andrew Schorr,Negative
 amp Dr Lamanna,Patient Power,Positive
 Depth,Elsevier Oncology,Positive
 Depth,Blood Journal,Negative
 Depth,"Raul Cordoba, MD, PhD",Negative
 Durability,Elsevier Oncology,Positive
 amp MDAndersonNews,Patient Power,Negative
 lifestyle,Patient Power,Negative
 lifestyle,Joe Dan Morgan,Positive
 yearold,Radical Remission,Positive
 VIDEO Paolo Ghia,VJHemOnc,Positive
 Expert Shares Insights,MedShr,Positive
 Ô∏è bud,Michael Wilburn,Positive
   family,Michael Wilburn,Positive
 Leukemia Treatment Strategies,Medscape Education,Negative
 Current FutureLandscape   drugs,Anna Deveau,Negative
    Minutes journalist Ed Bradley,Cancer Today,Negative
 watchandwait period,Patient Power,Negative
 watchandwait period,VJHemOnc,Negative
 extranodal NKTcell lymphoma,NK papers,Negative
 Dear Church Family,PBC,Positive
   summer library tour,CLL Warwick Uni,Negative
 stall,CLL Warwick Uni,Negative
 information contact details,CLL Warwick Uni,Negative
 Callout Ceremony,Wag-O-Shag Lodge #280,Positive
 ¬Æ venetoclax tablets,Rob Wilson,Positive
 ¬Æ venetoclax tablets,AmericanPharmacyNews,Negative
 ¬Æ venetoclax tablets,aeses.com,Negative
 ¬Æ venetoclax tablets,Financial Buzz,Negative
 ¬Æ venetoclax tablets,FDA Daily,Negative
 ¬Æ venetoclax tablets,RazzleTazzle,Negative
 CLL Treatment Danielle Brander MD,COPD News,Negative
 Evidencebased Review,"Dr T. Comeau , MD",Negative
 AntiCD Antibodycontaining Regimens,"Dr T. Comeau , MD",Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia Diffuse Large Bcell Lymphoma,"Dr T. Comeau , MD",Negative
   patient reporter,Patient Power,Negative
 Michele,Patient Power,Negative
   tomorrow,Patient Power,Negative
   tomorrow,NU Internal Medicine,Positive
 pm ET Pacific,Patient Power,Negative
   Health Care Costs,Scirp Papers,Positive
 Medicare Patients,Scirp Papers,Positive
 Kitchkinet,Wag-O-Shag Lodge #280,Positive
 smoke,Wag-O-Shag Lodge #280,Positive
 Thanks Kameron Anderson,Wag-O-Shag Lodge #280,Positive
 Umbralisib Shows Promise,COPD News,Negative
 RelapsedRefractory CLL Anthony R Mato MD MSCE,COPD News,Negative
 Clone Size,touchONCOLOGY,Negative
 RelapsedRefractory   Patients,touchONCOLOGY,Negative
 Clinical Stage,H4B Boston,Positive
 Prognostic Genetic Testing,CLL Society Inc.,Negative
 Prognostic Genetic Testing,Anthony Mato,Negative
 CLL Token,CryptoLiveLeak,Positive
 rd Exchange,CryptoLiveLeak,Negative
    Andy Moore,CLLSA,Negative
   mile   challenge,CLLSA,Negative
 Lands End,CLLSA,Negative
 OGroats,CLLSA,Negative
 CLLSA,CLLSA,Positive
 Andy Moore,CLLSA,Negative
 Andy Buclaw,CLLSA,Negative
 luck,CLLSA,Negative
 luck,Anna Deveau,Negative
 luck,brian brown,Negative
 El doctor Ram√≥n Amieva mandatario capitalino,TVBUS Noticias de Oaxaca,Positive
 El Fantasma presidente de la CLL firmaron el decreto,TVBUS Noticias de Oaxaca,Positive
 donde se,TVBUS Noticias de Oaxaca,Positive
 Lucha Libre como Patrimonio Cultural de la Ciudad de M√©xico,TVBUS Noticias de Oaxaca,Positive
 treatment plan,Andrew Schorr,Negative
 plan,Andrew Schorr,Negative
 plan,Lymphoma Canada,Negative
   opportunities,PharmacyTimesCE,Positive
 Asembia Live Webinar series,PharmacyTimesCE,Positive
 CLL Symposium,Alan Skarbnik,Negative
 Teaneck NJ,Alan Skarbnik,Negative
 nomination,CURE Magazine,Negative
 nomination,Connie Erpelding,Positive
 nomination period,CURE Magazine,Negative
 night,Amanda Marie,Positive
 „Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„Éà              √ó       Á•ûÈÉΩ„ÅÆÁ•à„ÇäÊúàÊó•ÔºàÊú®ÔºâÂ≠¶È£üÈöé„Å´„Å¶„ÄÅ„Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„Éà„ÇíÊé≤Á§∫„Åó„Å¶„ÅÑ„Åü„Å†„Åè„Å®„ÄÅÁ•ûÈÉΩ„ÅÆÁ•à„Çä„Çí‰Ωø„Å£„Åü„Çπ„Ç§„Éº„ÉÑ„ÇíÊâã„Å´ÂÖ•„Çå„Çã„Åì„Å®„Åå„Åß„Åç„Åæ„ÅôÔºÅ„Åú„Å≤„Åì„ÅÆÊ©ü‰ºö„Å´„ÄÅ„Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„Éà„Çí„ÇÇ„Å£„Å¶„ÄÅÂ≠¶È£üÈöé„Å´„ÅäË∂ä„Åó„Åè„Å†„Åï„ÅÑ ÔºÅ,ÁöáÂ≠∏È§®Â§ßÂ≠¶„Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„ÉàÂà©Áî®‰øÉÈÄ≤PJ,Positive
 Florence Cymbalista PhD,CLL Ireland,Negative
 setup,CLLSA,Negative
   members,CLLSA,Positive
 shares findings,OncologyGo,Negative
   ELIAS CAMPO,Oncobell Symposium,Negative
 hospital Pneumonia,Damian Bullimore,Positive
 Bored Tired,Damian Bullimore,Positive
 acquisitions,WheelieDealer,Negative
 Elias Campos,Oncobell Symposium,Positive
 Summer,CLL Warwick Uni,Negative
 Summer,Janette Fuller,Negative
 FREE Seminars,CLL Warwick Uni,Negative
     Cello Health PLC Preclose Trading Update,AIM Alerts!,Negative
 farmers farm workers,Matthews & Associates,Negative
 homeowners,Matthews & Associates,Negative
 Roundup Chronic Lymphocytic Leukemia CLL Lawsuit,Matthews & Associates,Positive
 Congratulations Calvin,CLLSA,Negative
 heat,CLLSA,Negative
 Derriford Chronic Lymphocytic Leukaemia CLL Support Group,Derriford Hospital,Negative
 Derriford Chronic Lymphocytic Leukaemia CLL Support Group,University Hospitals Plymouth NHS Trust,Negative
 launch event,Derriford Hospital,Negative
 launch event,University Hospitals Plymouth NHS Trust,Negative
 July Patients,Derriford Hospital,Negative
 July Patients,University Hospitals Plymouth NHS Trust,Negative
 best kind,Sara Hattersley,Positive
 graduates,Sara Hattersley,Positive
 graduates,CLL Warwick Uni,Negative
 graduates Congratulations,Sara Hattersley,Positive
 Trustee Gail Wiegman,CLLSA,Negative
 incredible ¬£ k,CLLSA,Negative
 Primeros dos que se van lo digital los Onii ChanCho chanchopipecll zetagcll,Yuriko Suzuki,Positive
 tgtx snss,Anna Deveau,Negative
 MSKCC CLL program,Anthony Mato,Negative
 Biomarkers evaluation,Hematology Conference,Negative
 Resolution,Cancer Papers,Negative
 Eosinophilia,Cancer Papers,Negative
 Elevated Immunoglobulin E,Cancer Papers,Negative
 VIDEO Stephen Robinson,VJHemOnc,Negative
 CAR Tcells,VJHemOnc,Negative
 CAR Tcells,AJMC,Negative
 CAR Tcells,Blood Journal,Negative
     Cello Health PLC Change,AIM Alerts!,Negative
 Exciting Advances,CONQUER the patient voice,Negative
 Couch,CLLSA,Negative
 ¬£ k,CLLSA,Negative
 Rac,Blood Journal,Negative
 Rac,Cancer Papers,Negative
 Human Herpesvirus,Internal Medicine: Open Access,Positive
 hHV,Internal Medicine: Open Access,Positive
 Leukemic LowGrade,Internal Medicine: Open Access,Positive
 Treatment Standards,SpecialtyPTimes,Negative
 Pharma ltd,Medicine For World,Negative
 contactcom,Medicine For World,Negative
 VIDEO Response,VJHemOnc,Negative
 CAR Tcell treatment,VJHemOnc,Negative
 illness Check,Warren Terry Knight,Positive
 Mauro,Graham Collins,Negative
 TKI cessation,Graham Collins,Negative
 CML Deeper remissions,Graham Collins,Negative
 TransplantDoc RT BloodJournal,Robert Z. Orlowski,Negative
 Moxetumomab pasudotox,Oncology Tube,Negative
 Lymphoma amp Leukemia Resource Center Watch Dr William G Wierda,Oncology Times,Negative
 C√≥mo acordarme del mejor campe√≥n mojonero que tiene Chile zetagcll lt,Yukiüî±,Positive
 Denny Marchel,The Leukemia & Lymphoma Society,Negative
 NOTCH Aberrations,Cancer Papers,Negative
 NOTCH Aberrations,Frontiers Oncology,Negative
 America CLL,Lucy Mills,Positive
 FCN Girls U,Lucy Mills,Positive
 PreGothia training,Lucy Mills,Positive
 bonding,Lucy Mills,Positive
 VIDEO Promises,VJHemOnc,Negative
 upandcoming,VJHemOnc,Negative
 Invasive   diseases,"Francisco Marty, MD",Negative
     inhibitors,"Francisco Marty, MD",Negative
 Elearning,CLL Warwick Uni,Negative
 Manager   PGDE student Sue,CLL Warwick Uni,Negative
   Summer Social,CLL Warwick Uni,Positive
 swing,CLL Warwick Uni,Negative
 swing,UAMS Cancer,Positive
 swing,Oxford Nanopore,Positive
 amp venetoclax Venclexta,CLL Ireland,Negative
 Tolerance,Oncology Tube,Negative
 Robert L Talley MD,OncLive SOSS,Negative
 Ordeals,Wag-O-Shag Lodge #280,Positive
   expert Anthony Mato,CLL Ireland,Negative
 Fantastic presentation,British Society for Proteome Research,Positive
 tcoyEGZUp,HappiDoc,Positive
 Rituximab New ChemotherapyFree Option,AONN+,Negative
 Osteomyelitis Chronic Fatigue syndrome Chronic Lymphocytic Leukemia DVTs,Tony Rothwell,Positive
 PEs,Tony Rothwell,Positive
 bastards,Tony Rothwell,Positive
 Ibrutinib Monotherapy,Dr Jayaprakash Madhavavan,Positive
 Ibrutinib Monotherapy,World Neonatology Congress,Negative
 Deletion,Dr Jayaprakash Madhavavan,Positive
 Deletion,World Neonatology Congress,Negative
 Deletion,"A. Emre E≈ükazan, MD ü©∏üî¨",Positive
 Deletion,George Papadopoulos,Positive
 Deletion,Dr. Sujie Tang,Positive
 p Chronic Lymphocytic Leukemia,Dr Jayaprakash Madhavavan,Positive
 p Chronic Lymphocytic Leukemia,World Neonatology Congress,Negative
 Man Alleges Chronic Lymphocytic,Top Class Actions,Positive
 MCCSpain study,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
   CLL patients,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 longterm remissions,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 longterm remissions,"Raul Cordoba, MD, PhD",Negative
 longterm remissions,Fierce Life Sciences Events,Positive
 longterm remissions,labguru,Positive
 longterm remissions,Only Medics,Negative
 longterm remissions,Josef Hermanns,Positive
 longterm remissions,Global Pharma News,Negative
 longterm remissions,SmartRx Systems,Positive
 longterm remissions,3BL Health,Positive
 longterm remissions,Daniel Bednarik,Positive
 longterm remissions,Beyond the Pill 2015,Positive
 longterm remissions,Mktingfarmaceutico,Positive
 longterm remissions,PISPOpharma,Positive
 longterm remissions,MyMexicanStore,Positive
 longterm remissions,David Ledger,Negative
 longterm remissions,DTN Pharma News,Positive
 longterm remissions,World Pharma News,Negative
 longterm remissions,HemaCare Corporation,Negative
 longterm remissions,Station X,Positive
 DOWNLOAD SLIDES,Carevƒ´ve,Negative
 VIDEO Tolerance,VJHemOnc,Negative
 LETS GOOOO BABYYYYYY lt,Mahmoud Turki,Negative
 phase III findings support combination obinutuzumab,Targeted Oncology,Negative
 Salvage Treatment,"Dr T. Comeau , MD",Negative
 Salvage Treatment,"Raul Cordoba, MD, PhD",Negative
 Indirect Comparison,"Dr T. Comeau , MD",Negative
 Indirect Comparison,"Raul Cordoba, MD, PhD",Negative
 Ibrutinib GIMEMA ERIC,"Dr T. Comeau , MD",Negative
 Ibrutinib GIMEMA ERIC,"Raul Cordoba, MD, PhD",Negative
 UK CLL FORUM Study,"Dr T. Comeau , MD",Negative
 UK CLL FORUM Study,"Raul Cordoba, MD, PhD",Negative
 tcoEqneeuhM,Anna Deveau,Negative
 ü§®,"Raul Cordoba, MD, PhD",Negative
 Midmark Teammates,Midmark News,Positive
 help coworker family member amp friend,Midmark News,Positive
 Mark Thomas,Midmark News,Positive
 Chronic Lymphocytic LeukemiaTeammates,Midmark News,Positive
 tshirts,Midmark News,Positive
 Midmark,Midmark News,Positive
 expenses,Midmark News,Positive
 lriley,Vincent McKee,Positive
   Allstars,Vincent McKee,Positive
 Murano trial,CLL Ireland,Negative
 Rong MD et al,Medical & Surgical Pathology,Positive
 PD Expression,Medical & Surgical Pathology,Positive
 PD Expression,histopathology üî¨,Positive
 PD Expression,Giuseppe Ingravallo,Positive
 PD Expression,Sameer Parikh,Negative
 PD Expression,Dendritic cells,Positive
 PD Expression,ImmunotherapyPapers,Negative
 Deficiency,ùîÑùîØùî´ùîûùî≤ùî° ùîç. ùîèùî¢ùî§ùîØùîûùî´ùî°,Positive
 ribonucleotide excision repair hypersensitises cancer cells,ùîÑùîØùî´ùîûùî≤ùî° ùîç. ùîèùî¢ùî§ùîØùîûùî´ùî°,Positive
 secondline chemoimmunotherapy,Cancer Papers,Negative
 SecondLine Chemoimmunotherapy,CLL Ireland,Negative
 Novel role,Blood Journal,Negative
 prostate apoptosis response tumor suppressor,Blood Journal,Negative
 Bcell chronic lymphocytic,Blood Journal,Negative
 Bcell chronic lymphocytic,Stefano Cattaneo DVM,Negative
 illustrated   tcoICFooDG,Nature Reviews Disease Primers,Negative
 RT TargetedOnc,Catalyst Trading,Positive
 Alison Job Search Adviser,CLL Warwick Uni,Negative
 graduate,CLL Warwick Uni,Negative
 VIDEO Moxetumomab pasudotox,VJHemOnc,Negative
 N√¶ste Temadag,LyLe Foreningen,Negative
 venetoclax resistance,MDLinx,Negative
 venetoclax resistance,Lymphoma Hub,Positive
 venetoclax resistance,Kadir C Akdemir,Positive
 venetoclax resistance,Blood Journal,Negative
 venetoclax resistance,Prof John,Negative
 ‚öï Ô∏è‚Äç ‚öï Ô∏è Grand Rounds series,CEC Oncology,Positive
 Malignancies,CEC Oncology,Positive
 ACCMEANCCACPE credit,CEC Oncology,Positive
 institution,CEC Oncology,Positive
 chimeric antigen receptor CAR T cell therapy,CLL Ireland,Negative
 Descansa,ArturTC3000 üê¨,Positive
 paz,ArturTC3000 üê¨,Positive
 Dr Talley,donnashort,Negative
 Christopher Fox,VJHemOnc,Negative
 Remission Duration,"Meagan Bryan, RN",Negative
 Remission Duration,OncologyNurseAdvisor,Negative
 Tecfidera,Must Stop MS!,Positive
 Growth Opportunities,Tech Journal Hub,Positive
 BCell Chronic Lymphocytic Leukemia market,Tech Journal Hub,Positive
 Global Industry,Tech Journal Hub,Positive
 analysis Expected Growth,Tech Journal Hub,Positive
 Forcast,Tech Journal Hub,Positive
   Therapy,Patient Power,Negative
 Oreofe Odejide MD MPH,Dana-Farber,Negative
 West Brom,LiveYourLife,Negative
 st    health amp wellbeing workshop,LiveYourLife,Negative
 Precision medicine,El Sol de la Florida,Positive
 Precision medicine,The Sun Post,Positive
 realworld venetoclaxtreated patients,Univadis UK,Positive
 multitude,VJHemOnc,Negative
 Vote,CryptoLiveLeak,Negative
 Mercatox Cryptocurrency Exchange,CryptoLiveLeak,Negative
 Dr Samuel Ng MD PhD,WorldCare Medical Second Opinions,Negative
 WorldCare Consortium member,WorldCare Medical Second Opinions,Positive
 nonHodgkin lymphoma Hodgkin lymphoma,WorldCare Medical Second Opinions,Negative
 iwCLL,"Raul Cordoba, MD, PhD",Negative
 iwCLL,Oncology Tube,Negative
 iwCLL,Patient Power,Negative
 diagnosis indications,"Raul Cordoba, MD, PhD",Positive
 diagnosis indications,Blood Journal,Negative
 diagnosis indications,@immunoonco_Meed,Positive
 diagnosis indications,Chan Cheah,Negative
 diagnosis indications,Izaskun Zeberio,Negative
 diagnosis indications,Dr. Jos√© A. Queiz√°n,Negative
 diagnosis indications,Jos√© Ant. Marcos,Positive
 diagnosis indications,Garbi√±e Lizeaga,Negative
 treatment response assessment,"Raul Cordoba, MD, PhD",Positive
 treatment response assessment,Blood Journal,Negative
 treatment response assessment,@immunoonco_Meed,Positive
 treatment response assessment,Chan Cheah,Negative
 treatment response assessment,Izaskun Zeberio,Negative
 treatment response assessment,Dr. Jos√© A. Queiz√°n,Negative
 treatment response assessment,Jos√© Ant. Marcos,Positive
 treatment response assessment,Garbi√±e Lizeaga,Negative
   Neues Verfahren knackt Tarnkappe von,EuropeanHospital_D,Negative
 einer pfiffigen Methode haben,EuropeanHospital_D,Negative
 und des Uniklinikums Heidelberg Blutkrebszellen dazu gebracht sich dem,EuropeanHospital_D,Negative
 angreifbar zu,EuropeanHospital_D,Negative
 Prognosis   evaluation,Hematology Conference,Negative
   biology,Marta Crespo,Negative
 Venetoclax novel Bcell lymphoma inhibitor,EurekaMag,Negative
 Venetoclax novel Bcell lymphoma inhibitor,FarmaOnco,Negative
 Venetoclax Management,EurekaMag,Negative
   ASCO,Anthony Mato,Negative
   ASCO,Lymphoma Hub,Negative
 Chronic Lymphocytic Leukemia Emanuela Rosati Stefano Baldoni Filomena De Falco Beatrice Del Papa Erica Dorillo Chiara,Frontiers Oncology,Negative
 Rompietti Elisa,Frontiers Oncology,Negative
 Albi Franca Falzetti,Frontiers Oncology,Negative
 Mauro Di Ianni Paolo Sportoletti,Frontiers Oncology,Negative
 RNS AIM,AIM Alerts!,Positive
 Cello Health PLC Holdings,AIM Alerts!,Positive
 New Post VenclextaRituxan Combo Extends Undetectable Disease,Lymphoma News Today,Negative
 review topic,Archi Miedes,Positive
 Nonhodgkins LymphomaChronic Lymphoma Lymphocytic LeukemiaAutoImmune Hemolytic anemia,Archi Miedes,Positive
 Paddle Cancer,BillyLushBoards&Brew,Positive
 AThe,BillyLushBoards&Brew,Positive
 Poker Run,BillyLushBoards&Brew,Positive
 East Tennessee paddler,BillyLushBoards&Brew,Positive
 VIDEO   mutations,VJHemOnc,Negative
   appt,Ed Toman,Positive
 Key Option Leader Dr Susan OBrien,Andrew Schorr,Negative
 UC Irvine,Andrew Schorr,Negative
 AbbvieGenentechs Venclexta,Andrew Schorr,Negative
 Rituxan approval,Andrew Schorr,Negative
 Al D√≠a Health NewsNew success,CubaHeal,Positive
   Video,CryptoLiveLeak,Negative
 CLL Attention Mining,CryptoLiveLeak,Negative
 New Undetectable Minimal Residual Disease Data,OBR,Negative
 Lessons,Anna Deveau,Negative
 Official Users,CryptoLiveLeak,Negative
 life partner,Saltanat Shafqat,Positive
 marriage,Saltanat Shafqat,Positive
 ‚Äò unfit ‚Äô   patients,MDedge Hematology & Oncology,Negative
 New Website users,CryptoLiveLeak,Negative
 Chronic Lymphocytic Leukemia CLL ‚Äì Pipeline Review H,Markets & Reports,Negative
 Chronic Lymphocytic Leukemia CLL ‚Äì Pipeline Review H,News Rooms,Positive
   curative cancer therapy,Anna Deveau,Negative
 Media Consumption,CryptoLiveLeak,Positive
 RT EHAHematology Rt,"Chared, Good Comms",Positive
 Jes√∫s Mar√≠a Hern√°ndez Rivas,"Chared, Good Comms",Negative
 Jes√∫s Mar√≠a Hern√°ndez Rivas,European Hematology Association,Negative
 Jes√∫s Mar√≠a Hern√°ndez Rivas,VJHemOnc,Negative
 HarmonynetEU   EHAHematology,"Chared, Good Comms",Negative
 HarmonynetEU   EHAHematology,European Hematology Association,Negative
 Rt,European Hematology Association,Positive
 RT VJHemOnc VIDEO,European Hematology Association,Negative
    stream,LymphomaAction,Negative
 therapy amp,LymphomaAction,Negative
 illustration,donnashort,Negative
 VIDEO Obinutuzumabchlorambucil,VJHemOnc,Negative
 Valentin Goede,VJHemOnc,Negative
 Green tea,"chadi nabhan MD, MBA, FACP",Negative
 Yes NoSee,"chadi nabhan MD, MBA, FACP",Negative
 bueno,GLEZY,Positive
 esos,GLEZY,Positive
 que intensidad,GLEZY,Positive
   member project,IHEC_Epigenomes,Positive
 infographic,Targeted Oncology,Negative
   Targeted Oncology,Targeted Oncology,Negative
 Tambi√©n hay poleras de mxcll,Giannina,Positive
 s√≠ganloPD En,Giannina,Positive
 cuanto pueda,Giannina,Positive
 Hay poleras del luchador,Giannina,Positive
 Cualquier consulta con √©l y s√≠ganlo,Giannina,Positive
 Saludos PD Est√°n Bkn,Giannina,Positive
 Nat Med,IUOPA,Negative
 Token Store,CryptoLiveLeak,Negative
     combo,MDedge Hematology & Oncology,Negative
 persons,Patient Power,Negative
 persons,Andrew Schorr,Negative
 persons,R&G Disease Network,Positive
 autoimmune cytopenias,"Raul Cordoba, MD, PhD",Negative
 Autoimmune cytopenias,"Raul Cordoba, MD, PhD",Negative
 Autoimmune cytopenias,Cancer Papers,Negative
 Autoimmune cytopenias,Karen Sweiss,Negative
 Darwin,"Raul Cordoba, MD, PhD",Negative
 ‚Äú tree,"Raul Cordoba, MD, PhD",Negative
 Tolllike receptor   stimulation,Autophagy Papers,Positive
 iwCLL guidelines,"Raul Cordoba, MD, PhD",Negative
 Special Report iwCLL guidelines,Blood Journal,Negative
 Biomarkers    Response,Gitte Pedersen,Negative
 T Cell Therapy   Genes,Gitte Pedersen,Negative
 effector T cells,Gitte Pedersen,Negative
 ILSTAT signature,Gitte Pedersen,Negative
 nonresponders expressed genes,Gitte Pedersen,Negative
 del,MDedge Hematology & Oncology,Negative
 del,qGenomics,Positive
    APTO,Anna Deveau,Negative
 APTONOT,Anna Deveau,Negative
 ‚Äú Dirty Kinase Inhibitor,Anna Deveau,Negative
 Coexistence,Cancer Papers,Positive
 Coexistence,Journal of Medical Case Reports,Positive
 correlation,"chadi nabhan MD, MBA, FACP",Negative
 pts gt years,"chadi nabhan MD, MBA, FACP",Negative
 biologic Tx,"chadi nabhan MD, MBA, FACP",Negative
 amp findings,"chadi nabhan MD, MBA, FACP",Negative
 Shaved kitty belly,Anthony,Positive
 ultrasound,Anthony,Positive
 FDA Approves New Treatment Option,Cord Blood News,Negative
 buzz,CLL Warwick Uni,Negative
 buzz,Andrew Schorr,Negative
 graduation,CLL Warwick Uni,Negative
 postgraduation celebration,CLL Warwick Uni,Negative
 tickets,CLL Warwick Uni,Negative
 tickets,Mahmoud Turki,Negative
 immunoglobulin,Andrew Schorr,Negative
 CLLtcogxjNxYwTx,Cancer_Tribune,Negative
 Venetoclax amp Rituxumab,Andrew Schorr,Negative
 MicroRNAap overexpression,microRNApapers,Negative
 √† lEHA des nouvelles,oncohebdo,Negative
 Venclyxto Abbvie associ√©,oncohebdo,Negative
 au,oncohebdo,Negative
 au,heyyo,Positive
 dans la,oncohebdo,Negative
 LLC RR,oncohebdo,Negative
 Minimal Residual Disease MRD,CLL Ireland,Negative
 Minimal Residual Disease MRD,Rx Times¬Æ,Positive
 Pd expression,Jessica Lois,Positive
 Ella,EKLLRF,Positive
 Treatment goals,E Squared Communications,Positive
 Treatment goals,Amin G T Amin,Positive
 South Model,Dr. StrangeBot,Positive
 Turtle,Dr. StrangeBot,Positive
 LyLe med p√• EHA Viden,LyLe Foreningen,Negative
 til bedre,LyLe Foreningen,Negative
 ogs√• vores blad,LyLe Foreningen,Negative
 Stor begejstring,LyLe Foreningen,Negative
 god,LyLe Foreningen,Negative
 til gavn,LyLe Foreningen,Negative
 patienternekontakt,LyLe Foreningen,Negative
 Ectopic Lck expression,Blood Advances,Negative
 La Dottssa,Uni San Raffaele,Positive
 √® stata selezionata,Uni San Raffaele,Positive
 Sore tootsies,Amy C. Cavers,Positive
 polygenic risk score,Mahmoud Aljurf,Negative
 polygenic risk score,ASH,Negative
 polygenic risk score,Peter G,Positive
 polygenic risk score,Blood Journal,Negative
 polygenic risk score,"Raul Cordoba, MD, PhD",Negative
 polygenic risk score,@immunoonco_Meed,Positive
 polygenic risk score,Claire Vajdic,Positive
 polygenic risk score,Philip McCarthy,Negative
 TGTX Safety,Biotech2050,Negative
 Ode,TEDxGangtok,Positive
 Demazong,TEDxGangtok,Positive
 evening,TEDxGangtok,Positive
 evening,Applied Photochem_SU,Positive
 evening,Lymphoma Hub,Negative
 Art scene,TEDxGangtok,Positive
 Sikkim,TEDxGangtok,Positive
 Professor Patrick Thornton,CLL Ireland,Negative
 Information Day,CLL Ireland,Positive
 Dublin Ireland,CLL Ireland,Negative
 Lina van der Straten,Dr. Avinash Dinmohamed,Positive
 Professor Strefford,Blood Cancer UK,Negative
 Findings link,Blood Cancer UK,Negative
 epigenetics,Blood Cancer UK,Negative
 epigenetics,VJHemOnc,Negative
 chemical tags,Blood Cancer UK,Negative
 DNA switch genes,Blood Cancer UK,Negative
 SLL Patients,aeses.com,Negative
 SLL Patients,CLL Ireland,Negative
   press briefings,VJHemOnc,Negative
 Breakthrough updates,VJHemOnc,Negative
 HARMONY platform,"Chared, Good Comms",Negative
 HARMONY platform,European Hematology Association,Negative
 HARMONY platform,HARMONY Alliance,Negative
 infoGMV JanssenGlobal data,European Hematology Association,Negative
 Grace,Amy C. Cavers,Negative
 MSKCC,Amy C. Cavers,Negative
 KI Intolerance presention,Amy C. Cavers,Negative
 Efficacy data,"chadi nabhan MD, MBA, FACP",Negative
 slide malfunction,"chadi nabhan MD, MBA, FACP",Negative
 Duvalisib,"chadi nabhan MD, MBA, FACP",Negative
 duvalisib,"chadi nabhan MD, MBA, FACP",Negative
 Younger   patients,Beth Torr,Positive
 measure,AbbVie,Negative
 measure,ASH,Negative
 healthcare providers,AbbVie,Negative
 disease journey,AbbVie,Negative
 Leeds,Beth Torr,Positive
 MRD response,Beth Torr,Positive
 venetoxlas,Targeted Oncology,Negative
 expert John Byrd,The James,Negative
 driver mutations,Andrew Schorr,Negative
 Chronic Lymphocytic Small Lymphocytic,JanssenUS,Negative
    impressive   results,Anna Deveau,Negative
 Science speakers sessions,Amy C. Cavers,Negative
 Vishva,suetodd16,Positive
 Vishva,Genentech,Negative
 Subbarao Bondadas,UK Research,Positive
 Chronic Lymphocytic Leukemias suppression,UK Research,Positive
 hosts,UK Research,Positive
 hosts,LymphomaAction,Negative
 rd European Hematology Association Annual Congress,Mike Gauthier,Negative
 rd European Hematology Association Annual Congress,HSMN,Negative
 rd European Hematology Association Annual Congress,Seattle's Banker,Negative
 Newsroom,Mike Gauthier,Negative
   Presents Clinical Data,1stOncology,Negative
   Presents Clinical Data,James Dean,Negative
   Presents Clinical Data,Dean James,Negative
   Presents Clinical Data,MC Services AG,Positive
 Blood Cancer Candidate,1stOncology,Negative
 venetoclaxtreated   pts,"chadi nabhan MD, MBA, FACP",Negative
 Dr Yucai Wang,Adaptive Biotech,Negative
 Chief Investigators,OCTO Oxford,Positive
   V NICE STUDY,Prof John,Negative
 INHIBITION SYNERGISE,Prof John,Negative
 TWEET TWEET,Prof John,Negative
 BIRD,Prof John,Negative
 DISRUPTS BCL,Prof John,Negative
 IPR,Prof John,Negative
 CDampD,Prof John,Negative
 Circular RNA,Wnt publications,Negative
 Circular RNA,CLL-seq,Negative
 MOR Presents Clinical Data,Odi Bruckman,Negative
 MOR Presents Clinical Data,flosz,Positive
 Blood Cancer Candidate MOR,Odi Bruckman,Negative
 Blood Cancer Candidate MOR,SPI News,Negative
 Blood Cancer Candidate MOR,flosz,Positive
 Blood Cancer Candidate MOR,James Dean,Positive
 Blood Cancer Candidate MOR,Dean James,Positive
 Blood Cancer Candidate MOR,BIO Deutschland,Positive
 Blood Cancer Candidate MOR,BioGer,Positive
 Blood Cancer Candidate MOR,DGAP-News-Int,Positive
 Hallek M,Dr. Jos√© A. Queiz√°n,Negative
 ‚û° Ô∏è Analysis,Centre for Genomic Regulation (CRG),Negative
 MorphoSys Presents Clinical Data,SPI News,Negative
 MorphoSys Presents Clinical Data,James Dean,Negative
 MorphoSys Presents Clinical Data,Dean James,Negative
 MorphoSys Presents Clinical Data,BIO Deutschland,Positive
 MorphoSys Presents Clinical Data,DGAP-News-Int,Positive
 New iwCLL guidelines,Dr. Jos√© A. Queiz√°n,Negative
 Rosenquist R,Dr. Jos√© A. Queiz√°n,Negative
 New technology,Beth Torr,Positive
 Updated Clinical Data,flosz,Positive
 AntiCD Antibody MOR,flosz,Positive
 RelapsedRefractory Chronic Lymphoc,Financial Buzz,Negative
 Conference,James Dean,Positive
 Conference,Dean James,Positive
 Conference,MC Services AG,Positive
 Conference,BioGer,Positive
 Conference,Margaret Walker,Negative
 Candidate,MC Services AG,Positive
 Candidate,Plexus Ventures,Negative
 European Hematology Association Overall Survival Benefit,Seattle's Banker,Positive
 European Hematology Association Overall Survival Benefit,Sicilia Informazioni,Positive
 European Hematology Association Overall Survival Benefit,RazzleTazzle,Negative
 EHA   Conference,BIO Deutschland,Positive
 rd European Hematology Association Annual ¬† Congress,RazzleTazzle,Negative
 MOR MorphoSys Presents Clinical Data,BioGer,Positive
 Medical Director,MD Anderson Leukemia,Negative
 amp   Section Chief,MD Anderson Leukemia,Negative
 Medical Director amp,MD Anderson Leukemia,Negative
 Section Chief,MD Anderson Leukemia,Negative
 Understanding CLL,R Hashimoto,Positive
 treatment goals,"chadi nabhan MD, MBA, FACP",Negative
 venetoclax monotherapy,"chadi nabhan MD, MBA, FACP",Negative
 venetoclax monotherapy,Gary Richardson,Positive
 Remarkable progress,"chadi nabhan MD, MBA, FACP",Negative
 relapsedrefractory   session,"chadi nabhan MD, MBA, FACP",Negative
 Visit Hall,Gilead Sciences,Negative
 PM CEST Stockholmsm√§ssan,Gilead Sciences,Negative
 Neue Updates f√ºr,AbbVie Schweiz,Positive
 Behandlung von   Heute und,AbbVie Schweiz,Positive
 NewTrip Venetoclax Venclexta,Trip Database,Negative
 Test Transaction,CryptoLiveLeak,Negative
 CryptoLiveLeak Attention Mining Mechanism,CryptoLiveLeak,Negative
 FUN      CLL,CryptoLiveLeak,Negative
 lymphocytes T,OTOdocs,Negative
 lymphocytes T,Cancer Papers,Negative
 Hall,Gilead Sciences,Negative
 Hall,Children‚Äôs Oncology Group,Negative
 Hall,CancerPOP,Positive
 Hall,"Pharmacyclics, an AbbVie Company",Positive
 Hall,Penn Medicine News,Positive
 Hall,ivy science,Negative
 Stockholmsm√§ssan,Gilead Sciences,Negative
 Glen Sabin,CCAR,Positive
 Pennsylvania man,ASGCT,Negative
 subgroup analysis,healthbook,Positive
 round,Blood Cancer UK Research,Negative
 round,Jackie Michele,Positive
 round,Patrick,Positive
 Chronic Lymphocytic Leukemia Market Research Report,Ken Research,Negative
 Chronic Lymphocytic Leukemia Market Research Report,Publish PressRelease,Positive
 ASH   Atlanta Dr John Byrd,CLL Society Inc.,Negative
 Stockholm,Medscape Education,Negative
 Stockholm,Janssen Sverige,Positive
 Drs Seymour,Medscape Education,Negative
 Wierda,Medscape Education,Negative
 Wierda,Patient Power,Positive
 Wierda,Andrew Schorr,Negative
 Wierda,CLL Ireland,Negative
 Wierda,Targeted Oncology,Negative
 Stilgenbauer,Medscape Education,Negative
 Stilgenbauer,Andrew Schorr,Negative
 Stilgenbauer,"Mike Thompson, MD, PhD, FASCO",Negative
 Hillmen,Medscape Education,Negative
 Hillmen,"chadi nabhan MD, MBA, FACP",Positive
 Roche Announces,Rare Diseases,Negative
 Roche Announces,Drug Discovery & Dev,Positive
 tcoQJtWiNjBim,CLL Ireland,Negative
 Venclexta Rituxan combination,PRICENTRIC,Positive
 Chronic Lymphocytic Leukemia FDA Updates,gilbert c faure,Negative
 Pharmaceutical Business Review,GESDAT GmbH,Positive
 RHHBY ROG,Medklik,Negative
 RHHBY ROG,Roche,Positive
   nonresponders,Vijaya L,Positive
 responders,Vijaya L,Positive
 Phase Trial Cirmtuzumab,Cancer Stem Cell News,Negative
 Phase Trial Cirmtuzumab,Hematopoiesis News,Negative
 Phase Trial Cirmtuzumab,NeuroStemCells,Positive
 Phase Trial Cirmtuzumab,Jim Till,Positive
 amp Stemness Signatures,Cancer Stem Cell News,Negative
 amp Stemness Signatures,Hematopoiesis News,Negative
 reactivating celldeath,Genentech,Negative
   Genentech Announces FDA Approval,PressReleasePoint,Negative
   Genentech Announces FDA Approval,ANTELLIS,Positive
   news FDA,Elaine Schattner,Negative
   news FDA,COPD News,Negative
 Der Entwurf,Krebsgesellschaft,Positive
 Chronische lymphatische,Krebsgesellschaft,Positive
 Chronische lymphatische,AbbVie Deutschland,Negative
 Chronische lymphatische,Roche Deutschland,Positive
 √§mie aus dem,Krebsgesellschaft,Positive
 Leitlinienprogramm Onkologie steht zur √∂ffentlichen,Krebsgesellschaft,Positive
 Konsultation Das √ÑZQ,Krebsgesellschaft,Positive
 Autumn,CLL Ireland,Negative
 FDA Approves Approves Venetoclax VENCLEXTA,"Stayin' Alive: Body, Mind, Spirit",Positive
 hubby,Andrea Levy,Positive
 hubby,Prof Maxine Lintern,Positive
 holiday,Andrea Levy,Positive
 FDA Approves Venetoclax VENCLEXTA,CLLSA,Negative
   Approves SecondLine,"A. Emre E≈ükazan, MD ü©∏üî¨",Positive
 ABBV Genentech Venclexta,UKiwiS,Negative
 III MURANO trial venetoclax Venclexta,Solomon Kamal,Positive
 Finds Experimental Drug Safe,BIOCIENCIA,Negative
 FDA Grants Venetoclax Approval,Alan Skarbnik,Negative
 p del,Alan Skarbnik,Negative
 p del,VJHemOnc,Negative
 p del,Nicolas COLLET,Positive
 ABBV   FDA,MAISA,Negative
 venetoclax VENCLEXTA,Lymphoma Research Foundation,Negative
 p status,"chadi nabhan MD, MBA, FACP",Negative
 CC    Excellent decision,"chadi nabhan MD, MBA, FACP",Negative
 Small Lymphocytic Lymphoma Patients,FDA Daily,Negative
 Small Lymphocytic Lymphoma Patients,RazzleTazzle,Negative
 patientsFDA Approves Treatment,Leukemia Research Foundation,Negative
 Approval news FDA,Hematology News,Negative
 Genentech Announces,Anand Rotte,Positive
 Genentech Announces,BioInnoPlayground,Positive
 FDA Approves Treatment,UKiwiS,Negative
 FDA Approves Treatment,Pharma Digest,Positive
 BREAKING Venetoclax,Targeted Oncology,Negative
   approved Venclexta,CURE Magazine,Negative
 Breaking News FDA Grants Venetoclax Approval,VuMedi Oncology,Positive
 ABBV AbbVieRoche,StockNews.com,Negative
 Cheesin,Amanda Marie,Positive
 Read yesterdays debate,Nick,Negative
 NICE approved treatment,Nick,Negative
 relapsed     patients,Nick,Negative
 amp circulate petition,Nick,Negative
 brothers wife,Denney,Positive
 Chipinge,Denney,Positive
 T cell biomarker,CancerWallonia,Negative
 T cell biomarker,For Laboratories,Positive
 T cell biomarker,"Raul Cordoba, MD, PhD",Negative
 T cell,CancerWallonia,Negative
 Real World Outcomes,"Raul Cordoba, MD, PhD",Negative
 Real World Outcomes,David A. Cohen,Negative
 VenetoclaxTreated Chronic Lymphocytic Leukemia,"Raul Cordoba, MD, PhD",Negative
 House,CLLSA,Negative
 Lords,CLLSA,Negative
 Polygenic risk score,Oscar Lahoud,Positive
 story Phase,Cancer Stem Cell News,Negative
 Non Hopkins Lymphoma,TSmrecansky,Positive
 groundbreaking research,Centre for Genomic Regulation (CRG),Negative
 following laboratory values,RNpedia,Positive
 longterm ibrutinib,Medivizor,Positive
 longterm ibrutinib,Brad M.D.,Positive
 hugs,Rachel Haywood,Positive
 CryptoLiveLeak IBO,CryptoLiveLeak,Negative
 Rewards,CryptoLiveLeak,Negative
 Participation,CryptoLiveLeak,Negative
 Participation,Patient Power,Negative
 EditorinChiefs,J Immunol,Negative
 face,CLL Warwick Uni,Negative
 face,BloodWork,Positive
 face,ACP Massachusetts,Positive
 Strax dax,Linda Mannila,Positive
 WF   upgrading rating,dough,Negative
 price target,dough,Negative
 novel PIkd inhibitor MEampafter discussion,dough,Negative
 Rituxan Hycela,@MyelomaTeacher - Cindy Chmielewski,Negative
 Rituxan Hycela,FDA Oncology,Negative
 info contact cindyinfo,@MyelomaTeacher - Cindy Chmielewski,Negative
 tcoziYvIFT,Cancer_Tribune,Negative
 LISTEN LIVEWednesday,Higher Ground at Lake Louise,Negative
 WLJN,Higher Ground at Lake Louise,Negative
 Special thanks,Anthony Mato,Negative
 Special thanks,Team Intake.Me,Negative
   education committee,Anthony Mato,Negative
 MSKs Dr Anthony Mato Director,Memorial Sloan Kettering Cancer Center,Negative
 Sends TG Therapeutics Stock,cafepharma,Negative
 Chronic Lymphocytic Leukemia Current Topics,D4 demon,Positive
 Microbiology,D4 demon,Positive
 Study Examines Demographic Disparities,Oncology Times,Negative
 display,MGH Cancer Center,Negative
 Adam Sklar,Cole Schotz P.C.,Positive
 Appellate Divisions,Cole Schotz P.C.,Negative
 Stefan Barta,Fox Chase Cancer Center,Positive
 HallA Clinical Activity safety,Fox Chase Cancer Center,Positive
 ASN,Fox Chase Cancer Center,Positive
 Jos Melenhorst,Penn Microbiology,Positive
 Joseph Fraietta,Penn Microbiology,Positive
 Umbralisib TGRin Patients,Tom Silver,Negative
 Cardiff Innovation,Nick,Negative
 Impact Awards,Nick,Negative
 adolescents,Children‚Äôs Oncology Group,Positive
 Hodgkin lymphoma,Children‚Äôs Oncology Group,Positive
 Hodgkin lymphoma,Cancer Papers,Negative
 Hodgkin lymphoma,Medivizor,Positive
 Hodgkin lymphoma,noel cole,Negative
 Hodgkin lymphoma,Keren Rozenfeld,Positive
 Children,Children‚Äôs Oncology Group,Positive
 Oncology Group COG trials,Children‚Äôs Oncology Group,Negative
 Dr Justine Kahn,Children‚Äôs Oncology Group,Negative
 Lymphoma amp Chronic Lymphocytic Leukemia Poster Session,Children‚Äôs Oncology Group,Negative
 Stemness Signatures,NeuroStemCells,Positive
 Stemness Signatures,Jim Till,Positive
 Noch bis morgen geht der internationale,Pharma Fakten,Positive
 von   tut sich,Pharma Fakten,Positive
 TGTX    investor updateAudio,Biotech2050,Negative
 Chronic Lymphocytic Leukemia Cell Stem Cell,Jim Till,Positive
 Tonight,BMS Myeloma,Positive
 Tonight,"Pat Euglow, Legacy Newbie",Negative
 Current Clinical Issues,BMS Myeloma,Positive
 AbbVie Inc,Stock Bot,Positive
 stock,Stock Bot,Positive
 stock,Leukaemia Care,Positive
 stock,Aaron Charles,Negative
   week low,Stock Bot,Positive
 staging system,JanssenUS,Negative
 Ibrutinib pi√π venetoclax combinazione vincente nella leucemia linfatica cronica,PharmaStar,Negative
 di malattia,PharmaStar,Negative
 chemofree world,"Raul Cordoba, MD, PhD",Negative
 MRD kinetics results,VJHemOnc,Negative
 poll,NYCDoc29,Negative
 guesses,NYCDoc29,Negative
 durability,NYCDoc29,Negative
 durability,Blood Journal,Negative
 durability,"Raul Cordoba, MD, PhD",Negative
    CR,"Raul Cordoba, MD, PhD",Negative
 NORTH CHICAGO,RazzleTazzle,Negative
 NORTH CHICAGO,satPRnews,Negative
 Ill June,RazzleTazzle,Negative
   pilot study,Genomics England,Positive
 TransplantDoc RT,Robert Z. Orlowski,Positive
   Winships Christopher R Flowers MD,Winship Cancer Institute of Emory University,Negative
 RT TransplantDoc RT CancerMedMDA Phase,Robert Z. Orlowski,Negative
 CAPTIVATE results,Robert Z. Orlowski,Negative
 CAPTIVATE results,Cancer Medicine,Positive
 ibrutinib   venetoclax,Robert Z. Orlowski,Negative
 ibrutinib   venetoclax,Cancer Medicine,Positive
 ibrutinib   venetoclax,WCM Lymphoma,Negative
 Potencjalny biorca,Jacek Kalinowski,Positive
 firstinhuman phase,CLL Ireland,Negative
 surgery,Janssen EMEA,Negative
 radiotherapy,Janssen EMEA,Negative
 Dr John Allan Dr Rick Furman amp research colleagues,WCM Lymphoma,Negative
 age gender,"chadi nabhan MD, MBA, FACP",Negative
 novel molecules,Lymphoma Hub,Negative
 Oncology LWW Journals blog,Oncology Board,Negative
 Oftentimes beta microglobulin BM,Oncology Board,Negative
 Transthoracic,Lung EOPH_papers,Positive
 Transthoracic,Cancer Papers,Negative
 ultrasonography,Lung EOPH_papers,Positive
 ultrasonography,Cancer Papers,Negative
 Experimental Drug Safe,newswise,Negative
 Experimental Drug Safe,S.K.,Positive
 Experimental Drug Safe,Prof. Dr. Omprakash Nautiyal,Positive
 Experimental Drug Safe,Stephen B. Harris,Positive
 Experimental Drug Safe,BIOCIENCIA,Negative
 Experimental Drug Safe,Patrick Arieno,Positive
 Experimental Drug Safe,Centro Medico Qx,Negative
 Experimental Drug Safe,MD.,Negative
 GLP overexpression,Cancer Papers,Negative
 Chronic Lymphocytic Leukemia CLL   Pipeline Insight Review H,EPR Network,Positive
 USA Attention,M3 Community,Positive
 PH study,Biotech2050,Negative
 COG,Children‚Äôs Oncology Group,Negative
 Poster Session Hematologic Malignancies,Children‚Äôs Oncology Group,Negative
 Monday June,Children‚Äôs Oncology Group,Negative
 SDBN Feed Phase,SDBN,Positive
 revision,CLL Warwick Uni,Negative
 essays,CLL Warwick Uni,Negative
 work family,CLL Warwick Uni,Negative
 Long distance learner Rose,CLL Warwick Uni,Negative
 better result,Andrew Schorr,Negative
 CLL Investigator Tom Kipps,Andrew Schorr,Negative
 ChemoFree Combo Therapy,SpecialtyPTimes,Negative
 Wins,SpecialtyPTimes,Negative
 ‚Äç ü§ù,VJHemOnc,Negative
   chapter,"chadi nabhan MD, MBA, FACP",Negative
 VIDEO Current,The Patient's Channel,Negative
 clone,Eslam Katab,Positive
 press residents,OHSU IM Residency,Positive
 Drs Max Gordon,OHSU IM Residency,Positive
 Stephen Amrock,OHSU IM Residency,Positive
 Blood Commentary years,Blood Journal,Negative
   Podcast episode ft Dean,UNC Hussman School of Journalism and Media,Positive
 founder,UNC Hussman School of Journalism and Media,Positive
 founder,Patient Power,Positive
 cancer community hub,UNC Hussman School of Journalism and Media,Positive
 lifes,UNC Hussman School of Journalism and Media,Positive
     diagnosis,CLLSA,Negative
   agenda,Continuous Lifecycle London (online),Negative
   agenda,Canadian Hematology,Positive
   agenda,CARE‚Ñ¢ Education,Negative
 IbrutinibObinutuzumab Combo,Targeted Oncology,Negative
 w ibrutinib,"chadi nabhan MD, MBA, FACP",Positive
 AFib,"chadi nabhan MD, MBA, FACP",Negative
 ABBVIE IMBRUVICA,AmericanPharmacyNews,Negative
 Clinical‚Äêgrade validation,The North West Genomic Laboratory Hub,Positive
 learnings,CLL Ireland,Negative
 Clinicalgrade variation,Genomics England,Positive
 fish talks,RIOH,Negative
 fish angiogenesis,RIOH,Negative
 petition,Nick,Negative
 petition,Shine Cancer Support,Positive
 grips,Leukaemia Care,Positive
 Plus ¬Æ   Phase,1stOncology,Negative
 iLLUMINATE,1stOncology,Negative
 iLLUMINATE,MoJo,Negative
 New review,Crown Bioscience,Negative
 Determinants,Santiago Carmona üß¨ üñ•Ô∏è üë®üèæ‚Äçüî¨,Positive
 Determinants,Hyun Goo Woo,Positive
 Determinants,Penn Path & Lab Medicine,Positive
 Determinants,SiCORE in Immunoregulation,Positive
 Determinants,CRISP_SCIENCE,Positive
 Determinants,Cell Therapy News,Negative
 Determinants,ImmunotherapyPapers,Negative
 Determinants,TumImmTxpapers,Negative
 Determinants,Krishan Maggon,Negative
 Determinants,"Bruce Levine, Ph.D.",Positive
 Determinants,All Ways Well,Positive
 Chronic Lymphocyti,Medivizor,Negative
 Chronic Lymphocyti,Krishan Maggon,Negative
 World Blood Cancer Day,LiveYourLife,Negative
 World Blood Cancer Day,Zack Pemberton-Whiteley,Negative
 amp blood cancers,LiveYourLife,Negative
 Diagnosis Chronic Lymphocytic LeukemiaAnd,Matt O,Positive
 end game,Matt O,Positive
 IMBRUVICA Plus GAZYVA Phase III iLLUMINATE Trial,Cord Blood News,Negative
 Researchers Complete Genomic Map,ReachMD,Positive
 Leeds members meeting,CLLSA,Positive
 Enjoy,CLLSA,Negative
 lookout,VJHemOnc,Negative
    Plus   Improves,CancerWallonia,Negative
 Aberrant CD Expression,leukemia,Negative
 Aberrant CD Expression,Mol Oncol Res,Positive
 Atypical,leukemia,Negative
 ReviewAuthors Bowen Li,leukemia,Negative
 Dominick Amato,leukemia,Negative
 Chen Wang,leukemia,Negative
 IMBRUVICA ibrutinib,Rare Diseases,Negative
 IMBRUVICA ibrutinib,Open Outcrier,Negative
 IMBRUVICA ibrutinib,manda materne,Positive
 IMBRUVICA ibrutinib,Orbis Biosciences,Negative
 IMBRUVICA ibrutinib,Scott Werntz,Negative
 GAZYVA obinutuzumab Ph iLLUMINATE Trial,Rare Diseases,Negative
 Combo ibrutinib,Targeted Oncology,Negative
 obinutuzumab Phase,‚öõÔ∏èLibertyüåä,Positive
 obinutuzumab Phase,OBR,Negative
 obinutuzumab Phase,Crwe World,Negative
 obinutuzumab Phase,Odi Bruckman,Negative
 Experts Dr Lamanna,Patient Power,Negative
 amp Dr Keating,Patient Power,Positive
 ¬Æ Trial,Pf Magazine,Negative
     Phase,MoJo,Negative
 Depth amp durability,CLL Ireland,Negative
 AbbVie eyes Imbruvica expansion,cafepharma,Negative
 Imbruvica growth strategy,cafepharma,Negative
 daunorubicin,PharmaFactz,Negative
 acute,PharmaFactz,Negative
 acute,VJHemOnc,Negative
   reference,Geoffrey Berguet,Positive
 Dr Keesha,Dr. Keesha Ewers,Positive
 Paleo Oven French Toast RecipeMy father,Dr. Keesha Ewers,Positive
   IMBRUVICA,OBR,Positive
 Bruh,my sharona,Positive
 Chronic Lymp,Crwe World,Negative
 Chronic Lymp,Financial Buzz,Negative
 Chronic Lymp,Pharmaceutical News,Negative
 Expert Perspective Tumor Board,Targeted Oncology,Negative
 Navigatordagar,TESSU-projekti,Positive
 √Öbo,TESSU-projekti,Positive
 √Öbo,√Öbo Akademi University,Positive
   partners,Blueprint,Positive
 patientreporter,Andrew Schorr,Negative
 NadeemBaker,Andrew Schorr,Negative
 followup testings,Andrew Schorr,Negative
 Chronic Lymphocytic LeukemiaSmall,Giuseppe Ingravallo,Positive
 BCell Lymphoma   Lethal Shortcut,TumorImmunoPapers,Negative
 BCell Lymphoma   Lethal Shortcut,Cancer Papers,Negative
 Delp Chronic Lymphocytic Leukemia,TumorImmunoPapers,Negative
 Patrick,CLL Ireland,Negative
 Expert Reviews CLL Advances,Alan Skarbnik,Negative
 NEWS Researchers,News Life Sciences,Positive
 Dr Crowther,McMaster Textbook of Internal Medicine,Positive
 Levels,CLL Ireland,Negative
 circulating sex hormones,CLL Ireland,Negative
 TFS,CLL Ireland,Negative
 Delp,Cancer Papers,Negative
 Delp,Christopher Steer,Negative
 Virtual Tumor Board,Targeted Oncology,Negative
 Chronic Lymphocytic Leukemia amp NonHodgkin,Oncology Times,Negative
 Sex hormone levels,CancerTherapyAdvisor,Negative
 Green tea extract,Green Tea HP,Positive
 check,Green Tea HP,Positive
 patientsAn extract,Green Tea HP,Positive
   guidelines,CLLSA,Negative
   guidelines,Oncology Tube,Negative
   guidelines,VJHemOnc,Negative
    una Infraestructura Cient√≠fica,Beatriz Albella Rdgz,Positive
 T√©cnica,Beatriz Albella Rdgz,Positive
 CNAGCRG,cnag-crg,Negative
 CD amp,Prof John,Negative
 VIDEO   options,The Patient's Channel,Negative
 maintenance therapy,Targeted Oncology,Negative
 maintenance therapy,healthbook,Positive
 maintenance therapy,MDedge Hematology & Oncology,Negative
 maintenance therapy,HemOnc Today,Positive
 maintenance therapy,Matthias Piesche,Negative
 maintenance therapy,A. Vroom - Ten Wolde,Negative
 Allogeneic Stem Cell Transplant,leukemia,Positive
 Allogeneic Stem Cell Transplant,Mol Oncol Res,Positive
 Allogeneic Stem Cell Transplant,"Pharmacyclics, an AbbVie Company",Negative
 Current EraAuthor,leukemia,Negative
 Francisco Socola,leukemia,Negative
 Mike,"David Bartlett, PhD",Negative
 associations,"David Bartlett, PhD",Negative
 LT,Maddrey PLLC,Positive
 Alphabet Soup,CLL Ireland,Negative
 Alphabet Soup,CancerWallonia,Negative
 Evolving Treatments,CLL Ireland,Negative
 complexity,CLL Ireland,Negative
 complexity,iwCLL,Negative
 USESRituxirel mg Injection,Ravispecialitiespharma_RSP,Negative
 ChronicLymphocytic Leukemia,Internal Medicine: Open Access,Negative
 Expert Assesses,CancerWallonia,Negative
 New Update,Medivizor,Negative
 Chronic Lymphocytic Leuk,Medivizor,Negative
 Zur Kommentierung freigegeben Patientenleitlinie Chronische lymphatische,MirjamBauer,Positive
 Haimatus Latam meeting,Francesc Bosch,Positive
 Sao Paulo,Francesc Bosch,Positive
 Novel BCL Inhibitor,Lymphomation.org,Negative
 USESMabtas RA mg Injection,Ravispecialitiespharma_RSP,Positive
 patients Data,"chadi nabhan MD, MBA, FACP",Negative
 amp colleagues,"chadi nabhan MD, MBA, FACP",Positive
 amp colleagues,ACS Journal Cancer,Negative
 amp colleagues,"Francisco Marty, MD",Negative
 ibrutinib Data b,"chadi nabhan MD, MBA, FACP",Negative
 perceptions,"chadi nabhan MD, MBA, FACP",Negative
 diagnosis Importance,"chadi nabhan MD, MBA, FACP",Negative
 patient voice b,"chadi nabhan MD, MBA, FACP",Negative
 RSVP,Cancer Support Ohio,Positive
   ¬†  PM Joseph Hofmeister MD,Cancer Support Ohio,Positive
 Columbus Oncology,Cancer Support Ohio,Positive
 Hematology Associates,Cancer Support Ohio,Positive
 Common Adverse Events,Medscape Education,Negative
 Nursing Management,Medscape Education,Negative
 agent orange,"chadi nabhan MD, MBA, FACP",Negative
 Scheuermann,UC San Diego ACTRI,Positive
 ACTRI Seminar Computational Methods,UC San Diego ACTRI,Positive
 Flow,UC San Diego ACTRI,Positive
 Mass Cytometry Data Chronic Lymphocytic Leukemia Illustration,UC San Diego ACTRI,Positive
 Patientenleitlinie zur chronischen lymphatischen,Deutsches √Ñrzteblatt,Positive
 Leuk√§mie zur Kommentierung,Deutsches √Ñrzteblatt,Positive
 Berlin,Deutsches √Ñrzteblatt,Positive
 Berlin,Leukemia Irst-Irccs della Romagna,Positive
 ‚Äì Das √Ñrztliche Zentrum f√ºr,Deutsches √Ñrzteblatt,Positive
 Qualit√§t,Deutsches √Ñrzteblatt,Positive
 Medizin √ÑZQ hat eine neue,Deutsches √Ñrzteblatt,Positive
 Patientenleitlinie,Deutsches √Ñrzteblatt,Positive
 CLL Forum,CLLSA,Negative
 preinfusion chimeric antigen receptor,Nature Medicine,Positive
 Sweden,NovelHealthStrategie,Positive
 Abbvies,NovelHealthStrategie,Positive
 waterfront,Higher Ground at Lake Louise,Negative
 Emma Teaching Fellow,CLL Warwick Uni,Negative
     degree programme,CLL Warwick Uni,Negative
 salvage therapies,Targeted Oncology,Negative
 salvage therapies,Lymphoma Coalition,Negative
 BENDAMUSTINE,MedLibrary.org,Negative
 BENDAMUSTINE,Scott Werntz,Negative
 Eagle Pharmaceuticals Inc Bendamustine Hydrochloride Injection,MedLibrary.org,Negative
 alkylating drug,MedLibrary.org,Negative
 TGTX safety amp efficacy,dough,Negative
 latest CryptoLiveLeak CLL Token Project Update   Upcoming Speaking Event,CryptoLiveLeak,Negative
     como,XNL,Positive
 Campe√≥n Nacional,XNL,Positive
 Campe√≥n Nacional,John Drago,Positive
 el a√±o Este,XNL,Positive
 el   tiene,XNL,Positive
 la oportunidad de convertirse,XNL,Positive
 Campe√≥n Absoluto de   si vence,XNL,Positive
 Thorsten Timu,Claranet,Positive
     dose,Anna Deveau,Negative
 ARI cells kg,Anna Deveau,Negative
 lymphodepletion,Anna Deveau,Negative
 mgm,Anna Deveau,Positive
 mgm,Lymphoma Hub,Negative
   CG,Anna Deveau,Negative
    Median TTNT,Anna Deveau,Negative
 OFA maintenance arm,Anna Deveau,Negative
 drug companies,CLL Ireland,Negative
 consortium colleagues,AEGLE,Negative
 Andreas Agathangelidis,AEGLE,Negative
 Alexandra Kosvyra,AEGLE,Negative
 AEGLE Project RampD platform,AEGLE,Negative
 Predictive Modelling,AEGLE,Negative
 EGRX,MAISA,Negative
 EGRX,Scott Spencer,Positive
 milliliter doses,MAISA,Negative
 bendamustine hydrochloride solution,MAISA,Negative
 Left meeting,Amy C. Cavers,Negative
 Raleigh,Amy C. Cavers,Negative
 planes,Amy C. Cavers,Negative
 Cuneo Italy,Amy C. Cavers,Negative
 staging systems,WCM Lymphoma,Positive
 New   regimen,MDLinx,Positive
 stem cell transplant,Leukaemia Care,Negative
 stem cell transplant,MD Anderson Cancer Center,Negative
 pose,Miss O'Donnell,Positive
 read tweet,CLL_Fightersüéó,Negative
 turn amp DENIES,CLL_Fightersüéó,Negative
 New Drug Combination,Patient Worthy,Negative
 New Drug Combination,"Tom Iarocci, MD",Negative
 dissertation deadlines essays,CLL Warwick Uni,Negative
 exams,CLL Warwick Uni,Negative
 exams,Joey Snella,Positive
 Kymriahthe presence,CLL Ireland,Negative
   populations,Crown Bioscience,Negative
 DNA damage pathways,@immunoonco_Meed,Positive
 Bcell lymphomagenesis,@immunoonco_Meed,Positive
 onlineDerek Clarke,Derek Clarke,Negative
 wellestablished supplier,Derek Clarke,Positive
 ZYDELIG mg,Derek Clarke,Positive
 mgWhat,Derek Clarke,Negative
 Blake,Josh Towsley,Positive
 Makin Yard,Josh Towsley,Positive
 SemiFinals,Josh Towsley,Positive
 Matthew Davids MD,CLL Ireland,Negative
 Huge thanks,Helen Jane Mee,Negative
 p Deletion Results,Philip McCarthy,Negative
 p Deletion Results,Mahmoud Aljurf,Negative
 p Deletion Results,FarmaOnco,Negative
 p Deletion Results,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 p Deletion Results,Cancer Papers,Negative
 Phase II Pivotal Trial,Philip McCarthy,Negative
 Phase II Pivotal Trial,Mahmoud Aljurf,Negative
 Phase II Pivotal Trial,FarmaOnco,Negative
 Phase II Pivotal Trial,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Phase II Pivotal Trial,Cancer Papers,Negative
 Ceremonies,Josh Towsley,Positive
 Justin Morneau Field,Josh Towsley,Positive
    komin,Jah Kuu,Negative
 Healthier Tcells,ASGCT,Negative
 Night sweats,John Walker,Positive
 ladies,Higher Ground at Lake Louise,Negative
 ladies,Marc Pavan,Positive
 Whippoorwill,Higher Ground at Lake Louise,Negative
 Complete Response,ALI ALAHMARI.,Negative
 Complete Response,CLL Society Inc.,Negative
 Complete Response,The ASCO Post,Negative
 Complete Response,GEDEFO,Negative
 Complete Response,Mahmoud Aljurf,Negative
 Complete Response,JAMA Oncology,Negative
 USESReditux mg Injection,Ravispecialitiespharma_RSP,Negative
 lymphocytic   CLL,NaturesZestNutrition,Positive
 varicella,NaturesZestNutrition,Positive
 Flight,Jason McConnell,Positive
 stops,Patient Power,Negative
   Slows Progression,SpecialtyPTimes,Negative
 Composite Dural Extranodal Marginal Zone Lymphoma,NeuroStemCells,Positive
 VIDEO Current   options,The Patient's Channel,Negative
 letter,LoganBerry,Positive
 letter,"chadi nabhan MD, MBA, FACP",Positive
 ‚ö† ‚ö† RT ‚ö† ‚ö† teacher,ùê¶ùêöùê†ùêßùêÆùê¨‚Å∑,Positive
 Specialty Pharmacy Times,Pepvax Inc,Negative
 Stephan Stilgenbauer et al report phase,Chan Cheah,Negative
 CR   year,Chan Cheah,Negative
   EBV Positive Diffuse Large B Cell Lymphoma,The Organic Institute CLG,Positive
 Chronic Lymphocytic Leukemia Patients Exhibit,The Organic Institute CLG,Positive
 AntidUTPase Antibodies,The Organic Institute CLG,Positive
 Biomarker,ReR üåê,Positive
 Biomarker,Journal of Clinical Pathways,Negative
 Biomarker,Lymphomation.org,Negative
 CAR Tcell,ReR üåê,Positive
 CAR Tcell,Genetic Engineering & Biotechnology News,Positive
 CAR Tcell,helpsy,Positive
 skin lymphoma Waldenstr√∂m,Helen Jane Mee,Negative
 macroglobulinaemia,Helen Jane Mee,Negative
 CLL Join,Helen Jane Mee,Negative
 New assays,NeoGenomics,Positive
 NeoGenomics    Flow Panel DUPSIRF Rearrangement,NeoGenomics,Positive
 test details,NeoGenomics,Positive
 USESMABTHERA,Ravispecialitiespharma_RSP,Negative
 MG INJECTION,Ravispecialitiespharma_RSP,Negative
 USESMabtas T mg Injection,Ravispecialitiespharma_RSP,Negative
 USESMaball mg Injection,Ravispecialitiespharma_RSP,Positive
 Chronic Lymphocytic LeukemiaDerived IL,@immunoonco_Meed,Positive
 Antitumor Immunity,@immunoonco_Meed,Positive
 Chronic Lymphocytic Leukemia Treatment Market Rise,Doctr,Positive
 Healthcare Trends,Doctr,Positive
 USESIGIV,Ravispecialitiespharma_RSP,Negative
 USESImbruvica,Ravispecialitiespharma_RSP,Negative
 USESImbruvica mg Capsule,Ravispecialitiespharma_RSP,Negative
 „Äê Kernel„Äë‰ºäËó§Êô∫ÈõÑÂÖàÁîü„Çâ„ÅÆË´ñÊñá„ÇíÂÖ¨Èñã„Åó„Åæ„Åó„Åü„ÄÇComposite Lymphoma,Kobe Univ. Kernel,Positive
 Cooccurrence,Kobe Univ. Kernel,Positive
 Advanced Chronic Lymphocytic,Kobe Univ. Kernel,Positive
 LeukemiaSmall Lymphocytic Lymphoma,Kobe Univ. Kernel,Positive
 Carrying Trisomy,Kobe Univ. Kernel,Positive
 t,Kobe Univ. Kernel,Positive
 t,Pre-IPO Pharma,Positive
 t,EurekaMag,Negative
 Peripheral Tcell Lymphoma,Kobe Univ. Kernel,Positive
 Combo rituximab,Targeted Oncology,Negative
 LaPrade,benzenelawyers,Positive
 job,benzenelawyers,Positive
 prepress technologist,benzenelawyers,Positive
 printing plates,benzenelawyers,Positive
 Ohio State University researcher,Cancer Papers,Negative
 imatinib,Juan Luis Steegmann,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Follicular Lymphoma Opportunity Landscape,1stOncology,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Follicular Lymphoma Opportunity Landscape,SNN Network,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Follicular Lymphoma Opportunity Landscape,ANTELLIS,Positive
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Follicular Lymphoma Opportunity Landscape,The Pharmaceutical Marketing Group,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Follicular Lymphoma Opportunity Landscape,Cancer News,Negative
 PreCommercial Initiatives,1stOncology,Negative
 PreCommercial Initiatives,SNN Network,Negative
 PreCommercial Initiatives,Verastem Oncology,Negative
 PreCommercial Initiatives,ANTELLIS,Positive
 PreCommercial Initiatives,The Pharmaceutical Marketing Group,Negative
 PreCommercial Initiatives,Cancer News,Negative
 Analyst,1stOncology,Negative
 Analyst,SNN Network,Negative
 Analyst,ANTELLIS,Positive
 Analyst,The Pharmaceutical Marketing Group,Negative
 Analyst,Cancer News,Negative
 Investor Day,1stOncology,Negative
 Investor Day,SNN Network,Negative
 Investor Day,The Pharmaceutical Marketing Group,Negative
 KGlugni,Roger Naegeli,Positive
 AnneMarie,CLL Warwick Uni,Negative
 HCT,EBMT,Positive
 Longterm Outcomes,leukemia,Negative
 Standard Therapy Authors Alvarado Ibarra Martha Mena Zepeda Veronica Ortiz Zepeda Maricela Alvarez Vera Jos√© Espitia R√≠os Maria Jim√©nez Alvarado Rosa,leukemia,Negative
 APTO   Aptose Exercises Early Option,Grant Beasley,Positive
 CG License,Grant Beasley,Positive
 CrystalGenomics CG,Grant Beasley,Positive
 sunshine,Natalie McGreevy,Positive
 student ambassadors,CLL Warwick Uni,Negative
 USESFludarabine phosphate,Ravispecialitiespharma_RSP,Negative
 MemoryRelated Genes,CancerWallonia,Negative
 MemoryRelated Genes,WorldStemCellSummit,Positive
 Overcome,CancerWallonia,Negative
 Overcome,WorldStemCellSummit,Positive
 VIDEO Evolving,VJHemOnc,Negative
 UK CLL Forum analysis,VJHemOnc,Negative
 Nanay,REGISTER TO VOTE!,Positive
 Erica,Leukaemia Care,Negative
 Dr Colt Egelston,Adaptive Biotech,Negative
 Response amp Resistance,Cell Therapy News,Positive
 CD CAR T Cell Therapy,Cell Therapy News,Positive
 Relevant T cell Populations,McHeyzer-Williams,Negative
 Todays   Information Day,CLL Ireland,Negative
 odds ratio,"Raul Cordoba, MD, PhD",Negative
 grade,"Raul Cordoba, MD, PhD",Positive
 Intrinsic Potency,McHeyzer-Williams,Negative
 Risk amp Controls Officer,SM1/7Jobs,Positive
 tcoDOBNuLnl          Case Checker,SM1/7Jobs,Positive
 Venetoclax   rituximab,ASH Clinical News,Negative
 Venetoclax   rituximab,Lymph_m_ni_c,Positive
 Signal Inhibitors,Allied Conferences,Positive
 Signal Inhibitors,Hematology Conference,Negative
 threeeyes,Higher Ground at Lake Louise,Negative
 Fun,Higher Ground at Lake Louise,Positive
 Fun,Dr Meg Boulton,Positive
 grade camp,Higher Ground at Lake Louise,Negative
 Shoe Looky,Higher Ground at Lake Louise,Negative
 Effective,"Meagan Bryan, RN",Negative
 Effective,OncologyNurseAdvisor,Negative
   rankings,CLL Warwick Uni,Negative
 Miss Lomas,Barton Clough Primary School,Positive
 nights staff meeting,Barton Clough Primary School,Positive
 Global Oncology,Oncology Board,Positive
 Deal trends players,Oncology Board,Positive
 PR Newswire press release,Oncology Board,Positive
 PR Newswire press release,Medicine World,Positive
 PR Newswire press release,Medicine Plaza,Positive
 PR Newswire press release,Dora Wurth,Positive
 PR Newswire press release,Cancer Daily,Negative
 financials,Oncology Board,Negative
 analysts,Verastem Oncology,Negative
 Investors,Verastem Oncology,Negative
 Follicular Lymphoma FL,Verastem Oncology,Negative
 Inv,ANTELLIS,Positive
 upgrades,nightmyworld,Positive
 Follicular,Oncology Board,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Follicular   Business Wire,Oncology Board,Negative
 Follicular LymFrom,$Stocknewsalerts,Negative
 Stock News Alerts App,$Stocknewsalerts,Positive
 Investor Day Duvelisib,Cancer News,Negative
 Kathleen D Hoffman,Digital Health Space,Positive
 Kathleen D Hoffman,Paul Wright,Positive
 Thurs,Patient Power,Negative
 Thurs,CLL Ireland,Negative
 ET pm,Patient Power,Negative
 LP,NEJM CPC,Positive
 LP,Los Lobos,Negative
 Elevated miRbp expression,Hypoxia Adaptation,Positive
 Comparable Efficacy,Cancer Papers,Negative
 Relapsedrefractory Chronic Lymphocytic Leukemia Retrospective Case,Cancer Papers,Negative
 Matched Study,Cancer Papers,Negative
 Polish Adult Leukemia Group,Cancer Papers,Negative
 proposed sequencing strategies,"chadi nabhan MD, MBA, FACP",Negative
 Educational Book,"chadi nabhan MD, MBA, FACP",Negative
 Educational Book,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 mas,Crashilda Corvis,Positive
 y aun,Crashilda Corvis,Positive
 hay,Crashilda Corvis,Positive
 CAR T cell therapy,"Raul Cordoba, MD, PhD",Negative
 Chronic Lymphocytic Leukemia International Experience,"Raul Cordoba, MD, PhD",Negative
 Named Patient Program,"Raul Cordoba, MD, PhD",Negative
 story Determinants,Cell Therapy News,Negative
 Healthgt,Health MasterDoctor,Positive
   Venetoclax,CureHuntr,Positive
   Venetoclax,Asim Shahzad,Positive
   Venetoclax,Lymphoma Hub,Negative
   Venetoclax,KevinFitts,Negative
   Venetoclax,Dakshak Nagrale,Positive
   Venetoclax,PerioTecnoAR,Positive
   Venetoclax,New Year Eve Dubai,Positive
   Venetoclax,Hossam,Positive
   Venetoclax,Luis M. Henry,Positive
 Ibrutinib Resistance Mutations,CureHuntr,Negative
 Ibrutinib Resistance Mutations Status,TrialBulletin,Negative
 Condition Summary Chronic Lymphocytic Leukemia Ibrutinib Resistance,TrialBulletin,Negative
    Congrats,Anna Deveau,Negative
 New Blog PostCheck,Higher Ground at Lake Louise,Negative
 year experience,CLL Ireland,Negative
 singleagent efficacy,CLL Ireland,Negative
 CAR T Cell Therapy,Medindia.net,Negative
 CAR T Cell Therapy,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Positive
 CAR T Cell Therapy,TumImmTxpapers,Negative
 USESArzerra mg Injection,Ravispecialitiespharma_RSP,Negative
 CD chimeric antigen receptor CAR,"Bruce Levine, Ph.D.",Positive
 daughters,AJ  ‚öæÔ∏è,Positive
 daughters,Stephen Brown,Negative
 Reminder speaker,i3 Health,Negative
 Farrukh T Awan MD MS,i3 Health,Negative
 selfstudy,i3 Health,Negative
 teaching,i3 Health,Negative
 Greg Simon,Jen Horonjeff üò∑ #askpatients,Positive
   Determinants,Continuum AEP,Positive
 Mondays,TRex,Positive
 heartwarming stories,TRex,Positive
 Bob,TRex,Positive
 pony,TRex,Positive
 pony,"Rustin M. Moore, DVM, PhD",Positive
 blood cancer Chronic Lymphocytic Leukemia,TRex,Positive
 Targeted Oncologys expert,Lisa Astor,Negative
 CANTMISS PRESENTATION Alison Duffy amp Amy Seung,CSI Specialty Group,Positive
 Current Emerging Treatment Standards,CSI Specialty Group,Positive
 Current Emerging Treatment Standards,AssistRx,Positive
 bay,Prof John,Negative
 RAC amp ruin,Prof John,Negative
 clip,Targeted Oncology,Negative
 tcoqZFuQml,Targeted Oncology,Positive
 MicroenvironmentInduced PIM Kinases Promote CXCRTriggered mTOR Pathway,Hematopoiesis News,Negative
 Chronic Lymphocytic Leukemia Cell Migration,Hematopoiesis News,Negative
 CLL Heres,Targeted Oncology,Negative
 Leukaemia   patients,CLL Ireland,Negative
 tonight,Amy Ramos,Negative
 tonight,"Pat Euglow, Legacy Newbie",Negative
 tonight,Deborah Stephens,Positive
 CLL Click,Targeted Oncology,Negative
 Excellent journal discussion yest,Toby Eyre,Negative
 Coffee croissants,Toby Eyre,Negative
 tcoLHSsgjySmk,Targeted Oncology,Negative
 Promising results,Targeted Oncology,Negative
 Toxicity Associated,"Raul Cordoba, MD, PhD",Negative
   Practical Approach,"Raul Cordoba, MD, PhD",Negative
 HawkesIdelalisib GI toxicityNice review paper link,Christopher Steer,Negative
 Veterinarians,"Rustin M. Moore, DVM, PhD",Positive
 Veterinarians,"Reda Mohamed Guessoum, DVM",Positive
 Veterinarians,AVMA (American Veterinary Medical Association),Positive
 year ibrutinib therapy,Lymphoma Hub,Negative
 wphysicians,"Reda Mohamed Guessoum, DVM",Positive
 OSUCCCJames,"Reda Mohamed Guessoum, DVM",Positive
 Anxiety,MD Anderson Leukemia,Negative
 Depression,MD Anderson Leukemia,Negative
   Diagnosis   tcoqJLFAwCl,MD Anderson Leukemia,Negative
   Dr Christopher Oaks,The James,Negative
 John   camp,Higher Ground at Lake Louise,Negative
 Excellent paper,"Raul Cordoba, MD, PhD",Positive
    Program,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 Cancer Center,"Bichoy Gabra, R.Ph., Ph.D.",Negative
 Cancer Center,Mehdi Hamadani,Positive
 RT TransplantDoc Singleagent ibrutinib,Robert Z. Orlowski,Negative
   synergizes,MDedge Hematology & Oncology,Negative
 Proteomics comparison,Molecular & Cellular Proteomics,Positive
 followup response,ASH Clinical News,Negative
 ibrutinib deepens,ASH Clinical News,Negative
 study authors,Targeted Oncology,Negative
 voxtalisib,Targeted Oncology,Negative
   patient population,Targeted Oncology,Negative
 Attendees,CLL Ireland,Negative
 Elderly CLL Patients,"Dr T. Comeau , MD",Negative
     TGTXA PH study,Biotech2050,Negative
 Blood Commentary Gene mutations,Blood Journal,Negative
 Mitochondrial Bioenergetics,mitopapers,Positive
 Therapeutic Strategy,mitopapers,Positive
 Therapeutic Strategy,NK papers,Negative
 AssistRxs Amy Seung,AssistRx,Positive
 Chronic Lymphocytic Leukemia CLL session,AssistRx,Positive
 AssistRxs booth,AssistRx,Positive
 Rare Blood Cancer,CLL Ireland,Negative
 BRICCEHA Speaker,Biotech Research & Innovation Centre (BRIC),Positive
 April isMartin Peifer,Biotech Research & Innovation Centre (BRIC),Positive
 Peifer,Biotech Research & Innovation Centre (BRIC),Positive
 UK Lymphoma Conference,Helen Jane Mee,Negative
 Composite Dural Extranodal Marginal Zone Lymphoma Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Mark Bustoros Benjamin Liechty David Zagzag Cynthia Liu Timothy Shepherd Deborah Gruber Bruce Raphael Dimitris G,Frontiers Neurology,Positive
 fab breakout sessions,LymphomaAction,Negative
 inc,LymphomaAction,Negative
 Dr Eileen Parry,LymphomaAction,Negative
 Book,LymphomaAction,Negative
 Book,MacmillanGLibraries,Positive
 Book,Connie Erpelding,Positive
 John Girbben,The Patient's Channel,Negative
   use case,AEGLE,Negative
 InterLymph Consortium,Claire Vajdic,Positive
 Mayos Geffen Kleinstern PRS,Claire Vajdic,Positive
 CLL precursorAssociation,Claire Vajdic,Positive
 mill cells,Andrew Schorr,Negative
 GSUM ‚úÖ Storm,tradingbrezz,Positive
 ‚òï,tradingbrezz,Positive
 Tweet Profit,tradingbrezz,Positive
 Positive Cancer Cell Apoptosis News,tradingbrezz,Positive
 Infections cause,CancerTherapyAdvisor,Negative
 concern,CancerTherapyAdvisor,Positive
   Clarke,Derek Clarke,Negative
 amp   pts,"chadi nabhan MD, MBA, FACP",Negative
 patient populations,Targeted Oncology,Positive
 ICYMI Venetoclaxrituximab combination,HemOnc Today,Negative
 twothirds,Targeted Oncology,Negative
    Kidney,Kenar Jhaveri,Positive
 Normal Cellular Counterpart Clues,Walaa,Positive
 Normal Cellular Counterpart Clues,ImmunePCPapers,Negative
 Functional Perspective,Walaa,Positive
 Functional Perspective,ImmunePCPapers,Negative
 Cellworks,CellworksLife,Positive
 Predicting Mechanisms,CellworksLife,Positive
 IbrutinibResistance,CellworksLife,Positive
 IbrutinibResistance,CancerPOP,Positive
 ComputationalBased Modeling,CellworksLife,Positive
 ComputationalBased Modeling,CancerPOP,Positive
 Personalized Therapy,CellworksLife,Positive
 Personalized Therapy,CancerPOP,Positive
 Clinical Validation,CellworksLife,Positive
 Clinical Validation,CancerPOP,Positive
 tcoFfYZCjojxy,CellworksLife,Negative
 Notes amp slides,CLLSA,Positive
 followAll,CLLSA,Negative
 World Awareness Day,CLL Ireland,Negative
 New formulation,Talal Hilal ü©∫,Negative
 tablet strengths,Talal Hilal ü©∫,Negative
 Infections Cause,Cyberknife,Positive
 Concern,Cyberknife,Positive
 Chronic Lymphocytic Leukemia Hematopoietic Stem Cells,Frontiers Oncology,Negative
 Mauro Di,Frontiers Oncology,Negative
 Ianni Stefano,Frontiers Oncology,Negative
 Ambra,Frontiers Oncology,Negative
 cofounders,Patient Power,Negative
 Dr Kline,"chadi nabhan MD, MBA, FACP",Negative
 True Blue,Carefree Blues Pod,Positive
 Inhibitor outperforms rivals,MDedge Hematology & Oncology,Negative
 PC,ImmunePCPapers,Positive
 Niagara Falls,Andrew Schorr,Negative
 Á•ù‰Ω†ÁîüÊó•Âø´‰πê ÔºÅ ÔºÅ,Lesoya,Positive
   RUNXPDCD fusion,Fabrice Leclerc,Negative
 novel tpq chromosome translocation,Fabrice Leclerc,Negative
 Sunrise Crew,Higher Ground at Lake Louise,Negative
 Intro Camp,Higher Ground at Lake Louise,Positive
    amp,LiveYourLife,Negative
    amp,Light The Night SD,Negative
 Novel fusion gene RUNXPDCD,Daniel Nicorici,Positive
   Chronic Lymphocytic Leukemia Pipeline Highlights,Financial Buzz,Negative
   Chronic Lymphocytic Leukemia Pipeline Highlights,The Pharmaceutical Marketing Group,Negative
   Chronic Lymphocytic Leukemia Pipeline Highlights,Latest News from Business Wire,Negative
 CLL Giveaway,CryptoLiveLeak,Negative
 Gene mutations,"Raul Cordoba, MD, PhD",Negative
 PD Dr Dominik Heim,healthbook,Positive
 Cyclacel,tradingbrezz,Positive
 Cyclacel,CLL Society Inc.,Negative
 Cyclacel,BioNJ,Positive
 Cyclacel,Financial Buzz,Negative
 Cyclacel,StockGuru,Positive
 Cyclacel,SPI News,Negative
 CYC CDK Inhibitor,tradingbrezz,Positive
 CYC CDK Inhibitor,CLL Society Inc.,Negative
 CYC CDK Inhibitor,BioNJ,Positive
 CYC CDK Inhibitor,Financial Buzz,Negative
 CYC CDK Inhibitor,SNN Network,Negative
 CYC CDK Inhibitor,StockGuru,Positive
 CYC CDK Inhibitor,SPI News,Negative
 Synergy,tradingbrezz,Positive
 Synergy,CLL Society Inc.,Negative
 Synergy,BioNJ,Positive
 Synergy,Financial Buzz,Negative
 Synergy,SNN Network,Negative
 Synergy,StockGuru,Positive
 Synergy,SPI News,Negative
 Dual Targeting,tradingbrezz,Positive
 Dual Targeting,CLL Society Inc.,Negative
 Dual Targeting,BioNJ,Positive
 Dual Targeting,Financial Buzz,Negative
 Dual Targeting,SNN Network,Negative
 Dual Targeting,StockGuru,Positive
 Dual Targeting,SPI News,Negative
 wChronic Lymphocytic Leukemia CLL,Bon in NC,Positive
 Venetoclax Shows Promise,Targeted Oncology,Negative
 Salvage Therapy,Targeted Oncology,Negative
 idelalisib ORR,"chadi nabhan MD, MBA, FACP",Negative
 soccer ball,Laboratory Career,Negative
 Daniel Landau WeillCornell NY Singlecell epigenomics,Dale Yuzuki,Positive
 Singlecell epigenomics,Weill Cornell Medicine,Positive
 Genetic Testing,CLL Ireland,Negative
 Genetic Testing,Patient Power,Positive
 Genetic Testing,Oncology Tube,Negative
 Adenosinergic Axis,„Å®„Åç‚ôÇ,Positive
 Adenosinergic Axis,TumImmTxpapers,Negative
 Adenosinergic Axis,IJMS MDPI,Positive
 Chronic Lymphocytic Leukemia Way,„Å®„Åç‚ôÇ,Positive
 Chronic Lymphocytic Leukemia Way,TumImmTxpapers,Negative
 Chronic Lymphocytic Leukemia Way,IJMS MDPI,Positive
 Tumor Niche,„Å®„Åç‚ôÇ,Positive
 Tumor Niche,TumImmTxpapers,Negative
 CYCC Cyclacel,SNN Network,Negative
 CLLSA Trustee Marc Aucklands,CLLSA,Negative
 Spanish,The Patient's Channel,Negative
   campaign,CLLSA,Positive
 ibrutinib apt apto,Anna Deveau,Negative
 patient interview,Nick,Negative
 BBC,Nick,Negative
    campaign,CLL Ireland,Negative
 Matthew S Davids MD,Targeted Oncology,Negative
 IMHO Watch amp Wait,CLL_Fightersüéó,Negative
 HOY    presenta,The Pepex Family,Positive
 HOY    presenta,Thu Pepex,Negative
 HOY    presenta,WWE Noticias FM,Positive
 Places,CLLSA,Negative
 Promising treatments,The Patient's Channel,Negative
 campaign   conference,CLLSA,Negative
   Grants    Review,CancerWallonia,Negative
 Sinovent Pharma,Anna Deveau,Negative
 National   Information Day,CLL Ireland,Negative
 Carers Demand,CLL Ireland,Negative
 Chronic Lymphocytic Leukemia Progressing,The ASCO Post,Positive
 Chronic Lymphocytic Leukemia Progressing,Chan Cheah,Negative
 Triplet Combination,Targeted Oncology,Negative
 Ibrutinib Venetoclax,Targeted Oncology,Negative
 Obinutuzumab Effective,Targeted Oncology,Negative
 Initial CLL Treatment,Targeted Oncology,Negative
 Work,Dr. Avinash Dinmohamed,Positive
 Work,Oncology Tube,Negative
 Chronic Lymphocytic Leukemia CLL Prognosis,Victoria Gescheidle,Positive
 Chronic Lymphocytic Leukemia CLL Prognosis,News Medical,Positive
 dissertation,CLL Warwick Uni,Negative
   Elias Campo,AlfonsoValencia,Positive
 CLLSALeukaemia Care UK buddy scheme,Nick,Negative
 Grade camp,Higher Ground at Lake Louise,Positive
   Niche,IJMS MDPI,Positive
 Hematogenix Laboratory Services Launches Minimal Residual Disease MRD Evaluation,RazzleTazzle,Positive
 Hematogenix Laboratory Services Launches Minimal Residual Disease MRD Evaluation,Sicilia Informazioni,Positive
 Hematogenix Laboratory Services Launches Minimal Residual Disease MRD Evaluation,Hikmat Daghestani,Positive
 X International Meeting,"Chared, Good Comms",Negative
 X International Meeting,European Hematology Association,Negative
 X International Meeting,HARMONY Alliance,Negative
 Das Leitlinienprogramm Onkologie hat eine,Krebsgesellschaft,Positive
 S zur Diagnostik Therapie,Krebsgesellschaft,Positive
 und Nachsorge f√ºr,Krebsgesellschaft,Positive
 Patienten mit einer,Krebsgesellschaft,Positive
 erarbeitet und ver√∂ffentlicht,Krebsgesellschaft,Positive
 Kostenloser Download,Krebsgesellschaft,Positive
 RT TransplantDoc Venetoclax,Robert Z. Orlowski,Positive
 PETMRI,Cancer Papers,Negative
 CXCR Imaging,Cancer Papers,Negative
 phosphotyrosine phosphatase,NPCE,Positive
 SHP,NPCE,Positive
 SHP,Reaction Biology,Positive
 CLLAN shares,CLL Advocates Network,Negative
 grief,CLL Advocates Network,Negative
 Lisa Minkove,CLL Advocates Network,Negative
 Lisa Minkove,Andrew Schorr,Negative
 Gold Sponsor,Southland,Positive
 Possibilities Fund,Southland,Positive
 Golf Tournament,Southland,Positive
 Duvelisib NDA,Joey Sales,Positive
 Duvelisib NDA,CLL Society Inc.,Negative
 RelapsedRefractory CLLSLL Follicular Lymphoma,Joey Sales,Positive
 RelapsedRefractory CLLSLL Follicular Lymphoma,CLL Society Inc.,Negative
 Detectar la,LMC AELEMIC Espa√±a,Positive
 Hematogenix Laboratory Services Launches,Rare Diseases,Negative
 EpsteinBarr virus reactivation,@immunoonco_Meed,Positive
 EpsteinBarr virus reactivation,ImmuneGCPapers,Positive
 therapyrelated immunosuppression,@immunoonco_Meed,Positive
 therapyrelated immunosuppression,ImmuneGCPapers,Positive
 bulky disease,Dr. Luis Villela,Positive
   NDA,MDedge Hematology & Oncology,Negative
 Hasta pronto mi gente,Nebel,Positive
 Nos volveremos,Nebel,Positive
 Hematogenix,Kathryn Evans Nu√±ez,Positive
   Grants,Kara Jill Stancell,Negative
   Grants,CancerWallonia,Positive
   afholder igen Temadag med sessioner,LyLe Foreningen,Negative
 √¶ft √¶mi og        p√• l√∏rdag d,LyLe Foreningen,Negative
 apr,LyLe Foreningen,Negative
 Aarhus,LyLe Foreningen,Negative
 F√∏lg med p√•,LyLe Foreningen,Negative
 nye hjemmeside,LyLe Foreningen,Negative
 om √¶ft     √¶ft,LyLe Foreningen,Negative
 term Outcomes,leukemia,Negative
 Standard Therapy,leukemia,Negative
 WONDERFUL,Cultura Lucha Libre,Positive
 Woken,Cultura Lucha Libre,Positive
 Matt Hardy,Cultura Lucha Libre,Positive
 y Bray Wyatt le ganan,Cultura Lucha Libre,Positive
 Titus Worldwide para pasar al torneo de la semana que viene,Cultura Lucha Libre,Positive
 Useless White Blood Cell Supremacists,Michael Fraser,Positive
 creator,Michael Fraser,Positive
 amp tcoINdgzQQo,Michael Fraser,Positive
 Selected Trials,Anna Deveau,Negative
 DUO study,Anna Deveau,Positive
 CLL community,CLL Ireland,Negative
 CLL community,CLLSA,Negative
   Related,Hematology & Thromboembolic Diseases,Positive
 Prior,Hematology & Thromboembolic Diseases,Positive
 Gracias por seguirnos hoy,Cultura Lucha Libre,Positive
 Wrestlemania New Orleans,Cultura Lucha Libre,Positive
 uno,Cultura Lucha Libre,Positive
 Brock Lesnar retiene el titulo,Cultura Lucha Libre,Positive
 Universal,Cultura Lucha Libre,Positive
 BOOOOOOOOOOOOOOOOO,Cultura Lucha Libre,Positive
   un,Cultura Lucha Libre,Positive
 SHINSUKE NAKAMURA,Cultura Lucha Libre,Positive
 acaba de traicionar,Cultura Lucha Libre,Positive
 AJ STYLES HOLY SHIT HOLY SHIT,Cultura Lucha Libre,Positive
 Eah,Cultura Lucha Libre,Positive
 Pu√± Todavia campeon AJ STYLES,Cultura Lucha Libre,Positive
 obinutuzumab Gazyva ibrutinib Imbruvica,Solomon Kamal,Positive
 Nia Jax,Cultura Lucha Libre,Positive
 Daniel Bryan,Cultura Lucha Libre,Positive
 gana contra Zayn y Owens,Cultura Lucha Libre,Positive
 Undertaker,Cultura Lucha Libre,Positive
 John Cena,Cultura Lucha Libre,Positive
 UNDERTAKEEER,Cultura Lucha Libre,Positive
 John Cena Sucks John Cena,Cultura Lucha Libre,Positive
 Bludgeon Brothers,Cultura Lucha Libre,Positive
 Usos y New Day,Cultura Lucha Libre,Positive
   en su debut gana con armbar,Cultura Lucha Libre,Positive
 NUEVO campeon,Cultura Lucha Libre,Positive
 Intercontinental Seth Freaking Rollins,Cultura Lucha Libre,Positive
 gana NAOMI,Cultura Lucha Libre,Positive
 se lo esperaba,Cultura Lucha Libre,Positive
 Segundo Upset NUEVO campeon de Estados Unidos Jinder Mahal,Cultura Lucha Libre,Positive
 WOOOOW el shock del a√±o Charlotte Flair retiene el titulo,Cultura Lucha Libre,Positive
 RBendamustine,Silvana Novelli,Positive
 RBendamustine,CancerTherapyAdvisor,Negative
   times,Silvana Novelli,Positive
 amp   clinicians,CLLSA,Negative
 document,CLLSA,Negative
 consultants,CLLSA,Negative
 ICYMI CAR Tcell therapy,HemOnc Today,Positive
    Kudos,Michele Nadeem-Baker,Negative
 New cancer treatment method,CLL Ireland,Negative
 Nieuw   tegen,A. Vroom - Ten Wolde,Negative
 maar erg duur,A. Vroom - Ten Wolde,Negative
 Expert Reviews,CancerWallonia,Negative
 editors,medwireNews,Negative
 Friends,Higher Ground at Lake Louise,Negative
 Friends,Joy is a Lifestyle,Positive
 Friends,ùìíùìªùì≤ùîÉùîÉùîÇ ùìüùìÆùìªùìªùîÇüåπ,Positive
 Tess,Sophie #HelpPH,Positive
 Tess,FNest,Positive
 Tess,MirandaüíÉüèª,Positive
 Tess,Billy Goco,Positive
 Alan Skarbnik MD,OncLive.com,Negative
 Alan Skarbnik MD,JTCancerCenter,Positive
 potentially life,Andrew Schorr,Negative
 fav,Andrew Schorr,Negative
 Seattle Today,Andrew Schorr,Negative
 nonsense,Biotech2050,Negative
 relapsed blood cancer,CLL Ireland,Negative
 measures,CLL Ireland,Negative
 Drug combination,CLL Ireland,Negative
 survival rate,CLL Ireland,Negative
    Centre Venetoclax Beats,David Langsam,Positive
 subscribe,David Langsam,Positive
 Biotech Daily,David Langsam,Positive
 Editorial piece,Cancer_Tribune,Negative
 bendamustine rituximab,Cancer_Tribune,Negative
 tcoMQQtLSvu,Cancer_Tribune,Negative
 review article,Cancer_Tribune,Negative
 frauds,T E S L V,Positive
 VenclextaRituxan Combo Reduced Disease Progression,Lymphoma News Today,Negative
 Relapsed CLL Patients,Lymphoma News Today,Positive
 Chronic Lymphocytic Leukemia CLL Epidemiology Forecast,Tech News by Qiosk,Negative
 Chronic Lymphocytic Leukemia CLL Epidemiology Forecast,COPD News,Negative
 CR Yine Yaptƒ± Yapacaƒüƒ±nƒ±,C√ºneyt √úNAL,Positive
 Helal Olsun,C√ºneyt √úNAL,Positive
 pienso,HO-360,Positive
 combinaciones,HO-360,Positive
 futuro,HO-360,Positive
 LLC Venettoclax,HO-360,Positive
 counsel patients,MDCalc.com,Positive
 TP Deletion p,CLL Ireland,Negative
 TP Deletion p,Cancer_Tribune,Negative
    CLL Quick Flip,TradingView Aus,Positive
 CLL Quick Flip,HG.ethüêÉ,Positive
 News   study,medwireNews,Negative
 Critically Elevated Potassium,Cancer Papers,Negative
 YearOld Female,Cancer Papers,Negative
 El Dr Emili Montserrat,Hospital CL√çNIC,Positive
 lelaboraci√≥ de la nova guia cl√≠nica,Hospital CL√çNIC,Negative
 al tractament,Hospital CL√çNIC,Negative
 la Leuc√®mia Limf√†tica Cr√≤nica publicada al,Hospital CL√çNIC,Negative
 Reviews,"Raul Cordoba, MD, PhD",Negative
 overviews,"Raul Cordoba, MD, PhD",Negative
 Follicular Lymphoma Marginal Zone Lymphoma Chronic Lymphocytic Leukemia,"Raul Cordoba, MD, PhD",Negative
 Gastric Carcinoma,Cureus,Negative
 Chronic Lymphocytic Leukemia Coincidence,Cureus,Negative
 Consequence,Cureus,Negative
 Mangal et al,Cureus,Negative
 TokenStore,CryptoLiveLeak,Negative
 Default Token,CryptoLiveLeak,Negative
 MyEtherWallet,CryptoLiveLeak,Negative
 VenclextaRituxan Delays Disease Progression,CLL Ireland,Negative
 VenclextaRituxan Delays Disease Progression,Todd C Bertsch,Positive
 II study voxtalisib,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 share advice,Patient Power,Negative
 filming,Lisa Astor,Negative
 pharmacokinetics,"Raul Cordoba, MD, PhD",Negative
 pharmacokinetics,MDLinx,Negative
 expert Dr Stephen Spurgeon,Patient Power,Negative
 July fun,Higher Ground at Lake Louise,Negative
 Winning,Higher Ground at Lake Louise,Negative
 Home Family Camp,Higher Ground at Lake Louise,Negative
 USESCytomab mg Injection,Ravispecialitiespharma_RSP,Negative
 RT   booklet,Nick,Negative
 QR code               print,Nick,Negative
 poster amp,Nick,Negative
 wall,Nick,Negative
 IBO Summary    CLL,CryptoLiveLeak,Negative
 CDvpotential treatment target,Cancer_Tribune,Negative
 multi billion dollar opportunity,Biotech2050,Negative
 noncovalent,Anna Deveau,Negative
 ABBV   tcokTyvWXbNo wonder,Biotech2050,Negative
 TGTX s drug,Biotech2050,Negative
 Reasons,"Raul Cordoba, MD, PhD",Negative
 Reasons,"chadi nabhan MD, MBA, FACP",Negative
 Reasons,"Tom Iarocci, MD",Negative
 Reasons,Scott Werntz,Positive
 Reasons,Cancer Daily,Positive
 Reasons,EMJ Hematology,Negative
 Reasons,Jerrie DanceMabus MS,Positive
 Reasons,The Peak Oil Poet,Positive
 Reasons,Science Codex,Negative
 Reasons,Healthy & Active,Positive
 Reasons,Michael Rahman,Positive
 Reasons,"Burke & Eisner, P.A.",Positive
 Reasons,HealthyTabs/pharmacy,Positive
 Reasons,JAMA Oncology,Negative
 Reasons,Titanhealth news,Negative
 Reasons,Future Consulting,Positive
 Reasons,Drug Daily,Positive
 Reasons,Ajinkya Ambre,Positive
 Reasons,sciencenewsfacts,Positive
 disease progression   lowno disease activity,"Raul Cordoba, MD, PhD",Negative
 Chronic Lymphocytic Leukemia Stopping Ibrutinib,"Raul Cordoba, MD, PhD",Negative
 Idelalisib Therapies,"Raul Cordoba, MD, PhD",Negative
 ECE,Gill Budgell,Positive
 English,Gill Budgell,Positive
 Languages,Gill Budgell,Positive
 kinase inhibitor discontinuation,"chadi nabhan MD, MBA, FACP",Negative
 prohibitinbinding compound fluorizoline,Dip√≤sit Digital UB,Positive
 prohibitinbinding compound fluorizoline,Cancer Papers,Negative
 Pubmed Cohesin RAD Gene Promoter Methylation,epigenetics_papers,Negative
 Cohesin RAD Gene Promoter Methylation,cohesin_papers,Positive
 Lars Bullinger ChariteBerlin,"Chared, Good Comms",Negative
 Lars Bullinger ChariteBerlin,European Hematology Association,Negative
   Lars Bullinger,HARMONY Alliance,Negative
 USESRistova mg Injection,Ravispecialitiespharma_RSP,Negative
 Acute Lymphocytic Leukemia,ALL UNIVERSITY NEWS,Positive
 Acute Lymphocytic Leukemia,Sultan Ibrahim Aljarba,Positive
 USMLE,ALL UNIVERSITY NEWS,Positive
 Personal Health,ALL UNIVERSITY NEWS,Positive
 New Post VenclextaRituxan Combo Reduced Disease Progression,Lymphoma News Today,Negative
 hemonc meetings,VJHemOnc,Negative
 ASH EBMT,VJHemOnc,Negative
 BSH,VJHemOnc,Negative
 focus Voxtalisib,CancerTherapyAdvisor,Negative
 CLL Bcell lymphomas,CancerTherapyAdvisor,Negative
 Microenvironmental regulation,Vinci-Biochem Srl,Positive
 Microenvironmental regulation,sandrineman,Negative
 Microenvironmental regulation,Mahmoud Aljurf,Negative
 Microenvironmental regulation,NatureRevClinOncol,Negative
 Microenvironmental regulation,Dr MariaTeresa Esposito,Positive
 VenclextaRituxan Combo Delays Disease Progression,CLL Society Inc.,Negative
 Lymphocytic Leukemia Trial Results,CLL Society Inc.,Negative
 Lymphocytic Leukemia Trial Results,Immuno-Oncology News,Positive
    Neon Therapeutics,Anna Deveau,Negative
 International CLL Group,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 trials guidelines,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Adewoye,FierceBiotech,Positive
 cancer programs,FierceBiotech,Positive
 Gilead,FierceBiotech,Positive
 Gilead,Gilead Sciences,Positive
 Gilead,Dr Ortega,Negative
 Gilead,pharmatutor,Positive
 Gilead,Pharmacutical Daily,Negative
 Gilead,aeses.com,Negative
 Zydelig,FierceBiotech,Positive
 Zydelig,Roots Analysis,Negative
 Zydelig,BusinessWireProducts,Negative
 Zydelig,dlvr news,Negative
 Zydelig,$Stocknewsalerts,Negative
 Zydelig,Aserrano,Positive
 Zydelig,scottidiego,Positive
 Zydelig,Dr Ortega,Negative
 Zydelig,CancerConnect,Negative
 Zydelig,pharmatutor,Positive
 Zydelig,aeses.com,Positive
 Zydelig,MAISA,Negative
 Zydelig,Plexus Ventures,Negative
 Zydelig,PANNA SHARMA,Positive
 Zydelig,Aktienmanufaktur,Negative
 Zydelig,Scott Werntz,Negative
 PK inhibitor,FierceBiotech,Positive
 New Post VenclextaRituxan Combo Delays Disease Progression,Immuno-Oncology News,Positive
 New post Drug Combination,Colorectal Cancer Charity,Positive
 New post Drug Combination,Jim Graham,Positive
 Colorectal Cancer Charity,Colorectal Cancer Charity,Positive
 China BCell Chronic Lymphocytic Leukemia Treatment Market Research Report,W M Reports,Positive
   playing,My name is David,Positive
 Global API Manufacturers,Tech News by Qiosk,Negative
 Global API Manufacturers,nsure io,Positive
 Global API Manufacturers,BusinessWireServices,Negative
 Global API Manufacturers,Business Wire-Health,Positive
 Global API Manufacturers,The Pharmaceutical Marketing Group,Negative
 Phase III Drugs Landscape   Report,Tech News by Qiosk,Negative
 Original Article Venetoclax,NEJM,Negative
   Fellows Program,"Fumiko Ladd Chino, MD",Positive
 continuum,"Fumiko Ladd Chino, MD",Positive
 continuum,Lymphoma Hub,Negative
 continuum,ZMB,Positive
 continuum,Albert Vilella,Positive
 continuum,Moreaux J√©r√¥me,Positive
 continuum,Calibr8 Your Life,Positive
 QampA time,Patient Power,Negative
 QampA time,Carmine DeLuca,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia J F Seymour,RAUL FERRANDO,Positive
 N Engl J Med,RAUL FERRANDO,Positive
 Nurse Practitioner Jackie BroadwayDuren,Patient Power,Negative
 Dr Keating,Patient Power,Positive
 Dr Keating,MD Anderson Leukemia,Positive
 Dr Keating,Lisa Palacios,Negative
 stem cell transplants,Patient Power,Negative
 stem cell transplants,VJHemOnc,Negative
 rituxan,donnashort,Negative
 Dr Skarbnik,donnashort,Negative
 Phase III Murano trial,CLL Ireland,Negative
 tcoNFubHXfO,CLL Ireland,Negative
   CR,Anna Deveau,Negative
   CR,"Caner Saygin, MD",Negative
 mnts,Anna Deveau,Negative
 venetoclaxrituximab treatment regimen,Targeted Oncology,Negative
 veces,Monte S,Positive
 encuentras,Monte S,Positive
 rituximab combos,Covington Beasley,Positive
 rituximab combos,ABABioBlurb,Positive
 Slide Library,i3 Health,Negative
 Heartfelt thanks,Esther Schorr,Negative
 oncology nurses,Esther Schorr,Negative
 depletion,NK cell Biology,Negative
 depletion,NK papers,Negative
 International CLL Group Updates Trials Guidelines,Clinical Trials,Negative
 Cancer Network International CLL Group Updates,Clinical Trials,Negative
 SC,MDedge Hematology & Oncology,Negative
 LSMO meeting,Razan Mohty,Positive
 Health Canada Approves RITUXAN,NE Live,Negative
 Health Canada Approves RITUXAN,Live Well Toronto,Positive
 Health Canada Approves RITUXAN,Alicia Bell IFBB Pro,Negative
 Health Canada Approves RITUXAN,RazzleTazzle,Negative
 ¬Æ Subcutaneous Formulation,NE Live,Negative
 ¬Æ Subcutaneous Formulation,Live Well Toronto,Positive
 ¬Æ Subcutaneous Formulation,Alicia Bell IFBB Pro,Negative
 ¬Æ Subcutaneous Formulation,RazzleTazzle,Negative
 Canadians,NE Live,Negative
 Canadians,Live Well Toronto,Positive
 Canadians,Alicia Bell IFBB Pro,Negative
 Canadians,Zeal Access,Positive
 Canadians,RazzleTazzle,Negative
 Canadians,Dickie Fox,Positive
 Extreme Morning Challenge,Higher Ground at Lake Louise,Negative
 Latest Treatment Developments,CancerWallonia,Negative
 Latest Treatment Developments,COPD News,Negative
   Genomic Epigenomic Landscape,SeqComplete,Negative
 Initial,CancerWallonia,Negative
 USESRituximab,Ravispecialitiespharma_RSP,Negative
 CLL guidelines,the limbic,Negative
 RR   venetoclax plus rituximab VR,Dr. Avinash Dinmohamed,Positive
 CLL Venetoclax,CancerTherapyAdvisor,Negative
 CLL Venetoclax,Lymphoma Coalition,Negative
 Czech     groups,Marek Trneny,Positive
 educatiion research science meeting,Marek Trneny,Positive
 ASHKongress,MEDIZINONLINE #COVID19-Update,Positive
 AtlantaKrebstherapie Der Thron wankt,MEDIZINONLINE #COVID19-Update,Positive
 Lymphom   Vedotin,MEDIZINONLINE #COVID19-Update,Positive
 Canada NewsWire press release,Live Well Toronto,Positive
 expert Dr Jeff Sharman,Patient Power,Negative
 expert Dr Jeff Sharman,Cassi Schmigotzki,Positive
 Health Canada Approves RITUXAN Subcutaneous Formulation,Zeal Access,Positive
 Seymour et al       HT,"Mike Thompson, MD, PhD, FASCO",Negative
 Relapsed Refractory Chronic Lymphocytic LeukemiaFunded,CancerEpiPapers,Negative
 Professor Peter Hillmen Professor,CLLSA,Negative
 Experimental,CLLSA,Negative
 amp Honorary Consultant,CLLSA,Negative
 quest,CLLSA,Negative
 quest,Lifelong Learning,Negative
 Phase    Venetoclax,"Salvatore Papa, PhD",Positive
 Cello Group plc,Isabella Pierre,Positive
 Cello Group plc,Broker Ratings,Positive
 Cello Group plc,MarketBeat,Negative
 Phase   Venetoclax   Rituximab,Cancer Cell,Negative
 DailyStrength,Brian Abbott,Positive
 DailyStrength,Alexander M. J.,Positive
 yr followup study,WCM Lymphoma,Negative
 Prolonged voriconazole treatment,Candida Papers,Positive
 Combi,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 IC concentrations,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 hr,üÖ±üÖ∏üÖæüÜÉüÖ¥üÖ≤üÖ∑,Negative
 Blanca Espinet et al,SEAP-IAP,Positive
 Complex Karyotypes,SEAP-IAP,Positive
 Chronic Lymphocytic Leukemia Comparison,SEAP-IAP,Positive
 Chromosome Banding Analysis,SEAP-IAP,Positive
 Genomic Microarray Techniques,SEAP-IAP,Positive
 USESUSESRituxirel mg Injection,Ravispecialitiespharma_RSP,Negative
 CLL Expert,COPD News,Negative
 investigator,FredNatLab PDO,Positive
 Road,Leukemia Research Foundation,Negative
 Road,Heather DelaCruz,Negative
 Road,Janette Fuller,Positive
 Dr Justin Kline,Leukemia Research Foundation,Negative
 guest blog,Patient Power,Negative
 Watch amp Wait,CLLSA,Negative
 grandmother,"Cristina, MD MSüò∑",Positive
 pictures,James Nova,Positive
 Colonial Systems LLC,CryptoLiveLeak,Negative
 Partnership,CryptoLiveLeak,Negative
 Web Development ICO Project,CryptoLiveLeak,Negative
 Nathan Simpson,CryptoLiveLeak,Negative
 Oncology Nursing Society,Andrew Schorr,Negative
 Oncology Nursing,Andrew Schorr,Negative
 Esther,Andrew Schorr,Negative
 Esther,Patient Power,Negative
 chilly start,CLL Warwick Uni,Negative
 JUNO CAR T,Biotech2050,Negative
 KITE amp NVSCR,Biotech2050,Negative
 amp ORR,Biotech2050,Negative
 worth,Biotech2050,Negative
 wellbeing,Helen Jane Mee,Negative
 phosphorylcholine,robo_gwas,Positive
 genetics phenotypic relation,robo_gwas,Positive
 Happy St,CLL Ireland,Negative
 Insufficient vitamin D levels,Alexander M. J.,Positive
 video review,CryptoLiveLeak,Negative
 ForkDelta Exchange,CryptoLiveLeak,Negative
 Facebook friends,Pippa Jones,Positive
 Feb birthday fundraiser days,Pippa Jones,Positive
 expert Dr Ronan Foley,NE Live,Negative
    therapy work,Patient Power,Negative
 CLL expert Dr Michael Keating,Patient Power,Negative
 Token,CryptoLiveLeak,Negative
 ForkDelta    CLL,CryptoLiveLeak,Negative
 Kinder Camp,Higher Ground at Lake Louise,Negative
 campfire,Higher Ground at Lake Louise,Negative
 parttime study,CLL Warwick Uni,Negative
 Token CLL,ForkDelta: The Decentralized Exchange,Positive
 Dr Rajat Bannerji,Dr. Andy Evens,Negative
 inhibitors ADCs Bispecific antibodies,Dr. Andy Evens,Negative
 Standing room,Dr. Andy Evens,Negative
 Dr Robert Strair,Dr. Andy Evens,Negative
 Elevated Levels,Human Immunology News,Negative
 Follicular T Helper Cells,Human Immunology News,Negative
 Therapeutic Effects,Human Immunology News,Negative
 SNX,Anna Deveau,Negative
 SNX,Lymphoma Canada,Negative
 SNX,Renal Cell Carcinoma,Negative
 SNX,Financial Buzz,Negative
 SNX,BusinessWireProducts,Negative
 SNX,Business Wire-Health,Negative
 SNX,Cancer News,Negative
 SNX,The Pharmaceutical Marketing Group,Negative
 established dose,Anna Deveau,Negative
 CS mutant clone,Anna Deveau,Negative
 Acute Promyelocytic Leukemia,Dra Catalina Solano,Positive
 Chronic Lymphocytic Leukemia Concomitant Presentation,Dra Catalina Solano,Positive
 Molecularly Distinct Entities,Dra Catalina Solano,Positive
 BCell Chronic Lymphocytic Leukemia Epidemiology Forecast,COPD News,Negative
 USD    DelveInsights BCell Chronic Lymphocytic Leukemia Epidemiology Forecast,COPD News,Negative
 Carl H June MD,Regina M Maxwell,Positive
 LifeSciences PA Scientific Achievement Award,Regina M Maxwell,Positive
 phosphotyrosine,Reaction Biology,Positive
 anergy,Reaction Biology,Positive
 Proud day,CLL Warwick Uni,Negative
 Warwick,CLL Warwick Uni,Negative
 International Universities,CLL Warwick Uni,Negative
 La √∫ltima vez que esos titulos estuvieron,Alison Evans,Negative
 TCells therapy,de Souza Institute,Positive
 Estimate prognosis,MDCalc.com,Positive
 amp time,MDCalc.com,Positive
 AntiCD immunotherapy,Cancer Papers,Negative
 bridge,Cancer Papers,Negative
 Chronic Lymphocytic Leukemia CLLSmall Lymphocytic Lymphoma SLL,CureHuntr,Negative
 Chronic Lymphocytic Leukemia CLLSmall Lymphocytic Lymphoma SLL Status,TrialBulletin,Negative
 Condition Su,TrialBulletin,Negative
 Deedee Chronic Lymphocytic Leukemia,"Lija Joseph, MD",Positive
 Familial Experience,"Lija Joseph, MD",Positive
 DrParul Bhargava professor,"Lija Joseph, MD",Positive
 UCSF,"Lija Joseph, MD",Positive
 NCI Treatment,Treatment Scores,Positive
 Angelo Agathanggelou,Blood Cancer UK Research,Negative
   Hamblin Prize,Blood Cancer UK Research,Negative
 Sunday Funday,Amanda Wysokowski,Positive
 Davids Discusses,CancerWallonia,Negative
   students,CLL Warwick Uni,Positive
 VIDEO CAR Tcell therapy,CLL Society Inc.,Negative
 CAR Tcell therapy amplsquoholds,CLL Society Inc.,Negative
 GOAT,.,Positive
 Finallyopening day,Amy Ramos,Negative
 diablittos,Jean-Marc JOACHIM,Positive
 Great Expert Forum   meeting,"Raul Cordoba, MD, PhD",Negative
 Mothers Day,CLL Warwick Uni,Positive
 Potential Utility,Garbi√±e Lizeaga,Negative
 Potential Utility,GEDEFO,Negative
 Potential Utility,Benito,Positive
 Potential Utility,sandrineman,Negative
 Biosimilars,Garbi√±e Lizeaga,Negative
 Biosimilars,GEDEFO,Negative
 Biosimilars,Benito,Positive
 upcoming Chicago Lymphoma Workshop,UChicagoCancerCenter,Positive
   RT incidence,Biotech2050,Negative
 –õ–µ—á–µ–Ω–∏–µ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π,–õ–µ—á–µ–Ω–∏–µ —Ä–∞–∫–∞,Positive
 –ª–∏–º—Ñ–æ—Ü–∏—Ç–∞—Ä–Ω–æ–π,–õ–µ—á–µ–Ω–∏–µ —Ä–∞–∫–∞,Positive
 –≤ –ò–∑—Ä–∞–∏–ª–µ–ü–æ–¥—Ä–æ–±–Ω–µ–µ,–õ–µ—á–µ–Ω–∏–µ —Ä–∞–∫–∞,Negative
 line treatment decisions,"Raul Cordoba, MD, PhD",Negative
 ŒòŒ≠œÉŒ∑ ŒµœÅŒ≥Œ±œÉŒØŒ±œÇ,tweet or not tweet,Positive
 Œ†œÅœåœÉŒ∫ŒªŒ∑œÉŒ∑ ŒïŒ∫Œ¥ŒÆŒªœâœÉŒ∑œÇ ŒïŒΩŒ¥ŒπŒ±œÜŒ≠œÅŒøŒΩœÑŒøœÇ Œ≥ŒπŒ± œÑŒ∑ŒΩ œÄŒªŒÆœÅœâœÉŒ∑,tweet or not tweet,Positive
 Œ∏Œ≠œÉŒ∑œÇ,tweet or not tweet,Positive
 œÄœÅŒøœÉœâœÄŒπŒ∫Œøœç,tweet or not tweet,Positive
 ŒºŒµ,tweet or not tweet,Positive
 Œ±ŒΩŒ¨Œ∏ŒµœÉŒ∑œÇ Œ≠œÅŒ≥ŒøœÖ œÉœÑŒø œÄŒªŒ±ŒØœÉŒπŒø œÑŒ∑œÇ,tweet or not tweet,Positive
 Œ†œÅŒ¨ŒæŒ∑œÇ,tweet or not tweet,Positive
 Chronic Lymphocytic Leukemia Pipeline Highlights,Financial Buzz,Negative
 Chronic Lymphocytic Leukemia Pipeline Highlights,Business Wire-Health,Positive
 Chronic Lymphocytic Leukemia Pipeline Highlights,The Pharmaceutical Marketing Group,Negative
 Update drug pipelines,Business Wire-Health,Negative
 offering,Business Wire-Health,Negative
 Grade Camp,Higher Ground at Lake Louise,Negative
 teammates,The Lion's Shed üè¥Û†ÅßÛ†Å¢Û†Å•Û†ÅÆÛ†ÅßÛ†Åø,Negative
 Cancer Experience Registry,Cancer Policy Institute,Positive
 Cancer Experience Registry,Linda Bohannon,Positive
 Specialty Registries,Cancer Policy Institute,Positive
 Customs Clearing Activity,Concessionary L.L,Negative
 Tin Island Port,Concessionary L.L,Negative
 Chronic Lymphocytic Leukemia Advances,Francesco Bertoni,Negative
 Dr Kolibaba,Patient Power,Positive
 Nora Larson,Patient Power,Negative
 Pour cette,Carmel La Lumiere,Negative
 MarsPens√©,Carmel La Lumiere,Negative
 Abat la discrimination,Carmel La Lumiere,Negative
 Abat la violence,Carmel La Lumiere,Negative
 √† la,Carmel La Lumiere,Negative
 International Womens Day,CLL Ireland,Negative
 CLL    tcoaGCqafQMn,Targeted Oncology,Negative
   yom history,achraf miry,Positive
 antiCLL vaccine,Andrew Schorr,Negative
 Constantine L Tam MD,Targeted Oncology,Negative
 LOVE,Mahmoud Turki,Negative
 MOVIE lt,Mahmoud Turki,Negative
 Nurse Practitioner,GetFaPrPhysJobs,Positive
 Physician Assistant Chronic Ly,GetFaPrPhysJobs,Positive
 Family Practice,GetFaPrPhysJobs,Positive
 Physician Jobs,GetFaPrPhysJobs,Positive
 inperson,Patient Power,Negative
 Prof Anna Schuh Chair,Nick,Negative
 UK CLL Forum Unmet,Nick,Negative
   Forum,CLLSA,Negative
   Forum,AbbVie Canada,Negative
 Annual   Meeting,CLLSA,Negative
 profile,CLLSA,Negative
 CLL journey amp benefit,CLLSA,Negative
 TGTX CEO,Biotech2050,Negative
 BCell diseases,Biotech2050,Negative
 Hey,Dell üò∑,Positive
 motivates,Jah Kuu,Negative
 New Video Review,CryptoLiveLeak,Negative
 Token   Airdrop Statistics Review,CryptoLiveLeak,Negative
 BTKCys mutations,Anna Deveau,Negative
   Activity,CureHuntr,Negative
 Frontline Venetoclax,CureHuntr,Negative
 Frontline Venetoclax,TrialBulletin,Negative
 Young Fit Patients,CureHuntr,Negative
 Young Fit Patients,TrialBulletin,Negative
 Condition Summary Chronic Myeloid Leukemia,TrialBulletin,Negative
 PanCanadian Oncology Drug Review,RazzleTazzle,Negative
 Oral Therapy,RazzleTazzle,Negative
   Ian W Flinn MD PhD,Targeted Oncology,Negative
 CLL Token Review,CryptoLiveLeak,Negative
 CoinFreakzTM     CLL,CryptoLiveLeak,Negative
 CART CLL patient,Teresa Bau,Positive
 Farmers farm workers landscape professionals,Matthews & Associates,Negative
 CLL Airdrop,CryptoLiveLeak,Positive
 Statistics,CryptoLiveLeak,Negative
 BNCP,TrialBulletin,Negative
 Ibrutinib Status,TrialBulletin,Negative
   Prof Massimo Degano Les liaisons,Dip. di Biotecnologie e Bioscienze - UNIMIB,Positive
 LongTerm Ibrutinib Yields,Christopher Steer,Negative
 LongTerm Ibrutinib Yields,DR.ARUN ACHUTHAN,Negative
 Deep Durable Responses,Christopher Steer,Negative
 Deep Durable Responses,DR.ARUN ACHUTHAN,Negative
 Social Studies student Lorraine,CLL Warwick Uni,Negative
 Symptomatic Chronic Lymphocytic Leukemia,Cancer News,Positive
 Symptomatic Chronic Lymphocytic Leukemia,E Lambrechts,Negative
 Symptomatic Chronic Lymphocytic Leukemia,CureHuntr,Negative
 Ib trials,Cancer News,Positive
 Quand une personne se,Carmel La Lumiere,Negative
 sup√©rieure aux autres,Carmel La Lumiere,Negative
 Cela,Carmel La Lumiere,Negative
 est d√ª,Carmel La Lumiere,Negative
 Teisha Helgerson,Triche,Positive
 LongTerm Ibrutinib Yields Deep Durable Responses,Medical HotSpot,Positive
 nd Annual International Congress,PER,Negative
 ¬Æ Focus,PER,Negative
 Leukemias Lymphomas,PER,Negative
 Myeloma,PER,Negative
 Myeloma,Matthews & Associates,Negative
 Atef Hsini,Mahmoud Turki,Negative
 ya khouya p lt,Mahmoud Turki,Negative
 Blood Commentary MRD negativity,Blood Journal,Negative
 surrogate,Blood Journal,Negative
 surrogate,"Raul Cordoba, MD, PhD",Negative
 boat,Higher Ground at Lake Louise,Negative
 John   campers,Higher Ground at Lake Louise,Negative
 Flinn Highlights,CancerWallonia,Negative
 poignant dayA day,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
   IbrutinibKombinationen,Medical Tribune,Positive
 vor allem,Medical Tribune,Positive
 der Erstlinie erfolgversprechend,Medical Tribune,Positive
 FC Dallas,Elizabeth Castillo,Positive
 Am√©rica,Elizabeth Castillo,Positive
 Frisco,Elizabeth Castillo,Positive
 Mission,Caldicott Computing,Positive
 rover,Caldicott Computing,Positive
 Mars,Caldicott Computing,Positive
 Constantine S Tam MD,Targeted Oncology,Negative
 phase III DUO trial,Targeted Oncology,Negative
 JAMA,JAMA Network Open,Negative
 NetworkWhat,JAMA Network Open,Negative
 baseline features,JAMA Network Open,Negative
 Chris   Nora Larson,Patient Power,Negative
 RCC regimen,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 rituximab maintenance,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 rituximab maintenance,ALI ALAHMARI.,Negative
 rituximab maintenance,Cancer Papers,Negative
 continents share experience,CLL Advocates Network,Negative
 ONA,Lymphoma Canada,Negative
 outcomes quality,US Oncology Network,Negative
 Necrobiotic xanthogranuloma,Cancer Papers,Negative
 III Drugs,Feel on,Negative
 III Drugs,Âø´ÈÅ©ÂÆ∂ÈõªLife,Negative
 III Drugs,nsure io,Positive
 III Drugs,„Åä„ÅÑ„Åó„ÅÑÁæéÈ£üÁîüÊ¥ª,Positive
 III Drugs,Seattle's Banker,Negative
 III Drugs,iTruck NEWS,Positive
 III Drugs,COPD News,Negative
 III Drugs,Sylvia Joyner,Positive
 Yaas Poster,Michael Moles,Positive
 ASM,Michael Moles,Positive
 Liverpool meeting,Michael Moles,Positive
 Hematologist ‚Äì Chronic Lymphocytic,SnackBaby,Positive
 Landscape    Business Wire press release,nsure io,Positive
   Relapsed Chronic Lymphocytic Leukemia CLL,ANTELLIS,Positive
 Phase III Drugs Landscape,ANTELLIS,Positive
 Phase III Drugs Landscape,BusinessWireServices,Positive
 Phase III Drugs Landscape,Business Wire-Health,Positive
 Phase III Drugs Landscape,The Pharmaceutical Marketing Group,Negative
 Phase III Drugs Landscape,Drug Delivery News,Negative
 Phase III Drugs Landscape,Âø´ÈÅ©ÂÆ∂ÈõªLife,Negative
 Phase III Drugs Landscape,Danvantri Farma,Negative
 Phase III Drugs Landscape,Feel on,Negative
 Phase III Drugs Landscape,„Åä„ÅÑ„Åó„ÅÑÁæéÈ£üÁîüÊ¥ª,Positive
 Phase III Drugs Landscape,BusinessWire-Science,Negative
 Phase III Drugs Landscape,nsure io,Positive
   Daratumumab,CureHuntr,Negative
 Symptomatic Chronic Lymphocytic Leukemia Status,TrialBulletin,Negative
   Karyotypic complexity,BVirtual Murciasalud,Negative
 Pirates baseball,Amy Ramos,Negative
 La regulaci√≥n microambiental del,Manuel Muro,Negative
 indolencia de la leucemia linfoc√≠tica cr√≥nica Microenvironmental regulation,Manuel Muro,Negative
 Microenvironmental Regulation,Human Immunology News,Negative
 ILRIL,Human Immunology News,Negative
 Axis Overrides Chronic Lymphocytic Leukemia Indolence,Human Immunology News,Negative
 snow,CLL Warwick Uni,Negative
 snow,Higher Ground at Lake Louise,Negative
 meantime,CLL Warwick Uni,Negative
 BCell Chronic Lymphocytic Leukemia Market Drug Mechanism,patesalo,Positive
 Action Patent Details Major Competitors,patesalo,Positive
 Healthcare Journal,patesalo,Positive
 inheritance,CLL Ireland,Negative
 regions,CLL Ireland,Negative
 Seminar Prof M Hallek amp B Eichhorst,"Raul Cordoba, MD, PhD",Negative
 Nearly half,Roche,Negative
 spring season,Amy Ramos,Negative
 VIDEO Cessation,VJHemOnc,Negative
 Chronic Lymphocytic LeukemiaA Pooled Analysis,Mahmoud Aljurf,Negative
   novel PIKŒ¥,"Raul Cordoba, MD, PhD",Negative
 casein kinaseŒµ inhibitor,"Raul Cordoba, MD, PhD",Negative
 Lymphoma amp CLL Patients,Lymphoma SA,Positive
 Chronic Lymphocytic Leukemia Optimization,Women's Publications,Positive
 Chronic Lymphocytic Leukemia Optimization,Clin Dermatol Res J,Positive
 Chronic Lymphocytic Leukemia Optimization,Clin Image Case Rep,Positive
 Approach,Women's Publications,Negative
 Approach,Clin Dermatol Res J,Positive
 Approach,Clin Image Case Rep,Negative
 Approach,Immuno-Oncology,Negative
 Approach,Patient Power,Negative
 Lymphoma CLL patients,Lymphoma SA,Positive
 families caregivers,Lymphoma SA,Positive
 Survey,Lymphoma SA,Positive
 Survey,Lymphoma News Today,Positive
 Survey,BioNews,Negative
 signif,JAMA Oncology,Negative
 CARE Winter,CARE‚Ñ¢ Education,Negative
 development drug target mechanism,ABNewswire,Negative
 development drug target mechanism,SouthernIndiaReporte,Positive
 development drug target mechanism,New Jersey Headlines,Positive
 action MoA route,ABNewswire,Negative
 action MoA route,SouthernIndiaReporte,Positive
 action MoA route,New Jersey Headlines,Positive
 administration RoA,ABNewswire,Negative
 administration RoA,SouthernIndiaReporte,Positive
 administration RoA,New Jersey Headlines,Positive
 ROR Update,Oncology Tube,Negative
 Crowded house,"Raul Cordoba, MD, PhD",Negative
 cell therapy,"Raul Cordoba, MD, PhD",Negative
 cell therapy,CLL Ireland,Negative
 cell therapy,Lymphoma Hub,Negative
 Spanish Group,"Raul Cordoba, MD, PhD",Negative
   Derivates,PROvendis GmbH,Negative
 Roberts,"Mike Thompson, MD, PhD, FASCO",Negative
 JAMA Network Complete Response,JAMA Network Open,Negative
 nearly Marchthat,Continuous Lifecycle London (online),Negative
 clock,Continuous Lifecycle London (online),Positive
 clock,Atlas of Science,Positive
   tix,Continuous Lifecycle London (online),Positive
 Grab,Continuous Lifecycle London (online),Positive
 BCell Chronic Lymphocytic Leukemia Global Pipeline Review H,Red Newswire,Positive
   Lo√Øc Ysebaert,@sehh_es,Negative
 B Tcell effects,@sehh_es,Negative
 year student Maura MurrayReeve,CLL Warwick Uni,Negative
   future scenario,"Raul Cordoba, MD, PhD",Negative
 REDOX,Prof John,Negative
 XEME Clinical Trials Chronic Lymphocytic Leukemia,XEME Biopharma Inc.,Positive
 GC    Richter transformation,ImmuneGCPapers,Positive
 MicroRNAp Overexpression,Hematopoiesis,Positive
 Peripheral Blood Mononuclear Cells,Hematopoiesis,Positive
 Peripheral Blood Mononuclear Cells,Cancer Papers,Negative
 Novel Independent Molecular Biomarker,Hematopoiesis,Positive
 Umbralisib Promising Therapy,Lymphoma Canada,Negative
 pace,BSI America,Negative
 BSIs,BSI America,Positive
 Fortbildning p√• g√•ng,Jan Holmg√•rd,Positive
 v√•ren,Jan Holmg√•rd,Positive
 √§r det Sursik skola som √∂ppnar,Jan Holmg√•rd,Positive
 Fancy joining team CLLSA,CLLSA,Positive
    Contact Sarah,CLLSA,Positive
 membershiporguk,CLLSA,Positive
 Firstinhuman,The Lancet Oncology,Negative
 online   Œ¥,The Lancet Oncology,Negative
 casein kinaseŒµ,The Lancet Oncology,Negative
 Postdoc position,All Jobs,Negative
   stiller med spennende abstract,Lars M√∏rland Knudsen,Positive
 NANO,Lars M√∏rland Knudsen,Positive
 Maintenance Rituximab,Suvir Singh,Positive
 accumulating evidence,Suvir Singh,Positive
 Especially elderlyor,Suvir Singh,Positive
 Verastem Submits NDA,Medicalnewser.com,Negative
 Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Ly,Medicalnewser.com,Negative
 Umbraslisib,COPD News,Negative
 PIKdelta inhibitor umbralisib TGR,COPD News,Negative
 Whitelist,CryptoLiveLeak,Negative
   CLL Airdrop,CryptoLiveLeak,Negative
 st    CLL,CryptoLiveLeak,Negative
 mannou ltTickets,Mahmoud Turki,Negative
 experts Inperson,Patient Power,Negative
 TICKETS,Mahmoud Turki,Negative
 Octrooi Biogen,IE-Forum,Positive
 voor gebruik rituximab,IE-Forum,Positive
 failed rounds,CLL Ireland,Negative
 Chemotherapy Bob Azopardi,CLL Ireland,Negative
 exhausted phenotype,"Raul Cordoba, MD, PhD",Negative
 GraftVersusLeukemia Responses,ALI ALAHMARI.,Negative
 Natural Killer Cell NK KIR Immunogenetics CIBMTR Analysis,ALI ALAHMARI.,Negative
 „Åì„Åì„Åæ„Åß„Åó„Å£„Åã„ÇäËß£Èáà„Åó„Çà„ÅÜÔºÉCLLÔºÉÊúùÊó•Êñ∞ËÅû,Ë°ÄÊ∂≤ÂÜÖÁßëÂåª„ÄÄ‰∏≠Êùë„ÄÄÂπ∏Âó£,Positive
 Tigres,Replay Mx,Positive
 esta noche,Replay Mx,Positive
 los universitarios,Replay Mx,Positive
 Herediano,Replay Mx,Positive
 el estadio Eladio Rosabal,Replay Mx,Positive
 Costa Rica,Replay Mx,Positive
 ILÂèóÂÆπ‰ΩìÁô∫ÁèæÂ∫¶„ÅØ,silexÁü•„ÅÆÊñáÁåÆ„Çµ„Éº„Éì„Çπ,Positive
 Veratsems NDA appication,Neil Sankar,Positive
 Philadelphia chromosome,L a b t h o l o g y üî¨,Positive
 Philadelphia chromosome,Lab Test,Negative
 failed chemotherapy,Weill Cornell Medicine,Positive
 Bob Azopardi,Weill Cornell Medicine,Positive
 Bob Azopardi,Andrew Schorr,Negative
 Low T syndrome,Cancer Papers,Negative
 chromosome p deletion,ÿØ.ÿ®ÿØÿ± ÿπÿ®ÿØÿßŸÑŸÇÿßÿØÿ±,Positive
 chromosome p deletion,Targeted Oncology,Negative
 realworld analysis,Lymphoma Hub,Positive
 ibrutinib safety,Lymphoma Hub,Negative
 storytelling,CLL Warwick Uni,Negative
 freetime,CLL Warwick Uni,Negative
 Gateway Information Session,CLL Warwick Uni,Negative
 Feburary,CLL Warwick Uni,Negative
 Cortisol catabolism,EurekaMag,Negative
 EARN CME,Oncology Times,Negative
   blog,CreativeLivingLondon,Negative
 Ski,CreativeLivingLondon,Positive
 CXCR,Frontiers Immunology,Negative
 Immunoregulatory Function,Frontiers Immunology,Negative
 Hila,Frontiers Immunology,Negative
 Shaim Zeev Estrov,Frontiers Immunology,Negative
 David Harris Mayra Hernandez Sanabria Zhiming Liu Peter Ruvolo Phillip Thompson,Frontiers Immunology,Negative
 OBrien Covers Evolution,CancerWallonia,Negative
 OBrien Covers Evolution,Targeted Oncology,Negative
 OBrien Covers Evolution,COPD News,Negative
 High CancerSpecific Stress,CLL Ireland,Negative
 Psychological Intervention,CLL Ireland,Negative
 Online Inperson registration,Patient Power,Negative
 Feat Drs,Patient Power,Negative
 SingleAgent Ibrutinib,Mahmoud Aljurf,Negative
 SingleAgent Ibrutinib,sandrineman,Negative
 SingleAgent Ibrutinib,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Positive
 SingleAgent Ibrutinib,Garbi√±e Lizeaga,Negative
 SingleAgent Ibrutinib,Oncology,Negative
 Year Experience,Mahmoud Aljurf,Negative
 Year Experience,SSBMT ÿßŸÑÿÆŸÑÿßŸäÿßÿßŸÑÿ¨ÿ∞ÿπŸäÿ©,Negative
 Year Experience,"Raul Cordoba, MD, PhD",Negative
 Year Experience,Garbi√±e Lizeaga,Negative
 Treatment Effects w Dr,Patient Power,Negative
 Camp Talent Shows,Higher Ground at Lake Louise,Negative
 aan de wereldwijde enqu√™te onder,Hematon,Negative
 promising   leukaemia trial treatment,CLL Ireland,Negative
 Current Treatment Strategies,Targeted Oncology,Negative
 Verastem Submits New Drug Application,Hematopoiesis News,Negative
 Verastem Submits New Drug Application,Cancer Stem Cell News,Negative
 Verastem Submits New Drug Application,SNN Network,Negative
 Verastem Submits New Drug Application,BusinessWireProducts,Negative
 Verastem Submits New Drug Application,Financial Buzz,Negative
 Verastem Submits New Drug Application,Business Wire-Health,Negative
 Verastem Submits New Drug Application,BusinessWire-Science,Negative
 Verastem Submits New Drug Application,The Pharmaceutical Marketing Group,Negative
 w Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma amp Follicular Lymphoma,Hematopoiesis News,Negative
 w Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma amp Follicular Lymphoma,Cancer Stem Cell News,Negative
 Current Approaches,Targeted Oncology,Negative
 Diagnosis Risk Stratification,Targeted Oncology,Negative
 VIDEO ‚Äú chemosparing ‚Äù MRDdriven strategy,VJHemOnc,Negative
 Avicenne Hospital,VJHemOnc,Negative
   BRD,AACR,Positive
 voices,Patient Power,Negative
 cancer research amp,Patient Power,Negative
 Kayleigh,CLL Warwick Uni,Negative
   Degree Student,CLL Warwick Uni,Negative
 rheumatoid arthritis,Abigail Jones,Positive
 Research Articles Microenvironmental regulation,Hampshire,Positive
 Research Articles Microenvironmental regulation,Linguainfo Services,Positive
 LongTerm Data,Targeted Oncology,Negative
 CLL Landscape,Targeted Oncology,Negative
 CLL Landscape,OncLive SOSS,Negative
 Lead Investigator,Targeted Oncology,Negative
 IbrutinibFCR Combo Highlights Significant Findings,Targeted Oncology,Negative
 Daves Cancer,Donna Penn,Positive
 Fancy joining team,CLLSA,Negative
 Ectopic ILT,Vinci-Biochem Srl,Positive
 Ectopic ILT,Blood Journal,Negative
 Ectopic ILT,NPCE,Positive
 BCRdependent activation,Vinci-Biochem Srl,Positive
 BCRdependent activation,Blood Journal,Negative
 BCRdependent activation,NPCE,Positive
 Akt,Vinci-Biochem Srl,Positive
 Akt,Blood Journal,Negative
 Akt,NPCE,Positive
 cancer landscape,Illumina Live Events,Positive
 Maman Ramsay,Somaieh Hedayat,Positive
 ‚≠ê Ô∏èÁöáÂ≠¶È§®Â§ßÂ≠¶ „Åø„Åà„Åæ„Å°„Ç≠„É£„É≥„Éë„Çπ,Âú∞Âüü√óÂ≠¶Áîü„Çµ„Éù„Éº„Çø„Éº„ÄéSBC„Äè,Positive
 „Çµ„Éà„Ç∑,Âú∞Âüü√óÂ≠¶Áîü„Çµ„Éù„Éº„Çø„Éº„ÄéSBC„Äè,Positive
 reasons,"chadi nabhan MD, MBA, FACP",Negative
 reasons,dough,Negative
 Susan OamprsquoBrien MD,COPD News,Negative
 RESONATE studies,COPD News,Negative
 RCC induction,ALI ALAHMARI.,Negative
 RCC induction,Cancer Papers,Negative
 ÿ•ŸäŸäŸäŸäÿ¨ÿß ŸÑŸÑ,Mahmoud Turki,Negative
 lt F√©vrier,Mahmoud Turki,Negative
 Phase III Drugs Landscape Report,Business Wire-Health,Negative
 Phase III Drugs Landscape Report,Financial Buzz,Negative
 Phase III Drugs Landscape Report,The Pharmaceutical Marketing Group,Negative
 DUBLINBUSINESS,Business Wire-Health,Negative
 New Blog Post,Higher Ground at Lake Louise,Negative
 Venetoclax potential,Lymphoma Hub,Negative
 relapsed   patients,Lymphoma Hub,Negative
 relapsed   patients,VJHemOnc,Negative
 relapsed   patients,"Anne Villeneuve-Magness, PhD",Positive
 XVII International Workshop,üÖæ Jaksic,Negative
 XVII International Workshop,Cancer Papers,Positive
 XVII International Workshop,ACGS,Positive
 VIDEO Results,VJHemOnc,Negative
 Chief Schools Inspector,CLL Warwick Uni,Negative
 Social Workers,CLL Warwick Uni,Negative
 Calin Lab,Viracta Therapeutics,Positive
 MD Anderson associates EBVpositivity,Viracta Therapeutics,Positive
 shortened survival,Viracta Therapeutics,Positive
 EpsteinBarr,Viracta Therapeutics,Positive
 EpsteinBarr,Community Blood Ctr,Positive
 EpsteinBarr,MD Anderson Cancer Center,Negative
 EpsteinBarr,EBioMedicine ‚Äì Published by The Lancet,Positive
 EARN CME Genomics,Oncology Times,Negative
 ibutrinbvenatoclax,AliKat üíô,Positive
 reach,AliKat üíô,Positive
 BBC article,CLL Ireland,Negative
 Simon Coxs involvement,CLL Ireland,Negative
 st   trial,CLL Ireland,Negative
 nonchemo drugs,CLL Ireland,Negative
 Radio   UK,CLL Ireland,Negative
 Digital Radio,CLL Ireland,Negative
 IE,CLL Ireland,Negative
 web link eg,CLL Ireland,Negative
 SingleAgent,"Raul Cordoba, MD, PhD",Negative
 SingleAgent,Oncology Tube,Negative
 Frontiers   Differences,gilbert c faure,Negative
 Expansion Potential,gilbert c faure,Negative
 Expansion Potential,Frontiers Immunology,Negative
 Expansion Potential,TumorImmunoPapers,Negative
 Naive Chimeric Antigen Receptor T Cells,gilbert c faure,Negative
 Naive Chimeric Antigen Receptor T Cells,Frontiers Immunology,Negative
 Naive Chimeric Antigen Receptor T Cells,TumorImmunoPapers,Negative
 Healthy Donors,gilbert c faure,Negative
 Healthy Donors,Frontiers Immunology,Negative
 Healthy Donors,TumorImmunoPapers,Negative
 Capture,TCRT Cancer Journal,Positive
 AmpliconBased Approaches,TCRT Cancer Journal,Positive
 Targeted NextGeneration Sequencing Pipeline,TCRT Cancer Journal,Positive
 Lymphoma Management,TCRT Cancer Journal,Positive
 Karen Koehler,CLL Ireland,Negative
 BBC News,BCAwareness,Positive
 BBC News,Revd Fiona Jenkinsonüá≥üáµ,Positive
 BBC News,Hannah Davis,Positive
 BBC News,Mike Durham -The Siesta Murders,Positive
 promising leukaemia trial treatment,BCAwareness,Negative
   Drug Heads,Plexus Ventures,Negative
    story amp,CLL_Fightersüéó,Negative
        rangers,German Cheer Dad (GCD),Negative
 „Éª„Éª„Éª,German Cheer Dad (GCD),Negative
 VIDEO Retrospective multicenter analysis,VJHemOnc,Negative
 ERIC recommendations,"Raul Cordoba, MD, PhD",Negative
 TP mutation analysis,"Raul Cordoba, MD, PhD",Negative
 TP mutation analysis,Oxford Nanopore,Positive
   seg,œÄ,Positive
 ‚ôÇ Ô∏è    darlo vuelta,œÄ,Positive
 ASH   Predicting Mechanisms,CellworksLife,Positive
 Stacey Worthy,Aimed Alliance,Positive
 segment,Aimed Alliance,Positive
 insurance companies,Aimed Alliance,Positive
 Chronic Lymphocytic Leukemia News,Aimed Alliance,Positive
 ‚Äú Preceptorship,"Raul Cordoba, MD, PhD",Negative
 Specialized Program,"Raul Cordoba, MD, PhD",Negative
 Clinical Excellence,"Raul Cordoba, MD, PhD",Negative
 Lymphoma Unit Fundacion Jimenez Diaz University Hospital,"Raul Cordoba, MD, PhD",Negative
 Madrid,"Raul Cordoba, MD, PhD",Negative
 Subscribe,Lymphoma Hub,Negative
 patient story,Nick,Negative
 patient story,Lymphoma Coalition,Negative
   diagnosis Travel,Nick,Negative
 depression,Nick,Negative
 ect,Angela Smith,Positive
 Yondelis   Leucemia Linfoc√≠tica Cr√≥nica,Pharma Jonpi .,Negative
 Chronic Lymphocytic Leukemia CLL   Building,Pharma Jonpi .,Negative
 Vitro Data,Pharma Jonpi .,Negative
 WellKnown Clinical Features,Pharma Jonpi .,Negative
 Mantlecell Lymphoma,Renal Cell Carcinoma,Negative
 Mantlecell Lymphoma,CureHuntr,Negative
 Mantlecell Lymphoma,TrialBulletin,Negative
 Routine Clinical Practice,Renal Cell Carcinoma,Negative
 Routine Clinical Practice,CureHuntr,Negative
 PAPER,CanadianLightSource,Positive
 BRD profiling,CanadianLightSource,Positive
 Submits New Drug Application,BioRunUp,Negative
 Routine Clinical Practice Status Active,TrialBulletin,Negative
 Condition Summary Leukemia Lymphocytic Chronic BCell Lymphoma MantleCell,TrialBulletin,Negative
 Submits Treatment Patients,CamTheMan,Positive
 Novartis plans,CLL Ireland,Negative
 ofatumumab Arzerra,CLL Ireland,Negative
 ofatumumab Arzerra,Lymphoma Research Foundation,Negative
 BRIEFVerastem Submits Marketing Application,Davalyn Corporation,Negative
 VERASTEM SUBMITS NEW DRUG APPLICATION,Davalyn Corporation,Negative
 RELAPSED REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIASMALL LYMPHOCYTIC LYMPHOMA,Davalyn Corporation,Negative
 BOSTONBUSINESS WIREVerastem Inc NASDAQ,Business Wire-Health,Negative
 Submits NDA,Odi Bruckman,Negative
 RR Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,Odi Bruckman,Negative
 BBC News story,BSH - Haematology,Positive
 Professor Hillmens   research,BSH - Haematology,Positive
 VIDEO Frontline use,VJHemOnc,Negative
 Gisteravond op de acute opname,Jeroen Schraven,Positive
 gewerkt,Jeroen Schraven,Positive
 AEGLEs Webinar,AEGLE,Negative
 DEMO,AEGLE,Negative
 AEGLEs Platform,AEGLE,Negative
   Promising developments,Thomas Leavitt,Positive
 Alarmist   headline,cycleopticüíôüíö,Positive
   charity,Helen Jane Mee,Negative
 Remarkable responseparadigm shift,CLLSA,Negative
 ASH conference,CLLSA,Negative
 uncertainty,CLLSA,Negative
 unpredictability Watch amp Worry,CLLSA,Negative
 mainstream media,Hannah Davis,Positive
 que n         M   faltar nessa festa √© Antarctica gelaaaada,Lucas,Positive
 l ll,Lucas,Positive
 health amp wellbeing conference,LiveYourLife,Negative
 Cooles Bild mit einigen CLLDoppelstartern zur RM West Repost Wir,German Cheer Dad (GCD),Negative
 Dance Team,German Cheer Dad (GCD),Negative
 unsere,German Cheer Dad (GCD),Negative
 CLL Peewee Dancers,German Cheer Dad (GCD),Negative
 QUIZFINAL   FISH workup,Dr George Paterakis,Positive
 FL MCL MZL,Dr George Paterakis,Positive
 LWW Journals,Genomics new,Positive
 LWW Journals,Genomics Plaza,Positive
 LWW Journals,Genomics watch,Positive
 Highdose Ibrutinib,CureHuntr,Negative
 Highdose Ibrutinib,TrialBulletin,Negative
 Progressive Disease,CureHuntr,Negative
 Progressive Disease,TrialBulletin,Negative
 Single Agent Ibrutinib,CureHuntr,Negative
 Single Agent Ibrutinib Status,TrialBulletin,Negative
 Condition Summary Chronic Lymphocytic Leukemia Small Lymphocytic Lympho,TrialBulletin,Negative
 Dr CatherineThese,@EbruTVKenya,Positive
 Blood cancers,the limbic,Positive
 funding boost,the limbic,Positive
   amp colleagues,Weill Cornell Medicine,Positive
 monitoring,Weill Cornell Medicine,Positive
   son,Joshashland,Positive
 Britain,CLLSA,Positive
 Britain,Lifelong Learning,Positive
 Britain,CFOLD,Positive
   fact,Leukaemia Care,Negative
 Clinical   Specialist,CLLSA,Positive
 amp   support,CLLSA,Positive
 Comprehensive DNA Methylation Analysis,lncRNApapers,Positive
 MethylCpGbinding Domain Capturebased Method,lncRNApapers,Positive
 World Cancer Day,RTI Health Solutions,Negative
 World Cancer Day,Nick,Negative
 World Cancer Day,Awkward in Scrubs,Positive
 Hair,CLL Ireland,Positive
 Hair,Ana Rosa Rubio,Positive
 Hair,Christopher Steer,Negative
 Hair,JAMA Network,Negative
 Hair,JAMA Dermatology,Positive
 Hair,M Jos√© Mart√≠nez Bautista,Positive
 Nail,CLL Ireland,Positive
 Longterm Therapy,CLL Ireland,Negative
 pilot,Nick,Negative
 predictors,Nick,Negative
 predictors,VJHemOnc,Negative
 Loophole,CancerWallonia,Negative
 Loophole,CCS,Positive
 Loophole,ckata,Positive
 Loophole,Clinical Oncology 2019,Positive
 Loophole,crazyarchitect.13,Positive
 Loophole,Civil Engineering,Positive
 Loophole,NaturaTech,Positive
 Loophole,Alex,Negative
 Loophole,Sci24H,Positive
 Loophole,Jane Dove TalentRoom,Positive
 Loophole,Sohail Ahmad,Positive
 Loophole,üòä Bill Ballentine,Positive
 Loophole,Crwe World,Negative
 Loophole,Parag Paleja,Positive
 Loophole,Robert Caro,Positive
 Loophole,Nicholas JVPR,Positive
 Loophole,Cesar Perez,Positive
 Loophole,JV Public Relations NY,Positive
 Loophole,TheBioConnection,Positive
 BCell Chronic Lymphocytic Leukemia Market Dynamics Segments Size,Diet Recipes & News,Positive
 Demand,Diet Recipes & News,Positive
 Arzerra discontinuation,the limbic,Negative
 CE,APSHO,Negative
 Pump,APSHO,Negative
 APSHO Educational Initiative,APSHO,Negative
 Targets,APSHO,Negative
 Richard Carwardine author,SIU Press,Negative
 Sense,SIU Press,Negative
 Humor,SIU Press,Negative
   Abraham Lincoln Institute Book Prize,SIU Press,Negative
 Reproducible diagnosis,üÖæ Jaksic,Positive
 BRD,AACR,Positive
 IbrutinibTreated Chronic Lymphocytic Leukemia Patients,"Raul Cordoba, MD, PhD",Negative
 United States RealWorld Analysis,"Raul Cordoba, MD, PhD",Negative
 press Largest series,"chadi nabhan MD, MBA, FACP",Negative
 Novartis Takes s Leukemia Drug,A. Vroom - Ten Wolde,Negative
 Low Use,A. Vroom - Ten Wolde,Negative
 Genmab promising,A. Vroom - Ten Wolde,Negative
 CCS researchers,CCS,Positive
 VIDEO MURANO safety,VJHemOnc,Negative
 transition,"Raul Cordoba, MD, PhD",Negative
 transition,Francesco Turturro,Negative
 Clinical Practice Recommendations,"Raul Cordoba, MD, PhD",Negative
 Clinical Practice Recommendations,"Dr T. Comeau , MD",Negative
 Allogeneic Hematopoietic Cell Transplantation,"Raul Cordoba, MD, PhD",Negative
 Behalf,"Raul Cordoba, MD, PhD",Negative
 Guidelines Committee,"Raul Cordoba, MD, PhD",Negative
 Combination Therapy Benefit Subset,CLL Ireland,Negative
 block CDb activation,AJMC,Negative
 tumor cells,AJMC,Negative
 tumor cells,VJHemOnc,Negative
 lymphoid organs,AJMC,Negative
 lymphoid organs,jt120651,Positive
 WAIHA,IM Board review,Positive
 NEW STUDY,MD Anderson Leukemia,Positive
 NEW STUDY,Lisa Palacios,Negative
 DoseAdjusted EPOCHR,MD Anderson Leukemia,Negative
 DoseAdjusted EPOCHR,Lisa Palacios,Negative
 Richters syndromePI Philip Thompson,MD Anderson Leukemia,Negative
 tcocFssbQiTBk,MD Anderson Leukemia,Negative
 CLL progressing,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 KOL Kathryn Kolibaba,Biotech2050,Negative
 Dr Ansell,Rawad Elias - Hartford #GeriOnc,Positive
 loophole,Dahir Galabgure,Positive
 loophole,Right Write,Positive
 loophole,EMJ Hematology,Negative
 loophole,Biyoloji,Positive
 loophole,Adetola A. Kehinde (IGBOMINA),Positive
 loophole,Victor Okwudiri,Positive
 loophole,Remy Barrios Smith,Positive
 loophole,Lymphoma Canada,Negative
 loophole,Junaid Mirza,Positive
 loophole,Medicalnewser.com,Negative
 loophole,DentalCinicList,Positive
 loophole,"Kerry J. Laing, PhD üë©üèª‚Äçüî¨ üè¥Û†ÅßÛ†Å¢Û†Å≥Û†Å£Û†Å¥Û†Åø üá∫üá∏",Positive
 loophole,Medical Xpress,Negative
 Cytogeneticmutation profile,Genetic Counselling,Positive
 VIDEO CAR Tcell development,VJHemOnc,Negative
 th grade week,Higher Ground at Lake Louise,Negative
 Dawn cabin,Higher Ground at Lake Louise,Negative
 Technique,MDedge Hematology & Oncology,Negative
 Technique,Dave C,Positive
 Technique,KTH,Positive
 Press Proteomics comparison,Molecular & Cellular Proteomics,Positive
 MMSc,WorldCare Medical Second Opinions,Negative
 CLL Cello Group,Ruth Gemmell,Negative
 healthcare expansion,Ruth Gemmell,Negative
 Dr Jorge E Cortes,ACS Journal Cancer,Negative
 Maintenance,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Maintenance,"Raul Cordoba, MD, PhD",Negative
 Maintenance,Oncologie Up-to-date,Positive
 Maintenance,Dr. JOSE VELASQUEZ,Negative
 Maintenance,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Maintenance,Marta Crespo,Negative
 Maintenance,Crown Bioscience,Negative
 remission times,Roche,Negative
 TPA,Oracle Seer #OracleSeer,Positive
 Bcells,Oracle Seer #OracleSeer,Positive
 Bcells,"Raul Cordoba, MD, PhD",Positive
 Bcells,Lymphoma Hub,Negative
 Isolated CNS Blast Crisis,leukemia,Negative
 Dasatinib Therapy,leukemia,Negative
 John F Seymour,ACRF,Positive
 haematology,ACRF,Positive
 ACRF supporters,ACRF,Positive
 nonUS markets,MDedge Hematology & Oncology,Negative
 Ofatumumab Arzerra,Encore BioMed,Positive
 Ofatumumab Arzerra,thasso,Positive
 compassionateuse,Encore BioMed,Positive
 exUS,Encore BioMed,Positive
 TopOur WhatNext,WhatNext.com,Negative
 Susan AshLee amp Dr John Burke,Patient Power,Negative
 Serverless,The Register,Positive
 juno celg,Anna Deveau,Negative
 Genetic Landscape,GEDEFO,Negative
 UltraStable Chronic Lymphocytic Leukemia Patients,GEDEFO,Negative
 immunemediated antiCLL activity,CancerTherapyAdvisor,Negative
 Message,Patient Power,Negative
 Newly Diagnosed   Patients,Patient Power,Negative
 Worker Nora Larson,Patient Power,Negative
 PRIMEs,PRIME Education,Positive
    Alliance Award,PRIME Education,Negative
 Outstanding CE Outcomes Assessment,PRIME Education,Negative
 education amp research teams,PRIME Education,Negative
 Europaweite   Helfen Sie uns ein,Janssen Deutschland,Positive
 Verst√§ndnis f√ºr,Janssen Deutschland,Positive
 Bed√ºrfnisse von,Janssen Deutschland,Positive
 zu erlangen amp teilen Sie uns Ihre Erfahrungen,Janssen Deutschland,Positive
 dieser anonymen min√ºtigen,Janssen Deutschland,Positive
 Umfrage mit,Janssen Deutschland,Positive
 KITE,dough,Negative
 JUNO,dough,Negative
 JUNO,"Raul Cordoba, MD, PhD",Negative
 „Åì„Çì„Å∞„Çì„ÅØOSBC„Çπ„Çø„ÉÉ„Éï„Åß„ÅôÔºÅ„Åì„ÅÆ„Åü„Å≥„ÄÅÊñ∞„Åó„ÅÑÊ¥ªÂãï„Å´Âêë„Åë„Å¶‰∫àÂëäÂãïÁîª„Çí‰ΩúÊàê„Åó„Åæ„Åó„Åü ‚ô™,Âú∞Âüü√óÂ≠¶Áîü„Çµ„Éù„Éº„Çø„Éº„ÄéSBC„Äè,Positive
 tcoNDMbqpUpUa,Âú∞Âüü√óÂ≠¶Áîü„Çµ„Éù„Éº„Çø„Éº„ÄéSBC„Äè,Positive
 WhatNexter,WhatNext.com,Negative
 StillFighting,WhatNext.com,Negative
 patientsWe‚Äôre,Leukaemia Care,Negative
 VIDEO Strategies,VJHemOnc,Negative
 Matthew Davids,VJHemOnc,Negative
 Matthew Davids,Lymphoma Hub,Negative
 Novel   Drugs,Patient Power,Negative
 w Dr Kolibaba,Patient Power,Positive
 Dr Spurgeon,Patient Power,Negative
 bookings,CLLSA,Negative
 members conference,CLLSA,Negative
 Clinical Trial   Medscape Medscape,Clinical Trials,Negative
 Clinical Trial Medscape,Clinical Trials,Negative
 Drug Combination,Radiation Research Society,Positive
 Drug Combination,The Purple Society,Negative
 Chronic Lymphocytic Leukemia NIH,Radiation Research Society,Positive
 Professor Chris Fegan,CLL Ireland,Negative
 Professor Chris Fegan,Leukaemia Care,Negative
 Professor Chris Fegan,Nick,Negative
 Nick Yorke,CLL Ireland,Negative
   patient perspective,CLL Ireland,Negative
 Net Cash,WheelieDealer,Negative
 news Decent business,WheelieDealer,Negative
   report,CLLSA,Negative
   report,Global Pharma News,Negative
   report,Michael R Bishop,Positive
 Priority recommendations,CLLSA,Negative
 report inc,CLLSA,Negative
   Strategy,CLLSA,Negative
 juno,Anna Deveau,Positive
 named CNS,CLLSA,Positive
 care Work,CLLSA,Negative
 Clinical   Specialist CNS,CLLSA,Negative
 report Access,CLLSA,Negative
 priority recommendation,CLLSA,Negative
 amp wait wampw,CLLSA,Negative
 amp ‚Äú wampw,CLLSA,Negative
   Survivors,Lisa Palacios,Negative
   Survivors,MD Anderson Leukemia,Negative
 Life Expectancy Quality,Lisa Palacios,Negative
 Life Expectancy Quality,MD Anderson Leukemia,Negative
 Life Expectancy Quality,Dr Amrish,Positive
    Recurrent Cytogenetic Abnormalities,Sumit Middha,Positive
   care,CLLSA,Positive
 Treatment advances,Medivizor,Negative
    tune,CLLSA,Negative
 Echo Project Management Group Inc,EchoPMG,Positive
 ‚Ñ¢ Ô∏è,EchoPMG,Positive
 Topics,EchoPMG,Positive
 ‚úà Ô∏è Chicago,Amanda Kruse RD,Positive
 Tissino et al,JExpMed,Positive
 Blood JournalsCasein Kinase,Philip McCarthy,Negative
 Therapeutic Target,Philip McCarthy,Negative
 Therapeutic Target,Wnt publications,Positive
 Therapeutic Target,SeqComplete,Negative
 tomorrow pm   Care,CLLSA,Positive
 Campaigns Advocacy Officer CLL patient,Leukaemia Care,Negative
 AfterMD,PRIME Education,Negative
 patient caregiver resources,PRIME Education,Negative
 healthamp wellbeing,Helen Jane Mee,Negative
     cancer diagnosis,Helen Jane Mee,Negative
 East,Helen Jane Mee,Negative
 Wexham haematology,Helen Jane Mee,Negative
 mailboxes,Higher Ground at Lake Louise,Negative
   brochures,Higher Ground at Lake Louise,Negative
 tailor treatment,CLL Ireland,Negative
 PhD Nicole Lamanna MD Steven Coutre MD,CLL Ireland,Negative
 stratify patients,CLL Ireland,Negative
 age fitness,CLL Ireland,Negative
 tcoLjzJogS,CLL Ireland,Negative
 nr,LiveYourLife,Negative
 N√§tverkar f√∂r ungdomarnas,Jaakko Helander,Positive
 b√§st√§,Jaakko Helander,Positive
 vi ska b√∂rja,Jaakko Helander,Positive
 teamdagar,Jaakko Helander,Positive
 BBmotivation,Jordan Coss,Positive
 tryouts,Jordan Coss,Positive
 tryouts,3'z Company YT,Positive
 Campbell California,Jordan Coss,Positive
 Chronic Lymphocytic Leukemia Treatment Market Research Report,Paid Search agent,Positive
 Digital Journal,Paid Search agent,Positive
 RiskStratifying Factors,Lurie Cancer Center,Negative
 Chronic Lymphocytic Leukemia PDF Download,Ahmed Gunied,Positive
 firstinclass btk,Anna Deveau,Negative
 ibrutinib refractory,Anna Deveau,Negative
 Archery lessons,Higher Ground at Lake Louise,Negative
 Theodoros Moysiadis,MarieSk≈ÇodowskaCurie,Positive
 VenetoclaxRituximab Outshines Bendamustine Rituximab,CLL Ireland,Negative
   types,ssgch_Miraj,Positive
   types,joeyetta is FERGUSON,Positive
   types,WCM Lymphoma,Negative
 relapsedrefractory chronic lymphocytic   RR CLL,OncologyNurseAdvisor,Negative
 readout data,Biotech2050,Negative
 Large B Cell,Biotech2050,Negative
 Apr√®s plusieurs mois de travail intensif,Clem Lavogez,Positive
 Watch Mollys video,CLL Ireland,Negative
 Un √©pisode par,Clem Lavogez,Positive
 sur la chaine youtube de   Format de   minutes,Clem Lavogez,Positive
 Casein Kinase,Wnt publications,Negative
 Chronic Lymphocytic Leukemia Casein Kinase,Wnt publications,Negative
 Chronic Lymphocytic Leukemia Blood,Wnt publications,Negative
 Authors Janovska P Verner J Kohoutek J Bryjova L Gregorova M Dzimkova M,Wnt publications,Negative
 √ßa l√†,Clem Lavogez,Positive
 ü§´,Clem Lavogez,Positive
 Prof Brigitte Voit,HTxA,Positive
 Dr Michael Boxer,US Oncology Network,Negative
 Dr Michael Boxer,McKesson Corporation,Negative
 Disease characteristics,Elsevier Hematology,Positive
 JUNO data,Anna Deveau,Negative
 Manufacturers Regions Type,Market Research Nest,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market Research Report,Anni,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market Research Report,In the Amys Bloomers,Positive
 Bob Frasca,Seattle DJC,Negative
 Seattle,Seattle DJC,Negative
 founding design partner,Seattle DJC,Positive
 Portlandbased Zimmer Gunsul Frasca,Seattle DJC,Positive
 BCL family members,Lymphoma Hub,Negative
 Casi olvidaba,Monte S,Positive
 la opini√≥n de hoy,Monte S,Positive
 CCS Researchers,CCS,Positive
 Hartmann Lab Contribute,CCS,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market Size Status,1MarketResearch.com,Positive
 ZGF Founding Partner Robert Frasca,ACE,Positive
 ZGF Founding Design Partner Robert Frasca,ACE,Positive
 Portland Ore,ACE,Positive
 Robert Frasca,contractmag,Positive
 founding partner,contractmag,Positive
 Portland Oregon,contractmag,Positive
 este lo conosco,Monte S,Positive
 hace tiempo confien,Monte S,Positive
 w Dr Michael Choi,Patient Power,Negative
 Promising phase II results,Lymphoma Hub,Negative
 Oral Abstract     article,Lymphoma Hub,Negative
 Long Term Followup,Oncology Tube,Positive
 Long Term Followup,Fighting the Fight,Positive
 treatmentVisit,Clinical Oncology 2019,Positive
 EcologyLoophole,CanadaCommunity,Positive
     Loophole,NEWS BI,Positive
     Loophole,News U.S.A.,Positive
     Loophole,News The American,Positive
     Loophole,News U.S. Alert,Positive
     Loophole,Malaio News World,Positive
   Combination Therapy News,Patient Power,Negative
   health amp wellbeing workshop,LiveYourLife,Negative
 Connected Learning,BSI America,Negative
 courses,BSI America,Negative
 Revolutionary Southampton research,Margaret Walker,Negative
 BCell Chronic Lymphocytic Leukemia Market Therapeutic Pipeline,Diet Recipes & News,Positive
 Major Key Growth Analysis,Diet Recipes & News,Positive
   Role,Mol Oncol Res,Positive
 Atypical Morphology,Mol Oncol Res,Positive
     Study,DentalCinicList,Positive
 CLL Researchers,"Kerry J. Laing, PhD üë©üèª‚Äçüî¨ üè¥Û†ÅßÛ†Å¢Û†Å≥Û†Å£Û†Å¥Û†Åø üá∫üá∏",Positive
 Dr Johnston amp Erin Streu,RIOH,Negative
 Hypogammaglobulinemia,RIOH,Negative
 Hypogammaglobulinemia,TumorImmunoPapers,Negative
 Hypogammaglobulinemia,Tran-Der Tan,Positive
 Hypogammaglobulinemia,MDLinx,Negative
 CLL   Watch,Lymphoma Hub,Negative
 TIGIT,NK papers,Negative
 CDT cells,NK papers,Negative
 DUO Trial,Lymphoma Hub,Negative
 duvelisib therapy,Lymphoma Hub,Negative
   host,Lymphoma Research Foundation,Negative
 Progressing,"Raul Cordoba, MD, PhD",Positive
 Day Daily Wrap,Patient Power,Negative
 w Dr Lamanna,Patient Power,Positive
 Gribben,Patient Power,Negative
   Camp Registration,Higher Ground at Lake Louise,Negative
 Finished treatment,LiveYourLife,Negative
 treatment efficacy,ASH,Negative
 treatment efficacy,RTI Health Solutions,Negative
 inservice exposure,VaClaims,Positive
 herbicide agents nonHodgkin,VaClaims,Positive
 lymphoma chronic,VaClaims,Positive
 Christmas tree,Tony Rothwell,Positive
 Fact Chronic lymphocytic,Roche,Positive
 Omar AbdelWahab,VJHemOnc,Negative
 Distribution,Cancer Papers,Positive
 rs genotypes,Cancer Papers,Negative
   CONQUER stories,CONQUER the patient voice,Negative
 Venkatraman Radhakrishnan,Venkatraman Radhakrishnan (Venky),Positive
 Global BCell Chronic,EPR Network,Positive
 Leukemia Treatment Market Analysis,EPR Network,Positive
 w Dr Keating,Patient Power,Positive
 tcoiOwxtVYZoO,Patient Power,Negative
 VIDEO   combination therapies,VJHemOnc,Negative
 booklet,Leukaemia Care,Positive
 booklet,CLL Ireland,Negative
 V√° gina,Robat Taylor Khalifa,Positive
 sua,Robat Taylor Khalifa,Positive
 espera pra comerem te,Robat Taylor Khalifa,Positive
 THC,Cancer Papers,Negative
 Healthy Individuals,Cancer Papers,Negative
 –≤ –ò–∑—Ä–∞–∏–ª–µ–°—Ç–∞—Ç—å—è,–õ–µ—á–µ–Ω–∏–µ —Ä–∞–∫–∞,Negative
 –õ–µ—á–µ–Ω–∏–µ–≤–ò–∑—Ä–∞–∏–ª–µ,–õ–µ—á–µ–Ω–∏–µ —Ä–∞–∫–∞,Negative
 OncologyHematology,PhysiciansFirstWatch,Positive
 OncologyHematology,NEJM Journal Watch,Negative
   Tweet,Hematopoiesis News,Positive
 PTPROt Tyrosine Phosphatase Functions,Hematopoiesis News,Positive
 Tumor Suppressor,Hematopoiesis News,Positive
 BCell Chronic Lymphocytic,Hematopoiesis News,Positive
 Dr Habte Yimer,US Oncology Network,Negative
   Daily Wrap Day,Patient Power,Negative
 amp Dr Mohit Trikha,Patient Power,Negative
 Male,Patient Power,Negative
 CD T Cells,Cancer Papers,Negative
 CD T Cells,Immuno-Oncology,Negative
    Roundtable w research news,Patient Power,Negative
 Early Disease Progression,SurvivalGear,Positive
 Early Disease Progression,Dr Amrish,Positive
 Worse Survival,SurvivalGear,Positive
 Worse Survival,Dr Amrish,Positive
 Rituximab maintenance,Cancer Papers,Negative
 observation,Cancer Papers,Negative
 CLL Survivors,Dr Amrish,Positive
 IbrutinibRefractory,CLL Society Inc.,Negative
 IbrutinibRefractory,Oncology Board,Negative
 Oncology Journal,CLL Society Inc.,Negative
 Oncology Journal,Lymphoma Canada,Negative
 OncHem,NEJM Journal Watch,Negative
 RT healthnfitnews Chronic Lymphocytic Leukemia,Jeff T Bowles,Positive
 Venetoclax Active,Oncology Board,Negative
 Venetoclax Active,Christopher Steer,Negative
 CLL   Cancer Network Venetoclax Active,Oncology Board,Negative
 IbrutinibRefractory CLL Cancer Network,Oncology Board,Negative
 HS soccer player,Glass Soccer,Positive
 hometown,Glass Soccer,Positive
 Leukemia Docs,Glass Soccer,Positive
 Cuando tenga una banda,Pocho,Positive
 hacer un tema que se,Pocho,Positive
 y Bonarda,Pocho,Positive
 IbrutinibFailed Chronic Lymphocytic Leukemia,Lymphoma Canada,Negative
 IbrutinibFailed Chronic Lymphocytic Leukemia,"Meagan Bryan, RN",Negative
         PubMed,CancerWallonia,Negative
 ASH    Highlights,Farid Ahmed PhD,Positive
 Product Description Companies Product,Diet Recipes & News,Positive
   EpiCast Report Chronic Lymphocytic Leukemia Epidemiology Forecast,Cancer News,Negative
 USD   EpiCast Report Chronic Lymphocytic Leukemia Epidemiology Forecast,Cancer News,Negative
 Treat Subtypes,Patient Power,Negative
 amp Dr Spurgeon,Patient Power,Negative
 F Chronic Lymphocytic Leukaemia Absolue lymphocytosis,Pink & Blue,Positive
 Campaigns Advocacy Officer   patient,Leukaemia Care,Negative
 Rebecca Harris,Leukaemia Care,Negative
 Cardiff,Leukaemia Care,Negative
 Vale University Health Board Nick,Leukaemia Care,Negative
 Rebecca,Leukaemia Care,Negative
   Christmas Hampers,Leukaemia Care,Negative
 Terdapat   jenis leukemia,ZAINUDDIN ISHAK,Positive
 AcuteSel kanser yang kurang matang amp membiak dengan pantasacute lymphocyticALL,ZAINUDDIN ISHAK,Positive
 acute myeloidAML,ZAINUDDIN ISHAK,Positive
 ChronicSel kanser yang matang,ZAINUDDIN ISHAK,Positive
 amp membiak,ZAINUDDIN ISHAK,Positive
 perlahanchronic lymphocyticCLL,ZAINUDDIN ISHAK,Positive
 chronic myeloidCMLKau rasa Sofia kena jenis mana,ZAINUDDIN ISHAK,Positive
 Interim analysis,Lymphoma Hub,Negative
 Phase III MURANO study,Lymphoma Hub,Negative
 LateBreaking Abstract,Lymphoma Hub,Negative
 TGTX management,Biotech2050,Negative
 News Venteoclax,medwireNews,Negative
 Onderrepresentatie plussers,Mednet (was: Medidact),Positive
 klinische bloedkankertrials,Mednet (was: Medidact),Positive
 VIDEO Primary analysis,VJHemOnc,Negative
 study data,VJHemOnc,Negative
 venetoclax exposure rituximab coadministration,Francesco Bertoni,Negative
 Wexham Park,LiveYourLife,Negative
 Therapy Choices,Lymphoma News Today,Positive
 Therapy Choices,BioNews,Negative
 booklets,Leukaemia Care,Negative
 Frontline ibrutinibchemoimmunotherapy,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Justpublished study,NY Genome Center,Negative
 Core Faculty Member Dan Landau MD PhD,NY Genome Center,Negative
     Treatment Start,Patient Power,Negative
 Earlier w Dr Keating,Patient Power,Negative
 PRIME,PRIME Education,Negative
 intervention,PRIME Education,Negative
 treatment practices,PRIME Education,Negative
 Vanavond Live Nascholing CLL,MEDtalks,Positive
 prof dr Arnon Kater,MEDtalks,Positive
 dr Michel van Gelder,MEDtalks,Positive
 MarkDavid Levin,MEDtalks,Positive
 ontwikkelingen,MEDtalks,Positive
 de behandeling van,MEDtalks,Positive
 geven Kijken Registreer,MEDtalks,Positive
   T cells,AIRR-seq papers,Negative
 Hematology ASH Conference,Leukemia Research Foundation,Negative
 live wrapup,Patient Power,Negative
 amp   experts,Patient Power,Negative
    TY,Michele Nadeem-Baker,Positive
 Source,Sumit Wadhwa,Positive
 Targeted Drug Boosts Response,Jack Shields,Positive
 Targeted Drug Boosts Response,ShieldsRx,Positive
 Targeted Drug Boosts Response,newswise,Negative
 Targeted Drug Boosts Response,MD.,Negative
 Targeted Drug Boosts Response,Centro Medico Qx,Negative
 Price Drop Prescribers,ŸÖÿ±ÿØ ŸÖÿ¨ÿßÿ≤Ÿä,Positive
 Guide Stahl,ŸÖÿ±ÿØ ŸÖÿ¨ÿßÿ≤Ÿä,Positive
    Wnta,ImmunologyPapers,Negative
 HS,ImmunologyPapers,Negative
 HS,Wnt publications,Negative
 Chronic Lymphocytic Leukemia CLL Market Overview,Diet Recipes & News,Positive
 Indicators,"Mauricio Perez-Davila, MD",Positive
 Indicators,OncLive.com,Negative
 proximo ano ou proximo m√™s,Robat Taylor Khalifa,Positive
 sentirse Endongoso,Robat Taylor Khalifa,Positive
   link,Jah Kuu,Negative
 SoundCloud,Jah Kuu,Positive
 bio‚ÄºÔ∏è,Jah Kuu,Negative
 New Developments,Lymphoma Canada,Negative
 VIDEO DUO trial,VJHemOnc,Negative
 ‚Äì Pipeline Review H,Markets & Reports,Negative
 ‚Äì Pipeline Review H,BizPR,Positive
 Texas Chancellor,Silvia Foster-Frau,Positive
 Dr Mohit Trikha,Patient Power,Negative
 Dr Curtis Lachowiez Obinutuzumab,OHSU IM Residency,Positive
 Rituximab Failure Case Report,OHSU IM Residency,Positive
 KOL,Biotech2050,Negative
 TGTX   investor update,Biotech2050,Negative
 central,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 NFATC activation,Calibr8 Your Life,Positive
 NFATC activation,Cancer Papers,Negative
 DNA hypomethylation,Calibr8 Your Life,Positive
 DNA hypomethylation,Cancer Papers,Negative
 MALT Inhibition,Jerry Lee,Negative
 Naive IbrutinibResistant Chronic Lymphocytic Leukemia,Jerry Lee,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market Dynamics Segments,In the Amys Bloomers,Positive
 Supply Demand,In the Amys Bloomers,Positive
 Chronic Lymphocytic Leukemia Survey,EKLLRF,Positive
 Patient Therapy Choices,EKLLRF,Positive
 ASH AbbVies,Advera Health,Negative
 trounces chemo,Advera Health,Negative
   roundtable,Andrew Schorr,Negative
 Campaigns,Leukaemia Care,Negative
 Advocacy Officer,Leukaemia Care,Negative
   priorities,CLLSA,Negative
 CLLSA Chair David Inneswe,CLLSA,Negative
   appraisals,CLLSA,Negative
 Relapsed Refractory,Imedex,Positive
 Relapsed Refractory,Lymphomation.org,Negative
 Research ‚û° Ô∏è Results,The James,Negative
 member   s   community,Andrew Schorr,Negative
 CLL friends,Andrew Schorr,Negative
 day visit,Beth Torr,Positive
   Histone Deacetylase,SeqComplete,Negative
 NEW Treatment,Medivizor,Negative
 rituximab verbetert,Oncologie Up-to-date,Positive
 VR,Dr Henry,Positive
 Metabolic Approach,CLL_Fightersüéó,Negative
 Rituximab New Standard,Christopher Steer,Negative
 VenclextaVenclyxto,MAISA,Negative
   MURANO trial,"Raul Cordoba, MD, PhD",Negative
 RR    R,"Raul Cordoba, MD, PhD",Negative
 HR   plt,"Raul Cordoba, MD, PhD",Negative
 PhIII   data,Kara Jill Stancell,Negative
 ‚Äú breakthrough ‚Äù combo,Kara Jill Stancell,Negative
 ambitions,Kara Jill Stancell,Negative
 line ibrutinib,"chadi nabhan MD, MBA, FACP",Negative
 Genentech Announces Phase III Data,Health|VBProfiles,Positive
 Genentech Announces Phase III Data,Business Wire-Health,Negative
 Genentech Announces Phase III Data,Business Wire-TS,Negative
 Genentech Announces Phase III Data,BusinessWireConsumer,Positive
 Genentech Announces Phase III Data,Crwe World,Negative
 Genentech Announces Phase III Data,The Pharmaceutical Marketing Group,Negative
 ROG RHHBY,Roche,Negative
 Death b,Crwe World,Negative
   LBA session,Genentech,Negative
   Chronic Lymphocytic Leukemia CLL Pipeline Review H   Report,Bio-Collaboration,Negative
   Chronic Lymphocytic Leukemia CLL Pipeline Review H   Report,DrugGenius,Negative
   Chronic Lymphocytic Leukemia CLL Pipeline Review H   Report,Cancer News,Negative
 USD   Chronic Lymphocytic Leukemia CLL Pipeline Review H SummaryGlobal Markets,Bio-Collaboration,Negative
 USD   Chronic Lymphocytic Leukemia CLL Pipeline Review H SummaryGlobal Markets,DrugGenius,Negative
 USD   Chronic Lymphocytic Leukemia CLL Pipeline Review H SummaryGlobal Markets,Cancer News,Negative
 VIDEO CART cell development,VJHemOnc,Negative
 Stephen K Woltz,Columbus Dispatch,Positive
   P Bose,MD Anderson Leukemia,Negative
   P Bose,Lisa Palacios,Negative
 Poster Pres,MD Anderson Leukemia,Negative
 Poster Pres,Lisa Palacios,Negative
 View Paper,MD Anderson Leukemia,Negative
 View Paper,Lisa Palacios,Negative
 Lower Doses,MD Anderson Leukemia,Negative
 Lower Doses,Lisa Palacios,Negative
 pts w,MD Anderson Leukemia,Positive
 pts w,Lisa Palacios,Negative
 pts w,Adaptive Biotech,Negative
 PM GWCC C,MD Anderson Leukemia,Negative
 PM GWCC C,Lisa Palacios,Negative
 Excellent organization,"chadi nabhan MD, MBA, FACP",Negative
 Program Oral,CancerWallonia,Negative
 Poster Abstracts,CancerWallonia,Negative
 Poster    Molecular Pharmacology Drug Resistance,CancerWallonia,Negative
 Lymphoid,CancerWallonia,Negative
 Diseases Chronic Lymphocytic Leukemia,CancerWallonia,Negative
 Lymphoid Diseases,CancerWallonia,Negative
 CONGRATULATIONS,Bernard A Fox,Positive
 Prof Robert O Dillman,Bernard A Fox,Positive
   past President,Bernard A Fox,Positive
 GURU,Bernard A Fox,Positive
 Dr Leylah Drusbosky,CancerPOP,Positive
 PMPM,CancerPOP,Positive
 Bldg Lvl,CancerPOP,Positive
 tcotEAsbwlHT,Healio,Negative
    r√©sultats,oncohebdo,Negative
 Saturdays Daily Wrap,Patient Power,Negative
 Soy Cruciferous Vegetables,Jeff Novick,Positive
 Verastem Announces Clinical Data,Christoph Westphal,Positive
 Verastem Announces Clinical Data,üá∫üá∏jonnyüá∫üá∏,Positive
 Verastem Announces Clinical Data,Financial Buzz,Negative
 Verastem Announces Clinical Data,MantasTrades,Positive
 Verastem Announces Clinical Data,N A S A,Positive
 Verastem Announces Clinical Data,Crwe World,Negative
 Verastem Announces Clinical Data,Business Wire-Health,Negative
 Verastem Announces Clinical Data,Business Wire-TS,Negative
 Verastem Announces Clinical Data,BusinessWireWebcasts,Negative
 Verastem Announces Clinical Data,BusinessWireProducts,Negative
 Verastem Announces Clinical Data,The Pharmaceutical Marketing Group,Negative
 Verastem Announces Clinical Data,BusinessWire-Science,Negative
 Pivotal Phase,Christoph Westphal,Positive
 Pivotal Phase,üá∫üá∏jonnyüá∫üá∏,Positive
 Pivotal Phase,Financial Buzz,Positive
 Pivotal Phase,MantasTrades,Positive
 Pivotal Phase,Mark,Positive
 Pivotal Phase,ANTELLIS,Positive
 Pivotal Phase,Kam Laurence,Positive
 Pivotal Phase,N A S A,Positive
 Pivotal Phase,Odi Bruckman,Positive
 Pivotal Phase,Crwe World,Positive
 Pivotal Phase,Business Wire-Health,Positive
 Pivotal Phase,Business Wire-TS,Positive
 Pivotal Phase,BusinessWireWebcasts,Positive
 Pivotal Phase,BusinessWireProducts,Negative
 Pivotal Phase,üò∑ Caleph B. Wilson,Positive
 Pivotal Phase,The Pharmaceutical Marketing Group,Positive
 Pivotal Phase,BusinessWire-Science,Negative
 Pivotal Phase,SNN Network,Negative
 Pivotal Phase,Cancer News,Negative
 Pivotal Phase,Lung Cancer News,Negative
 Pivotal Phase,Stockboard Media Inc,Negative
 Pivotal Phase,CRO Contract Res.,Negative
 Pivotal Phase,$Stocknewsalerts,Negative
 Pivotal Phase,Market Cheetah,Positive
 Pivotal Phase,1stOncology,Negative
 ‚Ñ¢ Study Duvelisib,Christoph Westphal,Positive
 ‚Ñ¢ Study Duvelisib,üá∫üá∏jonnyüá∫üá∏,Positive
 ‚Ñ¢ Study Duvelisib,Financial Buzz,Negative
 ‚Ñ¢ Study Duvelisib,MantasTrades,Positive
 ‚Ñ¢ Study Duvelisib,ANTELLIS,Positive
 ‚Ñ¢ Study Duvelisib,N A S A,Positive
 ‚Ñ¢ Study Duvelisib,Odi Bruckman,Negative
 ‚Ñ¢ Study Duvelisib,Crwe World,Negative
 ‚Ñ¢ Study Duvelisib,Business Wire-Health,Negative
 ‚Ñ¢ Study Duvelisib,Business Wire-TS,Negative
 ‚Ñ¢ Study Duvelisib,BusinessWireWebcasts,Negative
 ‚Ñ¢ Study Duvelisib,BusinessWireProducts,Negative
 ‚Ñ¢ Study Duvelisib,üò∑ Caleph B. Wilson,Positive
 ‚Ñ¢ Study Duvelisib,The Pharmaceutical Marketing Group,Negative
 ‚Ñ¢ Study Duvelisib,BusinessWire-Science,Negative
 Progression Free Survival,Christoph Westphal,Positive
 Progression Free Survival,üá∫üá∏jonnyüá∫üá∏,Positive
 Progression Free Survival,MantasTrades,Positive
 Progression Free Survival,Mark,Positive
 Progression Free Survival,ANTELLIS,Positive
 Progression Free Survival,Kam Laurence,Positive
 Progression Free Survival,N A S A,Positive
 Progression Free Survival,Business Wire-Health,Negative
 Progression Free Survival,Business Wire-TS,Negative
 Progression Free Survival,BusinessWireWebcasts,Negative
 Progression Free Survival,BusinessWireProducts,Negative
 Progression Free Survival,üò∑ Caleph B. Wilson,Positive
 Progression Free Survival,The Pharmaceutical Marketing Group,Negative
 Progression Free Survival,BusinessWire-Science,Negative
 Small Lymphocytic Lymphoma   Business Wire,Christoph Westphal,Positive
 Hoge respons,Oncologie Up-to-date,Positive
   VSTM,üá∫üá∏jonnyüá∫üá∏,Positive
 Basics,Patient Power,Negative
 Basics,Indonesian CML &GIST,Positive
 Continental News Combination,contclin,Positive
 Education Program,CancerWallonia,Negative
 copy,CLLSA,Negative
 leaflet,CLLSA,Negative
   study day,CLLSA,Negative
 Pharma Cos News IMBRUVICA,Giuseppe Michieli,Negative
 ¬Æ ibrutinib PatientReported Outc,Giuseppe Michieli,Negative
 Progres,Financial Buzz,Positive
 Hrs     Verastem Announces Clinical Data,Mark,Positive
 DUOTM Study Duvelisib,Mark,Positive
 DUOTM Study Duvelisib,Kam Laurence,Positive
   Poster Pres,Lisa Palacios,Positive
   Poster Pres,MD Anderson Leukemia,Positive
 Sustained LongLasting Responses,Lisa Palacios,Negative
 Sustained LongLasting Responses,MD Anderson Leukemia,Negative
 Lenalidomide Discontinuation,Lisa Palacios,Negative
 Lenalidomide Discontinuation,MD Anderson Leukemia,Negative
 Strati,Lisa Palacios,Negative
 Strati,MD Anderson Leukemia,Negative
 TGTX MRK,dough,Positive
 VIDEO   Results,VJHemOnc,Negative
   Verastem Announces Clinical Data,ANTELLIS,Positive
 Small Lym,ANTELLIS,Positive
 RS outcomes,"chadi nabhan MD, MBA, FACP",Negative
 Inc Significant News,Kam Laurence,Positive
   hour agoVerastem,Kam Laurence,Positive
 Announces Clinical Data,Kam Laurence,Positive
 Small Lymphocytic Lymphoma Press Release,Kam Laurence,Positive
 marrow MRD,"Caner Saygin, MD",Positive
 iFRC,"Caner Saygin, MD",Negative
 Dr David,"Caner Saygin, MD",Negative
 Reveals findings,CRWE News Wire,Positive
 latestage study testing duvelisib,CRWE News Wire,Positive
 Clinical Data,Odi Bruckman,Negative
 Small Lymphocytic Lymphoma BOSTONBUSINESS WIREVerastem,Business Wire-Health,Negative
    Verastem Announces Clinical Data,üò∑ Caleph B. Wilson,Positive
 CXCL BCA Plasma Levels,Lisa Palacios,Negative
 CXCL BCA Plasma Levels,MD Anderson Leukemia,Negative
 Useful Biological Marker,Lisa Palacios,Negative
 Useful Biological Marker,MD Anderson Leukemia,Negative
 Patients SivinaBurger,Lisa Palacios,Negative
 Patients SivinaBurger,MD Anderson Leukemia,Negative
 Repost Day,German Cheer Dad (GCD),Positive
 shoutout,German Cheer Dad (GCD),Negative
 shoutout,Alicia Maston Coffin,Positive
 starscheerleader,German Cheer Dad (GCD),Negative
    Oral Pres PM,Lisa Palacios,Negative
    Oral Pres PM,MD Anderson Leukemia,Negative
 Obinutuzumab GA,Lisa Palacios,Negative
 Obinutuzumab GA,MD Anderson Leukemia,Negative
 Obinutuzumab GA,Cancer Papers,Negative
 Obinutuzumab GA,Krishan Maggon,Negative
 Mutated IGHV amp wo TP Aberrationsl GWCC Murphy BR,Lisa Palacios,Negative
 Mutated IGHV amp wo TP Aberrationsl GWCC Murphy BR,MD Anderson Leukemia,Negative
 interviews,Patient Power,Negative
 interviews,Lymphoma Hub,Negative
 interviews,VJHemOnc,Negative
 New safety efficacy data,AstraZenecaUS,Negative
 combination trial,AstraZenecaUS,Negative
 Single Agent,AJMC-Oncology,Negative
 Patient WellBeing,AJMC-Oncology,Negative
 Awesome data,dough,Negative
 tonight   talk,dough,Negative
 tonight important   TGTX,dough,Negative
 twitter,"chadi nabhan MD, MBA, FACP",Negative
 twitter,CaturLifeLive,Positive
 nudge,"chadi nabhan MD, MBA, FACP",Negative
 Exciting meeting,"chadi nabhan MD, MBA, FACP",Negative
 patient voice w,"chadi nabhan MD, MBA, FACP",Negative
 David Matthews,"Caner Saygin, MD",Positive
 FCR   ibrutinib iFCR study,"Caner Saygin, MD",Negative
 Teva poster presentations,Teva Pharmaceuticals,Positive
 Honour,German Cheer Dad (GCD),Negative
 Coaches,German Cheer Dad (GCD),Negative
 Repost Unsere Rangers,German Cheer Dad (GCD),Positive
 Namensvetter Ranger Marketing f√ºr,German Cheer Dad (GCD),Negative
 Stimmung sorgen Wir gratulieren zum,German Cheer Dad (GCD),Negative
 Jubil√§um und freuen uns auf eine,German Cheer Dad (GCD),Negative
 Gala,German Cheer Dad (GCD),Negative
 relaxed amp understanding setting,CLLSA,Negative
 encouragement amp confidence,CLLSA,Negative
 RESONATE Trial,"chadi nabhan MD, MBA, FACP",Negative
 GWCC Murphy BR,MD Anderson Leukemia,Negative
 GWCC Murphy BR,Lisa Palacios,Negative
 Collaboration,"chadi nabhan MD, MBA, FACP",Positive
   poster   comparing cost,"chadi nabhan MD, MBA, FACP",Negative
 healthcare resources,"chadi nabhan MD, MBA, FACP",Negative
 ibrutinib amp chemotherapy,"chadi nabhan MD, MBA, FACP",Negative
 shot,Patient Power,Negative
 shot,info,Positive
 Olga,Patient Power,Negative
 Tomorrow morning,Dana-Farber,Negative
 DanaFarber,Dana-Farber,Negative
 DanaFarber,"Sean Young, PhD",Positive
 leukemia journey,Patient Power,Negative
   patient amp carepartner,Patient Power,Negative
 mins,Patient Power,Negative
 Followup study data,Hottest Stocks Now,Negative
 longterm benefits,Hottest Stocks Now,Negative
 ABBV s ibrutinib,Hottest Stocks Now,Negative
 Sequencing Therapy,The ASCO Post,Negative
 Chronic Lymphocytic Leukemia Visit Building,"Pharmacyclics, an AbbVie Company",Negative
 Level,"Pharmacyclics, an AbbVie Company",Negative
 CART cell therapy development,VJHemOnc,Negative
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,TalkingScarsMedia.com,Positive
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,Autotestdrivers.com,Positive
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,MineListings.com,Positive
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,IntoxicatedTrader,Positive
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,VPO/PR Newswire,Negative
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,CRE Demographics,Negative
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,ShareHRnews,Positive
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,iTruck NEWS,Positive
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,Mr Slot,Positive
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,Seattle's Banker,Negative
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,RazzleTazzle,Negative
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,Newmoney210,Negative
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,Crwe World,Negative
 ¬Æ ibrutinib PatientReported Outcomes Data Detail LongTerm Improvement,Financial Buzz,Negative
 Life Experience,TalkingScarsMedia.com,Positive
 Life Experience,Autotestdrivers.com,Positive
 Life Experience,VPO/PR Newswire,Negative
 Life Experience,CRE Demographics,Negative
 Life Experience,ShareHRnews,Positive
 Life Experience,Mr Slot,Positive
 Life Experience,Seattle's Banker,Negative
 Ami Solutions News IMBRUVICA,Laurent G - Francis,Negative
 ibrutinib PatientReported Outcomes Data Detail LongTerm,Laurent G - Francis,Negative
 CHICAGO Ill Dec,Mr Slot,Positive
 yr followup data,"Pharmacyclics, an AbbVie Company",Negative
 ABBV IMBRUVICA PatientReported Outcomes Data Detail LT Improvement,Odi Bruckman,Negative
 QOL Experience,Odi Bruckman,Negative
 Qu,Financial Buzz,Negative
 Day    Dancers,German Cheer Dad (GCD),Negative
 bodybuilders,German Cheer Dad (GCD),Negative
 ‚Äç ‚ôÇ Ô∏è nordic       „Éª„Éª„Éª,German Cheer Dad (GCD),Negative
 Meixiao Long,VJHemOnc,Negative
 temperature,CLLSA,Negative
   Daddy,MarlaJan- Luck Fupus,Positive
 Awesome start,Saad Z. Usmani MD MBA FACP (he/his/him),Positive
 guru    champion,Saad Z. Usmani MD MBA FACP (he/his/him),Positive
 Hem News advisor,Hematology News,Positive
 Sylvan et al,Ahmad Halwani,Positive
 Susan Slager PhD,Mayo Clinic Med Ed,Positive
 Mayo Clinic Health Sciences researcher,Mayo Clinic Med Ed,Positive
 Genetic Risk Factors,Mayo Clinic Med Ed,Positive
 Precursors,Mayo Clinic Med Ed,Positive
 Bldg B,Mayo Clinic Med Ed,Positive
 Lvl   B Georgia World Congress Center,Mayo Clinic Med Ed,Positive
 ALERT NEWS,CamTheMan,Positive
 Present Results,CamTheMan,Positive
 Present Results,SNN Network,Negative
 Present Results,Cancer News,Negative
 Present Results,Lung Cancer News,Negative
 Present Results,Crwe World,Negative
 Present Results,Business Wire-Health,Negative
 Present Results,BusinessWireWebcasts,Negative
 Present Results,The Pharmaceutical Marketing Group,Negative
 Present Results,Stockboard Media Inc,Negative
 Present Results,Odi Bruckman,Negative
 Present Results,CRO Contract Res.,Negative
 Present Results,$Stocknewsalerts,Negative
 Present Results,Financial Buzz,Negative
 Present Results,Business Wire-TS,Negative
 Present Results,Penny Stocks News,Positive
 Pivotal Study,CamTheMan,Positive
 patients voice,"chadi nabhan MD, MBA, FACP",Negative
 cancer care delivery,Carevƒ´ve,Positive
 Alberto Montero,Carevƒ´ve,Negative
   Preferential Usage,AIRR-seq papers,Negative
 Specific Immunoglobulin Heavy Chain Variable Region Genes,AIRR-seq papers,Negative
 Unmutated Profile,AIRR-seq papers,Negative
 Advanced Stage,AIRR-seq papers,Negative
 Common Features,AIRR-seq papers,Negative
 Senegal,AIRR-seq papers,Negative
 hour discussion,"chadi nabhan MD, MBA, FACP",Negative
 year message,CLLSA,Negative
 CLLSA Trustee Rupert Beazley,CLLSA,Negative
   Lymphoma Coalition,Gary Nolan,Positive
 CURE Media Group Partners,Bio-Collaboration,Negative
 CURE Media Group Partners,DrugGenius,Positive
 CURE Media Group Partners,CLL Society Inc.,Negative
 CURE Media Group Partners,Business Wire-Health,Negative
 CURE Media Group Partners,BusinessWireConsumer,Positive
 CURE Media Group Partners,BusinessWire-Science,Negative
 CURE Media Group Partners,BusinessWireContract,Positive
 CURE Media Group Partners,SPI News,Negative
 Chronic Lymphocytic Leukemia Society,Bio-Collaboration,Positive
 Chronic Lymphocytic Leukemia Society,DrugGenius,Positive
 Chronic Lymphocytic Leukemia Society,CLL Society Inc.,Negative
 Chronic Lymphocytic Leukemia Society,Business Wire-Health,Negative
 Chronic Lymphocytic Leukemia Society,BusinessWireConsumer,Positive
 Chronic Lymphocytic Leukemia Society,CRO Contract Res.,Negative
 Chronic Lymphocytic Leukemia Society,Cancer News,Negative
 Chronic Lymphocytic Leukemia Society,BusinessWire-Science,Negative
 Chronic Lymphocytic Leukemia Society,BusinessWireContract,Positive
 Chronic Lymphocytic Leukemia Society,SPI News,Negative
 treatment planning,Carevƒ´ve,Negative
 Amitkumar Mehta MD,Carevƒ´ve,Negative
 Dominic LeBlanc,Eunice O,Positive
 Chronic Lymphocytic Leukemia marrow donor,Eunice O,Positive
 Human Machine,German Cheer Dad (GCD),Negative
 Peewee,German Cheer Dad (GCD),Negative
 Junior Dancers,German Cheer Dad (GCD),Negative
 dr,Andrew Schorr,Negative
 Patients amp family members,Andrew Schorr,Negative
 watch amp,Andrew Schorr,Negative
 Keating,Andrew Schorr,Negative
 Keating,Patient Power,Positive
 Christmas,LiveYourLife,Negative
 workshops,LiveYourLife,Negative
 workshops,CancerCare,Negative
 Expert faculty,Med-IQ,Negative
 benefits challenges,Med-IQ,Negative
 Legend,Liam James Britton,Positive
 Federal cabinet minister,Jane Brown,Positive
 NB MP Dominic LeBlanc,MAX104.9 FM,Positive
 NB MP Dominic LeBlanc,K93 Grand Falls,Positive
 NB MP Dominic LeBlanc,105.3 The FOX,Positive
 NB MP Dominic LeBlanc,Fredericton's Move,Positive
 NB MP Dominic LeBlanc,Fredericton's Pure Country 103.5,Positive
 Este,Alison Evans,Negative
 Este,Taylor Wolf,Positive
 nos vemos,Alison Evans,Negative
   jab,CLLSA,Negative
 Federal Fisheries Minister Dominic LeBlanc,Yahoo Canada News,Positive
 Federal Fisheries Minister Dominic LeBlanc,CTV Atlantic,Positive
 Paper Safety,"Raul Cordoba, MD, PhD",Negative
 Idelalisib Treatment,"Raul Cordoba, MD, PhD",Negative
 Relapsing,"Raul Cordoba, MD, PhD",Negative
 Allogeneic Hematopoietic Cell Transplantation Survey,"Raul Cordoba, MD, PhD",Negative
 Chronic Malignancies,"Raul Cordoba, MD, PhD",Negative
 Lymphoma Working Parties,"Raul Cordoba, MD, PhD",Negative
 Paper Prolonged Improvement,"Raul Cordoba, MD, PhD",Negative
 PatientReported Outcomes PROs,"Raul Cordoba, MD, PhD",Negative
 Wellbeing,"Raul Cordoba, MD, PhD",Negative
 Ibrutinib Year Followup,"Raul Cordoba, MD, PhD",Negative
 RESONATE Study,"Raul Cordoba, MD, PhD",Positive
 Fisheries Minister Dominic LeBlanc,Laura Stone,Positive
 Fisheries Minister Dominic LeBlanc,Canada National NW,Positive
 Fisheries Minister Dominic LeBlanc,660 NEWS Calgary,Positive
 Fisheries Minister Dominic LeBlanc,CBC News Alerts,Positive
 reporters,Laura Stone,Positive
 drug efficacy,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 drug efficacy,RTI Health Solutions,Negative
 LeBlanc,Canada National NW,Positive
 Federal cabinet minister Dominic LeBlanc,NEWS 1130,Positive
 Fisheries minister Dominic LeBlanc,Ryan Maloney,Positive
 Fisheries minister Dominic LeBlanc,HuffPost Canada,Positive
 UPDATED,Amanda Connolly,Positive
 BREAKING Federal NB cabinet minister,Adam Huras,Positive
 Cabinet minister,Mike Le Couteur,Positive
 Fisheries amp Oceans Minister Dominic LeBlanc,CTV Power Play,Positive
 Fisheries amp Oceans Minister Dominic LeBlanc,AlysonFair,Positive
 Best wishes,Hon Deepak Obhrai PC,Positive
 statement,CTV Atlantic,Positive
 Fisheries,Nathalie Sturgeon,Positive
 Fisheries,Dave White,Positive
 Fisheries,Laura Ryckewaert,Positive
 Fisheries Minister,Angela ‚ÄúGot Mask?‚Äù Mulholland,Positive
 upsetting news,Monique Scotti,Positive
 Oceans Minister Dominic LeBlanc,Dave White,Positive
 Oceans Minister,Laura Ryckewaert,Positive
    CURE Media Group Partners,DrugGenius,Positive
    CURE Media Group Partners,Bio-Collaboration,Negative
    patients,Zack Pemberton-Whiteley,Negative
    patients,Marek Trneny,Positive
    patients,Jessica McDonald,Positive
    survey,Zack Pemberton-Whiteley,Negative
 Chronic Lymphocytic Leukemia Society CRANBURY NJBUSINESS,Business Wire-Health,Negative
 WIRECURE,Business Wire-Health,Negative
 Media Group Partners,Business Wire-Health,Negative
   CURE Media Group Partners,CRO Contract Res.,Negative
   CURE Media Group Partners,Cancer News,Negative
 Swag Bag,Higher Ground at Lake Louise,Negative
 observations,SNU P√¥le Emploi FSU Occitanie,Negative
 Repost It‚Äòs day,German Cheer Dad (GCD),Negative
 Captain Coaches,German Cheer Dad (GCD),Negative
 Small,SNN Network,Negative
 Small,Stockboard Media Inc,Negative
 tradeoff,Dr. Melody Davis,Negative
   risk,Dr. Melody Davis,Negative
 Atlanta GA,Anna Deveau,Negative
 Slide,Anna Deveau,Negative
 Research Development Event,Cancer News,Negative
 Research Development Event,Lung Cancer News,Negative
 Research Development Event,Business Wire-Health,Negative
 Research Development Event,BusinessWireWebcasts,Negative
 Research Development Event,The Pharmaceutical Marketing Group,Negative
 Research Development Event,CRO Contract Res.,Negative
 Research Development Event,Business Wire-TS,Negative
 ASH   Event,Cancer News,Negative
 ASH   Event,CRO Contract Res.,Negative
 Live Webcast,Cancer News,Negative
 Live Webcast,CRO Contract Res.,Negative
 ASH   BOSTONBUSINESS WIREVerastem Inc NASDAQVSTM,Business Wire-Health,Negative
 Small LyFrom,$Stocknewsalerts,Negative
 Pivotal Phase   DUO Study,Penny Stocks News,Positive
 amp Small,Penny Stocks News,Positive
 Druggable Target,Prof John,Negative
 P inhibitors Toxicity comparison,Biotech2050,Negative
 Interferon Regulatory Factor,Wei Du,Positive
 Regulating,Wei Du,Positive
 Ikaros,Wei Du,Positive
 metabolomics,mitopapers,Positive
 metabolomics,Cancer Papers,Negative
   Monosomal karyotype,BVirtual Murciasalud,Positive
 Lck,Cancer Papers,Negative
 Chronic Lymphocytic Leukemia CLL group,Antonio V. Borderia,Positive
 Poetic Licence,CLLSA,Negative
 Cello Groups,US Banking News,Negative
 rating,US Banking News,Negative
 rating,Paul Kettle,Negative
 FinnCap GBX,US Banking News,Positive
 FinnCap GBX,MarketBeat,Positive
 AKT inhibition,Anna Deveau,Negative
 Repost,German Cheer Dad (GCD),Positive
 Pyramid   CLL Rangers,German Cheer Dad (GCD),Negative
 advent CLLSA,CLLSA,Negative
 medetails,CLLSA,Negative
 NICE technology appraisal,CLLSA,Negative
 PTSD Rates,Michele Nadeem-Baker,Negative
 General Population,Michele Nadeem-Baker,Negative
 advent Blog Door,CLLSA,Negative
 VIDEO targeted treatment,VJHemOnc,Negative
 Preliminary encouraging data,Guillermo Sanz,Negative
 antiCD CAR TCell Therapy,Guillermo Sanz,Negative
 tcoZuoJFdGG,Guillermo Sanz,Negative
    health,LiveYourLife,Negative
 wellbeing workshop,LiveYourLife,Negative
 Hemmol,HematologiaValdecilla,Positive
 proyecto pionero para conocer mejor,HematologiaValdecilla,Positive
 Decoding,Patient Power,Negative
 w Dr Spurgeon,Patient Power,Negative
 amp Dr Sharman,Patient Power,Negative
 secondline treatment options,Dr. Andre Goy,Negative
 forthcoming   coverage,Lymphoma Hub,Negative
 Work week,Higher Ground at Lake Louise,Negative
 La question de la,Charente-Maritime,Positive
 du   √©crit,Charente-Maritime,Positive
 de lecture publique,Charente-Maritime,Positive
 du d√©bat ce matin lors de la journ√©e,Charente-Maritime,Positive
 d‚Äô√©tude,Charente-Maritime,Positive
 organis√©e par     aux archives d√©partementales,Charente-Maritime,Positive
 RT aHUSAllianceAct RT PatientPower Registration,Atypical HUS India,Positive
 Similar Mutational Landscape,Oncology,Negative
 Aberrant splicing,LiteratureFeed,Positive
 Camp Lake Louise Swag Bag,Higher Ground at Lake Louise,Negative
 Przewlek≈Ça,Medoinfo,Positive
 limfocytowa w pigu≈Çce,Medoinfo,Positive
 najwa≈ºniejsze FAKTY INFO,Medoinfo,Positive
    nowy obiecujƒÖcy lek,Medoinfo,Positive
 bia≈Çaczkƒô limfatycznƒÖ,Medoinfo,Positive
 kinase inhibitors,VJHemOnc,Positive
 kinase inhibitors,El tal Toni üéó#JoActuo #LlibertatPresosPolitics,Positive
 kinase inhibitors,Oncology Board,Negative
 kinase inhibitors,HemOnc Today,Negative
 kinase inhibitors,Prof John,Negative
 R outperforms Benda,Michael Dickinson,Negative
 value frameworks,"chadi nabhan MD, MBA, FACP",Negative
 Excellent analysis,"chadi nabhan MD, MBA, FACP",Negative
 JOP CC,"chadi nabhan MD, MBA, FACP",Negative
 amp   study purposes,Guillermo Sanz,Negative
 safety amp privacy,Guillermo Sanz,Negative
 VIDEO Nextgeneration BTK inhibitors,VJHemOnc,Negative
 EvidenceBased Focused Review FCR,Blood Journal,Negative
   Value Framework,Journal of Clinical Pathways,Negative
 Limitations,Journal of Clinical Pathways,Negative
   Expert w Dr Keating,Patient Power,Negative
 Treatment Response,Patient Power,Negative
 ATM function,CLL-seq,Negative
 ATM function,MD Anderson Library,Negative
 ATM function,Cancer Papers,Negative
 ATM gene mutations,CLL-seq,Negative
 ATM gene mutations,MD Anderson Library,Negative
 ATM gene mutations,Cancer Papers,Negative
 Venetoclaxrituximab,Christopher Steer,Negative
 bendamustinerituximab,Christopher Steer,Negative
 Profound improvement,Christopher Steer,Negative
 ASCOs   framework,Dr. Andre Goy,Negative
 Cellular kinetics,Blood Journal,Negative
 Cellular kinetics,"Raul Cordoba, MD, PhD",Negative
 Cellular kinetics,"Bruce Levine, Ph.D.",Positive
 CTL,Blood Journal,Negative
 CTL,"Raul Cordoba, MD, PhD",Negative
 CTL,"Bruce Levine, Ph.D.",Positive
 CTL,MDedge Hematology & Oncology,Negative
 Maverick,Casey Richardson,Positive
 tower,Casey Richardson,Positive
 campers,Higher Ground at Lake Louise,Negative
   survey,Zack Pemberton-Whiteley,Negative
 Retweeted,Indonesian CML &GIST,Positive
 Autoimmune complications,Patrick Walter,Positive
 RT sanzguille,"Chared, Good Comms",Negative
 RT sanzguille,European Hematology Association,Negative
 Relapsed NonHodgkin,"Raul Cordoba, MD, PhD",Negative
 Treatment Strategies,"Raul Cordoba, MD, PhD",Negative
 VIDEO introduction,VJHemOnc,Negative
 HOVON trial,VJHemOnc,Positive
 HOVON trial,CLL Ireland,Negative
   work,UM V-BID Center,Positive
 valuebased care studies,UM V-BID Center,Positive
   value framework,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Patients ‚Äô priorities,Blood Advances,Positive
 Patients ‚Äô priorities,"Raul Cordoba, MD, PhD",Negative
 Patients ‚Äô priorities,ASH,Negative
 FISH fluorescence,CLL Ireland,Negative
 situ hybridization testing,CLL Ireland,Negative
   Late breaker,Endpoints News,Negative
   Late breaker,Kara Jill Stancell,Negative
 Harmony,Nick,Negative
 stakeholders,Nick,Negative
 gaps,Nick,Negative
 Sistematic Review,MoJo,Negative
    ChlorRitux,BloodWork,Positive
 agent,BloodWork,Positive
 Diagnostic Approach,Women's Publications,Negative
 Diagnostic Approach,Clin Image Case Rep,Negative
 Macitentan,Hypoxia Adaptation,Positive
 circle,VJHemOnc,Negative
 Carlo Croce,VJHemOnc,Positive
 MALT inhibition,Wei Du,Positive
 MALT inhibition,sandrineman,Negative
 PTPROt tyrosine phosphatase functions,Wei Du,Positive
 obligate haploinsufficient tumor suppressor,Wei Du,Positive
 abstract   VR,Jessica Okosun,Positive
 arql,Anna Deveau,Negative
 snss slide,Anna Deveau,Negative
 EHA conference sep,Anna Deveau,Negative
 Crazy   results,Doug Haddad,Positive
 dat mijn broer,Jacquelien (wat een toestand moidje),Negative
 helaas,Jacquelien (wat een toestand moidje),Negative
 de donor niet maar onze zus,Jacquelien (wat een toestand moidje),Negative
 gaf op haar e het mooiste cadeau ooit aan onze broer,Jacquelien (wat een toestand moidje),Negative
     Sequencing Therapy,SeqComplete,Negative
 Rituximab biosimilar,ASH Clinical News,Negative
 Molecular Oncology TB discussion,Association for Molecular Pathology,Negative
 comments,Association for Molecular Pathology,Negative
 comments,John Harrington,Positive
    patient survey,Zack Pemberton-Whiteley,Negative
 patient responses,Zack Pemberton-Whiteley,Negative
    Venetoclax,"Raul Cordoba, MD, PhD",Negative
    Venetoclax,Kevin Garcha,Positive
    Venetoclax,360WiseBHAM ¬Æ,Positive
    Venetoclax,DeborahKing,Positive
    Venetoclax,Miami SCLC¬Æ,Positive
    Venetoclax,#KING OF FLORIDA üëë,Positive
    Venetoclax,Jorge Fernandez,Positive
    Venetoclax,The News Network,Positive
    Venetoclax,Arsoft,Positive
 PrePlanned Interim Analysis,"Raul Cordoba, MD, PhD",Negative
 POLL,VJHemOnc,Negative
   Liga,Fran!,Negative
 Provincial de Entre R√≠os,Fran!,Negative
 VIDEO Treatmentassociated,VJHemOnc,Negative
 Current Issue Diagnosing Chronic Lymphocytic Leukemia,journalneurooph,Negative
 Temporal Artery Biopsy,journalneurooph,Negative
 Current   Treatment Paradigm,CLL Ireland,Negative
   healthampwellbeing workshop,LiveYourLife,Negative
   ya sabe si,Team RadioZeta,Positive
 entradas,Team RadioZeta,Positive
 Epa wl,VERITO #RADIOZETA,Positive
 muy cerca,VERITO #RADIOZETA,Positive
 poner,LoZ PirataZ,Positive
 pr√°ctica,LoZ PirataZ,Positive
 FCR iFCR,Dana-Farber,Negative
 Molecular Oncology Tumor Board,ASCO,Positive
 Editor,Lymphoma Hub,Negative
 FCR therapy,Lymphoma Hub,Negative
 Michele NadeemBaker Weapons,Michele Nadeem-Baker,Negative
 Flu,Michele Nadeem-Baker,Negative
 Colds,Michele Nadeem-Baker,Negative
 Steroids,CLL Ireland,Negative
   treatment response,CLL Ireland,Negative
 Plaintiffs,Matthews & Associates,Negative
 VIDEO Exploring,VJHemOnc,Positive
   world,VJHemOnc,Positive
 Ulrich Jager,VJHemOnc,Positive
    PFS,BloodWork,Positive
 rules,BloodWork,Positive
 Chromosomal aberrations,Cancer Papers,Negative
 situ hybridization,Cancer Papers,Negative
      Reaches,CancerWallonia,Negative
 relapsed highrisk   patients,"Raul Cordoba, MD, PhD",Negative
 IbR,"Raul Cordoba, MD, PhD",Negative
 fellow   patients,Andrew Schorr,Negative
 stance,Archive: Nita Lowey,Positive
   Myth,Patient Power,Negative
 response criteria,Alexandra Mart√≠nez-Roca. MD.,Positive
 Diagrama de flujo MUY √∫til presentaci√≥n del DrLoscertales,Alexandra Mart√≠nez-Roca. MD.,Positive
 View experts opinions,ASCO,Negative
 leaflets,CLLSA,Negative
 tcoJeDgDhFgd,Higher Ground at Lake Louise,Negative
 Dr E Campo,LymphomaLeukemia,Positive
 Patient Clinical Features,CLL Ireland,Negative
 Dr Cuneo,LymphomaLeukemia,Positive
 Rochester MN,APSHO,Negative
 moms results,Jason Brown,Positive
 FB Live updates,Andrew Schorr,Negative
 Blood Work Classical Hodgkin,Blood Journal,Negative
    responses,Zack Pemberton-Whiteley,Negative
 Case Report Strongyloides,Nematode_papers,Positive
 stercoralis Hyperinfection,Nematode_papers,Positive
 WampW,CLL_Fightersüéó,Negative
 prospect,CLL_Fightersüéó,Negative
   speaker,i3 Health,Negative
 Dr Junes,Penn Medicine MD,Positive
 SnapShot Chronic Lymphocytic Leukemia,TumorImmunoPapers,Negative
 increase opportunity,Biotech2050,Negative
 Real‚ÄëLife,CureHuntr,Negative
 Real‚ÄëLife Setting Status,TrialBulletin,Negative
 education support group,UCI Health,Negative
 caretakers,UCI Health,Negative
 Meu sonho desde de puto √© ver peixe,Robat Taylor Khalifa,Positive
 Carapau vivo Acredito que √© sonho de muitos putos,Robat Taylor Khalifa,Positive
 discontinue ibrutinib,"chadi nabhan MD, MBA, FACP",Negative
 prednisone hostage situation,Stephen Brown,Negative
 SM OBrien,Dr.Alberto Mussetti,Negative
 JA Burger,Dr.Alberto Mussetti,Negative
 highlander,Dr.Alberto Mussetti,Negative
 Hepatocyte Growth Factor,Bentham Science,Positive
 Chronic Lymphocytic tcoTXyeRkymtC,Bentham Science,Positive
   class support group,UCI Health,Negative
 forma agora,Carolina,Positive
 Blood Work Aleukemic,Blood Journal,Negative
 cover image,Blood Advances,Positive
 International development,Cancer Papers,Negative
 EORTC diseasespecific quality,Cancer Papers,Negative
 Repost Throwback,German Cheer Dad (GCD),Negative
 RM,German Cheer Dad (GCD),Negative
 Feliz domingo,Robat Taylor Khalifa,Positive
 aben√ßoado Familia,Robat Taylor Khalifa,Positive
 ouvir,Robat Taylor Khalifa,Positive
 chegar assim,Robat Taylor Khalifa,Positive
 New   Chronic Lymphocytic Leukemia Molecular Oncology Tumor Board,Association for Molecular Pathology,Negative
 New   Chronic Lymphocytic Leukemia Molecular Oncology Tumor Board,ASCO,Negative
 Patient Advocate Bruce Wright,Becky Habecker,Positive
 Emerging role,"Raul Cordoba, MD, PhD",Positive
 Emerging role,Blood Advances,Positive
 Emerging role,Klaus Okkenhaug,Positive
 Emerging role,"Dr T. Comeau , MD",Negative
 GC    Expression,ImmuneGCPapers,Positive
 COBLL encoding novel ROR binding partner,ImmuneGCPapers,Positive
 COBLL encoding novel ROR binding partner,Wnt publications,Negative
 Norfolk,LiveYourLife,Negative
 health amp wellbeing workshop,LiveYourLife,Negative
 Vamos Luciano,Lucas ‚ôö,Negative
 docs,Christopher Steer,Negative
 factor,Christopher Steer,Negative
 Putos que,Robat Taylor Khalifa,Positive
 ficAram segundo distrito que passei s√£o todos vacabundos,Robat Taylor Khalifa,Positive
 amp challenges,Med-IQ,Positive
 amp challenges,Oncology Board,Negative
 Classical Hodgkin lymphoma,Pathowitter,Positive
 Classical Hodgkin lymphoma,NPCE,Positive
 Select,Medscape Education,Negative
 Drs Furman,Medscape Education,Negative
 amp Sharman,Medscape Education,Negative
 VIDEO Immunoglobulin receptor interactions,VJHemOnc,Negative
 Lewis Backler,AbbVie Canada,Negative
   events,LiveYourLife,Negative
   events,Patient Power,Negative
 Farrukh Awan MBBS,OncLive SOSS,Negative
 Farrukh Awan MBBS,Targeted Oncology,Negative
 New Pembrolizumab,Medivizor,Negative
 New üÜì Editorial DNA demethylation marks,Future Science OA,Positive
 Improved Survival,Oncology,Negative
 Improved Survival,Scott Werntz,Positive
 Improved Survival,IntoxicatedTrader,Negative
 Improved Survival,Rachel Smith,Positive
 Silicon Valley data,CLL_Fightersüéó,Negative
    end,BloodWork,Positive
 West,CLL Ireland,Negative
 Life Support,"Raul Cordoba, MD, PhD",Negative
   legend,"chadi nabhan MD, MBA, FACP",Negative
 Plus,Cancer Papers,Negative
 Plus,Michelle Blanch,Positive
 Plus,Bio Entrepreneurs,Positive
 Plus,drrohiniyer,Positive
 Plus,Diagnostics News,Negative
 Plus,Cancer News,Negative
 Plus,Soccer Life,Positive
 novel CD antibody,CLL_Fightersüéó,Negative
 WEBINAR    reimbursement models,Carevƒ´ve,Negative
 w patients,Carevƒ´ve,Negative
 Expert panel discussion,Carevƒ´ve,Negative
 filing,Plexus Ventures,Negative
 filing,Biotech2050,Negative
 Kinder camp crafts,Higher Ground at Lake Louise,Negative
 Capacity,Selma Errol Hassan,Positive
 pasta,Selma Errol Hassan,Positive
 water,Selma Errol Hassan,Positive
 trayGreat use,Selma Errol Hassan,Positive
 language,Selma Errol Hassan,Positive
 language,CLLUWISTA,Positive
 Retelling stories,Selma Errol Hassan,Positive
 w focus,Carevƒ´ve,Negative
 patient pop Expert panel,Carevƒ´ve,Negative
 blueprint,Carevƒ´ve,Negative
 valuebased care,Carevƒ´ve,Negative
   patient pop,Carevƒ´ve,Negative
 singleagent ibr,Anna Deveau,Negative
 PFS SNSS,Anna Deveau,Negative
 disclosures,Anna Deveau,Negative
       ¬Æ,CancerWallonia,Positive
 Patient Version,CancerWallonia,Negative
 NOTCHmut,"Raul Cordoba, MD, PhD",Negative
 Nurse Advisor Angela,Leukaemia Care,Negative
 NewHelp,Lillian Boone,Positive
 AntiTOSO,PROvendis GmbH,Negative
 CAR T Cells,PROvendis GmbH,Negative
    –õ—É—á—à–∏–π,Faruk Hossain,Positive
 –ø—Ä–æ–¥—É–∫—Ç –¥–ª—è –±–æ—Ä—å–±—ã,Faruk Hossain,Positive
   amp Exercise Thanks,CLL_Fightersüéó,Negative
 Martin Luther,Higher Ground at Lake Louise,Negative
 Treatment approach,Cancer Papers,Negative
 Webinar Introductory Presentation,Carevƒ´ve,Negative
 Cancer Care Reimbursement,Carevƒ´ve,Negative
 XFactor magic,Selma Errol Hassan,Positive
 puppet,Selma Errol Hassan,Positive
 refresher,Carevƒ´ve,Negative
 amp    Register,Carevƒ´ve,Negative
 Belly,DillytheKid,Positive
 sur mon soundcloud,DillytheKid,Positive
 tt,DAMSonians,Positive
 UNVERIFICATION,„Ö°,Positive
 Collision Metastasis,Medical & Surgical Pathology,Positive
 Collision Metastasis,ClinExprmntlPathol,Positive
 Collision Metastasis,J Clin Pathol Res,Positive
 Glioblastoma ACase Report,Medical & Surgical Pathology,Positive
 care models,Carevƒ´ve,Negative
 CLL Register,Carevƒ´ve,Negative
   negatively impacts sleep,CLL_Fightersüéó,Negative
 night sweats ‚Äô amp itchiness,CLL_Fightersüéó,Negative
 Ô∏è stress,CLL_Fightersüéó,Negative
 Sad day,CLL_Fightersüéó,Negative
 fellow   patient,CLL_Fightersüéó,Negative
 sugar amp,CLL_Fightersüéó,Negative
 VIDEO Richter syndrome,VJHemOnc,Negative
 Webinar Defining,Carevƒ´ve,Negative
 ŸàÿßŸÜÿ™Ÿà,ÿ±ÿ∂ŸàŸâ üê¨,Positive
 ÿßÿ®ÿ™ÿØŸäÿ™Ÿà,ÿ±ÿ∂ŸàŸâ üê¨,Positive
 ÿ®ÿßŸäŸá,ÿ±ÿ∂ŸàŸâ üê¨,Positive
 ŸàÿßŸÑŸÑŸá ÿßŸÜÿß ÿßÿ®ÿ™ÿØŸäÿ™ ÿ®ÿ≠ÿßŸÑÿ©,ÿ±ÿ∂ŸàŸâ üê¨,Positive
 Esanex Announces Patient,Lymphoma Canada,Negative
 Esanex Announces Patient,Renal Cell Carcinoma,Negative
 Esanex Announces Patient,Financial Buzz,Negative
 Esanex Announces Patient,BusinessWireProducts,Negative
 Esanex Announces Patient,Business Wire-Health,Negative
 Esanex Announces Patient,The Pharmaceutical Marketing Group,Negative
 OpenLabel Study,Lymphoma Canada,Negative
 OpenLabel Study,1stOncology,Negative
 OpenLabel Study,Renal Cell Carcinoma,Negative
 OpenLabel Study,Financial Buzz,Negative
 OpenLabel Study,BusinessWireProducts,Negative
 OpenLabel Study,Business Wire-Health,Negative
 OpenLabel Study,Cancer News,Negative
 OpenLabel Study,The Pharmaceutical Marketing Group,Negative
 Introduction,Carevƒ´ve,Negative
 Introduction,Lymphoma Hub,Negative
 Introduction,Lifelong Learning,Negative
 Introduction,AtlanticJOMedicine,Negative
 Introduction,Cecilia,Positive
 Introduction,ASH,Negative
 ValueBased Cancer Caredont miss,Carevƒ´ve,Negative
 VIDEO   Trials,VJHemOnc,Negative
 subsets,VJHemOnc,Negative
 subsets,CBPartners,Positive
 PCBs dioxin amp solvents,Collegium Ramazzini,Negative
 Estimates,Collegium Ramazzini,Negative
 Ë°ÄÊ∂≤Â°óÊäπÊ®ôÊú¨„Éâ„É©„Ç§„É§„Éº„Çí‰Ωø„ÅÜ„ÅÆ„ÅØÊó•Êú¨„Å†„Åë „ÇÑ „ÅØËá™ÁÑ∂‰πæÁá•„ÅÆ„Åª„ÅÜ„Åå„ÅÑ„ÅÑ,Ë°ÄÊ∂≤ÂÜÖÁßëÂåª„ÄÄ‰∏≠Êùë„ÄÄÂπ∏Âó£,Positive
 WebcastDefining,Carevƒ´ve,Negative
 crowd,WCM Lymphoma,Negative
 um bom dia pra fmr,Robat Taylor Khalifa,Positive
 Tanya crian√ßa,Robat Taylor Khalifa,Positive
 faltam inventar preservativo de Ben,Robat Taylor Khalifa,Positive
   Andrea Sitlinger,Warren Kibbe,Positive
 homes,Warren Kibbe,Positive
   Andrea Sitlinger      costs,Warren Kibbe,Positive
 max,Warren Kibbe,Positive
 OOP,Warren Kibbe,Positive
 medication costs,Warren Kibbe,Positive
 sequencing data,"chadi nabhan MD, MBA, FACP",Negative
 w novel therapies,"chadi nabhan MD, MBA, FACP",Negative
 Toxicities w ibrutinib,"chadi nabhan MD, MBA, FACP",Negative
 subside,"chadi nabhan MD, MBA, FACP",Negative
 time Data,"chadi nabhan MD, MBA, FACP",Negative
 Ireland Analysis,"Raul Cordoba, MD, PhD",Negative
 todays   session,WCM Lymphoma,Negative
 Discussion,"chadi nabhan MD, MBA, FACP",Negative
 Discussion,CLL Ireland,Negative
 Discussion,CLL Society Inc.,Negative
 Discussion,ASCO,Negative
 Critical,"chadi nabhan MD, MBA, FACP",Negative
 costume idea,Higher Ground at Lake Louise,Negative
 Cold,Patient Power,Negative
 Flu Season,Patient Power,Negative
 Webcast Expert,Carevƒ´ve,Negative
 CLLvaluebased care expert,Carevƒ´ve,Negative
 wknd mtg,"chadi nabhan MD, MBA, FACP",Negative
 amp   tracking disease,CLL_Fightersüéó,Negative
 New paradigm,Exec Director VCCC,Positive
 Dr Ferrajoli,MD Anderson Leukemia,Positive
 Dr Ferrajoli,Lisa Palacios,Negative
 Dr Ferrajoli,Patient Power,Negative
 Blood Thinners Safe,Patient Power,Negative
 Risk Assessment,APSHO,Negative
 Risk Assessment,Oncology Tube,Negative
 RiskAdapted Treatment Selection CaseBased Approach,APSHO,Negative
 SNS snss,Anna Deveau,Negative
 HARMONYERIC   project,"Chared, Good Comms",Negative
 HARMONYERIC   project,European Hematology Association,Negative
 HARMONYERIC   project,HARMONY Alliance,Negative
 CLL   Oncology Care Model symposium,Carevƒ´ve,Negative
 Neurotensin receptor type,Tracia.my.tupperware.com,Positive
   Reports Patient,1stOncology,Negative
 Chronic Lymphocytic Leukaemia Market Report,Aarkstore,Positive
 Andrew Hore,BrandUK,Negative
 wnonHodgkin,Matthews & Associates,Negative
 Topic Quick Review,medXclusive Learning,Positive
 Pointers,medXclusive Learning,Positive
 Study CAR TCell therapy,AJMC,Negative
 highrisk chronic lymphocytic tcotqnwzD,AJMC,Negative
 Dr Rajan Dewar,Michigan Pathology,Positive
 Chronic Lymphocytic Leukemia Rare Cause,mieloma,Positive
 Pathological Fracture,mieloma,Positive
 Femur,mieloma,Positive
 John G Gribben MD DSc FMedSci,PER,Negative
 Managing Patients,PER,Negative
 Managing Patients,"Mike Thompson, MD, PhD, FASCO",Negative
 Newly Diagnosed Chronic Lymphocytic,PER,Negative
 Vivement la communaut√©     √† campus el manar fdsptfsegtfst,Noomen,Positive
 postkinase inhibitor failure,Helen Marin,Positive
 imbruvica,Andrew Schorr,Negative
 LymphomaNHLChronic Lymphocytic LekemiaCLLMultiple MyelomaHairy Cell,Matthews & Associates,Negative
 Roundup exposure,Matthews & Associates,Negative
 Pro golfer,UAMS Cancer,Positive
 Bill Wrentz,UAMS Cancer,Positive
 New   poster,NeoGenomics,Positive
 nd Annual Clinical Cytometry Meeting,NeoGenomics,Positive
 CDc expression,SexGenomics,Negative
 CDc expression,Dendritic cells,Positive
 IMPORTANT,Leukemia Irst-Irccs della Romagna,Positive
 Der Gewinner,SpringerMedizin.de,Positive
 der Kategorie Orphan Drugs,SpringerMedizin.de,Positive
 Venclyxto von abbvie,SpringerMedizin.de,Positive
 Gl√ºckwunsch,SpringerMedizin.de,Positive
   Esanex Announces Patient,Cancer News,Negative
 Busine,The Pharmaceutical Marketing Group,Negative
 VIDEO BCL inhibition,VJHemOnc,Negative
 Second lung malignancy Richter syndrome,Respiratory Medicine at BMC,Positive
 ICYMI   expert,HemOnc Today,Negative
 ICYMI   expert,Healio,Negative
 Melanoma Risk,CLL Ireland,Negative
   w,Patient Power,Positive
 Woman,CLL Ireland,Negative
 Current Future Goals,Medscape Education,Negative
 Drs Hillmen Brown Eichhorst amp Ghia,Medscape Education,Negative
 NY Genome Center,Tal Nawy,Positive
 podium,Tal Nawy,Positive
   Tunis,Agenda du Libre,Positive
 Journ√©e Des Logiciels Libres,Agenda du Libre,Positive
 √©e,Agenda du Libre,Positive
 glyphosateRoundupnonHodgkin,Matthews & Associates,Negative
 LymphomaChronic Lymphocytic LeukemiaHairy Cell LeukemiaBCell Lymphoma,Matthews & Associates,Negative
 Mini encuentro   hermoso finde gracias club,Lucas ‚ôö,Negative
 Research seminar,UW_BMS,Positive
 precision medicine era,Sumit Middha,Positive
 TG   TGR combo,Crown Equity CRWE,Positive
 Chronic Lymphocytic Leukemia patients,Crown Equity CRWE,Positive
 Chronic Lymphocytic Leukemia patients,BioRelay,Positive
 iOnco Analytics,iOncoAnalytics,Positive
 Newsletter October,iOncoAnalytics,Positive
 VIDEO Nitin Jain,VJHemOnc,Negative
 prospects,VJHemOnc,Negative
 Blwyddyn Ll yn mwynhau gweithdy drama,Melin Gruffydd,Negative
 Cantrer Gwaelod Year Ll,Melin Gruffydd,Negative
 Cantre Gwaelod Workshop,Melin Gruffydd,Negative
 fisicas para,Alison Evans,Negative
 el Capitulo,Alison Evans,Negative
 EGR mutations,AU Oncology Reviews,Positive
 EGR mutations,Lymphoma Coalition,Negative
 EGR mutations,DTHSTR,Positive
 EGR mutations,DrugGenius,Negative
 EGR mutations,TumorImmunoPapers,Negative
 EGR mutations,Duane Hassane,Positive
 EGR mutations,Pathowitter,Positive
 Thanks guys,CLL_Fightersüéó,Negative
 New Hodgkin lymphoma,Medivizor,Negative
 flu jab protection,Nick,Negative
 CART cell therapies,iOncoAnalytics,Positive
 CLL Richter transformation,AU Oncology Reviews,Positive
 octobre conferences,Mahmoud Turki,Negative
 blogs,Andrew Schorr,Negative
 blogs,Patient Power,Negative
 precautions,Andrew Schorr,Negative
   pt,Andrew Schorr,Negative
   pt,"chadi nabhan MD, MBA, FACP",Negative
 Lymphoma Chronic Lymphocytic Leukemia Hairy Cell Leukemia,Matthews & Associates,Negative
 Abnormal Liver Function,Lymphoma Canada,Negative
 Abnormal Liver Function,CLL Society Inc.,Negative
 Inhibitor Therapy,Medscape Education,Negative
 Drs Gribben Cymbalista Kreuzer,Medscape Education,Negative
 Dose reduction,Lymphoma Hub,Negative
 Chronic Lymphocytic Leukemia Prevalence Outcomes,Sameer Parikh,Negative
 Chronic Lymphocytic Leukemia Prevalence Outcomes,Cancer Papers,Negative
 Pa,Sameer Parikh,Negative
 origin,Oncology Tube,Positive
 roof,Nick,Negative
   meeting summary amp videos,CLLSA,Negative
 IkgdarRetuximab Injection Chronic Lymphocytic Leukemia Treatment,JackMillion,Positive
 Celebramos el d√≠a,Corporaci√≥n Lady Lee,Positive
 nivel nacional,Corporaci√≥n Lady Lee,Positive
 todos los consentidos del hogar que forman,Corporaci√≥n Lady Lee,Positive
 parte,Corporaci√≥n Lady Lee,Positive
 de la gran,Corporaci√≥n Lady Lee,Positive
 familia,Corporaci√≥n Lady Lee,Positive
 familia,Centro Luso Larense,Negative
 ers,CLL_Fightersüéó,Negative
 ‚¨Ü Ô∏èrisk,CLL_Fightersüéó,Negative
 LymphomaNHLChronic Lymphocytic LekemiaCLLMultiple Myeloma Hairy Cell LeukemiaHCLall,Matthews & Associates,Negative
 Lenalidomide maintenance therapy,OncologyNurseAdvisor,Negative
 progression risk,OncologyNurseAdvisor,Negative
 Flu season,CLL Ireland,Negative
 Flu season,CLLSA,Negative
 timely reminder,CLL Ireland,Negative
 Innovative     v     Link,CLL_Fightersüéó,Negative
 cll metabolism amp disease progression,CLL_Fightersüéó,Negative
 √®ve √†                pr√©sents,SNU P√¥le Emploi FSU Occitanie,Negative
 Turnbull government subsidy,CLL Ireland,Negative
 cancer sufferers,CLL Ireland,Negative
 √®ve,SNU P√¥le Emploi FSU Occitanie,Positive
 √†   ce mardi,SNU P√¥le Emploi FSU Occitanie,Negative
 octobre,SNU P√¥le Emploi FSU Occitanie,Negative
 Appel de   syndicats,SNU P√¥le Emploi FSU Occitanie,Negative
 Dans,SNU P√¥le Emploi FSU Occitanie,Negative
 Invaluable list,CLL_Fightersüéó,Negative
 condominium associations HOAs,RLL LLC,Positive
 coops,RLL LLC,Positive
 risk transfer solution,RLL LLC,Positive
 Leicester CLLSA meeting summary,CLLSA,Negative
   medicine,Ethical Strategies,Positive
 PBS   Australians,Ethical Strategies,Positive
 Aus Government,Christopher Steer,Negative
 Janssens Ibrutinib,Christopher Steer,Negative
 VIDEO Nicole Lamanna,VJHemOnc,Positive
 mechanisms amp therapies,VJHemOnc,Negative
 CURE Magazine,CLL Society Inc.,Negative
 Leah Lee Photography,CLL Society Inc.,Negative
 VIDEO Phillip Thompson,VJHemOnc,Negative
 Lenalidomide maintenance,CLL Ireland,Negative
 Lenalidomide maintenance,Cancer Papers,Negative
 Lenalidomide maintenance,HemOnc Today,Negative
 highrisk   Phase III study,CLL Ireland,Negative
 w placebo aft firstline therapy,CLL Ireland,Negative
   Autumn forum,EYELATeachingSchool,Positive
 JackCoach Smith,james smith,Positive
 sodas,CLL_Fightersüéó,Negative
 Pronounce Cln,1ClickRepeater,Positive
 RT ‚ù§        LM,1ClickRepeater,Positive
 CLL Lenalidomide Maintenance Therapy Reduces Progression Risk,BlackSwan Analysis now part of Evaluate Pharma Ltd,Positive
 Black Swan Intelligent,BlackSwan Analysis now part of Evaluate Pharma Ltd,Positive
 systemic AL,Robert Z. Orlowski,Negative
 Arsenal fans,Sid,Positive
 VIDEO Matthew Davids,VJHemOnc,Negative
 PHAGOCYTOSIS,NK papers,Negative
 EXPRESSION,NK papers,Negative
 EXPRESSION,IJAR,Positive
 FCgRECEPTORS,NK papers,Negative
 CD MONOCYTES,NK papers,Negative
 Tsertsvad,NK papers,Negative
 New videos,Nick,Negative
 Welcome,Nick,Negative
 pickupListen,PUSHLiving,Positive
 Sun,PUSHLiving,Positive
 Leukemia Clinical impact,IUOPA,Negative
 CLL combination treatment,CancerTherapyAdvisor,Positive
 Bout,Jah Kuu,Negative
 snippet,Jah Kuu,Negative
 ‚ôÇ Ô∏è,Jah Kuu,Negative
 ü§¶,Jah Kuu,Negative
   patient survey,CLLSA,Negative
 amp perspectives,CLLSA,Negative
 Legendary Hockey Player,Elaine Lindsay üé§‚ôèÔ∏è,Positive
 Legendary Hockey Player,Windows to the Soul,Positive
 GameChanging Diagnosis,Elaine Lindsay üé§‚ôèÔ∏è,Positive
 GameChanging Diagnosis,Windows to the Soul,Positive
 ‚Äç SEEDY ü¶Ü ü¶Ü Inhibits,Prof John,Negative
 BCR BINGO,Prof John,Negative
 Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,Markets & Reports,Negative
 Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,EPR Network,Positive
 Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,BizPR,Positive
 Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,DrugGenius,Positive
 Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,COPD News,Negative
 √†   le           Manquent,SNU P√¥le Emploi FSU Occitanie,Negative
 √† lappel     comme souvent,SNU P√¥le Emploi FSU Occitanie,Negative
 Los Gimnastas Rusos,Estelar Gimnasia,Negative
 subir al podio,Estelar Gimnasia,Negative
 International cancer trial,CLL Ireland,Negative
 International cancer trial,Medical Independent,Positive
 University Hospital Galway Details,CLL Ireland,Negative
 BCell Lymphoma   Inhibitor Good News,Prof John,Negative
 Tcell PLL,Prof John,Negative
 Columbia intern Cavemom,Amy C. Cavers,Negative
 Chronic Lymphocytic Leukemia Hodgkins Lymphoma,CARE‚Ñ¢ Education,Negative
 lunch,CARE‚Ñ¢ Education,Negative
 lunch,TESL Canada,Positive
   Ph study,Janice Oliver,Positive
   Ph study,Genentech,Negative
 cosmos,CRPS UK,Positive
 BBC Radio,CLLSA,Negative
 Multilat√©rale entre la DR,SNU P√¥le Emploi FSU Occitanie,Negative
 et les,SNU P√¥le Emploi FSU Occitanie,Negative
 New CART cells,Medivizor,Negative
 Prodigiosin,CLL Society Inc.,Negative
 B T cells,CLL Society Inc.,Negative
    Want,Patient Power,Negative
 Email autumninfo,Patient Power,Negative
 chamam de louco,Robat Taylor Khalifa,Positive
 num mundo,Robat Taylor Khalifa,Positive
 que os certos Fazem bomba,Robat Taylor Khalifa,Positive
 Positive Relationship,Patient Power,Negative
   Restrictions,AIRR-seq papers,Positive
 Tcell repertoire,AIRR-seq papers,Positive
 Tcell repertoire,DrugGenius,Negative
 Tcell repertoire,SeqComplete,Negative
 Tcell repertoire,TumorImmunoPapers,Negative
 Tcell repertoire,CLL-seq,Negative
 Tcell repertoire,MDLinx,Negative
 relapsedrefractory   metaanalysis,"Raul Cordoba, MD, PhD",Negative
 Prolong Progressionfree Survival,osakahiro,Positive
 Prolong Progressionfree Survival,NACDA Program on Aging,Negative
 „Åã„Çâ,osakahiro,Positive
 Venclexta   Rituxan,Carolyn Thompson,Negative
 tcoevmQAPuX,Medical Independent,Positive
 flu,CLLSA,Negative
 Malin,Mary B. Gunter,Positive
 culture,Mary B. Gunter,Positive
 culture,GenPath Oncology,Negative
 reading,Mary B. Gunter,Positive
 Se va,Marc Puigvert,Positive
 votar de forma pacifica,Marc Puigvert,Positive
 creeping killer,Margaret Walker,Negative
 Cello Group plcs buy rating,MarketBeat,Positive
 Cello Group plcs buy rating,US Banking News,Positive
 CIENCIASMEDICASNEWS Chronic Lymphocytic Leukemia Treatment Options,Victor Norberto Cerasale Morteo,Negative
 wa,Patient Empowerment Network,Negative
 VOC√ä TEM CARA DE QUE N√ÉO CONHECE,Robat Taylor Khalifa,Positive
 PAI,Robat Taylor Khalifa,Positive
 tournament,Southland,Positive
 Snapshot,APSHO,Negative
 image JH Chronic Lymphocytic,ScienceSource Images,Positive
 allografts,Blood Journal,Negative
 allografts,"Raul Cordoba, MD, PhD",Negative
 Longterm outcome,Blood Journal,Negative
 Highrisk,Blood Journal,Negative
 Highrisk,MD Anderson Leukemia,Negative
 Highrisk,Lymphomation.org,Negative
 NEW   INSIGHT Ectopic Expression,Prof John,Negative
 ILT,Prof John,Negative
 BCRdependent Akt Activation,Prof John,Negative
 lifecycle,CLL_Fightersüéó,Negative
 freuen sich auf einen Tag voller,German Cheer Dad (GCD),Negative
 Stunts,German Cheer Dad (GCD),Negative
 Pathological Findings,Cancer Papers,Negative
 Nigga kizomba outro,Robat Taylor Khalifa,Positive
 kuduro,Robat Taylor Khalifa,Positive
 signposts,CLL_Fightersüéó,Negative
 MD PhD,CLL_Fightersüéó,Negative
 MD PhD,Lymphoma Hub,Negative
 Nora,Patient Power,Negative
   Tune,Patient Power,Negative
 High Response Rate   Negativity,CancerWallonia,Negative
 Amy Goodrich,Beth Faiman PhD,Positive
 Skin lesions,CLL Ireland,Negative
 hairdressers,Selma Errol Hassan,Positive
 hairdressers,Oncology Update,Positive
 Colonia Las Liebres,El Celta Restaurant,Positive
 de   Este,El Celta Restaurant,Positive
 joven     mendocino,El Celta Restaurant,Positive
 VIDEO   analyses,VJHemOnc,Negative
   TCell,CancerWallonia,Negative
 HighRisk Refractory,CancerWallonia,Negative
 Dr Turtle,SeattleCancerCareAlliance,Negative
 FB,SeattleCancerCareAlliance,Negative
 FB,Patient Power,Negative
 FB,Andrew Schorr,Negative
 FB,CLL Society Inc.,Negative
 chronic   problems,CLL_Fightersüéó,Negative
   People,CLLSA,Negative
   ‚Äç,Jah Kuu,Negative
    Checkout,Michele Nadeem-Baker,Negative
 amp s FB Live,Patient Power,Negative
 MicroRNA dysregulation,Lymphoma Canada,Negative
 Finncap,Vox Markets,Negative
 broker note,Vox Markets,Negative
 Cello Group,Vox Markets,Positive
 Cello Group,Share Prophets,Positive
 Cello Group,MarketBeat,Negative
 Cello Group,Buchanan,Positive
 Repost Tag,German Cheer Dad (GCD),Negative
 Ian Pollard,BrandUK,Positive
 Expectations,WheelieDealer,Negative
 Expectations,MDRing,Negative
 Interim Divvy,WheelieDealer,Negative
 Revenue,WheelieDealer,Negative
 Ph   study,BioPharma Dive,Negative
 starts,CLL_Fightersüéó,Negative
 starts,"chadi nabhan MD, MBA, FACP",Negative
 starts,iwCLL,Positive
 separate,CLL_Fightersüéó,Negative
       predicts,Pub Snips üî¨,Positive
    Outcomes amp MRD analysis,Lymphoma Hub,Negative
 VIDEO Florence Cymbalista,VJHemOnc,Negative
 Armed wnew data ABBV RHHBY,Kara Jill Stancell,Negative
 discovery amp role,CLL Ireland,Negative
 BCL amp microRNA,CLL Ireland,Negative
 epigeneticsamp genetics,CLL Ireland,Negative
 Fear,CLLSA,Negative
 amp unpredictability,CLLSA,Negative
 Novel chronic lymphocytic   therapy,Roche,Positive
 AbbVie Announces Positive Topline Results,Financial Buzz,Negative
 Phase   Trial Evaluating,Financial Buzz,Negative
 ‚Ñ¢ VENCLYXTO,Financial Buzz,Negative
 ‚Ñ¢ Venetoclax T,Financial Buzz,Negative
 P Trial,Odi Bruckman,Negative
 Venetoclax Tablets,Odi Bruckman,Negative
 Pats,Odi Bruckman,Negative
     News,CLL Ireland,Negative
 tcoDSPsZaoh,CLL Ireland,Negative
 Mini   reunion,Angela,Positive
 Ms Becca,Angela,Positive
 Hayde,Angela,Positive
   Session Westin,MD Anderson Leukemia,Positive
   Session Westin,Lisa Palacios,Positive
 CLL Questions,MD Anderson Leukemia,Negative
 CLL Questions,Lisa Palacios,Negative
 CLL Questions,The ASCO Post,Negative
 Abst CLL Venetoclax,Lisa Palacios,Negative
 Abst CLL Venetoclax,MD Anderson Leukemia,Negative
 RR CLL w p deletion,Lisa Palacios,Negative
 RR CLL w p deletion,MD Anderson Leukemia,Negative
 Case Study,MD Anderson Leukemia,Negative
 Case Study,Lisa Palacios,Negative
 Managing BTK Inhibitor Refractory CLL,MD Anderson Leukemia,Negative
 Managing BTK Inhibitor Refractory CLL,Lisa Palacios,Negative
 CLL State,MD Anderson Leukemia,Negative
 CLL State,Lisa Palacios,Negative
 Westin,Lisa Palacios,Negative
 Westin,MD Anderson Leukemia,Negative
 GalleriaLP Dr Keating,Lisa Palacios,Negative
 GalleriaLP Dr Keating,MD Anderson Leukemia,Negative
 ChemoFree Therapy,Lisa Palacios,Negative
 ChemoFree Therapy,MD Anderson Leukemia,Negative
 Quando uma mulher sofre,Robat Taylor Khalifa,Positive
 √© porque est√° sem internet,Robat Taylor Khalifa,Positive
 Adicionando Ublituximab,Fernando Medina,Positive
 Ibrutinib Melhora,Fernando Medina,Positive
 Taxas de Resposta CLL Reca√≠das,Fernando Medina,Positive
 Advanced     Patients,CLL Ireland,Negative
 Oral Duvelisib,CLL Ireland,Negative
 Maintenance lenalidomide,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Maintenance lenalidomide,Lymphoma Hub,Negative
 seasonSunday,Ashton Cricket Club,Positive
 Ashton,Ashton Cricket Club,Positive
 DNA methylation gene expression markers,Wnt publications,Negative
 Bcell NonHodgkins Lymphoma,Biotech2050,Negative
 TGTX TGR,Biotech2050,Negative
 „Äê Film„Äë‰∫ÄÊôÇÈñì„ÉªÈéåÂÄâ„ÅÆ„Ç≤„Çπ„Éà„Éè„Ç¶„Çπ„ÄÇ„Å®„Å£„Å¶„ÇÇËêΩ„Å°ÁùÄ„ÅèÂ†¥ÊâÄ„Åß„Åó„Åü„ÄÇ„Åú„Å≤„Åæ„ÅüË°å„Åç„Åü„ÅÑ„Å™„ÅÇÔºÅ„Éª,Toshitsugu Nakamura,Positive
 „Ç≤„Çπ„Éà„Éè„Ç¶„Çπ,Toshitsugu Nakamura,Positive
 Chronic Lymphocytic Leukemia Treatment Options,News Medical,Positive
 Chronic Lymphocytic Leukemia Treatment Options,Oncology Tube,Negative
 DrRosenbaum,Anna Deveau,Negative
 drug   effects,Michele Nadeem-Baker,Negative
 Navigating,Medscape Education,Negative
 New Oral Treatment Algorithms,Medscape Education,Negative
 w Drs Julio Delgado amp Stephan Stilgenbauer,Medscape Education,Negative
 bow,German Cheer Dad (GCD),Negative
 oxygen results,CLL Ireland,Negative
 oxygen results,VJHemOnc,Negative
 chemoimmunotherapy frontline,"Raul Cordoba, MD, PhD",Negative
 rivalry,"Pharmacyclics, an AbbVie Company",Negative
 rivalry,Jack Payette,Positive
 dominoes,"Pharmacyclics, an AbbVie Company",Negative
 golf,"Pharmacyclics, an AbbVie Company",Negative
 James diagnosis,"Pharmacyclics, an AbbVie Company",Negative
 Sweet Taste Receptors,CLL Ireland,Negative
 Body,CLL Ireland,Negative
 Body,Patient Power,Negative
 Body,Wes Ryan Landsdale,Positive
 Sinus Infections,CLL Ireland,Negative
    talk,MoJo,Negative
 MTP   Session Westin,Lisa Palacios,Negative
 MTP   Session Westin,MD Anderson Leukemia,Negative
 GalleriaLChevy f,Lisa Palacios,Negative
 GalleriaLChevy f,MD Anderson Leukemia,Negative
 CLL Common Problem,Lisa Palacios,Negative
 CLL Common Problem,MD Anderson Leukemia,Negative
 light‚Äêchain‚Äêdependent cross‚Äêreaction,Science Disseminat..,Positive
 Regulation,"chadi nabhan MD, MBA, FACP",Negative
 MAPK,"chadi nabhan MD, MBA, FACP",Negative
 MAPK,"Raul Cordoba, MD, PhD",Negative
 Se homosexualismo fosse,Robat Taylor Khalifa,Positive
 David Andrews,David Egan,Positive
 SNS,CLL Ireland,Negative
 SNS,Edison,Positive
 SNS,EdisonHealthcare,Positive
 Joe Crisara,Contracting Business,Positive
 premium midrange,Contracting Business,Positive
 economy pricing,Contracting Business,Positive
 Joe Crisara Pure Motive Pricing,Contracting Business,Positive
   customer,Contracting Business,Positive
 CDspecific CAR Tcell therapy,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 VIDEO Starving   cells,VJHemOnc,Negative
   bln,Anna Deveau,Negative
 Stefano Molica comments,BMC Medicine,Positive
 data ibrutinib,BMC Medicine,Negative
 Thomas J Kipps MD PhD,CLL Ireland,Negative
 –ø—Ä–æ–¥—É–∫—Ç –¥–ª—è,Faruk Hossain,Positive
 VIDEO Homeless tumour cells,VJHemOnc,Negative
 healing class,Michele Nadeem-Baker,Negative
 Quincy,Michele Nadeem-Baker,Negative
 Novel therapies,Dr Shushil Choubey,Positive
 VIDEO Novel therapies,VJHemOnc,Negative
 treatment Peter Hillmen,VJHemOnc,Negative
 Mulher magra,Robat Taylor Khalifa,Positive
 cal√ßinhaOuvi com este bro,Robat Taylor Khalifa,Positive
 VIDEO Prospects,VJHemOnc,Negative
 Salmonella,CLL Ireland,Negative
 BCell Chronic Lymphocytic Leukemia Global API,COPD News,Negative
   amp   conf,LymphomaAction,Positive
 Dr Arvind Arumainathan amp Dr Jan Ablett,LymphomaAction,Negative
     CDSpecific CAR TCell Therapy Effective,SeqComplete,Negative
 IbrutinibRefractory CLL,SeqComplete,Negative
 MicroRNA,microRNApapers,Negative
 MicroRNA,Tracia.my.tupperware.com,Positive
 quem ja apangou diareia,Robat Taylor Khalifa,Positive
 Andys story,Patient Power,Negative
 Chronic Lymphocytic Leukemia CLL Introduction,C. R.,Positive
 Dr Bomben,Invivoscribe,Negative
 Lectores Edeb√©,Edeb√© Chile,Positive
 volunteer,Cancer Hope Network,Positive
 AChangin   Milano,3PSolution,Positive
 Sep,3PSolution,Positive
 MichelangeloInfo e Iscrizioni,3PSolution,Negative
 RJ,Biotech2050,Negative
 TGTX   st line,Biotech2050,Negative
 ‚Üë,Scot Walker,Positive
 Chronic Lymphocytic   Metastatic Melanoma,NACDA Program on Aging,Negative
 Neartetraploidy,Blood Advances,Positive
 Neartetraploidy,CLL Ireland,Negative
 Neartetraploidy,MoJo,Negative
 ABBVInfinity castoff,Kara Jill Stancell,Negative
 Pivotal Phase   DUO Study inn,Christoph Westphal,Positive
 Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma,Christoph Westphal,Positive
 Verastem Announces Positive Topline Data,Financial Buzz,Negative
 Verastem Announces Positive Topline Data,Market Cheetah,Positive
 Verastem Announces Positive Topline Data,The Pharmaceutical Marketing Group,Negative
 DUO ‚Ñ¢ Study,Financial Buzz,Negative
 DUO ‚Ñ¢ Study,Market Cheetah,Positive
 DUO ‚Ñ¢ Study,The Pharmaceutical Marketing Group,Negative
 Refractory Chroni,Financial Buzz,Negative
 Relapsed Refractory Chronic L,Market Cheetah,Positive
 Sm,The Pharmaceutical Marketing Group,Negative
 management plan Inhye Ahn,VJHemOnc,Negative
 Multiple MyelomaHairy Cell LeukemiaChronic Lymphocytic Leukemiaand,Matthews & Associates,Negative
 ndQ,MAISA,Negative
   tests,Andrew Schorr,Negative
 s Blog Mutated,CLL_Fightersüéó,Negative
 Unmutated,CLL_Fightersüéó,Negative
 Blog,CLL_Fightersüéó,Negative
 Blog,Business News,Positive
 Blog,Prof John,Positive
 thinking,CLL_Fightersüéó,Negative
 Biyobenzer ile ba≈üetmenin yeni bir yolu,Prof Dr Mustafa Benekli ü©∫,Positive
   evolution,Margaret Walker,Negative
   evolution,CLL Ireland,Negative
 singerrapper icon Min Yoongi,heyyo,Positive
 basket,heyyo,Positive
 fruits,heyyo,Positive
 Park Jimin,heyyo,Positive
 Pls RT,CLLSA,Negative
   video amp help,CLLSA,Positive
 Severe Myasthenia Gravis,Cancer Papers,Negative
 press frm,CLL Ireland,Negative
 muchneeded attention,CLLSA,Negative
    BCell Chronic Lymphocytic Leukemia Pipeline Review H   Report,Cancer News,Negative
   characterization,Sumit Middha,Positive
    fundraiser,Michele Nadeem-Baker,Negative
 gene therapy,Michele Nadeem-Baker,Negative
 Cell,CLL_Fightersüéó,Negative
 Origin,CLL_Fightersüéó,Negative
 Origin,Lymphoma Hub,Negative
 Origin,Oncology Tube,Negative
 Olivier Bernard PhD,CLL_Fightersüéó,Negative
 Review Article Guidelines,Cristina Popa,Positive
     Awareness Month RT,CLLSA,Negative
   Awareness Month RT,CLLSA,Negative
     Month RT,CLLSA,Negative
 Awareness Month RT,CLLSA,Positive
 Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation,Cancer Papers,Negative
 Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation,NK papers,Negative
 Chronic lymphocytic   results,Roche,Positive
 buildup,Roche,Positive
 Chronic Lymphocytic Leukemia Cel,NK papers,Negative
 Altered,Frontiers Immunology,Negative
 Altered,Dendritic cells,Positive
 Altered,Cancer Papers,Negative
 NLinked Glycosylation,Frontiers Immunology,Negative
 NLinked Glycosylation,Dendritic cells,Positive
 NLinked Glycosylation,Cancer Papers,Negative
 NLinked Glycosylation,ImmuneGCPapers,Positive
 Chronic Lymphocytic Leukemia Involvement,Frontiers Immunology,Negative
 Chronic Lymphocytic Leukemia Involvement,Dendritic cells,Positive
 Chronic Lymphocytic Leukemia Involvement,Cancer Papers,Negative
 Northern hemisphere countries,CLL_Fightersüéó,Negative
 –≤ –ò–∑—Ä–∞–∏–ª–µ–ß–∏—Ç–∞—Ç—å   –õ–µ—á–µ–Ω–∏–µ–≤–ò–∑—Ä–∞–∏–ª–µ,–õ–µ—á–µ–Ω–∏–µ —Ä–∞–∫–∞,Negative
 August newsletter,Lymphoma Hub,Negative
   st,CLLSA,Negative
 RT amp,CLL Ireland,Negative
   September,CLLSA,Negative
 Mutated IGHV Receptors Shared Distinct Immunogenetic Features,GEDEFO,Negative
 Mutated IGHV Receptors Shared Distinct Immunogenetic Features,Jerry Lee,Negative
 Mutated IGHV Receptors Shared Distinct Immunogenetic Features,Cure Cancer Now,Negative
 Clini,Jerry Lee,Negative
 tumors,Merge Communications,Positive
 novel CART therapy,Beverley Newbury,Positive
 reprogramme cells,Beverley Newbury,Positive
 VIDEO genome sequencing,VJHemOnc,Negative
 VIDEO Nextgeneration   inhibitors,VJHemOnc,Negative
 cancer course,CLL_Fightersüéó,Negative
 trajectory,CLL_Fightersüéó,Negative
 Jimenez,Anna Deveau,Negative
 Novartis ‚Äô technology,Anna Deveau,Negative
 WWBH land,Elmer Puddpucker,Positive
 terminal cancer,Elmer Puddpucker,Positive
 Chronic Lymphocytic   Causes,NACDA Program on Aging,Negative
 Chronic Lymphocytic LeukemiaDoing,Kerry,Negative
 nd time,Kerry,Negative
 CCR   Drug Updates Venetoclax,Marlowe S Tessmer,Negative
 VIDEO Issues,VJHemOnc,Negative
 County level incidence rates,Future Oncology,Negative
 graciosas,Alison Evans,Negative
 tipo de tallas Soy de estatura promedio,Alison Evans,Negative
 newsletter sign,Lymphoma Hub,Negative
 thursday,Lymphoma Hub,Negative
   Biologics,CLL Ireland,Negative
 Invac,TrialBulletin,Negative
 Condition Summary Leukemia Lymphocytic Ch,TrialBulletin,Negative
   Ibrutinib Therapy Increases T Cell Repertoire Diversity,AIRR-seq papers,Positive
 Iris de Weerdt,VJHemOnc,Negative
 Unmet Clinical Need,CLL Ireland,Negative
 leukemiaAcute Lymphocytic Leukemia Acute Myelogenous Leukemia Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia,Nr.sara üíâüìã,Positive
 profile wall,Jah Kuu,Negative
 Bobby Brown,Jah Kuu,Negative
 HittaMiz Prod,Jah Kuu,Negative
 Don Fresco,Jah Kuu,Positive
 HittaMiz,Jah Kuu,Positive
 tcobXIBiUGWt ‚ô®,Jah Kuu,Negative
 vibe,Jah Kuu,Negative
 Âõ∫ÂÆöÁî®„ÄëÂçÉËëâ„Åß„É©„Ç§„Éñ„Éá„Ç£„Ç™„Å®„Éá„Ç£„Ç™„Éê„Éè‰πó„Å£„Å¶„Åæ„ÅôÔºÅ„Å´„Çè„Åã„Å™„Åå„ÇâÂéü‰ªò„Çπ„ÇØ„Éº„Çø„Éº„ÅåÂ•Ω„Åç„Åß„ÅôÔºÅÊòØÈùû„Éï„Ç©„É≠„Éº„ÅäÈ°ò„ÅÑ„Åó„Åæ„Åô„É©„Ç§„Éñ„Éá„Ç£„Ç™,„Éû„É≥„É¢„Çπ,Positive
 microscopeEuropean Commission,CLL Ireland,Negative
 CORDIS,CLL Ireland,Negative
 Inhibitor Therapies,Patient Power,Negative
 Inhibitor Therapies,Oncology Tube,Negative
 PDL Immune Checkpoints Molecules,Immuno-Oncology,Negative
 PDL Immune Checkpoints Molecules,Henning,Negative
 PDL Immune Checkpoints Molecules,Cancer Papers,Negative
 gap,CLL Ireland,Negative
 gap,VJHemOnc,Negative
 gap,AJMC-Oncology,Negative
 Man,Jah Kuu,Negative
 Man,HoneymoonGondol,Positive
 Realm,Jah Kuu,Negative
         ‚ô®,Jah Kuu,Negative
 bout,Jah Kuu,Negative
 haem malignancy,BloodWork,Positive
 rarely alters,BloodWork,Positive
 tgtx,Anna Deveau,Positive
 tgtx,Joe,Positive
 Sakharoff Protocol,Misha Sakharoff,Positive
 Lymphatic Cancer,Misha Sakharoff,Positive
 Case review,Misha Sakharoff,Positive
 Tumors,Lymphoma News Today,Positive
 Tumors,NACDA Program on Aging,Negative
 Tumors,BioNews,Negative
 Tumors,SeqComplete,Negative
 Trial Read,Lymphoma News Today,Negative
     en Urdinarrain,Lucas ‚ôö,Negative
 BCell Chronic Lymphocytic Leukemia Pipeline Insight,emailwire,Positive
 BCell Chronic Lymphocytic Leukemia Pipeline Insight,BizPR,Positive
 Therapeutic Assessment,emailwire,Positive
 Therapeutic Assessment,BizPR,Positive
 Therapeutic Assessment,EPR Network,Positive
 Cirmtuzumab   ibrutinib,Anna Deveau,Negative
 Pipeline ReviewC H pcoDcrxamppcocrx,@ReportsandMarkets,Positive
 Andys Story,Patient Power,Negative
 Tax ft HittaMiz Prod,Jah Kuu,Negative
 tcoGzsCPuUnOe,Jah Kuu,Negative
   pts amp family members,Andrew Schorr,Negative
 star cast,Andrew Schorr,Negative
 Portland event,Andrew Schorr,Negative
 Pls registe,Andrew Schorr,Negative
 Chronic Lymphocytic Leukemia Commentary,Cancer Papers,Negative
 lymphocyte activation gene,AU Oncology Reviews,Negative
 Californias,CIRM,Positive
 cell agency funds,CIRM,Positive
 El uso de lenalidomida revlimid,Dr. Luis Villela,Positive
 pacientes con leucemia linfocitica cr√≥nica posttrasplante alogeneico,Dr. Luis Villela,Positive
 Happy Days,Prof John,Negative
 HDAC Inhibition Ups CD amp,Prof John,Negative
 Neartetraploidy    copies,"Raul Cordoba, MD, PhD",Negative
 chromosomes,"Raul Cordoba, MD, PhD",Negative
 Protein p Isoforms,AURELIAN UDRISTIOIU,Negative
 Chronic Lymphocytic LeukemiaAurelian UdristioiuMolecular Biology Faculty,AURELIAN UDRISTIOIU,Negative
 viable option postalloSCT,Lymphoma Hub,Negative
 Muchas,Estelar Gimnasia,Negative
 todos los medallistas de la,Estelar Gimnasia,Negative
   amp s Dr Furman,NewYork-Presbyterian,Positive
   TCell Therapy,MoJo,Negative
 Narrative Review,MoJo,Negative
 Market Research,EPR Network,Positive
 Market Research,BizPR,Positive
   Dr Turtle,SeattleCancerCareAlliance,Negative
 Cdn hockey legend Paul Henderson,Janssen Canada,Positive
 lifesaving drug,VJHemOnc,Negative
 GC    Altered,ImmuneGCPapers,Positive
 Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H   Report,COPD News,Negative
 Pric,COPD News,Negative
   Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H   Report,CRO Contract Res.,Negative
 LAMIN,Prof John,Negative
 Lamin B,Prof John,Negative
 Nutr,Review Your Life,Positive
 T cell number,CLL Ireland,Negative
 Pronounce Cllr,1ClickRepeater,Positive
 ‚Ü∫,1ClickRepeater,Positive
 RT ‚ù§,1ClickRepeater,Positive
 chemorefractoriness,BloodWork,Positive
 fantasy football draft,Sean_Stewart,Positive
 hardware Cheers,Sean_Stewart,Positive
 Que manera de reirme con los pibes jajajaja que capos,Lucas ‚ôö,Negative
 Hamburguesas con la banda,Lucas ‚ôö,Negative
 Bruce D Cheson MD,CLL Society Inc.,Negative
 Bruce D Cheson MD,Gate 2 Wordy Freedom,Positive
   Portland Event,Patient Power,Negative
 el Duoc Sede Plaza Norte,The Pepex Family,Negative
 el Duoc Sede Plaza Norte,Indy Wrestling Chile,Negative
 NK cell dysfunction,NK papers,Negative
 NK cell dysfunction,NK cell Biology,Negative
 problem,CLL Ireland,Negative
 problem,Oncology Tube,Negative
 problem,VJHemOnc,Negative
 Julio Chavez MD,OncLive SOSS,Negative
 Shared Experiences   Couples Connect,Patient Power,Negative
 Dr Powers,CLL Ireland,Negative
 Ibrutinib ben√©fico,Fernando Medina,Positive
 com leucemia linfoc√≠tica cr√¥nica,Fernando Medina,Positive
 Research CAR Tcell therapy,Sue Carlson,Positive
 Research CAR Tcell therapy,WorldStemCellSummit,Positive
   inc   patients,CLL Ireland,Negative
 SA protein,Blood Journal,Negative
 exosomes,Blood Journal,Negative
 Live Life event,Helen Jane Mee,Negative
 AEGLE,AEGLE,Positive
 bigdata,AEGLE,Negative
 analytics Applied scenarios,AEGLE,Negative
 OS diffCLL,Marek Trneny,Positive
 effector functions,J Immunol,Negative
 Terraza Las Banderas de   un espacio recreativo para que todos disfrutemos,Corporaci√≥n Lady Lee,Positive
 momentos entre colegas,Corporaci√≥n Lady Lee,Positive
 y amigos,Corporaci√≥n Lady Lee,Positive
 RT VitaminDCouncil People,Jeff T Bowles,Positive
 Lab Tests,Patient Power,Positive
 Lab Tests,Lab Tests Online,Positive
 w Dr Kipps,Patient Power,Positive
 amp Dr Leclair,Patient Power,Negative
 prosurvival pathways,Turmeric,Negative
 prosurvival pathways,X8-NANO,Positive
 BCell Disorders,Turmeric,Positive
 mutations inc p deletion amp p,CLL Ireland,Negative
 VIDEO   update,VJHemOnc,Negative
 University Hospital Cologne,VJHemOnc,Negative
 postvenetoclax progression,"chadi nabhan MD, MBA, FACP",Negative
 Emerging Approaches,Oncology Tube,Positive
 Emerging Approaches,Patient Power,Negative
 Dr Sharmans presentation,CLL Ireland,Negative
 GENUINE trial,CLL Ireland,Negative
 tcoZTqenXNzo,CLL Ireland,Negative
   Couples,Oncology Tube,Negative
 Shared Experiences,Oncology Tube,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL Epidemiology Insights,COPD News,Negative
 Updated,COPD News,Positive
 Pri,COPD News,Negative
 Wendtner CM,Cancer Papers,Negative
 Gregor M Current,Cancer Papers,Negative
 New   research study,Shelley Webb,Negative
 New   research study,International Pain Foundation¬Æ,Positive
 New   research study,Debbie Woodbury,Positive
 New   research study,susanna sargsyan,Positive
 New   research study,Jennifer Huber,Positive
 New   research study,Gabe Howard,Positive
 New   research study,Sandy D.,Positive
 New   research study,Sharon Ann,Positive
 New   research study,Rhia Steele@ravishingrhia.com,Positive
 New   research study,Milton Donald,Positive
 New   research study,Colleen Busch,Negative
 New   research study,Amanda Haddock üß¨,Positive
 New   research study,tangerine McDaniel,Positive
 New   research study,Te Ha,Negative
 New   research study,mjohemme,Negative
 New   research study,Les Gallien,Positive
 New   research study,karaleigh2,Positive
 New   research study,Becky Burns,Positive
 New   research study,SeparatriX,Positive
 New   research study,(((Julianna Shapiro))),Positive
 New   research study,Katie,Positive
 New   research study,WEGO Health,Positive
 New   research study,"Rachel Kerstetter, APR",Positive
 New   research study,Fabio Gratton,Positive
 New   research study,CureClick,Positive
 New   research study,Cassi Schmigotzki,Negative
   amp   conference,LymphomaAction,Negative
 amp clinicaltrials,LymphomaAction,Negative
    Associated,CancerWallonia,Negative
 VIDEO Ulrich Jager,VJHemOnc,Negative
 Global Chronic Lymphocytic Leukemia Therapeutics Report,Gosretort777666,Positive
 Market Size,Gosretort777666,Positive
    update,CLL Ireland,Negative
 diagnosis risk stratification,CLL Ireland,Negative
 AntiCD Therapy,MLM Medical Labs,Positive
 AntiCD Therapy,CLL Ireland,Negative
 Relapsed Chronic,EPR Network,Positive
 gen sequencing lt,the limbic,Negative
 patients ‚Äô IGHV status,the limbic,Negative
 Drs Keating amp Sharman headline,Andrew Schorr,Negative
    expert panel,Andrew Schorr,Negative
 Sept   town meeting,Andrew Schorr,Negative
 Portland Oregon Registration,Andrew Schorr,Negative
 opening,Andrew Schorr,Negative
   Implications,Sumit Middha,Positive
 Novel   Discoveries,Sumit Middha,Positive
 Blood cancer drug Venetoclax,CLL Ireland,Negative
 Scotland Great news,CLL Ireland,Negative
 S√§chsischer Verdienstorden,"RC Dresden, Germany",Positive
 Dr Brigitte VoitAus den H√§nden von Sachsens Ministerpr√§sident,"RC Dresden, Germany",Positive
 Retinoic acid induction,TumorImmunoPapers,Negative
 Retinoic acid induction,NK papers,Negative
 Retinoic acid induction,Cancer Papers,Negative
   review,"chadi nabhan MD, MBA, FACP",Positive
   review,CADTH,Positive
   review,Patient Power,Positive
 Pharmacy Forum Obinutuzumab,Oncology Times,Negative
 Momento romantico,Alison Evans,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market   ‚Äì Industry Survey Market Size Competitive Trends Outlook,myMarketSize,Positive
 Declining Kidney Function,HoneymoonGondol,Positive
 Declining Kidney Function,AJKD,Positive
 FREE   Man,AJKD,Positive
 LymphomaNHLMultiple,Matthews & Associates,Negative
 MyelomaMMHairy Cell LeukemiaHCLChronic Lymphocytic,Matthews & Associates,Negative
    T   Active,CancerWallonia,Negative
 Rapid infusion,CLL Society Inc.,Negative
 Rapid infusion,Lymphoma Hub,Negative
 awareness ribbons,Zack Pemberton-Whiteley,Negative
 New Study Chronic Lymphocytic Leukemia Therapeutics Market Size Status,jayant khairkar,Positive
 Chronic Lymphocytic Leukemia CLL Pipeline,Drug Delivery News,Negative
 Cuban,Amy C. Cavers,Negative
 Bittersweet,Leesa Gabel,Positive
 mentor request,Leesa Gabel,Positive
 Ibrutinib beschikbaar voor nieuwe,Hematon,Negative
 Ibrutinibublituximab,CLL Ireland,Negative
   Exosomes Drive,Prof John,Negative
 Immunosuppresive Phenotype,Prof John,Negative
 SUPER video w LeClair amp Kipps,Andrew Schorr,Negative
 Novel SFB inframe deletions,Blood Advances,Positive
 Novel SFB inframe deletions,ASH,Negative
 Essential Lab Tests,Oncology Tube,Negative
 Sunesis,Edison,Positive
 Sunesis,EdisonHealthcare,Positive
 Sunesis,CLL Ireland,Negative
 Pase IbII study,Edison,Positive
 Pase IbII study,EdisonHealthcare,Positive
 spring,Edison,Positive
 spring,EdisonHealthcare,Positive
 Alex amp Christoph,Continuous Lifecycle London (online),Negative
 Pingworks,Continuous Lifecycle London (online),Negative
 amp Docker,Continuous Lifecycle London (online),Negative
   website,CLL Ireland,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL Market Insights Epidemiology,COPD News,Negative
 Prof John,the limbic,Negative
 Seymour,the limbic,Negative
 research highlights,the limbic,Negative
 ARC Forum,the limbic,Negative
    amp   conf,LymphomaAction,Positive
 charities,LymphomaAction,Negative
   Expert Bug Bite Reactions,CLL Ireland,Negative
 demand,APSHO,Negative
 Chronic Form,NACDA Program on Aging,Negative
 Emerge,NACDA Program on Aging,Negative
 tcolBOOMlobF,NACDA Program on Aging,Negative
 conf,LymphomaAction,Negative
    tremendo v√≠deo con parte de lo vivido,The Pepex Family,Negative
    tremendo v√≠deo con parte de lo vivido,Indy Wrestling Chile,Negative
 CLL RockFighter,The Pepex Family,Negative
 CLL RockFighter,Indy Wrestling Chile,Negative
 domingo,The Pepex Family,Negative
 domingo,Indy Wrestling Chile,Negative
 Treatment Path,Patient Power,Positive
 Treatment Path,Oncology Tube,Negative
 w Dr Burke,Patient Power,Positive
 Pathology expert Dr Selina ChenKiang,WCM Lymphoma,Negative
 VIDEO Anna Schuh,VJHemOnc,Positive
   LongTerm Survival,Journal of Clinical Pathways,Negative
 Novel Therapies,Journal of Clinical Pathways,Negative
 Clemens Wendtner,VJHemOnc,Positive
 tyrosine kinase BTK inhibitors,CLL Ireland,Negative
 tyrosine kinase BTK inhibitors,Oncology Tube,Negative
     domingo,The Pepex Family,Positive
     domingo,Thu Pepex,Negative
     domingo,WWE Noticias FM,Positive
     domingo,Don Pepex,Positive
 luchadores de NAG Lucha Libre hacer,The Pepex Family,Positive
 luchadores de NAG Lucha Libre hacer,Thu Pepex,Negative
 luchadores de NAG Lucha Libre hacer,WWE Noticias FM,Positive
 luchadores de NAG Lucha Libre hacer,Don Pepex,Positive
 otras,The Pepex Family,Positive
 otras,Thu Pepex,Negative
 otras,WWE Noticias FM,Positive
 otras,Don Pepex,Positive
      Esto,The Pepex Family,Negative
      Esto,Thu Pepex,Negative
      Esto,Indy Wrestling Chile,Negative
 Lucha presenta CLL RockFighterSiguiendo los,The Pepex Family,Negative
 Lucha presenta CLL RockFighterSiguiendo los,Thu Pepex,Negative
 Lucha presenta CLL RockFighterSiguiendo los,Indy Wrestling Chile,Negative
 UblituximabIbrutinib Beneficial,The ASCO Post,Negative
 contacting Facebook,@ReportsandMarkets,Positive
 VIDEO BCR inhibitors,VJHemOnc,Negative
 patient outcomes John Gribben,VJHemOnc,Negative
 Kenneth,Leukaemia Care,Negative
 GP,Leukaemia Care,Negative
 Hotel Michelangeloinfo e iscrizioni,3PSolution,Negative
   hospitals,Oncocheck,Positive
 mouse models,Tracia.my.tupperware.com,Positive
 Sophie Laird,ACGS,Positive
 Genetics Lab,ACGS,Positive
 Refining,VJHemOnc,Negative
 ÏÇ¨ÎûëÌï¥Ïöî,Christinaa,Positive
 JUSTOUT,"chadi nabhan MD, MBA, FACP",Negative
 timely review,"chadi nabhan MD, MBA, FACP",Negative
 Al airegt,MAPALIN,Positive
 Sifup,MAPALIN,Positive
 VIDEO Barbara Eichhorst University Hospital Cologne,VJHemOnc,Negative
 NEW Hodgkin lymphoma,Medivizor,Negative
 dinner,AddieBee,Positive
 boyfriend,AddieBee,Positive
 Clinica,Cure Cancer Now,Negative
 ContHairy Cell Leukemia HCLChronic Lymphocytic Leukemia,Matthews & Associates,Negative
 Woman Files New,Top Class Actions,Positive
 complaint,Andrew Schorr,Negative
 covers,LymphomaAction,Negative
   patient Andy,Blood Cancer UK,Positive
 Occurrence,mieloma,Positive
 AEGLE   engine,AEGLE,Negative
 Soy un lion,Alison Evans,Negative
 ICYMI Ublituximab,HemOnc Today,Negative
   amp Exercise,Oncology Tube,Negative
 Modified CBderived   target,MDedge Hematology & Oncology,Negative
 BL,MDedge Hematology & Oncology,Negative
 Roundup Exposure,kd live,Positive
 Roundup Exposure,L McSherry,Negative
 Roundup Exposure,AboutLawsuits.com,Positive
 Idealisib,Dr. Andre Goy,Negative
   Treatment Plan,CLL Ireland,Negative
 lifestyle commitment,CLL Ireland,Negative
 therapy comorbidities amp disease,CLL Ireland,Negative
 Gina Eagle,Claire Eyers,Positive
 Durable Molecular Remissions,sandrineman,Negative
 Durable Molecular Remissions,Chan Cheah,Negative
 Durable Molecular Remissions,Elad Sharon,Positive
 Durable Molecular Remissions,TumorImmunoPapers,Negative
 CDSpecific,sandrineman,Negative
 Chronic Lymphocytic Leukemia CBCDiff speedrun,nic...                                         ...,Positive
 patient amp carer conference,Helen Jane Mee,Negative
 Chronic Lymphocytic Leukemia w CD CAR Tcells,Chan Cheah,Negative
 Ibrutinib Failure,Chan Cheah,Negative
 BCell Chronic Lymphocytic Leukemia Pipeline Insight   Report,COPD News,Negative
 BCell Chronic Lymphocytic Leukemia Pipeline Insight   Report,Johnson & Johnson,Positive
 KNow,donnashort,Negative
   BCell Chronic Lymphocytic Leukemia Pipeline Insight   Report,CRO Contract Res.,Negative
 PROGNOSTIC SIGNIFICANCE,Cancer Papers,Negative
 COMBAIND EXPRESSION,Cancer Papers,Negative
   Treatment Path,Oncology Tube,Negative
 TreatmentResistant,Journal of Clinical Pathways,Negative
 VIDEO Claire Dearden,VJHemOnc,Negative
 tcoEjJKB,CLL Ireland,Negative
 Tcell number,Journal of Clinical Investigation,Negative
 Tcell number,Prof John,Negative
    Conference,Patient Power,Negative
 Living Club Level Life,Ryan Adams,Positive
 auditorium,tt film festival,Positive
 Tmrrw,CADTH,Negative
 Upfront,CancerWallonia,Negative
 Upfront,CLL Ireland,Negative
 Sunesis Announces st Patient,CLL Society Inc.,Negative
 Oral NonCovalent BTKinhibitor SNS,CLL Society Inc.,Negative
 BCell Chronic Lymphocytic Leukemia Epidemiology Insights,COPD News,Negative
 kidney,Oncology Board,Negative
 treatment path,Andrew Schorr,Negative
 Ô∏è click,Madeline Schuck,Positive
 BlLlD wedi mwynhau creu tariannau Celtaidd Year,Melin Gruffydd,Negative
 Celtic shields,Melin Gruffydd,Negative
 video interviews,Lymphoma Hub,Negative
     juno,Anna Deveau,Negative
   juno,Anna Deveau,Negative
 grade crs,Anna Deveau,Negative
 Webinar Replay,Patient Power,Negative
 Webinar Replay,Lab Tests Online,Positive
   Cello Group,Ruth Gemmell,Positive
   Cello Group,Markel Tax,Positive
   Cello Group,Craig Ribton,Positive
 CEO Mark Scott,Ruth Gemmell,Negative
 CEO Mark Scott,John Harrington,Positive
 CDChimeric Antigen Receptor T cells,Elad Sharon,Positive
 CancerPractical advice frm,CLL Ireland,Negative
 AntiCD CART Cells,Angelica Cortez,Positive
 Sunesis Pharmaceuticals Announces Patient,Financial Buzz,Negative
 Sunesis Pharmaceuticals Announces Patient,Crwe World,Negative
 Oral NonCovalent,Financial Buzz,Negative
 Phase b Study Evaluating Oral NonCovalent BTKinhibitor,Crwe World,Negative
 Dr LaVerne,Patient Power,Negative
 Year Anniversary,Patient Power,Negative
 AntiCD CART cells,CancerTherapyAdvisor,Negative
 CDSpecific Chimeric,TumorImmunoPapers,Negative
 CarT,CLL Ireland,Negative
 New Rituximab Formulation,Lymphoma Coalition,Negative
 Lymphomas Leukemia,Lymphoma Coalition,Negative
 BlLlD yn gwerthusor tai crwn Celtaidd Year,Melin Gruffydd,Negative
 LlD,Melin Gruffydd,Positive
 Mens style,Mike Luise,Positive
 Israel,Lymphoma Coalition,Negative
 Patient Meeting,Lymphoma Coalition,Negative
 Recent Scientific Conferences,Lymphoma Coalition,Negative
   novel BCL inhibitor,"Raul Cordoba, MD, PhD",Negative
 Se terminan,Lucas ‚ôö,Negative
 Œîp Kinaseamp,MPMI_UoM,Positive
 Prognosticators,donnashort,Negative
 xfire,donnashort,Negative
 Drs Kay barrientos Zent,donnashort,Negative
 VIDEO Stephan Stilgenbauer,VJHemOnc,Positive
 VIDEO Dr Brander,VJHemOnc,Negative
 Encouraging Activity,CLL Ireland,Negative
 tcoIeaHiQCSg,CLL Ireland,Negative
 expanded   treatment tool kit,PeerView,Negative
     master class,PeerView,Negative
 CLL DNA damage,UW_BMS,Positive
 Campath,Natalia Haraszkiewicz-Birkemeier,Positive
    Dr Talha Munir,Helen Jane Mee,Negative
 Susan Obrien Hardcover Book English,Fantastic Baby Items,Positive
 deubiquitinases,"Raul Cordoba, MD, PhD",Negative
 blcm bravo,Anna Deveau,Negative
 Umbilical amp Cord Blood CB Derived CAREngineered,Anna Deveau,Negative
 B Lymphoid Malignancies,Anna Deveau,Negative
 nonmedics,CLL Ireland,Negative
 animation,CLL Ireland,Negative
 st human,MD Anderson Leukemia,Negative
   Necessary,Patient Power,Negative
 Patients w experts,Patient Power,Negative
 Combination Induced High Rate,CancerWallonia,Negative
 Bone Marrow MRD Negativity   ORR,CancerWallonia,Negative
 Mutated,CancerWallonia,Negative
 Research strides,Open Access Gov,Positive
 Le TEF,CLL Language Centres,Positive
 Centres de langues,CLL Language Centres,Positive
 Video Professor Susan OBrien,Lymphoma Hub,Negative
 Lymphocyte,CLL Ireland,Negative
 IgG Levels,CLL Ireland,Negative
 Forefront   Timeline,ARC Journals,Positive
 Novartis CART,SwanBio,Positive
 VIDEODr OBrien,VJHemOnc,Negative
   susceptibility,Blood Journal,Negative
 variant,Blood Journal,Positive
 ITGB,Blood Journal,Negative
 ContHairy Cell Leukemia HCLChronic Lymphocytic Leukemia CLL,Matthews & Associates,Negative
 Chromosomal Abnormalities,Patient Power,Negative
 Chromosomal Abnormalities,OncLive.com,Negative
 w Dr Leclair amp Dr Wierda,Patient Power,Negative
 VIDEO Barbara Eichhorst,VJHemOnc,Positive
 refining,VJHemOnc,Negative
 deletions,Cancer Papers,Negative
 Eosinophilic folliculitis,JAAD Journals,Positive
 Lymphocyte amp IgG Levels,Oncology Tube,Negative
 Pacific Northwest,Andrew Schorr,Negative
 amp confidence,Andrew Schorr,Negative
 webinar replay,Andrew Schorr,Negative
 lab tests,Andrew Schorr,Positive
 Wednesday webinar sharing updates,The Leukemia & Lymphoma Society,Negative
 Chronic Lymphocytic Leukemia CLL Pipeline Review H,Financial Buzz,Negative
 Chronic Lymphocytic Leukemia CLL Pipeline Review H,Business Wire-Health,Positive
 Chronic Lymphocytic Leukemia CLL Pipeline Review H,Bio-Collaboration,Negative
 Chronic Lymphocytic Leukemia CLL Pipeline Review H,DrugGenius,Positive
 Markets,Financial Buzz,Positive
 Markets,Business Wire-Health,Positive
 Markets,Danvantri Farma,Negative
 Markets,satPRnews,Negative
 Markets,Feel on,Positive
 Markets,Âø´ÈÅ©ÂÆ∂ÈõªLife,Positive
 Markets,Market Cheetah,Positive
 Markets,EIN Presswire: Glaxo Newswire,Positive
 Markets,Scott Werntz,Positive
 VIDEO Thomas Kipps,VJHemOnc,Positive
 Hardcover Book English,CV and Parts. Transmission and Drivetrain,Positive
 Chronic Lymphocytic Leukemia Care Instructions,Gladys E Groff,Positive
 HCL Chronic Lymphocytic Leukemia CLL,Matthews & Associates,Negative
 morir nomah,Alison Evans,Negative
 Treatment EffectsFatigue,CLL Ireland,Negative
 VIDEO Elisa,VJHemOnc,Negative
 Pronounce Chronic Lymphocytic Leukemia,KnowYourSoy,Positive
 Pronounce Chronic Lymphocytic Leukemia,1ClickRepeater,Positive
 ‚Ü∫ RT ‚ù§,KnowYourSoy,Positive
 ‚Ü∫ RT ‚ù§,1ClickRepeater,Positive
 Dr Rick Furman,WCM Lymphoma,Negative
 expert debate,WCM Lymphoma,Negative
   workshop,Applied Photochem_SU,Positive
   band,Applied Photochem_SU,Positive
 Christmas Toast,javiboix,Positive
 Patients amp families,Wilmot Cancer Institute,Negative
 CFH,Lymphoma Canada,Negative
 Hear Dr Rod Johnson,NLTP,Positive
 hills,Marc Pavan,Positive
    defeat,Eddy P (Paradis),Positive
 victory,Eddy P (Paradis),Positive
 victory,Kyle Sprague,Positive
 ÿπŸäÿßŸÜ chronic,Ahmed Eidaroos,Positive
 babies,Selma Errol Hassan,Positive
 Novel SFB InFrame Deletions Result,Lymphoma Coalition,Negative
 Aberrant RNA Splicing,Lymphoma Coalition,Negative
   cure,CLL Ireland,Negative
   cure,Anna Deveau,Negative
 Initiating Therapy Peer Exchange video,CLL Ireland,Negative
 Michael Keating,CLL Ireland,Negative
 Michael Keating,VJHemOnc,Negative
 VIDEO Aliki Xochelli,VJHemOnc,Negative
 Oncology Tube Results,Oncology Board,Negative
 GENUINE study,Oncology Board,Negative
 GENUINE study,Oncology Tube,Negative
 GENUINE study,ASH Clinical News,Negative
 Expert Practice,CLL Ireland,Negative
 Deep Dive,CLL Ireland,Negative
 Haematology CNS study day,Lucy Henderson,Positive
 Chemotherapyfree approaches,CLL Ireland,Negative
   Feinstein Institute Scientist,PressReleasePoint,Negative
   Feinstein Institute Scientist,CRO Contract Res.,Negative
 Innovative Chronic Lymphocytic Leukemia Research,PressReleasePoint,Negative
 Innovative Chronic Lymphocytic Leukemia Research,NeuroBrain,Positive
 Innovative Chronic Lymphocytic Leukemia Research,Financial GamblR,Negative
 Chromosomal Abnormalities amp,Oncology Tube,Negative
 Medical Simulation,Medscape Education,Negative
 Dr Jennifer R Brown amp,Medscape Education,Negative
 Chronic Lymphocytic Leukemia contact,Matthews & Associates,Positive
 Blood Commentary CDddependent   progression,Blood Journal,Negative
 Perspective w Dr John Burke,Patient Power,Negative
 absence,Talal Hilal ü©∫,Negative
 randomized data,Talal Hilal ü©∫,Negative
 Invariant NKT cells,Blood Journal,Negative
 Invariant NKT cells,NK papers,Negative
 Invariant NKT cells,Lymphoma Canada,Negative
 VIDEO Debate,VJHemOnc,Negative
 Genetic Heterogeneity,Cancer Papers,Negative
 rr w,VJHemOnc,Negative
 Early Therapy,CureHuntr,Negative
 Early Therapy,TrialBulletin,Negative
 Relapsed Refractory Chronic Lymphocytic LeukemiaSmall Lympho,CureHuntr,Negative
 Condition Summary,TrialBulletin,Negative
 VENCLYXTO ‚Ñ¢ venetoclax,orphanpedia,Positive
 amp Dr Burke,Andrew Schorr,Negative
 VIDEO Won Seog Kim,VJHemOnc,Negative
 New SC   formulation,MDedge Hematology & Oncology,Negative
 s ass,Jackie Michele,Positive
 marketing,Michele Nadeem-Baker,Negative
 Etiology,JAMA Oncology,Positive
 Etiology,T√ºrkiye Klinikleri,Negative
 Etiology,myCME,Negative
 Ibrutinib Therapy Discontinuation,JAMA Oncology,Positive
 sustained PFS,Targeted Oncology,Negative
 Treatment Effects,Patient Power,Negative
 Treatment Effects,Oncology Tube,Negative
 w Barbara Eichorst,VJHemOnc,Negative
 Ibrutinib Fludarabine,TrialBulletin,Negative
 RelapsedRefractory Chronic Lymphocytic LeukemiaSmall L,TrialBulletin,Negative
              update,Turacoz Healthcare Solutions,Positive
 fact sheet,OncologyNurseAdvisor,Positive
 Clinicopathological features,Blood Journal,Negative
 outcoems,Blood Journal,Negative
 ContnonHodgkin,Matthews & Associates,Negative
 lymphoma NHLMultiple MyelomaChronic Lymphocytic Leukemia CLLHairy Cell Leukemia HCL,Matthews & Associates,Negative
     update,Michele Nadeem-Baker,Negative
 Video Blogs Month,Michele Nadeem-Baker,Negative
 Absolute Lymphocyte,Predictive Analytics,Positive
 PostFCR,Predictive Analytics,Positive
    Pharmacyclics√Ç,Cancer News,Negative
 Significant Milestone Payment,Cancer News,Negative
 Phase III Chronic Lymphocytic,Cancer News,Negative
 Venetoclax inhibidor de BCL otra terapia dirigida para,Guillermo Barranco Casta√±eda,Positive
 cuidar su,Guillermo Barranco Casta√±eda,Positive
   nvs,Anna Deveau,Negative
 Immunoglobulin Genes,MoJo,Negative
 Immunoglobulin Genes,CLL Ireland,Negative
 Chronic Lymphocytic Leukemia Key,MoJo,Negative
 Improving,MoJo,Negative
 Improving,CLL Ireland,Negative
 Improving,"Raul Cordoba, MD, PhD",Negative
 Risk Stratifica,MoJo,Negative
 ABBV Reports,1stOncology,Negative
 RR CLL CLL,1stOncology,Negative
 VIDEO S O‚ÄôBrien,VJHemOnc,Negative
   managing patients,Dr. Andre Goy,Negative
 TPdeficient chronic lymphocytic,Dr. Andre Goy,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia CLLPipeline Insights,COPD News,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia CLLPipeline Insights,Drug Delivery News,Negative
 Pr Stilgenbauer update,Marta Crespo,Negative
 AbTedeschi,Lymphoma Hub,Negative
 antimicrobial soaps,CLL Ireland,Negative
 Note,CLL Ireland,Negative
 Note,The ONC,Positive
 caution,CLL Ireland,Negative
 infection prevention,CLL Ireland,Negative
 TGTXMD Anderson Centre,Biotech2050,Negative
 TGR potential,Biotech2050,Negative
 Heavily pretreated Bcell malignancies,Biotech2050,Negative
 rock stars,Amy C. Cavers,Positive
 K people,Genentech,Negative
 Retweeted VJHemOnc VIDEO,El tal Toni üéó#JoActuo #LlibertatPresosPolitics,Positive
 Barbara Eichorst,El tal Toni üéó#JoActuo #LlibertatPresosPolitics,Positive
 Barbara Eichorst,VJHemOnc,Negative
 Hairy Cell Leukemia HCLChronic Lymphocytic Leukemia,Matthews & Associates,Negative
 UULM,"Chared, Good Comms",Negative
 UULM,HARMONY Alliance,Negative
 GFM france Uppsala,"Chared, Good Comms",Negative
 GFM france Uppsala,European Hematology Association,Negative
 GFM france Uppsala,HARMONY Alliance,Negative
 disease projects,HARMONY Alliance,Negative
 CLL Response Rates,Mehmet Tuna,Positive
 Subcutaneous Rituxan,"Neil Sankar M.D.,MPH",Positive
 CLL DLBCL,"Neil Sankar M.D.,MPH",Positive
 hyaluronidase combination,Lymphoma Coalition,Negative
 Chronic Lymphocytic Leukemia Phase,Patient Worthy,Negative
   journal,SAGE Health & Nursing,Positive
 lymphoma amp chronic lymphoid leukemia,SAGE Health & Nursing,Positive
 Follow,be ys Research International,Positive
 Follow,gn√∫bila France,Positive
 Follow,David MANSET,Positive
   Cell,Crown Bioscience,Negative
 C Moreno,"Raul Cordoba, MD, PhD",Negative
 Sid,Janssen EMEA,Negative
 dancing,Janssen EMEA,Negative
 Primer,Nature Reviews Disease Primers,Positive
   estimates,DRG Epidemiology,Negative
 CLL Powerpoint,PPT Search,Negative
 DSSG Digest,CLL Ireland,Negative
   trials,CLL Ireland,Negative
   trials,Lung Cancer News,Negative
 Lab Test Webinar,Lab Tests Online,Positive
 Lab Test Webinar,Patient Power,Negative
 Microenvironmental agonists,Blood Advances,Negative
 de novo phenotypic,Blood Advances,Negative
 Chornobyl Cleanup Workers,summodiscrimine,Positive
 Chornobyl Cleanup Workers,Cancer Papers,Negative
 LRFs Advocacy Center,Lymphoma Research Foundation,Negative
 Senators,Lymphoma Research Foundation,Negative
 iFCR,"Hayder Saeed, MD",Positive
 algorithm,"Hayder Saeed, MD",Positive
 algorithm,"Rob Dean, MD",Positive
 CLARITY IbrutinibVenetoclax,CLL Ireland,Negative
 Chronic Lymphocytic Leukemia Venetoclax,sandrineman,Negative
 w   amp   experts,Patient Power,Negative
 Dr John Burke,Andrew Schorr,Negative
 weighs,Andrew Schorr,Negative
 advice experts,Andrew Schorr,Negative
 w   s Keating amp,Andrew Schorr,Negative
 TPDeficient,"Mike Thompson, MD, PhD, FASCO",Negative
 Edelmann amp Gribben,"Mike Thompson, MD, PhD, FASCO",Negative
 Atrial fibrillation amp,"chadi nabhan MD, MBA, FACP",Negative
 NEW PhII Study Venetoclax ABT,Lisa Palacios,Negative
 NEW PhII Study Venetoclax ABT,MD Anderson Leukemia,Negative
 untreated   comparing ibrutinibrituximab,CLL Ireland,Negative
 tcowzZemfQ,CLL Ireland,Negative
 New Cancer Drug Defeats,Michele Nadeem-Baker,Negative
 Multiple Tumors,Michele Nadeem-Baker,Negative
   news Chronic Lymphocytic Leukemia,COPD News,Negative
 CLLAPI Insights,COPD News,Negative
 CLLAPI Insights,CRO Contract Res.,Negative
 Feinstein Institute Scientist,Cord Blood News,Negative
 Feinstein Institute Scientist,NeuroBrain,Positive
 Feinstein Institute Scientist,Financial GamblR,Negative
 Innovative Chronic Lymphocytic   Research,Cord Blood News,Negative
 VIDEO Progression,VJHemOnc,Negative
 w Nicole Lamanna,VJHemOnc,Negative
 Ibrutinibs Bright Future,CLL Ireland,Negative
 Landscape,CLL Ireland,Negative
 Landscape,BizPR,Negative
 Landscape,AJPB_Journal,Negative
 T Response Rates,Journal of Clinical Pathways,Negative
 Studie zu,Uniklinik K√∂ln,Positive
 ausgezeichnet,Uniklinik K√∂ln,Negative
 √∂ln,Uniklinik K√∂ln,Negative
 TGTX price target,Biotech2050,Negative
 Jefferies,Biotech2050,Negative
 probability,Biotech2050,Negative
 Research results,NIHR Research,Positive
   Passes,TheSocialMedwork,Positive
 II Test,TheSocialMedwork,Positive
 HERNegative Breast Cancers,TheSocialMedwork,Positive
 Complimentary Whitepaper Treatment Options,Biologics by McKesson,Positive
 Thursdays webinar,Patient Power,Negative
 Chronic Lymphocytic LeukemiaPipeline Review H,EIN Presswire: Merck Newswire,Positive
 Fathers Day,Kyle Sprague,Positive
 Montesano,Kyle Sprague,Positive
 TOC Tourney Brady,Kyle Sprague,Positive
 bump,Kyle Sprague,Positive
 hit,Kyle Sprague,Positive
 hit,BioPharm Insight,Positive
 hit,Los Lobos,Negative
 Monte,Kyle Sprague,Positive
 Julian,Shouting at people in my underpants,Negative
 Support Assn Chronic Lymphocytic Leukemia,Shouting at people in my underpants,Negative
 DaventrytoParis bikeride,Shouting at people in my underpants,Negative
 D Henderson amp M Hallek,VJHemOnc,Negative
 „Äê Âõ∫ÂÆöÁî®„ÄëÂçÉËëâ„Åß„É©„Ç§„Éñ„Éá„Ç£„Ç™„Å®„Éá„Ç£„Ç™„Éê„Éè‰πó„Å£„Å¶„Åæ„Åô„ÄÇÁü•Ë≠ò„ÅØÁÑ°„ÅÑ„Åë„Å©Âéü‰ªò„Çπ„ÇØ„Éº„Çø„Éº„ÅåÂ•Ω„Åç„Åß„Åô„ÄÇ„Éï„Ç©„É≠„Éº„ÅäÈ°ò„ÅÑ„Åó„Åæ„Åô„Éá„Ç£„Ç™„É©„Ç§„Éñ„Éá„Ç£„Ç™,„Éû„É≥„É¢„Çπ,Positive
 „Éá„Ç£„Ç™„Éê„ÉèÊóßÂéü‰ªò È¢®ËªäÈ´òÁü≠„Ç∑„É£„Ç≥„Çø„É≥,„Éû„É≥„É¢„Çπ,Positive
 Fathers Day Ruth Schorr,CLL Ireland,Negative
 ICYMI Selective Bruton,HemOnc Today,Negative
 longterm safety efficacy,HemOnc Today,Positive
 longterm safety efficacy,Healio,Negative
   Commandments,Contractor Magazine,Positive
   Commandments,Contracting Business,Positive
   Commandments,HPAC Engineering,Positive
 Managers,Contractor Magazine,Positive
 Managers,Contracting Business,Positive
 Managers,HPAC Engineering,Positive
 Assess Safety,TrialBulletin,Negative
 Assess Safety,CureHuntr,Negative
 ImbruvicaTM,TrialBulletin,Negative
 ImbruvicaTM,CureHuntr,Negative
 Indian Participants,TrialBulletin,Negative
 Indian Participants,CureHuntr,Negative
 Mantle Cell Ly,TrialBulletin,Negative
 Quarter,Lymphoma Canada,Negative
 Quarter,CLL Ireland,Negative
 IGHV Mutation,Lymphoma Canada,Negative
 IGHV Mutation,CLL Ireland,Negative
 Emerging Targeted Therapies,CLL Ireland,Negative
 Immunotherapies,CLL Ireland,Negative
 Forschung ausgezeichnet,Uniklinik K√∂ln,Negative
 Wissenschaftsgetriebene,Uniklinik K√∂ln,Negative
 VIDEO Ublituximab,HemOnc Today,Negative
 VIDEO Ublituximab,Healio,Negative
 BTK inhubitor,Lymphoma Hub,Negative
 DECOYADAY KEEPS BCR,Prof John,Negative
 BAY,Prof John,Negative
 IgM,Prof John,Negative
 ve regulator,Prof John,Negative
 RELEASE,Prof John,Negative
 ibrutinib   ublituximab,Lymphoma Hub,Negative
 Dr Nastoupil,Lymphoma Hub,Negative
 ublituxinab umbralisib,Lymphoma Hub,Negative
 IBRUTNIB,"Fabio R. Kerbauy, MDüáßüá∑ üá±üáß",Positive
 tumor shrinkage,"Raul Cordoba, MD, PhD",Negative
 North America,DRG Epidemiology,Negative
 Cell lines,Fabrice Leclerc,Negative
 Cell lines,Cancer Papers,Negative
 Cell lines,TumorImmunoPapers,Negative
 Innovative Chronic Lymphocytic Leukemia Research MANHASSET NY,CRO Contract Res.,Negative
 Abstracts amp   material,CLL Ireland,Negative
 nd Congress,CLL Ireland,Negative
 EHA Learning Center,CLL Ireland,Negative
    Meeting,Patient Power,Negative
 Correction IndoleCarbinol,Jerry Lee,Negative
 Restores Fludarabine Sensitivity,Jerry Lee,Negative
 Restores Fludarabine Sensitivity,TumorImmunoPapers,Negative
 Therapeutic Outlooks,CLL Ireland,Negative
 Shanghai Pudong International Airport ‰∏äÊµ∑Êµ¶Êù±ÂúãÈöõÊ©üÂ†¥,Gavin Conboy,Positive
   BCell Chronic Lymphocytic Leukemia Global Clinical Trials Review H,CRO Contract Res.,Negative
   BCell Chronic Lymphocytic Leukemia Global Clinical Trials Review H,CMLHope,Negative
 BCell Chronic Lymphocytic Leukemia Global Clinical Trials Review H,DrugGenius,Positive
 BCell Chronic Lymphocytic Leukemia Global Clinical Trials Review H,Newsliner.in,Positive
 BCell Chronic Lymphocytic Leukemia Global Clinical Trials Review H,Clinical Trials,Negative
 BCell Chronic Lymphocytic Leukemia Global Clinical Trials Review H,COPD News,Negative
 BCell Chronic Lymphocytic Leukemia Global Clinical Trials Review H,CRO Contract Res.,Negative
 BCell Chronic Lymphocytic Leukemia Global Clinical Trials Review H,SPI News,Negative
 Singleagent pembrolizumab,ASH Clinical News,Negative
 Dr Cramer,Lymphoma Hub,Negative
 CLLBAG Trial,Lymphoma Hub,Negative
 BeiGene Presents Updated Phase   Data,Financial Buzz,Negative
 BTK Inhibitor BGB,Financial Buzz,Positive
 BTK Inhibitor BGB,Odi Bruckman,Negative
 BTK Inhibitor BGB,CLL Society Inc.,Negative
 BTK Inhibitor BGB,Danvantri Farma,Negative
 BTK Inhibitor BGB,Gilles Gallant,Positive
 BTK Inhibitor BGB,SPI News,Negative
 amgueddfa Sain Ffagan Spinning wool activity,Melin Gruffydd,Negative
 St Fagans BlLlD,Melin Gruffydd,Negative
 Chronisch lymphatische Leuk√§mie Neues,AbbVie Schweiz,Positive
 Forschung,AbbVie Schweiz,Positive
 BRIEFBeigene,Beeznes.com,Positive
 BRIEFBeigene,NYC Social Group,Negative
 BGNE Presents Updated Phase,Odi Bruckman,Negative
 VIDEO D Brander,VJHemOnc,Negative
 previously treated   pts,VJHemOnc,Negative
 TPDeficient Chronic Lymphocytic Leukemia,Cancer Papers,Negative
 Clinical Lead,CLL Ireland,Negative
 Oncologists Share Findings,Lymphoma Coalition,Negative
 Data Presentations,Lymphoma Coalition,Negative
 Cancer Specialties,Lymphoma Coalition,Negative
 Voted    Cheadle,Helen Jane Mee,Negative
 Wilmslow Rd Sainsburys,Helen Jane Mee,Negative
 LocalCharityofYear,Helen Jane Mee,Negative
 important   amp   data,Lymphoma Hub,Negative
    Esto,The Pepex Family,Positive
    Esto,Thu Pepex,Negative
    Esto,WWE Noticias FM,Positive
    Esto,Indy Wrestling Chile,Positive
 Beneficio,The Pepex Family,Positive
 Beneficio,Thu Pepex,Negative
 Beneficio,WWE Noticias FM,Positive
 Beneficio,Indy Wrestling Chile,Negative
 el Centro,The Pepex Family,Positive
 el Centro,Thu Pepex,Negative
 el Centro,WWE Noticias FM,Positive
 Cultural Rojas MagallanesUna,The Pepex Family,Positive
 Cultural Rojas MagallanesUna,Thu Pepex,Negative
 Cultural Rojas MagallanesUna,WWE Noticias FM,Positive
 remission rates,CLL Ireland,Negative
 Leukaemia patients,CLL Ireland,Negative
 D Henderson   C Tam,VJHemOnc,Negative
 Pharmacy Forum Venetoclax Venclexta,Oncology Times,Negative
 Prof Gill,Lymphoma Hub,Positive
 CLL method,PPT Search,Positive
 PowerPoint Slides,PPT Search,Positive
   tgtx,Anna Deveau,Negative
    PTLA,Anna Deveau,Negative
 P Study,Shohta Kadomura Hospital Pharmacist,Negative
 Placebo w R,Shohta Kadomura Hospital Pharmacist,Negative
 Treatment Naive FL PERSPECTIVE,Shohta Kadomura Hospital Pharmacist,Negative
 IGHV Mutational Status Testing,SFBC,Positive
 Personalized Cell,Immune Regulation News,Negative
 Ther,Immune Regulation News,Negative
 Combined,Immune Regulation News,Negative
 Combined,Wendy Carvotta,Positive
 Combined,ivy science,Negative
 Achieves Complete Remission,Immune Regulation News,Negative
 Achieves Complete Remission,Wendy Carvotta,Positive
 Lymphocytic   Patients,Immune Regulation News,Negative
 Structure,VJHemOnc,Negative
 CTL CAR Tcell therapy,Lymphoma Hub,Negative
 Roundup cancer lawsuit,Matthews & Associates,Negative
 PC    Coexistence,ImmunePCPapers,Negative
 plaintiffs,Matthews & Associates,Positive
 farm workers,Matthews & Associates,Positive
 Therapeutics Development,BizPR,Negative
   Chronic Lymphocytic Leukemia CLL Pipeline Review H,COPD News,Positive
 USD   Chronic,DrugGenius,Positive
 Buena pr√°ctica,Lucas ‚ôö,Negative
 seguir sumando,Lucas ‚ôö,Negative
 Hematology Oncology   Merck Manuals Professional Edition,Rene Discarte,Positive
 Mutational Signatures,LiteratureFeed,Positive
 Pubmed genome sequencing,epigenetics_papers,Negative
   news Chronic Lymphocytic Leukemia CLL Pipeline Review H,COPD News,Positive
 Personalized Cell Therapy,Wendy Carvotta,Positive
 Personalized Cell Therapy,ivy science,Positive
 Personalized Cell Therapy,Penn Medicine News,Positive
 Personalized Cell Therapy,Celixir,Positive
 Personalized Cell Therapy,"Bruce Levine, Ph.D.",Positive
 Personalized Cell Therapy,Pennsylvania,Positive
 Blood Advances Talks Venetoclax,Blood Advances,Positive
 primer,Blood Advances,Positive
 PIKdelta inhibition,"Raul Cordoba, MD, PhD",Negative
 Leukemiacell proliferation disease progression,"Raul Cordoba, MD, PhD",Positive
 Leukemiacell proliferation disease progression,DrugGenius,Negative
 VIDEO Deborah Henderson,VJHemOnc,Negative
   patient story,VJHemOnc,Negative
   IGHV,ClinChemINFO,Positive
 Mutational Status Testing,ClinChemINFO,Positive
 chemotherapy session,hematologist,Negative
    Incidence,Medthority,Negative
 amp treatment options,Medthority,Negative
 fouryear followup,JanssenUS,Negative
 groundbreaking RESONATE study,JanssenUS,Negative
 Prof Saar Gill,Lymphoma Hub,Negative
 CD CART cells,Lymphoma Hub,Negative
 CD CART cells,"Raul Cordoba, MD, PhD",Negative
 Prof Jeff Sharman,Lymphoma Hub,Negative
 Phase III GEUINE,Lymphoma Hub,Negative
 Eb Discussion,ivy science,Negative
 Eb Discussion,Penn Medicine News,Negative
 PennCancer study,ivy science,Negative
 CD CART cells w Ibrutinib,Adaptive Biotech,Negative
 EB PM,Adaptive Biotech,Negative
 Dr Jia Ruan,WCM Lymphoma,Positive
 safety data,"Pharmacyclics, an AbbVie Company",Negative
 poster discussion,"Pharmacyclics, an AbbVie Company",Negative
 Eb,"Pharmacyclics, an AbbVie Company",Negative
 Prof Susan OBrien,Lymphoma Hub,Negative
 Targeted Approach,Ana Laura Caballero,Positive
 Targeted Approach,Hottest Stocks Now,Negative
 Targeted Approach,Financial Buzz,Negative
 Targeted Approach,Financial GamblR,Negative
 TGTX   Ublituximab,Tom Silver,Negative
 Swing,JanssenUS,Negative
 Poster   Hall,JanssenUS,Negative
 Poster   Hall,Adaptive Biotech,Negative
 Dr Park Phase,Memorial Sloan Kettering Cancer Center,Negative
 Hall PennMedicine,ivy science,Positive
 Saar Gill,ivy science,Positive
 TGTX Presents data,StockNews.com,Negative
 study CD CART cells w Ibrutinib,Adaptive Biotech,Negative
 pre AbbVie,Open Outcrier,Negative
 SI,Open Outcrier,Negative
 LongTerm IMBRUVICA,Financial Buzz,Negative
 LongTerm IMBRUVICA,VPO/PR Newswire,Negative
 Efficacy Safety Data,Financial Buzz,Negative
 Efficacy Safety Data,VPO/PR Newswire,Negative
 Consistent ProgressionFree Survival Benefit,Financial GamblR,Negative
 Consistent ProgressionFree Survival Benefit,NeuroBrain,Positive
 Chronic Lymphoc,Financial GamblR,Negative
 Chronic Lymphoc,Financial Buzz,Negative
 Chronic Lymphoc,PRN Biotech,Negative
      Intrigues,CancerWallonia,Negative
 TGTX    bullish,Scott Spencer,Positive
 PennMedicine presentation,ivy science,Negative
 High,CancerWallonia,Positive
 ublituximabibrutinib,ASH Clinical News,Negative
 HomoloGene Gene,Darwin Monkey,Positive
 RT TransplantDoc RT DrRaulCordoba Need,Robert Z. Orlowski,Negative
 Concurrent diagnosis,Cancer Papers,Negative
 VIDEO D Henderson amp M Hallek,VJHemOnc,Negative
 HTN,"Raul Cordoba, MD, PhD",Negative
 TGTX game changer,‚öæÔ∏èüèÄ‚öΩÔ∏èüé∏ü•Åüéßüé´ü§øüèäüèº‚Äç‚ôÇÔ∏èüèù,Positive
 TGTX Positive Data,Odi Bruckman,Negative
 P GENUINE Trial,Odi Bruckman,Negative
 Combo w Ibrutinib,Odi Bruckman,Negative
 High Risk CLL,Odi Bruckman,Negative
 GENUINE phase,TG Therapeutics,Positive
 NNECOS member,NNECOS,Positive
 Richters Syndrome,Lymphoma Hub,Negative
 Video Blog,Oncology Tube,Negative
 FACT,"Pharmacyclics, an AbbVie Company",Negative
 Dr June,ivy science,Negative
 Winding   Road,Oncology Tube,Negative
   audience,LymphomaAction,Negative
 Nurse Specialist Lesley,LymphomaAction,Negative
 VIDEO Role,VJHemOnc,Negative
 Michele NadeemBaker Video Blog Month,Oncology Tube,Negative
 Michele NadeemBaker Video Blog Month,Patient Power,Negative
 Read Brians story,AACR,Positive
 IHI rollout,CLL Ireland,Negative
   slowgrowing nonHodgkin Lymphoma,JanssenUS,Negative
 Key,CLL Ireland,Negative
 Key,"Raul Cordoba, MD, PhD",Negative
 Key,"John P. Leonard, MD",Positive
 Risk Stratification,CLL Ireland,Negative
 Risk Stratification,"Raul Cordoba, MD, PhD",Negative
 Immunoglobulin genes,TumorImmunoPapers,Negative
 lymph nodes liver,Teva Pharmaceuticals,Positive
 spleen,Teva Pharmaceuticals,Positive
 Het verslag van de bijeenkomst,Hematon,Positive
 Schiedam,Hematon,Negative
 Lazarex,Lazarex Cancer Fdn,Positive
 Cell therapy,Lymphoma Coalition,Negative
 Multidisciplinary team experts,MediCom Oncology,Positive
 Multidisciplinary team experts,Managing Myeloma,Negative
 Ibrutinib Achieves Complete Remission,Celixir,Positive
 Ibrutinib Achieves Complete Remission,"Bruce Levine, Ph.D.",Positive
 Ibrutinib Achieves Complete Remission,Pennsylvania,Positive
 Ibrutinib Achieves Complete Remission,ivy science,Negative
 Ibrutinib Achieves Complete Remission,Penn Medicine News,Negative
 High Percentage,Celixir,Positive
 High Percentage,"Bruce Levine, Ph.D.",Positive
 High Percentage,Pennsylvania,Positive
 High Percentage,ivy science,Negative
 High Percentage,Penn Medicine News,Negative
 Ig Genes,"Raul Cordoba, MD, PhD",Negative
 Resonancia Magn√©tica,John Drago,Positive
 ver que chucha,John Drago,Positive
 tengo,John Drago,Positive
 la rodilla,John Drago,Positive
 collaboration w,Novartis Science,Positive
 VIDEO John Gribben,VJHemOnc,Positive
 NOVN candidate,CBPartners,Positive
 Soy una coqueta,Alison Evans,Positive
 Clinical Practice Facilitator Laura,School of Oncology,Positive
 classspecificw,VJHemOnc,Negative
 pts   access,Patient Power,Negative
 Pls help,Patient Power,Negative
 VIDEO Danielle Brander,VJHemOnc,Negative
 CART cell therapy CTL,Cell Tribune,Positive
 fun season,Kimberly Bender,Positive
   Clinical,HealthyBuilds West Palm,Positive
   Clinical,IDA Construction,Positive
   Clinical,Sanders Inc.,Positive
 Molecular,HealthyBuilds West Palm,Positive
 Molecular,IDA Construction,Positive
 Molecular,Sanders Inc.,Positive
 Relapsed Bab,HealthyBuilds West Palm,Positive
 Relapsed Bab,IDA Construction,Positive
 Relapsed Bab,Sanders Inc.,Positive
 therapy combo,Alliance for Cancer Gene Therapy,Positive
 MEI Pharma Announces PreSpecified Response Rate,David Rozul (he/him/his),Positive
 MEI Pharma Announces PreSpecified Response Rate,IntoxicatedTrader,Negative
 MEI Pharma Announces PreSpecified Response Rate,Financial Buzz,Negative
 DoseEscalation Study,David Rozul (he/him/his),Positive
 DoseEscalation Study,IntoxicatedTrader,Negative
 DoseEscalation Study,Financial Buzz,Negative
   cell therapy candidate,Novartis,Positive
 Cell Therapy,ivy science,Negative
 Cell Therapy,Patient Power,Negative
 Immunophenotypic Aberrancy,Cancer Papers,Negative
 states,CLL Ireland,Negative
 states,Future Oncology,Positive
 states,Future Science OA,Positive
 Bcell lymphoid malignancies,"Raul Cordoba, MD, PhD",Negative
 EHA   Current,Oncology Tube,Positive
 Watch Dr   Jennifer Brown,ASH,Negative
 treatment approaches,ASH,Negative
 Chronic Lymphocytic Leukemia Glioblastoma ACase Report,ClinExprmntlPathol,Positive
 Clin Exp Pathol,ClinExprmntlPathol,Positive
 ROLE,Malaria Papers,Positive
 PLANT ARTEMISIA,Malaria Papers,Positive
 SURVIVAL,Malaria Papers,Positive
 SURVIVAL,Mohammed Saied Faraj,Positive
 SURVIVAL,Ahmed Dahduli,Positive
 INDUCTION,Malaria Papers,Positive
 APOPTOSIS,Malaria Papers,Positive
 Un hombre con ideas nuevas,Lucas ‚ôö,Negative
 un loco hasta que sus ideas triunfan,Lucas ‚ôö,Negative
 VIDEO N Lamanna,VJHemOnc,Positive
 el insta,BLADE ZETA,Negative
 Esta,Jose peproli,Positive
     Esto,Don Pepex,Positive
     Esto,The Pepex Family,Positive
     Esto,Thu Pepex,Negative
     Esto,WWE Noticias FM,Positive
 Lucha presenta CLL FIEBRE¬°¬°Despu√©s de lo,Don Pepex,Positive
 Lucha presenta CLL FIEBRE¬°¬°Despu√©s de lo,The Pepex Family,Positive
 Lucha presenta CLL FIEBRE¬°¬°Despu√©s de lo,Thu Pepex,Negative
 Lucha presenta CLL FIEBRE¬°¬°Despu√©s de lo,WWE Noticias FM,Positive
 Lucha presenta CLL FIEBRE¬°¬°Despu√©s de lo,Indy Wrestling Chile,Negative
 Viva La,Don Pepex,Positive
 Viva La,The Pepex Family,Positive
 Viva La,Thu Pepex,Negative
 Viva La,WWE Noticias FM,Positive
 Lucha presenta CLL Fiebre¬°¬°Despu√©s de lo,Indy Wrestling Chile,Negative
 Viva La Botch,Indy Wrestling Chile,Positive
 Cairo,yosra salah,Positive
 progression amp Richter transformation,Blood Advances,Positive
 Sdds,Vicküíï,Positive
 meu filho,Vicküíï,Positive
 Hiroshima,„Éë„É©„Éä„Çà„ÇäÊÑõ„Çí„Åì„ÇÅ„Å¶,Positive
 Nagasaki Japan,„Éë„É©„Éä„Çà„ÇäÊÑõ„Çí„Åì„ÇÅ„Å¶,Positive
 Economic Modeling,Cancer Papers,Negative
 Economic Modeling,FarmaOnco,Negative
 Initial Treatment,VJHemOnc,Negative
 Initial Treatment,iwCLL,Negative
   Explains,CancerWallonia,Negative
 CLL Subtype Report,Lymphoma Coalition,Negative
 BR combo,ASH Clinical News,Negative
 infection risk,ASH Clinical News,Negative
 Prof Michael Hallek,Lymphoma Hub,Negative
 Prof Silvia Deaglio,Lymphoma Hub,Negative
 Creativity,Helen Jane Mee,Negative
 Toby,Helen Jane Mee,Negative
 Clive James poetry,Helen Jane Mee,Negative
 Replay,Andrew Schorr,Negative
 Replay,Patient Power,Negative
 town mtg,Andrew Schorr,Positive
 Session   Replay,Patient Power,Negative
 Saturdays,Patient Power,Negative
 Town Mtg,Patient Power,Negative
 Expert shares,OncLive.com,Negative
 treatment moves frm,CLL Ireland,Negative
 amp immunotherapy,CLL Ireland,Negative
 PIK isoform inhibitors,Lymphoma Hub,Negative
 Professor Jennifer R Brown,Lymphoma Hub,Negative
 CAR TCell Therapy Healthcare Professionals,MedPipeline,Negative
 MUTATED IGHV RECEPTORS SHARED DISTINCT IMMUNOGENETIC FEATURES,Cure Cancer Now,Negative
 CLINICA,Cure Cancer Now,Negative
 julio chavez,donnashort,Negative
 CLLIPI analysis,donnashort,Negative
   Regional Lecture Series,APSHO,Negative
 Wac,Melin Gruffydd,Negative
 Phase   COMPLEMENT,Lymphoma Hub,Negative
 trial OFAFC,Lymphoma Hub,Negative
 Selective Bruton,Healio,Negative
 Selective Bruton,HemOnc Today,Negative
 Dawnsio,Melin Gruffydd,Negative
 Mr Urdd Year,Melin Gruffydd,Negative
 Mr Urdd dance,Melin Gruffydd,Negative
 Gweithgaredd gyntaf,Melin Gruffydd,Negative
 o gwmpas,Melin Gruffydd,Negative
 Assembly,Melin Gruffydd,Negative
 Unique Selling Point,Prof John,Negative
 Tania,Prof John,Negative
 Ffwrdd √¢ ni,Melin Gruffydd,Negative
 Year R parents,Wellstead Primary,Positive
 June   Webinar,Patient Power,Negative
 Lab Tests w Drs Leclair,Patient Power,Negative
 amp Kipps,Patient Power,Negative
 cameo appearance,amad√≠,Positive
 Sunesis ‚Äô drug SNSO,Sunesis Pharma,Positive
 Great   pt event,Andrew Schorr,Negative
 past Sat Replay,Andrew Schorr,Negative
 Evolution presentation,Lymphoma Hub,Negative
 HLAcompatible donors,Lymphoma Hub,Negative
 bloodforming cells,AbbVie,Negative
 AntiCD CART therapy,Lymphoma Hub,Negative
 amp Initial Treatment,VJHemOnc,Negative
 Hillmen R Furman,VJHemOnc,Negative
 S Mulligan,VJHemOnc,Negative
 Michele NadeemBakers Video Blog Month,Patient Power,Positive
 MGH doctors,Michele Nadeem-Baker,Negative
 Dr Yoos poster,Mount Sinai LIVE,Positive
 Unusual Pattern,Mount Sinai LIVE,Positive
 Pulmonary Involvement,Mount Sinai LIVE,Positive
 Area B,Mount Sinai LIVE,Positive
 Ibrutinib Inhibit Macrophage Response,"Wafik S. El-Deiry, MD, PhD, FACP",Negative
 Tuberculosis,"Wafik S. El-Deiry, MD, PhD, FACP",Negative
 Captain Leader Legend,Balraj Dhingra,Positive
 john terrys,ADAM GIDMAN,Positive
 chelsea game,ADAM GIDMAN,Positive
 Ibrutinib   FCG,CLL Ireland,Negative
 Mitternachtssnack         Landungsbr√ºcken,Robert Rauer,Positive
 Drs Wierda amp Burke,Patient Power,Negative
 El pr√≥ximo,Alison Evans,Negative
 de Mayo estar√©,Alison Evans,Negative
 luchando por una opci√≥n titularTe espero,Alison Evans,Negative
 Baseline,"Raul Cordoba, MD, PhD",Positive
 Baseline,Lymphoma Hub,Negative
 associated AF Multivariate,"Raul Cordoba, MD, PhD",Negative
 atrial abnormality,"Raul Cordoba, MD, PhD",Negative
 atrial abnormality,Lymphoma Hub,Negative
 imagination,TEC Center,Positive
 Leptomeningeal Involvement,fadra tedesco,Positive
 CD B cells,Nature Reviews Disease Primers,Negative
 IFI reduced expression,OTOdocs,Negative
 Haematology Summit London,Helen Jane Mee,Negative
 Cancer CNSs,Helen Jane Mee,Negative
 Prof Brown,Lymphoma Hub,Negative
    pts amp family members,Andrew Schorr,Positive
 Thx,Andrew Schorr,Negative
 Dr Davide Rossi,Lymphoma Hub,Negative
 Venetoclax Plus Rituximab Induces Durable Responses,Lymphoma Canada,Negative
 COMPLEMENT trial,Lymphoma Hub,Negative
 IbrutinibFCR,Lymphoma Hub,Negative
 duvelisibFCR,Lymphoma Hub,Negative
 Accessed Article Refractory Chronic Lymphocytic Leukemia,ccdt,Negative
 Therapeutic Challenge,ccdt,Negative
 Accessed Article Therapeutic Approach,ccdt,Positive
 Accessed Article Therapeutic Approach,CCDT,Positive
 Significant Comorbid,ccdt,Positive
 Significant Comorbid,CCDT,Positive
 Highlighted,ccdt,Negative
 Highlighted,CCDT,Negative
 Article Deregulation,ccdt,Negative
 Article Deregulation,CCDT,Negative
 screenshots,Chelsea‚ú®,Positive
 Immunization,George Ioannidis,Positive
 Excellent coverage,"Raul Cordoba, MD, PhD",Negative
 Revised iwCLL guidelines,Lymphoma Hub,Negative
   patient presentation,Lymphoma Hub,Negative
 Immunizations,"Raul Cordoba, MD, PhD",Negative
 LLS Resources,Oncology Tube,Negative
 amp Communities,Oncology Tube,Negative
 Hybrigenics inhibitor,EdisonHealthcare,Positive
 UbiquitinSpecific Protease   USP,EdisonHealthcare,Positive
 Autonomous BCR,Lymphoma Hub,Negative
 Dr Davide Rossi Interview,Lymphoma Hub,Negative
 NGS amp Sanger Sequencing,Lymphoma Hub,Negative
 downregulatory membrane environment,Lymphoma Hub,Negative
 UTX,Anna Deveau,Negative
 IB,Anna Deveau,Negative
        MRDve,Anna Deveau,Negative
     JUNO,Anna Deveau,Negative
 IL production,"Raul Cordoba, MD, PhD",Negative
 IL production,Lymphoma Hub,Negative
 IL production,Prof John,Negative
 Tcells,"Raul Cordoba, MD, PhD",Negative
 Tcells,Lymphoma Hub,Negative
 Monocytes amp NLCs,Lymphoma Hub,Negative
 Overview w Drs Lamanna,Patient Power,Negative
 amp Keating,Patient Power,Negative
 Professor John G Gribben,Lymphoma Hub,Negative
 CXCR expressionfunction amp,Lymphoma Hub,Negative
 neglect,Lymphoma Hub,Negative
 Professor Kanti Rai,Lymphoma Hub,Negative
 ÿ®ÿßÿ≥ŸÇÿßÿ™,Baseqat Arabia Consulting,Positive
 ÎÖÑ Ï†Ñ Í∑∏ÎÇ†,Ïú§Í≥µ,Positive
 ÏÇ∞Îã§ÎùºÎ∞ï NE,Ïú§Í≥µ,Positive
 Îç∞Î∑î,Ïú§Í≥µ,Positive
 ÎÇ†Ïùò,Ïú§Í≥µ,Positive
 Ï∂îÏñµ,Ïú§Í≥µ,Positive
 ÎÑ§Ïù¥Î≤Ñ TVÏó∞Ïòà,Ïú§Í≥µ,Positive
 ÏÇ∞Îã§ÎùºÎ∞ï Î∞ïÎ¥Ñ,Ïú§Í≥µ,Positive
 Ïî®Ïóò,Ïú§Í≥µ,Positive
 Largest International Assembly,Lymphoma Canada,Negative
 Largest International Assembly,CLL Society Inc.,Negative
 Largest International Assembly,VPO/PR Newswire,Negative
 Largest International Assembly,Financial GamblR,Negative
 Chronic Lymphocytic Leukemia CLL Kicks,Lymphoma Canada,Negative
 Chronic Lymphocytic Leukemia CLL Kicks,CLL Society Inc.,Negative
 Chronic Lymphocytic Leukemia CLL Kicks,Endocrine News,Positive
 Chronic Lymphocytic Leukemia CLL Kicks,VPO/PR Newswire,Negative
 Chronic Lymphocytic Leukemia CLL Kicks,Financial GamblR,Negative
 CLL Undergoing alloHCT,everett jackson,Positive
   Potential Clinical Efficacy,Rare Diseases,Negative
 highrisk SLL,Rare Diseases,Negative
 Clonal   mutations,Lymphoma Hub,Negative
 Macrophage response,Lymphoma Hub,Negative
 Mtb,Lymphoma Hub,Negative
 AntiCDCoated   Cells,Prof John,Negative
 ontogeny,Lymphoma Hub,Negative
   resistance strategies,Anna Deveau,Negative
 As√≠ mismo,Andrea Merino Veliz,Positive
 Lovely commentary,Danielle Townsley,Positive
 InyeAhns article,Danielle Townsley,Positive
 PCP risk,Danielle Townsley,Positive
 CZent,Danielle Townsley,Positive
 neutropenia,CLL Ireland,Negative
 Bloodwise,CLL Ireland,Negative
 lymphoma nurse hotline,Lymphoma Australia,Positive
 WCM investigator Dr Dan Avi Landau,WCM Lymphoma,Negative
 Noooo,Owen Roberts,Positive
 Yaaaaasssss,Owen Roberts,Positive
 Deb talks,VJHemOnc,Negative
 access issues,VJHemOnc,Negative
 Prof Hallek Listen,VJHemOnc,Negative
 IMBRUVICA Pooled Outcomes Data,NACDA Program on Aging,Negative
 Potential Clinical Efficacy,NACDA Program on Aging,Negative
 Potential Clinical Efficacy,Financial Buzz,Negative
 Dr Lesley Ann Sutton,iwCLL,Negative
 Uppsala Univ,iwCLL,Negative
 Insights,Lymphoma Hub,Negative
 Insights,MDedge Hematology & Oncology,Negative
 inherited susceptibility,Lymphoma Hub,Negative
 LH,Lymphoma Hub,Negative
 Lesley Ann Sutton,Lymphoma Hub,Negative
 ibrutinib Pooled Outcomes Data,Financial Buzz,Negative
 del q,Anna Deveau,Negative
 VIDEO preview,VJHemOnc,Negative
 Threeyear,NE Live,Negative
 Dr Nitin Jain,iwCLL,Negative
 Dr Nitin Jain,Patient Power,Negative
 Dr Nitin Jain,Robert Z. Orlowski,Negative
 MRD amp impact,"chadi nabhan MD, MBA, FACP",Negative
 QOL,"chadi nabhan MD, MBA, FACP",Negative
 QOL,Christopher Steer,Negative
 line study,"chadi nabhan MD, MBA, FACP",Negative
 UK Incorporating MRD,"chadi nabhan MD, MBA, FACP",Negative
 delpTP mutations,"Raul Cordoba, MD, PhD",Negative
 CLL line trial,NYCDoc29,Negative
   CIT gold standard,NYCDoc29,Negative
 imp Q,NYCDoc29,Negative
 Legendary   portrait,"Jose Sandoval S, MD FACP",Positive
 posterity,"Jose Sandoval S, MD FACP",Positive
 Proposal,"chadi nabhan MD, MBA, FACP",Negative
 line approach,"chadi nabhan MD, MBA, FACP",Negative
 Incorporating biomarkers,"chadi nabhan MD, MBA, FACP",Negative
 Biomarkers,"chadi nabhan MD, MBA, FACP",Negative
 Ofatumumabchlorambucil combination,NE Live,Negative
 NOTCH mutation,"chadi nabhan MD, MBA, FACP",Negative
 CIT amp novel agents,"chadi nabhan MD, MBA, FACP",Negative
 Packed room,"chadi nabhan MD, MBA, FACP",Negative
 Dr Thomas Kipps,iwCLL,Negative
 Dr Thomas Kipps,VJHemOnc,Negative
 Dr Thomas Kipps,Patient Power,Positive
 CD reverse,Prof John,Negative
 enhances,Prof John,Negative
 CD Bcell tumours,Prof John,Negative
 Dr Jumaa,Lymphoma Hub,Negative
 BCR expression,Lymphoma Hub,Negative
 Dr Klaus Rajewsky,Lymphoma Hub,Negative
 adherence,"chadi nabhan MD, MBA, FACP",Negative
 adherence,"Raul Cordoba, MD, PhD",Negative
 adherence,EMJ Oncology,Negative
 adherence,HemOnc Today,Negative
 adherence,Michael R Bishop,Positive
   master class,Mallory Ahern,Negative
   master class,PeerView,Positive
 bone marrow stroma,iwCLL,Negative
 tom,"chadi nabhan MD, MBA, FACP",Negative
 Dr Francesca Arruga,iwCLL,Negative
 NOTCH PEST domain,iwCLL,Negative
 growth advantage,iwCLL,Negative
 Dr Christopher Oakes,iwCLL,Negative
 methylation states,iwCLL,Negative
 Dr Carlo Croce,iwCLL,Negative
 influences,iwCLL,Negative
 Game Day,Tiffany Mon√≠que,Positive
 Catherine Wu,Lymphoma Hub,Negative
 Legends,VJHemOnc,Negative
 amp progression,"chadi nabhan MD, MBA, FACP",Negative
 Neutrophils amp Platelets,Oncology Tube,Negative
 Complex,Hematopoiesis News,Negative
 w HS,Hematopoiesis News,Negative
 Migration,Hematopoiesis News,Negative
 welcome reception,Lymphoma Hub,Negative
 ContChronic Lymphocytic Leukemia CLL,Matthews & Associates,Negative
 ‚Äì contact,Matthews & Associates,Negative
   tgtx fbio,$PENNY KING,Positive
   CLL pts,Andrew Schorr,Negative
 career opps,VJHemOnc,Negative
 W Con Tam,VJHemOnc,Negative
 Roundup glyphosate use,Matthews & Associates,Negative
 LymphomaMultiple MyelomaHairy Cell LeukemiaChronic Lymphocytic Leukemia,Matthews & Associates,Negative
 Hacken,VJHemOnc,Negative
    Largest International Assembly,Endocrine News,Positive
 th Biennial Meeting,VPO/PR Newswire,Negative
 th Biennial Meeting,Financial GamblR,Negative
 Ne,Financial GamblR,Negative
 AntiCD,Elsevier Hematology,Positive
 Immunoglobulin gene sequence analysis,DrugGenius,Negative
 Immunoglobulin gene sequence analysis,Pathowitter,Positive
 Transformed lymphoma cells,"Raul Cordoba, MD, PhD",Negative
 tissue,"Raul Cordoba, MD, PhD",Positive
 tissue,VJHemOnc,Negative
   transformation,"Raul Cordoba, MD, PhD",Negative
   transformation,"Naveen Pemmaraju, MD",Negative
   transformation,Marta Crespo,Negative
   transformation,"Andreas-Claudius Hoffmann, M.D.",Positive
 cancer workshop,LymphomaAction,Positive
   Mutations,Jitakshi,Positive
   Mutations,"Raul Cordoba, MD, PhD",Negative
   Mutations,Medicalnewser.com,Positive
   Mutations,üö¨ üç∑ I Am Not Sorry üç∑ üö¨,Positive
   Mutations,üàÇÔ∏èüçÜ‚úäü§úüèæThe Ambiguously Gay Duo Movieü§õüèæ‚úäüçÜüàÇÔ∏è,Positive
 resistancerelapse,Jitakshi,Positive
 development progression,iwCLL,Negative
 highrisk genetics,CLL Ireland,Negative
 highrisk genetics,Lymphoma Hub,Negative
 amp Mantle Cell Lymphoma,Lymphoma Coalition,Negative
 Sunday   event,PeerView,Negative
 subject matter experts Bicycle Infrastructure,Heather DelaCruz,Negative
 Rubber,Heather DelaCruz,Negative
 Personalized Drug Analysis,GeneSetPapers,Positive
 B Cell Chronic Lymphocytic Leukemia Patients,GeneSetPapers,Positive
 Journey,CLL Ireland,Negative
 Blood Cancer Survivor,CLL Ireland,Negative
 salute Cancer Nurses,CLL Ireland,Negative
 town meeting amp broadcast,Andrew Schorr,Negative
 DiseaseRelated Mortality,Journal of Clinical Pathways,Negative
 Support group,UCI Health,Negative
 Cello Group plcs,US Banking News,Negative
 N Singer GBX,US Banking News,Negative
 N Singer GBX,MarketBeat,Negative
 Rodilla,John Drago,Positive
 luego quiero volver al luchar,John Drago,Positive
 Developing Richter Syndrome,Oncology,Negative
 John Terryyyy,Gigi Lampard,Positive
 CLL pts,Lymphoma Hub,Positive
 Lucha presenta un,Indy Wrestling Chile,Negative
 nuevo,Indy Wrestling Chile,Negative
 de MayoUna vez m√°s hacemos,Indy Wrestling Chile,Negative
 VIDEO Jennifer Brown,VJHemOnc,Positive
 Roundup amp links,Matthews & Associates,Negative
 Va el er FanArt,Dweasley ü¶Ä (Œ® 7 ) 13 üé∏,Positive
 de   Saga    Mar√≠a confirmo como se va,Dweasley ü¶Ä (Œ® 7 ) 13 üé∏,Positive
 llamar,Dweasley ü¶Ä (Œ® 7 ) 13 üé∏,Positive
 de    DESAFIANDO LAS NORMAS,Dweasley ü¶Ä (Œ® 7 ) 13 üé∏,Positive
 Real Gent,Prof John,Negative
 FRS,Prof John,Negative
 Huge Congrats Max Cooper,Prof John,Negative
 Chronic Lymphocytic Leukemia Overview,Best Cancer Solution,Positive
 VIDEOgt,Best Cancer Solution,Positive
 w Michael Hallek,VJHemOnc,Negative
 Library,Heather DelaCruz,Negative
 New Athletic Fields,Heather DelaCruz,Positive
 Rituximab biosimilar rixathon,Lymphoma Hub,Negative
    TGTX,Anna Deveau,Negative
 VIDEO Jacqueline Barrientos,VJHemOnc,Positive
 amp sequencing,VJHemOnc,Positive
 Optimal sequencing,Ana Rosa Rubio,Positive
 Optimal sequencing,HemOnc Today,Negative
 Gunstige ‚Äô risicofactoren,Oncologie Up-to-date,Positive
 jonge pati√´nt,Oncologie Up-to-date,Positive
 embarrassment,"Raul Cordoba, MD, PhD",Negative
 embarrassment,Vicky‚Äôs Fashion Edit,Positive
 riches,"Raul Cordoba, MD, PhD",Negative
 Murine Models,Frontiers Oncology,Negative
 Lymphoid Interactions Spotlight,Frontiers Oncology,Negative
   ONOGS,Anna Deveau,Negative
 Dr K Rai,Barbara Pro,Positive
 Assimos lecture,Barbara Pro,Positive
 superstar,Julia's class,Positive
 Hofstra Northwell School,NU Internal Medicine,Positive
 Investigational BTK Inhibitor ONOGS,"Raul Cordoba, MD, PhD",Negative
 LongTerm Safety,"Raul Cordoba, MD, PhD",Negative
   lymphocytic,Sumit Middha,Positive
 VIDEO George,VJHemOnc,Negative
 Ibrutinib amp Rituximab,GEDEFO,Negative
 k people,LymphomaAction,Negative
 k people,NewYorkHealthWorks,Positive
 Dr Thornton,CLL Ireland,Negative
 Dr Cameron Turtle,The ASCO Post,Negative
 Dr Cameron Turtle,Life Science WA,Positive
 Dr Cameron Turtle,AJMC-Oncology,Negative
 Dr Cameron Turtle,Fred Hutch,Negative
 CAR TCell,The ASCO Post,Negative
 Benefiting Pts wTreatmentResistant Chronic Lymphocytic Leukemia,The ASCO Post,Negative
 CpG Simulated Karyotypic Analysis,ConferenceSeries,Positive
 Significant Prognostic,ConferenceSeries,Positive
   Response,CancerWallonia,Negative
 March newsletter,Lymphoma Hub,Positive
 plateauing,Amin G T Amin,Positive
 treatment curves,Amin G T Amin,Positive
 st line treatment,Amin G T Amin,Positive
 Pharmacotherapy,Age_and_Ageing,Positive
 cell markers,Amin G T Amin,Positive
   aetiology,Amin G T Amin,Positive
 Death Associated Protein Kinase,Autophagy Papers,Positive
 Cutaneous TCell Lymphoma Symposium,Lymphoma Coalition,Negative
 Friday April     pm    pm,Lymphoma Coalition,Negative
   Cost,HealthEconBot,Positive
 Illness,HealthEconBot,Positive
 ft Dr Skarbnik Register,JTCancerCenter,Positive
 expert tool,PeerView,Negative
 Symposium Register amp,PeerView,Negative
 medicines rixathon,ESMO - Eur. Oncology,Negative
 riximyo,ESMO - Eur. Oncology,Negative
 Problem,ASH,Negative
 Problem,Oncology Tube,Negative
 Hematologist,ASH,Positive
 Serum galectin,Robert Z. Orlowski,Negative
 legend,Simon Cottom,Positive
 legend,Shivam,Positive
 terry,Simon Cottom,Positive
   pre entrenamiento,Lucas ‚ôö,Negative
 Venetoclax ABT,TrialBulletin,Negative
 Venetoclax ABT,"Mike Thompson, MD, PhD, FASCO",Negative
 Venetoclax ABT,Francesco Turturro,Negative
 HighRisk Chronic Lymphocytic Leukemia CLL St,TrialBulletin,Negative
 VIDEO Clemens Wendtner,VJHemOnc,Positive
 flu season,CLL Ireland,Negative
 Much√≠simos,Lucas ‚ôö,Negative
 BCell Chronic Lymphocytic Leukemia ‚Äì Pipeline Review H Market Research Report Store,prsync.com,Positive
 Espectacular    de MAYO,BLADE ZETA,Negative
    Sala Premium,‚ìú‚ìê‚ìù‚ì§,Positive
 Centro De Eventos,‚ìú‚ìê‚ìù‚ì§,Positive
 minutos de partir,BLADE ZETA,Negative
 en Sala premium,BLADE ZETA,Negative
 las Sala premium,BLADE ZETA,Negative
   Frontline therapy,CLL Ireland,Negative
 Voor alle,Oncologie Up-to-date,Positive
 een studie,Oncologie Up-to-date,Positive
 Hoy Domingo,Dario Antilen,Positive
 de Abril,Dario Antilen,Positive
 Longer Survival,"Raul Cordoba, MD, PhD",Negative
 Longer Survival,Anna Deveau,Negative
 PLCG C domain mutations,DrugGenius,Negative
   relapse retreat,BloodWork,Positive
 allo,BloodWork,Positive
 allo,"Navneet Majhail, MD, MS",Positive
 Avslutningsmiddag med g√§nget,Esbj√∂rn H√§gerstedt,Positive
 Constructing,Heather DelaCruz,Negative
 Breaking newsPBAC,Christopher Steer,Positive
 beauti,H.A.dilshan kaushaly,Positive
 Transcriptomic Characterization,Nicolas Robine,Positive
 Transcriptomic Characterization,topbiopapers,Negative
 SFB Mutation,Nicolas Robine,Positive
 Pleiotropic Effects,Nicolas Robine,Positive
 Pleiotropic Effects,topbiopapers,Negative
 Ibrutinib Discontinuation,Anna Deveau,Negative
 Ibrutinib Discontinuation,myCME,Negative
 RT TransplantDoc Pembrolizumab,Robert Z. Orlowski,Negative
 Dyslipidemia,Cancer Papers,Positive
 Dyslipidemia,Christopher Steer,Negative
 Dyslipidemia,‚óà Cory B. Phillips ‚óà,Negative
 Dyslipidemia,Tom,Negative
 PopulationBased Study,Cancer Papers,Positive
 PopulationBased Study,Fanny Paris,Positive
 PopulationBased Study,Christopher Steer,Negative
 Telomere length analysis,Cancer Papers,Negative
 calendar,PeerView,Negative
 calendar,iwCLL,Negative
   toolkit,PeerView,Negative
 master class symposium,PeerView,Negative
 Gran trabajo de la Dra R Bosch de   FcŒ≥RIIb expression,Hematolog√≠a SantPau,Positive
 Interesting   topics,CLL Ireland,Negative
 Checkpoint Inhibitors,Patient Power,Positive
 Checkpoint Inhibitors,Oncology Tube,Negative
 Update w Dr Lamanna,Patient Power,Negative
    PLCG mutations,"Raul Cordoba, MD, PhD",Negative
 BTK mutations,"Raul Cordoba, MD, PhD",Negative
 BTK mutations,Lymphoma Hub,Negative
 CLL Ireland New Standards,Oncology Board,Negative
 timing,Alex Joannou,Positive
 timing,Patient Power,Negative
 Terry announcement,Alex Joannou,Positive
 BCL BCR Inhibitors Promise,CLL Ireland,Negative
 BCL BCR Inhibitors Promise,Dr. Melody Davis,Negative
 Clinical Advances,Medscape Education,Negative
 Clinical Advances,"John C. Wunsch, P.C.",Negative
 Novel Oral Therapeutics,Medscape Education,Negative
 VIDEO J Brown,VJHemOnc,Negative
 New Standards,CLL Ireland,Negative
    Chronic Lymphocytic LeukemiaÎßåÏÑ±Î¶ºÌîÑÍµ¨ÏÑ±Î∞±ÌòàÎ≥ëÎßåÏÑ± Î¶ºÌîÑÍµ¨ÏÑ±,Mijin Kim,Positive
 Akt inhibition,CLL Ireland,Negative
 Chemotherapyfree approach,Monash Medicine,Positive
 Watch Dr Jennifer Brown,ASH,Negative
 Quantitative miR analysis,Cancer Papers,Negative
 Chronic Lymphocytic Leukaemia Treatment,Christopher Steer,Negative
 hallmark,Nature Reviews Disease Primers,Negative
 tcooszIVGX,Anna Deveau,Negative
 combination drugs,Andrew Schorr,Negative
 Lymphadenopathy,PathGeek,Positive
 Lymphadenopathy,Dr. Melody Davis,Negative
     nation,Only Medics,Negative
 PrEP,Only Medics,Negative
 Carl June,CLL Ireland,Negative
 New Frontiers,CLL Ireland,Negative
   Long amp,Prof John,Negative
 IMBRUVICA ¬Æ ibrutinib,Lymphoma Hub,Negative
 IMBRUVICA ¬Æ ibrutinib,Jimmy Herard,Positive
 FDA Adverse Event Reporting System,Lymphoma Hub,Negative
 Roundup Chronic Lymphocytic Leukemia CLL,Matthews & Associates,Negative
 SMC,Leukaemia Care,Negative
 Cibola LL Junior Cubs,Cibola LL,Positive
 game time,Cibola LL,Positive
 Emotional,Heroes Foundation,Positive
 Mark Barnes,Steve Hunsley,Positive
 Watch Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors,CLL Ireland,Negative
 Franco Cavalli,VJHemOnc,Positive
 amp follicular,VJHemOnc,Positive
 VIDEO Elias Campo,VJHemOnc,Negative
 telomerase expression,microRNApapers,Negative
 Dr Ken Miller,Dr. Andy Evens,Negative
 amp application,Dr. Andy Evens,Negative
 AID Dicer,microRNApapers,Negative
 AID Dicer,Cancer Papers,Negative
 Drosha Expressions,microRNApapers,Negative
 Drosha Expressions,Cancer Papers,Negative
 Bodyguards,"Raul Cordoba, MD, PhD",Negative
 assassins Bcl family proteins,"Raul Cordoba, MD, PhD",Negative
 apoptosis control,"Raul Cordoba, MD, PhD",Negative
 CLL„ÅÆÂãâÂº∑‰ºö„Å®„Å¶„ÇÇ„Åü„ÇÅ„Å´„Å™„Å£„Åü„Åæ„ÅüÊÇ£ËÄÖ„Åï„Çì„Å´ÈÇÑÂÖÉ„Åó„Çà„ÅÜ,Ë°ÄÊ∂≤ÂÜÖÁßëÂåª„ÄÄ‰∏≠Êùë„ÄÄÂπ∏Âó£,Positive
 Duvelisib Phosphoinositide Kinase,Cancer Papers,Negative
 Lymphoma support group meeting,Helen Jane Mee,Negative
 Relevance,"Raul Cordoba, MD, PhD",Negative
   Research Duvelisib,Cytokine News,Positive
 Phosphoinositide Kinase Inhibitor,Cytokine News,Positive
 Dr Tim,Imedex,Positive
 BCR amp TLR,Lymphoma Hub,Negative
 lifts,Lymphoma Hub,Negative
 selinexor trials,Lymphoma Hub,Negative
 DLBCL amp,Lymphoma Hub,Negative
 patient deaths,Lymphoma Hub,Negative
 Monosomal karyotype,Cancer Papers,Negative
 frontline amp,VJHemOnc,Negative
   OncLive New Standards,Oncology Board,Negative
 RESEARCH STUDY,Heather Swift Morrison,Negative
 AVAILABLENew,Heather Swift Morrison,Negative
 th   program,Andrew Schorr,Negative
 Drs Burke,Andrew Schorr,Negative
 RockyMtnCancer amp,Andrew Schorr,Negative
 OncLive New Standards,Lymphomation.org,Negative
 Drs Keating,MD Anderson Leukemia,Negative
 J Brown,VJHemOnc,Negative
 J Brown,Lymphoma Hub,Positive
 amp mantle cell,VJHemOnc,Negative
 approach work,Anna Deveau,Negative
 Glenn Sabin heals,CCAR,Positive
 √ñzt√ºrk   chats,Cell Press,Positive
 Granulocytes,Cell Press,Positive
 Glioblastoma ACase Report Journal,J Clin Pathol Res,Positive
 Clin Path Research,J Clin Pathol Res,Positive
 Chronic Lymphocytic Lymphocytic Leukemia,Matthews & Associates,Negative
 Hear Drs Keating,Andrew Schorr,Negative
 amp Lamanna,Andrew Schorr,Negative
 MCL MZL amp CLL cell lines,Lymphoma Hub,Negative
 SC rituximab,Lymphoma Hub,Negative
 ODAC,Lymphoma Hub,Negative
 FL DLBCL amp,Lymphoma Hub,Negative
 blood jrnls,Testmobile,Positive
 blood jrnls,Hematology Review,Positive
   Dual inhibition,Anna Deveau,Negative
 Difference,Patient Power,Negative
 Difference,Oncology Tube,Negative
 Difference,Targeted Oncology,Negative
 Dr Keating amp,Patient Power,Negative
 Hairy Cell Leukemia HCL,Matthews & Associates,Negative
 Tremendo botch Parece,Christian Palomares,Positive
 FDA Panel Supports Subcutaneous Rituximab,CLL Ireland,Negative
 RR   tcoLeMhyzkW,CLL Ireland,Negative
 dinaciclib,CLL Ireland,Positive
 dinaciclib,FarmaOnco,Negative
 Members Constructing,Heather DelaCruz,Negative
 RR tcovIGSkEnn,CLL Ireland,Negative
 Lowdose alemtuzumab,Lymphoma Hub,Negative
 CLL   cluster,Scientia,Positive
 Therapeutic Development,BizPR,Negative
   Hope,Patient Power,Negative
   Hope,jc,Positive
 Hype w Dr Paul Bunn,Patient Power,Negative
 Weather problems,Erin Elizabeth,Positive
 planes land,Erin Elizabeth,Positive
 college station,Erin Elizabeth,Positive
 weather,Erin Elizabeth,Positive
 weather,Jacko,Positive
 gold standard,Marek Trneny,Positive
 fit patients results,Marek Trneny,Positive
 ARCTIC study,Marek Trneny,Positive
 Period,BizPR,Negative
 NOTCH Mutated Chronic Lymphocytic   Cells,Hematopoiesis News,Negative
 MYCRelated OE,Hematopoiesis News,Negative
 Nucleophosmin,Hematopoiesis News,Negative
 PIKŒ¥,"Raul Cordoba, MD, PhD",Positive
 PIKŒ¥,TumorImmunoPapers,Negative
 Human neutrophils,"Raul Cordoba, MD, PhD",Negative
 phagocytosis,"Raul Cordoba, MD, PhD",Negative
 phagocytosis,ImmunologyPapers,Negative
 phagocytosis,Francesco Turturro,Negative
 removal,"Raul Cordoba, MD, PhD",Negative
 removal,VJHemOnc,Positive
 Common Nonmutational NOTCH Activation,Hematopoiesis News,Negative
 Brad Adams,Patient Power,Negative
 Brad Adams,Oncology Tube,Negative
 Brad Adams,Andrew Schorr,Negative
 PhII,MD Anderson Leukemia,Negative
 Ruxolitinib,MD Anderson Leukemia,Negative
 Ruxolitinib,Holden Caulfield PhD,Positive
 Ruxolitinib,"Darcy Burbage, DNP, RN, AOCN",Negative
 Ruxolitinib,OncologyNurseAdvisor,Positive
 Ruxolitinib,"Meagan Bryan, RN",Negative
 diseaserelated symptoms,MD Anderson Leukemia,Negative
 Idelalisibduvelisib PIKŒ¥ blockade,Lymphoma Hub,Negative
 Dr Valentin Goedes expert comment,Lymphoma Hub,Negative
 William G,CLL Ireland,Negative
 FirstLine Options,CLL Ireland,Negative
 ResearchMoz Chronic lymphocytic Leukemia Market,„Ç§„Çø„É™„Ç¢ÁµåÊ∏à„Éã„É•„Éº„Çπ,Positive
 ResearchMoz Chronic lymphocytic Leukemia Market,BizPR,Negative
 United States EU France Germany Italy Spain UK,„Ç§„Çø„É™„Ç¢ÁµåÊ∏à„Éã„É•„Éº„Çπ,Positive
 UTR   mutation,Manoj Raghavan,Positive
   smallcap stocks,The Motley Fool UK,Positive
 United States EU France Germany,BizPR,Negative
   Blood Tests,CLL Ireland,Negative
 Immunoglobulin Blood,CLL Ireland,Negative
 Counts Platelets,CLL Ireland,Negative
 Susan J Leclair PhD CLS,CLL Ireland,Negative
 Bonus Resources,Managing Myeloma,Negative
 riskstratification,Managing Myeloma,Negative
 st treatment year,"Raul Cordoba, MD, PhD",Negative
 Pubmed NOTCH,epigenetics_papers,Negative
 New tech,Brad Tompkins,Positive
 Pubmed   NOTCH,Ribosome Papers,Positive
 bookworm,@nnystar,Positive
 amp broadcast,Andrew Schorr,Negative
       √≥n,The Pepex Family,Negative
       √≥n,Indy Wrestling Chile,Positive
 OnceDaily Oral Ibrutinib,Marlowe S Tessmer,Negative
 NEOONS Delp,OSCO,Positive
 NEOONS Delp,OSCO Nurses,Negative
   Cello,Ruth Gemmell,Positive
   Cello,Claudio Foscoli,Positive
   Cello item,John Harrington,Positive
 CEO Sorry,John Harrington,Positive
 cytotoxic lymphocytes,Journal of Clinical and Cellular Immunology,Negative
 CLL amp Bcell NHL pts,Lymphoma Hub,Negative
 Accessed Article Refractory Chronic Lymphocytic Leukemia Therapeutic Challenge,CCDT,Negative
 sos,John Harrington,Positive
   SLL,Oncology Tube,Negative
 NYC   Press registration,iwCLL,Positive
 Dublin dad,CLL Ireland,Negative
 wonder drug,CLL Ireland,Negative
 TKIs,"chadi nabhan MD, MBA, FACP",Positive
 TKIs,Lymphoma Coalition,Negative
 TKIs,Carla Casulo,Positive
 Blood Commentary Ibrutinibresistant,Blood Journal,Negative
 VIDEO J Barrientos,VJHemOnc,Positive
   despues,Mascarasraison2.0,Positive
 tanto,Mascarasraison2.0,Positive
 tiempoAhora,Mascarasraison2.0,Positive
 maipu mas cerca,Mascarasraison2.0,Positive
 Koryo,Cristian D√≠az R.,Positive
 camino,BLADE ZETA,Negative
 LAS HRS Evento Reborn de   falte ‚òï,BLADE ZETA,Negative
 Display Dysregulated Expression,"Raul Cordoba, MD, PhD",Negative
 Immune Checkpoints,"Raul Cordoba, MD, PhD",Negative
 Activation Markers,"Raul Cordoba, MD, PhD",Negative
 Exhausted CD Tcells,"Raul Cordoba, MD, PhD",Negative
 tumour DNA,Cancer Papers,Negative
 Scotland Places,LymphomaAction,Positive
 Glasgow,LymphomaAction,Positive
 Lymphoma conference,LymphomaAction,Positive
 Apr    event,CIUSSS Centre-Ouest-de-l'√éle-de-Montr√©al,Positive
 Dr N Johnson Tracy Regimbald Changing Landscape,CIUSSS Centre-Ouest-de-l'√éle-de-Montr√©al,Positive
 ibrutinib dose,Lymphoma Hub,Negative
 patient outcome,Lymphoma Hub,Negative
 Comparisons,Evidera,Positive
 Physicians Choice,Evidera,Positive
 amp Idelalisib Plus Ofatumumab,Evidera,Positive
 EHASWG,Lymphoma Hub,Negative
 Rare Lymphomas,Lymphoma Hub,Negative
 drug ‚Äì drug interaction study,VJHemOnc,Negative
 CYPA inhibitors,VJHemOnc,Negative
 Test post,cripto-wolf,Positive
 relapsed   Better w idela,"chadi nabhan MD, MBA, FACP",Negative
 doubt,"chadi nabhan MD, MBA, FACP",Negative
 Clinical Implications,TumorImmunoPapers,Negative
 Clinical Implications,"Dr T. Comeau , MD",Negative
 Clinical Implications,MPLN,Negative
 Clinical Implications,"Raul Cordoba, MD, PhD",Negative
 Clinical Implications,Francesco Bertoni,Negative
 Clinical Implications,GEDEFO,Negative
 Novel Genomic Discoveries,TumorImmunoPapers,Negative
 Novel Genomic Discoveries,"Dr T. Comeau , MD",Negative
 Novel Genomic Discoveries,MPLN,Negative
 Novel Genomic Discoveries,"Raul Cordoba, MD, PhD",Negative
 Novel Genomic Discoveries,Francesco Bertoni,Negative
 Novel Genomic Discoveries,GEDEFO,Negative
 MONTREAL,Lymphoma Canada,Negative
 LowDensity Lipoproteins,Jasmin Abd-el-Baki,Positive
 Melody Davis Deciphering Ibrutinib Resistance,Oncology Board,Negative
 Richters Syndrome Update,Oncology Tube,Negative
 Optimal Approaches,Oncology Tube,Negative
 Deletion p,Oncology Tube,Negative
 patient town hall,Andrew Schorr,Negative
 Lymphoma Canada Deciphering Ibrutinib Resistance,Oncology Board,Negative
 Global Chronic Lymphocytic Leukemia Market Review H,Top Political Manage,Positive
 Trends amp Analysis Forecasts,Top Political Manage,Positive
 Room B,Theodoros Moysiadis,Positive
 Interesting peer review,CLL Ireland,Negative
 nd opinions,CLL Ireland,Negative
 Human CD,Krishan Maggon,Negative
 Monoclonal Antibody Daratumumab,Krishan Maggon,Negative
 Hampers Leukemia,Krishan Maggon,Negative
 Microe,Krishan Maggon,Negative
 Brian Parkinson,AACR Foundation,Negative
 Ibrutinib ResistanceMechanisms amp Options,Oncology Tube,Negative
   paper,Invivoscribe,Negative
 Stamatopoulos et al Oxford U Hospt,Invivoscribe,Negative
 IGHV Leader SHM Assay,Invivoscribe,Negative
 amp bioinformatics,Invivoscribe,Negative
 IFU,Invivoscribe,Negative
 Trogocytose,Prof John,Negative
 √≠a MIRNA EXPRESSION,Medibooks,Negative
 PROFILE,Medibooks,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS,Medibooks,Negative
 Q DELETION,Medibooks,Negative
 position paper,Isaura R. Penin,Positive
 position paper,Ana Rosa Rubio,Positive
   VIDEO Dr John Byrd,The James,Negative
 Dr Anthony R Mato,Clin Adv Hem Onc,Negative
 earlybird tickets,Situation Publishing,Positive
 tcoABMQuZgmQq,Christopher Steer,Negative
   Cell Therapies,Anna Deveau,Negative
 enthusiasm,Anna Deveau,Negative
 Thoracic Complications,Cancer Papers,Negative
 Momentums,CLL Ireland,Negative
 Reference Guide BONUS,Tweet Dealz,Positive
 Reference Guide BONUS,Internet Medical,Positive
 Hill Resource Reference Guide Book,Tweet Dealz,Positive
    Succeeds,CancerWallonia,Negative
 tcoIZQGKlRjG,Patient Power,Negative
   Factors,ClinChemINFO,Positive
 thrive,Patient Power,Negative
 drugs idelalisib,CLL Ireland,Negative
 NEW PhII Study Administration,MD Anderson Leukemia,Negative
 Jakafi Ruxolitinib,MD Anderson Leukemia,Negative
 Prev Untreated,MD Anderson Leukemia,Negative
 Cinderella,Cancer Africa,Positive
 heres,brian brown,Negative
 land,brian brown,Negative
 beat,brian brown,Negative
 far round,brian brown,Negative
 yixlid jailor,brian brown,Negative
 dredge,brian brown,Negative
 Consolidation Therapy,Journal of Clinical Pathways,Negative
 Pubmed Aberrant,epigenetics_papers,Negative
 Positive Topline Data,1stOncology,Negative
 High Risk CLL TGTX,1stOncology,Negative
 TG Therapeutics ublituximab,Krishan Maggon,Negative
 TGTX JNJ,Biotech2050,Negative
 RelapsedRefractory Delp,"Raul Cordoba, MD, PhD",Negative
   Combo Succeeds,"Raul Cordoba, MD, PhD",Negative
 stage symptoms,April Gariepy,Positive
 TG Therapeutics Announces Positive Topline Data,Dr. Melody Davis,Negative
 TG Therapeutics Announces Positive Topline Data,Financial Buzz,Negative
 TG Therapeutics Announces Positive Topline Data,ForexTV,Positive
 RTX,Bernie Marini,Positive
 obi,Bernie Marini,Positive
 antiCD landscape,Bernie Marini,Positive
 PharmacyTimes Investigational   Drug Shows Promise,Pharmacy Podcast Network,Positive
 LateStage Trial,Pharmacy Podcast Network,Positive
 LateStage Trial,Pharmacy Times,Negative
 Investigational   Drug Shows Promise,Pharmacy Times,Negative
 TGTX    story,Anna Deveau,Negative
 Clonal kinetics,Michael Moles,Positive
 VIDEO Franco Cavalli,VJHemOnc,Negative
 Ibruti,Financial Buzz,Negative
 TGTX Imbruvica,Frank Tarazi,Positive
 TOLL,Prof John,Negative
 Nice Review,Prof John,Negative
 TGTX Positive Topline Data,Odi Bruckman,Negative
 Projektet Stig,√Öbo Akademi University,Positive
 Astu,√Öbo Akademi University,Positive
 Sis√§√§n,√Öbo Akademi University,Positive
 vill,√Öbo Akademi University,Positive
 av flyktingar,√Öbo Akademi University,Positive
 Cholesterol Levels,Cancer Papers,Negative
   flights,‚ú®üåúüê±Missing Mitz.‚ù§Ô∏èü™ê‚ú®,Positive
 las vegas,‚ú®üåúüê±Missing Mitz.‚ù§Ô∏èü™ê‚ú®,Positive
 TwoBiomarker Prognostic Model,Oncology,Negative
 Chronic Lymphocytic Leukemia Patient Outcome,Oncology,Negative
 Gebbie Hou,UBC Blood for Life,Positive
   Malignancy,McHeyzer-Williams,Negative
 Chronic Lymphocytic   PrimeView,McHeyzer-Williams,Negative
 TomKipps,McHeyzer-Williams,Negative
 caffeine,Immuno-Oncology,Negative
 caffeine,Cancer Papers,Negative
 suppression,Immuno-Oncology,Negative
 suppression,Cancer Papers,Negative
 T cell responses,Immuno-Oncology,Negative
 T cell responses,Cancer Papers,Negative
 amp Chronic Lymphocytic,McHeyzer-Williams,Negative
 SMEs UFO,Heather DelaCruz,Negative
 UAV,Heather DelaCruz,Negative
 Welcome Invasion,Heather DelaCruz,Negative
 Drones,Heather DelaCruz,Negative
 Public Works World,Heather DelaCruz,Negative
 Ms Pollyanna Meet,Patient Power,Negative
 Mr Negativity,Patient Power,Negative
 progression amp evolution,Lymphoma Hub,Negative
 PI Kinase Inhibitors,Anna Deveau,Negative
 Longterm diseasefree survival,"Raul Cordoba, MD, PhD",Negative
 argument,"Raul Cordoba, MD, PhD",Negative
 Longterm survival,"Raul Cordoba, MD, PhD",Negative
 Longterm survival,Adaptive Biotech,Negative
 Attn   community,CLL Ireland,Negative
 Patient amp Carer Info Day,CLL Ireland,Negative
 April SpeakersDrPatrick Thornton DrBrian Koffman DrTahla Munir,CLL Ireland,Negative
 Study   relapse,ARUP Laboratories,Positive
 los m√≠os,k√†,Positive
 Pictured APN Mary DiLorenzo,JTCancerCenter,Positive
 Ph   RCT,NCCP,Positive
 und chronische lymphatische Leuk√§mie,AbbVie Deutschland,Negative
 Vollst√§ndige,AbbVie Deutschland,Negative
 Dr Kevin Norris,DCG Seminar Series,Positive
 Vincent Yeung,DCG Seminar Series,Positive
 UG,DCG Seminar Series,Positive
 HWB,DCG Seminar Series,Positive
    TRUXIMA,"Raul Cordoba, MD, PhD",Negative
 Genetic Mutations,Journal of Clinical Pathways,Negative
 Genetic Mutations,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 amp David P Steensma   chair,Imedex,Positive
 disc,Imedex,Positive
 Saiba mais,SOBRAFO,Positive
 UK Cambridge MP,Margaret Walker,Negative
 CLLIPI New International Staging System,"Mike Thompson, MD, PhD, FASCO",Positive
 Dr Paw Jensen,MDS and You - MDS og Dig,Positive
 Global Chronic Lymphocytic Leukemia Market landscape Market segmentation,BizPR,Negative
 ROA,BizPR,Negative
 increased likelihood,OncLive SOSS,Negative
   Replace,Oncology Tube,Negative
 work views,Jimmy,Positive
 Watch   interview Dr Jeff Sharman,Fabio Gratton,Positive
 Watch   interview Dr Jeff Sharman,Rhia Steele@ravishingrhia.com,Negative
 Watch   interview Dr Jeff Sharman,Debbie Woodbury,Negative
 Watch   interview Dr Jeff Sharman,Sandy D.,Negative
 Watch   interview Dr Jeff Sharman,CureClick,Positive
 Watch   interview Dr Jeff Sharman,Senior Care Corner,Negative
 Watch   interview Dr Jeff Sharman,Cassi Schmigotzki,Negative
 Watch   interview Dr Jeff Sharman,Colleen Busch,Negative
 Watch   interview Dr Jeff Sharman,International Pain Foundation¬Æ,Negative
 Relapsed highrisk,"Holly Bertone, CNHP, PMP",Positive
 Relapsed highrisk,WEGO Health,Positive
 Relapsed highrisk,Rhia Steele@ravishingrhia.com,Positive
 Relapsed highrisk,CureClick,Positive
 Relapsed highrisk,Milton Donald,Negative
 Relapsed highrisk,Te Ha,Negative
 Relapsed highrisk,Maliyka to some Meeka to others,Positive
 Relapsed highrisk,Sandy D.,Negative
 Relapsed highrisk,International Pain Foundation¬Æ,Positive
 Relapsed highrisk,Nora Sheffield,Positive
 Relapsed highrisk,Kimberley Thomas,Negative
 Relapsed highrisk,Debra Ann Elliott-Christian Author & Speaker,Positive
 Relapsed highrisk,susanna sargsyan,Negative
 Relapsed highrisk,Becky Burns,Positive
 Relapsed highrisk,circa1835,Negative
 Relapsed highrisk,Grayson (he),Positive
 Relapsed highrisk,julie andrew,Positive
 Relapsed highrisk,Debbie Woodbury,Negative
 Relapsed highrisk,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 Relapsed highrisk,Colleen Busch,Negative
 Relapsed highrisk,mjohemme,Negative
   HELIOS,EMJ Hematology,Negative
   HELIOS,EMJ Reviews,Positive
 esa wesa cancer Chronic Lymphocytic Leukemia,üëë,Positive
 CLL Research   Identification,Stichting Leukemie,Positive
 Risk Genes,Stichting Leukemie,Positive
 Risk Genes,Margaret Walker,Negative
 Risk Genes,NACDA Program on Aging,Negative
 Magic pills,Cancer Papers,Negative
 Magic pills,Samantha Wilkinson,Positive
   km run,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
 Sanofiaventis,Medicalnewser.com,Negative
 Progressive Multifocal Leukoencephalopathy,"Raul Cordoba, MD, PhD",Negative
 Exchange w John Byrd amp Michael Keating,"Krishna Komanduri, MD, FASTCT",Positive
 Positive Review,Oncology Tube,Negative
 Ruxolitinib controls,HemOnc Today,Negative
 Ruxolitinib controls,Healio,Negative
 Journalists,iwCLL,Negative
 Immune System Genes,LabMedica.com,Positive
 indication approval,CBPartners,Positive
 distribution,Cancer Papers,Negative
 TP gene polymorphisms,Cancer Papers,Negative
 Mario,Old North Optometry,Positive
 Fred Vella,Old North Optometry,Positive
 Adam Viger,Old North Optometry,Positive
   Year Experience,Oncology Tube,Negative
 Brace,Mahmoud Turki,Positive
 Dreger,"Rob Dean, MD",Positive
 doses,"chadi nabhan MD, MBA, FACP",Negative
 Dreger poorrisk,"Rob Dean, MD",Positive
 Intervention Radio,Mahmoud Turki,Positive
 Steve Colbourne,Leukaemia Care,Negative
 Philippe Aftimos MD,Oncology Board,Negative
 BUG standstill,brian brown,Negative
 Small Molecule Combinations,Oncology Tube,Negative
 Day Supplant,Oncology Tube,Negative
 EB overexpression,Blood Journal,Negative
 mice,Blood Journal,Negative
 mice,TumorImmunoPapers,Negative
 mice,ImmuneGCPapers,Positive
 B Bcell expansion,Blood Journal,Negative
 Radiotherapy amp DLBCL Predicting Relapse,Dean Celia,Positive
 FLTAML Thoracic Complications,Dean Celia,Positive
 Resonate   Trial Update,Oncology Tube,Negative
 Reservez vos,Mahmoud Turki,Negative
 New   Data,Oncology Tube,Negative
 New   Data,"Pharmacyclics, an AbbVie Company",Negative
 Current Practices,Oncology Tube,Negative
   sessions aujourdhui,Mahmoud Turki,Negative
 et h,Mahmoud Turki,Negative
 replays,Andrew Schorr,Negative
 Chronic Lymphocytic Leukemia Symptoms amp Treatment Cleveland Clinic,BigDru,Positive
   Town Meeting Replay,Patient Power,Negative
   Prometheus,Dave Lexington,Positive
 FiveYear Experience,Oncology Tube,Negative
 ABBV VENCLEXTA,CBPartners,Positive
 w Georgios Nteliopoulos,VJHemOnc,Negative
 ORIGIN study,Robert Z. Orlowski,Negative
 st line therapy,Robert Z. Orlowski,Negative
 COMT,Austin Publishing,Positive
 ValMet Genotype,Austin Publishing,Positive
 Tumoral B Cells,Austin Publishing,Positive
 Chronic Lymphocytic Leukemia Patient Case Report,Austin Publishing,Positive
 VIDEO Identifying,VJHemOnc,Negative
 S Deaglio   Tumorhost interactions,ICGEB Official,Positive
 dinformations,Mahmoud Turki,Negative
 sur notre evenement,Mahmoud Turki,Negative
 fevreir lt salle des federations,Mahmoud Turki,Negative
 Bueno una vez m√°s,John Drago,Positive
 Promoter Hypomethylation,TumorImmunoPapers,Positive
 Mouse,TumorImmunoPapers,Positive
 pack,Nikhil Wagle,Positive
 Wolves,Nikhil Wagle,Positive
 VIDEO Kostas Stamatopoulos,VJHemOnc,Positive
 town hall meeting,Jeff Folloder,Positive
 GG guys,Mahmoud Turki,Negative
 lt,Mahmoud Turki,Positive
 lt,CAPhO,Negative
 Venetoclax ABTGDC,EMJ Hematology,Negative
 Venetoclax ABTGDC,Allergy & Immunology,Positive
 VIDEO C Tam,VJHemOnc,Positive
 BTK inhibitor Bgb,VJHemOnc,Positive
 Right   Testing,Patient Power,Negative
 Right Time w,Patient Power,Negative
   Overview,@sehh_es,Negative
 Cambios,Marta Crespo,Negative
 por,Marta Crespo,Negative
    pts amp caregivers,Andrew Schorr,Negative
 WowSo,Andrew Schorr,Negative
    line,Anna Deveau,Negative
 Perspective,Patient Power,Positive
 sideeffects profile,Oncology Tube,Positive
 events calendar,Medthority,Positive
 Concise Review,Cancer Papers,Negative
 Autoimmune Cytopenias,Cancer Papers,Negative
 associated,"Raul Cordoba, MD, PhD",Negative
 pathogenesis management,"Raul Cordoba, MD, PhD",Negative
 risk reduction strategies,"Raul Cordoba, MD, PhD",Negative
 Woo,brian brown,Negative
 community legacy league,brian brown,Negative
 survival differs,ACS Journal Cancer,Negative
 Immunogenetics,Cancer Papers,Negative
 CellIntrinsic Determinants,Garbi√±e Lizeaga,Negative
 CellIntrinsic Determinants,Jerry Lee,Negative
 IbrutinibInduced Apoptosis,Garbi√±e Lizeaga,Negative
 IbrutinibInduced Apoptosis,Jerry Lee,Negative
 Base,Amy Ramos,Negative
 ‚Äú family Reunion,Andrew Schorr,Negative
 Macrophagesconfer survival signals,Cure Cancer Now,Negative
 CCRdependent translational MCL induction,Cure Cancer Now,Negative
 CCRdependent translational MCL induction,DrugGenius,Negative
 Acquired BTK,Lymphoma Canada,Negative
 PLCG Mutations,Lymphoma Canada,Negative
 Future CLL Relapse   Cancer Therapy Advisor,Lymphoma Canada,Negative
 TP gene mutation analysis,Literature Bot,Positive
 TP gene mutation analysis,Oxford Nanopore,Positive
 TP gene mutation analysis,CompBiolPapers,Negative
 Chronic Lymphocytic Leukaemia      information,Christine McKenzie,Positive
 Macrophages,DrugGenius,Negative
 Macrophages,Oncology Tube,Negative
 survival signals,DrugGenius,Negative
 survival signals,Steve Warner,Positive
   Enhance,"Raul Cordoba, MD, PhD",Negative
 CAR TCell Treatment Impact,"Raul Cordoba, MD, PhD",Negative
   Patient Power LIVE Meeting,Oncology Tube,Negative
 Saturday Feb,Oncology Tube,Negative
 REGISTER,Oncology Tube,Negative
 ptfamily members,Patient Power,Negative
 VIDEO P Ghia,VJHemOnc,Negative
 reanalysis,VJHemOnc,Negative
 expert insight,OncLive SOSS,Negative
 Chronic Lymphocytic Leukemia Epidemiology,BizPR,Negative
 Market Analysis,BizPR,Negative
 w J Woyach,VJHemOnc,Negative
   Identifies,CancerWallonia,Negative
 Antidote,ActiveVoice Health,Positive
 VIDEO Developments,VJHemOnc,Negative
 CLL Patient Power Live Meeting February    Link,Oncology Tube,Negative
 Description,Oncology Tube,Negative
 NewTrip Venetoclax Venclyxto,Trip Database,Negative
 Chronic BCell,Trip Database,Negative
 mRNA overexpression,Elsevier Hematology,Positive
 HIFA,Elsevier Hematology,Positive
 VETMEDICS,Augustino Chengula,Negative
 Chronic Lymphocytic LeukemiaAbout Chronic Lymphocytic Leukemia,Augustino Chengula,Negative
   fucking years,Clay,Positive
 CLL chronic lymphocytic,TalkAboutHealth,Positive
 workingwhat,TalkAboutHealth,Positive
 DrBrown,TalkAboutHealth,Positive
 Significance ibrutinib,TalkAboutHealth,Positive
 Longterm outcomes update,MD Anderson Cancer Center,Negative
 Ibrutinib study,MD Anderson Cancer Center,Negative
 pt town meeting atbroadcast,Andrew Schorr,Negative
 horas,Indy Wrestling Chile,Negative
 nuestra Secci√≥n   subiremos,Indy Wrestling Chile,Negative
 el v√≠deo de    VS,Indy Wrestling Chile,Negative
 Shynron,Indy Wrestling Chile,Negative
 MX Cll amp,Indy Wrestling Chile,Negative
 Chronic Lymphocytic Leukemia Research Identification,Lymphoma Canada,Negative
 Leukemia Risk Genes,Lymphoma Canada,Negative
 Leukemia Risk Genes,Marcy Stiebs,Positive
 Leukemia Risk Genes,Natarajan Ganesan,Positive
 Leukemia Risk Genes,Senior Health Daily,Positive
 Leukemia Risk Genes,Healthy Living Daily,Positive
 Leukemia Risk Genes,Obesity Daily,Positive
 Leukemia Risk Genes,Drug Daily,Positive
 Leukemia Risk Genes,Cancer Daily,Negative
 Leukemia Risk Genes,Medi-Science Daily,Positive
 Leukemia Risk Genes,Dentist Daily,Positive
 Leukemia Risk Genes,Child Health Daily,Positive
 Leukemia Risk Genes,World Medical News,Positive
 ‚Äú size,Andrew Schorr,Negative
 ‚Äù disease,Andrew Schorr,Negative
 Online    implicates dysregulation,Nature Genetics,Positive
 immunity genes,Nature Genetics,Positive
 immunity genes,Cancer Papers,Negative
 SoC,Lymphoma Hub,Negative
 RR   results,Lymphoma Hub,Negative
 Case Letter,CUTIS,Positive
 Widespread Poikilodermatous Dermatomyositis,CUTIS,Positive
 w CYPA inhibitors,VJHemOnc,Negative
 Combination ublituximab,Lymphoma Hub,Negative
 Cost regulators,Client-Pharma Ltd,Positive
   treatmentoption,Client-Pharma Ltd,Positive
 tcolioeiK,Steven Philip Warner,Positive
 pharma initiatives,The Dollar Business,Positive
 pharma initiatives,Manish Kumar Pandey,Positive
 pharma initiatives,Avnish Goyal,Positive
 tcotivKQXLNbd,The Dollar Business,Positive
 tcoJEAZhtH,Manish Kumar Pandey,Positive
 tcosDELssdU,Avnish Goyal,Positive
 Meeting February,Liquid Grids,Positive
 NICE Approval,Patient Power,Negative
 Dr Michael,Oncology Tube,Negative
 Reflections,Oncology Tube,Negative
 Reflections,Patient Power,Positive
 Refractory Chronic Lymphocytic Leukemia CLL Treatment Market research New Study Overview Global Clinical,Dr. Gui√±ales,Positive
 Chronic Lymphocytic Leukemia Research   Identification,NACDA Program on Aging,Negative
 Chronic Lymphocytic Leukemia Research   Identification,Natarajan Ganesan,Positive
 Chronic Lymphocytic Leukemia Research   Identification,Senior Health Daily,Positive
 Chronic Lymphocytic Leukemia Research   Identification,Healthy Living Daily,Positive
 Chronic Lymphocytic Leukemia Research   Identification,Obesity Daily,Positive
 Chronic Lymphocytic Leukemia Research   Identification,Drug Daily,Positive
 Chronic Lymphocytic Leukemia Research   Identification,Cancer Daily,Negative
 Chronic Lymphocytic Leukemia Research   Identification,Medi-Science Daily,Positive
 Chronic Lymphocytic Leukemia Research   Identification,Dentist Daily,Positive
 Chronic Lymphocytic Leukemia Research   Identification,Child Health Daily,Positive
 Chronic Lymphocytic Leukemia Research   Identification,World Medical News,Positive
 Phase II trial results,Lymphoma Hub,Negative
 abexinostat,Lymphoma Hub,Negative
   Lucha Libre Esto,Indy Wrestling Chile,Negative
   Lucha Libre Esto,The Pepex Family,Negative
 Es Lucha presenta su primer,Indy Wrestling Chile,Negative
 Es Lucha presenta su primer,The Pepex Family,Negative
 del a√±oLuego de un exitoso,Indy Wrestling Chile,Negative
 del a√±oLuego de un exitoso,The Pepex Family,Negative
 CAR TCell Therapy Combinations,Oncology Nursing News,Negative
   Therapy Increases T Cell Repertoire Diversity,MoJo,Negative
   Deborah,Patient Power,Negative
 Blwyddyn LlD yn mwynhau yng Nghanolfan Ddwr Cilfynydd,Melin Gruffydd,Negative
 Cilfynydd Water Centre,Melin Gruffydd,Negative
 Chronic Lymphocytic Leukemia Market Volume Analysis size share,hussain96,Positive
 Key Trends,hussain96,Positive
 CLL method Powerpoint Presentations,PPT Search,Negative
 Wit,Augustino Chengula,Positive
 leukemia risk genes,Medical Daily,Positive
 clinic day,Andrew Schorr,Negative
   yo lady,Andrew Schorr,Negative
 Santa Barb,Andrew Schorr,Negative
 GazyvaImbruvica trial,Andrew Schorr,Negative
 Moores Cancer Ctr,Andrew Schorr,Negative
 checkup,Andrew Schorr,Negative
 Genomewide association analysis,Cancer Papers,Negative
 dysregulation,Cancer Papers,Negative
 Variation,Cancer Papers,Negative
 Prognostic Factor Chronic Lymphocytic Leukemia,Cancer Papers,Negative
 Chronic Lymphocytic Leukemia Market Trends Drivers Strategies Applications,satPRnews,Negative
 Robert,NewYork-Presbyterian,Positive
 nd lease,NewYork-Presbyterian,Positive
 Updated Clinical Practice Guideline,GURU,Positive
 news story,The ICR,Positive
 Adenosine,Blood Advances,Positive
 Adenosine,üÖæ Jaksic,Negative
 amp patient empowerment,VJHemOnc,Negative
   influence,"Houlston Lab, ICR",Positive
 Lenalidomide Maintenance Extends PFS,Lymphomation.org,Negative
   Chronic Lymphocytic Leukemia CLL Market research,Swapnil Devale,Negative
 New Study Global Clinical Trials Review H,Swapnil Devale,Negative
 wolf,Jimmy,Positive
 European Research Initiative,VJHemOnc,Positive
 Current Research,Oncology Tube,Negative
 Drug Treatments,Oncology Tube,Negative
 st Annual Chris Lewis Memorial Silent Auction,Charger Baseball,Positive
 Tumour suppressor MCPH,The FEBS Journal,Positive
 Optimal Sequencing,"Dr T. Comeau , MD",Negative
 Optimal Sequencing,Cancer Papers,Negative
 Optimal Sequencing,"Raul Cordoba, MD, PhD",Negative
 Ibrutinib Idelalisib,"Dr T. Comeau , MD",Negative
 Ibrutinib Idelalisib,Cancer Papers,Negative
 Ibrutinib Idelalisib,"Raul Cordoba, MD, PhD",Negative
 miRNA expression replacement,DrugGenius,Negative
 miRNA expression replacement,microRNApapers,Negative
 video podcast,AU Oncology Reviews,Negative
 video podcast,Research Review AU,Positive
 Annual Hematology Meeting Updates,Oncology Tube,Negative
 employees,Seven Foot Cowboy‚Ñ¢,Positive
 Decade,OncLive SOSS,Negative
 Firstline,A. Vroom - Ten Wolde,Negative
 Seine Therapie bezeichnet Hagen,Janssen Deutschland,Positive
 Bergbesteigung Wie,Janssen Deutschland,Positive
 zum Gipfel,Janssen Deutschland,Positive
 geschafft hat,Janssen Deutschland,Positive
 Susan,Andrew Schorr,Negative
 airport,Andrew Schorr,Negative
 World expert Dr Michael Keating,Andrew Schorr,Negative
 Chronic Lymphocytic Leukemia Initiating Therapy,Lymphoma Canada,Negative
 Chronic Lymphocytic Leukemia Initiating Therapy,OncLive.com,Negative
 Public Works,Heather DelaCruz,Negative
 Bookings,LymphomaAction,Negative
 Chronic Lymphocytic Leukemia Leukemia CLL,Matthews & Associates,Negative
 Lenalidomide Maintenance Delays Progression,Glenn Sabin,Positive
 tcofZaeLvjPO,PRICENTRIC,Positive
 CLLMayo Clinic,Get This Hub,Positive
 CLLMayo Clinic,Shoppingdealer,Positive
 Chronic Lymphocytic Leukemia Therapeutics Market size,Publish PressRelease,Positive
 volume,Publish PressRelease,Positive
 routine   access,Margaret Walker,Negative
 Idag √§r vi stolta,Janssen Sverige,Positive
 f√∂r arrangemanget,Janssen Sverige,Positive
 Antigen receptor stereotypy,DTHSTR,Positive
 Antigen receptor stereotypy,"Raul Cordoba, MD, PhD",Negative
 Antigen receptor stereotypy,DrugGenius,Negative
 Deborah,Oncology Tube,Negative
 Story ABT,Oncology Tube,Negative
 NEW STUDY Atezolizumab,MD Anderson Leukemia,Negative
 Combo w Obinutuzumab amp Ibrutinib,MD Anderson Leukemia,Negative
 pts w RR,MD Anderson Leukemia,Negative
 Firefighter role play,Class 2,Positive
 Innate NKcell Immunity,New OhioLINK ETDs,Positive
 microvesicle generation,"Raul Cordoba, MD, PhD",Negative
 microvesicle generation,TumorImmunoPapers,Negative
 Bcell chronic lymphocytic   implication,"Raul Cordoba, MD, PhD",Negative
   downregulates,"Raul Cordoba, MD, PhD",Negative
 upregulation,"Raul Cordoba, MD, PhD",Negative
 tumor suppressors,"Raul Cordoba, MD, PhD",Negative
 NICE Uturn,Margaret Walker,Negative
 PPARdelta,DrugGenius,Negative
 PPARdelta,TumorImmunoPapers,Negative
 PPARdelta,Hypoxia Adaptation,Positive
 PPARdelta,Cancer Papers,Negative
 PPARdelta,IamMitochondria,Positive
 PEST domain,DrugGenius,Negative
 CCLdriven homing,DrugGenius,Negative
 baseball practice,Amy Ramos,Negative
 Emerging Therapies,MinuteCE,Positive
 Leukemia Lymphoma,MinuteCE,Positive
 Eradication,PracticeUpdate,Negative
 Eradication,Oncology,Negative
 Eradication,Patient Power,Positive
 Letai,VJHemOnc,Negative
 human,VJHemOnc,Negative
 quiz questions,Medthority,Negative
 patient case study scenarios,Medthority,Negative
 New Pharmacotherapies,P&T,Positive
 New Pharmacotherapies,P&TCommunity,Positive
   antitumor immunomodulator,"Raul Cordoba, MD, PhD",Negative
 Ib trial,Lymphoma Hub,Negative
 Idelalisib   bendamustine,The Lancet Oncology,Negative
 CARE Perspectives,CARE‚Ñ¢ Education,Positive
 CARE Perspectives,Canadian Hematology,Positive
   CME activity,Medthority,Negative
 CPD credits,Medthority,Negative
 Sun Jan,Michael Towner,Positive
 Scout Hall,Michael Towner,Positive
 coquitlamlittleleagueca,Michael Towner,Positive
 VIDEO Importance,VJHemOnc,Negative
 w P Langerbeins,VJHemOnc,Negative
 Andrew Zelenetz MD,OncLive SOSS,Negative
 SIOG Management,balaji jegannathan,Positive
 SIOG Management,Christopher Steer,Negative
 SIOG Management,Lymphoma Canada,Negative
 Combo Therapy,Lymphoma News Today,Positive
 VIDEO F Cavalli,VJHemOnc,Negative
 routine   treatment,Cancer Matters,Positive
 Money talks,CBPartners,Positive
 Lymphoma amp Chronic Lymphocytic Leukemia Treatment Options,Oncology Tube,Negative
 st day,Lidija Pecova,Positive
 st day,CML AdvocatesNetwork,Negative
 age groups,"Raul Cordoba, MD, PhD",Positive
 quando razionalizziamo la chimica rischiamo di perderla,GaZeusE‚ö°,Positive
 sempre,GaZeusE‚ö°,Positive
 Chronic Lymphocytic Leukemia Pipeline Highlights    Research,Danvantri Farma,Negative
 Chronic Lymphocytic Leukemia Pipeline Highlights    Research,satPRnews,Negative
 Chronic Lymphocytic Leukemia Pipeline Highlights    Research,Business Wire-Health,Negative
 VIDEO Jennifer Woyach,VJHemOnc,Positive
 stand,CML AdvocatesNetwork,Negative
 stand,CLL,Negative
     work,CML AdvocatesNetwork,Negative
   therapy reccomendations,David A. Cohen,Negative
   Highlights,David A. Cohen,Negative
    Blockbuster treatment,David A. Cohen,Negative
 Chemitheraoy,David A. Cohen,Negative
 NICE technology appr guidance,ESMO - Eur. Oncology,Negative
 prev,ESMO - Eur. Oncology,Negative
 Great   podcast,Dr. Ronald Hoffman,Positive
 DUM,Adelita Vizcaino,Positive
 Oral Targeted Therapies,MSHO,Positive
 Oral Targeted Therapies,Christopher Steer,Negative
 Oral Targeted Therapies,The Medical Ed Cons.,Negative
 Oral Targeted Therapies,Cancer Papers,Negative
 Ibrutinib Therapy Increases T Cell Repertoire Diversity,MD Anderson Library,Negative
 Ibrutinib Therapy Increases T Cell Repertoire Diversity,Krishan Maggon,Negative
 RampD,California Partnership for Access to Treatment,Positive
 Consortium member,WorldCare Medical Second Opinions,Negative
    Lymphocytic,ProPath,Positive
 amp diagnose,ProPath,Positive
    Register,Heather DelaCruz,Negative
 upcoming CLL,Heather DelaCruz,Negative
 Dynamic Employees,Heather DelaCruz,Negative
 ET CT MT,Heather DelaCruz,Negative
 Fundaci√≥n Jim√©nez D√≠az University Hospital,"Raul Cordoba, MD, PhD",Negative
 Het Hematooncologieregister van de   kan realword data leveren wat betreft diagnostiek,Dr. Avinash Dinmohamed,Positive
 behandeling van,Dr. Avinash Dinmohamed,Positive
 Nederland,Dr. Avinash Dinmohamed,Positive
 Review Chronic Lymphocytic,Hematopoiesis News,Negative
 VIDEO Andreas Strasser,VJHemOnc,Negative
 drug combinations,VJHemOnc,Positive
   Today SDeaglio    Host interactions,ICGEB Official,Positive
 News NICE,The Lancet Oncology,Negative
 allograft,Dr. Avinash Dinmohamed,Positive
 Feb     event,Patient Power,Negative
 Bone marrow biopsy,Nature Reviews Disease Primers,Negative
 treatment failure,EBMT,Positive
 treatment failure,VJHemOnc,Negative
 allo transplantation,EBMT,Positive
 PTS w    report,EBMT,Positive
 CLL Therapeutics Global,Shrikant Mandlik,Positive
 TNF alpha,Cancer Papers,Negative
 Available Therapies,Heather Swift Morrison,Negative
 Available Therapies,OncLive.com,Negative
 Chronic Lymphocytic Leukemia Market Value Chain,Denver Greene,Negative
 Meeting Deadline Jan,"Raul Cordoba, MD, PhD",Negative
 Keepin,College Life,Positive
 iwCLL meeting,Oncology Tube,Negative
 BGNE AZN,Helen Ong,Positive
 supercrowded space TGTX,Helen Ong,Positive
 GC    tqq,ImmuneGCPapers,Positive
 amp Ottawa,Bill Both,Positive
 Catherine Wu MD,Dana-Farber,Positive
 SIOG Task Force,Isaura R. Penin,Negative
 SIOG Task Force,Cancer Library VCC,Positive
 Oxford Academic,Isaura R. Penin,Negative
 Venetoclax   Rituximab,The ASCO Post,Negative
   position paper,Christopher Steer,Negative
 Symptom Control,"Darcy Burbage, DNP, RN, AOCN",Negative
 Symptom Control,"Meagan Bryan, RN",Negative
 NEW Primer,Nature Reviews Disease Primers,Negative
 ABBV INFI Duvelisib treatment,Tom Silver,Negative
 EGR Mutations,Oncology,Negative
 EGR Mutations,Hematopoiesis News,Negative
 New Clinically Aggressive Subgroup,Oncology,Negative
 New Clinically Aggressive Subgroup,Hematopoiesis News,Negative
    Coevolution,ImmunologyPapers,Negative
 TG Therapeutics Announces   Designation,Orbis Biosciences,Negative
 TG Therapeutics Announces   Designation,1stOncology,Negative
 Feb   event,Andrew Schorr,Negative
 New Event XVII,EventsInAmerica.com,Positive
   Therapy Current Status amp Issues,Oncology Tube,Negative
 VIDEO J Gribben,VJHemOnc,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market Volume Forecast,Newsliner.in,Negative
 Value Chain,Newsliner.in,Negative
 Pneumocystis pneumonia,UpToDate,Positive
 w use,UpToDate,Positive
 Rituximab biosimilar TruximaTM,Lymphoma Hub,Negative
 Dan,MD Anderson Cancer Center,Negative
 endothelin,epigenetics_papers,Negative
 Novel Therapy Yields High Responses,Milly Evans,Positive
 Novel Therapy Yields High Responses,Gendron Recherche,Negative
 Novel Therapy Yields High Responses,Selvyn Kennedy,Positive
 TreatmentResistant Chronic Lymphocytic Leukemia,Milly Evans,Positive
 TreatmentResistant Chronic Lymphocytic Leukemia,Michelle Blanch,Positive
 TreatmentResistant Chronic Lymphocytic Leukemia,Bio Entrepreneurs,Positive
 TreatmentResistant Chronic Lymphocytic Leukemia,drrohiniyer,Positive
 TreatmentResistant Chronic Lymphocytic Leukemia,Diagnostics News,Negative
 TreatmentResistant Chronic Lymphocytic Leukemia,Cancer News,Negative
 TreatmentResistant Chronic Lymphocytic Leukemia,Soccer Life,Positive
 TreatmentResistant Chronic Lymphocytic Leukemia,Gendron Recherche,Negative
 TreatmentResistant Chronic Lymphocytic Leukemia,Selvyn Kennedy,Positive
 Rapid Development,Oncology Tube,Negative
 New Drugs,Oncology Tube,Negative
 New Drugs,Kawther Salam,Positive
 New Challenges,Oncology Tube,Negative
 fortunately advances,iwCLL,Positive
 Dual SYKJAK inhibition,Cancer Papers,Negative
 VIDEO E Montserrat,VJHemOnc,Negative
 TGA,Amanda Jayne Griffin,Positive
 TGA,Chan Cheah,Negative
 Sufferers,Amanda Jayne Griffin,Positive
 Profs Andrew Roberts,Christopher Steer,Negative
 Doug Hilton,Christopher Steer,Negative
 Phase Ib study,Oncology Tube,Negative
 Phase Ib study,VJHemOnc,Negative
 TollLike Receptors,TumorImmunoPapers,Negative
 sustained adherence,"Raul Cordoba, MD, PhD",Negative
 Diagnostic Therapeutic Biomarkers,microRNApapers,Negative
 Positive Expectations,Stephen Brown,Negative
 New Cancerwise blog entry Remission,Oliver Bogler,Positive
 HDAC inhibitors,Lymphoma Hub,Negative
 BTK expression amp,Lymphoma Hub,Negative
 Global   town meeting feat,Andrew Schorr,Negative
 Drs Keating amp Lamanna,Andrew Schorr,Negative
 Sandra Hurley,MD Anderson Cancer Center,Negative
 Singleagent Ibrutinib Therapy,Lymphoma Canada,Negative
 Singleagent Ibrutinib Therapy,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 gen PIK delta inhibitor,Lymphomation.org,Negative
 Dr Chadi Nabhan,Casey Foster,Positive
 patient survival,Casey Foster,Positive
 VIDEO T Robak,VJHemOnc,Negative
 Medical University,VJHemOnc,Negative
 Lodz,VJHemOnc,Negative
 Selfemployed amp,David McLean,Positive
 ass,David McLean,Positive
 premiums,David McLean,Positive
 Black Swan Intell,BlackSwan Analysis now part of Evaluate Pharma Ltd,Positive
 Methylprednisolone,Master Li,Positive
 Methylprednisolone,Cancer Papers,Negative
 toast,Master Li,Positive
 yay,Master Li,Positive
 PPARDelta Promotes Survival,Hematopoiesis News,Negative
 Energetically Unfavorable Conditions,Hematopoiesis News,Negative
 VIDEO Economics,VJHemOnc,Negative
 w J Gribben,VJHemOnc,Negative
 ESMO consensus,"Raul Cordoba, MD, PhD",Positive
 New   treatment,Melbourne University Health Initiative (MUHI),Positive
   Patient Caf√©,Oncology Tube,Positive
 Dating,Oncology Tube,Positive
 Ma√±ana,Orozcoüå™,Positive
 el Coliseo de Gurabo,Orozcoüå™,Positive
 Newer Treatments,Oncology Tube,Negative
 Newer Treatments,Patient Power,Negative
 Frontline Treatment Decrease Future Efficacy,Oncology Tube,Negative
   Patient Caf√©   Participants,Oncology Tube,Negative
 Dating Advice,Oncology Tube,Negative
 Dating Advice,Patient Power,Negative
   Accessing Best Care town hall mtg,Lisa Palacios,Negative
   Accessing Best Care town hall mtg,MD Anderson Leukemia,Negative
 TG Therapeutics Reports,1stOncology,Negative
 Melts Cancer,Margaret Walker,Negative
 Gizmodo Australia,Margaret Walker,Negative
 Peel Hunt GBX,MarketBeat,Positive
    T cells,"Raul Cordoba, MD, PhD",Negative
     Research Fellow,üò∑ Caleph B. Wilson,Positive
 Vs Physicians Choice,"Raul Cordoba, MD, PhD",Negative
 IdelalisibOfatumumab,"Raul Cordoba, MD, PhD",Negative
 VIDEO Richters transformation,VJHemOnc,Negative
 Relapsed andor Refractory Chronic Lymphocytic,PracticeUpdate,Negative
 Relapsed andor Refractory Chronic Lymphocytic,Oncology,Negative
 ICYMI Oral Therapy,Journal of Clinical Pathways,Negative
 chromosomal changes,Fanni Gergely,Positive
   gene expression,Thomas,Positive
 MRD Eradication,balaji jegannathan,Positive
 Alemtuzumab Consolidation,balaji jegannathan,Positive
 OS PFS,balaji jegannathan,Positive
 Blood histamine levels,EurekaMag,Negative
 Derek Caine,Patient Power,Negative
 MYC rearrangement,"Raul Cordoba, MD, PhD",Negative
    Oral Therapy,Journal of Clinical Pathways,Negative
 Creating,Journal of Clinical Pathways,Negative
 enhancer,"Raul Cordoba, MD, PhD",Negative
 chromosome p result,"Raul Cordoba, MD, PhD",Negative
 RNA processing export MYC activity,"Raul Cordoba, MD, PhD",Negative
 TG Therapeutics Announces Orphan Drug Designation,Denver Greene,Positive
 TG Therapeutics Announces Orphan Drug Designation,Financial Buzz,Positive
 TG Therapeutics Announces Orphan Drug Designation,Alyssa Howard,Positive
 TG Therapeutics Announces Orphan Drug Designation,biotechnologies,Positive
 TG Therapeutics Announces Orphan Drug Designation,SPI News,Negative
 TG Therapeutics Announces Orphan Drug Designation,Clinical Leader,Positive
 TG Therapeutics Announces Orphan Drug Designation,INN Life Science,Positive
 TG Therapeutics Announces Orphan Drug Designation,Danvantri Farma,Negative
 TG Therapeutics Announces Orphan Drug Designation,Biotech2050,Negative
 TG Therapeutics Announces Orphan Drug Designation,Krunox,Positive
 TG Therapeutics Announces Orphan Drug Designation,Timothy Kelly,Positive
 Synchronous Metachronous Hairy Cell Leukemia,Frontiers Oncology,Negative
 Chronic Lymphocytic Leukemia Case Series,Frontiers Oncology,Negative
 TGTX TG,Dustin Phan,Positive
   designation,BluePrint Orphan,Positive
   designation,MDedge Hematology & Oncology,Negative
 Company Update NASDAQTGTX TG Therapeutics Inc Announces Orphan Drug Designation,üí• OTC ARMY üí•,Positive
    evolution,Francesco Turturro,Negative
 tcokcmtDYCl,Francesco Turturro,Negative
 VIDEO Constantine Tam,VJHemOnc,Positive
 Bgb,VJHemOnc,Positive
 TGTX Orphan Drug Designation,Bio Stocks‚Ñ¢,Positive
 BeiGene Presents Updated Clinical Data,CLL Society Inc.,Negative
 BeiGene Presents Updated Clinical Data,Danvantri Farma,Negative
 BeiGene Presents Updated Clinical Data,Financial Buzz,Negative
 BeiGene Presents Updated Clinical Data,Gilles Gallant,Positive
 BeiGene Presents Updated Clinical Data,SPI News,Negative
 Spleen Tyrosine Kinase,Hematopoiesis News,Negative
 Spleen Tyrosine Kinase,Cure Cancer Now,Negative
 Spleen Tyrosine Kinase,ÈÉ°Â±±Â•≥Â≠êÂ§ßÂ≠¶Âõ≥Êõ∏È§®,Positive
 Spleen Tyrosine Kinase,Cancer Papers,Negative
 CD Signal Transduction Pathway,Hematopoiesis News,Negative
 CD Signal Transduction Pathway,Cure Cancer Now,Negative
 CD Signal Transduction Pathway,ÈÉ°Â±±Â•≥Â≠êÂ§ßÂ≠¶Âõ≥Êõ∏È§®,Positive
 CD Signal Transduction Pathway,Cancer Papers,Negative
 Autoimmune cytopenia,EurekaMag,Negative
 dejo autoregalos,Dweasley ü¶Ä (Œ® 7 ) 13 üé∏,Positive
   aid research,VJHemOnc,Negative
 Chromosome aberrations,EurekaMag,Negative
 Protein,Pastel BioScience,Positive
 Protein,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Positive
 Protein,Cancer Papers,Negative
 LIVE QampA session,MediCom Oncology,Positive
 LIVE QampA session,Managing Myeloma,Positive
 town mtg amp broadcast,Andrew Schorr,Negative
 Long Term Follow,GRACE,Negative
 Chronic Lymphocytic Leukemia Patients ASH podcast,GRACE,Negative
 Faculty members,Research To Practice,Negative
 IGHV Mutation Status w Dr Sharman,Patient Power,Negative
      JUNO,Anna Deveau,Negative
 rd International Conference,Anna Deveau,Negative
 New Concepts,Anna Deveau,Negative
 Lymphoid Malignancies Focus,Anna Deveau,Negative
 amp Indolent Lymphoma,Anna Deveau,Negative
    discusses drug,"Raul Cordoba, MD, PhD",Negative
 drug interactions,"Raul Cordoba, MD, PhD",Negative
 drug interactions,OncLive.com,Negative
 drug ‚Äì drug interactions,VJHemOnc,Negative
 Chronic Lymphocytic Leukemia Market Size Growth Drivers Market Opportunities Industry Trends,Publish PressRelease,Positive
 Chronic Lymphocytic Leukemia Market Driving Factors Market Analysis Investment Feasibility,Top 10,Negative
 proteins,EurekaMag,Negative
 CLLIPI New Prognostic Index,Oncology Tube,Negative
 Current Status amp Issues,Oncology Tube,Negative
 Lo,üíú,Positive
 hacer planes,üíú,Positive
 prognostication,TumorImmunoPapers,Negative
 prognostication,"Raul Cordoba, MD, PhD",Negative
 Malignos,Karina Teran,Positive
 treatment na√Øve cohort toxicity,"Raul Cordoba, MD, PhD",Negative
 LIVE QampA,Managing Myeloma,Positive
 LIVE QampA,MediCom Oncology,Negative
 January date,Managing Myeloma,Negative
 January date,MediCom Oncology,Negative
 CDCCancer New drugs,Margaret_Farrell,Negative
 Obinutuzmab Ibrutinib,Rare Disease Report,Positive
 Obinutuzmab Ibrutinib,Dr. Melody Davis,Negative
 VJHemOnc VIDEO Peter Hillmen,Oncology Board,Negative
 Wntainduced Rac activation,DrugGenius,Negative
 Restrictions,DrugGenius,Negative
 Restrictions,TumorImmunoPapers,Negative
 Restrictions,CLL-seq,Negative
 IGHV Mutation Status,Oncology Tube,Negative
 Feb    event,Patient Power,Negative
 w   Sign,Patient Power,Negative
 Cyclophosphamide Cancers,Actizapharmaceutical,Positive
 cyclophosphFor,Actizapharmaceutical,Positive
 Nancy Drew,Nancy Drew,Positive
 Clue,Nancy Drew,Positive
 Nutritional Th,Dominic Brewington,Negative
 Therapy htt,Dominic Brewington,Negative
 microRNA,"Raul Cordoba, MD, PhD",Negative
 microRNA,microRNApapers,Positive
 microRNA,VJHemOnc,Negative
 microRNA,RNAi papers,Positive
 microRNA,Oncology Tube,Negative
 microRNA,exRNA,Positive
 microRNA,Diagnostics News,Negative
 microRNA,Laura Strong,Positive
 microRNA,Biblioteca CCBS-UFCG,Positive
 microRNA,7thSpace Interactive,Positive
 microRNA,Press Office (J. Hofer),Positive
 microRNA,News Reactions,Positive
 microRNA,Breaking News,Negative
 microRNA,Media Tower,Positive
 microRNA,News Stories,Positive
 microRNA,Scott Werntz,Negative
     brakes,Francesco Turturro,Negative
 BTKtargeting,Francesco Turturro,Negative
 Drug Holidays,Oncology Tube,Negative
   √©,Patient Power,Positive
 Dr Jones,The James,Negative
 JUNO Highlevel ROR associates,"Dr. Paul DeSantis, PharmD",Negative
 accelerated disease progression,"Dr. Paul DeSantis, PharmD",Negative
 accelerated disease progression,Francesco Turturro,Negative
 Karens,Memorial Sloan Kettering Cancer Center,Positive
 Dr shaman,Andrew Schorr,Negative
 Annual Cost,ASH,Negative
 Nearly   Percent,ASH,Negative
 Nearly   Percent,Health|VBProfiles,Positive
 Nearly   Percent,Aktienmanufaktur,Negative
 Nearly   Percent,Jean-Michel TERME,Negative
 Nearly   Percent,BusinessWireProducts,Negative
 Nearly   Percent,dlvr news,Negative
 Nearly   Percent,Business Wire-Health,Negative
 Nearly   Percent,Business Wire-TS,Negative
 Nearly   Percent,dlvr health,Negative
 leukemoid rxn,pammyeol,Positive
 LAP score,pammyeol,Positive
 George Miller,MD Anderson Cancer Center,Negative
 Frontline Approach,Patient Power,Negative
 Future FCR Efficacy,Patient Power,Negative
 amp   patients,VJHemOnc,Negative
 HemOnc Today ICYMI Maintenance therapy,Oncology Board,Negative
   ICYMI Maintenance therapy,Oncology Board,Negative
 ICYMI Maintenance therapy,HemOnc Today,Negative
 ICYMI Maintenance therapy,Healio,Negative
 Measure,ASH,Negative
 Ibrutinib efficacy,Blood Journal,Negative
 Ibrutinib efficacy,GEDEFO,Negative
 Ibrutinib efficacy,"Raul Cordoba, MD, PhD",Negative
 Ibrutinib efficacy,"Dr T. Comeau , MD",Negative
 Ibrutinib efficacy,ARB,Positive
 Ibrutinib efficacy,TumorImmunoPapers,Negative
 Ibrutinib efficacy,Karen Sweiss,Negative
 HemaCare,HemaCare Corporation,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H   Prices,COPD News,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H   Prices,DrugGenius,Positive
 Relapsed Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H   Prices,Bio-Collaboration,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H   Prices,CRO Contract Res.,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H   Prices,SPI News,Negative
   Promising,Oncology Tube,Negative
   Promising,Patient Power,Negative
   amp CAR TCell Therapy,Oncology Tube,Negative
 Cont Multiple,Matthews & Associates,Negative
 HCLChronic Lymphocytic Leukemia,Matthews & Associates,Negative
 Attack,Oncology Tube,Negative
 Patient Caf√©,Oncology Tube,Positive
 Romantic Relationships,Oncology Tube,Negative
 Romantic Relationships,Patient Power,Negative
 MedIQ CE Review,Oncology Board,Negative
 Nurselike Cells,TumorImmunoPapers,Negative
 Interferon Œ≥,TumorImmunoPapers,Negative
 Interrupt Chronic Lymphocytic Leukemia Cell,TumorImmunoPapers,Negative
 EBI overexpression,TumorImmunoPapers,Negative
 B B cell expansion,TumorImmunoPapers,Negative
 B B cell expansion,ImmuneGCPapers,Positive
 GC    EBI overexpression,ImmuneGCPapers,Positive
 Updated Phase,Oncology Tube,Negative
 Resonate Study,Oncology Tube,Negative
 techniques,"Raul Cordoba, MD, PhD",Negative
 HN,6HN Oncology Nurses,Negative
 Chronic Lymphocytic Leukemia talk,6HN Oncology Nurses,Negative
 UPenn,6HN Oncology Nurses,Negative
 NYP,6HN Oncology Nurses,Negative
 p deletion chromosomal aberration,"Raul Cordoba, MD, PhD",Negative
 exposure rituximab coadministration,"Raul Cordoba, MD, PhD",Negative
 Expert Answers,Dr. Melody Davis,Negative
 amp members,Patient Power,Negative
   Month Median PFS,Oncology Tube,Negative
 Relapsed Refractory   Patients,Oncology Tube,Negative
 Highlevel ROR associates,Francesco Turturro,Negative
 tcolqQjDYLIw,Francesco Turturro,Negative
    efficacy,Francesco Turturro,Negative
 Ibrutinib efficacy amp tolerability,FarmaOnco,Negative
 Elimin,Hematopoiesis News,Negative
 Stromal Microenvironment,Hematopoiesis News,Negative
 CPT,Hematopoiesis News,Negative
 Raul Cordoba Management,Oncology Board,Negative
 Elderly Position Paper,Oncology Board,Negative
 Elderly Position Paper,"Raul Cordoba, MD, PhD",Negative
 Elderly Position Paper,Christopher Steer,Negative
 Elderly Position Paper,Cancer Library VCC,Positive
 International Society Geriatric,Oncology Board,Negative
 Elderly Review article,"Raul Cordoba, MD, PhD",Negative
 JBarrientos,"Raul Cordoba, MD, PhD",Negative
 International Society Geriatric Oncology,"Raul Cordoba, MD, PhD",Negative
 Annes experience,RBCH Research,Positive
 Ibrutinib superior,Healio,Negative
 Ibrutinib superior,HemOnc Today,Negative
   Daily Wrap w,Patient Power,Negative
 amp Dr Stilgenbauer,Patient Power,Negative
 Ric,Janssen Canada,Positive
 PPIG Glycodendrimers,Cancer Papers,Negative
 TRAILInduced Apoptosis,Cancer Papers,Negative
 AlloSCT,"Dr T. Comeau , MD",Negative
 ASBMT,"Dr T. Comeau , MD",Negative
 ASBMT,Jordan Gauthier,Positive
   Withdraws,Lucie Ellis,Positive
 ¬£,Lucie Ellis,Positive
 √≠a,Medibooks,Positive
 CASE,Medibooks,Negative
 SRSF,Medibooks,Negative
 MUTATION,Medibooks,Negative
   mnawrin,Mahmoud Turki,Negative
 l Hult Prize lt,Mahmoud Turki,Negative
 Chronic Lymphocytic Leukemia Market Revenue Opportunity,Alyssa Howard,Negative
    Disruption,ImmunologyPapers,Negative
 vivo Chronic Lymphocytic Leukemia TumorMicroenvironment Interactions,ImmunologyPapers,Negative
 vivo Chronic Lymphocytic Leukemia TumorMicroenvironment Interactions,TumorImmunoPapers,Negative
 Disruption,TumorImmunoPapers,Negative
 Disruption,Just Cancer News,Negative
    q,Anna Deveau,Negative
   diet,mike matyska,Positive
   diet,Ryan Hobson,Positive
 Size Analysis,Soft Solutions,Positive
 Forecast Report,Soft Solutions,Positive
   supplies,Alison Clark,Positive
 equipment,Alison Clark,Positive
 Big News,Oncology Tube,Positive
 Chronic GVHD,Oncology Tube,Negative
 Patient Care,Oncology Tube,Negative
 Patient Care,PeerView,Negative
   Idelalisib BR,Lymphoma Hub,Negative
 Phase IbII PCYC trial Durable responses,Lymphoma Hub,Negative
 Lipids,Cancer Papers,Negative
 Allogeneic Transplants Total Lymphoid Irradiation,Oncology Tube,Negative
 amp Antithymocyte Globulin Conditioning,Oncology Tube,Negative
 Year Evolution,GenomeWeb Daily News,Positive
 Multiple   Clones,GenomeWeb Daily News,Positive
 Single Patient,GenomeWeb Daily News,Positive
 ORR PFS,MDedge Hematology & Oncology,Negative
 w S Stilgenbauer,VJHemOnc,Negative
 ÿ≠ÿßŸÑÿ©,saleh hassan,Positive
 Oncology Tube   Treatment Trends,Oncology Board,Negative
 Future Outlook,Oncology Tube,Negative
   Patient Caf√© Participants,Oncology Tube,Negative
   Treatment Trends,Oncology Tube,Negative
 Pubmed Characterization,epigenetics_papers,Negative
 TET,epigenetics_papers,Negative
 TET,5hmCpapers,Positive
 TET,Calibr8 Your Life,Positive
 IDH,epigenetics_papers,Negative
 IDH,5hmCpapers,Positive
 IDH,Calibr8 Your Life,Positive
 Resonate Study Highlights,Oncology Tube,Negative
 q deletion disorder,Oncology Tube,Negative
 Prognostication,"Dr T. Comeau , MD",Negative
 Blood Commentary Measure,Blood Journal,Negative
 TGTX   Ph II results,Dustin Phan,Positive
 TG ibrutinib,Dustin Phan,Positive
 Recurrent Cytogenetic Abnormalities,PrecisionMedNews,Positive
 NHL amp Chronic Lymphocytic Leukemia,PrecisionMedNews,Positive
 yearold Raul Hinojosa,Delmarva News Watch,Positive
 Refractory Chronic Lymphocytic Leukemia CLL Market Therapeutics Landscape,Top 10,Negative
 Ofatumab Fludarabine,Lymph_m_ni_c,Positive
 Enzyme,TCS ATX,Positive
 Enzyme,Ruth Glendinning,Positive
 Enzyme,DEAD RECKONING,Positive
 prostate amp breast cancer,TCS ATX,Positive
 prostate amp breast cancer,Ruth Glendinning,Positive
 prostate amp breast cancer,DEAD RECKONING,Positive
 animals,TCS ATX,Positive
 animals,Ruth Glendinning,Positive
 animals,DEAD RECKONING,Positive
 lifespan,TCS ATX,Positive
 lifespan,Ruth Glendinning,Positive
 lifespan,DEAD RECKONING,Positive
 Mutated IGHV,Lymphoma Hub,Negative
 ColonyStimulating Factor Receptor,Krishan Maggon,Negative
 ColonyStimulating Factor Receptor,Just Cancer News,Negative
 ColonyStimulating Factor Receptor,Jerry Lee,Negative
 Nurselike Cell Survival,Krishan Maggon,Negative
 Nurselike Cell Survival,Just Cancer News,Negative
 Nurselike Cell Survival,Jerry Lee,Negative
 Transposon Mutagenesis,Just Cancer News,Negative
 Transposon Mutagenesis,Jerry Lee,Negative
 genome sequencing data analysis,VJHemOnc,Negative
 LIVE QampA session THURSDAY,MediCom Oncology,Negative
 LIVE QampA session THURSDAY,Managing Myeloma,Negative
 Patients Intolerant,Oncology Tube,Negative
 PFS Primary results,Lymphoma Hub,Positive
 CONTINUUM trial,Lymphoma Hub,Negative
 swot analysis,Ryan Hobson,Positive
 Easterwood Field,every airport,Positive
 Genomic Profile,CompBiolPapers,Negative
 Genomic Profile,Cancer Papers,Negative
 Korea,CompBiolPapers,Negative
 Korea,Cancer Papers,Negative
 Korea,Robert Z. Orlowski,Negative
 Targeted Sequencing,CompBiolPapers,Negative
 Targeted Sequencing,Cancer Papers,Negative
    news,Andrew Schorr,Negative
    news,Patient Power,Negative
 Single dose venetoclax,CARE‚Ñ¢ Education,Negative
 inducingone,CARE‚Ñ¢ Education,Negative
 December date,Managing Myeloma,Negative
 December date,MediCom Oncology,Negative
 liquid,VJHemOnc,Positive
    Extension,Lymphoma Hub,Negative
 Phase III RESONATE trial Singleagent ibrutinib,Lymphoma Hub,Negative
   Maintenance lenalidomide,Lymphoma Hub,Negative
 VIDEO New treatments guidelines,VJHemOnc,Negative
 authorization,R&G Disease Network,Positive
 Crosby,Danny's Limited Edition Tweets,Positive
 B B cells,JExpMed,Negative
 restricted BCRs,JExpMed,Negative
 Early Trial,Oncology Tube,Negative
 RHBBY,BluePrint Orphan,Positive
 pts relref,WCM Lymphoma,Negative
 amp idelalisib tcoQMakDqUsDk,WCM Lymphoma,Negative
 agroup,CARE‚Ñ¢ Education,Negative
   classes,BSI America,Negative
 Roches Leukemia Drug,Helen Ong,Positive
 Conditional Marketing RHHBY,Helen Ong,Positive
 Vuela vuela Con tu imaginaci√≥n,John Drago,Positive
   Expert Panel Emerging,Oncology Tube,Negative
    Signals,CancerWallonia,Negative
    Induces,CancerWallonia,Negative
   Response Rate,CancerWallonia,Negative
 Realworld results,"Raul Cordoba, MD, PhD",Negative
 RR   data,"Raul Cordoba, MD, PhD",Negative
 Cirmtuzumab Inhibits WntaInduced RacActivation,Hematopoiesis News,Negative
 GENbio CAR Tcell,TweetedScience,Positive
 plus,TweetedScience,Positive
 plus,Genetic Engineering & Biotechnology News,Negative
 breakthrough drug,The James,Negative
   p del TP mut patients,Lymphoma Hub,Negative
 Oncology Tube Drug Holidays,Oncology Board,Negative
 Mucho mejor,John Drago,Positive
 Venclyxto OK‚Äôd,Margaret Walker,Negative
 UAB,O'Neal Comprehensive Cancer Center at UAB,Positive
 Conditional Marketing Approval,1stOncology,Negative
 √© Participants,Patient Power,Negative
 EC grants,MDedge Hematology & Oncology,Negative
 Donors,CancerCareMBFdn,Positive
 Chronic Lymphocytic Leukemia CLL research excellence,CancerCareMBFdn,Positive
   Month Median,Oncology Tube,Negative
 ContHairy Cell Leukemia HCLChronic,Matthews & Associates,Negative
 CLLcontact,Matthews & Associates,Negative
 UABs Dr Randall Davis,UAB,Positive
 research grant,UAB,Positive
 research grant,LLSTennessee,Positive
 Leukemia amp Lymphoma Society,UAB,Positive
 Leukemia amp Lymphoma Society,AbbVie,Negative
   amp ArQule,Future Med Chem Jnl,Positive
 BTK inhibitor ARQ,Future Med Chem Jnl,Positive
 painstaking work,fiona olivier,Positive
 European Commission Conditional Marketing Approval,Krishan Maggon,Negative
 VENCLYXTO ‚Ñ¢ venetoclax Leukemia,Krishan Maggon,Negative
    grants,Mike Ward,Negative
 oncology leaguevenetoclax,Jur,Positive
   terrific chemistry,Andrew Schorr,Negative
 bw   experts,Andrew Schorr,Negative
 Drs Lamanna,Andrew Schorr,Negative
 Destroy   cells,joel mathews,Positive
 Destroy   cells,Genentech,Negative
   Thanks,Andrew Schorr,Negative
 treatment amp research Video,Andrew Schorr,Negative
   Daily Wrap,Patient Power,Negative
 Dr Stilgenbauer,Patient Power,Negative
 VIDEO John Pagel,VJHemOnc,Positive
 Happpy birthday JT,Gentleman Jamz üá¶üá¨,Positive
 Chimeric Antigen Receptor TCell,Tripti Sahu,Positive
 Immunotherapy Scientists,Tripti Sahu,Positive
 water supply,Talal Hilal ü©∫,Negative
 Positivt,Anneli Zell,Positive
 yrkesvux med spr√•kst√∂d,Anneli Zell,Positive
 vi hoppas,Anneli Zell,Positive
 Abstract deadline,Kraig.Steubing,Positive
 Broadcast,ecancer,Negative
 register,ecancer,Negative
 register,Patient Power,Negative
 vera,Ann. Saudi Med.,Positive
 Pneumocystis jirovecii Pneumonia,Cancer Papers,Negative
 Pneumocystis jirovecii Pneumonia,Francesco Turturro,Negative
 Pneumocystis jirovecii Pneumonia,Christopher Steer,Negative
 Pneumocystis jirovecii Pneumonia,Dr. JOSE VELASQUEZ,Negative
 TreatmentNaive Patient,Cancer Papers,Negative
 Maer c√¥r,Melin Gruffydd,Negative
 mwynhau canu,Melin Gruffydd,Negative
 choir,Melin Gruffydd,Negative
 CDtargeting CAR Tcell,EMJ Oncology,Negative
 CDtargeting CAR Tcell,Dr. Steven Eisenberg,Negative
 Drug Combination Yields Results,Gendron Recherche,Negative
 Drug Combination Yields Results,Selvyn Kennedy,Positive
 Be≈üikta≈üƒ±mƒ±zƒ±n,No Pasaran BJK,Positive
 var,No Pasaran BJK,Positive
 Juno Therapeutics Announces Complete Response,Pre-IPO Pharma,Positive
 Corresponding,Pre-IPO Pharma,Positive
 Early Survival Data,Pre-IPO Pharma,Positive
 Dr Kadri,UChicagoCancerCenter,Positive
 coach,Esther Schorr,Negative
 teamwork,Esther Schorr,Negative
 crossover therapies,Esther Schorr,Negative
 CAR TCell Immunotherapy,Michelle Blanch,Positive
 CAR TCell Immunotherapy,Bio Entrepreneurs,Positive
 CAR TCell Immunotherapy,drrohiniyer,Positive
 CAR TCell Immunotherapy,Soccer Life,Positive
 Treatment Choices,Mike Hennessy,Positive
 fredhutch shows promise,TweetedScience,Negative
 introdng,"chadi nabhan MD, MBA, FACP",Negative
 GEN Genetic Engineering,drrohiniyer,Positive
 Murine B Cells Exhibit Potential,Prof John,Negative
 Release IMBRUVICA ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic L,NGO News,Positive
   Final Recommendation,CADTH,Negative
 Release IMBRUVICA ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Year Analysis,Biotech World,Positive
   news CAR TCell,Diagnostics News,Negative
   CAR TCell Immunotherapy,Cancer News,Negative
   Effects,EBioMedicine ‚Äì Published by The Lancet,Positive
 Comment,EBioMedicine ‚Äì Published by The Lancet,Positive
 Experimental   treatment,NorthJersey.com,Positive
 lifesaver,NorthJersey.com,Positive
 Industry Analysis Trends,Alyssa Howard,Negative
 Industry Analysis Trends,Denver Greene,Negative
 Revenue Growth,Alyssa Howard,Negative
 Revenue Growth,Denver Greene,Negative
 ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Year Analysis,OBR,Negative
 ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Year Analysis,Ana Laura Caballero,Positive
 ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Year Analysis,Dr. Melody Davis,Negative
 ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Year Analysis,Financial Buzz,Negative
 ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Year Analysis,NeuroBrain,Positive
 ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Year Analysis,TEKGROUP Healthcare News,Positive
 PIK Pathway,"Raul Cordoba, MD, PhD",Negative
 prolonged PFS,Oncologie Up-to-date,Positive
 y gano,Julio Henriquez,Positive
 Jose Leis,The ASCO Post,Negative
 gracias,Julio Henriquez,Positive
 CD mAb   idelalisib,Deborah Stephens,Positive
   sequencing data analysis,VJHemOnc,Negative
 Main Len,"chadi nabhan MD, MBA, FACP",Negative
 Study Evaluating,Cancer News,Positive
 Study Evaluating,TrialBulletin,Negative
 Professor dr Kanti Rai,Sanne v‚≠ïn Wüíâssen,Positive
 Rai classification,Sanne v‚≠ïn Wüíâssen,Positive
 professor Kater,Sanne v‚≠ïn Wüíâssen,Positive
 dr Steele,Sanne v‚≠ïn Wüíâssen,Positive
 Cytokine PD,AJMC,Negative
 Cytokine PD,AJMC-Oncology,Negative
 CD   cells,AJMC,Negative
 CD   cells,AJMC-Oncology,Positive
 patients prognostication,Theodoros Moysiadis,Positive
 Mutation,Oncologie Up-to-date,Positive
 Mutation,topbiopapers,Negative
 Mutation,Francesco Turturro,Negative
 Mutation,ASCO,Negative
 pathway precedes,Oncologie Up-to-date,Positive
 nivolumab,"Raul Cordoba, MD, PhD",Negative
 RR   amp Richter transformation,"Raul Cordoba, MD, PhD",Negative
    Refractory,"Raul Cordoba, MD, PhD",Negative
 Transformaron,"Raul Cordoba, MD, PhD",Negative
 Chronic Lymphocytic Leukemia CLLMayo,No1 Doctor,Positive
 Paul Barr Resonate ibrutinib,Christopher Steer,Negative
 ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Year,IntoxicatedTrader,Negative
    lenalidomide maintenance prolongs,Lymphoma Hub,Negative
 significantly PFS,Lymphoma Hub,Negative
   IMBRUVICA√Ç ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Year Analysis,Cancer News,Negative
 ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,satPRnews,Negative
 Ill Dec,satPRnews,Negative
   Barrientos,"Matt Kalaycio, MD",Negative
 Andrew Zelenetz,The ASCO Post,Negative
 Andrew Zelenetz,VJHemOnc,Positive
 NivolumabIbrutinib Combo Shows Promise,Christopher Steer,Negative
 Cytokine Biomarkers,AJMC-Oncology,Negative
 CAR TCell Treatment,AJMC-Oncology,Negative
    Kanti Rai,Paresh Sewpaul,Positive
    Jain,Paresh Sewpaul,Positive
 Probability,Bursatil Biotech,Positive
 marrow response amp neurotoxicity,Bursatil Biotech,Positive
     expression,AJMC-Oncology,Negative
 CD CDL,AJMC-Oncology,Negative
 Dr Melenhorst,AJMC-Oncology,Negative
 CARTcells,Deborah Stephens,Positive
 Fred Hutch,Fred Hutch,Negative
 juno    update,Anna Deveau,Negative
 Ibrutinibresistant CLL cells,Deborah Stephens,Positive
   option,AJMC-Oncology,Negative
   Oral,MD Anderson Leukemia,Negative
 Largest series,"chadi nabhan MD, MBA, FACP",Negative
 VIDEO Jasmin Bahlo,VJHemOnc,Positive
    Restrictions,SeqComplete,Negative
 Wntainduced Racactivation,TumorImmunoPapers,Negative
 Heres T,Oncology Times,Negative
 Projected Financial Burden,The ASCO Post,Negative
   Study Evaluating Venetoclax,CureHuntr,Negative
 w colleagues,"chadi nabhan MD, MBA, FACP",Negative
 Dr Ajay Gopal,"chadi nabhan MD, MBA, FACP",Negative
 hall,"chadi nabhan MD, MBA, FACP",Negative
   news Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,COPD News,Negative
 Chronic Lymphocytic    Symptoms,A M Billah Sumon,Negative
 wayside,KnotGrumpy,Positive
 gtgtRole,KnotGrumpy,Positive
 CLL management,KnotGrumpy,Positive
 CLL management,OncLive.com,Negative
 CLL management,Targeted Oncology,Negative
 CLL Guide,MerMer Goodburn üåàüá™üá∫ü©∏,Negative
 Potential Concerns,Oncology Tube,Negative
 amp Richters transformation,Oncology Tube,Negative
 amp Richters transformation,VJHemOnc,Negative
 Oncology Tube,Oncology Board,Positive
 Action amp Combination,Oncology Board,Negative
 Action amp Combination,Oncology Tube,Negative
 Delta T Cells,Just Cancer News,Negative
 Delta T Cells,Jerry Lee,Negative
 Chronic Lymphocytic Leukemia ClinicalGrade ExpansionDifferentiation,Just Cancer News,Negative
 Chronic Lymphocytic Leukemia ClinicalGrade ExpansionDifferentiation,Jerry Lee,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia UK amp Ireland Analysis,"Raul Cordoba, MD, PhD",Negative
 Cell Surface Markers,Oncology Tube,Negative
 Different Stages,Oncology Tube,Negative
 Richters Transformation amp,Oncology Tube,Negative
   relationships,Andrew Schorr,Negative
 Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review H   Prices,COPD News,Negative
 Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review H   Prices,DrugGenius,Negative
 Refractory Chronic,COPD News,Negative
 USD   Refractory Chronic,DrugGenius,Negative
 Conversations Doctors,Oncology Tube,Negative
   Costs,MPLN,Negative
   Featured cover paper,Oncotarget,Positive
 VolNo,Oncotarget,Positive
 anti effects,"SLIMS by Genohm, A part of Agilent",Positive
   trade secrets,Business News,Positive
 Customs Read Blog,Business News,Positive
 CD CART Cells,"Raul Cordoba, MD, PhD",Negative
 IbrutinibRefractory Chronic Lymphocytic Leukemia,"Raul Cordoba, MD, PhD",Negative
 CART cell phenotypes,"Raul Cordoba, MD, PhD",Negative
 antitumor responses,"Raul Cordoba, MD, PhD",Negative
 z CAR T cell administration,"Raul Cordoba, MD, PhD",Negative
 CAR TCell Manufacturing,"Raul Cordoba, MD, PhD",Negative
 Phenotype,"Raul Cordoba, MD, PhD",Negative
 Phenotype,Francesco Turturro,Negative
 twodrug approach,Oncology Tube,Negative
 twodrug approach,VJHemOnc,Positive
   interviews,Andrew Schorr,Negative
 Kipps,Andrew Schorr,Negative
 Kipps,CancerWallonia,Negative
   Targeted therapy drugs,Georges Azzi,Positive
 MPLN,MPLN,Positive
 MPLN,Geneuity,Positive
 samples,Paul Brennan (He/His),Positive
 amp advance science,"chadi nabhan MD, MBA, FACP",Negative
 NY,Oncology Tube,Negative
   Lymphocytic Leukemia Therapeutics Industry,MRR,Positive
 Life Cycle,Oncology Tube,Negative
 Strict Adherence,MsPrissySis,Positive
 VIDEO P Langerbeins,VJHemOnc,Negative
 Skyrocket,Francesco Turturro,Negative
   AlemtuzumabUses,PharmaFactz,Negative
   Elias Campo   project followup search,AlfonsoValencia,Negative
 targeted inhibitors,AlfonsoValencia,Negative
   Elias Campo    NGS,AlfonsoValencia,Negative
 CLL consumption increases,Grupo PK.gen SEFH,Positive
 Puente,AlfonsoValencia,Negative
 et al Nature,AlfonsoValencia,Negative
 ie NOTCH,AlfonsoValencia,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market Segments Opportunity Growth,Press Releases,Positive
 Chronic Lymphocytic Leukemia Therapeutics Market Segments Opportunity Growth,satPRnews,Negative
 SD,"chadi nabhan MD, MBA, FACP",Negative
 United,The Medical Ed Cons.,Negative
 United,Cancer Papers,Negative
 contact        rmatthewscom,Matthews & Associates,Negative
 Oct    Patient,Oncology Tube,Negative
 Caf√©,Oncology Tube,Negative
 Arial fibrillation,Cancer Papers,Negative
 Translocation pq Case Report,Cancer Papers,Negative
 Fludarabine Treatment,Cancer Papers,Negative
 Digital Ischemia,Cancer Papers,Negative
 ≈üikta≈ü,Emrah TA≈ûKIN,Positive
 Uk patients,Kevin Ellis,Positive
 Removal,Oncology Tube,Negative
 Tissue Stops,Oncology Tube,Negative
 B·ªánh b·∫°ch c·∫ßu b·∫°ch huy·∫øt b√†o m·∫°n,AKchongungthu,Positive
 t√≠nh,AKchongungthu,Positive
 Novel Algorithms,Oncology Tube,Negative
 Novel Algorithms,Oncology Board,Negative
 Pattern Recognition,Oncology Tube,Negative
 price tag,Melanie,Negative
 CDF leukaemia drug,Melanie,Negative
 price drop,Melanie,Negative
 line chemotherapy,Cancer Papers,Negative
 Smudge cell,"ùìëùì≤ùìÆùì∑ùì™,ùì°ùìúùì£ üå∑",Positive
 Phase II,"Cryoport, Inc.",Positive
 Phase II,MD Anderson Cancer Center,Negative
 lymphoma patient,"Cryoport, Inc.",Positive
   Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review H   Prices,Cancer News,Positive
 Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review H,COPD News,Negative
 Refractory Chronic Lymphocytic Leukemia CLL,DrugGenius,Positive
 Refractory Chronic Lymphocytic Leukemia CLL,Pitch Ticker,Positive
 Refractory Chronic Lymphocytic Leukemia CLL,Business Wire-Health,Negative
 Refractory Chronic Lymphocytic Leukemia CLL,Scott Werntz,Negative
 VIDEO J von Tresckow,VJHemOnc,Negative
 CLLBIG trial,VJHemOnc,Negative
 VIDEO Petra,VJHemOnc,Negative
 SecondGeneration BTK Inhibitor,Oncology Tube,Negative
 Recommendation,Oncology Tube,Negative
 Recommendation,Matthias Piesche,Negative
 Announces,Papers Wanted,Positive
 Venetoclax w Obinutuzumab,Lymphomation.org,Negative
 Previously Untreated   amp,Lymphomation.org,Negative
 Coexisting Conditions Final runin Results,Lymphomation.org,Negative
 mutation detection,VJHemOnc,Negative
 standardized   technology,VJHemOnc,Negative
 Novel   drugs,MDedge Hematology & Oncology,Negative
    International Workshop,Endocrine News,Positive
 Abstra,Endocrine News,Positive
 healthcare,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 grandpa,Dylan Jones,Positive
 Honokiol,Jose Donahue,Positive
 Honokiol,EIN Presswire: Lung Cancer Newswire,Negative
 Honokiol,OccuWorld üè¥,Positive
 Boooking,Nor Hafizah,Positive
 BookingKereta utk disewa Sementara masih adeanda pasti puas,Nor Hafizah,Positive
 kereta sewa Atam kereta sewa,Nor Hafizah,Positive
 kL,Nor Hafizah,Positive
   involvement,Basu Gopal üò∑ üëêüí¶ üßçüößüßç üëâüè†,Positive
 Walid   Zied   Karim,Mahmoud Turki,Negative
 le membres yaatiko saa charreftouna lt,Mahmoud Turki,Negative
   member D,Mahmoud Turki,Negative
 yn y Big Pit heddiw,Melin Gruffydd,Negative
 BCell Chronic Lymphocytic Leukemia Global Clinical Trials Review H   Prices,COPD News,Negative
 VIDEO Nicholas Chiorazzi,VJHemOnc,Positive
 airports,Sam,Positive
 TSA,Sam,Positive
   PatientCafe,Patient Power,Negative
 Confer Survival Benefit,"Darcy Burbage, DNP, RN, AOCN",Negative
 Global Chronic Lymphocytic Leukemia Treatment Options,Danvantri Farma,Negative
 Global Chronic Lymphocytic Leukemia Treatment Options,Business Wire-Health,Negative
 Attributes Market Positioning Reimbursement Landscape,Danvantri Farma,Negative
 Negative MRD status,ASH Clinical News,Negative
 VIDEO F CaligarisCappio,VJHemOnc,Positive
 Global Chronic Lymphocytic Leukemia Treatment Options Attributes Market Positioning Reimbursement Landscape amp New,NeuroBrain,Positive
 Attributes Market Positioning Reimbursement,Business Wire-Health,Negative
 Landscape amp,Business Wire-Health,Negative
 Ghia   reminder,Christopher Steer,Negative
 Ghia   Ibrutinib,Christopher Steer,Negative
   P Ghia,Christopher Steer,Negative
 ProfPGhia,"Raul Cordoba, MD, PhD",Negative
   PICK Review,Portland Press,Positive
 JC Strefford,Portland Press,Positive
 Targeted Inhibitors,Cancer Papers,Negative
   Dr Ferrajoli,Christopher Steer,Negative
 Refractory Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H   Prices,DrugGenius,Positive
 IV   patient,MD Anderson Cancer Center,Negative
 Study Venetoclax,TrialBulletin,Negative
 Presence,TrialBulletin,Negative
 p Del,TrialBulletin,Negative
 p Del,Christopher Steer,Negative
 Understanding Biology,Oncology Tube,Negative
 amp RelapsedRefractory,Oncology Tube,Negative
   Study Venetoclax,CureHuntr,Negative
 Pres,CureHuntr,Negative
 Wu,Cancer Cell,Negative
 Elderly   Patients,Oncology Tube,Negative
 Developments,Oncology Tube,Negative
 CLL MRD,MedPage Today,Negative
 abstracts Submission deadline,iwCLL,Positive
 Targeted Molecules,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Table quiz,CLG Na Fianna,Positive
 Fri nite,CLG Na Fianna,Positive
 CLLI Chronic Lymphocytic Leukemia Irl details,CLG Na Fianna,Positive
 Great   session,Stefano Arganese,Positive
 Chronic Lymphocytic Leukemia Market Research Overview Advances Opportunity Analysis,Market Research,Positive
 Chronic Lymphocytic Leukemia Market Research Overview Advances Opportunity Analysis,Mark Research new,Positive
 MedicalInvention Research,Swapnil Devale,Negative
 Precision Medicine,Oncology Tube,Negative
 amp Mutation Detection Advances,Oncology Tube,Negative
 Germ line mutations,Pathowitter,Positive
 shelterin complex genes,Pathowitter,Positive
 shelterin complex genes,Francesco Turturro,Negative
 action amp,VJHemOnc,Negative
 Biological analysis,Biocomputing,Positive
 Biological analysis,microRNApapers,Negative
 WAFCIP,EurekaMag,Negative
 Current Meds,Cancer Agent,Negative
 CLL Patients New Treatments,Cancer Agent,Negative
 Opportunity Analyzer Chronic Lymphocytic Leukemia,satPRnews,Negative
 Opportunity Analyzer Chronic Lymphocytic Leukemia,BizPR,Negative
 Opportunity Analysis,satPRnews,Negative
 Opportunity Analysis,BizPR,Negative
 Opportunity Analysis,Scott Werntz,Negative
 Ya estamos,HN Fotograf√≠a,Positive
 Lorna Warwick,Zack Pemberton-Whiteley,Positive
 farewell,Zack Pemberton-Whiteley,Negative
 VIDEO CLLIPI,VJHemOnc,Negative
 Dr Ben Kennedy,Zack Pemberton-Whiteley,Positive
 Activated Allogeneic NK Cells,NK cell Biology,Negative
 Activated Allogeneic NK Cells,NK papers,Negative
 Activated Allogeneic NK Cells,Frontiers Immunology,Negative
 Kill Poor Prognosis,NK cell Biology,Negative
 Kill Poor Prognosis,NK papers,Negative
 Kill Poor Prognosis,Frontiers Immunology,Negative
 Droplet digital PCR analysis,Cancer Papers,Negative
 NOTCH gene mutations,Cancer Papers,Negative
 S√°,NK papers,Negative
 Lymphoma Coalition,Charlotte Roffiaen,Positive
 Lymphoma Coalition,Zack Pemberton-Whiteley,Negative
 Belgrade,Charlotte Roffiaen,Positive
 Belgrade,Zack Pemberton-Whiteley,Negative
 occasion,Charlotte Roffiaen,Positive
   Issues,CancerWallonia,Positive
   P Aumont,Charlotte Roffiaen,Positive
 French   org,Charlotte Roffiaen,Positive
 patient org,Charlotte Roffiaen,Positive
 amp involvement,Charlotte Roffiaen,Positive
 Health policy,Charlotte Roffiaen,Positive
 Pierre Aumont SILLC,Zack Pemberton-Whiteley,Negative
 patient surveys,Zack Pemberton-Whiteley,Negative
 Negative Messages,Oncology Tube,Negative
 Charlotte Roffiaen,Zack Pemberton-Whiteley,Negative
 access challenges,Zack Pemberton-Whiteley,Negative
 Dr Arnon Kater   Clinical Trials,Zack Pemberton-Whiteley,Negative
 la alianza global por,AEAL,Positive
 AEAL ha publicado un estudio de sensibilizaci√≥n sobre las necesidades de los pacientes,AEAL,Positive
 con LLC,AEAL,Positive
 Manejar la ausencia de tratamiento,AEAL,Positive
 Leucemia Linfoc√≠tica Cr√≥nica Watch ampor,AEAL,Positive
 Wait,AEAL,Positive
 DELpTP MUTATION ALLOGENEIC HEMATOPOIETIC,Medibooks,Negative
 El Dr Christofer Fegan explica,AEAL,Positive
 Dr Fegan sobre la perspectiva del paciente La mayor parte de los pacientes piensa,AEAL,Positive
 diario,AEAL,Positive
 DrKater,CML AdvocatesNetwork,Negative
   Dr Arnon Kater,Charlotte Roffiaen,Positive
 NL,Charlotte Roffiaen,Positive
 Dr Arnon Kater,Zack Pemberton-Whiteley,Negative
 andor,Zack Pemberton-Whiteley,Negative
 FBA,Johan Kullb√§ck ‚õ≥Ô∏è,Positive
 Novel Treatment Landscape,The ONC,Positive
 Unfolds,The ONC,Positive
 Ph Venetoclax amp Ibrutinib,"Mike Thompson, MD, PhD, FASCO",Negative
 Chronic Lymphocytic Leukemia CLLPI,"Mike Thompson, MD, PhD, FASCO",Negative
    experts,Andrew Schorr,Negative
 Specialists,Patient Power,Negative
 Specialists,Oncology Tube,Negative
 Finish st day,CML AdvocatesNetwork,Negative
 Horizons,CML AdvocatesNetwork,Negative
 Horizons,Celia Mar√≠n,Positive
 Horizons,Margaret Walker,Negative
 advocates networks,CML AdvocatesNetwork,Negative
 Chronic lymphocytic   HLAE,ACS Journal Cancer,Negative
 amp sHLAE levels,ACS Journal Cancer,Negative
 Lorna Warwick ViceChair,Zack Pemberton-Whiteley,Negative
 CLLAN,Zack Pemberton-Whiteley,Negative
 vision statements governance board development,Zack Pemberton-Whiteley,Negative
 patient orgs,Zack Pemberton-Whiteley,Negative
   treatment planner app,Treatment Planner,Positive
 IOS Android,Treatment Planner,Positive
 Windows,Treatment Planner,Positive
 Telomere shelterin complex germ line mutations,Blood Journal,Negative
 familial,Blood Journal,Negative
 organization,CML AdvocatesNetwork,Negative
 Cofounder,CML AdvocatesNetwork,Negative
 Michael Rynne,Zack Pemberton-Whiteley,Negative
 Ireland CLL Support Group,Zack Pemberton-Whiteley,Negative
 advocacy session,Zack Pemberton-Whiteley,Negative
   Prof Chris Fegan,Charlotte Roffiaen,Positive
   recommends,MDedge Hematology & Oncology,Positive
 Decreased deformability,Alyssa Howard,Negative
 Decreased deformability,Denver Greene,Negative
 prognostics,Zack Pemberton-Whiteley,Negative
 representatives,CML AdvocatesNetwork,Negative
 st   Horizons,CML AdvocatesNetwork,Negative
 Dr Kennedy,CML AdvocatesNetwork,Negative
 CLL diagnosed DrStamatopoulus,CML AdvocatesNetwork,Negative
 st International Conference,Celia Mar√≠n,Negative
 organizations,Celia Mar√≠n,Negative
 Dr Stamatopoulus,CML AdvocatesNetwork,Negative
 CLL invisibleinconclusive incurable,CML AdvocatesNetwork,Negative
 Choose Appropriate Agents,Anna Deveau,Negative
 PFS Endpoint,Anna Deveau,Negative
   line mutations,Francesco Turturro,Negative
 Novel biomarker,ACS Journal Cancer,Negative
 sHLAE levels,ACS Journal Cancer,Negative
 Cont Hairy Cell Leukemia HCLChronic Lymphocytic Leukemia,Matthews & Associates,Negative
 origin amp work,VJHemOnc,Negative
   level ROR associates,Francesco Turturro,Negative
 accelerated diseaseprogression,Francesco Turturro,Negative
    Delta,Francesco Turturro,Negative
 Gene expression profile,Cancer Papers,Negative
 Antigen Receptor Stereotypy,Hematopoiesis News,Negative
 comedy pleasure,"Pat Euglow, Legacy Newbie",Negative
 Bone marrow,TumorImmunoPapers,Negative
 Bone marrow,Cancer Papers,Negative
 pipeline therapies,Decision Resources Group,Negative
 Chronic Lymphocytic Leukemia Click,Decision Resources Group,Negative
 exome sequencing,Blood Journal,Negative
 Integrin Œ≤,Blood Journal,Negative
 disease susceptibility,Blood Journal,Negative
 transformation w Barbara Eichhorst,VJHemOnc,Negative
 Chronic Lymphocytic Leukemia market,Decision Resources Group,Negative
 Meet,MPLN,Negative
 MPLNs Dr Bevan Tandon,MPLN,Negative
 Poster H,MPLN,Negative
 Life Expectancy Symptoms Prognosis,Health&Wealth,Positive
 hopes,VJHemOnc,Negative
 hopes,Oksana Komarova,Positive
 cell surface markers,Oncology Tube,Negative
 cell surface markers,VJHemOnc,Negative
 dyslipidemia,JNCI,Negative
 PATIENTS WEB EXPERIENCE,Elma Research,Positive
 NonHodgkinamps Lymphoma,Andrew Merron,Positive
 DRG,Andrew Merron,Positive
 NIGHT,Medibooks,Negative
 WORK,Medibooks,Negative
 MCCSPAIN,Medibooks,Negative
 CASE¬ñCONTROL STUDY,Medibooks,Negative
 susceptibility,varsome,Positive
 CLL Facts,iwCLL,Negative
 Elderly paper,Javier Martinez Peromingo,Positive
 SIOG,Javier Martinez Peromingo,Positive
 El trabajo da sus frutos m√°s,Carlos Llavador,Negative
 o menos,Carlos Llavador,Negative
 r√°pido Sin embargo sin,Carlos Llavador,Negative
 trabajo,Carlos Llavador,Negative
 se consigue NADA,Carlos Llavador,Negative
 BCR inhibitor failure,ASH,Negative
 unmet,ASH,Negative
 VIDEO J Bahlo,VJHemOnc,Negative
 IPI,BloodWork,Positive
 IPI,QxMD | Decision Support & Quality Improvement,Positive
 Age Stage BMG TP amp IGVH,BloodWork,Positive
   CLLIPI,Lymphoma Hub,Negative
 VIDEO B Eichhorst,VJHemOnc,Negative
 XPO,VJHemOnc,Negative
 VIDEO Federico CaligarisCappio,VJHemOnc,Negative
 Ghost,stephen young,Positive
 War,T‚Ç¨¬£JA¬•,Positive
 VIDEO Michael Keating,VJHemOnc,Negative
 Pubmed Antigen receptor stereotypy,epigenetics_papers,Negative
 w experts,Patient Power,Positive
 data b,"chadi nabhan MD, MBA, FACP",Negative
 discussed day,"chadi nabhan MD, MBA, FACP",Negative
 amp outcomes,"chadi nabhan MD, MBA, FACP",Negative
 clinicans,Oncology Tube,Negative
 hope amp expectations,Oncology Tube,Negative
 Guidance,Oncology Tube,Negative
 VIDEO N Chiorazzi,VJHemOnc,Negative
 action amp combination,Oncology Tube,Negative
 CLL RORs,Prof John,Negative
 HighLevel ROR,Prof John,Negative
 Tom Kips,Prof John,Negative
 et al       leukemia,Prof John,Negative
 Blood Commentary BCR inhibitor failure,Blood Journal,Negative
 Maintenance Lenhighrisk,"chadi nabhan MD, MBA, FACP",Negative
 PFS Thoughts,"chadi nabhan MD, MBA, FACP",Negative
 wk,"chadi nabhan MD, MBA, FACP",Negative
 Clinical outcomes,Blood Journal,Negative
 flow,MDedge Hematology & Oncology,Negative
 HTS,MDedge Hematology & Oncology,Negative
 Dr Jennifer R Brown MD PhD,PER,Negative
 Chemoimmunotherapy combination,HemOnc Today,Negative
 Dr William G Wierda MD PhD,PER,Negative
 Posttranscriptional Upregulation,TumorImmunoPapers,Negative
 Commentary,"chadi nabhan MD, MBA, FACP",Negative
 Richters Transformation amp Acute Leukemia,Oncology Tube,Negative
 New   Treatments,Oncology Tube,Negative
 amp Importance,Oncology Tube,Negative
   participant,MD Anderson Cancer Center,Negative
 Blood Ibrutinib efficacy,Teresa Villaescusa,Positive
 VIDEO Michael Hallek,VJHemOnc,Positive
 consolidation therapy,HemOnc Today,Negative
   Licenses,Plexus Ventures,Negative
 Upfront Ibrutinib,Precision Med US,Positive
 Upfront Ibrutinib,Dr. Melody Davis,Negative
 roughly   hours,"Pat Euglow, Legacy Newbie",Negative
 Online,Oncology Tube,Negative
 SHM status,MPLN,Negative
 International Prognostic Index working group,MPLN,Negative
 BloodIbrutinib efficacy,Philip McCarthy,Negative
 Key Companies Analysis,Top 10,Negative
   efficacy,Francesco Turturro,Negative
   efficacy,üÖæ Jaksic,Negative
 RT Pete Hillmen,"chadi nabhan MD, MBA, FACP",Negative
 longterm survival,HemOnc Today,Negative
    Neutrophils,ImmunologyPapers,Negative
 Cinque cose da sapere sulla leucemia linfatica cronica,Giuseppe Cotellessa,Positive
 VIDEO Carlo Croce,VJHemOnc,Positive
 New Improved Staging System,MPLN,Negative
 iwCLL   meeting,Oncology Tube,Negative
 Rai CLL staging system,Lymphoma Hub,Negative
 amp Improve Therapies,Oncology Tube,Negative
 Talks,Blood Cancer UK,Negative
 Students,Blood Cancer UK,Negative
 amp Clinical Fellows Day,Blood Cancer UK,Negative
 st SIV,Amy C. Cavers,Negative
 Czech Rep TGTX UNITYCLL trial,Amy C. Cavers,Negative
    signature,Sumit Middha,Positive
   guest,Patient Power,Negative
   amp   Drug Combinations,Oncology Tube,Negative
   Template,Pathowitter,Positive
 reporting,Pathowitter,Positive
 biomarker testing,Pathowitter,Positive
 Upcoming CLL Trial,Oncology Tube,Negative
    subjectivity,MPLN,Negative
    subjectivity,Geneuity,Positive
 biology treatment amp,VJHemOnc,Negative
 Clin Oncol R Coll Radiol,Oncology,Negative
   acquired immunodeficiency disease,ASH,Negative
 Hexa,AttyCreditRepair,Positive
 Hexa,LeadValets Lead Generation Agency,Positive
 Hexa,iPlethora,Positive
 Hexa,REI Lending,Positive
 Edisi ling lung entah kemana vNemunya kesini sini juga,BianFahrezy.,Positive
 upcoming   meeting,VJHemOnc,Negative
 upcoming   workshop,VJHemOnc,Negative
 Elimination,TumorImmunoPapers,Positive
 Elimination,Drug Delivery News,Positive
 Patients Tumor Lysis Risk Status,Oncology Tube,Negative
 methodologies,Geneuity,Positive
 methodologies,MPLN,Negative
 toAcute Myeloid Leukemia AMLAcute Lymphocytic Leukemia ALLChronic Lymphocytic Leukemia CLL,Matthews & Associates,Negative
 VIDEO Dan Landau,VJHemOnc,Negative
 upcoming CLLGIVe trial,VJHemOnc,Negative
 Circulating,microRNApapers,Positive
 Circulating,exRNA,Positive
 Circulating,Diagnostics News,Negative
 populationbased cohort,"Raul Cordoba, MD, PhD",Negative
 TTFT CLLIPI,Lymphoma Hub,Negative
 MDACCPI,Lymphoma Hub,Negative
   Customs Clear,Concessionary L.L,Negative
 Jose Leis MD,OncLive.com,Negative
 VIDEO C Niemann,VJHemOnc,Positive
 methods,VJHemOnc,Negative
   IPI,"chadi nabhan MD, MBA, FACP",Negative
 Origin amp Work,Oncology Tube,Negative
 Weill Cornell Dr Richard Furman,Lymphomation.org,Negative
 Phenotypic alteration,TumorImmunoPapers,Positive
 Phenotypic alteration,Cancer Papers,Negative
 CD T cells,TumorImmunoPapers,Positive
 CD T cells,epigenetics_papers,Positive
 CD T cells,Cancer Papers,Negative
 Pubmed Phenotypic alteration,epigenetics_papers,Positive
      length,Anna Deveau,Negative
 persistence months,Anna Deveau,Negative
   Prof John Gribben,EMJ Hematology,Positive
 Education,APSHO,Negative
 schedule visit s website,APSHO,Negative
 CLLGIVe trial,VJHemOnc,Negative
 SecondGeneration,Oncology Tube,Negative
 SecondGeneration,Patient Power,Negative
 Industry Challenges Key Vendors Drivers Trends,Top 10,Negative
 rmatthewscom,Matthews & Associates,Positive
 Erstmals,Uniklinikum T√ºbingen,Positive
 neuartiger   gegen chronische,Uniklinikum T√ºbingen,Positive
 erprobt,Uniklinikum T√ºbingen,Positive
 w F CaligarisCappio,VJHemOnc,Negative
 Dr Sanghas presentation,CARE‚Ñ¢ Education,Negative
 Impacts,ICES,Positive
 metabolic syndrome,ICES,Positive
 Exploring,Patient Power,Negative
 SecondGeneration   Inhibitors w Dr Lamanna,Patient Power,Negative
 amp Dr Thompson,Patient Power,Positive
 HemOnc Today Optimal sequencing,Oncology Board,Negative
 Expert Update,Oncology Tube,Negative
 ‚óà,‚óà Cory B. Phillips ‚óà,Negative
 Chronic Lymphocytic Leukemia PopulationBased Study Background,‚óà Cory B. Phillips ‚óà,Negative
 Singlecell findings,MDedge Hematology & Oncology,Negative
 dr leis,donnashort,Negative
 Good lord,Jordan Munson,Positive
 boy,Jordan Munson,Positive
 Atypical Pneumocystis jirovecii pneumonia,Chan Cheah,Negative
 Atypical Pneumocystis jirovecii pneumonia,Blood Journal,Negative
 nextgeneration treatments,International Pain Foundation¬Æ,Negative
 nextgeneration treatments,Susan Rahn,Positive
 nextgeneration treatments,"Holly Bertone, CNHP, PMP",Negative
 nextgeneration treatments,Paula Pyzia,Negative
 nextgeneration treatments,circa1835,Positive
 nextgeneration treatments,Colleen Busch,Negative
 nextgeneration treatments,Cassi Schmigotzki,Positive
 nextgeneration treatments,SeparatriX,Positive
 nextgeneration treatments,Sandy D.,Negative
 nextgeneration treatments,Kimberley Thomas,Negative
 nextgeneration treatments,Rhia Steele@ravishingrhia.com,Negative
 nextgeneration treatments,Debbie Woodbury,Negative
 nextgeneration treatments,Nora Sheffield,Positive
 nextgeneration treatments,Grayson (he),Positive
 nextgeneration treatments,Senior Care Corner,Negative
 nextgeneration treatments,Katie,Positive
 nextgeneration treatments,Kat,Positive
 nextgeneration treatments,julie andrew,Positive
 nextgeneration treatments,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 nextgeneration treatments,Becky Burns,Positive
 CLL Therapeutics,Top 10,Negative
 Market Segmentation Application Technology,Top 10,Negative
 McMasters,Clinton Lewis,Positive
   patient Dr La Verne Abe Harris,Andrew Schorr,Negative
 picture,Andrew Schorr,Negative
 w Dr Nicole Lamanna,Patient Power,Positive
 tcouOprNSy,Patient Power,Negative
 Roches,Regulatory Jobs,Positive
 Roches,Cpl Life Sciences,Negative
 leukaemia drug venetoclax,Regulatory Jobs,Positive
 leukaemia drug venetoclax,Cpl Life Sciences,Negative
 EU market,Regulatory Jobs,Positive
 EU market,Cpl Life Sciences,Negative
 Tissue,Oncology Tube,Negative
 VIDEO Prof Stilgenbauer,VJHemOnc,Negative
 disease biology mutations,VJHemOnc,Negative
 Mastering,Med-IQ,Negative
 Clinical Challenges,Med-IQ,Negative
 Oral Agents Free   webinar,Med-IQ,Negative
   video update,CARE‚Ñ¢ Education,Positive
 Oncology Tube Use,Oncology Board,Negative
 novel algorithms,VJHemOnc,Negative
 Olimpia suma una racha de   juegos como locale,Los Invasores,Positive
 donde gano,Los Invasores,Positive
 anoto,Los Invasores,Positive
 goles,Los Invasores,Positive
 Discovery,Oncology Tube,Negative
 New   Drugs,Oncology Tube,Negative
 Awesome project,ilove claremont,Positive
 hometown boy scouts,ilove claremont,Positive
 CLL drug,Marco Ricci,Positive
 Absolutely   video,Anna Deveau,Negative
 Ocular lymphoma,EurekaMag,Negative
 bf,HGSMVM‚ù§Ô∏è,Positive
 HUGE,Lucian D. Light üí°,Positive
    Champion,Lucian D. Light üí°,Positive
 Ibrutinib Chemo,Helen Ong,Positive
 Novel Combos,Helen Ong,Positive
 IndoleCarbinol,TumorImmunoPapers,Negative
 playtruehockey,Sebastien Gervais,Positive
 Antigen Selection,TumorImmunoPapers,Negative
 Tcell Repertoire,TumorImmunoPapers,Negative
 Tcell Repertoire,AIRR-seq papers,Negative
 Oncologys,LIH_Luxembourg,Positive
 acquired immunodeficiency disease,Blood Journal,Negative
 acquired immunodeficiency disease,"Raul Cordoba, MD, PhD",Negative
 RT citohans,Tech Buddhaa,Positive
 Latest News CHMP,AbbVie,Negative
   Antigen Selection,AIRR-seq papers,Negative
 Auf dem   diskutieren,AbbVie Deutschland,Negative
 Experten heute,AbbVie Deutschland,Negative
 zuk√ºnftige Therapien bei schwer zu behandelnder,AbbVie Deutschland,Negative
 bringen,AbbVie Deutschland,Negative
 shortcut,Endpoints News,Positive
 lead drug,Endpoints News,Positive
 LYN Kinase,"Raul Cordoba, MD, PhD",Negative
 LYN Kinase,Olivier Elemento,Negative
 JNJNews,Nicolai M√ºnch,Positive
 Guest Blog,Patient Power,Negative
 CJ Trebuchets Flying Cows,Patient Power,Negative
 tcojFmcSD,"Francisco Marty, MD",Negative
   Virtual Community,Oncology Tube,Negative
 Worldwide Relapsed Chronic Lymphocytic Leukemia CLL Market Size Share Growth Trends Key Players Competi,News Batam,Positive
 Worldwide Relapsed Chronic Lymphocytic Leukemia CLL Market Size Share Growth Trends Key Players Competi,Info Batam,Negative
 Chronic Lymphocytic Leukemia CLL Market Size Share Growth Trends Ke,Batam Port,Positive
 Worldwide Relapsed Chronic Lymphocytic Leukemia CLL Market Size Share Growth Trends Ke,BATAM Kepri,Negative
 Pos Metro Batam,BATAM Kepri,Positive
 Global Relapsed Chronic Lymphocytic Leukemia CLL Market Size Share Growth Trends Key,Run Direct Magazine,Positive
 Global Relapsed Chronic Lymphocytic Leukemia CLL Market Size Share Growth Trends Key,BizPR,Negative
 Experiencia adquirida,Chelo Martin de Dios,Positive
 Dr Elias Campo,Chelo Martin de Dios,Positive
 jornada de,Chelo Martin de Dios,Positive
 Information fr√•n huvudpartner,St Olav Waterway,Positive
 p√• St,St Olav Waterway,Positive
 Waterway,St Olav Waterway,Positive
 Rainbow,Liana Gardner,Positive
 Treatment Modality,AJMC,Negative
 Global   profiling,Santhilal Subhash,Positive
 Adverse Effects,Oncology Tube,Negative
 Frontline   Management,Lymphoma Coalition,Negative
 AEs amp maximize adherence,Med-IQ,Negative
 Major Types,Medical laboratory,Positive
 gt CARRY CHRONIC LYMPHOCYTIC LEUKEMIADONT,Frustrated Quests,Positive
 CARRY CHRONIC LYMPHOCYTIC LEUKEMIA,Frustrated Quests,Positive
 Medical Imaging,Intrinsic Imaging,Positive
 Intrinsic Imaging,Intrinsic Imaging,Positive
 Novel Treatment Strategies,Targeted Oncology,Negative
 Novel Treatment Strategies,EMJ Hematology,Negative
 Novel Treatment Strategies,NACDA Program on Aging,Negative
 tcoMEoMMysXFQ,Targeted Oncology,Negative
 Current Questions,Targeted Oncology,Negative
 Frontline   Treatment tcoIHbkkRhEk,Targeted Oncology,Negative
   Newsletter,Andrew Schorr,Negative
 Diagnostic Testing,AJMC,Negative
 EvidenceBased Treatment,AJMC,Negative
 Cancer Care,AJMC,Negative
 Unmet Needs,AJMC,Negative
 Membrane expression,EurekaMag,Negative
 IL alpha,EurekaMag,Negative
 ContHairy Cell Leukemia,Matthews & Associates,Negative
 HCL Chronic Lymphocytic Leukemia,Matthews & Associates,Negative
 CLL contact,Matthews & Associates,Negative
 Refractory Chronic Lymphocytic Leukemia CLL Market,BizPR,Positive
 Refractory Chronic Lymphocytic Leukemia CLL Market,Info Batam,Negative
 Refractory Chronic Lymphocytic Leukemia CLL Market,BATAM Kepri,Negative
 Refractory Chronic Lymphocytic Leukemia CLL Market,Run Direct Magazine,Positive
 ‚Äì Global Clinical Trials Review H,BizPR,Positive
 ‚Äì Global Clinical Trials Review H,Run Direct Magazine,Positive
 Global Clinical Trials Review H,Info Batam,Negative
 Global Clinical Trials Review H,BATAM Kepri,Negative
 Acute Market,Info Batam,Negative
    productos metalmec√°nicos tienen potencial de exportaci√≥n,Gestiona Per√∫,Positive
    productos metalmec√°nicos tienen potencial de exportaci√≥n,ExportandOnline,Positive
    productos metalmec√°nicos tienen potencial de exportaci√≥n,Exportando_Per√∫,Positive
    productos metalmec√°nicos tienen potencial de exportaci√≥n,Posiciona_tu_marca,Positive
    productos metalmec√°nicos tienen potencial de exportaci√≥n,Im√°genes & Eventos,Positive
 Mollys story,Melanie,Negative
 GCLLSG   trials,VJHemOnc,Negative
 Elevated ILA,Cancer Papers,Negative
 ‡πÄ‡∏Ñ‡∏•‡∏µ‡∏¢‡∏£‡πå‡∏û‡∏∑‡πâ‡∏ô‡∏ó‡∏µ‡πà‡∏î‡πà‡∏ß‡∏ô ‡∏ó‡∏•‡∏Å‡∏≥‡∏•‡∏±‡∏á‡∏£‡πâ‡∏≠‡∏ô,NEVERLINE (‡πÄ‡∏õ‡∏¥‡∏î‡∏≠‡∏≠),Positive
 Study Affirms,EMJ Hematology,Negative
 EOSINOPHILLIA CHRONIC LYMPHOCYTIC LEUKEMIA SICKLE CELL ANEMIA,Vinny,Positive
 PERNICIOUS ANEMIA IRON,Vinny,Positive
 ANEMIA,Vinny,Positive
 YES,Vinny,Positive
 Live Webinar   Review,Med-IQ,Negative
 life cycle,VJHemOnc,Positive
 treatmentw N Chiorazzi,VJHemOnc,Negative
 Erratum,Cancer Papers,Negative
 New ESMO guidelines,Christopher Steer,Negative
 CLL patienter,LyLe Foreningen,Negative
 mwahrin xD,Mahmoud Turki,Negative
 ‡πÄ‡∏î‡πá‡∏Å‡πÜ‡∏à‡∏∞‡∏õ‡∏•‡πà‡∏≠‡∏¢‡∏ó‡∏µ‡πÄ‡∏ã‡∏≠‡∏£‡πå‡∏•‡πà‡∏∞,We love CLL thailand,Positive
 Amb amics,Taty DOMINGUEZ üôãüèª‚Äç‚ôÄÔ∏è #Quetornielemerito ‚úä,Positive
 ESMO guidelines,iwCLL,Negative
 treatment recommendations,iwCLL,Negative
 Key Insights     Disorders,Oncology Tube,Negative
     Wierda Discusses,CancerWallonia,Negative
   medication,Ahmed Dahduli,Positive
   medication,AbbVie Canada,Negative
 Round table,Oncology Tube,Negative
 Round table,VJHemOnc,Negative
 John Gribben MD,Oncology Tube,Negative
 Favorable Survival High Response Rate,Christopher Steer,Negative
 Favorable Survival High Response Rate,Dr. Melody Davis,Negative
 Favorable Survival High Response Rate,NACDA Program on Aging,Negative
 SideEffects,Oncology Tube,Negative
 Inotuzumab Ozogamicin,Oncology Tube,Negative
 officers,Concessionary L.L,Negative
 duties,Concessionary L.L,Negative
 stone,Concessionary L.L,Negative
 Allogeneic Stem Cell Transplantation,Oncology Tube,Negative
 Allogeneic Stem Cell Transplantation,Current Reports,Positive
 biology treatment amp rr,VJHemOnc,Negative
 Rd,"Pat Euglow, Legacy Newbie",Negative
 Hex Depths,"Pat Euglow, Legacy Newbie",Negative
 Colorless Eldrazi,"Pat Euglow, Legacy Newbie",Negative
 guysgals,Community Legacy League,Negative
 MTGO Chat room,Community Legacy League,Negative
 discord app,Community Legacy League,Negative
 talk Link,Community Legacy League,Negative
 Pts w Dr Lamanna,Patient Power,Negative
 JLL lt samedi,Mahmoud Turki,Positive
 oct,Mahmoud Turki,Positive
 FST,Mahmoud Turki,Positive
 Best Approach,Oncology Tube,Negative
 Multiple Relapsed,Oncology Tube,Negative
 Evolving Role,Clin Adv Hem Onc,Negative
 Evolving Role,COPD News,Negative
 VIDEO Emili Montserrat,VJHemOnc,Positive
 drug cost,VJHemOnc,Negative
   bei,IQWiG,Positive
 Zusatznutzen,IQWiG,Positive
 w Nicholas Chiorazzi,VJHemOnc,Negative
 Richard R Furman MD,Oncology Tube,Negative
 Evolutionary Perspective,Oncology Tube,Negative
 Methods,Oncology Tube,Negative
 Tyrosine kinase inhibitors,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 frontline chronic lymphocytic   management,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Previously Treated   Patient,Oncology Tube,Negative
 briefs Dr Matthew Davids,CARE‚Ñ¢ Education,Negative
 Steven Coutre MD,OncLive.com,Negative
 Steven Coutre MD,AJMC-Oncology,Positive
 Steven Coutre MD,Health Adviser,Positive
 Steven Coutre MD,AJMC,Negative
 frontline treatment decisions,OncLive.com,Negative
 New Compounds,Oncology Tube,Negative
 ICYMI Maintenance rituximab prolongs,HemOnc Today,Negative
 Dr Andrew Zelenetz,OncologyEducation,Negative
 Dr Andrew Zelenetz,Lymphoma Hub,Negative
 Dr Andrew Zelenetz,VJHemOnc,Negative
 relapsed disease,CAPhO,Negative
   line fit ptslt,CAPhO,Negative
 antimicrobial prophylaxis,CAPhO,Negative
 AntiCD therapy,CAPhO,Negative
 rituximab sig,CAPhO,Negative
 Fit vs Frail Assessment Strategies,Soha,Positive
   chemo,CAPhO,Negative
   diagnoses,CAPhO,Negative
 chronic disease,CAPhO,Negative
 chronic disease,Patient Power,Negative
 ‡∏Ç‡∏≠‡∏ô‡∏¥‡∏¢‡∏≤‡∏°‡∏†‡∏≤‡∏û‡∏ô‡∏µ‡πâ‡∏ß‡πà‡∏≤ ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏õ‡∏≤‡∏Å‡πÄ‡∏´‡∏ß‡∏ô‡∏µ‡πâ,‡∏ú‡∏π‡πâ‡πÇ‡∏ä‡∏Ñ‡∏î‡∏µ ‚úåüèª,Positive
 C Building Mae,‡∏ú‡∏π‡πâ‡πÇ‡∏ä‡∏Ñ‡∏î‡∏µ ‚úåüèª,Positive
 Pubmed Epigenetic silencing,epigenetics_papers,Positive
 tumor suppressor,epigenetics_papers,Negative
 RNA BM,epigenetics_papers,Negative
 YearOld Patient,Cancer Papers,Negative
 Hypoechoic Nodular Spleen,Cancer Papers,Negative
   blogger ‚Äú CJ,Andrew Schorr,Negative
 Explore KOLs¬í priorities,FirstWord Pharma,Negative
 Crossresistance,Cancer Papers,Negative
 HighRisk CLL Watch,Debbie Woodbury,Negative
 HighRisk CLL Watch,Rhia Steele@ravishingrhia.com,Negative
 HighRisk CLL Watch,WEGO Health,Negative
 HighRisk CLL Watch,‚ô•Melissa‚ô•,Positive
 HighRisk CLL Watch,Sandy D.,Negative
 HighRisk CLL Watch,Paula Pyzia,Negative
 HighRisk CLL Watch,Senior Care Corner,Negative
 HighRisk CLL Watch,International Pain Foundation¬Æ,Negative
 HighRisk CLL Watch,Colleen Busch,Negative
 HighRisk CLL Watch,Katie,Positive
 ibrutinib experience,RIOH,Negative
 Manitoba   Dr Banerji reviews results,RIOH,Negative
 Metformin,TumorImmunoPapers,Negative
 cell cycle progression,TumorImmunoPapers,Negative
 antimalarials,RIOH,Negative
 DNA repair,RIOH,Negative
 DNA repair,Cancer Papers,Negative
 w bendamustine,RIOH,Negative
 KatyalJohnston labs,RIOH,Negative
 Phase II data,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Negative
 Phase II data,Lymphoma Hub,Negative
 clarification purposes,Greg Little,Positive
 lymphoblastic,Greg Little,Positive
 Constantine Tam MD,OncLive.com,Negative
 Peter MacCallum Cancer Center,OncLive.com,Negative
 Register   meeting dates,iwCLL,Negative
 Ibrutinib Effective,Oncology,Negative
 Ibrutinib Effective,Ulla,Positive
 Ibrutinib Effective,Krishan Maggon,Positive
 Allogeneic stem,Lymphoma Hub,Negative
 Infusion,Oncology Tube,Negative
 allogeneic antiCD CAR Tcells,Oncology Tube,Negative
 relapsed CLL Learn,Te Ha,Negative
 relapsed CLL Learn,Rhia Steele@ravishingrhia.com,Positive
 relapsed CLL Learn,Paula Pyzia,Negative
 relapsed CLL Learn,Sandy D.,Negative
 relapsed CLL Learn,Kimberley Thomas,Negative
 relapsed CLL Learn,Grayson (he),Positive
 relapsed CLL Learn,International Pain Foundation¬Æ,Negative
 relapsed CLL Learn,Cassi Schmigotzki,Negative
 relapsed CLL Learn,Debbie Woodbury,Negative
 relapsed CLL Learn,Chronic Sex,Positive
 relapsed CLL Learn,SeparatriX,Positive
 relapsed CLL Learn,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 relapsed CLL Learn,WEGO Health,Negative
 MoA,Jane Cheung,Negative
 Testing PIK delta inhibitor,Lymphomation.org,Negative
 RelapsedRefractory SLL,Lymphomation.org,Negative
 Obinutuzumab Ibrutinib amp Venetoclax,"Mike Thompson, MD, PhD, FASCO",Negative
 L amp,"Mike Thompson, MD, PhD, FASCO",Negative
 Rel Chronic Lymphocytic Leukemia CLL,"Mike Thompson, MD, PhD, FASCO",Negative
 Jeff Jones,"Mike Thompson, MD, PhD, FASCO",Negative
 q Deletion w Dr Lamanna,Patient Power,Negative
   research study,Amanda Haddock üß¨,Negative
   research study,WEGO Health,Negative
 enhance outcomes,FirstWord Pharma,Negative
 experts¬í views,FirstWord Pharma,Negative
    Crosstalk,ImmunologyPapers,Negative
 Alexander S Wiener Lecture Dr Wiener,NY Blood Center,Positive
 todays role,VJHemOnc,Negative
 Chronic Lymphocytic   CLL Treatment,eCatalysis,Positive
 Chronic Lymphocytic   CLL Treatment,Mayo Clinic Cancer Center,Negative
 MayoClinic,eCatalysis,Positive
 PETpositive lymphadenopathy,"Naveen Pemmaraju, MD",Negative
 Pemmaraju et al,"Naveen Pemmaraju, MD",Negative
 Interphase cytogenetics,EurekaMag,Negative
 arrhythmias,CancerTherapyAdvisor,Negative
 safety concerns influence use,FirstWord Pharma,Negative
 Therapeutics,Oncology Board,Negative
 Therapeutics,Oncology Tube,Negative
 Therapeutics,Patient Power,Negative
       tconowOWNpexP,Oncology.TV,Negative
   New Report,CMLHope,Negative
 Available Refractory Chronic Lymphocytic Leukemia CLL Glo,CMLHope,Negative
   FDA Approval,A. Vroom - Ten Wolde,Negative
 Fludarabine amp Cyclophosphamide,A. Vroom - Ten Wolde,Negative
 Hawaii,PeerView,Positive
 Summaryclinical trial,Rock,Positive
 Refractory Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review,Rock,Positive
 procedures,Patient Power,Negative
 Mae Fah Luang University,‡∏ú‡∏π‡πâ‡πÇ‡∏ä‡∏Ñ‡∏î‡∏µ ‚úåüèª,Positive
 Global Refractory Chronic Lymphocytic Leukemia Market,News Batam,Positive
 Global Refractory Chronic Lymphocytic Leukemia Market,BizPR,Negative
 Global Refractory Chronic Lymphocytic Leukemia Market,Info Batam,Negative
 Global Refractory Chronic Lymphocytic Leukemia Market,Batam Port,Positive
 Global Refractory Chronic Lymphocytic Leukemia Market,BATAM Kepri,Negative
 ‚Äì Industry Trends Market Size Segments,News Batam,Positive
 ‚Äì Industry Trends Market Size Segments,Info Batam,Negative
 ‚Äì Industry Trends Market,BizPR,Negative
 ‚Äì Industry Trends Marke,Batam Port,Positive
 ‚Äì Industry Trends Marke   Pos Metro Batam,BATAM Kepri,Negative
 CLL NKs KOed NK activity,Prof John,Negative
 SCL,Prof John,Negative
   ist,Janssen Deutschland,Positive
 b√∂sartige chronische Erkrankung,Janssen Deutschland,Positive
 Mehr zu Verlauf,Janssen Deutschland,Positive
 und Therapie,Janssen Deutschland,Positive
 General knowledge,Cancerllationüéó,Positive
 Chronic Lymphocytic Leukemia Value,AJMC,Negative
 RealWorld Data,AJMC,Negative
 VIDEO Dr Landau,VJHemOnc,Negative
 Pipeline   drug candidates,FirstWord Pharma,Negative
 novel pathways,FirstWord Pharma,Negative
 appendix,Cancer Papers,Negative
 VIDEO Dr Eichhorst,VJHemOnc,Negative
   Awareness Month Dr Tait Shanafelt,eCatalysis,Positive
   Awareness Month Dr Tait Shanafelt,Mayo Clinic Cancer Center,Positive
   Awareness Month Dr Tait Shanafelt,Mayo Clinic,Negative
 treatment patterns,AJMC,Negative
 nextgeneration competitors,FirstWord Pharma,Negative
 Dr Graeme Frasers,CARE‚Ñ¢ Education,Negative
   exports,Concessionary L.L,Negative
 customs,Concessionary L.L,Negative
 Nontraditional,Business News,Positive
 Wife,Andrew Schorr,Negative
 unsung heros,Patient Power,Negative
 Prospect amp progress,"Chaitra Ujjani, MD",Positive
 expert insights,FirstWord Pharma,Negative
   ljudi dobije,Roche d.o.o.,Positive
 svake godine,Roche d.o.o.,Positive
 Od,Roche d.o.o.,Positive
 osoba,Roche d.o.o.,Positive
 Safety Efficacy Considerations,AJMC,Negative
 pub,"chadi nabhan MD, MBA, FACP",Positive
 Collin effort,"chadi nabhan MD, MBA, FACP",Negative
 Reimbursement,AJMC,Negative
 European Language Portfolio ELP,Bet√ºl Pehlivanlƒ±,Positive
 Homepage,Bet√ºl Pehlivanlƒ±,Positive
 comScore Location Lift,GroundTruth,Positive
 xAd Trusted Accurate Scalable,GroundTruth,Positive
   Cluster   Crossresistance amp synergy,RIOH,Negative
 VIDEO Zelenetz,VJHemOnc,Negative
 Decreased WNT expression,Cancer Papers,Negative
 Changing Treatment Paradigm,AJMC,Negative
 RESONATE   HELIOS Trials,AJMC,Negative
 Clinical Impact,AJMC,Negative
 Clinical Impact,CancerTherapyAdvisor,Negative
 Payers Assess Value,AJMC,Negative
 New ESMO Guidelines eUpdate Chronic    treatment,ESMO - Eur. Oncology,Negative
 HELIOS trials,AJMC-Oncology,Negative
 VIDEO Tadeusz Robak,VJHemOnc,Positive
 Wie macht sich,Janssen Deutschland,Positive
 Erkrankung bemerkbar,Janssen Deutschland,Positive
 hei√üt,Janssen Deutschland,Positive
 mit ihr,Janssen Deutschland,Positive
 zu leben,Janssen Deutschland,Positive
 Mato et al Outcomes,Chan Cheah,Negative
 HemOnc Today ICYMI New treatment options,Hematology Board,Negative
 Current Thought,Oncology Tube,Negative
 ICYMI New treatment options,HemOnc Today,Negative
   colleagues,AbbVie Canada,Negative
 hematologist Dr Sarit Assouline amp patient,AbbVie Canada,Negative
 AmericanCancer,Margaret_Farrell,Negative
 Retweeted American Cancer Soc,RFL #EDRLT,Positive
 „Äê Pubmed,ATGCË´ñÊñá„ÉÅ„Çß„ÉÉ„Ç´„Éº,Positive
 P gene,AURELIAN UDRISTIOIU,Positive
 oncogenenesis,AURELIAN UDRISTIOIU,Positive
 CLL CLLGiVe trials,Oncology Tube,Negative
 CLL CLLGiVe trials,VJHemOnc,Negative
   launch event,Community Legacy League,Negative
    PM EST,Community Legacy League,Negative
 pharmaceutical research,NewYorkHealthWorks,Positive
 VENCLEXTA venetoclax,Dr. JOSE VELASQUEZ,Negative
 Ibrutinib Active,Dr. JOSE VELASQUEZ,Negative
   blood cancers,JanssenUS,Negative
 Rituximabinduced acute thrombocytopenia,Cancer Papers,Negative
 Un par de loquitos,nnete,Positive
 Queretarock ü§ò,nnete,Positive
    check,Team Intake.Me,Negative
 Spurs,CancerWallonia,Negative
 w data,"chadi nabhan MD, MBA, FACP",Negative
 amp personalized approaches,VJHemOnc,Negative
 DUAL TORKDNAPK INHIBITION BLOCKS,Medibooks,Negative
 SIGNALING PATHWAYS,Medibooks,Negative
 night shift work,Mithu Storoni MD PhD,Positive
 Diplomat Dispensing IMBRUVICA,Financial Buzz,Positive
 Diplomat Dispensing IMBRUVICA,Google  News,Positive
 Diplomat Dispensing IMBRUVICA,IntoxicatedTrader,Negative
 intvw w Dr Eichhorst,VJHemOnc,Negative
 settings,Katie Gould,Positive
 Proceedings,VJHemOnc,Negative
 Cologne,VJHemOnc,Negative
 Dr Carsten Niemann,VJHemOnc,Negative
 Lawn Bowling,Nicole Appleton,Positive
 lady,Nicole Appleton,Positive
 Paper ‚Äú Detection,qGenomics,Negative
 chromothripsislike patterns,qGenomics,Positive
 custom array platform,qGenomics,Positive
 Infografik,AbbVie Deutschland,Negative
 JPM enhancers,Genome Biology,Positive
 Horizons   Conference,Margaret Walker,Negative
    nowy,Jan Doktorowicz,Positive
 Symptome der chronischen lymphatischen Leuk√§mie,AbbVie Deutschland,Negative
 cat,Alice Lott,Positive
 points,Alice Lott,Positive
 relapsed highrisk,Rhia Steele@ravishingrhia.com,Negative
 relapsed highrisk,Cassi Schmigotzki,Negative
 relapsed highrisk,Te Ha,Negative
 relapsed highrisk,Milton Donald,Negative
 relapsed highrisk,Kimberley Thomas,Negative
 relapsed highrisk,International Pain Foundation¬Æ,Negative
 relapsed highrisk,mjohemme,Positive
 relapsed highrisk,Colleen Busch,Positive
 relapsed highrisk,DOMINIC GONZALES,Positive
 relapsed highrisk,Mighty #WearAMask Casey ‚òÄÔ∏è,Positive
 relapsed highrisk,circa1835,Negative
   Innovation,NGO News,Positive
 Read Blog,NGO News,Positive
 chord,Ruth Gemmell,Negative
 dividend hike,Ruth Gemmell,Negative
 N Singer,MarketBeat,Negative
 N Singer,Broker Ratings,Negative
 Adult Chronic Lymphocytic Leukemia,CancerDotNet,Negative
 Cenkos Securities Ltd,MarketBeat,Negative
 Recent Success,NCCP,Positive
 Spurs Development,NCCP,Positive
 Welche Organe,AbbVie Deutschland,Negative
 Event Abstract Role,AURELIAN UDRISTIOIU,Negative
 Chronic Lymphocytic LeukemiaAURELIAN UDRISTIOIU,AURELIAN UDRISTIOIU,Negative
   Al,Telemundo Deportes,Positive
 Gooooool de   Franco Jara marca,Telemundo Deportes,Positive
 pase,Telemundo Deportes,Positive
 outmart,Andrew Schorr,Negative
 initiative cohort,Mayo Clinic Labs,Positive
 Source hunt,Rachel Tompa,Positive
 folks,Rachel Tompa,Positive
 folks,Los Lobos,Negative
 amp waitindolent cancers,Rachel Tompa,Positive
 Pharmaceutical Costs,NACDA Program on Aging,Negative
 Studies T Cells,Lymphomation.org,Negative
 Multiple Tumor Associated Antigens,Lymphomation.org,Negative
 Powers Andrew Schorr,Cassi Schmigotzki,Positive
 lovehate relationship,Stephen Brown,Negative
 decadron,Stephen Brown,Negative
 OneSizeFitsAll,CURE Magazine,Negative
 ESMO World Lung,Andrew Schorr,Negative
   Approves Ofatumumab Combination,Novateur Ventures,Positive
 Expert Perspectives Chronic Lymphocytic Leukemia CLL,Oncology Tube,Positive
 Thompson et al     patients,Chan Cheah,Negative
 OT,Patient Power,Negative
 OT,Siharam Media Network,Positive
 Autoimmune Diseases,Oncology Tube,Negative
 Donnerstag ist,AbbVie Deutschland,Negative
 Die chronische lymphatische,AbbVie Deutschland,Negative
 CLLnd,KristopherMaday PA-C,Negative
 relapsed  ,WEGO Health,Negative
 NCCN Guidelines,BluntAdvice,Positive
   Overcoming,Educancer,Positive
 safety analysis,VJHemOnc,Positive
 birds,Concessionary L.L,Positive
 fence,Concessionary L.L,Negative
 farmer,Concessionary L.L,Negative
 rifle,Concessionary L.L,Negative
 New AntiCD,Oncology Tube,Negative
 Interviewing,VJHemOnc,Negative
 Dr Michael va Gelder,VJHemOnc,Negative
 NODSCID ILRŒ≥null mouse xenograft model,IL7Papers,Positive
 Regulatory network reconstruction,LiteratureFeed,Positive
 Regulatory network reconstruction,BioNetPapers,Positive
 Regulatory network reconstruction,BioGPS,Positive
 Regulatory network reconstruction,Biocomputing,Positive
 Best Frontline Regimen,Oncology Tube,Negative
 Patient Aged,Oncology Tube,Negative
 Unanswered Questions,Dana-Farber,Positive
 Expert Advice,Oncology Tube,Negative
 Expert Advice,Patient Power,Negative
 Experience,Patient Power,Negative
 Medical Insurance Billing amp Doctor Office Visits,Patient Power,Negative
 Away Tumors,LabRoots,Positive
 Chronic Lymphocytic Leukemia Market Analysis,BizPR,Negative
 Share Study,BizPR,Negative
 ‚Äì Market Reports Center,BizPR,Negative
 HELIOS trial CAR Tcell therapy amp CLLIPI score,VJHemOnc,Negative
 Venetoclax ¬†  approvalChronic lymphocytic   remissionNo effects,Mar√≠a J. D√≠az Candamio,Positive
 RESONATE Trial Discussion,Health Adviser,Positive
 TKIintolerant patients,CancerTherapyAdvisor,Negative
 amp fellow w   BCL inhibitors,MD Anderson Leukemia,Negative
 BCell Receptor Inhibitors Old,MD Anderson Leukemia,Negative
 Microenvironment,MD Anderson Leukemia,Positive
 Dr Rossi,MD Anderson Leukemia,Negative
 presents summary,MD Anderson Leukemia,Negative
 Dr Wierda    Section Chief,MD Anderson Leukemia,Negative
 monocytemacrophage population,MD Anderson Library,Negative
 allogeneic conditioning,Francesco Turturro,Negative
 tcoKaABzQwEj,Francesco Turturro,Negative
 Dead,Oncology Board,Negative
 Dead,Oncology Tube,Negative
 Cheson Highlights Choices,Margaret Walker,Negative
 ROSinduced p,Cancer Papers,Negative
   Chronic lymphocytic,Sumit Middha,Positive
 Hexa Reports,New Jersey Headlines,Positive
 Hexa Reports,Shillong Herald,Positive
 Hexa Reports,ABNewswire,Positive
 Javier PinillaIbarz MD,LLS of South Florida,Positive
    Arzerra,"Anne Villeneuve-Magness, PhD",Positive
 th indication,"Anne Villeneuve-Magness, PhD",Positive
 FC,"Anne Villeneuve-Magness, PhD",Positive
 FC,Khurram Nawaz,Positive
 collb,"chadi nabhan MD, MBA, FACP",Negative
 w    data,"chadi nabhan MD, MBA, FACP",Negative
 Robert Oblak,AdvocatesIndependent,Positive
 recurrence,AdvocatesIndependent,Positive
 Autoerotische Abenteuer von BZellKlonen,GnomeIncorp,Positive
 Global Chronic Lymphocytic Leukemia CLL Market guidelines,Andre Heath,Positive
    Resource page,John Shaw,Positive
 CLL Canada,John Shaw,Positive
   roller coaster,Patient Power,Negative
 Maintenance therapy,HemOnc Today,Negative
   ABBV FDA End date PDUFA sNDA st Review HELIOS ImbruvicaChronic Lymphocytic LeukemiaCLLSmall Cell Lymphocytic,Michael Raines,Positive
 Hoy mi nariz sufrio,ü§òAnyii Vegaü§ò,Positive
 te odio,ü§òAnyii Vegaü§ò,Positive
 anticancer agent,Patient Daily,Negative
 VIDEO   drug combinations amp mechanism,VJHemOnc,Negative
 w Zelenetz,VJHemOnc,Negative
 Paul Barr MD Additional ChemoImmunotherapy,Targeted Oncology,Negative
 Javier PinillaIbarz MD PhD Additional ChemoImmunotherapy,Targeted Oncology,Negative
 design safetyefficacy results,AJMC,Negative
 El d√≠a de hoy,Indy Wrestling Chile,Positive
 Esto,Indy Wrestling Chile,Negative
 LuchaHecho,Indy Wrestling Chile,Negative
 Chile,Indy Wrestling Chile,Negative
 protein kinase expression,Cancer Papers,Negative
 protein kinase expression,Autophagy Papers,Positive
 Patient Selection,AJMC-Oncology,Negative
 Patient Selection,AJMC,Negative
 VIDEO Safety analysis,VJHemOnc,Negative
 RESONATE Trial Safety,AJMC,Negative
 Underlying Mutational Processes,CLL-seq,Negative
 Global BCell Chronic Lymphocytic Leukemia,Info Batam,Negative
 Global BCell Chronic Lymphocytic Leukemia,Batam Port,Positive
 Global BCell Chronic Lymphocytic Leukemia,BATAM Kepri,Negative
 AnalysisCompetitive Strategies,Info Batam,Negative
 AnalysisCompetitive Strat,Batam Port,Positive
 AnalysisCompetitive Strat,BATAM Kepri,Negative
 VIDEO William Wierda,VJHemOnc,Negative
   highlights,VJHemOnc,Negative
 Sleep Cycle,Institut Catal√† d'Oncologia,Positive
 Sleep Cycle,Heather Swift Morrison,Negative
 Sleep Cycle,"Terry Cralle, R.N.",Positive
 Sleep Cycle,jonathan r goodman,Positive
 Causal Factor,Institut Catal√† d'Oncologia,Positive
 Causal Factor,Heather Swift Morrison,Negative
 Causal Factor,"Terry Cralle, R.N.",Positive
 Causal Factor,jonathan r goodman,Positive
 Inherited Genetic Variant Increases Risk,AmerAssn Bioanalysts,Positive
 Video Update Dr Andrew Zelenetz,OncologyEducation,Positive
   Global Chronic Lymphocytic Leukemia Market Research,CMLHope,Negative
 stline Chronic Lymphocytic,Elsevier Pharma,Positive
 Fulldose Fludarabine,Elsevier Pharma,Positive
 VIDEO Novel agents,VJHemOnc,Negative
 affordability,VJHemOnc,Negative
 w Emili Montserrat,VJHemOnc,Negative
 Hands,Spud Lovr,Positive
 Wisconsin Scott Walker,Spud Lovr,Positive
 UW,Spud Lovr,Positive
 extended,Oncology Nursing News,Negative
 Hairy Cell Leukemia HCLChronic,Matthews & Associates,Negative
 FDA Approves Ofatumumab,Dr. JOSE VELASQUEZ,Negative
 FDA Approves Ofatumumab,Targeted Oncology,Negative
 FDA Approves Ofatumumab,MORE Health,Positive
 FDA Approves Ofatumumab,The Medical Ed Cons.,Negative
 FDA Approves Ofatumumab,NACDA Program on Aging,Negative
 FDA Approves Ofatumumab,UKiwiS,Negative
 FDA Approves Ofatumumab,CancerTherapyAdvisor,Negative
 Chemo,Dr. JOSE VELASQUEZ,Negative
 Chemo,Matthias Piesche,Positive
 GEN,Bursatil Biotech,Positive
 VIDEO FCR,Oncology Tube,Negative
 Vaccines Dead,GRACE,Negative
 CLL Watch,GRACE,Negative
 BREAKING Arzerra Combination FDA,CURE Magazine,Negative
 Arzerra   combination,HemOnc Today,Negative
 th FDA label,Khurram Nawaz,Positive
 JampJ   Innovation,WEHI (Walter and Eliza Hall Institute),Positive
 Medical Research Prize,WEHI (Walter and Eliza Hall Institute),Positive
 Chronic Lymphocytic Leukemia Ideal,Naji Salim ¬©Ô∏èüá¥üá≤,Positive
 BRIEFGenmab FDA,miguel oliveira,Positive
 BRIEFGenmab FDA,NNY News.ca,Positive
 BRIEFGenmab FDA,Pure Leverage Rep,Negative
 BRIEFGenmab FDA,karin55marin,Negative
 BRIEFGenmab FDA,NYC Social Group,Negative
 BRIEFGenmab FDA,TTC,Positive
 BRIEFGenmab FDA,JP Duvenhage,Negative
 BRIEFGenmab FDA,StartupStudio,Negative
 BRIEFGenmab FDA,URL Shortener,Negative
 BRIEFGenmab FDA,Healthcare Industry,Positive
 BRIEFGenmab FDA,Cedar Consultants,Negative
 BRIEFGenmab FDA,Charlotte Biz Owners,Positive
 BRIEFGenmab FDA,I.Gazette,Negative
 BRIEFGenmab FDA,Hanung Nugroho,Positive
 BRIEFGenmab FDA,mediat XEX business,Positive
 BRIEFGenmab FDA,WorldNews,Positive
 BRIEFGenmab FDA,Michel Francoeur,Positive
 MicroRNAs,CLL-seq,Negative
 MicroRNAs,microRNApapers,Positive
   BRIEFGenmab FDA,Thomas Van Ahn,Negative
 Cell Rep Genetic Predisposition,IUOPA,Negative
 BMF SuperEnhancer Polymorphism,IUOPA,Negative
 BMF SuperEnhancer Polymorphism,Jose F. Ruiz,Positive
 BMF SuperEnhancer Polymorphism,Pilade Cortellazzi,Positive
 BMF SuperEnhancer Polymorphism,epigenetics_papers,Negative
 Beckwith Kyle Novel Immunotherapeutic Strategies,New OhioLINK ETDs,Positive
 Ed,Steve McCabe,Positive
 Pubmed MicroRNAs,epigenetics_papers,Negative
 Aangepast advies,Mednet (was: Medidact),Positive
 afronding risicobeoordeling idelalisib,Mednet (was: Medidact),Positive
 DIFFERENT SPECTRA,Medibooks,Negative
 RECURRENT GENE,Medibooks,Negative
 MUTATIONS,Medibooks,Positive
 SUBSETS,Medibooks,Negative
 MRDneg CR patients,"Raul Cordoba, MD, PhD",Negative
 MRDpos PR,"Raul Cordoba, MD, PhD",Negative
 significantly shorter OS NR v m P,"Raul Cordoba, MD, PhD",Negative
 nodal,"Raul Cordoba, MD, PhD",Negative
 Treatment Focus,FarmaOnco,Negative
 Chronic Lymphocytic Leukemia Advances EDITORIAL,FarmaOnco,Negative
 Pts wChronic Lymphocytic Leukemia amp Small Lymphocytic Lymphoma,The ASCO Post,Negative
 antimetabolite purine analog,PharmaFactz,Negative
 Oncology Tube VIDEO Molecular stratification,Oncology Board,Positive
 NYGC,NY Genome Center,Positive
 VIDEO Molecular stratification,Oncology Tube,Negative
 Symptomatic Hypercalcemia,Cancer Papers,Negative
 amp Dr Jeff Sharman,WEGO Health,Positive
 Chronic Lymphocytic Leukemiacontact     rmatthewscom,Matthews & Associates,Negative
 VIDEO Tumor lysis syndrome,Oncology Tube,Negative
   Agent,Rare Diseases,Negative
 beacon,Ohio State,Positive
 personalized   therapy,VJHemOnc,Negative
 VIDEO New drugs,Oncology Tube,Negative
 Man kan ju undra,LAKEM.,Positive
 varf√∂r dom inte g√∂r,LAKEM.,Positive
 enklare l√∂sning,LAKEM.,Positive
 f√∂r dom,LAKEM.,Positive
 ESCLL EarlyStage Chronic Lymphocytic Leukemia Diseases,Abbreviations.com,Positive
 Interventions,Advances in Therapy,Positive
 Unfit Patients,Advances in Therapy,Positive
   novel PIK delta inhibitor,VJHemOnc,Negative
 AbbVieRoche leukaemia drug,Marco Ricci,Positive
 AbbVieRoche leukaemia drug,pharmaphorum,Negative
 Genetic Predisposition,Jose F. Ruiz,Positive
 Genetic Predisposition,Pilade Cortellazzi,Positive
 SingleAgent CD Immunotherapy,Europe PMC articles,Positive
 FludarabineRefractory Chronic Lymphocytic Leukemia,Europe PMC articles,Positive
 Vera Figueiredo,MDRing,Negative
 SP Fabio Kerbauy,MDRing,Negative
 SP,MDRing,Negative
   Horizons,Margaret Walker,Negative
 Stock Update NASDAQTGTX TG Therapeutics Inc Announces Orphan Drug Designation,Stock Advisor,Positive
 BRIEFTG Therapeutics,karin55marin,Negative
 BRIEFTG Therapeutics,NYC Social Group,Negative
 BRIEFTG Therapeutics,Cedar Consultants,Negative
 CLLIPI Validated,Christopher Steer,Negative
 MDACC Index,Christopher Steer,Negative
 Chronic    TGTX,Biotech2050,Negative
 TGTX Announces Orphan Drug Designation,BioRunUp,Negative
 Efficacy Safety Considerations,AJMC,Negative
 Coverage Decisions,AJMC,Negative
 MDACC index,CancerTherapyAdvisor,Negative
 Patient Cafe,Patient Power,Negative
 Patient Cafe,Patient Empowerment Network,Negative
 Acute Myeloid Leukemia AMLAcute Lymphocytic Leukemia ALLChronic Lymphocytic Leukemia CLL,Matthews & Associates,Negative
 Neat CART cell trick,Prof John,Negative
 CLL   Target TOSO,Prof John,Negative
 added specificity,Prof John,Negative
 Ofatumumab Active,Dr. JOSE VELASQUEZ,Negative
 Ofatumumab Active,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 VIDEO CLL therapy,Oncology Tube,Negative
 venetoclax resistance End,"chadi nabhan MD, MBA, FACP",Negative
   y     PARTICIPANDO   DEL,CONSEJO/PROTECCION,Positive
 √ìN   √ìNDEPROYECTOS PARA,CONSEJO/PROTECCION,Positive
 Y,CONSEJO/PROTECCION,Positive
 Y,John Drago,Positive
 EN EL,CONSEJO/PROTECCION,Positive
 Genetic Investigations,OncLive.com,Negative
 Genetic Investigations,Nicole Brudos Ferrara,Positive
 nd session,Patient Empowerment Network,Negative
 Dr Seymour prevention,Chan Cheah,Negative
 Dr Kay Genetic Investigations,CLL Society Inc.,Negative
 gusta quebrarle,John Drago,Positive
 gente como,John Drago,Positive
 delpTP Mutation AlloSCT,"Dr T. Comeau , MD",Negative
 TLADR axis,TumorImmunoPapers,Negative
 Emerging data flu Vax,brett johnson,Positive
 Ibrutinib    cc,brett johnson,Positive
 Influenza Vaccine,Swine Flu News,Positive
 Influenza Vaccine,COPD News,Negative
 Cellintrinsic determinants,Cure Cancer Now,Negative
 mira,TumorImmunoPapers,Negative
 mira,microRNApapers,Negative
 Seasonal Influenza Vaccination,Cancer Papers,Negative
 New POT,varsome,Positive
 stopSunday,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
 Edmonton,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
 long noncoding,Cancer Papers,Negative
 RNA MIAT,Cancer Papers,Negative
 Pts w,JAMA Oncology,Negative
 tcoomJWTCb,Patient Power,Negative
 PCP,Dr. Mahesh Jain,Negative
 PCP,Curatio Technologies,Negative
 PC    Cryoglobulinemia,ImmunePCPapers,Negative
 Pubmed Genetic Predisposition,epigenetics_papers,Negative
   Venetoclax ABTGDC,EMJ Hematology,Negative
   predisposition,"SLIMS by Genohm, A part of Agilent",Positive
   Advocates Network website,Margaret Walker,Negative
 amp registrations,Margaret Walker,Negative
    underlies,varsome,Positive
 risk locus,varsome,Positive
 Est,3'z Company YT,Positive
 Est,Matthew Kauffman,Negative
 PsDm,3'z Company YT,Positive
 VIDEO Lawrence Boise PhD,Winship Cancer Institute of Emory University,Negative
 VIDE   therapy,VJHemOnc,Negative
 bloodproducing cells,EMJ Hematology,Negative
 MOV,Mohammed Hmood,Positive
 Expert Perspectives Chronic Lymphocytic Leukemia,Oncology Tube,Positive
 Best Friends Best Enemy,John Drago,Positive
 presenta su,Indy Wrestling Chile,Negative
 Especial D√≠a del Ni√±o,Indy Wrestling Chile,Negative
 BCL rearrangements,EurekaMag,Negative
 Prognostic Index,Dr. JOSE VELASQUEZ,Negative
 Prognostic Index,NACDA Program on Aging,Negative
 Survival Timetofirsttreatment,Dr. JOSE VELASQUEZ,Negative
 Survival Timetofirsttreatment,NACDA Program on Aging,Negative
 VIDEO Antonio Pagliuca,VJHemOnc,Negative
 VIDEO Lawrence Boise,VJHemOnc,Negative
   Zydelig,EMJ Hematology,Positive
   Zydelig,EMJ Reviews,Positive
 Force,EMJ Hematology,Positive
 Force,EMJ Reviews,Positive
   Pneumocystis jirovecii pneumonia,Francesco Turturro,Negative
 chemofree treatment,John Shaw,Positive
 VIDEO WATCH Prof Peter Hillmen,VJHemOnc,Negative
    BTK Inhibitors,Francesco Turturro,Negative
 tomorow,gova,Positive
 game day,gova,Positive
 Player,Sonja,Positive
 Lamentablemente el Subcampe√≥n Mundial Individual Manrique Larduet,Estelar Gimnasia,Negative
 el Tobillo,Estelar Gimnasia,Negative
 Maravilloso el Gimnasta Japon√©s,Estelar Gimnasia,Negative
 cerrando con una,Estelar Gimnasia,Negative
 nota de   en Barra Fija,Estelar Gimnasia,Negative
 Aqu√≠ se van,Estelar Gimnasia,Negative
 BRONCE Individual,Estelar Gimnasia,Negative
 Ryohei Kato,Estelar Gimnasia,Negative
 cae de Barra Fija,Estelar Gimnasia,Negative
 en su,Estelar Gimnasia,Negative
 Resultados ta RondaVerniaiev   Uchimura   Whitlock,Estela de la Torre OLY üá≤üáΩ,Negative
 Resultados ta RondaVerniaiev   Uchimura   Whitlock,Estelar Gimnasia,Negative
 Belyavskiy,Estela de la Torre OLY üá≤üáΩ,Negative
 Belyavskiy,Estelar Gimnasia,Negative
 Saludos hasta,Estelar Gimnasia,Negative
 todos los que han apoyado,Estelar Gimnasia,Negative
 jirovecii pneumonia,CancerTherapyAdvisor,Negative
 Brillante Final AA Individual,Estela de la Torre OLY üá≤üáΩ,Negative
   despu√©s de la tercera ronda,Estela de la Torre OLY üá≤üáΩ,Negative
 Resultados da RondaUchimura,Estela de la Torre OLY üá≤üáΩ,Negative
 Resultados da RondaUchimura,Estelar Gimnasia,Negative
 Whitlock,Estela de la Torre OLY üá≤üáΩ,Negative
 Whitlock,Estelar Gimnasia,Negative
 Vernyayev,Estela de la Torre OLY üá≤üáΩ,Negative
 Vernyayev,Estelar Gimnasia,Negative
 Kato,Estela de la Torre OLY üá≤üáΩ,Positive
 Kato,Estelar Gimnasia,Positive
 Resultados raRondaWhitlock,Estela de la Torre OLY üá≤üáΩ,Negative
 Resultados raRondaWhitlock,Estelar Gimnasia,Negative
 Uchimura,Estela de la Torre OLY üá≤üáΩ,Negative
 Uchimura,Estelar Gimnasia,Negative
 Larduet,Estela de la Torre OLY üá≤üáΩ,Negative
 Larduet,Estelar Gimnasia,Negative
 CIENCIASMEDICASNEWS Chronic Lymphocytic Leukemia Treatment PDQ,Victor Norberto Cerasale Morteo,Negative
 HALORoche MabThera SC,Biotech2050,Negative
 Hoy se,Estelar Gimnasia,Negative
 cabo,Estelar Gimnasia,Negative
 el   de   donde,Estelar Gimnasia,Negative
 ¬° Mucho,Estelar Gimnasia,Negative
 todos,Estelar Gimnasia,Negative
   Clinical Extension Study,Stem Cell News,Negative
 UC Cirmtuzumab,Stem Cell News,Negative
 Chronic Lymphocytic Leukemia Treate,Stem Cell News,Negative
 Int J Cancer Night shift work,IUOPA,Negative
    Video Blog update,Patient Power,Negative
    Participants,Patient Power,Negative
 Spleen Hilar Nodes Chronic Lymphocytic Leukemia,Alyssa Howard,Negative
 Spleen Hilar Nodes Chronic Lymphocytic Leukemia,Denver Greene,Negative
 VIDEO Dr Barrientos,VJHemOnc,Negative
 drug treatment options,VJHemOnc,Negative
 NFŒ∫B activation,TumorImmunoPapers,Negative
 Pubmed NFŒ∫B activation,epigenetics_papers,Negative
 Chronic Lymphocytic Leukemia Combination Treatments,AJMC,Negative
 Changing Therapeutic Landscape,OMICS International,Positive
 Market Overview,vanaja gude,Positive
 Flexibility,AJMC,Negative
 Response Rates w Dr Thompson,Patient Power,Negative
 Pathophysiology Prognostic Factors,AJMC,Negative
 Potential Risks,AJMC,Negative
 Influence Treatment,AJMC,Negative
 strikes,Francesco Turturro,Negative
 tcobkYphpeYU,Francesco Turturro,Negative
 tcowRpDuALL,Francesco Turturro,Negative
 Till Acute Market Reports,Info Batam,Negative
 Telomere status,Cancer Papers,Negative
 premier hematology,Lymphoma Hub,Negative
 Aug   pm,Lymphoma Hub,Negative
 SPORTS,Francisco,Positive
 Nail Effects,Ana Rosa Rubio,Positive
 Nail Effects,Christopher Steer,Negative
 Nail Effects,JAMA Network,Negative
 Nail Effects,JAMA Dermatology,Positive
 Nail Effects,M Jos√© Mart√≠nez Bautista,Positive
 ATTACK,Prof John,Negative
 ENVIRONMENT BTKinhibition,Prof John,Negative
 SDFmediated upregulation,Prof John,Negative
 ibrutinib incidence,Lymphoma Hub,Negative
 Drug combinations,VJHemOnc,Negative
 Ofatumumabbased Consolidation,Dr. JOSE VELASQUEZ,Negative
 Ofatumumabbased Consolidation,NACDA Program on Aging,Positive
 Blood Commentary strikes,Blood Journal,Negative
 ATM mutations,Cancer Papers,Negative
 Ibrutinib IMBRUVICA,Invest World News,Positive
 Ibrutinib IMBRUVICA,Dr. Melody Davis,Negative
 Ibrutinib IMBRUVICA,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 Ibrutinib IMBRUVICA,IntoxicatedTrader,Positive
 Ibrutinib IMBRUVICA,Financial Buzz,Negative
 Ibrutinib IMBRUVICA,Med-Chemist- Researcher & Academician by Choiceü§î,Positive
 Ibrutinib IMBRUVICA,Carrot Recruitment,Positive
 Ibrutinib IMBRUVICA,Diaceutics PLC,Negative
 Ibrutinib IMBRUVICA,Scott Werntz,Positive
 Ibrutinib IMBRUVICA,AFOLABI LUKMAN,Positive
 Ibrutinib IMBRUVICA,World Medical News,Positive
 Ibrutinib IMBRUVICA,VoyagerMed,Positive
 Ibrutinib IMBRUVICA,DatZoom PR,Positive
 Ibrutinib IMBRUVICA,satPRnews,Negative
 Ibrutinib IMBRUVICA,Ez2Trade,Positive
 Ibrutinib IMBRUVICA,Hot Trades,Positive
 Ibrutinib IMBRUVICA,Penny Stocks,Negative
 Ibrutinib IMBRUVICA,Daniel Able,Positive
 Ibrutinib IMBRUVICA,PRN Biotech,Negative
 Ibrutinib IMBRUVICA,Security Stocks,Positive
 Ibrutinib IMBRUVICA,Stock Runners,Positive
 Ibrutinib IMBRUVICA,Penny Stock Irish,Negative
 ProgressionFree,Invest World News,Negative
 ProgressionFree,Mohammed Saied Faraj,Positive
 Versus,Invest World News,Negative
 Versus,Biotech2050,Negative
 TreatmentNaive Chronic Lymphocytic Leukemia Patients,Invest World News,Negative
 TreatmentNaive Chronic Lymphocytic Leukemia Patients,Dr. Melody Davis,Negative
 TreatmentNaive Chronic Lymphocytic Leukemia Patients,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 TreatmentNaive Chronic Lymphocytic Leukemia Patients,Financial Buzz,Negative
 TreatmentNaive Chronic Lymphocytic Leukemia Patients,DrugGenius,Negative
 TreatmentNaive Chronic Lymphocytic Leukemia Patients,Scott Werntz,Positive
 TreatmentNaive Chronic Lymphocytic Leukemia Patients,Rachel Smith,Positive
 RESO,Invest World News,Negative
    Understanding ultra highrisk,EMJ Hematology,Positive
    Understanding ultra highrisk,EMJ Rheumatology,Positive
 Blood Commentary IL,Blood Journal,Negative
 drug affordability,VJHemOnc,Negative
 BCell Chronic Lymphocyt,Shrikant Mandlik,Positive
 surface IgM expression,Blood Journal,Negative
 surface IgM expression,"Raul Cordoba, MD, PhD",Negative
 surface IgM expression,@sehh_es,Negative
 surface IgM expression,ASH,Negative
 surface IgM expression,Lymphoma Hub,Negative
 Cytogenetic Findings,TerkkoLib,Positive
 Bcell Chronic Lymphocytic Leukemia Second IWCCLL,TerkkoLib,Positive
 Compilat,TerkkoLib,Positive
 Onclive,CancerWallonia,Positive
   Chlorodeoxyadenosine treatment,EurekaMag,Negative
 CLL Challenge,Medscape Education,Negative
 Regulatory B lymphocyte functions,TumorImmunoPapers,Negative
 Regulatory B lymphocyte functions,Cancer Papers,Negative
 BCell malignancies,Lymphoma Hub,Negative
 CLL MCL WM FL,Lymphoma Hub,Negative
 treatment advice,VJHemOnc,Negative
 Extracellular vesicles,Blood Journal,Negative
 Extracellular vesicles,microRNApapers,Negative
 Extracellular vesicles,TumorImmunoPapers,Negative
 alter CD Tcell,Blood Journal,Negative
 relapsed   New,WEGO Health,Negative
 relapsed   New,Senior Care Corner,Negative
 relapsed   New,Mighty #WearAMask Casey ‚òÄÔ∏è,Negative
 New Health Hashtag,Symplur Hashtags,Positive
   menu,Rocksteadyjaboca,Positive
 APR,Lymphoma Hub,Negative
 deletion,Lymphoma Hub,Negative
 p shows,Lymphoma Hub,Negative
 Chief executive,DirectorsTalk,Positive
 Mark Scott,DirectorsTalk,Positive
 Cello Group Plc LON,DirectorsTalk,Positive
 Expressions,James Porreca,Positive
 Interest,James Porreca,Negative
 idelalisibassociated hepatotoxicity,ASH Clinical News,Negative
 film verschenen,Mednet (was: Medidact),Positive
 chronische lymfatische,Mednet (was: Medidact),Positive
 Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia,Health&Wealth,Positive
 Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia,M Usman Javed,Positive
 Histologic transformation,"Dr T. Comeau , MD",Negative
 Dat Voyager Canoe Doe,Jimmy,Positive
 OncCentral treatment landscape,Oncology Board,Negative
 Blood Commentary Synergy karyotypes,Blood Journal,Negative
 Vicki Morrison Assessment,Lymphomation.org,Negative
 Fitness Function,Lymphomation.org,Negative
 QOL Essential,Lymphomation.org,Negative
 KRAS,Blood Journal,Negative
 New header,Keanu,Positive
 Brutons tyrosine kinase inhibitors,"Dr T. Comeau , MD",Negative
 Brutons tyrosine kinase inhibitors,Cancer Papers,Negative
 Synergy karyotypes,Francesco Turturro,Negative
 tcoPCDgmUYq,Francesco Turturro,Negative
 Great news Health Canada Approves IMBRUVICA,CLL Society Inc.,Negative
 PublicationClonal evolution,NY Genome Center,Negative
 timeI,Matthew Kauffman,Negative
 EMAs PRAC,ESMO - Eur. Oncology,Negative
 RHHBY    filing,Biotech2050,Negative
 outcome differences,"chadi nabhan MD, MBA, FACP",Negative
 Dr Estrov,Patient Power,Positive
 w Dr Brown,Patient Power,Negative
 JNJ Health Canada,$Stocknewsalerts,Negative
 Chronic Lymphocytic LeukemiaFrom,$Stocknewsalerts,Positive
 Susan OBrien MD,AJMC-Oncology,Negative
 Susan OBrien MD,The Leukemia & Lymphoma Society,Positive
 Susan OBrien MD,Light The Night NCA,Positive
 Susan OBrien MD,Light The Night,Positive
 BRIEFJanssen,Paul Devereaux,Positive
 BRIEFJanssen,Pure Leverage Rep,Negative
 BRIEFJanssen,Davalyn Corporation,Positive
 BRIEFJanssen,URL Shortener,Positive
 BRIEFJanssen,NYC Social Group,Negative
 BRIEFJanssen,Mca Represenative,Positive
 BRIEFJanssen,Cedar Consultants,Negative
 BRIEFJanssen,indofx,Positive
 BRIEFJanssen,I.Gazette,Negative
 BRIEFJanssen,Today's Deals,Positive
 BRIEFJanssen,OyoBoi,Negative
   BRIEFJanssen,Thomas Van Ahn,Negative
 Dr Brad Kahl,PeerView,Negative
 bcl inhibition,Carmine DeLuca,Negative
 morbidity,PeerView,Negative
 bcr inhibitors,Carmine DeLuca,Negative
 Dr James Armitage,PeerView,Negative
 snapshot,PeerView,Negative
 biologic rationale,Carmine DeLuca,Negative
 Dr Armitage,Carmine DeLuca,Negative
 Dx,Patient Empowerment Network,Negative
 wDr Nicole Lamanna,Patient Empowerment Network,Negative
 amp Tina Sapienza,Patient Empowerment Network,Negative
 Join industry experts,ASH,Negative
 ASH webinar,ASH,Negative
    Impressive Phase III results,EMJ Hematology,Positive
    Impressive Phase III results,EMJ Rheumatology,Positive
    Impressive Phase III results,EMJ Oncology,Negative
 Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review,Swapnil Devale,Negative
 mrr pvt Ltd,Swapnil Devale,Positive
 Ethical Approval,B3C newswire,Positive
 Anticancer Effect,B3C newswire,Positive
 Depletion,B3C newswire,Positive
 que comience,#LeoWeichafe,Positive
 White Dinner Cruise,everstage.de,Positive
 Technikcheck thetowerhotel,everstage.de,Positive
 Rituximab Shows Activity,Dr. JOSE VELASQUEZ,Negative
 Chronic Lymphocytic Leukemia July,"Mike Thompson, MD, PhD, FASCO",Negative
 Night shift work,Cancer Papers,Negative
 Night shift work,Stigmabase | ES,Positive
 guest blogger Eliot,Patient Power,Negative
 W Dr Lamanna,Patient Power,Negative
 Kll i√ßin yeni evreleme,mehmet ali u√ßar,Positive
 Bactrim prophylaxis,Roberto C.  Montoya,Negative
 w Andrew Zelenetz,VJHemOnc,Negative
 Patienten mit √§mie wissen √ºren f√ºr,Roche Deutschland,Negative
 Therapie,Roche Deutschland,Negative
 Rien nest √©ternelle,Sadoudounn,Positive
 Retiens,Sadoudounn,Positive
 ta respiration,Sadoudounn,Positive
 seconde,Sadoudounn,Positive
 vie,Sadoudounn,Positive
 te para√Ætra moins longue,Sadoudounn,Positive
 cest,Sadoudounn,Positive
 Distinct Clones,ImmunePCPapers,Negative
 Latest   Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H,SPI News,Negative
 Global China Chronic Lymphocytic Leukemia Treatment Market Outlook Growth Industry,BizPR,Negative
 Global China Chronic Lymphocytic Leukemia Treatment Market Outlook Growth Industry,pressreleasesbrasil,Positive
 Global China Chronic Lymphocytic Leukemia Treatment Market Outlook Growth Industry Trends,pressreleasesbrasil,Positive
 Global Chronic Lymphocytic Leukemia Treatment Industry Report,pressreleasesbrasil,Positive
 advance,PeerView,Negative
 Dr Ranjana Advani,Clin Adv Hem Onc,Negative
 Dr Joshua Brody,The Levy Library at Icahn School of Medicine,Positive
 FDA treatment,LifeCare Medicines,Negative
 Peel Hunt,MarketBeat,Negative
 Peel Hunt,Broker Ratings,Negative
 Peel Hunt,US Banking News,Negative
 Chronic Lymphocytic Leukemia symptoms‚Ä¢ Lymphadenopathy‚Ä¢ Spleen,Doctors*Overseas,Negative
 enlargement‚Ä¢ Infection,Doctors*Overseas,Negative
 enlargement‚Ä¢ Infection,Virtute_USMLE,Negative
 Perspectives,Oncology.TV,Negative
 Chronic    Treatment,Jenn Joy,Positive
 Newly Diagnosed Recurrent Chronic Lymphocytic Leukemia,CancerConnect,Negative
 Newly Diagnosed Recurrent Chronic Lymphocytic Leukemia,Focus on Cancer,Negative
 conversation wyour doctor,Patient Empowerment Network,Negative
 Global Chronic Lymphocytic Leukemia Market Size Share Analysis,BizDirect,Positive
 BCell Chronic Lymphocytic Leukemia Industry,BluntAdvice,Positive
 BCell Chronic Lymphocytic Leukemia Industry,Acute Market Reports,Positive
 BCell Chronic Lymphocytic Leukemia Industry,BizDirect,Positive
 Central Little,The Hope of the Hillside,Positive
 rd Place,The Hope of the Hillside,Positive
 Lymphoma Hairy Cell Leukemia,Matthews & Associates,Positive
 Leukemia contact,Matthews & Associates,Positive
 Bruno SilvaSantos Lab,iMM,Positive
 Delta,iMM,Positive
 ContMultiple Myeloma,Matthews & Associates,Negative
 MMHairy Cell Leukemia HCLChronic Lymphocytic Leukemia,Matthews & Associates,Negative
   Cortisol catabolism,EurekaMag,Negative
     Therapeutics Market,Radiant Insights,Positive
 Unmet,Lymphomation.org,Negative
 Open Studies,Lymphomation.org,Negative
 MR,"chadi nabhan MD, MBA, FACP",Negative
 myth,"chadi nabhan MD, MBA, FACP",Negative
 sharing,iwCLL,Negative
   abstracts Submission deadline,Hematology Board,Positive
 Differential Expressions,Cancer Papers,Negative
 p pR hRRM,Cancer Papers,Negative
 PBR,Cancer Papers,Negative
   Research,Cancer News,Positive
 SecondLine Treatment,Gendron Recherche,Negative
 SecondLine Treatment,Cancer Daily,Negative
 SecondLine Treatment,Targeted Oncology,Negative
 Treatment Barriers,PeerView,Negative
 Innovative Therapy,PeerView,Negative
 meeting dates,iwCLL,Negative
 Charley,St. Francis Vet Spec,Positive
 Howard Burris,VJHemOnc,Negative
 Breaking,StockGuru,Negative
 Breaking,Patient Power,Negative
 Breaking,Oncology Consortium,Negative
 Breaking,PER,Negative
 Breaking,AJHO,Positive
 Cancer Genetics Inc Receives New York State Approval,StockGuru,Negative
 FocusCLL,StockGuru,Positive
 FocusCLL,Cancer Genetics Inc.,Positive
 FocusCLL,Financial Buzz,Negative
 FocusCLL,John Stock Pro,Positive
 ‚Ñ¢ Unique NGS Panel,StockGuru,Negative
 Crunch Dig Scoop Ducklings,Ducklings Class,Positive
     skills,Ducklings Class,Positive
 mornings construction activity,Ducklings Class,Positive
   Dr LaVerne,Patient Power,Negative
 Hats,ValueBase,Positive
 Waldenstr√∂ms macroglobulinaemia,ValueBase,Positive
 far   months,Roberto C.  Montoya,Negative
 Treatment outcomes,VJHemOnc,Negative
 press brief,VJHemOnc,Negative
 J Jones,VJHemOnc,Negative
 w Dr Eichhorst,VJHemOnc,Negative
 w B Eichhorst,VJHemOnc,Negative
 nonHodgkin Lymphoma Hairy Cell Leukemia,Matthews & Associates,Negative
 Goodbye Lake Louise,Andre Blanchet,Positive
 problemschallenges,RCCG | TOD Youths,Positive
 sing praises,RCCG | TOD Youths,Positive
 Rituximab maintenance therapy,CancerTherapyAdvisor,Negative
 pretreated CLL,CancerTherapyAdvisor,Negative
 Pretreated CLL,NACDA Program on Aging,Negative
 Jennifer Abraham,Patient Power,Negative
 Sails,Patient Power,Negative
   tcoAdShgfDkD,Patient Power,Negative
 epidemiology diagnosis management treatment,Medthority,Positive
   videos,APSHO,Negative
 fulllength presentations w audience QampA,APSHO,Negative
 Cancer Genetics Inc,Cancer Genetics Inc.,Positive
 Cancer Genetics Inc,Financial Buzz,Negative
 Cancer Genetics Inc,StockGuru,Negative
 Cancer Genetics Inc,John Stock Pro,Positive
 Cancer Genetics Inc,Stuart Manning,Positive
 New York State Approval,Cancer Genetics Inc.,Positive
 New York State Approval,Financial Buzz,Negative
 New York State Approval,StockGuru,Negative
 New York State Approval,John Stock Pro,Positive
 Unique NGS Panel,Cancer Genetics Inc.,Positive
 Unique NGS Panel,Financial Buzz,Negative
 Unique NGS Panel,StockGuru,Negative
 Unique NGS Panel,John Stock Pro,Positive
 CGIX Cancer Genetics,Chill Till,Positive
 New York State approval,Chill Till,Positive
 FocusCLL panel,Chill Till,Positive
 Chronic Lymphocytic Leukemia CLL Moon Shot update,Oncology Tube,Positive
 Jan Guillou,√Öbo Akademi University,Positive
 Hans Backe,√Öbo Akademi University,Positive
 V√§lkommen,√Öbo Akademi University,Positive
 Akademiforum,√Öbo Akademi University,Positive
 Hematology Practice Implications,Roberto C.  Montoya,Negative
 HELIOS Ibrutinib   bendamustine,Roberto C.  Montoya,Negative
 Oncology Research,Patient Power,Negative
 Anna Tramontano U,AlfonsoValencia,Negative
 Business SPIT,Simon Morice,Positive
   New drug,B. Smirnov,Positive
 Libs,B. Smirnov,Positive
 w Dr Zelenetz,Patient Power,Negative
    data,BioPharm Insight,Positive
    data,CancerWallonia,Negative
    ist,Janssen Deutschland,Positive
 Erkrankung bei der sich,Janssen Deutschland,Positive
 Lymphozyten,Janssen Deutschland,Positive
 Menos juntas y m√†s m√†quinas,Poncho Carrillo,Positive
 Francesco Forconi MD,OncLive.com,Negative
 w Dr Michael Keating,Patient Power,Negative
 ABT resistance,Blood Journal,Negative
 chromatin accessibility landscape,Andr√© Rendeiro,Positive
 Deregulation,Krishan Maggon,Negative
 Deregulation,Immune Regulation News,Negative
 Deregulation,Dendritic cells,Positive
 Deregulation,TumorImmunoPapers,Negative
 Deregulation,Cancer Papers,Negative
 SOCS,Krishan Maggon,Negative
 SOCS,Immune Regulation News,Negative
 SOCS,Dendritic cells,Positive
 SOCS,ImmunologyPapers,Negative
 SOCS,TumorImmunoPapers,Negative
 SOCS,Cancer Papers,Negative
 amp future,"chadi nabhan MD, MBA, FACP",Negative
 DC Function,Immune Regulation News,Negative
 Campe√≥n de Madrid,Carlos Llavador,Negative
   Issues Negative Opinion,1stOncology,Negative
 Maintenance Treatment,1stOncology,Negative
     Paints,CancerWallonia,Negative
 Cytochrome P Allele CYPAC Associates wAdverse Outcomes,Denise Genett,Positive
 Chronic Lymphocytic Leukemia Breast ampLung Cancer,Denise Genett,Positive
 symptoms‚Ä¢ Lymphadenopathy‚Ä¢ Spleen,Virtute_USMLE,Negative
 presentationwith,Virtute_USMLE,Negative
 research activities,VJHemOnc,Negative
 Chronic Lymphocytic Leukemia CLL amp Chronic Myelogenous Leukemia CML,INFO Kebutuhan Darah dari Blood4LifeID,Positive
    Chronic Lymphocytic Leukemia,MoreFunz,Negative
 Electromagnetic Fields,MoreFunz,Negative
   page,MoreFunz,Positive
 Ya queda menos Te esperamos este domingo,CLL Esto es Lucha!,Positive
 claim,matthew thomas,Positive
 fame,matthew thomas,Positive
 inspiration,Maureen,Positive
 Kenali Lebih Dekat Chronic Lymphocytic Leukemia,Maureen,Positive
 Technavio Announces,Seductionpros,Positive
 Technavio Announces,COPD News,Negative
 Technavio Announces,EIN Presswire: Merck Newswire,Positive
 Technavio Announces,Business Wire-Health,Negative
 Technavio Announces,dlvr news,Negative
 Vendors,Seductionpros,Positive
 Vendors,COPD News,Negative
 Vendors,EIN Presswire: Merck Newswire,Positive
 Vendors,DrugGenius,Negative
 Vendors,Business Wire-Health,Negative
 Vendors,dlvr news,Negative
   Cancer Moonshot,CMLHope,Negative
 bone marrow Jean Sumner,World Wellness,Positive
 Progettazione partecipata comincia ora il secondo forum,Monti Dauni,Positive
 costruire insieme il futuro dei,Monti Dauni,Positive
 Maintenance rituximab,HemOnc Today,Negative
 Maintenance rituximab,Mary Jo Dales,Positive
 Tg Therapeuticscmn TGTX   TGTX Chronic Lymphocytic Leukemia Market,Stock_Tracker,Positive
 PR Newswi,Stock_Tracker,Positive
 lymphoma conference,PeerView,Negative
   lunch symposium,PeerView,Negative
 Tuesday July,PeerView,Negative
   panel,MedWatch News,Positive
   panel,WCM Lymphoma,Negative
 News Technavio Announces,DrugGenius,Negative
 wnonHodgkin Lymphoma Hairy Cell Leukemia,Matthews & Associates,Positive
 News Chronic Lymphocytic Leukemia Market,Roche,Negative
 News Chronic Lymphocytic Leukemia Market,Johnson & Johnson,Positive
 Ibrutinib substandard dose achieves,Oncology Practice,Positive
 discusses challenges,OncLive.com,Negative
 Europe PMC Article   Europe PMC,Lymphomation.org,Negative
 Paolo Ghia talks,VJHemOnc,Negative
 W   Interview wpatient advocate Jennifer Abraham,Patient Empowerment Network,Negative
 structure amp function,VJHemOnc,Negative
 Francesco Forconi,VJHemOnc,Negative
 labs,Sarah Sunshine,Positive
 consult,Sarah Sunshine,Positive
   Expert Perspectives Chronic Lymphocytic Leukemia,Educancer,Positive
 anniversary cruise,Stormy Pollard,Positive
    Deregulation,ImmunologyPapers,Negative
 International Prognostic Index,The ASCO Post,Negative
 International Prognostic Index,The Lancet Oncology,Negative
 International Prognostic Index,NACDA Program on Aging,Negative
 transaminitis,VJHemOnc,Negative
 w William Wierda,VJHemOnc,Negative
 VIDEO New treatment options,Oncology Consortium,Negative
 VIDEO New treatment options,HemOnc Today,Negative
 Blood Commentary IL IgM,Blood Journal,Negative
 Clinical Predictors,American Association of Pharmaceutical Scientists,Positive
 Clinical Predictors,Grupo PK.gen SEFH,Positive
 Venetoclax PK,American Association of Pharmaceutical Scientists,Positive
 Lymphoma Patients,American Association of Pharmaceutical Scientists,Positive
   poster discussion,Lymphoma Hub,Positive
   poster discussion,Sameer Khanijo,Positive
 PI kinase inhibition,Lymphoma Hub,Negative
 Pics,Lymphoma Hub,Negative
 Education session,Lymphoma Hub,Negative
 surface IgM,Blood Journal,Negative
 Delta T cells,TumorImmunoPapers,Negative
 Delta T cells,TumImmTxpapers,Negative
 Delta T cells,Cure Cancer Now,Negative
 Pics   abstract   ‚Äì results,Lymphoma Hub,Negative
 randomized    SA trial,Lymphoma Hub,Negative
 LIGHT chain touch,Prof John,Negative
 Doctor doctor,the cummunist,Positive
 Gimme,the cummunist,Positive
 Global Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review,Business Wire-Health,Negative
 Allogeneic Transplantation,NACDA Program on Aging,Negative
 presents updates,HemOnc Today,Negative
 w Dr Furman,Patient Power,Positive
 w Dr Sharman,Patient Power,Positive
 Dr Kuruvilla,CARE‚Ñ¢ Education,Negative
    Integration,ImmunologyPapers,Positive
 Idelalisib CLL,Christopher Steer,Negative
 Global Chronic Lymphocytic Leukemia Market Growth,Financial Buzz,Negative
 Global Chronic Lymphocytic Leukemia Market Growth,EIN Presswire: Pharmaceutical Newswire,Negative
 Global Chronic Lymphocytic Leukemia Market Growth,Business Wire-Health,Negative
 Analysis Technologies,Financial Buzz,Negative
 Analysis Technologies,EIN Presswire: Pharmaceutical Newswire,Negative
 Case Study CLL,Oncology.TV,Negative
 Case Study CLL,MD Anderson Leukemia,Negative
   GILD,Biotech2050,Negative
 Puro narcoperros kcastellana monteria,Wilson Mart√≠nez mestra,Positive
 cordoba,Wilson Mart√≠nez mestra,Positive
 Brutons tyrosine kinase,JADPRO,Negative
   Dr La Verne,Patient Power,Negative
   survival story,Patient Power,Negative
 performance,Patient Power,Negative
 performance,Los Lobos,Negative
 FCR firstline,"Raul Cordoba, MD, PhD",Negative
 IGHV MUT,"Raul Cordoba, MD, PhD",Negative
 nodelp,"Raul Cordoba, MD, PhD",Negative
 Alex Smith,HMRN UK,Positive
   Cancer Data amp Outcomes Conference,HMRN UK,Positive
 Rabbitte,Michael O'Dwyer,Positive
 Fianna F√°il,Michael O'Dwyer,Positive
 Longterm remissions,Jesus F Sierra,Positive
 Longterm remissions,IQPC,Positive
 Longterm remissions,Cold Chain Global Forum,Positive
 Longterm remissions,Plexus Ventures,Negative
 LongerTerm Studies,Diaceutics PLC,Negative
 LongerTerm Studies,Financial Buzz,Negative
 Dr Eichhorst,VJHemOnc,Negative
 Dr Eichhorst,Christopher Steer,Negative
 Thought,ant,Positive
 Shanafelt MD,QxMD | Decision Support & Quality Improvement,Positive
 iOS Android,QxMD | Decision Support & Quality Improvement,Positive
 mobile web,QxMD | Decision Support & Quality Improvement,Positive
 Retweeted Genentech Destroy   cells,Abhishek Choudhary (AC),Positive
 anti CD,Cesar,Positive
   Poster Selection   Realworld experience,"Raul Cordoba, MD, PhD",Negative
   Poster Selection,"Raul Cordoba, MD, PhD",Negative
 Alvocidib flavopiridol,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 Acute Lymphoblastic Leukemia,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Positive
 Acute Lymphoblastic Leukemia,microRNApapers,Negative
 Acute Lymphoblastic Leukemia,TumImmTxpapers,Negative
 TGTX Reports,Odi Bruckman,Negative
 Recaps LongTerm Safety Efficacy Data,Odi Bruckman,Negative
 NHLs,Odi Bruckman,Negative
 Global Chronic Lymphocytic Leukemia market,MKT Research Reports,Positive
 Market Segments Size Trend,MKT Research Reports,Positive
   EVALUATION,oncoletter,Negative
 DELETION,oncoletter,Negative
 P CHRONIC LYMPHOCYTIC LEUKEMIA,oncoletter,Negative
 amp NonHodgkin,Grupo PK.gen SEFH,Positive
    amp   data,AbbVie,Negative
 Poster Sessions,AbbVie,Negative
 rnatthewscom,Matthews & Associates,Negative
 neccessary,Patient Power,Negative
 FCR Regimen,Christopher Steer,Negative
 FCR Regimen,Dr. Melody Davis,Negative
 FCR Regimen,CancerTherapyAdvisor,Negative
 FCR Regimen,Scott Werntz,Negative
 Standard Frontline Regimen,Christopher Steer,Negative
 Standard Frontline Regimen,Dr. Melody Davis,Negative
 Dr Ghia Dr Gordon Dr Stilgenbauer,AbbVie,Negative
      Dr Thompson,Patient Power,Negative
   Lyft,SafeRidesNow,Positive
 Packed st meeting,VJHemOnc,Negative
 Phase II trial safety amp efficacy,Lymphoma Hub,Negative
 HOVON,Lymphoma Hub,Negative
 cisplatinbased immunochemotherapy,Lymphoma Hub,Negative
 Lake Park Eastern,Jack Payette,Positive
   Global Chronic Lymphocytic Leukemia therapeutics market,CMLHope,Negative
 Global Chronic Lymphocytic Leukemia Market Trends Size Drivers Strategies,BizPR,Negative
 Special Regulatory Designations,CRO Contract Res.,Negative
 Global Chronic Lymphocytic Leukemia Therapeutic,CRO Contract Res.,Negative
   Tio Sky tu,El Patr√≥n,Positive
 quien,El Patr√≥n,Positive
 le vas Lyon,El Patr√≥n,Positive
   PORFAVOOOR Escojan,El Patr√≥n,Positive
 Teemo,El Patr√≥n,Positive
 Sydney,Los Lobos,Positive
 Los Lobos,Los Lobos,Positive
 Afternoon Session Replay,Patient Power,Negative
   hardly backbone,NYCDoc29,Negative
 approved   indication,NYCDoc29,Negative
 Active Agent,NYCDoc29,Negative
 NextGeneration Agents,Lymphoma Coalition,Negative
 reiterations,Biotech2050,Negative
 price targets,Biotech2050,Negative
 Global     Market Forecast,Swapnil Devale,Negative
 TGTX   Link,Biotech2050,Negative
 yesterdays,Biotech2050,Negative
 IBB,Biotech2050,Negative
 exploits,C_R_Williamson,Positive
 PB   ph,NE Live,Negative
 Dr Fraser   CR MRD ve rates,NE Live,Negative
 contin ibrutinib,NE Live,Negative
 PB    Outcomes,NE Live,Negative
 ORR amp   CR,NE Live,Negative
 RR   pts,NE Live,Negative
 venetoclax mgday analysis,NE Live,Negative
 ph   trial,NE Live,Negative
   CLL IPI,Lymphoma Hub,Negative
 home messages,Lymphoma Hub,Negative
 N Lamana,Lymphoma Hub,Negative
   N Lamana,Lymphoma Hub,Negative
   JC Barrientos,Lymphoma Hub,Negative
 idela   BR,Lymphoma Hub,Negative
   Phase III,Lymphoma Hub,Negative
 RR   Results,Lymphoma Hub,Negative
 IGHV mut tumor burden,Lymphoma Hub,Negative
 JC Barrientos,Lymphoma Hub,Negative
 MTP Initial Therapy,MDRing,Negative
 Robust Body,Financial Buzz,Negative
 Robust Body,IntoxicatedTrader,Negative
 LongerTerm,IntoxicatedTrader,Negative
 FDA Grants Venclexta Venetoclax Accelerated Approval,GPSN,Positive
 HardTo,GPSN,Positive
 EC broadens indication,MDedge Hematology & Oncology,Negative
 RESONATE amp RESONATE trials,"Pharmacyclics, an AbbVie Company",Negative
 Bendamustine amp rituximab,Lymphoma Hub,Negative
 L therapy,Lymphoma Hub,Negative
 CLL LLC,tennessee companies,Positive
 Carmen fan,(((Wendi))),Positive
 New Ibrutinib Combination Regimen,Oncology Tube,Positive
 New Ibrutinib Combination Regimen,Diaceutics PLC,Negative
 New Ibrutinib Combination Regimen,The ASCO Post,Negative
 New Ibrutinib Combination Regimen,Scott Werntz,Negative
 Dr Dartigeas,NE Live,Negative
 yr Rmaint,NE Live,Negative
 abrrev,NE Live,Negative
   OS,Mary Jo Dales,Positive
 QoL advantage,Mary Jo Dales,Positive
   w CD CAR Tcells,Matthias Piesche,Negative
    Americans,"Pharmacyclics, an AbbVie Company",Negative
 FDAapproved treatment,"Pharmacyclics, an AbbVie Company",Negative
 FDA Approves New Drug,John James,Positive
 FDA Approves New Drug,Bhavna Saxena,Positive
 FDA Approves New Drug,Health-News,Positive
 FDA Approves New Drug,muzaffar,Positive
 FDA Approves New Drug,Medical Reel,Negative
 FDA Approves New Drug,YWNH,Positive
 FDA Approves New Drug,MedicinaMX,Positive
 FDA Approves New Drug,Green Inc USA,Positive
 FDA Approves New Drug,C.A.I. Corporation,Positive
 FDA Approves New Drug,MHC,Negative
 FDA Approves New Drug,Hilda Tryon,Positive
 FDA Approves New Drug,Health Information,Positive
 FDA Approves New Drug,Little Bugs Store,Positive
 FDA Approves New Drug,Science.gov,Positive
 FDA Approves New Drug,NaturalMedicines,Positive
 FDA Approves New Drug,Hands on Health,Positive
 FDA Approves New Drug,Eleonor_Morgan,Positive
 FDA Approves New Drug,Welly Wired,Positive
 FDA Approves New Drug,Mahesh Khuman,Positive
 FDA Approves New Drug,Salubrious Diet,Positive
 FDA Approves New Drug,Biblioteca CCBS-UFCG,Negative
 FDA Approves New Drug,Cord Blood News,Negative
 FDA Approves New Drug,henrietta,Positive
 Specific Chromosomal Abnormality,John James,Positive
 Specific Chromosomal Abnormality,Bhavna Saxena,Positive
 Specific Chromosomal Abnormality,YWNH,Positive
 Specific Chromosomal Abnormality,Green Inc USA,Positive
 Specific Chromosomal Abnormality,C.A.I. Corporation,Positive
 Specific Chromosomal Abnormality,MHC,Negative
 Specific Chromosomal Abnormality,Hilda Tryon,Positive
 Specific Chromosomal Abnormality,Science.gov,Positive
 Specific Chromosomal Abnormality,Mahesh Khuman,Positive
 Specific Chromosomal Abnormality,Salubrious Diet,Positive
 Specific Chromosomal Abnormality,Biblioteca CCBS-UFCG,Negative
 Specific Chromosomal Abnormality,Cord Blood News,Negative
 Mission MRD,Morgan Dulfer,Positive
 Mission MRD,Genentech,Negative
 y break,Lymphoma Hub,Negative
 John Pagel,Lymphoma Hub,Negative
   PIK inhibitors,Lymphoma Hub,Negative
   Idelalisib,Lymphoma Hub,Negative
 nd line treatment,Lymphoma Hub,Negative
   Management,Lymphoma Hub,Negative
 home whattodos,M. El Mehdi,Positive
 quality sample size,Bursatil Biotech,Positive
 CDF,European Pharmaceutical Review,Positive
 CDF,Only Medics,Negative
 CDF,Regulatory Jobs,Positive
 randomized trials,Lymphoma Hub,Negative
   Michael Hallek,Lymphoma Hub,Negative
 nd line,Lymphoma Hub,Negative
   st line treatment,Lymphoma Hub,Negative
 home conclusions,M. El Mehdi,Positive
 CMLL logo,El Rey de la Bodegaüá™üá®,Positive
 isopeptidase inhibitor,Cancer Papers,Negative
 ATM activation,Cancer Papers,Negative
 High Likelihood,Dr. JOSE VELASQUEZ,Positive
 High Likelihood,Christopher Steer,Negative
 Hepatotoxicity,Dr. JOSE VELASQUEZ,Positive
 Hepatotoxicity,Christopher Steer,Negative
 Obinutuzumab merrier,Matthias Piesche,Negative
 gen XPO inhibitor,Lymphoma Hub,Negative
 improved efficacy amp,Lymphoma Hub,Negative
 vivo tolerability,Lymphoma Hub,Negative
 KRAS amp POT mutations impact,Lymphoma Hub,Negative
 Clb,Lymphoma Hub,Negative
 Clb,Chan Cheah,Positive
 HALO,Biotech2050,Positive
 European Commission Approves IMBRUVICA,Hematopoiesis News,Negative
 European Commission Approves IMBRUVICA,Dr. Leona Saunders,Positive
 European Commission Approves IMBRUVICA,Financial Buzz,Negative
 European Commission Approves IMBRUVICA,militaryeyed,Positive
 European Commission Approves IMBRUVICA,PRN Biotech,Negative
 European Commission Approves IMBRUVICA,IntoxicatedTrader,Negative
 individuals cell mutations,WCM Lymphoma,Negative
 Janssens   drug,Marco Ricci,Positive
 EU Approves,Drug Discovery & Dev,Positive
 Injectable   Therapy,Drug Discovery & Dev,Positive
 imp data,Chan Cheah,Negative
 Sprouty,Lymphoma Hub,Negative
 novel attenuator,Lymphoma Hub,Negative
 MAPKErk,Lymphoma Hub,Negative
 inclusion,Blood Cancer UK,Negative
 immunotherapy agents,OncLive.com,Negative
 ABBV EC,MAISA,Negative
 firstline treatment option,MAISA,Negative
   Barbara,Patient Power,Negative
    story,Patient Power,Positive
 approval     indication,Fabrizio Bellina,Positive
 seat,Team Intake.Me,Positive
 seat,Patient Empowerment Network,Negative
 Chronic Lymphocytic Le,Dr. Leona Saunders,Positive
 Delp CLL,Oncology.TV,Negative
 MabTherea,Encore BioMed,Positive
   Gets,Pharmaceutical News,Negative
 Europes Approval,Pharmaceutical News,Negative
 Europes Approval,NACDA Program on Aging,Negative
 Europes Approval,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",Positive
   ABBV,Pharmaceutical News,Positive
 TORK,Prof John,Negative
 TOWN,Prof John,Negative
 FDAapproved medication,Pamela Helton,Positive
 relapsed Chronic Lymphocytic Leukemia,Pamela Helton,Positive
 toxicmoAb,JediPD,Negative
 Chronic Lymphocyt,Financial Buzz,Negative
 EU Commission,Biotech 5,Positive
 ABBV European Commission Approves IMBRUVICA,Luke üî¥‚ö´Ô∏è #MTW,Positive
 FirstLine AbbVie Newsroom,Luke üî¥‚ö´Ô∏è #MTW,Positive
 RHBBY approval,Biotech2050,Negative
 L chemoimmunotherapy,Lymphoma Hub,Negative
 advanced   CLL phase,Lymphoma Hub,Negative
 SageLinQ,info,Positive
 chronic   leukemia,info,Positive
 Article Roches MabTherea,Shawn Franz,Positive
 Con los     y sus dem√°s,Pam Garcia,Positive
 m√°s bonitos del mundo,Pam Garcia,Positive
 InfusionRelated Reactions,A. Vroom - Ten Wolde,Negative
 InfusionRelated Reactions,Cancer Papers,Negative
 Chronic Lymphocytic Leukemia Receiving Obinutuzumab,A. Vroom - Ten Wolde,Negative
 Specific Chromosomal Abnor,GPSN,Positive
 patient Prof Leblond,Janssen Nederland,Positive
 Drs Castro,Patient Power,Negative
 InterferonŒ≥,TumorImmunoPapers,Negative
 InterferonŒ≥,Cancer Papers,Negative
 Kwok M Davies,AtlanticJOMedicine,Negative
 N Agathanggelou et al ATR inhibition,AtlanticJOMedicine,Negative
 RBenda,Florian Slimano,Negative
 Thr,Azmat Kamal,Positive
   billlik divorc,Azmat Kamal,Positive
 proprty vulgar advt breastfedng bt,Azmat Kamal,Positive
 lin,Azmat Kamal,Positive
 Read Article,Blood Journal,Negative
 IGHV status,Blood Journal,Negative
 IGHV status,Francesco Turturro,Negative
 FISH testing,Blood Journal,Negative
 FISH testing,Francesco Turturro,Negative
 Chemo day,Beth Rank,Positive
 aphidicolin,Cancer Papers,Negative
 Reactivation,Cancer Papers,Negative
 Ofatumumab amp lenalidomide,Lymphoma Hub,Negative
 RR   correlation,Lymphoma Hub,Negative
 Dimen Group,9Dimen Group,Positive
 OA,Joey Snella,Positive
 camp,Joey Snella,Positive
   morning replay,Patient Power,Negative
 w Dr Thompson,Patient Power,Positive
 Dicer Gene Expression,microRNApapers,Negative
 Prognostic Factor,microRNApapers,Negative
 Interesting letter,"chadi nabhan MD, MBA, FACP",Negative
 metaanalysis,Lymphoma Hub,Negative
 metaanalysis,Amber B Clemmons,Positive
 ‚¨á Ô∏è Sags,Phil Paige,Positive
 MAN,Phil Paige,Positive
 Quinn,janine‚Äôs reputationüè≥Ô∏è‚Äçüåà,Positive
 tackle season,janine‚Äôs reputationüè≥Ô∏è‚Äçüåà,Positive
 PatientPowered   news w experts,Patient Power,Positive
 Engagement,LRA: New articles,Positive
 Engagement,TumorImmunoPapers,Negative
 Dr Leclair,Patient Power,Negative
   afternoon session replay,Patient Power,Negative
 interview Dr Furman,Nora Sheffield,Negative
 interview Dr Furman,Louise Monteleone,Positive
 interview Dr Furman,Cassi Schmigotzki,Positive
 interview Dr Furman,James C Whitfield,Positive
 interview Dr Furman,Sandy D.,Negative
 interview Dr Furman,International Pain Foundation¬Æ,Positive
 interview Dr Furman,Katie,Positive
 interview Dr Furman,mjohemme,Positive
 interview Dr Furman,Stella Koch,Positive
 interview Dr Furman,Jay Chou,Positive
 interview Dr Furman,Milton Donald,Negative
 interview Dr Furman,Debbie Woodbury,Positive
 interview Dr Furman,Senior Care Corner,Negative
 interview Dr Furman,Susan Rahn,Positive
 interview Dr Furman,Punksmom77,Positive
 interview Dr Furman,Colleen Busch,Positive
 interview Dr Furman,Rhia Steele@ravishingrhia.com,Negative
 interview Dr Furman,Kat,Positive
 interview Dr Furman,CureClick,Positive
 landscape evolution,Nora Sheffield,Negative
 landscape evolution,Louise Monteleone,Positive
 landscape evolution,Cassi Schmigotzki,Positive
 landscape evolution,James C Whitfield,Positive
 landscape evolution,Sandy D.,Negative
 landscape evolution,International Pain Foundation¬Æ,Positive
 landscape evolution,Katie,Positive
 landscape evolution,mjohemme,Positive
 landscape evolution,Stella Koch,Positive
 landscape evolution,Jay Chou,Positive
 landscape evolution,Milton Donald,Negative
 landscape evolution,Debbie Woodbury,Positive
 landscape evolution,Senior Care Corner,Positive
 landscape evolution,Susan Rahn,Positive
 landscape evolution,Punksmom77,Positive
 landscape evolution,Colleen Busch,Positive
 landscape evolution,Rhia Steele@ravishingrhia.com,Negative
 landscape evolution,Kat,Positive
 landscape evolution,CureClick,Positive
 FDA Approves Label Expansion,Eva M Kozlowski|Student Pilot|Oncology Pharmacist,Positive
 Leukemia Drug,Eva M Kozlowski|Student Pilot|Oncology Pharmacist,Positive
 meticulously undertaken study Experts,june Garcia,Positive
 proven cre,june Garcia,Positive
 Chronic Lymphocytic Leukemia Program,JTCancerCenter,Positive
 Dr Weismans,Evan Altman,Positive
 Images,ARRS GoldMiner¬Æ,Negative
 TelomeraseSpecific Adoptive Tcell Therapy,Krishan Maggon,Negative
 TelomeraseSpecific Adoptive Tcell Therapy,TumorImmunoPapers,Negative
 frontline Imbruvica,CURE Magazine,Negative
 hepatitis B reactivation liver test abnormalities,"Raul Cordoba, MD, PhD",Negative
 FDA   Approves New Drug,Paul Kent,Positive
 Specific   Chromosomal Abnormality,Paul Kent,Positive
 Multiple   Myeloma,Matthews & Associates,Negative
 Os gifts,Lisa Marie,Positive
 Colleague,Jo Mason üíô üá™üá∫,Positive
 treatment cessation,Journal of Clinical Pathways,Negative
 Patient Powers,Patient Power,Positive
 Bright Smile Dental,BizDirect,Positive
 Beaverton Oregon,BizDirect,Positive
 Specific Chromosomal,Health-News,Positive
 Specific Chromosomal,Medical Reel,Negative
 Specific Chromosomal,henrietta,Positive
 Specific Chromosomal Abnormality S,muzaffar,Positive
 Specific Chromosomal Abnormality S,Little Bugs Store,Positive
 Specific Chromosomal Abnormality S,NaturalMedicines,Positive
 Specific Chromosomal Abnormality S,Hands on Health,Positive
 Specific Chromosomal Abnormality S,Eleonor_Morgan,Positive
 Medical news,Medical Reel,Positive
 Specific Chromosom,MedicinaMX,Positive
 Specific Chromosomal Ab,Health Information,Positive
 Specific Chromosomal Ab,Welly Wired,Positive
 Health FDA Approves New Drug,8 Pack Abs,Positive
 Specific Chromosomal Abnorm,8 Pack Abs,Positive
 TODAYS CLL webinar,The Leukemia & Lymphoma Society,Negative
 DECLARACI√ìN SENIORS,k√†,Positive
    Interleukin,ImmunologyPapers,Negative
 CDActivated Chronic Lymphocytic Leukemia,ImmunologyPapers,Negative
 CDActivated Chronic Lymphocytic Leukemia,Krishan Maggon,Negative
 Great Senior Project Presentation,WK Anatomy & Health,Positive
 CDActivated Chronic Lymphocytic Leukemia Cells,Biocomputing,Positive
 CDActivated Chronic Lymphocytic Leukemia Cells,ImmunologyPapers,Negative
 CDActivated Chronic Lymphocytic Leukemia Cells,Just Science News,Positive
 moon,andy,Positive
   morning session,Patient Power,Negative
 National Cancer,Margaret_Farrell,Positive
 Inst Venetoclax Venclexta,Margaret_Farrell,Positive
 Vitamin D insufficiency amp prognosis,"Mike Thompson, MD, PhD, FASCO",Positive
 Ûæ≠ª urbano encu√©ntranos,I News Boutique,Positive
 Risk Groups,NACDA Program on Aging,Negative
 AbbVieRoches Venclexta,Marco Ricci,Positive
 AbbVieRoches Venclexta,Andrew McConaghie,Positive
 CD Antibodies,Alpha Diagnostic Int,Positive
 CD Antibodies,Antibody Resource,Positive
 SPRY,Blood Journal,Negative
 BcR,J Immunol,Negative
 SUBSET,J Immunol,Negative
 SUBSET,Medibooks,Negative
 Debate Standard frontline therapy,Clin Adv Hem Onc,Negative
 Annas pep,Rob P,Positive
 CLL amp Habitat,Rob P,Positive
 Humanity,Rob P,Positive
 pathophysiology,Medthority,Positive
 settlement,Ruth Gemmell,Negative
 VAT dispute,Ruth Gemmell,Negative
 Relapsed Refractory Chronic Lymphocytic LeukemiaClinCancerRes,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 Tocilizumab,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 Tocilizumab,Francesco Turturro,Negative
 Tocilizumab,TumorImmunoPapers,Negative
 Tocilizumab,Cure Cancer Now,Negative
 Chronic Lymphocytic LeukemiaClin Cancer Resopen access,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 Altered treatment,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 Altered treatment,Cancer Papers,Negative
 Caspaseb,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 PPAcŒ±,ÂçöÂ£´„Çø„É≠„Éº (HakaseTaro),Negative
 ¬Æ Label,Cancer Stem Cell News,Negative
 ¬Æ Label,Sean McGrath,Positive
 Overall Survival Data,Cancer Stem Cell News,Negative
 Overall Survival Data,Dr. Melody Davis,Negative
 Overall Survival Data,IntoxicatedTrader,Negative
 Overall Survival Data,Financial Buzz,Negative
 FDA Updates Label,CURE Magazine,Negative
 Affirm Efficacy,CURE Magazine,Negative
 Dr John Pagel Focus,CLL Society Inc.,Negative
 QampA Session,Patient Power,Negative
    effects,Patient Power,Negative
 convo,Patient Power,Negative
 Larry amp Jennifer,Patient Power,Negative
 talk monitoring,Patient Power,Negative
 planning,Patient Power,Negative
 starting,Patient Empowerment Network,Negative
   minutes tune,Patient Power,Negative
 notes,Patient Power,Negative
 Dit,Cindy Beelen,Positive
 Patients Families,Debbie Woodbury,Positive
 Care Partners,Debbie Woodbury,Positive
 ‚Ñ¢ venetoclax,vincenzo abruscato,Positive
 FDA test,vincenzo abruscato,Positive
   board,Mo Obaid,Positive
 WeekInReview w experts,Patient Power,Negative
 tomorrows event,Patient Power,Negative
 ny kontraktGleder mitt hjerte,PT-WOO,Positive
 Daar ben,Jacquelien (wat een toestand moidje),Negative
 controle,Jacquelien (wat een toestand moidje),Positive
 ik mocht weer,Jacquelien (wat een toestand moidje),Negative
 op de weegschaal,Jacquelien (wat een toestand moidje),Negative
   Collection,Patient Power,Negative
 relapsedrRefractory Delp CLL,CancerTherapyAdvisor,Negative
 Ik tel de dagen niet maar morgen,Jacquelien (wat een toestand moidje),Negative
 uitslagen,Jacquelien (wat een toestand moidje),Negative
 Ma√±ana dura de desplazamientos √öltimo d√≠a de desplazamientos,Carlos Llavador,Negative
 antes,Carlos Llavador,Negative
 L treatment,Lymphoma Hub,Negative
 SMPs amp Richter transformation,Lymphoma Hub,Negative
 Chelsea fans,Chelsea Rooter,Positive
 Chelsea fans,MOHAMED SHOUKRY,Positive
 tribute,Chelsea Rooter,Positive
 tribute,MOHAMED SHOUKRY,Positive
 Anfield,Chelsea Rooter,Positive
     events,Patient Power,Negative
 Sat Sun Sign,Patient Power,Negative
 Study Confirms Activity,Dr. JOSE VELASQUEZ,Negative
 RelapsedRefractory Delp CLL,Dr. JOSE VELASQUEZ,Negative
 Anfieldÿ¨ŸÖŸáŸàÿ± ÿ™ÿ¥ŸäŸÑÿ≥Ÿâ,MOHAMED SHOUKRY,Positive
 ÿßŸÑÿπÿ∏ŸäŸÖ,MOHAMED SHOUKRY,Positive
 ÿ®Ÿäÿ≠ÿßÿ±ÿ®,MOHAMED SHOUKRY,Positive
 FB guy,H_Ram,Positive
 cancer fundraiser,H_Ram,Positive
   UPDATED,DAVA Oncology,Negative
 Compass,DAVA Oncology,Positive
 New therapies,RGA,Positive
 Chief executive Mark Scott Cello Group,DirectorsTalk,Positive
 ‚Äú vibrant ‚Äù,DirectorsTalk,Positive
 Nextgeneration IgVH sequencing,Lymphoma Hub,Negative
 Estamos trabajando para,John Drago,Positive
 un mejor servicio,John Drago,Positive
    info,Patient Power,Negative
    difference,Patient Power,Negative
   Fludarabine,EurekaMag,Negative
 fludaribine,EurekaMag,Negative
 epirubicin,EurekaMag,Negative
 Label,1stOncology,Negative
 Drug News FDA,Medthority,Negative
 label update,Medthority,Negative
 label update,"Pharmacyclics, an AbbVie Company",Negative
   strings,Ruth Gemmell,Negative
 Cellos,Ruth Gemmell,Negative
 Chronic Lymphocytic Leukemia LP,LR Perrett,Positive
 ibrutinib Label,Dr. Melody Davis,Negative
 ibrutinib Label,IntoxicatedTrader,Negative
 ibrutinib Label,Financial Buzz,Negative
 Weill Cornell,Cassi Schmigotzki,Negative
 Jeffrey Jones MD MPH,The ASCO Post,Positive
 Optimizing Treatment,The ASCO Post,Negative
 OS Data,Sean McGrath,Positive
 HDLlike,STEMCELL Tech,Positive
 OS data,"Pharmacyclics, an AbbVie Company",Negative
 personalised therapy,VJHemOnc,Negative
 expansion,"Pharmacyclics, an AbbVie Company",Negative
 Europe Chronic Lymphocytic Leukemia Market Report,Business Wire-Health,Negative
 Technologies amp,Business Wire-Health,Negative
 Dr Ana Schuh Advances,VJHemOnc,Negative
 Fairview Summer Menu Quebec,Andre Blanchet,Positive
 Foie Gras,Andre Blanchet,Positive
 Fairview Summer   MenuBeet Caprese,Andre Blanchet,Positive
 Campe√≥n,Carlos Llavador,Negative
 Campe√≥n,Malchofa,Positive
 el √∫ltimo torneo nacional de Mejorada del Campo Madrid Buen,Carlos Llavador,Negative
 a√±o ganando,Carlos Llavador,Negative
 de los,Carlos Llavador,Negative
 √∫ltimo torneo nacional,Carlos Llavador,Negative
 Mejorada del Campo,Carlos Llavador,Negative
 Furries,FurriesAgainstWords,Positive
 CLL webinar,Light The Night NCA,Positive
 Best CostEffectiveness amp Impact Investment,clinicaltherapeutics,Negative
 Dose Fludarabine,clinicaltherapeutics,Negative
 Emerging Chronic Lymphocytic Leukemia,OncLive.com,Negative
      WilliamWierda,Oncology.TV,Negative
 Idelalisib Rituximab,Oncology Tube,Negative
 blink,Javier Jara,Positive
 Video Emerging Chronic Lymphocytic   Therapies,NACDA Program on Aging,Negative
 MaMa La Verne,Patient Power,Negative
    plan,Patient Power,Negative
 w Dr Hillmen,Patient Power,Negative
 froom,Patient Power,Negative
 w Dr Brian Koffman,Patient Power,Negative
 amp Dr Farooqui,Patient Power,Negative
 th CLL webinar,The Leukemia & Lymphoma Society,Negative
 th CLL webinar,Light The Night,Positive
 CIENCIASMEDICASNEWS Venetoclax,Victor Norberto Cerasale Morteo,Negative
 Nati,Victor Norberto Cerasale Morteo,Positive
 herenciageneticayenfermedad Venetoclax,Victor Norberto Cerasale Morteo,Negative
 CLL Noncoding mutations,Lymphoma Coalition,Negative
 Certified Cancer Care GiverOncoCareGiversProgram,Anil Ahluwalia,Positive
 Ibrutinib dose adherence,HemOnc Today,Negative
   treatment news,Patient Power,Negative
 Global Chronic Lymphocytic Leukemia Market Analysis,Market Cheetah,Positive
 Trends Technologies ampamp,Market Cheetah,Positive
 Bendamustine   Rituximab Effective,Dr. JOSE VELASQUEZ,Negative
 Reallife Study,Dr. JOSE VELASQUEZ,Negative
 w Dr Estrov,Patient Power,Positive
 th event,Patient Power,Negative
 SENIORS COUNTDOWN,k√†,Positive
 yay Influencers,Patient Power,Negative
 Dnmta,Cell Reports,Positive
 Dr Xose Puente,ecancer,Negative
 PatientPowered   news,Patient Power,Positive
 w Dr Wierda,Patient Power,Negative
 Dr Turtle Patient,Fred Hutch,Negative
 NonHodgkin Lymphoma Hairy Cell Leukemia,Matthews & Associates,Negative
 SpecificAdoptive Tcell Therapy,Francesco Turturro,Negative
 Solid Malignancies,Francesco Turturro,Negative
 Janice,Blood Cancer UK,Negative
 Destiny,Chris,Positive
 Targeted Leukemia Rx,University Pharmacy,Positive
 Targeted Leukemia Rx,Chapman Pharmacy,Positive
 Targeted Leukemia Rx,Bella Ward,Positive
 Targeted Leukemia Rx,tristatemedicalgroup,Positive
 Targeted Leukemia Rx,Ruwe Family Pharmacy,Positive
 Targeted Leukemia Rx,Family,Positive
 Targeted Leukemia Rx,Food City RX Marion,Positive
 Targeted Leukemia Rx,Devine's Pharmacy,Positive
 Targeted Leukemia Rx,JOHNSTON DRUG,Positive
 Targeted Leukemia Rx,Save Rite Pharmacy,Positive
 Targeted Leukemia Rx,The Medicine Shoppe,Positive
 Targeted Leukemia Rx,HealthRidge Pharmacy,Positive
 Targeted Leukemia Rx,Med Fast Pharmacy,Positive
 Targeted Leukemia Rx,Hopkinton Drug,Positive
 Targeted Leukemia Rx,Medicine To Go,Positive
 Targeted Leukemia Rx,"Medicine Mart Lex,SC",Positive
 Targeted Leukemia Rx,MPS of WNY,Positive
 Targeted Leukemia Rx,Marcrom's Pharmacy,Positive
 Targeted Leukemia Rx,Professional Pharmac,Positive
 Targeted Leukemia Rx,Lula Pharmacy,Positive
 Targeted Leukemia Rx,Tug Valley Pharmacy,Positive
 Targeted Leukemia Rx,Vail Valley Pharmacy,Positive
 Targeted Leukemia Rx,Mt. View Pharmacy,Positive
 Targeted Leukemia Rx,Buena Vista Drug,Positive
 Targeted Leukemia Rx,ValleyDrug&Variety,Positive
 Targeted Leukemia Rx,Magnolia Pharmacy,Positive
 Targeted Leukemia Rx,Norland Ave Pharmacy,Positive
 Targeted Leukemia Rx,La Botica Pharmacy,Positive
 Targeted Leukemia Rx,Fox Drug of Torrance,Positive
 Targeted Leukemia Rx,Rivergate Pharmacy,Positive
 Targeted Leukemia Rx,Countryside Pharmacy,Positive
 Targeted Leukemia Rx,Greenwood Drug,Positive
 Targeted Leukemia Rx,Woodsprings Pharmacy,Positive
 Targeted Leukemia Rx,Horseshoe Health & M,Positive
 Targeted Leukemia Rx,Cobb's Pharmacy,Positive
 Targeted Leukemia Rx,Eagle Highland Pharm,Positive
 Targeted Leukemia Rx,Phillips Pharmacy,Positive
 Targeted Leukemia Rx,PRINCE ADEKOYA,Positive
 Targeted Leukemia Rx,Health Park Pharmacy,Positive
 Targeted Leukemia Rx,Milltown Pharmacy,Positive
 Targeted Leukemia Rx,Jackson-Pace Pharm,Positive
 Targeted Leukemia Rx,Mat's Pharmacy,Positive
 Targeted Leukemia Rx,Garcia Pharmacy,Positive
 Targeted Leukemia Rx,Dr. Aziz Pharmacy,Positive
 Targeted Leukemia Rx,New Clinton Pharmacy,Positive
 Targeted Leukemia Rx,Granby Pharmacy,Positive
 Targeted Leukemia Rx,Schaefer Drugs,Positive
 Targeted Leukemia Rx,Powers Healthmart,Positive
 Targeted Leukemia Rx,Bay Street Pharmacy,Positive
 Targeted Leukemia Rx,Friendship Pharmacy,Positive
 Targeted Leukemia Rx,HocksPharmacy,Positive
 Targeted Leukemia Rx,Crescent Pharmacy,Positive
 Targeted Leukemia Rx,Muniz Pharmacy,Positive
 Targeted Leukemia Rx,RogersvilleRx & Soda,Positive
 Targeted Leukemia Rx,Stilwell Pharmacy,Positive
 Targeted Leukemia Rx,Newpointe Pharmacy,Positive
 Targeted Leukemia Rx,Linton Pharmacy,Positive
 Targeted Leukemia Rx,Morganton Drug,Positive
 Targeted Leukemia Rx,Punxsy HT Pharmacy,Positive
 Targeted Leukemia Rx,Taylor's Drug Store,Positive
 Targeted Leukemia Rx,Paoli Apothecary,Positive
 Targeted Leukemia Rx,Davenport Pharmacy,Positive
 Targeted Leukemia Rx,John Richards,Positive
 Targeted Leukemia Rx,Guilbeau's Pharmacy,Positive
 Targeted Leukemia Rx,Shermanpharmacy,Positive
 Targeted Leukemia Rx,Curtis Pharmacy,Positive
 Targeted Leukemia Rx,Yost Pharmacy Inc,Positive
 Targeted Leukemia Rx,Lyons Drug Store,Positive
 Green Light,University Pharmacy,Positive
 Green Light,Chapman Pharmacy,Positive
 Green Light,Bella Ward,Positive
 Green Light,tristatemedicalgroup,Positive
 Green Light,Ruwe Family Pharmacy,Positive
 Green Light,Family,Positive
 Green Light,Food City RX Marion,Positive
 Green Light,Devine's Pharmacy,Positive
 Green Light,JOHNSTON DRUG,Positive
 Green Light,Save Rite Pharmacy,Positive
 Green Light,The Medicine Shoppe,Positive
 Green Light,HealthRidge Pharmacy,Positive
 Green Light,Med Fast Pharmacy,Positive
 Green Light,Hopkinton Drug,Positive
 Green Light,Medicine To Go,Positive
 Green Light,"Medicine Mart Lex,SC",Positive
 Green Light,MPS of WNY,Positive
 Green Light,Marcrom's Pharmacy,Positive
 Green Light,Professional Pharmac,Positive
 Green Light,Lula Pharmacy,Positive
 Green Light,Tug Valley Pharmacy,Positive
 Green Light,Vail Valley Pharmacy,Positive
 Green Light,Mt. View Pharmacy,Positive
 Green Light,Buena Vista Drug,Positive
 Green Light,ValleyDrug&Variety,Positive
 Green Light,Magnolia Pharmacy,Positive
 Green Light,Norland Ave Pharmacy,Positive
 Green Light,La Botica Pharmacy,Positive
 Green Light,Fox Drug of Torrance,Positive
 Green Light,Rivergate Pharmacy,Positive
 Green Light,Countryside Pharmacy,Positive
 Green Light,Greenwood Drug,Positive
 Green Light,Woodsprings Pharmacy,Positive
 Green Light,Horseshoe Health & M,Positive
 Green Light,Cobb's Pharmacy,Positive
 Green Light,Eagle Highland Pharm,Positive
 Green Light,Phillips Pharmacy,Positive
 Green Light,PRINCE ADEKOYA,Positive
 Green Light,Health Park Pharmacy,Positive
 Green Light,Milltown Pharmacy,Positive
 Green Light,Jackson-Pace Pharm,Positive
 Green Light,Mat's Pharmacy,Positive
 Green Light,Garcia Pharmacy,Positive
 Green Light,Dr. Aziz Pharmacy,Positive
 Green Light,New Clinton Pharmacy,Positive
 Green Light,Granby Pharmacy,Positive
 Green Light,Schaefer Drugs,Positive
 Green Light,Powers Healthmart,Positive
 Green Light,Bay Street Pharmacy,Positive
 Green Light,Friendship Pharmacy,Positive
 Green Light,HocksPharmacy,Positive
 Green Light,Crescent Pharmacy,Positive
 Green Light,Muniz Pharmacy,Positive
 Green Light,RogersvilleRx & Soda,Positive
 Green Light,Stilwell Pharmacy,Positive
 Green Light,Newpointe Pharmacy,Positive
 Green Light,Linton Pharmacy,Positive
 Green Light,Morganton Drug,Positive
 Green Light,Punxsy HT Pharmacy,Positive
 Green Light,Taylor's Drug Store,Positive
 Green Light,Paoli Apothecary,Positive
 Green Light,Davenport Pharmacy,Positive
 Green Light,John Richards,Positive
 Green Light,Guilbeau's Pharmacy,Positive
 Green Light,Shermanpharmacy,Positive
 Green Light,Curtis Pharmacy,Positive
 Green Light,Yost Pharmacy Inc,Positive
 Green Light,Lyons Drug Store,Positive
   Papers Prognostic impact,Epigenetics News,Positive
 B Cell Chronic Lymphocytic Leukemia,Dr George Paterakis,Positive
 Mile   Photo Horses,International Pain Foundation¬Æ,Negative
 Brianna Leukemia,International Pain Foundation¬Æ,Negative
 Dr Sharmans,Lymphomation.org,Negative
 Blog Discusses use,Lymphomation.org,Negative
 Venclexta ABT,Lymphomation.org,Negative
 Venclexta ABT,Patient Power,Negative
 Pubmed Prognostic impact,epigenetics_papers,Negative
 Receives,1stOncology,Negative
 Venclexa,Focus on Cancer,Negative
 FirstLine Treatme,Financial Buzz,Negative
 AbbVies Venclexta venetoclax,Ball Ground Pharmacy,Positive
 Dr John Gribben Era,VJHemOnc,Negative
 allogeneic transplantation,VJHemOnc,Negative
 epigenomes,Poetry pays no rent. Cats are the real landlords.,Positive
 BONE MARROW BIOPSY,IJAR,Positive
 IRAQI PEOPLE,IJAR,Positive
 Separating,Roberto C.  Montoya,Negative
    advice,Patient Power,Negative
 CDIL,microRNApapers,Negative
 CDIL,TumorImmunoPapers,Negative
 CDIL,Prof John,Negative
 Multiple Myeloma MM   Hairy Cell Leukemia HCL Chronic Lymphocytic Leukemia CLL      rmatthewscom,Matthews & Associates,Negative
 NEW CLINICAL TRIAL,Rhia Steele@ravishingrhia.com,Positive
 ExtraAdrenal Myelolipoma,Cancer Papers,Negative
 Small Lymphocytic LymphomaChronic Lymphocytic Leukemia Case,Cancer Papers,Negative
 Joan Justice,Marie Ennis-O'Connor,Positive
 FDA Approves Venclexta venetoclax,ŸÉŸàŸÑŸÉÿ¥ÿß || kolkcha,Positive
 FDA Approves Venclexta venetoclax,MedPipeline,Negative
 FDA Approves Venclexta venetoclax,Hlthnews,Negative
 FDA Approves Venclexta venetoclax,Medicine Science,Negative
 FDA Approves Venclexta venetoclax,Jess  Ochieng,Positive
   Drs Wierda amp Ferrajoli,MD Anderson Leukemia,Negative
 √âNERO,CONSEJO/PROTECCION,Positive
 ICYMI Venclexta,Biologics by McKesson,Negative
 EV,Prof John,Negative
 √≠a CLINICAL IMPACT,Medibooks,Negative
 MYD MUTATIONS,Medibooks,Negative
 Venclexta trial,Patient Power,Negative
     w,Patient Power,Negative
 p deletion chromosomal abnormality,Station X,Positive
 Dr Luis Fayad,MDRing,Negative
 Collision Breast Tumor,Cancer Papers,Positive
 MiRNA expression profile,Cancer Papers,Negative
 MiRNA expression profile,microRNApapers,Negative
 hardtotreat type,Lampe & Company,Negative
 hardtotreat type,Rajkumar Gupta Basics of DRA,Positive
 hardtotreat type,Roche,Negative
 chronic Lymphocytic,Lampe & Company,Negative
 PHONEWEB,Cancer Support Community Pasadena,Positive
 Adding,The ASCO Post,Positive
 Adding,Matthias Piesche,Negative
     What¬ís,EMJ Hematology,Negative
 grande,CLLFutbol,Positive
 que,CLLFutbol,Positive
   Chronic Lymphocytic Leukemia CLL Market,SeguidorFinanzas,Positive
 Global API,SeguidorFinanzas,Positive
 Global,Business Wire-Health,Negative
 API Manufacturers,Business Wire-Health,Negative
 Venclexta venetoclax Tablets,BernCarte Pharma,Positive
 New Drug Approvals,BernCarte Pharma,Positive
 New Drug Approvals,Clinical Pharmacy,Negative
 New Drug Approvals,LightTheNightOntario,Positive
 New Drug Approvals,LLSCanada,Negative
 New Drug Approvals,Scott Werntz,Negative
 Salimos,juanchi,Negative
 Chronic Lymphocytic   Treatment Balancing Efficacy Safety amp Cost,EMJ Reviews,Positive
 Chronic Lymphocytic   Treatment Balancing Efficacy Safety amp Cost,EMJ Oncology,Positive
 Kyle Field,Jason McConnell,Positive
 background,Jason McConnell,Positive
 background,Chris Thomson,Negative
 Heads,DC Cancer Action,Positive
 Heads,Coping with Cancer,Negative
 Serum,Cancer Papers,Negative
 Peak Med Ed Case,Peak Medical Editing,Positive
 Chronic Lymphocytic Leukemia w Epigallocatechingallate Treatment,Peak Medical Editing,Positive
 contact,Matthews & Associates,Negative
 Volunteers,Overland Park Now,Negative
 Laura Crowe,Overland Park Now,Positive
 w p deletion,GoFIR,Negative
 w p deletion,ESMO - Eur. Oncology,Negative
 BioSpace Venetoclax,Farmacia Son Espases,Positive
 HIFalpha,AtlanticJOMedicine,Negative
   weekinreview w experts,Patient Power,Negative
 invite,Patient Power,Negative
 sideeffects,VJHemOnc,Negative
 specialty provider,Biologics by McKesson,Negative
 Dr Stephan Stilgenbauer,The ASCO Post,Negative
 Chronic Lymphocytic Leukemia Golden Drug,The ASCO Post,Negative
 Golden Agers,The ASCO Post,Negative
 wonder,SL Baker,Positive
 daughter,Patient Power,Negative
 story amp,Patient Power,Negative
 Ruth,Patient Power,Negative
 Dr Mahoney,Patient Power,Negative
 Opportunity,CADTH,Negative
 Patient Power   members,Andrew Schorr,Negative
 CTS Blog New Chronic Lymphocytic Leukemia Cancer Drug,Clinical Trials,Negative
 Coachella Valley Takeover,Matthew Kauffman,Negative
 Ûæ≠ª,Matthew Kauffman,Negative
 Diamond,Matthew Kauffman,Negative
 Matthews amp Associates Law Firm,Matthews & Associates,Negative
 breakthrough therapy,Dana-Farber,Negative
 breakthrough therapy,Targeted Oncology,Negative
 Xose S Puente,The Snarky Scientist,Positive
 treatment objectives,WCM Lymphoma,Negative
 VenclextaTM venetoclax,dlvr health,Negative
 VenclextaTM venetoclax,Business Wire-Health,Negative
 Patient Powered,Patient Power,Negative
 Waldenstrom,Lymphoma Canada,Negative
 Macroglobulinemia,Lymphoma Canada,Negative
 Chronic Lymphocytic Leukemia Optimizing Treatment,The ASCO Post,Negative
   Pharmacy,Pharmaceutical News,Negative
   DPLO,Pharmaceutical News,Negative
 DPLO,ZoZoTrader,Positive
 haem,Lymphoma Hub,Negative
 DNA instability,Lymphoma Hub,Negative
 net,Kelly Cummings,Positive
 IMMU Immunomedics,Briefing.com,Negative
 Dishevelled proteins,Cancer Papers,Negative
   ¬ø,Violet Melankolie,Positive
 qu√© te dedicas,Violet Melankolie,Positive
 intentar,Violet Melankolie,Positive
 morir,Violet Melankolie,Positive
 mum,Melanie,Positive
 lifeextending drugs,Melanie,Negative
 Clinic Ofatumumab,The ASCO Post,Positive
       New Treatment,AL Pharmacy Brd Atty,Positive
 PatientPowered   weekinreview w experts,Patient Power,Negative
 Venclexta     RT,European Pharmaceutical Review,Negative
 MLO April,MedicalLab,Negative
 LABline PPIs,MedicalLab,Negative
 kidney failure Abbott,MedicalLab,Positive
 Todays MLO LABline PPIs,MedicalLab,Negative
 Open Day,Lifelong Learning,Positive
 High Levels,epigenetics_papers,Negative
 Constitutively Activated STAT Induces Apoptosis,epigenetics_papers,Negative
 Novel Biomarker Proteins,Cancer Papers,Negative
 Chronic Lymphocytic Leukemia Impact,Cancer Papers,Negative
 P deletion,Patient Power,Negative
 amp Richard Stephens,Patient Power,Negative
 Vysis CLL FISH Probe Kit,GenomeWeb Daily News,Positive
 drug Venclexta,GenomeWeb Daily News,Positive
 P   deletion,Roberto C.  Montoya,Negative
 aftermath,6HN Oncology Nurses,Negative
 LLS Welcomes FDA Approval,NACDA Program on Aging,Negative
 LLS Welcomes FDA Approval,Lymphoma News Today,Negative
 Venclexta     PRT,European Pharmaceutical Review,Negative
 Certain Chronic Lymphocytic,Lymphoma News Today,Negative
 stLine Ibrutinib,The ASCO Post,Positive
 balance,VJHemOnc,Negative
 cancer care,VJHemOnc,Negative
 Caspase,Prof John,Negative
 Glada,Helena Heino,Positive
 skolan g√•,Helena Heino,Positive
 DrSusan OBrien,"Raul Cordoba, MD, PhD",Negative
 TGTX   Ibrunitb,T Allen,Positive
   update Change,Liana Gardner,Positive
 Values,Liana Gardner,Positive
 FDA Approves Venclexta Venetoclax,Health & Lifestyle,Positive
 FDA Approves Venclexta Venetoclax,Cancer Blog,Negative
 FDA Approves Venclexta Venetoclax,PGM/Trumbull Labs,Positive
 FDA Approves Venclexta Venetoclax,RFL of Elkton MD,Positive
 FDA Approves Venclexta Venetoclax,Erica,Positive
 Type,Health & Lifestyle,Positive
 Type,Cancer Blog,Negative
 Type,PGM/Trumbull Labs,Positive
 Type,RFL of Elkton MD,Positive
 Type,Erica,Positive
 Type,Sunshine Hospitals,Positive
 Type,Lisa Scott,Positive
 Food Drug Administr,Health & Lifestyle,Positive
 Food Drug Administr,Cancer Blog,Negative
 deletion disease Work,"Francisco Marty, MD",Negative
   nd Plenary,CAPhO,Negative
 speak,Patient Power,Negative
    landscape,Patient Power,Negative
 Pharmacovigilance,OncLive.com,Negative
 Recurrent Hyperkalemia,Pro-CME,Negative
 CSCC,Pro-CME,Negative
 FDA APPROVES NEW DRUG,CFPR,Positive
 CHRONIC LYMPHOCYTICLEUKEMIA,CFPR,Positive
 New   Treatment,Patient Power,Negative
 finder tool,Patient Power,Negative
   Venclexta venetoclax,"Anne Villeneuve-Magness, PhD",Positive
 p deletion st anti BCL,"Anne Villeneuve-Magness, PhD",Positive
 Approves New Pill,"Hayes, Inc",Positive
 News Exclusive Interview,Patient Power,Negative
 venetoclax Approval,Patient Power,Negative
 p del chronic lymphocytic,VJHemOnc,Negative
 Market Insights Epidemiology,Business Wire-Health,Negative
 Market Insights Epidemiology,BusinessWireServices,Negative
 Market Insights Epidemiology,SeguidorFinanzas,Positive
 Market Forecasts,Business Wire-Health,Negative
 Market Forecasts,BusinessWireServices,Negative
 Market Forecasts,SeguidorFinanzas,Positive
 FDA Approves Venclexta Medicine,Realpharmacyx,Positive
   Approves Chronic Lymphocytic   Drug,SpecialtyPTimes,Negative
 st line chemo,XpertDox,Positive
 Venclexta   st BCL Inh,George Papadopoulos,Positive
 RR CLL Patients,George Papadopoulos,Positive
 Global Chronic Lymphocytic Leukemia Market Insights Epidemiology    Research,Business Wire-Health,Negative
 venetoclax BCL inhibitor,Lymphoma Hub,Negative
 RR CLL patients,Lymphoma Hub,Negative
 Roche Reports FDA Grants,1stOncology,Negative
 venetoclax    inhibitor,Dr. Sujie Tang,Positive
   Approves Venetoclax,The ASCO Post,Negative
 Venetoclax approval,Tarmo Seliste,Positive
   Approves New Treatment Option,GW BMES,Positive
 HardToTreat Type,GW BMES,Positive
 CLL p Deletion,Dr. JOSE VELASQUEZ,Negative
         Fort,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
 patients AbbVieRoche drug,Tolero Pharma,Positive
 ACS Press Release,RFL of Elkton MD,Positive
 Foo,RFL of Elkton MD,Positive
 CMLHope,CMLHope,Negative
 Leukemia amp Lymphoma Society Applauds Approval,CMLHope,Negative
 New Therapy,CMLHope,Negative
 Chro,CMLHope,Negative
 accelerated approval FDA,RA Komins,Positive
 DanaFarber Patients,STRT Boston,Positive
 CLL p deletion,CancerTherapyAdvisor,Negative
 FDA Accelerated Approval,Gunel Huseynova,Positive
 FDA Accelerated Approval,Krishan Maggon,Negative
 FDA Accelerated Approval,Financial Buzz,Positive
 FDA Accelerated Approval,Medelis: OncologyCRO,Positive
 FDA Accelerated Approval,PRN Biotech,Negative
 FDA Accelerated Approval,IntoxicatedTrader,Negative
 Venclexta ‚Ñ¢ venetoclax,Gunel Huseynova,Positive
 Excitingwelcome news,üèùBonneIsolationüèï,Positive
 Venclexta ABBV deals,BioWorld,Positive
 INDUSTRY NEWS FDA Approves Venclexta venetoclax,@EPMScientific,Positive
 deadline Help,AbbVie Canada,Negative
 Venclexta ‚Ñ¢ venetoclax Tablets,Krishan Maggon,Negative
 Venclexta ‚Ñ¢ venetoclax Tablets,Financial Buzz,Positive
 Venclexta ‚Ñ¢ venetoclax Tablets,Medelis: OncologyCRO,Positive
 Venclexta ‚Ñ¢ venetoclax Tablets,PRN Biotech,Negative
 Venclexta ‚Ñ¢ venetoclax Tablets,IntoxicatedTrader,Negative
 Inhibi,Krishan Maggon,Negative
 Venclexta venetoclax AbbVie Roche,Krishan Maggon,Negative
 el venetoclax para el,Yinec Varela,Positive
 el venetoclax para el,Genotipia,Positive
 tratamiento de la leucemia,Yinec Varela,Positive
 tratamiento de la leucemia,Genotipia,Positive
 News Roches Venclexta,Roche,Negative
 Roches Venclexta,Women's Health News,Positive
 FDA Approves Venclexta,Doctors Lounge,Negative
 p Deletion Drug,Doctors Lounge,Negative
 FDA Grants Venclexta,BioInnoPlayground,Positive
 FDA Grants Venclexta,Jean-Michel TERME,Negative
 ‚Ñ¢ venetoclax Accelerated Approval,BioInnoPlayground,Positive
 ‚Ñ¢ venetoclax Accelerated Approval,Jean-Michel TERME,Negative
 FDA grants medicine,Roche,Negative
 Rela,Financial Buzz,Positive
 Rela,PRN Biotech,Negative
 Anderson et al,Chan Cheah,Negative
 BH,Chan Cheah,Negative
 apotosis,Chan Cheah,Negative
   BCL inhibitorVenclexta venetoclax,Dr. Rakesh Sonawane,Positive
   armamentarium,Carla Casulo,Positive
 ABBVAbbVie,kyookine,Positive
 Venclexta Tabletsin RelapsedRefractory Chronic Lymphocytic Leukemia Patients,kyookine,Positive
   Genentech Announces,Jean-Michel TERME,Negative
 News FDA Approves Venetoclax,Oncology Consortium,Negative
 News FDA Approves Venetoclax,PER,Negative
 News FDA Approves Venetoclax,AJHO,Positive
 FDA Green Lights,Pharmaceutical News,Negative
 FDA Green Lights,Mike Gauthier,Negative
 Genentechs New Chronic Lymphocytic Leukemia Drug Venclexta,Pharmaceutical News,Negative
 Genentechs New Chronic Lymphocytic Leukemia Drug Venclexta,Corixis,Positive
 Genentechs New Chronic Lymphocytic Leukemia Drug Venclexta,Pharmaceutical,Positive
 Genentechs New Chronic Lymphocytic Leukemia Drug Venclexta,Biotechnology,Positive
 Breaking news Venclexta ABT,Patient Power,Negative
 p Deletion April,Medicine Science,Negative
 New   drug approval,Dana-Farber,Negative
 wA,Paladin üêâ,Positive
 Drug Information,esg divisi√≥n m√©dic@,Positive
 Specific Genetic Blood Cancer form,Doctors Lounge,Negative
   Approves Drug,Wellmighty,Positive
 CONSTELLATION,Wellmighty,Positive
 FDA Green Lights AbbVie Genentechs New Chronic Lymphocytic Leukemia Drug Venclexta,Pharma Commons,Negative
 AbbVieRoche drug,Sherie Masse,Positive
 Hooray,ScottO,Positive
 Venclexta AbbVie,Anand Rotte,Positive
 ASCO Tumor Boards,Pro-CME,Negative
 Breaking News,AJPB_Journal,Negative
 Breaking News,Lymphomation.org,Negative
 Breaking News,Patient Power,Positive
 FDA Green Lights AbbVie,Corixis,Positive
 FDA Green Lights AbbVie,Pharmaceutical,Positive
 FDA Green Lights AbbVie,Biotechnology,Positive
 Life Sciences Jobs,Corixis,Positive
 Life Sciences Jobs,Pharmaceutical,Positive
 Life Sciences Jobs,Biotechnology,Positive
 ABBV Genentech RHHBYs New Chronic Lymphocytic Leukemia,Mike Gauthier,Negative
 Drug Venclexta,Mike Gauthier,Negative
 Abbvies Caancer drug Venetoclax,Elite Exec Search,Positive
 previouslytreated p del,Dustin Phan,Positive
 Bcl inhibitor,Bissan Al-Lazikani,Positive
 BCL therapy,MedChem & ONCo,Negative
 CLL   FDA,MedChem & ONCo,Negative
 FDA Approval Venclexta venetoclax,MedChem & ONCo,Negative
 chromosomal abnormality,ADIL Med Monitor,Positive
 FDA Press Release FDA,foodbloggernews,Positive
 FDA FDA,US Government News,Positive
 FDA PR,SAC Tracker,Positive
   OKs,Donna Young,Negative
 chromosomal region,TumorImmunoPapers,Negative
 synteny,TumorImmunoPapers,Negative
 human q,TumorImmunoPapers,Negative
 SmallMolecule Inhibitors Ibrutinib,OncLive.com,Negative
 w Prof Wierda,VJHemOnc,Negative
 living,Spud Lovr,Positive
 Safety activity,"Raul Cordoba, MD, PhD",Negative
 antiCDB,"Raul Cordoba, MD, PhD",Negative
 drug conjugate polatuzumab vedotin RR Bcell,"Raul Cordoba, MD, PhD",Negative
 starting lineup,AhramOnlineSports,Positive
 Bejaia,AhramOnlineSports,Positive
 Champions League,AhramOnlineSports,Positive
 Zamalek,AhramOnlineSports,Positive
 AHLY,AhramOnlineSports,Positive
 Amr Gamal,AhramOnlineSports,Positive
    Targeting,ImmunologyPapers,Negative
    Targeting,EUFUCKBACK2,Positive
   Maintenance Lenalidomide,Christopher Steer,Negative
 Limited Feasibility,Christopher Steer,Negative
 OPENING DAY DAY AWAY,Clackamas LL,Positive
 Juega,juanchi,Negative
 New generation BTK inhibitors,Beatriz P√©rez Sanz,Positive
 JCI insight Improving models,Journal of Clinical Investigation,Negative
   Andrew Zelentz MD,i3 Health,Negative
 Immunotherapeutic synergy,Piotr Stƒôpniak,Positive
 ASCO Post Jeffrey Jones MD MPH,Chicago Chapter ONS,Positive
 miRA,epigenetics_papers,Negative
 STELA,VJHemOnc,Negative
 CLL Maintenance Lenalidomide,"Mike Thompson, MD, PhD, FASCO",Negative
 Researches,ecancer,Negative
   Furniture,Vilo Kanis,Positive
 WA,Vilo Kanis,Positive
 WA,Melissa Loomis,Positive
 BBcd,Vilo Kanis,Positive
 Line Tarli aufar,Vilo Kanis,Positive
 CYPA Allele,"Mike Thompson, MD, PhD, FASCO",Negative
 CYPA Allele,Ashley Phillips,Positive
 Worsen Outcomes,"Mike Thompson, MD, PhD, FASCO",Negative
 Worsen Outcomes,Ashley Phillips,Positive
 Cancer Types,"Mike Thompson, MD, PhD, FASCO",Negative
 Cancer Types,Ashley Phillips,Positive
 Neat CLL,Elaine Schattner,Negative
 Hospital Experience,AbbVie Canada,Negative
 New Developments Provide Answers,CURE Magazine,Negative
 New Questions,CURE Magazine,Negative
 Drs Estrov,Patient Power,Negative
 Dr Jeffrey Jones,OncLive.com,Negative
 Dr Jeffrey Jones,Helen Ong,Positive
 Dr Jeffrey Jones,PER,Negative
 NCCN Recommendations,OncLive.com,Negative
 Relapsed Patients,OncLive.com,Negative
 tcowSKYomo,OncLive.com,Negative
 Dr Maloney,Patient Power,Negative
 Tweetchat amp,Patient Empowerment Network,Negative
 Det virtuella,cecilia cia valve,Positive
 sp√§nnande,cecilia cia valve,Positive
 Rapid changes,Jordan Gauthier,Positive
 nd generation BTKi,Jordan Gauthier,Positive
 BTKiBCLi combinations,Jordan Gauthier,Positive
 P Dreger,Jordan Gauthier,Positive
 Owen OConnor,VJHemOnc,Negative
 PIKdelta inhibitor,VJHemOnc,Negative
   Dr Gribben,"Navneet Majhail, MD, MS",Positive
   Prof GribbenTimes,Dr.Alberto Mussetti,Negative
 smudge cells,apapapa,Positive
 Pts wChronic Lymphocytic Leukemia,The ASCO Post,Negative
 Soy el,Coyii ,Positive
 tiene,Coyii ,Positive
   vs   trial,VJHemOnc,Negative
 √≠a INNOVATION,Medibooks,Negative
 PROGNOSTICATION,Medibooks,Negative
 TP GENE,Medibooks,Negative
 Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells,TumorImmunoPapers,Negative
 Shows,TumorImmunoPapers,Negative
 practitioners,APSHO,Negative
 expression amp function,Lymphoma Hub,Negative
 sIgM,Lymphoma Hub,Negative
    Inflammatory Drive,Francesco Turturro,Negative
   characteristics,Francesco Turturro,Negative
 BCell Chronic Lymphocytic Leukemia Research,Kerry Gracious,Positive
 BCell Chronic Lymphocytic Leukemia Research,Sharon Hall,Positive
 BCell Chronic Lymphocytic Leukemia Research,David Stoffel,Positive
    options,Patient Power,Negative
   Bob,Patient Power,Negative
 rearview mirror,Patient Power,Negative
 Dr Allan,WCMNYPJCTO,Negative
 Discuss Findings,Biotechnology News,Negative
 Chronic Lymphocytic Leukemia Realtime,Biotechnology News,Negative
   GEN,Biotechnology News,Negative
 firstline use,WCM Lymphoma,Negative
 Exclusivity,Rare Diseases,Negative
 BENDEKA,Rare Diseases,Negative
 BENDEKA,MedWatcher,Positive
 de abril,Taylor Wolf,Positive
   triggers cell,Francesco Turturro,Negative
 Infos,Roche Deutschland,Negative
 der h√§ufigsten Form von,Roche Deutschland,Negative
 bei Erwachsenen,Roche Deutschland,Negative
   ¬Æ,Dr. Stefan Fischer,Negative
 Einschr√§nkungen bei,Dr. Stefan Fischer,Negative
 und rezidiviertem follikul√§ren,Dr. Stefan Fischer,Negative
 Global BCell Chronic Lymphocytic Leukemia Therapeutics Development Pipeline Review H,Âø´ÈÅ©ÂÆ∂ÈõªLife,Negative
 Global BCell Chronic Lymphocytic Leukemia Therapeutics Development Pipeline Review H,Feel on,Negative
 Global BCell Chronic Lymphocytic Leukemia Therapeutics Development Pipeline Review H,Business Wire-Health,Negative
 Un amor de persona,John Drago,Positive
 love person,John Drago,Positive
 Cell Leukemia HCLChronic Lymphocytic Leukemia,Matthews & Associates,Negative
 Ciƒô≈ºko bƒôdzie wybroniƒá jaki≈õ karny golkiperce szwedzkiej,Karol ≈ªuradzki,Positive
 ContinuedHairy Cell Leukemia HCLChronic Lymphocytic Leukemia,Matthews & Associates,Negative
   har l√¶rt mye,Ellen Romstad,Positive
 Dr Castro,Patient Power,Positive
 postgraduate study,Lifelong Learning,Negative
 Prayers,Paul Mitchell,Positive
 New video,Patient Power,Negative
 combination treatments,Patient Power,Negative
 Dr Lloyd E Damon,Clin Adv Hem Onc,Negative
   Richters Transformation Patients,Patient Power,Negative
 Incidence amp,GEDEFO,Negative
 Patient Power team,Patient Power,Negative
 w cancers,AbbVie Canada,Negative
 Deadline April,AbbVie Canada,Negative
 Chronic Lymphocytic Leukemia Citation Classic,ClinChemINFO,Positive
 Maintaining Response,Hemomadrid,Negative
 Maintaining Response,Avery92,Positive
 Maintaining Response,DR. JAWAHAR TICKU,Positive
 medscapeeducation,Hemomadrid,Negative
 CNBCTV ALERT Bendamustine Injection,CNBC-TV18,Negative
 Anders √ñsterborg,VJHemOnc,Negative
 CYPAC allele,Eva M Kozlowski|Student Pilot|Oncology Pharmacist,Positive
 CYPAC allele,OncoTherapy Network,Negative
 poorer outcomes,Eva M Kozlowski|Student Pilot|Oncology Pharmacist,Positive
        Fort,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
 Nike,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Positive
   assessment,Mehdi Hamadani,Positive
 Hodgkin,Birger Armstrong üí¨,Positive
 Hodgkin,"Raul Cordoba, MD, PhD",Negative
 Hodgkin,Lymphoma News Today,Negative
 Hodgkin,Centro Medico Qx,Negative
 Hodgkin,MD.,Negative
 Newest Patient Guidelines,Birger Armstrong üí¨,Positive
 Newest Patient Guidelines,"Raul Cordoba, MD, PhD",Negative
 Newest Patient Guidelines,Lymphoma News Today,Negative
 Cancer Network   Lymphoma News,Birger Armstrong üí¨,Positive
 TP gene analysis,"Raul Cordoba, MD, PhD",Negative
 Normal B Cells,TumorImmunoPapers,Negative
 Normal B Cells,ImmunologyPapers,Positive
 Normal B Cells,AIRR-seq papers,Negative
 Normal B Cells,Europe PMC articles,Positive
 Normal B Cells,Klaus Okkenhaug,Positive
 Lymphoma News,"Raul Cordoba, MD, PhD",Negative
 talks oncology,Patient Power,Negative
 INDOLECARBINOL,Medibooks,Negative
 RESTORES FLUDARABINE,Medibooks,Negative
 SENSITIVITY,Medibooks,Negative
    PIK,ImmunologyPapers,Negative
   PIK,AIRR-seq papers,Negative
 Ethereum,Sean Champ,Positive
 contracts,Sean Champ,Positive
 Meetup,Sean Champ,Positive
 Amsterdam Q,Sean Champ,Positive
 Expert Panel,Patient Power,Negative
 FDA Approves Ibrutinib,Health Coach Academy,Positive
 FDA Approves Ibrutinib,Christina Lizaso,Positive
 FDA Approves Ibrutinib,PEYRAT Jean-Pierre,Positive
 FirstLine   Treatment,Health Coach Academy,Positive
 FirstLine   Treatment,Christopher Steer,Negative
 FirstLine   Treatment,Christina Lizaso,Positive
 Stephen Stilgenbauer MD,OncLive.com,Negative
 GWASs,Lymphoma Hub,Negative
 casa por el pr√≥ximo mes,Carlos Llavador,Negative
     amp   trial,VJHemOnc,Negative
 VAT decision,Markel Tax,Positive
 Great Discussion,Silas Inman,Negative
 CYPA allele,CancerTherapyAdvisor,Negative
 cancer types,CancerTherapyAdvisor,Negative
 cancer types,Elias Mokbel,Positive
 OncoTherapy Network,Christopher Steer,Negative
   Deaths Decline New   Treatment,Oncology Now,Negative
 amp Financial Burden,Oncology Now,Negative
 Week   class content,Team Intake.Me,Negative
 illness perceptions,Lymphoma Hub,Negative
 depression amp fatigue,Lymphoma Hub,Negative
   Peel Hunt,Paul Kettle,Negative
 GBX,MarketBeat,Negative
 GBX,US Banking News,Negative
 buy,MarketBeat,Negative
 buy,Share Prophets,Negative
 CLL   Cello Group plc   Price Target,US Banking News,Negative
       Fort Saskatchewan,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
 patient group,CADTH,Negative
 Join   today     session w,Winship Cancer Institute of Emory University,Negative
   Postgraduate Diplomas,Lifelong Learning,Positive
 venetoclax ABT,VJHemOnc,Positive
 Lenalidomide treatment,Lymphoma Hub,Negative
   Chronic Lymphocytic Leukemia CLL Treatment,Rowing HQ,Positive
 Network,Lymphoma News Today,Negative
 Simon Rule,VJHemOnc,Negative
 longterm therapy,Lymphoma Hub,Negative
 Lymphoma Overview Chronic Lymphocytic,Lymphoma News Today,Negative
 Pharmacokinetics safety amp efficacy,Lymphoma Hub,Negative
 IV rituximab,Lymphoma Hub,Negative
 SAWYER phase b trial,Lymphoma Hub,Negative
 Haematology trials,Christopher Steer,Negative
 Lenalidomide Treatment,Hematopoiesis News,Negative
 Raised response rate,JADPRO,Negative
 Easter enhancements,Tishylishy,Positive
 Lively case,Dr. Andre Goy,Negative
 Class,Team Intake.Me,Negative
 Class,Prairie Lakes Church,Negative
 Penn Study Mutations,Cancer Research News,Positive
 Penn Study Mutations,EIN Presswire: Prostate Cancer Newswire,Negative
 Penn Study Mutations,Healthcanal,Negative
 Penn Study Mutations,Precision Medicine,Positive
 Penn Study Mutations,First4Training,Positive
 Penn Study Mutations,Penn Medicine News,Negative
 Suggest Potential New Uses,Cancer Research News,Positive
 Suggest Potential New Uses,EIN Presswire: Prostate Cancer Newswire,Negative
 Suggest Potential New Uses,Healthcanal,Positive
 Suggest Potential New Uses,Precision Medicine,Positive
 Suggest Potential New Uses,Oxford virtual,Positive
 Suggest Potential New Uses,First4Training,Positive
 Suggest Potential New Uses,ivy science,Negative
 Suggest Potential New Uses,Penn Medicine News,Negative
 Suggest Potential New Uses,newswise,Negative
 Suggest Potential New Uses,Centro Medico Qx,Negative
 Suggest Potential New Uses,MD.,Negative
 Suggest Potential New Uses,Cristina Reyes,Positive
 Existing Canc,Cancer Research News,Positive
 Miami,Anthony Mato,Negative
 TLS data,Anthony Mato,Negative
 abt,Anthony Mato,Negative
 Intravenous Formulation,Dr. JOSE VELASQUEZ,Negative
   weekinreview,Patient Power,Negative
 NCCN Publishes New Patient Education Resources,Clinical Pharmacy,Negative
 NCCN Publishes New Patient Education Resources,MD Anderson Library,Negative
 NCCN Publishes New Patient Education Resources,Cyndie Annett,Positive
 NCCN Publishes New Patient Education Resources,TheraGlobal,Positive
 NCCN Publishes New Patient Education Resources,EIN Presswire: Prostate Cancer Newswire,Positive
 NCCN Publishes New Patient Education Resources,EIN Presswire: Lung Cancer Newswire,Positive
 NCCN Publishes New Patient Education Resources,EIN Presswire: Education Newswire,Positive
 NCCN Publishes New Patient Education Resources,Cision News,Negative
 NCCN Publishes New Patient Education Resources,Centro Medico Qx,Negative
 NCCN Publishes New Patient Education Resources,MD.,Negative
 NCCN Publishes New Patient Education Resources,John Mclean,Positive
 NCCN Publishes New Patient Education Resources,newswise,Negative
 NCCN Publishes New Patient Education Resources,Emma Gabriela,Positive
 Hodgkin Lymphoma,Clinical Pharmacy,Negative
 Hodgkin Lymphoma,"Tom Iarocci, MD",Negative
 Hodgkin Lymphoma,Cyndie Annett,Positive
 Subcutaneous rituximab,CancerTherapyAdvisor,Negative
 Enrollment,Team Intake.Me,Negative
 RTshare,Team Intake.Me,Negative
 Dr Sharmans Blog      Perspective,Lymphomation.org,Negative
 Pod√©is,Carlos Llavador,Negative
 mi nueva,Carlos Llavador,Negative
 cuenta,Carlos Llavador,Negative
 dud√©is de echarle un vistazo,Carlos Llavador,Negative
 ePatient Health Academy,Christina Lizaso,Positive
 genomewide association studies,Yale School of Public Health,Positive
 genomewide association studies,Andr√© Rendeiro,Positive
 genomewide association studies,Krishan Maggon,Negative
 genomewide association studies,gilbert c faure,Negative
 genomewide association studies,GWAS_lit,Positive
 Idelalisib Combination Trials,Patient Power,Negative
 amp   Leading expert,Patient Power,Negative
 death   pathway,British Journal of Clinical Pharmacology,Positive
 discusses sideeffects,VJHemOnc,Negative
 pts Data,"chadi nabhan MD, MBA, FACP",Negative
 Diagnose Chronische lymphatische,Roche Deutschland,Negative
 Welche Ma√ünahmen,Roche Deutschland,Negative
 jetzt getroffen,Roche Deutschland,Negative
   XI,Telemundo Deportes,Positive
 Marches√≠n Izquierdoz,Telemundo Deportes,Positive
 Araujo Abella Villafa√±a,Telemundo Deportes,Positive
 Gonzal√©z,Telemundo Deportes,Positive
 Molina Calder√≥n D√°vila,Telemundo Deportes,Positive
 Mendoza y Bravo,Telemundo Deportes,Positive
 FDA alerts,CancerTherapyAdvisor,Negative
 Bloodstream infections,pseudomonaspapers,Negative
    DPLO,Pharmaceutical News,Negative
 Pharmacy,Pharmaceutical News,Negative
 Dispensing IMBRUVICA√Ø¬ø¬Ω,Pharmaceutical News,Negative
 V√©ronique Leblond,VJHemOnc,Negative
   heaven,sugar,Positive
 Abington Hospital,Anthony Mato,Negative
 FDA Halts Idelalisib Combination Studies,Lymphomation.org,Negative
 DNA methylation dynamics,Lymphoma Hub,Negative
 DNA methylation dynamics,Albert Vilella,Positive
 DNA methylation dynamics,Moreaux J√©r√¥me,Positive
 DNA methylation dynamics,Calibr8 Your Life,Positive
 B cell maturation,Lymphoma Hub,Negative
 B cell maturation,Albert Vilella,Positive
 B cell maturation,Moreaux J√©r√¥me,Positive
 B cell maturation,Calibr8 Your Life,Positive
 disease phenotypes,Lymphoma Hub,Negative
 disease phenotypes,Albert Vilella,Positive
 disease phenotypes,Moreaux J√©r√¥me,Positive
 disease phenotypes,Calibr8 Your Life,Positive
 Pneumonitis,CancerTherapyAdvisor,Negative
 CLL NHL,CancerTherapyAdvisor,Negative
 Missed Endpoint,Matthias Piesche,Negative
 community service hours,ILLINOIS Social Work,Negative
 Dispensing IMBRUVICA√Ç,COPD News,Negative
 Chronic Lymphocytic Leukemia FLINT Mich March,Google  News,Positive
 amp Richters Syndrome,Patient Power,Negative
 Diplomat Dispensing Imbruvica,Diplomat,Negative
 th treatment indication,Coping with Cancer,Positive
 E phase,Lymphoma Hub,Negative
 CostEffectiveness,Cancer Papers,Negative
 CostEffectiveness,Mois√©s S√°nchez,Positive
 CostEffectiveness,clinicaltherapeutics,Negative
 FirstLine Chronic Lymphocytic Leukemia Treatments,Cancer Papers,Negative
 Hematology Treatment Center,Dana-Farber,Negative
 Chronic Lymphocytic Leukemia CLL Treatment,Sameer Parikh,Negative
 Dr Tait Shanafelt Chair,Sameer Parikh,Negative
 Mayo CLL Group,Sameer Parikh,Negative
 CAR Tcell Function Efficacy,Tolga Artan,Positive
 CAR Tcell Function Efficacy,Dr. Melody Davis,Negative
 CAR Tcell Function Efficacy,Susan Murphy,Positive
   Approves Ibrutinib,SpecialtyPTimes,Positive
 Cytochrome P Allele CYPAC Associates,Cancer Papers,Positive
 Adverse Outcomes,Cancer Papers,Positive
 La Agencia Europea Med Inicia la revisi√≥n de un nuevo farmaco,"Rodolfo Mataix, Dr",Positive
 y   folicular Idelalisib Zydelig,"Rodolfo Mataix, Dr",Positive
 Expanded Indication,Diaceutics PLC,Negative
 Expanded Indication,Pharmacy Times,Negative
 Expanded Indication,Kosius,Positive
 Expanded Indication,NACDA Program on Aging,Negative
 Expanded Indication,Pharmacy Podcast Network,Positive
 Expanded Indication,Rx Generator | Business Strategy,Positive
   strategy game,Stephen Brown,Negative
 Section Editor Dr Susan OBrien,ACS Journal Cancer,Negative
 New   GWAS metastudy Metaanalysis,Andr√© Rendeiro,Positive
 Prof Stephan Stilgenbauer,VJHemOnc,Negative
 optic nerve sheath biopsy,"BernadetteHromin,MD",Positive
 FullDose Fludarabine,Mois√©s S√°nchez,Positive
   Trillium Wins Funding,CMLHope,Positive
 Lead Candidate chronic lymphocytic le,CMLHope,Positive
 firstline   treatment,OncoTherapy Network,Negative
 Transposon mutagenesis,TumorImmunoPapers,Negative
 Transposon mutagenesis,Cure Cancer Now,Negative
 fludarabineresistance mechanisms,TumorImmunoPapers,Negative
 fludarabineresistance mechanisms,Cure Cancer Now,Negative
 AbbVie Inc amp JampJ,GxPeople,Positive
 Chronic Lymphocytic Leukemia C,Phillip Glover,Positive
      √ìNENCOMPETENCIASPARALAVIDA √ëOSNI√ëASYADOLESCENTES,CONSEJO/PROTECCION,Positive
 CLL therapy data,VJHemOnc,Negative
 ROR inhibitor,VJHemOnc,Negative
 blood cancer world,Stephen Brown,Negative
 PharmacyTimes,Pharmacy Podcast Network,Positive
 Chronic Lymphocytic    Treatment,Pharmacy Podcast Network,Positive
 Expert Jacqueline Barrientos MD,CCO Oncology,Positive
    Approves Imbruvica,LIBERTADOR ¬Æ,Positive
 Chronic Lymphocytic   Treatment,NACDA Program on Aging,Negative
 firstline chronic lymphocytic   patients,Lymphoma Research Foundation,Negative
 HORSHAM Pa,frothmouth,Positive
 Managing Monitoring    Effects w experts,Patient Power,Negative
     Great webcast,Cathy Wu,Positive
 Hematologic Malignancies sessions,Cathy Wu,Positive
 DISTINCT MOLECULAR SUBTYPES,Medibooks,Negative
 Professor Peter Hillmen,VJHemOnc,Negative
 Webseite Leben Mit Lymphom bietet,Roche Deutschland,Negative
 Patienten mit,Roche Deutschland,Positive
 Informationen zu,Roche Deutschland,Negative
 RT     FDA,Pharmaceutical Mkt,Positive
 Sharis life,Patient Power,Negative
   therapies,Patient Power,Negative
   therapies,Francesco Turturro,Negative
   therapies,Jonathan Friedberg,Positive
 RT PatientPower,Plano IVF,Positive
 RT PatientPower,Garland IVF,Positive
 RT PatientPower,Dallas IVF,Positive
 research work,"Raul Cordoba, MD, PhD",Negative
 FIRSTLINE TREATMENT,American Preclinical,Negative
 CHRONIC LYMPHOCYTIC LEUK,American Preclinical,Negative
 firstline nod,Vicente Torres,Positive
 LINE treatment,JaimePerezdeOteyza,Positive
 Chronic Lymphocytic Leukemia Excellent news,JaimePerezdeOteyza,Positive
 firstline   therapy,MDedge Hematology & Oncology,Negative
 Pharma News FDA,Pharma Industry News,Positive
 Somos La Mejor Pareja Del Universo,John Drago,Positive
 Gracias,‚ìú‚ìê‚ìù‚ì§,Positive
 Gracias,Carlos Llavador,Negative
 Gracias,Eddy Marty,Positive
 la polera,‚ìú‚ìê‚ìù‚ì§,Positive
 Lake Louise,Jim Fowler,Negative
 Lake Louise,Annuaire du tourisme,Positive
 feet,Jim Fowler,Negative
 Jasper,Jim Fowler,Negative
 Pilot Trial CART,Lymphomation.org,Negative
 RR CD,Lymphomation.org,Negative
   news FDA Approves IMBRUVICA√Ç ibrutinib,COPD News,Negative
 Ibrutinib primary Rx,JediPD,Negative
 approved IMBRUVICA,JanssenUS,Negative
 CLL FDA,CancerTherapyAdvisor,Negative
 JNJ FDA,$Stocknewsalerts,Negative
 ABBV AbbVie FDA,Briefing.com,Negative
 New Lymphoma,TheraGlobal,Positive
 New Lymphoma,Lymphoma News Today,Negative
 Ps Michele,Patient Power,Negative
 health update,Patient Power,Negative
 NCCN Patient Education Resources,"Tom Iarocci, MD",Negative
 FDA Grants,SpecialtyPTimes,Negative
 FDA Grants,1stOncology,Positive
 Drug Priority Review,SpecialtyPTimes,Negative
   WeekinReview,Patient Power,Negative
 Dr Silver,WCMNYPJCTO,Negative
 ABBV JNJ Imbruvica,Dustin Phan,Positive
 UKs NICE,Dustin Phan,Positive
 costbenefit evaluation,Dustin Phan,Positive
 NHS patients,Scrip,Negative
 Hodgkin Lymp,Cision News,Negative
 Hodgkin Lymp,John Mclean,Positive
 Hodgkin Lymp,newswise,Negative
   NCCN,CMLHope,Negative
 Publishes New Patient Education Resources,CMLHope,Negative
 Hodgkin Lymphomaa,Emma Gabriela,Positive
 Rare,Emma Gabriela,Positive
 Curab,Emma Gabriela,Positive
 Realworld data,VJHemOnc,Negative
   Anders √ñsterborg,VJHemOnc,Negative
 PAP Optic Neuropathy,journalneurooph,Positive
 Optic Nerve Sheath Biopsy,journalneurooph,Negative
 Optic Nerve Sheath Biopsy,Eye Center,Positive
 Pathetic NICE,Sean McGrath,Positive
 contest,Idea Couture,Positive
 session w,Winship Cancer Institute of Emory University,Positive
   OncPrac Summit Dr Jorge Cortes,Oncology Tube,Positive
   research reflections,Patient Power,Negative
 Patient Powered   news,Patient Power,Negative
 Fun fact,Lifelong Learning,Negative
 March st,Lifelong Learning,Negative
 Happy St Davids Day,Lifelong Learning,Negative
 Rare cancer,JanssenUS,Negative
   Center,Dana-Farber,Negative
 Longterm Survivors,Dr. Melody Davis,Negative
 Longterm Survivors,Christopher Steer,Negative
 Longterm Survivors,NACDA Program on Aging,Negative
 Emerging   Options,Patient Power,Negative
 el manejo de la LLC,"Rodolfo Mataix, Dr",Positive
 Prognostic Impact,UroToday.com,Positive
 LongTerm Survivors,UroToday.com,Positive
     ÏÜê Ïî®ÏóòÏî® ÏòàÎªêÏßÄÍ≤å,Lookwa,Positive
 Wellmy dad,.,Positive
 Dr Robin Fo√† New trends,VJHemOnc,Negative
     Transform,CancerWallonia,Negative
 √≠a SPLEEN TYROSINE KINASE,Medibooks,Negative
 INHIBITORS REDUCE CDLINDUCED PROLIFERATION,Medibooks,Negative
 ŒïœÅŒ≥Œ±œÉŒØŒ±Study,All Jobs,Positive
    CLL patients,"Avraham Z. Cooper, MD",Positive
 Longterm survivors,CancerTherapyAdvisor,Negative
   exome sequencing,Francesco Turturro,Negative
 RRCLL Correlation,Francesco Turturro,Negative
 Immune Characteristics,Francesco Turturro,Negative
    Targeted Therapy,Francesco Turturro,Negative
 SYK inhibitor,OncLive.com,Negative
 feat experts,Patient Power,Negative
 CAR Tcell function,VJHemOnc,Negative
 Improved Improves,Susan Murphy,Positive
 CAR Tcell function efficacy,CancerTherapyAdvisor,Negative
 New Feature,Patient Power,Negative
 P Sharable guides,Patient Power,Negative
 Global challenges,VJHemOnc,Negative
 Macrophages Sensitizes Chronic Lymphocytic Leukemia,Dominique,Positive
 Macrophages Sensitizes Chronic Lymphocytic Leukemia,TumorImmunoPapers,Negative
 Inhibits,Dominique,Positive
 ILK induction,jt120651,Positive
 RDHAP,CancerTherapyAdvisor,Negative
 CLL Update,Oncology Tube,Negative
 ASH    Susan OBrien MD,Oncology Tube,Negative
 Valter Longo,USC Leonard Davis School of Gerontology,Positive
 Jeff   Sharman MD,OncLive.com,Negative
 amp Dr Lamannd,Patient Power,Negative
 profiling,Patient Power,Negative
 P Team Member Michele,Patient Power,Negative
    experience,Patient Power,Negative
 basics,Patient Power,Negative
 basics,Lifelong Learning,Negative
 experts Dr Lamanna,Patient Power,Negative
   testing,Patient Power,Negative
 Dr Bill Plunkett,Patient Power,Negative
 care partnerwife,Patient Power,Negative
 Nelia,Patient Power,Negative
 FrontLine Chemoimmunotherapy,OncLive.com,Positive
 New Therapies,OncLive.com,Negative
 Palbociclib,"Raul Cordoba, MD, PhD",Negative
 Optic Neuropathy,Eye Center,Positive
 Optic Neuropathy,Cancer Papers,Negative
   cohorta,Connie Erpelding,Positive
 Rapid induction,Fanni Gergely,Positive
 Rapid induction,Cancer Papers,Negative
 RiskAdapted Therapy,Cancer Papers,Negative
 CisplatinBased Immunochemotherapy,Hematopoiesis News,Negative
 MrClean MrClean,Van Yoeun,Negative
 Ottawa Hospital,Van Yoeun,Positive
 General Campus,Van Yoeun,Positive
 Bye,Van Yoeun,Negative
 hair,Van Yoeun,Negative
 Dr Leblond,NE Live,Negative
 MaBLe study,NE Live,Negative
 RClb,NE Live,Negative
 CLL Allogeneic HCT,CancerTherapyAdvisor,Negative
    progression,Patient Power,Negative
 macht sich,Roche Deutschland,Negative
 bemerkbar,Roche Deutschland,Negative
 reflections,Patient Power,Negative
 tcoIvgJZxsoch,NACDA Program on Aging,Negative
    Advances Promising,CancerConnect,Negative
 Dr Januario Castro,Patient Power,Negative
 Dr Michael Keating amp Dr Januario Castro,Patient Power,Negative
 Apoptosis Inhibits Disease,TumorImmunoPapers,Negative
 CLL Targeting,Prof John,Negative
 Chronic Lymphocytic Leukaemia ESMO Clinical Practice Guidelines,J. De Munter,Negative
 Ep,Reddit FoodNerds,Positive
 Popular Combination,Cancer Journal,Positive
 Targeted Drugs,Cancer Journal,Positive
 Targeted Drugs,Cancer Papers,Negative
 experts Dr Keating amp Castro,Patient Power,Negative
 WeekInReview   videos,Patient Power,Negative
 Civil WarS√°bado,Javier Jara,Positive
 de Febrero hrsCentro Cultural Rojas MagallanesValor,Javier Jara,Positive
 Targeting macrophages,Cancer Cell,Negative
   Evolving w Dr William Wierda,Patient Power,Negative
     Inflammatory Drive,Francesco Turturro,Negative
 New   CME activity,Medthority,Negative
 epgonline,Medthority,Negative
 Azerra Delays Cancer Progression,Focus on Cancer,Negative
 Advanced Chronic Lymphocytic Leukemia,Focus on Cancer,Negative
 FCR Immunochemotherapy,Jean Plante,Negative
 FCR Immunochemotherapy,NACDA Program on Aging,Negative
 Chronic Lymphocytic LeukemiaStephan Stilgenbauer,Dr. Jos√© A. Queiz√°n,Negative
 FYI Upcoming immunotherapy education session,Stacey Tinianov,Positive
 CLL merupakan penyakit,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 leukemia yg banyak diderita penduduk,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 Barat,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 New developments,Cancer Papers,Negative
 New developments,NACDA Program on Aging,Negative
 Patient Power Team Member,Patient Power,Negative
 Retweeted Yuri Hiranuma Clinical characteristics,Kohshi,Positive
 RT ClinicalProfess Researchers,David Cooper,Positive
 Con Brandon Jara,Malchofa,Positive
   Pada leukemia kronis ada Chronic Lymphocytic Leukemia CLL,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 leukemia yang,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 stereotyped B cell receptors,TumorImmunoPapers,Negative
 stereotyped B cell receptors,Cancer Papers,Negative
   Begitu juga,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 leukemia kronis yang jenisnya,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 CLL amp Chronic Myelogenous Leukemia CML,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 Inflammatory Drive,TumorImmunoPapers,Negative
 Inflammatory Drive,Cure Cancer Now,Negative
   Leukemia kronis terdiri atas,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 Study   targets,doctorportal,Negative
 email,Patient Power,Negative
 email,CLL,Negative
 Chronic Lymphocytic Leukemia Market analysis,Run Direct Magazine,Positive
 Veelbelovende behandelingsopties,Oncologie Up-to-date,Positive
 videointerview Arnon,Oncologie Up-to-date,Positive
 Drs Koehrer,Clin Adv Hem Onc,Negative
 Ya tengo,Carlos Llavador,Negative
 estos son,Carlos Llavador,Negative
 smudge cell,Odessa Ramos,Positive
 HIFa,Hematopoiesis News,Negative
 Interaction,Hematopoiesis News,Negative
 FrontLine Chemo,Matthias Piesche,Negative
 Chronic Lymphocytic Leukemia Harnessing,Cancer Papers,Negative
   ook mijn dag,Jacquelien (wat een toestand moidje),Negative
 Remarkable results,"Thomas LeBlanc, MD, MA, MHS, FAAHPM",Negative
 PatientPowered   News,Patient Power,Negative
 Blood Commentary BCR engagement,Blood Journal,Negative
 Clonal Subclonal Mutations,CancerTherapyAdvisor,Negative
 BCR stimulation,Blood Journal,Negative
 mRNA translation,Blood Journal,Negative
 meds,Deb Maskens,Positive
 paperwork delays,Deb Maskens,Positive
 takehome pillsl,Deb Maskens,Positive
 AbbVies Venetoclax,Cord Blood News,Negative
 AbbVies Venetoclax,üê∏ gab.ai/wu üê∏,Positive
 AbbVies Venetoclax,Hematopoiesis News,Positive
 AbbVies Venetoclax,Tracking Healthcare,Positive
 AbbVies Venetoclax,Financial Buzz,Negative
 AbbVies Venetoclax,IntoxicatedTrader,Negative
 Combination w Rituximab,Cord Blood News,Positive
 Combination w Rituximab,Hematopoiesis News,Negative
 Spotlight,MOASC,Positive
 ASH   Susan OBrien MD UCI,MOASC,Positive
 Emerging,Patient Power,Negative
 Popular Science,The Health Elixir,Positive
 ASAP awards finals,Chris Wolff,Positive
 alliance,Chris Wolff,Positive
   AntiTOSO,PROvendis GmbH,Negative
 maturation states,ZMB,Positive
 Targeting BCL,Nature Reviews Disease Primers,Negative
 Venetoclax Safe Active,Lymphoma Hub,Negative
 Venetoclax Safe Active,CancerTherapyAdvisor,Negative
 Relapsed CLL SLL,Lymphoma Hub,Negative
 Relapsed CLL SLL,CancerTherapyAdvisor,Negative
 Poor Prognostic Features,Lymphoma Hub,Negative
 Poor Prognostic Features,CancerTherapyAdvisor,Negative
    Hematopoietic Stem Cell Transplantation,T√ºrkiye Klinikleri,Negative
    Novel Molecules,T√ºrkiye Klinikleri,Negative
    Treatment,T√ºrkiye Klinikleri,Negative
    Treatment,Sandra Kear,Positive
    Treatment,Vegan NoGluten Sara,Positive
    FrontLine Therapy,T√ºrkiye Klinikleri,Negative
    Supportive Treatment,T√ºrkiye Klinikleri,Negative
 Chronic Lymphocytic Leukemia Appr,T√ºrkiye Klinikleri,Negative
   reflections,Patient Power,Negative
    Staging,T√ºrkiye Klinikleri,Negative
 scans,Patient Power,Negative
 Dr Lisa Hicks,Patient Power,Negative
    Chronic Lymphocytic Leukemia Clinical Findings Diagnosis,T√ºrkiye Klinikleri,Negative
    Pathogenesis,T√ºrkiye Klinikleri,Negative
 Chronic Lymphocytic Leukemia Cytogenetics,T√ºrkiye Klinikleri,Negative
    Chronic Lymphocytic Leukemia Epidemiology,T√ºrkiye Klinikleri,Negative
     CLL,iDATA INSIGHTS,Positive
     CLL,Miya Muisi,Positive
     CLL,Stella,Positive
     CLL,Chhavi Shardul,Positive
     CLL,Connie Hu,Positive
     CLL,Wise Guy Reports,Positive
 friendfamily CJ discusses,Patient Power,Negative
 VenetoclaxRituximab Combo Gains FDA Breakthrough Designation,Oncology Consortium,Negative
 VenetoclaxRituximab Combo Gains FDA Breakthrough Designation,Targeted Oncology,Negative
 Blood Commentary Innate,Blood Journal,Negative
 club,NoonesChampion,Positive
 Chelsea treatment,Kendall Pino,Positive
 disgrace,Kendall Pino,Positive
 Elongated Treatment,Targeted Oncology,Negative
 Retweeted Blood Journal TLR activation,ICSCCB Pune,Positive
 TLR activation,Blood Journal,Negative
 CLL method Powerpoint Templates,PPT Search,Negative
      Fort Saskatchewan Alberta,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
   Coaches Clinic,JT O'Sullivan,Positive
 Intolerance,Targeted Oncology,Negative
 Chronic Lymphoid Leukaemia,Sophie Macura üíô,Positive
 Miracle drug,CaregiverAsia,Positive
 Feat Dr Zelenetz,Patient Power,Negative
 life treatment,Blood Cancer UK,Negative
 Lisa Nodzon,Patient Power,Negative
 New Drug Application Priority Review,CancerTherapyAdvisor,Negative
 Community Learning Lab,ILLINOIS Social Work,Negative
 IMPACT,ILLINOIS Social Work,Negative
   Eagle Pharm Announce Commercial Availability,Rare Diseases,Negative
 BENDEKATM Injection,Rare Diseases,Negative
 JohnsonSyndrome,Rare Diseases,Negative
     Progress,Michael Baker,Positive
 tcoPKGYFy,NACDA Program on Aging,Negative
 m RoutineCheck    oder,SpringerMedizin.de,Positive
   Integration,Francesco Turturro,Negative
     engagement,Francesco Turturro,Negative
 m√∏de hvor,LyLe Foreningen,Negative
 gruppe tumler med,LyLe Foreningen,Negative
 Chronic Lymphocytic Leukemia Pipeline Therapeutics Assessment Review H,Pitch Ticker,Positive
 tcoTghHcaS,Medcomic,Negative
 Hear Prof Seymour,Dr Ruth Hadfield,Positive
 ecancertv,Dr Ruth Hadfield,Positive
 ZAP expression,Ashley Carter,Positive
 flow cytometry,Ashley Carter,Positive
 cancer breakthrough,CancernetUK,Positive
       Fort Saskatchewan Alberta,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
     BCL,Francesco Turturro,Negative
 tcoAkzLciPcg,"Jason Westin, MD FACP",Positive
 Strong Weapon,The ASCO Post,Negative
 PoorPrognosis Chronic Lymphocytic Leukemia,The ASCO Post,Negative
 Severe Toxicities,The ASCO Post,Negative
 Younger Pts,The ASCO Post,Negative
 FrontLine Idelalisib,The ASCO Post,Negative
 reflektieren,DocCheck,Positive
 theprojecttv RT,Anthony Howards,Positive
 Venetoclax   BCL inhibitor,"YAZ, MD",Positive
   nd generation,Dr Ahmed Kalebi,Positive
 acalabrutinibBruton,Dr Ahmed Kalebi,Positive
 amp Jennifer Brown,"Francisco Marty, MD",Negative
 Relapsed   Prof Andrew Roberts,Christopher Steer,Negative
 NEJM   news,Shankara Paneesha,Negative
 Original Article,NEJM,Positive
 Cello Group plcs hold rating,MarketBeat,Negative
 RNA networks,epigenetics_papers,Positive
 RNA networks,microRNApapers,Negative
 RNA networks,yukiüåæ„äóÔ∏èÔºñ„Åï„ÅÑüéâ‚öî,Positive
 Gold standard   treatments,Crown Bioscience,Positive
 Neem leaf extract,Erin Early,Positive
 n√Å√ÅltaiEamplteid RyfKfg,FullyFunctionalPhil,Positive
 fy,FullyFunctionalPhil,Positive
 kk,FullyFunctionalPhil,Positive
 Yx‚Éë√Åmampgtk√Åfprutyugty E ùÑû hxeamp‚Éëulnz‚Éëcltplt√Åclte,FullyFunctionalPhil,Positive
 ùÑû b ednxqgtrsmnxampcAb √Å,FullyFunctionalPhil,Positive
   Experts Review,Patient Power,Negative
 Persistent Relapsed Chronic Lymphocytic Leukemia,Stem Cell News,Negative
 Venetoclax Receives Breakthrough Therapy Designation,Rare Diseases,Negative
 Disseminated Herpes Zoster,Cancer Papers,Negative
 Review Article MRD,Blood Journal,Negative
 venetoclax combo,European Pharmaceutical Review,Negative
   mins,Michelle,Positive
 wow updates,Michelle,Positive
 drug Venetoclax,"Robinson Ortiz, MD",Negative
 Breakthrough Designation,"Robinson Ortiz, MD",Negative
 Concomitant Ibrutinib Therapy,CancerTherapyAdvisor,Positive
 longterm diseasefree survival,GEDEFO,Negative
 longterm diseasefree survival,Francesco Turturro,Negative
 Expert Perspectives,Patient Power,Negative
 Complete Partial Response,MORE Health,Positive
 Complete Partial Response,The Medical Ed Cons.,Negative
 Complete Partial Response,The ASCO Post,Negative
 Risk   Study,HRA,Positive
 FDA Approves New   Prescription,Hi-School Pharmacy,Positive
 Arzerra ofatumumab,Lymphoma Hub,Negative
 Arzerra ofatumumab,HHF,Negative
 Arzerra ofatumumab,Cancer Agent,Negative
 Arzerra ofatumumab,Today Topics,Negative
   FCR treatment,Francesco Turturro,Negative
    Gains    Designation,CancerWallonia,Negative
 Genmabs,Tracking Healthcare,Positive
 Genmabs,Matthias Piesche,Negative
 Genmabs,A. Vroom - Ten Wolde,Negative
 Availability,OncLive.com,Negative
 „Åì„Çå„Åæ„ÅüÁ¥†Êïµ„Å™„Éû„Çπ„ÇØ,„Éû„Çπ„ÇØ„ÉâÈπøË°å,Positive
   Diet,Patient Power,Negative
     ROGVX Combo Gains FDA BT Designation,Sandra Kear,Positive
 Fludarabine CFM amp rituximab treatment,FarmaOnco,Negative
 longterm DFS,FarmaOnco,Negative
 discusses use,WCM Lymphoma,Negative
 IMAGE,fiberopticgal,Positive
 Dr V√©ronique Leblond,VJHemOnc,Negative
 connection,Patient Power,Negative
 expert Dr Hillmen,Patient Power,Negative
 Leeds University,Patient Power,Negative
 Tre,Financial Buzz,Negative
 New Leukemia Rx,Yost Pharmacy Inc,Positive
 New Leukemia Rx,Digital Pharmacist,Positive
 Potent Novel Therapy,"Joseph Gulfo, MD",Positive
 Chronic Lymphocytic Leukemia CLL Venetoclax,"Joseph Gulfo, MD",Positive
 Recurrent Progressive Chronic,NACDA Program on Aging,Negative
   Approves Maintenance Ofatumumab,Matthias Piesche,Negative
 New   approval,MedWatch News,Positive
 sales drop analyst,MedWatch News,Positive
   gene expression response,BVirtual Murciasalud,Negative
   Meeting Treatment Challenges,Medscape Education,Negative
 Recurrent Progressive Chronic Leukemia,UKiwiS,Negative
 Recurrent Progressive Chronic Leukemia,CancerTherapyAdvisor,Negative
 ofatumumab Arzerr,UKiwiS,Negative
 Novartis,Onesmo Mpanju,Positive
 Novartis,Pharma Commons,Negative
 Novartis,Hal Palmer,Positive
 Novartis,Scott Werntz,Negative
 Novartis,ABABioBlurb,Positive
 promising advance,Team In Training-SC,Positive
 promising advance,LLS NCFL Chapter,Positive
 Attention CLL patients,Coping with Cancer,Negative
 BREAKING FDA Approves,CURE Magazine,Negative
 Extended Therapy,CURE Magazine,Negative
 IgHV,Marta Crespo,Negative
 FCR regimen,Marta Crespo,Negative
 Blood Commentary FCR,Blood Journal,Negative
   Approves Ofatumumab,The ASCO Post,Negative
 KPTI nd Generation Sine CompoundExtract,Biotech2050,Negative
   ABT,VJHemOnc,Negative
   ABT,Tapan Kadia,Negative
 Prof Thomas Kipps,VJHemOnc,Negative
 WIlliam Wierda,Patient Power,Negative
 expert Dr Richard Furman,Patient Power,Negative
 advocate Brian Koffman,Patient Power,Negative
 Prof Gribben,VJHemOnc,Negative
 Prof Gribben,Barts Cancer Institute,Positive
 Prof Stilgenbauer,VJHemOnc,Negative
 Bruton Kinase Inhibitor,Cancer Papers,Negative
 December   Frontline idealisib,Blood Journal,Negative
 th minute heel equaliser,Corlett,Positive
   Issues Venetoclax Priority Review,Targeted Oncology,Negative
 practicechanging update,DynaMed¬Æ,Positive
 JTs,Shivam,Positive
 appearance amp,Shivam,Positive
 Nurselike cells,Cancer Papers,Positive
 Chronic Tcell Lymphocytic Leukemia,Cancer Papers,Negative
 Black Swan   Cygnus atratus,Cancer Papers,Negative
 venetoclax NDA,European Pharmaceutical Review,Negative
 Fludarabine Cyclophosphamide Ofatumumab,CancerTherapyAdvisor,Negative
 Fludarabine Cyclophosphamide Ofatumumab,NACDA Program on Aging,Negative
 Fludarabine Cyclophosphamide Ofatumumab,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
   Focus,DynaMed¬Æ,Positive
 CLL   Cancer Therapy Advisor,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Black Swan,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
   reversibele,MedicalFacts,Positive
   progression amp,Patient Power,Negative
 w Drs KeatingEstov,Patient Power,Negative
 ampDr Lamanna,Patient Power,Negative
 term remissions,Francesco Turturro,Negative
 Dr Tam Constantine,VJHemOnc,Negative
 Roche AbbVie,Lymphoma Hub,Negative
 priority review status,Lymphoma Hub,Negative
 tconydgASmpi,VJHemOnc,Negative
 quiescent   cells,VJHemOnc,Negative
 tconPjOKl,VJHemOnc,Negative
 ‚úî Ô∏è Zumba w mom,Erika,Positive
 VENETOCLAX,JediPD,Negative
 VENETOCLAX,Ahmed Dahduli,Positive
 VENETOCLAX,Douglas Allan,Positive
 VENETOCLAX,Andrew Young,Positive
 salvage treatments,VJHemOnc,Negative
 Prof Martin Dyer,VJHemOnc,Negative
 ID helixloophelix proteins,TumorImmunoPapers,Negative
 ID helixloophelix proteins,Biocomputing,Positive
 ID helixloophelix proteins,Scott Werntz,Negative
 determinants,TumorImmunoPapers,Negative
 determinants,Biocomputing,Positive
 determinants,Scott Werntz,Negative
      nopotsy,KŒµ–ø–øƒ± Kƒ±—Ö—Ö,Negative
 Blood Commentary Obinutuzumab,Blood Journal,Negative
 Merrier,Blood Journal,Negative
 Dr Hromas,Patient Power,Negative
 tendencies,Patient Power,Negative
 WBC doubling time,Patient Power,Negative
 Felicitaciones por los logros de      ‚É£,Dweasley ü¶Ä (Œ® 7 ) 13 üé∏,Positive
 Te lo mereces,Dweasley ü¶Ä (Œ® 7 ) 13 üé∏,Positive
 disfr√∫talo mucho,Dweasley ü¶Ä (Œ® 7 ) 13 üé∏,Positive
   Research Highlights,Patient Power,Negative
 Eg,Elias Mokbel,Positive
 cancer type affecting bone marrow,Indian Med Guru,Positive
 Patient age,Oncology Nursing News,Negative
 Generic Imbruvica Ibrutinib,LifeCare Medicines,Negative
 news feat experts,Patient Power,Negative
 spirits,darkpoetfawn,Positive
 smallbreed dogs,Stefano Cattaneo DVM,Negative
    merrier,Francesco Turturro,Negative
 Breed Distribution,Cancer Papers,Negative
 Clinical Characteristics,Cancer Papers,Negative
 B Cell Chronic Lymphocytic,Cancer Papers,Negative
 Website,ReaderUSA,Positive
 Emerging Treatments,OncLive.com,Negative
 Bone marrow transplantation,Atlas of Science,Positive
 Elderly,Moffitt Research,Positive
   dia,juanchi,Negative
    Dr Barbara Eichhorst,EMJ Hematology,Negative
    Dr Barbara Eichhorst,EMJ Rheumatology,Negative
 ABT monotherapy amp combination trials,EMJ Hematology,Positive
 ABT monotherapy amp combination trials,EMJ Rheumatology,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia Correlation Bet,NK papers,Negative
    Chronic Lymphocytic Leukemia Foundation,MoreFunz,Negative
   Economic Burden,HealthEconBot,Positive
 QualityofLife Effects,HealthEconBot,Positive
 Featured CME Case,myCME,Negative
 YearOld White Male,myCME,Negative
 q Deletion,myCME,Negative
 Plan,Patient Empowerment Network,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia Correlation Betw,Cure Cancer Now,Negative
   Sementara itu,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 pasien Chronic Lymphocytic Leukemia CLL,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 dying disease progression,Süíâmon M‚≠ïÔ∏è‚≠ïÔ∏èijaart,Positive
 Global BCell Chronic Lymphocytic Leukemia Pipeline Review H,Run Direct Magazine,Positive
 Praia,Allan Alves de Jesus,Positive
 Peru√≠be,Allan Alves de Jesus,Positive
 Young Elderly Patients,Oncology Nursing News,Negative
 Dr Estov,Patient Power,Negative
   treatment home run,Patient Power,Negative
 Nuevos f√°rmacos,Teresa Bau,Positive
 Dr Bosch,Teresa Bau,Positive
   Sedangkan leukemia kronik,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 Chronic Lymphocytic Leukemia CLL pasien biasanya tidak mengeluhkan gejala,INFO Kebutuhan Darah dari Blood4LifeID,Negative
 Medcomic,Kerri Connell,Positive
 BCell Chronic Lymphocytic Leukemia Industry ‚Äì Pipeline Review H,Run Direct Magazine,Positive
 Novel Treatments,Targeted Oncology,Positive
 Novel Treatments,LightTheNightOntario,Positive
 Novel Treatments,Dr Ortega,Positive
 Novel Treatments,NACDA Program on Aging,Negative
 Novel Treatments,CLL Society Inc.,Negative
 Novel Treatments,Sandra Kear,Positive
 Special Cases,Targeted Oncology,Positive
 Special Cases,LightTheNightOntario,Positive
 Special Cases,Dr Ortega,Positive
 Special Cases,NACDA Program on Aging,Negative
 Special Cases,CLL Society Inc.,Negative
 Special Cases,Sandra Kear,Positive
   semana para,juanchi,Negative
 el debut,juanchi,Negative
 Liga Provincial,juanchi,Negative
 April   Role,Targeted Oncology,Negative
 Maintenance treatment,OncLive.com,Negative
 Popular   interviews,Patient Power,Negative
 Drs Sharman Lamanna Keating Leclair,Patient Power,Negative
 assistance,Dr. Hedrick,Positive
 BTKdependent cell proliferation,MoJo,Negative
 Heightened BTKdependent cell proliferation,Cancer Papers,Negative
 Related,Patient Power,Negative
 Familietrek van de Finkers,Inge Klinkert,Positive
 Herman,Inge Klinkert,Positive
 de acceptatie van leukemie,Inge Klinkert,Positive
 Mooi Ik,Inge Klinkert,Positive
 dat,Inge Klinkert,Positive
 Lemanne et al,Cureus,Positive
 Chronic Lymphocytic Inflammation,Cancer Papers,Negative
 Pontine Perivascular Enhancement Responsive,Cancer Papers,Negative
 Infinity,ComplexPharm,Positive
 Infinity,pharmabr,Negative
 Infinity,Danvantri Farma,Negative
 Infinity,"Bruce Rogers, Ph.D.",Positive
 Infinity,Jason Ford,Positive
 Infinity,Mike McFarlane,Positive
 Infinity,Matt Miller,Positive
 Infinity,Scott Werntz,Negative
 target enrollment,ComplexPharm,Positive
 target enrollment,pharmabr,Negative
 target enrollment,Danvantri Farma,Negative
 Phase   study,ComplexPharm,Positive
 Phase   study,pharmabr,Negative
 Phase   study,Danvantri Farma,Negative
    Roundtable w,Patient Power,Negative
 Professor Gribben,Patient Power,Negative
 Improves Outcomes,CancerTherapyAdvisor,Negative
   Ibrutinib Bests Chlorambucil,Oncology,Negative
   Ibrutinib Bests Chlorambucil,PracticeUpdate,Negative
 Obinutuzumab Novel AntiCD Monoclonal Antibody,Cancer Papers,Negative
 CLL Society Newsletter,CLL Society Inc.,Negative
 Dr Furman Answering Chronic Lymphocytic,CLL Society Inc.,Negative
 Surprise   gift,„Ç≥„É™„É≥ „ÅØ„Çì,Positive
 Dinaciclib,Oncology,Negative
 Dinaciclib,PracticeUpdate,Negative
 Potential Activity,Oncology,Negative
 Potential Activity,PracticeUpdate,Negative
 New BTK Inhibitor,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Isochromosome q,Cancer Papers,Negative
 Checklisten f√ºr,Roche Deutschland,Negative
 Qamp,Patient Power,Negative
   PubMed listing,Lymphoma Hub,Negative
 Decembers,Lymphoma Hub,Negative
 best Lymphoma CLL articles,Lymphoma Hub,Negative
 RORROR receptor,Marta Crespo,Negative
 amp Dr Burger,Patient Power,Negative
 Treanda amp Rituxan,MORE Health,Positive
 ÿ¨ÿßŸÖÿπÿ©,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Pennsylvania,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Pennsylvania,Immunology,Positive
 Pennsylvania,DarrasLaw,Positive
 Collection,Patient Power,Negative
 ACP Bruton,CancerConnect,Negative
 Tyrosine Kinase Inhibitor Safe,CancerConnect,Negative
 Expert Dr Jeff Sharman,Patient Empowerment Network,Negative
 Œ≤ Microglobulin Normalization,Oncology,Negative
 IbrutinibTreated,Oncology,Negative
 Hope Challenges,Clinical Pharmacy,Negative
 Hope Challenges,LightTheNightOntario,Positive
 Hope Challenges,LLSCanada,Negative
 Hope Challenges,Scott Werntz,Negative
 Awesome meeting,BaronVonFunkenstein,Positive
 Richters patients,Matthias Piesche,Negative
 Lag times,NDMPapers,Positive
 Pubmed Lag times,epigenetics_papers,Negative
 Exciting advance,Prof John,Negative
 CLLSLL therapy,Prof John,Negative
 Bespoke Human Immune Cell Assays,Prof John,Positive
    Outlook,CancerWallonia,Negative
   de diciembre,Giovanni Ariza Sanch,Positive
 de   Gala artistica corporaci√≥n cultiba,Giovanni Ariza Sanch,Positive
 los esperamos,Giovanni Ariza Sanch,Positive
 Wholeexome sequencing,TumorImmunoPapers,Negative
 Wholeexome sequencing,CompBiolPapers,Negative
 Blood Commentary Idealisib,Blood Journal,Negative
 NEJM Original Article Ibrutinib,"Sean Young, PhD",Positive
 Hematologyoncology case,Med-IQ,Positive
 Clinical Trials Observations Frontline idelalisib,Blood Journal,Negative
 La banda,Florencia,Negative
 La banda,juanchi,Negative
   comments,Teresa Bau,Positive
 √≠ticaDelAmor por,Carlos Llavador,Negative
 estar,Carlos Llavador,Negative
 lo m√°s alto,Carlos Llavador,Negative
 Ph study,"Navneet Majhail, MD, MS",Negative
 Large Granular Lymphocytic Leukemia,Susan Murphy,Positive
 Large Granular Lymphocytic Leukemia,CancerTherapyAdvisor,Negative
 Dr Elaine Schattner,Andrew Schorr,Negative
 DanaFarber RT PatientPower,"Sean Young, PhD",Positive
 andrewschorr,"Sean Young, PhD",Positive
 Fellow   experts,Patient Power,Negative
 Dr Jeff Forman,Patient Power,Negative
     s Dr Jennifer Brown,Patient Power,Negative
 Italiana,Carlos Llavador,Negative
 Concept Elicitation,Paul Wicks,Positive
 PatientPowered Research Networks,Paul Wicks,Positive
 Feasibility Study,Paul Wicks,Positive
 tcogbkqoeNjG,Francesco Turturro,Negative
 Therapeutic Combinations,Oncology Consortium,Negative
 Therapeutic Combinations,OncLive.com,Negative
 Sequences,Oncology Consortium,Negative
 Sequences,OncLive.com,Negative
 qd,Pico üíâüíâ,Positive
 compare,Pico üíâüíâ,Positive
   RHHBY Touts,BioSpace,Positive
    interview,Patient Power,Negative
 w   expert,Patient Power,Negative
 ampthen,Patient Power,Negative
 pill,Swedish,Positive
 chemo infusions,Swedish,Positive
 BLymphoblastic Leukemia,UKNEQASLI,Positive
 Chronic Lymphocytic Leukemia Report,UKNEQASLI,Positive
 Bendeka injection,Oncology Nursing News,Negative
 Ki,SexGenomics,Negative
 Missed,Living Safely,Positive
 rapidinfusion Bendeka,Oncology Nursing News,Negative
 LSS,Kelvin Dickenson,Positive
 tradition,Kelvin Dickenson,Positive
 Join   tonite,Winship Cancer Institute of Emory University,Negative
 Clinical Trial Results,WUN,Positive
 Clinical Trial Results,Drug Discovery & Dev,Positive
 Telephones,Javier Jara,Positive
 FMNI Student leadership Art Workshop,Pearl Ortiz,Positive
   today,Pearl Ortiz,Positive
 Frontline Imbruvica,Sheri Hendricks,Positive
 Frontline Imbruvica,CURE Magazine,Negative
 Frontline Imbruvica,Bill Rodgers,Negative
 Frontline Imbruvica,Survival Plan Kits,Negative
 Gracias gracias,ùíûùíæùìÉùíπùìé¬†ùíØ‚Ñ¥ùìáùìá‚ÑØùìà üå∏,Positive
 sus,ùíûùíæùìÉùíπùìé¬†ùíØ‚Ñ¥ùìáùìá‚ÑØùìà üå∏,Positive
    Drug Combination,Comfycozys for Chemo,Positive
 Jeffrey Jones MD,Targeted Oncology,Negative
 Collaborators,Rx Times¬Æ,Positive
 Present New Data,Rx Times¬Æ,Positive
 Reports Phase,Salutedomani,Positive
 Reports Phase,fainfo salute,Positive
 Reports Phase,Derma News OK,Positive
 Reports Phase,saluteH24.com,Positive
 Reports Phase,Antonio Caperna,Positive
 Reports Phase,Dr. Melody Davis,Negative
 Reports Phase,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 Reports Phase,IntoxicatedTrader,Negative
 Reports Phase,Financial Buzz,Negative
 Reports Phase,wallstreet:online.de,Positive
 Reports Phase,Frank,Positive
 Reports Phase,Roche,Negative
 Reports Phase,Aktienmanufaktur,Negative
 Reports Phase,VPO/PR Newswire,Negative
 Reports Phase,stocksandmoney.com,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia Patients,Salutedomani,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia Patients,Derma News OK,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia Patients,saluteH24.com,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia Patients,Antonio Caperna,Positive
 Veux rajouter un projet,Lory,Positive
 Generic Bendamustine,Targeted Oncology,Negative
   Penn Study Mutations,Healthcanal,Negative
   Chronic Lymphocytic Leukemia Patients,Healthcanal,Negative
 NextGeneration Drug Challenging Imbruvica,CURE Magazine,Negative
 near   ORR,Targeted Oncology,Positive
 Kinase inhibitor,Oncology Nursing News,Negative
 funding research,Kate Evans,Positive
   announces,European Pharmaceutical Review,Negative
   announces,PharmaCentra,Positive
   announces,Novartis,Positive
 MEDICINE Ibrutinib,JebSource,Positive
 Chronic Lymphocytic    study summary,doctorportal,Negative
 Dr Diego Villa,Canadian Hematology,Positive
 Watch Dr Diego Villa,CARE‚Ñ¢ Education,Negative
 rapidinfusion,MDedge Hematology & Oncology,Negative
 ‡§Ü‡§Ø‡•Å‡§∑ ‡§¶‡§∞‡•ç‡§™‡§£ Chronic Lymphocytic Leukemia Mutations,DR NAVIN CH. JOSHI,Positive
 Relapsed Chronic Lymphocytic   study,doctorportal,Negative
 NewEvidence team,NE Live,Negative
 Dr Tedeschi,NE Live,Negative
 pendulum,Society of Hospital Medicine,Positive
 Relapsed Refractory Chronic Lymphocytic Leukemia Patients wit,Salutedomani,Negative
 work life,Society of Hospital Medicine,Positive
 Appropriate Choice,Oncology,Negative
 Pts w Previously Chronic,Oncology,Negative
 halves,CancerWallonia,Negative
 Chronic Lymphocytic   Mutations,Medindia.net,Negative
 New Uses,Medindia.net,Negative
 New Uses,Gendron Recherche,Negative
 New Uses,Cancer Daily,Negative
 Existing   Drugs,Medindia.net,Negative
   survival rates,Targeted Oncology,Negative
 frontline ibrutinib,Targeted Oncology,Negative
 Jan Burger    Ibrutinib,Tapan Kadia,Negative
 RESP ORR CR MRD,Tapan Kadia,Negative
 ADV grps p CRORR unmut CRORR FluRef CRORR,Tapan Kadia,Negative
 pts doseescalation mgd xpansion,Tapan Kadia,Negative
 w   novel drug trials,Tapan Kadia,Negative
 frontline ACP,Tapan Kadia,Negative
 RR pts amp ABT,Tapan Kadia,Negative
 New Treatment Option,Yost Pharmacy Inc,Positive
 Adult Leukemia,Yost Pharmacy Inc,Positive
 CLL drugs,Shankara Paneesha,Negative
 BCL wVenetoclax,"chadi nabhan MD, MBA, FACP",Negative
 Generic         FDA,Sandra Kear,Positive
 Sustainable Pricing,Dr. Melody Davis,Negative
 Sustainable Pricing,Diaceutics PLC,Negative
 Oral Treatments,Dr. Melody Davis,Negative
 Oral Treatments,Diaceutics PLC,Negative
   Approves Generic,CancerWallonia,Negative
 Chronic Lymphocytic Leukemia pts,Market Ready Rx,Positive
 Idelalisib Trial,Chris Ralph,Positive
 Overwhelming Efficacy,Chris Ralph,Positive
 Selective targeting,Senology,Positive
 Q Chronic Lymphocytic Leukemia SnapShot,"dtw Research, Inc",Positive
 coincidence,rattenniMD,Positive
 ASH Ibrutinib,rattenniMD,Negative
 CyclinDependent    PA Induces Apoptosis,Reaction Biology,Positive
 JNKp MAPKDependent Manner,Reaction Biology,Positive
 Chronic Lymphocytic   BCells,Reaction Biology,Positive
 Metabolism pathways,microRNApapers,Negative
   immunotherapy therapy CTL,Speaking of Research,Positive
 GM mice,Speaking of Research,Positive
 Phase III combination study data,Roots Analysis,Negative
 RT   Venetoclax,Bradley Arcuri,Positive
 Superb overview,David Kroll,Positive
 antibcl drug,David Kroll,Positive
   oncologist colleague,David Kroll,Positive
 Forbes Venetoclax,STU,Positive
 J Sitra Dior,J Sitra Dior,Positive
 Buy Lops,J Sitra Dior,Negative
 Real Reason,J Sitra Dior,Negative
 Principled ‚Äô Celebrities,J Sitra Dior,Negative
 Public,J Sitra Dior,Negative
 NovicesVenetoclax,3novices,Positive
     Venetoclax,Juan Garcia,Positive
 Forbes   Venetoclax,VisualAssay,Positive
   Day,IScienceWriter,Positive
   Day,Sue Pearson,Positive
   Day,Tom Carleton,Positive
 Big Advances,IScienceWriter,Positive
 Big Advances,Sue Pearson,Positive
 Big Advances,Tom Carleton,Positive
 Big Advances,NACDA Program on Aging,Negative
 Breakthrough therapy designation,ASST Ospedale Niguarda,Positive
 NEJM Ibrutinib,Christie Library,Positive
 Chronic Lymphocytic Leukemia Mutations,Gendron Recherche,Negative
 Chronic Lymphocytic Leukemia Mutations,Cancer Daily,Negative
 Safety Concerns,CancerWallonia,Negative
 Obinutuzumab vsRituximab,Ahmad Halwani,Positive
 CITTreated,Ahmad Halwani,Positive
 Bendeka,JADPRO,Negative
 ‚Ñ¢ injection,JADPRO,Negative
 formulation,JADPRO,Negative
 Watch Los Lobos,Los Lobos,Negative
 Short,Los Lobos,Negative
 Research News Chronic    patients,Living Safely,Negative
 Leukemia patients,Diabetes Greg,Positive
 Leukemia patients,HealthyTabs/pharmacy,Positive
 Leukemia patients,Gary Skinner,Positive
 Leukemia patients,SanFranciscoTickets,Positive
 Leukemia patients,Naim Khan,Positive
    Survival,Sandra Kear,Positive
    Shows,Sandra Kear,Positive
   Results,Empire Genomics LLC,Positive
   Results,RareCancersAustralia,Positive
 Pivotal Phase   study,1stOncology,Negative
 Pivotal Phase II Study,Mike Gauthier,Negative
 Pivotal Phase II Study,Health|VBProfiles,Positive
 Pivotal Phase II Study,Aktienmanufaktur,Negative
 Pivotal Phase II Study,BusinessWireProducts,Negative
 Pivotal Phase II Study,dlvr news,Negative
 Pivotal Phase II Study,Business Wire-Health,Negative
 Pivotal Phase II Study,Business Wire-TS,Negative
 Pivotal Phase II Study,dlvr health,Negative
 Pivotal Phase II Study,CPhI Online,Positive
 Pivotal Phase II Study,Brighter Futures Inc,Positive
 Pivotal Phase II Study,Scott Werntz,Negative
    superior,Oncology Central,Positive
    ABT LBA,NYCDoc29,Negative
     AEs,NYCDoc29,Negative
     Nodes,NYCDoc29,Negative
     wow ABT drops counts,NYCDoc29,Negative
 rocket,NYCDoc29,Negative
    LBA,NYCDoc29,Positive
   Zelenetz Idelalisib,Chan Cheah,Negative
 PFS HR,Chan Cheah,Negative
 OS HR,Chan Cheah,Negative
 benda rituximab,Chan Cheah,Negative
   LBA,NYCDoc29,Negative
 Gilead study,Gilead Sciences,Negative
 GILD Phase,$Stocknewsalerts,Negative
 GILD Phase,MAISA,Negative
 Stock News Alerts,$Stocknewsalerts,Negative
 GILD   Phase,Aserrano,Positive
 GILD   Phase,scottidiego,Positive
 Bendamustine amp Rituximab,Aserrano,Positive
 Bendamustine amp Rituximab,scottidiego,Positive
 IBRUTINIB IMBRUVICA,Mohammed Saied Faraj,Positive
 IBRUTINIB IMBRUVICA,Ahmed Dahduli,Positive
 TREATMENTNAIVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS,Mohammed Saied Faraj,Positive
 TREATMENTNAIVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS,Ahmed Dahduli,Positive
 Big advances,The Leukemia & Lymphoma Society,Negative
 ASH Ibrutinib Bests Chlorambucil,Doctors Lounge,Negative
 firstline   use,Regulatory Insights,Positive
 tcovkHWdxLVYX,Regulatory Insights,Positive
 RESONATE Data Robust Clinical Activity,IntoxicatedTrader,Negative
   Ma,Chan Cheah,Negative
 irrespective,Chan Cheah,Negative
 PennMedNews Chronic Lymphocytic Leukemia Patients,ivy science,Negative
 game changer,Linsen T. Samuel,Positive
 relapsed CLLSLL,Linsen T. Samuel,Positive
 New   Drug,The Rob Branham Foundation,Positive
 Helena,UFCW Canada,Positive
 diagnosis Helena,UFCW Canada,Positive
 Ultra,The ASCO Post,Negative
   Chronic lymphocytic   mutations,Steve Wawman,Positive
   Chronic lymphocytic   mutations,Science Progress,Positive
 ibrutinib superior,Scott Merville,Negative
 death amp disease progression,"Pharmacyclics, an AbbVie Company",Negative
 w chemo chlorambucil,"Pharmacyclics, an AbbVie Company",Negative
 Chronic Lymphocytic Leukemia Study,Afshine Emrani  MD FACC,Positive
 Chronic Lymphocytic Leukemia Study,Immuno-Oncology News,Positive
 Drug Alternative,Afshine Emrani  MD FACC,Positive
 –ò–∑—Ä–∞–∏–ª–µ–°—Ç–∞—Ç—å—è —Ü–µ–ª–∏–∫–æ–º,–õ–µ—á–µ–Ω–∏–µ —Ä–∞–∫–∞,Negative
 Existing Cancer Drugs Min,First4Training,Positive
 PennMedNews Penn Study Mutations,ivy science,Negative
 Phase   Venetoclax,Cancer Cell,Negative
 NORTH CHI,Dr. Melody Davis,Negative
 NORTH CHICAGO Ill D,Dr. Melody Davis,Negative
 dogs Mutations,Nelson,Positive
 Announces New England Journal,Health News view,Positive
 Announces New England Journal,militaryape,Positive
 Announces New England Journal,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 Announces New England Journal,Medicine World,Positive
 Announces New England Journal,Medicine Plaza,Positive
 Announces New England Journal,Dora Wurth,Positive
 Announces New England Journal,MilitaryLoop,Positive
 Announces New England Journal,Aktienmanufaktur,Negative
 Announces New England Journal,PRNhealth,Positive
 Announces New England Journal,PRN Biotech,Negative
 Announces New England Journal,IntoxicatedTrader,Negative
 FINANCIAL,Health News view,Positive
 FINANCIAL,Bill Rodgers,Negative
 FINANCIAL,Survival Plan Kits,Negative
 BOOM,Holahola,Positive
 Follow KevinFitts,KevinFitts,Positive
 Medicine Online Publication,militaryape,Positive
 Medicine Online Publication,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 Medicine Online Publication,Medicine World,Positive
 Medicine Online Publication,Medicine Plaza,Positive
 Medicine Online Publication,Dora Wurth,Positive
 Medicine Online Publication,MilitaryLoop,Positive
 Medicine Online Publication,Aktienmanufaktur,Negative
 Medicine Online Publication,PRNhealth,Positive
 Medicine Online Publication,PRN Biotech,Negative
 Medicine Online Publication,IntoxicatedTrader,Negative
 Venetoclax Phase,militaryape,Positive
 Venetoclax Phase,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 Venetoclax Phase,MilitaryLoop,Positive
 Venetoclax Phase,Aktienmanufaktur,Negative
 Venetoclax Phase,PRNhealth,Positive
 Venetoclax Phase,PRN Biotech,Negative
 Venetoclax Phase,IntoxicatedTrader,Negative
 RelapsedRefract,militaryape,Positive
 RelapsedRefract,MilitaryLoop,Positive
 ABBVIE ANNOUNCES NEW ENGLAND JOURNAL,Ahmed Dahduli,Positive
 MEDICINE ONLINE PUBLICATION,Ahmed Dahduli,Positive
 VENETOCLAX PHASE,Ahmed Dahduli,Positive
 DATA,Ahmed Dahduli,Positive
 RELAPSEDREFRACTOR,Ahmed Dahduli,Positive
 ABBVIE REPORTS,Ahmed Dahduli,Positive
 RESULTS,Ahmed Dahduli,Positive
 RELAPSEDREFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS,Ahmed Dahduli,Positive
 RELAPSEDREFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS,Douglas Allan,Positive
 P D,Ahmed Dahduli,Positive
 RelapsedRefracto,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 RT ChpHealthcare Mutations,David Cooper,Positive
    Mutations,Derrick,Positive
 New Mutations,Sciences and tech,Positive
   Mining,Nadia Rice,Negative
 NEJM PCYC Ibrutinib,Tom Silver,Negative
 Deshidratados y un poco mariados,Javier Jara,Positive
 OBR,Sean McGrath,Positive
 Kind,Sean McGrath,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia Patients,ùïøùñçùñä ùï¥ùñíùñïùñäùñóùñôùñéùñìùñäùñìùñô üîõ üîú,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Patients,Financial Buzz,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Patients,wallstreet:online.de,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia Patients,Frank,Positive
 RelapsedRefractory Chronic Lymphocytic Leukemia Patients,Roche,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Patients,VPO/PR Newswire,Negative
 RelapsedRefractory Chronic Lymphocytic Leukemia Patients,stocksandmoney.com,Positive
 Connect   Cohort Study,Winship Cancer Institute of Emory University,Negative
 Session Upfront   Therapy,NE Live,Negative
 Transplantation Dec,NE Live,Negative
 Webcast,Michele Nadeem-Baker,Negative
 Webcast,Lymphoma Coalition,Negative
   community members,Patient Power,Negative
 breaking news,Michele Nadeem-Baker,Negative
 breaking news,Patient Power,Positive
 ie nd Generation BTK,Michele Nadeem-Baker,Negative
   NOWY obiecujƒÖcy lek w leczeniu przewlek≈Çej bia≈Çaczki limfatycznej,Medoinfo,Positive
 HardtoTreat Type,Health|VBProfiles,Positive
 HardtoTreat Type,Aktienmanufaktur,Negative
 HardtoTreat Type,Jean-Michel TERME,Negative
 HardtoTreat Type,BusinessWireProducts,Negative
 HardtoTreat Type,dlvr news,Negative
 HardtoTreat Type,Business Wire-Health,Negative
 HardtoTreat Type,Business Wire-TS,Negative
 HardtoTreat Type,dlvr health,Negative
 HardtoTreat Type,CPhI Online,Positive
 HardtoTreat Type,Brighter Futures Inc,Positive
 HardtoTreat Type,Scott Werntz,Negative
   Idelalisib   bendamustine,Medscape Pharmacists,Negative
   Idelalisib   bendamustine,Medscape Oncology,Negative
   Idelalisib   bendamustine,Medscape,Negative
   Pivotal Phase II Study,Jean-Michel TERME,Negative
 Chronic Ly,Jean-Michel TERME,Negative
 RelapsedRef,PRNhealth,Positive
 RelapsedRef,PRN Biotech,Negative
   Qs,Patient Power,Negative
 Ibrutinib VS Chlorambucil,Blood Buff,Positive
 TreatmentNaive Chronic Lymphocytic Leukemia,IntoxicatedTrader,Positive
 TreatmentNaive Chronic Lymphocytic Leukemia,Bio Stocks‚Ñ¢,Negative
 PRESS RELEASE,Pauly@spz_trader,Positive
 PHASE II STUDY,Pauly@spz_trader,Positive
 SHOWED NEARLY,Pauly@spz_trader,Positive
 PEOPLE,Pauly@spz_trader,Positive
 PEOPLE,Health|VBProfiles,Positive
 PEOPLE,BusinessWireProducts,Negative
 PEOPLE,Business Wire-Health,Negative
 PEOPLE,wallstreet:online.de,Positive
 PEOPLE,dlvr news,Negative
 HARDTOTREAT TYPE,Pauly@spz_trader,Positive
 News Ibrutinib IMBRUVICA√Ç,DrugGenius,Negative
 Pha,DrugGenius,Negative
 News AbbVie,Roche,Negative
 RelapsedRefractory Chronic Lymphocytic Le,Aktienmanufaktur,Negative
 response rate duration amp survival,C. Michael Gibson MD,Positive
 w chlorambucil,C. Michael Gibson MD,Positive
 death disease progression,C. Michael Gibson MD,Positive
 Chronic Lymphocytic Leukemia Data,MedChem & ONCo,Negative
   survival rate,MedChem & ONCo,Negative
 abbv,Douglas Allan,Positive
 PH RESULTS,Douglas Allan,Positive
 P DELETION,Douglas Allan,Positive
   Press Program,JanssenUS,Negative
 GEN   RESONATE   data,JanssenUS,Negative
 Expert w Dr Sharman,Patient Power,Negative
 eastern,Patient Power,Negative
 Prolymphocytic Leukemia,Roche,Negative
 NEW RESULTS,Health|VBProfiles,Positive
 NEW RESULTS,BusinessWireProducts,Negative
 NEW RESULTS,Business Wire-Health,Negative
 NEW RESULTS,wallstreet:online.de,Positive
 NEW RESULTS,dlvr news,Negative
 CLL STUDY GAZYVA,Health|VBProfiles,Positive
 CLL STUDY GAZYVA,BusinessWireProducts,Negative
 CLL STUDY GAZYVA,Business Wire-Health,Negative
 CLL STUDY GAZYVA,wallstreet:online.de,Positive
 CLL STUDY GAZYVA,dlvr news,Negative
 UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA,Health|VBProfiles,Positive
 UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA,BusinessWireProducts,Negative
 UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA,Business Wire-Health,Negative
 UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA,dlvr news,Negative
 UNTREATED CHRONIC LYMPHOCYTIC LEUKEM,wallstreet:online.de,Positive
 Roche ASH,MedChem & ONCo,Negative
 Orlando Data,MedChem & ONCo,Negative
 Chronic Lymphocytic Leukemia CLL amp nonHodgkin lymphoma NHL,MedChem & ONCo,Negative
 highlight progress,Gilead Sciences,Negative
 indolent,Gilead Sciences,Negative
 gt abstracts,Gilead Sciences,Negative
   latebreaker,Gilead Sciences,Negative
 Lipid Raft Proteome,Proteo & Bioinfo,Positive
 Human MEC Chronic Lymphocytic Leukemia Cells,Proteo & Bioinfo,Positive
 Lo q,Bella Carstairs,Negative
 yo por conseguir,Bella Carstairs,Negative
 uno de esos marcap√°ginas cuquis cuquis firmados por,Bella Carstairs,Negative
 ‚ô• ‚ô•,Bella Carstairs,Negative
 Latest   News feat interviews,Patient Power,Negative
 w Drs Jeff Sharman amp Kanti Rai,Patient Power,Negative
 Del p,"Pharmacyclics, an AbbVie Company",Negative
 Lymphoproliferative Disorders,Hospital Medicine Virtual Journal Club,Positive
 MOLECULAR HETEROGENOUS DISEASE,Medibooks,Negative
   Quality Improvement Approach,CureHuntr,Negative
 LeukemiaSMUDGE CELLS,Baby MLSüë∂üëº,Positive
   antiCD antibodies,OncLive.com,Negative
 CLL work,OncLive.com,Negative
   Inhibitor ACP,Christopher Steer,Negative
 Marked Activity,Christopher Steer,Negative
 Favorable Safety Profile,Christopher Steer,Negative
 Venetoclax ABT Monotherapy,Christopher Steer,Negative
   Vs Chlorambucil,Christopher Steer,Negative
    Needs,Equality Couple,Negative
 RETWEET,Equality Couple,Negative
 Dr Rodney T Miller,ProPath,Positive
 CLLSA Meeting,Esther Wroughton,Positive
 Chronic     Cancer,Esther Wroughton,Positive
 Xose de Puente Mon   Nov,IMPPC,Positive
 IMPPC,IMPPC,Positive
 Byrd JC Furman RR Coutre SE et al Targeting BTK,Coding Inside,Positive
 Saliendo para gchu queremos la copa,juanchi,Negative
 Morton LM Curtis Linet MS et al Second malignancy risks,Coding Inside,Positive
 nonHodgkins lymphoma,Coding Inside,Positive
 nonHodgkins lymphoma,Megan Johnson,Positive
 TURNN UPP W GIRL,Daisyüíã,Positive
 Chronic Lymphocytic Leukemia Therapeutics Global Market Research Report Industry,Swapnil Devale,Negative
 Ongoing Role,OncLive.com,Negative
 Community Matters New Blog,Patient Power,Negative
 CJ,Patient Power,Negative
 gchu,juanchi,Positive
 dark,NACDA Program on Aging,Negative
 genomeIn Cell Death amp,NACDA Program on Aging,Negative
 DifferentiationtcofbcitvRt,NACDA Program on Aging,Negative
 System Money,Patient Power,Negative
    ‚úå,Florencia,Positive
 CacyBPSIP,SexGenomics,Negative
 Farhana,Schlesinger Group UK,Positive
   United States Chronic Lymphocytic Leukemia Therapeutics Industry Review,Pitch Ticker,Positive
 Axl,Steve Warner,Positive
 FGFR pathway,Steve Warner,Positive
   Spotlight,ASH,Negative
 novel mechanism,ASH,Negative
 Con los ni√±os,Mr. Ma√±as,Positive
 Planet,Mr. Ma√±as,Positive
 plenty,cnaamani,Positive
 Dr Michael Keating Reflections,Patient Power,Negative
 Clinical Trials Novel Therapeutics,Penn Medicine MD,Positive
 Duvelisib Treatment,Immuno-Oncology News,Positive
 Videos   s Sept Patient Cafe,Patient Power,Negative
 √≠a DETECTION,Medibooks,Negative
 CUSTOM ARRAY PLATFORM,Medibooks,Negative
   acquires,btobioinnovation,Positive
 Mijn zus,Jacquelien (wat een toestand moidje),Negative
 jarig,Jacquelien (wat een toestand moidje),Negative
 op haar e verjaardag gaf ze ons broer,Jacquelien (wat een toestand moidje),Negative
 zijn e leven,Jacquelien (wat een toestand moidje),Negative
 Arsenal game,James Ball,Positive
 Carzorla   man,James Ball,Positive
 Chem Combined CXCRCXCR measurements,ImmunologyPapers,Negative
 CAL,Oncology Tube,Positive
 tcoJwTtrDY,NACDA Program on Aging,Negative
 CE opportunity,JADPRO,Negative
 Axl inhibitor,Steve Warner,Positive
 Thomas Kipps MD PhD,Targeted Oncology,Negative
 OB,Bioinformatics Feeds,Positive
 Cure   Day Zero,Janette Fuller,Positive
 janettefullerblogspotcomatransplantforcuredayzerohtmlspreftw,Janette Fuller,Negative
 Superior Efficacy,Dr Ortega,Negative
 Superior Efficacy,pharmatutor,Positive
 Superior Efficacy,aeses.com,Negative
 Phas,Dr Ortega,Negative
   Transplant,Janette Fuller,Positive
 DIFFERENTIATE,Briana,Positive
 MYELOID LEUKEMIA CHRONIC MYELOID LEUKEMIA,Briana,Positive
 LYMPHOCYTIC LEUKEMIA,Briana,Positive
 CHRONIC LYMPHOCYTIC LEUKEMIA UGH,Briana,Positive
 Idelalisib trial,The ONC,Positive
 DH Cancer Drug Fund,CLLSA,Negative
 Chronic Lymphocytic Leukemia Therapeutics Strategies Market Research Report     blog,Mark Research new,Positive
 Chronic Lymphocytic Leukemia Therapeutics Strategies Market Research Report     blog,Market Research,Positive
 Chronic Lymphocytic Leukemia Therapeutics Strategies Market Research Report     blog,Paid Search agent,Positive
   XHyvqf,FullyFunctionalPhil,Positive
 Neupogen Shot,Janette Fuller,Negative
 Stem Cell Donation,Janette Fuller,Negative
 Treanda,CancerConnect,Negative
 CLL isolation,Prof John,Negative
 Completion,"Bruce Rogers, Ph.D.",Positive
 Completion,Jason Ford,Positive
 Completion,Mike McFarlane,Positive
 Completion,Matt Miller,Positive
 DUO,"Bruce Rogers, Ph.D.",Positive
 DUO,Jason Ford,Positive
 DUO,Mike McFarlane,Positive
 DUO,Matt Miller,Positive
 CAMBRIDGE Mass Nov,"Bruce Rogers, Ph.D.",Positive
 Stem Cell Transplantation,OncLive.com,Negative
 Study   CAMBRIDGE Mass Nov    P,Jason Ford,Positive
 Study   CAMBRIDGE Mass Nov    P,Mike McFarlane,Positive
 hotri,The Bodykit Channel,Positive
    Offer,CancerWallonia,Negative
 Zydelig Trial Unblinded,Personalized Nutrition Intervention 24/7 On Demand,Negative
 Clear Survival Benefit,Personalized Nutrition Intervention 24/7 On Demand,Negative
 HIGHGRADE LYMPHOMA CHRONIC LYMPHOCYTIC LEUKEMIA,Medibooks,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIAPHENOTYPE,Medibooks,Negative
 RT   Gilead leukemia drug trial,Bryan Zwan,Positive
 Gilead leukemia drug trial,HHF,Negative
 ‚Ñ¢ Phase,Matt Miller,Positive
 Proliferation centres,Cancer Papers,Negative
 Goedemorgen,Jacquelien (wat een toestand moidje),Negative
 werken dan,Jacquelien (wat een toestand moidje),Negative
     Halts,CancerWallonia,Negative
 Imbruvica Phase III combination data,European Pharmaceutical Review,Negative
 GILD combo,Ali Urman,Positive
 Gilead GILD,Ralph Casale,Positive
 Romans,Lifelong Learning,Negative
 Words,Lifelong Learning,Negative
 ÿßŸÑŸàŸÉŸäŸÖŸäÿß ŸÑÿßŸäŸÜÿ™ŸÇŸÑ,ÿ®ŸÜŸÉ ÿßŸÑÿØŸÖ ÿßŸÑŸÖÿ´ÿßŸÑŸäü©∏üá∏üá¶,Positive
 ÿ∑ÿ±ŸäŸÇ ŸÜŸÇŸÑ ÿßŸÑÿØŸÖ ŸÉŸÖÿß ŸÉÿßŸÜ Ÿäÿπÿ™ŸÇÿØ,ÿ®ŸÜŸÉ ÿßŸÑÿØŸÖ ÿßŸÑŸÖÿ´ÿßŸÑŸäü©∏üá∏üá¶,Positive
 Cure   Transplant Countdown,Janette Fuller,Negative
 Stem Cell Donor,Janette Fuller,Negative
 Neupogen Injection,Janette Fuller,Negative
 Moving Forward,Janette Fuller,Negative
 CLINICAL SIGNIFICANCE,Cancer Papers,Negative
 BAXBCL RATIO,Cancer Papers,Negative
 Final   league dinner,Monton Sports Club,Positive
 Spontaneous Immunity,Dendritic cells,Positive
 Spontaneous Immunity,Krishan Maggon,Negative
 Receptor Tyrosine Kinase ROR,Dendritic cells,Positive
 Receptor Tyrosine Kinase ROR,Krishan Maggon,Negative
 Blood LPL,"Chris Cogbill, MD",Positive
 amp mast cells,"Chris Cogbill, MD",Positive
 Distinct mast cells,"Chris Cogbill, MD",Positive
   cancer,Marilyn Tarpley,Positive
 Blood Transfusion,Labcold üíô,Positive
 Blood Transfusion,CancerTherapyAdvisor,Negative
 Blood Transfusion,Christopher Steer,Negative
 Blood Transfusion,NACDA Program on Aging,Negative
 Blood Transfusion,"Tom Iarocci, MD",Negative
 Afternoon Session,Patient Power,Negative
 Replay   Town Meeting,Patient Power,Negative
 Worldfirst blood cancer drug trial,Kathryn Stephens,Positive
 legacy,Dr Lesly Huxley,Positive
 Restorative Approaches,Lifelong Learning,Negative
 Schools,Lifelong Learning,Negative
 Drug ‚Äò lifechanging,MDedge Hematology & Oncology,Negative
   Eichhorst,Christopher Steer,Negative
    EichhorstTake,Christopher Steer,Negative
 Treatment practice,Christopher Steer,Negative
 Modern Art,Lifelong Learning,Negative
 Feature Chronic Lymphocytic Leukemia,CancerTherapyAdvisor,Negative
 Phew Chronic Lymphocytic Leukemia,Christopher Steer,Negative
 music,Lifelong Learning,Negative
 receptor T cells,Fuera los cubanos,Positive
 sustained remissions,Fuera los cubanos,Positive
 sustained remissions,GEG-tech.com,Positive
 sustained remissions,andira bintang,Positive
 sustained remissions,Human Immunology News,Negative
 sustained remissions,MS Papers,Positive
 sustained remissions,Francesco Turturro,Negative
 sustained remissions,Dominique,Positive
 sustained remissions,Krishan Maggon,Negative
 sustained remissions,"Bruce Levine, Ph.D.",Positive
 sustained remissions,Gaurab Chakrabarti,Positive
 Glad    webinars,Dr.Gretchen Morrison,Positive
 Ts,Dr.Gretchen Morrison,Positive
 w Ss,Dr.Gretchen Morrison,Positive
   UpdateNew Data amp Analysis,Advera Health,Negative
 Study medieval England,Lifelong Learning,Negative
 Norman Conquest,Lifelong Learning,Negative
 Dandy Highwayman Romantic rogue,Lifelong Learning,Negative
 Boa noite amantes,CLL,Negative
 February   Dr Wu,LLSTennessee,Positive
 LLS,LLSTennessee,Positive
 cures,LLSTennessee,Positive
 Fairview,Jimmy,Positive
 Commentary Ibrutinib,ASH,Negative
 sides,ASH,Negative
 coin,ASH,Negative
 Classification,Download Ebooks,Positive
 CLL Free Ebooks,Download Ebooks,Positive
 Humoral immunity,ASH,Negative
 Online fiction writing,Lifelong Learning,Negative
 Terminando,Malchofa,Positive
 CLL esto,Malchofa,Positive
 lucha,Malchofa,Positive
 Cure   DIY IV Treatments,Janette Fuller,Negative
 Blood Clot,Janette Fuller,Negative
 Donna Fight Chronic Lymphocytic Leukemia,elisha minsal,Positive
 Jeremy Abramson MD FACP,ACP Massachusetts,Positive
 Dr Abramson,Andrew Zimolzak,Positive
 Bcell Pathway Inhibitors,Christopher Steer,Negative
 Clear Benefit,Christopher Steer,Negative
 Clear Benefit,CancerWallonia,Negative
 Dutcher,"Chris Cogbill, MD",Positive
 Cure   Tow Truck,Janette Fuller,Negative
 Prayer,Janette Fuller,Negative
 Robert Kyle award,Vincent Rajkumar,Negative
 coins,CFOLD,Positive
 coins,Lifelong Learning,Negative
 handson access,CFOLD,Positive
 handson access,Lifelong Learning,Negative
   Dr Saleem Shafeek,MDRing,Negative
 LargeScale Genomic Analysis,Dr. Melody Davis,Negative
 New Insights,Dr. Melody Davis,Negative
 Chronology Evolution,Dr. Melody Davis,Negative
 Multiple Recurrent Mutations,CancerTherapyAdvisor,Negative
 Worse Outcome,CancerTherapyAdvisor,Negative
 Cure   Angels,Janette Fuller,Negative
 Haematological Illnesses,BMTx3,Positive
 Bendito sea el momento,lupis citalan,Positive
 la hora,lupis citalan,Positive
 y el lugar donde te conoc√≠,lupis citalan,Positive
 Cure   Fungus,Janette Fuller,Negative
 JTs press conference,Nikki L,Positive
 Obinutuzumab Doses Efficacious,"John C. Wunsch, P.C.",Negative
 Obinutuzumab Doses Efficacious,CancerTherapyAdvisor,Positive
 Obinutuzumab Doses Efficacious,NACDA Program on Aging,Negative
 IBRUTINIB por,Mari√°ngel Gil,Positive
 la noche,Mari√°ngel Gil,Positive
 y con est√≥mago vac√≠o mejora tolerabilidad g√°strica,Mari√°ngel Gil,Positive
 Si artralgia,Mari√°ngel Gil,Positive
 Replay   Town Meeting Morning Session,Patient Power,Negative
 Ups,Patient Power,Negative
 Downs,Patient Power,Negative
   Journey,Patient Power,Negative
 Vemurafenib,HHF,Negative
 Vemurafenib,CancerTherapyAdvisor,Negative
 Relapsed Refractory Hairycell Leukemia,HHF,Negative
 Relapsed Refractory Hairycell Leukemia,CancerTherapyAdvisor,Negative
 incidence rates,Future Science OA,Positive
 Tekort aan afweereiwitten,Hematon,Negative
 chronische lymfatische leukemie,Hematon,Negative
   miles,Dadpreneur,Positive
   miles,Defunct Account,Positive
 IbrutinibAssociated Adverse Events,OncLive.com,Negative
 IbrutinibAssociated Adverse Events,Scott Werntz,Negative
 Cure   Complications,Janette Fuller,Negative
 Cancellations,Janette Fuller,Negative
 tumor suppressor miR contributes,epigenetics_papers,Negative
 Chronic Myeloid LeukemiaChronic Lymphocytic LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia,HANAHRAF,Positive
 Chem Crosstalk,ImmunologyPapers,Negative
 Vuelta Espa√±a por unos d√≠as y,Carlos Llavador,Negative
 el martes,Carlos Llavador,Negative
 Rumbo,Carlos Llavador,Negative
 Tokio,Carlos Llavador,Negative
 Chronic Lymphocytic Leuke,"dtw Research, Inc",Negative
 gimnastas clasificados,Estela de la Torre OLY üá≤üáΩ,Negative
 las preliminares,Estela de la Torre OLY üá≤üáΩ,Negative
 el T√≠tulo Absoluto Individual,Estela de la Torre OLY üá≤üáΩ,Negative
 Annual Exhibition,Richard Drewyor,Positive
 Alumni Artists Club,ASU Art,Positive
 Cure   Super Woman,Janette Fuller,Negative
 checkin counter,TESL Canada,Positive
 morning symposia,TESL Canada,Positive
 Bcl phosphorylation confers resistance,AFFINImeter,Positive
 Bcl phosphorylation confers resistance,Prof John,Negative
 Seminar   Oct Genomewide methylation studies,Shrikant Mantri,Positive
 Akademi bjuder,√Öbo Akademi University,Positive
 Que partido nos trajimos,juanchi,Negative
 dale lucho,juanchi,Negative
 Rasburicaseinduced Heinz body hemolytic anemia,TumorImmunoPapers,Negative
 Rasburicaseinduced Heinz body hemolytic anemia,AtlanticJOMedicine,Negative
 Antigen selection,MDLinx,Negative
 TESL Canada board,TESL Canada,Positive
 Matthew Kauffman,Matthew Kauffman,Negative
 Breakthrough Developments,Hemedicus,Positive
 Bld Cancers,Hemedicus,Positive
 transmission,Dr. Ilin Gilberto de la Torre MD üò∑,Positive
 transmission,NACDA Program on Aging,Negative
 transmission,AtlanticJOMedicine,Negative
 transmission,Dr Gail Miflin,Positive
 transmission,Francesco Turturro,Negative
 transmission,Mehdi Hamadani,Positive
 CARE Perspectives report,Canadian Hematology,Positive
 IWCLL,Canadian Hematology,Positive
 Cure   Campath Summer,Janette Fuller,Negative
 Chronic Lymphocytic LeukemiaThink,Erika,Positive
   shirt,Erika,Positive
 collection,Erika,Positive
    Discusses,CancerWallonia,Negative
 cancer mutations,Lymphoma Hub,Negative
 Scientists Discover Chronic Lymphocytic Leukemia Driver Mutations,NACDA Program on Aging,Negative
 Scientists Discover Chronic Lymphocytic Leukemia Driver Mutations,CancerTherapyAdvisor,Negative
 unknowntcouRLmHrKFg,NACDA Program on Aging,Negative
 Ven probar nuestros exquisitos platos,Bistr√≥ Santa Marta,Positive
 Obinutuzumab Monotherapy,Oncology,Negative
 Obinutuzumab Monotherapy,Tran-Der Tan,Negative
 Retweeted Cancer Therapy Adv Scientists Discover Chronic Lymphocytic Leukemia Driver,Treatment Scores,Positive
   induces,HemOnc Today,Negative
 Longterm Diseasefree Survival,CancerTherapyAdvisor,Negative
 IGHVmutated CLL,CancerTherapyAdvisor,Negative
 Con mi compadre campe√≥n,Malchofa,Positive
 parejas,Malchofa,Positive
 FISH test,Jeff Folloder,Positive
 rain,Patient Power,Negative
 Chronic Lymphocytic Leukemia CLL Small Lymphocytic,podDVR.com - the first VIZdex,Positive
 HEAR,podDVR.com - the first VIZdex,Positive
 CRASH USMLE,Amy Houston,Positive
 Hematopathologist Treatment approach,ASH,Negative
 CLL Powerpoint Presentations,PPT Search,Negative
 DrHallek,"Raul Cordoba, MD, PhD",Negative
 hematogeriatrics,"Raul Cordoba, MD, PhD",Negative
 Valencia Spain,"Raul Cordoba, MD, PhD",Negative
 blood transfusion,NACDA Program on Aging,Negative
 blood transfusion,Francesco Turturro,Negative
 blood transfusion,Mehdi Hamadani,Positive
 Reverse Pseudohyperkalemia,Cancer Papers,Negative
 Important Clinical Entity,Cancer Papers,Negative
 SCANDAT data,Dr Gail Miflin,Positive
 Cure   Bump,Janette Fuller,Positive
 CLL Drives Global RNA,Prof John,Negative
 MYC Translation,Prof John,Negative
 Potential New Therapies,Prof John,Negative
 Inhibitor Synergy,Prof John,Negative
 DNA chip,qGenomics,Negative
 DNA chip,Winter Genomics,Positive
 DNA chip,XploreHealth_en,Positive
 DNA chip,Biotech-Spain.com,Positive
 Elizabeth Shpall MD,OncLive.com,Negative
 idelalisib ibrutinib,OncLive.com,Negative
 Pelotonias dollars,Pelotonia,Positive
    Transplant,Janette Fuller,Negative
 Hemline,aviatebrand,Positive
 BryanCollege Station,aviatebrand,Positive
 Blog   PelotoniaThe Blog   Pelotonia,Philip Payne,Positive
 league cricket,Neil Bonnar,Positive
 Lancashire LgeNth Lg area,Neil Bonnar,Positive
 Initiating Therapy,OncLive.com,Negative
   wicked combo,brett pearson,Positive
 Image,Lifelong Learning,Negative
 CareerBoosting Benefits,Lifelong Learning,Negative
 passage,Lifelong Learning,Negative
 Arctic,Lifelong Learning,Negative
 Orient,Lifelong Learning,Negative
 Byrd Discusses,CancerWallonia,Negative
 Study Charts Genomic Biography,Dana-Farber,Negative
 Commentary FCR,ASH,Negative
 Una nueva familia de anticuerpos m√°s,M@ry Liz,Positive
 para tratar el c√°ncer,M@ry Liz,Positive
 Dozens,Pharmacogenomics,Positive
 poster   Paris,Prof John,Negative
 International Hematology Club,Prof John,Negative
 Gene expression,Fabrice Leclerc,Negative
 Gene expression,CompBiolPapers,Negative
 splicing,Fabrice Leclerc,Negative
 splicing,CompBiolPapers,Negative
 published writer,Lifelong Learning,Negative
 poetry,Lifelong Learning,Positive
 Saturday class,Lifelong Learning,Positive
 Dosing study,Mauricio Salazar,Positive
 Untreated CLL tcopTmBXsiO,NACDA Program on Aging,Negative
 Brief Report Durable Remission,ASH,Negative
 Gene expression amp splicing alterations,BioGPS,Positive
 highthroughput sequencing data,Laboratory Robotics,Positive
 highthroughput sequencing data,PersonalizedMedicine,Positive
 highthroughput sequencing data,LabAutomation (LRIG),Positive
 highthroughput sequencing data,Automated Storage,Positive
 highthroughput sequencing data,Joe Whittaker,Positive
 highthroughput sequencing data,Genetics report,Positive
 highthroughput sequencing data,GeneScan,Positive
 highthroughput sequencing data,Phil Ochs Ghost,Positive
 highthroughput sequencing data,Surma Health & Info.,Positive
 highthroughput sequencing data,AllCEUs Counselor Education with Dawn-Elise Snipes,Positive
 highthroughput sequencing data,VoyagerMed,Positive
 highthroughput sequencing data,Medi-Science Daily,Positive
 PROLONG study,Lymphoma Hub,Negative
 antiCD maintenance therapy,Lymphoma Hub,Negative
 CLL Ibrutinib Therapy,Erika Hunt,Positive
 CLL Ibrutinib Therapy,CLL Society Inc.,Negative
 CLL Ibrutinib Therapy,CancerTherapyAdvisor,Negative
 Lower Rate,Erika Hunt,Positive
 Lower Rate,CLL Society Inc.,Negative
 Lower Rate,CancerTherapyAdvisor,Negative
 Autoimmune Cytopenia,Erika Hunt,Positive
 Autoimmune Cytopenia,CLL Society Inc.,Negative
 Autoimmune Cytopenia,CancerTherapyAdvisor,Negative
 New   post,Patient Power,Negative
 ParentChild Dialogue,Patient Power,Negative
 Patient Powers CLL community,Andrew Schorr,Negative
 partn,Andrew Schorr,Negative
 WeekThatWas,Genetic Engineering & Biotechnology News,Negative
 Tired Weary,Janette Fuller,Negative
 Worn,Janette Fuller,Negative
 Ma√±ana arrancamos la,juanchi,Negative
 Chronic Lymphocytic Leukemia Education Empowerment,EventSetter,Positive
 Chronic Lymphocytic Leukemia Education Empowerment,CanCare Inc.,Positive
 Learni,EventSetter,Positive
 Initial Findings Acceptable Safety,CancerTherapyAdvisor,Negative
 Asymptomatic Highrisk CLL,CancerTherapyAdvisor,Negative
 Adap Lenalidomide,ImmunologyPapers,Negative
 tumorpromoting properties,ImmunologyPapers,Negative
 tcoVERvKMMrQ,NACDA Program on Aging,Negative
 IPH,OncoTherapy Network,Negative
 IPH,Dr. Melody Davis,Negative
 IPH,[iito] Life Science,Positive
 IPH,Innate Pharma,Positive
 IPH,satPRnews,Positive
 near future,OncoTherapy Network,Negative
   Sequencing,Station X,Positive
 Uncovers Driver Genes,Station X,Positive
 Progression Relapse,Station X,Positive
 Mutations driving leukemia,SanFranciscoTickets,Positive
 Learning,CanCare Inc.,Positive
 Learning,jessetink,Positive
 Middle East Molecular Biology Society,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Genetic Background,Molecular Biology(MEMBS) ŸÖÿ¨ÿ™ŸÖÿπ ÿßŸÑÿ®ŸäŸàŸÑŸàÿ¨Ÿäÿß ÿßŸÑÿ¨ÿ≤Ÿäÿ¶Ÿäÿ©,Negative
 Supplemental NDA,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Supplemental NDA,CancerTherapyAdvisor,Negative
 Black Swan Int,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 New Clinical Trial Phase,CLL Society Inc.,Negative
 New Clinical Trial Phase,WCM Lymphoma,Positive
 Evolving    Paradigm,Patient Power,Negative
 tcoefIkESSpjS,Patient Power,Negative
 Poor Outcomes,CancerTherapyAdvisor,Negative
 Acute Leukemia MDS,CancerTherapyAdvisor,Negative
 M milestone,Clarivate Cortellis,Negative
 lirilumab,Clarivate Cortellis,Negative
 Compound,IIBm (CSIC-UAM),Positive
 broccoli,IIBm (CSIC-UAM),Positive
 market deal,Labiotech.eu,Positive
 fatty acids supplementation,expertomega3,Positive
 Chem CCL chemokine expression,ImmunologyPapers,Negative
 CCL chemokine expression,Cancer Papers,Negative
 Testing safety,Lymphomation.org,Negative
 IMMU,Lymphomation.org,Negative
 Relapsed Refractory nonHodgkin,Lymphomation.org,Negative
 Con mi partner,Malchofa,Positive
 Brandon,Malchofa,Positive
 CLL Esto,Malchofa,Positive
 Es Lucha,Malchofa,Positive
 Ac√° apoyando,CasaDelFantico WWE,Positive
 ReplyPrognosis,Lymphomation.org,Negative
 Chronic Lymphocytic LeukemiaLetters,Lymphomation.org,Negative
 Ab Science Paris,Stock_Tracker,Positive
 ABSCF Global BCell Chronic Lymphocytic Leukemia Pipeline Review H,Stock_Tracker,Positive
 Peter Green,Esther Wroughton,Positive
        amp,Esther Wroughton,Positive
 NHL Star Paul Henderson Talks,NACDA Program on Aging,Negative
 Chronic Lymphocytic LeukemiaReply,Cancer Papers,Negative
 Low monocytes,Patient Power,Negative
 lab test question,Patient Power,Negative
 Dai Yuntao,New OhioLINK ETDs,Positive
 TCLMURINE BA CELL,New OhioLINK ETDs,Positive
 SOACloud article,Vikas Gupta,Positive
 Chronic Lymphocytic Leukemia Pipeline Review Report H,Vikas Gupta,Positive
 Penn Memorial Sloan,BioProcessing - Informa Connect,Positive
 Kettering amp National Cancer Institute,BioProcessing - Informa Connect,Positive
 Tcell therapy,BioProcessing - Informa Connect,Positive
 Tcell therapy,JNCI,Negative
 Chronic Lymphocytic Leukemia Pipeline Review H,BusinessWireServices,Negative
 conhe√ßo,Pspspspspspsps,Positive
 minhas metas e os motivos para lutar,Pspspspspspsps,Positive
 Innate Pharma,[iito] Life Science,Positive
 Ph trial,[iito] Life Science,Positive
   patient Michele,Patient Power,Negative
 Optic Nerve,Cancer Papers,Negative
 INNATE PHARMA,satPRnews,Positive
 OPENING,satPRnews,Positive
 PHASE III TRIAL,satPRnews,Positive
 COMBINATION,satPRnews,Positive
 COMBINATION,Scott Werntz,Negative
 Hematology News Absence,Hemoglobin News,Positive
 Delayed Development,Hemoglobin News,Positive
 EŒºTCL,Hemoglobin News,Positive
 Fortschritte,Dr. Stefan Fischer,Positive
 der Therapie der tcoyfXVgWav,Dr. Stefan Fischer,Negative
 Piquetage des profs du C√©gep L√©visLauzon ce matin,David-Maxime Samson,Positive
 accueillait les √©tudiants,David-Maxime Samson,Positive
 Personalized Tcell Trial LongTerm Remissions,Clinical Pharmacy,Negative
 Personalized Tcell Trial LongTerm Remissions,CancerTherapyAdvisor,Negative
 Agenda     amp Myeloma,Lymphomation.org,Negative
 Venetoclax BCL inhibitor,Nicolas COLLET,Positive
 Venetoclax BCL inhibitor,Ann F Cheung,Positive
 refractory CLL,Nicolas COLLET,Positive
 Idelalisib Novel PIKdelta Inhibitor,The Annals,Positive
 Idelalisib Novel PIKdelta Inhibitor,FarmaOnco,Negative
 Chronic Lymphocytic Leukemia Arpita Shah Abhishek MangaonkarOc,The Annals,Negative
     experts,Canadian Hematology,Positive
 web discussing collaboration,"chadi nabhan MD, MBA, FACP",Negative
 future   research,"chadi nabhan MD, MBA, FACP",Negative
 Danza de la victoria,John Drago,Positive
 Peter Dorfman vicechair CLL Patient Advocacy Group,RIOH,Negative
 Robert Azopardi,WCM Lymphoma,Negative
 borrowed time,WCM Lymphoma,Negative
 Huge TY,Barts Cancer Institute,Positive
 patient Deborah,Barts Cancer Institute,Positive
 Dawn,Lifelong Learning,Negative
 Cultural Heritage,Lifelong Learning,Negative
 Singlecell PCR,RIOH,Negative
 New    Options,Patient Power,Negative
 leukemia Tips,ReaderUSA,Positive
 BPT,ReaderUSA,Positive
 ONS Meeting,OSCO Nurses,Negative
 ONS Meeting,OSCO,Negative
 Clinical advances,Issels Treatment,Positive
 Chem JAK tyrosine kinase,ImmunologyPapers,Negative
 integrin activation,ImmunologyPapers,Negative
 CXCL,ImmunologyPapers,Negative
 Pablo Oppezzo,Screenshots,Positive
 Blood Bank Study,"Stephanie Zimmerman, MSN",Positive
 Leukemia Transmission Risk,"Stephanie Zimmerman, MSN",Positive
 Complete Picture,Danvantri Farma,Negative
 Chronic Lymphocytic Leukemia Marketed,Danvantri Farma,Negative
 Pipeline Drugs,Danvantri Farma,Negative
 Relapsed Refractory Chronic Lymphocytic Leukemia CLLPipeline Insights SummaryRelapsed Refractory Chroni,Cancer Research,Positive
 Relapsed Chronic Lymphocytic Leukemia CLLPipeline Insights SummaryRelapsed Chronic Lymphocytic Leukemia,Cancer Research,Positive
 Gran,Malchofa,Positive
 CLL Entradas,Malchofa,Positive
 el pr√≥ximo,Malchofa,Positive
 Fewer Infections Partial Restoration,Christopher Steer,Negative
 Fewer Infections Partial Restoration,CancerTherapyAdvisor,Negative
 Humoral Immunity,Christopher Steer,Negative
 Humoral Immunity,CancerTherapyAdvisor,Negative
 Chronic Lymphocytic Leukemia Current Concepts,Cancer Papers,Negative
 nd line therapy,I Am Biotech,Positive
 relapse win,I Am Biotech,Positive
 „Ç∞„É¨„Éº„Ç∑„É£„ÉÑ„Å®„Ç∏„Éº„É≥„Ç∫Ë¢´„ÇäË≥¢ËÄÖÂ±ã„ÅÆÂ∑ª,Toshitsugu Nakamura,Positive
    juno kite,Anna Deveau,Negative
 Interview wPaul Henderson,That Hockey Show,Positive
 Job de lapr√®smidi,Made In Acoustic,Positive
   bitelike,Int J Dermatology,Negative
 reaction,Int J Dermatology,Negative
 UK cost gatekeeper,Plexus Ventures,Negative
 Barr Virus MicroRNAs,Johan Van Weyenbergh,Negative
 Correlate,Johan Van Weyenbergh,Negative
 Correlate,microRNApapers,Negative
 Blood Kissing Disease miRNAs,Johan Van Weyenbergh,Negative
   Grants Priority Review,Crown Bioscience,Negative
     idelalisib,Mike Ward,Negative
 Gelfilled touchscreen,Magi Sait Manas√©s,Positive
 IPHPA,oru2day,Positive
 Phba trial,oru2day,Positive
 Term   ,CancerWallonia,Negative
 Announces Submission,Cord Blood News,Negative
 Announces Submission,PRN Biotech,Negative
 Announces Submission,IntoxicatedTrader,Negative
 Status novel,A. Vroom - Ten Wolde,Negative
 shadows,A. Vroom - Ten Wolde,Negative
 VIDEO Dr Lamanna,ColumbiaCancer,Positive
   tags,Matthias Piesche,Negative
 GNMSF,Matthias Piesche,Negative
 ICYMI Dr Thompson,Patient Power,Negative
 mAb,MDedge Hematology & Oncology,Negative
 Macam,Izyan Nafisa,Positive
 nd Myeloid Malignancies,Moffitt Research,Positive
 Large Cohort,Moffitt Research,Positive
 Chronic Lymphocytic Leukemia Single Institution Experience,Moffitt Research,Positive
 ibrutinib Supplemental New Drug Application,Diaceutics PLC,Negative
 ibrutinib Supplemental New Drug Application,aeses.com,Negative
 ibrutinib Supplemental New Drug Application,DatZoom PR,Positive
 ibrutinib Supplemental New Drug Application,IntoxicatedTrader,Negative
 ibrutinib Supplemental New Drug Application,satPRnews,Negative
 Treatmentnaive CLL,Diaceutics PLC,Negative
 Big Data,David MANSET,Positive
 Chronic Lymphocytic Leukemia Type   Diabetes,David MANSET,Positive
 Intensive Car,David MANSET,Positive
 GNMSF GMXAY NVS GSK,A. Vroom - Ten Wolde,Negative
 Cholecalciferol,Lymphomation.org,Negative
 Cholecalciferol,VoyagerMed,Positive
 Vitamin D Deficiency,Lymphomation.org,Negative
 HighGrade Lymphoma Chronic Lymphocytic Leukemia,Cancer Papers,Negative
 PubMed Mitochondrial DNA,NeuroGenetics papers,Positive
 Testing Adoptive T Cells therapy CARs,Lymphomation.org,Negative
    MedPage,Melanie Johnson,Positive
 worries,Melanie Johnson,Positive
 Inna Ibrutinib,ImmunologyPapers,Negative
     Define,CancerWallonia,Negative
 CELL Remnants,USMLE Case Review,Positive
 nurse love,MD Anderson Leukemia,Negative
   Years,JediPD,Negative
 Durable Remission,JediPD,Negative
 Durable Remission,CancerTherapyAdvisor,Negative
 CTL CAR Tcells,JediPD,Negative
 CLLPROGRESS,JediPD,Negative
 Subscribers,Joe Hedden,Negative
 Prof Ghia,ecancer,Negative
 crystallography,ecancer,Negative
 Bcell receptor immunoglobulin,ecancer,Negative
 polymorphism,Cancer Papers,Negative
 CD gene,Cancer Papers,Negative
 Con,MD Anderson Leukemia,Negative
 PM Neil E Kay MD,MD Anderson Leukemia,Negative
 Dr Rawstron,ecancer,Negative
 harmonisation,ecancer,Negative
   Session IV,MD Anderson Leukemia,Positive
 Montserrat   Delp CLL,MD Anderson Leukemia,Negative
   Session IV Chronic Lymphocytic,MD Anderson Leukemia,Negative
 Global Chronic Lymphocytic Leukemia Therapeutics Market ‚Äì Report,logic solutions,Positive
   Session,MD Anderson Leukemia,Negative
 IV Chronic Lymphocytic Leukemia,MD Anderson Leukemia,Negative
 Dr Wiestner,MD Anderson Leukemia,Negative
 CLL Insight,MD Anderson Leukemia,Negative
 Disease Biology,MD Anderson Leukemia,Negative
 Session IV Chronic Lymphocytic Leukemia,MD Anderson Leukemia,Negative
 Special Protocol Assessment SPA Agreement,A. Vroom - Ten Wolde,Negative
 Newly Diagnosed NonHodgkin Lymphoma,VoyagerMed,Positive
 TGTX Announces,Biotech2050,Negative
 Emerging Evidence,National Comprehensive Cancer Network (NCCN),Negative
 Longterm,Living Safely,Positive
   Research Markets Chronic Lymphocytic Leukemia CLL,Jean-Michel TERME,Negative
 Research Markets Chronic Lymphocytic Leukemia CLL,Business Wire-Health,Negative
   Sanlam rates CELLO GROUP,Vox Markets,Negative
    Trading inline,Vox Markets,Negative
 year consensus numbers,Vox Markets,Negative
 microRb,Salva Ferr√© B.,Positive
 Treatmentna√Øve CLL,aeses.com,Negative
 CELLO,Martin Luke,Positive
 Interims,Martin Luke,Negative
 Interim Results,Vox Markets,Negative
 IMBRUVICAibrutinib New Drug App,Research Analyst,Positive
 Treatmentnaive Chronic Lymphocytic Leukemia,Research Analyst,Positive
 Treatmentnaive Chronic Lymphocytic Leukemia,satPRnews,Negative
    file,Paul Lane,Negative
 Ofatumumabchlorambucil,"Navneet Majhail, MD, MS",Negative
 Research Highlights,Patient Power,Negative
    participant talks,Patient Empowerment Network,Negative
 Positive Experience,Patient Empowerment Network,Negative
    sNDA,1stOncology,Negative
 Treatmentna√Øve Chronic Lymphocytic,1stOncology,Negative
 Drs Fabienne McClanahan,Clin Adv Hem Onc,Negative
 Excellent piece,Karen Weintraub,Positive
 Farrukh T Awan MD,Lymphomation.org,Negative
    evidence,Francesco Turturro,Negative
 WORLD LYMPHOMA AWARENESS DAY,Charlotte Roffiaen,Positive
 TGTX piggybanks,Biotech2050,Negative
 Treatmentna√Øve Chronic Lymphocytic Leukemia S,DatZoom PR,Positive
 new sNDA,JanssenUS,Negative
 recipients,Fierce Life Sciences Events,Positive
 Ofatumumab Superior,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 Observation,BlackSwan Analysis now part of Evaluate Pharma Ltd,Negative
 novel   inhibitor,Lymphoma Hub,Negative
 Shari cares,Sarah Cannon Docs,Positive
 Treatmentnaive Chronic,IntoxicatedTrader,Negative
 Cell Analysis,Francesco Turturro,Negative
 ImmunoSequencing,Francesco Turturro,Negative
 tcoukgWBQXGLd,Francesco Turturro,Negative
 Chemotherapyantibody combination,Lymphoma Hub,Negative
 TreatmentNa,PRN Biotech,Negative
 News IMBRUVICA√Ç ibrutinib Supplemental New Drug Application,DrugGenius,Negative
 Treatmentnaive Chronic Lymphocytic Leukemia Submi,DrugGenius,Negative
 ABBV Submits sNDA,Bio Stocks‚Ñ¢,Negative
 Pan PIkinasemTOR inhibitor activity,Prof John,Positive
 HaematoOnc Relaunch,Prof John,Positive
 Gros bonhomme,Deux Fans,Positive
 ‚Äú Bienvenue,Deux Fans,Positive
 OL,Deux Fans,Positive
 Fran√ßois Cot√©,Deux Fans,Positive
 la famille des Carabins,Deux Fans,Positive
 Colonie Little League,Katie,Positive
 seasons,Chris Williams,Positive
 bowling sweatband swingers,Chris Williams,Positive
 Que felicidad vamos lucho,Juanci,Positive
 Direction MTL,Jp-Levesque,Positive
 √† h,Jp-Levesque,Positive
 decision makers,Dixy_Dalton,Positive
 Krishan Maggon Cluster Marker exp,Ferez Nallaseth,Positive
 Oncology Links,Oncology Links,Positive
 Expression Data,Krishan Maggon,Negative
 Expression Data,Aiden Wallace,Positive
 Expression Data,Lorna Schamber,Positive
 New Molecular Subdivisions,Krishan Maggon,Negative
   Report LongTerm Remissions,conciergedoc,Positive
 st Group,conciergedoc,Positive
 Personalized Cellular Therapy,conciergedoc,Positive
 Kevin,Cherry Garden School üçí,Positive
 ABC song,Cherry Garden School üçí,Positive
 JAK Inhibitor Help,Patient Power,Negative
 Lselectin,AtlanticJOMedicine,Negative
 trafficking,AtlanticJOMedicine,Negative
 Reveals New Molecular Subdivisions,Aiden Wallace,Positive
 Reveals New Molecular Subdivisions,Lorna Schamber,Positive
 Dr David Miklos Stanford,Adaptive Biotech,Negative
 NGSbased MRD testing,Adaptive Biotech,Negative
 respond,Immunology,Positive
 Adap PIK,ImmunologyPapers,Negative
 Chronic Lymphocytic Leukemia CLL PIK,ImmunologyPapers,Negative
 Chimeric antigen receptor T cells,GEG-tech.com,Positive
 Chimeric antigen receptor T cells,MS Papers,Positive
 Chimeric antigen receptor T cells,Dominique,Positive
 Chimeric antigen receptor T cells,Krishan Maggon,Negative
 grt   videos,Adaptive Biotech,Negative
 acute   amp chronic,Adaptive Biotech,Negative
 Join Profs Gribben Hallek Keating amp Rai,ecancer,Negative
 EVShare price,Biotech2050,Negative
 TGTX slide   development plan,Biotech2050,Negative
 IBBXBI,Biotech2050,Negative
 especially men,Adaptive Biotech,Negative
 asymptomaticSmudge cells,KristopherMaday PA-C,Negative
 TG Therapeutics Launches TripleTherapy Study,1stOncology,Negative
 TG Therapeutics Inc Launches Phase,John Stock Pro,Positive
 TG Therapeutics Inc Launches Phase,satPRnews,Negative
 TG Therapeutics Inc Launches Phase,StockGuru,Negative
 TripleTherapy Study,John Stock Pro,Positive
 TripleTherapy Study,StockGuru,Negative
 TripleTherapy Study,Biotech2050,Negative
 PD Checkpoint,John Stock Pro,Positive
 PD Checkpoint,StockGuru,Negative
 ampquotTripleTherapyampquot Study,satPRnews,Negative
 TGTX Launches Phase,Biotech2050,Negative
   Pew Research Center pollster Andrew Kohut,Rotten Dead Pool,Positive
 MMilone sharing data,Congress Immunology,Positive
 plus year,Oksana Komarova,Positive
 Micro RNAs,Nitin Jain,Negative
 List studies,Lymphomation.org,Negative
 agonists,Lymphomation.org,Negative
 resiquimod,Lymphomation.org,Negative
 Watch Geoff,Gilead Sciences,Negative
 st group,Plexus Ventures,Negative
 Todays   metschronicadv,Emily Drake üò∑ #AYACSM,Positive
 travel,Emily Drake üò∑ #AYACSM,Positive
 ET TONIGHT,Emily Drake üò∑ #AYACSM,Positive
 Prof Vajdic,Oncology Update,Positive
 Professor Claire Vajdic,Oncology Update,Positive
 Global Chronic Lymphocytic Leukemia Therapeutics Market    Increase,World Tech News,Negative
 Global Chronic Lymphocytic Leukemia Therapeutics Market    Increase,PRN Biotech,Negative
 Global Chronic Lymphocytic Leukemia Therapeutics Market    Increase,satPRnews,Negative
 Patient Pool Market Driver,World Tech News,Positive
 Patient Pool,PRN Biotech,Negative
 Patient Pool,satPRnews,Negative
 Patient Pool Market,Vegas Blog App,Positive
 Driver,Vegas Blog App,Positive
 Research Markets Global Chronic Lymphocytic Leukemia Therapeutics Market,EIN Presswire: Pfizer Newswire,Positive
 Research Markets Global Chronic Lymphocytic Leukemia Therapeutics Market,WLST.com,Positive
 Research Markets Global Chronic Lymphocytic Leukemia Therapeutics Market,Business Wire-Health,Negative
 Research Markets Global Chronic Lymphocytic Leukemia Therapeutics Market,EIN Presswire: Pharmaceutical Newswire,Negative
 F HoffmannLa,EIN Presswire: Pfizer Newswire,Positive
 F HoffmannLa,EIN Presswire: Pharmaceutical Newswire,Negative
 F H,WLST.com,Positive
   Research Markets Global Chronic Lymphocytic Leukemia Therapeutics Market,Jean-Michel TERME,Negative
 F Ho,Jean-Michel TERME,Negative
 Lymphocytic   Therapeutics Market   Companies,Alessio Rombolotti,Positive
 haematologists,Christopher Steer,Negative
 CIRS score,Christopher Steer,Positive
 SYDGoede,Christopher Steer,Negative
 live   panel share experiences,ecancer,Negative
 Translational research,ecancer,Negative
 tcotfMpEHFgy,ecancer,Negative
 Global Chronic Lymphocytic Leukemia Therapeutics MarketSizeShareTrendsForecast,adam norton,Positive
 idelalisib   rituximab,ecancer,Negative
 Live broadcast,ecancer,Negative
 DTN Pharma News Researchers,DTN Pharma News,Positive
 personalized ce,DTN Pharma News,Positive
 Opinions,Matthew Kauffman,Negative
 Bills,Matthew Kauffman,Negative
 personalized   trial,HemaCare Corporation,Negative
 Clinical Research Coordinator II III Chronic Lymphocytic Leukemia,kelly stallworth,Positive
 Patient stories,Christopher Steer,Negative
    Fred Hutch Clinical Research Coordinator II III Chronic Lymphocytic Leukemia Fred HutchJob,Marketing Jobs,Positive
 ANTIGEN SELECTION,Cancer Papers,Negative
 ANTIGEN SELECTION,Cure Cancer Now,Negative
 ANTIGEN SELECTION,Just Cancer News,Negative
 Chronic Lymphocytic LeukemiagtThe exp,Health MasterDoctor,Positive
    humanimmunenews CAR T cells,andira bintang,Positive
 st CTL trial,myCME,Negative
 Novartis team,Aspen Biosciences,Positive
 Novartis team,Mark Fortner,Positive
 pioneering CART study,Aspen Biosciences,Positive
 pioneering CART study,Mark Fortner,Positive
 Chronic   tcoNvewneYt,Blood & Lymph,Positive
   reconstitution,Francesco Turturro,Negative
 Agent,Lymphomation.org,Negative
 Chronic Lymphocytic Leukemia Therapeutics Market Research Global Industry     blog,Market Research,Positive
 Chronic Lymphocytic Leukemia Therapeutics Market Research Global Industry     blog,Mark Research new,Positive
 Immune Cell Therapy,MS Papers,Positive
 Immune Cell Therapy,Drugs.com,Negative
 REOLYSIN,Oncolytics Biotech,Positive
 ‚Äû katastrophale zellul√§re,ùô∞ùöùùöéùöñùöîùöõùöíùöúùöùùöäùöïùöï,Positive
 amp kann,ùô∞ùöùùöéùöñùöîùöõùöíùöúùöùùöäùöïùöï,Positive
 zB,ùô∞ùöùùöéùöñùöîùöõùöíùöúùöùùöäùöïùöï,Positive
 HELIOS trial Ibrutinib,VJHemOnc,Negative
 CLL w vertigo,Mayo Clinic Med Ed,Positive
 cancerkilling therapy,HCMS,Positive
   ICD CHRONIC LYMPHOCYTIC LEUKEMIA,Max Titze,Positive
 ICD,Max Titze,Positive
   antigen receptor T cells,Francesco Turturro,Negative
 relapsed refractory,Francesco Turturro,Negative
 relapsed refractory,Lymphoma Hub,Negative
 August   roundup,Lymphoma Hub,Negative
 mijn eerste,Jacquelien (wat een toestand moidje),Negative
 staat ook hier gaat de controle door,Jacquelien (wat een toestand moidje),Negative
 SAUDI ARABIA,GLOBAL YOUTH,Positive
 SAUDI ARABIA,oviams news 1st,Positive
 SAUDI ARABIA,Siharam Media Network,Positive
 CHOCOLATE COMPANY DELIVERY,GLOBAL YOUTH,Positive
 CHOCOLATE COMPANY DELIVERY,oviams news 1st,Positive
 CHOCOLATE COMPANY DELIVERY,Siharam Media Network,Positive
 DRIVERSalary       OTINTARVIEW,GLOBAL YOUTH,Positive
 DRIVERSalary       OTINTARVIEW,oviams news 1st,Positive
 DRIVERSalary       OTINTARVIEW,Siharam Media Network,Positive
 AUG TH,GLOBAL YOUTH,Positive
 AUG TH,oviams news 1st,Positive
 AUG TH,Siharam Media Network,Positive
 Brandon Stewart,Matthew Kauffman,Negative
 Chronic Lymphocytic Leukemia Story,VoyagerMed,Positive
 relap,Krishan Maggon,Negative
   Abramson Cancer Center Researchers,Healthcanal,Negative
 LongTerm Remissions,Healthcanal,Negative
 personalized cell therapy trial,Station X,Positive
     Treatment prolongs life,Melanie Johnson,Positive
     Treatment prolongs life,Carole Johnson,Positive
 Burton Cup,Middleton C.C.,Positive
 North American Education Forum,Gilead Sciences,Negative
 Brooklyn,Gilead Sciences,Negative
 lymphoma amp,Gilead Sciences,Negative
 PALs Trial,Lymphomation.org,Negative
 graduate program classes,Prairie Lakes Church,Negative
 KLKB,ClinicalBiochemistry,Positive
 Weill Cornell Video DrFurman,Lymphomation.org,Negative
 Emerging Strategies,Lymphomation.org,Negative
   nowy lek,Medoinfo,Negative
   nowy lek,Jan Doktorowicz,Negative
 leczenia przewlek≈Çej bia≈Çaczki limfocytowej,Medoinfo,Negative
 leczenia przewlek≈Çej bia≈Çaczki limfocytowej,Jan Doktorowicz,Negative
 Indolecarbinol,Cure Cancer Now,Negative
 Indolecarbinol,Just Cancer News,Negative
 fludarabine sensitivity,Cure Cancer Now,Negative
 fludarabine sensitivity,Just Cancer News,Negative
 ESMO Guidelines,ESMO - Eur. Oncology,Negative
   class,jessetink,Positive
 Leadership,jessetink,Positive
 tumorsupportive,Pub Snips üî¨,Positive
   Dyer,Meredith O. Fleming,Positive
 Antigen Expression,MDRing,Negative
 Followup,MDRing,Negative
   Patient Cafe members,Patient Power,Negative
 Blood amp,Sunshine Hospitals,Positive
 Spongy Tissue,Sunshine Hospitals,Positive
 Bones,Sunshine Hospitals,Positive
 Blood Cells,Sunshine Hospitals,Positive
 Dyer,"Manolete John Garcia ""Meidas Guy All The Way""",Positive
 Dyer,W.F. Casey Ebsary Jr,Positive
 Newest Regional Executive,Matthew Kauffman,Negative
 Marvin Simons,Matthew Kauffman,Negative
 Wayne Dyer,MaryTiffany,Positive
 NBC,W.F. Casey Ebsary Jr,Positive
   New video,Patient Power,Negative
 Semoga darmian amp,fans emyu,Positive
 dpt poin penuh utk merebut tahta klasemen,fans emyu,Positive
 Premier,Le Peuple L√©vis,Positive
 des Faucons de L√©visLauzon,Le Peuple L√©vis,Positive
 flips,Jonderic,Positive
 Exosomes,AtlanticJOMedicine,Positive
 Exosomes,microRNApapers,Negative
 NORD,CLL Info,Negative
 Chronic Lymphocytic Leukemia Raising,MDRing,Negative
 Treatment ofElderly Patients,MDRing,Negative
   Man,Los Lobos,Negative
 anniversary,Los Lobos,Negative
 Kikos release,Los Lobos,Negative
 mood amp magic,Los Lobos,Negative
 album,Los Lobos,Negative
 crime,Matthias Piesche,Negative
 Pharmacokinetic Study,MDRing,Negative
 BTCTA,MDRing,Negative
 GMCSF,Sean Tiernan,Positive
 FludarabineContaining Regimens,Sean Tiernan,Positive
 Major Infection Risk,Graham Atherton,Positive
 Major Infection Risk,National Aspergillosis Centre,Negative
 Aspergillus,Graham Atherton,Positive
 Chronic Lymphocytic Leukemia Analysis,National Aspergillosis Centre,Negative
 Major Infectio,National Aspergillosis Centre,Negative
 Omg Malm√∂ hamnade,Lucas Sj√∂gren,Positive
 Acute AMLgtMYELOCYTIC,MikHaiL „ÉÑ,Positive
 LEUKEMIAjd,MikHaiL „ÉÑ,Positive
 pd adultALLgtgtLYMPHOCYTIC LEUKEMIAknkChronicCMLgtgtMYELOBLASTIC LEUKEMIA CLLgtgt LYMPHOBLASTIC LEUKEMIA,MikHaiL „ÉÑ,Positive
 zusammengefasst,Dr. Stefan Fischer,Negative
 der wwwarzneimitteltherapie,Dr. Stefan Fischer,Negative
 Nr   Erscheint,Dr. Stefan Fischer,Negative
 August Promotion,Matthew Kauffman,Negative
 Table,Matthew Kauffman,Negative
 Excuses,Matthew Kauffman,Negative
 PBAC,Christopher Steer,Negative
 Patient Cafe series,Patient Power,Negative
 p Deletion Meets Primary Endpoint,Cord Blood News,Negative
 p Deletion Meets Primary Endpoint,Scott Werntz,Negative
 backbone,OncLive.com,Negative
 sections,Medthority,Negative
 disease awareness,Medthority,Negative
 bcell lymphoma,Scott Merville,Negative
 Dan Rooker,Scott Merville,Negative
 Rituximab MabThera,CureHuntr,Negative
 Chem Interleukin,ImmunologyPapers,Negative
 day follow,Van Yoeun,Negative
 Pharmacogenetics,Personalized Nutrition Intervention 24/7 On Demand,Negative
 NCCN Guide,Personalized Nutrition Intervention 24/7 On Demand,Negative
 IGHV Interphase Cytogenetics,JAMA Oncology,Negative
 IGHV Interphase Cytogenetics,Cancer Papers,Negative
 Patient Basics Chronic Lymphocytic Leukemia CLL,2 Minute Medicine¬Æ,Positive
 Ibrutinib amp   target BCRcontrolled adhesion,Lymphoma Hub,Negative
 ARResT,tan jie,Positive
 AssignSubsets,tan jie,Positive
 Robust Subclassification,tan jie,Positive
 Hill Resource Reference Guide,Internet Medical,Positive
 supresa da jak,luan camilo,Positive
 tia parabens teamo,luan camilo,Positive
   obrig por fazer parte,luan camilo,Positive
 vida tia teamo,luan camilo,Positive
 Yay,I ü§ç‚ù§Ô∏è 32 & 26!!,Positive
 todays game,I ü§ç‚ù§Ô∏è 32 & 26!!,Positive
 mybrandcolombia gracias por,Eddy Marty,Positive
 el regalo baaammmmmm,Eddy Marty,Positive
 MT   IGHV,JAMA,Negative
 Interphase,JAMA,Negative
 El √öltimo Lonco International Trailer,Fabian Sangu M.,Positive
 ver al cine,Fabian Sangu M.,Positive
 Money,Matthew Kauffman,Negative
 EpsteinBarr Virus MicroRNAs,microRNApapers,Negative
 EpsteinBarr Virus MicroRNAs,Cancer Papers,Negative
 Overall,microRNApapers,Negative
 Recognition,Freddie Dudbridge,Positive
 antigenspecific Bcell receptors,Freddie Dudbridge,Positive
 Leukemia amp Lymphoma Society Applauds Encouraging Data,IntoxicatedTrader,Negative
 Iowa,Prairie Lakes Church,Negative
 Airport,Offsite Airport Park,Negative
 airport parking park sleep,Offsite Airport Park,Positive
 hotel packages,Offsite Airport Park,Positive
 World Chronic Lymphocytic Leukemia Therapeutics Market,Lisa Scott,Positive
 Route,Lisa Scott,Positive
 Molecule,Lisa Scott,Positive
 Sandler Research,Lisa Scott,Negative
 Dream,Los Lobos,Negative
 Blue,Los Lobos,Negative
 song,Los Lobos,Positive
 cllpagca,Patient Power,Positive
 Balu          CLL,Ana Catarina Bento,Negative
 Supplements Diet,Patient Power,Positive
 Jax,Jimmy,Positive
 Meets Primary Endpoint,HHF,Negative
 Meets Primary Endpoint,CancerTherapyAdvisor,Negative
 Meets Primary Endpoint,BioRunUp,Negative
 Lowrisk Patients,CancerTherapyAdvisor,Negative
 Denmark Patrick,Lymphoma Coalition,Negative
 classics,Lifelong Learning,Negative
 Chronic Lymphocytic Leukemia CLL Evaluating Managing ¬† Options,Joe Fournet,Negative
 Mind,Matthew Kauffman,Negative
 Wallet,Matthew Kauffman,Negative
 Pampaumay ng Umaga,ùî©ùî¢ùî∞ùî±ùî¢ùîØ,Positive
 Hahahaha,ùî©ùî¢ùî∞ùî±ùî¢ùîØ,Positive
 Peach,ùî©ùî¢ùî∞ùî±ùî¢ùîØ,Positive
   prediction,Francesco Turturro,Negative
 New DNA Standard Shape Accuracy,Patient Power,Positive
 Blood Test Results,Patient Power,Positive
 leukaemia drug,Cpl Life Sciences,Negative
 PhII data,Cpl Life Sciences,Negative
 Popular Management,CO_Oncology,Positive
 p Deletion Meet,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,Positive
 Complete Blood Count Foolproof,Patient Power,Positive
 CHD,Medibooks,Negative
 CHD,IUOPA,Negative
 CHD,ASH,Negative
 CHD,AtlanticJOMedicine,Negative
 CHD,epigenetics_papers,Negative
 CHD,Francesco Turturro,Negative
 DEFECTIVE ASSOCIATION,Medibooks,Negative
 ACTIVE,Medibooks,Negative
 CHROMATIN,Medibooks,Negative
 Spells trouble,NYCDoc29,Negative
 PCYC amp   sales,NYCDoc29,Negative
 del patients,Lymphoma Hub,Negative
 potential   therapy,AbbVie,Negative
 oncology pipeline,AbbVie,Negative
 slowgrowing cancer,Roche,Positive
 STUDY,Andrew Young,Positive
 RELAPSEDREFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA MEETS PRIMARY ENDPOINT,Andrew Young,Positive
 Exciting Phase II trial results,Emma,Positive
 Investigational Medicine Venetoclax Met Primary Endpoint,Brighter Futures Inc,Positive
 Investigational Medicine Venetoclax Met Primary Endpoint,Scott Werntz,Negative
 Venetoclax AbbVie,Krishan Maggon,Negative
 p Deletio,PRN Biotech,Negative
   RHHBY,Donna Young,Negative
 pII study,Roche,Negative
 ABBV Phase   Study,BioRunUp,Negative
    amp     expert,Patient Power,Negative
 Hydration Influence Hemoglobin Test Evaluation,Patient Power,Positive
 SAUDI,GLOBAL YOUTH,Positive
 SAUDI,thooralfirst,Positive
 SAUDI,Siharam Media Network,Positive
 MASS CHOCOLATE,GLOBAL YOUTH,Positive
 MASS CHOCOLATE,thooralfirst,Positive
 MASS CHOCOLATE,Siharam Media Network,Positive
 COMPANYSTOREKEEPER OTODER TAKER OTFORKLIFT OTHEAVY,GLOBAL YOUTH,Positive
 COMPANYSTOREKEEPER OTODER TAKER OTFORKLIFT OTHEAVY,thooralfirst,Positive
 COMPANYSTOREKEEPER OTODER TAKER OTFORKLIFT OTHEAVY,Siharam Media Network,Positive
 DRIVER,GLOBAL YOUTH,Positive
 DRIVER,thooralfirst,Positive
 DRIVER,Siharam Media Network,Positive
 Pan   inhibitor,Mehdi Hamadani,Positive
 Routine Use,Cancer Papers,Negative
 GeriatricMed Management,Dr Alex Concorde,Negative
 Chem,ImmunologyPapers,Positive
 shaping,ImmunologyPapers,Negative
 lymphoid follicle,ImmunologyPapers,Negative
 Pubmed Assessment,epigenetics_papers,Negative
 p ATM functionality,epigenetics_papers,Negative
 CRAZY LIFE,ÂåóÂúíÈöºÂ§ß/shunta kitazono,Positive
 LABÈù¢ÁôΩ„Åã„Å£„ÅüÔºÅÔºÅ‰πÖ„ÄÖ„ÅÇ„Çì„Å™Âñã„Å£„Åü„Åó„ÄÅËá™ÂàÜ„ÅÆ‰æ°ÂÄ§Ë¶≥Â§â„Çè„Çã„Åç„Å£„Åã„Åë„ÅÆ„Å§„Å´„Å™„Çä„Åù„ÅÜ„ÄÇ„Åæ„ÅüÊó•„ÅÆParty„Å´„ÇÇ„ÅäÈÇ™È≠î„Åó„Åæ„Åô ÔºÅ,ÂåóÂúíÈöºÂ§ß/shunta kitazono,Positive
 ÂÖàËº©„Å®ÁæéÂ•≥„Å®ÁôΩË°£„Å®ÁßÅ,ÂåóÂúíÈöºÂ§ß/shunta kitazono,Positive
 Giovani DOS SANTOS,Dennis Pope,Positive
 Giovani DOS SANTOS Giovani DOS SANTOS,Dennis Pope,Positive
 Reaaaaal luv ‚òÄ Ô∏è,nnete,Positive
 Con Tam    risk stratification,Christopher Steer,Negative
 IgHV mutation status,Christopher Steer,Negative
 relapsed diseaseSome patients,Christopher Steer,Negative
 reveals cells,Christopher Steer,Negative
 Con Tam    effectsDiarrhoea Bleeding AF lymphocytosisPatients,Christopher Steer,Negative
 Con Tam   cells,Christopher Steer,Negative
 Con Tam   p mutations,Christopher Steer,Negative
 Mulligan,Christopher Steer,Negative
 care cf bendamustinerituximab,Christopher Steer,Negative
 New Business Partners,Matthew Kauffman,Negative
 Sue Zurface,The James,Negative
 Sue Zurface,Team Buckeye,Positive
   ride,The James,Negative
   ride,Team Buckeye,Positive
 CC w,WCM Lymphoma,Negative
 accelerator,Francesco Turturro,Negative
 Hetero launches Maball,Clarivate Cortellis,Negative
 Oncology Times POINTCOUNTERPOINT,Lymphomation.org,Negative
 Sexy beasts,Ana Catarina Bento,Negative
 New Cell Line Model,Prof John,Negative
 Looks Kosher,Prof John,Negative
 MUGshot,Prairie Lakes Church,Negative
 Academic Dean,Prairie Lakes Church,Negative
 adjunct professor,Prairie Lakes Church,Negative
 HYPOXIA,Prof John,Negative
 Green Tea Compound,RedLeafTea.com,Positive
 NHL Survivors,Allison,Positive
 Autocrine,Scott Werntz,Negative
   Text tcosqSZTvT,Matthew Kauffman,Negative
 LeukemiaAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia,The Little Mermaid,Positive
 Hai X,CaturLifeLive,Positive
 Research Markets Global Refractory Chronic Lymphocytic Leukemia CLL Therapeutics Pipeline Report,Scott Werntz,Negative
 Companies,Scott Werntz,Positive
 Companies,Business Wire-Health,Negative
 Research Markets Global Refractory Chronic Lymphocytic Leukemia CLL Therapeutics,Business Wire-Health,Negative
 Global Refractory Chronic Lymphocytic Leukemia CLL Therapeutics Pipeline Report,Scott Werntz,Negative
 Drug Profiles,Scott Werntz,Positive
 Drug Profiles,Business Wire-Health,Negative
 Best Care Support Team,Patient Power,Positive
 multipledose rituximab,ACS Journal Cancer,Negative
 gains amp losses,GenPath Oncology,Negative
 RT conkers,Free Cello Tuner,Negative
 Phase III Trials,Mehdi Hamadani,Positive
 accrual,Mehdi Hamadani,Positive
 Lynn Wang amp Gordana Raca,UChicagoCancerCenter,Positive
 Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review,Prof. M D Al-Sarraf,Positive
 Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review,Scott Werntz,Negative
 Overview H,Prof. M D Al-Sarraf,Positive
 Overview H,Scott Werntz,Negative
 cited papers,Paul Brennan (He/His),Positive
 Refractory Chronic Lymphocytic Leukemia CLL Comparative Analysis Pipeline Review H,Scott Werntz,Negative
   news Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review H,COPD News,Negative
 News Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review H,Roche,Negative
 ultra highrisk,VJHemOnc,Negative
 New Approvals Shift CLL Treatment,Scott Werntz,Negative
 Foggy morning,Jimmy,Positive
 New Meets Old Case Study,Journal of the @NCCN,Negative
 amp Review,Journal of the @NCCN,Negative
 Novel Therapeutics,Journal of the @NCCN,Negative
 theTreatment,Journal of the @NCCN,Negative
 PIKDELTA,Scott Werntz,Negative
 Refractory Chronic Lymphocytic Leukemia CLL   Pipeline Review H,Reportstack,Positive
 Previously Treated tcoOOUuFFvR,Care+Wear,Positive
 Global Medical Discovery,GMD,Positive
   William Dameshek Prize,ASH,Negative
 Awesome reviews,"Navneet Majhail, MD, MS",Negative
 ASU Alumni Artists Club,ASU Art,Positive
 Annual ExhibitionOctober,ASU Art,Positive
 November Reception October,ASU Art,Positive
 Medical Dictionary Bibliography,Donny Gilbreath,Positive
 Annotated Research Guide,Donny Gilbreath,Positive
 updates amp impt,Cancer Treatment Centers of America (CTCA),Positive
 EN   HORAS,Florencia,Negative
 VOY BARILOCHE,Florencia,Negative
 Hockey Star Paul Henderson,Patient Power,Positive
 Good,Patient Power,Positive
   Elucidates Recurrent,Centre for Genomic Regulation (CRG),Negative
 IDs Potential Treatment Strategy,Centre for Genomic Regulation (CRG),Negative
 minha porquitchona,Ana Catarina Bento,Negative
 Blood Mutations,IUOPA,Negative
 stats,NCI Cancer Stats,Negative
 Chronic Lymphocytic Leukemia CLL Therapeutic Pipeline Review H,Scott Werntz,Negative
 Relapsed Chronic Lymphocytic Leukemia Pipeline Review H,VEGAROSE  WOMAN,Positive
 New Movement,Matthew Kauffman,Negative
 Income,Matthew Kauffman,Negative
 Book Travel,Matthew Kauffman,Negative
     Movement,Matthew Kauffman,Negative
 Coachella Valley,Matthew Kauffman,Negative
 Monoclonal Bcell lymphocytosis,AtlanticJOMedicine,Negative
 Monoclonal Bcell lymphocytosis,Francesco Turturro,Negative
 IWU mug,Prairie Lakes Church,Negative
 precursor,MolecularMatch,Positive
 UTR mutations,MolecularMatch,Positive
 Arzerra sBLA,Scott Werntz,Negative
 Arzerra sBLA,Breaking News,Negative
 Relapsed Chronic Lymphocytic Leukemia CLL Pipeline Review H,GSK GlaxoSmithKline,Positive
 Relapsed Chronic Lymphocytic Leukemia CLL Pipeline Review H,COPD News,Negative
 Chem Microenvironment dependency,ImmunologyPapers,Negative
 splash,Craig Ribton,Positive
 pond,Craig Ribton,Positive
 Graph,Paul Brennan (He/His),Positive
 publications,Paul Brennan (He/His),Positive
 Chem Microenvironment interactions,ImmunologyPapers,Negative
 Chronic Lymphocytic Leukemia Implications,ImmunologyPapers,Negative
 Chronic Lymphocytic Leukemia Implications,NK papers,Negative
 Transplantation Failure,TumImmTxpapers,Negative
 Transplantation Failure,Muzaffar Qazilbash,Negative
 Transplantation Failure,Francesco Turturro,Positive
 Transplantation Failure,"Andreas-Claudius Hoffmann, M.D.",Positive
 Transplantation Failure,MediTech Media,Positive
 Transplantation Failure,Just Cancer News,Negative
 Microenvironment interactions,Cancer Papers,Negative
 Microenvironment interactions,NK papers,Negative
 dise,NK papers,Negative
 Huge Shout,Matthew Kauffman,Negative
 Newest Member,Matthew Kauffman,Negative
 SalesPromotions SalesPromotions ChristineLeeTIC,Lynmar Enterprises,Negative
 SalesPromotions ChristineLeeTIC,Lynmar Enterprises,Negative
 ChristineLeeTIC   CT,Lynmar Enterprises,Negative
 MDACC Hematologic Malignancies Retreat,Robert Z. Orlowski,Negative
 ROR CAR Tcells,Robert Z. Orlowski,Negative
    minute survey,Dallas Jobs,Positive
 Chronic Lymphocytic Leukemia CLL International Parkway,Dallas Jobs,Positive
 MD Anderson Hematologic Malignancies Retreat,Robert Z. Orlowski,Positive
 DRAM,krysta,Positive
 Cha Cha,krysta,Positive
 FAB,Prof John,Negative
 FABIENNE,Prof John,Negative
 TACI,Prof John,Negative
 Acute dacryocystitis,Eye Center,Positive
 presenting sign,Eye Center,Positive
 Contemporary Era,Cancer Papers,Negative
 Chronic Lymphocytic Leukemia Objective,The Annals,Negative
   d√≠as barilocheeeeeeeeee,Florencia,Negative
 Lirilumab,Lymphomation.org,Negative
 CRC   Dr Neil Kay,CLL Society Inc.,Negative
 Prognostic Indicators,CLL Society Inc.,Negative
 Standard Early Care,CLL Society Inc.,Negative
 Hodgkin transformation,Lymphoma Hub,Negative
 Hodgkin transformation,MDLinx,Negative
   potential,Francesco Turturro,Negative
 FISH Guest blogger,Patient Power,Positive
 Dr Randall Goskowicz,Patient Power,Positive
 Chronic Lymphocytic Leukemia tx,Current Reports,Positive
 Cur Hema Malig Rpts,Current Reports,Positive
 guides,People Who UK,Positive
 Salvage Outcomes,Tran-Der Tan,Negative
 PracticeUpdate,Tran-Der Tan,Positive
 Newly Diagnosed Chronic Lymphocytic Leukemia,Tran-Der Tan,Positive
 Dr Michael Hallek,Patient Power,Positive
 Dr Michael Hallek,"chadi nabhan MD, MBA, FACP",Negative
 GS,WCM Lymphoma,Negative
 GS,Francesco Turturro,Negative
   brochure,Lifelong Learning,Negative
 Ohe,Amy Lacks,Positive
 games,Amy Lacks,Positive
 Won,Amy Lacks,Positive
 Abramson counterpoint,Lymphomation.org,Negative
 BendaR,Lymphomation.org,Negative
 Relapsed   ASCO Post,Lymphomation.org,Negative
 ASCO Post Ibrutinib   BendamustineRituximab,Lymphomation.org,Negative
 CLL    Cancer Frontline   Cancer newsletter,Scott Merville,Negative
 relapsed Chronic Lymphatic,ecancerpatient,Positive
 CLL change,Aziz Nazha,Positive
 tcoFzUNsWW,Francesco Turturro,Negative
 highlighlts,Alberto Herreros,Positive
 CLL papers,Alberto Herreros,Positive
 ASCOs congress,Alberto Herreros,Positive
 u amp ur bestfriends,Brownskin_cee,Positive
 neva,Brownskin_cee,Positive
   gear,Connie Erpelding,Positive
 Chronic Lymphocytic Leukemia Pipeline Insights,Business Wire-Health,Negative
 Chronic Lymphocytic Leukemia Pipeline Insights,Scott Werntz,Negative
 BCell Chronic Lymphocytic Leukemia Pipeline Insights,Scott Werntz,Negative
 Syncytial Giant Cell Hepatitis,Cancer Papers,Negative
 Centre du livre,M√©dia Centre-Ouest,Negative
 et de la lecture,M√©dia Centre-Ouest,Negative
 PoitouCharentes,M√©dia Centre-Ouest,Positive
 Un certificat de qualification professionnelle,M√©dia Centre-Ouest,Negative
 ‚Äú Editeur num√©rique,M√©dia Centre-Ouest,Negative
    Author,Ramona Miranda,Positive
 IndiaSpeaking,Ramona Miranda,Positive
 New Leadership Insights,Ramona Miranda,Positive
 antibody therapy,Megan Johnson,Positive
 antibody therapy,–í–∞–ª–µ—Ä–∏—è –í–∏–Ω–æ–≥—Ä–∞–¥–æ–≤–∞,Positive
   Clinical Research Coordinator,Cord Blood News,Negative
 Overestimation error,Stefano Cattaneo DVM,Negative
 RBC,Stefano Cattaneo DVM,Negative
 Fred Hutch Clinical Research Coordinator II III Chronic Lymphocytic Leukemia Fred HutchJob ID,TECH JOBS,Positive
 Fred Hutch Clinical Research Coordinator II III Chronic Lymphocytic Leukemia Fred HutchJob ID,USA Technology Jobs,Positive
 NewVia    Drug,debra cincioni,Positive
 Programmed Death,Scott Werntz,Negative
 Ligand,Scott Werntz,Negative
 Different Compartments,Scott Werntz,Negative
 Perturbation,Francesco Turturro,Negative
 Richard Furman,Weill Cornell Medicine Meyer Cancer Center,Positive
 optimism,Weill Cornell Medicine Meyer Cancer Center,Negative
 Pharmacological Protein Profiling,Francesco Turturro,Negative
 Optimal Partner,Francesco Turturro,Negative
 tcoVMZYKPyR,Francesco Turturro,Negative
 Multiplicom,Scott Werntz,Negative
 Multiplicom,Chad Allen MRI,Positive
 Multiplicom,Medical Devices News,Positive
 Multiplicom,medicaldevices,Positive
 Multiplicom,CLL Society Inc.,Negative
 Largest Clinical Trial,Stuart Manning,Positive
 Largest Clinical Trial,John Pennett,Positive
 Company Histor,Stuart Manning,Positive
 Als CLL pati√´nt zonder,Jolanda,Positive
 wakker worden,Jolanda,Positive
 zwaar opgezette lymfeklieren kan dat door de warmte komen,Jolanda,Positive
 Demasiado sensuais,Ana Catarina Bento,Negative
 Carlos Lucas Lopes,Ana Catarina Bento,Positive
 Equita√ß√£o,Ana Catarina Bento,Positive
 que hem fet enguany,Alba Traguany,Positive
 Newer inhibitor treatments,Patient Power,Positive
 New CME   Impact,Pro-CME,Negative
 Individualized Therapies,Pro-CME,Negative
 Cancer Genetics,John Pennett,Positive
 Company History,John Pennett,Positive
 Comprehensive Testing,John Pennett,Positive
 CGIX,Cancer Genetics Inc.,Positive
 CGIX,Rachel Smith,Positive
 CGIX,Stocks News&Markets,Positive
 CGIX,Fundamentaltechs,Positive
 comprehensive   amp,Lymphoma Hub,Negative
   Multiplicom,PressReleasePoint,Negative
 Onc,Vicky‚Äôs Fashion Edit,Positive
     √≥n √önica,Kuck,Positive
 Cost analysis request,Dr Jobin Shaeri,Positive
 Zydelig Roche amp Biogen MabThera combination,Dr Jobin Shaeri,Positive
 ZYDELIG Idelalisib Treats Cancer,Molecular Imaging,Positive
 ZYDELIG Idelalisib Treats Cancer,Fight Cancer Team,Negative
 ZYDELIG Idelalisib Treats Cancer,Practical Statistics,Positive
 Chronic Lymphocytic Leukemia CLL Follicular BCell,Molecular Imaging,Positive
 Chronic Lymphocytic Leukemia CLL Follicular BCell,Fight Cancer Team,Negative
 Chronic Lymphocytic Leukemia CLL Follicular BCell,Practical Statistics,Positive
 Estto De Poder,Ciin Bj‚ô•,Positive
 Abrir Mi Tweeter,Ciin Bj‚ô•,Positive
 Een Mi,Ciin Bj‚ô•,Positive
 Drs John Allan,"John P. Leonard, MD",Positive
 Sarah Rutherford,"John P. Leonard, MD",Positive
 MATCH DAY st,CromptonCricketClub,Positive
 clubs,CromptonCricketClub,Positive
 clubs,Jacko,Positive
 RT CancerWallonia,SPRTG,Positive
 Significantly Extends,SPRTG,Positive
     Significantly Extends,CancerWallonia,Negative
 Impressive   response rate w,"Navneet Majhail, MD, MS",Negative
 Dr Gianluca Gaidano,Oncol Views & News,Positive
 Nos vamos,Nazarena Papes,Negative
 filter,Jimmy,Positive
 Establishment,Cancer Papers,Negative
 PCL,Cancer Papers,Negative
 BLOOD CANCER CHRONIC LYMPHOCYTIC LEUKEMIA,LightTheNightOntario,Positive
 Nowe leczenie przewlek≈Çej bia≈Çaczki limfatycznej   prze≈Çomowe leki,Medoinfo,Negative
 Przewlek≈Ça bia≈Çaczka limfocytowa,Medoinfo,Negative
 Realtime feedback,simrit parmar,Positive
 board review course,simrit parmar,Positive
 Clinical Research Coordinator III,MGT Candidates,Positive
 Clinical Research Coordinator III,Melissa Loomis,Positive
 Seattle WA,MGT Candidates,Positive
 Horizon,CancerWallonia,Negative
   de julio llega,Florencia,Negative
 mi mochila felizzzz,Florencia,Negative
 RockampRoll Review,Los Lobos,Negative
 Shakin Shakin,Los Lobos,Negative
 limfatyczna,Medoinfo,Negative
 limfocytowa,Medoinfo,Negative
 nowo≈õci w leczeniu nowe leki,Medoinfo,Negative
 Dr Susan M OBrien,OncLive.com,Negative
 idealisib,OncLive.com,Negative
 RT BIOCOMCA Novartis,SPRTG,Positive
 progressionfree,SPRTG,Positive
 peux pas changer le pass√©,Mar‚Äô ‚åõÔ∏è,Positive
 Comprehensive Analysis,Ken Yaw Agyeman-Badu,Positive
 Comprehensive Analysis,Krishan Maggon,Negative
 Comprehensive Analysis,Literature Bot,Negative
 Comprehensive Analysis,CompBiolPapers,Negative
 Comprehensive Analysis,Scott Werntz,Negative
 DiseaseRelated Genes,Ken Yaw Agyeman-Badu,Positive
 DiseaseRelated Genes,Krishan Maggon,Negative
 DiseaseRelated Genes,Stephane Jankowski,Positive
 DiseaseRelated Genes,SeqComplete,Negative
 DiseaseRelated Genes,Literature Bot,Negative
 DiseaseRelated Genes,CompBiolPapers,Negative
 DiseaseRelated Genes,Scott Werntz,Negative
 Multiplex,Ken Yaw Agyeman-Badu,Positive
 Multiplex,Literature Bot,Negative
 Multiplex,CompBiolPapers,Negative
 Multiplex,Scott Werntz,Negative
 La miraba con los ojos entornados y una,Words Of Books,Positive
 sonrisa torcida,Words Of Books,Positive
 Backstage,Keri Carpenter,Positive
 Omni Hotel,Keri Carpenter,Positive
 Ublituximab Phase II,Ulla,Positive
 pretreated Chronic Lymphocytic Leukemia,Ulla,Positive
 Proteins,BioNetPapers,Negative
 Proteins,Biocomputing,Positive
 Proteins,Scott Werntz,Negative
 interaction network,BioNetPapers,Negative
 interaction network,Biocomputing,Positive
 interaction network,Scott Werntz,Negative
 modeling,BioNetPapers,Negative
 modeling,Biocomputing,Positive
 modeling,Dr Alex Concorde,Negative
 modeling,Scott Werntz,Negative
 Onco FronChina,Oncol Views & News,Positive
 Optimal FirstLine Therapy,Scott Werntz,Positive
 CancersNews Proteins interaction network,Dr Alex Concorde,Negative
 Draft   guidance,Joe Hedden,Negative
 GILD,Joe Hedden,Negative
 GILD,Biotech2050,Positive
 ibrutinib inhibits BTK,Cure Cancer Now,Negative
 ibrutinib inhibits BTK,Just Cancer News,Negative
 ibrutinib inhibits BTK,Scott Werntz,Negative
 duty –º–µ–¥–∞–ª—å,–û–∫—Å–∞–Ω–∞ –ù–æ–≤–∏–∫–æ–≤–∞,Positive
 duty –º–µ–¥–∞–ª—å,–ê–Ω–∞—Å—Ç–∞—Å–∏—è –ú–∏—Ä–æ–Ω–æ–≤–∞,Positive
 –∑–∞ –æ—Ç–≤–∞–≥—É,–û–∫—Å–∞–Ω–∞ –ù–æ–≤–∏–∫–æ–≤–∞,Positive
 —Å–∫–∞—á–∞—Ç—å,–û–∫—Å–∞–Ω–∞ –ù–æ–≤–∏–∫–æ–≤–∞,Positive
 Ublituximab TG Therapeutics Phase II,Krishan Maggon,Positive
 pretreated HighRisk Chronic Lymp,Krishan Maggon,Negative
 Multiplex PCRBas,Krishan Maggon,Negative
 BFR,Chan Cheah,Negative
 Dr Khouri,Chan Cheah,Negative
   JBahlo,Erick Lansigan,Positive
 √≠a PRECLINICAL ACTIVITY,Medibooks,Negative
 HIGHRISK CHRONIC LYMPHOCYTIC LEUKEMIA,Medibooks,Negative
 Options Choice,Jon Henderson üçªüç∫ üíõüíô,Positive
 Chronic Lymphocytic LeukemiaSept Sydney,Hematopoiesis News,Negative
 upfront,Miguel Perales M.D.,Negative
 Unders,Jacko,Positive
 CL   B cells,X8-NANO,Positive
 Ver y,Nomade,Positive
   feliz,Nomade,Positive
     Advantages,Leukemia,Negative
 Train,Los Lobos,Negative
 Reports Outline Chronic Lymphocytic Leukemia Study Findings,Scott Werntz,Negative
 Pharmacyclics Inc Outcomes,Scott Werntz,Negative
 Cascade,TJFozzie,Positive
 AllStars,TJFozzie,Positive
 Hematopathology Chronic Lymphocytic,WebPathology,Positive
 Small Lymphocytic    images,WebPathology,Positive
 –≤ –ò–∑—Ä–∞–∏–ª–µ–ß–∏—Ç–∞—Ç—å –≤—Å—é —Å—Ç–∞—Ç—å—é,–õ–µ—á–µ–Ω–∏–µ —Ä–∞–∫–∞,Negative
   selection,Lymphoma Hub,Positive
 Un nouveau site web tr√®s r√©ussi,M√©dia Centre-Ouest,Negative
 le Centre du Livre et de la Lecture PoitouCharentes,M√©dia Centre-Ouest,Negative
 Rituxin,HE survivor,Positive
 autpimmune disorders,HE survivor,Positive
   Comprehensive Analysis,Stephane Jankowski,Positive
 Multiplex PCRBa,Stephane Jankowski,Positive
    Dr Tausch,"Naveen Pemmaraju, MD",Negative
 novel Prog factor,"Naveen Pemmaraju, MD",Negative
 Division champions,Amy Lacks,Positive
 Record,Amy Lacks,Positive
 Pubmed Genomic,epigenetics_papers,Negative
 PROLONG,Mednet (was: Medidact),Positive
 Rivetti di Val,AtlanticJOMedicine,Negative
 Cervo P,AtlanticJOMedicine,Negative
 Tucci,AtlanticJOMedicine,Negative
 P Majid,AtlanticJOMedicine,Negative
 et al p,AtlanticJOMedicine,Negative
 Itch,AtlanticJOMedicine,Negative
   CT CART experience,"Naveen Pemmaraju, MD",Negative
 Najnowsze eksperymentalne leki w leczeniu przewlek≈Çej bia≈Çaczki limfocytowej,Medoinfo,Negative
    Improves,CancerWallonia,Negative
 Reuni√≥n,Farmacia HUCA,Positive
 Asturias y,Farmacia HUCA,Positive
 Cantabria Avances,Farmacia HUCA,Positive
 en √≠a nuevos tratamientos de   avance del a√±o,Farmacia HUCA,Positive
 Novartis drug ArzerraR,Jock Breitwieser,Positive
 El mas grande,fache,Positive
 traffic,Oxford Media Factory,Positive
 Messe Wien,Oxford Media Factory,Positive
 Novartis drug Arzerra,DatZoom PR,Positive
 Novartis drug Arzerra,Scott Werntz,Negative
 previously treated   results,"chadi nabhan MD, MBA, FACP",Negative
 BloodOutstanding reviewNitin Jain,"Naveen Pemmaraju, MD",Negative
 ampSusan,"Naveen Pemmaraju, MD",Negative
 Investigational Treatment Venetoclax,IntoxicatedTrader,Negative
 Investigational Treatment Venetoclax,PRN Biotech,Negative
 Investigational Treatment Venetoclax,Penny Stocks,Negative
 Investigational Treatment Venetoclax,Hot Trades,Positive
 Investigational Treatment Venetoclax,Daniel Able,Positive
 Investigational Treatment Venetoclax,Security Stocks,Positive
 Investigational Treatment Venetoclax,Ez2Trade,Positive
 Investigational Treatment Venetoclax,Penny Stock Irish,Negative
 Investigational Treatment Venetoclax,Stock Runners,Positive
 Investigational Treatment Venetoclax,satPRnews,Negative
 Press Conference eha          Messe Wien,Oxford Media Factory,Positive
 Rituximab Shows Clinical Response,PRN Biotech,Negative
 Rituximab Shows Clinical Response,Penny Stocks,Negative
 Rituximab Shows Clinical Response,Hot Trades,Positive
 Rituximab Shows Clinical Response,Daniel Able,Positive
 Rituximab Shows Clinical Response,Security Stocks,Positive
 Rituximab Shows Clinical Response,Ez2Trade,Positive
 Rituximab Shows Clinical Response,Penny Stock Irish,Negative
 Rituximab Shows Clinical Response,Stock Runners,Positive
 Rituximab Shows Clinical Response,satPRnews,Negative
 GNWNews Novartis drug Arzerra,Scott Werntz,Negative
 Rel,Penny Stocks,Negative
 Rel,Hot Trades,Positive
 Rel,Daniel Able,Positive
 Rel,Security Stocks,Positive
 Rel,Ez2Trade,Positive
 Rel,Penny Stock Irish,Negative
 Rel,Stock Runners,Positive
 Press Release Novartis drug ArzerraR,Presse- & Mediennews,Positive
 amp   disease,Biocom California,Positive
 Chronic Lymphocytic Leukemia CLLMayo Clinic,anthony phillips,Positive
 Radcliffe CC,David Costello,Positive
 Expansion,TumorImmunoPapers,Negative
 NKGD expression,TumorImmunoPapers,Negative
   Team,Centre for Genomic Regulation (CRG),Negative
 Treating Chronic Lymphocytic Leukemia webinar,LLS Illinois,Positive
 Treating Chronic Lymphocytic Leukemia webinar,The Leukemia & Lymphoma Society,Negative
 TODAY Register,LLS Illinois,Positive
 CDPD,Scott Werntz,Negative
 CDPD Cells,Scott Werntz,Negative
 Canto Veracruz,Los Lobos,Negative
    Comprehensive Analysis,SeqComplete,Negative
 Certified Travel Agent,Matthew Kauffman,Negative
 Fill,Matthew Kauffman,Negative
 database,Patient Power,Negative
 Chronische lymphatische √§mie,SpringerMedizin.de,Positive
 Therapiekonzepte,SpringerMedizin.de,Positive
 Holla,CaturLifeLive,Positive
 NFKBIE mutations,Ontores,Positive
 NFKBIE mutations,JExpMed,Negative
 Marian,Sarah Cannon Docs,Positive
 Johnmother amp son,Sarah Cannon Docs,Positive
 photo amp story,Sarah Cannon Docs,Positive
 pleotropic activity,Ava White,Positive
 pleotropic activity,Robert Thompson,Positive
 pleotropic activity,Sarah Wright,Positive
 pleotropic activity,Amanda Martinez,Positive
 pleotropic activity,Karen Williams,Positive
 pleotropic activity,jesse thomas,Positive
 pleotropic activity,Robert Lopez,Positive
 pleotropic activity,Olivia Scott,Positive
 pleotropic activity, Emilie Thompson,Positive
 pleotropic activity, Hannah Wright,Positive
 pleotropic activity,Brenda Wright,Positive
 pleotropic activity,Carly Johnson,Positive
 pleotropic activity,Heather Roberts,Positive
 pleotropic activity,Jessica Craft,Positive
 pleotropic activity,Kathrina Laura,Positive
 pleotropic activity, Camilla White,Positive
 pleotropic activity,jessica johnson,Positive
 pleotropic activity,Helen Thomas,Positive
 pleotropic activity,Amanda BARGA,Positive
 pleotropic activity,Victor Jackson,Positive
 pleotropic activity,ava walker,Positive
 pleotropic activity,Ashleigh BARREIRO,Positive
 pleotropic activity,David BEAUDET,Positive
 pleotropic activity,Mark Williams,Positive
 pleotropic activity,olivia lopez,Positive
 pleotropic activity,Helpinus Media,Positive
 pleotropic activity,Titanhealth news,Negative
 Rx Strategies,PracticeUpdate,Negative
 quercetin,Helpinus Media,Positive
 quercetin,Titanhealth news,Negative
 Molecular Signatures,Scott Werntz,Negative
 GHV,JAMA Oncology,Negative
 pt w chronic lymphocytic,JAMA Oncology,Negative
 ABBVibrutinib,MAISA,Negative
 Najwa≈ºniejsze,Medoinfo,Negative
 o przewlek≈Çej,Medoinfo,Negative
 bia≈Çaczce limfocytowej,Medoinfo,Negative
 Oncology News Ibrutinib IMBRUVICA,Oncology by News-Medical,Positive
 Cancer News Ibrutinib IMBRUVICA,Cancer News by News-Medical,Positive
 Recommended mg Dose,Invest World News,Negative
 Recommended mg Dose,Financial Buzz,Negative
 Recommended mg Dose,Penny Stock Irish,Negative
 Recommended mg Dose,Ez2Trade,Negative
 Recommended mg Dose,Penny Stocks,Negative
 Recommended mg Dose,IntoxicatedTrader,Negative
 IMBRUVICA ibrutinib Results,Invest World News,Negative
 Interim Analysis Study Data Significant Reductions,Invest World News,Negative
 Phase III HELIOS Study Results,Invest World News,Negative
 Ibrutinib IMBRUVICA Combination Therapy,Invest World News,Negative
 AbbVies Ibrutinib,Scott Werntz,Negative
 province,Lymphoma Canada,Negative
   Improved Survival,Dominique,Positive
 TreatmentNaive Chronic Lymphocytic,Dominique,Positive
 Phase III RESONATE Trial,"Pharmacyclics, an AbbVie Company",Negative
 Phase III RESONATE Trial,Scott Werntz,Negative
 proposed   restructure,Jon Henderson üçªüç∫ üíõüíô,Positive
 LCB,Jon Henderson üçªüç∫ üíõüíô,Positive
 Excellent Junior,Jon Henderson üçªüç∫ üíõüíô,Positive
 rd Team structure,Jon Henderson üçªüç∫ üíõüíô,Positive
 ‚Ñ¢ Trial,Scott Werntz,Negative
 ABBV   Ibrutinib IMBRUVICA,Rachel Smith,Positive
 awesome   min set,Los Lobos,Negative
 Revolution,Los Lobos,Negative
 Rattlesnake Shake,Los Lobos,Negative
 Dear Mr Fantasy,Los Lobos,Negative
 Woodstock,Los Lobos,Positive
 Ûæ†¶,Matthew Kauffman,Positive
 Tuveson amp Rais,JExpMed,Negative
 Pubmed Mutations,epigenetics_papers,Negative
 type amp frequency,Dr. Saad A . Hatem,Positive
 „Ää Leukemia „Äã,Dr. Saad A . Hatem,Positive
 childrenALL,Dr. Saad A . Hatem,Positive
 Jay age,Diplomat,Negative
 Œª,JExpMed,Negative
 resolution amp,JExpMed,Negative
 June issue,JExpMed,Negative
 Á±≥ÂõΩËá®Â∫äËÖ´ÁòçÂ≠¶‰ºö„ÅÆÁîüÊ∂ØÊïôËÇ≤„Çµ„Ç§„Éà„ÄåÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊ≤ªÁôÇ„ÄçÔºöManagement,Ê£Æ„ÄÄÂãá‰∏Ä,Positive
 IdelalisibOfatumumab Combination,Helen Ong,Positive
 CLLGILD,Helen Ong,Positive
   disturbance,PracticeUpdate,Negative
 votes,Jon Wiggans,Positive
 acad√®mia catalana ci√®ncies,Marta Crespo,Negative
 Daily Observation,CaturLifeLive,Positive
 PreviouslyTreated Patients,aeses.com,Negative
 PreviouslyTreated Patients,PANNA SHARMA,Positive
 PreviouslyTreated Patients,Paul Lane,Negative
 PreviouslyTreated Patients,Scott Werntz,Negative
 PreviouslyTreated Patients,Financescom-stocks,Positive
 HELIOS Interim Analysis Study Data Significant Reductions,DatZoom PR,Positive
 HELIOS Interim Analysis Study Data Significant Reductions,satPRnews,Negative
 HELIOS Interim Analysis Study Data Significant Reductions,IntoxicatedTrader,Negative
 HELIOS Interim Analysis Study Data Significant Reductions,Ez2Trade,Positive
 HELIOS Interim Analysis Study Data Significant Reductions,Hot Trades,Positive
 HELIOS Interim Analysis Study Data Significant Reductions,Penny Stocks,Negative
 HELIOS Interim Analysis Study Data Significant Reductions,Daniel Able,Positive
 HELIOS Interim Analysis Study Data Significant Reductions,PRN Biotech,Negative
 HELIOS Interim Analysis Study Data Significant Reductions,Security Stocks,Positive
 HELIOS Interim Analysis Study Data Significant Reductions,Stock Runners,Positive
 HELIOS Interim Analysis Study Data Significant Reductions,Penny Stock Irish,Negative
 Pelotonia dollars,Pelotonia,Positive
 work MT,Pelotonia,Positive
 Wally Yocum,Pelotonia,Positive
 Wally Yocum,The James,Negative
 Imprime PGGMAb Combination Therapy,genetic insidER,Positive
 Imprime PGGMAb Combination Therapy,Ellen Una,Positive
 Imprime PGGMAb Combination Therapy,Cyndi Joycelyn,Positive
 Imprime PGGMAb Combination Therapy,jennifermcaiyr1983,Positive
 Imprime PGGMAb Combination Therapy,Lelah Lakita,Positive
 Imprime PGGMAb Combination Therapy,Cancer Blog,Negative
 Imprime PGGMAb Combination Therapy,CRO Contract Res.,Negative
 Imprime PGGMAb Combination Therapy,BusinessWireProducts,Negative
 Imprime PGGMAb Combination Therapy,Scott Werntz,Negative
 Imprime PGGMAb Combination Therapy,dlvr news,Negative
 Vroege klinische activiteit duvelisib,Mednet (was: Medidact),Positive
 behandelingsna√Øeve CLL,Mednet (was: Medidact),Positive
 Chronic Lymphocytic Leukemia GILD,Michael,Positive
 Morning inspiration,Weill Cornell Medicine Meyer Cancer Center,Negative
 transformative   treatment w patient Robert Azopardi,Weill Cornell Medicine Meyer Cancer Center,Negative
 harmthen,Weill Cornell Medicine Meyer Cancer Center,Negative
   Dr Furmans edu session,Weill Cornell Medicine Meyer Cancer Center,Negative
   Agent Tx Thwarts,Francesco Turturro,Negative
 presumption,Jacko,Positive
 Heywood,Jacko,Positive
 leap,Jacko,Positive
 Dale dale dale daleeeeeeee,Nazarena Papes,Negative
 GILD„ÇÆ„É™„Ç¢„Éâ„Çµ„Ç§„Ç®„É≥„Ç∑„Éº„Ç∫„ÅÆÊäóËÖ´ÁòçÈñãÁô∫„Éç„ÇøÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÊÇ£ËÄÖ„Å´„Åä„Åë„ÇãZydelig,kyookine,Positive
 INFI ASCO Phase Duvelisib,Tom Silver,Negative
 ‚Ñ¢ Data Shows Adherence,Financial Buzz,Negative
 ‚Ñ¢ Data Shows Adherence,Penny Stock Irish,Negative
 ‚Ñ¢ Data Shows Adherence,Ez2Trade,Negative
 ‚Ñ¢ Data Shows Adherence,Penny Stocks,Negative
 ‚Ñ¢ Data Shows Adherence,IntoxicatedTrader,Negative
 ‚Ñ¢ Data Shows Adherence,Cancer Daily,Negative
   PGGMAb Combination Therapy,Paul Lane,Negative
   Reports,Paul Lane,Negative
 Ph Data,Paul Lane,Negative
 Clinical Activity,Paul Lane,Negative
 Clinical Activity,Scott Werntz,Negative
 Clinical Activity,Financescom-stocks,Positive
   Announces LongTerm Safety,Paul Lane,Negative
 ChronicPhase Chronic Myeloid,Paul Lane,Negative
 Ph Clinical Trial,Paul Lane,Negative
 ‚Ñ¢ Data,Paul Lane,Negative
 mg Dose,Paul Lane,Negative
 Improved Efficacy Benefits,Paul Lane,Negative
 IVGH,Michael R Bishop,Positive
 workup,Michael R Bishop,Positive
 IVGH status,Michael R Bishop,Positive
   PFS,Michael R Bishop,Positive
   expert Tune,Patient Power,Negative
 Data analysis Adherence,"Pharmacyclics, an AbbVie Company",Negative
 dose results,"Pharmacyclics, an AbbVie Company",Negative
 improved efficacy benefits,"Pharmacyclics, an AbbVie Company",Negative
 CLL   responses,Biothera Pharma,Positive
 CR patients,Biothera Pharma,Positive
 Ph CLL,Biothera Pharma,Positive
 CR    PGG,Biothera Pharma,Positive
 ¬Æ ibrutinib Resul,Penny Stock Irish,Negative
 ¬Æ ibrutinib Resul,Ez2Trade,Negative
 ¬Æ ibrutinib Resul,Penny Stocks,Negative
 PreviouslyTr,Aktienmanufaktur,Negative
 Infinity Reports,Scott Werntz,Negative
 INFI Infinity Reports,Financescom-stocks,Positive
 Phase   Data,Financescom-stocks,Positive
 GILD ZydeligR,Financescom-stocks,Positive
   Floridas,KModyMD,Positive
 Dr   presented game,KModyMD,Positive
    HELIOS trial,Michael R Bishop,Positive
 ibrutinbIBR,Michael R Bishop,Positive
 placeboBR,Michael R Bishop,Positive
 relapsed difference,Michael R Bishop,Positive
 OS placebo progressors,Michael R Bishop,Positive
    phase HELIOS,Michael R Bishop,Positive
 trial ibrutinbIBR,Michael R Bishop,Positive
 placeboBR IBR results,Michael R Bishop,Positive
 Dr Asher ChananKhan,CancerDotNet,Negative
   Wendy Stock,Mehdi Hamadani,Positive
 Expert Columbias,Columbia Med School,Positive
   Noon ET,Columbia Med School,Positive
   Breaking News,ASCO,Negative
 New ibrutinib combo,ASCO,Negative
 Phase III HELIOS study,"Pharmacyclics, an AbbVie Company",Negative
 Chroniclymphocytic leukemia CLL,JNCI,Negative
 De,Ez2Trade,Positive
 De,Hot Trades,Positive
 De,Penny Stocks,Negative
 De,Daniel Able,Positive
 De,Security Stocks,Positive
 De,Stock Runners,Positive
 De,Penny Stock Irish,Negative
 Phase III HELIOS Study Results Ibrutinib IMBRUVICA,Financial Buzz,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA CELLS,Medibooks,Positive
 LYMPH NODES,Medibooks,Negative
    Dr Jones,Rare Disease Report,Negative
 ColumbiaMed RT,ivy science,Negative
 Nicole Lamanna Co,ivy science,Negative
 CARE   Session,CARE‚Ñ¢ Education,Negative
 CARE   Session,Canadian Hematology,Positive
 drugrelated hepatotoxicity,Anna Deveau,Negative
 colitis,Anna Deveau,Negative
 SUV amp s transformation     sr author Dr Ferrajoli,"Naveen Pemmaraju, MD",Negative
 Hear tonights,Jacko,Positive
 merger meeting,Jacko,Positive
   Warburg effect,Francesco Turturro,Negative
 teleconference,NC Chapter LLS ,Positive
 RandyPEN Board member,Patient Empowerment Network,Negative
 Carolyr,Patient Empowerment Network,Negative
 Aberrant NK cell associated marker CD,NK cell Biology,Negative
 Aberrant NK cell associated marker CD,NK papers,Negative
 Erysipelothrix rhusiopathiae,pseudomonaspapers,Negative
 Novel biologic agents,TumImmTxpapers,Negative
 –∑–∞ –æ—Ç–≤–∞–≥—É —Å—à–∞,–ê–Ω–∞—Å—Ç–∞—Å–∏—è –ú–∏—Ä–æ–Ω–æ–≤–∞,Positive
 Heywood CC,Jon Henderson üçªüç∫ üíõüíô,Positive
 Molecular Landscape,Lymphoma Hub,Negative
 Molecular Landscape,Hematopoiesis News,Negative
 Molecular Landscape,Cord Blood News,Negative
 Chronic Lymphocytic Leukemia Time Frame,Lymphoma Hub,Negative
 Chronic Lymphocytic Leukemia Time Frame,Hematopoiesis News,Negative
 Chronic Lymphocytic Leukemia Time Frame,Cord Blood News,Negative
 Disease Evolution,Lymphoma Hub,Negative
 Disease Evolution,Hematopoiesis News,Negative
 Disease Evolution,Cord Blood News,Negative
 Lancement des pr√©inscriptions,Social Foot,Positive
 Venez consultez,Social Foot,Positive
   SARXL,Francesco Turturro,Negative
 Venetoclax Desginated Breakthrough Therapy,Haider Alleg,Positive
 Venetoclax Desginated Breakthrough Therapy,Kainjoo,Positive
 Venetoclax Desginated Breakthrough Therapy,treatmybrand,Positive
 Venetoclax Desginated Breakthrough Therapy,Dr. Leona Saunders,Positive
 Venetoclax Desginated Breakthrough Therapy,Scott Werntz,Negative
 IgE,MDLinx,Negative
 David E,Matthew Kauffman,Negative
 roomies,Sid,Positive
 Janet OBrien   RT patient,Patient Power,Positive
 selfadvocacy advice,Patient Power,Positive
 Inspired amp,Connie Erpelding,Positive
 mail,Connie Erpelding,Positive
 partnering,Connie Erpelding,Positive
 Grantee Jennifer R Brown MD PhD director,gabriellesangels.org,Positive
 Chronic Lymphocytic Leukemia Center,gabriellesangels.org,Positive
 DanaFarber Cancer,gabriellesangels.org,Positive
 HighRisk Chronic Lymphocytic Leukemia Relapsing,Muzaffar Qazilbash,Negative
 HighRisk Chronic Lymphocytic Leukemia Relapsing,Francesco Turturro,Negative
 HighRisk Chronic Lymphocytic Leukemia Relapsing,Jerry Lee,Negative
 HighRisk Chronic Lymphocytic Leukemia Relapsing,ASCO,Negative
 HighRisk Chronic Lymphocytic Leukemia Relapsing,PER,Negative
 HighRisk Chronic Lymphocytic Leukemia Relapsing,Scott Werntz,Negative
 HighRisk Chronic Lymphocytic Leukemia Relapsing,FarmaOnco,Negative
 Allogeneic StemCell Transplantation,Muzaffar Qazilbash,Negative
 Allogeneic StemCell Transplantation,jc,Positive
 Allogeneic StemCell Transplantation,Francesco Turturro,Positive
 Allogeneic StemCell Transplantation,ASCO,Negative
 Allogeneic StemCell Transplantation,PER,Negative
 ‡∏Å‡πá‡∏Ñ‡∏ô‡∏ñ‡∏π‡∏Å‡∏ó‡∏¥‡πâ‡∏á‡∏°‡∏±‡∏ô‡πÄ‡∏õ‡πá‡∏ô‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏ô‡∏µ‡πâ,‚òÅÔ∏èùó∫ùòÜùóª,Positive
 Tada,CaturLifeLive,Positive
 cyclophosphamide fludarabine,drryna,Positive
 endpoint,Philip Shaheen,Positive
 Chronic Lymphocytic   Treatment Balancing Efficacy Safety,EMJ Oncology,Negative
   Ethics,Matthew Kauffman,Negative
 ‚úî,Matthew Kauffman,Negative
   nowe leki,Medoinfo,Negative
 leczenia przewlek≈Çej bia≈Çaczki limfatycznej zarejestrowane w Europie,Medoinfo,Negative
 Clubs,Jon Henderson üçªüç∫ üíõüíô,Positive
 GML,Jon Henderson üçªüç∫ üíõüíô,Positive
   exosomes,Francesco Turturro,Negative
 IŒ∫BŒµ mutations,JExpMed,Negative
 patient tumors,JExpMed,Negative
 Rebekah Combination Therapies,New OhioLINK ETDs,Positive
 Blue Eyes,Romulo Mayo,Positive
 Mitchell Smith,ASH Clinical News,Negative
 Steve Coutre,ASH Clinical News,Negative
 Drawing Blood,ASH Clinical News,Negative
 CD Agonist,Paul Scolardi,Positive
 Induce,Paul Scolardi,Positive
 Cell Death,Paul Scolardi,Positive
 Cell Death,PLOS Medicine,Positive
 Cell Death,Kazeem Olalekan,Positive
 Cell Death,Scott Werntz,Negative
 Mice,Paul Scolardi,Positive
   ya noche,A.G.,Positive
 te gusta,A.G.,Positive
 Mejor,A.G.,Positive
 lo hagas,A.G.,Positive
 Education Book p,"Mike Thompson, MD, PhD, FASCO",Negative
 Recent Phase   trial,Lymphoma Hub,Positive
 navitoclax,Lymphoma Hub,Positive
 JEM Mansouri et al,JExpMed,Negative
   acts,JExpMed,Negative
 w pigu≈Çece,Medoinfo,Negative
 limfocytowej,Medoinfo,Negative
   nowe leki zarejestrowane w Europie,Medoinfo,Negative
 ≈Çaczka,Medoinfo,Negative
 Novel Natural Product KL,JournalAgent,Positive
 Proliferation Induces Apoptosis,JournalAgent,Positive
 QampA Register,Patient Power,Positive
 Communication honesty,Patient Power,Positive
 CLL VIDEO,Lymphoma Coalition,Negative
 Kinase Inhibitor therapies,Lymphoma Coalition,Negative
 season,Heyside FC,Positive
 season,Shadley vanSchalkwyk,Positive
 season,Chris Murray,Positive
 season,Nick Barker,Positive
    Flow cytometry,Neel Fotedar,Negative
 CD   T cell marker,Neel Fotedar,Negative
 leukemic B cells,Neel Fotedar,Negative
 AJHP Role,UGCFarmacia Hosp. CG,Positive
 Station   Airport,Offsite Airport Park,Negative
   New    StoriesHow,Patient Empowerment Network,Positive
 Josep Carreras Leukaemia Research Institute,Marta Crespo,Negative
 TRIL,Jeremy Arizola,Positive
 Daughter,Matthew Kauffman,Negative
 Paycations,Matthew Kauffman,Negative
 CT RNA pdependent,Fabrice Leclerc,Negative
 networks,Fabrice Leclerc,Negative
 pdependent noncoding,microRNApapers,Negative
 pdependent noncoding,yukiüåæ„äóÔ∏èÔºñ„Åï„ÅÑüéâ‚öî,Positive
 lo par√≥,M,Positive
 √±aba,M,Positive
 C gamma,"Andreas-Claudius Hoffmann, M.D.",Positive
 C gamma,Francesco Turturro,Negative
 Moertel Lecture,Erick Lansigan,Positive
 Chicago,Erick Lansigan,Positive
 New Market Research Report,Scott Werntz,Negative
 yuhu,CaturLifeLive,Positive
 Investigational Medicine Venetoclax,Scott Werntz,Negative
 Investigational Medicine Venetoclax,Dominique,Positive
 Investigational Medicine Venetoclax,Dr. Leona Saunders,Positive
 Investigational Medicine Venetoclax,IntoxicatedTrader,Negative
 Investigational Medicine Venetoclax,satPRnews,Negative
 Pre,Scott Werntz,Negative
 Salvage therapies,HemOnc Today,Negative
 Salvage therapies,Healio,Negative
 synergizes,Francesco Turturro,Positive
 TG Therapeutics Announces Clinical Data,Rare Diseases,Negative
 phospholipase,Francesco Turturro,Negative
 WebMD,Medscape Education,Negative
 Provider,Medscape Education,Negative
 patienthcp dialogue,Medscape Education,Negative
 Primer partido adentro,micaelaüíö,Positive
 Tonight MT,Weill Cornell Medicine Meyer Cancer Center,Negative
 w Chronic Lymphocytic Leukemia Free audio resource,NCCS - National Coalition for Cancer Survivorship,Positive
 resource store,NCCS - National Coalition for Cancer Survivorship,Positive
 Manda case,CancerDartmouth,Negative
 Dr Sudhir Mandas,CancerDartmouth,Positive
 Therapeutic Landscape,CancerDartmouth,Positive
 p ET,CancerDartmouth,Negative
 Long Goodbye,Personalized Nutrition Intervention 24/7 On Demand,Negative
 Weill Cornell Clinical Trials,Lymphomation.org,Negative
 Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma trial archive,Lymphomation.org,Negative
 Writers,Sid,Positive
 √≠a HOPE,Medibooks,Negative
 HIGHRISK CHRONIC LYMPHOCYTIC LEUKEMIA RELAPSING,Medibooks,Negative
 ALLOGENEIC,Medibooks,Negative
 STEMCELL TRANSPLANTATION,Medibooks,Negative
 UNCH   AGM statement,Martin Luke,Negative
 ASCT,Lymphoma Coalition,Negative
 Guy,CancerWallonia,Negative
 lymphomaBTK inhibitors,Francesco Turturro,Negative
 Abstract   novel,Biotech2050,Negative
 Abstract   plus   activity safety profile,Biotech2050,Negative
 RHHBY blood   drug,Ali Urman,Positive
 p deletion relapsedrefractory,European Pharmaceutical Review,Negative
 p deletion relapsedrefractory,Matthias Piesche,Negative
 Ayyy Terry,Balraj Dhingra,Positive
 penalty,[[Sach]],Positive
 Great Video,Matthew Kauffman,Negative
 Delq,Lunarteddy,Positive
 Delq,Pedro Aleixo,Positive
 Delq,histopathology üî¨,Positive
 Bruton tyrosine kinase inhibitor ibrutinib,Nicolas Gendron,Positive
 Bruton tyrosine kinase inhibitor ibrutinib,Muzaffar Qazilbash,Negative
 Bruton tyrosine kinase inhibitor ibrutinib,GEDEFO,Negative
 Dr Boxer,AZ Blood Cancer,Positive
 Strategy Chronic Lymphocytic Leukemia,AlgoTrader,Positive
 PharmacyTimes Venetoclax,Pharmacy Podcast Network,Positive
 drug conjugate,Francesco Turturro,Negative
 RR Bcell nonHodgkin,Francesco Turturro,Negative
 Roches   drug,visiongain Pharma,Positive
 Boom   donation,Sue Zurface,Positive
 Jo Ann,Sue Zurface,Positive
 Support cancer research,Sue Zurface,Positive
 Allogeneic StemCell Transplantation EDITORIALS,Jerry Lee,Negative
 backstory,Patient Power,Positive
 Health   Google News Chronic Lymphocytic Leukemia Breakthrough Drug,"Think, Stop The Silenceüè≥‚Äçüåà",Positive
 Chronic Lymphocytic Leukemia Breakthrough Drug,Steve Nolito,Positive
 Chronic Lymphocytic Leukemia Breakthrough Drug,Biotech Stock,Positive
 Chronic Lymphocytic Leukemia Breakthrough Drug,Abahoo,Positive
 Chronic Lymphocytic Leukemia Breakthrough Drug,United States News,Positive
 Chronic Lymphocytic Leukemia Breakthrough Drug,EZ HomeCare,Positive
 Chronic Lymphocytic Leukemia Breakthrough Drug,NaturalMedicines,Positive
 Chronic Lymphocytic Leukemia Breakthrough Drug,Silver Valley Doctor,Positive
 Chronic Lymphocytic Leukemia Breakthrough Drug,US Health News,Positive
 Chronic Lymphocytic Leukemia Breakthrough Drug,Gary Ross,Positive
 Novel Biologic Agents,Clinical Pharmacy,Negative
 Novel Biologic Agents,"CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",Positive
 Novel Biologic Agents,Scott Werntz,Positive
 Novel Biologic Agents,COPD News,Negative
 Chronic Lymphocytic Leukemia Adoptive Cellular Immunotherapy,Clinical Pharmacy,Negative
 WallStreet OTCChronic Lymphocytic Leukemia Breakthrough Drug,Healthy Society,Positive
 FDAWallStreet,Healthy Society,Positive
 OTCThe Venet,Healthy Society,Positive
 WallStreet OTC WallStreet,EZ HomeCare,Positive
 WallStreet OTC WallStreet,NaturalMedicines,Positive
 WallStreet OTC WallStreet,Silver Valley Doctor,Positive
 WallStreet OTC WallStreet OTCChronic Lymphocytic Leukemi,Gary Ross,Positive
 FDA breakthrough therapy designation,Roche,Positive
 COMPLEMENT,MediTech Media,Positive
 investigational Bcl inhibitor venetoclax,CGB3 Beck,Positive
 p deletion relapsedrefractory CLL,CGB3 Beck,Positive
 AbbVie Receives Breakthrough Designation,Drug Discovery & Dev,Positive
 Cancer Drug,Drug Discovery & Dev,Positive
 RelapsedRefractory p CLL,Ann F Cheung,Positive
 AbbVies venetoclax,LLZ Consulting,Negative
 w P deletion,WCM Lymphoma,Negative
 Bcl inhibitor venetoclax gains Breakthrough Therapy Designation,Dominique Fontanilla,Positive
 FDA Breakthrough Therapy AbbVie,Pedro Lendinez,Positive
 p Deletion AbbVie,Pedro Lendinez,Positive
 annou,Pedro Lendinez,Positive
 Refract,Dominique,Positive
 ABBV Venetoclax ABT,Andy Biotech,Positive
 CLL   Communication amp Support,Lymphoma Coalition,Negative
 TGTX PROPRIETARY COMBODevelopment plan,Biotech2050,Negative
 Prev,Biotech2050,Negative
 tcoWfGETD,Biotech2050,Negative
 s√© si eres,‚àû,Positive
 el mejor,‚àû,Positive
 o el m√°s,‚àû,Positive
 porque,‚àû,Positive
 practicar,fache,Positive
 Mayo Clinic Q,‡¶ì‡¶∞‡ßá ‡¶ó‡ßç‡¶∞‡¶π‡¶¨‡¶æ‡¶∏‡ßÄ ‡¶ñ‡ßã‡¶≤ ‡¶ó‡¶æ‡¶Å*üòí ‡¶ñ‡ßã‡¶≤!!!,Positive
 Picture,Steve Cusack,Positive
 parade day,Steve Cusack,Positive
 New Challenger,ASH,Positive
 Excellent investigation,"chadi nabhan MD, MBA, FACP",Negative
 Hier,*,Positive
 une journ√©e,*,Positive
 parfaite,*,Positive
 Diagnosis approach,Scott Werntz,Negative
    Delays,CancerWallonia,Negative
 terry shirt,Gentleman Jamz üá¶üá¨,Positive
   Great   Conference,Patient Empowerment Network,Positive
 Canada Empowers,Patient Empowerment Network,Positive
 Pubmed Cytotoxic Activity,epigenetics_papers,Negative
 Valproic Acid,epigenetics_papers,Negative
 Nicht,Michael Milberger,Positive
 nicht,Michael Milberger,Positive
 JT fucking warrior,Mike C.,Positive
 CAPITANO JT,Drew Mohr,Positive
 TERRY,Balraj Dhingra,Positive
   CLL,Patient Empowerment Network,Positive
 ibrutinib amp Zydelig,Matthias Piesche,Negative
   como leer un libro,Nataly Rojas Peinado,Positive
 jajaja P parte,Nataly Rojas Peinado,Positive
 MT   QampA Researchers,Matthias Piesche,Negative
 C√°ssio anuncia,ResumoPB,Positive
 SenadoLeia,ResumoPB,Positive
 CLL Molecular Onc Tumor Board forum,ASCO,Negative
 Healthwatch HealthwatchKilling Blood Cancer CLL,WeAreGreenBay,Positive
 SEATTLE Ivanhoe,WeAreGreenBay,Positive
 Understanding RBC Indices,Greencrest Pharmacy,Positive
 Approvals Action Janssens,Pharma in Focus,Positive
 Novartis Arzerra,Matthias Piesche,Negative
 NVS Ph study,Matthias Piesche,Negative
    IL UpRegulates MiR,BVirtual Murciasalud,Negative
 MiRNAs,BVirtual Murciasalud,Negative
 MiRNAs,microRNApapers,Negative
 MiRNAs,Scott Werntz,Negative
 Hosted,BVirtual Murciasalud,Negative
 Hosted,microRNApapers,Negative
 Hosted,Scott Werntz,Negative
 CLCN Gene,BVirtual Murciasalud,Negative
 CLCN Gene,microRNApapers,Negative
 CLCN Gene,Scott Werntz,Negative
   CHRONIC LYMPHOCYTIC LEUKEMIA,My PG Notes,Positive
 Lymphocytes,My PG Notes,Positive
 size andconfiguration,My PG Notes,Positive
 force,Kevin Adatsi üëÅ,Positive
 Vamos con todo,Nazarena Papes,Negative
 Lynn Rich ANPBC,Alicia Maston Coffin,Positive
 OCN,Alicia Maston Coffin,Positive
 Upstate NY,Alicia Maston Coffin,Positive
 keynote address,"chadi nabhan MD, MBA, FACP",Negative
 sympos,"chadi nabhan MD, MBA, FACP",Negative
 Dr Furnan,"chadi nabhan MD, MBA, FACP",Negative
 shoukd b,"chadi nabhan MD, MBA, FACP",Negative
 IL UpRegulates MiR,microRNApapers,Negative
 IL UpRegulates MiR,Scott Werntz,Negative
 Kagami,Killua/Nic ·ïï(·êõ)·ïó,Positive
 Chem Rho,ImmunologyPapers,Negative
 Rap guanosine triphosphatase,ImmunologyPapers,Negative
 skovasaurus,TreePlanters,Positive
 Adventures,TreePlanters,Positive
 chateau,TreePlanters,Positive
   cochair Jennifer Brown MD PhD,ASH,Negative
 Hollie Mueller Hawn,Funkabillybongo,Positive
 deleted markers,Funkabillybongo,Positive
 Splenomegaly,Patient Power,Positive
 amp Symptoms,Greencrest Pharmacy,Positive
 Chronic Lymphatic Luekemia,Greencrest Pharmacy,Positive
 Ekata CancerCare client,CancerCare,Negative
   longerterm followup data,CancerWallonia,Negative
 George Sandra Smith,Patient Power,Positive
    amp   Meeting,Light The Night SD,Negative
 UCSD Moores,Light The Night SD,Positive
   antigen reactivity,Francesco Turturro,Negative
 RHHBY development pipeline,Biotech2050,Negative
 registrations,Biotech2050,Negative
 Demonstrate,Rare Diseases,Negative
 T Blood cancers,ASH,Negative
 heterogeneic disease,ASH,Negative
 diff people,ASH,Negative
 FollowUp Data Durable Responses,SPEC,Positive
 RIPNRIP,Moreaux J√©r√¥me,Positive
 RIPNRIP,Francesco Turturro,Negative
 Incl Complete Responses,1stOncology,Negative
 CLL Molecular Oncology Tumor Board forum,ASCO,Negative
 Twitter    Program member amp Director,WCM Lymphoma,Negative
   Research Center,WCM Lymphoma,Negative
 Chronic Lymphocytic Leukemia Julia Christine Gutjahr,Frontiers Immunology,Negative
 Molecular Oncology Tumor Boards,Dibson Gondim M.D.,Positive
 Molecular Oncology Tumor Boards,"Chris Cogbill, MD",Positive
    LongerTerm FollowUp,Dominique,Positive
 Data Demonstrate,Dominique,Positive
 Data Demonstrate,truebluetribune,Positive
   Followup data,"Pharmacyclics, an AbbVie Company",Negative
 Complete Responses,truebluetribune,Positive
 JE interpro,M√©dia Centre-Ouest,Negative
 La librairie,M√©dia Centre-Ouest,Positive
 CoPlayers,Tim Kapadia,Positive
 Game B,Tim Kapadia,Positive
 Cozy,Tim Kapadia,Positive
 quality game,Shadley vanSchalkwyk,Positive
 st win,Shadley vanSchalkwyk,Positive
 winner,Spence,Positive
 winner,Focus on Cancer,Negative
 Altas aventuras,Brun√£o,Positive
 Good Prognosis,nancy murphy bowles,Positive
 Good Prognosis,CancerTherapyAdvisor,Negative
 Good Prognosis,Stem Cell Foundation,Positive
 Good Prognosis,Stem cell Watch,Positive
 Good Prognosis,Michelet St. Preuve,Positive
 Good Prognosis,Scott Werntz,Negative
 Chronic Leukemia Progression,nancy murphy bowles,Positive
 Chronic Leukemia Progression,Stem Cell Foundation,Positive
 Chronic Leukemia Progression,Stem cell Watch,Positive
 Chronic Leukemia Progression,Michelet St. Preuve,Positive
 Chronic Leukemia Progression,Scott Werntz,Negative
 Stem Cell Transplant,nancy murphy bowles,Positive
 Stem Cell Transplant,Stem Cell Foundation,Positive
 Stem Cell Transplant,Stem cell Watch,Positive
 Stem Cell Transplant,Scott Werntz,Negative
 Cricket bag,Chris Murray,Positive
 research story,Laura Strong,Positive
 review Role,Laura Strong,Positive
 TGTX pipeline,Biotech2050,Negative
    HAGD,‚Ä¢ Honey üß£‚Ä¢,Positive
 Video Update,Cary Higgins,Positive
 Uncertainty,Cary Higgins,Positive
 Roles,Cary Higgins,Positive
 StemCell Transplantation Failure,ASCO,Negative
 Blood Outcomes,Tran-Der Tan,Negative
 Sanlam Securities,MarketBeat,Negative
 treatmentna√Øve amp,Francesco Turturro,Negative
 amp SLL,Francesco Turturro,Negative
 singleagent tcorJibOr,Francesco Turturro,Negative
 tcoiomGbBedq,Francesco Turturro,Negative
 Cool resource Chronic Lymphocytic Leukemia,"Chris Cogbill, MD",Positive
 Living w Chronic Lymphocytic Leukemia,NCCS - National Coalition for Cancer Survivorship,Positive
 Apprendre le N√©erlandais,NORA,Positive
 Susan Novick dxd CLL,Patient Power,Positive
   PatientCentered Care,Medscape Education,Negative
 New   Molecular Oncology Tumor Board,ASCO,Negative
 ‚Äî   Adoptive Cellular Immunotherapy SmallMolecule Inh,Scott Werntz,Negative
 Geoff,Gilead Sciences,Negative
 CLL CLL,ihealthkonnect,Positive
 lymphoid cells,ihealthkonnect,Positive
 Syk inhibitor entospletinib,Lymphoma Hub,Negative
 √≠a LAG TIMES,Medibooks,Negative
 LYMPHOPROLIFERATIVE DISORDER,Medibooks,Negative
 CLINICAL DIAGNOSIS,Medibooks,Negative
 Radiant Insights Inc,Scott Werntz,Negative
   promising data,Pens_Horizon,Positive
 spliceosome,PANNA SHARMA,Positive
 spliceosome,Cure Cancer Now,Negative
 Episode   Steve Brown Chronic Lymphocytic Leukemia Survivor,Living With Podcast,Positive
 Ultra Athlete,Living With Podcast,Positive
 Inna HLAG,ImmunologyPapers,Negative
 component,ImmunologyPapers,Positive
 Adap HLAG,ImmunologyPapers,Negative
 IgHVunmutated,Gina Eagle,Negative
 Allogeneic StemCell Transplantation Editorials,Scott Werntz,Negative
 Allogeneic StemCell Transplantation Editorials,FarmaOnco,Negative
 Dr La Verne,Patient Power,Positive
 pseudo s transformation,"Andreas-Claudius Hoffmann, M.D.",Positive
 OpportunityAnalyzer Chronic Lymphocytic Leukemia,Scott Werntz,Negative
 TCL,Pharma Models,Positive
 causal relationships,Pharma Models,Positive
   expression,Pharma Models,Positive
 mutated TCL gene,Pharma Models,Positive
 champions,Wear A Mask!,Positive
 causal relationship,Pharma Models,Positive
 Tcell defects,Pharma Models,Positive
 Chronic   Progression,CancerTherapyAdvisor,Negative
 CLLchronic lymphocytic   patientwhat,TalkAboutHealth,Positive
 leukemia foundation Mom,Geekgirl,Positive
 PhaSeal,FarmaOnco,Negative
 entospletinib GS,FarmaOnco,Negative
 novel largescale,Cleveland Clinic MD,Negative
 ethnicityspecific genes,Cleveland Clinic MD,Positive
 Capnocytophaga,AntibioticResistance,Positive
 bacteremia,AntibioticResistance,Positive
      Type II,Master Kim,Positive
 Prediabetes Knees,Master Kim,Positive
    trial,Francesco Turturro,Negative
 pathway inhibitor,WCM Lymphoma,Negative
 Study Results,Lymphomation.org,Negative
 shows,Lymphomation.org,Negative
 end dates,Lymphomation.org,Negative
 tcoFvfDvbSrB,Francesco Turturro,Negative
   visit,Los Lobos,Negative
 Chronic Lymphocytic Leukemia Life Expectancy,Healt Harticles,Positive
 Chronic Lymphocytic Leukemia Life Expectancy,Andrew Prohorov,Positive
 Chronic Lymphocytic Leukemia Life Expectancy,Amanda Jones,Positive
   Hay Smudge cells,Dr. Ellis,Positive
 Nodality Unveils,Scott Werntz,Negative
 menu options,Patient Power,Positive
 burner,Patient Power,Positive
 Research Markets Chronic Lymphocytic Leukemia Pipeline Highlights Report,Scott Werntz,Positive
 Stem Cell Transplant Patients,Michelet St. Preuve,Positive
 Chronic Lymphocytic Leukemia Pipeline Highlights Report,Scott Werntz,Negative
 Polypeptides,Scott Werntz,Negative
 BCRcontrolled adhesion,Francesco Turturro,Negative
 Transplantation Failure Hematologic Malignancy,Scott Werntz,Negative
 delata la sonrisa cuando escucho su nombre,‚àû,Positive
 Sunday set,Jon Henderson üçªüç∫ üíõüíô,Positive
 lads,Jon Henderson üçªüç∫ üíõüíô,Positive
 Ataxia,CLL Society Inc.,Negative
 Telangiectasia Mutated ATM null phenotype,CLL Society Inc.,Negative
 Meet Honored Teammate HalHal,Team In Training GAT,Positive
 Atypical Chronic Lymphocytic Leukemia CLL,Team In Training GAT,Positive
 Bom,wilmyson linhares,Positive
 gente linda,wilmyson linhares,Positive
 Listos para,Javier Jara,Positive
 Excellent data,"chadi nabhan MD, MBA, FACP",Negative
 PIK inhibition,"chadi nabhan MD, MBA, FACP",Negative
 Little League Opening Day,Josh Cantor,Positive
 Listo,Javier Jara,Positive
 Nodality Inc Launches,Scott Werntz,Negative
 PathPro Chronic Lymphocytic Leukemia CLL Panels,Scott Werntz,Negative
 PathPro Chronic Lymphocytic Leukemia CLL Panels,COPD News,Negative
 PathPro Chronic Lymphocytic Leukemia CLL Panels,Epigenetics News,Positive
 PathPro Chronic Lymphocytic Leukemia CLL Panels,Lung Cancer News,Negative
 PathPro Chronic Lymphocytic Leukemia CLL Panels,Johnson & Johnson,Positive
 PathPro Chronic Lymphocytic Leukemia CLL Panels,Stem Cell News,Negative
 Leading Single Cell Network Profiling SCNPTM Platform,Scott Werntz,Positive
 protein profiling,Francesco Turturro,Negative
 tcoIRfnJZKy,Francesco Turturro,Negative
 Nodality Launches PathPro ‚Ñ¢ Chronic Lymphocytic Leukemia CLL Panels,Susan Murphy,Positive
 Nodality Launches PathPro ‚Ñ¢ Chronic Lymphocytic Leukemia CLL Panels,EIN Presswire: Pharmaceutical Newswire,Negative
 Nodality Launches PathPro ‚Ñ¢ Chronic Lymphocytic Leukemia CLL Panels,Business Wire-Health,Negative
 Nodality Launches PathPro ‚Ñ¢ Chronic Lymphocytic Leukemia CLL Panels,Scott Werntz,Negative
 Nodality Launches PathPro ‚Ñ¢ Chronic Lymphocytic Leukemia CLL Panels,BusinessWireProducts,Negative
 Nodality Launches PathPro ‚Ñ¢ Chronic Lymphocytic Leukemia CLL Panels,BusinessWire-Science,Negative
 Nodality Launches PathPro ‚Ñ¢ Chronic Lymphocytic Leukemia CLL Panels,dlvr news,Negative
 Nodality Launches,COPD News,Negative
 Nodality Launches,Lung Cancer News,Negative
 Nodality Launches,Stem Cell News,Negative
 Leading Single Cell Network,COPD News,Negative
 Leading Single Cell Network,Epigenetics News,Positive
 PathProTM Chronic Lymphocytic Leukemia CLL panels,Precision Medicine World Conference,Positive
 News Nodality Launches,Epigenetics News,Positive
 News Nodality Launches,Johnson & Johnson,Positive
 Leading Single Cell N,Lung Cancer News,Negative
 New   panels,"Nodality, Inc",Positive
 Leading Single Cell,EIN Presswire: Pharmaceutical Newswire,Negative
 Nodality Launches PathPro Chronic Lymphocytic Leukemia CLL Panels,Drug Delivery News,Positive
 Nodality Launches PathPro Chronic Lymphocytic Leukemia CLL Panels,Invitro Diagnostics News & Research,Positive
 Nodality Launches PathPro Chronic Lymphocytic Leukemia CLL Panels,CRO Contract Res.,Negative
 Leading Single Cell Network Profiling S,Drug Delivery News,Positive
 Leading Single Cell Network Profiling S,Invitro Diagnostics News & Research,Positive
 Leading Single Cell Network Profiling S,CRO Contract Res.,Negative
 Leading Single Cell Network Profi,Johnson & Johnson,Positive
 Leading Single Cell Ne,Stem Cell News,Negative
 Leading Single Cell Network Profiling,Business Wire-Health,Negative
 Leading Single Cell Network Profiling,BusinessWireProducts,Negative
 Leading Single Cell Network Profiling,BusinessWire-Science,Negative
 Leading Single Cell Network Profiling,dlvr news,Negative
 Practica,Nazarena Papes,Positive
 amp microRNA signature,Francesco Turturro,Negative
   impairs,Francesco Turturro,Negative
 Sensual nivel,Ana Catarina Bento,Negative
 Antioxidant NAC Treatment,Francesco Turturro,Negative
 TCL Transgenic Mouse Model,Francesco Turturro,Negative
 amp ROS Modulation,Francesco Turturro,Negative
 Pharmacological protein profiling,Scott Werntz,Negative
 Pharmacological protein profiling,Just Cancer News,Negative
 pharmaceutical cost,MDLinx,Negative
 Extremamente sensuais,Ana Catarina Bento,Negative
 Extended Ibrutinib Exposure Prolongs CLLSLL Remission,Luis H Camacho,Positive
 Phoenix AZ   Town Mtg,Patient Power,Negative
 lo olvide Este sabado,Dani üé∂,Positive
 RNA sequencing,SHCYuma,Positive
 RNA sequencing,CLL Society Inc.,Negative
 RNA sequencing,Fabrice Leclerc,Negative
 Susan F Connection volunteer,AZ Blood Cancer,Positive
 colonoscapy,AZ Blood Cancer,Positive
 Dr Munoz,AZ Blood Cancer,Positive
 answering,AZ Blood Cancer,Positive
 L Checkpoint Blockade Prevents Immune Dysfunction Leukemia Development,"Andreas-Claudius Hoffmann, M.D.",Positive
 Transform,CancerWallonia,Negative
 pndbrennan,Zach Kettell //BLM,Positive
 learning landscape onlline resources,Dr Lesly Huxley,Positive
 ibrutinibBR,"chadi nabhan MD, MBA, FACP",Negative
 PFS cw BR,"chadi nabhan MD, MBA, FACP",Negative
 relapsed   Study,"chadi nabhan MD, MBA, FACP",Negative
       Allogeneic T Cells,Anna Deveau,Negative
 AntiCD Chimeric Antigen Receptor,Anna Deveau,Negative
   Journal,Aziz Nazha,Positive
   Town Hall,AZ Blood Cancer,Positive
 JOHN TERRY JOHN TERRY JOHN TERRY,Saprudien Cote,Positive
 Lipoprotein Lipase SNPs rs,Scott Werntz,Negative
 rs Correlate,Scott Werntz,Negative
 Spectrum,Scott Werntz,Negative
 Kidney Pathology,Scott Werntz,Negative
 Small Lymphocytic Lymphoma Year Multicenter Experience,Scott Werntz,Negative
 Er ikke noe annet enn fortjent,PT-WOO,Positive
 Nots,CancerWallonia,Negative
 tcoSTScGcO,Francesco Turturro,Negative
 tcossPZWmUMiO,Francesco Turturro,Negative
 Deutsche wir kommen,Lucy Michaelis‚ô•‚ô•,Positive
 platz,Lucy Michaelis‚ô•‚ô•,Positive
 Leiden,Hematon,Negative
 Dr Skirvin,Amber B Clemmons,Positive
 IVIg use,Amber B Clemmons,Positive
 Allelespecific loss,microRNApapers,Negative
 Allelespecific loss,Gang Wu,Positive
 transcription,microRNApapers,Negative
 transcription,epigenetics_papers,Negative
 transcription,Gang Wu,Positive
 miRa cluster,microRNApapers,Negative
 miRa cluster,epigenetics_papers,Negative
 miRa cluster,Gang Wu,Positive
 ignorance,Shine Cancer Support,Positive
 Pubmed Allelespecific loss,epigenetics_papers,Negative
 mutation status,RNA-Seq Blog,Positive
    Peter Chatterton,Dr Lesly Huxley,Positive
 amp pm Dr Jennifer Brown,Einstein Montefiore Medicine,Positive
 BCELL EPIGENETIC SIGNATURE,Medibooks,Negative
 BIOLOGIC SUBGROUPS,Medibooks,Negative
 TGTX PH trial,Biotech2050,Negative
 tcohBPzrABBV PCYC,Biotech2050,Negative
 Ravindra Kolhe,The Pathologist,Positive
 Ravi Kolhe,Greenwood Genetic,Positive
 GGC,Greenwood Genetic,Positive
 Zydelig experience,Lymphoma Canada,Positive
 Dr Richard Furmans,WCM Lymphoma,Negative
 Campeones,WiLaR,Positive
 NRBCs,Marn√© Prinsloo,Positive
 Sunshine Coast,Marn√© Prinsloo,Positive
 Viendo el gran cl√°sico desde el sal√≥n,Centro Luso Larense,Negative
 Borrelia Infection,SCIENCEDOMAIN Int.,Positive
 Amanita phalloides,SCIENCEDOMAIN Int.,Positive
   Clinical KappaCD T Lymphocytes Chronic Lymphocytic Leukemia Bcell Lymphoma,Stem Cell News,Negative
 Multiple Myeloma CHARK,Stem Cell News,Negative
 Citizen Journalist,prabir ghose,Positive
 Con las ni√±as,Dani üé∂,Positive
 en la plaza de maipu,Dani üé∂,Positive
 Noah,Heather Kidder,Negative
 Bernie,Heather Kidder,Positive
 kids,Heather Kidder,Negative
 Opening ceremonies,Heather Kidder,Negative
 ‚Äò Advance,Lymphoma Hub,Negative
 saddle      √ßao,Teresa Aguiar,Negative
 saddle,Teresa Aguiar,Negative
 Vandaag,Jolanda,Positive
 Doreen te,Jolanda,Positive
 Raa gepromoveerd op,Jolanda,Positive
 een onderzoek naar betere therapie voor,Jolanda,Positive
 Doreen te Raa,Jolanda,Positive
 op een,Jolanda,Positive
     Versus,Biotech2050,Negative
 Previously Treated HighRisk TGTX PH trial,Biotech2050,Negative
 fludarabinecyclophosphamide,Chan Cheah,Negative
   cocktail,Oksana Komarova,Positive
   CLL HCP education series,Lymphoma Hub,Negative
 parking lot,Los Lobos,Negative
 Foxboro,Los Lobos,Negative
 Jerry Garcia,Los Lobos,Negative
 Bob Weir,Los Lobos,Negative
 Las chicas del Lucho,Nazarena Papes,Negative
 erythropoiesis,Patient Power,Positive
 CANAM,CLL,Negative
 piling,CLL,Negative
 Whangarei Hospital,CLL,Negative
    Extends,CancerWallonia,Negative
 Imbruvica Significantly Delays Disease Progression,Scott Werntz,Negative
 CLLSLL Study,Scott Werntz,Negative
 line optimizing maintenance,Lymphoma Hub,Negative
 Significant Delay,1stOncology,Negative
 TreandaRituxanImbruvica,Michael Goodman,Negative
 TR,Michael Goodman,Positive
 ISI,Michael Goodman,Negative
 st line bodes,Michael Goodman,Negative
 Imb,Michael Goodman,Negative
 earlier   settings,Michael Goodman,Negative
 CLL   study,"Pharmacyclics, an AbbVie Company",Negative
   G,Francesco Turturro,Negative
 amp fludarabinecyclophosphamide GFC,Francesco Turturro,Negative
 bendamustine GB,Francesco Turturro,Negative
    Novel Biologic Agents,Shawn Watson,Positive
   discontinuation,HemOnc Today,Negative
   discontinuation,Healio,Negative
 GSK,Todd A Nolan,Positive
 Nev,Long Stop,Positive
 finger,Long Stop,Positive
 maipu,John Drago,Positive
 Plaza Monumento,John Drago,Positive
 Productividad y solidaridad colectiva taller para socios,Centro Luso Larense,Negative
 tu,Centro Luso Larense,Positive
 Recuerden,Alessandro üá®üá±,Positive
 de Marzo,Alessandro üá®üá±,Positive
 General Information,J Mol Diagnostics,Positive
 Buen escrachin,Nazarena Papes,Negative
 NICE supports use,Scott Werntz,Negative
 Nenussssss,Nazarena Papes,Negative
 Este viernes,Centro Luso Larense,Negative
 Jornada Educativa Deportiva pm,Centro Luso Larense,Negative
 amigos,Centro Luso Larense,Negative
 Lymphoma Hub Awards,Lymphoma Hub,Negative
 vote,Lymphoma Hub,Negative
 Lifeline blood cancer drug Gazyvaro,Matt Kaiser,Positive
 Addenbrookes,Matt Kaiser,Positive
 Le contrat d√©dition,M√©dia Centre-Ouest,Negative
 JE interprofessionnelle,M√©dia Centre-Ouest,Negative
 ŒùŒ≠Œ± ŒºŒøœÅŒπŒ±Œ∫ŒÆ œÑŒ±ŒæŒπŒΩœåŒºŒ∑œÉŒ∑,Ygeiaonline.gr,Positive
 Una crack que se,Nazarena Papes,Negative
    concert,Los Lobos,Negative
 Austin TX,Los Lobos,Negative
 nt Worry Baby,Los Lobos,Negative
 floor,Chris Thomson,Negative
 Point,Chris Thomson,Negative
 SEDA,Chris Thomson,Negative
 Change Leader award,Chris Thomson,Negative
   coaching skills,Chris Thomson,Negative
 technology support staff,Chris Thomson,Negative
 institutions,Chris Thomson,Positive
    work,Chris Thomson,Negative
   agilestyle,Chris Thomson,Negative
   Barriers,Chris Thomson,Negative
 TEL,Chris Thomson,Negative
 workloads capabilities,Chris Thomson,Negative
 confidence,Chris Thomson,Negative
   lessons,Chris Thomson,Negative
 pharma industry,Chris Thomson,Negative
   Consistency,Chris Thomson,Negative
 Changing Learner Landscape programme,Chris Thomson,Negative
 tcoqWthpgxsPh trial,Biotech2050,Negative
 TGTXPCYC ABBV,Biotech2050,Negative
 MD ANDERSON Clinical Trials,Biotech2050,Negative
 CDCART CellsCDspecific Tcell,Biotech2050,Negative
 Chronic     ZIOP,Biotech2050,Negative
 BCell Chronic Lymphocytic Leukemia Therapeutic Pipeline Market Review H,Pitch Ticker,Positive
 dioxin contaminated incinerator,CLL,Negative
 Beeen,Thommed Snooze üò¥,Positive
 Push Ups,Thommed Snooze üò¥,Positive
 Lol,Thommed Snooze üò¥,Positive
 Honored Teammate,Team In Training GAT,Positive
 Rodney Brown Rodney Brown,Team In Training GAT,Positive
 Super Crazy,Oscar,Positive
 El mi√©rcoles los de,Florencia,Negative
 las clases,Florencia,Negative
   en,cba_perez,Positive
 mas Ayer,cba_perez,Positive
 mi regalo Pulsera del mas,cba_perez,Positive
 PeerExchange FirstLine Treatment Selection,OncLive.com,Negative
 Super Crazy conchetumare,Oscar,Positive
 Super crazy,Andy ‚Ä¢ ·¥¨·µá ∏À¢À¢ ‚Ä¢ üê≥,Positive
 insane luchadoooor,Miguel Gonz√°lez,Positive
 Esperando esta sea la primera de muchas,Andy ‚Ä¢ ·¥¨·µá ∏À¢À¢ ‚Ä¢ üê≥,Positive
 momentos de empezar,Oscar,Positive
 RelapsedRefractory Indolent Bcell,Biotech2050,Negative
 Derochando gronchada,Nazarena Papes,Negative
 tumorsuppressor,Qatar Research,Positive
 tumorsuppressor,microRNApapers,Negative
 tumorsuppressor,epigenetics_papers,Negative
 tumorsuppressor,Peng,Positive
 Herkenbaar   Ik ben,MarinaRoeit,Positive
 een soort oldtimer,MarinaRoeit,Positive
 Ik,MarinaRoeit,Positive
 naar de garage maar,MarinaRoeit,Positive
 ik loop nog steeds,MarinaRoeit,Positive
 HaematoOncology researches,Barts Cancer Institute,Positive
 Monoclonal B Lymphocytosis,JournalAgent,Positive
 Degree Relatives,JournalAgent,Positive
 LeMoyne reunion,Matt Shaler,Positive
 WNYPE,Matt Shaler,Positive
 Leukemias butt,Ro Lewis,Positive
   BCR,Francesco Turturro,Negative
 antiLAG,WCM Lymphoma,Negative
 Brief history,JediPD,Negative
 Educational,JediPD,Negative
 Chronic Lymphocytic Leukemia Pipeline Review,Business Wire-Health,Negative
 Chronic Lymphocytic Leukemia Pipeline Review,Scott Werntz,Negative
 BCell Chronic Lymphocytic Leukemia Pipeline Review,Scott Werntz,Negative
 El lunes vamos,Florencia,Negative
 nini,Florencia,Negative
 comprar,Florencia,Negative
 todo para,Florencia,Negative
 el upd,Florencia,Negative
 promo,Florencia,Negative
 Juro amar las,mili,Positive
 que tenemos con las chicas,mili,Positive
 puedo re√≠r,mili,Positive
 Goodnight,CFCùóßrenzs,Positive
 Serenata Nortena,Los Lobos,Negative
   album,Los Lobos,Positive
 Wolf,Los Lobos,Negative
 CD Agonist Peptides,PLOS Medicine,Positive
 Refractory Chronic Lymphocytic Leukemia Bcells,PLOS Medicine,Positive
 PLCŒ≥ activation,PLOS Medicine,Positive
   CD Agonist Peptides Induce,Kazeem Olalekan,Positive
 Refractory Chronic Lymphocytic Leukemia B Cells,Kazeem Olalekan,Positive
 Refractory Chronic Lymphocytic Leukemia B Cells,Scott Werntz,Negative
 CD Agonist Peptides Induce,Scott Werntz,Negative
 PLCŒ≥ Activation Evidence,Scott Werntz,Negative
 ibrutinib therapy discontinuation,EMJ Hematology,Negative
 ibrutinib therapy discontinuation,Jerrie DanceMabus MS,Positive
 ibrutinib therapy discontinuation,Scott Werntz,Positive
 ibrutinib therapy discontinuation,Dr Alex Concorde,Negative
 ibrutinib therapy discontinuation,The Peak Oil Poet,Positive
 ibrutinib therapy discontinuation,Science Codex,Negative
 ibrutinib therapy discontinuation,Cancer Daily,Positive
 ibrutinib therapy discontinuation,Healthy & Active,Positive
 ibrutinib therapy discontinuation,Michael Rahman,Positive
 ibrutinib therapy discontinuation,"Burke & Eisner, P.A.",Positive
 ibrutinib therapy discontinuation,HealthyTabs/pharmacy,Positive
 ibrutinib therapy discontinuation,Titanhealth news,Negative
 ibrutinib therapy discontinuation,Future Consulting,Positive
 ibrutinib therapy discontinuation,Drug Daily,Positive
 ibrutinib therapy discontinuation,Ajinkya Ambre,Positive
 ibrutinib therapy discontinuation,sciencenewsfacts,Positive
 Sanlam Securities GBX,MarketBeat,Negative
 d√≠as de arrancar las,Florencia,Negative
 upd brccccc Amo,Florencia,Negative
 GNAC baseball player,Jeff Honeysett,Positive
 CWU   HR   RBI   SB,Jeff Honeysett,Positive
 wins,Jeff Honeysett,Positive
 MSU,Jeff Honeysett,Positive
 Brief History,JediPD,Negative
 √§mie    Betroffene,Roche Deutschland,Negative
 Faith hope,MD Anderson Cancer Center,Negative
 Miracles,MD Anderson Cancer Center,Negative
 Bioscience Factoids Reasons,Dr Alex Concorde,Negative
 BLOG CHRONIC LYMPHOCYTIC LEUKEMIA,George J Huba PhD,Positive
 dysfunction,George J Huba PhD,Positive
 Post,JediPD,Negative
   percent,kapiteinlabs.com,Positive
   percent,Smart City,Positive
   percent,Molecular Biology,Positive
 Monica,MD Anderson Leukemia,Negative
 DL Nice breakdown,CancerSystemsBiology,Positive
 origin lymphocyticmyeloid,CancerSystemsBiology,Positive
 effect chronicacute,CancerSystemsBiology,Positive
 glivec,CancerSystemsBiology,Positive
 Leukaemia Cardiff University breakthrough,Mike Durham -The Siesta Murders,Positive
 disease treatment,Mike Durham -The Siesta Murders,Positive
 FINAL Te Puru Pump Station,CLL,Negative
 Te Puru Pump Station,CLL,Negative
 therapy stoppage,JAMA Oncology,Negative
 Hoy hace cuatro meses que mi,‚àû,Positive
 y apellidos√°s,‚àû,Positive
 Mi culete,Mireia,Positive
 da para m√°s,Mireia,Positive
   piles,CLL,Negative
 mm,CLL,Negative
 dia,CLL,Negative
 x,CLL,Negative
 microRNAs regulating genes,BMC,Positive
   Moonshot,MD Anderson Cancer Center,Negative
 LinkedIn,CLL,Negative
 th Australia New Zealand Conference,CLL,Negative
 Geomechanics,CLL,Negative
 works,CLL,Negative
 Completed Cliff Stabilisation,CLL,Negative
 Clifton Road Auckland,CLL,Negative
 NZ,CLL,Positive
 Cliff Stabilisation process,CLL,Negative
 Clifton Road Auckland NZ,CLL,Negative
 Stone Columns,CLL,Negative
 Wellington,CLL,Negative
 Ryman Healtcare,CLL,Negative
 CFA piling video,CLL,Negative
 Mangere Countdown,CLL,Negative
 diameter multipole,CLL,Negative
 m diamete grout filled columns,CLL,Negative
   ÏóêÎäî,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 ÎèÑ,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 ÏûàÍ≥†,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 Lisp,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 LanguageÏù∏,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 Í≥º,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 Ïù¥,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 ÏûàÎã§,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 Í∏∞Ï°¥,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 Î™ª Ïì∞Îäî,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
 Í±∏Íπå,ùö¢ùöòùöòùöóùöúùöûùöóùöê.ùöéùöùùöë | ùöÜùöíùöùùöë‚òïÔ∏è ùöÉùöòùöîùöéùöó ùöÇùöéùöïùöïùöéùöõ,Positive
   assessments,CLL,Negative
 JOHN DRAGOPd,John Drago,Positive
 hay una polilla,John Drago,Positive
 News Role,7thSpace Interactive,Positive
 Press Alert Role,Press Office (J. Hofer),Positive
 La conversaci√≥n con las chicas jajajajaj,mili,Positive
 las amo,mili,Positive
   Great   post,Patient Empowerment Network,Positive
 Targeted Axl Inhibition Primes   BCells,Francesco Turturro,Negative
 Researchers Highlight,CancerWallonia,Negative
 cancer research,CAPO,Positive
 cancer research,Michael Fisch MD MPH,Positive
 ‚Äú Advance,CAPO,Positive
 ‚Äú Advance,Michael Fisch MD MPH,Positive
 Dia,Ana Catarina Bento,Negative
 quinta,Ana Catarina Bento,Negative
 Cell Penetrating Peptides,NK papers,Negative
 Arrouss Decaudin D Ch,NK papers,Negative
 VHIR,Vall d'Hebron Institut de Recerca,Positive
 Aggressiveness,Tom,Negative
 Aggressiveness,Scott Werntz,Positive
 Aggressiveness,"Johanna Craig, PhD.",Positive
 Aggressiveness,"Tom Iarocci, MD",Negative
 Aggressiveness,Shrikant Mantri,Positive
 Aggressiveness,The Peak Oil Poet,Negative
 Aggressiveness,Science Codex,Negative
 Aggressiveness,Cancer Daily,Negative
     Report,1stOncology,Negative
 License,1stOncology,Negative
 Commercialize,1stOncology,Negative
 Eagle,1stOncology,Negative
 Rapid Infusion Product,1stOncology,Negative
 Neighborhood,Los Lobos,Negative
 ibrutinib Treatment,Diaceutics PLC,Negative
 ibrutinib Treatment,Michelet St. Preuve,Positive
 ibrutinib Treatment,IntoxicatedTrader,Negative
 ibrutinib Treatment,Scott Werntz,Negative
 Cancer Genetics Unique,Scott Werntz,Positive
 Cancer Genetics Unique,MedFirst - MedComms,Positive
 Generation Sequencing Panel,Scott Werntz,Positive
 Generation Sequencing Panel,MedFirst - MedComms,Positive
 New therapeutics,Michael A. Cantrell,Positive
 Cancer Advance,Michael A. Cantrell,Positive
 Cancer Advance,ASCO,Negative
 Cancer Advance,MAISA,Negative
 Heavily Treated Chronic Lymphocytic Leukemia Patients,Scott Werntz,Positive
 Allogene,Scott Werntz,Negative
 Chronic    MarketWatch,MedFirst - MedComms,Positive
 POG,POG Research,Positive
 IMBRUVICAR ibrutinib Treatment,Scott Werntz,Negative
 Allog,Scott Werntz,Negative
 CGIX Chronic Lymphocytic Leukemia,Value Trader,Positive
 Leading Biotechnology Company,Value Trader,Positive
 CGIXs FocusCLL NGSpanel,Cancer Genetics Inc.,Positive
 IMBRUVICA√Ç ibrutinib Treatment,Scott Werntz,Negative
 Allogenei,Scott Werntz,Negative
 Allogen,Scott Werntz,Negative
 Feliz d√≠a Hoy previo al Miercoles de ceniza,Centro Luso Larense,Negative
 compartir y disfrutar,Centro Luso Larense,Negative
 Ayer,Centro Luso Larense,Negative
 velada,Centro Luso Larense,Negative
 Selected,Scott Werntz,Negative
 Cancer Genetics Unique Generation Sequencing Panel,Rachel Smith,Positive
 Cancer Genetics Unique Generation Sequencing Panel,Stocks News&Markets,Positive
 Cancer Genetics Unique Generation Sequencing Panel,Fundamentaltechs,Positive
 Hematopoietic Cell Transplantation,COPD News,Negative
     releases,Lymphoma Hub,Negative
 Agg NonHodgkin Lymphoma,Biotech2050,Negative
 Cello Group plcs PT,MarketBeat,Negative
 Cancer Research Prediagnostic immunoglobulin E levels,Dr Steve,Positive
 Prediagnostic immunoglobulin E levels,TumorImmunoPapers,Negative
 Prediagnostic immunoglobulin E levels,Libro Azul,Positive
 Novel Btk Inhibitor Heads,Oncology Tube,Negative
 III Trials,Oncology Tube,Negative
 Alemtuzumab Rituximab,yeast_papers,Positive
 PGG Beta Glucan,yeast_papers,Positive
 Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia BCells,Cure Cancer Now,Positive
 Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia BCells,tampapers,Positive
 Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia BCells,Scott Werntz,Negative
 Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia BCells,Just Cancer News,Negative
 Syn,Cure Cancer Now,Negative
 SynergisticAdditive,tampapers,Positive
 Chronic Lymphocytic Leukemia Treatment Balancing Efficacy Safety,EMJ Oncology,Positive
 ZIOP,Aaron Charles,Positive
 Good turnout,CLL,Negative
   managerscoaches,CLL,Negative
 Zane,CLL,Negative
   Trials Vaccine Therapy,Cancer News,Negative
 Guess,CLL,Negative
   manager,CLL,Negative
 coach meeting,CLL,Negative
 Spring Run Elementary,CLL,Negative
 studio,City Living London,Positive
 SynergisticAdditive Effects,Scott Werntz,Negative
 SynergisticAdditive Eff,Just Cancer News,Negative
   Opening Night,CLL,Negative
 Idelalisib FirstinClass PIK Delta Inhibitor,Scott Werntz,Negative
 Idelalisib FirstinClass PIK Delta Inhibitor,Just Cancer News,Negative
 Chronic Lymphocytic Leukemia Small Lymphocytic Leukemia,Scott Werntz,Negative
 Follicul,Scott Werntz,Negative
 Broker,Brand Communications,Positive
 disclosure,Brand Communications,Positive
 newsletter,Webdadi,Positive
     results,CancerWallonia,Negative
 Carl Miessen,CancerWallonia,Negative
 Chronic Lymphocytic Leukemia Small Lymphocyt,Just Cancer News,Negative
 Derek Trucks,Los Lobos,Negative
 w Cesar,Los Lobos,Negative
 Dave,Los Lobos,Negative
 rockin version,Los Lobos,Negative
 Wonderin,Los Lobos,Negative
 supplements,Patient Power,Positive
 doc,Patient Power,Positive
   Spring Chesterfield Little League season,CLL,Negative
 News Aberrant EpsteinBarr virus antibody patterns,7thSpace Interactive,Positive
 les,ùòÆùò¶ùò≠·∂ú,Positive
 Press Alert Aberrant EpsteinBarr virus antibody patterns,Press Office (J. Hofer),Positive
 Aberrant EpsteinBarr virus antibody patterns,News Reactions,Positive
 Aberrant EpsteinBarr virus antibody patterns,Breaking News,Negative
 Aberrant EpsteinBarr virus antibody patterns,Media Tower,Positive
 Aberrant EpsteinBarr virus antibody patterns,News Stories,Positive
 Aberrant EpsteinBarr virus antibody patterns,Pharma & Health,Positive
 Aberrant EpsteinBarr virus antibody patterns,Pharma News,Negative
 Aberrant EpsteinBarr virus antibody patterns,Scott Werntz,Negative
   CLLL HMRC,Ian Morgan-Smith,Positive
 VAT investgation,Ian Morgan-Smith,Positive
 variability,"Johanna Craig, PhD.",Positive
   Genmab transfers,antonio ramon mu√±oz,Positive
 Quien Al ‚ò∫ PD ‚ô• Aburrida En Mi Casa,maria bentancourt,Positive
 Bioscience Factoids Aggressiveness,Dr Alex Concorde,Negative
   Prof John Gribben amp Prof Peter Hillmen,EMJ Reviews,Positive
 Quien Al ‚ò∫,maria bentancourt,Positive
 PD ‚ô•,maria bentancourt,Positive
 Aburrida,maria bentancourt,Positive
 Novel largescale study,Cleveland Clinic MD,Negative
 CNIO scientists,Scott Werntz,Negative
 aggressiveness,Scott Werntz,Negative
 aggressiveness,Leukaemia&Katherine,Positive
 Vacancy,Siharam Media Network,Positive
 SaudigtMarket Cleaners,Siharam Media Network,Positive
 OTgtForklift Operator,Siharam Media Network,Positive
 OTgtHVDriver SLDL,Siharam Media Network,Positive
 Ian Flinn MD PhD,OncLive.com,Negative
 Te necesitamos compa√±ero polit√©cnico te necesitamos,ComiteDe Lucha Lenin,Positive
 Public Release Feb CNIO scientists,Leukaemia&Katherine,Positive
 Mm,Jayden ,Positive
 CNIOScientis Link Aggresivenes,„Éê„Ç§„Ç™„Éû„Éº„Ç±„ÉÉ„Éàjp,Positive
 Degree,„Éê„Ç§„Ç™„Éû„Éº„Ç±„ÉÉ„Éàjp,Positive
 Genetic Variability,„Éê„Ç§„Ç™„Éû„Éº„Ç±„ÉÉ„Éàjp,Positive
 Chronic Lymphocytic Leukemia Pts,The ASCO Post,Negative
 Pubmed DNA methylation,epigenetics_papers,Negative
   DNA methylation,Peng,Positive
 XENCOR   Reports,Scott Werntz,Negative
 Chronic Lymphocytic Leukemia Study Results,Scott Werntz,Negative
 Xencor phase,Scott Werntz,Negative
 Fcengineered CD,Scott Werntz,Negative
 XmAb,Scott Werntz,Negative
   time cancer survivor,Patient Power,Negative
   time cancer survivor,PatientPower Hodgkin,Negative
 TCL targeting miR,microRNApapers,Negative
 tumor protein p,microRNApapers,Negative
 Louie Perez,Los Lobos,Negative
 AntiCD mAb,TumorImmunoPapers,Negative
   lecture,Dr Meg Boulton,Positive
 panel discussion Dr Richard Furman,WCM Lymphoma,Negative
 Research study,YA Cancer Connection,Positive
 Sutton,CancerWallonia,Negative
 Rosenquist,CancerWallonia,Negative
 Initial Presentation,Francois Maignen,Positive
 Initial Presentation,JAMA,Negative
 Chronic Lymphocytic Leukemia Diagnosis facts,MRCP NOTES,Positive
 MHR papers,Matt Hastings,Positive
 lymphocyte debris,JAMA,Negative
 Saudade, Yvianna   Ô£ø,Positive
 STAT inhibitor WP,ImmunologyPapers,Negative
 Antiapoptosis function,Mastopedia,Positive
 TNFalpha,Mastopedia,Positive
 radiation,summodiscrimine,Negative
 postChernobyl cleanup work,summodiscrimine,Negative
 amp Mantle Cell Lymphoma Treatment,Jimmy Herard,Positive
 Cancer Research Complementary,Dr Steve,Positive
 Myron Czuczman MD,Roswell Park,Positive
 Myron Czuczman MD,Jason Broderick,Negative
 firstline CLL treatment,Roswell Park,Positive
 firstline CLL treatment,Jason Broderick,Negative
 Poor outcomes,Lymphoma Hub,Negative
 Pubmed Higher gene expression variability,epigenetics_papers,Negative
 family friends,Patient Power,Positive
 coworkers,Patient Power,Positive
 Chronic Lymphocytic Leukemia Current Status,Edurne Gamarra,Positive
 Chronic Lymphocytic Leukemia Current Status,TumorImmunoPapers,Negative
 leczenia przewlek≈Çej ≈Çaczki limfocytowej ≈Çoniaka z kom√≥rek p≈Çaszcza,Medoinfo,Negative
    obiecujƒÖcy lek w leczeniu przewlek≈Çej ≈Çaczki limfatycznej,Medoinfo,Negative
 Medoinfo,Medoinfo,Negative
 Expert advice,Patient Power,Positive
 HALORHHBY,Biotech2050,Negative
   Chronic Lymphocytic Leukemia CLL Pulse Survey,Medisafe UK Ltd.,Positive
 ARTICLETP Mutation Analysis,Wiley Genetics,Positive
 Clinical Practice Lessons,Wiley Genetics,Positive
 paper gene expression variability,AlfonsoValencia,Negative
 predictor    progression,AlfonsoValencia,Negative
 Surrey Fusion Festival Lobos,Los Lobos,Negative
 Newer Therapies,MD Anderson Leukemia,Negative
 FirstLine Treatment Selection,MD Anderson Leukemia,Negative
 FirstLine Treatment Selection,LINE AGENT,Positive
 FirstLine Treatment Selection,OncLive.com,Negative
 MD Anderson   studies,MD Anderson Leukemia,Negative
 tcohjWTtPmlA,MD Anderson Leukemia,Negative
 FY trading statement,Share Prophets,Negative
 Observations,MD Anderson Cancer Center,Negative
 MD Anderson waiting room,MD Anderson Cancer Center,Negative
 Godfather,"chadi nabhan MD, MBA, FACP",Negative
 research advance,Acupath Laboratories,Positive
 Gains,Acupath Laboratories,Positive
 Gains,Gilead Sciences,Negative
 Implants,Milly Evans,Negative
 Implants,dentapress.com,Positive
 TGTX Great company,Solar Melt,Positive
 RIP David,michael rush,Positive
 Êàë‰∏çËØ¥‰Ω†‰∏çÈóÆËøôÂ∞±ÊòØË∑ùÁ¶ª,NK~,Positive
 Dr Preetesh Jain,"Naveen Pemmaraju, MD",Negative
   names,"Merry-Jennifer Markham, MD, FACP, FASCO",Positive
   names,Markian Hawryluk,Positive
   Advance,"Merry-Jennifer Markham, MD, FACP, FASCO",Positive
   Advance,Man VS Cancer,Positive
 amp diagnose ZAP,ProPath,Positive
 Amo mi promo,Florencia,Negative
 son lo mejor que,Florencia,Negative
   LEUKEMIA,BlackBunie,Positive
 cancer advancements,Michael A. Cantrell,Positive
 cancer advance,Jonathan Friedberg,Positive
 Cancer advance,Steve Carpowich,Positive
 gains,Steve Carpowich,Positive
 Tredimensionella effekter med mobil,Maria S√∂derbacka,Positive
 Mobile Technology,Maria S√∂derbacka,Positive
 Sensory Learner,Maria S√∂derbacka,Positive
 Year treatment,ASCO,Negative
   Names ‚Äò Advance,Francesco Turturro,Negative
 Year ‚Äô Transformation,Francesco Turturro,Negative
 tcoUDnVFlxJv,Francesco Turturro,Negative
 Dutch Hematology Congress,Goda Choi,Positive
 concise video review,Marco,Positive
   target,Marco,Positive
 researcher John Byrd,Anita Shaffer,Positive
 ASCO salute,Anita Shaffer,Positive
 La Bamba,Los Lobos,Negative
 MTV Awards Crowd,Los Lobos,Negative
 cancer Advance,Gilead Sciences,Negative
 ‚Äò Cancer Advance,Oncology Times,Negative
 Year‚Äôin,Oncology Times,Negative
 Year Transformation,Man VS Cancer,Positive
 CLL breakthroughs,Jason Broderick,Negative
 ASCOs Cancer Advance,Jason Broderick,Negative
 Year Heres expert discussion,Jason Broderick,Negative
 Si te hace re√≠r,‚àû,Positive
 y el tiempo,‚àû,Positive
 busques,‚àû,Positive
 persona correcta,‚àû,Positive
 Pipeline Insights,Business Wire-Health,Positive
 Pipeline Insights,Scott Werntz,Positive
 cytometric analysis,NK papers,Negative
 lymphoid enhancerbinding factor,NK papers,Negative
 Discontinuing Ibrutinib,Hematopoiesis News,Negative
 Fundraiser,Transplant Views,Positive
 Garden City Cafe,Transplant Views,Positive
 Bill Riddle family,Transplant Views,Positive
   Live QampA,Patient Power,Positive
   Live QampA,PatientPower Hodgkin,Negative
 Dr James Berenson,Patient Power,Positive
 Dr James Berenson,PatientPower Hodgkin,Negative
 RT   lymphocytic,Nore,Positive
 RT   lymphocytic,Caracas en la lucha,Positive
 championship,Raphael DeLaGhetto,Positive
 seanyb,Raphael DeLaGhetto,Positive
 FDA Approves Gazyva,CancerConnect,Negative
 DonateloPen,ŸÖŸÜÿ™ÿØŸäÿßÿ™ ŸäŸÑÿß ŸáŸàÿ≥ÿ™ ,Positive
           CLL,Ana Catarina Bento,Negative
 City Living London,City Living London,Positive
 London Rental Standard,City Living London,Positive
 Incidence outcomes,"Andreas-Claudius Hoffmann, M.D.",Positive
   gtgt,Roger Selverstone,Positive
   recording,Roger Selverstone,Positive
   recording,Los Lobos,Negative
 Kiko,Roger Selverstone,Positive
 Kiko,Los Lobos,Negative
 Lavender Moon,Roger Selverstone,Positive
 Lavender Moon,Los Lobos,Negative
 DrugFree Macromolecular Therapeutics Induce Apoptosis,Jon D. Moulton,Positive
 Patient Chronic Lymphocytic Leukemia Cells,Jon D. Moulton,Positive
    patient,thesecondopinion,Positive
   Dr Barbara Eichhorst,EMJ Hematology,Negative
 ASH   ABT,EMJ Hematology,Negative
 monotherapy amp combination trials,EMJ Hematology,Negative
 RT GrindertraderUK,Free Cello Tuner,Positive
 anticipation,Ian Morgan-Smith,Positive
 Nederlands,No√©mie Jadoulle,Positive
 Eerste cursus,No√©mie Jadoulle,Positive
 de CLL,No√©mie Jadoulle,Positive
 Gran finde con √©l,‚àû,Positive
   REVIEW,Hematopoiesis News,Negative
 Novel largescale,Cleveland Clinic MD,Negative
 VIDEO Introduction Upfront Treatment,Oncology News Update,Negative
 REVIEW,Cord Blood News,Negative
 √≠a CHRONIC LYMPHOCYTIC LEUKEMIA,Medibooks,Positive
 ELDERLY CLINICOBIOLOGICAL FEATURES OUTCOMES,Medibooks,Negative
 PROPOSAL,Medibooks,Negative
 NCCN National Comprehensive Cancer Network,"Pharmacyclics, an AbbVie Company",Negative
 suggested treatment regimen,"Pharmacyclics, an AbbVie Company",Negative
 IMBRUVICAR Data,Warren Research,Positive
 Previously Untreated,Warren Research,Positive
 Previously Untreated,"Tom Iarocci, MD",Negative
 Previously Untreated,Diaceutics PLC,Negative
 Previously Untreated,Scott Werntz,Positive
 Previously Untreated,"Pharmacyclics, an AbbVie Company",Negative
 RelapsedRefractory HighRisk Chronic Lymphocytic Leukemia Patients,Warren Research,Positive
 RelapsedRefractory HighRisk Chronic Lymphocytic Leukemia Patients,Scott Werntz,Negative
 Balancing Efficacy,EMJ Oncology,Negative
 New development,Lymphoma Coalition,Negative
 Pubmed Molecular basis,epigenetics_papers,Negative
 √≠a MDM PROMOTOR POLYMORPHISM DISEASE CHARACTERISTICS,Medibooks,Negative
 CHRONIC LYMPHOCYTIC LEUKEMIA RESULTS,Medibooks,Negative
 cricket,Nick Barker,Positive
 middle,Nick Barker,Positive
 PROGNOSTIC IMPACT,Medibooks,Negative
 MINIMAL RESIDUAL DISEASE,Medibooks,Negative
 TCL TCell Dysfunction,Curatio Technologies,Positive
 TCL TCell Dysfunction,Dr. Mahesh Jain,Positive
 Healthcare Marketing,Curatio Technologies,Negative
   Clinical study,Patient Power,Positive
 band,Los Lobos,Negative
 jam   CLL,Los Lobos,Negative
 RelapsedRefractory HighRisk,"Tom Iarocci, MD",Negative
 RelapsedRefractory HighRisk,Diaceutics PLC,Negative
 RelapsedRefractory HighRisk,"Pharmacyclics, an AbbVie Company",Negative
 dat bird,CaturEkoPutro,Positive
 IMBRUVICA Data,Scott Werntz,Negative
 homie,OüëÖüçâüç≠,Positive
 Bestfriend,OüëÖüçâüç≠,Positive
 Yo sinceramente,‚àû,Positive
 Coulter Award,ASH,Negative
 Lifetime Achievement recipient,ASH,Negative
 Kanti Rai MD,ASH,Negative
 STIMULATION,Medibooks,Negative
 SURFACE IGM,Medibooks,Negative
 UNFOLDED PROTEIN RESPONSE,Medibooks,Negative
 fixtures,Werneth Cricket,Positive
   fixture,Werneth Cricket,Positive
 seconds host Rochdale cc,Werneth Cricket,Positive
 opening day,Werneth Cricket,Positive
 ampOno,"John P. Leonard, MD",Positive
 BTKicombo PIKiBTKi,"John P. Leonard, MD",Positive
 gen BTKis,"John P. Leonard, MD",Positive
 rx,"John P. Leonard, MD",Positive
 Zusatznutzen von,IQWiG,Positive
 weder f√ºr,IQWiG,Positive
 noch f√ºr,IQWiG,Positive
 follikul√§res Lymphom belegt,IQWiG,Positive
 PTK EXPRESSION,Medibooks,Negative
 IMMUNOCHEMOTHERAPY,Medibooks,Negative
 OUTCOME,Medibooks,Negative
 √≠a MUTATIONS,Medibooks,Negative
